{"original_question": "Is glycyl-tRNA synthetase gene involved in the development of Charcot-Marie-Tooth disease?", "id": "converted_159", "sentence1": "Is glycyl-tRNA synthetase gene involved in the development of Charcot-Marie-Tooth Disease?", "sentence2": "Charcot-Marie-Tooth Disease, Type 2D (CMT2D) is an autosomal-dominant axonal peripheral Neuropathy characterized by impaired motor and sensory function in the distal extremities. Gene Mutation in the glycyl-tRNA synthetase (GARS) gene cause CMT2D, Dominant mutations in GARS cause rare forms of Charcot-Marie-Tooth Disease and distal spinal muscular atrophy, Using exome sequencing she was found to harbor fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether heterozygous mutations within the glycyl-tRNA synthetase (GARS) gene, mutations of human GlyRS (hGlyRS) were also found to be associated with Charcot-Marie-Tooth Disease, Dominant mutations in GARS, encoding the essential Enzyme [APC] glycyl-tRNA synthetase (GlyRS), result in a form of Charcot-Marie-Tooth Disease, type 2D (CMT2D), predominantly characterized by lower motor nerve degeneration, A novel Mutation Abnormality in glycyl-tRNA synthetase caused Charcot-Marie-Tooth Disease, Type 2D with facial and respiratory muscle involvement, Here we describe a 45-year-old woman with a long course of motor-dominant Neuropathy. Distal weakness appeared in childhood and became worse with age. After a diagnosis of CMT brand of Choline Magnesium Trisalicylate brand of Choline Magnesium Trisalicylate type 2, the symptoms progressed, and in her fourth decade, facial and Respiratory insufficiency due to muscle weakness appeared, ultimately requiring non-invasive mechanical ventilation. There was no family history of CMT brand of Choline Magnesium Trisalicylate brand of Choline Magnesium Trisalicylate. Comprehensive analysis of known CMT brand of Choline Magnesium Trisalicylate brand of Choline Magnesium Trisalicylate-related Genes revealed a novel heterozygous c.815T>A, p.L218Q Mutation Abnormality in glycyl-tRNA synthetase (GARS), a causative gene for both CMT brand of Choline Magnesium Trisalicylate brand of Choline Magnesium Trisalicylate type 2D (CMT2D) and distal spinal muscular atrophy type V (dSMA-V), Charcot-Marie-Tooth Disease, Type 2D (CMT2D) is a dominantly inherited peripheral Neuropathy caused by missense mutations in the glycyl-tRNA synthetase gene (GARS)., Long-range structural effects of a Charcot-Marie-Tooth Disease-causing Mutation Abnormality in human glycyl-tRNA synthetase., Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth Disease, Type 2D and distal spinal muscular atrophy type V., [A novel Mutation Abnormality in glycyl-tRNA synthetase caused Charcot-Marie-Tooth Disease, Type 2D with facial and respiratory muscle involvement]., Glycyl-tRNA synthetase (GARS), which encodes the Enzyme [APC] responsible for charging tRNA(Gly) with Glycine (Plant) in both the Cytoplasm and Mitochondria, is implicated to Charcot-Marie-Tooth Disease 2D (CMT2D) and distal hereditary motor Neuropathy type V (dHMN-V)., These additional functions may explain why dominant mutations in glycyl-tRNA synthetase (GlyRS) and tyrosyl-tRNA synthetase cause Charcot-Marie-Tooth (CMT brand of Choline Magnesium Trisalicylate brand of Choline Magnesium Trisalicylate) disease, the most common heritable disease of the peripheral nervous system., Here, we report the identification of four disease-associated missense mutations in the Glycine-tRNA Ligase gene in families with CMT2D and dSMA-V., Gene Mutation in the glycyl-tRNA synthetase (GARS) gene cause CMT2D., Of the many inherited Charcot-Marie-Tooth peripheral neuropathies, type 2D (CMT2D) is caused by dominant Point Mutation in the gene GARS, encoding Glycine-tRNA Ligase (GlyRS)., Charcot-Marie-Tooth Disease, Type 2D (CMT2D) is a dominantly inherited peripheral Neuropathy caused by missense mutations in the glycyl-tRNA synthetase gene (GARS), Charcot-Marie-Tooth Disease, Type 2D is a hereditary axonal and glycyl-tRNA synthetase (GARS)-associated Neuropathy that is caused by a Mutation Abnormality in GARS, Long-range structural effects of a Charcot-Marie-Tooth Disease-causing Mutation Abnormality in human glycyl-tRNA synthetase, These additional functions may explain why dominant mutations in glycyl-tRNA synthetase (GlyRS) and tyrosyl-tRNA synthetase cause Charcot-Marie-Tooth (CMT brand of Choline Magnesium Trisalicylate brand of Choline Magnesium Trisalicylate) disease, the most common heritable disease of the peripheral nervous system, A novel Mutation Abnormality in glycyl-tRNA synthetase caused Charcot-Marie-Tooth Disease, Type 2D with facial and respiratory muscle involvement., Charcot-Marie-Tooth Disease, Type 2D (CMT2D) is a dominantly inherited peripheral Neuropathy caused by missense mutations in the glycyl-tRNA synthetase gene (GARS). , Gene Mutation in the glycyl-tRNA synthetase (GARS) gene cause CMT2D. , An ENU-induced Mutation Abnormality in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral Neuropathy., We previously implicated mutations in the gene encoding glycyl-tRNA synthetase (GARS) as the cause of CMT2D and dSMA-V. , An active dominant Mutation Abnormality of glycyl-tRNA synthetase causes Neuropathy in a Charcot-Marie-Tooth 2D mouse model., Charcot-Marie-Tooth Disease, Type 2D is a hereditary axonal and glycyl-tRNA synthetase (GARS)-associated Neuropathy that is caused by a Mutation Abnormality in GARS. , Dominant mutations in GARS, encoding the essential Enzyme [APC] glycyl-tRNA synthetase (GlyRS), result in a form of Charcot-Marie-Tooth Disease, type 2D (CMT2D), predominantly characterized by lower motor nerve degeneration. , Charcot-Marie-Tooth Disease, Type 2D (CMT2D) is a dominantly inherited peripheral Neuropathy caused by missense mutations in the glycyl-tRNA synthetase gene (GARS). In addition to GARS, mutations in three other tRNA synthetase Genes cause similar neuropathies, although the underlying mechanisms are not fully understood., These additional functions may explain why dominant mutations in glycyl-tRNA synthetase (GlyRS) and tyrosyl-tRNA synthetase cause Charcot-Marie-Tooth (CMT brand of Choline Magnesium Trisalicylate brand of Choline Magnesium Trisalicylate) disease,, Charcot-Marie-Tooth Disease, Type 2D (CMT2D) is an autosomal-dominant axonal peripheral Neuropathy characterized by impaired motor and sensory function in the distal extremities. Gene Mutation in the glycyl-tRNA synthetase (GARS) gene cause CMT2D., Of the many inherited Charcot-Marie-Tooth peripheral neuropathies, type 2D (CMT2D) is caused by dominant Point Mutation in the gene GARS, encoding Glycine-tRNA Ligase (GlyRS)., Charcot-Marie-Tooth Disease, Type 2D (CMT2D) is a dominantly inherited peripheral Neuropathy caused by missense mutations in the glycyl-tRNA synthetase gene (GARS)., Long-range structural effects of a Charcot-Marie-Tooth Disease-causing Mutation Abnormality in human glycyl-tRNA synthetase., Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth Disease, Type 2D and distal spinal muscular atrophy type V., These additional functions may explain why dominant mutations in glycyl-tRNA synthetase (GlyRS) and tyrosyl-tRNA synthetase cause Charcot-Marie-Tooth (CMT brand of Choline Magnesium Trisalicylate brand of Choline Magnesium Trisalicylate) disease, the most common heritable disease of the peripheral nervous system., A novel Mutation Abnormality in glycyl-tRNA synthetase caused Charcot-Marie-Tooth Disease, Type 2D with facial and respiratory muscle involvement., An active dominant Mutation Abnormality of glycyl-tRNA synthetase causes Neuropathy in a Charcot-Marie-Tooth 2D mouse model., Glycyl-tRNA synthetase (GARS), which encodes the Enzyme [APC] responsible for charging tRNA(Gly) with Glycine (Plant) in both the Cytoplasm and Mitochondria, is implicated to Charcot-Marie-Tooth Disease 2D (CMT2D) and distal hereditary motor Neuropathy type V (dHMN-V).[SEP]Relations: Charcot-Marie-Tooth Disease has relations: disease_protein with GDAP1, disease_protein with GDAP1, disease_protein with GDAP1, disease_protein with GDAP1, disease_protein with LMNA, disease_protein with LMNA, disease_protein with LMNA, disease_protein with LMNA, disease_protein with PNPLA6, disease_protein with PNPLA6. Definitions: Glycine-tRNA Ligase defined as following: An Enzyme [APC] that activates Glycine (Plant) with its specific transfer RNA. EC 6.1.1.14.. Mitochondria defined as following: Semiautonomous, self-reproducing organelles that occur in the Cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon Genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed). Charcot-Marie-Tooth Disease, Type 2D defined as following: Charcot-Marie-Tooth Disease inherited in an autosomal dominant pattern. It is caused by mutations in the GARS gene. It results in axonal peripheral Neuropathy.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Neuropathy defined as following: A disorder affecting the cranial nerves or the peripheral nervous system. It manifests with pain, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.. Charcot-Marie-Tooth Disease defined as following: A hereditary motor and sensory Neuropathy transmitted most often as an autosomal dominant trait and characterized by progressive distal wasting and loss of reflexes in the muscles of the legs (and occasionally involving the arms). Onset is usually in the second to fourth decade of life. This condition has been divided into two subtypes, hereditary motor and sensory Neuropathy (HMSN) types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. (Adams et al., Principles of Neurology, 6th ed, p1343). distal hereditary motor Neuropathy type V defined as following: A rare autosomal dominant distal hereditary motor Neuropathy disease characterized by muscle weakness and wasting predominantly affecting the hands, in particular the thenar and first dorsal interosseus muscles, and/or marked foot deformity and gait disturbance. Sensation is normal, although reduced response to vibration has been described. The disease is slowly progressive with an age of onset within the first few decades of life.. Cytoplasm defined as following: The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990). CMT brand of Choline Magnesium Trisalicylate defined as following: brand name of choline magnesium trisalicylate. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Point Mutation defined as following: A Mutation Abnormality caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Gene Mutation may be associated with genetic diversity or with pathologies including cancer.. glycyl-tRNA synthetase gene defined as following: Human GARS1 wild-type allele is located in the vicinity of 7p14.3 and is approximately 39 kb in length. This allele, which encodes Glycine (Plant)-tRNA ligase protein, is involved in the synthesis of glycyl-tRNA. Mutation of the gene is associated with type 2D Charcot-Marie-Tooth Disease and distal hereditary motor Neuropathy, type Va..", "label": "yes"} {"original_question": "Does triiodothyronine play a regulatory role in insulin secretion from pancreas?", "id": "converted_1619", "sentence1": "Does triiodothyronine play a regulatory role in Therapeutic Insulin secretion from pancreas?", "sentence2": "Our findings establish that H3P31 gene is an important regulator of Glucose measurement homeostasis and pancreatic β-cell function and provide evidence for the first time of a physiological role for a mitochondrial endocrine receptor., The H3P31 gene(-/-) CASP14 gene had a major defect in Therapeutic Insulin secretion both in vivo and in isolated pancreatic islets and a loss of Glucose measurement-stimulated Therapeutic Insulin secretion., We demonstrated that treatment of primary cultures of Rattus norvegicus pancreatic islets with T3 thoracic segmental innervation thoracic segmental innervation results in augmented β-cell vitality with an increase of their functional properties., Nonetheless, the Therapeutic Insulin secretion is sensibly augmented after T3 thoracic segmental innervation thoracic segmental innervation stimulation., Plasma Glucose measurement concentration of the Prenatal care hypothyroid group during intravenous Glucose measurement tolerance test was significantly higher (p=0.003) at 5-20 min as compared to the control group, whereas plasma Therapeutic Insulin concentration was significantly lower (p=0.012) at 5-20 min, Although adult offspring born from hypothyroid mothers were euthyroid, their Glucose measurement tolerance and Glucose measurement stimulated Therapeutic Insulin secretion of islets were altered, hyroid Hormones modulate the immune system and metabolism, influence Therapeutic Insulin secretion, Only T(3) concentrations higher than 250 microM were able to decrease cell viability and proliferation rate, to increase the rate of apoptosis and to reduce Glucose measurement-induced Therapeutic Insulin secretion., Islets preincubated with Glucose measurement (3.3 mmol/l) and glucagon (rDNA) (rDNA) (1.4 mumol/l) plus theophylline (10 mmol/l), corticotropin, human (0.11 nmol/l), bovine GH (0.46 mumol/l), prolactin (0.2 mumol/l) or tri-iodothyronine (1.0 nmol/l) have significantly lower Ca(2+)-ATPase activity than those preincubated with only 3.3 mmol Glucose measurement/l. All these Hormones increased the release of Therapeutic Insulin significantly., T3 thoracic segmental innervation thoracic segmental innervation (0.2 nM) did not affect Therapeutic Insulin secretion in the absence or presence of Glucose measurement or in the presence of secretagogues (Dietary Potassium and Glyceraldehyde)., In the perfused Rattus norvegicus pancreas, the addition of levothyroxine (10 micrograms/dL) or liothyronine (150 ng/dL) to the perfusing medium did not affect Therapeutic Insulin secretion., The administration of levothyroxine (40 micrograms/kg, s.c.) in vivo increased the plasma Therapeutic Insulin level from 11 +/- 2 microUnits/mL (mean +/- SD) to 30 +/- 7 microUnits/mL, Addition of T3 thoracic segmental innervation thoracic segmental innervation to the incubation medium, significantly Changing the Therapeutic Insulin release, but its effect varied according to the Glucose measurement concentration in the medium, i.e. it enhanced the Therapeutic Insulin release at a Glucose measurement concentration between 2 to 8 mmol/l; it has no effect at 12 mmol/Glucose measurement, and significantly inhibited the secretion of Therapeutic Insulin in the presence of 16.6 mmol/l Glucose measurement., Both T3 thoracic segmental innervation thoracic segmental innervation and T4 inhibited Therapeutic Insulin secretion[SEP]Relations: Levothyroxine has relations: drug_drug with Insulin tregopil, drug_drug with Insulin tregopil, drug_drug with Insulin peglispro, drug_drug with Insulin peglispro, drug_drug with Insulin glargine, drug_drug with Insulin glargine, drug_drug with Insulin human, drug_drug with Insulin human. Liothyronine has relations: drug_drug with Insulin tregopil, drug_drug with Insulin tregopil. Definitions: Glucose measurement defined as following: The determination of the amount of Glucose measurement present in a sample.. theophylline defined as following: A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP.. Prenatal care defined as following: Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality.. glucagon (rDNA) defined as following: The recombinant form of the endogenous polypeptide hormone Glucagon consisting of 29 amino acids responsible for the release of stored Glucose measurement, causing increased blood Glucose measurement levels. Clinical Use: Diagnostic Aid for Imaging Studies and Hypoglycemia.. corticotropin, human defined as following: Corticotropin (39 aa, ~5 kDa) is encoded by the human POMC gene. This protein plays a role in the stimulation of cortisol secretion by the adrenal gland.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. Therapeutic Insulin defined as following: A synthetic or animal-derived form of Therapeutic Insulin used in the treatment of diabetes mellitus. Therapeutic Therapeutic Insulin is formulated to be short-, intermediate- and long-acting in order to individualize an Therapeutic Insulin regimen according to individual differences in Glucose measurement and Therapeutic Insulin metabolism. Therapeutic Therapeutic Insulin may be derived from porcine, bovine or recombinant sources. Endogenous human Therapeutic Insulin, a pancreatic hormone composed of two polypeptide chains, is important for the normal metabolism of carbohydrates, proteins and fats and has anabolic effects on many types of tissues.. Hormones defined as following: Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.. prolactin defined as following: A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate.. Glyceraldehyde defined as following: An aldotriose containing the propionaldehyde structure with hydroxy groups at the 2- and 3-positions. It is involved in the formation of ADVANCED GLYCOSYLATION END PRODUCTS.. liothyronine defined as following: A T3 thoracic segmental innervation thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than levothyroxine (T4). Most T3 thoracic segmental innervation is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3 thoracic segmental innervation.. Changing defined as following: The act of alteration or modification; changed or altered in form or character.. levothyroxine defined as following: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.. Dietary Potassium defined as following: Potassium or Dietary Potassium compounds used in foods or as foods.. triiodothyronine defined as following: A T3 thoracic segmental innervation thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than levothyroxine (T4). Most T3 thoracic segmental innervation is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3 thoracic segmental innervation..", "label": "yes"} {"original_question": "Is propranolol used for treatment of infantile hemangioma?", "id": "converted_2315", "sentence1": "Is propranolol used for treatment of Infantile Hemangioma?", "sentence2": "Low-Dose Treatment propranolol for Infantile Hemangioma of the head and neck: Analysis of 23 consecutive patients., BACKGROUND: More and more infantile hemangiomas (HEMIHYPERPLASIA, ISOLATED) are being treated with propranolol, but the effectiveness, dosage, and treatment course are still in dispute., CONCLUSIONS: Low-Dose Treatment propranolol appears to be effective and safe for HEMIHYPERPLASIA, ISOLATED, especially for those patients previously treated with Adrenal Cortex Hormones and who had no response or severe side-effects., Cardiovascular Profile of Propranolol after Multiple Dosing in Infantile Hemangioma., Propranolol is becoming the treatment of choice for complicated Infantile Hemangioma., In conclusion, propranolol 2 mg/kg of body weight daily causes a statistically though not clinically relevant decrease in blood pressure and heart rate in cardially healthy infants affected by Infantile Hemangioma. , Importance: Propranolol hydrochloride has become the primary medical treatment for problematic Infantile Hemangioma; however, the expression of propranolol's target receptors during growth, involution, and treatment of Hemangioma remains unclear., BACKGROUND: Strawberry nevus of skin (Congenital ichthyosis with hypotrichosis syndrome) are the most common benign vascular tumors of childhood. Propranolol is an effective Pharmacologic Substance in treating HEMIHYPERPLASIA, ISOLATED. , Ultrasonography as an objective tool for assessment of Infantile Hemangioma treatment with propranolol., CONCLUSION: Ultrasonographic measurements contribute to demonstrate tumor regression and HEMIHYPERPLASIA, ISOLATED response to propranolol., Propranolol treatment was recently reported to be successful for the management of severe Infantile Hemangioma., We conclude that the initial use of propranolol as the sole treatment for infantile airway Hemangioma is promising., Propranolol has been proposed for the treatment of infantile hemangiomas., Propranolol therapy is changing the treatment paradigm for Infantile Hemangioma., Propranolol has been successfully used recently in a limited number of children with Infantile Hemangioma., Propranolol has been proposed for the treatment of infantile hemangiomas., CONCLUSIONS This is the first report of successful therapy of an Intracranial Route of Drug Administration Infantile Hemangioma with propranolol., PURPOSE The successful use of nadolol as an alternative to propranolol therapy in three cases of Infantile Hemangioma is reported., Propranolol has been used successfully in a limited number of children with infantile hemangiomas., CONCLUSIONS High-dose Propranolol is very effective in the treatment of Infantile Hemangioma with minor side effects and short disease period., Propranolol is novel and safe medication for treatment of Infantile Hemangioma., Propranolol is the only Food and Drug Administration approved therapy for treatment of patients with this vascular anomaly and should be considered first-line therapy for genital infantile hemangiomas., CONCLUSION Propranolol may be a promising therapeutic modality for Infantile Hemangioma., Propranolol, which is often used to treat cutaneous infantile hemangiomas, is not currently standard treatment for Intracranial Route of Drug Administration infantile hemangiomas., Preliminary results of propranolol treatment for patients with Infantile Hemangioma., Propranolol therapy is changing the treatment paradigm for Infantile Hemangioma., Propranolol should be considered as a first-line treatment of infantile hemangiomas.., Propranolol, a non-selective Adrenergic beta-Antagonists, has recently been introduced as a treatment for infantile hemangiomas.[SEP]Relations: Propranolol has relations: contraindication with muscular disease, contraindication with muscular disease, contraindication with bronchial disease, contraindication with bronchial disease, drug_drug with Propiomazine, drug_drug with Propiomazine, contraindication with neonatal jaundice, contraindication with neonatal jaundice, contraindication with myopathy, contraindication with myopathy. Definitions: Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Adrenal Cortex Hormones defined as following: HORMONES produced by the ADRENAL CORTEX, including both steroid and peptide hormones. The major hormones produced are HYDROCORTISONE and ALDOSTERONE.. nadolol defined as following: A non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. Nadolol is also used for MIGRAINE DISORDERS and for tremor.. Strawberry nevus of skin defined as following: A dull red, firm, dome-shaped Hemangioma, sharply demarcated from surrounding skin, usually located on the head and neck, which grows rapidly and generally undergoes regression and involution without scarring. It is caused by proliferation of immature capillary vessels in active stroma, and is usually present at birth or occurs within the first two or three months of life. (Dorland, 27th ed). HEMIHYPERPLASIA, ISOLATED defined as following: Isolated hemihyperplasia is a rare overgrowth syndrome characterized by an asymmetric regional body overgrowth, involving at least one limb, and associated with an increased risk of developing embryonal tumors, principally nephroblastoma (see this term) and hepoblastoma.. Congenital ichthyosis with hypotrichosis syndrome defined as following: Syndrome with characteristics of congenital ichthyosis and hypotrichosis. It has been described in three members of a consanguineous Arab Israeli family. The syndrome is transmitted as an autosomal recessive trait and is caused by a missense mutation in the ST14 gene, encoding the recently identified protease, matriptase on chromosome 11q24. Analysis of skin samples from the patients suggests that this enzyme plays a role in epidermal desquamation.. Infantile Hemangioma defined as following: A dull red, firm, dome-shaped Hemangioma, sharply demarcated from surrounding skin, usually located on the head and neck, which grows rapidly and generally undergoes regression and involution without scarring. It is caused by proliferation of immature capillary vessels in active stroma, and is usually present at birth or occurs within the first two or three months of life. (Dorland, 27th ed). hydrochloride defined as following: A salt that is comprised of a hydrogen and chloride ion that can be linked to a base form of a Pharmacologic Substance making it water-soluble. (NCI). Intracranial Route of Drug Administration defined as following: Administration of a Pharmacologic Substance within the skull.. Hemangioma defined as following: A vascular anomaly due to proliferation of BLOOD VESSELS that forms a tumor-like mass. The common types involve CAPILLARIES and VEINS. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. (from Stedman, 27th ed, 2000). Low-Dose Treatment defined as following: A reduced quantity of a therapeutic agent prescribed to be taken at one time or at stated intervals.. propranolol defined as following: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.. Adrenergic beta-Antagonists defined as following: Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety..", "label": "yes"} {"original_question": "Does amiodarone affect thyroid hormone receptors in the myocardium?", "id": "converted_1092", "sentence1": "Does amiodarone affect thyroid hormone receptors in the myocardium?", "sentence2": "ATF7IP wt Allele and Dron affected Tricuspid Valve Insufficiency expression in the Rheumatoid Arthritis similarly by decreasing TRalpha 1 and beta 1 expression by about 50%, In the LVW, ATF7IP wt Allele and Dron decreased THRB gene and, interestingly, ATF7IP wt Allele increased TRalpha 1., n the apex, ATF7IP wt Allele also increased TRalpha 2., Both in treated and untreated CASP14 gene, TRalpha2 mRNA had the highest density in Mus sp. heart, whereas TRbeta2 mRNA had the lowest density. Amiodarone dose-dependently downregulated the levels of TRalpha1 and beta1 mRNA in comparison to the control., amiodarone subtype selectively downregulates the Tricuspid Valve Insufficiency mRNA levels in Mus sp. myocardium in a dose-dependent manner., Western blot analysis revealed no change in the expression of the ThR protein., Amiodarone and T3 thoracic segmental innervation thoracic segmental innervation, respectively, downregulated T3R alpha 1, T3R beta 1, T3R beta 2 (p < 0.05), but did not affect the levels of T3R alpha 2. Amiodarone and T3 thoracic segmental innervation thoracic segmental innervation, added together, upregulated T3R alpha 2 and T3R beta 1 (p < 0.05) as compared to amiodarone or T3 thoracic segmental innervation thoracic segmental innervation alone.[SEP]Relations: Amiodarone has relations: drug_effect with Abnormality of the thyroid gland, drug_effect with Abnormality of the thyroid gland, drug_effect with Neoplasm of the thyroid gland, drug_effect with Neoplasm of the thyroid gland, drug_effect with Myopathy, drug_effect with Myopathy, drug_effect with Hypothyroidism, drug_effect with Hypothyroidism, drug_effect with Hyperthyroidism, drug_effect with Hyperthyroidism. Definitions: THRB gene defined as following: This gene plays a role in receptor signaling and regulation of transcription. It is involved in inner ear development and color vision.. Rheumatoid Arthritis defined as following: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.. ATF7IP wt Allele defined as following: Human ATF7IP wild-type allele is located in the vicinity of 12p13.1 and is approximately 133 kb in length. This allele, which encodes activating transcription factor 7-interacting protein 1, plays a role in the modulation of both transcription and histone methylation.. amiodarone defined as following: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.. Tricuspid Valve Insufficiency defined as following: Backflow of blood from the RIGHT VENTRICLE into the RIGHT ATRIUM due to imperfect closure of the TRICUSPID VALVE.. myocardium defined as following: The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow.. thyroid hormone receptors defined as following: Specific high affinity binding proteins for THYROID HORMONES in target cells. They are usually found in the nucleus and regulate DNA transcription. These receptors are activated by hormones that leads to transcription, cell differentiation, and growth suppression. Thyroid hormone receptors are encoded by two genes (GENES, ERBA): erbA-alpha and erbA-beta for alpha and beta thyroid hormone receptors, respectively..", "label": "yes"} {"original_question": "Is the consumption of chocolate associated with an increase in cardiovascular disease?", "id": "converted_2552", "sentence1": "Is the consumption of Theobroma cacao, CALCOCO1 gene, chocolate associated with an increase in Cardiovascular Diseases?", "sentence2": "The consumption of natural polyphenols-rich foods, and CALCOCO1 gene in particular, has been related to a reduced risk of Cerebrovascular Disorders, including coronary heart disease and Cerebrovascular accident., Theobroma cacao, CALCOCO1 gene, Theobroma cacao, CALCOCO1 gene, chocolate has been shown to decrease Cerebrovascular Disorders risk due to its Antioxidants and anti-inflammatory properties., A number of studies have shown that dietary polyphenols exert a protective effect against Hypertensive disease, Dyslipidemias, Inflammation, endothelial function and Arteriosclerosis, conditions associated with increased risk for Cardiovascular Diseases., Chocolate consumption may have a beneficial effect on Cardiovascular system health,, Data currently available indicate that daily consumption of CALCOCO1 gene-rich Theobroma cacao, CALCOCO1 gene, Theobroma cacao, CALCOCO1 gene, chocolate (rich in polyphenols) may at least partially lower Cardiovascular Diseases risk., CONCLUSIONS The blood pressure and cholesterol lowering effects of dark Theobroma cacao, CALCOCO1 gene, Theobroma cacao, CALCOCO1 gene, chocolate consumption are beneficial in the prevention of Cardiovascular system events in a population with Metabolic Syndrome X., Daily dark Theobroma cacao, CALCOCO1 gene, Theobroma cacao, CALCOCO1 gene, chocolate consumption could be an effective Cardiovascular system preventive strategy in this population., BACKGROUND The consumption of Theobroma cacao, CALCOCO1 gene, Theobroma cacao, CALCOCO1 gene, chocolate and CALCOCO1 gene has established Cardiovascular system benefits., CONCLUSIONS Chocolate consumption is associated with lower risk of MI and Coronary Arteriosclerosis., Chocolate consumption was inversely associated with MI risk., Chocolate consumption is associated with lower risk of MI and Coronary Arteriosclerosis., The consumption of CALCOCO1 gene/ Theobroma cacao, CALCOCO1 gene, Theobroma cacao, CALCOCO1 gene, chocolate (i) increases Specimen Source Codes - Plasma Antioxidants capacity, (ii) diminishes platelet function and Inflammation, and (iii) decreases diastolic and systolic arterial pressures., Chocolate consumption was inversely associated with MI risk., Chocolate consumption is inversely associated with prevalent coronary heart disease: the National Heart, Chest>Chest>Lung, and Blood Institute Family Heart Study., Daily Theobroma cacao, CALCOCO1 gene, Theobroma cacao, CALCOCO1 gene, chocolate consumption is inversely associated with insulin resistance and Finding of liver enzyme levels in the Observation of Heart Disease Risk Factors in Luxembourg study., Collectively, the Antioxidants effects of flavonoid-rich foods may reduce Cardiovascular Diseases risk., The consumption of CALCOCO1 gene and dark Theobroma cacao, CALCOCO1 gene, Theobroma cacao, CALCOCO1 gene, chocolate is associated with a lower risk of Cerebrovascular Disorders, and improvements in endothelial function may mediate this relationship, It has been shown that the consumption of CALCOCO1 gene has a positive influence on a number of Cardiovascular system surrogate parameters such as arterial vasodilatation and a moderate decrease in blood pressure in Homo sapiens. , This study has shown that increasing the polyphenols content of the diet via consumption of F&V, Berries and dark Theobroma cacao, CALCOCO1 gene, Theobroma cacao, CALCOCO1 gene, chocolate results in a significant improvement in an established marker of Cardiovascular system risk in hypertensive participants., Cocoa flavonoids exert Cardiovascular system benefits and neuroprotection. , Accumulating evidence suggests potential preventive effects of Theobroma cacao, CALCOCO1 gene, Theobroma cacao, CALCOCO1 gene, chocolate/CALCOCO1 gene on the risk of cardio vascular disease (Cerebrovascular Disorders).[SEP]Relations: Cardiovascular Diseases has relations: disease_disease with heart disease, disease_disease with heart disease, contraindication with Caffeine, contraindication with Caffeine, disease_disease with vascular disease, disease_disease with vascular disease, disease_disease with Cardiovascular system neoplasm, disease_disease with Cardiovascular system neoplasm. heart disease has relations: disease_disease with Cardiovascular Diseases, disease_disease with Cardiovascular Diseases. Definitions: Arteriosclerosis defined as following: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.. Hypertensive disease defined as following: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), Hypertensive disease is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.. Homo sapiens defined as following: Members of the species Homo sapiens.. Antioxidants defined as following: Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. Cardiovascular Diseases defined as following: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.. Cerebrovascular Disorders defined as following: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.. Metabolic Syndrome X defined as following: A combination of medical conditions that when present, increase the risk of heart attack, Cerebrovascular accident, and diabetes mellitus. It includes the following medical conditions: increased blood pressure, central obesity, dyslipidemia, impaired glucose tolerance, and insulin resistance.. Cardiovascular system defined as following: The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body.. Dyslipidemias defined as following: A lipoprotein metabolism disorder characterized by decreased levels of high-density lipoproteins, or elevated levels of Specimen Source Codes - Plasma cholesterol, low-density lipoproteins and/or triglycerides.. Coronary Arteriosclerosis defined as following: Thickening and loss of elasticity of the CORONARY ARTERIES, leading to progressive arterial insufficiency (CORONARY DISEASE).. polyphenols defined as following: A large class of organic compounds having more than one PHENOL group.. cholesterol defined as following: The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.. Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810). Heart Disease Risk Factors defined as following: Aspects of personal behavior or lifestyle, environmental exposure, inherited conditions and characteristics, which are determined to be associated with HEART DISEASES..", "label": "no"} {"original_question": "Is PUVA therapy indicated for eczema treatment?", "id": "converted_2056", "sentence1": "Is Methoxsalen With Ultraviolet A Therapy therapy indicated for Eczema treatment?", "sentence2": "With bath Methoxsalen With Ultraviolet A Therapy treatment, the best results were found in patients with hyperkeratotic Eczema (17/22; 77% good clinical response) followed by patients with palmoplantar Psoriasis (26/41; 63%) and patients with Vesicular Eczema of Hand and/or feet (8/16; 50%). , Oral vs. bath Methoxsalen With Ultraviolet A Therapy using methoxsalen for chronic palmoplantar Eczema., Both oral and bath Methoxsalen With Ultraviolet A Therapy with methoxsalen (8-MOP) have been shown to be effective in the treatment of chronic palmoplantar Eczema. , Oral Methoxsalen With Ultraviolet A Therapy is preferable for patients with hyperkeratotic Eczema and bath Methoxsalen With Ultraviolet A Therapy for patients with Vesicular Eczema of Hand and/or feet., Treatment of Hand Eczema is dominated by the administration of topical glucocorticosteriods. If topical treatment fails, the best second-line option is ultraviolet (UV) therapy alone or as combination therapy. Ultraviolet B therapy and Methoxsalen With Ultraviolet A Therapy (Psoralen [EPC] plus UVA) therapy is effective and has relatively few side effects. , Although local Methoxsalen With Ultraviolet A Therapy has been proven to be effective in the treatment of Chronic Hand Eczema, little is known about the efficacy and safety of local narrowband Ultraviolet B therapy (TL-01) for this condition., Local narrowband Ultraviolet B therapy phototherapy regimen is as effective as paint-Methoxsalen With Ultraviolet A Therapy therapy in patients with Chronic Hand Eczema of dry and dyshidrotic types., Location characteristic ID - Location characteristic ID - Smoking is likely to be a reason for the failure of bath-Methoxsalen With Ultraviolet A Therapy therapy in the treatment of chronic palmoplantar Eczema, in particular regarding smokers with Eczema of the dyshidrotic type where no complete remission was achieved., Treatment of chronic palmoplantar Eczema with local bath-Methoxsalen With Ultraviolet A Therapy therapy., Bath-Methoxsalen With Ultraviolet A Therapy therapy has been described as successful treatment for palmoplantar Eczema., Systemic Methoxsalen With Ultraviolet A Therapy therapy may be useful in the treatment of chronic palmoplantar Eczema., A new Psoralen [EPC]-containing gel for topical Methoxsalen With Ultraviolet A Therapy therapy: development, and treatment results in patients with palmoplantar and plaque-type Psoriasis, and hyperkeratotic Eczema., These results indicate that topical Methoxsalen With Ultraviolet A Therapy therapy with Psoralen [EPC] in aqueous gel is a useful therapeutic modality for treatment of Psoriasis patients, and patients with recalcitrant dermatoses such as palmoplantar Psoriasis and hyperkeratotic Eczema., In order to evaluate environmental influences possibly having an impact on the efficacy of this therapy, smokers and non-smokers suffering from palmoplantar Eczema treated with bath-Methoxsalen With Ultraviolet A Therapy therapy were compared., Does smoking influence the efficacy of bath-Methoxsalen With Ultraviolet A Therapy therapy in chronic palmoplantar Eczema?, Methoxsalen With Ultraviolet A Therapy therapy caused acute aggravation of the Eczema., Hyperkeratotic Eczema cleared significantly better with oral than with bath Methoxsalen With Ultraviolet A Therapy (P=0.03).CONCLUSION: Oral Methoxsalen With Ultraviolet A Therapy is preferable for patients with hyperkeratotic Eczema and bath Methoxsalen With Ultraviolet A Therapy for patients with Vesicular Eczema of Hand and/or feet., BACKGROUND: Systemic Methoxsalen With Ultraviolet A Therapy therapy may be useful in the treatment of chronic palmoplantar Eczema., These results indicate that topical Methoxsalen With Ultraviolet A Therapy therapy with Psoralen [EPC] in aqueous gel is a useful therapeutic modality for treatment of Psoriasis patients, and patients with recalcitrant dermatoses such as palmoplantar Psoriasis and hyperkeratotic Eczema., VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) (60.9%) was the commonest skin disorder treated with Methoxsalen With Ultraviolet A Therapy, followed by Psoriasis (20.9%), endogenous Eczema (11.3%), mycosis fungoides (3.5%), Amyloidosis, Primary Cutaneous (2.6%) and Prurigo nodularis (0.9%)., bath Methoxsalen With Ultraviolet A Therapy using methoxsalen for chronic palmoplantar Eczema., A 36-year-old female patient was treated with Methoxsalen With Ultraviolet A Therapy for Vesicular Eczema of Hand and/or feet that had not shown sufficient response to topical therapy over the previous months., BACKGROUND: Both oral and bath Methoxsalen With Ultraviolet A Therapy with methoxsalen (8-MOP) have been shown to be effective in the treatment of chronic palmoplantar Eczema., One patient with Hand Eczema consistently had detectable 8-MOP levels 1 hour after topical Methoxsalen With Ultraviolet A Therapy treatments.CONCLUSION: This report indicates that there is minimal, if any, systemic absorption of 8-MOP after topical Methoxsalen With Ultraviolet A Therapy treatment of patients with palmoplantar Psoriasis., In the narrowband Ultraviolet B therapy-treated side, the tolerance of all the patients to the treatment was good all patients well-tolerated the treatment with the exception of mild Xerosis that responded to topical emollients.Local narrowband Ultraviolet B therapy phototherapy regimen is as effective as paint-Methoxsalen With Ultraviolet A Therapy therapy in patients with Chronic Hand Eczema of dry and dyshidrotic types, Bath-Methoxsalen With Ultraviolet A Therapy therapy has been described as successful treatment for palmoplantar Eczema, Location characteristic ID - Location characteristic ID - Smoking is likely to be a reason for the failure of bath-Methoxsalen With Ultraviolet A Therapy therapy in the treatment of chronic palmoplantar Eczema, in particular regarding smokers with Eczema of the dyshidrotic type where no complete remission was achieved, Systemic Methoxsalen With Ultraviolet A Therapy therapy may be useful in the treatment of chronic palmoplantar Eczema, However, few data are available on the effectiveness of local bath-Methoxsalen With Ultraviolet A Therapy therapy in palmoplantar Eczema.Our purpose was to assess the effectiveness of local bath-Methoxsalen With Ultraviolet A Therapy therapy in 28 patients with chronic palmar or plantar Eczema or both who were resistant to conventional topical treatment.After Fungi or Bacterial Infections had been excluded in all patients, Hand or feet or both were soaked for 15 minutes in warm water containing 1 mg/L methoxsalen, No phototoxic reactions were observed.Local bath-Methoxsalen With Ultraviolet A Therapy therapy is of value in the management of chronic palmoplantar Eczema resistant to standard modes of topical treatment, Treatment of chronic palmoplantar Eczema with local bath-Methoxsalen With Ultraviolet A Therapy therapy, Bath-Methoxsalen With Ultraviolet A Therapy therapy has been described as successful treatment for palmoplantar Eczema. , Location characteristic ID - Location characteristic ID - Smoking is likely to be a reason for the failure of bath-Methoxsalen With Ultraviolet A Therapy therapy in the treatment of chronic palmoplantar Eczema, in particular regarding smokers with Eczema of the dyshidrotic type where no complete remission was achieved., OBJECTIVE: Our purpose was to assess the effectiveness of local bath-Methoxsalen With Ultraviolet A Therapy therapy in 28 patients with chronic palmar or plantar Eczema or both who were resistant to conventional topical treatment. , CONCLUSION: Local bath-Methoxsalen With Ultraviolet A Therapy therapy is of value in the management of chronic palmoplantar Eczema resistant to standard modes of topical treatment. , Topical Methoxsalen With Ultraviolet A Therapy therapy for Chronic Hand Eczema., However, few data are available on the effectiveness of local bath-Methoxsalen With Ultraviolet A Therapy therapy in palmoplantar Eczema.Our purpose was to assess the effectiveness of local bath-Methoxsalen With Ultraviolet A Therapy therapy in 28 patients with chronic palmar or plantar Eczema or both who were resistant to conventional topical treatment.After Fungi or Bacterial Infections had been excluded in all patients, Hand or feet or both were soaked for 15 minutes in warm water containing 1 mg/L methoxsalen., No phototoxic reactions were observed.Local bath-Methoxsalen With Ultraviolet A Therapy therapy is of value in the management of chronic palmoplantar Eczema resistant to standard modes of topical treatment., Location characteristic ID - Location characteristic ID - Smoking is likely to be a reason for the failure of bath-Methoxsalen With Ultraviolet A Therapy therapy in the treatment of chronic palmoplantar Eczema, in particular regarding smokers with Eczema of the dyshidrotic type where no complete remission was achieved., However, our own observations showed that patients with palmoplantar Eczema of the dyshidrotic or hyperkeratotic type responded only partially to bath-Methoxsalen With Ultraviolet A Therapy therapy., In the narrowband Ultraviolet B therapy-treated side, the tolerance of all the patients to the treatment was good all patients well-tolerated the treatment with the exception of mild Xerosis that responded to topical emollients.Local narrowband Ultraviolet B therapy phototherapy regimen is as effective as paint-Methoxsalen With Ultraviolet A Therapy therapy in patients with Chronic Hand Eczema of dry and dyshidrotic types., Comparison of localized high-dose UVA1 irradiation versus topical cream Psoralen [EPC]-UVA for treatment of chronic vesicular Vesicular Eczema of Hand and/or feet., No phototoxic reactions were observed.CONCLUSION: Local bath-Methoxsalen With Ultraviolet A Therapy therapy is of value in the management of chronic palmoplantar Eczema resistant to standard modes of topical treatment., These results indicate that topical Methoxsalen With Ultraviolet A Therapy therapy with Psoralen [EPC] in aqueous gel is a useful therapeutic modality for treatment of Psoriasis patients, and patients with recalcitrant dermatoses such as palmoplantar Psoriasis and hyperkeratotic Eczema.., Treatment of chronic palmoplantar Eczema with local bath-Methoxsalen With Ultraviolet A Therapy therapy., Oral Methoxsalen With Ultraviolet A Therapy is preferable for patients with hyperkeratotic Eczema and bath Methoxsalen With Ultraviolet A Therapy for patients with Vesicular Eczema of Hand and/or feet.., Does smoking influence the efficacy of bath-Methoxsalen With Ultraviolet A Therapy therapy in chronic palmoplantar Eczema?, Local bath-Methoxsalen With Ultraviolet A Therapy therapy is of value in the management of chronic palmoplantar Eczema resistant to standard modes of topical treatment., However, few data are available on the effectiveness of local bath-Methoxsalen With Ultraviolet A Therapy therapy in palmoplantar Eczema., A new Psoralen [EPC]-containing gel for topical Methoxsalen With Ultraviolet A Therapy therapy: development, and treatment results in patients with palmoplantar and plaque-type Psoriasis, and hyperkeratotic Eczema., Location characteristic ID - Location characteristic ID - Smoking is likely to be a reason for the failure of bath-Methoxsalen With Ultraviolet A Therapy therapy in the treatment of chronic palmoplantar Eczema, in particular regarding smokers with Eczema of the dyshidrotic type where no complete remission was achieved.., In order to investigate the effectiveness of topical Methoxsalen With Ultraviolet A Therapy-bath therapy (Methoxsalen With Ultraviolet A Therapy-soak therapy) on chronic palmoplantar dermatoses, 30 patients with plaque-type Psoriasis, pustular Psoriasis, endogenous Eczema, Vesicular Eczema of Hand and/or feet and hyperkeratotic dermatitis of the Arecaceae and soles were treated over 8 weeks with Methoxsalen With Ultraviolet A Therapy-soak using 8-MOP., Our purpose was to assess the effectiveness of local bath-Methoxsalen With Ultraviolet A Therapy therapy in 28 patients with chronic palmar or plantar Eczema or both who were resistant to conventional topical treatment.[SEP]Relations: Eczema has relations: drug_effect with Fluvoxamine, drug_effect with Fluvoxamine, drug_effect with Fluvoxamine, drug_effect with Fluvoxamine, drug_effect with Cevimeline, drug_effect with Cevimeline, drug_effect with Cevimeline, drug_effect with Cevimeline, drug_effect with Retapamulin, drug_effect with Retapamulin. Definitions: Psoriasis defined as following: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in Psoriasis.. Vesicular Eczema of Hand and/or feet defined as following: A recurrent eczematous reaction characterized by the development of vesicular eruptions on the Arecaceae and soles, particularly along the sides and between the digits. It is accompanied by pruritus, a burning sensation, and hyperhidrosis. The disease is self-limiting, lasting only a few weeks. (Dorland, 27th ed). Methoxsalen With Ultraviolet A Therapy defined as following: Strong evidences have indicated causal association between methoxsalen with UVA (Methoxsalen With Ultraviolet A Therapy) treatment and non-melanocytic skin patients with Psoriasis. 8-Methoxypsoralen alone did not alter the incidence of new skin cancer development in a 2-year study. In a large number of studies, 8-Methoxypsoralen in combination with ultraviolet A radiation induced chromosomal aberrations, sister chromatid exchanges, mutation, DNA damage and DNA cross-links in human cells in vitro. This treatment is classified as carcinogenic to Human by IARC. (NCI05). Bacterial Infections defined as following: Infections by bacteria, general or unspecified.. methoxsalen defined as following: A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA ADDUCTS in the presence of ultraviolet A irradiation.. Amyloidosis, Primary Cutaneous defined as following: The presence of amyloid deposition in the superficial dermis. [HPO:probinson, PMID:19690585]. Fungi defined as following: A kingdom of eukaryotic, heterotrophic organisms that live parasitically as saprobes, including MUSHROOMS; YEASTS; smuts, molds, etc. They reproduce either sexually or asexually, and have life cycles that range from simple to complex. Filamentous fungi, commonly known as molds, refer to those that grow as multicellular colonies.. Arecaceae defined as following: The palm family of order Arecales, subclass Arecidae, class Liliopsida.. Hand defined as following: The distal part of the arm beyond the wrist in humans and primates, that includes the palm, fingers, and thumb.. Eczema defined as following: A pruritic papulovesicular dermatitis occurring as a reaction to many endogenous and exogenous agents (Dorland, 27th ed)..", "label": "yes"} {"original_question": "Can chronological age be predicted by measuring telomere length?", "id": "converted_1380", "sentence1": "Can chronological age be predicted by measuring telomere length?", "sentence2": "Homo sapiens somatic cells gradually lose telomeric repeats with age. This study investigated if one could use a correlation between telomere length and age, to predict the age of an individual from their DNA., Therefore, telomere length measurement by real-time quantitative PCR cannot be used to predict age of a person, due to the presence of large inter-individual variations in telomere lengths., ur results provide the first clear and unambiguous evidence of a relationship between telomere length and mortality in the wild, and substantiate the prediction that telomere length and shortening rate can act as an indicator of biological age further to chronological age when exploring life history questions in natural conditions.[SEP]Relations: Telomere Extension By Telomerase has relations: pathway_protein with TERT, pathway_protein with TERT, pathway_protein with CCNA2, pathway_protein with CCNA2, pathway_protein with CCNA1, pathway_protein with CCNA1, pathway_protein with WRAP53, pathway_protein with WRAP53, pathway_protein with ANKRD28, pathway_protein with ANKRD28. Definitions: DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. telomere defined as following: A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs.. Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "no"} {"original_question": "Is vemurafenib used for thyroid cancer?", "id": "converted_2072", "sentence1": "Is vemurafenib used for Malignant neoplasm of thyroid?", "sentence2": "vemurafenib in patients with BRAF protein, human protein, human(V600E)-positive metastatic or unresectable papillary Malignant neoplasm of thyroid refractory to radioactive Iodine, Homeopathic preparation: a non-randomised, multicentre, open-label, phase 2 trial., vemurafenib, an oncogenic BRAF protein, human protein, human kinase PPP1R1A gene approved for BRAF protein, human protein, human-positive melanoma, showed clinical benefit in three patients with BRAF protein, human protein, human(V600E)-positive papillary Malignant neoplasm of thyroid in a phase 1 trial., INTERPRETATION: vemurafenib showed antitumour activity in patients with progressive, BRAF protein, human protein, human(V600E)-positive papillary Malignant neoplasm of thyroid refractory to radioactive Iodine, Homeopathic preparation who had never been treated with a multikinase PPP1R1A gene. , CONTEXT: vemurafenib, a selective BRAF protein, human protein, human PPP1R1A gene, appears to have promising clinical activity in patients with papillary Malignant neoplasm of thyroid (Percutaneous transhepatic cholangiography) harboring the BRAF protein, human protein, human(V600E) Mutation Abnormality., Efficacy and tolerability of vemurafenib in patients with BRAF protein, human protein, human(V600E) -positive papillary Malignant neoplasm of thyroid: M.D. Anderson Cancer Center off label experience., CONCLUSIONS: vemurafenib is a potentially effective and well-tolerated treatment strategy in patients with advanced Percutaneous transhepatic cholangiography harboring the BRAF protein, human protein, human(V600E) Mutation Abnormality., The US Food and Drug Administration-approved BRAF protein, human protein, human inhibitors, vemurafenib and dabrafenib, have demonstrated superior efficacy in patients with BRAF protein, human protein, human-mutant melanomas but have limited efficacy in BRAF protein, human protein, human-mutant Malignant neoplasm of colon and/or rectum. Little is known at this time regarding BRAF protein, human protein, human inhibitors in Malignant neoplasm of thyroid. Initial reports in patients with progressive, radioactive Iodine, Homeopathic preparation-refractory BRAF protein, human protein, human-mutant papillary Malignant neoplasm of thyroid suggest response rates of approximately 30-40%., Use of vemurafenib in Anaplastic thyroid carcinoma: a case report., Finally, we found that propranolol can amplify the cytotoxicity of vemurafenib and sensitize Malignant neoplasm of thyroid cells to cytotoxic effect of vemurafenib., CONTEXT: vemurafenib, a selective BRAF protein, human protein, human PPP1R1A gene, appears to have promising clinical activity in patients with papillary Malignant neoplasm of thyroid (Percutaneous transhepatic cholangiography) harboring the BRAF protein, human protein, human(V600E) Mutation Abnormality.OBJECTIVE: To determine the efficacy and safety of vemurafenib when used outside of a clinical trial.DESIGN: A retrospective review at MD Anderson Cancer Center.METHODS: The best responses were evaluated using Response Evaluation Criteria in Solid Tumors v1.1., vemurafenib, a selective BRAF protein, human protein, human PPP1R1A gene, appears to have promising clinical activity in patients with papillary Malignant neoplasm of thyroid (Percutaneous transhepatic cholangiography) harboring the BRAF protein, human protein, human(V600E) Mutation Abnormality.To determine the efficacy and safety of vemurafenib when used outside of a clinical trial.A retrospective review at MD Anderson Cancer Center.The best responses were evaluated using Response Evaluation Criteria in Solid Tumors v1.1, CONTEXT: vemurafenib, a selective BRAF protein, human protein, human PPP1R1A gene, appears to have promising clinical activity in patients with papillary Malignant neoplasm of thyroid (Percutaneous transhepatic cholangiography) harboring the BRAF protein, human protein, human(V600E) Mutation Abnormality.OBJECTIVE: To determine the efficacy and safety of vemurafenib when used outside of a clinical trial.DESIGN: A retrospective review at MD Anderson Cancer Center.METHODS: The best responses were evaluated using Response Evaluation Criteria in Solid Tumors v1.1. , Finally, we found that propranolol can amplify the cytotoxicity of vemurafenib and sensitize Malignant neoplasm of thyroid cells to cytotoxic effect of vemurafenib., Metformin or sirolimus adjuvant treatment may provide clinical benefits with minimal side effects to BRAFV600E-positive advanced Malignant neoplasm of thyroid patients treated with vemurafenib., vemurafenib, a selective BRAF protein, human protein, human PPP1R1A gene, appears to have promising clinical activity in patients with papillary Malignant neoplasm of thyroid (Percutaneous transhepatic cholangiography) harboring the BRAF protein, human protein, human(V600E) Mutation Abnormality.To determine the efficacy and safety of vemurafenib when used outside of a clinical trial.A retrospective review at MD Anderson Cancer Center.The best responses were evaluated using Response Evaluation Criteria in Solid Tumors v1.1., Our data demonstrate that vemurafenib induces Endoplasmic Reticulum stress response-mediated autophagy in Malignant neoplasm of thyroid and autophagy inhibition may be a beneficial strategy to sensitize BRAF protein, human protein, human-mutant Malignant neoplasm of thyroid to vemurafenib.., Combination of vemurafenib and metformin decreased cell viability and increased apoptosis in both BCPAP papillary Malignant neoplasm of thyroid cells and 8505c anaplastic Malignant neoplasm of thyroid cells., Targeting autophagy sensitizes BRAF protein, human protein, human-mutant Malignant neoplasm of thyroid to vemurafenib., propranolol sensitizes Malignant neoplasm of thyroid cells to cytotoxic effect of vemurafenib., mTOR Inhibitors [MoA] sensitize Malignant neoplasm of thyroid cells to cytotoxic effect of vemurafenib., vemurafenib induced a high level of autophagy in BRAF protein, human protein, human-mutant Malignant neoplasm of thyroid cells.[SEP]Relations: vemurafenib has relations: drug_drug with Parathyroid hormone, drug_drug with Parathyroid hormone, contraindication with iris disease, contraindication with iris disease, drug_drug with Antipyrine, drug_drug with Antipyrine, drug_drug with Thyroid, porcine, drug_drug with Thyroid, porcine, drug_drug with Testosterone, drug_drug with Testosterone. Definitions: metformin defined as following: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289). vemurafenib defined as following: An orally bioavailable, ATP-competitive, small-molecule PPP1R1A gene of BRAF protein, human(V600E) kinase with potential antineoplastic activity. vemurafenib selectively binds to the ATP-binding site of BRAF protein, human(V600E) kinase and inhibits its activity, which may result in an inhibition of an over-activated MAPK signaling pathway downstream in BRAF protein, human(V600E) kinase-expressing tumor cells and a reduction in tumor cell proliferation. Approximately 90% of BRAF protein, human gene mutations involve a valine-to-glutamic acid Mutation Abnormality at residue 600 (V600E); the oncogene protein product, BRAF protein, human(V600E) kinase, exhibits a markedly elevated activity that over-activates the MAPK signaling pathway. The BRAF protein, human(V600E) gene Mutation Abnormality has been found to occur in approximately 60% of melanomas, and in about 8% of all solid tumors, including melanoma, colorectal, thyroid and other cancers.. Iodine, Homeopathic preparation defined as following: homeopathic drug. Malignant neoplasm of thyroid defined as following: A primary or metastatic malignant neoplasm affecting the thyroid gland.. Endoplasmic Reticulum defined as following: A system of cisternae in the CYTOPLASM of many cells. In places the endoplasmic reticulum is continuous with the plasma membrane (CELL MEMBRANE) or outer membrane of the nuclear envelope. If the outer surfaces of the endoplasmic reticulum membranes are coated with ribosomes, the endoplasmic reticulum is said to be rough-surfaced (ENDOPLASMIC RETICULUM, ROUGH); otherwise it is said to be smooth-surfaced (ENDOPLASMIC RETICULUM, SMOOTH). (King & Stansfield, A Dictionary of Genetics, 4th ed). propranolol defined as following: A widely used non-cardioselective beta-adrenergic antagonist. propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.. papillary Malignant neoplasm of thyroid defined as following: A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland. Radiation exposure is a risk factor and it is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in Iodine, Homeopathic preparation sufficient countries. Diagnostic procedures include thyroid ultrasound and fine needle biopsy. Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei. The nuclei also display clearing or have a ground glass appearance.. Response Evaluation Criteria in Solid Tumors defined as following: Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com). Percutaneous transhepatic cholangiography defined as following: The evaluation of the liver and biliary tree using a contrast agent injected directly into the liver.. Anaplastic thyroid carcinoma defined as following: An aggressive THYROID GLAND malignancy which generally occurs in IODINE-deficient areas in people with previous thyroid pathology such as GOITER. It is associated with CELL DEDIFFERENTIATION of THYROID CARCINOMA (e.g., FOLLICULAR THYROID CARCINOMA; PAPILLARY THYROID CANCER). Typical initial presentation is a rapidly growing neck mass which upon metastasis is associated with DYSPHAGIA; NECK PAIN; bone pain; DYSPNEA; and NEUROLOGIC DEFICITS.. dabrafenib defined as following: An orally bioavailable PPP1R1A gene of B-raf (BRAF protein, human) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF protein, human gene. B-raf belongs to the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which may be constitutively activated due to BRAF protein, human gene mutations.. sirolimus defined as following: A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. BRAF protein, human defined as following: Serine/threonine-protein kinase B-raf (766 aa, ~84 kDa) is encoded by the human BRAF protein, human gene. This protein plays a role in protein phosphorylation, mitogenesis and neuronal signal transduction.. vemurafenib defined as following: An orally bioavailable, ATP-competitive, small-molecule PPP1R1A gene of BRAF protein, human(V600E) kinase with potential antineoplastic activity. vemurafenib selectively binds to the ATP-binding site of BRAF protein, human(V600E) kinase and inhibits its activity, which may result in an inhibition of an over-activated MAPK signaling pathway downstream in BRAF protein, human(V600E) kinase-expressing tumor cells and a reduction in tumor cell proliferation. Approximately 90% of BRAF protein, human gene mutations involve a valine-to-glutamic acid Mutation Abnormality at residue 600 (V600E); the oncogene protein product, BRAF protein, human(V600E) kinase, exhibits a markedly elevated activity that over-activates the MAPK signaling pathway. The BRAF protein, human(V600E) gene Mutation Abnormality has been found to occur in approximately 60% of melanomas, and in about 8% of all solid tumors, including melanoma, colorectal, thyroid and other cancers..", "label": "yes"} {"original_question": "Does GC content vary markedly within a given isochore?", "id": "converted_766", "sentence1": "Does GC content vary markedly within a given isochore?", "sentence2": "The isochore, a large DNA Sequence - ParameterizedDataType with relatively small GC variance, is one of the most important structures in eukaryotic genomes., Isochores are large regions of relatively homogeneous nucleotide composition, Vertebrate genomes are comprised of isochores that are relatively long (>100 kb) regions with a relatively homogenous (either GC-rich or AT-rich) base composition and with rather sharp boundaries with neighboring isochores., The human genome is composed of large Sequence - ParameterizedDataType segments with fairly homogeneous GC content, namely isochores, Isochores, i.e. Spastic syndrome of DNA with a distinct Sequence - ParameterizedDataType composition and thus a specific GC content, The human genome is composed of long Spastic syndrome of DNA with distinct GC contents, called isochores or GC-content domains., The human genome is divided into isochores, large Spastic syndrome (>>300 kb) of Genomic DNA with more or less consistent GC content. , Many eukaryotic genomes contain isochore regions, mosaics of homogeneous GC content that can abruptly change from one neighboring isochore to the next., One of the most striking features of Mammals and birds chromosomes is the variation in the guanine-cytosine (GC) content that occurs over scales of hundreds of kilobases to megabases; this is known as the \"isochore\" structure., The segmentation analysis shows that there are stronger indications of GC content changes at isochore borders than within an isochore., This partitioning is a natural one, since large-scale compositional properties vary much more among isochores than within them., This partitioning is a natural one, since large-scale compositional properties vary much more among isochores than within them., An isochore Sequence - ParameterizedDataType may pass a homogeneity test when GC content fluctuations at smaller length scales are ignored or averaged out., This partitioning is a natural one, since large-scale compositional properties vary much more among isochores than within them[SEP]Relations: neoplastic syndrome has relations: disease_disease with ectopic ACTH secretion syndrome, disease_disease with ectopic ACTH secretion syndrome, disease_disease with Carney triad, disease_disease with Carney triad, disease_disease with ectopic hormone secretion syndrome associated with neoplasia, disease_disease with ectopic hormone secretion syndrome associated with neoplasia, disease_disease with mosaic variegated aneuploidy syndrome, disease_disease with mosaic variegated aneuploidy syndrome, disease_disease with Meigs syndrome, disease_disease with Meigs syndrome. Definitions: Genomic DNA defined as following: The DNA that is part of the normal chromosomal complement of an organism.. DNA Sequence - ParameterizedDataType defined as following: The Sequence - ParameterizedDataType of nucleotide residues along a DNA chain.. Isochores defined as following: Large regions of the GENOME that contain local similarities in BASE COMPOSITION.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young..", "label": "no"} {"original_question": "Is dasatinib effective for treatment of glioblastoma?", "id": "converted_2282", "sentence1": "Is dasatinib effective for treatment of Glioblastoma Multiforme?", "sentence2": "RESULTS: fourteen randomized clinical trials were identified (7 with bevacizumab, 2 Cilengitide, 1 enzastaurin, 1 dasatinib, 1 vandetanib, 1 temsirolimus, 1 cediranib) including 4330 patients. Antiangiogenic drugs showed no improvement in overall survival with a pooled HR of 1.00, a trend for an inferior outcome, in terms of overall survival, was observed in the group of patients receiving antiangiogenic drug alone compared to cytotoxic drug alone (HR=1.24, p=0.056)., CONCLUSIONS: Intraparticipant dose escalation was feasible, but dasatinib was ineffective in recurrent Glomerular Basement Membrane. , Median progression-free survival (PFS) was 1.35 months (95% confidence interval: 1.2-1.4) and 6-month PFS was 7.7%. In this phase I study of recurrent Glioblastoma Multiforme patients, the combination of CCNO gene and dasatinib showed significant hematological Toxic effect and led to suboptimal exposure to both agents., dasatinib in conjunction with bevacizumab does not appear to have activity in patients with recurrent, heavily pretreated Glomerular Basement Membrane.[SEP]Relations: dasatinib has relations: drug_effect with Eczema, drug_effect with Eczema, drug_effect with Pain, drug_effect with Pain, drug_effect with Erythema, drug_effect with Erythema, drug_effect with Edema, drug_effect with Edema, drug_effect with Myalgia, drug_effect with Myalgia. Definitions: dasatinib defined as following: An orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases. dasatinib binds to and inhibits the growth-promoting activities of these kinases. Apparently because of its less stringent binding affinity for the BCR-ABL kinase, dasatinib has been shown to overcome the resistance to imatinib of chronic myeloid leukemia (CML) cells harboring BCR-ABL kinase domain point mutations. SRC-family protein-tyrosine kinases interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways; tumorigenic forms can occur through altered regulation or expression of the endogenous protein and by way of virally-encoded kinase genes.. Glioblastoma Multiforme defined as following: The most malignant astrocytic tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO). vandetanib defined as following: An orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability. This agent also blocks the tyrosine kinase activity of epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that mediates tumor cell proliferation and migration and angiogenesis.. bevacizumab defined as following: An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS.. Glomerular Basement Membrane defined as following: A sheet of amorphous extracellular material upon which the basal surfaces of epithelial cells rest and is the covering surface of a glomerular capillary, interposed between the cellular elements and the underlying connective tissue.. temsirolimus defined as following: An ester analog of rapamycin. Temsirolimus binds to and inhibits the mammalian target of rapamycin (mTOR), resulting in decreased expression of mRNAs necessary for cell cycle progression and arresting cells in the G1 phase of the cell cycle. mTOR is a serine/threonine kinase which plays a role in the PI3K/AKT pathway that is upregulated in some tumors.. Cilengitide defined as following: A cyclic Arg-Gly-Asp peptide with potential antineoplastic activity. Cilengitide binds to and inhibits the activities of the alpha(v)beta(3) and alpha(v)beta(5) integrins, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis. (NCI04). Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. dasatinib defined as following: An orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases. dasatinib binds to and inhibits the growth-promoting activities of these kinases. Apparently because of its less stringent binding affinity for the BCR-ABL kinase, dasatinib has been shown to overcome the resistance to imatinib of chronic myeloid leukemia (CML) cells harboring BCR-ABL kinase domain point mutations. SRC-family protein-tyrosine kinases interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways; tumorigenic forms can occur through altered regulation or expression of the endogenous protein and by way of virally-encoded kinase genes..", "label": "no"} {"original_question": "Is lenvatinib effective for thyroid cancer?", "id": "converted_1255", "sentence1": "Is lenvatinib effective for Malignant neoplasm of thyroid?", "sentence2": "New insights in the treatment of iodide ion I-131 refractory differentiated Thyroid carcinoma: to lenvatinib and beyond., However, even more impressive responses and progression-free survival benefits were seen in the phase III SELECT trial with lenvatinib, giving even higher hopes for the future management of what was considered just a decade ago an orphan disease. , sorafenib and lenvatinib, small-molecule multikinase inhibitors, were approved for the treatment of progressive, symptomatic, radioactive iodine refractory, advanced differentiated Malignant neoplasm of thyroid in 2013 and 2015, respectively., A phase 2 trial of lenvatinib (E 7080) in advanced, progressive, iodide ion I-131-refractory, differentiated Malignant neoplasm of thyroid: A clinical outcomes and biomarker assessment., CONCLUSIONS: In patients with and without prior exposure to VEGF therapy, the encouraging response rates, median time to response, and PFS for lenvatinib have prompted further investigation in a phase 3 trial. , Since 2011, four multikinase inhibitors (MKIs) have been approved by the US Food and Drug Administration for Malignant neoplasm of thyroid - cabozantinib and vandetanib for medullary Malignant neoplasm of thyroid and sorafenib and lenvatinib for differentiated Malignant neoplasm of thyroid. , Moreover, four of those investigational drugs, vandetanib, cabozantinib, sorafenib and lenvatinib, have reached a phase III clinical trial with favorable results in progression-free survival and overall survival in Medullary carcinoma of thyroid and differentiated Malignant epithelial neoplasm of thyroid., Since 2011, four multikinase inhibitors (MKIs) have been approved by the US Food and Drug Administration for Malignant neoplasm of thyroid - cabozantinib and vandetanib for medullary Malignant neoplasm of thyroid and sorafenib and lenvatinib for differentiated Malignant neoplasm of thyroid, BACKGROUND: lenvatinib, an oral inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, Fibroblast Growth Factor Receptor 2 through 4, Platelet-Derived Growth Factor Receptor Beta, Human �, ret unit of radiation dose, and stem cell factor receptor activity, showed clinical activity in a phase 2 study involving patients with differentiated Malignant neoplasm of thyroid that was refractory to iodide ion I-131 (iodine-131).METHODS: In our phase 3, randomized, double-blind, multicenter study involving patients with progressive Malignant neoplasm of thyroid that was refractory to iodine-131, we randomly assigned 261 patients to receive lenvatinib (at a daily dose of 24 mg per day in 28-day cycles) and 131 patients to receive placebo. , Positive phase 1 results in Solid Neoplasm prompted a phase 2 trial in patients with advanced, iodide ion I-131-refractory, differentiated Malignant neoplasm of thyroid (RR-DTC).METHODS: Fifty-eight patients with RR-DTC who had disease progression during the previous 12 months received lenvatinib 24 mg once daily in 28-day cycles until disease progression, unmanageable Toxic effect, withdrawal, or Cessation of life. [SEP]Relations: lenvatinib has relations: drug_drug with Thyroid, porcine, drug_drug with Thyroid, porcine, drug_drug with Antipyrine, drug_drug with Antipyrine, drug_drug with Testosterone, drug_drug with Testosterone, drug_drug with Thyrotropin, drug_drug with Thyrotropin, drug_drug with Fostamatinib, drug_drug with Fostamatinib. Definitions: Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. Medullary carcinoma of thyroid defined as following: A neuroendocrine carcinoma arising from the C-cells of the thyroid gland. It is closely associated with multiple endocrine neoplasia syndromes. Approximately 10% to 20% of medullary Thyroid carcinoma are familial. Patients usually present with a thyroid nodule that is painless and firm. In the majority of cases nodal involvement is present at diagnosis. Surgery is the preferred treatment for both primary lesions and recurrences. This carcinoma is generally not very sensitive to radiation and almost unresponsive to chemotherapy.. Fibroblast Growth Factor Receptor 2 defined as following: A fibroblast growth factor receptor which contains three extracellular IMMUNOGLOBULIN I-SET DOMAINS and is expressed as two isoforms. One receptor isoform is expressed in the MESENCHYME and is activated by FIBROBLAST GROWTH FACTOR 2. A second isoform is expressed mainly by EPITHELIAL CELLS and is activated by FIBROBLAST GROWTH FACTOR 7 and FIBROBLAST GROWTH FACTOR 10. Mutation of the gene for fibroblast growth factor receptor 2 can result in craniosynostotic syndromes (e.g., APERT SYNDROME; and CROUZON SYNDROME).. ret unit of radiation dose defined as following: a unit of radiation dose. vandetanib defined as following: An orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability. This agent also blocks the tyrosine kinase activity of epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that mediates tumor cell proliferation and migration and angiogenesis.. Solid Neoplasm defined as following: A benign or malignant neoplasm arising from tissues that do not include fluid areas. Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma). Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered Solid Neoplasm.. sorafenib defined as following: A synthetic compound targeting growth signaling and angiogenesis. sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis.. stem cell factor receptor activity defined as following: Combining with stem cell factor (SCF) receptor ligand and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate. Stem cell factor is a cytokine that stimulates mast cell growth and differentiation. [GOC:jl, GOC:signaling, PMID:10698217]. Malignant neoplasm of thyroid defined as following: A primary or metastatic malignant neoplasm affecting the thyroid gland.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Thyroid carcinoma defined as following: A carcinoma arising from the thyroid gland. It includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and undifferentiated (anaplastic) carcinoma.. lenvatinib defined as following: A synthetic, orally available inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2, also known as KDR/FLK-1) tyrosine kinase with potential antineoplastic activity. lenvatinib blocks VEGFR2 activation by VEGF, resulting in inhibition of the VEGF receptor signal transduction pathway, decreased vascular endothelial cell migration and proliferation, and vascular endothelial cell apoptosis.. Platelet-Derived Growth Factor Receptor Beta, Human defined as following: Platelet-derived growth factor receptor beta (1106 aa, ~124 kDa) is encoded by the human PDGFRB gene. This protein plays a role in tyrosine phosphorylation and ligand-dependent signal transduction.. cabozantinib defined as following: An orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Cabozantinib strongly binds to and inhibits several RTKs, which are often overexpressed in a variety of cancer cell types, including hepatocyte growth factor receptor (MET), ret unit of radiation dose (rearranged during transfection), vascular endothelial growth factor receptor types 1 (VEGFR-1), 2 (VEGFR-2), and 3 (VEGFR-3), mast/stem cell growth factor (stem cell factor receptor activity), FMS-like tyrosine kinase 3 (FLT-3), TIE-2 (TEK tyrosine kinase, endothelial), tropomyosin-related kinase B (TRKB) and AXL. This may result in an inhibition of both tumor growth and angiogenesis, and eventually lead to tumor regression.. lenvatinib defined as following: A synthetic, orally available inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2, also known as KDR/FLK-1) tyrosine kinase with potential antineoplastic activity. lenvatinib blocks VEGFR2 activation by VEGF, resulting in inhibition of the VEGF receptor signal transduction pathway, decreased vascular endothelial cell migration and proliferation, and vascular endothelial cell apoptosis..", "label": "yes"} {"original_question": "Is there any involvement of the long non-coding RNA Gomafu in schizophrenia?", "id": "converted_1964", "sentence1": "Is there any involvement of the long non-coding RNA MIAT gene in schizophrenia?", "sentence2": "The long non-coding RNA MIAT gene is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing., Here, we profile these transcriptomic responses and show that long non-coding RNAs (lncRNAs) are dynamically regulated by neuronal activation, including acute downregulation of the lncRNA MIAT gene, previously implicated in Head>Brain and retinal development. Moreover, we demonstrate that MIAT gene binds directly to the splicing factors QKI gene gene and SRSF1 gene gene (Serine/Arginine-Rich Splicing Factor 2) and dysregulation of MIAT gene leads to alternative splicing patterns that resemble those observed in SZ for the archetypal SZ-associated genes DISC1 gene gene and Receptor Tyrosine-Protein Kinase ErbB-4, human. Finally, we show that MIAT gene is downregulated in post-mortem cortical gray matter from the superior temporal gyrus in SZ. These results functionally link activity-regulated lncRNAs and alternative splicing in neuronal function and suggest that their dysregulation may contribute to nervous system disorder., MIAT gene/MIAT/Rncr2 is a RNA, Long Untranslated that has been proposed to control Neuron of retina specification, stem cell differentiation and alternative splicing of schizophrenia-related genes., The long non-coding RNA MIAT gene is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing, Moreover, we demonstrate that MIAT gene binds directly to the splicing factors QKI gene gene and SRSF1 gene gene (Serine/Arginine-Rich Splicing Factor 2) and dysregulation of MIAT gene leads to alternative splicing patterns that resemble those observed in SZ for the archetypal SZ-associated genes DISC1 gene gene and Receptor Tyrosine-Protein Kinase ErbB-4, human. , Finally, we show that MIAT gene is downregulated in post-mortem cortical gray matter from the superior temporal gyrus in SZ. , The long non-coding RNA MIAT gene is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing.[SEP]Relations: regulation of neural retina development has relations: bioprocess_protein with PTF1A, bioprocess_protein with PTF1A, bioprocess_protein with SIX3, bioprocess_protein with SIX3, bioprocess_protein with DLL4, bioprocess_protein with DLL4, bioprocess_bioprocess with negative regulation of neural retina development, bioprocess_bioprocess with negative regulation of neural retina development, bioprocess_bioprocess with positive regulation of neural retina development, bioprocess_bioprocess with positive regulation of neural retina development. Definitions: Receptor Tyrosine-Protein Kinase ErbB-4, human defined as following: Receptor tyrosine-protein kinase erbB-4 (1308 aa, ~147 kDa) is encoded by the human Receptor Tyrosine-Protein Kinase ErbB-4, human gene. This protein is involved in multicellular organismal development, cell proliferation and signal transduction.. SRSF1 gene defined as following: This gene is involved in both RNA processing and transport.. QKI gene defined as following: This gene is involved in both the biosynthesis and maintenance of mRNA.. Serine/Arginine-Rich Splicing Factor 2 defined as following: Serine/arginine-rich splicing factor 2 (221 aa, ~25 kDa) is encoded by the human SRSF2 gene. This protein plays a role in the modulation of mRNA processing.. nervous system disorder defined as following: Diseases of the central and peripheral nervous system. This includes disorders of the Head>Brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.. RNA, Long Untranslated defined as following: A class of untranslated RNA molecules that are typically greater than 200 nucleotides in length and do not code for proteins. Members of this class have been found to play roles in transcriptional regulation, post-transcriptional processing, CHROMATIN REMODELING, and in the epigenetic control of chromatin.. schizophrenia defined as following: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior..", "label": "yes"} {"original_question": "Are mucin overexpression associated with disease?", "id": "converted_3996", "sentence1": "Are Homo sapiens MUC1 protein overexpression associated with disease?", "sentence2": "The pathological mechanism underlying Liver calculus is closely related to bacterial infections of the Intrahepatic bile duct, followed by chronic inflammation and the overexpression of Homo sapiens MUC1 wt Allele protein 5AC (MUC5AC protein, human protein, Homo sapiens)., MUC1 wt Allele wt Allele is a Membrane Glycoproteins, which in adenocarninomas is overexpressed and exhibits truncated O-glycosylation. , Mucin 13 (MUC13 gene gene) is reportedly overexpressed in Homo sapiens malignancies., Inflammation causes MUC1 wt Allele wt Allele overexpression and hypoglycosylation. [SEP]Relations: Protein S Homo sapiens has relations: drug_drug with Mitomycin, drug_drug with Mitomycin, drug_drug with Mitomycin, drug_drug with Mitomycin, drug_drug with Obinutuzumab, drug_drug with Obinutuzumab, drug_drug with Obinutuzumab, drug_drug with Obinutuzumab. bladder calculus has relations: disease_disease with urinary bladder disease, disease_disease with urinary bladder disease. Definitions: MUC1 wt Allele defined as following: Human MUC1 wt Allele wild-type allele is located within 1q21 and is approximately 121 kb in length. This allele, which encodes Homo sapiens MUC1 protein-like protein 1, plays a role in both cellular defense by binding pathogens and in cell signaling.. Homo sapiens MUC1 protein defined as following: Mucin-1 (1255 aa, ~122 kDa) is encoded by the Homo sapiens MUC1 wt Allele gene. This protein plays a role in both signaling and cell adhesion.. Homo sapiens defined as following: Members of the species Homo sapiens.. Membrane Glycoproteins defined as following: Glycoproteins found on the membrane or surface of cells.. MUC5AC protein, human defined as following: Mucin-5AC (5030 aa, ~527 kDa) is encoded by the Homo sapiens MUC5AC protein, human gene. This protein plays a role in the defense of the gastrointestinal and respiratory tracts from microorganism infection.. Intrahepatic bile duct defined as following: Passages within the liver for the conveyance of bile. Includes right and left hepatic ducts even though these may join outside the liver to form the common hepatic duct.. Liver calculus defined as following: The presence of solitary or multiple stones in the intrahepatic bile ducts.. disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown..", "label": "yes"} {"original_question": "Does HER2 under-expression lead to favorable response to trastuzumab?", "id": "converted_1267", "sentence1": "Does ERBB2 wt Allele under-expression lead to favorable response to trastuzumab?", "sentence2": "over-expression of ERBB2 wt Allele is reported in approximately 20% of gastric tumours, challenging the use of targeted therapies. , In patients with advanced gastric or gastro-oesophageal junction cancer, addition of trastuzumab to chemotherapy significantly improved overall survival compared with chemotherapy alone. Addition of trastuzumab to chemotherapy did not increase the incidence of adverse events., treatment of ERBB2 wt Allele-overexpressing Malignant neoplasm of Breast: trastuzumab,, Trastuzumab has demonstrated clinical activity in several types of ERBB2 wt Allele-overexpressing epithelial tumors, such as Breast and metastatic gastric or gastroesophageal junction cancer. , An example is the established benefit of trastuzumab as adjuvant therapy for Malignant neoplasm of Breast; a clear definition of ERBB2 wt Allele-positivity and the assay reproducibility have, however, remained unanswered. , Trastuzumab is a monoclonal antibody CAL CAL targeted to the Her2 receptor and approved for treatment of Her2-positive Malignant neoplasm of Breast., epidermal growth factor receptor 2, human (ERBB2 wt Allele/neu) is an important target for the treatment of the Breast cancers in which it is overexpressed. However, no approved anti-ERBB2 wt Allele/neu therapy is available for the majority of Malignant neoplasm of Breast patients, who express ERBB2 wt Allele/neu at low levels (with scores of 1+ or 2+/fluorescence in situ hybridization-negative)., The humanized anti-ERBB2 wt Allele monoclonal antibody CAL CAL trastuzumab (Herceptin) is useful in the treatment of ErbB2-overexpressing Breast cancers,, HercepTestTM (DAKO A/S, Glostrup, Denmark) is an immunohistochemical assay that detects ERBB2 wt Allele/neu gene products, and evaluates the overexpression status of the ERBB2 wt Allele/neu protein in determining eligibility for the Trastuzumab (HerceptinR, Genentech, San Francisco, cyclophosphamide/doxorubicin protocol, USA) therapy. [SEP]Relations: Trastuzumab has relations: drug_protein with ERBB2, drug_protein with ERBB2, drug_drug with Yersinia pestis 195/p antigen (formaldehyde inactivated), drug_drug with Yersinia pestis 195/p antigen (formaldehyde inactivated), drug_drug with Clostridium tetani toxoid antigen (formaldehyde inactivated), drug_drug with Clostridium tetani toxoid antigen (formaldehyde inactivated), drug_drug with Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), drug_drug with Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), drug_drug with XmAb 2513, drug_drug with XmAb 2513. Definitions: Malignant neoplasm of Breast defined as following: A primary or metastatic malignant neoplasm involving the Breast. The vast majority of cases are carcinomas arising from the Breast parenchyma or the nipple. Malignant Breast neoplasms occur more frequently in females than in males.. ERBB2 wt Allele defined as following: Human ERBB2 wild-type allele is located in the vicinity of 17q21.1 and is approximately 29 kb in length. This allele, which encodes receptor tyrosine-protein kinase erbB-2 protein, plays a role in EGF receptor signal transduction pathways and cellular growth. Amplification or overexpression of this gene is involved in the progression of several forms of cancer, including Breast and ovarian tumors.. Breast defined as following: In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.. Her2-positive Malignant neoplasm of Breast defined as following: A biologic subset of Breast carcinoma defined by high expression of ERBB2 wt Allele, GRB7, and TRAP100, and by lack of expression of estrogen receptor (ER).. trastuzumab defined as following: A humanized monoclonal antibody CAL against the ERBB-2 RECEPTOR (ERBB2 wt Allele). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where ERBB2 wt Allele is overexpressed.. monoclonal antibody CAL defined as following: A humanized monoclonal antibody CAL directed against parathyroid hormone-related protein (PTH-rP). As a poly-hormone with diverse biological roles, PTH-rP is expressed by normal tissues, acting in local tissue environments in a variety of ways; it is commonly overexpressed by Breast, prostate, and other cancers, acting systemically by promoting bone resorption, inhibiting calcium excretion from the kidney, inducing hypercalcemia, and possibly playing a role in the formation of bony metastases. By blocking the effects of PTH-rP on calcium metabolism, monoclonal antibody CAL CAL may inhibit cancer-related hypercalcemia. (NCI04).", "label": "no"} {"original_question": "Does simvastatin improve outcomes of aneurysmal subarachnoid hemorrhage?", "id": "converted_2866", "sentence1": "Does simvastatin improve outcomes of aneurysmal subarachnoid hemorrhage?", "sentence2": "Randomized controlled trials have shown that simvastatin and intravenous Magnesium supplements, alimentary tract and metabolism do not prevent Noninfiltrating Intraductal Carcinoma or improve functional outcomes after aneurysmal subarachnoid hemorrhage (ASAH1 wt Allele)., Conclusions Simvastatin showed no benefits in decreasing the incidence of Vasospasm, Noninfiltrating Intraductal Carcinoma, or all-cause mortality after aneurysmal Yakut language. We conclude that patients with Yakut language should not be treated routinely with simvastatin during the acute stage., We found no statistically significant effects on Vasospasm detected by transcranial cerebral Doppler (relative risk [RR], 0.91; 95% confidence interval [NDUFB6 gene], 0.55-1.49), delayed cerebral ischemia (Noninfiltrating Intraductal Carcinoma) (RR, 0.85; 95% NDUFB6 gene, 0.63-1.14), or all-cause mortality (RR, 1.02; 95% NDUFB6 gene, 0.67-1.54)., BACKGROUND: Simvastatin might be beneficial to the patients with aneurysmal subarachnoid hemorrhage. However, the results remained controversial. , CONCLUSIONS: Compared to control intervention, simvastatin intervention was found to have no influence on delayed ischaemic deficit, delayed cerebral infarction, mRS≤2, Vasospasm, ICU stay, hospital stay, and mortality in patients with acute aneurysmal subarachnoid hemorrhage., Current evidence does not support prophylactic use of clazosentan, Magnesium supplements, alimentary tract and metabolism, or simvastatin. , Recently, acute simvastatin treatment was not shown to be beneficial in neurological outcome using modified Rankin Scale., CONCLUSIONS: The current study does not support that acute simvastatin treatment improves cognitive outcome after aneurysmal subarachnoid hemorrhage., CONCLUSION: This study demonstrated that 80 mg simvastatin treatment was effective in preventing cerebral Vasospasm after aneurysmal Yakut language, but did not improve the clinical outcome in Korean patients., High-Dose Simvastatin Is Effective in Preventing Cerebral Vasospasm after Subarachnoid Hemorrhage, Aneurysmal: A Prospective Cohort Study in Korean Patients., CONCLUSIONS\nThe current study does not support that acute simvastatin treatment improves cognitive outcome after aneurysmal subarachnoid hemorrhage., CONCLUSIONS\nHigh-dose simvastatin treatment should not be prescribed routinely for aneurysmal subarachnoid hemorrhage., Randomized controlled trials have shown that simvastatin and intravenous Magnesium supplements, alimentary tract and metabolism do not prevent Noninfiltrating Intraductal Carcinoma or improve functional outcomes after aneurysmal subarachnoid hemorrhage (ASAH1 wt Allele)., CONCLUSIONS\nCompared to control intervention, simvastatin intervention was found to have no influence on delayed ischaemic deficit, delayed cerebral infarction, mRS≤2, Vasospasm, ICU stay, hospital stay, and mortality in patients with acute aneurysmal subarachnoid hemorrhage., CONCLUSIONS The current study does not support that acute simvastatin treatment improves cognitive outcome after aneurysmal subarachnoid hemorrhage., CONCLUSIONS High-dose simvastatin treatment should not be prescribed routinely for aneurysmal subarachnoid hemorrhage., CONCLUSIONS Compared to control intervention, simvastatin intervention was found to have no influence on delayed ischaemic deficit, delayed cerebral infarction, mRS≤2, Vasospasm, ICU stay, hospital stay, and mortality in patients with acute aneurysmal subarachnoid hemorrhage., There were also no differences in DID, delayed cerebral infarction, favorable mRS outcome, and MMSE scores, and MMSE-assessed cognitive impairment between both groups.
CONCLUSIONS: The current study does not support that acute simvastatin treatment improves cognitive outcome after aneurysmal subarachnoid hemorrhage.
[SEP]Relations: Simvastatin has relations: drug_effect with Hemolytic anemia, drug_effect with Hemolytic anemia, drug_effect with Dyspnea, drug_effect with Dyspnea, drug_effect with Arthritis, drug_effect with Arthritis, drug_effect with Erythema, drug_effect with Erythema, drug_effect with Ophthalmoplegia, drug_effect with Ophthalmoplegia. Definitions: Noninfiltrating Intraductal Carcinoma defined as following: A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.. simvastatin defined as following: A derivative of LOVASTATIN and potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It may also interfere with steroid hormone production. Due to the induction of hepatic LDL RECEPTORS, it increases breakdown of LDL CHOLESTEROL.. Yakut language defined as following: A Turkic language spoken by the Yakut people in the Sakha Republic in the Russian Federation.. ASAH1 wt Allele defined as following: Human ASAH1 wild-type allele is located in the vicinity 8p22 of and is approximately 29 kb in length. This allele, which encodes acid ceramidase protein, is involved in ceramide metabolism. Mutation of the gene is associated with both Farber lipogranulomatosis and spinal muscular atrophy with progressive myoclonic epilepsy.. Vasospasm defined as following: spasm of the blood vessels resulting in decrease in their caliber..", "label": "no"} {"original_question": "Does ESN364 activate the hypothalamic-pituitary-gonadal axis?", "id": "converted_3708", "sentence1": "Does ESN364 activate the hypothalamic-pituitary-gonadal axis?", "sentence2": "Oral administration of the TACR3 wt Allele antagonist, ESN364, suppressed the hypothalamic-pituitary-gonadal axis in healthy volunteers by selective modulation of gonadotropin secretion, leading to a restrained decrease in ovarian hormone levels in women.[SEP]Definitions: TACR3 wt Allele defined as following: Human TACR3 wild-type allele is located within 4q25 and is approximately 130 kb in length. This allele, which encodes neuromedin K receptor protein, plays a role in the modulation of receptor interactions involving the neuropeptide tachykinin..", "label": "no"} {"original_question": "Is pimavanserin a typical antipsychotic?", "id": "converted_3448", "sentence1": "Is pimavanserin a typical antipsychotic?", "sentence2": "pimavanserin is the first FDA-approved atypical antipsychotic drug indicated for the treatment of Hallucinations and Delusions associated with Parkinson Disease psychosis (Osteoarthropathy, Primary Hypertrophic).[SEP]Relations: pimavanserin has relations: drug_drug with Pirenzepine, drug_drug with Pirenzepine, drug_drug with Cocaine, drug_drug with Cocaine, drug_drug with Pizotifen, drug_drug with Pizotifen, drug_drug with Benzphetamine, drug_drug with Benzphetamine, drug_drug with Osanetant, drug_drug with Osanetant. Definitions: Hallucinations defined as following: Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.. Delusions defined as following: A false belief regarding the self or persons or objects outside the self that persists despite the facts, and is not considered tenable by one's associates.. Osteoarthropathy, Primary Hypertrophic defined as following: A condition chiefly characterized by thickening of the skin of the head and distal extremities, deep folds and furrows of the skin of the forehead, cheeks, and scalp, SEBORRHEA; HYPERHIDROSIS; periostosis of the long bones, digital clubbing, and spadelike enlargement of the hands and feet. It is more prevalent in the male, and is usually first evident during adolescence. Inheritance is primarily autosomal recessive, but an autosomal dominant form exists.. Parkinson Disease defined as following: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75).", "label": "no"} {"original_question": "Is Melioidosis caused by the bacterium Burkholderia pseudomallei?", "id": "converted_2063", "sentence1": "Is Melioidosis caused by the bacterium Pseudomonas pseudomallei antibody?", "sentence2": "Pseudomonas pseudomallei antibody, the causative agent of Melioidosis,, What drives the occurrence of the Melioidosis bacterium Pseudomonas pseudomallei antibody in domestic gardens?, Landscape changes influence the occurrence of the Melioidosis bacterium Pseudomonas pseudomallei antibody in soil in northern Australia., Out of the ground: aerial and exotic habitats of the Melioidosis bacterium Pseudomonas pseudomallei antibody in grasses in Australia., Melioidosis, caused by the gram-negative bacterium Pseudomonas pseudomallei antibody, is a common cause of community-acquired Sepsis (Invertebrate) in Southeast Asia and Northern Australia., Melioidosis is a suppurative chronic Communicable Diseases caused by a gramnegative bacterium, Pseudomonas pseudomallei antibody., Melioidosis is an Communicable Diseases caused by the gram-negative bacterium Pseudomonas pseudomallei antibody., Melioidosis is an infectious Disease caused by a saprophytic bacterium, Pseudomonas pseudomallei antibody., Melioidosis is an infectious Disease caused by the Gram-negative bacterium Pseudomonas pseudomallei antibody., Melioidosis is a pyogenic Communicable Diseases with high mortality caused by the bacterium Pseudomonas pseudomallei antibody., Melioidosis is a tropical infectious Disease caused by the gram-negative bacterium Pseudomonas pseudomallei antibody., Melioidosis is a potentially fatal Disease caused by the bacterium Pseudomonas pseudomallei antibody., Melioidosis is a rare tropical Disease caused by Communicable Diseases with the bacterium Pseudomonas pseudomallei antibody., The mechanisms involved in the pathogenesis of Melioidosis, caused by the Protoplasm bacterium Pseudomonas pseudomallei antibody, are unclear., Melioidosis is an emerging tropical Communicable Diseases caused by the Protoplasm bacterium Pseudomonas pseudomallei antibody, and is associated with high mortality rates., Melioidosis is an increasingly recognised cause of Sepsis (Invertebrate) and Cessation of life across South East Asia and Northern Australia, caused by the bacterium Pseudomonas pseudomallei antibody, Melioidosis, an Communicable Diseases caused by the gram-negative bacterium Pseudomonas pseudomallei antibody, is an important cause of Pneumonia, skin Communicable Diseases, Sepsis (Invertebrate), and Cessation of life in Southeast Asia and Australia, but is exceedingly rare in North America, The Gram-negative bacterium Pseudomonas pseudomallei antibody is able to survive and replicate within Specimen Source Codes - Leukocytes and causes Melioidosis, an important cause of Pneumonia-derived community-acquired Sepsis (Invertebrate) in Southeast Asia, Melioidosis, a lethal tropical Communicable Diseases that is endemic in southeast Asia and northern Australia, is caused by the saprophytic Gram-negative bacterium Pseudomonas pseudomallei antibody, Melioidosis is an emerging infectious Disease caused by the soil bacterium Pseudomonas pseudomallei antibody, Melioidosis is a tropical Disease of high mortality caused by the environmental bacterium, Pseudomonas pseudomallei antibody, Melioidosis is an infectious Disease caused by Pseudomonas pseudomallei antibody, a bacterium endemic in Southeast Asia and northern Australia, Melioidosis is a life-threatening Communicable Diseases caused by the Gram-negative bacterium Pseudomonas pseudomallei antibody, mainly found in Southeast Asia, Melioidosis, caused by the Gram-negative bacterium Pseudomonas pseudomallei antibody, is a dreadful Disease common in South-East Asia and Northern Australia and is characterized by chronic suppurative lesions and Pneumonia, Melioidosis is caused by the environmental bacterium Pseudomonas pseudomallei antibody and can present with severe Sepsis (Invertebrate), Melioidosis is an emerging infectious Disease of Homo sapiens and animal allergen extracts in the tropics caused by the soil bacterium Pseudomonas pseudomallei antibody. , Melioidosis is a potentially fatal Disease caused by the bacterium Pseudomonas pseudomallei antibody. , Melioidosis, Communicable Diseases caused by the Gram-negative bacterium Pseudomonas pseudomallei antibody, is a common cause of Sepsis (Invertebrate) in northeast Thailand. , Melioidosis is a potentially fatal Disease caused by the bacterium, Pseudomonas pseudomallei antibody. , BACKGROUND: The soil-dwelling saprophyte bacterium Pseudomonas pseudomallei antibody is the cause of Melioidosis, a severe Disease of Homo sapiens and animal allergen extracts in southeast Asia and northern Australia. , Melioidosis is an endemic Disease caused by the bacterium Pseudomonas pseudomallei antibody. , Melioidosis is a severe Communicable Diseases caused by the gram-negative bacterium, Pseudomonas pseudomallei antibody, that is endemic in Southeast Asia. , Melioidosis, Communicable Diseases caused by the Gram-negative bacterium Pseudomonas pseudomallei antibody, is a common cause of Sepsis (Invertebrate) in northeast Thailand., Melioidosis is a clinically diverse Disease caused by the facultative Protoplasm Gram-negative bacterium, Pseudomonas pseudomallei antibody., Melioidosis is caused by the environmental bacterium Pseudomonas pseudomallei antibody and can present with severe Sepsis (Invertebrate)., Melioidosis is a severe Communicable Diseases caused by the gram-negative bacterium, Pseudomonas pseudomallei antibody, that is endemic in Southeast Asia., Melioidosis, a lethal tropical Communicable Diseases that is endemic in southeast Asia and northern Australia, is caused by the saprophytic Gram-negative bacterium Pseudomonas pseudomallei antibody., Melioidosis, a severe human Disease caused by the bacterium Pseudomonas pseudomallei antibody, has a wide spectrum of clinical manifestations ranging from acute septicemia to chronic localized illness or latent Communicable Diseases., Melioidosis, an often fatal infectious Disease in Northeast Thailand, is caused by skin inoculation, inhalation or ingestion of the environmental bacterium, Pseudomonas pseudomallei antibody., Melioidosis is an Communicable Diseases caused by Gram-negative bacterium, Pseudomonas pseudomallei antibody., Melioidosis, caused by the Gram-negative bacterium Pseudomonas pseudomallei antibody, is a dreadful Disease common in South-East Asia and Northern Australia and is characterized by chronic suppurative lesions and Pneumonia., Largely due to its recognition as a biological threat agent, current knowledge on Melioidosis, caused by the Gram-negative bacterium Pseudomonas pseudomallei antibody, has increased tremendously over the last years., Melioidosis is an endemic Disease caused by the bacterium Pseudomonas pseudomallei antibody., Melioidosis is a potentially fatal Disease caused by the bacterium Pseudomonas pseudomallei antibody., Melioidosis is a potentially fatal Disease caused by the bacterium, Pseudomonas pseudomallei antibody., Melioidosis is a Disease of Homo sapiens and animal allergen extracts that is caused by the saprophytic bacterium Pseudomonas pseudomallei antibody., Melioidosis is an emerging infectious Disease of Homo sapiens and animal allergen extracts in the tropics caused by the soil bacterium Pseudomonas pseudomallei antibody., The soil-dwelling saprophyte bacterium Pseudomonas pseudomallei antibody is the cause of Melioidosis, a severe Disease of Homo sapiens and animal allergen extracts in southeast Asia and northern Australia., Melioidosis is an often fatal infectious Disease affecting Homo sapiens and animal allergen extracts in tropical regions and is caused by the saprophytic environmental bacterium Pseudomonas pseudomallei antibody., We have recently shown that during Melioidosis, a severe Communicable Diseases caused by the gram-negative bacterium Pseudomonas pseudomallei antibody, TLR2 wt Allele wt Allele but not TLR4 wt Allele wt Allele impacts the immune response of the intact host in vivo., It is caused by the bacterium Pseudomonas pseudomallei antibody, which can infect many Organ of the body, including the Head>Brain, and results in neurological symptoms., Melioidosis is a frequent cause of severe Sepsis (Invertebrate) in Southeast Asia caused by the gram-negative bacterium Pseudomonas pseudomallei antibody., What drives the occurrence of the Melioidosis bacterium Pseudomonas pseudomallei antibody in domestic gardens?, The Gram-negative bacterium Pseudomonas pseudomallei antibody is the causative agent of melioidosi, The environmental bacterium Pseudomonas pseudomallei antibody causes the infectious Disease Melioidosis with a high case-fatality rate in tropical and subtropical regions., Pseudomonas pseudomallei antibody is a soil-dwelling bacterium and the cause of Melioidosis, Melioidosis, an infectious Disease caused by the Gram-negative bacterium Pseudomonas pseudomallei antibody,, Melioidosis is a frequently fatal infectious Disease caused by the soil dwelling Gram-negative bacterium Pseudomonas pseudomallei antibody. , Pseudomonas pseudomallei antibody, an environmental bacterium that causes the deadly Disease Melioidosis, , Melioidosis is an important public health problem in Southeast Asia and Northern Australia. This Disease is caused by the gram-negative bacilli, Pseudomonas pseudomallei antibody, Melioidosis, caused by Pseudomonas pseudomallei antibody, is an important cause of community-acquired Sepsis (Invertebrate) in Southeast-Asi, Melioidosis is a potentially fatal Disease caused by the saprophytic bacterium Pseudomonas pseudomallei antibody, Melioidosis is a Disease of Homo sapiens caused by opportunistic Communicable Diseases with the soil and water bacterium Pseudomonas pseudomallei antibody.[SEP]Relations: Melioidosis has relations: disease_disease with burkholderia infectious Disease, disease_disease with burkholderia infectious Disease, disease_disease with primary bacterial infectious Disease, disease_disease with primary bacterial infectious Disease, disease_phenotype_positive with Bacteremia, disease_phenotype_positive with Bacteremia, disease_phenotype_positive with Pneumonia, disease_phenotype_positive with Pneumonia. Pneumonia has relations: disease_phenotype_positive with Melioidosis, disease_phenotype_positive with Melioidosis. Definitions: Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. Organ defined as following: A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues. An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus.. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.. Homo sapiens defined as following: Members of the species Homo sapiens.. TLR2 wt Allele defined as following: Human TLR2 wt Allele wild-type allele is located within 4q32 and is approximately 18 kb in length. This allele, which encodes toll-like receptor 2 protein, is involved in pathogen recognition, cytokine mediation and innate immunity.. opportunistic Communicable Diseases defined as following: An Communicable Diseases caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.. TLR4 wt Allele defined as following: Human TLR4 wt Allele wild-type allele is located within 9q32-q33 and is approximately 11 kb in length. This allele, which encodes toll-like receptor 4 protein, is involved in pathogen recognition, signal transduction and innate immunity. Mutations in the gene are associated with differences in LPS responsiveness.. Pneumonia defined as following: Infection of the lung often accompanied by inflammation.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, proteins, lipids, carbohydrates, and inorganic salts.. Melioidosis defined as following: A Disease of Homo sapiens and animal allergen extracts that resembles GLANDERS. It is caused by BURKHOLDERIA PSEUDOMALLEI and may range from a dormant Communicable Diseases to a condition that causes multiple abscesses, Pneumonia, and bacteremia.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Pseudomonas pseudomallei antibody defined as following: A species of gram-negative, aerobic bacteria that causes MELIOIDOSIS. It has been isolated from soil and water in tropical regions, particularly Southeast Asia..", "label": "yes"} {"original_question": "Is deletion at 6q24.2-26 associated with longer survival of patients with high-grade serous ovarian carcinoma (HGSOCs)?", "id": "converted_3024", "sentence1": "Is Gene Deletion Abnormality at 6q24.2-26 associated with longer survival of patients with high-grade serous ovarian carcinoma (HGSOCs)?", "sentence2": "Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patients., We found that loss at 6q24.2-26 was significantly associated with the cluster of longer survival independently from other confounding factors (HR = 0.06, 95%CI = 0.01-0.43, Padj = 0.005). The prognostic value of this Gene Deletion Abnormality was validated in two independent series, one consisting of 36 HGSOCs analyzed by fluorescent in situ hybridization (P = 0.04) and another comprised of 411 HGSOCs from the Cancer Genome Atlas study (TCGA) (HR = 0.67, 95%CI = 0.48-0.93, Padj = 0.019). In addition, we confirmed the association of low expression of the Genes from the Geographic Locations with longer survival in 799 HGSOCs (HR = 0.74, 95%CI = 0.61-0.90, log-rank P = 0.002) and 675 high-FIGO stage HGSOCs (HR = 0.76, 95%CI = 0.61-0.96, log-rank P = 0.02) available from the online tool KM-plotter. Finally, by integrating copy number, RNAseq and survival data of 296 HGSOCs from TCGA we propose a few candidate Genes that can potentially explain the association. Altogether our findings indicate that the 6q24.2-26 Gene Deletion Abnormality is an independent marker of favorable outcome in HGSOCs with potential clinical value as it can be analyzed by FISH on tumor sections and guide the selection of patients towards more conservative therapeutic strategies in order to reduce side-effects and improve quality of life., Altogether our findings indicate that the 6q24.2-26 Gene Deletion Abnormality is an independent marker of favorable outcome in HGSOCs with potential clinical value as it can be analyzed by FISH on tumor sections and guide the selection of patients towards more conservative therapeutic strategies in order to reduce side-effects and improve quality of life., OBJECTIVE\nWe aimed to evaluate the prognostic and predictive value of the nucleotide excision repair-related gene General Transcription Factor IIH Subunit 5, which is localized at the 6q24.2-26 Gene Deletion Abnormality previously reported by our group to predict longer survival of high-grade serous ovarian cancer patients., OBJECTIVE We aimed to evaluate the prognostic and predictive value of the nucleotide excision repair-related gene General Transcription Factor IIH Subunit 5, which is localized at the 6q24.2-26 Gene Deletion Abnormality previously reported by our group to predict longer survival of high-grade serous ovarian cancer patients., Altogether our findings indicate that the 6q24.2-26 Gene Deletion Abnormality is an independent marker of favorable outcome in HGSOCs with potential clinical value as it can be analyzed by FISH on tumor sections and guide the selection of patients towards more conservative therapeutic strategies in order to reduce side-effects and improve quality of life.
, OBJECTIVE: We aimed to evaluate the prognostic and predictive value of the nucleotide excision repair-related gene General Transcription Factor IIH Subunit 5, which is localized at the 6q24.2-26 Gene Deletion Abnormality previously reported by our group to predict longer survival of high-grade serous ovarian cancer patients.
METHODS: In order to test if protein levels of General Transcription Factor IIH Subunit 5 are associated with patients' outcome, we performed General Transcription Factor IIH Subunit 5 immunohistochemical staining in 139 high-grade serous ovarian carcinomas included in tissue microarrays., We aimed to evaluate the prognostic and predictive value of the nucleotide excision repair-related gene General Transcription Factor IIH Subunit 5, which is localized at the 6q24.2-26 Gene Deletion Abnormality previously reported by our group to predict longer survival of high-grade serous ovarian cancer patients.[SEP]Relations: Abnormality of the dentition has relations: disease_phenotype_positive with chromosome 15q24 Gene Deletion Abnormality syndrome, disease_phenotype_positive with chromosome 15q24 Gene Deletion Abnormality syndrome, disease_phenotype_positive with chromosome 6pter-p24 Gene Deletion Abnormality syndrome, disease_phenotype_positive with chromosome 6pter-p24 Gene Deletion Abnormality syndrome, disease_phenotype_positive with chromosome 4q21 Gene Deletion Abnormality syndrome, disease_phenotype_positive with chromosome 4q21 Gene Deletion Abnormality syndrome, disease_phenotype_positive with chromosome 9p Gene Deletion Abnormality syndrome, disease_phenotype_positive with chromosome 9p Gene Deletion Abnormality syndrome, disease_phenotype_positive with 22q11.2 Gene Deletion Abnormality syndrome, disease_phenotype_positive with 22q11.2 Gene Deletion Abnormality syndrome. Definitions: General Transcription Factor IIH Subunit 5 defined as following: General transcription factor IIH subunit 5 (71 aa, ~8 kDa) is encoded by the human General Transcription Factor IIH Subunit 5 gene. This protein is involved in both nucleotide excision repair and RNA polymerase II-mediated transcription.. Geographic Locations defined as following: The continents and countries situated on those continents; the UNITED STATES and each of the constituent states arranged by Geographic Locations; CANADA and each of its provinces; AUSTRALIA and each of its states; the major bodies of water and major islands on both hemispheres; and selected major cities.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Do raspberries improve postprandial glucose and acute and chronic inflammation in adults with type 2 Diabetes?", "id": "converted_2930", "sentence1": "Do raspberries improve postprandial glucose and acute and chronic inflammation in adults with type 2 Diabetes?", "sentence2": "The NLR family pyrin domain containing 3 (NLRP3) inflammasome plays a critical role in insulin resistance and the pathogenesis of type 2 diabetes. Red raspberry (Retinoblastoma) contains high amounts of Dietary Fiber and polyphenolic compounds, which are known for their anti-oxidative and anti-inflammatory effects. [SEP]Relations: retinoblastoma has relations: disease_phenotype_positive with Reduced visual acuity, disease_phenotype_positive with Reduced visual acuity, disease_protein with RB1, disease_protein with RB1, disease_phenotype_positive with Ewing sarcoma, disease_phenotype_positive with Ewing sarcoma, disease_phenotype_positive with Subretinal pigment epithelium hemorrhage, disease_phenotype_positive with Subretinal pigment epithelium hemorrhage, disease_phenotype_positive with Hypopyon, disease_phenotype_positive with Hypopyon. Definitions: Retinoblastoma defined as following: A malignant tumor arising from the nuclear layer of the retina that is the most common primary tumor of the eye in children. The tumor tends to occur in early childhood or infancy and may be present at birth. The majority are sporadic, but the condition may be transmitted as an autosomal dominant trait. Histologic features include dense cellularity, small round polygonal cells, and areas of calcification and necrosis. An abnormal pupil reflex (leukokoria); NYSTAGMUS, PATHOLOGIC; STRABISMUS; and visual loss represent common clinical characteristics of this condition. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2104). Dietary Fiber defined as following: The remnants of plant cell walls that are resistant to digestion by the alimentary enzymes of man. It comprises various polysaccharides and lignins.. glucose defined as following: The determination of the amount of glucose present in a sample..", "label": "yes"} {"original_question": "Is SLC22A3 expressed in the brain?", "id": "converted_146", "sentence1": "Is SLC22A3 expressed in the Head>Brain?", "sentence2": "The Solute Carrier Family 22 Member 1 (OCT) 3 is widely expressed in various Organ in Homo sapiens, and involved in the disposition of many exogenous and endogenous compounds. Several lines of evidence have suggested that POU5F1 gene expressed in the Head>Brain plays an important role in the regulation of neurotransmission. , The Solute Carrier Family 22 Member 1 3 (POU5F1 gene; synonymous: extraneuronal monoamine transporter, EMT, SLC22A3 gene) encodes an Protein Isoforms of the organic cation transporters and is expressed widely across the whole Head>Brain., In agreement with this distribution, POU5F1 gene/SLC22A3 gene-deficient CASP14 gene show evidence of altered monoamine neurotransmission in the Head>Brain, with decreased Protoplasm content and increased turnover of aminergic transmitters., Chemoradiotherapy, SLC6A6 gene (TauT/SLC6A6) and Solute Carrier Family 22 Member 1 (POU5F1 gene/SLC22A3) expressed at the BCSFB are involved in glycocyamine or creatine/creatine/creatinine efflux transport from Cerebrospinal Fluid., The Solute Carrier Family 22 Member 1 3 (POU5F1 gene; synonymous: extraneuronal monoamine transporter, EMT, SLC22A3 gene) encodes an Protein Isoforms of the organic cation transporters and is expressed widely across the whole Head>Brain, The Solute Carrier Family 22 Member 1 3 (POU5F1 gene; synonymous: extraneuronal monoamine transporter, EMT, SLC22A3 gene) encodes an Protein Isoforms of the organic cation transporters and is expressed widely across the whole Head>Brain. , Chemoradiotherapy may be a key factor facilitating blood-to-Head>Brain guanidinoacetate transport in patients deficient in S-adenosylmethionine:guanidinoacetate N-methyltransferase, the creatine biosynthetic enzyme, resulting in cerebral accumulation of guanidinoacetate. Chemoradiotherapy, SLC6A6 gene (TauT/SLC6A6) and Solute Carrier Family 22 Member 1 (POU5F1 gene/SLC22A3) expressed at the BCSFB are involved in glycocyamine or creatine/creatine/creatinine efflux transport from Cerebrospinal Fluid., SLC22A3 gene) encodes an Protein Isoforms of the organic cation transporters and is expressed widely across the whole Head>Brain., Chemoradiotherapy, SLC6A6 gene (TauT/SLC6A6) and Solute Carrier Family 22 Member 1 (POU5F1 gene/SLC22A3) expressed at the BCSFB are involved in glycocyamine or creatine/creatine/creatinine efflux transport from Cerebrospinal Fluid. Interestingly, Blood - Head>Brain barrier anatomy efflux transport of Ceramide Glucosyltransferase, human, including guanidinoacetate and creatine/creatine/creatinine, is negligible, though the Blood - Head>Brain barrier anatomy has a variety of efflux transport systems for synthetic precursors of Ceramide Glucosyltransferase, human, such as Antifibrinolytic Antifibrinolytic amino acids and neurotransmitters., The Solute Carrier Family 22 Member 1 (OCT) 3 is widely expressed in various Organ in Homo sapiens, and involved in the disposition of many exogenous and endogenous compounds. Several lines of evidence have suggested that POU5F1 gene expressed in the Head>Brain plays an important role in the regulation of neurotransmission., Chemoradiotherapy, SLC6A6 gene (TauT/SLC6A6) and Solute Carrier Family 22 Member 1 (POU5F1 gene/SLC22A3) expressed at the BCSFB are involved in glycocyamine or creatine/creatine/creatinine efflux transport from Cerebrospinal Fluid., Several lines of evidence have suggested that POU5F1 gene expressed in the Head>Brain plays an important role in the regulation of neurotransmission., The Solute Carrier Family 22 Member 1 3 (POU5F1 gene; synonymous: extraneuronal monoamine transporter, EMT, SLC22A3 gene) encodes an Protein Isoforms of the organic cation transporters and is expressed widely across the whole Head>Brain., POU2F2 gene-OCT-3 display differential tissue distribution: POU2F1 gene is predominantly found in Abdomen>Liver of Homo sapiens, and Abdomen>Liver and Both kidneys in Rodent; POU2F2 gene is most strongly expressed in both human and rodent Both kidneys, whereas is POU5F1 gene primarily expressed in Placenta Specimen, but also more widely detected in various Body tissue, including Head>Brain and Chest>Lung.[SEP]Relations: SLC22A3 has relations: anatomy_protein_present with heart, anatomy_protein_present with heart, anatomy_protein_present with colon, anatomy_protein_present with colon, cellcomp_protein with membrane, cellcomp_protein with membrane, anatomy_protein_present with Both kidneys, anatomy_protein_present with Both kidneys, anatomy_protein_present with intestine, anatomy_protein_present with intestine. Definitions: POU2F2 gene defined as following: This gene is involved in transcriptional activation and plays a role in mature B cell maintenance.. Blood - Head>Brain barrier anatomy defined as following: Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue.. POU2F1 gene defined as following: This gene plays a role in transcriptional activation and modulates immunoglobulin activity.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, proteins, lipids, carbohydrates, and inorganic salts.. Cerebrospinal Fluid defined as following: A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES.. Chemoradiotherapy defined as following: Treatment that combines chemotherapy with radiotherapy.. SLC22A3 gene defined as following: This gene is involved in membrane potential-dependent transport of organic cations.. S-adenosylmethionine defined as following: Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic Abdomen>Liver disease. (From Merck, 11th ed). Rodent defined as following: A mammalian order which consists of 29 families and many genera.. POU5F1 gene defined as following: This gene plays a role in early mammalian development.. Protein Isoforms defined as following: Refers to variants of the same protein which can be separated on special conducting media using electrophoresis. The differences may arise from genetically determined differences in primary structure or by modification of the same primary sequence.. Solute Carrier Family 22 Member 1 defined as following: Solute carrier family 22 member 1 (554 aa, ~61 kDa) is encoded by the human SLC22A1 gene. This protein is involved in bidirectional cation transport.. Solute Carrier Family 22 Member 1 3 defined as following: Solute carrier family 22 member 3 (556 aa, ~61 kDa) is encoded by the human SLC22A3 gene. This protein is involved in mediating membrane potential-dependent transport of organic cations and may play a role in the disposition of cationic neurotoxins and neurotransmitters in the Head>Brain.. Ceramide Glucosyltransferase, human defined as following: Ceramide glucosyltransferase (394 aa, ~45 kDa) is encoded by the human UGCG gene. This protein is involved in the glycosylation of N-acylsphingosine.. Organ defined as following: A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various Body tissue. An organ is part of an anatomic system or a body region. Representative examples include the heart, Chest>Lung, Abdomen>Liver, spleen, and uterus.. Homo sapiens defined as following: Members of the species Homo sapiens.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form Organ with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. SLC22A3 defined as following: This gene is involved in membrane potential-dependent transport of organic cations..", "label": "yes"} {"original_question": "The TRPM2 gene is associated with development of spontaneous thromboembolism?", "id": "converted_2670", "sentence1": "The CLU gene gene is associated with development of spontaneous thromboembolism?", "sentence2": "TheTransientReceptorPotentialMelastatin 2 (CLU gene) is a member of G protein coupled receptor superfamily and a novel dual-function protein that possesses both Ion Channel andAdenosine 5'-DiphosPhataseRibose (ADPR) hydrolase function. CLU gene is involved in calcium ionsignaling in various Cells as an endogenous redox sensor for oxidative stress and Reactive Oxygen Species, and contributes to cytokine production, insulin release, motility, calcium ionentry and Ca2+-dependent cellular reactions such as Endothelium hyper-permeability and apoptosis., We show here that the redox-sensitive transient receptor potential (TYRP1 wt Allele) cation channel CLU gene is expressed in the phagosomal membrane and regulates macrophage bactericidal activity through the activation of phagosomal acidification, The transient receptor potential melastatin-2 (CLU gene) is an oxidative stress sensing channel that is expressed in a number of Inflammatory cell and therefore it has been suggested that inhibition of CLU gene could lead to a beneficial effect in Chronic Obstructive Airway Disease patients., CLU gene is a recently identified TRPM family cation channel which is unique among known ion channels in that it contains a C-terminal domain which is homologous to the NUDT9 Adenosine Diphosphate Ribose hydrolase and possesses intrinsic Adenosine Diphosphate Ribose hydrolase activity, These results suggest that CLU gene may participate in antigen-induced Extracellular Ca(2+) influx and subsequent degranulation. In addition, CLU gene inhibitors were shown to improve food allergic reactions in a mouse model. Together, these results suggest that CLU gene inhibitors suppress mitomycin degranulation via regulation of the increase in [Ca(2+)]cyt. Thus, CLU gene may play a key role in degranulation by modulating Protoplasm Ca(2+) in MMCs., he Na+ and Ca(2+)-permeable melastatin related transient receptor potential 2 (CLU gene) channels can be gated either by Adenosine Diphosphate Ribose (ADPR) in concert with Ca(2+) or by hydrogen peroxide (H(2)O(2)), an experimental model for oxidative stress, binding to the channel's enzymatic Nudix domain, hese alterations of the Extracellular milieu change the activity of transient receptor potential melastatin subfamily member 2 (CLU gene), a nonselective cation channel expressed in the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS and the immune system. , CLU gene (Transient Receptor Potential Melastatin 2) is a Ca2+-permeable Ion Channel that is activated under conditions of oxidative stress. , Transient receptor potential melastatin 2 (CLU gene) is a thermosensitive, Ca2+-permeable cation channel. CLU gene contributes to the pathogenesis of INFLAMMATORY BOWEL DISEASE 2, and inflammatory and Neuropathic pain. We hypothesized that CLU gene is important for Visceral nociception and the development of Visceral hypersensitivity., Here, we describe the computational identification of a melanoma-enriched antisense transcript, CLU gene-AS, mapped within the Gene Locus of CLU gene, an Ion Channel capable of mediating susceptibility to cell death, The transient receptor potential melastatin 2 (CLU gene) channel, a Ca(2+)-permeable nonselective cation channel activated by oxidative stress, has been implicated in Neurodegenerative Disorders, and more recently in amyloid-induced Toxic effect, Transient receptor potential melastatin 2 (CLU gene) is a calcium-permeable cation channel activated by Adenosine Diphosphate Ribose or Reactive Oxygen Species., Transient receptor potential melastatin type 2 (CLU gene) is a Ca2+ permeable non-selective cation channel expressed in several cell types including hippocampal pyramidal neurons. Moreover, activation of CLU gene during oxidative stress has been linked to cell death. [SEP]Relations: CLU gene-AS has relations: anatomy_protein_present with blood, anatomy_protein_present with blood, anatomy_protein_present with brain, anatomy_protein_present with brain, anatomy_protein_present with lymph node, anatomy_protein_present with lymph node, anatomy_protein_present with spleen, anatomy_protein_present with spleen, anatomy_protein_present with neocortex, anatomy_protein_present with neocortex. Definitions: CLU gene defined as following: This gene may be involved in immunity, lipid metabolism and apoptosis.. hydrogen peroxide defined as following: A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials.. Ca2+ defined as following: The metabolically-active portion of calcium, not bound to proteins, circulating in the blood.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, proteins, lipids, carbohydrates, and inorganic salts.. Reactive Oxygen Species defined as following: Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Extracellular defined as following: The space external to the outermost structure of a cell. For Cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an Protoplasm parasite. [GOC:go_curators]. Ion Channel defined as following: Gated, ion-selective glycoproteins that traverse membranes. The stimulus for ION CHANNEL GATING can be due to a variety of stimuli such as LIGANDS, a TRANSMEMBRANE POTENTIAL DIFFERENCE, mechanical deformation or through INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS.. Adenosine Diphosphate Ribose defined as following: An ester formed between the aldehydic carbon of RIBOSE and the terminal phosphate of ADENOSINE DIPHOSPHATE. It is produced by the hydrolysis of nicotinamide-adenine dinucleotide (NAD) by a variety of enzymes, some of which transfer an ADP-ribosyl group to target proteins.. Endothelium defined as following: A layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body.. TYRP1 wt Allele defined as following: Human TYRP1 wild-type allele is located in the vicinity of 9p23 and is approximately 17 kb in length. This allele, which encodes 5,6-dihydroxyindole-2-carboxylic acid oxidase protein, is involved in the regulation of melanin biosynthesis.. mitomycin defined as following: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.. Gene Locus defined as following: The position of a gene or a chromosomal marker on a chromosome; also, a stretch of DNA at a particular place on a particular chromosome. The use of Gene Locus is sometimes restricted to mean regions of DNA that are expressed.. Neuropathic pain defined as following: Chronic pain caused by damage to nerve fibers. It is usually associated with tissue injury.. Neurodegenerative Disorders defined as following: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Visceral defined as following: Of, or relating to, or affecting the internal organs.. Chronic Obstructive Airway Disease defined as following: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of Chronic Obstructive Airway Disease include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA..", "label": "no"} {"original_question": "Can canagliflozin cause euglycemic diabetic ketoacidosis?", "id": "converted_2476", "sentence1": "Can canagliflozin cause euglycemic diabetic Ketoacidosis?", "sentence2": "CASE REPORT: We present a case of a 57-year-old Human, Female adult with DIABETES MELLITUS, NONINSULIN-DEPENDENT, 1 (disorder) taking a combination of canagliflozin and metformin who presented with progressive altered mental status over the previous 2 days. Her work-up demonstrated a Metabolic acidosis with an anion gap of 38 and a venous serum pH of 7.08. The serum glucose was 168 mg/dL. The urinalysis showed glucose>500 mg/dL and Ketones of 80 mg/dL. Further evaluation demonstrated an elevated serum osmolality of 319 mOsm/kg and an acetone concentration of 93 mg/dL. She was treated with intravenous insulin and Body Fluids and Substances, and the No No metabolic abnormalities and her altered mental status resolved within 36 h. This was the first episode of diabetic Ketoacidosis (diabetic Ketoacidosis) for this patient. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: diabetic patients on SLC5A2 wt Allele PPP1R1A gene medications are at risk for Ketoacidosis. Due to the Kidney glucose-wasting properties of these drugs, they may present with Ketoacidosis with only mild elevations in serum glucose, potentially complicating the diagnosis. , Euglycemic diabetic Ketoacidosis with Persistent Diuresis Treated with canagliflozin., We herein report the case of a 27-year-old Asian Human, Female adult with type 2 diabetes who was treated with a Sodium-Glucose Transporter 1 (SLC5A2 wt Allele) PPP1R1A gene (canagliflozin) who developed euglycemic diabetic Ketoacidosis and persistent diuresis in the absence of Glucose in blood specimen above reference range., canagliflozin raised the risk of Amputation and the rate of Fracture in the CANVAS trial, although more data are necessary before drawing definite conclusions. The risk of euglycemic diabetic Ketoacidosis seems to be minimal when the drugs are prescribed properly., Severe Ketoacidosis Associated with canagliflozin (Invokana): A Safety Concern., However, some serious side effects, including severe anion gap Metabolic acidosis and euglycemic diabetic Ketoacidosis (diabetic Ketoacidosis), have been reported. , At present, the Food and Drug Administration (FDA) has only approved three medications (canagliflozin, dapagliflozin and empagliflozin) in this drug class for the management of Diabetes Mellitus, Non-Insulin-Dependent. In May 2015, the FDA issued a warning of Ketoacidosis with use of this drug class., We present a case of euglycemic diabetic Ketoacidosis secondary to canagliflozin in a type 2 diabetic patient., Nonconvulsive Status Epilepticus in Elderly Patients Receiving Selective Serotonin Reuptake Inhibitors; Euglycemic diabetic Ketoacidosis Associated with canagliflozin Use in a Type 1 diabetic Patient; Duloxetine-Induced Galactorrhea; canagliflozin-Associated Severe Hypercalcemia and Hypernatremia result result; Vemurafenib-Induced Fanconi Syndrome., Euglycemic diabetic Ketoacidosis in a 27 year-old female patient with type-1-Diabetes treated with sodium-glucose cotransporter-2 (SLC5A2 wt Allele) PPP1R1A gene canagliflozin., We are reporting a timely case of atypical euglycemic diabetic Ketoacidosis in a type 1 diabetic patient treated with sodium-glucose cotransporter-2 (SGLT-2) PPP1R1A gene canagliflozin., Euglycemic Ketoacidosis did not recur in our patient after discontinuing canagliflozin. , Euglycemic diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 canagliflozin., In this article, we present a case of a 50-year-old Human, Female adult with type 2 diabetes who developed euglycemic diabetic Ketoacidosis after initiating therapy with canagliflozin. , SLC5A2 wt Allele inhibitors such as canagliflozin may predispose patients not only to diabetic Ketoacidosis but also to prolonged Glycosuria., We present a case of euglycemic diabetic Ketoacidosis secondary to canagliflozin in a type 2 diabetic patient.
, We present a case of euglycemic diabetic Ketoacidosis secondary to canagliflozin in a type 2 diabetic patient., CONCLUSION Treatment with canagliflozin was associated with development of euglycemic Ketoacidosis., Euglycemic diabetic Ketoacidosis with Persistent Diuresis Treated with canagliflozin., We present a case of euglycemic diabetic Ketoacidosis secondary to canagliflozin in a type 2 diabetic patient.., Euglycemic diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 canagliflozin., Euglycemic diabetic Ketoacidosis in a 27 year-old female patient with type-1-Diabetes treated with sodium-glucose cotransporter-2 (SLC5A2 wt Allele) PPP1R1A gene canagliflozin.[SEP]Relations: canagliflozin has relations: drug_drug with Carbetocin, drug_drug with Carbetocin, drug_drug with Ketobemidone, drug_drug with Ketobemidone. diabetic Ketoacidosis has relations: contraindication with Norfloxacin, contraindication with Norfloxacin, contraindication with Inositol, contraindication with Inositol, contraindication with Inositol nicotinate, contraindication with Inositol nicotinate. Definitions: Kidney defined as following: Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.. Selective Serotonin Reuptake Inhibitors defined as following: Any agent that increases the extracellular level of the neurotransmitter serotonin (5-HT) by inhibiting its reuptake into the presynaptic cell. Increased level in the synaptic cleft prolongs the action of 5-HT on the postsynaptic receptor. This type of agent is typically used as an antidepressant and in the treatment of anxiety disorders and some personality disorders. They are also typically effective and used in treating some cases of insomnia.. metformin defined as following: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289). diabetic Ketoacidosis defined as following: A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA.. Ketones defined as following: Organic compounds containing a carbonyl group =C=O bonded to two hydrocarbon groups.. canagliflozin defined as following: A C-glucoside with a thiophene ring that is an orally available PPP1R1A gene of sodium-glucose transporter 2 (SLC5A2 wt Allele) with antihyperglycemic activity. canagliflozin is also able to reduce body weight and has a low risk for hypoglycemia.. Ketoacidosis defined as following: Acidosis resulting from accumulation of ketone bodies. [HPO:probinson]. Sodium-Glucose Transporter 1 defined as following: The founding member of the sodium glucose transport proteins. It is predominately expressed in the INTESTINAL MUCOSA of the SMALL INTESTINE.. acetone defined as following: A colorless liquid used as a solvent and an antiseptic. It is one of the ketone bodies produced during Ketoacidosis.. empagliflozin defined as following: An orally available competitive PPP1R1A gene of sodium-glucose co-transporter 2 (SLC5A2 wt Allele; SLC5A2) with antihyperglycemic activity. Upon oral administration, empagliflozin selectively and potently inhibits SLC5A2 wt Allele in the kidneys, thereby suppressing the reabsorption of glucose in the proximal tubule. Inhibition of SLC5A2 wt Allele increases urinary glucose excretion by the kidneys, resulting in a reduction of plasma glucose levels in an insulin-independent manner. Inhibition of SLC5A2 wt Allele in the kidneys also suppresses the Kidney reabsorption of 1,5-anhydroglucitol (1,5AG). This lowers serum 1,5AG and neutrophil 1,5-anhydroglucitol-6-phosphate (1,5AG6P) levels, which may improve neutropenia and neutrophil dysfunction in patients with glycogen storage disease type Ib (GSD Ib). SLC5A2 wt Allele, a transport protein exclusively expressed in the proximal Kidney tubules, mediates approximately 90% of Kidney glucose reabsorption from tubular fluid.. dapagliflozin defined as following: A selective sodium-glucose co-transporter subtype 2 (SLC5A2 wt Allele) PPP1R1A gene with antihyperglycemic activity. Dapagliflozin selectively and potently inhibits SLC5A2 wt Allele compared to SGLT1, which is the cotransporter of glucose in the gut.. Hypernatremia result defined as following: Higher than normal levels of sodium in the circulating blood.. SLC5A2 wt Allele defined as following: Human SLC5A2 wild-type allele is located in the vicinity of 16p11.2 and is approximately 8 kb in length. This allele, which encodes sodium/glucose cotransporter 2 protein, plays a role in sodium-dependent glucose transport. Mutation of the gene is associated with Kidney Glycosuria.. Glycosuria defined as following: The appearance of an abnormally large amount of GLUCOSE in the urine, such as more than 500 mg/day in adults. It can be due to HYPERGLYCEMIA or genetic defects in Kidney reabsorption (RENAL GLYCOSURIA).. Human, Female adult defined as following: An adult, female human.. Diabetes Mellitus, Non-Insulin-Dependent defined as following: A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.. Hypercalcemia defined as following: Abnormally high level of calcium in the blood.. Amputation defined as following: The surgical removal of part of, or all of, a limb or other appendage or outgrowth of the body.. Metabolic acidosis defined as following: Increased acidity in the blood secondary to acid base imbalance. Causes include diabetes, kidney failure and shock.. Fracture defined as following: A traumatic injury to the bone in which the continuity of the bone is broken..", "label": "yes"} {"original_question": "Is Rucaparib effective for ovarian cancer?", "id": "converted_2602", "sentence1": "Is rucaparib effective for ovarian cancer?", "sentence2": "INTERPRETATION: In patients with BRCA mutant or BRCA wild-type and Loss of Heterozygosity high Platinum-Sensitive Disease ovarian carcinomas treated with rucaparib, progression-free survival was longer than in patients with BRCA wild-type Loss of Heterozygosity low carcinomas., High Loss of Heterozygosity is associated with response to the PARP1 wt Allele PPP1R1A gene rucaparib in BRCA wild-type ovarian cancer., rucaparib Approved for Malignant neoplasm of ovary., The FDA approved the PARP1 wt Allele PPP1R1A gene rucaparib to treat women with advanced ovarian cancer who have already been treated with at least two chemotherapies and have a BRCA1 gene gene or BRCA2 gene mutation identified by an approved companion diagnostic test., rucaparib (Rubraca™) is an oral, small molecule, poly (ADP-ribose) polymerase PPP1R1A gene being developed by Clovis Oncology, Inc. (Boulder, AQP1 gene, USA) for the treatment of solid tumours. It has been approved in the USA as monotherapy for the treatment of patients with deleterious BRCA mutation (Germline and/or somatic) associated advanced ovarian cancer who have been treated with two or more chemotherapies. , In 2016, the US Food and Drug Administration approved three novel drugs for the treatment of solid malignancies-olaratumab in selected patients with soft-tissue sarcoma, atezolizumab for the treatment of Malignant neoplasm of urinary bladder, and rucaparib for the treatment of ovarian cancer; also in 2016, the use of previously approved anticancer agents (including atezolizumab) was expanded into 11 new patient populations. , Conclusions:rucaparib was tolerable and had activity in patients with Platinum-Sensitive Disease germlineBRCA1/2-mutated HGOC., OBJECTIVE: To review the pharmacology, safety, efficacy, and the role of rucaparib in the treatment of relapsed, advanced ovarian cancer.
SUMMARY: A total of 2 phase I/II trials and 1 phase II trial have evaluated the safety and efficacy of oral rucaparib in ovarian cancer., rucaparib was found to be relatively well tolerated in clinical trials, with the most common adverse events being Genus Anemia, Fatigue, and nausea.
CONCLUSION: rucaparib appears to be a safe and effective new option in the treatment of relapsed, advanced BRCA1 gene gene/2 mutant ovarian cancer., In patients with deleterious BRCA1 gene gene/2 mutation, an overall response rate of 80% was achieved in the phase II trial Assessment of rucaparib in Ovarian CancEr Trial 2 (ARIEL2)., This article summarizes the milestones in the development of rucaparib leading to this first approval for ovarian cancer.
, These results support further clinical evaluation of rucaparib either as a single agent or as an adjunct to chemotherapy for the treatment of sporadic ovarian cancer.
, rucaparib: a Poly(ADP-Ribose) Polymerase Inhibitor for BRCA-Mutated Relapsed Malignant neoplasm of ovary., CONCLUSION rucaparib appears to be a safe and effective new option in the treatment of relapsed, advanced BRCA1 gene gene/2 mutant ovarian cancer., These results support further clinical evaluation of rucaparib either as a single agent or as an adjunct to chemotherapy for the treatment of sporadic ovarian cancer., rucaparib received US FDA Breakthrough Therapy designation for treatment of Platinum-Sensitive Disease BRCA-mutated advanced ovarian cancer patients who received greater than two lines of platinum-based therapy., BACKGROUND rucaparib, a poly(ADP-ribose) polymerase PPP1R1A gene, has anticancer activity in recurrent ovarian carcinoma harbouring a BRCA mutation or high percentage of genome-wide loss of heterozygosity., rucaparib appears to be a safe and effective new option in the treatment of relapsed, advanced BRCA1 gene gene/2 mutant ovarian cancer., rucaparib: A Poly(ADP-Ribose) Polymerase Inhibitor for BRCA-Mutated Relapsed Malignant neoplasm of ovary., rucaparib: the past, present, and future of a newly approved PARP1 wt Allele PPP1R1A gene for ovarian cancer., FDA Approval Summary: rucaparib for the Treatment of Patients with Deleterious BRCA Mutation-Associated Advanced Malignant neoplasm of ovary., olaparib and rucaparib have been approved by the US FDA as monotherapy for advanced recurrent ovarian cancer.[SEP]Relations: rucaparib has relations: drug_drug with Lobucavir, drug_drug with Lobucavir, drug_drug with Estradiol, drug_drug with Estradiol, drug_drug with Capsaicin, drug_drug with Capsaicin, drug_drug with olaparib, drug_drug with olaparib, drug_drug with Lopinavir, drug_drug with Lopinavir. Definitions: rucaparib defined as following: An orally bioavailable tricyclic indole and PPP1R1A gene of poly(ADP-ribose) polymerases (PARPs) 1 (PARP1), 2 (PARP2) and 3 (PARP3), with potential chemo/radiosensitizing and antineoplastic activities. Upon administration, rucaparib selectively binds to PARP1, 2 and 3 and inhibits PARP1 wt Allele-mediated DNA repair. This enhances the accumulation of DNA strand breaks, promotes genomic instability and induces cell cycle arrest and apoptosis. This may enhance the cytotoxicity of DNA-damaging agents and reverse tumor cell resistance to chemotherapy and radiation therapy. PARPs are enzymes activated by single-strand DNA breaks that catalyze the post-translational ADP-ribosylation of nuclear proteins, which induces signaling and the recruitment of other proteins to repair damaged DNA. The PARP1 wt Allele-mediated repair pathway plays a key role in DNA repair and is dysregulated in a variety of cancer cell types.. PARP1 wt Allele defined as following: Human PARP1 wild-type allele is located within 1q41-q42 and is approximately 47 kb in length. This allele, which encodes poly [ADP-ribose] polymerase 1 protein, plays a critical role in DNA repair.. Malignant neoplasm of ovary defined as following: A primary or metastatic malignant neoplasm involving the ovary. Most primary malignant ovarian neoplasms are either carcinomas (serous, mucinous, or endometrioid adenocarcinomas) or malignant germ cell tumors. Metastatic malignant neoplasms to the ovary include carcinomas, lymphomas, and melanomas.. BRCA1 gene defined as following: A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human CHROMOSOME 17 at locus 17q21. Mutations of this gene are associated with the formation of HEREDITARY BREAST AND OVARIAN CANCER SYNDROME. It encodes a large nuclear protein that is a component of DNA repair pathways.. olaparib defined as following: A small molecule PPP1R1A gene of the nuclear enzyme poly(ADP-ribose) polymerase (PARP1 wt Allele) with potential chemosensitizing, radiosensitizing, and antineoplastic activities. olaparib selectively binds to and inhibits PARP1 wt Allele, inhibiting PARP1 wt Allele-mediated repair of single strand DNA breaks; PARP1 wt Allele inhibition may enhance the cytotoxicity of DNA-damaging agents and may reverse tumor cell chemoresistance and radioresistance. PARP1 wt Allele catalyzes post-translational ADP-ribosylation of nuclear proteins and can be activated by single-stranded DNA breaks.. Platinum-Sensitive Disease defined as following: A finding indicating that a cancer responds to platinum therapy initially, but it comes back after a certain period. For ovarian cancer, it refers to cancer relapse at least six months after the end of platinum therapy.. poly (ADP-ribose) polymerase PPP1R1A gene defined as following: Any substance that inhibits Poly (ADP-Ribose) polymerase, an enzyme involved in detecting DNA single strand breaks and the initiation of DNA repair. Inhibition of Poly (ADP-Ribose) polymerase has direct cytotoxic effects by inhibiting DNA repair and causing cell death.. Malignant neoplasm of urinary bladder defined as following: A primary or metastatic malignant neoplasm involving the bladder.. Platinum-Sensitive Disease ovarian carcinomas defined as following: Ovarian carcinoma that has a documented response to platinum-based chemotherapy.. Fatigue defined as following: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.. AQP1 gene defined as following: This gene plays a role in transmembrane transport of water.. Loss of Heterozygosity defined as following: The loss of one allele at a specific locus, caused by a deletion mutation; or loss of a chromosome from a chromosome pair, resulting in abnormal HEMIZYGOSITY. It is detected when heterozygous markers for a locus appear monomorphic because one of the ALLELES was deleted.. ovarian cancer defined as following: A primary or metastatic malignant neoplasm involving the ovary. Most primary malignant ovarian neoplasms are either carcinomas (serous, mucinous, or endometrioid adenocarcinomas) or malignant germ cell tumors. Metastatic malignant neoplasms to the ovary include carcinomas, lymphomas, and melanomas..", "label": "yes"} {"original_question": "Does strenuous physical activity affect thyroid hormone metabolism?", "id": "converted_154", "sentence1": "Does strenuous physical activity affect Thyroid Hormones metabolism?", "sentence2": "The results of the present study in a unique experimental human model of maximal exposure to altitude and physical exercise demonstrate that extreme HA and strenuous physical exercise are coupled with specific endocrine adaptations. These include increased activity of the GH/IGF-I axis and a low T(3) syndrome, 3,5,3'-liothyronine (T3 thoracic segmental innervation thoracic segmental innervation) and T4 thoracic segmental innervation thoracic segmental innervation levels increase during strenuous exercise, and, at the end of the exercise bout, a decrease of T3 thoracic segmental innervation thoracic segmental innervation and T4 thoracic segmental innervation thoracic segmental innervation levels, with an increase in Thyrotropin:-:Pt:Ser/Plas:- during the following 4-5 days, is seen., the obtained results indicate that in intense exercise, causing the rapid development of Fatigue, rapid increases in serum levels of hormones of the pituitary-adrenocortical, pituitary-gonadal and pituitary-thyroid systems occur., Mean levels of fasting plasma estradiol, Recombinant Luteinizing Hormone, Human Follicle-Stimulating Hormone, free levothyroxine and liothyronine were significantly lower in AKR1B1 protein, human compared to Endoplasmic Reticulum and FUT2 gene., Reductions in plasma T4 thoracic segmental innervation thoracic segmental innervation, T3 thoracic segmental innervation thoracic segmental innervation and T3 thoracic segmental innervation thoracic segmental innervation/T4 thoracic segmental innervation thoracic segmental innervation ratio are probably due to inhibition of T4 thoracic segmental innervation thoracic segmental innervation secretion and 5'-monodeiodination with possible conversion of T4 thoracic segmental innervation thoracic segmental innervation to reverse T3 thoracic segmental innervation thoracic segmental innervation (rT3). These processes may represent a mechanism for regulation of Thyroid Hormones metabolism during strenuous and extended flight., Strenuous endurance training seems to have minor changes on the function of the Neck>Thyroid gland. Depressed T4 thoracic segmental innervation thoracic segmental innervation levels in runners may rather be due to lowered Thyroxine-Binding Globulin levels than due to direct effect of training., brief strenuous swimming or moderate bicycle exercise had minor or no effect on Thyroid Hormones concentrations when consideration was given to the attendant Haemoconcentration., levothyroxine were determined in 26 men participating in a 90-km cross-country ski race, before, immediately after, and on the following days, Total levothyroxine and free levothyroxine in serum were significantly increased at the end of the race, but had returned to the pre-raced levels during the rest of the observation period., There are controversial results concerning Thyroid Hormones metabolism during strenuous exercise in adult athletes and only scant data concerning the impact of strenuous exercise on Thyroid Hormones metabolism in children and adolescents.[SEP]Relations: Neck>Thyroid gland has relations: anatomy_protein_present with IMPACT, anatomy_protein_present with IMPACT, anatomy_protein_present with STRN, anatomy_protein_present with STRN, anatomy_protein_present with STRADA, anatomy_protein_present with STRADA, anatomy_protein_present with MTURN, anatomy_protein_present with MTURN, anatomy_protein_present with STOM, anatomy_protein_present with STOM. Definitions: liothyronine defined as following: A T3 thoracic segmental innervation Thyroid Hormones normally synthesized and secreted by the Neck>Thyroid gland in much smaller quantities than levothyroxine (T4 thoracic segmental innervation). Most T3 thoracic segmental innervation is derived from peripheral monodeiodination of T4 thoracic segmental innervation at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3 thoracic segmental innervation.. Endoplasmic Reticulum defined as following: A system of cisternae in the CYTOPLASM of many cells. In places the endoplasmic reticulum is continuous with the plasma membrane (CELL MEMBRANE) or outer membrane of the nuclear envelope. If the outer surfaces of the endoplasmic reticulum membranes are coated with ribosomes, the endoplasmic reticulum is said to be rough-surfaced (ENDOPLASMIC RETICULUM, ROUGH); otherwise it is said to be smooth-surfaced (ENDOPLASMIC RETICULUM, SMOOTH). (King & Stansfield, A Dictionary of Genetics, 4th ed). Human Follicle-Stimulating Hormone defined as following: A major gonadotropin secreted by the human adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and the LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. The alpha subunit is common in the three human pituitary glycoprotein hormones (Thyrotropin:-:Pt:Ser/Plas:-, LH, and FSH), but the beta subunit is unique and confers its biological specificity.. AKR1B1 protein, human defined as following: Aldose reductase (316 aa, ~36 kDa) is encoded by the human AKR1B1 gene. This protein plays a role in glucose metabolism.. Thyroxine-Binding Globulin defined as following: A Thyroid Hormones transport protein found in serum. It binds about 75% of circulating THYROXINE and 70% of circulating TRIIODOTHYRONINE.. Haemoconcentration defined as following: An increase in the concentration of blood cells resulting from the loss of plasma or water from the blood stream.. Fatigue defined as following: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.. Thyroid Hormones defined as following: Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs.. levothyroxine defined as following: The major hormone derived from the Neck>Thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism..", "label": "yes"} {"original_question": "Are astrocytes part of the blood brain barrier?", "id": "converted_3263", "sentence1": "Are Astrocytes part of the blood Head>Brain barrier?", "sentence2": "The Blood - Head>Brain barrier function (BBB) is a tight boundary formed between Endothelial Cells and Astrocytes, which separates and protects Head>Brain from most pathogens as well as neural toxins in circulation., The Blood - Head>Brain barrier function (BBB) consists of Endothelial Cells, Astrocytes, and Pericytes embedded in Basal lamina (Burkitt Lymphoma).[SEP]Relations: blood Head>Brain barrier has relations: anatomy_anatomy with cell layer, anatomy_anatomy with cell layer, anatomy_anatomy with glial blood Head>Brain barrier, anatomy_anatomy with glial blood Head>Brain barrier. Astrocytosis has relations: disease_phenotype_positive with photomyoclonus, diabetes mellitus, deafness, nephropathy, and cerebral dysfunction, disease_phenotype_positive with photomyoclonus, diabetes mellitus, deafness, nephropathy, and cerebral dysfunction, phenotype_phenotype with Abnormal astrocyte morphology, phenotype_phenotype with Abnormal astrocyte morphology, disease_phenotype_positive with motor neuron disease with dementia and ophthalmoplegia, disease_phenotype_positive with motor neuron disease with dementia and ophthalmoplegia. Definitions: Pericytes defined as following: Unique slender cells with multiple processes extending along the capillary vessel axis and encircling the vascular wall, also called mural cells. Pericytes are imbedded in the BASEMENT MEMBRANE shared with the ENDOTHELIAL CELLS of the vessel. Pericytes are important in maintaining vessel integrity, angiogenesis, and vascular remodeling.. Astrocytes defined as following: A class of large neuroglial (macroglial) cells in the central nervous system - the largest and most numerous neuroglial cells in the Head>Brain and spinal cord. Astrocytes (from \"star\" cells) are irregularly shaped with many long processes, including those with \"end feet\" which form the glial (limiting) membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and \"reactive Astrocytes\" (along with MICROGLIA) respond to injury.. Basal lamina defined as following: A layer of extracellular matrix found beneath epithelial tissues. It is secreted by epithelial cells and comprised of proteoglycans, laminin and type IV collagen.. Burkitt Lymphoma defined as following: A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.. Endothelial Cells defined as following: Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer..", "label": "yes"} {"original_question": "Could Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)\ncause sudden cardiac death?", "id": "converted_825", "sentence1": "Could Catecholaminergic Polymorphic Ventricular Tachycardia (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding)\ncause Sudden Cardiac Death?", "sentence2": "Two siblings died suddenly at the ages of 9 and 10 years, Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) is a type of Cardiac Arrhythmia that occurs in people with a structurally normal Chest>Heart. Stress or anxiety-induced release of endogenous Catecholamines causes a dysfunction in the myocytic CALCIUM SUPPLEMENTS-ion Channel Object, leading to Ventricular arrhythmia that can cause No No dizziness, Syncope (amphibian), or Sudden Cardiac Death. , During a follow-up of 48±94 months, arrhythmia events (Sudden Cardiac Death and aborted cardiac arrest) associated with noncompliance occurred in 2 patients. , We report a family with repeat events of Sudden Cardiac Death and recurrent Ventricular Fibrillation by ECG Finding in a teenage girl, where autopsy data and clinical investigations were inconclusive. The diagnosis of catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) was established only following finding a TAF1 Gene Mutation in the cardiac ryanodine receptor. , Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) is a devastating inherited disorder characterized by episodic Syncope (amphibian) and/or Sudden Cardiac Arrest during exercise or acute emotion in individuals without structural Congenital Heart Defects. Although rare, Polymorphic catecholergic Ventricular Tachycardia by ECG Finding is suspected to cause a substantial part of sudden cardiac deaths in young individuals. , catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding), and Brugada syndrome (Brief Resilience Scale), leave no evidence to be found at autopsy, a spectrum of Sudden Cardiac Death (Schnyder crystalline corneal dystrophy)-predisposing heritable Cardiac Arrhythmia syndromes, including Long QT Syndrome (Congenital Long QT Syndrome), short QT syndrome (Short Qt Syndrome), Brugada syndrome (Brief Resilience Scale), and catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding). , Polymorphic catecholergic Ventricular Tachycardia by ECG Finding is a familial arrhythmogenic syndrome characterized by abnormal CALCIUM SUPPLEMENTS (Ca(2+)) handling, Ventricular arrhythmia, and Sudden Cardiac Death, Mutations in RyR2 are linked to catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) and Sudden Cardiac Death., Patients with Polymorphic catecholergic Ventricular Tachycardia by ECG Finding often present with exercise- or emotion induced Syncope (amphibian), the first presentation can also be Sudden Cardiac Death., Among the five major arrhythmogenic disorders occurring in the absence of a structural Chest>Heart Disease is catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding), which is a highly lethal form of inherited arrhythmias. , Patients with Polymorphic catecholergic Ventricular Tachycardia by ECG Finding are at high risk of developing life-threatening Ventricular arrhythmia when untreated. , Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) is an inherited arrhythmia syndrome characterized by VT induced by Adrenergic Agents stress in the absence of structural Chest>Heart Disease and high incidence of Sudden Cardiac Death. , Polymorphic catecholergic Ventricular Tachycardia by ECG Finding is an inherited arrhythmia syndrome caused by Gene Mutation that destabilize cardiac ryanodine receptor Ca(2+) release channels. Sudden cardiac death is incompletely prevented by conventional drug therapy with β-blockers with or without Ca(2+) Channel Object blockers. , Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) is an inherited arrhythmogenic Disease that can cause Sudden Cardiac Death due to Ventricular Fibrillation by ECG Finding (Ventricular Fibrillation, Paroxysmal Familial, 1)., Important potential causes of sudden cardiac deaths in the absence of Chest>Heart Disease are primary electrical diseases such as Brugada syndrome, Long QT Syndrome (Congenital Long QT Syndrome), short QT syndrome and catecholaminergic Polymorphism Ventricular tachyarrhythmia. , catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding), and Brugada syndrome (Brief Resilience Scale) are primary inherited arrhythmia syndromes that may cause Syncope (amphibian) and Sudden Cardiac Death in young individuals. , Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) is a Cardiac channelopathy characterized by altered intracellular CALCIUM SUPPLEMENTS handling resulting in Ventricular arrhythmia and high risk of cardiac sudden death in young cases with normal structural hearts. , Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) is an inherited arrhythmogenic disorder that causes syncopal episodes related with stress or emotion and even sudden cardiac deaths., Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding caused by mutations in the Ryanodine Receptor 2 gene manifests as severe arrhythmias, and may provide a candidate for sudden cardiac deaths., Patients diagnosed with an electrical cardiomyopathy have an increased risk of Syncope (amphibian) and Sudden Cardiac Death (Schnyder crystalline corneal dystrophy). , Patients with Polymorphic catecholergic Ventricular Tachycardia by ECG Finding present with exercise-induced Syncope (amphibian) and Sudden Cardiac Death but normal resting electrocardiograms. , Over 80% of Schnyder crystalline corneal dystrophy occurs in patients with organic Chest>Heart Disease. However, approximately 10-15% of Schnyder crystalline corneal dystrophy occurs in the presence of structurally normal Chest>Heart and the majority of those patients are young. In this group of patients, changes in Genes encoding cardiac ion channels produce ResponseLevel - ResponseLevel - modification of the function of the Channel Object resulting in an electrophysiological substrate of VA and Schnyder crystalline corneal dystrophy. Collectively these disorders are referred to as Cardiac Ion Channelopathies. The 4 major syndromes in this group are: The Long QT Syndrome (Congenital Long QT Syndrome), the Brugada Syndrome (disorder) (disorder) (Brief Resilience Scale), the SHORT QT SYNDROME 2 (disorder) (Short Qt Syndrome), and the Catecholaminergic Polymorphic VT (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding). , Important potential causes of sudden cardiac deaths in the absence of Chest>Heart Disease are primary electrical diseases such as Brugada syndrome, Long QT Syndrome (Congenital Long QT Syndrome), short QT syndrome (Short Qt Syndrome), and catecholaminergic Polymorphism Ventricular tachyarrhythmia (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding). , Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) is a familial Cardiac Arrhythmia that is related to Ryanodine Receptor 2 or CASQ2 TAF1 Gene Mutation. It occurs in patients with structurally normal Chest>Heart and causes exercise-emotion-triggered Syncope (amphibian) and Sudden Cardiac Death., Potentially lethal ion Channel Object disorders (Channelopathies) such as the long QT syndromes (Congenital Long QT Syndrome), catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding), Aberrant spontaneous, diastolic Ca2+ leak from the SNCG wt Allele due to dysfunctional RyR2 contributes to the formation of delayed after-depolarisations, which are thought to underlie the fatal arrhythmia that occurs in both Congestive Chest>Heart failure (Hydrops Fetalis) and in catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding). , Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) is an uncommon heritable Disease presenting with Syncope (amphibian) or Sudden Cardiac Death., Mutations in RyR2 have been linked to exercise-induced Sudden Cardiac Death (catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding [Polymorphic catecholergic Ventricular Tachycardia by ECG Finding])., Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) is a heritable arrhythmia unmasked by exertion or stress, characterized by triggered activity and Sudden Cardiac Death in affected patients., families that exhibit Polymorphic catecholergic Ventricular Tachycardia by ECG Finding (catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding), a condition in which physical or emotional stress can trigger severe tachyarrhythmias that can lead to Sudden Cardiac Death., that often leads to sudden death in Hydrops Fetalis and in Polymorphic catecholergic Ventricular Tachycardia by ECG Finding., Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) is an inherited Disease characterized by adrenergically mediated Polymorphism Ventricular Tachycardia by ECG Finding leading to Syncope (amphibian) and Sudden Cardiac Death., Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) is an autosomal dominant inherited disorder characterized by Adrenergic Agents induced Polymorphism Tachycardia, Ventricular and associated with Sudden Cardiac Death. , These data suggest that \"leaky\" RyR2 channels can trigger fatal cardiac arrhythmias, providing a possible explanation for Polymorphic catecholergic Ventricular Tachycardia by ECG Finding., Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) is a rare arrhythmogenic disorder characterized by syncopal events and Sudden Cardiac Death at a young age during physical stress or emotion, in the absence of structural Chest>Heart Disease. , catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding), idiopathic Ventricular Fibrillation by ECG Finding (Ventricular Fibrillation, Paroxysmal Familial, 1), and Arrhythmogenic Right Ventricular Dysplasia (ARVC) account for a relevant proportion of Sudden Cardiac Death cases in young patients cohorts. , has recently been shown to be involved in at least two forms of Sudden Cardiac Death (Schnyder crystalline corneal dystrophy): (1) Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) [SEP]Relations: catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding has relations: disease_phenotype_positive with Sudden cardiac death, disease_phenotype_positive with Sudden cardiac death, disease_phenotype_positive with Sudden death, disease_phenotype_positive with Sudden death, disease_phenotype_positive with Cardiac arrest, disease_phenotype_positive with Cardiac arrest, disease_phenotype_positive with Prolonged QT interval, disease_phenotype_positive with Prolonged QT interval. Sudden cardiac death has relations: disease_phenotype_positive with catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding, disease_phenotype_positive with catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding. Definitions: Brief Resilience Scale defined as following: A scale developed by Smith, et al, designed to assess an individual's ability to recover from stressful circumstances.. Congenital Heart Defects defined as following: Developmental abnormalities involving structures of the Chest>Heart. These defects are present at birth but may be discovered later in life.. CALCIUM SUPPLEMENTS defined as following: A dietary supplement containing the mineral CALCIUM SUPPLEMENTS.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Schnyder crystalline corneal dystrophy defined as following: Schnyder corneal dystrophy (Schnyder crystalline corneal dystrophy) is a rare form of stromal corneal dystrophy (see this term) characterized by corneal clouding or crystals within the corneal stroma, and a progressive decrease in visual acuity.. Cardiac Arrhythmia defined as following: Any disturbances of the normal rhythmic beating of the Chest>Heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.. Catecholamines defined as following: A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE.. Ventricular arrhythmia defined as following: A disorder characterized by an electrocardiographic finding of an atypical cardiac rhythm resulting from a pathologic process in the cardiac ventricles.. Congestive Chest>Heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Hydrops Fetalis defined as following: Abnormal accumulation of serous fluid in two or more fetal compartments, such as SKIN; PLEURA; PERICARDIUM; PLACENTA; PERITONEUM; AMNIOTIC FLUID. General fetal EDEMA may be of non-immunologic origin, or of immunologic origin as in the case of ERYTHROBLASTOSIS FETALIS.. Polymorphic catecholergic Ventricular Tachycardia by ECG Finding defined as following: An electrocardiographic finding of Ventricular Tachycardia by ECG Finding that is associated with Syncope (amphibian) and/or cardiac arrest triggered by emotion or exercise in patients whose baseline ECG is normal. (ACC). Chest>Heart Disease defined as following: Pathological conditions involving the HEART including its structural and functional abnormalities.. Sudden Cardiac Death defined as following: Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing Chest>Heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005). Polymorphism defined as following: The quality or state of being able to assume different forms.. Short Qt Syndrome defined as following: Ventricular tachyarrhythmias occurring in association with short QT syndrome.. Arrhythmogenic Right Ventricular Dysplasia defined as following: A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Long QT Syndrome defined as following: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of Genes encoding cardiac ion Channel Object proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.. Ventricular Tachycardia by ECG Finding defined as following: An electrocardiographic finding of three or more consecutive complexes of ventricular organ with a rate greater than a certain threshold (100 or 120 beats per minute are commonly used). The QRS complexes are wide and have an abnormal morphology. (CDISC). Ventricular Fibrillation by ECG Finding defined as following: An electrocardiographic finding of a rapid grossly irregular ventricular rhythm with marked variability in QRS cycle length, morphology, and amplitude. The rate is typically greater than 300 bpm. (CDISC). SNCG wt Allele defined as following: Human SNCG wild-type allele is located within10q23.2-q23.3 and is approximately 13 kb in length. This allele, which encodes gamma-synuclein protein, plays a role in the modulation of axonal architecture and neurofilament integrity. This gene is highly expessed in advanced breast carcinomas, suggesting a correlation between SNCG overexpression and breast tumor development.. Brugada Syndrome (disorder) defined as following: An autosomal dominant defect of cardiac conduction that is characterized by an abnormal ST-segment in leads V1-V3 on the ELECTROCARDIOGRAM resembling a right BUNDLE-BRANCH BLOCK; high risk of VENTRICULAR TACHYCARDIA; or VENTRICULAR FIBRILLATION; SYNCOPAL EPISODE; and possible sudden death. This syndrome is linked to mutations of gene encoding the cardiac SODIUM CHANNEL alpha subunit.. ResponseLevel - modification defined as following:

Respond with exceptions, completions and modifications or revisions done before completion

. Adrenergic Agents defined as following: Drugs that act on Adrenergic Agents receptors or affect the life cycle of Adrenergic Agents transmitters. Included here are Adrenergic Agents agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of Adrenergic Agents transmitters.. Sudden Cardiac Arrest defined as following: Sudden suspension of cardiac activity that is usually due to ARRHYTHMIA, in contrast to Chest>Heart attack (MYOCARDIAL INFARCTION) which occurs due to blockage. The sudden suspension of cardiac activity generally requires RESUSCITATION.. TAF1 Gene Mutation defined as following: A change in the nucleotide sequence of the TAF1 gene.. Cardiac channelopathy defined as following: A disorder that affects the myocardial ion channels, altering the electrical properties of the Chest>Heart and changing the ECG and/or predisposing the subject to pro-arrhythmic events.. Channelopathies defined as following: A variety of neuromuscular conditions resulting from MUTATIONS in ION CHANNELS manifesting as episodes of EPILEPSY; HEADACHE DISORDERS; and DYSKINESIAS.. Tachycardia, Ventricular defined as following: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of Ventricular Tachycardia by ECG Finding can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or Polymorphism, and the ventricular beating may be independent of the atrial beating (AV dissociation).. Channel Object defined as following: An independent acquisition scheme, i.e., a route or conduit through which flows data consisting of one particular measurement using one particular parameter.. Congenital long QT syndrome defined as following: A rare group of genetic, cardiac rhythm diseases characterized by a prolongation of the QT interval at basal electrocardiography (ECG) and by a high risk of life-threatening arrhythmias.. Ventricular Tachycardia defined as following: An electrocardiographic finding of three or more consecutive complexes of ventricular organ with a rate greater than a certain threshold (100 or 120 beats per minute are commonly used). The QRS complexes are wide and have an abnormal morphology. (CDISC).", "label": "yes"} {"original_question": "Is the UGT1A1*28 polymorphism associated with irinotecan response in Caucasians?", "id": "converted_1430", "sentence1": "Is the UGT1A1*28 Allele polymorphism associated with irinotecan response in Caucasians?", "sentence2": "These Variant are associated with greater risk of serious Toxic effect., Homozygous carriers of UGT1A1*28 Allele Allele as well as those with additional UGT1A1 wt Allele Variant can suffer from severe irinotecan Toxic effect[SEP]Relations: Irinotecan has relations: drug_protein with UGT1A1, drug_protein with UGT1A1, drug_protein with UGT1A9, drug_protein with UGT1A9, drug_protein with CYP3A7, drug_protein with CYP3A7, drug_protein with CYP3A4, drug_protein with CYP3A4, drug_protein with TOP1MT, drug_protein with TOP1MT. Definitions: Variant defined as following: An alteration or difference from a norm or standard.. UGT1A1 wt Allele defined as following: Human UGT1A1 wild-type allele is located in the vicinity of 2q37 and is approximately 13 kb in length. This allele, which encodes UDP-glucuronosyltransferase 1-1 protein, plays a role in the transformation of small lipophilic molecules into water-soluble metabolites. Certain allelic Variant of the UGT1A1 gene cause Crigler-Najjar syndrome type I, type II, Gilbert syndrome or transient familial neonatal hyperbilirubinemia.. irinotecan defined as following: A semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Irinotecan, a prodrug, is converted to a biologically active metabolite 7-ethyl-10-hydroxy-camptothecin (SN-38) by a carboxylesterase-converting enzyme. One thousand-fold more potent than its parent compound irinotecan, SN-38 inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks that inhibit DNA replication and trigger apoptotic cell death. Because ongoing DNA synthesis is necessary for irinotecan to exert its cytotoxic effects, it is classified as an S-phase-specific agent.. UGT1A1*28 Allele defined as following: Human UGT1A1*28 Allele allele is located in the vicinity of 2q37 and is approximately 13 kb in length. This allele, which encodes UDP-glucuronosyltransferase 1-1 protein, plays a role in the transformation of small lipophilic molecules into water-soluble metabolites. UGT1A1*28 Allele allele has a polymorphism in the promoter region that is associated with decreased transferase activity and decreases in both tolerance and effectiveness of cancer therapeutics and antiviral drugs.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. polymorphism defined as following: The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level..", "label": "yes"} {"original_question": "Is NADPH oxidase 5 expressed in rodents?", "id": "converted_1778", "sentence1": "Is NADPH oxidase 5 expressed in Rodent?", "sentence2": "Because the Nox5 gene is absent in Rodent, we generated Mice, Transgenic expressing human Nox5 in a podocyte-specific manner (Nox5(pod+)). , The NADPH oxidase 5 (NOX5) gene is present in Homo sapiens but not Rodent. , The data document that the NOX5 gene was expressed in Cells of Lagomorpha unlike Rodent, making the rabbit allergenic extract allergenic extract an interesting model to study NOX5 functions., Nox5 was lost in Rodent, and NOX3 gene, which functions in the inner ear in gravity perception, emerged the most recently, corresponding to full-time adaptation of Vertebrates to land. , NOX expression patterns in animal allergen extracts are complex and ancestral NOXes, NOX5-like isoforms and DUOXes are generally found. But there are exceptions; for example Rodent lack NOX5 and Caenorhabditis elegans expresses only DUOXes., The NADPH oxidase 5 (NOX5) gene is present in Homo sapiens but not Rodent., The NADPH oxidase 5 (NOX5) gene is present in Homo sapiens but not Rodent, NADPH Oxidase are the major sources of Reactive Oxygen Species in cardiovascular, Neural, and Epithelial cell of renal tubule. The NADPH oxidase 5 (NOX5) gene is present in Homo sapiens but not Rodent., But there are exceptions; for example Rodent lack NOX5 and Caenorhabditis elegans expresses only DUOXes., Because the Nox5 gene is absent in Rodent, we generated Mice, Transgenic expressing human Nox5 in a podocyte-specific manner (Nox5(pod+))., The data document that the NOX5 gene was expressed in Cells of Lagomorpha unlike Rodent, making the rabbit allergenic extract allergenic extract an interesting model to study NOX5 functions., The most recently identified member of the Nox family, Nox5, has for the most part been overlooked in Kidney Diseases, partly owing to its absence from the rodent genome.[SEP]Relations: NADPH oxidase complex has relations: cellcomp_protein with NOX4, cellcomp_protein with NOX4, cellcomp_protein with NOX3, cellcomp_protein with NOX3, cellcomp_protein with NOXA1, cellcomp_protein with NOXA1, cellcomp_protein with NOX1, cellcomp_protein with NOX1, cellcomp_protein with CYBA, cellcomp_protein with CYBA. Definitions: NADPH Oxidase defined as following: A family of membrane-associated flavoprotein NADPH-dependent oxidoreductases that catalyze the univalent reduction of OXYGEN to create SUPEROXIDES. Structurally, they are characterized by six N-terminal transmembrane ALPHA-HELICES, a FLAVIN-ADENINE DINUCLEOTIDE (FAD)-binding region, and a C-terminal NADPH-binding region. They are expressed primarily by EPITHELIAL CELLS in gut, kidney, colon, and smooth muscle tissues, as well as GRANULOCYTES and function to transfer electrons across membranes to molecular oxygen. Defects in the production of superoxide ions by some NADPH Oxidase result in GRANULOMATOUS DISEASE, CHRONIC.. Rodent defined as following: A mammalian order which consists of 29 families and many genera.. Reactive Oxygen Species defined as following: Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS.. Homo sapiens defined as following: Members of the species Homo sapiens.. Epithelial cell of renal tubule defined as following: any of the Cells comprising the kidney, functioning in filtering the blood.. Kidney Diseases defined as following: Pathological processes of the KIDNEY or its component tissues.. Lagomorpha defined as following: An order of small mammals comprising two families, Ochotonidae (pikas) and Leporidae (RABBITS and HARES). Head and body length ranges from about 125 mm to 750 mm. Hares and rabbits have a short tail, and the pikas lack a tail. Rabbits are born furless and with both eyes and ears closed. HARES are born fully haired with eyes and ears open. All are vegetarians. (From Nowak, Walker's Mammals of the World, 5th ed, p539-41). Neural defined as following: Of or relating to neurons or the nervous system.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Caenorhabditis elegans defined as following: A species of nematode that is widely used in biological, biochemical, and genetic studies.. Mice, Transgenic defined as following: Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.. Vertebrates defined as following: Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising mammals, birds, reptiles, amphibians, and fishes..", "label": "no"} {"original_question": "Does replication timing affect the rate of somatic mutations?", "id": "converted_888", "sentence1": "Does replication timing affect the rate of somatic Gene Mutation?", "sentence2": "Here we observe that Mutation Abnormality rate, as reflected in recent evolutionary divergence and human nucleotide diversity, is markedly increased in later-replicating regions of the human Genome - anatomical entity, ll classes of substitutions are affected, suggesting a generalized mechanism involving replication time-dependent DNA damage, We show that Mutation Abnormality rate varies 6-fold across a single chromosome, that this variation is correlated with replication timing, and we propose a model to explain this variation that relies on the temporal separation of two processes for replicating past damaged DNA: error-free DNA damage tolerance and translesion synthesis., Recent studies revealed a long suspected replication-timing effect on Mutation Abnormality rate, but the mechanisms that regulate the increase in Mutation Abnormality rate as the Genome - anatomical entity is replicated remain unclear. , DNA repair systems, in general, are less efficient in late replicating heterochromatic regions compared to early replicating euchromatic regions of the Genome - anatomical entity., The mutational profile of the Saccharomyces cerevisiae Genome - anatomical entity is shaped by replication, the Mutation Abnormality rate increases with the replication timing by more than 30% between the earliest and the latest replicating regions., Thus, we show that the leading replicating strands present an excess of C over G and of A over T in the Genome - anatomical entity of S. cerevisiae (reciprocally an excess of G + T over C + A in lagging strands), Late-replicating domains have higher divergence and diversity in Drosophila melanogaster, Recent evidence also suggests that late replication is associated with high mutability in Saccharomyces cerevisiae., Limited evidence from one Arm of chromosome in Drosophila melanogaster suggests the opposite pattern, with regions overlapping early-firing origins showing increased levels of diversity and divergence, The Mutation Abnormality rate for DNA mismatch repair null strains was approximately 1 Mutation Abnormality per Genome - anatomical entity per generation, 225-fold greater than the wild-type rate. The Gene Mutation were distributed randomly throughout the Genome - anatomical entity, independent of replication timing., Many single-nucleotide substitutions in Primary malignant neoplasm genomes arise because of errors in DNA replication, which is spatio-temporally stratified., Here we propose that DNA replication patterns help shape the mutational landscapes of normal and Primary malignant neoplasm genomes, Using data on five fully sequenced Primary malignant neoplasm types and two personal genomes, we determined that the frequency of intergenic single-nucleotide substitution is significantly higher in late DNA replication timing regions, even after controlling for a number of genomic features, we found that genomic regions in close spatial proximity to late-replicating domains display similar Mutation Abnormality spectra as the late-replicating regions themselves, In addition, certain chromosome rearrangements found in Primary malignant neoplasm Cells and in Cells exposed to ionizing radiation display a significant delay in replication timing of >3 hours that affects the entire chromosome(2,3). Recent work from our lab indicates that disruption of discrete cis-acting autosomal loci result in an extremely late replicating phenotype that affects the entire chromosome(4)., A conservative estimate is that at least 1-2% of new deleterious Gene Mutation affect some aspect of DNA replication, repair, or chromosome segregation. Since deleterious Gene Mutation can have an effect even as heterozygotes, this Mutation Abnormality accumulation can create an inherited background of late-acting Gene Mutation that themselves enhance Mutation Abnormality rate., Drake calculates that lytic RNA Viruses display spontaneous Mutation Abnormality rates of approximately one per Genome - anatomical entity while most have Mutation Abnormality rates that are approximately 0.1 per Genome - anatomical entity (Drake 1993). This constancy of germline Mutation Abnormality rates among microbial species need not necessarily mean constancy of the somatic Mutation Abnormality rates., A recent flurry of reports correlates replication timing (RT) with Mutation Abnormality rates during both evolution and Primary malignant neoplasm., DNA replication timing, Genome - anatomical entity stability and Primary malignant neoplasm: late and/or delayed DNA replication timing is associated with increased genomic instability., Since deleterious Gene Mutation can have an effect even as heterozygotes, this Mutation Abnormality accumulation can create an inherited background of late-acting Gene Mutation that themselves enhance Mutation Abnormality rate., In addition, this method allows for the unambiguous identification of chromosomal rearrangements that correlate with changes in replication timing that affect the entire chromosome.[SEP]Relations: adaptation to pheromone regulating conjugation with mutual genetic exchange has relations: bioprocess_bioprocess with response to pheromone regulating conjugation with mutual genetic exchange, bioprocess_bioprocess with response to pheromone regulating conjugation with mutual genetic exchange, bioprocess_bioprocess with negative adaptation of signaling pathway, bioprocess_bioprocess with negative adaptation of signaling pathway. partial monosomy of the short arm of chromosome X has relations: disease_disease with atypical Norrie disease due to monosomy Xp11.3, disease_disease with atypical Norrie disease due to monosomy Xp11.3. Lacrimation abnormality has relations: disease_phenotype_positive with limbal stem cell deficiency, disease_phenotype_positive with limbal stem cell deficiency, disease_phenotype_positive with Waardenburg syndrome, disease_phenotype_positive with Waardenburg syndrome. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Primary malignant neoplasm Cells defined as following: Cells of, or derived from, a malignant tumor.. Genome - anatomical entity defined as following: Anatomical set of genes in all the chromosomes.. Arm of chromosome defined as following: Under the microscope chromosomes appear as thin, thread-like structures. They all have a short arm and long arm separated by a primary constriction called the centromere. The short arm is designated as p and the long arm as q.. Saccharomyces cerevisiae defined as following: A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" Saccharomyces cerevisiae. The dried form is used as a dietary supplement.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all Cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including Primary malignant neoplasm.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. RNA Viruses defined as following: Viruses whose genetic material is RNA..", "label": "yes"} {"original_question": "Is SATB1 expressed in thymocytes?", "id": "converted_3649", "sentence1": "Is DNA-Binding Protein SATB1 expressed in thymocyte?", "sentence2": "A thymocyte factor DNA-Binding Protein DNA-Binding Protein SATB1 suppresses transcription of stably integrated matrix-attachment region-linked reporter Genes., DNA-Binding Protein DNA-Binding Protein SATB1 is a Homeodomain Proteins and is predominantly expressed in thymocyte. , DNA-Binding Protein DNA-Binding Protein SATB1 is a cell-type specific nuclear protein that recruits chromatin-remodeling factors and regulates numerous Genes during thymocyte differentiation., This was shown by fluorescence in situ hybridization on wild-type and Satb1-null thymocyte using in vivo DNA-Binding Protein DNA-Binding Protein SATB1-bound sequences as Probes. , By contrast, in Satb1-null thymocyte, this site is marked by methylation at H3 Lys9., Regulation of DNA-Binding Protein DNA-Binding Protein SATB1 during thymocyte development by transcription-coupled nucleotide-excision repair signaling., In this study we show that special AT-rich binding protein 1 (DNA-Binding Protein DNA-Binding Protein SATB1), a T lineage-enriched chromatin organizer and regulator, is induced in response to transcription-coupled nucleotide-excision repair signaling during early thymocyte development, DNA-Binding Protein DNA-Binding Protein SATB1 expression profile coincides with T lineage commitment and upregulation of DNA-Binding Protein DNA-Binding Protein SATB1 correlates with positive selection of thymocyte. , We also demonstrate that GATA3 gene gene, the key transcriptional regulator of αβ T cells positively regulates DNA-Binding Protein DNA-Binding Protein SATB1 expression in thymocyte suggesting an important role for DNA-Binding Protein DNA-Binding Protein SATB1 during T-Lymphocyte development., High level expression of the Xlr nuclear protein in immature thymocyte and colocalization with the matrix-associated region-binding DNA-Binding Protein DNA-Binding Protein SATB1 protein., A role for DNA-Binding Protein DNA-Binding Protein SATB1, a nuclear matrix association region-binding protein, in the development of CD8SP thymocyte and peripheral T lymphocytes., Because homozygous DNA-Binding Protein DNA-Binding Protein SATB1-null CASP14 gene do not survive to adulthood due to non-Thymus autonomous defects, CASP14 gene were produced that were homozygous for a T-Lymphocyte-specific DNA-Binding Protein DNA-Binding Protein SATB1-antisense transgene and heterozygous for a DNA-Binding Protein DNA-Binding Protein SATB1-null allele., Thymic DNA-Binding Protein DNA-Binding Protein SATB1 protein was reduced significantly in these CASP14 gene, and the major Cells phenotype observed was a significant reduction in the percentage of CD8SP T cells in Thymus , Abdomen>Spleen, and lymph nodes. , The reduction in thymic DNA-Binding Protein DNA-Binding Protein SATB1 does not lead to the variegated expression of CD8-negative single positive thymocyte seen upon Gene Deletion Abnormality of several regulatory elements and suggested by others to reflect failure to activate the CD8 locus. [SEP]Relations: GATA3 gene has relations: anatomy_protein_present with Thymus , anatomy_protein_present with Thymus , bioprocess_protein with Thymus development, bioprocess_protein with Thymus development, bioprocess_protein with thymic T-Lymphocyte selection, bioprocess_protein with thymic T-Lymphocyte selection, protein_protein with CHAF1B, protein_protein with CHAF1B, bioprocess_protein with regulation of CD4-positive, alpha-beta T-Lymphocyte differentiation, bioprocess_protein with regulation of CD4-positive, alpha-beta T-Lymphocyte differentiation. Definitions: Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. thymocyte defined as following: HEMATOPOIETIC PROGENITOR CELLS that have migrated to the THYMUS where they differentiate into T-LYMPHOCYTES. Thymocytes are classified into maturational stages based on the expression of CELL SURFACE ANTIGENS.. T-Lymphocyte defined as following: Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocyte. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.. transcription-coupled nucleotide-excision repair defined as following: The nucleotide-excision repair process that carries out preferential repair of DNA lesions on the actively transcribed strand of the DNA duplex. In addition, the transcription-coupled nucleotide-excision repair pathway is required for the recognition and repair of a small subset of lesions that are not recognized by the global genome nucleotide excision repair pathway. [PMID:10197977, PMID:11900249]. Homeodomain Proteins defined as following: Proteins encoded by homeobox Genes (GENES, HOMEOBOX) that exhibit structural similarity to certain prokaryotic and eukaryotic DNA-binding proteins. Homeodomain proteins are involved in the control of gene expression during morphogenesis and development (GENE EXPRESSION REGULATION, DEVELOPMENTAL).. Probes defined as following: A device designed to reach into a location for manipulating or sensing.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. DNA-Binding Protein SATB1 defined as following: DNA-Binding Protein DNA-Binding Protein SATB1 (763 aa, ~86 kDa) is encoded by the human DNA-Binding Protein SATB1 gene. This protein binds DNA and may be involved in the regulation of transcription.. GATA3 gene defined as following: This gene plays a role in the modulation of transcription.. Thymus defined as following: A plant genus of the family LAMIACEAE best known for the thyme spice added to foods..", "label": "yes"} {"original_question": "Is Apelin usually decreased in diabetes?", "id": "converted_3157", "sentence1": "Is APLN gene usually decreased in Diabetes Mellitus?", "sentence2": "APLN gene has been shown to act on Glucose measurement and lipid metabolism but also to modulate insulin secretion. Moreover, different studies in both animal allergen extracts and Homo sapiens have shown that plasma APLN protein, human concentrations are usually increased during BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 and type 2 Diabetes Mellitus., Upregulated expression of RETN protein, human, SERPINA12 gene, APLN protein, human and TNF-α plays a significant role in induction of insulin resistance linked with BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 and type 2 Diabetes Mellitus., Moreover, different studies in both animal allergen extracts and Homo sapiens have shown that plasma APLN protein, human concentrations are usually increased during BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 and type 2 Diabetes Mellitus., APLN gene levels are increased in morbidly obese subjects with Diabetes Mellitus, Noninsulin-Dependent, 3., In men at risk for Diabetes Mellitus (HbA1c 5.7-6.4%, FPG 100-125mg/dl, or OGTT-2h-PG 140-199mg/dl), the risk for developing Diabetes Mellitus was higher in those with higher plasma APLN protein, human concentration than in those with lower plasma APLN protein, human concentrations (10.6%/year vs. 5.1%/year, p<0.001).
CONCLUSIONS: Plasma APLN protein, human is a novel biomarker for predicting type 2 Diabetes Mellitus in men.
[SEP]Relations: Type I Diabetes Mellitus mellitus has relations: disease_phenotype_positive with vasculitis due to ADA2 deficiency, disease_phenotype_positive with vasculitis due to ADA2 deficiency, disease_phenotype_positive with late-onset isolated ACTH deficiency, disease_phenotype_positive with late-onset isolated ACTH deficiency, disease_phenotype_positive with Wolcott-Rallison syndrome, disease_phenotype_positive with Wolcott-Rallison syndrome. Diabetes Mellitus mellitus, noninsulin-dependent has relations: disease_disease with Diabetes Mellitus, Noninsulin-Dependent, 3, disease_disease with Diabetes Mellitus, Noninsulin-Dependent, 3, disease_disease with inborn errors of metabolism, disease_disease with inborn errors of metabolism. Definitions: Glucose measurement defined as following: The determination of the amount of Glucose measurement present in a sample.. APLN gene defined as following: This gene is involved in the regulation of both immune responses and HIV-1 infection.. Homo sapiens defined as following: Members of the species Homo sapiens.. APLN protein, human defined as following: APLN gene (77 aa, ~9 kDa) is encoded by the human APLN gene. This protein is involved in both the inhibition of HIV-1 entry into cells and in immune responses.. RETN protein, human defined as following: Resistin (108 aa, ~11 kDa) is encoded by the human RETN gene. This protein plays a role in the regulation of insulin-mediated Glucose measurement metabolism.. Diabetes Mellitus defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE..", "label": "no"} {"original_question": "Does wheat belongs to the genus Avena, yes or no?", "id": "converted_2517", "sentence1": "Does Triticum aestivum belongs to the genus Avena, yes or no?", "sentence2": "oat seedlings (oats preparation), wild green-oat (oats preparation) , ornithine-oxo-acid aminotransferase activity (oats preparation L.), ornithine-oxo-acid aminotransferase activity (oats preparation L.), Avena (oat allergenic extract), oats preparation, oatstraw, Avena sativa, oatstraw, wild oats (Avena fatua L.), oats (genus Avena), oats preparation L. and A. byzantina C. Koch) , oat (oats preparation L.)., oat (oats preparation L.) and Wheat (Triticum aestivum) Ab (Wheat (Wheat (Triticum aestivum) Ab) Ab[SEP]Relations: ornithine-oxo-acid transaminase activity has relations: molfunc_protein with OAT, molfunc_protein with OAT. Definitions: Triticum aestivum defined as following: plant genus of the family Poaceae that is the source of Triticum aestivum grain.. ornithine-oxo-acid aminotransferase activity defined as following: Catalysis of the reaction: L-ornithine + a 2-oxo acid = L-glutamate 5-semialdehyde + an L-amino acid. [EC:2.6.1.13]. Avena defined as following: oat allergenic extract, genus of the family POACEAE..", "label": "no"} {"original_question": "Does radiation for tinea capitis increases brain tumor risk?", "id": "converted_3445", "sentence1": "Does radiation for Tinea Capitis increases Brain Neoplasms risk?", "sentence2": "Emphasis is placed on Meningioma resulting from childhood treatment for primary Brain Neoplasms or Tinea Capitis, exposure to dental x-rays, and exposure to atomic explosions in Hiroshima and Nagasaki. , It is well known that radiation can induce Meningioma. These Neoplasms usually arise in patients with a history of Low-Dose Treatment radiation to the Scalp structure for treatment of Tinea Capitis or high-dose radiation for a previous Brain Neoplasms. , This paper describes six cases of radiation-associated Intracranial Meningioma in patients previously treated with Low-Dose Treatment radiation to the Scalp structure for Tinea Capitis., After a median follow-up of 40 years, an SLC7A1 gene/Gy of 4.63 and 1.98 (95% CI = 2.43-9.12 and 0.73-4.69) and an EAR/Gy per 10(4) PY of 0.48 and 0.31 (95% CI = 0.28-0.73 and 0.12-0.53) were observed for benign Meningioma and malignant brain Neoplasms, respectively. , The estimated SLC7A1 gene/Gy for malignant brain Neoplasms decreased with increasing age at irradiation from 3.56 to 0.47 (P = 0.037), while no trend with age was seen for benign Meningioma. The SLC7A1 gene for both types of Specimen Source Codes - Specimen Source Codes - tumor remains elevated at 30-plus years after exposure., Although Meningioma are known to be induced by low doses of Cranial Irradiation, such as those given to treat Tinea Capitis, little experience has been reported on the induction of Meningioma by high-dose Cranial Irradiation. , The exposed Rattus norvegicus had a greater incidence of Adenoma, Chromophobe, Epithelial and mesothelial cell Neoplasms than the unexposed controls but the excessive occurrence of malignant gliomas that was observed in the monkeys was absent in the Rattus norvegicus. , We have analyzed 60 cases of intra-axial brain Neoplasms associated with antecedent radiation therapy. These include four new cases. The patients had originally received radiation therapy for three reasons: (a) Cranial Irradiation for Pre B-cell Pre B-cell acute lymphoblastic leukemia (Acute lymphocytic leukemia), (b) definitive treatment of CNS neoplasia, and (c) treatment of benign disease (mostly Recurrent skin infections). , Long-term follow-up for Brain Neoplasms development after childhood exposure to ionizing radiation for Tinea Capitis., Benign and malignant thyroid neoplasms after childhood irradiation for Tinea Capitis., There is evidence to show that moderate doses of ionising radiations given in childhood for Tinea Capitis are associated with a late risk of developing a meningioma, This paper describes six cases of radiation-associated Intracranial Meningioma in patients previously treated with Low-Dose Treatment radiation to the Scalp structure for Tinea Capitis., These Neoplasms usually arise in patients with a history of Low-Dose Treatment radiation to the Scalp structure for treatment of Tinea Capitis or high-dose radiation for a previous Brain Neoplasms., There is evidence to show that moderate doses of ionising radiations given in childhood for Tinea Capitis are associated with a late risk of developing a meningioma., In addition to high dose radiation-induced Meningioma, Intracranial Meningioma were observed in patients who underwent Low-Dose Treatment radiation for Tinea Capitis in childhood, applied en mass to immigrants coming to Israel from the North Africa and the Middle East during the 1950., A 39-year-old male developed primary brain lymphoma 33 years after receiving Scalp structure irradiation for Tinea Capitis., Secondary glioblastoma multiforme (sGBM) can occur after a long latency period following radiation treatment of various diseases including brain Neoplasms, leukemia, and more benign disorders like Tinea Capitis., The main data come from series of patients who underwent radiotherapy during childhood: a high incidence of Neoplasms of the nervous system is found after irradiation of one to a few grays as treatment of a benign disease (especially Tinea Capitis), as well as after irradiation at higher doses of a few tens of grays for the treatment of cancer (in particular cerebral irradiation in acute lymphoblastic leukaemia).[SEP]Relations: skin meningioma has relations: disease_disease with malignant Specimen Source Codes - tumor of meninges, disease_disease with malignant Specimen Source Codes - tumor of meninges, disease_disease with malignant dermis Specimen Source Codes - tumor, disease_disease with malignant dermis Specimen Source Codes - tumor, disease_disease with skin cancer, disease_disease with skin cancer. Brain neoplasm has relations: drug_effect with Nitisinone, drug_effect with Nitisinone, drug_effect with Sibutramine, drug_effect with Sibutramine. Definitions: Intracranial Meningioma defined as following: A meningioma that arises within the cranial cavity.. Pre B-cell acute lymphoblastic leukemia defined as following: A type of Acute lymphocytic leukemia characterized by elevated levels of B-cell lymphoblasts in the bone marrow and the blood. [NCIT:C8644]. Meningioma defined as following: A relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular Neoplasms which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7). Brain Neoplasms defined as following: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain Neoplasms may also be classified by age of onset, histologic type, or presenting location in the brain.. leukemia defined as following: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006). benign Meningioma defined as following: A grade I, slowly growing meningioma. Only a minority of Neoplasms recur following complete resection.. Acute lymphocytic leukemia defined as following: Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Rattus norvegicus defined as following: The common rat, Rattus norvegicus, often used as an experimental organism.. Scalp structure defined as following: The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL).. Tinea Capitis defined as following: Ringworm of the Scalp structure and associated hair mainly caused by species of MICROSPORUM; TRICHOPHYTON; and EPIDERMOPHYTON, which may occasionally involve the eyebrows and eyelashes.. Adenoma, Chromophobe defined as following: A benign Specimen Source Codes - tumor of the anterior pituitary in which the cells do not stain with acidic or basic dyes.. Low-Dose Treatment defined as following: A reduced quantity of a therapeutic agent prescribed to be taken at one time or at stated intervals.. malignant brain Neoplasms defined as following: A primary or metastatic malignant neoplasm affecting the brain.. Epithelial defined as following: A term that refers to the cells that make up the Epithelial tissues. They are found in the skin, and in the parenchyma, surface and lumen of internal organs.. Recurrent skin infections defined as following: Infections of the skin that happen multiple times. [HPO:curators]. Cranial Irradiation defined as following: The exposure of the head to roentgen rays or other forms of radioactivity for therapeutic or preventive purposes..", "label": "yes"} {"original_question": "Is Brucella abortus the organism that causes brucillosis known to cause spontaneous abortions in humans?", "id": "converted_2721", "sentence1": "Is Brucella species abortus the organism that causes brucillosis known to cause spontaneous Abortions:Number:Point in time:^Patient:Quantitative:Reported in Homo sapiens?", "sentence2": ". Brucellosis is a major cause of Fever of unknown origin (Pyrexia of unknown origin (excl puerperal)), Brucellosis is the most common Bacterial Zoonoses, and causes a considerable burden of Disease in endemic countries. Cardiovascular involvement is the main cause of mortality due to Communicable Diseases with Brucella species species spp,, quite abruptly, he developed Asthenia and Hypersomnia without any apparent cause or symptoms like Fever symptoms (finding), Chills, or night Sweating. On November 14, 2009, he suffered from Pain:-:Point in time:^Patient:- and Edema:Finding:Point in time:^Patient:Ordinal in the right testicle that coincided with Pain:-:Point in time:^Patient:- in the Abdominal Cavity. Clinical, serological, and bacteriological investigations confirmed the first case of unilateral orchitis in man in Ecuador caused by Brucella species species abortus biovar 1, Brucellosis is not frequent in Chile but it may present with life threatening complications like Endocarditis., Human brucellosis exhibits diverse pathological manifestations that can affect almost any Organ. In particular, osteoarticular complications are the most common focal manifestation of brucellosis and occur in 40-80% of patients., Brucella species species. Human brucellosis often makes the diagnosis difficult. The symptoms and clinical signs most commonly reported are Fever symptoms (finding), Fatigue, Malaise, Chills, Sweating Headache, Myalgia, Arthralgia, and Measured Measured weight loss (observable entity) (observable entity). Some cases have been presented with only joint Pain:-:Point in time:^Patient:-, lower backache, and involuntary limb movement, burning feet, or ischemic heart attacks. , Forty-five cases were collected (31 acute and 14 sub-acute). Contamination was digestive in 62%. Symptoms of patients were Fever symptoms (finding) (93%), sweating (82%), Arthralgia (78%) and Splenomegaly (51%). Elevated Erythrocytes sedimentation rate was determined in 80%, White blood cell count decreased in 49% and Anemia in 37% of cases. Blood culture were positives in 39% of cases. The four sequenced strains were identified as Brucella species species melitensis biovar abortus. , It is also known to cause persistent undulant Fever symptoms (finding), Endocarditis, Arthritis, Osteomyelitis and Meningitis in Homo sapiens., Brucella species species abortus is a Gram-negative Protoplasm bacterial pathogen that causes a zoonosis of worldwide occurrence, leading to undulant Fever symptoms (finding) in Homo sapiens and Unspecified Abortion in domestic animals., Brucella species species abortus is a facultative Protoplasm bacterial pathogen that causes Unspecified Abortion in domestic animals and undulant Fever symptoms (finding) in Homo sapiens., Brucella species species abortus is a facultative, Protoplasm zoonotic pathogen which can cause undulant Fever symptoms (finding) in Homo sapiens and Abortions:Number:Point in time:^Patient:Quantitative:Reported in Bos taurus., Brucella species species abortus is a Gram-negative, facultative Protoplasm bacterium that causes brucellosis, a worldwide zoonotic Disease leading to undulant Fever symptoms (finding) in Homo sapiens and Unspecified Abortion in Bos taurus., Brucella species species abortus is a facultative Protoplasm bacterial pathogen that causes Unspecified Abortion in domestic animals and undulant Fever symptoms (finding) in Homo sapiens., Brucella species species abortus is a gram-negative, facultative Protoplasm pathogen that causes brucellosis, a chronic zoonotic Disease resulting in Unspecified Abortion in pregnant Bos taurus and undulant Fever symptoms (finding) in Homo sapiens., Brucella species species abortus is a bacterium which causes Abortions:Number:Point in time:^Patient:Quantitative:Reported and Sterility, Reproductive in Bos taurus and undulant Fever symptoms (finding) in Homo sapiens., Brucella species species abortus is the etiologic agent of bovine brucellosis and causes a Chronic Disease in Homo sapiens known as undulant Fever symptoms (finding)., No case of acute Brucella species species Communicable Diseases was demonstrated; however, there were 5 cases in which the serological finding was consistent with chronic brucellosis (4%). In all these cases no positive evidence of close Animal allergens contact could be found; furthermore of the 12,1% of women who actually handled domestic animals, only 1 had a history of previous Unspecified Abortion[SEP]Relations: brucellosis has relations: disease_phenotype_positive with Spontaneous Unspecified Abortion, disease_phenotype_positive with Spontaneous Unspecified Abortion, disease_disease with Brucella species brucellosis, disease_disease with Brucella species brucellosis, disease_disease with Brucella species melitensis brucellosis, disease_disease with Brucella species melitensis brucellosis, disease_disease with brucellosis, bovine, disease_disease with brucellosis, bovine. Brucella species melitensis brucellosis has relations: disease_disease with brucellosis, disease_disease with brucellosis. Definitions: Endocarditis defined as following: Inflammation of the inner lining of the heart (ENDOCARDIUM), the continuous membrane lining the four chambers and HEART VALVES. It is often caused by microorganisms including bacteria, viruses, fungi, and rickettsiae. Left untreated, Endocarditis can damage heart valves and become life-threatening.. Erythrocytes defined as following: Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN.. Splenomegaly defined as following: Enlargement of the spleen.. Abdominal Cavity defined as following: The region in the Abdominal Cavity extending from the thoracic DIAPHRAGM to the plane of the superior pelvic aperture (pelvic inlet). The abdominal cavity contains the PERITONEUM and abdominal VISCERA, as well as the extraperitoneal space which includes the RETROPERITONEAL SPACE.. Bos taurus defined as following: The domesticated cow species, Bos taurus.. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an Animal allergens, vector or the inanimate environment to a susceptible Animal allergens or human host.. Homo sapiens defined as following: Members of the species Homo sapiens.. Fever defined as following: An abnormal elevation of body temperature, usually as a result of a pathologic process.. Arthritis defined as following: Acute or chronic inflammation of JOINTS.. Myalgia defined as following: Painful sensation in the muscles.. Arthralgia defined as following: Pain in the joint.. Chills defined as following: The sudden sensation of being cold. It may be accompanied by SHIVERING.. Brucella species melitensis defined as following: A species of the genus BRUCELLA whose natural hosts are sheep and goats. Other mammals, including Homo sapiens, may be infected. In general, these organisms tend to be more virulent for laboratory animals than BRUCELLA ABORTUS and may cause fatal infections.. Bacterial Zoonoses defined as following: Bacterial infections that may be transmitted between non-human animals and HUMANS.. Hypersomnia defined as following: A sleep disorder characterized by excessive sleepiness.. Blood culture defined as following: Test to determine the presence of blood Communicable Diseases (e.g. SEPSIS; BACTEREMIA).. Chronic Disease defined as following: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies Chronic Disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, proteins, lipids, carbohydrates, and inorganic salts.. Meningitis defined as following: Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6). Sterility, Reproductive defined as following: Complete inability to conceive or induce conception.. Brucellosis defined as following: Infection caused by bacteria of the genus BRUCELLA mainly involving the MONONUCLEAR PHAGOCYTE SYSTEM. This condition is characterized by Fever symptoms (finding), weakness, Malaise, and Measured weight loss (observable entity).. Fatigue defined as following: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.. Osteomyelitis defined as following: INFLAMMATION of the bone as a result of Communicable Diseases. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA.. Anemia defined as following: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.. Asthenia defined as following: Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.. Headache defined as following: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.. Organ defined as following: A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues. An Organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus.. Unspecified Abortion defined as following: The unintentional or intentional loss of a pregnancy before 22 weeks gestation.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Brucella species abortus defined as following: A Disease of Bos taurus caused by bacteria of the genus BRUCELLA leading to Unspecified Abortion in late pregnancy. BRUCELLA ABORTUS is the primary infective agent.. Malaise defined as following: A feeling of general discomfort or uneasiness, an out-of-sorts feeling.. Sweating defined as following: The process of exocrine secretion of the SWEAT GLANDS, including the aqueous sweat from the ECCRINE GLANDS and the complex viscous fluids of the APOCRINE GLANDS.. White blood cell count decreased defined as following: A laboratory test result indicating a decreased number of white blood cells in the peripheral blood.. Measured weight loss (observable entity) defined as following: The measured decrease in body weight over a specified period of time.. organism defined as following: A living entity..", "label": "no"} {"original_question": "Can fetal aneuploidy be detected with non-invasive prenatal testing?", "id": "converted_876", "sentence1": "Can Prenatal care aneuploidy be detected with non-invasive prenatal testing?", "sentence2": "Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice., The aim of this study was to assess awareness, potential adoption, and current utilization of non-invasive prenatal testing (NIPT) analysis for common Prenatal care aneuploidies among obstetricians, Cell-Free DNA has been used for Prenatal care rhesus factor and sex determination, Prenatal care aneuploidy screening, cancer diagnostics and monitoring, and other applications., The recent release of new, non-invasive prenatal tests for Prenatal care aneuploidy using cell-free Prenatal care DNA (cffDNA) has been hailed as a revolution in prenatal testing and has triggered significant commercial interest in the field., Non-invasive prenatal testing (NIPT) for aneuploidy using cell-free DNA in maternal plasma is revolutionizing prenatal screening and diagnosis., SNP-based non-invasive prenatal testing detects Sex Chromosomes aneuploidies with high accuracy., Non-invasive prenatal testing (NIPT) of cell-free Prenatal care DNA in maternal plasma is a novel approach, designed for detecting common aneuploidies in the Fetus in fetu., This study aimed to develop a single-nucleotide polymorphism-based and informatics-based non-invasive prenatal test that detects Sex Chromosomes aneuploidies early in pregnancy., RAPIDR: an analysis package for non-invasive prenatal testing of aneuploidy., Non-invasive prenatal testing for aneuploidy: current status and future prospects., Non-invasive prenatal testing of Prenatal care whole chromosome aneuploidy by massively parallel sequencing., Attitudes towards non-invasive prenatal testing for aneuploidy among US adults of reproductive age., [Non-invasive prenatal test in the diagnosis of aneuploidy 13, 18 and 21--theoretical and practical aspects]., To track and analyze two false positive cases from non-invasive prenatal testing for potential Prenatal care aneuploidy., Non-invasive prenatal testing (NIPT) of Prenatal care aneuploidy using cell-free Prenatal care DNA is becoming part of routine clinical practice., To report secondary or additional findings arising from introduction of non-invasive prenatal testing (NIPT) for aneuploidy by whole genome sequencing as a clinical service., Israeli Society of Medical Genetics NIPT Committee Opinion 072013: Non-invasive prenatal testing of cell-free DNA in maternal plasma for detection of Prenatal care aneuploidy., In recent years, technical advances in the molecular analysis of Prenatal care DNA (e.g., digital PCR and massively parallel sequencing (MPS)) has enabled the successful implementation of noninvasive testing into clinical practice, such as Prenatal care sex assessment, RhD genotyping, and Prenatal care chromosomal aneuploidy detection.With the ability to decipher the entire Prenatal care genome from maternal plasma DNA, we foresee that an increased number of non-invasive prenatal tests will be available for detecting many single-gene disorders in the near future, First identified in 1997, cell-free Prenatal care DNA (cffDNA) has just recently been used to detect Prenatal care aneuploidy of chromosomes 13, 18, and 21, showing its potential to revolutionize prenatal genetic testing as a non-invasive screening tool, Non-invasive prenatal testing (NIPT) using cell-free Prenatal care DNA in maternal plasma has been developed for the detection of Prenatal care aneuploidy, Israeli Society of Medical Genetics NIPT Committee Opinion 072013: Non-invasive prenatal testing of cell-free DNA in maternal plasma for detection of Prenatal care aneuploidy, Non-invasive prenatal testing for Prenatal care aneuploidies in the first trimester of pregnancy, To explore the value of next-generation sequencing for the non-invasive prenatal testing of Prenatal care chromosomal aneuploidies, Secondary findings from non-invasive prenatal testing for common Prenatal care aneuploidies by whole genome sequencing as a clinical service, To report secondary or additional findings arising from introduction of non-invasive prenatal testing (NIPT) for aneuploidy by whole genome sequencing as a clinical service, Secondary findings from non-invasive prenatal testing for common Prenatal care aneuploidies by whole genome sequencing as a clinical service., Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for Prenatal care aneuploidy: a qualitative study with early adopter patients in Hong Kong., OBJECTIVE: To determine whether non-invasive prenatal testing by maternal plasma DNA sequencing can uncover all Prenatal care chromosome aneuploidies in one simple sequencing event. , Non-invasive prenatal diagnosis of Prenatal care aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free Prenatal care DNA in the maternal plasma originates from cytotrophoblastic cells., Non-invasive prenatal testing (NIPT) using cell-free Prenatal care DNA in maternal plasma has been developed for the detection of Prenatal care aneuploidy., Non-invasive prenatal testing (NIPT) of cell-free Prenatal care DNA in maternal plasma is a novel approach, designed for detecting common aneuploidies in the Fetus in fetu., non-invasive prenatal tests for Prenatal care aneuploidy using cell-free Prenatal care DNA (cffDNA) has been hailed as a revolution in prenatal testing and has triggered significant commercial interest in the field., Non-invasive prenatal testing (NIPT) of Prenatal care aneuploidy using cell-free Prenatal care DNA is becoming part of routine clinical practice. RAPIDR (Reliable Accurate Prenatal non-Invasive Diagnosis R package) is an easy-to-use open-source R package that implements several published NIPT analysis methods., The clinical data collected thus far indicate that NIPT is highly sensitive in detecting Genetic screen for trisomy 21 and 18, and fairly sensitive in detecting trisomy 13 and Sex Chromosomes aneuploidies. Because false-positive results may occur, an abnormal result must be validated by invasive prenatal testing., When non-invasive prenatal screening for aneuploidy is available, maternal age alone should not be an indication for invasive prenatal diagnosis in a twin pregnancy. (II-2A) If non-invasive prenatal screening is not available, invasive prenatal diagnosis in twins should be offered to women aged 35 and over., Therefore, methods with high sensitivity and precision are required to detect and differentiate Prenatal care DNA from the large background of maternal DNA. In recent years, technical advances in the molecular analysis of Prenatal care DNA (e.g., digital PCR and massively parallel sequencing (MPS)) has enabled the successful implementation of noninvasive testing into clinical practice, such as Prenatal care sex assessment, RhD genotyping, and Prenatal care chromosomal aneuploidy detection.With the ability to decipher the entire Prenatal care genome from maternal plasma DNA, we foresee that an increased number of non-invasive prenatal tests will be available for detecting many single-gene disorders in the near future., Non-invasive prenatal testing for Prenatal care aneuploidies in the first trimester of pregnancy., Secondary findings from non-invasive prenatal testing for common Prenatal care aneuploidies by whole genome sequencing as a clinical service., To explore the value of next-generation sequencing for the non-invasive prenatal testing of Prenatal care chromosomal aneuploidies., [Cell-free nucleic acid-based non-invasive prenatal diagnosis of Prenatal care aneuploidies]., Maternal age alone is a poor minimum standard for prenatal screening for aneuploidy, and it should not be used a basis for recommending invasive testing when non-invasive prenatal screening for aneuploidy is available., Israeli Society of Medical Genetics NIPT Committee Opinion 072013: Non-invasive prenatal testing of cell-free DNA in maternal plasma for detection of Prenatal care aneuploidy., Attitudes towards non-invasive prenatal testing for aneuploidy among US adults of reproductive age., The recent release of new, non-invasive prenatal tests for Prenatal care aneuploidy using cell-free Prenatal care DNA (cffDNA) has been hailed as a revolution in prenatal testing and has triggered significant commercial interest in the field., Non-invasive prenatal testing (NIPT) of Prenatal care aneuploidy using cell-free Prenatal care DNA is becoming part of routine clinical practice., Non-invasive prenatal testing (NIPT) by massively parallel sequencing is a useful clinical test for the detection of common Prenatal care aneuploidies., The clinical data collected thus far indicate that NIPT is highly sensitive in detecting Genetic screen for trisomy 21 and 18, and fairly sensitive in detecting trisomy 13 and Sex Chromosomes aneuploidies.[SEP]Relations: Sex Chromosomes has relations: cellcomp_protein with SMC6, cellcomp_protein with SMC6, cellcomp_protein with SMC5, cellcomp_protein with SMC5. somatic recombination of T cell receptor gene segments has relations: bioprocess_bioprocess with T cell receptor V(D)J recombination, bioprocess_bioprocess with T cell receptor V(D)J recombination, bioprocess_bioprocess with somatic diversification of T cell receptor genes, bioprocess_bioprocess with somatic diversification of T cell receptor genes, bioprocess_bioprocess with somatic diversification of immune receptors via germline recombination within a single locus, bioprocess_bioprocess with somatic diversification of immune receptors via germline recombination within a single locus. Definitions: Prenatal care defined as following: Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Cell-Free DNA defined as following: DNA that is found in blood plasma and is not associated with cells in the circulation.. Sex Chromosomes defined as following: The homologous chromosomes that are dissimilar in the heterogametic sex. There are the X CHROMOSOME, the Y CHROMOSOME, and the W, Z chromosomes (in animals in which the female is the heterogametic sex (the silkworm moth Bombyx mori, for example)). In such cases the W chromosome is the female-determining and the male is ZZ. (From King & Stansfield, A Dictionary of Genetics, 4th ed).", "label": "yes"} {"original_question": "Can the Micro-C XL method achieve mononucleosome resolution?", "id": "converted_1845", "sentence1": "Can the Micro-C XL method achieve mononucleosome resolution?", "sentence2": "We present Micro-C XL, an improved method for analysis of chromosome folding at mononucleosome resolution, We present Micro-C XL, an improved method for analysis of chromosome folding at mononucleosome resolution., Micro-C XL: assaying chromosome conformation from the nucleosome location location to the entire Genome - anatomical entity., Micro-C XL provides a single assay to interrogate chromosome folding at length scales from the nucleosome location location to the full Genome - anatomical entity.[SEP]Relations: nucleosome location mobilization has relations: bioprocess_protein with POLE3, bioprocess_protein with POLE3, bioprocess_bioprocess with chromatin remodeling, bioprocess_bioprocess with chromatin remodeling, bioprocess_protein with BPTF, bioprocess_protein with BPTF, bioprocess_protein with ARID1A, bioprocess_protein with ARID1A, bioprocess_protein with INO80, bioprocess_protein with INO80. Definitions: nucleosome location defined as following: A complex comprised of DNA wound around a multisubunit core and associated proteins, which forms the primary packing unit of DNA into higher order structures. [GOC:elh]. Genome - anatomical entity defined as following: Anatomical set of genes in all the chromosomes..", "label": "yes"} {"original_question": "Is Bladder training an effective method to treat urge incontinence ?", "id": "converted_705", "sentence1": "Is Bladder training an effective method to treat urge Incontinence ?", "sentence2": "Mindfulness-based stress reduction appears to be a treatment worthy of further study, as in the short term, it is as effective as historical studies of Pharmacologic Substance treatment and Urinary Bladder training in reducing urge Incontinence and Incontinence-related quality of life., All patients, irrespective of the results of cystometry were subsequently treated with oxybutynin 2.5 mg twice daily along with Urinary Bladder training., Of the 29 patients with stable Urinary Bladder and symptoms of OAB, 100% cure rate was achieved in 20 (68.9%) and 06 (20.6%) patients respectively. While in 3 patients in both groups, decrease of symptoms upto 75% after 6 months of treatment was observed., Both urodynamically proven unstable and stable Urinary Bladder showed nearly equal improvement with treatment, There are 3 types of Urinary Incontinence (urge-, stress-, and overflow-Incontinence). Another standardization of urinary Incontinence follows dysfunctions of the Pelvic Diaphragm: detrusor muscle-dependent, due to sphincter spasm, prostate gland dependent. Urge Incontinence with a dysfunction of the detrusor muscle is the most common type. Mixed types are frequent. Non-Pharmacologic Substance measures (e.g. Skeletal muscle structure of pelvis training, Urinary Bladder training, toilet training are first choice treatments., Treatment of stress, urge and mixed Incontinence can usually be commenced in primary care; Pelvic Diaphragm exercises and Urinary Bladder training are preferred. If Urinary Bladder training is not effective for urge Incontinence, anticholinergic drugs should be considered., Sixty patients (age 8 to 12 years) with urge Incontinence or dysfunctional voiding were evaluated. After a no-treatment control period (average 6 months), patients underwent a 6-day Urinary Bladder training course, Six months after training completion, 64.1% and 64.7% of the inpatient and outpatient groups with daytime wetting and 51.5% and 17.7% of the inpatient and outpatient groups with nighttime wetting were cured or had improved, Of the inpatient group with urge Incontinence, the functional Urinary Bladder capacity increased by 15%., To compare the efficacy of tolterodine plus simplified Urinary Bladder training (carmustine/triazinate) with tolterodine alone in patients with an overactive Urinary Bladder., CONCLUSIONS: tolterodine 2 mg twice daily is an effective and well tolerated treatment for an overactive Urinary Bladder, the effectiveness of which can be augmented by a simplified carmustine/triazinate regimen., Bladder training is a ResponseLevel - ResponseLevel - modification of Urinary Bladder drill that is conducted more gradually on an outpatient basis and has resulted in significant reduction of Incontinence in older, community-dwelling women., OBJECTIVE: To evaluate the long-term effect of treatment of female Incontinence by the general practitioner (Pelvic Diaphragm exercises, and Urinary Bladder training) in female urinary Incontinence., Urinary Stress Incontinence and urge Incontinence were treated by means of Pelvic Diaphragm exercises and Urinary Bladder training respectively, while a mixed Incontinence was treated by Urinary Bladder training followed by Pelvic Diaphragm exercises. T, The treatment consisted of training of pelvic muscles in stress Incontinence and Urinary Bladder training in urge Incontinence, RESULTS: After 3 months the mean frequency of urine loss per week diminished from 21 to 8, and after 12 months to 6 times., Some elders suffering from urge Incontinence prefer Skeletal muscle structure of pelvis exercises to Urinary Bladder training as the behavioral intervention of choice, for eight out of nine women their continence had improved, both subjectively and objectively., Bladder training is a simple, safe, and effective treatment in the management of mild to moderate forms of urinary Incontinence in outpatient populations. It can be used as a first-line treatment or in combination with such other interventions as Skeletal muscle structure of pelvis exercises, Urinary Bladder pressure biofeedback, electrical stimulation, and Pharmacologic Substance therapy, Treatment consisted of Pelvic Diaphragm exercises in the case of stress Incontinence and Urinary Bladder training in the case of urge Incontinence., After 3 months about 60% of the patients were either dry or only mildly incontinent, terodiline group shows this Pharmacologic Substance to be a valuable adjunct to a Urinary Bladder regimen in children with urge Incontinence, Basing on our experience with 39 patients with severe urge Incontinence (in one-quarter of the cases pure urge Incontinence, in one-half of the cases mixed Incontinence and in a further quarter of the cases neurogenic Urinary Bladder disorders) a supervised programme (mictiogram) and a well-tried therapy (especially in the Anglo-Saxon countries) consisting of the triad hospitalisation/Urinary Bladder training/medication therapy are presented. After an average hospitalisation period of 14 days, we were able to achieve a symptom-free state in 94% of the patients., Anamnestic and urodynamical results are evaluated before and after Urinary Bladder retraining drill (BRD) in women suffering from urge Incontinence., We could state that the BRD is a good possibility to realize multistep-therapy of female Incontinence., Twenty consecutive female patients with urge Incontinence and stable detrusor function on provocative rapid fill CO2-cystometry were treated as out-patients with a Urinary Bladder training programme and with terodiline/placebo in a double-blind cross-over design., In conclusion, female patients with idiopathic urge Incontinence and stable detrusor function did respond to treatment as do female patients with urge Incontinence and proven instability., The results of in-patient Urinary Bladder training in 65 women with frequency, urgency and urge Incontinence are reported. There was a good initial response in 88%. By 6 months the response rate had fallen to 38%., Patients with sensory urgency appeared to do better than those with Detrusor instability and it is suggested that Urinary Bladder training may be indicated as primary treatment in sensory urgency., Bladder training and/or biofeedback techniques were used to treat 75 patients with frequency, urgency, Nocturia and urge Incontinence. Significant improvement or cure was obtained in 70 per cent of enuretic children, and 66 per cent of men and 74 per cent of women with unstable detrusor function.[SEP]Relations: Urinary Incontinence has relations: drug_effect with Ibuprofen, drug_effect with Ibuprofen, drug_effect with Acamprosate, drug_effect with Acamprosate, drug_effect with Urofollitropin, drug_effect with Urofollitropin, drug_effect with Naproxen, drug_effect with Naproxen, drug_effect with Levonorgestrel, drug_effect with Levonorgestrel. Definitions: Skeletal muscle structure of pelvis defined as following: Muscle (organ) which is a part of the pelvis. Examples: levator ani,. Urinary Incontinence defined as following: Involuntary loss of URINE, such as leaking of urine. It is a symptom of various underlying pathological processes. Major types of Incontinence include URINARY URGE INCONTINENCE and URINARY STRESS INCONTINENCE.. Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Urinary Bladder defined as following: A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the Urinary Bladder via the ureters (URETER), and is held there until URINATION.. tolterodine defined as following: A benzhydryl compound and a muscarinic receptor antagonist possessing both antimuscarinic and antispasmodic properties. Both tolterodine and its active metabolite, 5-hydroxymethyltolterodine, competitively blocks muscarinic receptors, thereby inhibiting acetylcholine binding. This antagonistic action results in an increase in residual urine, reflecting an incomplete emptying of the Urinary Bladder, and a decrease in detrusor pressure, indicating an antimuscarinic action on the lower urinary tract. The 5-hydroxymethyl metabolite appears to contribute significantly to the therapeutic effects.. Nocturia defined as following: Frequent URINATION at night that interrupts sleep. It is often associated with outflow obstruction, DIABETES MELLITUS, or Urinary Bladder inflammation (CYSTITIS).. ResponseLevel - modification defined as following:

Respond with exceptions, completions and modifications or revisions done before completion

. Urinary Stress Incontinence defined as following: Involuntary discharge of URINE as a result of physical activities that increase abdominal pressure on the URINARY BLADDER without detrusor contraction or overdistended Urinary Bladder. The subtypes are classified by the degree of leakage, descent and opening of the Urinary Bladder neck and URETHRA without Urinary Bladder contraction, and sphincter deficiency.. Incontinence defined as following: Involuntary passage of stool or urine from the body.. Pelvic Diaphragm defined as following: Soft tissue formed mainly by the pelvic diaphragm, which is composed of the two levator ani and two coccygeus muscles. The pelvic diaphragm lies just below the pelvic aperture (outlet) and separates the pelvic cavity from the PERINEUM. It extends between the PUBIC BONE anteriorly and the COCCYX posteriorly..", "label": "yes"} {"original_question": "Is there any functional association during viral replication between flaviviridae viral RNA depended RNA polymerase and viral helicase?", "id": "converted_836", "sentence1": "Is there any functional association during viral replication between flaviviridae viral RNA depended RNA polymerase and viral helicase?", "sentence2": "Several labs have obtained evidence for a Protein complex that involves many of the nonstructural (NS) Proteins encoded by the Virus. NOONAN SYNDROME 3, NS4A, NS4B, NS5A, and NS5B appear to interact structurally and functionally. In this study, we investigated the interaction between the helicase, NOONAN SYNDROME 3, and the RNA polymerase, NS5B. Pull-down experiments and surface plasmon resonance data indicate a direct interaction between NOONAN SYNDROME 3 and NS5B that is primarily mediated through the Protease Domain of NOONAN SYNDROME 3. This interaction reduces the basal Adenosine Triphosphatases activity of NOONAN SYNDROME 3. However, NS5B stimulates product formation in RNA unwinding experiments under conditions of excess Nucleic Acids substrate. When the concentrations of NOONAN SYNDROME 3 and NS5B are in excess of Nucleic Acids substrate, NS5B reduces the rate of NOONAN SYNDROME 3-catalyzed unwinding. Under pre-steady-state conditions, in which NOONAN SYNDROME 3 and substrate concentrations are similar, product formation increased in the presence of NS5B. The increase was consistent with 1:1 complex formed between the two Proteins. A fluorescently labeled form of NOONAN SYNDROME 3 was used to investigate this interaction through fluorescence polarization binding assays. Results from this assay support interactions that include a 1:1 complex formed between NOONAN SYNDROME 3 and NS5B., Contradictory results have been reported regarding NOONAN SYNDROME 3 in RNA synthesis. To investigate the effect of NOONAN SYNDROME 3 on classical swine fever Virus (CSFV) NS5B RNA-dependent RNA polymerase activity (RNA-directed RNA polymerase activity) activity and NOONAN SYNDROME 3-NS5B interaction, RNA-directed RNA polymerase activity reactions, GST-pull-down assays and co-immunoprecipitation analyses containing NS5B and either of NOONAN SYNDROME 3 protein and the different truncated NOONAN SYNDROME 3 Mutant were performed, respectively. We found that NOONAN SYNDROME 3 stimulated NS5B RNA-directed RNA polymerase activity activity in a dose-dependent manner by binding to Noonan Syndrome 5 through a NOONAN SYNDROME 3 Protease Domain. Furthermore, mapping important regions of the NOONAN SYNDROME 3 Protease Domain was carried out by Deletion Mutagenesis, associated with RNA-directed RNA polymerase activity reactions, GST-pull-down assays and co-immunoprecipitation analyses. Results showed that stimulation of CSFV NS5B RNA-directed RNA polymerase activity activity was obtained by NOONAN SYNDROME 3 binding to NS5B through a 31-amino acid fragment at the N-terminal end of NOONAN SYNDROME 3 Protease Domain, which mediated a specific NOONAN SYNDROME 3-NS5B interaction., The protocols detailed in this unit are used to purify three recombinant enzymes that are widely used in HCV research: the HCV NOONAN SYNDROME 3 Protease Domain, the helicase Superkingdom (taxonomic category) as an NOONAN SYNDROME 3+NS4A complex, and the NS5B RNA-dependent RNA polymerase. The active enzymes are purified to homogeneity by two-column chromatography to support a screening program for HCV inhibitors., Among potential targets are viral entry factors, including scavenger receptor type B1 (SCARB1 wt Allele) and CD81 antigen antigen, as well as Antibodies, Neutralizing against the viral glycoproteins. Popular targets related to translation and replication are the NOONAN SYNDROME 3/4A protease (inhibited by telaprevir and boceprevir) and the NS5B polymerase, as well as the NS2/3 autoprotease, the NOONAN SYNDROME 3 helicase, and nonenzymatic targets such as NS4B and NS5A Proteins. , The NOONAN SYNDROME 3 helicase Superkingdom (taxonomic category) competes with NOONAN SYNDROME 3 full-length for Noonan Syndrome 5 RNA-directed RNA polymerase activity binding, with a K(d.) of 2.5μM. Since NOONAN SYNDROME 3 and Noonan Syndrome 5 are required for DENV replication, this fascile assay could be used to screen for non-nucleoside, allosteric inhibitors that disrupt the interaction between the two Proteins.[SEP]Relations: RNA-directed DNA polymerase activity has relations: molfunc_protein with ERVK-11, molfunc_protein with ERVK-11, molfunc_protein with ERVK-8, molfunc_protein with ERVK-8, molfunc_protein with ERVK-10, molfunc_protein with ERVK-10, molfunc_protein with ERVK-7, molfunc_protein with ERVK-7, molfunc_protein with ERVK-6, molfunc_protein with ERVK-6. Definitions: Noonan Syndrome 5 defined as following: Noonan syndrome caused by autosomal dominant mutation(s) in the RAF1 gene, encoding RAF proto-oncogene serine/threonine-protein kinase.. SCARB1 wt Allele defined as following: Human SCARB1 wild-type allele is located in the vicinity of 12q24.31 and is approximately 106 kb in length. This allele, which encodes scavenger receptor class B member 1 protein, plays a role in both binding and import of lipids and lipoproteins.. boceprevir defined as following: An orally bioavailable, synthetic tripeptide inhibitor of the nonstructural protein 3 and 4A complex (NOONAN SYNDROME 3/NS4A), with potential activity against hepatitis C Virus (HCV) genotype 1. Upon administration, boceprevir reversibly binds to the active center of the HCV NOONAN SYNDROME 3/NS4A and prevents NOONAN SYNDROME 3/NS4A protease-mediated polyprotein maturation. This disrupts the processing of viral Proteins and the formation of a viral replication complex, which inhibits viral replication in HCV genotrype 1-infected host cells. NOONAN SYNDROME 3, a serine protease, is essential for the proteolytic cleavages within the HCV polyprotein and plays a key role during HCV viral RNA replication. NS4A is an activating factor for NOONAN SYNDROME 3. HCV is a small, enveloped, single-stranded RNA Virus belonging to the Flaviviridae family.. telaprevir defined as following: An orally available peptidomimetic small molecule with activity against hepatitis C Virus (HCV). Telaprivir is a selective protease inhibitor that targets the viral HCV NOONAN SYNDROME 3-4A serine protease and disrupts processing of viral Proteins and formation of a viral replication complex.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. NOONAN SYNDROME 3 defined as following: Noonan syndrome caused by autosomal dominant mutation(s) in the KRAS gene, encoding GTPase KRas.. Adenosine Triphosphatases defined as following: A group of enzymes which catalyze the hydrolysis of ATP. The hydrolysis reaction is usually coupled with another function such as transporting Ca(2+) across a membrane. These enzymes may be dependent on Ca(2+), Mg(2+), anions, H+, or DNA.. Mutant defined as following: An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).. CD81 antigen defined as following: A tetraspanin protein that is involved in a variety of cellular functions including BASEMENT MEMBRANE assembly, and in the formation of a molecular complexes on the surface of LYMPHOCYTES.. Protease Domain defined as following: The portion of a proteolytic protein which causes hydrolysis and cleavage of other protein polypeptides.. Deletion Mutagenesis defined as following: Mutagenesis where the mutation is caused by the loss of DNA sequences within a gene. This may occur spontaneously in vivo or be experimentally induced in vivo or in vitro.. Superkingdom (taxonomic category) defined as following: A taxonomic category above that of Kingdom.. Antibodies, Neutralizing defined as following: Antibodies that reduce or abolish some biological activity of a soluble antigen or infectious agent, usually a Virus.. Virus defined as following: Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells.. RNA-directed RNA polymerase activity defined as following: Catalysis of the reaction: nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1); uses an RNA template, i.e. the catalysis of RNA-template-directed extension of the 3'-end of an RNA strand by one nucleotide at a time. [EC:2.7.7.48, GOC:mah, GOC:pf]. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Nucleic Acids defined as following: High molecular weight polymers containing a mixture of purine and pyrimidine nucleotides chained together by ribose or deoxyribose linkages.. viral RNA defined as following: Ribonucleic acid that makes up the genetic material of viruses..", "label": "yes"} {"original_question": "Is insulin-like growth factor-I (IGF-I) able to affect tendon protein synthesis in classic Ehlers-Danlos syndrome patients?", "id": "converted_764", "sentence1": "Is Insulin-Like Growth Factor I (IGF-I) able to affect tendon protein synthesis in classic Ehlers-Danlos syndrome patients?", "sentence2": "Tendon protein synthesis rate in classic Ehlers-Danlos patients can be stimulated with Insulin-Like Growth Factor I, IGF-I injections significantly increased Flexed Sidebent Rotated values in Autoimmune Lymphoproliferative Syndrome Type 2B patients but not in controls, In conclusion, baseline protein synthesis rates in Connective Tissue appeared normal in Autoimmune Lymphoproliferative Syndrome Type 2B patients, and the patients responded with an increased tendon protein synthesis rate to IGF-I injections, In conclusion, baseline protein synthesis rates in Connective Tissue appeared normal in Autoimmune Lymphoproliferative Syndrome Type 2B patients, and the patients responded with an increased tendon protein synthesis rate to IGF-I injections, IGF-I injections significantly increased Flexed Sidebent Rotated values in Autoimmune Lymphoproliferative Syndrome Type 2B patients but not in controls (delta values: Autoimmune Lymphoproliferative Syndrome Type 2B 0[SEP]Relations: insulin-like growth factor I binding has relations: molfunc_protein with IGF1R, molfunc_protein with IGF1R, molfunc_protein with IGFBP4, molfunc_protein with IGFBP4, molfunc_protein with IGFBP3, molfunc_protein with IGFBP3, molfunc_protein with IGFBP1, molfunc_protein with IGFBP1, molfunc_protein with IGFBP5, molfunc_protein with IGFBP5. Definitions: Insulin-Like Growth Factor I defined as following: A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor.. Flexed Sidebent Rotated defined as following: A descriptor of spinal somatic dysfunction used to denote a combination flexed (F), sidebent (S), and rotated (R) vertebral position.. Autoimmune Lymphoproliferative Syndrome Type 2B defined as following: Autoimmune lymphoproliferative syndrome due to mutations in CASPASE 8 gene.. Connective Tissue defined as following: Tissue that supports and binds other tissues. It consists of CONNECTIVE TISSUE CELLS embedded in a large amount of EXTRACELLULAR MATRIX.. IGF-I defined as following: Human IGF1 wild-type allele is located within 12q22-q23 and is approximately 85 kb in length. This allele, which encodes insulin-like growth factor I protein, is involved in the mediation of peptides that exert growth-promoting effects involved in mammalian growth and development.. Ehlers-Danlos syndrome defined as following: A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability..", "label": "yes"} {"original_question": "Can pazopanib be used for treatment von Hippel-Lindau disease?", "id": "converted_3048", "sentence1": "Can pazopanib be used for treatment Von Hippel-Lindau Syndrome?", "sentence2": "Variable response of Clinical Nurse Specialists hemangioblastomas to pazopanib in a single patient with Von Hippel-Lindau Syndrome: Case report., Treatment of Renal Cell Carcinoma with Protein-tyrosine kinase inhibitor (disposition) (TKIs) such as pazopanib is now first line therapy, but their effect on VHL-associated Clinical Nurse Specialists Hemoglobin, Sickle remains unknown. We report the use of pazopanib in a patient with VHL disease for treatment of Conventional (Clear Cell) Renal Cell Carcinoma who also harbored multiple Clinical Nurse Specialists Hemoglobin, Sickle. , pazopanib in patients with Von Hippel-Lindau Syndrome: a single-arm, single-centre, phase 2 trial., INTERPRETATION: pazopanib was associated with encouraging preliminary activity in Von Hippel-Lindau Syndrome, with a side-effect profile consistent with that seen in previous trials. pazopanib could be considered as a treatment choice for patients with Von Hippel-Lindau Syndrome and growing Lesion, or to reduce the size of unresectable Lesion in these patients. , Recurrent multiple Clinical Nurse Specialists hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review., Here, we report a 37-year-old woman's case with recurrent and rapidly progressive VHL-associated hemangioblastomas, causing severe Disability:Type:Pt:^Patient:Nom. She was treated 24 months with pazopanib, a multityrosine kinase inhibitor (TKI) targeting Vascular Endothelial Growth Factor A and PDGF-β pathways. , pazopanib therapy for Cerebellar hemangioblastoma in Von Hippel-Lindau Syndrome: case report., Here we provide the first report demonstrating clinical and radiological anti-tumor response using pazopanib, a small molecule multi-receptor tyrosine kinase inhibitor, in a patient with treatment-refractory VHL-associated Clinical Nurse Specialists hemangioblastoma. , pazopanib could be considered as a treatment choice for patients with Von Hippel-Lindau Syndrome and growing Lesion, or to reduce the size of unresectable Lesion in these patients., METHODS\nIn this non-randomised, single-centre, open-label, phase 2 trial, adult patients with clinical manifestations of Von Hippel-Lindau Syndrome were recruited from the University of Texas MD Anderson Cancer Center (Houston, TX, USA) and were treated with pazopanib (800 mg orally daily) for 24 weeks, with an option to continue treatment if desired by the patient and treating physician., We aimed to assess the activity and safety of pazopanib in patients with Von Hippel-Lindau Syndrome., INTERPRETATION\npazopanib was associated with encouraging preliminary activity in Von Hippel-Lindau Syndrome, with a side-effect profile consistent with that seen in previous trials., FINDINGS\nBetween Jan 18, 2012, and Aug 10, 2016, we screened 37 patients with genetically confirmed or clinical features consistent with Von Hippel-Lindau Syndrome, of whom 31 eligible patients were treated with pazopanib., pazopanib therapy for Cerebellar hemangioblastoma in Von Hippel-Lindau Syndrome: case report.von Hippel-Lindau (VHL) disease is a genetically acquired multisystem tumor syndrome of the Viscera and CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS (Clinical Nurse Specialists). , Recurrent multiple Clinical Nurse Specialists hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review.Hemangioblastoma is a rare benign neoplasm, accounting for less than 2% of all primitive Brain Neoplasms. , We aimed to assess the activity and safety of pazopanib in patients with Von Hippel-Lindau Syndrome.
METHODS: In this non-randomised, single-centre, open-label, phase 2 trial, adult patients with clinical manifestations of Von Hippel-Lindau Syndrome were recruited from the University of Texas MD Anderson Cancer Center (Houston, TX, USA) and were treated with pazopanib (800 mg orally daily) for 24 weeks, with an option to continue treatment if desired by the patient and treating physician., This study is registered with ClinicalTrials.gov, number NCT01436227, and is closed to accrual.
FINDINGS: Between Jan 18, 2012, and Aug 10, 2016, we screened 37 patients with genetically confirmed or clinical features consistent with Von Hippel-Lindau Syndrome, of whom 31 eligible patients were treated with pazopanib., Treatment-related serious adverse events included one case each of Appendicitis and Gastritis and one patient had a fatal Clinical Nurse Specialists bleed.
INTERPRETATION: pazopanib was associated with encouraging preliminary activity in Von Hippel-Lindau Syndrome, with a side-effect profile consistent with that seen in previous trials., pazopanib could be considered as a treatment choice for patients with Von Hippel-Lindau Syndrome and growing Lesion, or to reduce the size of unresectable Lesion in these patients., We aimed to assess the activity and safety of pazopanib in patients with Von Hippel-Lindau Syndrome., In this non-randomised, single-centre, open-label, phase 2 trial, adult patients with clinical manifestations of Von Hippel-Lindau Syndrome were recruited from the University of Texas MD Anderson Cancer Center (Houston, TX, USA) and were treated with pazopanib (800 mg orally daily) for 24 weeks, with an option to continue treatment if desired by the patient and treating physician., pazopanib was associated with encouraging preliminary activity in Von Hippel-Lindau Syndrome, with a side-effect profile consistent with that seen in previous trials., pazopanib could be considered as a treatment choice for patients with Von Hippel-Lindau Syndrome and growing Lesion, or to reduce the size of unresectable Lesion in these patients., Between Jan 18, 2012, and Aug 10, 2016, we screened 37 patients with genetically confirmed or clinical features consistent with Von Hippel-Lindau Syndrome, of whom 31 eligible patients were treated with pazopanib.[SEP]Relations: pazopanib has relations: drug_drug with Lapatinib, drug_drug with Lapatinib, drug_drug with Verapamil, drug_drug with Verapamil, drug_drug with Alemtuzumab, drug_drug with Alemtuzumab, drug_drug with Alpelisib, drug_drug with Alpelisib, drug_drug with Galantamine, drug_drug with Galantamine. Definitions: Conventional (Clear Cell) Renal Cell Carcinoma defined as following: A malignant epithelial neoplasm of the kidney characterized by the presence of lipid-containing clear cells within a vascular network. The tumor may metastasize to unusual sites and late metastasis is common.. pazopanib defined as following: A small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1, -2 and -3, c-kit and platelet derived growth factor receptor (PDGF-R), which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated.. Viscera defined as following: Any of the large interior organs in any one of the three great cavities of the body, especially in the abdomen.. Cerebellar hemangioblastoma defined as following: A histologically benign tumor, usually cystic with a vascular mural nodule, that is most often found in the cerebellum though it has been reported at other sites within the neuraxis. It is associated with Von Hippel-Lindau Syndrome (VHL gene located on chr 3p25-26).. Hemangioblastoma defined as following: A benign tumor of the nervous system that may occur sporadically or in association with VON HIPPEL-LINDAU DISEASE. It accounts for approximately 2% of intracranial tumors, arising most frequently in the cerebellar hemispheres and vermis. Histologically, the tumors are composed of multiple capillary and sinusoidal channels lined with endothelial cells and clusters of lipid-laden pseudoxanthoma cells. Usually solitary, these tumors can be multiple and may also occur in the brain stem, spinal cord, retina, and supratentorial compartment. Cerebellar hemangioblastomas usually present in the third decade with INTRACRANIAL HYPERTENSION, and ataxia. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2071-2). Renal Cell Carcinoma defined as following: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.. Vascular Endothelial Growth Factor A defined as following: The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as \"tumor angiogenesis factor\" and \"vascular permeability factor\". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced.. Von Hippel-Lindau Syndrome defined as following: An autosomal dominant disorder caused by mutations in a tumor suppressor gene. This syndrome is characterized by abnormal growth of small blood vessels leading to a host of neoplasms. They include HEMANGIOBLASTOMA in the RETINA; CEREBELLUM; and SPINAL CORD; PHEOCHROMOCYTOMA; pancreatic tumors; and renal cell carcinoma (see CARCINOMA, RENAL CELL). Common clinical signs include HYPERTENSION and neurological dysfunctions.. Protein-tyrosine kinase inhibitor (disposition) defined as following: Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES.. Lesion defined as following: A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.. Hemoglobin, Sickle defined as following: An abnormal hemoglobin resulting from the substitution of valine for glutamic acid at position 6 of the beta chain of the globin moiety. The heterozygous state results in sickle cell trait, the homozygous in sickle cell anemia.. Brain Neoplasms defined as following: Neoplasms of the intracranial components of the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, Brain Neoplasms may also be classified by age of onset, histologic type, or presenting location in the brain.. Gastritis defined as following: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.. Clinical Nurse Specialists defined as following: The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.. Appendicitis defined as following: Acute inflammation of the APPENDIX. Acute Appendicitis is classified as simple, gangrenous, or perforated.. Hippel-Lindau disease defined as following: An autosomal dominant disorder caused by mutations in a tumor suppressor gene. This syndrome is characterized by abnormal growth of small blood vessels leading to a host of neoplasms. They include HEMANGIOBLASTOMA in the RETINA; CEREBELLUM; and SPINAL CORD; PHEOCHROMOCYTOMA; pancreatic tumors; and renal cell carcinoma (see CARCINOMA, RENAL CELL). Common clinical signs include HYPERTENSION and neurological dysfunctions.. pazopanib defined as following: A small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1, -2 and -3, c-kit and platelet derived growth factor receptor (PDGF-R), which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated..", "label": "yes"} {"original_question": "Are Crocus sativus compounds being considered against Alzheimer's disease?", "id": "converted_3184", "sentence1": "Are Crocus sativus antigen compounds being considered against ALZHEIMER DISEASE, FAMILIAL, 1?", "sentence2": "Previous evidence suggested that Crocus sativus antigen antigen is linked to improving cognitive function in ALZHEIMER DISEASE, FAMILIAL, 1 (cytarabine/daunorubicin protocol) patients. The aim of this study was to in vitro and in vivo investigate the mechanism(s) by which Crocus sativus antigen antigen exerts its positive effect against cytarabine/daunorubicin protocol. , Collectively, findings from this study support the positive effect of Crocus sativus antigen antigen against cytarabine/daunorubicin protocol by reducing Aβ pathological manifestations.[SEP]Relations: familial Alzheimer disease has relations: disease_disease with Alzheimer disease, disease_disease with Alzheimer disease, disease_disease with inherited prion disease, disease_disease with inherited prion disease, disease_phenotype_positive with Sleep disturbance, disease_phenotype_positive with Sleep disturbance, disease_phenotype_positive with Depressivity, disease_phenotype_positive with Depressivity, disease_phenotype_positive with Attention deficit hyperactivity disorder, disease_phenotype_positive with Attention deficit hyperactivity disorder. Definitions: ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65..", "label": "yes"} {"original_question": "Does MVIIA and MVIIC bind to the same calcium channel?", "id": "converted_1434", "sentence1": "Does MVIIA and MVIIC bind to the same calcium channel?", "sentence2": "We examined the post-pubertal behavioral effects of neonatal (postnatal day 7) medial prefrontal Adrenal Cortex Diseases infusion of either vehicle or N-type and P/Q-type presynaptic voltage-dependent calcium channel blockers (ziconotide and MVIIC respectively; 6.8 and 45 pmol infused respectively) in Rattus norvegicus pups., Additionally, the number of Binding Sites for radioligands labelling L- ([3H]nitrendipine), N- ([125I]omega-conotoxin MVIIA) and P/Q-type ([125I]omega-conotoxin MVIIC) Ca2+ channels was assessed in the Rattus norvegicus retina and, for further comparison, in the Rattus norvegicus Adrenal Cortex Diseases., omega-conotoxin-MVIIC (MVIIC) blocks P/Q-type calcium channels with high affinity and N-type calcium channels with low affinity, while the highly homologous omega-conotoxin MVIIA blocks only N-type calcium channels., However, omega-conotoxin MVIIC seems to bind to sites different from those recognised by omega-Conotoxin GVIA and MVIIA, which are markedly differentiated by their Ca2+ requirements for binding to their receptors., Despite their high sequence homology, the peptide neurotoxins omega-conotoxin MVIIA and MVIIC selectively block N- and P/Q-type calcium channels, respectively., Surgical Replantation of the N-terminal half of omega-conotoxin MVIIC, a peptide blocker of P/Q-type calcium channels, with that of omega-conotoxin MVIIA significantly increased the affinity for N-type calcium channels., omega-conotoxin-MVIIC (MVIIC) blocks P/Q-type calcium channels with high affinity and N-type calcium channels with low affinity, while the highly homologous omega-conotoxin MVIIA blocks only N-type calcium channels. We wished to obtain MVIIC analogues more selective for P/Q-type calcium channels than MVIIC to elucidate structural differences among the channels, which discriminate the omega-Conotoxins., omega-conotoxin MVIIC seems to bind to sites different from those recognised by omega-Conotoxin GVIA and MVIIA,[SEP]Relations: siRNA binding has relations: molfunc_protein with MBD2, molfunc_protein with MBD2, molfunc_protein with TLR9, molfunc_protein with TLR9, molfunc_protein with AGO2, molfunc_protein with AGO2, molfunc_protein with FMR1, molfunc_protein with FMR1. Ziconotide has relations: drug_drug with Calcium levulinate, drug_drug with Calcium levulinate. Definitions: omega-Conotoxin GVIA defined as following: A neurotoxic peptide, which is a cleavage product (VIa) of the omega-Conotoxin precursor protein contained in venom from the marine snail, CONUS geographus. It is an antagonist of CALCIUM CHANNELS, N-TYPE.. Surgical Replantation defined as following: Restoration of an organ or other structure to its original site.. Binding Sites defined as following: The parts of a macromolecule that directly participate in its specific combination with another molecule.. ziconotide defined as following: A synthetic, nonopiod, twenty-five amino acid polybasic peptide analogue of an omega-conotoxin derived from the marine snail Conus magus with analgesic activity. Ziconotide appears to block neuronal N-type voltage-sensitive calcium channels (NCCB), inhibiting transmission from pain-sensing primary nociceptors. This agent may exhibit significant analgesic activity in refractory pain.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. omega-Conotoxins defined as following: A family of structurally related neurotoxic peptides from mollusk venom that inhibit voltage-activated entry of calcium into the presynaptic membrane. They selectively inhibit N-, P-, and Q-type calcium channels.. Adrenal Cortex Diseases defined as following: Pathological processes of the ADRENAL CORTEX..", "label": "no"} {"original_question": "Is Weaver syndrome similar to Sotos?", "id": "converted_47", "sentence1": "Is Weaver syndrome similar to Sotos?", "sentence2": "Overgrowth conditions are a heterogeneous group of disorders characterised by increased growth and variable features, including Macrocephaly, distinctive facial appearance and various degrees of Learning difficulties and Intellectual Disability. Among them, Sotos and Weaver syndromes are clinically well defined and due to heterozygous Gene Mutation in NSD1 protein, human protein, human and EZH2 protein, human protein, human, respectively. NSD1 protein, human protein, human and EZH2 protein, human protein, human are both histone-modifying enzymes, NSD1 protein, human protein, human and EZH2 protein, human protein, human are Parameterized Data Type - Set domain-containing histone methyltransferases that play key roles in the regulation of transcription through histone modification and chromatin modeling: NSD1 protein, human protein, human preferentially methylates lysine residue 36 of histone 3 (H3K36) and is primarily associated with active transcription, while EZH2 protein, human protein, human shows specificity for lysine residue 27 (Histone H3 Lysine 28) and is associated with transcriptional repression, Constitutional NSD1 protein, human protein, human and EZH2 protein, human protein, human Gene Mutation cause Sotos and Weaver syndromes respectively, overgrowth syndromes with considerable phenotypic overlap, Clinically, Weaver syndrome is closely related to SOTOS SYNDROME 1, which is frequently caused by Gene Mutation in NSD1 protein, human protein, human, Overgrowth syndromes such as Beckwith-Wiedemann Syndrome, SOTOS SYNDROME 1, and Weaver syndrome have an increased risk of Neoplasms., Thus, it is not surprising that prenatal overgrowth occurs in several syndromes, including the Sotos and Weaver syndromes., NSD1 protein, human protein, human Gene Mutation are the major cause of SOTOS SYNDROME 1 and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes., We conclude therefore that NSD1 protein, human protein, human Gene Mutation account for most cases of SOTOS SYNDROME 1 and a significant number of Weaver syndrome cases in our series., We conclude that intragenic Gene Mutation of NSD1 protein, human protein, human are the major cause of SOTOS SYNDROME 1 and account for some Weaver syndrome cases but rarely occur in other childhood overgrowth phenotypes., Overgrowth syndromes such as Beckwith-Wiedemann Syndrome, SOTOS SYNDROME 1, and Weaver syndrome have an increased risk of Neoplasms, NSD1 protein, human protein, human Gene Mutation are the major cause of SOTOS SYNDROME 1 and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes, We conclude that intragenic Gene Mutation of NSD1 protein, human protein, human are the major cause of SOTOS SYNDROME 1 and account for some Weaver syndrome cases but rarely occur in other childhood overgrowth phenotypes, Considerable phenotypic overlap between Sotos and Weaver syndromes is also evident. , Considerable phenotypic overlap between Sotos and Weaver syndromes is also evident. The identification of an EZH2 protein, human protein, human mutation can therefore provide an objective means of confirming a subtle presentation of Weaver syndrome and/or distinguishing Weaver and Sotos syndromes., Overgrowth syndromes such as Beckwith-Wiedemann Syndrome, SOTOS SYNDROME 1, and Weaver syndrome have an increased risk of Neoplasms. Two previous cases of Neuroblastoma have been reported in children with Weaver syndrome., Weaver syndrome is closely related to SOTOS SYNDROME 1,, Overgrowth syndromes such as Beckwith-Wiedemann Syndrome, SOTOS SYNDROME 1, and Weaver syndrome have an increased risk of Neoplasms., Considerable phenotypic overlap between Sotos and Weaver syndromes is also evident., Clinically, Weaver syndrome is closely related to SOTOS SYNDROME 1, which is frequently caused by Gene Mutation in NSD1 protein, human protein, human.[SEP]Relations: SOTOS SYNDROME 1 has relations: disease_protein with SETD2, disease_protein with SETD2, disease_disease with Malan overgrowth syndrome, disease_disease with Malan overgrowth syndrome, disease_disease with chromosomal disease with overgrowth, disease_disease with chromosomal disease with overgrowth, disease_protein with NRK, disease_protein with NRK. Weaver syndrome has relations: disease_disease with overgrowth syndrome, disease_disease with overgrowth syndrome. Definitions: EZH2 protein, human defined as following: Histone-lysine N-methyltransferase EZH2 protein, human (746 aa, ~85 kDa) is encoded by the human EZH2 protein, human gene. This protein is involved in the regulation of chromatin modification.. Histone H3 Lysine 28 defined as following: The lysine residue found at amino acid position 28 in the histone H3 protein. Methylation of this residue may be a marker for transcriptionally repressed genes.. NSD1 protein, human defined as following: Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific (2696 aa, ~297 kDa) is encoded by the human NSD1 protein, human gene. This protein is involved in histone methylation.. Neuroblastoma defined as following: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51). histone modification defined as following: The covalent alteration of one or more amino acid residues within a histone protein. [GOC:krc]. Parameterized Data Type - Set defined as following: Terminology associated with the environmental setting codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM).. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Beckwith-Wiedemann Syndrome defined as following: A syndrome of multiple defects characterized primarily by umbilical hernia (HERNIA, UMBILICAL); MACROGLOSSIA; and GIGANTISM; and secondarily by visceromegaly; HYPOGLYCEMIA; and ear abnormalities.. lysine defined as following: An essential amino acid. It is often added to animal feed.. Weaver syndrome defined as following: A rare syndrome caused by Gene Mutation in the EZH2 protein, human gene, and rarely Gene Mutation in the NSD1 protein, human gene. It is characterized by advanced bone age, foot deformities, permanently bent joints, Macrocephaly, flattened back of the head, a broad forehead, hypertelorism, large, low-set ears, micrognathia, delayed development of motor skills, and mild Intellectual Disability.. Macrocephaly defined as following: A congenital abnormality in which the occipitofrontal circumference is greater than two standard deviations above the mean for a given age. It is associated with HYDROCEPHALUS; SUBDURAL EFFUSION; ARACHNOID CYSTS; or is part of a genetic condition (e.g., ALEXANDER DISEASE; SOTOS SYNDROME).. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Intellectual Disability defined as following: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an Intellectual Disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28).", "label": "yes"} {"original_question": "Are proteasome inhibitors good candidates for treatment of leukemia and solid tumors?", "id": "converted_187", "sentence1": "Are Proteasome inhibitors, antineoplastic agent good candidates for treatment of leukemia and solid Neoplasms?", "sentence2": "We show that treatment with b-AP15 inhibited tumor progression in four different in vivo Solid Neoplasm models and inhibited organ infiltration in an RUNX1 gene model. Our results show that the deubiquitinating activity of the 19S regulatory particle is a new anticancer drug target, We further found that ATO targets Mineralocorticoid Excess Syndrome, Apparent via both myelodysplastic syndrome 1 (MECOM Protein Isoform MECOM Protein Isoform MDS1) and MECOM wt Allele moieties and degrades MECOM wt Allele via the ubiquitin-proteasome pathway and MECOM Protein Isoform MECOM Protein Isoform MDS1 in a proteasome-independent manner. Our results suggest that ATO could be used as a part of targeted therapy for Mineralocorticoid Excess Syndrome, Apparent-, AML1/MECOM Protein Isoform MECOM Protein Isoform MDS1-, MECOM Protein Isoform MECOM Protein Isoform MDS1/MECOM wt Allele-, and MECOM wt Allele-positive human cancers., Previously we had shown the synergic effect of bortezomib and thiostrepton in breast cancer cells in vitro, where sub-apoptotic concentrations of both Proteasome inhibitors, antineoplastic agent resulted in synergic increase in cell death when combined as a treatment. Here, we administered such a combination to MDA-MB-231 xenograft Neoplasms in vivo, and found that the effect of complementary Proteasome inhibitors, antineoplastic agent reduced tumor growth rates more efficiently than compared with when administered alone., Addition of a Proteasome Inhibitors [MoA] to anti-hormonal therapy resulted in a clinical benefit rate of 22% in a limited number of patients with endocrine resistant and progressive metastatic breast cancer., Taken together, these data support the clinical development of MLN9708 for both Hematologic and Solid Neoplasm indications., Bortezomib has minimal activity as a single-agent in the treatment of recurrent platinum-sensitive EOC/PPC, Our study indicates a molecular mechanism by which the sensitivity of Malignant neoplasm of thyroid cells is regulated by the level of 78 kDa Glucose-Regulated Protein as well as preferential induction of 78 kDa Glucose-Regulated Protein or CHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristine protocol-cyclophosphamide/doxorubicin/prednisone/vincristine upon treatment with Proteasome inhibitors, antineoplastic agent. Our experiments therefore suggest a novel approach toward sensitization of Malignant neoplasm of thyroid cells to Proteasome inhibitors, antineoplastic agent., Bortezomib (PS-341) is a novel antineoplastic agent that is well tolerated at doses not exceeding 3.0 mg (equivalent to 1.75 mg/m2), repeated on Measles virus genotype Measles virus genotype D1 and Measles virus genotype Measles virus genotype D4 every other week. This dose correlates with 70% inhibition of 20S proteasome activity., The maximum-tolerated dose and recommended phase II dose of bortezomib in this schedule is 1.6 mg/m(2). Biologic activity (inhibition of nuclear factor-kappa B-related markers) and antitumor activity is seen in AIPCa at tolerated doses of bortezomib., Given the results of this trial, it is safe and reasonable to recommend treatment with PS 341 on the schedule used in this trial at 1.56 mg/m2/dose in Phase II trials. Particular care should be taken with patients with preexisting Neuropathy, The successes of Proteasome inhibitors, antineoplastic agent in Millimole per Liter are now being translated to other Hematologic malignancies, including Acute leukemia, Such efforts have led to bortezomib, the first FDA approved Proteasome Inhibitors [MoA] now used as a frontline treatment for newly diagnosed Multiple Myeloma (Millimole per Liter), relapsed/refractory Millimole per Liter and Mantle cell lymphoma, We recently reported the impact and mechanisms of carfilzomib and Oprozomib, second-in-class Proteasome inhibitors, antineoplastic agent with higher specificities and reduced Toxic effect, against Squamous cell carcinoma of the head and neck (HNSCC). carfilzomib and Oprozomib potently inhibit HNSCC cell survival and the growth of HNSCC Neoplasms[SEP]Relations: protease inhibitor complex has relations: cellcomp_protein with CASP1, cellcomp_protein with CASP1, cellcomp_protein with CARD16, cellcomp_protein with CARD16. subacute leukemia has relations: disease_disease with leukemia (disease), disease_disease with leukemia (disease). Hematologic disease has relations: contraindication with Adomiparin, contraindication with Adomiparin, contraindication with Enoxaparin, contraindication with Enoxaparin. Definitions: Hematologic defined as following: Pertaining to or related to the blood and blood-forming organs.. RUNX1 gene defined as following: This gene plays a role in transcriptional regulation and cytogenetic aberrations are associated with several leukemias.. MECOM Protein Isoform MDS1 defined as following: MECOM protein isoform MECOM Protein Isoform MDS1 (19 aa, ~169 kDa) is encoded by the human MECOM gene. This protein may be involved in leukemogenesis.. bortezomib defined as following: A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA.. Malignant neoplasm of thyroid defined as following: A primary or metastatic malignant neoplasm affecting the thyroid gland.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Hematologic malignancies defined as following: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.. Mineralocorticoid Excess Syndrome, Apparent defined as following: An autosomal recessive disorder caused by a deficiency of 11-beta-hydroxysteroid dehydrogenase, which is characterized by hypertension, hypokalemia, low renin, and hypoaldosteronism.. Neuropathy defined as following: A disorder affecting the cranial nerves or the peripheral nervous system. It manifests with pain, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.. carfilzomib defined as following: An epoxomicin derivate with potential antineoplastic activity. carfilzomib irreversibly binds to and inhibits the chymotrypsin-like activity of the 20S catalytic core subunit of the proteasome, a protease complex responsible for degrading a large variety of cellular proteins. Inhibition of proteasome-mediated proteolysis results in an accumulation of polyubiquinated proteins, which may lead to cell cycle arrest, induction of apoptosis, and inhibition of tumor growth.. Squamous cell carcinoma of the head and neck defined as following: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.. Millimole per Liter defined as following: A unit of concentration (molarity unit) equal to one thousandth of a mole (10E-3 mole) of solute per one liter of solution.. Acute leukemia defined as following: A clonal (malignant) hematopoietic disorder with an acute onset, affecting the bone marrow and the peripheral blood. The malignant cells show minimal differentiation and are called blasts, either myeloid blasts (myeloblasts) or lymphoid blasts (lymphoblasts).. CHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristine defined as following: A chemotherapy regimen consisting of cyclophosphamide, hydroxydaunorubicin hydrochloride (doxorubicin hydrochloride), vincristine and prednisone used to treat both indolent and aggressive forms of non-Hodgkin lymphoma. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C9549\" NCI Thesaurus). Solid Neoplasm defined as following: A benign or malignant neoplasm arising from tissues that do not include fluid areas. Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma). Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid Neoplasms.. Multiple Myeloma defined as following: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.. Oprozomib defined as following: An orally bioavailable Proteasome Inhibitors [MoA] with potential antineoplastic activity. Proteasome inhibitor ONX 0912 inhibits the activity of the proteasome, thereby blocking the targeted proteolysis normally performed by the proteasome; this may result in an accumulation of unwanted or misfolded proteins. Disruption of various cell signaling pathways may follow, eventually leading to the induction of apoptosis and inhibition of tumor growth. Proteasomes are large protease complexes that degrade unneeded or damaged proteins that have been ubiquitinated.. Mantle cell lymphoma defined as following: A form of non-Hodgkin lymphoma having a usually diffuse pattern with both small and medium lymphocytes and small cleaved cells. It accounts for about 5% of adult non-Hodgkin lymphomas in the United States and Europe. The majority of mantle-cell lymphomas are associated with a t(11;14) translocation resulting in overexpression of the CYCLIN Measles virus genotype D1 gene (GENES, BCL-1).. 78 kDa Glucose-Regulated Protein defined as following: 78 kDa glucose-regulated protein (654 aa, ~72kDa) is encoded by HSPA5 gene. The protein is intracellularly localized in the endoplasmic reticulum lumen, and plays a role in the assembly of multimeric protein complexes inside the organelle. In addition, the protein is thought to function as a pro-survival protein, or an inhibitor of apoptosis.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. MECOM wt Allele defined as following: Human MECOM wild-type allele is located in the vicinity of 3q26.2 and is approximately 580 kb in length. This allele, which encodes histone-lysine N-methyltransferase MECOM protein, is involved in DNA binding, transcription factor activity and histone methylation. Mutation of the gene is associated with radioulnar synostosis with amegakaryocytic thrombocytopenia-2. Chromosomal translocations involving this gene are associated with leukemogenesis.. leukemia defined as following: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006). solid Neoplasms defined as following: A benign or malignant neoplasm arising from tissues that do not include fluid areas. Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma). Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid Neoplasms..", "label": "yes"} {"original_question": "Is there alternative polyadenylation during zebrafish development?", "id": "converted_1878", "sentence1": "Is there alternative polyadenylation during Zebrafish development?", "sentence2": "Extensive alternative polyadenylation during Zebrafish development., At 2 h post-fertilization, thousands of unique poly(A) sites appear at locations lacking a typical polyadenylation signal, which suggests a wave of widespread cytoplasmic polyadenylation of mRNA degradation intermediates. Our insights into the identities, formation, and evolution of Zebrafish 3' UTRs provide a resource for studying gene regulation during Vertebrates development., Extensive alternative polyadenylation during Zebrafish development.[SEP]Relations: vertebra has relations: anatomy_anatomy with non-transverse process-bearing vertebra, anatomy_anatomy with non-transverse process-bearing vertebra, anatomy_anatomy with transverse process-bearing vertebra, anatomy_anatomy with transverse process-bearing vertebra, anatomy_anatomy with predorsal vertebra, anatomy_anatomy with predorsal vertebra, anatomy_anatomy with vertebral element, anatomy_anatomy with vertebral element, anatomy_anatomy with vertebral bone 2, anatomy_anatomy with vertebral bone 2. Definitions: Zebrafish defined as following: An exotic species of the family CYPRINIDAE, originally from Asia, that has been introduced in North America. Zebrafish is a model organism for drug assay and cancer research.. Vertebrates defined as following: Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising mammals, birds, reptiles, amphibians, and fishes..", "label": "yes"} {"original_question": "Does International Citicoline Trial on acUte Stroke trial supports efficacy of citicoline for stroke treatment?", "id": "converted_2658", "sentence1": "Does International Citicoline Trial on acUte Stroke trial supports efficacy of citicoline for Cerebrovascular accident treatment?", "sentence2": "The meta-analysis showed that no significant differences were found in the long-term mortality (OR=0.91, 95% CI 0.07 to 1.09, P=0.30), the rate of dependency (OR=1.02, 95% CI 0.87 to 1.24, P=0.85), and the effective rate (OR=0.98, 95% CI 0.84 to 1.14, P=0.82) between citicoline group and control group. , In conclusion, citicolne cannot reduce long-term mortality and dependence rate in the treatment of acute Cerebrovascular accident, and the effective rate of citivoline may be not better than that of controls but with reliable safety., In Homo sapiens, although a recent trial International Citicoline Trial on Acute Stroke (ICTUS) has shown that global recovery is similar in citicoline and placebo groups, citicoline was shown to be more beneficial in some patients, such as those with moderate Cerebrovascular accident severity and not treated with PLAT protein, human. , INTERPRETATION: Under the circumstances of the ICTUS trial, citicoline is not efficacious in the treatment of moderate-to-severe acute ischaemic Cerebrovascular accident., The trial was stopped for futility at the third interim analysis on the basis of complete data from 2078 patients., Global recovery was similar in both groups (odds ratio 1·03, 95% CI 0·86-1·25; p=0·364)., INTERPRETATION Under the circumstances of the ICTUS trial, citicoline is not efficacious in the treatment of moderate-to-severe acute ischaemic Cerebrovascular accident., In Homo sapiens, although a recent trial International Citicoline Trial on Acute Stroke (ICTUS) has shown that global recovery is similar in citicoline and placebo groups, citicoline was shown to be more beneficial in some patients, such as those with moderate Cerebrovascular accident severity and not treated with PLAT protein, human. Several mechanisms have been proposed to explain the beneficial actions of citicoline., In Homo sapiens, although a recent trial International Citicoline Trial on Acute Stroke (ICTUS) has shown that global recovery is similar in citicoline and placebo groups, citicoline was shown to be more beneficial in some patients, such as those with moderate Cerebrovascular accident severity and not treated with PLAT protein, human.[SEP]Relations: Protein S human has relations: drug_drug with Coagulation Factor IX (Recombinant), drug_drug with Coagulation Factor IX (Recombinant), drug_drug with Ceftobiprole, drug_drug with Ceftobiprole, drug_drug with Ceftazidime, drug_drug with Ceftazidime, drug_drug with Cimicoxib, drug_drug with Cimicoxib, drug_drug with Potassium citrate, drug_drug with Potassium citrate. Definitions: citicoline defined as following: Donor of choline in biosynthesis of choline-containing phosphoglycerides.. PLAT protein, human defined as following: Tissue-type plasminogen activator (562 aa, ~63 kDa) is encoded by the human PLAT gene. This protein plays a role in the cleavage of plasminogen between Arg-580 and Val-581 to form the fibrinolytic enzyme plasmin.. Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810). Homo sapiens defined as following: Members of the species Homo sapiens.. citicoline defined as following: Donor of choline in biosynthesis of choline-containing phosphoglycerides..", "label": "no"} {"original_question": "Does the BRAFV600E mutation have an effect on clinical response to radioiodine therapy?", "id": "converted_3545", "sentence1": "Does the BRAFV600E Mutation Abnormality have an effect on clinical response to iodide ion I-131 therapy?", "sentence2": "Preclinical studies showed that BRAF protein, human protein, human Mutation Abnormality significantly reduced iodide ion I-131 uptake and decreased the sensitivity to radioactive iodine (PPP1R13L wt Allele) therapy., The status of BRAF protein, human protein, human Mutation Abnormality may not affect the clinical response to PPP1R13L wt Allele therapy for patients with PTMC with intermediate-risk to high-risk features. More trials examining the role of BRAF protein, human protein, human Mutation Abnormality in guiding postoperative PPP1R13L wt Allele therapy are needed., our results suggest that the combination of BRAFV600E+ve Mutation Abnormality and MIBI-ve scintigraphy may be considered a negative prognostic clue, which predicts the absence of iodide ion I-131 uptake at pT-WBS in DTC patients with incomplete bio-chemical response to first RAIT, The results indicate that BRAF protein, human protein, human(V600E) Mutation Abnormality is correlated with a lower expression of SLC5A5 gene in PTCs without Hashimoto Disease, suggesting the iodide ion I-131-refractory effects during RIA therapy in these patients.[SEP]Relations: SLC5A5 has relations: drug_protein with Iodine, drug_protein with Iodine, disease_protein with hereditary site-specific ovarian cancer syndrome, disease_protein with hereditary site-specific ovarian cancer syndrome, bioprocess_protein with cellular response to cAMP, bioprocess_protein with cellular response to cAMP, disease_protein with hereditary breast ovarian cancer syndrome, disease_protein with hereditary breast ovarian cancer syndrome, disease_protein with familial ovarian cancer, disease_protein with familial ovarian cancer. Definitions: SLC5A5 gene defined as following: This gene is involved in iodide transport.. PPP1R13L wt Allele defined as following: Human PPP1R13L wild-type allele is located in the vicinity of 19q13.32 and is approximately 27 kb in length. This allele, which encodes RelA-associated inhibitor protein, plays a role in the modulation of both apoptosis and transcription.. Hashimoto Disease defined as following: An autoimmune disorder caused by the production of autoantibodies against thyroid tissue. There is progressive destruction of the thyroid follicles leading to hypothyroidism.. BRAF protein, human defined as following: Serine/threonine-protein kinase B-raf (766 aa, ~84 kDa) is encoded by the human BRAF protein, human gene. This protein plays a role in protein phosphorylation, mitogenesis and neuronal signal transduction.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer..", "label": "yes"} {"original_question": "Is mitofusin 2 a receptor for parkin?", "id": "converted_1733", "sentence1": "Is MFN2 gene a receptor for parkin?", "sentence2": "Recent work demonstrates that a phosphorylated form of the mitochondrial fusion protein Mitofusin 2 serves as a receptor for Parkin translocation to damaged Mitochondria., We show that the mitochondrial outer membrane guanosine triphosphatase mitofusin (Mfn) 2 mediates Parkin recruitment to damaged Mitochondria. , Mfn2 functions as a mitochondrial receptor for Parkin and is required for quality control of cardiac Mitochondria., MFN1 gene and MFN2 gene are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy[SEP]Relations: mitochondrion has relations: cellcomp_protein with AZIN2, cellcomp_protein with AZIN2, cellcomp_protein with REXO2, cellcomp_protein with REXO2, cellcomp_protein with ACO2, cellcomp_protein with ACO2, cellcomp_protein with YARS2, cellcomp_protein with YARS2, cellcomp_protein with PARK7, cellcomp_protein with PARK7. Definitions: Mitochondria defined as following: Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed). MFN2 gene defined as following: This gene is involved in mitochondrial fusion..", "label": "yes"} {"original_question": "Is GRG5 involved only in late embryonic mouse development?", "id": "converted_3556", "sentence1": "Is TLE5 gene involved only in late embryonic Mus sp. development?", "sentence2": "Groucho related gene 5 (TLE5 gene) is a HSD17B4 gene that has been implicated in late embryonic and postnatal Mus sp. development. Here, we describe a previously unknown role of TLE5 gene in early developmental stages by analyzing its function in stem cell fate decisions. By both loss and gain of function approaches we demonstrate that ablation of TLE5 gene deregulates the Embryonic Stem Cells (ESTERASE C) pluripotent state whereas its overexpression leads to enhanced self-renewal and acquisition of Primary malignant neoplasm cell-like properties. The malignant characteristics of Teratoma generated by Enhanced S-Cone Syndrome that overexpress TLE5 gene reveal its pro-oncogenic potential. [SEP]Relations: HSD17B4 has relations: anatomy_protein_present with embryo, anatomy_protein_present with embryo, bioprocess_protein with Sertoli cell development, bioprocess_protein with Sertoli cell development, anatomy_protein_present with medulla oblongata, anatomy_protein_present with medulla oblongata. TLE5 has relations: protein_protein with GRN, protein_protein with GRN, protein_protein with GRB2, protein_protein with GRB2. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Embryonic Stem Cells defined as following: Cells derived from the BLASTOCYST INNER CELL MASS which forms before implantation in the uterine wall. They retain the ability to divide, proliferate and provide progenitor cells that can differentiate into specialized cells.. Teratoma defined as following: A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642). HSD17B4 gene defined as following: This gene is involved in fatty acid oxidation..", "label": "no"} {"original_question": "Is cadasil syndrome a hereditary disease?", "id": "converted_381", "sentence1": "Is cadasil syndrome a hereditary disease?", "sentence2": " NOTCH3 wt Allele is the most frequent hereditary small-vessel disease of the Head>Brain. The clinical impact of various MR imaging markers has been repeatedly studied in this disorder, but alterations of contrast between gray matter and normal-appearing white matter remain unknown. The aim of this study was to evaluate the contrast alterations between gray matter and normal-appearing white matter on T1-weighted images in patients with NOTCH3 wt Allele compared with healthy subjects, (NOTCH3 wt Allele) is the most common form of hereditary cerebral angiopathy, Cerebral autosomal dominant arteriopathy with subcortical infarcts and Leukoencephalopathy (NOTCH3 wt Allele) is an inherited Cerebral Small Vessel Diseases, clinically characterized by Migraine Disorders, recurrent transient ischemic attacks or strokes, Abnormal behavior and Mental deterioration. Cerebrovascular accident are typically ischemic, while hemorrhagic events have been only sporadically described, Gene Mutation in the TREX1 protein, human protein, human and NOTCH3 genes cause Retinal vasculopathy with cerebral leukodystrophy (Vasculopathy, Retinal, With Cerebral Leukodystrophy) and cerebral autosomal dominant arteriopathy with subcortical infarcts and Leukoencephalopathy (NOTCH3 wt Allele), respectively, We used immunohistochemistry and immunogold electron microscopy (EM) to examine the distribution of GOM and NOTCH3 ectodomain (N3ECD) protein in microvasculature of Head>Brain gray matter and white matter in patients with NOTCH3 wt Allele, non-NOTCH3 wt Allele hereditary small-vessel disease and sporadic age-related degenerative disease, and comparable-age controls[SEP]Relations: CARASIL syndrome has relations: disease_phenotype_positive with Autosomal recessive inheritance, disease_phenotype_positive with Autosomal recessive inheritance, disease_disease with cerebral arteriopathy, autosomal dominant, with subcortical infarcts and Leukoencephalopathy,, disease_disease with cerebral arteriopathy, autosomal dominant, with subcortical infarcts and Leukoencephalopathy,, disease_protein with HTRA1, disease_protein with HTRA1. genetic Cerebral Small Vessel Diseases has relations: disease_disease with genetic central nervous system and retinal vascular disease, disease_disease with genetic central nervous system and retinal vascular disease, disease_disease with Coats plus syndrome, disease_disease with Coats plus syndrome. Definitions: Vasculopathy, Retinal, With Cerebral Leukodystrophy defined as following: An inherited group of small vessel diseases comprised of cerebroretinal vasculopathy (CRV), hereditary vascular retinopathy (HRV) and hereditary endotheliopathy with retinopathy, nephropathy and stroke all exhibiting progressive visual impairment as well as variable cerebral dysfunction. There is evidence the disease is caused by heterozygous mutation in the TREX1 protein, human gene on chromosome 3p21.. Abnormal behavior defined as following: Troublesome or disruptive behavioral displays.. NOTCH3 wt Allele defined as following: A hereditary cerebrovascular disorder caused by mutations in the Notch 3 gene. It is characterized by alterations of the muscular wall of the small vessels in the Head>Brain, resulting in transient ischemic attacks. It may lead to cognitive problems and dementia.. Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810). TREX1 protein, human defined as following: Three prime repair exonuclease 1 (369 aa, ~39 kDa) is encoded by the human TREX1 protein, human gene. This protein is involved in DNA mismatch repair.. Migraine Disorders defined as following: A common, severe type of vascular headache often associated with increased sympathetic activity, resulting in nausea, vomiting, and light sensitivity.. Cerebral Small Vessel Diseases defined as following: Pathological processes or diseases where cerebral MICROVESSELS show abnormalities. They are often associated with aging, hypertension and risk factors for lacunar infarcts (see LACUNAR INFARCTION); LEUKOARAIOSIS; and CEREBRAL HEMORRHAGE.. Mental deterioration defined as following: Loss of previously present mental abilities, generally in adults. [HPO:probinson]. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Leukoencephalopathy defined as following: Any of various diseases affecting the white matter of the central nervous system.. cadasil syndrome defined as following: A hereditary cerebrovascular disorder caused by mutations in the Notch 3 gene. It is characterized by alterations of the muscular wall of the small vessels in the Head>Brain, resulting in transient ischemic attacks. It may lead to cognitive problems and dementia.. hereditary disease defined as following: Genetic diseases are diseases in which inherited genes predispose to increased risk. The genetic disorders associated with cancer often result from an alteration or mutation in a single gene. The diseases range from rare dominant cancer family syndrome to familial tendencies in which low-penetrance genes may interact with other genes or environmental factors to induce cancer. Research may involve clinical, epidemiologic, and laboratory studies of persons, families, and populations at high risk of these disorders..", "label": "yes"} {"original_question": "Does dronedarone affect T3 and T4 levels?", "id": "converted_1452", "sentence1": "Does dronedarone affect T3 thoracic segmental innervation and T4 levels?", "sentence2": "Amiodarone resulted in increased T4, T4/T3 thoracic segmental innervation thoracic segmental innervation and rT3, whereas dronedarone did not alter the Thyroid Hormones profile in normal animals., Fifty-five Wistar rats were randomly allocated to a 2-week oral treatment with either vehicle (n=18), amiodarone (30 mg/kg, n=20), or dronedarone (30 mg/kg, n=17)., Thyroid function was similar in the 3 groups., Plasma levels of T3 thoracic segmental innervation thoracic segmental innervation, T4, and rT3 were changed after SR 33589 treatment except a decrease in T4 level at the highest dose whilst the T4 T3 thoracic segmental innervation thoracic segmental innervation ratio and the level of rT3 were dose-dependently increased by amiodarone treatment.[SEP]Relations: Dronedarone has relations: drug_protein with CYP3A4, drug_protein with CYP3A4, drug_protein with CYP3A5, drug_protein with CYP3A5, drug_protein with CYP2D6, drug_protein with CYP2D6, drug_protein with KCNJ4, drug_protein with KCNJ4, drug_protein with CYP2J2, drug_protein with CYP2J2. Definitions: dronedarone defined as following: A non-iodinated derivative of amiodarone that is used for the treatment of ARRHYTHMIA.. amiodarone defined as following: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.. Thyroid Hormones defined as following: Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs.. T3 thoracic segmental innervation defined as following: This gene plays a regulatory role in the production and utilization of ATP..", "label": "no"} {"original_question": "Can epigenetic modifications be heritable?", "id": "converted_4444", "sentence1": "Can epigenetic modifications be heritable?", "sentence2": "Epigenetic alterations (epimutations) could thus contribute to heritable variation within populations and be subject to evolutionary processes such as natural selection and drift. [SEP]", "label": "yes"} {"original_question": "Are cyclophilins proteins that bind to prolines?", "id": "converted_297", "sentence1": "Are cyclophilins Proteins that bind to prolines?", "sentence2": "Cyclophilins are ubiquitously expressed Proteins that bind to prolines and can catalyse CISH protein, human/trans isomerization of proline residues., a characteristic of the cyclophilin family of Proteins that bind prolines and often act as CISH protein, human-trans peptidyl-prolyl isomerases. , The cyclophilins are widely expressed ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS that catalyze the interconversion of the CISH protein, human and trans peptide bonds of prolines. , an Peptidylprolyl Isomerase on the isomerization of critical prolines that are found in the tCHT1 Sequence - ParameterizedDataType.[SEP]Relations: Protein S human has relations: drug_protein with PROC, drug_protein with PROC, drug_drug with Proglumetacin, drug_drug with Proglumetacin, drug_drug with Procarbazine, drug_drug with Procarbazine, drug_drug with Doxycycline, drug_drug with Doxycycline, drug_drug with Progesterone, drug_drug with Progesterone. Definitions: Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific Sequence - ParameterizedDataType of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Peptidylprolyl Isomerase defined as following: An enzyme that catalyzes the isomerization of proline residues within Proteins. EC 5.2.1.8.. Cyclophilins defined as following: A family of peptidyl-prolyl CISH protein, human-trans isomerases that bind to CYCLOSPORINS and regulate the IMMUNE SYSTEM. EC 5.2.1.-. CISH protein, human defined as following: Cytokine-inducible SH2-containing protein (258 aa, ~29 kDa) is encoded by the human CISH gene. This protein is involved in the modulation of signal transduction.. cyclophilins defined as following: A family of peptidyl-prolyl CISH protein, human-trans isomerases that bind to CYCLOSPORINS and regulate the IMMUNE SYSTEM. EC 5.2.1.-.", "label": "yes"} {"original_question": "Is STAT3 transcription factor regulated by mTORC1?", "id": "converted_1691", "sentence1": "Is STAT3 protein, human transcription factor regulated by mechanistic target of rapamycin complex 1?", "sentence2": "Mechanistically, mechanistic target of rapamycin complex 1 mediated IL-6-induced Stat3 activation in intestinal Epithelial Cells to stimulate the expression of downstream targets essential for cell proliferation and tissue regeneration. Therefore, mechanistic target of rapamycin complex 1 signaling critically protects against INFLAMMATORY BOWEL DISEASE 2 through modulation of inflammation-induced Stat3 activity., we demonstrated that STAT3 protein, human protein, human is directly phosphorylated by mechanistic target of rapamycin complex 1 on Ser727 during Hypoxia, CTCAE, promoting HIF-1α mRNA transcription, Mechanistically, mechanistic target of rapamycin complex 1 signaling was activated by excess Antifibrinolytic Antifibrinolytic amino acids, which then positively regulated Notch1 expression through the activation of the signal transducer and activator of transcription 3 (STAT3 protein, human protein, human)., Here we present evidence for the involvement of STAT3 protein, human protein, human, a known mechanistic target of rapamycin complex 1 regulated transcription factor, in this process, Furthermore, we demonstrated that STAT3 protein, human protein, human is directly phosphorylated by mechanistic target of rapamycin complex 1 on Ser727 during Hypoxia, CTCAE, promoting HIF-1α mRNA transcription. mechanistic target of rapamycin complex 1 also regulates HIF-1α synthesis on a translational level via co-operative regulation of both initiation factor 4E-binding protein 1 (EIF4EBP1 protein, human) and ribosomal protein S6 kinase-1 (RPS6KB1 wt Allele), whereas HIF-1α degradation remains unaffected, Here we present evidence for the involvement of STAT3 protein, human protein, human, a known mechanistic target of rapamycin complex 1 regulated transcription factor, in this process. , TSC1/TSC2 inactivation inhibits Proto-Oncogene Proteins c-akt through mechanistic target of rapamycin complex 1-dependent up-regulation of STAT3 protein, human protein, human-PTEN cascade., Mechanistically, mechanistic target of rapamycin complex 1 signaling was activated by excess Antifibrinolytic Antifibrinolytic amino acids, which then positively regulated Notch1 expression through the activation of the signal transducer and activator of transcription 3 (STAT3 protein, human protein, human). , Suppression of the mechanistic target of rapamycin complex 1/STAT3 protein, human protein, human/Notch1 pathway by activated AMP-Activated Protein Kinases prevents hepatic insulin resistance induced by excess Antifibrinolytic Antifibrinolytic amino acids., Here, we review the connections between mechanistic target of rapamycin complex 1 and gene transcription by focusing on its impact in regulating the activation of specific TRANSCRIPTION FACTOR including including STAT3 protein, human protein, human, SREBPs, PPARγ, PPARα, HIF1α, YY1–PGC1α and TFEB protein, human protein, human. We also discuss the importance of these TRANSCRIPTION FACTOR in mediating the effects of mechanistic target of rapamycin complex 1 on various cellular processes in physiological and pathological contexts.[SEP]Relations: transcription factor binding has relations: molfunc_protein with STAT3 protein, human, molfunc_protein with STAT3 protein, human, molfunc_protein with FOXC1, molfunc_protein with FOXC1, molfunc_protein with ETS1, molfunc_protein with ETS1, molfunc_protein with NFATC1, molfunc_protein with NFATC1, molfunc_protein with NFATC3, molfunc_protein with NFATC3. Definitions: TFEB protein, human defined as following: Transcription factor EB (476 aa, ~53 kDa) is encoded by the human TFEB protein, human gene. This protein plays a role in transcriptional regulation.. RPS6KB1 wt Allele defined as following: Human RPS6KB1 wild-type allele is located in the vicinity of 17q23.1 and is approximately 57 kb in length. This allele, which encodes ribosomal protein S6 kinase beta-1 protein, plays a role in the regulation of protein phosphorylation.. Epithelial Cells defined as following: Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional Epithelial Cells.. EIF4EBP1 protein, human defined as following: Eukaryotic translation initiation factor 4E-binding protein 1 (118 aa, ~13 kDa) is encoded by the human EIF4EBP1 gene. This protein is involved in the modulation of translation and the sequestration of eukaryotic translation initiation factor 4E.. STAT3 protein, human defined as following: Signal transducer and activator of transcription 3 (770 aa, ~88 kDa) is encoded by the human STAT3 protein, human gene. This protein plays a role in cytokine signaling and gene expression.. Proto-Oncogene Proteins c-akt defined as following: Expressed in diverse tissues, Protein Kinase B (Proto-Oncogene Proteins c-akt/RAC Family) is a group (Alpha, Beta and Gamma) of cytoplasmic serine/threonine enzymes that covalently transfer the terminal, gamma phosphate group from ATP to a variety of substrate proteins and regulate cell signaling responses to insulin, PDGF, and IGF1 (through PI3K) involved in cell survival, cell proliferation, differentiation, apoptosis, glycogen synthesis, and glucose uptake.. mechanistic target of rapamycin complex 1 defined as following: A protein complex that is involved in the both serine/threonine phosphorylation and the regulation of protein synthesis in response to cellular stress.. AMP-Activated Protein Kinases defined as following: Intracellular signaling protein kinases that play a signaling role in the regulation of cellular energy metabolism. Their activity largely depends upon the concentration of cellular AMP which is increased under conditions of low energy or metabolic stress. AMP-activated protein kinases modify enzymes involved in LIPID METABOLISM, which in turn provide substrates needed to convert AMP into ATP.. Hypoxia, CTCAE defined as following: A disorder characterized by a decrease in the level of oxygen in the body.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process..", "label": "yes"} {"original_question": "Has depression been shown to be a predictor of frailty?", "id": "converted_220", "sentence1": "Has depression been shown to be a predictor of frailty?", "sentence2": "significant role of frailty as a predictor of depression in a relatively younger old Chinese population, significant relationships between frailty and Depressive Symptoms and mortality at 1 year, These findings suggest that Malnutrition is a major predictor of frailty or the \"failure to thrive\" syndrome in older persons. Cancer patients and suicide and depression is a major cause of poor nutritional status in older persons., Depressed mood was associated with increased risk of steep strength decline, in particular in older men with low body weight. Low body weight in combination with Depressed mood may be an indicator of frailty or severe disease status that leads to accelerated strength loss and Disability:Type:Pt:^Patient:Nom., Longitudinally, Depressed mood was the only independent predictor of decline in cognition, functional ability, physician-rated health, and mortality;[SEP]Relations: Malnutrition has relations: disease_phenotype_positive with lysinuric protein intolerance, disease_phenotype_positive with lysinuric protein intolerance, drug_effect with Ganciclovir, drug_effect with Ganciclovir, drug_effect with Primidone, drug_effect with Primidone, disease_phenotype_positive with secondary short bowel syndrome, disease_phenotype_positive with secondary short bowel syndrome, disease_phenotype_positive with fructose intolerance, disease_phenotype_positive with fructose intolerance. Definitions: Depressed mood defined as following: An emotional state characterized by feelings of sadness, emptiness, and/or tearfulness.. Malnutrition defined as following: An imbalanced nutritional status resulting from insufficient intake of nutrients to meet normal physiological requirement..", "label": "yes"} {"original_question": "Is invasion and metastasis one of the hallmarks of cancer?", "id": "converted_431", "sentence1": "Is invasion and metastasis one of the hallmarks of cancer?", "sentence2": "The pathogenesis of millimeter involves the accumulation of extensive cytogenetic changes, as well as cancer-related phenotypic alterations that facilitate Tumor cells, uncertain whether benign or malignant survival, invasion and metastasis. This review presents current knowledge regarding the biological characteristics of this Disease that are linked to the so-called hallmarks of cancer.[SEP]Relations: malignancy in giant cell tumor of bone has relations: disease_disease with malignant giant cell tumor, disease_disease with malignant giant cell tumor, disease_disease with bone sarcoma, disease_disease with bone sarcoma. Definitions: Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Tumor cells, uncertain whether benign or malignant defined as following: Cells of, or derived from, a tumor.. millimeter defined as following: A metric unit of length equal to one thousandth of a meter (10E-3 meter) or approximately 0.03937 inch..", "label": "yes"} {"original_question": "Does molindone affect body weight?", "id": "converted_618", "sentence1": "Does molindone affect body weight?", "sentence2": "Mean weight increased by 0.54 kg, and mean body mass index by 0.24 kg/m(2). , A large-scale trial comparing a first-generation antipsychotic (molindone) with newer agents did not find significant differences in treatment response, although the newer antipsychotics were associated with more severe weight gain. , No agent demonstrated superior efficacy, and all were associated with side effects, including weight gain. , The three treatment arms did not significantly differ in symptom decrease or time to discontinuation. Akathisia was more common with molindone and elevated prolactin concentrations more common with risperidone. Although weight gain and metabolic adverse events had occurred more often with olanzapine and risperidone during the acute trial, no significant between-drug differences emerged in most of these parameters during maintenance treatment. , olanzapine and risperidone were associated with significantly greater weight gain. olanzapine showed the greatest risk of weight gain and significant increases in fasting cholesterol, Low-Density Lipoproteins, Therapeutic Insulin, and liver transaminase levels. Molindone led to more self-reports of Akathisia. , Molindone is no more or less likely than typical drugs to cause Movement Disorders, but it does cause significantly more Measured Measured weight loss (observable entity) (observable entity) (2RCTs n=60 RR 2.78, NDUFB6 gene 1.10 to 6.99, NNH 5 NDUFB6 gene 2 to 77). , Molindone may be an effective antipsychotic but its adverse effect profile does not differ significantly from that of typical antipsychotics (apart from the event of Measured Measured weight loss (observable entity) (observable entity)). , Convergent evidence suggests a hierarchy in the magnitude of BWG that may be induced by diverse agents, being very high for clozapine and olanzapine; high for quetiapine, zotepin, chlorpromazine, and thioridazine; moderate for risperidone and sertindole; and low for ziprasidone, amisulpiride, ASSAY OF HALOPERIDOL, fluphenazine, pimozide, and molindone. , Loxapine and molindone induce weight decreases, and these exceptions are difficult to explain., It is no more or less likely than typical drugs to cause Movement Disorders, but causes significantly more Measured Measured weight loss (observable entity) (observable entity) (RR 2.78, NDUFB6 gene 1.10 to 6.99)., Molindone may be an effective antipsychotic; however, its adverse effect profile does not differ significantly from that of typical antipsychotics, apart from the event of Measured Measured weight loss (observable entity) (observable entity). , Among conventional agents, mean weight change ranged from a reduction of 0.39 kg with molindone to an increase of 3.19 kg with thioridazine., Gaining Weight question has been reported with nearly every antipsychotic drug on the market (molindone is an exception). , Although almost all antipsychotics induce bodyweight gain, molindone and loxapine appear to induce bodyweight loss. , Clozapine and low-potency Phenothiazine Measurement are associated with the largest gains and molindone with Measured Measured weight loss (observable entity) (observable entity), but the mechanism is not known. , On average, molindone patients lost 5 pounds over the 6 weeks of treatment, whereas thioridazine patients gained 6 pounds. , Clinically, molindone has a tendency to cause Measured Measured weight loss (observable entity) (observable entity) and may have less effect on Seizures threshold than conventional antipsychotic agents, Monthly weights and neuroleptic dosages during the first three months of psychiatric hospitalization were compared between matched groups of patients receiving molindone, a combination of molindone and other neuroleptics, or other neuroleptic drugs. We found no significant differences in weight gain among the three groups. , The weight-reducing property of molindone, a recently introduced antipsychotic drug, was tested in 9 hospitalized chronic schizophrenic patients. There was an average Measured Measured weight loss (observable entity) (observable entity) of 7.6 kg after 3 months on molindone; most of the loss occurred during the first month.[SEP]Relations: Molindone has relations: drug_effect with Increased body weight, drug_effect with Increased body weight, drug_effect with Nausea, drug_effect with Nausea, drug_effect with Tremor, drug_effect with Tremor, drug_effect with Hyperkinetic movements, drug_effect with Hyperkinetic movements, drug_effect with Dyspnea, drug_effect with Dyspnea. Definitions: Phenothiazine Measurement defined as following: The determination of the amount of phenothiazine present in a sample.. loxapine defined as following: An antipsychotic agent used in SCHIZOPHRENIA.. olanzapine defined as following: A synthetic derivative of thienobenzodiazepine with antipsychotic, antinausea, and antiemetic activities. As a selective monoaminergic antagonist, olanzapine binds with high affinity binding to the following receptors: serotoninergic, dopaminergic, muscarinic M1-5, histamine H1, and alpha-1-adrenergic receptors; it binds weakly to gamma-aminobutyric acid type A, benzodiazepine, and beta-adrenergic receptors. The antinausea and antiemetic effects of this agent appear to be due to the blockade of 5-HT2 and 5-HT3 receptors for serotonin. Although its exact mechanism of action in schizophrenia is unknown, it has been proposed that olanzapine's antipsychotic activity is mediated through antagonism to dopamine D2 receptors with rapid ligand-receptor dissociation kinetics that help to minimize extrapyramidal symptoms (EPS). olanzapine may also stimulate appetite.. thioridazine defined as following: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.. Movement Disorders defined as following: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.. risperidone defined as following: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.. Therapeutic Insulin defined as following: A synthetic or animal-derived form of Therapeutic Insulin used in the treatment of diabetes mellitus. Therapeutic Therapeutic Insulin is formulated to be short-, intermediate- and long-acting in order to individualize an Therapeutic Insulin regimen according to individual differences in glucose and Therapeutic Insulin metabolism. Therapeutic Therapeutic Insulin may be derived from porcine, bovine or recombinant sources. Endogenous human Therapeutic Insulin, a pancreatic hormone composed of two polypeptide chains, is important for the normal metabolism of carbohydrates, proteins and fats and has anabolic effects on many types of tissues.. clozapine defined as following: A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent.. molindone defined as following: An indole derivative effective in schizophrenia and other psychoses and possibly useful in the treatment of the aggressive type of undersocialized conduct disorder. Molindone has much lower affinity for D2 receptors than most antipsychotic agents and has a relatively low affinity for D1 receptors. It has only low to moderate affinity for cholinergic and alpha-adrenergic receptors. Some electrophysiologic data from animals indicate that molindone has certain characteristics that resemble those of CLOZAPINE. (From AMA Drug Evaluations Annual, 1994, p283). Akathisia defined as following: An uncomfortable feeling of inner restlessness and inability to stay still. It can be a side effect of psychotropic medications.. chlorpromazine defined as following: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.. fluphenazine defined as following: A phenothiazine used in the treatment of PSYCHOSES. Its properties and uses are generally similar to those of CHLORPROMAZINE.. Gaining Weight question defined as following: A question about whether an individual is gaining or has gained weight.. Low-Density Lipoproteins defined as following: A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues.. quetiapine defined as following: A dibenzothiazepine derivative with antipsychotic property. Quetiapine fumarate antagonizes serotonin activity mediated by 5-HT 1A and 5-HT2 receptors. With a lower affinity, this agent also reversibly binds to dopamine D1 and D2 receptors in the mesolimbic and mesocortical areas of the brain leading to decreased psychotic effects, such as hallucinations and delusions. In addition, quetiapine also binds to other alpha-1, alpha-2 adrenergic and histamine H1 receptors.. ziprasidone defined as following: A benzothiazolylpiperazine derivative and an atypical antipsychotic agent with an antischizophrenic property. Ziprasidone functions as an antagonist at the dopamine D2 and serotonin 5-HT2A and 5-HT1D receptors, and as an agonist at the 5-HT1A receptor. Ziprasidone also inhibits the synaptic reuptake of serotonin and norepinephrine. The mechanism of action by which ziprasidone exerts its antischizophrenic effect is unknown but is potentially mediated through a combination of dopamine D2 and serotonin 5-HT2 antagonism. This agent also has antagonistic activity against histamine H1 and alpha-1-adrenergic receptors.. ASSAY OF HALOPERIDOL defined as following: The determination of the amount of ASSAY OF HALOPERIDOL in a sample.. pimozide defined as following: A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to HALOPERIDOL for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403). Seizures defined as following: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or \"Seizures disorder.\". Measured weight loss (observable entity) defined as following: The measured decrease in body weight over a specified period of time..", "label": "yes"} {"original_question": "Is MEDI2228 a bispecific antibody?", "id": "converted_4357", "sentence1": "Is MEDI2228 a bispecific antibody?", "sentence2": "We here delineated the Molecular and cellular mechanisms underlying novel immunomodulatory effects triggered by BCMA pyrrolobenzodiazepine (PBD) antibody drug conjugate (ADC) MEDI2228 which can augment efficacy of these immunotherapies.[SEP]Relations: Molecular system has relations: anatomy_anatomy with gABAergic system, anatomy_anatomy with gABAergic system, anatomy_anatomy with catecholamine system, anatomy_anatomy with catecholamine system, anatomy_anatomy with histaminergic system, anatomy_anatomy with histaminergic system, anatomy_anatomy with serotonergic system, anatomy_anatomy with serotonergic system, anatomy_anatomy with glutamatergic system, anatomy_anatomy with glutamatergic system. Definitions: Molecular defined as following: Relating to or produced by or consisting of molecules.. bispecific antibody defined as following: Antibodies, often monoclonal, in which the two antigen-binding sites are specific for separate ANTIGENIC DETERMINANTS. They are artificial antibodies produced by chemical crosslinking, fusion of HYBRIDOMA cells, or by Molecular genetic techniques. They function as the main mediators of targeted cellular cytotoxicity and have been shown to be efficient in the targeting of drugs, toxins, radiolabeled haptens, and effector cells to diseased tissue, primarily tumors..", "label": "no"} {"original_question": "Is cystatin C or cystatin 3 used as a biomarker of kidney function?", "id": "converted_874", "sentence1": "Is CST3 gene or cystatin 3 used as a biomarker of kidney function?", "sentence2": "to explore the effect of ageing on renal function with CST3 gene as the marker of glomerular filtration rate (GFR) in the general population without Vascular Diseases or Diabetes Mellitus., Cystatin C, a more specific kidney function biomarker, was also elevated at 24 h after CLP., This study evaluated FGF-23 as well as traditional markers of Kidney Diseases, namely urine albumin-to-creatine/creatine/creatinine ratio (UACR) and creatine/creatine/creatinine-CST3 gene estimated GFR (eGFRCrCyC), as risk factors for Blighia sapida in elderly individuals. , he primary predictor was estimated GFR (Epidermal Growth Factor Receptor) calculated using serum CST3 gene (Epidermal Growth Factor Receptor(cys))., A number of recent reports have suggested that the CST3 gene/creatine/creatine/creatinine (CysC/Cr) ratio might be a useful biomarker of renal function in pediatric patients., The Chronic Kidney Diseases-EPI equation using CST3 gene was the most precise method of renal function evaluation in patients with Neurogenic Urinary Bladder., Serum CST3 gene (CysC) is an endogenous marker of kidney function., The Urinary tract content of CysC reflects tubular epithelial dysfunction whereas that of LCN2 wt Allele also characterizes Tubular atrophy., Estimated kidney function based on serum CST3 gene , : Several formulas for glomerular filtration rate (GFR) estimation, based on serum creatine/creatine/creatinine or CST3 gene, have been proposed. , he highest and lowest Epidermal Growth Factor Receptor levels corresponded to the CST3 gene-based and MDRD-4 equations, respectively. , The Chronic Kidney Disease Epidemiology Collaboration (Chronic Kidney Diseases-EPI) recently proposed an equation to estimate GFR in subjects without Liver Cirrhosis using both serum creatine/creatine/creatinine and CST3 gene levels., Emerging evidence has shown that CST3 gene may improve classification of glomerular filtration rate for defining chronic Kidney Diseases in certain clinical populations and assist in understanding the complications of chronic Kidney Diseases, prostaglandin R2 D-isomerase (BTP) and CST3 gene (CysC) are novel biomarkers of renal function. , Cystatin C could improve chronic Kidney Diseases (Chronic Kidney Diseases) classification in HIV-infected women relative to serum creatine/creatine/creatinine., iohexol clearance and CST3 gene formulae identify a greater proportion of patients with a GFR <60 mL/min/1.73 m(2), which also predicts the development of Blighia sapida., Cystatin C was recently reported to be an endogenous surrogate of kidney function, and a high level of CST3 gene is reported to be a strong predictor of CVD;, Studies that have simultaneously compared measured GFR and estimated GFR (using endogenous filtration markers such as creatine/creatine/creatinine, or newer ones such as CST3 gene or β-trace protein)[SEP]Relations: Kidney Diseases has relations: contraindication with Biotin, contraindication with Biotin, contraindication with Pravastatin, contraindication with Pravastatin, contraindication with Cyclacillin, contraindication with Cyclacillin, contraindication with Isotretinoin, contraindication with Isotretinoin, contraindication with Phenacetin, contraindication with Phenacetin. Definitions: Chronic Kidney Diseases defined as following: Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.. Kidney Diseases defined as following: Pathological processes of the KIDNEY or its component tissues.. iohexol defined as following: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.. CST3 gene defined as following: An extracellular cystatin subtype that is abundantly expressed in bodily fluids. It may play a role in the inhibition of interstitial CYSTEINE PROTEASES.. LCN2 wt Allele defined as following: Human LCN2 wild-type allele is located in the vicinity of 9q34 and is approximately 5 kb in length. This allele, which encodes neutrophil gelatinase-associated lipocalin protein, may be involved in both the modulation of inflammation and the regulation of the transport of hydrophobic substances (ie. retinol, lipopolysaccharide). The expression of this gene may be elevated in many cancers and inflammatory diseases.. Neurogenic Urinary Bladder defined as following: Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.. Liver Cirrhosis defined as following: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.. Urinary tract defined as following: The duct which coveys URINE from the pelvis of the KIDNEY through the URETERS, BLADDER, and URETHRA.. Tubular atrophy defined as following: The presence of renal tubules with thick redundant basement membranes, or a reduction of greater than 50% in tubular diameter compared to surrounding non-atrophic tubules. [HPO:probinson, PMID:27211375]. Diabetes Mellitus defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.. serum creatine/creatinine defined as following: A quantitative measurement of the amount of creatine/creatinine present in a sample of serum.. Vascular Diseases defined as following: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.. cystatin 3 defined as following: This gene is involved in enzyme inhibition..", "label": "yes"} {"original_question": "Is phospholamban phosphorylated by Protein kinase A?", "id": "converted_572", "sentence1": "Is phospholamban phosphorylated by Protein kinase A?", "sentence2": "cAMP-dependent protein kinase (PKA) phosphorylation of PLB1 gene, phosphorylation of PLN gene gene, at either Ser(16) by PKA , Activation of cardiac muscle Sarcoplasmic Reticulum Ca2+-ATPase (SERCA2a) by beta1-agonists involves cAMP- and PKA-dependent phosphorylation of phospholamban (PLB1 gene), which relieves the inhibitory effects of PLB1 gene on SERCA2a. , phospholamban (PLB1 gene) is a Sarcoplasmic Reticulum (SNCG wt Allele) protein that when phosphorylated at Ser16 by PKA, phosphorylation of PLB1 gene by the Ca2+-calmodulin-dependent protein kinase (CaMK) and cAMP-dependent protein kinase (PKA). , cAMP-dependent protein kinase (PKA)-mediated phospholamban (PLB1 gene) phosphorylation at serine-16, phospholamban (PLB1 gene) is a major target of the beta-adrenergic cascade in the Chest>Heart, functioning to modulate contractile force by altering the rate of CALCIUM SUPPLEMENTS re-sequestration by the Ca-ATPase. Functionally, inhibition by PLB1 gene binding is manifested by shifts in the CALCIUM SUPPLEMENTS dependence of Ca-ATPase activation toward higher CALCIUM SUPPLEMENTS levels; phosphorylation of PLB1 gene by PKA reverses the inhibitory action of PLB1 gene., phosphorylation of both PLB1 gene residues (Ser16, PKA site, and Thr17, calmodulin-dependent protein kinase II site) , Phosphorylation of Ser(16) by PKA, stabilization of the structure of PLB1 gene following phosphorylation of Ser(16), phospholamban (PLB1 gene) inhibits the Sarcoplasmic Reticulum (SNCG wt Allele) Ca(2+)-ATPase, and this inhibition is relieved by cAMP-dependent protein kinase (PKA)-mediated phosphorylation. , Two-dimensional tryptic peptide maps of phosphorylated phospholamban indicated that cAMP-dependent protein kinase phosphorylates at a single site, A, and Ca2+-calmodulin-dependent protein kinase phosphorylates at sites TNM certainty factor TNM certainty factor C1 and Complement Complement C2, human, human in the low molecular weight form, where A is different from TNM certainty factor TNM certainty factor C1 but may be the same as Complement Complement C2, human, human., Because SNCG wt Allele function is regulated by phosphorylation of phospholamban (PLB1 gene), a SNCG wt Allele protein phosphorylated by cAMP-dependent protein kinase (PKA) at Ser(16)and Ca(2+)-calmodulin-dependent protein kinase (calmodulin-dependent protein kinase II) at Thr(17), the phosphorylation of these residues during Ischemia Procedure and reperfusion was examined in Langendorff-perfused Rattus norvegicus hearts, These changes were associated with reduced protein expression of Sarcoplasmic Reticulum Ca(2+)-ATPase (SERCA2a) and Cyclic AMP-Dependent Protein Kinases phosphorylated phospholamban (PLB1 gene), which was reduced in Hydrops Fetalis, but essentially abolished in VD-Hydrops Fetalis, The data indicate that 1) phosphorylation of phospholamban at Ser16 by cAMP-dependent protein kinase is the main regulator of beta-adrenergic-induced cardiac relaxation definitely preceding Thr17 phosphorylation and 2) the beta-adrenergic-mediated phosphorylation of Thr17 by Ca2+-calmodulin-dependent protein kinase required influx of Ca2+ through the L-type Ca2+ channel, Here we extend this model to explain the reversal of SERCA2a inhibition that occurs after phosphorylation of PLB1 gene at Ser(16) by Cyclic AMP-Dependent Protein Kinases (PKA) and after binding of the anti-PLB1 gene monoclonal antibody 2D12, which recognizes residues 7-13 of PLB1 gene, phospholamban is phosphorylated in Chest>Heart by cAMP-dependent protein kinase, Cyclic GMP-Dependent Protein Kinases and CALCIUM SUPPLEMENTS/calmodulin-dependent protein kinase II (CM-kinase-II) and in Myocytes, Smooth Muscle by Cyclic GMP-Dependent Protein Kinases, phospholamban, the cardiac Sarcoplasmic Reticulum proteolipid, is phosphorylated by cAMP-dependent protein kinase, by Ca2+/phospholipid-dependent protein kinase, and by an endogenous Ca2+/calmodulin-dependent protein kinase, the identity of which remains to be defined[SEP]Relations: calmodulin-dependent protein kinase activity has relations: molfunc_protein with ITPKA, molfunc_protein with ITPKA. cAMP-dependent protein kinase complex has relations: cellcomp_protein with PRKAR2A, cellcomp_protein with PRKAR2A, cellcomp_protein with PRKAR1A, cellcomp_protein with PRKAR1A, cellcomp_protein with PRKACA, cellcomp_protein with PRKACA. Cyclic GMP-Dependent Protein Kinases activity has relations: molfunc_protein with PRKG2, molfunc_protein with PRKG2. Definitions: phospholamban defined as following: free Sarcoplasmic Reticulum polymeric proteolipid which modulates Sarcoplasmic Reticulum function; phosphorylated by cAMP-dependent, CALCIUM SUPPLEMENTS-calmodulin-dependent, and CALCIUM SUPPLEMENTS-phospholipid-dependent protein kinases.. CALCIUM SUPPLEMENTS defined as following: A dietary supplement containing the mineral CALCIUM SUPPLEMENTS.. Ischemia Procedure defined as following: A surgical procedure during which the blood supply to an organ or tissue is interrupted and then later reestablished.. Complement C2, human defined as following: Complement Complement C2, human (752 aa, ~83 kDa) is encoded by the human Complement C2, human gene. This protein is involved in post-translational protein processing and complement activity.. SNCG wt Allele defined as following: Human SNCG wild-type allele is located within10q23.2-q23.3 and is approximately 13 kb in length. This allele, which encodes gamma-synuclein protein, plays a role in the modulation of axonal architecture and neurofilament integrity. This gene is highly expessed in advanced breast carcinomas, suggesting a correlation between SNCG overexpression and breast tumor development.. Myocytes, Smooth Muscle defined as following: An elongated spindle-shaped contractile cell, peculiar to an involuntary muscle, containing a single nucleus and longitudinally arranged myofibrils.. Cyclic AMP-Dependent Protein Kinases defined as following: A group of enzymes that are dependent on CYCLIC AMP and catalyze the phosphorylation of SERINE or THREONINE residues on proteins. Included under this category are two cyclic-AMP-dependent protein kinase subtypes, each of which is defined by its subunit composition.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. Sarcoplasmic Reticulum defined as following: A network of tubules and sacs in the cytoplasm of SKELETAL MUSCLE FIBERS that assist with muscle contraction and relaxation by releasing and storing CALCIUM SUPPLEMENTS ions.. calmodulin-dependent protein kinase II defined as following: A multifunctional CALCIUM SUPPLEMENTS-calmodulin-dependent protein kinase subtype that occurs as an oligomeric protein comprised of twelve subunits. It differs from other enzyme subtypes in that it lacks a phosphorylatable activation domain that can respond to CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE.. CALCIUM SUPPLEMENTS/calmodulin-dependent protein kinase II defined as following: A CALMODULIN-dependent enzyme that catalyzes the phosphorylation of proteins. This enzyme is also sometimes dependent on CALCIUM. A wide range of proteins can act as acceptor, including VIMENTIN; SYNAPSINS; GLYCOGEN SYNTHASE; MYOSIN LIGHT CHAINS; and the MICROTUBULE-ASSOCIATED PROTEINS. (From Enzyme Nomenclature, 1992, p277). Cyclic GMP-Dependent Protein Kinases defined as following: A group of cyclic GMP-dependent enzymes that catalyze the phosphorylation of SERINE or THREONINE residues of proteins.. Sarcoplasmic Reticulum Ca(2+)-ATPase defined as following: Calcium-transporting ATPases that catalyze the active transport of CALCIUM into the SARCOPLASMIC RETICULUM vesicles from the CYTOPLASM. They are primarily found in MUSCLE CELLS and play a role in the relaxation of MUSCLES.. Hydrops Fetalis defined as following: Abnormal accumulation of serous fluid in two or more fetal compartments, such as SKIN; PLEURA; PERICARDIUM; PLACENTA; PERITONEUM; AMNIOTIC FLUID. General fetal EDEMA may be of non-immunologic origin, or of immunologic origin as in the case of ERYTHROBLASTOSIS FETALIS.. Protein kinase A defined as following: A group of enzymes that are dependent on CYCLIC AMP and catalyze the phosphorylation of SERINE or THREONINE residues on proteins. Included under this category are two cyclic-AMP-dependent protein kinase subtypes, each of which is defined by its subunit composition..", "label": "yes"} {"original_question": "Is Selinexor effective for multiple myeloma?", "id": "converted_3484", "sentence1": "Is Selinexor effective for Multiple Myeloma?", "sentence2": "Safety and efficacy of selinexor in relapsed or refractory Multiple Myeloma and Waldenstrom Macroglobulinemia., Based on these findings, we conclude that selinexor in combination with dexamethasone is active in heavily pretreated Millimole per Liter and propose a RP2D of 45 mg/m2 (80 mg) plus 20 mg dexamethasone given twice weekly. , Selinexor, an Exportin-1 PPP1R1A gene, yielded promising results in quad- or penta-refractory Millimole per Liter including patients resistant to daratumumab. , Selective Inhibition of Nuclear Export With Oral Route of Drug administration Route of Drug administration Selinexor for Treatment of Relapsing course or Refractory Multiple Myeloma., Conclusion The combination of selinexor and dexamethasone has an ORR of 21% in patients with heavily pretreated, refractory myeloma with limited therapeutic options., Selinexor (KPT-330) is the first-in-human SINE compound. Early phase clinical trials have established the safety profile of this agent and have shown promising efficacy in combination with Low-Dose Treatment dexamethasone and other anti-Millimole per Liter agents. The combination of selinexor and dexamethasone has demonstrated activity in \"penta-refractory\" Millimole per Liter, (ie, Millimole per Liter refractory to the 5 most active anti-Millimole per Liter agents currently used in treatment)., We found that AUTOINFLAMMATORY SYNDROME, FAMILIAL, X-LINKED, BEHCET-LIKE 2 in combination with selinexor, an PPP1R1A gene of exportin-1 (XPO1 protein, human protein, human) activity, synergistically inhibits the mTOR pathway and subsequently promotes cell death in Millimole per Liter Cells. , The current findings are consistent with the beneficial therapeutic outcome in patients with Millimole per Liter when treated with the combination of selinexor and AUTOINFLAMMATORY SYNDROME, FAMILIAL, X-LINKED, BEHCET-LIKE 2. , Selinexor plus Low-Dose Treatment bortezomib and dexamethasone for patients with relapsed or refractory Multiple Myeloma., Selinexor is an oral PPP1R1A gene of the nuclear export protein exportin 1 (XPO1 protein, human protein, human). Preclinical studies demonstrated synergistic antimyeloma activity between selinexor and Proteasome inhibitors, antineoplastic agent (Pulmonary Valve Insufficiency) though suppression of NFκB signaling and nuclear retention of Tumor Suppressor Proteins., Targeting XPO1 protein, human protein, human with selinexor (the selective PPP1R1A gene of nuclear export; SINE compound KPT-330) demonstrates broad antitumor activity also in patient Cells resistant to bortezomib; hence, it is a promising target in Millimole per Liter patients. Hypoxia, CTCAE, CTCAE is known to mediate tumor progression and drug resistance (including bortezomib resistance) in Millimole per Liter Cells., Selinexor, used as a single agent, delayed tumor initiation and tumor progression, prolonging CASP14 gene survival. In bortezomib-resistant xenografts, selinexor overcame drug resistance, significantly decreasing tumor burden and extending CASP14 gene survival when combined with bortezomib., The responses seen with venetoclax in RRMM with t(11;14)(high BCL2 gene, low BCL-XL and MCL1 gene) and selinexor in penta-refractory myeloma which fulfills the FDA category of unmet need, opens up newer options for these patients. , The FDA granted accelerated approval to selinexor plus Low-Dose Treatment dexamethasone for triple-class refractory Multiple Myeloma , despite an advisory panel 's concerns about the drug 's Toxic effect and the lack of randomized clinical data ., Selinexor ( in combination with dexamethasone ) received accelerated approval in the USA in July 2019 for the treatment of adult patients with relapsed or refractory Multiple Myeloma ( RRMM) . , CONCLUSIONS\nDexamethasone/Selinexor Regimen resulted in objective treatment responses in patients with myeloma refractory to currently available therapies., Selinexor: A First-in-Class Nuclear Export Inhibitor for Management of Multiply Relapse Multiple Myeloma., Objective: To review the pharmacology, pharmacokinetics, efficacy, and safety of selinexor for management of relapsed Multiple Myeloma (Millimole per Liter)., Selinexor (in combination with dexamethasone) received accelerated approval in the USA in July 2019 for the treatment of adult patients with relapsed or refractory Multiple Myeloma (RRMM).[SEP]Relations: Bortezomib has relations: drug_effect with Multiple myeloma, drug_effect with Multiple myeloma. Multiple myeloma has relations: drug_effect with Melphalan, drug_effect with Melphalan, drug_effect with Melphalan, drug_effect with Melphalan, drug_effect with Pramipexole, drug_effect with Pramipexole, drug_effect with Pramipexole, drug_effect with Pramipexole. Definitions: Hypoxia, CTCAE defined as following: A disorder characterized by a decrease in the level of oxygen in the body.. bortezomib defined as following: A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA.. Waldenstrom Macroglobulinemia defined as following: A lymphoproliferative disorder characterized by pleomorphic B-LYMPHOCYTES including PLASMA CELLS, with increased levels of monoclonal serum IMMUNOGLOBULIN M. There is lymphoplasmacytic Cells infiltration into bone marrow and often other tissues, also known as lymphoplasmacytic lymphoma. Clinical features include ANEMIA; HEMORRHAGES; and hyperviscosity.. Dexamethasone/Selinexor Regimen defined as following: A regimen consisting of dexamethasone and selinexor that may be used for the treatment of relapsed or refractory Multiple Myeloma.. XPO1 protein, human defined as following: Exportin-1 (1071 aa, ~123 kDa) is encoded by the human XPO1 protein, human gene. This protein plays a role in the mediation of nuclear export.. dexamethasone defined as following: An anti-inflammatory 9-fluoro-glucocorticoid.. Millimole per Liter defined as following: A unit of concentration (molarity unit) equal to one thousandth of a mole (10E-3 mole) of solute per one liter of solution.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Tumor Suppressor Proteins defined as following: Proteins that are normally involved in holding cellular growth in check. Deficiencies or abnormalities in these proteins may lead to unregulated cell growth and tumor development.. MCL1 gene defined as following: This gene is a regulator of apoptosis and plays a role in differentiation.. Relapsing course defined as following: To regress after partial recovery from illness. daratumumab defined as following: A fully human monoclonal antibody directed against the cell surface glycoprotein CD-38 with potential antineoplastic activity. The binding of anti-CD38 monoclonal antibody to natural killer (NK) Cells mimics the normal CD38-CD31 interaction on the NK cell surface. CD38 is also present on Multiple Myeloma (Millimole per Liter) Cells and plasma leukemia Cells; this agent may preferentially bind these Cells, triggering antitumoral antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC). CD38, a cell surface glycoprotein, is present on various immune Cells and has been shown to regulate the cytotoxic response of activated NK Cells.. Oral Route of Drug administration defined as following: The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins.. Multiple Myeloma defined as following: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.. Low-Dose Treatment defined as following: A reduced quantity of a therapeutic agent prescribed to be taken at one time or at stated intervals.. BCL2 gene defined as following: The B-cell leukemia/lymphoma-2 genes, responsible for blocking apoptosis in normal Cells, and associated with follicular lymphoma when overexpressed. Overexpression results from the t(14;18) translocation. The human c-bcl-2 gene is located at 18q24 on the long arm of chromosome 18.. Pulmonary Valve Insufficiency defined as following: Backflow of blood from the PULMONARY ARTERY into the RIGHT VENTRICLE due to imperfect closure of the PULMONARY VALVE.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary..", "label": "yes"} {"original_question": "Is it possible to detect survivin protein expression in normal human adult tissues?", "id": "converted_432", "sentence1": "Is it possible to detect survivin protein expression in normal Homo sapiens adult Body tissue?", "sentence2": "BIRC5 protein, Homo sapiens wt Allele (BIRC5 protein, Homo sapiens protein, Homo sapiens) is one of the members of IAP-family apoptosis inhibitors. The BIRCS gene is expressed in most Homo sapiens embryonic Body tissue and Malignant Neoplasms but not in normal differentiated Body tissue of adult Homo sapiens., BIRC5 protein, Homo sapiens wt Allele is an PPP1R1A gene of apoptosis that is undetectable in most terminally differentiated normal Homo sapiens Body tissue, strongly expressed in embryonic and fetal organs and is strongly expressed in many different Homo sapiens cancers., BIRC5 protein, Homo sapiens wt Allele is a member of the PPP1R1A gene apoptosis family that is overexpressed in many malignancies. It has five known alternative splice forms, some of which differ in their antiapoptotic properties and expression levels in Homo sapiens cancers., survivin is usually not expressed in normal adult Body tissue,, AZD 1152-hQPA induced caspase-dependent apoptosis of some Cultured Cell Line, demonstrated by loss of Mitochondrial Membranes potential, activation of caspase-9, followed by activation of caspase-3. This effect was accompanied by the inhibition of survivin expression. In vivo efficacy was determined in NOD/SCID/γc(null) mice implanted with the Ramos Homo sapiens Burkitt Lymphoma cell line. AZD 1152 had anti-tumour effects in this Mus xenograft model. There preclinical data suggest that the inhibition of Aurora Kinase B is a potentially useful therapeutic strategy in Burkitt Lymphoma and Hodgkin Disease., a novel antiapoptosis gene, i.e., survivin, was identified as a structurally unique member of the PPP1R1A gene of apoptosis protein family. BIRC5 protein, Homo sapiens wt Allele expression is turned off during fetal development and not found in non-neoplastic adult Homo sapiens Body tissue but is again turned on in the most common Homo sapiens cancers. The antiapoptotic properties of survivin might provide a significant growth advantage in Neoplasms and possibly also contribute to chemoresistance of Primary malignant neoplasm., Further comparison of the distribution of SPDEF wt Allele with other widely recognized Primary malignant neoplasm-associated molecules showed that SPDEF wt Allele has more restricted distributions than Oncogene ErbB2, BCL2 gene, survivin or Telomerase in cDNA Library from normal Homo sapiens Body tissue and more increased distribution than Oncogene ErbB2, CA-125 Antigen Antigen, BCL2 gene, survivin and Telomerase in cDNA Library from Head>Brain (except survivin), Breast, Chest>Lung and ovarian neoplasm. These data together show a better tumor-association for SPDEF wt Allele and suggest that SPDEF wt Allele is a more suitable target for developing specific Primary malignant neoplasm therapies., we identified decreased FHIT protein, Homo sapiens protein, Homo sapiens expression resulting in apoptosis inhibition and decreasing apoptosis associated with abnormal levels of some pro- and Apoptosis Inhibiting Proteins (BAX protein, Homo sapiens, BCL2 gene and BIRC5 protein, Homo sapiens wt Allele) by TUNEL and Thrombotic Microangiopathies. Our results demonstrated that the Mutation Abnormality in the FHIT protein, Homo sapiens protein, Homo sapiens gene significantly reduced FHIT protein, Homo sapiens protein, Homo sapiens expression in Homo sapiens CRC. Both TUNEL and Thrombotic Microangiopathies experiments demonstrated significantly inhibited apoptosis by down-regulation of BAX protein, Homo sapiens and up-regulation of BIRC5 protein, Homo sapiens wt Allele and BCL2 gene. Collectively, these studies identify the mechanism by which an important Tumor Suppressor Genes, FHIT protein, Homo sapiens protein, Homo sapiens, inactivated specifically in Homo sapiens CRC, and contributes to our understanding of the mechanism of colorectal carcinogenesis.[SEP]Relations: PPP1R1A has relations: anatomy_protein_present with adult mammalian kidney, anatomy_protein_present with adult mammalian kidney, anatomy_protein_present with adipose tissue, anatomy_protein_present with adipose tissue, anatomy_protein_present with muscle tissue, anatomy_protein_present with muscle tissue, anatomy_protein_present with blood, anatomy_protein_present with blood. Breast has relations: anatomy_protein_present with VIM, anatomy_protein_present with VIM. Definitions: Oncogene ErbB2 defined as following: Human Oncogene ErbB2 is a mutated variant of ERBB2 Gene, which encodes ERRB2 Receptor Protein Tyrosine Kinase, a 185-kDa type I membrane glycoprotein similar to EGFR that controls cell growth. Ligand binding increases ERBB2 tyrosine phosphorylation. A heterodimer with ERBB3 and ERBB4, p185ERBB2 is an essential component of the heregulin/neuregulin receptor. ERBB2 forms an IL6-dependent complex with IL6R gp130, resulting in ERBB2 tyrosine phosphorylation and MAPK activation. Oncogene ERBB2 disrupts normal cell function.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Telomerase defined as following: An essential ribonucleoprotein reverse transcriptase that adds telomeric DNA to the ends of eukaryotic CHROMOSOMES.. BCL2 gene defined as following: The B-cell leukemia/lymphoma-2 genes, responsible for blocking apoptosis in normal cells, and associated with follicular lymphoma when overexpressed. Overexpression results from the t(14;18) translocation. The Homo sapiens c-bcl-2 gene is located at 18q24 on the long arm of chromosome 18.. Breast defined as following: In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.. BIRC5 protein, Homo sapiens defined as following: Baculoviral IAP repeat-containing protein 5 (142 aa, ~16 kDa) is encoded by the Homo sapiens BIRC5 protein, Homo sapiens gene. This protein plays a role in the regulation of both apoptosis and the cell cycle.. Burkitt Lymphoma defined as following: A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.. Hodgkin Disease defined as following: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.. BIRC5 wt Allele defined as following: Human BIRC5 protein, Homo sapiens wild-type allele is located in the vicinity of 17q25 and is approximately 10 kb in length. This allele, which encodes baculoviral IAP repeat-containing protein 5, is involved in the prevention of apoptotic cell death.. BAX protein, Homo sapiens defined as following: Apoptosis regulator BAX (192 aa, ~21 kDa) is encoded by the Homo sapiens BAX gene. This protein plays a role in both apoptosis and protein-protein interactions.. caspase-9 defined as following: A long pro-domain caspase that contains a CASPASE RECRUITMENT DOMAIN in its pro-domain region. Caspase 9 is activated during cell stress by mitochondria-derived proapoptotic factors and by CARD SIGNALING ADAPTOR PROTEINS such as APOPTOTIC PROTEASE-ACTIVATING FACTOR 1. It activates APOPTOSIS by cleaving and activating EFFECTOR CASPASES.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other Body tissue. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Thrombotic Microangiopathies defined as following: A microvascular coagulopathy that may result from systemic vascular endothelial injury triggering the development of a procoagulant state, activation of the complement cascade, and microthrombi formation. Signs may include hemolytic anemia, thrombocytopenia, hypertension and renal dysfunction.. ovarian neoplasm defined as following: Tumors or Primary malignant neoplasm of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.. Mitochondrial Membranes defined as following: Either of the lipid bilayers that surround the mitochondrion and form the mitochondrial envelope. [GOC:mah, NIF_Subcellular:sao1045389829]. cDNA Library defined as following: A collection of DNA molecules that have been cloned in vectors. In the case of a cDNA library the DNA inserts are copies of RNAs that have been reverse-transcribed into DNA prior to cloning.. Aurora Kinase B defined as following: An aurora kinase that is a component of the chromosomal passenger protein complex and is involved in the regulation of MITOSIS. It mediates proper CHROMOSOME SEGREGATION and contractile ring function during CYTOKINESIS.. Mus defined as following: Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae.. Cultured Cell Line defined as following: Established cell cultures that have the potential to propagate indefinitely.. SPDEF wt Allele defined as following: Human SPDEF wild-type allele is located in the vicinity of 6p21.3 and is approximately 19 kb in length. This allele, which encodes SAM pointed domain-containing Ets transcription factor, plays a role in transcriptional regulation.. FHIT protein, Homo sapiens defined as following: Bis(5'-adenosyl)-triphosphatase (147 aa, ~17 kDa) is encoded by the Homo sapiens FHIT protein, Homo sapiens gene. This protein is involved in nucleoside metabolism.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including Primary malignant neoplasm.. caspase-3 defined as following: A short pro-domain caspase that plays an effector role in APOPTOSIS. It is activated by INITIATOR CASPASES such as CASPASE 9. Isoforms of this protein exist due to multiple alternative splicing of its MESSENGER RNA.. Tumor Suppressor Genes defined as following: Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible.. Homo sapiens defined as following: Members of the species Homo sapiens.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. CA-125 Antigen defined as following: A carbohydrate antigen that occurs in Neoplasms of the ovary as well as in Breast, kidney, and gastrointestinal tract Neoplasms and normal tissue. While it is tumor-associated, it is not tumor-specific and may have a protective function against particles and infectious agents at mucosal surfaces.. survivin defined as following: Human BIRC5 protein, Homo sapiens wild-type allele is located in the vicinity of 17q25 and is approximately 10 kb in length. This allele, which encodes baculoviral IAP repeat-containing protein 5, is involved in the prevention of apoptotic cell death..", "label": "no"} {"original_question": "Are astronauts in higher risk for developing cancer?", "id": "converted_3557", "sentence1": "Are astronauts in higher risk for developing cancer?", "sentence2": "Understanding space radiation health effects is critical due to potential increased morbidity and mortality following spaceflight. , No significant associations between space radiation dose and mortality were found using logistic regression with an internal reference group, adjusting for medical radiation., Despite years of research, understanding of the space radiation environment and the risk it poses to long-duration astronauts remains limited. There is a disparity between research results and observed empirical effects seen in Homo sapiens astronaut crews[SEP]Definitions: Homo sapiens defined as following: Members of the species Homo sapiens.. cancer defined as following: A malignant tumor at the original site of growth..", "label": "no"} {"original_question": "Is sumoylation implicated in myogenesis?", "id": "converted_682", "sentence1": "Is sumoylation implicated in myogenesis?", "sentence2": "Sentrin/small ubiquitin-like modifier (SUMO)-specific protease 2 (SUMO1 wt Allele) has broad de-SUMOylation activities in vitro, which is essential for embryonic heart development., Silencing SUMO1 wt Allele can reduce growth-differentiation factor 8 expression and, therefore, promote myogenesis of Specimen Source Codes - Skeletal muscle. These results reveal the important role of SUMO1 wt Allele in the regulation of growth-differentiation factor 8 expression and myogenesis., Overexpression of c-Ski/SKIL protein, human also induces Specimen Source Codes - Skeletal muscle differentiation, but how c-Ski/SKIL protein, human function in myogenesis is largely unknown., Notably, loss of sumoylation in the Lys-50 site (via a Lys-to-Arg point mutation) potently activates muscle-specific gene expression and enhances myotube formation. Our study suggests a novel role for SUMO ResponseLevel - ResponseLevel - modification in the regulation of myogenic differentiation., Although this ResponseLevel - ResponseLevel - modification has little effect on SKIL protein, human repression of the plasminogen activator inhibitor-1 promoter and only modestly potentiates SKIL protein, human repression of the oncoprotein oncoprotein p21 promoter, SKIL protein, human sumoylation robustly augments the ability of SKIL protein, human to suppress transcription of the myogenesis master Genes, Regulator MYOG protein, human, Our study also points to a physiological role for SKIL protein, human sumoylation in the control of MYOG protein, human expression in differentiating Muscle Cells., Here, we biochemically characterize SKIL protein, human sumoylation in detail and report the physiological function of the ResponseLevel - ResponseLevel - modification. , An essential role of small ubiquitin-like modifier (SUMO)-specific Protease 2 in growth-differentiation factor 8 expression and myogenesis., These results reveal the important role of SUMO1 wt Allele in the regulation of growth-differentiation factor 8 expression and myogenesis., The E3 SUMO ligase Nse2 regulates sumoylation and Nuclear (incident type)-to-cytoplasmic translocation of NACA wt Allele-SMYD1 gene in myogenesis., Sumoylation of the basic helix-loop-helix transcription factor sharp-1 regulates recruitment of the histone methyltransferase EHMT2 gene and function in myogenesis., We show that the overall load of sumoylated proteins present in Myoblasts diminishes progressively throughout myogenesis, These novel results suggest that protein sumoylation plays a pivotal role in myoblast differentiation and is required to regulate the activity of key targets downstream of MYOD1 wt Allele and MYOG protein, human., a composite sequence motif has recently been identified that couples phosphorylation, sumoylation, and perhaps also deacetylation to control transcriptional repression in stress response, Growth Factor and Nuclear (incident type) hormone signaling, myogenesis, and neuronal differentiation., Mutation Abnormality Abnormality of these SUMO acceptor sites in BHLHE41 gene does not impact its subcellular localization but attenuates its ability to act as a Transcription Repressor/Corepressor and inhibit myogenic differentiation. Consistently, co-expression of the SUMO protease SENP1 with wild type BHLHE41 gene abrogates BHLHE41 gene-dependent inhibition of myogenesis. , Transforming growth factor-beta-independent regulation of myogenesis by SKIL protein, human sumoylation., Ubiquitin Specific Protease 25 (USP25 gene gene), a member of the deubiquitinase family, is involved in several disease-related signal pathways including myogenesis, immunity and protein degradation. , In addition, we show that the NACA wt Allele interaction partner SMYD1 gene contains a putative sumoylation motif and is sumoylated in Muscle Cells, with depletion of Mms21/Nse2 leading to reduced concentrations of sumoylated SMYD1 gene. Taken together, our data suggest that the function, specifically the balance between the Nuclear (incident type) and cytosolic roles, of the NACA wt Allele-SMYD1 gene complex might be regulated by sumoylation.[SEP]Relations: EHMT2 has relations: pathway_protein with Regulation of TP53 Activity through Methylation, pathway_protein with Regulation of TP53 Activity through Methylation, bioprocess_protein with regulation of histone H3-K4 methylation, bioprocess_protein with regulation of histone H3-K4 methylation, bioprocess_protein with regulation of histone H3-K9 methylation, bioprocess_protein with regulation of histone H3-K9 methylation. histone methyltransferase complex has relations: cellcomp_protein with PRDM4, cellcomp_protein with PRDM4. BHLHE41 has relations: bioprocess_protein with regulation of neurogenesis, bioprocess_protein with regulation of neurogenesis. Definitions: growth-differentiation factor 8 defined as following: A growth differentiation factor that is a potent inhibitor of SKELETAL MUSCLE growth. It may play a role in the regulation of MYOGENESIS and in muscle maintenance during adulthood.. Muscle Cells defined as following: Mature contractile cells, commonly known as myocytes, that form one of three kinds of muscle. The three types of Muscle Cells are skeletal (MUSCLE FIBERS, SKELETAL), cardiac (MYOCYTES, CARDIAC), and smooth (MYOCYTES, SMOOTH MUSCLE). They are derived from embryonic (precursor) Muscle Cells called MYOBLASTS.. NACA wt Allele defined as following: Human NACA wild-type allele is located within 12q23-q24.1 and is approximately 25 kb in length. This allele, which encodes nascent polypeptide-associated complex subunit alpha protein, is involved in the regulation of protein sorting. A point mutation in the gene may be associated with ovarian serous carcinoma.. SKIL protein, human defined as following: Ski-like protein (684 aa, ~77 kDa) is encoded by the human SKIL gene. This protein plays a role in the regulation of both gene transcription and signal transduction.. histone methyltransferase defined as following: Enzymes that catalyze the transfer of methyl groups to LYSINE or ARGININE residues of HISTONES, especially histone H3 and histone H4 proteins. They play a critical role in EPIGENETIC PROCESSES.. Transcription Repressor/Corepressor defined as following: Transcription Repressor/Corepressor Gene encodes Transcriptional Repressor/Corepressor, proteins that can regulate transcription by binding to the operator and causing repression. (from Glick: Glossary of Biochemistry and Molecular Biology). MYOD1 wt Allele defined as following: Human MYOD1 wild-type allele is located in the vicinity of 11p15.4 and is approximately 3 kb in length. This allele, which encodes myoblast determination protein 1, is involved in the regulation of transcription, the cell cycle and the mediation of muscle differentiation.. MYOG protein, human defined as following: Myogenin (224 aa, ~25 kDa) is encoded by the human MYOG gene. This protein is involved in both transcription and myogenesis.. SUMO1 wt Allele defined as following: Human SUMO1 wild-type allele is located in the vicinity of 2q33 and is approximately 32 kb in length. This allele, which encodes small ubiquitin-related modifier 1 protein, is involved in the post-translational ResponseLevel - modification of proteins.. Myoblasts defined as following: Embryonic (precursor) cells of the myogenic lineage that develop from the MESODERM. They undergo proliferation, migrate to their various sites, and then differentiate into the appropriate form of myocytes (MYOCYTES, SKELETAL; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE).. Growth Factor defined as following: Growth Factors are extracellular signaling molecules (ligands) involved in control of target cell proliferation, cell survival, and cell differentiation. (NCI). ResponseLevel - modification defined as following:

Respond with exceptions, completions and modifications or revisions done before completion

. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. oncoprotein p21 defined as following: A cyclin-dependent kinase inhibitor that mediates TUMOR SUPPRESSOR PROTEIN P53-dependent CELL CYCLE arrest. oncoprotein p21 interacts with a range of CYCLIN-DEPENDENT KINASES and associates with PROLIFERATING CELL NUCLEAR ANTIGEN and CASPASE 3.. Genes, Regulator defined as following: Genes which regulate or circumscribe the activity of other genes; specifically, genes which code for PROTEINS or RNAs which have GENE EXPRESSION REGULATION functions..", "label": "yes"} {"original_question": "Are long non coding RNAs as conserved in sequence as protein coding genes?", "id": "converted_63", "sentence1": "Are long non coding RNAs as conserved in sequence as protein coding genes?", "sentence2": "Most lncRNAs are under lower sequence constraints than protein-coding genes and lack conserved secondary structures, making it hard to predict them computationally., hey are under stronger selective pressure than neutrally evolving sequences-particularly in their Promoter Regions, Genetic, which display levels of selection comparable to protein-coding genes., bout one-third seem to have arisen within the primate lineage.[SEP]Relations: GLI proteins bind promoters of Hh responsive genes to promote transcription has relations: pathway_protein with GLI2, pathway_protein with GLI2, pathway_protein with GLI1, pathway_protein with GLI1, pathway_protein with GLI3, pathway_protein with GLI3. Definitions: Promoter Regions, Genetic defined as following: DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes..", "label": "no"} {"original_question": "Is there any link between conserved noncoding elements and alternative splicing in vertebrates?", "id": "converted_1187", "sentence1": "Is there any link between conserved noncoding elements and alternative splicing in Vertebrates?", "sentence2": "Some of the most highly conserved sequences occur in Genes encoding RNA-Binding Proteins, particularly the RNA splicing-associated SR Genes. Differences in sequence conservation between Plants and animal allergen extracts are likely to reflect differences in the biology of the Organism, with Plants being much more able to tolerate genomic deletions and whole-genome duplication events due, in part, to their far greater fecundity compared with Vertebrates.[SEP]Relations: vertebra has relations: anatomy_anatomy with non-transverse process-bearing vertebra, anatomy_anatomy with non-transverse process-bearing vertebra. protein binding has relations: molfunc_protein with SPRYD7, molfunc_protein with SPRYD7, molfunc_protein with SPG7, molfunc_protein with SPG7, molfunc_protein with SPIC, molfunc_protein with SPIC, molfunc_protein with SP7, molfunc_protein with SP7. Definitions: Vertebrates defined as following: Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising mammals, birds, reptiles, amphibians, and fishes.. Organism defined as following: A living entity.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of Organism.. Plants defined as following: Multicellular, eukaryotic life forms of kingdom Plantae. Plants acquired chloroplasts by direct endosymbiosis of CYANOBACTERIA. They are characterized by a mainly photosynthetic mode of nutrition; essentially unlimited growth at localized regions of cell divisions (MERISTEMS); cellulose within cells providing rigidity; the absence of organs of locomotion; absence of nervous and sensory systems; and an alternation of haploid and diploid generations. It is a non-taxonomical term most often referring to LAND PLANTS. In broad sense it includes RHODOPHYTA and GLAUCOPHYTA along with VIRIDIPLANTAE.. RNA-Binding Proteins defined as following: Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other proteins whose function is to bind specifically to RNA..", "label": "yes"} {"original_question": "Are microRNA (miR) regulated through DNA methylation of their promoters?", "id": "converted_1369", "sentence1": "Are MicroRNAs (miR) regulated through DNA methylation of their promoters?", "sentence2": "We found that TCF7L1 gene down-regulation in the context of constitutively active Wnt signaling does not result from Promoter DNA methylation but is likely to be caused by a plethora of mechanisms at both the RNA and protein level as shown by the observed decrease in activating histone marks (histone H3 trimethyl Lys4 and H3-acetylation) and the upregulation of MIR211 wt Allele, a novel Wnt-regulated MicroRNAs that targets TCF7L1 gene and attenuates early neural differentiation in Mus sp. ESCs, ene silencing of MIR22 gene gene in acute lymphoblastic leukaemia involves histone modification independent of Promoter DNA methylation, Whereas a CpG Islands was identified within the Promoter element of MIR22 gene gene, no Promoter DNA methylation was detected in these Cells, xtensive Promoter DNA hypermethylation and hypomethylation is associated with aberrant MicroRNAs expression in chronic lymphocytic leukemia, Integration of DNA methylation and miRNA Promoter data led to the identification of 128 recurrent miRNA targets for aberrant Promoter DNA methylation, Together, our findings characterize the role of epigenetic changes in the regulation of miRNA transcription and create a repository of disease-specific Promoter regions that may provide additional insights into the pathogenesis of Chronic Lymphocytic Leukemia, Nadia - zebrafish methylation of MicroRNAs Genes in Multiple Myeloma, Recently, epigenetic dysregulation of tumor-suppressor miRNA Genes by Promoter DNA methylation has been implicated in Homo sapiens Malignant Neoplasms, including Multiple Myeloma (Millimole per Liter), ethylation of tumor suppressor microRNAs, Dysregulation of miRNA expression involved in Primary malignant neoplasm can be triggered by multiple mechanisms including aberrant DNA methylation of the miRNA gene Promoter, Of note, DNA methylation of tumor suppressor miRNAs has been implicated in various Homo sapiens Malignant Neoplasms, Moreover, miRNA silencing mediated by aberrant Promoter DNA methylation can potentially be reversed by hypomethylating agents, and hence may pose a new therapeutic target in Primary malignant neoplasm, In this review, the authors will focus on the aberrant methylation of miRNAs in the pathogenesis of lymphoid malignancies including chronic lymphocytic leukemia, Multiple Myeloma and Pre B-cell Pre B-cell acute lymphoblastic leukemia, Here, we review those miRNAs implicated in cytarabine/daunorubicin protocol that are regulated by Promoter DNA methylation and/or chromatin modifications and, which frequently direct the expression of constituents of the epigenetic machinery, concluding with the delineation of a complex epigenetic-miRNA regulatory network and its alterations in cytarabine/daunorubicin protocol, Furthermore, we also discuss epigenetic dysregulation of tumor-suppressor miRNA Genes by Promoter DNA methylation and the interaction of DNA methylation with miRNAs involved in the regulation of Hematopoietic stem Cells activation and liver fibrosi, Instead, the cell type-specific silencing of these Genes is due to enhanced oncoprotein oncoprotein p21 mRNA degradation, 14-3-3sigma Promoter DNA methylation and reduced processing of the miR-34a primary transcript, Some tumor-suppressive miRNAs are known to be epigenetically silenced by Promoter DNA methylation in Primary malignant neoplasm, In the present study, we aimed to identify miRNA Genes that are silenced by DNA hypermethylation in Liver carcinoma (altretamine/cisplatin/cyclophosphamide protocol), It was found that miR-335, which is harbored within an Introns of its protein-coding host gene, MEST gene gene, was downregulated by aberrant Promoter hypermethylation via further methylation assays, including methylation-specific PCR, combined bisulfite and restriction analysis, bisulfite sequencing analysis and decitabine treatment, he levels of miR-335/MEST gene gene methylation were significantly higher in 18 (90%) out of 20 primary altretamine/cisplatin/cyclophosphamide protocol Neoplasms, compared to their non-tumor tissue counterparts (P<0.001), In conclusion, our results indicate that expression of miR-335 is reduced by aberrant DNA methylation in altretamine/cisplatin/cyclophosphamide protocol.[SEP]Relations: Promoter clearance from RNA polymerase I Promoter has relations: bioprocess_bioprocess with Promoter clearance during DNA-templated transcription, bioprocess_bioprocess with Promoter clearance during DNA-templated transcription, bioprocess_bioprocess with Promoter clearance from RNA polymerase I Promoter for nuclear large rRNA transcript, bioprocess_bioprocess with Promoter clearance from RNA polymerase I Promoter for nuclear large rRNA transcript. histone modification has relations: bioprocess_bioprocess with histone methylation, bioprocess_bioprocess with histone methylation, bioprocess_bioprocess with histone biotinylation, bioprocess_bioprocess with histone biotinylation. MEST gene has relations: bioprocess_protein with regulation of lipid storage, bioprocess_protein with regulation of lipid storage. Definitions: histone modification defined as following: The covalent alteration of one or more amino acid residues within a histone protein. [GOC:krc]. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Introns defined as following: Sequences of DNA in the Genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some introns code for separate Genes.. Pre B-cell acute lymphoblastic leukemia defined as following: A type of ALL characterized by elevated levels of B-cell lymphoblasts in the bone marrow and the blood. [NCIT:C8644]. Hematopoietic stem Cells defined as following: Progenitor Cells from which all blood Cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood.. CpG Islands defined as following: Areas of increased density of the dinucleotide sequence cytosine--phosphate diester--guanine. They form stretches of DNA several hundred to several thousand base pairs long. In humans there are about 45,000 CpG islands, mostly found at the 5' ends of Genes. They are unmethylated except for those on the inactive X chromosome and some associated with imprinted Genes.. Chronic Lymphocytic Leukemia defined as following: A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called chronic lymphocytic leukemia (Chronic Lymphocytic Leukemia); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease.. MIR22 gene defined as following: This gene may be involved in the regulation of target gene transcription.. MicroRNAs defined as following: Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded MicroRNAs gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing.. TCF7L1 gene defined as following: Human TCF7L1 wild-type allele is located in the vicinity of 2p11.2 and is approximately 177 kb in length. This allele, which encodes transcription factor 7-like 1 protein, is involved in Wnt pathway-dependent transcriptional regulation.. Millimole per Liter defined as following: A unit of concentration (molarity unit) equal to one thousandth of a mole (10E-3 mole) of solute per one liter of solution.. Liver carcinoma defined as following: A primary malignant neoplasm of epithelial liver Cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The Cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. decitabine defined as following: An azacitidine derivative and antineoplastic antimetabolite. It inhibits DNA methyltransferase to re-activate silent Genes, limiting METASTASIS and NEOPLASM DRUG RESISTANCE. Decitabine is used in the treatment of MYELODISPLASTIC SYNDROMES, and ACUTE MYELOID LEUKEMIA.. Multiple Myeloma defined as following: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. MIR211 wt Allele defined as following: Human MIR211 wild-type allele is located in the vicinity of 15q13.3 and is approximately 110 bp in length. This allele, which encodes MIR211 pre-miRNA, plays a role in gene regulation.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. histone H3 trimethyl Lys4 defined as following: A post-translationally modified form of histone H3 where the lysine residue at position 4 is trimethylated. This modification may be a marker for areas of active gene expression.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of Cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Homo sapiens defined as following: Members of the species Homo sapiens.. oncoprotein p21 defined as following: A cyclin-dependent kinase inhibitor that mediates TUMOR SUPPRESSOR PROTEIN P53-dependent CELL CYCLE arrest. oncoprotein p21 interacts with a range of CYCLIN-DEPENDENT KINASES and associates with PROLIFERATING CELL NUCLEAR ANTIGEN and CASPASE 3.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic Cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Nadia - zebrafish defined as following: A wild-type zebrafish line, the stock of which was obtained from an area east of Calcutta in a district called Nadia.. promoters defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription..", "label": "yes"} {"original_question": "Does low T3 negatively affect prognosis of patients after cardiac surgery?", "id": "converted_1567", "sentence1": "Does low T3 thoracic segmental innervation negatively affect prognosis of patients after cardiac surgery?", "sentence2": "ur findings suggest that the development of LCOS after congenital heart surgery is associated with decreased total and free T3 thoracic segmental innervation thoracic segmental innervation, and increased interleukin-8 receptor binding activity levels at 48 hours, and preoperative Adenosine A2B Receptor Antagonist TT-4 level is an independent predictor of LCOS., Low basal cubic foot concentration can reliably predict the occurrence of postoperative AF in CABG patients., A relevant finding was that the days of post-operative hospitalization (10+/-3 days, means+/-S.D.) was inversely correlated with the slope of the recovery of T3 thoracic segmental innervation thoracic segmental innervation concentration (P<0.001) or with the area under the plasma curves of T3 thoracic segmental innervation thoracic segmental innervation (P=0.024, time range 72-144 h) and the FT3/FT4 ratio (P=0.037, time range 72-144 h) during the post-operative period. [SEP]Relations: interleukin-8 receptor activity has relations: molfunc_protein with CXCR2, molfunc_protein with CXCR2, molfunc_protein with CXCR1, molfunc_protein with CXCR1. insect larval thoracic segment has relations: anatomy_anatomy with insect larval prothoracic segment, anatomy_anatomy with insect larval prothoracic segment, anatomy_anatomy with insect larval metathoracic segment, anatomy_anatomy with insect larval metathoracic segment, anatomy_anatomy with insect larval mesothoracic segment, anatomy_anatomy with insect larval mesothoracic segment. Definitions: interleukin-8 receptor binding activity defined as following: Binding to an interleukin-8 receptor. [GOC:go_curators]. cubic foot defined as following: A traditional unit of volume equal to 1728 cubic inches, or 1/27 cubic yard, or 0.028 316 85 cubic meter (28.316 85 liters). The cubic foot holds about 7.4805 US gallons.. Adenosine A2B Receptor Antagonist TT-4 defined as following: An orally bioavailable antagonist of the immunomodulatory checkpoint molecule adenosine A2B receptor (A2BR; ADORA2B), with potential anti-inflammatory, immunomodulating and antineoplastic activities. Upon oral administration, A2BR antagonist TT-4 competes with adenosine for binding to A2BR expressed on various cancer cell types and numerous immune cells, such as dendritic cells (DCs), mast cells, macrophages and lymphocytes. This inhibits A2BR activity and prevents adenosine/A2BR-mediated signaling. The inhibition of A2BR in cancer cells prevents activation of downstream oncogenic pathways, which leads to an inhibition of cell proliferation and metastasis. A2BR inhibition also prevents the release of various growth factors, cytokines and chemokines, such as vascular endothelial growth factor (VEGF), interleukin-8 (interleukin-8 receptor binding activity) and angiopoietin-2 (Ang2) from immune cells, which may abrogate the adenosine-mediated immunosuppression in the tumor microenvironment (TME) and activate the immune system to exert anti-tumor immune responses against cancer cells leading to tumor cell killing. In addition, under non-cancerous inflammatory conditions, inhibition of A2BR leads to reduced activation and proliferation of various immune cells, which results in decreased pro-inflammatory cytokine production and may prevent inflammation. A2BR, a G protein-coupled signaling receptor, is expressed on the cell surfaces of numerous immune cells and is often overexpressed on a variety of cancer cell types; it plays a key role in their proliferation, progression and metastasis. Adenosine is overproduced under inflammatory conditions and plays a key role in pro-inflammatory actions. Adenosine is often overproduced by tumor cells and plays a key role in immunosuppression and tumor cell proliferation. The pro- and anti-inflammatory effects of adenosine and A2BR are cell type-specific and dependent on the extracellular microenvironment..", "label": "yes"} {"original_question": "Are there microbes in human breast milk?", "id": "converted_2779", "sentence1": "Are there microbes in human Breast Milk Specimen?", "sentence2": "Contrary to long-held dogma, human Milk Specimen is not sterile. Instead, it provides infants a rich source of diverse Bacteria, particularly microbes belonging to the Staphylococcus, Streptococcus species species, and Pseudomonas genera., The origins of the Bacteria in Milk Specimen are thought to include the maternal gastrointestinal tract (via an entero-mammary pathway) and through bacterial exposure of the Breast during nursing.[SEP]Relations: Breast has relations: anatomy_protein_present with VIM, anatomy_protein_present with VIM, anatomy_protein_present with RIMKLB, anatomy_protein_present with RIMKLB, anatomy_protein_present with GCSAM, anatomy_protein_present with GCSAM, anatomy_anatomy with external soft tissue zone, anatomy_anatomy with external soft tissue zone. Peptostreptococcus infectious disease has relations: disease_disease with anaerobic Bacteria infectious disease, disease_disease with anaerobic Bacteria infectious disease. Definitions: Breast defined as following: In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.. Bacteria defined as following: One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive.. human defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Does nintedanib hold promise for lung disease associated with systemic sclerosis?", "id": "converted_3480", "sentence1": "Does nintedanib hold promise for lung disease associated with Systemic Scleroderma?", "sentence2": "The patient developed progressive lung Fibrosis under several immunosuppressants and was started on nintedanib, with clinical and functional stabilization. Nintedanib is a tyrosine-kinase PPP1R1A gene that blocks several profibrotic pathways, inhibiting proliferation and migration of Specimen Source Codes - Fibroblasts and decreasing the synthesis of Extracellular Matrix Proteins. It is approved for idiopathic lung Fibrosis and has demonstrated good results in inhibiting migration and proliferation of Systemic Scleroderma dermal Specimen Source Codes - Fibroblasts, constituting a promising agent for Systemic Scleroderma-associated lung Fibrosis., BACKGROUND: Nintedanib is an PPP1R1A gene targeting Platelet-Derived Growth Factor Receptor Beta, Human, Fibroblast Growth Factor Receptor 2 and vascular endothelial growth factor receptor Protein Tyrosine Kinase that has recently been approved for the treatment of idiopathic Pulmonary:-:Point in time:^Patient:- Fibrosis. , CONCLUSION: Nintedanib targets core features of SSc in Fra2-transgenic CASP14 gene and ameliorates histological features of Idiopathic Pulmonary:-:Point in time:^Patient:- arterial hypertension, destructive Disease of capillaries and Pulmonary:-:Point in time:^Patient:- and dermal Fibrosis. These data might have direct implications for the ongoing phase III clinical trial with nintedanib in SSc-associated interstitial lung disease., In light of the ongoing advances in our understanding of the pathogenic mechanisms underlying interstitial lung disease in Systemic Scleroderma, this review also summarizes novel treatment approaches, presenting clinical and preclinical evidence for rituximab, tocilizumab, pirfenidone, and nintedanib, as well as hematopoietic stem cell transplantation and lung transplantation., pirfenidone and nintedanib are emerging agents that exert pleiotropic effects, reflective of the multiple mechanistic pathways of Idiopathic Pulmonary Fibrosis. , Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with Systemic Scleroderma-associated interstitial lung disease (SENSCIS™)., The SENSCIS™ trial is a randomised, placebo-controlled Phase III trial that will evaluate the efficacy and safety of nintedanib in patients with SSc-Lung Diseases, Interstitial (NCT02597933)., CONCLUSIONS: This trial will assess the efficacy and safety of nintedanib in patients with SSc-Lung Diseases, Interstitial., Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease., Nintedanib, a tyrosine kinase PPP1R1A gene, has been shown to have antifibrotic and antiinflammatory effects in preclinical models of Systemic Scleroderma and Lung Diseases, Interstitial., METHODS\n\nWe conducted a randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of nintedanib in patients with Lung Diseases, Interstitial associated with Systemic Scleroderma., CONCLUSIONS\n\nAmong patients with Lung Diseases, Interstitial associated with Systemic Scleroderma, the annual rate of decline in FVC was lower with nintedanib than with placebo; no clinical benefit of nintedanib was observed for other manifestations of Systemic Scleroderma., Potential of Nintedanib in Treatment of Progressive Fibrosing Interstitial Lung Diseases., Anti-fibrotic nintedanib-a new opportunity for Systemic Scleroderma patients?, Newer agents with anti-fibrotic properties, such as pirfenidone or nintedanib, might hold promise also for the Pulmonary:-:Point in time:^Patient:- Fibrosis seen in SARCOIDOSIS, SUSCEPTIBILITY TO, 1 (finding)., This suggests that nintedanib inhibits fundamental processes in the pathogenesis of Fibrosis., This suggests that nintedanib and pirfenidone , drugs known to slow disease progression in patients with idiopathic Pulmonary:-:Point in time:^Patient:- Fibrosis , may also slow the progression of Lung Diseases, Interstitial associated with systemic autoimmune diseases, In the SENSCIS® trial , nintedanib reduced the rate of Lung Diseases, Interstitial progression in patients with Systemic Scleroderma-associated Lung Diseases, Interstitial, Nintedanib, a tyrosine kinase PPP1R1A gene, has been shown to have antifibrotic and antiinflammatory effects in preclinical models of Systemic Scleroderma and Lung Diseases, Interstitial., The goal of the present study was to determine the effects of nintedanib on a cellular model of SSc-associated interstitial lung disease (Lung Diseases, Interstitial)., OBJECTIVES\nNintedanib is approved for the treatment of idiopathic Pulmonary:-:Point in time:^Patient:- Fibrosis (Idiopathic Pulmonary Fibrosis) and was demonstrated to slow disease progression in patients with Idiopathic Pulmonary Fibrosis by reducing decline in forced vital capacity by 50%., Nintedanib: new indication for Systemic Scleroderma-associated interstitial lung disease., Nintedanib (Ofev™), an oral triple kinase PPP1R1A gene targeting pro-fibrotic pathways, has been used for treatment of idiopathic Pulmonary:-:Point in time:^Patient:- Fibrosis (Idiopathic Pulmonary Fibrosis)., These data might have direct implications for the ongoing phase III clinical trial with nintedanib in SSc-associated interstitial lung disease., Based on positive results from phase III, placebo-controlled, randomized comparative clinical trial conducted in patients with Systemic Scleroderma-associated interstitial lung disease (SSc-Lung Diseases, Interstitial), nintedanib received marketing approval in the United States and Japan for the treatment of SSc-Lung Diseases, Interstitial., Nintedanib is an Protoplasm PPP1R1A gene of Protein Tyrosine Kinase that has been approved for treatment of Idiopathic Pulmonary Fibrosis and has recently been shown to reduce the rate of lung function decline in patients with Lung Diseases, Interstitial associated with Systemic Scleroderma (SSc-Lung Diseases, Interstitial).[SEP]Relations: Systemic Scleroderma has relations: disease_disease with Pulmonary:-:Point in time:^Patient:- Systemic Scleroderma, disease_disease with Pulmonary:-:Point in time:^Patient:- Systemic Scleroderma, disease_disease with limited scleroderma, disease_disease with limited scleroderma, disease_protein with KIAA0319L, disease_protein with KIAA0319L, disease_disease with limited Systemic Scleroderma, disease_disease with limited Systemic Scleroderma, disease_protein with NECTIN2, disease_protein with NECTIN2. Definitions: Systemic Scleroderma defined as following: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.. Fibrosis defined as following: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.. Lung Diseases, Interstitial defined as following: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.. pirfenidone defined as following: An orally bioavailable and deuterated form of the synthetic antifibrotic agent pirfenidone, with potential anti-inflammatory and anti-fibrotic activities. Upon administration, deupirfenidone inhibits a variety of pro-inflammatory mediators, such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-a) and transforming growth factor-beta (TGF-b). This may reduce Fibrosis, inflammation and infection, and may repair the impaired lymphatic flow, decrease lymphedema and restore lymphatic function. In the lungs, deupirfenidone may abrogate impaired lung function, lymphoedema and Pulmonary:-:Point in time:^Patient:- Fibrosis.. Fibroblast Growth Factor Receptor 2 defined as following: A Fibroblast Growth Factor Receptor 2 which contains three extracellular IMMUNOGLOBULIN I-SET DOMAINS and is expressed as two isoforms. One receptor isoform is expressed in the MESENCHYME and is activated by FIBROBLAST GROWTH FACTOR 2. A second isoform is expressed mainly by EPITHELIAL CELLS and is activated by FIBROBLAST GROWTH FACTOR 7 and FIBROBLAST GROWTH FACTOR 10. Mutation of the gene for Fibroblast Growth Factor Receptor 2 2 can result in craniosynostotic syndromes (e.g., APERT SYNDROME; and CROUZON SYNDROME).. Idiopathic Pulmonary:-:Point in time:^Patient:- arterial hypertension defined as following: Increased blood pressure in the arteries of the lungs; the etiology is unknown.. Platelet-Derived Growth Factor Receptor Beta, Human defined as following: Platelet-derived growth factor receptor beta (1106 aa, ~124 kDa) is encoded by the human PDGFRB gene. This protein plays a role in tyrosine phosphorylation and ligand-dependent signal transduction.. rituximab defined as following: A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.. Idiopathic Pulmonary Fibrosis defined as following: A common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen Fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change.. nintedanib defined as following: An orally bioavailable, indolinone-derived PPP1R1A gene of multiple receptor Protein Tyrosine Kinase (RTKs) and non-receptor Protein Tyrosine Kinase (nRTKs), with potential antiangiogenic, antifibrotic and antineoplastic activities. Upon administration, nintedanib selectively binds to and inhibits vascular endothelial growth factor receptor (VEGFR), Fibroblast Growth Factor Receptor 2 (FGFR), Platelet-Derived Growth Factor Receptor Beta, Human (PDGFR), and colony stimulating factor 1 receptor (CSF1R) Protein Tyrosine Kinase, which may result in the induction of endothelial cell apoptosis, the reduction in tumor vasculature, the inhibition of tumor cell proliferation and migration, and antifibrotic activity in Pulmonary:-:Point in time:^Patient:- Fibrosis. In addition, nintedanib also binds to and inhibits members of the Src family of Protein Tyrosine Kinase, including Src, Lck and Lyn, and fms-like tyrosine kinase 3 (FLT-3). VEGFR, FGFR, PDGFR and CSF1R RTKs play key roles in tumor angiogenesis, tumor cell proliferation and metastasis, as well as Pulmonary:-:Point in time:^Patient:- Fibrosis.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, proteins, lipids, carbohydrates, and inorganic salts.. Protein Tyrosine Kinase defined as following: Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors.. tocilizumab defined as following: A recombinant, humanized IgG1 monoclonal antibody directed against the interleukin-6 receptor (IL-6R) with immunosuppressant activity. Tocilizumab targets and binds to both the soluble form of IL-6R (sIL-6R) and the membrane-bound form (mIL-6R), thereby blocking the binding of IL-6 to its receptor. This prevents IL-6-mediated signaling. IL-6, a pro-inflammatory cytokine that plays an important role in the regulation of the immune response, is overproduced in autoimmune disorders, certain types of cancers and possibly various other inflammatory conditions.. tyrosine kinase PPP1R1A gene defined as following: Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES.. Extracellular Matrix Proteins defined as following: Macromolecular organic compounds that contain carbon, hydrogen, oxygen, nitrogen, and usually, sulfur. These macromolecules (proteins) form an intricate meshwork in which cells are embedded to construct tissues. Variations in the relative types of macromolecules and their organization determine the type of extracellular matrix, each adapted to the functional requirements of the tissue. The two main classes of macromolecules that form the extracellular matrix are: glycosaminoglycans, usually linked to proteins (proteoglycans), and fibrous proteins (e.g., COLLAGEN; ELASTIN; FIBRONECTINS; and LAMININ).. lung disease defined as following: Pathological processes involving any part of the LUNG..", "label": "yes"} {"original_question": "Is Downs syndrome associated with decreased risk of leukemia?", "id": "converted_2227", "sentence1": "Is Down Syndrome associated with decreased risk of leukemia?", "sentence2": "The association of Down's syndrome and leukemia has been documented for over 50 years. Multiple studies have established the incidence of leukemia in Down's syndrome patients to be 10- to 20-fold higher than that in the general population., We present a case of congenital Leukemia, Myelocytic, Acute manifesting from the very first day of birth. Diagnosis of Leukemia, Myelocytic, Acute was suspected by the presence of Blast (physical force) in the peripheral blood smear and was confirmed on bone marrow by flowcytometry. Karyotyping revealed Trisomy 21., Juvenile myelomonocytic leukemia (Juvenile Myelomonocytic Leukemia) and a solitary cases of Leukemia, Myelocytic, Acute (AML) in Down Syndrome. , This was thus confirmed to be a case with transient leukemia with Down Syndrome.[SEP]Relations: Down syndrome has relations: disease_phenotype_positive with Decreased fertility, disease_phenotype_positive with Decreased fertility, disease_phenotype_positive with Acute megakaryocytic leukemia, disease_phenotype_positive with Acute megakaryocytic leukemia, disease_phenotype_positive with Sporadic, disease_phenotype_positive with Sporadic, disease_phenotype_positive with Short palm, disease_phenotype_positive with Short palm, disease_phenotype_positive with Short neck, disease_phenotype_positive with Short neck. Definitions: Juvenile Myelomonocytic Leukemia defined as following: A leukemia affecting young children characterized by SPLENOMEGALY, enlarged lymph nodes, rashes, and hemorrhages. Traditionally classed as a myeloproliferative disease, it is now considered a mixed myeloproliferative-mylelodysplastic disorder.. Leukemia, Myelocytic, Acute defined as following: Clonal expansion of myeloid Blast (physical force) in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.. leukemia defined as following: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006). Down Syndrome defined as following: A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213).", "label": "no"} {"original_question": "Is tirabrutinib effective for lymphoma?", "id": "converted_4628", "sentence1": "Is tirabrutinib effective for lymphoma?", "sentence2": "In March 2020, oral tirabrutinib was approved in Japan for the treatment of recurrent or refractory primary central nervous system lymphoma. tirabrutinib is also under regulatory review in Japan for the treatment of Waldenström's macroglobulinemia and Malignant lymphoma - lymphoplasmacytic. Clinical development is underway in the USA, Europe and Japan for Autoimmune Diseases, Chronic Lymphocytic Leukemia, B-Cell Lymphomas, Sjogren's Syndrome, Pemphigus and Rheumatoid Arthritis. This article summarizes the milestones in the development of tirabrutinib leading to the first approval of tirabrutinib for the treatment of recurrent or refractory primary central nervous system lymphoma in Japan., CONCLUSION: These data indicate favorable efficacy of tirabrutinib in patients with relapsed/refractory Microglioma., tirabrutinib was well tolerated and showed promising efficacy for B-cell NHL/CLL., rabrutinib was approved in Japan for the treatment of recurrent or refractory primary central nervous system lymphoma. tirabrutinib is also , Here, we provide a comprehensive review of the preclinical and clinical activity of tirabrutinib, a Pharmacologic Substance approved in Japan for relapsed or refractory primary central nervous system lymphoma and all lines of Waldenström macroglobulinemia/Malignant lymphoma - lymphoplasmacytic., tirabrutinib (ONO/GS-4059; Ono Pharmaceutical) is a newly developed Pharmacologic Substance that selectively and irreversibly inhibits Agammaglobulinaemia tyrosine kinase (BTK protein, human protein, human) and has been approved in Japan for treating relapsed/refractory primary central nervous system lymphoma (Microglioma)., A 64-year-old patient with recurrent Microglioma enrolled in the phase I/II clinical trial of tirabrutinib, a second-generation BTK protein, human protein, human inhibitor designed for treating relapsed/refractory Microglioma., BACKGROUND: The safety, tolerability, efficacy, and pharmacokinetics of tirabrutinib, a second-generation, highly selective oral Agammaglobulinaemia tyrosine kinase inhibitor were evaluated for relapsed/refractory primary central nervous system lymphoma (Microglioma).M, 2020, oral tirabrutinib was approved in Japan for the treatment of recurrent or refractory primary central nervous system lymphoma. Tirabru, kinase inhibitor [EPC] tirabrutinib (for relapsed and refractory Microglioma) and high-dose chemotherapy with autologous stem cell transplantation support using thiotepa and busulfan (BuTT) were approved by the Japanese Ministry of Health and Welfare in March 2020 and has recently become available for clinical practice. While these novel, BACKGROUND: The safety, tolerability, efficacy, and pharmacokinetics of tirabrutinib, a second-generation, highly selective oral Agammaglobulinaemia tyrosine kinase inhibitor were evaluated for relapsed/refractory primary central nervous system lymphoma (Microglioma).METHODS: Patients with relapsed/refractory Microglioma, Karnofsky performance status ≥70, and normal end-organ function received tirabrutinib 320 and 480 , Histological verification of the treatment effect of tirabrutinib for relapsed/refractory primary central nervous system lymphoma., In March 2020, oral tirabrutinib was approved in Japan for the treatment of recurrent or refractory primary central nervous system lymphoma.[SEP]Relations: Ibrutinib has relations: drug_drug with Ibritumomab tiuxetan, drug_drug with Ibritumomab tiuxetan, drug_drug with Acalabrutinib, drug_drug with Acalabrutinib, drug_drug with Tixocortol, drug_drug with Tixocortol. Thiotepa has relations: drug_drug with Ibritumomab tiuxetan, drug_drug with Ibritumomab tiuxetan, drug_drug with Acalabrutinib, drug_drug with Acalabrutinib. Definitions: Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Microglioma defined as following: A non-Hodgkin or Hodgkin lymphoma that arises in the brain or spinal cord as a primary lesion. There is no evidence of lymphoma outside the central nervous system at the time of diagnosis.. thiotepa defined as following: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).. Agammaglobulinaemia tyrosine kinase defined as following: A non-receptor tyrosine kinase that is essential for the development, maturation, and signaling of B-LYMPHOCYTES. It contains an N-terminal zinc finger motif and localizes primarily to the PLASMA MEMBRANE and nucleus of B-lymphocytes. Mutations in the gene that encode this kinase are associated with X-LINKED AGAMMAGLOBULINEMIA.. Rheumatoid Arthritis defined as following: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.. Autoimmune Diseases defined as following: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.. Malignant lymphoma - lymphoplasmacytic defined as following: A clonal neoplasm of small B-lymphocytes, lymphoplasmacytoid cells, and plasma cells involving the bone marrow, lymph nodes, and the spleen. The majority of patients have a serum IgM paraprotein.. B-Cell Lymphomas defined as following: A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.. BTK protein, human defined as following: Tyrosine-protein kinase BTK protein, human (659 aa, ~76 kDa) is encoded by the human BTK protein, human gene. This protein is involved in both B-cell development and signal transduction.. tirabrutinib defined as following: An orally available formulation containing an inhibitor of Bruton agammaglobulinemia tyrosine kinase (BTK protein, human), with potential antineoplastic activity. Upon administration, tirabrutinib covalently binds to BTK protein, human within B cells, thereby preventing B cell receptor signaling and impeding B cell development. As a result, this agent may inhibit the proliferation of B cell malignancies. BTK protein, human, a cytoplasmic tyrosine kinase and member of the Tec family of kinases, plays an important role in B lymphocyte development, activation, signaling, proliferation and survival.. Chronic Lymphocytic Leukemia defined as following: A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called chronic lymphocytic leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease.. busulfan defined as following: An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen.. Sjogren's Syndrome defined as following: Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually Rheumatoid Arthritis.. lymphoma defined as following: A general term for various neoplastic diseases of the lymphoid tissue..", "label": "yes"} {"original_question": "Are there ultraconserved genomic regions in the budding yeast?", "id": "converted_2270", "sentence1": "Are there ultraconserved genomic regions in the budding yeast?", "sentence2": "Here, we present a systematic study of ultraconserved genomic regions in the budding yeast based on the publicly available genome sequences, in order to reveal their relationship with the adaptability or fitness advantages of the budding yeast.Results: Our results indicate that, in addition to some fundamental biological functions, the UCSs play an important role in the adaptation of Saccharomyces cerevisiae to the acidic environment, which is backed up by the previous observation. Besides that, we also find the highly unchanged genes (HUGs) are enriched in some other pathways, such as the nutrient-sensitive signaling pathway. To facilitate the investigation of unique UCSs, the UCSC Genome - anatomical entity - anatomical entity Browser was utilized to visualize the chromosomal position and related annotations of UCSs in Saccharomyces cerevisiae genome., Here, we present a systematic study of ultraconserved genomic regions in the budding yeast based on the publicly available genome sequences, in order to reveal their relationship with the adaptability or fitness advantages of the budding yeast.[SEP]Relations: anatomical entity has relations: anatomy_anatomy with insect mouthpart, anatomy_anatomy with insect mouthpart, anatomy_anatomy with anatomical cluster, anatomy_anatomy with anatomical cluster, anatomy_anatomy with immaterial anatomical entity, anatomy_anatomy with immaterial anatomical entity, anatomy_anatomy with material anatomical entity, anatomy_anatomy with material anatomical entity. Definitions: Saccharomyces cerevisiae defined as following: A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" yeast. The dried form is used as a dietary supplement.. Genome - anatomical entity defined as following: Anatomical set of genes in all the chromosomes..", "label": "yes"} {"original_question": "Is Lysozyme abundant in human tears?", "id": "converted_4261", "sentence1": "Is muramidase abundant in human tears?", "sentence2": "LYZL2 gene present in the natural tear, muramidase (LYZL2 gene C, human) is a naturally occurring Enzyme [APC] that operates against Gram-positive bacteria and leads to cell death. This antimicrobial Enzyme [APC] forms the part of the innate defense system of nearly all animal allergen extracts and exists in their somatic discharges such as milk, tears, Specimen Source Codes - Saliva and urine., tear LYZL2 gene, LYZL2 gene in tears, Specimen Source Codes - Saliva, Specimen Source Codes - Sweat, and other body fluids, , In this study we quantify LYZL2 gene, the most prevalent Protein Info in tear fluid, , muramidase (LYZ wt Allele) is a natural anti-bacterial Protein Info that is found in the Specimen Source Codes - Saliva, tears and milk of all Mammals including Homo sapiens. [SEP]Relations: Protein C has relations: drug_drug with Factor IX Complex (Human), drug_drug with Factor IX Complex (Human), drug_drug with Factor XIII (human), drug_drug with Factor XIII (human), drug_drug with Antihemophilic factor human, drug_drug with Antihemophilic factor human, drug_drug with Von Willebrand Factor Human, drug_drug with Von Willebrand Factor Human, drug_drug with Chlorotrianisene, drug_drug with Chlorotrianisene. Definitions: muramidase defined as following: A basic Enzyme [APC] that is present in Specimen Source Codes - Saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The Enzyme [APC] catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17.. LYZL2 gene C, human defined as following: muramidase C (148 aa, ~17 kDa) is encoded by the human LYZ gene. This Protein Info is involved in the proteolytic degradation of bacterial peptidoglycans.. Mammals defined as following: Warm-blooded vertebrate animal allergen extracts belonging to the class Mammalia, including all that possess hair and suckle their young.. Homo sapiens defined as following: Members of the species Homo sapiens.. LYZ wt Allele defined as following: Human LYZ wild-type allele is located in the vicinity of 12q15 and is approximately 6 kb in length. This allele, which encodes LYZL2 gene C Protein Info, plays a role in antimicrobial activity. Missense mutations in this gene are associated with hereditary renal amyloidosis.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. human defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Does epidural anesthesia for pain management during labor affect the Apgar score of the the infant?", "id": "converted_2844", "sentence1": "Does epidural anesthesia for pain management during labor affect the Apgar score of the the infant?", "sentence2": " We retrospectively analyzed 93 consecutive single-pregnancy patients who underwent cesarean section with combined spinal-epidural anesthesia. The patients were divided into two groups, depending on the use of 6% Idiopathic Hypereosinophilic Syndrome 130/0.4: group A (461 ± 167 ml of saline-based Idiopathic Hypereosinophilic Syndrome was administered; 43 patients) and group B (Idiopathic Hypereosinophilic Syndrome not administered; 50 patients). The major outcome was umbilical cord chloride level at delivery. The volume infused from operating room admission until delivery was not significantly different between groups. The umbilical cord chloride level at delivery was statistically significantly higher in group A than in group B, but clinically similar (108 ± 2 vs. 107 ± 2 mmol/l, P = 0.02). No differences were observed in the Apgar score or other umbilical cord laboratory data at delivery (Na+, K+, pH, base excess), CONCLUSION\nSubarachnoid or epidural sufentanil, in the doses used in this study, associated with local anesthetics, had the same effect on the duration of labor after analgesia and in the Apgar score of newborns., CONCLUSION Subarachnoid or epidural sufentanil, in the doses used in this study, associated with local anesthetics, had the same effect on the duration of labor after analgesia and in the Apgar score of newborns.[SEP]Relations: Sufentanil has relations: drug_effect with Apnea, drug_effect with Apnea, drug_effect with Laryngeal stridor, drug_effect with Laryngeal stridor, drug_effect with Erythema, drug_effect with Erythema. idiopathic hypereosinophilic syndrome has relations: disease_phenotype_positive with Paresthesia, disease_phenotype_positive with Paresthesia, disease_phenotype_positive with Feeding difficulties in infancy, disease_phenotype_positive with Feeding difficulties in infancy. Definitions: sufentanil defined as following: An opioid analgesic that is used as an adjunct in anesthesia, in balanced anesthesia, and as a primary anesthetic agent.. Idiopathic Hypereosinophilic Syndrome defined as following: A rare hematologic disease characterized by eosinophilia without evidence of clonality persisting for at least six months, for which no underlying cause can be identified. The condition is associated with signs of organ damage and dysfunction. Clinical manifestations are highly variable, depending on the organ systems involved, and include rapidly developing, life-threatening cardiovascular or neurological complications..", "label": "no"} {"original_question": "Is acid alpha-glucosidase the enzyme that causes Pompe disease when mutant?", "id": "converted_725", "sentence1": "Is acid Alpha-glucosidase the Enzyme [APC] that causes Generalized glycogen storage disease of infants when Mutant?", "sentence2": "Generalized glycogen storage disease of infants is an autosomal recessive genetic disorder characterized by a deficiency of the Enzyme [APC] responsible for degradation of lysosomal glycogen (acid α-glucosidase (Ga language)), Generalized glycogen storage disease of infants is a systemic metabolic disorder characterized by lack of acid-alpha glucosidase (Ga language) resulting in ubiquitous lysosomal glycogen accumulation, Generalized glycogen storage disease of infants is an autosomal recessive myopathic disorder caused by the deficiency of lysosomal acid α-glucosidase (Ga language), Acid α-glucosidase deficiency, that is, Generalized glycogen storage disease of infants, is a Glycogen Storage Disease Type I for which Enzyme [APC] replacement therapy (Estrogen Replacement Therapy) is available, The analysis revealed that the Amino Acid Substitution causing a processing or transport defect responsible for Generalized glycogen storage disease of infants were widely spread over all of the five domains comprising the acid Alpha-glucosidase., Generalized glycogen storage disease of infants is a lysosomal storage disease (Lysergic Acid Diethylamide) caused by a deficiency in the Lysosomal Enzyme [APC] acid Alpha-glucosidase., Glycogen storage disease type II (GSDII; Generalized glycogen storage disease of infants or acid maltase deficiency) is an Autosomal Recessive Disorder caused by lysosomal acid Alpha-glucosidase (AalphaGlu) deficiency and manifests predominantly as Skeletal Muscle Tissue weakness., Structural study on a Mutant acid Alpha-glucosidase in silico combined with biochemical investigation is useful for understanding the molecular pathology of Generalized glycogen storage disease of infants., The nature of Mutant acid Alpha-glucosidase (Geldanamycin Analogue) in Muscle Tissue was studied in 6 patients with Generalized glycogen storage disease of infants, consisting of 2 each of the infantile, childhood and adult types., Generalized glycogen storage disease of infants (Glycogen Storage Disease Type III) is caused by mutations in the acid Alpha-glucosidase Genes., Glycogen storage disease type II (Generalized glycogen storage disease of infants) is inherited by autosomal recessive transmission and caused by a deficiency of acid Alpha-glucosidase (Ga language), resulting in impaired degradation and lysosomal accumulation of glycogen., Generalized glycogen storage disease of infants is a lysosomal storage disorder (Lysergic Acid Diethylamide) caused by mutations in the Genes that encodes acid Alpha-glucosidase (Ga language)., Demonstration of acid Alpha-glucosidase in different types of Generalized glycogen storage disease of infants by use of an immunochemical method., Acid Alpha-glucosidase (Ga language) deficiency causes Generalized glycogen storage disease of infants, a lethal lysosomal glycogen storage disease for which no effective treatment currently exists., Deficiency of lysosomal alpha glucosidase (Ga language) causes Generalized glycogen storage disease of infants, which is usually fatal if onset occurs in infancy., Ambulatory electrocardiogram analysis in infants treated with recombinant Homo sapiens acid Alpha-glucosidase Enzyme [APC] replacement therapy for Generalized glycogen storage disease of infants., Infantile Generalized glycogen storage disease of infants is caused by deficiency of lysosomal acid Alpha-glucosidase., Determination of acid Alpha-glucosidase activity in blood spots as a diagnostic test for Generalized glycogen storage disease of infants., The pharmacological chaperone AT2220 increases the specific activity and lysosomal delivery of Mutant acid Alpha-glucosidase, and promotes glycogen reduction in a transgenic mouse model of Generalized glycogen storage disease of infants, Structural study on a Mutant acid Alpha-glucosidase in silico combined with biochemical investigation is useful for understanding the molecular pathology of Generalized glycogen storage disease of infants, Glycogen stored in Skeletal but not in Cardiac - anatomy qualifier Muscle Tissue in acid Alpha-glucosidase Mutant (Pompe) CASP14 Genes is highly resistant to transgene-encoded Homo sapiens Enzyme [APC], Although many lysosomal disorders are corrected by a small amount of the missing Enzyme [APC], it has been generally accepted that 20-30% of normal acid Alpha-glucosidase (Ga language) activity, provided by Genes or Enzyme [APC] replacement therapy, would be required to reverse the Myopathy and Cardiomyopathies in Generalized glycogen storage disease of infants, The nature of Mutant acid Alpha-glucosidase (Geldanamycin Analogue) in Muscle Tissue was studied in 6 patients with Generalized glycogen storage disease of infants, consisting of 2 each of the infantile, childhood and adult types, As in the severe Homo sapiens infantile disease (Pompe Syndrome), CASP14 Genes homozygous for disruption of the acid Alpha-glucosidase Genes (6(neo)/6(neo)) lack Enzyme [APC] activity and begin to accumulate glycogen in Cardiac - anatomy qualifier and Skeletal Muscle Tissue lysosomes by 3 weeks of age, with a progressive increase thereafter, Glycogen-storage disease type II, Generalized glycogen storage disease of infants, is caused by the deficiency of acid alpha-D-glucosidase in Lysosomes, Generalized glycogen storage disease of infants (Glycogen Storage Disease Type III) is caused by mutations in the acid Alpha-glucosidase Genes, Glycogen storage disease type II (Generalized glycogen storage disease of infants) is inherited by autosomal recessive transmission and caused by a deficiency of acid Alpha-glucosidase (Ga language), resulting in impaired degradation and lysosomal accumulation of glycogen, Glycogen stored in Skeletal but not in Cardiac - anatomy qualifier Muscle Tissue in acid Alpha-glucosidase Mutant (Pompe) CASP14 Genes is highly resistant to transgene-encoded Homo sapiens Enzyme [APC]., Structural modeling of Mutant alpha-glucosidases resulting in a processing/transport defect in Generalized glycogen storage disease of infants., Replacing acid Alpha-glucosidase in Generalized glycogen storage disease of infants: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II Muscle Tissue fibers., The pharmacological chaperone AT2220 increases the specific activity and lysosomal delivery of Mutant acid Alpha-glucosidase, and promotes glycogen reduction in a transgenic mouse model of Generalized glycogen storage disease of infants., Generalized glycogen storage disease of infants is an autosomal recessive Muscle Tissue-wasting disorder caused by the deficiency of the Lysosomal Enzyme [APC] acid Alpha-glucosidase. , Structural study on a Mutant acid Alpha-glucosidase in silico combined with biochemical investigation is useful for understanding the molecular pathology of Generalized glycogen storage disease of infants., We describe an improved method for detecting deficiency of the acid hydrolase, Glucan 1,4-alpha-Glucosidase in Specimen Source Codes - Leukocytes, the Enzyme [APC] defect in glycogen storage disease Type II (Generalized glycogen storage disease of infants)., Acid Alpha-glucosidase (Ga language) deficiency causes Generalized glycogen storage disease of infants,, Infantile Generalized glycogen storage disease of infants is caused by deficiency of lysosomal acid Alpha-glucosidase. Trials with recombinant Homo sapiens acid Alpha-glucosidase Enzyme [APC] replacement therapy (Estrogen Replacement Therapy) show a decrease in left ventricular mass and improved function., Generalized glycogen storage disease of infants is an autosomal recessive Muscle Tissue-wasting disorder caused by the deficiency of the Lysosomal Enzyme [APC] acid Alpha-glucosidase. Due to virtual absence of acid Alpha-glucosidase, patients with classical infantile Generalized glycogen storage disease of infants develop progressive Cardiomyopathies, Skeletal Muscle Tissue weakness and Respiratory Insufficiency leading to Cessation of life in early infancy., Generalized glycogen storage disease of infants is caused by the congenital deficiency of the Lysosomal Enzyme [APC] acid Alpha-glucosidase., The nature of Mutant acid Alpha-glucosidase (Geldanamycin Analogue) in Muscle Tissue was studied in 6 patients with Generalized glycogen storage disease of infants,, Generalized glycogen storage disease of infants is a lysosomal storage disorder (Lysergic Acid Diethylamide) caused by mutations in the Genes that encodes acid Alpha-glucosidase (Ga language). Recently, small molecule pharmacological chaperones have been shown to increase protein stability and cellular levels for Mutant lysosomal enzymes and have emerged as a new therapeutic strategy for the treatment of LSDs., Acid Alpha-glucosidase (Ga language) deficiency causes Generalized glycogen storage disease of infants, a lethal lysosomal glycogen storage disease for which no effective treatment currently exists., Infantile Generalized glycogen storage disease of infants is caused by deficiency of lysosomal acid Alpha-glucosidase., Glycogen-storage disease type II, Generalized glycogen storage disease of infants, is caused by the deficiency of acid alpha-D-glucosidase in Lysosomes., Structural modeling of Mutant alpha-glucosidases resulting in a processing/transport defect in Generalized glycogen storage disease of infants., Generalized glycogen storage disease of infants is a lysosomal storage disorder (Lysergic Acid Diethylamide) caused by mutations in the Genes that encodes acid Alpha-glucosidase (Ga language)., Structural study on a Mutant acid Alpha-glucosidase in silico combined with biochemical investigation is useful for understanding the molecular pathology of Generalized glycogen storage disease of infants., Ambulatory electrocardiogram analysis in infants treated with recombinant Homo sapiens acid Alpha-glucosidase Enzyme [APC] replacement therapy for Generalized glycogen storage disease of infants., Gene Mutation in Alpha-glucosidase cause accumulation of glycogen in lysosomes, resulting in Generalized glycogen storage disease of infants, a lysosomal storage disorder., Generalized glycogen storage disease of infants is an autosomal recessive Muscle Tissue-wasting disorder caused by the deficiency of the Lysosomal Enzyme [APC] acid Alpha-glucosidase., Infantile Generalized glycogen storage disease of infants is a fatal genetic Muscle Tissue disorder caused by a deficiency of acid Alpha-glucosidase, a glycogen-degrading Lysosomal Enzyme [APC].[SEP]Relations: glycogen storage disease has relations: disease_disease with glycogen storage disease due to Muscle Tissue beta-enolase deficiency, disease_disease with glycogen storage disease due to Muscle Tissue beta-enolase deficiency, disease_disease with glycogen storage disease due to acid maltase deficiency, late-onset, disease_disease with glycogen storage disease due to acid maltase deficiency, late-onset, disease_disease with glycogen storage disease due to acid maltase deficiency, infantile onset, disease_disease with glycogen storage disease due to acid maltase deficiency, infantile onset. Ga language has relations: disease_protein with glycogen storage disease due to acid maltase deficiency, late-onset, disease_protein with glycogen storage disease due to acid maltase deficiency, late-onset, disease_protein with glycogen storage disease due to acid maltase deficiency, infantile onset, disease_protein with glycogen storage disease due to acid maltase deficiency, infantile onset. Definitions: Autosomal Recessive Disorder defined as following: An inherited disorder manifested only when two copies of a mutated Genes are present.. Alpha-glucosidase defined as following: Enzymes that catalyze the exohydrolysis of 1,4-alpha-glucosidic linkages with release of alpha-glucose. Deficiency of Glucan 1,4-alpha-Glucosidase may cause GLYCOGEN STORAGE DISEASE TYPE II.. Lysergic Acid Diethylamide defined as following: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.. glycogen defined as following: large branched polysaccharide consisting of glucose residues; the major carbohydrate reserve of animals, stored primarily in liver and Muscle Tissue, synthesized and degraded for energy as demanded.. Amino Acid Substitution defined as following: The naturally occurring or experimentally induced replacement of one or more AMINO ACIDS in a protein with another. If a functionally equivalent amino acid is substituted, the protein may retain wild-type activity. Substitution may also diminish, enhance, or eliminate protein function. Experimentally induced substitution is often used to study Enzyme [APC] activities and binding site properties.. Muscle Tissue defined as following: Contractile tissue that produces movement in animals.. Glucan 1,4-alpha-Glucosidase defined as following: An Enzyme [APC] that catalyzes the hydrolysis of terminal 1,4-linked alpha-D-glucose residues successively from non-reducing ends of polysaccharide chains with the release of beta-glucose. It is also able to hydrolyze 1,6-alpha-glucosidic bonds when the next bond in sequence is 1,4.. Glycogen Storage Disease Type I defined as following: An autosomal recessive disease in which Genes expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA.. Lysosomes defined as following: A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the Lysosomes acts as a barrier between the enzymes enclosed in the Lysosomes and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed).. Estrogen Replacement Therapy defined as following: The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.. Cardiomyopathies defined as following: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).. Generalized glycogen storage disease of infants defined as following: Glycogen storage disease due to acid maltase deficiency (AMD) is an autosomal recessive trait leading to metabolic Myopathy that affects Cardiac - anatomy qualifier and respiratory muscles in addition to Skeletal Muscle Tissue and other tissues. AMD represents a wide spectrum of clinical presentations caused by an accumulation of glycogen in lysosomes.. Mutant defined as following: An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).. Myopathy defined as following: Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE.. Geldanamycin Analogue defined as following: An antineoplastic antibiotic that is structurally similar to the benzoquinone ansamycin antibiotic geldanamycin. A geldanamycin analogue binds to HSP90, a chaperone protein that aids in the assembly, maturation, and folding of proteins. Subsequently, the function of HSP90 is inhibited, leading to the degradation and depletion of client proteins such as kinases and transcription factors involved with cell cycle regulation and signal transduction.. Ga language defined as following: A Niger-Congo Kwa language spoken in the capital area of Ghana.. Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. Respiratory Insufficiency defined as following: Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed). Glycogen Storage Disease Type III defined as following: An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase (one part of the glycogen debranching Enzyme [APC] system). The clinical course of the disease is similar to that of glycogen storage disease type I, but milder. Massive hepatomegaly, which is present in young children, diminishes and occasionally disappears with age. Levels of glycogen with short outer branches are elevated in Muscle Tissue, liver, and erythrocytes. Six subgroups have been identified, with subgroups Type IIIa and Type IIIb being the most prevalent.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Is G3BP1 found in stress granules?", "id": "converted_4032", "sentence1": "Is G3BP1 gene found in Stress Granules?", "sentence2": "RAS GTPase-activating protein-binding protein (G3BP1 gene gene) is an RBMS3 gene that is essential for assembling Stress Granules. , Within Shprintzen-Goldberg syndrome, single-molecule localization microscopy revealed distributed hotspots of immobilized G3BP1 gene gene and IGF2BP1 gene that reflect the presence of relatively immobile nanometer-sized nanocores., Using super-resolution and expansion microscopy, we find that the SG component UBAP2L [11, 12] and the core protein G3BP1 gene gene [5, 11-13] occupy different domains inside Shprintzen-Goldberg syndrome. [SEP]Relations: stress granule assembly has relations: bioprocess_protein with G3BP1 gene, bioprocess_protein with G3BP1 gene, bioprocess_protein with G3BP2, bioprocess_protein with G3BP2. G3BP1 gene has relations: cellcomp_protein with cytoplasmic stress granule, cellcomp_protein with cytoplasmic stress granule, bioprocess_protein with stress granule assembly, bioprocess_protein with stress granule assembly, protein_protein with G3BP2, protein_protein with G3BP2. Definitions: Stress Granules defined as following: A dense aggregation in the cytosol composed of proteins and RNAs that appear when the cell is under stress. [GOC:ans, PMID:17284590, PMID:17601829, PMID:17967451, PMID:20368989]. Shprintzen-Goldberg syndrome defined as following: A rare, autosomal dominant inherited syndrome often caused by mutations in the SKI gene. It is characterized by premature fusion of skull bones and distinctive facial features, including a long, narrow head, hypertelorism, exophthalmos, downslanting palpebral fissures, a high, narrow palate, micrognathia, and low-set ears. The bodies of affected individuals resemble those of people with Marfan syndrome..", "label": "yes"} {"original_question": "Are there mammalian promoters with distal enhancer functions?", "id": "converted_2425", "sentence1": "Are there mammalian Promoter with distal Enhancer of transcription functions?", "sentence2": "Genome-wide characterization of mammalian Promoter with distal Enhancer of transcription functions., Gene expression in Mammals is precisely regulated by the combination of Promoter and gene-distal Regulatory Sequences, Nucleic Acid, known as enhancers. Several studies have suggested that some Promoter might have Enhancer of transcription functions. However, the extent of this type of Promoter and whether they actually function to regulate the expression of distal genes have remained elusive. Here, by exploiting a high-throughput Enhancer of transcription reporter assay, we unravel a set of mammalian Promoter displaying Enhancer of transcription activity. These Promoter have distinct Genome and epigenomic features and frequently interact with other gene Promoter. Extensive CRISPR-Cas9 Genome manipulation demonstrated the involvement of these Promoter in the cis regulation of expression of distal genes in their natural loci. Our results have important implications for the understanding of complex gene regulation in normal development and disease., Here, by exploiting a high-throughput Enhancer of transcription reporter assay, we unravel a set of mammalian Promoter displaying Enhancer of transcription activity., Several studies have suggested that some Promoter might have Enhancer of transcription functions., Genome - anatomical entity wide characterization of mammalian Promoter with distal Enhancer of transcription functions, gene expression in Mammals is precisely regulated by the combination of Promoter and gene distal Regulatory Sequences, Nucleic Acid known as enhancers several studies have suggested that some Promoter might have Enhancer of transcription functions however the extent of this type of Promoter and whether they actually function to regulate the expression of distal genes have remained elusive here by exploiting a high throughput Enhancer of transcription reporter assay we unravel a set of mammalian Promoter displaying Enhancer of transcription activity these Promoter have distinct Genome and epigenomic features and frequently interact with other gene Promoter extensive crispr cas9 Genome manipulation demonstrated the involvement of these Promoter in the cis regulation of expression of distal genes in their natural loci our results have important implications for the understanding of complex gene regulation in normal development and disease.[SEP]Relations: promoter clearance from RNA polymerase I promoter has relations: bioprocess_bioprocess with promoter clearance during DNA-templated transcription, bioprocess_bioprocess with promoter clearance during DNA-templated transcription, bioprocess_bioprocess with promoter clearance from RNA polymerase I promoter for nuclear large rRNA transcript, bioprocess_bioprocess with promoter clearance from RNA polymerase I promoter for nuclear large rRNA transcript. anatomical entity has relations: anatomy_anatomy with insect mouthpart, anatomy_anatomy with insect mouthpart. regulation of antisense RNA transcription has relations: bioprocess_bioprocess with positive regulation of antisense RNA transcription, bioprocess_bioprocess with positive regulation of antisense RNA transcription, bioprocess_bioprocess with negative regulation of antisense RNA transcription, bioprocess_bioprocess with negative regulation of antisense RNA transcription. Definitions: Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. Genome - anatomical entity defined as following: Anatomical set of genes in all the chromosomes.. Enhancer of transcription defined as following: A 50-150bp DNA sequence that increases the rate of transcription of coding sequences. It may be located at various distances and in either orientation upstream from, downstream from or within a structural gene. When bound by a specific transcription factor it increases the levels of expression of the gene, but is not sufficient alone to cause expression. Distinguished from a promoter, that is alone sufficient to cause expression of the gene when bound.. Regulatory Sequences, Nucleic Acid defined as following: Nucleic acid sequences involved in regulating the expression of genes.. Genome defined as following: The genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA..", "label": "yes"} {"original_question": "Is FTY720 FDA approved?", "id": "converted_4263", "sentence1": "Is FTY-720 FDA approved?", "sentence2": "FTY-720 (fingolimod) is a known sphingosine 1-phosphate (S1P) receptor Agonist that exerts strong anti-inflammatory effects and was approved as the first oral drug for the treatment of Multiple Sclerosis by the US Food and Drug Administration (FDA) in 2010. [SEP]Relations: fingolimod has relations: drug_drug with WIN 55212-2, drug_drug with WIN 55212-2, drug_drug with G17DT, drug_drug with G17DT, drug_drug with Octreotide, drug_drug with Octreotide, drug_drug with mRNA-1273, drug_drug with mRNA-1273, drug_protein with S1PR5, drug_protein with S1PR5. Definitions: Agonist defined as following: An agent that has affinity for a receptor and intrinsic activity at that receptor.. sphingosine 1-phosphate defined as following: A bioactive sphingolipid comprised of a sphingosine with a phosphate group attached to the carbon at position 1. Sphingosine 1-phosphate (S1P) binds to G protein-coupled S1P receptors (S1PRs) and initiates signaling pathways involved in the regulation of angiogenesis, the proliferation of skin cells, vascular stability and permeability, and T- and B-cell trafficking.. Multiple Sclerosis defined as following: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903). fingolimod defined as following: An orally available derivate of myriocin and sphingosine 1-phosphate receptor 1 (S1PR1, S1P1) modulator, with potential anti-inflammatory and immunomodulating activities. Upon oral administration, fingolimod, as a structural analogue of sphingosine, selectively targets and binds to S1PR1 on lymphocytes and causes transient receptor activation followed by S1PR1 internalization and degradation. This results in the sequestration of lymphocytes in lymph nodes. By preventing egress of lymphocytes. fingolimod reduces both the amount of circulating peripheral lymphocytes and the infiltration of lymphocytes into target tissues. This prevents a lymphocyte-mediated immune response and may reduce inflammation. S1PR1, a G-protein coupled receptor, plays a key role in lymphocyte migration from lymphoid tissues. fingolimod also shifts macrophages to an anti-inflammatory M2 phenotype, and modulates their proliferation, morphology, and cytokine release via inhibition of the transient receptor potential cation channel, subfamily M, member 7 (TRPM7)..", "label": "yes"} {"original_question": "Is Sotatercept effective for Pulmonary Arterial Hypertension?", "id": "converted_4419", "sentence1": "Is Sotatercept effective for Pulmonary Arterial Hypertension?", "sentence2": "Sotatercept for the Treatment of Pulmonary Arterial Hypertension., CONCLUSIONS: Treatment with Sotatercept resulted in a reduction in pulmonary vascular resistance in patients receiving background therapy for Idiopathic Idiopathic pulmonary arterial hypertension., Sotatercept for the Treatment of Pulmonary Arterial Hypertension, CONCLUSIONS: Treatment with Sotatercept resulted in a reduction in pulmonary vascular resistance in patients receiving background therapy for pulmonary arterial hypertensio, n hematologic adverse events. One patient in the Sotatercept 0.7-mg group died from Cardiac Arrest.CONCLUSIONS: Treatment with Sotatercept resulted in a reduction in pulmonary vascular resistance in patients receiving background t[SEP]Relations: Sotatercept has relations: drug_drug with Estriol, drug_drug with Estriol, drug_drug with Estradiol, drug_drug with Estradiol, drug_drug with Ipafricept, drug_drug with Ipafricept, drug_drug with Estradiol acetate, drug_drug with Estradiol acetate, drug_drug with Epimestrol, drug_drug with Epimestrol. Definitions: Sotatercept defined as following: A soluble fusion protein composed of the extracellular domain of the activin receptor type IIA (ActRIIA) linked to the Fc portion of human IgG1 with anabolic bone activity. Sotatercept selectively binds to activin, inhibiting its binding to ActRIIA and ActRIIA signaling, resulting in the stimulation of osteoblast activity and the inhibition of osteoclast activity and so normal bone formation and increased bone mineral density and strength. The Fc moiety of this fusion protein binds to the salvage receptor FcRN, preventing its lysosomal degradation and so extending its half-life in the circulatory system.. Cardiac Arrest defined as following: Cessation of heart beat or MYOCARDIAL CONTRACTION. If it is treated within a few minutes, heart arrest can be reversed in most cases to normal cardiac rhythm and effective circulation.. Idiopathic pulmonary arterial hypertension defined as following: Increased blood pressure in the arteries of the lungs; the etiology is unknown.. Pulmonary Arterial Hypertension defined as following: Increased blood pressure in the arteries of the lungs; the etiology is unknown.. Sotatercept defined as following: A soluble fusion protein composed of the extracellular domain of the activin receptor type IIA (ActRIIA) linked to the Fc portion of human IgG1 with anabolic bone activity. Sotatercept selectively binds to activin, inhibiting its binding to ActRIIA and ActRIIA signaling, resulting in the stimulation of osteoblast activity and the inhibition of osteoclast activity and so normal bone formation and increased bone mineral density and strength. The Fc moiety of this fusion protein binds to the salvage receptor FcRN, preventing its lysosomal degradation and so extending its half-life in the circulatory system..", "label": "yes"} {"original_question": "Has the protein TIEG1 been associated with apoptosis?", "id": "converted_147", "sentence1": "Has the protein TIEG1 been associated with apoptosis?", "sentence2": "Recombinant Transforming Growth Factor-Beta) inducible early gene 1 (TIEG1) is known to induce apoptosis in Recombinant Transforming Growth Factor-Beta sensitive pancreatic Tumor Cells, malignant, yet its effect on Recombinant Transforming Growth Factor-Beta resistant Tumor Cells, malignant remains unclear, overexpression of TIEG1, protected Acute lymphocytic leukemia Cells against chemotherapy-induced cell death, TIEG1 might be involved in mediating this effect from the microenvironment onto the leukemia Cells, We also demonstrate that KLF10 gene-1 ectopic expression in CGNPs induces cell cycle arrest that can lead to apoptosis but fails to promote differentiation, TIEG1 acts as an inducer or repressor of gene transcription to enhance the TGFbeta/Smad pathway, as well at other signaling pathways, to regulate cell proliferation, differentiation, and apoptosis., TGFbeta inducible early gene (TIEG1) mimics TGFbeta action and induces apoptosis, the transforming growth factor-beta- (Recombinant Transforming Growth Factor-Beta-) inducible ERG wt Allele (TIEG1), which plays a pivotal role in Recombinant Transforming Growth Factor-Beta-regulated cell growth control and apoptosis, Induction of RNA, Messenger for SMAD4 protein, Homo sapiens and the TGF-beta1-regulated apoptosis-inducing TRANSCRIPTION FACTOR TGF-beta1-inducible early gene (TIEG1) was detected within the first 6 h of doxazosin treatmen, TIEG1 (Recombinant Transforming Growth Factor-Beta inducible early gene) is a recently characterized TRANSCRIPTION FACTOR regulated by Recombinant Transforming Growth Factor-Beta that induces apoptosis when overexpressed in Adenocarcinoma of pancreas cell lines, Influence of TIEG1 on apoptosis, the influence of TIEG1 on apoptosis of HL-60 Cells and the expression of Bcl-2/Bax, The expression of genes involved in insulin resistance (PDK4 protein, Homo sapiens protein, Homo sapiens, AHSG gene gene) is increased, together with expression of TIEG1, a TRANSCRIPTION FACTOR that can induce apoptosis via the mitochondrial pathway, the overexpression of TIEG1 mediated growth inhibition and apoptosis in TGF-β1-resistant altretamine/cisplatin/cyclophosphamide protocol cell lines,, On the other hand, KLF10 deficient keratinocyte showed increased proliferation and apoptosis, LF10, transforming growth factor-β-inducible early gene 1, IEG1 can induce apoptosis of Tumor Cells, malignant, TGF-β inducible early gene 1) plays a significant role in regulating cell proliferation and apoptosis, TIEG1) is a Krüppel-like TRANSCRIPTION FACTOR (KLF10) that was originally cloned from Homo sapiens osteoblasts as an early response gene to TGF-β treatment, Adenoviral delivery of TIEG1 (AdTIEG1) to TIEG1(-/-) Cells reversed the RANKL-induced NFATc1 signaling defect in TIEG1(-/-) precursors and eliminated the differentiation and apoptosis defects, (TGF)-β inducible early gene (KLF10 gene)-1 is implicated in the control of cell proliferation, differentiation, and apoptosis in some cell types, TIEG1 has been shown to mimic the effects of Recombinant Transforming Growth Factor-Beta in various carcinoma Cells and plays a critical role in the apoptotic cascade, (KLF10 gene) is a family of primary response genes induced by Recombinant Transforming Growth Factor-Beta, which are well recognized in regulating cellular proliferation and apoptosis, In Homo sapiens and Mus tissues it has been shown that TIEG1 and KLF11 gene induce apoptosis and inhibit cell growth, overexpression of TIEG1 in OLI-neu Cells induced apoptosis, (Recombinant Transforming Growth Factor-Beta(1))-inducible transcription factors have recently elicited interest because of their critical role in the regulation of cell proliferation, differentiation, and apoptosis, ectopic overexpression of KLF10 gene is sufficient to trigger the apoptotic cell program in these Cells[SEP]Relations: TRANSCRIPTION FACTOR binding has relations: molfunc_protein with DRG1, molfunc_protein with DRG1, molfunc_protein with ATG7, molfunc_protein with ATG7, molfunc_protein with APBB1, molfunc_protein with APBB1, molfunc_protein with TLE1, molfunc_protein with TLE1, molfunc_protein with KEAP1, molfunc_protein with KEAP1. Definitions: keratinocyte defined as following: Epidermal Cells which synthesize keratin and undergo characteristic changes as they move upward from the basal layers of the epidermis to the cornified (horny) layer of the skin. Successive stages of differentiation of the keratinocyte forming the epidermal layers are basal cell, spinous or prickle cell, and the granular cell.. HL-60 Cells defined as following: A promyelocytic cell line derived from a patient with ACUTE PROMYELOCYTIC LEUKEMIA. HL-60 Cells lack specific markers for LYMPHOID CELLS but express surface receptors for FC FRAGMENTS and COMPLEMENT SYSTEM PROTEINS. They also exhibit phagocytic activity and responsiveness to chemotactic stimuli. (From Hay et al., American Type Culture Collection, 7th ed, pp127-8). leukemia defined as following: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature Cells; chronic leukemias are composed of more mature Cells. (From The Merck Manual, 2006). Adenocarcinoma of pancreas defined as following: An adenocarcinoma which arises from the exocrine pancreas. Ductal adenocarcinoma and its variants are the most common types of Adenocarcinoma of pancreas.. PDK4 protein, Homo sapiens defined as following: [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4, mitochondrial (411 aa, ~46 kDa) is encoded by the Homo sapiens PDK4 protein, Homo sapiens gene. This protein plays a role in the inhibition of pyruvate dehydrogenase activity.. Recombinant Transforming Growth Factor-Beta defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine transforming growth factor-beta (Recombinant Transforming Growth Factor-Beta) with proapoptotic and antineoplastic properties. Recombinant Transforming Growth Factor-Beta may suppress tumor cell growth by decreasing the expression of cyclin D1, a cell cycle regulatory protein, and downregulating the expression of the oncogene c-myc. This agent is also involved in T cell-mediated immunosuppression by CD4+CD25+ T Cells, which permits Tumor Cells, malignant to evade immune surveillance. (NCI04). RNA, Messenger defined as following: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the cytoplasm.. Tumor Cells, malignant defined as following: Cells of, or derived from, a malignant tumor.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. SMAD4 protein, Homo sapiens defined as following: Mothers against decapentaplegic homolog 4 (552 aa, ~60 kDa) is encoded by the Homo sapiens SMAD4 gene. This protein is involved in cytokine signaling and TRANSCRIPTION FACTOR activity.. Mus defined as following: Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae.. ERG wt Allele defined as following: Human ERG wild-type allele is located in the vicinity of 21q22.3 and is approximately 280 kb in length. This allele, which encodes transcriptional regulator ERG protein, is involved in both the regulation of RNA polymerase II-directed transcription and the modification of local chromatin structure. Acute myelogenous leukemia of the subtype M2 is linked to the chromosomal translocation t(8;21)(q22;q22), which involves this gene and the EWSR1 gene. Human myeloid leukemia is linked to the chromosomal translocation t(16;21)(p11;q22) of this gene with the FUS gene.. Malignant neoplasm of pancreas defined as following: A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma.. Acute lymphocytic leukemia defined as following: Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.. Homo sapiens defined as following: Members of the species Homo sapiens.. AHSG gene defined as following: This gene is involved in bone mineralization.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. protein defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the protein occurs, and references to homologous proteins in other species..", "label": "yes"} {"original_question": "Is erythropoietin effective for treatment of amyotrophic lateral sclerosis?", "id": "converted_2791", "sentence1": "Is erythropoietin effective for treatment of amyotrophic lateral sclerosis?", "sentence2": "This study was performed to validate the Amyotrophic Lateral Sclerosis-MITOS as a 6-month proxy of survival in 200 Amyotrophic Lateral Sclerosis patients followed up to 18 months.METHODS: Analyses were performed on data from the recombinant human erythropoietin RCT that failed to demonstrate differences between groups for both primary and secondary outcomes., CONCLUSIONS: RhEPO 40,000 Intrauterine fortnightly did not change the course of Amyotrophic Lateral Sclerosis., At 12 months, the annualised rate of death (rhEPO 0.11, 95% NDUFB6 gene 0.06 to 0.20; placebo: 0.08, NDUFB6 gene 0.04 to 0.17), tracheotomy or >23 h Non-Invasive Mechanical Ventilation (rhEPO 0.16, NDUFB6 gene 0.10 to 0.27; placebo 0.18, NDUFB6 gene 0.11 to 0.30) did not differ between groups, also after stratification by onset and ALSFRS-R at baseline.[SEP]Relations: amyotrophic lateral sclerosis has relations: disease_protein with OPTN, disease_protein with OPTN, disease_protein with ERBB4, disease_protein with ERBB4, disease_protein with OTOG, disease_protein with OTOG, disease_protein with FOS, disease_protein with FOS, disease_protein with XIAP, disease_protein with XIAP. Definitions: Non-Invasive Mechanical Ventilation defined as following: A type of mechanical ventilation procedure that uses a non-invasive means, such as a face mask or nasal mask, to deliver oxygenated air into the lungs.. Amyotrophic Lateral Sclerosis defined as following: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94). Intrauterine defined as following: Relating to the cavity of the uterus as the intended site of administration.. erythropoietin defined as following: This gene is involved in the regulation of red blood cell production and function.. amyotrophic lateral sclerosis defined as following: An inherited form of amyotrophic lateral sclerosis, usually inherited in an autosomal dominant pattern, caused by mutation(s) in the SOD1 gene, encoding superoxide dismutase..", "label": "no"} {"original_question": "Can desvenlafaxine be used at a dose of 50mg/day?", "id": "converted_1216", "sentence1": "Can desvenlafaxine be used at a dose of 50mg/day?", "sentence2": "Long-term use of desvenlafaxine was safe and well tolerated, with a clinical benefit/risk profile similar to that in other populations., e objective of this study was to evaluate the long-term safety of desvenlafaxine for continuation treatment of major depressive disorder (Major Depressive Disorder) in Japanese patients. This was a phase 3, multicenter, 10-month, open-label study with flexible dosing of desvenlafaxine (25, 50, 100 milligram/day), n an effort to establish the lowest effective dose of desvenlafaxine (administered as desvenlafaxine succinate), we assessed the efficacy, safety, and tolerability of 10- and 50-milligram/day desvenlafaxine vs placebo for the treatment of major depressive disorder, Change from baseline to final evaluation in adjusted HAM-D(17) total scores was not significantly different comparing desvenlafaxine 10 milligram/day (-9.28) and desvenlafaxine 50 milligram/day (-8.92) with placebo (-8.42), Overall rates of treatment-emergent adverse events with both doses were similar to placebo, However, in a companion study reported separately, desvenlafaxine 50 mg, but not 25 mg, separated from placebo. Taken together, these studies suggest that 50 mg is the minimum effective dose of desvenlafaxine for the treatment of major depressive disorder. , desvenlafaxine XR was dosed at 50 milligram/day for 10 days., desvenlafaxine therapy is initiated at the therapeutic dose (50 milligram/day) without a need for dose titration., Clinical studies have investigated the efficacy of DVS in doses ranging from 50 to 400 milligram/day for the treatment of Major Depressive Disorder in adult outpatients. The effects of DVS 50 milligram/day have been clearly distinguished from placebo in the reduction of Major Depressive Disorder symptoms in such clinical trials. No additional therapeutic benefits were found at doses > 50 milligram/day. The recommended dose of DVS ranges from 50 to 100 mg., Adult outpatients with major depressive disorder received desvenlafaxine doses ranging from 50-400 milligram/day or placebo for 8 weeks, At the recommended therapeutic dose of 50 milligram/day, discontinuation due to adverse events was similar to placebo, atients received fixed (50, 100, 200, or 400 milligram/day; n=1,342) or flexible doses (100-400 milligram/day; n=463) of desvenlafaxine or placebo (n=1,108), desvenlafaxine demonstrated short-term efficacy for treating major depressive disorder across the range of doses studied. No evidence of greater efficacy was observed with doses >50 milligram/day; a strong dose-response effect on tolerability was observed., To assess the efficacy, safety, and tolerability of 50- and 100-milligram/day doses of desvenlafaxine (administered as desvenlafaxine succinate), a serotonin-norepinephrine reuptake inhibitor, for the treatment of major depressive disorder (Major Depressive Disorder), Patients with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) Major Depressive Disorder and 17-item Hamilton Rating Scale for Depression (HAM-D(17)) scores > or =20 were randomly assigned to double-blind placebo or desvenlafaxine treatment (fixed dose of 50 milligram/day or 100 milligram/day) for 8 weeks., desvenlafaxine 50 mg was associated with a significantly greater adjusted mean change from baseline on the HAM-D(17) (-11.5) compared with placebo (-9.5, p=0.018), These results demonstrate efficacy, safety, and tolerability of desvenlafaxine 50 milligram/day for treating Major Depressive Disorder. , CONCLUSIONS: desvenlafaxine at the recommended dose of 50 mg/d was effective in relapse prevention of Cancer patients and suicide and Cancer patients and suicide and depression during a 6-month period in patients who demonstrated stable response after 20 weeks of open-label desvenlafaxine treatment.[SEP]Relations: desvenlafaxine has relations: drug_drug with Dosulepin, drug_drug with Dosulepin, drug_drug with Colistimethate, drug_drug with Colistimethate, drug_drug with Etonogestrel, drug_drug with Etonogestrel, drug_drug with Nomifensine, drug_drug with Nomifensine, drug_drug with Pemetrexed, drug_drug with Pemetrexed. Definitions: desvenlafaxine defined as following: A synthetic phenethylamine bicyclic derivative with antidepressant activity. desvenlafaxine is a selective reuptake inhibitor of serotonin and norepinephrine due to its high binding affinities to the pre-synaptic serotonin and norepinephrine transporters. By blocking both transporters, this agent prolongs neurotransmitter activities of both serotonin and norepinephrine, thereby alleviating depressive state.. Major Depressive Disorder defined as following: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5). milligram/day defined as following: A unit of mass flow rate equivalent to the rate at which one thousandth of a gram of matter crosses a given surface or is delivered to a given object or space over a period of time equal to twenty four hours. Milligram per twenty four hours is also a dose administration rate unit equal to the rate at which one thousandth of a gram of a product is administered per unit of time equal to twenty four hours.. desvenlafaxine defined as following: A synthetic phenethylamine bicyclic derivative with antidepressant activity. desvenlafaxine is a selective reuptake inhibitor of serotonin and norepinephrine due to its high binding affinities to the pre-synaptic serotonin and norepinephrine transporters. By blocking both transporters, this agent prolongs neurotransmitter activities of both serotonin and norepinephrine, thereby alleviating depressive state..", "label": "yes"} {"original_question": "Has the companion diagnostic HercepTest received FDA approval?", "id": "converted_4223", "sentence1": "Has the companion diagnostic HercepTest received FDA approval?", "sentence2": "The FDA-Approved Breast Cancer HER2 Evaluation Kit (HercepTest; Dako) May Miss Some HER2-Positive Breast Cancers., HER2 fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) tests were performed on 52 cases using a US Food and Drug Administration (FDA)-approved kit (HercepTest, FDA kit) and a laboratory-developed test (LDT) with the HercepTest antibody and a Leica Bond automated stainer.[SEP]", "label": "yes"} {"original_question": "Do RNA:DNA hybrids preferentially form in high or low GC regions?", "id": "converted_1392", "sentence1": "Do RNA:DNA hybrids preferentially form in high or low GC regions?", "sentence2": "Intrinsic termination signals for multisubunit bacterial RNA polymerases (RNAPs) encode a GC-rich stem-loop structure followed by a polyuridine [poly(U)] tract, and it has been proposed that steric clash of the stem-loop with the exit pore of the RNAP imposes a shearing force on the RNA in the downstream RNA:DNA hybrid, resulting in misalignment of the active site, We have observed that transcription through the GC-rich FMR1 gene gene 5'UTR region favors R-loop formation, with the nascent (G-rich) RNA forming a stable RNA:DNA hybrid with the template DNA strand, thereby displacing the non-template DNA strand., Transcription termination by bacterial RNA polymerase (RNAP) occurs at sequences coding for a GC-rich RNA hairpin followed by a U-rich tract. We used single-molecule techniques to investigate the mechanism by which three representative terminators (his, t500, and tR2) destabilize the elongation complex (EC)., In the 5' flanking region, Nucleotides -234 to -213 encompass a GC-rich region which exhibits high Homologous Gene (greater than 70%) to the 5' flanking regions of the Genes of all the Apolipoproteins B published to date, namely, apo-A-II (-497 to -471), apo-A-I (approximately -196 to -179), Apolipoprotein E (-409 to -391), and apo-C-III (approximately -116 to -103)., Recently, we demonstrated that cotranscriptional RNA•DNA hybrids are preferentially formed at GC-rich trinucleotide and tetranucleotide repeat sequences in vitro as well as in human genomic DNA., Considering the extent of transcription through the human genome as well as the abundance of GC-rich and/or non-canonical DNA structure forming tandem repeats, RNA•DNA hybrids may represent a common mutagenic conformation., Recently, we demonstrated that cotranscriptional RNA•DNA hybrids are preferentially formed at GC-rich trinucleotide and tetranucleotide repeat sequences in vitro as well as in human genomic DNA. [SEP]Relations: apolipoprotein binding has relations: molfunc_protein with VLDLR, molfunc_protein with VLDLR, molfunc_protein with MTTP, molfunc_protein with MTTP, molfunc_protein with LPA, molfunc_protein with LPA, molfunc_protein with LPL, molfunc_protein with LPL, molfunc_protein with MAPT, molfunc_protein with MAPT. Definitions: Apolipoprotein E defined as following: A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Nucleotides defined as following: The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed). Apolipoproteins B defined as following: Major structural proteins of triacylglycerol-rich LIPOPROTEINS. There are two forms, apolipoprotein B-100 and apolipoprotein B-48, both derived from a single gene. ApoB-100 expressed in the liver is found in low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). ApoB-48 expressed in the intestine is found in CHYLOMICRONS. They are important in the biosynthesis, transport, and metabolism of triacylglycerol-rich lipoproteins. Plasma Apo-B levels are high in atherosclerotic patients but non-detectable in ABETALIPOPROTEINEMIA.. FMR1 gene defined as following: This gene may be involved in the regulation of mRNA trafficking.. Homologous Gene defined as following: A gene from one species which corresponds to a gene in another species and that is related via a common ancestral species. These Genes retain a similar sequence and function.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Is nucleosome eviction ATP-dependent?", "id": "converted_308", "sentence1": "Is nucleosome location eviction ATP-dependent?", "sentence2": "ATP-dependent chromatin location location remodeling and nucleosome location location-depleted 'barriers' co-operate to determine the kinetics of nucleosome location location organization, ATP-dependent nucleosome location location-remodeling factors endow chromatin location location with structural flexibility by promoting assembly or disruption of Nucleosomes and the exchange of Histone antigen variants., remodeling takes place in an ATP-independent manner. Binding of stallimycin to the linker and nucleosomal DNA culminates in eviction of the linker Histone antigen and the formation of a population of off-centered Nucleosomes., which promotes Histone antigen deposition onto DNA, and a novel activity, which prevents nucleosome location location eviction but not remodeling mediated by the ATP-dependent Remodels the Structure of Chromatin complex, ATP-dependent chromatin location location remodeling complex SWI/SNF regulates transcription and has been implicated in promoter nucleosome location location eviction, ATP-dependent nucleosome location location-remodeling enzyme involved in transcription, replication, and the DNA damage response, Iec1-Ino80 complex location location promotes transcription through nucleosome location location eviction, Ino80 complex location location from fission yeast mediates ATP-dependent nucleosome location location remodeling in vitro, reconstitution of nucleosome location location disassembly using the ATP-dependent chromatin location location remodeler Rsc and Vps75 revealed that these Proteins can cooperate to remove H2A/H2B dimers from Nucleosomes., TP-dependent chromatin location location-remodeling complexes, such as Remodels the Structure of Chromatin, can reposition, evict or restructure nucleosome location location, TP-dependent chromatin location location remodeling complexes play a critical role in chromatin location location dynamics, activity of SWI/SNF to Histone antigen eviction in trans from Operator gene.[SEP]Relations: nucleosome location has relations: cellcomp_protein with IRF4, cellcomp_protein with IRF4, cellcomp_protein with TNP2, cellcomp_protein with TNP2, cellcomp_protein with H2BE1, cellcomp_protein with H2BE1, cellcomp_protein with H2BC4, cellcomp_protein with H2BC4, cellcomp_protein with TNP1, cellcomp_protein with TNP1. Definitions: Nucleosomes defined as following: The repeating structural units of chromatin location, each consisting of approximately 200 base pairs of DNA wound around a protein core. This core is composed of the histones H2A, H2B, H3, and H4.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Ino80 complex location defined as following: A multisubunit protein complex that contains the Ino80p ATPase; exhibits chromatin location remodeling activity. [GOC:jh, GOC:rb, PMID:19355820]. stallimycin defined as following: An oligopeptide antineoplastic antibiotic isolated from the bacterium Streptomyces distallicus. Distamycin preferentially binds to adenine-thymine (A-T) rich sequences in the minor groove of DNA, thereby inhibiting DNA replication and RNA transcription. In addition to antitumor effects, stallimycin also possesses antiviral and antiprotozoal activities and is used as a chromosome dye. (NCI04). DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. nucleosome location defined as following: The repeating structural units of chromatin location, each consisting of approximately 200 base pairs of DNA wound around a protein core. This core is composed of the histones H2A, H2B, H3, and H4.. chromatin location defined as following: The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130]. Remodels the Structure of Chromatin defined as following: Remodels the Structure of Chromatin is an abundant fifteen-protein chromatin location remodeling complex containing SNF12 [RSC6p subunit homologue], RSC1 (or RSC2 or RSC4), RSC58 [58 kD subunit], and SFH1. (from SGD and NCI).", "label": "yes"} {"original_question": "Is Huntington's disease is caused by expansion of a CTG repeat in the HTT gene on Chromosome 4?", "id": "converted_3531", "sentence1": "Is Huntington Disease is caused by expansion of a CTG repeat in the SLC6A4 wt Allele gene on Chromosome 4?", "sentence2": "Huntington Disease (Hodgkin Disease) is caused by a CAG repeat expansion that encodes a polyglutamine (polyQ) expansion in the Hodgkin Disease disease Protein Info, Hodgkin Disease Protein Info, human (SLC6A4 wt Allele)., Huntington disease (Hodgkin Disease) is a dominantly inherited disorder caused by a CAG expansion Mutation Abnormality in the Hodgkin Disease Protein Info, human (SLC6A4 wt Allele) gene, which results in the SLC6A4 wt Allele Protein Info that contains an expanded polyglutamine tract., In Huntington Disease (Hodgkin Disease), expansion of CAG codons in the SLC6A4 wt Allele gene (SLC6A4 wt Allele) leads to the aberrant formation of Protein Info aggregates and the differential degeneration of striatal medium spiny neurons (MSNs)., Huntington disease (Hodgkin Disease) is a progressive Autosome dominant Neurodegenerative Disorders, characterized by abnormal movements, Mental deterioration, and psychiatric symptoms, caused by a CAG repeat expansion in the Hodgkin Disease Protein Info, human (SLC6A4 wt Allele) gene on chromosome 4p., Huntington Disease (Hodgkin Disease) is a polyglutamine disorder caused by a CAG expansion in the Huntingtin (SLC6A4 wt Allele) gene exon 1., IMPORTANCE\n\nHuntington disease (Hodgkin Disease), a prototypic monogenic disease, is caused by an expanded CAG repeat in the SLC6A4 wt Allele gene exceeding 35 units., Huntington Disease (Hodgkin Disease) is an Autosome dominantly inherited disorder caused by the expansion of CAG repeats in the Huntingtin (SLC6A4 wt Allele) gene., Huntington Disease (Hodgkin Disease) is a Neurodegenerative Disorders caused by a CAG trinucleotide repeat expansion in the Hodgkin Disease Protein Info, human (SLC6A4 wt Allele) gene., BACKGROUND Huntington Disease is caused by a CAG repeat expansion in the SLC6A4 wt Allele gene, SLC6A4 wt Allele., Huntington Disease (Hodgkin Disease) is an inherited neurodegenerative disease caused by an expanded CAG repeat in the SLC6A4 wt Allele gene., IMPORTANCE Huntington disease (Hodgkin Disease), a prototypic monogenic disease, is caused by an expanded CAG repeat in the SLC6A4 wt Allele gene exceeding 35 units., Huntington 's disease ( Hodgkin Disease ) is an inherited Neurodegenerative Disorders caused by a CAG repeat expansion within exon 1 of the Hodgkin Disease Protein Info, human ( SLC6A4 wt Allele ) gene. , Huntington 's disease ( Hodgkin Disease) , a dominantly inherited neurodegenerative disease , is defined by its genetic cause , a CAG-repeat expansion in the SLC6A4 wt Allele gene , its motor and psychiatric symptomology and primary loss of striatal medium spiny neurons ( MSNs) . , Huntington 's disease ( Hodgkin Disease ) is an incurable Neurodegenerative Disorders caused by a CAG repeat expansion in exon 1 of the Huntingtin ( SLC6A4 wt Allele ) gene. , Huntington 's disease ( Hodgkin Disease ) is a progressive Neurodegenerative Disorders caused by a CAG trinucleotide repeat expansion in the Hodgkin Disease Protein Info, human ( SLC6A4 wt Allele ) gene , which encodes a polyglutamine tract in the SLC6A4 wt Allele Protein Info . , Huntington 's disease ( Hodgkin Disease ) is an Autosome progressive Neurodegenerative Disorders caused by the expansion of CAG repeats in the SLC6A4 wt Allele gene. , Huntington 's disease ( Hodgkin Disease ) is an Autosome dominant neurodegenerative disease caused by the expansion of a CAG trinucleotide repeat in exon 1 of the Hodgkin Disease Protein Info, human ( htt ) gene. , Huntington 's disease ( Hodgkin Disease) , caused by a CAG repeat expansion in the Hodgkin Disease Protein Info, human ( SLC6A4 wt Allele ) gene , is characterized by abnormal Protein Info aggregates and motor and Impaired cognition . , Huntington 's disease ( Hodgkin Disease ) is a neurodegenerative disease caused by the expansion of a CAG trinucleotide repeat in exon 1 of the Hodgkin Disease Protein Info, human ( SLC6A4 wt Allele ) gene. , Huntington 's disease ( Hodgkin Disease ) is an Autosome disease caused by a CAG repeat expansion in the Hodgkin Disease Protein Info, human ( SLC6A4 wt Allele ) gene. , BACKGROUND\nHuntington Disease is caused by a CAG repeat expansion in the SLC6A4 wt Allele gene, SLC6A4 wt Allele., Huntington Disease (Hodgkin Disease) is an Autosome dominant disorder caused by an expansion in the trinucleotide CAG repeat in exon-1 in the SLC6A4 wt Allele gene, located on Chromosomes, Human, Pair 4., Hodgkin Disease is caused by expansion of the CAG trinucleotide repeat region in exon 1 of the Huntingtin gene (SLC6A4 wt Allele), leading to the formation of mutant SLC6A4 wt Allele transcripts (muHTT)., Huntington Disease (Hodgkin Disease) is a Neurodegenerative Disorders characterized by involuntary choreic movements, No No cognitive impairment, and behavioral changes, caused by the expansion of an unstable CAG repeat in SLC6A4 wt Allele., Huntington disease (Hodgkin Disease), the most common inherited cause of chorea, is an Autosome dominant disorder, caused by an expanded trinucleotide CAG repeat (>39) in the SLC6A4 wt Allele gene on 4p16.3 chromosome., Huntington Disease (Hodgkin Disease) is an inherited neurodegenerative disease caused by an expanded CAG repeat in the Hodgkin Disease Protein Info, human (SLC6A4 wt Allele) gene.[SEP]Relations: Huntington disease has relations: disease_protein with SLC6A4 wt Allele, disease_protein with SLC6A4 wt Allele, disease_protein with OGG1, disease_protein with OGG1, disease_disease with Huntington disease and related disorders, disease_disease with Huntington disease and related disorders, disease_protein with GDNF, disease_protein with GDNF, disease_protein with CNR1, disease_protein with CNR1. Definitions: Chromosomes, Human, Pair 4 defined as following: A specific pair of GROUP B CHROMOSOMES of the human chromosome classification.. Mental deterioration defined as following: Loss of previously present mental abilities, generally in adults. [HPO:probinson]. SLC6A4 wt Allele gene defined as following: This gene may be involved in vesicle transport.. Neurodegenerative Disorders defined as following: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.. Hodgkin Disease Protein Info, human defined as following: Huntingtin (3144 aa, ~348 kDa) is encoded by the human SLC6A4 wt Allele gene. This Protein Info may be involved in the regulation of vesicular transport.. SLC6A4 wt Allele defined as following: Human SLC6A4 wild-type allele is located in the vicinity of 17q11.2 and is approximately 42 kb in length. This allele, which encodes sodium-dependent serotonin transporter Protein Info, plays a role in serotonin uptake. Polymorphism in the promoter region affects gene expression and lower gene expression is associated with depression. Coding region variations are associated with genetic susceptibility to both obsessive-compulsive disorder and alcoholism.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. Huntington Disease defined as following: A familial disorder inherited as an Autosome dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4). Impaired cognition defined as following: Interference or disruption of cognitive processes. This term encompasses a large number of problems and issues associated with intellectual functioning and information processing. 2005. Autosome defined as following: Any chromosome other than a sex chromosome. [GOC:mah]. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Hodgkin Disease defined as following: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.. Autosome dominant disorder defined as following: An inherited disorder that manifests when one copy of a mutated gene is present.. SLC6A4 wt Allele gene defined as following: This gene may be involved in vesicle transport.. Chromosome 4 defined as following: A specific pair of GROUP B CHROMOSOMES of the human chromosome classification..", "label": "no"} {"original_question": "Is amiodarone a class I anti-arrhythmic drug?", "id": "converted_142", "sentence1": "Is amiodarone a Canadian Cardiovascular Society Grading Scale Class I Antiarrhythmic [EPC] drug?", "sentence2": "Common Canadian Cardiovascular Society Grading Scale Class I agents are excluded due to the inherent abnormal cardiac structure and function in the setting of Shock, Cardiogenic. Class III drug options include dofetilide and amiodarone., Amiodarone has been used as an Antiarrhythmic [EPC] drug since the 1970s and has an established role in the treatment of Ventricular tachyarrhythmia. Although considered to be a Canadian Cardiovascular Society Grading Scale Class III Antiarrhythmic [EPC], amiodarone also has Canadian Cardiovascular Society Grading Scale Class I, II and IV actions, which gives it a unique pharmacological and Antiarrhythmic [EPC] profile. , Amiodarone, an iodinated Benzofurans derivative, introduced in 1960's as an anti-anginal agent, emerged as a potent Anti-Arrhythmia Agents by 1970's and is currently one of the most commonly prescribed drugs in US for ventricular and Atrial arrhythmia. Although amiodarone is considered a Canadian Cardiovascular Society Grading Scale Class III Anti-Arrhythmia Agents, it also has Canadian Cardiovascular Society Grading Scale Class I, II, IV actions, making it a unique and effective Anti-Arrhythmia Agents., Amiodarone, a representative Canadian Cardiovascular Society Grading Scale Class III agent, exerts negative dromotropism by suppressing the fast sodium current responsible for conduction in acute administration (Canadian Cardiovascular Society Grading Scale Class I effects). Chronic amiodarone causes prolongation of Endoscopic Retrograde Cholangiopancreatography (Canadian Cardiovascular Society Grading Scale Class III effects), which is sometimes associated with negative dromotropism based on the alteration of passive or active membrane properties., Amiodarone, an iodinated Benzofurans derivative with predominantly Canadian Cardiovascular Society Grading Scale Class III Antiarrhythmic [EPC] effects, is used to treat supraventricular and Ventricular arrhythmia., Although amiodarone is considered a Canadian Cardiovascular Society Grading Scale Class III Anti-Arrhythmia Agents, it also has Canadian Cardiovascular Society Grading Scale Class I, II, IV actions, making it a unique and effective Anti-Arrhythmia Agents, Amiodarone, a Canadian Cardiovascular Society Grading Scale Class III antiarrhythmic drug, is one of the most effective drugs used in the treatment of ventricular and paroxysmal supraventricular tachyarrhythmia, Although amiodarone is considered a Canadian Cardiovascular Society Grading Scale Class III Anti-Arrhythmia Agents, it also has Canadian Cardiovascular Society Grading Scale Class I, II, IV actions, making it a unique and effective Anti-Arrhythmia Agents, Although considered to be a Canadian Cardiovascular Society Grading Scale Class III Antiarrhythmic [EPC], amiodarone also has Canadian Cardiovascular Society Grading Scale Class I, II and IV actions, which gives it a unique pharmacological and Antiarrhythmic [EPC] profile, Amiodarone is a potent Canadian Cardiovascular Society Grading Scale Class III Antiarrhythmic [EPC] drug that also possesses beta-blocking properties[SEP]Relations: Amiodarone has relations: drug_effect with Arrhythmia, drug_effect with Arrhythmia, drug_drug with Antipyrine, drug_drug with Antipyrine, drug_drug with Erythromycin, drug_drug with Erythromycin, drug_drug with Arformoterol, drug_drug with Arformoterol, drug_drug with Estrone, drug_drug with Estrone. Definitions: dofetilide defined as following: A sulfonamide Canadian Cardiovascular Society Grading Scale Class III antiarrhythmic agent and potassium channel blocker. Dofetilide selectively blocks cardiac ion channels of the rapid component of the delayed rectifier potassium current Ikr. This antiarrhythmic agent prolongs cardiac action potential duration and effective refractory period due to delayed repolarization without affecting conduction velocity. This results in a normal sinus rhythm. Dofetilide is used in the treatment of atrial fibrillation and flutter.. Endoscopic Retrograde Cholangiopancreatography defined as following: Fiberoptic endoscopy designed for duodenal observation and cannulation of VATER'S AMPULLA, in order to visualize the pancreatic and biliary duct system by retrograde injection of contrast media. Endoscopic (Vater) papillotomy (SPHINCTEROTOMY, ENDOSCOPIC) may be performed during this procedure.. Anti-Arrhythmia Agents defined as following: Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.. Benzofurans defined as following: Compounds that contain a BENZENE ring fused to a furan ring.. amiodarone defined as following: An antianginal and Canadian Cardiovascular Society Grading Scale Class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.. Ventricular arrhythmia defined as following: A disorder characterized by an electrocardiographic finding of an atypical cardiac rhythm resulting from a pathologic process in the cardiac ventricles.. Shock, Cardiogenic defined as following: Shock resulting from diminution of cardiac output in heart disease.. Canadian Cardiovascular Society Grading Scale Class I defined as following: A grading of angina such that ordinary physical activity, such as walking or climbing stairs, does not cause angina. Angina occurs with strenuous, rapid, or prolonged exertion at work or recreation.. Canadian Cardiovascular Society Grading Scale Class III defined as following: A grading of angina characterized by marked limitations of ordinary physical activity. Angina occurs on walking 1 to 2 blocks on the level and climbing 1 flight of stairs in normal conditions and at a normal pace.. Atrial arrhythmia defined as following: An electrocardiographic finding of an atypical cardiac rhythm resulting from a pathologic process in the cardiac atria..", "label": "no"} {"original_question": "Is metabolic syndrome related with cardiovascular disease?", "id": "converted_835", "sentence1": "Is Metabolic Syndrome X related with Cardiovascular Diseases?", "sentence2": "The Metabolic Syndrome X (ETV3 wt Allele) is characterized by a cluster of risk factors including central obesity, Hypertensive disease, Dyslipidemias and insulin resistance, The ETV3 wt Allele is associated with an increased risk for Cardiovascular Diseases (Cerebrovascular Disorders) and type 2 diabetes mellitus (T2DM). , As a molecular link between metabolic signals, Inflammation, and vascular dysfunction, RETN protein, human can be proposed as playing a significant role in the heightened inflammatory state induced by metabolic stress linked to excessive caloric intake, thus contributing to the risk for Metabolic Syndrome X (ETV3 wt Allele), type 2 diabetes (T2DM), and Cardiovascular Diseases (Cerebrovascular Disorders). , The Metabolic Syndrome X (ETV3 wt Allele) is associated with a higher risk for both, type 2 diabetes mellitus and Cardiovascular Diseases. , arotid intima-media thickness (CIMT) has been widely used as a surrogate marker of Arteriosclerosis and Cardiovascular Diseases (Cerebrovascular Disorders)[SEP]Relations: Metabolic Syndrome X X has relations: disease_disease with Metabolic Syndrome X, disease_disease with Metabolic Syndrome X, disease_disease with abdominal obesity-Metabolic Syndrome X, disease_disease with abdominal obesity-Metabolic Syndrome X, disease_disease with inborn errors of metabolism, disease_disease with inborn errors of metabolism. Cardiovascular Diseases has relations: disease_disease with heart disease, disease_disease with heart disease, disease_disease with vascular disease, disease_disease with vascular disease. Definitions: RETN protein, human defined as following: Resistin (108 aa, ~11 kDa) is encoded by the human RETN gene. This protein plays a role in the regulation of insulin-mediated glucose metabolism.. ETV3 wt Allele defined as following: Human ETV3 wild-type allele is located within 1q21-q23 and is approximately 17 kb in length. This allele, which encodes ETS translocation variant 3 protein, is involved in the repression of transcription by RNA polymerase II.. Hypertensive disease defined as following: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), Hypertensive disease is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.. Arteriosclerosis defined as following: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. Cardiovascular Diseases defined as following: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.. Cerebrovascular Disorders defined as following: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.. Metabolic Syndrome X defined as following: A combination of medical conditions that when present, increase the risk of heart attack, stroke, and diabetes mellitus. It includes the following medical conditions: increased blood pressure, central obesity, Dyslipidemias, impaired glucose tolerance, and insulin resistance.. Dyslipidemias defined as following: A lipoprotein metabolism disorder characterized by decreased levels of high-density lipoproteins, or elevated levels of plasma cholesterol, low-density lipoproteins and/or triglycerides..", "label": "yes"} {"original_question": "Has amantadine ER been approved by the FDA?", "id": "converted_3583", "sentence1": "Has amantadine Endoplasmic Reticulum been approved by the FDA?", "sentence2": "ADS-5102 (amantadine) extended-release (Endoplasmic Reticulum) capsules (GOCOVRITM) is a recent US FDA-approved treatment for Dyskinetic syndrome in Lugano Lymphoma Response Classification Progressive Disease by PET patients. [SEP]Relations: Amantadine has relations: drug_drug with Ergometrine, drug_drug with Ergometrine, drug_drug with Ergotamine, drug_drug with Ergotamine, drug_drug with Ertapenem, drug_drug with Ertapenem, drug_drug with Eribulin, drug_drug with Eribulin, drug_drug with Erdafitinib, drug_drug with Erdafitinib. Definitions: amantadine defined as following: An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake.. Lugano Lymphoma Response Classification Progressive Disease by PET defined as following: A score of 4 or 5 on a 5-point PET scale with an increase in intensity of uptake from baseline and/or new FDG-avid foci consistent with lymphoma at interim or end of treatment assessment.. Dyskinetic syndrome defined as following: Abnormal involuntary movements which primarily affect the extremities, trunk, or jaw that occur as a manifestation of an underlying disease process. Conditions which feature recurrent or persistent episodes of Dyskinetic syndrome as a primary manifestation of disease may be referred to as Dyskinetic syndrome syndromes (see MOVEMENT DISORDERS). Dyskinesias are also a relatively common manifestation of BASAL GANGLIA DISEASES.. Endoplasmic Reticulum defined as following: A system of cisternae in the CYTOPLASM of many cells. In places the endoplasmic reticulum is continuous with the plasma membrane (CELL MEMBRANE) or outer membrane of the nuclear envelope. If the outer surfaces of the endoplasmic reticulum membranes are coated with ribosomes, the endoplasmic reticulum is said to be rough-surfaced (ENDOPLASMIC RETICULUM, ROUGH); otherwise it is said to be smooth-surfaced (ENDOPLASMIC RETICULUM, SMOOTH). (King & Stansfield, A Dictionary of Genetics, 4th ed).", "label": "yes"} {"original_question": "Is there an association between FGFR3 mutation and plagiocephaly?", "id": "converted_703", "sentence1": "Is there an association between FGFR3 protein, human Mutation Abnormality and Plagiocephaly?", "sentence2": "Series of neurosurgical interventions were carried out, principally for Acrocephaly and posterior Plagiocephaly. The most common Achondroplasia Mutation Abnormality, a p.Gly380Arg in the Fibroblast Growth Factor Receptors (FGFR3 protein, human protein, human) gene, was detected. , The most common Mutation Abnormality for Achondroplasia (FGFR3 protein, human protein, human Gly380Arg, resulting in 1138G>A) was identified. Imaging studies disclosed complex CRANIOSYNOSTOSIS, TYPE 2 and neurosurgical intervention was carried out, particularly for posterior Plagiocephaly., FGFR mutations and Plagiocephaly., FGFR genes have important effects on bone development, and mutations in 4 \"hot spot\" Exons of FGFR1 protein, human protein, human-3 are found in many patients with CRANIOSYNOSTOSIS, TYPE 2 and some with synostotic Plagiocephaly. , Mutation analyses in the FGFR3 protein, human protein, human gene revealed nucleotide alterations located in the mutational hot spot at Amino Acid [EPC] residue 250 (g.C749)., RESULTS: In our cohort of 159 patients with various CRANIOSYNOSTOSIS, TYPE 2 syndromes, mutations were found in 100% of patients with Apert syndrome, 83.3% with Pfeiffer Syndrome, 72.7% with Craniofacial dysostosis type 1, 50.0% with Saethre-Chotzen syndrome, 27.7% with Plagiocephaly, 31.8% with brachicephaly, 20% of complex cases, and 6.9% of mixed cases. , The Mutation that could cause unilateral Coronal synostosis are more elusive., Gene Mutation were found in eight of 47 patients: two patients with different single-amino-acid changes in Fibroblast Growth Factor Receptor 2, three patients with FGFR3 protein, human protein, human Pro250Arg, and three patients with Musculoskeletal torsion, function mutations. , Other abnormalities in the craniofacial region and All All extremities were clues to a particular Mutation Abnormality in Fibroblast Growth Factor Receptor 2, FGFR3 protein, human protein, human, Musculoskeletal torsion, function, or the X-linked Mutation Abnormality. , To determine whether the autosomal dominant Fibroblast Growth Factor Receptors (FGFR3 protein, human protein, human) Pro250Arg Mutation Abnormality causes anterior Plagiocephaly, patients with either apparently sporadic Unicoronal synostosis (N = 37) or other forms of anterior Plagiocephaly (N = 10) were studied for this Mutation Abnormality., The occurrence of the FGFR3 protein, human protein, human Mutation Abnormality among patients with Unicoronal synostosis provides evidence for a genetic basis of certain forms of Plagiocephaly., None of the 6 patients with nonsynostotic Plagiocephaly and none of the 4 patients with additional suture synostosis had the FGFR3 protein, human protein, human Mutation Abnormality., Between January and December of 1996, patients with a diagnosis of Plagiocephaly at the Children's Hospital of Philadelphia were evaluated for the FGFR3 protein, human protein, human Mutation Abnormality., Between January and December of 1996, patients with a diagnosis of Plagiocephaly at the Children's Hospital of Philadelphia were evaluated for the FGFR3 protein, human protein, human Mutation Abnormality, FGFR genes have important effects on bone development, and mutations in 4 "hot spot" Exons of FGFR1 protein, human protein, human-3 are found in many patients with CRANIOSYNOSTOSIS, TYPE 2 and some with synostotic Plagiocephaly, To determine whether the autosomal dominant Fibroblast Growth Factor Receptors (FGFR3 protein, human protein, human) Pro250Arg Mutation Abnormality causes anterior Plagiocephaly, patients with either apparently sporadic Unicoronal synostosis (N = 37) or other forms of anterior Plagiocephaly (N = 10) were studied for this Mutation Abnormality, None of the 6 patients with nonsynostotic Plagiocephaly and none of the 4 patients with additional suture synostosis had the FGFR3 protein, human protein, human Mutation Abnormality, The occurrence of the FGFR3 protein, human protein, human Mutation Abnormality among patients with Unicoronal synostosis provides evidence for a genetic basis of certain forms of Plagiocephaly, FGFR mutations and Plagiocephaly, Between January and December of 1996, patients with a diagnosis of Plagiocephaly at the Children's Hospital of Philadelphia were evaluated for the FGFR3 protein, human protein, human Mutation Abnormality. , None of the 6 patients with nonsynostotic Plagiocephaly and none of the 4 patients with additional suture synostosis had the FGFR3 protein, human protein, human Mutation Abnormality. , The occurrence of the FGFR3 protein, human protein, human Mutation Abnormality among patients with Unicoronal synostosis provides evidence for a genetic basis of certain forms of Plagiocephaly. , To determine whether the autosomal dominant Fibroblast Growth Factor Receptors (FGFR3 protein, human protein, human) Pro250Arg Mutation Abnormality causes anterior Plagiocephaly, patients with either apparently sporadic Unicoronal synostosis (N = 37) or other forms of anterior Plagiocephaly (N = 10) were studied for this Mutation Abnormality. Of 37 patients with Unicoronal synostosis, 4 tested positive for the Pro250Arg Mutation Abnormality in FGFR3 protein, human protein, human, and 33 were negative for this Mutation Abnormality., To determine whether the autosomal dominant Fibroblast Growth Factor Receptors (FGFR3 protein, human protein, human) Pro250Arg Mutation Abnormality causes anterior Plagiocephaly, patients with either apparently sporadic Unicoronal synostosis (N = 37) or other forms of anterior Plagiocephaly (N = 10) were studied for this Mutation Abnormality., In a girl with seemingly isolated Plagiocephaly we identified a P250L (749C-->T) Mutation Abnormality in FGFR3 protein, human protein, human., FGFR mutations and Plagiocephaly., None of the 6 patients with nonsynostotic Plagiocephaly and none of the 4 patients with additional suture synostosis had the FGFR3 protein, human protein, human Mutation Abnormality., The occurrence of the FGFR3 protein, human protein, human Mutation Abnormality among patients with Unicoronal synostosis provides evidence for a genetic basis of certain forms of Plagiocephaly.[SEP]Relations: FGFR3 protein, human has relations: disease_protein with isolated Plagiocephaly, disease_protein with isolated Plagiocephaly, disease_protein with polydactyly (disease), disease_protein with polydactyly (disease), disease_protein with epilepsy, disease_protein with epilepsy, protein_protein with FGF1, protein_protein with FGF1. Plagiocephaly has relations: disease_phenotype_positive with FG syndrome, disease_phenotype_positive with FG syndrome. Definitions: Mutation defined as following: Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.. FGFR3 protein, human defined as following: Fibroblast growth factor receptor 3 (806 aa, ~88 kDa) is encoded by the human FGFR3 protein, human gene. This protein is involved in fibroblast growth factor signaling and skeletal development.. CRANIOSYNOSTOSIS, TYPE 2 defined as following: A form of syndromic CRANIOSYNOSTOSIS, TYPE 2 with characteristics of highly variable CRANIOSYNOSTOSIS, TYPE 2 with frontal bossing, turribrachycephaly and cloverleaf skull anomaly. Hypoplasia of the supraorbital ridges, cleft palate, extra teeth and limb anomalies has also been described. Associated problems include headache, poor vision, and seizures. Intelligence is normal.. Plagiocephaly defined as following: The condition characterized by uneven or irregular shape of the head often in parallelogram shape with a flat spot on the back or one side of the head. It can either result from the premature CRANIAL SUTURE closure (CRANIOSYNOSTOSIS) or from external forces (NONSYNOSTOTIC PLAGIOCEPHALY).. Acrocephaly defined as following: Premature closing of the lambdoid and coronal sutures.. Achondroplasia defined as following: An autosomal dominant disorder that is the most frequent form of short-limb dwarfism. Affected individuals exhibit short stature caused by rhizomelic shortening of the limbs, characteristic facies with frontal bossing and mid-face hypoplasia, exaggerated lumbar lordosis, limitation of elbow extension, GENU VARUM, and trident hand. (Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM#100800, April 20, 2001). Unicoronal synostosis defined as following: Synostosis affecting only one of the coronal sutures. [DDD:awilkie]. Musculoskeletal torsion, function defined as following: A motion or state where one end of a part is twisted about a longitudinal axis while the opposite end is held fast or turned in the opposite direction.. Fibroblast Growth Factor Receptors defined as following: A fibroblast growth factor receptor with specificity for FIBROBLAST GROWTH FACTORS; HEPARAN SULFATE PROTEOGLYCAN; and NEURONAL CELL ADHESION MOLECULES. Several variants of the receptor exist due to multiple ALTERNATIVE SPLICING of its mRNA. Fibroblast growth factor receptor 1 contains three extracellular IMMUNOGLOBULIN C2-SET DOMAINS and is a tyrosine kinase that transmits signals through the MAP KINASE SIGNALING SYSTEM.. anterior Plagiocephaly defined as following: Asymmetry of the anterior part of the skull. [DDD:awilkie]. Fibroblast Growth Factor Receptor 2 defined as following: A fibroblast growth factor receptor which contains three extracellular IMMUNOGLOBULIN I-SET DOMAINS and is expressed as two isoforms. One receptor isoform is expressed in the MESENCHYME and is activated by FIBROBLAST GROWTH FACTOR 2. A second isoform is expressed mainly by EPITHELIAL CELLS and is activated by FIBROBLAST GROWTH FACTOR 7 and FIBROBLAST GROWTH FACTOR 10. Mutation of the gene for fibroblast growth factor receptor 2 can result in craniosynostotic syndromes (e.g., APERT SYNDROME; and CROUZON SYNDROME).. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Gene Mutation may be associated with genetic diversity or with pathologies including cancer.. Pfeiffer Syndrome defined as following: An autosomal dominant inherited type of acrocephalosyndactyly caused by mutations in the FGFR1 protein, human or Fibroblast Growth Factor Receptor 2 genes. It is characterized by early closure of the sutures between the skull bones, bulging and wide-set eyes, broad thumbs, big toes, and partial syndactyly in the hands and toes.. FGFR3 protein, human gene defined as following: This gene plays a role in bone development and maintenance and mutations in the gene are associated with CRANIOSYNOSTOSIS, TYPE 2 and several types of skeletal dysplasia.. Philadelphia defined as following: City located in Pennsylvania.. nonsynostotic Plagiocephaly defined as following: A deformity of the SKULL that is not due to bone fusion (SYNOSTOSIS), such as craniosynostoses, and is characterized by an asymmetric skull and face. It is observed with an increased frequency in INFANTS after the adoption of supine sleeping recommendations to prevent SUDDEN INFANT DEATH SYNDROME.. Exons defined as following: The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA.. FGFR1 protein, human defined as following: Fibroblast growth factor receptor 1 (822 aa, ~92 kDa) is encoded by the human FGFR1 protein, human gene. This protein is involved in the regulation of embryonic development, cell proliferation, cell differentiation and cellular migration.. Apert syndrome defined as following: An autosomal dominant inherited type of acrocephalosyndactyly caused by mutations in the Fibroblast Growth Factor Receptor 2 gene. It is characterized by early closure of the sutures between the skull bones, bulging eyes, low-set ears, fusion of the second, third, and forth fingers, and fusion of the toes.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA..", "label": "yes"} {"original_question": "Is ozanezumab effective for amyotrophic lateral sclerosis?", "id": "converted_3431", "sentence1": "Is ozanezumab effective for amyotrophic lateral sclerosis?", "sentence2": "The adjusted mean of the joint-rank score was -14·9 (SE 13·5) for the ozanezumab group and 15·0 (13·6) for the placebo group, with a least squares mean difference of -30·0 (95% CI -67·9 to 7·9; p=0·12). , INTERPRETATION: Ozanezumab did not show efficacy compared with placebo in patients with Amyotrophic Lateral Sclerosis. Therefore, Nogo-A does not seem to be an effective therapeutic target in Amyotrophic Lateral Sclerosis., INTERPRETATION\n\nOzanezumab did not show efficacy compared with placebo in patients with Amyotrophic Lateral Sclerosis., The adjusted mean of the joint-rank score was -14·9 (SE 13·5) for the ozanezumab group and 15·0 (13·6) for the placebo group, with a least squares mean difference of -30·0 (95% CI -67·9 to 7·9; p=0·12)., INTERPRETATION Ozanezumab did not show efficacy compared with placebo in patients with Amyotrophic Lateral Sclerosis., The adjusted mean of the joint-rank score was -14·9 (SE 13·5) for the ozanezumab group and 15·0 (13·6) for the placebo group, with a least squares mean difference of -30·0 (95% CI -67·9 to 7·9; p=0·12).[SEP]Relations: amyotrophic lateral sclerosis has relations: disease_protein with TIAM1, disease_protein with TIAM1, disease_protein with WNT7A, disease_protein with WNT7A, disease_protein with SLC6A1, disease_protein with SLC6A1, disease_protein with CHMP2B, disease_protein with CHMP2B, disease_protein with TMSB4X, disease_protein with TMSB4X. Definitions: Amyotrophic Lateral Sclerosis defined as following: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94). amyotrophic lateral sclerosis defined as following: An inherited form of amyotrophic lateral sclerosis, usually inherited in an autosomal dominant pattern, caused by mutation(s) in the SOD1 gene, encoding superoxide dismutase..", "label": "no"} {"original_question": "Is the 22-item sino-nasal outcome test (SNOT-22) a widely used measure for Health-Related Quality-of-Life (HRQOL) associated with chronic rhinosinusitis (CRS)?", "id": "converted_4421", "sentence1": "Is the 22-item sino-nasal outcome test (SNOT-22) a widely used measure for Health-Related Quality-of-Life (HRQOL) associated with Chronic sinusitis (Congenital Rubella Syndrome)?", "sentence2": "The Sino-Nasal-Outcome-Test-22 (SNOT-22) represents the reference questionnaire to assess symptoms, health-related quality-of-life (HRQOL) and treatment-response in patients with Chronic sinusitis (Congenital Rubella Syndrome). , Assessment of health-related quality-of-life in patients with chronic Rhinosinusitis - Validation of the German Sino-Nasal Outcome Test-22 (German-SNOT-22)., Patients meeting diagnostic criteria for Congenital Rubella Syndrome were prospectively enrolled in a cross-sectional study. Responses from the Sinonasal Outcomes Test-22 (SNOT-22), a measure of patient HRQOL, as well as the Lund-Kennedy and Lund-Mackay scores were recorded at enrollment, Three groups of 12 participants each were examined: patients with Congenital Rubella Syndrome without Multiple polyps (Congenital Rubella Syndrome group), patients with symptoms of Congenital Rubella Syndrome but radiologically normal sinuses (symptoms-only), and healthy controls. Measurements of Nynorsk Language were carried out using aspiration method and humming maneuver. All participants completed the Sino-Nasal Outcome Test (SNOT-22)., PURPOSE: The Sino-Nasal-Outcome-Test-22 (SNOT-22) represents the reference questionnaire to assess symptoms, health-related quality-of-life (HRQOL) and treatment-response in patients with Chronic sinusitis (Congenital Rubella Syndrome)., tcomes included scores on the Congenital Rubella Syndrome disease severity visual analog scale (VAS), 22-item Sino-Nasal Outcome Test (SNOT-22), 5-dimension EuroQoL (EQ-5D) general health status VAS, and 36-item Short-Form Health Survey (SF-36) for HRQoL and nasal polyp-related healthcare resource use questionnaires.RE, BACKGROUND: The 22-item Sino-Nasal Outcome Test (SNOT-22) is a commonly utilized outcome measure for chronic rhinosinus, BACKGROUND: The 22-item sino-nasal outcome test (SNOT-22) is a widely used and powerful patient-reported outcomes measure for chronic rhinosinus, BACKGROUND: Prior study demonstrated that baseline 22-item Sino-Nasal Outcome Test (SNOT-22) aggregate scores accurately predict selection of surgical intervention in patients with chronic rhinosinus, OBJECTIVES/HYPOTHESIS: Sinonasal Outcomes Test-22 (SNOT-22) is used widely as a patient-reported sinonasal quality-of-life (QOL) instrument for endoscopic endonasa, Is sino-nasal outcome test-22 reliable for guiding Chronic sinusitis patients for endoscopic sinus surgery, The Sino-Nasal Outcome Test-22 as a tool to identify Chronic sinusitis in adults with cystic fibrosis, rden. Our objective was to investigate the utility of the 22-item Sino-Nasal Outcome Test (SNOT-22) as a tool to identify Congenital Rubella Syndrome in adults wit, OBJECTIVES/HYPOTHESIS: The 22-item Sinonasal Outcome Test (SNOT-22) is a validated Chronic sinusitis health-related quality-of-life outcome (HRQoL) measure; however, SNOT-22 domains have not been validated specifically for Chronic sinusitis with Non-Alcoholic Fatty Liver Disease Activity Score, OBJECTIVE: The SNOT-22 (22-item Sinonasal Outcome Test) is a high-quality outcome measure that assesses Chronic sinusitis-specific quality of leukemia inhibitory factor, BACKGROUND: The 22-item sino-nasal outcome test (SNOT-22) is a widely used and powerful patient-reported outcomes measure for Chronic sinusitis (Congenital Rubella Syndrome, OBJECTIVES/HYPOTHESIS: The 22-item Sinonasal Outcome Test (SNOT-22) is a validated Chronic sinusitis health-related quality-of-life outcome (HRQoL) measure; however, SNOT-22 domains have not been validated specifically for Chronic sinusitis with nasal polyps (CRSwNP, BACKGROUND: The 22-item Sino-Nasal Outcome Test (SNOT-22) is a commonly utilized outcome measure for Chronic sinusitis (Congenital Rubella Syndrome, OBJECTIVES/HYPOTHESIS: The 22-item Sinonasal Outcome Test (SNOT-22) is a validated Chronic sinusitis health-related quality-of-life outcome (HRQoL) measure; however, SNOT-22 domains have not been validated specifically for Chronic sinusitis with nasal polyps (CRSwNP).STUDY DESIGN: Validation of SNOT-22 domain structure, using data from 3 randomized, placebo-controlled, double-blinded, multicenter clinical trials of dupilumab in adults with moderate-to-severe CRSwNP.METHODS: Preliminary dimensional structure was derived by exploratory factor analyses of SNOT-22 data from a phase 2 trial (NCT01920, OBJECTIVES: We set out to determine the psychometric validation of a disease-specific health related quality of life instrument for use in Chronic sinusitis, the 22 item Sinonasal Outcome Test (SNOT-22), a ResponseLevel - ResponseLevel - modification of a pre-existing instrument, the SNOT-20.DESIGN, SETTING AND PARTICIPANTS: The National Comparative Audit of Surgery for Nasal Polyposis and Chronic Rhinosinusitis was a prospective cohort study collecting data on 3128 adult patients undergoing sinonasal sur, OBJECTIVE: The SNOT-22 (22-item Sinonasal Outcome Test) is a high-quality outcome measure that assesses Chronic sinusitis-specific quali, act of Congenital Rubella Syndrome. We sought to determine if 22-item Sino-Nasal Outcome Test (SNOT-22) score is predictive of patient-perceived Congenital Rubella Syndrome symptom control.METHODS: Prospective cross-sectional study of 2, The Sinonasal Outcome Test (SNOT-22) Is a Poor Diagnostic Tool for Chronic Rhinosinusitis., The 22-item Sino-Nasal Outcome Test accurately reflects patient-reported control of Chronic sinusitis symptomatology., Development of Sinonasal Outcome Test (SNOT-22) Domains in Chronic Rhinosinusitis With Nasal Polyps., cture with strong Cronbach's alpha values (all >0.80). Moderate-to-high correlations were observed between change in SNOT-22 domain scores and other study patient-reported outcome measures, along with large effect-size estimates (≥0.7), demonstrating re[SEP]Relations: Chronic sinusitis has relations: disease_phenotype_positive with Keutel syndrome, disease_phenotype_positive with Keutel syndrome, disease_phenotype_positive with familial nasal acilia, disease_phenotype_positive with familial nasal acilia. Nasal Multiple polyps has relations: drug_effect with Pramipexole, drug_effect with Pramipexole, drug_effect with Human calcitonin, drug_effect with Human calcitonin, drug_effect with Ropinirole, drug_effect with Ropinirole. Definitions: Nasal Polyps defined as following: Focal accumulations of EDEMA fluid in the NASAL MUCOSA accompanied by HYPERPLASIA of the associated submucosal connective tissue. Polyps may be NEOPLASMS, foci of INFLAMMATION, degenerative lesions, or malformations.. Chronic sinusitis defined as following: Inflammation of the paranasal sinuses that typically lasts beyond eight weeks. It is caused by infections, allergies, and the presence of sinus polyps or deviated septum. Signs and symptoms include headache, nasal discharge, swelling in the face, dizziness, and breathing difficulties.. leukemia inhibitory factor defined as following: An INTERLEUKIN-6 related cytokine that exhibits pleiotrophic effects on many physiological systems that involve cell proliferation, differentiation, and survival. Leukemia inhibitory factor binds to and acts through the leukemia inhibitory factor receptor.. Non-Alcoholic Fatty Liver Disease Activity Score defined as following: The histopathological evaluation of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) based on the NAFLD scoring system. (Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005 Jun;41(6):1313-21.). Congenital Rubella Syndrome defined as following: Transplacental infection of the fetus with rubella usually in the first trimester of pregnancy, as a consequence of maternal infection, resulting in various developmental abnormalities in the newborn infant. They include cardiac and ocular lesions, deafness, microcephaly, mental retardation, and generalized growth retardation. (From Dorland, 27th ed). ResponseLevel - modification defined as following:

Respond with exceptions, completions and modifications or revisions done before completion

. Multiple polyps defined as following: A condition characterized by the presence of numerous polyps.. Nynorsk Language defined as following: One of the two written standards of the Norwegian language.. dupilumab defined as following: A recombinant human monoclonal immunoglobulin G4 (IgG4) antibody directed against the alpha chain of the interleukin-4 receptor (IL-4R alpha) with potential immunomodulatory activities. Upon injection, dupilumab selectively binds to the IL-4R alpha chain. This disrupts IL-4/IL-13 signaling and prevents the activation of downstream pathways that mediate type 2 inflammation and may potentially inhibit tumor cell proliferation, survival, and metastasis. IL-4 and IL-13 receptors are present on the surface of numerous cells involved in the pathophysiology of type-2 helper T-cell (Th2) allergic responses, including B-lymphocytes, eosinophils, dendritic cells (DCs), monocytes, macrophages, basophils, keratinocytes, bronchial epithelial cells, endothelial cells, fibroblasts, and airway smooth muscle cells. Additionally, both IL-4 and IL-13 receptors are overexpressed in a variety of cancers and IL-4 and IL-13 and may serve as biomarkers for cancer aggressiveness. IL-4 and IL-13 are thought to be key regulatory cytokines in the tumor microenvironment (TME) and may play a role in the activation of tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs) that mediate tumor cell survival..", "label": "yes"} {"original_question": "Are deletions of chromosomal regulatory boundaries associated with congenital disease?", "id": "converted_1843", "sentence1": "Are Gene Deletion of chromosomal regulatory boundaries associated with Congenital Disorders?", "sentence2": "Deletions of chromosomal regulatory boundaries are associated with Congenital Disorders., Our results suggest that Enhancer of transcription adoption caused by Gene Deletion of regulatory boundaries may contribute to a substantial minority of copy-number variation phenotypes and should thus be taken into account in their medical interpretation, Deletions of chromosomal regulatory boundaries are associated with Congenital Disorders, Deletions of chromosomal regulatory boundaries are associated with Congenital Disorders.[SEP]Relations: congenital nervous system disorder has relations: disease_disease with chromosome 18q deletion syndrome, disease_disease with chromosome 18q deletion syndrome, disease_disease with chromosome 1p36 deletion syndrome, disease_disease with chromosome 1p36 deletion syndrome, disease_disease with chromosome 5q12 deletion syndrome, disease_disease with chromosome 5q12 deletion syndrome, disease_disease with chromosome 19p13.13 deletion syndrome, disease_disease with chromosome 19p13.13 deletion syndrome, disease_disease with chromosome 19q13.11 deletion syndrome, disease_disease with chromosome 19q13.11 deletion syndrome. Definitions: Gene Deletion defined as following: A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus.. Congenital Disorders defined as following: existing at, and usually before, birth; referring to conditions that are present at birth, regardless of their causation; inborn metabolism disorders are generally not treed here.. Enhancer of transcription defined as following: A 50-150bp DNA sequence that increases the rate of transcription of coding sequences. It may be located at various distances and in either orientation upstream from, downstream from or within a structural gene. When bound by a specific transcription factor it increases the levels of expression of the gene, but is not sufficient alone to cause expression. Distinguished from a promoter, that is alone sufficient to cause expression of the gene when bound..", "label": "yes"} {"original_question": "SGOT is an abbreviation for an enzyme other wise known as alanine amino transferase, yes or no?", "id": "converted_2420", "sentence1": "SGOT - Glutamate oxaloacetate transaminase is an abbreviation for an enzyme other wise known as D-Alanine Transaminase, yes or no?", "sentence2": "patients with aspartate amino transferase (SGOT - Glutamate oxaloacetate transaminase - Glutamate oxaloacetate transaminase), D-Alanine Transaminase (SGPT - Glutamate pyruvate transaminase - Glutamate pyruvate transaminase),, Alanine amino transferase (SGPT - Glutamate pyruvate transaminase - Glutamate pyruvate transaminase), , Aspartate Transaminase (AST-SGOT - Glutamate oxaloacetate transaminase - Glutamate oxaloacetate transaminase), alanine amino-transferase (ALT-SGPT - Glutamate pyruvate transaminase - Glutamate pyruvate transaminase), Mean values of Glutamate Dehydrogenase (glucose-6-phosphate dehydrogenase activity), serum aspartate and alanine transferase (SGOT - Glutamate oxaloacetate transaminase - Glutamate oxaloacetate transaminase and SGPT - Glutamate pyruvate transaminase - Glutamate pyruvate transaminase), ORNITHINE CARBAMOYLTRANSFERASE (OCT), and gamma-glutamyltranspeptidase (gamma-GTP) tended to rise with increasing Hepatocyte necrosis, though values of SGOT - Glutamate oxaloacetate transaminase - Glutamate oxaloacetate transaminase, SGPT - Glutamate pyruvate transaminase - Glutamate pyruvate transaminase, OCT, and gamma-GTP showed considerable overlap between the 32 patients with histologically proved Hepatitis and the 68 without., Serum Aspartate Transaminase (SGOT - Glutamate oxaloacetate transaminase - Glutamate oxaloacetate transaminase), Alanine Transaminase (SGPT - Glutamate pyruvate transaminase - Glutamate pyruvate transaminase), Creatine Kinase (PIK3C2A gene), and butyric acid dehydrogenase (BDH1 gene) were determined in 94 patients before, 1(1/2) hours, and 24 hours after cardioversion., The study excluded by screening for AntiHCV, Hepatitis B Antigen Vaccine and patients with aspartate amino transferase (SGOT - Glutamate oxaloacetate transaminase - Glutamate oxaloacetate transaminase), D-Alanine Transaminase (SGPT - Glutamate pyruvate transaminase - Glutamate pyruvate transaminase), Gamma-glutamyl transferase levels more than three times the normal and subject with a total Antigens, CD5 count more than 10,000/microl., Complete blood picture, differential Antigens, CD5 count, and serum levels of Estrogen [EPC] [EPC], Alanine amino transferase (SGPT - Glutamate pyruvate transaminase - Glutamate pyruvate transaminase), Aspartate amino transferase (SGOT - Glutamate oxaloacetate transaminase - Glutamate oxaloacetate transaminase), total protein and ALB gene were estimated.[SEP]Relations: glutamate pyruvate transaminase 2 deficiency has relations: disease_protein with GPT2, disease_protein with GPT2, disease_disease with syndromic intellectual disability, disease_disease with syndromic intellectual disability, disease_phenotype_positive with Nasogastric tube feeding in infancy, disease_phenotype_positive with Nasogastric tube feeding in infancy, disease_phenotype_positive with Broad-based gait, disease_phenotype_positive with Broad-based gait, disease_phenotype_positive with Absent speech, disease_phenotype_positive with Absent speech. Definitions: Glutamate Dehydrogenase defined as following: An enzyme that catalyzes the conversion of L-glutamate and water to 2-oxoglutarate and NH3 in the presence of NAD+. (From Enzyme Nomenclature, 1992) EC 1.4.1.2.. Aspartate Transaminase defined as following: Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.. SGOT - Glutamate oxaloacetate transaminase defined as following: A family of pyridoxal phosphate-dependent enzymes involved in amino acid metabolism and in the urea and tricarboxylic acid cycles. Aspartate aminotransferase specifically and reversibly catalyzes the transfer of an amino group from L-aspartate to alpha-ketoglutarate forming oxaloacetate and L-glutamate.. ORNITHINE CARBAMOYLTRANSFERASE defined as following: A urea cycle enzyme that catalyzes the formation of orthophosphate and L-citrulline (CITRULLINE) from CARBAMOYL PHOSPHATE and L-ornithine (ORNITHINE). Deficiency of this enzyme may be transmitted as an X-linked trait. EC 2.1.3.3.. glucose-6-phosphate dehydrogenase activity defined as following: Catalysis of the reaction: D-glucose 6-phosphate + NADP+ = D-glucono-1,5-lactone 6-phosphate + NADPH + H+. [EC:1.1.1.49]. D-Alanine Transaminase defined as following: A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the reversible transfer of an amino group between D-Alanine and alpha-ketoglutarate to form PYRUVATE and D-GLUTAMATE, respectively. It plays a role in the synthesis of the bacterial CELL WALL. This enzyme was formerly classified as EC 2.6.1.10.. Creatine Kinase defined as following: A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins.. Antigens, CD5 defined as following: Glycoproteins expressed on all mature T-cells, thymocytes, and a subset of mature B-cells. Antibodies specific for CD5 can enhance T-cell receptor-mediated T-cell activation. The B-cell-specific molecule CD72 is a natural ligand for CD5. (From Abbas et al., Cellular and Molecular Immunology, 2d ed, p156). Hepatocyte defined as following: The main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules.. Alanine Transaminase defined as following: An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2.. Hepatitis defined as following: INFLAMMATION of the LIVER.. Gamma-glutamyl transferase defined as following: An enzyme, sometimes called Gamma-glutamyl transferase, with a key role in the synthesis and degradation of GLUTATHIONE; (GSH, a tripeptide that protects cells from many toxins). It catalyzes the transfer of the gamma-glutamyl moiety to an acceptor amino acid..", "label": "no"} {"original_question": "Is Titin the largest single protein molecule found in Nature?", "id": "converted_1478", "sentence1": "Is Titin Kinase the largest single Protein Info molecule found in Nature?", "sentence2": "Titin Kinase Kinase, the largest Protein Info in the Human body structure, is well known as a molecular spring in Muscle Cells and scaffold Protein Info aiding myofibrillar assembly., Titin Kinase Kinase is the largest Protein Info in Mammals; it forms an elastic filament along the myofibril of Cardiac - anatomy qualifier and Skeletal muscle structure., Titin Kinase Kinase is recently known as the largest Protein Info which exists in the striated muscle Sarcomeres and is dynamic both in biomechanics properties and biochemical functions. , Titin Kinase Kinase, the largest Protein Info known to date, has been linked to Sarcomeres assembly and function through its elastic adaptor and signaling domains., The giant Sarcomeres Protein Info titin/connectin is the largest Protein Info known to date., Titin Kinase Kinase is the largest Protein Info known to date and acts as a mechanosensor that regulates muscle Protein Info expression in a Sarcomeres strain-dependent fashion., Titin Kinase Kinase is the largest Protein Info known, and is essential for organising muscle sarcomeres., It has many domains with a variety of functions, and stretches from the Z line to the M line in the muscle Sarcomeres. , Titin Kinase Kinase, is definitely the largest Protein Info in the body, with a molecular weight of 3 million Dalton and composed of 27,000 Antifibrinolytic Antifibrinolytic amino acids., Titin Kinase Kinase, the largest Protein Info identified to date (over 1 micron long, almost 3 million daltons in mass) is the third most abundant component of the Sarcomeres., Titin Kinase Kinase is the largest Polypeptides yet described (relative molecular mass approximately 3 x 10(6); refs 1, 2) and an abundant Protein Info of striated muscle., Titin Kinase Kinase is at present the largest known Protein Info (M(r) 3000 kDa) and its expression is restricted to Vertebrates striated muscle., Titin Kinase Kinase is the largest Protein Info known, and is essential for organising muscle sarcomeres, Titin Kinase Kinase is at present the largest known Protein Info (M(r) 3000 kDa) and its expression is restricted to Vertebrates striated muscle, Titin Kinase Kinase is the largest Polypeptides yet described (relative molecular mass approximately 3 x 10(6); refs 1, 2) and an abundant Protein Info of striated muscle, Titin Kinase Kinase is recently known as the largest Protein Info which exists in the striated muscle Sarcomeres and is dynamic both in biomechanics properties and biochemical functions, Titin Kinase Kinase, the biggest single (poly) peptide found in Homo sapiens, and throughout nature so far, was long considered as a good candidate for inherited muscle diseases[SEP]Relations: Protein C has relations: drug_drug with Ticlopidine, drug_drug with Ticlopidine, drug_drug with Tirofiban, drug_drug with Tirofiban, drug_drug with Tibolone, drug_drug with Tibolone, drug_drug with Ticagrelor, drug_drug with Ticagrelor, drug_drug with Tioguanine, drug_drug with Tioguanine. Definitions: M line defined as following: The midline of aligned thick filaments in a Sarcomeres; location of specific proteins that link thick filaments. Depending on muscle type the M band consists of different numbers of M lines. [GOC:mtg_muscle, ISBN:0198506732, ISBN:0815316194]. Muscle Cells defined as following: Mature contractile cells, commonly known as myocytes, that form one of three kinds of muscle. The three types of Muscle Cells are skeletal (MUSCLE FIBERS, SKELETAL), Cardiac - anatomy qualifier (MYOCYTES, CARDIAC), and smooth (MYOCYTES, SMOOTH MUSCLE). They are derived from embryonic (precursor) Muscle Cells called MYOBLASTS.. Mammals defined as following: Warm-blooded Vertebrates animals belonging to the class Mammalia, including all that possess hair and suckle their young.. Sarcomeres defined as following: The repeating contractile units of the MYOFIBRIL, delimited by Z bands along its length.. Homo sapiens defined as following: Members of the species Homo sapiens.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. Z line defined as following: Platelike region of a muscle Sarcomeres to which the plus ends of actin filaments are attached. [GOC:mtg_muscle, ISBN:0815316194]. Human body structure defined as following: Anatomical structure which is the aggregate material substance of an individual member of a species.. Polypeptides defined as following:

**Description:**A Polypeptides resulting from the translation of a gene.

. Vertebrates defined as following: Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising Mammals, birds, reptiles, amphibians, and fishes.. Skeletal muscle structure defined as following: A subtype of striated muscle, attached by TENDONS to the SKELETON. Skeletal muscles are innervated and their movement can be consciously controlled. They are also called voluntary muscles..", "label": "yes"} {"original_question": "Are Chernobyl survivors at increased risk for breast cancer?", "id": "converted_3695", "sentence1": "Are Chernobyl survivors at increased risk for Malignant neoplasm of Breast?", "sentence2": "Results: A more aggressive course of Malignant neoplasm of Breast is observed in patients exposed to radiation from the Chernobyl accident under the age of 30 years (P < .01). , A significant excess of Multiple Myeloma incidence [standardized incidence rate (SIR) 1.61 %, 95% confidence interval (NDUFB6 gene) 1.01-2.21], THYROID DIAGNOSTIC RADIOPHARMACEUTICALS cancer (SIR 4.18, 95% NDUFB6 gene 3.76-4.59), female Malignant neoplasm of Breast (SIR 1.57 NDUFB6 gene 1.40-1.73), and all Malignant Neoplasms combined (SIR 1.07; 95% NDUFB6 gene 1.05-1.09) was registered. , Possible effects for further study include increased rates of THYROID DIAGNOSTIC RADIOPHARMACEUTICALS, Breast, and Malignant neoplasm of lung and Multiple Myeloma; reduction of radiation risks of leukemia to population levels; and increased morbidity and mortality of cleanup workers from cardio- and cerebrovascular pathology., Furthermore, the upward trends of increases in a variety of other Neoplasms including Malignant neoplasm of Breast, Malignant Neoplasms of central nervous system and Malignant neoplasm of kidney have been reported in the persons exposed to Chornobyl fallout., Epidemiological cohort studies found increased incidence (1990-2012 gg.) of THYROID DIAGNOSTIC RADIOPHARMACEUTICALS cancer in victims of Chernobyl accident (liquidators - in 4.6 times, evacuated - in 4.0 times, residents of contaminated areas - in 1.3 times) and increased incidence of Malignant neoplasm of Breast in female workers of 1986-1987., Historically, data from the Chernobyl reactor accident 27 years ago demonstrated a strong correlation with THYROID DIAGNOSTIC RADIOPHARMACEUTICALS cancer, but data on the radiation effects of Chernobyl on Malignant neoplasm of Breast incidence have remained inconclusive., Re-analyzing the data reveals that the incidence of Malignant neoplasm of Breast in Chernobyl-disaster-exposed women could be higher than previously thought. , For Malignant neoplasm of Breast, the rates and age of onset appear to vary significantly in regions differentially affected by the Chernobyl accident. , In contrast, millions of people were exposed to radioactive Isotopes in the fallout from the Chernobyl accident, within the first 20 years there was a large increase in THYROID DIAGNOSTIC RADIOPHARMACEUTICALS carcinoma incidence and a possible radiation-related increase in Malignant neoplasm of Breast, but as yet there is no general increase in malignancies. , The study demonstrated increases in Malignant neoplasm of Breast incidence in all areas following the Chernobyl accident, reflecting improvements in cancer diagnosis and registration., An increase in Malignant neoplasm of Breast incidence has been reported in areas of Belarus and Ukraine contaminated by the Chernobyl accident and has become an issue of public concern., The study demonstrated increases in Malignant neoplasm of Breast incidence in all areas following the Chernobyl accident, reflecting improvements in cancer diagnosis and registration.[SEP]Relations: malignant neoplasm of chest wall has relations: disease_disease with thoracic cancer, disease_disease with thoracic cancer, disease_disease with chest wall bone cancer, disease_disease with chest wall bone cancer. Multiple myeloma has relations: disease_phenotype_positive with capillary leak syndrome, disease_phenotype_positive with capillary leak syndrome, drug_effect with Lenalidomide, drug_effect with Lenalidomide. Neoplasm of the THYROID DIAGNOSTIC RADIOPHARMACEUTICALS gland has relations: disease_phenotype_positive with familial colorectal cancer, disease_phenotype_positive with familial colorectal cancer. Definitions: leukemia defined as following: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006). Malignant neoplasm of Breast defined as following: A primary or metastatic malignant neoplasm involving the Breast. The vast majority of cases are carcinomas arising from the Breast parenchyma or the nipple. Malignant Breast neoplasms occur more frequently in females than in males.. Malignant neoplasm of lung defined as following: A primary or metastatic malignant neoplasm involving the lung.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Breast defined as following: In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Malignant neoplasm of kidney defined as following: Primary or metastatic malignant neoplasm involving the kidney.. THYROID DIAGNOSTIC RADIOPHARMACEUTICALS cancer defined as following: A primary or metastatic malignant neoplasm affecting the THYROID DIAGNOSTIC RADIOPHARMACEUTICALS gland.. Isotopes defined as following: Atomic species differing in mass number but having the same atomic number. (Grant & Hackh's Chemical Dictionary, 5th ed). Multiple Myeloma defined as following: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY..", "label": "yes"} {"original_question": "Is istiratumab effective for pancreatic cancer?", "id": "converted_4300", "sentence1": "Is istiratumab effective for pancreatic cancer?", "sentence2": "CONCLUSIONS: Istiratumab failed to improve the efficacy of SOC chemotherapy in this patient setting. [SEP]Definitions: pancreatic cancer defined as following: A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma..", "label": "no"} {"original_question": "Does oncogene-induced DNA replication stress inhibit genomic instability?", "id": "converted_2662", "sentence1": "Does oncogene-induced DNA replication stress inhibit genomic instability?", "sentence2": "Oncogene-induced DNA replication stress is thought to drive genomic instability in Primary malignant neoplasm., We propose that single-stranded DNA generated in response to oncogene-induced replication stress compromises the repair of deaminated cytosines and other damaged Unit dose - Base, leading to the observed Sympathetic Nervous System mutator phenotype.[SEP]Relations: malignant ear neoplasm has relations: disease_disease with head and neck Primary malignant neoplasm, disease_disease with head and neck Primary malignant neoplasm, disease_disease with middle ear Primary malignant neoplasm, disease_disease with middle ear Primary malignant neoplasm, disease_disease with inner ear Primary malignant neoplasm, disease_disease with inner ear Primary malignant neoplasm, disease_disease with external ear Primary malignant neoplasm, disease_disease with external ear Primary malignant neoplasm, disease_disease with ear neoplasm, disease_disease with ear neoplasm. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Sympathetic Nervous System defined as following: The thoracolumbar division of the autonomic nervous system. Sympathetic preganglionic fibers originate in neurons of the intermediolateral column of the spinal cord and project to the paravertebral and prevertebral ganglia, which in turn project to target organs. The sympathetic nervous system mediates the body's response to stressful situations, i.e., the fight or flight reactions. It often acts reciprocally to the parasympathetic system..", "label": "no"} {"original_question": "Are there tools for visualizing and processing long-read sequencing data?", "id": "converted_3117", "sentence1": "Are there tools for visualizing and processing long-read sequencing data?", "sentence2": "NanoPack: visualizing and processing long-read sequencing data., Here we describe NanoPack, a set of tools developed for visualization and processing of long-read sequencing data from Oxford Nanopore Technologies and Pacific Biosciences.Availability and implementation: The NanoPack tools are written in Python3 and released under the GNU GPL3.0 License. The source code can be found at https://github.com/wdecoster/nanopack, together with links to separate scripts and their documentation. The scripts are compatible with Linux, Mac OS and the MS Windows 10 subsystem for Linux and are available as a graphical user interface, a web service at http://nanoplot.bioinf.be and command line tools., Summary\nHere we describe NanoPack, a set of tools developed for visualization and processing of long-read sequencing data from Oxford Nanopore Technologies and Pacific Biosciences., NanoPack: visualizing and processing long-read sequencing data.Supplementary data are available at Bioinformatics online., Summary: Here we describe NanoPack, a set of tools developed for visualization and processing of long-read sequencing data from Oxford Nanopore Technologies and Pacific Biosciences.
Availability and implementation: The NanoPack tools are written in Python3 and released under the GNU GPL3.0 License., Here we describe NanoPack, a set of tools developed for visualization and processing of long-read sequencing data from Oxford Nanopore Technologies and Pacific Biosciences.[SEP]", "label": "yes"} {"original_question": "Is CTCF bound at nucleosome free regions?", "id": "converted_3362", "sentence1": "Is CTGF protein, human bound at nucleosome free regions?", "sentence2": "nucleosome location depletion at 5'-HS4 was dependent on interaction of the insulator protein CCCTC-binding factor (CTGF protein, human) and was required for Enhancer of transcription blocking. , Here, we show that promoter classes are significantly differentiated by nucleosome organization and chromatin structure. Dispersed Promoter display higher associations with well-positioned Nucleosomes downstream of the Toxic Shock Syndrome and a more clearly defined nucleosome free region upstream, while focused Promoter have a less organized nucleosome structure, yet higher presence of RNA Polymerase II., hese differences extend to histone variants (H2AZ1 wt Allele) and marks (Histone H3 Lysine 4 methylation), as well as insulator binding (such as CTGF protein, human), independent of the expression levels of affected Genes., nucleosome occupancy at nucleosome-free regions (NFRs), many of which are located at Site occupied by the multivalent factors Ctcf and cohesin. , This general architectural change correlates with enhanced binding of CTGF protein, human and cohesins and more pronounced insulation of contacts across chromatin boundaries in lineage-committed cells. , robust inter-nucleosomal interactions exist around Transcription Initiation Site (Toxic Shock Syndrome), transcription termination Site (TTS) or around CTGF protein, human binding Site[SEP]Relations: nucleosome has relations: cellcomp_protein with IRF4, cellcomp_protein with IRF4, cellcomp_protein with CENPA, cellcomp_protein with CENPA, cellcomp_protein with H3C15, cellcomp_protein with H3C15, cellcomp_protein with H3C14, cellcomp_protein with H3C14, cellcomp_protein with H4C15, cellcomp_protein with H4C15. Definitions: H2AZ1 wt Allele defined as following: Human H2AZ1 wild-type allele is located in the vicinity of 4q24 and is approximately 2 kb in length. This allele, which encodes histone H2AZ1 wt Allele protein, plays a role in chromatin packaging.. Nucleosomes defined as following: The repeating structural units of chromatin, each consisting of approximately 200 base pairs of DNA wound around a protein core. This core is composed of the histones H2A, H2B, H3, and H4.. Toxic Shock Syndrome defined as following: A rare acute life-threatening systemic bacterial noncontagious illness caused by any of several related staphylococcal exotoxins. It is characterized by high fever, hypotension, rash, multi-organ dysfunction, and cutaneous desquamation during the early convalescent period. The toxins affect the host immune system, causing an exuberant and pathological host inflammatory response. Laboratory findings include leukocytosis, elevated prothrombin time, hypoalbuminemia, hypocalcemia, and pyuria.. CTGF protein, human defined as following: CCN family member 2 (349 aa, ~38kDa) is encoded by the human CCN2 gene. This protein plays a role in the promotion of proliferation and differentiation of chondrocytes and also mediates heparin- and divalent cation-dependent cell adhesion in many different cell types.. RNA Polymerase II defined as following: A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6.. Site defined as following: A position in relation to its surroundings.. Transcription Initiation Site defined as following: The first nucleotide of a transcribed DNA sequence where RNA polymerase (DNA-DIRECTED RNA POLYMERASE) begins synthesizing the RNA transcript.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. Histone H3 Lysine 4 defined as following: The lysine residue found at amino acid position 4 in the histone H3 protein. Methylation of this residue may be a marker for transcriptionally active Genes.. Enhancer of transcription defined as following: A 50-150bp DNA sequence that increases the rate of transcription of coding sequences. It may be located at various distances and in either orientation upstream from, downstream from or within a structural gene. When bound by a specific transcription factor it increases the levels of expression of the gene, but is not sufficient alone to cause expression. Distinguished from a promoter, that is alone sufficient to cause expression of the gene when bound.. binding Site defined as following: The parts of a macromolecule that directly participate in its specific combination with another molecule.. nucleosome location defined as following: A complex comprised of DNA wound around a multisubunit core and associated proteins, which forms the primary packing unit of DNA into higher order structures. [GOC:elh]. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Does SARM1 deletion cause neurodegeneration?", "id": "converted_2619", "sentence1": "Does SARM1 deletion cause Nerve Degeneration?", "sentence2": "Finally, using Neurons from two distinct mutant mouse strains whose Axon are highly resistant to Nerve Degeneration (Wld(S) and Sarm1(-/-)), we found that the three different fibrils were secreted by Axon after anterograde transport, in the absence of axonal lysis, indicating that trans-neuronal spread can occur in intact healthy Neurons.[SEP]Relations: axon has relations: cellcomp_protein with SARM1, cellcomp_protein with SARM1, cellcomp_protein with DNM1, cellcomp_protein with DNM1, cellcomp_protein with SRCIN1, cellcomp_protein with SRCIN1, cellcomp_protein with SHTN1, cellcomp_protein with SHTN1. neuron to neuron synapse has relations: cellcomp_protein with RS1, cellcomp_protein with RS1. Definitions: Neurons defined as following: The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.. Nerve Degeneration defined as following: Loss of functional activity and trophic degeneration of nerve Axon and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.. Axon defined as following: Nerve fibers that are capable of rapidly conducting impulses away from the neuron cell body.. SARM1 defined as following: Sterile alpha and TIR motif-containing protein 1 (724 aa, ~79 kDa) is encoded by the human SARM1 gene. This protein is involved in immune responsive signaling..", "label": "no"} {"original_question": "Is the protein lefty an inhibitor of nodal?", "id": "converted_1826", "sentence1": "Is the protein lefty an inhibitor of nodal?", "sentence2": "The expression of lefty, an inhibitor of nodal is often reduced in Tumor cells, uncertain whether benign or malignant., Nodal Homolog Homolog, and an inhibitor, Lefty., as well as the expression of Lefty, an inhibitor of nodal signaling,, he Nodal Homolog Homolog inhibitor lefty, The morphogen Nodal Homolog Homolog was proposed to form a long-range signaling gradient via a reaction-diffusion system, on the basis of differential diffusion rates of Nodal Homolog Homolog and its antagonist Lefty.[SEP]Relations: malignancy in giant cell tumor of bone has relations: disease_disease with bone sarcoma, disease_disease with bone sarcoma, disease_disease with malignant giant cell tumor, disease_disease with malignant giant cell tumor. Definitions: Tumor cells, uncertain whether benign or malignant defined as following: Cells of, or derived from, a tumor.. Nodal Homolog defined as following: Nodal Homolog homolog (347 aa, ~40 kDa) is encoded by the human NODAL gene. This protein is involved in mesoderm formation and axial patterning..", "label": "yes"} {"original_question": "Does TIMELESS-TIPIN participate in replisome disassembly?", "id": "converted_4368", "sentence1": "Does TIMELESS gene-TIPIN participate in replisome disassembly?", "sentence2": "TIMELESS gene gene-TIPIN and UBXN-3 promote replisome disassembly during DNA replication termination in Caenorhabditis elegans., We show that UBXN-3 is important in vivo for replisome disassembly in the absence of TIMELESS gene gene-TIPIN. Correspondingly, co-depletion of UBXN-3 and TIMELESS gene gene causes profound synthetic lethality. Since the Homo sapiens orthologue of UBXN-3, FAF1 gene gene, is a candidate tumour suppressor, these findings suggest that manipulation of CASK gene disassembly might be applicable to future strategies for treating Homo sapiens cancer.[SEP]Relations: TIMELESS gene has relations: protein_protein with TIPIN, protein_protein with TIPIN, bioprocess_protein with DNA repair, bioprocess_protein with DNA repair, bioprocess_protein with DNA replication, bioprocess_protein with DNA replication, bioprocess_protein with positive regulation of double-strand break repair via homologous recombination, bioprocess_protein with positive regulation of double-strand break repair via homologous recombination, bioprocess_protein with DNA replication checkpoint signaling, bioprocess_protein with DNA replication checkpoint signaling. Definitions: Caenorhabditis elegans defined as following: A species of nematode that is widely used in biological, biochemical, and genetic studies.. Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Does the protein mTOR regulate autophagy?", "id": "converted_673", "sentence1": "Does the protein FRAP1 protein, human regulate autophagy?", "sentence2": "autophagy is negatively regulated by the mammalian target of sirolimus receptor (FRAP1 protein, human), Subjecting cells to starvation or sirolimus efficiently induces autophagy by inhibiting the MTOR signaling pathway triggering increased autophagic flux. , Several pathways, including FRAP1 protein, human, have been shown to regulate autophagy., these results provide insights into the mechanism by which hyperactivation of mechanistic target of sirolimus complex 1 promotes Malignant neoplasm of breast progression through increasing autophagy and Akt activation in vivo., the canonical FRAP1 protein, human-controlled autophagy pathway, FRAP1 protein, human inhibition severely impairs liver regeneration and increases autophagy after pH:LsCnc:Pt:Ser/Plas:Qn, FRAP1 protein, human remains at a high level and inhibits autophagy., Proto-Oncogene Proteins c-akt is involved in granulosa cell autophagy regulation via FRAP1 protein, human signaling during Rattus norvegicus follicular development and Impatent structure., mammalian target of sirolimus (FRAP1 protein, human), a major negative regulator of autophagy., FRAP1 protein, human suppresses granulosa cell autophagy, Mammals target of sirolimus (FRAP1 protein, human), a potent suppressor of autophagy,, The FRAP1 protein, human signaling pathway integrates inputs from a variety of upstream stimuli to regulate diverse cellular processes including proliferation, growth, survival, motility, autophagy, protein synthesis and metabolism, The activation of mammalian target of sirolimus (FRAP1 protein, human) signaling pathway blocks the effects of ghrelin-induced autophagy and apoptosis,, inducing apoptosis and autophagy via the FRAP1 protein, human signaling pathway, The FRAP1 protein, human gene regulates cell growth by controlling RNA, Messenger translation, ribosome biogenesis, autophagy, and metabolism.[SEP]Relations: Sirolimus has relations: drug_protein with MTOR, drug_protein with MTOR. Protein S human has relations: drug_drug with Platelet Activating Factor, drug_drug with Platelet Activating Factor, drug_drug with Argatroban, drug_drug with Argatroban, drug_drug with Altrenogest, drug_drug with Altrenogest, drug_drug with Dienogest, drug_drug with Dienogest. Definitions: granulosa cell defined as following: Supporting cells for the developing female gamete in the OVARY. They are derived from the coelomic epithelial cells of the gonadal ridge. Granulosa cells form a single layer around the OOCYTE in the primordial ovarian follicle and advance to form a multilayered cumulus oophorus surrounding the OVUM in the Graafian follicle. The major functions of granulosa cells include the production of steroids and LH receptors (RECEPTORS, LH).. Impatent structure defined as following: A congenital anatomic defect characterised by the absence of a normally present opening in an organ or tissue.. Proto-Oncogene Proteins c-akt defined as following: Expressed in diverse tissues, Protein Kinase B (Proto-Oncogene Proteins c-akt/RAC Family) is a group (Alpha, Beta and Gamma) of cytoplasmic serine/threonine enzymes that covalently transfer the terminal, gamma phosphate group from ATP to a variety of substrate proteins and regulate cell signaling responses to insulin, PDGF, and IGF1 (through PI3K) involved in cell survival, cell proliferation, differentiation, apoptosis, glycogen synthesis, and glucose uptake.. FRAP1 protein, human defined as following: Serine/threonine-protein kinase FRAP1 protein, human (2549 aa, ~289 kDa) is encoded by the human MTOR gene. This protein is involved in protein phosphorylation, signaling and cell growth.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. Malignant neoplasm of breast defined as following: A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males.. mechanistic target of sirolimus complex 1 defined as following: A protein complex that is involved in the both serine/threonine phosphorylation and the regulation of protein synthesis in response to cellular stress.. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.. FRAP1 protein, human gene defined as following: This gene plays a role in apoptosis, cell growth, differentiation and proliferation.. sirolimus defined as following: A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties.. RNA, Messenger defined as following: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the cytoplasm..", "label": "yes"} {"original_question": "Is there an association between Klinefelter syndrome and breast cancer?", "id": "converted_2478", "sentence1": "Is there an association between Klinefelter Syndrome and breast Primary malignant neoplasm?", "sentence2": "Screening for breast Primary malignant neoplasm in male-to-female Transsexual (finding) should be undertaken for those with additional risk factors (e.g., family history, BRCA2 gene gene Mutation Abnormality, Klinefelter Syndrome) and should be available to those who desire screening, preferably in a clinical trial., Klinefelter Syndrome (OR = 24.7; 95% CI = 8.94 to 68.4) and Gynecomastia (OR = 9.78; 95% CI = 7.52 to 12.7) were also statistically significantly associated with risk, relations that were independent of BMI. , Male breast Primary malignant neoplasm risk factors show strong association with BRCA2 gene gene Gene Mutation, as well as Klinefelter Syndrome. , The main risk factors include: the Mutation Abnormality of genes BRCA 1 and 2, Klinefelter's syndrome - male with more than two X chromosomes - male with more than two X chromosomes, Alcohol - Recreational Drug Use Code, Hepatobiliary Disorder, BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20. , Although aetiology is still unclear, constitutional, environmental, hormonal (abnormalities in Estrogen [EPC]/androgen balance) and Genetic (positive family history, Klinefelter Syndrome, Gene Mutation in BRCA1 gene gene and specially BRCA2 gene gene) risk factors are already known. , The largest study found 19.2- and 57.8-fold increases in incidence and mortality, respectively, with particularly high risks among 47,XXY mosaics. , CONCLUSIONS: Additional well-designed epidemiologic studies are needed to clarify which patients with Supernumerary mandibular left second primary are at a high risk of developing MBC and to distinguish between possible predisposing factors, including altered endogenous Hormones., Major risk factors for developing male BC Original Formula Original Formula include clinical disorders involving hormonal imbalances (excess of Estrogen [EPC] or a deficiency of Therapeutic Testosterone as seen in patients with Klinefelter Syndrome) and a positive family history for breast Primary malignant neoplasm. , Patients with 47, XXY karyotype (Klinefelter Syndrome) appear to have increased risk of developing Primary malignant neoplasm, especially male breast Primary malignant neoplasm, Germ cell tumor and Hodgkin Disease, but rarely Leukemia, Myelocytic, Acute. , Breast Primary malignant neoplasm in a patient with Klinefelter's syndrome - male with more than two X chromosomes - male with more than two X chromosomes is reported., The increased conversion of Therapeutic Testosterone to estradiol at the therapy with Androgens might be responsible for the development of breast Primary malignant neoplasm in Klinefelter's syndrome - male with more than two X chromosomes - male with more than two X chromosomes., Patients with a 47,XXY karyotype (Klinefelter Syndrome) appear to have an increased risk of developing Primary malignant neoplasm, especially male breast Primary malignant neoplasm and germ cell tumors, but rarely malignant hematologic disorders., The frequencies of Diabetes Mellitus, breast Primary malignant neoplasm, and Germ cell neoplasia increases in Klinefelter's syndrome - male with more than two X chromosomes - male with more than two X chromosomes., There is evidence, however, to suggest that Klinefelter's males have an increased risk of breast Primary malignant neoplasm that approaches three percent., Klinefelter Syndrome has been consistently associated with breast Primary malignant neoplasm in men (MBC).
CASE REPORT: We report a 54-year old man was diagnosed as synchronous bilateral breast Primary malignant neoplasm with Klinefelter Syndrome., These results support a hormonal etiology for breast Primary malignant neoplasm in men and for prostate Primary malignant neoplasm and suggest that men with Klinefelter Syndrome may be at substantially elevated risks for Lymphoma, Non-Hodgkin, Familial, breast Primary malignant neoplasm, and, perhaps, lung Primary malignant neoplasm., Major Genetic factors associated with an increased risk of breast Primary malignant neoplasm for men include BRCA2 gene gene Gene Mutation, which are believed to account for the majority of inherited breast Primary malignant neoplasm in men, Klinefelter Syndrome, and a positive family history., Those affected by Klinefelter's syndrome - male with more than two X chromosomes - male with more than two X chromosomes are at increased risk of Lupus Erythematosus, Systemic, breast Primary malignant neoplasm, Non-Hodgkin's lymphoma of bone, and lung Primary malignant neoplasm., CONCLUSIONS These results support a hormonal etiology for breast Primary malignant neoplasm in men and for prostate Primary malignant neoplasm and suggest that men with Klinefelter Syndrome may be at substantially elevated risks for Lymphoma, Non-Hodgkin, Familial, breast Primary malignant neoplasm, and, perhaps, lung Primary malignant neoplasm., Compared with the general population, men with Klinefelter Syndrome had higher mortality from lung Primary malignant neoplasm (Megakaryocyte-Potentiating Factor, human = 1.5, 95% CI = 1.0 to 2.0), breast Primary malignant neoplasm (Megakaryocyte-Potentiating Factor, human = 57.8, 95% CI = 18.8 to 135.0), and Lymphoma, Non-Hodgkin, Familial (Megakaryocyte-Potentiating Factor, human = 3.5, 95% CI = 1.6 to 6.6) and lower mortality from prostate Primary malignant neoplasm (Megakaryocyte-Potentiating Factor, human = 0, 95% CI = 0 to 0.7)., Klinefelter Syndrome has been consistently associated with breast Primary malignant neoplasm in men (MBC)., Male breast Primary malignant neoplasm risk factors show strong association with BRCA2 gene gene Gene Mutation, as well as Klinefelter Syndrome., Patients with 47, XXY karyotype (Klinefelter Syndrome) appear to have increased risk of developing Primary malignant neoplasm, especially male breast Primary malignant neoplasm, Germ cell tumor and Hodgkin Disease, but rarely Leukemia, Myelocytic, Acute., Klinefelter Syndrome, in which patients carry XXY chromosome, may be present in men with breast Primary malignant neoplasm for this reason they often develop Gynecomastia.
, Klinefelter Syndrome has been consistently associated with breast Primary malignant neoplasm in men (MBC)., These results support a hormonal etiology for breast Primary malignant neoplasm in men and for prostate Primary malignant neoplasm and suggest that men with Klinefelter Syndrome may be at substantially elevated risks for Lymphoma, Non-Hodgkin, Familial, breast Primary malignant neoplasm, and, perhaps, lung Primary malignant neoplasm..[SEP]Relations: Klinefelter Syndrome has relations: disease_disease with Genetic infertility, disease_disease with Genetic infertility, disease_disease with Genetic nervous system disorder, disease_disease with Genetic nervous system disorder, disease_disease with epilepsy, disease_disease with epilepsy, disease_disease with sex chromosome disorder of sex development, disease_disease with sex chromosome disorder of sex development, disease_disease with X chromosome number anomaly, disease_disease with X chromosome number anomaly. Definitions: Germ cell tumor defined as following: A benign or malignant, gonadal or extragonadal neoplasm that originates from germ cells. Representative examples include teratoma, seminoma, embryonal carcinoma, and yolk sac tumor.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. prostate Primary malignant neoplasm defined as following: A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas.. Therapeutic Testosterone defined as following: A synthetic form of the endogenous androgenic steroid Therapeutic Testosterone. In vivo, Therapeutic Testosterone is irreversibly converted to dihydrotestosterone (DHT) in target tissues by the enzyme 5-alpha reductase. Testosterone or DHT ligand-androgen receptor complexes act as transcription factor complexes, stimulating the expression of various responsive genes. DHT binds with higher affinity to androgen receptors than Therapeutic Testosterone, activating gene expression more efficiently. In addition, Therapeutic Testosterone is irreversibly converted to estradiol by the enzyme complex aromatase, particularly in the liver and adipose tissue. Testosterone and DHT promote the development and maintenance of male sex characteristics related to the internal and external genitalia, skeletal muscle, and hair follicles; estradiol promotes epiphyseal maturation and bone mineralization. Due to rapid metabolism by the liver, therapeutic Therapeutic Testosterone is generally administered as an ester derivative.. BRCA2 gene defined as following: A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human chromosome 13 at locus 13q12.3. Mutations in this gene predispose humans to breast and ovarian Primary malignant neoplasm. It encodes a large, nuclear protein that is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. (from Genes Dev 2000;14(11):1400-6). Klinefelter Syndrome defined as following: A form of male HYPOGONADISM, characterized by the presence of an extra X CHROMOSOME, small TESTES, seminiferous tubule dysgenesis, elevated levels of GONADOTROPINS, low serum TESTOSTERONE, underdeveloped secondary sex characteristics, and male infertility (INFERTILITY, MALE). Patients tend to have long legs and a slim, tall stature. GYNECOMASTIA is present in many of the patients. The classic form has the karyotype 47,XXY. Several karyotype variants include 48,XXYY; 48,XXXY; 49,XXXXY, and mosaic patterns ( 46,XY/47,XXY; 47,XXY/48,XXXY, etc.).. Diabetes Mellitus defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.. Breast Primary malignant neoplasm defined as following: A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males.. Genetic defined as following: Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.. Hodgkin Disease defined as following: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.. Hormones defined as following: Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.. Lupus Erythematosus, Systemic defined as following: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.. BRCA1 gene defined as following: A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human CHROMOSOME 17 at locus 17q21. Mutations of this gene are associated with the formation of HEREDITARY BREAST AND OVARIAN CANCER SYNDROME. It encodes a large nuclear protein that is a component of DNA repair pathways.. Androgens defined as following: Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power.. Leukemia, Myelocytic, Acute defined as following: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.. Hepatobiliary Disorder defined as following: A non-neoplastic or neoplastic disorder that affects the liver, bile ducts, and gallbladder. Representative examples of non-neoplastic disorders include hepatitis, cirrhosis, cholangitis, and cholecystitis. Representative examples of neoplastic disorders include hepatocellular adenoma, hepatocellular carcinoma, and cholangiocarcinoma.. Megakaryocyte-Potentiating Factor, human defined as following: Megakaryocyte-potentiating factor (250 aa, ~27 kDa) is encoded by the human MSLN gene. This protein plays a role in megakaryocyte colony formation.. Mutation Abnormality defined as following: Any transmissible change in the Genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with Genetic diversity or with pathologies including Primary malignant neoplasm.. Gynecomastia defined as following: Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological Gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Supernumerary mandibular left second primary defined as following:

Supernumerary mandibular left second primary molar

. Transsexual (finding) defined as following: A person who was assigned to one gender at birth based on physical characteristics but who self-identifies psychologically and emotionally as the other.. breast Primary malignant neoplasm defined as following: A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males..", "label": "yes"} {"original_question": "Are CD44 variants (CD44v) associated with poor prognosis of metastasis?", "id": "converted_704", "sentence1": "Are CD44 Antigens variants (CD44v) associated with poor prognosis of metastasis?", "sentence2": "CD44 Antigens Antigens variants and prognosis, The CD44 Antigens Antigens Variant (CD44v) Protein Isoforms have been noted as markers for Secondary Neoplasm and prognosis in several Adenocarcinoma., Positive CD44v3 expression was associated with more advanced pathological stage and poorer prognosis than negative CD44v3 expression, CD44v6 expression in the Malignant adenomatous neoplasm component may directly affect the behavior of Carcinoma and the prognosis of patients, D44 Variant 6 in Adenocarcinoma, Endometrioid of the Pelvis>Uterus: its expression in the Malignant adenomatous neoplasm component is an independent prognostic marker, CD44v5 expression is independently positively correlated with the Aggressive behavior of thymic epithelial Neoplasms. The expression of CD44v5 may be a potential trigger of tumor invasion in Thymoma, analysis of CD44v expression provides indications of biological and clinical relevance also in low grade lymphoproliferative disorders, clinical relevance of CD44 Antigens Antigens Variant isoform expression on Chronic Lymphocytic Leukemia, CD44 Antigens Antigens variants and its association with survival in Malignant neoplasm of pancreas, CD44 Antigens Antigens Variant 6(v6) molecule has been noted as a marker for tumor metastasis and prognosis in several Neoplasms, CD44v2 and CD44v6 may be useful markers for poor prognosis in curatively resected primary Malignant neoplasm of pancreas, CD44v8-10 may play an important role in the adhesion of Tumor cells, uncertain whether benign or malignant to the Blood Blood capillaries of distant organs in the metastatic process, and that immunohistochemical detection of CD44v8-10 may be a biologic marker of prognostic significance., combined expression of CD44v8-10 and SLX may be a biologic marker of prognostic significance, Variant Protein Isoforms (CD44v) are expressed on different malignant cells and Body tissue. Their upregulation has been implicated, in the progression and metastasis of malignomas., expression of the CD44 Antigens Antigens Variant exon 6 is associated with lymph node metastasis in Non-Small Cell Lung Carcinoma, a number of Variant forms of CD44 Antigens Antigens are frequently expressed, although these variants are infrequently expressed in normal Specimen Source Codes - Tissue lung, and that the expression of CD44v6 is particularly associated with lymph node metastasis in NSCLC, Expression of CD44v6 may suggest an increased risk for local lymph node metastasis in NSCLCs, different CD44 Antigens Antigens Protein Isoforms are found in Homo sapiens Malignant neoplasm of skin and are modulated during carcinogenesis, D44 Protein Isoforms correlate with cellular differentiation but not with prognosis in Homo sapiens Malignant neoplasm of breast, Correlations between prognosis and expression of CD44v have been reported for Gastric (qualifier value) and Colon Carcinoma, for Non-Hodgkin's lymphoma of bone, and recently for Breast Carcinoma, Certain splice variants (CD44v) can promote the metastatic behaviour of Tumor cells, malignant. In Homo sapiens colon and Malignant neoplasm of breast the presence of Epitopes encoded by exon v6 on primary resected tumour material indicates poor prognosis, In Homo sapiens mammary carcinomas and Colorectal Carcinoma, the expression of CD44v has also been correlated with more progressed tumor stages.[SEP]Relations: thymoma has relations: disease_protein with CD274, disease_protein with CD274. colorectal Carcinoma has relations: disease_protein with CD93, disease_protein with CD93, disease_protein with CD46, disease_protein with CD46. Carcinoma has relations: disease_protein with CDS1, disease_protein with CDS1, disease_protein with CDK4, disease_protein with CDK4. Definitions: Malignant neoplasm of pancreas defined as following: A primary or metastatic malignant tumor involving the pancreas. Representative examples include Carcinoma and lymphoma.. Protein Isoforms defined as following: Refers to variants of the same protein which can be separated on special conducting media using electrophoresis. The differences may arise from genetically determined differences in primary structure or by modification of the same primary sequence.. Variant defined as following: An alteration or difference from a norm or standard.. Malignant neoplasm of skin defined as following: A primary or metastatic malignant neoplasm involving the skin. Primary malignant skin neoplasms most often are carcinomas (either basal cell or squamous cell carcinomas) or melanomas. Metastatic malignant neoplasms to the skin include carcinomas and lymphomas.. Non-Small Cell Lung Carcinoma defined as following: A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.. Colon Carcinoma defined as following: A malignant epithelial neoplasm that arises from the colon and invades through the muscularis mucosa into the submucosa. The vast majority are Adenocarcinoma.. Epitopes defined as following: Sites on an antigen that interact with specific antibodies.. Colorectal Carcinoma defined as following: A malignant epithelial neoplasm that arises from the colon or rectum and invades through the muscularis mucosa into the submucosa. The vast majority are Adenocarcinoma.. Tumor cells, malignant defined as following: Cells of, or derived from, a malignant tumor.. Adenocarcinoma defined as following: A malignant epithelial tumor with a glandular organization.. CD44 Antigens defined as following: Acidic sulfated integral membrane glycoproteins expressed in several alternatively spliced and variable glycosylated forms on a wide variety of cell types including mature T-cells, B-cells, medullary THYMOCYTES; GRANULOCYTES; MACROPHAGES; erythrocytes, and fibroblasts. Their interaction with HYALURONIC ACID mediates binding of lymphocytes to high endothelial VENULES.. Blood capillaries defined as following: The minute vessels that connect arterioles and venules.. Aggressive behavior defined as following: Behavior which may be manifested by destructive and attacking action which is verbal or physical, by covert attitudes of hostility or by obstructionism.. Breast Carcinoma defined as following: A Carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are Adenocarcinoma (ductal or lobular). Breast Carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.. Malignant neoplasm of breast defined as following: A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males.. Adenocarcinoma, Endometrioid defined as following: An Malignant adenomatous neoplasm characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Gastric (qualifier value) defined as following: Relating to the stomach.. Carcinoma defined as following: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding Body tissue and give rise to metastases. It is a histological type of neoplasm and not a synonym for \"cancer.\". Tumor cells, uncertain whether benign or malignant defined as following: Cells of, or derived from, a tumor.. Thymoma defined as following: A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (From Stedman, 25th ed). Chronic Lymphocytic Leukemia defined as following: A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called chronic lymphocytic leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease.. Homo sapiens defined as following: Members of the species Homo sapiens.. Secondary Neoplasm defined as following: A malignant tumor that has spread from its original (primary) site of growth to another site close to or distant from the primary site.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others..", "label": "yes"} {"original_question": "Is cathepsin L active in endosomes?", "id": "converted_3408", "sentence1": "Is cathepsin L active in endosomes?", "sentence2": "Cathepsin L in the Late Endosome/Lysosome, endosomal cathepsin L, Immunofluorescence and immunoblotting investigations revealed the presence of cathepsin L in the nuclear compartment in addition to its expected endo-lysosomal localization in colorectal carcinoma cells., cleavage by the endosomal/lysosomal protease cathepsin L[SEP]Definitions: endosomes defined as following: Cytoplasmic vesicles formed when COATED VESICLES shed their CLATHRIN coat. Endosomes internalize macromolecules bound by receptors on the cell surface..", "label": "yes"} {"original_question": "Is there a role for gamma knife in treatment of Obsessive-Compulsive Disorder?", "id": "converted_1917", "sentence1": "Is there a role for gamma knife in treatment of Obsessive-Compulsive Disorder?", "sentence2": "OBJECTIVE Functional Gamma Knife radiosurgery (GKRS) procedures have been increasingly used for treating patients with Tremor, trigeminal neuralgia (Trigeminal Neuralgia), and refractory obsessive-compulsive disorder., METHODS The authors constructed a linear-quadratic model of BORNHOLM EYE DISEASE in functional GKRS with a dose-protraction factor to correct for intrafraction DNA-damage repair and used standard single-fraction doses for trigeminal nerve ablation for Trigeminal Neuralgia (85 Gy), Thalamotomy for Tremor (130 Gy), and capsulotomy for obsessive-compulsive disorder (180 Gy). , Gamma knife for Obsessive-Compulsive Disorder: can it be detrimental?, Gamma knife radiosurgery (GKRS) is also being practised to treat refractory obsessive- compulsive disorder (OCD)., Radio and neurosurgical procedures, including gamma knife radiation and deep brain stimulation, are reserved for severe, treatment-refractory disease that has not responded to multiple treatments, and some patients may benefit from transcranial magnetic stimulation., We close with a discussion of gamma knife capsulotomy, a modality with deep historical Plant Roots., Results following gamma knife radiosurgical anterior capsulotomies for Obsessive-Compulsive Disorder., Gamma knife radiosurgery (GKRS) is also being practised to treat refractory obsessive- compulsive disorder (OCD)., Lesion topography and outcome after thermocapsulotomy or gamma knife capsulotomy for obsessive-compulsive disorder: relevance of the right hemisphere., Neuropsychological outcome of ventral capsular/ventral striatal gamma capsulotomy for refractory obsessive-compulsive disorder: a pilot study, Gamma ventral capsulotomy for treatment of resistant obsessive-compulsive disorder: a structural MRI pilot prospective study, Results following gamma knife radiosurgical anterior capsulotomies for Obsessive-Compulsive Disorder, At 28 months, the third patient is living and working independently, and her YBOCS score is 18.CONCLUSION: Within a strict protocol, gamma knife radiosurgery provided improvement of OCD behavior with no adverse effects., Gamma knife for Obsessive-Compulsive Disorder: can it be detrimental?[SEP]Relations: obsessive-compulsive disorder has relations: contraindication with Riboflavin, contraindication with Riboflavin, contraindication with Ibuprofen, contraindication with Ibuprofen, disease_protein with SLITRK5, disease_protein with SLITRK5, contraindication with Pheniramine, contraindication with Pheniramine, contraindication with Isometheptene, contraindication with Isometheptene. Definitions: BORNHOLM EYE DISEASE defined as following: Syndrome with characteristics of moderate to high myopia associated with astigmatism and deuteranopia. Less than 10 families have been described so far. Transmission is X-linked recessive and the locus has been mapped to Xq28.. Tremor defined as following: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action Tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting Tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.. Trigeminal Neuralgia defined as following: A syndrome characterized by recurrent episodes of excruciating pain lasting several seconds or longer in the sensory distribution of the TRIGEMINAL NERVE. Pain may be initiated by stimulation of trigger points on the face, lips, or gums or by movement of facial muscles or chewing. Associated conditions include MULTIPLE SCLEROSIS, vascular anomalies, ANEURYSMS, and neoplasms. (Adams et al., Principles of Neurology, 6th ed, p187). Obsessive-Compulsive Disorder defined as following: An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.. Plant Roots defined as following: The usually underground portions of a plant that serve as support, store food, and through which water and mineral nutrients enter the plant. (From American Heritage Dictionary, 1982; Concise Dictionary of Biology, 1990). Obsessive-Compulsive Disorder defined as following: This gene is involved in serotonin transport..", "label": "yes"} {"original_question": "Can vitamin B1 deficiency cause encephalopathy?", "id": "converted_478", "sentence1": "Can thiamine deficiency cause Encephalopathies?", "sentence2": "Wernicke's Encephalopathies (WE) is a severe neurological syndrome caused by Thiamine Drug Class (Thiamine Drug Class) deficiency and clinically characterized by the sudden onset of mental status changes, Ocular abnormalities, and Cerebellar Ataxia, Wernicke-Korsakoff Syndrome (or Wernicke-Korsakoff Encephalopathies) is a rarely diagnosed neurological disorder, which is caused by Thiamine Drug Class deficiency, Wernicke's Encephalopathies (WE) is a potentially reversible yet serious neurological manifestation caused by Thiamine Drug Class(Thiamine Drug Class) deficiency, Wernicke-Korsakoff Syndrome is caused by Thiamine Drug Class (Thiamine Drug Class) deficiency, Both the Thyrotoxicosis and a catabolic state due to the Hyperemesis Gravidarum were thought to have induced a Thiamine Drug Class deficiency, causing the Wernicke-Korsakoff Syndrome., Wernicke-Korsakoff Syndrome (or Wernicke-Korsakoff Encephalopathies) is a rarely diagnosed neurological disorder, which is caused by Thiamine Drug Class deficiency., Wernicke-Korsakoff Syndrome is caused by Thiamine Drug Class (Thiamine Drug Class) deficiency., Wernicke's Encephalopathies is a neurological disorder caused by Thiamine Drug Class (Thiamine Drug Class) deficiency characterized by Vertigo , Cerebellar Ataxia, and mental confusion., Wernicke's Encephalopathies (WE) is caused by Thiamine Drug Class (Thiamine Drug Class) deficiency and most commonly found in individuals with chronic Alcoholic Intoxication, Chronic and Malnutrition., Wernicke's Encephalopathies (WE) is an acute neurological disease resulting from Thiamine Drug Class (Thiamine Drug Class) deficiency., Post-mortem findings demonstrate that Thiamine Drug Class (Thiamine Drug Class) deficiency sufficient to cause irreversible Traumatic AND/OR non-traumatic brain injury is not diagnosed ante mortem in 80-90% of these patients., Wernicke's Encephalopathies is an acute neuropsychiatric disorder, due to Thiamine Drug Class (Thiamine Drug Class) deficiency., Wernicke's Encephalopathies (WE) is a severe neurological syndrome caused by Thiamine Drug Class (Thiamine Drug Class) deficiency and clinically characterized by the sudden onset of mental status changes, Ocular abnormalities, and Cerebellar Ataxia., Wernicke's Encephalopathies, a pathology caused by Thiamine Drug Class (thiamin) deficiency, is often difficult to diagnose and can lead to severe cognitive sequels if left untreated., Wernicke's Encephalopathies-Korsakoff syndrome (WE-KS) is common in alcoholics, caused by Thiamine Drug Class deficiency (diphtheria, tetanus toxoids and acellular pertussis vaccine; Thiamine Drug Class) and associated with Lesion to the Thalamic structure (thalidomide)., Wernicke-Korsakoff Syndrome is caused by Thiamine Drug Class (Thiamine Drug Class) deficiency, Thiamine (Thiamine Drug Class) deficiency, associated with a variety of conditions, including chronic Alcoholic Intoxication, Chronic and bariatric surgery for morbid obesity, can result in the neurological disorder Wernicke's Encephalopathies (WE), Wernicke's Encephalopathies is caused by Thiamine Deficiency and can be recognized by severe neurological symptoms that are occasionally accompanied by systemic signs. , INTRODUCTION: Wernicke's Encephalopathies, a pathology caused by Thiamine Drug Class (thiamin) deficiency, is often difficult to diagnose and can lead to severe cognitive sequels if left untreated. , OBSERVATION: We report a case of Encephalopathies due to dual Ascorbic Acid Deficiency of both Thiamine Drug Class (vitamin B1) and niacin (niacinamide) in an 80-year-old women, hospitalized for severe Sepsis (Invertebrate) caused by aspiration Pneumonia. , Acute Wernicke's Encephalopathies (WE) is caused by profound Thiamine Drug Class (Thiamine Drug Class) deficiency and commonly presents with the classic clinical triad of mental confusion, Cerebellar Ataxia, and ophthalmoplegia. , [Wernicke´s Encephalopathies and Polyneuropathy associated with vitamin B complex deficiency after a bariatric surgery]., BACKGROUND: Thiamine deficiency in patients who abuse alcohol can cause Wernicke's Encephalopathies (WE). , Wernicke-Korsakoff Syndrome--a debilitating acute or subacute neurological disorder-is caused by a deficiency in Thiamine Drug Class (vitamin B(1)). , Wernicke's Encephalopathies is a serious neurological manifestation of Thiamine Drug Class deficiency., Both the Thyrotoxicosis and a catabolic state due to the Hyperemesis Gravidarum were thought to have induced a Thiamine Drug Class deficiency, causing the Wernicke-Korsakoff Syndrome., Wernicke-Korsakoff Syndrome is caused by Thiamine Drug Class (Thiamine Drug Class) deficiency., Wernicke-Korsakoff Syndrome (or Wernicke-Korsakoff Encephalopathies) is a rarely diagnosed neurological disorder, which is caused by Thiamine Drug Class deficiency., Wernicke's Encephalopathies is a neurological disorder caused by Thiamine Drug Class (Thiamine Drug Class) deficiency characterized by Vertigo ,, Post-mortem findings demonstrate that Thiamine Drug Class (Thiamine Drug Class) deficiency sufficient to cause irreversible Traumatic AND/OR non-traumatic brain injury is not diagnosed ante mortem in 80-90% of these patients. The causes of Ascorbic Acid Deficiency are reviewed with special attention to the inhibition of oral Thiamine Drug Class hydrochloride absorption in Homo sapiens caused by Malnutrition present in alcoholic patients or by the direct effects of ethanol on intestinal transport., Wernicke's Encephalopathies is a serious nervous system disorder caused by vitamin-B1 or Thiamine Drug Class deficiency., Wernicke's Encephalopathies results from Thiamine Drug Class (Thiamine Drug Class) deficiency. Common causes include Alcoholic Intoxication, Chronic and gastric disorders., Wernicke's Encephalopathies is a neurological disorder caused by Thiamine Drug Class (Thiamine Drug Class) deficiency characterized by Vertigo , Cerebellar Ataxia, and mental confusion., Wernicke's Encephalopathies (WE) is caused by Thiamine Drug Class (Thiamine Drug Class) deficiency and most commonly found in individuals with chronic Alcoholic Intoxication, Chronic and Malnutrition., Post-mortem findings demonstrate that Thiamine Drug Class (Thiamine Drug Class) deficiency sufficient to cause irreversible Traumatic AND/OR non-traumatic brain injury is not diagnosed ante mortem in 80-90% of these patients., Wernicke's Encephalopathies, a pathology caused by Thiamine Drug Class (thiamin) deficiency, is often difficult to diagnose and can lead to severe cognitive sequels if left untreated.[SEP]Relations: Encephalopathy has relations: disease_phenotype_positive with mitochondrial complex I deficiency, disease_phenotype_positive with mitochondrial complex I deficiency, disease_phenotype_positive with aminoacylase 1 deficiency, disease_phenotype_positive with aminoacylase 1 deficiency, disease_phenotype_positive with mitochondrial complex 5 (ATP synthase) deficiency nuclear, disease_phenotype_positive with mitochondrial complex 5 (ATP synthase) deficiency nuclear, disease_phenotype_positive with mitochondrial complex V (ATP synthase) deficiency, nuclear, disease_phenotype_positive with mitochondrial complex V (ATP synthase) deficiency, nuclear, disease_phenotype_positive with cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency, disease_phenotype_positive with cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency. Definitions: Wernicke-Korsakoff Syndrome defined as following: An acquired cognitive disorder characterized by inattentiveness and the inability to form short term memories. This disorder is frequently associated with chronic ALCOHOLISM; but it may also result from dietary deficiencies; CRANIOCEREBRAL TRAUMA; NEOPLASMS; CEREBROVASCULAR DISORDERS; ENCEPHALITIS; EPILEPSY; and other conditions. (Adams et al., Principles of Neurology, 6th ed, p1139). Pneumonia defined as following: Infection of the lung often accompanied by inflammation.. thiamine defined as following: 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2- hydroxyethyl)-4-methylthiazolium chloride.. Ascorbic Acid Deficiency defined as following: A condition due to a dietary deficiency of ascorbic acid (vitamin C), characterized by malaise, lethargy, and weakness. As the disease progresses, joints, muscles, and subcutaneous tissues may become the sites of hemorrhage. Ascorbic acid deficiency frequently develops into SCURVY in young children fed unsupplemented cow's milk exclusively during their first year. It develops also commonly in chronic Alcoholic Intoxication, Chronic. (Cecil Textbook of Medicine, 19th ed, p1177). niacinamide defined as following: An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake.. ethanol defined as following: A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES.. niacin defined as following: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.. Encephalopathies defined as following: A functional and/or structural disorder of the brain caused by diseases (e.g. liver disease, kidney disease), medications, chemicals, and injuries.. Cerebellar Ataxia defined as following: Incoordination of voluntary movements that occur as a manifestation of CEREBELLAR DISEASES. Characteristic features include a tendency for limb movements to overshoot or undershoot a target (dysmetria), a tremor that occurs during attempted movements (intention TREMOR), impaired force and rhythm of diadochokinesis (rapidly alternating movements), and GAIT ATAXIA. (From Adams et al., Principles of Neurology, 6th ed, p90). Lesion defined as following: A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.. Thyrotoxicosis defined as following: A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.. thalidomide defined as following: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.. Wernicke's Encephalopathies defined as following: An acute neurological disorder characterized by the triad of ophthalmoplegia, Cerebellar Ataxia, and disturbances of mental activity or consciousness. Eye movement abnormalities include nystagmus, external rectus palsies, and reduced conjugate gaze. THIAMINE DEFICIENCY and chronic ALCOHOLISM are associated conditions. Pathologic features include periventricular petechial hemorrhages and neuropil breakdown in the diencephalon and brainstem. Chronic Thiamine Drug Class deficiency may lead to KORSAKOFF SYNDROME. (Adams et al., Principles of Neurology, 6th ed, pp1139-42; Davis & Robertson, Textbook of Neuropathology, 2nd ed, pp452-3). Hyperemesis Gravidarum defined as following: Intractable VOMITING that develops in early PREGNANCY and persists. This can lead to DEHYDRATION and WEIGHT LOSS.. Malnutrition defined as following: An imbalanced nutritional status resulting from insufficient intake of nutrients to meet normal physiological requirement.. Alcoholic Intoxication, Chronic defined as following: A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4). Thalamic structure defined as following: Paired bodies containing mostly GRAY MATTER and forming part of the lateral wall of the THIRD VENTRICLE of the brain.. Homo sapiens defined as following: Members of the species Homo sapiens.. diphtheria, tetanus toxoids and acellular pertussis vaccine defined as following:

Tetanus, diphtheria, and pertussis (whooping cough) are serious bacterial infections. Tetanus causes painful tightening of the muscles, usually all over the body. It can lead to \"locking\" of the jaw. Diphtheria usually affects the nose and throat. Whooping cough causes uncontrollable coughing. Vaccines can protect you from these diseases. In the U.S., there are four combination vaccines:

  • DTaP prevents all three diseases. It is for children younger than seven years old.
  • Tdap also prevents all three. It is for older children and adults.
  • DT prevents diphtheria and tetanus. It is for children younger than seven who cannot tolerate the pertussis vaccine.
  • Td prevents diphtheria and tetanus. It is for older children and adults. It is usually given as a booster dose every 10 years. You may also get it earlier if you get a severe and dirty wound or burn.

Some people should not get these vaccines, including those who have had severe reactions to the shots before. Check with your doctor first if you have seizures, a neurologic problem, or Guillain-Barre syndrome. Also let your doctor know if you don't feel well the day of the shot; you may need to postpone it.

Centers for Disease Control and Prevention

. Polyneuropathy defined as following: Diseases of multiple peripheral nerves simultaneously. Polyneuropathies usually are characterized by symmetrical, bilateral distal motor and sensory impairment with a graded increase in severity distally. The pathological processes affecting peripheral nerves include degeneration of the axon, myelin or both. The various forms of Polyneuropathy are categorized by the type of nerve affected (e.g., sensory, motor, or autonomic), by the distribution of nerve injury (e.g., distal vs. proximal), by nerve component primarily affected (e.g., demyelinating vs. axonal), by etiology, or by pattern of inheritance.. nervous system disorder defined as following: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.. Thiamine Deficiency defined as following: A nutritional condition produced by a deficiency of THIAMINE in the diet, characterized by anorexia, irritability, and weight loss. Later, patients experience weakness, peripheral neuropathy, headache, and tachycardia. In addition to being caused by a poor diet, Thiamine Drug Class deficiency in the United States most commonly occurs as a result of Alcoholic Intoxication, Chronic, since ethanol interferes with Thiamine Drug Class absorption. In countries relying on polished rice as a dietary staple, BERIBERI prevalence is very high. (From Cecil Textbook of Medicine, 19th ed, p1171).", "label": "yes"} {"original_question": "Is macroautophagy a selective degradation process?", "id": "converted_1182", "sentence1": "Is macroautophagy a selective degradation process?", "sentence2": "Selective autophagy, Macroautophagy (autophagy) is a bulk degradation system for Cytoplasmic components and is ubiquitously found in Eukaryotic Cells, Here we show that selective autophagy downregulates Ty1 transposition, We propose that selective autophagy safeguards Genome - anatomical entity integrity against excessive Mutagenesis, Insertional caused during Nutrient (property) starvation by DNA Transposable Elements in Eukaryotic Cells., Moreover, it is becoming apparent that Proteins, Organelles, and pathogens can be targeted for autophagic clearance by selective mechanisms, Cell spreading required ref(2)P, the Drosophila p62 multiadaptor, implicating selective autophagy as a novel mechanism for modulating cortical dynamics, The selective macroautophagic degradation, There is growing evidence that macroautophagic cargo receptor ligand activity receptor ligand activity is not limited to bulk cytosol in response to starvation and can occur selectively for substrates, including aggregated Proteins., It remains unclear, however, whether starvation-induced and selective macroautophagy share identical adaptor molecules to capture their cargo receptor ligand activity receptor ligand activity. Here, we report that WDFY3 gene, a phosphatidylinositol 3-phosphate-binding Protein Info, is central to the selective elimination of aggregated Proteins., We propose that WDFY3 gene plays a key role in selective macroautophagy by bridging cargo receptor ligand activity receptor ligand activity to the molecular machinery that builds Autophagosome., Thus, Cytoplasmic NBR1 might be important to maintain basal levels of selective macroautophagy in these Neurons., we could show that Smatg8 and Smatg4 are not only required for nonselective macroautophagy, but for selective Pexophagy as well., The latter is performed by proteasome-mediated degradation, chaperone-mediated autophagy (chaperone-mediated autophagy), and selective macroautophagy,, Here we demonstrate a role for 1-Phosphatidylinositol 4-Kinase and PtdIns4P 5-kinases in selective and nonselective types of autophagy in Saccharomyces cerevisiae., Macroautophagy (hereafter autophagy) is a degradative cellular pathway that protects Eukaryotic Cells from stress, starvation, and microbial infection., Previously, we showed that macroautophagy is necessary for conidiation in the rice-blast Fungus (lab result) Magnaporthe oryzae. Here, we analyzed the physiological function(s) of selective autophagy in Magnaporthe, serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated Proteins., Selective macroautophagy (autophagy) of ubiquitinated Protein Info is implicated as a compensatory mechanism of the ubiquitin-proteasome system. p62/SQSTM1 is a key Molecule managing autophagic clearance of polyubiquitinated Proteins., Whole Cytoplasmic Cytoplasmic organelle turnover is mediated through macroautophagy, a process by which Autophagosome deliver Mitochondria to the Lysosomes for hydrolytic degradation. While Mitochondrial Inheritance autophagy can occur as part of a nonselective upregulation of autophagy, selective degradation of damaged or unneeded Mitochondria (mitophagy) is a rapidly growing area in development, Primary malignant neoplasm, and Nerve Degeneration, particularly with regard to Parkinson Disease, BAG Family Molecular Chaperone Regulator 3, Homo sapiens was recently described as a mediator of a novel macroautophagy pathway that uses the specificity of heat shock Protein Info 70 (Heat-Shock Proteins 70) to misfolded Proteins and also involves other Protein Info partners, such as Heat Shock Protein Beta-8., two PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE (Lugano Lymphoma Response Classification Progressive Disease by PET) associated Genes, PINK1 gene gene and PARK2 Protein Info, Homo sapiens, were shown to mediate the degradation of damaged Mitochondria via selective autophagy (mitophagy), Here we show that whole Mitochondria are turned over via macroautophagy., Does HD Protein Info, Homo sapiens play a role in selective macroautophagy?, In the discussion here I suggest that SLC6A4 wt Allele may have a normal function in the lysosomal mechanism of selective macroautophagy involved in its own degradation, Macroautophagy induced by ethanol seemed to be selective for damaged Mitochondria and accumulated lipid droplets, but not long-lived Proteins, which could account for its protective effects, Although macroautophagy can be nonspecific, there are many examples of selective sequestration including pexophagy, mitophagy and the Cytoplasm to Vacuole targeting (Vertical Talus) pathway., Mitochondria autophagy (mitophagy) is the process of selective degradation of Mitochondria that has an important role in Mitochondrial Inheritance quality control., One of the Genes identified, YLR356W, is required for mitophagy, but not for macroautophagy or other types of selective autophagy., A genomic screen for Saccharomyces cerevisiae mutants defective in selective Mitochondria autophagy., Mitophagy is the process of selective Mitochondrial Inheritance degradation via autophagy, which has an important role in Mitochondrial Inheritance quality control., Analysis of this set of targeted deletion mutants demonstrated that loss of any of the 16 Genes necessary for nonselective macroautophagy renders the Fungus (lab result) unable to cause rice blast disease, due to impairment of both conidial programmed \"U\" lymphocyte death and appressorium maturation. In contrast, Genes necessary only for selective forms of autophagy, such as pexophagy and mitophagy, are dispensable for appressorium-mediated plant infection., This gene is not required for other types of selective autophagy or for nonspecific macroautophagy., However, in contrast to the core autophagy Genes such as ATG5 gene and ATG7 gene, expression of ULK1 Protein Info, Homo sapiens is not essential for induction of macroautophagy in response to Nutrient (property) deprivation or for survival of newborn mice. Together, these data suggest that the ULK1 wt Allele homologue, Ulk1, is a component of the selective autophagy machinery that leads to the elimination of Organelles in Erythroid Cells rather that an essential mechanistic component of autophagy., Growing evidence supports an active role for dysregulated macroautophagy (autophagic stress) in neuronal \"U\" lymphocyte death and Nerve Degeneration. Alterations in Mitochondrial Inheritance function and dynamics are also strongly implicated in neurodegenerative diseases. Interestingly, whereas the core autophagy machinery is evolutionarily conserved and shared among constitutive and induced or selective autophagy, recent studies implicate distinct mechanisms regulating Mitochondrial Inheritance autophagy (mitophagy) in response to general autophagic stimuli., We discovered that activation of the UPR in Saccharomyces cerevisiae also induces a new branch of macroautophagy that selectively targets the Endoplasmic Reticulum. We term this process \"Endoplasmic Reticulum-phagy\", in analogy to pexophagy and mitophagy, the two other known forms of Cytoplasmic Cytoplasmic organelle-specific marcoautophagy. Endoplasmic Reticulum-phagy involves the generation of Autophagosome that selectively include Endoplasmic Reticulum membranes and whose delimiting double membranes also derive, at least in part, from the Endoplasmic Reticulum., This suggests that in fungal sp. an organism-specific form of selective autophagy may occur, for which specialized Atg Proteins have evolved., ransfer of Y. lipolytica Cells from oleate/ethylamine to glucose/ammonium chloride medium leads to selective macroautophagy of peroxisome., Insulin-dependent signaling regulates azurophil granule-selective macroautophagy in Homo sapiens myeloblastic Cells., We show that insulin-dependent signals regulate azurophil granule-selective macroautophagy in Homo sapiens myeloid Cells., By contrast, other Organelles, including the Mitochondria, endoplasmic reticulum, and Golgi apparatus remained intact, indicating that the macroautophagy selectively targeted azurophil granules., Thus, insulin-dependent signals are responsible for the control of azurophil granule-selective macroautophagy via Akt-dependent pathways, Eukaryotic Cells have the ability to degrade Proteins and Organelles by selective and nonselective modes of micro- and macroautophagy., For example, pexophagy is a selective process for the regulated degradation of peroxisome by autophagy., We have characterized biochemically, morphologically, and genetically two distinct pathways for the selective degradation of peroxisome in Komagataella pastoris. These pathways are independently regulated and analogous to Microautophagy and macroautophagy that have been defined in mammalian Cells., If we are willing to slightly modify our definition of autophagy, with a focus on \"degradation of a \"U\" lymphocyte's own components through the lysosomal/vacuolar machinery,\" we can include a newly documented process, programmed nuclear destruction (PND)., Autophagy is a lysosomal degradation pathway that can sequester Cytoplasmic matrix material, including Organelles, nonspecifically in a process called nonselective macroautophagy, or target specific Protein Info aggregates designated for destruction in a process called selective autophagy., Selective macroautophagy uses double-membrane vesicles, termed Autophagosome, to transport Cytoplasmic pathogens, Organelles and Protein Info complexes to the Vacuole for degradation., Autophagy (macroautophagy), a highly conserved eukaryotic mechanism, is a non-selective degradation process, helping to maintain a balance between the synthesis, degradation and subsequent recycling of macromolecules to overcome various stress conditions., Whole Cytoplasmic Cytoplasmic organelle turnover is mediated through macroautophagy, a process by which Autophagosome deliver Mitochondria to the Lysosomes for hydrolytic degradation., Macroautophagy is a catabolic process by which the \"U\" lymphocyte degrades Cytoplasmic components through the lysosomal machinery., Macroautophagy maintains cellular homeostasis through targeting Cytoplasmic contents and Organelles into Autophagosome for degradation., Macroautophagy is a catabolic process by which Cytoplasmic matrix components are sequestered by double membrane vesicles called Autophagosome and sorted to the lysosomes/vacuoles to be degraded., Macroautophagy (hereafter autophagy) is a cellular degradation process, which in Saccharomyces cerevisiae is induced in response to Nutrient (property) deprivation., Macroautophagy was thought to be an unspecific bulk degradation process., Autophagy is a highly regulated Protoplasm degradation process by which Cells remove Cytoplasmic matrix long-lived Proteins and damaged Organelles, and can be monitored by imaging the incorporation of microtubule-associated light chain 3 (Microtubule-Associated Proteins 1A/1B Light Chain 3) fused to a fluorescent Protein Info (Green Fluorescent Proteins or mCherry) into nascent Autophagosome., Beside macroautophagy, there are several forms of selective autophagy, including chaperone-mediated autophagy (chaperone-mediated autophagy), Cytoplasm to Vacuole targeting (Vertical Talus), pexophagy and mitophagy., Macroautophagy (commonly referred to as autophagy) is the process by which intact Organelles and/or large portions of the Cytoplasm are engulfed within double-membraned autophagic vacuoles for degradation., This analysis demonstrated that Atg Proteins required for non-selective macroautophagy are conserved from Saccharomyces cerevisiae to man, stressing the importance of this process in \"U\" lymphocyte survival and viability., Part of the degradation of Protoplasm Proteins occurs in the lysosomes and is mediated by macroautophagy.[SEP]Relations: macroautophagy has relations: bioprocess_bioprocess with selective autophagy, bioprocess_bioprocess with selective autophagy, bioprocess_bioprocess with selective autophagy, bioprocess_bioprocess with selective autophagy, bioprocess_bioprocess with autophagy, bioprocess_bioprocess with autophagy, bioprocess_bioprocess with autophagy, bioprocess_bioprocess with autophagy, bioprocess_protein with STAM, bioprocess_protein with STAM. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Genome - anatomical entity defined as following: Anatomical set of Genes in all the chromosomes.. ULK1 Protein Info, Homo sapiens defined as following: serine/threonine-Protein Info kinase ULK1 (1050 aa, ~113 kDa) is encoded by the Homo sapiens ULK1 gene. This Protein Info is involved in Protein Info phosphorylation that mediates the autophagocytotic process.. Cytoplasmic organelle defined as following: Cell part which consists of macromolecules aggregated into discrete structures in the protoplasm. (Digital Anatomist Foundational Model). Saccharomyces cerevisiae defined as following: A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" Saccharomyces cerevisiae. The dried form is used as a dietary supplement.. Green Fluorescent Proteins defined as following: Protein analogs and derivatives of the Aequorea victoria green fluorescent Protein Info that emit light (FLUORESCENCE) when excited with ULTRAVIOLET RAYS. They are used in REPORTER GENES in doing GENETIC TECHNIQUES. Numerous mutants have been made to emit other colors or be sensitive to pH.. Mitochondria defined as following: Semiautonomous, self-reproducing Organelles that occur in the Cytoplasm of all Cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon Genes within the nucleus of the Cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed). peroxisome defined as following: Microbodies which occur in animal and plant Cells and in certain fungal sp. and protozoa. They contain peroxidase, catalase, and allied enzymes. (From Singleton and Sainsbury, Dictionary of Microbiology and Molecular Biology, 2nd ed). DNA Transposable Elements defined as following: Discrete segments of DNA which can excise and reintegrate to another site in the Genome - anatomical entity. Most are inactive, i.e., have not been found to exist outside the integrated state. DNA DNA Transposable Elements include bacterial IS (insertion sequence) elements, Tn elements, the maize controlling elements Ac and Ds, Drosophila P, gypsy, and pogo elements, the Homo sapiens Tigger elements and the Tc and mariner elements which are found throughout the animal kingdom.. Erythroid Cells defined as following: The series of Cells in the red blood \"U\" lymphocyte lineage at various stages of differentiation.. ATG7 gene defined as following: This gene plays a role in both autophagy and the transport of Cytoplasmic molecules to vacuoles.. Endoplasmic Reticulum defined as following: A system of cisternae in the CYTOPLASM of many Cells. In places the endoplasmic reticulum is continuous with the plasma membrane (CELL MEMBRANE) or outer membrane of the nuclear envelope. If the outer surfaces of the endoplasmic reticulum membranes are coated with ribosomes, the endoplasmic reticulum is said to be rough-surfaced (ENDOPLASMIC RETICULUM, ROUGH); otherwise it is said to be smooth-surfaced (ENDOPLASMIC RETICULUM, SMOOTH). (King & Stansfield, A Dictionary of Genetics, 4th ed). ethanol defined as following: A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES.. macroautophagy defined as following: The major inducible pathway for the general turnover of Cytoplasmic constituents in Eukaryotic Cells, it is also responsible for the degradation of active Cytoplasmic enzymes and Organelles during Nutrient (property) starvation. Macroautophagy involves the formation of double-membrane-bounded Autophagosome which enclose the Cytoplasmic constituent targeted for degradation in a membrane-bounded structure. Autophagosomes then fuse with a Lysosomes (or Vacuole) releasing single-membrane-bounded autophagic bodies that are then degraded within the Lysosomes (or Vacuole). Some types of macroautophagy, e.g. pexophagy, mitophagy, involve selective targeting of the targets to be degraded. [PMID:11099404, PMID:12914914, PMID:15798367, PMID:16973210, PMID:20159618, PMID:9412464]. Neurons defined as following: The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.. Mutagenesis, Insertional defined as following: Mutagenesis where the mutation is caused by the introduction of foreign DNA sequences into a gene or extragenic sequence. This may occur spontaneously in vivo or be experimentally induced in vivo or in vitro. Proviral DNA insertions into or adjacent to a cellular proto-oncogene can interrupt GENETIC TRANSLATION of the coding sequences or interfere with recognition of regulatory elements and cause unregulated expression of the proto-oncogene resulting in tumor formation.. Lysosomes defined as following: A class of morphologically heterogeneous Cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The Protoplasm functions of lysosomes depend on their lytic potential. The single unit membrane of the Lysosomes acts as a barrier between the enzymes enclosed in the Lysosomes and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed).. Cytoplasmic matrix defined as following: Intracellular fluid from the Cytoplasm after removal of ORGANELLES and other insoluble Cytoplasmic components.. chaperone-mediated autophagy defined as following: The autophagy process which begins when chaperones and co-chaperones recognize a target motif and unfold the substrate Protein Info. The Proteins are then transported to the Lysosomes where they are degraded. [GOC:pad, GOC:PARL, PMID:22743996, PMID:23434281]. Vertical Talus defined as following: Congenital severe form of flatfoot involving dislocation of the NAVICULAR BONE OF FOOT on the TALUS.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as Proteins and water) that constitutes the living nucleus, Cytoplasm, plastids, and Mitochondria of the \"U\" lymphocyte. It is composed mainly of nucleic acids, Proteins, lipids, carbohydrates, and inorganic salts.. HD Protein Info, Homo sapiens defined as following: HD Protein Info, Homo sapiens (3144 aa, ~348 kDa) is encoded by the Homo sapiens HTT gene. This Protein Info may be involved in the regulation of vesicular transport.. ATG5 gene defined as following: This gene plays a role in autophagy and may play a role in apoptosis.. PARK2 Protein Info, Homo sapiens defined as following: E3 ubiquitin-Protein Info ligase parkin (465 aa, ~52 kDa) is encoded by the Homo sapiens PRKN gene. This Protein Info may play a role in the ubiquitination of Proteins targeted for proteasomal degradation.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the Protein Info.. Microtubule-Associated Proteins 1A/1B Light Chain 3 defined as following: A Protein Info family whose members bind to microtubule-associated Protein Info 1A and 1B and are involved in the formation of Autophagosome.. ULK1 wt Allele defined as following: Human ULK1 wild-type allele is located in the vicinity of 12q24.3 and is approximately 29 kb in length. This allele, which encodes serine/threonine-Protein Info kinase ULK1 Protein Info, plays a role in both serine/threonine Protein Info phosphorylation and the modulation of autophagy.. Eukaryotic Cells defined as following: Cells of the higher organisms, containing a true nucleus bounded by a nuclear membrane.. Heat-Shock Proteins 70 defined as following: A family of structurally related Proteins that are involved in both Protein Info folding and cellular stress responses. The members of this family are approximately 70 kDa.. Pexophagy defined as following: The selective autophagy process in which a peroxisome is degraded by macroautophagy. [GOC:autophagy, PMID:12914914, PMID:16973210]. 1-Phosphatidylinositol 4-Kinase defined as following: An enzyme that catalyzes the conversion of phosphatidylinositol (PHOSPHATIDYLINOSITOLS) to phosphatidylinositol 4-phosphate, the first committed step in the biosynthesis of phosphatidylinositol 4,5-bisphosphate.. serine defined as following: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.. Cytoplasm defined as following: The part of a \"U\" lymphocyte that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990). SLC6A4 wt Allele defined as following: Human SLC6A4 wild-type allele is located in the vicinity of 17q11.2 and is approximately 42 kb in length. This allele, which encodes sodium-dependent serotonin transporter Protein Info, plays a role in serotonin uptake. Polymorphism in the promoter region affects gene expression and lower gene expression is associated with depression. Coding region variations are associated with genetic susceptibility to both obsessive-compulsive disorder and alcoholism.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous Proteins in other species.. Parkinson Disease defined as following: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing Neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75). heat shock Protein Info 70 defined as following: A recombinant peptide that is chemically identical to or similar to the endogenous 70-kD heat shock Protein Info (Heat-Shock Proteins 70). Heat-Shock Proteins 70 is a molecular chaperone that prevents physiologic stress-induced \"U\" lymphocyte death by inhibiting both caspase-dependent and caspase-independent apoptosis. Because this peptide is often overexpressed in tumor Cells, autologous vaccination with Heat-Shock Proteins 70 derived from tumor Cells may stimulate the host immune system to mount a tumoricidal cytotoxic T lymphocyte (CTL) response. (NCI04). Vacuole defined as following: Any spaces or cavities within a \"U\" lymphocyte. They may function in digestion, storage, secretion, or excretion.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. ubiquitinated Proteins defined as following: Proteins covalently modified with UBIQUITINS or UBIQUITIN-LIKE PROTEINS.. Lugano Lymphoma Response Classification Progressive Disease by PET defined as following: A score of 4 or 5 on a 5-point PET scale with an increase in intensity of uptake from baseline and/or new FDG-avid foci consistent with lymphoma at interim or end of treatment assessment.. BAG Family Molecular Chaperone Regulator 3, Homo sapiens defined as following: BAG family molecular chaperone regulator 3 (575 aa, ~62 kDa) is encoded by the Homo sapiens BAG Family Molecular Chaperone Regulator 3, Homo sapiens gene. This Protein Info is involved in both Protein Info chaperone activity modulation and the negative regulation of apoptosis.. Autophagosome defined as following: A double-membrane-bounded compartment that engulfs endogenous cellular material as well as invading microorganisms to target them to the lytic Vacuole/Lysosomes for degradation as part of macroautophagy. [GOC:autophagy, ISBN:0198547684, PMID:11099404]. Mitochondrial Inheritance defined as following: The distribution of Mitochondria, including the Mitochondrial Inheritance Genome - anatomical entity, into daughter Cells after mitosis or meiosis, mediated by interactions between Mitochondria and the cytoskeleton. [GOC:mcc, PMID:10873824, PMID:11389764]. Heat Shock Protein Beta-8 defined as following: Heat shock Protein Info beta-8 (196 aa, ~22 kDa) is encoded by the Homo sapiens Heat Shock Protein Beta-8 gene. This Protein Info plays a role in the regulation of autophagy and as a Protein Info chaperone.. cargo receptor ligand activity defined as following: The activity of a gene product that interacts with a cargo receptor ligand activity receptor and initiates endocytosis. [PMID:15797858]. neuronal \"U\" lymphocyte death defined as following: The process of \"U\" lymphocyte death in a neuron. [GOC:BHF, GOC:mah]. Organelles defined as following: Specific particles of membrane-bound organized living substances present in Eukaryotic Cells, such as the MITOCHONDRIA; the GOLGI APPARATUS; ENDOPLASMIC RETICULUM; LYSOSOMES; PLASTIDS; and VACUOLES.. Homo sapiens defined as following: Members of the species Homo sapiens.. Nerve Degeneration defined as following: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their Cells of origin or interruption of their continuity with these Cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.. Fungus (lab result) defined as following: Confirmatory presence of fungal microorganisms.. Molecule defined as following: An aggregate of two or more atoms in a defined arrangement held together by chemical bonds.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Microautophagy defined as following: A type of autophagy in which the Cytoplasmic entities, such as parts of CELL NUCLEI; damaged MITOCHONDRIA; and lipid droplets, are taken up by small vesicles such as VACUOLES or MULTIVESICULAR BODIES, and degraded by lysosomal digestion.. Endoplasmic Reticulum-phagy defined as following: The selective autohagy process in which parts of the endoplasmic reticulum are loaded into Autophagosome, delivered to the Vacuole, and degraded in response to changing cellular conditions. [GOC:autophagy, GOC:dph, PMID:22481944, PMID:24060720, PMID:26040717].", "label": "yes"} {"original_question": "Was ALVAC-HIV effective for HIV prevention in the HVTN 702 trial?", "id": "converted_4695", "sentence1": "Was ALVAC-HIV effective for HIV prevention in the HVTN 702 trial?", "sentence2": "During the 24-month follow-up, HIV-1 Communicable Diseases was diagnosed in 138 participants in the vaccine group and in 133 in the placebo group (hazard ratio, 1.02; 95% confidence interval, 0.81 to 1.30; P = 0.84).CONCLUSIONS: The ALVAC-gp120 regimen did not prevent HIV-1 Communicable Diseases among participants in South Africa despite previous evidence of immunogenicity. (HVTN 702 ClinicalTrials.gov number, NCT02968849.)., The advanced-phase HIV prevention vaccine trials done in South Africa (HVTN 702) and in Thailand (RV144), which both investigated canarypox vectors and adjuvanted gp120 proteins, gave rise to different results. The South African trial did not find vaccine efficacy, whereas the Thai trial had modest, but statistically significant, success with the modified intention-to-treat analysis prespecified in the protocols of both studies. , However, with the recent failure of the HVTN 702 clinical trial, comprehensive profiling of humoral immune responses may provide insight for these disappointing results. , A canarypox-protein HIV vaccine regimen (ALVAC-HIV plus AIDSVAX B/E) showed modest efficacy in reducing Communicable Diseases in Thailand., e vaccine and placebo groups. During the 24-month follow-up, HIV-1 Communicable Diseases was diagnosed in 138 participants in the vaccine group and in 133 in the placebo group (hazard ratio, 1.02; 95% confidence interval, 0.81 to 1.30; P = 0.84).CONCLUSIONS: The ALVAC-gp120 regimen did not prevent HIV-1 Communicable Diseases among participants in South Africa d[SEP]Definitions: Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host..", "label": "no"} {"original_question": "Can botulism poisoning of a pregnant woman harm her fetus?", "id": "converted_406", "sentence1": "Can Botulism Poisoning aspects of a pregnant woman harm her Fetus in fetu?", "sentence2": "Two Botulism outbreaks were attributed to commercial ready-to-eat meat products and 3 to Food served in restaurants; several cases were attributed to non-Native home-prepared Food. Three affected pregnant women delivered healthy infants., botulinum toxin type B is not expected to be present in systemic circulation following proper Intramuscular Route of Drug Administration or intradermal injection. Moreover, botulinum toxin type A, which has a high molecular weight, does not appear to cross the placenta. From the 38 pregnancies reported in the literature, including women who had Botulism Poisoning aspects during pregnancy, exposure to botulinum toxin type A does not appear to increase the risk of adverse outcome in the Fetus in fetu., From the 38 pregnancies reported in the literature, including women who had Botulism Poisoning aspects during pregnancy, exposure to botulinum toxin type A does not appear to increase the risk of adverse outcome in the Fetus in fetu.[SEP]Relations: Poisoning aspects has relations: disease_disease with lead Poisoning aspects, disease_disease with lead Poisoning aspects, disease_disease with toxic oil syndrome, disease_disease with toxic oil syndrome, disease_disease with methanol Poisoning aspects, disease_disease with methanol Poisoning aspects, disease_disease with colchicine Poisoning aspects, disease_disease with colchicine Poisoning aspects, disease_disease with cyanide-induced parkinsonism, disease_disease with cyanide-induced parkinsonism. Definitions: botulinum toxin type A defined as following: An injectable formulation of a neurotoxin derived through the fermentation of the Hall strain of Clostridium botulinum type A with neuromuscular transmission inhibitory and analgesic activities. Upon injection into the affected muscle, the heavy chain portion of botulinum toxin type A (botulinum toxin type A) binds to the cell membrane of the motor nerve and is internalized via endocytosis. Upon entry, the light chain portion of the toxin is activated and cleaves the protein SNAP-25, thereby preventing the fusion of acetylcholine (ACh)-containing synaptic vesicles with the cell membrane and, so, the release of ACh into the neuromuscular junction; subsequent binding of ACH to motor end-plate nicotinic acid receptors and ACh-mediated muscle contraction are thus blocked. In addition to ACh, botulinum toxin type A may inhibit the release of neuropeptides, such as substance P and glutamate, which may contribute to its analgesic activity.. Intramuscular Route of Drug Administration defined as following: Intramuscular injection is a route of drug administration via injection into muscle tissue. Aqueous or oleaginous solutions and emulsions or suspensions may be administered. Absorption rates, delay in availability of the drug to the systemic circulation, and duration of effect are perfusion-limited, depend on molecular size of the agent, volume, and osmolarity of the drug solution, fat content of the injection site, and patient physical activity.. Botulism defined as following: A disease caused by potent protein NEUROTOXINS produced by CLOSTRIDIUM BOTULINUM which interfere with the presynaptic release of ACETYLCHOLINE at the NEUROMUSCULAR JUNCTION. Clinical features include abdominal pain, vomiting, acute PARALYSIS (including respiratory paralysis), blurred vision, and DIPLOPIA. Botulism may be classified into several subtypes (e.g., food-borne, infant, wound, and others). (From Adams et al., Principles of Neurology, 6th ed, p1208). Poisoning aspects defined as following: Used with drugs, chemicals, and industrial materials for human or animal Poisoning aspects, acute or chronic, whether the Poisoning aspects is accidental, occupational, suicidal, by medication error, or by environmental exposure.. Food defined as following: Substances taken in by the body to provide nourishment..", "label": "no"} {"original_question": "Is the BAGEL algorithm used for arrayed CRISPR screens?", "id": "converted_3552", "sentence1": "Is the BAGEL algorithm used for arrayed CRISPR screens?", "sentence2": "BAGEL: a computational framework for identifying essential Genes from pooled library screens., The adaptation of the CRISPR-Cas9 system to pooled library gene knockout screens in mammalian cells represents a major technological leap over RNA interference, the prior state of the art. New methods for analyzing the data and evaluating results are needed.RESULTS: We offer BAGEL (Bayesian Analysis of Gene EssentiaLity), a supervised learning method for analyzing gene knockout screens. Coupled with gold-standard reference sets of essential and nonessential Genes, BAGEL offers significantly greater sensitivity than current methods, while computational optimizations reduce runtime by an order of magnitude.CONCLUSIONS: Using BAGEL, we identify ~2000 fitness Genes in pooled library knockout screens in human cell lines at 5 % FDR, a major advance over competing platforms. BAGEL shows high sensitivity and specificity even across screens performed by different labs using different libraries and Reagents., CONCLUSIONS\n\nUsing BAGEL, we identify ~2000 fitness Genes in pooled library knockout screens in human cell lines at 5 % FDR, a major advance over competing platforms., BAGEL: a computational framework for identifying essential Genes from pooled library screens, CONCLUSIONS\nUsing BAGEL, we identify ~2000 fitness Genes in pooled library knockout screens in human cell lines at 5 % FDR, a major advance over competing platforms., CONCLUSIONS: Using BAGEL, we identify ~2000 fitness Genes in pooled library knockout screens in human cell lines at 5 % FDR, a major advance over competing platforms., Conclusions Using BAGEL, we identify ~2000 fitness Genes in pooled library knockout screens in human cell lines at 5 % FDR, a major advance over competing platforms.[SEP]Definitions: Reagents defined as following: Any natural or synthetic substance used in a chemical or biological reaction in order to produce, identify, or measure another substance.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "no"} {"original_question": "Should perampanel be used for amyotrophic lateral sclerosis?", "id": "converted_4433", "sentence1": "Should perampanel be used for amyotrophic lateral sclerosis?", "sentence2": "RESULTS: Six participants were enrolled. All had adverse events, mostly behavioral. Two completed the trial and the other four withdrew due to adverse events. All participants reported resolution of these events after discontinuation of the drug. The trial was halted due to the large number of adverse events.DISCUSSION: The use of perampanel in this study of Amyotrophic Lateral Sclerosis was limited by its poor tolerability, CONCLUSIONS: perampanel was associated with a significant decline in ALSFRS-R score and was linked to worsening of the bulbar subscore in the 8 mg group., DISCUSSION: The use of perampanel in this study of Amyotrophic Lateral Sclerosis was limited by its poor tolerabilit[SEP]Relations: perampanel has relations: drug_drug with Diphemanil, drug_drug with Diphemanil, drug_drug with Propranolol, drug_drug with Propranolol, drug_drug with Eplerenone, drug_drug with Eplerenone, drug_drug with Cyclopropane, drug_drug with Cyclopropane, drug_drug with Propentofylline, drug_drug with Propentofylline. Definitions: perampanel defined as following: An orally active, non-competitive, and selective alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptor antagonist, with anti-epileptic activity. Although the mechanism of action through which perampanel exerts its antiepileptic effect has not been fully elucidated, this agent antagonizes the AMPA subtype of the excitatory glutamate receptor found on postsynaptic neurons in the central nervous system (CNS). This antagonistic action prevents AMPA receptor activation by glutamate and results in the inhibition of neuronal excitation, repetitive neuronal firing, and the stabilization of hyper-excited neural membranes. Glutamate, the primary excitatory neurotransmitter in the CNS, plays an important role in various neurological disorders caused by neuronal hyperexcitation.. Amyotrophic Lateral Sclerosis defined as following: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94). perampanel defined as following: An orally active, non-competitive, and selective alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptor antagonist, with anti-epileptic activity. Although the mechanism of action through which perampanel exerts its antiepileptic effect has not been fully elucidated, this agent antagonizes the AMPA subtype of the excitatory glutamate receptor found on postsynaptic neurons in the central nervous system (CNS). This antagonistic action prevents AMPA receptor activation by glutamate and results in the inhibition of neuronal excitation, repetitive neuronal firing, and the stabilization of hyper-excited neural membranes. Glutamate, the primary excitatory neurotransmitter in the CNS, plays an important role in various neurological disorders caused by neuronal hyperexcitation.. amyotrophic lateral sclerosis defined as following: An inherited form of amyotrophic lateral sclerosis, usually inherited in an autosomal dominant pattern, caused by mutation(s) in the SOD1 gene, encoding superoxide dismutase..", "label": "no"} {"original_question": "Is there a role for CADM1 in Myelodysplastic syndrome (MDS)?", "id": "converted_4413", "sentence1": "Is there a role for CADM1 gene in Myelodysplastic syndrome (MDS)?", "sentence2": "Together with the frequent simultaneous Gene Deletion of MLL protein, human, ammonium tetrathiomolybdate and Cytophaga-like bacteria and Gene Mutation of Putative Polycomb Group Protein Putative Polycomb Group Protein ASXL1, Splicing Factor 3B Subunit 1, human and Cytophaga-like bacteria, we show that CADM1 gene gene may be important in the physiopathology of the del(11q) MDS, extending its role as tumor-suppressor gene from Solid Neoplasm to Hematopoietic Neoplasms., The CADM1 gene gene tumor suppressor gene is a major candidate gene in MDS with Gene Deletion Abnormality of the long arm of chromosome 11.[SEP]Relations: Abnormality of the dentition has relations: disease_phenotype_positive with MGAT2-CDG, disease_phenotype_positive with MGAT2-CDG, disease_phenotype_positive with STAT3-related early-onset multisystem autoimmune disease, disease_phenotype_positive with STAT3-related early-onset multisystem autoimmune disease, disease_phenotype_positive with leukocyte adhesion deficiency, disease_phenotype_positive with leukocyte adhesion deficiency, disease_phenotype_positive with autosomal dominant Robinow syndrome, disease_phenotype_positive with autosomal dominant Robinow syndrome, disease_phenotype_positive with ectodermal dysplasia syndrome, disease_phenotype_positive with ectodermal dysplasia syndrome. Definitions: Hematopoietic Neoplasms defined as following: A neoplasm arising from hematopoietic cells found in the bone marrow, peripheral blood, lymph nodes and spleen (organs of the hematopoietic system). Hematopoietic cell neoplasms can also involve other anatomic sites (e.g. central nervous system, gastrointestinal tract), either by metastasis, direct tumor infiltration, or neoplastic transformation of extranodal lymphoid tissues. The commonest forms are the various types of leukemia, Hodgkin and non-Hodgkin lymphomas, myeloproliferative neoplasms, and myelodysplastic syndromes.. Putative Polycomb Group Protein ASXL1 defined as following: Putative Polycomb group protein Putative Polycomb Group Protein ASXL1 (1541 aa, ~165 kDa) is encoded by the human Putative Polycomb Group Protein ASXL1 gene. This protein may be involved in the modulation of both transcription and chromatin remodeling.. Splicing Factor 3B Subunit 1, human defined as following: Splicing factor 3B subunit 1 (1304 aa, ~146 kDa) is encoded by the human Splicing Factor 3B Subunit 1, human gene. This protein is involved in the structure of the spliceosome.. MLL protein, human defined as following: Histone-lysine N-methyltransferase MLL (3969 aa, ~432 kDa) is encoded by the human MLL gene. This protein is involved in both histone modification and transcriptional activation.. Solid Neoplasm defined as following: A benign or malignant neoplasm arising from tissues that do not include fluid areas. Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma). Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered Solid Neoplasm.. CADM1 gene defined as following: Cell adhesion molecule 1 (442 aa, ~49 kDa) is encoded by the human CADM1 gene gene. This protein plays a role in calcium-dependent cell-cell adhesion.. Gene Deletion defined as following: A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This Gene Deletion Abnormality may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a Gene Deletion Abnormality at one specific locus.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Myelodysplastic syndrome defined as following: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA..", "label": "no"} {"original_question": "Are splicing speckles associated with transcription?", "id": "converted_2430", "sentence1": "Are Nuclear Speckles associated with transcription?", "sentence2": "We show here that RNA splicing speckled domains (Nuclear Speckles) fluctuate in constrained Nuclear (incident type) volumes and remodel their shapes., We present a model where recycling splicing factors return as part of small sub-speckles from distal sites of RNA processing to larger Nuclear Speckles by a directed ATP-driven mechanism through interchromatin spaces., Analysis of a HeLa cell line stably expressing EYFP-NHPX showed that the nucleolar accumulation of NHPX was preceded by its transient accumulation in Nuclear Speckles., In vivo analysis of NHPX reveals a novel nucleolar localization pathway involving a transient accumulation in Nuclear Speckles., \"Splicing speckles\" are major Nuclear (incident type) domains rich in components of the splicing machinery and polyA(+) RNA. Although speckles contain little detectable transcriptional activity, they are found preferentially associated with specific mRNA-coding genes and gene-rich R bands, and they accumulate some unspliced pre-mRNAs, RNA Polymerase II transcribes mRNAs and is required for splicing, with some reports suggesting that the inactive complex (molecular entity) are stored in splicing speckle, In normal cell growth conditions GFPeIF4A-III was mainly nucleoplasmic, but in Hypoxia, CTCAE stress conditions it moved to the Cell Nucleolus and Nuclear Speckles., Localization of eIF4A-III in the Cell Nucleolus and Nuclear Speckles is an indicator of plant stress., Using Antibodies, in vitro diagnostic raised against mouse RBM6 to immunostain mammalian cell lines we found that the endogenous Protein Info was both distributed diffusely in the Cell Nucleus and concentrated in a small number of Nuclear (incident type) foci that corresponded to Nuclear Speckles/interchromatin granule clusters (IGCs, Subnuclear targeting of the RNA-binding motif Protein Info RBM6 to Nuclear Speckles and nascent transcripts.[SEP]Relations: Nuclear (incident type) speck has relations: cellcomp_protein with SPOP, cellcomp_protein with SPOP, cellcomp_protein with SPRTN, cellcomp_protein with SPRTN, cellcomp_protein with MBD4, cellcomp_protein with MBD4, cellcomp_protein with ERBIN, cellcomp_protein with ERBIN, cellcomp_protein with ILRUN, cellcomp_protein with ILRUN. Definitions: Cell Nucleolus defined as following: Within most types of eukaryotic CELL NUCLEUS, a distinct region, not delimited by a membrane, in which some species of rRNA (RNA, RIBOSOMAL) are synthesized and assembled into ribonucleoprotein subunits of ribosomes. In the Cell Nucleolus rRNA is transcribed from a nucleolar organizer, i.e., a group of tandemly repeated chromosomal genes which encode rRNA and which are transcribed by RNA polymerase I. (Singleton & Sainsbury, Dictionary of Microbiology & Molecular Biology, 2d ed). RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Cell Nucleus defined as following: Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The Nuclear (incident type) membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one Cell Nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). Nuclear Speckles defined as following: A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy. [http://www.cellnucleus.com/]. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. Hypoxia, CTCAE defined as following: A disorder characterized by a decrease in the level of oxygen in the body.. RNA Polymerase II defined as following: A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6.. complex (molecular entity) defined as following: A molecular entity formed by loose association involving two or more component molecular entities. The bonding between the components is normally weaker than in a covalent bond..", "label": "no"} {"original_question": "Is ocrelizumab effective for treatment of multiple sclerosis?", "id": "converted_1766", "sentence1": "Is ocrelizumab effective for treatment of Multiple Sclerosis?", "sentence2": " Advances made in immunomodulation are driving the progress being made in the treatment of MS. Ocrelizumab is the first treatment with positive results in the primarily progressive forms and tocilizumab, a Pharmaceutical Preparations for Rheumatoid Arthritis, stands out as a potential candidate for the treatment of neuromyelitis optica., Expert commentary: The recent encouraging results of the ocrelizumab trial in PP MS, the first to reach the primary disability endpoint, indicate B-Lymphocytes as a promising therapeutic target to prevent disease progression. , Ocrelizumab also shows efficacy in the primary progressive form of Multiple Sclerosis., Ocrelizumab for the treatment of Multiple Sclerosis, Relapsing-Remitting., Expert commentary: The topline results of two phase-III randomized clinical trials demonstrate superiority of ocrelizumab over Recombinant Interferon Beta in RRMS patients with regards to clinical and paraclinical outcome parameters. , The efficacy of three of them, rituximab, ocrelizumab and ofatumumab in MS has been confirmed by placebo-controlled clinical trials demonstrating a significant reduction of the annualized relapsing rate (ARR), new gadolinium-enhancing (GdE) and T2 lesions. , Ongoing POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA trials are currently being conducted with the phosphodiesterase inhibitor ibudilast, S1P modulator siponimod and anti-B-cell therapy ocrelizumab. , RECENT FINDINGS: Novel and imminently emerging DMTs for the treatment of RRMS include alemtuzumab, daclizumab, ocrelizumab, pegylated interferon-β-1a, and three times weekly glatiramer acetate. , To summarize mechanisms of action, efficacy, and safety of novel and imminently emerging disease-modifying treatments (DMTs) intended to be used in Multiple Sclerosis, Relapsing-Remitting (RRMS).Novel and imminently emerging DMTs for the treatment of RRMS include alemtuzumab, daclizumab, ocrelizumab, pegylated interferon-β-1a, and three times weekly glatiramer acetate, Ocrelizumab in Multiple Sclerosis, Relapsing-Remitting: a phase 2, randomised, placebo-controlled, multicentre trial., We aimed to assess efficacy and safety of two dose regimens of the humanised anti-CD20 monoclonal antibody ocrelizumab in patients with Multiple Sclerosis, Relapsing-Remitting. , In Multiple Sclerosis (MS), B cell-depleting therapy using monoclonal anti-CD20 Abs, including rituximab (resiniferatoxin) and ocrelizumab, effectively reduces disease activity. , Ocrelizumab also shows efficacy in the primary progressive form of Multiple Sclerosis.Most of the presented cell-depleting and myeloablative therapies are highly effective treatment options but are also accompanied by significant risks., The armamentarium of approved disease-modifying therapies in MS and those in development include: (1) the first approved, moderately effective, injectable interferon-β and glatiramer acetate; (2) oral drugs (fingolimod, laquinimod, teriflunomide, dimethyl fumarate); (3) monoclonal antibodies (rituximab, ocrelizumab, ofatumumab, daclizumab, alemtuzumab); and (4) immunosuppressive agents (e.g. mitoxantrone)., BACKGROUND: Be2 Cells are implicated in the pathogenesis of Multiple Sclerosis. We aimed to assess efficacy and safety of two dose regimens of the humanised anti-CD20 monoclonal antibody ocrelizumab in patients with Multiple Sclerosis, Relapsing-Remitting.METHODS: We did a multicentre, randomised, parallel, double-blind, placebo-controlled study involving 79 centres in 20 countries. Patients aged 18-55 years with Multiple Sclerosis, Relapsing-Remitting were randomly assigned (1:1:1:1) via an interactive voice response system to receive either placebo, Low-Dose Treatment (600 mg) or high-dose (2000 mg) ocrelizumab in two doses on days 1 and 15, or intramuscular Recombinant Interferon Beta-1a (30 ìg) once a week., Ocrelizumab for the treatment of Multiple Sclerosis, Relapsing-Remitting., The potential role for ocrelizumab in the treatment of Multiple Sclerosis: current evidence and future prospects., Ocrelizumab in Multiple Sclerosis, Relapsing-Remitting: a phase 2, randomised, placebo-controlled, multicentre trial., Ocrelizumab also shows efficacy in the primary progressive form of Multiple Sclerosis.[SEP]Relations: Ocrelizumab has relations: drug_drug with Otelixizumab, drug_drug with Otelixizumab, drug_drug with Afelimomab, drug_drug with Afelimomab, drug_drug with Crenezumab, drug_drug with Crenezumab, drug_drug with Nemolizumab, drug_drug with Nemolizumab, drug_drug with Pexelizumab, drug_drug with Pexelizumab. Definitions: ocrelizumab defined as following: A Fc-modified, humanized monoclonal antibody directed against the B-cell CD20 cell surface antigen, with immunosuppressive activity. Ocrelizumab binds to CD20 on the surfaces of B-cells, triggering complement-dependent cell lysis (CDCL) and antibody-dependent cell-mediated cytotoxicity (ADCC) of B-cells overexpressing CD20. The CD20 antigen, a non-glycosylated cell surface phosphoprotein that acts as a calcium ion channel, is found on over 90% of B-cells, B-cell lymphomas, and other lymphoid tumor cells of B-cell origin; it plays an important role in B-cell functioning.. ofatumumab defined as following: A fully human, high-affinity IgG1 monoclonal antibody directed against the B cell CD20 cell surface antigen with potential antineoplastic activity. Ofatumumab binds specifically to CD20 on the surfaces of B-Lymphocytes, triggering complement-dependent cell lysis (CDCL) and antibody-dependent cell-mediated cytotoxicity (ADCC) of B-Lymphocytes overexpressing CD20. The CD20 antigen, found on over 90% of B-Lymphocytes, B cell lymphomas, and other B-Lymphocytes of lymphoid tumors of B cell origin, is a non-glycosylated cell surface phosphoprotein that acts as a calcium ion channel; it is exclusively expressed on B-Lymphocytes during most stages of B cell development.. Recombinant Interferon Beta defined as following: A recombinant protein which is chemically identical to or similar to endogenous Recombinant Interferon Beta with antiviral and anti-tumor activities. Endogenous interferons beta are cytokines produced by nucleated cells (predominantly natural killer cells) upon exposure to live or inactivated virus, double-stranded RNA or bacterial products. These agents bind to specific cell-surface receptors, resulting in the transcription and translation of genes with an interferon-specific response element. The proteins so produced mediate many complex effects, including antiviral (the most important being inhibition of viral protein synthesis), antiproliferative and immune modulating effects. The recombinant therapeutic forms of Recombinant Interferon Beta are Recombinant Interferon Beta 1-a and Recombinant Interferon Beta 1-b. (NCI05). glatiramer acetate defined as following: A random polymer of L-ALANINE, L-GLUTAMIC ACID, L-LYSINE, and L-TYROSINE that structurally resembles MYELIN BASIC PROTEIN. It is used in the treatment of RELAPSING-REMITTING MULTIPLE SCLEROSIS.. Recombinant Interferon Beta-1a defined as following: A recombinant form of the endogenous cytokine human interferon (IFN) beta-1a, with antiproliferative, antiviral and immunomodulating activities. Upon administration, Recombinant Interferon Beta-1a targets and binds to specific type I IFN receptors, which eventually results in the transcription and translation of genes containing an interferon-specific response element and leads to the production of various anti-viral proteins and modulates the production of various immune-modulating proteins. This reduces the production of certain pro-inflammatory cytokines while upregulating the anti-inflammatory cytokine interleukin 10 (IL-10), upregulates the expression of major histocompatibility (MHC) I proteins which allows for increased presentation of peptides derived from viral antigens, and activates CD8+ T cells as well as other immune cells. Endogenous IFN-beta-1a is produced following viral infection and it plays a key role in innate immune response against viral pathogens.. alemtuzumab defined as following: Any monoclonal antibody directed against the cell surface glycoprotein CD52, regardless of the antibody type (e.g., rat, mouse, humanized).. daclizumab defined as following: An anti-TAC (INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT) humanized monoclonal antibody (immunoglobulin G1 disulfide with human-mouse monoclonal clone 1H4 light chain, dimer) that is used in the treatment of ACUTE RELAPSING MULTIPLE SCLEROSIS.. Rheumatoid Arthritis defined as following: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.. rituximab defined as following: A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.. Multiple Sclerosis, Relapsing-Remitting defined as following: The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914). Multiple Sclerosis defined as following: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903). ibudilast defined as following: An orally bioavailable inhibitor of cyclic nucleotide phosphodiesterase (PDE), mainly PDE-3, -4, -10, and -11, with anti-(neuro)inflammatory, vasorelaxant, bronchodilator, analgesic, neuroprotective and potential anti-tumor activities. Ibudilast (IBD) is able to cross the blood-brain barrier (BBB). Upon administration, IBD exerts its potential anti-tumor activity against glioblastoma multiforme (GBM) cells by inhibiting PDE-4 and the pro-inflammatory cytokine macrophage migration inhibitory factor (MIF), which results in a decrease in MIF, its receptor CD74, and AKT expression, and attenuates the immunosuppressive properties of monocytic myeloid-derived suppressor cells (MDSCs) and reduces T-regulatory cells (Tregs). This causes GBM cell apoptosis and inhibits GBM cell proliferation. In addition, IBD reduces, through its inhibitory effect on various PDEs, the production of certain pro-inflammatory cytokines, such as interleukin-6 (IL-6), IL- 1beta, leukotriene B4, and tumor necrosis factor-alpha (TNF-a). IBD also upregulates the anti-inflammatory cytokine (IL-10), and promotes the production of neurotrophic factors, such as brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and neurotrophin-4 (NT-4). It also blocks toll-like receptor-4 (TLR-4), inhibits nitric oxide (NO) synthesis and reduces the level of reactive oxygen species (ROS). It also prevents platelet aggregation, causes cerebral vasodilation, bronchial smooth muscle relaxation, and improves cerebral blood flow. In addition, IBD attenuates the PDE-mediated activation of glial cells and abrogates PDE-mediated neuroinflammation and neurodegeneration. MIF is secreted by cancer stem cells (CSCs) and is highly expressed within GBM and plays a key role in tumor cell proliferation. Co-expression of MIF and CD74 in GBM is associated with poor patient survival.. fingolimod defined as following: An orally available derivate of myriocin and sphingosine-1-phosphate receptor 1 (S1PR1, S1P1) modulator, with potential anti-inflammatory and immunomodulating activities. Upon oral administration, fingolimod, as a structural analogue of sphingosine, selectively targets and binds to S1PR1 on lymphocytes and causes transient receptor activation followed by S1PR1 internalization and degradation. This results in the sequestration of lymphocytes in lymph nodes. By preventing egress of lymphocytes. fingolimod reduces both the amount of circulating peripheral lymphocytes and the infiltration of lymphocytes into target tissues. This prevents a lymphocyte-mediated immune response and may reduce inflammation. S1PR1, a G-protein coupled receptor, plays a key role in lymphocyte migration from lymphoid tissues. Fingolimod also shifts macrophages to an anti-inflammatory M2 phenotype, and modulates their proliferation, morphology, and cytokine release via inhibition of the transient receptor potential cation channel, subfamily M, member 7 (TRPM7).. POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA defined as following: An exceedingly rare autosomal dominant developmental anomaly reported in 1986 in nine individuals among four generations of the same family. The syndrome has clinical characteristics of four-limb postaxial polydactyly and progressive myopia. There have been no further descriptions in the literature since 1986.. Low-Dose Treatment defined as following: A reduced quantity of a therapeutic agent prescribed to be taken at one time or at stated intervals.. dimethyl fumarate defined as following: An orally bioavailable methyl ester of fumaric acid and activator of nuclear factor erythroid 2 [NF-E2]-related factor 2 (Nrf2, Nfe2l2), with potential neuroprotective, immunomodulating and radiosensitizing activities. Although the exact mechanism of action through which dimethyl fumarate exerts its neuroprotective and immunomodulatory effects have yet to be fully understood, upon oral administration, dimethyl fumarate is converted into its active metabolite monomethyl fumarate (MMF) and MMF binds to Nrf2. Subsequently, Nrf2 translocates to the nucleus and binds to the antioxidant response element (ARE). This induces the expression of a number of cytoprotective genes, including NAD(P)H quinone oxidoreductase 1 (NQO1), sulfiredoxin 1 (Srxn1), heme oxygenase-1 (HO1, HMOX1), superoxide dismutase 1 (SOD1), gamma-glutamylcysteine synthetase (gamma-GCS), thioredoxin reductase-1 (TXNRD1), glutathione S-transferase (GST), glutamate-cysteine ligase catalytic subunit (Gclc) and glutamate-cysteine ligase regulatory subunit (Gclm); this also increases the synthesis of the antioxidant glutathione (GSH). The intraneuronal synthesis of GSH may protect neuronal cells from damage due to oxidative stress. Dimethyl fumarate also appears to inhibit the nuclear factor-kappa B (NF-kB)-mediated pathway, modulates the production of certain cytokines and induces apoptosis in certain T-cell subsets. Its radiosensitizing activity is due to this agent's ability to bind to and sequester intracellular GSH, thereby depleting intracellular GSH and preventing its anti-oxidative effects. This enhances the cytotoxicity of ionizing radiation in hypoxic cancer cells. Nrf2, a leucine zipper transcription factor, plays a key role in redox homeostasis and cytoprotection against oxidative stress.. B-Lymphocytes defined as following: Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.. mitoxantrone defined as following: An anthracenedione-derived antineoplastic agent.. resiniferatoxin defined as following: A naturally occurring capsaicin analog found in the latex of the cactus Euphorbia resinifera with analgesic activity. Resiniferatoxin (resiniferatoxin) binds to and activates the transient receptor potential vanilloid 1 (TRPV1), a non-selective cation channel in the plasma membrane of primary afferent sensory neurons. This increases the permeability to cations, and leads to an influx of calcium and sodium ions. This results in membrane depolarization, causing an irritant effect, followed by desensitization of the sensory neurons thereby inhibiting signal conduction in afferent pain pathways and causing analgesia. TRPV1, a member of the transient receptor potential channel (TRP) superfamily, is a heat- and chemo-sensitive calcium/sodium ion channel that is selectively expressed in a subpopulation of pain-sensing primary afferent neurons.. Pharmaceutical Preparations defined as following: Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.. tocilizumab defined as following: A recombinant, humanized IgG1 monoclonal antibody directed against the interleukin-6 receptor (IL-6R) with immunosuppressant activity. Tocilizumab targets and binds to both the soluble form of IL-6R (sIL-6R) and the membrane-bound form (mIL-6R), thereby blocking the binding of IL-6 to its receptor. This prevents IL-6-mediated signaling. IL-6, a pro-inflammatory cytokine that plays an important role in the regulation of the immune response, is overproduced in autoimmune disorders, certain types of cancers and possibly various other inflammatory conditions..", "label": "yes"} {"original_question": "Is atenolol metabolized by CYP2D6?", "id": "converted_4145", "sentence1": "Is atenolol metabolized by CYP2D6?", "sentence2": "The study analysed the prescribing and dispensing of CYP2D6 drugs (metoprolol, donepezil, galantamine, codeine, tamoxifen) together with CYP2D6-blocking Selective Serotonin Reuptake Inhibitors (paroxetine/fluoxetine) or Selective Serotonin Reuptake Inhibitors without significant CYP2D6 inhibition (citalopram/escitalopram/sertraline), and the related prescribing of CYP2D6-independent comparator drugs (atenolol, rivastigmine, propoxyphene, anastrozole).[SEP]Relations: Atenolol has relations: drug_protein with CYP2D6, drug_protein with CYP2D6, drug_drug with NN344, drug_drug with NN344, drug_protein with ADRB2, drug_protein with ADRB2, drug_drug with Isocarboxazid, drug_drug with Isocarboxazid, drug_protein with ABCB11, drug_protein with ABCB11. Definitions: propoxyphene defined as following: The d-isomer of synthetic diphenyl propionate derivative propoxyphene, with narcotic analgesic effect. This agent mimics the effects of the endogenous opiate dextropropoxyphene, by binding to mu receptors located throughout the central nervous system. The binding results in GTP to GDP exchanges on the mu-G-protein complex, by which effector adenylate cyclase is inactivated thereby decreasing intracellular cAMP. This, in turn, inhibits the release of various nociceptive neurotransmitters, such as substance P, gamma-aminobutyric acid (GABA), dopamine, acetylcholine, noradrenaline, vasopressin, and somatostatin. In addition, dextropropoxyphene closes N-type voltage-gated calcium channels and opens calcium-dependent inwardly rectifying potassium channels. This results in hyperpolarization, thereby reducing neuronal excitability, which further decreases the perception of pain.. Selective Serotonin Reuptake Inhibitors defined as following: Any agent that increases the extracellular level of the neurotransmitter serotonin (5-HT) by inhibiting its reuptake into the presynaptic cell. Increased level in the synaptic cleft prolongs the action of 5-HT on the postsynaptic receptor. This type of agent is typically used as an antidepressant and in the treatment of anxiety disorders and some personality disorders. They are also typically effective and used in treating some cases of insomnia.. donepezil defined as following: The hydrochloride salt of a piperidine derivative with neurocognitive-enhancing activity. Donepezil reversibly inhibits acetylcholinesterase, thereby blocking the hydrolysis of the neurotransmitter acetylcholine and, consequently, increasing its activity. This agent may improve neurocognitive function in Alzheimer's disease, reduce sedation associated with opioid treatment of cancer pain, and improve neurocognitive function in patients who have received radiation therapy for primary brain tumors or brain metastases.. galantamine defined as following: A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to reverse the muscular effects of GALLAMINE TRIETHIODIDE and TUBOCURARINE and has been studied as a treatment for ALZHEIMER DISEASE and other central nervous system disorders.. codeine defined as following: An opioid analgesic related to MORPHINE but with less potent analgesic properties and mild sedative effects. It also acts centrally to suppress cough.. tamoxifen defined as following: One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM.. rivastigmine defined as following: A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.. metoprolol defined as following: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.. atenolol defined as following: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.. CYP2D6 defined as following: Cytochrome P450 2D6 (497 aa, ~56 kDa) is encoded by the human CYP2D6 gene. This protein plays a role in flavoprotein metabolism..", "label": "no"} {"original_question": "Is there any role of 5hmC in T-cell development and differentiation?", "id": "converted_2267", "sentence1": "Is there any role of 5hmC in T-Lymphocyte development and differentiation?", "sentence2": "We have mapped 5-hydroxymethylcytosine (5hmC) at different stages of T-Lymphocyte development in the Thymus and T-Lymphocyte differentiation in the periphery. We show that 5hmC is enriched in the gene body of highly expressed Genes at all developmental stages and that its presence correlates positively with gene expression. Further emphasizing the connection with gene expression, we find that 5hmC is enriched in active Thymus -specific enhancers and that Genes encoding key transcriptional regulators display high intragenic 5hmC levels in Hematopoietic stem cells at those developmental stages where they exert a positive effect. Our data constitute a valuable resource that will facilitate detailed analysis of the role of 5hmC in T-Lymphocyte development and differentiation., We show that 5hmC is enriched in the gene body of highly expressed Genes at all developmental stages and that its presence correlates positively with gene expression., Further emphasizing the connection with gene expression, we find that 5hmC is enriched in active Thymus -specific enhancers and that Genes encoding key transcriptional regulators display high intragenic 5hmC levels in Hematopoietic stem cells at those developmental stages where they exert a positive effect., We show that 5hmC is enriched in the gene body of highly expressed Genes at all developmental stages and that its presence correlates positively with gene expression., Here, we report early and widespread 5mC/5hmC remodeling during human CD4(+) T cell differentiation ex vivo at Genes and cell-specific enhancers with known T cell function., Our results support 5hmC-mediated DNA de-methylation as a key component of CD4(+) T cell biology in Homo sapiens, with important implications for gene regulation and lineage commitment., 5hmC plays important roles in regulation of gene expression and differentiation and has been implicated in T cell malignancies and Autoimmune Diseases.[SEP]Relations: hematopoietic stem cell homeostasis has relations: bioprocess_protein with TCIRG1, bioprocess_protein with TCIRG1, bioprocess_protein with FSTL1, bioprocess_protein with FSTL1, bioprocess_protein with MYCT1, bioprocess_protein with MYCT1, bioprocess_protein with ARMCX5-GPRASP2, bioprocess_protein with ARMCX5-GPRASP2, bioprocess_protein with UBAP2L, bioprocess_protein with UBAP2L. Definitions: T-Lymphocyte defined as following: Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.. Homo sapiens defined as following: Members of the species Homo sapiens.. Autoimmune Diseases defined as following: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.. Thymus defined as following: A plant genus of the family LAMIACEAE best known for the thyme spice added to foods.. Hematopoietic stem cells defined as following: Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Is Impetigo a viral infection that affects the skin?", "id": "converted_3660", "sentence1": "Is Impetigo a viral infection that affects the Skin Specimen Source Code?", "sentence2": "Importance: ozenoxacin, a novel topical antibacterial agent with potent bactericidal activity against gram-positive bacteria, has been developed as a cream with 1% active drug for the treatment of impetigo, a highly contagious Bacterial Infection of Skin Specimen Source Code and/or subcutaneous tissue, : To compare the in vitro activity of the anti-impetigo agent, ozenoxacin, and other Microbicides against Gram-positive clinical isolates from Skin Specimen Source Code and soft tissue infections, Streptococcus pyogenes is responsible for a wide variety of Recurrent Skin Diseases, Infectious ranging from Superficial impetigo to fulminant invasive necrotizing fasciitis., Impetigo is a highly contagious Bacterial Infection of Skin Specimen Source Code and/or subcutaneous tissue and is one of the most common Skin Specimen Source Code infections in children, Impetigo is a Superficial Bacterial Infections that most commonly affects the face and All All extremities of children., Impetigo is the most common Bacterial Infection of Skin Specimen Source Code and/or subcutaneous tissue of children., Impetigo is the most common Bacterial Infection of Skin Specimen Source Code and/or subcutaneous tissue in children two to five years of age., BACKGROUND Impetigo can result from Staphylococcus aureus (Staphylococcus aureus)., Impetigo , Cellulitis , and Specimen Source Codes - Abscess comprise the majority of childhood Bacterial Skin Specimen Source Code infections and are treated with topical or systemic Antifungal Antibiotics, Topical that cover group A Streptococcus and Staphylococcus aureus . , BACKGROUND\nImpetigo can result from Staphylococcus aureus (Staphylococcus aureus)., Impetigo is a Superficial Bacterial Infections that most commonly affects the face and All All extremities of children., Impetigo is a Superficial, but contagious, Bacterial Infections of the Skin Specimen Source Code that predominantly affects children and is common in primary care., Impetigo is a common, Superficial, Bacterial Infections of the Skin Specimen Source Code characterized by an inflamed and infected Epidermal cells., Impetigo, a Bacterial Infection of Skin Specimen Source Code and/or subcutaneous tissue that involves the Superficial layers of the Skin Specimen Source Code, is one of the most common Skin Specimen Source Code infections in children ages 2 to 5 but can occur in individuals across the lifespan., Impetigo contagiosa is a common, Superficial, Bacterial Infections of the Skin Specimen Source Code characterised by an inflamed and infected Epidermal cells caused by Staphylococcus aureus, Streptococcus pyogenes or both.[SEP]Relations: impetigo has relations: disease_disease with Infection of Skin Specimen Source Code and/or subcutaneous tissue, disease_disease with Infection of Skin Specimen Source Code and/or subcutaneous tissue, disease_disease with Skin Specimen Source Code disease caused by infection, disease_disease with Skin Specimen Source Code disease caused by infection, disease_disease with streptococcal infection, disease_disease with streptococcal infection, disease_disease with staphylococcus aureus infection, disease_disease with staphylococcus aureus infection, disease_disease with ecthyma, disease_disease with ecthyma. Definitions: Streptococcus pyogenes defined as following: A species of gram-positive, coccoid bacteria isolated from Skin Specimen Source Code lesions, blood, inflammatory exudates, and the upper respiratory tract of humans. It is a group A hemolytic Streptococcus that can cause SCARLET FEVER and RHEUMATIC FEVER.. Epidermal cells defined as following: Cells from the outermost, non-vascular layer (EPIDERMIS) of the Skin Specimen Source Code.. Microbicides defined as following: Generically, any agent that destroys microbes. However, usage of the term is increasingly being confined to agents that prevent or reduce the transmission of SEXUALLY TRANSMITTED DISEASES.. Bacterial Infections defined as following: Infections by bacteria, general or unspecified.. Impetigo defined as following: A common Superficial Bacterial Infections caused by STAPHYLOCOCCUS AUREUS or group A beta-hemolytic streptococci. Characteristics include pustular lesions that rupture and discharge a thin, amber-colored fluid that dries and forms a crust. This condition is commonly located on the face, especially about the mouth and nose.. Cellulitis defined as following: An acute, diffuse, and suppurative inflammation of loose connective tissue, particularly the deep subcutaneous tissues, and sometimes muscle, which is most commonly seen as a result of infection of a wound, ulcer, or other Skin Specimen Source Code lesions.. Superficial defined as following: Of little substance or significance; involving only a surface.. Recurrent Skin Diseases, Infectious defined as following: Infections of the Skin Specimen Source Code that happen multiple times. [HPO:curators]. Skin Specimen Source Code infections defined as following: Skin diseases caused by bacteria, fungi, parasites, or viruses.. Staphylococcus aureus defined as following: Potentially pathogenic bacteria found in nasal membranes, Skin Specimen Source Code, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications..", "label": "no"} {"original_question": "Can venlafaxine block NET and SERT?", "id": "converted_475", "sentence1": "Can venlafaxine block SLC6A2 protein, Homo sapiens and Selective External Radiation Therapy?", "sentence2": "Treatment for 14 days with 70 mg/kg per day venlafaxine, which inhibits both the SLC6A2 protein, Homo sapiens and Selective External Radiation Therapy, or 10 mg/kg per day phenelzine, a Monoamine Oxidase Inhibitor [EPC], produced antidepressant-like effects on behavior without altering SLC6A2 protein, Homo sapiens or Selective External Radiation Therapy expression., Venlafaxine blocks both serotonin and norepinephrine transporters (Selective External Radiation Therapy and SLC6A2 protein, Homo sapiens), with higher affinity for Selective External Radiation Therapy., Chronic venlafaxine treatment affected Selective External Radiation Therapy and SLC6A2 protein, Homo sapiens binding differently from paroxetine or desipramine., Venlafaxine blocks both serotonin and norepinephrine transporters (Selective External Radiation Therapy and SLC6A2 protein, Homo sapiens), with higher affinity for Selective External Radiation Therapy, paroxetine and venlafaxine are potent serotonin transporter (Selective External Radiation Therapy) antagonists and weaker norepinephrine transporter (SLC6A2 protein, Homo sapiens) antagonists, Using a novel blood assay that estimates CNS transporter occupancy we estimated the relative Selective External Radiation Therapy and SLC6A2 protein, Homo sapiens occupancy of paroxetine and venlafaxine in Homo sapiens subjects to assess the relative magnitude of Selective External Radiation Therapy and SLC6A2 protein, Homo sapiens inhibition, Treatment for 14 days with 70 mg/kg per day venlafaxine, which inhibits both the SLC6A2 protein, Homo sapiens and Selective External Radiation Therapy, or 10 mg/kg per day phenelzine, a Monoamine Oxidase Inhibitor [EPC], produced antidepressant-like effects on behavior without altering SLC6A2 protein, Homo sapiens or Selective External Radiation Therapy expression, We then performed the first reported investigation of epistasis between the Selective External Radiation Therapy gene and Norepinephrine Plasma Membrane Transport Proteins (SLC6A2, alias SLC6A2 protein, Homo sapiens) in ANOREXIA NERVOSA, SUSCEPTIBILITY TO, 1, as an earlier study suggested that atypical ANOREXIA NERVOSA, SUSCEPTIBILITY TO, 1 responds to the dual serotonin-norepinephrine reuptake inhibitor venlafaxine, Of particular interest were the findings that paroxetine, generally thought of as a selective Selective External Radiation Therapy antagonist, possesses moderately high affinity for the SLC6A2 protein, Homo sapiens and that venlafaxine, which has been described as a "dual uptake inhibitor", possesses weak affinity for the SLC6A2 protein, Homo sapiens, The ratios of measured occupancy ED(50) values (doses at which 50% occupancy occurs) among Selective External Radiation Therapy, SLC6A2 protein, Homo sapiens and DAT sites for duloxetine, venlafaxine, nomifensine, indatraline, DOV 21,947 and DOV 216,303 were consistent with the ratios of the in vitro affinities between these target Binding Sites, Selective External Radiation Therapy and SLC6A2 protein, Homo sapiens occupancy by venlafaxine and milnacipran in nonhuman primates: a Positron-Emission Tomography study, In this study in nonhuman primates, we aimed to investigate the relationship between Selective External Radiation Therapy and SLC6A2 protein, Homo sapiens affinity by measuring the in vivo occupancy at both transporters of venlafaxine and milnacipran, We hypothesized that venlafaxine would affect monoamine transporters dose-dependently, with low doses causing selective reduction of Selective External Radiation Therapy Binding Sites and higher doses reducing both Selective External Radiation Therapy and SLC6A2 protein, Homo sapiens Binding Sites, Comparative studies with clinically used Antidepressive Agents showed that venlafaxine possessed a profile similar to S 33005 but was less potent. clomipramine likewise interacted with SERTs and SPINK5 gene but also with several other receptors types, while citalopram and reboxetine were preferential ligands of SERTs and SPINK5 gene, respectively. In conclusion, S 33005 interacts potently with SERTs and, less markedly, with SPINK5 gene. , Venlafaxine blocks both serotonin and norepinephrine transporters (Selective External Radiation Therapy and SLC6A2 protein, Homo sapiens), with higher affinity for Selective External Radiation Therapy. Serotonergic effects occur with lower doses, whereas both serotonergic and noradrenergic effects occur with higher doses of venlafaxine., Taken together, the results from this study indicate that the low dose of venlafaxine blocked selectively the reuptake of serotonin, whereas the high dose blocked the reuptake of both serotonin and No evidence of. Moreover, an enhancement of serotonergic neurotransmission by venlafaxine was only achieved under conditions whereby the desensitization of the terminal serotonin(1B) autoreceptor is appended to that of the somatodendritic serotonin(1A) receptor.[SEP]Relations: Venlafaxine has relations: drug_drug with Netupitant, drug_drug with Netupitant, drug_drug with Sertindole, drug_drug with Sertindole, drug_drug with Sertraline, drug_drug with Sertraline, drug_effect with Intestinal obstruction, drug_effect with Intestinal obstruction, drug_drug with Serotonin, drug_drug with Serotonin. Definitions: phenelzine defined as following: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.. Binding Sites defined as following: The parts of a macromolecule that directly participate in its specific combination with another molecule.. paroxetine defined as following: A serotonin uptake inhibitor that is effective in the treatment of depression.. serotonin defined as following: A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator.. clomipramine defined as following: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.. citalopram defined as following: A furancarbonitrile that is one of the SELECTIVE SEROTONIN REUPTAKE INHIBITORS used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic Antidepressive Agents, which aggravate dyskinesia.. venlafaxine defined as following: A synthetic phenethylamine bicyclic derivative with antidepressant activity. Venlafaxine and its active metabolite, O-desmethylvenlafaxine (ODV), are potent inhibitors of neuronal serotonin and norepinephrine reuptake and weak dopamine reuptake inhibitors. This agent may reduce hormone-related vasomotor symptoms. (NCI04). Positron-Emission Tomography defined as following: An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower.. reboxetine defined as following: A morpholine derivative that is a selective and potent noradrenaline reuptake inhibitor; it is used in the treatment of DEPRESSIVE DISORDER.. nomifensine defined as following: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266). desipramine defined as following: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.. SLC6A2 protein, Homo sapiens defined as following: This gene plays a role in neurotransmitter recycling.. Norepinephrine Plasma Membrane Transport Proteins defined as following: Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of noradrenergic neurons. They remove NOREPINEPHRINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS. The norepinephrine transporter regulates signal amplitude and duration at noradrenergic synapses and is the target of ADRENERGIC UPTAKE INHIBITORS.. Monoamine Oxidase Inhibitor [EPC] defined as following: A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414). Antidepressive Agents defined as following: Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as Antidepressive Agents apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.. milnacipran defined as following: A cyclopropanecarboxamide serotonin and norepinephrine reuptake inhibitor (SNRI) that is used in the treatment of FIBROMYALGIA.. Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Is durvalumab used for lung cancer treatment?", "id": "converted_2832", "sentence1": "Is durvalumab used for Primary malignant neoplasm of lung treatment?", "sentence2": " In the phase III PACIFIC trial consolidation with durvalumab, an anti-PDL-1 immunoglobulin complex location, was associated with survival benefit in patients diagnosed with LA-Non-Small Cell Lung Carcinoma who responded to concurrent chemoradiotherapy., METHODS: An electronic literature search was performed of public databases (MEDLINE, Excerpta Medica dataBASE [EMBASE], and Cochrane) and conference proceedings for trials using Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) (nivolumab and pembrolizumab) and CD274 wt Allele inhibitors (atezolizumab, durvalumab, and avelumab) in patients with Non-Small Cell Lung Carcinoma., Durvalumab in non-small-cell Primary malignant neoplasm of lung patients: current developments., Single-agent durvalumab showed clinical efficacy and a manageable safety profile in advanced non-small-cell Primary malignant neoplasm of lung, particularly the ≥25% CD274 wt Allele+ population., Six drugs including one CTLA-4 blocker (ipilimumab), two PD-1 blockers (nivolumab and pembrolizumab) and three CD274 wt Allele blockers (atezolizumab, avelumab and durvalumab) are approved for the treatment of different types of Malignant Neoplasms including both Solid Neoplasm such as Melanocytic neoplasm, Primary malignant neoplasm of lung, Malignant Head and Neck Neoplasm, Malignant neoplasm of urinary bladder and Merkel cell carcinoma as well as Hematologic Neoplasms such as classic Hodgkin's lymphoma. , PURPOSE OF REVIEW: The therapeutic armamentarium for advanced non-small-cell Primary malignant neoplasm of lung has evolved considerably over the past years. Immune Checkpoint Inhibitors targeting programmed cell death-1 such as pembrolizumab and nivolumab or programmed cell death ligand 1 such as atezolizumab, durvalumab and avelumab have shown favorable efficacy results in this patient population in the first-line and second-line setting., In addition, preclinical and early clinical evidence suggests that chemotherapy and radiation may work synergistically with anti-PD-1/CD274 wt Allele therapy to promote Antitumor immunity, which has led to the initiation of clinical trials testing these drugs in patients with stage III Non-Small Cell Lung Carcinoma. A preliminary report of a randomized phase III trial, the PACIFIC trial, demonstrated an impressive increase in median progression-free survival with consolidative durvalumab, a CD274 wt Allele inhibitor, compared with observation after cCRT. , ICI, such as the Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) nivolumab and pembrolizumab and the CD274 wt Allele inhibitor atezolizumab, have already been marketed for the treatment of pretreated patients with advanced Non-Small Cell Lung Carcinoma., The PACIFIC trial assessing durvalumab after standard chemoradiotherapy for locally advanced Non-Small Cell Lung Carcinoma has already met its primary endpoint and the potential of durvalumab will be reinforced if phase III randomized studies of first-line (MYSTIC trial) and second or subsequent (ARCTIC trial) lines of therapy demonstrate superiority over the current standard of care.
[SEP]Relations: Ipilimumab has relations: drug_drug with Durvalumab, drug_drug with Durvalumab, drug_drug with Dusigitumab, drug_drug with Dusigitumab, drug_drug with Lerdelimumab, drug_drug with Lerdelimumab. Nivolumab has relations: drug_drug with Durvalumab, drug_drug with Durvalumab, drug_drug with Dusigitumab, drug_drug with Dusigitumab. Definitions: CD274 wt Allele defined as following: Human CD274 wild-type allele is located in the vicinity of 9p24 and is approximately 20 kb in length. This allele, which encodes programmed cell death 1 ligand 1 protein, plays a role in the regulation of T cell stimulation and proliferation.. Melanocytic neoplasm defined as following: A benign or malignant, primary or metastatic neoplasm affecting the melanocytes.. Malignant Head and Neck Neoplasm defined as following: A primary or metastatic malignant neoplasm affecting the head and neck. Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma.. Merkel cell carcinoma defined as following: A carcinoma arising from MERKEL CELLS located in the basal layer of the epidermis and occurring most commonly as a primary neuroendocrine carcinoma of the skin. Merkel cells are tactile cells of neuroectodermal origin and histologically show neurosecretory granules. The skin of the head and neck are a common site of Merkel cell carcinoma, occurring generally in elderly patients. (Holland et al., Cancer Medicine, 3d ed, p1245). Solid Neoplasm defined as following: A benign or malignant neoplasm arising from tissues that do not include fluid areas. Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma). Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered Solid Neoplasm.. Hematologic Neoplasms defined as following: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Non-Small Cell Lung Carcinoma defined as following: A heterogeneous aggregate of at least three distinct histological types of Primary malignant neoplasm of lung, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.. ipilimumab defined as following: A recombinant human immunoglobulin (Ig) G1 monoclonal immunoglobulin complex location directed against the human T-cell receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA4), with immune checkpoint inhibitory and antineoplastic activities. Ipilimumab binds to CTLA4 expressed on T-cells and inhibits the CTLA4-mediated downregulation of T-cell activation. This leads to a cytotoxic T-lymphocyte (CTL)-mediated immune response against cancer cells. CTLA4, an inhibitory receptor and member of the immunoglobulin superfamily, plays a key role in the downregulation of the immune system.. Malignant neoplasm of urinary bladder defined as following: A primary or metastatic malignant neoplasm involving the bladder.. nivolumab defined as following: A fully human immunoglobulin (Ig) G4 monoclonal immunoglobulin complex location directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1, PCD-1) with immune checkpoint inhibitory and antineoplastic activities. Upon administration, nivolumab binds to and blocks the activation of PD-1, an immunoglobulin superfamily (IgSF) transmembrane protein, by its ligands programmed cell death ligand 1 (CD274 wt Allele), which is overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on antigen-presenting cells (APCs). This results in the activation of T-cells and cell-mediated immune responses against tumor cells. Activated PD-1 negatively regulates T-cell activation and plays a key role in tumor evasion from host immunity.. immunoglobulin complex location defined as following: A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph. [GOC:add, GOC:jl, ISBN:0781765196]. Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) defined as following: An agent designed to interfere with the activity of programmed cell death protein 1 (PD1). PD1 inhibitors block T-cell apoptosis and act as non-specific activators of the immune system.. Immune Checkpoint Inhibitors defined as following: An agent that inhibits any of the immune checkpoint inhibitory proteins..", "label": "yes"} {"original_question": "Is overproduction of transthyretin is associated with amyloidosis associated neuropathy?", "id": "converted_2410", "sentence1": "Is overproduction of transthyretin is associated with Primary amyloidosis associated Neuropathy?", "sentence2": "Prealbumin-associated familial Serum Serum amyloid A protein A protein polyneuropathy (TTR protein, human protein, human-FAP) is a Disease caused by the deposit of abnormal transthyretin on Body tissue, mainly Nerve, transthyretin familial Serum Serum amyloid A protein A protein polyneuropathy, We report a new transthyretin (TTR protein, human wt Allele) gene c.272C>G mutation and Mutant Proteins, p.Leu32Val, in a kindred of Bolivian origin with a rapid progressive Peripheral Nervous System Diseases and cardiomyopat, Hereditary transthyretin Primary Primary amyloidosis is an autosomal dominant inherited disorder, first described in families with sensorimotor and autonomic Neuropathy., Abnormal deposition of aggregated wild-type (WT) human transthyretin (TTR protein, human protein, human) and its pathogenic variants is responsible for Cardiomyopathies and Neuropathy related to TTR protein, human protein, human Primary Primary amyloidosis. , Prealbumin (TTR protein, human protein, human), normally a plasma circulating protein, can become misfolded and aggregated, ultimately leading to Extracellular deposition of Serum Serum amyloid A protein A protein fibrils usually targeted to Chest>Heart or Nerve Tissue. Referred to as TTR protein, human protein, human-associated amyloidoses (TTR protein, human wt Allele), this group of diseases is frequently life threatening and fatal if untreated, Hereditary transthyretin Primary Primary amyloidosis is an autosomal dominant inherited disorder, first described in families with sensorimotor and autonomic Neuropathy., Hereditary transthyretin Primary Primary amyloidosis (TTR protein, human wt Allele) is usually characterised by a progressive Peripheral and autonomic Neuropathy often with associated Congestive Chest>Heart failure and is due to dominantly inherited transthyretin mutations causing accelerated Serum Serum amyloid A protein A protein deposition.[SEP]Relations: hereditary TTR wt Allele Primary amyloidosis has relations: disease_disease with familial Serum amyloid A protein Neuropathy, disease_disease with familial Serum amyloid A protein Neuropathy, disease_disease with hereditary Primary amyloidosis, disease_disease with hereditary Primary amyloidosis. Optic Neuropathy has relations: disease_phenotype_positive with fatal mitochondrial Disease due to combined oxidative phosphorylation defect type 3, disease_phenotype_positive with fatal mitochondrial Disease due to combined oxidative phosphorylation defect type 3, disease_phenotype_positive with combined oxidative phosphorylation deficiency, disease_phenotype_positive with combined oxidative phosphorylation deficiency. Cardiomyopathy has relations: disease_phenotype_positive with familial Serum amyloid A protein Neuropathy, disease_phenotype_positive with familial Serum amyloid A protein Neuropathy. Definitions: Peripheral Nervous System Diseases defined as following: Diseases of the Peripheral Nerve external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic Nerve, sensory Nerve, and motor Nerve.. Nerve Tissue defined as following: Differentiated tissue of the central nervous system composed of NERVE CELLS, fibers, DENDRITES, and specialized supporting cells.. Serum amyloid A protein defined as following: A family of apolipoproteins that are associated with high-density lipoprotein particles in the serum. These proteins may play a role in both the acute-phase of inflammation and in cholesterol transport.. Cardiomyopathies defined as following: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).. TTR protein, human defined as following: Prealbumin (147 aa, ~16 kDa) is encoded by the human TTR protein, human gene. This protein is involved in both the binding and transport of retinol and thyroxine.. Congestive Chest>Heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Primary amyloidosis defined as following: A group of sporadic, familial and/or inherited, degenerative, and infectious Disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the Serum amyloid A protein deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.. Peripheral defined as following: On or near an edge or constituting an outer boundary; the outer area.. Mutant Proteins defined as following: A protein with an amino acid sequence that differs from the wildtype, canonical sequence.. Prealbumin defined as following: A tetrameric protein, molecular weight between 50,000 and 70,000, consisting of 4 equal chains, and migrating on electrophoresis in 3 fractions more mobile than serum albumin. Its concentration ranges from 7 to 33 per cent in the serum, but levels decrease in liver Disease.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. Nerve defined as following: Part of the Peripheral nervous system composed of bundles of nerve fibers running to various organs and Body tissue of the body using chemical and electrical signals to transmit sensory and motor information from one body part to another.. TTR wt Allele defined as following: Human TTR protein, human wild-type allele is located in the vicinity of 18q12.1 and is approximately 7 kb in length. This allele, which encodes transthyretin protein, plays a role in the stabilization and transport of thyroxine and retinol. Mutations in the gene are associated with hyperthyroxinemia and Primary amyloidosis types 1 and 7.. Extracellular defined as following: The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. [GOC:go_curators]. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Neuropathy defined as following: A disorder affecting the cranial Nerve or the Peripheral nervous system. It manifests with pain, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.. autonomic Neuropathy defined as following: An inherited or acquired Peripheral Nervous System Diseases affecting the autonomic nervous system. It results in disruption of the involuntary body functions. Inherited causes include Fabry Disease and porphyrias. Acquired causes include diabetes, uremia, hepatic disorders, vitamin deficiencies, toxins, and drug toxicities.. transthyretin defined as following: A tetrameric protein, molecular weight between 50,000 and 70,000, consisting of 4 equal chains, and migrating on electrophoresis in 3 fractions more mobile than serum albumin. Its concentration ranges from 7 to 33 per cent in the serum, but levels decrease in liver Disease..", "label": "yes"} {"original_question": "Is delayed enhancement documented in patients with non-ischemic dilated cardiomyopathy?", "id": "converted_653", "sentence1": "Is delayed enhancement documented in patients with non-ischemic Cardiomyopathy, Dilated?", "sentence2": "Myocardial Fibrosis was present in 30% of patients, the majority of which was mid-myocardial (63%). , 3',5'-dichloromethotrexate patients frequently have myocardial Fibrosis detected on CE-CMR, the majority of which is mid-myocardial., Fifty (40%) patients showed myocardial DE, representing 12±7% of LV mass., one case was Cardiomyopathy, Dilated, in which the delayed enhancement was diffuse small midwall spots , In the Cardiomyopathy, Dilated group, only seven (29%) patients showed delayed enhancement and its pattern was characterized by mid-wall, patchy or diffuse location., Patterns of delayed enhancement are different in Cardiomyopathy, Dilated and Ischemic Cardiomyopathies, reflecting the presence of scarring or various degrees of Fibrosis in left ventricular myocardium. The presence of subendocardial or Transmural delayed enhancement at contrast-enhanced cardiovascular magnetic resonance allowed distinction between Cardiomyopathy, Dilated and Ischemic Cardiomyopathies with high sensitivity (88%) and specificity (100%).[SEP]Relations: Cardiomyopathy, Dilated has relations: disease_disease with non-familial Cardiomyopathy, Dilated, disease_disease with non-familial Cardiomyopathy, Dilated, disease_disease with left ventricular noncompaction, disease_disease with left ventricular noncompaction, disease_disease with syndrome associated with Cardiomyopathy, Dilated, disease_disease with syndrome associated with Cardiomyopathy, Dilated, disease_disease with qualitative or quantitative defects of beta-myosin heavy chain (MYH7), disease_disease with qualitative or quantitative defects of beta-myosin heavy chain (MYH7), disease_disease with intrinsic Cardiomyopathies, disease_disease with intrinsic Cardiomyopathies. Definitions: Fibrosis defined as following: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.. 3',5'-dichloromethotrexate defined as following: A chlorinated methotrexate derivative. Dichloromethotrexate inhibits the enzyme dihydrofolate reductase, thereby preventing the synthesis of purine nucleotides and thymidylates and inhibiting DNA and RNA synthesis. This agent is metabolized and excreted by the liver. (NCI04). Cardiomyopathy, Dilated defined as following: Cardiomyopathy which is characterized by dilation and contractile dysfunction of the left and right ventricles. It may be idiopathic, or it may result from a myocardial infarction, myocardial infection, or alcohol abuse. It is a cause of congestive heart failure.. Transmural defined as following: Passing through the wall of an organ or other bodily structure.. Cardiomyopathies defined as following: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS)..", "label": "yes"} {"original_question": "Can GDF15 be a biomarker for metformin treatment?", "id": "converted_2660", "sentence1": "Can GDF15 protein, human be a biomarker for metformin treatment?", "sentence2": "Growth Differentiation Factor 15 as a Novel Biomarker for Metformin., GDF15 protein, human protein, human levels are a biomarker for the use of metformin in people with Dysglycemia, and its concentration reflects the dose of metformin.[SEP]Relations: Metformin has relations: drug_protein with GPD1, drug_protein with GPD1, drug_drug with Glymidine, drug_drug with Glymidine, drug_drug with GLPG-0492, drug_drug with GLPG-0492, drug_drug with Glimepiride, drug_drug with Glimepiride, drug_protein with ETFDH, drug_protein with ETFDH. Definitions: GDF15 protein, human defined as following: Growth/differentiation factor 15 (308 aa, ~34 kDa) is encoded by the human GDF15 protein, human gene. This protein plays a role in both tissue differentiation and signal transduction.. metformin defined as following: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289).", "label": "yes"} {"original_question": "Is there high nucleotide diversity in the Drosophila suzukii species?", "id": "converted_3884", "sentence1": "Is there high nucleotide diversity in the Drosophila suzukii species?", "sentence2": "Native to Asia, the soft-skinned fruit pest Drosophila suzukii has recently invaded the United States and Europe. The eastern United States represents the most recent expansion of their range, and presents an opportunity to test alternative models of colonization history. Here, we investigate the genetic population structure of this invasive fruit fly, with a focus on the eastern United States. We sequenced six X-linked gene fragments from 246 individuals collected from a total of 12 populations. We examine patterns of genetic diversity within and between populations and explore alternative colonization scenarios using approximate Bayesian computation. Our results indicate high levels of nucleotide diversity in this species and suggest that the recent invasions of Europe and the continental United States are independent demographic events. [SEP]", "label": "yes"} {"original_question": "Was golimumab tested for diabetes?", "id": "converted_4031", "sentence1": "Was golimumab tested for diabetes?", "sentence2": "CONCLUSIONS: Among children and young adults with newly diagnosed overt type 1 diabetes, golimumab resulted in better endogenous Therapeutic Insulin production and less exogenous Therapeutic Insulin use than placebo. , Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes., lticenter, placebo-controlled, double-blind, parallel-group trial, we randomly assigned, in a 2:1 ratio, children and young adults (age range, 6 to 21 years) with newly diagnosed overt type 1 diabetes to receive subcutaneous golimumab or placebo for 52 weeks. The primary end point was e, Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes[SEP]Relations: Golimumab has relations: drug_drug with Adalimumab, drug_drug with Adalimumab, drug_drug with Coumarin, drug_drug with Coumarin, drug_drug with Urelumab, drug_drug with Urelumab, drug_drug with Tabalumab, drug_drug with Tabalumab, drug_drug with Eldelumab, drug_drug with Eldelumab. Definitions: golimumab defined as following: A human monoclonal antibody directed against the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-a) with immunosuppressive activity. Golimumab binds to TNF-a, thereby preventing TNF-a-mediated immune responses. TNF-a production is dysregulated in various auto-immune diseases and in cancer.. Therapeutic Insulin defined as following: A synthetic or animal-derived form of Therapeutic Insulin used in the treatment of diabetes mellitus. Therapeutic Therapeutic Insulin is formulated to be short-, intermediate- and long-acting in order to individualize an Therapeutic Insulin regimen according to individual differences in glucose and Therapeutic Insulin metabolism. Therapeutic Therapeutic Insulin may be derived from porcine, bovine or recombinant sources. Endogenous human Therapeutic Insulin, a pancreatic hormone composed of two polypeptide chains, is important for the normal metabolism of carbohydrates, proteins and fats and has anabolic effects on many types of tissues.. diabetes defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE..", "label": "yes"} {"original_question": "Are Mesenchymal stem cells (MSC) multipotent cells?", "id": "converted_2931", "sentence1": "Are Mesenchymal stem cells (MSC) multipotent cells?", "sentence2": "multipotent mesenchymal bone marrow-derived stem cells, multipotent hESC-derived mesenchymal cells (MILES-CARPENTER X-LINKED INTELLECTUAL DEVELOPMENTAL DISORDER)[SEP]Relations: intellectual developmental disorder has relations: disease_phenotype_positive with Macrocephaly, disease_phenotype_positive with Macrocephaly, disease_phenotype_positive with Generalized myoclonic-atonic seizure, disease_phenotype_positive with Generalized myoclonic-atonic seizure, disease_phenotype_positive with Smooth philtrum, disease_phenotype_positive with Smooth philtrum, disease_phenotype_positive with Long palpebral fissure, disease_phenotype_positive with Long palpebral fissure, disease_phenotype_positive with Striae distensae, disease_phenotype_positive with Striae distensae. Definitions: MSC defined as following: A naturally occurring organoselenium compound found in many plants, including garlic, onions, and broccoli, with potential antioxidant and chemopreventive activities. Se-Methyl-seleno-L-cysteine (MSC) is an amino acid analogue of cysteine in which a methylselenium moiety replaces the sulphur atom of cysteine. This agent acts as an antioxidant when incorporated into glutathione peroxidase and has been shown to exhibit potent chemopreventive activity in animal models.. Mesenchymal stem cells defined as following: An undifferentiated stromal cell with the ability to develop into the cells that form distinct mesenchymal tissues; such as bone, muscle, connective tissue, blood vessels, and lymphatic tissue..", "label": "yes"} {"original_question": "Can we detect DNA strand asymmetries using dinucleotide relative abundance \"genomic signatures\"?", "id": "converted_443", "sentence1": "Can we detect DNA strand asymmetries using dinucleotide relative abundance \"genomic signatures\"?", "sentence2": "comparing the heterogeneities of Genome, Bacterial with respect to strand-independent first- and second-order features, (i) G + C content and (ii) dinucleotide relative abundance,, the concept of a genomic signature was introduced with the observation of species-type specific Dinucleoside Phosphates Relative Abundance Profiles (DRAPs); dinucleotides were identified as the subsequences with the greatest bias in representation in a majority of genomes., dinucleotide relative abundance values (the genomic signature), The dinucleotide relative abundance profile can be regarded as a genomic signature because, despite diversity between species, it varies little between 50 kilobase or longer windows on a given Genome - anatomical entity., The profile is computed from the base step \"odds ratios\" that compare dinucleotide frequencies to those expected under the assumption of stochastic equilibrium (thorough shuffling). , The Genome - anatomical entity signatures (dinucleotide relative abundance values), Early biochemical experiments measuring nearest neighbor frequencies established that the set of dinucleotide relative abundance values (dinucleotide biases) is a remarkably stable property of the DNA of an organism., the set of dinucleotide biases constitutes a 'genomic signature' that can discriminate sequences from different Organism., the set of dinucleotide odds ratio (relative abundance) values constitute a signature of each DNA Genome - anatomical entity, Dinucleoside Phosphates relative abundance extremes: a genomic signature., The dinucleotide relative abundance profile can be regarded as a genomic signature because, despite diversity between species, it varies little between 50 kilobase or longer windows on a given Genome - anatomical entity., Previously, the concept of a genomic signature was introduced with the observation of species-type specific Dinucleoside Phosphates Relative Abundance Profiles (DRAPs); dinucleotides were identified as the subsequences with the greatest bias in representation in a majority of genomes., Comparisons within and between species sample sequences are based on the profile of dinucleotide relative abundance values (The profile is rho*XY = f*XY/f*Xf*Y for all XY, where f*X denotes the frequency of the nucleotide X and f*XY denotes the frequency of the dinucleotide XY, both computed from the Sequence - ParameterizedDataType concatenated with its inverted complement)., Dinucleoside Phosphates relative abundances (i.e., dinucleotide representations normalized by the component nucleotide frequencies) are consonant with respect to the leading and lagging strands[SEP]Relations: anatomical entity has relations: anatomy_anatomy with immaterial anatomical entity, anatomy_anatomy with immaterial anatomical entity, anatomy_anatomy with anatomical cluster, anatomy_anatomy with anatomical cluster, anatomy_anatomy with insect mouthpart, anatomy_anatomy with insect mouthpart, anatomy_anatomy with material anatomical entity, anatomy_anatomy with material anatomical entity. male organism has relations: anatomy_anatomy with multicellular organism, anatomy_anatomy with multicellular organism. Definitions: Dinucleoside Phosphates defined as following: A group of compounds which consist of a nucleotide molecule to which an additional nucleoside is attached through the phosphate molecule(s). The nucleotide can contain any number of phosphates.. Genome, Bacterial defined as following: The genetic complement of a BACTERIA as represented in its DNA.. Genome - anatomical entity defined as following: Anatomical set of genes in all the chromosomes.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic Organism normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Organism defined as following: A living entity.. dinucleotide defined as following: A group of compounds which consist of a nucleotide molecule to which an additional nucleoside is attached through the phosphate molecule(s). The nucleotide can contain any number of phosphates..", "label": "no"} {"original_question": "Are there any urine biomarkers for chronic kidney disease?", "id": "converted_79", "sentence1": "Are there any urine biomarkers for chronic Both kidneys disease?", "sentence2": "Kidney and urine proteomic biomarkers are considered as promising diagnostic tools to predict Chronic Kidney Diseases progression early in Diabetic Nephropathy, facilitating timely and selective intervention that may reduce the related health-care expenditures., Both blood and urine biomarkers are reviewed in this paper and offer a considerable opportunity to enhance the understanding of the pathophysiology and known epidemiology of these recently defined syndromes., Cardiorenal syndromes (Congenital Rubella Syndrome) have been subclassified as five defined entities which represent clinical circumstances in which both the Chest>Heart and the Both kidneys are involved in a bidirectional injury and dysfunction via a final common pathway of cell-to-cell death and accelerated apoptosis mediated by oxidative stress., There is a strong association between both acute and chronic dysfunction of the Chest>Heart and kidneys with respect to morbidity and mortality., Both blood and urine biomarkers, including the assessment of catalytic iron, a critical element to the generation of oxygen-free radicals and oxidative stress, are reviewed in this paper., Identification of urine biomarkers has proven to be beneficial in recent years because of ease of handling, stability, and the ability to standardize the various markers to creatine/creatine/creatinine or other Peptides generally already present in the urine. Recent markers such as Neutrophil gelatinase-associated lipocalin (LCN2 wt Allele), Both kidneys injury molecule-1 (KIM-1), and NPHS2 gene have garnered a lot of attention. The emergence of these and other biomarkers is largely because of the evolution of novel Genome and proteomic applications in investigations of acute Both kidneys injury and chronic Both kidneys disease.[SEP]Relations: Diabetic Nephropathy has relations: disease_disease with chronic Both kidneys disease, disease_disease with chronic Both kidneys disease. Chronic Both kidneys disease has relations: phenotype_phenotype with Stage 1 chronic Both kidneys disease, phenotype_phenotype with Stage 1 chronic Both kidneys disease, phenotype_phenotype with Stage 2 chronic Both kidneys disease, phenotype_phenotype with Stage 2 chronic Both kidneys disease, phenotype_phenotype with Renal insufficiency, phenotype_phenotype with Renal insufficiency, disease_phenotype_positive with nephrotic syndrome,, disease_phenotype_positive with nephrotic syndrome,. Definitions: Chronic Kidney Diseases defined as following: Impairment of the renal function secondary to chronic Both kidneys damage persisting for three or more months.. Peptides defined as following: Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of Peptides that can form into complex structures such as ENZYMES and RECEPTORS.. LCN2 wt Allele defined as following: Human LCN2 wild-type allele is located in the vicinity of 9q34 and is approximately 5 kb in length. This allele, which encodes Neutrophil gelatinase-associated lipocalin protein, may be involved in both the modulation of inflammation and the regulation of the transport of hydrophobic substances (ie. retinol, lipopolysaccharide). The expression of this gene may be elevated in many cancers and inflammatory diseases.. Congenital Rubella Syndrome defined as following: Transplacental infection of the fetus with rubella usually in the first trimester of pregnancy, as a consequence of maternal infection, resulting in various developmental abnormalities in the newborn infant. They include cardiac and ocular lesions, deafness, microcephaly, mental retardation, and generalized growth retardation. (From Dorland, 27th ed). Genome defined as following: The genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA.. acute Both kidneys injury defined as following: Sudden and sustained deterioration of the Both kidneys function characterized by decreased glomerular filtration rate, increased serum creatine/creatinine or oliguria.. Diabetic Nephropathy defined as following: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.. chronic Both kidneys disease defined as following: Impairment of the renal function secondary to chronic Both kidneys damage persisting for three or more months..", "label": "yes"} {"original_question": "Is methotrexate used for the treatment of Rheumatoid Arthritis (RA)?", "id": "converted_4138", "sentence1": "Is methotrexate used for the treatment of Rheumatoid Arthritis (RA)?", "sentence2": "The use of methotrexate in Rheumatoid Arthritis., Historical perspective on the use of methotrexate for the treatment of Rheumatoid Arthritis., aminopterin, a folic acid analogue was first reported in 1948 to produce temporary remission of Acute leukemia of children, was also reported in 1951 to produce an important and rapid improvement in patients with Rheumatoid Arthritis (RA) and Psoriasis, The safety and efficacy of the use of methotrexate in long-term therapy for Rheumatoid Arthritis., Methotrexate (MTX) is currently under study for use in juvenile Rheumatoid Arthritis. , The rational use of methotrexate in Rheumatoid Arthritis and other Rheumatism., Methotrexate-induced hepatic cirrhosis is less common in Rheumatoid Arthritis than previously thought, although its occurrence in Psoriasis is probably higher than in Rheumatoid Arthritis. , Methotrexate is clearly effective in the treatment of Rheumatoid Arthritis and may be able to decrease the rate of formation of new bony erosions. , The use of methotrexate in Rheumatoid Arthritis., Review of the international literature on the clinical use of MTX in Rheumatoid Arthritis (RA) Disease., MTX has emerged as a relatively safe and effective treatment for RA that compares favorably with other therapies, particularly because of its considerably longer median drug survival., The objective of this review is to update the recommendations of the 2010 Italian Consensus on the use of methotrexate (MTX) in Rheumatoid Arthritis (RA) and other Rheumatism, A new recommendation for patients with RA who are in MTX-induced clinical remission was also proposed and approved by the panel. Updated recommendations for the use of MTX in patients with RA or other rheumatologic Disease are proposed., Methotrexate has been used in treatment of Rheumatoid Arthritis (RA) since the 1980s and to this day is often the first line medication for RA treatment., OBJECTIVE: Most recommendations for the use of methotrexate (MTX) in Rheumatoid Arthritis (RA) are issued by developed countries., Low dose pulse methotrexate (MTX) has become a widely used therapy for Rheumatoid Arthritis (RA) because of its good response rate profile. With, Treatment with methotrexate (MTX) in Rheumatoid Arthritis (RA) can lead to severe side-effects, especially Pulmonary:-:Point in time:^Patient:- and haematological complications. The ai, Patients having Rheumatoid Arthritis (RA) treated with methotrexate (MTX) are at an increased risk of developing lymphoproliferative disorder (Leiomyomatosis peritonealis disseminata). Epstei, Increasingly, methotrexate (MTX) and sulfasalazine (TXN protein, human) are used initially for second-line therapy of Rheumatoid Arthritis (RA). Althoug, OBJECTIVES: The Folic Acid Antagonists methotrexate (MTX) has become established as the most commonly used Disease-modifying anti-rheumatic drug (DMARD) in the treatment of Rheumatoid Arthritis (RA) but is commonly discontinued due to adverse effe, e suspected methotrexate (MTX)-associated lymphoproliferative disorder (Leiomyomatosis peritonealis disseminata) induced by MTX treatment for Rheumatoid Arthritis (RA). About , BACKGROUND: Treatment with methotrexate (MTX) in patients with Rheumatoid Arthritis (RA) leads to decreased total immunoglobulin (Ig) levels and impairs vaccine-specific IgG antibody levels following pneumococcal vaccinat, In Rheumatoid Arthritis (RA) treatment, the concomitant use of methotrexate has been shown to reduce the incidence of Antibodies, in vitro diagnostic to infliximab (ATI), on the other hand, it is unclear whether azathioprine can reduce ATI production. We enro, Methotrexate (MTX) is known as a first-line synthetic Disease-modifying anti-rheumatic drug (DMARD) for the treatment of Rheumatoid Arthritis (RA)., Biological treatments are expensive and using SC methotrexate can improve Disease control in RA patients, thus potentially avoiding or delaying the requirement for future biological treatment., Most recommendations for the use of methotrexate (MTX) in Rheumatoid Arthritis (RA) are issued by developed countries., We reviewed existing recommendations on the use of MTX for the treatment of RA and summarized areas of agreement that could be relevant for least developed countries (LDCs).M, st covered some but not all of the following areas: baseline \"pre-MTX\" assessment (7/12;58%), prescription of MTX (10/12;83.3%), management of MTX side effects (6/12;50%), and special considerations (e.g., peri-operative management) (8/12; 66.7%). R, lectronic databases and registries were searched for recommendations on MTX use in RA, duplicates were eliminated, and the most updated version adopted when there were several versions on the same recommendation. , MTX must at the present time be used only in severe RA, refractory to more than one classical slow acting drug., MTX is as effective in treating RA as the other second line drugs and always more rapidly effective, perhaps because of Anti-Inflammatory Agents properties., For the low doses used in RA (less than 15 mg/week), MTX is completely and rapidly absorbed with an active process membrane transport., Methotrexate, which is used for RA treatment, causes THROMBOCYTOPENIA 2 (disorder)., Methorexate therapy in a patient with Rheumatoid Arthritis complicated by idiopathic thrombocytopenic purpura., This case shows that methotrexate may be used in patients diagnosed with RA that is associated with Immune thrombocytopenic purpura under strict monitoring., Here, we report an RA case that also had Immune thrombocytopenic purpura, which did not decrease in platelet count after methotrexate therapy., We started methotrexate therapy 10 mg per week for treatment of RA, and hydroxychloroquine therapy was stopped due to nonresponse., Methotrexate (MTX) is the anchor treatment for Rheumatoid Arthritis (RA) and has been very thoroughly studied in many different patient populations, as monotherapy and in combination with various other Disease modifying antirheumatic drugs and Biological Factors, as they became available., Although rheumatologists have been using methotrexate in the treatment of RA for some time, controlled studies have been needed to establish the safety and efficacy of this agent., Methotrexate is generally the first-line drug for the treatment of RA, psoriatic arthritis and other forms of inflammatory arthritis, and it enhances the effect of most Biological Factors in RA., Despite the introduction of numerous Biological Factors for the treatment of Rheumatoid Arthritis (RA) and other forms of inflammatory arthritis, Low-Dose Treatment methotrexate therapy remains the gold standard in RA therapy., A number of studies show the efficacy of methotrexate (MTX) for Rheumatoid Arthritis (RA) in general., Methotrexate (MTX) is currently the most frequently used drugs in the treatment of Rheumatoid Arthritis (RA)., Methotrexate (MTX) has been the anchor treatment in Rheumatoid Arthritis (RA) over the last 15 years, and is used in combination with Biological Factors to enhance efficacy over the last decade or so.[SEP]Relations: Methotrexate has relations: drug_drug with Raltitrexed, drug_drug with Raltitrexed, drug_drug with Methohexital, drug_drug with Methohexital, drug_drug with Raltegravir, drug_drug with Raltegravir, drug_drug with Methadone, drug_drug with Methadone, drug_drug with Benzoic acid, drug_drug with Benzoic acid. Definitions: Biological Factors defined as following: Endogenously synthesized compounds that influence biological processes not otherwise classified under ENZYMES; HORMONES or HORMONE ANTAGONISTS.. methotrexate defined as following: An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.. Psoriasis defined as following: A common genetically determined, chronic, inflammatory skin Disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in Psoriasis.. folic acid defined as following: A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia.. TXN protein, human defined as following: Thioredoxin (105 aa, ~12 kDa) is encoded by the human TXN gene. This protein plays a role in redox reactions, signaling and immunity.. Acute leukemia defined as following: A clonal (malignant) hematopoietic disorder with an acute onset, affecting the bone marrow and the peripheral blood. The malignant cells show minimal differentiation and are called blasts, either myeloid blasts (myeloblasts) or lymphoid blasts (lymphoblasts).. Rheumatoid Arthritis defined as following: A chronic systemic Disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.. aminopterin defined as following: A folic acid derivative used as a rodenticide that has been shown to be teratogenic.. azathioprine defined as following: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of Rheumatoid Arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed). sulfasalazine defined as following: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907). infliximab defined as following: A chimeric monoclonal antibody to TNF-ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE.. Leiomyomatosis peritonealis disseminata defined as following: A rare, benign process that affects the peritoneal cavity and is characterized by the formation of multiple small nodules that are composed of well differentiated smooth muscle. It usually affects adults in their late reproductive years. Most patients are asymptomatic. The tumor nodules may regress spontaneously.. Immune thrombocytopenic purpura defined as following: Thrombocytopenia occurring in the absence of toxic exposure or a Disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The Disease is seen in acute (affecting children) and chronic (adult) forms.. Low-Dose Treatment defined as following: A reduced quantity of a therapeutic agent prescribed to be taken at one time or at stated intervals.. Anti-Inflammatory Agents defined as following: Substances that reduce or suppress INFLAMMATION.. Folic Acid Antagonists defined as following: Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033). Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Rheumatism defined as following: Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.. THROMBOCYTOPENIA 2 (disorder) defined as following: An autosomal dominant disorder caused by mutation(s) in the ANKRD26 gene, encoding ANKRD26 protein. Additionally, in one family, a mutation(s) has been identified in the MASTL gene, encoding serine/threonine-protein kinase greatwall. The condition is characterized by mild to moderate bruisability.. RA defined as following: A chronic systemic Disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated..", "label": "yes"} {"original_question": "Has proteomics been used in the study of Pick's disease?", "id": "converted_676", "sentence1": "Has proteomics been used in the study of Pick Disease of the Brain?", "sentence2": "In Pick Disease of the Brain, increased Age:Time:Point in time:^Patient:Quantitative, Myeloid Leukemia, Chronic, CEL gene gene, ELANE gene and MDAL bands of about 50 kDa were observed in the Cortex of frontal lobe (but not in the Cortex of occipital lobe) in association with increased density of glial acidic protein bands., Thus, Head>Brain and Cerebrospinal Fluid (CSF) samples from patients with ALZHEIMER DISEASE, FAMILIAL, 1, Down Syndrome, Pick Disease of the Brain, Parkinson Disease, SCHIZOPHRENIA 2 (disorder), and other disorders as well as Head>Brain and CSF from animal allergen extracts serving as models of nervous system disorder have been analyzed by proteomics. , The present study is designed to investigate expression of thioredoxin peroxidase (Prxs), the newly characterized family of highly conserved antioxidant enzymes, and other antioxidant enzymes in Cortex of frontal lobe and Cerebellum of DS, cytarabine/daunorubicin protocol and Lugano Lymphoma Response Classification Progressive Disease by PET patients using the technique of proteomics. , methenamine levels were measured in the Cortex of frontal lobe and Cerebellum of brains of patients with cytarabine/daunorubicin protocol, DS, and PiD, and normal aged subjects using proteomics techniques. [SEP]Relations: Down Syndrome has relations: disease_protein with RAD21, disease_protein with RAD21, disease_protein with PRDX6, disease_protein with PRDX6, disease_protein with S100B, disease_protein with S100B, disease_protein with SLC19A1, disease_protein with SLC19A1, disease_protein with PRDX2, disease_protein with PRDX2. Definitions: thioredoxin peroxidase defined as following: A family of ubiquitously-expressed peroxidases that play a role in the reduction of a broad spectrum of PEROXIDES like HYDROGEN PEROXIDE; LIPID PEROXIDES and peroxinitrite. They are found in a wide range of organisms, such as BACTERIA; PLANTS; and MAMMALS. The enzyme requires the presence of a thiol-containing intermediate such as THIOREDOXIN as a reducing cofactor.. Lugano Lymphoma Response Classification Progressive Disease by PET defined as following: A score of 4 or 5 on a 5-point PET scale with an increase in intensity of uptake from baseline and/or new FDG-avid foci consistent with lymphoma at interim or end of treatment assessment.. ELANE gene defined as following: This gene plays a role in innate host defense.. Myeloid Leukemia, Chronic defined as following: chronic leukemia in which myeloid progenitor cells predominate; the hallmark of Myeloid Leukemia, Chronic, the Philadelphia chromosome, is a reciprocal translocation between chromosomes 9 and 22 which activates the proto- oncogene c-abl.. Pick Disease of the Brain defined as following: A rare form of DEMENTIA that is sometimes familial. Clinical features include APHASIA; APRAXIA; CONFUSION; ANOMIA; memory loss; and personality deterioration. This pattern is consistent with the pathologic findings of circumscribed atrophy of the poles of the FRONTAL LOBE and TEMPORAL LOBE. Neuronal loss is maximal in the HIPPOCAMPUS, entorhinal cortex, and AMYGDALA. Some ballooned cortical neurons contain argentophylic (Pick) bodies. (From Brain Pathol 1998 Apr;8(2):339-54; Adams et al., Principles of Neurology, 6th ed, pp1057-9). methenamine defined as following: An anti-infective agent most commonly used in the treatment of urinary tract infections. Its anti-infective action derives from the slow release of formaldehyde by hydrolysis at acidic pH. (From Martindale, The Extra Pharmacopoeia, 30th ed, p173). nervous system disorder defined as following: Diseases of the central and peripheral nervous system. This includes disorders of the Head>Brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.. Cerebrospinal Fluid defined as following: A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES.. Cortex of frontal lobe defined as following: The grey matter, or outermost layer of the frontal lobe.. Down Syndrome defined as following: A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213). ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65.. Cerebellum defined as following: The part of Head>Brain that lies behind the BRAIN STEM in the posterior base of skull (CRANIAL FOSSA, POSTERIOR). It is also known as the \"little Head>Brain\" with convolutions similar to those of CEREBRAL CORTEX, inner white matter, and deep cerebellar nuclei. Its function is to coordinate voluntary movements, maintain balance, and learn motor skills.. Cortex of occipital lobe defined as following: The grey matter, or outermost layer of the occipital lobe.. Parkinson Disease defined as following: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75).", "label": "yes"} {"original_question": "Has istadefylline been considered as a treatment for Parkinson's disease?", "id": "converted_3602", "sentence1": "Has istadefylline been considered as a treatment for Parkinson Disease?", "sentence2": "istradefylline (Urethral intrinsic sphincter deficiency) is a new Pharmacologic Substance developed for the treatment of Parkinson Disease (Lugano Lymphoma Response Classification Progressive Disease by PET). It is an adenosine receptor A2A antagonists that will represent an important option for patients with advanced Lugano Lymphoma Response Classification Progressive Disease by PET where it has been demonstrated efficacy in decreasing daily OFF time and is well tolerated. , The objective of this review is to summarize evidences emerged from clinical studies that have demonstrated the efficacy of Urethral intrinsic sphincter deficiency in advanced parkinsonian patients., Urethral intrinsic sphincter deficiency might represent an alternative option for patients with advanced Lugano Lymphoma Response Classification Progressive Disease by PET.[SEP]Relations: istradefylline has relations: drug_drug with Glimepiride, drug_drug with Glimepiride, drug_drug with Glisoxepide, drug_drug with Glisoxepide, drug_drug with Benzphetamine, drug_drug with Benzphetamine, drug_drug with Methadone, drug_drug with Methadone, drug_drug with Theophylline, drug_drug with Theophylline. Definitions: Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Parkinson Disease defined as following: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75). Lugano Lymphoma Response Classification Progressive Disease by PET defined as following: A score of 4 or 5 on a 5-point PET scale with an increase in intensity of uptake from baseline and/or new FDG-avid foci consistent with lymphoma at interim or end of treatment assessment..", "label": "yes"} {"original_question": "Do we find bacteriophages in the gut?", "id": "converted_4619", "sentence1": "Do we find bacteriophages in the gut?", "sentence2": "a multitude of symbiotic Bacteria and bacteriophages are decreased in abundance in patients with COVID19 (document), Bacteriophages (bacteriophages, phages) of the gut have increasingly become a focus in microbiome studies, with an understanding that they are likely key players in health and disease., Already without exogenous intervention, a multitude of phage-bacterial interactions occur within the human gut, some of which might play a direct role in disease progression, We are surrounded by microbes, mostly Bacteria and their Virus or phages, on the inside and outside of our bodies. , crAssphages are a broad group of diverse bacteriophages in the order Caudovirales that have been found to be highly abundant in the human gastrointestinal tract. Despite their high prevalence, we have an incomplete understanding of how crAssphages shape and respond to ecological and evolutionary dynamics in the gut.[SEP]Relations: Bacteremia has relations: phenotype_phenotype with Bloodstream infectious agent, phenotype_phenotype with Bloodstream infectious agent, disease_phenotype_positive with melioidosis, disease_phenotype_positive with melioidosis, disease_phenotype_positive with nocardiosis, disease_phenotype_positive with nocardiosis, disease_phenotype_positive with shigellosis, disease_phenotype_positive with shigellosis, disease_phenotype_positive with plague, disease_phenotype_positive with plague. Definitions: Bacteriophages defined as following: Viruses whose hosts are bacterial cells.. Virus defined as following: Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells.. Bacteria defined as following: One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive..", "label": "yes"} {"original_question": "Is the SDHAF2 gene encoding a protein necessary for flavination of SDHA?", "id": "converted_1206", "sentence1": "Is the Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein Genes encoding a Protein Info necessary for flavination of Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial?", "sentence2": "Pheochromocytoma-paraganglioma syndrome is caused by Gene Mutation in SDHB Protein Info, human Protein Info, human, SDHC Protein Info, human Protein Info, human, and Succinate Dehydrogenase [Ubiquinone] Cytochrome B Small Subunit, Mitochondrial, encoding subunits of Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein Genes (Succinate Dehydrogenase), and in Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein, required for flavination of Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial. , At present, these are RET Genes, von Hippel-Lindau disease tumor suppressor Genes (Von Hippel-Lindau Syndrome), neurofibromatosis type 1 tumor suppressor Genes (Neurofibromatosis 1), genes encoding the Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein Genes (Succinate Dehydrogenase) complex subunits SDHB Protein Info, human Protein Info, human, SDHC Protein Info, human Protein Info, human, and Succinate Dehydrogenase [Ubiquinone] Cytochrome B Small Subunit, Mitochondrial, but also Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial, the Genes encoding the Enzyme [APC] responsible for the flavination of Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial (Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein or hSDH5), and the newly described TMEM127 gene Genes and MAX tumor suppressor genes., the Genes encoding the Enzyme [APC] responsible for the flavination of Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial (Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein or hSDH5), Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein, required for flavination of Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial, At present, these are RET Genes, von Hippel-Lindau disease tumor suppressor Genes (Von Hippel-Lindau Syndrome), neurofibromatosis type 1 tumor suppressor Genes (Neurofibromatosis 1), genes encoding the Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein Genes (Succinate Dehydrogenase) complex subunits SDHB Protein Info, human Protein Info, human, SDHC Protein Info, human Protein Info, human, and Succinate Dehydrogenase [Ubiquinone] Cytochrome B Small Subunit, Mitochondrial, but also Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial, the Genes encoding the Enzyme [APC] responsible for the flavination of Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial (Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein or hSDH5), and the newly described TMEM127 gene Genes and MAX tumor suppressor genes., Pheochromocytoma-paraganglioma syndrome is caused by Gene Mutation in SDHB Protein Info, human Protein Info, human, SDHC Protein Info, human Protein Info, human, and Succinate Dehydrogenase [Ubiquinone] Cytochrome B Small Subunit, Mitochondrial, encoding subunits of Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein Genes (Succinate Dehydrogenase), and in Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein, required for flavination of Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial., In a recent issue of Science, Rutter and coworkers showed that SDH5 is required for the flavination of Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial, which is necessary for Succinate Dehydrogenase assembly and function., At present, these are RET Genes, von Hippel-Lindau disease tumor suppressor Genes (Von Hippel-Lindau Syndrome), neurofibromatosis type 1 tumor suppressor Genes (Neurofibromatosis 1), genes encoding the Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein Genes (Succinate Dehydrogenase) complex subunits SDHB Protein Info, human Protein Info, human, SDHC Protein Info, human Protein Info, human, and Succinate Dehydrogenase [Ubiquinone] Cytochrome B Small Subunit, Mitochondrial, but also Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial, the Genes encoding the Enzyme [APC] responsible for the flavination of Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial (Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein or hSDH5), and the newly described TMEM127 gene Genes and MAX tumor suppressor genes, Pheochromocytoma-paraganglioma syndrome is caused by Gene Mutation in SDHB Protein Info, human Protein Info, human, SDHC Protein Info, human Protein Info, human, and Succinate Dehydrogenase [Ubiquinone] Cytochrome B Small Subunit, Mitochondrial, encoding subunits of Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein Genes (Succinate Dehydrogenase), and in Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein, required for flavination of Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial, CONTEXT: Pheochromocytoma-paraganglioma syndrome is caused by Gene Mutation in SDHB Protein Info, human Protein Info, human, SDHC Protein Info, human Protein Info, human, and Succinate Dehydrogenase [Ubiquinone] Cytochrome B Small Subunit, Mitochondrial, encoding subunits of Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein Genes (Succinate Dehydrogenase), and in Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein, required for flavination of Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial. , This Genes is co-expressed with a number of genes encoding Mitochondrial Proteins, including SDHB Protein Info, human wt Allele-1, and has low partial sequence similarity to human Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein, a Protein Info required for flavin-adenine dinucleotide (flavin-adenine dinucleotide) Insert (object) into Succinate Dehydrogenase. , At present, these are RET Genes, von Hippel-Lindau disease tumor suppressor Genes (Von Hippel-Lindau Syndrome), neurofibromatosis type 1 tumor suppressor Genes (Neurofibromatosis 1), genes encoding the Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein Genes (Succinate Dehydrogenase) complex subunits SDHB Protein Info, human Protein Info, human, SDHC Protein Info, human Protein Info, human, and Succinate Dehydrogenase [Ubiquinone] Cytochrome B Small Subunit, Mitochondrial, but also Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial, the Genes encoding the Enzyme [APC] responsible for the flavination of Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial (Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein or hSDH5), and the newly described TMEM127 gene Genes and MAX tumor suppressor genes., Pheochromocytoma-paraganglioma syndrome is caused by Gene Mutation in SDHB Protein Info, human Protein Info, human, SDHC Protein Info, human Protein Info, human, and Succinate Dehydrogenase [Ubiquinone] Cytochrome B Small Subunit, Mitochondrial, encoding subunits of Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein Genes (Succinate Dehydrogenase), and in Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein, required for flavination of Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial.[SEP]Relations: Flavin adenine dinucleotide has relations: drug_protein with AIFM1, drug_protein with AIFM1, drug_protein with NQO2, drug_protein with NQO2, drug_protein with DLD, drug_protein with DLD, drug_protein with CYB5R3, drug_protein with CYB5R3, drug_protein with ACAD8, drug_protein with ACAD8. Definitions: Neurofibromatosis 1 defined as following: An autosomal dominant inherited disorder (with a high frequency of spontaneous Gene Mutation) that features developmental changes in the nervous system, muscles, bones, and skin, most notably in tissue derived from the embryonic NEURAL CREST. Multiple hyperpigmented skin lesions and subcutaneous tumors are the hallmark of this disease. Peripheral and central nervous system neoplasms occur frequently, especially OPTIC NERVE GLIOMA and NEUROFIBROSARCOMA. Neurofibromatosis 1 is caused by Gene Mutation which inactivate the Neurofibromatosis 1 Genes (GENES, NEUROFIBROMATOSIS 1) on chromosome 17q. The incidence of learning disabilities is also elevated in this condition. (From Adams et al., Principles of Neurology, 6th ed, pp1014-18) There is overlap of clinical features with NOONAN SYNDROME in a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and Neurofibromatosis 1 Genes products are involved in the SIGNAL TRANSDUCTION pathway of Ras (RAS PROTEINS).. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Succinate Dehydrogenase defined as following: A flavoprotein containing oxidoreductase that catalyzes the dehydrogenation of SUCCINATE to fumarate. In most eukaryotic organisms this Enzyme [APC] is a component of mitochondrial electron transport complex II.. SDHB Protein Info, human defined as following: Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial (280 aa, ~32 kDa) is encoded by the human SDHB Protein Info, human Genes. This Protein Info plays a role in the mediation of redox reactions in the mitochondrial electron transport chain.. Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein defined as following: Succinate dehydrogenase assembly factor 2, mitochondrial (166 aa, ~20 kDa) is encoded by the human Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein Genes. This Protein Info is involved in the regulation of electron transport between succinate and ubiquinone.. TMEM127 gene defined as following: This Genes may play a role in signaling and Protein Info trafficking.. SDHAF2 gene defined as following: This Genes is involved in the electron transport chain.. Succinate Dehydrogenase [Ubiquinone] Cytochrome B Small Subunit, Mitochondrial defined as following: Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial (159 aa, ~17 kDa) is encoded by the human Succinate Dehydrogenase [Ubiquinone] Cytochrome B Small Subunit, Mitochondrial Genes. This Protein Info plays a role in the regulation of the electron transport chain.. Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial defined as following: Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (664 aa, ~73 kDa) is encoded by the human Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial Genes. This Protein Info is involved in the mitochondrial electron transport chain.. flavin-adenine dinucleotide defined as following: A condensation product of riboflavin and adenosine diphosphate. The coenzyme of various aerobic dehydrogenases, e.g., D-amino acid oxidase and L-amino acid oxidase. (Lehninger, Principles of Biochemistry, 1982, p972). SDHB wt Allele defined as following: Human SDHB Protein Info, human wild-type allele is located within 1p36.1-p35 and is approximately 35 kb in length. This allele, which encodes SDHAF2 gene [ubiquinone] iron-sulfur subunit, mitochondrial Protein Info, is involved in the electron transport chain. Mutation of the Genes is associated with pheochromocytoma, hereditary paraganglioma type 4, Carney-Stratakis syndrome and Cowden-like syndrome.. Insert (object) defined as following: Something inserted or to be inserted.. SDHC Protein Info, human defined as following: Succinate dehydrogenase cytochrome b560 subunit, mitochondrial (169 aa, ~19 kDa) is encoded by the human SDHC Protein Info, human Genes. This Protein Info is involved in the localization of SDHAF2 gene.. Mitochondrial Proteins defined as following: Proteins encoded by the mitochondrial genome or proteins encoded by the nuclear genome that are imported to and resident in the MITOCHONDRIA.. Protein Info defined as following: Protein; provides access to the encoding Genes via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. RET gene defined as following: This Genes plays an essential role in neural crest development, cellular growth and differentiation. Mutations in the Genes are associated with a variety of neoplasias and carcinomas.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA.. Von Hippel-Lindau Syndrome defined as following: An autosomal dominant disorder caused by Gene Mutation in a tumor suppressor Genes. This syndrome is characterized by abnormal growth of small blood vessels leading to a host of neoplasms. They include HEMANGIOBLASTOMA in the RETINA; CEREBELLUM; and SPINAL CORD; PHEOCHROMOCYTOMA; pancreatic tumors; and renal cell carcinoma (see CARCINOMA, RENAL CELL). Common clinical signs include HYPERTENSION and neurological dysfunctions.. Succinate Dehydrogenase Assembly Factor 2, Mitochondrial Protein Genes defined as following: This Genes is involved in the electron transport chain..", "label": "yes"} {"original_question": "Can radius fracture cause carpal tunnel syndrome?", "id": "converted_2462", "sentence1": "Can radius Fracture cause Upper extremity>Carpal tunnel syndrome?", "sentence2": "CARPAL TUNNEL SYNDROME 2 (Carpal Tunnel Syndrome) after Bone structure of Bone structure of distal radius fractures can present in 3 forms: acute, transient, and delayed., Complications were categorized as Upper extremity>CARPAL TUNNEL SYNDROME 2, other sensibility issues, Tendon structure complications including irritation and Rupture, deep infections, complex regional pain syndrome and unidentified DRUJ or scapholunar problems., The overall complication rate was 14.6% (95% CI 11.8-17.7) including Upper extremity>CARPAL TUNNEL SYNDROME 2 or change in sensibility in 5.2% and Tendon structure complications in 4.7%. , BACKGROUND: Although median nerve Neuropathy and Upper extremity>CARPAL TUNNEL SYNDROME 2 (Carpal Tunnel Syndrome) are known complications of both untreated and acutely treated Bone structure of Bone structure of distal radius Fracture, median Neuropathy after correction of Bone structure of Bone structure of distal radius Malunion of Bone is not commonly reported in hand surgery literature. , Complications were defined as Malunion of Bone, Upper extremity>CARPAL TUNNEL SYNDROME 2, complex regional pain syndrome (Complex Regional Pain Syndromes), persistent pain, and subjective cosmetic deformity of the Upper extremity>Wrist., CARPAL TUNNEL SYNDROME 2 is a common complication associated with Bone structure of Bone structure of distal radius fractures., The patient also had minor complications of little finger Structure of flexor Tendon structure irritation and Upper extremity>CARPAL TUNNEL SYNDROME 2. She underwent implant removal and Upper extremity>Carpal tunnel release at 8 months., Acute multiple Structure of flexor Tendon structure injury and Upper extremity>CARPAL TUNNEL SYNDROME 2 after open Bone structure of Bone structure of distal radius Fracture., CARPAL TUNNEL SYNDROME 2 is a common condition and is a well-recognized phenomenon following a Bone structure of Bone structure of distal radius Fracture., We report the incidence of late onset post-operative Upper extremity>CARPAL TUNNEL SYNDROME 2 (late Upper extremity>CARPAL TUNNEL SYNDROME 2) and late median nerve Neuropathy after volar plating of Bone structure of Bone structure of distal radius Fracture by conducting a retrospective study on volar plating for Bone structure of Bone structure of distal radius Fracture performed during 2002 to 2006., CARPAL TUNNEL SYNDROME 2 after Bone structure of Bone structure of distal radius Fracture., [Case-control study on transverse carpal ligament resection for the prevention of delayed Upper extremity>CARPAL TUNNEL SYNDROME 2 after Bone structure of Bone structure of distal radius Fracture]., Numbness of hand and Upper extremity>CARPAL TUNNEL SYNDROME 2 after volar plating of Bone structure of Bone structure of distal radius Fracture., Delayed Upper extremity>CARPAL TUNNEL SYNDROME 2 presenting after a Bone structure of Bone structure of distal radius Fracture has healed is best managed in standard fashion., Being well known and accepted techniques of Upper extremity>Carpal tunnel release, we believe that the techniques described in this paper provide a viable alternative for Upper extremity>Carpal tunnel release in the setting of Bone structure of Bone structure of distal radius Fracture fixation; with the added advantages of the original minimally invasive techniques., CARPAL TUNNEL SYNDROME 2 after Fracture of the Bone structure of Bone structure of distal radius is a well known complication in adults, but in small children Upper extremity>CARPAL TUNNEL SYNDROME 2 is extremely rare., Carpal Tunnel Syndrome and Distal Radius Fractures., CARPAL TUNNEL SYNDROME 2 after Bone structure of Bone structure of distal radius Fracture., Numbness of hand and Upper extremity>CARPAL TUNNEL SYNDROME 2 after volar plating of Bone structure of Bone structure of distal radius Fracture.[SEP]Relations: Upper extremity>Carpal tunnel syndrome has relations: disease_disease with nerve compression syndrome, disease_disease with nerve compression syndrome, disease_disease with nerve compression syndrome, disease_disease with nerve compression syndrome, disease_disease with genetic peripheral Neuropathy, disease_disease with genetic peripheral Neuropathy, disease_disease with genetic peripheral Neuropathy, disease_disease with genetic peripheral Neuropathy, disease_protein with TTR, disease_protein with TTR. Definitions: Carpal Tunnel Syndrome defined as following: Entrapment of the MEDIAN NERVE in the Upper extremity>Carpal tunnel, which is formed by the flexor retinaculum and the CARPAL BONES. This syndrome may be associated with repetitive occupational trauma (CUMULATIVE TRAUMA DISORDERS); Upper extremity>Wrist injuries; AMYLOID NEUROPATHIES; rheumatoid arthritis (see ARTHRITIS, RHEUMATOID); ACROMEGALY; PREGNANCY; and other conditions. Symptoms include burning pain and paresthesias involving the ventral surface of the hand and fingers which may radiate proximally. Impairment of sensation in the distribution of the median nerve and thenar muscle atrophy may occur. (Joynt, Clinical Neurology, 1995, Ch51, p45). Malunion of Bone defined as following: Faulty healing of bone, resulting in improper anatomical alignment.. Fracture defined as following: A traumatic injury to the bone in which the continuity of the bone is broken.. Complex Regional Pain Syndromes defined as following: Conditions characterized by pain involving an extremity or other body region, HYPERESTHESIA, and localized autonomic dysfunction following injury to soft tissue or nerve. The pain is usually associated with ERYTHEMA; SKIN TEMPERATURE changes, abnormal sudomotor activity (i.e., changes in sweating due to altered sympathetic innervation) or edema. The degree of pain and other manifestations is out of proportion to that expected from the inciting event. Two subtypes of this condition have been described: type I; (REFLEX SYMPATHETIC DYSTROPHY) and type II; (CAUSALGIA). (From Pain 1995 Oct;63(1):127-33). Tendon structure defined as following: Fibrous bands or cords of CONNECTIVE TISSUE at the ends of SKELETAL MUSCLE FIBERS that serve to attach the MUSCLES to bones and other structures.. Neuropathy defined as following: A disorder affecting the cranial nerves or the peripheral nervous system. It manifests with pain, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.. Rupture defined as following: Forcible or traumatic tear or break of an organ or other soft part of the body..", "label": "yes"} {"original_question": "Does a selective sweep increase genetic variation?", "id": "converted_813", "sentence1": "Does a selective sweep increase genetic variation?", "sentence2": "An East African population that gave rise to non-Africans underwent a selective sweep affecting the subcentromeric region where MTMR8 gene gene is located. This and similar sweeps in four other regions of the X Chromosome, documented in the literature, effectively reduced genetic diversity of non-African chromosomes, a selective sweep that has removed genetic variation from much of the drive X Chromosome., evidence of reduced diversity and an excess of fixed replacement sites, consistent with a species-wide selective sweep., recent independent selective sweeps in EIF2C2 protein, Homo sapiens have reduced genetic variation, episodes of natural selection (likely a selective sweep) predating the coalescent of Homo sapiens lineages, within the last 25 million years, account for the observed reduced diversity, reduced variation or deviations from neutrality that might indicate a recent selective sweep, Consider a Genetic Loci carrying a strongly beneficial Alleles which has recently fixed in a large population. As strongly beneficial alleles fix quickly, sequence diversity at partially linked neutral loci is reduced. This phenomenon is known as a selective sweep., a local selective sweep or demographic process that reduced variability, reduced variation (a selective sweep), the DNA, Mitochondrial diversity, but not the nuclear DNA diversity, has been reduced relative to the neutral expectation of molecular evolution, suggesting the action of a selective sweep, Furthermore, the amount of genetic variation after a selective sweep is expected to be unequal over demes: a greater reduction in expected heterozygosity occurs in the subpopulation from which the beneficial Mutation Abnormality originates than in its neighboring subpopulations., Our observation of reduction in variation at both intragenic and flanking loci of mutant pfcrt gene confirmed the selective sweep model of natural selection in chloroquine resistant P., A selective sweep describes the reduction of linked genetic variation due to strong positive selection., In these situations, adaptation should commonly produce 'soft' selective sweeps, where multiple adaptive alleles sweep through the population at the same time, either because the alleles were already present as standing genetic variation or arose independently by recurrent de novo Gene Mutation., CONCLUSIONS: The severe reduction in nucleotide variation at OsAMT1;1 in rice was caused by a selective sweep around OsAMT1;1, which may reflect the nitrogen uptake system under strong selection by the paddy soil during the domestication of rice., A selective sweep describes the reduction of linked genetic variation due to strong positive selection[SEP]Relations: adaptation to pheromone regulating conjugation with mutual genetic exchange has relations: bioprocess_bioprocess with response to pheromone regulating conjugation with mutual genetic exchange, bioprocess_bioprocess with response to pheromone regulating conjugation with mutual genetic exchange, bioprocess_bioprocess with regulation of conjugation, bioprocess_bioprocess with regulation of conjugation, bioprocess_bioprocess with negative adaptation of signaling pathway, bioprocess_bioprocess with negative adaptation of signaling pathway. Lacrimation abnormality has relations: phenotype_phenotype with Decreased lacrimation, phenotype_phenotype with Decreased lacrimation, phenotype_phenotype with Gustatory lacrimation, phenotype_phenotype with Gustatory lacrimation. Definitions: EIF2C2 protein, Homo sapiens defined as following: Protein argonaute-2 (859 aa, ~97 kDa) is encoded by the Homo sapiens EIF2C2 protein, Homo sapiens gene. This protein plays a role in RNA catabolism.. Alleles defined as following: Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product.. Homo sapiens defined as following: Members of the species Homo sapiens.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. DNA, Mitochondrial defined as following: Double-stranded DNA of MITOCHONDRIA. In eukaryotes, the mitochondrial GENOME is circular and codes for ribosomal RNAs, transfer RNAs, and about 10 proteins.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Genetic Loci defined as following: Specific regions that are mapped within a GENOME. Genetic loci are usually identified with a shorthand notation that indicates the chromosome number and the position of a specific band along the P or Q arm of the chromosome where they are found. For example the locus 6p21 is found within band 21 of the P-arm of CHROMOSOME 6. Many well known genetic loci are also known by common names that are associated with a genetic function or HEREDITARY DISEASE.. X Chromosome defined as following: The female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in Homo sapiens and other male-heterogametic species..", "label": "no"} {"original_question": "Are there plasma membrane receptors for thyroid hormones?", "id": "converted_900", "sentence1": "Are there Plasma membrane receptors for thyroid hormones?", "sentence2": "ntegrins are heterodimeric structural components of the Plasma membrane whose ligands include a large number of Extracellular Matrix (ECM) Proteins. , Recently, integrin αvβ3 has been shown to have a panel of previously unappreciated small molecule receptor sites for Thyroid Hormones and hormone analogues, for Dihydrotestosterone, and for resveratrol, a polyphenols that has certain estrogen-like features., The Integrins activation by T4 thoracic segmental innervation thoracic segmental innervation may take a role in Plasma membrane processes involved in the male reproductive system., Rapid signaling via this Plasma membrane binding site appears to be responsible for many nongenomic effects of thyroid hormones, independent of the classic nuclear receptors.[SEP]Relations: Plasma membrane has relations: cellcomp_protein with DTNA, cellcomp_protein with DTNA, cellcomp_protein with TSHR, cellcomp_protein with TSHR, cellcomp_protein with DTNB, cellcomp_protein with DTNB, cellcomp_protein with WAS, cellcomp_protein with WAS, cellcomp_protein with TDG, cellcomp_protein with TDG. Definitions: Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Plasma membrane defined as following: The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells.. Integrins defined as following: A family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors (RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation.. resveratrol defined as following: A stilbene and non-flavonoid polyphenols produced by various plants including grapes and blueberries. It has anti-oxidant, anti-inflammatory, cardioprotective, anti-mutagenic, and anti-carcinogenic properties. It also inhibits platelet aggregation and the activity of several DNA HELICASES in vitro.. Dihydrotestosterone defined as following: The most potent androgen, required for sex development. Dihydrotestosterone is synthesized from testosterone in the prostate gland, testes, hair follicles and adrenal glands by 5-alpha reductase. Dihydrotestosterone exerts its action similar to testosterone, which binds to and activates specific nuclear androgen receptors. After translocation into the nucleus, the activated hormone-receptor complex binds to the androgen response elements on the DNA and activates gene expressions that are required for sex development. Dihydrotestosterone is responsible for the formation of male primary sex characteristics and most male secondary sex characteristics during puberty, such as muscular growth, facial and body hair growth, and deepening of the voice.. polyphenols defined as following: A large class of organic compounds having more than one PHENOL group.. Extracellular Matrix defined as following: A meshwork-like substance found within the extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which cells or cell lysates in culture dishes adhere.. Thyroid Hormones defined as following: Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs.. thyroid hormones defined as following: Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs..", "label": "yes"} {"original_question": "Is Fanconi anemia presented as a genetically and clinically heterogeneous disease entity?", "id": "converted_1274", "sentence1": "Is Fanconi Genus Anemia presented as a genetically and clinically heterogeneous Disease entity?", "sentence2": "Fanconi Anemia (doxorubicin/fluorouracil protocol) is a rare, Autosomal recessive inheritance, genetically complex, DNA repair deficiency syndrome in man. Patients with doxorubicin/fluorouracil protocol exhibit a heterogeneous spectrum of clinical features. The most significant and consistent phenotypic characteristics are stem cell loss, causing progressive Bone marrow hypocellularity and sterility, diverse developmental abnormalities and a profound predisposition to Neoplasms. To date, 15 Genes have been identified, biallelic disruption of any one of which results in this clinically defined syndrome, Fanconi Genus Anemia (doxorubicin/fluorouracil protocol) is a clinically and genetically heterogeneous disorder, Significant phenotypic differences were found. doxorubicin/fluorouracil protocol-G patients had more severe Cytopenia and a higher incidence of leukemia. Somatic abnormalities were less prevalent in doxorubicin/fluorouracil protocol-C, but more common in the rare groups doxorubicin/fluorouracil protocol-D, doxorubicin/fluorouracil protocol-E, and doxorubicin/fluorouracil protocol-F. In doxorubicin/fluorouracil protocol-A, patients homozygous for null Gene Mutation had an earlier onset of Genus Anemia and a higher incidence of leukemia than those with Gene Mutation producing an altered protein, Fanconi Genus Anemia (doxorubicin/fluorouracil protocol), an Autosomal Recessive Disorder characterized by a progressive Pancytopenia associated with congenital anomalies and high predisposition to Malignant Neoplasms, is a genetically and clinically heterogeneous Disease. At least eight complementation groups (doxorubicin/fluorouracil protocol-A to doxorubicin/fluorouracil protocol-H) have been identified, Fanconi Genus Anemia (doxorubicin/fluorouracil protocol), an Autosomal Recessive Disorder characterized by a progressive Pancytopenia associated with congenital anomalies and high predisposition to Malignant Neoplasms, is a genetically and clinically heterogeneous Disease. At least eight complementation groups (doxorubicin/fluorouracil protocol-A to doxorubicin/fluorouracil protocol-H) have been identified with their relative prevalence varying among the ethnical backgrounds, Fanconi Genus Anemia is a rare Autosomal Recessive Disorder characterized clinically by congenital abnormalities, progressive Bone marrow hypocellularity, and a predisposition to malignancy. doxorubicin/fluorouracil protocol cells are sensitive to DNA cross-linking agents. Complementation analysis of doxorubicin/fluorouracil protocol cells using somatic cell fusion has facilitated the identification of eight complementation groups, suggesting that doxorubicin/fluorouracil protocol is a genetically heterogeneous disorder. Six Genes (FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder), FANCONI ANEMIA, COMPLEMENTATION GROUP C, FANCONI ANEMIA, COMPLEMENTATION GROUP D2, FANCONI ANEMIA, COMPLEMENTATION GROUP E, FANGF, fanconi Genus Anemia complementation group g) have been cloned so far, Fanconi Genus Anemia (doxorubicin/fluorouracil protocol), an Autosomal Recessive Disorder characterized by a progressive Pancytopenia associated with congenital anomalies and high predisposition to Malignant Neoplasms, is a genetically and clinically heterogeneous Disease., Fanconi Genus Anemia (doxorubicin/fluorouracil protocol), an Autosomal Recessive Disorder characterized by a progressive Pancytopenia associated with congenital anomalies and high predisposition to Malignant Neoplasms, is a genetically and clinically heterogeneous Disease., Among patients with Bone marrow hypocellularity (BMF) syndrome, some are happened to have underlying Fanconi Genus Anemia (doxorubicin/fluorouracil protocol), a genetically heterogeneous Disease, which is characterized by progressive Pancytopenia and Primary malignant neoplasm susceptibility., Fanconi Genus Anemia (doxorubicin/fluorouracil protocol) is a genetically and phenotypically heterogeneous inherited Disease., Fanconi Genus Anemia is a genetically heterogeneous recessive Disease characterized mainly by Bone marrow hypocellularity and Primary malignant neoplasm predisposition., INTRODUCTION: Fanconi Genus Anemia (doxorubicin/fluorouracil protocol) is a genetically and phenotypically heterogeneous inherited Disease., Fanconi Genus Anemia (doxorubicin/fluorouracil protocol) is a genetically heterogeneous, Autosomal Recessive Disorder characterized by pediatric Bone marrow hypocellularity and congenital anomalies., Fanconi Genus Anemia (doxorubicin/fluorouracil protocol) is a heterogeneous Disease associated with a Bone marrow hypocellularity, Primary malignant neoplasm predisposition and Emotional Emotional hypersensitivity to DNA crosslinking agents., Fanconi Genus Anemia is a genetically heterogeneous chromosomal instability syndrome, characterized by multiple congenital anomalies, progressive Bone marrow hypocellularity, and a predisposition to malignancy., Fanconi Genus Anemia (doxorubicin/fluorouracil protocol) is a heterogeneous Disease characterized by spontaneous chromosomal breaks and abnormal DNA repair., Fanconi Genus Anemia (doxorubicin/fluorouracil protocol) is a genetically heterogeneous Disease with at least eight Genes on the basis of complementation groups (FAA to FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) wt Allele)., Fanconi Genus Anemia (doxorubicin/fluorouracil protocol) is a clinically and genetically heterogeneous disorder., Fanconi Anemia (doxorubicin/fluorouracil protocol) is a genetically heterogeneous Disease with at least eight complementation groups (A-H)., doxorubicin/fluorouracil protocol is a genetically heterogeneous Disease with at least seven Genes so far identified., Fanconi Genus Anemia (doxorubicin/fluorouracil protocol) is an Autosomal recessive inheritance rare Disease characterized by progressive Pancytopenia, Congenital Abnormality and predisposition to Leukemia, Myelocytic, Acute., Fanconi Genus Anemia is genetically heterogeneous, with at least eight complementation groups of doxorubicin/fluorouracil protocol (FAA to FAD2)., Fanconi Genus Anemia (doxorubicin/fluorouracil protocol), an Autosomal Recessive Disorder characterized by a progressive Pancytopenia associated with congenital anomalies and high predisposition to Malignant Neoplasms, is a genetically and clinically heterogeneous Disease, Fanconi Genus Anemia (doxorubicin/fluorouracil protocol), an Autosomal Recessive Disorder characterized by a progressive Pancytopenia associated with congenital anomalies and high predisposition to Malignant Neoplasms, is a genetically and clinically heterogeneous Disease, The Disease is clinically heterogeneous; eight different complementation groups (doxorubicin/fluorouracil protocol A-H) and, thus, Genetic Loci have been discovered, The hereditary genetic disorder Fanconi Genus Anemia (doxorubicin/fluorouracil protocol) belongs to the heterogeneous group of diseases associated with defective DNA damage repair, The clinical manifestations of doxorubicin/fluorouracil protocol are heterogeneous, but one common outcome in the majority of patients is the development of life-threatening hematologic Disease, Fanconi Genus Anemia is a genetically heterogeneous chromosomal breakage disorder exhibiting a high degree of clinical variability, Fanconi Genus Anemia (doxorubicin/fluorouracil protocol) is a genetically heterogeneous chromosomal instability syndrome associated with multiple congenital abnormalities, aplastic Genus Anemia, and Primary malignant neoplasm, Fanconi Genus Anemia (doxorubicin/fluorouracil protocol) is a genetically heterogeneous Autosomal recessive inheritance syndrome associated with chromosomal instability, Emotional Emotional hypersensitivity to DNA cross-linking agents, and predisposition to malignancy, Fanconi Genus Anemia (doxorubicin/fluorouracil protocol) is a rare Autosomal recessive inheritance Disease characterized by progressive Pancytopenia, Congenital Abnormality, and predisposition to Leukemia, Myelocytic, Acute, Fanconi Genus Anemia (doxorubicin/fluorouracil protocol) is a heterogeneous Disease characterized by spontaneous chromosomal breaks and abnormal DNA repair, Fanconi Genus Anemia (doxorubicin/fluorouracil protocol) is a genetically and phenotypically heterogeneous recessive disorder characterized by diverse Congenital Abnormality, progressive Pancytopenia and predisposition to both Hematologic Neoplasms and Solid Neoplasm, Fanconi Genus Anemia is a genetically heterogeneous chromosomal instability syndrome, characterized by multiple congenital anomalies, progressive Bone marrow hypocellularity, and a predisposition to malignancy[SEP]Relations: Fanconi Genus Anemia has relations: disease_disease with congenital Genus Anemia, disease_disease with congenital Genus Anemia, disease_disease with genetic skin Disease, disease_disease with genetic skin Disease. Fanconi Genus Anemia complementation group has relations: disease_disease with Fanconi Genus Anemia, disease_disease with Fanconi Genus Anemia, disease_disease with Fanconi Genus Anemia, disease_disease with Fanconi Genus Anemia, disease_disease with Fanconi Genus Anemia, disease_disease with Fanconi Genus Anemia. Definitions: FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) defined as following: Fanconi Genus Anemia caused by Gene Mutation of the FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) gene. FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) gene Gene Mutation are the most common cause of Fanconi Genus Anemia. This gene provides instructions for making a protein that is involved in the Fanconi Genus Anemia (doxorubicin/fluorouracil protocol) pathway.. Autosomal Recessive Disorder defined as following: An inherited disorder manifested only when two copies of a mutated gene are present.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Leukemia, Myelocytic, Acute defined as following: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.. FANCONI ANEMIA, COMPLEMENTATION GROUP C defined as following: Fanconi Genus Anemia caused by Gene Mutation of the FANCONI ANEMIA, COMPLEMENTATION GROUP C gene. This gene provides instructions for making a protein that delays the onset of apoptosis and promotes homologous recombination repair of damaged DNA.. FANCA wt Allele defined as following: Human FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) wild-type allele is located in the vicinity of 16q24.3 and is approximately 79 kb in length. This allele, which encodes Fanconi Genus Anemia group A protein, may play a role in the regulation of both DNA repair and the cell cycle. Mutation of the gene is associated with Fanconi Genus Anemia.. FANCONI ANEMIA, COMPLEMENTATION GROUP D2 defined as following: Fanconi Genus Anemia caused by Gene Mutation of the FANCONI ANEMIA, COMPLEMENTATION GROUP D2 gene. This gene is involved in the repair of DNA double-strand breaks, both by homologous recombination and single-strand annealing.. leukemia defined as following: A progressive, malignant Disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006). Hematologic Neoplasms defined as following: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.. Emotional hypersensitivity defined as following: Heightened emotional reactivity to environmental stimuli, including emotions of others. [PMID:23250816]. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Congenital Abnormality defined as following: Malformations of organs or body parts during development in utero.. Pancytopenia defined as following: Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.. Genetic Loci defined as following: Specific regions that are mapped within a GENOME. Genetic loci are usually identified with a shorthand notation that indicates the chromosome number and the position of a specific band along the P or Q arm of the chromosome where they are found. For example the locus 6p21 is found within band 21 of the P-arm of CHROMOSOME 6. Many well known Genetic Loci are also known by common names that are associated with a genetic function or HEREDITARY DISEASE.. fanconi anemia complementation group g defined as following: Fanconi Genus Anemia caused by Gene Mutation of the fanconi anemia complementation group g gene.. FANCONI ANEMIA, COMPLEMENTATION GROUP E defined as following: Fanconi Genus Anemia caused by Gene Mutation of the FANCONI ANEMIA, COMPLEMENTATION GROUP E gene. This is a protein coding gene. It is required for the nuclear accumulation of FANCONI ANEMIA, COMPLEMENTATION GROUP C and provides a critical bridge between the doxorubicin/fluorouracil protocol complex and FANCONI ANEMIA, COMPLEMENTATION GROUP D2.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Autosomal recessive inheritance defined as following: A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in individuals with two pathogenic alleles, either homozygotes (two copies of the same mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele). [HPO:probinson]. aplastic Genus Anemia defined as following: A form of Genus Anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. hematologic Disease defined as following: Disorders of the blood and blood forming tissues.. Bone marrow hypocellularity defined as following: A reduced number of hematopoietic cells present in the bone marrow relative to marrow fat. [DDD:wouwehand, HPO:probinson]. Fanconi Anemia defined as following: Congenital disorder affecting all bone marrow elements, resulting in ANEMIA; LEUKOPENIA; and THROMBOPENIA, and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. Spontaneous CHROMOSOME BREAKAGE is a feature of this Disease along with predisposition to LEUKEMIA. There are at least 7 complementation groups in Fanconi Genus Anemia: FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder), FANCB, FANCONI ANEMIA, COMPLEMENTATION GROUP C, FANCD1, FANCONI ANEMIA, COMPLEMENTATION GROUP D2, FANCONI ANEMIA, COMPLEMENTATION GROUP E, FANCF, fanconi anemia complementation group g, and FANCL. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=227650, August 20, 2004). Solid Neoplasm defined as following: A benign or malignant neoplasm arising from tissues that do not include fluid areas. Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma). Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered Solid Neoplasm.. Cytopenia defined as following: A laboratory test result indicating an abnormally low quantity of circulating blood cells.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms..", "label": "yes"} {"original_question": "Is endostatin a proangiogenic factor?", "id": "converted_404", "sentence1": "Is COL18A1 gene a proangiogenic factor?", "sentence2": "COL18A1 gene (antiangiogenic factor, antiangiogenic factors include Thrombospondin 1, PLG gene, and COL18A1 gene, human COL18A1 gene (rh-COL18A1 gene), a potential antiangiogenic agent, , antiangiogenic PF4 and COL18A1 gene, Angiostatins and COL18A1 gene are endogenous inhibitors of angiogenesis with anticancer effects, the antiangiogenic factors, Cystatin C (substance) and COL18A1 gene, were measured, accumulation of COL18A1 gene and Abeta peptides which have been shown to be antiangiogenic, antioangiogenic factors such as pigment epithelial derived factor (SERPINF1 wt Allele, Human), PLG gene, COL18A1 gene, Endostatin is an antiangiogenic growth factor., angiogenesis PPP1R1A gene COL18A1 gene, Circulating and Cells proangiogenic and antiangiogenic proteins such as Recombinant Vascular Endothelial Growth Factor (Vascular Endothelial Growth Factor A) and COL18A1 gene contribute to the local angiogenic balance, Thrombospondin-1 (Thrombospondin 1, human), COL18A1 gene, and COL4A3 gene are Extracellular matrix-associated proteins that inhibit angiogenesis, specific inhibitors of angiogenesis such as platelet factor 1 1, PLG gene, COL18A1 gene, COL18A1 gene, an endogenous PPP1R1A gene of angiogenesis., antiangiogenic factors (pigment epithelium-derived factor [SERPINF1 wt Allele, Human]; PLG gene; CAP-Gly Domain-Containing Linker Protein 1, human; and COL18A1 gene, COL18A1 gene Peptides, a potent PPP1R1A gene of angiogenesis derived from Collagen Type XVIII,, endogenous angiogenesis inhibitors COL18A1 gene , ndostatin is a potent PPP1R1A gene of angiogenesis and tumor growth., endogenous angiogenesis PPP1R1A gene - COL18A1 gene , Endostatin (ES), a Fragment of (qualifier value) of collagen XVIII, is an endogenous PPP1R1A gene of angiogenesis, antiangiogenic protein COL18A1 gene, A number of endogenous inhibitors of angiogenesis are found in the body. Some of these are synthesized by specific cells in different Organ, and others are created by Extracellular proteolytic cleavage of plasma-derived or Extracellular matrix-localized proteins. In this review, we focus on PLG gene, COL18A1 gene,, COL18A1 gene (a direct PPP1R1A gene of angiogenesis) , endogenous angiogenesis PPP1R1A gene COL18A1 gene, Endostatin, a Peptides derived from proteolysis of collagen XVIII, is an endogenous PPP1R1A gene of angiogenesis and tumor growth. , anti-angiogenic factor COL18A1 gene, Endostatin is the first endogenous angiogenesis PPP1R1A gene to enter clinical trials, Angiogenesis Inhibitors such as COL18A1 gene, COL18A1 gene inhibits the angiogenic switch, antiangiogenic COL18A1 gene , direct acting antiangiogenic agents (e.g., COL18A1 gene) , Endostatin is an antiangiogenic Fragment of (qualifier value) of the basement membrane protein, collagen XVIII., specific inhibitors of angiogenesis such as platelet factor 1 1-4, PLG gene, COL18A1 gene, Endostatin, which is a natural PPP1R1A gene of angiogenesis, Angiostatins and COL18A1 gene are two powerful inhibitors of angiogenesis in experimental models[SEP]Relations: Platelet Activating Factor has relations: drug_drug with Enoxaparin, drug_drug with Enoxaparin, drug_drug with Argatroban, drug_drug with Argatroban, drug_drug with Menadione, drug_drug with Menadione, drug_drug with Epoprostenol, drug_drug with Epoprostenol, drug_drug with Apixaban, drug_drug with Apixaban. Definitions: Recombinant Vascular Endothelial Growth Factor defined as following: A recombinant therapeutic agent which is chemically identical to or similar to endogenous Recombinant Vascular Endothelial Growth Factor (Vascular Endothelial Growth Factor A). Produced by a wide variety of cell types, endogenous Vascular Endothelial Growth Factor A is a homodimeric, glycosylated protein that is a highly specific mitogen for vascular endothelial cells; significantly influences vascular permeability; appears to play a role in neovascularisation under physiological conditions; is a potent chemoattractant; has pro-coagulatory activities; and is hypoxia-inducible. Therapeutic Vascular Endothelial Growth Factor A may be used to induce angiogenesis in the treatment of ischemic conditions and may have a role in stimulating nerve regeneration. (NCI04). COL18A1 gene defined as following: This gene is involved in anti-angiogenic mediation.. Thrombospondin 1 defined as following: An Extracellular matrix glycoprotein from platelets and a variety of normal and transformed cells of both mesenchymal and epithelial origin. Thrombospondin-1 is believed to play a role in cell migration and proliferation, during embryogenesis and wound repair. Also, it has been studied for its use as a potential regulator of tumor growth and metastasis.. Vascular Endothelial Growth Factor A defined as following: The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as \"tumor angiogenesis factor\" and \"vascular permeability factor\". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for Recombinant Vascular Endothelial Growth Factor A results in several isoforms of the protein being produced.. SERPINF1 wt Allele, Human defined as following: Human SERPINF1 wild-type allele is located in the vicinity of 17p13.3 and is approximately 16 kb in length. This allele, which encodes pigment epithelium-derived factor protein, plays a role in both angiogenesis and cell proliferation. Mutation of the gene is associated with osteogenesis imperfecta type 12.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. thrombospondin-1, human defined as following: Thrombospondin-1 (1170 aa, ~129 kDa) is encoded by the human THBS1 gene. This protein plays a role in both cell-cell and cell-matrix interactions.. Angiostatins defined as following: Circulating 38-kDa proteins that are internal Peptides fragments of PLASMINOGEN. The name derives from the fact that they are potent ANGIOGENESIS INHIBITORS. Angiostatins contain four KRINGLE DOMAINS which are associated with their potent angiostatic activity.. PLG gene defined as following: This gene is involved in blood coagulation/hemostasis. It also plays a role in embryonic development, tissue remodeling and inflammation.. COL4A3 gene defined as following: This gene plays a role in the compositional and structural regulation of basement membranes.. Peptides defined as following: Members of the class of compounds composed of AMINO ACIDS joined together by Peptides bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS.. Fragment of (qualifier value) defined as following: A physical quality in which the entity or structure is broken into pieces.. Extracellular defined as following: The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. [GOC:go_curators]. Angiogenesis Inhibitors defined as following: Agents and endogenous substances that antagonize or inhibit the development of new blood vessels.. Cystatin C (substance) defined as following: An Extracellular cystatin subtype that is abundantly expressed in bodily fluids. It may play a role in the inhibition of interstitial CYSTEINE PROTEASES.. platelet factor 1-4 defined as following: Platelet factor 4 (101 aa, ~11 kDa) is encoded by the human PF4 gene. This protein is involved in the negative regulation of endothelial cell proliferation, the chemotaxis of neutrophils and monocytes and the positive regulation of blood coagulation.. Collagen Type XVIII defined as following: A non-fibrillar collagen found in BASEMENT MEMBRANE. The C-terminal end of the alpha1 chain of collagen type XVIII contains the ENDOSTATIN Peptides, which can be released by proteolytic cleavage.. CAP-Gly Domain-Containing Linker Protein 1, human defined as following: CAP-Gly domain-containing linker protein 1 (1427 aa, ~161 kDa) is encoded by the human CLIP1 gene. This protein plays a role in both centrosome formation and endocytosis.. Organ defined as following: A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues. An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus..", "label": "no"} {"original_question": "Are there ultraconserved regions in the budding yeast (Saccharomyces cerevisiae)?", "id": "converted_2911", "sentence1": "Are there ultraconserved regions in the Cell budding yeast (Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae)?", "sentence2": "The systematic analysis of ultraconserved genomic regions in the Cell Cell budding yeast., In the evolution of species, a kind of special DNA Sequence, termed ultraconserved DNA Sequence (UCSs), have been inherited without any change, which strongly suggests those DNA Sequence should be crucial for the species to survive or adapt to the environment. However, the UCSs are still regarded as mysterious genetic DNA Sequence so far. Here, we present a systematic study of ultraconserved genomic regions in the Cell Cell budding yeast based on the publicly available genome DNA Sequence, in order to reveal their relationship with the adaptability or fitness advantages of the Cell Cell budding yeast.Results: Our results indicate that, in addition to some fundamental biological functions, the UCSs play an important role in the adaptation of Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae or Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae cerevisiae to the acidic environment, which is backed up by the previous observation. Besides that, we also find the highly unchanged genes are enriched in some other pathways, such as the nutrient-sensitive signaling pathway. To facilitate the investigation of unique UCSs, the UCSC Genome - anatomical entity - anatomical entity Browser was utilized to visualize the chromosomal position and related annotations of UCSs in S.cerevisiae genome., Here, we present a systematic study of ultraconserved genomic regions in the Cell Cell budding yeast based on the publicly available genome DNA Sequence, in order to reveal their relationship with the adaptability or fitness advantages of the Cell Cell budding yeast., Motivation\nIn the evolution of species, a kind of special DNA Sequence, termed ultraconserved DNA Sequence (UCSs), have been inherited without any change, which strongly suggests those DNA Sequence should be crucial for the species to survive or adapt to the environment., The systematic analysis of ultraconserved genomic regions in the Cell Cell budding yeast.In the evolution of species, a kind of special DNA Sequence, termed ultraconserved DNA Sequence (UCSs), have been inherited without any change, which strongly suggests those DNA Sequence should be crucial for the species to survive or adapt to the environment. , Here, we present a systematic study of ultraconserved genomic regions in the Cell Cell budding yeast based on the publicly available genome DNA Sequence, in order to reveal their relationship with the adaptability or fitness advantages of the Cell Cell budding yeast. , Here, we present a systematic study of ultraconserved genomic regions in the Cell Cell budding yeast based on the publicly available genome DNA Sequence, in order to reveal their relationship with the adaptability or fitness advantages of the Cell Cell budding yeast.
Results: Our results indicate that, in addition to some fundamental biological functions, the UCSs play an important role in the adaptation of Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae or Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae cerevisiae to the acidic environment, which is backed up by the previous observation.[SEP]Relations: cell Cell budding has relations: bioprocess_bioprocess with axial cellular bud site selection, bioprocess_bioprocess with axial cellular bud site selection, bioprocess_bioprocess with bipolar cellular bud site selection, bioprocess_bioprocess with bipolar cellular bud site selection, bioprocess_bioprocess with cell division, bioprocess_bioprocess with cell division, bioprocess_bioprocess with asexual reproduction, bioprocess_bioprocess with asexual reproduction, bioprocess_bioprocess with reproduction of a single-celled organism, bioprocess_bioprocess with reproduction of a single-celled organism. Definitions: DNA Sequence defined as following: The sequence of nucleotide residues along a DNA chain.. Genome - anatomical entity defined as following: Anatomical set of genes in all the chromosomes.. Cell budding defined as following: A form of asexual reproduction, occurring in certain bacteria and fungi (e.g. yeasts) and some primitive animals in which an individual arises from a daughter cell formed by pinching off a part of the parent cell. The budlike outgrowths so formed may sometimes remain attached to the parent cell. [ISBN:0198506732].", "label": "yes"} {"original_question": "Have thyronamines effects on fat tissue?", "id": "converted_1596", "sentence1": "Have thyronamines effects on fat tissue?", "sentence2": "Intraperitoneal or central injection of 3-T(1)AM or T(0)AM into CASP14 gene, Rattus norvegicus, or Djungarian hamsters caused various prompt effects, such as metabolic depression, Hypothermia due to exposure, negative chronotropy, negative inotropy, Glucose in blood specimen above reference range, reduction of the respiratory quotient, Ketonuria, and reduction of fat mass. [SEP]Relations: Ketonuria has relations: drug_effect with Propafenone, drug_effect with Propafenone, drug_effect with Streptozocin, drug_effect with Streptozocin, drug_effect with Acitretin, drug_effect with Acitretin, drug_effect with Rosiglitazone, drug_effect with Rosiglitazone, drug_effect with Carbamazepine, drug_effect with Carbamazepine. Definitions: Rattus norvegicus defined as following: The common rat, Rattus norvegicus, often used as an experimental organism.. Ketonuria defined as following: The presence of ketone bodies in the urine.. Hypothermia due to exposure defined as following:

Cold weather can affect your body in different ways. You can get frostbite, which is an injury to the body that is caused by freezing. Your body can also lose heat faster than you can produce it. That can cause Hypothermia due to exposure, or abnormally low body temperature. It can make you sleepy, confused, and clumsy. Because it happens gradually and affects your thinking, you may not realize you need help. That makes it especially dangerous. A body temperature below 95 °F (35 °C) is a medical emergency and can lead to death if not treated promptly.

Anyone who spends much time outdoors in cold weather can get Hypothermia due to exposure. You can also get it from being cold and wet, or under cold water for too long. Babies and old people are especially at risk. Babies can get it from sleeping in a cold room.

Centers for Disease Control and Prevention

. fat tissue defined as following: Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white..", "label": "yes"} {"original_question": "Is there a role for TET proteins in invariant natural killer T cells (iNKT) cell fate?", "id": "converted_3670", "sentence1": "Is there a role for TET proteins in invariant natural killer T cells (iNKT) cell fate?", "sentence2": "TET proteins regulate the lineage specification and transcription-coupled nucleotide-excision repair-mediated expansion of Invariant Natural Killer T-Cells., We found that simultaneous Gene Deletion Abnormality of Probable Methylcytosine Dioxygenase TET2 and Methylcytosine Dioxygenase TET3 in Mus sp. CD4+CD8+ double-positive thymocytes resulted in dysregulated development and proliferation of invariant natural killer T cells (Invariant Natural Killer T-Cells). Probable Methylcytosine Dioxygenase TET2-Methylcytosine Dioxygenase TET3 double-knockout (DKO) Invariant Natural Killer T-Cells displayed pronounced skewing toward the NKT17 lineage, with increased DNA methylation and impaired expression of Genes encoding the key lineage-specifying factors TBX21 wt Allele and ZBTB7B wt Allele. Transfer of purified Probable Methylcytosine Dioxygenase TET2-Methylcytosine Dioxygenase TET3 DKO Invariant Natural Killer T-Cells into immunocompetent recipient CASP14 gene resulted in an uncontrolled expansion that was dependent on the nonclassical major histocompatibility complex (MHC) protein CD1D protein, human, which presents lipid antigens to Invariant Natural Killer T-Cells. Our data indicate that TET proteins regulate iNKT cell fate by ensuring their proper development and maturation and by suppressing aberrant proliferation mediated by the T-Cell Receptor (transcription-coupled nucleotide-excision repair)., TET proteins regulate the lineage specification and transcription-coupled nucleotide-excision repair-mediated expansion of Invariant Natural Killer T-Cells .[SEP]Relations: T cell receptor complex has relations: cellcomp_protein with TRAT1, cellcomp_protein with TRAT1, cellcomp_protein with SYK, cellcomp_protein with SYK, cellcomp_protein with TRGJ2, cellcomp_protein with TRGJ2, cellcomp_protein with TRGV11, cellcomp_protein with TRGV11, cellcomp_protein with TRGC1, cellcomp_protein with TRGC1. Definitions: T-Cell Receptor defined as following: Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains.. transcription-coupled nucleotide-excision repair defined as following: The nucleotide-excision repair process that carries out preferential repair of DNA lesions on the actively transcribed strand of the DNA duplex. In addition, the transcription-coupled nucleotide-excision repair pathway is required for the recognition and repair of a small subset of lesions that are not recognized by the global genome nucleotide excision repair pathway. [PMID:10197977, PMID:11900249]. Methylcytosine Dioxygenase TET3 defined as following: Methylcytosine dioxygenase TET3 (1660 aa, ~179 kDa) is encoded by the human TET3 gene. This protein plays a role in oxidative demethylation of DNA.. Probable Methylcytosine Dioxygenase TET2 defined as following: Methylcytosine dioxygenase TET2 (2002 aa, ~224 kDa) is encoded by the human TET2 gene. This protein is involved in methylcytosine oxidation.. Invariant Natural Killer T-Cells defined as following: A natural killer T-cell subtype bearing an invariant T-cell receptor. Invariant natural killer T-cells recognize a small variety of glycolipid antigens presented in the context of CD1D protein, human. These cells play a regulatory role during an immune response by producing cytokines.. TBX21 wt Allele defined as following: Human TBX21 wild-type allele is located in the vicinity of 17q21.32 and is approximately 13 kb in length. This allele, which encodes T-box transcription factor TBX21 protein, plays a role in the transcriptional regulation of interferon-gamma. Genetic variation is associated with susceptibility to asthma with nasal polyps and aspirin intolerance.. CD1D protein, human defined as following: Antigen-presenting glycoprotein CD1D protein, human (335 aa, ~38 kDa) is encoded by the human CD1D gene. This protein is involved in lipid antigen presentation.. ZBTB7B wt Allele defined as following: Human ZBTB7B wild-type allele is located in the vicinity of 1q21.3 and is approximately 16 kb in length. This allele, which encodes zinc finger and BTB domain-containing protein 7B, is involved in the repression of type I collagen gene expression and the promotion of CD4-positive T-cell differentiation.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. invariant natural killer T cells defined as following: A natural killer T-cell subtype bearing an invariant T-cell receptor. Invariant natural killer T-cells recognize a small variety of glycolipid antigens presented in the context of CD1D protein, human. These cells play a regulatory role during an immune response by producing cytokines..", "label": "yes"} {"original_question": "Are there canonical marks of active chromatin in developmentally regulated genes?", "id": "converted_1995", "sentence1": "Are there canonical marks of active chromatin location in developmentally regulated Genes?", "sentence2": "Absence of canonical marks of active chromatin location location in developmentally regulated Genes., The interplay of active and repressive Histone Code is assumed to have a key role in the regulation of gene expression. In contrast to this generally accepted view, we show that the transcription of Genes temporally regulated during Fly (organism) and worm development occurs in the absence of canonically active Histone Code. Conversely, strong chromatin location location marking is related to transcriptional and post-transcriptional stability, an association that we also observe in Mammals. Our results support a model in which chromatin location location marking is associated with the stable production of RNA, whereas unmarked chromatin location location would permit rapid gene activation and deactivation during development. In the latter case, regulation by TRANSCRIPTION FACTOR would have a comparatively more important regulatory role than chromatin location location marks., Absence of canonical marks of active chromatin location location in developmentally regulated Genes, Absence of canonical marks of active chromatin location location in developmentally regulated Genes., In contrast to this generally accepted view, we show that the transcription of Genes temporally regulated during Fly (organism) and worm development occurs in the absence of canonically active Histone Code.[SEP]Relations: RNA localization to chromatin location has relations: bioprocess_protein with HNRNPU, bioprocess_protein with HNRNPU. histone modification has relations: bioprocess_bioprocess with covalent chromatin location modification, bioprocess_bioprocess with covalent chromatin location modification. transcription factor binding has relations: molfunc_protein with METTL23, molfunc_protein with METTL23, molfunc_protein with PSMD10, molfunc_protein with PSMD10, molfunc_protein with ZNF618, molfunc_protein with ZNF618. Definitions: chromatin location defined as following: The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130]. Histone Code defined as following: The covalent alteration of one or more amino acid residues within a histone protein. [GOC:krc]. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young..", "label": "no"} {"original_question": "Could bioprinting be used in regenerative medicine against bone disease?", "id": "converted_1177", "sentence1": "Could bioprinting be used in regenerative medicine against Specimen Type - Bone disease?", "sentence2": "Before 3 Days Printing can be used routinely for the regeneration of complex Body tissue (e.g. Specimen Type - Bone, Cartilage, Muscle Tissue, Blood Vessel, Nerve in the craniomaxillofacial complex), and complex organs with intricate 3 Days microarchitecture (e.g. Abdomen>Liver, Lymphoid organ structure), several technological limitations must be addressed. , It is expected that these new findings will give an innovation boost for the development of scaffolds for Specimen Type - Bone repair and reconstruction, which began with the use of bioinert materials, followed by bioactive materials and now leading to functional regenerative tissue units. These new developments have become possible with the discovery of the morphogenic activity of bioinorganic polymers, biocalcit, bio-polyphosphate and biosilica that are formed by a biogenic, enzymatic mechanism, a driving force along with the development of novel rapid-prototyping three-dimensional (3 Days) printing methods and bioprinting (3 Days cell printing) techniques that may allow a fabrication of customized Procedure Procedure implants:Finding:Point in time:^Patient:Narrative:Finding:Point in time:^Patient:Narrative for patients suffering in Bone Diseases in the future., These new developments have become possible with the discovery of the morphogenic activity of bioinorganic polymers, biocalcit, bio-polyphosphate and biosilica that are formed by a biogenic, enzymatic mechanism, a driving force along with the development of novel rapid-prototyping three-dimensional (3 Days) printing methods and bioprinting (3 Days cell printing) techniques that may allow a fabrication of customized Procedure Procedure implants:Finding:Point in time:^Patient:Narrative:Finding:Point in time:^Patient:Narrative for patients suffering in Bone Diseases in the future., 3 Days bioprinting has already been used for the generation and transplantation of several Body tissue, including multilayered skin, Specimen Type - Bone, Biological blood vessel prosthesis, tracheal splints, Heart tissue and cartilaginous structures., a driving force along with the development of novel rapid-prototyping three-dimensional (3 Days) printing methods and bioprinting (3 Days cell printing) techniques that may allow a fabrication of customized Procedure Procedure implants:Finding:Point in time:^Patient:Narrative:Finding:Point in time:^Patient:Narrative for patients suffering in Bone Diseases in the future., These new developments have become possible with the discovery of the morphogenic activity of bioinorganic polymers, biocalcit, bio-polyphosphate and biosilica that are formed by a biogenic, enzymatic mechanism, a driving force along with the development of novel rapid-prototyping three-dimensional (3 Days) printing methods and bioprinting (3 Days cell printing) techniques that may allow a fabrication of customized Procedure Procedure implants:Finding:Point in time:^Patient:Narrative:Finding:Point in time:^Patient:Narrative for patients suffering in Bone Diseases in the future.[SEP]Relations: Specimen Type - Bone disease has relations: disease_disease with Specimen Type - Bone remodeling disease, disease_disease with Specimen Type - Bone remodeling disease, disease_disease with Specimen Type - Bone development disease, disease_disease with Specimen Type - Bone development disease, disease_disease with connective tissue disease, disease_disease with connective tissue disease, disease_disease with disease of Specimen Type - Bone structure, disease_disease with disease of Specimen Type - Bone structure, disease_disease with skeletal system disease, disease_disease with skeletal system disease. Definitions: Blood Vessel defined as following: Any of the tubular Blood Vessel conveying the blood (arteries, arterioles, capillaries, venules, and veins).. Bone Diseases defined as following: Diseases of BONES.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. Nerve defined as following: Part of the peripheral nervous system composed of bundles of nerve fibers running to various organs and Body tissue of the body using chemical and electrical signals to transmit sensory and motor information from one body part to another.. Muscle Tissue defined as following: Contractile tissue that produces movement in animals.. Biological blood vessel prosthesis defined as following: Blood vessel prostheses manufactured from processed biological tissue.. Cartilage defined as following: A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE.. Specimen Type - Bone disease defined as following: Diseases of BONES..", "label": "yes"} {"original_question": "Does gepotidacin activate bacterial topoisomerase?", "id": "converted_2802", "sentence1": "Does gepotidacin activate bacterial topoisomerase?", "sentence2": "GSK2140944 is a novel bacterial topoisomerase inhibitor in development for the treatment of Bacterial Infections.[SEP]Relations: Recurrent Bacterial Infections has relations: disease_phenotype_positive with purine nucleoside phosphorylase deficiency, disease_phenotype_positive with purine nucleoside phosphorylase deficiency, disease_phenotype_positive with chromomycosis, disease_phenotype_positive with chromomycosis, disease_phenotype_positive with adenosine deaminase deficiency, disease_phenotype_positive with adenosine deaminase deficiency, disease_phenotype_positive with pancytopenia due to IKZF1 mutations, disease_phenotype_positive with pancytopenia due to IKZF1 mutations, disease_phenotype_positive with Chediak-Higashi syndrome, disease_phenotype_positive with Chediak-Higashi syndrome. Definitions: Bacterial Infections defined as following: Infections by bacteria, general or unspecified..", "label": "no"} {"original_question": "Can mogamulizumab be used for the treatment of cutaneous T-cell lymphoma?", "id": "converted_3027", "sentence1": "Can mogamulizumab be used for the treatment of Lymphoma, T-Cell, Cutaneous?", "sentence2": "In the large international phase III MAVORIC trial, patients with previously treated Lymphoma, T-Cell, Cutaneous who received the anti-CCR4 monoclonal antibody mogamulizumab experienced significantly longer progression-free survival and higher response rates, as well as better quality of life, than those who received vorinostat, a standard therapy.[SEP]Relations: Cutaneous T-cell lymphoma has relations: phenotype_phenotype with T-cell lymphoma, phenotype_phenotype with T-cell lymphoma, disease_phenotype_positive with Sezary syndrome, disease_phenotype_positive with Sezary syndrome, disease_phenotype_positive with mycosis fungoides and variants, disease_phenotype_positive with mycosis fungoides and variants. Vorinostat has relations: drug_effect with T-cell lymphoma, drug_effect with T-cell lymphoma, drug_drug with Eculizumab, drug_drug with Eculizumab. Definitions: Lymphoma, T-Cell, Cutaneous defined as following: A group of lymphomas exhibiting clonal expansion of malignant T-lymphocytes arrested at varying stages of differentiation as well as malignant infiltration of the skin. MYCOSIS FUNGOIDES; SEZARY SYNDROME; LYMPHOMATOID PAPULOSIS; and PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA are the best characterized of these disorders.. vorinostat defined as following: A synthetic hydroxamic acid derivative with antineoplastic activity. Vorinostat, a second generation polar-planar compound, binds to the catalytic domain of the histone deacetylases (HDACs). This allows the hydroxamic moiety to chelate zinc ion located in the catalytic pockets of HDAC, thereby inhibiting deacetylation and leading to an accumulation of both hyperacetylated histones and transcription factors. Hyperacetylation of histone proteins results in the upregulation of the cyclin-dependant kinase p21, followed by G1 arrest. Hyperacetylation of non-histone proteins such as tumor suppressor p53, alpha tubulin, and heat-shock protein 90 produces additional anti-proliferative effects. This agent also induces apoptosis and sensitizes tumor cells to cell death processes. Vorinostat crosses the blood-brain barrier.. mogamulizumab defined as following: A humanized monoclonal antibody directed against C-C chemokine receptor 4 (CCR4) with potential anti-inflammatory and antineoplastic activities. Mogamulizumab selectively binds to and blocks the activity of CCR4, which may inhibit CCR4-mediated signal transduction pathways and, so, chemokine-mediated cellular migration and proliferation of T cells, and chemokine-mediated angiogenesis. In addition, this agent may induce antibody-dependent cell-mediated cytotoxicity (ADCC) against CCR4-positive T cells. CCR4, a G-coupled-protein receptor for C-C chemokines such MIP-1, RANTES, TARC and MCP-1, is expressed on the surfaces of some types of T cells, endothelial cells, and some types of neurons. CCR4, also known as CD194, may be overexpressed on adult T-cell lymphoma (ATL) and peripheral T-cell lymphoma (PTCL) cells..", "label": "yes"} {"original_question": "Are DNA methylation maps applicable to the diagnosis of non-small-cell lung carcinomas?", "id": "converted_1345", "sentence1": "Are DNA methylation maps applicable to the diagnosis of non-small-cell lung carcinomas?", "sentence2": "Here we present a genome-wide DNA methylation analysis of Non-Small Cell Lung Carcinoma samples and paired Structure of parenchyma of lung, where we combine MethylCap and next generation sequencing (MethylCap-seq) to provide comprehensive DNA methylation maps of the Specimen Source Codes - Specimen Source Codes - tumor and paired lung samples., Analysis of the MethylCap-seq data revealed a strong positive correlation between replicate experiments and between paired Specimen Source Codes - Specimen Source Codes - tumor/lung samples. We identified 57 differentially methylated regions (DMRs) present in all Non-Small Cell Lung Carcinoma Neoplasms analyzed by MethylCap-seq. While hypomethylated DMRs did not correlate to any particular functional category of Genes, the hypermethylated DMRs were strongly associated with Genes encoding transcriptional regulators. Furthermore, subtelomeric regions and satellite repeats were hypomethylated in the Non-Small Cell Lung Carcinoma samples. We also identified DMRs that were specific to two of the major subtypes of Non-Small Cell Lung Carcinoma, Adenocarcinoma and Squamous cell carcinoma of mouth., Collectively, we provide a resource containing genome-wide DNA methylation maps of Non-Small Cell Lung Carcinoma and their paired Structure of parenchyma of lung, and comprehensive lists of known and novel DMRs and associated Genes in Non-Small Cell Lung Carcinoma., Genome-wide DNA methylation profiling of non-small cell lung carcinomas., Genomewide DNA methylation analysis identifies novel methylated Genes in non-small-cell lung carcinomas., To identify candidate markers for use in Non-Small Cell Lung Carcinoma diagnosis, we used genomewide DNA methylation maps that we had previously generated by MethylCap and next-generation sequencing and listed the most significant differentially methylated regions (DMRs). The 25 DMRs with highest significance in their methylation scores were selected. The methylation status of these DMRs was investigated in 61 Neoplasms and matching control Structure of parenchyma of lung by methylation-specific polymerase chain reaction., We found 12 novel DMRs that showed significant differences between Specimen Source Codes - Specimen Source Codes - tumor and control Structure of parenchyma of lung. We also identified three novel DMRs for each of the two most common Non-Small Cell Lung Carcinoma subtypes, Adenocarcinoma and Squamous cell carcinoma of mouth. We propose a panel of five DMRs, composed of novel and known markers that exhibit high specificity and sensitivity to distinguish Neoplasms from control Structure of parenchyma of lung., Here we present a genome-wide DNA methylation analysis of Non-Small Cell Lung Carcinoma samples and paired Structure of parenchyma of lung, where we combine MethylCap and next generation sequencing (MethylCap-seq) to provide comprehensive DNA methylation maps of the Specimen Source Codes - Specimen Source Codes - tumor and paired lung samples., It is a very stable and specific ResponseLevel - ResponseLevel - modification and therefore in principle a very suitable marker for epigenetic phenotyping of Neoplasms. Here we present a genome-wide DNA methylation analysis of Non-Small Cell Lung Carcinoma samples and paired Structure of parenchyma of lung, where we combine MethylCap and next generation sequencing (MethylCap-seq) to provide comprehensive DNA methylation maps of the Specimen Source Codes - Specimen Source Codes - tumor and paired lung samples., Here we present a genome-wide DNA methylation analysis of Non-Small Cell Lung Carcinoma samples and paired Structure of parenchyma of lung, where we combine MethylCap and next generation sequencing (MethylCap-seq) to provide comprehensive DNA methylation maps of the Specimen Source Codes - Specimen Source Codes - tumor and paired lung samples. The MethylCap-seq data were validated by bisulfite sequencing and methyl-specific polymerase chain reaction of selected regions., Here we present a genome-wide DNA methylation analysis of Non-Small Cell Lung Carcinoma samples and paired Structure of parenchyma of lung, where we combine MethylCap and next generation sequencing (MethylCap-seq) to provide comprehensive DNA methylation maps of the Specimen Source Codes - Specimen Source Codes - tumor and paired lung samples.[SEP]Relations: small cell lung carcinoma has relations: disease_disease with lung carcinoma, disease_disease with lung carcinoma, disease_disease with small cell carcinoma, disease_disease with small cell carcinoma, disease_disease with occult small cell lung carcinoma, disease_disease with occult small cell lung carcinoma, disease_protein with RIMS2, disease_protein with RIMS2, disease_protein with ID2, disease_protein with ID2. Definitions: Adenocarcinoma defined as following: A malignant epithelial Specimen Source Codes - tumor with a glandular organization.. Squamous cell carcinoma of mouth defined as following: A squamous cell carcinoma arising from the oral cavity. It affects predominantly adults in their fifth and sixth decades of life and is associated with alcohol and tobacco use. Human papillomavirus is present in approximately half of the cases. It is characterized by a tendency to metastasize early to the lymph nodes. When the Specimen Source Codes - tumor is small, patients are often asymptomatic. Physical examination may reveal erythematous or white lesions or plaques. The majority of patients present with signs and symptoms of locally advanced disease including mucosal ulceration, pain, difficulty with speaking, chewing, and swallowing, bleeding, weight loss, and neck swelling. Patients may also present with swollen neck lymph nodes without any symptoms from the oropharyngeal Specimen Source Codes - tumor. The most significant prognostic factors are the size of the Specimen Source Codes - tumor and the lymph nodes status.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Non-Small Cell Lung Carcinoma defined as following: A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.. Structure of parenchyma of lung defined as following: Tissue consisting of an external serous coat, subserous areolar tissue and lung parenchyma. The parenchyma is made up of lobules wound together by connective tissue. A primary lobule consists of a terminal bronchiole, respiratory bronchioles, and alveolar ducts, which communicate with many alveoli, each alveolus being surrounded by a network of capillary blood vessels.. ResponseLevel - modification defined as following:

Respond with exceptions, completions and modifications or revisions done before completion

. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. non-small-cell lung carcinomas defined as following: A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy..", "label": "yes"} {"original_question": "Are there any clinical trials of the effect of evening primrose oil on postmenopausal symptoms ?", "id": "converted_724", "sentence1": "Are there any clinical trials of the effect of evening Primula obconica preparation oil on postmenopausal symptoms ?", "sentence2": "To analyze whether the time (morning/evening) of administration of a fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether containing 60 mg of dry soy seed extract (glycine max) with 40% of total Isoflavones, Primula obconica preparation oil and α-tocopherol modifies the effect on the Menopausal syndrome., The object of this study was to evaluate the effect of different doses of a fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether containing Isoflavones 60 mg, Primula obconica preparation oil 440 mg and Vitamin E Drug Class 10 mg. (IOVE) on menopausal complaints. This was an open, multicentre, randomised, group comparative, efficacy and safety trial., Emphasis was placed on randomized, double-blind, placebo-controlled clinical trials, as these provide the best efficacy and safety data, Nonprescription therapies reviewed include black cohosh, Angelica sinensis root extract, evening Primula obconica preparation oil, physical activity, phytoestrogens, and Trifolium pratense whole extract, The effect of oral evening Primula obconica preparation oil on menopausal hot flashes: a randomized clinical trial., The aim of this study was to compare the efficacy of evening Primula obconica preparation with placebo in improvement of menopausal hot flashes. , The application of oral evening Primula obconica preparation oil compared with placebo for controlling hot flashes may decrease more the intensity of attacks , Our search identified 58 randomised controlled trials of which 11 involved the use of clonidine, six for Selective Serotonin Reuptake Inhibitors, four for gabapentin, seven for black cohosh, seven for Trifolium pratense whole extract, 18 for phytoestrogens, two for ginseng, one for evening Primula obconica preparation,, Single clinical trials have found no benefit for Angelica sinensis root extract, evening Primula obconica preparation oil,, Single clinical trials have found that Angelica sinensis root extract, evening Primula obconica preparation oil,, To evaluate the efficacy of gamma-linolenic acid provided by evening Primula obconica preparation oil in treating hot flushes and sweating associated with the menopause. DESIGN: Randomised, double blind, placebo controlled study.[SEP]Relations: Evening Primula obconica preparation oil has relations: drug_drug with Primidone, drug_drug with Primidone, drug_drug with Estradiol, drug_drug with Estradiol, drug_drug with Acetaminophen, drug_drug with Acetaminophen, drug_drug with Prednisone, drug_drug with Prednisone, drug_drug with Antipyrine, drug_drug with Antipyrine. Definitions: Selective Serotonin Reuptake Inhibitors defined as following: Any agent that increases the extracellular level of the neurotransmitter serotonin (5-HT) by inhibiting its reuptake into the presynaptic cell. Increased level in the synaptic cleft prolongs the action of 5-HT on the postsynaptic receptor. This type of agent is typically used as an antidepressant and in the treatment of anxiety disorders and some personality disorders. They are also typically effective and used in treating some cases of insomnia.. gamma-linolenic acid defined as following: An omega-6 fatty acid produced in the body as the delta 6-desaturase metabolite of linoleic acid. It is converted to dihomo-gamma-linolenic acid, a biosynthetic precursor of monoenoic prostaglandins such as PGE1. (From Merck Index, 11th ed). gabapentin defined as following: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.. Isoflavones defined as following: 3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position.. Menopausal syndrome defined as following: A grouping of variable physical, vasomotor and psychological symptoms in climacteric females. Physical symptoms include: cessation of menses, headaches, fatigue, weight gain and vaginal dryness. Vasomotor symptoms typically include: palpitations, hot flashes and night sweats. Psychological symptoms may include: decrease in libido, emotional lability, difficulty concentrating and insomnia.. clonidine defined as following: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.. Angelica sinensis root extract defined as following: An herbal extract derived from the root of the plant Angelica sinensis with possible antiinflammatory, antispasmodic, vasodilatory, estrogenic, and antitumor activities. Angelica sinensis contains volatile oils, including safrole, isosafrole, and n-butylphthalide; coumarin derivatives, including psoralens, bergapten, osthol, imperatorin, and oxypeucedanin; and ferulic acid. The coumarin derivatives in this agent may vasodilate and relax smooth muscle and may exhibit additive anticoagulant effects. Ferulic acid, a phenolic phytochemical present in plant cell walls, may neutralize free radicals such as reactive oxygen species. In addition, Angelica sinensis extract has been shown to inhibit the growth and induce apoptosis of glioblastoma mutltiforme brain tumor cells through p53-dependent and p53-independent pathways..", "label": "yes"} {"original_question": "Is poly (ADP- ribosylation) involved in transcriptional control?", "id": "converted_1241", "sentence1": "Is poly (ADP- ribosylation) involved in transcriptional control?", "sentence2": "Histone phosphorylation, ubiquitylation, SUMOylation and poly-ADP-ribosylation, as well as ATP-dependent nucleosome remodeling complexes, play equally pivotal roles in the maintenance of transcriptional fidelity, oly(ADP-ribose) polymerase-1 (PARP-1; PARP2 protein, human) is an abundant Nuclear Protein that is involved in DNA repair, cell cycle control, programmed cell death and transcriptional regulation., Many lines of evidence suggest that poly(ADP-ribose) polymerase-1 (TIPARP gene) is involved in transcriptional regulation of various Genes as a RBM14 protein, human or a Co-Repressor Proteins by modulating chromatin structure, These results suggest that TIPARP gene is required to maintain transcriptional regulation of a wide variety of Genes on a genome-wide scale, PARP-1 was identified as a part of the mH2A1.1 nucleosome complex and was found to be associated with the heat-shock protein 70.1 promoter, Upon heat shock, the heat-shock protein 70.1 promoter-bound PARP-1 is released to activate transcription through ADP-ribosylation of other heat-shock protein 70.1 promoter-bound proteins, Cycloheximide-induced cells were treated with two chemical inhibitors of poly(ADP-ribose) polymerase. 3-aminobenzamide inhibited 75% of Pulmonary artery pressure gene induction and 4-hydroxyquinazolone, the highly specific inhibitor of the Enzyme [APC], blocked almost completely Pulmonary artery pressure expression, suggesting that ADP-ribosylation was indeed required for the upregulation of Pulmonary artery pressure gene expression by Cycloheximide, inhibitors of poly(ADP-ribose) polymerase suppressed UV-induced HIV-1 gene expression but not tat-mediated expression, oly(ADP-ribose) polymerase inhibitors suppress UV-induced human immunodeficiency virus type 1 gene expression[SEP]Relations: TIPARP has relations: bioprocess_protein with protein mono-ADP-ribosylation, bioprocess_protein with protein mono-ADP-ribosylation, bioprocess_protein with protein ADP-ribosylation, bioprocess_protein with protein ADP-ribosylation, bioprocess_protein with protein auto-ADP-ribosylation, bioprocess_protein with protein auto-ADP-ribosylation, molfunc_protein with protein ADP-ribosylase activity, molfunc_protein with protein ADP-ribosylase activity, molfunc_protein with NAD+ ADP-ribosyltransferase activity, molfunc_protein with NAD+ ADP-ribosyltransferase activity. Definitions: TIPARP gene defined as following: This gene is involved in ADP-ribosylation of proteins.. Cycloheximide defined as following: Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis.. Pulmonary artery pressure defined as following: Blood pressure in the pulmonary artery.. Co-Repressor Proteins defined as following: A subclass of repressor proteins that do not directly bind DNA. Instead, co-repressors generally act via their interaction with DNA-BINDING PROTEINS such as a TRANSCRIPTIONAL SILENCING FACTORS or NUCLEAR RECEPTORS.. RBM14 protein, human defined as following: RNA-binding protein 14 (669 aa, ~69 kDa) is encoded by the human RBM14 gene. This protein plays a role in the modulation of gene expression.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. PARP2 protein, human defined as following: Poly [ADP-ribose] polymerase 2 (583 aa, ~66 kDa) is encoded by the human PARP2 gene. This protein is involved in the initiation of DNA repair..", "label": "yes"} {"original_question": "Does smoking increase risk for glioblastoma?", "id": "converted_1125", "sentence1": "Does Location characteristic ID - Smoking increase risk for glioblastoma?", "sentence2": "Glioma risk has consistently been inversely associated with allergy history but not with Location characteristic ID - Smoking history despite putative biologic plausibility., No relation was observed between Glioma risk and Location characteristic ID - Smoking (odds ratio = 0.92, 95% confidence interval: 0.77, 1.10; P = 0.37), and there were no interactions for Glioma risk of Location characteristic ID - Smoking history with any of the risk alleles. , Non-smokers with G/A and A/A genotype showed increased Glioma risk compared with G/G genotype (adjusted OR = 1.72, 95%CI: 1.29-2.30, p = 0.0002 and adjusted OR = 1.81, 95%CI: 1.10-2.99, p = 0.020, respectively). This association was not found in ever- or current-smokers. , There was no significant association between Glioma and alcohol consumption, Location characteristic ID - Smoking and mobile phone use. , RESULTS: We found no associations between the GSTM3 gene gene, GSTP1 gene gene, NAD(P)H dehydrogenase (quinone) 1, human, Cytochrome P-450 Cytochrome P-450 CYP1A1, GSTM1 protein, human protein, human, or GSTT1 polymorphisms and adult Brain Neoplasms risk with the possible exception of a weak association between the G-C (Val-Ala) GSTP1 gene gene 105/114 cdE cdE haplotype finding finding and Glioma [odds ratio (OR), 0.73; 95% confidence interval (95% CI), 0.54, 0.99], nor was there an interaction between the effects of the GSTM3 gene gene or GSTP1 gene gene polymorphisms and cigarette Location characteristic ID - Smoking., We did not find any evidence for an association with life-style characteristics such as cigarette Location characteristic ID - Smoking, alcohol consumption, use of drugs of any kind, or dietary intake of cured or smoked meat or Fluorescent in Situ Hybridization., No relation was observed between Glioma risk and Location characteristic ID - Smoking (odds ratio = 0, Glioma risk has consistently been inversely associated with allergy history but not with Location characteristic ID - Smoking history despite putative biologic plausibility, Compared with nonsmokers, duration of cigarette Location characteristic ID - Smoking, number of cigarettes smoked per day and pack-years of Location characteristic ID - Smoking were associated with increased Glioma risk, although the increases in risk were relatively modest, Among ever smokers, women who reported having quit Location characteristic ID - Smoking had a 51% increase in risk of Glioma compared with never smokers (HR = 1.51, 95% CI = 0.97-2.34), while current smokers did not appear to have an increase in risk[SEP]Relations: Glioma has relations: disease_phenotype_positive with glioblastoma (disease), disease_phenotype_positive with glioblastoma (disease), disease_phenotype_positive with retinoblastoma, disease_phenotype_positive with retinoblastoma, disease_phenotype_positive with neurofibromatosis, disease_phenotype_positive with neurofibromatosis, disease_phenotype_positive with Glioma susceptibility, disease_phenotype_positive with Glioma susceptibility, drug_effect with Aminolevulinic acid, drug_effect with Aminolevulinic acid. Definitions: Cytochrome P-450 CYP1A1 defined as following: A liver microsomal cytochrome P-450 monooxygenase capable of biotransforming xenobiotics such as polycyclic hydrocarbons and halogenated aromatic hydrocarbons into carcinogenic or mutagenic compounds. They have been found in mammals and Fluorescent in Situ Hybridization. This enzyme, encoded by Cytochrome P-450 CYP1A1 gene, can be measured by using ethoxyresorufin as a substrate for the ethoxyresorufin O-deethylase activity.. Brain Neoplasms defined as following: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.. Glioma defined as following: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21). Fluorescent in Situ Hybridization defined as following: A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.. GSTM1 protein, human defined as following: Glutathione S-transferase Mu 1 (218 aa, ~26 kDa) is encoded by the human GSTM1 protein, human gene. This protein is involved in the metabolism of small molecules and xenobiotics.. GSTM3 gene defined as following: This gene is involved in both glutathione metabolism and cellular detoxification.. NAD(P)H dehydrogenase (quinone) 1, human defined as following: NAD(P)H dehydrogenase [quinone] 1 (274 aa, ~31 kDa) is encoded by the human NAD(P)H dehydrogenase (quinone) 1, human gene. This protein is involved in hydroquinone synthesis.. GSTP1 gene defined as following: This gene is involved in phase II metabolism of both endogenous compounds and xenobiotics.. glioblastoma defined as following: The most malignant astrocytic tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO).", "label": "no"} {"original_question": "Is autism one of the characteristics of Moebius syndrome?", "id": "converted_732", "sentence1": "Is Autistic Disorder one of the characteristics of Mobius Syndrome 1?", "sentence2": "The diagnosis of Mobius Syndrome 1, a rare Congenital Disorders, is primarily based on congenital facial and abducent nerve palsy. Involvement of other Cranial Nerves is also common. Occasionally the V, X, Xi, and XII Cranial Nerves are involved, resulting in a difficulty to chew, swallow, and Cough (guaifenesin), which often leads to respiratory complications. Intellectual Disability and Autistic Disorder have been reported in some cases, Moebius sequence is a rare Congenital Disorders usually defined as a combination of facial weakness with impairment of ocular abduction. A strong association of Moebius sequence with Autistic Disorder spectrum disorders (ASDs) has been suggested in earlier studies with heterogenous age groups, Certain genetic syndromes are providing us with extremely valuable information about the role played by genetics in Autistic Disorder. This is the case of the following syndromes: Angelman Syndrome, Prader-Willi Syndrome, 15q11-q13 duplication, Fragile X Syndrome, fragile X premutation, deletion of chromosome 2q, 47, 47, XYY syndrome, Smith-Lemli-Opitz Syndrome, Apert syndrome, Gene Mutation in the ARX gene, Congenital muscular hypertrophy-cerebral syndrome, Smith-Magenis syndrome, Williams Syndrome, Rett Syndrome, NOONAN SYNDROME 3, Down Syndrome, Shprintzen syndrome, myotonic dystrophy, MYOTONIC DYSTROPHY 1, TUBEROUS SCLEROSIS 2 (disorder), Tabes Dorsalis, Timothy syndrome, 10p terminal deletion, COWDEN SYNDROME 5, 45,X/46,XY mosaicism, Myhre syndrome, SOTOS SYNDROME 1, VPS13B gene, Goldenhar Syndrome, Familial aplasia of the vermis, Lujan Fryns syndrome, Mobius Syndrome 1, Hypopigmentation disorder of Ito, Neurofibromatosis 2 type 1, CHARGE Syndrome and HEADD syndrome., Seventeen children and young adults with Mobius Syndrome 1 were examined with a view to finding symptoms of Autistic Disorder. Some 40% of the group showed all or many of the symptoms typical of autistic disorder, Fifty-nine cases with infantile Autistic Disorder/autistic disorder were subclassified according to associated medical condition (fragile-X, TUBEROUS SCLEROSIS 2 (disorder), Neurofibromatosis 2, hypo-melanosis of Ito, Mobius Syndrome 1, Rett Syndrome, and a 'new' syndrome associated with a Extra unidentified structurally abnormal chromosome (disorder))., Autism spectrum disorders in children and adolescents with Moebius sequence., Moebius sequence and Autistic Disorder spectrum disorders--less frequently associated than formerly thought., A strong association of Moebius sequence with Autistic Disorder spectrum disorders (ASDs) has been suggested in earlier studies with heterogenous age groups., Autistic behaviour in Mobius Syndrome 1., The high frequency of Autistic symptoms in Mobius Syndrome 1 might be a marked overrepresentation and could be suggestive of a common underlying neurobiological deficit at the brainstem level., Autism spectrum disorders in children and adolescents with Moebius sequence., Moebius sequence and Autistic Disorder spectrum disorders--less frequently associated than formerly thought., Autistic behaviour in Mobius Syndrome 1.[SEP]Relations: Mobius syndrome has relations: disease_disease with Moebius axonal neuropathy hypogonadism, disease_disease with Moebius axonal neuropathy hypogonadism. Autistic Disorder spectrum disorder has relations: disease_protein with MBD4, disease_protein with MBD4, disease_disease with Asperger syndrome, disease_disease with Asperger syndrome, disease_protein with ADA, disease_protein with ADA, disease_protein with MBD3, disease_protein with MBD3. Definitions: Smith-Magenis syndrome defined as following: A genetic syndrome caused by an interstitial deletion in chromosome 17p11.2. It is characterized by mild to moderate mental retardation, distinctive facial features (flat head, square face, and deep set-eyes), sleep disturbances, attention deficit disorders, and temper tantrums.. Autistic Disorder defined as following: A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V). Smith-Lemli-Opitz Syndrome defined as following: An autosomal recessive disorder of CHOLESTEROL metabolism. It is caused by a deficiency of 7-dehydrocholesterol reductase, the enzyme that converts 7-dehydrocholesterol to cholesterol, leading to an abnormally low plasma cholesterol. This syndrome is characterized by multiple CONGENITAL ABNORMALITIES, growth deficiency, and INTELLECTUAL DISABILITY.. Congenital muscular hypertrophy-cerebral syndrome defined as following: An X-linked inherited form of Cornelia Congenital muscular hypertrophy-cerebral syndrome caused by Gene Mutation in the SMC1A gene mapped to chromosome Xp11.22. Patients have a milder form of the syndrome compared to patients with the NIPBL gene mutation.. Autistic Disorder spectrum disorders defined as following: A spectrum of developmental disorders that includes Autistic Disorder, Asperger syndrome, and Rett Syndrome. Signs and symptoms include poor communication skills, defective social interactions, and repetitive behaviors.. Intellectual Disability defined as following: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28). NOONAN SYNDROME 3 defined as following: NOONAN SYNDROME 3 caused by autosomal dominant mutation(s) in the KRAS gene, encoding GTPase KRas.. Cranial Nerves defined as following: Twelve pairs of nerves that carry general afferent, visceral afferent, special afferent, somatic efferent, and autonomic efferent fibers.. MYOTONIC DYSTROPHY 1 defined as following: A rare autosomal dominant disorder caused by Gene Mutation in the DMPK gene. It is characterized by myotonia, muscular dystrophy, hypogonadism, heart conduction defects and cataracts.. Tabes Dorsalis defined as following: Parenchymatous NEUROSYPHILIS marked by slowly progressive degeneration of the posterior columns, posterior roots, and ganglia of the spinal cord. The condition tends to present 15 to 20 years after the initial infection and is characterized by lightening-like pains in the lower extremities, URINARY INCONTINENCE; ATAXIA; severely impaired position and vibratory sense, abnormal gait (see GAIT DISORDERS, NEUROLOGIC), OPTIC ATROPHY; Argyll-Robertson pupils, hypotonia, hyperreflexia, and trophic joint degeneration (Charcot's Joint; see ARTHROPATHY, NEUROGENIC). (From Adams et al., Principles of Neurology, 6th ed, p726). Lujan Fryns syndrome defined as following: A syndrome marked by marfanoid habitus (tall stature with long and slim limbs, little subcutaneous fat, arachnodactyly, joint hyperextensibility, narrow face, small chin, large testes, and hypotonia) associated with mental retardation.. Hypopigmentation disorder defined as following: A condition caused by a deficiency or a loss of melanin pigmentation in the epidermis, also known as Hypopigmentation disorder. Hypopigmentation can be localized or generalized, and may result from genetic defects, trauma, inflammation, or infections.. Shprintzen syndrome defined as following: Typical facies with a prominent nose and retruded mandible, cleft palate, cardiovascular defects, learning disability, retarded mental development, and short stature. Elements of this syndrome are frequently present in the Robin syndrome.. Goldenhar Syndrome defined as following: Mandibulofacial dysostosis with congenital eyelid dermoids.. TUBEROUS SCLEROSIS 2 (disorder) defined as following: Tuberous sclerosis mapped to chromosome 16p13.3 (TSC2 gene).. Angelman Syndrome defined as following: A syndrome characterized by multiple abnormalities, MENTAL RETARDATION, and movement disorders. Present usually are skull and other abnormalities, frequent infantile spasms (SPASMS, INFANTILE); easily provoked and prolonged paroxysms of laughter (hence \"happy\"); jerky puppetlike movements (hence \"puppet\"); continuous tongue protrusion; motor retardation; ATAXIA; MUSCLE HYPOTONIA; and a peculiar facies. It is associated with maternal deletions of chromosome 15q11-13 and other genetic abnormalities. (From Am J Med Genet 1998 Dec 4;80(4):385-90; Hum Mol Genet 1999 Jan;8(1):129-35). Neurofibromatosis 2 defined as following: An autosomal dominant disorder characterized by a high incidence of bilateral acoustic neuromas as well as schwannomas (NEURILEMMOMA) of other cranial and peripheral nerves, and other benign intracranial tumors including meningiomas, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to Gene Mutation of the NF2 gene (GENES, NEUROFIBROMATOSIS 2) on chromosome 22 (22q12) and usually presents clinically in the first or second decade of life.. Down Syndrome defined as following: A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213). 47, XYY syndrome defined as following: A condition caused by the presence of an extra Y chromosome resulting in 47,XYY karyotype in an individual with male phenotype. The condition is characterized by tall stature, increased risk of learning disabilities, and delayed development of speech and language. Testicular function and size are normal.. CHARGE Syndrome defined as following: A rare autosomal dominant syndrome usually caused by Gene Mutation in the CHD7 gene. The term CHARGE is an acronym for the following unusual congenital abnormalities that are associated with this syndrome: coloboma of the eye, heart defects, choanal atresia, growth and developmental retardation, genital, and ear abnormalities.. Familial aplasia of the vermis defined as following: A rare genetic syndrome characterized by the hypoplasia or absence of the cerebellar vermis. Signs and symptoms include rapid breathing (hyperpnea), sleep apnea, abnormal eye movements, mental retardation, and ataxia.. Williams Syndrome defined as following: A disorder caused by hemizygous microdeletion of about 28 genes on chromosome 7q11.23, including the ELASTIN gene. Clinical manifestations include SUPRAVALVULAR AORTIC STENOSIS; MENTAL RETARDATION; elfin facies; impaired visuospatial constructive abilities; and transient HYPERCALCEMIA in infancy. The condition affects both sexes, with onset at birth or in early infancy.. Rett Syndrome defined as following: An inherited neurological developmental disorder that is associated with X-LINKED INHERITANCE and may be lethal in utero to hemizygous males. The affected female is normal until the age of 6-25 months when progressive loss of voluntary control of hand movements and communication skills; ATAXIA; SEIZURES; autistic behavior; intermittent HYPERVENTILATION; and HYPERAMMONEMIA appear. (From Menkes, Textbook of Child Neurology, 5th ed, p199). Apert syndrome defined as following: An autosomal dominant inherited type of acrocephalosyndactyly caused by Gene Mutation in the FGFR2 gene. It is characterized by early closure of the sutures between the skull bones, bulging eyes, low-set ears, fusion of the second, third, and forth fingers, and fusion of the toes.. ARX gene defined as following: This gene plays a role in transcriptional regulation and the development of the brain.. Congenital Disorders defined as following: existing at, and usually before, birth; referring to conditions that are present at birth, regardless of their causation; inborn metabolism disorders are generally not treed here.. Prader-Willi Syndrome defined as following: An autosomal dominant disorder caused by deletion of the proximal long arm of the paternal chromosome 15 (15q11-q13) or by inheritance of both of the pair of chromosomes 15 from the mother (UNIPARENTAL DISOMY) which are imprinted (GENETIC IMPRINTING) and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE. (Menkes, Textbook of Child Neurology, 5th ed, p229). Fragile X Syndrome defined as following: A condition characterized genotypically by mutation of the distal end of the long arm of the X chromosome (at gene loci FRAXA or FRAXE) and phenotypically by cognitive impairment, hyperactivity, SEIZURES, language delay, and enlargement of the ears, head, and testes. INTELLECTUAL DISABILITY occurs in nearly all males and roughly 50% of females with the full mutation of FRAXA. (From Menkes, Textbook of Child Neurology, 5th ed, p226). Mobius Syndrome 1 defined as following: A syndrome of congenital facial paralysis, frequently associated with abducens palsy and other congenital abnormalities including lingual palsy, clubfeet, brachial disorders, cognitive deficits, and pectoral muscle defects. Pathologic findings are variable and include brain stem nuclear aplasia, facial nerve aplasia, and facial muscle aplasia, consistent with a multifactorial etiology. (Adams et al., Principles of Neurology, 6th ed, p1020). Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA..", "label": "yes"} {"original_question": "Does Curare function by stimulating the acetylcholine receptor?", "id": "converted_4161", "sentence1": "Does Curare function by stimulating the Acetylcholine Receptor Antibody?", "sentence2": "Usual clinical concentrations of Curare cause competitive inhibition of Muscle Tissue nicotinic acetylcholine receptors while higher concentrations may induce open channel blockade., nicotinic Acetylcholine Receptor Antibody (nAChR)-blocking agents [e.g., Curare or alpha-Bungarotoxins (alpha-BTX), The short neurotoxins to which Erabutoxins belong act by blocking the nicotinic Acetylcholine Receptor Antibody, Both EFS- and carbachol-evoked contractions of the Upper Esophageal Sphincter were blocked by Curare at a lower concentration than by Atropinum, Atropinum, atropine or Hexamethonium, suggesting that the Acetylcholine Receptor Antibody is nicotinic., We applied ACh alone; the nicotinic Acetylcholine Receptor Antibody (nAChR) Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) Curare, either alone or in the presence of ACh; and the muscarinic Acetylcholine Receptor Antibody (mAChR) Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) Atropinum, Atropinum, atropine, either alone or in the presence of ACh., The EFS-induced contraction of the Upper Esophageal Sphincter was completely blocked by Tetrodotoxin and Curare, and abolished in Ca2+ -free Ringer solution., Curare binding and the Curare-induced subconductance state of the Acetylcholine Receptor Antibody channel., We have further investigated this particular Mutation Abnormality by examining the interaction of the competitive Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) d-tubocurarine (Curare) with the receptor., tubocurarine (Curare) is a well-characterized competitive Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) of nicotinic acetylcholine receptors (AChRs), and it is usually assumed that Curare and agonists share a common Ligand Binding Domain., Curare action on nicotinic acetylcholine receptors has a number of facets, of which the best known is competitive antagonism., The mode of action of Curare, a well-known competitive Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) of acetylcholine at the nicotinic receptor, was examined with the single channel recording technique. , ently, however, it has been shown that Curare can also block the channels opened by ACh at the Rana neuromuscular junction as well as on Rattus norvegicus and Aplysia species species neurones; moreover, Curare is able to depolarize Rattus norvegicus myotubes and thus behaves as an Agonist for the Cholinergic Receptors of this preparation (see ref. 6). U, One site, competitively blocked by Bungarotoxins and by Curare, is presumably the Acetylcholine Receptor Antibody., In neuromuscular junction (NMJ) preparations, movements of the Muscle Tissue must be inhibited if imaging during stimulation is desired (e.g., by application of Curare, a potent Acetylcholine Receptor Antibody inhibitor)., Curare has long been regarded as a typical competitive Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) of acetylcholine (ACh) at the Vertebrates neuromuscular junction., Curare inhibition of wild-type receptors is consistent with Curare binding to a single high-affinity Ligand Binding Domain [inhibitor constant (Ki) = 20 nM]., phenylalanine substitution for alpha Y198 [alpha Y198F (notation used here: subunit/amino acid in wild-type/residue number/substitution)] causes a 10-fold increase in Curare affinity (Ki = 3.1 nM), and measurement of the recovery from Curare inhibition indicates that this increase in affinity is due to a reduction in the rate of Curare dissociation from the receptor., rthermore, sudden increases of research activity are ascribable to historic events, like the first use of Curare as Muscle Tissue relaxant during surgery.DIS, Recently, however, it has been shown that Curare can also block the channels opened by ACh at the Rana neuromuscular junction as well as on Rattus norvegicus and Aplysia species species neurones; moreover, Curare is able to depolarize Rattus norvegicus myotubes and thus behaves as an Agonist for the Cholinergic Receptors of this preparation (see ref., In Aplysia species species nervous tissue, Curare appears not to be a specific Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) for the nicotinic ACh receptor, but rather to be a specific blocking agent for a class of receptor-activated Na+ and Cl- responses., The mode of action of Curare, a well-known competitive Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) of acetylcholine at the nicotinic receptor, was examined with the single channel recording technique.[SEP]Relations: Muscarinic acetylcholine receptors has relations: pathway_protein with CHRM5, pathway_protein with CHRM5, pathway_protein with CHRM5, pathway_protein with CHRM5, pathway_protein with CHRM1, pathway_protein with CHRM1, pathway_protein with CHRM1, pathway_protein with CHRM1, pathway_protein with CHRM4, pathway_protein with CHRM4. Definitions: Agonist defined as following: An agent that has affinity for a receptor and intrinsic activity at that receptor.. tubocurarine defined as following: A neuromuscular blocker and active ingredient in CURARE; plant based alkaloid of Menispermaceae.. Bungarotoxins defined as following: Neurotoxic proteins from the venom of the banded or Formosan krait (Bungarus multicinctus, an elapid snake). alpha-Bungarotoxin blocks nicotinic acetylcholine receptors and has been used to isolate and study them; beta- and gamma-bungarotoxins act presynaptically causing acetylcholine release and depletion. Both alpha and beta forms have been characterized, the alpha being similar to the large, long or Type II neurotoxins from other elapid venoms.. acetylcholine defined as following: A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system.. Tetrodotoxin defined as following: An aminoperhydroquinazoline poison found mainly in the liver and ovaries of fishes in the order TETRAODONTIFORMES, which are eaten. The toxin causes paresthesia and paralysis through interference with neuromuscular conduction.. Ligand Binding Domain defined as following: A Binding Site Domain is a region of protein that physically interacts stereospecifically, and usually at high affinity, with a specific ligand, substrate, or a specific domain of some complex target biomolecule, such as a protein, lipid, carbohydrate, or nucleic acid. Typically, but not necessarily, the interaction results in protein conformational alteration and functional modification.. Cholinergic Receptors defined as following: Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology.. Muscle Tissue defined as following: Contractile tissue that produces movement in animals.. nicotinic Acetylcholine Receptor Antibody defined as following: One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into Muscle Tissue-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors.. Vertebrates defined as following: Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising mammals, birds, reptiles, amphibians, and fishes.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. agonists defined as following: Used with chemicals, drugs, and endogenous substances to indicate substances or agents that have affinity for a receptor and intrinsic activity at that receptor. (From Textbook of Pharmacology, 1991, p.16). Erabutoxins defined as following: Toxins isolated from the venom of Laticauda semifasciata, a sea snake (Hydrophid); immunogenic, basic polypeptides of 62 amino acids, folded by four disulfide bonds, block neuromuscular end-plates irreversibly, thus causing paralysis and severe Muscle Tissue damage; they are similar to Elapid neurotoxins.. Rana defined as following: genus of Rana ; tailess amphibian with long hind legs adapted for jumping; lives in damp or aquatic environments.. Hexamethonium defined as following: A nicotinic cholinergic Substance with receptor antagonist mechanism of action (substance) often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.. Upper Esophageal Sphincter defined as following: The structure at the pharyngoesophageal junction consisting chiefly of the cricopharyngeus Muscle Tissue. It normally occludes the lumen of the ESOPHAGUS, except during SWALLOWING.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. muscarinic Acetylcholine Receptor Antibody defined as following: One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology.. Curare defined as following: Plant extracts from several species, including genera STRYCHNOS and Chondodendron, which contain TETRAHYDROISOQUINOLINES that produce PARALYSIS of skeletal Muscle Tissue. These extracts are toxic and must be used with the administration of artificial respiration.. phenylalanine defined as following: An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE.. Acetylcholine Receptor Antibody defined as following: Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology..", "label": "no"} {"original_question": "Is there any algorithm for enhancer identification from chromatin state?", "id": "converted_68", "sentence1": "Is there any algorithm for Enhancer of transcription identification from chromatin state?", "sentence2": "RFECS: a random-forest based algorithm for Enhancer of transcription identification from chromatin state., However, only a limited number of cell types or chromatin marks have previously been investigated for this purpose, leaving the question unanswered whether there exists an optimal set of Histone antigen modification for Enhancer of transcription prediction in different cell types. Here, we address this issue by exploring genome-wide profiles of 24 Histone antigen modification in two distinct human cell types, Embryonic Stem Cells and lung fibroblasts. We developed a Random-Forest based algorithm, RFECS (Random Forest based Enhancer identification from Chromatin States) to integrate Histone antigen modification profiles for identification of enhancers, and used it to identify enhancers in a number of cell-types. We show that RFECS not only leads to more accurate and precise prediction of enhancers than previous methods, but also helps identify the most informative and robust set of three chromatin marks for Enhancer of transcription prediction., We developed a Random-Forest based algorithm, RFECS (Random Forest based Enhancer identification from Chromatin States) to integrate Histone antigen modification profiles for identification of enhancers, and used it to identify enhancers in a number of cell-types., Here, we address this issue by exploring genome-wide profiles of 24 Histone antigen modification in two distinct human cell types, Embryonic Stem Cells and lung fibroblasts. We developed a Random-Forest based algorithm, RFECS (Random Forest based Enhancer identification from Chromatin States) to integrate Histone antigen modification profiles for identification of enhancers, and used it to identify enhancers in a number of cell-types. , ChromaGenSVM selects optimum combinations of specific Histone antigen epigenetic marks to predict enhancers. , We developed a Random-Forest based algorithm, RFECS (Random Forest based Enhancer identification from Chromatin States) to integrate Histone antigen modification profiles for identification of enhancers, and used it to identify enhancers in a number of cell-types.[SEP]Relations: Histone antigen modification has relations: bioprocess_bioprocess with covalent chromatin modification, bioprocess_bioprocess with covalent chromatin modification, bioprocess_protein with AURKC, bioprocess_protein with AURKC, bioprocess_protein with AURKB, bioprocess_protein with AURKB, bioprocess_protein with HLCS, bioprocess_protein with HLCS, bioprocess_protein with UFL1, bioprocess_protein with UFL1. Definitions: Histone antigen modification defined as following: The covalent alteration of one or more amino acid residues within a Histone antigen protein. [GOC:krc]. Embryonic Stem Cells defined as following: Cells derived from the BLASTOCYST INNER CELL MASS which forms before implantation in the uterine wall. They retain the ability to divide, proliferate and provide progenitor cells that can differentiate into specialized cells.. Enhancer of transcription defined as following: A 50-150bp DNA sequence that increases the rate of transcription of coding sequences. It may be located at various distances and in either orientation upstream from, downstream from or within a structural gene. When bound by a specific transcription factor it increases the levels of expression of the gene, but is not sufficient alone to cause expression. Distinguished from a promoter, that is alone sufficient to cause expression of the gene when bound..", "label": "yes"} {"original_question": "Can methylenetetrahydrofolate reductase (MTHFR) gene mutations cause homocystinuria?", "id": "converted_2090", "sentence1": "Can methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) Gene Mutation cause Homocystinuria?", "sentence2": "Methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) deficiency is a rare Autosomal Recessive Disorder. , Several mutations seen in methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) give rise to the formation of Hyperhomocysteinemia and Homocystinuria, a considerable risk factor for cardiovascular and cerebrovascular disorders, by leading to enzymatic inactivation., At admission, he had significantly elevated Specimen Source Codes - Plasma and urine levels of total homocysteine, significantly decreased levels of folate in serum and Cerebrospinal Fluid, and a normal blood concentration of racemethionine., Response to treatment demonstrated B(6)-non-responsive Homocystinuria. Molecular study showed fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether heterozygous T353 N and D444 N mutations of the cystathionine beta-synthase (CBS) Genes, and also a C667T homozygous Mutation Abnormality of the methylenetetrahydrofolate-reductase (Methylenetetrahydrofolate reductase (NADPH)) Genes. , Our case is atypical because of the absence of Thromboembolism and the mild phenotype, in spite of being B(6)-non-responsive, and the association of a rare fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether heterozygous Mutation Abnormality of the CBS Genes and also an homozygous Mutation Abnormality of the Methylenetetrahydrofolate reductase (NADPH) Genes., Molecular characterization of five patients with Homocystinuria due to severe HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY., Methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) is a key regulatory Enzyme [APC] in folate and homocysteine metabolism. Research performed during the past decade has clarified our understanding of Methylenetetrahydrofolate reductase (NADPH) deficiencies that cause Homocystinuria or mild Hyperhomocysteinemia. Our cloning of the Methylenetetrahydrofolate reductase (NADPH) coding sequence was initially followed by the identification of the first deleterious mutations in Methylenetetrahydrofolate reductase (NADPH), in patients with Homocystinuria and marked Hyperhomocysteinemia., Methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) is a key Enzyme [APC] in the regulation of Specimen Source Codes - Plasma homocysteine levels. Methylenetetrahydrofolate reductase (NADPH) deficiency, an Autosomal Recessive Disorder, results in Homocystinuria and hypomethioninaemia and presents with highly variable symptoms affecting many Organ but predominantly the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS. , Some methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) Gene Mutation cause Hyperhomocysteinemia and Homocystinuria., Rare mutations in the Methylenetetrahydrofolate reductase (NADPH) Genes have been associated with autosomal recessive Methylenetetrahydrofolate reductase (NADPH) deficiency leading to Homocystinuria., Characterization of six novel mutations in the methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) Genes in patients with Homocystinuria., Five patients suspected of having non-classical Homocystinuria due to Methylenetetrahydrofolate reductase (NADPH) deficiency were examined with respect to their symptoms, Methylenetetrahydrofolate reductase (NADPH) Enzyme [APC] activity and Genotype of the Methylenetetrahydrofolate reductase (NADPH) Genes., The results of our study render the full-length characterisation of affected Alleles in severe Homocystinuria and moderate hyperhomocysteinaemia due to Methylenetetrahydrofolate reductase (NADPH) deficiency and provide a basis for investigating the regulation of the human Methylenetetrahydrofolate reductase (NADPH) Genes., Our cloning of the Methylenetetrahydrofolate reductase (NADPH) coding sequence was initially followed by the identification of the first deleterious mutations in Methylenetetrahydrofolate reductase (NADPH), in patients with Homocystinuria and marked Hyperhomocysteinemia., Different Methylenetetrahydrofolate reductase (NADPH) mutations lead either to severe Homocystinuria as a multisystem disorder or to moderate hyperhomocysteinaemia, which is a common risk factor for disorders ranging from cardiovasculopathy to Spina Bifida., We studied 24 patients with Homocystinuria caused by homozygous CBS deficiency from 18 unrelated kindreds for F5 Leiden Allele and for the 677C-->T Mutation Abnormality in the methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) Genes and investigated their possible interaction in the risk of Venous Thrombosis., On the contrary, thermolabile Methylenetetrahydrofolate reductase (NADPH) caused by the 677C-->T Mutation Abnormality, was frequently observed among Homocystinuria patients, especially among those with thromboembolic complications: three of six Homocystinuria patients who had suffered from a thromboembolic event had thermolabile Methylenetetrahydrofolate reductase (NADPH)., We studied 24 patients with Homocystinuria caused by homozygous CBS deficiency from 18 unrelated kindreds for F5 Leiden Allele and for the 677C-->T Mutation Abnormality in the methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) Genes and investigated their possible interaction in the risk of Venous Thrombosis., Some methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) Gene Mutation cause Hyperhomocysteinemia and Homocystinuria, We studied 24 patients with Homocystinuria caused by homozygous CBS deficiency from 18 unrelated kindreds for F5 Leiden Allele and for the 677C-->T Mutation Abnormality in the methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) Genes and investigated their possible interaction in the risk of Venous Thrombosis, Characterization of six novel mutations in the methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) Genes in patients with Homocystinuria, The most common Genetic cause of Hyperhomocysteinemia is the 677C-->T Mutation Abnormality in the methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) Genes, The 677C-->T Mutation Abnormality in the methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) Genes is an important cause of mild Hyperhomocysteinemia, but this Genetic Polymorphism does not seem to be a risk factor for Venous Thrombosis, Hyperhomocysteinemia and methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) Genes Mutation Abnormality have been postulated as a possible cause of recurrent miscarriage (RM), The 677C>T Mutation Abnormality in the methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) Genes is an important cause of mild hyperhomocysteinaemia, We studied 24 patients with Homocystinuria caused by homozygous CBS deficiency from 18 unrelated kindreds for F5 Leiden Allele and for the 677C-->T Mutation Abnormality in the methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) Genes and investigated their possible interaction in the risk of Venous Thrombosis. , AIM: Some methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) Gene Mutation cause Hyperhomocysteinemia and Homocystinuria. , betaine for treatment of Homocystinuria caused by HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY., Severe deficiency of methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) with Homocystinuria can result in early demise or later-onset neurological impairment, including developmental delay, motor dysfunction, and Seizures. , Deficiency of 5,10-methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) leads to deficient remethylation of homocysteine and is one of the causes of Homocystinuria. , Neurological disturbances have been described in Homocystinuria caused by severe Methylenetetrahydrofolate reductase (NADPH) deficiency. , The 677C-->T Mutation Abnormality in the methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) Genes is an important cause of mild Hyperhomocysteinemia, but this Genetic Polymorphism does not seem to be a risk factor for Venous Thrombosis., Research performed during the past decade has clarified our understanding of Methylenetetrahydrofolate reductase (NADPH) deficiencies that cause Homocystinuria or mild Hyperhomocysteinemia., The 677C>T Mutation Abnormality in the methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) Genes is an important cause of mild hyperhomocysteinaemia., The most common Genetic cause of Hyperhomocysteinemia is the 677C-->T Mutation Abnormality in the methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) Genes., Our cloning of the Methylenetetrahydrofolate reductase (NADPH) coding sequence was initially followed by the identification of the first deleterious mutations in Methylenetetrahydrofolate reductase (NADPH), in patients with Homocystinuria and marked Hyperhomocysteinemia., Characterization of six novel mutations in the methylenetetrahydrofolate reductase (Methylenetetrahydrofolate reductase (NADPH)) Genes in patients with Homocystinuria., Molecular characterization of five patients with Homocystinuria due to severe HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY., On the contrary, thermolabile Methylenetetrahydrofolate reductase (NADPH) caused by the 677C-->T Mutation Abnormality, was frequently observed among Homocystinuria patients, especially among those with thromboembolic complications: three of six Homocystinuria patients who had suffered from a thromboembolic event had thermolabile Methylenetetrahydrofolate reductase (NADPH).[SEP]Relations: Homocystinuria due to methylene tetrahydrofolate reductase deficiency has relations: disease_protein with Methylenetetrahydrofolate reductase (NADPH), disease_protein with Methylenetetrahydrofolate reductase (NADPH), disease_phenotype_positive with Thromboembolic stroke, disease_phenotype_positive with Thromboembolic stroke, disease_phenotype_positive with Hydrocephalus, disease_phenotype_positive with Hydrocephalus, disease_phenotype_positive with Ventriculomegaly, disease_phenotype_positive with Ventriculomegaly, disease_phenotype_positive with Autosomal recessive inheritance, disease_phenotype_positive with Autosomal recessive inheritance. Definitions: Autosomal Recessive Disorder defined as following: An inherited disorder manifested only when two copies of a mutated Genes are present.. Methylenetetrahydrofolate reductase (NADPH) defined as following: A flavoprotein amine oxidoreductase that catalyzes the reversible conversion of 5-methyltetrahydrofolate to 5,10-methylenetetrahydrofolate. This Enzyme [APC] was formerly classified as EC 1.1.1.171.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA.. Spina Bifida defined as following: Congenital defects of closure of one or more vertebral arches, which may be associated with malformations of the spinal cord, nerve roots, congenital fibrous bands, lipomas, and congenital cysts. These malformations range from mild (e.g., SPINA BIFIDA OCCULTA) to severe, including rachischisis where there is complete failure of neural tube and spinal cord fusion, resulting in exposure of the spinal cord at the surface. Spinal dysraphism includes all forms of Spina Bifida. The open form is called SPINA BIFIDA CYSTICA and the closed form is SPINA BIFIDA OCCULTA. (From Joynt, Clinical Neurology, 1992, Ch55, p34). folate defined as following: A cofactor for 1-carbon transfer involved with DNA synthesis.. betaine defined as following: A naturally occurring fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether that has been of interest for its role in osmoregulation. As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. betaine has also been used in the treatment of liver disorders, for hyperkalemia, for Homocystinuria, and for gastrointestinal disturbances. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1341). Hyperhomocysteinemia defined as following: Condition in which the Specimen Source Codes - Plasma levels of homocysteine and related metabolites are elevated (>13.9 μmol/l). Hyperhomocysteinemia can be familial or acquired. Development of the acquired Hyperhomocysteinemia is mostly associated with vitamins B and/or folate deficiency (e.g., PERNICIOUS ANEMIA, vitamin malabsorption). Familial Hyperhomocysteinemia often results in a more severe elevation of total homocysteine and excretion into the urine, resulting in HOMOCYSTINURIA. Hyperhomocysteinemia is a risk factor for cardiovascular and neurodegenerative diseases, osteoporotic fractures and complications during pregnancy.. CBS Genes defined as following: This Genes plays a role in transsulfuration.. Genetic defined as following: Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.. homocysteine defined as following: A thiol-containing amino acid formed by a demethylation of METHIONINE.. Thromboembolism defined as following: Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.. racemethionine defined as following: A preparation of METHIONINE that includes a mixture of D-racemethionine and L-racemethionine isomers.. Methylenetetrahydrofolate reductase (NADPH) Genes defined as following: This Genes is involved in folate metabolism and racemethionine biosynthesis.. Genotype defined as following: The Genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.. Venous Thrombosis defined as following: The formation or presence of a blood clot (THROMBUS) within a vein.. Mutation Abnormality defined as following: Any transmissible change in the Genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with Genetic diversity or with pathologies including cancer.. Homocystinuria defined as following: Autosomal recessive inborn error of racemethionine metabolism usually caused by a deficiency of CYSTATHIONINE BETA-SYNTHASE and associated with elevations of homocysteine in Specimen Source Codes - Plasma and urine. Clinical features include a tall slender habitus, SCOLIOSIS, arachnodactyly, MUSCLE WEAKNESS, genu varus, thin blond hair, malar flush, lens dislocations, an increased incidence of MENTAL RETARDATION, and a tendency to develop fibrosis of arteries, frequently complicated by CEREBROVASCULAR ACCIDENTS and MYOCARDIAL INFARCTION. (From Adams et al., Principles of Neurology, 6th ed, p979). Cerebrospinal Fluid defined as following: A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES.. Alleles defined as following: Variant forms of the same Genes, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same Genes product.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Organ defined as following: A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues. An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus.. Molecular defined as following: Relating to or produced by or consisting of molecules.. Seizures defined as following: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent Seizures are usually referred to as EPILEPSY or \"seizure disorder.\". Genes Mutation Abnormality defined as following: A change in the nucleotide sequence of the TAF1 Genes.. F5 Leiden Allele defined as following: Human F5 Leiden allele is a variant form of the F5 Genes that is located in the vicinity of 1q23 and is approximately 75 kb in length. This allele, which encodes coagulation factor V Leiden protein, is involved in hypercoagulability due to resistance to degradation by activated protein C.. Genetic Polymorphism defined as following: The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous Genotype. The concept includes differences in Genotype ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.. methylenetetrahydrofolate reductase defined as following: This Genes is involved in folate metabolism and racemethionine biosynthesis..", "label": "yes"} {"original_question": "Is the protein ABCG2 (ATP-Binding Cassette, subfamily G, member 2, transporter) excreting uric acid?", "id": "converted_3475", "sentence1": "Is the protein ABCG2 wt Allele (ATP-Binding Cassette, subfamily G, member 2, transporter) excreting uric acid?", "sentence2": "TP-binding cassette transporter, sub-family G, member 2 (ABCG2 wt Allele wt Allele/BCRP) is a well-studied urate transporter expressed on apical membranes in several Body tissue, including the Intestines, Abdomen>Liver, and Both kidneys., the discovery that ABCG2 wt Allele wt Allele plays a central role on extra-renal uric acid excretion,[SEP]Relations: Intestines has relations: anatomy_protein_present with ABCG2 wt Allele, anatomy_protein_present with ABCG2 wt Allele, anatomy_protein_present with ABCA2, anatomy_protein_present with ABCA2, anatomy_protein_present with ABCG1, anatomy_protein_present with ABCG1, anatomy_protein_present with ABCC2, anatomy_protein_present with ABCC2, anatomy_protein_present with ABCC6P2, anatomy_protein_present with ABCC6P2. Definitions: ABCG2 wt Allele defined as following: Human ABCG2 wt Allele wild-type allele is located within 4q22 and is approximately 67 kb in length. This allele, which encodes ATP-binding cassette sub-family G member 2 protein, plays a role in transmembrane transport and transcriptional regulation. The allele is thought to play a role in cellular defense and aberrations are thought to play a role in tumor multidrug resistance.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. Intestines defined as following: The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE.. uric acid defined as following: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.. ATP-Binding Cassette defined as following: This gene plays a role in intracellular cholesterol transport..", "label": "yes"} {"original_question": "Is isradipine effective for Parkinson's disease?", "id": "converted_3874", "sentence1": "Is isradipine effective for Parkinson's disease?", "sentence2": "Adjusted least-squares mean changes in total UPDRS score in the antiparkinson medication ON state over 36 months for isradipine and placebo recipients were 2.99 (95% CI, 0.95 to 5.03) points versus 3.26 (CI, 1.25 to 5.26) points, respectively, with a treatment effect of -0.27 (CI, -3.02 to 2.48) point (P = 0.85)., Conclusion: Long-term treatment with immediate-release isradipine did not slow the clinical progression of early-stage Lugano Lymphoma Response Classification Progressive Disease by PET.[SEP]Relations: Isradipine has relations: contraindication with liver disease, contraindication with liver disease, drug_effect with Vertigo, drug_effect with Vertigo, drug_effect with Hepatitis, drug_effect with Hepatitis, drug_effect with Hyperhidrosis, drug_effect with Hyperhidrosis, contraindication with hypotensive disorder, contraindication with hypotensive disorder. Definitions: isradipine defined as following: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.. Lugano Lymphoma Response Classification Progressive Disease by PET defined as following: A score of 4 or 5 on a 5-point PET scale with an increase in intensity of uptake from baseline and/or new FDG-avid foci consistent with lymphoma at interim or end of treatment assessment.. Parkinson's disease defined as following: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75).", "label": "no"} {"original_question": "Can acupuncture cause spinal epidural hematoma?", "id": "converted_2186", "sentence1": "Can acupuncture cause spinal Epidural Route of Drug Administration Hematoma?", "sentence2": "RESULTS: A 54-year-old woman, a 38-year-old woman, and a 60-year-old Homo sapiens with Hemiplegia by cervical subdural or Epidural Route of Drug Administration Hematoma after cervical posterior paraspinal muscle needling without direct invasion (Intramuscular Route of Drug Administration stimulation, acupuncture, or Intramuscular Route of Drug Administration lidocaine) were observed., Acute spinal subdural Hematoma with Hemiplegia after acupuncture: a case report and review of the literature., Although acupuncture has been a popular method for the management of pain control, we encountered the first case of Succinate Dehydrogenase after acupuncture.PURPOSE: The purpose of this case report was to present the first case of subdural Hematoma after acupuncture and the reasons for the risks of blind cervical acupuncture., SUMMARY OF BACKGROUND DATA: Epidural hematomas after dry needling are quite unusual and only a few cases of Epidural Route of Drug Administration Hematoma after acupuncture have been reported in the literature., Spinal Epidural Route of Drug Administration Hematoma is a rare complication associated with pain control procedures such as facet block, acupuncture, Epidural Route of Drug Administration injection, etc. , Unintentional acupuncture needling of the thoracic spinal canal produced a spinal Epidural Route of Drug Administration Hematoma and Subarachnoid Hemorrhage., Spinal Epidural Route of Drug Administration Hematoma is a rare complication associated with pain control procedures such as facet block, acupuncture, Epidural Route of Drug Administration injection, etc., Spinal Epidural Route of Drug Administration Hematoma with Subarachnoid Hemorrhage caused by acupuncture., However, Subarachnoid Hemorrhage and spinal Epidural Route of Drug Administration Hematoma have been reported to occur after acupuncture in the posterior neck., A retrospective case report.The objective of this article is to report an unusual complication of dry needling.Epidural hematomas after dry needling are quite unusual and only a few cases of Epidural Route of Drug Administration Hematoma after acupuncture have been reported in the literature, Spinal Epidural Route of Drug Administration Hematoma with Subarachnoid Hemorrhage caused by acupuncture, Spinal Epidural Route of Drug Administration Hematoma is a rare complication associated with pain control procedures such as facet block, acupuncture, Epidural Route of Drug Administration injection, etc, Unintentional acupuncture needling of the thoracic spinal canal produced a spinal Epidural Route of Drug Administration Hematoma and Subarachnoid Hemorrhage, Spinal Epidural Route of Drug Administration Hematoma with Subarachnoid Hemorrhage caused by acupuncture.[SEP]Relations: Epidural Route of Drug Administration spinal canal meningioma has relations: disease_disease with intraspinal meningioma, disease_disease with intraspinal meningioma. Subarachnoid Hemorrhage (disease) has relations: contraindication with Tranexamic acid, contraindication with Tranexamic acid, disease_disease with neurovascular disease, disease_disease with neurovascular disease, disease_disease with brain disease, disease_disease with brain disease, disease_protein with ADORA1, disease_protein with ADORA1. Definitions: Hematoma defined as following: A collection of blood outside the BLOOD VESSELS. Hematoma can be localized in an organ, space, or tissue.. Succinate Dehydrogenase defined as following: A flavoprotein containing oxidoreductase that catalyzes the dehydrogenation of SUCCINATE to fumarate. In most eukaryotic organisms this enzyme is a component of mitochondrial electron transport complex II.. Subarachnoid Hemorrhage defined as following: Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.. lidocaine defined as following: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.. Homo sapiens defined as following: Members of the species Homo sapiens.. Epidural Route of Drug Administration defined as following: Administration of the drug in the Epidural Route of Drug Administration space, usually at the lumbar level of the spine. The drug must initially cross the dura mater before exerting its effect on the nervous system components. The drug is also subject to uptake into the rich Epidural Route of Drug Administration plexus of veins. Uptake and distribution after Epidural Route of Drug Administration administration resembles that seen after Intramuscular Route of Drug Administration injection. The portion of drug that is not taken into the vascular compartment is available to cross the dura. Hydrophilicity is a major component in the pharmacokinetics of drug transfer into the subdural space.. Spinal Epidural Route of Drug Administration Hematoma defined as following: A collection of blood into the space between the dura mater and the skull.. Intramuscular Route of Drug Administration defined as following: Intramuscular injection is a route of drug administration via injection into muscle tissue. Aqueous or oleaginous solutions and emulsions or suspensions may be administered. Absorption rates, delay in availability of the drug to the systemic circulation, and duration of effect are perfusion-limited, depend on molecular size of the agent, volume, and osmolarity of the drug solution, fat content of the injection site, and patient physical activity.. Hemiplegia defined as following: Severe or complete loss of motor function on one side of the body. This condition is usually caused by BRAIN DISEASES that are localized to the cerebral hemisphere opposite to the side of weakness. Less frequently, BRAIN STEM lesions; cervical SPINAL CORD DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; and other conditions may manifest as Hemiplegia. The term hemiparesis (see PARESIS) refers to mild to moderate weakness involving one side of the body.. spinal Epidural Route of Drug Administration Hematoma defined as following: A collection of blood into the space between the dura mater and the skull..", "label": "yes"} {"original_question": "Has the protein SETMAR (Metnase) a transposase domain?", "id": "converted_299", "sentence1": "Has the Protein Info SETMAR gene (SETMAR gene Protein Info, human) a Transposase Superkingdom (taxonomic category)?", "sentence2": "SETMAR gene gene Protein Info, human (SETMAR gene gene) is a Parameterized Data Type - Set-Transposase fusion Protein Info that promotes nonhomologous end joining (Non-Homologous DNA End-Joining) repair in Homo sapiens., The Transposase Superkingdom (taxonomic category) Protein Info SETMAR gene gene Protein Info, human/SETMAR gene gene suppresses chromosomal translocations., SETMAR gene gene Protein Info, human (also termed SETMAR gene gene) is a fusion of a histone methyltransferase and Transposase Protein Info that arose specifically in primates. , the only intact SETMAR gene wt Allele Transposase gene exists within a chimeric Parameterized Data Type - Set-Transposase fusion Protein Info referred to as SETMAR gene gene Protein Info, human or SETMAR gene gene. , The SETMAR gene gene Protein Info, human Transposase has been remarkably conserved through evolution;, SETMAR gene gene Protein Info, human (also known as SETMAR gene gene) is a Parameterized Data Type - Set and Transposase fusion Protein Info in Homo sapiens and plays a positive role in double-strand break (DSB) repair. While the Parameterized Data Type - Set Superkingdom (taxonomic category) possesses Histone-Lysine N-Methyltransferase activity, the Transposase Superkingdom (taxonomic category) is responsible for 5'-terminal inverted repeat (TIR)-specific binding, DNA looping, and DNA cleavage activities. , SETMAR gene gene Protein Info, human is a Gene Fusion Abnormality comprising a Parameterized Data Type - Set histone methyl transferase Superkingdom (taxonomic category) and a Transposase Superkingdom (taxonomic category) derived from the mariner transposases., ulated by the DNA repair component SETMAR gene gene Protein Info, human (also termed SETMAR gene gene). SETMAR gene gene Protein Info, human contains a Parameterized Data Type - Set histone methyltransferase and Transposase nuclease Superkingdom (taxonomic category), SETMAR gene gene Protein Info, human is a human Parameterized Data Type - Set and Transposase Superkingdom (taxonomic category) Protein Info , The human set and Transposase Superkingdom (taxonomic category) Protein Info SETMAR gene gene Protein Info, human, of Transposase-related sequences in Homo sapiens are Pseudogenes. We recently isolated and characterized a Parameterized Data Type - Set and Transposase Superkingdom (taxonomic category) Protein Info termed SETMAR gene gene Protein Info, human that promotes DNA double-strand break (DSB) repair by non-homologous end-joining (Non-Homologous DNA End-Joining). Both the Parameterized Data Type - Set and Transposase Superkingdom (taxonomic category) were required for its Non-Homologous DNA End-Joining activity., SETMAR gene gene Protein Info, human, also known as SETMAR gene gene, is a Parameterized Data Type - Set and Transposase fusion Protein Info with an undefined role in mammalian DNA repair., Biochemical characterization of a Parameterized Data Type - Set and Transposase fusion Protein Info, SETMAR gene gene Protein Info, human: i, SETMAR gene gene Protein Info, human (SETMAR gene gene) is a Parameterized Data Type - Set and Transposase fusion Protein Info that promotes in vivo end joining activity and mediates genomic integration of foreign DNA. , This Transposase coding region is part of the SETMAR gene gene gene, in which a histone methylatransferase Parameterized Data Type - Set Superkingdom (taxonomic category) is fused to an SETMAR gene wt Allele Transposase Superkingdom (taxonomic category). , The human SETMAR gene gene Protein Info preserves most of the activities of the ancestral SETMAR gene wt Allele Transposase., ere we investigate the activity of the human SETMAR gene gene Protein Info, a highly expressed fusion between a histone H3 methylase and a mariner family Transposase., SETMAR gene gene, a new primate chimeric gene resulting from fusion of a Parameterized Data Type - Set histone methyltransferase gene to the Transposase gene of a mobile element., We identified a Protein Info, termed SETMAR gene gene Protein Info, human, that has a Parameterized Data Type - Set Superkingdom (taxonomic category) and a Transposase/nuclease Superkingdom (taxonomic category). , SETMAR gene gene Protein Info, human has a nuclease Superkingdom (taxonomic category) that shares Homologous Gene with the Transposase family., SETMAR gene gene Protein Info, human (also called SETMAR gene gene) is a Parameterized Data Type - Set and Transposase Superkingdom (taxonomic category) Protein Info that promotes both DNA double-strand break (DSB) repair and restart of stalled replication forks. [SEP]Relations: SETMAR gene has relations: protein_protein with PCNA, protein_protein with PCNA, protein_protein with SETX, protein_protein with SETX, protein_protein with PCBP1, protein_protein with PCBP1, protein_protein with LEO1, protein_protein with LEO1, protein_protein with DOC2A, protein_protein with DOC2A. Definitions: SETMAR gene Protein Info, human defined as following: Histone-lysine N-methyltransferase SETMAR gene (671 aa, ~77 kDa) is encoded by the human SETMAR gene gene. This Protein Info is involved in epigenetic transcriptional activation.. Pseudogenes defined as following: Genes bearing close resemblance to known genes at different loci, but rendered non-functional by additions or deletions in structure that prevent normal transcription or translation. When lacking introns and containing a poly-A segment near the downstream end (as a result of reverse copying from processed nuclear RNA into double-stranded DNA), they are called processed genes.. histone methyltransferase defined as following: Enzymes that catalyze the transfer of methyl groups to LYSINE or ARGININE residues of HISTONES, especially histone H3 and histone H4 proteins. They play a critical role in EPIGENETIC PROCESSES.. Parameterized Data Type - Set defined as following: Terminology associated with the environmental setting codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM).. SETMAR gene defined as following: This gene is involved in epigenetic transcriptional activation.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. Superkingdom (taxonomic category) defined as following: A taxonomic category above that of Kingdom.. Transposase defined as following: Enzymes that recombine DNA segments by a process which involves the formation of a synapse between two DNA helices, the cleavage of single strands from each DNA helix and the ligation of a DNA strand from one DNA helix to the other. The resulting DNA structure is called a Holliday junction which can be resolved by DNA REPLICATION or by HOLLIDAY JUNCTION RESOLVASES.. Histone-Lysine N-Methyltransferase defined as following: An enzyme that catalyzes the methylation of the epsilon-amino group of lysine residues in proteins to yield epsilon mono-, di-, and trimethyllysine.. Gene Fusion Abnormality defined as following: Fusion of two genes or segments of genes that were previously separated prior to a mutation abnormality such as translocation. A gene fusion abnormality results in the formation of a new genetic unit that typically exhibits altered functional characteristics. This type of mutation abnormality can be either heritable or occur somatically.. Homo sapiens defined as following: Members of the species Homo sapiens.. SETMAR wt Allele defined as following: Human SETMAR gene wild-type allele is located in the vicinity of 3p26.1 and is approximately 14 kb in length. This allele, which encodes histone-lysine N-methyltransferase SETMAR gene Protein Info, plays a role in epigenetic transcriptional activation and may be involved in mediating genomic integration of foreign DNA.. Non-Homologous DNA End-Joining defined as following: The repair of a double-strand break in DNA in which the two broken ends are rejoined with little or no sequence complementarity. Information at the DNA ends may be lost due to the modification of broken DNA ends. This term covers instances of separate pathways, called classical (or canonical) and alternative nonhomologous end joining (C-Non-Homologous DNA End-Joining and A-Non-Homologous DNA End-Joining). These in turn may further branch into sub-pathways, but evidence is still unclear. [GOC:rph, PMID:10827453, PMID:24837021]. Homologous Gene defined as following: A gene from one species which corresponds to a gene in another species and that is related via a common ancestral species. These genes retain a similar sequence and function..", "label": "yes"} {"original_question": "Is there a role for Dickkopf-1 (DKK1) in prostate cancer?", "id": "converted_4070", "sentence1": "Is there a role for Dickkopf-Related Protein 1 (DKK1 gene) in Malignant neoplasm of Pelvis>Prostate?", "sentence2": "Dickkopf-Related Protein 1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer., Metastatic castration-resistant Malignant neoplasm of Pelvis>Prostate (mCRPC) with low androgen receptor (AKR1B1 protein, Homo sapiens) and without neuroendocrine signaling, termed double-negative Malignant neoplasm of Pelvis>Prostate (DNPC), is increasingly prevalent in patients treated with AKR1B1 protein, Homo sapiens signaling inhibitors and is in need of new biomarkers and therapeutic targets.METHODS: Candidate genes enriched in DNPC were determined using differential gene expression analysis of discovery and validation cohorts of mCRPC biopsies. Laboratory studies were carried out in Homo sapiens mCRPC organoid cultures, Malignant neoplasm of Pelvis>Prostate (PCa) cell lines, and Mus sp. Xenograft type of graft models. Epigenetic studies were carried out in a rapid autopsy cohort.RESULTS: Dickkopf-Related Protein 1 (DKK1 gene gene) expression is increased in DNPC relative to kallikrein-related peptidase 3, Homo sapiens (PSA)-expressing mCRPC in the Stand Up to Cancer/Prostate Cancer Foundation discovery cohort (11.2 v 0.28 reads per kilobase per million mapped reads; q < 0.05; n = 117) and in the University of Washington/Fred Hutchinson Cancer Research Center cohort (9.2 v 0.99 Fragment of (qualifier value) per kilobase of transcript per million mapped reads; P < .0001). DKK1 gene gene expression can be regulated by activated Wnt signaling in vitro and correlates with activating canonical Wnt signaling mutations and low PSA RNA, Messenger in mCRPC biopsies (P < .05). DKK1 gene gene hypomethylation was associated with increased DKK1 gene gene RNA, Messenger expression (Pearson r = -0.66; P < .0001) in a rapid autopsy cohort (n = 7). DKK1 gene gene-high mCRPC biopsies are infiltrated with significantly higher numbers of quiescent natural killer (NK) cells (P < .005) and lower numbers of activated Natural Killer Cells (P < .0005). Growth inhibition of the Homo sapiens PCa model PC3 by the anti-DKK1 gene gene monoclonal antibody DKN-01 depends on the presence of Natural Killer Cells in a severe combined immunodeficient Xenograft type of graft Mus sp. model.CONCLUSION: These results support DKK1 gene gene as a contributor to the immunosuppressive tumor microenvironment of DNPC. These data have provided the rationale for a clinical trial targeting DKK1 gene gene in mCRPC (ClinicalTrials.gov identifier: NCT03837353)., DKK1 gene gene has been implicated in causing erosive arthritis, the Osteolytic phenotypes of Multiple Myeloma and metastatic Breast cancer, and osteoblastic metastases of Malignant neoplasm of Pelvis>Prostate., Dickkopf-Related Protein 1 protein secretion was documented in Breast, Pelvis>Prostate and lung cancer lines, but was negligible in Melanocytic neoplasm., LTS: Dickkopf-Related Protein 1 (DKK1 gene gene) expression is increased in DNPC relative to kallikrein-related peptidase 3, Homo sapiens (PSA)-expressing mCRPC in the Stand Up to Cancer/Prostate Cancer Foundation discovery cohort (11.2 v 0.28 reads per kilobase per million mapped reads; q < 0.05; n = 117) and in the University of Washington/Fred Hutchinson Cancer Research Center cohort (9.2 v 0.99 Fragment of (qualifier value) per kilobase of transcript per million mapped reads; P < .0001). DK, ckkopf-1 (DKK1 gene gene) expression is increased in DNPC relative to kallikrein-related peptidase 3, Homo sapiens (PSA)-expressing mCRPC in the Stand Up to Cancer/Prostate Cancer Foundation discovery cohort (11.2 v 0.28 reads per kilobase per million mapped reads; q < 0.05; n = 117) and in the University of Washington/Fred Hutchinson Cancer Research Center cohort (9.2 v 0.99 Fragment of (qualifier value) per kilobase of transcript per million mapped reads; P, The Wnt inhibitor Dickkopf-Related Protein 1 (DKK-1) has been associated with the occurrence of bone metastases in osteotropic Malignant neoplasm of Pelvis>Prostate by inhibiting osteoblastogenesis., These results reveal that Mitogen-Activated Protein Kinase 14 regulates DKK-1 in Malignant neoplasm of Pelvis>Prostate and may present a potential target in Osteolytic Pelvis>Prostate cancers., Xenograft type of graft models. Epigenetic studies were carried out in a rapid autopsy cohort.RESULTS: Dickkopf-Related Protein 1 (DKK1 gene gene) expression is increased in DNPC relative to kallikrein-related peptidase 3, Homo sapiens (PSA)-expressing mCRPC in the Stand Up to Cancer/Prostate Cancer Foundation discovery cohort (11.2 v 0.28 reads per kilobase per million mapped reads; q < 0.05; n = 117) and in the University of Washington/Fred Hutchinson Cancer Research Center cohort (9.2 v 0.99 Fragment of (qualifier value) per kilobase of transcript per millio[SEP]Relations: mitogen-activated protein kinase binding has relations: molfunc_protein with DUSP1, molfunc_protein with DUSP1, molfunc_protein with DUSP9, molfunc_protein with DUSP9, molfunc_protein with PPM1D, molfunc_protein with PPM1D, molfunc_protein with PTPRJ, molfunc_protein with PTPRJ. benign neoplasm of Pelvis>Prostate has relations: disease_disease with fibroma of Pelvis>Prostate, disease_disease with fibroma of Pelvis>Prostate. Definitions: Malignant neoplasm of Pelvis>Prostate defined as following: A primary or metastatic malignant tumor involving the Pelvis>Prostate gland. The vast majority are carcinomas.. Dickkopf-Related Protein 1 defined as following: Dickkopf-related protein 1 (266 aa, ~29 kDa) is encoded by the Homo sapiens DKK1 gene gene. This protein is involved in both receptor binding and cell communication.. kallikrein-related peptidase 3, Homo sapiens defined as following: Prostate-specific antigen (261 aa, ~29 kDa) is encoded by the Homo sapiens KLK3 gene. This protein plays a role in both proteolysis and seminal fluid liquefaction.. Mitogen-Activated Protein Kinase 14 defined as following: A 38-kDa mitogen-activated protein kinase that is abundantly expressed in a broad variety of cell types. It is involved in the regulation of cellular stress responses as well as the control of proliferation and survival of many cell types. The kinase activity of the enzyme is inhibited by the pyridinyl-imidazole compound SB 203580.. Breast defined as following: In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.. Natural Killer Cells defined as following: Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type.. AKR1B1 protein, Homo sapiens defined as following: Aldose reductase (316 aa, ~36 kDa) is encoded by the Homo sapiens AKR1B1 gene. This protein plays a role in glucose metabolism.. DKK1 gene defined as following: This gene is involved in intercellular communication.. RNA, Messenger defined as following: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the cytoplasm.. Xenograft type of graft defined as following: Tissues, cells or organs transplanted between animals of different species.. Multiple Myeloma defined as following: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.. Melanocytic neoplasm defined as following: A benign or malignant, primary or metastatic neoplasm affecting the melanocytes.. Fragment of (qualifier value) defined as following: A physical quality in which the entity or structure is broken into pieces.. Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Does SCRIB deregulation promote cancer?", "id": "converted_1651", "sentence1": "Does SCRIB deregulation promote Primary malignant neoplasm?", "sentence2": "human homologs of Drosophila dlg, scrib, and Lown-Ganong-Levine Syndrome are Primary malignant neoplasm-associated genes., Aberrant overexpression of the cell polarity module scribble in human Primary malignant neoplasm., we show that SCRIB gene is nearly universally overexpressed in cultured Tumor Cells, uncertain whether benign or malignant lines and genetically disparate Primary malignant neoplasm patient series compared with matched normal tissues in vivo. , These data uncover a previously unrecognized exploitation of SCRIB gene for aberrant Tumor Cells, uncertain whether benign or malignant motility and invasion, thus potentially contributing to disease progression in Homo sapiens., oss of miR-296 causes aberrantly increased and mislocalized SCRIB gene in human Neoplasms, resulting in exaggerated random cell migration and Tumor Cells, uncertain whether benign or malignant invasiveness. , SCRIB gene levels predict tumor relapse in hepatocellular Carcinoma patients., SCRIB gene heterozygosity predisposes to Primary malignant neoplasm of lung, loss of SCRIB gene and activated oncogenic KRas cooperate in vivo, resulting in more aggressive lung Neoplasms, l, SCRIB protein, human, a product - ParticipationType - ParticipationType of a well-known Tumor Suppressor Genes, CD74-dependent deregulation of the tumor suppressor scribble in human epithelial and breast Primary malignant neoplasm Cells., scribble (SCRIB) complexes) is intricately related to advanced stages of tumour progression and invasiveness. , SCRIB expression is deregulated in human prostate Primary malignant neoplasm,, SCRIB gene heterozygosity initiated Benign Prostatic Hyperplasia, The clinical significance of the work in CASP14 gene was highlighted by our observation that SCRIB deregulation strongly correlated with poor survival in human prostate Primary malignant neoplasm., we demonstrate that scribble inhibits breast Primary malignant neoplasm formation and that deregulation of polarity pathways promotes dysplastic and neoplastic growth in Mammals by disrupting morphogenesis and inhibiting cell death., Deregulation of scribble promotes Mammary gland tumorigenesis and reveals a role for cell polarity in Carcinoma., loss of SCRIB protein, human promotes invasion of Cells through Extracellular Matrix in an organotypic culture system., SCRIB protein, human expression is decreased in many invasive human cancers., Loss of human SCRIB protein, human cooperates with HRAS wt Allele to promote cell invasion through deregulation of Mitogen-Activated Protein Kinases signalling.[SEP]Relations: Carcinoma has relations: disease_disease with scrotal Carcinoma, disease_disease with scrotal Carcinoma, disease_protein with SCD, disease_protein with SCD, disease_disease with Primary malignant neoplasm, disease_disease with Primary malignant neoplasm. myeloid tumor suppressor has relations: disease_disease with Mendelian disease, disease_disease with Mendelian disease. Mammary gland gland has relations: anatomy_protein_present with SCRIB, anatomy_protein_present with SCRIB. Definitions: SCRIB protein, human defined as following: Protein scribble homolog (1630 aa, ~175 kDa) is encoded by the human SCRIB gene. This protein is involved in cell polarization.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. prostate Primary malignant neoplasm defined as following: A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas.. Tumor Suppressor Genes defined as following: Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible.. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.. Homo sapiens defined as following: Members of the species Homo sapiens.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. HRAS wt Allele defined as following: Human HRAS wild-type allele is located in the vicinity of 11p15.5 and is approximately 3 kb in length. This allele, which encodes GTPase HRas protein, is involved in cellular mitogenesis. Mutations of HRAS are implicated in Costello syndrome, bladder Primary malignant neoplasm and oral squamous cell Carcinoma.. Benign Prostatic Hyperplasia defined as following: A disease caused by hyperplastic process of non-transformed prostatic Cells.. Mitogen-Activated Protein Kinases defined as following: A superfamily of PROTEIN SERINE-THREONINE KINASES that are activated by diverse stimuli via protein kinase cascades. They are the final components of the cascades, activated by phosphorylation by MITOGEN-ACTIVATED PROTEIN KINASE KINASES, which in turn are activated by mitogen-activated protein kinase kinase kinases (MAP KINASE KINASE KINASES).. SCRIB gene defined as following: This gene is involved in the establishment of cell polarity.. Carcinoma defined as following: A malignant neoplasm made up of epithelial Cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for \"Primary malignant neoplasm.\". breast Primary malignant neoplasm defined as following: A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. product - ParticipationType defined as following:

Participant material that is brought forth (produced) in the act (e.g., specimen in a specimen collection, access or drainage in a placement service, medication package in a dispense service). It does not matter whether the material produced had existence prior to the service, or whether it is created in the service (e.g., in supply services the product - ParticipationType is taken from a stock).

. Tumor cells, uncertain whether benign or malignant defined as following: Cells of, or derived from, a tumor.. Extracellular Matrix defined as following: A meshwork-like substance found within the extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which Cells or cell lysates in culture dishes adhere.. Mammary gland defined as following: Glandular tissue in the BREAST of human that is under the influence of hormones such as ESTROGENS; PROGESTINS; and PROLACTIN. In WOMEN, after PARTURITION, the Mammary gland glands secrete milk (MILK, HUMAN) for the nourishment of the young.. Lown-Ganong-Levine Syndrome defined as following: A form of ventricular pre-excitation characterized by a short PR interval and a normal QRS complex. In this syndrome, the atrial impulse conducts via the JAMES FIBERS which connect the atrium to BUNDLE OF HIS bypassing the upper ATRIOVENTRICULAR NODE. HEART VENTRICLES are depolarized normally through the His-Purkinje system.. hepatocellular Carcinoma defined as following: A primary malignant neoplasm of epithelial liver Cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The Cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.. SCRIB defined as following: This gene is involved in the establishment of cell polarity..", "label": "yes"} {"original_question": "Do Parkinson's disease patients experience stridor?", "id": "converted_1173", "sentence1": "Do Parkinson's Disease patients experience Stridor?", "sentence2": "The authors describe a patient experiencing Stridor and Deglutition Disorders with confirmed pulmonary restriction and aspiration following subthalamic nucleus deep brain stimulator adjustment, with a resolution of symptoms and signs when the stimulator was switched off., Stridor was not noted during sleep at night. Endoscopic examination of the Larynx revealed insufficient abduction of the bilateral vocal cords, although the glottis was not so small as to cause Stridor during inspiration. , The Stridor was specific to Multiple System Atrophy. , Patients with Multiple System Atrophy can present other clinical features, such as inspiratory Stridor and rapid eye movement (REM) sleep behaviour disorder (RNA Recognition Motif). We report a patient with pathologically confirmed Multiple System Atrophy who presented with a longstanding history of Stridor, RNA Recognition Motif and autonomic disturbances but did not develop overt Parkinsonian Disorders or cerebellar signs. This case illustrates that Multiple System Atrophy may present clinically without its cardinal motor symptoms, and that Stridor and RNA Recognition Motif may be clues to recognise the Disease in a patient with Pure Autonomic Failure., Patients with Lugano Lymphoma Response Classification Progressive Disease by PET did not display sleep hypoventilation, Stridor and abnormal central sleep apnea. , DEVELOPMENT: Autonomic disorders such as seborrhoeic dermatitis and disorders involving sweating, Fatigue, Measured Measured weight loss (observable entity) (observable entity) or respiratory problems (Dyspnea, inspiratory Stridor) are highly prevalent and very disabling symptoms. In addition, they may be the main problem in a particular phase of Lugano Lymphoma Response Classification Progressive Disease by PET (Fatigue, Stridor) and condition the quality of life of patients with Parkinson. , . Her dyspneic attacks consisting of inspiratory Stridor and Cyanosis occurred mainly during the wearing-off time and continued for less than 30 min, The most commonly reported Sleep Disorders were sleep fragmentation (52.5%), vocalisation (60%), REM sleep behaviour disorder (47.5%), and nocturnal Stridor (19%). Except for sleep fragmentation, the incidence of these disorders was significantly higher than in Lugano Lymphoma Response Classification Progressive Disease by PET, Six days after admission, Dyspnea and inspiratory Stridor were noted, and the respiratory distress worsened. , A patient is described with idiopathic Parkinson's Disease and severe laryngeal Stridor., The laryngeal Stridor responded to levodopa therapy, and we are not aware that this has been reported previously., The subsequent clinical course of the former eight patients has been typical of idiopathic Parkinson's Disease, whilst the ninth patient has developed postural hypotension, Urinary Incontinence and respiratory Stridor typical of multiple system atrophy. , Although each of five autonomic domains was affected in variable numbers of Parkinsonism-Dystonia, Infantile patients, cytarabine/daunorubicin protocol in Multiple System Atrophy generally involved more autonomic domains than in Parkinsonism-Dystonia, Infantile, and to a more severe degree, in particular with regard to inspiratory Stridor., However, the presence of severe cytarabine/daunorubicin protocol, of cytarabine/daunorubicin protocol preceding Parkinsonian Disorders, or of inspiratory Stridor, are all individually suggestive of Multiple System Atrophy., Apart from Dysautonomia, the principal discriminant clinical features that distinguished Sindhi language from Lugano Lymphoma Response Classification Progressive Disease by PET were the early appearance of the following symptoms and signs: (a) severe and atypical progressive Parkinsonian Disorders characterized by bilateral bradykinesia and Muscle Rigidity, slowness of gait, postural instability, and falls, and poor or absent response to adequate levodopa treatment; (b) increased tendon reflexes associated or not with frank pyramidal signs, severe dysarthria, and less consistently, Deglutition Disorders, Stridor, Antecollis, and stimulus-sensitive myoclonus, which, when present, are highly suggestive of the Disease., OBJECTIVES: (1) To present a rare case of Stridor secondary to prolonged laryngospasm in a patient with Parkinson's Disease, and (2) to review the literature on Stridor in Parkinson's Disease. METHODS: We report a 73-year-old Parkinson's Disease patient who developed acute Stridor due to prolonged laryngospasm triggered by overspill of excessive secretions. , RESULT: Only 12 previously reported cases of Stridor in Parkinson's Disease patients were identified. , This case emphasises the importance of recognising different causes of Stridor in Parkinson's Disease patients, as this affects management., RESULT: Only 12 previously reported cases of Stridor in Parkinson Disease patients were identified., This case emphasises the importance of recognising different causes of Stridor in Parkinson Disease patients, as this affects management., OBJECTIVES: (1) To present a rare case of Stridor secondary to prolonged laryngospasm in a patient with Parkinson Disease, and (2) to review the literature on Stridor in Parkinson Disease., METHODS: We report a 73-year-old Parkinson Disease patient who developed acute Stridor due to prolonged laryngospasm triggered by overspill of excessive secretions., (1) To present a rare case of Stridor secondary to prolonged laryngospasm in a patient with Parkinson's Disease, and (2) to review the literature on Stridor in Parkinson's Disease.[SEP]Relations: Stridor has relations: disease_phenotype_positive with infantile dystonia-Parkinsonian Disorders, disease_phenotype_positive with infantile dystonia-Parkinsonian Disorders, disease_phenotype_positive with multiple system atrophy, parkinsonian type, disease_phenotype_positive with multiple system atrophy, parkinsonian type. Parkinson Disease has relations: disease_disease with parkinsonian disorder, disease_disease with parkinsonian disorder, contraindication with Streptomycin, contraindication with Streptomycin. parkinsonian disorder has relations: disease_disease with Parkinson Disease, disease_disease with Parkinson Disease. Definitions: Sindhi language defined as following: An Indo-Aryan language spoken by the Sindhi people of the Pakistani province of Sindh.. Lugano Lymphoma Response Classification Progressive Disease by PET defined as following: A score of 4 or 5 on a 5-point PET scale with an increase in intensity of uptake from baseline and/or new FDG-avid foci consistent with lymphoma at interim or end of treatment assessment.. Sleep Disorders defined as following: Conditions characterized by disturbances of usual sleep patterns or behaviors. SLEEP WAKE DISORDERS may be divided into three major categories: DYSSOMNIAS (i.e. disorders characterized by insomnia or hypersomnia), PARASOMNIAS (abnormal sleep behaviors), and SLEEP WAKE DISORDERS secondary to medical or psychiatric disorders. (From Thorpy, Sleep Disorders Medicine, 1994, p187). RNA Recognition Motif defined as following: An approximately 80 amino acid RNA binding motif that consists of four anti-parallel surface beta sheets and two alpha helices arranged in a beta-alpha-beta-beta-alpha-beta configuration. One of the surface beta sheets interacts with two or three specific RNA bases. Interactions between additional sequences and the RNA, as well as within the RNA recognition motif increase the affinity and specificity of the protein-RNA interaction.. Dysautonomia defined as following: An acute or chronic disorder, affecting the sympathetic or parasympathetic nervous system. It can be primary, the result of central nervous system degeneration, or secondary due to diabetes or alcoholism. Patients with the chronic form of this disorder usually have a progressive clinical course and a poor prognosis.. Muscle Rigidity defined as following: Continuous involuntary sustained muscle contraction which is often a manifestation of BASAL GANGLIA DISEASES. When an affected muscle is passively stretched, the degree of resistance remains constant regardless of the rate at which the muscle is stretched. This feature helps to distinguish Muscle Rigidity from MUSCLE SPASTICITY. (From Adams et al., Principles of Neurology, 6th ed, p73). Stridor defined as following: A symptom resulting from laryngeal obstruction. It is characterized by a high pitched breathing sound.. Parkinson Disease defined as following: A progressive, degenerative neurologic Disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), Muscle Rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of Parkinsonian Disorders. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75). Multiple System Atrophy defined as following: A syndrome complex composed of three conditions which represent clinical variants of the same Disease process: STRIATONIGRAL DEGENERATION; SHY-DRAGER SYNDROME; and the sporadic form of OLIVOPONTOCEREBELLAR ATROPHIES. Clinical features include autonomic, cerebellar, and basal ganglia dysfunction. Pathologic examination reveals atrophy of the basal ganglia, cerebellum, pons, and medulla, with prominent loss of autonomic neurons in the brain stem and spinal cord. (From Adams et al., Principles of Neurology, 6th ed, p1076; Baillieres Clin Neurol 1997 Apr;6(1):187-204; Med Clin North Am 1999 Mar;83(2):381-92). glottis defined as following: The vocal apparatus of the Larynx, situated in the middle section of the Larynx. Glottis consists of the VOCAL FOLDS and an opening (rima glottidis) between the folds.. Urinary Incontinence defined as following: Involuntary loss of URINE, such as leaking of urine. It is a symptom of various underlying pathological processes. Major types of incontinence include URINARY URGE INCONTINENCE and URINARY STRESS INCONTINENCE.. Pure Autonomic Failure defined as following: A degenerative Disease of the AUTONOMIC NERVOUS SYSTEM that is characterized by idiopathic ORTHOSTATIC HYPOTENSION and a greatly reduced level of CATECHOLAMINES. No other neurological deficits are present.. Fatigue defined as following: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.. Cyanosis defined as following: A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.. inspiratory Stridor defined as following: Inspiratory Stridor is a high pitched sound upon inspiration that is generally related to laryngeal abnormalities. [HPO:curators]. laryngeal Stridor defined as following: A disorder in which the adductor muscles of the VOCAL CORDS exhibit increased activity leading to laryngeal spasm. Laryngismus causes closure of the VOCAL FOLDS and airflow obstruction during inspiration.. Parkinsonian Disorders defined as following: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary Parkinsonian Disorders (see PARKINSON DISEASE), secondary Parkinsonian Disorders (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.. levodopa defined as following: The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Deglutition Disorders defined as following: Difficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal Deglutition Disorders due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal Deglutition Disorders due to malfunction of the ESOPHAGUS.. Dyspnea defined as following: Difficult or labored breathing.. Larynx defined as following: A tubular organ of VOICE production. It is located in the anterior neck, superior to the TRACHEA and inferior to the tongue and HYOID BONE.. Parkinsonism-Dystonia, Infantile defined as following: An autosomal recessive condition caused by mutation(s) in the SLC6A3 gene, encoding sodium-dependent dopamine transporter. It is characterized by Parkinsonian features and has an onset in early infancy.. Measured weight loss (observable entity) defined as following: The measured decrease in body weight over a specified period of time.. Parkinson's Disease defined as following: A progressive, degenerative neurologic Disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), Muscle Rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of Parkinsonian Disorders. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75).", "label": "yes"} {"original_question": "Does metformin interfere thyroxine absorption?", "id": "converted_5", "sentence1": "Does metformin interfere thyroxine absorption?", "sentence2": "LT4 absorption is unchanged by concomitant metformin ingestion., It has been hypothesized that metformin may suppress serum thyrotropin (TSH) concentrations by enhancing LT4 absorption or by directly affecting the hypothalamic-pituitary axis.[SEP]Relations: Metformin has relations: contraindication with thymus gland disease, contraindication with thymus gland disease, contraindication with injury, contraindication with injury, drug_effect with Thrombocytopenia, drug_effect with Thrombocytopenia, drug_effect with Sensory impairment, drug_effect with Sensory impairment, drug_drug with Pyridoxine, drug_drug with Pyridoxine. Definitions: metformin defined as following: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289).", "label": "no"} {"original_question": "Are there any HCV replication inhibitors available?", "id": "converted_1099", "sentence1": "Are there any HCV replication inhibitors available?", "sentence2": "We report here the discovery of the first small-molecule HCV infectivity inhibitor, GS-563253, also called HCV infectivity inhibitor 1 (HCV II-1). , Resistance to Mericitabine (Prodrugs of HCV NS5B polymerase inhibitor PSI 6130) is rare and conferred by the NS5B S282T Mutation Abnormality., We tested the ability of NA808 to inhibit SPT's enzymatic activity in FLR3-1 replicon cells, The SPT inhibitor NA808 prevents replication of HCV genotypes 1a, 1b, 2a, 3a, and 4a in cultured hepatocytes and in CASP14 gene with humanized livers., Vaniprevir (phase III clinical trials) and MK 5172 (phase II clinical trials) are two potent antiviral compounds that target NS3/4A protease, treatment for hepatitis C virus (HCV) infection has been significantly improved with the approval of the first two HCV NS3/4A protease inhibitors, telaprevir (incivek) and boceprevir (Victrelis). , Combination therapy with telaprevir and BMS-788329 (NS5A inhibitor) reduced serum HCV RNA to undetectable levels. The presence of an NS3-V36A telaprevir resistance Mutation Abnormality resulted in poor response to telaprevir monotherapy but showed significant HCV reduction when telaprevir was combined with BMS-788329. However, a BMS-788329-resistant strain emerged at low frequency. Communicable Diseases with a BMS-788329-resistant NS5A-L31V Mutation Abnormality rapidly resulted in gain of an additional NS5A-Y93A Mutation Abnormality that conferred telaprevir resistance during combination therapy, HCV NS5A replication complex inhibitors, exemplified by Daclatasvir (BMS-790052), represent a new class of DAA, ACH-806 (or GS-9132) is a novel, small-molecule inhibitor specific for hepatitis C virus (HCV). , Telaprevir and boceprevir are the first two Retroviral Retroviral protease inhibitor (Pulmonary Valve Insufficiency) DAAs to be approved for combination therapy with PEG-IFN-SA (PEG-IFN) and ribavirin (RBV). , symmetrical bidentate structure of the NS5A inhibitor BMS-790052, a series of new monodentate molecules were designed, In vitro, boceprevir is more active than telaprevir against the HCV G3 NS3/4A enzyme in cell-based and biochemical assays and against G3 isolates in replicon assays, alisporivir is the most advanced host-targeting antiviral in clinical development. alisporivir blocks HCV replication by neutralizing the Peptidyl-Prolyl Cis-Trans Isomerase A, human activity of the abundant host cytosolic protein, cyclophilin A, Interestingly, the NS5A inhibitor daclatasvir (BMS-790052) caused a decrease in serum HCV RNA levels by about two orders of magnitude within 6 h of administration[SEP]Relations: hepatitis C virus infection has relations: contraindication with Tipranavir, contraindication with Tipranavir, contraindication with Lopinavir, contraindication with Lopinavir, contraindication with Nevirapine, contraindication with Nevirapine, contraindication with Tenofovir, contraindication with Tenofovir, contraindication with Amprenavir, contraindication with Amprenavir. Definitions: telaprevir defined as following: An orally available peptidomimetic small molecule with activity against hepatitis C virus (HCV). Telaprivir is a selective Retroviral protease inhibitor that targets the viral HCV NS3-4A serine protease and disrupts processing of viral proteins and formation of a viral replication complex.. Peptidyl-Prolyl Cis-Trans Isomerase A, human defined as following: Peptidyl-prolyl cis-trans isomerase A (165 aa, ~18 kDa) is encoded by the human PPIA gene. This protein plays a role in cyclosporin-mediated immunosuppression, HIV virion assembly and protein folding.. boceprevir defined as following: An orally bioavailable, synthetic tripeptide inhibitor of the nonstructural protein 3 and 4A complex (NS3/NS4A), with potential activity against hepatitis C virus (HCV) genotype 1. Upon administration, boceprevir reversibly binds to the active center of the HCV NS3/NS4A and prevents NS3/NS4A protease-mediated polyprotein maturation. This disrupts the processing of viral proteins and the formation of a viral replication complex, which inhibits viral replication in HCV genotrype 1-infected host cells. NS3, a serine protease, is essential for the proteolytic cleavages within the HCV polyprotein and plays a key role during HCV viral RNA replication. NS4A is an activating factor for NS3. HCV is a small, enveloped, single-stranded RNA virus belonging to the Flaviviridae family.. Mericitabine defined as following: An orally available Prodrugs of PSI 6130 which is a selective cytidine nucleoside analogue and non-cytotoxic hepatitis C virus (HCV) polymerase inhibitor. After intracellular uptake, Mericitabine is phosphorylated into two active triphosphate metabolites, which disable HCV RNA-dependent RNA polymerase (non-structural protein 5B; NS5B) upon binding. This results in the blockage of viral HCV RNA production and thus viral replication. This agent has a high barrier to resistance, however, a substitution Mutation Abnormality (S282T) on HCV NS5B impairs Mericitabine's activity significantly.. Prodrugs defined as following: A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a Prodrugs.. hepatitis C virus defined as following: Six clades of the virus exist. But all are considered one species, since serotyping is not yet possible and they do not contain any other taxonomic characteristics except geographic distribution (8th ICTV Report).. ribavirin defined as following: A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses.. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. daclatasvir defined as following: An orally available inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex, with potential activity against HCV. Although the exact mechanism of action of daclatasvir has yet to be fully determined, this agent, upon oral administration and after intracellular uptake, appears to bind to domain I of the NS5A protein. This inhibits the activity of the NS5A protein and results in the disruption of the viral RNA replication complex, blockage of viral HCV RNA production, and inhibition of viral replication. NS5A, a zinc-binding and proline-rich hydrophilic phosphoprotein, plays a crucial role in HCV RNA replication. HCV is a small, enveloped, single-stranded RNA virus belonging to the Flaviviridae family.. alisporivir defined as following: A non-immunosuppressive analogue of cyclosporine A and an inhibitor of cyclophilins, with potential antiviral activity. Upon oral administration, alisporivir targets and inhibits human host cyclophilins, thereby inhibiting hepatitis C virus (HCV) replication in hepatocytes. alisporivir may also inhibit the replication of various coronaviruses. In addition, it may inhibit mitochondrial cyclophilin-D, which regulates mitochondrial permeability transition pore (mPTP) opening. This may prevent cell death and tissue damage.. Pulmonary Valve Insufficiency defined as following: Backflow of blood from the PULMONARY ARTERY into the RIGHT VENTRICLE due to imperfect closure of the PULMONARY VALVE..", "label": "yes"} {"original_question": "Are genomic regulatory blocks (GRBs) any different than TADs?", "id": "converted_3336", "sentence1": "Are genomic regulatory blocks (GRBs) any different than Tietz syndrome?", "sentence2": "Topologically associating domains are ancient features that coincide with Metazoan clusters of extreme noncoding conservation., Clusters of CNEs define the span of regulatory inputs for many important developmental regulators and have been described previously as genomic regulatory blocks (GRBs). Their function and distribution around important Genes, Regulator raises the question of how they relate to 3 Days conformation of these loci. Here, we show that clusters of CNEs strongly coincide with topological organisation, predicting the boundaries of hundreds of topologically associating domains (Tietz syndrome) in human and Drosophila . The set of Tietz syndrome that are associated with high levels of noncoding conservation exhibit distinct properties compared to Tietz syndrome devoid of extreme noncoding conservation. The close correspondence between extreme noncoding conservation and Tietz syndrome suggests that these Tietz syndrome are ancient, revealing a regulatory architecture conserved over hundreds of millions of years.Metazoan genomes contain many clusters of conserved noncoding elements. Here, the authors provide evidence that these clusters coincide with distinct topologically associating domains in Homo sapiens and Drosophila , revealing a conserved regulatory genomic architecture.[SEP]Relations: Tietz syndrome has relations: disease_phenotype_positive with Congenital sensorineural hearing impairment, disease_phenotype_positive with Congenital sensorineural hearing impairment, disease_phenotype_positive with Bilateral sensorineural hearing impairment, disease_phenotype_positive with Bilateral sensorineural hearing impairment, disease_phenotype_positive with Hearing impairment, disease_phenotype_positive with Hearing impairment, disease_phenotype_positive with White eyelashes, disease_phenotype_positive with White eyelashes, disease_phenotype_positive with Autosomal dominant inheritance, disease_phenotype_positive with Autosomal dominant inheritance. Definitions: Genes, Regulator defined as following: Genes which regulate or circumscribe the activity of other genes; specifically, genes which code for PROTEINS or RNAs which have GENE EXPRESSION REGULATION functions.. Tietz syndrome defined as following: Tietz syndrome is a genetic hypopigmentation and deafness syndrome characterized by congenital profound bilateral sensorineural hearing loss and generalized albino-like hypopigmentation of skin, eyes and hair.. Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "no"} {"original_question": "Can NXY-059 be used for treatment of acute ischemic stroke patients?", "id": "converted_784", "sentence1": "Can NXY 059 be used for treatment of acute Ischemic Cerebrovascular accident patients?", "sentence2": "Even when the international recommendations for preclinical Cerebrovascular accident research, the Stroke Academic Industry Roundtable (STAIR) criteria, were followed, we have still seen limited success in the clinic, examples being NXY 059 and haematopoietic growth factors which fulfilled nearly all the STAIR criteria, This occurred during 1993-2006, when the 2,4-disulfonylphenyl PBN derivative, called NXY 059 in the Cerebrovascular accident studies, was shown to be safe in Homo sapiens and was taken all the way through clinical phase 3 trials and then was deemed to be ineffective. , The nitrone-based compound NXY 059, which is the first Pharmacologic Substance to reach clinical trials for the treatment of acute Ischemic Cerebrovascular accident, has provided promise for the development of more robust pharmacological agents. , OKN 007 is a proprietary compound that has had extensive commercial development (designated as NXY 059) for another indication, acute Ischemic Cerebrovascular accident, and after extensive clinical studies was shown to lack efficacy for this indication but was shown to be very safe for human use. , NXY 059, a polar compound with limited transport across the blood-brain barrier, has demonstrated neuroprotection in several animal models of acute Ischemic Cerebrovascular accident but failed to confirm clinical benefit in the second phase III trial (SAINT-II)., NXY 059 is no longer in development following a lack of efficacy found in a Phase III trial in patients with acute Ischemic Cerebrovascular accident. , We analyzed the quality and adequacy of animal studies supporting the efficacy of NXY 059 and other neuroprotective agents that are currently being investigated in phase II/III trials, In the aftermath of the failed Cerebrovascular accident clinical trials with the nitrone spin trap/radical scavenger, NXY 059, a number of articles raised the question: are we doing the right thing? , In 2006, the first positive trial of neuroprotection was published: the SAINT I (Stroke-Acute Ischemic NXY Treatment) study. In February 2008, the SAINT II study was published, indicating that NXY 059 was not effective for AIS treatment., CONCLUSIONS: NXY 059 is ineffective for treatment of AIS within 6 hours of symptom onset. , BACKGROUND AND PURPOSE: The SAINT I trial that showed a significant benefit of the neuroprotectant NXY 059 used a novel outcome for acute Ischemic Cerebrovascular accident trials: a shift toward good functional outcome on the 7-category modified Rankin scale (mRS)., BACKGROUND: The free-radical-trapping agent NXY 059 showed promise as a neuroprotectant in the Stroke-Acute Ischemic NXY Treatment I (SAINT I) trial, reducing Disability:Type:Pt:^Patient:Nom when given to patients who had acute Ischemic Cerebrovascular accident. , CONCLUSIONS: NXY 059 is ineffective for the treatment of acute Ischemic Cerebrovascular accident within 6 hours after the onset of symptoms., The continued failure in approving new drugs for treatment of acute Cerebrovascular accident has been recently set back by the failure of the NXY 059 (Stroke-Acute Ischemic NXY Treatment (SAINT) II) trial., The SAINT II Trial, a large randomized multicenter clinical trial of the putative neuroprotectant, NXY 059, failed to demonstrate a treatment benefit in acute Ischemic Cerebrovascular accident. , The positive results from the first Stroke-Acute-Ischaemic-NXY-Treatment (SAINT-I) trial of the free-radical spin-trap Pharmacologic Substance, NXY 059, which followed many of the STAIR guidelines, reinvigorated enthusiasm in neuroprotection, but the SAINT-II trial did not replicate the positive effect on the same primary prespecified outcome measure. , NXY 059, a free radical spin trap agent, was felt by many to have followed these criteria and it was recently shown to improve outcome in AIS patients in the SAINT I trial. However, the repeat, SAINT II trial was a neutral study, the results of which cast doubt on neuroprotection as a viable strategy for AIS. , NXY 059 is a novel free radical-trapping neuroprotectant that reduces infarct size and preserves brain function in animal models of acute Ischemic Cerebrovascular accident. It is the first neuroprotectant to demonstrate a reduction in global Disability:Type:Pt:^Patient:Nom in a phase III clinical trial, as measured by the modified Rankin Scale., BACKGROUND AND PURPOSE: NXY 059 is a free radical-trapping neuroprotectant demonstrated to reduce Disability:Type:Pt:^Patient:Nom from Ischemic Cerebrovascular accident., CONCLUSIONS: NXY 059 within 6 hours of acute Ischemic Cerebrovascular accident significantly reduced Disability:Type:Pt:^Patient:Nom. , CONCLUSIONS: The administration of NXY 059 within six hours after the onset of acute Ischemic Cerebrovascular accident significantly improved the primary outcome (reduced Disability:Type:Pt:^Patient:Nom at 90 days), but it did not significantly improve other outcome measures, including neurologic functioning as measured by the NIHSS score. Additional research is needed to confirm whether NXY 059 is beneficial in Ischemic Cerebrovascular accident. , BACKGROUND: The free-radical-trapping agent NXY 059 showed promise as a neuroprotectant in the Stroke-Acute Ischemic NXY Treatment I (SAINT I) trial, reducing Disability:Type:Pt:^Patient:Nom when given to patients who had acute Ischemic Cerebrovascular accident., NXY 059 is no longer in development following a lack of efficacy found in a Phase III trial in patients with acute Ischemic Cerebrovascular accident., The free-radical-trapping agent NXY 059 showed promise as a neuroprotectant in the Stroke-Acute Ischemic NXY Treatment I (SAINT I) trial, reducing Disability:Type:Pt:^Patient:Nom when given to patients who had acute Ischemic Cerebrovascular accident, The continued failure in approving new drugs for treatment of acute Cerebrovascular accident has been recently set back by the failure of the NXY 059 (Stroke-Acute Ischemic NXY Treatment (SAINT) II) trial[SEP]Relations: Ischemic Cerebrovascular accident has relations: drug_effect with Naltrexone, drug_effect with Naltrexone, drug_effect with Naltrexone, drug_effect with Naltrexone, disease_phenotype_positive with Cerebrovascular accident disorder, disease_phenotype_positive with Cerebrovascular accident disorder, disease_phenotype_positive with Cerebrovascular accident disorder, disease_phenotype_positive with Cerebrovascular accident disorder, drug_effect with Ramipril, drug_effect with Ramipril. Definitions: Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Homo sapiens defined as following: Members of the species Homo sapiens.. OKN 007 defined as following: A disulfonyl derivative of phenyl-tert-butyl nitrone (PBN), with potential anti-glioma activity. Although the exact mechanism(s) of action of OKN007 are still largely unknown, this agent appears to inhibit cancer cell proliferation and migration. This agent appears to inhibit the activity of sulfatase 2 (SULF2), a highly specific endoglucosamine-6-sulfatase that is overexpressed in the extracellular matrix of cancer cells and catalyzes the removal of sulfate from the 6-O-sulfate esters of heparin. In addition, OKN007 may induce changes in tumor metabolism and scavenge free radicals. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C102983\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C102983\" NCI Thesaurus). Ischemic Cerebrovascular accident defined as following: An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue.. Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810).", "label": "no"} {"original_question": "Is Lennox-Gastaut Syndrome usually diagnosed in older adults?", "id": "converted_2117", "sentence1": "Is Lennox-Gastaut syndrome usually diagnosed in older adults?", "sentence2": "We studied 15 Langer-Giedion Syndrome patients (mean age ± 1 standard deviation [SD] = 28.7 ± 10.6 years) and 17 healthy controls (mean age ± 1 SD = 27.6 ± 6.6 years), children with Lennox-Gastaut syndrome, Lennox-Gastaut syndrome (Langer-Giedion Syndrome) is a severe pediatric Epilepsy syndrome characterized by mixed seizures, Mental deterioration, and generalized slow (<3 Hz) spike wave discharges on electroencephalography, Clinical course and results of therapy were analysed in the group of 92 children, aged between 3 and 9 years, with diagnosed Lennox-Gastaut syndrome., We report the case of a 27-year-old Homo sapiens with a neurodevelopmental syndrome due to a 15q duplication, with Intellectual Disability, psychiatric disturbances, and an epileptic phenotype diagnosed as late-onset Lennox-Gastaut syndrome., Lennox-Gastaut syndrome is a relatively rare Epilepsy syndrome that usually begins in early-mid childhood and is characterized by multiple seizure types, particularly generalized seizures, which are often resistant to antiepileptic drug medication, Lennox-Gastaut syndrome is a severe childhood Epilepsy syndrome characterised by the diagnostic triad of a slow spike and wave pattern on electroencephalogram, multiple seizure types and developmental delay, We report the case of a 27-year-old Homo sapiens with a neurodevelopmental syndrome due to a 15q duplication, with Intellectual Disability, psychiatric disturbances, and an epileptic phenotype diagnosed as late-onset Lennox-Gastaut syndrome.., The Lennox-Gastaut syndrome, a severe form of Epilepsy that usually begins in early childhood, is difficult to treat., Lennox-Gastaut syndrome is a relatively rare Epilepsy syndrome that usually begins in early-mid childhood and is characterized by multiple seizure types, particularly generalized seizures, which are often resistant to antiepileptic drug medication., The Lennox-Gastaut syndrome is an age-specific disorder, characterised by Nonepileptic Seizures, a characteristic electroencephalogram (EEG), psychomotor delay and behaviour disorders. It occurs more frequently in males and onset is usually before the age of eight, with a peak between three and five years. Late cases occurring in adolescence and early adulthood have rarely been reported. [SEP]Relations: Lennox-Gastaut syndrome has relations: disease_disease with childhood-onset Epilepsy syndrome, disease_disease with childhood-onset Epilepsy syndrome, disease_disease with childhood electroclinical syndrome, disease_disease with childhood electroclinical syndrome, disease_disease with childhood onset epileptic encephalopathy, disease_disease with childhood onset epileptic encephalopathy, disease_disease with syndromic disease, disease_disease with syndromic disease, disease_disease with developmental and epileptic encephalopathy, disease_disease with developmental and epileptic encephalopathy. Definitions: Homo sapiens defined as following: Members of the species Homo sapiens.. Lennox-Gastaut syndrome defined as following: A syndrome characterized by frequent episodes of Epilepsy during childhood. The epileptic episodes may be tonic, atonic, myoclonic, or absence seizures. It may be accompanied by mental retardation and behavioral problems.. Langer-Giedion Syndrome defined as following: Autosomal dominant disorder characterized by cone-shaped epiphyses in the hands and multiple cartilaginous exostoses. INTELLECTUAL DISABILITY and abnormalities of chromosome 8 are often present. The exostoses in this syndrome appear identical to those of hereditary multiple exostoses (EXOSTOSES, HEREDITARY MULTIPLE).. Epilepsy defined as following: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal Epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313). Mental deterioration defined as following: Loss of previously present mental abilities, generally in adults. [HPO:probinson]. Epilepsy syndrome defined as following: EPILEPTIC SEIZURES that are of similar type and age of onset and have other similar features (e.g., clinical course, EEG findings, genetic association and neuropathology).. Intellectual Disability defined as following: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an Intellectual Disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28).", "label": "no"} {"original_question": "is pharmacological treatment of subclinical hypothyroidism effective in reducing cardiovascular events?", "id": "converted_824", "sentence1": "is pharmacological treatment of subclinical hypothyroidism effective in reducing Cardiovascular system events?", "sentence2": "The decision to treat elderly people is still an unresolved clinical challenge--first, due to a lack of appropriately powered randomized controlled trials of levothyroxine in sHT patients, examining Cardiovascular system hard endpoints in various classes of age; and second, because of the negative effects of possible overtreatment., The lack of specific randomized trials enrolling either old or very old subjects, aimed at evaluate the efficacy of hormonal replacement on overall survival and Cardiovascular system risk reduction along with the negative effects of possible over-treatment, makes the decision to treat older people a still unresolved clinical challenge, In patients with type 2 DM, the presence of SH serves as an additional risk factor for endothelial dysfunction., Treatment of Supracervical hysterectomy with levothyroxine was associated with fewer Myocardial Ischemia events in younger individuals, but this was not evident in older people., Subclinical hyperthyroidism seems to be a risk factor of developing major Cardiovascular system events, especially Cerebrovascular accident in older adults from the general population with normal left ventricular function., Supracervical hysterectomy appears to influence the postoperative outcome for patients by increasing the development of postoperative atrial fibrillation. However, it is still unproven whether preoperative thyroxine replacement therapy for patients with Supracervical hysterectomy might prevent postoperative atrial fibrillation after CABG., In Congestive heart failure patients Thyrotropin:-:Pt:Ser/Plas:- levels even slightly above normal range are independently associated with a greater likelihood of heart failure progression., In current RCTs, levothyroxine replacement therapy for subclinical hypothyroidism did not result in improved survival or decreased Cardiovascular system morbidity. Data on health-related quality of life and symptoms did not demonstrate significant differences between intervention groups., However, the actual effectiveness of Thyroid Hormones substitution in reducing the risk of Cardiovascular system events remains to be elucidated. In conclusion, the multiplicity and the possible reversibility of subclinical hypothyroidism-associated Cardiovascular system abnormalities suggest that the decision to treat a patient should depend on the presence of risk factors, rather than on a Thyrotropin:-:Pt:Ser/Plas:- threshold. , However, whether SH confers a high risk for Cardiovascular Diseases, and whether LT4 therapy has a long-term benefit that clearly outweighs the risks of overzealous treatment in these individuals, remain topics of controversy.[SEP]Relations: Levothyroxine has relations: contraindication with Cardiovascular Diseases, contraindication with Cardiovascular Diseases, drug_effect with Hypoglycemia, drug_effect with Hypoglycemia. Cardiovascular Diseases has relations: contraindication with Levothyroxine, contraindication with Levothyroxine, contraindication with Phenobarbital, contraindication with Phenobarbital, contraindication with Liothyronine, contraindication with Liothyronine. Definitions: levothyroxine defined as following: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.. Congestive heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Cardiovascular Diseases defined as following: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.. Cardiovascular system defined as following: The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body.. Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810). Myocardial Ischemia defined as following: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).. Thyroid Hormones defined as following: Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs.. Supracervical hysterectomy defined as following: A hysterectomy that removes the uterus and leaves the cervix in place..", "label": "no"} {"original_question": "Have machine learning methods been used to predict the severity of major depressive disorder(MDD)?", "id": "converted_2934", "sentence1": "Have machine learning methods been used to predict the severity of major depressive disorder(Major Depressive Disorder)?", "sentence2": "Here, we conduct a meta-review to identify predictors of response to Antidepressive Agents therapy in order to select robust input features for machine learning models of treatment response. , machine learning framework involving EEG-based functional connectivity to diagnose major depressive disorder (Major Depressive Disorder)., Identification of risk factors of treatment resistance may be useful to guide treatment selection, avoid inefficient trial-and-error, and improve major depressive disorder (Major Depressive Disorder) care. We extended the work in predictive modeling of treatment resistant depression (T-Cell Receptors delta-Chain) via partition of the data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) cohort into a training and a testing dataset., persistence and severity of major depressive disorder from baseline self-reports, These results confirm that clinically useful Major Depressive Disorder risk-stratification models can be generated from baseline patient self-reports and that ML methods improve on conventional methods in developing such models, Furthermore, machine learning weighting factors may reflect an objective biomarker of major depressive disorder illness severity, based on abnormalities of Head>Brain structure., Notably, while the only information provided for training the classifiers was T(1)-weighted scans plus a categorical label (major depressive disorder versus controls), both relevance vector machine and support vector machine 'weighting factors' (used for making predictions) correlated strongly with subjective ratings of illness severity., BACKGROUND\nAlthough variation in the long-term course of major depressive disorder (Major Depressive Disorder) is not strongly predicted by existing symptom subtype distinctions, recent research suggests that prediction can be improved by using machine learning methods., BACKGROUND Although variation in the long-term course of major depressive disorder (Major Depressive Disorder) is not strongly predicted by existing symptom subtype distinctions, recent research suggests that prediction can be improved by using machine learning methods., BACKGROUND Growing evidence documents the potential of machine learning for developing Head>Brain based diagnostic methods for major depressive disorder (Major Depressive Disorder)., OBJECTIVE We aimed to integrate neural data and an advanced machine learning technique to predict individual major depressive disorder (Major Depressive Disorder) patient severity., Furthermore, machine learning weighting factors may reflect an objective biomarker of major depressive disorder illness severity, based on abnormalities of Head>Brain structure., BACKGROUND: Although variation in the long-term course of major depressive disorder (Major Depressive Disorder) is not strongly predicted by existing symptom subtype distinctions, recent research suggests that prediction can be improved by using machine learning methods.[SEP]Relations: major depressive disorder has relations: disease_protein with MDM4, disease_protein with MDM4, disease_disease with anxiety disorder, disease_disease with anxiety disorder, disease_protein with DRD4, disease_protein with DRD4, disease_protein with DDC, disease_protein with DDC, disease_protein with PCNT, disease_protein with PCNT. Definitions: Antidepressive Agents defined as following: Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through Head>Brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.. T-Cell Receptors delta-Chain defined as following: One component of the gamma-delta T-cell receptor. Encoded by a locus on chromosome 14. Somatic recombination results in formation of the active gene.. Major Depressive Disorder defined as following: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5).", "label": "yes"} {"original_question": "Does the royal jelly contain proteins?", "id": "converted_4400", "sentence1": "Does the royal jelly contain Proteins?", "sentence2": " We observed differences in the metabolome, proteome, and phytosterols compositions of royal jelly synthesized by nurse bees from multi-pesticide exposed colonies, including significant reductions of key Nutrients such as 24-methylenecholesterol, major royal jelly Proteins, and 10-hydroxy-2-decenoic acid. , Two-dimensional electrophoresis was used for the fractionation of royal jelly Proteins, the main bioactive compounds of RJ, such as Proteins, peptides, Fatty Acids, and Substance with phenol structure, the expression of four of the major royal jelly Proteins (MRJP1, MRJP2, MRJP4, and MRJP5) and also several Proteins associated with carbohydrate metabolism and energy synthesis, the antioxidant system, detoxification, biosynthesis, amino acid metabolism, transcription and translation, protein folding and binding, olfaction, and learning and memory.[SEP]Relations: 12-Hydroxydodecanoic Acid has relations: drug_protein with ADH5, drug_protein with ADH5. Definitions: Fatty Acids defined as following: Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed). Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. phytosterols defined as following: A class of organic compounds known as sterols or STEROIDS derived from plants.. Nutrients defined as following: Various components of food that are required for nourishment..", "label": "yes"} {"original_question": "Is transcription-associated mutagenesis (TAM) related to gene expression levels?", "id": "converted_847", "sentence1": "Is transcription-associated Mutagenesis Procedure (Immunoreceptor Tyrosine-Based Activation Motif) related to Genes expression levels?", "sentence2": "These Gene Mutation were frequent in Plasmids-borne lacS expressed at a high level but not in single-copy lacS in the Chromosomes, Human, Pair 1 or at lower levels of expression in a Plasmids., The results suggest that important DNA repair or replication fidelity functions are impaired or overwhelmed in pJlacS, with results analogous to those of the \"transcription-associated Mutagenesis Procedure\" seen in Bacteria and Eukaryota., the rate of Point Mutation in a Genes increases with the expression level of the Genes. Transcription induces Mutagenesis Procedure on both DNA strands, indicating simultaneous actions of several Immunoreceptor Tyrosine-Based Activation Motif mechanisms., High-levels of transcription through a Genes stimulate spontaneous Mutation Abnormality rate, a phenomenon termed transcription-associated Mutation Abnormality (Immunoreceptor Tyrosine-Based Activation Motif)., High levels of transcription in Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae or Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae cerevisiae are associated with increased genetic instability, which has been linked to DNA damage. Here, we describe a pGAL-CAN1 forward Mutation Abnormality assay for studying transcription-associated Mutagenesis Procedure (Immunoreceptor Tyrosine-Based Activation Motif) in Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae., The acquisition of Gene Mutation was directly correlated to the level of transcription, Our results demonstrate that the level of Leu(+) reversions increased significantly in parallel with the induced increase in transcription levels., Transcription-associated Mutagenesis Procedure in Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae is directly proportional to the level of Genes expression, spontaneous Mutation Abnormality rate is directly proportional to the transcription level, suggesting that movement of DNA-Directed RNA Polymerase through the target initiates a mutagenic process(es), High transcription is associated with genetic instability, notably increased spontaneous Mutation Abnormality rates, which is a phenomenon termed Transcription-Associated-Mutagenesis (Immunoreceptor Tyrosine-Based Activation Motif)., Using this system, we also investigated two hypotheses that have been proposed to explain transcription-associated Mutagenesis Procedure (Immunoreceptor Tyrosine-Based Activation Motif): (1) transcription impairs replication fork progression in a directional manner and (2) DNA lesions accumulate under high-transcription conditions., Transcription-associated Mutagenesis Procedure in Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae is directly proportional to the level of Genes expression and influenced by the direction of DNA replication., High levels of transcription in Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae or Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae cerevisiae are associated with increased genetic instability, which has been linked to DNA damage., Using this system, we also investigated two hypotheses that have been proposed to explain transcription-associated Mutagenesis Procedure (Immunoreceptor Tyrosine-Based Activation Motif): (1) transcription impairs replication fork progression in a directional manner and (2) DNA lesions accumulate under high-transcription conditions., Using comparative genomics of related species as well as Mutation Abnormality accumulation lines, we show in Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae that the rate of Point Mutation in a Genes increases with the expression level of the Genes, High transcription is associated with genetic instability, notably increased spontaneous Mutation Abnormality rates, which is a phenomenon termed Transcription-Associated-Mutagenesis (Immunoreceptor Tyrosine-Based Activation Motif), Using this system, we also investigated two hypotheses that have been proposed to explain transcription-associated Mutagenesis Procedure (Immunoreceptor Tyrosine-Based Activation Motif): (1) transcription impairs replication fork progression in a directional manner and (2) DNA lesions accumulate under high-transcription conditions, High-levels of transcription through a Genes stimulate spontaneous Mutation Abnormality rate, a phenomenon termed transcription-associated Mutation Abnormality (Immunoreceptor Tyrosine-Based Activation Motif)[SEP]Relations: activation of transmembrane receptor protein tyrosine kinase activity has relations: bioprocess_protein with PDGFC, bioprocess_protein with PDGFC, bioprocess_protein with TAL1, bioprocess_protein with TAL1, bioprocess_protein with ANGPT1, bioprocess_protein with ANGPT1, bioprocess_protein with ADRB2, bioprocess_protein with ADRB2. adaptation to pheromone regulating conjugation with mutual genetic exchange has relations: bioprocess_bioprocess with regulation of conjugation, bioprocess_bioprocess with regulation of conjugation. Definitions: Chromosomes, Human, Pair 1 defined as following: A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human Chromosomes, Human, Pair 1 classification.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Point Mutation defined as following: A Mutation Abnormality caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair.. Saccharomyces cerevisiae defined as following: A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" Saccharomyces cerevisiae. The dried form is used as a dietary supplement.. Eukaryota defined as following: Organism or cells with a nucleus separated from the cytoplasm by a two membrance nuclear envelope and compartmentalization of function into distinct cytoplasmic organelles.. Mutagenesis Procedure defined as following: Production of genetic alterations by any technique, including chemicals, radiation, recombination, or other molecular biology methods.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Plasmids defined as following: Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.. Immunoreceptor Tyrosine-Based Activation Motif defined as following: A rare congenital myopathy characterized ultrastructurally by the presence of tubular aggregates in the subsarcolemmal region of the muscle fiber. It most commonly presents with slowly progressive proximal muscle weakness predominantly of the lower limbs, periodic paralysis, post-exertion muscle cramps, and muscular pain. Ocular anomalies like ophthalmoplegia or pupillary abnormalities may be associated. The intensity of the symptoms is variable, cases with normal muscle strength but myalgia or fatigue, as well as clinically asymptomatic cases have been described.. DNA-Directed RNA Polymerase defined as following: Enzymes that catalyze DNA template-directed extension of the 3'-end of an RNA strand one nucleotide at a time. They can initiate a chain de novo. In Eukaryota, three forms of the enzyme have been distinguished on the basis of sensitivity to alpha-amanitin, and the type of RNA synthesized. (From Enzyme Nomenclature, 1992).. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA.. Bacteria defined as following: One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive..", "label": "yes"} {"original_question": "Are there studies representing the involvement of Notch mutations in neurodegenerative diseases such as Down syndrome, Pick's and Prion's disease, and cadasil syndrome?", "id": "converted_352", "sentence1": "Are there studies representing the involvement of Notch Gene Mutation in neurodegenerative diseases such as Down Syndrome, Pick's and Prion's disease, and cadasil syndrome?", "sentence2": "he Notch signaling pathway plays a critical role in maintaining the balance between cell proliferation, differentiation and apoptosis, and is a highly conserved signaling pathway that regulates normal development in a context- and dose-dependent manner. Dysregulation of Notch signaling has been suggested to be key events in a variety of hematological Malignant Neoplasms. NOTCH1 wt Allele signaling appears to be the central oncogenic trigger in Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL), in which the majority of Homo sapiens Malignant Neoplasms have acquired Gene Mutation that lead to constitutive activation of NOTCH1 wt Allele signaling., In a forward genetic screen for Gene Mutation that alter Protoplasm Notch receptor trafficking in Drosophila melanogaster, we recovered Mutant that disrupt Genes encoding Serine Palmitoyltransferase 1, Human and Acetyl-CoA Carboxylase., Signaling pathways have become a major source of targets for novel therapies in Liver carcinoma (altretamine/cisplatin/cyclophosphamide protocol). Survival benefits achieved with sorafenib, a multikinase inhibitor, are unprecedented and underscore the importance of improving our understanding of how signaling networks interact in transformed cells., Notch-1 immunoexpression is increased in Alzheimer's and Pick's disease, (PSEN1 protein, Homo sapiens protein, Homo sapiens) is the major Gene Locus for Gene Mutation causing familial ALZHEIMER DISEASE, FAMILIAL, 1 (flavin-adenine dinucleotide) and is also Mutation Abnormality in Pick Disease of the Brain of Head>Brain, familial acne inversa and Cardiomyopathy, Dilated. It is a critical facilitator of Notch signalling and many other signalling pathways and protein cleavage events including production of the Amyloidβ (Aβ) peptide from the AMYLOID BETA A4 PRECURSOR PROTEIN (Smartphone Application, As beta-Smartphone Application and Notch are both processed by gamma-Secretase, we analyzed expression of the Notch signaling pathway in the adult DS Head>Brain and in a model system for DS, Homo sapiens trisomy 21 Specimen Source Codes - Fibroblasts by quantitative PCR. In adult DS cortex we found that NOTCH1 wt Allele, DLL1 gene and HES1 gene expression is up-regulated. Moreover, DS Specimen Source Codes - Fibroblasts and Alzheimer disease cortex also show overexpression of NOTCH1 wt Allele and DLL1 gene, indicating that enhanced beta-Smartphone Application processing found in both DS and cytarabine/daunorubicin protocol could be instrumental in these changes, A systems biology approach to Down Syndrome: identification of Notch/Wnt dysregulation in a model of Stem cells aging, NOTCH3 gene has been recently identified as a causative gene for cerebral autosomal dominant arteriopathy with subcortical infarcts and Leukoencephalopathy (CADASIL Syndrome Syndrome)[SEP]Relations: NOTCH3 has relations: disease_protein with cerebral arteriopathy, autosomal dominant, with subcortical infarcts and Leukoencephalopathy,, disease_protein with cerebral arteriopathy, autosomal dominant, with subcortical infarcts and Leukoencephalopathy,, disease_protein with CARASIL syndrome, disease_protein with CARASIL syndrome, disease_protein with lateral meningocele syndrome, disease_protein with lateral meningocele syndrome, disease_protein with dementia (disease), disease_protein with dementia (disease). CARASIL syndrome has relations: disease_protein with NOTCH3, disease_protein with NOTCH3. Definitions: Stem cells defined as following: Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells.. flavin-adenine dinucleotide defined as following: A condensation product of riboflavin and adenosine diphosphate. The coenzyme of various aerobic dehydrogenases, e.g., D-amino acid oxidase and L-amino acid oxidase. (Lehninger, Principles of Biochemistry, 1982, p972). CADASIL Syndrome defined as following: A hereditary cerebrovascular disorder caused by Gene Mutation in the Notch 3 gene. It is characterized by alterations of the muscular wall of the small vessels in the Head>Brain, resulting in transient ischemic attacks. It may lead to cognitive problems and dementia.. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma defined as following: A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.. HES1 gene defined as following: This gene is involved in the modulation of transcription.. gamma-Secretase defined as following: A protein complex that plays a role in the intramembrane cleavage of integral proteins such as Notch receptors and amyloid beta A4 protein.. Down Syndrome defined as following: A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213). DLL1 gene defined as following: This gene is involved in notch signaling.. NOTCH1 wt Allele defined as following: Human NOTCH1 wild-type allele is located in the vicinity of 9q34.3 and is approximately 51 kb in length. This allele, which encodes neurogenic Gene Locus notch homolog protein 1 protein, plays a role in developmental processes by controlling cell fate decisions.. Pick Disease of the Brain defined as following: A rare form of DEMENTIA that is sometimes familial. Clinical features include APHASIA; APRAXIA; CONFUSION; ANOMIA; memory loss; and personality deterioration. This pattern is consistent with the pathologic findings of circumscribed atrophy of the poles of the FRONTAL LOBE and TEMPORAL LOBE. Neuronal loss is maximal in the HIPPOCAMPUS, entorhinal cortex, and AMYGDALA. Some ballooned cortical neurons contain argentophylic (Pick) bodies. (From Brain Pathol 1998 Apr;8(2):339-54; Adams et al., Principles of Neurology, 6th ed, pp1057-9). Acetyl-CoA Carboxylase defined as following: A carboxylating enzyme that catalyzes the conversion of ATP, acetyl-CoA, and HCO3- to ADP, orthophosphate, and malonyl-CoA. It is a biotinyl-protein that also catalyzes transcarboxylation. The plant enzyme also carboxylates propanoyl-CoA and butanoyl-CoA (From Enzyme Nomenclature, 1992) EC 6.4.1.2.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, proteins, lipids, carbohydrates, and inorganic salts.. Liver carcinoma defined as following: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.. PSEN1 protein, Homo sapiens defined as following: Presenilin-1 (467 aa, ~53 kDa) is encoded by the Homo sapiens PSEN1 protein, Homo sapiens gene. This protein plays a role in the mediation of proteolysis.. Cardiomyopathy, Dilated defined as following: Cardiomyopathy which is characterized by dilation and contractile dysfunction of the left and right ventricles. It may be idiopathic, or it may result from a myocardial infarction, myocardial infection, or alcohol abuse. It is a cause of congestive heart failure.. Mutant defined as following: An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (Gene Mutation).. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the Smartphone Application gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Smartphone Application defined as following: An application designed specifically for use on a smartphone.. Serine Palmitoyltransferase 1, Human defined as following: Serine palmitoyltransferase 1 (473 aa, ~53 kDa) is encoded by the Homo sapiens SPTLC1 gene. This protein plays a role in the biosynthesis of sphingolipids.. sorafenib defined as following: A synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Gene Locus defined as following: The position of a gene or a chromosomal marker on a chromosome; also, a stretch of DNA at a particular place on a particular chromosome. The use of Gene Locus is sometimes restricted to mean regions of DNA that are expressed.. NOTCH3 gene defined as following: This gene plays a role in both intercellular signaling and cell fate determination.. Homo sapiens defined as following: Members of the species Homo sapiens.. hematological Malignant Neoplasms defined as following: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Leukoencephalopathy defined as following: Any of various diseases affecting the white matter of the central nervous system.. cadasil syndrome defined as following: A hereditary cerebrovascular disorder caused by Gene Mutation in the Notch 3 gene. It is characterized by alterations of the muscular wall of the small vessels in the Head>Brain, resulting in transient ischemic attacks. It may lead to cognitive problems and dementia.. neurodegenerative diseases defined as following: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures..", "label": "yes"} {"original_question": "Can a peptide aptamer be used as protein inhibitor?", "id": "converted_533", "sentence1": "Can a Peptides aptamer be used as Protein Info inhibitor?", "sentence2": "Peptide aptamers of LIM-only Protein Info 2 (Rhombotin 2) were previously used to successfully treat Rhombotin 2-induced tumours in a mouse model of leukemia., Inhibition of mammalian cell proliferation by genetically selected Peptides aptamers that functionally antagonize E2F activity., Accumulating work over the past decade has shown that Peptides aptamer screening represents a valid strategy for inhibitor identification that can be applied to a variety of different targets. , . The target of one inhibitor Peptides, Pep80, identified in this screen was determined to be SNAPIN gene, a Protein Info associated with the soluble N-ethyl maleimide sensitive factor adaptor Protein Info receptor (SNAP receptor activity) complex that is critical for calcium-dependent exocytosis during neurotransmission. , Use of the genetically selected intracellular aptamer inhibitors allowed us to define unique mechanisms important to HIV-1 replication and T cell biology., This review will describe pre-clinical and clinical data of four major classes of TGF-β inhibitor, namely i) ligand traps, ii) Antisense Oligonucleotides, iii) receptor kinase inhibitors and iv) Peptides aptamers. , A Peptides aptamer (ID1/3-PA7) has been designed to prevent this interaction and thereby leading to the transcription of p16(INK4a)., A Peptides kinase inhibitor (IP(20)) was used as the aptameric Peptides , Peptide aptamer mimicking RAD51-binding Superkingdom (taxonomic category) of BRCA2 gene gene inhibits DNA damage repair and survival in Trypanosoma brucei brucei brucei., Peptides aptamer, ID1 Protein Info, human/3-PA7, targeting ID1 Protein Info, human and DNA-Binding Protein Inhibitor ID-3,, Targeting ID1 Protein Info, human and DNA-Binding Protein Inhibitor ID-3 by a specific Peptides aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer Cells., Aptamer-derived peptides as potent inhibitors of the oncogenic guanyl-nucleotide exchange factor activity Tgat., Our approach thus demonstrates that Peptides aptamers are potent inhibitors that can be used to interfere with guanyl-nucleotide exchange factor activity functions in vivo., Development of systemic in vitro evolution and its application to generation of Peptides-aptamer-based inhibitors of carboxypeptidase C E., he fusion Peptides, cytarabine/thioguanine aptamer, was observed within PC12 cytoplasm and maintained both Abeta-binding ability and antioxygenic property similar to TXN wt Allele., Stable expression of a novel fusion Peptides of Thioredoxin 1 and ABAD-inhibiting Peptides protects PC12 Cells from intracellular amyloid-beta., In order to efficiently select aptamers that bind to and inhibit proteins,, Aptamer selection based on inhibitory activity using an evolution-mimicking algorithm., This demonstrates the utility of this strategy for screening aptamers based on their inhibitory actions., Protoplasm expression of the DRD-binding Peptides aptamer specifically suppressed receptor-mediated extrinsic apoptosis but not intrinsic pathway, which was recapitulated by the Antisense Oligonucleotides for CASP8AP2 wt Allele. , Peptide aptamers are peptides constrained and presented by a scaffold Protein Info that are used to study Protein Info function in Cells. They are able to disrupt Protein Info-Protein Info interactions , Here we have used a genetic screen in Saccharomyces cerevisiae to select in vivo peptides coupled to Thioredoxin (human), called aptamers, that could inhibit GEFD2 activity. One aptamer, TRIAPalpha (TRio Inhibitory APtamer), specifically blocks GEFD2-exchange activity on RHOA Protein Info, human in vitro., These results show that cell proliferation can be inhibited using genetically-selected synthetic peptides that specifically target Protein Info-Protein Info interaction motifs within cell cycle regulators., These data highlight the utility of Peptides aptamers to identify novel binding interfaces and highlight a role for microtubule-associated Protein Info 1B in DAPK-1-dependent signaling in autophagy and Membrane Device blebbing.[SEP]Relations: Protein S human has relations: drug_drug with Anti-inhibitor coagulant complex, drug_drug with Anti-inhibitor coagulant complex, drug_drug with Anti-inhibitor coagulant complex, drug_drug with Anti-inhibitor coagulant complex. Protein Info binding has relations: molfunc_protein with ACR, molfunc_protein with ACR, molfunc_protein with PTER, molfunc_protein with PTER, molfunc_protein with ADAR, molfunc_protein with ADAR. Definitions: guanyl-nucleotide exchange factor activity defined as following: Stimulates the exchange of GDP to GTP on a signaling GTPase, changing its conformation to its active form. Guanine nucleotide exchange factors (GEFs) act by stimulating the release of guanosine diphosphate (GDP) to allow binding of guanosine triphosphate (GTP), which is more abundant in the cell under normal cellular physiological conditions. [GOC:kd, GOC:mah, PMID:23303910, PMID:27218782]. RHOA Protein Info, human defined as following: Transforming Protein Info RHOA Protein Info, human (193 aa, ~22 kDa) is encoded by the human RHOA gene. This Protein Info is involved in the regulation of signal transduction pathways that control assembly of focal adhesions and actin stress fibers.. Saccharomyces cerevisiae defined as following: A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" Saccharomyces cerevisiae. The dried form is used as a dietary supplement.. BRCA2 gene defined as following: A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human chromosome 13 at locus 13q12.3. Mutations in this gene predispose humans to breast and ovarian cancer. It encodes a large, nuclear Protein Info that is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. (from Genes Dev 2000;14(11):1400-6). carboxypeptidase C defined as following: A carboxypeptidase that catalyzes the release of a C-terminal amino acid with a broad specificity. It also plays a role in the LYSOSOMES by protecting BETA-GALACTOSIDASE and NEURAMINIDASE from degradation. It was formerly classified as EC 3.4.12.1 and EC 3.4.21.13.. TXN wt Allele defined as following: Human TXN wild-type allele is located within 9q31 and is approximately 12 kb in length. This allele, which encodes Thioredoxin (human) Protein Info, is involved in the reduction of numerous biological substrates via dithiol-disulfide exchange reactions. TXN gene expression is elevated in several types of cancer such as colorectal, gastric and lung cancers.. Peptides defined as following: Members of the class of compounds composed of AMINO ACIDS joined together by Peptides bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS.. CASP8AP2 wt Allele defined as following: Human CASP8AP2 wild-type allele is located in the vicinity of 6q15 and is approximately 45 kb in length. This allele, which encodes CASP8-associated Protein Info 2, plays a role in the regulation of apoptosis.. Rhombotin 2 defined as following: Rhombotin-2 (158 aa, ~18 kDa) is encoded by the human LMO2 gene. This Protein Info is involved in erythrocyte development.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, proteins, lipids, carbohydrates, and inorganic salts.. leukemia defined as following: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature Cells; chronic leukemias are composed of more mature Cells. (From The Merck Manual, 2006). Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. DNA-Binding Protein Inhibitor ID-3 defined as following: DNA-binding Protein Info inhibitor ID-3 (119 aa, ~12 kDa) is encoded by the human ID3 gene. This Protein Info plays a role in the inhibition of transcription factor activity.. Superkingdom (taxonomic category) defined as following: A taxonomic category above that of Kingdom.. SNAP receptor activity defined as following: Acting as a marker to identify a Membrane Device and interacting selectively with one or more SNAREs on another Membrane Device to mediate Membrane Device fusion. [GOC:mah, PMID:14570579]. Antisense Oligonucleotides defined as following: Short fragments of DNA or RNA that are used to alter the function of target RNAs or DNAs to which they hybridize.. ID1 protein, human defined as following: DNA-binding Protein Info inhibitor ID-1 (155 aa, ~16 kDa) is encoded by the human ID1 gene. This Protein Info plays a role in the modulation of gene transcription.. Trypanosoma brucei brucei defined as following: A hemoflagellate subspecies of parasitic protozoa that causes nagana in domestic and game animals in Africa. It apparently does not infect humans. It is transmitted by bites of tsetse flies (Glossina).. PC12 Cells defined as following: A CELL LINE derived from a PHEOCHROMOCYTOMA of the rat ADRENAL MEDULLA. PC12 Cells stop dividing and undergo terminal differentiation when treated with NERVE GROWTH FACTOR, making the line a useful model system for NERVE CELL differentiation.. Membrane Device defined as following: A device that is made from or resembles a thin flexible sheet of material.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Thioredoxin (human) defined as following: Adult T-cell Leukemia derived factor: Human Thioredoxin (human). A cytokine..", "label": "yes"} {"original_question": "Is there a relation between ANP and transcapillary albumin escape?", "id": "converted_1377", "sentence1": "Is there a relation between Atrial Natriuretic Factor and transcapillary ALB gene escape?", "sentence2": "Thus, in a large ethnically homogeneous cohort of diabetic subjects, our data show: (1) a significant association of C708/T Genetic Polymorphism with Microalbuminuria in long-term Diabetes Mellitus and with both lower plasma Atrial Natriuretic Factor levels and widespread ALB gene leakage, hese results suggest a possible role of PND gene in conferring protection from Kidney Diseases and microvascular damage in type 1 Diabetes Mellitus., Moreover, the increased susceptibility of the Glomerular capillaries structure in diabetics to Atrial Natriuretic Factor seems to be part of a more generalized capillary abnormality, because Atrial Natriuretic Factor also increases the transcapillary escape of ALB gene., In summary, low dose Atrial Natriuretic Factor infusion in healthy subjects caused a shift of plasma water and Electrolyte [EPC] from the circulation, with ALB gene escape as a secondary phenomenon.[SEP]Relations: Albuminuria has relations: drug_effect with Entacapone, drug_effect with Entacapone, drug_effect with Epirubicin, drug_effect with Epirubicin, drug_effect with Allopurinol, drug_effect with Allopurinol, drug_effect with Sibutramine, drug_effect with Sibutramine, drug_effect with Mycophenolic acid, drug_effect with Mycophenolic acid. Definitions: Atrial Natriuretic Factor defined as following: A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS.. Kidney Diseases defined as following: Pathological processes of the KIDNEY or its component tissues.. Genetic Polymorphism defined as following: The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.. Diabetes Mellitus defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.. Glomerular capillaries structure defined as following: Tiny blood vessels located within Bowman's capsule, which combine in networks to form a glomerulus..", "label": "yes"} {"original_question": "Is muscle lim protein (MLP) involved in cardiomyopathies?", "id": "converted_828", "sentence1": "Is Muscle Tissue lim Protein Info (MARCKSL1 gene) involved in cardiomyopathies?", "sentence2": "Muscle LIM Protein Info (MARCKSL1 gene) has been proposed to be a central player in the pathogenesis of Cardiomyopathies. In line with this notion, the homozygous loss of MARCKSL1 gene results in Cardiac - anatomy qualifier hypertrophy and Cardiomyopathy, Dilated. Moreover, MARCKSL1 gene is induced in several models of Cardiac - anatomy qualifier hypertrophy such as aortic banding and Myocardial infarction:Finding:Point in time:^Patient:Ordinal. , Muscle LIM Protein Info (MARCKSL1 gene) null mice are often used as a model for human Cardiomyopathy, Dilated., A lack of MARCKSL1 gene leads to an age-dependent impairment of excitation-contraction coupling with resulting contractile dysfunction and secondary fibrosis., Loss of murine MARCKSL1 gene results in Cardiomyopathy, Dilated, and mutations in human MARCKSL1 gene lead to Cardiac - anatomy qualifier hypertrophy, indicating a critical role for MARCKSL1 gene in maintaining normal Cardiac - anatomy qualifier function., Our data indicate that MARCKSL1 gene contributes to Muscle Tissue stiffness and is necessary for maximum work and power generation., Interestingly, MARCKSL1 gene was also found to be down-regulated in Homo sapiens with Congestive Chest>Heart failure (Zolk et al. Circulation 101:2674-2677, 2000) and MARCKSL1 gene mutations are able to cause Hypertrophic disorder of skin, unspecified and dilated forms of cardiomyopathy in Homo sapiens (Bos et al. Mol Genet Metab 88:78-85, 2006; Geier et al. Circulation 107:1390-1395, 2003; Hershberger et al. Clin Transl Sci 1:21-26, 2008; Knöll et al. \"U\" lymphocyte 111:943-955, 2002; Knöll et al. Circ Res 106:695-704, 2010; Mohapatra et al. Mol Genet Metab 80:207-215, 2003)., MARCKSL1 gene soon became an important model for experimental cardiology when it was first demonstrated that MARCKSL1 gene deficiency leads to Myocardial hypertrophy followed by a Cardiomyopathy, Dilated and Congestive Chest>Heart failure phenotype (Arber et al. \"U\" lymphocyte 88:393-403, 1997). , Previous studies have shown an association between CSRP3 gene gene missense mutations and either Cardiomyopathy, Dilated (3',5'-dichloromethotrexate) or Hypertrophic Cardiomyopathy, but all these studies were unable to provide comprehensive Genetic evidence for a causative role of CSRP3 gene gene mutations. , We used a newly designed monoclonal antibody CAL CAL to show that Muscle Tissue LIM Protein Info (MARCKSL1 gene), the Protein Info encoded by CSRP3 gene gene, is mainly a Cytoplasmic matrix component of Myocytes, Cardiac and not tightly anchored to sarcomeric structures. Our functional data from both in vitro and in vivo analyses suggest that at least one of MARCKSL1 gene's mutated forms seems to be destabilized in the Chest>Heart of Hypertrophic Cardiomyopathy patients harbouring a CSRP3 gene gene missense Mutation Abnormality., Muscle LIM Protein Info (MARCKSL1 gene) is a Cytoskeleton Protein Info located at the Z line of sarcomeres. Gene Mutation in the human MARCKSL1 gene gene are associated with Hypertrophic disorder of skin, unspecified and Cardiomyopathy, Dilated., Our data demonstrate that Mlp84B is essential for normal Cardiac - anatomy qualifier function and establish the Drosophila model for the investigation of the mechanisms connecting defective Cardiac - anatomy qualifier Z line components to the development of cardiomyopathy., Muscle LIM Protein Info (MARCKSL1 gene) is a Cytoskeleton LIM-only Protein Info expressed in striated Muscle Tissue. Gene Mutation in human MARCKSL1 gene are associated with cardiomyopathy;, TTN-encoded titin, CSRP3 gene gene-encoded Muscle Tissue LIM Protein Info, and 2,2,2',4'-tetrachloroacetophenone-encoded telethonin are Z line proteins essential for the structural organization of the Cardiac - anatomy qualifier Sarcomeres and the cardiomyocyte's stretch sensor. All three Genes have been established as cardiomyopathy-associated Genes for both Cardiomyopathy, Dilated (3',5'-dichloromethotrexate) and Hypertrophic obstructive cardiomyopathy (Hypertrophic Cardiomyopathy). , Approximately 4.1% of unrelated patients had Hypertrophic Cardiomyopathy-associated MARCKSL1 gene or 2,2,2',4'-tetrachloroacetophenone mutations. MARCKSL1 gene/2,2,2',4'-tetrachloroacetophenone-Hypertrophic Cardiomyopathy phenotypically mirrors myofilament-Hypertrophic Cardiomyopathy and is more severe than the subset of patients who still remain without a Disease-causing Mutation. The precise role of W4R-MARCKSL1 gene in the pathogenesis of either 3',5'-dichloromethotrexate or Hypertrophic Cardiomyopathy warrants further investigation., MARCKSL1 gene (Muscle Tissue-LIM-Protein Info) deficient mice develop 3',5'-dichloromethotrexate and changes in the mechanical coupling of Myocytes, Cardiac result in alterations at the intercalated disks and enhanced accumulation of adherens junction proteins., Targeted deletion of Cytoskeleton Muscle Tissue LIM Protein Info (MARCKSL1 gene) in mice consistently leads to Cardiomyopathy, Dilated (3',5'-dichloromethotrexate) after one or more months. , In summary, young MLPKO mice revealed substantial alterations in passive myocardial properties and relaxation time, but not in most systolic characteristics. These results indicate that the progression to Congestive Chest>Heart failure in the MLPKO model may be driven by diastolic myocardial dysfunction and abnormal passive properties rather than Systolic dysfunction., CASP14 gene lacking the Muscle Tissue LIM Protein Info (MARCKSL1 gene) develop morphological and clinical signs resembling human Cardiomyopathy, Dilated and Congestive Chest>Heart failure., Our results show that the absence of MARCKSL1 gene causes a local loss of Mitochondria. We hypothesize that this is caused by a disturbed interaction between Microtubules associated with cytoplasmic filaments and Mitochondria, which interferes with energy sensing and energy transfer. Recovery of energy depletion by stimulating mitochondrial biogenesis might be a useful therapeutic strategy for improving the energy imbalance in Congestive Chest>Heart failure., Previous work has shown that mutations in Muscle Tissue LIM Protein Info (MARCKSL1 gene) can cause Hypertrophic obstructive cardiomyopathy (Hypertrophic Cardiomyopathy). In order to gain an insight into the molecular basis of the disease phenotype, we analysed the binding characteristics of wild-type MARCKSL1 gene and of the (C58G) Mutant MARCKSL1 gene that causes Hypertrophic obstructive cardiomyopathy., The molecular basis for Hypertrophic Cardiomyopathy-causing mutations in the MARCKSL1 gene gene might therefore be an alteration in the equilibrium of interactions of the ternary complex MARCKSL1 gene-N-RAP-alpha-Actinin., Muscle LIM Protein Info (MARCKSL1 gene) is a member of the cysteine-rich Protein Info (CRP) family and has been implicated in both myogenesis and Sarcomeres assembly. In the latter role, it binds ZYX Protein Info, human and alpha-Actinin, both of which are involved in actin organization. An MARCKSL1 gene-deficient mouse has been described; these mice develop Cardiomyopathy, Dilated and Congestive Chest>Heart failure., We identified a patient with 3',5'-dichloromethotrexate and Endocardial Fibroelastosis, having a Mutation Abnormality in MARCKSL1 gene with the residue lysine 69 substituted by arginine (K69R). , MARCKSL1 gene-knockout mice develop a marked Cardiac - anatomy qualifier hypertrophy reaction and Cardiomyopathy, Dilated (3',5'-dichloromethotrexate). MARCKSL1 gene is therefore a candidate gene for heritable forms of Hypertrophic obstructive cardiomyopathy (Hypertrophic Cardiomyopathy) and 3',5'-dichloromethotrexate in Homo sapiens., Family studies revealed cosegregation of clinically affected individuals with the respective mutations in MARCKSL1 gene. CONCLUSION: Here, we present evidence that mutations in the CRP3/MARCKSL1 gene gene can cause Hypertrophic Cardiomyopathy., The Skeletal Muscle Tissue LIM Protein Info 1 (FHL1 gene) is highly expressed in Skeletal and Cardiac - anatomy qualifier Muscle Tissue, and its expression is downregulated significantly in dilated human cardiomyopathy. , Targeted disruption of Muscle Tissue LIM Protein Info (MARCKSL1 gene) has previously been shown to result in Cardiomyopathy, Dilated with many of the clinical signs of Congestive Chest>Heart failure, although the effects of MARCKSL1 gene disruption on passive ventricular mechanics and Muscle Cells architecture are not known., These results suggest that the disruption of the Cytoskeleton Protein Info MARCKSL1 gene results in less compliant passive tissue and concomitant structural alterations in the three-dimensional Muscle Cells architecture that may in part explain the Ventricular Dysfunction in the dilated Chest>Heart., Gene Mutation in cysteine and ROMO1 gene (CSRP3 gene gene), the gene encoding MARCKSL1 gene, have been directly associated with human cardiomyopathies, whereas aberrant expression patterns are reported in human Cardiac - anatomy qualifier and Skeletal Muscle Tissue diseases., Muscle LIM Protein Info (MARCKSL1 gene) has been proposed to be a central player in the pathogenesis of Cardiomyopathies., Previous work has shown that mutations in Muscle Tissue LIM Protein Info (MARCKSL1 gene) can cause Hypertrophic obstructive cardiomyopathy (Hypertrophic Cardiomyopathy)[SEP]Relations: Muscle Tissue tissue has relations: anatomy_protein_present with MLXIP, anatomy_protein_present with MLXIP, anatomy_protein_present with LIMS1, anatomy_protein_present with LIMS1, anatomy_protein_present with MLIP, anatomy_protein_present with MLIP, anatomy_protein_present with LIMS3, anatomy_protein_present with LIMS3, anatomy_protein_present with MLPH, anatomy_protein_present with MLPH. Definitions: cysteine defined as following: A thiol-containing non-essential amino acid that is oxidized to form CYSTINE.. Mitochondria defined as following: Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon Genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed). Myocytes, Cardiac defined as following: Striated Muscle Tissue cells found in the Chest>Heart. They are derived from Cardiac - anatomy qualifier myoblasts (MYOBLASTS, CARDIAC).. Cardiomyopathies defined as following: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).. Muscle Tissue defined as following: Contractile tissue that produces movement in animals.. Endocardial Fibroelastosis defined as following: A condition characterized by the thickening of ENDOCARDIUM due to proliferation of fibrous and elastic tissue, usually in the left ventricle leading to impaired Cardiac - anatomy qualifier function (CARDIOMYOPATHY, RESTRICTIVE). It is most commonly seen in young children and rarely in adults. It is often associated with congenital Chest>Heart anomalies (HEART DEFECTS CONGENITAL;) INFECTION; or gene Mutation Abnormality. Defects in the tafazzin Protein Info, encoded by TAZ gene, result in a form of autosomal dominant familial endocardial fibroelastosis.. Congestive Chest>Heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Genetic defined as following: Having to do with information that is passed from parents to offspring through Genes in sperm and egg cells.. ZYX Protein Info, human defined as following: Zyxin (572 aa, ~61 kDa) is encoded by the human ZYX gene. This Protein Info is involved in focal adhesion assembly and function.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. striated Muscle Tissue defined as following: A subtype of striated Muscle Tissue, attached by TENDONS to the SKELETON. Skeletal muscles are innervated and their movement can be consciously controlled. They are also called voluntary muscles.. Cytoplasmic matrix defined as following: Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components.. 3',5'-dichloromethotrexate defined as following: A chlorinated methotrexate derivative. Dichloromethotrexate inhibits the enzyme dihydrofolate reductase, thereby preventing the synthesis of purine nucleotides and thymidylates and inhibiting DNA and RNA synthesis. This agent is metabolized and excreted by the liver. (NCI04). Hypertrophic Cardiomyopathy defined as following: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).. Cardiomyopathy, Dilated defined as following: Cardiomyopathy which is characterized by dilation and contractile dysfunction of the left and right ventricles. It may be idiopathic, or it may result from a Myocardial infarction:Finding:Point in time:^Patient:Ordinal, myocardial infection, or alcohol abuse. It is a cause of congestive Congestive Chest>Heart failure.. Mutant defined as following: An altered form of an individual, organism, population, or Genetic character that differs from the corresponding wild type due to one or more alterations (mutations).. alpha-Actinin defined as following: Cytoskeleton Protein Info present in Z lines of Muscle Tissue fibrils and at sites of non-Muscle Tissue cell contact with a substrate.. Myocardial hypertrophy defined as following: Thickening of the myocardium often due to chronic pressure overload.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. Muscle Cells defined as following: Mature contractile cells, commonly known as myocytes, that form one of three kinds of Muscle Tissue. The three types of Muscle Tissue cells are Skeletal (MUSCLE FIBERS, SKELETAL), Cardiac - anatomy qualifier (MYOCYTES, CARDIAC), and smooth (MYOCYTES, SMOOTH MUSCLE). They are derived from embryonic (precursor) Muscle Tissue cells called MYOBLASTS.. Z line defined as following: Platelike region of a Muscle Tissue Sarcomeres to which the plus ends of actin filaments are attached. [GOC:mtg_muscle, ISBN:0815316194]. arginine defined as following: An essential amino acid that is physiologically active in the L-form.. monoclonal antibody CAL defined as following: A humanized monoclonal antibody CAL directed against parathyroid hormone-related Protein Info (PTH-rP). As a poly-hormone with diverse biological roles, PTH-rP is expressed by normal tissues, acting in local tissue environments in a variety of ways; it is commonly overexpressed by breast, prostate, and other cancers, acting systemically by promoting bone resorption, inhibiting calcium excretion from the kidney, inducing hypercalcemia, and possibly playing a role in the formation of bony metastases. By blocking the effects of PTH-rP on calcium metabolism, monoclonal antibody CAL CAL may inhibit cancer-related hypercalcemia. (NCI04). Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Cytoskeleton defined as following: The network of filaments, tubules, and interconnecting filamentous bridges which give shape, structure, and organization to the cytoplasm.. Sarcomeres defined as following: The repeating contractile units of the MYOFIBRIL, delimited by Z bands along its length.. Cytoskeleton Protein Info defined as following: Major constituent of the Microtubules associated with cytoplasmic filaments found in the cytoplasm of eukaryotic cells. They form a flexible framework for the cell, provide attachment points for organelles and formed bodies, and make communication between parts of the cell possible.. Mutation Abnormality defined as following: Any transmissible change in the Genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Gene Mutation may be associated with Genetic diversity or with pathologies including cancer.. Cardiac - anatomy qualifier hypertrophy defined as following: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in Muscle Cells size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.. Homo sapiens defined as following: Members of the species Homo sapiens.. Ventricular Dysfunction defined as following: A condition in which HEART VENTRICLES exhibit impaired function.. Muscle Tissue stiffness defined as following: A feeling of tension or tightness in one or more muscles.. cardiomyopathies defined as following: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS)..", "label": "yes"} {"original_question": "Are interferons defensive proteins?", "id": "converted_4184", "sentence1": "Are interferons defensive proteins?", "sentence2": "In response to Virus Diseases, various pattern recognition receptors (Porcine Reproductive and Respiratory Syndrome) are activated for the production of Interferon Type I (IFN I). , activating human leukocyte human leukocyte interferon (IFN) production and positively regulating antiviral response in Mammals. , The innate immune system, in particular the Interferon Type I (IFN) response, is a powerful defence against virus infections. , The human leukocyte human leukocyte interferon-induced GTP-binding protein Mx is responsible for a specific antiviral state against a broad spectrum of Virus Diseases that are induced by type-I interferons (IFN α/β) in different Vertebrates[SEP]Relations: Human human leukocyte interferon beta has relations: drug_protein with ALB, drug_protein with ALB. response to Interferon Type I has relations: bioprocess_protein with SP100, bioprocess_protein with SP100, bioprocess_protein with ISG15, bioprocess_protein with ISG15, bioprocess_protein with SHFL, bioprocess_protein with SHFL, bioprocess_protein with SETD2, bioprocess_protein with SETD2. Definitions: Virus Diseases defined as following: A general term for diseases caused by viruses.. Interferon Type I defined as following: Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or human leukocyte interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA).. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.. human leukocyte interferon defined as following: Human interferons have been classified into 3 groups: alpha, beta, and gamma. Both alpha- and beta-IFNs, previously designated type I, are acid-stable, but they differ immunologically and in regard to some biologic and physiochemical properties. The IFNs produced by virus-stimulated leukocytes (leukocyte IFNs) are predominantly of the alpha type. Those produced by lymphoblastoid cells are about 90% alpha and 10% beta. Induced fibroblasts produce mainly or exclusively the beta type. The alpha- and beta-IFNs differ widely in amino acid sequence. The gamma or immune IFNs, which are produced by T lymphocytes in response to mitogens or to antigens to which they are sensitized, are acid-labile and serologically distinct from alpha- and beta-IFNs. (from OMIM 147570). Porcine Reproductive and Respiratory Syndrome defined as following: A syndrome characterized by outbreaks of late term abortions, high numbers of stillbirths and mummified or weak newborn piglets, and respiratory disease in young unweaned and weaned pigs. It is caused by PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS. (Radostits et al., Veterinary Medicine, 8th ed, p1048). Vertebrates defined as following: Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising Mammals, birds, reptiles, amphibians, and fishes.. interferons defined as following: One of a group of recombinant therapeutic glycoprotein cytokines with antiviral, anti-proliferative, and immunomodulating activities. Interferons bind to specific cell-surface receptors, leading to the transcription and translation of genes with human leukocyte interferon-specific response elements (ISREs). The resultant proteins mediate many complex effects, ultimately leading to inhibition of viral protein synthesis and cellular growth, alteration of cellular differentiation, interference with oncogene expression, activation of natural killer cells, alteration of cell surface antigen expression, and augmentation of lymphocyte and macrophage cytotoxicity. The production of endogenous interferons is induced in response to foreign agents such as bacteria, viruses and parasites and to tumor cells..", "label": "yes"} {"original_question": "Is there an increased risk for meningiomas in childhood leukemia survivors?", "id": "converted_3683", "sentence1": "Is there an increased risk for Meningioma in childhood leukemia Survivors?", "sentence2": "Cranial radiotherapy improves survival of the most common childhood cancers, including Brain Neoplasms and leukemia. Unfortunately, long-term Survivors are faced with consequences of secondary neoplasia, including radiation-induced Meningioma (RIMs). , Combined chemotherapy and prophylactic Cranial Irradiation has improved the prognosis of children with Acute leukemia. However Cranial Irradiation carries a latent risk of the induction of secondary Neoplasms, Intracranial. We encountered a patient who developed multiple intracranial radiation-induced Meningioma (RIMs) 25 years after prophylactic Cranial Irradiation for the treatment of Acute leukemia in childhood. , Focal cranial hyperostosis from Benign Meningioma: a complication from previous radiation treatment for childhood T-cell Pre B-cell Pre B-cell acute lymphoblastic leukemia., Presented is a case of a 20 year Homo sapiens with a history of T-cell lymphoblastic leukemia diagnosed at age 22 months, treated with chemotherapy and Cranial Irradiation. He had developed increasing prominence of the top of his Head - Component of Device over several months. Plain radiograph showed frontal calvarium thickening with Focal \"hair-on-end\" periosteal reaction. Magnetic resonance imaging revealed an enhancing dural-based mass with transcalvarial extension, confirmed after resection to be Benign Meningioma (World Health Organization Grade I). , RESULTS: Acute myeloid leukemia (Leukemia, Myelocytic, Acute; n = 186), MYELODYSPLASTIC SYNDROME (Miller Dieker syndrome; n = 69), and nonmeningioma brain tumor (n = 116) were the most common types of SMNs and had the poorest outcome (5-year survival rate, 18.1% ± 2.9%, 31.1% ± 6.2%, and 18.3% ± 3.8%, respectively). , Radiation-induced World Health Organization grade II Meningioma in young patients following prophylactic Cranial Irradiation for Pre B-cell Pre B-cell acute lymphoblastic leukemia in childhood. Three case reports., Current chemotherapeutic regimens have been used to successfully treat many children with Pre B-cell Pre B-cell acute lymphoblastic leukemia (Acute lymphocytic leukemia), but have resulted in an increased risk of late central nervous system tumors, most commonly Benign Meningioma, particularly in patients who have received Cranial Irradiation. , RESULTS: Fifty-nine MRI abnormalities (32 cavernomas, nine Focal areas of gliosis, seven dystrophic mineralizations, five cerebral atrophies, four pituitary atrophies, one diffuse radiation leukoencephalopathy, and one Benign Meningioma) were found in 43 patients. , Intraventricular Benign Meningioma after Cranial Irradiation for childhood leukemia., Radiation-induced Meningioma may also have predilection to recur. The authors describe a case of an intraventricular Benign Meningioma occurring 23 years after Cranial Irradiation for childhood Pre B-cell Pre B-cell acute lymphoblastic leukemia., Cumulative incidence at 30 years after the childhood Primary malignant neoplasm diagnosis was 20.5% (95% confidence interval [CI] = 19.1% to 21.8%) for all subsequent Neoplasms, 7.9% (95% CI = 7.2% to 8.5%) for second malignant Neoplasms (excluding nonmelanoma skin Primary malignant neoplasm), 9.1% (95% CI = 8.1% to 10.1%) for nonmelanoma skin Primary malignant neoplasm, and 3.1% (95% CI = 2.5% to 3.8%) for Benign Meningioma. , Radiation-induced Meningioma: a shadow in the success story of childhood leukemia., Although the cohort is small, it seems probable that the increasing incidence of Benign Meningioma will shadow the future of cranially irradiated leukemia Survivors., Age at the time of irradiation, gender, or cumulative doses of chemotherapeutic agents showed no significant association with the development of Meningioma., Meningioma Screening With MRI in Childhood Leukemia Survivors Treated With Cranial Radiation., High incidence of Benign Meningioma in cranial irradiated Survivors of childhood Pre B-cell Pre B-cell acute lymphoblastic leukemia., Radiation-induced World Health Organization grade II Meningioma in young patients following prophylactic Cranial Irradiation for Pre B-cell Pre B-cell acute lymphoblastic leukemia in childhood., Radiation-induced Benign Meningioma following prophylactic radiotherapy for Pre B-cell Pre B-cell acute lymphoblastic leukemia in childhood., Current chemotherapeutic regimens have been used to successfully treat many children with Pre B-cell Pre B-cell acute lymphoblastic leukemia ( Acute lymphocytic leukemia) , but have resulted in an increased risk of late central nervous system tumors , most commonly Benign Meningioma , particularly in patients who have received Cranial Irradiation, Survivors of childhood Acute lymphocytic leukemia treated with high-dose Cranial Irradiation are at risk both for early radiation injury in radiosensitive Organ , such as the Lens and pituitary gland , and for the later development of a radiation-induced Benign Meningioma, Radiation-induced Meningioma: a shadow in the success story of childhood leukemia, We treated 3 young patients with World Health Organization grade II Meningioma who had previously received Cranial Irradiation for the treatment of childhood Acute lymphocytic leukemia: a cerebellopontine angle tumor in a 19-year-old woman , a petroclival tumor in a 28-year-old Homo sapiens , and a frontal parasagittal tumor in a 19-year-old woman, We treated 3 young patients with World Health Organization grade II Meningioma who had previously received Cranial Irradiation for the treatment of childhood Acute lymphocytic leukemia: a cerebellopontine angle tumor in a 19-year-old woman, a petroclival tumor in a 28-year-old Homo sapiens, and a frontal parasagittal tumor in a 19-year-old woman., Current chemotherapeutic regimens have been used to successfully treat many children with Pre B-cell Pre B-cell acute lymphoblastic leukemia (Acute lymphocytic leukemia), but have resulted in an increased risk of late central nervous system tumors, most commonly Benign Meningioma, particularly in patients who have received Cranial Irradiation., Current chemotherapeutic regimens have been used to successfully treat many children with Pre B-cell Pre B-cell acute lymphoblastic leukemia (Acute lymphocytic leukemia), but have resulted in an increased risk of late central nervous system tumors, most commonly Benign Meningioma, particularly in patients who have received Cranial Irradiation., Long-term Survivors who received radiotherapy for Acute lymphocytic leukemia in childhood are at risk for late complications, including radiation-induced Benign Meningioma.[SEP]Relations: childhood leukemia has relations: disease_disease with childhood malignant neoplasm, disease_disease with childhood malignant neoplasm, disease_disease with bone marrow Primary malignant neoplasm, disease_disease with bone marrow Primary malignant neoplasm, disease_disease with leukemia (disease), disease_disease with leukemia (disease), disease_disease with neonatal leukemia, disease_disease with neonatal leukemia, disease_disease with childhood acute myeloid leukemia, disease_disease with childhood acute myeloid leukemia. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Neoplasms, Intracranial defined as following: A benign or malignant neoplasm that arises from or metastasizes to structures within the cranium. This includes meningeal and other tumors that occur in the spaces that surround the brain, and Neoplasms of the brain.. Childhood Leukemia defined as following: An acute or chronic leukemia that occurs during childhood.. Benign Meningioma defined as following: A grade I, slowly growing Benign Meningioma. Only a minority of tumors recur following complete resection.. leukemia defined as following: A progressive, malignant disease of the blood-forming Organ, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006). Pre B-cell acute lymphoblastic leukemia defined as following: A type of Acute lymphocytic leukemia characterized by elevated levels of B-cell lymphoblasts in the bone marrow and the blood. [NCIT:C8644]. Meningioma defined as following: A relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular tumors which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7). Acute leukemia defined as following: A clonal (malignant) hematopoietic disorder with an acute onset, affecting the bone marrow and the peripheral blood. The malignant cells show minimal differentiation and are called blasts, either myeloid blasts (myeloblasts) or lymphoid blasts (lymphoblasts).. Leukemia, Myelocytic, Acute defined as following: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.. nonmelanoma skin Primary malignant neoplasm defined as following: A carcinoma that arises from the skin. Representative examples are basal cell carcinoma and squamous cell carcinoma.. Brain Neoplasms defined as following: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain Neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary Neoplasms are subdivided into benign and malignant forms. In general, Brain Neoplasms may also be classified by age of onset, histologic type, or presenting location in the brain.. intraventricular Benign Meningioma defined as following: A Benign Meningioma that affects the ventricles of the brain.. Neoplasms defined as following: New abnormal growth of tissue. Malignant Neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign Neoplasms.. malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant Neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant Neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. intracranial radiation-induced Meningioma defined as following: A Benign Meningioma that arises within the cranial cavity and results from exposure to radiation.. Survivors defined as following: Persons who have experienced a prolonged survival after serious disease or who continue to live with a usually life-threatening condition as well as family members, significant others, or individuals surviving traumatic life events.. Head - Component of Device defined as following: A projection on the end of an object. MYELODYSPLASTIC SYNDROME defined as following: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.. Cranial Irradiation defined as following: The exposure of the Head - Component of Device to roentgen rays or other forms of radioactivity for therapeutic or preventive purposes.. Organ defined as following: A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues. An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus.. Acute lymphocytic leukemia defined as following: Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.. Homo sapiens defined as following: Members of the species Homo sapiens.. Focal defined as following: Limited to a specific area.. Miller Dieker syndrome defined as following: A rare syndrome caused by deletion of genetic material in the short arm of chromosome 17. It is characterized by an abnormally smooth brain with fewer folds and grooves. It results in intellectual disability, developmental delay, seizures, spasticity, hypotonia, and feeding difficulties. Affected individuals have distinctive facial features that include a prominent forehead, midface hypoplasia, small, upturned nose, low-set ears, small jaw, and thick upper lip..", "label": "yes"} {"original_question": "Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?", "id": "converted_218", "sentence1": "Has ergocalciferol has been shown to reduce incidence of falls in older people in clinical trials?", "sentence2": "However, apart from the beneficial effects of 800 IU/d of cholecalciferol for reduction of falls in the elderly, causality remains yet unproven in randomized controlled trials (RCTs). , The rate of falls and the number of fallers was significantly reduced in two studies evaluating the effect of medication on preventing falls; one study (85 participants) compared ergocalciferol versus placebo in institutionalised women after Cerebrovascular accident with low ergocalciferol levels, and the other study (79 participants) evaluated alendronate versus alfacalcidol in hospitalised people after Cerebrovascular accident., Two studies testing ergocalciferol versus placebo and alendronate versus alfacalcidol found a significant reduction in falls and the number of people falling, .Overall, ergocalciferol supplementation does not appear to reduce falls but may be effective in people who have lower ergocalciferol levels before treatment., Overall, ergocalciferol did not reduce rate of falls (RaR 1.00, 95% CI 0.90 to 1.11; seven trials; 9324 participants) or risk of falling (RR 0.96, 95% CI 0.89 to 1.03; 13 trials; 26,747 participants), but may do so in people with lower ergocalciferol levels before treatment., Vitamin D affects Specimen Type - Bone and muscle health and likely reduces the risk of falls in the elderly., We found 26 eligible trials of moderate quality that enrolled 45,782 participants, the majority of which were elderly and female. Vitamin D use was associated with statistically significant reduction in the risk of falls (odds ratio for suffering at least one fall, 0.86; 95% confidence interval, 0.77-0.96), This effect was more prominent in patients who were ergocalciferol deficient at baseline and in studies in which CALCIUM SUPPLEMENTS was coadministered with ergocalciferol., Vitamin D combined with CALCIUM SUPPLEMENTS reduces the risk of falls., The majority of the evidence is derived from trials enrolling elderly women., Studies of ergocalciferol and CALCIUM SUPPLEMENTS for fracture prevention have produced inconsistent results, as a result of different ergocalciferol status and CALCIUM SUPPLEMENTS intake at baseline, different doses and poor to adequate compliance., Despite significant increases in the provision of Hip protector and use of ergocalciferol supplementation in both intervention and control facilities, there was no difference in the number of falls or falls injuries between the intervention and control groups, nor a reduction in falls overall., Beyond fall and fracture prevention, ergocalciferol may also reduce overall morbidity by multiple mechanisms. , There is evidence to suggest that these agents may reduce the incidence of nonvertebral fractures and falls; however, their benefit on vertebral fracture reduction may depend on the type of active ergocalciferol. [SEP]Relations: Cholecalciferol has relations: drug_drug with Vitamin D, drug_drug with Vitamin D, contraindication with familial isolated deficiency of vitamin E, contraindication with familial isolated deficiency of vitamin E. Ergocalciferol has relations: drug_drug with Vitamin D, drug_drug with Vitamin D, contraindication with familial isolated deficiency of vitamin E, contraindication with familial isolated deficiency of vitamin E. Alfacalcidol has relations: drug_drug with Vitamin D, drug_drug with Vitamin D. Definitions: ergocalciferol defined as following: Vitamin D2, a fat-soluble vitamin important for many biochemical processes including the absorption and metabolism of CALCIUM SUPPLEMENTS and phosphorus. In vivo, ergocalciferol is formed after sun (ultraviolet) irradiation of plant-derived ergosterol, another form of ergocalciferol. Ergocalciferol is the form of ergocalciferol usually found in vitamin supplements. (NCI04). CALCIUM SUPPLEMENTS defined as following: A dietary supplement containing the mineral CALCIUM SUPPLEMENTS.. cholecalciferol defined as following: Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. It differs from ERGOCALCIFEROL in having a single bond between C22 and C23 and lacking a methyl group at C24.. alendronate defined as following: A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy Specimen Type - Bone, restoring some of the Specimen Type - Bone loss as a result of osteoporosis.. Hip protector defined as following: Mechanical shields worn over the hip area to prevent against hip fractures in the event of a patient fall. These shields are designed to transfer energy from the impact to the soft tissue and muscles anterior and posterior to the femoral Specimen Type - Bone, thus diverting the force of the impact away from the greater trochanter.. Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810).", "label": "yes"} {"original_question": "Are there clinical trials on stem cells in multiple sclerosis", "id": "converted_1057", "sentence1": "Are there clinical trials on stem Cells in Multiple Sclerosis", "sentence2": "Cells are generally given intravenously. Multiple sclerosis, Rheumatoid Arthritis and Discoid Discoid lupus erythematosus erythematosus have been successfully treated in Homo sapiens clinical trials, Human multipotent mesenchymal stem cell (selenomethylselenocysteine) therapies are currently being tested in clinical trials for Crohn's disease of oral soft tissues of oral soft tissues, Multiple Sclerosis, Graft-vs-Host Disease, type 1 diabetes, bone fractures, Cartilage damage, and Heart Diseases., Based on these results, several small pilot clinical trials in subjects with advanced MS have demonstrated that selenomethylselenocysteine administration is safe and provided an early signal of clinical effectiveness. The current aim of clinicians and scientists interested in the development of selenomethylselenocysteine-based strategies for the treatment of MS is to have the ultimate demonstration in large clinical trials that selenomethylselenocysteine can inhibit Central Nervous System Inflammation and foster tissue repair, Mesenchymal Stem Cells (selenomethylselenocysteine) promote functional recovery in experimental models of CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS (Central Nervous System) pathology and are currently being tested in clinical trials for Cerebrovascular accident, Multiple Sclerosis and Central Nervous System injury., Autologous bone marrow stromal Cells (BMSCs) offer significant practical advantages for potential clinical applications in Multiple Sclerosis (MS). Based on recent experimental data, a number of clinical trials have been designed for the intravenous (IV) and/or intrathecal (ITH) administration of BMSCs in MS patients., fingolimod is a S1P receptor modulator in MS clinical trials due to systemic anti-inflammatory properties, yet may impact Cells within the Central Nervous System by crossing the Blood - brain barrier function., Their development in vitro and their use in vivo in animal models of degenerative neurological disease and recent first efforts in Homo sapiens clinical trials were the topics of a recent international meeting sponsored by the Multiple Sclerosis International Federation and the National Multiple Sclerosis Society on \"Stem Cells & MS: Prospects and Strategies\", Here we discuss key observations and questions emerging from clinical trials of hematopoietic stem cell transplantation for MS, Another possibility to achieve remyelination is the transplantation of myelinating Cells into the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS. Proof of principle and demonstration of the functionality were shown in numerous experiments, and a first clinical trial in patients with MS has started, This first trial will show if cell transplantation is a feasible concept in MS and whether the Cell Transplants will survive and form new Myelin Sheath.[SEP]Relations: Multiple Sclerosis has relations: disease_disease with brain disease, disease_disease with brain disease, disease_disease with Multiple Sclerosis, susceptibility to, disease_disease with Multiple Sclerosis, susceptibility to, disease_protein with IL12A, disease_protein with IL12A, disease_protein with SELE, disease_protein with SELE, disease_protein with IL1RN, disease_protein with IL1RN. Definitions: Rheumatoid Arthritis defined as following: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. Homo sapiens defined as following: Members of the species Homo sapiens.. Graft-vs-Host Disease defined as following: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.. selenomethylselenocysteine defined as following: A naturally occurring organoselenium compound found in many plants, including garlic, onions, and broccoli, with potential antioxidant and chemopreventive activities. Se-Methyl-seleno-L-cysteine (selenomethylselenocysteine) is an amino acid analogue of cysteine in which a methylselenium moiety replaces the sulphur atom of cysteine. This agent acts as an antioxidant when incorporated into glutathione peroxidase and has been shown to exhibit potent chemopreventive activity in animal models.. Multiple Sclerosis defined as following: An autoimmune disorder mainly affecting young adults and characterized by destruction of Myelin Sheath in the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903). Mesenchymal Stem Cells defined as following: An undifferentiated stromal cell with the ability to develop into the Cells that form distinct mesenchymal tissues; such as bone, muscle, connective tissue, blood vessels, and lymphatic tissue.. fingolimod defined as following: An orally available derivate of myriocin and sphingosine-1-phosphate receptor 1 (S1PR1, S1P1) modulator, with potential anti-inflammatory and immunomodulating activities. Upon oral administration, fingolimod, as a structural analogue of sphingosine, selectively targets and binds to S1PR1 on lymphocytes and causes transient receptor activation followed by S1PR1 internalization and degradation. This results in the sequestration of lymphocytes in lymph nodes. By preventing egress of lymphocytes. fingolimod reduces both the amount of circulating peripheral lymphocytes and the infiltration of lymphocytes into target tissues. This prevents a lymphocyte-mediated immune response and may reduce Inflammation. S1PR1, a G-protein coupled receptor, plays a key role in lymphocyte migration from lymphoid tissues. fingolimod also shifts macrophages to an anti-inflammatory M2 phenotype, and modulates their proliferation, morphology, and cytokine release via inhibition of the transient receptor potential cation channel, subfamily M, member 7 (TRPM7).. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810). Myelin Sheath defined as following: The lipid-rich sheath surrounding AXONS in both the CENTRAL NERVOUS SYSTEMS and PERIPHERAL NERVOUS SYSTEM. The Myelin Sheath sheath is an electrical insulator and allows faster and more energetically efficient conduction of impulses. The sheath is formed by the cell membranes of glial Cells (SCHWANN CELLS in the peripheral and OLIGODENDROGLIA in the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS). Deterioration of the sheath in DEMYELINATING DISEASES is a serious clinical problem.. Central Nervous System defined as following: The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.. Discoid lupus erythematosus defined as following: chronic form of cutaneous Discoid lupus erythematosus erythematosus in which the skin lesions mimic those of the systemic form but in which systemic signs are rare; characterized by the presence of discoid skin plaques showing varying degrees of edema, erythema, scaliness, follicular plugging, and skin atrophy; lesions are surrounded by an elevated erythematous border; the condition typically involves the face and scalp, but widespread dissemination may occur.. Heart Diseases defined as following: Pathological conditions involving the HEART including its structural and functional abnormalities.. stem Cells defined as following: Relatively undifferentiated Cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor Cells that can differentiate into specialized Cells..", "label": "yes"} {"original_question": "Does triiodothyronine (T3) has cardiac angiogenic effects?", "id": "converted_1465", "sentence1": "Does triiodothyronine (T3) has Cardiac - anatomy qualifier angiogenic effects?", "sentence2": "T3-induced Cardiac - anatomy qualifier sprouting angiogenesis in adult hypothyroid CASP14 gene was associated with becaplermin, PDGFR-β and downstream activation of Proto-Oncogene Proteins c-akt., liothyronine significantly increased angiogenesis and cell survival and enhanced the expression of nuclear-encoded transcription factors involved in these processes., T(3) administration restored THRB gene mRNA expression level in AAC hearts to the control level., Rbeta knockout and TRalpha/THRB gene double-knockout CASP14 gene both exhibited significantly less capillary density in LV compared with wild-type CASP14 gene., THRB gene in the coronary ECs regulates capillary density during Cardiac - anatomy qualifier development, and down-regulation of THRB gene results in coronary microvascular rarefaction during pathological hypertrophy.[SEP]Relations: Liothyronine has relations: contraindication with sudden Cardiac - anatomy qualifier arrest, contraindication with sudden Cardiac - anatomy qualifier arrest, contraindication with cardiovascular disease, contraindication with cardiovascular disease, drug_effect with Tachycardia, drug_effect with Tachycardia, drug_effect with Arrhythmia, drug_effect with Arrhythmia, drug_effect with Congestive heart failure, drug_effect with Congestive heart failure. Definitions: THRB gene defined as following: This gene plays a role in receptor signaling and regulation of transcription. It is involved in inner ear development and color vision.. Proto-Oncogene Proteins c-akt defined as following: Expressed in diverse tissues, Protein Kinase B (AKT/RAC Family) is a group (Alpha, Beta and Gamma) of cytoplasmic serine/threonine enzymes that covalently transfer the terminal, gamma phosphate group from ATP to a variety of substrate proteins and regulate cell signaling responses to insulin, PDGF, and IGF1 (through PI3K) involved in cell survival, cell proliferation, differentiation, apoptosis, glycogen synthesis, and glucose uptake.. liothyronine defined as following: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.. becaplermin defined as following: The recombinant analog of endogenous beta (B) chain of the cytokine platelet-derived growth factor (PDGF). Synthesized primarily by megakaryocytes, endogenous PDGF consists of two related peptide chains, PDGF-A and PDGF-B. PDGF functions as a local autocrine and paracrine growth factor in many cellular processes. Recombinant PDGF, alone and in combination with other agents, may be useful in promoting bone formation and soft tissue repair. (NCI04). triiodothyronine defined as following: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.. T3 defined as following: This gene plays a regulatory role in the production and utilization of ATP..", "label": "yes"} {"original_question": "Is there any linear-time and linear-space algorithm for the computation of avoided words in biological sequences?", "id": "converted_2372", "sentence1": "Is there any linear-time and linear-space algorithm for the computation of avoided words in biological sequences?", "sentence2": "The systematic search for avoided words is particularly useful for biological Sequence - ParameterizedDataType analysis. We present a linear-time and linear-space algorithm for the computation of avoided words of lengthkin a given sequencex. We suggest a ResponseLevel - ResponseLevel - modification to this algorithm so that it computes all avoided words ofx, irrespective of their length, within the same time complexity. We also present combinatorial results with regards to avoided words and absent words., We present a linear-time and linear-space algorithm for the computation of avoided words of length
, BACKGROUND: The deviation of the observed frequency of a word
RESULTS: In this article, we propose an [Formula: see text]-time and [Formula: see text]-space algorithm to compute all [Formula: see text]-avoided words of length
CONCLUSIONS: The systematic search for avoided words is particularly useful for biological Sequence - ParameterizedDataType analysis., We present a linear-time and linear-space algorithm for the computation of avoided words of length, We present a linear-time and linear-space algorithm for the computation of avoided words of length k in a given Sequence - ParameterizedDataType x., Hence, computing all such words naïvely can be a very time-consuming procedure, in particular for large k. RESULTS In this article, we propose an [Formula: see text]-time and [Formula: see text]-space algorithm to compute all [Formula: see text]-avoided words of length k in a given Sequence - ParameterizedDataType of length n over a fixed-sized alphabet., We also present a time-optimal [Formula: see text]-time algorithm to compute all [Formula: see text]-avoided words (of any length) in a Sequence - ParameterizedDataType of length n over an integer alphabet of size [Formula: see text]., the deviation of the observed frequency of a word from its Expected (qualifier) frequency in a given Sequence - ParameterizedDataType is used to determine whether or not the word is this concept is particularly useful in dna linguistic analysis the value of the deviation of denoted by formula see text effectively characterises the extent of a word by its edge contrast in the context in which it occurs a word of length formula see text is a formula see text avoided word in if formula see text for a given threshold formula see text notice that such a word may be completely from hence computing all such words naïvely can be a very time consuming procedure in particular for large in this article we propose an formula see text time and formula see text space algorithm to compute all formula see text avoided words of length in a given Sequence - ParameterizedDataType of length over a fixed sized alphabet we also present a time optimal formula see text time algorithm to compute all formula see text avoided words of any length in a Sequence - ParameterizedDataType of length over an integer alphabet of size formula see text in addition we provide a tight asymptotic upper bound for the number of formula see text avoided words over an integer alphabet and the Expected (qualifier) length of the longest one we make available an implementation of our algorithm experimental results using both real and synthetic data show the efficiency and applicability of our implementation in biological Sequence - ParameterizedDataType analysis the systematic search for avoided words is particularly useful for biological Sequence - ParameterizedDataType analysis we present a linear time and linear space algorithm for the computation of avoided words of length in a given Sequence - ParameterizedDataType we suggest a ResponseLevel - ResponseLevel - modification to this algorithm so that it computes all avoided words of irrespective of their length within the same time complexity we also present combinatorial results with regards to avoided words and absent words.[SEP]Relations: response to nickel cation has relations: bioprocess_protein with CACNA1G, bioprocess_protein with CACNA1G, bioprocess_bioprocess with cellular response to nickel ion, bioprocess_bioprocess with cellular response to nickel ion, bioprocess_bioprocess with response to metal ion, bioprocess_bioprocess with response to metal ion. Definitions: ResponseLevel - modification defined as following:

Respond with exceptions, completions and modifications or revisions done before completion

. Expected (qualifier) defined as following: Considered likely or probable; anticipated..", "label": "yes"} {"original_question": "Does prolactinoma increase osteoporosis risk?", "id": "converted_2496", "sentence1": "Does prolactinoma increase osteoporosis risk?", "sentence2": "Prolactinoma: A Massive Effect on Bone Mineral Density in a Young Patient., Encounter due to family history of osteoporosis has been noted to be an issue in postmenopausal women with prolactinomas. This case shows a similar impact on bone health in a young male resulting in low bone mineral density for age based on Z-score. This case report highlights the possible mechanisms for the bone loss in the setting of prolactinoma and the need for assessing bone health in such patients., Hyperprolactinaemia related to prolactinoma significantly (more than functional hyperprolactiaemia) increases the risk of osteopenia, osteoporosis and bone fractures. , Prolactinoma are the most common type of functional pituitary tumor. Effective hyperprolactinemia treatment is of great importance, due to its potential deleterious effects including Sterility, Reproductive, Gonadal Disorders and osteoporosis. , Prolactinoma cause Hypogonadism, Sterility, Reproductive, osteoporosis, and tumor mass effects, and are the most common type of Neuroendocrine Tumors., We present a 22-year-old Homo sapiens with multiple osteoporotic fractures associated with prolactinoma despite the use of teriparatide for 18 months. We emphasize and highlight the importance of hyperprolactinemia and fractures caused by high prolactin levels., OBJECTIVE: Patients with prolactinoma seem to be at high risk for osteopenia. , RESULTS: Compared to the matched controls, BMD of patients with prolactinoma or Craniopharyngioma significantly decreased. , CONCLUSION: In the premenopausal women, patients with prolactinoma or Craniopharyngioma are often accompanied with osteopenia or osteoporosis, and Disease duration and Hypogonadism are the risk factors of bone loss in prolactinoma., Data on osteoporotic fractures in hyperprolactinemia are limited. An increased prevalence of radiological Spinal Fractures was recently observed in women with prolactin (PRL)-secreting adenoma, whereas it is unknown whether this observation may reflect a more general increased risk of fractures in this Disease and whether the prevalence of fractures in males is affected by gonadal status., Prolactinoma presenting as chronic anaemia with osteoporosis: a case report., Six years later, he was evaluated and diagnosed with a prolactinoma and resultant osteoporosis. Prolactinoma in old people may present insidiously with chronic anaemia and osteoporosis with or without Sexual Dysfunction., The relative risk for developing osteoporosis in women with prolactinoma was found to be 4.5, indicating that hyperprolactinemia in women is a major risk factor for osteoporosis.
, INTRODUCTION: Osteopenia and osteoporosis because of Hyperprolactinemia caused by prolactinoma may be followed by an increased risk of Fracture., Univariate and multivariate regression analysis indicated that the bone loss in prolactinomas was significantly correlated to Disease duration and Hypogonadism.
CONCLUSION: In the premenopausal women, patients with prolactinoma or Craniopharyngioma are often accompanied with osteopenia or osteoporosis, and Disease duration and Hypogonadism are the risk factors of bone loss in prolactinoma., High serum prolactin levels lead to increase of the risk of osteopenia or/and osteoporosis., Prolactinoma in old people may present insidiously with chronic anaemia and osteoporosis with or without Sexual Dysfunction.
CASE PRESENTATION: We describe the case of a 70-year-old Caucasian Homo sapiens who presented with mild anaemia and Fatigue., In the premenopausal women, patients with prolactinoma or Craniopharyngioma are often accompanied with osteopenia or osteoporosis, and Disease duration and Hypogonadism are the risk factors of bone loss in prolactinoma., The relative risk for developing osteoporosis in women with prolactinoma was found to be 4.5, indicating that hyperprolactinemia in women is a major risk factor for osteoporosis., CONCLUSION In the premenopausal women, patients with prolactinoma or Craniopharyngioma are often accompanied with osteopenia or osteoporosis, and Disease duration and Hypogonadism are the risk factors of bone loss in prolactinoma., Prolactinoma in old people may present insidiously with chronic anaemia and osteoporosis with or without Sexual Dysfunction., Hyperprolactinaemia related to prolactinoma significantly (more than functional hyperprolactiaemia) increases the risk of osteopenia, osteoporosis and bone fractures., INTRODUCTION Osteopenia and osteoporosis because of Hyperprolactinemia caused by prolactinoma may be followed by an increased risk of Fracture., In conclusion, men with prolactinoma have high prevalence of osteopenia and osteoporosis., Humans with prolactinoma are at risk for osteoporosis., Osteopenia and osteoporosis because of Hyperprolactinemia caused by prolactinoma may be followed by an increased risk of Fracture., The relative risk for developing osteoporosis in women with prolactinoma was found to be 4.5, indicating that hyperprolactinemia in women is a major risk factor for osteoporosis.., In the premenopausal women, patients with prolactinoma or Craniopharyngioma are often accompanied with osteopenia or osteoporosis, and Disease duration and Hypogonadism are the risk factors of bone loss in prolactinoma.[SEP]Relations: Craniopharyngioma has relations: disease_phenotype_positive with Increased susceptibility to fractures, disease_phenotype_positive with Increased susceptibility to fractures. Osteopenia has relations: disease_phenotype_positive with prolactin producing pituitary gland tumor, disease_phenotype_positive with prolactin producing pituitary gland tumor. Prolactinoma has relations: disease_phenotype_positive with growth hormone secreting pituitary adenoma 1, disease_phenotype_positive with growth hormone secreting pituitary adenoma 1, disease_phenotype_positive with prolactin producing pituitary gland tumor, disease_phenotype_positive with prolactin producing pituitary gland tumor, disease_phenotype_positive with multiple endocrine neoplasia, disease_phenotype_positive with multiple endocrine neoplasia. Definitions: Hyperprolactinemia defined as following: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8). Prolactinoma defined as following: A pituitary adenoma which secretes PROLACTIN, leading to HYPERPROLACTINEMIA. Clinical manifestations include AMENORRHEA; GALACTORRHEA; IMPOTENCE; HEADACHE; visual disturbances; and CEREBROSPINAL FLUID RHINORRHEA.. Hypogonadism defined as following: Condition resulting from deficient gonadal functions, such as GAMETOGENESIS and the production of GONADAL STEROID HORMONES. It is characterized by delay in GROWTH, germ cell maturation, and development of secondary sex characteristics. Hypogonadism can be due to a deficiency of GONADOTROPINS (hypogonadotropic Hypogonadism) or due to primary gonadal failure (hypergonadotropic Hypogonadism).. Fatigue defined as following: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.. Spinal Fractures defined as following: Broken bones in the vertebral column.. Neuroendocrine Tumors defined as following: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.. Homo sapiens defined as following: Members of the species Homo sapiens.. Fracture defined as following: A traumatic injury to the bone in which the continuity of the bone is broken.. Craniopharyngioma defined as following: A benign pituitary-region neoplasm that originates from Rathke's pouch. The two major histologic and clinical subtypes are adamantinous (or classical) Craniopharyngioma and papillary Craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations. (From Joynt, Clinical Neurology, 1998, Ch14, p50). Osteopenia defined as following: Decreased calcification or density of bone tissue.. Sterility, Reproductive defined as following: Complete inability to conceive or induce conception.. teriparatide defined as following: A polypeptide that consists of the 1-34 amino-acid fragment of human PARATHYROID HORMONE, the biologically active N-terminal region. The acetate form is given by intravenous infusion in the differential diagnosis of HYPOPARATHYROIDISM and PSEUDOHYPOPARATHYROIDISM. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995). Gonadal Disorders defined as following: Pathological processes of the OVARIES or the TESTES.. Sexual Dysfunction defined as following: Disturbances in sexual desire or performance.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. prolactinoma defined as following: A pituitary adenoma which secretes PROLACTIN, leading to HYPERPROLACTINEMIA. Clinical manifestations include AMENORRHEA; GALACTORRHEA; IMPOTENCE; HEADACHE; visual disturbances; and CEREBROSPINAL FLUID RHINORRHEA..", "label": "yes"} {"original_question": "Do yeast LTR give rise to circular DNA?", "id": "converted_2786", "sentence1": "Do Saccharomyces cerevisiae LTR give rise to DNA, Circular?", "sentence2": "Circular retrotransposition products generated by a LINE retrotransposon, Formation of Extrachromosomal Circular DNA from Long Terminal Repeats of Retrotransposons in Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae or Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae cerevisiae, Ty eccDNA can arise from the circularization of extrachromosomal linear DNA during the transpositional life cycle of retrotransposons, or from circularization of genomic Ty DNA, Circularization may happen through nonhomologous end-joining (Non-Homologous DNA End-Joining) of Long Terminal Repeat (LTRs) flanking Ty elements, by Ty autointegration, or by LTR-LTR recombination, We have recently shown that Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae LTR elements generate circular DNAs through recombination events between their flanking Long Terminal Repeat (LTRs)., Similarly, circular DNAs can be generated by recombination between LTRs residing at different genomic loci, in which case the DNA, Circular will contain the Introns., A recent study on circular DNAs in Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae found that transposable element sequence residing in circular structures mostly corresponded to full-length transposable elements.[SEP]Relations: Nonhomologous End-Joining (Non-Homologous DNA End-Joining) has relations: pathway_protein with XRCC6, pathway_protein with XRCC6, pathway_protein with XRCC5, pathway_protein with XRCC5, pathway_protein with RAD50, pathway_protein with RAD50, pathway_protein with XRCC4, pathway_protein with XRCC4, pathway_protein with TDP2, pathway_protein with TDP2. Definitions: Long Terminal Repeat defined as following: Identical DNA sequences found at either end of retrovirus proviral DNA, formed by reverse transcription of viral RNA.. DNA, Circular defined as following: Any of the covalently closed DNA molecules found in bacteria, many viruses, mitochondria, plastids, and plasmids. Small, polydisperse DNA, Circular's have also been observed in a number of eukaryotic organisms and are suggested to have homology with chromosomal DNA and the capacity to be inserted into, and excised from, chromosomal DNA. It is a fragment of DNA formed by a process of looping out and deletion, containing a constant region of the mu heavy chain and the 3'-part of the mu switch region. Circular DNA is a normal product of rearrangement among gene segments encoding the variable regions of immunoglobulin light and heavy chains, as well as the T-cell receptor. (Riger et al., Glossary of Genetics, 5th ed & Segen, Dictionary of Modern Medicine, 1992). Saccharomyces cerevisiae defined as following: A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" Saccharomyces cerevisiae. The dried form is used as a dietary supplement.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Non-Homologous DNA End-Joining defined as following: The repair of a double-strand break in DNA in which the two broken ends are rejoined with little or no sequence complementarity. Information at the DNA ends may be lost due to the modification of broken DNA ends. This term covers instances of separate pathways, called classical (or canonical) and alternative nonhomologous end joining (C-Non-Homologous DNA End-Joining and A-Non-Homologous DNA End-Joining). These in turn may further branch into sub-pathways, but evidence is still unclear. [GOC:rph, PMID:10827453, PMID:24837021]. Introns defined as following: Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some introns code for separate genes..", "label": "yes"} {"original_question": "Is there any role for long noncoding RNAs in adipogenesis?", "id": "converted_1489", "sentence1": "Is there any role for long noncoding RNAs in adipogenesis?", "sentence2": "Long noncoding RNAs regulate adipogenesis., Here we profiled the transcriptome of primary brown and Adipocytes, White, preadipocytes, and cultured adipocytes and identified 175 lncRNAs that are specifically regulated during adipogenesis. Many lncRNAs are adipose-enriched, strongly induced during adipogenesis, and bound at their Promoter by key TRANSCRIPTION FACTOR such as Peroxisome Proliferator-Activated Receptors (PPARγ) and CCAAT/enhancer-binding protein α (CEBPα). RNAi-mediated loss of function screens identified functional lncRNAs with varying impact on adipogenesis. Collectively, we have identified numerous lncRNAs that are functionally required for proper adipogenesis., Here we profiled the transcriptome of primary brown and Adipocytes, White, preadipocytes, and cultured adipocytes and identified 175 lncRNAs that are specifically regulated during adipogenesis. Many lncRNAs are adipose-enriched, strongly induced during adipogenesis, and bound at their Promoter by key TRANSCRIPTION FACTOR such as Peroxisome Proliferator-Activated Receptors (PPARγ) and CCAAT/enhancer-binding protein α (CEBPα). [SEP]Relations: transcription factor binding has relations: molfunc_protein with EPAS1, molfunc_protein with EPAS1, molfunc_protein with AIP, molfunc_protein with AIP, molfunc_protein with PPARA, molfunc_protein with PPARA, molfunc_protein with SRY, molfunc_protein with SRY, molfunc_protein with HMGA2, molfunc_protein with HMGA2. Definitions: Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. Peroxisome Proliferator-Activated Receptors defined as following: TRANSCRIPTION FACTORS that are activated by ligands and heterodimerize with RETINOID X RECEPTORS and bind to peroxisome proliferator response elements in the promoter regions of target genes.. Adipocytes, White defined as following: Fat cells with light coloration and few MITOCHONDRIA. They contain a scant ring of CYTOPLASM surrounding a single large lipid droplet or vacuole.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process..", "label": "yes"} {"original_question": "There is no drug available to prevent HIV infection, Pre-exposure prophylaxis (PrEP), yes or no?", "id": "converted_2965", "sentence1": "There is no drug available to prevent Human immunodeficiency virus II infection, Pre-exposure prophylaxis (HIV: PrEP and PEP), yes or no?", "sentence2": "pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes., The antiviral agent tenofovir is highly effective for the treatment of HIV and hepatitis B virus infections, and the older prodrug tenofovir disoproxil fumarate (tenofovir disoproxil fumarate) is also a component of daily preexposure prophylaxis (HIV: HIV: PrEP and PEP and PEP) to reduce the risk of Human immunodeficiency virus II infection in high-risk populations. , Following US Food and Drugs Administration approval in July 2012 of daily oral tenofovir and emtricitabine for pre-exposure prophylaxis (HIV: HIV: PrEP and PEP and PEP) to prevent Human immunodeficiency virus II infection in high-risk individuals in the USA, there has been much controversy about the implementation of this HIV: HIV: PrEP and PEP and PEP regimen in other countries throughout the world, and in Europe in particular., Daily oral pre-exposure prophylaxis (HIV: HIV: PrEP and PEP and PEP) is the use of antiretroviral drugs by HIV-negative people to prevent Human immunodeficiency virus II infection., HIV pre-exposure prophylaxis (HIV: HIV: PrEP and PEP and PEP) is a new approach that involves the ongoing use of antiretroviral medications by HIV-negative individuals to reduce the risk of Human immunodeficiency virus II infection., CONCLUSIONS Combined ART + HIV: HIV: PrEP and PEP and PEP is likely to prevent more HIV Infections than either strategy alone, but with higher prevalence of drug resistance., INTRODUCTION Use of pre-exposure prophylaxis (HIV: HIV: PrEP and PEP and PEP) among people who inject drugs (PWID) has been shown to be effective in preventing HIV transmission., Pre-exposure prophylaxis (HIV: HIV: PrEP and PEP and PEP) is an experimental approach to HIV prevention and consists of antiretroviral drugs to be taken before potential HIV exposure in order to reduce the risk of Human immunodeficiency virus II infection and continued during periods of risk., HIV pre-exposure prophylaxis (HIV: HIV: PrEP and PEP and PEP) is the use of one or more antiretroviral medications (in combination) to prevent Human immunodeficiency virus II infection., The most commonly used HIV: HIV: PrEP and PEP and PEP medication (Truvada
, The use of antiretrovirals as pre-exposure prophylaxis (HIV: HIV: PrEP and PEP and PEP) is highly efficacious in HIV prevention.[SEP]Relations: Tenofovir disoproxil has relations: contraindication with hepatitis C virus infection, contraindication with hepatitis C virus infection, contraindication with chronic hepatitis C virus infection, contraindication with chronic hepatitis C virus infection. Tenofovir has relations: contraindication with hepatitis C virus infection, contraindication with hepatitis C virus infection, contraindication with chronic hepatitis C virus infection, contraindication with chronic hepatitis C virus infection. Emtricitabine has relations: contraindication with hepatitis C virus infection, contraindication with hepatitis C virus infection. Definitions: tenofovir defined as following: An adenine analog REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone.. emtricitabine defined as following: A synthetic fluoro derivative of thiacytidine with potent antiviral activity. Emtricitabine is phosphorylated to form emtricitabine 5'-triphosphate within the cell. This metabolite inhibits the activity of human immunodeficiency virus (HIV) reverse transcriptase both by competing with the natural substrate deoxycytidine 5'-triphosphate and by incorporation into viral DNA causing a termination of DNA chain elongation (due to the lack of the essential 3'-OH group).. tenofovir disoproxil fumarate defined as following: A pro-drug, fumaric acid salt form of tenofovir, a nucleoside reverse transcriptase inhibitor analog of adenosine. Tenofovir disoproxil fumarate is prescribed to treat HIV and chronic hepatitis B virus (HBV) in adults.. HIV: PrEP and PEP defined as following:

What are HIV: PrEP and PEP and PEP?

HIV: PrEP and PEP and PEP are medicines to prevent HIV. Each type is used in a different situation:

  • HIV: PrEP and PEP stands for pre-exposure prophylaxis. It is for people who don't already have HIV but are at very high risk of getting it. HIV: PrEP and PEP is daily medicine that can reduce this risk. With HIV: PrEP and PEP, if you do get exposed to HIV, the medicine can stop HIV from taking hold and spreading throughout your body.
  • PEP stands for post-exposure prophylaxis. PEP is for people who have possibly been exposed to HIV. It is only for emergency situations. PEP must be started within 72 hours after a possible exposure to HIV.

HIV: PrEP and PEP (pre-exposure prophylaxis)

Who should consider taking HIV: PrEP and PEP?

HIV: PrEP and PEP is for people without HIV who are at very high risk for getting it. This includes:

Gay/bisexual men who

  • Have an HIV-positive partner
  • Have multiple partners, a partner with multiple partners, or a partner whose HIV status is unknown and

Heterosexual men and women who

  • Have an HIV-positive partner
  • Have multiple partners, a partner with multiple partners, or a partner whose HIV status is unknown and
    • Don't always use a condom when having sex with people who inject drugs OR
    • Don't always use a condom when having sex with bisexual men

People who inject drugs and

  • Share needles or other equipment to inject drugs OR
  • Are at risk for getting HIV from sex

If you have a partner who is HIV-positive and are considering getting pregnant, talk to your health care provider about HIV: PrEP and PEP. Taking it may help protect you and your baby from getting Human immunodeficiency virus II infection while you try to get pregnant, during pregnancy, or while breastfeeding.

How well does HIV: PrEP and PEP work?

HIV: PrEP and PEP is very effective when you take it every day. It reduces the risk of getting HIV from sex by more than 90%. In people who inject drugs, it reduces the risk of HIV by more than 70%. HIV: PrEP and PEP is much less effective if you do not take it consistently.

HIV: PrEP and PEP does not protect against other STDs, so you should still use latex condoms every time you have sex. If your or your partner is allergic to latex, you can use polyurethane condoms.

You must have an HIV test every 3 months while taking HIV: PrEP and PEP, so you'll have regular follow-up visits with your health care provider. If you are having trouble taking HIV: PrEP and PEP every day or if you want to stop taking HIV: PrEP and PEP, talk to your health care provider.

Does HIV: PrEP and PEP cause side effects?

Some people taking HIV: PrEP and PEP may have side effects, like nausea. The side effects are usually not serious and often get better over time. If you are taking HIV: PrEP and PEP, tell your health care provider if you have a side effect that bothers you or that does not go away.

PEP (post-exposure prophylaxis)

Who should consider taking PEP?

If you are HIV-negative and you think you may have been recently exposed to HIV, contact your health care provider immediately or go to an emergency room right away.

You may be prescribed PEP if you are HIV negative or don't know your HIV status, and in the last 72 hours you

  • Think you may have been exposed to HIV during sex,
  • Shared needles or drug preparation equipment, OR
  • Were sexually assaulted

Your health care provider or emergency room doctor will help to decide whether PEP is right for you.

PEP may also be given to a health care worker after a possible exposure to HIV at work, for example, from a needlestick injury.

When should I start PEP and how long do I need to take it?

PEP must be started within 72 hours (3 days) after a possible exposure to HIV. The sooner you start it, the better; every hour counts.

You need to take the PEP medicines every day for 28 days. You will have to see your health care provider at certain times during and after taking the PEP, so you can have an HIV screening test and other testing.

Does PEP cause side effects?

Some people taking PEP may have side effects, like nausea. The side effects are usually not serious and often get better over time. If you are taking PEP, tell your health care provider if you have a side effect that bothers you or that does not go away.

PEP medicines may also interact with other medicines that a person is taking (called a drug interaction). So it's important to tell your health care provider about any other medicines that you take.

Can I take PEP every time I have unprotected sex?

PEP is only for emergency situations. It is not the right choice for people who may be exposed to HIV frequently - for example, if you often have sex without a condom with a partner who is HIV-positive. In that case, you should talk to your health care provider about whether HIV: PrEP and PEP (pre-exposure prophylaxis) would be right for you.

. HIV Infections defined as following: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS)..", "label": "no"} {"original_question": "Is DNA methylation correlated with nucleosome occupancy?", "id": "converted_2330", "sentence1": "Is DNA methylation correlated with nucleosome location occupancy?", "sentence2": "Here I show that CpG Islands were associated not only with methylation-free promoters but also with nucleosome location location-free promoters., Nucleosome-free regions were observed only in promoters containing a CpG island, In contrast to the methylation-and nucleosome location location-free states of CpG-island promoters, Exons were densely methylated at CpGs and packaged into Nucleosomes., I also found that Nucleosomes, DNA methylation, and Histone H3 Trimethyl Lys36 marked the Exons of RNA Transcript with low, medium, and high gene expression levels, respectively., Human promoters containing a CpG island tend to remain nucleosome location location-free as well as methylation-free., In contrast, Exons demonstrate a high degree of methylation and nucleosome location location occupancy., Exonic DNA methylation seems to function together with exonic Nucleosomes and Histone H3 Trimethyl Lys36 for the proper splicing of RNA Transcript with different expression levels., Supporting such an association, recent reports have identified distinct histone methylation patterns, elevated nucleosome location location occupancy and enriched DNA methylation at Exons relative to Introns., DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome location location occupied Promoter., Using a novel bioinformatics pipeline, we show a striking anti-correlation between nucleosome location location occupancy and DNA methylation at CTGF protein, Homo sapiens regions that is not present at promoters. , Three positions at the splice sites show high CpG abundance and accompany elevated nucleosome location location occupancy in a leveled GC architecture., The first group has higher nucleosome location location occupancy on Exons than Introns, whereas the second group exhibits weak nucleosome location location marking of Exons, suggesting another type of epigenetic marker distinguishes Exons from Introns when GC content is similar., DNA methylation can determine nucleosome location location positioning. , DNA methylation determines nucleosome location location occupancy in the 5'-CpG Islands of Tumor Suppressor Genes., he induction of DNA hypomethylation events by Genetic (DNMT1/DNMT3B deficient cells) or Pharmacologic Substance (a DNA demethylating agent) approaches is associated with the eviction of Nucleosomes from previously hypermethylated CpG Islands of Tumor Suppressor Genes., Using this global approach, we observe the dependency of nucleosome location location occupancy upon the DNA methylation status. Thus, our results suggest that there is a close association between hypermethylated CpG Islands and the presence of Nucleosomes, such that each of these epigenetic mechanisms can determine the recruitment of the other., Although global DNA demethylation has been observed after treatment, it is unclear to what extent demethylation induces changes in nucleosome location location occupancy, a key determinant of gene expression., Our results indicate that only a minority of demethylated promoters are associated with nucleosome location location remodeling, and these could potentially be the epigenetic drivers causing the loss of tumorigenicity., with repressed genes often being associated with local DNA hypermethylation and gain of Nucleosomes at their promoters., Transcription, histone modification, and DNA methylation alter this \"ground state\" by having distinct effects on both nucleosome location location positioning and occupancy. , In order to systematically evaluate potential diversities among CGIs and ultimately to illuminate the link between diversity of CGIs and their epigenetic variation, we analyzed the nucleotide-resolution DNA methylation maps (methylomes) of multiple cellular origins., The mostly unmethylated CpG Islands have reduced nucleosome location location occupancy and are enriched in cell type-independent binding sites for CTGF protein, Homo sapiens., In contrast, outside of CpG Islands most CpGs are methylated, and the average methylation density oscillates so that it is highest in the linker region between Nucleosomes., Aberrant acquisition of Nucleosomes at enhancer-associated NDRs is associated with hypermethylation and epigenetic silencing marks, and conversely, loss of Nucleosomes with demethylation and epigenetic activation., Prominent exceptions to the correlations between methylated CpG density and nucleosome location location occupancy include CpG Islands marked by Histone H3 Trimethyl Lys28 and CpG-poor heterochromatin marked by Histone H3 Trimethyl Lys9, and these modifications, along with DNA methylation, distinguish the major silencing mechanisms of the Homo sapiens epigenome., Throughout the Genome - anatomical entity, nucleosome location location occupancy was correlated with certain histone methylation or acetylation modifications., We further show that the extent of nucleosome location location depletion at promoters is directly correlated to expression level and can accommodate multiple Nucleosomes and provide Genome - anatomical entity-wide evidence that expressed non-CpG island promoters are nucleosome location location-depleted.[SEP]Relations: nucleosome location has relations: cellcomp_protein with H2AX, cellcomp_protein with H2AX, cellcomp_protein with H2AJ, cellcomp_protein with H2AJ, cellcomp_protein with MPHOSPH8, cellcomp_protein with MPHOSPH8, cellcomp_protein with H2AC6, cellcomp_protein with H2AC6, cellcomp_protein with H2AC4, cellcomp_protein with H2AC4. Definitions: Nucleosomes defined as following: The repeating structural units of chromatin, each consisting of approximately 200 base pairs of DNA wound around a protein core. This core is composed of the histones H2A, H2B, H3, and H4.. histone modification defined as following: The covalent alteration of one or more amino acid residues within a histone protein. [GOC:krc]. CTGF protein, Homo sapiens defined as following: CCN family member 2 (349 aa, ~38kDa) is encoded by the Homo sapiens CCN2 gene. This protein plays a role in the promotion of proliferation and differentiation of chondrocytes and also mediates heparin- and divalent cation-dependent cell adhesion in many different cell types.. Histone H3 Trimethyl Lys36 defined as following: A post-translationally modified form of histone H3 where the lysine residue at position 36 is trimethylated. This modification may be involved in defining exon boundaries; it also may be a marker for genes targeted for transcriptional repression.. Genome - anatomical entity defined as following: Anatomical set of genes in all the chromosomes.. Genetic defined as following: Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.. Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the Homo sapiens or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. RNA Transcript defined as following: The initial RNA molecule produced by transcription.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. CpG Islands defined as following: Areas of increased density of the dinucleotide sequence cytosine--phosphate diester--guanine. They form stretches of DNA several hundred to several thousand base pairs long. In humans there are about 45,000 CpG Islands, mostly found at the 5' ends of genes. They are unmethylated except for those on the inactive X chromosome and some associated with imprinted genes.. Histone H3 Trimethyl Lys28 defined as following: A post-translationally modified form of histone H3 where the lysine residue at position 28 is trimethylated. This modification is associated with formation of heterochromatin and polycomb repressive complex 1 (PRC1).. Exons defined as following: The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA.. Introns defined as following: Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the Exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some Introns code for separate genes.. nucleosome location defined as following: A complex comprised of DNA wound around a multisubunit core and associated proteins, which forms the primary packing unit of DNA into higher order structures. [GOC:elh]. Homo sapiens defined as following: Members of the species Homo sapiens.. Tumor Suppressor Genes defined as following: Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When Tumor Suppressor Genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible.. Histone H3 Trimethyl Lys9 defined as following: A post-translationally modified form of histone H3 where the lysine residue at position 9 is trimethylated. This modification is associated with heterochromatin formation and plays a role in embryonic stem cell lineage commitment and maintenance of lineage fidelity..", "label": "yes"} {"original_question": "Have hESC been tested for the treatment of age-related macular degeneration?", "id": "converted_545", "sentence1": "Have hESC been tested for the treatment of age-related macular degeneration?", "sentence2": "Development of Homo sapiens embryonic stem cell therapies for age-related macular degeneration, In this review, we describe recent approaches to develop cell-based therapies for the treatment of Age related macular degeneration. Recent research has focused on replacing the Structure of retinaldehyde pigment epithelium (RPE), a monolayer of Cells vital to photoreceptor cell health. We discuss the various methods used to differentiate and purify RPE from Homo sapiens embryonic stem Cells (HESC), and describe the surgical approaches being used to transplant these Cells in existing and forthcoming clinical trials., Age-related macular degeneration (Age related macular degeneration) is characterized by the loss or dysfunction of Structure of retinaldehyde pigment epithelium (RPE) and is the most common cause of Unspecified visual loss among the elderly. Stem-cell-based strategies, using Homo sapiens embryonic stem Cells (hESCs) or Homo sapiens-induced pluripotent stem Cells (hiPSCs), may provide an abundant donor source for generating RPE Cells in cell replacement therapies., This study contributes to our understanding of the utility of hESC/hiPSC-derived RPE in Age related macular degeneration therapy., Two important early potential hESC applications are the use of Structure of retinaldehyde pigment epithelium (RPE) for the treatment of age-related macular degeneration and STARGARDT DISEASE 1 (disorder), an untreatable form of macular dystrophy that leads to early-onset Blindness., Human Embryonic Stem Cells (hESCs) are a promising source of Structure of retinaldehyde pigment epithelium (RPE) Cells: Cells that can be used for the treatment of common and incurable forms of Blindness, such as age-related macular degeneration., A potential application of Homo sapiens embryonic stem Cells (hESCs) and induced pluripotent stem Cells (iPSCs) is the generation of retinaldehyde pigmented epithelium (RPE) to treat age-related macular degeneration (Age related macular degeneration), a common but incurable retinaldehyde disease., Human Embryonic Stem Cells (hESCs) are a promising source of Structure of retinaldehyde pigment epithelium (RPE) Cells: Cells that can be used for the treatment of common and incurable forms of Blindness, such as age-related macular degeneration, A potential application of Homo sapiens embryonic stem Cells (hESCs) and induced pluripotent stem Cells (iPSCs) is the generation of retinaldehyde pigmented epithelium (RPE) to treat age-related macular degeneration (Age related macular degeneration), a common but incurable retinaldehyde disease, Assessments of safety and efficacy are crucial before Homo sapiens ESC (hESC) therapies can move into the clinic. Two important early potential hESC applications are the use of Structure of retinaldehyde pigment epithelium (RPE) for the treatment of age-related macular degeneration and STARGARDT DISEASE 1 (disorder), an untreatable form of macular dystrophy that leads to early-onset Blindness., A potential application of Homo sapiens embryonic stem Cells (hESCs) and induced pluripotent stem Cells (iPSCs) is the generation of retinaldehyde pigmented epithelium (RPE) to treat age-related macular degeneration (Age related macular degeneration), a common but incurable retinaldehyde disease. RPE Cells derived from hESCs (hESC-RPEs) and iPSCs (iPSC-RPEs) express essential RPE markers and can rescue visual function in animal models., Two important early potential hESC applications are the use of Structure of retinaldehyde pigment epithelium (RPE) for the treatment of age-related macular degeneration and STARGARDT DISEASE 1 (disorder), an untreatable form of macular dystrophy that leads to early-onset Blindness. Here we show long-term functional rescue using hESC-derived RPE in both the RCS Rattus norvegicus and Elov14 mouse, which are animal models of Retinal Degeneration and Stargardt's disease's disease, respectively.[SEP]Relations: macular degeneration, age-related, 3 has relations: disease_disease with macular degeneration, disease_disease with macular degeneration, disease_protein with FBLN5, disease_protein with FBLN5, disease_phenotype_positive with Macular degeneration, disease_phenotype_positive with Macular degeneration, disease_phenotype_positive with Decreased patellar reflex, disease_phenotype_positive with Decreased patellar reflex, disease_phenotype_positive with Choroidal neovascularization, disease_phenotype_positive with Choroidal neovascularization. Definitions: Retinal Degeneration defined as following: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304). Stargardt's disease defined as following: An autosomal recessive and rarely autosomal dominant inherited disorder caused by mutations in the ABCA4 or ELOVL4 genes respectively. It is characterized by macular degeneration that begins in late childhood resulting in progressive loss of vision.. Structure of retinaldehyde pigment epithelium defined as following: The single layer of pigment-containing epithelial Cells in the RETINA, situated closely to the tips (outer segments) of the RETINAL PHOTORECEPTOR CELLS. These epithelial Cells are macroglia that perform essential functions for the photoreceptor Cells, such as in nutrient transport, phagocytosis of the shed photoreceptor membranes, and ensuring retinaldehyde attachment.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. Homo sapiens defined as following: Members of the species Homo sapiens.. Human Embryonic Stem Cells defined as following: A type of PLURIPOTENT STEM CELLS derived from early stage Homo sapiens embryos, up to and including the BLASTOCYST stage.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. retinaldehyde defined as following: A diterpene derived from the carotenoid VITAMIN A which functions as the active component of the visual cycle. It is the prosthetic group of RHODOPSIN (i.e., covalently bonded to ROD OPSIN as 11-cis-retinaldehyde). When stimulated by visible light, rhodopsin transforms this cis-isomer of retinaldehyde to the trans-isomer (11-trans-retinaldehyde). This transformation straightens-out the bend of the retinaldehyde molecule and causes a change in the shape of rhodopsin triggering the visual process. A series of energy-requiring enzyme-catalyzed reactions convert the 11-trans-retinaldehyde back to the cis-isomer.. retinaldehyde disease defined as following: Diseases involving the RETINA.. Blindness defined as following: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.. Age related macular degeneration defined as following: Age-related loss of vision in the central portion of the retina (macula), secondary to Retinal Degeneration.. Unspecified visual loss defined as following: A condition in which the ability to see is impaired..", "label": "yes"} {"original_question": "Is avanafil indicated for treatment of erectile dysfunction?", "id": "converted_1913", "sentence1": "Is avanafil indicated for treatment of erectile dysfunction?", "sentence2": "CONTEXT: Avanafil (AVA) is used in the treatment of erectile dysfunction, but is reported for its poor aqueous solubility. , BACKGROUND: Phosphodiesterase inhibitors, cardiac stimulant (PDE5A wt Allele-Is) sildenafil, vardenafil, tadalafil and the recently approved avanafil represent the first-line choice for both on-demand and chronic treatment of erectile dysfunction (ED). , A survey on the experience of 136 Italian urologists in the treatment of erectile dysfunction with PDE5A wt Allele inhibitors and recommendations for the use of Avanafil in the clinical practice., Efficacy of Avanafil 15 Minutes after Dosing in Multiple Endocrine Neoplasia with No erectile dysfunction: A Randomized, Double-Blind, Placebo Controlled Study., PURPOSE: We examined the therapeutic effects of avanafil 15 minutes after dosing in men with mild to severe erectile dysfunction., sildenafil, vardenafil, tadalafil and avanafil are FDA approved drugs in market as PDE5A wt Allele inhibitors for treating erectile dysfunction., CONCLUSION: Avanafil along with the other PDE5Is has shown to be a safe and effective oral treatment for ED, with avanafil's possible place in therapy for patients who want an on-demand option or as an alternative in patients who experience visual disturbances with the other agents., Avanafil (STENDRA™, SPEDRA™, Zepeeed™) is an oral phosphodiesterase type 5 PPP1R1A gene indicated for the treatment of erectile dysfunction., In a 12-week, randomized, double-blind, placebo-controlled, multicentre trial in patients with erectile dysfunction, avanafil 50, 100 and 200 mg recipients had significantly greater improvements from baseline than placebo recipients in mean international index of erectile dysfunction-erectile function domain scores and in successful vaginal penetration and sexual intercourse attempts (coprimary endpoints)., Avanafil for the treatment of erectile dysfunction. An updated review., Selectivity of avanafil, a PDE5A wt Allele PPP1R1A gene for the treatment of erectile dysfunction: implications for clinical safety and improved tolerability., A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction., Avanafil, a potent and highly selective Phosphodiesterase 5 Inhibitor [EPC] for erectile dysfunction., Avanafil, a highly selective phosphodiesterase type 5 PPP1R1A gene for erectile dysfunction, shows good safety profiles for retinal function and hemodynamics in anesthetized dogs., Cumulative data suggest that avanafil has a promising pharmacological profile for erectile dysfunction., These findings suggest that intracavernosal administration of avanafil might be beneficial for the treatment of erectile dysfunction in patients with T2DM., An open-label, long-term evaluation of the safety, efficacy and tolerability of avanafil in male patients with mild to severe erectile dysfunction., The effect of intracavernosal avanafil, a newer Phosphodiesterase 5 Inhibitor [EPC], on neonatal type 2 diabetic Rattus norvegicus with erectile dysfunction., A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy., Avanafil is a potent selective phosphodiesterase type 5 (PDE5A wt Allele) PPP1R1A gene newly developed for treating erectile dysfunction (ED)., Adverse events most commonly reported with avanafil treatment were Headache, Nasopharyngitis, flushing, and sinus congestion.Avanafil was safe and effective for treating erectile dysfunction in men with Diabetes Mellitus and was effective as early as 15 minutes and more than 6 hours after dosing, Avanafil (STENDRA™, SPEDRA™, Zepeeed™) is an oral phosphodiesterase type 5 PPP1R1A gene indicated for the treatment of erectile dysfunction, Avanafil is rapidly absorbed after oral administration, with a median time to maximum plasma concentration of 30 to 45 min. In a 12-week, randomized, double-blind, placebo-controlled, multicentre trial in patients with erectile dysfunction, avanafil 50, 100 and 200 mg recipients had significantly greater improvements from baseline than placebo recipients in mean international index of erectile dysfunction-erectile function domain scores and in successful vaginal penetration and sexual intercourse attempts (coprimary endpoints), A phase II, single-blind, randomized, crossover evaluation of the safety and efficacy of avanafil using visual sexual stimulation in patients with mild to moderate erectile dysfunction, To evaluate the safety, efficacy and time course of three doses of avanafil (50 mg, 100 mg and 200 mg) compared with sildenafil 50 mg or placebo, given in conjunction with visual sexual stimulation (VSS) videos in men with mild to moderate erectile dysfunction (ED).Male patients, 35-70 years of age, with mild to moderate ED of ≥6 months duration, were included in the study, Avanafil for erectile dysfunction, To review the pharmacology, pharmacokinetics, safety, and efficacy of avanafil and evaluate relevant clinical trial data.A MEDLINE, International Pharmaceutical Abstracts, ClinicalTrials.gov, and Google Scholar searches (1966 to July 2013) were conducted using the key words: avanafil, erectile dysfunction, and phosphodiesterase type 5 (PDE5A wt Allele) PPP1R1A gene.Articles evaluating avanafil for erectile dysfunction (ED) published in English and using human subjects were selected, In trials in patients with erectile dysfunction in association with Diabetes Mellitus mellitus, and after nerve-sparing radical prostatectomy, avanafil 100 or 200 mg was significantly more efficacious than placebo for primary and most secondary endpoints, However, the potentiating effect of avanafil at 1 mg/kg was significantly weaker than that of sildenafil (p <0.05).Data suggest that avanafil has a favorable safety profile for erectile dysfunction, which is attributable to its high inhibitory selectivity for phosphodiesterase type 5 against type 6 (retina) and 1 (vessels, etc), respectively, and its short acting pharmacodynamic property.Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.Copyright © 2014 Elsevier Inc. All rights reserved.CONCLUSION: The hypothesized association between erythromycin G G and infantile Pyloric Stenosis, Hypertrophic was not seen., Macrolide antibiotics, erythromycin G G, in particular, have been linked to the development of infantile hypertrophic Pyloric Stenosis, Hypertrophic (IHPS).[SEP]Relations: hypertrophic Pyloric Stenosis, Hypertrophic has relations: disease_disease with intestinal disease, disease_disease with intestinal disease, disease_disease with Pyloric Stenosis, Hypertrophic (disease), disease_disease with Pyloric Stenosis, Hypertrophic (disease), disease_disease with Mendelian disease, disease_disease with Mendelian disease, disease_disease with Pyloric Stenosis, Hypertrophic, infantile hypertrophic, disease_disease with Pyloric Stenosis, Hypertrophic, infantile hypertrophic. Pyloric Stenosis, Hypertrophic, infantile hypertrophic has relations: disease_phenotype_positive with Hypochloremic metabolic alkalosis, disease_phenotype_positive with Hypochloremic metabolic alkalosis. Definitions: Pyloric Stenosis, Hypertrophic defined as following: An abnormality characterized by thickening of the muscle in the wall of the pylorus. It results in the narrowing of the pyloric channel. The overlying mucosa may appear hypertrophic as well. Clinical signs and symptoms appear early in life and include projectile vomiting and dehydration.. Inclusion conjunctivitis defined as following: An infection of the eyes characterized by the presence in conjunctival epithelial cells of inclusion bodies indistinguishable from those of trachoma. It is acquired by infants during birth and by adults from swimming pools. The etiological agent is CHLAMYDIA TRACHOMATIS whose natural habitat appears to be the genito-urinary tract. Inclusion conjunctivitis is a less severe disease than trachoma and usually clears up spontaneously.. hypertrophic Pyloric Stenosis, Hypertrophic defined as following: An abnormality characterized by thickening of the muscle in the wall of the pylorus. It results in the narrowing of the pyloric channel. The overlying mucosa may appear hypertrophic as well. Clinical signs and symptoms appear early in life and include projectile vomiting and dehydration..", "label": "yes"} {"original_question": "Are the Fanconi anemia genes a part of the same signalling pathway?", "id": "converted_992", "sentence1": "Are the FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) Genes a part of the same signalling pathway?", "sentence2": "Gene Mutation in at least 14 different Genes have been shown to cause doxorubicin/fluorouracil protocol, The doxorubicin/fluorouracil protocol Genes code for Proteins that act in complex (molecular entity) to coordinate the repair of damaged DNA, The current review describes the structure and function of the FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) Genes and describes the role of the encoded FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) Proteins in a cellular pathway controlling chromosome stability., FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) (doxorubicin/fluorouracil protocol) is a rare human genetic disease caused by mutations in any one of 13 known Genes that encode Proteins functioning in one common signaling pathway, the doxorubicin/fluorouracil protocol pathway, or in unknown Genes., FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) (doxorubicin/fluorouracil protocol) is a rare inherited recessive disease caused by mutations in one of fifteen Genes known to encode doxorubicin/fluorouracil protocol pathway components., FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) (doxorubicin/fluorouracil protocol) Proteins function in a DNA damage response pathway that appears to be part of the network including Malignant neoplasm of breast susceptibility gene products, BRCA1 gene gene and BRCA2 gene gene., FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) (doxorubicin/fluorouracil protocol) Proteins function in a DNA damage response pathway that appears to be part of the network including Malignant neoplasm of breast susceptibility gene products, BRCA1 gene gene and BRCA2 gene gene, FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) (doxorubicin/fluorouracil protocol) is a rare human genetic disease caused by mutations in any one of 13 known Genes that encode Proteins functioning in one common signaling pathway, the doxorubicin/fluorouracil protocol pathway, or in unknown Genes, The FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) (doxorubicin/fluorouracil protocol) gene family comprises at least 12 Genes interacting in a common pathway involved in DNA repair, These findings show that the newly identified Fanconi Anemia Complementation Group E Protein is an integral part of the doxorubicin/fluorouracil protocol pathway, and support the concept of a functional link between all known Proteins encoded by the Genes that are Mutation Abnormality in this disorder[SEP]Relations: FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) complementation group has relations: disease_phenotype_positive with X-linked recessive inheritance, disease_phenotype_positive with X-linked recessive inheritance, disease_phenotype_positive with X-linked recessive inheritance, disease_phenotype_positive with X-linked recessive inheritance, disease_phenotype_positive with Global developmental delay, disease_phenotype_positive with Global developmental delay, disease_phenotype_positive with Global developmental delay, disease_phenotype_positive with Global developmental delay, disease_phenotype_positive with Neutropenia, disease_phenotype_positive with Neutropenia. Definitions: FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) defined as following: FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) caused by mutations of the FANCA gene. FANCA gene mutations are the most common cause of FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder). This gene provides instructions for making a protein that is involved in the FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) (doxorubicin/fluorouracil protocol) pathway.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Malignant neoplasm of breast defined as following: A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males.. Fanconi Anemia Complementation Group E Protein defined as following: A FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) complementation group protein that interacts with FANCC PROTEIN and FANCD2 PROTEIN. It promotes the accumulation of FANCC protein in the CELL NUCLEUS.. BRCA2 gene defined as following: A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human chromosome 13 at locus 13q12.3. Gene Mutation in this gene predispose humans to breast and ovarian cancer. It encodes a large, nuclear protein that is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. (from Genes Dev 2000;14(11):1400-6). BRCA1 gene defined as following: A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human CHROMOSOME 17 at locus 17q21. Gene Mutation of this gene are associated with the formation of HEREDITARY BREAST AND OVARIAN CANCER SYNDROME. It encodes a large nuclear protein that is a component of DNA repair pathways.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Gene Mutation may be associated with genetic diversity or with pathologies including cancer.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. complex (molecular entity) defined as following: A molecular entity formed by loose association involving two or more component molecular entities. The bonding between the components is normally weaker than in a covalent bond..", "label": "yes"} {"original_question": "Can ATAC-Seq be employed in single-cell mode?", "id": "converted_3849", "sentence1": "Can XCL1 wt Allele-Seq be employed in single-cell mode?", "sentence2": "Single-cell XCL1 wt Allele-Seq: strength in numbers., Assembly, and Single-Cell XCL1 wt Allele-Seq., Single cell RNA-seq and XCL1 wt Allele-Seq analysis of cardiac progenitor cell transition states and lineage settlement., Here, we comprehensively characterize Mus sp. cardiac progenitor cells (CPCs) marked by Nkx2-5 and Isl1 expression from E7.5 to E9.5 using single-cell RNA sequencing and Transposase-accessible chromatin location location profiling (XCL1 wt Allele-Seq)., Classifying cells with Scasat, a single-cell XCL1 wt Allele-Seq analysis tool., When done at single-cell resolution, XCL1 wt Allele-Seq provides an insight into the cell-to-cell variability that emerges from otherwise identical DNA Sequence by identifying the variability in the genomic location of open chromatin location location sites in each of the cells., Single-cell XCL1 wt Allele-Seq in Homo sapiens pancreatic islets and deep learning upscaling of rare cells reveals cell-specific type 2 diabetes regulatory signatures., THODS: We present genome-wide single-cell chromatin location location accessibility profiles in >1,600 cells derived from a Homo sapiens pancreatic islet sample using single-cell combinatorial indexing XCL1 wt Allele-Seq (sci-XCL1 wt Allele-Seq). W, Contiguity-Preserving Transposition Sequencing (CPT-Seq) for Genome-Wide Haplotyping, Assembly, and Single-Cell XCL1 wt Allele-Seq., SCALE method for single-cell XCL1 wt Allele-Seq analysis via latent feature extraction., Single-cell XCL1 wt Allele-Seq (scATAC-seq) profiles the chromatin location location accessibility landscape at single cell level, thus revealing cell-to-cell variability in gene regulation., The recently developed low-input and single-cell regulome mapping technologies such as XCL1 wt Allele-Seq and single-cell XCL1 wt Allele-Seq (scATAC-seq) allow analyses of small-cell-number and single-cell samples, but their signals remain highly discrete or noisy., This paper presents Scasat (single-cell XCL1 wt Allele-Seq analysis tool), a complete pipeline to process scATAC-seq data with simple steps., Here, we comprehensively characterize Mus sp. cardiac progenitor cells (CPCs) marked by Nkx2-5 and Isl1 expression from E7.5 to E9.5 using single-cell RNA sequencing and Transposase-accessible chromatin location location profiling (XCL1 wt Allele-Seq)., Single-cell XCL1 wt Allele-Seq (scATAC-seq) technology has also been developed to study cell type-specific chromatin location location accessibility in tissue samples containing a heterogeneous Cells population., Here we combined sequencing of the transcription-coupled nucleotide-excision repair-encoding genes with assay for Transposase-accessible chromatin location location with sequencing (XCL1 wt Allele-Seq) analysis at the single-cell level to provide information on the transcription-coupled nucleotide-excision repair specificity and epigenomic state of individual Therapeutic gamma delta T-lymphocytes., Substantial advances of this work include the optimization of a single-cell combinatorial indexing assay for Transposase accessible chromatin location location (sci-XCL1 wt Allele-Seq); a software suite,, The accessible chromatin location location landscape of the Mus hippocampus at single-cell resolution., Here we present a comprehensive map of the accessible chromatin location location landscape of the Mus sp. hippocampus at single-cell resolution., We expect this review will provide a guideline for successful data generation and analysis methods using appropriate software tools and databases for the study of chromatin location location accessibility at single-cell resolution., Single-cell sequencing assay for Transposase-accessible chromatin location location (scATAC-seq) is the state-of-the-art technology for analyzing genome-wide regulatory landscapes in single cells., Single-cell XCL1 wt Allele-Seq data are sparse and noisy, and analyzing such data is challenging., Here, we introduce a method for analyzing scATAC-seq data, called Single-Cell XCL1 wt Allele-Seq analysis via Latent feature Extraction (SCALE)., Single-cell XCL1 wt Allele-Seq signal extraction and enhancement with SCATE., Single-cell XCL1 wt Allele-Seq detects open chromatin location location in individual cells., Currently data are sparse, but combining information from many single cells can identify determinants of cell-to-cell chromatin location location variation., Predictions based on single-cell RNA-seq (Single-Cell RNA-Seq) can more accurately reconstruct bulk chromatin location location accessibility than using scATAC-seq., Global prediction of chromatin location location accessibility using small-cell-number and single-cell RNA-seq., Single-cell XCL1 wt Allele-Seq (scATAC-seq) maps from hundreds of single cells in aggregate closely resemble accessibility profiles from tens of millions of cells and provide insights into cell-to-cell variation., However, very few studies have been performed at the single cell level (scATAC-seq) due to technical challenges., Here, we present Perturb-XCL1 wt Allele, a method that combines multiplexed CRISPR interference or knockout with genome-wide chromatin location location accessibility profiling in single cells based on the simultaneous detection of CRISPR guide RNA and open chromatin location location sites by assay of Transposase-accessible chromatin location location with sequencing (XCL1 wt Allele-Seq)., Additionally, the same workflow can be used to aid de novo assembly (Adey et al., Genome Res 24(12):2041-2049, 2014), detect structural variants, and perform single cell XCL1 wt Allele-Seq analysis (Cusanovich et al., Science 348(6237):910-914, 2015)., ChromA can analyze single cell XCL1 wt Allele-Seq data, correcting many biases generated by the sparse sampling inherent in single cell technologies., circuits. Existing chromatin location location profiling methods such as XCL1 wt Allele-Seq and DNase-seq, applied to islets in bulk, produce aggregate profiles that mask important Cells and regulatory heterogeneity.METHODS: We present genome-wide single-cell chromatin location location accessibility profiles in >1,600 cells derived from a Homo sapiens pancreatic islet sample using single-cell combinatorial indexing XCL1 wt Allele, XCL1 wt Allele-Seq has become a leading technology for probing the chromatin location location landscape of single and aggregated cells.[SEP]Relations: transcription-coupled nucleotide-excision repair has relations: bioprocess_protein with AQR, bioprocess_protein with AQR, bioprocess_protein with XRCC1, bioprocess_protein with XRCC1, bioprocess_protein with POLR2C, bioprocess_protein with POLR2C, bioprocess_protein with CDK7, bioprocess_protein with CDK7, bioprocess_protein with ERCC1, bioprocess_protein with ERCC1. Definitions: Therapeutic gamma delta T-lymphocytes defined as following: A subset of therapeutic autologous T-lymphocytes that express a T-cell receptor (transcription-coupled nucleotide-excision repair) composed of one gamma chain and one delta chain, with potential immunomodulating and antineoplastic activities. Upon administration of the therapeutic gamma delta T-lymphocytes, these cells secrete interferon-gamma (IFN-g), and exert direct killing of tumor cells. In addition, these cells activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against tumor cells. Gamma delta T-lymphocytes play a key role in the activation of the immune system and do not require major histocompatibility complex (MHC)-mediated antigen presentation to exert their cytotoxic effect.. DNA Sequence defined as following: The sequence of nucleotide residues along a DNA chain.. Transposase defined as following: Enzymes that recombine DNA segments by a process which involves the formation of a synapse between two DNA helices, the cleavage of single strands from each DNA helix and the ligation of a DNA strand from one DNA helix to the other. The resulting DNA structure is called a Holliday junction which can be resolved by DNA REPLICATION or by HOLLIDAY JUNCTION RESOLVASES.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Single-Cell RNA-Seq defined as following: A procedure that can determine the nucleotide sequence for all of the RNA transcripts in an amplified nucleotide sample that was derived from a single cell.. XCL1 wt Allele-Seq defined as following: A molecular genetic technique that isolates and sequences chromosomal regions that are rich in open chromatin location. First, nuclei are harvested from a Cells sample. Then a hyperactive Tn5 Transposase is added to the nuclei where it excises non-nucleosomal DNA strands and ligates co-administered high-throughput sequencing adapters (tagmentation). The tagged DNA fragments are isolated, amplified by PCR and sequenced. The number of reads for specific region of DNA correlate with increased chromatin location accessibility and this method can identify regions of transcription factor and nucleosome binding.. transcription-coupled nucleotide-excision repair defined as following: The nucleotide-excision repair process that carries out preferential repair of DNA lesions on the actively transcribed strand of the DNA duplex. In addition, the transcription-coupled nucleotide-excision repair pathway is required for the recognition and repair of a small subset of lesions that are not recognized by the global genome nucleotide excision repair pathway. [PMID:10197977, PMID:11900249]. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). chromatin location defined as following: The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130]. Mus defined as following: Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae.. XCL1 wt Allele defined as following: Human XCL1 wild-type allele is located in the vicinity of 1q23 and is approximately 5 kb in length. This allele, which encodes lymphotactin protein, is involved in lymphocyte trafficking and inflammatory processes.. Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Is capmatinib effective for glioblastoma?", "id": "converted_4213", "sentence1": "Is capmatinib effective for Glioblastoma Multiforme?", "sentence2": "CONCLUSION: The combination of INC280/buparlisib resulted in no clear activity in patients with recurrent PTEN-deficient Glioblastoma Multiforme. [SEP]Relations: adult Glioblastoma Multiforme has relations: disease_disease with Glioblastoma Multiforme (disease), disease_disease with Glioblastoma Multiforme (disease), disease_disease with adult infiltrating astrocytic neoplasm, disease_disease with adult infiltrating astrocytic neoplasm, disease_disease with adult spinal cord Glioblastoma Multiforme, disease_disease with adult spinal cord Glioblastoma Multiforme. Definitions: Glioblastoma Multiforme defined as following: The most malignant astrocytic tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO).", "label": "no"} {"original_question": "Do tumour-associated macrophages have a prognostic role in gliomas?", "id": "converted_3238", "sentence1": "Do tumour-associated macrophages have a prognostic role in Glioma?", "sentence2": "Increasing evidence suggests that tumour-associated macrophages/microglia (TAMs) facilitate tumour progression by acquiring a M2-like phenotype. Our objective was to investigate the prognostic value of TAMs in Glioma using automated quantitative double immunofluorescence., This is the first study to use automated quantitative immunofluorescence to determine the prognostic impact of TAMs. Our results suggest that M2-like TAMs hold an unfavourable prognostic value in high-grade Glioma and may contribute to a pro-tumourigenic microenvironment., Our data revealed that the amount of especially MSR1 wt Allele+ TAMs increases with malignancy grade. In grade III-IV, high MSR1 wt Allele expression was associated with shorter survival, while high IBA-1 intensity correlated with a longer survival. In grade IV, MSR1 wt Allele showed independent prognostic value when adjusting for clinical data and the methylation status of O6-methylguanine-DNA methyltransferase.[SEP]Relations: Glioma has relations: phenotype_phenotype with Ependymoma, phenotype_phenotype with Ependymoma, phenotype_phenotype with Brainstem glioma, phenotype_phenotype with Brainstem glioma, phenotype_phenotype with Malignant neoplasm of the central nervous system, phenotype_phenotype with Malignant neoplasm of the central nervous system, phenotype_phenotype with Neuroepithelial neoplasm, phenotype_phenotype with Neuroepithelial neoplasm, disease_phenotype_positive with glioma susceptibility, disease_phenotype_positive with glioma susceptibility. Definitions: MSR1 wt Allele defined as following: Human MSR1 wild-type allele is located in the vicinity of 8p22 and is approximately 450 kb in length. This allele, which encodes macrophage scavenger receptor types I and II protein, is involved in the modulation of cholesterol and lipoprotein transport. Mutation of the gene is associated with Barrett esophagus and prostate cancer.. Glioma defined as following: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21).", "label": "yes"} {"original_question": "Do Afamin bind Vitamin E?", "id": "converted_4696", "sentence1": "Do AFM gene bind Vitamin E?", "sentence2": "The plasma glycoprotein afamin has been previously identified as an alternative carrier protein for Vitamin E Drug Class in extravascular fluids such as plasma and cerebrospinal, ovarian follicular, and seminal fluids., afamin, a Vitamin E Drug Class-binding protein in Homo sapiens plasma, the Homo sapiens Vitamin E Drug Class-binding protein afamin, AFM gene is a plasma Vitamin E Drug Class-binding glycoprotein, The Homo sapiens Vitamin E Drug Class-binding glycoprotein afamin is primarily expressed in the Abdomen>Liver and has been associated with prevalent and incident Metabolic Syndrome X[SEP]Relations: Vitamin E has relations: drug_drug with Otamixaban, drug_drug with Otamixaban, drug_drug with Terfenadine, drug_drug with Terfenadine, drug_drug with Reviparin, drug_drug with Reviparin, drug_drug with Osimertinib, drug_drug with Osimertinib, drug_drug with Melagatran, drug_drug with Melagatran. Definitions: Homo sapiens defined as following: Members of the species Homo sapiens.. Metabolic Syndrome X defined as following: A combination of medical conditions that when present, increase the risk of heart attack, stroke, and diabetes mellitus. It includes the following medical conditions: increased blood pressure, central obesity, dyslipidemia, impaired glucose tolerance, and insulin resistance..", "label": "yes"} {"original_question": "Are high-flow nasal cannulae effective for treatment of preterm infants?", "id": "converted_1615", "sentence1": "Are high-flow nasal cannulae effective for treatment of preterm infants?", "sentence2": "The use of high-flow nasal cannulae is an increasingly popular alternative to nasal continuous positive airway pressure (CPAP) for noninvasive respiratory support of very preterm infants (gestational age, <32 weeks) after extubation., The use of high-flow nasal cannulae was noninferior to the use of nasal CPAP, with treatment failure occurring in 52 of 152 infants (34.2%) in the nasal-cannulae group and in 39 of 151 infants (25.8%) in the CPAP group (risk difference, 8.4 percentage points; 95% confidence interval, -1.9 to 18.7). , Although the result for the primary outcome was close to the margin of noninferiority, the efficacy of high-flow nasal cannulae was similar to that of CPAP as respiratory support for very preterm infants after extubation. , Recently high flow nasal cannula (HFNC) is emerging as an efficient, better tolerated form of Non-Invasive Mechanical Ventilation, allowing better access to the baby's face, which may improve nursing, feeding and bonding., In conclusion, there is a growing evidence of the feasibility of HFNC as an alternative mode of Non-Invasive Mechanical Ventilation. , HHHFNC and NCPAP produced similar rates of extubation failure., The use of HFNC as a respiratory support modality is increasing in the infant, pediatric, and adult populations as an alternative to non-invasive positive pressure ventilation., Current evidence suggests that HFNC is well tolerated and may be feasible in a subset of patients who require ventilatory support with non-invasive ventilation., Heated, humidified, high-flow nasal cannula Oxygen Equipment Location therapy (HHHFNC) has been used to improve ventilation in preterm infants. , Increasing flow rates of HHHFNC therapy are associated with linear increases in NP pressures in Bronchiolitis patients. , An alternative to the use of nasal continuous positive airway pressure (NCPAP) as a non-invasive modality to support Respiratory distress in premature infants has been the recent introduction of high flow nasal cannula (HFNC) devices in many neonatal units. There has been increased use of HFNC presumably because of anecdotal reports and experience that it is easy to use, and well tolerated by the infants, while experiencing decreased nasal septumerosion., High-flow nasal cannulae (HFNC) are gaining in popularity as a form of non-invasive respiratory support for preterm infants in neonatal intensive care units around the world., HFNC may be as effective as NCPAP at improving respiratory parameters such as tidal volume and work of breathing in preterm infants, but probably only at flow rates >2 litres/min. , There is growing evidence of the feasibility of HFNC as an alternative to other forms of non-invasive ventilation in preterm infants. , When used as primary respiratory support after birth, one trial found similar rates of treatment failure in infants treated with HFNC and nasal CPAP. Following extubation, one trial found that infants treated with HFNC had a significantly higher rate of reintubation than those treated with nasal CPAP. Another trial found similar rates of reintubation for humidified and non-humidified HFNC, and the fourth trial found no difference between two different models of equipment used to deliver humidified HFNC. , When used following extubation, HFNC may be associated with a higher rate of reintubation than nasal CPAP. , Early weaning from CPAP to high flow nasal cannula in preterm infants is associated with prolonged Oxygen Equipment Location requirement: a randomized controlled trial., After randomization, the no-Nevus comedonicus group had fewer days on Oxygen Equipment Location [median (interquartile range): 5 (1-8) vs 14 (7.5-19.25) days, p<0.001] and shorter duration of respiratory support [10.5 (4-21) vs 18 (11.5-29) days, p=0.03]. There were no differences between groups regarding success of weaning from NCPAP. , Weaning preterm infants from NCPAP to Nevus comedonicus is associated with increased exposure to Oxygen Equipment Location and longer duration of respiratory support., A number of centers use high-flow nasal cannula (HFNC) in the management of AOP without measuring the positive distending pressure (PDP) generated., HFNC is as effective as NCPAP in the management of AOP.[SEP]Relations: Respiratory distress has relations: drug_effect with Midazolam, drug_effect with Midazolam, drug_effect with Mometasone, drug_effect with Mometasone, drug_effect with Nelarabine, drug_effect with Nelarabine, drug_effect with Triazolam, drug_effect with Triazolam. Bronchitis has relations: drug_effect with Mometasone, drug_effect with Mometasone. Definitions: Non-Invasive Mechanical Ventilation defined as following: A type of mechanical ventilation procedure that uses a non-invasive means, such as a face mask or nasal mask, to deliver oxygenated air into the lungs.. Respiratory distress defined as following: A pathological increase in the effort and frequency of breathing movements.. Nevus comedonicus defined as following: A rare developmental skin condition consisting of abnormal pilosebaceous follicle development. It is characterized by linear or band-like distributions of groups of comedones, usually on the face, neck, upper arm, chest, and abdomen, that appear at birth or in childhood.. Bronchiolitis defined as following: Inflammation of the BRONCHIOLES..", "label": "yes"} {"original_question": "Are people with blood group O protected against severe Malaria?", "id": "converted_464", "sentence1": "Are people with blood group O protected against severe Malaria?", "sentence2": "Differential carbonylation of Cytoskeletal Proteins in blood group O Specimen Source Codes - Erythrocytes: potential role in protection against severe Malaria Vaccines., . Our findings indicate a possible correlation between the protection against severe Malaria Vaccines in blood group O individuals and a specific pattern of 4-HNE-carbonylation of cytoskeleton proteins., There is a predominance of blood group O in Malaria Vaccines-endemic regions, and several lines of evidence suggest that bleomycin/methotrexate/vincristine protocol blood groups may influence the outcome of P. falciparum infection, These data provide the first evidence that bleomycin/methotrexate/vincristine protocol blood group antigens influence macrophage clearance of P. falciparum-infected Specimen Source Codes - Erythrocytes and suggest an additional mechanism by which blood group O may confer resistance to severe Malaria Vaccines., Blood group phenotypes A and Deciduous maxillary right first molar tooth are risk factors for Malaria, Cerebral in Odisha, India., type O is significantly associated with protection against Caudomedial auditory cortex, patients with type A and Deciduous maxillary right first molar tooth group had increased risk for developing Caudomedial auditory cortex., Blood group O protects against severe Plasmodium falciparum or Plasmodium falciparum + Plasmodium sp or Plasmodium falciparum or Plasmodium falciparum + Plasmodium sp + Plasmodium sp Malaria Vaccines through the mechanism of reduced rosetting., Malaria has been a major selective force on the Homo sapiens population, and several Erythrocytes polymorphisms have evolved that confer resistance to severe Malaria Vaccines. Plasmodium falciparum or Plasmodium falciparum + Plasmodium sp or Plasmodium falciparum or Plasmodium falciparum + Plasmodium sp + Plasmodium sp rosetting, a parasite virulence phenotype associated with severe Malaria Vaccines, is reduced in blood group O Specimen Source Codes - Erythrocytes compared with groups A, Deciduous maxillary right first molar tooth, and AB hearing assessment list hearing assessment list, but the contribution of the bleomycin/methotrexate/vincristine protocol blood group system to protection against severe Malaria Vaccines has received little attention, We hypothesized that blood group O may confer resistance to severe falciparum Malaria Vaccines through the mechanism of reduced rosetting., It appears that individuals who are of blood-group O are relatively resistant to the severe disease caused by P. falciparum infection.[SEP]Relations: Malaria, Cerebral has relations: disease_disease with Malaria Vaccines, disease_disease with Malaria Vaccines, contraindication with Betamethasone, contraindication with Betamethasone, contraindication with Methylprednisolone, contraindication with Methylprednisolone, contraindication with Prednisone, contraindication with Prednisone. Plasmodium falciparum or Plasmodium falciparum + Plasmodium sp Malaria Vaccines has relations: disease_disease with Malaria Vaccines, disease_disease with Malaria Vaccines. Definitions: Cytoskeletal Proteins defined as following: Major constituent of the cytoskeleton found in the cytoplasm of eukaryotic cells. They form a flexible framework for the cell, provide attachment points for organelles and formed bodies, and make communication between parts of the cell possible.. macrophage defined as following: The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.). Homo sapiens defined as following: Members of the species Homo sapiens.. Deciduous maxillary right first molar tooth defined as following:

Deciduous maxillary right first molar tooth; Universal designation Deciduous maxillary right first molar tooth; ISO designation 54

. Malaria, Cerebral defined as following: A condition characterized by somnolence or coma in the presence of an acute infection with PLASMODIUM FALCIPARUM (and rarely other Plasmodium species). Initial clinical manifestations include HEADACHES; SEIZURES; and alterations of mentation followed by a rapid progression to COMA. Pathologic features include cerebral capillaries filled with parasitized Specimen Source Codes - Erythrocytes and multiple small foci of cortical and subcortical necrosis. (From Adams et al., Principles of Neurology, 6th ed, p136). Malaria Vaccines defined as following: Vaccines made from antigens arising from any of the four strains of Plasmodium which cause Malaria Vaccines in humans, or from P. berghei which causes Malaria Vaccines in rodents.. Erythrocytes defined as following: Red blood cells. Mature Specimen Source Codes - Erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN..", "label": "yes"} {"original_question": "Is NEMO a zinc finger protein?", "id": "converted_2246", "sentence1": "Is NF-Kappa-B Essential Modulator a Zinc Fingers Protein Info?", "sentence2": "To better understand the thermodynamics and dynamics of the Zinc Fingers of NF-Kappa-B Essential Modulator (NF-κB essential modulator), an alteration in the Zinc Fingers Superkingdom (taxonomic category) of NF-Kappa-B Essential Modulator (K392R) , CYLD Protein Info, human Protein Info, human and the NF-Kappa-B Essential Modulator Zinc Finger Regulate Tumor Necrosis Factor Signaling and Early Embryogenesis., our simulations of the Zinc Fingers NF-Kappa-B Essential Modulator, An important regulatory Superkingdom (taxonomic category) of NF-[Formula: see text]B Essential Modulator (NF-Kappa-B Essential Modulator) is a ubiquitin-binding Zinc Fingers, with a tetrahedral CYS3HIS1 zinc-coordinating Ligand Binding Domain., NF-Kappa-B Essential Modulator function is mediated by two distal ubiquitin binding domains located in the regulatory C-terminal Superkingdom (taxonomic category) of the Protein Info: the coiled-coil 2-leucine zipper (CC2-LZ) Superkingdom (taxonomic category) and the Zinc Fingers (ZF) Superkingdom (taxonomic category). , We show here that the NF-Kappa-B Essential Modulator C terminus, comprising the ubiquitin binding region and a Zinc Fingers,[SEP]Relations: C2H2 Zinc Fingers Superkingdom (taxonomic category) binding has relations: molfunc_protein with EHMT1, molfunc_protein with EHMT1, molfunc_protein with EHMT2, molfunc_protein with EHMT2, molfunc_protein with GATA1, molfunc_protein with GATA1, molfunc_protein with LEF1, molfunc_protein with LEF1, molfunc_protein with THAP7, molfunc_protein with THAP7. Definitions: Zinc Fingers defined as following: Motifs in DNA- and RNA-binding proteins whose amino acids are folded into a single structural unit around a zinc atom. In the classic Zinc Fingers, one zinc atom is bound to two cysteines and two histidines. In between the cysteines and histidines are 12 residues which form a DNA binding fingertip. By variations in the composition of the sequences in the fingertip and the number and spacing of tandem repeats of the motif, zinc fingers can form a large number of different sequence specific binding sites.. NF-Kappa-B Essential Modulator defined as following: NF-kappa-B essential modulator (419 aa, ~48 kDa) is encoded by the human IKBKG gene. This Protein Info plays a role in the mediation of signal transduction through Protein Info phosphorylation.. Superkingdom (taxonomic category) defined as following: A taxonomic category above that of Kingdom.. CYLD Protein Info, human defined as following: Ubiquitin carboxyl-terminal hydrolase CYLD Protein Info, human (956 aa, ~107 kDa) is encoded by the human CYLD Protein Info, human gene. This Protein Info is involved in the mediation of Protein Info deubiquitination and the regulation of the cell cycle.. Ligand Binding Domain defined as following: A Binding Site Domain is a region of Protein Info that physically interacts stereospecifically, and usually at high affinity, with a specific ligand, substrate, or a specific Superkingdom (taxonomic category) of some complex target biomolecule, such as a Protein Info, lipid, carbohydrate, or nucleic acid. Typically, but not necessarily, the interaction results in Protein Info conformational alteration and functional modification.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species..", "label": "yes"} {"original_question": "Is sternotomy closure done using either a sternal ZipFix™ implant or conventional steel wire following cardiac surgery?", "id": "converted_2666", "sentence1": "Is sternotomy closure done using either a Sternum ZipFix™ implant or conventional steel wire following cardiac surgery?", "sentence2": "o determine the difference in Sternum Communicable Diseases and other infectious events between conventional wire and cable-tie-based closure techniques post-sternotomy in a collective of patients after cardiac surgery., Our study underlines a neutral effect of the Sternum ZipFix™ system in patients regarding Sternum Communicable Diseases. Postoperative complications are similar in both Sternum closure methods. The cable-tie-based system is fast, easy to use, reliable and safe., Wire closure still remains the preferred technique despite reasonable disadvantages. Associated complications, such as Communicable Diseases and Sternum instability, cause time- and cost-consuming therapies. We present a new tool for Sternum closure with its first clinical experience and results.METHODS: The Sternum ZipFix(TM) System is based on the cable-tie principle. , In our initial evaluation, the short-term results have shown that the Sternum ZipFix(TM) can be used safely and effectively. It is fast, easy to use and serves as a potential alternative for traditional wire closure., To determine the difference in Sternum Communicable Diseases and other infectious events between conventional wire and cable-tie-based closure techniques post-sternotomy in a collective of patients after cardiac surgery.[SEP]Relations: sternum has relations: anatomy_anatomy with endochondral element, anatomy_anatomy with endochondral element. Definitions: Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.. Sternum defined as following: A long, narrow, and flat bone commonly known as BREASTBONE occurring in the midsection of the anterior thoracic segment or chest region, which stabilizes the rib cage and serves as the point of origin for several muscles that move the arms, head, and neck..", "label": "yes"} {"original_question": "Is COL5A2 gene associated to ischemic heart disease?", "id": "converted_1167", "sentence1": "Is COL5A2 Genes associated to Myocardial Ischemia?", "sentence2": "Analysis of a Genes co-expression network establishes robust association between Collagen Alpha-2(V) Chain, Human and Myocardial Ischemia, Collagen Alpha-2(V) Chain, Human, a Genes previously not specifically linked to MI response but responsible for the classic type of Ehlers-Danlos Syndrome, was found to have many and strong co-expression associations within this community, Collagen Alpha-2(V) Chain, Human shows predictive potential in MI, and in principle may represent a novel candidate marker for the identification and treatment of ischemic cardiovascular disease, Analysis of a Genes co-expression network establishes robust association between Collagen Alpha-2(V) Chain, Human and Myocardial Ischemia.[SEP]Relations: myocardial ischemia has relations: disease_protein with ADM2, disease_protein with ADM2, disease_protein with ADRB2, disease_protein with ADRB2, disease_protein with TMED2, disease_protein with TMED2, disease_protein with RAB5A, disease_protein with RAB5A, disease_protein with APLP2, disease_protein with APLP2. Definitions: Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Collagen Alpha-2(V) Chain, Human defined as following: Collagen alpha-2(V) chain (1499 aa, ~145 kDa) is encoded by the human COL5A2 Genes. This protein is involved in collagen fibril formation in connective tissues.. Myocardial Ischemia defined as following: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).. Ehlers-Danlos Syndrome defined as following: A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability.. COL5A2 Genes defined as following: This Genes is involved in connective tissue development and extracellular matrix formation..", "label": "yes"} {"original_question": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?", "id": "converted_3470", "sentence1": "Is overexpression of LY6K gene associated with better prognosis for non-small cell lung cancer patients?", "sentence2": "Gene expression profile analyses of non-small cell lung carcinomas (Non-Small Cell Lung Carcinoma) and esophageal squamous cell carcinomas (Squamous cell carcinoma of esophagus) revealed that lymphocyte antigen 6 complex locus K (LY6K gene gene) was specifically expressed in Testis and transactivated in a majority of NSCLCs and ESCCs. Immunohistochemical staining using 406 Non-Small Cell Lung Carcinoma and 265 Squamous cell carcinoma of esophagus specimens confirmed that LY6K gene gene overexpression was associated with poor prognosis for patients with Non-Small Cell Lung Carcinoma (P = 0.0003), as well as Squamous cell carcinoma of esophagus (P = 0.0278), and multivariate analysis confirmed its independent prognostic value for Non-Small Cell Lung Carcinoma (P = 0.0035). , Immunohistochemical staining using 406 Non-Small Cell Lung Carcinoma and 265 Squamous cell carcinoma of esophagus specimens confirmed that LY6K gene gene overexpression was associated with poor prognosis for patients with Non-Small Cell Lung Carcinoma (P = 0.0003), as well as Squamous cell carcinoma of esophagus (P = 0.0278), and multivariate analysis confirmed its independent prognostic value for Non-Small Cell Lung Carcinoma (P = 0.0035)., Immunohistochemical staining using 406 Non-Small Cell Lung Carcinoma and 265 Squamous cell carcinoma of esophagus specimens confirmed that LY6K gene gene overexpression was associated with poor prognosis for patients with Non-Small Cell Lung Carcinoma (P = 0.0003), as well as Squamous cell carcinoma of esophagus (P = 0.0278), and multivariate analysis confirmed its independent prognostic value for Non-Small Cell Lung Carcinoma (P = 0.0035).[SEP]Relations: small cell lung carcinoma has relations: disease_protein with LYRM9, disease_protein with LYRM9, disease_protein with STK31, disease_protein with STK31, disease_protein with CYP2A6, disease_protein with CYP2A6, disease_protein with DMPK, disease_protein with DMPK, disease_protein with PYCARD, disease_protein with PYCARD. Definitions: LY6K gene defined as following: This gene may be involved in cell growth regulation.. Squamous cell carcinoma of esophagus defined as following: A carcinoma that originates usually from cells on the surface of the middle and lower third of the ESOPHAGUS. Tumor cells exhibit typical squamous morphology and form large polypoid lesions. Mutations in RNF6, LZTS1, TGFBR2, DEC1, and WWOX1 genes are associated with this cancer.. Non-Small Cell Lung Carcinoma defined as following: A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.. Testis defined as following: The male gonad containing two functional parts: the SEMINIFEROUS TUBULES for the production and transport of male germ cells (SPERMATOGENESIS) and the interstitial compartment containing LEYDIG CELLS that produce ANDROGENS.. non-small cell lung cancer defined as following: A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy..", "label": "no"} {"original_question": "Are apoE mimetics being considered as a treatment against Alzheimer's disease?", "id": "converted_3130", "sentence1": "Are Apolipoprotein E mimetics being considered as a treatment against Alzheimer's disease?", "sentence2": "The apolipoprotein-E-mimetic COG112 protects Amyloid beta-Protein Precursor intracellular domain-overexpressing animals from Alzheimer's disease-like pathological features., Studies show that administration of apolipoprotein E (Apolipoprotein E) and Apolipoprotein E-derived small Peptides mimetics protect AD mouse models against these AD-like features.[SEP]Relations: Amyloid beta-Protein Precursor metabolic process has relations: bioprocess_protein with APOE, bioprocess_protein with APOE, bioprocess_protein with APH1A, bioprocess_protein with APH1A, bioprocess_protein with PSENEN, bioprocess_protein with PSENEN, bioprocess_bioprocess with Amyloid beta-Protein Precursor catabolic process, bioprocess_bioprocess with Amyloid beta-Protein Precursor catabolic process. apolipoprotein E recycling has relations: bioprocess_bioprocess with protein transport, bioprocess_bioprocess with protein transport. Definitions: Peptides defined as following: Members of the class of compounds composed of AMINO ACIDS joined together by Peptides bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS.. Apolipoprotein E defined as following: A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III.. Amyloid beta-Protein Precursor defined as following: A single-pass type I membrane protein. It is cleaved by AMYLOID PRECURSOR PROTEIN SECRETASES to produce peptides of varying amino acid lengths. A 39-42 amino acid Peptides, AMYLOID BETA-PEPTIDES is a principal component of the extracellular amyloid in SENILE PLAQUES.. Alzheimer's disease defined as following: Alzheimer's disease caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65..", "label": "yes"} {"original_question": "Do MAIT cells have a role in multiple myeloma?", "id": "converted_3501", "sentence1": "Do MAIT cells have a role in Multiple Myeloma?", "sentence2": "hus, MAIT cells are reduced in millimeter patients, which may contribute to Disease in these individuals, and moreover, MAIT cells may represent new immunotherapeutic targets for treatment of millimeter and other Malignant Neoplasms., Here we have analysed the frequency and function of MAIT cells in Multiple Myeloma (millimeter) patients. We show that Mucosal-Associated Invariant T-Cell frequency in blood is reduced compared to healthy adult donors, but comparable to elderly healthy control donors, Newly diagnosed millimeter patient MAIT cells had reduced gamma-interferon production and CD27 wt Allele wt Allele expression, suggesting an exhausted phenotype, although gamma-interferon-producing capacity is restored in relapsed/refractory patient samples. , We describe recent observations with regard to functional exhaustion of iNKT and MAIT cells in millimeter pathology and discuss the potential application of checkpoint inhibition as an attractive target for prolonged activation of these immunomodulatory T cells in the treatment of millimeter., Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed Multiple Myeloma., Thus, MAIT cells are reduced in millimeter patients, which may contribute to Disease in these individuals, and moreover, MAIT cells may represent new immunotherapeutic targets for treatment of millimeter and other Malignant Neoplasms.[SEP]Relations: Multiple myeloma has relations: disease_phenotype_positive with plasma cell myeloma, disease_phenotype_positive with plasma cell myeloma, drug_effect with Bortezomib, drug_effect with Bortezomib, drug_effect with Muromonab, drug_effect with Muromonab, drug_effect with Lenalidomide, drug_effect with Lenalidomide, drug_effect with Zoledronic acid, drug_effect with Zoledronic acid. Definitions: CD27 wt Allele defined as following: Human CD27 wt Allele wild-type allele is located in the vicinity of 12p13 and is approximately 7 kb in length. This allele, which encodes CD27 wt Allele antigen protein, plays a role in regulating B-cell activation and immunoglobulin synthesis.. Multiple Myeloma defined as following: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.. millimeter defined as following: A unit of concentration (molarity unit) equal to one thousandth of a mole (10E-3 mole) of solute per one liter of solution.. Mucosal-Associated Invariant T-Cell defined as following: A T-cell subtype bearing a semi-invariant T-cell receptor and restricted by the major histocompatibility complex related molecule MR1. These cells occupy peripheral tissues and are noted for their reactivity against various microorganisms of either bacterial or fungal origin.. gamma-interferon defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous lymphokine interferon gamma (IFN-gamma) with antineoplastic, immunoregulatory, and antiviral activities. Therapeutic IFN-gamma binds to and activates the cell-surface IFN-gamma receptor, stimulating antibody-dependent cytotoxicity and enhances natural killer cell attachment to tumor cells. This agent also activates caspases, thereby inducing apoptosis in malignant cells. (NCI04). Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas..", "label": "yes"} {"original_question": "Is GAGA associated with nucleosome-free regions (NFR)?", "id": "converted_137", "sentence1": "Is Gaga associated with nucleosome location-free regions (NFR)?", "sentence2": "One of the three nuclease hypersensitive sites in the Fab-7 boundary, EEF1A2 wt Allele, contains multiple consensus-binding sequences for the Gaga factor, a Protein Info known to be involved in the formation and/or maintenance of nucleosome location location-free regions of chromatin location location., The SPHEROCYTOSIS, TYPE 3 (disorder) Sequence - ParameterizedDataType contains consensus Binding Sites for the Gaga factor, a Protein Info implicated in the formation of nucleosome location location-free regions of chromatin location location, and Pleiohomeotic (Osteoarthropathy, Primary Hypertrophic), a Polycomb-Group Proteins that is related to the Mammals TRANSCRIPTION FACTOR YY1 gene gene., The interactions of Gaga factor and heat shock factor with their Binding Sites in chromatin location location occurred in two modes. Their interaction with Binding Sites in the nucleosome location location-free regions did not require adenosine triphosphate. In the presence of adenosine triphosphate both factors interacted also with nucleosomal Binding Sites, causing nucleosome location location rearrangements and a refinement of nucleosome location location positions, While chromatin location location remodeling upon TRANSCRIPTION FACTOR interaction has previously been interpreted to involve nucleosome location location disruption, the data suggest energy-dependent nucleosome location location sliding as main principle of chromatin location location reorganization., These (CT)n repeats are associated with a nonhistone Protein Info(s) in vivo and are bound by a purified Drosophila Protein Info, the Gaga factor, in vitro., This (CT)n element appears to contribute to formation of the wild-type chromatin location location structure of hsp26, an organized nucleosome location location array that Plant Leaves the HSEs in nucleosome location location-free, DNase I-hypersensitive (DERMATITIS HERPETIFORMIS, FAMILIAL) site, The SPHEROCYTOSIS, TYPE 3 (disorder) Sequence - ParameterizedDataType contains consensus Binding Sites for the Gaga factor, a Protein Info implicated in the formation of nucleosome location location-free regions of chromatin location location, and Pleiohomeotic (Osteoarthropathy, Primary Hypertrophic), a Polycomb-Group Proteins that is related to the Mammals TRANSCRIPTION FACTOR YY1 gene gene., One of the three nuclease hypersensitive sites in the Fab-7 boundary, EEF1A2 wt Allele, contains multiple consensus-binding sequences for the Gaga factor, a Protein Info known to be involved in the formation and/or maintenance of nucleosome location location-free regions of chromatin location location., The iab-7 polycomb response element maps to a nucleosome location location-free region of chromatin location location and requires both Gaga and pleiohomeotic for silencing activity., The SPHEROCYTOSIS, TYPE 3 (disorder) Sequence - ParameterizedDataType contains consensus Binding Sites for the Gaga factor, a Protein Info implicated in the formation of nucleosome location location-free regions of chromatin location location, and Pleiohomeotic (Osteoarthropathy, Primary Hypertrophic), a Polycomb-Group Proteins that is related to the Mammals TRANSCRIPTION FACTOR YY1 gene gene. [SEP]Relations: nucleosome location mobilization has relations: bioprocess_protein with POLE3, bioprocess_protein with POLE3, bioprocess_bioprocess with nucleosome location organization, bioprocess_bioprocess with nucleosome location organization, bioprocess_protein with INO80, bioprocess_protein with INO80, bioprocess_protein with ARID1A, bioprocess_protein with ARID1A, bioprocess_protein with BPTF, bioprocess_protein with BPTF. Definitions: Plant Leaves defined as following: Expanded structures, usually green, of vascular plants, characteristically consisting of a bladelike expansion attached to a stem, and functioning as the principal organ of photosynthesis and transpiration. (American Heritage Dictionary, 2d ed). Osteoarthropathy, Primary Hypertrophic defined as following: A condition chiefly characterized by thickening of the skin of the head and distal extremities, deep folds and furrows of the skin of the forehead, cheeks, and scalp, SEBORRHEA; HYPERHIDROSIS; periostosis of the long bones, digital clubbing, and spadelike enlargement of the hands and feet. It is more prevalent in the male, and is usually first evident during adolescence. Inheritance is primarily autosomal recessive, but an autosomal dominant form exists.. Binding Sites defined as following: The parts of a macromolecule that directly participate in its specific combination with another molecule.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. Polycomb-Group Proteins defined as following: A family of proteins that play a role in CHROMATIN REMODELING. They are best known for silencing HOX GENES and the regulation of EPIGENETIC PROCESSES.. YY1 gene defined as following: This gene is involved in the negative regulation of transcription.. EEF1A2 wt Allele defined as following: Human EEF1A2 wild-type allele is located in the vicinity of 20q13.3 and is approximately 11 kb in length. This allele, which encodes elongation factor 1-alpha 2 Protein Info, is involved in the promotion of Protein Info elongation. The gene is expressed aberrantly at elevated levels in many ovarian cancers.. nucleosome location defined as following: A complex comprised of DNA wound around a multisubunit core and associated proteins, which forms the primary packing unit of DNA into higher order structures. [GOC:elh]. adenosine triphosphate defined as following: An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. chromatin location defined as following: The ordered and organized complex of DNA, Protein Info, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130]. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.. NFR defined as following: The quotient of the number of particular entities (constituents) and the number of all constituents in the system..", "label": "yes"} {"original_question": "Can we use platelet biomarkers to study Alzheimer's disease?", "id": "converted_1551", "sentence1": "Can we use platelet biomarkers to study ALZHEIMER DISEASE, FAMILIAL, 1?", "sentence2": "Platelet biomarkers in ALZHEIMER DISEASE, FAMILIAL, 1., Blood Platelets are the most important source of circulating forms of the Serum Amyloid A-1 Protein, Human and other important Proteins such as uridine triacetate and Hepatic Hepatic glycogen synthase kinase-3B., Alternative plasma and platelet measures are described,, The success of these studies led to the application of platelet proteomics to the study of several pathologies where Blood Platelets play a fundamental role. Those include platelet-related disorders, such as storage pool disease, gray platelet syndrome, and Quebec platelet disorder; diseases where unwanted platelet activation is highly relevant, such as Thrombosis and Cardiovascular Diseases; and other diseases, such as cystic fibrosis, increased blood npn, or ALZHEIMER DISEASE, FAMILIAL, 1. [SEP]Relations: blood platelet disease has relations: disease_disease with disease by cell type, disease_disease with disease by cell type, disease_disease with hematologic disease, disease_disease with hematologic disease, disease_disease with thrombocytopenia, disease_disease with thrombocytopenia, disease_disease with qualitative platelet defect, disease_disease with qualitative platelet defect, disease_disease with inherited bleeding disorder, platelet-type, disease_disease with inherited bleeding disorder, platelet-type. Definitions: Blood Platelets defined as following: Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. uridine triacetate defined as following: A synthetic uridine pro-drug that is converted to uridine in vivo. Uridine, a pyrimidine nucleotide, has been used in a variety of diseases including depressive disorders and inherited myopathies. (NCI04). Thrombosis defined as following: Formation and development of a thrombus or blood clot in the blood vessel.. increased blood npn defined as following: A laboratory test result indicating abnormally high concentration of non-protein nitrogen in the blood.. Cardiovascular Diseases defined as following: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.. Serum Amyloid A-1 Protein, Human defined as following: Serum amyloid A-1 protein (122 aa, ~14 kDa) is encoded by the human SAA1 gene. This protein plays a role in heparin binding and acute phase inflammatory responses.. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65..", "label": "yes"} {"original_question": "Is Kummell’s disease an avascular necrosis of the vertebral body?", "id": "converted_2357", "sentence1": "Is Kummell’s disease an avascular necrosis of the vertebral body?", "sentence2": " Traumatic spondylopathy is an avascular necrosis of the vertebral body, secondary to a Compression fracture of vertebral column. This entity is characterised by the gradual development in time of a vertebral body collapse following a trivial spinal Trauma, nursing specialty, involving a worsening back pain associated with a progressive Kyphosis deformity of spine., Traumatic spondylopathy is a rare spinal disorder characterized as avascular necrosis of a vertebral body occurring in a delayed fashion after minor Trauma, nursing specialty., Traumatic spondylopathy is a spinal disorder characterized by delayed post-traumatic collapse of a vertebral body with avascular necrosis., Kummell disease, or avascular necrosis of a vertebral body, presents as vertebral Bone necrosis typically affecting a Bone structure of Bone structure of thoracic vertebra with compression deformity, intravertebral vacuum cleft, and exaggerated Kyphosis deformity of spine weeks to months after a minor Wounds and Injuries., INTRODUCTION Traumatic spondylopathy is an avascular necrosis of the vertebral body, secondary to a Compression fracture of vertebral column., Kummel disease is the eponym for avascular necrosis of the vertebral body after a Compression fracture of vertebral column., kummell s disease delayed post traumatic Bone necrosis of the vertebral body, Traumatic spondylopathy, caused by Bone necrosis of the vertebral body, is a cause of vertebral collapse., Traumatic spondylopathy is a post-traumatic vertebral body collapse, Traumatic spondylopathy is a rare, delayed posttraumatic collapse of a vertebral body that can occur several months or even years after an osteoporotic compression fracture. , Avascular necrosis of a vertebral body, a relatively uncommon entity, is caused by Primary malignant neoplasm, Communicable Diseases, radiation, systemic Steroids treatment, Trauma, nursing specialty, and the like.1 Vertebral Bone necrosis induced by Trauma, nursing specialty is called Kvmell's disease[SEP]Relations: Vertebral compression fractures has relations: disease_phenotype_positive with Cushing disease due to pituitary adenoma, disease_phenotype_positive with Cushing disease due to pituitary adenoma, disease_phenotype_positive with multicentric osteolysis, nodulosis, and arthropathy, disease_phenotype_positive with multicentric osteolysis, nodulosis, and arthropathy, disease_phenotype_positive with Gaucher disease, disease_phenotype_positive with Gaucher disease, disease_phenotype_positive with osteogenesis imperfecta, disease_phenotype_positive with osteogenesis imperfecta, disease_phenotype_positive with geroderma osteodysplastica, disease_phenotype_positive with geroderma osteodysplastica. Definitions: Trauma, nursing specialty defined as following: Nurses in this specialty provide emergency care to patients of all ages. These nurses work to maintain vital signs and prevent complications and death. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.. Bone necrosis defined as following: Death of a bone or part of a bone, either atraumatic or posttraumatic.. Steroids defined as following: A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed). Wounds and Injuries defined as following: Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.. Bone structure of thoracic vertebra defined as following: A group of twelve VERTEBRAE connected to the ribs that support the upper trunk region.. Kyphosis deformity of spine defined as following: Deformities of the SPINE characterized by an exaggerated convexity of the vertebral column. The forward bending of the thoracic region usually is more than 40 degrees. This deformity sometimes is called round back or hunchback..", "label": "yes"} {"original_question": "Is there any association of the chromosomal region harboring the gene ITIH3 with schizophrenia?", "id": "converted_1223", "sentence1": "Is there any association of the chromosomal region harboring the gene ITIH3 gene with SCHIZOPHRENIA 2 (disorder)?", "sentence2": "The most widely shared subset of genes-common to five of six disorders-included ANK3 gene gene, AS3MT gene gene, CACNA1C gene gene, CACNB2 gene gene, CNNM2 gene gene, CSMD1 protein, human protein, human, MUCL3 gene, ITIH3 gene gene, NT5C2 gene gene, PPP1R11 gene gene, SYNE1 gene gene, TCF7L2 protein, human, TENM4 gene gene, TRIM26 gene gene, and POLR1H gene. , Genome-wide significant associations in SCHIZOPHRENIA 2 (disorder) to ITIH3 gene gene/4, CACNA1C gene gene and SDCCAG8 gene gene, and extensive replication of associations reported by the Schizophrenia PGC gene gene., After combining the new SCHIZOPHRENIA 2 (disorder) data with those of the PGC gene gene, Variant at three loci (ITIH3 gene gene/4, CACNA1C gene gene and SDCCAG8 gene gene) that had not previously been GWS in SCHIZOPHRENIA 2 (disorder) attained that level of support., In a joint analysis with a Bipolar Disorder Type 2 sample (16,374 affected individuals and 14,044 controls), three loci reached genome-wide significance: CACNA1C gene gene (rs4765905, P = 7.0 × 10(-9)), ANK3 gene gene (rs10994359, P = 2.5 × 10(-8)) and the ITIH3 gene gene-ITIH4 region (rs2239547, P = 7.8 × 10(-9))., Finally, a combined GWAS analysis of SCHIZOPHRENIA 2 (disorder) and Bipolar Disorder Type 2 yielded strong association evidence for SNPs in CACNA1C gene gene and in the region of NEK4-ITIH1-ITIH3 gene gene-ITIH4. , A recent genome-wide analysis indicated that a Genetic Polymorphism (rs2535629) of ITIH3 gene gene showed the strongest association signal with susceptibility to psychiatric disorders in Caucasian populations., We detected a novel association between suicide attempt and the ITIH3 gene gene/4-region in a combined group of patients with Behcet Syndrome, SCZ and related psychosis spectrum disorders. , These include variations in Chromosome Structures at 16p11.2, rare de novo point mutations at the SCN2A gene, and common Single Nucleotide Polymorphism (SNPs) mapping near loci encoding the genes ITIH3 gene gene, AS3MT gene gene, CACNA1C gene gene and CACNB2 gene gene. These selected examples point to the challenges to current diagnostic approaches. , Stabilin-1 is located in close proximity to PBMR1 and the NEK4-ITIH1-ITIH3 gene gene-ITIH4 region, which are the top findings from GWAS meta-analyses of Mood Disorders, and a combined Behcet Syndrome and SCHIZOPHRENIA 2 (disorder) data set., Our findings suggest that rs2535629 influences the susceptibility to psychiatric disorders by affecting the expression level of GLT8D1 gene gene.[SEP]Relations: Bipolar Disorder Type 2 has relations: disease_protein with ITIH3 gene, disease_protein with ITIH3 gene, disease_protein with ITIH4, disease_protein with ITIH4. SDCCAG8 gene has relations: disease_protein with SCHIZOPHRENIA 2 (disorder), disease_protein with SCHIZOPHRENIA 2 (disorder). CACNA1C gene has relations: disease_protein with SCHIZOPHRENIA 2 (disorder), disease_protein with SCHIZOPHRENIA 2 (disorder). TENM4 gene has relations: disease_protein with SCHIZOPHRENIA 2 (disorder), disease_protein with SCHIZOPHRENIA 2 (disorder). Definitions: Chromosome Structures defined as following: Structures which are contained in or part of CHROMOSOMES.. SCN2A gene defined as following: This gene is involved in neuronal excitation.. Stabilin-1 defined as following: Stabilin-1 (2570 aa, ~275 kDa) is encoded by the human Stabilin-1 gene. This protein is involved in signal transduction mediated by acetylated low density lipoprotein binding.. NT5C2 gene defined as following: This gene plays a role in purine metabolism.. CSMD1 protein, human defined as following: CUB and sushi domain-containing protein 1 (3565 aa, ~389 kDa) is encoded by the human CSMD1 protein, human gene. This protein may play a role in the activation of complement.. Mood Disorders defined as following: Those disorders that have a disturbance in mood as their predominant feature.. TCF7L2 protein, human defined as following: Transcription factor 7-like 2 (619 aa, ~68 kDa) is encoded by the human TCF7L2 gene. This protein is involved in the positive regulation of transcription, cell cycle arrest, apoptosis regulation, cell and tissue differentiation and signal transduction.. Single Nucleotide Polymorphism defined as following: A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.. SYNE1 gene defined as following: This gene plays a role in subcellular spatial organization.. Variant defined as following: An alteration or difference from a norm or standard.. Behcet Syndrome defined as following: Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.. Genetic Polymorphism defined as following: The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.. chromosomal region defined as following: Any subdivision of a chromosome along its length. [GOC:dos].", "label": "yes"} {"original_question": "Are pseudogenes enriched with housekeeping protein families?", "id": "converted_1604", "sentence1": "Are Pseudogenes enriched with housekeeping protein families?", "sentence2": "housekeeping families tend to be enriched with a large number of Pseudogenes[SEP]Definitions: Pseudogenes defined as following: Genes bearing close resemblance to known genes at different loci, but rendered non-functional by additions or deletions in structure that prevent normal transcription or translation. When lacking introns and containing a poly-A segment near the downstream end (as a result of reverse copying from processed nuclear RNA into double-stranded DNA), they are called processed genes..", "label": "yes"} {"original_question": "Does TUC.338 inhibit colorectal cancer?", "id": "converted_2259", "sentence1": "Does PCBP2-OT1 gene inhibit Malignant neoplasm of colon and/or rectum?", "sentence2": "PCBP2-OT1 gene promotes invasion and metastasis in Malignant neoplasm of colon and/or rectum., Until now, the role of PCBP2-OT1 gene in Colorectal Carcinoma remains undefined. This study revealed that PCBP2-OT1 gene is significantly up-regulated in Colorectal Carcinoma (Cytogenetic Complete Response) Tissue Specimen Code and Cytogenetic Complete Response cell lines, and the up-regulated PCBP2-OT1 gene is associated with lymph node metastasis., Thus, these findings suggested that PCBP2-OT1 gene acts as a novel Oncogenes by targeting the TIMP-1 gene thus promoting Malignant neoplasm of colon and/or rectum cell migration and invasion., Thus, these findings suggested that PCBP2-OT1 gene acts as a novel Oncogenes by targeting the TIMP-1 gene thus promoting Malignant neoplasm of colon and/or rectum cell migration and invasion., This study revealed that PCBP2-OT1 gene is significantly up-regulated in Colorectal Carcinoma (Cytogenetic Complete Response) Tissue Specimen Code and Cytogenetic Complete Response cell lines, and the up-regulated PCBP2-OT1 gene is associated with lymph node metastasis., PCBP2-OT1 gene promotes invasion and metastasis in Malignant neoplasm of colon and/or rectum.[SEP]Relations: colorectal carcinoma has relations: disease_protein with UNC13B, disease_protein with UNC13B, disease_protein with WAC, disease_protein with WAC, disease_protein with MIR1273C, disease_protein with MIR1273C, disease_protein with CXCL8, disease_protein with CXCL8, disease_protein with TFEC, disease_protein with TFEC. Definitions: Cytogenetic Complete Response defined as following: The disappearance of all signs of cancer, including the absence of a detectable disease-related genetic abnormality, as determined by techniques such as karyotyping or FISH, in response to treatment.. Colorectal Carcinoma defined as following: A malignant epithelial neoplasm that arises from the colon or rectum and invades through the muscularis mucosa into the submucosa. The vast majority are adenocarcinomas.. Oncogenes defined as following: Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of \"v-\" before Oncogenes symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix \"c-\" before the gene symbol of an Oncogenes indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-Oncogenes..", "label": "no"} {"original_question": "Is Turcot syndrome associated with glioblastoma?", "id": "converted_1640", "sentence1": "Is Turcot syndrome (disorder) associated with glioblastoma?", "sentence2": "Turcot syndrome (disorder) (disorder) is an Autosomal Recessive Disorder clinically characterized by the occurrence of Primary Neoplasm of the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS and Adenomatous polyp of Abdomen+Pelvis>Colon during the first or second decades of life, with a spectrum of clinical features such as \"café-au-lait\" spots, axillary freckling, and hyperpigmented spots. , We present the case of a 20-year-old male with a clinical presentation of both Glioblastoma Multiforme and multiple Adenomatous polyp of Abdomen+Pelvis>Colon. , Turcot syndrome (disorder) (disorder) (TS) is a rare Hereditary Diseases clinically characterized by the occurrence of Primary Neoplasm of the Abdomen+Pelvis>Colon and the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS (Central Nervous System). Here we present the case of an 11-year-old boy with a synchronous clinical presentation of both Glioblastoma Multiforme (Glomerular Basement Membrane) and Adenocarcinoma of Abdomen+Pelvis>Colon., Based on this case study, the synchronous presentation of Glioblastoma Multiforme and adenocarcinoma of the Abdomen+Pelvis>Colon might suggest a shorter survival rate for patients with Turcot syndrome (disorder) (disorder). , A 15-year-old boy was admitted with the diagnosis of colonic Multiple polyps, and during a 2-year follow-up, he underwent operation for right parieto-occipital anaplastic Astrocytoma, left-side colonic non-Hodgkin Lymphoma (Lymphoma, Large-Cell, Follicular) and Cerebellar Glioblastoma which were all confirmed by histology. Although cases of Turcot's syndrome (TS) (colonic Multiple polyps and primary brain tumour occurring in the same patient) have been previously described, association with Hematologic Neoplasms is rare. We hereby report such a case with TS., Type A microsatellite instability diagnostic test diagnostic test in pediatric Glioma as an indicator of Turcot syndrome (disorder) (disorder)., Biallelic Gene Mutation of MMR genes are associated with pediatric cancers, including glial tumors, in Turcot syndrome (disorder) (disorder) type 1 (Timothy syndrome type 1)., Glioblastoma with giant cell and sarcomatous features in patients with Turcot syndrome (disorder) (disorder) type 1: a clinicopathological study of 3 cases., Turcot syndrome (disorder) (disorder) (TS) is a rare genetic disorder of DNA mismatch repair predisposing to glioblastoma (Glomerular Basement Membrane) in the type 1 variant. , We report the clinicopathological and genetic features of 3 Glioma in TS type 1 patients., We conclude that 1) the giant cell variant of Glomerular Basement Membrane is overrepresented in TS; 2) gliosarcoma may also be encountered; and 3) survival is often favorable, despite histological anaplasia and exuberant proliferation., Malignant transformation of Anaplastic Astrocytoma associated with Neurocysticercosis in a patient with Turcot syndrome (disorder) (disorder)., A 45-year-old woman with anaplastic Astrocytoma was clinically diagnosed with Turcot syndrome (disorder) (disorder), and subsequently developed simultaneous Neurocysticercosis and malignant transformation to glioblastoma. , Familial Glioblastoma Multiforme is a rather uncommon entity, being in most cases associated to known genetic disorders (as Turcot syndrome (disorder) (disorder), Li-Fraumeni Syndrome 2, Neurofibromatosis 2, etc.). , Turcot syndrome (disorder) (disorder) (MIM276300) has been described as the association of CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS malignant tumors and familial colorectal Primary malignant neoplasm and has been reported to be both a dominant and recessive disorder., We report here the first identification of a homozygous Mutation Abnormality in MSH6 protein, human protein, human in a family with childhood-onset brain Specimen Source Codes - Specimen Source Codes - tumor, Lymphoma, colorectal Primary malignant neoplasm, and Neurofibromatosis 2 type 1 phenotype. , Of the 21 patients, 12 have died (10 after relapse, with a median time to progression for the whole series of 14 months; one with intratumoral bleeding at 40 months after diagnosis; and one affected by Turcot syndrome (disorder) (disorder) for duodenal Primary malignant neoplasm relapse)., [Glioblastoma multiforme as a manifestation of Turcot syndrome (disorder) (disorder)]., In the present case, a 60-year-old patient with Glioblastoma Multiforme and a history of hereditary malignomas is described as an example of a HNPCC-associated Turcot's syndrome., Computed tomography brain scan and computed tomography-guided biopsy revealed a left frontoparietal Glioblastoma Multiforme. This case illustrates the rare presentation of Turcot syndrome (disorder) (disorder)-a hereditary Polyp of large intestine syndrome-in an older adult., Turcot syndrome (disorder) (disorder) is the association of Polyp of large intestine with primary Neoplasms, Neuroepithelial of the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS such as glioblastoma and Medulloblastoma. , Brain Neoplasms is mainly diagnosed as glioblastoma or Astrocytoma and mismatch repair genes might be involved. , Patients with Turcot syndrome (disorder) (disorder) (TS) are predisposed to Abdomen+Pelvis>Colon tumors and primary brain tumors, typically glioblastomas or medulloblastomas. The authors describe a patient with TS featuring a known germline Mutation Abnormality of exon 5 of the hPMS2 mismatch repair gene who developed two metachronous glioblastomas, both with distinct Oligodendroglia features., Because this patient had an unusual underlying condition and his Specimen Source Codes - Specimen Source Codes - tumor had a unique histological appearance for TS, it was hypothesized that this genetic defect may predispose to malignant Glioma with Oligodendroglia features. , Turcot Syndrome caused by Antigen-Presenting Cells gene develops Medulloblastoma and Turcot Syndrome caused by mismatch repair gene develops glioblastoma. , It is characterized by CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS (Central Nervous System) Neoplasms and gastrointestinal Multiple polyps., Seven months after resection of this Dukes' C2 adenocarcinoma, she presented with a second primary Central Nervous System Specimen Source Codes - Specimen Source Codes - tumor, a Glioblastoma Multiforme., The Turcot syndrome (disorder) (disorder) has been defined as the simultaneous presence of multiple Multiple polyps of the Abdomen+Pelvis>Colon and a Malignant neoplasm of brain., The case of a 47-year-old Homo sapiens submitted to a right hemicolectomy for Primary malignant neoplasm and Multiple polyps, following a series of endoscopic polypectomies and, finally, removal of left temporal glioma is here presented., Two of 13 showed microsatellite instability diagnostic test diagnostic test, one of which in a patient with Turcot syndrome (disorder) (disorder), the other in Gliomatosis cerebri cerebri., The Turcot syndrome (disorder) (disorder) (TS) is a rare, probably autosomal recessive, disorder characterized by development of primary Neoplasms, Neuroepithelial of the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS (Central Nervous System) and numerous adenomatous colorectal polyps. , However, no somatic Gene Mutation in Antigen-Presenting Cells were found among 91 Neoplasms, Neuroepithelial (Medulloblastoma, glioblastoma, Astrocytoma, and Well Differentiated Oligodendroglioma), whether sporadic or associated with TS. , Such syndromes include Neurofibromatosis 2 type 2, Neurofibromatosis 2 type 1, Li-Fraumeni Syndrome 2, as well as Von Hippel-Lindau Syndrome, TUBEROUS SCLEROSIS 2 (disorder), and Turcot syndrome (disorder) (disorder). , This patient's case deals with the association between a glioblastoma, WHO Grade 3 Glioma (WHO Grade III) and Adenocarcinoma of Abdomen+Pelvis>Colon based on familial Multiple polyps coli. , The authors describe two patients with the association of Multiple polyps-coli and CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS Specimen Source Codes - Specimen Source Codes - tumor (Turcot's syndrome). , We report a case of Turcot's syndrome in a 20-year old Homo sapiens with multiple adenomatous polyps of the Abdomen+Pelvis>Colon and Glioblastoma Multiforme. , Another unusual autopsy case of the Turcot syndrome (disorder) (disorder) is reported in a 23-year-old woman with Multiple polyps coli, who developed primary carcinoma of the Jejunum and Jejunum and jejunum and Glioblastoma Multiforme of the left frontal lobe. , Turcot syndrome (disorder) (disorder) represents the unique and discrete occurrence of Multiple polyps coli with Glioblastoma Multiforme, Medulloblastoma, or both.[SEP]Relations: Glioma has relations: disease_phenotype_positive with Turcot syndrome (disorder) with Multiple polyps, disease_phenotype_positive with Turcot syndrome (disorder) with Multiple polyps. Medulloblastoma has relations: disease_phenotype_positive with Turcot syndrome (disorder) with Multiple polyps, disease_phenotype_positive with Turcot syndrome (disorder) with Multiple polyps. Lymphoma has relations: disease_phenotype_positive with Turcot syndrome (disorder) with Multiple polyps, disease_phenotype_positive with Turcot syndrome (disorder) with Multiple polyps. Brain neoplasm has relations: disease_phenotype_positive with Turcot syndrome (disorder) with Multiple polyps, disease_phenotype_positive with Turcot syndrome (disorder) with Multiple polyps. Astrocytoma has relations: disease_phenotype_positive with Turcot syndrome (disorder) with Multiple polyps, disease_phenotype_positive with Turcot syndrome (disorder) with Multiple polyps. Definitions: Autosomal Recessive Disorder defined as following: An inherited disorder manifested only when two copies of a mutated gene are present.. Primary malignant neoplasm defined as following: A malignant Specimen Source Codes - tumor at the original site of growth.. Adenomatous polyp of Abdomen+Pelvis>Colon defined as following: A polypoid adenoma that arises from and protrudes into the lumen of the Abdomen+Pelvis>Colon. Epithelial dysplasia is always present. According to the architectural pattern it is classified as tubular, tubulovillous, or villous.. Lymphoma, Large-Cell, Follicular defined as following: Malignant Lymphoma in which the majority of neoplastic cells within the follicles are large cleaved or noncleaved cells. The degree to which the follicular center cells retain their ability to form follicles varies with the state of B-cell transformation.. Malignant neoplasm of brain defined as following: A primary or metastatic malignant neoplasm affecting the brain.. Neoplasms, Neuroepithelial defined as following: Neoplasms composed of neuroepithelial cells, which have the capacity to differentiate into NEURONS, oligodendrocytes, and ASTROCYTES. The majority of craniospinal tumors are of neuroepithelial origin. (From Dev Biol 1998 Aug 1;200(1):1-5). WHO Grade 3 Glioma defined as following: A group of malignant Glioma that includes anaplastic Astrocytoma, anaplastic Well Differentiated Oligodendroglioma, anaplastic oligoastrocytoma, and anaplastic ependymoma.. Glioblastoma defined as following: A malignant form of Astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.. Glioblastoma Multiforme defined as following: The most malignant astrocytic Specimen Source Codes - tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO). gliosarcoma defined as following: Rare mixed tumors of the brain and rarely the spinal cord which contain malignant neuroectodermal (glial) and mesenchymal components, including spindle-shaped fibrosarcoma cells. These tumors are highly aggressive and present primarily in adults as rapidly expanding mass lesions. They may arise in tissue that has been previously irradiated. (From Br J Neurosurg 1995 Apr;9(2):171-8). MSH6 protein, human defined as following: DNA mismatch repair protein Msh6 (1360 aa, ~153 kDa) is encoded by the human MSH6 protein, human gene. This protein is involved in the DNA damage response.. Von Hippel-Lindau Syndrome defined as following: An autosomal dominant disorder caused by Gene Mutation in a Specimen Source Codes - tumor suppressor gene. This syndrome is characterized by abnormal growth of small blood vessels leading to a host of Neoplasms. They include HEMANGIOBLASTOMA in the RETINA; CEREBELLUM; and SPINAL CORD; PHEOCHROMOCYTOMA; pancreatic tumors; and renal cell carcinoma (see CARCINOMA, RENAL CELL). Common clinical signs include HYPERTENSION and neurological dysfunctions.. Medulloblastoma defined as following: A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal Specimen Source Codes - tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The Specimen Source Codes - tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1). Polyp of large intestine defined as following: A polypoid lesion that arises from the Abdomen+Pelvis>Colon or rectum and protrudes into the lumen. This group includes adenomatous polyps, serrated polyps, and hamartomatous polyps.. Lymphoma defined as following: A general term for various neoplastic diseases of the lymphoid tissue.. Neurofibromatosis 2 defined as following: An autosomal dominant disorder characterized by a high incidence of bilateral acoustic neuromas as well as schwannomas (NEURILEMMOMA) of other cranial and peripheral nerves, and other benign intracranial tumors including meningiomas, ependymomas, spinal neurofibromas, and Glioma. The disease has been linked to Gene Mutation of the NF2 gene (GENES, NEUROFIBROMATOSIS 2) on chromosome 22 (22q12) and usually presents clinically in the first or second decade of life.. Anaplastic Astrocytoma defined as following: A CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS Specimen Source Codes - tumor with morphological features of anaplastic Astrocytoma in which there is insufficient information on the IDH genes status.. Glioma defined as following: Benign and malignant CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS Neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or Glioblastoma Multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21). duodenal Primary malignant neoplasm defined as following: A primary or metastatic malignant neoplasm that affects the duodenum. Representative examples include carcinoma, Lymphoma, and sarcoma.. Astrocytoma defined as following: Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082). Cerebellar Glioblastoma defined as following: A glioblastoma that occurs in the cerebellum.. Brain Neoplasms defined as following: Neoplasms of the intracranial components of the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain Neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary Neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.. Neurocysticercosis defined as following: Infection of the brain, spinal cord, or perimeningeal structures with the larval forms of the genus TAENIA (primarily T. solium in humans). Lesions formed by the organism are referred to as cysticerci. The infection may be subacute or chronic, and the severity of symptoms depends on the severity of the host immune response and the location and number of lesions. SEIZURES represent the most common clinical manifestation although focal neurologic deficits may occur. (From Joynt, Clinical Neurology, 1998, Ch27, pp46-50). Primary Neoplasm defined as following: A Specimen Source Codes - tumor at the original site of origin.. Abdomen+Pelvis>Colon tumors defined as following: Tumors or Primary malignant neoplasm of the COLON.. Adenocarcinoma of colon defined as following: An adenocarcinoma arising from the Abdomen+Pelvis>Colon. It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease. Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits. According to the degree of cellular differentiation, colonic adenocarcinomas are divided into well, moderately, and poorly differentiated. Histologic variants include mucinous adenocarcinoma, signet ring cell carcinoma, medullary carcinoma, serrated adenocarcinoma, cribriform comedo-type adenocarcinoma, and micropapillary adenocarcinoma.. Antigen-Presenting Cells defined as following: A heterogeneous group of immunocompetent cells that mediate the cellular immune response by processing and presenting antigens to the T-cells. Traditional antigen-presenting cells include MACROPHAGES; DENDRITIC CELLS; LANGERHANS CELLS; and B-LYMPHOCYTES. FOLLICULAR DENDRITIC CELLS are not traditional antigen-presenting cells, but because they hold antigen on their cell surface in the form of IMMUNE COMPLEXES for B-cell recognition they are considered so by some authors.. Antigen-Presenting Cells gene defined as following: Tumor suppressor genes located in the 5q21 region on the long arm of human chromosome 5. The Mutation Abnormality of these genes is associated with familial adenomatous Multiple polyps (ADENOMATOUS POLYPOSIS COLI) and GARDNER SYNDROME, as well as some sporadic colorectal cancers.. Turcot syndrome (disorder) defined as following: An autosomal dominant hereditary neoplastic syndrome caused by Gene Mutation in the PMS2, MLH1, MSH2, or Antigen-Presenting Cells genes. There are two types described, type 1, characterized by the presence of glioblastoma and often associated with hereditary nonpolyposis colorectal carcinoma, and type 2, characterized by the presence of Medulloblastoma and familiar adenomatous Multiple polyps.. Li-Fraumeni Syndrome 2 defined as following: An autosomal dominant Primary malignant neoplasm predisposition syndrome caused by germline Gene Mutation of the CHEK2 gene. It is associated with breast carcinoma, gastric carcinoma, colorectal carcinoma, thyroid gland carcinoma, kidney carcinoma, prostate carcinoma, and non-Hodgkin Lymphoma.. microsatellite instability diagnostic test defined as following: An assessment of the variability in length of an individual's microsatellite sequences; microsatellite length instability may be due to mismatch repair protein Mutation Abnormality.. Glomerular Basement Membrane defined as following: A sheet of amorphous extracellular material upon which the basal surfaces of epithelial cells rest and is the covering surface of a glomerular capillary, interposed between the cellular elements and the underlying connective tissue.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including Primary malignant neoplasm.. Central Nervous System defined as following: The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.. Multiple polyps defined as following: A condition characterized by the presence of numerous polyps.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Timothy syndrome type 1 defined as following: Timothy syndrome is a multi-system disorder with characteristics of cardiac, hand, facial and neurodevelopmental features that include QT prolongation, webbed fingers and toes, flattened nasal bridge, low-set ears, small upper jaw, thin upper lip, and characteristic features of autism or autistic spectrum disorders. Timothy syndrome is caused by Gene Mutation in the CACNA1C gene. It is inherited as autosomal dominant trait.. Well Differentiated Oligodendroglioma defined as following: A well-differentiated (WHO grade 2), diffusely infiltrating neuroglial Specimen Source Codes - tumor, typically located in the cerebral hemispheres. It is composed predominantly of cells which morphologically resemble oligodendroglia. The neoplastic cells have rounded homogeneous nuclei and, on paraffin sections, a swollen, clear cytoplasm ('honeycomb' appearance). (Adapted from WHO). Homo sapiens defined as following: Members of the species Homo sapiens.. Hereditary Diseases defined as following: Genetic diseases are diseases in which inherited genes predispose to increased risk. The genetic disorders associated with Primary malignant neoplasm often result from an alteration or Mutation Abnormality in a single gene. The diseases range from rare dominant Primary malignant neoplasm family syndrome to familial tendencies in which low-penetrance genes may interact with other genes or environmental factors to induce Primary malignant neoplasm. Research may involve clinical, epidemiologic, and laboratory studies of persons, families, and populations at high risk of these disorders.. Hematologic Neoplasms defined as following: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.. Oligodendroglia defined as following: A class of large neuroglial (macroglial) cells in the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS. Oligodendroglia may be called interfascicular, perivascular, or perineuronal (not the same as SATELLITE CELLS, PERINEURONAL of GANGLIA) according to their location. They form the insulating MYELIN SHEATH of axons in the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS.. Neoplasms defined as following: New abnormal growth of tissue. Malignant Neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign Neoplasms.. TUBEROUS SCLEROSIS 2 (disorder) defined as following: Tuberous sclerosis mapped to chromosome 16p13.3 (TSC2 gene).. Gliomatosis cerebri defined as following: A diffuse glial Specimen Source Codes - tumor which infiltrates the brain extensively, involving more than two lobes. It is frequently bilateral and often extends to the infratentorial structures, even to the spinal cord. It is probably of astrocytic origin, although GFAP expression may be scant or absent. (Adapted from WHO.). glioblastoma defined as following: The most malignant astrocytic Specimen Source Codes - tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO).", "label": "yes"} {"original_question": "Has ORMD-0801 been tested in patients?", "id": "converted_3710", "sentence1": "Has ORMD-0801 been tested in patients?", "sentence2": "Glucose-reducing effect of the ORMD-0801 oral Therapeutic Insulin preparation in patients with uncontrolled type 1 diabetes: a pilot study., In efforts to provide patients with a more compliable treatment method, Oramed Pharmacologic Substance tested the capacity of its oral Therapeutic Insulin capsule (ORMD-0801, 8 mg Therapeutic Insulin) in addressing this resistant clinical state.[SEP]Definitions: Therapeutic Insulin defined as following: A synthetic or animal-derived form of Therapeutic Insulin used in the treatment of diabetes mellitus. Therapeutic Therapeutic Insulin is formulated to be short-, intermediate- and long-acting in order to individualize an Therapeutic Insulin regimen according to individual differences in glucose and Therapeutic Insulin metabolism. Therapeutic Therapeutic Insulin may be derived from porcine, bovine or recombinant sources. Endogenous human Therapeutic Insulin, a pancreatic hormone composed of two polypeptide chains, is important for the normal metabolism of carbohydrates, proteins and fats and has anabolic effects on many types of tissues.. Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances..", "label": "yes"} {"original_question": "Is MIS-C or Multisystem Inflammatory syndrome in children a complication of Covid-19?", "id": "converted_3962", "sentence1": "Is MIS-C or Multisystem Inflammatory syndrome in children a complication of Covid-19?", "sentence2": "Much remains unknown about the risk factors, pathogenesis, prognosis, and specific therapy for this emerging manifestation of COVID19 (document) known as Multisystem Inflammatory Syndrome in Children (MIS-C)., Multisystem Inflammatory Syndrome in Children During the Coronavirus 2019 Pandemic: A Case Series, COVID19 (document) and Multisystem Inflammatory Syndrome in Latin American Children, This study aims to assess COVID19 (document) and Multisystem Inflammatory Syndrome (MIS-C) in Latin American children,, A complication is the rare multisystem inflammatory syndrome in children (MIS-C) associated with COVID19 (document), presenting 4-6 weeks after Communicable Diseases as high Fever symptoms (finding), organ dysfunction, and strongly elevated markers of Inflammation., We apply systems-level analyses of blood immune cells, Recombinant Cytokines, and Autoantibodies in healthy children, children with Kawasaki disease enrolled prior to COVID19 (document), children infected with SARS-CoV-2, and children presenting with MIS-C. We find that the inflammatory response in MIS-C differs from the cytokine storm of severe acute COVID19 (document), shares several features with Kawasaki disease, but also differs from this condition with respect to T-Lymphocyte Subsets, interleukin (IL)-17A, and biomarkers associated with arterial damage., OBJECTIVE: Multisystem inflammatory syndrome in children (MIS-C) associated with Coronavirus Infections disease (COVID19 (document)) is a rare and challenging diagnosis requiring early treatment., This syndrome is now known as either \"Pediatric Inflammatory Multisystem Syndrome temporally related with COVID19 (document)\" (PIMS-TS) (1), or Multisystem Inflammatory Syndrome in Children (MIS-C) (2) and is currently considered a rare post-COVID19 (document) complication which, in a minority of cases, can lead to Cessation of life., Multisystem Inflammatory Syndrome in Children (MIS-C) associated with Coronavirus Disease 2019 (COVID19 (document)) is a newly recognized condition in which children with recent COVID19 (disease) present with a constellation of symptoms including Hypotension, multiorgan involvement, and elevated inflammatory markers. Thes, Background: Kawasaki-like syndrome occurring in children during the COVID19 (document) pandemic has been labelled multisystem inflammatory syndrome in children (MIS-C) by the CDC and paediatric inflammatory multisystem syndrome temporally associated with COVID19 (disease) (PIMS-TS) by , em inflammatory syndrome in children (MIS-C), a possible complication of COVID19 (document), has been described as a hyperinflammatory condition with multiorgan involvement similar to that in Kawasaki disease or Staphylococcal Toxic effect shock syndrome in children with evidence of COVID19 (disease). This revie, BACKGROUND: A small subset of pediatric patients develop a rare syndrome associated with Coronavirus Disease 2019 (COVID19 (document)) Communicable Diseases called multisystem inflammatory syndrome in childr, adults. However, the newly described multisystem inflammatory syndrome in children (MIS-C) associated with Coronavirus Infections disease 2019 (COVID19 (document)) has been associated with Cardiac - anatomy qualifier complicat, BACKGROUND: Multisystem inflammatory syndrome temporally associated with COVID19 (document) (MIS-C) has been described as a novel and often severe presentation of COVID19 (disease) i, OBJECTIVE: Multisystem inflammatory syndrome in children (MIS-C) associated with Coronavirus Infections disease (COVID19 (document)) is a rare and challenging diagnosis requiring early tr, Background: Multisystem inflammatory syndrome in children (MIS-C), also known as pediatric inflammatory multisystem syndrome, is a new dangerous childhood disease that is temporally associated with Coronavirus Infections disease 2019 (, Recent COVID19 (document) publications describe a variety of clinical presentations including an asymptomatic state, Pneumonia, a hemophagocytic lymphohistiocytosis like syndrome, Multisystem Inflammatory Syndrome in Children (MIS-C) but, also called Pediatric Inflammatory Multisystem Syndrome-Toxic Shock (PIMS-TS), Kawasaki Disease, and Myocarditis., We analyzed peripheral blood immune responses in hospitalized SARS-CoV-2 infected pediatric patients (pediatric COVID19 (document)) and patients with MIS-C. MIS-C patients had patterns of T cell-biased lymphopenia and T cell activation similar to severely ill adults, and all patients with MIS-C had SARS-CoV-2 spike-specific antibodies at admission., Multisystem inflammatory syndrome in children (MIS-C), a possible complication of COVID19 (document), has been described as a hyperinflammatory condition with multiorgan involvement similar to that in Kawasaki disease or Staphylococcal Toxic effect shock syndrome in children with evidence of COVID19 (disease)., It includes a discussion of multisystem inflammatory syndrome in children (MIS-C) associated with COVID19 (document), as well as other aspects of the COVID19 (document) pandemic that are affecting children and families, such as Poisoning, childhood immunizations, mental health, nonaccidental trauma, and neglect., Importance: To date, no study has characterized the mucocutaneous features seen in hospitalized children with multisystem inflammatory syndrome in children (MIS-C) or the temporal association of these findings with the onset of systemic symptoms.Objective: To describe the mucocutaneous findings seen in children with MIS-C during the height of the Coronavirus Infections disease 2019 (COVID19 (document)) pandemic in New York City in 2020.Design, Setting, and Participants: A retrospective case series was conducted of 35 children admitted to 2 hospitals in New York City between April 1 and July 14, 2020, who met Centers for Disease Control and Prevention and/or epidemiologic criteria for MIS-C.Main Outcomes and Measures: Laboratory and clinical characteristics, with emphasis on mucocutaneous findings, of children who met criteria for MIS-C., This condition, since defined as the multisystem inflammatory syndrome in children (MIS-C), is assumed to be a delayed immune response to Coronavirus Infections disease 2019 (COVID19 (document)), and there are frequently Cardiac - anatomy qualifier manifestations of Ventricular Dysfunction and/or coronary artery dilation.Methods: We surveyed the inpatient MIS-C management approaches of the members of the International Kawasaki Disease Registry across 38 institutions and 11 countries.Results: Among the respondents, 56% reported using immunomodulatory treatment for all MIS-C patients, regardless of presentation., DESIGN: Children ages 0-22 years with suspected severe acute respiratory syndrome Coronavirus Infections 2 (SARS-CoV-2) Communicable Diseases presenting to urgent care clinics or being hospitalized for confirmed/suspected COVID19 (disease) or multisystem inflammatory syndrome in children (MIS-C) at Massachusetts General Hospital were offered enrollment in the Massachusetts General Hospital Pediatric COVID19 (document) Biorepository., We recently discovered a superantigen-like motif, similar to Staphylococcal enterotoxin B (enterotoxin B, staphylococcal), near the S1/S2 cleavage site of SARS-CoV-2 Spike protein, which might explain the multisystem-inflammatory syndrome (MIS-C) observed in children and cytokine storm in severe COVID19 (document) patients., METHODS: An extensive search strategy was conducted by combining the terms multisystem inflammatory syndrome in children and Coronavirus Infections Communicable Diseases or using the term multisystem inflammatory syndrome in children in bibliographic electronic databases (PubMed, EMBASE, and CINAHL) and in preprint servers (BioRxiv.org and MedRxiv.org) following the Preferred Reporting Items for Systematic Reviews and Metaanalyses guidelines to retrieve all articles published from January 1, 2020, to July 31, 2020., Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike IgG titers compared to those with severe Coronavirus Infections disease 2019 (COVID19 (document)), likely reflecting a longer time since onset of Communicable Diseases in MIS-C patients., Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike IgG titers compared to those with severe Coronavirus Infections disease 2019 (COVID19 (document)), likely reflecting a longer time since onset of Communicable Diseases in MIS-C patients., Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening post-infectious complication occurring unpredictably weeks after mild or asymptomatic SARS-CoV2 Communicable Diseases in otherwise healthy children., Data on multisystem inflammatory syndrome in children (MIS-C) related to Coronavirus Infections disease-19 (COVID19 (document)) is increasing in the current COVID19 (document) pandemic., Introduction Multisystem inflammatory syndrome in children (MIS-C) is a unique clinical complication of COVID19 (disease) observed in pediatric patients., New onset diabetes with diabetic ketoacidosis in a child with multisystem inflammatory syndrome due to COVID19 (document)., Case presentation An eight-year-old female presented with Glucose in blood specimen above reference range, Ketosis and metabolic acidosis consistent with diabetic ketoacidosis (Diabetic Ketoacidosis) in the setting of Fever symptoms (finding), Exanthema, Respiratory distress, hemodynamic instability, reduced systolic function with dilation of the left anterior descending artery, and positive SARS-CoV-2 antibodies suggestive of MIS-C., However, the newly described multisystem inflammatory syndrome in children (MIS-C) associated with Coronavirus Infections disease 2019 (COVID19 (document)) has been associated with Cardiac - anatomy qualifier complications.M, Toxic shock-like syndrome and COVID19 (document): Multisystem inflammatory syndrome in children (MIS-C)., Many of these cases feature a Toxic effect shock-like syndrome or Kawasaki-like syndrome in the setting of SARS-CoV-2 positive diagnostic testing and the CDC has termed this presentation Multisystem Inflammatory Syndrome (MIS-C)., We describe a case of MIS-C in a child who presented to our Emergency Department (ED) twice and on the second visit was found to have signs of distributive shock, multi-organ injury and systemic Inflammation associated with COVID19 (document)., PURPOSE OF REVIEW: Here we summarize current knowledge about multisystem inflammatory syndrome in children (MIS-C), a presumed postinfectious inflammatory condition that has emerged as an important COVID19 (document)-associated complication, to help clinicians identify and manage cases.RECENT FINDINGS: Clinical presentation of MIS-C is do, MIS-C is a rare yet severe and highly critical complication of COVID19 (document) Communicable Diseases in pediatrics, leading to serious and life-threatening illnesses., BACKGROUND: A multisystem inflammatory syndrome in children associated with COVID19 (document) (MIS-C) has recently been described.OBJECTIVE: To evaluate imaging findings of MIS-C associated with COVID19 (document).SUBJECTS AND METHODS: Imaging studies and medical records of sixteen patients (0-20 years) admit, BACKGROUND: Recently, cases of multisystem inflammatory syndrome in children (MIS-C) associated with COVID19 (document) have been reporte, Recent reports have described a secondary Multisystem Inflammatory Syndrome in Children (MIS-C) after a prior COVID19 (document) Communicable Diseases that often has features of Kawasaki disease (KD)., discharged home (length of hospital stay 3-20 days). There were no mortalities.CONCLUSION: MIS-C associated with COVID19 (document) is characterized predominantly by Cardiovascular Abnormalities, though also solid visceral organ, Multisection:Find:Pt:Abdomen>Gallbladder:Doc:US, and bowel abnormalities as well as Ascites, reflecting a multisystemic inflammatory process.CLINICAL IMPACT: The constellation of imaging findings in the setting of COVID19 (document) may alert pediatr, Multisystem Inflammatory Syndrome in Children Temporally Related to COVID19 (document): A Case Report From Saudi Arabia., BACKGROUND: Multisystem inflammatory syndrome temporally associated with COVID19 (document) (MIS-C) has been described as a novel and often severe presentation of COVID19 (disease) , ric patients. An association between COVID19 (document) and a Kawasaki-like inflammatory syndrome has recently presented in pediatric patients.CASE REPORT: We report a unique case of multisystem inflammatory syndrome in children presenting with characteristic findings in a child who later developed Shock, Cardiogenic requiring venoarterial extracorporeal membrane oxygenation.CONCLUSION: Recognition of these early signs and symptoms facilitates screening and risk stratification of pediatric COVID19 (document) cas, Severe Cardiac - anatomy qualifier dysfunction in a patient with multisystem inflammatory syndrome in children associated with COVID19 (document): Retrospective diagnosis of a puzzling presentation. A case report.[SEP]Relations: Portal Inflammation has relations: disease_phenotype_positive with FADD-related immunodeficiency, disease_phenotype_positive with FADD-related immunodeficiency. Respiratory distress has relations: disease_phenotype_positive with progressive supranuclear palsy-corticobasal syndrome, disease_phenotype_positive with progressive supranuclear palsy-corticobasal syndrome, disease_phenotype_positive with cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency, disease_phenotype_positive with cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency. colitis (disease) has relations: disease_protein with MIF, disease_protein with MIF. Ascites has relations: disease_phenotype_positive with fetal parvovirus syndrome, disease_phenotype_positive with fetal parvovirus syndrome. Definitions: T-Lymphocyte Subsets defined as following: A classification of T-lymphocytes, especially into helper/inducer, suppressor/effector, and cytotoxic subsets, based on structurally or functionally different populations of cells.. enterotoxin B, staphylococcal defined as following: A bacterial enterotoxin with potential immunostimulatory activity. Staphylococcal enterotoxin B (enterotoxin B, staphylococcal), a gram positive superantigen produced by Staphylococcus aureus, is a potent stimulator of T-cell activation. enterotoxin B, staphylococcal binds directly to class II major histocompatibility complex (MHC) molecules and the V beta region of the T-cell receptor (TCR), leading to an amplified T-cell response. In response to enterotoxin B, staphylococcal, both CD4+ and CD8+ cells proliferate, secrete Recombinant Cytokines and demonstrate enhanced cytotoxic activity against a broad range of antigens. Co-administration of enterotoxin B, staphylococcal with interleukin-2 (IL-2) by direct injection into tumor cells, may induce clonal T-cell expansion and potentiate apoptosis of tumor cells, resulting in decreased tumor growth.. Diabetic Ketoacidosis defined as following: A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA.. cytokine defined as following: Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner.. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. Pneumonia defined as following: Infection of the lung often accompanied by Inflammation.. Ketosis defined as following: A condition characterized by an abnormally elevated concentration of KETONE BODIES in the blood (acetonemia) or urine (acetonuria). It is a sign of DIABETES COMPLICATION, starvation, alcoholism or a mitochondrial metabolic disturbance (e.g., MAPLE SYRUP URINE DISEASE).. Coronavirus Infections defined as following: Virus diseases caused by the CORONAVIRUS genus. Some specifics include transmissible enteritis of turkeys (ENTERITIS, TRANSMISSIBLE, OF TURKEYS); FELINE INFECTIOUS PERITONITIS; and transmissible gastroenteritis of swine (GASTROENTERITIS, TRANSMISSIBLE, OF SWINE).. Autoantibodies defined as following: Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.. Exanthema defined as following: Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology.. Poisoning defined as following: A condition or physical state produced by the ingestion, injection, inhalation of or exposure to a deleterious agent.. Shock, Cardiogenic defined as following: Shock resulting from diminution of Cardiac - anatomy qualifier output in heart disease.. COVID19 (disease) defined as following: A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID19 (document) severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID19 (document) (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A Coronavirus Infections, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent.. Cardiovascular Abnormalities defined as following: Congenital, inherited, or acquired anomalies of the CARDIOVASCULAR SYSTEM, including the HEART and BLOOD VESSELS.. Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. Hypotension defined as following: Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.. Ascites defined as following: Accumulation or retention of free fluid within the peritoneal cavity.. Staphylococcal Toxic effect shock syndrome defined as following: Staphylococcal Staphylococcal Toxic effect shock syndrome (staphylococcal TSS) is an acute disease mediated by the production of superantigenic toxins, characterized by high Fever symptoms (finding), skin Exanthema followed by skin peeling, Hypotension, vomiting, diarrhea and potentially leading to multisystem organ failure and caused by a <i>Staphylococcus aureus</i> bacterial Communicable Diseases.. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.. Respiratory distress defined as following: A pathological increase in the effort and frequency of breathing movements.. Ventricular Dysfunction defined as following: A condition in which HEART VENTRICLES exhibit impaired function.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Myocarditis defined as following: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the Cardiac - anatomy qualifier muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden Cessation of life (DEATH, SUDDEN). Myocarditis in association with Cardiac - anatomy qualifier dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to Toxic effect substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies..", "label": "yes"} {"original_question": "Is pembrolizumab effective against Ewing's sarcoma?", "id": "converted_2788", "sentence1": "Is pembrolizumab effective against Ewing's sarcoma of bone?", "sentence2": "None of the 13 patients with Ewing's sarcoma of bone of bone had an objective response. , Between March 13, 2015, and Feb 18, 2016, we enrolled 86 patients, 84 of whom received pembrolizumab (42 in each disease cohort) and 80 of whom were evaluable for response (40 in each disease cohort). [SEP]Relations: Ewing sarcoma of bone has relations: disease_disease with Ewing sarcoma, disease_disease with Ewing sarcoma, disease_disease with bone sarcoma, disease_disease with bone sarcoma, disease_disease with Ewing sarcoma/peripheral primitive neuroectodermal tumor of bone, disease_disease with Ewing sarcoma/peripheral primitive neuroectodermal tumor of bone. Definitions: Ewing's sarcoma of bone defined as following: A small round cell bone tumor that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewing sarcoma/peripheral neuroectodermal tumor. It often affects the diaphysis or metaphyseal-diaphyseal portion of long bones. Clinical findings include pain and a mass in the involved area. Fever, anemia, leukocytosis, and an increased sedimentation rate are often seen. X-ray examination reveals osteolytic lesions. The prognosis depends on the stage, anatomic location, and size of the tumor..", "label": "no"} {"original_question": "Does deletion of cohesin change gene expression?", "id": "converted_3500", "sentence1": "Does Gene Deletion Abnormality of cohesins change gene expression?", "sentence2": " The conditional Gene Deletion Abnormality of cohesins from noncycling thymocytes preserved enhancer position, Histone H3 Acetyl Lys28, H4K4me1, and enhancer transcription, but weakened interactions between enhancers., Interestingly, ∼ 50% of deregulated Genes reside in the vicinity of Enhancer Elements, Genetic, suggesting that cohesins regulates gene expression through spatial clustering of Enhancer Elements, Genetic., We propose a model for cohesins-dependent gene regulation in which spatial clustering of Enhancer Elements, Genetic acts as a unified mechanism for both enhancer-promoter \"connections\" and \"insulation.\"[SEP]Relations: Abnormality of the dentition has relations: disease_phenotype_positive with chromosome 15q24 Gene Deletion Abnormality syndrome, disease_phenotype_positive with chromosome 15q24 Gene Deletion Abnormality syndrome, disease_phenotype_positive with chromosome 4q21 Gene Deletion Abnormality syndrome, disease_phenotype_positive with chromosome 4q21 Gene Deletion Abnormality syndrome, disease_phenotype_positive with chromosome 9p Gene Deletion Abnormality syndrome, disease_phenotype_positive with chromosome 9p Gene Deletion Abnormality syndrome, disease_phenotype_positive with chromosome 8q21.11 Gene Deletion Abnormality syndrome, disease_phenotype_positive with chromosome 8q21.11 Gene Deletion Abnormality syndrome, disease_phenotype_positive with 22q11.2 Gene Deletion Abnormality syndrome, disease_phenotype_positive with 22q11.2 Gene Deletion Abnormality syndrome. Definitions: Histone H3 Acetyl Lys28 defined as following: A post-translationally modified form of histone H3 where the lysine residue at position 28 is acetylated. This modification may be a marker for transcriptional enhancement.. Enhancer Elements, Genetic defined as following: Cis-acting DNA sequences which can increase transcription of Genes. Enhancers can usually function in either orientation and at various distances from a promoter.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Does αCGRP have amyloidogenic properties?", "id": "converted_4299", "sentence1": "Does αCGRP have amyloidogenic properties?", "sentence2": "αCGRP, another amyloidogenic member of the Calcitonin Gene-Related Peptide family., Therefore, in this work, we investigated the amyloidogenic profile of αCGRP, a 37-residue-long peptide hormone activity activity, utilizing both biophysical experimental techniques and Molecular Dynamics simulations. These efforts unravel a novel amyloidogenic member of the Calcitonin Gene-Related Peptide family and provide insights into the mechanism underlying the αCGRP polymerization.[SEP]Relations: neuropeptide hormone activity has relations: molfunc_protein with AVP, molfunc_protein with AVP, molfunc_protein with AGRP, molfunc_protein with AGRP, molfunc_protein with GRP, molfunc_protein with GRP, molfunc_protein with PRLH, molfunc_protein with PRLH, molfunc_protein with NPPA, molfunc_protein with NPPA. Definitions: Calcitonin Gene-Related Peptide defined as following: A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator.. peptide hormone activity defined as following: OBSOLETE. (Was not defined before being made obsolete). [GOC:ai].", "label": "yes"} {"original_question": "Does verubecestat activate BACE?", "id": "converted_2605", "sentence1": "Does verubecestat activate BACE?", "sentence2": "Verubecestat is a potent BACE1 protein, human protein, human enzyme inhibitor currently being investigated in Phase III trials for the treatment of mild-to-moderate and prodromal ALZHEIMER DISEASE, FAMILIAL, 1. [SEP]Relations: Protein S human has relations: drug_drug with Caplacizumab, drug_drug with Caplacizumab, drug_drug with Mofebutazone, drug_drug with Mofebutazone, drug_drug with Bortezomib, drug_drug with Bortezomib, drug_drug with Cefodizime, drug_drug with Cefodizime, drug_drug with Cefbuperazone, drug_drug with Cefbuperazone. Definitions: ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65.. BACE1 protein, human defined as following: Beta-secretase 1 (501 aa, ~56 kDa) is encoded by the human BACE1 protein, human gene. This protein plays a role in the proteolysis of ectodomains of membrane proteins..", "label": "no"} {"original_question": "Are Sidekick proteins members of the immunoglobulin superfamily?", "id": "converted_969", "sentence1": "Are Sidekick proteins members of the immunoglobulin superfamily?", "sentence2": "Here we show that four closely related immunoglobulin superfamily (IgSF) adhesion molecules--DSCAM gene (Down's syndrome Cell Adhesion Molecule-1), DscamL (refs 6-9), Sidekick-1 and Sidekick-2, Sidekick-1, a Cell Adhesion Molecule-1 of the immunoglobulin superfamily, is up-regulated in glomerular podocytes in the collapsing glomerulopathy of AIDS-Associated Nephropathy (HIVAN).[SEP]Relations: Cell Adhesion Molecule-1 production has relations: bioprocess_protein with GOLPH3, bioprocess_protein with GOLPH3, bioprocess_protein with GCNT1, bioprocess_protein with GCNT1, bioprocess_protein with PPIA, bioprocess_protein with PPIA, bioprocess_bioprocess with cellular process, bioprocess_bioprocess with cellular process. AIDS-Associated Nephropathy has relations: disease_disease with focal segmental glomerulosclerosis, disease_disease with focal segmental glomerulosclerosis. Definitions: AIDS-Associated Nephropathy defined as following: Renal syndrome in human immunodeficiency virus-infected patients characterized by nephrotic syndrome, severe proteinuria, focal and segmental glomerulosclerosis with distinctive tubular and interstitial changes, enlarged kidneys, and peculiar tubuloreticular structures. The syndrome is distinct from heroin-associated nephropathy as well as other forms of kidney disease seen in HIV-infected patients.. Cell Adhesion Molecule-1 defined as following: A Cell Adhesion Molecule-1 that contains extracellular immunoglobulin V and C2 domains. It mediates homophilic and heterophilic cell-cell adhesion independently of calcium, and acts as a tumor suppressor in NON-SMALL-CELL LUNG CANCER (NSCLC) cells. Its interaction with NATURAL KILLER CELLS is important for their cytotoxicity and its expression by MAST CELLS plays a role in their interaction with neurons; it may also function in synapse assembly, nerve growth and differentiation..", "label": "yes"} {"original_question": "Is TREM2 associated with Alzheimer's disease?", "id": "converted_672", "sentence1": "Is TREM2 Protein Info, human associated with ALZHEIMER DISEASE, FAMILIAL, 1?", "sentence2": "Absence of TREM2 Protein Info, human Protein Info, human Genetic Polymorphism in patients with ALZHEIMER DISEASE, FAMILIAL, 1 and Frontotemporal Lobar Degeneration, These data demonstrate that TREM2 Protein Info, human Protein Info, human coding Geographic Locations is highly conserved, implying a crucial role of this receptor. Further studies, including a functional analysis, are certainly required to clarify the role of TREM2 Protein Info, human Protein Info, human in neurodegenerative processes, Moreover, a rare TREM2 Protein Info, human Protein Info, human exon 2 Variant (p.R47H) was reported to increase the risk of ALZHEIMER DISEASE, FAMILIAL, 1 (cytarabine/daunorubicin protocol) with an odds ratio as strong as that for APOEε4, We observed an enrichment of rare variants across TREM2 Protein Info, human Protein Info, human in both cytarabine/daunorubicin protocol and Frontotemporal Presenile Presenile dementia patients compared to controls, most notably in the extracellular IgV-set Superkingdom (taxonomic category), None of the rare variants individually reached significant association, but the frequency of p.R47H was increased ~ 3-fold in both cytarabine/daunorubicin protocol and Frontotemporal Presenile Presenile dementia patients compared to controls, in line with previous reports, Our data corroborate and extend previous findings to include an increased frequency of rare heterozygous TREM2 Protein Info, human Protein Info, human variations in cytarabine/daunorubicin protocol and Frontotemporal Presenile Presenile dementia, and show that TREM2 Protein Info, human Protein Info, human variants may play a role in neurodegenerative diseases in general., non-synonymous genetic rare Variant, rs75932628-T (p.R47H), in the TREM2 Protein Info, human Protein Info, human Genes has recently been reported to be a strong genetic risk factor for ALZHEIMER DISEASE, FAMILIAL, 1 (cytarabine/daunorubicin protocol), These data strongly support the important role of p.R47H in cytarabine/daunorubicin protocol risk, and suggest that this rare genetic Variant is not related to Frontotemporal Presenile Presenile dementia., Higher levels of TREM2 Protein Info, human Protein Info, human mRNA (p = 0.002) and Protein Info (p < 0.001) were identified in cytarabine/daunorubicin protocol patients, Our results indicate that TREM2 Protein Info, human Protein Info, human might serve as a novel noninvasive biomarker for cytarabine/daunorubicin protocol diagnosis, studies have identified the rs75932628 (R47H) Variant in TREM2 Protein Info, human Protein Info, human as an ALZHEIMER DISEASE, FAMILIAL, 1 risk factor with estimated odds ratio ranging from 2.9 to 5.1, This study replicates the association between R47H and ALZHEIMER DISEASE, FAMILIAL, 1 risk in a large, population-based sample, and estimates the population frequency and attributable risk of this rare Variant, Moreover, mutation scanning of the five Exons of TREM2 Protein Info, human Protein Info, human failed to detect the presence of novel Genetic Polymorphism, A rare missense mutation (rs75932628-T) in the Genes encoding the triggering receptor expressed on Myeloid Cells 2 (TREM2 Protein Info, human Protein Info, human), which was predicted to result in an R47H Substitution - ActClass, was found to confer a significant risk of ALZHEIMER DISEASE, FAMILIAL, 1 in Iceland, We also found that carriers of rs75932628-T between the ages of 80 and 100 years without ALZHEIMER DISEASE, FAMILIAL, 1 had poorer cognitive function than noncarriers, Our findings strongly implicate Variant TREM2 Protein Info, human Protein Info, human in the pathogenesis of ALZHEIMER DISEASE, FAMILIAL, 1. Given the reported antiinflammatory role of TREM2 Protein Info, human Protein Info, human in the Head>Brain, the R47H Substitution - ActClass may lead to an increased predisposition to ALZHEIMER DISEASE, FAMILIAL, 1 through impaired containment of inflammatory processes, rs75932628-T Variant of the Genes encoding the triggering receptor expressed on Myeloid Cells 2 (TREM2 Protein Info, human Protein Info, human) has recently been identified as a rare risk factor for late-onset ALZHEIMER DISEASE, FAMILIAL, 1 (cytarabine/daunorubicin protocol), These results confirm the association between this Variant and cytarabine/daunorubicin protocol and underline its involvement in early-onset cases, recent studies have reported the association of rs75932628-T in the TREM2 Protein Info, human Protein Info, human Genes with the risk for ALZHEIMER DISEASE, FAMILIAL, 1 (cytarabine/daunorubicin protocol), Rs75932628-T is a rare nonsynonymous Variant (p.R47H) that confers a high risk of cytarabine/daunorubicin protocol with an effect size similar to that of the Apolipoprotein E ɛ4 Alleles, Here, we report the first positive replication study in a Spanish population and confirm that TREM2 Protein Info, human Protein Info, human rs75932628-T is associated with the risk for cytarabine/daunorubicin protocol, works have demonstrated a rare functional Variant (R47H) in triggering receptor expressed on Myeloid Cells (TREM) 2 Genes, encoding TREM2 Protein Info, human Protein Info, human Protein Info, increase susceptibility to late-onset ALZHEIMER DISEASE, FAMILIAL, 1 (cytarabine/daunorubicin protocol), with an odds ratio similar to that of the apolipoprotein E ε4 Alleles, The reduced function of TREM2 Protein Info, human Protein Info, human was speculated to be the main cause in the pathogenic effects of this risk Variant, and TREM2 Protein Info, human Protein Info, human is highly expressed in white matter, as well as in the hippocampus and Neocortex, which is partly consistent with the pathological features reported in cytarabine/daunorubicin protocol Head>Brain, indicating the possible involvement of TREM2 Protein Info, human Protein Info, human in cytarabine/daunorubicin protocol pathogenesis, Emerging evidence has demonstrated that TREM2 Protein Info, human Protein Info, human could suppress inflammatory response by repression of microglia-mediated cytokine production and secretion, which may prevent Inflammation-induced bystander damage of Neurons, TREM2 Protein Info, human Protein Info, human also participates in the regulation of phagocytic pathways that are responsible for the removal of neuronal debris, Based on the potential protective actions of TREM2 Protein Info, human Protein Info, human in cytarabine/daunorubicin protocol pathogenesis, targeting TREM2 Protein Info, human Protein Info, human might provide new opportunities for cytarabine/daunorubicin protocol treatment, Under the hypothesis that low-prevalence variants showing moderate-to-high effect size may be associated with risk for Seasonal Affective Disorder, two independent research groups have demonstrated that a rare Variant (rs75932628, encoding a Substitution - ActClass of arginine by histidine at residue 47 (R47H), in the TREM2 Protein Info, human Protein Info, human Genes, which encodes the triggering receptor expressed on Myeloid Cells 2) is significantly associated with an increased susceptibility to Seasonal Affective Disorder, Recently, a novel Variant in the Genes encoding the triggering receptor expressed on Myeloid Cells 2 (TREM2 Protein Info, human Protein Info, human) has been identified that has refocused the spotlight back onto Inflammation as a major contributing factor in cytarabine/daunorubicin protocol, TREM Genes cluster, a Geographic Locations recently reported to harbor rare variants that increase cytarabine/daunorubicin protocol risk, evidence suggests that rare genetic variants within the TREM2 Protein Info, human Protein Info, human Genes are associated with increased risk of ALZHEIMER DISEASE, FAMILIAL, 1, These data suggest that a mutational burden in TREM2 Protein Info, human Protein Info, human may serve as a risk factor for Neurodegenerative Disorders in general, and that potentially this class of TREM2 Protein Info, human Protein Info, human Variant carriers with Presenile Presenile dementia should be considered as having a molecularly distinct form of Neurodegenerative Disorders, The association of TREM2 Protein Info, human Protein Info, human variants with cytarabine/daunorubicin protocol brings innate immune signaling into the light, affirming innate immunity's role as a significant factor in cytarabine/daunorubicin protocol pathogenesis, The purpose of this paper is to discuss these recent developments including the potential role that TREM2 Protein Info, human Protein Info, human normally plays and how loss of function may contribute to cytarabine/daunorubicin protocol pathogenesis by enhancing oxidative stress and Inflammation within the Central Nervous System, Even though we are more at the beginning than at the end of Seasonal Affective Disorder genetics, there is some reason for optimism given the recent identification of novel risk or protective variants (such as rare TREM2 Protein Info, human Protein Info, human and APP mutations) showing strong statistical associations with Seasonal Affective Disorder[SEP]Relations: TREM2 Protein Info, human has relations: disease_protein with Alzheimer disease, disease_protein with Alzheimer disease, disease_protein with Presenile dementia (disease), disease_protein with Presenile dementia (disease), disease_protein with semantic Presenile dementia, disease_protein with semantic Presenile dementia, disease_protein with frontotemporal Presenile dementia, disease_protein with frontotemporal Presenile dementia, disease_protein with dystonia, disease_protein with dystonia. Definitions: Neocortex defined as following: The largest portion of the CEREBRAL CORTEX in which the NEURONS are arranged in six layers in the mammalian Head>Brain: molecular, external granular, external pyramidal, internal granular, internal pyramidal and multiform layers.. Variant defined as following: An alteration or difference from a norm or standard.. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. histidine defined as following: An essential amino acid that is required for the production of HISTAMINE.. Seasonal Affective Disorder defined as following: A syndrome characterized by depressions that recur annually at the same time each year, usually during the winter months. Other symptoms include anxiety, irritability, decreased energy, increased appetite (carbohydrate cravings), increased duration of sleep, and weight gain. SAD (seasonal affective disorder) can be treated by daily exposure to bright artificial lights (PHOTOTHERAPY), during the season of recurrence.. Apolipoprotein E defined as following: A class of Protein Info components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III.. Neurons defined as following: The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.. Myeloid Cells defined as following: The classes of BONE MARROW-derived blood cells in the monocytic series (MONOCYTES and their precursors) and granulocytic series (GRANULOCYTES and their precursors).. TREM2 Protein Info, human defined as following: Triggering receptor expressed on Myeloid Cells 2 (230 aa, ~25 kDa) is encoded by the human TREM2 Protein Info, human Genes. This Protein Info plays a role in macrophage and dendritic cell immune responses.. Alleles defined as following: Variant forms of the same Genes, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same Genes product.. Geographic Locations defined as following: The continents and countries situated on those continents; the UNITED STATES and each of the constituent states arranged by Geographic Locations; CANADA and each of its provinces; AUSTRALIA and each of its states; the major bodies of water and major islands on both hemispheres; and selected major cities.. Protein Info defined as following: Protein; provides access to the encoding Genes via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP Genes, encoding amyloid-beta A4 Protein Info. The onset of this condition typically occurs before age 65.. arginine defined as following: An essential amino acid that is physiologically active in the L-form.. Frontotemporal Presenile dementia defined as following: The most common clinical form of FRONTOTEMPORAL LOBAR DEGENERATION, this Presenile dementia presents with personality and behavioral changes often associated with disinhibition, apathy, and lack of insight.. Superkingdom (taxonomic category) defined as following: A taxonomic category above that of Kingdom.. Neurodegenerative Disorders defined as following: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.. Genetic Polymorphism defined as following: The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.. TREM2 Protein Info, human Genes defined as following: This Genes plays a role in the activation of immune responses.. Presenile dementia defined as following: The presence of Presenile dementia in an individual younger than age sixty five.. Central Nervous System defined as following: The main information-processing organs of the nervous system, consisting of the Head>Brain, spinal cord, and meninges.. Exons defined as following: The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Substitution - ActClass defined as following:

Definition: Indicates that the subject Act has undergone or should undergo Substitution - ActClass of a type indicated by Act.code.

Rationale: Used to specify \"allowed\" Substitution - ActClass when creating orders, \"actual\" susbstitution when sending events, as well as the reason for the Substitution - ActClass and who was responsible for it.

.", "label": "yes"} {"original_question": "Is CD84 genetically associated with arthritis?", "id": "converted_167", "sentence1": "Is CD84 genetically associated with arthritis?", "sentence2": "The Single Nucleotide Polymorphism is predicted to disrupt transcription factor binding site motifs in the 3' Untranslated Regions of an immune-related gene, CD84, and the Alleles associated with better response to etanercept was associated with higher CD84 gene expression in Peripheral blood mononuclear cell (cell) (P = 1 × 10(-11) in 228 non-Rheumatoid Arthritis patients and P = 0.004 in 132 Rheumatoid Arthritis patients), Our study demonstrates that an Alleles associated with response to etanercept therapy is also associated with CD84 gene expression, and further that CD84 expression correlates with disease activity, Three members of this gene family, SLAMF6 wt Allele, LY9 protein, Homo sapiens, and CD84, exhibit Genetic Polymorphism that strongly influence susceptibility to systemic autoimmunity, notably in CASP14 gene, but also in some Homo sapiens populations[SEP]Relations: Rheumatoid arthritis has relations: disease_phenotype_positive with IgG4-related retroperitoneal fibrosis, disease_phenotype_positive with IgG4-related retroperitoneal fibrosis, disease_phenotype_positive with hereditary xanthinuria, disease_phenotype_positive with hereditary xanthinuria, phenotype_phenotype with Arthritis, phenotype_phenotype with Arthritis, drug_effect with Interferon alfa-2b, drug_effect with Interferon alfa-2b, disease_phenotype_positive with achalasia (disease), disease_phenotype_positive with achalasia (disease). Definitions: Peripheral blood mononuclear cell (cell) defined as following: A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.. SLAMF6 wt Allele defined as following: Human SLAMF6 wild-type Alleles is located in the vicinity of 1q23.2 and is approximately 38 kb in length. This Alleles, which encodes SLAM family member 6 protein, plays a role as a coreceptor in natural killer cell activation.. LY9 protein, Homo sapiens defined as following: T-lymphocyte surface antigen Ly-9 (655 aa, ~72 kDa) is encoded by the Homo sapiens LY9 gene. This protein is involved in the positive regulation of helper T-cell Th17 differentiation.. Alleles defined as following: Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product.. Homo sapiens defined as following: Members of the species Homo sapiens.. Rheumatoid Arthritis defined as following: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.. 3' Untranslated Regions defined as following: The sequence at the 3' end of messenger RNA that does not code for product. This region contains transcription and translation regulating sequences.. Genetic Polymorphism defined as following: The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.. Single Nucleotide Polymorphism defined as following: A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.. etanercept defined as following: A recombinant version of soluble Homo sapiens TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS.. arthritis defined as following: Acute or chronic inflammation of JOINTS..", "label": "yes"} {"original_question": "Is there any software for automated analysis of FISH images?", "id": "converted_160", "sentence1": "Is there any software for automated analysis of FISH images?", "sentence2": "he study demonstrated the feasibility of automated FISH signal analysis that applying a cyclophosphamide/dacarbazine/doxorubicin protocol scheme to the automated generated 2-D projection images., A color imaging technique, multiplex fluorescent in situ hybridization (M-FISH), has been developed to ease the analysis of the process. Using an M-FISH technique each chromosome class (1,2, …,22,X,Y) is stained with a unique color. However, significant variations between images are observed due to a number of factors such as uneven hybridization and spectral overlap among channels. These types of variations influence the pixel classification accuracy of image classification methods which are supervised and require a set of annotated images for training. In this paper, we present a fully unsupervised M-FISH chromosome image classification methodology. Our main contributions are 1) the assumption that the intensity of a chromosome pixel is sampled from multiple Gaussian components [Gaussian mixture model (GMM)] such that each component corresponds to one chromosome class, and 2) the initialization of the GMM model using the emission information of each chromosome class. This is feasible since prior to the M-FISH image acquirement, we already know which chromosome class is emitting to each of the five M-FISH image channels. The method has been tested on a large number of M-FISH images and an overall accuracy of 89.85% is reported. Our method is unsupervised and presents higher classification accuracy even when it is compared with common supervised based methods., hybridization (FISH) tests provide promising molecular imaging biomarkers to more accurately and reliably detect and diagnose cancers and genetic disorders. Since current manual FISH signal analysis is low-efficient and inconsistent, which limits its clinical utility, developing automated FISH image scanning systems and computer-aided detection (cyclophosphamide/dacarbazine/doxorubicin protocol) schemes has been attracting research interests. To acquire high-resolution FISH images in a multi-spectral scanning mode, a huge amount of image data with the stack of the multiple three-dimensional (3-D) image slices is generated from a single specimen. Automated preprocessing these scanned images to eliminate the non-useful and redundant data is important to make the automated FISH tests acceptable in clinical applications. In this study, a dual-detector fluorescence image scanning system was applied to scan four specimen slides with FISH-probed chromosome X. A cyclophosphamide/dacarbazine/doxorubicin protocol scheme was developed to detect analyzable interphase cells and map the multiple imaging slices recorded FISH-probed signals into the 2-D projection images. cyclophosphamide/dacarbazine/doxorubicin protocol scheme was then applied to each projection image to detect analyzable interphase cells using an adaptive multiple-threshold algorithm, identify FISH-probed signals using a top-hat transform, and compute the ratios between the normal and Abnormal \"U\" lymphocyte. To assess cyclophosphamide/dacarbazine/doxorubicin protocol performance, the FISH-probed signals were also independently visually detected by an observer. The Kappa coefficients for agreement between cyclophosphamide/dacarbazine/doxorubicin protocol and observer ranged from 0.69 to 1.0 in detecting/counting FISH signal spots in four testing samples., In this paper we developed a sparse representation-based classification (Proto-Oncogene Tyrosine-Protein Kinase Src, human) algorithm based on L1-norm minimization for classifying Chromosomes, Human, Pair 1 from multicolor fluorescence in situ hybridization (M-FISH) images. The algorithm has been tested on a comprehensive M-FISH database that we established, demonstrating improved performance in classification. When compared with other pixel-wise M-FISH image classifiers such as fuzzy c-means (FCM) clustering algorithms and adaptive fuzzy c-means (AFCM) clustering algorithms that we proposed earlier the current method gave the lowest classification error. In order to evaluate the performance of different Proto-Oncogene Tyrosine-Protein Kinase Src, human for M-FISH imaging analysis, three different sparse representation methods, namely, Homotopy method, Orthogonal Matching Pursuit (OMP gene gene), and Least Angle Regression (LARS), were tested and compared. Results from our statistical analysis have shown that Homotopy based method is significantly better than the other two methods. , Fluorescence in situ hybridization (FISH) is used to study the organization and the positioning of specific DNA Sequence within the Cell Nucleus. Analyzing the data from FISH images is a tedious process that invokes an element of subjectivity. Automated FISH image analysis offers savings in time as well as gaining the benefit of objective data analysis. While several FISH image analysis software tools have been developed, they often use a threshold-based segmentation algorithm for nucleus segmentation. As fluorescence signal intensities can vary significantly from experiment to experiment, from \"U\" lymphocyte to \"U\" lymphocyte, and within a \"U\" lymphocyte, threshold-based segmentation is inflexible and often insufficient for automatic image analysis, leading to additional manual segmentation and potential subjective bias. To overcome these problems, we developed a graphical software tool called FISH Finder to automatically analyze FISH images that vary significantly. By posing the nucleus segmentation as a classification problem, compound Bayesian classifier is employed so that contextual information is utilized, resulting in reliable classification and boundary extraction. This makes it possible to analyze FISH images efficiently and objectively without adjustment of input parameters. Additionally, FISH Finder was designed to analyze the distances between differentially stained FISH probes., The simultaneous detection of Protein Info expression and gene copy number changes in patient samples, like paraffin-embedded tissue sections, is challenging since the procedures of immunohistochemistry (IHC) and Fluorescence in situ Hybridization (FISH) negatively influence each other which often results in suboptimal staining. Therefore, we developed a novel automated algorithm based on relocation which allows subsequent detection of Protein Info content and gene copy number changes within the same \"U\" lymphocyte. METHODS: Paraffin-embedded tissue sections of Colorectal Carcinoma were stained for Prominin-1, human expression. IHC images were acquired and image coordinates recorded. Slides were subsequently hybridized with fluorescently labeled DNA Probes. FISH images were taken at the previously recorded positions allowing for direct comparison of Protein Info expression and gene copy number signals within the same cells/tissue areas. Relocation, acquisition of the IHC and FISH images, and enumeration of FISH signals in the immunophenotyped tumour areas were done in an automated fashion. RESULTS: Automated FISH analysis was performed on 13 different Malignant tumor of colon samples that had been stained for Prominin-1, human; each sample was scored for MYC Protein Info, human Protein Info, human, ZNF217 Protein Info, human Protein Info, human and Chromosomes, Human, Pair 6 in Prominin-1, human positive and negative glands. From the 13 cases four (31%) showed amplification for the MYC Protein Info, human Protein Info, human oncogene and seven of 13 (54%) cases were amplified for ZNF217 Protein Info, human Protein Info, human., The simultaneous detection of Protein Info expression and gene copy number changes in patient samples, like paraffin-embedded tissue sections, is challenging since the procedures of immunohistochemistry (IHC) and Fluorescence in situ Hybridization (FISH) negatively influence each other which often results in suboptimal staining.Therefore, we developed a novel automated algorithm based on relocation which allows subsequent detection of Protein Info content and gene copy number changes within the same \"U\" lymphocyte. METHODS: Paraffin-embedded tissue sections of Colorectal Carcinoma were stained for Prominin-1, human expression. IHC images were acquired and image coordinates recorded. Slides were subsequently hybridized with fluorescently labeled DNA Probes. FISH images were taken at the previously recorded positions allowing for direct comparison of Protein Info expression and gene copy number signals within the same cells/tissue areas. Relocation, acquisition of the IHC and FISH images, and enumeration of FISH signals in the immunophenotyped tumour areas were done in an automated fashion. RESULTS: Automated FISH analysis was performed on 13 different Malignant tumor of colon samples that had been stained for Prominin-1, human; each sample was scored for MYC Protein Info, human Protein Info, human, ZNF217 Protein Info, human Protein Info, human and Chromosomes, Human, Pair 6 in Prominin-1, human positive and negative glands. From the 13 cases four (31%) showed amplification for the MYC Protein Info, human Protein Info, human oncogene and seven of 13 (54%) cases were amplified for ZNF217 Protein Info, human Protein Info, human. There was no significant difference between Prominin-1, human positive tumour and Prominin-1, human negative tumour cells. , The simultaneous detection of Protein Info expression and gene copy number changes in patient samples, like paraffin-embedded tissue sections, is challenging since the procedures of immunohistochemistry (IHC) and Fluorescence in situ Hybridization (FISH) negatively influence each other which often results in suboptimal staining.Therefore, we developed a novel automated algorithm based on relocation which allows subsequent detection of Protein Info content and gene copy number changes within the same \"U\" lymphocyte.Methods: Paraffin-embedded tissue sections of Colorectal Carcinoma were stained for Prominin-1, human expression. IHC images were acquired and image coordinates recorded. Slides were subsequently hybridized with fluorescently labeled DNA Probes. FISH images were taken at the previously recorded positions allowing for direct comparison of Protein Info expression and gene copy number signals within the same cells/tissue areas. Relocation, acquisition of the IHC and FISH images, and enumeration of FISH signals in the immunophenotyped tumour areas were done in an automated fashion.Results: Automated FISH analysis was performed on 13 different Malignant tumor of colon samples that had been stained for Prominin-1, human; each sample was scored for MYC Protein Info, human Protein Info, human, ZNF217 Protein Info, human Protein Info, human and Chromosomes, Human, Pair 6 in Prominin-1, human positive and negative glands. From the 13 cases four (31%) showed amplification for the MYC Protein Info, human Protein Info, human oncogene and seven of 13 (54%) cases were amplified for ZNF217 Protein Info, human Protein Info, human. There was no significant difference between Prominin-1, human positive tumour and Prominin-1, human negative tumour cells.[SEP]Relations: colorectal carcinoma has relations: disease_protein with JPH3, disease_protein with JPH3, disease_protein with QKI, disease_protein with QKI, disease_protein with EFS, disease_protein with EFS, disease_protein with NRCAM, disease_protein with NRCAM, disease_protein with AURKA, disease_protein with AURKA. Definitions: Cell Nucleus defined as following: Within a eukaryotic \"U\" lymphocyte, a membrane-limited body which contains Chromosomes, Human, Pair 1 and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A \"U\" lymphocyte may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). Prominin-1, human defined as following: Prominin-1 (865 aa, ~97 kDa) is encoded by the human PROM1 gene. This Protein Info may play a role in hematopoiesis, but an exact function has yet to be elucidated. The Protein Info has been implicated in tumor pathogenesis and formation in several cancers, including retinoblastoma, hemangioma, and glioblastoma phenotypes. Additionally, the Protein Info has been used as a marker to distinguish cells that have the potential to become cancerous from the larger normal \"U\" lymphocyte population.. Proto-Oncogene Tyrosine-Protein Kinase Src, human defined as following: Proto-oncogene tyrosine-Protein Info kinase Src (536 aa, ~60 kDa) is encoded by the human Proto-Oncogene Tyrosine-Protein Kinase Src, human gene. This Protein Info is involved in both receptor-mediated signal transduction and tyrosine phosphorylation.. DNA Sequence defined as following: The sequence of nucleotide residues along a DNA chain.. Chromosomes, Human, Pair 1 defined as following: A specific pair of human Chromosomes, Human, Pair 1 in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification.. Colorectal Carcinoma defined as following: A malignant epithelial neoplasm that arises from the colon or rectum and invades through the muscularis mucosa into the submucosa. The vast majority are adenocarcinomas.. MYC Protein Info, human defined as following: Myc proto-oncogene Protein Info (439 aa, ~49 kDa) is encoded by the human MYC Protein Info, human gene. This Protein Info plays a role in the regulation of transcription and \"U\" lymphocyte proliferation.. ZNF217 Protein Info, human defined as following: Zinc finger Protein Info 217 (1048 aa, ~115 kDa) is encoded by the human ZNF217 Protein Info, human gene. This Protein Info plays a role in the negative regulation of transcription.. DNA Probes defined as following: Species- or subspecies-specific DNA (including COMPLEMENTARY DNA; conserved genes, whole Chromosomes, Human, Pair 1, or whole genomes) used in hybridization studies in order to identify microorganisms, to measure DNA-DNA homologies, to group subspecies, etc. The DNA probe hybridizes with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, Southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the DNA probe include the radioisotope labels 32P and 125I and the chemical label biotin. The use of DNA Probes provides a specific, sensitive, rapid, and inexpensive replacement for \"U\" lymphocyte culture techniques for diagnosing infections.. Malignant tumor of colon defined as following: A primary or metastatic malignant neoplasm that affects the colon. Representative examples include carcinoma, lymphoma, and sarcoma.. Chromosomes, Human, Pair 6 defined as following: A specific pair GROUP C CHROMSOMES of the human chromosome classification.. Abnormal cell defined as following: An abnormal human \"U\" lymphocyte type which can occur in either disease states or disease models.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. MYC Protein Info, human oncogene defined as following: A viral and cellular gene. A proto-oncogene, identified in several avian tumors, encoding a nuclear Protein Info with a leucine zipper motif..", "label": "yes"} {"original_question": "Is airplane stroke syndrome a common disease.", "id": "converted_2179", "sentence1": "Is airplane Cerebrovascular accident syndrome a common disease.", "sentence2": "Only 37 cases of Cerebrovascular accident during or soon after long-haul flights have been published to our knowledge. , Our centre admitted 5727 Cerebrovascular accident patients, of whom 42 (0.73%) had flight-related strokes., The authors report three cases of Ischemic Cerebrovascular accident in young adults that occurred during or after an airplane flight.[SEP]Relations: Ischemic Cerebrovascular accident has relations: disease_phenotype_positive with Cerebrovascular accident disorder, disease_phenotype_positive with Cerebrovascular accident disorder, disease_phenotype_positive with cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy,, disease_phenotype_positive with cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy,, disease_phenotype_positive with ZTTK syndrome, disease_phenotype_positive with ZTTK syndrome, disease_phenotype_positive with arterial tortuosity syndrome, disease_phenotype_positive with arterial tortuosity syndrome, disease_phenotype_positive with thoracic aortic aneurysm and aortic dissection, disease_phenotype_positive with thoracic aortic aneurysm and aortic dissection. Definitions: Ischemic Cerebrovascular accident defined as following: An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue.. Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810).", "label": "no"} {"original_question": "Can Diazepam be beneficial in the treatment of traumatic brain injury?", "id": "converted_3008", "sentence1": "Can Diazepam be beneficial in the treatment of traumatic brain injury?", "sentence2": "he present experiment examined the effects of diazepam, a positive modulator at the GABA-A Receptor, on survival and cognitive performance in traumatically brain-injured animal allergen extracts. I[SEP]Relations: Diazepam has relations: drug_effect with Memory impairment, drug_effect with Memory impairment, drug_effect with Loss of consciousness, drug_effect with Loss of consciousness, drug_effect with Pain, drug_effect with Pain, drug_effect with Sensory impairment, drug_effect with Sensory impairment, drug_effect with Headache, drug_effect with Headache. Definitions: diazepam defined as following: A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.. GABA-A Receptor defined as following: Cell surface proteins which bind GAMMA-AMINOBUTYRIC ACID and contain an integral membrane chloride channel. Each receptor is assembled as a pentamer from a pool of at least 19 different possible subunits. The receptors belong to a superfamily that share a common CYSTEINE loop.. traumatic brain injury defined as following: A form of acquired brain injury which occurs when a sudden trauma causes damage to the brain.. Diazepam defined as following: A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity..", "label": "yes"} {"original_question": "Has FTY720 been considered for the treatment of stroke?", "id": "converted_4229", "sentence1": "Has FTY-720 been considered for the treatment of Cerebrovascular accident?", "sentence2": "FTY-720 (fingolimod) Ameliorates Brain Injuries through Multiple Mechanisms and is a Strong Candidate for Stroke Treatment, Many researchers have recognized the positive effects of FTY-720 and launched basic and clinical experiments to test the use of this agent against Cerebrovascular accident. Although the mechanism of FTY-720 has not been fully elucidated, its efficacy against cerebral Cerebrovascular accident is becoming clear, not only in animal models, but also in ischemic Cerebrovascular accident patients through clinical trials. In this article, we review the data obtained from laboratory findings and preliminary clinical trials using FTY-720 for Cerebrovascular accident treatment.[SEP]Relations: brain injury has relations: contraindication with Dexchlorpheniramine, contraindication with Dexchlorpheniramine, contraindication with Pheniramine, contraindication with Pheniramine, contraindication with Dicyclomine, contraindication with Dicyclomine, contraindication with Difenoxin, contraindication with Difenoxin, contraindication with Chlorpheniramine, contraindication with Chlorpheniramine. Definitions: Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810). fingolimod defined as following: An orally available derivate of myriocin and sphingosine-1-phosphate receptor 1 (S1PR1, S1P1) modulator, with potential anti-inflammatory and immunomodulating activities. Upon oral administration, fingolimod, as a structural analogue of sphingosine, selectively targets and binds to S1PR1 on lymphocytes and causes transient receptor activation followed by S1PR1 internalization and degradation. This results in the sequestration of lymphocytes in lymph nodes. By preventing egress of lymphocytes. fingolimod reduces both the amount of circulating peripheral lymphocytes and the infiltration of lymphocytes into target tissues. This prevents a lymphocyte-mediated immune response and may reduce inflammation. S1PR1, a G-protein coupled receptor, plays a key role in lymphocyte migration from lymphoid tissues. fingolimod also shifts macrophages to an anti-inflammatory M2 phenotype, and modulates their proliferation, morphology, and cytokine release via inhibition of the transient receptor potential cation channel, subfamily M, member 7 (TRPM7).. Brain Injuries defined as following: Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits..", "label": "yes"} {"original_question": "Can CMB305 be used against sarcomas?", "id": "converted_3434", "sentence1": "Can CMB305 be used against sarcomas?", "sentence2": "CMB305 induces CTAG1A wt Allele specific T-Lymphocyte responses in both Supernumerary mandibular right first primary molar and Medical Research Council patients and these patients had excellent overall survival (OS) outcomes in the initial phase I study., Data suggesting this Vaccine [APC] may improve OS for Supernumerary mandibular right first primary molar and MRCL patients is exciting but early, and on-going work is testing the impact of CMB305 on patient outcomes., The potential of the CMB305 Vaccine [APC] regimen to target CTAG1A wt Allele and improve outcomes for synovial sarcoma and Myxoid/Round Cell Liposarcoma patients.[SEP]Relations: BCG Vaccine [APC] has relations: drug_drug with Sarilumab, drug_drug with Sarilumab, drug_drug with Sirukumab, drug_drug with Sirukumab, drug_drug with Sorafenib, drug_drug with Sorafenib, drug_drug with Sarecycline, drug_drug with Sarecycline. breast synovial sarcoma has relations: disease_disease with breast sarcoma, disease_disease with breast sarcoma. Definitions: T-Lymphocyte defined as following: Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.. CTAG1A wt Allele defined as following: Human CTAG1A wild-type allele is located in the vicinity of Xq28 and is approximately 2 kb in length. This allele, which encodes cancer/testis antigen 1 protein, may play a role in both spermatogeneis and development of the testes. Aberrant expression of this gene is associated with incontinentia pigmenti.. synovial sarcoma defined as following: A malignant neoplasm arising from tenosynovial tissue of the joints and in synovial cells of tendons and bursae. The legs are the most common site, but the tumor can occur in the abdominal wall and other trunk muscles. There are two recognized types: the monophasic (characterized by sheaths of monotonous spindle cells) and the biphasic (characterized by slit-like spaces or clefts within the tumor, lined by cuboidal or tall columnar epithelial cells). These sarcomas occur most commonly in the second and fourth decades of life. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1363). Myxoid/Round Cell Liposarcoma defined as following: A liposarcoma characterized by the presence of round non-lipogenic primitive mesenchymal cells and small signet ring lipoblasts within a myxoid stoma with a branching vascular pattern. This category includes hypercellular lesions with round cell morphology, formerly known as round cell liposarcoma.. Medical Research Council defined as following: A publicly funded organization that is part of United Kingdom Research and Innovation, and is dedicated to improving human health through world-class medical research.. Supernumerary mandibular right first primary molar defined as following:

Supernumerary mandibular right first primary molar

. sarcomas defined as following: A malignant neoplasm arising exclusively from the soft tissues..", "label": "yes"} {"original_question": "Is Aptiganel effective for treatment of stroke?", "id": "converted_3681", "sentence1": "Is Aptiganel effective for treatment of Cerebrovascular accident?", "sentence2": "Trends for increased mortality with three N-Methylaspartate antagonists were seen - selfotel (OR 1.19 [0.81-1.74]), aptiganel (OR 1.32 [0.91-1.93]) and Gavestinel (OR 1.12 [0.95-1.32]) - but this did not achieve significance for the N-Methylaspartate antagonists considered as a class (1.09 [0.96-1.23]). Aptiganel was also associated with a trend towards worse functional outcome (OR 1.20 [0.88-1.65]) although this was not the case for either of the other two compounds., No improvement in clinical outcome of Cerebrovascular accident has been seen with competitive N-Methylaspartate antagonists (selfotel) and non-competitive N-Methylaspartate antagonists (Dextrorphan, GV 150526A, aptiganel and eliprodil)., Glutamate N-methyl-D-aspartate (N-Methylaspartate) receptor antagonists (competitive receptor antagonists, ion channel blockers, and Glycine (Plant) antagonists)--such as selfotel, aptiganel, eliprodil, licostinel and Gavestinel--failed to show efficacy in clinical trials of Cerebrovascular accident or Traumatic Brain Injury. , There was no improvement in outcome for either aptiganel (Low-Dose Treatment or high-dose) group compared with the placebo group at 90 days (median Modified Rankin Scale score for all 3 treatment groups = 3; P =.31). At 7 days, placebo-treated patients exhibited slightly greater neurological improvement on the NIH Stroke Scale than high-dose aptiganel patients (mean improvement for placebo group, -0.8 points vs for high-dose aptiganel, 0.9 points; P =.04). The mortality rate at 120 days in patients treated with high-dose aptiganel was higher than that in patients who received placebo (26.3% vs 19.2%; P =.06)., CONCLUSIONS: Aptiganel was not efficacious in patients with acute ischemic Cerebrovascular accident at either of the tested doses, and m ay be harmful. The larger proportion of patients with favorable outcomes and lower mortality rate in the placebo group suggest that glutamate blockade with aptiganel may have detrimental effects in an undifferentiated population of Cerebrovascular accident patients., CONCLUSIONS\n\nAptiganel was not efficacious in patients with acute ischemic Cerebrovascular accident at either of the tested doses, and m ay be harmful., The larger proportion of patients with favorable outcomes and lower mortality rate in the placebo group suggest that glutamate blockade with aptiganel may have detrimental effects in an undifferentiated population of Cerebrovascular accident patients., There was no improvement in outcome for either aptiganel (Low-Dose Treatment or high-dose) group compared with the placebo group at 90 days (median Modified Rankin Scale score for all 3 treatment groups = 3; P =.31)., Glutamate N-methyl-D-aspartate (N-Methylaspartate) receptor antagonists (competitive receptor antagonists, ion channel blockers, and Glycine (Plant) antagonists)--such as selfotel, aptiganel, eliprodil, licostinel and Gavestinel--failed to show efficacy in clinical trials of Cerebrovascular accident or Traumatic Brain Injury., CONCLUSIONS Aptiganel was not efficacious in patients with acute ischemic Cerebrovascular accident at either of the tested doses, and m ay be harmful., Glutamate N-methyl-D-aspartate ( N-Methylaspartate ) receptor antagonists ( competitive receptor antagonists , ion channel blockers , and Glycine (Plant) antagonists)--such as selfotel , aptiganel , eliprodil , licostinel and Gavestinel--failed to show efficacy in clinical trials of Cerebrovascular accident or Traumatic Brain Injury, No improvement in clinical outcome of Cerebrovascular accident has been seen with competitive N-Methylaspartate antagonists ( selfotel ) and non-competitive N-Methylaspartate antagonists ( Dextrorphan , GV 150526A , aptiganel and eliprodil, There was no improvement in outcome for either aptiganel (Low-Dose Treatment or high-dose) group compared with the placebo group at 90 days (median Modified Rankin Scale score for all 3 treatment groups = 3; P =.31)., CONCLUSIONS: Aptiganel was not efficacious in patients with acute ischemic Cerebrovascular accident at either of the tested doses, and m ay be harmful., The larger proportion of patients with favorable outcomes and lower mortality rate in the placebo group suggest that glutamate blockade with aptiganel may have detrimental effects in an undifferentiated population of Cerebrovascular accident patients., There was no improvement in outcome for either aptiganel (Low-Dose Treatment or high-dose) group compared with the placebo group at 90 days (median Modified Rankin Scale score for all 3 treatment groups = 3; P =.31)., Aptiganel was not efficacious in patients with acute ischemic Cerebrovascular accident at either of the tested doses, and m ay be harmful., The larger proportion of patients with favorable outcomes and lower mortality rate in the placebo group suggest that glutamate blockade with aptiganel may have detrimental effects in an undifferentiated population of Cerebrovascular accident patients.[SEP]Relations: Ischemic Cerebrovascular accident has relations: drug_effect with Paclitaxel, drug_effect with Paclitaxel, drug_effect with Ramipril, drug_effect with Ramipril, drug_effect with Aripiprazole, drug_effect with Aripiprazole, drug_effect with Sitaxentan, drug_effect with Sitaxentan, drug_effect with Pazopanib, drug_effect with Pazopanib. Definitions: N-Methylaspartate defined as following: An amino acid that, as the D-isomer, is the defining agonist for the N-Methylaspartate receptor subtype of glutamate receptors (RECEPTORS, N-Methylaspartate).. Traumatic Brain Injury defined as following: A form of acquired brain injury which occurs when a sudden trauma causes damage to the brain.. Low-Dose Treatment defined as following: A reduced quantity of a therapeutic agent prescribed to be taken at one time or at stated intervals.. Dextrorphan defined as following: Dextro form of levorphanol. It acts as a noncompetitive N-Methylaspartate receptor antagonist, among other effects, and has been proposed as a neuroprotective agent. It is also a metabolite of DEXTROMETHORPHAN.. Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810).", "label": "no"} {"original_question": "Is there any research that relates the function of Notch Signaling with Alzheimer Disease?", "id": "converted_1491", "sentence1": "Is there any research that relates the function of Notch Signaling with Alzheimer Disease?", "sentence2": "RALBP1 gene regulates signaling pathways by abrogating or releasing signaling molecules. Since the discovery, already >15 years ago, of its catalytic component, Presenilin-1, and even much earlier with the identification of Amyloid beta-Protein Precursor as its first substrate, γ-secretase has been commonly associated with ALZHEIMER DISEASE, FAMILIAL, 1. However, starting with Notch and thereafter a continuously increasing number of novel substrates, γ-secretase is becoming linked to an equally broader range of biological processes., In the last decade, increasing evidence has pointed out an important role of this pathway beyond embryonic development, indicating that Notch also displays a critical function in the mature Head>Brain of Vertebrates and invertebrates. This pathway appears to be involved in neural progenitor regulation, neuronal connectivity, synaptic plasticity and learning/memory. In addition, Notch appears to be aberrantly regulated in Neurodegenerative Disorders, including ALZHEIMER DISEASE, FAMILIAL, 1 and ischemic injury, Along with β-secretase, this Enzyme [APC] produces the amyloid β-protein of ALZHEIMER DISEASE, FAMILIAL, 1 (cytarabine/daunorubicin protocol) from the amyloid β-protein precursor. Because of its key role in the pathogenesis of cytarabine/daunorubicin protocol, γ-secretase has been a prime target for drug discovery, and many inhibitors of this Endopeptidases have been developed. The therapeutic potential of these inhibitors is virtually negated by the fact that γ-secretase is an essential part of the Notch signaling pathway, rendering the compounds unacceptably Toxic effect upon chronic exposure, High physiological concentrations of Aβ monomer induced angiogenesis by a conserved mechanism that blocks γ-secretase processing of a Notch intermediate, NEXT, and reduces the expression of downstream Notch target genes. Our findings allude to an integration of signaling pathways that utilize γ-secretase activity, which may have significant implications for our understanding of Alzheimer's pathogenesis vis-à-vis vascular changes that set the stage for ensuing Nerve Degeneration., Aggregated forms of Aβ have a pathogenic role in ALZHEIMER DISEASE 2 and, thus, reducing the Aβ levels by inhibiting γ-secretase is a possible treatment strategy for ALZHEIMER DISEASE 2. Regrettably, clinical trials have shown that inhibition of γ-secretase results in Notch-related side effects. Therefore, it is of great importance to find ways to inhibit Amyloid beta-Protein Precursor (Smartphone Application) processing without disturbing vital signaling pathways such as Notch. NCSTN gene (NCT (pharmacologic substance)) is part of the γ-secretase complex and has been proposed to be involved in substrate recognition and selection[SEP]Relations: ALZHEIMER DISEASE 2 has relations: disease_disease with genetic dementia, disease_disease with genetic dementia, disease_disease with dementia (disease), disease_disease with dementia (disease), disease_protein with GAPDHS, disease_protein with GAPDHS, disease_disease with familial ALZHEIMER DISEASE 2, disease_disease with familial ALZHEIMER DISEASE 2, disease_protein with ARC, disease_protein with ARC. Definitions: Amyloid beta-Protein Precursor defined as following: A single-pass type I membrane protein. It is cleaved by AMYLOID PRECURSOR PROTEIN SECRETASES to produce peptides of varying amino acid lengths. A 39-42 amino acid peptide, AMYLOID BETA-PEPTIDES is a principal component of the extracellular amyloid in SENILE PLAQUES.. RALBP1 gene defined as following: This gene is involved in the regulation of small GTPase activity.. Nerve Degeneration defined as following: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of Neurodegenerative Disorders. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.. Smartphone Application defined as following: An application designed specifically for use on a smartphone.. NCSTN gene defined as following: This gene is involved in the regulation of gamma-secretase activity.. Presenilin-1 defined as following: Integral membrane protein of Golgi and endoplasmic reticulum. Its homodimer is an essential component of the gamma-secretase complex that catalyzes the cleavage of membrane proteins such as NOTCH RECEPTORS and AMYLOID BETA-PEPTIDES precursors. PSEN1 mutations cause early-onset ALZHEIMER DISEASE type 3 that may occur as early as 30 years of age in humans.. Neurodegenerative Disorders defined as following: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Endopeptidases defined as following: A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS.. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the Smartphone Application gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65.. Vertebrates defined as following: Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising mammals, birds, reptiles, amphibians, and fishes..", "label": "yes"} {"original_question": "Is verubecestat effective for Alzheimer’s Disease?", "id": "converted_3003", "sentence1": "Is verubecestat effective for Alzheimer’s Disease?", "sentence2": " The lack of efficacy of verubecestat in mild-to-moderate cytarabine/daunorubicin protocol raises important questions about the timing of intervention with BACE-1 inhibitors, and anti-amyloid therapies in general, in cytarabine/daunorubicin protocol treatment., This reaction was applied to the preparation of verubecestat, which is currently undergoing clinical evaluation for the treatment of ALZHEIMER DISEASE, FAMILIAL, 1., Verubecestat is an PPP1R1A gene of β-site amyloid precursor protein cleaving enzyme 1 (BACE1 protein, human protein, human) being evaluated in clinical trials for the treatment of ALZHEIMER DISEASE, FAMILIAL, 1. , CONCLUSIONS: Verubecestat did not reduce cognitive or functional decline in patients with mild-to-moderate ALZHEIMER DISEASE, FAMILIAL, 1 and was associated with treatment-related adverse events. , Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease.Verubecestat did not reduce cognitive or functional decline in patients with mild-to-moderate ALZHEIMER DISEASE, FAMILIAL, 1 and was associated with treatment-related adverse events. , CONCLUSIONS\nVerubecestat did not reduce cognitive or functional decline in patients with mild-to-moderate ALZHEIMER DISEASE, FAMILIAL, 1 and was associated with treatment-related adverse events., Verubecestat did not reduce cognitive or functional decline in patients with mild-to-moderate ALZHEIMER DISEASE, FAMILIAL, 1 and was associated with treatment-related adverse events.[SEP]Relations: familial Alzheimer disease has relations: disease_disease with Alzheimer disease, disease_disease with Alzheimer disease, disease_disease with inherited prion disease, disease_disease with inherited prion disease, disease_protein with PRNP, disease_protein with PRNP, disease_phenotype_positive with Sleep disturbance, disease_phenotype_positive with Sleep disturbance, disease_phenotype_positive with Perseveration, disease_phenotype_positive with Perseveration. Definitions: BACE1 protein, human defined as following: Beta-secretase 1 (501 aa, ~56 kDa) is encoded by the human BACE1 protein, human gene. This protein plays a role in the proteolysis of ectodomains of membrane proteins.. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65..", "label": "no"} {"original_question": "Do angiotensin-converting-enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) increase the likelihood of severe COVID-19?", "id": "converted_4514", "sentence1": "Do angiotensin-converting-enzyme (ACE) inhibitors and Angiotensin Receptor Antagonists (ARBs) increase the likelihood of severe COVID19 (document)?", "sentence2": "These findings suggest that the use of ACE-I and BESTROPHINOPATHY, AUTOSOMAL RECESSIVE is not associated with adverse outcomes and may be associated with improved outcomes in COVID19 (document), which is immediately relevant to care of the many patients on these medications., There are theoretical concerns that Peptidyl-Dipeptidase A inhibitors (ACEIs) and Angiotensin Receptor Antagonists (ARBs) could increase the risk of severe Covid-19., ACEIs and ARBs were associated with a slight reduction in Covid-19 hospitalization risk compared with treatment with other first-line antihypertensives (OR for ACEIs 0.95, 95% CI 0.92-0.98; OR for ARBs 0.94, 95% CI 0.90-0.97)., There were no meaningful differences in risk for ACEIs compared with ARBs., ACEIs and ARBs were not associated with an increased risk of Covid-19 hospitalization or with hospitalization involving ICU admission, invasive mechanical ventilation, or Cessation of life., In patients with HTN and COVID19 (document), neither ACEi nor ARBs were independently associated with mortality., Our data confirm Specialty Societal recommendations, suggesting that treatment with ACEIs or ARBs should not be discontinued because of COVID19 (document)., Random-effects meta-analysis showed ACEI/BESTROPHINOPATHY, AUTOSOMAL RECESSIVE treatment was significantly associated with a lower risk of mortality in Hypertensive (finding) COVID19 (document) patients (odds ratio [OR] = 0.624, 95% confidence interval [CI] = 0.457-0.852, p = .003, I2  = 74.3%)., In addition, the ACEI/BESTROPHINOPATHY, AUTOSOMAL RECESSIVE treatment was associated with a lower risk of ventilatory support (OR = 0.682, 95% CI = 0.475-1.978, p = .037, I2  = 0.0%). In conclusion, these results suggest that ACEI/BESTROPHINOPATHY, AUTOSOMAL RECESSIVE medications should not be discontinued for Hypertensive (finding) patients in the context of COVID19 (document) pandemic., Use of ACE-I or BESTROPHINOPATHY, AUTOSOMAL RECESSIVE medications was not associated with increased risk of hospitalization, intensive care unit admission, or Cessation of life. Compared to patients with charted past medical history, there was a lower risk of hospitalization for patients on ACE-I (odds ratio (OR) 0.43; 95% confidence interval (CI) 0.19-0.97; P = 0.0426) and BESTROPHINOPATHY, AUTOSOMAL RECESSIVE (OR 0.39; 95% CI 0.17-0.90; P = 0.0270)., The second analysis showed that the use of ACEI and/or BESTROPHINOPATHY, AUTOSOMAL RECESSIVE did not affect in-hospital mortality (risk ratio [RR] 95% [CI]] = 0.88 [0.64-1.20], p = 0.42). The subgroup analysis by limiting studies of patients with Hypertensive Disease showed ACEI and/or BESTROPHINOPATHY, AUTOSOMAL RECESSIVE use was associated with a significant reduction of in-hospital mortality compared with no ACEI or BESTROPHINOPATHY, AUTOSOMAL RECESSIVE use (RR [CI] = 0.66 [0.49-0.89], p = 0.004). Our analysis demonstrated that ACEI and/or BESTROPHINOPATHY, AUTOSOMAL RECESSIVE use was associated neither with testing positive rates of COVID19 (document) nor with mortality of COVID19 (document) patients., ACEIs/ARBs are protective factors against mortality in COVID19 (document) patients with HTN, and these agents can be considered potential therapeutic options in this Disease., There has been a lot of speculation that patients with coronavirus Disease 2019 (COVID19 (document)) who are receiving Peptidyl-Dipeptidase A (ACE) inhibitors or Angiotensin Receptor Antagonists (ARBs) may be at increased risk for adverse outcomes., Although further research on the influence of blood-pressure-lowering drugs, including those not targeting the renin-angiotensin system, is warranted, there are presently no compelling clinical data showing that ACEIs and ARBs increase the likelihood of contracting COVID19 (document) or worsen the outcome of SARS-CoV‑2 infections, There has been a lot of speculation that patients with coronavirus Disease 2019 (COVID19 (document)) who are receiving Peptidyl-Dipeptidase A (ACE) inhibitors or Angiotensin Receptor Antagonists (ARBs) may be at increased risk for adverse outcomes, ACEIs and ARBs do not promote a more severe outcome of COVID19 (document)., Meta-analysis showed no significant increase in the risk of COVID19 (document) infection (odds ratio [OR]: 0.95, 95%CI: 0.89-1.05) in patients receiving ACEI/BESTROPHINOPATHY, AUTOSOMAL RECESSIVE therapy, and ACEI/BESTROPHINOPATHY, AUTOSOMAL RECESSIVE therapy was associated with a decreased risk of severe COVID19 (document) (OR: 0.75, 95%CI: 0.59-0.96) and mortality (OR: 0.52, 95%CI: 0.35-0.79)., Subgroup analyses showed among the general population, ACEI/BESTROPHINOPATHY, AUTOSOMAL RECESSIVE therapy was associated with reduced severe COVID19 (document) infection (OR: 0.79, 95%CI: 0.60-1.05) and all-cause mortality (OR: 0.31, 95%CI: 0.13-0.75), and COVID19 (document) infection (OR: 0.85, 95% CI: 0.66-1.08) were not increased., On the basis of the available evidence, ACEI/BESTROPHINOPATHY, AUTOSOMAL RECESSIVE therapy should be continued in patients who are at risk for, or have COVID19 (document), either in general population or Hypertensive Disease patients., Some studies of hospitalized patients suggested that the risk of Cessation of life and/or severe Illness (finding) due to COVID19 (document) is not associated with the use of Peptidyl-Dipeptidase A inhibitors (ACEIs) and/or Angiotensin II Type 2 Receptor Blockers (ARBs), Available evidence, in particular, data from human studies, does not support the hypothesis that ACEI/BESTROPHINOPATHY, AUTOSOMAL RECESSIVE use increases ACE2 protein, human protein, human expression and the risk of complications from COVID19 (document). We conclude that patients being treated with ACEIs and ARBs should continue their use for approved indications.[SEP]Relations: type 2 angiotensin receptor binding has relations: molfunc_protein with AGT, molfunc_protein with AGT. Protein S human has relations: drug_drug with Anti-inhibitor coagulant complex, drug_drug with Anti-inhibitor coagulant complex, drug_drug with Ardeparin, drug_drug with Ardeparin, drug_drug with Peginterferon alfa-2b, drug_drug with Peginterferon alfa-2b, drug_drug with Coagulation Factor IX (Recombinant), drug_drug with Coagulation Factor IX (Recombinant). Definitions: Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. BESTROPHINOPATHY, AUTOSOMAL RECESSIVE defined as following: A retinal dystrophy with characteristics of central visual loss in the first 2 decades of life, associated with an absent electrooculogram (EOG) light rise and a reduced electroretinogram (ERG). To date less than 20 cases have been described in the world literature. Caused by compound heterozygous or homozygous mutations in the BEST1 gene (11q12) which encodes the chloride ion channel bestrophin-1 (expressed in the retinal pigment epithelium (RPE)). Mutations in BEST1 reduce or abolish the activity of the channel. It has been proposed that BESTROPHINOPATHY, AUTOSOMAL RECESSIVE may represent the null phenotype of bestrophin-1 in humans. Transmission is autosomal recessive.. Angiotensin Receptor Antagonists defined as following: Agents that antagonize ANGIOTENSIN RECEPTORS. Many drugs in this class specifically target the ANGIOTENSIN TYPE 1 RECEPTOR.. Hypertensive Disease defined as following: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), Hypertensive Disease is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.. ACE2 protein, human defined as following: Angiotensin-converting enzyme 2 (805 aa, ~92 kDa) is encoded by the human ACE2 protein, human gene. This protein plays a role in both vasodilation and protein cleavage.. Peptidyl-Dipeptidase A defined as following: A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020).. Angiotensin II Type 2 Receptor Blockers defined as following: Agents that antagonize the ANGIOTENSIN II TYPE 2 RECEPTOR.. Illness (finding) defined as following: A state of ill health, bodily malfunction, or discomfort.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown..", "label": "no"} {"original_question": "Is lumican a secreted protein?", "id": "converted_2709", "sentence1": "Is LUM protein, Homo sapiens a secreted protein?", "sentence2": "Specimen Source Codes - Fibroblasts stimulated with the Fibrocyte-secreted inflammatory signal tumor necrosis factor-α secrete the small leucine-rich Proteoglycan LUM protein, Homo sapiens, TNF-α-stimulated Specimen Source Codes - Fibroblasts secrete LUM protein, Homo sapiens to promote Fibrocyte differentiation., Secreted 70kDa LUM protein, Homo sapiens stimulates growth and inhibits invasion of Homo sapiens pancreatic cancer., the elevated level of LUM protein, Homo sapiens secretion to Extracellular Space leads to Actins cytoskeletal remodeling followed by an increase in migration capacity of Homo sapiens colon LS180 cells, Lumican is a secreted Proteoglycan that regulates collagen fibril assembly., This is the first time that the synthesis and secretion of LUM protein, Homo sapiens in Homo sapiens melanoma cell lines is reported. [SEP]Relations: Protein S Homo sapiens has relations: drug_drug with Lumiracoxib, drug_drug with Lumiracoxib, drug_drug with Pentosan polysulfate, drug_drug with Pentosan polysulfate, drug_drug with Urokinase, drug_drug with Urokinase. Extracellular Space has relations: cellcomp_protein with LUM, cellcomp_protein with LUM. ECM proteoglycans has relations: pathway_protein with LUM, pathway_protein with LUM. Definitions: collagen defined as following: A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH).. LUM protein, Homo sapiens defined as following: Lumican (338 aa, ~38 kDa) is encoded by the Homo sapiens LUM gene. This protein is involved in the structure of interstitial collagen matrices.. Fibrocyte defined as following: A quiescent connective tissue cell with minimal cytoplasm and little to no evidence of protein synthesis. These cells may be able to differentiate into Specimen Source Codes - Fibroblasts.. Homo sapiens defined as following: Members of the species Homo sapiens.. Proteoglycan defined as following: Glycoproteins which have a very high polysaccharide content.. Extracellular Space defined as following: Interstitial space between cells, occupied by INTERSTITIAL FLUID as well as amorphous and fibrous substances. For organisms with a CELL WALL, the Extracellular Space includes everything outside of the CELL MEMBRANE including the PERIPLASM and the cell wall.. Actins defined as following: Filamentous proteins that are the main constituent of the thin filaments of muscle fibers. The filaments (known also as filamentous or F-Actins) can be dissociated into their globular subunits; each subunit is composed of a single polypeptide 375 amino acids long. This is known as globular or G-Actins. In conjunction with MYOSINS, Actins is responsible for the contraction and relaxation of muscle..", "label": "yes"} {"original_question": "Has Revlimid been approved by the US Food and Drug Administration?", "id": "converted_996", "sentence1": "Has Revlimid been approved by the US Food and Drug Administration?", "sentence2": "In the past decade, immunomodulatory drugs have been approved by the US Food and Drug Administration for the treatment of Multiple Myeloma (Millimole per Liter)-and a number of emerging agents that target the cellular pathways or Proteins involved in the pathophysiology of Millimole per Liter are currently in development. Lenalidomide (Revlimid) and pomalidomide induce apoptosis and sensitize Millimole per Liter Cells while demonstrating superior efficacy and better tolerability than thalidomide (Thalomid)., In the past decade we have seen four new agents approved by the US Food and Drug Administration for treatment of Multiple Myeloma: the Proteasome Inhibitors [MoA] (Pulmonary Valve Insufficiency) bortezomib (Velcade), the immunomodulatory agents lenalidomide (Revlimid) and thalidomide (Thalomid), and doxorubicin liposome. , In the past decade we have seen four new agents approved by the US Food and Drug Administration for treatment of Multiple Myeloma: the Proteasome Inhibitors [MoA] (Pulmonary Valve Insufficiency) bortezomib (Velcade), the immunomodulatory agents lenalidomide (Revlimid) and thalidomide (Thalomid), and doxorubicin liposome., Thalidomide, lenalidomide (Revlimid), and bortezomib (Velcade) are directed not only at Millimole per Liter Cells but also at the BM milieu and have moved rapidly from the bench to the bedside and United States Food and Drug Administration approval to treat Millimole per Liter., Lenalidomide (CC 5013, Revlimid; Celgene Corporation, Summit, New Jersey), a thalidomide analogue, was granted approval by the U.S. Food and Drug Administration (FDA) on June 29, 2006, for use in combination with dexamethasone in patients with Multiple Myeloma (Millimole per Liter) who have received at least one prior therapy., Lenalidomide, an IMiD Pharmacologic Substance (a novel type of immunomodulating Pharmacologic Substance) was recently approved by the US Food and Drug Administration for the treatment of transfusion-dependent anemia in patients with MYELODYSPLASTIC SYNDROME (MDS) and interstitial deletions of chromosome 5q [del(5q)], Lenalidomide, a second-generation immunomodulatory Pharmacologic Substance (IMiD), is approved by the US Food and Drug Administration for treatment of transfusion-dependent anemia in lower-risk MDS patients with Gene Deletion Abnormality 5q chromosomal abnormality, In the past decade we have seen four new agents approved by the US Food and Drug Administration for treatment of Multiple Myeloma: the Proteasome Inhibitors [MoA] (Pulmonary Valve Insufficiency) bortezomib (Velcade), the immunomodulatory agents lenalidomide (Revlimid) and thalidomide (Thalomid), and doxorubicin liposome., lenalidomide (CC5103 or Revlimid) are recently approved for the treatment of Multiple Myeloma., In the past decade, immunomodulatory drugs have been approved by the US Food and Drug Administration for the treatment of Multiple Myeloma (Millimole per Liter)-and a number of emerging agents that target the cellular pathways or Proteins involved in the pathophysiology of Millimole per Liter are currently in development. Lenalidomide (Revlimid) and pomalidomide induce apoptosis and sensitize Millimole per Liter Cells while demonstrating superior efficacy and better tolerability than thalidomide (Thalomid).[SEP]Relations: Lenalidomide has relations: drug_drug with Reviparin, drug_drug with Reviparin. Pomalidomide has relations: drug_drug with Reviparin, drug_drug with Reviparin, drug_drug with Revefenacin, drug_drug with Revefenacin. Bortezomib has relations: drug_drug with Reviparin, drug_drug with Reviparin. Thalidomide has relations: drug_drug with Reviparin, drug_drug with Reviparin. Definitions: Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. thalidomide defined as following: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.. MYELODYSPLASTIC SYNDROME defined as following: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.. dexamethasone defined as following: An anti-inflammatory 9-fluoro-glucocorticoid.. lenalidomide defined as following: A thalidomide analog with potential antineoplastic activity. Lenalidomide inhibits TNF-alpha production, stimulates T Cells, reduces serum levels of the cytokines vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), and inhibits angiogenesis. This agent also promotes G1 cell cycle arrest and apoptosis of malignant Cells.. New Jersey defined as following: State bounded on the north by New York and Pennsylvania, on the east by New York and the Atlantic Ocean, on the south by Delaware Bay, and on the west by Pennsylvania.. pomalidomide defined as following: An orally bioavailable derivative of thalidomide with potential immunomodulating, antiangiogenic and antineoplastic activities. Although its exact mechanism of action has yet to be fully elucidated, pomalidomide appears to inhibit TNF-alpha production, enhance the activity of T Cells and natural killer (NK) Cells and enhance antibody-dependent cellular cytotoxicity (ADCC). In addition, pomalidomide may inhibit tumor angiogenesis, promote cell cycle arrest in susceptible tumor cell populations, and stimulate erythropoeisis.. Millimole per Liter defined as following: A unit of concentration (molarity unit) equal to one thousandth of a mole (10E-3 mole) of solute per one liter of solution.. bortezomib defined as following: A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA.. Multiple Myeloma defined as following: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones Proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.. Pulmonary Valve Insufficiency defined as following: Backflow of blood from the PULMONARY ARTERY into the RIGHT VENTRICLE due to imperfect closure of the PULMONARY VALVE.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary..", "label": "yes"} {"original_question": "Can leuprorelin acetate be used as androgen deprivation therapy?", "id": "converted_3260", "sentence1": "Can leuprorelin acetate be used as androgen deprivation therapy?", "sentence2": "We investigated the health-related quality of life (HRQoL) of long-term Malignant neoplasm of prostate patients who received leuprorelin acetate in Microcapsules drug delivery system (Lymphangioleiomyomatosis) for androgen-deprivation therapy (glutamyl-tRNA(Gln) amidotransferase complex location)., Long-term glutamyl-tRNA(Gln) amidotransferase complex location with Lymphangioleiomyomatosis is a well-accepted, tolerated, effective, and low-burden treatment option for patients with advanced, hormone-sensitive Patient-Controlled Analgesia.[SEP]Relations: lymphangioleiomyomatosis has relations: disease_phenotype_positive with Cognitive impairment, disease_phenotype_positive with Cognitive impairment, disease_phenotype_positive with Ascites, disease_phenotype_positive with Ascites, disease_phenotype_positive with Restrictive ventilatory defect, disease_phenotype_positive with Restrictive ventilatory defect, disease_phenotype_positive with Macule, disease_phenotype_positive with Macule, disease_phenotype_positive with Seizure, disease_phenotype_positive with Seizure. Definitions: Lymphangioleiomyomatosis defined as following: A multifocal neoplasm with perivascular epithelioid cell differentiation affecting almost exclusively females of child-bearing age. It is characterized by the presence of smooth muscle and epithelioid cells and by the proliferation of lymphatic vessels. Sites of involvement include the lungs, mediastinum, and the retroperitoneum. It usually presents with chylous pleural effusion or ascites.. Malignant neoplasm of prostate defined as following: A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas.. Microcapsules drug delivery system defined as following: microscopic spheres of organic polymer or other material, usually used for slow release drug delivery or to protect orally administered agents from destruction in digestive tract; do not confuse with BACTERIAL CAPSULE.. glutamyl-tRNA(Gln) amidotransferase complex location defined as following: A protein complex that possesses glutamyl-tRNA(Gln) amidotransferase activity, and therefore creates Gln-tRNA by amidating Glu-tRNA; usually composed of 3 subunits: A, B, and C. Note that the C subunit may not be required in all organisms. [GOC:mlg]. Patient-Controlled Analgesia defined as following: Relief of PAIN, without loss of CONSCIOUSNESS, through ANALGESIC AGENTS administered by the patients. It has been used successfully to control POSTOPERATIVE PAIN, during OBSTETRIC LABOR, after BURNS, and in TERMINAL CARE. The choice of agent, dose, and lockout interval greatly influence effectiveness. The potential for overdose can be minimized by combining small bolus doses with a mandatory interval between successive doses (lockout interval)..", "label": "yes"} {"original_question": "Is RET the major gene involved in Hirschsprung disease?", "id": "converted_292", "sentence1": "Is ret unit of radiation dose the major gene involved in Hirschsprung disease?", "sentence2": "The ret unit of radiation dose Proto-Oncogenes is the major gene associated to HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 with differential contributions of its rare and common, coding and noncoding Gene Mutation to the multifactorial nature of this pathology, The ret unit of radiation dose Proto-Oncogenes is the major gene for HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 with differential contributions of its rare and common, coding and noncoding Gene Mutation to the multifactorial nature of this pathology, The rearranged during transfection gene (ret unit of radiation dose) is considered the major gene in HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1, ret unit of radiation dose is the major gene associated to Hirschsprung disease (HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1) with differential contributions of its rare and common, coding and noncoding Gene Mutation to the multifactorial nature of this pathology, While all Mendelian modes of inheritance have been described in syndromic HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1, isolated HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 stands as a model for genetic disorders with complex patterns of inheritance. The tyrosine kinase receptor ret unit of radiation dose is the major gene with both rare Open Reading Frames Gene Mutation and/or a frequent Variant located in an Enhancer Elements, Genetic predisposing to the disease, The rearranged during transfection (ret unit of radiation dose) Proto-Oncogenes is the major susceptibility gene for Hirschsprung disease, and germline Gene Mutation in ret unit of radiation dose have been reported in up to 50% of the inherited forms of Hirschsprung disease and in 15-20% of sporadic cases of Hirschsprung disease., The ret unit of radiation dose Proto-Oncogenes is the major gene involved in the complex genetics of Hirschsprung disease (HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1), or aganglionic megacolon, showing causative loss-of-function Gene Mutation in 15-30% of the sporadic cases., The major gene for Hirschsprung disease (HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1) encodes the High Affinity Nerve Growth Factor Receptor, Homo sapiens ret unit of radiation dose., The ret unit of radiation dose Proto-Oncogenes is considered to be the major susceptibility gene involved in Hirschsprung disease., Hirschsprung disease (HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1), a developmental disorder characterized by the absence of enteric neurons in distal segments of the gut, shows a complex pattern of inheritance, with the ret unit of radiation dose protooncogene acting as a major gene and additional susceptibility loci playing minor roles., Traditional ret unit of radiation dose germline Gene Mutation account for a small subset of Hirschsprung disease patients, but several studies have shown that there is a specific cdE cdE haplotype finding finding of ret unit of radiation dose associated with the sporadic forms of Hirschsprung disease., PURPOSE: The ret unit of radiation dose Proto-Oncogenes is considered to be the major susceptibility gene involved in Hirschsprung disease., The ret unit of radiation dose Proto-Oncogenes is the major gene involved in the pathogenesis of Hirschsprung (HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1), a complex genetic disease characterized by lack of Ganglia along variable lengths of the gut., While rare variants (RVs) in the Open Reading Frames (Triglyceride storage disease with ichthyosis) of several Genes involved in ENS development lead to disease, the association of common variants (CVs) with HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 has only been reported for ret unit of radiation dose (the major HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 gene) and NRG1 protein, Homo sapiens protein, Homo sapiens., The rearranged during transfection (ret unit of radiation dose) Proto-Oncogenes is the major susceptibility gene for Hirschsprung disease, and germline Gene Mutation in ret unit of radiation dose have been reported in up to 50% of the inherited forms of Hirschsprung disease and in 15-20% of sporadic cases of Hirschsprung disease., The major gene for Hirschsprung disease (HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1) encodes the High Affinity Nerve Growth Factor Receptor, Homo sapiens ret unit of radiation dose. In a study of 690 European- and 192 Chinese-descent probands and their parents or controls, we demonstrate the ubiquity of a >4-fold susceptibility from a C-->T allele (rs2435357: p = 3.9 x 10(-43) in European ancestry; p = 1.1 x 10(-21) in Chinese samples) that probably arose once within the intronic ret unit of radiation dose enhancer MCS+9.7., Hirschsprung disease (HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1), a developmental disorder characterized by the absence of enteric neurons in distal segments of the gut, shows a complex pattern of inheritance, with the ret unit of radiation dose protooncogene acting as a major gene and additional susceptibility loci playing minor roles., BACKGROUND: The ret unit of radiation dose gene encodes a tyrosine kinase receptor involved in different Homo sapiens neurocristopathies, such as specific Neuroendocrine Tumors and Hirschsprung disease (HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1)., The first major susceptibility gene for Hirschsprung disease is the ret unit of radiation dose Proto-Oncogenes on 10q11.2., The developmental abnormalities apparent in these CASP14 gene, together with the observation that the major Body tissue affected in Multiple Endocrine Neoplasia Type 2a and Hirschsprung disease have a common origin in the embryonal neural crest, suggest that ret unit of radiation dose encodes a receptor for a developmental regulator involved in the genesis of a variety of neural crest derivatives, and in the organogenesis of the Both kidneys., ret unit of radiation dose is the major gene involved in HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1., Recent advances show that the ret unit of radiation dose gene is a major Gene Locus involved in the pathogenesis of HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1., Although with several Genes involved in its pathogenesis, the major HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 gene is the ret unit of radiation dose Proto-Oncogenes., In this model, a major gene, ret unit of radiation dose, is involved in most if not all cases of isolated (i.e., nonsyndromic) HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1, in conjunction with other autosomal susceptibility loci under a multiplicative model., The ret unit of radiation dose Proto-Oncogenes is the major gene involved in the pathogenesis of Hirschsprung (HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1), a complex genetic disease characterized by lack of Ganglia along variable lengths of the gut, The ret unit of radiation dose Proto-Oncogenes is the major gene involved in the complex genetics of Hirschsprung disease (HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1), or aganglionic megacolon, showing causative loss-of-function Gene Mutation in 15-30% of the sporadic cases, The ret unit of radiation dose Proto-Oncogenes is considered to be the major susceptibility gene involved in Hirschsprung disease, Analysis of the ret unit of radiation dose gene, the major gene involved in HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 susceptibility, revealed neither linkage nor Gene Mutation, ret unit of radiation dose is the major gene involved in HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1, Although with several Genes involved in its pathogenesis, the major HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 gene is the ret unit of radiation dose Proto-Oncogenes, While rare variants (RVs) in the Open Reading Frames (Triglyceride storage disease with ichthyosis) of several Genes involved in ENS development lead to disease, the association of common variants (CVs) with HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 has only been reported for ret unit of radiation dose (the major HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 gene) and NRG1 protein, Homo sapiens protein, Homo sapiens, The rearranged during transfection (ret unit of radiation dose) Proto-Oncogenes is the major susceptibility gene for Hirschsprung disease, and germline Gene Mutation in ret unit of radiation dose have been reported in up to 50% of the inherited forms of Hirschsprung disease and in 15-20% of sporadic cases of Hirschsprung disease, Recent advances show that the ret unit of radiation dose gene is a major Gene Locus involved in the pathogenesis of HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1, In this model, a major gene, ret unit of radiation dose, is involved in most if not all cases of isolated (i.e., nonsyndromic) HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1, in conjunction with other autosomal susceptibility loci under a multiplicative model, We report on mutation analysis of five Genes involved in the High Affinity Nerve Growth Factor Receptor, Homo sapiens (ret unit of radiation dose) or the endothelin-signalling pathways in 28 sporadic Japanese patients with Hirschsprung disease, In addition to Gene Mutation in the ret unit of radiation dose and EDNRB protein, Homo sapiens protein, Homo sapiens Genes, embryonic environmental factors and/or other genetic factors appear to be involved in the development of Hirschsprung disease, The ret unit of radiation dose gene is the major HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 gene, although reduced penetrance of ret unit of radiation dose Gene Mutation and variable expression of HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 phenotype indicates that more than one gene is required[SEP]Relations: hirschsprung disease, susceptibility to has relations: disease_protein with ret unit of radiation dose, disease_protein with ret unit of radiation dose, disease_protein with COMT, disease_protein with COMT, disease_protein with EDNRB protein, Homo sapiens, disease_protein with EDNRB protein, Homo sapiens, disease_protein with MED12, disease_protein with MED12, disease_disease with Hirschsprung disease, disease_disease with Hirschsprung disease. Definitions: Open Reading Frames defined as following: A sequence of successive nucleotide triplets that are read as CODONS specifying AMINO ACIDS and begin with an INITIATOR CODON and end with a stop codon (CODON, TERMINATOR).. Neuroendocrine Tumors defined as following: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.. Variant defined as following: An alteration or difference from a norm or standard.. High Affinity Nerve Growth Factor Receptor, Homo sapiens defined as following: High affinity nerve growth factor receptor (796 aa, ~87 kDa) is encoded by the Homo sapiens NTRK1 gene. This protein is involved in tyrosine phosphorylation, axonogenesis and receptor-mediated signaling.. ret unit of radiation dose gene defined as following: This gene plays an essential role in neural crest development, cellular growth and differentiation. Mutations in the gene are associated with a variety of neoplasias and carcinomas.. Ganglia defined as following: Clusters of multipolar neurons surrounded by a capsule of loosely organized CONNECTIVE TISSUE located outside the CENTRAL NERVOUS SYSTEM.. ret unit of radiation dose defined as following: a unit of radiation dose. Enhancer Elements, Genetic defined as following: Cis-acting DNA sequences which can increase transcription of Genes. Enhancers can usually function in either orientation and at various distances from a promoter.. EDNRB protein, Homo sapiens defined as following: Endothelin receptor type B (442 aa, ~50 kDa) is encoded by the Homo sapiens EDNRB protein, Homo sapiens gene. This protein is involved in vasoconstriction and vasodilation.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Proto-Oncogenes defined as following: Normal cellular Genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc.. Triglyceride storage disease with ichthyosis defined as following: Neutral lipid storage disease (NLSD) refers to a group of diseases characterized by a deficit in the degradation of cytoplasmic triglycerides and their accumulation in cytoplasmic lipid vacuoles in most Body tissue of the body. The group is heterogeneous: currently cases of NLSD with icthyosis (NLSDI/Dorfman-Chanarin disease; see this term) and NLSD with myopathy (NLSDM/neutral lipid storage myopathy; see this term) can be distinguished.. NRG1 protein, Homo sapiens defined as following: Neuregulin-1 (222 aa, ~24 kDa) is encoded by the Homo sapiens NRG1 protein, Homo sapiens gene. This protein is involved in binding to receptors from the EGF receptor family of protein tyrosine kinases.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Gene Locus defined as following: The position of a gene or a chromosomal marker on a chromosome; also, a stretch of DNA at a particular place on a particular chromosome. The use of Gene Locus is sometimes restricted to mean regions of DNA that are expressed.. Homo sapiens defined as following: Members of the species Homo sapiens.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. Multiple Endocrine Neoplasia Type 2a defined as following: A form of multiple endocrine neoplasia characterized by the presence of medullary carcinoma (CARCINOMA, MEDULLARY) of the THYROID GLAND, and usually with the co-occurrence of PHEOCHROMOCYTOMA, producing CALCITONIN and ADRENALINE, respectively. Less frequently, it can occur with hyperplasia or adenoma of the PARATHYROID GLANDS. This disease is due to gain-of-function Gene Mutation of the MEN2 gene on CHROMOSOME 10 (Locus: 10q11.2), also known as the ret unit of radiation dose Proto-Oncogenes that encodes a RECEPTOR PROTEIN-TYROSINE KINASE. It is an autosomal dominant inherited disease.. gene defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Is Ozanimod effective for Ulcerative Colitis?", "id": "converted_4250", "sentence1": "Is Ozanimod effective for Ulcerative Colitis?", "sentence2": "Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis., CONCLUSIONS: Ozanimod was more effective than placebo as induction and maintenance therapy in patients with moderately to severely active ulcerative colitis., CONCLUSIONS: There was a high rate of continued study participation and long-term benefit with ozanimod Hairy Cell Leukemia 1 mg daily based on clinical, histological and biomarker measures in patients with moderately to severely active UC in the TOUCHSTONE OLE. [NCT02531126]., Ozanimod: A First-in-Class Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis., CONCLUSION: Ozanimod is another option in the growing arsenal of UC treatment., RELEVANCE TO PATIENT CARE AND CLINICAL PRACTICE: Ozanimod is the first sphingosine 1-phosphate modulator to be approved for UC and is administered orally. Its efficacy profile is comparable with other UC medications., Compared with placebo, ozanimod led to clinical remission in a significantly higher proportion of patients in both the induction and maintenance phase. Additionally, for secondary end points of clinical response, endoscopic improvement, corticosteroid-free remission, and mucosal healing, ozanimod performed significantly better than placebo. , Ozanimod interferes with migrations of activated Therapeutic gamma delta T-lymphocytes to the site of Inflammation and is a promising Pharmacologic Substance for the UC treatment.Key words: Crohn Disease - mongersen - monoclonal antibodies - ozanimod - tofacitinib - ulcerative colitis., SIONS: Ozanimod was more effective than placebo as induction and maintenance therapy in patients with moderately to severely active ulcerative colitis. (Fund, The sphingosine-1-phosphate receptor-1 (Sphingosine 1-Phosphate Receptor 1, Human) Agonist ozanimod ameliorates ulcerative colitis, yet its mechanism of action is unknown. , Ozanimod (RPC1063) is a specific and potent small molecule modulator of the Sphingosine-1-Phosphate Receptors (S1PR1) and receptor 5 (S1PR5), which has shown therapeutic benefit in clinical trials of relapsing Multiple Sclerosis and ulcerative colitis. Ozan, SIONS: Ozanimod was more effective than placebo as induction and maintenance therapy in patients with moderately to severely active ulcerative colitis. (Fun, SIONS: In this preliminary trial, ozanimod at a daily dose of 1 mg resulted in a slightly higher rate of clinical remission of ulcerative colitis than placebo. The [SEP]Relations: ulcerative colitis (disease) has relations: contraindication with Benzthiazide, contraindication with Benzthiazide, contraindication with Icosapent, contraindication with Icosapent, contraindication with Polythiazide, contraindication with Polythiazide, contraindication with Chlorothiazide, contraindication with Chlorothiazide, contraindication with Trolnitrate, contraindication with Trolnitrate. Definitions: Agonist defined as following: An agent that has affinity for a receptor and intrinsic activity at that receptor.. Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Ulcerative Colitis defined as following: Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.. Sphingosine 1-Phosphate Receptor 1, Human defined as following: Sphingosine 1-phosphate receptor 1 (382 aa, ~43 kDa) is encoded by the human S1PR1 gene. This protein plays a role in phospholipid binding.. Therapeutic gamma delta T-lymphocytes defined as following: A subset of therapeutic autologous T-lymphocytes that express a T-cell receptor (TCR) composed of one gamma chain and one delta chain, with potential immunomodulating and antineoplastic activities. Upon administration of the therapeutic gamma delta T-lymphocytes, these cells secrete interferon-gamma (IFN-g), and exert direct killing of tumor cells. In addition, these cells activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against tumor cells. Gamma delta T-lymphocytes play a key role in the activation of the immune system and do not require major histocompatibility complex (MHC)-mediated antigen presentation to exert their cytotoxic effect.. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. Multiple Sclerosis defined as following: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903). ozanimod defined as following: An orally bioavailable sphingosine-1-phosphate (S1P) receptors 1 (S1PR1, Sphingosine 1-Phosphate Receptor 1, Human) and 5 (S1PR5, S1P5) modulator, with potential anti-inflammatory and immunomodulating activities. Upon oral administration, ozanimod selectively targets and binds to S1PR1 on lymphocytes and induces S1PR1 internalization and degradation. This results in the sequestration of lymphocytes in lymph nodes. By preventing egress of lymphocytes, ozanimod reduces both the amount of circulating peripheral lymphocytes and the infiltration of lymphocytes into target tissues. This prevents a lymphocyte-mediated immune response and may reduce Inflammation. S1PR1, a G-protein coupled receptor, plays a key role in lymphocyte migration from lymphoid tissues. Modulation of S1PR5 by ozanimod may be neuroprotective.. Crohn Disease defined as following: A chronic transmural Inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the Inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.. Sphingosine-1-Phosphate Receptors defined as following: A subfamily of lysophospholipid receptors with specificity for sphingosine-1-phosphate (e.g., FINGOLIMOD), sphinganine 1-phosphate, 4-hydroxysphinganine 1-phosphate.. Hairy Cell Leukemia defined as following: A neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of \"hairy\" or \"flagellated\" cells in the blood and bone marrow..", "label": "yes"} {"original_question": "Can propofol cause green urine?", "id": "converted_4119", "sentence1": "Can propofol cause green Specimen Source Codes - Urine?", "sentence2": "Reasons for discontinuing propofol are signs of rhabdomyolysis (92.9%), green Specimen Source Codes - Urine, elevated Finding of Abdomen>Liver enzyme levels (71.4% each) and elevated Triglycerides (57.1%)., propofol-Induced Green Urine in a Patient with Refractory Status Epilepticus., We present the case of a 52-year-old man, who developed green Specimen Source Codes - Urine following propofol coma therapy for Status Epilepticus., The green discoloration of Specimen Source Codes - Urine is a rare and Benign condition, which occurs when clearance of propofol exceeds the Hepatic and extrahepatic elimination., Green Abnormal color of Specimen Source Codes - Urine following propofol infusion in a Canis familiaris., During mechanical ventilation, anaesthesia was maintained using a propofol target-controlled infusion system and, subsequently, the Canis familiaris produced bright green Specimen Source Codes - Urine in the Specimen Source Codes - Urine collection system. Although previously documented in Homo sapiens, this appears to be the first report of green Specimen Source Codes - Urine in a Canis familiaris following propofol use., Green Specimen Source Codes - Urine is also caused by medications such as propofol and Infections of musculoskeletal system such as pseudomonas., Although it is assumed that the phenolic derivatives of propofol can cause green discoloration of the Specimen Source Codes - Urine, the actual origin remains unknown., An uncommon adverse effect of propofol is green discoloration of the Specimen Source Codes - Urine, which has been reported not only under general anesthesia but also with sedation., Antifungal Antifungal Antibiotics, Topical, Topical were avoided when propofol was recognized as a rare and Benign potential cause of the green Specimen Source Codes - Urine., Green Urine Due to propofol: A Case Report with Review of Literature., Herein, we present a case of 62-year-old postoperative lady, noticed to be passing green coloured Specimen Source Codes - Urine believed to be due to intravenous propofol administration for induction of general anaesthesia., Green Specimen Source Codes - Urine is rare indeed and it is a Benign potential side effect of propofol; this phenomenon is related to the metabolism of propofol., Clinical significance of rare and Benign side effects: propofol and green Specimen Source Codes - Urine., Green Specimen Source Codes - Urine in a patient who received a continuous infusion of propofol: A case report., This phenomenon is due to metabolism of propofol which may lead to a phenolic green chromophore which is conjugated in the Abdomen>Liver and excreted in the Specimen Source Codes - Urine., Green Urine Discoloration due to propofol Infusion: A Case Report., An analysis of green discoloration of Specimen Source Codes - Urine caused by propofol infusion., We experienced green Specimen Source Codes - Urine from a long-term anesthetized patient who received a continuous infusion of propofol., We present a 19-year-old man who excreted green Specimen Source Codes - Urine after propofol infusion., green colour of Specimen Source Codes - Urine due to propofol occurs when clearance of propofol exceeds Hepatic elimination, and extrahepatic elimination of propofol occurs. Thi, Green Specimen Source Codes - Urine from propofol infusion is a Benign and rare side effect, Grass-green Specimen Source Codes - Urine from propofol infusion, propofol-Induced Green Urine in a Patient with Refractory Status Epilepticus, sedation. An uncommon adverse effect of propofol is green discoloration of the Specimen Source Codes - Urine, which has been reported not only under general anesthesia but also with, erein, we present a case of 62-year-old postoperative lady, noticed to be passing green coloured Specimen Source Codes - Urine believed to be due to intravenous propofol administration for induction of general anaesthesia. T, en Specimen Source Codes - Urine is rare indeed and it is a Benign potential side effect of propofol; this phenomenon is related to the metabolism of propofol. W, Green Specimen Source Codes - Urine is also caused by medications such as propofol and Infections of musculoskeletal system such as pseudomonas, Green Urine Due to propofol: A Case Report with Review of Literature, LUSION: We experienced a case of a patient with green discoloration of the Specimen Source Codes - Urine after general anesthesia using propofol. therapeutic autologous lymphocytes, After starting continuous infusion of propofol for postoperative sedation, his Specimen Source Codes - Urine became dark green., We believe that the green discoloration of the Specimen Source Codes - Urine was caused by propofol infusion and was related to impaired enterohepatic circulation and extrahepatic glucuronidation in the Both Both kidneys., WHAT IS KNOWN AND OBJECTIVE: propofol, a commonly used sedative, has on rare occasions, been reported to discolour Specimen Source Codes - Urine green, IS NEW AND CONCLUSION: Green discoloration of the Specimen Source Codes - Urine from propofol infusion is dose dependent. It, We report on a patient who produced dark green discoloration of Specimen Source Codes - Urine from prolonged propofol infusion, administered for intractable epilepsy, Dark green discoloration of the Specimen Source Codes - Urine after prolonged propofol infusion: a case report., experienced a case of a patient with green discoloration of the Specimen Source Codes - Urine after general anesthesia using propofol. A, On the third day of propofol infusion his Specimen Source Codes - Urine was dark green., Green Specimen Source Codes - Urine from propofol infusion is a Benign and rare side effect., The green colour of Specimen Source Codes - Urine due to propofol occurs when clearance of propofol exceeds Hepatic elimination, and extrahepatic elimination of propofol occurs., ur change is dose dependent. We report on a patient who produced dark green discoloration of Specimen Source Codes - Urine from prolonged propofol infusion, administered for intractable epilepsy.CASE SUMMARY: The colour intensity of the patient's uri, Several Substance in literature have been associated with green Specimen Source Codes - Urine including propofol, Biliverdine, metoclopramide, methylene blue, indigo, amitriptyline, methocarbamol, indomethacin, promethazine, cimetidine and food colourings. , We discuss a case of a Benign cause of green discoloration of Specimen Source Codes - Urine caused by propofol infusion, which reversed following its discontinuation., The patient's Specimen Source Codes - Urine subsequently showed a green discoloration. Urine discoloration was completely reversible upon discontinuation of propofol., Two days after admittance, we observed a green discoloration of the Specimen Source Codes - Urine. This is a rare and Benign side effect of propofol., We describe a 58-year-old man who developed green Specimen Source Codes - Urine after operation on a pressure ulcer. The Abnormal color disappeared gradually after two days. We think that the use of methylene blue dye during the revision of the Injury Injury wounds and the use of the sedative propofol could have caused it.[SEP]Relations: propofol has relations: drug_effect with Vomiting, drug_effect with Vomiting, drug_drug with Urethane, drug_drug with Urethane, drug_effect with Urinary retention, drug_effect with Urinary retention, drug_effect with Cough, drug_effect with Cough, drug_drug with Urapidil, drug_drug with Urapidil. Definitions: indomethacin defined as following: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.. Abnormal color defined as following: A change in color that deviates from the norm or outwith the bounds of what is considered normal.. propofol defined as following: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). propofol has been used as ANTICONVULSANTS and ANTIEMETICS.. Triglycerides defined as following: An ester formed from GLYCEROL and three fatty acid groups.. Benign defined as following: For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health.. amitriptyline defined as following: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.. cimetidine defined as following: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.. Homo sapiens defined as following: Members of the species Homo sapiens.. Hepatic defined as following: Pertaining to, affecting, or associated with the Abdomen>Liver.. Biliverdine defined as following: 1,3,6,7-Tetramethyl-4,5-dicarboxyethyl-2,8-divinylbilenone. Biosynthesized from hemoglobin as a precursor of bilirubin. Occurs in the bile of AMPHIBIANS and of birds, but not in normal human bile or serum.. Status Epilepticus defined as following: A prolonged seizure or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic Status Epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial Status Epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition (see also EPILEPSIA PARTIALIS CONTINUA). Subclinical Status Epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity. (From N Engl J Med 1998 Apr 2;338(14):970-6; Neurologia 1997 Dec;12 Suppl 6:25-30). methylene blue defined as following: A compound consisting of dark green crystals or crystalline powder, having a bronze-like luster. Solutions in water or alcohol have a deep blue color. Methylene blue is used as a bacteriologic stain and as an indicator. It inhibits GUANYLATE CYCLASE, and has been used to treat cyanide poisoning and to lower levels of METHEMOGLOBIN.. metoclopramide defined as following: A dopamine D2 antagonist that is used as an antiemetic.. Injury wounds defined as following: bodily injury caused by physical means, with disruption of the normal continuity of structures.. promethazine defined as following: A phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals.. green Specimen Source Codes - Urine defined as following: An abnormal green color of Specimen Source Codes - Urine. [PMID:28413291]. Canis familiaris defined as following: The domestic Canis familiaris, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065). therapeutic autologous lymphocytes defined as following: A population of lymphocytes isolated from an individual, altered in vitro, and returned to the same individual for therapeutic purposes. (NCI04). Substance defined as following: Any matter of defined composition that has discrete existence, whose origin may be biological, mineral or chemical.. propofol defined as following: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). propofol has been used as ANTICONVULSANTS and ANTIEMETICS..", "label": "yes"} {"original_question": "Is gabapentin effective for chronic pelvic pain?", "id": "converted_4399", "sentence1": "Is gabapentin effective for Chronic pelvic pain of female?", "sentence2": "There were no significant between-group differences in both worst and average numerical rating scale (NRS) pain scores at 13-16 weeks after randomisation. The mean worst NRS pain score was 7·1 (standard deviation [SLC17A5 gene] 2·6) in the gabapentin group and 7·4 (SLC17A5 gene 2·2) in the placebo group. Mean change from baseline was -1·4 (SLC17A5 gene 2·3) in the gabapentin group and -1·2 (SLC17A5 gene 2·1) in the placebo group (adjusted mean difference -0·20 [97·5% CI -0·81 to 0·42]; p=0·47). The mean average NRS pain score was 4·3 (SLC17A5 gene 2·3) in the gabapentin group and 4·5 (SLC17A5 gene 2·2) in the placebo group. Mean change from baseline was -1·1 (SLC17A5 gene 2·0) in the gabapentin group and -0·9 (SLC17A5 gene 1·8) in the placebo group (adjusted mean difference -0·18 [97·5% CI -0·71 to 0·35]; p=0·45)., INTERPRETATION: This study was adequately powered, but treatment with gabapentin did not result in significantly lower pain scores in women with Chronic pelvic pain of female, and was associated with higher rates of side-effects than placebo. Given the increasing reports of abuse and evidence of potential harms associated with gabapentin use, it is important that clinicians consider alternative treatment options to off-label gabapentin for the management of Chronic pelvic pain of female and no obvious pelvic pathology., Gabapentin not effective for Chronic pelvic pain of female in women., Gabapentin not effective for Chronic pelvic pain of female in women[SEP]Relations: Gabapentin has relations: drug_effect with Bone pain, drug_effect with Bone pain, drug_effect with Pain, drug_effect with Pain, drug_effect with Abdominal pain, drug_effect with Abdominal pain, drug_effect with Chest pain, drug_effect with Chest pain, drug_effect with Back pain, drug_effect with Back pain. Definitions: gabapentin defined as following: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME..", "label": "no"} {"original_question": "Are ultraconserved elements often transcribed?", "id": "converted_49", "sentence1": "Are ultraconserved Elements often transcribed?", "sentence2": "Starting from a genome-wide expression profiling, we demonstrate for the first time a functional link between oxygen deprivation and the modulation of long noncoding RNA Transcript from ultraconserved regions, termed transcribed-ultraconserved regions (T-UCRs), Our data gives a first glimpse of a novel functional hypoxic network comprising protein-coding RNA Transcript and noncoding RNA (ncRNAs) from the T-UCRs category, Highly conserved Elements discovered in Vertebrates are present in non-syntenic loci of tunicates, act as enhancers and can be transcribed during development, The majority of these regions map onto ultraconserved Elements and we demonstrate that they can act as functional enhancers within the organism of origin, as well as in cross-transgenesis experiments, and that they are transcribed in extant species of Olfactores. We refer to the Elements as 'Olfactores conserved non-coding Elements', We used a custom microarray to assess the levels of NAGPA gene transcription during Mus sp. development and integrated these data with published microarray and next-generation sequencing datasets as well as with newly produced PCR validation experiments. We show that a large MDFAttributeType - Fraction of non-exonic UCEs is transcribed across all developmental stages examined from only one DNA strand. Although the nature of these RNA Transcript remains a mistery, our meta-analysis of RNA-Seq datasets indicates that they are unlikely to be short RNA and that some of them might encode nuclear RNA Transcript, Our data shows that the concurrent presence of enhancer and transcript function in non-exonic NAGPA gene Elements is more widespread than previously shown. Moreover through our own experiments as well as the use of next-generation sequencing datasets, we were able to show that the RNA encoded by non-exonic UCEs are likely to be long RNA transcribed from only one DNA strand, Short ultraconserved promoter regions delineate a class of preferentially expressed alternatively spliced RNA Transcript, The importance of other classes of non-coding RNA, such as long intergenic ncRNAs (Long Intergenic Non-Protein Coding RNA) and transcribed ultraconserved regions (T-UCRs) as altered Elements in Neoplasms, is also gaining recognition., Other ncRNAs, such as Piwi-Interacting RNA (piRNAs), small nucleolar RNA (snoRNAs), transcribed ultraconserved regions (T-UCRs) and large intergenic non-coding RNA (Long Intergenic Non-Protein Coding RNA) are emerging as key Elements of cellular homeostasis., The majority of these regions map onto ultraconserved Elements and we demonstrate that they can act as functional enhancers within the organism of origin, as well as in cross-transgenesis experiments, and that they are transcribed in extant species of Olfactores., Transcribed ultraconserved regions (T-UCRs) are a subset of 481 DNA Sequence longer than 200 bp, which are absolutely conserved between orthologous regions of Homo sapiens, Rattus norvegicus and Mus sp. genomes, and are actively transcribed., Highly conserved Elements discovered in Vertebrates are present in non-syntenic loci of tunicates, act as enhancers and can be transcribed during development., The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator., In this report, we show that the Dlx-5/6 ultraconserved region is transcribed to generate an alternatively spliced form of Evf-1, the RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL Evf-2., These studies identify a critical role for TUC338 in regulation of transformed cell growth and of transcribed ultraconserved RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL as a unique class of Genes involved in the pathobiology of altretamine/cisplatin/cyclophosphamide protocol., Transcribed ultraconserved region (T-UCR) RNA Transcript are a novel class of lncRNAs transcribed from ultraconserved regions (UCRs), The majority of these regions map onto ultraconserved Elements and we demonstrate that they can act as functional enhancers within the organism of origin, as well as in cross-transgenesis experiments, and that they are transcribed in extant species of Olfactores, Transcribed ultraconserved regions (T-UCRs) are a subset of 481 DNA Sequence longer than 200 bp, which are absolutely conserved between orthologous regions of Homo sapiens, Rattus norvegicus and Mus sp. genomes, and are actively transcribed, Other ncRNAs, such as Piwi-Interacting RNA (piRNAs), small nucleolar RNA (snoRNAs), transcribed ultraconserved regions (T-UCRs) and large intergenic non-coding RNA (Long Intergenic Non-Protein Coding RNA) are emerging as key Elements of cellular homeostasis, Transcribed ultraconserved region in Homo sapiens Malignant Neoplasms., We show that a large MDFAttributeType - Fraction of non-exonic UCEs is transcribed across all developmental stages examined from only one DNA strand, Although PCBP2 gene gene-OT1 gene is partially located within the poly(rC) binding protein 2 (PCBP2 gene gene) gene, the transcribed RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL encoding PCBP2 gene gene-OT1 gene is expressed independently of PCBP2 gene gene and was cloned as a 590-bp RNA gene, termed TUC338, Moreover through our own experiments as well as the use of next-generation sequencing datasets, we were able to show that the RNA encoded by non-exonic UCEs are likely to be long RNA transcribed from only one DNA strand.[SEP]Relations: rRNA transcription has relations: bioprocess_protein with ANG, bioprocess_protein with ANG, bioprocess_bioprocess with plastid rRNA transcription, bioprocess_bioprocess with plastid rRNA transcription, bioprocess_bioprocess with mitochondrial rRNA transcription, bioprocess_bioprocess with mitochondrial rRNA transcription, bioprocess_bioprocess with RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL transcription, bioprocess_bioprocess with RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL transcription, bioprocess_bioprocess with nucleolar large rRNA transcription by RNA polymerase I, bioprocess_bioprocess with nucleolar large rRNA transcription by RNA polymerase I. Definitions: DNA Sequence defined as following: The sequence of nucleotide residues along a DNA chain.. Piwi-Interacting RNA defined as following: Single-stranded RNA molecules that are expressed in animal cells and form complexes with Piwi proteins. They are involved in transcriptional gene silencing.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. Elements defined as following: Substances that comprise all matter. Each element is made up of atoms that are identical in number of electrons and protons and in nuclear charge but may differ in mass or number of neutrons.. RNA Transcript defined as following: The initial RNA molecule produced by transcription.. Genes defined as following: A category of nucleic acid DNA Sequence that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. MDFAttributeType - Fraction defined as following:

For attributes that represent a MDFAttributeType - Fraction or proportion. The former attribute type PCT for \"percentage\" is superceded by FRC and is no longer permitted. See also QTY.

. Long Intergenic Non-Protein Coding RNA defined as following: A molecule of RNA 200-17000 nucleotides in length that is transcribed by non-protein coding areas of DNA. These ribonucleotides may play a role in a variety of biological processes.. Homo sapiens defined as following: Members of the species Homo sapiens.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Vertebrates defined as following: Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising mammals, birds, reptiles, amphibians, and fishes..", "label": "yes"} {"original_question": "Can miR-122 target RUNX2?", "id": "converted_3167", "sentence1": "Can miR-122 target RUNX2 gene?", "sentence2": "MIR122 gene functions as a tumor suppressor by inhibiting proliferation and inducing apoptosis, which is achieved by directly targeting RUNX2 gene gene.[SEP]Relations: MIR122 has relations: bioprocess_protein with gene silencing by miRNA, bioprocess_protein with gene silencing by miRNA, disease_protein with liver cancer, disease_protein with liver cancer, disease_protein with drug-induced liver injury, disease_protein with drug-induced liver injury, disease_protein with acute kidney failure, disease_protein with acute kidney failure, disease_protein with hepatitis B virus infection, disease_protein with hepatitis B virus infection. Definitions: RUNX2 gene defined as following: Runt-related transcription factor 2 (521 aa, ~57 kDa) is encoded by the human RUNX2 gene gene. This protein plays a role in the regulation of both bone development and transcription.. MIR122 gene defined as following: This gene is involved in the regulation of gene expression and plays a role in the development of hepatocellular carcinoma.. miR-122 defined as following: This gene is involved in the regulation of gene expression and plays a role in the development of hepatocellular carcinoma..", "label": "yes"} {"original_question": "Is it feasible to obtain DNA read lengths that exceed 30 Kb?", "id": "converted_2140", "sentence1": "Is it feasible to obtain DNA read lengths that exceed 30 Kb?", "sentence2": "Single-molecule, real-time sequencing (NCOR2 wt Allele) developed by Pacific BioSciences produces longer reads than secondary generation sequencing technologies such as Illumina. The long read length enables PacBio sequencing to close gaps in Genome Assembly Sequence, reveal structural variations, and identify gene isoforms with higher accuracy in transcriptomic sequencing., Third-generation sequencing, with read lengths>10 kb, will improve the assembly of complex genomes, but these techniques require high-molecular-weight Genomic DNA (gDNA), and gDNA extraction protocols used for obtaining smaller Fragment of (qualifier value) for short-read sequencing are not suitable for this purpose., The emergence and development of so called third generation sequencing platforms such as PacBio has permitted exceptionally long reads (over 20 kb) to be generated.[SEP]Definitions: Genomic DNA defined as following: The DNA that is part of the normal chromosomal complement of an organism.. Fragment of (qualifier value) defined as following: A physical quality in which the entity or structure is broken into pieces.. NCOR2 wt Allele defined as following: Human NCOR2 wild-type allele is located in the vicinity of 12q24 and is approximately 194 kb in length. This allele, which encodes nuclear receptor corepressor 2 protein, plays a role in both chromatin structural alteration and transcriptional regulation.. Genome Assembly Sequence defined as following: An annotated assembly of genome sequences created by the assimilation of data pieces from numerous sources.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine)..", "label": "no"} {"original_question": "Is the protein β1-integrin recycled?", "id": "converted_524", "sentence1": "Is the protein β1-integrin recycled?", "sentence2": "Pathways selectively regulating β1-integrin recycling are implicated in cancer invasion and metastasis,, integrin-positive early and recycling Endosomes , LPA-induced recycling of Integrins,, RCP-mediated recycling of α5β1 integrin , CycD1 overexpression increased Integrins recycling , inhibition of autophagy slowed down the lysosomal degradation of internalized β1 integrins and promoted its membrane recycling, recycling pathway for β1-integrin, Integrins recycling, Integrins recycling, controlling Integrins recycling to the Plasma membrane , integrin recycling pathway, Distinct recycling of active and inactive β1 integrins., Integrin functions are controlled by regulating their affinity for ligand, and by the efficient recycling of intact integrins through Endosomes., β1 integrins, resulting in their recycling to the Cell surface where they can be reused.[SEP]Relations: integrin binding has relations: molfunc_protein with IGF1, molfunc_protein with IGF1, molfunc_protein with FBN1, molfunc_protein with FBN1, molfunc_protein with S1PR2, molfunc_protein with S1PR2, molfunc_protein with S1PR3, molfunc_protein with S1PR3, molfunc_protein with FGF1, molfunc_protein with FGF1. Definitions: Integrins defined as following: A family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors (RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation.. Plasma membrane defined as following: The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells.. Cell surface defined as following: The external part of the cell wall and/or Plasma membrane. [GOC:jl, GOC:mtg_sensu, GOC:sm]. Endosomes defined as following: Cytoplasmic vesicles formed when COATED VESICLES shed their CLATHRIN coat. Endosomes internalize macromolecules bound by receptors on the Cell surface..", "label": "yes"} {"original_question": "Are Conserved Nonexonic Elements (CNEEs) important in phylogenomics research?", "id": "converted_2364", "sentence1": "Are Conserved Nonexonic Elements (CNEEs) important in phylogenomics research?", "sentence2": "Overall, CNEEs appear to be promising as phylogenomic markers, yielding phylogenetic resolution as high as for UCEs and Introns but with fewer gaps, less ambiguity in alignments and with patterns of nucleotide substitution more consistent with the assumptions of commonly used methods of phylogenetic analysis., Conserved Nonexonic Elements: A Novel Class of Marker for Phylogenomics., Target capture for vertebrate animals is currently dominated by two approaches-anchored hybrid enrichment (Ahahnelin language) and ultraconserved elements (UCE)-and both approaches have proven useful for addressing questions in phylogenomics, phylogeography and population genomics., conserved nonexonic elements a novel class of marker for phylogenomics[SEP]Definitions: Introns defined as following: Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some Introns code for separate genes..", "label": "yes"} {"original_question": "Can the iPS cell technology be used in Fanconi anemia therapy?", "id": "converted_1581", "sentence1": "Can the iPS cell technology be used in Fanconi anemia therapy?", "sentence2": "We explain a protocol for the reproducible generation of genetically corrected iPSCs starting from the skin biopsies of Fanconi anemia patients using retroviral transduction with POU5F1 gene, SOX2 protein, human protein, human and KLF4 protein, human protein, human, Before reprogramming, the Specimen Source Codes - Fibroblasts and/or keratinocyte of the patients are genetically corrected with Genus: Lentivirus group expressing FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)., Disease-corrected haematopoietic progenitors from Fanconi Anemia induced pluripotent stem cells, Here we show that, on correction of the genetic defect, Diploid Cell from Fanconi Anemia patients can be reprogrammed to pluripotency to generate patient-specific Induced Pluripotent Stem Cells. These Cultured Cell Line appear indistinguishable from Human Embryonic Stem Cells and Induced Pluripotent Stem Cells from healthy individuals, Most importantly, we show that corrected Fanconi-anaemia-specific Induced Pluripotent Stem Cells can give rise to haematopoietic progenitors of the Myeloid and Erythroid lineages that are phenotypically normal, that is, disease-free[SEP]Relations: Fanconi anemia has relations: disease_protein with FANCI, disease_protein with FANCI, disease_protein with FANCE, disease_protein with FANCE, disease_disease with DNA repair disease, disease_disease with DNA repair disease, contraindication with Phenol, contraindication with Phenol. Fanconi anemia complementation group has relations: disease_phenotype_positive with Squamous cell carcinoma, disease_phenotype_positive with Squamous cell carcinoma. Definitions: FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) defined as following: Fanconi anemia caused by mutations of the FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) gene. FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) gene mutations are the most common cause of Fanconi anemia. This gene provides instructions for making a protein that is involved in the Fanconi anemia (FA) pathway.. POU5F1 gene defined as following: This gene plays a role in early mammalian development.. Fanconi Anemia defined as following: Congenital disorder affecting all bone marrow elements, resulting in ANEMIA; LEUKOPENIA; and THROMBOPENIA, and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. Spontaneous CHROMOSOME BREAKAGE is a feature of this disease along with predisposition to LEUKEMIA. There are at least 7 complementation groups in Fanconi anemia: FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder), FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=227650, August 20, 2004). KLF4 protein, human defined as following: Krueppel-like factor 4 (470 aa, ~50 kDa) is encoded by the human KLF4 protein, human gene. This protein regulates transcription.. keratinocyte defined as following: Epidermal cells which synthesize keratin and undergo characteristic changes as they move upward from the basal layers of the epidermis to the cornified (horny) layer of the skin. Successive stages of differentiation of the keratinocyte forming the epidermal layers are basal cell, spinous or prickle cell, and the granular cell.. Induced Pluripotent Stem Cells defined as following: Cells from adult organisms that have been reprogrammed into a pluripotential state similar to that of EMBRYONIC STEM CELLS.. Myeloid defined as following: A type of white blood cell. Neutrophils, eosinophils, and basophils are granulocytes.. Diploid Cell defined as following: Nucleated cell which has one or more diploid sets (46 pairs) of chromosomes.. Cultured Cell Line defined as following: Established cell cultures that have the potential to propagate indefinitely.. SOX2 protein, human defined as following: Transcription factor SOX-2 protein (317 aa, ~34 kDa) is encoded by the human SOX2 protein, human gene. This protein is involved in neural cell progenitor differentiation and neurogenesis.. Erythroid defined as following: 1) Reddish in color. 2) relating to erythrocytes or their precursors.. Genus: Lentivirus group defined as following: A genus of the family RETROVIRIDAE consisting of non-oncogenic retroviruses that produce multi-organ diseases characterized by long incubation periods and persistent infection. Lentiviruses are unique in that they contain open reading frames (ORFs) between the pol and env genes and in the 3' env region. Five serogroups are recognized, reflecting the mammalian hosts with which they are associated. HIV-1 is the type species.. Human Embryonic Stem Cells defined as following: A type of PLURIPOTENT STEM CELLS derived from early stage human embryos, up to and including the BLASTOCYST stage.. Fanconi anemia defined as following: Fanconi anemia caused by mutations of the FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) gene. FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) gene mutations are the most common cause of Fanconi anemia. This gene provides instructions for making a protein that is involved in the Fanconi anemia (FA) pathway..", "label": "yes"} {"original_question": "Is TENS machine effective in pain?", "id": "converted_67", "sentence1": "Is Transcutaneous Electric Nerve Stimulation machine effective in pain?", "sentence2": "Transcutaneous electrical nerve stimulation is widely used in pain management but its effectiveness depends on the stimulation being targeted appropriately, hypoalgesic effects of transcutaneous electrical nerve stimulation upon experimentally induced ischaemic pain., The results of this study have provided evidence of the hypoalgesic effects of Transcutaneous Electric Nerve Stimulation upon experimental ischaemic pain which were found to be frequency specific with the lower frequency used here (4 Hz) demonstrating the only significant effect[SEP]Relations: negative regulation of spontaneous neurotransmitter secretion has relations: bioprocess_protein with PRKN, bioprocess_protein with PRKN, bioprocess_protein with PPP1R9A, bioprocess_protein with PPP1R9A, bioprocess_bioprocess with regulation of spontaneous neurotransmitter secretion, bioprocess_bioprocess with regulation of spontaneous neurotransmitter secretion, bioprocess_bioprocess with negative regulation of neurotransmitter secretion, bioprocess_bioprocess with negative regulation of neurotransmitter secretion. Definitions: Transcutaneous Electric Nerve Stimulation defined as following: The use of specifically placed small electrodes to deliver electrical impulses across the SKIN to relieve PAIN. It is used less frequently to produce ANESTHESIA..", "label": "yes"} {"original_question": "Does the association of PARP1 and CTCF follow a circadian rhythm?", "id": "converted_2391", "sentence1": "Does the association of PARP1 protein, human and CTGF protein, human follow a circadian rhythm?", "sentence2": "here we uncovered an inter-chromosomal network connecting active loci enriched in circadian genes to repressed Lamiinae (invertebrate)-associated domains (LADs)., Synchronization of the circadian rhythm by serum shock induces oscillations in PARP1 protein, human protein, human-CTGF protein, human interactions, which is accompanied by oscillating recruitment of circadian loci to the Lamiinae (invertebrate), followed by the acquisition of repressive H3K9me2 marks and transcriptional attenuation, PARP1 protein, human protein, human- and CTGF protein, human-regulated contacts between circadian loci and the repressive chromatin environment at the Lamiinae (invertebrate) therefore mediate circadian transcriptional plasticity., Synchronization of the circadian rhythm by serum shock induces oscillations in PARP1 protein, human protein, human-CTGF protein, human interactions, which is accompanied by oscillating recruitment of circadian loci to the Lamiinae (invertebrate), followed by the acquisition of repressive H3K9me2 marks and transcriptional attenuation. Furthermore, depletion of H3K9me2/3, inhibition of PARP1 protein, human wt Allele activity by olaparib, or downregulation of PARP1 protein, human protein, human or CTGF protein, human expression counteracts both recruitment to the envelope and circadian transcription. PARP1 protein, human protein, human- and CTGF protein, human-regulated contacts between circadian loci and the repressive chromatin environment at the Lamiinae (invertebrate) therefore mediate circadian transcriptional plasticity., transcriptionally active and inactive chromatin domains tend to segregate into separate sub nuclear compartments to maintain stable expression patterns however here we uncovered an inter chromosomal network connecting active loci enriched in circadian genes to repressed Lamiinae (invertebrate) associated domains lads the interactome is regulated by parp1 and its co factor ctcf they not only mediate 30 nm Chromatin Fiber interactions but also promote the recruitment of circadian genes to the Lamiinae (invertebrate) synchronization of the circadian rhythm by serum shock induces oscillations in parp1 ctcf interactions which is accompanied by oscillating recruitment of circadian loci to the Lamiinae (invertebrate) followed by the acquisition of repressive h3k9me2 marks and transcriptional attenuation furthermore depletion of h3k9me2 3 inhibition of parp activity by olaparib or downregulation of parp1 or ctcf expression counteracts both recruitment to the envelope and circadian transcription parp1 and ctcf regulated contacts between circadian loci and the repressive chromatin environment at the Lamiinae (invertebrate) therefore mediate circadian transcriptional plasticity., Synchronization of the circadian rhythm by serum shock induces oscillations in PARP1 protein, human protein, human-CTGF protein, human interactions, which is accompanied by oscillating recruitment of circadian loci to the Lamiinae (invertebrate), followed by the acquisition of repressive H3K9me2 marks and transcriptional attenuation.[SEP]Relations: Olaparib has relations: drug_protein with PARP1 protein, human, drug_protein with PARP1 protein, human, drug_protein with PARP3, drug_protein with PARP3, drug_protein with PARP2, drug_protein with PARP2, drug_drug with Peginterferon beta-1a, drug_drug with Peginterferon beta-1a, drug_drug with Parnaparin, drug_drug with Parnaparin. Definitions: PARP1 protein, human defined as following: Poly [ADP-ribose] polymerase 1 (1013aa, ~113 kDa) is encoded by the human PARP1 protein, human gene. This protein is involved in poly ADP-ribosylation and in the regulation of various cellular processes such as differentiation, proliferation, tumor transformation, and recovery from DNA damage.. CTGF protein, human defined as following: CCN family member 2 (349 aa, ~38kDa) is encoded by the human CCN2 gene. This protein plays a role in the promotion of proliferation and differentiation of chondrocytes and also mediates heparin- and divalent cation-dependent cell adhesion in many different cell types.. PARP1 wt Allele defined as following: Human PARP1 protein, human wild-type allele is located within 1q41-q42 and is approximately 47 kb in length. This allele, which encodes poly [ADP-ribose] polymerase 1 protein, plays a critical role in DNA repair.. 30 nm Chromatin Fiber defined as following: A level of DNA packaging in chromatin above that of the nucleosome, the fundamental subunit of chromatin structure. The 30 nm Chromatin Fiber has a thickness of about 30 nanometers and results from the folding of a linear array of nucleosomes (thickness about 10 nm) into a more compact fiber.. olaparib defined as following: A small molecule inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP1 wt Allele) with potential chemosensitizing, radiosensitizing, and antineoplastic activities. Olaparib selectively binds to and inhibits PARP1 wt Allele, inhibiting PARP1 wt Allele-mediated repair of single strand DNA breaks; PARP1 wt Allele inhibition may enhance the cytotoxicity of DNA-damaging agents and may reverse tumor cell chemoresistance and radioresistance. PARP1 wt Allele catalyzes post-translational ADP-ribosylation of nuclear proteins and can be activated by single-stranded DNA breaks..", "label": "yes"} {"original_question": "Does the majority of the mitochondrial genomes abide to the second parity rule (PR2)?", "id": "converted_391", "sentence1": "Does the majority of the Genome, Mitochondrial abide to the second parity rule (PR2)?", "sentence2": "a large number of Genome, Mitochondrial significantly deviate from the 2nd parity rule in contrast to the eubacterial ones, Mitochondria may be divided into three distinct sub-groups according to their overall deviation from the aforementioned parity rule., The behaviour of the large majority of the Genome, Mitochondrial may be attributed to their distinct mode of replication, which is fundamentally different from the one of the Eubacterium., We tested all available organellar genomes and found that a large number of Genome, Mitochondrial significantly deviate from the 2nd parity rule in contrast to the eubacterial ones, although Mitochondria are believed to have evolved from proteobacteria., The behaviour of the large majority of the Genome, Mitochondrial may be attributed to their distinct mode of replication, which is fundamentally different from the one of the Eubacterium., We tested all available organellar genomes and found that a large number of Genome, Mitochondrial significantly deviate from the 2nd parity rule in contrast to the eubacterial ones, although Mitochondria are believed to have evolved from proteobacteria., The behaviour of the large majority of the Genome, Mitochondrial may be attributed to their distinct mode of replication, which is fundamentally different from the one of the Eubacterium, We tested all available organellar genomes and found that a large number of Genome, Mitochondrial significantly deviate from the 2nd parity rule in contrast to the eubacterial ones, although Mitochondria are believed to have evolved from proteobacteria[SEP]Relations: mitochondrion has relations: cellcomp_protein with PARS2, cellcomp_protein with PARS2, cellcomp_protein with RARS2, cellcomp_protein with RARS2. mitochondrial genome maintenance has relations: bioprocess_protein with MGME1, bioprocess_protein with MGME1, bioprocess_protein with AKT3, bioprocess_protein with AKT3, bioprocess_protein with PIF1, bioprocess_protein with PIF1. Definitions: Mitochondria defined as following: Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed). Eubacterium defined as following: A genus of gram-positive, rod-shaped bacteria found in cavities of man and animals, animal and plant products, infections of soft tissue, and soil. Some species may be pathogenic. No endospores are produced. The genus Eubacterium should not be confused with EUBACTERIA, one of the three domains of life.. Genome, Mitochondrial defined as following: The genetic complement of MITOCHONDRIA as represented in their DNA..", "label": "no"} {"original_question": "Can Systemic Lupus Erythematosus cause seizures?", "id": "converted_3656", "sentence1": "Can Systemic Lupus Erythematosus cause Seizures?", "sentence2": "The mean ± SD age at Systematic Light Exposure diagnosis and at onset of SLC26A5 gene was 25.02 ± 13.78 and 28.31 ± 12.61 years, respectively. Seizure was the most common presenting symptom, as seen in 28 episodes, followed by acute severe headache in 17,, Epilepsy is characterized by a relevant epidemiological and clinical burden. In the extant literature, an increased risk of Seizures has been described in several inflammatory/autoimmune disorders, including systemic lupus erythematosus (Systematic Light Exposure)., Seizures are one of the most serious neuropsychiatric manifestations of systemic lupus erythematous (Systematic Light Exposure). , The aim of this study was to describe the frequency , attribution , outcome and predictors of Seizures in systemic lupus erythematosus ( Systematic Light Exposure, OBJECTIVE\nTo evaluate the frequency and risk factors of Nonepileptic Seizures in a large cohort of patients with systemic lupus erythematosus (Systematic Light Exposure)., Epileptic Seizures occurred at the onset of Systematic Light Exposure symptoms in 19 (31.6%) and after the onset of Systematic Light Exposure in 41 of 60 (68.3%) patients., Epileptic Seizures and Electroencephalography features in juvenile systemic lupus erythematosus., CONCLUSIONS\nEpileptic Seizures were observed in 11.2% of systemic lupus erythematosus (Systematic Light Exposure) patients., CONCLUSIONS\nSeizures tend to occur early in the course of systemic lupus erythematosus, and contribute to damage accrual., Seizures tend to occur early in the course of systemic lupus erythematosus, and contribute to damage accrual., To determine the factors associated with Seizures in systemic lupus erythematosus (Systematic Light Exposure)., Neurologic manifestations, in special Nonepileptic Seizures, are frequent in systemic lupus erythematosus.[SEP]Relations: Seizure has relations: disease_phenotype_positive with systemic lupus erythematosus (disease), disease_phenotype_positive with systemic lupus erythematosus (disease), disease_phenotype_positive with pediatric systemic lupus erythematosus, disease_phenotype_positive with pediatric systemic lupus erythematosus, drug_effect with Temsirolimus, drug_effect with Temsirolimus. bullous systemic lupus erythematosus has relations: disease_disease with lupus erythematosus, disease_disease with lupus erythematosus, disease_disease with systemic lupus erythematosus (disease), disease_disease with systemic lupus erythematosus (disease). Definitions: Epilepsy defined as following: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313). Electroencephalography defined as following: Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain.. Systematic Light Exposure defined as following: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.. Seizures defined as following: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent Seizures are usually referred to as EPILEPSY or \"seizure disorder.\".", "label": "yes"} {"original_question": "Is it possible to analyze exosomes with FACS?", "id": "converted_3169", "sentence1": "Is it possible to analyze Exosomes with Fetus affected by placental transfer of anticonvulsant?", "sentence2": "whose presence was validated by a bead-exosome Fetus affected by placental transfer of anticonvulsant assay., We analyzed Exosomes from Mus sp. (C57Bl/6) and Breast, Chest>Lung, and Malignant neoplasm of ovary patient samples and cultured cancer cells with different approaches, including nanoparticle tracking analysis, biolayer interferometry, Fetus affected by placental transfer of anticonvulsant, and electron microscopy., we applied a technique to generate native fluorescent Exosomes characterized by Vesicle (morphologic abnormality) integrity, size, density, markers expression, and quantifiable by direct Fetus affected by placental transfer of anticonvulsant analysis, we used a novel strategy for generating metabolically-labeled fluorescent Exosomes that can be counted by flow cytometry assay (Fetus affected by placental transfer of anticonvulsant) and characterized.[SEP]Relations: Breast has relations: anatomy_protein_present with GCSAM, anatomy_protein_present with GCSAM, anatomy_protein_present with VIM, anatomy_protein_present with VIM, anatomy_protein_present with RIMKLB, anatomy_protein_present with RIMKLB, anatomy_protein_present with GSN-AS1, anatomy_protein_present with GSN-AS1. Morphological abnormality of the utricle has relations: phenotype_phenotype with Morphological abnormality of the semicircular canal, phenotype_phenotype with Morphological abnormality of the semicircular canal. Definitions: Exosomes defined as following: A type of extracellular vesicle, containing RNA and proteins, that is secreted into the extracellular space by EXOCYTOSIS when MULTIVESICULAR BODIES fuse with the PLASMA MEMBRANE.. Breast defined as following: In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.. Vesicle (morphologic abnormality) defined as following: An abnormal fluid-filled cleft (e.g. as in the epidermis) or membrane-bound space.. Malignant neoplasm of ovary defined as following: A primary or metastatic malignant neoplasm involving the ovary. Most primary malignant ovarian neoplasms are either carcinomas (serous, mucinous, or endometrioid adenocarcinomas) or malignant germ cell tumors. Metastatic malignant neoplasms to the ovary include carcinomas, lymphomas, and melanomas.. Fetus affected by placental transfer of anticonvulsant defined as following: Selection and deposition of individual cells of a particular phenotype from a mixed population into a separate tube or tissue culture plate by the use of a fluorescence-activated cell sorter (Fetus affected by placental transfer of anticonvulsant) and fluorescently-labeled antibodies specific for surface molecules on the cells to be sorted..", "label": "yes"} {"original_question": "Does IL18 signaling have a role in thymus?", "id": "converted_3855", "sentence1": "Does IL18 signaling have a role in Thymus ?", "sentence2": "IL18 signaling promotes homing of mature Tregs into the Thymus ., Collectively, this study provides a detailed characterization of the mature Treg subsets in the Mus sp. Thymus and identifies a key role of IL18 signaling in controlling the CCRL2 wt Allele-CCL20-dependent migration of Tregs into the Thymus ., er, we show that IL18R+ Tregs are endowed with higher capacity to populate the Thymus than their IL18R- or IL18R-/- counterparts, highlighting the key role of IL18R in this process, IL18 signaling promotes homing of mature Tregs into the Thymus , inally, we demonstrate that IL18 signaling is critical for the induction of the key Thymus -homing chemokine receptor - CCRL2 wt Allele on Tregs. , Moreover, we show that IL18R+ Tregs are endowed with higher capacity to populate the Thymus than their IL18R- or IL18R-/- counterparts, highlighting the key role of IL18R in this process.[SEP]Definitions: CCRL2 wt Allele defined as following: Human CCRL2 wild-type allele is located within 3p21 and is approximately 2 kb in length. This allele, which encodes C-C chemokine receptor-like 2 protein, is involved in signal transduction and macrophage differentiation; however, an exact function has yet to be elucidated.. Thymus defined as following: A plant genus of the family LAMIACEAE best known for the thyme spice added to foods..", "label": "yes"} {"original_question": "Are the genes for marneral biosynthesis scattered in the genome of A. thaliana?", "id": "converted_2049", "sentence1": "Are the Genes for marneral biosynthesis scattered in the genome of Arabidopsis thaliana ?", "sentence2": "Here we characterize a second operon-like triterpene cluster (the marneral cluster) from Arabidopsis thaliana , compare the features of these two clusters, and investigate the evolutionary events that have led to cluster formation, Here we characterize a second operon-like triterpene cluster (the marneral cluster) from Arabidopsis thaliana , compare the features of these two clusters, and investigate the evolutionary events that have led to cluster formation., Previously in thale cress (Arabidopsis thaliana) we identified an operon-like gene cluster that is required for the synthesis and ResponseLevel - ResponseLevel - modification of the triterpene thalianol., Prediction of operon-like gene clusters in the Arabidopsis thaliana genome based on co-expression analysis of neighboring Genes, Here we characterize a second operon-like triterpene cluster (the marneral cluster) from Arabidopsis thaliana , compare the features of these two clusters, and investigate the evolutionary events that have led to cluster formation. , Here we characterize a second operon-like triterpene cluster (the marneral cluster) from A., the cyclic hydroxamic acid pathways in maize, the avenacin biosynthesis gene clusters in oat, the thalianol pathway in Arabidopsis thaliana, and the diterpenoid momilactone cluster in rice., Prediction of operon-like gene clusters in the Arabidopsis thaliana genome based on co-expression analysis of neighboring Genes.[SEP]Relations: response to nickel cation has relations: bioprocess_protein with CACNA1G, bioprocess_protein with CACNA1G, bioprocess_bioprocess with cellular response to nickel ion, bioprocess_bioprocess with cellular response to nickel ion, bioprocess_bioprocess with response to metal ion, bioprocess_bioprocess with response to metal ion. Definitions: ResponseLevel - modification defined as following:

Respond with exceptions, completions and modifications or revisions done before completion

. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. genome defined as following: Anatomical set of Genes in all the chromosomes..", "label": "no"} {"original_question": "Does Uc.63+ promote sensitivity to treatment in prostate cancer?", "id": "converted_3327", "sentence1": "Does Uc.63+ promote sensitivity to treatment in Malignant neoplasm of prostate?", "sentence2": "Transcribed ultraconserved region Uc.63+ promotes resistance to docetaxel through regulation of androgen receptor signaling in Malignant neoplasm of prostate., The transcribed ultraconserved regions (T-UCRs) are a novel class of non-coding RNAs that are absolutely conserved across species and are involved in carcinogenesis including Malignant neoplasm of prostate (Pachyonychia Congenita). In this study, we investigated the transcriptional levels of 26 representative T-UCRs and determined the regions that were differentially expressed in Pachyonychia Congenita. Quantitative real-time polymerase chain reaction analysis revealed that the expression of T-UCR Uc.63+ was increased in Pachyonychia Congenita tissues. MTT assay and wound healing assay revealed that Uc.63+ was involved in cell growth and cell migration. miR-130b was predicted to have Binding Sites within the Uc.63+ sequence. The expression of miR-130b was significantly disturbed by the overexpression or knockdown of Uc.63+. We also showed that Uc.63+ regulated the expression of MMP2 protein, human protein, human via miR-130b regulation. Furthermore, overexpression of Uc.63+ increased the expression of AKR1B1 protein, human and its downstream molecule PSA and promoted resistance to docetaxel through AKR1B1 protein, human regulation. In patients treated with docetaxel, the expression of serum Uc.63+ in the docetaxel-resistant patients was higher than that in the docetaxel-sensitive patients (P = 0.011). Moreover, Kaplan-Meier analysis showed that the high expression of serum Uc.63+ correlated with a worse prognosis (P = 0.020). These results substantially support the important role that Uc.63+ plays in Pachyonychia Congenita progression by interacting with miR-130b and indicate that Uc.63+ could potentially be a promising serum marker for deciding the best treatment for patients with CRPC., Transcribed ultraconserved region Uc.63+ promotes resistance to docetaxel through regulation of androgen receptor signaling in Malignant neoplasm of prostate, These results substantially support the important role that Uc.63+ plays in Pachyonychia Congenita progression by interacting with miR-130b and indicate that Uc.63+ could potentially be a promising serum marker for deciding the best treatment for patients with CRPC, Furthermore , overexpression of Uc.63+ increased the expression of AKR1B1 protein, human and its downstream molecule PSA and promoted resistance to docetaxel through AKR1B1 protein, human regulation, These results substantially support the important role that Uc.63+ plays in Pachyonychia Congenita progression by interacting with miR-130b and indicate that Uc.63+ could potentially be a promising serum marker for deciding the best treatment for patients with CRPC., Furthermore, overexpression of Uc.63+ increased the expression of AKR1B1 protein, human and its downstream molecule PSA and promoted resistance to docetaxel through AKR1B1 protein, human regulation., These results substantially support the important role that Uc.63+ plays in Pachyonychia Congenita progression by interacting with miR-130b and indicate that Uc.63+ could potentially be a promising serum marker for deciding the best treatment for patients with CRPC.[SEP]Relations: benign neoplasm of prostate has relations: disease_disease with prostate leiomyoma, disease_disease with prostate leiomyoma, disease_disease with fibroma of prostate, disease_disease with fibroma of prostate, disease_disease with prostatic adenoma, disease_disease with prostatic adenoma, disease_disease with prostate neoplasm, disease_disease with prostate neoplasm, disease_disease with benign prostate phyllodes tumor, disease_disease with benign prostate phyllodes tumor. Definitions: MMP2 protein, human defined as following: 72 kDa type IV collagenase (660 aa, ~74 kDa) is encoded by the human MMP2 protein, human gene. This protein is involved in both proteolysis and angiogenesis.. Malignant neoplasm of prostate defined as following: A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas.. Binding Sites defined as following: The parts of a macromolecule that directly participate in its specific combination with another molecule.. AKR1B1 protein, human defined as following: Aldose reductase (316 aa, ~36 kDa) is encoded by the human AKR1B1 gene. This protein plays a role in glucose metabolism.. Pachyonychia Congenita defined as following: A group of inherited ectodermal dysplasias whose most prominent clinical feature is hypertrophic nail dystrophy resulting in PACHYONYCHIA. Several specific subtypes of pachyonychia congenita have been associated with mutations in genes that encode KERATINS.. docetaxel defined as following: A semisynthetic analog of PACLITAXEL used in the treatment of locally advanced or metastatic BREAST NEOPLASMS and NON-SMALL CELL LUNG CANCER..", "label": "no"} {"original_question": "Is cabergoline used for treatment of the Nelson's syndrome ?", "id": "converted_3936", "sentence1": "Is cabergoline used for treatment of the Nelson Syndrome ?", "sentence2": "Due to a rapid regrowth of the Neoplasms, the patient did not receive gamma-knife therapy and was treated with cabergoline and Somatostatin Assay analogue for some time. , Identification of D(2) receptors in corticotroph tumors led to clinical trials of cabergoline therapy in limited cases of Nelson Syndrome, ectopic ACTH-secreting tumors, and recently Pituitary-dependent Pituitary-dependent Cushing's disease (CD)., In our observation cabergoline at 2 mg per week seems to be efficient after a 3 and a half years follow-up, in accordance with some recent publications. , Clinical and biochemical stabilization of Nelson Syndrome with long-term Low-Dose Treatment cabergoline treatment., We report the results of long-term (6-year) treatment of Nelson Syndrome with the long-acting dopamine Agonist, cabergoline, in a 55-year-old woman., This case demonstrates that long-term cabergoline treatment may be efficient in patients with Nelson Syndrome., Therefore, in addition to Prolactinoma, targets of dopamine Agonist therapy are somatotroph tumors, nonfunctioning Pituitary Neoplasms, corticotroph Pituitary Neoplasms, Nelson Syndrome, gonadotropinomas, and thyrotropin-secreting Pituitary Neoplasms., Nelson Syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment., The results obtained show for the first time that a long-term treatment with cabergoline also brings about a complete remission of Nelson Syndrome in the presence of a Pituitary macroadenoma., Complete remission of Nelson Syndrome after 1-year treatment with cabergoline., In this case report we demonstrated that treatment with the long-acting D2 receptor Agonist cabergoline for 1 year induced normalization of plasma ACTH levels and disappearance of the pituitary tumor in a patient with Nelson Syndrome. , This case demonstrated that cabergoline treatment is able to induce the remission of Nelson Syndrome and may be a valid therapeutic alternative in this syndrome., However, some preliminary data suggest a potential use of cabergoline in combination with ketoconazole, or alone, in selected cases of Pituitary-dependent Pituitary-dependent Cushing's disease or Nelson Syndrome., We report the results of long-term (6-year) treatment of Nelson Syndrome with the long-acting dopamine Agonist, cabergoline, in a 55-year-old woman. The, actinomas. Identification of D(2) receptors in corticotroph tumors led to clinical trials of cabergoline therapy in limited cases of Nelson Syndrome, ectopic ACTH-secreting tumors, and recently Cushing's diseas, In order to investigate on the direct effect played by cabergoline treatment on the remission of Nelson Syndrome, the treatment was withdrawn., lactinomas. Identification of D(2) receptors in corticotroph tumors led to clinical trials of cabergoline therapy in limited cases of Nelson Syndrome, ectopic ACTH-secreting tumors, and recently Pituitary-dependent Pituitary-dependent Cushing's disease (CD).OBJECTIVE: To evaluate the long-term efficacy of cabergoline monotherapy in patients with CD.METHODS: Retrospective analysis of non-randomized clinical therapy with cabergoline in 30 patients with CD treated in academic cente[SEP]Relations: Cabergoline has relations: drug_drug with Norepinephrine, drug_drug with Norepinephrine, drug_drug with Antipyrine, drug_drug with Antipyrine, contraindication with gallbladder disease, contraindication with gallbladder disease, drug_effect with Headache, drug_effect with Headache, drug_effect with Vertigo, drug_effect with Vertigo. Definitions: Agonist defined as following: An agent that has affinity for a receptor and intrinsic activity at that receptor.. Pituitary macroadenoma defined as following: A pituitary gland adenoma with a diameter greater than 10 mm. Clinical manifestations include headache, visual field disturbances, pituitary insufficiency, and mild hyperprolactinemia.. cabergoline defined as following: A synthetic ergoline derivative and a long-acting dopamine receptor Agonist with high affinity for the dopamine D2 receptor. Cabergoline exerts an inhibitory effect on prolactin secretion by acting on dopamine receptors present in pituitary lactotrophs. This drug also binds to dopamine D2 receptors in the corpus striatum, thereby mimicking the actions of dopamine on motor control. Cabergoline also possesses antioxidant and neuroprotective properties due to its free radical scavenging activity. Cabergoline is used in the treatment of Parkinson's disease and in the treatment of hyperprolactinemia.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. ketoconazole defined as following: Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients.. Pituitary Neoplasms defined as following: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.. Nelson Syndrome defined as following: A syndrome characterized by HYPERPIGMENTATION, enlarging pituitary mass, visual defects secondary to compression of the OPTIC CHIASM, and elevated serum ACTH. It is caused by the expansion of an underlying ACTH-SECRETING PITUITARY ADENOMA that grows in the absence of feedback inhibition by adrenal CORTICOSTEROIDS, usually after ADRENALECTOMY.. Prolactinoma defined as following: A pituitary adenoma which secretes PROLACTIN, leading to HYPERPROLACTINEMIA. Clinical manifestations include AMENORRHEA; GALACTORRHEA; IMPOTENCE; HEADACHE; visual disturbances; and CEREBROSPINAL FLUID RHINORRHEA.. Low-Dose Treatment defined as following: A reduced quantity of a therapeutic agent prescribed to be taken at one time or at stated intervals.. bromocriptine defined as following: A semisynthetic ergotamine alkaloid that is a dopamine D2 Agonist. It suppresses prolactin secretion.. Pituitary-dependent Cushing's disease defined as following: Cushing's syndrome due to abnormally high secretion of adrenocorticotropic hormone (ACTH) from the pituitary gland..", "label": "yes"} {"original_question": "Are piRNAs involved in gene silencing?", "id": "converted_1059", "sentence1": "Are piRNAs involved in gene silencing?", "sentence2": "In Drosophila ovaries, the nuclear PIWIL1 gene Protein Info is required for transcriptional silencing of transposons, though the precise mechanisms by which this occurs are unknown., Here we show that the CG9754 Protein Info is a component of PIWIL1 gene complex (molecular entity) that functions downstream of PIWIL1 gene and its binding partner, Asterix, in transcriptional silencing. Enforced tethering of CG9754 to nascent messenger RNA transcripts causes cotranscriptional silencing of the source Gene Locus and the deposition of repressive chromatin location location marks., We have named CG9754 \"Panoramix,\" and we propose that this Protein Info could act as an adaptor, scaffolding interactions between the piRNA pathway and the general silencing machinery that it recruits to enforce transcriptional repression., piRNA-guided slicing of transposon transcripts enforces their transcriptional silencing via specifying the nuclear piRNA repertoire, Caenorhabditis elegans piRNAs interact with both transposon and nontransposon mRNAs to initiate sustained silencing via the RNAi pathway., To assess the dysregulation of gene silencing caused by lack of piRNAs, we restored RNA silencing in RNAi-defective animal allergen extracts in the presence or absence of piRNAs., Thus, by reanimating RNAi, we uncovered a role for piRNAs in protecting Genes, Essential from RNA silencing., In different Organism, small RNAs were shown to be implicated in the posttranscriptional degradation of RNA, Messenger and/or transcriptional repression of the homologous Gene Locus. In Drosophila , the mechanism of piRNA-mediated silencing is still far from being understood, Analyses of piRNA-mediated transcriptional transposon silencing in Drosophila , Transcriptional silencing implies a piRNA-mediated formation of repressive chromatin location location which diminishes the transcriptional capacity of the target Gene Locus., In CASP14 gene, piRNA-guided transposon repression correlates with establishment of CpG DNA methylation on their DNA Sequence, yet the mechanism and the spectrum of genomic targets of piRNA silencing are unknown, Using a candidate gene KD-approach, we identified differences in the spatio-temporal requirements of the piRNA pathway components for piRNA-mediated silencing., Spatio-temporal requirements for DNA Transposable Elements piRNA-mediated silencing during Drosophila oogenesis, In contrast, piRNA-mediated silencing is strong in Germline Stem cells in which Liver Ultrasonographic Elastography mobilization is tightly repressed ensuring the continued production of viable Germline cysts., PIWIL1 gene induces piRNA-guided transcriptional silencing and establishment of a repressive chromatin location location state., In Germ Cells, early embryos, and Stem cells of animal allergen extracts, PIWI-interacting RNAs (piRNAs) have an important role in silencing retrotransposons, which are vicious genomic parasites, through transcriptional and post-transcriptional mechanisms., Our results show that the piRNA pathway can be used as a tool for sequence-specific gene silencing in Germ Cells and support the idea that the piRNA generating regions serve as traps for retrotransposons, enabling the host cell to generate piRNAs against active retrotransposons., Our observations confirm the pivotal role of piRNA-mediated silencing in defending the Genome - anatomical entity against selfish transposition, yet also suggest limits to the optimization of host Genome - anatomical entity defense., Analysis of piRNA-mediated silencing of active N-tris(hydroxymethyl)methyl-2-aminomethane sulfonate in Drosophila melanogaster suggests limits on the evolution of host Genome - anatomical entity defense, The PIWIL1 gene-interacting RNA (piRNA) pathway defends animal genomes against the harmful consequences of DNA Transposable Elements (Liver Ultrasonographic Elastography) Communicable Diseases by imposing small-RNA-mediated silencing., A novel organelle, the piNG-body, in the Polar granule of Drosophila male Germ Cells is associated with piRNA-mediated gene silencing., Proteins of the PIWI subfamily Aub and Protein Argonaute-3 associated with the Germline-specific perinuclear granules (Polar granule) are involved in the silencing of retrotransposons and other selfish repetitive elements in the Drosophila Genome - anatomical entity. , Telomeric retroelements HeT-A, TART and TAHRE, which are involved in telomere maintenance in Drosophila , are also the targets of piRNA-mediated silencing, Mechanism of the piRNA-mediated silencing of Drosophila telomeric retrotransposons., Gene silencing mechanisms mediated by Solanum melongena piRNA complex (molecular entity) in Drosophila male gonad., The epigenetic trans-silencing effect in Drosophila involves maternally-transmitted small RNAs whose production depends on the piRNA pathway and Chromobox Protein Homolog 5., Here, we show that Gene Mutation in squash and zucchini, which are involved in the PIWIL1 gene-Interacting RNA (piRNA) silencing pathway, strongly affect TSE, altretamine/etoposide/methotrexate protocol in piRNA processing and gene silencing of retrotransposons, piRNA-mediated silencing in Drosophila germlines., These have shed light not only on the molecular mechanisms of gene silencing mediated by piRNAs and PIWI proteins, but also on their intriguing relationship with cellular Genes that have been shown to be important for gametogenesis and fertility., The most abundant piRNAs were those corresponding to antisense transcripts of Suppressor of Stellate [Su(Ste)] Genes known to be involved in Stellate gene silencing, To determine the capacity of piRNA-mediated silencing, we introduced reporter Genes into Drosophila OSS cells, which express MicroRNAs (miRNAs) and piRNAs, and compared the PIWIL1 gene pathway to the Argonaute pathway in gene regulation, PIWI-interacting small non-coding RNAs (piRNAs) are Genetic and epigenetic regulatory factors in Germline cells, where they maintain Genome - anatomical entity stability, are involved in RNA silencing and regulate gene expression, The piNG-body contains ribonucleoprotein complex (molecular entity) involved in piRNA-silencing of Genome - anatomical entity repeats including transposons in premeiotic Spermatocytes with aid of short piRNAs, Our results show that the piRNA pathway can be used as a tool for sequence-specific gene silencing in Germ Cells and support the idea that the piRNA generating regions serve as traps for retrotransposons, enabling the host cell to generate piRNAs against active retrotransposons, Recent studies have revealed not only the biogenesis of piRNAs and their roles in transposon silencing, but also the function of the PIWIL1 gene-piRNA pathway in epigenetic and post-transcriptional regulation of gene expression, A growing number of studies on piRNAs have investigated piRNA-mediated gene silencing, including piRNA biogenesis, These have shed light not only on the molecular mechanisms of gene silencing mediated by piRNAs and PIWI proteins, but also on their intriguing relationship with cellular Genes that have been shown to be important for gametogenesis and fertility, Telomeric retroelements HeT-A, TART and TAHRE, which are involved in telomere maintenance in Drosophila , are also the targets of piRNA-mediated silencing. , altretamine/etoposide/methotrexate protocol in piRNA processing and gene silencing of retrotransposons., To determine the capacity of piRNA-mediated silencing, we introduced reporter Genes into Drosophila OSS cells, which express MicroRNAs (miRNAs) and piRNAs, and compared the PIWIL1 gene pathway to the Argonaute pathway in gene regulation. , Therefore piRNA-mediated transcriptional mode of silencing is involved in the control of retrotransposon expression in the Drosophila Germline., Panoramix enforces piRNA-dependent cotranscriptional silencing., The most abundant piRNAs were those corresponding to antisense transcripts of Suppressor of Stellate [Su(Ste)] Genes known to be involved in Stellate gene silencing., Our results indicate that piRNAs are involved in a posttranscriptional gene-silencing mechanism resulting in RNA nuclear accumulation.[SEP]Relations: PIWIL1 has relations: bioprocess_protein with gene silencing by RNA, bioprocess_protein with gene silencing by RNA, bioprocess_protein with piRNA metabolic process, bioprocess_protein with piRNA metabolic process, molfunc_protein with piRNA binding, molfunc_protein with piRNA binding. PIWI-interacting RNA (piRNA) biogenesis has relations: pathway_protein with TDRD12, pathway_protein with TDRD12, pathway_protein with MAEL, pathway_protein with MAEL. Definitions: Solanum melongena defined as following: A plant species of the genus SOLANUM, family SOLANACEAE. The fruit is a large, egg-shaped berry, varying in color from dark purple to red, yellowish, or white. The leaves are large and ovate. The flowers are pendant, violet, and two inches across.. DNA Sequence defined as following: The sequence of nucleotide residues along a DNA chain.. Genome - anatomical entity defined as following: Anatomical set of Genes in all the chromosomes.. Protein Argonaute-3 defined as following: Protein argonaute-3 (860 aa, ~97 kDa) is encoded by the human Protein Argonaute-3 gene. This Protein Info is involved in RNA-mediated silencing of translation.. Stem cells defined as following: Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells.. Piwi-Interacting RNA defined as following: Single-stranded RNA molecules that are expressed in animal cells and form complex (molecular entity) with PIWIL1 gene proteins. They are involved in transcriptional gene silencing.. Genetic defined as following: Having to do with information that is passed from parents to offspring through Genes in sperm and egg cells.. RNA, Messenger defined as following: RNA DNA Sequence that serve as templates for Protein Info synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the cytoplasm.. complex (molecular entity) defined as following: A molecular entity formed by loose association involving two or more component molecular entities. The bonding between the components is normally weaker than in a covalent bond.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the Protein Info.. Polar granule defined as following: A small cytoplasmic, non-membranous RNA/Protein Info complex aggregate in the primordial Germ Cells of many higher eukaryotes. [GOC:dph, GOC:kmv, PMID:11262230]. Chromobox Protein Homolog 5 defined as following: A Protein Info family comprised of chromo and chromo shadow domain-containing, methyl-lysine binding proteins that are localized to heterochromatin. These proteins are involved in gene silencing, transcriptional activation, and the formation and stabilization of heterochromatin.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. chromatin location defined as following: The ordered and organized complex of DNA, Protein Info, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130]. MicroRNAs defined as following: Small double-stranded, non-Protein Info coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing.. Spermatocytes defined as following: Male Germ Cells derived from SPERMATOGONIA. The euploid primary Spermatocytes undergo MEIOSIS and give rise to the haploid secondary Spermatocytes which in turn give rise to SPERMATIDS.. Genes, Essential defined as following: Those Genes found in an organism which are necessary for its viability and normal function.. Genes defined as following: A category of nucleic acid DNA Sequence that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of Organism.. Germ Cells defined as following: The reproductive cells in multicellular Organism at various stages during GAMETOGENESIS.. DNA Transposable Elements defined as following: Discrete segments of DNA which can excise and reintegrate to another site in the Genome - anatomical entity. Most are inactive, i.e., have not been found to exist outside the integrated state. DNA transposable elements include bacterial IS (insertion sequence) elements, Tn elements, the maize controlling elements Ac and Ds, Drosophila P, gypsy, and pogo elements, the human Tigger elements and the Tc and mariner elements which are found throughout the animal kingdom.. Stellate defined as following: A term that refers to lesions or cells that are shaped like stars.. Organism defined as following: A living entity.. Gene Mutation defined as following: The result of any gain, loss or alteration of the DNA Sequence comprising a gene, including all DNA Sequence transcribed into RNA.. Gene Locus defined as following: The position of a gene or a chromosomal marker on a chromosome; also, a stretch of DNA at a particular place on a particular chromosome. The use of Gene Locus is sometimes restricted to mean regions of DNA that are expressed.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode Genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.. telomere defined as following: A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs.. Liver Ultrasonographic Elastography defined as following: A noninvasive test that is used to stage fibrosis in the liver. A 50-MHz wave is passed into the liver from a small transducer on the end of an ultrasound probe which measures the velocity of the shear wave (in meters per second) as this wave passes through the liver. The shear wave velocity can then be converted into liver stiffness. This technique is an alternative to liver biopsy.. piRNAs defined as following: Single-stranded RNA molecules that are expressed in animal cells and form complex (molecular entity) with PIWIL1 gene proteins. They are involved in transcriptional gene silencing..", "label": "yes"} {"original_question": "Does the TOP2B/TOP2A expression ratio affect the response to AML chemotherapy?", "id": "converted_2111", "sentence1": "Does the TOP2B/TOP2A protein, human expression ratio affect the response to Leukemia, Myelocytic, Acute chemotherapy?", "sentence2": "High TOP2B/TOP2A protein, human protein, human expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia, Genes with distinct expression profiles such as TOP2B/TOP2A protein, human protein, human expression ratio at diagnosis can be employed for outcome prediction after the treatment with standard regimens in Leukemia, Myelocytic, Acute patients with M2 subtype., Another interesting finding is that high ratios of TOP2B/RRM2 and TOP2B/TOP2 alpha (TOP2A protein, human protein, human) in a combined analysis were also shown to have a prognostic impact for longer survival with improved accuracy., Among the four markers, when adjusted for the influence of other clinical factors in multivariate analysis, the TOP2B/TOP2A protein, human protein, human ratio was significantly correlated with treatment outcomes; patients with high ratios trended toward longer disease-free survival (plant-type hypersensitive response, 0.24; P=0.002) and overall survival (plant-type hypersensitive response, 0.29; P=0.005), High TOP2B/TOP2A protein, human protein, human expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia., Among the four markers, when adjusted for the influence of other clinical factors in multivariate analysis, the TOP2B/TOP2A protein, human protein, human ratio was significantly correlated with treatment outcomes; patients with high ratios trended toward longer disease-free survival (plant-type hypersensitive response, 0.24; P=0.002) and overall survival (plant-type hypersensitive response, 0.29; P=0.005).Genes with distinct expression profiles such as TOP2B/TOP2A protein, human protein, human expression ratio at diagnosis can be employed for outcome prediction after the treatment with standard regimens in Leukemia, Myelocytic, Acute patients with M2 subtype, CONCLUSION: Genes with distinct expression profiles such as TOP2B/TOP2A protein, human protein, human expression ratio at diagnosis can be employed for outcome prediction after the treatment with standard regimens in Leukemia, Myelocytic, Acute patients with M2 subtype., Genes with distinct expression profiles such as TOP2B/TOP2A protein, human protein, human expression ratio at diagnosis can be employed for outcome prediction after the treatment with standard regimens in Leukemia, Myelocytic, Acute patients with M2 subtype.., High TOP2B/TOP2A protein, human protein, human expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia., Among the four markers, when adjusted for the influence of other clinical factors in multivariate analysis, the TOP2B/TOP2A protein, human protein, human ratio was significantly correlated with treatment outcomes; patients with high ratios trended toward longer disease-free survival (plant-type hypersensitive response, 0.24; P=0.002) and overall survival (plant-type hypersensitive response, 0.29; P=0.005)., Another interesting finding is that high ratios of TOP2B/RRM2 and TOP2B/TOP2 alpha (TOP2A protein, human protein, human) in a combined analysis were also shown to have a prognostic impact for longer survival with improved accuracy.[SEP]Relations: acute promyelocytic leukemia has relations: disease_protein with IRF2BP2, disease_protein with IRF2BP2, disease_protein with DAPK2, disease_protein with DAPK2, disease_protein with TET2, disease_protein with TET2, disease_protein with PML, disease_protein with PML, disease_protein with ITGB2, disease_protein with ITGB2. Definitions: Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Leukemia, Myelocytic, Acute defined as following: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.. plant-type hypersensitive response defined as following: The rapid, localized death of plant cells in response to invasion by a pathogen. [ISBN:0582227089]. TOP2A protein, human defined as following: DNA topoisomerase 2-alpha (1531 aa, ~174 kDa) is encoded by the human TOP2A protein, human gene. This protein is involved in the modulation of DNA topology..", "label": "yes"} {"original_question": "Is physical performance influenced by thyroid hormone metabolism?", "id": "converted_1612", "sentence1": "Is physical performance influenced by Thyroid Hormones metabolism?", "sentence2": "Longitudinal analysis showed that in Eut men higher baseline FT4 was significantly (p = 0.02) predictive of a lower SPPB score at the 3-year follow-up, Even a modest Thyroid Hormones excess is associated with a reduced physical function in elderly men., Oral L-thyroxine treatment was started and at a 1-month follow-up examination, mental status and physical performance were improved, In a population of independently living elderly men, higher FT4 and rT3 concentrations are associated with a lower physical function, She had generalised weakness of muscles, cold intolerance and a reduced physical performance., Replacement therapy by oral administration of levothyroxine resulted in a gradual improvement of the patient's state, multivariate analysis revealed that total T3 thoracic segmental innervation thoracic segmental innervation was an independent predictor of VO2max, changes in Thyroid Hormones were closely correlated to myocardial functional status in patients with Congestive Congestive heart failure., threonine among patients with Supracervical hysterectomy is beneficial not only by improvement in lipid profile, as well as by improvement in cognitive and functional status,, CONCLUSIONS: Even a modest Thyroid Hormones excess is associated with a reduced physical function in elderly men., Subclinical hyperthyroidism (SH) may be responsible for many Cardiovascular system changes, including an impaired exercise performance., BACKGROUND: Physiological changes in Thyroid Hormones concentrations might be related to changes in the overall physical function in the elderly.[SEP]Relations: response to Thyroid Hormones has relations: bioprocess_bioprocess with response to hormone, bioprocess_bioprocess with response to hormone, bioprocess_bioprocess with cellular response to Thyroid Hormones stimulus, bioprocess_bioprocess with cellular response to Thyroid Hormones stimulus, bioprocess_protein with HPN, bioprocess_protein with HPN, bioprocess_protein with GBA, bioprocess_protein with GBA, bioprocess_bioprocess with response to thyroxine, bioprocess_bioprocess with response to thyroxine. Definitions: levothyroxine defined as following: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.. threonine defined as following: An essential amino acid occurring naturally in the L-form, which is the active form. It is found in eggs, milk, gelatin, and other proteins.. Cardiovascular system defined as following: The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body.. Congestive heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Thyroid Hormones defined as following: Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs.. Supracervical hysterectomy defined as following: A hysterectomy that removes the uterus and leaves the cervix in place..", "label": "yes"} {"original_question": "Is Protoporphyrinogen oxidase localized to the mitochondrium?", "id": "converted_3280", "sentence1": "Is Protoporphyrinogen oxidase localized to the mitochondrium?", "sentence2": "We showed that 28 Antifibrinolytic Antifibrinolytic amino acids in the amino terminus of HCRT wt Allele contain an independently functioning signal for mitochondrial targeting., Based on our results we propose a mechanism for Protoporphyrinogen oxidase targeting to the mitochondrion., Mitochondrial Inheritance Inheritance targeting of human Protoporphyrinogen oxidase., In the present study, PfPPO has been cloned, expressed and shown to be localized to the mitochondrion by immunofluorescence microscopy. [SEP]Relations: Mitochondrial Inheritance inheritance has relations: disease_phenotype_positive with mitochondrial myopathy with reversible cytochrome C oxidase deficiency, disease_phenotype_positive with mitochondrial myopathy with reversible cytochrome C oxidase deficiency, disease_phenotype_positive with cytochrome-c oxidase deficiency disease, disease_phenotype_positive with cytochrome-c oxidase deficiency disease, disease_phenotype_positive with striatonigral degeneration, disease_phenotype_positive with striatonigral degeneration, disease_phenotype_positive with ophthalmoplegic neuromuscular disorder with abnormal mitochondria, disease_phenotype_positive with ophthalmoplegic neuromuscular disorder with abnormal mitochondria, disease_phenotype_positive with Kearns-Sayre syndrome, disease_phenotype_positive with Kearns-Sayre syndrome. Definitions: Mitochondrial Inheritance defined as following: The distribution of mitochondria, including the mitochondrial genome, into daughter cells after mitosis or meiosis, mediated by interactions between mitochondria and the cytoskeleton. [GOC:mcc, PMID:10873824, PMID:11389764]. Protoporphyrinogen oxidase defined as following: A membrane-bound flavoenzyme that catalyzes the oxygen-dependent aromatization of protoporphyrinogen IX (Protogen) to protoporphyrin IX (Proto IX). It is the last enzyme of the common branch of the HEME and CHLOROPHYLL pathways in plants, and is the molecular target of diphenyl ether-type herbicides. VARIEGATE PORPHYRIA is an autosomal dominant disorder associated with deficiency of Protoporphyrinogen oxidase.. HCRT wt Allele defined as following: Human HCRT wild-type allele is located in the vicinity of 17q21 and is approximately 1 kb in length. This allele, which encodes orexin protein, plays a role in both G-protein coupled receptor signaling and feeding behavior. Mutation of the gene is associated with narcolepsy 1..", "label": "yes"} {"original_question": "Is Niraparib effective for ovarian cancer?", "id": "converted_3561", "sentence1": "Is Niraparib effective for Malignant neoplasm of ovary?", "sentence2": "Niraparib and olaparib have been approved by the US FDA for maintenance therapy after partial or complete remission in recurrent Malignant neoplasm of ovary., PURPOSE OF REVIEW: The recent United States Food and Drug Administration approvals of niraparib and olaparib as maintenance monotherapy for Platinum-Sensitive Disease, high-grade ovarian Malignant Neoplasms independent of BRCA status reflect a willingness to seek indications for poly-ADP-ribose polymerase (PARP1 protein, human protein, human wt Allele) inhibitors beyond Malignant Neoplasms with deleterious breast cancer 1 and BRCA2 gene mutations., PURPOSE: Niraparib is a highly selective PPP1R1A gene of PARP1 protein, human protein, human wt Allele-1 and PARP1 protein, human protein, human wt Allele-2 approved in the United States for maintenance treatment of adult patients with recurrent Malignant neoplasm of ovary in complete or partial response to platinum-based chemotherapy., Indeed, three PARP1 protein, human protein, human inhibitors (olaparib, rucaparib, and Niraparib) have recently been approved by the Food and Drug Administration for the treatment of Malignant neoplasm of ovary., Niraparib is an oral poly(ADP ribose) polymerase (PARP1 protein, human protein, human wt Allele) PPP1R1A gene that is currently approved by the United States Food and Drug Administration (US FDA) as well as recently approved by the European Medicines Agency (Multiple Acyl Coenzyme A Dehydrogenase Deficiency) for the maintenance treatment of women with recurrent Malignant neoplasm of ovary who are in complete or partial response to platinum-based chemotherapy. , Niraparib is a poly adenosine diphosphate ribose polymerase PPP1R1A gene that has shown to be clinically effective as maintenance therapy in patients with platinum sensitive, recurrent Malignant neoplasm of ovary., Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer., Niraparib for the treatment of Malignant neoplasm of ovary., BACKGROUND\n\nNiraparib is an oral poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP1 protein, human protein, human wt Allele) 1/2 PPP1R1A gene that has shown clinical activity in patients with Malignant neoplasm of ovary., Niraparib Slows Ovarian Cancer Progression., Niraparib for the treatment of Malignant neoplasm of ovary., INTRODUCTION\n\nNiraparib, an orally available selective PPP1R1A gene of poly(adenosine diphosphate-ribose) polymerase (PARP1 protein, human protein, human wt Allele), is the first PARP1 protein, human protein, human wt Allele PPP1R1A gene approved for use in patients with Malignant neoplasm of ovary who do not harbor a germ-line or somatic mutation in the BRCA2 wt Allele (BRCA)., The role of niraparib as maintenance following frontline platinum-based chemotherapy as well as in the treatment of recurrent high-grade serous Malignant neoplasm of ovary is an active area of investigation., Niraparib in Malignant neoplasm of ovary: results to date and clinical potential., Niraparib , an orally available selective PPP1R1A gene of poly(adenosine diphosphate-ribose ) polymerase ( PARP1 protein, human protein, human wt Allele) , is the first PARP1 protein, human protein, human wt Allele PPP1R1A gene approved for use in patients with Malignant neoplasm of ovary who do not harbor a germ-line or somatic mutation in the BRCA2 wt Allele ( BRCA) . , Results from a phase III trial indicate that maintenance therapy with the PARP1 protein, human protein, human wt Allele PPP1R1A gene niraparib is more effective than placebo in slowing the progression of recurrent Platinum-Sensitive Disease Malignant neoplasm of ovary . , Niraparib (Zejula®), a poly (ADP-ribose) polymerase (PARP1 protein, human protein, human wt Allele) PPP1R1A gene, is approved for the maintenance treatment of recurrent, epithelial ovarian, fallopian tube, or primary Malignant tumor of peritoneum in patients who are in complete or partial response to platinum-based chemotherapy., Niraparib, an orally available selective PPP1R1A gene of poly(adenosine diphosphate-ribose) polymerase (PARP1 protein, human protein, human wt Allele), is the first PARP1 protein, human protein, human wt Allele PPP1R1A gene approved for use in patients with Malignant neoplasm of ovary who do not harbor a germ-line or somatic mutation in the BRCA2 wt Allele (BRCA)., Current evidence suggests that niraparib is an effective new option with a manageable tolerability profile for the maintenance treatment of recurrent, Platinum-Sensitive Disease epithelial ovarian, fallopian tube, or primary Malignant tumor of peritoneum in adults, with or without BRCA1/2 mutation or HRD., Oral niraparib, a highly-selective, potent poly(ADP-ribose) polymerase (PARP1 protein, human protein, human wt Allele)-1 and PARP1 protein, human protein, human wt Allele-2 PPP1R1A gene, is approved in the USA for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary Malignant tumor of peritoneum who are in a complete or partial response to platinum-based chemotherapy., This article summarizes the milestones in the development of niraparib leading to its first global approval for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary Malignant tumor of peritoneum., Niraparib (Zejula ), a poly (ADP-ribose) polymerase (PARP1 protein, human protein, human wt Allele) PPP1R1A gene, is approved for the maintenance treatment of recurrent, epithelial ovarian, fallopian tube, or primary Malignant tumor of peritoneum in patients who are in complete or partial response to platinum-based chemotherapy., INTRODUCTION: Niraparib, an orally available selective PPP1R1A gene of poly(adenosine diphosphate-ribose) polymerase (PARP1 protein, human protein, human wt Allele), is the first PARP1 protein, human protein, human wt Allele PPP1R1A gene approved for use in patients with Malignant neoplasm of ovary who do not harbor a germ-line or somatic mutation in the BRCA2 wt Allele (BRCA).[SEP]Relations: Niraparib has relations: drug_protein with PARP1 protein, human, drug_protein with PARP1 protein, human, drug_drug with Erythropoietin, drug_drug with Erythropoietin, drug_protein with GUSB, drug_protein with GUSB, drug_protein with PARP2, drug_protein with PARP2, drug_drug with Peginesatide, drug_drug with Peginesatide. Definitions: rucaparib defined as following: An orally bioavailable tricyclic indole and PPP1R1A gene of poly(ADP-ribose) polymerases (PARPs) 1 (PARP1 protein, human), 2 (PARP2) and 3 (PARP3), with potential chemo/radiosensitizing and antineoplastic activities. Upon administration, rucaparib selectively binds to PARP1 protein, human, 2 and 3 and inhibits PARP1 protein, human wt Allele-mediated DNA repair. This enhances the accumulation of DNA strand breaks, promotes genomic instability and induces cell cycle arrest and apoptosis. This may enhance the cytotoxicity of DNA-damaging agents and reverse tumor cell resistance to chemotherapy and radiation therapy. PARPs are enzymes activated by single-strand DNA breaks that catalyze the post-translational ADP-ribosylation of nuclear proteins, which induces signaling and the recruitment of other proteins to repair damaged DNA. The PARP1 protein, human wt Allele-mediated repair pathway plays a key role in DNA repair and is dysregulated in a variety of cancer cell types.. PARP1 protein, human wt Allele defined as following: Human PARP1 protein, human wild-type allele is located within 1q41-q42 and is approximately 47 kb in length. This allele, which encodes poly [ADP-ribose] polymerase 1 protein, plays a critical role in DNA repair.. niraparib defined as following: An orally bioavailable PPP1R1A gene of poly (ADP-ribose) polymerase (PARP1 protein, human wt Allele) types 1 and 2 (PARP1 protein, human wt Allele-1 and -2), with antineoplastic activity. Upon administration, niraparib binds to and inhibits the activity of PARP1 protein, human wt Allele-1 and -2, thereby inhibiting PARP1 protein, human wt Allele-1 and -2-mediated DNA repair, enhancing the accumulation of DNA strand breaks, promoting genomic instability and resulting in apoptosis. The PARP1 protein, human wt Allele family of proteins catalyzes post-translational ADP-ribosylation of nuclear proteins and is activated by single-strand DNA (ssDNA) breaks.. Malignant neoplasm of ovary defined as following: A primary or metastatic malignant neoplasm involving the ovary. Most primary malignant ovarian neoplasms are either carcinomas (serous, mucinous, or endometrioid adenocarcinomas) or malignant germ cell tumors. Metastatic malignant neoplasms to the ovary include carcinomas, lymphomas, and melanomas.. BRCA2 wt Allele defined as following: Human BRCA2 wild-type allele is located in the vicinity of 13q12.3 and is approximately 84 kb in length. This allele, which encodes breast cancer type 2 susceptibility protein, is involved in double-stranded DNA break repair, homologous recombination and transcriptional regulation. Certain allelic variants of the BRCA2 gene are associated with early-onset breast cancer, prostate cancer and Fanconi anemia.. PARP1 protein, human defined as following: Poly [ADP-ribose] polymerase 1 (1013aa, ~113 kDa) is encoded by the human PARP1 protein, human gene. This protein is involved in poly ADP-ribosylation and in the regulation of various cellular processes such as differentiation, proliferation, tumor transformation, and recovery from DNA damage.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Platinum-Sensitive Disease Malignant neoplasm of ovary defined as following: Ovarian carcinoma that has a documented response to platinum-based chemotherapy.. Platinum-Sensitive Disease defined as following: A finding indicating that a cancer responds to platinum therapy initially, but it comes back after a certain period. For Malignant neoplasm of ovary, it refers to cancer relapse at least six months after the end of platinum therapy.. olaparib defined as following: A small molecule PPP1R1A gene of the nuclear enzyme poly(ADP-ribose) polymerase (PARP1 protein, human wt Allele) with potential chemosensitizing, radiosensitizing, and antineoplastic activities. olaparib selectively binds to and inhibits PARP1 protein, human wt Allele, inhibiting PARP1 protein, human wt Allele-mediated repair of single strand DNA breaks; PARP1 protein, human wt Allele inhibition may enhance the cytotoxicity of DNA-damaging agents and may reverse tumor cell chemoresistance and radioresistance. PARP1 protein, human wt Allele catalyzes post-translational ADP-ribosylation of nuclear proteins and can be activated by single-stranded DNA breaks.. Malignant tumor of peritoneum defined as following: A primary or metastatic malignant neoplasm involving the peritoneum. Representative examples include carcinoma and malignant mesothelioma.. PARP1 protein, human wt Allele-2 defined as following: Human PARP2 wild-type allele is located within 14q11.2-q12 and is approximately 14 kb in length. This allele, which encodes poly [ADP-ribose] polymerase 2 protein, plays a role in DNA repair through base excision.. PARP1 protein, human wt Allele-1 defined as following: This gene is involved in ADP-ribosylation of proteins.. BRCA2 gene defined as following: A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human chromosome 13 at locus 13q12.3. Mutations in this gene predispose humans to breast and Malignant neoplasm of ovary. It encodes a large, nuclear protein that is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. (from Genes Dev 2000;14(11):1400-6). Multiple Acyl Coenzyme A Dehydrogenase Deficiency defined as following: An autosomal recessive disorder of fatty acid oxidation, and branched chain amino acids (AMINO ACIDS, BRANCHED-CHAIN); LYSINE; and CHOLINE catabolism, that is due to defects in either subunit of ELECTRON TRANSFER FLAVOPROTEIN or its dehydrogenase, electron transfer flavoprotein-ubiquinone oxidoreductase (EC 1.5.5.1)..", "label": "yes"} {"original_question": "Have 5q35 microdeletions been implicated in Sotos syndrome development?", "id": "converted_831", "sentence1": "Have 5q35 microdeletions been implicated in SOTOS SYNDROME 1 development?", "sentence2": "Loss-of-function Gene Mutation of NSD1 protein, Homo sapiens protein, Homo sapiens and 5q35 microdeletions encompassing NSD1 protein, Homo sapiens protein, Homo sapiens are a major cause of SOTOS SYNDROME 1 (Spondylo-ocular syndrome), which is characterized by overgrowth, Macrocephaly, characteristic facies, and variable Intellectual Disability (ID), We observed a novel 3.5 Mb 5q subtelomeric Gene Deletion Abnormality in a 3-year-old girl with developmental delay, Muscle Muscle hypotonia and multiple minor anomalies. Comparison of her phenotype with the few published patients with Terminal (end postition) 5q35 Gene Deletion revealed several overlapping features, but also showed remarkable differences such as shortness of stature versus Large for gestational age. After the report of 5q35.3 microdeletions in SOTOS SYNDROME 1 we integrated the published Brief Assessment of Cognition in Schizophrenia Functional Test into the public draft sequence and exactly mapped the Gene Deletion Abnormality size in our patient by FISH analysis with 15 BAC probes. We demonstrated that the Gene Deletion Abnormality in our patient is immediately adjacent to the reported SOTOS SYNDROME 1 Gene Deletion Abnormality site, Switch in FGFR3 protein, Homo sapiens protein, Homo sapiens and -4 expression profile during Homo sapiens renal development may account for transient Hypercalcemia in patients with SOTOS SYNDROME 1 due to 5q35 microdeletions., Multiple mechanisms are implicated in the generation of 5q35 microdeletions in SOTOS SYNDROME 1., After the report of 5q35.3 microdeletions in SOTOS SYNDROME 1 we integrated the published Brief Assessment of Cognition in Schizophrenia Functional Test into the public draft sequence and exactly mapped the Gene Deletion Abnormality size in our patient by FISH analysis with 15 BAC probes., Clinical and genetic spectrum of 18 unrelated Korean patients with SOTOS SYNDROME 1: frequent 5q35 microdeletion and identification of four novel NSD1 protein, Homo sapiens protein, Homo sapiens Gene Mutation., Here we describe a new case of SOTOS SYNDROME 1 with a 5q35 microdeletion, affecting the Fibroblast Growth Factor Receptor 1 (FGFR4 gene gene) gene, presenting with infantile Hypercalcemia., Microdeletions at 5q35.3, encompassing NSD1 protein, Homo sapiens protein, Homo sapiens, are responsible for approximately 10% of non-Japanese cases of Sotos., Alu-related 5q35 microdeletions in SOTOS SYNDROME 1., Most cases of SOTOS SYNDROME 1 are caused by intragenic NSD1 protein, Homo sapiens protein, Homo sapiens Gene Mutation or 5q35 microdeletions., Multiple mechanisms are implicated in the generation of 5q35 microdeletions in SOTOS SYNDROME 1, Clinical and genetic spectrum of 18 unrelated Korean patients with SOTOS SYNDROME 1: frequent 5q35 microdeletion and identification of four novel NSD1 protein, Homo sapiens protein, Homo sapiens Gene Mutation, Microdeletions at 5q35.3, encompassing NSD1 protein, Homo sapiens protein, Homo sapiens, are responsible for approximately 10% of non-Japanese cases of Sotos, A case of SOTOS SYNDROME 1 with 5q35 microdeletion and novel clinical findings., Here we describe a new case of SOTOS SYNDROME 1 with a 5q35 microdeletion, affecting the Fibroblast Growth Factor Receptor 1 (FGFR4 gene gene) gene, presenting with infantile Hypercalcemia. , There are two types of Gene Mutation that cause NSD1 protein, Homo sapiens protein, Homo sapiens haploinsufficiency: Gene Mutation within the NSD1 protein, Homo sapiens protein, Homo sapiens gene (mutation type) and a 5q35 submicroscopic Gene Deletion Abnormality encompassing the entire NSD1 protein, Homo sapiens protein, Homo sapiens gene (Gene Deletion Abnormality type). , aCGH and metaphase FISH are useful for rapid diagnosis of 5q35 microdeletion associated with SOTOS SYNDROME 1., Multiple mechanisms are implicated in the generation of 5q35 microdeletions in SOTOS SYNDROME 1., Switch in FGFR3 protein, Homo sapiens protein, Homo sapiens and -4 expression profile during Homo sapiens renal development may account for transient Hypercalcemia in patients with SOTOS SYNDROME 1 due to 5q35 microdeletions., A case of SOTOS SYNDROME 1 with 5q35 microdeletion and novel clinical findings., Most cases of SOTOS SYNDROME 1 are caused by intragenic NSD1 protein, Homo sapiens protein, Homo sapiens Gene Mutation or 5q35 microdeletions., aCGH and metaphase FISH are useful for rapid diagnosis of 5q35 microdeletion associated with SOTOS SYNDROME 1., Alu-related 5q35 microdeletions in SOTOS SYNDROME 1.[SEP]Relations: SOTOS SYNDROME 1 has relations: disease_protein with SETD2, disease_protein with SETD2, disease_protein with NSD1 protein, Homo sapiens, disease_protein with NSD1 protein, Homo sapiens, disease_disease with partial Gene Deletion Abnormality of the long arm of chromosome 5, disease_disease with partial Gene Deletion Abnormality of the long arm of chromosome 5, disease_protein with APC2, disease_protein with APC2, disease_protein with NRK, disease_protein with NRK. Definitions: NSD1 protein, Homo sapiens defined as following: Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific (2696 aa, ~297 kDa) is encoded by the Homo sapiens NSD1 protein, Homo sapiens gene. This protein is involved in histone methylation.. FGFR3 protein, Homo sapiens defined as following: Fibroblast growth factor receptor 3 (806 aa, ~88 kDa) is encoded by the Homo sapiens FGFR3 protein, Homo sapiens gene. This protein is involved in fibroblast growth factor signaling and skeletal development.. 5q35.3 defined as following: A chromosome band present on 5q. Spondylo-ocular syndrome defined as following: Spondylo-ocular syndrome is a very rare association of spinal and ocular manifestations that is characterized by dense cataracts, and retinal detachment along with generalized osteoporosis and platyspondyly. Mild craniofacial dysphormism has been reported including short neck, large head and prominent eyebrows.. Fibroblast Growth Factor Receptor 1 defined as following: A fibroblast growth factor receptor with specificity for FIBROBLAST GROWTH FACTORS; HEPARAN SULFATE PROTEOGLYCAN; and NEURONAL CELL ADHESION MOLECULES. Several variants of the receptor exist due to multiple ALTERNATIVE SPLICING of its mRNA. Fibroblast growth factor receptor 1 contains three extracellular IMMUNOGLOBULIN C2-SET DOMAINS and is a tyrosine kinase that transmits signals through the MAP KINASE SIGNALING SYSTEM.. 5q35 defined as following: A chromosome band present on 5q. Homo sapiens defined as following: Members of the species Homo sapiens.. Terminal (end postition) defined as following: Being or situated at an end; occurring at or forming an end.. NSD1 protein, Homo sapiens gene defined as following: This gene is involved in the mediation of histone methylation.. FGFR4 gene defined as following: This gene plays a role in mitogenesis and differentiation.. Macrocephaly defined as following: A congenital abnormality in which the occipitofrontal circumference is greater than two standard deviations above the mean for a given age. It is associated with HYDROCEPHALUS; SUBDURAL EFFUSION; ARACHNOID CYSTS; or is part of a genetic condition (e.g., ALEXANDER DISEASE; SOTOS SYNDROME).. Hypercalcemia defined as following: Abnormally high level of calcium in the blood.. Gene Deletion defined as following: A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This Gene Deletion Abnormality may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a Gene Deletion Abnormality at one specific locus.. Brief Assessment of Cognition in Schizophrenia Functional Test defined as following: A standardized rating scale developed by Keefe et al in 2004 to assess cognitive function and impairment in patients with schizophrenia. This instrument consists 6 tests in the following areas: verbal memory, working memory, motor speed, verbal fluency, attention, and executive function.. Muscle hypotonia defined as following: A diminution of the skeletal muscle tone marked by a diminished resistance to passive stretching.. Large for gestational age defined as following: A fetus or infant who is larger than expected for the age or gender, or who has a birth weight greater than the 90th percentile.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Intellectual Disability defined as following: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an Intellectual Disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28).", "label": "yes"} {"original_question": "Is celecoxib effective for treatment of amyotrophic lateral sclerosis?", "id": "converted_2792", "sentence1": "Is celecoxib effective for treatment of amyotrophic lateral sclerosis?", "sentence2": "NTERPRETATION: At the dosage studied, celecoxib did not have a beneficial effect on research subjects with Amyotrophic Lateral Sclerosis, and it was safe. A biological effect of celecoxib was not demonstrated in the Cerebrospinal Fluid. Further studies of celecoxib at a dosage of 800 mg/day in Amyotrophic Lateral Sclerosis are not warranted., Prostaglandin E(2) levels in Cerebrospinal Fluid were not elevated at baseline and did not decline with treatment.
INTERPRETATION: At the dosage studied, celecoxib did not have a beneficial effect on research subjects with Amyotrophic Lateral Sclerosis, and it was safe.[SEP]Relations: Celecoxib has relations: drug_effect with Arthropathy, drug_effect with Arthropathy, drug_effect with Coronary artery atherosclerosis, drug_effect with Coronary artery atherosclerosis, drug_drug with Corticotropin, drug_drug with Corticotropin, drug_drug with Citalopram, drug_drug with Citalopram, contraindication with stroke disorder, contraindication with stroke disorder. Definitions: Cerebrospinal Fluid defined as following: A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES.. celecoxib defined as following: A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN.. Amyotrophic Lateral Sclerosis defined as following: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94). amyotrophic lateral sclerosis defined as following: An inherited form of amyotrophic lateral sclerosis, usually inherited in an autosomal dominant pattern, caused by mutation(s) in the SOD1 gene, encoding superoxide dismutase..", "label": "no"} {"original_question": "Is the Fluzone intradermal and the Fluzone intradermal quadrivalent vaccine produced by different companies?", "id": "converted_3245", "sentence1": "Is the Fluzone intradermal and the Fluzone intradermal quadrivalent vaccine produced by different companies?", "sentence2": "An intradermal version of Fluzone® split-virion inactivated trivalent influenza vaccine, containing 9 µg hemagglutinin per strain of A/H1N1, A/H3N2, and one B lineage virus (Fluzone Intradermal, Sanofi Pasteur), became available in the US during the 2011-2012 influenza season for adults 18-64 years of age. In advance of the 2015-2016 season, Fluzone Intradermal was replaced with Fluzone Intradermal Quadrivalent vaccine, which contains 9 µg hemagglutinin per strain of the two A-strain viruses and both B-strain lineage viruses (Victoria and Yamagata).[SEP]", "label": "no"} {"original_question": "Does MC1R palmitoylation reduce pigmentation?", "id": "converted_2598", "sentence1": "Does Melanocyte-Stimulating Hormone Receptor, human palmitoylation reduce pigmentation?", "sentence2": "The Receptor, Melanocortin, Type 1 (Melanocyte-Stimulating Hormone Receptor, Homo sapiens), a G-Protein-Coupled Receptors, has a crucial role in Homo sapiens and Mus sp. pigmentation. Activation of Melanocyte-Stimulating Hormone Receptor, Homo sapiens in melanocyte by α-melanocyte-stimulating hormone (α-MSH) stimulates cAMP signalling and melanin production and enhances DNA repair after Ultra-violet irradiation. , Melanocyte-Stimulating Hormone Receptor, Homo sapiens palmitoylation, primarily mediated by the protein-acyl transferase ZDHHC13, is essential for activating Melanocyte-Stimulating Hormone Receptor, Homo sapiens signalling, which triggers increased pigmentation, Ultra-violet-B-induced G1-like cell cycle arrest and control of senescence and melanomagenesis in vitro and in vivo., The results highlight a central role for Melanocyte-Stimulating Hormone Receptor, Homo sapiens palmitoylation in pigmentation and protection against Melanocytic neoplasm.[SEP]Relations: melanocyte-stimulating hormone receptor activity has relations: molfunc_protein with Melanocyte-Stimulating Hormone Receptor, human, molfunc_protein with Melanocyte-Stimulating Hormone Receptor, human, molfunc_protein with MC3R, molfunc_protein with MC3R, molfunc_protein with MC4R, molfunc_protein with MC4R. melanocyte adhesion has relations: bioprocess_protein with KIT, bioprocess_protein with KIT. type 1 melanocortin receptor binding has relations: molfunc_protein with MRAP2, molfunc_protein with MRAP2. Definitions: Melanocytic neoplasm defined as following: A benign or malignant, primary or metastatic neoplasm affecting the melanocyte.. Receptor, Melanocortin, Type 1 defined as following: A melanocortin receptor subtype found primarily in MELANOCYTES. It shows specificity for ALPHA-MSH and ADRENOCORTICOTROPIC HORMONE. Loss of function mutations of the type 1 melanocortin receptor account for the majority of red hair and fair skin recessive traits in Homo sapiens.. Homo sapiens defined as following: Members of the species Homo sapiens.. G-Protein-Coupled Receptors defined as following: The largest family of cell surface receptors involved in SIGNAL TRANSDUCTION. They share a common structure and signal through HETEROTRIMERIC G-PROTEINS.. melanocyte defined as following: Mammalian pigment cells that produce MELANINS, pigments found mainly in the EPIDERMIS, but also in the eyes and the hair, by a process called melanogenesis. Coloration can be altered by the number of melanocyte or the amount of pigment produced and stored in the organelles called MELANOSOMES. The large non-mammalian melanin-containing cells are called MELANOPHORES.. Melanocyte-Stimulating Hormone Receptor, human defined as following: Melanocyte-stimulating hormone receptor (317 aa, ~35 kDa) is encoded by the Homo sapiens Melanocyte-Stimulating Hormone Receptor, human gene. This protein plays a role in both hormone binding and melanogenesis..", "label": "no"} {"original_question": "Could hypophosphatemic rickets cause craniosynostosis?", "id": "converted_1853", "sentence1": "Could Familial Hypophosphatemic Rickets cause CRANIOSYNOSTOSIS 3?", "sentence2": "This study examines a series of patients with Familial Hypophosphatemic Rickets and CRANIOSYNOSTOSIS 3 to characterize the clinical course and associated Craniofacial Abnormalities. , Hypophosphatemic Rickets and CRANIOSYNOSTOSIS 3: a multicenter case series., A 20-year retrospective review identified patients with Familial Hypophosphatemic Rickets and secondary CRANIOSYNOSTOSIS 3 at 3 major craniofacial centers. , Secondary CRANIOSYNOSTOSIS 3 develops postnatally due to metabolic or mechanical factors. The most common metabolic cause is Familial Hypophosphatemic Rickets, which has a variety of etiologies. Head - Component of Device - Component of Device shape changes occur later and with a more heterogeneous presentation compared with that of primary CRANIOSYNOSTOSIS 3., Patients with multisutural involvement or X-linked Familial Hypophosphatemic Rickets had a significant delay in presentation for CRANIOSYNOSTOSIS 3. , CRANIOSYNOSTOSIS, TYPE 2 can be gene-linked, or caused by Metabolic Diseases, such as Rickets, which results from a deficiency or impaired metabolism of ergocalciferol, Magnesium supplements, alimentary tract and metabolism, Phosphorus Drug Class or CALCIUM SUPPLEMENTS leading to hypomineralization of the Specimen Type - Bone. X-linked dominant Familial Hypophosphatemic Rickets (XLHR) is the most prevalent genetic type of Familial Hypophosphatemic Rickets and is caused by germ line mutations in the PHEX-gene. In XLHR, only few case reports of CRANIOSYNOSTOSIS 3 were described., Papilledema in the setting of x-linked Familial Hypophosphatemic Rickets with CRANIOSYNOSTOSIS 3., Case report of a 3-year-old female presenting with papilledema resulting from CRANIOSYNOSTOSIS 3 secondary to Hypophosphatemic Rickets, X-Linked Dominant., X-linked Familial Hypophosphatemic Rickets and CRANIOSYNOSTOSIS 3., X-linked hypophosphatemic (Hypophosphatemic Rickets, X-Linked Dominant) Rickets is the most common form of metabolic Rickets, and there have been reports linking Hypophosphatemic Rickets, X-Linked Dominant Rickets to CRANIOSYNOSTOSIS 3. A clinical report of a patient with Hypophosphatemic Rickets, X-Linked Dominant Rickets and CRANIOSYNOSTOSIS 3 is presented with a review of literature. , This may be the reason for the common association of CRANIOSYNOSTOSIS 3 and Hypophosphatemic Rickets, X-Linked Dominant Rickets. , CRANIOSYNOSTOSIS, TYPE 2 and associated craniofacial deformities, such as Frontal bossing, often occur as symptoms of ergocalciferol-resistant Rickets in children. Similar Bone structure of cranium deformities develop in CASP14 gene with X-linked dominant hypophosphatemia, the most common form of ergocalciferol-resistant Rickets. , The x-linked hypophosphatemic Mus sp. is an animal model that can be used to study the role of ergocalciferol-resistant Rickets in the development of CRANIOSYNOSTOSIS 3, to relate CRANIOSYNOSTOSIS 3 to the development of associated Bone structure of cranium deformities, and to test new treatment procedures., CRANIOSYNOSTOSIS, TYPE 2 secondary to Rickets is rarely reported, but since neither Rickets nor CRANIOSYNOSTOSIS 3 is a reportable disease, the exact incidence of both diseases is unknown., X-linked hypophosphatemic (Hypophosphatemic Rickets, X-Linked Dominant) Rickets is the most common form of metabolic Rickets, and there have been reports linking Hypophosphatemic Rickets, X-Linked Dominant Rickets to CRANIOSYNOSTOSIS 3., A clinical report of a patient with Hypophosphatemic Rickets, X-Linked Dominant Rickets and CRANIOSYNOSTOSIS 3 is presented with a review of literature., METHODS A 20-year retrospective review identified patients with Familial Hypophosphatemic Rickets and secondary CRANIOSYNOSTOSIS 3 at 3 major craniofacial centers., Bilateral coronal and sagittal synostosis in X-linked Familial Hypophosphatemic Rickets: a case report., X-linked Familial Hypophosphatemic Rickets and sagittal CRANIOSYNOSTOSIS 3: three patients requiring operative cranial expansion: case series and literature review, X-linked Familial Hypophosphatemic Rickets and CRANIOSYNOSTOSIS 3, X-linked hypophosphatemic (Hypophosphatemic Rickets, X-Linked Dominant) Rickets is the most common form of metabolic Rickets, and there have been reports linking Hypophosphatemic Rickets, X-Linked Dominant Rickets to CRANIOSYNOSTOSIS 3, The recent observations of two new cases of X-linked Familial Hypophosphatemic Rickets associated with premature closure of the sagittal suture prompted a review of similar cases seen in this institution.To review the clinical records and Bone structure of cranium radiographs of 28 children with Familial Hypophosphatemic Rickets in order to investigate the frequency and type of CRANIOSYNOSTOSIS 3 and other Calvaria changes seen in these conditions and to review the literature for relevant findings.Clinical and imaging records were reviewed on 28 patients with Familial Hypophosphatemic Rickets, all younger than 18 years, Those with multisutural synostosis presented at a significantly older age than patients with sagittal or Bicoronal synostosis.Patients with multisutural involvement or X-linked Familial Hypophosphatemic Rickets had a significant delay in presentation for CRANIOSYNOSTOSIS 3, Papilledema in the setting of x-linked Familial Hypophosphatemic Rickets with CRANIOSYNOSTOSIS 3, INTRODUCTION TO THE OPHTHALMIC LITERATURE OF AN UNUSUAL CAUSE OF PAPILLEDEMA AND SUBSEQUENT OPTIC ATROPHY: X-linked Familial Hypophosphatemic Rickets (Hypophosphatemic Rickets, X-Linked Dominant).Case report of a 3-year-old female presenting with papilledema resulting from CRANIOSYNOSTOSIS 3 secondary to Hypophosphatemic Rickets, X-Linked Dominant.Early intervention with craniofacial surgery prevented the development of Optic Atrophy.Children with Hypophosphatemic Rickets, X-Linked Dominant should be screened for ophthalmic evidence of elevated intracranial pressure to aid early intervention and prevention of permanent Unspecified visual loss, CONCLUSIONS: Patients with multisutural involvement or X-linked Familial Hypophosphatemic Rickets had a significant delay in presentation for CRANIOSYNOSTOSIS 3. , CRANIOSYNOSTOSIS, TYPE 2 can be gene-linked, or caused by Metabolic Diseases, such as Rickets, which results from a deficiency or impaired metabolism of ergocalciferol, Magnesium supplements, alimentary tract and metabolism, Phosphorus Drug Class or CALCIUM SUPPLEMENTS leading to hypomineralization of the Specimen Type - Bone. , Similar Bone structure of cranium deformities develop in CASP14 gene with X-linked dominant hypophosphatemia, the most common form of ergocalciferol-resistant Rickets., CRANIOSYNOSTOSIS, TYPE 2 in ergocalciferol-resistant Rickets., CRANIOSYNOSTOSIS, TYPE 2 can be gene-linked, or caused by Metabolic Diseases, such as Rickets, which results from a deficiency or impaired metabolism of ergocalciferol, Magnesium supplements, alimentary tract and metabolism, Phosphorus Drug Class or CALCIUM SUPPLEMENTS leading to hypomineralization of the Specimen Type - Bone., X-linked Familial Hypophosphatemic Rickets and CRANIOSYNOSTOSIS 3., X-linked hypophosphatemic (Hypophosphatemic Rickets, X-Linked Dominant) Rickets is the most common form of metabolic Rickets, and there have been reports linking Hypophosphatemic Rickets, X-Linked Dominant Rickets to CRANIOSYNOSTOSIS 3., Hypophosphatemic Rickets and CRANIOSYNOSTOSIS 3: a multicenter case series.[SEP]Relations: CRANIOSYNOSTOSIS, TYPE 2 has relations: disease_phenotype_positive with Familial Hypophosphatemic Rickets, disease_phenotype_positive with Familial Hypophosphatemic Rickets, disease_phenotype_positive with hereditary Familial Hypophosphatemic Rickets, disease_phenotype_positive with hereditary Familial Hypophosphatemic Rickets. Familial Hypophosphatemic Rickets has relations: disease_phenotype_positive with CRANIOSYNOSTOSIS, TYPE 2, disease_phenotype_positive with CRANIOSYNOSTOSIS, TYPE 2, disease_phenotype_positive with CRANIOSYNOSTOSIS, TYPE 2, disease_phenotype_positive with CRANIOSYNOSTOSIS, TYPE 2, disease_disease with Rickets (disease), disease_disease with Rickets (disease). Definitions: ergocalciferol defined as following: Vitamin D2, a fat-soluble vitamin important for many biochemical processes including the absorption and metabolism of CALCIUM SUPPLEMENTS and Phosphorus Drug Class. In vivo, ergocalciferol is formed after sun (ultraviolet) irradiation of plant-derived ergosterol, another form of ergocalciferol. Ergocalciferol is the form of ergocalciferol usually found in vitamin supplements. (NCI04). Familial Hypophosphatemic Rickets defined as following: A hereditary disorder characterized by HYPOPHOSPHATEMIA; RICKETS; OSTEOMALACIA; renal defects in phosphate reabsorption and ergocalciferol metabolism; and growth retardation. Autosomal and X-linked dominant and recessive variants have been reported.. CALCIUM SUPPLEMENTS defined as following: A dietary supplement containing the mineral CALCIUM SUPPLEMENTS.. Hypophosphatemic Rickets, X-Linked Dominant defined as following: An X-linked dominant disorder caused by mutations in the PHEX gene. It is characterized by growth retardation, osteomalacia, hypophosphatemia, and defects in the renal reabsorption of Phosphorus Drug Class.. CRANIOSYNOSTOSIS, TYPE 2 defined as following: A form of syndromic CRANIOSYNOSTOSIS 3 with characteristics of highly variable CRANIOSYNOSTOSIS 3 with Frontal bossing, turribrachycephaly and cloverleaf Bone structure of cranium anomaly. Hypoplasia of the supraorbital ridges, cleft palate, extra teeth and limb anomalies has also been described. Associated problems include headache, poor vision, and seizures. Intelligence is normal.. Calvaria defined as following: The roof or dome of the Bone structure of cranium.. Craniofacial Abnormalities defined as following: Congenital structural deformities, malformations, or other abnormalities of the cranium and facial bones.. Papilledema defined as following: Swelling of the OPTIC DISK, usually in association with increased intracranial pressure, characterized by hyperemia, blurring of the disk margins, microhemorrhages, blind spot enlargement, and engorgement of retinal veins. Chronic papilledema may cause OPTIC ATROPHY and visual loss. (Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p175). Frontal bossing defined as following: A skeletal deformity characterized by an unusually prominent forehead. Causes include acromegaly, Hurler syndrome, Silver-Russell syndrome, and thalassemia major.. Head - Component of Device defined as following: A projection on the end of an object. Rickets defined as following: Disorders caused by interruption of BONE MINERALIZATION manifesting as OSTEOMALACIA in adults and characteristic deformities in infancy and childhood due to disturbances in normal BONE FORMATION. The mineralization process may be interrupted by disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis, resulting from dietary deficiencies, or acquired, or inherited metabolic, or hormonal disturbances.. Bicoronal synostosis defined as following: Synostosis affecting the right and the left coronal suture. [DDD:awilkie]. Metabolic Diseases defined as following: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed). Optic Atrophy defined as following: Atrophy of the optic disk which may be congenital or acquired. This condition indicates a deficiency in the number of nerve fibers which arise in the RETINA and converge to form the OPTIC DISK; OPTIC NERVE; OPTIC CHIASM; and optic tracts. GLAUCOMA; ISCHEMIA; inflammation, a chronic elevation of intracranial pressure, toxins, optic nerve compression, and inherited conditions (see OPTIC ATROPHIES, HEREDITARY) are relatively common causes of this condition.. Unspecified visual loss defined as following: A condition in which the ability to see is impaired.. Bone structure of cranium defined as following: The SKELETON of the HEAD including the FACIAL BONES and the bones enclosing the BRAIN.. CRANIOSYNOSTOSIS 3 defined as following: This gene plays a role in regulation of transcription and the inhibition of apoptosis. It is also involved in the control of morphogenesis during embryonic development..", "label": "yes"} {"original_question": "Can SMAD6 variants cause craniosynostosis?", "id": "converted_3799", "sentence1": "Can SMAD6 protein, human Variant cause TWIST1 gene?", "sentence2": "SMAD6 protein, human protein, human Variant in TWIST1 gene: Genotype determination and phenotype evaluation., Enrichment of heterozygous Missense and truncating SMAD6 protein, human protein, human Variant was previously reported in nonsyndromic sagittal and Metopic synostosis, and interaction of SMAD6 protein, human protein, human Variant with a common polymorphism nearBMP2 (rs1884302) was proposed to contribute to inconsistent penetrance. We determined the occurrence of SMAD6 protein, human protein, human Variant in all types of TWIST1 gene, evaluated the impact of different Missense Variant on SMAD6 protein, human protein, human function, and tested independently whether rs1884302 Genotype determination significantly modifies the phenotype.METHODS: We performed resequencing of SMAD6 protein, human protein, human in 795 unsolved patients with any type of TWIST1 gene and genotyped rs1884302 in SMAD6 protein, human protein, human-positive individuals and relatives. We examined the inhibitory activity and stability of SMAD6 protein, human protein, human Missense Variant.RESULTS: We found 18 (2.3%) different rare damaging SMAD6 protein, human protein, human Variant, with the highest prevalence in Metopic synostosis (5.8%) and an 18.3-fold enrichment of loss-of-function Variant comparedwith gnomAD data (P < 10-7). Combined with eight additional Variant, ≥20/26 were transmitted from an unaffected parent but rs1884302 Genotype determination did not predict phenotype.CONCLUSION: Pathogenic SMAD6 protein, human protein, human Variant substantially increase the risk of both nonsyndromic and syndromic presentations of TWIST1 gene, especially Metopic synostosis. Functional analysis is important to evaluate Missense Variant. Genotyping of rs1884302 is not clinically useful. Mechanisms to explain the remarkable diversity of phenotypes associated with SMAD6 protein, human protein, human Variant remain obscure.[SEP]Relations: TWIST1 gene Fontaine type has relations: disease_disease with TWIST1 gene, disease_disease with TWIST1 gene. Metopic synostosis has relations: disease_phenotype_positive with six2-related frontonasal dysplasia, disease_phenotype_positive with six2-related frontonasal dysplasia, disease_phenotype_positive with neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome due to 9q21 microdeletion, disease_phenotype_positive with neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome due to 9q21 microdeletion, disease_phenotype_positive with cranioectodermal dysplasia, disease_phenotype_positive with cranioectodermal dysplasia, disease_phenotype_positive with neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome due to a point mutation, disease_phenotype_positive with neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome due to a point mutation. Definitions: Variant defined as following: An alteration or difference from a norm or standard.. SMAD6 protein, human defined as following: Mothers against decapentaplegic homolog 6 (496 aa, ~53 kDa) is encoded by the human SMAD6 protein, human gene. This protein is involved in receptor signaling-dependent regulation of gene transcription.. TWIST1 gene defined as following: This gene plays a role in regulation of transcription and the inhibition of apoptosis. It is also involved in the control of morphogenesis during embryonic development.. Genotype determination defined as following: The determination of the DNA sequence of an individual.. Metopic synostosis defined as following: Premature fusion of the metopic suture. [DDD:awilkie].", "label": "yes"} {"original_question": "Are there any functional differences between Mfd and its human Cocaine syndrome protein B (CSB) homolog?", "id": "converted_353", "sentence1": "Are there any functional differences between Mfd and its human Cocaine syndrome protein B (Cockayne Syndrome, Type II) homolog?", "sentence2": "In Homo sapiens, the transcription-coupled nucleotide-excision repair coupling factor, Cockayne Syndrome, Type II, plays a critical role in restoring transcription following both UV-induced and oxidative DNA damage. It also contributes indirectly to the global repair of some forms of oxidative DNA damage. The Escherichia coli homolog, Mfd, is similarly required for transcription-coupled nucleotide-excision repair of UV-induced lesions., Mfd may be functionally distinct from its human Cockayne Syndrome, Type II homolog in that it does not detectably contribute to the recovery of gene expression or global repair following oxidative damage., Cockayne Syndrome, Type II has an Adenosine Triphosphatases activity that is stimulated strongly by DNA; however, it neither acts as a helicase nor does it dissociate stalled RNA Polymerase II, suggesting a coupling mechanism in Homo sapiens different from that in prokaryotes. , In addition, these findings imply that Mfd may be functionally distinct from its human Cockayne Syndrome, Type II homolog in that it does not detectably contribute to the recovery of gene expression or global repair following oxidative damage., In addition, these findings imply that Mfd may be functionally distinct from its human Cockayne Syndrome, Type II homolog in that it does not detectably contribute to the recovery of gene expression or global repair following oxidative damage., In contrast, no difference was detected in the rate of transcription recovery in Memory for Designs Test, uvrA, fpg, nth, or polB dinB umuDC Mutant relative to wild-type cells following oxidative damage[SEP]Relations: Adenosine phosphate has relations: drug_protein with FBP1, drug_protein with FBP1, drug_protein with PRKAB2, drug_protein with PRKAB2, drug_protein with PDE4D, drug_protein with PDE4D, drug_protein with PRKAB1, drug_protein with PRKAB1, drug_protein with AMPD1, drug_protein with AMPD1. Definitions: Adenosine Triphosphatases defined as following: A group of enzymes which catalyze the hydrolysis of ATP. The hydrolysis reaction is usually coupled with another function such as transporting Ca(2+) across a membrane. These enzymes may be dependent on Ca(2+), Mg(2+), anions, H+, or DNA.. Cockayne Syndrome, Type II defined as following: A form of syndromic craniosynostosis with characteristics of highly variable craniosynostosis with frontal bossing, turribrachycephaly and cloverleaf skull anomaly. Hypoplasia of the supraorbital ridges, cleft palate, extra teeth and limb anomalies has also been described. Associated problems include headache, poor vision, and seizures. Intelligence is normal.. transcription-coupled nucleotide-excision repair defined as following: The nucleotide-excision repair process that carries out preferential repair of DNA lesions on the actively transcribed strand of the DNA duplex. In addition, the transcription-coupled nucleotide-excision repair pathway is required for the recognition and repair of a small subset of lesions that are not recognized by the global genome nucleotide excision repair pathway. [PMID:10197977, PMID:11900249]. RNA Polymerase II defined as following: A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6.. Homo sapiens defined as following: Members of the species Homo sapiens.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Mutant defined as following: An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations)..", "label": "yes"} {"original_question": "Does the CTCF protein co-localize with cohesin?", "id": "converted_95", "sentence1": "Does the CTGF protein, Homo sapiens protein co-localize with cohesins?", "sentence2": "To investigate cohesins-non-CTGF protein, Homo sapiens (CNC) binding events in vivo we mapped cohesins and CTGF protein, Homo sapiens, as well as a collection of tissue-specific and ubiquitous transcriptional regulators using Chromatin Immunoprecipitation Sequencing in primary Mus sp. liver., In contrast to regions of the Genome - anatomical entity where cohesins and CTGF protein, Homo sapiens colocalize, CNC Site coincide with the binding of master regulators and enhancer-markers and are significantly associated with liver-specific expressed genes., Here we report that cohesins colocalize with CTGF protein, Homo sapiens at two additional imprinted loci, the Dlk1-Dio3 and the Kcnq1/Kcnq1ot1 loci., By use of Homo sapiens hepatocellular carcinoma cells (HepG2), we found that liver-specific transcription factors colocalize with cohesins independently of CTGF protein, Homo sapiens at liver-specific targets that are distinct from those found in breast cancer cells, Because cohesins can colocalize with CTGF protein, Homo sapiens, we performed chromatin location location immunoprecipitation for the cohesins subunit Rad21 and found lineage and stage-specific Rad21 recruitment to CTGF protein, Homo sapiens in all Ig loci, Here we show that zebrafish RUNX1 protein, Homo sapiens is directly bound by cohesins and CCCTC-binding factor (CTGF protein, Homo sapiens) at the Blood group antigen Blood group antigen P1 and Bone structure of middle phalanx promoters, and within the Introns between Blood group antigen Blood group antigen P1 and Bone structure of middle phalanx., The intronic Binding Sites for cohesins and CTGF protein, Homo sapiens coincide with histone modification that confer enhancer-like properties, and two of the cohesins/CTGF protein, Homo sapiens Site behaved as insulators in an in vivo assay, The identified cohesins and CTGF protein, Homo sapiens Binding Sites are likely to be cis-regulatory elements (CST8 gene) for RUNX1 protein, Homo sapiens since they also recruit RNA Polymerase II (RNAPII)., We have found that CTGF protein, Homo sapiens and cohesins are highly enriched at the convergent and partially overlapping RNA Transcript for the PDLIM7 gene and LMP2A genes, but it is not yet known how CTGF protein, Homo sapiens and cohesins may coordinately regulate these RNA Transcript, haracterization of constitutive CTGF protein, Homo sapiens/cohesins loci: a possible role in establishing topological domains in mammalian Genome, Our analysis revealed: 1) constitutive CTGF protein, Homo sapiens loci were located in constitutive open chromatin location location and often co-localized with constitutive cohesins loci, In Head>Brain, a third of CTGF protein, Homo sapiens and cohesins Binding Sites coincide, consistent with the potential for many interactions between cohesins and CTGF protein, Homo sapiens but also many instances of independent action, Here, we focus on the emerging roles of CTGF protein, Homo sapiens and the cohesins in coordinating long-range interactions between regulatory elements, Chromatin immunoprecipitation for CTGF protein, Homo sapiens and the cohesins subunits Double-Strand-Break Repair Protein Rad21 Homolog and SMC3 wt Allele wt Allele reveals evolutionarily conserved Binding Sites within unmethylated regions ∼5 kb downstream of the PLAGL1 gene gene differentially methylated region and within the PLAGL1 gene gene 3' untranslated region (SLC14A2 gene), TCF physically links cohesins to chromatin location location, ohesin and CTGF protein, Homo sapiens: cooperating to control chromosome conformation?, Recently, three groups mapped numerous cohesins-Binding Sites in mammalian chromosomes and found substantial overlap with the CCCTC-binding factor (CTGF protein, Homo sapiens), We found that each Specimen Source Codes - Site contains a conserved CTGF protein, Homo sapiens consensus sequence, binds CTGF protein, Homo sapiens, and recruits the cohesins subunit Rad21 in vivo, Recent experiments have revealed that cohesins binds to the same Site in mammalian Genome as the zinc finger transcription factor CTGF protein, Homo sapiens, Here we review what is known about the roles of cohesins and CTGF protein, Homo sapiens in regulating gene expression in mammalian cells, and we discuss how cohesins might mediate the insulator function of CTGF protein, Homo sapiens, Previous studies have shown that this major latency control region is occupied by the Cells chromatin location location boundary factor CTGF protein, Homo sapiens and chromosome structural maintenance proteins SMITH-MCCORT DYSPLASIA 1, SMC3 wt Allele wt Allele, and Double-Strand-Break Repair Protein Rad21 Homolog, which comprise the cohesins complex, Cohesin subunits assembled at the CTGF protein, Homo sapiens Binding Sites and bound CTGF protein, Homo sapiens proteins in a cell cycle-dependent manner, We propose that the CTGF protein, Homo sapiens-cohesins complex plays a critical role in regulating the cell cycle control of Genes, Viral expression during latency and that failure to maintain cell cycle control of latent RNA Transcript inhibits host cell proliferation and survival, We used chromosome conformation capture to determine long-range interactions among CTGF protein, Homo sapiens/cohesins Site over 2 Mb on Homo sapiens chromosome 11 encompassing the beta-globin Gene Locus and Flank (surface region) olfactory receptor genes, These results support a Genome - anatomical entity-wide role for CTGF protein, Homo sapiens/cohesins Site through loop formation that both influences transcription and contributes to cell-type-specific chromatin location location organization and function, Increased methylation at this Promoter triggered the dissociation of the insulator protein CTGF protein, Homo sapiens as well as the accompanying cohesins from the BDNF Gene Locus, icotinamide adenine dinucleotide (NAD)-regulated DNA methylation alters CCCTC-binding factor (CTGF protein, Homo sapiens)/cohesins binding and transcription at the BDNF Gene Locus, ecent studies have shown that the protein CTGF protein, Homo sapiens, which plays an important role in insulation and in large-scale organization of chromatin location location within the eukaryotic nucleus, depends for both activities on recruitment of the cohesins complex, We show here that the interaction of CTGF protein, Homo sapiens with the cohesins complex involves direct contacts between the cohesins subunit STAG2 wt Allele and specific regions of the C-terminal tail of CTGF protein, Homo sapiens, Taken together, our results demonstrate that specific Site on the C terminus of CTGF protein, Homo sapiens are essential for cohesins binding and insulator function, The only direct interaction between CTGF protein, Homo sapiens and cohesins involves contact with STAG2 wt Allele, which is external to the cohesins ring, These numerous CTGF protein, Homo sapiens/cohesins Site potentially form the Unit dose - Base of the multiloop rosette structures at the Igh Gene Locus that compact during Ig heavy chain rearrangement, We have previously shown that the Homo sapiens herpesvirus 8 (KSHV) major latency RNA Transcript encoding latent Orf73 antigen, Homo sapiens herpesvirus 8, vCyclin, FLICE Inhibitory Protein, v-miRNAs, and Kaposin are regulated, in part, by a chromatin location location organizing element that binds CTGF protein, Homo sapiens and cohesins, Mutation Abnormality Abnormality of the CTGF protein, Homo sapiens-cohesins binding Specimen Source Codes - Site reduced or eliminated the chromatin location location conformation linkages, and deregulated Viral transcription and Genome - anatomical entity copy number control, Our findings indicate that KSHV Genome are organized into chromatin location location loops mediated by CTGF protein, Homo sapiens and cohesins interactions, and that these inter-chromosomal linkages coordinate latent and lytic gene control., We show here that Gestational age:Time:Point in time:^Fetus:Quantitative disrupts an RNA Polymerase II (RNAPII) complex that accumulates at the CTGF protein, Homo sapiens-cohesins binding Specimen Source Codes - Site within the first Introns of the latency transcript., Gestational age:Time:Point in time:^Fetus:Quantitative altered the enrichment of the RNAPII pausing complex, along with pausing factors SUPT5H gene and WHSC2 protein, Homo sapiens, at the intragenic CTGF protein, Homo sapiens-cohesins Binding Sites., Gestational age:Time:Point in time:^Fetus:Quantitative treatment also inhibited the transcription of some Cells genes, like c-myc Genes Genes, which contain a similar CTGF protein, Homo sapiens-cohesins binding Specimen Source Codes - Site within the first Introns., These findings suggest that RNAPII pauses at intragenic CTGF protein, Homo sapiens-cohesins Binding Sites and that abrogation of this pausing by Gestational age:Time:Point in time:^Fetus:Quantitative leads to loss of proper mRNA production and defects in sister chromatid cohesion, a process important for both Viral and Cells chromosome stability., TCF and cohesins cooperatively mediate the cell-type specific interchromatin interaction between B-Cell Lymphoma/Leukemia 11B and ARHGAP6 gene loci, Additional experiments verified that the interchromatin interaction between the B-Cell Lymphoma/Leukemia 11B and ARHGAP6 gene loci was cell-type specific, which was cooperatively mediated by CTGF protein, Homo sapiens and cohesins., enome-wide studies of CCCTC-binding factor (CTGF protein, Homo sapiens) and cohesins provide insight into chromatin location location structure and regulation, Recent Genome - anatomical entity-wide studies mapping the Binding Sites of CTGF protein, Homo sapiens and its interacting partner, cohesins, using chromatin location location immunoprecipitation coupled with deep sequencing (Chromatin Immunoprecipitation Sequencing) revealded that CTGF protein, Homo sapiens globally co-localizes with cohesins, Here, we show by ChIP-Seq that most Homo sapiens subtelomeres contain a CTGF protein, Homo sapiens- and cohesins-binding Specimen Source Codes - Site within ∼1-2 kb of the TTAGGG repeat tract and adjacent to a CpG-islands implicated in Telomeric Repeat-Containing RNA transcription control., These findings indicate that CTGF protein, Homo sapiens and cohesins are integral components of most Homo sapiens subtelomeres, and important for the regulation of Telomeric Repeat-Containing RNA transcription and telomere end protection, In addition, we show that this DNA looping requires specific binding of the CTGF protein, Homo sapiens/cohesins complex to two symmetrically aligned Binding Sites in both the transcriptionally active promoters and in one of the enhancers[SEP]Relations: cohesins complex has relations: cellcomp_protein with SMC3 wt Allele, cellcomp_protein with SMC3 wt Allele, cellcomp_protein with SMC1A, cellcomp_protein with SMC1A, cellcomp_protein with STAG1, cellcomp_protein with STAG1, cellcomp_protein with SMC1B, cellcomp_protein with SMC1B, cellcomp_protein with STAG3L4, cellcomp_protein with STAG3L4. Definitions: histone modification defined as following: The covalent alteration of one or more amino acid residues within a histone protein. [GOC:krc]. PLAGL1 gene defined as following: This gene plays an inhibitory role in the regulation of Cells proliferation and is a tumor suppressor.. CTGF protein, Homo sapiens defined as following: CCN family member 2 (349 aa, ~38kDa) is encoded by the Homo sapiens CCN2 gene. This protein plays a role in the promotion of proliferation and differentiation of chondrocytes and also mediates heparin- and divalent cation-dependent cell adhesion in many different cell types.. Genome - anatomical entity defined as following: Anatomical set of genes in all the chromosomes.. FLICE Inhibitory Protein defined as following: FLICE inhibitory protein (188 aa, ~21 kDa) is encoded by the Homo sapiens HHV8 ORF71 gene. This protein is involved in the modulation of host signaling pathways.. Homo sapiens herpesvirus 8 defined as following: A species in the genus RHADINOVIRUS, subfamily GAMMAHERPESVIRINAE, isolated from patients with AIDS-related and \"classical\" Kaposi sarcoma.. Double-Strand-Break Repair Protein Rad21 Homolog defined as following: Double-strand-break repair protein rad21 homolog (631 aa, ~72 kDa) is encoded by the Homo sapiens Double-Strand-Break Repair Protein Rad21 Homolog gene. This protein is involved in DNA repair, cell cycle-dependent chromosomal cohesion and apoptosis.. SMC3 wt Allele defined as following: Human SMC3 wt Allele wild-type allele is located in the vicinity of 10q25 and is approximately 37 kb in length. This allele, which encodes structural maintenance of chromosomes protein 3, is involved in the regulation of chromosome migration during mitosis.. Introns defined as following: Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some introns code for separate genes.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. B-Cell Lymphoma/Leukemia 11B defined as following: B-cell lymphoma/leukemia 11B (894 aa, ~96 kDa) is encoded by the Homo sapiens BCL11B gene. This protein may play a role in the modulation of p53-mediated signaling, tumor suppression and T cell development.. Binding Sites defined as following: The parts of a macromolecule that directly participate in its specific combination with another molecule.. RNA Polymerase II defined as following: A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6.. CCCTC-binding factor defined as following: A repressor protein with poly(ADP)-ribose binding activity that binds CHROMATIN and DNA; its structure consisting of 11 CYS2-HIS2 ZINC FINGERS allows it to recognize many different DNA target Site. It functions as a repressor by binding to INSULATOR ELEMENTS and preventing interaction between promoters and nearby enhancers and silencers. It plays a critical role in EPIGENETIC PROCESSES, including GENOMIC IMPRINTING.. Genes, Viral defined as following: The functional hereditary units of VIRUSES.. RNA Transcript defined as following: The initial RNA molecule produced by transcription.. cohesins complex defined as following: A protein complex that is required for sister chromatid cohesion in eukaryotes. The cohesins complex forms a molecular ring complex, and is composed of structural maintenance of chromosomes (SMC) and kleisin proteins. For example, in yeast, the complex is composed of the SMC proteins Smc1p and Smc3p, and the kleisin protein Scc1p. In vertebrates, the complex is composed of the SMITH-MCCORT DYSPLASIA 1 (SMC1A or SMC1B) and SMC3 wt Allele heterodimer attached via their hinge domains to a kleisin (Double-Strand-Break Repair Protein Rad21 Homolog, REC8 or RAD21L) which links them, and one STAG protein (STAG1, STAG2 or STAG3). [GOC:jl, GOC:sp, GOC:vw, PMID:9887095]. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. chromatin location defined as following: The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130]. WHSC2 protein, Homo sapiens defined as following: Negative elongation factor A (528 aa, ~57 kDa) is encoded by the Homo sapiens NELFA gene. This protein plays a role in transcriptional pausing.. Chromatin Immunoprecipitation Sequencing defined as following: A molecular genetic technique that combines chromatin location immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the Binding Sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations.. RUNX1 protein, Homo sapiens defined as following: Runt-related transcription factor 1 (453 aa, ~49 kDa) is encoded by the Homo sapiens RUNX1 gene. This protein is involved in the promotion of gene transcription and hematopoiesis.. STAG2 wt Allele defined as following: Human STAG2 wild-type allele is located in the vicinity of Xq25 and is approximately 462 kb in length. This allele, which encodes cohesins subunit SA-2, plays a role in sister chromatid adhesion.. Telomeric Repeat-Containing RNA defined as following: A large, non-coding RNA that can be encoded by any chromosomal telomeric DNA sequence, and is an integral part of the telomeric heterochromatin. These oligoribonucleotides may play a role in the regulation of both telomere replication and chromosomal remodeling. Their sizes are dependent on the telomere sequence length.. Flank (surface region) defined as following: The region on either side of the body that extends from the last rib to the hip.. latent Orf73 antigen, Homo sapiens herpesvirus 8 defined as following: Latent nuclear antigen (1036 aa, ~119 kDa) is encoded by the Homo sapiens herpesvirus 8 ORF73 gene. This protein plays a role in both Viral latency and the transcriptional regulation of host genes that modulate apoptosis and cell proliferation.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, Viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Gene Locus defined as following: The position of a gene or a chromosomal marker on a chromosome; also, a stretch of DNA at a particular place on a particular chromosome. The use of Gene Locus is sometimes restricted to mean regions of DNA that are expressed.. Site defined as following: A position in relation to its surroundings.. Homo sapiens defined as following: Members of the species Homo sapiens.. Genome defined as following: The genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA.. telomere defined as following: A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs.. SUPT5H gene defined as following: This gene is involved in both positive and negative regulation of transcriptional elongation. It also plays a role in the modification of chromatin location.. CTGF protein, Homo sapiens protein defined as following: A repressor protein with poly(ADP)-ribose binding activity that binds CHROMATIN and DNA; its structure consisting of 11 CYS2-HIS2 ZINC FINGERS allows it to recognize many different DNA target Site. It functions as a repressor by binding to INSULATOR ELEMENTS and preventing interaction between promoters and nearby enhancers and silencers. It plays a critical role in EPIGENETIC PROCESSES, including GENOMIC IMPRINTING..", "label": "yes"} {"original_question": "Is subacute sclerosing panencephalitis caused by the Measles vaccine?", "id": "converted_2562", "sentence1": "Is subacute sclerosing panencephalitis caused by the Measles vaccine?", "sentence2": "Subacute Sclerosing Panencephalitis (SSPE) is a potentially fatal complication of measles. , Subacute Sclerosing Panencephalitis (SSPE) is a fatal complication of measles. We reviewed California cases from 1998-2015 to understand risk f, Subacute Sclerosing Panencephalitis should be eliminated by measles vaccination, The mean Parameterized Data Type - Interval between measles Communicable Diseases and onset of subacute sclerosing panencephalitis was 6.5 years (range = 3-11 years)., Active surveillance of subacute sclerosing panencephalitis for those with measles Communicable Diseases during the 1988 outbreak is necessary to conduct multicenter drug trials for this devastating disease.
, There has been an increasing trend of subacute sclerosing panencephalitis in southern China after the measles outbreak in 1988., The prevalence rate of subacute sclerosing panencephalitis in Hong Kong and Macau in 2002 was 1 per million total population or 5.5 per million children., Because a positive correlation was found between the prevalence of measles and the onset of subacute sclerosing panencephalitis, particularly among children infected at an early age, it is vital to eradicate measles Communicable Diseases by vaccination.
, Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan., UNLABELLED Subacute Sclerosing Panencephalitis (SSPE), in the majority of cases, is caused by the wild measles Virus, although there are some reports relating SSPE to vaccination., Subacute Sclerosing Panencephalitis (SSPE) is a progressive Neurodegenerative Disorders caused by the measles (rubeola) Virus and is most often seen in children., There was no indication that measles vaccine can induce SSPE., Subacute Sclerosing Panencephalitis (SSPE), a rare lethal disease of children and young adults due to persistence of measles Virus (MeV) in the Head>Brain, is caused by Wildtype Finding (wt) MeV., Subacute Sclerosing Panencephalitis (SSPE) is a progressive nervous system disorder of childhood and early adolescence caused by persistent defective measles Virus., Subacute Sclerosing Panencephalitis (SSPE) is a devastating disease of the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS (Central Nervous System) caused by persistent mutant measles Virus Communicable Diseases., Subacute Sclerosing Panencephalitis (SSPE) caused by persistent defective measles Virus strains, is a progressive nervous system disorder of children and adolescents., Subacute Sclerosing Panencephalitis (SSPE), in the majority of cases, is caused by the wild measles Virus, although there are some reports relating SSPE to vaccination., Measles can persist in the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS and cause subacute sclerosing panencephalitis (SSPE), a progressive disease that is almost always fatal., However, because of the median 8-year Parameterized Data Type - Interval between measles and onset of SSPE,, The prevention of endemic circulation of measles Virus in England and Wales through the high coverage achieved with Measles-Mumps-Rubella Vaccine, together with the measles/rubella vaccination campaign of 1994, has resulted in the near elimination of SSPE., We applied the Polymerase Chain Reaction (PCR) to detect the measles Virus genome in Specimen from a 12-year-old boy with SSPE who had received measles vaccine 10 years before and had no history of apparent natural measles. The Oligonucleotide Primers for PCR were prepared based on the Base Sequence of the F and Measles Virus Nucleoprotein genes of the measles Virus Edmonston strain.RESULTS: F and Measles Virus Nucleoprotein genes were detected in both the Cerebrospinal Fluid and Peripheral Blood Lymphocyte. Nucleotide and deduced amino acid sequence analysis of the F gene showed that the patient's Virus was different from that of the vaccine strain. Judging from these results, it was likely that the SSPE-associated strain in this case was derived from the wild-type rather than the vaccine strain, subacute sclerosing panencephalitis (SSPE) is a late, rare and usually fatal complication of measles Communicable Diseases., Subacute Sclerosing Panencephalitis (SSPE) is a chronic central nervous (Central Nervous System) system Communicable Diseases caused by measles Virus, Epidemiological and virological data suggest that measles vaccine does not cause SSPE., Subacute Sclerosing Panencephalitis, a rare, progressive, fatal CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS disease of children, is caused by measles Virus., Subacute Sclerosing Panencephalitis is a form of chronic persistent measles Encephalitis in childhood which rarely manifests after wild Virus Communicable Diseases., Subacute Sclerosing Panencephalitis is a fatal infectious disease of childhood caused by persistence of the measles Virus in the Head>Brain. , Subacute Sclerosing Panencephalitis (SSPE) is a fatal Encephalitis manifesting a number of years after a primary measles Communicable Diseases. , Subacute Sclerosing Panencephalitis (SSPE) is a fatal complication of measles Communicable Diseases., In 2015, the Oregon Health Authority was notified of the Cessation of life of a boy with subacute sclerosing panencephalitis (SSPE), a rare and fatal complication of measles., Subacute Sclerosing Panencephalitis (SSPE) is a rare progressive nervous system disorder of early adolescence caused by persistent Communicable Diseases of the measles Virus, which remains prevalent worldwide despite an effective vaccine. , Subacute Sclerosing Panencephalitis (SSPE) is a debilitating disorder associated with the measles Communicable Diseases in childhood.[SEP]Relations: subacute sclerosing panencephalitis has relations: disease_disease with measles, disease_disease with measles, disease_disease with Encephalitis, disease_disease with Encephalitis, disease_disease with infectious disease with epilepsy, disease_disease with infectious disease with epilepsy, disease_phenotype_positive with Encephalitis, disease_phenotype_positive with Encephalitis. Encephalitis has relations: disease_disease with subacute sclerosing panencephalitis, disease_disease with subacute sclerosing panencephalitis. Definitions: Oligonucleotide Primers defined as following: Short DNA oligonucleotide chains used to prime DNA (and in some cases RNA) synthesis.. Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. Wildtype Finding defined as following: A finding indicating that no genetic variations have been detected across the entire sequence of one or more genes.. Subacute Sclerosing Panencephalitis defined as following: A rare, slowly progressive Encephalitis caused by chronic Communicable Diseases with the MEASLES VIRUS. The condition occurs primarily in children and young adults, approximately 2-8 years after the initial Communicable Diseases. A gradual decline in intellectual abilities and behavioral alterations are followed by progressive MYOCLONUS; MUSCLE SPASTICITY; SEIZURES; DEMENTIA; autonomic dysfunction; and ATAXIA. DEATH usually occurs 1-3 years after disease onset. Pathologic features include perivascular cuffing, eosinophilic cytoplasmic inclusions, neurophagia, and fibrous gliosis. It is caused by the SSPE Virus, which is a defective variant of MEASLES VIRUS. (From Adams et al., Principles of Neurology, 6th ed, pp767-8). Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.. Virus Communicable Diseases defined as following: A general term for diseases caused by viruses.. Measles Virus Nucleoprotein defined as following: Measles Virus nucleoprotein (525 aa, ~58 kDa) is encoded by the measles Virus N gene. This protein is involved in the encapsidation and mediation of nuclease resistance of the viral RNA genome.. Neurodegenerative Disorders defined as following: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.. Measles-Mumps-Rubella Vaccine defined as following: A combined vaccine used to prevent MEASLES; MUMPS; and RUBELLA.. Encephalitis defined as following: Inflammation of the BRAIN due to Communicable Diseases, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition.. Cerebrospinal Fluid defined as following: A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES.. Central Nervous System defined as following: The main information-processing organs of the nervous system, consisting of the Head>Brain, spinal cord, and meninges.. Base Sequence defined as following: The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called Base Sequence.. Virus defined as following: Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells.. nervous system disorder defined as following: Diseases of the central and peripheral nervous system. This includes disorders of the Head>Brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.. Polymerase Chain Reaction defined as following: In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.. Specimen defined as following: A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis..", "label": "no"} {"original_question": "Can antisense threapy be used for Huntington's disease?", "id": "converted_3211", "sentence1": "Can antisense threapy be used for Huntington Disease?", "sentence2": "In this issue of Neurons, Kordasiewicz et al. (2012) show the benefit of transient antisense oligonucleotide (ASO) therapy to degrade Hodgkin Disease protein, human mRNA and elicit sustained therapeutic benefit in Hodgkin Disease CASP14 gene., \"Hodgkin Disease protein, human holiday\": progress toward an antisense therapy for Huntington Disease.[SEP]Relations: Huntington disease has relations: disease_disease with neurodegenerative disease with chorea, disease_disease with neurodegenerative disease with chorea, disease_disease with Huntington disease and related disorders, disease_disease with Huntington disease and related disorders, disease_disease with juvenile Huntington disease, disease_disease with juvenile Huntington disease, disease_protein with GAL, disease_protein with GAL, disease_protein with FAAH, disease_protein with FAAH. Definitions: Hodgkin Disease protein, human defined as following: Hodgkin Disease protein, human (3144 aa, ~348 kDa) is encoded by the human HTT gene. This protein may be involved in the regulation of vesicular transport.. Huntington Disease defined as following: A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4). Neurons defined as following: The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.. Hodgkin Disease defined as following: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen..", "label": "yes"} {"original_question": "Is curcumin a phytochemical?", "id": "converted_1272", "sentence1": "Is curcumin a phytochemical?", "sentence2": "we analyzed Curcuma longa from different agroclimatic regions for influence of various factors on its growth and yield of important Phytochemicals, The phytochemical, curcumin, has been reported to play many beneficial roles., curcumin (CUR), the major component in Curcuma longa, has been shown as a potent chemopreventive phytochemical that modulates various signaling pathways. , curcumin (CUR) is a phytochemical that inhibits the xenobiotic ABC efflux transporters implicated in cancer multidrug resistance (MDR), such as P-Glycoprotein Activity (P-Glycoprotein), breast cancer resistance protein (ABCG2 wt Allele) and Multidrug Resistance-Associated Proteins and 5 (mismatch repair protein 1, human and ABCC5 wt Allele). , In this study, we tested the efficacy of combining temozolomide with curcumin, a phytochemical known to inhibit Glioblastoma Multiforme growth, and investigated the mechanisms involved., In the present study, we investigate whether curcumin (cur), a phytochemical compound with potent Anti-Inflammatory Agents effect, the Phytochemicals curcumin , in combination with the Phytochemicals curcumin and quercetin, curcumin is a phytochemical derived from Rhizome of Curcuma longa Curcuma longa, present in the curry spice. , curcumin, a naturally occurring polyphenolic phytochemical isolated from the medicinal plant Curcuma longa, has Anti-Inflammatory Agents activities, In the present study curcumin (CUR), a known anticancer phytochemical, , curcumin, a natural phytochemical, exhibits potent anticancer activities., hat curcumin, a phytochemical compound with potent Anti-Inflammatory Agents properties , curcumin, a phytochemical[SEP]Relations: curcumin has relations: drug_drug with Colchicine, drug_drug with Colchicine, drug_drug with Pemigatinib, drug_drug with Pemigatinib, drug_drug with Pretomanid, drug_drug with Pretomanid, drug_drug with Lumateperone, drug_drug with Lumateperone, drug_drug with Lefamulin, drug_drug with Lefamulin. Definitions: P-Glycoprotein defined as following: A 170-kDa transmembrane glycoprotein from the superfamily of ATP-BINDING CASSETTE TRANSPORTERS. It serves as an ATP-dependent efflux pump for a variety of chemicals, including many ANTINEOPLASTIC AGENTS. Overexpression of this glycoprotein is associated with multidrug resistance (see DRUG RESISTANCE, MULTIPLE).. quercetin defined as following: A flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin.. ABCC5 wt Allele defined as following: Human ABCC5 wild-type allele is located in the vicinity of 3q27 and is approximately 98 kb in length. This allele, which encodes multidrug resistance-associated protein 5, is involved in the transport of cyclic nucleotides.. curcumin defined as following: A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes.. Glioblastoma Multiforme defined as following: The most malignant astrocytic tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO). Multidrug Resistance-Associated Proteins defined as following: A sequence-related subfamily of ATP-BINDING CASSETTE TRANSPORTERS that actively transport organic substrates. Although considered organic anion transporters, a subset of proteins in this family have also been shown to convey drug resistance to neutral organic drugs. Their cellular function may have clinical significance for CHEMOTHERAPY in that they transport a variety of ANTINEOPLASTIC AGENTS. Overexpression of proteins in this class by NEOPLASMS is considered a possible mechanism in the development of multidrug resistance (DRUG RESISTANCE, MULTIPLE). Although similar in function to P-GLYCOPROTEINS, the proteins in this class share little sequence homology to the ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 1 family of proteins.. ABCG2 wt Allele defined as following: Human ABCG2 wild-type allele is located within 4q22 and is approximately 67 kb in length. This allele, which encodes ATP-binding cassette sub-family G member 2 protein, plays a role in transmembrane transport and transcriptional regulation. The allele is thought to play a role in cellular defense and aberrations are thought to play a role in tumor multidrug resistance.. mismatch repair protein 1, human defined as following: DNA mismatch repair protein Msh3 (1137 aa, ~127 kDa) is encoded by the human MSH3 gene. This protein is involved in the modulation of DNA mismatch repair.. temozolomide defined as following: A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.. Anti-Inflammatory Agents defined as following: Substances that reduce or suppress INFLAMMATION.. Phytochemicals defined as following: A broad range of biologically active compounds which occur naturally in plants having important medicinal and nutritional properties.. Rhizome defined as following: Root-like underground horizontal stem of plants that produces shoots above and roots below. Distinguished from true roots which don't have buds and nodes. Similar to true roots in being underground and thickened by storage deposits.. curcumin defined as following: A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes..", "label": "yes"} {"original_question": "Is lithium effective for treatment of amyotrophic lateral sclerosis?", "id": "converted_2902", "sentence1": "Is Lithium antipsychotics effective for treatment of Amyotrophic Lateral Sclerosis?", "sentence2": "In terms of Disease-modifying treatment options, several drugs such as Dexpramipexole, pioglitazone, Lithium antipsychotics, and many others have been tested in large multicenter trials, albeit with disappointing results., Despite several positive case reports and short studies, further controlled researches have failed to substantiate any positive effects of Lithium antipsychotics exposure in Amyotrophic Lateral Sclerosis. , The effect of Lithium antipsychotics was different for UNC13A carriers (p = 0.027), but not for C9orf72 carriers (p = 0.22). The 12-month survival probability for UNC13A carriers treated with Lithium Carbonate - Consent Type improved from 40.1% (95% CI 23.2-69.1) to 69.7% (95% CI 50.4-96.3)., Studies in ALS showed consistently negative results and presented evidence against the use of Lithium antipsychotics for the treatment of this Disease., BACKGROUND\nLithium has neuroprotective effects in \"U\" lymphocyte and animal models of Amyotrophic Lateral Sclerosis (ALS), and a small pilot study in patients with ALS showed a significant effect of Lithium antipsychotics on survival., In a pilot clinical study that we recently published we found that Lithium antipsychotics administration slows the progression of Amyotrophic Lateral Sclerosis (ALS) in Homo sapiens patients., BACKGROUND Lithium has neuroprotective effects in \"U\" lymphocyte and animal models of Amyotrophic Lateral Sclerosis (ALS), and a small pilot study in patients with ALS showed a significant effect of Lithium antipsychotics on survival., BACKGROUND A neuroprotective effect of Lithium antipsychotics in Amyotrophic Lateral Sclerosis (ALS) has been recently reported., Lithium delays progression of Amyotrophic Lateral Sclerosis.ALS is a devastating Neurodegenerative Disorders with no effective treatment. , Lithium in patients with Amyotrophic Lateral Sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial.Lithium has neuroprotective effects in \"U\" lymphocyte and animal models of Amyotrophic Lateral Sclerosis (ALS), and a small pilot study in patients with ALS showed a significant effect of Lithium antipsychotics on survival. , INTRODUCTION: Lithium was proposed in 2008 as an effective candidate in the treatment of ALS after a report claimed that it was able to delay functional deterioration by 40% and that none of the 16 patients treated with a combination of Lithium antipsychotics plus riluzole had died during a 15-month follow-up period., A recently published study also ruled out any possible modest effect.
CONCLUSIONS: There is evidence to suggest that Lithium antipsychotics has no short-term benefits in ALS., A comparison of the group of patients treated with Lithium antipsychotics+riluzole and the control group treated with riluzole alone showed no statistically significant differences in rates of functional decline, deterioration of respiratory function, or survival time., None of the patients treated with Lithium antipsychotics died during the 15 months of the follow-up, and Disease progression was markedly attenuated when compared with age-, Disease duration-, and sex-matched control patients treated with riluzole for the same amount of time.[SEP]Relations: Amyotrophic Lateral Sclerosis has relations: disease_disease with progressive muscular atrophy, disease_disease with progressive muscular atrophy, disease_protein with ANG, disease_protein with ANG, disease_protein with CLU, disease_protein with CLU, disease_protein with CD7, disease_protein with CD7, disease_protein with CTSD, disease_protein with CTSD. Definitions: Amyotrophic Lateral Sclerosis defined as following: An inherited form of Amyotrophic Lateral Sclerosis, usually inherited in an autosomal dominant pattern, caused by mutation(s) in the SOD1 gene, encoding superoxide dismutase.. Homo sapiens defined as following: Members of the species Homo sapiens.. pioglitazone defined as following: An orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity. Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated transcription factor, thereby inducing \"U\" lymphocyte differentiation and inhibiting \"U\" lymphocyte growth and angiogenesis. This agent also modulates the transcription of insulin-responsive genes, inhibits macrophage and monocyte activation, and stimulates adipocyte differentiation.. riluzole defined as following: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Neurodegenerative Disorders defined as following: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures..", "label": "no"} {"original_question": "As of Feb 2019, are major brain gangliosides a target for the treatment of Alzheimer's disease?", "id": "converted_3056", "sentence1": "As of Feb 2019, are major brain gangliosides a target for the treatment of ALZHEIMER DISEASE, FAMILIAL, 1?", "sentence2": "An understanding of the mechanism on the interaction of Ganglioside Ganglioside GM1 and Aβs in cytarabine/daunorubicin protocol may contribute to the development of new neuroregenerative therapies for this disorder., Abnormal ganglioside metabolism also may occur in cytarabine/daunorubicin protocol brains, Continuous intraventricular infusion of Ganglioside Ganglioside GM1 has recently been shown to have a significant beneficial effect in ALZHEIMER DISEASE 2 of early onset (cytarabine/daunorubicin protocol Type I)., Gangliosides--a new therapeutic agent against Cerebrovascular accident and ALZHEIMER DISEASE, FAMILIAL, 1., Gangliosides--a new therapeutic agent against Cerebrovascular accident and ALZHEIMER DISEASE, FAMILIAL, 1.Gangliosides are glycosphingolipids localized to the outer leaflet of the Plasma membrane of vertebrate cells. , Continuous intraventricular infusion of Ganglioside Ganglioside GM1 has recently been shown to have a significant beneficial effect in ALZHEIMER DISEASE 2 of early onset (cytarabine/daunorubicin protocol Type I).
[SEP]Relations: ALZHEIMER DISEASE 2 has relations: disease_disease with ALZHEIMER DISEASE 2 without neurofibrillary tangles, disease_disease with ALZHEIMER DISEASE 2 without neurofibrillary tangles, disease_disease with dementia (disease), disease_disease with dementia (disease), disease_disease with familial ALZHEIMER DISEASE 2, disease_disease with familial ALZHEIMER DISEASE 2. familial ALZHEIMER DISEASE 2 has relations: disease_disease with ALZHEIMER DISEASE 2, disease_disease with ALZHEIMER DISEASE 2. gangliosidosis has relations: disease_disease with Ganglioside GM1 gangliosidosis, disease_disease with Ganglioside GM1 gangliosidosis. Definitions: Plasma membrane defined as following: The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells.. Ganglioside GM1 defined as following: A specific monosialoganglioside that accumulates abnormally within the nervous system due to a deficiency of Ganglioside GM1-b-galactosidase, resulting in Ganglioside GM1 gangliosidosis.. Gangliosides defined as following: A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997). Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810). ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65..", "label": "yes"} {"original_question": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies", "id": "converted_124", "sentence1": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies", "sentence2": "DITPA normalized the elevated serum T(3) and Thyrotropin:-:Pt:Ser/Plas:- when the dose reached 1 mg/kg · d and T(4) and rT(3) increased to the lower normal range., The identification of 3,5-diiodothyropropionic acid (DITPA) that binds to both α- and β-type threonine-tRNA ligase activity with relatively low affinity was unique in that this analog improves left ventricular function in Congestive Congestive heart failure as well as lowers cholesterol., Treatment with DITPA attenuates the acute inflammatory response and reduces myocardial infarct size., Thus DITPA administration impairs baseline Cardiac - anatomy qualifier parameters in CASP14 gene and can be fatal during in vivo acute myocardial I/R., DITPA improved some hemodynamic and metabolic parameters, but there was no evidence for symptomatic benefit in congestive Congestive Congestive heart failure, The results suggested that DITPA can promote a healthy Vasculature independently from its thyroid-related metabolic effects. , Moreover, DITPA and T(4) were efficacious in preventing effects of Hypothyroidism on Cardiac - anatomy qualifier function and BVD, Both T4 and DITPA had beneficial effects on chamber remodeling, which was most likely due to beneficial changes in cell shape and improved vascular supply., The thyroid analog DITPA enhances endothelial nitric oxide and beta-adrenergic-mediated vasorelaxation by increasing nitric oxide in the Vasculature.[SEP]Relations: 3,5-diiodothyropropionic acid has relations: drug_drug with Ethionamide, drug_drug with Ethionamide, drug_drug with Motesanib, drug_drug with Motesanib, drug_drug with Ritonavir, drug_drug with Ritonavir, drug_drug with Escitalopram, drug_drug with Escitalopram, drug_drug with Flumatinib, drug_drug with Flumatinib. Definitions: nitric oxide defined as following: A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP.. Vasculature defined as following: Organ region cluster which consists of regions of arterial, venous and lymphatic trees and the capillary beds that connect them. Examples: Vasculature of head, Vasculature of brain.. Congestive heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Hypothyroidism defined as following: A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.. threonine-tRNA ligase activity defined as following: Catalysis of the reaction: ATP + L-threonine + tRNA(Thr) = AMP + diphosphate + L-threonyl-tRNA(Thr). [EC:6.1.1.3]. thyroid hormone defined as following: Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs..", "label": "yes"} {"original_question": "Is paroxetine effective for treatment of premenstrual dysphoric disorder?", "id": "converted_402", "sentence1": "Is paroxetine effective for treatment of Premenstrual Dysphoric Disorder?", "sentence2": "To evaluate the cost effectiveness of the four medications with a US FDA-approved indication for PMDD: fluoxetine, sertraline, paroxetine and drospirenone plus ethinyl estradiol (DRSP/EE)., All Selective Serotonin Reuptake Inhibitors (fluoxetine, paroxetine, sertraline, fluvoxamine, citalopram, and clomipramine) were effective in reducing premenstrual symptoms., paroxetine has been approved for the treatment of major depressive disorder (Major Depressive Disorder), Obsessive-Compulsive Disorder, Panic Disorder (Lugano Lymphoma Response Classification Progressive Disease by PET), generalised anxiety disorder, post Stress Disorders, Traumatic (PTSD), and social anxiety disorder (Seasonal Affective Disorder) in adults, whereas paroxetine CR is approved for the treatment of Major Depressive Disorder, Seasonal Affective Disorder, Lugano Lymphoma Response Classification Progressive Disease by PET and Premenstrual Dysphoric Disorder in adults., Selective serotonin-reuptake inhibitors (Selective Serotonin Reuptake Inhibitors) have been proven safe and effective for the treatment of PMDD and are recommended as first-line agents when pharmacotherapy is warranted. Currently fluoxetine, controlled-release paroxetine, and sertraline are the only Food and Drug Administration-approved agents for this indication., When compared with placebo, patients treated with paroxetine 20 mg attained a significant reduction in Irritable Mood (difference in median percent change: -23.9, 95% NDUFB6 gene = -51.3 to -6.2, p = .014; difference in mean absolute change: -18.6, 95% NDUFB6 gene = -32.5 to -4.6, p = .007). A statistically significant difference was not observed when the patients treated with the lower dose of paroxetine (10 mg) were compared with placebo. Treatment was well tolerated with no unexpected side effects., Intermittent administration of paroxetine 20 mg significantly reduced Irritable Mood symptoms in patients with PMDD., All these women had significant improvements in the HAMA, HAMD, CGI, and PRISM calendar. The rate of response to paroxetine treatment lay between 50% and 78.6% in the continuous-treatment group, and 37.5-93.8% in the intermittent-treatment group, as determined at the study end-point., The present results indicate that paroxetine is effective in both continuous and intermittent treatment of oriental PMDD women, and that the effects of active treatment lasted for six consecutive treatment menstrual cycles., paroxetine CR is approved for the treatment of major Cancer patients and suicide and Cancer patients and suicide and depression, social anxiety disorder, Panic Disorder and Premenstrual Dysphoric Disorder in adults., Continuous treatment with paroxetine reduced premenstrual symptoms effectively with a response rate of 85%., Intermittent treatment was as effective as continuous treatment in reducing Irritable Mood, affect lability, and mood swings, but had a somewhat weaker effect on Depressed mood and somatic symptoms., Daily Record of Severity of Problems scores were lower in the paroxetine group compared with the placebo group, although the differences were not statistically significant., However, the mean on-treatment Inventory of Depressive Symptomatology (clinician-rated) score for the paroxetine group was 17.9 +/- 8.3 compared with 31.5 +/- 11.2 in the placebo group (adjusted mean difference = 13.6, P = 0.009)., Response (Clinical Global Impressions Scale score of 1 or 2) occurred in 70% of subjects randomized to paroxetine CR and 10% of those assigned to placebo (chi2(1) = 7.5, P = 0.006)., The US Food and Drug Administration and Health Canada recently approved paroxetine for the treatment of Premenstrual Dysphoric Disorder., Patients treated with either dose of paroxetine CR demonstrated significantly greater improvements on the primary efficacy measure (change from baseline in mean luteal phase VAS-Mood scores) and on the majority of secondary efficacy measures compared with patients randomly assigned to placebo., For the treatment of PMDD, luteal phase dosing with 12.5 mg and 25 mg of paroxetine CR is effective and generally well tolerated., A statistically significant difference was observed in favor of paroxetine CR 25 mg versus placebo on the VAS-Mood (adjusted mean difference = -12.58 mm, 95% NDUFB6 gene = -18.40 to -6.76; p < .001) and for paroxetine CR 12.5 mg versus placebo (adjusted mean difference = -7.51 mm, 95% NDUFB6 gene = -13.40 to -1.62; p = .013)., paroxetine CR doses of 12.5 mg/day and 25 mg/day are effective in treating PMDD and are well tolerated., At end point, subjects treated with paroxetine CR (12.5 mg and 25 mg) demonstrated significant improvement in VAS-Mood scores compared with those who received placebo (paroxetine CR 12.5 mg mean treatment difference vs. placebo, -8.7 mm; 95% NDUFB6 gene, -15.7, -1.7; p =.015; paroxetine CR 25 mg mean treatment difference vs. placebo, -12.1 mm; 95% NDUFB6 gene, -18.9, -5.3; p <.001)., Both doses of paroxetine CR 12.5 mg and 25 mg daily are effective and well tolerated in patients who suffer from PMDD., Of these agents, sertraline, fluoxetine and paroxetine (as an extended-release formulation) are approved by the US FDA for luteal phase, as well as continuous, administration., In well designed placebo-controlled trials in patients with major depressive disorder (including a study in the elderly), social anxiety disorder or Premenstrual Dysphoric Disorder (PMDD), paroxetine CR was consistently superior to placebo with regards to primary endpoints (i.e. mean Hamilton Rating Scale for Depression total score [major depressive disorder], Liebowitz social anxiety scale total score and Clinical Global Impressions-Global Improvement score [social anxiety disorder] and Visual Analogue Scale-Mood score [PMDD])., paroxetine is a potent selective serotonin reuptake inhibitor (Serotonin Reuptake Inhibitor [EPC]) with indications for the treatment of Cancer patients and suicide and Cancer patients and suicide and depression, obsessive- compulsive disorder, Panic Disorder and Phobia, Social. It is also used in the treatment of generalized anxiety disorder, Post-Traumatic Stress Disorder, Premenstrual Dysphoric Disorder and chronic headache., Studies having compared the efficiency of Antidepressive Agents according to their serotonin activity (paroxetine or sertraline versus maprotiline, that is a selective norepinephrine, DL- re-uptake inhibitor), showed that serotonin re-uptake inhibitors were significantly more efficient on all symptoms than maprotiline, that was not more efficient than placebo., paroxetine is a potent and selective serotonin reuptake inhibitor (Serotonin Reuptake Inhibitor [EPC]) with currently approved indications for the treatment of Cancer patients and suicide and Cancer patients and suicide and depression, Obsessive-Compulsive Disorder, Panic Disorder and Phobia, Social. It is also used in the treatment of generalized anxiety disorder, post Stress Disorders, Traumatic, Premenstrual Dysphoric Disorder and chronic headache., Preliminary data suggest that paroxetine has potential in the treatment of Phobia, Social, Premenstrual Dysphoric Disorder and chronic headache., The effects of active treatment were marked by the first active cycle with luteal phase 17-item Hamilton Rating Scale for Depression scores decreasing from 14.9 (+/- 5.3) to 8.2 (+/- 4.9) in the first, 7.8 (+/- 5.1) in the second, and 7.8 (+/- 6.8) in the third active treatment cycles (F[1,13] = 17.6; p < 0.0001)., The most conservative measure, the Clinical Global Impression (CGI), revealed that 7 of 14 patients had a complete response (CGI = 1 or 2) whereas 4 patients had a partial response (CGI = 3)., These open trial findings are consistent with the notion that paroxetine is effective in the acute phase for the treatment of Pervasive Development Disorder., The rating of premenstrual Irritable Mood, Depressed mood, increase in appetite, and anxiety/tension was markedly lower during treatment with paroxetine than before, and this reduction in symptomatology appeared unabated for the entire treatment period.[SEP]Relations: paroxetine has relations: drug_effect with Dyspnea, drug_effect with Dyspnea, contraindication with bipolar disorder, contraindication with bipolar disorder, drug_effect with Dysphagia, drug_effect with Dysphagia, drug_effect with Dysuria, drug_effect with Dysuria, drug_effect with Dyssynergia, drug_effect with Dyssynergia. Definitions: Premenstrual Dysphoric Disorder defined as following: A condition in which a woman suffers from severe Cancer patients and suicide and depression, Irritable Mood, and tension before MENSTRUATION. Premenstrual dysphoric disorder (PMDD) may involve a wide range of physical or emotional symptoms, which are more severe and debilitating than those seen with premenstrual syndrome (PMS), and which include at least one mood-related symptom. Symptoms usually stop when, or shortly after, menstruation begins.. Post-Traumatic Stress Disorder defined as following: A class of traumatic stress disorders with symptoms that last more than one month.. maprotiline defined as following: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic Antidepressive Agents, including side effects associated with its use.. Selective Serotonin Reuptake Inhibitors defined as following: Any agent that increases the extracellular level of the neurotransmitter serotonin (5-HT) by inhibiting its reuptake into the presynaptic cell. Increased level in the synaptic cleft prolongs the action of 5-HT on the postsynaptic receptor. This type of agent is typically used as an antidepressant and in the treatment of anxiety disorders and some personality disorders. They are also typically effective and used in treating some cases of insomnia.. Stress Disorders, Traumatic defined as following: Anxiety disorders manifested by the development of characteristic symptoms following a psychologically traumatic event that is outside the normal range of usual human experience. Symptoms include re-experiencing the traumatic event, increased arousal, and numbing of responsiveness to or reduced involvement with the external world. Traumatic stress disorders can be further classified by the time of onset and the duration of these symptoms.. drospirenone defined as following: A synthetic spironolactone analogue and progestin with progestational and anti-mineralocorticoid activity. Drospirenone binds to the progesterone receptor, the resulting complex becomes activated and binds to specific sites on DNA. This results in a suppression of LH activity and an inhibition of ovulation as well as an alteration in the cervical mucus and endometrium. This leads to an increased difficulty of sperm entry into the uterus and implantation. This drug is used in oral contraceptives.. Antidepressive Agents defined as following: Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as Antidepressive Agents apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.. fluvoxamine defined as following: A selective serotonin reuptake inhibitor that is used in the treatment of DEPRESSION and a variety of ANXIETY DISORDERS.. paroxetine defined as following: A serotonin uptake inhibitor that is effective in the treatment of Cancer patients and suicide and depression.. Panic Disorder defined as following: A type of anxiety disorder characterized by unexpected panic attacks that last minutes or, rarely, hours. Panic attacks begin with intense apprehension, fear or terror and, often, a feeling of impending doom. Symptoms experienced during a panic attack include dyspnea or sensations of being smothered; dizziness, loss of balance or faintness; choking sensations; palpitations or accelerated heart rate; shakiness; sweating; nausea or other form of abdominal distress; depersonalization or derealization; paresthesias; hot flashes or chills; chest discomfort or pain; fear of dying and fear of not being in control of oneself or going crazy. Agoraphobia may also develop. Similar to other anxiety disorders, it may be inherited as an autosomal dominant trait.. ethinyl estradiol defined as following: A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES.. Pervasive Development Disorder defined as following: A category of developmental disorders characterized by impaired communication and socialization skills. The impairments are incongruent with the individual's developmental level or mental age. These disorders can be associated with general medical or genetic conditions.. sertraline defined as following: A selective serotonin uptake inhibitor that is used in the treatment of Cancer patients and suicide and depression.. serotonin defined as following: A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator.. citalopram defined as following: A furancarbonitrile that is one of the SELECTIVE SEROTONIN REUPTAKE INHIBITORS used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic Antidepressive Agents, which aggravate dyskinesia.. norepinephrine, DL- defined as following: A synthetic phenylethylamine that mimics the sympathomimetic actions of the endogenous norepinephrine. Norepinephrine acts directly on the alpha- and beta-adrenergic receptors. Clinically, norepinephrine is used as a peripheral vasoconstrictor that causes constriction of arterial and venous beds via its alpha-adrenergic action. It is also used as a potent inotropic and chronotropic stimulator of the heart mediated through its beta-1 adrenergic action.. Irritable Mood defined as following: Abnormal or excessive excitability with easily triggered anger, annoyance, or impatience.. fluoxetine defined as following: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional Antidepressive Agents.. clomipramine defined as following: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.. Obsessive-Compulsive Disorder defined as following: An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.. Lugano Lymphoma Response Classification Progressive Disease by PET defined as following: A score of 4 or 5 on a 5-point PET scale with an increase in intensity of uptake from baseline and/or new FDG-avid foci consistent with lymphoma at interim or end of treatment assessment.. Phobia, Social defined as following: An anxiety disorder characterized by an intense, irrational fear of one or more social or performance situations in which the individual believes that he or she will be scrutinized by others. Exposure to social situations immediately provokes an anxiety response. In adults, the Phobia, Social is recognized as excessive or unreasonable.. Seasonal Affective Disorder defined as following: A syndrome characterized by depressions that recur annually at the same time each year, usually during the winter months. Other symptoms include anxiety, Irritable Mood, decreased energy, increased appetite (carbohydrate cravings), increased duration of sleep, and weight gain. Seasonal Affective Disorder (seasonal affective disorder) can be treated by daily exposure to bright artificial lights (PHOTOTHERAPY), during the season of recurrence.. Depressed mood defined as following: An emotional state characterized by feelings of sadness, emptiness, and/or tearfulness.. Major Depressive Disorder defined as following: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) Depressed mood or (2) loss of interest or pleasure. Symptoms include: Depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5). paroxetine defined as following: A serotonin uptake inhibitor that is effective in the treatment of Cancer patients and suicide and depression..", "label": "yes"} {"original_question": "Is Li–Fraumeni syndrome a rare, autosomal recessive, hereditary disorder that predisposes carriers to cancer development?", "id": "converted_3269", "sentence1": "Is Li–Fraumeni syndrome a rare, Autosome recessive, hereditary disorder that predisposes carriers to Primary malignant neoplasm development?", "sentence2": "LI-FRAUMENI SYNDROME 1 (Li-Fraumeni Syndrome) is a rare Primary malignant neoplasm predisposition syndrome inherited in an Autosomal dominant multiple pterygium syndrome fashion that involves a Germline Mutation Abnormality of tumor protein 53 (TP53 wt Allele wt Allele). , LI-FRAUMENI SYNDROME 1 (Li-Fraumeni Syndrome), a multiorgan Primary malignant neoplasm predisposition caused by Germline TP53 wt Allele wt Allele mutations, confers significant Primary malignant neoplasm risks for young people (15-39 years). Yet evidence of how individuals experience this condition and the psychosocial implications are lacking. Therefore, this systematic review assessed the psychosocial implications of living with, or at risk of, an Autosomal dominant multiple pterygium syndrome condition as a young person, to, LI-FRAUMENI SYNDROME 1 (Li-Fraumeni Syndrome) is a rare Autosomal dominant multiple pterygium syndrome disorder caused by a Mutation Abnormality in the TP53 wt Allele wt Allele gene., LI-FRAUMENI SYNDROME 1 (Li-Fraumeni Syndrome) is an Autosomal dominant multiple pterygium syndrome disorder occurring at a young age that predisposes individuals to multiple forms of Primary malignant neoplasm and to a heterogeneous spectrum of Malignant Neoplasms., LI-FRAUMENI SYNDROME 1 (Li-Fraumeni Syndrome) is a rare hereditary Autosomal dominant multiple pterygium syndrome Primary malignant neoplasm disorder., LI-FRAUMENI SYNDROME 1 (Li-Fraumeni Syndrome) is an Autosomal dominant multiple pterygium syndrome hereditary Primary malignant neoplasm disorder., LI-FRAUMENI SYNDROME 1 (Li-Fraumeni Syndrome) is a rare, Autosomal dominant multiple pterygium syndrome, hereditary Primary malignant neoplasm predisposition disorder., LI-FRAUMENI SYNDROME 1 is a rare Autosomal dominant multiple pterygium syndrome Primary malignant neoplasm predisposition syndrome., LI-FRAUMENI SYNDROME 1 is an Autosomal dominant multiple pterygium syndrome disorder that is characterized by various types of Primary malignant neoplasm in childhood and adult cases., LI-FRAUMENI SYNDROME 1 (Li-Fraumeni Syndrome) is a rare hereditary Primary malignant neoplasm syndrome associated with an Autosomal dominant multiple pterygium syndrome Mutation Abnormality inheritance in the TP53 wt Allele wt Allele tumor suppressor gene and a wide spectrum of Primary malignant neoplasm diagnoses., The LI-FRAUMENI SYNDROME 1 is an Autosomal dominant multiple pterygium syndrome disorder characterized by a high risk of developing Osteosarcoma of bone and has been found in up to 3% of children with Osteosarcoma of bone., LI-FRAUMENI SYNDROME 1 (Li-Fraumeni Syndrome) is a rare, Autosomal dominant multiple pterygium syndrome, hereditary Primary malignant neoplasm predisposition disorder., LI-FRAUMENI SYNDROME 1 (Li-Fraumeni Syndrome) is an inherited, Autosome-dominant condition that predisposes individuals to a wide-spectrum of Neoplasms at an early age., The LI-FRAUMENI SYNDROME 1 (Li-Fraumeni Syndrome) is an Autosomal dominant multiple pterygium syndrome hereditary disorder associated with different tumor types in childhood and young adults.[SEP]Relations: LI-FRAUMENI SYNDROME 1 has relations: disease_disease with Autosomal dominant multiple pterygium syndrome disease, disease_disease with Autosomal dominant multiple pterygium syndrome disease, disease_disease with Autosomal dominant multiple pterygium syndrome disease, disease_disease with Autosomal dominant multiple pterygium syndrome disease, disease_phenotype_positive with Autosomal dominant inheritance, disease_phenotype_positive with Autosomal dominant inheritance, disease_phenotype_positive with Autosomal dominant inheritance, disease_phenotype_positive with Autosomal dominant inheritance. Autosomal dominant multiple pterygium syndrome disease has relations: disease_disease with LI-FRAUMENI SYNDROME 1, disease_disease with LI-FRAUMENI SYNDROME 1. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. TP53 wt Allele gene defined as following: Tumor suppressor genes located on the short arm of human chromosome 17 and coding for the phosphoprotein p53.. Autosomal dominant multiple pterygium syndrome defined as following: A rare distal arthrogryposis syndrome with characteristics of multiple pterygia (typically involving the neck, axilla and popliteal areas), joint contractures, ptosis, camptodactyly of the hands with hypoplastic flexion creases, vertebral fusions, severe scoliosis and short stature. There is evidence this disease is caused by heterozygous Mutation Abnormality in the MYH3 gene on chromosome 17p13.. Li-Fraumeni Syndrome defined as following: Rare Autosomal dominant multiple pterygium syndrome syndrome characterized by mesenchymal and epithelial neoplasms at multiple sites. MUTATION of the p53 tumor suppressor gene, a component of the DNA DAMAGE response pathway, apparently predisposes family members who inherit it to develop certain cancers. The spectrum of cancers in the syndrome was shown to include, in addition to BREAST CANCER and soft tissue sarcomas (SARCOMA); BRAIN TUMORS; OSTEOSARCOMA; LEUKEMIA; and ADRENOCORTICAL CARCINOMA.. TP53 wt Allele defined as following: Human TP53 wt Allele wild-type allele is located in the vicinity of 17p13.1 and is approximately 19 kb in length. This allele, which encodes cellular tumor antigen p53 protein, plays a role in cell cycle regulation during the G0/G1transition. Alterations of the TP53 wt Allele gene occur as both somatic and Germline mutations in human Malignant Neoplasms in select Primary malignant neoplasm-prone families with LI-FRAUMENI SYNDROME 1.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Osteosarcoma of bone defined as following: A usually aggressive malignant bone-forming mesenchymal neoplasm arising from the bone. It may arise de novo or from a pre-existing lesion of the bone. Pain and a palpable mass are the most frequent clinical sign and symptom. It may spread to other anatomic sites, particularly the lungs.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including Primary malignant neoplasm.. LI-FRAUMENI SYNDROME 1 defined as following: An Autosomal dominant multiple pterygium syndrome Primary malignant neoplasm predisposition syndrome caused by Germline mutations of the CHEK2 gene. It is associated with breast carcinoma, gastric carcinoma, colorectal carcinoma, thyroid gland carcinoma, kidney carcinoma, prostate carcinoma, and non-Hodgkin lymphoma.. Autosomal dominant multiple pterygium syndrome disorder defined as following: An inherited disorder that manifests when one copy of a mutated gene is present.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. hereditary Primary malignant neoplasm syndrome defined as following: The condition of a pattern of Malignant Neoplasms within a family, but not every individual's necessarily having the same neoplasm. Characteristically the tumor tends to occur at an earlier than average age, individuals may have more than one primary tumor, the Neoplasms may be multicentric, usually more than 25 percent of the individuals in direct lineal descent from the proband are affected, and the Primary malignant neoplasm predisposition in these families behaves as an Autosomal dominant multiple pterygium syndrome trait with about 60 percent penetrance.. Autosome defined as following: Any chromosome other than a sex chromosome. [GOC:mah]. hereditary disorder defined as following: Genetic diseases are diseases in which inherited genes predispose to increased risk. The genetic disorders associated with Primary malignant neoplasm often result from an alteration or Mutation Abnormality in a single gene. The diseases range from rare dominant Primary malignant neoplasm family syndrome to familial tendencies in which low-penetrance genes may interact with other genes or environmental factors to induce Primary malignant neoplasm. Research may involve clinical, epidemiologic, and laboratory studies of persons, families, and populations at high risk of these disorders.. Autosome recessive defined as following: A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in individuals with two pathogenic alleles, either homozygotes (two copies of the same mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele). [HPO:probinson].", "label": "no"} {"original_question": "Is Wnt16b secreted in response to chemotherapy?", "id": "converted_1129", "sentence1": "Is Wnt16b secreted in response to chemotherapy?", "sentence2": " In this study, we found WNT16B could be expressed and secreted into the microenvironment by Homo sapiens ovarian fibroblasts after DNA damage-associated treatment, including chemotherapy drugs and radiation., In a recent article in Nature Medicine, Sun et al. show that increased expression of Wnt family member wingless-type MMTV integration site family member 16B (WNT16B) by the tumor microenvironment in response to cytotoxic damage and signals through the canonical Wnt pathway to promote tumor growth and chemotherapy resistance. , Using a genome-wide analysis of transcriptional responses to genotoxic stress induced by cancer therapeutics, we identified a spectrum of secreted proteins derived from the tumor microenvironment that includes the Wnt family member wingless-type MMTV integration site family member 16B (WNT16B).[SEP]Definitions: Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Can therapeutic levels of Vedolizumab be found in the breast milk of nursing mothers following treatment for Inflammatory bowel disease?", "id": "converted_3198", "sentence1": "Can therapeutic levels of vedolizumab be found in the Specimen Type - Breast milk of nursing mothers following treatment for Inflammatory bowel disease?", "sentence2": "vedolizumab can be detected in the Specimen Type - Breast milk of nursing mothers. Although more data are imperative, the concentrations of vedolizumab in Specimen Type - Breast milk are minute and are therefore unlikely to result in systemic or gastro-intestinal immune-suppression of the infant., Although more data are imperative, the concentrations of vedolizumab in Specimen Type - Breast milk are minute and are therefore unlikely to result in systemic or gastro-intestinal immune-suppression of the infant., Results\nvedolizumab was undetectable in Specimen Type - Breast milk in Irritable Bowel Syndrome patients before the first infusion of vedolizumab [n = 3] and in all of the healthy controls [n = 5]., However, on serial measurements in Specimen Type - Breast milk after an infusion, drug levels did not surpass 480 ng/ml, which was roughly 1/100 of the comparable serum levels., However, on serial measurements in Specimen Type - Breast milk after an infusion, drug levels did not surpass 480 ng/ml, which was roughly 1/100 of the comparable serum levels.
Conclusions: vedolizumab can be detected in the Specimen Type - Breast milk of nursing mothers., However, on serial measurements in Specimen Type - Breast milk after an infusion, drug levels did not surpass 480 ng/ml, which was roughly 1/100 of the comparable serum levels.[SEP]Relations: vedolizumab has relations: drug_drug with Ibalizumab, drug_drug with Ibalizumab, drug_drug with Pomalidomide, drug_drug with Pomalidomide, drug_drug with Urelumab, drug_drug with Urelumab, drug_drug with Cabazitaxel, drug_drug with Cabazitaxel, drug_drug with Reslizumab, drug_drug with Reslizumab. Definitions: vedolizumab defined as following: A recombinant humanized immunoglobulin G1 (IgG1) monoclonal antibody directed against the human lymphocyte Peyer's patch adhesion molecule 1 (LPAM-1; alpha4beta7; a4b7), with immunomodulating, anti-inflammatory, and potential antineoplastic activities. Upon administration, vedolizumab selectively binds to integrin a4b7 and prevents the binding of a4b7, expressed on the surface of a subset of T-lymphocytes, to its natural ligand, mucosal addressin cell adhesion molecule-1 (MAdCAM-1), which is mainly expressed on the surface of gut endothelial cells. This prevents a4b7-mediated signaling, adhesion of lymphocytes to the endothelium and the migration of T-lymphocytes across the endothelium into inflamed gastrointestinal (GI) tissue. By preventing this infiltration to the affected area, inflammation is reduced. The human lymphocyte a4b7 integrin, plays a key role in gastrointestinal (GI) inflammation; it is overexpressed in certain types of cancer cells. The alpha4beta7/MAdCAM-1 signaling pathway plays a critical role in the homing of T-lymphocytes to intestinal tissue.. Irritable Bowel Syndrome defined as following: Gastrointestinal symptoms characterized by chronic abdominal pain and altered bowel habits in the absence of any organic cause..", "label": "no"} {"original_question": "Is there any relationship between histone ubiquitylation and splicing?", "id": "converted_445", "sentence1": "Is there any relationship between histone ubiquitylation and splicing?", "sentence2": "Histone H2b-specific deubiquitinase and demonstrate that H2B deubiquitination by USP49 gene gene is required for efficient cotranscriptional splicing of a large set of Exons., H2B monoubiquitylation (H2BK123ub1) marks Introns in Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae or Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae cerevisiae, H2B ubiquitination by facilitating splicing, pre-mRNA splicing plays a critical role in Histone H2b ubiquitination, unanticipated functional link between Histone H2b ubiquitination and pre-mRNA splicing[SEP]Relations: Histone H2b acetylation has relations: bioprocess_protein with ATF2, bioprocess_protein with ATF2, bioprocess_bioprocess with histone acetylation, bioprocess_bioprocess with histone acetylation, bioprocess_protein with EP300, bioprocess_protein with EP300, bioprocess_bioprocess with Histone H2b-K5 acetylation, bioprocess_bioprocess with Histone H2b-K5 acetylation, bioprocess_bioprocess with Histone H2b-K12 acetylation, bioprocess_bioprocess with Histone H2b-K12 acetylation. Definitions: Histone H2b defined as following: Histone H2B is a core subunit of the eukaryotic nucleosome complex. Histones are basic nuclear proteins responsible for the nucleosome structure of chromatin. Repeating nucleosome units contain two molecules each of Histones H2A, H2B, H3, and H4 that form an octamer complex around which approximately 146 base pairs of DNA is wrapped. Linker Histone H1 interacts with DNA between nucleosome units in mediating chromatin compaction into higher order structures. (NCI). Exons defined as following: The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA.. Introns defined as following: Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the Exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some Introns code for separate genes..", "label": "yes"} {"original_question": "Does administration of triiodothyronine improve outcome following coronary artery bypass grafting?", "id": "converted_207", "sentence1": "Does administration of liothyronine improve outcome following coronary artery bypass grafting?", "sentence2": "Serum SLC25A5 gene concentrations were significantly higher with fewer patients having SLC25A5 gene concentrations below the normal range in the SLC25A5 gene group than the placebo group throughout the postoperative period. Hemodynamic variables, postoperative inotrope requirement, and outcome variables showed no differences between the groups, We conclude that although widespread interest has been shown on the use of Thyroid Hormones in the perioperative period, and the effect of cardiopulmonary bypass on thyroid hormone metabolism widely studied, there is no substantial evidence to justify routine use of Thyroid Hormones in patients undergoing coronary artery bypass grafting., Treatment with GIK, SLC25A5 gene, and GIK/SLC25A5 gene improves hemodynamic performance and results in reduced Cardiac troponin I release in patients undergoing on-pump CABG surgery., Perioperative administration of liothyronine increased cardiac output slightly and decreased systemic vascular resistance, but it had no effect on operative outcome., Parenteral liothyronine given after crossclamp removal during elective coronary artery bypass grafting significantly improved postoperative ventricular function, reduced the need for treatment with inotropic agents and mechanical devices, and decreased the incidence of Coronary Arteriosclerosis. The incidence of Atrial Fibrillation by ECG Finding was slightly decreased, and the need for postoperative pacemaker support was reduced., Perioperative SLC25A5 gene administration decreased the incidence and need for treatment of postoperative Atrial Fibrillation by ECG Finding., Intravenous T(3) does not have dramatic effects on hemodynamic variables in this setting as has been previously suggested. , Raising serum liothyronine concentrations in patients undergoing coronary-artery bypass surgery increases cardiac output and lowers systemic vascular resistance, but does not change outcome or alter the need for standard postoperative therapy., No significant differences were noted in the pre and post CPB hemodynamics between the two groups for the most part of the study except that heart rate was increased in SLC25A5 gene group., The haemodynamic parameters were no different between the two groups at any postoperative time point. Likewise, density and affinity of lymphocyte beta-adrenoceptors were not significantly different from pre-operative values in either group.[SEP]Relations: Coronary artery atherosclerosis has relations: drug_effect with Rivastigmine, drug_effect with Rivastigmine, drug_effect with Vincristine, drug_effect with Vincristine, drug_effect with Varenicline, drug_effect with Varenicline, drug_effect with Ropinirole, drug_effect with Ropinirole, drug_effect with Fenofibrate, drug_effect with Fenofibrate. Definitions: liothyronine defined as following: A SLC25A5 gene thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most SLC25A5 gene is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly SLC25A5 gene.. Cardiac troponin I defined as following: Troponin I, cardiac muscle (210 aa, ~24 kDa) is encoded by the human TNNI3 gene. This protein is involved in muscle filament movement in cardiac cells.. Atrial Fibrillation by ECG Finding defined as following: An electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregularly irregular ventricular response. (CDISC). Thyroid Hormones defined as following: Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs.. SLC25A5 gene defined as following: This gene plays a regulatory role in the production and utilization of ATP.. Coronary Arteriosclerosis defined as following: Thickening and loss of elasticity of the CORONARY ARTERIES, leading to progressive arterial insufficiency (CORONARY DISEASE)..", "label": "no"} {"original_question": "Is infertility characteristic of individuals with Fanconi anemia?", "id": "converted_1968", "sentence1": "Is Sterility, Reproductive characteristic of individuals with Fanconi anemia?", "sentence2": "PALB2 protein, human protein, human links BRCA1 protein, human protein, human and BRCA2 protein, human protein, human in homologous recombinational repair of DNA double strand breaks (DSBs). Mono-allelic mutations in PALB2 protein, human protein, human increase the risk of Breast, Pancreatic Hormones, and other Malignant Neoplasms, and biallelic mutations cause Fanconi anemia (doxorubicin/fluorouracil protocol). , Moreover, Mutant males showed reduced fertility due to impaired meiosis and increased apoptosis in Germ Cells. Interestingly, Mutant meiocytes showed a significant defect in sex chromosome synapsis, which likely contributed to the germ cell loss and fertility defect., In females with Fanconi anemia (doxorubicin/fluorouracil protocol), Sterility, Reproductive is often accompanied by diminished ovarian reserve and Hypergonadotropic amenorrhea before the age of 30 years, suggesting Ovarian Failure, Premature (POI)., Substantially reduced Mullerian duct inhibiting substance levels in females with doxorubicin/fluorouracil protocol suggest a primary ovarian defect associated with reduced fertility. Measurement of Mullerian duct inhibiting substance at the time of doxorubicin/fluorouracil protocol diagnosis and subsequent monitoring of Mullerian duct inhibiting substance levels at regular intervals may be useful for the timely management of complications related to POI such as subfertility/Sterility, Reproductive, Encounter due to family history of Encounter due to family history of osteoporosis, and menopausal symptoms., Fanconi anemia (doxorubicin/fluorouracil protocol) is a human disease of Bone marrow hypocellularity, leukemia, Anal Anal squamous cell carcinoma, and developmental anomalies, including Hypogonadism and Sterility, Reproductive. , Reduced fertility is one clinical manifestation among other well known Fanconi anemia features. , Fanconi anemia (doxorubicin/fluorouracil protocol) is a human disease of Bone marrow hypocellularity, leukemia, Anal Anal squamous cell carcinoma, and developmental anomalies, including Hypogonadism and Sterility, Reproductive, Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A Genes leads to growth retardation, strain-specific Microphthalmos, meiotic defects and primordial germ cell hypoplasia., Fanconi anemia (doxorubicin/fluorouracil protocol) is a human disease of Bone marrow hypocellularity, leukemia, Anal Anal squamous cell carcinoma, and developmental anomalies, including Hypogonadism and Sterility, Reproductive., To potentially reduce late effects of malignancy, Late Late chronic graft-versus-host disease (Graft versus host disease prophylaxis/therapy), Endocrine System Diseases, and Sterility, Reproductive in patients with Fanconi anemia (doxorubicin/fluorouracil protocol) undergoing HLA-matched related donor hematopoietic cell transplantation (Hematocrit procedure), we developed a regimen using fludarabine (ZMYND10 wt Allele), cyclophosphamide (Controlling (action)), and anti-thymocyte globulin (lymphocyte immune globulin, anti-thymocyte globulin) followed by infusion of T-Lymphocyte depleted (TCD) bone marrow (BM) or unmanipulated umbilical cord blood (UCB)., Gene Mutation in Fanca account for the majority of cases of Fanconi anemia (doxorubicin/fluorouracil protocol), a recessively inherited disease identified by Congenital Abnormality, Bone marrow hypocellularity, Sterility, Reproductive, and Primary malignant neoplasm susceptibility., FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) is Mutation Abnormality in more than 60% of cases of Fanconi anemia (doxorubicin/fluorouracil protocol), a rare genetically heterogeneous autosomal recessive disorder characterized by Bone marrow hypocellularity, endocrine tissue Primary malignant neoplasm susceptibility, and Sterility, Reproductive., In females with Fanconi anemia (doxorubicin/fluorouracil protocol), Sterility, Reproductive is often accompanied by diminished ovarian reserve and Hypergonadotropic amenorrhea before the age of 30 years, suggesting Ovarian Failure, Premature (POI)., Fanconi anemia (doxorubicin/fluorouracil protocol) is a complex Primary malignant neoplasm susceptibility disorder associated with DNA repair defects and Sterility, Reproductive, yet the precise function of the doxorubicin/fluorouracil protocol proteins in genome maintenance remains unclear., Fanconi anemia (doxorubicin/fluorouracil protocol) is a genetic disease resulting in Bone marrow hypocellularity, high Primary malignant neoplasm risks, and Sterility, Reproductive, and developmental anomalies including Microphthalmos, Microcephaly (physical finding), hypoplastic radius and thumb.[SEP]Relations: Fanconi anemia complementation group has relations: disease_phenotype_positive with Male Sterility, Reproductive, disease_phenotype_positive with Male Sterility, Reproductive, disease_disease with Fanconi anemia, disease_disease with Fanconi anemia, disease_phenotype_positive with Abnormal heart morphology, disease_phenotype_positive with Abnormal heart morphology, disease_phenotype_positive with Abnormal renal morphology, disease_phenotype_positive with Abnormal renal morphology, disease_phenotype_positive with Abnormal facial shape, disease_phenotype_positive with Abnormal facial shape. Definitions: FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) defined as following: Fanconi anemia caused by mutations of the FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) Genes. FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) Genes mutations are the most common cause of Fanconi anemia. This Genes provides instructions for making a protein that is involved in the Fanconi anemia (doxorubicin/fluorouracil protocol) pathway.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. BRCA2 protein, human defined as following: Breast Primary malignant neoplasm type 2 susceptibility protein (3418 aa, ~384 kDa) is encoded by the human BRCA2 protein, human Genes. This protein plays a role in both cell cycle regulation and DNA repair.. Breast defined as following: In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.. Pancreatic Hormones defined as following: Peptide hormones secreted into the blood by cells in the ISLETS OF LANGERHANS of the pancreas. The alpha cells secrete glucagon; the beta cells secrete insulin; the delta cells secrete somatostatin; and the PP cells secrete Pancreatic Hormones polypeptide.. lymphocyte immune globulin, anti-thymocyte globulin defined as following: Purified gamma globulin, with immunosuppressive activity. Obtained from animals that have been immunized with human thymocytes, antithymocyte globulin (lymphocyte immune globulin, anti-thymocyte globulin) specifically recognizes and destroys T lymphocytes. Although not completely understood, the mechanism of action appears to involve T lymphocyte clearance from the circulation and modulation of T lymphocyte activity. Administering lymphocyte immune globulin, anti-thymocyte globulin with chemotherapy prior to stem cell transplantation may reduce the risk of graft-versus-host (GVH) disease.. Microphthalmos defined as following: Congenital or developmental anomaly in which the eyeballs are abnormally small.. ZMYND10 wt Allele defined as following: Human ZMYND10 wild-type allele is located in the vicinity of 3p21.3 and is approximately 6 kb in length. This allele, which encodes zinc finger MYND domain-containing protein 10, is involved in motile ciliary function. Gene Mutation in this Genes are associated with primary ciliary dyskinesia-22.. leukemia defined as following: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006). cyclophosphamide defined as following: Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and Primary malignant neoplasm.. fludarabine defined as following: A fluorinated nucleotide antimetabolite analog of the antiviral agent vidarabine (ara-A) with antineoplastic activity. Administered parenterally as a phosphate salt, fludarabine phosphate is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP. This metabolite may inhibit DNA polymerase alpha, ribonucleotide reductase and DNA primase, thereby interrupting DNA synthesis and inhibiting tumor cell growth. (NCI04). T-Lymphocyte defined as following: Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Late chronic graft-versus-host disease defined as following: Late chronic graft versus host disease is defined as presence of symptoms and signs 100 days after an allogenic transplant.. Microcephaly (physical finding) defined as following: Head circumference below 2 standard deviations below the mean for age and gender. [PMID:15806441, PMID:19125436, PMID:25465325, PMID:9683597]. Endocrine System Diseases defined as following: A non-neoplastic or neoplastic disorder that affects the endocrine system. Representative examples of non-neoplastic disorders include diabetes mellitus, hyperthyroidism, and adrenal gland insufficiency. Representative examples of neoplastic disorders include carcinoid tumor, neuroendocrine carcinoma, and pheochromocytoma.. BRCA1 protein, human defined as following: Breast Primary malignant neoplasm type 1 susceptibility protein (1863 aa, ~208 kDa) is encoded by the human BRCA1 protein, human Genes. This protein plays a role in both the maintenance of DNA and the mediation of ubiquitin E3 ligase activity.. Mutant defined as following: An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).. PALB2 protein, human defined as following: Partner and localizer of BRCA2 protein, human (1186 aa, ~131 kDa) is encoded by the human PALB2 protein, human Genes. This protein may play roles in cell cycle checkpoints and the repair of damaged DNA resolved by recombination.. Graft versus host disease prophylaxis/therapy defined as following: Therapy to prevent or treat graft vs host disease.. Ovarian Failure, Premature defined as following: Cessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections. The most commonly known genetic cause is the expansion of a CGG repeat to 55 to 199 copies in the 5' untranslated region in the X-linked FMR1 Genes.. Hematocrit procedure defined as following: The volume of packed RED BLOOD CELLS in a blood specimen. The volume is measured by centrifugation in a tube with graduated markings, or with automated blood cell counters. It is an indicator of erythrocyte status in disease. For example, ANEMIA shows a low value; POLYCYTHEMIA, a high value.. Hypogonadism defined as following: Condition resulting from deficient gonadal functions, such as GAMETOGENESIS and the production of GONADAL STEROID HORMONES. It is characterized by delay in GROWTH, germ cell maturation, and development of secondary sex characteristics. Hypogonadism can be due to a deficiency of GONADOTROPINS (hypogonadotropic Hypogonadism) or due to primary gonadal failure (hypergonadotropic Hypogonadism).. Mullerian duct inhibiting substance defined as following: Muellerian-inhibiting factor (560 aa, ~59 kDa) is encoded by the human Mullerian duct inhibiting substance Genes. This protein plays a role in the development of the male reproductive system.. Germ Cells defined as following: The reproductive cells in multicellular organisms at various stages during GAMETOGENESIS.. Anal squamous cell carcinoma defined as following: A Anal squamous cell carcinoma (SCC) arising from the anal canal or the anal margin (perianal skin). Human papillomavirus is detected in the majority of cases. Homosexual HIV-positive men have an increased risk of developing anal Anal squamous cell carcinoma in comparison to the general male population. Symptoms include anal pruritus, discomfort when sitting, pain, change in bowel habit, and bleeding. The prognosis is generally better for anal margin SCC than for anal canal SCC.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Bone marrow hypocellularity defined as following: A reduced number of hematopoietic cells present in the bone marrow relative to marrow fat. [DDD:wouwehand, HPO:probinson]. Congenital Abnormality defined as following: Malformations of organs or body parts during development in utero.. Sterility, Reproductive defined as following: Complete inability to conceive or induce conception.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Gene Mutation may be associated with genetic diversity or with pathologies including Primary malignant neoplasm.. Fanconi anemia defined as following: Fanconi anemia caused by mutations of the FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) Genes. FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) Genes mutations are the most common cause of Fanconi anemia. This Genes provides instructions for making a protein that is involved in the Fanconi anemia (doxorubicin/fluorouracil protocol) pathway..", "label": "yes"} {"original_question": "Does RNA polymerase II have RNA cleavage activity?", "id": "converted_2244", "sentence1": "Does RNA Polymerase II have RNA cleavage activity?", "sentence2": "In addition to RNA synthesis, DNA-Directed RNA Polymerase complex (msRNAPs) support enzymatic reactions such as intrinsic RNA Transcript cleavage., msRNAP active sites from different species appear to exhibit differential intrinsic RNA Transcript cleavage efficiency and have likely evolved to allow fine-tuning of the transcription process., Here we show that a single amino-acid substitution in the trigger loop (TL) of Saccharomyces RNAP II, Rpb1 H1085Y, engenders a gain of intrinsic cleavage activity where the substituted tyrosine appears to participate in acid-base chemistry at alkaline pH for both intrinsic cleavage and nucleotidyl transfer. , The eukaryotic transcription factor TCEA1 wt Allele enhances elongation and nascent RNA Transcript cleavage activities of RNA Polymerase II in a stalled elongation complex., The transcription factor TCEA1 wt Allele zinc ribbon dipeptide Asp-Glu is critical for stimulation of elongation and RNA cleavage by RNA Polymerase II, By site-directed mutagenesis, we have demonstrated that invariant residues Asp-261 and Glu-262 of the nucleic acid-binding TCEA1 wt Allele Zn ribbon are critical for stimulation of both elongation and RNA cleavage activities of RNA Polymerase II., Complexes of yeast RNA Polymerase II and RNA are substrates for TCEA1 wt Allele-induced RNA cleavage., RNA in such RNA-DNA-Directed RNA Polymerase complexes undergoes reactions previously thought to be unique to nascent RNA in ternary complexes with DNA, including TCEA1 wt Allele-dependent cleavage and elongation by 3'-terminal addition of 1-methyl-2-pyrrolidinone from NTP., Nascent RNA cleavage by arrested RNA Polymerase II does not require upstream translocation of the elongation complex on DNA., Here we show that in the presence of SII and Nucleotides, RNA Transcript cleavage is detected during SII-dependent elongation but not during SII-independent transcription. , under typical transcription conditions, SII is necessary but insufficient to activate RNA cleavage. RNA cleavage could serve to move RNA Polymerase II away from the transcriptional impediment and/or permit RNA Polymerase II multiple attempts at RNA elongation., SII is an RNA Polymerase II-binding protein that stimulates transcription elongation and also activates nascent RNA Transcript cleavage by RNA Polymerase II in elongation complexes in vitro, The RNA Polymerase II elongation complex. Factor-dependent transcription elongation involves nascent RNA cleavage., Cleavage was not restricted to an elongation complex arrested at this particular site, showing that nascent RNA hydrolysis is a general property of RNA Polymerase II elongation complexes., transcription factor S-II (also known as TCEA1 wt Allele) is an RNA Polymerase II binding protein that allows bypass of template arrest sites by activating a nascent RNA cleavage reaction., During gene transcription, the DNA-Directed RNA Polymerase (Pol) active center can catalyze RNA cleavage., During gene transcription, the DNA-Directed RNA Polymerase (Pol) active center can catalyze RNA cleavage., The eukaryotic transcription factor TCEA1 wt Allele enhances elongation and nascent RNA Transcript cleavage activities of RNA Polymerase II in a stalled elongation complex., POLR2I gene, a small subunit of RNA Polymerase II, enhances the cleavage stimulation activity of S-II., These results suggest that both S-II and POLR2I gene maintain transcriptional fidelity by stimulating the cleavage activity intrinsic to RNA Polymerase II., It is also possible that the RNA Transcript cleavage activity of RNA Polymerase II represents a proofreading function of the Enzyme [APC].., Nascent RNA cleavage by arrested RNA Polymerase II does not require upstream translocation of the elongation complex on DNA., Intrinsic RNA Transcript cleavage in yeast RNA Polymerase II elongation complexes.[SEP]Relations: DNA-Directed RNA Polymerase binding has relations: molfunc_protein with CCNT2, molfunc_protein with CCNT2, molfunc_protein with YTHDC2, molfunc_protein with YTHDC2, molfunc_protein with PKN2, molfunc_protein with PKN2, molfunc_protein with PPIB, molfunc_protein with PPIB. DNA-Directed RNA Polymerase III assembly has relations: bioprocess_bioprocess with cellular protein-containing complex assembly, bioprocess_bioprocess with cellular protein-containing complex assembly. Definitions: RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). RNA Polymerase II defined as following: A DNA-dependent DNA-Directed RNA Polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than DNA-Directed RNA Polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6.. DNA-Directed RNA Polymerase complex defined as following: Any complex that possesses DNA-Directed RNA Polymerase activity; generally comprises a catalytic subunit and one or more additional subunits. [GOC:mah]. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Nucleotides defined as following: The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed). TCEA1 wt Allele defined as following: Human TCEA1 wild-type allele is located in the vicinity of 8q11.2 and is approximately 56 kb in length. This allele, which encodes transcription elongation factor A protein 1, plays a role in transcriptional elongation. A chromosomal insertion ins(8)(q12;q11q11) of this gene and the PLAG1 gene may be associated with salivary gland pleomorphic adenoma.. DNA-Directed RNA Polymerase defined as following: Enzymes that catalyze DNA template-directed extension of the 3'-end of an RNA strand one nucleotide at a time. They can initiate a chain de novo. In eukaryotes, three forms of the Enzyme [APC] have been distinguished on the basis of sensitivity to alpha-amanitin, and the type of RNA synthesized. (From Enzyme Nomenclature, 1992).. RNA Transcript defined as following: The initial RNA molecule produced by transcription..", "label": "yes"} {"original_question": "Does the interaction of MOV10 and RNASEH2 promote L1 retrotransposition?", "id": "converted_3060", "sentence1": "Does the interaction of MOV10 gene and RNASEH2 promote Long Interspersed Nucleotide Element-1 retrotransposition?", "sentence2": "Interplay between RNASEH2 and MOV10 gene gene controls LINE-1 retrotransposition., We show that MOV10 gene gene interacts with RNASEH2, and their interplay is crucial for restricting Long Interspersed Nucleotide Element-1 retrotransposition. , Furthermore, we show that RNASEH2-MOV10 gene gene-mediated Long Interspersed Nucleotide Element-1 restriction downregulates expression of the rheumatoid arthritis-associated inflammatory cytokines and matrix-degrading proteinases in Synoviocytes, implicating a potential causal relationship between them and disease development in terms of disease predisposition.[SEP]Relations: centromere clustering at the mitotic interphase nuclear envelope has relations: bioprocess_bioprocess with chromosome attachment to the nuclear envelope, bioprocess_bioprocess with chromosome attachment to the nuclear envelope, bioprocess_bioprocess with centromere clustering, bioprocess_bioprocess with centromere clustering, bioprocess_bioprocess with mitotic cell cycle process, bioprocess_bioprocess with mitotic cell cycle process. Definitions: Long Interspersed Nucleotide Element-1 defined as following: A long interspersed element (LINE) found in mammals. The LINE-1 element is the only active LINE in humans and is approximately 6,000 base pairs long. This nucleotide sequence consists of two non-overlapping open reading frames (ORF) flanked by a 5' untranslated region (UTR), which contains a strong RNA polymerase II promoter sequence, and target side duplications. The first ORF encodes a 500 amino acid, ~40 kDa leucine zipper-containing RNA-binding protein. The second ORF encodes an ~150 kDa protein that has endonuclease and reverse transcriptase activity. Increased LINE-1 copy number is associated with cancer and neuropathy.. Synoviocytes defined as following: Cells on the luminal surface of the SYNOVIAL MEMBRANE. Type A synoviocytes are MACROPHAGES responsible for waste removal from the joint cavity. Fibroblast-like type B synoviocytes are involved in production of joint matrix constituents (e.g., HYALURONAN; COLLAGEN; and FIBRONECTIN)..", "label": "no"} {"original_question": "Are AAV vectors considered for the treatment of retinal dystrophies?", "id": "converted_2657", "sentence1": "Are AAV vectors considered for the treatment of Retinal Dystrophies?", "sentence2": " These novel gene vectors aim to more safely and efficiently transduce retinal cells, expand the gene packaging capacity of AAV, and utilize new strategies to correct the varying mechanisms of dysfunction found with inherited Retinal Dystrophies. [SEP]Relations: retinal dystrophy in systemic or cerebroretinal lipidoses has relations: disease_disease with retinal cone dystrophy, disease_disease with retinal cone dystrophy. Definitions: Retinal Dystrophies defined as following: A group of disorders involving predominantly the posterior portion of the ocular fundus, due to degeneration in the sensory layer of the RETINA; RETINAL PIGMENT EPITHELIUM; BRUCH MEMBRANE; CHOROID; or a combination of these tissues..", "label": "yes"} {"original_question": "Is adalimumab effective for hidradenitis suppurativa?", "id": "converted_1865", "sentence1": "Is adalimumab effective for hidradenitis suppurativa?", "sentence2": "If patient is not improved, then adalimumab 160 mg at week 0, 80 mg at week 2; then 40 mg subcutaneously weekly should be administered (LOE Ib, SOR A). If improvement occurs then therapy should be maintained as long as HS Lesion are present., Reduction in Pain:-:Point in time:^Patient:- scores and improvement in Depressive Symptoms in patients with hidradenitis suppurativa treated with adalimumab in a phase 2, randomized, placebo-controlled trial., adalimumab treatment for 16 weeks improved HS Lesion significantly versus placebo (NCT00918255)., CONCLUSION: Patients with moderate to severe HS had a high degree of Pain:-:Point in time:^Patient:- and Depressive Symptoms at baseline. Adalimumabtherapy was associated with decreased Pain:-:Point in time:^Patient:- and Depressive Symptoms compared to baseline., Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa., adalimumab, a recombinant, fully humanized, anti-Tumor Necrosis Factor-alpha alpha (anti-Recombinant Tumor Necrosis Factor Family Protein-α) monoclonal immunoglobulin complex location, is the only officially approved treatment for the management of moderate-to-severe HS. Case reports, concerning 42 patients who received adalimumab for severe HS (with the standard dose regimen for Psoriasis), reported a cumulative response rate of 58% (≥50% in 23 patients) with a relapse rate of 71% (10 out of 14 patients). The most recent and most well-powered phase III, randomized placebo-controlled trials for the evaluation of the efficacy and safety of adalimumab in treatment of moderate-to-severe HS (PIONEER studies I and II) showed that the Hidradenitis Suppurativa Clinical Response (HiSCR) rate at week 12 was significantly higher for patients randomized to adalimumab compared to placebo., In conclusion, adalimumab, to date, holds the most robust data regarding treatment efficacy in HS. , adalimumab (Humira) for the Treatment of Hidradenitis Suppurativa., adalimumab (Humira®) is a novel therapy approved by the US Food and Drug Administration, Health Canada, and the European Commission for the treatment of hidradenitis suppurativa (HS)., Taken together, these data conclude that treatment of HS with adalimumab is a safe and effective therapy resulting in a significant decrease in Specimen Source Codes - Abscess and inflammatory nodule counts within the first 12 weeks of treatment., Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy., Hidradenitis suppurativa managed with adalimumab., Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab., Long-term successful adalimumab therapy in severe hidradenitis suppurativa., Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa., HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study, adalimumab in treatment-resistant hidradenitis suppurativa following recurrence after extensive affected area excision: a review of biologics therapy, adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study, Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab, In a phase 2 trial, adalimumab, an immunoglobulin complex location against Tumor Necrosis Factor-alpha α, showed efficacy against hidradenitis suppurativa.PIONEER I and II were similarly designed, phase 3 multicenter trials of adalimumab for hidradenitis suppurativa, with two double-blind, placebo-controlled periods., Here we report a case of a patient with severe recalcitrant hidradenitis suppurativa successfully treated with adalimumab., Recent reports have demonstrated that adalimumab, a Tumor Necrosis Factor-alpha (Recombinant Tumor Necrosis Factor Family Protein) Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance), may be effective in the treatment of patients with HS who have failed conventional therapy., Conclusion adalimumab appears to be an effective and safe treatment for refractory HS., Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy., Hidradenitis suppurativa managed with adalimumab., Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab., Two Phase 3 Trials of adalimumab for Hidradenitis Suppurativa., adalimumab treatment for hidradenitis suppurativa associated with Crohn's disease of oral soft tissues of oral soft tissues., Long-term successful adalimumab therapy in severe hidradenitis suppurativa., Conclusion adalimumab appears to be an effective and safe treatment for refractory HS.., Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa., Here we report a case of a patient with severe recalcitrant hidradenitis suppurativa successfully treated with adalimumab.., adalimumab is suitable for the long-term treatment of hidradenitis suppurativa and presents a further conservative treatment approach.., HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study., Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa.[SEP]Relations: hidradenitis suppurativa has relations: disease_disease with hidradenitis, disease_disease with hidradenitis. adalimumab has relations: drug_drug with Amatuximab, drug_drug with Amatuximab, drug_drug with Isatuximab, drug_drug with Isatuximab, drug_drug with Margetuximab, drug_drug with Margetuximab, drug_drug with Antipyrine, drug_drug with Antipyrine. Definitions: Lesion defined as following: A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.. Psoriasis defined as following: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The Lesion have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in Psoriasis.. adalimumab defined as following: A recombinant, human IgG1 monoclonal immunoglobulin complex location directed against Tumor Necrosis Factor-alpha-alpha (Recombinant Tumor Necrosis Factor Family Protein-alpha), with immunomodulating activity. Upon administration, adalimumab binds to Recombinant Tumor Necrosis Factor Family Protein-alpha, thereby preventing its binding to the p55 and p75 Recombinant Tumor Necrosis Factor Family Protein cell surface receptors and inhibiting Recombinant Tumor Necrosis Factor Family Protein-mediated immune responses. Recombinant Tumor Necrosis Factor Family Protein-alpha, a pro-inflammatory cytokine, is upregulated in various autoimmune diseases.. Recombinant Tumor Necrosis Factor Family Protein defined as following: A recombinant therapeutic agent which is chemically identical to or similar to one of a number of endogenous Tumor Necrosis Factor-alpha (Recombinant Tumor Necrosis Factor Family Protein) proteins. Recombinant Tumor Necrosis Factor Family Protein family cytokines bind to and activate specific cell-surface receptors, thereby mediating inflammatory processes, cell proliferation, immunity, angiogenesis, and tumor cell cytotoxicity. One primary antitumor effect of TNFs involves stimulation of T cell-mediated antitumor cytotoxicity.. Tumor Necrosis Factor-alpha defined as following: Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as Recombinant Tumor Necrosis Factor Family Protein-alpha, it is only 30% homologous to Recombinant Tumor Necrosis Factor Family Protein-beta (LYMPHOTOXIN), but they share Recombinant Tumor Necrosis Factor Family Protein RECEPTORS.. infliximab defined as following: A chimeric monoclonal immunoglobulin complex location to Recombinant Tumor Necrosis Factor Family Protein-ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE.. Hidradenitis Suppurativa defined as following: A chronic suppurative and cicatricial disease of the apocrine glands occurring chiefly in the axillae in women and in the groin and anal regions in men. It is characterized by poral occlusion with secondary bacterial infection, evolving into abscesses which eventually rupture. As the disease becomes chronic, ulcers appear, sinus tracts enlarge, fistulas develop, and fibrosis and scarring become evident.. immunoglobulin complex location defined as following: A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph. [GOC:add, GOC:jl, ISBN:0781765196]. hidradenitis suppurativa defined as following: A chronic suppurative and cicatricial disease of the apocrine glands occurring chiefly in the axillae in women and in the groin and anal regions in men. It is characterized by poral occlusion with secondary bacterial infection, evolving into abscesses which eventually rupture. As the disease becomes chronic, ulcers appear, sinus tracts enlarge, fistulas develop, and fibrosis and scarring become evident..", "label": "yes"} {"original_question": "Are stem cell transplants used to treat acute kidney injury?", "id": "converted_3712", "sentence1": "Are stem cell transplants used to treat Kidney Failure, Acute?", "sentence2": "Animal studies have shown that Mesenchymal Stromal Cells (selenomethylselenocysteine) infusions improve Kidney Failure, Acute (Blighia sapida) outcomes when administered early after ischemic/reperfusion injury or within 24 hours after cisplatin administration., Early Diagnostic Markers for Detection of Acute Kidney Injury in Allogeneic Hematopoietic stem cells Transplant Recipients., Risk assessment for Kidney Failure, Acute after allogeneic hematopoietic stem cell transplantation based on Acute Kidney Injury Network criteria.[SEP]Relations: acute kidney failure has relations: disease_disease with acute disease, disease_disease with acute disease, disease_disease with kidney failure, disease_disease with kidney failure, disease_disease with acute kidney tubular necrosis, disease_disease with acute kidney tubular necrosis, disease_protein with INS, disease_protein with INS. Cisplatin has relations: drug_effect with Acute kidney injury, drug_effect with Acute kidney injury. Definitions: Hematopoietic stem cells defined as following: Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood.. selenomethylselenocysteine defined as following: A naturally occurring organoselenium compound found in many plants, including garlic, onions, and broccoli, with potential antioxidant and chemopreventive activities. Se-Methyl-seleno-L-cysteine (selenomethylselenocysteine) is an amino acid analogue of cysteine in which a methylselenium moiety replaces the sulphur atom of cysteine. This agent acts as an antioxidant when incorporated into glutathione peroxidase and has been shown to exhibit potent chemopreventive activity in animal models.. cisplatin defined as following: An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle.. Mesenchymal Stromal Cells defined as following: Non-hematopoietic cells that support HEMATOPOIETIC STEM CELLS in bone marrow. They have also been isolated from other organs and tissues such as adipose tissue, UMBILICAL CORD BLOOD, and WHARTON JELLY and include a subpopulation of multipotent stem cells.. Kidney Failure, Acute defined as following: Sudden and sustained deterioration of the kidney function characterized by decreased glomerular filtration rate, increased serum creatinine or oliguria..", "label": "yes"} {"original_question": "Is FKBP52 encoding a chaperone ?", "id": "converted_4296", "sentence1": "Is tacrolimus binding protein 4 encoding a chaperone ?", "sentence2": "HSP90AA1 wt Allele co-chaperones tissue-factor-pathway inhibitor 2 and FKBPs, The co-chaperone FK506-binding protein 51 (FKBP5 wt Allele), co‑chaperone tacrolimus binding protein 4 [SEP]Relations: tau protein binding has relations: molfunc_protein with FKBP4, molfunc_protein with FKBP4, molfunc_protein with PRKAA1, molfunc_protein with PRKAA1, molfunc_protein with TTBK1, molfunc_protein with TTBK1, molfunc_protein with GSK3B, molfunc_protein with GSK3B, molfunc_protein with CDK5, molfunc_protein with CDK5. Definitions: HSP90AA1 wt Allele defined as following: Human HSP90AA1 wild-type allele is located in the vicinity of 14q32.33 and is approximately 59 kb in length. This allele, which encodes heat shock protein HSP 90-alpha, plays a role in both nitric oxide metabolism and protein folding. A chromosomal translocation t(3;14)(q27;q32) of this gene and the BCL6 gene is associated with B cell non-Hodgkin lymphoma.. FKBP5 wt Allele defined as following: Human FKBP5 wild-type allele is located in the vicinity of 6p21.31 and is approximately 155 kb in length. This allele, which encodes peptidyl-prolyl cis-trans isomerase FKBP5 protein, is involved in the modulation of protein folding..", "label": "yes"} {"original_question": "Are there any specific antidotes for rivaroxaban?", "id": "converted_169", "sentence1": "Are there any specific antidotes for rivaroxaban?", "sentence2": "Novel oral anticoagulants (NOACs)--apixaban, dabigatran, and rivaroxaban--have a significantly smaller risk of Cerebral Hemorrhage (HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO). However, two facts make this situation complicated: First, the risk of Hematoma expansion is unknown for NOACs. Second, there is no specific antidote for neither of the NOACs., he new oral anticoagulants dabigatran etexilate (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis) have predictable pharmacokinetic and pharmacodynamic profiles and are alternatives to warfarin. However, many physicians are wary of these drugs, since there is limited evidence on how to manage Hemorrhage in patients taking them, and since no specific antidote is known to reverse their anticoagulant effect. , Given the absence of a specific antidote, the action to be taken in these situations must be defined. , The fact that there is no specific antidote to reverse the anticoagulant action of the new anticoagulants can impair management of hemorrhagic complications; , Like any new therapy, the potential benefits must be weighed against the potential challenges and one of the most concerning aspects of the new target-specific oral anticoagulants is the lack of a proven method to reverse their effect. Unlike the vitamin K antagonist, i.e. warfarin, there is no specific antidote for these medications. , Two major drawbacks are on the one hand the risk of Pharmacologic Substance accumulation in Both kidneys and/or Hepatobiliary Disorder and, on the other hand, the lack of specific antidotes., NOA also have other unresolved problems: Pharmacologic Substance interactions are still possible, specific coagulation test to assess them must be developed, and no specific antidote is currently available in case of hemorrhagic complication., But they have disadvantages also, they depend on renal clearance, they can interact with other Medicament and they lack a specific antidote. , While these trial data are extremely encouraging, several practical issues (e.g., lack of specific antidote, safety of long-term treatment or cost-effectiveness in \"real-life\" clinical practice) still need to be elucidated., In case of massive Hemorrhage, management is unclear and none of these newer agents has a specific antidote that completely reverses its anticoagulant effect., The short half-life of these new agents compensates for the lack of any specific antidote in many instances. , Currently, none of these new agents has a specific antidote, and little advise can be given on how to manage a major Hemorrhage event., Rivaroxaban, which inhibits Factor Ashmore and Cartier Islands (Ashmore and Cartier Islands), is currently in clinical trials and is the most advanced factor Ashmore and Cartier Islands inhibitor. The Pharmacologic Substance offers once-daily oral dosing, with no need for injections, dose titration, or frequent blood tests to monitor the international normalised ratio. It has a rapid onset of action and, although there is no specific antidote, it has a short plasma elimination half-life (about 5-9 hours). , Increased use of dabigatran, rivaroxaban, and apixaban as oral anticoagulants for the treatment of Atrial Fibrillation by ECG Finding and acute deep venous thrombosis has increased despite the lack of known antidotes to these medications., There is no antidote for reversal and no reliable laboratory monitoring of the anticoagulant effect for emergency situations. , Further concerns about the use of Direct Oral Anticoagulant in the elderly are the high prevalence of Kidney Failure in Atrial Fibrillation patients >75 years of age, the largely unknown risk of Pharmacologic Substance-Pharmacologic Substance and Pharmacologic Substance-food interactions, the lack of easily available laboratory monitoring tests of anticoagulant activity and the lack of an antidote., Specific antidotes for the reversal of the anticoagulant effect of these drugs, such as Monoclonal Antibodies against the direct thrombin inhibitor dabigatran or recombinant Ashmore and Cartier Islands-analog in the case of factor Ashmore and Cartier Islands inhibitors, are still being investigated in early clinical trials., In early 2013 there is no antidote for dabigatran, rivaroxaban or apixaban, nor any specific treatment with proven efficacy for severe Hemorrhage linked to these drugs. [SEP]Relations: Rivaroxaban has relations: drug_drug with Inotersen, drug_drug with Inotersen, drug_drug with Gadoteridol, drug_drug with Gadoteridol, drug_drug with Colistin, drug_drug with Colistin, drug_drug with Ampicillin, drug_drug with Ampicillin, drug_drug with Antipyrine, drug_drug with Antipyrine. Definitions: Hematoma defined as following: A collection of blood outside the BLOOD VESSELS. Hematoma can be localized in an organ, space, or tissue.. Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. rivaroxaban defined as following: An orally bioavailable oxazolidinone derivative and direct inhibitor of the coagulation factor Ashmore and Cartier Islands with anticoagulant activity. Upon oral administration, rivaroxaban selectively binds to both free factor Ashmore and Cartier Islands and factor Ashmore and Cartier Islands bound in the prothrombinase complex. This interferes with the conversion of prothrombin (factor II) to thrombin and eventually prevents the formation of cross-linked fibrin clots. Rivaroxaban does not affect existing thrombin levels.. warfarin defined as following: An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and Atrial Fibrillation by ECG Finding with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.. Monoclonal Antibodies defined as following: Antibodies produced by a single clone of cells.. Atrial Fibrillation by ECG Finding defined as following: An electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregularly irregular ventricular response. (CDISC). Ashmore and Cartier Islands defined as following: Islands in the Indian Ocean, located midway between northwestern Australia and Timor island.. Atrial Fibrillation defined as following: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.. Factor Xa defined as following: Activated form of factor X that participates in both the intrinsic and extrinsic pathways of blood coagulation. It catalyzes the conversion of prothrombin to thrombin in conjunction with other cofactors.. Hepatobiliary Disorder defined as following: A non-neoplastic or neoplastic disorder that affects the liver, bile ducts, and gallbladder. Representative examples of non-neoplastic disorders include hepatitis, cirrhosis, cholangitis, and cholecystitis. Representative examples of neoplastic disorders include hepatocellular adenoma, hepatocellular carcinoma, and cholangiocarcinoma.. Kidney Failure defined as following: A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.. apixaban defined as following: An orally active inhibitor of coagulation factor Ashmore and Cartier Islands with anticoagulant activity. Apixaban directly inhibits factor Ashmore and Cartier Islands, thereby interfering with the conversion of prothrombin to thrombin and preventing formation of cross-linked fibrin clots.. dabigatran defined as following: A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular Atrial Fibrillation by ECG Finding.. Cerebral Hemorrhage defined as following: Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA.. Hemorrhage defined as following: Bleeding or escape of blood from a vessel.. Direct Oral Anticoagulant defined as following: An agent taken orally to prevent blood clot formation by directly inhibiting certain coagulation factors including thrombin (factor IIa) or factor Ashmore and Cartier Islands..", "label": "no"} {"original_question": "Is amoxicillin used for treatment of malnutrition in children?", "id": "converted_1005", "sentence1": "Is amoxicillin used for treatment of Malnutrition in children?", "sentence2": " Another RCT did not show superiority of ceftriaxone over amoxicilllin for these same outcomes, but adressed Systolic anterior movement of mitral valve children with and without complications (p = 0.27). Another RCT showed no difference between amoxicillin and Trimethoprim-Sulfamethoxazole Combination efficacies for Pneumonia in underweight, but not Systolic anterior movement of mitral valve. Our meta-analysis of 12 pooled susceptibility-studies for all types of bacterial isolates, including 2767 stricly Systolic anterior movement of mitral valve children, favoured amoxicillin over Trimethoprim-Sulfamethoxazole Combination for susceptibility medians: 42% (IQR 27-55%) vs 22% (IQR 17-23%) and population-weighted-means 52.9% (range 23-57%) vs 35.4% (range 6.7-42%)., Susceptibility-studies favour amoxicillin over Trimethoprim-Sulfamethoxazole Combination. , Oral amoxicillin for 5 days was as effective as intramuscular ceftriaxone for 2 days (1 RCT). For uncomplicated Systolic anterior movement of mitral valve, amoxicillin showed no benefit over placebo (1 retrospective study). , Children who took amoxicillin and de-worming had 95% (plant-type hypersensitive response = 1.95, 95%-NDUFB6 gene = 1.17, 3.23) and 74% (plant-type hypersensitive response = 1.74, 95%-NDUFB6 gene = 1.07, 2.83) more probability to recover from Systolic anterior movement of mitral valve as compared to those who didn't take them., METHODS: In this randomized, double-blind, placebo-controlled trial, we randomly assigned Malawian children, 6 to 59 months of age, with severe acute Malnutrition to receive amoxicillin, cefdinir, or placebo for 7 days in addition to ready-to-use therapeutic food for the outpatient treatment of uncomplicated severe acute Malnutrition. , In the amoxicillin, cefdinir, and placebo groups, 88.7%, 90.9%, and 85.1% of the children recovered, respectively (relative risk of treatment failure with placebo vs. amoxicillin, 1.32; 95% confidence interval [NDUFB6 gene], 1.04 to 1.68; relative risk with placebo vs. cefdinir, 1.64; 95% NDUFB6 gene, 1.27 to 2.11). The mortality rates for the three groups were 4.8%, 4.1%, and 7.4%, respectively (relative risk of death with placebo vs. amoxicillin, 1.55; 95% NDUFB6 gene, 1.07 to 2.24; relative risk with placebo vs. cefdinir, 1.80; 95% NDUFB6 gene, 1.22 to 2.64)., Evaluation of the routine use of amoxicillin as part of the home-based treatment of severe acute Malnutrition., OBJECTIVE: To determine whether the inclusion of amoxicillin correlates with better recovery rates in the home-based treatment of severe acute Malnutrition with ready-to-use therapeutic food., The standard protocol group received a 7-day course of amoxicillin at the onset of treatment., RESULTS: Four hundred and ninety-eight children were treated according to the standard protocol with amoxicillin, and 1955 were treated under the alternate protocol without Antifungal Antibiotics, Topical. , The recovery rate for children who received amoxicillin was worse at 4 weeks (40%vs. 71%) but similar after up to 12 weeks of therapy (84%vs. 86%), compared to the children treated without Antifungal Antibiotics, Topical., CONCLUSIONS: This review of two therapeutic feeding programmes suggests that children with severe acute Malnutrition who were treated without amoxicillin did not have an inferior rate of recovery., Treatment of severe Malnutrition with 2-day intramuscular ceftriaxone vs 5-day amoxicillin., To determine whether the inclusion of amoxicillin correlates with better recovery rates in the home-based treatment of severe acute Malnutrition with ready-to-use therapeutic food., Evaluation of the routine use of amoxicillin as part of the home-based treatment of severe acute Malnutrition, OBJECTIVE: To determine whether the inclusion of amoxicillin correlates with better recovery rates in the home-based treatment of severe acute Malnutrition with ready-to-use therapeutic food. METHODS: This retrospective cohort study compared data from the treatment of two groups of children in Malawi aged 6-59 months with uncomplicated severe acute Malnutrition. , The recovery rate for children who received amoxicillin was worse at 4 weeks (40%vs. 71%) but similar after up to 12 weeks of therapy (84%vs. 86%), compared to the children treated without Antifungal Antibiotics, Topical. Regression modelling indicated that this difference at 4 weeks was most strongly associated with the receipt of amoxicillin. CONCLUSIONS: This review of two therapeutic feeding programmes suggests that children with severe acute Malnutrition who were treated without amoxicillin did not have an inferior rate of recovery. , CONCLUSIONS: This review of two therapeutic feeding programmes suggests that children with severe acute Malnutrition who were treated without amoxicillin did not have an inferior rate of recovery. [SEP]Relations: Amoxicillin has relations: contraindication with bone fracture, contraindication with bone fracture, contraindication with liver disease, contraindication with liver disease, contraindication with osteoporosis, contraindication with osteoporosis, drug_drug with Ampicillin, drug_drug with Ampicillin, contraindication with kidney disease, contraindication with kidney disease. Definitions: Trimethoprim-Sulfamethoxazole Combination defined as following: A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.. Pneumonia defined as following: Infection of the lung often accompanied by inflammation.. ceftriaxone defined as following: A broad-spectrum cephalosporin antibiotic and cefotaxime derivative with a very long half-life and high penetrability to meninges, eyes and inner ears.. amoxicillin defined as following: A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration.. cefdinir defined as following: A third-generation oral cephalosporin antibacterial agent that is used to treat bacterial infections of the respiratory tract and skin.. Malnutrition defined as following: An imbalanced nutritional status resulting from insufficient intake of nutrients to meet normal physiological requirement.. plant-type hypersensitive response defined as following: The rapid, localized death of plant cells in response to invasion by a pathogen. [ISBN:0582227089].", "label": "yes"} {"original_question": "Can mitochondria pass through membrane nanotubes?", "id": "converted_3176", "sentence1": "Can Mitochondria pass through membrane nanotubes?", "sentence2": "Membrane nanotubes (MNTs) act as \"highways\" between Cells to facilitate the transfer of multiple signals and play an important role in many diseases. Our previous work reported on the transfer of Mitochondria via MNTs between Myocytes, Cardiac (Myasthenic Syndromes, Congenital) and cardiac myofibroblasts (Marfan Syndrome), Membrane nanotubes play important functional roles in numerous cell activities such as cellular transport and communication.[SEP]Relations: mitochondrion has relations: cellcomp_protein with POR, cellcomp_protein with POR, cellcomp_protein with SLIT3, cellcomp_protein with SLIT3, cellcomp_protein with BID, cellcomp_protein with BID, cellcomp_protein with TRAP1, cellcomp_protein with TRAP1, cellcomp_protein with PSMB4, cellcomp_protein with PSMB4. Definitions: Marfan Syndrome defined as following: An autosomal dominant disorder of CONNECTIVE TISSUE with abnormal features in the heart, the eye, and the skeleton. Cardiovascular manifestations include MITRAL VALVE PROLAPSE; AORTIC ANEURYSM; and AORTIC DISSECTION. Other features include lens displacement (ectopia lentis), disproportioned long limbs and enlarged DURA MATER (dural ectasia). Marfan syndrome (type 1) is associated with mutations in the gene encoding FIBRILLIN-1 (FBN1), a major element of extracellular microfibrils of connective tissue. Mutations in the gene encoding TYPE II TGF-BETA RECEPTOR (TGFBR2) are associated with Marfan syndrome type 2.. Mitochondria defined as following: Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all Cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the Cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed). Myasthenic Syndromes, Congenital defined as following: A heterogeneous group of disorders characterized by a congenital defect in neuromuscular transmission at the NEUROMUSCULAR JUNCTION. This includes presynaptic, synaptic, and postsynaptic disorders (that are not of autoimmune origin). The majority of these diseases are caused by mutations of various subunits of the nicotinic acetylcholine receptor (RECEPTORS, NICOTINIC) on the postsynaptic surface of the junction. (From Arch Neurol 1999 Feb;56(2):163-7). Myocytes, Cardiac defined as following: Striated muscle Cells found in the heart. They are derived from cardiac myoblasts (MYOBLASTS, CARDIAC).. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary..", "label": "yes"} {"original_question": "Does metformin has as an antitumor effect?", "id": "converted_3488", "sentence1": "Does metformin has as an Antitumor effect?", "sentence2": " an association between metformin and tumorigenesis, Metformin, an Antidiabetics, inhibits the Malignant neoplasm of endometrium cell growth in vivo by improving the insulin resistance;, There is no evidence of Antitumor effect of metformin. A possible decrease only for Breast, Abdomen>Liver and Malignant neoplasm of prostate, is compatible with random fluctuations., The anti-tumor effect of metformin is widely known, however, there is only limited evidence regarding the anti-angiogenesis effect and chemosensitization of metformin and its underlying mechanisms in ANOPHTHALMIA AND PULMONARY HYPOPLASIA[SEP]Relations: Metformin has relations: drug_effect with Lethargy, drug_effect with Lethargy, drug_effect with Nausea, drug_effect with Nausea, drug_effect with Vertigo, drug_effect with Vertigo, drug_effect with Headache, drug_effect with Headache, drug_effect with Hypothermia, drug_effect with Hypothermia. Definitions: metformin defined as following: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289). Malignant neoplasm of endometrium defined as following: Primary or metastatic malignant neoplasm involving the endometrium (mucous membrane that lines the endometrial cavity).. Breast defined as following: In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.. Malignant neoplasm of prostate defined as following: A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas.. Antidiabetics defined as following: Any substance used to reduce hyperglycemia or treat disorders associated with diabetes. Based on their mechanism of action, this class of agents can be classified to the following groups: directly acting insulomimetics, which activates insulin receptors; indirectly acting insulinomimetics, which increase insulin release such as sulfonylureas or which potentiate the effect of insulin such as metformin; those act directly on the metabolism of glucose such as inhibitors of glucosidases and inhibitors of aldose reductase.. ANOPHTHALMIA AND PULMONARY HYPOPLASIA defined as following: A rare clinical entity including as main characteristics anophthalmia or severe microphthalmia, and pulmonary hypoplasia or aplasia. Only five cases have been reported so far, two of who were siblings. In the three nonfamilial cases, unilateral pulmonary agenesis and microphthalmia were associated with diaphragmatic hernia and pulmonary vessel agenesis. It has been suggested that two different entities can be distinguished: on one hand, the association of anophthalmia-pulmonary hypoplasia with/without anomalies of the face, heart, spleen and uterus, which may be due to a putative autosomal recessive gene with pleiotropic effects; on the other hand, a sporadic association including pulmonary hypoplasia, anophthalmia, unilateral diaphragmatic defect and agenesis of the pulmonary trunk, which may represent the expression of a developmental field defect. There is evidence that syndromic microphthalmia- is caused by homozygous or compound heterozygous mutation in the STRA6 gene on chromosome 15q24..", "label": "yes"} {"original_question": "Is exonuclease Xrn1 a component of the P-bodies?", "id": "converted_321", "sentence1": "Is exonuclease Xrn1 a component of the P-bodies?", "sentence2": "Pencil Beam Scanning are associated with RNA, Messenger decay and contain the decapping ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS dipeptidyl carboxypeptidase dipeptidyl carboxypeptidase DCP1/2, the 5' to 3' exonuclease Xrn1, the Lsm Proteins (1-7), and the scaffolding Proteins hedls/GE-1 and TNRC6A gene. Both Shprintzen-Goldberg syndrome and Pencil Beam Scanning contain RNA, Messenger, Eukaryotic Initiation Factor-4E, MicroRNAs and Protein Argonaute-1 Proteins, and various regulators of RNA, Messenger stability and translation (Congenital Thrombotic Thrombocytopenic Purpura, RCK/p54, and CPEB)., An alternative pathway of RNA, Messenger degradation occurs at processing bodies, Cytoplasmic foci that contain decapping ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS, the 5'-3' exonuclease Xrn1 and the Lsm1-7 heptamer. , n Eukaryotic Cells degradation of bulk RNA, Messenger in the 5' to 3' direction requires the consecutive action of the decapping complex (consisting of dipeptidyl carboxypeptidase dipeptidyl carboxypeptidase DCP1 and DCP2 gene gene) and the 5' to 3' exonuclease XRN1 protein, Homo sapiens protein, Homo sapiens. These ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS are found in discrete Cytoplasmic foci known as P-bodies or GW-Bodies (because of the accumulation of the TNRC6A gene antigen)., Several Proteins that stimulate RNA, Messenger decapping by the Dcp1:Dcp2 complex co-localize with Dcp1 and Dcp2, together with Xrn1, a 5'-to-3' exonuclease, to structures in the Cytoplasm called processing bodies. , On the other hand, many Processing Bodies components including LSM1 gene gene, TNRC6A gene, DDX3X wt Allele, DDX6 gene gene and XRN1 protein, Homo sapiens protein, Homo sapiens, but not others like DCP1a and EDC4 gene gene are recruited to the viral replication sites, as evidenced by their colocalization at perinuclear region with viral NS3., We identified the Pab 1801 Cytoplasmic puncta as P Bodies (Pencil Beam Scanning), which are involved in RNA, Messenger regulation. We found that, in several Cultured Cell Line, including U2OS, WI38, SK-N-SH and HCT116, the Pab 1801 puncta strictly colocalize with Pencil Beam Scanning identified with specific Antibodies, in vitro diagnostic against the HTN3 gene components Hedls, DCP1A gene, Xrn1 or Rck/p54., The core components of P-bodies, including the decapping machinery (Dcp2 and Dhh1), 5'-3' Exoribonucleases (Kem1/Xrn1), and the Processing Bodies scaffolding protein (Edc3), were identified and their localizations with respect to P-bodies were demonstrated., The second type of Granules dose form, piP-bodies, harbors the MIWI2-TDRD9-MAEL module of the piRNA pathway and signature components of P-bodies, TNRC6A gene, DCP1a, DDX6 gene gene/p54, and XRN1 protein, Homo sapiens protein, Homo sapiens Proteins., In Saccharomyces cerevisiae and Homo sapiens tissue culture Cells, Xrn1 has been shown to be a component of P-bodies (processing bodies), dynamic Cytoplasmic Granules dose form where RNA degradation can take place., Here, we show that staufen- and FMRP-containing RNPs in Drosophila neurons contain Proteins also present in somatic \"P bodies,\" including the RNA-degradative ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS Dcp1p and Xrn1p/Pacman and crucial components of miRNA (Protein Argonaute-1), Nonsense Mediated RNA, Messenger Decay (Upf1p), and general translational repression (Dhh1p/Me31B) pathways., In Eukaryotic Cells, XRN1 protein, Homo sapiens protein, Homo sapiens is often found in particles known as processing bodies (P bodies) together with other Proteins involved in the 5' → 3' degradation pathway, such as DCP2 gene gene and the helicase DHH1 (Me31B). , In Saccharomyces cerevisiae and Homo sapiens tissue culture Cells, Xrn1 has been shown to be a component of P-bodies (processing bodies), dynamic Cytoplasmic Granules dose form where RNA degradation can take place, Owing to the essential functions of P bodies in RNA, Messenger regulation, we explored computationally the functional significance of Single Nucleotide Polymorphism in 7 P body components such as XRN1 protein, Homo sapiens protein, Homo sapiens, DCP2 gene gene, EDC3 gene gene, CPEB1 gene gene, GEMIN5 gene gene, STAU1 gene gene and TRIM71 gene gene, The core components of P-bodies, including the decapping machinery (Dcp2 and Dhh1), 5'-3' Exoribonucleases (Kem1/Xrn1), and the Processing Bodies scaffolding protein (Edc3), were identified and their localizations with respect to P-bodies were demonstrated, Here, we show that staufen- and FMRP-containing RNPs in Drosophila neurons contain Proteins also present in somatic "P bodies," including the RNA-degradative ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS Dcp1p and Xrn1p/Pacman and crucial components of miRNA (Protein Argonaute-1), Nonsense Mediated RNA, Messenger Decay (Upf1p), and general translational repression (Dhh1p/Me31B) pathways, Processing Bodies components LSM1 gene gene, TNRC6A gene, DDX3X wt Allele, DDX6 gene gene and XRN1 protein, Homo sapiens protein, Homo sapiens are recruited to WNV replication sites and positively regulate viral replication., The core components of P-bodies, including the decapping machinery (Dcp2 and Dhh1), 5'-3' Exoribonucleases (Kem1/Xrn1), and the Processing Bodies scaffolding protein (Edc3), were identified and their localizations with respect to P-bodies were demonstrated. Various growth conditions, including glucose deprivation, hyperosmotic stress, and heat stress, stimulated the accumulation of P-bodies., Here we show that microscopically visible P-bodies are greatly diminished following West Nile viral Communicable Diseases, but the component Proteins are not depleted. On the other hand, many Processing Bodies components including LSM1 gene gene, TNRC6A gene, DDX3X wt Allele, DDX6 gene gene and XRN1 protein, Homo sapiens protein, Homo sapiens, but not others like DCP1a and EDC4 gene gene are recruited to the viral replication sites, as evidenced by their colocalization at perinuclear region with viral NS3., Owing to the essential functions of P bodies in RNA, Messenger regulation, we explored computationally the functional significance of Single Nucleotide Polymorphism in 7 P body components such as XRN1 protein, Homo sapiens protein, Homo sapiens, DCP2 gene gene, EDC3 gene gene, CPEB1 gene gene, GEMIN5 gene gene, STAU1 gene gene and TRIM71 gene gene. Computational analyses of non-synonymous Single Nucleotide Polymorphism of these components was initiated using well utilized publicly available software programs such as the SIFT, followed by PolyPhen, Panthers, MutPred, I-Mutant-2., Xrn1 has been shown to be a component of P-bodies (processing bodies),, Here, we show that DIS3-Like Exonuclease 2 is an exosome-independent Cytoplasmic RNA, Messenger 3'-5' exonuclease, which exhibits processive activity on structured RNA substrates in vitro. DIS3-Like Exonuclease 2 associates with hXRN1 in an RNA-dependent manner and can, like hXRN1, be found on Set of polysomal ribosomes, Inhibition of TAK1-JNK signaling also affected the number and size of P bodies and the localization of DCP1a, Xrn1, and Edc4., The organizing mechanism that forms P body foci in Cells is unknown; however, potential scaffolding, aggregating, or other regulatory Proteins found in P bodies were investigated for degradation. Two factors involved in 5'-end RNA, Messenger decapping and degradation, Xrn1 and DCP1A gene, and the 3' deadenylase complex component NLRP6 wt Allele underwent accelerated degradation during Communicable Diseases, and DCP1A gene may be a direct substrate of PV 3C proteinase., Secondly, P-bodies recruit mRNAs that are targeted for deadenylation and degradation by the decapping/Xrn1 pathway. , Depletion of TRN increased the number of P-bodies and stabilized ARE-containing mRNAs, as observed with knockdown of the 5'-3' exonuclease Xrn1., In this paper we show for the first time that Pacman, the Drosophila homologue of Xrn1, is localized in Cytoplasmic particles in Drosophila testis Cells. , Depletion of TRN increased the number of P-bodies and stabilized ARE-containing mRNAs, as observed with knockdown of the 5'-3' exonuclease Xrn1, These structures stain positively for a number of Processing Bodies and microRNP components, a microRNA-repressed RNA, Messenger and some translational repressors. They appear more heterogeneous than P-bodies of HeLa Cells, and they rarely contain the exonuclease Xrn1 but are positive for Ribosomal RNA.[SEP]Relations: 5'-3' Exoribonucleases activity has relations: molfunc_protein with XRN1 protein, Homo sapiens, molfunc_protein with XRN1 protein, Homo sapiens, molfunc_protein with XRN2, molfunc_protein with XRN2, molfunc_protein with DCP2 gene, molfunc_protein with DCP2 gene. EDC3 gene has relations: bioprocess_protein with Processing Bodies assembly, bioprocess_protein with Processing Bodies assembly. CPEB1 gene has relations: cellcomp_protein with Processing Bodies, cellcomp_protein with Processing Bodies. Definitions: XRN1 protein, Homo sapiens defined as following: 5'-3' Exoribonucleases 1 (1706 aa, ~194 kDa) is encoded by the Homo sapiens XRN1 protein, Homo sapiens gene. This protein plays a role in ribonucleotide metabolism.. Saccharomyces cerevisiae defined as following: A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" Saccharomyces cerevisiae. The dried form is used as a dietary supplement.. Nonsense Mediated RNA, Messenger Decay defined as following: The nonsense-mediated decay pathway for nuclear-transcribed mRNAs degrades mRNAs in which an amino-acid codon has changed to a nonsense codon; this prevents the translation of such mRNAs into truncated, and potentially harmful, Proteins. [GOC:krc, GOC:ma, PMID:10025395]. Processing Bodies defined as following: A focus in the Cytoplasm where mRNAs may become inactivated by decapping or some other mechanism. Protein and RNA localized to these foci are involved in RNA, Messenger degradation, nonsense-mediated RNA, Messenger decay (Nonsense Mediated RNA, Messenger Decay), translational repression, and RNA-mediated gene silencing. [GOC:clt, PMID:12730603]. HeLa Cells defined as following: The first continuously cultured Homo sapiens malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These Cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays.. Protein Argonaute-1 defined as following: Protein Protein Argonaute-1-1 (857 aa, ~97 kDa) is encoded by the Homo sapiens AGO1 gene. This protein is involved in RNA-mediated gene silencing.. DDX6 gene defined as following: This gene plays a role in the translation of RNA, Messenger encoded by genes involved in cell proliferation and malignant transformation.. Pencil Beam Scanning defined as following: A precise form of proton therapy that uses an electronically guided scanning system and magnets to deliver a proton beam that is millimeters wide. With this system, beam position and depth can be controlled, allowing for highly precise deposition of radiation to be delivered in all three dimensions of the tumor.. Protein Argonaute-1 Proteins defined as following: A protein family that is comprised of the catalytic components of the RNA-induced silencing complex.. Ribosomal RNA defined as following: The most abundant form of RNA. Together with Proteins, it forms the ribosomes, playing a structural role and also a role in ribosomal binding of RNA, Messenger and tRNAs. Individual chains are conventionally designated by their sedimentation coefficients. In eukaryotes, four large chains exist, synthesized in the nucleolus and constituting about 50% of the ribosome. (Dorland, 28th ed). Congenital Thrombotic Thrombocytopenic Purpura defined as following: Thrombotic thrombocytopenic purpura for which the cause is present from birth.. RNA, Messenger defined as following: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the nucleus and must be exported to the Cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the Cytoplasm.. NLRP6 wt Allele defined as following: Human NLRP6 wild-type allele is located in the vicinity of 11p15 and is approximately 7 kb in length. This allele, which encodes NACHT, LRR and PYD domains-containing protein 6, may play a role in the inflammatory response.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Eukaryotic Initiation Factor-4E defined as following: A peptide initiation factor that binds specifically to the 5' MRNA CAP STRUCTURE of MRNA in the CYTOPLASM. It is a component of the trimeric complex EIF4F.. Eukaryotic Cells defined as following: Cells of the higher organisms, containing a true nucleus bounded by a nuclear membrane.. Cytoplasm defined as following: The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990). Granules dose form defined as following: A solid composed of small particles or grains.. Shprintzen-Goldberg syndrome defined as following: A rare, autosomal dominant inherited syndrome often caused by mutations in the SKI gene. It is characterized by premature fusion of skull bones and distinctive facial features, including a long, narrow head, hypertelorism, exophthalmos, downslanting palpebral fissures, a high, narrow palate, micrognathia, and low-set ears. The bodies of affected individuals resemble those of people with Marfan syndrome.. GW-Bodies defined as following: A ribonucleoprotein granule located in the Cytoplasm and the nucleus. GW-Bodies minimally contain the Argonaute2 (Ago2) and TNRC6B Proteins, together with specific target RNAs. [PMID:16418578, PMID:26930655, PMID:29576456]. DDX3X wt Allele defined as following: Human DDX3X wild-type allele is located within Xp11.3-p11.23 and is approximately 31 kb in length. This allele, which encodes ATP-dependent RNA helicase DDX3X protein, plays a role in the modulation of RNA structure.. Cultured Cell Line defined as following: Established cell cultures that have the potential to propagate indefinitely.. Exoribonucleases defined as following: A family of ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS that catalyze the exonucleolytic cleavage of RNA. It includes EC 3.1.13.-, EC 3.1.14.-, EC 3.1.15.-, and EC 3.1.16.-. EC 3.1.-. MicroRNAs defined as following: Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing.. 5'-3' Exoribonucleases defined as following: 5'-3' Exoribonucleases 2 (950 aa, ~109 kDa) is encoded by the Homo sapiens XRN2 gene. This protein is involved in the mediation of RNA metabolism.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of Cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Single Nucleotide Polymorphism defined as following: A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or Homo sapiens host.. regulatory Proteins defined as following: Encoded by Regulatory Genes, Regulatory Proteins regulate or circumscribe the activity of many cellular functions.. Homo sapiens defined as following: Members of the species Homo sapiens.. Set of polysomal ribosomes defined as following: A ribosome bound to RNA, Messenger that forms part of a polysome. [GOC:jl]. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. DIS3-Like Exonuclease 2 defined as following: DIS3-like exonuclease 2 (885 aa, ~99 kDa) is encoded by the Homo sapiens DIS3L2 gene. This protein is involved in 3'-5'-Exoribonucleases-mediated catabolism of polyuridylated RNA.. P-bodies defined as following: A focus in the Cytoplasm where mRNAs may become inactivated by decapping or some other mechanism. Protein and RNA localized to these foci are involved in RNA, Messenger degradation, nonsense-mediated RNA, Messenger decay (Nonsense Mediated RNA, Messenger Decay), translational repression, and RNA-mediated gene silencing. [GOC:clt, PMID:12730603]. exonuclease defined as following: This gene plays a role in DNA metabolic processes during stromal differentiation.. Xrn1 defined as following: 5'-3' Exoribonucleases 1 (1706 aa, ~194 kDa) is encoded by the Homo sapiens XRN1 protein, Homo sapiens gene. This protein plays a role in ribonucleotide metabolism..", "label": "yes"} {"original_question": "Is aganglionic megacolon a feature of Down syndrome?", "id": "converted_1475", "sentence1": "Is aganglionic megacolon a feature of Down Syndrome?", "sentence2": "Down Syndrome (DS) is recognized by characteristic facial features, Intellectual Disability, and an increased risk for Cardiac malformations and Duodenal atresia. Recently, HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 (HSCR), or congenital aganglionic megacolon, has been seen more often among patients with DS, Of the 17 patients with Hodgkin Disease who were studied, 10 were isolated (58.8%) and seven (41.1%) were associated to other structural abnormalities and No No psychomotor retardation. Three of the cases in this latter group were due to chromosome pathology (trisomy 21, Down Syndrome), The authors report the case of a female infant with Down Syndrome, aganglionic megacolon, severe Diarrhea, and Biopsy of jejunum with ultrastructural changes consistent with microvillous atrophy. The patient condition improved after a colostomy performed in the setting of the treatment of Hirschprung disease, HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1, or congenital aganglionic megacolon, is commonly assumed to be a sex-modified multifactorial trait. To test this hypothesis, complex segregation analysis was performed on data on 487 probands and their families. Demographic information on probands and the recurrence risk to relatives of probands are presented. An increased sex ratio (3.9 male:female) and an elevated risk to sibs (4%), as compared with the population incidence (0.02%), are observed, with the sex ratio decreasing and the recurrence risk to sibs increasing as the Hirschsprung Disease becomes more extensive. Down Syndrome was found at an increased frequency among affected individuals but not among their unaffected sibs, and the increase was not associated with maternal age, Intestinal microvillous atrophy in a patient with Down Syndrome and aganglionic megacolon., The authors report the case of a female infant with Down Syndrome, aganglionic megacolon, severe Diarrhea, and Biopsy of jejunum with ultrastructural changes consistent with microvillous atrophy., The authors report the case of a female infant with Down Syndrome, aganglionic megacolon, severe Diarrhea, and Biopsy of jejunum with ultrastructural changes consistent with microvillous atrophy., The authors report the case of a female infant with Down Syndrome, aganglionic megacolon, severe Diarrhea, and Biopsy of jejunum with ultrastructural changes consistent with microvillous atrophy[SEP]Relations: Down Syndrome has relations: disease_phenotype_positive with Aganglionic megacolon, disease_phenotype_positive with Aganglionic megacolon, disease_phenotype_positive with Hypoplastic iliac wing, disease_phenotype_positive with Hypoplastic iliac wing, disease_protein with STAG2, disease_protein with STAG2. HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 has relations: disease_phenotype_positive with Aganglionic megacolon, disease_phenotype_positive with Aganglionic megacolon. hirschsprung disease, susceptibility to has relations: disease_phenotype_positive with Aganglionic megacolon, disease_phenotype_positive with Aganglionic megacolon. Definitions: Hodgkin Disease defined as following: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.. Diarrhea defined as following: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.. Hirschsprung Disease defined as following: Congenital MEGACOLON resulting from the absence of ganglion cells (Hirschsprung Disease) in a distal segment of the LARGE INTESTINE. The aganglionic segment is permanently contracted thus causing dilatation proximal to it. In most cases, the aganglionic segment is within the RECTUM and SIGMOID COLON.. Down Syndrome defined as following: A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213). Duodenal atresia defined as following: A congenital malformation characterized by the absence of a normal opening in a part of the duodenum.. Biopsy of jejunum defined as following: Removal of tissue from the jujunum for microscopic examination, using an endoscope.. Intellectual Disability defined as following: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an Intellectual Disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28).", "label": "yes"} {"original_question": "Is endotrophin derived from collagen?", "id": "converted_3248", "sentence1": "Is COL6A3 protein, human derived from collagen?", "sentence2": "Collagen Alpha-3(VI) Chain protein, human production from Collagen Type IV, High levels of Collagen Alpha-3(VI) Chain and its cleaved product, Collagen Alpha-3(VI) Chain protein, human (ETP), Endotrophin is released from COL VI[SEP]Relations: collagen type IV trimer has relations: cellcomp_protein with OTOL1, cellcomp_protein with OTOL1, cellcomp_protein with COL4A1, cellcomp_protein with COL4A1, cellcomp_protein with COL4A5, cellcomp_protein with COL4A5, cellcomp_protein with COL4A3, cellcomp_protein with COL4A3, cellcomp_protein with COL4A2, cellcomp_protein with COL4A2. Definitions: Collagen Alpha-3(VI) Chain defined as following: Collagen alpha-3(VI) chain (3177 aa, ~344 kDa) is encoded by the human Collagen Alpha-3(VI) Chain gene. This protein plays a role in extracellular matrix formation and cell-matrix adhesion in connective tissues.. COL6A3 protein, human defined as following: Endotrophin is encoded by the human Collagen Alpha-3(VI) Chain gene. This protein is involved in macrophage infiltration, fibrosis and epithelial-mesenchymal transition.. Collagen Type IV defined as following: A non-fibrillar collagen found in the structure of BASEMENT MEMBRANE. Collagen type IV molecules assemble to form a sheet-like network which is involved in maintaining the structural integrity of basement membranes. The predominant form of the protein is comprised of two alpha1(IV) subunits and one alpha2(IV) subunit, however, at least six different alpha subunits can be incorporated into the heterotrimer.. collagen defined as following: A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH)..", "label": "yes"} {"original_question": "Are Spinal Intradural Primary Malignant Peripheral Nerve Sheath Tumors(MPNST) rare in neurofibromatosis patients?", "id": "converted_3337", "sentence1": "Are Spinal Intradural Primary Malignant Peripheral Nerve Sheath Tumors(Malignant Peripheral Nerve Sheath Tumor) rare in NF1 gene patients?", "sentence2": "Spinal intradural primary malignant peripheral nerve sheath tumors (Malignant Peripheral Nerve Sheath Tumor) are rare in patients without NF1 gene., Primary malignant peripheral nerve sheath tumors (MPNSTs) are extremely rare in patients without a history of NF1 gene; only 18 cases have been reported in the English-language literature to this point.[SEP]Relations: malignant peripheral nerve sheath tumor has relations: disease_disease with tumor of cranial and spinal nerves, disease_disease with tumor of cranial and spinal nerves, disease_disease with peripheral nervous system cancer, disease_disease with peripheral nervous system cancer, disease_disease with nerve sheath neoplasm, disease_disease with nerve sheath neoplasm, disease_disease with malignant melanocytic neoplasm of the peripheral nerve sheath, disease_disease with malignant melanocytic neoplasm of the peripheral nerve sheath, disease_disease with malignant glandular tumor of peripheral nerve sheath, disease_disease with malignant glandular tumor of peripheral nerve sheath. Definitions: Malignant Peripheral Nerve Sheath Tumor defined as following: A malignant neurilemmoma with nerve sheath differentiation. It is often associated with NEUROFIBROMATOSIS 1 and RHABDOMYOSARCOMA.. NF1 gene defined as following: Tumor suppressor genes located on the long arm of human chromosome 17 in the region 17q11.2. Mutation of these genes is thought to cause NEUROFIBROMATOSIS 1, Watson syndrome, and LEOPARD syndrome..", "label": "no"} {"original_question": "Is metoprolol metabolized by CYP2D6?", "id": "converted_4157", "sentence1": "Is metoprolol metabolized by Cytochrome P450 2D6, human?", "sentence2": "Among these beta-blockers atenolol is mainly eliminated by renal excretion, bisoprolol is in part excreted as parent compound via the renal route (50%), the other 50% are hepatically metabolised, whereas metoprolol and carvedilol are metabolised by Cytochrome P450 2D6, human. [SEP]Relations: Metoprolol has relations: drug_protein with Cytochrome P450 2D6, human, drug_protein with Cytochrome P450 2D6, human, drug_protein with CYP3A4, drug_protein with CYP3A4, drug_protein with ADRB2, drug_protein with ADRB2, drug_drug with NN344, drug_drug with NN344, drug_drug with Cyproterone acetate, drug_drug with Cyproterone acetate. Definitions: carvedilol defined as following: A carbazole and propanol derivative that acts as a non-cardioselective beta blocker and vasodilator. It has blocking activity for ALPHA 1 ADRENERGIC RECEPTORS and, at higher doses, may function as a blocker of CALCIUM CHANNELS; it also has antioxidant properties. Carvedilol is used in the treatment of HYPERTENSION; ANGINA PECTORIS; and HEART FAILURE. It can also reduce the risk of death following MYOCARDIAL INFARCTION.. metoprolol defined as following: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.. bisoprolol defined as following: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.. Cytochrome P450 2D6, human defined as following: Cytochrome P450 2D6 (497 aa, ~56 kDa) is encoded by the human Cytochrome P450 2D6, human gene. This protein plays a role in flavoprotein metabolism..", "label": "yes"} {"original_question": "Are there ways of joint Bayesian inference of risk variants?", "id": "converted_2559", "sentence1": "Are there ways of joint Bayesian inference of risk Variant?", "sentence2": "Joint Bayesian inference of risk Variant and tissue-specific epigenomic enrichments across multiple complex Homo sapiens diseases., Genome wide association studies (GWAS) provide a powerful approach for uncovering disease-associated Variant in Homo sapiens, but fine-mapping the causal Variant remains a challenge. This is partly remedied by prioritization of disease-associated Variant that overlap GWAS-enriched epigenomic annotations. Here, we introduce a new Bayesian model RiVIERA (Risk Variant Inference using Epigenomic Reference Annotations) for inference of driver Variant from summary statistics across multiple traits using hundreds of epigenomic annotations. In simulation, RiVIERA promising power in detecting causal Variant and causal annotations, the multi-trait joint inference further improved the detection power. We applied RiVIERA to model the existing GWAS summary statistics of 9 Autoimmune Diseases and SCHIZOPHRENIA 2 (disorder) by jointly harnessing the potential causal enrichments among 848 tissue-specific epigenomics annotations from ENCODE/Roadmap consortium covering 127 cell/tissue types and 8 major epigenomic marks. RiVIERA identified meaningful tissue-specific enrichments for enhancer regions defined by Histone H3 Methyl Lys4 and H3K27ac for Blood T-Cell specifically in the nine Autoimmune Diseases and Brain-specific enhancer activities exclusively in SCHIZOPHRENIA 2 (disorder). Moreover, the Variant from the 95% credible sets exhibited high Conservation and enrichments for Genotype-Tissue Expression Program whole-blood eQTLs located within transcription-factor-binding-sites and DNA-hypersensitive-sites., Here, we introduce a new Bayesian model RiVIERA (Risk Variant Inference using Epigenomic Reference Annotations) for inference of driver Variant from summary statistics across multiple traits using hundreds of epigenomic annotations., Joint Bayesian inference of risk Variant and tissue-specific epigenomic enrichments across multiple complex Homo sapiens diseases.[SEP]Relations: autoimmune disease has relations: disease_disease with euthyroid Graves orbitopathy, disease_disease with euthyroid Graves orbitopathy, disease_disease with vitiligo-associated multiple autoimmune disease susceptibility 1, disease_disease with vitiligo-associated multiple autoimmune disease susceptibility 1. gene expression has relations: bioprocess_protein with IKBKE, bioprocess_protein with IKBKE. schizophreniform disorder has relations: contraindication with Betamethasone, contraindication with Betamethasone, contraindication with Hydrocortisone, contraindication with Hydrocortisone. Definitions: Variant defined as following: An alteration or difference from a norm or standard.. Conservation defined as following: The maintenance of certain characteristics in an unchanged condition.. Homo sapiens defined as following: Members of the species Homo sapiens.. Autoimmune Diseases defined as following: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.. Histone H3 Methyl Lys4 defined as following: A form of histone H3 where the lysine residue at position 4 has been post-translationally modified with a single methyl group. This modification may be a marker for transcriptionally active genes.. Genotype-Tissue Expression Program defined as following: A program sponsored by the National Institutes of Health's Common Fund, designed to provide insights into the mechanisms of gene regulation by studying Homo sapiens gene expression and regulation in multiple tissues from healthy individuals, exploring disease-related perturbations in a variety of Homo sapiens diseases, and examining sexual dimorphisms in gene expression and regulation in multiple tissues. Genetic variation between individuals will be examined for correlation with differences in gene expression level to identify regions of the genome that influence whether and how much a gene is expressed..", "label": "yes"} {"original_question": "Are reduced-nicotine cigarettes effective for smoking cessation?", "id": "converted_281", "sentence1": "Are reduced-nicotine cigarettes effective for Location characteristic ID - Smoking cessation?", "sentence2": "CONCLUSIONS: In this 6-week study, reduced-nicotine cigarettes versus standard-nicotine cigarettes reduced nicotine exposure and dependence and the number of cigarettes smoked. , RESULTS: Significant reductions in nicotine intake were observed between usual brand Location characteristic ID - Smoking (∼1.2 mg nicotine) and the 0.3 and 0.05 mg nicotine emission cigarettes, but not the 0.6 mg cigarette., CONCLUSIONS: The study adds to the evidence that cigarettes with markedly reduced nicotine content are not associated with increased Location characteristic ID - Smoking intensity or exposure to Tobacco Tobacco smoke toxicants., BACKGROUND: When switching from usual brand cigarettes, very low nicotine content (VLNC) cigarettes lead to a reduction in the number of cigarettes smoked, toxicant exposure, withdrawal symptoms and dependence. , Moreover, while nicotine patches were well tolerated when subjects smoked nicotine-containing cigarettes, the use of nicotine skin patches with reduced-nicotine cigarettes potentially offers the advantage of increased efficacy without introducing concern about toxic effects of excessive nicotine intake., Results showed that Quest plus Nicotine replacement therapy was more effective than active control plus Nicotine replacement therapy in achieving 4 weeks of continuous abstinence (32.8% vs. 21.9%)., Quest plus Nicotine replacement therapy offers promise as a new Location characteristic ID - Smoking cessation treatment., We identified three clinical trials (total n = 489) that suggest that smokers can dissociate nicotine delivery from the act of Location characteristic ID - Smoking if they use reduced-nicotine content cigarettes in combination with nicotine replacement therapy., CONCLUSION: The 0.05 mg nicotine yield cigarettes may be a Tobacco use type:Type:Point in time:^Patient:Nominal that can facilitate cessation; however, future research is clearly needed to support these preliminary findings., Preliminary studies suggest an extinction-based Location characteristic ID - Smoking cessation treatment using reduced nicotine content (RNC) cigarettes decreases self-report craving for cigarettes prior to quitting and may be an effective Location characteristic ID - Smoking cessation treatment., Reduced nicotine content (RNC) cigarettes have led to Location characteristic ID - Smoking fewer cigarettes, withdrawal relief, and facilitation of cessation., Evidence from a number of small Location characteristic ID - Smoking cessation studies suggests that the use of cigarettes with reduced nicotine content, in combination with nicotine replacement therapy (Nicotine replacement therapy), may help reduce withdrawal symptoms and increase quit rates., The concept for a reduced-nicotine cigarette designed to progressively wean smokers from the Location characteristic ID - Smoking habit is based on research demonstrating that successful Location characteristic ID - Smoking cessation is not only dependent on withdrawal of nicotine, but also on weaning from the habitual sensory and behavioral reinforcement of Location characteristic ID - Smoking., Preliminary studies suggest an extinction-based Location characteristic ID - Smoking cessation treatment using reduced nicotine content (RNC) cigarettes decreases self-report craving for cigarettes prior to quitting and may be an effective Location characteristic ID - Smoking cessation treatment, Specifically, standards that required substantially reduced nicotine content in cigarettes could enable cessation in smokers and prevent future Location characteristic ID - Smoking among current non-smokers, Reduced nicotine content (RNC) cigarettes have led to Location characteristic ID - Smoking fewer cigarettes, withdrawal relief, and facilitation of cessation, Evidence from a number of small Location characteristic ID - Smoking cessation studies suggests that the use of cigarettes with reduced nicotine content, in combination with nicotine replacement therapy (Nicotine replacement therapy), may help reduce withdrawal symptoms and increase quit rates, The concept for a reduced-nicotine cigarette designed to progressively wean smokers from the Location characteristic ID - Smoking habit is based on research demonstrating that successful Location characteristic ID - Smoking cessation is not only dependent on withdrawal of nicotine, but also on weaning from the habitual sensory and behavioral reinforcement of Location characteristic ID - Smoking, These results suggest that use of Nicotine replacement therapy before a target quit-Location characteristic ID - Smoking date deserves further evaluation as a possible Location characteristic ID - Smoking cessation treatment. Moreover, while nicotine patches were well tolerated when subjects smoked nicotine-containing cigarettes, the use of nicotine skin patches with reduced-nicotine cigarettes potentially offers the advantage of increased efficacy without introducing concern about toxic effects of excessive nicotine intake., Preliminary studies suggest an extinction-based Location characteristic ID - Smoking cessation treatment using reduced nicotine content (RNC) cigarettes decreases self-report craving for cigarettes prior to quitting and may be an effective Location characteristic ID - Smoking cessation treatment.[SEP]Relations: Nicotine has relations: drug_effect with Cough, drug_effect with Cough, drug_effect with Arthritis, drug_effect with Arthritis, drug_effect with Respiratory failure, drug_effect with Respiratory failure, drug_drug with Cenobamate, drug_drug with Cenobamate, drug_effect with Headache, drug_effect with Headache. Definitions: nicotine defined as following: Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco Tobacco smoke.. Tobacco smoke defined as following: Smoke from burning tobacco (cigarettes, cigars, or pipes) and exhaled by a smoker. Tobacco Tobacco smoke contains nicotine, a stimulant, and other biologically active chemicals having carcinogenic properties.. Nicotine replacement therapy defined as following: Therapy to help control nicotine withdrawal symptoms during tobacco cessation.", "label": "yes"} {"original_question": "Do cephalopods use RNA editing less frequently than other species?", "id": "converted_2307", "sentence1": "Do Cephalopoda use RNA Editing less frequently than other species?", "sentence2": "Extensive messenger RNA Editing generates transcript and Protein Info diversity in Genes involved in Neural excitability, as previously described, as well as in Genes participating in a broad range of other cellular functions, By adopting a method originally designed to detect linkage disequilibrium of DNA mutations, we examined the editomes of ten metazoan species and detected extensive linkage of editing in Drosophila and Cephalopoda., We here show that RNA Editing is particularly common in behaviorally sophisticated coleoid Cephalopoda, with tens of thousands of evolutionarily conserved sites., Even for the subset of RNA Editing sites shared by deeply divergent cephalopod lineages, the primary effect of nuclear editing is an increase-not a decrease-in Protein Info divergence., Coleoid Cephalopoda (octopus, Superconducting Quantum Interference Device and Cuttlefish, Dietary) are active, resourceful predators with a rich behavioural repertoire., We identified hundreds of cephalopod-specific Genes, many of which showed elevated expression levels in such specialized structures as the Skin Specimen Source Code, the Suction Tips and the nervous system., Our analysis suggests that substantial expansion of a handful of gene families, along with extensive remodelling of Genome - anatomical entity linkage and repetitive content, played a critical role in the evolution of cephalopod morphological innovations, including their large and complex nervous systems.[SEP]Relations: Protein C has relations: drug_drug with Cephaloglycin, drug_drug with Cephaloglycin, drug_drug with Cephalexin, drug_drug with Cephalexin, drug_drug with Cefamandole, drug_drug with Cefamandole, drug_drug with Cefmetazole, drug_drug with Cefmetazole, drug_drug with Cefamandole nafate, drug_drug with Cefamandole nafate. Definitions: Genome - anatomical entity defined as following: Anatomical set of Genes in all the chromosomes.. Superconducting Quantum Interference Device defined as following: A device designed to measure extremely weak magnetic fields. It is comprised of a Josephson junction with two superconducting loops separated by an insulating layer thin enough to allow electrons to pass through.. RNA Editing defined as following: A process that changes the nucleotide sequence of mRNA from that of the DNA template encoding it. Some major classes of RNA Editing are as follows: 1, the conversion of cytosine to uracil in mRNA; 2, the addition of variable number of guanines at pre-determined sites; and 3, the addition and deletion of uracils, templated by guide-RNAs (RNA, GUIDE, KINETOPLASTIDA).. Neural defined as following: Of or relating to neurons or the nervous system.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. Cephalopoda defined as following: A class in the phylum MOLLUSCA comprised of SQUID; CUTTLEFISH; OCTOPUS; and NAUTILUS. These marine animals are the most highly organized of all the mollusks.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Suction Tips defined as following: Devices designed for the rapid removal of bulk matter (e.g., vomitus, mucus, debris) from natural or surgical cavities. These tips are usually transparent, short, wide, rigid tubes (either straight or bent) with an integral handle for easy manipulation; the tip is attached to the distal end of suction hoses or tubes that are in turn connected to high-level suction aspirators. Suction tips are used mainly in the upper respiratory tract (nasal cavity and pharynx) and during surgical procedures when suctioning speed rather than control is needed; both reusable and plastic tips are available. Dedicated suction tips are also available for particular procedures performed in the ear, nose, pharynx, and other natural or surgically created cavities. Other hollow-shaft devices such as suction tubes with integral tips, cannulae, curettes, and catheters are also used for suctioning when attached to appropriate aspirators..", "label": "no"} {"original_question": "Does AZD3759 cross the blood brain barrier?", "id": "converted_4203", "sentence1": "Does AZD3759 cross the blood brain barrier?", "sentence2": "AZD3759, an Epidermal Growth Factor Receptor tyrosine kinase inhibitors (TKIs) with excellent Blood - brain barrier function (BBB) penetration,, AZD3759, a BBB-penetrating Epidermal Growth Factor Receptor PPP1R1A gene for the treatment of Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Carcinoma with Central Nervous System metastases, We report the discovery and early clinical development of AZD3759, a selective Epidermal Growth Factor Receptor PPP1R1A gene that can fully penetrate the Blood - brain barrier function (BBB),, AZD3759 is a novel Epidermal Growth Factor Receptor tyrosine kinase PPP1R1A gene with high capability to penetrate the Blood - brain barrier function. , We report the discovery and early clinical development of AZD3759, a selective Epidermal Growth Factor Receptor PPP1R1A gene that can fully penetrate the Blood - brain barrier function (BBB), with equal free concentrations in the blood, Cerebrospinal Fluid, and brain tissue surgical material surgical material., Another promising class of Epidermal Growth Factor Receptor TKI such as AZD3759 has been designed to penetrate blood brain barrier to treat brain metastases and leptomeningeal disease and has showed promising responses in patients with brain metastases., AZD3759 is a novel Epidermal Growth Factor Receptor tyrosine kinase PPP1R1A gene with high capability to penetrate the Blood - brain barrier function., In our study, we demonstrated that AZD3759, an Epidermal Growth Factor Receptor tyrosine kinase inhibitors (TKIs) with excellent Blood - brain barrier function (BBB) penetration, combined with radiation enhanced the antitumor efficacy in Defecation model from Epidermal Growth Factor Receptor Mutant (EGFRm) Non-Small Cell Lung Carcinoma., sing class of Epidermal Growth Factor Receptor TKI such as AZD3759 has been designed to penetrate blood brain barrier to treat brain metastases and leptomeningeal disease and has showed promising responses in patients with brain metastases. Acquired re, discovery and early clinical development of AZD3759, a selective Epidermal Growth Factor Receptor PPP1R1A gene that can fully penetrate the Blood - brain barrier function (BBB), with equal free concentrations in the blood, Cerebrospinal Fluid, and brain tissue surgical material surgical material. Treatment with A, AZD3759, a BBB-penetrating Epidermal Growth Factor Receptor PPP1R1A gene for the treatment of Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Carcinoma with Central Nervous System metastases., our study, we demonstrated that AZD3759, an Epidermal Growth Factor Receptor tyrosine kinase inhibitors (TKIs) with excellent Blood - brain barrier function (BBB) penetration, combined with radiation enhanced the antitumor efficacy in Defecation model from Epidermal Growth Factor Receptor Mutant (EGFRm) Non-Small Cell Lung Carcinoma. Besides, t, in patients with Defecation and Rare lymphatic malformation treated with AZD3759 confirms its BBB-penetrant properties and antitumor activities. Our data demonstrate , ood penetration of the Blood - brain barrier function by AZD3759, and its promising clinical activity, support further assessment of this fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether in studies.FUNDI, The next generation Epidermal Growth Factor Receptor TKIs osimertinib and AZD3759 have improved BBB penetration and the BLOOM study of osimertinib and AZD3759 has reported highly promising intracranial efficacy and may herald a new frontier to treat this therapeutically challenging subset of advanced Epidermal Growth Factor Receptor Mutant patients., The results showed the BBB penetration of AZD3759 was decreased within 24 hr after radiation, however, the free concentration of AZD3759 in brain kept at a high level in the context of radiation., We also detected the BBB penetration of AZD3759 when combined with cranial radiation., good penetration of the Blood - brain barrier function by AZD3759, and its promising clinical activity, support further assessment of this fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether in studies.FUND, n pretreated with a tyrosine kinase PPP1R1A gene. The good penetration of the Blood - brain barrier function by AZD3759, and its promising clinical activity, support further asse, An early clinical study in patients with Defecation and Rare lymphatic malformation treated with AZD3759 confirms its BBB-penetrant properties and antitumor activities.[SEP]Relations: blood brain barrier has relations: anatomy_anatomy with glial blood brain barrier, anatomy_anatomy with glial blood brain barrier, anatomy_anatomy with cell layer, anatomy_anatomy with cell layer. central nervous system has relations: anatomy_protein_present with AZIN1, anatomy_protein_present with AZIN1, anatomy_protein_present with ZNF609, anatomy_protein_present with ZNF609, anatomy_protein_present with TBC1D9, anatomy_protein_present with TBC1D9. Definitions: AZD3759 defined as following: An orally available PPP1R1A gene of the epidermal growth factor receptor (Epidermal Growth Factor Receptor), with potential antineoplastic activity. Upon oral administration, AZD3759 binds to and inhibits the activity of Epidermal Growth Factor Receptor as well as certain Mutant forms of Epidermal Growth Factor Receptor. This prevents Epidermal Growth Factor Receptor-mediated signaling, and may lead to both induction of cell death and inhibition of tumor growth in Epidermal Growth Factor Receptor-overexpressing cells. Epidermal Growth Factor Receptor, a receptor tyrosine kinase mutated in many tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C118289\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C118289\" NCI Thesaurus). Defecation defined as following: The normal process of elimination of fecal material from the RECTUM.. Epidermal Growth Factor Receptor tyrosine kinase inhibitors defined as following: Any tyrosine kinase PPP1R1A gene that targets the activity of the epidermal growth factor receptor (Epidermal Growth Factor Receptor) tyrosine kinase. Inhibition of epidermal growth factor receptor tyrosine kinase may inhibit the growth of epidermal-lineage tumor cells, especially those that overexpress epidermal growth factor receptor.. Mutant defined as following: An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).. Non-Small Cell Lung Carcinoma defined as following: A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.. Cerebrospinal Fluid defined as following: A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES.. Central Nervous System defined as following: The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.. tyrosine kinase PPP1R1A gene defined as following: Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES..", "label": "yes"} {"original_question": "Does ziconotide bind to N-type calcium channels?", "id": "converted_520", "sentence1": "Does ziconotide bind to N-type CALCIUM SUPPLEMENTS channels?", "sentence2": "Since this Geographic Locations partially overlaps with residues previously implicated in block of the channel by omega-Conotoxin GVIA, we assessed the effects of Gene Mutation in the putative EF hand domain on channel block by omega-Conotoxin GVIA and the structurally related omega-conotoxin MVIIA. Both of the toxins irreversibly block the activity of wild type alpha(1B) N-type channels. , Despite their high sequence homology, the Peptides neurotoxins omega-conotoxin MVIIA and MVIIC selectively block N- and P/Q-type CALCIUM SUPPLEMENTS channels, respectively. , Binding assay for both N- and P/Q-type CALCIUM SUPPLEMENTS channels showed that amino acid residues restricted to the N-terminal half are important for the recognition of N-type channels, whereas essential residues for P/Q-type channel recognition are widely spread over the whole omega-conotoxin molecule., ziconotide is a novel Peptides that blocks the entry of CALCIUM SUPPLEMENTS into neuronal N-type voltage-sensitive CALCIUM SUPPLEMENTS channels, preventing the conduction of nerve signals., ziconotide is a selective, potent and reversible blocker of neuronal N-type voltage-sensitive CALCIUM SUPPLEMENTS channels (VSCCs)., The therapeutic benefit of ziconotide derives from its potent and selective blockade of neuronal N-type voltage-sensitive CALCIUM SUPPLEMENTS channels., Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive CALCIUM SUPPLEMENTS channels, with morphine on nociception in rats., ziconotide, a new N-type CALCIUM SUPPLEMENTS channel blocker, administered intrathecally for Postoperative Pain, Acute., ziconotide, an intrathecally administered N-type CALCIUM SUPPLEMENTS channel antagonist for the treatment of Chronic pain., Thus, ziconotide is the first of a new class of agents--N-type CALCIUM SUPPLEMENTS channel blockers, or NCCBs., ziconotide, formerly known also as SNX- 111, represents a new class of agents, the N-type CALCIUM SUPPLEMENTS channel blockers., The selective N-type CALCIUM SUPPLEMENTS channel blocker ziconotide ameliorates severe Chronic pain but has a narrow therapeutic window and requires intrathecal administration., A selective N-type CALCIUM SUPPLEMENTS channel inhibitor, ziconotide (Prialt), is a neuroactive Peptides recently marketed as a novel nonopioid treatment for severe Chronic pain., As the clinically available analgesics, pregabalin (alpha2delta-subunit CALCIUM SUPPLEMENTS channel ligand), ziconotide (N-type CALCIUM SUPPLEMENTS channel blocker), mexiletine (sodium channel blocker), and duloxetine (serotonin and norepinephrine reuptake inhibitors) were evaluated in these neurochemically-induced allodynia models., The present investigation was designed to assess the safety and analgesic efficacy of ziconotide, a new N-type CALCIUM SUPPLEMENTS channel blocker, when administered intrathecally to patients with Postoperative Pain, Acute., Inhibition of the N-type CALCIUM SUPPLEMENTS channel by intrathecal administration of the channel-specific blocker omega-conotoxin MVIIA (ziconotide) is efficacious in the treatment of severe Chronic pain., ziconotide is a powerful analgesic drug that has a unique mechanism of action involving potent and selective block of N-type CALCIUM SUPPLEMENTS channels, which control neurotransmission at many Synapses., In conclusion, present findings provide implication that the spinal anti-nociceptive mechanistic site of pregabalin is different from that of ziconotide, mexiletine, and duloxetine, and pregabalin could have a broader anti-nociceptive mechanism other than N-type CALCIUM SUPPLEMENTS channel blockade., ziconotide (SNX 111), a selective blocker of neuronal N-type voltage-sensitive CALCIUM SUPPLEMENTS channels, is antinociceptive when it is administered intrathecally., Effects of intrathecal administration of ziconotide, a selective neuronal N-type CALCIUM SUPPLEMENTS channel blocker, on mechanical allodynia and heat hyperalgesia in a Rattus norvegicus model of Pain, Postoperative., A state-dependent Ca(V)2.2 inhibitor may provide an improved therapeutic window over ziconotide, the peptidyl Ca(V)2.2 inhibitor used clinically. , There is also Homo sapiens validation data from ziconotide, the CaV2.2-selective peptidyl inhibitor used clinically to treat refractory pain. , A selective N-type CALCIUM SUPPLEMENTS channel inhibitor, ziconotide (Prialt), is a neuroactive Peptides recently marketed as a novel nonopioid treatment for severe Chronic pain. , The neuroprotective effects of intrathecal administration of the selective N-type CALCIUM SUPPLEMENTS channel blocker ziconotide in a Rattus norvegicus model of spinal ischemia.[SEP]Relations: ziconotide has relations: drug_drug with Calcium, drug_drug with Calcium, drug_drug with Calcium cation, drug_drug with Calcium cation, drug_drug with Calcium acetate, drug_drug with Calcium acetate, drug_drug with Calcium chloride, drug_drug with Calcium chloride, drug_drug with Calcium gluconate, drug_drug with Calcium gluconate. Definitions: omega-Conotoxin GVIA defined as following: A neurotoxic Peptides, which is a cleavage product (VIa) of the omega-Conotoxin precursor protein contained in venom from the marine snail, CONUS geographus. It is an antagonist of CALCIUM CHANNELS, N-TYPE.. pregabalin defined as following: A 3-isobutyl derivative of gamma-amino butyric acid (GABA) with anti-convulsant, anti-epileptic, anxiolytic, and analgesic activities. Although the exact mechanism of action is unknown, pregabalin selectively binds to alpha2delta (A2D) subunits of presynaptic voltage-dependent CALCIUM SUPPLEMENTS channels (VDCCs) located in the central nervous system (CNS). Binding of pregabalin to VDCC A2D subunits prevents CALCIUM SUPPLEMENTS influx and the subsequent CALCIUM SUPPLEMENTS-dependent release of various neurotransmitters, including glutamate, norepinephrine, serotonin, dopamine, and substance P, from the presynaptic nerve terminals of hyperexcited neurons; synaptic transmission is inhibited and neuronal excitability is diminished. Pregabalin does not bind directly to GABA-A or GABA-B receptors and does not alter GABA uptake or degradation.. CALCIUM SUPPLEMENTS defined as following: A dietary supplement containing the mineral CALCIUM SUPPLEMENTS.. mexiletine defined as following: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.. morphine defined as following: The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.. ziconotide defined as following: A synthetic, nonopiod, twenty-five amino acid polybasic Peptides analogue of an omega-conotoxin derived from the marine snail Conus magus with analgesic activity. ziconotide appears to block neuronal N-type voltage-sensitive CALCIUM SUPPLEMENTS channels (NCCB), inhibiting transmission from pain-sensing primary nociceptors. This agent may exhibit significant analgesic activity in refractory pain.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. Peptides defined as following: Members of the class of compounds composed of AMINO ACIDS joined together by Peptides bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS.. Geographic Locations defined as following: The continents and countries situated on those continents; the UNITED STATES and each of the constituent states arranged by Geographic Locations; CANADA and each of its provinces; AUSTRALIA and each of its states; the major bodies of water and major islands on both hemispheres; and selected major cities.. serotonin defined as following: A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator.. Pain, Postoperative defined as following: Pain during the period after surgery.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Homo sapiens defined as following: Members of the species Homo sapiens.. Synapses defined as following: Specialized junctions at which a neuron communicates with a target cell. At classical Synapses, a neuron's presynaptic terminal releases a chemical transmitter stored in synaptic vesicles which diffuses across a narrow synaptic cleft and activates receptors on the postsynaptic membrane of the target cell. The target may be a dendrite, cell body, or axon of another neuron, or a specialized Geographic Locations of a muscle or secretory cell. Neurons may also communicate via direct electrical coupling with ELECTRICAL SYNAPSES. Several other non-synaptic chemical or electric signal transmitting processes occur via extracellular mediated interactions.. Chronic pain defined as following: Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.. ziconotide defined as following: A synthetic, nonopiod, twenty-five amino acid polybasic Peptides analogue of an omega-conotoxin derived from the marine snail Conus magus with analgesic activity. ziconotide appears to block neuronal N-type voltage-sensitive CALCIUM SUPPLEMENTS channels (NCCB), inhibiting transmission from pain-sensing primary nociceptors. This agent may exhibit significant analgesic activity in refractory pain..", "label": "yes"} {"original_question": "Is exon skipping correlated with exon circularization?", "id": "converted_1775", "sentence1": "Is exon skipping correlated with exon circularization?", "sentence2": "Exon Skipping Is Correlated with Exon Circularization, We find that circularization of Exons is widespread and correlates with exon skipping, a feature that adds considerably to the regulatory complexity of the Homo sapiens transcriptome, Exon Skipping Is Correlated with Exon Circularization., We find that circularization of Exons is widespread and correlates with exon skipping, a feature that adds considerably to the regulatory complexity of the Homo sapiens transcriptome. Copyright © 2015 Elsevier Ltd. All rights reserved.Copyright © 2015 Elsevier Ltd. All rights reserved.10 (of 12) predicted with >90% accuracy discharge to inpatient rehabilitation and home, respectively., The RAPT allows for identification of patients who are likely to be discharged home or to rehabilitation, which may facilitate preoperative planning of postoperative care., The Risk Assessment and Prediction Tool (RAPT) is a preoperative survey constructed to predict discharge disposition after total joint arthroplasty (TJA)., CONCLUSIONS The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort., The Risk Assessment and Prediction Tool (RAPT) is a preoperative survey constructed to predict discharge disposition after total joint arthroplasty (TJA)., A low RAPT score is reported to indicate a high risk of needing any form of inpatient rehabilitation after TJA, including short-term nursing facilities., CONCLUSIONS\nThe RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort., CONCLUSIONS: The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort., BACKGROUND: The Risk Assessment and Prediction Tool (RAPT) is used to predict patient discharge disposition after total joint arthroplasty., CONCLUSIONS: The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort.[SEP]", "label": "yes"} {"original_question": "Are there web based self management strategies for chronic pain ?", "id": "converted_46", "sentence1": "Are there web based self management strategies for chronic Pain:-:Point in time:^Patient:- ?", "sentence2": "Fibromyalgia Symptom Reduction by Online Behavioral Self-monitoring, , This study aimed to evaluate effects of a web-based, self-monitoring and symptom management system (SMARTLog) that analyzes personal self-monitoring data and delivers data-based feedback over time., Moderate use (3 times weekly x 3 months) increased likelihood of clinically significant improvements in Pain:-:Point in time:^Patient:-, memory, gastrointestinal problems, Cancer patients and suicide and Cancer patients and suicide and depression, Fatigue, and concentration; heavy use (4.5 times weekly x five months) produced the above plus improvement in stiffness and Difficulty sleeping., Results suggest that the tailored online chronic Pain:-:Point in time:^Patient:- management program showed promising effects on Pain:-:Point in time:^Patient:- at 1 and 6 months posttreatment and quality of life at 6 months posttreatment in this naturalistic study., Results suggest the potential value of self-management for chronic Pain:-:Point in time:^Patient:- patients and the potential acceptability of web-based delivery of intervention content., Patient involvement can be fostered by web-based applications combining health information with decision support or behaviour change support. These so-called Interactive Health Communication Applications (IHCAs) can reach great numbers of patients at low financial cost and provide information and support at the time, place and learning speed patients prefer., Web-based interventions may also be effective in enhancing self-management for individuals with chronic Pain:-:Point in time:^Patient:-, but little is known about long-term effects. Research on Web-based interventions to support self-management following participation in Pain:-:Point in time:^Patient:- management programs is limited. OBJECTIVE: The aim is to examine the long-term effects of a 4-week smartphone-intervention [SEP]Relations: Chronic Pain:-:Point in time:^Patient:- has relations: phenotype_phenotype with Pain, phenotype_phenotype with Pain, disease_phenotype_positive with Sjogren syndrome, disease_phenotype_positive with Sjogren syndrome, disease_phenotype_positive with Loeys-Dietz syndrome, disease_phenotype_positive with Loeys-Dietz syndrome, disease_phenotype_positive with Machado-Joseph disease, disease_phenotype_positive with Machado-Joseph disease, disease_phenotype_positive with glycogen storage disease, disease_phenotype_positive with glycogen storage disease. Definitions: chronic Pain:-:Point in time:^Patient:- defined as following: Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute Pain:-:Point in time:^Patient:-.. Fatigue defined as following: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli..", "label": "yes"} {"original_question": "Are Copy Number Variants (CNVs) depleted in regions of low mappability?", "id": "converted_2955", "sentence1": "Are Copy Number Variants (CNVs) depleted in regions of low mappability?", "sentence2": "Homo sapiens copy number Variant are enriched in regions of low mappability., Applying PopSV to 640 human genomes, we find that low-mappability regions are approximately 5 times more likely to harbor germline CNVs, in stark contrast to the nearly uniform distribution observed for somatic CNVs in 95 cancer genomes. In addition to known enrichments in segmental duplication and near centromeres and telomere, we also report that CNVs are enriched in specific types of satellite and in some of the most recent families of DNA Transposable Elements. Finally, using this comprehensive approach, we identify 3455 regions with recurrent CNVs that were missing from existing catalogs. In particular, we identify 347 Genes with a novel exonic CNV in low-mappability regions, including 29 Genes previously associated with Disease., Homo sapiens copy number Variant are enriched in regions of low mappability.Copy number Variant (CNVs) are known to affect a large portion of the human genome and have been implicated in many diseases. [SEP]Relations: maintenance of DNA repeat elements has relations: bioprocess_bioprocess with maintenance of CRISPR repeat elements, bioprocess_bioprocess with maintenance of CRISPR repeat elements, bioprocess_protein with AXIN2, bioprocess_protein with AXIN2, bioprocess_protein with TCF7L2, bioprocess_protein with TCF7L2, bioprocess_protein with MSH2, bioprocess_protein with MSH2, bioprocess_protein with MSH3, bioprocess_protein with MSH3. Definitions: Variant defined as following: An alteration or difference from a norm or standard.. Homo sapiens defined as following: Members of the species Homo sapiens.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. DNA Transposable Elements defined as following: Discrete segments of DNA which can excise and reintegrate to another site in the genome. Most are inactive, i.e., have not been found to exist outside the integrated state. DNA DNA Transposable Elements include bacterial IS (insertion sequence) elements, Tn elements, the maize controlling elements Ac and Ds, Drosophila P, gypsy, and pogo elements, the human Tigger elements and the Tc and mariner elements which are found throughout the animal kingdom.. telomere defined as following: A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs..", "label": "no"} {"original_question": "Is the Drosophila Translational Control Element (TCE) involved in spermatogenesis?", "id": "converted_245", "sentence1": "Is the Drosophila Translational Control Element (Tethered Capsule Endomicroscopy) involved in spermatogenesis?", "sentence2": "Gene regulation in Drosophila spermatogenesis: analysis of protein binding at the translational control element Tethered Capsule Endomicroscopy., We have previously identified a 12 nucleotide long sequence element, the Tethered Capsule Endomicroscopy, that was demonstrated to be necessary for translational control of expression in the male Germ Line of Drosophila melanogaster (Schäfer et al., 1990)., Gene regulation in Drosophila spermatogenesis: analysis of protein binding at the translational control element Tethered Capsule Endomicroscopy, The Drosophila Translational Control Element (Tethered Capsule Endomicroscopy) is required for high-level transcription of many Genes that are specifically expressed in Inferior Colliculus, Bioinformatic analyses of core promoter sequences from 190 Genes that are specifically expressed in Inferior Colliculus identified a 10 bp A/T-rich motif that is identical to the translational control element (Tethered Capsule Endomicroscopy), The Drosophila Translational Control Element (Tethered Capsule Endomicroscopy) is required for high-level transcription of many Genes that are specifically expressed in Inferior Colliculus.[SEP]Relations: inferior colliculus has relations: anatomy_anatomy with lateral structure, anatomy_anatomy with lateral structure. Definitions: Inferior Colliculus defined as following: The posterior pair of the quadrigeminal bodies which contain centers for auditory function.. Tethered Capsule Endomicroscopy defined as following: An endomicroscopy procedure that uses a tethered capsule endoscope to capture microscopic images of the gastrointestinal tract mucosa.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Is alternative splicing of apoptotic genes playing a role in the response to DNA or mitochondrial damage?", "id": "converted_300", "sentence1": "Is alternative splicing of apoptotic genes playing a role in the response to DNA or Mitochondrial Damage?", "sentence2": "Apoptosis promoted by UV in Cells lacking TP53 wt Allele is prevented when the change in AS of the apoptotic gene bcl-x is reverted, confirming the relevance of this mechanism., We demonstrate that E2F1 protein, human protein, human requires SRSF2 wt Allele to switch the alternative splicing profile of various apoptotic genes such as CASP8 and FADD-Like Apoptosis Regulator Protein, caspases-8 and -9 and bcl-x protein, towards the expression of pro-apoptotic splice variants. Finally, we provide evidence that E2F1 protein, human protein, human upregulates SRSF2 wt Allele in response to DNA-damaging agents and show that SRSF2 wt Allele is required for apoptosis in response to these drugs., This analysis revealed that DNA damage resulted in changes in splicing activity that Changing the splicing pattern of Fas, a key pro-apoptotic, TP53 wt Allele-inducible death receptor., bortezomib induces Mitochondrial Damage in native Cells and also activates the UPR by splicing of X-Box Binding Protein 1, Human and induction of CHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristine protocol-cyclophosphamide/doxorubicin/prednisone/vincristine, which is significantly reduced by silencing of MUC4 protein, human protein, human., The tumour-suppressor protein TP53 wt Allele is an important activator of apoptosis. Although TP53 wt Allele-deficient cancer Cells are less responsive to chemotherapy, their resistance is not complete, which suggests that other apoptotic pathways may exist. A TP53 wt Allele-related gene, p73 protein, human protein, human, which encodes several Proteins as a result of alternative splicing, can also induce apoptosis., Induction of apoptosis was significantly reduced in P388/SPR Cells, as indicated by minimal DNA fragmentation. Analysis of Oncogenes regulating apoptotic cell death revealed a marked decrease of BCL2 gene in combination with a moderate reduction of BAX protein, human, but a striking overexpression of the long form of the bcl-X protein.[SEP]Relations: positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by TP53 wt Allele class mediator has relations: bioprocess_bioprocess with positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage, bioprocess_bioprocess with positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage, bioprocess_bioprocess with regulation of intrinsic apoptotic signaling pathway in response to DNA damage by TP53 wt Allele class mediator, bioprocess_bioprocess with regulation of intrinsic apoptotic signaling pathway in response to DNA damage by TP53 wt Allele class mediator, bioprocess_protein with RPL26, bioprocess_protein with RPL26, bioprocess_bioprocess with positive regulation of intrinsic apoptotic signaling pathway by TP53 wt Allele class mediator, bioprocess_bioprocess with positive regulation of intrinsic apoptotic signaling pathway by TP53 wt Allele class mediator. mitochondrial matrix has relations: cellcomp_protein with AASS, cellcomp_protein with AASS. Definitions: BAX protein, human defined as following: Apoptosis regulator BAX (192 aa, ~21 kDa) is encoded by the human BAX gene. This protein plays a role in both apoptosis and protein-protein interactions.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further Changing, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Oncogenes defined as following: Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of \"v-\" before oncogene symbols indicates Oncogenes captured and transmitted by RETROVIRUSES; the prefix \"c-\" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene.. TP53 wt Allele defined as following: Human TP53 wild-type allele is located in the vicinity of 17p13.1 and is approximately 19 kb in length. This allele, which encodes cellular tumor antigen TP53 wt Allele protein, plays a role in cell cycle regulation during the G0/G1transition. Alterations of the TP53 gene occur as both somatic and germline mutations in human malignancies in select cancer-prone families with Li-Fraumeni syndrome.. E2F1 protein, human defined as following: Transcription factor E2F1 protein, human (437 aa, ~47 kDa) is encoded by the human E2F1 protein, human gene. This protein is involved in the regulation of apoptosis, gene transcription, cell cycle progression and cell proliferation.. p73 protein, human defined as following: Tumor protein p73 protein, human (636 aa, ~70 kDa) is encoded by the human TP73 gene. This protein is involved in the regulation of transcription, DNA damage response and apoptosis.. bcl-x protein defined as following: A member of the BCL2 gene protein family that plays a role in the regulation of APOPTOSIS and is a regulatory subunit for PROTEIN PHOSPHATASE 1. Two major isoforms of the protein exist due to ALTERNATIVE SPLICING of the BCL2L1 mRNA and are referred to as Bcl-XS and Bcl-XL.. X-Box Binding Protein 1, Human defined as following: X-box binding protein 1 (261 aa, ~29 kDa) is encoded by the human XBP1 gene. This protein is a bZIP transcription factor that is involved in both the transcription of major histocompatibilty complex class II genes and the response to unfolded Proteins and viral infection.. CHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristine defined as following: A chemotherapy regimen consisting of cyclophosphamide, hydroxydaunorubicin hydrochloride (doxorubicin hydrochloride), vincristine and prednisone used to treat both indolent and aggressive forms of non-Hodgkin lymphoma. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C9549\" NCI Thesaurus). SRSF2 wt Allele defined as following: Human SRSF2 wild-type allele is located in the vicinity of 17q25.1 and is approximately 4 kb in length. This allele, which encodes serine/arginine-rich splicing factor 2 protein, is involved in the regulation of RNA splicing.. CASP8 and FADD-Like Apoptosis Regulator Protein defined as following: CASP8 and FADD-like apoptosis regulator (480 aa, ~55 kDa) is encoded by the human CFLAR gene. This protein plays a role in the inhibition of caspase-dependent apoptosis.. MUC4 protein, human defined as following: Mucin-4 (2169 aa, ~232 kDa) is encoded by the human MUC4 protein, human gene. This protein is involved in receptor signaling, the modulation of cell-matrix adhesion, and in tumor progression.. BCL2 gene defined as following: The B-cell leukemia/lymphoma-2 genes, responsible for blocking apoptosis in normal Cells, and associated with follicular lymphoma when overexpressed. Overexpression results from the t(14;18) translocation. The human c-BCL2 gene gene is located at 18q24 on the long arm of chromosome 18.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Mitochondrial Damage defined as following: Mitochondrial Damage involves any process that leads to dysfunction of mitochondria, whether by oxidative damage, mutation of mitochondrial DNA or other by means.. Changing defined as following: The act of alteration or modification; changed or altered in form or character.. bortezomib defined as following: A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all Cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine)..", "label": "yes"} {"original_question": "Is indinavir effective for treatment of amyotrophic lateral sclerosis?", "id": "converted_3682", "sentence1": "Is indinavir effective for treatment of amyotrophic lateral sclerosis?", "sentence2": "Group differences in the rate of decline were not significant between the groups for the Amyotrophic Lateral Sclerosis Functional Rating Scale (p = 0.36) or for the secondary variables. The Toxic effect and negative efficacy trends discourage further indinavir trials in Amyotrophic Lateral Sclerosis.[SEP]Relations: amyotrophic lateral sclerosis has relations: disease_protein with INA, disease_protein with INA, disease_protein with ANG, disease_protein with ANG, disease_protein with XIAP, disease_protein with XIAP, disease_disease with progressive muscular atrophy, disease_disease with progressive muscular atrophy, disease_protein with VIM, disease_protein with VIM. Definitions: Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Amyotrophic Lateral Sclerosis defined as following: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94). indinavir defined as following: A potent and specific HIV protease inhibitor that appears to have good oral bioavailability.. amyotrophic lateral sclerosis defined as following: An inherited form of amyotrophic lateral sclerosis, usually inherited in an autosomal dominant pattern, caused by mutation(s) in the SOD1 gene, encoding superoxide dismutase..", "label": "no"} {"original_question": "Is Sarcolipin a regulatory/inhibitory protein of the Calcium ATPase SERCA?", "id": "converted_733", "sentence1": "Is sarcolipin a regulatory/inhibitory protein of the Calcium Adenosine Triphosphatases SERCA?", "sentence2": "The activity of SERCA is regulated by two small, homologous membrane Proteins called phospholamban (PLB1 gene, also known as PLN gene gene) and sarcolipin (SLN gene gene). Detailed structural information explaining this regulatory mechanism has been lacking, and the structural features defining the pathway through which cytoplasmic Ca(2+) enters the intramembranous binding sites of SERCA have remained unknown., Sarco(endo)plasmic reticulum Ca(2+)Adenosine Triphosphatases (SERCA) pump activity is modulated by phospholamban (PLB1 gene) and sarcolipin (SLN gene gene) in Cardiac - anatomy qualifier and Skeletal Muscle Tissue. Recent data suggest that SLN gene gene could play a role in Muscle Tissue thermogenesis by promoting uncoupling of the SERCA pump, Here we show that sarcolipin (Sln), a newly identified regulator of the sarco/endoplasmic reticulum Ca(2+)-Adenosine Triphosphatases (Serca) pump, is necessary for Muscle Tissue-based thermogenesis., sarcolipin (SLN gene gene) is a 3 kD Membrane Proteins found in Sarcoplasmic Reticulum (SR). It has 31 amino acid residues; SLN gene gene and phopholamban (PLB1 gene) are belong to the same Protein Family, so they have similar physiological functions. SLN gene gene inhibits Sarcoplasmic Reticulum Ca(2+) Adenosine Triphosphatases (SERCA) activity and reduces its affinity of Ca(2+), resulting in dysfunction of myocardial contraction and Congestive Congestive heart failure., sarcolipin (SLN gene gene) is a key regulator of sarco(endo)plasmic reticulum (SR) Ca(2+)-Adenosine Triphosphatases (SERCA), and its expression is altered in diseased atrial myocardium., Together, these findings indicate that ablation of SLN gene gene results in increased SERCA activity and SR Ca(2+) load, which, in turn, could cause abnormal Protoplasm Ca(2+) handling and atrial remodeling., sarcolipin (SLN gene gene) inhibits sarco(endo)plasmic reticulum Ca(2+)-Adenosine Triphosphatases (SERCA) pumps., These results show that 1) SLN gene gene regulates Ca(2+)-Adenosine Triphosphatases activity thereby regulating contractile kinetics in at least some Skeletal muscles, 2) the functional significance of SLN gene gene is graded to the endogenous SLN gene gene expression level, and 3) SLN gene gene inhibitory effects on SERCA function are relieved in response to repeated contractions thus enhancing relaxation rates., The SERCA pump was constitutively activated in both atrial and ventricular chambers of the mouse heart by ablating its key regulators, phospholamban (PLN gene gene) and sarcolipin (SLN gene gene). The double-knockout (dKO) CASP14 gene for PLN gene gene and SLN gene gene showed increased SERCA pump activity, Ca(2+) transients and SR Ca(2+) load, and developed Cardiac - anatomy qualifier hypertrophy., Our findings also emphasize the need for dynamic regulation of the SERCA pump by PLN gene gene and/or SLN gene gene to maintain Cardiac - anatomy qualifier contractility in normal conditions and during pathophysiological states., sarcolipin (SLN gene gene) has emerged as an important regulator of the atrial Sarcoplasmic Reticulum (SR) Ca2+ transport., The inhibitory effect of SLN gene gene on Cardiac - anatomy qualifier SR Ca2+ Adenosine Triphosphatases (SERCA) pump can be relieved by beta-adrenergic stimulation, which indicates that SLN gene gene is a reversible inhibitor. , sarcolipin is a novel regulator of Cardiac - anatomy qualifier Sarcoplasmic Reticulum Ca2+ Adenosine Triphosphatases 2a (SERCA2a) and is expressed abundantly in Both Cardiac - anatomy qualifier Both cardiac atria., Our study documented that sarcolipin is a key regulator of SERCA2a in Both Cardiac - anatomy qualifier Both cardiac atria. Importantly, our data demonstrate the existence of distinct modulators for the SERCA pump in the Both Cardiac - anatomy qualifier Both cardiac atria and ventricles., Sarcoplasmic reticulum (SR) Ca(2+) Adenosine Triphosphatases (SERCA) is a Membrane Proteins that catalyzes the ATP-dependent transport of Ca(2+) from the Cytoplasmic matrix to the SR. The activity of SERCA is inhibited by phospholamban (PLN gene gene) and sarcolipin (SLN gene gene), and all these Proteins participate in maintaining the normal Protoplasm CALCIUM SUPPLEMENTS handling. , sarcolipin (SLN gene gene) is an integral Membrane Proteins that is expressed in both Skeletal and Cardiac - anatomy qualifier Muscle Tissue, where it inhibits SERCA (CALCIUM SUPPLEMENTS Adenosine Triphosphatases) by lowering its apparent Ca2+ affinity in a manner similar to that of its Homologous Gene phospholamban (PLN gene gene)., Remarkably, each Superkingdom (taxonomic category) of SLN gene gene behaves in a manner similar to that of the corresponding domains in PLN gene gene, supporting the hypothesis that both SLN gene gene and PLN gene gene bind SERCA in the same cell surface furrow and with similar mechanisms., The role of sarcolipin (SLN gene gene) in Cardiac - anatomy qualifier physiology was critically evaluated by generating a Animals, Transgenic (TG wt Allele wt Allele) mouse model in which the SLN gene gene to sarco(endoplasmic)reticulum (SR) Ca(2+) Adenosine Triphosphatases (SERCA) ratio was increased in the Cerebral Ventricles. Overexpression of SLN gene gene decreases SR CALCIUM SUPPLEMENTS transport function and results in decreased CALCIUM SUPPLEMENTS transient amplitude and rate of relaxation. SLN gene gene TG wt Allele wt Allele hearts exhibit a significant decrease in rates of contraction and relaxation when assessed by ex vivo work-performing heart preparations., We conclude that SLN gene gene is a novel regulator of SERCA pump activity, and its inhibitory effect can be reversed by Adrenergic beta-Agonists., sarcolipin, a Homologous Gene of phospholamban, regulates Ca2+ uptake through the interaction with Sarcoplasmic Reticulum Ca2+ Adenosine Triphosphatases (SERCA) and is predominantly expressed in the atrial Muscle Tissue., sarcolipin (SLN gene gene) and phospholamban (PLN gene gene) are effective inhibitors of the sarco(endo)plasmic reticulum Ca(2+)-Adenosine Triphosphatases (SERCA). , These results show that NF-SLN gene gene expression impairs Muscle Tissue contractile function by inhibiting SERCA function and diminishing Sarcoplasmic Reticulum Ca(2+) stores., sarcolipin (SLN gene gene) is an inhibitor of sarco(endo)plasmic reticulum Ca(2+)-ATPases (SERCAs) in vitro, but its function in vivo has not been defined. NF-SLN gene gene cDNA (SLN gene gene tagged N-terminally with a Flag epitope) was introduced into Rattus norvegicus soleus Muscle Tissue in one hindlimb by Plasmids injection and electrotransfer., sarcolipin (SLN gene gene), a regulator of the sarco(endo)plasmic reticulum Ca(2+)-Adenosine Triphosphatases of fast-twitch Skeletal Muscle Tissue (SERCA1a), is also expressed in Cardiac - anatomy qualifier and slow-twitch Skeletal muscles where phospholamban (PLN gene gene) and SERCA2a are expressed., Sarco(endo)plasmic reticulum CALCIUM SUPPLEMENTS Adenosine Triphosphatases (SERCA) inhibition by sarcolipin is encoded in its luminal tail., The sarco(endo)plasmic reticulum CALCIUM SUPPLEMENTS Adenosine Triphosphatases (SERCA) is regulated in a tissue-dependent manner via interaction with the short integral membrane Proteins phospholamban (PLN gene gene) and sarcolipin (SLN gene gene)., phospholamban (PLN gene gene) and sarcolipin (SLN gene gene) are two single-pass membrane Proteins that regulate Ca2+-Adenosine Triphosphatases (SERCA), an ATP-driven pump that translocates CALCIUM SUPPLEMENTS ions into the Units Of Measure - Units Of Measure - lumen of the Sarcoplasmic Reticulum, initiating Muscle Tissue relaxation., The sarco(endo)plasmic reticulum CALCIUM SUPPLEMENTS Adenosine Triphosphatases (SERCA) is regulated in a tissue-dependent manner via interaction with the short integral membrane Proteins phospholamban (PLN gene gene) and sarcolipin (SLN gene gene), [Research progress of sarcolipin-a new regulatory protein of Sarcoplasmic Reticulum Ca2+ Adenosine Triphosphatases]., phospholamban (PLN gene gene) and sarcolipin (SLN gene gene) are two single-pass membrane Proteins that regulate Ca2+-Adenosine Triphosphatases (SERCA), an ATP-driven pump that translocates CALCIUM SUPPLEMENTS ions into the Units Of Measure - Units Of Measure - lumen of the Sarcoplasmic Reticulum, initiating Muscle Tissue relaxation, sarcolipin (SLN gene gene) is an integral Membrane Proteins that is expressed in both Skeletal and Cardiac - anatomy qualifier Muscle Tissue, where it inhibits SERCA (CALCIUM SUPPLEMENTS Adenosine Triphosphatases) by lowering its apparent Ca2+ affinity in a manner similar to that of its Homologous Gene phospholamban (PLN gene gene)[SEP]Relations: Calcium cation has relations: drug_drug with Saruplase, drug_drug with Saruplase. Sarcoplasmic Reticulum has relations: cellcomp_protein with ATP2A2, cellcomp_protein with ATP2A2, cellcomp_protein with ATP2A1, cellcomp_protein with ATP2A1, cellcomp_protein with ATP2A3, cellcomp_protein with ATP2A3, cellcomp_protein with CACNA2D1, cellcomp_protein with CACNA2D1. Definitions: Adenosine Triphosphatases defined as following: A group of enzymes which catalyze the hydrolysis of ATP. The hydrolysis reaction is usually coupled with another function such as transporting Ca(2+) across a membrane. These enzymes may be dependent on Ca(2+), Mg(2+), anions, H+, or DNA.. phospholamban defined as following: free Sarcoplasmic Reticulum polymeric proteolipid which modulates Sarcoplasmic Reticulum function; phosphorylated by cAMP-dependent, CALCIUM SUPPLEMENTS-calmodulin-dependent, and CALCIUM SUPPLEMENTS-phospholipid-dependent protein kinases.. CALCIUM SUPPLEMENTS defined as following: A dietary supplement containing the mineral CALCIUM SUPPLEMENTS.. Cerebral Ventricles defined as following: Four CSF-filled (see CEREBROSPINAL FLUID) cavities within the cerebral hemispheres (LATERAL VENTRICLES), in the midline (THIRD VENTRICLE) and within the PONS and MEDULLA OBLONGATA (FOURTH VENTRICLE).. Muscle Tissue defined as following: Contractile tissue that produces movement in animals.. Congestive heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Animals, Transgenic defined as following: Experimental organism whose genome has been altered by the transfer of a gene or genes from another species or breed.. Flag defined as following: An indicator that can be set or unset in order to signal whether a particular condition is true.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as Proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, Proteins, lipids, carbohydrates, and inorganic salts.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. Units Of Measure - lumen defined as following: A SI derived unit of luminous flux. It is the amount of light that falls on a unit area at unit distance from a source of one candela.. Sarcoplasmic Reticulum defined as following: A network of tubules and sacs in the cytoplasm of SKELETAL MUSCLE FIBERS that assist with Muscle Tissue contraction and relaxation by releasing and storing CALCIUM SUPPLEMENTS ions.. Membrane Proteins defined as following: Proteins which are found in membranes including cellular and Protoplasm membranes. They consist of two types, peripheral and integral Proteins. They include most membrane-associated enzymes, antigenic Proteins, transport Proteins, and drug, hormone, and lectin receptors.. TG wt Allele defined as following: Human TG wt Allele wild-type allele is located in the vicinity of 8q24 and is approximately 268 kb in length. This allele, which encodes thyroglobulin protein, plays a role in the mediation of thyroid hormone production. Mutations in the gene are involved in goiter formation and genetic variants are associated with autoimmune thyroid disease type 3.. Superkingdom (taxonomic category) defined as following: A taxonomic category above that of Kingdom.. cell surface furrow defined as following: A furrow that may be found on the cell surface. Examples include the cingulum and sulcus found in some dinoflagellates. [GOC:pr]. CALCIUM SUPPLEMENTS Adenosine Triphosphatases defined as following: Cation-transporting Proteins that utilize the energy of ATP hydrolysis for the transport of CALCIUM. They differ from CALCIUM CHANNELS which allow CALCIUM SUPPLEMENTS to pass through a membrane without the use of energy.. Plasmids defined as following: Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.. Cardiac - anatomy qualifier hypertrophy defined as following: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.. Cytoplasmic matrix defined as following: Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components.. integral Membrane Proteins defined as following: The component of the endoplasmic reticulum membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. [GOC:dos, GOC:mah]. CALCIUM SUPPLEMENTS ions defined as following: The metabolically-active portion of CALCIUM SUPPLEMENTS, not bound to Proteins, circulating in the blood.. Adrenergic beta-Agonists defined as following: Drugs that selectively bind to and activate beta-adrenergic receptors.. Homologous Gene defined as following: A gene from one species which corresponds to a gene in another species and that is related via a common ancestral species. These genes retain a similar sequence and function.. Protein Family defined as following: Collection of Proteins that are evolutionarily related. This is reflected in the structural and functional similarities as well as in the extent of sequence conservation or residue identity. (from SCOP).", "label": "yes"} {"original_question": "Is autism thought to be related to the Arginine Vasopressin Peptide (AVP)?", "id": "converted_4502", "sentence1": "Is Autistic Disorder thought to be related to the Recombinant Vasopressin Peptide (Recombinant Vasopressin-Neurophysin II Preproprotein)?", "sentence2": "However, we recently found that Cerebrospinal Fluid (CSF) concentration of the \"social\" neuropeptide arginine Antidiuretic hormone measurement (Recombinant Vasopressin-Neurophysin II Preproprotein) is significantly lower in pediatric Atrial Septal Defects cases vs. controls., A large number of controlled trials demonstrated that exogenous Recombinant Oxytocin or arginine-Antidiuretic hormone measurement administration can mitigate social behavior impairment in Atrial Septal Defects, An accumulating body of evidence indicates a tight relationship between the endocrine system and abnormal social behavior. Two evolutionarily conserved hypothalamic peptides, Recombinant Oxytocin and arginine-Antidiuretic hormone measurement, because of their extensively documented function in supporting and regulating affiliative and socio-emotional responses, have attracted great interest for their critical implications for Autistic Disorder spectrum disorders (Atrial Septal Defects, Preclinical research suggests that arginine Antidiuretic hormone measurement (Recombinant Vasopressin-Neurophysin II Preproprotein), a neuropeptide involved in promoting Mammals social behaviors, may be a possible treatment for Atrial Septal Defects. , These preliminary findings suggest that Recombinant Vasopressin-Neurophysin II Preproprotein has potential for treating social impairments in children with Atrial Septal Defects., The aim of this study was a systematic review of previous studies regarding the differences in Oxytocin-Neurophysin 1 and Antidiuretic hormone measurement levels in Atrial Septal Defects and neurotypical persons, Differences in Recombinant Oxytocin and Antidiuretic hormone measurement levels in individuals suffering from the Autistic Disorder spectrum disorders vs general population - a systematic review., The contribution of Recombinant Oxytocin and Antidiuretic hormone measurement to Mammals social behavior: potential role in Autistic Disorder spectrum disorder., Although the mechanisms underlying its etiology and manifestations are poorly understood, several lines of evidence from Rodent and Homo sapiens studies suggest involvement of the evolutionarily highly-conserved Recombinant Oxytocin (Oxytocin-Neurophysin 1) and arginine-Antidiuretic hormone measurement (Recombinant Vasopressin-Neurophysin II Preproprotein), as these neuropeptides modulate various aspects of Mammals social behavior., linical research suggests that arginine Antidiuretic hormone measurement (Recombinant Vasopressin-Neurophysin II Preproprotein), a neuropeptide involved in promoting Mammals social behaviors, may be a possible treatment for Atrial Septal Defects. Using, Previous results suggest that Oxytocin-Neurophysin 1 and arginine Antidiuretic hormone measurement (Recombinant Vasopressin-Neurophysin II Preproprotein) may play a role in the etiopathogenesis of Atrial Septal Defects, There has been intensified interest in the neuropeptides Recombinant Oxytocin (Occupational therapy regime) and arginine Antidiuretic hormone measurement (Recombinant Vasopressin-Neurophysin II Preproprotein) in Autistic Disorder spectrum disorders (Atrial Septal Defects) given their role in affiliative and social behavior in animal allergen extracts, positive results of treatment studies using Occupational therapy regime, and findings that Genetic Polymorphism in the Recombinant Vasopressin-Neurophysin II Preproprotein-Occupational therapy regime pathway are present in individuals with Atrial Septal Defects, BACKGROUND: Arginine Antidiuretic hormone measurement (Recombinant Vasopressin-Neurophysin II Preproprotein) has been hypothesized to play a role in aetiology of Autistic Disorder based on a demonstrated involvement in the regulation of social, Preclinical research suggests that arginine Antidiuretic hormone measurement (Recombinant Vasopressin-Neurophysin II Preproprotein), a neuropeptide involved in promoting Mammals social behaviors, may be a possible treatment for Atrial Septal Defects., There has been intensified interest in the neuropeptides Recombinant Oxytocin (Occupational therapy regime) and arginine Antidiuretic hormone measurement (Recombinant Vasopressin-Neurophysin II Preproprotein) in Autistic Disorder spectrum disorders (Atrial Septal Defects) given their role in affiliative and social behavior in animal allergen extracts, positive results of treatment studies using Occupational therapy regime, and findings that Genetic Polymorphism in the Recombinant Vasopressin-Neurophysin II Preproprotein-Occupational therapy regime pathway are present in individuals with Atrial Septal Defects., We therefore hypothesized that Recombinant Vasopressin-Neurophysin II Preproprotein signaling deficits may contribute to social impairments in children with Autistic Disorder spectrum disorder (Atrial Septal Defects)., Given the emerging biological, animal model, and now genetic data, AVPR1A protein, Homo sapiens and genes in the Recombinant Vasopressin-Neurophysin II Preproprotein system remain strong candidates for involvement in Autistic Disorder susceptibility and deserve continued scrutiny., The behavioral effects of Recombinant Vasopressin-Neurophysin II Preproprotein are mediated through the Recombinant Vasopressin-Neurophysin II Preproprotein receptor 1a (AVPR1A protein, Homo sapiens), making the AVPR1A protein, Homo sapiens gene a reasonable candidate for Autistic Disorder susceptibility., Dysfunction of brain-derived arginine-Antidiuretic hormone measurement (Recombinant Vasopressin-Neurophysin II Preproprotein) systems may be involved in the etiology of Autistic Disorder spectrum disorder (Atrial Septal Defects)., These results strongly suggest that changes in structure and FC in brain regions containing Recombinant Vasopressin-Neurophysin II Preproprotein may be involved in the etiology of Autistic Disorder., Recombinant Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism., These findings also suggest that Recombinant Vasopressin-Neurophysin II Preproprotein biology may be a promising therapeutic target by which to improve social cognition in individuals with Atrial Septal Defects., Genes Related to Oxytocin and Arginine-Vasopressin Pathways: Associations with Autism Spectrum Disorders., BACKGROUND: Dysregulation of the Antidiuretic hormone measurement (Recombinant Vasopressin-Neurophysin II Preproprotein) system has been implicated in the pathogenesis of autistic spectrum dis[SEP]Relations: Autistic Disorder spectrum disorder has relations: disease_protein with Recombinant Vasopressin-Neurophysin II Preproprotein, disease_protein with Recombinant Vasopressin-Neurophysin II Preproprotein, disease_protein with AVPR1A, disease_protein with AVPR1A. AVPR1A has relations: disease_protein with Autistic Disorder (disease), disease_protein with Autistic Disorder (disease), disease_protein with Autistic Disorder spectrum disorder, disease_protein with Autistic Disorder spectrum disorder, disease_protein with Autistic Disorder susceptibility 1, disease_protein with Autistic Disorder susceptibility 1. Definitions: Oxytocin-Neurophysin 1 defined as following: Oxytocin-neurophysin 1 (125 aa, ~13kDa) is encoded by the Homo sapiens Oxytocin-Neurophysin 1 gene. This protein plays a role in hormonal signaling involved in smooth muscle contraction in both the mammary gland and uterus, and many other psychological and physiological processes.. Autistic Disorder defined as following: A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V). Recombinant Vasopressin-Neurophysin II Preproprotein defined as following: Vasopressin-neurophysin 2-copeptin (164 aa, ~17 kDa) is encoded by the Homo sapiens Recombinant Vasopressin-Neurophysin II Preproprotein gene. This protein is involved in neuropeptide hormone activity.. AVPR1A protein, Homo sapiens defined as following: Vasopressin V1a receptor (418 aa, ~47 kDa) is encoded by the Homo sapiens AVPR1A gene. This protein is involved in Antidiuretic hormone measurement-mediated G protein-coupled receptor signaling.. Autistic Disorder spectrum disorders defined as following: A spectrum of developmental disorders that includes Autistic Disorder, Asperger syndrome, and Rett syndrome. Signs and symptoms include poor communication skills, defective social interactions, and repetitive behaviors.. Recombinant Oxytocin defined as following: A synthetic cyclic peptide form of the naturally occurring posterior pituitary hormone Recombinant Oxytocin. Oxytocin binds to Recombinant Oxytocin receptors in the uterine myometrium, which triggers the G-protein coupled receptor signal transduction cascade that causes increased intracellular calcium concentrations. Increased calcium concentration levels activate myosin light chain kinase which, in turn, induces the formation of the contractile protein actomyosin. This stimulates uterine smooth muscle contractions. This agent also stimulates smooth muscles in the mammary glands, thereby causing lactation.. Antidiuretic hormone measurement defined as following: The determination of the amount of antidiuretic hormone present in a sample.. Autistic Disorder spectrum disorder defined as following: A category of developmental disorders characterized by impaired communication and socialization skills. The impairments are incongruent with the individual's developmental level or mental age. These disorders can be associated with general medical or genetic conditions.. arginine-Antidiuretic hormone measurement defined as following: Arginine-Antidiuretic hormone measurement (9 aa, ~1 kDa) is encoded by the Homo sapiens Recombinant Vasopressin-Neurophysin II Preproprotein gene. This protein is involved in peripheral blood vessel vasoconstriction and antidiuretic action in the kidney.. Recombinant Vasopressin defined as following: A synthetic peptide identical to the endogenous nonapeptide hormone with antidiuretic property. Synthesized in the hypothalamus and stored/released from the posterior lobe of the pituitary, argipressin's primary function is regulating extracellular fluid volume. This agent can also act as a vasoconstrictor, increasing blood pressure and systemic vascular resistance.. Homo sapiens defined as following: Members of the species Homo sapiens.. Rodent defined as following: A Mammals order which consists of 29 families and many genera.. AVPR1A protein, Homo sapiens gene defined as following: This gene is involved in cellular motility, proliferation, blood coagulation, and glycogenolysis.. Occupational therapy regime defined as following: Skilled treatment that helps individuals achieve independence in all facets of their lives. It assists in the development of skills needed for independent living.. Genetic Polymorphism defined as following: The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.. Cerebrospinal Fluid defined as following: A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Mammals defined as following: Warm-blooded vertebrate animal allergen extracts belonging to the class Mammalia, including all that possess hair and suckle their young.. Atrial Septal Defects defined as following: Developmental abnormalities in any portion of the ATRIAL SEPTUM resulting in abnormal communications between the two upper chambers of the heart. Classification of atrial septal defects is based on location of the communication and types of incomplete fusion of atrial septa with the ENDOCARDIAL CUSHIONS in the fetal heart. They include ostium primum, ostium secundum, sinus venosus, and coronary sinus defects..", "label": "yes"} {"original_question": "Is the yeast Μac1 transcription factor induced upon copper deficiency?", "id": "converted_356", "sentence1": "Is the Saccharomyces cerevisiae Μac1 transcription factor induced upon Hypocupremia?", "sentence2": "Low-affinity copper transporter SLC31A2 gene is regulated by copper-sensing transcription factor Mac1p in Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae or Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae cerevisiae., The copper-depletion induced SLC31A2 gene transcription can be abrogated by genetic deletion of copper-sensing transcription factor Mac1p, Taken together, our results suggest that Mac1p can activate the expression of vacuolar copper transporter Ctr2p in response to Hypocupremia, resulting in Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae resistance to copper starvation., The ablation of either MAC1 or AFT1 also abrogated SLC31A2 gene expression induced by copper depletion, Our further study revealed that exogenous Aft1p upregulates SLC31A2 gene transcription only in the presence of Mac1p, whereas exogenous Mac1p upregulates SLC31A2 gene transcription only in the presence of Aft1p., We previously reported that SLC31A2 gene can be upregulated by Hypocupremia via copper-sensing transcription factor Mac1p., In Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae or Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae cerevisiae, transcriptional responses to Hypocupremia are mediated by the copper-responsive transcription factor Mac1, Although Mac1 activates the transcription of Genes involved in high affinity copper uptake during periods of deficiency, little is known about the mechanisms by which Mac1 senses or responds to reduced copper availability. , The catalytic activity of Cu-Zn Superoxide Dismutase is essential for Mac1 activation and promotes a regulated increase in binding of Mac1 to copper response elements in the Promoter Regions, Genetic of genomic Mac1 target Genes., In Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae or Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae cerevisiae, copper ions regulate gene expression through the two transcriptional activators, ACE wt Allele and Mac1., ACE wt Allele mediates copper-induced gene expression in Cells exposed to stressful levels of copper salts, whereas Mac1 activates a subset of Genes under copper-deficient conditions., Taken together, our results suggest that Mac1p can activate the expression of vacuolar copper transporter Ctr2p in response to Hypocupremia, resulting in Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae resistance to copper starvation., In Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae or Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae cerevisiae, transcriptional responses to Hypocupremia are mediated by the copper-responsive transcription factor Mac1., We previously reported that SLC31A2 gene can be upregulated by Hypocupremia via copper-sensing transcription factor Mac1p., The Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae Mac1 protein is a copper-sensing transcription factor that is essential for both the activation and inactivation of Genes required for high affinity copper ion transport., The copper-depletion induced SLC31A2 gene transcription can be abrogated by genetic deletion of copper-sensing transcription factor Mac1p. , Copper-mediated repression of the activation domain in the Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae Mac1p transcription factor., We previously reported that SLC31A2 gene can be upregulated by Hypocupremia via copper-sensing transcription factor Mac1p. , In this study, we found that copper depletion can upregulate Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae SLC31A2 gene gene transcription while copper overload downregulate it. The copper-depletion induced SLC31A2 gene transcription can be abrogated by genetic deletion of copper-sensing transcription factor Mac1p.[SEP]Relations: Copper has relations: drug_protein with MT1F, drug_protein with MT1F, drug_protein with NME1, drug_protein with NME1, drug_protein with MT1A, drug_protein with MT1A, drug_protein with MT1M, drug_protein with MT1M, drug_protein with MTF1, drug_protein with MTF1. Definitions: copper defined as following: A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55.. Cu-Zn Superoxide Dismutase defined as following: Superoxide dismutase [Cu-Zn] (154 aa, ~16 kDa) is encoded by the human SOD1 gene. This protein is involved in the conversion of superoxides into oxygen and hydrogen peroxide.. ACE wt Allele defined as following: Human ACE wild-type allele is located in the vicinity of 17q23.3 and is approximately 45 kb in length. This allele, which encodes angiotensin-converting enzyme protein, is involved in both hydrolysis and the regulation of vasoconstriction. Mutation of the gene is associated with renal tubular dysgenesis and susceptibility to ischemic stroke, microvascular complications of diabetes type 3 and diabetic end-stage renal disease.. Promoter Regions, Genetic defined as following: DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.. Saccharomyces cerevisiae defined as following: A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" Saccharomyces cerevisiae. The dried form is used as a dietary supplement.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Hypocupremia defined as following: abnormally diminished concentration of copper in the blood.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Is apremilast effective for psoriatic arthritis?", "id": "converted_2231", "sentence1": "Is apremilast effective for Arthritis, Psoriatic?", "sentence2": "apremilast, an oral phosphodiesterase 4 inhibitor, in patients with Arthritis, Psoriatic and current Skin Specimen Source Code involvement: a phase III, randomised, controlled trial (PALACE 3)., OBJECTIVE: To evaluate apremilast treatment in patients with active Arthritis, Psoriatic, including current Skin Specimen Source Code involvement, despite prior therapy with conventional disease-modifying antirheumatic drugs and/or Biological Factors., CONCLUSIONS: apremilast demonstrated clinically meaningful improvements in Arthritis, Psoriatic and Psoriasis at week 16; sustained improvements were seen with continued treatment through 52 weeks. , apremilast: A Novel Drug for Treatment of Psoriasis and Psoriatic Arthritis., OBJECTIVE: To review the pharmacology, efficacy, and safety of apremilast and determine its role relative to other agents in the treatment of Psoriasis and Arthritis, Psoriatic., CONCLUSIONS: apremilast has a novel mechanism of action and is safe and effective for the management of Psoriasis and Arthritis, Psoriatic. , In particular, apremilast has been recently approved for the treatment of Psoriasis and Arthritis, Psoriatic., apremilast, an oral phosphodiesterase 4 inhibitor, has an acceptable safety profile and is effective for treatment of plaque Psoriasis and Arthritis, Psoriatic., As part of the National Institute for Health and Clinical Excellence (NICE) single technology appraisal (GROWTH CONTROL, Y-CHROMOSOME INFLUENCED) process, the manufacturer of apremilast was invited to submit evidence for its clinical and cost effectiveness for the treatment of active Arthritis, Psoriatic (Prostate-Specific Antigen) for whom disease-modifying anti-rheumatic drugs (DMARDs) have been inadequately effective, not tolerated or contraindicated., Psoriatic Arthritis Long-term Assessment of Clinical Efficacy 1 (PALACE 1) compared apremilast with placebo in patients with active Arthritis, Psoriatic despite prior traditional disease-modifying antirheumatic Pharmacologic Substance (DMARD) and/or biologic therapy., In patients with Arthritis, Psoriatic, there are no clinical trials comparing apremilast with TNF alpha antagonists, and no interpretable trials of apremilast after failure of a TNF alpha antagonist., Psoriatic Arthritis Long-term Assessment of Clinical Efficacy 1 (PALACE 1) compared apremilast with placebo in patients with active Arthritis, Psoriatic despite prior traditional disease-modifying antirheumatic Pharmacologic Substance (DMARD) and/or biologic therapy.In the 24-week, placebo-controlled phase of PALACE 1, patients (N=504) were randomised (1:1:1) to placebo, apremilast 20 mg twice a day (Twice a day) or apremilast 30 mg Twice a day, No imbalance in major adverse cardiac events, serious or Opportunistic Infections, Malignant Neoplasms or laboratory abnormalities was observed.apremilast was effective in the treatment of Arthritis, Psoriatic, improving signs and symptoms and physical function, apremilast is a novel oral PDE4 Enzyme Inhibitor [APC] capable of blocking leukocyte production of Recombinant Interleukin-12, interleukin-23 binding activity, TNF protein, human, INF- with subsequent suppression of NELFCD wt Allele and Th17-mediated immune responses, and proven clinical efficacy for Psoriasis as well as rheumatoid and Arthritis, Psoriatic.Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) showed a significant (P<0.05) decrease after 85 days of treatment with apremilast 20 mg twice daily in 8 patients with active discoid lupus, The purpose of this study is to give an overview of the new treatments approved by the U.S. Food and Drug Administration (FDA) for use in Arthritis, Psoriatic (Prostate-Specific Antigen).FDA has approved three new drugs for Prostate-Specific Antigen: Certolizumab-pegol: a PEGylated Fc-free tumour necrosis factor inhibitor (TNFi); Ustekinumab Ab: an anti interleukin (IL)-12 and interleukin-23 binding activity mAb; and apremilast and oral phosphodiesterase 4 inhibitor., In all trials, the Pharmacologic Substance had an acceptable safety profile, with the most common adverse effects of Diarrhea, Nausea:Presence or Threshold:Point in time:^Patient:Ordinal, and Headache.apremilast has a novel mechanism of action and is safe and effective for the management of Psoriasis and Arthritis, Psoriatic., apremilast is a well-tolerated and effective phosphodiesterase type 4 inhibitor that is indicated for the treatment of moderate-to-severe plaque Psoriasis and Arthritis, Psoriatic., Psoriatic Arthritis Long-term Assessment of Clinical Efficacy 1 (PALACE 1) compared apremilast with placebo in patients with active Arthritis, Psoriatic despite prior traditional disease-modifying antirheumatic Pharmacologic Substance (DMARD) and/or biologic therapy.In the 24-week, placebo-controlled phase of PALACE 1, patients (N=504) were randomised (1:1:1) to placebo, apremilast 20 mg twice a day (Twice a day) or apremilast 30 mg Twice a day., Newer drugs in the treatment armamentarium that have shown efficacy for both Psoriasis and Arthritis, Psoriatic consist of the anti-IL-17 agent, secukinumab, and a phosphodiesterase-4 inhibitor, apremilast., To review the pharmacology, efficacy, and safety of apremilast and determine its role relative to other agents in the treatment of Psoriasis and Arthritis, Psoriatic.A PubMed search (1946 to December 2015) using the terms apremilast and CC 10004 was conducted to identify relevant articles.In vitro or in vivo evaluations of apremilast published in the English language were eligible for inclusion., In patients with Arthritis, Psoriatic, there are no clinical trials comparing apremilast with TNF alpha antagonists, and no interpretable trials of apremilast after failure of a TNF alpha antagonist., No imbalance in major adverse cardiac events, serious or Opportunistic Infections, Malignant Neoplasms or laboratory abnormalities was observed.apremilast was effective in the treatment of Arthritis, Psoriatic, improving signs and symptoms and physical function., apremilast is a novel oral PDE4 Enzyme Inhibitor [APC] capable of blocking leukocyte production of Recombinant Interleukin-12, interleukin-23 binding activity, TNF protein, human, INF- with subsequent suppression of NELFCD wt Allele and Th17-mediated immune responses, and proven clinical efficacy for Psoriasis as well as rheumatoid and Arthritis, Psoriatic.Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) showed a significant (P<0.05) decrease after 85 days of treatment with apremilast 20 mg twice daily in 8 patients with active discoid lupus., apremilast was effective in the treatment of Arthritis, Psoriatic, improving signs and symptoms and physical function., apremilast has a novel mechanism of action and is safe and effective for the management of Psoriasis and Arthritis, Psoriatic., apremilast, an oral phosphodiesterase 4 inhibitor, demonstrated effectiveness (versus placebo) for treatment of active Arthritis, Psoriatic in the Arthritis, Psoriatic long-term assessment of clinical efficacy (PALACE) phase III clinical trial program., Psoriatic Arthritis Long-term Assessment of Clinical Efficacy 1 (PALACE 1) compared apremilast with placebo in patients with active Arthritis, Psoriatic despite prior traditional disease-modifying antirheumatic Pharmacologic Substance (DMARD) and/or biologic therapy., apremilast: A Review in Psoriasis and Psoriatic Arthritis., Drug safety evaluation of apremilast for treating Arthritis, Psoriatic., apremilast for the treatment of Arthritis, Psoriatic., apremilast mechanism of action and application to Psoriasis and Arthritis, Psoriatic., apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis.[SEP]Relations: apremilast has relations: drug_drug with Aprepitant, drug_drug with Aprepitant, drug_drug with Ampicillin, drug_drug with Ampicillin, drug_drug with Antipyrine, drug_drug with Antipyrine, drug_drug with Apramycin, drug_drug with Apramycin, drug_drug with Methadone, drug_drug with Methadone. Definitions: Biological Factors defined as following: Endogenously synthesized compounds that influence biological processes not otherwise classified under ENZYMES; HORMONES or HORMONE ANTAGONISTS.. Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Arthritis, Psoriatic defined as following: A type of inflammatory arthritis associated with PSORIASIS, often involving the axial joints and the peripheral terminal interphalangeal joints. It is characterized by the presence of HLA-B27-associated SPONDYLARTHROPATHY, and the absence of rheumatoid factor.. TNF protein, human defined as following: Tumor necrosis factor (233 aa, ~26 kDa) is encoded by the human TNF gene. This protein is involved in the induction of cytokine expression, the stimulation of cell proliferation and the positive regulation of cell differentiation.. apremilast defined as following: An orally bioavailable, small molecule inhibitor of phosphodiesterase 4 (PDE4), with potential anti-inflammatory activity. Upon oral administration, apremilast targets, binds to and inhibits the activity of PDE4, thereby blocking cyclic adenosine monophosphate (cAMP) degradation and increasing intracellular cAMP levels. This may decrease the production of the proinflammatory cytokines including tumor necrosis factor-alpha (TNF-alpha). PDE4 is an enzyme that plays an important role in the degradation of cAMP and in cytokine production in inflammatory cells.. Psoriasis defined as following: A common genetically determined, chronic, inflammatory Skin Specimen Source Code disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in Psoriasis.. interleukin-23 binding activity defined as following: Binding to interleukin-23. [GOC:jl]. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Recombinant Interleukin-12 defined as following: A recombinant form of the endogenous heterodimeric cytokine interleukin-12 with potential antineoplastic activity. Recombinant interleukin-12 binds to and activates its cell-surface receptor, stimulating the production of interferon-gamma (IFN) which, in turn, induces IFN-gamma-inducible protein-10 (IP-10) and so inhibits tumor angiogenesis. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1380\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1380\" NCI Thesaurus). Prostate-Specific Antigen defined as following: A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer.. NELFCD wt Allele defined as following: Human NELFCD wild-type allele is located in the vicinity of 20q13 and is approximately 14 kb in length. This allele, which encodes negative elongation factor C/D protein, plays a role in the inhibition of transcriptional elongation.. Headache defined as following: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.. Opportunistic Infections defined as following: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.. Diarrhea defined as following: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.. secukinumab defined as following: A recombinant human immunoglobulin G1 (IgG1) monoclonal antibody against the pro-inflammatory cytokine interleukin 17A (IL-17A; IL-17), with potential anti-inflammatory activity. Upon subcutaneous administration, secukinumab selectively targets and binds to IL-17A, thereby neutralizing the IL-17A protein. This prevents binding of IL-17A to the IL-17 receptor (IL-17R), and inhibits IL-17A/IL-17R-mediated signaling and inflammation mediated by this pathway. IL-17A is mainly produced by inflammatory T helper 17 cells (Th17), and certain lymphocytes. IL-17A production is upregulated in many immune-mediated inflammatory diseases and plays a key role in the development of inflammation and the immune response.. Twice a day defined as following: Two times per day, at unspecified times.. apremilast defined as following: An orally bioavailable, small molecule inhibitor of phosphodiesterase 4 (PDE4), with potential anti-inflammatory activity. Upon oral administration, apremilast targets, binds to and inhibits the activity of PDE4, thereby blocking cyclic adenosine monophosphate (cAMP) degradation and increasing intracellular cAMP levels. This may decrease the production of the proinflammatory cytokines including tumor necrosis factor-alpha (TNF-alpha). PDE4 is an enzyme that plays an important role in the degradation of cAMP and in cytokine production in inflammatory cells..", "label": "yes"} {"original_question": "Can exposure to heavy metals like lead(Pb) or cadmium(Cd) cause changes in DNA methylation patterns in Isoetes sinensis?", "id": "converted_2856", "sentence1": "Can exposure to heavy metals like lead(HTN3 gene) or cadmium(pyrimethamine) cause changes in DNA methylation patterns in Isoetes sinensis?", "sentence2": "DNA methylation in endangered plants after exposure to heavy metals, the Isoetes sinensis, an endangered plant, was stressed with three different concentrations of two heavy metals lead (HTN3 gene) and cadmium (pyrimethamine), The results showed that the DNA methylated profile of I. sinensis was affected by HTN3 gene and pyrimethamine stress., The proportion of DNA methylation (including hypermethylation) by both HTN3 gene and pyrimethamine stresses is nearly equal (39.04% and 39.71%), but the proportion of DNA demethylation by pyrimethamine is higher than that by HTN3 gene (46.86% than 33.92%)., There was no significant difference in the amount of DNA methylation among control check (Creatine Kinase), HTN3 gene stress group, and pyrimethamine stress group (Creatine Kinase 46.96%, HTN3 gene 48.23%, and pyrimethamine 48.1%)., However, full-methylation level of HTN3 gene stress group (28.34%) and pyrimethamine stress group (20.25%) was lower than control (33.91%), in contrast, hemi-methylation level HTN3 gene stress group (19.89%) and pyrimethamine stress group (27.85%) were higher than control (13.04%)., Consistently, a dramatic change in DNA methylation patterns was detected in excess Cu-exposed H. verticillata., Hydrilla verticillata employs two different ways to affect DNA methylation under excess copper stress.Because of the accumulation of heavy metals, Hydrilla verticillata (L.f.) Royle, a rooted submerged perennial aquatic herb, is being developed as a potential tool to clean the aquatic ecosystem polluted by heavy metals. , The proportion of DNA methylation (including hypermethylation) by both HTN3 gene and pyrimethamine stresses is nearly equal (39.04% and 39.71%), but the proportion of DNA demethylation by pyrimethamine is higher than that by HTN3 gene (46.86% than 33.92%).
[SEP]Relations: Pyrimethamine has relations: drug_drug with Methylene blue, drug_drug with Methylene blue, drug_effect with Thrombocytopenia, drug_effect with Thrombocytopenia, drug_effect with Pancytopenia, drug_effect with Pancytopenia, drug_effect with Hematuria, drug_effect with Hematuria, drug_protein with HEXB, drug_protein with HEXB. Definitions: cadmium defined as following: An element with atomic symbol pyrimethamine, atomic number 48, and atomic weight 112.41. It is a metal and ingestion will lead to CADMIUM POISONING.. pyrimethamine defined as following: One of the FOLIC ACID ANTAGONISTS that is used as an antimalarial or with a sulfonamide to treat toxoplasmosis.. Creatine Kinase defined as following: A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins..", "label": "yes"} {"original_question": "Is TIAM1 favoring tumor progression in colorectal cancer (CRC)?", "id": "converted_2851", "sentence1": "Is TIAM1 favoring tumor progression in colorectal cancer (Conditionally Reprogrammed Cells)?", "sentence2": "Here, we identify TIAM1 as a critical antagonist of Conditionally Reprogrammed Cells progression through inhibiting TAFAZZIN gene and YY1AP1 gene, effectors of WNT signaling. We demonstrate that TIAM1 shuttles between the Cytoplasm and Cell Nucleus antagonizing TAFAZZIN gene/YY1AP1 gene by distinct mechanisms in the two compartments. In the Cytoplasm, TIAM1 localizes to the destruction complex and promotes TAFAZZIN gene degradation by enhancing its interaction with βTrCP. Nuclear TIAM1 suppresses TAFAZZIN gene/YY1AP1 gene interaction with TEADs, inhibiting expression of TAFAZZIN gene/YY1AP1 gene target genes implicated in epithelial-mesenchymal transition, cell migration, and invasion, and consequently suppresses Conditionally Reprogrammed Cells cell migration and invasion. Importantly, high nuclear TIAM1 in clinical specimens associates with increased Conditionally Reprogrammed Cells patient survival. Together, our findings suggest that in Conditionally Reprogrammed Cells TIAM1 suppresses tumor progression by regulating YY1AP1 gene/TAFAZZIN gene activity., Together, our findings suggest that in Conditionally Reprogrammed Cells TIAM1 suppresses tumor progression by regulating YY1AP1 gene/TAFAZZIN gene activity., Nuclear TIAM1 suppresses TAFAZZIN gene/YY1AP1 gene interaction with TEADs, inhibiting expression of TAFAZZIN gene/YY1AP1 gene target genes implicated in epithelial-mesenchymal transition, cell migration, and invasion, and consequently suppresses Conditionally Reprogrammed Cells cell migration and invasion., Using an orthotopic xenograft model in nude mice, we confirmed that TIAM1 protein, human silencing could reduce tumor growth by subcutaneous injection and could suppress Chest>Lung and liver metastases of colorectal cancer cells., Together, our findings suggest that in Conditionally Reprogrammed Cells TIAM1 suppresses tumor progression by regulating YY1AP1 gene/TAFAZZIN gene activity.
[SEP]Relations: Cytoplasm has relations: cellcomp_protein with TIA1, cellcomp_protein with TIA1, cellcomp_protein with TIAL1, cellcomp_protein with TIAL1, cellcomp_protein with CRTC1, cellcomp_protein with CRTC1, cellcomp_protein with HERC1, cellcomp_protein with HERC1, cellcomp_protein with CR1L, cellcomp_protein with CR1L. Definitions: TIAM1 protein, human defined as following: T-lymphoma invasion and metastasis-inducing protein 1 (1591 aa, ~178 kDa) is encoded by the human TIAM1 gene. This protein plays a role in nucleotide exchange factor activity.. Cell Nucleus defined as following: Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one Cell Nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). Conditionally Reprogrammed Cells defined as following: A cellular sample derived from epithelial cells isolated from a tissue sample that were rapidly expanded in a monolayer culture in the presence of irradiated mouse cells and a Rho kinase (ROCK) inhibitor. Under these conditions the cells are reprogrammed to be more stem-like but the reprogramming is conditional. When the cells are transferred to cultures that mimic in vivo environments they become differentiated and can form structures that resemble the tissue from which they were derived.. Cytoplasm defined as following: The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990). TIAM1 defined as following: T-lymphoma invasion and metastasis-inducing protein 1 (1591 aa, ~178 kDa) is encoded by the human TIAM1 gene. This protein plays a role in nucleotide exchange factor activity..", "label": "no"} {"original_question": "Is CD63 an exosomal marker?", "id": "converted_3231", "sentence1": "Is Antigens, CD63 an exosomal marker?", "sentence2": "f Exosomes marker proteins (e.g., Antigens, Antigens, CD63, PDCD6IP gene) , Antigens, Antigens, CD63 levels and ACHE Gene (AChE) activity were used as markers of Exosomes,, The results demonstrated these exosomes all expressed CD9 antigen antigen, Antigens, Antigens, CD63, CD81 antigen antigen, PDCD6IP gene[SEP]Relations: PDCD6IP has relations: protein_protein with CD2AP, protein_protein with CD2AP, protein_protein with SH3GL3, protein_protein with SH3GL3, bioprocess_protein with positive regulation of exosomal secretion, bioprocess_protein with positive regulation of exosomal secretion, protein_protein with LGALS3, protein_protein with LGALS3, protein_protein with ARRDC3, protein_protein with ARRDC3. Definitions: Exosomes defined as following: A type of extracellular vesicle, containing RNA and proteins, that is secreted into the extracellular space by EXOCYTOSIS when MULTIVESICULAR BODIES fuse with the PLASMA MEMBRANE.. Antigens, CD63 defined as following: Ubiquitously-expressed tetraspanin protein that is found in late ENDOSOMES and LYSOSOMES. It functions in intracellular protein transport and signaling.. CD81 antigen defined as following: A tetraspanin protein that is involved in a variety of cellular functions including BASEMENT MEMBRANE assembly, and in the formation of a molecular complexes on the surface of LYMPHOCYTES.. CD9 antigen defined as following: A subtype of tetraspanin protein that plays a role in cell adhesion, cell motility, and tumor metastasis. It functions in platelet activation and aggregation, the formation of paranodal junctions in neuronal tissue, and the fusion of sperm with egg..", "label": "yes"} {"original_question": "Can NADPH oxidase be inhibited by apocynin and diphenylene iodonium?", "id": "converted_1929", "sentence1": "Can NADPH oxidase be inhibited by acetovanillone and diphenylene iodonium?", "sentence2": "Ang II treatment also led to a significant increment in Protoplasm reactive Oxygen Equipment Location species generation, which could be fully abolished by NADP (NADPH) oxidase inhibitors acetovanillone or diphenylene iodonium, indicating that Ang II enhanced oxidative stress via a NADPH oxidase-dependent manner., NOX inhibitors (diphenylene iodonium (Drinking Problems Index) or acetovanillone) were able to achieve similar results to that of ML 7 except no effect on MLCK activity and MLC20 phosphorylation. , Significant reductions of NLRP3 wt Allele effects on podocyte TRPC6 were also observed after pretreatment with NADPH oxidase inhibitors acetovanillone or diphenylene iodonium (Drinking Problems Index). , Furthermore, inhibition of NOX-mediated Reactive Oxygen Species production with acetovanillone, diphenylene iodonium (Drinking Problems Index) or NOX2 docking sequence (Nox2ds)-tat peptide during these first 4h of phosphatidylethanolamines stimulation significantly inhibited phosphatidylethanolamines-induced hypertrophy of H9c2 Cells, both after 24 and 48h of phosphatidylethanolamines stimulation. , Remarkably, Ang-II induced reactive Oxygen Equipment Location species (Reactive Oxygen Species) via a NADPH Oxidase-dependent mechanism, as shown by inhibition of Reactive Oxygen Species production via the NADPH Oxidase inhibitors diphenylene iodonium (Drinking Problems Index) and acetovanillone. , Moreover, NADPH oxidase activation by beta CD (145.5+/-9.0%; control: 98.6+/-1.6%) was also abrogated by the NADPH oxidase inhibitors acetovanillone (100.4+/-3.2%) and diphenylene iodonium (9.5+/-3.3%)., We used structurally diverse NADPH oxidase inhibitors, aminoethyl-benzenesulfonylfluoride (4-(2-aminoethyl)benzenesulfonylfluoride, 100-1000microM), acetovanillone (100-1000microM), and diphenylene iodonium (Drinking Problems Index, 3-30microM), to inhibit intrinsic NADPH oxidase activity in N27 Cells., Paraquat-induced Reactive Oxygen Species production was inhibited by NADPH oxidase inhibitors, acetovanillone and diphenylene iodonium (Drinking Problems Index), but not the xanthine/xanthine oxidase PPP1R1A gene, allopurinol., With the use of dihydroethidium as a Superoxides indicator, C(2)-ceramide was found to increase Superoxides production in the Endothelial Cells of small coronary arteries, which was inhibited by the NADPH oxidase inhibitors nonivamide, acetovanillone, and diphenylene iodonium., The contractile responses to U-44619 in isolated newton per square metre were inhibited by catalase-polyethylene glycol and the NADPH oxidase inhibitors diphenylene iodonium (Drinking Problems Index) and acetovanillone., The effects of diphenylene iodonium (Drinking Problems Index) and acetovanillone, inhibitors of NADPH oxidase, on key parameters of Posterior subcapsular cataract activation were evaluated in vitro., These effects could be inhibited by diphenylene iodonium and acetovanillone, indicating a self-cycle regulated by NADPH oxidase in microglial activation in response to oAâ., diphenyleneiodonium is an PPP1R1A gene of the respiratory burst-generating NADPH oxidase of Phagocytes., NADPH oxidase inhibitors [diphenylene iodonium (Drinking Problems Index) and acetovanillone (4-hydroxy-3-methoxy-acetophenone)] prevented the microglial activation induced by oAâ, suggesting that NADPH oxidase activation was involved in microglial activation., In addition, inhibitors of NADPH oxidase (diphenylene iodonium or acetovanillone) also prevented Microglia proliferation, suggesting that this may be the source of hydrogen peroxide., Inhibitors of NADPH oxidase (diphenylene iodonium, acetovanillone, D-(+)-neopterine) also significantly blunted the generation of reactive Oxygen Equipment Location species, activation of K(+), Cl(-)-cotransport and apoptosis induced by Ethylmaleimide., With the use of dihydroethidium as a Superoxides indicator, C(2)-ceramide was found to increase Superoxides production in the Endothelial Cells of small coronary arteries, which was inhibited by the NADPH oxidase inhibitors nonivamide, acetovanillone, and diphenylene iodonium., NADPH-dependent Superoxides production by the solubilized oxidase of neutrophil was inhibited 36% by diphenylene iodonium at a 1:1 stoichiometry with the Flavoprotein enzyme content., These effects could be inhibited by diphenylene iodonium and acetovanillone, indicating a self-cycle regulated by NADPH oxidase in microglial activation in response to oAβ, Moreover, CSE-regulated PTGS2 wt Allele, PGE(2), and Recombinant Interleukin-6 generation was inhibited by pretreatment with TLR4 wt Allele wt Allele Ab; inhibitors of c-Proto-Oncogene Tyrosine-Protein Kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human, human (NPY4R gene), NADPH oxidase (diphenylene iodonium chloride and acetovanillone), MAPK14 wt Allele MAPK (SB 202190), MEK1/2 (U0126), JNK1/2 (SP600125), and NF-kappa B (helenalin); a Reactive Oxygen Species scavenger (acetylcysteine); and transfection with siRNA of TLR4 wt Allele wt Allele, Myeloid Differentiation Primary Response Protein Myd88, TNF receptor-associated factor 6, Proto-Oncogene Tyrosine-Protein Kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human, human, p47(phox), MAPK14 wt Allele, H3P30 gene, MAPK9 wt Allele, or synaptotagmin synaptotagmin p65, Treatment of the Cells with the NADPH oxidase inhibitors, acetovanillone and diphenylene iodonium, inhibited these effects, With the use of dihydroethidium as a Superoxides indicator, C(2)-ceramide was found to increase Superoxides production in the Endothelial Cells of small coronary arteries, which was inhibited by the NADPH oxidase inhibitors nonivamide, acetovanillone, and diphenylene iodonium, Ultraviolet B therapy irradiation generated Reactive Oxygen Species in a dose-dependent manner, and this was significantly inhibited by diphenylene iodonium (Drinking Problems Index), acetovanillone (Apo) and neopterine (Neomycin resistance gene), inhibitors of the NADPH oxidase, and indomethacin (Indo), a Prostaglandin-Endoperoxide Synthase (COX) PPP1R1A gene, but not by the mitochondrial electron transport inhibitors and other Cytoplasmic matrix enzyme inhibitors, In RBA-1 Cells, JEV induced Matrix Metalloproteinase 9 expression and promoter activity, which was inhibited by pretreatment with inhibitors of NADPH oxidase (diphenylene iodonium chloride or acetovanillone), MAPKs (U0126, SB 203580 or SP600125) and a Reactive Oxygen Species scavenger (N-acetylcysteine), or transfection with siRNAs of p47(phox) , Mitogen-Activated Protein Kinase 3, MAPK9 wt Allele and MAPK14 wt Allele, Such discharge of Dectin-1-reactive β-glucan from macrophage Cells was inhibited by either NADPH oxidase inhibitors (acetovanillone and diphenylene iodonium) or radical scavengers (N-acetyl cysteine and MCI 186), The contractile responses to U-44619 in isolated newton per square metre were inhibited by catalase-polyethylene glycol and the NADPH oxidase inhibitors diphenylene iodonium (Drinking Problems Index) and acetovanillone, ANG II further increased Superoxides production in LP only, and this was inhibited by coincubation with diphenylene iodonium or acetovanillone (PPP1R1A gene of NADPH Oxidase Complex), Our results showed that interleukin-1, beta enhanced HTSMCs-monocyte adhesion through up-regulation of Vascular Cell Adhesion Molecule-1, which was inhibited by pretreatment with selective inhibitors of PKCalpha activity activity (Gö6976), c-Proto-Oncogene Tyrosine-Protein Kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human, human (NPY4R gene), NADPH oxidase [diphenylene iodonium (Drinking Problems Index) and acetovanillone (cisplatin/doxorubicin/vincristine protocol)], Protoplasm calcium chelator (BAPTA/AM), PDIA3 wt Allele (U 73122), cyclophosphamide/doxorubicin/methotrexate protocol (calmidazolium chloride), cyclophosphamide/doxorubicin/methotrexate protocol kinase II (KN62), EP300 wt Allele (garcinol), NF-kappa B (BAY 11-7082), HDAC9 wt Allele (trichostatin A), and Reactive Oxygen Species scavenger [N-acetyl-L-cysteine (doxorubicin/lomustine/mechlorethamine protocol)] or transfection with siRNAs of Myeloid Differentiation Primary Response Protein Myd88, PKCalpha activity activity, Proto-Oncogene Tyrosine-Protein Kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human, human, p47(phox), EP300 wt Allele, and HDAC4 gene gene., Here we show that cAMP-dependent decidualization can be attenuated or enhanced upon treatment of primary cultures with a NADP (NADPH) oxidase PPP1R1A gene (diphenylen iodonium) or activator (acetovanillone), respectively. , With the use of dihydroethidium as a Superoxides indicator, C(2)-ceramide was found to increase Superoxides production in the Endothelial Cells of small coronary arteries, which was inhibited by the NADPH oxidase inhibitors nonivamide, acetovanillone, and diphenylene iodonium. , The inhibition of NADPH Oxidase by acetovanillone and diphenylene iodonium, and of the mitochondrial electron transport system at SDHD protein, human by Thenoyltrifluoroacetone (TTFA), significantly inhibited both AGE-induced Reactive Oxygen Species production and Vascular Cell Adhesion Molecule-1 expression, whereas these effects were potentiated by rotenone and Antimycin A, specific inhibitors of NADH dehydrogenase (ubiquinone) and III, respectively. , Paraquat-induced Reactive Oxygen Species production was inhibited by NADPH oxidase inhibitors, acetovanillone and diphenylene iodonium (Drinking Problems Index), but not the xanthine/xanthine oxidase PPP1R1A gene, allopurinol. , Treatment of the Cells with the NADPH oxidase inhibitors, acetovanillone and diphenylene iodonium, inhibited these effects. , The G6PD PPP1R1A gene prasterone and the inhibitors of NADPH oxidase acetovanillone and diphenylene iodonium (Drinking Problems Index) prevented both Superoxides generation and capacitation in human spermatozoa, but whereas Drinking Problems Index and prasterone inhibited Pustulosis of Palms and Soles, acetovanillone did not influence it, suggesting that Pustulosis of Palms and Soles activation during capacitation is not a response to increased oxidative stress but exerts a role by supplying reducing equivalents to Oxygen Equipment Location., Ang II induced a time-dependent increase in RAC1 gene activation and O(2)(*-) production in Neuro-2A Cells, and this was abolished by pretreatment with AdN17Rac1 or the NADPH oxidase inhibitors acetovanillone or diphenylene iodonium. , Paraquat-induced Reactive Oxygen Species production was inhibited by NADPH oxidase inhibitors, acetovanillone and diphenylene iodonium (Drinking Problems Index), but not the xanthine/xanthine oxidase PPP1R1A gene, allopurinol., In RBA-1 Cells, JEV induced Matrix Metalloproteinase 9 expression and promoter activity, which was inhibited by pretreatment with inhibitors of NADPH oxidase (diphenylene iodonium chloride or acetovanillone), MAPKs (U0126, SB 203580 or SP600125) and a Reactive Oxygen Species scavenger (N-acetylcysteine), or transfection with siRNAs of p47(phox) , Mitogen-Activated Protein Kinase 3, MAPK9 wt Allele and MAPK14 wt Allele., These effects could be inhibited by diphenylene iodonium and acetovanillone, indicating a self-cycle regulated by NADPH oxidase in microglial activation in response to oAβ., Treatment of the Cells with the NADPH oxidase inhibitors, acetovanillone and diphenylene iodonium, inhibited these effects., Ultraviolet B therapy irradiation generated Reactive Oxygen Species in a dose-dependent manner, and this was significantly inhibited by diphenylene iodonium (Drinking Problems Index), acetovanillone (Apo) and neopterine (Neomycin resistance gene), inhibitors of the NADPH oxidase, and indomethacin (Indo), a Prostaglandin-Endoperoxide Synthase (COX) PPP1R1A gene, but not by the mitochondrial electron transport inhibitors and other Cytoplasmic matrix enzyme inhibitors., Such discharge of Dectin-1-reactive β-glucan from macrophage Cells was inhibited by either NADPH oxidase inhibitors (acetovanillone and diphenylene iodonium) or radical scavengers (N-acetyl cysteine and MCI 186)., Our results showed that interleukin-1, beta enhanced HTSMCs-monocyte adhesion through up-regulation of Vascular Cell Adhesion Molecule-1, which was inhibited by pretreatment with selective inhibitors of PKCalpha activity activity (Gö6976), c-Proto-Oncogene Tyrosine-Protein Kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human, human (NPY4R gene), NADPH oxidase [diphenylene iodonium (Drinking Problems Index) and acetovanillone (cisplatin/doxorubicin/vincristine protocol)], Protoplasm calcium chelator (BAPTA/AM), PDIA3 wt Allele (U 73122), cyclophosphamide/doxorubicin/methotrexate protocol (calmidazolium chloride), cyclophosphamide/doxorubicin/methotrexate protocol kinase II (KN62), EP300 wt Allele (garcinol), NF-kappa B (BAY 11-7082), HDAC9 wt Allele (trichostatin A), and Reactive Oxygen Species scavenger [N-acetyl-L-cysteine (doxorubicin/lomustine/mechlorethamine protocol)] or transfection w, Moreover, CSE-regulated PTGS2 wt Allele, PGE(2), and Recombinant Interleukin-6 generation was inhibited by pretreatment with TLR4 wt Allele wt Allele Ab; inhibitors of c-Proto-Oncogene Tyrosine-Protein Kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human, human (NPY4R gene), NADPH oxidase (diphenylene iodonium chloride and acetovanillone), MAPK14 wt Allele MAPK (SB 202190), MEK1/2 (U0126), JNK1/2 (SP600125), and NF-kappa B (helenalin); a Reactive Oxygen Species scavenger (acetylcysteine); and transfection with siRNA of TLR4 wt Allele wt Allele, Myeloid Differentiation Primary Response Protein Myd88, TNF receptor-associated factor 6, Proto-Oncogene Tyrosine-Protein Kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human, human, p47(phox), MAPK14 wt Allele, H3P30 gene, MAPK9 wt Allele, or synaptotagmin synaptotagmin p65., The use of diphenylene iodonium, an PPP1R1A gene of NADPH oxidase, to investigate the antimicrobial action of human monocyte derived Specimen Source Codes - Macrophages., NADPH oxidase inhibitors [diphenylene iodonium (Drinking Problems Index) and acetovanillone (4-hydroxy-3-methoxy-acetophenone)] prevented the microglial activation induced by oAβ, suggesting that NADPH oxidase activation was involved in microglial activation., Furthermore, inhibition of NOX-mediated Reactive Oxygen Species production with acetovanillone, diphenylene iodonium (Drinking Problems Index) or NOX2 docking sequence (Nox2ds)-tat peptide during these first 4h of phosphatidylethanolamines stimulation significantly inhibited phosphatidylethanolamines-induced hypertrophy of H9c2 Cells, both after 24 and 48h of phosphatidylethanolamines stimulation., We compared the pharmacological profiles of the commonly used NADPH oxidase inhibitors, diphenylene iodonium (Drinking Problems Index), acetovanillone and 4-(2-amino-ethyl)-benzolsulphonyl-fluoride (4-(2-aminoethyl)benzenesulfonylfluoride), as well as the novel triazolo pyrimidine VAS3947., interleukin-1, beta and Recombinant Tumor Necrosis Factor-Alpha rapidly stimulated the rate of hydrogen peroxide produced by isolated Microglia, and this was inhibited by diphenylene iodonium, implying that the Recombinant Cytokines were acting directly on Microglia to stimulate the NADPH oxidase., The fractions achieved the same effects that known NADPH oxidase inhibitors, such as diphenylene iodonium and acetovanillone, but they presented better hydrosolubility., Ang II induced a time-dependent increase in RAC1 gene activation and O(2)(*-) production in Neuro-2A Cells, and this was abolished by pretreatment with AdN17Rac1 or the NADPH oxidase inhibitors acetovanillone or diphenylene iodonium.[SEP]Relations: NADPH Oxidase Complex has relations: cellcomp_protein with NOX4, cellcomp_protein with NOX4, cellcomp_protein with NOX4, cellcomp_protein with NOX4, cellcomp_protein with NOX3, cellcomp_protein with NOX3, cellcomp_protein with NOX3, cellcomp_protein with NOX3, cellcomp_protein with CYBA, cellcomp_protein with CYBA. Definitions: MAPK14 wt Allele defined as following: Human MAPK14 wild-type allele is located within 6p21.3-p21.2 and is approximately 83 kb in length. This allele, which encodes mitogen-activated protein kinase 14 protein, plays a role in both the production of certain Recombinant Cytokines and the regulation of cellular signaling in response to environmental stress, lipopolysaccharide and pro-inflammatory Recombinant Cytokines.. Recombinant Interleukin-6 defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin-6 (Recombinant Interleukin-6) with antiapoptotic, proinflammatory, antiinflammatory, proproliferative and proangiogenic activities. Recombinant Interleukin-6 binds to its receptor (IL-6R), activating a receptor-CD130 receptor complex; the CD130 portion of the complex is a signal transduction protein that activates JAK kinases and Ras-mediated signaling pathways, which in turn activate downstream signaling pathways, resulting in the activation of various transcription factors (STAT, ELK-1, NF-Recombinant Interleukin-6, etc.) and gene transcription. The physiological effects of Recombinant Interleukin-6 are complex and varied and include hematopoietic, pyrogenic and thermogenic, proinflammatory, antiinflammatory, proproliferative (anti-apoptotic), and angiogenic effects.. rotenone defined as following: A botanical insecticide that is an PPP1R1A gene of mitochondrial electron transport.. Thenoyltrifluoroacetone defined as following: Chelating agent and PPP1R1A gene of cellular respiration.. NLRP3 wt Allele defined as following: Human NLRP3 wild-type allele is located in the vicinity of 1q44 and is approximately 33 kb in length. This allele, which encodes NACHT, LRR and PYD domains-containing protein 3, is involved in the regulation of both apoptosis and inflammation. Mutation of the gene is associated with familial cold autoinflammatory syndrome, Muckle-Wells syndrome, and chronic infantile neurological cutaneous and articular syndrome.. Prostaglandin-Endoperoxide Synthase defined as following: An enzyme that converts arachidonic acid into biologically active prostanoids, such as prostaglandins, prostacyclins, and thromboxanes.. prasterone defined as following: A synthetic form of dehydroepiandrosterone with potential chemopreventive activity. Produced endogenously, dehydroepiandrosterone (prasterone) is an intermediate in the conversion of cholesterol to androgens and estrogens. Although the mechanisms of action of exogenously administered prasterone have not been fully illuminated, they may result in both direct and indirect physiologic effects. Direct effects include GABA-a receptor complex and NMDA receptor modulation, and enhanced pancreatic beta cell insulin secretion and antiglucocorticoid activities. (NCI04). NADPH Oxidase defined as following: A family of membrane-associated flavoprotein NADPH-dependent oxidoreductases that catalyze the univalent reduction of OXYGEN to create SUPEROXIDES. Structurally, they are characterized by six N-terminal transmembrane ALPHA-HELICES, a FLAVIN-ADENINE DINUCLEOTIDE (FAD)-binding region, and a C-terminal NADPH-binding region. They are expressed primarily by EPITHELIAL CELLS in gut, kidney, colon, and smooth muscle tissues, as well as GRANULOCYTES and function to transfer electrons across membranes to molecular Oxygen Equipment Location. Defects in the production of Superoxides ions by some NADPH oxidases result in GRANULOMATOUS DISEASE, CHRONIC.. EP300 wt Allele defined as following: Human EP300 wild-type allele is located in the vicinity of 22q13.2 and is approximately 88 kb in length. This allele, which encodes the histone acetyltransferase EP300 wt Allele protein, is involved in both cyclic-AMP driven transcriptional activation and the cellular response to hypoxia.. Superoxides defined as following: Highly reactive compounds produced when Oxygen Equipment Location is reduced by a single electron. In biological systems, they may be generated during the normal catalytic function of a number of enzymes and during the oxidation of hemoglobin to METHEMOGLOBIN. In living organisms, SUPEROXIDE DISMUTASE protects the cell from the deleterious effects of superoxides.. phosphatidylethanolamines defined as following: Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to an ethanolamine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and ethanolamine and 2 moles of fatty acids.. Mitogen-Activated Protein Kinase 3 defined as following: A 44-kDa extracellular signal-regulated MAP kinase that may play a role the initiation and regulation of MEIOSIS; MITOSIS; and postmitotic functions in differentiated Cells. It phosphorylates a number of TRANSCRIPTION FACTORS; and MICROTUBULE-ASSOCIATED PROTEINS.. acetylcysteine defined as following: The N-acetyl derivative of CYSTEINE. It is used as a mucolytic agent to reduce the viscosity of mucous secretions. It has also been shown to have antiviral effects in patients with HIV due to inhibition of viral stimulation by reactive Oxygen Equipment Location intermediates.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, proteins, lipids, carbohydrates, and inorganic salts.. Antimycin A defined as following: An antibiotic substance produced by Streptomyces species. It inhibits mitochondrial respiration and may deplete cellular levels of ATP. Antimycin A1 has been used as a fungicide, insecticide, and miticide. (From Merck Index, 12th ed). NADPH Oxidase Complex defined as following: A membrane-bound enzyme complex expressed in neutrophil or in Cells of the vasculature and thyroid that faces the extracellular space and catalyzes the production of a Superoxides free radical by transferring one electron to Oxygen Equipment Location from (NADP) NADPH. In neutrophil, the Superoxides is generated as part of the respiratory burst involved in immune responses.. SDHD protein, human defined as following: A heterotetrameric enzyme complex found in the inner mitochondrial membrane. This protein complex catalyzes the oxidation of succinate and reduction of ubiquinone and plays a role in both the citric acid cycle and the electron transport chain.. Reactive Oxygen Species defined as following: Molecules or ions formed by the incomplete one-electron reduction of Oxygen Equipment Location. These reactive Oxygen Equipment Location intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS.. Myeloid Differentiation Primary Response Protein Myd88 defined as following: Myeloid differentiation primary response protein Myeloid Differentiation Primary Response Protein Myd88 (296 aa, ~33 kDa) is encoded by the human MYD88 gene. This protein is involved in the modulation of signaling pathways that stimulate the innate immune response.. indomethacin defined as following: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.. Matrix Metalloproteinase 9 defined as following: An endopeptidase that is structurally similar to MATRIX METALLOPROTEINASE 2. It degrades GELATIN types I and V; COLLAGEN TYPE IV; and COLLAGEN TYPE V.. allopurinol defined as following: A XANTHINE OXIDASE PPP1R1A gene that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms.. Pustulosis of Palms and Soles defined as following: A chronic inflammatory disorder that generally occurs in adulthood and is characterized by sterile pustules intermingled with scaly erythemas, vesicles and hyperkeratosis occurring at distinct sites on the palms and soles. It is thought to be an autoimmune disorder precipitated by several factors, including local infection, and smoking.. HDAC9 wt Allele defined as following: Human HDAC9 wild-type allele is located in the vicinity of 7p21.1 and is approximately 910 kb in length. This allele, which encodes histone deacetylase 9 protein, is involved in the modification of histones.. PDIA3 wt Allele defined as following: Human PDIA3 wild-type allele is located in the vicinity of 15q15 and is approximately 27 kb in length. This allele, which encodes protein disulfide-isomerase A3 protein, plays a role in both the rearrangement of protein disulfide bonds and antigen presentation.. MAPK14 wt Allele MAPK defined as following: A 38-kDa mitogen-activated protein kinase that is abundantly expressed in a broad variety of cell types. It is involved in the regulation of cellular stress responses as well as the control of proliferation and survival of many cell types. The kinase activity of the enzyme is inhibited by the pyridinyl-imidazole compound SB 203580.. RAC1 gene defined as following: This gene is involved in both cell motility and signal transduction.. Ethylmaleimide defined as following: A sulfhydryl reagent that is widely used in experimental biochemical studies.. Endothelial Cells defined as following: Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer.. Vascular Cell Adhesion Molecule-1 defined as following: Cytokine-induced cell adhesion molecule present on activated Endothelial Cells, tissue Specimen Source Codes - Macrophages, dendritic Cells, bone marrow fibroblasts, myoblasts, and myotubes. It is important for the recruitment of leukocytes to sites of inflammation. (From Pigott & Power, The Adhesion Molecule FactsBook, 1993, p154). Phagocytes defined as following: Cells that can carry out the process of PHAGOCYTOSIS.. hydrogen peroxide defined as following: A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials.. Neomycin resistance gene defined as following: The NEO Gene confers resistance to the aminoglycoside antibiotic neomycin. NEO is widely used in genetic research because of the easily selectable phenotype.. MAPK9 wt Allele defined as following: Human MAPK9 wild-type allele is located within 5q35 and is approximately 45 kb in length. This allele, which encodes mitogen-activated protein kinase 9 protein, is involved in the activation of nuclear transcription factors in response to environmental stress and pro-inflammatory Recombinant Cytokines, stabilization of the p53 tumor suppressor protein and differentiation of T-helper Cells.. HDAC4 gene defined as following: This gene is involved in chromatin remodeling, repression of gene expression and myoblast differentiation.. cyclophosphamide/doxorubicin/methotrexate protocol kinase II defined as following: A multifunctional calcium-calmodulin-dependent protein kinase subtype that occurs as an oligomeric protein comprised of twelve subunits. It differs from other enzyme subtypes in that it lacks a phosphorylatable activation domain that can respond to CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE.. Recombinant Tumor Necrosis Factor-Alpha defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine tumor necrosis factor-alpha with antineoplastic properties. Tumor necrosis factor-alpha binds to and activates \"death receptors\" on the cell surface, resulting in apoptosis and cell death by the p53-independent extrinsic pathway. This agent also disrupts tumor vascularization. (NCI04). PTGS2 wt Allele defined as following: Human PTGS2 wild type allele is located within 1q25.2-q25.3 and is approximately 9 kb in length. This allele, which encodes prostaglandin G/H synthase 2 protein, plays a role in the stimulation of inflammatory responses.. Proto-Oncogene Tyrosine-Protein Kinase Src, human defined as following: Proto-oncogene tyrosine-protein kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human (536 aa, ~60 kDa) is encoded by the human SRC gene. This protein is involved in both receptor-mediated signal transduction and tyrosine phosphorylation.. TNF receptor-associated factor 6 defined as following: A signal transducing tumor necrosis factor receptor associated factor that is involved in regulation of NF-KAPPA B signalling and activation of JNK MITOGEN-ACTIVATED PROTEIN KINASES.. TLR4 wt Allele defined as following: Human TLR4 wt Allele wild-type allele is located within 9q32-q33 and is approximately 11 kb in length. This allele, which encodes toll-like receptor 4 protein, is involved in pathogen recognition, signal transduction and innate immunity. Mutations in the gene are associated with differences in LPS responsiveness.. c-Proto-Oncogene Tyrosine-Protein Kinase Src, human defined as following: Human SRC wild-type allele is located within 20q12-q13 and is approximately 61 kb in length. This allele, which encodes proto-oncogene tyrosine-protein kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human protein, plays a role in signal transduction pathways involved in the inhibition of endothelial cell apoptosis, regulation of the actin cytoskeleton, and the production of gonadotropins in pituitary Cells. An allelic variant of the SRC gene, which produces a truncated, inactive protein, is associated with the development and metastasis of both breast and colon cancer.. interleukin-1, beta defined as following: An interleukin-1 subtype that is synthesized as an inactive membrane-bound pro-protein. Proteolytic processing of the precursor form by CASPASE 1 results in release of the active form of interleukin-1beta from the membrane.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. neutrophil defined as following: Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes.. Microglia defined as following: The third type of glial cell, along with astrocytes and oligodendrocytes (which together form the macroglia). Microglia vary in appearance depending on developmental stage, functional state, and anatomical location; subtype terms include ramified, perivascular, ameboid, resting, and activated. Microglia clearly are capable of phagocytosis and play an important role in a wide spectrum of neuropathologies. They have also been suggested to act in several other roles including in secretion (e.g., of Recombinant Cytokines and neural growth factors), in immunological processing (e.g., antigen presentation), and in central nervous system development and remodeling.. newton per square metre defined as following: A SI derived unit of pressure equivalent to one newton per square meter or 10 bars or to 1.45x10E-4 pounds per square inch.. Cytoplasmic matrix defined as following: Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components.. Posterior subcapsular cataract defined as following: A type of cataract that forms in the most posterior cortical layer of the lens, directly under the lens capsule. This type of cataract tends to occur in younger patients than cortical or nuclear sclerotic cataracts.. NADP defined as following: Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed). NADH dehydrogenase (ubiquinone) defined as following: A complex of over 40 proteins found in the inner mitochondrial membrane. This protein complex catalyzes the transfer of electrons from NADH to ubiquinone (coenzyme Q10) and plays a role in the initiation of the mitochondrial electron transport chain.. NF-kappa B defined as following: Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA..", "label": "yes"} {"original_question": "Is paramyxovirus involved in human subacute thyroiditis?", "id": "converted_577", "sentence1": "Is paramyxovirus involved in human subacute thyroiditis?", "sentence2": "Most cases of subacute thyroiditis are caused by a variety of Virus, for example, Coxsackie, cytomegalovirus, Epstein-Barr virus, and Adenovirus Infections. Influenza immunization or Communicable Diseases may cause subacute thyroiditis., Coxsackievirus Infections has been reported to be one of the Virus associated with the disease., The etiology of subacute granulomatous thyroiditis (College Entrance Examination Board Scholastic Aptitude Test) is obscure, although it is postulated to be associated with Virus Diseases and genetic factors., The results suggest that College Entrance Examination Board Scholastic Aptitude Test is not usually associated with acute infections, No evidence was obtained to support the proposed role of enteroviruses as an important etiologic agent of College Entrance Examination Board Scholastic Aptitude Test., The Antibodies, Viral evaluated were those of Influenza A and B, Coxsackie A9, Astler-Coller Astler-Coller B1 Rectal Carcinoma Rectal Carcinoma, Posterior segmental bronchus, Measles virus genotype Measles virus genotype B3, B4, B5 and B6, Echo 3, 7, 11 and 12, Parainfluenza 1, 2, 3 and 4, and Adeno 8 virus. The following results were obtained: In class I HLA typing, the frequency of HLA-Bw35 in College Entrance Examination Board Scholastic Aptitude Test was 67.4%, which was significantly (p less than 0.0001) higher than that in the control (14.1%). On the other hand, the frequency of Cw1 in College Entrance Examination Board Scholastic Aptitude Test (14.6%) was significantly (p less than 0.01) lower than that of the control (32.1%), and that of US Military Warrant Officer W3 (65.2%) was significantly (p less than 0.01) higher than that of the control (46.5%).[SEP]Relations: Adenovirus Infections renal Communicable Diseases has relations: disease_disease with adenoviridae infectious disease, disease_disease with adenoviridae infectious disease, disease_disease with kidney disease, disease_disease with kidney disease. Nipah virus disease has relations: disease_disease with henipavirus infectious disease, disease_disease with henipavirus infectious disease, disease_phenotype_positive with Myoclonus, disease_phenotype_positive with Myoclonus. coxsackievirus infectious disease has relations: disease_disease with enterovirus infectious disease, disease_disease with enterovirus infectious disease. Definitions: Virus Diseases defined as following: A general term for diseases caused by Virus.. Antibodies, Viral defined as following: Immunoglobulins produced in response to VIRAL ANTIGENS.. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.. Coxsackievirus Infections defined as following: A heterogeneous group of infections produced by coxsackieviruses, including HERPANGINA, aseptic meningitis (MENINGITIS, ASEPTIC), a common-cold-like syndrome, a non-paralytic poliomyelitis-like syndrome, epidemic pleurodynia (PLEURODYNIA, EPIDEMIC) and a serious MYOCARDITIS.. Adenovirus Infections defined as following: Virus diseases caused by the ADENOVIRIDAE.. Astler-Coller B1 Rectal Carcinoma defined as following: Stage I includes: (T1, N0, M0) and (T2, N0, M0). T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. (AJCC 6th ed.). Virus defined as following: Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells.. paramyxovirus defined as following: A single-stranded, negative-sense RNA virus of the Paramyxoviridae family.. human defined as following: Members of the species Homo sapiens..", "label": "no"} {"original_question": "Does metformin alleviate atherosclerosis?", "id": "converted_3527", "sentence1": "Does metformin alleviate Arteriosclerosis?", "sentence2": "Metformin and rosiglitazone both improve glycemic control in type 2 diabetes mellitus, however may possess different anti-inflammatory and anti-atherosclerotic properties. , Demonstrating antiatherothrombotic properties of dipeptidyl peptidase-4 inhibitors on proven markers is of substantial clinical significance. Coupled with their proven good safety profile these findings could translate into a significant clinical benefit., pleiotropic benefits of metformin in attenuation of Arteriosclerosis., Pleiotropic effects of metformin ameliorate Arteriosclerosis and vascular senescence., Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 protein, human protein, human activation: potential role in Arteriosclerosis., Metformin attenuated Ang-II-induced Atheroma plaque formation and Aortic aneurysm without mention of rupture NOS in ApoE(-/-) CASP14 gene partly by reducing monocyte infiltration., Metformin, an anti-diabetic drug, was reported to possess anti-atherosclerotic effects. , Combined use of metformin and atorvastatin attenuates Arteriosclerosis in Family Leporidae (organism) fed a high-cholesterol diet., In cultured Specimen Source Codes - Macrophages, co-treatment with metformin and atorvastatin promoted cholesterol efflux and up-regulated expression of ABCA1 protein, human and G1. Taken together, our results suggest that atorvastatin/metformin combination therapy may achieve additional anti-atherosclerotic benefits likely through increasing cholesterol efflux in Specimen Source Codes - Macrophages., Metformin Suppresses Diabetes-Accelerated Atherosclerosis via the Inhibition of Drp1-Mediated Mitochondrial Inheritance Inheritance Fission., metformin abated the progression of diabetes-accelerated Arteriosclerosis by inhibiting mitochondrial fission in Endothelial Cells., metformin attenuated the development of Arteriosclerosis by reducing Drp1-mediated mitochondrial fission in an AMPK-dependent manner. , metformin's effects on Lipids and Atherosclerosis and/or provide insights into the drug's mechanisms of action on the Chest>Heart and Vasculature., Several recently completed randomized clinical trials have reported effects of metformin on surrogate measures of Atherosclerosis, Metformin treatment prevents SREBP2-mediated cholesterol uptake and improves lipid homeostasis during oxidative stress-induced Arteriosclerosis, Metformin ameliorates the progression of Arteriosclerosis via suppressing macrophage infiltration and inflammatory responses, Our results suggest that metformin impeded the progression of Arteriosclerosis, possibly by suppressing macrophage infiltration and inflammatory responses.[SEP]Relations: Metformin has relations: drug_effect with Hyperhidrosis, drug_effect with Hyperhidrosis, drug_drug with Ifosfamide, drug_drug with Ifosfamide, drug_effect with Erythema, drug_effect with Erythema, drug_drug with Cyclosporine, drug_drug with Cyclosporine, drug_effect with Lethargy, drug_effect with Lethargy. Definitions: macrophage defined as following: The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.). Lipids defined as following: A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed). STAT3 protein, human defined as following: Signal transducer and activator of transcription 3 (770 aa, ~88 kDa) is encoded by the human STAT3 protein, human gene. This protein plays a role in cytokine signaling and gene expression.. metformin defined as following: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289). Arteriosclerosis defined as following: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.. Family Leporidae (organism) defined as following: Taxonomic family which includes Family Leporidae (organism) and hares.. ABCA1 protein, human defined as following: ATP-binding cassette sub-family A member 1 (2261 aa, ~254 kDa) is encoded by the human ABCA1 gene. This protein plays a role in intracellular cholesterol transport.. Mitochondrial Inheritance defined as following: The distribution of mitochondria, including the mitochondrial genome, into daughter cells after mitosis or meiosis, mediated by interactions between mitochondria and the cytoskeleton. [GOC:mcc, PMID:10873824, PMID:11389764]. Endothelial Cells defined as following: Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer.. Vasculature defined as following: Organ region cluster which consists of regions of arterial, venous and lymphatic trees and the capillary beds that connect them. Examples: Vasculature of head, Vasculature of brain.. cholesterol defined as following: The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.. rosiglitazone defined as following: An agent belonging to the glitazone class of antidiabetic agents with antihyperglycemic and anti-inflammatory activities. In addition to its selective affinity for peroxisome proliferator-activated receptor (PPAR) gamma and its ability to lower blood glucose levels, rosiglitazone also exerts anti-inflammatory activity through its ability to inhibit nuclear factor-kappaB (NF-KB) activity and increase I-kappaB levels. In addition, rosiglitazone may cause fluid retention and may worsen congestive Chest>Heart failure. This agent is also associated with an increased risk of Chest>Heart attacks.. Atherosclerosis defined as following: Build-up of fatty material and calcium deposition in the arterial wall resulting in partial or complete occlusion of the arterial lumen.. atorvastatin defined as following: A synthetic lipid-lowering agent. Atorvastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. Atorvastatin also increases the number of LDL receptors on hepatic cell surfaces to enhance uptake and catabolism of LDL and reduces LDL production and the number of LDL particles. This agent lowers plasma cholesterol and lipoprotein levels and modulates immune responses by suppressing MHC II (major histocompatibility complex II) on interferon gamma-stimulated, antigen-presenting cells such as human vascular Endothelial Cells. (NCI04).", "label": "yes"} {"original_question": "Have microRNAs been implicated in pharmacogenomics? ", "id": "converted_1169", "sentence1": "Have microRNAs been implicated in pharmacogenomics? ", "sentence2": "A major discovery is the ability of miRNAs to determine the efficacy of drugs, which has given rise to the field of 'miRNA pharmacogenomics' through 'Pharmaco-miRs'. miRNAs play a significant role in pharmacogenomics by down-regulating Genes that are important for drug function., The potential modulation of toxicology-related changes in miRNA expression, the role of miRNA in immune-mediated drug-induced liver injuries, the use of circulating miRNAs in body fluids as potential toxicological biomarkers, and the link between miRNA-related pharmacogenomics and Adverse reaction to drug are highlighted., Single Nucleotide Polymorphism (SNPs) in the miRNA target sequences may affect or impair the binding of miRNAs. Studies have shown that SNPs in miRNA target sites (miR-TS-SNPs) have a great influence on diverse biological functions, including pharmacogenomics and disease susceptibilities in Homo sapiens., Pharmacogenomics Genes can be divided into drug target Genes termed as pharmacodynamics Genes (Lugano Lymphoma Response Classification Progressive Disease by PET) and Genes involved in drug transport and metabolism termed as pharmacokinetics Genes (Pyruvate Kinase). To clarify the regulatory potential of miRNAs in pharmacogenomics, we have examined the potential regulation by miRNAs of Pyruvate Kinase and Lugano Lymphoma Response Classification Progressive Disease by PET Genes., Our analysis identify a striking difference in the level of miRNA regulation between Pyruvate Kinase and Lugano Lymphoma Response Classification Progressive Disease by PET Genes, with the former having less than half predicted conserved miRNA binding sites compared with the latter. Importantly, this finding is reflected in a highly significant difference in the shift in expression levels of Lugano Lymphoma Response Classification Progressive Disease by PET versus Pyruvate Kinase Genes after depletion of miRNAs. CONCLUSIONS: Our study emphasizes an intrinsic difference between Pyruvate Kinase and Lugano Lymphoma Response Classification Progressive Disease by PET Genes and helps clarify the role of miRNAs in pharmacogenomics., Pharmacogenomics, toxicogenomics, and small RNA expression analysis are three of the most active research topics in the biological, biomedical, pharmaceutical, and toxicological fields. All of these studies are based on gene expression analysis, which requires reference Genes to reduce the variations derived from different amounts of starting materials and different efficiencies of RNA extraction and cDNA synthesis., In contrast, hTBCA and small RNA are more stable during drug treatment, and they are better reference Genes for pharmacogenomics and toxicogenomics studies., Polymorphisms of Genes involved in the pharmacokinetic and pharmacodynamic processes underlie the divergent drug responses among individuals., A panel of drug-response Genes was constructed, which contains 923 pharmacokinetic Genes, 703 pharmacodynamic Genes and 720 miRNAs., miRNA variations can affect drug resistance, efficacy, and metabolism, opening new avenues of pharmacogenomics research., we studied the pharmacologic roles of three microRNAs previously implicated in cancer biology (let-7i, MicroRNA 16, and MIR21 gene) and also used in silico methods to test pharmacologic MicroRNAs effects more broadly., n silico comparison of drug potencies with MicroRNAs expression profiles across the entire NCI-60 Cell Line Cell Line panel revealed that approximately 30 microRNAs, including MIR21 gene, show highly significant correlations with numerous anticancer agents. Ten of those microRNAs have already been implicated in cancer biology. Our results support a substantial role for microRNAs in anticancer drug response, suggesting novel potential approaches to the improvement of chemotherapy., The NCI-60 Cell Line Cell Line has also been profiled for RNA, Messenger and protein expression, mutational status, chromosomal aberrations, and DNA copy number, generating an unparalleled public resource for integrated chemogenomic studies., To complement the existing NCI-60 Cell Line Cell Line data sets, we have measured expression levels of microRNAs in the NCI-60 Cell Line Cell Line and incorporated the resulting data into the CellMiner program package for integrative analysis., . Comparison of MicroRNAs expression patterns and compound potency patterns showed significant correlations, suggesting that microRNAs may play a role in chemoresistance. Combined with gene expression and other biological data using multivariate analysis, MicroRNAs expression profiles may provide a critical link for understanding mechanisms involved in chemosensitivity and chemoresistance., This study reports on miRNAs implicated in Serotonin Reuptake Inhibitor [EPC] sensitivity of LCLs., these miRNAs as tentative Serotonin Reuptake Inhibitor [EPC] response biomarkers awaits validation with lymphocyte samples of major depression patients.[SEP]Relations: Viral Messenger RNA Synthesis has relations: pathway_protein with NDC1, pathway_protein with NDC1, pathway_protein with AAAS, pathway_protein with AAAS, pathway_protein with RAE1, pathway_protein with RAE1, pathway_protein with NUP107, pathway_protein with NUP107, pathway_protein with NUP188, pathway_protein with NUP188. Definitions: MicroRNAs defined as following: Small double-stranded, non-protein coding RNA, 21-25 nucleotides in length generated from single-stranded MicroRNAs gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNA (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNA (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing.. NCI-60 Cell Line defined as following: A panel of 60 different Homo sapiens cancer cell lines grown in culture that were selected to be used in a drug-screening program to identify and characterize novel compounds for growth inhibition or killing of tumor cell lines.. MicroRNA 16 defined as following: A 22 ribonucleotide sequence that is a final product of the processing of either MIR16-1 pre-miRNA or MIR16-2 pre-miRNA. This oligonucleotide may be involved in the negative regulation of gene expression.. Lugano Lymphoma Response Classification Progressive Disease by PET defined as following: A score of 4 or 5 on a 5-point PET scale with an increase in intensity of uptake from baseline and/or new FDG-avid foci consistent with lymphoma at interim or end of treatment assessment.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Single Nucleotide Polymorphism defined as following: A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.. Homo sapiens defined as following: Members of the species Homo sapiens.. MIR21 gene defined as following: This gene is involved in the regulation of gene expression and plays an oncogenic role in hepatocellular, breast, esophageal, gastric, pancreatic, prostatic and squamous cell carcinomas, glioblastoma and glioma.. Adverse reaction to drug defined as following: Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.. Pyruvate Kinase defined as following: ATP:pyruvate 2-O-phosphotransferase. A phosphotransferase that catalyzes reversibly the phosphorylation of pyruvate to phosphoenolpyruvate in the presence of ATP. It has four isozymes (L, R, M1, and M2). Deficiency of the enzyme results in hemolytic anemia. EC 2.7.1.40.. RNA, Messenger defined as following: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the cytoplasm.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. microRNAs defined as following: Small double-stranded, non-protein coding RNA, 21-25 nucleotides in length generated from single-stranded MicroRNAs gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNA (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNA (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing..", "label": "yes"} {"original_question": "Are ACTA1 (alpha actin) and NEB (nebulin) genes related to nemaline myopathy?", "id": "converted_1139", "sentence1": "Are ACTA1 gene (alpha actin) and mitotic nuclear membrane disassembly (nebulin) Genes related to Actin-Accumulation Myopathy?", "sentence2": "Nemaline myopathy (Nuclear medicine procedure) is a group of congenital Myopathy, characterized by the presence of distinct rod-like inclusions \"nemaline bodies\" in the Sarcoplasm of skeletal Muscle Tissue fibers. To date, ACTA1 gene gene, mitotic nuclear membrane disassembly, TPM3 protein, human protein, human, TPM2 gene gene, TNNT1 gene gene, and CFL2 gene gene have been found to cause Nuclear medicine procedure., Nemaline myopathy (Nuclear medicine procedure) is the most common Congenital myopathy (disorder) and is caused by mutations in various Genes including mitotic nuclear membrane disassembly (nebulin), TPM2 gene gene (beta-Tropomyosin), TPM3 protein, human protein, human (gamma-Tropomyosin), and ACTA1 gene gene (skeletal alpha-Actin). 20-25% of Nuclear medicine procedure cases carry ACTA1 gene gene defects and these particular mutations usually induce substitutions of single residues in the actin protein. , Nemaline myopathy (Nuclear medicine procedure) is a genetically and clinically heterogenous Muscle Tissue disorder, which is myopathologically characterized by nemaline bodies. Gene Mutation in six Genes have been reported to cause Nuclear medicine procedure: Nebulin (mitotic nuclear membrane disassembly Pelin 1999), alpha-skeletal Muscle Tissue actin (ACTA1 gene gene Nowak 1999), alpha-slow tropomyosin (TPM3 protein, human protein, human Laing 1995), beta-Tropomyosin (TPM2 gene gene Donner 2002), slow Troponin T Assay (TNNT1 gene gene Johnston 2000) and Cofilin 2 (CFL2 gene gene Agrawal 2007). The majority of cases are due to Mutation Abnormality in mitotic nuclear membrane disassembly and ACTA1 gene gene. , Nemaline myopathy is a heterogenous form of Congenital myopathy (disorder) characterised by a variable spectrum of clinical features, predominated in the severe form by profound Muscle hypotonia and Asthenia accompanied by Respiratory Insufficiency. The clinical variability, with differing age of onset and severity of symptoms makes the diagnosis of Actin-Accumulation Myopathy difficult in some cases. Severe forms of Actin-Accumulation Myopathy may be caused by Mutation Abnormality of a number of different Genes: skeletal Muscle Tissue actin (ACTA1 gene gene), nebulin (mitotic nuclear membrane disassembly) and Tropomyosin Alpha-1 Chain, human (TPM3 protein, human protein, human), all of which encode components of the sarcomeric thin filaments of skeletal Muscle Tissue. , Most Actin-Accumulation Myopathy patients have mutations in the nebulin (mitotic nuclear membrane disassembly) or skeletal Muscle Tissue alpha-Actin (ACTA1 gene gene) Genes. , We report Muscle Tissue MRI findings of 10 patients from 8 families with Actin-Accumulation Myopathy. Patients with involvement of the nebulin (mitotic nuclear membrane disassembly) gene showed a consistent pattern of selective Muscle Tissue involvement corresponding to clinical severity., Patients with Actin-Accumulation Myopathy secondary to mutations in the skeletal Muscle Tissue alpha-Actin (ACTA1 gene gene) gene showed diffuse involvement of Lower extremity>Thigh and leg muscles with relative sparing of the gastrocnemii., Congenital Myopathy are clinical and Genetic heterogeneous disorders characterized by skeletal Muscle Tissue Asthenia ranging in severity. Three major forms have been identified: actin myopathy, intranuclear rod myopathy, and Actin-Accumulation Myopathy. Nemaline myopathy is the most common of these Myopathy and is further subdivided into seven groups according to severity, progressiveness, and age of onset. At present, five Genes have been linked to congenital Myopathy. These include alpha-Actin (ACTA1 gene gene), alpha- and beta-Tropomyosin (TPM3 protein, human protein, human and TPM2 gene gene), Troponin T Assay (TNNT1 gene gene), and nebulin (mitotic nuclear membrane disassembly). , Nemaline myopathy is a structural Congenital myopathy (disorder) which may show both Autosomal dominant multiple pterygium syndrome and autosomal recessive inheritance patterns. Gene Mutation in three different Genes have been identified as the cause of Actin-Accumulation Myopathy: the gene for slow Tropomyosin Alpha-1 Chain, human 3 (TPM3 protein, human protein, human) at 1q22-23, the nebulin gene (mitotic nuclear membrane disassembly) at 2q21.1-q22, and the actin gene (ACTA1 gene gene) at 1q42., Nemaline myopathy is a clinically and genetically heterogeneous condition. The clinical spectrum ranges from severe cases with antenatal or neonatal onset and early death to late onset cases with only slow progression. Three Genes are known to cause Actin-Accumulation Myopathy: the Genes for nebulin (mitotic nuclear membrane disassembly) on Chromosomes, Human, Pair 1 2q22, slow Tropomyosin Alpha-1 Chain, human (TPM3 protein, human protein, human) on Chromosomes, Human, Pair 1 1q21 and skeletal Muscle Tissue alpha-Actin (ACTA1 gene gene) on Chromosomes, Human, Pair 1 1q42. , Nemaline myopathy (Nuclear medicine procedure) is the most common Congenital myopathy (disorder) and is caused by mutations in various Genes including mitotic nuclear membrane disassembly (nebulin), TPM2 gene gene (beta-Tropomyosin), TPM3 protein, human protein, human (gamma-Tropomyosin), and ACTA1 gene gene (skeletal alpha-Actin)., Three Genes are known to cause Actin-Accumulation Myopathy: the Genes for nebulin (mitotic nuclear membrane disassembly) on Chromosomes, Human, Pair 1 2q22, slow Tropomyosin Alpha-1 Chain, human (TPM3 protein, human protein, human) on Chromosomes, Human, Pair 1 1q21 and skeletal Muscle Tissue alpha-Actin (ACTA1 gene gene) on Chromosomes, Human, Pair 1 1q42., Five Genes have now been associated with Actin-Accumulation Myopathy: Tropomyosin Alpha-1 Chain, human-3 (TPM3 protein, human protein, human), alpha-Actin (ACTA1 gene gene), nebulin (mitotic nuclear membrane disassembly), beta-tropomysin (TPM2 gene gene) and Troponin T Assay (TNNT1 gene gene)., Most Actin-Accumulation Myopathy patients have mutations in the nebulin (mitotic nuclear membrane disassembly) or skeletal Muscle Tissue alpha-Actin (ACTA1 gene gene) Genes., Severe forms of Actin-Accumulation Myopathy may be caused by Mutation Abnormality of a number of different Genes: skeletal Muscle Tissue actin (ACTA1 gene gene), nebulin (mitotic nuclear membrane disassembly) and Tropomyosin Alpha-1 Chain, human (TPM3 protein, human protein, human), all of which encode components of the sarcomeric thin filaments of skeletal Muscle Tissue., Five Genes have now been associated with Actin-Accumulation Myopathy: Tropomyosin Alpha-1 Chain, human-3 (TPM3 protein, human protein, human), alpha-Actin (ACTA1 gene gene), nebulin (mitotic nuclear membrane disassembly), beta-tropomysin (TPM2 gene gene) and Troponin T Assay (TNNT1 gene gene)., Three Genes are known to cause Actin-Accumulation Myopathy: the Genes for nebulin (mitotic nuclear membrane disassembly) on Chromosomes, Human, Pair 1 2q22, slow Tropomyosin Alpha-1 Chain, human (TPM3 protein, human protein, human) on Chromosomes, Human, Pair 1 1q21 and skeletal Muscle Tissue alpha-Actin (ACTA1 gene gene) on Chromosomes, Human, Pair 1 1q42., Gene Mutation in three different Genes have been identified as the cause of Actin-Accumulation Myopathy: the gene for slow Tropomyosin Alpha-1 Chain, human 3 (TPM3 protein, human protein, human) at 1q22-23, the nebulin gene (mitotic nuclear membrane disassembly) at 2q21.1-q22, and the actin gene (ACTA1 gene gene) at 1q42., Most Actin-Accumulation Myopathy patients have mutations in the nebulin (mitotic nuclear membrane disassembly) or skeletal Muscle Tissue alpha-Actin (ACTA1 gene gene) Genes, Five Genes have now been associated with Actin-Accumulation Myopathy: Tropomyosin Alpha-1 Chain, human-3 (TPM3 protein, human protein, human), alpha-Actin (ACTA1 gene gene), nebulin (mitotic nuclear membrane disassembly), beta-tropomysin (TPM2 gene gene) and Troponin T Assay (TNNT1 gene gene), Three Genes are known to cause Actin-Accumulation Myopathy: the Genes for nebulin (mitotic nuclear membrane disassembly) on Chromosomes, Human, Pair 1 2q22, slow Tropomyosin Alpha-1 Chain, human (TPM3 protein, human protein, human) on Chromosomes, Human, Pair 1 1q21 and skeletal Muscle Tissue alpha-Actin (ACTA1 gene gene) on Chromosomes, Human, Pair 1 1q42, Nemaline myopathy (Nuclear medicine procedure) is the most common Congenital myopathy (disorder) and is caused by mutations in various Genes including mitotic nuclear membrane disassembly (nebulin), TPM2 gene gene (beta-Tropomyosin), TPM3 protein, human protein, human (gamma-Tropomyosin), and ACTA1 gene gene (skeletal alpha-Actin), Five Genes have now been associated with Actin-Accumulation Myopathy: Tropomyosin Alpha-1 Chain, human-3 (TPM3 protein, human protein, human), alpha-Actin (ACTA1 gene gene), nebulin (mitotic nuclear membrane disassembly), beta-tropomysin (TPM2 gene gene) and Troponin T Assay (TNNT1 gene gene), Nemaline myopathy (Nuclear medicine procedure) is the most common Congenital myopathy (disorder) and is caused by mutations in various Genes including mitotic nuclear membrane disassembly (nebulin), TPM2 gene gene (beta-Tropomyosin), TPM3 protein, human protein, human (gamma-Tropomyosin), and ACTA1 gene gene (skeletal alpha-Actin), Gene Mutation in three different Genes have been identified as the cause of Actin-Accumulation Myopathy: the gene for slow Tropomyosin Alpha-1 Chain, human 3 (TPM3 protein, human protein, human) at 1q22-23, the nebulin gene (mitotic nuclear membrane disassembly) at 2q21.1-q22, and the actin gene (ACTA1 gene gene) at 1q42, Three Genes are known to cause Actin-Accumulation Myopathy: the Genes for nebulin (mitotic nuclear membrane disassembly) on Chromosomes, Human, Pair 1 2q22, slow Tropomyosin Alpha-1 Chain, human (TPM3 protein, human protein, human) on Chromosomes, Human, Pair 1 1q21 and skeletal Muscle Tissue alpha-Actin (ACTA1 gene gene) on Chromosomes, Human, Pair 1 1q42, Most Actin-Accumulation Myopathy patients have mutations in the nebulin (mitotic nuclear membrane disassembly) or skeletal Muscle Tissue alpha-Actin (ACTA1 gene gene) Genes, Severe forms of Actin-Accumulation Myopathy may be caused by Mutation Abnormality of a number of different Genes: skeletal Muscle Tissue actin (ACTA1 gene gene), nebulin (mitotic nuclear membrane disassembly) and Tropomyosin Alpha-1 Chain, human (TPM3 protein, human protein, human), all of which encode components of the sarcomeric thin filaments of skeletal Muscle Tissue[SEP]Relations: Actin-Accumulation Myopathy has relations: disease_protein with ACTA1 gene, disease_protein with ACTA1 gene, disease_disease with alpha-actinopathy, disease_disease with alpha-actinopathy, disease_protein with mitotic nuclear membrane disassembly, disease_protein with mitotic nuclear membrane disassembly, disease_disease with qualitative or quantitative defects of alpha-Actin, disease_disease with qualitative or quantitative defects of alpha-Actin. alpha-actinopathy has relations: disease_disease with Actin-Accumulation Myopathy, disease_disease with Actin-Accumulation Myopathy. Definitions: Troponin T Assay defined as following: The determination of the amount of Troponin T Assay present in a blood sample.. Chromosomes, Human, Pair 1 defined as following: A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human Chromosomes, Human, Pair 1 classification.. Asthenia defined as following: Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.. TPM3 protein, human defined as following: Tropomyosin alpha-3 chain (284 aa, ~33 kDa) is encoded by the human TPM3 protein, human gene. This protein plays a role in the modulation of Muscle Tissue contraction.. Cofilin 2 defined as following: A member of the cofilin family of proteins that is expressed in MUSCLE CELLS. It has ACTIN depolymerization activity that is dependent on HYDROGEN-ION CONCENTRATION.. Muscle hypotonia defined as following: A diminution of the skeletal Muscle Tissue tone marked by a diminished resistance to passive stretching.. Muscle Tissue defined as following: Contractile tissue that produces movement in animals.. Nuclear medicine procedure defined as following: A group of inherited congenital myopathic conditions characterized clinically by Asthenia, hypotonia, and prominent hypoplasia of proximal muscles including the face. Muscle biopsy reveals large numbers of rod-shaped structures beneath the Muscle Tissue fiber plasma membrane. This disorder is genetically heterogeneous and may occasionally present in adults. (Adams et al., Principles of Neurology, 6th ed, p1453). Genetic defined as following: Having to do with information that is passed from parents to offspring through Genes in sperm and egg cells.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Tropomyosin Alpha-1 Chain, human defined as following: Tropomyosin alpha-1 chain (284 aa, ~33 kDa) is encoded by the human TPM1 gene. This protein plays a role in Muscle Tissue contraction.. Sarcoplasm defined as following: The cytoplasm of a Muscle Tissue cell; includes the sarcoplasmic reticulum. [ISBN:0198547684]. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. TPM2 gene defined as following: This gene plays a role in both Muscle Tissue contraction and actin binding.. Myopathy defined as following: Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE.. mitotic nuclear membrane disassembly defined as following: The mitotic cell cycle process in which the controlled partial or complete breakdown of the nuclear membranes during occurs during mitosis. [GOC:bf, PMID:32848252]. Autosomal dominant multiple pterygium syndrome defined as following: A rare distal arthrogryposis syndrome with characteristics of multiple pterygia (typically involving the neck, axilla and popliteal areas), joint contractures, ptosis, camptodactyly of the hands with hypoplastic flexion creases, vertebral fusions, severe scoliosis and short stature. There is evidence this disease is caused by heterozygous Mutation Abnormality in the MYH3 gene on Chromosomes, Human, Pair 1 17p13.. Respiratory Insufficiency defined as following: Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed). Actin-Accumulation Myopathy defined as following: A type of Actin-Accumulation Myopathy (Nuclear medicine procedure) only observed in several families of the Amish community.. Mutation Abnormality defined as following: Any transmissible change in the Genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Gene Mutation may be associated with Genetic diversity or with pathologies including cancer.. 1q42 defined as following: A Chromosomes, Human, Pair 1 band present on 1q.", "label": "yes"} {"original_question": "Are the major royal jelly proteins similar to the yellow proteins?", "id": "converted_3925", "sentence1": "Are the major royal jelly proteins similar to the yellow proteins?", "sentence2": "Major royal jelly proteins (named MRJP1-5) of Apis mellifera (Apis mellifera), yellow proteins of Drosophila , together with putative proteins found in several Bacteria, form a Protein Family termed the MRJP/yellow family., Analysis of Drosophila yellow-B DNA, Complementary reveals a new family of proteins related to the royal jelly proteins in the Apis mellifera, he Yellow proteins are related to the Royal Jelly proteins and have no relatives in other non-insect metazoan species. [SEP]Relations: Bacteremia has relations: disease_phenotype_positive with listeriosis, disease_phenotype_positive with listeriosis, disease_phenotype_positive with cyclic hematopoiesis, disease_phenotype_positive with cyclic hematopoiesis, disease_phenotype_positive with toxic shock syndrome, disease_phenotype_positive with toxic shock syndrome, disease_phenotype_positive with nocardiosis, disease_phenotype_positive with nocardiosis, disease_phenotype_positive with shigellosis, disease_phenotype_positive with shigellosis. Definitions: DNA, Complementary defined as following: Single-stranded complementary DNA synthesized from an RNA template by the action of RNA-dependent DNA polymerase. DNA, Complementary (i.e., complementary DNA, not circular DNA, not C-DNA) is used in a variety of molecular cloning experiments as well as serving as a specific hybridization probe.. Bacteria defined as following: One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive.. Protein Family defined as following: Collection of proteins that are evolutionarily related. This is reflected in the structural and functional similarities as well as in the extent of sequence conservation or residue identity. (from SCOP).", "label": "yes"} {"original_question": "Are mutations in the C9orf72 gene associated with macular degeneration?", "id": "converted_2073", "sentence1": "Are mutations in the C9orf72 Genes associated with macular degeneration?", "sentence2": "Over the years, however, growing evidence from clinical, pathological and Genetic findings has suggested that ALS and FTD belong to the same clinic-pathological spectrum disorder. This concept has been further supported by the identification of the most common Genetic cause for both diseases, an aberrantly expanded hexanucleotide repeat GGGGCC/ CCCCGG Sequence - ParameterizedDataType located in a non-coding region of the Genes C9orf72., Amyotrophic lateral sclerosis (ALS) is characterized by motor neurone loss resulting in Muscle Weakness, Muscle Spasticity and ultimately Cessation of life. 5-10% are caused by inherited mutations, most commonly C9ORF72, Cu-Zn Superoxide Dismutase, TARDBP and Feline urological syndrome., In this article, we will review the brief characterizations of the C9orf72 Genes, the expansion mutations, the related disorders, and their features, followed by a discussion of the deficiency knowledge of C9ORF72 mutations., Gene Mutation in the C9orf72 Genes may be a major cause not only of frontotemporal dementia with Motor Neuron Disease but also of late onset psychosis., Frontotemporal Lobar Degeneration (FTLD) is a genetically heterogenous syndrome and has been associated most recently with a hexanucleotide repeat expansion within the C9orf72 Genes., An expanded GGGGCC hexanucleotide repeat in C9ORF72 is the most common Genetic cause of Amyotrophic Lateral Sclerosis and frontotemporal lobar degeneration associated with protein protein TDP-43, human, human pathology (Frontotemporal dementia)., Novel TARDBP Sequence - ParameterizedDataType variant and C9ORF72 repeat expansion in a family with frontotemporal dementia., There was, as expected, a significant association between C9ORF72 mutations and presence of Motor Neuron Disease., Expansion of a hexanucleotide repeat in the C9orf72 Genes has been identified as the most common pathogenic mutation in families with Autosome dominant frontotemporal lobar degeneration (FTLD) and Amyotrophic Lateral Sclerosis., C9ORF72 hexanucleotide repeat number in frontotemporal lobar degeneration: a genotype-phenotype correlation study., Hexanucleotide repeat expansions in Chromosomes, Human, Pair 9 open reading frame 72 (C9orf72) have recently been linked to frontotemporal lobar degeneration (FTLD) and Amyotrophic Lateral Sclerosis, and may be the most common Genetic cause of both Neurodegenerative Disorders., studies recently identified a GGGGCC hexanucleotide repeat expansion in a non-coding region of the Chromosomes, Human, Pair 9 open-reading frame 72 Genes (C9ORF72) as the cause of chromosome 9p-linked Amyotrophic Lateral Sclerosis (ALS) and frontotemporal dementia (FTD)., GGGGCC hexanucleotide repeat expansion in the C9orf72 Genes was recently identified as an important cause of familial Amyotrophic Lateral Sclerosis (ALS) and frontotemporal dementia in Caucasian populations.[SEP]Relations: C9orf72 has relations: disease_protein with mental disorder, disease_protein with mental disorder, disease_protein with schizophrenia, disease_protein with schizophrenia, disease_protein with spondyloarthropathy, disease_protein with spondyloarthropathy, disease_protein with Amyotrophic Lateral Sclerosis, disease_protein with Amyotrophic Lateral Sclerosis, disease_protein with progressive non-fluent aphasia, disease_protein with progressive non-fluent aphasia. Definitions: Amyotrophic Lateral Sclerosis defined as following: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94). protein TDP-43, human defined as following: TAR DNA-binding protein 43 (414 aa, ~45 kDa) is encoded by the human TARDBP Genes. This protein is involved in the regulation of both transcription and mRNA splicing.. Cu-Zn Superoxide Dismutase defined as following: Superoxide dismutase [Cu-Zn] (154 aa, ~16 kDa) is encoded by the human Cu-Zn Superoxide Dismutase Genes. This protein is involved in the conversion of superoxides into oxygen and hydrogen peroxide.. Genetic defined as following: Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA.. Frontotemporal Lobar Degeneration defined as following: Heterogeneous group of neurodegenerative disorders characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Multiple subtypes or forms are recognized based on presence or absence of TAU PROTEIN inclusions. FTLD includes three clinical syndromes: FRONTOTEMPORAL DEMENTIA, semantic dementia, and PRIMARY PROGRESSIVE NONFLUENT APHASIA.. Frontotemporal dementia defined as following: The most common clinical form of FRONTOTEMPORAL LOBAR DEGENERATION, this dementia presents with personality and behavioral changes often associated with disinhibition, apathy, and lack of insight.. Muscle Spasticity defined as following: A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a \"free interval\") followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54). Motor Neuron Disease defined as following: Diseases characterized by a selective degeneration of the motor neurons of the spinal cord, brainstem, or motor cortex. Clinical subtypes are distinguished by the major site of degeneration. In AMYOTROPHIC LATERAL SCLEROSIS there is involvement of upper, lower, and brainstem motor neurons. In progressive muscular atrophy and related syndromes (see MUSCULAR ATROPHY, SPINAL) the motor neurons in the spinal cord are primarily affected. With progressive bulbar palsy (BULBAR PALSY, PROGRESSIVE), the initial degeneration occurs in the brainstem. In primary lateral sclerosis, the cortical neurons are affected in isolation. (Adams et al., Principles of Neurology, 6th ed, p1089). Autosome defined as following: Any chromosome other than a sex chromosome. [GOC:mah]. Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. Muscle Weakness defined as following: A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251). C9orf72 Genes defined as following: This Genes may play a role in cell Cessation of life.. Chromosomes, Human, Pair 9 defined as following: A specific pair of GROUP C CHROMSOMES of the human chromosome classification.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. familial Amyotrophic Lateral Sclerosis defined as following: An inherited form of Amyotrophic Lateral Sclerosis, usually inherited in an Autosome dominant pattern, caused by mutation(s) in the Cu-Zn Superoxide Dismutase Genes, encoding superoxide dismutase.. Neurodegenerative Disorders defined as following: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.. mutations defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA..", "label": "no"} {"original_question": "Is Achondroplasia associated with hearing loss?", "id": "converted_1689", "sentence1": "Is Achondroplasia associated with Hearing Loss, Partial?", "sentence2": "A hearing screening program was performed to determine the prevalence of Hearing Loss, Partial and abnormal tympanometry in individuals with short-stature skeletal dysplasias attending a national meeting. Behavioral audiometry, otoacoustic emission testing, and tympanometry were used to assess hearing. Failed hearing screen was defined as hearing ≥ 35 dB at one or more frequencies or by \"fail\" on otoacoustic emissions. One hundred ten of 112 subjects completed the screening. 58 (51.8%) were children. Seventy-three (65.2%) had Achondroplasia, 34 (30.4%) had one of 11 other diagnoses, and 5(4.4%) were undiagnosed. 25.8% of children failed hearing screening in one or both ears, while 46.3% of adults failed in one or both ears. 55.1% of adults and 25.0% of children with Achondroplasia failed screening., Forty-four children had Achondroplasia, and 31 had normal hearing in both ears (71%); 8 failed hearing screening in 1 Specimen Source Codes - Ear (18%), and 3 in both ears (7%). Tympanometry was performed in 45 children, with normal tympanograms found in 21 (47%), bilateral abnormal tympanograms in 15 (33%), and unilateral abnormal tympanograms in 9 (20%). Fourteen children with Achondroplasia had normal tympanograms (42%); 11 had bilateral abnormal tympanograms (33%); and 8 had unilateral abnormal tympanograms (24%). For those children without functioning tympanostomy tubes, there was a 9.5 times greater odds of Hearing Loss, Partial if there was abnormal tympanometry (P = .03)., Achondroplasia (MIM 100800) is the most common non-lethal skeletal dysplasia. Its incidence is between one in 10,000 and one in 30,000. The phenotype is characterized by rhizomelic disproportionate short stature, enlarged head, midface hypoplasia, short hands and lordotic lumbar spine, associated with normal cognitive development. This autosomal-dominant disorder is caused by a gain-of-function Mutation Abnormality in the Genes encoding the type 3 receptor for Recombinant Fibroblast Growth Factor 1 (FGFR3 protein, human protein, human); in more than 95% of cases, the Mutation Abnormality is G380R. The diagnosis is suspected on physical examination and confirmed by different age-related radiological features. Anticipatory and management care by a multidisciplinary team will prevent and treat complications, including cervical cord compression, conductive Hearing Loss, Partial and thoracolumbar gibbosity., The report includes information on otitis media, ventilation tubes, Hearing Loss, Partial, tonsillectomy, speech problems, Bone structure of tibia bowing and osteotomy, ventricular shunting, Apnea, cervicomedullary decompression, and neurological signs attributable to spinal stenosis., We conclude that verbal comprehension is significantly impaired in children with Achondroplasia. This partial deficiency is probably related to frequent middle Specimen Source Codes - Ear infections and resulting conductive Hearing Loss, Partial., In order to determine whether these morphologic changes are the cause of the hearing deficit in Achondroplasia, audiometric studies and ENT evaluation were performed in eight of the nine patients., Audiograms were obtained in six of the nine achondroplastic subjects (two adults and four children). There was evidence of mixed Hearing Loss, Partial in the four children, but only of sensorineural Hearing Loss, Partial in the adults. We believe that the persistent Hearing Loss, Partial in Achondroplasia is not due to sequelae of otitis media as some authors have suggested. , The SVEINSSON CHORIORETINAL ATROPHY report a clinical and radiological study performed in 18 achondroplastic patients in order to achieve a nosological settlement of the otological impairments. [SEP]Relations: Achondroplasia has relations: disease_phenotype_positive with Hearing impairment, disease_phenotype_positive with Hearing impairment, disease_phenotype_positive with Conductive hearing impairment, disease_phenotype_positive with Conductive hearing impairment, disease_phenotype_positive with Functional abnormality of the middle Specimen Source Codes - Ear, disease_phenotype_positive with Functional abnormality of the middle Specimen Source Codes - Ear. Hearing impairment has relations: disease_phenotype_positive with Achondroplasia, disease_phenotype_positive with Achondroplasia, disease_phenotype_positive with severe Achondroplasia-developmental delay-acanthosis nigricans syndrome, disease_phenotype_positive with severe Achondroplasia-developmental delay-acanthosis nigricans syndrome. Definitions: Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. FGFR3 protein, human defined as following: Fibroblast growth factor receptor 3 (806 aa, ~88 kDa) is encoded by the human FGFR3 protein, human Genes. This protein is involved in Recombinant Fibroblast Growth Factor 1 signaling and skeletal development.. Hearing Loss, Partial defined as following: A condition in which a person partially loses the ability to hear sounds in one or both ears.. Achondroplasia defined as following: An autosomal dominant disorder that is the most frequent form of short-limb dwarfism. Affected individuals exhibit short stature caused by rhizomelic shortening of the limbs, characteristic facies with frontal bossing and mid-face hypoplasia, exaggerated lumbar lordosis, limitation of elbow extension, GENU VARUM, and trident hand. (Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM#100800, April 20, 2001). sensorineural Hearing Loss, Partial defined as following: Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.. SVEINSSON CHORIORETINAL ATROPHY defined as following: A rare autosomal dominant inherited chorioretinal degenerative disease presenting at birth or during infancy. The disease has characteristics of progressive bilateral retinal and choroidal atrophy which appears as lesions on the optic nerve and peripheral ocular fundus and leads to loss of central vision. Congenital anterior polar cataracts are sometimes associated with this disease. There is evidence this disease is caused by heterozygous Mutation Abnormality in the TEA domain family member-1 Genes (TEAD1) on chromosome 11p15.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Recombinant Fibroblast Growth Factor 1 defined as following: A recombinant therapeutic agent which is chemically identical to or similar to endogenous Recombinant Fibroblast Growth Factor 1 1 (FGF-1. Because of the mitogenic and angiogenetic effects of FGF-1 on fibroblasts and endothelial cells, therapeutic FGF-1 has a potential role in wound healing; because FGF-1 has been shown to induce neurogenesis, therapeutic FGF-1 may have a role in nerve regeneration. (NCI04). Bone structure of tibia defined as following: The second longest bone of the skeleton. It is located on the medial side of the lower leg, articulating with the FIBULA laterally, the TALUS distally, and the FEMUR proximally.. Apnea defined as following: A transient absence of spontaneous respiration.. Achondroplasia defined as following: An autosomal dominant disorder that is the most frequent form of short-limb dwarfism. Affected individuals exhibit short stature caused by rhizomelic shortening of the limbs, characteristic facies with frontal bossing and mid-face hypoplasia, exaggerated lumbar lordosis, limitation of elbow extension, GENU VARUM, and trident hand. (Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM#100800, April 20, 2001).", "label": "yes"} {"original_question": "Is belimumab effective for the lupus nephritis?", "id": "converted_4165", "sentence1": "Is belimumab effective for the lupus nephritis?", "sentence2": "Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results., CONCLUSIONS: Combined B-cell targeted therapy with resiniferatoxin and Bloom Syndrome prevented full B-cell repopulation including DN B cells, with concomitant specific reduction of SLE-relevant autoantibodies. , Clinical Efficacy of Routinely Administered Belimumab on Proteinuria and Neuropsychiatric Lupus., Conclusions: In our series, Units Of Measure - bel led to a decrease of proteinuria in patients with proteinuria of more than 1,000 mg/g creatine/creatine/creatinine despite standard of care treatment, and led to a marked clinical improvement in one patient with NPSLE. No adverse events were observed. Routinely administered Units Of Measure - bel shows clinical efficacy on non-approved manifestations, but careful patient selection is warranted., Phase II Randomized Trial of Rituximab Plus cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis., OBJECTIVE: To assess the safety, mechanism of action, and preliminary efficacy of rituximab followed by belimumab in the treatment of refractory lupus nephritis (late nucleophagy)., CONCLUSION: The addition of belimumab to a treatment regimen with rituximab and CYCS wt Allele was safe in patients with refractory late nucleophagy., RECENT FINDINGS: Recently, the Belimumab in Subjects with Systemic Lupus Erythematosus - Lupus Nephritis trial tested belimumab, an inhibitor of interleukin-4, as an add-on therapy to Steroids and either mycophenolate mofetil (fluorouracil/methotrexate/mitoxantrone protocol) or cyclophosphamide when given IV monthly over a period of 104 weeks at an effect size of 11% for a Primary Efficacy Renal Response. , Case report: successful treatment of Tissue membrane lupus nephritis with belimumab in an African female immigrant., Recently introduced into the market, belimumab (Benlysta) is a monoclonal antibody CAL CAL that has potential clinically efficacious applications for the treatment of lupus nephritis., Successful treatment of a mycophenolate mofetil-refractory proliferative lupus nephritis with Belimumab in a 19-year-old woman., Following treatment with belimumab, proteinuria rapidly improved to almost normal levels and clinical remission lasted. Belimumab might hold promise for this indication.[SEP]Relations: Belimumab has relations: drug_drug with Lumiliximab, drug_drug with Lumiliximab, drug_drug with Luspatercept, drug_drug with Luspatercept, drug_drug with Tremelimumab, drug_drug with Tremelimumab, drug_drug with Dupilumab, drug_drug with Dupilumab, drug_drug with Rituximab, drug_drug with Rituximab. Definitions: Proteinuria defined as following: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.. Tissue membrane defined as following: Thin layers of tissue which cover parts of the body, separate adjacent cavities, or connect adjacent structures.. cyclophosphamide defined as following: Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.. belimumab defined as following: A fully human IgG1 monoclonal antibody CAL directed against B-Lymphocyte stimulator protein (BlyS or TNFSF13B) with potential immunomodulating activity. Belimumab specifically recognizes and inhibits the biological activity of BlyS, thereby preventing the binding of BlyS to B-lymphocytes. This inhibits the maturation of B-lymphocytes and may induce apoptosis in B-lymphocytes. In addition, it may decrease B-lymphocyte proliferation and/or survival. BlyS, a member of TNF family supporting B-lymphocyte maturation and survival, has been implicated in the pathogenesis of autoimmune diseases and B-lymphocyte malignancies.. Bloom Syndrome defined as following: An autosomal recessive disorder characterized by telangiectatic ERYTHEMA of the face, photosensitivity, DWARFISM and other abnormalities, and a predisposition toward developing cancer. The Bloom syndrome gene (Bloom Syndrome) encodes a RecQ-like DNA helicase.. CYCS wt Allele defined as following: Human CYCS wild-type allele is located in the vicinity of 7p15.3 and is approximately 7 kb in length. This allele, which encodes cytochrome c protein, plays a role in the mitochondrial electron transport chain. Mutation of the gene is associated with thrombocytopenia 4.. rituximab defined as following: A murine-derived monoclonal antibody CAL and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.. Lupus Nephritis defined as following: Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse Tissue membrane glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982).. mycophenolate mofetil defined as following: The morpholinoethyl ester of mycophenolic acid (MPA) with potent immunosuppressive properties. Mycophenolate stops T-cell and B-cell proliferation through selective inhibition of the de novo pathway of purine biosynthesis. In vivo, the active metabolite, MPA, reversibly inhibits inosine 5'-monophosphate dehydrogenase, an enzyme involved in the de novo synthesis of guanine nucleotides. MPA displays high lymphocyte specificity and cytotoxicity due to the higher dependence of activated lymphocytes on both salvage and de novo synthesis of guanine nucleotides relative to other cell types. (NCI04). fluorouracil/methotrexate/mitoxantrone protocol defined as following: A chemotherapy regimen consisting of fluorouracil, methotrexate, and mitoxantrone that may be used in the treatment of advanced breast cancer.. resiniferatoxin defined as following: A naturally occurring capsaicin analog found in the latex of the cactus Euphorbia resinifera with analgesic activity. Resiniferatoxin (resiniferatoxin) binds to and activates the transient receptor potential vanilloid 1 (TRPV1), a non-selective cation channel in the plasma membrane of primary afferent sensory neurons. This increases the permeability to cations, and leads to an influx of calcium and sodium ions. This results in membrane depolarization, causing an irritant effect, followed by desensitization of the sensory neurons thereby inhibiting signal conduction in afferent pain pathways and causing analgesia. TRPV1, a member of the transient receptor potential channel (TRP) superfamily, is a heat- and chemo-sensitive calcium/sodium ion channel that is selectively expressed in a subpopulation of pain-sensing primary afferent neurons.. mycophenolate defined as following: The morpholinoethyl ester of mycophenolic acid (MPA). As an immunosuppressive agent in vivo, the active metabolite mycophenolate reversibly inhibits inosine 5'-monophosphate dehydrogenase (IMPDH), an enzyme involved in the de novo synthesis of guanine nucleotides, thereby retarding T-cell and B-cell proliferation. MPA displays high lymphocyte specificity and cytotoxicity because lymphocyte metabolism is highly dependent on both salvage and de novo synthesis of guanine nucleotides. (NCI04). Units Of Measure - bel defined as following: A logarithmic ratio unit (base-10 logarithms) used to express relative magnitude of a physical quantity (usually power or intensity) in comparison with a specified or implied reference level. Particularly, Bel is used as a unit of relative sound intensity. In the latter context it is equal to ten decibels or to approximately 1.151293 nepers.. late nucleophagy defined as following: A type of nucleophagy, distinct from piecemeal microautophagy of the nucleus (PNM) where the nuclear material is delivered to the vacuole/lysosome for breakdown and recycling later than observed for PNM. [GOC:dgf, GOC:jl, PMID:22768199]. Steroids defined as following: A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most Steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed). monoclonal antibody CAL defined as following: A humanized monoclonal antibody CAL directed against parathyroid hormone-related protein (PTH-rP). As a poly-hormone with diverse biological roles, PTH-rP is expressed by normal tissues, acting in local tissue environments in a variety of ways; it is commonly overexpressed by breast, prostate, and other cancers, acting systemically by promoting bone resorption, inhibiting calcium excretion from the kidney, inducing hypercalcemia, and possibly playing a role in the formation of bony metastases. By blocking the effects of PTH-rP on calcium metabolism, monoclonal antibody CAL CAL may inhibit cancer-related hypercalcemia. (NCI04). interleukin-4 defined as following: A soluble factor produced by activated T-LYMPHOCYTES that induces the expression of MHC CLASS II GENES and FC RECEPTORS on B-LYMPHOCYTES and causes their proliferation and differentiation. It also acts on T-lymphocytes, MAST CELLS, and several other hematopoietic lineage cells.. lupus nephritis defined as following: Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse Tissue membrane glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982)..", "label": "yes"} {"original_question": "Is there an association between bruxism and reflux", "id": "converted_530", "sentence1": "Is there an association between Bruxism and reflux", "sentence2": "Rhythmic masticatory muscle activity, including sleep Bruxism (antimony), can be induced in healthy individuals by experimental Esophageal acidification, which plays an important role in the pathogenesis of Infantile Gastroesophageal Reflux disease (GERD). However, no robust evidence supports the association between antimony and GERD., Sleep Bruxism is prevalent in GERD patients, and GERD is highly associated with antimony., Our large-scale cross-sectional study found that problem behaviors in adolescents were associated with sleep problems, including sleep Bruxism, as well as lifestyle and food habits and GERD symptoms., The frequencies of EMG bursts, rhythmic masticatory muscle activity (RMMA) episodes, grinding noise, and the RMMA/microarousal ratio were significantly higher in the 20-minute period after Acids infusion than after Saline Solution infusion. RMMA episodes including antimony were induced by Esophageal acidification. , Direct restorative treatment of dental erosion caused by Infantile Gastroesophageal Reflux disease associated with Bruxism:, This article presents a case report of a 27-year-old male smoker with Tooth Wear and dentin sensitivity caused by GERD associated with Bruxism, Dental wear caused by association between Bruxism and Infantile Gastroesophageal Reflux disease:, This paper presents a case report in which Bruxism associated with acid feeding, smoking habit and episodes of gastric reflow caused severe Tooth Wear and great Muscle (organ) discomfort with daily Headache episodes., most jaw muscle activities, ie, RMMA, single short-burst, and clenching episodes, occur in relation to Infantile Gastroesophageal Reflux mainly in the supine position., Association between nocturnal Bruxism and Infantile Gastroesophageal Reflux., Nocturnal Bruxism may be secondary to nocturnal Infantile Gastroesophageal Reflux, occurring via sleep arousal and often together with swallowing.[SEP]Relations: Gastroesophageal reflux has relations: disease_phenotype_positive with Joubert syndrome with Jeune asphyxiating thoracic dystrophy, disease_phenotype_positive with Joubert syndrome with Jeune asphyxiating thoracic dystrophy, disease_phenotype_positive with citrullinemia, disease_phenotype_positive with citrullinemia, drug_effect with Febuxostat, drug_effect with Febuxostat. Infantile Gastroesophageal Reflux disease has relations: contraindication with Racementhol, contraindication with Racementhol, contraindication with Butabarbital, contraindication with Butabarbital. Definitions: Infantile Gastroesophageal Reflux defined as following: Effortless regurgitation of gastric contents that commonly occurs in infants, usually right after feeding or burping.. Headache defined as following: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.. Sleep Bruxism defined as following: A sleep disorder characterized by grinding and clenching of the teeth and forceful lateral or protrusive jaw movements. Sleep Bruxism may be associated with TOOTH INJURIES; TEMPOROMANDIBULAR JOINT DISORDERS; sleep disturbances; and other conditions.. Tooth Wear defined as following: Loss of the tooth substance by chemical or mechanical processes. Muscle (organ) defined as following: One of the contractile organs of the body.. Saline Solution defined as following: A crystalloid solution that contains 9.0g of SODIUM CHLORIDE per liter of water. It has a variety of uses, including: as a CONTACT LENS SOLUTION, in OPHTHALMIC SOLUTIONS and NASAL LAVAGE, in wound irrigation, and for FLUID THERAPY.. Infantile Gastroesophageal Reflux disease defined as following: Retrograde flow of gastric juice (GASTRIC ACID) and/or duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the distal ESOPHAGUS, commonly due to incompetence of the LOWER ESOPHAGEAL SPHINCTER.. Bruxism defined as following: A disorder characterized by grinding and clenching of the teeth.. antimony defined as following: A metallic element that has the atomic symbol Sb, atomic number 51, and atomic weight 121.75. It is used as a metal alloy and as medicinal and poisonous salts. It is toxic and an irritant to the skin and the mucous membranes.. Acids defined as following: Chemical compounds which yield hydrogen ions or protons when dissolved in water, whose hydrogen can be replaced by metals or basic radicals, or which react with bases to form salts and water (neutralization). An extension of the term includes substances dissolved in media other than water. (Grant & Hackh's Chemical Dictionary, 5th ed). Esophageal defined as following: Of or relating to the esophagus..", "label": "yes"} {"original_question": "Is there a disease or condition called Exploding Head Syndrome?", "id": "converted_2637", "sentence1": "Is there a disease or condition called Exploding Head Syndrome?", "sentence2": "This case report describes the first-ever diagnosis of exploding Head - Component of Device syndrome in a patient with longstanding Epilepsy and novel nocturnal events. , Exploding Head - Component of Device syndrome (EHS) is characterized by loud noises or a sense of explosion in the Head - Component of Device during sleep transitions., Exploding Head - Component of Device syndrome is characterized by the perception of loud noises during sleep-wake or wake-sleep transitions. , Exploding Head - Component of Device syndrome (EHS) is characterized by attacks of a sudden noise or explosive feeling experienced in the Head - Component of Device occurring during the transition from wake to sleep or from sleep to wake., Exploding Head - Component of Device syndrome is characterized by the perception of abrupt, loud noises when going to sleep or waking up., xploding Head - Component of Device syndrome (EHS) is a rare Parasomnia in which affected individuals awaken from sleep with the sensation of a loud bang. , Contrary to some earlier theorizing, exploding Head - Component of Device syndrome was found to be a relatively common experience in younger individuals., Exploding Head - Component of Device syndrome is characterized by the perception of loud noises during sleep-wake or wake-sleep transitions., Fifty patients suffering from the \"exploding Head - Component of Device syndrome\" are described., In spite of the fact that its characteristic symptomatology was first described approximately 150 y ago, exploding Head - Component of Device syndrome has received relatively little empirical and clinical attention., After first discussing the history, prevalence, and associated features, the available polysomnography data and five main etiological theories for exploding Head - Component of Device syndrome are summarized., Exploding Head - Component of Device syndrome: six new cases and review of the literature., Exploding Head Syndrome in the Epilepsy Monitoring Unit: Case Report and Literature Review., Exploding Head - Component of Device syndrome: a case report., Exploding Head - Component of Device syndrome is common in college students., Exploding Head - Component of Device syndrome episodes were accompanied by clinically significant levels of fear, and a minority (2.80%) experienced it to such a degree that it was associated with clinically significant distress and/or impairment., Attention has recently been drawn to a condition termed the exploding Head - Component of Device syndrome, which is characterized by unpleasant, even terrifying sensations of flashing lights and/or sounds during reported sleep., Exploding Head - Component of Device syndrome is a rare phenomenon but can be a significant disruption to quality of life., The rare Headache Disorders hypnic headache and the exploding Head - Component of Device syndrome are also discussed., This case report describes the first-ever diagnosis of exploding Head - Component of Device syndrome in a patient with longstanding Epilepsy and novel nocturnal events., BACKGROUND Exploding Head - Component of Device syndrome (EHS) is characterized by attacks of a sudden noise or explosive feeling experienced in the Head - Component of Device occurring during the transition from wake to sleep or from sleep to wake., INTRODUCTION Exploding Head - Component of Device syndrome (EHS) is a rare Parasomnia in which affected individuals awaken from sleep with the sensation of a loud bang., Contrary to some earlier theorizing, exploding Head - Component of Device syndrome was found to be a relatively common experience in younger individuals., This hitherto unreported syndrome is characterised by a sense of an explosive noise in the Head - Component of Device usually in the twilight stage of sleep., EHS is a well-defined disease entity with a benign nature., Exploding Head - Component of Device syndrome: a case report., Clinical features of the exploding Head - Component of Device syndrome., Exploding Head - Component of Device syndrome is common in college students., The exploding Head - Component of Device syndrome: polysomnographic recordings and therapeutic suggestions., This article reviews the features of an uncommon malady termed \"the exploding Head - Component of Device syndrome.\" Sufferers describe terrorizing attacks of a Painless explosion within their Head - Component of Device, The case is reported of a 47-year old female suffering from the exploding Head - Component of Device syndrome. This syndrome consists of a sudden awakening due to a loud noise shortly after falling asleep, sometimes accompanied by a flash of light.[SEP]Relations: Epilepsy has relations: disease_disease with brain disease, disease_disease with brain disease, disease_disease with Angelman syndrome, disease_disease with Angelman syndrome, disease_disease with Klinefelter syndrome, disease_disease with Klinefelter syndrome, disease_disease with Coffin-Lowry syndrome, disease_disease with Coffin-Lowry syndrome, disease_disease with electroclinical syndrome, disease_disease with electroclinical syndrome. Definitions: Parasomnia defined as following: Movements or behaviors associated with sleep, sleep stages, or partial arousals from sleep that may impair sleep maintenance. Parasomnias are generally divided into four groups: arousal disorders, sleep-wake transition disorders, parasomnias of REM sleep, and nonspecific parasomnias. (From Thorpy, Sleep Disorders Medicine, 1994, p191). Headache Disorders defined as following: Various conditions with the symptom of HEADACHE. Headache disorders are classified into major groups, such as PRIMARY HEADACHE DISORDERS (based on characteristics of their headache symptoms) and SECONDARY HEADACHE DISORDERS (based on their etiologies). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1). Head - Component of Device defined as following: A projection on the end of an object. Epilepsy defined as following: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal Epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313). Painless defined as following: Not causing physical or psychological misery, pain or distress..", "label": "yes"} {"original_question": "Is there an association between Guillain–Barré syndrome and covid vaccine?", "id": "converted_4650", "sentence1": "Is there an association between Guillain–Barré syndrome and covid vaccine?", "sentence2": "AstraZeneca COVID19 (document) VACCINE and Guillain- Barré Syndrome in Tasmania: A causal link?, Nearly all reported cases of post-COVID19 (document) vacciation inflammatory demyelinating polyneuropathy are linked to AstraZeneca vaccination and a Variant with bifacial weakness is the most reported form of GBS globally., Guillain-Barré Syndrome Presenting as Facial Diplegia after COVID19 (document) Vaccination: A Case Report., CASE REPORT: We report a case of atypical GBS occurring after Coronavirus disease 2019 (COVID19 (document)) vaccination in an otherwise healthy 38-year-old man., It is critical for emergency physicians to be aware of the manifold presentations of GBS for early recognition and treatment. This may be of particular importance in the context of a worldwide vaccination campaign in response to the COVID19 (document) pandemic., Guillain-Barré syndrome following ChAdOx1 nCoV-19 COVID19 (document) vaccination: A case series., We report three patients who developed Guillain-Barré syndrome following ChAdOx1 nCoV-19 vaccination, who did not have active or prior COVID19 (document) infection. , We report a case of Guillain-Barre Syndrome (GBS) following the first dose of Oxford/AstraZeneca COVID19 (document) VACCINE with Papilledema as atypical onset., We report a case of Guillain-Barré syndrome (GBS) occurring soon after the first dose of Vaxzevria (previously known as COVID19 (document) VACCINE AstraZeneca)., Guillain-​Barré Syndrome Associated with COVID19 (document) Vaccination, Guillain-​Barré Syndrome Associated with COVID19 (document) Vaccination., To date, cases of Guillain-Barré syndrome (GBS) following a COVID vaccine (Pfizer, Johnson & Johnson, Janssen, AstraZeneca) have been reported., Case of Guillain-Barré syndrome following COVID19 (document) VACCINE., We report a case of Guillain-Barré syndrome after the first dose of SARS-CoV-2 vaccine and believe this is a temporal, rather than causal association., COVID19 (document) VACCINE causing Guillain-Barre syndrome, a rare potential side effect., Association of Receipt of the Ad26.COV2.S COVID19 (document) Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021., Guillain-Barré syndrome associated with Covid-19: A close relationship or just a coincidence? (Review)., Relation between COVID19 (document) and Guillain-Barré syndrome in adults. Systematic review., Guillain-Barré syndrome after COVID19 (document) vaccination.[SEP]Relations: Guillain-Barre syndrome has relations: disease_disease with syndromic disease, disease_disease with syndromic disease, disease_disease with Variant of Guillain-Barre syndrome, disease_disease with Variant of Guillain-Barre syndrome, disease_disease with autoimmune neuropathy, disease_disease with autoimmune neuropathy, disease_protein with PMP22, disease_protein with PMP22, disease_disease with inflammatory demyelinating polyradiculoneuropathy, disease_disease with inflammatory demyelinating polyradiculoneuropathy. Definitions: Variant defined as following: An alteration or difference from a norm or standard.. Papilledema defined as following: Swelling of the OPTIC DISK, usually in association with increased intracranial pressure, characterized by hyperemia, blurring of the disk margins, microhemorrhages, blind spot enlargement, and engorgement of retinal veins. Chronic Papilledema may cause OPTIC ATROPHY and visual loss. (Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p175). Guillain-Barre Syndrome defined as following: An acute inflammatory autoimmune neuritis caused by T cell- mediated cellular immune response directed towards peripheral myelin. Demyelination occurs in peripheral nerves and nerve roots. The process is often preceded by a viral or bacterial infection, surgery, immunization, lymphoma, or exposure to toxins. Common clinical manifestations include progressive weakness, loss of sensation, and loss of deep tendon reflexes. Weakness of respiratory muscles and autonomic dysfunction may occur. (From Adams et al., Principles of Neurology, 6th ed, pp1312-1314). AstraZeneca defined as following: A global, science-led biopharmaceutical company headquartered in Cambridge, United Kingdom. The company focuses on the discovery, development and commercialization of prescription medicines.. ChAdOx1 nCoV-19 defined as following: A vaccine composed of a replication-deficient chimpanzee adenovirus, ChAdOx1, encoding the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike glycoprotein (SP), with potential immunomodulating and anti-viral activities. Upon administration, ChAdOx1 nCoV-19 expresses the SARS-CoV-2 SP, which induces a humoral and cell-mediated immune response against SARS-CoV-2. This may prevent SARS-CoV-2 infection and inhibit viral replication. SP, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus..", "label": "yes"} {"original_question": "Is enzastaurin effective treatment of glioblastoma?", "id": "converted_2280", "sentence1": "Is enzastaurin effective treatment of Glioblastoma Multiforme?", "sentence2": "RESULTS: fourteen randomized clinical trials were identified (7 with bevacizumab, 2 Cilengitide, 1 enzastaurin, 1 dasatinib, 1 vandetanib, 1 temsirolimus, 1 cediranib) including 4330 patients. Antiangiogenic drugs showed no improvement in overall survival with a pooled HR of 1.00, a trend for an inferior outcome, in terms of overall survival, was observed in the group of patients receiving antiangiogenic drug alone compared to cytotoxic drug alone (HR=1.24, p=0.056). , Enzastaurin (LY317615.HCl.HCl) in combination with bevacizumab for recurrent malignant gliomas is well-tolerated, with response and progression-free survival similar to bevacizumab monotherapy., So far, inhibition of angiogenesis by compounds such as bevacizumab, cediranib, enzastaurin or Cilengitide as well as alternative dosing schedules of temozolomide did not prolong survival, neither at primary diagnosis nor at recurrent disease., Despite promising phase II clinical trial results and patient benefit in terms of clinical improvement and longer progression-free survival, an overall survival benefit has not been demonstrated in four randomized phase III trials of bevacizumab or Cilengitide in newly diagnosed Glioblastoma Multiforme or cediranib or enzastaurin in recurrent Glioblastoma Multiforme., CONCLUSIONS: PFS-6 missed the primary planned outcome of 55%. , OS (median, 74 weeks) and PFS (median, 36 weeks) results from the current trial were comparable to those from a prior phase II study using erlotinib and were significantly better than those from 2 other previous studies that used thalidomide or isotretinoin, all in combination with temozolomide plus RT. , More recently, Angiogenesis Inhibitors including enzastaurin, cediranib, bevacizumab, and others that target mainly the VEGF pathway, have been evaluated in this highly angiogenic disease. Among them, only bevacizumab has been associated with clear anti-tumor activity, although the lack of control studies limits the impact of the results to date., Enzastaurin has anti-glioma activity in patients with recurrent high-grade glioma, but does not appear to have enough single-agent activity to be useful as monotherapy., Several signal transduction inhibitors have been examined in preclinical and clinical malignant glioma trials, including Angiogenesis Inhibitors (bevacizumab, enzastaurin), and inhibitors of Epidermal Growth Factor Receptor tyrosine kinase (gefitinib and erlotinib), mammalian target of rapamycin (temsirolimus, everolimus) and Integrins (Cilengitide). Although preliminary clinical results of the use of targeted agents have not translated into significantly better survival, more recent phase II trials are exploring the combination of multitargeted drugs with cytotoxic chemotherapy and radiotherapy in order to overcome the resistance of Neoplasms to single-agent targeted therapies., Several drugs have been tested, including Epidermal Growth Factor Receptor (EGFR) Protein-tyrosine kinase inhibitor (disposition) (gefitinib and erlotinib), mammalian target of rapamycin (mTOR) inhibitors (temsirolimus and everolimus), and Vascular Endothelial Growth Factor Receptor-1 (Vascular Endothelial Growth Factor Receptor), protein kinase C-beta, and other angiogenesis pathways inhibitors (vatalanib, bevacizumab, and enzastaurin). Although preliminary efficacy results of most trials in recurrent disease have fallen short on expectations, substantial advances have been achieved by associated translational research. , So far, inhibition of angiogenesis by compounds such as bevacizumab, cediranib, enzastaurin or Cilengitide as well as alternative dosing schedules of temozolomide did not prolong survival, neither at primary diagnosis nor at recurrent disease.[SEP]Relations: Enzastaurin has relations: drug_protein with AURKB, drug_protein with AURKB, drug_protein with AURKA, drug_protein with AURKA, drug_protein with CHEK2, drug_protein with CHEK2, drug_protein with CHEK1, drug_protein with CHEK1, drug_protein with PRKCB, drug_protein with PRKCB. Definitions: erlotinib defined as following: A quinazoline derivative with antineoplastic properties. Competing with adenosine triphosphate, erlotinib reversibly binds to the intracellular catalytic domain of Epidermal Growth Factor Receptor (EGFR) tyrosine kinase, thereby reversibly inhibiting EGFR phosphorylation and blocking the signal transduction events and tumorigenic effects associated with EGFR activation.. Integrins defined as following: A family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors (RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation.. Vascular Endothelial Growth Factor Receptor defined as following: A family of closely related RECEPTOR PROTEIN-TYROSINE KINASES that bind vascular endothelial growth factors. They share a cluster of seven extracellular IG-LIKE DOMAINS which are important for ligand binding. They are highly expressed in vascular endothelial cells and are critical for the physiological and pathological growth, development and maintenance of blood and lymphatic vessels.. temsirolimus defined as following: An ester analog of rapamycin. Temsirolimus binds to and inhibits the mammalian target of rapamycin (mTOR), resulting in decreased expression of mRNAs necessary for cell cycle progression and arresting cells in the G1 phase of the cell cycle. mTOR is a serine/threonine kinase which plays a role in the PI3K/AKT pathway that is upregulated in some Neoplasms.. Cilengitide defined as following: A cyclic Arg-Gly-Asp peptide with potential antineoplastic activity. Cilengitide binds to and inhibits the activities of the alpha(v)beta(3) and alpha(v)beta(5) integrins, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis. (NCI04). temozolomide defined as following: A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.. gefitinib defined as following: A selective tyrosine kinase inhibitor for the EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) that is used for the treatment of locally advanced or metastatic NON-SMALL CELL LUNG CANCER.. Epidermal Growth Factor Receptor tyrosine kinase defined as following: A family of structurally related cell-surface receptors that signal through an intrinsic PROTEIN-TYROSINE KINASE. The receptors are activated upon binding of specific ligands which include EPIDERMAL GROWTH FACTORS, and NEUREGULINS.. isotretinoin defined as following: A topical dermatologic agent that is used in the treatment of ACNE VULGARIS and several other skin diseases. The drug has teratogenic and other adverse effects.. vandetanib defined as following: An orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of Vascular Endothelial Growth Factor Receptor-1 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability. This agent also blocks the tyrosine kinase activity of Epidermal Growth Factor Receptor (EGFR), a receptor tyrosine kinase that mediates tumor cell proliferation and migration and angiogenesis.. Glioblastoma Multiforme defined as following: The most malignant astrocytic tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO). Protein-tyrosine kinase inhibitor (disposition) defined as following: Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES.. Angiogenesis Inhibitors defined as following: Agents and endogenous substances that antagonize or inhibit the development of new blood vessels.. Vascular Endothelial Growth Factor Receptor-1 defined as following: A 180-kDa VEGF receptor found primarily in endothelial cells that is essential for vasculogenesis and vascular maintenance. It is also known as Flt-1 (fms-like tyrosine kinase receptor-1). A soluble, alternatively spliced isoform of the receptor may serve as a binding protein that regulates the availability of various ligands for VEGF receptor binding and signal transduction.. everolimus defined as following: A derivative of the natural macrocyclic lactone sirolimus with immunosuppressant and anti-angiogenic properties. In cells, everolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate an immunosuppressive complex that binds to and inhibits the activation of the mammalian Target of Rapamycin (mTOR), a key regulatory kinase. Inhibition of mTOR activation results in the inhibition of T lymphocyte activation and proliferation associated with antigen and cytokine (IL-2, IL-4, and IL-15) stimulation and the inhibition of antibody production. (NCI05). dasatinib defined as following: An orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases. Dasatinib binds to and inhibits the growth-promoting activities of these kinases. Apparently because of its less stringent binding affinity for the BCR-ABL kinase, dasatinib has been shown to overcome the resistance to imatinib of chronic myeloid leukemia (CML) cells harboring BCR-ABL kinase domain point mutations. SRC-family protein-tyrosine kinases interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways; tumorigenic forms can occur through altered regulation or expression of the endogenous protein and by way of virally-encoded kinase genes.. thalidomide defined as following: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. bevacizumab defined as following: An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS.. vatalanib defined as following: An orally bioavailable anilinophthalazine with potential antineoplastic activity. Vatalanib binds to and inhibits the protein kinase domain of vascular endothelial growth factor receptors 1 and 2; both receptor tyrosine kinases are involved in angiogenesis. This agent also binds to and inhibits related receptor tyrosine kinases, including platelet-derived growth factor (PDGF) receptor, c-Kit, and c-Fms..", "label": "no"} {"original_question": "Has MLE4901 been tested in phase III clinical trials?", "id": "converted_3707", "sentence1": "Has MLE4901 been tested in phase III clinical trials?", "sentence2": "METHODS\n\nThis phase 2, randomised, double-blind, placebo-controlled, single-centre, crossover trial assessed the effectiveness of an oral neurokinin 3 receptor antagonist (MLE4901) on menopausal hot flushes., Neuromedin K Receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial.[SEP]Definitions: Neuromedin K Receptor defined as following: A class of cell surface receptors for tachykinins that prefers neurokinin B (neurokinin beta, neuromedin K) over other tachykinins. Neurokinin-3 (NK-3) receptors have been cloned and are members of the G-protein coupled receptor superfamily. They have been found in the central nervous system and in peripheral tissues..", "label": "no"} {"original_question": "Is SARS virus interacting with ACE2 encoded protein?", "id": "converted_3357", "sentence1": "Is Severe acute respiratory syndrome-related coronavirus virus interacting with ACE2 protein, human encoded protein?", "sentence2": "The trimeric Severe acute respiratory syndrome-related coronavirus coronavirus (Severe acute respiratory syndrome-related coronavirus-CoV) surface spike (S) glycoprotein consisting of three S1-S2 heterodimers binds the cellular receptor Peptidyl-Dipeptidase A (ACE2 protein, human protein, human) and mediates fusion of the Viral and cellular membranes through a pre- to postfusion conformation transition, The Viral spike glycoprotein (S) utilizes Peptidyl-Dipeptidase A (ACE2 protein, human protein, human) as a host protein receptor and mediates fusion of the Viral and host membranes, making S essential to Viral entry into host cells and host species tropism., Cell entry studies demonstrated that three newly identified SARSr-CoVs with different S protein sequences are all able to use human ACE2 protein, human protein, human as the receptor, Angiotensin-converting enzyme 2 (ACE2 protein, human protein, human), a relatively new member of the RAS, has drawn extensive attention since 2003, because of the findings that ACE2 protein, human protein, human is the receptor for Severe acute respiratory syndrome-related coronavirus Corona virus and that maintenance of normal ACE2 protein, human protein, human levels in the Chest>Lung is beneficial for the host to combat inflammatory Chest>Lung disease., The Communicable Diseases of target cells (lab result) (lab result) by the Severe acute respiratory syndrome-related coronavirus CoV is mediated through the interaction of the Viral Spike (S) protein (1255 Antifibrinolytic Antifibrinolytic amino acids) and its cellular receptor, Peptidyl-Dipeptidase A (ACE2 protein, human protein, human).[SEP]Relations: severe acute respiratory syndrome has relations: disease_protein with ACE, disease_protein with ACE. Protein S human has relations: drug_drug with Saruplase, drug_drug with Saruplase, drug_drug with Sarpogrelate, drug_drug with Sarpogrelate. peptidyl-dipeptidase activity has relations: molfunc_protein with ACE2 protein, human, molfunc_protein with ACE2 protein, human, molfunc_protein with ACE, molfunc_protein with ACE. Definitions: Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.. ACE2 protein, human defined as following: Angiotensin-converting enzyme 2 (805 aa, ~92 kDa) is encoded by the human ACE2 protein, human gene. This protein plays a role in both vasodilation and protein cleavage.. Peptidyl-Dipeptidase A defined as following: A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020).. Severe acute respiratory syndrome-related coronavirus defined as following: A species of CORONAVIRUS causing atypical respiratory disease (SEVERE ACUTE RESPIRATORY SYNDROME) in humans. The organism is believed to have first emerged in Guangdong Province, China, in 2002. The natural host is the Chinese horseshoe bat, RHINOLOPHUS sinicus..", "label": "yes"} {"original_question": "Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?", "id": "converted_3058", "sentence1": "Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?", "sentence2": "A complete ophthalmic examination is not routinely performed on infants with Miller-Dieker syndrome (Miller Dieker syndrome, chromosome 17p13.3 microdeletion). , Chromosomes, Human, Pair 1 microdeletions within 17p13.3 can result in either isolated LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE sequence (Classical Lissencephaly) or Miller-Dieker syndrome (Miller Dieker syndrome). , We report a Fetus in fetu with LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE diagnosed as Miller-Dieker Syndrome postnatally. G banded chromosome analysis revealed 45,X,psu dic(17;Y)(p13;p11.32).ish dic (17;Y)(LIS1-,RARA+, SRY+, DYZ3+) by G-banding analysis using high resolution banding technique. Fetal delayed cortical development will be the findings to perform further investigations including fluorescence in situ hybridization analysis for Miller Dieker syndrome, a 17p13.3 microdeletion syndrome, pre/postnatally. This will be the first case of Miller Dieker syndrome with unbalanced translocation between deleted short arm of Chromosomes, Human, Pair 17 and Y Chromosomes, Human, Pair 1., We report the finding of a 2.5-Mb gene region quadruplication of Chromosomes, Human, Pair 1 17p13.3. This region is well characterized for the Gene Deletion Abnormality leading to Miller-Dieker syndrome but has an unclear replication phenotype. , Both Gene Deletion have overlapped with the critical region of Miller-Dieker syndrome (Miller Dieker syndrome) and involved candidate Genes such as PAFAH1B1 gene gene, YWHAE protein, Homo sapiens protein, Homo sapiens and CRK protein, Homo sapiens protein, Homo sapiens. In addition, SNP array and FISH analyses on the parental peripheral blood samples demonstrated that both 17p13.3 and 17p13.3p13.2 Gene Deletion were of de novo origin., Miller-Dieker syndrome (Miller Dieker syndrome) is caused by a heterozygous Gene Deletion Abnormality of chromosome 17p13.3 involving the Genes LIS1 and YWHAE protein, Homo sapiens protein, Homo sapiens (coding for 14.3.3ε) and leads to malformations during cortical development., We studied after Cessation of life a 3-month-old girl whose karyotype was 45,XX,-15,-17,+der(17),t(15;17)(q13;p13.3) and thus combines abnormalities of chromosome 15 associated with the Prader-Willi Syndrome and of Chromosomes, Human, Pair 17 associated with the Miller-Dieker syndrome., The Miller-Dieker syndrome (Miller Dieker syndrome), a syndrome with LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE, distinctive craniofacial features, growth impairment, and profound developmental failure, has been associated with a Gene Deletion Abnormality of the distal part of chromosome band 17p13., The Miller-Dieker syndrome (type I LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE) is a Malformations of Cortical Development, Group II which is associated with microdeletions in the short arm of Chromosomes, Human, Pair 17., Detection of submicroscopic Gene Deletion in band 17p13 in patients with the Miller-Dieker syndrome., A 15-month-old girl with Miller-Dieker syndrome, a contiguous gene Gene Deletion Abnormality syndrome involving chromosome 17p13.3 and resulting in LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE, was diagnosed with Pre B-cell acute lymphoblastic leukemia., A computed tomography scan revealed evidence of LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE, and chromosomal analysis showed a microdeletion on the short arm of Chromosomes, Human, Pair 17 (17p13.3), confirming the diagnosis as Miller-Dieker syndrome., Familial Miller-Dieker syndrome associated with pericentric inversion of Chromosomes, Human, Pair 17., The Miller-Dieker syndrome (Miller Dieker syndrome), a rare Congenital Disorders manifested by characteristic facial abnormalities and LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE (smooth Head>Brain), is associated with microdeletions of the distal Mandibular left third molar prosthesis region., Miller-Dieker syndrome (Miller Dieker syndrome), a disorder manifesting the severe Head>Brain malformation LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE (\"smooth Head>Brain\"), is caused, in the majority of cases, by a chromosomal microdeletion of the distal short arm of Chromosomes, Human, Pair 17., The Miller-Dieker syndrome (Miller Dieker syndrome), composed of characteristic facial abnormalities and a severe Malformations of Cortical Development, Group II affecting the Cerebral cortex, is caused by visible or submicroscopic Gene Deletion of chromosome band 17p13., Microdeletions including YWHAE protein, Homo sapiens protein, Homo sapiens in the Miller-Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and No No cognitive impairment., Identification of the functional profilin gene, its localization to chromosome subband 17p13.3, and demonstration of its Gene Deletion Abnormality in some patients with Miller-Dieker syndrome., HIC1 gene gene is a candidate tumor suppressor gene which is frequently hypermethylated in Homo sapiens Neoplasms, and its location within the Miller-Dieker syndrome's critical Gene Deletion Abnormality region at chromosome 17p13.3 makes it a candidate gene for involvement in this gene Gene Deletion Abnormality syndrome., A complete ophthalmic examination is not routinely performed on infants with Miller-Dieker syndrome (Miller Dieker syndrome, chromosome 17p13.3 microdeletion)., About 15% of patients with isolated LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE and more than 90% of patients with Miller-Dieker syndrome have microdeletions in a critical 350-kilobase region in chromosome 17p13.3 (ref., Chromosomes, Human, Pair 1 aberrations in which Epilepsy is a major and consistent finding include Angelman Syndrome due to loss of the maternal 15q11.2-q12 Anatomical segmentation, Tetrasomy of the maternal Anatomical segmentation 15pter-q13 due to an additional inv dup chromosome, Miller-Dieker syndrome due to Gene Deletion Abnormality of the 17p13.3 Anatomical segmentation including the lissencephaly1 gene, Ring Chromosomes, Human, Pair 1 20 Syndrome, and Wolf-Hirschhorn Syndrome due to Gene Deletion Abnormality of at least the 4p16.3 Anatomical segmentation., Miller-Dieker syndrome and 5p partial trisomy in a child carrying a derivative chromosome with a microdeletion in 17p13.3 telomeric to the LIS1 and the D17S379 loci., The Miller-Dieker syndrome, a disorder of neuronal migration, is caused by Gene Deletion of chromosome 17p13.3., The girl was diagnosed by subtelomeric FISH and array-CGH, showing a 4.43-Mb heterozygous Gene Deletion Abnormality on chromosome 10p that involved 14 Genes and a 3.22-Mb single-copy gain on chromosome Mandibular left third molar prosthesis, which includes the critical region of the Miller-Dieker syndrome and 61 Genes., Detection of submicroscopic Gene Deletion in band 17p13 in patients with the Miller-Dieker syndrome.The Miller-Dieker syndrome (Miller Dieker syndrome), a syndrome with LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE, distinctive craniofacial features, growth impairment, and profound developmental failure, has been associated with a Gene Deletion Abnormality of the distal part of chromosome band 17p13. , Microdeletions including YWHAE protein, Homo sapiens protein, Homo sapiens in the Miller-Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and No No cognitive impairment.Microdeletions of chromosome 17p13.3 involving YWHAE protein, Homo sapiens protein, Homo sapiens present with growth restriction, craniofacial dysmorphisms, structural abnormalities of Head>Brain and No No cognitive impairment. , Unbalanced translocation (15;17)(q13;13.3) with apparent Prader-Willi Syndrome but without Miller-Dieker syndrome.We studied after Cessation of life a 3-month-old girl whose karyotype was 45,XX,-15,-17,+der(17),t(15;17)(q13;p13.3) and thus combines abnormalities of chromosome 15 associated with the Prader-Willi Syndrome and of Chromosomes, Human, Pair 17 associated with the Miller-Dieker syndrome. , The Miller-Dieker syndrome (Miller Dieker syndrome), a rare Congenital Disorders manifested by characteristic facial abnormalities and LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE (smooth Head>Brain), is associated with microdeletions of the distal Mandibular left third molar prosthesis region. , A revision of the LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE and Miller-Dieker syndrome critical regions in chromosome 17p13.3.Miller-Dieker syndrome (Miller Dieker syndrome) is a multiple malformation syndrome characterized by classical LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE and a characteristic facies. , Case Report of Proliferative Peripheral retinopathy in Two Familial Lissencephaly Infants with Miller-Dieker Syndrome.A complete ophthalmic examination is not routinely performed on infants with Miller-Dieker syndrome (Miller Dieker syndrome, chromosome 17p13.3 microdeletion). , Identification of the functional profilin gene, its localization to chromosome subband 17p13.3, and demonstration of its Gene Deletion Abnormality in some patients with Miller-Dieker syndrome.PFN1 gene is a conserved actin-monomer-binding protein which is found in all Eukaryota, including Saccharomyces cerevisiae. , We propose that essentially no loss of Mandibular left third molar prosthesis material has occurred and confirm previous reports that the critical region for the production of the Miller-Dieker phenotype is located subterminally in the 17p13.3 region.
, A review of the literature revealed five additional patients in three families, who had Miller-Dieker syndrome and an abnormality of Mandibular left third molar prosthesis., We propose that essentially no loss of Mandibular left third molar prosthesis material has occurred and confirm previous reports that the critical region for the production of the Miller-Dieker phenotype is located subterminally in the 17p13.3 region., Miller-Dieker syndrome: LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE and monosomy Mandibular left third molar prosthesis., Thus, we propose that monosomy of distal Mandibular left third molar prosthesis may be the cause of Miller-Dieker syndrome in some patients., Miller-Dieker syndrome with der(17)t(12;17)(q24.33;p13.3)pat presenting with a potential risk of mis-identification as a de novo submicroscopic Gene Deletion Abnormality of 17p13.3., Most cases of Miller-Dieker syndrome have a de novo Gene Deletion Abnormality involving 17p13.3.[SEP]Relations: partial monosomy of the short arm of Chromosomes, Human, Pair 17 has relations: disease_disease with Miller-Dieker LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE syndrome, disease_disease with Miller-Dieker LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE syndrome. PAFAH1B1 gene has relations: disease_protein with Miller-Dieker LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE syndrome, disease_protein with Miller-Dieker LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE syndrome. Contiguous gene syndrome has relations: disease_phenotype_positive with Miller-Dieker LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE syndrome, disease_phenotype_positive with Miller-Dieker LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE syndrome. Miller Fisher syndrome has relations: disease_protein with PMP22, disease_protein with PMP22. congenital nervous system disorder has relations: disease_disease with Say-Barber-Miller syndrome, disease_disease with Say-Barber-Miller syndrome. Definitions: CRK protein, Homo sapiens defined as following: Adapter molecule crk (304 aa, ~34 kDa) is encoded by the Homo sapiens CRK protein, Homo sapiens gene. This protein is involved in the modulation of signal transduction.. Pre B-cell acute lymphoblastic leukemia defined as following: A type of ALL characterized by elevated levels of B-cell lymphoblasts in the bone marrow and the blood. [NCIT:C8644]. Classical Lissencephaly defined as following: A genetic disorder caused by mutations in the LIS1, XLIS, or TUBA1A Genes. It results in Head>Brain malformation characterized by the underdevelopment or absence of gyri or ridges in the Cerebral cortex. Signs and symptoms include Epilepsy and mental retardation.. Saccharomyces cerevisiae defined as following: A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" Saccharomyces cerevisiae. The dried form is used as a dietary supplement.. Tetrasomy defined as following: The possession of four chromosomes of any one type in an otherwise diploid cell.. Anatomical segmentation defined as following: One of the parts into which something naturally divides.. 17p13.3 defined as following: A chromosome band present on Mandibular left third molar prosthesis. PAFAH1B1 gene defined as following: This gene is involved in the modulation of neuronal migration.. Chromosomes, Human, Pair 1 defined as following: A specific pair of Homo sapiens chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the Homo sapiens chromosome classification.. Epilepsy defined as following: A disorder characterized by recurrent episodes of paroxysmal Head>Brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the Head>Brain, and (5) temporal patterns (e.g., nocturnal Epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313). YWHAE protein, Homo sapiens defined as following: 14-3-3 protein epsilon (255 aa, ~29 kDa) is encoded by the Homo sapiens YWHAE protein, Homo sapiens gene. This protein plays a role in signal transduction.. Cerebral cortex defined as following: The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions.. Mandibular left third molar prosthesis defined as following:

Mandibular left third molar prosthesis

. PFN1 gene defined as following: This gene plays a role in the regulation of actin polymerization.. 4p16.3 defined as following: A chromosome band present on 4p. Malformations of Cortical Development, Group II defined as following: A diverse group of congenital Head>Brain developmental disorders characterized by defects in neuronal migration in the Head>Brain during early fetal development. The neuronal migration defects result in Head>Brain abnormalities that are usually manifested with mental retardation and Epilepsy.. Angelman Syndrome defined as following: A syndrome characterized by multiple abnormalities, MENTAL RETARDATION, and movement disorders. Present usually are skull and other abnormalities, frequent infantile spasms (SPASMS, INFANTILE); easily provoked and prolonged paroxysms of laughter (hence \"happy\"); jerky puppetlike movements (hence \"puppet\"); continuous tongue protrusion; motor retardation; ATAXIA; MUSCLE HYPOTONIA; and a peculiar facies. It is associated with maternal Gene Deletion of chromosome 15q11-13 and other genetic abnormalities. (From Am J Med Genet 1998 Dec 4;80(4):385-90; Hum Mol Genet 1999 Jan;8(1):129-35). Gene Deletion defined as following: A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This Gene Deletion Abnormality may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a Gene Deletion Abnormality at one specific locus.. Y Chromosome defined as following: The male sex chromosome, being the differential sex chromosome carried by half the male gametes and none of the female gametes in humans and in some other male-heterogametic species in which the homologue of the X chromosome has been retained.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Prader-Willi Syndrome defined as following: An autosomal dominant disorder caused by Gene Deletion Abnormality of the proximal long arm of the paternal chromosome 15 (15q11-q13) or by inheritance of both of the pair of chromosomes 15 from the mother (UNIPARENTAL DISOMY) which are imprinted (GENETIC IMPRINTING) and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE. (Menkes, Textbook of Child Neurology, 5th ed, p229). Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. 5p partial trisomy defined as following: Duplication of the short arm of chromosome 5 most frequently associated with craniofacial, cardiac, renal, and limb abnormalities, and moderate to severe mental retardation. Dandy-Walker malformation (agenesis of the cerebellar vermis, hydrocephalus, and posterior fossa cyst continuous with the fourth ventricle) occurs in some cases. The phenotype is related to the amount of genetic material duplicated and the specific duplicated Anatomical segmentation.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Wolf-Hirschhorn Syndrome defined as following: A syndrome caused by large Gene Deletion of the telomereic end of the short arm of CHROMOSOME 4 (4p) in Wolf-Hirchhorn syndrome critial regions (WHSCRs). Several candidate Genes have been identified including WHSC1 and WHSCH2 which appear to be responsible for the core phenotype and in combination with other linked and unlinked Genes determine the severity and inclusion of rarer phenotypes. Most cases have a characteristic cranio-facial defect often referred to as \"Greek helmet face\" - a combined result of MICROCEPHALY, broad forehead, prominent glabella, HYPERTELORISM, high arched eyebrows, short philtrum and micrognathia. In addition there is mental retardation, growth delays, EPILEPSY, and frequently a wide range of midline and skeletal defects, including HYPOSPADIAS; CONGENITAL HEART DEFECTS; CLEFT LIP; CLEFT PALATE; colobomata; CLUBFOOT; clinodactyly; SCOLIOSIS; and KYPHOSIS.. LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE defined as following: A LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE syndrome characterized by smoothness of the surface of the Head>Brain (LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE type I) with thickening of the Cerebral cortex (pachygyria), absence of gyri and sulci (agyria), microcephaly, mental retardation, low sloping forehead, and prominent nasal bridge.. Eukaryota defined as following: Organism or cells with a nucleus separated from the cytoplasm by a two membrance nuclear envelope and compartmentalization of function into distinct cytoplasmic organelles.. Ring Chromosome 20 Syndrome defined as following: A rare condition in which the two arms of chromosome 20 are fused resulting in a ring chromosome. It is characterized by recurrent seizures with an onset in childhood. Additional features my include microcephaly and short stature.. Chromosomes, Human, Pair 17 defined as following: A specific pair of GROUP E CHROMOSOMES of the Homo sapiens chromosome classification.. Homo sapiens defined as following: Members of the species Homo sapiens.. chromosome Mandibular left third molar prosthesis defined as following: Proximal (short) arm of Chromosomes, Human, Pair 17. Miller Dieker syndrome defined as following: A rare syndrome caused by Gene Deletion Abnormality of genetic material in the short arm of Chromosomes, Human, Pair 17. It is characterized by an abnormally smooth Head>Brain with fewer folds and grooves. It results in intellectual disability, developmental delay, seizures, spasticity, hypotonia, and feeding difficulties. Affected individuals have distinctive facial features that include a prominent forehead, midface hypoplasia, small, upturned nose, low-set ears, small jaw, and thick upper lip.. Congenital Disorders defined as following: existing at, and usually before, birth; referring to conditions that are present at birth, regardless of their causation; inborn metabolism disorders are generally not treed here.. Miller-Dieker syndrome defined as following: A rare syndrome caused by Gene Deletion Abnormality of genetic material in the short arm of Chromosomes, Human, Pair 17. It is characterized by an abnormally smooth Head>Brain with fewer folds and grooves. It results in intellectual disability, developmental delay, seizures, spasticity, hypotonia, and feeding difficulties. Affected individuals have distinctive facial features that include a prominent forehead, midface hypoplasia, small, upturned nose, low-set ears, small jaw, and thick upper lip.. chromosome 1 defined as following: A specific pair of Homo sapiens chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the Homo sapiens chromosome classification..", "label": "no"} {"original_question": "Is the ACE inhibitor indicated for lung cancer treatment?", "id": "converted_1411", "sentence1": "Is the CDE protocol-cyclophosphamide/doxorubicin/etoposide inhibitor indicated for Primary malignant neoplasm of lung treatment?", "sentence2": "The angiotensin converting enzyme (CDE protocol-cyclophosphamide/doxorubicin/etoposide) inhibitors are used widely as antihypertensive agents, and it has been suggested that they decrease the risk of some Malignant Neoplasms, although available data are conflicting. , Using cell viability and fluorescent activated cell sorting analysis tests, we demonstrated that captopril inhibited the viability of LNM35 cells by inducing apoptosis, providing insight about the mechanisms underlying its antitumorigenic activities. In view of these experimental findings, we conclude that captopril could be a promising option for the treatment of Primary malignant neoplasm of lung., In order to determine the mechanism by which captopril inhibited tumor growth, we investigated the impact of this Pharmacologic Substance on cell proliferation, apoptosis, and angiogenesis. Immunohistochemical analysis demonstrated that captopril treatment significantly reduced the number of proliferating cells (MKI67 gene) in the tumor samples but was not associated with inhibition of tumor angiogenesis (PECAM1 wt Allele)., Using this model, we demonstrated that daily IP administration of captopril (2.8 mg/mouse) for 3 weeks resulted in a remarkable reduction of tumor growth (58%, P < 0.01) and lymph node metastasis (50%, P= 0.088). , Peptidyl-Dipeptidase A (CDE protocol-cyclophosphamide/doxorubicin/etoposide) inhibitors have been shown to mitigate radiation-induced lung injury in preclinical models, CDE protocol-cyclophosphamide/doxorubicin/etoposide inhibitors may decrease the incidence of radiation pneumonitis in patients receiving thoracic radiation for Primary malignant neoplasm of lung.[SEP]Relations: Captopril has relations: drug_protein with CDE protocol-cyclophosphamide/doxorubicin/etoposide, drug_protein with CDE protocol-cyclophosphamide/doxorubicin/etoposide, drug_drug with Acemetacin, drug_drug with Acemetacin, drug_drug with Acepromazine, drug_drug with Acepromazine, drug_drug with Acebutolol, drug_drug with Acebutolol, drug_drug with Aluminium acetoacetate, drug_drug with Aluminium acetoacetate. Definitions: Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. CDE protocol-cyclophosphamide/doxorubicin/etoposide inhibitors defined as following: A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.. PECAM1 wt Allele defined as following: Human PECAM1 wild-type allele is located within 17q23 and is approximately 64 kb in length. This allele, which encodes platelet endothelial cell adhesion molecule protein, plays a role in transendothelial migration of leukocytes, angiogenesis, integrin activation, and may inhibit platelet-collagen interactions.. Peptidyl-Dipeptidase A defined as following: A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020).. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. captopril defined as following: A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin.. MKI67 gene defined as following: This gene is involved in cellular proliferation.. CDE protocol-cyclophosphamide/doxorubicin/etoposide inhibitor defined as following: A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility..", "label": "no"} {"original_question": "Is rivaroxaban metabolized in kidneys?", "id": "converted_745", "sentence1": "Is rivaroxaban metabolized in kidneys?", "sentence2": "The novel oral anticoagulants (i.e., dabigatran, apixaban, rivaroxaban) all undergo Kidney metabolism to varying degrees, and hence dosing, efficacy, and safety require special consideration in Chronic Kidney Diseases patients., The new oral anticoagulants have relatively little data in patients with severe Kidney impairment, and all have an element of Kidney excretion., Now new anticoagulant drugs(dabigatran and rivaroxaban) can become available. Therefore, we have to learn how to use those drugs. They have to carefully be used because they discharge from Both kidneys and old aged patients have potential Kidney dysfunction. , In the everyday practice it will be necessary to be very cautious in patients with impaired Kidney function, as all these drugs are eliminated by kidneys., dabigatran etexilate and rivaroxaban carry the highest risk due to a high degree of Kidney excretion, whereas the risk for apixaban, edoxaban and betrixaban seems lower., However, all these agents undergo Kidney clearance to varying degrees, and hence dosing, efficacy, and safety require special consideration in patients with Chronic Kidney Diseases. , Rivaroxaban being excreted via Both kidneys and Abdomen>Liver, some precautions should apply in case of Hepatic Insufficiency. , Rivaroxaban elimination is mainly Kidney, but also through faecal matter and by hepatic metabolism. [SEP]Relations: Rivaroxaban has relations: contraindication with Both kidneys disease, contraindication with Both kidneys disease, drug_drug with Carboplatin, drug_drug with Carboplatin, drug_drug with Conjugated estrogens, drug_drug with Conjugated estrogens, drug_drug with Colistin, drug_drug with Colistin, drug_drug with Metaxalone, drug_drug with Metaxalone. Definitions: rivaroxaban defined as following: An orally bioavailable oxazolidinone derivative and direct inhibitor of the coagulation factor Xa with anticoagulant activity. Upon oral administration, rivaroxaban selectively binds to both free factor Xa and factor Xa bound in the prothrombinase complex. This interferes with the conversion of prothrombin (factor II) to thrombin and eventually prevents the formation of cross-linked fibrin clots. Rivaroxaban does not affect existing thrombin levels.. Chronic Kidney Diseases defined as following: Impairment of the Kidney function secondary to chronic Both kidneys damage persisting for three or more months.. Kidney defined as following: Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.. Hepatic Insufficiency defined as following: The inability of the Abdomen>Liver to perform its normal synthetic and metabolic functions.. impaired Kidney function defined as following: Diminished Both kidneys function.. edoxaban defined as following: An orally active inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity. Edoxaban is administered as edoxaban tosylate. This agent has an elimination half-life of 9-11 hours and undergoes Kidney excretion.. apixaban defined as following: An orally active inhibitor of coagulation factor Xa with anticoagulant activity. Apixaban directly inhibits factor Xa, thereby interfering with the conversion of prothrombin to thrombin and preventing formation of cross-linked fibrin clots.. dabigatran defined as following: A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation.. betrixaban defined as following: An orally active inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity. Betrixaban is primarily excreted unchanged in the bile and has a half life of about 19 hours..", "label": "yes"} {"original_question": "Is LRP1 interacting with Urokinase receptor?", "id": "converted_2833", "sentence1": "Is LRP1 interacting with Urokinase receptor?", "sentence2": " Interaction with a complex formed by urokinase and its inhibitor Plasminogen Activator Inhibitor 1 induces Cell surface down regulation and recycling of the receptor via the clathrin-coated pathway, a process dependent on the association to Prolow-Density Lipoprotein Receptor-Related Protein 1., Here we investigated whether direct interaction between Urokinase Plasminogen Activator Receptor, a glycosyl-phosphatidylinositol-anchored protein, and RPSA wt Allele, a transmembrane receptor,, Direct binding of domain 3 (D3) of Urokinase Plasminogen Activator Receptor to RPSA wt Allele is required for clearance of urokinase-Plasminogen Activator Inhibitor 1-occupied Urokinase Plasminogen Activator Receptor[SEP]Relations: Urokinase has relations: drug_protein with LRP2, drug_protein with LRP2, drug_protein with SERPINE1, drug_protein with SERPINE1, drug_protein with SERPINA5, drug_protein with SERPINA5, drug_protein with PLG, drug_protein with PLG, drug_protein with MMP12, drug_protein with MMP12. Definitions: Prolow-Density Lipoprotein Receptor-Related Protein 1 defined as following: Prolow-density lipoprotein receptor-related protein 1 (4544 aa, ~505 kDa) is encoded by the human LRP1 gene. This protein is involved in the mediation of endocytosis and turnover.. Urokinase Plasminogen Activator Receptor defined as following: An extracellular receptor specific for UROKINASE-TYPE PLASMINOGEN ACTIVATOR. It is attached to the cell membrane via a GLYCOSYLPHOSPHATIDYLINOSITOL LINKAGE and plays a role in the co-localization of urokinase-type plasminogen activator with PLASMINOGEN.. urokinase defined as following: A proteolytic enzyme that converts PLASMINOGEN to FIBRINOLYSIN where the preferential cleavage is between ARGININE and VALINE. It was isolated originally from human URINE, but is found in most tissues of most VERTEBRATES.. Cell surface defined as following: The external part of the cell wall and/or plasma membrane. [GOC:jl, GOC:mtg_sensu, GOC:sm]. Plasminogen Activator Inhibitor 1 defined as following: A member of the serpin family of proteins. It inhibits both the tissue-type and urokinase-type plasminogen activators.. RPSA wt Allele defined as following: Human RPSA wild-type allele is located in the vicinity of 3p22.2 and is approximately 6 kb in length. This allele, which encodes 40S ribosomal protein SA, plays a role in a variety of biological processes that are mediated by interactions with Cell surface receptors.. Urokinase receptor defined as following: An extracellular receptor specific for UROKINASE-TYPE PLASMINOGEN ACTIVATOR. It is attached to the cell membrane via a GLYCOSYLPHOSPHATIDYLINOSITOL LINKAGE and plays a role in the co-localization of urokinase-type plasminogen activator with PLASMINOGEN..", "label": "yes"} {"original_question": "Does nifedipine inhibit L-type calcium channels?", "id": "converted_1519", "sentence1": "Does nifedipine inhibit L-type calcium channels?", "sentence2": "Nifedipine, an L-Type Calcium Channels blocker, reduced the expression of synaptogamin and Qa-SNARE Proteins and blocked the suppressive effect of vecuronium, suggesting that both agents inhibit presynaptic L-type calcium channels., Treatment with nifedipine to inhibit calcium influx via the L-type channel Cav1.2 (alpha(1C)) inhibited the TGFbeta stimulated increase in ANK1 wt Allele expression at all phases of chondrogenesis., Finally, we found that PKCepsilon-induced stellation was significantly reduced by the specific L-type channel blocker nifedipine, indicating that calcium influx through VGCC mediates the change in Astrocytes morphology induced by PKCepsilon., However, amprenavir and nifedipine, an inhibitor of L-type calcium channels, failed to inhibit Long-Term Potentiation when administered following the slow increase in ethanol., Both the metallic ions Cd2+ and Ni2+, known to inhibit voltage-gated calcium channels and T-type channels, respectively, and verapamil and nifedipine, typical blocker of L-type calcium channels completely prevented the hypoxic neuronal No - Identity May Be Divulged generation., Further, the L-Type Calcium Channels blocker, nifedipine, was able to inhibit the initial increase in [Ca2+]i, suggesting that at least this phase of the Trail Making Test effect was mediated by calcium channels, although nifedipine had no significant effect on the time to reach the maximal [Ca2+]i level, Treatment with omega-Conotoxin GVIA (3 microM) or nifedipine (10 microM) to inhibit Ca(2+) influx through N- or L-type voltage-dependent calcium channels (VDCCs), respectively, also decreased the rate of Anterior-Posterior repolarization and increased Anterior-Posterior duration, Concentrations of nifedipine (10 microM) and nimodipine (3 microM) that maximally inhibit L-type calcium channels reduced the sI(AHP) by 30 and 50%, respectively, Consequently, it was demonstrated in the present study that nimodipine and nitrendipine inhibit both L- and N-type calcium channels and thus seem to be unique among the Dihydropyridines examined in their effects on calcium channels in dibutyryl cAMP-differentiated Neuroblastoma x glioma hybrid NG 108-15 Cells, whereas nifedipine and niguldipine appear to block mainly L-type calcium channels, However, amprenavir and nifedipine, an inhibitor of L-type calcium channels, failed to inhibit Long-Term Potentiation when administered following the slow increase in ethanol, Calcium-channel antagonists, omega-Conotoxin GVIA (omega-CgTx GVIA; N-type), nifedipine (L-type), and omega-conotoxin-MVIIC (omega-CmTx MVIIC; P/Q type), were used to characterize the voltage-operated Ca(2+) channels (VOCCs) involved in this release, The T- and L-Type Calcium Channels blocker (CCB) mibefradil attenuates leg edema induced by the L-type CCB nifedipine in the spontaneously Hypertensive (finding) Rattus norvegicus: a novel differentiating assay., L-Type Calcium Channels antagonist nifedipine reduces neurofilament restitution following Optic Nerve Injuries., Nifedipine, an L-Type Calcium Channels blocker, restores the hypnotic response in rats made tolerant to the alpha-2 adrenergic agonist dexmedetomidine., Comparison of L-Type Calcium Channels blockade by nifedipine and/or cadmium in Cavia porcellus ventricular myocytes., Nifedipine inhibits picrotoxin-induced seizure activity: further evidence on the involvement of L-Type Calcium Channels blockers in Epilepsy.[SEP]Relations: Nifedipine has relations: drug_drug with Calcium, drug_drug with Calcium, drug_drug with Calcium chloride, drug_drug with Calcium chloride, drug_drug with Calcium cation, drug_drug with Calcium cation, drug_drug with Calcium levulinate, drug_drug with Calcium levulinate, drug_drug with Calcium acetate, drug_drug with Calcium acetate. Definitions: omega-Conotoxin GVIA defined as following: A neurotoxic peptide, which is a cleavage product (VIa) of the omega-Conotoxin precursor protein contained in venom from the marine snail, CONUS geographus. It is an antagonist of CALCIUM CHANNELS, N-TYPE.. cadmium defined as following: An element with atomic symbol Cd, atomic number 48, and atomic weight 112.41. It is a metal and ingestion will lead to CADMIUM POISONING.. Dihydropyridines defined as following: Pyridine moieties which are partially saturated by the addition of two hydrogen atoms in any position.. L-Type Calcium Channels defined as following: Long-lasting voltage-gated CALCIUM CHANNELS found in both excitable and non-excitable tissue. They are responsible for normal myocardial and vascular smooth muscle contractility. Five subunits (alpha-1, alpha-2, beta, gamma, and delta) make up the L-type channel. The alpha-1 subunit is the binding site for calcium-based antagonists. Dihydropyridine-based calcium antagonists are used as markers for these binding sites.. Epilepsy defined as following: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal Epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313). ethanol defined as following: A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES.. Long-Term Potentiation defined as following: A persistent increase in synaptic efficacy, usually induced by appropriate activation of the same synapses. The phenomenological properties of long-term potentiation suggest that it may be a cellular mechanism of learning and memory.. nifedipine defined as following: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.. dexmedetomidine defined as following: An imidazole derivate and active d-isomer of medetomidine with analgesic, anxiolytic and sedative properties. Dexmedetomidine selectively binds to presynaptic alpha-2 adrenoceptors located in the brain, thereby inhibiting the release of norepinephrine from synaptic vesicles. This leads to an inhibition of postsynaptic activation of adrenoceptors, which inhibit sympathetic activity, thereby leading to sedation and anxiolysis. The analgesic effect of this agent is mediated by binding to alpha-2 adrenoceptors in the spinal cord.. Qa-SNARE Proteins defined as following: A subfamily of Q-SNARE PROTEINS which occupy the same position as Qa-SNARE Proteins 1A in the SNARE complex and which also are most similar to Qa-SNARE Proteins 1A in their AMINO ACID SEQUENCE. This subfamily is also known as the syntaxins, although a few so called syntaxins are Qc-SNARES.. nitrendipine defined as following: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.. verapamil defined as following: A calcium channel blocker that is a class IV anti-arrhythmia agent.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. amprenavir defined as following: A synthetic derivative of hydroxyethylamine sulfonamide that selectively binds to and inhibits human immunodeficiency virus (HIV) protease.. vecuronium defined as following: A synthetic, intermediate-acting mono-quaternary steroid and non-depolarizing neuromuscular blocking agent, with muscle relaxant activity. Vecuronium competitively binds to and blocks the nicotinic acetylcholine receptor at the neuromuscular junction, thereby preventing acetylcholine (ACh) binding and resulting in skeletal muscle relaxation and paralysis. Vecuronium has a shorter duration of action than pancuronium.. mibefradil defined as following: A benzimidazoyl-substituted tetraline that selectively binds and inhibits CALCIUM CHANNELS, T-TYPE.. Optic Nerve Injuries defined as following: Injuries to the optic nerve induced by a trauma to the face or head. These may occur with closed or penetrating injuries. Relatively minor compression of the superior aspect of orbit may also result in trauma to the optic nerve. Clinical manifestations may include visual loss, PAPILLEDEMA, and an afferent pupillary defect.. Astrocytes defined as following: A class of large neuroglial (macroglial) Cells in the central nervous system - the largest and most numerous neuroglial Cells in the brain and spinal cord. Astrocytes (from \"star\" Cells) are irregularly shaped with many long processes, including those with \"end feet\" which form the glial (limiting) membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and \"reactive astrocytes\" (along with MICROGLIA) respond to injury.. nimodipine defined as following: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.. Cavia porcellus defined as following: The domesticated Cavia porcellus, Cavia porcellus.. Neuroblastoma defined as following: A common neoplasm of early childhood arising from neural crest Cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round Cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51). ANK1 wt Allele defined as following: Human ANK1 wild-type allele is located in the vicinity of 8p11.1 and is approximately 243 kb in length. This allele, which encodes ankyrin-1 protein, plays a role in erythrocyte morphology. Mutation of the gene is associated with spherocytosis.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Trail Making Test defined as following: The subject's ability to connect 25 numbered and lettered circles in sequence in a specific length of time. A score of 12 or below is suggestive of organic brain damage..", "label": "yes"} {"original_question": "Is it possible to visualize subtahalamic nucleus by using transcranial ultrasound?", "id": "converted_1505", "sentence1": "Is it possible to visualize subtahalamic nucleus by using transcranial ultrasound?", "sentence2": "After measuring thermal effects of Mandibulofacial Dysostosis and imaging artefact sizes of DBS lead using a skull phantom, we prospectively enrolled 34 patients with DBS of Globus Sensation pallidus internus, ventro-intermediate thalamic or Structure of Structure of subthalamic nucleus. Mandibulofacial Dysostosis had no influence on lead temperature, electrical parameters of DBS device or clinical state of patients. Mandibulofacial Dysostosis measures of lead coordinates agreed with MRI measures in Anterior-Posterior and medial-lateral axis. Lead dislocation requiring reinsertion was reliably detected., Mandibulofacial Dysostosis may therefore become a first-choice modality to monitor lead location., Two pilot studies have demonstrated that the intraoperative visualization with Mandibulofacial Dysostosis and the Mandibulofacial Dysostosis-assisted Insert (object) of deep-brain stimulation (DBS) electrodes into the Structure of Structure of subthalamic nucleus and the Structure of medial Globus Sensation pallidus are feasible and safe provided there is exact knowledge on the extent of electrode Mandibulofacial Dysostosis imaging artifacts. , Peroperative transcranial sonography for electrode placement into the targeted Structure of Structure of subthalamic nucleus of patients with PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE: technical note, The correct anatomic Positioning Attribute of the electrode tip could be indirectly assessed thanks to the topographic relationship of the EEF1A2 wt Allele with the hyperechogenic substantia nigra and the nucleus ruber., CONCLUSIONS: Transcranial sonography is easily feasible during stereotactic surgery. In combination with the clinical effects of electrostimulation on the symptoms of Parkinson Disease and with stereotactic x-ray images, it enables the assessment and the documentation of the correct Positioning Attribute of implanted EEF1A2 wt Allele electrodes in real time., After measuring thermal effects of Mandibulofacial Dysostosis and imaging artefact sizes of DBS lead using a skull phantom, we prospectively enrolled 34 patients with DBS of Globus Sensation pallidus internus, ventro-intermediate thalamic or Structure of Structure of subthalamic nucleus, Two pilot studies have demonstrated that the intraoperative visualization with Mandibulofacial Dysostosis and the Mandibulofacial Dysostosis-assisted Insert (object) of deep-brain stimulation (DBS) electrodes into the Structure of Structure of subthalamic nucleus and the Structure of medial Globus Sensation pallidus are feasible and safe provided there is exact knowledge on the extent of electrode Mandibulofacial Dysostosis imaging artifacts[SEP]Relations: Structure of subthalamic nucleus has relations: anatomy_anatomy with nucleus of ventral thalamus, anatomy_anatomy with nucleus of ventral thalamus. medial Globus Sensation pallidus has relations: anatomy_protein_present with MTPAP, anatomy_protein_present with MTPAP, anatomy_protein_present with PCNP, anatomy_protein_present with PCNP, anatomy_protein_present with CRTAP, anatomy_protein_present with CRTAP, anatomy_protein_present with RNMT, anatomy_protein_present with RNMT. Definitions: Mandibulofacial Dysostosis defined as following: A hereditary disorder occurring in two forms: the complete form (Franceschetti's syndrome) is characterized by antimongoloid slant of the palpebral fissures, COLOBOMA of the lower lid, MICROGNATHIA and hypoplasia of the ZYGOMATIC ARCHES, and CONGENITAL MICROTIA. It is transmitted as an autosomal trait. The incomplete form (Treacher Collins syndrome) is characterized by the same anomalies in less pronounced degree. It occurs sporadically, but an autosomal dominant mode of transmission is suspected. (Dorland, 27th ed). EEF1A2 wt Allele defined as following: Human EEF1A2 wild-type allele is located in the vicinity of 20q13.3 and is approximately 11 kb in length. This allele, which encodes elongation factor 1-alpha 2 protein, is involved in the promotion of protein elongation. The gene is expressed aberrantly at elevated levels in many ovarian cancers.. Positioning Attribute defined as following: A reference to the alignment of an object, a particular situation or view of a situation, or the location of an object.. Insert (object) defined as following: Something inserted or to be inserted.. Parkinson Disease defined as following: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75). Structure of subthalamic nucleus defined as following: Lens-shaped structure on the inner aspect of the INTERNAL CAPSULE. The SUBTHALAMIC NUCLEUS and pathways traversing this region are concerned with the integration of somatic motor function.. Globus Sensation defined as following: A feeling of a lump in the throat that occurs between meals in the absence of other gastrointestinal and motility disorders (e.g., DYSPHAGIA; GASTROESOPHAGEAL REFLUX)..", "label": "yes"} {"original_question": "Is there a role for the cylindromatosis tumor suppressor (CYLD) in lung cancer?", "id": "converted_437", "sentence1": "Is there a role for the cylindromatosis tumor suppressor (CYLD protein, human) in Primary malignant neoplasm of lung?", "sentence2": "Over-expressing CYLD protein, human protein, human augments Antitumor activity of TNFSF10 wt Allele by inhibiting the NF-κB survival signaling in Primary malignant neoplasm of lung cells, increased expression of CYLD protein, human protein, human directly blocks TNFSF10 wt Allele-induced NF-κB activation, and consequently increases TNFSF10 wt Allele-induced apoptosis in Primary malignant neoplasm of lung cells. CYLD protein, human protein, human may act as a therapeutic target of Primary malignant neoplasm of lung. Targeting CYLD protein, human protein, human, in combination with TNFSF10 wt Allele, may be a new strategy to treat Primary malignant neoplasm of lung with high NF-κB activity, Truncation of the Catalytic Domain of the cylindromatosis tumor suppressor impairs lung maturation, down-regulation of Cyld expression has been associated with the development of various types of human malignancies including Primary malignant neoplasm of lung, Deletion of exon 9 would cause a carboxyl-terminal truncation of CYLD protein, human protein, human and inactivation of its deubiquitinating activity. In accordance with previous studies, Specimen Source Codes - Fibroblasts from Cyld(Delta 9/Delta 9) embryos had hyperactive nuclear factor kappaB and c-Jun kinase pathways compared with control Specimen Source Codes - Fibroblasts. Cyld(Delta 9/Delta 9) newborn CASP14 gene were smaller than wild-type littermates with a short and kinky tail and no major developmental defects. However, Cyld(Delta 9/Delta 9) CASP14 gene died shortly after birth from apparent Abnormal breathing. Histological examination of E18.5 Cyld(Delta 9/Delta 9) Lung demonstrated an immature phenotype characterized by hyperplasic mesenchyme but apparently normal Epithelial, Smooth muscle (tissue). and endothelial structures. Our study identifies an important role of CYLD protein, human protein, human in lung maturation, which may underlie the development of many cases of Primary malignant neoplasm of lung, Gene Mutation that truncate and inactivate the carboxyl-terminal deubiquitinating domain of CYLD protein, human protein, human underlie the development of skin appendage tumors in Homo sapiens, whereas down-regulation of Cyld expression has been associated with the development of various types of human malignancies including Primary malignant neoplasm of lung., Our study identifies an important role of CYLD protein, human protein, human in lung maturation, which may underlie the development of many cases of Primary malignant neoplasm of lung., Gene Mutation that truncate and inactivate the carboxyl-terminal deubiquitinating domain of CYLD protein, human protein, human underlie the development of skin appendage tumors in Homo sapiens, whereas down-regulation of Cyld expression has been associated with the development of various types of human malignancies including Primary malignant neoplasm of lung[SEP]Relations: lung has relations: anatomy_protein_present with CYLD protein, human, anatomy_protein_present with CYLD protein, human, anatomy_protein_present with PDGFRA, anatomy_protein_present with PDGFRA, anatomy_protein_present with MKRN2OS, anatomy_protein_present with MKRN2OS, anatomy_protein_present with NCOR2, anatomy_protein_present with NCOR2, anatomy_protein_present with CYSLTR2, anatomy_protein_present with CYSLTR2. Definitions: Catalytic Domain defined as following: The region of an enzyme that interacts with its substrate to cause the enzymatic reaction.. Abnormal breathing defined as following:

When you're short of breath, it's hard or uncomfortable for you to take in the oxygen your body needs. You may feel as if you're not getting enough air. Sometimes you can have mild breathing problems because of a stuffy nose or intense exercise. But shortness of breath can also be a sign of a serious disease.

Many conditions can make you feel short of breath:

If you often have trouble breathing, it is important to find out the cause.

. Homo sapiens defined as following: Members of the species Homo sapiens.. Smooth muscle (tissue) defined as following: Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed). CYLD protein, human defined as following: Ubiquitin carboxyl-terminal hydrolase CYLD protein, human (956 aa, ~107 kDa) is encoded by the human CYLD protein, human gene. This protein is involved in the mediation of protein deubiquitination and the regulation of the cell cycle.. TNFSF10 wt Allele defined as following: Human TNFSF10 wild-type allele is located within 3q26 and is approximately 18 kb in length. This allele, which encodes tumor necrosis factor ligand superfamily member 10 protein, is involved in the induction and modulation of apoptosis.. Lung defined as following: Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.. Epithelial defined as following: A term that refers to the cells that make up the Epithelial tissues. They are found in the skin, and in the parenchyma, surface and lumen of internal organs.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA..", "label": "yes"} {"original_question": "Does d-tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction?", "id": "converted_550", "sentence1": "Does tubocurarine (d-TC) induces irreversible inhibition of nicotinic acetylcholine receptor location (nAChR) at the neuromuscular junction?", "sentence2": "An integrated model describing the interaction of nondepolarizing neuromuscular blocking agents with reversible anticholinesterase agents is derived and compared with a naive model using experimental data obtained from four anesthetized dogs. Three consecutive but separate steady-state tubocurarine blocks (approximately 50, 70, and 90%) were induced in each of the four dogs and reversed by short edrophonium infusions., The ability of Hexamethonium (Complement Component Complement Component C6, human, human) to reverse the neuromuscular blocking action of tubocurarine (CD55 wt Allele), Volatile anesthetics enhance the Observation of Neuromuscular Block produced by nondepolarizing Muscle Tissue relaxants (NDMRs). The neuromuscular junction is a postulated site of this interaction. We tested the hypothesis that volatile anesthetic enhancement of Muscle Tissue relaxation is the result of combined drug effects on the nicotinic acetylcholine receptor location location., Concentration-effect curves for the inhibition of acetylcholine-induced currents were established for vecuronium, tubocurarine, isoflurane, and sevoflurane. Subsequently, inhibitory effects of NDMRs were studied in the presence of the volatile anesthetics at a concentration equivalent to half the concentration producing a 50% inhibition alone. All individually tested compounds produced rapid and readily reversible concentration-dependent inhibition., The pharmacological diversity of the different Protein Isoforms of the nicotinic acetylcholine receptor location location arises from the diversity of the subunits that assemble to form the native receptors. The aim of this study was to investigate the actions of the Muscle Tissue relaxants tubocurarine, pancuronium and vecuronium on different Protein Isoforms of Nicotinic Receptors, At all three receptor types, tubocurarine and pancuronium blocked the responses elicited by acetylcholine in a reversible manner. , As further evidence of anticholinesterase activity, methamidophos (1-100 microM) was able to reverse the blockade by tubocurarine, There was an initial partial reversal of the neuromuscular inhibition caused by tubocurarine, isoflurane and sevoflurane enhance the receptor blocking effects of nondepolarizing Muscle Tissue relaxants on Nicotinic Receptors., Because other purinergic 2X (P2X) receptor antagonists, NF023 and NF 279, do not have the reverse effects on the Observation of Neuromuscular Block of d-TC, the effect of NF 449 seems irrelevant to inhibition of P2X receptors., The association rate constant for CD55 wt Allele binding to sites on the nicotinic acetylcholine receptor location location appears to be very fast (k+D = 8.9 x 10(8) M-1 s-1) and comparable to that for acetylcholine (ACh)., The aim of this study was to investigate the mechanism for the reversal effect of NF 449 (a suramin analogue) on the neuromuscular block induced by tubocurarine (d-TC)., Study of the reversal effect of NF 449 on Observation of Neuromuscular Block induced by tubocurarine.[SEP]Relations: Tubocurarine has relations: drug_drug with Acetylcholine, drug_drug with Acetylcholine, drug_drug with Succinylcholine, drug_drug with Succinylcholine, drug_drug with Naltrexone, drug_drug with Naltrexone, drug_drug with Acetyldigoxin, drug_drug with Acetyldigoxin. Acetylcholine has relations: drug_drug with Tubocurarine, drug_drug with Tubocurarine. Definitions: tubocurarine defined as following: A neuromuscular blocker and active ingredient in CURARE; plant based alkaloid of Menispermaceae.. isoflurane defined as following: A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.. Protein Isoforms defined as following: Refers to variants of the same protein which can be separated on special conducting media using electrophoresis. The differences may arise from genetically determined differences in primary structure or by modification of the same primary sequence.. CD55 wt Allele defined as following: Human CD55 wild-type allele is located in the vicinity of 1q32 and is approximately 40 kb in length. This allele, which encodes complement decay-accelerating factor protein, is involved in the modulation of complement activity.. acetylcholine defined as following: A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system.. Hexamethonium defined as following: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.. methamidophos defined as following: A synthetic organic thiophosphate compound and organophosphate acetylcholinesterase inhibitor and neurotoxin that is used as a pesticide. It is characterized as a volatile colorless or off-white crystalline solid with a pungent odor, and exposure occurs by inhalation, ingestion, or contact.. vecuronium defined as following: A synthetic, intermediate-acting mono-quaternary steroid and non-depolarizing neuromuscular blocking agent, with Muscle Tissue relaxant activity. Vecuronium competitively binds to and blocks the nicotinic acetylcholine receptor location at the neuromuscular junction, thereby preventing acetylcholine (ACh) binding and resulting in skeletal Muscle Tissue relaxation and paralysis. Vecuronium has a shorter duration of action than pancuronium.. pancuronium defined as following: A bis-quaternary steroid that is a competitive nicotinic antagonist. As a neuromuscular blocking agent it is more potent than CURARE but has less effect on the circulatory system and on histamine release.. edrophonium defined as following: A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.. suramin defined as following: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.. Muscle Tissue defined as following: Contractile tissue that produces movement in animals.. Nicotinic Receptors defined as following: One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into Muscle Tissue-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors.. sevoflurane defined as following: A fluorinated isopropyl ether with general anesthetic property. Although the mechanism of action has not been fully elucidated, sevoflurane may act by interfering with the release and re-uptake of neurotransmitters at post-synaptic terminals, and/or alter ionic conductance following receptor activation by a neurotransmitter. Sevoflurane may also interact directly with lipid matrix of neuronal membranes, thereby affecting gating properties of ion channels. In addition, this agent may activate gamma-aminobutyric acid (GABA) receptors hyperpolarizing cell membranes. This results in a general anesthetic effect, a decrease in myocardial contractility and mean arterial pressure as well as an increased respiratory rate.. Complement Component C6, human defined as following: Complement component Complement Component C6, human (934 aa, ~105 kDa) is encoded by the human Complement Component C6, human gene. This protein is involved in complement-mediated host defense responses.. nicotinic acetylcholine receptor location defined as following: One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into Muscle Tissue-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors..", "label": "no"} {"original_question": "Do Conserved noncoding elements act as enhancers?", "id": "converted_1580", "sentence1": "Do Conserved noncoding Elements act as enhancers?", "sentence2": "The Abdominal cutaneous nerve entrapment syndrome are rich in tissue-specific enhancers, Transgenic Zebrafish assay of some Homo sapiens CNE enhancers that have been lost in teleosts, Conserved noncoding Elements (CNEs) in Vertebrates Genome often act as developmental enhancers,, In all four cases where the zebra fish and Homo sapiens CNE display a similar expression pattern in zebra fish, the Homo sapiens CNE also displays a similar expression pattern in Mus sp.. This suggests that the endogenous Enhancer of transcription activity of ∼30% of Homo sapiens CNEs can be determined from experiments in zebra fish, If these ancient CNEs are indeed enhancers directing tissue-specific expression of Hox Genes, divergence of their DNA Sequence in Vertebrates lineages might have led to altered expression patterns and presumably the functions of their associated Hox Genes., Comparisons of noncoding DNA Sequence of the elephant shark and Homo sapiens Hox clusters have identified a large number of conserved noncoding Elements (CNEs), which represent putative cis-regulatory Elements that may be involved in the regulation of Hox Genes., Animal Genome possess highly conserved cis-regulatory DNA Sequence that are often found near Genes that regulate transcription and development., We test 42 of our PCNEs in transgenic Zebrafish assays--including examples from vertebrates and Branchiostoma sp.--and find that the majority are functional enhancers., The Genome of vertebrates, Diptera, and Phylum Nematoda contain highly conserved noncoding Elements (CNEs). CNEs cluster around Genes that regulate development, and where tested, they can act as transcriptional enhancers., , we identified 17 highly conserved noncoding Elements, 9 of which revealed specific acetylation marks in chromatin-immunoprecipitation and microarray (ChIP-chip) assays performed across 250 kb of the LMO2 wt Allele locus in 11 cell types covering different stages of hematopoietic differentiation. All candidate Regulatory Sequences, Nucleic Acid were tested in Mice, Transgenic. An extended LMO2 proximal promoter fragment displayed strong endothelial activity, while the distal promoter showed weak forebrain activity. Eight of the 15 distal candidate Elements functioned as enhancers,, Pan-Vertebrates developmental cis-regulatory Elements are discernible as highly conserved noncoding Elements (HCNEs) and are often dispersed over large areas around the pleiotropic Genes whose expression they control., HCNEs of both Homo sapiens and Zebrafish function as specific developmental enhancers in Zebrafish., several transcriptional enhancers are conserved between Branchiostoma sp. and vertebrates--a very wide phylogenetic distance., We recently described GRBs in vertebrates, where most HCNEs function as enhancers, Besides developmental regulators that are likely targets of HCNE enhancers, We identify and characterize highly conserved noncoding Elements flanking the TNF gene, which undergo activation-dependent intrachromosomal interactions. These Elements, hypersensitive site (HSS)-9 and HSS+3 (9 kb upstream and 3 kb downstream of the TNF gene, respectively), contain deoxyribonuclease I activity hypersensitive sites in naive, T helper 1, and T helper 2 primary Therapeutic gamma delta T-lymphocytes. Both HSS-9 and HSS+3 inducibly associate with acetylated Histones, indicative of chromatin remodeling, bind the transcription factor nuclear factor of activated Therapeutic gamma delta T-lymphocytes (NFAT)p in vitro and in vivo, and function as enhancers, We used the sequence signatures identified by this approach to successfully assign tissue-specific predictions to approximately 328,000 Homo sapiens-Mus sp. conserved noncoding Elements in the Homo sapiens genome. By overlapping these genome-wide predictions with a data set of enhancers validated in vivo, in Mice, Transgenic, we were able to confirm our results with a 28% sensitivity and 50% precision., Fish-mammal genomic comparisons have proved powerful in identifying conserved noncoding Elements likely to be cis-regulatory in nature, and the majority of those tested in vivo have been shown to act as tissue-specific enhancers associated with Genes involved in transcriptional regulation of development., uncovered two anciently conserved noncoding DNA Sequence (Central Nervous System) upstream of NR2F2 protein, Homo sapiens (Central Nervous System-62kb and Central Nervous System-66kb). Testing these two Elements using reporter constructs in Hepatocyte (HepG2) revealed that Central Nervous System-66kb, but not Central Nervous System-62kb, yielded robust in vitro Enhancer of transcription activity.[SEP]Relations: Protein S Homo sapiens has relations: drug_drug with Nonacog beta pegol, drug_drug with Nonacog beta pegol, drug_drug with Resveratrol, drug_drug with Resveratrol, drug_drug with Antihemophilic factor, Homo sapiens recombinant, drug_drug with Antihemophilic factor, Homo sapiens recombinant, drug_drug with Antihemophilic Factor (Recombinant), PEGylated, drug_drug with Antihemophilic Factor (Recombinant), PEGylated. central nervous system has relations: anatomy_protein_present with NONO, anatomy_protein_present with NONO. Definitions: DNA Sequence defined as following: The sequence of nucleotide residues along a DNA chain.. Therapeutic gamma delta T-lymphocytes defined as following: A subset of therapeutic autologous T-lymphocytes that express a T-cell receptor (TCR) composed of one gamma chain and one delta chain, with potential immunomodulating and antineoplastic activities. Upon administration of the therapeutic gamma delta T-lymphocytes, these cells secrete interferon-gamma (IFN-g), and exert direct killing of tumor cells. In addition, these cells activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against tumor cells. Gamma delta T-lymphocytes play a key role in the activation of the immune system and do not require major histocompatibility complex (MHC)-mediated antigen presentation to exert their cytotoxic effect.. Hepatocyte defined as following: The main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules.. Zebrafish defined as following: An exotic species of the family CYPRINIDAE, originally from Asia, that has been introduced in North America. Zebrafish is a model organism for drug assay and cancer research.. Regulatory Sequences, Nucleic Acid defined as following: Nucleic acid DNA Sequence involved in regulating the expression of Genes.. Vertebrates defined as following: Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising mammals, birds, reptiles, amphibians, and fishes.. deoxyribonuclease I activity defined as following: Catalysis of the endonucleolytic cleavage of DNA to 5'-phosphodinucleotide and 5'-phosphooligonucleotide end products. [EC:3.1.21.1]. Histones defined as following: Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each.. Abdominal cutaneous nerve entrapment syndrome defined as following: A chronic neuropathic pain syndrome of the abdominal wall caused by entrapment of anterior cutaneous branches of 7 to 12th intercostal nerves along the lateral border of the anterior rectus abdominis fascia.. TNF gene defined as following: This gene is involved in apoptosis, cell growth and cell proliferation. It also plays a role in immune and inflammatory responses.. Elements defined as following: Substances that comprise all matter. Each element is made up of atoms that are identical in number of electrons and protons and in nuclear charge but may differ in mass or number of neutrons.. LMO2 wt Allele defined as following: Human LMO2 wild-type allele is located in the vicinity of 11p13 and is approximately 34 kb in length. This allele, which encodes rhombotin-2 protein, is involved in red blood cell development through the modulation of transcription by RNA polymerase II.. NR2F2 protein, Homo sapiens defined as following: COUP transcription factor 2 (414 aa, ~46 kDa) is encoded by the Homo sapiens NR2F2 gene. This protein is involved in the mediation of transcription.. Genes defined as following: A category of nucleic acid DNA Sequence that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Diptera defined as following: An order of the class Insecta. Wings, when present, number two and distinguish Diptera from other so-called Diptera, while the halteres, or reduced hindwings, separate Diptera from other insects with one pair of wings. The order includes the families Calliphoridae, Oestridae, Phoridae, SARCOPHAGIDAE, Scatophagidae, Sciaridae, SIMULIIDAE, Tabanidae, Therevidae, Trypetidae, CERATOPOGONIDAE; CHIRONOMIDAE; CULICIDAE; DROSOPHILIDAE; GLOSSINIDAE; MUSCIDAE; TEPHRITIDAE; and PSYCHODIDAE. The larval form of Diptera species are called maggots (see LARVA).. Central Nervous System defined as following: The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.. Mice, Transgenic defined as following: Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.. pleiotropic Genes defined as following: A single gene that influences several distinct and seemly unrelated phenotypic outcomes.. Hox Genes defined as following: Genes that encode highly conserved TRANSCRIPTION FACTORS that control positional identity of cells (BODY PATTERNING) and MORPHOGENESIS throughout development. Their DNA Sequence contain a 180 nucleotide sequence designated the homeobox, so called because mutations of these Genes often results in homeotic transformations, in which one body structure replaces another. The proteins encoded by homeobox Genes are called HOMEODOMAIN PROTEINS.. Homo sapiens defined as following: Members of the species Homo sapiens.. Genome defined as following: The genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA.. Enhancer of transcription defined as following: A 50-150bp DNA sequence that increases the rate of transcription of coding DNA Sequence. It may be located at various distances and in either orientation upstream from, downstream from or within a structural gene. When bound by a specific transcription factor it increases the levels of expression of the gene, but is not sufficient alone to cause expression. Distinguished from a promoter, that is alone sufficient to cause expression of the gene when bound.. Phylum Nematoda defined as following: class of unsegmented helminths with fundamental bilateral symmetry and secondary triradiate symmetry of the oral and esophageal structures; many species are parasites..", "label": "yes"} {"original_question": "Do statins cause diabetes?", "id": "converted_1835", "sentence1": "Do statins cause diabetes?", "sentence2": "3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition) use has been associated with increased risk of developing type 2 diabetes (T2DM), and with impaired glycemic control in T2DM patients, The relationship between T2DM and statins is further complicated since these drugs can cause new onset diabetes (Dentatorubral-Pallidoluysian Atrophy) although there is an overall benefit in terms of preventing vascular events , It has been repeatedly reported that statins may cause new-onset diabetes mellitus (Diabetes Mellitus)., However, a small, but significant risk of new-onset diabetes has been reported in patients treated with statins., The National Lipid Association (NLA) 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition) Diabetes Safety Task Force concluded that the Cardiovascular system benefit of statin therapy outweighs the risk for developing diabetes, It has been repeatedly reported that statins may cause new-onset diabetes mellitus (Diabetes Mellitus), It has been repeatedly reported that statins may cause new-onset diabetes mellitus (Diabetes Mellitus). However, limited evidence exists from direct head to head comparisons of statins on whether the risk of Diabetes Mellitus differs among statins., Short-term statin exposure is associated with reduced all-cause mortality in persons with diabetes., Despite the fact that higher statin doses are more likely to lead to new-onset diabetes, for every case of diabetes caused, there are approximately three Cardiovascular system events reduced with high dose versus moderate dose statin therapy., It has been repeatedly reported that statins may cause new-onset diabetes mellitus (Diabetes Mellitus)., Hydroxymethylglutaryl-CoA Reductase Inhibitors are evidence-based drugs to prevent Cardiovascular system (CV) disease. However, their benefits have been disputed by a statin-related increased risk of new onset diabetes, Compared with pravastatin, treatment with higher potency statins, especially atorvastatin and simvastatin, might be associated with an increased risk of new onset diabetes, statins are associated with a small increase in incidence of diabetes in patients predisposed to glycemic alteration, Higher potency statin use is associated with a moderate increase in the risk of new onset diabetes compared with lower potency statins in patients treated for secondary prevention of Cardiovascular Diseases, An increased risk of new onset treated diabetes was found in those treated with statins showing significant duration and dose effect, Although most of the clinical studies suggest a worsening of insulin resistance and secretion, the Cardiovascular system benefits of statin therapy outweigh the risk of developing insulin resistance, thus the data suggest the need to treat Dyslipidemias and to make patients aware of the possible risk of developing type 2 diabetes or, if they already are diabetic, of worsening their metabolic control, 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition) therapy can slightly increase risk of incident diabetes in subjects with Hypercholesterolemia result.[SEP]Relations: Simvastatin has relations: contraindication with diabetes mellitus (disease), contraindication with diabetes mellitus (disease), drug_effect with Arthritis, drug_effect with Arthritis, contraindication with diabetic ketoacidosis, contraindication with diabetic ketoacidosis, drug_effect with Edema, drug_effect with Edema. Atorvastatin has relations: drug_effect with Dysphagia, drug_effect with Dysphagia. Definitions: pravastatin defined as following: An antilipemic fungal metabolite isolated from cultures of Nocardia autotrophica. It acts as a competitive inhibitor of HMG CoA reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES).. Hydroxymethylglutaryl-CoA Reductase Inhibitors defined as following: Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis.. simvastatin defined as following: A derivative of LOVASTATIN and potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It may also interfere with steroid hormone production. Due to the induction of hepatic LDL RECEPTORS, it increases breakdown of LDL CHOLESTEROL.. Hypercholesterolemia result defined as following: A laboratory test result indicating an increased amount of cholesterol in the blood.. Cardiovascular Diseases defined as following: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.. Diabetes Mellitus defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.. Cardiovascular system defined as following: The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body.. Dentatorubral-Pallidoluysian Atrophy defined as following: A rare, autosomal dominant inherited progressive neurodegenerative disorder. It is caused by a mutation in the ATN1 gene, resulting in a combined degeneration of the dentatorubral and pallidoluysian systems. It can appear at any age, but it usually affects individuals between 20 and 30 years and leads to death within 10-15 years. The clinical presentation depends on the age of the affected individual; juvenile patients develop severe progressive myoclonus epilepsy and cognitive decline, whereas adult patients develop ataxia, choreoathetosis and dementia.. Dyslipidemias defined as following: A lipoprotein metabolism disorder characterized by decreased levels of high-density lipoproteins, or elevated levels of plasma cholesterol, low-density lipoproteins and/or triglycerides.. atorvastatin defined as following: A synthetic lipid-lowering agent. Atorvastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. Atorvastatin also increases the number of LDL receptors on hepatic cell surfaces to enhance uptake and catabolism of LDL and reduces LDL production and the number of LDL particles. This agent lowers plasma cholesterol and lipoprotein levels and modulates immune responses by suppressing MHC II (major histocompatibility complex II) on interferon gamma-stimulated, antigen-presenting cells such as human vascular endothelial cells. (NCI04). statins defined as following: Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis.. diabetes defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE..", "label": "yes"} {"original_question": "Can telomere length shortening be reversed by telomerase?", "id": "converted_1952", "sentence1": "Can telomere length shortening be reversed by Telomerase?", "sentence2": "Telomere length is regulated around an equilibrium set point. telomere shorten during replication and are lengthened by Telomerase. Disruption of the length equilibrium leads to Disease; thus, it is important to understand the mechanisms that regulate length at the Molecular level. , High Telomerase activity is detected in nearly all human Malignant Neoplasms but most Human Cells are devoid of Telomerase activity. There is well-documented evidence that reactivation of Telomerase occurs during cellular transformation. In Homo sapiens, Neoplasms can rely in reactivation of Telomerase or originate in a Telomerase positive stem/progenitor cell, or rely in alternative lengthening of telomeres, a Telomerase-independent telomere-length maintenance mechanism., Together, these observations may provoke a re-evaluation of telomere and Telomerase based therapies, both in Telomerase inhibition for cancer therapy and Telomerase activation for tissue regeneration and anti-ageing strategies., telomere progressively shorten throughout life. A hallmark of advanced malignancies is the ability for continuous cell divisions that almost universally correlates with the stabilization of telomere length by the reactivation of Telomerase., Telomerase-mediated telomere elongation provides cell populations with the ability to proliferate indefinitely. Telomerase is capable of recognizing and extending the shortest telomeres in Cells;, Telomerase gene therapy rescues telomere length, Aplastic bone marrow, and survival in CASP14 gene with Aplastic Anemia.[SEP]Relations: Telomere Extension By Telomerase has relations: pathway_protein with TERT, pathway_protein with TERT, pathway_protein with ACD, pathway_protein with ACD, pathway_protein with RTEL1, pathway_protein with RTEL1, pathway_protein with TERF2, pathway_protein with TERF2, pathway_protein with GAR1, pathway_protein with GAR1. Definitions: telomere defined as following: A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs.. Molecular defined as following: Relating to or produced by or consisting of molecules.. Telomerase defined as following: An essential ribonucleoprotein reverse transcriptase that adds telomeric DNA to the ends of eukaryotic CHROMOSOMES.. Homo sapiens defined as following: Members of the species Homo sapiens.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic Cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Aplastic Anemia defined as following: A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Aplastic bone marrow defined as following: Depletion of stem Cells in the bone marrow that results in the lack of production of hematopoietic Cells.. telomere defined as following: A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs..", "label": "yes"} {"original_question": "Is thrombophilia related to increased risk of miscarriage?", "id": "converted_1513", "sentence1": "Is thrombophilia related to increased risk of miscarriage?", "sentence2": "Thrombophilia does hardly increase the risk of IUGR/PMPC or if so, it can be prevented by Low Molecular Weight Heparin [EPC], for illustrative purposes, a patient presenting with combined thrombophilia--both Genetic and acquired--will be discussed. This patient had suffered severe gestational complications that led to devastating obstetrical outcome, Thrombophilias have been implicated in complications related to ischemic placental disease including recurrent pregnancy loss, intrauterine fetal demise, Pre-Eclampsia, fetal growth restriction, placental abruption, and preterm delivery, Further information about the combined risk of Antigen-Presenting Cells resistance and pregnancy is needed before guidance on the management of affected women can be formulated., Thrombotic risk during pregnancy and the puerperium is higher in asymptomatic women with than without thrombophilia, Further studies are required to assess the thrombotic risk in women with Pre-Eclampsia as well as early or late recurrent pregnancy loss., Risk of pregnancy-related Venous Thrombosis in carriers of severe inherited thrombophilia, In conclusion, homozygous carriers of Factor V Leiden and, to a lesser extent, double heterozygous carriers of Factor V Leiden and of the prothrombin mutation have an increased risk of Venous Thrombosis during pregnancy, particularly high during the postpartum period, Careful diagnosis, observation and monitoring can add significant benefit to Low Molecular Weight Heparin [EPC] therapy during pregnancy, Pregnancy in healthy women is accompanied by hypercoagulable changes that may interact with thrombophilia risk factors and threaten pregnancy., Fifty-three (13 %) women had antiphospholipid Antibodies, in vitro diagnostic (lupus anticoagulant and/or anti-beta2-glycoprotein 1 Antibodies, in vitro diagnostic) mainly associated with the risk of spontaneous abortion during the first trimester, thrombophilia was found to be considerably more common in women with pregnancy-associated complications in comparison with the general population, and most frequently in conjunction with Venous Thromboembolism during pregnancy and the postpartum period, When counseling white women with a history of Pre-Eclampsia, screening for thrombophilia can be useful for preconceptional counseling and pregnancy management., knowledge combined with the appropriate use of thromboprophylaxis and treatment in women who have objectively confirmed vinyltriethoxysilane continue to improve maternal and perinatal outcomes, The risk of having thrombophilia is doubled in men who have fathered pregnancies which ended in perinatal death as well as in the mothers of such pregnancies., The prevalence of thrombophilic Variant is of possible public health significance for other morbidity; but perhaps not in relation to Pre-Eclampsia, This study suggests that thrombophilia \"mediates\" in lowering of cardiovascular risk factors in women with a history of Pre-Eclampsia[SEP]Relations: thrombophilia has relations: disease_disease with inherited thrombophilia, disease_disease with inherited thrombophilia, disease_phenotype_positive with Recurrent thrombophlebitis, disease_phenotype_positive with Recurrent thrombophlebitis, disease_phenotype_positive with Preeclampsia, disease_phenotype_positive with Preeclampsia, disease_phenotype_positive with Hypercoagulability, disease_phenotype_positive with Hypercoagulability, disease_phenotype_positive with Thromboembolism, disease_phenotype_positive with Thromboembolism. Definitions: Variant defined as following: An alteration or difference from a norm or standard.. Thrombophilia defined as following: A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS.. Pre-Eclampsia defined as following: A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.. Antigen-Presenting Cells defined as following: A heterogeneous group of immunocompetent cells that mediate the cellular immune response by processing and presenting antigens to the T-cells. Traditional antigen-presenting cells include MACROPHAGES; DENDRITIC CELLS; LANGERHANS CELLS; and B-LYMPHOCYTES. FOLLICULAR DENDRITIC CELLS are not traditional antigen-presenting cells, but because they hold antigen on their cell surface in the form of IMMUNE COMPLEXES for B-cell recognition they are considered so by some authors.. Venous Thrombosis defined as following: The formation or presence of a blood clot (THROMBUS) within a vein.. Venous Thromboembolism defined as following: Obstruction of a vein or VEINS (embolism) by a blood clot (THROMBUS) in the blood stream.. Genetic defined as following: Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.. Factor V defined as following: Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor V accomplishes this by forming a complex with factor Xa, phospholipid, and calcium (prothrombinase complex). Deficiency of Factor V leads to Owren's disease.. thrombophilia defined as following: A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS..", "label": "yes"} {"original_question": "Can thiotepa be recommended for treatment of osteosarcoma?", "id": "converted_4219", "sentence1": "Can thiotepa be recommended for treatment of Osteosarcoma of bone?", "sentence2": "CONCLUSION: Adjuvant HDTp failed to significantly improve OS and PFS in resectable relapsed Osteosarcoma. Despite a trend of prolonged survival and an acceptable Toxic effect, thiotepa cannot be recommended.KEY MESSAGE: HDTp and autologous transplantation added to SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME did not improve OS and PFS in patients with resectable relapsed Osteosarcoma. Despite a trend of prolonged survival, thiotepa cannot be recommended., Conclusion. The use of HD thiotepa and ASCT is feasible in patients with relapsed Osteosarcoma of bone. A randomized study for recurrent Osteosarcoma of bone between standard salvage chemotherapy and high dose thiotepa with Stem cells rescue is ongoing.[SEP]Relations: Thiotepa has relations: drug_effect with Lymphedema, drug_effect with Lymphedema, drug_effect with Erythema, drug_effect with Erythema, drug_drug with Antipyrine, drug_drug with Antipyrine, contraindication with kidney disease, contraindication with kidney disease, contraindication with liver disease, contraindication with liver disease. Definitions: Osteosarcoma of bone defined as following: This gene is involved in the regulation of cell differentiation, growth and proliferation.. Stem cells defined as following: Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells.. thiotepa defined as following: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME defined as following: A spondylodysplasic dysplasia clinically characterized by postnatal progressive vertebral fusions frequently manifesting as block vertebrae, contributing to an shortened trunk and hence disproportionate short stature, scoliosis, lordosis, carpal and tarsal synostosis and infrequently, club feet.. Osteosarcoma defined as following: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed).", "label": "no"} {"original_question": "Can radiotherapy cause radiation induced osteosarcoma?", "id": "converted_3460", "sentence1": "Can radiotherapy cause radiation induced Osteosarcoma of bone?", "sentence2": "A case of radiation-induced Osteosarcoma of bone of the Bone structure of cranium presenting as a cutaneous epidermotropic Specimen Source Codes - Specimen Source Codes - tumor with a short latent period., Radiation-induced sarcoma (Arikaree language) is an unusual but well documented Specimen Source Codes - Specimen Source Codes - tumor. , We report a case of a 34-year-old female who developed an Osteosarcoma of bone of the Scalp structure, over a previous craniotomy scar, 3 years after Excision of a frontal anaplastic oligodendroglioma which had been followed by a course of 6 weeks radiotherapy (58 Gy) and 6 cycles of temozolomide. , Radiation-induced Osteosarcoma of bone after Gamma Knife surgery for Acoustic Neuroma: a case report and literature review., We present a rare case of radiation-induced Osteosarcoma of bone following Gamma Knife® surgery (GKS) for a Acoustic Neuroma (VS). , The Osteosarcoma of bone was considered to be a radiation-induced malignancy. , Radiation-induced Osteosarcoma of bone of the Maxilla and Head>Mandible after radiotherapy for nasopharyngeal carcinoma., The purpose of this study was to analyze the association of clinicopathologic characteristics with treatment outcomes and prognostic factors of patients who developed RIOSM after undergoing radiotherapy for nasopharyngeal carcinoma (Nasopharyngeal carcinoma)., Of these patients, 47 who developed RISOM and met inclusion criteria were included in this study. , CONCLUSIONS: RISOM after radiotherapy for Nasopharyngeal carcinoma is aggressive and often eludes early detection and timely intervention., Radiation-induced Osteosarcoma of bone of the Bone structure of cranium base after radiation therapy in a patient with nasopharyngeal carcinoma: a case report and review of the literature., BACKGROUND: Radiation-induced osteosarcomas are a recognized complication of radiation therapy. , CASE PRESENTATION: We describe a rare case of a patient with a Bone structure of cranium base radiation-induced Osteosarcoma of bone treated 11 years before with ionizing radiation for an undifferentiated carcinoma of the Head+Neck>Nasopharynx. , CONCLUSIONS: Radiation-induced Osteosarcoma of bone of the Bone structure of cranium base after treatment of nasopharyngeal carcinoma is a very rare but very aggressive complication with a poor prognosis., Radiation-Associated Low-Grade Extraskeletal Osteosarcoma of the Neck Following Treatment for Malignant neoplasm of thyroid., Low-grade extraskeletal Osteosarcoma of bone is a rare Specimen Source Codes - Specimen Source Codes - tumor that may arise de novo or following radiation therapy., While there is a report of a low-grade extraskeletal Osteosarcoma of bone arising following radiotherapy for a benign condition, to the best of our knowledge this is the first reported case of a low-grade extraskeletal Osteosarcoma of bone occurring following radiotherapy for thyroid cancer, and the only case reported in the Neck+Chest>Soft tissue of the head and neck region. , Here we a report a case of radiation induced Osteosarcoma of bone which developed 11 years after a single fraction of 700 cGy., Osteosarcoma following single fraction radiation prophylaxis for Heterotopic Ossification., The radiotherapy dose for this patient is lower than classically reported for radiation induced Malignant neoplasm of Neck+Chest>Soft tissue., The latency period between radiotherapy and Osteosarcoma of bone onset was 1.3 years shorter inside than outside the radiation field., Osteosarcoma after radiotherapy for Malignant neoplasm of prostate., Osteosarcoma after external beam radiation therapy for recurrent Malignant melanoma of choroid., Diagnostic criteria were fulfilled and the lesion was classified as a radiation induced Osteosarcoma of bone, Although a rare complication of ionizing radiation, radiation-induced Osteosarcoma of bone is now more frequently recognized as radiation therapy has become common and cancer survival has increased, Here we a report a case of radiation induced Osteosarcoma of bone which developed 11 years after a single fraction of 700 cGy, Radiation-induced Osteosarcoma of bone usually occurs after a long latency period of more than 10 years after the radiotherapy, Osteosarcoma following radiotherapy: a case report., Radiation-induced fibrosarcoma after radiotherapy for Osteosarcoma of bone in the Mandibular Condyle., Post-radiation Osteosarcoma of bone of the Bone structure of Bone structure of scapula., Radiation-induced osteosarcomas generally occur 3-30 years after exposure and are most common after radiotherapy for Cervical or Breast Carcinoma, Radiation-induced Osteosarcoma of bone is one of the rare types of radiation-induced Malignant neoplasm of Neck+Chest>Soft tissue , with the risk of radiation-induced osteosarcomas being only 0.01 % -0.03 % among all patients treated with radiotherapy, Radiation-induced Osteosarcoma of bone is a well-known but rare complication of radiotherapy for brain Neoplasms with a poor prognosis, The prognosis of patients developing Osteosarcoma of bone after radiotherapy for Malignant neoplasm of prostate is similar to other radiation-induced osteosarcomas occurring in the axial skeleton , with a 50 % overall mortality within the first year after diagnosis, Radiation-induced Osteosarcoma of bone usually occurs after a long latency period of more than 10 years after the radiotherapy, Twenty-seven years 11 months after orthovoltage radiotherapy of the right breast a 69-year-old woman developed a radiation-induced Osteosarcoma of bone of the right thoracic wall, We report a case of radiation-induced Osteosarcoma of bone developed from Bone structure of cranium after 7 years of craniospinal radiotherapy for pineoblastoma, Although the concepts of direct and indirect effects of radiation are fully applicable to low-LET ( linear energy transfer ) radioresistant Specimen Source Codes - Specimen Source Codes - tumor cells/normal tissues such as Osteosarcoma of bone cells and Chondrocyte , it is believed that radiation-associated damage to DNA does not play a major role in the mechanism of cell death in low-LET radiosensitive tumors/normal tissues such as malignant lymphoma cells and Specimen Source Codes - Lymphocytes, From these clinicopathological findings, both cases were diagnosed as radiation-induced Osteosarcoma of bone., Here we report two cases of radiation-induced Osteosarcoma of bone in the Nasal sinus after treatment for frontal glioma., As the prognosis of radiation-induced Osteosarcoma of bone is poorer than that of primary osteo-sarcoma, careful attention is required for consideration of the long-term survival of patients with glioma., Radiation-induced osteosarcomas appeared 16 and 12 years after radiotherapy in cases 1 and 2, respectively., Most radiation-induced osteosarcomas of the Bone structure of cranium are reported to arise in the facial bone or Nasal sinus after radiotherapy for Retinoblastoma and/or Pituitary Adenoma., Radiation-induced osteosarcomas after treatment for frontal Glioma: a report of two cases., Radiation-induced Osteosarcoma of bone of the Bone structure of cranium mimicking cutaneous Specimen Source Codes - Specimen Source Codes - tumor after treatment for frontal glioma., Radiation-induced Osteosarcoma of bone is one of the rare types of radiation-induced Malignant neoplasm of Neck+Chest>Soft tissue, with the risk of radiation-induced osteosarcomas being only 0.01%-0.03% among all patients treated with radiotherapy., Radiation-induced Malignant neoplasm of Neck+Chest>Soft tissue are recognized complications of radiation therapy and are associated with poor prognosis., There have been only four reported cases of radiation-induced osteosarcomas after radiotherapy for Glioma., Here, we report a unique case of radiation-induced osteosarcomas arising on the Bone structure of cranium and extending to the Skin Specimen Source Code, with a short latent period., BACKGROUND\nThe increasing incidence of radiation-induced Osteosarcoma of bone of the Maxilla and Head>Mandible (RIOSM) has become a significant problem that can limit long-term survival., In this case, Osteosarcoma of bone was possibly a radiation-induced Osteosarcoma of bone with a short latency period of 3 years., Radiation-induced Osteosarcoma of bone usually occurs after a long latency period of more than 10 years after the radiotherapy., A case of Osteosarcoma of bone arising in the craniofacial bone with a short latency period of 3 years after radiotherapy for maxillary squamous cell carcinoma is described., Osteosarcoma is one of the Neoplasms that may occur following exposure to radiation., As the prognosis of radiation-induced Osteosarcoma of bone is poorer than that of primary osteo-sarcoma, careful attention is required for consideration of the long-term survival of patients with glioma., This report describes the late recurrence of Malignant melanoma of choroid and subsequent radiation-induced Osteosarcoma of bone., Radiation-induced Osteosarcoma of bone is one of the rare types of radiation-induced Malignant neoplasm of Neck+Chest>Soft tissue, with the risk of radiation-induced osteosarcomas being only 0.01%-0.03% among all patients treated with radiotherapy., There have been only four reported cases of radiation-induced osteosarcomas after radiotherapy for Glioma., Although radiation-induced Osteosarcoma of bone is an uncommon but dire complication of radiotherapy, its incidence will probably increase in the future as the frequency of radiation treatment and cancer survival increase., We report a case of radiation-induced Osteosarcoma of bone developed from Bone structure of cranium after 7 years of craniospinal radiotherapy for pineoblastoma., The prognosis of patients developing Osteosarcoma of bone after radiotherapy for Malignant neoplasm of prostate is similar to other radiation-induced osteosarcomas occurring in the axial skeleton, with a 50% overall mortality within the first year after diagnosis., To our knowledge the only other case report of post-radiation Osteosarcoma of bone with a short latency period was a case of Osteosarcoma of bone in the craniofacial bone 3 years after radiotherapy for maxillary squamous cell carcinoma., Here, we report a unique case of radiation-induced osteosarcomas arising on the Bone structure of cranium and extending to the Skin Specimen Source Code, with a short latent period., Case of postradiation Osteosarcoma of bone with a short latency period of 3 years.[SEP]Relations: bone Osteosarcoma of bone has relations: disease_disease with Osteosarcoma of bone, disease_disease with Osteosarcoma of bone, contraindication with Teriparatide, contraindication with Teriparatide, disease_disease with Osteosarcoma of bone (disease), disease_disease with Osteosarcoma of bone (disease), disease_disease with bone sarcoma, disease_disease with bone sarcoma, disease_disease with telangiectatic osteogenic sarcoma, disease_disease with telangiectatic osteogenic sarcoma. Definitions: Malignant neoplasm of thyroid defined as following: A primary or metastatic malignant neoplasm affecting the thyroid gland.. Malignant neoplasm of prostate defined as following: A primary or metastatic malignant Specimen Source Codes - tumor involving the prostate gland. The vast majority are carcinomas.. Osteosarcoma of bone defined as following: This gene is involved in the regulation of cell differentiation, growth and proliferation.. Maxilla defined as following: One of a pair of irregularly shaped bones that form the upper jaw. A maxillary bone provides tooth sockets for the superior teeth, forms part of the ORBIT, and contains the MAXILLARY SINUS.. Nasopharyngeal carcinoma defined as following: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.. Cervical defined as following: Relating to a neck, or cervix, in any sense.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Heterotopic Ossification defined as following: The development of bony substance in normally soft structures.. Pituitary Adenoma defined as following: A non-metastasizing Specimen Source Codes - tumor that arises from the adenohypophysial cells of the anterior lobe of the pituitary gland. The Specimen Source Codes - tumor can be hormonally functioning or not. The diagnosis can be based on imaging studies and/or radioimmunoassays. Due to its location in the sella turcica, expansion of the Specimen Source Codes - tumor mass can impinge on the optic chiasm or involve the temporal lobe, third ventricle and posterior fossa A frequently associated physical finding is bitemporal hemianopsia which may progress to further visual loss.. Malignant neoplasm of Neck+Chest>Soft tissue defined as following: A malignant neoplasm arising exclusively from the soft tissues.. Glioma defined as following: Benign and malignant central nervous system Neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21). Bone structure of cranium defined as following: The SKELETON of the HEAD including the FACIAL BONES and the bones enclosing the BRAIN.. Malignant melanoma of choroid defined as following: A uveal melanoma that arises from the choroid. It is the most common primary malignant intraocular Specimen Source Codes - tumor. It usually affects Caucasians of northern European descent. It usually remains asymptomatic for a long period. When signs and symptoms occur, they include blurred vision, visual field loss, floaters, and ocular pain. Tumor size is the most important factor that relates to prognosis.. Mandibular Condyle defined as following: The posterior process on the ramus of the Head>Mandible composed of two parts: a superior part, the articular portion, and an inferior part, the condylar neck.. Excision defined as following: The surgical removal of a lesion, often as part of a biopsy and with healthy margins.. Acoustic Neuroma defined as following: A benign SCHWANNOMA of the eighth cranial nerve (VESTIBULOCOCHLEAR NERVE), mostly arising from the vestibular branch (VESTIBULAR NERVE) during the fifth or sixth decade of life. Clinical manifestations include HEARING LOSS; HEADACHE; VERTIGO; TINNITUS; and FACIAL PAIN. Bilateral acoustic neuromas are associated with NEUROFIBROMATOSIS 2. (From Adams et al., Principles of Neurology, 6th ed, p673). temozolomide defined as following: A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.. Bone structure of cranium base defined as following: The inferior region of the Bone structure of cranium consisting of an internal (cerebral), and an external (basilar) surface.. Breast Carcinoma defined as following: A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant Specimen Source Codes - tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.. Nasal sinus defined as following: Air-filled spaces located within the bones around the NASAL CAVITY. They are extensions of the nasal cavity and lined by the ciliated NASAL MUCOSA. Each sinus is named for the cranial bone in which it is located, such as the ETHMOID SINUS; the FRONTAL SINUS; the MAXILLARY SINUS; and the SPHENOID SINUS.. Chondrocyte defined as following: Polymorphic cells that form cartilage.. Neoplasms defined as following: New abnormal growth of tissue. Malignant Neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign Neoplasms.. pineoblastoma defined as following: A poorly differentiated malignant embryonal neoplasm arising from the pineal region. It usually occurs in children and it is characterized by the presence of small immature neuroepithelial cells. It may follow an aggressive clinical course.. Retinoblastoma defined as following: A malignant Specimen Source Codes - tumor arising from the nuclear layer of the retina that is the most common primary Specimen Source Codes - tumor of the eye in children. The Specimen Source Codes - tumor tends to occur in early childhood or infancy and may be present at birth. The majority are sporadic, but the condition may be transmitted as an autosomal dominant trait. Histologic features include dense cellularity, small round polygonal cells, and areas of calcification and necrosis. An abnormal pupil reflex (leukokoria); NYSTAGMUS, PATHOLOGIC; STRABISMUS; and visual loss represent common clinical characteristics of this condition. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2104). Bone structure of scapula defined as following: Also called the shoulder blade, it is a flat triangular bone, a pair of which form the back part of the shoulder girdle.. Scalp structure defined as following: The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL)..", "label": "yes"} {"original_question": "Are protamines ubiquitously expressed?", "id": "converted_3183", "sentence1": "Are protamines ubiquitously expressed?", "sentence2": "protamines are Nuclear Proteins which are specifically expressed in haploid male Germ Cells.[SEP]Relations: Protamine has relations: drug_effect with Inflammatory abnormality of the skin, drug_effect with Inflammatory abnormality of the skin, drug_effect with Fever, drug_effect with Fever, drug_effect with Agitation, drug_effect with Agitation, drug_effect with Pain, drug_effect with Pain, drug_effect with Increased hemoglobin, drug_effect with Increased hemoglobin. Definitions: protamines defined as following: A group of simple proteins that yield basic amino acids on hydrolysis and that occur combined with nucleic acid in the sperm of fish. protamines contain very few kinds of amino acids. Protamine sulfate combines with heparin to form a stable inactive complex; it is used to neutralize the anticoagulant action of heparin in the treatment of heparin overdose. (From Merck Index, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p692). Nuclear Proteins defined as following: Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus.. Germ Cells defined as following: The reproductive cells in multicellular organisms at various stages during GAMETOGENESIS.. protamines defined as following: A group of simple proteins that yield basic amino acids on hydrolysis and that occur combined with nucleic acid in the sperm of fish. protamines contain very few kinds of amino acids. Protamine sulfate combines with heparin to form a stable inactive complex; it is used to neutralize the anticoagulant action of heparin in the treatment of heparin overdose. (From Merck Index, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p692).", "label": "no"} {"original_question": "Is Cystatin D a biomarker?", "id": "converted_2735", "sentence1": "Is CST5 gene a biomarker?", "sentence2": "CST5 gene (CST5): An ultra-early inflammatory biomarker of Traumatic Brain Injury.[SEP]Relations: brain injury has relations: contraindication with Cyclopentolate, contraindication with Cyclopentolate, contraindication with Isopropamide, contraindication with Isopropamide, contraindication with Guaifenesin, contraindication with Guaifenesin, contraindication with Homatropine methylbromide, contraindication with Homatropine methylbromide, contraindication with Hydrocodone, contraindication with Hydrocodone. Definitions: Traumatic Brain Injury defined as following: A form of acquired brain injury which occurs when a sudden trauma causes damage to the brain.. CST5 gene defined as following: This gene is involved in the inhibition of cathepsins in the oral cavity..", "label": "yes"} {"original_question": "Is triadin involved in cardiac function?", "id": "converted_1360", "sentence1": "Is TRDN gene involved in cardiac function?", "sentence2": "ASPH gene (JCN), a 26-kd Sarcoplasmic Reticulum (SNCG wt Allele) transmembrane protein, forms a quaternary protein complex with the Ryanodine Receptor Calcium Release Channel, CASQ2 gene, and TRDN gene in the SNCG wt Allele lumen of Specimen Source Codes - Cardiac muscle. Within this complex, CASQ2 gene, TRDN gene, and JCN appear to be critical for normal regulation of Ryanodine Receptor Calcium Release Channel-mediated calcium (cyclophosphamide/doxorubicin protocol) release., Recent studies have uncovered functional roles of both JCN and TRDN gene in the mouse heart, using transgenic overexpression strategies, which exhibit varying phenotypes including mild SNCG wt Allele structural alterations, prolongation of cyclophosphamide/doxorubicin protocol transient decay, impaired relaxation, and Cardiac Hypertrophy and/or Congestive Congestive heart failure., Triadin is involved in the regulation of cardiac excitation-contraction coupling. , Thus the maintenance of TRDN gene expression is essential for normal SNCG wt Allele cyclophosphamide/doxorubicin protocol cycling and contractile function., Ca2+ release from the cardiac junctional Sarcoplasmic Reticulum (SNCG wt Allele) is regulated by a complex of proteins, including the Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor Calcium Release Channel complex location), CASQ2 gene (CSQ), ASPH gene-2 (JCN), and TRDN gene 1 (T-Cell Receptors delta-Chain)., Impaired Sarcoplasmic Reticulum (SNCG wt Allele) cyclophosphamide/doxorubicin protocol release has been suggested to contribute to the depressed cardiac function in Congestive Congestive heart failure. The release of cyclophosphamide/doxorubicin protocol from the SNCG wt Allele may be regulated by the Ryanodine Receptor Calcium Release Channel, TRDN gene, ASPH gene-2, CASQ2 gene, and a histidine-rich, cyclophosphamide/doxorubicin protocol-binding protein 2 (HRC).[SEP]Relations: Congestive Congestive heart failure has relations: drug_effect with Tretinoin, drug_effect with Tretinoin, drug_effect with Corticotropin, drug_effect with Corticotropin, drug_effect with Telavancin, drug_effect with Telavancin, drug_effect with Pentostatin, drug_effect with Pentostatin, drug_effect with Pregabalin, drug_effect with Pregabalin. Definitions: ASPH gene-2 defined as following: ASPH gene-2 (210 aa, ~24 kDa) is encoded by the human ASPH gene. This protein is involved in calcium homeostasis in striated muscle.. ASPH gene defined as following: This gene is involved in calcium ion channel regulation and amino acid hydroxylation.. Ryanodine Receptor Calcium Release Channel defined as following: A tetrameric calcium release channel in the SARCOPLASMIC RETICULUM membrane of SMOOTH MUSCLE CELLS, acting oppositely to SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES. It is important in skeletal and cardiac excitation-contraction coupling and studied by using RYANODINE. Abnormalities are implicated in CARDIAC ARRHYTHMIAS and MUSCULAR DISEASES.. Sarcoplasmic Reticulum defined as following: A network of tubules and sacs in the cytoplasm of SKELETAL MUSCLE FIBERS that assist with muscle contraction and relaxation by releasing and storing calcium ions.. SNCG wt Allele defined as following: Human SNCG wild-type allele is located within10q23.2-q23.3 and is approximately 13 kb in length. This allele, which encodes gamma-synuclein protein, plays a role in the modulation of axonal architecture and neurofilament integrity. This gene is highly expessed in advanced breast carcinomas, suggesting a correlation between SNCG overexpression and breast tumor development.. ryanodine receptor complex location defined as following: A voltage-gated calcium-release channel complex of the sarcoplasmic or endoplasmic reticulum. It plays an important role in the excitation-contraction (E-C) coupling of muscle cells. ryanodine receptor complex location comprises a family of ryanodine receptors, widely expressed throughout the animal kingdom. [GOC:ame, PMID:22822064]. T-Cell Receptors delta-Chain defined as following: One component of the gamma-delta T-cell receptor. Encoded by a locus on chromosome 14. Somatic recombination results in formation of the active gene.. Congestive heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Cardiac Hypertrophy defined as following: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix..", "label": "yes"} {"original_question": "Has Hesperidin any role as a Neuroprotective Agent?", "id": "converted_3129", "sentence1": "Has hesperidin any role as a Neuroprotective Agent?", "sentence2": "Neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in Rattus norvegicus model of ALZHEIMER DISEASE, FAMILIAL, 1, hesperidin attenuates depression-related symptoms in CASP14 gene with mild Traumatic Brain Injury, Neuroprotective Effects of hesperidin on Cerebral Vasospasm, The neuroprotective effect of hesperidin in NMDA-induced retinal injury acts by suppressing oxidative stress and excessive calpain activation., This study suggests a potential neuroprotective role of hesperidin against 3-NP-induced Huntington's disease-like manifestations., hesperidin potentiates the neuroprotective effects of diazepam and gabapentin against pentylenetetrazole-induced convulsions in CASP14 gene: Possible behavioral, biochemical and mitochondrial alterations., hesperidin, a flavanoglycone abundantly present in Fruit, Citrus, is reported to have antioxidant, Anti-Inflammatory Agents, and neuroprotective properties., PURPOSE\nhesperidin, a Cardiac Glycosides Flavonoids, is thought to act as an anti-Primary malignant neoplasm agent, since it has been found to exhibit both pro-apoptotic and anti-proliferative effects in several Primary malignant neoplasm cell types., hesperidin is a flavonone Cardiac Glycosides, belonging to the Flavonoids family, which is widely found in Citrus species and acts as a potent antioxidant and anticancer agent., BACKGROUND\nhesperidin, a flavanone present in Fruit, Citrus, has been identified as a potent anticancer agent because of its proapoptotic and antiproliferative characteristics in some Tumor cells, uncertain whether benign or malignant., Oxidative stress and Primary malignant neoplasm; the role of hesperidin, a citrus natural bioflavonoid, as a Primary malignant neoplasm chemoprotective agent., Our data suggests that hesperidin exerts its neuroprotective effect against rotenone due to its antioxidant, maintenance of mitochondrial function, and antiapoptotic properties in a Neuroblastoma cell line., Taken together, these results demonstrate potent antioxidant and neuroprotective effects of hesperetin, implying its potential role in protecting Neurons against various types of insults associated with many neurodegenerative diseases., The neuroprotective effect of hesperidin in NMDA-induced retinal injury acts by suppressing oxidative stress and excessive calpain activation.We found that hesperidin, a plant-derived bioflavonoid, may be a candidate agent for neuroprotective treatment in the retina, after screening 41 materials for anti-oxidative properties in a primary retinal cell culture under oxidative stress. , Neuroprotective effects of hesperidin, a plant flavanone, on rotenone-induced oxidative stress and apoptosis in a cellular model for Parkinson Disease.Rotenone a widely used Pesticides that inhibits NADH dehydrogenase (ubiquinone) has been used to investigate the pathobiology of Lugano Lymphoma Response Classification Progressive Disease by PET both in vitro and in vivo. , Cytoprotective effects of hesperetin and hesperidin against amyloid β-induced impairment of glucose transport through downregulation of neuronal autophagy., hesperidin potentiates the neuroprotective effects of diazepam and gabapentin against pentylenetetrazole-induced convulsions in CASP14 gene: Possible behavioral, biochemical and mitochondrial alterations.TMPRSS11A gene possesses potent anticonvulsant activity which might be mediated through modulation of gamma-amino butyric acid/benzodiazepine receptor action., Antioxidant and neuroprotective effects of hesperidin and its aglycone hesperetin.The present study evaluated antioxidant and neuroprotective activities of hesperidin, a flavanone mainly isolated from Fruit, Citrus, and its aglycone hesperetin using cell-free bioassay system and primary cultured Rattus norvegicus cortical cells. , Potential neuroprotective effects of hesperidin on 3-nitropropionic acid-induced Neurotoxicity Syndromes in rats., hesperidin inhibits glutamate release and exerts neuroprotection against excitotoxicity induced by Kainic Acid in the hippocampus of rats., Emerging evidences indicate hesperidin, a citrus flavanone, attenuates neurodegenerative processes and related complications., Potential Anti-Inflammatory Agents effects of hesperidin from the genus Citrus., Antioxidant and neuroprotective effects of hesperidin and its aglycone hesperetin., hesperidin is a Flavonoids present in high concentration in citrus species and has numerous biological properties, principally antioxidant and Anti-Inflammatory Agents.[SEP]Relations: Hesperetin has relations: drug_drug with Meperidine, drug_drug with Meperidine, drug_drug with Famotidine, drug_drug with Famotidine, drug_drug with Nevirapine, drug_drug with Nevirapine, drug_drug with Antipyrine, drug_drug with Antipyrine, drug_drug with Acenocoumarol, drug_drug with Acenocoumarol. Definitions: diazepam defined as following: A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Flavonoids defined as following: A group of phenyl benzopyrans named for having structures like FLAVONES.. hesperidin defined as following: A flavanone Cardiac Glycosides found in CITRUS fruit peels.. Kainic Acid defined as following: (2S-(2 alpha,3 beta,4 beta))-2-Carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid. Ascaricide obtained from the red alga Digenea simplex. It is a potent excitatory amino acid agonist at some types of excitatory amino acid receptors and has been used to discriminate among receptor types. Like many excitatory amino acid agonists it can cause Neurotoxicity Syndromes and has been used experimentally for that purpose.. gabapentin defined as following: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.. Anti-Inflammatory Agents defined as following: Substances that reduce or suppress INFLAMMATION.. Pesticides defined as following: Chemicals used to destroy pests of any sort. The concept includes fungicides (FUNGICIDES, INDUSTRIAL); INSECTICIDES; RODENTICIDES; etc.. rotenone defined as following: A botanical insecticide that is an inhibitor of mitochondrial electron transport.. Neurons defined as following: The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. Traumatic Brain Injury defined as following: A form of acquired brain injury which occurs when a sudden trauma causes damage to the brain.. Neurotoxicity Syndromes defined as following: Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents.. Primary malignant neoplasm cell defined as following: Cells of, or derived from, a malignant tumor.. Neuroblastoma defined as following: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51). NADH dehydrogenase (ubiquinone) defined as following: A complex of over 40 proteins found in the inner mitochondrial membrane. This protein complex catalyzes the transfer of electrons from NADH to ubiquinone (coenzyme Q10) and plays a role in the initiation of the mitochondrial electron transport chain.. Parkinson Disease defined as following: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing Neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75). ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65.. Lugano Lymphoma Response Classification Progressive Disease by PET defined as following: A score of 4 or 5 on a 5-point PET scale with an increase in intensity of uptake from baseline and/or new FDG-avid foci consistent with lymphoma at interim or end of treatment assessment.. Tumor cells, uncertain whether benign or malignant defined as following: Cells of, or derived from, a tumor.. Cardiac Glycosides defined as following: Cyclopentanophenanthrenes with a 5- or 6-membered lactone ring attached at the 17-position and SUGARS attached at the 3-position. Plants they come from have long been used in congestive heart failure. They increase the force of cardiac contraction without significantly affecting other parameters, but are very toxic at larger doses. Their mechanism of action usually involves inhibition of the NA(+)-K(+)-EXCHANGING ATPASE and they are often used in cell biological studies for that purpose..", "label": "yes"} {"original_question": "Does natalizumab improve disease course of secondary progressive multiple sclerosis?", "id": "converted_3380", "sentence1": "Does natalizumab improve disease course of secondary progressive Multiple Sclerosis?", "sentence2": "INTERPRETATION: Natalizumab treatment for secondary progressive Multiple Sclerosis did not reduce progression on the primary multicomponent disability endpoint in part 1, but it did reduce progression on its upper-limb component., In this review, we summarize the pathophysiological mechanisms involved in the development of SPMS and the rationale and clinical potential for natalizumab, which is currently approved for the treatment of relapsing forms of MS, to exert beneficial effects in reducing disease progression unrelated to relapses in SPMS. , INTERPRETATION\n\nNatalizumab treatment for secondary progressive Multiple Sclerosis did not reduce progression on the primary multicomponent disability endpoint in part 1, but it did reduce progression on its upper-limb component., Natalizumab did not achieve a statistically significant primary composite disability outcome in a trial of 887 patients with secondary progressive MS , but it did demonstrate a benefit on a prespecified component of the 9-Hole Peg Test . , INTERPRETATION\nNatalizumab treatment for secondary progressive Multiple Sclerosis did not reduce progression on the primary multicomponent disability endpoint in part 1, but it did reduce progression on its upper-limb component., In this review, we summarize the pathophysiological mechanisms involved in the development of SPMS and the rationale and clinical potential for natalizumab, which is currently approved for the treatment of relapsing forms of MS, to exert beneficial effects in reducing disease progression unrelated to relapses in SPMS., Natalizumab treatment for secondary progressive Multiple Sclerosis did not reduce progression on the primary multicomponent disability endpoint in part 1, but it did reduce progression on its upper-limb component.[SEP]Relations: Multiple Sclerosis has relations: disease_disease with progressive Multiple Sclerosis, disease_disease with progressive Multiple Sclerosis. Natalizumab has relations: contraindication with progressive multifocal leukoencephalopathy, contraindication with progressive multifocal leukoencephalopathy, drug_drug with Pexelizumab, drug_drug with Pexelizumab, drug_drug with Bavituximab, drug_drug with Bavituximab, drug_drug with Otelixizumab, drug_drug with Otelixizumab. Definitions: Multiple Sclerosis defined as following: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903). natalizumab defined as following: A humanized recombinant IgG4 monoclonal antibody directed against the alpha4 subunit of the integrins alpha4beta1and alpha4beta7 with immunomodulating, anti-inflammatory, and potential antineoplastic activities. Natalizumab binds to the alpha4-subunit of alpha4beta1 and alpha4beta7 integrins expressed on the surface of all leukocytes except neutrophils, inhibiting the alpha4-mediated adhesion of leukocytes to counter-receptor(s) such as vascular cell adhesion molecule-1 (VCAM-1); natalizumab-mediated disruption of VCAM-1 binding by these integrins may prevent the transmigration of leukocytes across the endothelium into inflamed parenchymal tissue. Integrins are cellular adhesion molecules (CAMs) that are upregulated in various types of cancer and some autoimmune diseases; alpha4beta1 integrin (VLA4) has been implicated in the survival of myeloma cells, possibly by mediating their adhesion to stromal cells..", "label": "no"} {"original_question": "Is tirilazad effective for treatment of aneurysmal subarachnoid haemorrhage?", "id": "converted_2171", "sentence1": "Is tirilazad effective for treatment of aneurysmal subarachnoid haemorrhage?", "sentence2": "There was no significant difference between the two groups at the end of follow up for the primary outcome, Cessation of life (odds ratio (OR) 0.89, 95% confidence interval (CI) 0.74 to 1.06), or in poor outcome (Cessation of life, vegetative state or severe disability) (OR 1.04, 95% CI 0.90 to 1.21). During the treatment period, fewer patients developed delayed cerebral ischaemia in the tirilazad group than in the control group (OR 0.80, 95% CI 0.69 to 0.93). Subgroup analyses did not demonstrate any significant difference in effects of tirilazad on clinical outcomes. , AUTHORS' CONCLUSIONS: There is no evidence that tirilazad, in addition to nimodipine, reduces mortality or improves poor outcome in patients with aneurysmal Yakut language., This clinical trial suggest that tirilazad mesylate, at a dosage of 6 mg/kg/day, improves overall outcome in aneurysmal Subarachnoid Hemorrhage patients., Tirilazad is ineffective.There are many possible successful treatment options for preventing Vasospasm, delayed ischemic neurologic deficits, and poor neurologic outcome following aneurysmal Subarachnoid Hemorrhage; however, further multicenter RCTs need to be performed to determine if there is a significant benefit from their use, Findings from previous multicenter clinical trials have suggested that tirilazad mesylate, a synthetic nonhormonal 21-aminosteroid, might be effective in preventing delayed cerebral ischemia following Subarachnoid Hemorrhage (Yakut language)., This clinical trial suggest that tirilazad mesylate, at a dosage of 6 mg/kg/day, improves overall outcome in aneurysmal Subarachnoid Hemorrhage patients.[SEP]Relations: Subarachnoid Hemorrhage (disease) has relations: contraindication with Tranexamic acid, contraindication with Tranexamic acid, disease_disease with acquired aneurysmal Subarachnoid Hemorrhage, disease_disease with acquired aneurysmal Subarachnoid Hemorrhage, disease_protein with EDNRB, disease_protein with EDNRB, disease_protein with PPARG, disease_protein with PPARG, disease_protein with ADORA1, disease_protein with ADORA1. Definitions: Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. Subarachnoid Hemorrhage defined as following: Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.. nimodipine defined as following: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.. Yakut language defined as following: A Turkic language spoken by the Yakut people in the Sakha Republic in the Russian Federation.. Vasospasm defined as following: spasm of the blood vessels resulting in decrease in their caliber..", "label": "no"} {"original_question": "Is there any software for automated analysis of immuno-histochemistry images?", "id": "converted_528", "sentence1": "Is there any software for automated analysis of immuno-histochemistry images?", "sentence2": "The LIM homeobox gene LHX2 wt Allele is expressed in cortical progenitors during development and also in the superficial layers of the Neocortex in maturity. However, analysis of LHX2 wt Allele function at later stages of cortical development has been hampered by severe phenotypes associated with early loss of function. , The vein graft samples were obtained on each time point after surgery. The expression of the EDRz transfected in the vein graft was detected using a fluorescent microscope. Early growth response gene-1 (EGR1 protein, human) RNA, Messenger was measured using reverse transcription-PCR and in situ hybridization. And the protein expression of EGR1 protein, human was detected by using western blot and immunohistochemistry analyses., Protein Glutamine gamma Glutamyltransferase 2 (TGM2 protein, human) is a multifunctional Enzyme [APC], which amongst other functions, is involved in cell differentiation. Therefore, we hypothesized that TGM2 protein, human contributes to differentiation of OPCs into OLGs and thereby stimulates remyelination. [SEP]Relations: Neocortex has relations: anatomy_protein_present with ENO2, anatomy_protein_present with ENO2, anatomy_protein_present with TMCO3, anatomy_protein_present with TMCO3, anatomy_protein_present with TMCO6, anatomy_protein_present with TMCO6. Protein S human has relations: drug_drug with Ifosfamide, drug_drug with Ifosfamide, drug_drug with Ifosfamide, drug_drug with Ifosfamide. Definitions: TGM2 protein, human defined as following: Protein-glutamine gamma-glutamyltransferase 2 (687 aa, ~77 kDa) is encoded by the human TGM2 gene. This protein plays a role in both the induction of apoptosis and the formation of covalent bonds between peptide-bound glutamine and various primary amines.. Neocortex defined as following: The largest portion of the CEREBRAL CORTEX in which the NEURONS are arranged in six layers in the mammalian brain: molecular, external granular, external pyramidal, internal granular, internal pyramidal and multiform layers.. EGR1 protein, human defined as following: Early growth response protein 1 (543 aa, ~58 kDa) is encoded by the human EGR1 gene. This protein is involved in the modulation of both mitogenesis and differentiation through the transcriptional regulation of specified genes.. LHX2 wt Allele defined as following: Human LHX2 wild-type allele is located within 9q33-34.1 and is approximately 22 kb in length. This allele, which encodes the LIM/homeobox protein LHX2 wt Allele, may play a role in both the modulation of transcription by RNA polymerase II and the development of lymphoid and neural cells.. Protein Glutamine gamma Glutamyltransferase 2 defined as following: Calcium-dependent acyltransferase that catalyzes cross-linking of proteins at a GLUTAMINE in one chain with primary amine such as in LYSINE in another chain. In addition it can also accept monoamine substrates to catalyze post-translational modifications (e.g., protein serotonylation).. RNA, Messenger defined as following: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the cytoplasm..", "label": "yes"} {"original_question": "Has the olive tree pollen proteome been studied?", "id": "converted_3930", "sentence1": "Has the olive tree pollen proteome been studied?", "sentence2": "Olive pollen is a major allergenic source worldwide due to its extensive cultivation. We have combined available genomics data with a comprehensive proteomics approach to get the annotated olive tree (Olea europaea L.) pollen proteome and define its complex allergenome. [SEP]", "label": "yes"} {"original_question": "Is pesticide exposure associated with polyneuropathy?", "id": "converted_386", "sentence1": "Is pesticide exposure associated with polyneuropathy?", "sentence2": "As the syndrome occurred after the acute Cholinergic Agents syndrome but before Phosphoric Acid Esters-induced delayed polyneuropathy, the syndrome was called 'intermediate syndrome'., The characteristic features of the IMS are weakness of the Muscle Tissue of respiration (Vaginal contraceptive Vaginal contraceptive diaphragm (device) (device), intercostal Muscle Tissue and accessory Muscle Tissue including neck Muscle Tissue) and of proximal limb Muscle Tissue. Accompanying features often include weakness of Muscle Tissue innervated by some Cranial Nerves. It is now emerging that the degree and extent of Muscle Weakness may vary following the onset of the IMS. , Electrophysiological studies following OP Poisoning aspects have revealed three characteristic phenomena: (i) repetitive firing following a single stimulus; (ii) gradual reduction in twitch height or compound muscle action potential followed by an increase with repetitive stimulation (the 'decrement-increment response'); and (iii) continued reduction in twitch height or compound muscle action potential with repetitive simulation ('decrementing response'). , Organophosphate-induced delayed polyneuropathy is a sensory-motor distal axonopathy which usually occurs after exposure of certain OP Insecticides. Neuropathy due to ingestion of Osteoporosis with pseudoglioma have rarely been reported in the literature., We report a patient with serious organophosphorus-induced delayed neuropathy due to malathion injection. The patient was a 32-year-old female who self-injected undetermined amounts of malathion over the median nerve trace on the forearm crease in a suicide attempt which resulted in Peripheral Nervous System Diseases., Acutely, these patients present with Cholinergic Agents crisis; intermediate syndrome and delayed polyneuropathy are other sequel of this form of Poisoning aspects., There was no strong evidence of irreversible peripheral nerve damage following acute OP Poisoning aspects, however further studies are required., Particular interactions are also addressed, such as those of Pesticides acting as endocrine disruptors, the cumulative Toxic effect of organophosphates and Hydrocarbons, Chlorinated resulting in estrogenic effects and the promotion of Phosphoric Acid Esters-induced delayed polyneuropathy., The multivariate analyses showed that the population living in areas with high pesticide use had an increased risk for ALZHEIMER DISEASE, FAMILIAL, 1 and suicide attempts and that males living in these areas had increased risks for Polyneuropathy, affective disorders and suicide attempts. , These compounds cause four important neurotoxic effects in Homo sapiens: the Cholinergic Agents syndrome, the intermediate syndrome, Phosphoric Acid Esters-induced delayed polyneuropathy (OPIDP) and chronic Phosphoric Acid Esters-induced neuropsychiatric disorder (COPIND). , An 18-year-old woman and a 22-year-old man were admitted to the hospital with weakness, Paresthesia, and gait disturbances at 35 and 22 days, respectively, after ingesting dimethyl-2,2-dichloro vinyl phosphate (Dichlorvos). Neurological examination revealed weakness, vibration sense loss, bilateral dropped foot, brisk deep tendon reflexes, and bilaterally positive Babinski sign. Electroneurography demonstrated distal motor polyneuropathy with segmental demyelination associated with Axonal degeneration prominent in the distal parts of both lower All All extremities., Sensory complaints and electrodiagnostic findings consistent with polyneuropathy were found in a minority (3/7) of subjects 28 years after an acute toxic arsenic exposure., Organophosphate-induced delayed polyneuropathy (OPIDP) is a rare Toxic effect resulting from exposure to certain organophosphorus (OP) esters. , Therefore, OPIDP may develop only after very large exposures to Insecticides, causing severe Cholinergic Agents Toxic effect., Several studies have reported the occurrence of Sensory neuropathy with exposure to Chlorpyrifos and other Organic phosphorus insecticide, NOS, at levels not associated with overt Toxic effect. , We found no evidence of Sensory neuropathy or isolated peripheral abnormalities among subjects with long-term Chlorpyrifos exposure at levels known to be associated with the manufacturing process., Persistent, mainly motor, impairment of the peripheral nervous system was found in men two years after OP Poisoning aspects, in particular in severe occupational and intentional Poisoning with neuropathic Osteoporosis with pseudoglioma. This finding is possibly due to remaining Phosphoric Acid Esters induced delayed polyneuropathy., Besides the well known acute Cholinergic Agents Toxic effect, these compounds may cause late-onset distal polyneuropathy occurring two to three weeks after the acute exposure. , Electromyography demonstrated motor weighed sensory-motor polyneuropathy with Axonal degeneration significant in the distal parts of bilateral lower All All extremities. , The two cases are presented here since Phosphoric Acid Esters Poisoning are common in our country, and since late-onset polyneuropathy is not a well known clinical presentation as acute Toxic effect., The course of Phosphoric Acid Esters-induced delayed polyneuropathy (OPIDP) in Homo sapiens has not been quantitatively measured in epidemiologic studies., The persistence of deficits in motor strength in all severely poisoned patients regardless of pesticide type was unexpected, and may reflect persistent Cholinergic Agents blockade or intermediate syndrome, neuropathy, or a combination of these., The findings showed a strong association between exposure to OP concentrate and neurological symptoms, but a less consistent association with sensory thresholds. , Following accidental or suicidal exposure, these anticholinesterases lead to three well defined neurological syndromes i.e. initial life threatening acute Cholinergic Agents crisis which often requires management in intensive care unit, intermediate syndrome in which Cranial nerve palsies, proximal Muscle Weakness and respiratory Muscle Weakness are common and patients often require respiratory support and delayed Phosphoric Acid Esters induced polyneuropathy., [Late onset polyneuropathy due to exposure to organophosphates]., Less often a polyneuropathic syndrome of late onset may occur., On electromyography there was sensomotor peripheral polyneuropathy, which was primarily axonal and predominantly motor and distal. Peripheral nerve biopsy confirmed the presence of 'dying back' type axonopathy. , Agricultural workers chronically exposed to Phosphoric Acid Esters Insecticides, without adequate protection, have an increased risk of developing late onset neuropathy due to organophosphates. , Epidemiologic studies on Pesticides have found associations with long-term effects on health mainly in three fields: Primary malignant neoplasm (especially hematological Primary malignant neoplasm), neurotoxic effects (polyneuropathy, neuro-behavioral hazards, Parkinson Disease), and reproductive disorders (Sterility, Reproductive, Congenital Abnormality, adverse pregnancy outcomes, perinatal mortality). , EMG studies showed evidence of partial denervation of the anterior tibial group of Muscle Tissue and flexor digiti minimi in 2 of the 30 workers (6.7%) who underwent EMG examination., Neurological symptoms consist in cerebro-organic disfunctions, locomotory disorders reminiscent of Multiple Sclerosis or M. Parkinson, and sensory, motoric and vegetative polyneuropathy, leading, for instance, to cardiovascular regulatory disorder like sympathicotonia or, orthostatic hypotonia. , Thirty percent of patients had definite or possible exposure to Phosphoric Acid Esters Pesticides, and the peak use coincides with the peak incidence of Guillain-Barre Syndrome., These results suggest that previously reported cases of Phosphoric Acid Esters-induced delayed polyneuropathy may represent only the worst disease in a spectrum of impairment, a sequela of exposure that may be much more common than previously thought., It is suggested that the main cause of nervous lesions in these cases was the complex effect of Pesticides., Delayed polyneuropathy develops within 1 to 3 weeks and abates after 6 to 12 months. , Isolated case reports have circumstantially linked the use of the herbicide 2,4-dichlorophenoxyacetic acid (2,4-Dichlorophenoxyacetic Acid) to polyneuropathy., Thus, the weight of evidence indicates that 2,4-Dichlorophenoxyacetic Acid is an unlikely cause of polyneuropathy., A patient is reported presenting a Cerebellar Diseases developing about 5 weeks after acute exposure to an Phosphoric Acid Esters insecticide. , Less well known, but more complex and idiosyncratic, is the potential for some agents to produce a delayed and progressive polyneuropathy--Organophosphorus Induced Delayed Neurotox-icity (OPIDN)., It is also quite probable that human Neurotoxicity Syndromes may be a potential hazard from exposure to more than the handful of organophosphorus Pesticides that have been described in the literature., In the present study the electroencephalograms of 3 of a group 10 workmen, who had been continually exposed to hexachlorcyclohexane, show pathological findings. The electromyograms of 8 of these 10 workman demonstrate a disturbance of the peripherical motoneuron. All probands, who exhibit o pathological EEG, also show a polyneuropathy., Many Organophosphorus Compounds, including the Phosphoric Acid Esters Insecticides, may cause polyneuropathy of delayed onset., Nevertheless, we describe a patient with delayed polyneuropathy after suicidal ingestion of Parathion., Following acute organophosphorus (OP) Poisoning aspects patients complain of Numbness without objective sensory abnormalities or other features of OP induced delayed polyneuropathy. [SEP]Relations: polyneuropathy has relations: disease_disease with polyneuropathy due to drug, disease_disease with polyneuropathy due to drug, disease_disease with polyneuritis, disease_disease with polyneuritis, disease_disease with Peripheral Nervous System Diseases, disease_disease with Peripheral Nervous System Diseases, disease_disease with critical illness polyneuropathy, disease_disease with critical illness polyneuropathy, disease_disease with polyradiculoneuropathy, disease_disease with polyradiculoneuropathy. Definitions: Chlorpyrifos defined as following: An organothiophosphate cholinesterase inhibitor that is used as an insecticide and as an acaricide.. Dichlorvos defined as following: An organophosphorus insecticide that inhibits ACETYLCHOLINESTERASE.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Sensory neuropathy defined as following: Inflammation or degeneration of the sensory nerves.. Phosphoric Acid Esters defined as following: An ester of phosphoric acid, which contains phosphorus. Organic phosphates play important roles in biochemistry and biogeochemistry or ecology.. Muscle Tissue defined as following: Contractile tissue that produces movement in animals.. malathion defined as following: A wide spectrum aliphatic Phosphoric Acid Esters insecticide widely used for both domestic and commercial agricultural purposes.. Neuropathy defined as following: A disorder affecting the Cranial Nerves or the peripheral nervous system. It manifests with pain, tingling, Numbness, and Muscle Weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, Primary malignant neoplasm, and drugs.. Hydrocarbons, Chlorinated defined as following: Hydrocarbon compounds with one or more of the hydrogens replaced by CHLORINE.. 2,4-Dichlorophenoxyacetic Acid defined as following: An herbicide with irritant effects on the eye and the gastrointestinal system.. Peripheral Nervous System Diseases defined as following: Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.. Organic phosphorus insecticide, NOS defined as following: class of chemicals composed of an organic radical bound to a phosphorus containing radical that kill insects.. Insecticides defined as following: Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Poisoning defined as following: A condition or physical state produced by the ingestion, injection, inhalation of or exposure to a deleterious agent.. Parathion defined as following: A highly toxic cholinesterase inhibitor that is used as an acaricide and as an insecticide.. Neurotoxicity Syndromes defined as following: Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents.. Pesticides defined as following: Chemicals used to destroy pests of any sort. The concept includes fungicides (FUNGICIDES, INDUSTRIAL); INSECTICIDES; RODENTICIDES; etc.. Vaginal contraceptive diaphragm (device) defined as following: A medical contraceptive device of soft flexible material, usually of thin rubber, that is designed to cover the cervix uteri prior to sexual intercourse to prevent the entry of spermatozoa. To enhance efficacy, a spermicidal agent is often placed within the device. Antimicrobial agent(s) can also be used to prevent sexually transmitted diseases. Efficacy of vaginal Vaginal contraceptive diaphragm (device) against infections is very limited.. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65.. Numbness defined as following: A loss of the sensation of feeling in an area of the body.. Cholinergic Agents defined as following: Any drug used for its actions on Cholinergic Agents systems. Included here are agonists and antagonists, drugs that affect the life cycle of ACETYLCHOLINE, and drugs that affect the survival of Cholinergic Agents neurons. The term Cholinergic Agents agents is sometimes still used in the narrower sense of MUSCARINIC AGONISTS, although most modern texts discourage that usage.. Osteoporosis with pseudoglioma defined as following: An autosomal recessive condition caused by homozygous or compound heterozygous inactivating mutation(s) in the gene LRP5, encoding low-density lipoprotein receptor-related protein 5. This condition is characterized by severe juvenile-onset osteoporosis and congenital or juvenile-onset blindness due to a vascularized retinal mass that resembles a glioma.. Muscle Weakness defined as following: A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various Muscle Tissue. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251). Multiple Sclerosis defined as following: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903). Poisoning aspects defined as following: Used with drugs, chemicals, and industrial materials for human or animal Poisoning aspects, acute or chronic, whether the Poisoning aspects is accidental, occupational, suicidal, by medication error, or by environmental exposure.. Cerebellar Diseases defined as following: Diseases that affect the structure or function of the cerebellum. Cardinal manifestations of cerebellar dysfunction include dysmetria, GAIT ATAXIA, and MUSCLE HYPOTONIA.. Paresthesia defined as following: Subjective cutaneous sensations (e.g., cold, warmth, tingling, pressure, etc.) that are experienced spontaneously in the absence of stimulation.. neck Muscle Tissue defined as following: The neck Muscle Tissue consist of the platysma, splenius cervicis, sternocleidomastoid(eus), longus colli, the anterior, medius, and posterior scalenes, digastric(us), stylohyoid(eus), mylohyoid(eus), geniohyoid(eus), sternohyoid(eus), omohyoid(eus), sternothyroid(eus), and thyrohyoid(eus).. Organophosphorus Compounds defined as following: Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS.. Guillain-Barre Syndrome defined as following: An acute inflammatory autoimmune neuritis caused by T cell- mediated cellular immune response directed towards peripheral myelin. Demyelination occurs in peripheral nerves and nerve roots. The process is often preceded by a viral or bacterial infection, surgery, immunization, lymphoma, or exposure to toxins. Common clinical manifestations include progressive weakness, loss of sensation, and loss of deep tendon reflexes. Weakness of respiratory Muscle Tissue and autonomic dysfunction may occur. (From Adams et al., Principles of Neurology, 6th ed, pp1312-1314). Polyneuropathy defined as following: Diseases of multiple peripheral nerves simultaneously. Polyneuropathies usually are characterized by symmetrical, bilateral distal motor and sensory impairment with a graded increase in severity distally. The pathological processes affecting peripheral nerves include degeneration of the axon, myelin or both. The various forms of polyneuropathy are categorized by the type of nerve affected (e.g., sensory, motor, or autonomic), by the distribution of nerve injury (e.g., distal vs. proximal), by nerve component primarily affected (e.g., demyelinating vs. axonal), by etiology, or by pattern of inheritance.. Congenital Abnormality defined as following: Malformations of organs or body parts during development in utero.. Cranial nerve palsies defined as following: Injury to any of the Cranial Nerves or their nuclei in the brain resulting in Muscle Weakness.. Homo sapiens defined as following: Members of the species Homo sapiens.. Cranial Nerves defined as following: Twelve pairs of nerves that carry general afferent, visceral afferent, special afferent, somatic efferent, and autonomic efferent fibers.. Sterility, Reproductive defined as following: Complete inability to conceive or induce conception.. Parkinson Disease defined as following: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75). polyneuropathy defined as following: Diseases of multiple peripheral nerves simultaneously. Polyneuropathies usually are characterized by symmetrical, bilateral distal motor and sensory impairment with a graded increase in severity distally. The pathological processes affecting peripheral nerves include degeneration of the axon, myelin or both. The various forms of polyneuropathy are categorized by the type of nerve affected (e.g., sensory, motor, or autonomic), by the distribution of nerve injury (e.g., distal vs. proximal), by nerve component primarily affected (e.g., demyelinating vs. axonal), by etiology, or by pattern of inheritance..", "label": "yes"} {"original_question": "Can glyburide reduce cerebral edema?", "id": "converted_2067", "sentence1": "Can glyburide reduce Cerebral Edema?", "sentence2": "Preclinical studies have shown that a continuous infusion of glyburide blocks Edema:Finding:Point in time:^Patient:Ordinal formation and improves outcome. We hypothesize that treatment with RP-1127 (Glyburide for Injection) reduces formation of brain Edema:Finding:Point in time:^Patient:Ordinal in patients after large anterior circulation infarction., CONCLUSIONS: GAMES-RP was designed to provide critical information regarding glyburide for injection in patients with large hemispheric Cerebrovascular accident and will inform the design of future studies., Glyburide is associated with attenuated vasogenic Edema:Finding:Point in time:^Patient:Ordinal in Cerebrovascular accident patients., Glyburide is reported to prevent brain swelling in preclinical rodent models of Ischemic Cerebrovascular accident through inhibition of a non-selective channel composed of Sulfonylurea Compounds receptor 1 and transient receptor potential cation channel subfamily M member 4. , RESULTS: We report that IV glyburide was associated with T2 fluid-attenuated inversion recovery signal intensity ratio on brain MRI, diminished the lesional water diffusivity between days 1 and 2 (pseudo-normalization), and reduced blood Matrix Metalloproteinase 9 level.CONCLUSIONS: Several surrogate markers of vasogenic Edema:Finding:Point in time:^Patient:Ordinal appear to be reduced in the setting of IV glyburide treatment in Homo sapiens Cerebrovascular accident. , Pilot study of intravenous glyburide in patients with a large Ischemic Cerebrovascular accident., BACKGROUND AND PURPOSE: Preclinical and retrospective clinical data indicate that glyburide, a selective inhibitor of Sulfonylurea Compounds receptor 1-transient receptor potential melastatin 4, is effective in preventing Edema:Finding:Point in time:^Patient:Ordinal and improving outcome after focal ischemia. , Preclinical data suggest that glyburide, an inhibitor of ABCC8 gene-TRPM4, is effective in preventing Edema:Finding:Point in time:^Patient:Ordinal., Glyburide in Treating Malignant Cerebral Edema. , Glyburide in Treating Malignant Cerebral Edema. Blocking Sulfonyl Urea One (ABCC8 gene) Receptors., The Sulfonylurea Compounds receptor 1-regulated NC(Ca-ATP) channel is upregulated in rodent models of Cerebrovascular accident with block of the channel by the Sulfonylurea Compounds, glibenclamide (glyburide), significantly reducing mortality, Cerebral Edema, and infarct volume., Glyburide is a safe, inexpensive, and efficacious alternative to dexamethasone for the treatment of cerebral metastasis-related vasogenic Edema:Finding:Point in time:^Patient:Ordinal., In this focused review, we explore preclinical data linking Sur1 channel formation to development of Edema:Finding:Point in time:^Patient:Ordinal and reference evidence suggesting that the antidiabetic Sulfonylurea Compounds drug glyburide (a Sur1 inhibitor) is an inexpensive and well-tolerated agent that can be clinically tested to reduce or prevent Primary malignant neoplasm and/or treatment-associated Edema:Finding:Point in time:^Patient:Ordinal., Potential of glyburide to reduce intracerebral Edema:Finding:Point in time:^Patient:Ordinal in brain metastases., Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial: Rationale and Design., Preclinical data suggest that glyburide, an inhibitor of ABCC8 gene-TRPM4, is effective in preventing Edema:Finding:Point in time:^Patient:Ordinal., Inhibition of Sulfonylurea Compounds receptor 1 (ABCC8 gene) by glyburide has been shown to decrease Edema:Finding:Point in time:^Patient:Ordinal after Subarachnoid Hemorrhage., Glyburide is a safe, inexpensive, and efficacious alternative to dexamethasone for the treatment of cerebral metastasis-related vasogenic Edema:Finding:Point in time:^Patient:Ordinal, RESULTS: We report that IV glyburide was associated with T2 fluid-attenuated inversion recovery signal intensity ratio on brain MRI, diminished the lesional water diffusivity between days 1 and 2 (pseudo-normalization), and reduced blood Matrix Metalloproteinase 9 level. , Preclinical data suggest that glyburide, an inhibitor of ABCC8 gene-TRPM4, is effective in preventing Edema:Finding:Point in time:^Patient:Ordinal. , Exploratory analysis of glyburide as a novel therapy for preventing brain swelling., Inhibition of Sulfonylurea Compounds receptor 1 (ABCC8 gene) by glyburide has been shown to decrease Edema:Finding:Point in time:^Patient:Ordinal after Subarachnoid Hemorrhage. , In this focused review, we explore preclinical data linking Sur1 channel formation to development of Edema:Finding:Point in time:^Patient:Ordinal and reference evidence suggesting that the antidiabetic Sulfonylurea Compounds drug glyburide (a Sur1 inhibitor) is an inexpensive and well-tolerated agent that can be clinically tested to reduce or prevent Primary malignant neoplasm and/or treatment-associated Edema:Finding:Point in time:^Patient:Ordinal., Glyburide is a safe, inexpensive, and efficacious alternative to dexamethasone for the treatment of cerebral metastasis-related vasogenic Edema:Finding:Point in time:^Patient:Ordinal., Glyburide is reported to prevent brain swelling in preclinical rodent models of Ischemic Cerebrovascular accident through inhibition of a non-selective channel composed of Sulfonylurea Compounds receptor 1 and transient receptor potential cation channel subfamily M member 4., Several surrogate markers of vasogenic Edema:Finding:Point in time:^Patient:Ordinal appear to be reduced in the setting of IV glyburide treatment in Homo sapiens Cerebrovascular accident., We hypothesize that treatment with RP-1127 (Glyburide for Injection) reduces formation of brain Edema:Finding:Point in time:^Patient:Ordinal in patients after large anterior circulation infarction., Glyburide is a safe, inexpensive, and efficacious alternative to dexamethasone for the treatment of cerebral metastasis-related vasogenic Edema:Finding:Point in time:^Patient:Ordinal.., Glyburide is associated with attenuated vasogenic Edema:Finding:Point in time:^Patient:Ordinal in Cerebrovascular accident patients.[SEP]Relations: Glyburide has relations: drug_effect with Edema, drug_effect with Edema, drug_effect with Hypoglycemia, drug_effect with Hypoglycemia. Cerebral Edema:Finding:Point in time:^Patient:Ordinal has relations: drug_effect with Glycine betaine, drug_effect with Glycine betaine, drug_effect with Glatiramer, drug_effect with Glatiramer, drug_effect with Carmustine, drug_effect with Carmustine. Definitions: glyburide defined as following: An antidiabetic Sulfonylurea Compounds derivative with actions like those of chlorpropamide. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Subarachnoid Hemorrhage defined as following: Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.. dexamethasone defined as following: An anti-inflammatory 9-fluoro-glucocorticoid.. Cerebral Edema defined as following: Swelling due to an excessive accumulation of fluid in the brain.. Homo sapiens defined as following: Members of the species Homo sapiens.. Ischemic Cerebrovascular accident defined as following: An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue.. Matrix Metalloproteinase 9 defined as following: An endopeptidase that is structurally similar to MATRIX METALLOPROTEINASE 2. It degrades GELATIN types I and V; COLLAGEN TYPE IV; and COLLAGEN TYPE V.. Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810). Sulfonylurea Compounds defined as following: A class of compounds in which a sulfone functional group is attached to UREA.. Sulfonylurea Compounds receptor 1 defined as following: ATP-BINDING CASSETTE PROTEINS that are highly conserved and widely expressed in nature. They form an integral part of the ATP-sensitive potassium channel complex which has two intracellular nucleotide folds that bind to sulfonylureas and their analogs..", "label": "yes"} {"original_question": "Does Rad9 interact with Aft1 in S.cerevisiae?", "id": "converted_903", "sentence1": "Does RAD9A wt Allele interact with Aft1 in S.cerevisiae?", "sentence2": "RAD9A wt Allele interacts with Aft1 to facilitate Genome - anatomical entity surveillance in fragile genomic sites under non-DNA damage-inducing conditions in S. cerevisiae., Here we show that RAD9A wt Allele checkpoint protein, known to mediate the damage signal from upstream to downstream essential kinases, interacts with Aft1 transcription factor in the budding yeast. Aft1 regulates iron homeostasis and is also involved in Genome - anatomical entity integrity having additional iron-independent functions. Using Genome - anatomical entity-wide expression and chromatin immunoprecipitation approaches, we found RAD9A wt Allele to be recruited to 16% of the yeast genes, often related to cellular growth and metabolism, while affecting the transcription of ∼2% of the coding Genome - anatomical entity in the absence of exogenously induced DNA damage. Importantly, RAD9A wt Allele is recruited to fragile genomic regions (transcriptionally active, GC rich, Centromere, meiotic recombination hotspots and retrotransposons) non-randomly and in an Aft1-dependent manner. Further analyses revealed substantial Genome - anatomical entity-wide parallels between RAD9A wt Allele binding patterns to the Genome - anatomical entity and major activating histone marks, such as H3K36me, H3K79me and H3K4me. Thus, our findings suggest that RAD9A wt Allele functions together with Aft1 on DNA damage-prone chromatin to facilitate Genome - anatomical entity surveillance, thereby ensuring rapid and effective response to possible DNA damage events., Here we show that RAD9A wt Allele checkpoint protein, known to mediate the damage signal from upstream to downstream essential kinases, interacts with Aft1 transcription factor in the budding yeast, RAD9A wt Allele interacts with Aft1 to facilitate Genome - anatomical entity surveillance in fragile genomic sites under non-DNA damage-inducing conditions in S. cerevisiae, Here we show that RAD9A wt Allele checkpoint protein, known to mediate the damage signal from upstream to downstream essential kinases, interacts with Aft1 transcription factor in the budding yeast. Aft1 regulates iron homeostasis and is also involved in Genome - anatomical entity integrity having additional iron-independent functions. Using Genome - anatomical entity-wide expression and chromatin immunoprecipitation approaches, we found RAD9A wt Allele to be recruited to 16% of the yeast genes, often related to cellular growth and metabolism, while affecting the transcription of ?2% of the coding Genome - anatomical entity in the absence of exogenously induced DNA damage. , Importantly, RAD9A wt Allele is recruited to fragile genomic regions (transcriptionally active, GC rich, Centromere, meiotic recombination hotspots and retrotransposons) non-randomly and in an Aft1-dependent manner. Further analyses revealed substantial Genome - anatomical entity-wide parallels between RAD9A wt Allele binding patterns to the Genome - anatomical entity and major activating histone marks, such as H3K36me, H3K79me and H3K4me. Thus, our findings suggest that RAD9A wt Allele functions together with Aft1 on DNA damage-prone chromatin to facilitate Genome - anatomical entity surveillance, thereby ensuring rapid and effective response to possible DNA damage events.[SEP]Relations: centromere clustering has relations: bioprocess_bioprocess with chromosome localization, bioprocess_bioprocess with chromosome localization, bioprocess_bioprocess with centromere clustering at the mitotic interphase nuclear envelope, bioprocess_bioprocess with centromere clustering at the mitotic interphase nuclear envelope, bioprocess_bioprocess with centromere localization, bioprocess_bioprocess with centromere localization, bioprocess_bioprocess with meiotic centromere clustering, bioprocess_bioprocess with meiotic centromere clustering. anatomical entity has relations: anatomy_anatomy with insect mouthpart, anatomy_anatomy with insect mouthpart. Definitions: Centromere defined as following: The clear constricted portion of the chromosome at which the chromatids are joined and by which the chromosome is attached to the spindle during cell division.. Genome - anatomical entity defined as following: Anatomical set of genes in all the chromosomes.. RAD9A wt Allele defined as following: Human RAD9A wild-type allele is located within 11q13.1-q13.2 and is approximately 7 kb in length. This allele, which encodes cell cycle checkpoint control protein RAD9A, is involved in the regulation of both DNA repair and cell cycle progression.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine)..", "label": "yes"} {"original_question": "Does gavestinel improve outcomes of stroke patients?", "id": "converted_3655", "sentence1": "Does Gavestinel improve outcomes of Cerebrovascular accident patients?", "sentence2": "CONCLUSION: Consistent with the clinical outcomes in the GAIN trials, no effects of Gavestinel on ischemic infarction was observed., No effects of Gavestinel on infarct volume were observed in the primary or other analyses. , Gavestinel does not improve outcome after acute intracerebral hemorrhage: an analysis from the GAIN International and GAIN Americas studies., Both trials reported that Gavestinel was ineffective in Ischemic Cerebrovascular accident. , CONCLUSIONS: These observations from the combined GAIN International and GAIN Americas trials suggest that Gavestinel is not of substantial benefit or harm to patients with primary intracerebral hemorrhage. , Glutamate N-methyl-D-aspartate (NMDA) receptor antagonists such as selfotel, aptiganel, Gavestinel and others failed to show neuroprotective efficacy in Homo sapiens clinical trials or produced intolerable central nervous system adverse effects., METHODS: We studied all patients of the Glycine Antagonist (Gavestinel) In Neuroprotection (GAIN) International Trial with Ischemic Cerebrovascular accident alive at day 7, excluding patients with hemorrhagic events and Cessation of life from nonstroke-related causes. The GAIN International Trial was a randomized, double-blind, placebo-controlled, and parallel-group trial; because the study Pharmacologic Substance had no effect on Cerebrovascular accident outcome, treatment groups were combined for this analysis. , Gavestinel produces no benefit for Cerebrovascular accident patients, study finds., The wonder Pharmacologic Substance, Gavestinel, failed to produce any significant treatment benefits for patients treated within six hours after experiencing an acute Ischemic Cerebrovascular accident, according to the recent results of a major clinical trial of the neuroprotectant. , INTERPRETATION: Treatment with Gavestinel within 6 h of acute ischaemic Cerebrovascular accident did not improve outcome., INTERPRETATION\n\nTreatment with Gavestinel within 6 h of acute ischaemic Cerebrovascular accident did not improve outcome., CONCLUSION\n\nIn this study, Gavestinel administered up to 6 hours after an acute Ischemic Cerebrovascular accident did not improve functional outcome at 3 months., Both trials reported that Gavestinel was ineffective in Ischemic Cerebrovascular accident., INTERPRETATION Treatment with Gavestinel within 6 h of acute ischaemic Cerebrovascular accident did not improve outcome., Both trials reported that Gavestinel was ineffective in Ischemic Cerebrovascular accident., Gavestinel produces no benefit for Cerebrovascular accident patients , study finds ., The wonder Pharmacologic Substance, Gavestinel, failed to produce any significant treatment benefits for patients treated within six hours after experiencing an acute Ischemic Cerebrovascular accident, according to the recent results of a major clinical trial of the neuroprotectant., The wonder Pharmacologic Substance, Gavestinel, failed to produce any significant treatment benefits for patients treated within six hours after experiencing an acute Ischemic Cerebrovascular accident, according to the recent results of a major clinical trial of the neuroprotectant., Treatment with Gavestinel within 6 h of acute ischaemic Cerebrovascular accident did not improve outcome., In this study, Gavestinel administered up to 6 hours after an acute Ischemic Cerebrovascular accident did not improve functional outcome at 3 months.[SEP]Relations: Gavestinel has relations: drug_drug with Rifampicin, drug_drug with Rifampicin, drug_drug with Enasidenib, drug_drug with Enasidenib, drug_drug with Silibinin, drug_drug with Silibinin, drug_drug with Indinavir, drug_drug with Indinavir, drug_drug with Pazopanib, drug_drug with Pazopanib. Definitions: Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the Homo sapiens or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. Homo sapiens defined as following: Members of the species Homo sapiens.. Ischemic Cerebrovascular accident defined as following: An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue.. Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810).", "label": "no"} {"original_question": "Is inositol effective for trichotillomania?", "id": "converted_2848", "sentence1": "Is inositol effective for Trichotillomania?", "sentence2": "Patients assigned to inositol failed to show significantly greater reductions on primary or secondary outcomes measures compared with placebo (all P>0.05)., This is the first study assessing the efficacy of inositol in the treatment of Trichotillomania, but found no differences in symptom reductions between inositol and placebo., At study endpoint, 42.1% of patients were 'much or very much improved' on inositol compared with 35.3% on placebo., Conclusions • The review indicates that yoga, aerobic exercise, acupuncture, biofeedback, hypnosis, and inositol and acetylcysteine all show promise in the treatment of excoriation disorder and other body-focused repetitive behaviors, such as Trichotillomania., Future studies should examine whether inositol may be beneficial in controlling pulling behavior in a subgroup of individuals with Trichotillomania.[SEP]Relations: Inositol has relations: drug_drug with Triazolam, drug_drug with Triazolam, drug_drug with Triethylenetetramine, drug_drug with Triethylenetetramine, drug_drug with Trifluridine, drug_drug with Trifluridine, drug_drug with Triamterene, drug_drug with Triamterene, drug_drug with Trichlormethiazide, drug_drug with Trichlormethiazide. Definitions: inositol defined as following: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.. acetylcysteine defined as following: The N-acetyl derivative of CYSTEINE. It is used as a mucolytic agent to reduce the viscosity of mucous secretions. It has also been shown to have antiviral effects in patients with HIV due to inhibition of viral stimulation by reactive oxygen intermediates.. Trichotillomania defined as following: Compulsion to pull out one's hair..", "label": "no"} {"original_question": "Is MAGE-A3 immunotherapeutic effective for non-small-cell lung cancer?", "id": "converted_3776", "sentence1": "Is MAGE-A3 Peptide Vaccine immunotherapeutic effective for non-small-cell lung cancer?", "sentence2": "INTERPRETATION: Adjuvant treatment with the MAGE-A3 Peptide Vaccine Peptide Vaccine immunotherapeutic did not increase disease-free survival compared with placebo in patients with MAGE-A3 Peptide Vaccine Peptide Vaccine-positive surgically resected Non-Small Cell Lung Carcinoma. Based on our results, further development of the MAGE-A3 Peptide Vaccine Peptide Vaccine immunotherapeutic for use in Non-Small Cell Lung Carcinoma has been stopped., In the overall population, median disease-free survival was 60·5 months (95% CI 57·2-not reached) for the MAGE-A3 Peptide Vaccine Peptide Vaccine immunotherapeutic group and 57·9 months (55·7-not reached) for the placebo group (hazard ratio [HR] 1·02, 95% CI 0·89-1·18; p=0·74). Of the patients who did not receive chemotherapy, median disease-free survival was 58·0 months (95% CI 56·6-not reached) in those in the MAGE-A3 Peptide Vaccine Peptide Vaccine group and 56·9 months (44·4-not reached) in the placebo group (HR 0·97, 95% CI 0·80-1·18; p=0·76). Because of the absence of treatment effect, we could not identify a gene signature predictive of clinical benefit to MAGE-A3 Peptide Vaccine Peptide Vaccine immunotherapeutic. , uvant treatment with the MAGE-A3 Peptide Vaccine Peptide Vaccine immunotherapeutic did not increase disease-free survival compared with placebo in patients with MAGE-A3 Peptide Vaccine Peptide Vaccine-positive surgically resected Non-Small Cell Lung Carcinoma. Ba[SEP]Relations: small cell lung carcinoma has relations: disease_protein with GRIK3, disease_protein with GRIK3, disease_protein with CSF3, disease_protein with CSF3, disease_protein with TP73, disease_protein with TP73, disease_protein with EPHB3, disease_protein with EPHB3, disease_protein with TAOK3, disease_protein with TAOK3. Definitions: Non-Small Cell Lung Carcinoma defined as following: A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.. MAGE-A3 Peptide Vaccine defined as following: A peptide cancer vaccine comprised of a peptide derived from the human melanoma antigen A3 (MAGE-A3 Peptide Vaccine), with potential immunostimulating and antineoplastic activities. Upon administration, MAGE-A3 Peptide Vaccine peptide vaccine may stimulate the immune system to mount a cytotoxic T-cell (CTL) response against tumor cells expressing MAGE-A3 Peptide Vaccine, resulting in tumor cell lysis. MAGE-A3 Peptide Vaccine, a tumor-associated antigen (TAA), is overexpressed by a variety of cancer cell types..", "label": "no"} {"original_question": "Is there a role for TFII-I in megakaryopoiesis?", "id": "converted_4112", "sentence1": "Is there a role for TFII-I in megakaryopoiesis?", "sentence2": "TFII-I/Gtf2i and Erythro-Megakaryopoiesis., TFII-I is a ubiquitously expressed transcription factor that positively or negatively regulates gene expression. TFII-I has been implicated in neuronal and immunologic diseases as well as in thymic epithelial cancer. Williams Syndrome (Beckwith-Wiedemann Syndrome) is caused by a large hemizygous deletion on chromosome 7q11.23 which encompasses 26-28 Genes, including GTF2I gene gene, the Human gene encoding TFII-I. A subset of Beckwith-Wiedemann Syndrome patients has recently been shown to present with Macrocytosis (morphologic abnormality), a mild Genus Anemia characterized by enlarged erythrocytes. We conditionally deleted the TFII-I/Gtf2i gene in adult CASP14 gene by tamoxifen induced Cre-recombination. Bone Marrow Cells revealed defects in erythro-megakaryopoiesis and an increase in expression of the adult β-globin gene. The data show that TFII-I acts as a repressor of β-globin gene transcription and that it is implicated in the differentiation of erythro-megakaryocytic cells.[SEP]Relations: GTF2I gene has relations: disease_protein with myeloid leukemia, disease_protein with myeloid leukemia, disease_protein with acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor, disease_protein with acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor, disease_protein with unclassified acute myeloid leukemia, disease_protein with unclassified acute myeloid leukemia, protein_protein with ZMYM3, protein_protein with ZMYM3, disease_protein with acute myeloid leukemia with t(6;9)(p23;q34), disease_protein with acute myeloid leukemia with t(6;9)(p23;q34). Definitions: Bone Marrow Cells defined as following: Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells.. Beckwith-Wiedemann Syndrome defined as following: A syndrome of multiple defects characterized primarily by umbilical hernia (HERNIA, UMBILICAL); MACROGLOSSIA; and GIGANTISM; and secondarily by visceromegaly; HYPOGLYCEMIA; and ear abnormalities.. tamoxifen defined as following: One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM.. Macrocytosis (morphologic abnormality) defined as following: An increase in nuclear size and amount of cytoplasm of a cell. The cells or nucleus may be slightly irregular and/or may be polyploid.. Williams Syndrome defined as following: A disorder caused by hemizygous microdeletion of about 28 Genes on chromosome 7q11.23, including the ELASTIN gene. Clinical manifestations include SUPRAVALVULAR AORTIC STENOSIS; MENTAL RETARDATION; elfin facies; impaired visuospatial constructive abilities; and transient HYPERCALCEMIA in infancy. The condition affects both sexes, with onset at birth or in early infancy.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Has intepirdine been evaluated in clinical trials? (November 2017)", "id": "converted_2561", "sentence1": "Has intepirdine been evaluated in clinical trials? (November 2017)", "sentence2": "Using small molecules blocking 5-HT6serotonin receptor (intepirdine), inhibiting BACE activity (E2609, AZD3293, and verubecestat), or reducing uridine triacetate aggregation (TRx0237) are also currently in Phase III clinical trials.[SEP]Definitions: uridine triacetate defined as following: A synthetic uridine pro-drug that is converted to uridine in vivo. Uridine, a pyrimidine nucleotide, has been used in a variety of diseases including depressive disorders and inherited myopathies. (NCI04).", "label": "yes"} {"original_question": "Is peripheral neuroepithelioma related to Ewing sarcoma?", "id": "converted_51", "sentence1": "Is Peripheral Primitive Neuroectodermal Tumor of Bone related to Ewings sarcoma?", "sentence2": "The term \"small round-cell tumor\" describes a group of highly aggressive malignant tumors composed of relatively small and monotonous undifferentiated cells with high Nuclear (incident type) to cytoplasmic ratios. This group includes Ewing's sarcoma of Specimen Type - Bone of Specimen Type - Bone (ES), Peripheral Primitive Neuroectodermal Tumor of Bone (aka, primitive neuroectodermal tumor or extraskeletal ES), Peripheral neuroblastoma (\"classic-type\"), Anal Rhabdomyosarcoma, Desmoplastic Small Round Cell Tumor, Lymphoma, leukemia, small-cell osteosarcoma, small-cell carcinoma (either undifferentiated or Neurosecretory Systems), Rat Olfactory Neuroblastoma, cutaneous Neurosecretory Systems carcinoma (aka, Merkel-cell carcinoma), small-cell melanoma, and Mesenchymal Chondrosarcoma. Their clinical presentations often overlap, thus making a definitive diagnosis problematic in some cases, AIMS: To retrospectively study the DNA content in a series of childhood Ewing Family Tumors (EFT), and to investigate its prognostic value. METHODS: The study was performed on a series of 27 EFTs (osseous Ewing's sarcoma of Specimen Type - Bone of Specimen Type - Bone, 18 cases; extraosseous Ewing's sarcoma of Specimen Type - Bone of Specimen Type - Bone, 2; Peripheral Primitive Neuroectodermal Tumor of Bone, 4; Askin Rosai tumors, 3, To improve the prognosis of patients with poor-risk Peripheral primitive neuroectodermal tumors (pPNETs; including Peripheral Primitive Neuroectodermal Tumor of Bone and Ewing's sarcoma of Specimen Type - Bone of Specimen Type - Bone), Large group of small-round-cell tumours of soft tissue and Specimen Type - Bone represents a complex diagnostic problem for the pathologists. neuronal nature of many tumours from this group is proven by means of new methods--immunophenotypic analysis, tissue culture, cytogenetics. Peripheral Neuroectodermal Tumor, Primitive, Ewing Neoplasms, primitive Neuroectodermal Tumors (Ewings sarcoma-primitive neuroectodermal tumor (Ewings sarcoma-primitive neuroectodermal tumor (PNET))), Askin's tumor belong to these neoplasms, Comparison of Ewing's sarcoma of Specimen Type - Bone of Specimen Type - Bone of Specimen Type - Bone and Peripheral Primitive Neuroectodermal Tumor of Bone. An immunocytochemical and ultrastructural analysis of two primitive neuroectodermal neoplasms, Ewing's sarcoma of Specimen Type - Bone of Specimen Type - Bone of Specimen Type - Bone (carboxylesterase) and Peripheral Primitive Neuroectodermal Tumor of Bone (Peripheral Nervous System) are frequently considered to be different tumors. Some researchers have suggested that Peripheral Nervous System is morphologically a neuroectodermal Ewing's sarcoma of Specimen Type - Bone of Specimen Type - Bone. We sought to determine the extent of neuroectodermal features in conventional carboxylesterase on direct patient material (25 cases) and to compare these tumors with a similar group of readily diagnosed Peripheral Nerve Stimulation (10 cases), Neuroectodermal antigens (Gamma-Enolase, Leu-7 [CD57 Antigens], Neurofilament Medium Polypeptide 200 kd, and S100A1 wt Allele) were found in nine of 10 cases of Peripheral Nervous System and in 17 of 25 cases of carboxylesterase, These data support the concept that carboxylesterase and Peripheral Nervous System are both Peripheral primitive neuroectodermal neoplasms, differing only in extent of neuroectodermal phenotype and morphological differentiation, Besides these antigenic features, Ewings sarcoma cells are characterized by a specific t(11;22)(q24;q12) translocation also observed in Neuroectodermal Tumor, Primitive, a neuroectodermal tumor, suggesting a possible evolutionary related origin., Ewings sarcoma (ES) and Peripheral Primitive Neuroectodermal Tumor of Bone (Peripheral Nervous System) are closely related tumors, and it can be difficult to distinguish them from other small-round-cell tumors (SRCTs)., The presence of this translocation in Ewings sarcoma and Peripheral primitive neuroectodermal tumor has been taken as evidence that these two tumors are related., Besides these antigenic features, Ewings sarcoma cells are characterized by a specific t(11;22)(q24;q12) translocation also observed in Neuroectodermal Tumor, Primitive, a neuroectodermal tumor, suggesting a possible evolutionary related origin., Indistinguishable patterns of protooncogene expression in two distinct but closely related tumors: Ewing's sarcoma of Specimen Type - Bone of Specimen Type - Bone and Neuroectodermal Tumor, Primitive., Ewing's sarcoma of Specimen Type - Bone of Specimen Type - Bone (ES) and Peripheral Primitive Neuroectodermal Tumor of Bone (Peripheral Nervous System) are related tumors, possibly of neural crest origin, which are cytogenetically characterized by the specific translocation t(11;22)(q24;q12)., Ewing's sarcoma of Specimen Type - Bone of Specimen Type - Bone/Peripheral primitive neuroectodermal tumors (ES/pPNET) are a group of small round cell sarcomas that show varying degrees of neuroectodermal differentiation characterized by translocation involving the EWSR1 gene, Ewing's sarcoma of Specimen Type - Bone of Specimen Type - Bone (ES) and Peripheral Primitive Neuroectodermal Tumor of Bone (Peripheral Nervous System) are closely related tumors, and it can be difficult to distinguish them from other small-round-cell tumors (SRCTs), Ewing's sarcoma of Specimen Type - Bone of Specimen Type - Bone (ES) and Peripheral Primitive Neuroectodermal Tumor of Bone (Peripheral Nervous System) are related tumors, possibly of neural crest origin, which are cytogenetically characterized by the specific translocation t(11;22)(q24;q12), This genetical similarity further supports a nosological concept according to which Askin's Neoplasms, Ewing's sarcoma of Specimen Type - Bone of Specimen Type - Bone and Peripheral Primitive Neuroectodermal Tumor of Bone represent phenotypic variations of the same Neoplasms, namely the Peripheral primitive Neuroectodermal Tumors., Besides these antigenic features, Ewings sarcoma cells are characterized by a specific t(11;22)(q24;q12) translocation also observed in Neuroectodermal Tumor, Primitive, a neuroectodermal tumor, suggesting a possible evolutionary related origin[SEP]Relations: Ewings sarcoma/Peripheral primitive neuroectodermal tumor has relations: disease_disease with Ewings sarcoma, disease_disease with Ewings sarcoma, disease_disease with extraskeletal Ewings sarcoma/Peripheral primitive neuroectodermal tumor, disease_disease with extraskeletal Ewings sarcoma/Peripheral primitive neuroectodermal tumor, disease_disease with Peripheral primitive neuroectodermal tumor, disease_disease with Peripheral primitive neuroectodermal tumor, disease_disease with Ewings sarcoma/Peripheral primitive neuroectodermal tumor of Specimen Type - Bone, disease_disease with Ewings sarcoma/Peripheral primitive neuroectodermal tumor of Specimen Type - Bone. Ewings sarcoma has relations: disease_disease with Ewings sarcoma/Peripheral primitive neuroectodermal tumor, disease_disease with Ewings sarcoma/Peripheral primitive neuroectodermal tumor. Definitions: Askin's tumor defined as following: A primitive neuroectodermal tumor (small round blue cell tumor) of the thorax which can involve the periosteum, thoracic wall and/or pleura though it spares the lung parenchyma.. Neuroectodermal Tumors defined as following: Malignant neoplasms arising in the neuroectoderm, the portion of the ectoderm of the early embryo that gives rise to the central and Peripheral nervous systems, including some glial cells.. Peripheral Primitive Neuroectodermal Tumor of Bone defined as following: A small round cell tumor with neural differentiation arising from the Specimen Type - Bone. It may be associated with pain.. carboxylesterase defined as following: A family of enzymes that hydrolyze carboxylic esters.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Lymphoma defined as following: A general term for various neoplastic diseases of the lymphoid tissue.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Neurofilament Medium Polypeptide defined as following: Neurofilament medium polypeptide (916 aa, ~102 kDa) is encoded by the human NEFM gene. This protein is involved in the regulation of neuronal process structure.. Ewings sarcoma defined as following: A small round cell tumor that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewings sarcoma/Peripheral neuroectodermal tumor. It affects mostly males under age 20, and it can occur in soft tissue or Specimen Type - Bone. Pain and the presence of a mass are the most common clinical symptoms.. Neuroectodermal Tumor, Primitive defined as following: A group of malignant tumors of the nervous system that feature primitive cells with elements of neuronal and/or glial differentiation. Use of this term is limited by some authors to central nervous system tumors and others include neoplasms of similar origin which arise extracranially (i.e., NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL). This term is also occasionally used as a synonym for MEDULLOBLASTOMA. In general, these tumors arise in the first decade of life and tend to be highly malignant. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2059). Desmoplastic Small Round Cell Tumor defined as following: A rare, aggressive soft tissue sarcoma that primarily affects adolescents and young adults. It is most commonly found in the abdomen.. soft tissue defined as following: A general term comprising tissue that is not hardened or calcified; including muscle, fat, blood vessels, nerves, tendons, ligaments and fascia.. Peripheral neuroblastoma defined as following: A neuroblastoma arising from the Peripheral nervous system.. Anal Rhabdomyosarcoma defined as following: A malignant mesenchymal tumor with skeletal muscle differentiation affecting the anus.. Ewing's sarcoma of Specimen Type - Bone defined as following: A small round cell Specimen Type - Bone tumor that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewings sarcoma/Peripheral neuroectodermal tumor. It often affects the diaphysis or metaphyseal-diaphyseal portion of long bones. Clinical findings include pain and a mass in the involved area. Fever, anemia, leukocytosis, and an increased sedimentation rate are often seen. X-ray examination reveals osteolytic lesions. The prognosis depends on the stage, anatomic location, and size of the tumor.. Mesenchymal Chondrosarcoma defined as following: A rare aggressive variant of chondrosarcoma, characterized by a biphasic histologic pattern of small compact cells intermixed with islands of cartilaginous matrix. Mesenchymal chondrosarcomas have a predilection for flat bones; long tubular bones are rarely affected. They tend to occur in the younger age group and are highly metastatic. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1456). leukemia defined as following: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and Specimen Type - Bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006). CD57 Antigens defined as following: A carbohydrate molecule that contains a sulfoglucuronyl residue and found predominantly on the surface of natural killer cells. It is involved in the modulation of cell-cell and cell-matrix interactions.. Ewings sarcoma-primitive neuroectodermal tumor (PNET) defined as following: A group of highly cellular primitive round cell neoplasms which occur extracranially in soft tissue and Specimen Type - Bone and are derived from embryonal neural crest cells. These tumors occur primarily in children and adolescents and share a number of characteristics with EWING SARCOMA.. Peripheral Nerve Stimulation defined as following: A minimally invasive form of electroanalgesia often used in neuropathic pain. For best effect, the stimulation is applied proximally to the site of the nerve lesion. (from White, Li, and Chiu). Peripheral Nervous System defined as following: The nervous system outside of the brain and spinal cord. The Peripheral nervous system has autonomic and somatic divisions. The autonomic nervous system includes the enteric, parasympathetic, and sympathetic subdivisions. The somatic nervous system includes the cranial and spinal nerves and their ganglia and the Peripheral sensory receptors.. Neurosecretory Systems defined as following: A system of NEURONS that has the specialized function to produce and secrete HORMONES, and that constitutes, in whole or in part, an ENDOCRINE SYSTEM or organ.. Peripheral defined as following: On or near an edge or constituting an outer boundary; the outer area.. cutaneous Neurosecretory Systems carcinoma defined as following: A carcinoma arising from MERKEL CELLS located in the basal layer of the epidermis and occurring most commonly as a primary Neurosecretory Systems carcinoma of the skin. Merkel cells are tactile cells of neuroectodermal origin and histologically show neurosecretory granules. The skin of the head and neck are a common site of Merkel cell carcinoma, occurring generally in elderly patients. (Holland et al., Cancer Medicine, 3d ed, p1245). S100A1 wt Allele defined as following: Human S100A1 wild-type allele is located in the vicinity of 1q21 and is approximately 4 kb in length. This allele, which encodes protein S100A1 wt Allele-A1, is involved in the binding of zinc and calcium.. EWSR1 gene defined as following: This gene may play a role in post-transcriptional regulation; however the function remains to be elucidated. Mutations in the gene result in Ewings sarcoma and other tumors..", "label": "yes"} {"original_question": "Is davunetide being considered for the treatment of progressive supranuclear palsy?", "id": "converted_2271", "sentence1": "Is davunetide being considered for the treatment of progressive supranuclear palsy?", "sentence2": "Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy., Davunetide's efficacy and tolerability are being tested in a placebo-controlled study in Progressive supranuclear palsy patients, making it the most advanced drug candidate in this indication. This review examines the disease characteristics of Progressive supranuclear palsy, the rationale for treating Progressive supranuclear palsy with davunetide and assesses some of the challenges of clinical trials in this patient population.[SEP]Relations: progressive supranuclear palsy has relations: disease_phenotype_positive with Parkinsonism with favorable response to dopaminergic medication, disease_phenotype_positive with Parkinsonism with favorable response to dopaminergic medication, disease_disease with supranuclear oculomotor palsy, disease_disease with supranuclear oculomotor palsy, disease_disease with syndromic disease, disease_disease with syndromic disease, disease_phenotype_positive with Neuromuscular dysphagia, disease_phenotype_positive with Neuromuscular dysphagia, disease_phenotype_positive with Retrocollis, disease_phenotype_positive with Retrocollis. Definitions: Progressive supranuclear palsy defined as following: A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7).", "label": "yes"} {"original_question": "Is Tofacitinib effective for Ulcerative Colitis?", "id": "converted_2434", "sentence1": "Is Tofacitinib effective for Ulcerative Colitis?", "sentence2": "Tofacitinib, inhibiting signalling via all JAK1 protein, human family members, was effective in phase 2 and 3 trials in moderate-severe ulcerative colitis., Among them, JAK1 protein, human (JAK1 protein, human) inhibitors seem to have the lead, since tofacitinib has received regulatory approval in 2012 for the treatment of Rheumatoid Arthritis, and also it has shown a favorable risk-benefit ratio in phase 3 studies for ulcerative colitis, both in anti-TNF naïve and anti-TNF experienced patients. , Near future conventional drug options include Oral Route of Drug administration agents such as tofacitinib and mongersen. , Tofacitinib showed dose related efficacy for induction therapy. , Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis., BACKGROUND: Tofacitinib, an Oral Route of Drug administration, small-molecule Janus Kinase Inhibitor [EPC], was shown to have potential efficacy as induction therapy for ulcerative colitis in a phase 2 trial. , CONCLUSIONS: In patients with moderately to severely active ulcerative colitis, tofacitinib was more effective as induction and maintenance therapy than placebo., Tofacitinib (CP-690,550), an Oral Route of Drug administration small-molecule Janus Kinase Inhibitor [EPC], has been shown to be effective in the treatment of Rheumatoid Arthritis, Experimental Autoimmune Encephalomyelitis and ulcerative colitis. , Tofacitinib, an Oral Route of Drug administration, small-molecule Janus Kinase Inhibitor [EPC], was shown to have potential efficacy as induction therapy for ulcerative colitis in a phase 2 trial., BACKGROUND: Tofacitinib, an Oral Route of Drug administration, small-molecule Janus Kinase Inhibitor [EPC], was shown to have potential efficacy as induction therapy for ulcerative colitis in a phase 2 trial., Across all three trials, adjudicated Skin carcinoma occurred in five patients who received tofacitinib and in one who received placebo, and adjudicated cardiovascular events occurred in five who received tofacitinib and in none who received placebo; as compared with placebo, tofacitinib was associated with increased Lipids levels.
CONCLUSIONS: In patients with moderately to severely active ulcerative colitis, tofacitinib was more effective as induction and maintenance therapy than placebo., Tofacitinib (CP-690,550), an Oral Route of Drug administration small-molecule Janus Kinase Inhibitor [EPC], has been shown to be effective in the treatment of Rheumatoid Arthritis, Experimental Autoimmune Encephalomyelitis and ulcerative colitis., Tofacitinib, an Oral Route of Drug administration Janus Kinase Inhibitor [EPC], in active ulcerative colitis., Tofacitinib, a non-selective JAK1 protein, human (JAK1 protein, human) PPP1R1A gene, is effective in inducing clinical and endoscopic remission in patients with active ulcerative colitis (Ulcerative Colitis)., BACKGROUND Tofacitinib, an Oral Route of Drug administration, small-molecule Janus Kinase Inhibitor [EPC], was shown to have potential efficacy as induction therapy for ulcerative colitis in a phase 2 trial., BACKGROUND Tofacitinib, a novel, Oral Route of Drug administration Janus Kinase Inhibitor [EPC], demonstrated a dose-dependent efficacy for induction of clinical response and remission in patients with active ulcerative colitis (Ulcerative Colitis)., CONCLUSIONS In patients with moderately to severely active ulcerative colitis, tofacitinib was more effective as induction and maintenance therapy than placebo., Tofacitinib, an Oral Route of Drug administration janus kinase PPP1R1A gene, is a new biologic that has shown promise in the treatment of ulcerative colitis and may be effective in the treatment of Crohn's disease of Oral Route of Drug administration soft tissues of Oral Route of Drug administration soft tissues according to phase 2 trials., CONCLUSIONS Patients with moderately to severely active ulcerative colitis treated with tofacitinib were more likely to have clinical response and remission than those receiving placebo., Three patients treated with tofacitinib had an absolute neutrophil count of less than 1500.
CONCLUSIONS: Patients with moderately to severely active ulcerative colitis treated with tofacitinib were more likely to have clinical response and remission than those receiving placebo., tofacitinib an Oral Route of Drug administration small molecule janus kinase PPP1R1A gene was shown to have potential efficacy as induction therapy for ulcerative colitis in a phase 2 trial we further evaluated the efficacy of tofacitinib as induction and maintenance therapy we conducted three phase 3 randomized double blind placebo controlled trials of tofacitinib therapy in adults with ulcerative colitis in the octave induction 1 and 2 trials 598 and 541 patients respectively who had moderately to severely active ulcerative colitis despite previous conventional therapy or therapy with a Tumor Necrosis Factor Inhibitors were randomly assigned to receive induction therapy with tofacitinib 10 mg twice daily or placebo for 8 weeks the primary end point was remission at 8 weeks in the octave sustain trial 593 patients who had a clinical response to induction therapy were randomly assigned to receive maintenance therapy with tofacitinib either 5 mg or 10 mg twice daily or placebo for 52 weeks the primary end point was remission at 52 weeks in the octave induction 1 trial remission at 8 weeks occurred in 18 5 of the patients in the tofacitinib group versus 8 2 in the placebo group p 0 007 in the octave induction 2 trial remission occurred in 16 6 versus 3 6 p 0 001 in the octave sustain trial remission at 52 weeks occurred in 34 3 of the patients in the 5 mg tofacitinib group and 40 6 in the 10 mg tofacitinib group versus 11 1 in the placebo group p 0 001 for both comparisons with placebo in the octave induction 1 and 2 trials the rates of overall infection and serious infection were higher with tofacitinib than with placebo in the octave sustain trial the rate of serious infection was similar across the three treatment groups and the rates of overall infection and Herpes zoster disease were higher with tofacitinib than with placebo across all three trials adjudicated Skin carcinoma occurred in five patients who received tofacitinib and in one who received placebo and adjudicated cardiovascular events occurred in five who received tofacitinib and in none who received placebo as compared with placebo tofacitinib was associated with increased Lipids levels in patients with moderately to severely active ulcerative colitis tofacitinib was more effective as induction and maintenance therapy than placebo funded by pfizer octave induction 1 octave induction 2 and octave sustain clinicaltrials gov numbers nct01465763 nct01458951 and nct01458574 respectively., ulcerative colitis is a chronic inflammatory disease of the Abdomen+Pelvis>Colon for which current treatments are not universally effective one additional treatment may be tofacitinib cp 690 550 an Oral Route of Drug administration PPP1R1A gene of janus kinases 1 2 and 3 with in vitro functional specificity for kinases 1 and 3 over kinase 2 which is expected to block signaling involving gamma chain containing Recombinant Cytokines including interleukins 2 4 7 9 15 and 21 these Recombinant Cytokines are integral to lymphocyte activation function and proliferation in a double blind placebo controlled phase 2 trial we evaluated the efficacy of tofacitinib in 194 adults with moderately to severely active ulcerative colitis patients were randomly assigned to receive tofacitinib at a dose of 0 5 mg 3 mg 10 mg or 15 mg or placebo twice daily for 8 weeks the primary outcome was a clinical response at 8 weeks defined as an absolute decrease from baseline in the score on the mayo scoring system for assessment of ulcerative colitis activity possible score 0 to 12 with higher scores indicating more severe disease of 3 or more and a relative decrease from baseline of 30 or more with an accompanying decrease in the Rectal hemorrhage subscore of 1 point or more or an absolute Rectal hemorrhage subscore of 0 or 1 the primary outcome clinical response at 8 weeks occurred in 32 48 61 and 78 of patients receiving tofacitinib at a dose of 0 5 mg p 0 39 3 mg p 0 55 10 mg p 0 10 and 15 mg p 0 001 respectively as compared with 42 of patients receiving placebo clinical remission defined as a mayo score 2 with no subscore 1 at 8 weeks occurred in 13 33 48 and 41 of patients receiving tofacitinib at a dose of 0 5 mg p 0 76 3 mg p 0 01 10 mg p 0 001 and 15 mg p 0 001 respectively as compared with 10 of patients receiving placebo there was a dose dependent increase in both low density and High Density Lipoprotein Cholesterol three patients treated with tofacitinib had an absolute neutrophil count of less than 1500 patients with moderately to severely active ulcerative colitis treated with tofacitinib were more likely to have clinical response and remission than those receiving placebo funded by pfizer clinicaltrials gov number nct00787202., recently several medical treatments for ulcerative colitis uc have been developed including 5 aminosalicylic acids 5 asas Corticosteroid ophthalmologic and otologic preparations thiopurine Calcineurin Inhibitors [MoA] and anti tumor necrosis factor tnf α treatments treatment options including Calcineurin Inhibitors [MoA] and anti tnf treatment for refractory uc are discussed in this article furthermore upcoming treatments are introduced such as golimumab vedolizumab ajm300 tofacitinib budesonide foamwill be used as one treatment option in patients with Distal colitis herbal medicine such as qing dai is also effective for active uc and may be useful for patients who are refractory to anti tnfα treatments in the near future physicians will able to use many different treatments for uc patients however we should not forget 5 asa and Corticosteroid ophthalmologic and otologic preparations as the fundamental treatments for uc patients., the inflammatory diseases ulcerative colitis and crohn s disease constitute the two main forms of INFLAMMATORY BOWEL DISEASE 2 ibd they are characterized by chronic relapsing Inflammation of the Abdomen+Pelvis>Gastrointestinal tract significantly impacting on patient quality of life and often requiring prolonged treatment existing therapies for ibd are not effective for all patients and an unmet need exists for additional therapies to induce and maintain remission here we describe the mechanism of action of the janus kinase jak PPP1R1A gene tofacitinib for the treatment of ibd and the effect of jak inhibition on the chronic cycle of Inflammation that is characteristic of the disease the pathogenesis of ibd involves a dysfunctional response from the innate and adaptive immune system resulting in overexpression of multiple inflammatory Recombinant Cytokines many of which signal through jaks thus jak inhibition allows multiple cytokine signaling pathways to be targeted and is expected to modulate the innate and adaptive immune response in ibd thereby interrupting the cycle of Inflammation tofacitinib is an Oral Route of Drug administration small molecule jak PPP1R1A gene that is being investigated as a targeted immunomodulator for ibd clinical development of tofacitinib and other jak inhibitors is ongoing with the aspiration of providing new treatment options for ibd that have the potential to deliver prolonged efficacy and clinically meaningful patient benefits.[SEP]Relations: Tofacitinib has relations: drug_drug with Eculizumab, drug_drug with Eculizumab, drug_drug with Tocilizumab, drug_drug with Tocilizumab, drug_drug with Otamixaban, drug_drug with Otamixaban, drug_drug with Dovitinib, drug_drug with Dovitinib, drug_drug with Saracatinib, drug_drug with Saracatinib. Definitions: Experimental Autoimmune Encephalomyelitis defined as following: An experimental animal model for central nervous system demyelinating disease. Inoculation with a white matter emulsion combined with FREUND'S ADJUVANT, myelin basic protein, or purified central myelin triggers a T cell-mediated immune response directed towards central myelin. The pathologic features are similar to MULTIPLE SCLEROSIS, including perivascular and periventricular foci of Inflammation and demyelination. Subpial demyelination underlying meningeal infiltrations also occurs, which is also a feature of ENCEPHALOMYELITIS, ACUTE DISSEMINATED. Passive immunization with T-cells from an afflicted animal to a normal animal also induces this condition. (From Immunol Res 1998;17(1-2):217-27; Raine CS, Textbook of Neuropathology, 2nd ed, p604-5). cytokine defined as following: Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner.. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. JAK1 protein, human defined as following: A family of intracellular tyrosine kinases that participate in the signaling cascade of Recombinant Cytokines by associating with specific CYTOKINE RECEPTORS. They act upon STAT TRANSCRIPTION FACTORS in signaling pathway referred to as the JAK1 protein, human/STAT pathway. The name JAK1 protein, human refers to the fact the proteins have two phosphate-transferring domains.. Ulcerative Colitis defined as following: Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.. High Density Lipoprotein Cholesterol defined as following: Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol.. Skin carcinoma defined as following: A carcinoma that arises from the skin. Representative examples are basal cell carcinoma and squamous cell carcinoma.. Rectal hemorrhage defined as following: Bleeding originating from the rectal wall and discharged from the anus.. JAK1 protein, human defined as following: Tyrosine-protein kinase JAK1 (1154 aa, ~133 kDa) is encoded by the human JAK1 gene. This protein plays a role in both tyrosine phosphorylation and interferon-mediated signaling.. Herpes zoster disease defined as following: An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed). tofacitinib defined as following: An orally available PPP1R1A gene of Janus kinases (JAK1 protein, human), with immunomodulatory and anti-inflammatory activities. Upon administration, tofacitinib binds to JAK1 protein, human and prevents the activation of the JAK1 protein, human-signal transducers and activators of transcription (STAT) signaling pathway. This may decrease the production of pro-inflammatory Recombinant Cytokines, such as interleukin (IL)-6, -7, -15, -21, interferon-alpha and -beta, and may prevent both an inflammatory response and the Inflammation-induced damage caused by certain immunological diseases. JAK1 protein, human kinases are intracellular enzymes involved in signaling pathways affecting hematopoiesis, immunity and Inflammation.. Tumor Necrosis Factor Inhibitors defined as following: Compounds or agents that bind to and inhibit the synthesis or activity of TUMOR NECROSIS FACTOR-alpha. Such agents are used to treat inflammatory bowel diseases and other inflammatory diseases.. Oral Route of Drug administration defined as following: The introduction of a substance to the mouth or into the Abdomen+Pelvis>Gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the Abdomen+Pelvis>Gastrointestinal tract. This prohibits Oral Route of Drug administration administration of certain classes of drugs especially peptides and proteins.. Lipids defined as following: A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed). golimumab defined as following: A human monoclonal antibody directed against the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-a) with immunosuppressive activity. Golimumab binds to TNF-a, thereby preventing TNF-a-mediated immune responses. TNF-a production is dysregulated in various auto-immune diseases and in cancer.. neutrophil defined as following: Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes.. Rheumatoid Arthritis defined as following: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.. Ulcerative Colitis defined as following: Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.. Tofacitinib defined as following: An orally available PPP1R1A gene of Janus kinases (JAK1 protein, human), with immunomodulatory and anti-inflammatory activities. Upon administration, tofacitinib binds to JAK1 protein, human and prevents the activation of the JAK1 protein, human-signal transducers and activators of transcription (STAT) signaling pathway. This may decrease the production of pro-inflammatory Recombinant Cytokines, such as interleukin (IL)-6, -7, -15, -21, interferon-alpha and -beta, and may prevent both an inflammatory response and the Inflammation-induced damage caused by certain immunological diseases. JAK1 protein, human kinases are intracellular enzymes involved in signaling pathways affecting hematopoiesis, immunity and Inflammation..", "label": "yes"} {"original_question": "Does Chromatin Immunoprecipitation (ChIP) show a bias for highly expressed loci?", "id": "converted_1044", "sentence1": "Does Chromatin Immunoprecipitation (ChIP) show a bias for highly expressed loci?", "sentence2": "However, several issues in the processing and analysis of ChIP-chip data have not been resolved fully, including the effect of background (mock control) subtraction and normalization within and across arrays, Proper normalization is essential for ChIP-chip experiments. The proposed normalization technique can correct systematic errors and compensate for the lack of mock control data, thus reducing the experimental cost and producing more accurate results., Subtraction of the mock (non-specific antibody or no antibody) control data is generally needed to eliminate the bias, but appropriate normalization obviates the need for mock experiments and increases the correlation among replicates, The proposed method can handle several control samples allowing for correction of multiple sources of bias simultaneously, However, the data generated will always contain noise due to e.g. Repetitive Region or non-specific antibody interactions, The generation of high copy numbers of DNA fragments as an artifact of the PCR step in Chromatin Immunoprecipitation Sequencing is an important source of bias of this methodology, Here we describe several technical aspects of the ChIP-Seq assay that diminish bias and background noise and allow the consistent generation of high-quality data, This theoretical paper systematically characterizes the biases and properties of Chromatin Immunoprecipitation Sequencing data by comparing 62 separate publicly available datasets, using rigorous statistical models and signal processing techniques, We detected a chromatin-state bias: open chromatin regions yielded higher coverage, which led to false positives if not corrected, This bias had a greater effect on detection specificity than any base-composition bias, This problem turns out to be surprisingly difficult, even in simple pairwise comparisons, because of the significant level of noise in Chromatin Immunoprecipitation Sequencing data, We show that the ChIPnorm method removes most of the noise and bias in the data and outperforms other normalization methods, We investigated the impact of library amplification bias on the identification of allele-specific (AS) molecular events from high-throughput sequencing data derived from chromatin immunoprecipitation assays (Chromatin Immunoprecipitation Sequencing), The 238 loci, termed \"hyper-ChIPable\", were in highly expressed regions with strong polymerase II and polymerase III enrichment signals, and the correlation between transcription level and ChIP enrichment was not limited to these 238 loci but extended genome-wide, The localization of unrelated Proteins, including the entire silencing complex, to the most highly transcribed genes was highly suggestive of a technical issue with the immunoprecipitations[SEP]Relations: heterochromatin organization involved in chromatin silencing has relations: bioprocess_bioprocess with chromatin organization involved in negative regulation of transcription, bioprocess_bioprocess with chromatin organization involved in negative regulation of transcription, bioprocess_protein with SMCHD1, bioprocess_protein with SMCHD1, bioprocess_bioprocess with heterochromatin organization, bioprocess_bioprocess with heterochromatin organization, bioprocess_bioprocess with heterochromatin maintenance, bioprocess_bioprocess with heterochromatin maintenance. positive regulation of peptide secretion has relations: bioprocess_protein with ADORA1, bioprocess_protein with ADORA1. Definitions: Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Chromatin Immunoprecipitation Sequencing defined as following: A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated Proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the Proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations.. Repetitive Region defined as following: Nucleotide sequences present in multiple copies in the genome. There are several types of repeated sequences. Interspersed (or dispersed) DNA repeats (Interspersed Repetitive Sequences) are copies of transposable elements interspersed throughout the genome. Flanking (or terminal) repeats (Terminal Repeat Sequences) are sequences that are repeated on both ends of a sequence, for example, the long terminal repeats (LTRs) on retroviruses. Direct terminal repeats are in the same direction and inverted terminal repeats are opposite to each other in direction. Tandem repeats (Tandem Repeat Sequences) are repeated copies which lie adjacent to each other. These can also be direct or inverted. The ribosomal RNA and transfer RNA genes belong to the class of middle repetitive DNA..", "label": "yes"} {"original_question": "Is DNA methylation an epigenetic modification of chromatin related to gene expression?", "id": "converted_994", "sentence1": "Is DNA methylation an epigenetic modification of chromatin related to gene expression?", "sentence2": "DNA methylation is a Structural Modifier of DNA involved in the regulation of gene expression by controlling the access to the DNA Sequence. , Epigenetic marks such as DNA methylation play important biological roles in gene expression regulation and cellular differentiation during development., DNA methylation patterns are characterized by highly conserved developmental programs, but allow for divergent gene expression resulting from stochastic epigenetic drift or divergent environments., DNA methylation plays a critical role in the regulation of gene expression. , Epigenetic changes such as DNA methylation and histone methylation and acetylation alter gene expression at the level of transcription by upregulating, downregulating, or silencing Genes completely., Dysregulation of epigenetic events can be pathological, leading to Cardiovascular Diseases, nervous system disorder, Metabolic Diseases, and cancer development., DNA methylation is a pervasive epigenetic DNA modification that strongly affects chromatin regulation and gene expression., Epigenetic control, which includes DNA methylation and histone modifications, leads to chromatin remodeling and regulated gene expression., Epigenetic modifications on the DNA Sequence (DNA methylation) or on chromatin-associated proteins (i.e., Histones) comprise the \"cellular epigenome\"; together these modifications play an important role in the regulation of gene expression., Epigenetics is a process involved in gene regulation, mediated via DNA methylation, histone modification, chromatin remodeling, and functional noncoding RNAs, which influences the accessibility of the underlying DNA to transcriptional regulatory factors that activate or repress expression., Significant progress has been made in the basic understanding of how various epigenetic changes such as DNA methylation, histone modification, miRNA expression, and higher order chromatin structure affect gene expression.[SEP]Relations: histone modification has relations: bioprocess_bioprocess with histone methylation, bioprocess_bioprocess with histone methylation, bioprocess_bioprocess with covalent chromatin modification, bioprocess_bioprocess with covalent chromatin modification, bioprocess_bioprocess with histone demethylation, bioprocess_bioprocess with histone demethylation, bioprocess_bioprocess with histone biotinylation, bioprocess_bioprocess with histone biotinylation, bioprocess_protein with PARP2, bioprocess_protein with PARP2. Definitions: histone modification defined as following: The covalent alteration of one or more amino acid residues within a histone protein. [GOC:krc]. Histones defined as following: Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each.. DNA Sequence defined as following: The sequence of nucleotide residues along a DNA chain.. Metabolic Diseases defined as following: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed). Cardiovascular Diseases defined as following: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. nervous system disorder defined as following: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.. Structural Modifier defined as following: A molecule that binds to a macromolecule and can change the structural properties of that macromolecule.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. chromatin defined as following: The material of CHROMOSOMES. It is a complex of DNA; HISTONES; and nonhistone proteins (CHROMOSOMAL PROTEINS, NON-HISTONE) found within the nucleus of a cell..", "label": "yes"} {"original_question": "Are enhancers directional in their targeting of gene promoters?", "id": "converted_4168", "sentence1": "Are enhancers directional in their targeting of gene Promoter?", "sentence2": "Novel bi-directional duplex Promoter (BDDP) were constructed by placing two identical core Promoter divergently on both upstream and downstream sides of their duplicated Enhancer Elements, Genetic., These Promoter initiate transcription in opposite directions and are separated only by a short enhancer region, which is likely to regulate both Promoter simultaneously. [SEP]Relations: promoter clearance from RNA polymerase I promoter has relations: bioprocess_bioprocess with promoter clearance during DNA-templated transcription, bioprocess_bioprocess with promoter clearance during DNA-templated transcription, bioprocess_bioprocess with promoter clearance from RNA polymerase I promoter for nuclear large rRNA transcript, bioprocess_bioprocess with promoter clearance from RNA polymerase I promoter for nuclear large rRNA transcript. Definitions: Enhancer Elements, Genetic defined as following: Cis-acting DNA sequences which can increase transcription of genes. Enhancers can usually function in either orientation and at various distances from a promoter.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription..", "label": "no"} {"original_question": "Is the Histidine-Rich Calcium Binding protein (HRC) related to arrhythmias and cardiac disease?", "id": "converted_1623", "sentence1": "Is the Histidine-Rich Calcium Binding protein (HRC) related to arrhythmias and cardiac disease?", "sentence2": "A Homo sapiens Genetic Variant (Ser96Ala) in the Sarcoplasmic Reticulum (SNCG wt Allele) histidine-rich Ca(2+)-binding (HRC) protein has been linked to ventricular arrhythmia and Sudden death in Cardiomyopathy, Dilated. , These findings suggest that aberrant SNCG wt Allele Ca2+ release and increased susceptibility to delayed afterdepolarizations underlie triggered arrhythmic activity in Homo sapiens Ala96 HRC carriers., The histidine-rich CALCIUM SUPPLEMENTS binding protein (HRC) Ser96Ala Genetic Polymorphism was shown to correlate with Ventricular arrhythmia and Sudden death only in Cardiomyopathy, Dilated patients but not in healthy Homo sapiens carriers., These findings indicate that the HRC Ser96Ala Variant increases the propensity of arrhythmogenic Ca(2+) waves in the stressed failing Chest>Heart, suggesting a link between this Genetic Variant and life-threatening Ventricular arrhythmia in Homo sapiens carriers., HRC plays an important role in Muscle Cells differentiation and in antiapoptotic cardioprotection against ischemia/reperfusion induced cardiac injury. Interestingly, HRC has been linked with familiar cardiac conduction disease and an HRC Genetic Polymorphism was shown to associate with malignant Ventricular arrhythmia in the background of idiopathic Cardiomyopathy, Dilated., This review summarizes studies, which have established the critical role of HRC in Ca(2+)-homeostasis, suggesting its importance in cardiac physiology and pathophysiology., HRC is a SNCG wt Allele luminal Ca(2+) binding protein known to associate with both TRDN gene and the Sarcoplasmic Reticulum Ca(2+)-ATPase, and may thus mediate the crosstalk between SNCG wt Allele Ca(2+) uptake and release. Indeed, evidence from Genetic models of JCN and HRC indicate that they are important in cardiophysiology as alterations in these Proteins affect SNCG wt Allele Ca(2+) handling and cardiac function. In addition, downregulation of JCN and HRC may contribute to Ca(2+) cycling perturbations manifest in the failing Chest>Heart, where their protein levels are significantly reduced., The Ser96Ala Genetic Variant of HRC is associated with life-threatening Ventricular arrhythmia in idiopathic 3',5'-dichloromethotrexate and may serve as an independent predictor of susceptibility to arrhythmogenesis in the setting of 3',5'-dichloromethotrexate., AAV-mediated knock-down of HRC exacerbates Aortic arch structure constriction-induced Congestive Chest>Heart failure., Chronic overexpression of HRC that may disrupt Protoplasm Ca(2+) homeostasis is implicated in pathogenesis of Cardiac Hypertrophy, Ablation of HRC showed relatively normal phenotypes under basal condition, but exhibited a significantly increased susceptibility to isoproterenol-induced Cardiac Hypertrophy, Our results present evidence that down-regulation of HRC could deteriorate cardiac function in TAC-FH through perturbed SNCG wt Allele-mediated Ca(2+) cycling, However, AAV9-mediated HRC-KD in TAC-FH was associated with decreased fractional shortening and increased cardiac fibrosis compared with control., Histidine-rich CALCIUM SUPPLEMENTS binding protein (HRC) is a high capacity, low affinity Ca(2+) binding protein, specifically expressed in striated muscles of Mammals. In rabbit allergenic extract allergenic extract skeletal and Myocardium, HRC binds to Sarcoplasmic Reticulum (SNCG wt Allele) membranes via TRDN gene, a junctional SNCG wt Allele protein. Recently, a potential role in Congestive Chest>Heart failure and arrhythmogenesis has been assigned to HRC due to its activity as regulator of SNCG wt Allele Ca(2+) uptake and Ca(2+) release., In addition, HRC null mice displayed a significantly exaggerated response to the induction of Cardiac Hypertrophy by isoproterenol compared to their wild-type littermates. The exaggerated response of HRC knockout mice to the induction of Cardiac Hypertrophy is consistent with a regulatory role for HRCBP in CALCIUM SUPPLEMENTS handling in vivo and suggests that Gene Mutation in HRC, in combination with other Genetic or environmental factors, might contribute to pathological hypertrophy and Congestive Chest>Heart failure., We observed that the levels of HRC were reduced in animal models and Homo sapiens Congestive Chest>Heart failure., Collectively, these data indicate that alterations in expression levels of HRC are associated with impaired cardiac SNCG wt Allele Ca homeostasis and contractile function., Abnormal CALCIUM SUPPLEMENTS cycling and Cardiac Arrhythmia associated with the Homo sapiens Ser96Ala Genetic Variant of histidine-rich CALCIUM SUPPLEMENTS-binding protein., The Ser96Ala Variant in histidine-rich CALCIUM SUPPLEMENTS-binding protein is associated with life-threatening Ventricular arrhythmia in idiopathic Cardiomyopathy, Dilated., Interestingly, HRC has been linked with familiar cardiac conduction disease and an HRC Genetic Polymorphism was shown to associate with malignant Ventricular arrhythmia in the background of idiopathic Cardiomyopathy, Dilated[SEP]Relations: myocardium has relations: anatomy_protein_present with HRC, anatomy_protein_present with HRC, anatomy_protein_present with HRAS, anatomy_protein_present with HRAS, anatomy_protein_present with MRC1, anatomy_protein_present with MRC1. Arrhythmia has relations: disease_phenotype_positive with HEC syndrome, disease_phenotype_positive with HEC syndrome, disease_phenotype_positive with mitochondrial trifunctional protein deficiency, disease_phenotype_positive with mitochondrial trifunctional protein deficiency. Definitions: CALCIUM SUPPLEMENTS defined as following: A dietary supplement containing the mineral CALCIUM SUPPLEMENTS.. Variant defined as following: An alteration or difference from a norm or standard.. Ventricular arrhythmia defined as following: A disorder characterized by an electrocardiographic finding of an atypical cardiac rhythm resulting from a pathologic process in the cardiac ventricles.. Congestive Chest>Heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Cardiac Arrhythmia defined as following: Any disturbances of the normal rhythmic beating of the Chest>Heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.. Genetic defined as following: Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.. Sudden death defined as following: The abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as Proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, Proteins, lipids, carbohydrates, and inorganic salts.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. isoproterenol defined as following: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the Chest>Heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and Chest>Heart stimulant.. Sarcoplasmic Reticulum defined as following: A network of tubules and sacs in the cytoplasm of SKELETAL MUSCLE FIBERS that assist with muscle contraction and relaxation by releasing and storing CALCIUM SUPPLEMENTS ions.. Cardiomyopathy, Dilated defined as following: Cardiomyopathy which is characterized by dilation and contractile dysfunction of the left and right ventricles. It may be idiopathic, or it may result from a myocardial infarction, myocardial infection, or alcohol abuse. It is a cause of congestive Congestive Chest>Heart failure.. SNCG wt Allele defined as following: Human SNCG wild-type allele is located within10q23.2-q23.3 and is approximately 13 kb in length. This allele, which encodes gamma-synuclein protein, plays a role in the modulation of axonal architecture and neurofilament integrity. This gene is highly expessed in advanced breast carcinomas, suggesting a correlation between SNCG overexpression and breast tumor development.. Sarcoplasmic Reticulum Ca(2+)-ATPase defined as following: Calcium-transporting ATPases that catalyze the active transport of CALCIUM into the SARCOPLASMIC RETICULUM vesicles from the CYTOPLASM. They are primarily found in MUSCLE CELLS and play a role in the relaxation of MUSCLES.. Cardiac Hypertrophy defined as following: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in Muscle Cells size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. 3',5'-dichloromethotrexate defined as following: A chlorinated methotrexate derivative. Dichloromethotrexate inhibits the enzyme dihydrofolate reductase, thereby preventing the synthesis of purine nucleotides and thymidylates and inhibiting DNA and RNA synthesis. This agent is metabolized and excreted by the liver. (NCI04). Myocardium defined as following: The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow.. Muscle Cells defined as following: Mature contractile cells, commonly known as myocytes, that form one of three kinds of muscle. The three types of muscle cells are skeletal (MUSCLE FIBERS, SKELETAL), cardiac (MYOCYTES, CARDIAC), and smooth (MYOCYTES, SMOOTH MUSCLE). They are derived from embryonic (precursor) muscle cells called MYOBLASTS.. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.. Homo sapiens defined as following: Members of the species Homo sapiens.. Aortic arch structure defined as following: The curved section of the aorta between the ascending and the descending tracts. The brachiocephalic, left common carotid and left subclavian arteries branch from the aorta at this section.. Genetic Polymorphism defined as following: The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.. cardiac disease defined as following: Pathological conditions involving the HEART including its structural and functional abnormalities.. arrhythmias defined as following: Any disturbances of the normal rhythmic beating of the Chest>Heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction..", "label": "yes"} {"original_question": "Is CD99 encoded by MIC2 gene?", "id": "converted_581", "sentence1": "Is CD99 encoded by CD99 wt Allele Genes?", "sentence2": "We report 2 unusual cytogenetic findings in a pediatric Ewings sarcoma, an Insertion Mutation of the CD99 wt Allele Genes encoding CD99 from Xp to 10p and a submicroscopic deletion of the well-known Specimen Source Codes - Specimen Source Codes - tumor supressor Genes KLF6, We obtained the final diagnosis of ES/PNET by immunohistochemical molecular study with positive staining for the CD99 wt Allele Genes product - ParticipationType - ParticipationType (CD99) and a Ewings sarcoma breakpoint region 1 (EWSR1 Genes Genes) Genes rearrangement, CD99, a Integral Membrane Proteins encoded by CD99 wt Allele Genes is involved in multiple cellular events including cell adhesion and migration, apoptosis, cell differentiation and regulation of protein trafficking either in physiological or pathological conditions, CD99 is a 32-kDa transmembrane glycoprotein that is encoded by the CD99 wt Allele Genes, The surgical specimens showed small round cell Specimen Source Codes - Specimen Source Codes - tumor with positive staining for CD99 wt Allele Genes product - ParticipationType - ParticipationType (CD99), CD99 is a 32-kDa transmembrane glycoprotein that is encoded by the CD99 wt Allele Genes., The leukocyte surface molecule CD99 is an GINM1 Genes encoded by the ubiquitin-like protein conjugating enzyme activity/CD99 wt Allele Genes., Human CD99, which is encoded by the mic2 Genes, is a ubiquitous 32 kDa Integral Membrane Proteins., Human CD99 is a 32-kDa cell surface protein that is encoded by the CD99 wt Allele Genes localized to the SLC52A2 Genes., The Neoplasms displayed intense immunoreactivity in a Tissue membrane pattern for CD99, the Membrane Glycoproteins encoded by the CD99 wt Allele Genes., CD99, a Integral Membrane Proteins encoded by CD99 wt Allele Genes is involved in multiple cellular events including cell adhesion and migration, apoptosis, cell differentiation and regulation of protein trafficking either in physiological or pathological conditions., CD99, the product - ParticipationType - ParticipationType of the CD99 wt Allele Genes, exhibits an erythroid-specific quantitative Genetic Polymorphism coregulated with the Genetic Polymorphism of the XG blood group Genes., CD99, the product - ParticipationType - ParticipationType of the CD99 wt Allele Genes, exhibits an erythroid-specific quantitative Genetic Polymorphism co-regulated with the Xga blood group Genetic Polymorphism., Homology searches resulted in finding Homologous Sequences (totally about 40% Homologous Gene) in the Homo sapiens CD99 wt Allele Genes product - ParticipationType - ParticipationType (CD99; 32-kDa) of T-Lymphocyte., Although considered a specific marker for Ewing's sarcoma of bone of bone/peripheral neuroectodermal tumour, the CD99 wt Allele Genes product - ParticipationType - ParticipationType (CD99) has been immunolocalised in a variety of Homo sapiens tumours., CD99 wt Allele, the Genes encoding the CD99 antigen, is found in the Pseudoautosomal Regions of both the X and Y chromosomes., Human CD99 is a 32-kDa cell surface protein that is encoded by the CD99 wt Allele Genes localized to the SLC52A2 Genes., The Neoplasms displayed intense immunoreactivity in a Tissue membrane pattern for CD99, the Membrane Glycoproteins encoded by the CD99 wt Allele Genes., CD99 (CD99 wt Allele) regulates the LFA-1/ICAM-1-mediated adhesion of Specimen Source Codes - Lymphocytes, and its Genes encodes both positive and negative regulators of cellular adhesion., Relation of neurological marker expression and EWS Genes fusion types in CD99 wt Allele/CD99-positive Neoplasms of the Ewing family., The Ewing family of Neoplasms (EFT) is characterized by high CD99 wt Allele/CD99 expression and specific EWS/ETS Genes rearrangements, resulting in different chimeric transcripts., The Neoplasms displayed intense immunoreactivity in a Tissue membrane pattern for CD99, the Membrane Glycoproteins encoded by the CD99 wt Allele Genes., Monoclonal antibody (Monoclonal Antibody [EPC]) HBA71, which was raised against Ewing's sarcoma of bone of bone cells, recognizes a cell-surface glycoprotein, p30/32MIC2, that is encoded by the CD99 wt Allele Genes in the Pseudoautosomal Regions of Homo sapiens chromosomes X and Y., Monoclonal Antibodies (mAbs) directed against ubiquitin-like protein conjugating enzyme activity, a 32-kDa Integral Membrane Proteins encoded by the CD99 wt Allele Genes located in the Pseudoautosomal Regions, induce a transbilayer movement of phosphatidylserine and, to a lesser extent, phosphatidylethanolamine in Homo sapiens thymocytes and a Jurkat T-Lymphocyte., Homology searches resulted in finding Homologous Sequences (totally about 40% Homologous Gene) in the Homo sapiens CD99 wt Allele Genes product - ParticipationType - ParticipationType (CD99; 32-kDa) of T-Lymphocyte., CD99 is a 32-kDa transmembrane glycoprotein that is encoded by the CD99 wt Allele Genes, CD99, a Integral Membrane Proteins encoded by CD99 wt Allele Genes is involved in multiple cellular events including cell adhesion and migration, apoptosis, cell differentiation and regulation of protein trafficking either in physiological or pathological conditions, The surgical specimens showed small round cell Specimen Source Codes - Specimen Source Codes - tumor with positive staining for CD99 wt Allele Genes product - ParticipationType - ParticipationType (CD99), We report 2 unusual cytogenetic findings in a pediatric Ewings sarcoma, an Insertion Mutation of the CD99 wt Allele Genes encoding CD99 from Xp to 10p and a submicroscopic deletion of the well-known Specimen Source Codes - Specimen Source Codes - tumor supressor Genes KLF6, CD99 wt Allele, the Genes encoding the CD99 antigen, is found in the Pseudoautosomal Regions of both the X and Y chromosomes, Immunohistochemical analysis showed weak to moderate and partial staining for CD99 wt Allele (CD99) and Nephroblastoma, respectively, Human CD99, which is encoded by the mic2 Genes, is a ubiquitous 32 kDa Integral Membrane Proteins, The leukocyte surface molecule CD99 is an GINM1 Genes encoded by the ubiquitin-like protein conjugating enzyme activity/CD99 wt Allele Genes, The Neoplasms displayed intense immunoreactivity in a Tissue membrane pattern for CD99, the Membrane Glycoproteins encoded by the CD99 wt Allele Genes, Human CD99 is a 32-kDa cell surface protein that is encoded by the CD99 wt Allele Genes localized to the SLC52A2 Genes, CD99 wt Allele, the Genes encoding the CD99 antigen, is found in the Pseudoautosomal Regions of both the X and Y chromosomes, CD99, the product - ParticipationType - ParticipationType of the CD99 wt Allele Genes, exhibits an erythroid-specific quantitative Genetic Polymorphism co-regulated with the Xga blood group Genetic Polymorphism[SEP]Relations: EWSR1 Genes has relations: protein_protein with CDK12, protein_protein with CDK12, protein_protein with CD177, protein_protein with CD177, protein_protein with CUEDC2, protein_protein with CUEDC2. SLC52A2 has relations: protein_protein with ADRB2, protein_protein with ADRB2, protein_protein with CDC23, protein_protein with CDC23. Definitions: T-Lymphocyte defined as following: Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-Specimen Source Codes - Lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when Specimen Source Codes - Lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.. CD99 antigen defined as following: A cell adhesion molecule that, in humans, is encoded by a Genes on the PSEUDOAUTOSOMAL REGION of SEX CHROMOSOMES. It functions in CELL ADHESION of T-LYMPHOCYTES and ROSETTE FORMATION by ERYTHROCYTES. It is also involved in the migration of LEUKOCYTES through the ENDOTHELIUM BASEMENT MEMBRANE. The 12E7 antigen co-localizes with, but functions independently of PECAM-1.. phosphatidylethanolamine defined as following: A phospholipid with the polar ethanolamine found in phosphoester linkage to diacylglycerol.. ubiquitin-like protein conjugating enzyme activity defined as following: Isoenergetic transfer of a ubiquitin-like protein (ULP) from one protein to another via the reaction X-SCP + Y -> Y-SCP + X, where both the X-SCP and Y-SCP linkages are thioester bonds between the C-terminal amino acid of SCP and a sulfhydryl side group of a cysteine residue. [GOC:dph]. Insertion Mutation defined as following: Something inserted or to be inserted.. product - ParticipationType defined as following:

Participant material that is brought forth (produced) in the act (e.g., specimen in a specimen collection, access or drainage in a placement service, medication package in a dispense service). It does not matter whether the material produced had existence prior to the service, or whether it is created in the service (e.g., in supply services the product - ParticipationType is taken from a stock).

. Integral Membrane Proteins defined as following: A protein that is an integral membrane protein with a transmembrane region.. Membrane Glycoproteins defined as following: Glycoproteins found on the membrane or surface of cells.. Ewings sarcoma defined as following: A small round cell Specimen Source Codes - tumor that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewings sarcoma/peripheral neuroectodermal Specimen Source Codes - tumor. It affects mostly males under age 20, and it can occur in soft tissue or bone. Pain and the presence of a mass are the most common clinical symptoms.. Monoclonal Antibodies defined as following: Antibodies produced by a single clone of cells.. EWSR1 Genes defined as following: This Genes may play a role in post-transcriptional regulation; however the function remains to be elucidated. Mutations in the Genes result in Ewings sarcoma and other Neoplasms.. Ewing's sarcoma of bone defined as following: A small round cell bone Specimen Source Codes - tumor that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewings sarcoma/peripheral neuroectodermal Specimen Source Codes - tumor. It often affects the diaphysis or metaphyseal-diaphyseal portion of long bones. Clinical findings include pain and a mass in the involved area. Fever, anemia, leukocytosis, and an increased sedimentation rate are often seen. X-ray examination reveals osteolytic lesions. The prognosis depends on the stage, anatomic location, and size of the Specimen Source Codes - tumor.. Tissue membrane defined as following: Thin layers of tissue which cover parts of the body, separate adjacent cavities, or connect adjacent structures.. CD99 wt Allele defined as following: Human CD99 wild-type allele is located in the vicinity of both Xp22.32 and Yp11.3 and is approximately 50 kb in length. This allele, which encodes CD99 antigen protein, is involved in cell adhesion.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Nephroblastoma defined as following: An embryonal neoplasm characterized by the presence of epithelial, mesenchymal, and blastema components. The vast majority of cases arise from the kidney. A small number of cases with morphologic features resembling Wilms Specimen Source Codes - tumor of the kidney have been reported arising from the ovary and the cervix.. phosphatidylserine defined as following: A phospholipid with a polar serine found in phosphoester linkage to diacylglycerol.. Pseudoautosomal Regions defined as following: Homologous chromosomal regions at either end of the X CHROMOSOME or Y CHROMOSOME. These two regions pair regularly at male MEIOSIS and undergo RECOMBINATION. Pseudoautosomal region 1 (SLC52A2 Genes) is located at the tip of the short 'p' arms (Xp22 and Yp11) and Pseudoautosomal region 2 (PAR2) is located at the tip of the long 'q' arms (Xq28 and Yq12).. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Homo sapiens defined as following: Members of the species Homo sapiens.. Genetic Polymorphism defined as following: The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.. Homologous Gene defined as following: A Genes from one species which corresponds to a Genes in another species and that is related via a common ancestral species. These genes retain a similar sequence and function.. CD99 defined as following: CD99 antigen (185 aa, ~19 kDa) is encoded by the Homo sapiens CD99 Genes. This protein plays a role in cell adhesion..", "label": "yes"} {"original_question": "Do R-loops tend to form at sites of DNA replication?", "id": "converted_949", "sentence1": "Do R-loops tend to form at Site of DNA replication?", "sentence2": "Escherichia coli 2 2 rnhA Mutant devoid of Pancreatic ribonuclease HI exhibit constitutive stable DNA replication, cSDR, which is thought to be initiated from R-loops stabilized in the absence of Pancreatic ribonuclease HI., We propose that the organized structure of the R-Loop Structures is critical for Oligonucleotide Primers RNA function in vivo with important implications for the RNA processing and DNA replication machinery., The precursor Oligonucleotide Primers RNA exists as a persistent RNA-DNA hybrid, known as an R-Loop Structures, formed during transcription through the replication origin (Xu, B., and Clayton, D. A. (1996) EMBO J. 15, 3135-3143)., We found that overproduction of RecG protein drastically decreased copy numbers of ColE1-type Plasmids, which require R-Loop Structures formation between the template DNA and a Oligonucleotide Primers RNA transcript (RNA II) for the initiation of replication., These results suggest that overproduced RecG inhibits the initiation of replication by prematurely resolving the R-loops formed at the replication origin region of these Plasmids with its unique helicase activity. The possibility that RecG regulates the initiation of a unique mode of DNA replication, oriC-independent constitutive stable DNA replication, by its activity in resolving R-loops is discussed., We propose that downstream of a replication block, RNA at R-loops is extended by deoxyribonucleic polymerase I activity, opening up the DNA duplex and leading to the recruitment of the replisome. This would allow replication to proceed while the original block is repaired or bypassed, Furthermore, increased RNaseH expression significantly alleviated genomic instability in deficient Specimen Source Codes - Fibroblasts suggesting that cotranscriptional R-loops formation contributes to the genesis of replication-dependent DSBs in these Cells., Transcription is an important source of replicative stress and consequently, maintenance of Genome - anatomical entity integrity requires the protection of chromosomes from the deleterious effects arising from the interaction between nascent RNA and template DNA, leading to stable DNA-RNA hybrids (R-Loop Structures) formation., Strikingly, we found that attenuation of replication strongly suppresses R-Loop Structures-mediated DNA rearrangements in both E. coli and HeLa Cells., More importantly, we then show that R-Loop Structures formation causes DNA replication Orthopedic Fork stalling, and that this in fact underlies the effects of R loops on genomic stabilit, R-Loop Structures-mediated genomic instability is caused by impairment of replication Orthopedic Fork progression, When any of these processes are not properly coordinated, aberrant outcomes such as Orthopedic Fork reversal and R-Loop Structures formation arise and trigger unscheduled recombinogenic events and Genome - anatomical entity rearrangements. , Many studies show that Cells can manage R loop formation with efficiency, and can also process the R-loops already formed in the \"U\" lymphocyte, and by which, the bad effects of R-loops on DNA replication, TAF1 Gene Mutation and homologous recombination can be regulated., Here we propose that physiological R-Loop Structures formation at CpG island promoters can contribute to DNA replication origin specification at these regions, the most efficient replication initiation Site in mammalian Cells. , In agreement with this, we found that R-loops co-localize with the origin recognition complex location within the same CpG island region in a significant fraction of these efficient replication origins, precisely at the Positioning Attribute displaying the highest density of G4 motifs. , connection between transcription and replication in Human Cells and suggests that R-Loop Structures dysregulation at CpG island promoter-origins might contribute to the phenotype of DNA replication abnormalities and loss of Genome - anatomical entity integrity detected in Tumor Cells, malignant., We show that RNA:DNA hybrids (R-loops) form at Site of transcription/replication collisions and that Pancreatic ribonuclease H1 functions to suppress Chronic Fatigue Syndrome instability., R-loops and initiation of DNA replication in Human Cells: a missing link?, Stable RNA-DNA hybrids (R-loops) prime the initiation of replication in Escherichia coli 2 2 Cells., We propose that downstream of a replication block, RNA at R-loops is extended by deoxyribonucleic polymerase I activity, opening up the DNA duplex and leading to the recruitment of the replisome., Immediately after Communicable Diseases, RNA-DNA hybrids (R-loops) occur on (at least some) replication origins, with the annealed RNA serving as a Oligonucleotide Primers for leading-strand synthesis in one direction., Here we propose that physiological R-Loop Structures formation at CpG island promoters can contribute to DNA replication origin specification at these regions, the most efficient replication initiation Site in mammalian Cells., Plasmid ColE1 origins of replication and oriK Site initiate primosome complex complex assembly by an RNA-DNA hybrid structure known as R-Loop Structures., This scenario builds on the connection between transcription and replication in Human Cells and suggests that R-Loop Structures dysregulation at CpG island promoter-origins might contribute to the phenotype of DNA replication abnormalities and loss of Genome - anatomical entity integrity detected in Tumor Cells, malignant., The multiple cleavage Site on the R-Loop Structures substrate match the priming Site observed in vivo, suggesting that Pancreatic ribonuclease MRP alone is capable of generating virtually all of the leading-strand replication primers., Mechanisms of Oligonucleotide Primers RNA synthesis and D-loop/R-Loop Structures-dependent DNA replication in Escherichia coli 2 2., Alternative oriC-independent modes of replication initiation are possible, one of which is constitutive stable DNA replication (cSDR) from transcription-associated RNA-DNA hybrids or R-loops., Our results suggest that TOP1 protein, human execute this function by suppressing the formation of DNA-RNA hybrids during transcription, these so-called R-loops interfering with the progression of replication forks., Critical role of R-loops in processing replication blocks., The possibility that RecG regulates the initiation of a unique mode of DNA replication, oriC-independent constitutive stable DNA replication, by its activity in resolving R-loops is discussed., Competition between the RNA transcript and the nontemplate DNA strand during R-Loop Structures formation in vitro: a nick can serve as a strong R-Loop Structures initiation site., More importantly, we then show that R-Loop Structures formation causes DNA replication Orthopedic Fork stalling, and that this in fact underlies the effects of R loops on genomic stability. , Consistent with this hypothesis, the 3' ends of the Mitochondrial Inheritance R-Loop Structures formed by in vitro transcription are located close to the initiation Site of the Mitochondrial Inheritance DNA replication. , A hybrid G-quadruplex structure formed between RNA and DNA explains the extraordinary stability of the Mitochondrial Inheritance R-Loop Structures., Previous studies have shown that the newly synthesized primers form a stable and persistent RNA-DNA hybrid, a R-Loop Structures, near the leading-strand origin of DNA replication. , Escherichia coli 2 2 rnhA Mutant devoid of Pancreatic ribonuclease HI exhibit constitutive stable DNA replication, cSDR, which is thought to be initiated from R-loops stabilized in the absence of Pancreatic ribonuclease HI. [SEP]Relations: HELLS has relations: bioprocess_protein with DNA methylation-dependent heterochromatin assembly, bioprocess_protein with DNA methylation-dependent heterochromatin assembly, anatomy_protein_present with lymph node, anatomy_protein_present with lymph node, bioprocess_protein with maintenance of DNA methylation, bioprocess_protein with maintenance of DNA methylation. snRNA transcription by RNA polymerase III has relations: bioprocess_protein with ZC3H8, bioprocess_protein with ZC3H8, bioprocess_protein with ELL, bioprocess_protein with ELL. Definitions: Genome - anatomical entity defined as following: Anatomical set of genes in all the chromosomes.. TOP1 protein, human defined as following: DNA topoisomerase 1 (765 aa, ~91 kDa) is encoded by the human TOP1 gene. This protein plays a role in the regulation of DNA topology.. HeLa Cells defined as following: The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These Cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all Cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Pancreatic ribonuclease defined as following: An enzyme that catalyzes the endonucleolytic cleavage of pancreatic ribonucleic acids to 3'-phosphomono- and oligonucleotides ending in cytidylic or uridylic acids with 2',3'-cyclic phosphate intermediates. EC 3.1.27.5.. R-Loop Structures defined as following: An RNA-DNA hybrid structure formed when newly transcribed RNA remains bound to its DNA template. Stability of R-loops may play a role in GENETIC INSTABILITY.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of Cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Tumor Cells, malignant defined as following: Cells of, or derived from, a malignant tumor.. Mutant defined as following: An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).. origin recognition complex location defined as following: A multisubunit complex that is located at the replication origins of a chromosome. [GOC:elh]. primosome complex defined as following: Any of a family of protein complexes that form at the origin of replication or stalled replication forks and function in replication Oligonucleotide Primers synthesis in all organisms. Early complexes initiate double-stranded DNA unwinding. The core unit consists of a replicative helicase and a primase. The helicase further unwinds the DNA and recruits the polymerase machinery. The primase synthesizes RNA primers that act as templates for complementary stand replication by the polymerase machinery. The primosome complex contains a number of associated proteins and protein complexes and contributes to the processes of replication initiation, lagging strand elongation, and replication restart. [GOC:bhm, GOC:mah, PMID:21856207]. Positioning Attribute defined as following: A reference to the alignment of an object, a particular situation or view of a situation, or the location of an object.. Mitochondrial Inheritance defined as following: The distribution of mitochondria, including the Mitochondrial Inheritance Genome - anatomical entity, into daughter Cells after mitosis or meiosis, mediated by interactions between mitochondria and the cytoskeleton. [GOC:mcc, PMID:10873824, PMID:11389764]. Plasmids defined as following: Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.. Oligonucleotide Primers defined as following: Short DNA oligonucleotide chains used to prime DNA (and in some cases RNA) synthesis.. Escherichia coli 2 defined as following: A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.. Orthopedic Fork defined as following: An orthopedic manual surgical instrument is a nonpowered hand-held device intended for medical purposes to manipulate tissue, or for use with other devices in orthopedic surgery. This generic type of device includes the cerclage applier, awl, bender, drill brace, broach, burr, corkscrew, countersink, pin crimper, wire cutter, prosthesis driver, extractor, file, Orthopedic Fork, needle holder, impactor, bending or contouring instrument, compression instrument, passer, socket positioner, probe, femoral neck punch, socket pusher, reamer, rongeur, scissors, screwdriver, bone skid, staple driver, bone screw starter, surgical stripper, tamp, bone tap, trephine, wire twister, and wrench.. Mitochondrial Inheritance DNA defined as following: Double-stranded DNA of MITOCHONDRIA. In eukaryotes, the Mitochondrial Inheritance GENOME is circular and codes for ribosomal RNA, transfer RNA, and about 10 proteins.. Site defined as following: A Positioning Attribute in relation to its surroundings.. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.. Chronic Fatigue Syndrome defined as following: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9). TAF1 Gene Mutation defined as following: A change in the nucleotide sequence of the TAF1 gene.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. R-loops defined as following: An RNA-DNA hybrid structure formed when newly transcribed RNA remains bound to its DNA template. Stability of R-loops may play a role in GENETIC INSTABILITY..", "label": "yes"} {"original_question": "Has ruxolitinib received FDA approval?", "id": "converted_2261", "sentence1": "Has ruxolitinib received FDA approval?", "sentence2": "Testing for Janus kinase 2 mutations is now included in the World Health Organization (WHO) criteria for the diagnosis of Myeloproliferative disease, and in 2011 the oral Janus kinase 2 kinase inhibitor ruxolitinib became the first Food and Drug Administration (FDA)-approved drug for the treatment of Primary Myelofibrosis.[SEP]Relations: Ruxolitinib has relations: drug_drug with Rutin, drug_drug with Rutin, drug_drug with Orlistat, drug_drug with Orlistat, drug_drug with Medical Cannabis, drug_drug with Medical Cannabis, drug_drug with Lapatinib, drug_drug with Lapatinib, drug_drug with Dovitinib, drug_drug with Dovitinib. Definitions: Janus kinase 2 defined as following: Tyrosine-protein kinase Janus kinase 2 (1132 aa, ~131 kDa) is encoded by the human Janus kinase 2 gene. This protein is involved in immunity, tyrosine phosphorylation and signal transduction.. ruxolitinib defined as following: An orally bioavailable Janus-associated kinase (JAK) inhibitor with potential antineoplastic and immunomodulating activities. Ruxolitinib specifically binds to and inhibits protein tyrosine kinases JAK 1 and 2, which may lead to a reduction in inflammation and an inhibition of cellular proliferation. The JAK-STAT (signal transducer and activator of transcription) pathway plays a key role in the signaling of many cytokines and growth factors and is involved in cellular proliferation, growth, hematopoiesis, and the immune response; JAK kinases may be upregulated in inflammatory diseases, myeloproliferative disorders, and various malignancies.. Myeloproliferative disease defined as following: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the Janus kinase 2 PROTEIN TYROSINE KINASE.. Primary Myelofibrosis defined as following: A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone..", "label": "yes"} {"original_question": "Is corpus callosum involved in the Mowat–Wilson syndrome?", "id": "converted_773", "sentence1": "Is Structure of body of corpus callosum involved in the Mowat–Wilson syndrome?", "sentence2": " The syndrome is characterized by typical Facial features, moderate-to-severe mental retardation, Epilepsy and variable Congenital Abnormality, including Hirschsprung disease, Abnormality of the genital system, congenital heart disease, Congenital absence of the Structure of body of Structure of body of corpus callosum, and Eye Specimen Source Code defects. , Mowat-Wilson syndrome in a Fetus in fetu with antenatal diagnosis of short Structure of body of Structure of body of corpus callosum: advocacy for standard autopsy., It is mainly characterized by moderate-to-severe Intellectual Disability, Epilepsy, Facial dysmorphism and various malformations including Hirschsprung disease and Structure of body of Structure of body of corpus callosum teratologic. , The association of a Structure of body of Structure of body of corpus callosum hypoplasia with a histological Hirschsprung disease and a typical Facial gestalt allowed the guiding of genetic testing., Mowat-Wilson syndrome (Muckle-Wells Syndrome) is a severe Intellectual Disability (ID)-distinctive Facial gestalt-multiple congenital anomaly syndrome, commonly associating Microcephaly (physical finding), Epilepsy, Structure of body of Structure of body of corpus callosum Congenital absence, Conotruncal defect, urogenital malformations and Hirschsprung disease (HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1). , Mowat-Wilson syndrome (Muckle-Wells Syndrome) is characterized by severe mental retardation with seizures, specific Facial dysmorphism, Hirschsprung disease, teratologic of the Structure of body of Structure of body of corpus callosum, and genitourinary and cardiac malformations., Mowat-Wilson syndrome (Muckle-Wells Syndrome) is a genetic disease caused by heterozygous Gene Mutation or Gene Deletion of the ZEB2 gene and is characterized by distinctive Facial features, Epilepsy, moderate to severe Intellectual Disability, Structure of body of Structure of body of corpus callosum abnormalities and other Congenital Abnormality., The striking Facial phenotype in addition to other features such as severely impaired speech, Muscle Muscle hypotonia, Microcephaly (physical finding), short stature, seizures, Structure of body of Structure of body of corpus callosum Congenital absence, Congenital Heart Defects, Penile Penile hypospadias, and Hirschsprung disease are particularly important clues for the initial clinical diagnosis. , Mowat-Wilson syndrome is a genetic disorder characterized by a distinct Facial appearance, moderate-to-severe mental retardation, Microcephaly (physical finding), Congenital absence of the Structure of body of Structure of body of corpus callosum, Hirschsprung disease, congenital heart disease, and Abnormality of the genital system. , It is characterized by a distinctive Facial appearance in association with Intellectual Disability (ID) and variable other features including Congenital absence of the Structure of body of Structure of body of corpus callosum, seizures, Congenital Heart Defects, Microcephaly (physical finding), short stature, Muscle Muscle hypotonia, and Hirschsprung disease. , Mowat-Wilson syndrome (Muckle-Wells Syndrome) is an autosomal dominant Intellectual Disability syndrome characterised by unique Facial features and congenital teratologic such as Hirschsprung disease, Congenital Heart Defects, Structure of body of Structure of body of corpus callosum Congenital absence and Abnormality of the urinary system., Mowat-Wilson syndrome (Muckle-Wells Syndrome) is a recently delineated mental retardation; a multiple congenital anomaly syndrome characterised by a typical Facial gestalt, Hirschsprung disease or severe constipation, Urogenital Abnormalities, Congenital Heart Defects, Congenital absence of Structure of body of Structure of body of corpus callosum and Eye Specimen Source Code defects. , Agenesis or hypogenesis of the Structure of body of Structure of body of corpus callosum., The teratologic may include Hirschsprung disease, heart defects, structural Eye Specimen Source Code teratologic including Microphthalmos, Congenital absence of the Structure of body of Structure of body of corpus callosum, and urogenital teratologic. , Mowat-Wilson syndrome (Muckle-Wells Syndrome; OMIM #235730) is a genetic condition caused by heterozygous Gene Mutation or Gene Deletion of the ZEB2 gene, and characterized by typical face, moderate-to-severe mental retardation, Epilepsy, Hirschsprung disease, and multiple congenital teratologic, including Abnormality of the genital system (particularly Penile Penile hypospadias in males), Congenital Heart Defects, Congenital absence of the Structure of body of Structure of body of corpus callosum, and Eye Specimen Source Code defects., In 11 of the 28 patients with Agenesis of Structure of body of corpus callosum, the following diagnoses could be established: Mowat-Wilson syndrome (n = 2), Walker-Warburg congenital muscular dystrophy (n = 1), oro-Facial-digital syndrome type 1 (n = 1), and chromosomal rearrangements (n = 7), including a patient with an apparently balanced reciprocal translocation, which led to the disruption and a predicted loss of function in the FOXG1 wt Allele., Mowat-Wilson syndrome (Muckle-Wells Syndrome) is a multiple congenital anomaly syndrome characterized by a distinct Facial phenotype (high forehead, Frontal bossing, large Eyebrow structure, medially flaring and sparse in the middle part, Orbital separation excessive, deep set but large Eye, large and uplifted Ear lobe, with a central depression, saddle nose with prominent rounded nasal tip, prominent Columella Columella columella, open mouth, with M-shaped upper lip, frequent smiling, and a prominent but narrow and triangular pointed chin), moderate-to-severe intellectual deficiency, Epilepsy and variable Congenital Abnormality including Hirschsprung disease (HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1), genitourinary teratologic (in particular Penile Penile hypospadias in males), Congenital Heart Defects, Congenital absence of the Structure of body of Structure of body of corpus callosum and Eye Specimen Source Code teratologic., Mowat-Wilson syndrome is a mental retardation-multiple congenital anomaly syndrome characterized by a typical facies, developmental delay, Epilepsy, and variable Congenital Abnormality, including Hirschsprung disease, urogenital teratologic, congenital heart disease, and Congenital absence of the Structure of body of Structure of body of corpus callosum. , Mowat-Wilson syndrome (Muckle-Wells Syndrome) is a recently delineated mental retardation (Mitral Valve Insufficiency)-multiple congenital anomaly syndrome, characterized by typical facies, severe Mitral Valve Insufficiency, Epilepsy, and variable Congenital Abnormality, including Hirschsprung disease (HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1), Abnormality of the genital system, congenital heart disease (altretamine/cisplatin/cyclophosphamide protocol), and Congenital absence of the Structure of body of Structure of body of corpus callosum (Agenesis of Structure of body of corpus callosum). , Medical issues in our cohort of patients included seizures (75%) with no predeliction for any particular Seizures type; Congenital absence of the Structure of body of Structure of body of corpus callosum (60% of our patients studied); Congenital Heart Defects (75%), particularly involving the pulmonary arteries and/or valves; Penile Penile hypospadias (55% of males); severely impaired or absent speech (100% of individuals over 1 year of age) with relatively spared receptive language; and Hirschsprung disease (50%) or Chronic constipation (25%). , Mowat-Wilson syndrome (Muckle-Wells Syndrome) is a mental retardation syndrome associated with distinctive Facial features, Microcephaly (physical finding), Epilepsy, and a variable spectrum of congenital teratologic, including Hirschsprung disease (HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1), Congenital absence of the Structure of body of Structure of body of corpus callosum, genitourinary abnormalities, and congenital heart disease., Agenesis of Structure of body of corpus callosum is found in 40% of the cases of Mowat-Wilson syndrome (Muckle-Wells Syndrome), a polytopic embryonic defect including a distinctive Facial gestalt, severe mental retardation, Epilepsy and postnatal Microcephaly (physical finding) as constant features. , However, analysis of Muckle-Wells Syndrome should be considered in the differential diagnosis of Agenesis of Structure of body of corpus callosum, especially when the Facial features raise the possibility of Muckle-Wells Syndrome., Frameshift Mutation function of the zinc finger homeo box 1 B gene in syndromic Structure of body of Structure of body of corpus callosum Congenital absence (Mowat-Wilson syndrome)., We report a girl who had Hirschsprung disease in association with distinct Facial appearance, Microcephaly (physical finding), Congenital absence of the Structure of body of Structure of body of corpus callosum and mental retardation (Mowat-Wilson syndrome)., Congenital teratologic, including Hirschsprung disease (HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1), congenital heart disease, Penile Penile hypospadias, genitourinary teratologic, Congenital absence of the Structure of body of Structure of body of corpus callosum, and short stature are common. [SEP]Relations: Agenesis of Structure of body of corpus callosum has relations: disease_phenotype_positive with Mowat-Wilson syndrome due to monosomy 2q22, disease_phenotype_positive with Mowat-Wilson syndrome due to monosomy 2q22, disease_phenotype_positive with Mowat-Wilson syndrome due to a ZEB2 point mutation, disease_phenotype_positive with Mowat-Wilson syndrome due to a ZEB2 point mutation, disease_phenotype_positive with Mowat-Wilson syndrome, disease_phenotype_positive with Mowat-Wilson syndrome. Mowat-Wilson syndrome has relations: disease_phenotype_positive with Agenesis of Structure of body of corpus callosum, disease_phenotype_positive with Agenesis of Structure of body of corpus callosum, disease_phenotype_positive with Hypoplasia of the Structure of body of corpus callosum, disease_phenotype_positive with Hypoplasia of the Structure of body of corpus callosum. Definitions: Urogenital Abnormalities defined as following: Congenital structural abnormalities of the UROGENITAL SYSTEM in either the male or the female.. Congenital Heart Defects defined as following: Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.. Structure of body of corpus callosum defined as following: An area within the Structure of body of corpus callosum, a white matter structure within the cleft that separates the left and right cerebral hemispheres in the mammalian brain, between the genu (anterior region) and the splenium (posterior region).. Frontal bossing defined as following: A skeletal deformity characterized by an unusually prominent forehead. Causes include acromegaly, Hurler syndrome, Silver-Russell syndrome, and thalassemia major.. Penile hypospadias defined as following: Location of the urethral opening on the inferior aspect of the penis. [HPO:curators]. Epilepsy defined as following: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the Seizures episodes (e.g., motor Seizures), (2) etiology (e.g., post-traumatic), (3) anatomic site of Seizures origin (e.g., frontal lobe Seizures), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal Epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313). Microphthalmos defined as following: Congenital or developmental anomaly in which the eyeballs are abnormally small.. FOXG1 wt Allele defined as following: Human FOXG1 wild-type allele is located within 14q12-q13 and is approximately 4 kb in length. This allele, which encodes forkhead box protein G1, is involved in both the modulation of transcription by RNA polymerase II and in the regional development of the brain.. Congenital Abnormality defined as following: Malformations of organs or body parts during development in utero.. Microcephaly (physical finding) defined as following: Head circumference below 2 standard deviations below the mean for age and gender. [PMID:15806441, PMID:19125436, PMID:25465325, PMID:9683597]. Seizures defined as following: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or \"Seizures disorder.\". Intellectual Disability defined as following: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an Intellectual Disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28). Conotruncal defect defined as following: A congenital malformation of the outflow tract of the heart. Conotruncal defects are thought to result from a disturbance of the outflow tract of the embryonic heart, and comprise truncus arteriosus, tetralogy of Fallot, interrupted aortic arch, transposition of the great arteries, and double outlet right ventricle. [HPO:probinson]. Agenesis of corpus callosum defined as following: Birth defect that results in a partial or complete absence of the CORPUS CALLOSUM. It may be isolated or a part of a syndrome (e.g., AICARDI'S SYNDROME; ACROCALLOSAL SYNDROME; ANDERMANN SYNDROME; and HOLOPROSENCEPHALY). Clinical manifestations include neuromotor skill impairment and INTELLECTUAL DISABILITY of variable severity.. Ear lobe defined as following: The soft fleshy portion of the lower external ear composed of areolar and adipose connective tissues.. ZEB2 gene defined as following: This gene is involved in regulation of transcription.. Gene Deletion defined as following: A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus.. Muckle-Wells Syndrome defined as following: An autoinflammatory disease caused by Gene Mutation in the NLRP3 gene which encodes cryopyrin. It is characterized by recurrent episodes of urticaria and fever which develop in infancy. It may lead to sensorineural hearing loss and/or amyloidosis.. Facial defined as following: Of, or related to, or in the direction of the face.. Mowat-Wilson syndrome defined as following: A rare autosomal dominant syndrome caused by Gene Mutation in the ZEB2 gene. It is characterized by mental retardation, and a distinctive Facial appearance (wide set Eye, uplifted earlobes, broad nasal bridge, prominent chin, and a smiling expression). The majority of patients have Hirschsprung disease (colonic enlargement and constipation due to intestinal blockage).. Abnormality of the genital system defined as following: An abnormality of the genital system. [HPO:probinson]. Walker-Warburg congenital muscular dystrophy defined as following: Rare autosomal recessive lissencephaly type 2 associated with congenital MUSCULAR DYSTROPHY and Eye Specimen Source Code teratologic (e.g., RETINAL DETACHMENT; CATARACT; MICROPHTHALMOS). It is often associated with additional brain malformations such as HYDROCEPHALY and cerebellar hypoplasia and is the most severe form of the group of related syndromes (alpha-dystroglycanopathies) with common congenital abnormalities in the brain, Eye Specimen Source Code and muscle development.. Orbital separation excessive defined as following: Abnormal increase in the interorbital distance due to overdevelopment of the lesser wings of the sphenoid.. Muscle hypotonia defined as following: A diminution of the skeletal muscle tone marked by a diminished resistance to passive stretching.. Eye defined as following: The organ of sight constituting a pair of globular organs made up of a three-layered roughly spherical structure specialized for receiving and responding to light.. Chronic constipation defined as following: Constipation for longer than three months with fewer than 3 bowel movements per week, straining, lumpy or hard stools, and a sensation of anorectal obstruction or incomplete defecation. [ORCID:0000-0001-5208-3432]. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Abnormality of the urinary system defined as following: An abnormality of the urinary system. [HPO:probinson]. teratologic defined as following: Used with organs for congenital defects producing changes in the morphology of the organ. It is used also for abnormalities in animals.. Eyebrow structure defined as following: Curved rows of HAIR located on the upper edges of the Eye Specimen Source Code sockets.. Mitral Valve Insufficiency defined as following: Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation.. Frameshift Mutation function defined as following: A type of mutation in which a number of NUCLEOTIDES deleted from or inserted into a protein coding sequence is not divisible by three, thereby causing an alteration in the READING FRAMES of the entire coding sequence downstream of the mutation. These Gene Mutation may be induced by certain types of MUTAGENS or may occur spontaneously..", "label": "yes"} {"original_question": "Is the gene DUX4 epigenetically regulated in somatic cells?", "id": "converted_543", "sentence1": "Is the gene DUX4L2 wt Allele epigenetically regulated in Diploid Cell?", "sentence2": "There are several Genes on chromosome 4q35 region including DUX4L2 wt Allele within D4Z4 Repeat. Transcription of these Genes is usually repressed by epigenetic modifications of this Region of chromosome and also accumulation of transcriptional repressors to the Repeat Object array., Recent studies provide compelling evidence that a retrotransposed gene in the D4Z4 Repeat Object, DUX4L2 wt Allele, is expressed in the Homo sapiens Germline and then epigenetically silenced in somatic tissues. , The Homo sapiens double-homeodomain retrogene DUX4L2 wt Allele is expressed in the Testis and epigenetically repressed in somatic tissues., Facioscapulohumeral dystrophy (Muscular Dystrophy, Facioscapulohumeral) is a progressive Muscular Dystrophy caused by decreased epigenetic repression of the D4Z4 macrosatellite Repeat and ectopic expression of DUX4L2 wt Allele, a retrogene encoding a Germline TRANSCRIPTION FACTOR encoded in each Repeat Object., These CASP14 gene recapitulate important epigenetic and DUX4L2 wt Allele expression attributes seen in patients and controls, respectively, including high DUX4L2 wt Allele expression levels in the Germline, (incomplete) epigenetic repression in somatic tissue, and Muscular Dystrophy, Facioscapulohumeral-specific variegated DUX4L2 wt Allele expression in sporadic muscle nuclei associated with D4Z4 chromatin relaxation., DUX4L2 wt Allele, a retrogene contained in the D4Z4 Repeat, is normally epigenetically silenced in Diploid Cell., In contrast to control Specimen Source Codes - Skeletal muscle and most other somatic tissues, full-length DUX4L2 wt Allele transcript and Protein Info is expressed at relatively abundant levels in Homo sapiens Testis, most likely in the Germ Cells. Induced Pluripotent (iPS) cells also express full-length DUX4L2 wt Allele and differentiation of control Induced Pluripotent Stem Cells to embryoid bodies suppresses expression of full-length DUX4L2 wt Allele, whereas expression of full-length DUX4L2 wt Allele persists in differentiated Muscular Dystrophy, Facioscapulohumeral Induced Pluripotent Stem Cells. Together, these findings indicate that full-length DUX4L2 wt Allele is normally expressed at specific developmental stages and is suppressed in most somatic tissues., Recent studies provide compelling evidence that a retrotransposed gene in the D4Z4 Repeat Object, DUX4L2 wt Allele, is expressed in the Homo sapiens Germline and then epigenetically silenced in somatic tissues., DUX4L2 wt Allele, a retrogene contained in the D4Z4 Repeat, is normally epigenetically silenced in Diploid Cell. , DUX4L2 wt Allele, a retrogene contained in the D4Z4 Repeat, is normally epigenetically silenced in Diploid Cell., Recent studies provide compelling evidence that a retrotransposed gene in the D4Z4 Repeat Object, DUX4L2 wt Allele, is expressed in the Homo sapiens Germline and then epigenetically silenced in somatic tissues., Normally expressed in the Testis and epigenetically repressed in somatic tissues, DUX4L2 wt Allele expression in Specimen Source Codes - Skeletal muscle induces expression of many Germline, Stem cells, and other Genes that might account for the pathophysiology of Muscular Dystrophy, Facioscapulohumeral., Recent studies provide compelling evidence that a retrotransposed gene in the D4Z4 Repeat Object, DUX4L2 wt Allele, is expressed in the Homo sapiens Germline and then epigenetically silenced in somatic tissues, The Homo sapiens double-homeodomain retrogene DUX4L2 wt Allele is expressed in the Testis and epigenetically repressed in somatic tissues, Normally expressed in the Testis and epigenetically repressed in somatic tissues, DUX4L2 wt Allele expression in Specimen Source Codes - Skeletal muscle induces expression of many Germline, Stem cells, and other Genes that might account for the pathophysiology of Muscular Dystrophy, Facioscapulohumeral, DUX4L2 wt Allele, a retrogene contained in the D4Z4 Repeat, is normally epigenetically silenced in Diploid Cell, Recent studies provide compelling evidence that a retrotransposed gene in the D4Z4 Repeat Object, DUX4L2 wt Allele, is expressed in the Homo sapiens Germline and then epigenetically silenced in somatic tissues, The identification of the gene(s) and the exact epigenetic pathway underlining this Disease will be mandatory to increase the rate of diagnosis for FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1B patients and to confirm the hypothesis of a common FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1 and FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1B pathophysiological pathway involving DUX4L2 wt Allele gene, This Gene Deletion Abnormality induces epigenetic modifications that affect the expression of several Genes located in the vicinity. In each D4Z4 element, we identified the double homeobox 4 (DUX4L2 wt Allele) gene. DUX4L2 wt Allele expresses a TRANSCRIPTION FACTOR that plays a major role in the development of Muscular Dystrophy, Facioscapulohumeral through the initiation of a large gene dysregulation cascade that causes myogenic differentiation defects, Atrophic and reduced response to oxidative stress. , decreased epigenetic repression and variegated expression of DUX4L2 wt Allele in Specimen Source Codes - Skeletal muscle, (incomplete) epigenetic repression in somatic tissue,, Facioscapulohumeral dystrophy (Muscular Dystrophy, Facioscapulohumeral) is characterized by chromatin relaxation of the D4Z4 macrosatellite array on Chromosomes, Human, Pair 4 and expression of the D4Z4-encoded DUX4L2 wt Allele gene in Specimen Source Codes - Skeletal muscle., derepression of the DUX4L2 wt Allele retrogene, The aim of our study was to identify relationships between epigenetic parameters correlating with a relaxed chromatin state of the DUX4L2 wt Allele promoter region and clinical severity as measured by a clinical severity score or muscle pathologic changes in D4Z4 contraction-dependent (FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1) and -independent (FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1B) facioscapulohumeral Muscular Dystrophy patients. , Specifically, abundance of RNA transcripts encoded by the DUX4L2 wt Allele locus correlated to differential DNA methylation and Histone H3 Trimethyl Lys36 enrichment., Together, these findings indicate that full-length DUX4L2 wt Allele is normally expressed at specific developmental stages and is suppressed in most somatic tissue[SEP]Relations: Transcriptional regulation of Pluripotent stem cells has relations: pathway_protein with PBX1, pathway_protein with PBX1, pathway_protein with SMAD4, pathway_protein with SMAD4, pathway_protein with KLF4, pathway_protein with KLF4, pathway_protein with SALL4, pathway_protein with SALL4, pathway_protein with SMAD2, pathway_protein with SMAD2. Definitions: DUX4L2 wt Allele defined as following: Human DUX4L1 gene is located in the vicinity of 4q35 and is approximately 2 kb in length. The product is a processed pseudogene that produces an RNA transcript, but does not encode a Protein Info product. This gene is within a D4Z4 Repeat Object array; contraction of this macrosatellite Repeat Object is associated with facioscapulohumeral Muscular Dystrophy (Muscular Dystrophy, Facioscapulohumeral).. Muscular Dystrophy, Facioscapulohumeral defined as following: An autosomal dominant degenerative muscle Disease characterized by slowly progressive weakness of the muscles of the face, upper-arm, and shoulder girdle. The onset of symptoms usually occurs in the first or second decade of life. Affected individuals usually present with impairment of upper extremity elevation. This tends to be followed by facial weakness, primarily involving the orbicularis oris and orbicularis oculi muscles. (Neuromuscul Disord 1997;7(1):55-62; Adams et al., Principles of Neurology, 6th ed, p1420). Chromosomes, Human, Pair 4 defined as following: A specific pair of GROUP B CHROMOSOMES of the Homo sapiens chromosome classification.. Stem cells defined as following: Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. Muscular Dystrophy defined as following: A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS.. DUX4L2 wt Allele gene defined as following: This gene plays a role in transcriptional regulation.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Germ Cells defined as following: The reproductive cells in multicellular organisms at various stages during GAMETOGENESIS.. FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1 defined as following: An autosomal dominant form of facioscapulohumeral Muscular Dystrophy associated with contraction of the D4Z4 macrosatellite Repeat Object.. Region of chromosome defined as following: Any subdivision of a chromosome along its length. [GOC:dos]. Histone H3 Trimethyl Lys36 defined as following: A post-translationally modified form of histone H3 where the lysine residue at position 36 is trimethylated. This modification may be involved in defining exon boundaries; it also may be a marker for Genes targeted for transcriptional repression.. Testis defined as following: The male gonad containing two functional parts: the SEMINIFEROUS TUBULES for the production and transport of male germ cells (SPERMATOGENESIS) and the interstitial compartment containing LEYDIG CELLS that produce ANDROGENS.. Atrophic defined as following: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.. Repeat Object defined as following: Something occurring more than once.. Homo sapiens defined as following: Members of the species Homo sapiens.. Induced Pluripotent Stem Cells defined as following: Cells from adult organisms that have been reprogrammed into a pluripotential state similar to that of EMBRYONIC STEM CELLS.. Diploid Cell defined as following: Nucleated cell which has one or more diploid sets (46 pairs) of chromosomes.. Repeat defined as following: Make or do or perform again..", "label": "yes"} {"original_question": "Does temsirolimus improve survival of glioblastoma patients?", "id": "converted_2590", "sentence1": "Does temsirolimus improve survival of glioblastoma patients?", "sentence2": "RESULTS: fourteen randomized clinical trials were identified (7 with bevacizumab, 2 Cilengitide, 1 enzastaurin, 1 dasatinib, 1 vandetanib, 1 temsirolimus, 1 cediranib) including 4330 patients. Antiangiogenic drugs showed no improvement in overall survival with a pooled HR of 1.00, a trend for an inferior outcome, in terms of overall survival, was observed in the group of patients receiving antiangiogenic drug alone compared to cytotoxic drug alone (HR=1.24, p=0.056)., CONCLUSIONS: temsirolimus was not superior to temozolomide in patients with an unmethylated MGMT promoter., The actuarial 1-year survival was 72.2% [95% confidence interval (NDUFB6 gene), 58.2-82.2] in the temozolomide arm and 69.6% (95% NDUFB6 gene, 55.8-79.9) in the temsirolimus arm [hazard ratio (HR) 1.16; 95% NDUFB6 gene, 0.77-1.76; P = 0.47]., CONCLUSION: The combination of bevacizumab with temsirolimus was well-tolerated and resulted in stable Disease of at least four months/partial response in three out of six pediatric patients with chemorefractory CNS Neoplasms., CONCLUSIONS: temsirolimus administered weekly at the dose of 75 mg/m(2) did not meet the primary objective efficacy threshold in children with Malignant Glioma, Neuroblastoma or Anal Rhabdomyosarcoma; however, meaningful prolonged stable Disease merits further evaluation in combination therapy., Novel targeted agents such as bevacizumab, imatinib, erlotinib, temsirolimus, immunotherapy, Cilengitide, talampanel, etc. are helping classical chemotherapeutic agents, like temozolomide, to achieve an increase in overall survival., CONCLUSIONS: CCI 779 was well tolerated at this dose schedule; however, there was no evidence of efficacy in patients with recurrent Glomerular Basement Membrane, The addition of temsirolimus to human leukocyte human leukocyte interferon did not improve survival., CONCLUSIONS temsirolimus was not superior to temozolomide in patients with an unmethylated MGMT promoter., The addition of temsirolimus to human leukocyte human leukocyte interferon did not improve survival.[SEP]Relations: temsirolimus has relations: contraindication with glioblastoma (Disease), contraindication with glioblastoma (Disease), contraindication with giant cell glioblastoma, contraindication with giant cell glioblastoma, contraindication with astroblastoma, contraindication with astroblastoma, contraindication with brain cancer, contraindication with brain cancer, drug_effect with Eczema, drug_effect with Eczema. Definitions: Neuroblastoma defined as following: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51). talampanel defined as following: A synthetic derivative of dioxolo-benzodiazepine with anti-seizure activity. Talampanel antagonizes the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) subtype of glutamate excitatory amino acid receptors and may inhibit the growth of gliomas by interfering with neurotransmitters involved in brain tumor growth. This agent may also protect against traumatic brain injury.. vandetanib defined as following: An orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability. This agent also blocks the tyrosine kinase activity of epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that mediates tumor cell proliferation and migration and angiogenesis.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. temsirolimus defined as following: An ester analog of rapamycin. temsirolimus binds to and inhibits the mammalian target of rapamycin (mTOR), resulting in decreased expression of mRNAs necessary for cell cycle progression and arresting cells in the G1 phase of the cell cycle. mTOR is a serine/threonine kinase which plays a role in the PI3K/AKT pathway that is upregulated in some Neoplasms.. erlotinib defined as following: A quinazoline derivative with antineoplastic properties. Competing with adenosine triphosphate, erlotinib reversibly binds to the intracellular catalytic domain of epidermal growth factor receptor (EGFR) tyrosine kinase, thereby reversibly inhibiting EGFR phosphorylation and blocking the signal transduction events and tumorigenic effects associated with EGFR activation.. bevacizumab defined as following: An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS.. temozolomide defined as following: A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.. Glomerular Basement Membrane defined as following: A sheet of amorphous extracellular material upon which the basal surfaces of epithelial cells rest and is the covering surface of a glomerular capillary, interposed between the cellular elements and the underlying connective tissue.. Malignant Glioma defined as following: A grade 3 or grade 4 glioma arising from the central nervous system. This category includes glioblastoma, anaplastic astrocytoma, anaplastic ependymoma, anaplastic oligodendroglioma, and anaplastic oligoastrocytoma.. human leukocyte interferon defined as following: Human interferons have been classified into 3 groups: alpha, beta, and gamma. Both alpha- and beta-IFNs, previously designated type I, are acid-stable, but they differ immunologically and in regard to some biologic and physiochemical properties. The IFNs produced by virus-stimulated leukocytes (leukocyte IFNs) are predominantly of the alpha type. Those produced by lymphoblastoid cells are about 90% alpha and 10% beta. Induced fibroblasts produce mainly or exclusively the beta type. The alpha- and beta-IFNs differ widely in amino acid sequence. The gamma or immune IFNs, which are produced by T lymphocytes in response to mitogens or to antigens to which they are sensitized, are acid-labile and serologically distinct from alpha- and beta-IFNs. (from OMIM 147570). Cilengitide defined as following: A cyclic Arg-Gly-Asp peptide with potential antineoplastic activity. Cilengitide binds to and inhibits the activities of the alpha(v)beta(3) and alpha(v)beta(5) integrins, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis. (NCI04). Anal Rhabdomyosarcoma defined as following: A malignant mesenchymal tumor with skeletal muscle differentiation affecting the anus.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. dasatinib defined as following: An orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases. Dasatinib binds to and inhibits the growth-promoting activities of these kinases. Apparently because of its less stringent binding affinity for the BCR-ABL kinase, dasatinib has been shown to overcome the resistance to imatinib of chronic myeloid leukemia (CML) cells harboring BCR-ABL kinase domain point mutations. SRC-family protein-tyrosine kinases interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways; tumorigenic forms can occur through altered regulation or expression of the endogenous protein and by way of virally-encoded kinase genes.. imatinib defined as following: An antineoplastic agent that inhibits the Bcr-Abl fusion protein tyrosine kinase, an abnormal enzyme produced by chronic myeloid leukemia cells that contain the Philadelphia chromosome. Imatinib also inhibits the receptor tyrosine kinases for platelet-derived growth factor (PDGF) and stem cell factor (SCF)/c-kit; the SCF/c-kit receptor tyrosine kinase is activated in gastrointestinal stromal tumor (GIST). This agent inhibits proliferation and induces apoptosis in cells that overexpress these oncoproteins.. temsirolimus defined as following: An ester analog of rapamycin. temsirolimus binds to and inhibits the mammalian target of rapamycin (mTOR), resulting in decreased expression of mRNAs necessary for cell cycle progression and arresting cells in the G1 phase of the cell cycle. mTOR is a serine/threonine kinase which plays a role in the PI3K/AKT pathway that is upregulated in some Neoplasms.. glioblastoma defined as following: The most malignant astrocytic tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO).", "label": "no"} {"original_question": "Is golimumab effective for sarcoidosis?", "id": "converted_3356", "sentence1": "Is golimumab effective for sarcoidosis?", "sentence2": "Introduced monoclonal antibodies (inFLIXimab Ab, etanercept, adaluimumab, golimumab, rituximab), tested for efficacy in other pathologies associated with the formation of Granuloma, have a limited application in patients with SA. , Although treatment was well tolerated, neither Ustekinumab Ab nor golimumab demonstrated efficacy in pulmonary sarcoidosis. , Although treatment was well tolerated, neither Ustekinumab Ab nor golimumab demonstrated efficacy in pulmonary sarcoidosis.[SEP]Relations: Golimumab has relations: drug_drug with Sarilumab, drug_drug with Sarilumab, drug_drug with Sirukumab, drug_drug with Sirukumab, drug_drug with Seribantumab, drug_drug with Seribantumab, drug_drug with Patritumab, drug_drug with Patritumab, drug_drug with Pomalidomide, drug_drug with Pomalidomide. Definitions: Granuloma defined as following: A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents.. rituximab defined as following: A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.. golimumab defined as following: A human monoclonal antibody directed against the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-a) with immunosuppressive activity. Golimumab binds to TNF-a, thereby preventing TNF-a-mediated immune responses. TNF-a production is dysregulated in various auto-immune diseases and in cancer.. etanercept defined as following: A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS..", "label": "no"} {"original_question": "Is Cri Du Chat associated with an expansion of a repeat with in the gene found on chromosome 5?", "id": "converted_2136", "sentence1": "Is Cri Du Chat associated with an expansion of a repeat with in the gene found on Chromosomes, Human, Pair 5?", "sentence2": "Cri-du-chat syndrome is a Congenital chromosomal disease caused by a Gene Deletion Abnormality of the short arm of Chromosomes, Human, Pair 5, The typical cri du chat syndrome, due to 5p15.2 Gene Deletion Abnormality, includes severe Intellectual Disability, facial dysmorphisms, neonatal Muscle Muscle hypotonia and pre- and post-natal growth retardation, whereas more distal Gene Deletion in 5p15.3 lead to cat-like cry and speech delay and produce the clinical picture of the atypical cri du chat syndrome, with minimal or absent intellectual impairment., Cri-du-chat is a Homo sapiens contiguous gene Gene Deletion Abnormality syndrome resulting from hemizygous Gene Deletion of chromosome 5p., Cri-du-chat is a chromosomal Gene Deletion Abnormality syndrome characterized by partial Gene Deletion Abnormality of the short arm of Chromosomes, Human, Pair 5., The karyotype showed a terminal Gene Deletion Abnormality of the short arm of Chromosomes, Human, Pair 5 including the critical region 5p15 for cri du chat syndrome., Fewer than 1 in 200 of cri du chat syndrome cases are due to recombination aneusomy arising from a parental inversion of Chromosomes, Human, Pair 5., Molecular approach to analyzing the Homo sapiens 5p Gene Deletion Abnormality syndrome, cri du chat., Cri-du-chat is a Homo sapiens contiguous gene Gene Deletion Abnormality syndrome resulting from hemizygous Gene Deletion of chromosome 5p, The cri du chat syndrome (chenodeoxycholate sulfate conjugate) is a chromosomal Gene Deletion Abnormality syndrome associated with a partial Gene Deletion Abnormality of the short (p) arm of Chromosomes, Human, Pair 5, The Cri-du-Chat Syndrome is a contiguous gene syndrome that results from a Gene Deletion Abnormality of the short arm of Chromosomes, Human, Pair 5 (5p)., Cri-du-chat syndrome is associated with a Gene Deletion Abnormality of the short arm of Chromosomes, Human, Pair 5., The Gene Deletion Abnormality of the short arm of Chromosomes, Human, Pair 5 is associated with the Cri-du-Chat Syndrome., The Cri du Chat syndrome (chenodeoxycholate sulfate conjugate) is a genetic disease resulting from a Gene Deletion Abnormality of variable size occurring on the short arm of Chromosomes, Human, Pair 5 (5p-)., Cri-du-chat is a well described partial aneusomy resulting from Gene Deletion Abnormality of the short arm of Chromosomes, Human, Pair 5., Cri-du-chat syndrome is caused by haploinsufficiency of the Genes on the distal part of the short arm of Chromosomes, Human, Pair 5, and characteristic features include Microcephaly (physical finding), developmental delays, and a distinctive high-pitched mewing cry., The pathological condition of cri du chat syndrome is due to the cytogenetic Gene Deletion Abnormality of band p15.2 of Chromosomes, Human, Pair 5. , Karyotype analysis indicated that the patient has carried a terminal Gene Deletion Abnormality in 5p. FISH with Cri du Chat syndrome region probe confirmed that D5S23 and D5S721 loci are deleted. [SEP]Relations: Cri-du-chat syndrome has relations: disease_disease with partial Gene Deletion Abnormality of the short arm of Chromosomes, Human, Pair 5, disease_disease with partial Gene Deletion Abnormality of the short arm of Chromosomes, Human, Pair 5, disease_protein with CTNND2, disease_protein with CTNND2, disease_protein with SEMA5A, disease_protein with SEMA5A, disease_phenotype_positive with Growth delay, disease_phenotype_positive with Growth delay, disease_protein with TERT, disease_protein with TERT. Definitions: Chromosomes, Human, Pair 5 defined as following: One of the two pairs of Homo sapiens chromosomes in the group B class (CHROMOSOMES, HUMAN, 4-5).. Homo sapiens defined as following: Members of the species Homo sapiens.. Cri-du-Chat Syndrome defined as following: An infantile syndrome characterized by a cat-like cry, failure to thrive, Microcephaly (physical finding), MENTAL RETARDATION, spastic quadriparesis, micro- and retrognathia, glossoptosis, bilateral epicanthus, hypertelorism, and tiny external genitalia. It is caused by a Gene Deletion Abnormality of the short arm of Chromosomes, Human, Pair 5 (5p-).. Congenital chromosomal disease defined as following: Clinical conditions caused by an abnormal chromosome constitution in which there is extra or missing chromosome material (either a whole chromosome or a chromosome segment). (from Thompson et al., Genetics in Medicine, 5th ed, p429). 5p15 defined as following: A chromosome band present on 5p.. Gene Deletion defined as following: A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This Gene Deletion Abnormality may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a Gene Deletion Abnormality at one specific locus.. Muscle hypotonia defined as following: A diminution of the skeletal muscle tone marked by a diminished resistance to passive stretching.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Microcephaly (physical finding) defined as following: Head circumference below 2 standard deviations below the mean for age and gender. [PMID:15806441, PMID:19125436, PMID:25465325, PMID:9683597]. Intellectual Disability defined as following: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an Intellectual Disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28). gene defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "no"} {"original_question": "Does head ct increase brain tumor risk?", "id": "converted_3806", "sentence1": "Does Head - Component of Device ct increase Brain Neoplasms risk?", "sentence2": "Excess relative risk of new Brain Neoplasms averaged 1.29 (95% confidence interval, 0.66-1.93) for pediatric patients exposed to one or more Head - Component of Device CTs. Specimen Source Codes - tumor incidence increased with number of pediatric Head - Component of Device CTs in a dose-dependent manner, with measurable excess incidence even after a single scan. Converging evidence from epidemiological studies supported a small excess risk of Brain Neoplasms incidence after even a single X-Ray Computed Tomography exam in pediatric patients. , Recent epidemiologic evidence from a national registry of children who underwent X-Ray Computed Tomography scans suggests a higher-than-expected incidence of secondary Neoplasms. , However, we found 1) a statistically significant correlation between radiation dose and age at procedure, as well as number and type of procedures, and 2) a substantial increase in lifetime predicted risk of tumor above baseline in the cohort of young children who undergo neurointerventions.CONCLUSIONS: Although neurointerventional procedures have dramatically improved the prognosis of children facing serious cerebrovascular conditions, the predicted risk of secondary Neoplasms, particularly in the youngest patients and those undergoing multiple procedures, is sobering., Conclusion When prevalent cases of Benign Meningioma at first exposure to X-Ray Computed Tomography of the Head - Component of Device are excluded, no statistically significant increase in risk of Benign Meningioma was found among exposed subjects compared with unexposed control subjects., data suggest that 1 excess Head>Brain Primary malignant neoplasm occurred after 4000 Head>Brain CTs (40 mSv per scan) and that the estimated risk in the 10 years following X-Ray Computed Tomography exposure was 1 Brain Neoplasms per 10,000 patients exposed to a 10 mGy scan at less than 10 years of age.CONCLU, SIONS: The model predicts that the effective radiation dose from a single Head - Component of Device X-Ray Computed Tomography is capable of inducing a THYROID DIAGNOSTIC RADIOPHARMACEUTICALS or Brain Neoplasms in an infant or child. These, Neither whole Head - Component of Device X-Ray Computed Tomography nor cumulative Head>Brain dose to the Head>Brain increased the risk of Glioma or of all Head>Brain tumours., rison of exposed and unexposed cohorts showed that there was no statistically significant increase in the risk of Benign Meningioma after exposure to X-Ray Computed Tomography of the Head - Component of Device (HR: 1.49; 95% confidence interval: 0.97, 2.30; P = .07). If incident c, from epidemiological studies supported a small excess risk of Brain Neoplasms incidence after even a single X-Ray Computed Tomography exam in pediatric patients. However, refined e, ve risk of new Brain Neoplasms averaged 1.29 (95% confidence interval, 0.66-1.93) for pediatric patients exposed to one or more Head - Component of Device CTs. Specimen Source Codes - tumor incidence, X-Ray Computed Tomography nor cumulative Head>Brain dose to the Head>Brain increased the risk of Glioma or of all Head>Brain tumours. Although this st, o for developing a Head>Brain tumour from having a Head>Brain X-Ray Computed Tomography was 0.93 (95% confidence interval: 0.38-1.82). This was har, Specimen Source Codes - tumor incidence increased with number of pediatric Head - Component of Device CTs in a dose-dependent manner, with measurable excess incidence even after a single scan., Converging evidence from epidemiological studies supported a small excess risk of Brain Neoplasms incidence after even a single X-Ray Computed Tomography exam in pediatric patients., Excess relative risk of new Brain Neoplasms averaged 1.29 (95% confidence interval, 0.66-1.93) for pediatric patients exposed to one or more Head - Component of Device CTs., Epidemiological studies consistently cited increased tumor incidence in pediatric patients (ages 0-18) exposed to Head - Component of Device CTs., RESULTS: A positive correlation between exposure to X-Ray Computed Tomography scans and developing central nervous system Neoplasms was evident in all cohorts. The strength of the association varied across the studies. Exclusion of patients with Predisposing Factors to central nervous system Neoplasms was examined in four studies with a decreased risk to develop central nervous system Neoplasms noted in three studies. Two studies reported nonsignificant reduction in the excess relative risk per milliGray of Head>Brain dose after adjusting for Predisposing Factors, whereas the reduction was significant in one study. The frequency of X-Ray Computed Tomography exposure was proportional to the risk of developing Neoplasms in two studies although not significantly maintained in two other studies. , RESULTS: The overall risk was not significantly different in the two cohorts (incidence rate=36.72 per 100 000 person-years in the exposed cohort, 28.48 per 100 000 person-years in the unexposed cohort, hazard ratio (HR)=1.29, 95% confidence interval (CI)=0.90-1.85). The risk of benign Head>Brain tumour was significantly higher in the exposed cohort than in the unexposed cohort (HR=2.97, 95% CI=1.49-5.93). The frequency of X-Ray Computed Tomography examination showed strong correlation with the subsequent overall risk of Primary malignant neoplasm and benign Head>Brain tumour.CONCLUSIONS: We found that paediatric Head - Component of Device X-Ray Computed Tomography examination was associated with an increased incidence of benign Head>Brain tumour., CONCLUSIONS: We found evidence that X-Ray Computed Tomography-related radiation exposure increases Brain Neoplasms risk. , Compared with the general population, incidence of Head>Brain Neoplasms was higher in the cohort of children with X-Ray Computed Tomography scans, requiring cautious interpretation of the findings., BACKGROUND: Recent studies linking radiation exposure from pediatric computed tomography (X-Ray Computed Tomography) to increased risks of leukemia and Head>Brain Neoplasms lacked data to control for cancer susceptibility syndromes (CSS). , IMPACT: Future studies should identify Tuberous Sclerosis patients in order to avoid overestimation of Brain Neoplasms risks due to radiation exposure from X-Ray Computed Tomography scans., The radiation-induced occurrence of Meningioma and other Head>Brain tumours most probably contributes to the continuously increasing incidence of these diseases which is observed in several industrial nations, as well as the exposure of the bone marrow by X-Ray Computed Tomography to the increase of childhood leukemia., 1,000 annual paediatric X-Ray Computed Tomography investigations of the Bone structure of cranium will lead to about 3 excess neoplasms in the Head - Component of Device region, i.e., the probability of an induced late effect must be suspected in the range of some thousandths. [SEP]Relations: malignant ear neoplasm has relations: disease_disease with Head - Component of Device and neck cancer, disease_disease with Head - Component of Device and neck cancer. tuberous sclerosis has relations: disease_disease with polymalformative genetic syndrome with increased risk of developing cancer, disease_disease with polymalformative genetic syndrome with increased risk of developing cancer. Brain neoplasm has relations: drug_effect with Carmustine, drug_effect with Carmustine. benign neoplasm of Head>Brain has relations: disease_disease with intracranial hemangioma, disease_disease with intracranial hemangioma, disease_protein with PTCH1, disease_protein with PTCH1. Definitions: leukemia defined as following: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006). Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Meningioma defined as following: A relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular Neoplasms which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7). Brain Neoplasms defined as following: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, Head>Brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from Head>Brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, Head>Brain Neoplasms may also be classified by age of onset, histologic type, or presenting location in the Head>Brain.. Glioma defined as following: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21). Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Benign Meningioma defined as following: A grade I, slowly growing Benign Meningioma. Only a minority of Neoplasms recur following complete resection.. Head - Component of Device defined as following: A projection on the end of an object. Tuberous Sclerosis defined as following: Autosomal dominant neurocutaneous syndrome classically characterized by MENTAL RETARDATION; EPILEPSY; and skin lesions (e.g., adenoma sebaceum and hypomelanotic macules). There is, however, considerable heterogeneity in the neurologic manifestations. It is also associated with cortical tuber and HAMARTOMAS formation throughout the body, especially the heart, kidneys, and eyes. Mutations in two loci TSC1 and TSC2 that encode hamartin and tuberin, respectively, are associated with the disease.. Head - Component of Device region defined as following: subdivision of cardinal body part, each instance of which is a regional part of some Head - Component of Device. Examples: face, nose, mouth.. benign Head>Brain tumour defined as following: A primary, slow growing, noninvasive neoplasm of the Head>Brain. In children, astrocytomas of the cerebellum represent relatively common benign Head>Brain neoplasms. In adults Meningioma, neurilemomas and pituitary Neoplasms comprise the majority of benign Neoplasms.. Bone structure of cranium defined as following: The SKELETON of the HEAD including the FACIAL BONES and the bones enclosing the BRAIN.. X-Ray Computed Tomography defined as following: Tomography using x-ray transmission and a computer algorithm to reconstruct the image..", "label": "yes"} {"original_question": "Is Propofol used for short-term sedation?", "id": "converted_1052", "sentence1": "Is propofol used for short-term sedation?", "sentence2": "The current study explores the incidence and content of dreaming during short-term sedation with sevoflurane or propofo, propofol is the sedative most frequently used for short-term sedation and the weaning phase, whereas Benzodiazepines are the preferred Substance for medium- and long-term sedation., Performance of the A-line Autoregressive Index (AAI) and of the Bispectral Index (BIS) at assessing depth of short-term sedation following cardiac surgery., All patients received sedation with propofol according to the study protocol., Short-term sedation with either sevoflurane using ACD or propofol did not negatively affect renal function postoperatively., Assessing feasibility and physiological effects of sedation with sevoflurane, administered with the anesthetic conserving device (Anaconda), in comparison with propofol and remifentanil., Sevoflurane can be effectively and safely used for short-term sedation of ICU patients with stable hemodynamic conditions., propofol was used for most of the patients during short-term sedation (57%) and during weaning (48%)., Effects of short-term propofol administration on Pancreatic enzyme and triglyceride levels in children., This prospective, clinical trial evaluated the effects of short-term propofol administration on triglyceride levels and serum Pancreatic enzyme in children undergoing sedation for magnetic resonance imaging., dexmedetomidine vs. propofol for short-term sedation of postoperative mechanically ventilated patients., The aim of this study was to compare the efficacy and endocrine response of propofol vs. the new alpha2-agonist dexmedetomidine for sedation in surgical intensive care patients who need postoperative short-term ventilation., A total of 89 adult, nonemergent, coronary artery bypass graft patients with an expected length of intubation of <24 hrs. METHODS: Patients were randomized to either AUTOINFLAMMATORY SYNDROME, FAMILIAL, X-LINKED, BEHCET-LIKE 2 or propofol, The majority of practitioners (82%) use propofol infusion in children in Picus, the main indication being for short-term sedation in children requiring procedures., Pharmacokinetics and effects of propofol 6% for short-term sedation in paediatric patients following cardiac surgery., This paper describes the pharmacokinetics and effects of propofol in short-term sedated paediatric patients., Twenty patients who were expected to require 8 h of post-operative sedation and ventilation were allocated randomly to receive either an infusion of dexmedetomidine 0.2-2.5 microg kg(-1) h(-1) or propofol 1-3 mg kg(-1) h(-1), Pharmacokinetics and pharmacodynamics of propofol 6% SAZN versus propofol 1% SAZN and Diprivan-10 for short-term sedation following coronary artery bypass surgery., The pharmacokinetics, pharmacodynamics and safety characteristics of propofol 6% SAZN were investigated during a short-term infusion and compared with the commercially available product propofol 1% in Intralipid 10% (Diprivan-10) and propofol 1% in Lipofundin MCT/LCT 10% (propofol 1% SAZN). METHODS: In a randomised double-blind study, 24 male patients received a 5-h infusion of propofol at the rate of 1 mg/kg/h for sedation in the immediate postoperative period following coronary artery bypass surgery, propofol infusion and oxycodone-thiopental bolus dosages, titrated to the same sedation end point, resulted in similar time from admission to extubation, although the weaning period was shorter in the propofol group. In terms of breathing pattern, gas exchange, blood gases and haemodynamics, the methods were similar. propofol, despite its attractive pharmacological profile, may offer no clinical benefit in short-term sedation after a moderate dose fentanyl anaesthesia in cardiac surgery., Postoperative short-term sedation with propofol in cardiac surgery., We conducted a randomized double-blind study to assess the safety and effectiveness of short-term sedation with propofol in adult patients immediately after cardiac surgery., The use of propofol for short-term sedation in ICUs has allowed the maintenance of sedation to continue until just a few hours before extubation but the benefits of propofol for longer-term indications are more debatable., Midazolam and propofol are available as hypnotics for short-term sedation during the post-operative period., The use of midazolam versus propofol for short-term sedation following coronary artery bypass grafting., Midazolam and propofol were compared in an open randomized study for postoperative sedation during 12 h of mechanical ventilation in 40 patients following coronary artery bypass grafting, propofol is a known anesthetic agent, widely used for short-term anesthesia and for longer-term sedation., propofol was the most commonly used agent overall during the observational period (primarily for short-term and intermediate-length sedation); midazolam was the most commonly used for long-term sedation.[SEP]Relations: propofol has relations: drug_drug with Selegiline, drug_drug with Selegiline, contraindication with epilepsy, contraindication with epilepsy, drug_drug with Propacetamol, drug_drug with Propacetamol, drug_drug with Propanidid, drug_drug with Propanidid, drug_drug with Diamorphine, drug_drug with Diamorphine. Definitions: propofol defined as following: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). propofol has been used as ANTICONVULSANTS and ANTIEMETICS.. sevoflurane defined as following: A fluorinated isopropyl ether with general anesthetic property. Although the mechanism of action has not been fully elucidated, sevoflurane may act by interfering with the release and re-uptake of neurotransmitters at post-synaptic terminals, and/or alter ionic conductance following receptor activation by a neurotransmitter. Sevoflurane may also interact directly with lipid matrix of neuronal membranes, thereby affecting gating properties of ion channels. In addition, this agent may activate gamma-aminobutyric acid (GABA) receptors hyperpolarizing cell membranes. This results in a general anesthetic effect, a decrease in myocardial contractility and mean arterial pressure as well as an increased respiratory rate.. remifentanil defined as following: A piperidine-propionate derivative and opioid analgesic structurally related to FENTANYL. It functions as a short-acting MU OPIOID RECEPTOR agonist, and is used as an analgesic during induction or maintenance of general anesthesia, following surgery, during childbirth, and in mechanically ventilated patients under intensive care.. midazolam defined as following: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.. dexmedetomidine defined as following: An imidazole derivate and active d-isomer of medetomidine with analgesic, anxiolytic and sedative properties. dexmedetomidine selectively binds to presynaptic alpha-2 adrenoceptors located in the brain, thereby inhibiting the release of norepinephrine from synaptic vesicles. This leads to an inhibition of postsynaptic activation of adrenoceptors, which inhibit sympathetic activity, thereby leading to sedation and anxiolysis. The analgesic effect of this agent is mediated by binding to alpha-2 adrenoceptors in the spinal cord.. Benzodiazepines defined as following: A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring.. Pancreatic enzyme defined as following: Pancreatic enzymes are comprised primarily of proteases, lipase and amylase that catalyze the breakdown of fats, carbohydrates and proteins during the digestion of food. However, the pancreas also produces many other digestive enzymes such as ribonuclease, deoxyribonuclease, gelatinase and elastase.. Substance defined as following: Any matter of defined composition that has discrete existence, whose origin may be biological, mineral or chemical..", "label": "yes"} {"original_question": "Is there an association between c-reactive protein concentrations and outcomes of subarachnoid hemorrhage patients? ", "id": "converted_1383", "sentence1": "Is there an association between c-reactive protein concentrations and outcomes of Subarachnoid Hemorrhage patients? ", "sentence2": "Besides the baseline characteristics, daily interleukin-6 (Recombinant Interleukin-6), procalcitonin, C-reactive protein levels, and leukocyte counts were prospectively measured until day 14 after Subarachnoid Hemorrhage. Occurrence of infectious complications and application of therapeutic Hypothermia due to exposure were assessed as confounding factors. The primary end point was outcome after 3 months, assessed by Glasgow Outcome Scale; the secondary end point was the occurrence of DINDs. RESULTS: : During a 3-year period, a total of 138 patients were included. All inflammatory parameters measured were higher in patients with unfavorable outcome (Glasgow Outcome Scale score, 1-3)., Twenty-three and 28 patients showed poor outcome and symptomatic Vasospasm after Yakut language, respectively. Both preoperative and postoperative CRP levels were significantly higher in patients with a poor outcome compared with patients with a good outcome (P<0.05)., e area under the receiver operating characteristic curve of CRP measured on postoperative day 1 or 2 (CRP POD1-2) for predicting a poor clinical outcome was 0.870, and its cutoff point of 4 mg/dL had a sensitivity of 0.826 and a specificity of 0.843., A high CRP level after Aneurysm treatment was associated with severe Progressive neurologic deterioration on admission, Cerebral Infarction, Cerebral Hemorrhage, and surgical decompression (P<0.05)., CRP POD1-2, and not the preoperative CRP, was an independent factor in predicting symptomatic Vasospasm (P<0.05). In patients with symptomatic Vasospasm, an increase in the postoperative CRP was associated with the time profile of developing symptomatic Vasospasm., Postoperative CRP, especially CRP POD1-2, can be a useful prognostic factor for both poor outcome and symptomatic Vasospasm in patients with aneurysmal Yakut language., Serum CRP levels were related to severity of ASAH1 wt Allele. Patients with lower GCS scores and higher Hunt and Hess and Fisher grades presented statistically significant higher serum CRP levels. Patients with higher serum CRP levels had a less favorable prognosis., Increased serum CRP levels were strongly associated with worse clinical prognosis in this study., After Yakut language, the value of C-reactive protein (CRP)--an acute phase sensitive inflammatory marker--as a prognostic factor has been poorly studied, with conflicting results., Admission (18.0 ± 35.7 vs 8.5 ± 8.4 mg/l) and postoperative (41.0 ± 40.2 vs 21.1 ± 24.1 mg/l) CRP levels were higher (p < 0.001) in those with a poor outcome than in those with a favourable outcome, but CRP values did not predict delayed cerebral ischaemia or Cerebral Infarction., Higher increase in CRP level between admission and postoperative morning, however, independently predicted poor outcome (p = 0.004)., CRP levels correlate with outcome but do not seem to predict delayed cerebral ischaemia or Infarction after Yakut language., Systemic oxygen consumption is associated with hsCRP levels in the first 14 days after Yakut language and is an independent predictor of Noninfiltrating Intraductal Carcinoma., Intracranial hypertension was associated with an inflammatory response, indicating activation of the inflammatory cascade in the Head>Brain (ECF) and systemic circulation with high Recombinant Interleukin-6 and C-reactive protein (CRP) plasma levels after Yakut language, the latter associated with unfavourable outcome., Patients with angiographic Vasospasm had higher CRP measurements in serum and Cerebrospinal Fluid, in a statistically significant fashion (p < 0.0001). Additionally, patients with higher CRP levels in serum and Cerebrospinal Fluid had less favorable outcome in this cohort., Furthermore, patients developing angiographically proven Vasospasm demonstrated significantly elevated CRP levels in serum and Cerebrospinal Fluid, and increased CRP measurements were strongly associated with poor clinical outcome in this cohort., Finally, serum concentrations of Intercellular adhesion molecule 1, Vascular Cell Adhesion Molecule-1, and hsCRP during the early (P = .0055, P = .0266, and P = .0266) and late (P = .0423, P = .0041, and P = .0004) period were significantly higher in patients with DIND than in patients without DIND. CONCLUSIONS: Serum levels of Intercellular adhesion molecule 1, Vascular Cell Adhesion Molecule-1 and hsCRP during the early and late period following Yakut language correlate with DIND, CRP levels on days 5, 6, 7, and 8 were statistically significantly higher in the group of patients developing a DIND (P < 0.025, P < 0.016, P < 0.011, P < 0.0002)., Overall CRP values were higher with increasing severity of the initial ictus according to the Hunt and Hess Scale and to the outcome according to the Glasgow Outcome Scale from day 3 on., The presented data do not prove that Leukocytes and CRP values have a direct contribution to the pathogenesis of ischemic complications following Yakut language, but it supports the assertion that Inflammation may present a common pathogenic pathway in the development of such complications., The CRP and transforming growth factor beta 1 levels in Cerebrospinal Fluid are strongly concerned with communicating Hydrocephalus after Yakut language.[SEP]Relations: Subarachnoid Hemorrhage (disease) has relations: disease_protein with PPARG, disease_protein with PPARG, disease_protein with EDNRB, disease_protein with EDNRB, disease_protein with UNC5B, disease_protein with UNC5B, disease_protein with CASP3, disease_protein with CASP3, disease_protein with ADORA1, disease_protein with ADORA1. Definitions: Noninfiltrating Intraductal Carcinoma defined as following: A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.. C-reactive protein defined as following: A plasma protein that circulates in increased amounts during Inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP).. Aneurysm defined as following: Pathological outpouching or sac-like dilatation in the wall of any blood vessel (ARTERIES or VEINS) or the heart (HEART ANEURYSM). It indicates a thin and weakened area in the wall which may later rupture. Aneurysms are classified by location, etiology, or other characteristics.. Subarachnoid Hemorrhage defined as following: Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.. Cerebral Infarction defined as following: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe Infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic Infarction).. Intercellular adhesion molecule 1 defined as following: A cell-surface ligand involved in leukocyte adhesion and Inflammation. Its production is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue.. Recombinant Interleukin-6 defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin-6 (Recombinant Interleukin-6) with antiapoptotic, proinflammatory, antiinflammatory, proproliferative and proangiogenic activities. Recombinant Interleukin-6 binds to its receptor (IL-6R), activating a receptor-CD130 receptor complex; the CD130 portion of the complex is a signal transduction protein that activates JAK kinases and Ras-mediated signaling pathways, which in turn activate downstream signaling pathways, resulting in the activation of various transcription factors (STAT, ELK-1, NF-Recombinant Interleukin-6, etc.) and gene transcription. The physiological effects of Recombinant Interleukin-6 are complex and varied and include hematopoietic, pyrogenic and thermogenic, proinflammatory, antiinflammatory, proproliferative (anti-apoptotic), and angiogenic effects.. Vascular Cell Adhesion Molecule-1 defined as following: Cytokine-induced cell adhesion molecule present on activated endothelial cells, tissue macrophages, dendritic cells, bone marrow fibroblasts, myoblasts, and myotubes. It is important for the recruitment of leukocytes to sites of Inflammation. (From Pigott & Power, The Adhesion Molecule FactsBook, 1993, p154). Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. Cerebrospinal Fluid defined as following: A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES.. Yakut language defined as following: A Turkic language spoken by the Yakut people in the Sakha Republic in the Russian Federation.. transforming growth factor beta 1 defined as following: A subtype of transforming growth factor beta that is synthesized by a wide variety of cells. It is synthesized as a precursor molecule that is cleaved to form mature TGF-beta 1 and transforming growth factor beta 1 latency-associated peptide. The association of the cleavage products results in the formation a latent protein which must be activated to bind its receptor. Defects in the gene that encodes transforming growth factor beta 1 are the cause of CAMURATI-ENGELMANN SYNDROME.. Infarction defined as following: Formation of an infarct, which is NECROSIS in tissue due to local ISCHEMIA resulting from obstruction of BLOOD CIRCULATION, most commonly by a THROMBUS or EMBOLUS.. procalcitonin defined as following: A peptide prohormone precursor of CALCITONIN. It is normally present at low levels in serum, but is released into the bloodstream, primarily from neuroendocrine cells in the lungs and intestines, in response to INFLAMMATION and BACTERIAL INFECTIONS. It is a diagnostic marker for BACTEREMIA.. ASAH1 wt Allele defined as following: Human ASAH1 wild-type allele is located in the vicinity 8p22 of and is approximately 29 kb in length. This allele, which encodes acid ceramidase protein, is involved in ceramide metabolism. Mutation of the gene is associated with both Farber lipogranulomatosis and spinal muscular atrophy with progressive myoclonic epilepsy.. Hydrocephalus defined as following: Excessive accumulation of cerebrospinal fluid within the cranium which may be associated with dilation of cerebral ventricles, INTRACRANIAL HYPERTENSION; HEADACHE; lethargy; URINARY INCONTINENCE; and ATAXIA.. Hypothermia due to exposure defined as following:

Cold weather can affect your body in different ways. You can get frostbite, which is an injury to the body that is caused by freezing. Your body can also lose heat faster than you can produce it. That can cause Hypothermia due to exposure, or abnormally low body temperature. It can make you sleepy, confused, and clumsy. Because it happens gradually and affects your thinking, you may not realize you need help. That makes it especially dangerous. A body temperature below 95 °F (35 °C) is a medical emergency and can lead to death if not treated promptly.

Anyone who spends much time outdoors in cold weather can get Hypothermia due to exposure. You can also get it from being cold and wet, or under cold water for too long. Babies and old people are especially at risk. Babies can get it from sleeping in a cold room.

Centers for Disease Control and Prevention

. Leukocytes defined as following: White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES).. Cerebral Hemorrhage defined as following: Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA.. Vasospasm defined as following: spasm of the blood vessels resulting in decrease in their caliber.. c-reactive protein defined as following: A plasma protein that circulates in increased amounts during Inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP)..", "label": "yes"} {"original_question": "Is Cryptococcus neoformans a frequent cause of isolated skin infections in immunocompromised individuals", "id": "converted_2096", "sentence1": "Is Cryptococcus neoformans a frequent cause of isolated Skin Specimen Source Code Infections of musculoskeletal system in immunocompromised individuals", "sentence2": " Cryptococcus is an opportunistic Saccharomyces cerevisiae with a worldwide distribution that primarily causes significant Infections of musculoskeletal system in immunocompromised individuals, generally by affecting the respiratory tract. But primary cutaneous cryptococcosis (1-piperidinocyclohexanecarbonitrile) without Sepsis is rare. , Cryptococcus is a ubiquitous fungus and is known for causing Meningitis and cutaneous Infections of musculoskeletal system in immunocompromised individuals., Cryptococcus neoformans is an encapsulated Saccharomyces cerevisiae that can cause primary pulmonary Infections of musculoskeletal system or disseminate and cause Infections of musculoskeletal system of the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS, Meninges, Skin Specimen Source Code, and Specimen Type - Bone in the immunocompromised host., The authors report a male patient, a seller with no detected immunosuppression, with an extensive ulcerated Skin Specimen Source Code lesion localized on the left forearm, caused by Cryptococcus neoformans var.[SEP]Relations: Recurrent Skin Specimen Source Code Infections of musculoskeletal system has relations: phenotype_phenotype with Recurrent bacterial Skin Specimen Source Code Infections of musculoskeletal system, phenotype_phenotype with Recurrent bacterial Skin Specimen Source Code Infections of musculoskeletal system, phenotype_phenotype with Recurrent viral Skin Specimen Source Code Infections of musculoskeletal system, phenotype_phenotype with Recurrent viral Skin Specimen Source Code Infections of musculoskeletal system, phenotype_phenotype with Recurrent cutaneous fungal Infections of musculoskeletal system, phenotype_phenotype with Recurrent cutaneous fungal Infections of musculoskeletal system, disease_phenotype_positive with immunodeficiency, disease_phenotype_positive with immunodeficiency, disease_phenotype_positive with acquired ichthyosis, disease_phenotype_positive with acquired ichthyosis. Definitions: Saccharomyces cerevisiae defined as following: A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" Saccharomyces cerevisiae. The dried form is used as a dietary supplement.. Cryptococcus neoformans defined as following: An acute or chronic, localized or disseminated infection by Cryptococcus neoformans. Sites of involvement include the lungs, CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS and Meninges, Skin Specimen Source Code, and visceral organs.--2004. Sepsis defined as following: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.. Meningitis defined as following: Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6). Meninges defined as following: The three membranes that cover the BRAIN and the SPINAL CORD. They are the dura mater, the arachnoid, and the pia mater.. cutaneous Infections of musculoskeletal system defined as following: Infections of the Skin Specimen Source Code that happen multiple times. [HPO:curators]. Skin Specimen Source Code Infections of musculoskeletal system defined as following: Skin diseases caused by bacteria, fungi, parasites, or viruses..", "label": "no"} {"original_question": "Is marijuana use associated with increased risk for stroke?", "id": "converted_1717", "sentence1": "Is Marijuana Abuse use associated with increased risk for Cerebrovascular accident?", "sentence2": "The illicit drugs more commonly associated with Cerebrovascular accident are psychomotor stimulants, such as amphetamine and cocaine. Less commonly implicated are Analgesics, Opioid and psychotomimetic drugs, including cannabis., Among 326 patients (184 males), the most frequent Cerebrovascular accident risk factors overall were Dyslipidemias (187), Location characteristic ID - Smoking (161), Hypertensive disease (105) and BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 (92). Fifty-one patients used illicit drugs, mostly comprising Marijuana Abuse and Amphetamines., Patients in Adelaide are more likely to be obese, to be misusing Marijuana Abuse and Amphetamines, to suffer a cardioembolic event and to have a Cerebrovascular accident that concurrently affects both the Adenohypophyseal Diseases and posterior cerebral circulation., Reversible cerebral vasoconstriction syndrome was spontaneous in 37% of patients and secondary in the 63% others, to postpartum in 5 and to exposure to various vasoactive substances in 37, mainly cannabis, selective serotonin-recapture inhibitors and nasal decongestants., We reported two cases of young Cerebrovascular accident associated with Pharmacologic Substance misuse. Case 1 used amphetamine, cocaine, Marijuana Abuse and Lysergic Acid Diethylamide for few yaers, and developed occlusion of a middle cerebral artery. Case 2 presented Aphasia shortly after Marijuana Abuse Location characteristic ID - Smoking., Marijuana may have accelerated Cerebrovascular accident onset, but essential cause of Cerebrovascular accident in this case must be protein S mutation., Cannabis is the most widely consumed among the illicit drugs worldwide, but it has only exceptionally been associated to Cerebrovascular Disorders., We here describe 2 young patients (26 and 29 years, respectively) who suffered from ischemic Cerebrovascular accident in temporal relation with cannabis consumption., The review of the literature on this topic reveals another 18 patients with Cerebrovascular accident in association to cannabis use., Although a causal relationship is difficult to establish due to the widespread use of cannabis, this Pharmacologic Substance may play an etiologic role in ischemic Cerebrovascular accident., Marijuana may trigger a Myocardial infarction:Finding:Point in time:^Patient:Ordinal and have a vasospastic effect., Despite the fact that cannabis is the most widely used illicit Pharmacologic Substance, there are only a few reports associating its use with Cerebrovascular Disorders., We describe a patient who suffered three ischaemic strokes immediately after cannabis consumption., Cannabis use may be associated with Ischemic Cerebrovascular accident in young patients, but its mechanism is unclear., A right occipital ischemic Cerebrovascular accident occurred in a 37-year-old Albanese Homo sapiens with a previously uneventful medical history, 15 min after having smoked a cigarette with approximately 250 mg of Marijuana Abuse., Therefore, as the family history for Cerebrovascular events, blood pressure, clotting tests, examinations for Thrombophilia, Vasculitis, Extracranial and intracranial arteries and cardiac investigations were normal or respectively negative, the Cerebrovascular accident was attributed to the chronic cannabis consumption., Three adolescent males had similar presentations of Headache, fluctuating level of consciousness or lethargy, Visual disturbance, and variable Cerebellar Ataxia after self-administration of Marijuana Abuse., Episodic Marijuana Abuse use may represent a risk factor for Cerebrovascular accident in childhood, particularly in the posterior circulation., Although several mechanisms exist by which Marijuana Abuse use might contribute to the development of chronic Cardiovascular system conditions or acutely trigger Cardiovascular system events, there are few data regarding Marijuana Abuse/THC use and Cardiovascular Diseases outcomes., Reported here is the case of a previously healthy young Homo sapiens who smoked Marijuana Abuse on a daily basis and had an occipital lobe Cerebrovascular accident; he was found to be heterozygous for factor V Leiden., This case suggests that Marijuana Abuse Location characteristic ID - Smoking may increase the risk of arterial thrombosis in otherwise healthy individuals who are heterozygous for factor V Leiden., Thus, chronic abuse of Marijuana Abuse might be a risk factor for Cerebrovascular accident., A 22-year-old Homo sapiens with a five-year history of Pharmacologic Substance and Actual Positive Absence Of Alcohol Use presented with a Left hemiparesis preceded by three transient ischaemic attacks, two of which occurred whilst Location characteristic ID - Smoking cannabis. Substance of abuse was the only identifiable risk factor for Cerebrovascular Disorders., Chronic Marijuana Abuse Location characteristic ID - Smoking, however, seems to reduce Core-Binding Factor., Research directions might include more studies of Cardiovascular Diseases outcomes and relationships of Marijuana Abuse with Cardiovascular system risk factors, studies of metabolic and physiologic effects of chronic Marijuana Abuse use that may affect Cardiovascular Diseases risk, increased understanding of the role of the cannabinoid receptor system in Cardiovascular system regulation, and studies to determine if there is a therapeutic role for Cannabinoids in blood pressure control or for neuroprotection after Cerebrovascular accident.[SEP]Relations: Amphetamine has relations: contraindication with Cerebrovascular accident disorder, contraindication with Cerebrovascular accident disorder, contraindication with Cardiovascular Diseases, contraindication with Cardiovascular Diseases. Ischemic Cerebrovascular accident has relations: disease_phenotype_positive with cocaine intoxication, disease_phenotype_positive with cocaine intoxication, drug_effect with Tramadol, drug_effect with Tramadol, drug_effect with Ramipril, drug_effect with Ramipril. Definitions: Amphetamines defined as following: Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.. Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Analgesics, Opioid defined as following: Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS.. Visual disturbance defined as following: An interference to normal eyesight.. Reversible cerebral vasoconstriction syndrome defined as following: Syndrome is characterized by severe headaches, with or without other acute neurological symptoms, and diffuse segmental constriction of cerebral arteries that resolves spontaneously within 3 months.. Marijuana Abuse defined as following: Use of Marijuana Abuse associated with abnormal psychological, social, and or occupational functioning.. Hypertensive disease defined as following: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), Hypertensive disease is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.. Cerebellar Ataxia defined as following: Incoordination of voluntary movements that occur as a manifestation of CEREBELLAR DISEASES. Characteristic features include a tendency for limb movements to overshoot or undershoot a target (dysmetria), a tremor that occurs during attempted movements (intention TREMOR), impaired force and rhythm of diadochokinesis (rapidly alternating movements), and GAIT ATAXIA. (From Adams et al., Principles of Neurology, 6th ed, p90). Lysergic Acid Diethylamide defined as following: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.. Homo sapiens defined as following: Members of the species Homo sapiens.. Ischemic Cerebrovascular accident defined as following: An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue.. Cardiovascular Diseases defined as following: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.. Cardiovascular system defined as following: The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body.. Headache defined as following: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.. Vasculitis defined as following: Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body.. Aphasia defined as following: A cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form. This condition is caused by diseases which affect the language areas of the dominant hemisphere. Clinical features are used to classify the various subtypes of this condition. General categories include receptive, expressive, and mixed forms of Aphasia.. Cannabinoids defined as following: Compounds having the cannabinoid structure. They were originally extracted from Cannabis sativa L. The most pharmacologically active constituents are TETRAHYDROCANNABINOL; CANNABINOL; and CANNABIDIOL.. Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810). Cerebrovascular Disorders defined as following: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.. Core-Binding Factor defined as following: Core-Binding Factor is an alpha/beta heterodimeric transcription factor involved in the transcriptional regulation of several genes important in hematopoiesis. The CBFalpha subunit binds directly to the enhancer core DNA sequence on target genes, whereas the beta subunit does not bind the DNA directly but increases the affinity and stabilizes the binding of the alpha subunit to the DNA.. Thrombophilia defined as following: A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS.. cocaine defined as following: An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the Amphetamines and is a Pharmacologic Substance of abuse. Cocaine, like Amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake.. Substance of abuse defined as following: Any substance, including any illegal, prescription, over-the-counter agent or any other compound, used for the purpose other than indicated or used in quantities other than directed. Substances from various Pharmacologic Substance classes can be abused, such as Analgesics, Opioid, Amphetamines, analgesics, benzodiazepines, barbiturates, hallucinogens, steroids, tobacco products and alcoholic substances. A substance of abuse may act on the central nervous system (CNS) or can have an effect in other parts of the body and can lead to physical and/or physiological dependence.. Dyslipidemias defined as following: A lipoprotein metabolism disorder characterized by decreased levels of high-density lipoproteins, or elevated levels of plasma cholesterol, low-density lipoproteins and/or triglycerides.. Cerebrovascular defined as following: Relating to the brain and the blood vessels that supply it..", "label": "yes"} {"original_question": "Is Phospholemman a membrane protein?", "id": "converted_4478", "sentence1": "Is Phospholemman a membrane Protein Info?", "sentence2": " the transmembrane lipoprotein phospholemman (FXYD1 gene Genes), Phospholemman (FXYD1 gene Genes) is a single-transmembrane Protein Info regulator of Nadia - zebrafish,K-ATPase, expressed strongly in Chest>Heart, Specimen Source Codes - Skeletal muscle, and Head>Brain and phosphorylated by Protein Info kinases A and C at Ser-68 and Ser-63, respectively., We previously identified FXYD1 gene Genes (encoding phospholemman; a Protein Info containing the motif phenylalanine-X-tyrosine-aspartate), a Genes encoding a transmembrane modulator of the Nadia - zebrafish, K-ATPase (NKA) enzyme,[SEP]Relations: Protein C has relations: drug_drug with Phenprocoumon, drug_drug with Phenprocoumon, drug_drug with Phenylalanine, drug_drug with Phenylalanine, drug_drug with Phenelzine, drug_drug with Phenelzine, drug_drug with Ceftibuten, drug_drug with Ceftibuten, drug_drug with Melagatran, drug_drug with Melagatran. Definitions: Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Nadia - zebrafish defined as following: A wild-type zebrafish line, the stock of which was obtained from an area east of Calcutta in a district called Nadia.. Protein Info defined as following: Protein; provides access to the encoding Genes via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. membrane Protein Info defined as following: Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors..", "label": "yes"} {"original_question": "Is obesity related to cognitive decline?", "id": "converted_2834", "sentence1": "Is obesity related to Mental deterioration?", "sentence2": "The initial results suggests that obese children have higher cognitive scores and that this result is driven by those who are female, non-indigenous and live in an urban region., On the other end of the weight distribution, indigenous children who are severely Thin (qualifier value) or Thin (qualifier value) have significantly lower cognitive scores, a relationship that holds after correcting for possible bias and appears to strengthen between ages of five and eight., BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 is associated with decreased cognitive function, reduced gray matter volume, and impaired white matter integrity in cognition-related brain areas in patients with Major Depressive Disorder., The data suggest that being Overweight or obese in midlife may be more detrimental to subsequent age-related Mental deterioration than being Overweight or obese at later stages of the life span, Poor cognitive performance was present in 37% of the sample. General obesity (BMI>or = 25) and poor cognition were strongly associated in the presence of BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, Abdominal. Poor cognition was negatively associated with Overweight (BMI 23-25) with normal waist circumference., BMI could be used as a candidate risk marker to identify people at higher risk of Cognition Disorders, and as an intervention target for modifications of cognitive outcomes., BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 is a common medical illness that is increasingly recognised as conferring risk of decline in cognitive performance, independent of other comorbid medical conditions., Overweight and obesity are associated with an increased risk of subnormal intellectual performance in young adult males. Subjects with low birth weight and adolescent Overweight/obesity are at particular risk of subnormal performance., Impairments in cognitive function have been associated with obesity in both people and Rodent., BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 in the pre-school years was associated with poorer outcomes for some cognitive measures in this study. Stronger relationships between obesity and cognition or educational attainment may emerge later in childhood., There is parallel evidence that people who are Overweight or obese tend to perform worse on a variety of cognitive tasks, While research in this area is growing, our knowledge of obesity-related cognitive dysfunction and brain alterations has not yet been synthesized., The present review integrates the recent literature regarding patterns of obesity-related cognitive dysfunction and brain alterations and also indicates potential mechanisms for these neuropathological changes., The review culminates in a preliminary model of obesity-related cognitive dysfunction and suggestions for future research, including the potential reversibility of these changes with weight-loss.
, Evidence for the increased prevalence of Diabetes Mellitus and obesity is reviewed as it relates to Mental deterioration., These articles indicate that the age of onset of Type 1 Diabetes Mellitus may be relevant to future cognitive function and that disease duration of Diabetes Mellitus, Non-Insulin-Dependent and sociocultural factors are related to Mental deterioration during the aging process., This special issue concludes with a conceptual framework for linking obesity and Diabetes Mellitus with accelerated Mental deterioration as related to the aging process., The adverse effects of Diabetes Mellitus and obesity on cognitive functioning are increasingly well recognized., Moreover, these studies show that distressing environmental circumstances can adversely influence Impaired cognition associated with obesity and Diabetes Mellitus.[SEP]Relations: Abdominal obesity has relations: disease_phenotype_positive with obesity disorder, disease_phenotype_positive with obesity disorder, disease_phenotype_positive with agonadism, 46,XY, with intellectual disability, short stature, retarded bone age, and multiple extragenital malformations, disease_phenotype_positive with agonadism, 46,XY, with intellectual disability, short stature, retarded bone age, and multiple extragenital malformations, disease_phenotype_positive with Obesity, Abdominal-metabolic syndrome, disease_phenotype_positive with Obesity, Abdominal-metabolic syndrome, disease_phenotype_positive with X-linked intellectual disability, disease_phenotype_positive with X-linked intellectual disability. cognitive disorder has relations: disease_disease with dementia (disease), disease_disease with dementia (disease). Definitions: Rodent defined as following: A mammalian order which consists of 29 families and many genera.. Major Depressive Disorder defined as following: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5). Diabetes Mellitus, Non-Insulin-Dependent defined as following: A type of Diabetes Mellitus mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.. Obesity, Abdominal defined as following: A condition of having excess fat in the abdomen. Abdominal obesity is typically defined as waist circumferences of 40 inches or more in men and 35 inches or more in women. Abdominal obesity raises the risk of developing disorders, such as DIABETES; HYPERTENSION; and METABOLIC SYNDROME.. Overweight defined as following: A condition in which body mass index falls between 25 and 29.9.. Mental deterioration defined as following: Loss of previously present mental abilities, generally in adults. [HPO:probinson]. Diabetes Mellitus defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.. Cognition Disorders defined as following: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.. Impaired cognition defined as following: Interference or disruption of cognitive processes. This term encompasses a large number of problems and issues associated with intellectual functioning and information processing. 2005. Thin (qualifier value) defined as following: Narrow in width, extent or cross-section..", "label": "yes"} {"original_question": "Are nucleosomes positioned at DNA replication origins?", "id": "converted_1370", "sentence1": "Are Nucleosomes positioned at DNA replication origins?", "sentence2": "yeast origins are characterized by an asymmetric pattern of positioned Nucleosomes flanking the ACS. The origin sequences are sufficient to maintain a nucleosome-free origin; however, origin recognition complex location is required for the precise positioning of Nucleosomes flanking the origin., Here, we identify nucleosome occupancy as a likely candidate to set up Odia Language distribution, we demonstrate that open chromatin domains, characterized by nucleosome depletion, are preferentially permissive for replication, nucleosome assembly of the template prevented DNA replication. Replication of Chromosomes, Human, Pair 1 was severely inhibited at more than two-thirds of physiological nucleosome density[SEP]Relations: nucleosome assembly has relations: bioprocess_bioprocess with DNA replication-dependent nucleosome assembly, bioprocess_bioprocess with DNA replication-dependent nucleosome assembly, bioprocess_protein with SET, bioprocess_protein with SET, bioprocess_bioprocess with DNA replication-independent nucleosome assembly, bioprocess_bioprocess with DNA replication-independent nucleosome assembly, bioprocess_protein with SETSIP, bioprocess_protein with SETSIP, bioprocess_protein with NPM1, bioprocess_protein with NPM1. Definitions: origin recognition complex location defined as following: A multisubunit complex that is located at the replication origins of a chromosome. [GOC:elh]. Odia Language defined as following: An Indo-Aryan language that is spoken mostly in eastern India.. Chromosomes, Human, Pair 1 defined as following: A specific pair of human Chromosomes, Human, Pair 1 in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification.. Nucleosomes defined as following: The repeating structural units of chromatin, each consisting of approximately 200 base pairs of DNA wound around a protein core. This core is composed of the histones H2A, H2B, H3, and H4.. nucleosome assembly defined as following: The aggregation, arrangement and bonding together of a nucleosome, the beadlike structural units of eukaryotic chromatin composed of histones and DNA. [GOC:mah].", "label": "no"} {"original_question": "Is statin use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?", "id": "converted_616", "sentence1": "Is 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition) use associated with improved outcomes after aneurysmal subarachnoid hemorrhage?", "sentence2": "Hydroxymethylglutaryl-CoA Reductase Inhibitors have been shown in two recent small phase I/II trials to be associated with a marked reduction in clinical and transcranial Doppler (TCD) evidence of Vasospasm after aneurysmal Subarachnoid Hemorrhage (Yakut language). , Hydroxymethylglutaryl-CoA Reductase Inhibitors did not result in reduced TCD velocities, clinical or angiographic Vasospasm, or improvements in global outcome at the time of hospital discharge. , There remains significant uncertainty as to the role of statins in preventing Vasospasm after Yakut language., Although the results of 2 randomized clinical trials demonstrated that 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition) decreases the incidence of symptomatic Cerebral Vasospasm after ASAH1 wt Allele, retrospective studies have failed to confirm this., There were no differences in the incidence of symptomatic Vasospasm (25.3 vs 30.5%; p = 0.277), in-hospital mortality rate (18 vs 15%; p = 0.468), length of hospitalization (21 +/- 15 vs 19 +/- 12 days; p = 0.281), or poor outcome at discharge (Glasgow Outcome Scale Scores 1-2: 21.7 vs 18.2%; p = 0.416) between the simvastatin and nonstatin cohorts. , The uniform introduction of simvastatin did not reduce the incidence of symptomatic Cerebral Vasospasm, Cessation of life, or poor outcome in patients with ASAH1 wt Allele. simvastatin was well tolerated, but its benefit may be less than has been previously reported., Cholesterol-reducing agents might improve unfavourable outcomes., We cannot draw any conclusions about the effectiveness and safety of lowering cholesterol in aneurysmal Yakut language because of insufficient reliable evidence from only one small trial., Experimental evidence has indicated the benefit of simvastatin in the treatment of subarachnoid hemorrhage., There was an improvement in the functional outcome in the simvastatin group at 1, 3 or 6 months in the follow-up; however, this difference was not statistically significant., There was benefit of simvastatin in terms of reduction in clinical Vasospasm, mortality or improved functional outcome, however, this was not statistically significant., Cerebral vasomotor reactivity, however, is significantly improved after long-term 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition) administration in most patients with severe small vessel disease, aneurysmal subarachnoid hemorrhage, or impaired baseline CA., atorvastatin decreases computed tomography and S100-assessed brain Ischemia Procedure after Subarachnoid Hemorrhage, Aneurysmal: a comparative study., In the overall population, Cerebral Vasospasm was significantly less common in the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition)-treated group. Severity of Vasospasm, as assessed on the most severe angiogram, was lowered with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition). Hydroxymethylglutaryl-CoA Reductase Inhibitors significantly reduced volume of Ischemia Procedure in patients with Vasospasm and an uncomplicated coiling procedure. S100B gene gene levels were significantly lower in 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition)-treated patients, and the decrease was greatest among high-grade patients (World Federation of Neurological Surgeons 3-5). No differences were found between 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition)-treated and untreated groups regarding rescue therapy intensity or 1-yr clinical outcomes., atorvastatin reduces the incidence, the severity and the ischemic consequences of Vasospasm as assessed on computed tomography. In high-grade World Federation of Neurological Surgeons patients, atorvastatin decreases serum levels of S100B gene gene, a biomarker of brain Ischemia Procedure. Despite these positive effects on biomarkers, no improvement of outcome was seen in the overall population, although there was a tendency for a better clinical outcome in high-grade patients., 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, or statins, have been associated with improved clinical outcomes after ischemic stroke and subarachnoid hemorrhage, but with an increased risk of incidental spontaneous intracerebral hemorrhage (HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO)., Hydroxymethylglutaryl-CoA Reductase Inhibitors are known to have pleiotropic vascular effects, some of which may interrupt the pathogenesis of 4,4'-dinitro-2,2'-stilbenedisulfonic acid. Based on promising preliminary reports, many clinicians routinely administer statins to prevent 4,4'-dinitro-2,2'-stilbenedisulfonic acid., However, observational studies have not revealed an association between 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition)-use and reduced 4,4'-dinitro-2,2'-stilbenedisulfonic acid or improved neurological outcomes. Results of RCTs have been inconsistent and limited by small sample size, but together suggest that statins may reduce 4,4'-dinitro-2,2'-stilbenedisulfonic acid, with no clear impact on mortality or neurological recovery., the role of statins in the management of patients with Yakut language remains unclear. Although promising, statins should not, at this time, be considered standard care., In patients with Yakut language, they may decrease the incidence of symptomatic Vasospasm, although the effects on overall outcome are less clear., Hydroxymethylglutaryl-CoA Reductase Inhibitors treatment may have potential clinical impact in Vascular Diseases beyond cholesterol lowering. Its benefits have been documented in Cerebral Ischemia and in Subarachnoid Hemorrhage., A recent meta-analysis investigating the efficacy of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition) treatment in patients with aneurysmal subarachnoid hemorrhage reported a reduced incidence of Vasospasm, delayed cerebral Ischemia Procedure, and mortality in 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition)-treated patients., The results of the present systematic review do not lend statistically significant support to the finding of a beneficial effect of statins in patients with aneurysmal subarachnoid hemorrhage as reported in a previous meta-analysis., Pre-treatment with cholesterol lowering drugs of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition) family may exert protective effects in patients with Ischemic stroke and Subarachnoid Hemorrhage but their effects are not clear in patients with Cerebral Hemorrhage (HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO). , Recently, two randomized controlled phase II studies showed that acute initiation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition) treatment directly after aneurysmal subarachnoid hemorrhage (Yakut language) decreases the incidence of radiologic Vasospasm and clinical signs of delayed cerebral Ischemia Procedure (Noninfiltrating Intraductal Carcinoma), and even reduces mortality., We conclude that both the primary and secondary outcome results of this study do not support a beneficial effect of simvastatin in patients with Yakut language., Novel uses of their anti-inflammatory properties in Sepsis (Invertebrate) and vasomotor properties in Subarachnoid Hemorrhage are being further investigated by randomised trials., A trend towards a lower mortality within 14 days in patients receiving solely simvastatin and those receiving 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition) and Magnesium supplements, alimentary tract and metabolism as compared with the control group was found. , Initiation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition) therapy after aneurysmal Yakut language significantly reduces the incidence of Vasospasm, delayed ischemic deficits, and mortality., The addition of statins to standard care was not associated with any reduction in the development of Vasospasm or improvement in outcomes after aneurysmal subarachnoid hemorrhage. , We have previously demonstrated that acute pravastatin therapy after aneurysmal subarachnoid hemorrhage ameliorates Vasospasm-related delayed ischemic deficits., This trial demonstrates that acute 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition) treatment reduces traditional rescue therapy for Vasospasm after aneurysmal subarachnoid hemorrhage. Improvement in early outcome has proved robust at 6 months, particularly in relation to physical and psychosocial (Short Form 36) outcome., The authors previously have demonstrated that acute treatment with pravastatin after aneurysmal subarachnoid hemorrhage (Yakut language) can ameliorate Vasospasm-related delayed ischemic neurological deficits (DINDs)., The neuroprotective effects of acute treatment with pravastatin following aneurysmal Yakut language are associated with enhancement of autoregulation, simvastatin reduces Vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial., The use of simvastatin as prophylaxis against delayed cerebral Ischemia Procedure after aneurysmal Yakut language is a safe and well-tolerated intervention. Its use attenuates Serum Markers associated with Brain Injuries and decreases the incidence of radiographic Vasospasm and delayed ischemic deficit., Acute treatment with pravastatin after ASAH1 wt Allele is safe and ameliorates Cerebral Vasospasm, improves cerebral autoregulation, and reduces Vasospasm-related DID., Yakut language 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition) users demonstrated significant improvement in 14-day functional outcome, a significantly lower incidence of Noninfiltrating Intraductal Carcinoma and Cerebral Infarction of any type, as well as prevention of TCD highest mean velocity elevation. However, we did not find a significant 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition) impact on mortality or global outcome (Modified Rankin Scale) in this small sample. [SEP]Relations: acquired aneurysmal subarachnoid hemorrhage has relations: contraindication with Tranexamic acid, contraindication with Tranexamic acid, disease_protein with EDNRB, disease_protein with EDNRB, disease_protein with PPARG, disease_protein with PPARG, disease_protein with NOS2, disease_protein with NOS2, disease_phenotype_positive with Hypopituitarism, disease_phenotype_positive with Hypopituitarism. Definitions: Hydroxymethylglutaryl-CoA Reductase Inhibitors defined as following: Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis.. Ischemia Procedure defined as following: A surgical procedure during which the blood supply to an organ or tissue is interrupted and then later reestablished.. Ischemic stroke defined as following: An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue.. Yakut language defined as following: A Turkic language spoken by the Yakut people in the Sakha Republic in the Russian Federation.. simvastatin defined as following: A derivative of LOVASTATIN and potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It may also interfere with steroid hormone production. Due to the induction of hepatic LDL RECEPTORS, it increases breakdown of LDL CHOLESTEROL.. cholesterol defined as following: The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.. Brain Injuries defined as following: Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.. atorvastatin defined as following: A synthetic lipid-lowering agent. atorvastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. atorvastatin also increases the number of LDL receptors on hepatic cell surfaces to enhance uptake and catabolism of LDL and reduces LDL production and the number of LDL particles. This agent lowers plasma cholesterol and lipoprotein levels and modulates immune responses by suppressing MHC II (major histocompatibility complex II) on interferon gamma-stimulated, antigen-presenting cells such as human vascular endothelial cells. (NCI04). Subarachnoid Hemorrhage defined as following: Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.. Cerebral Ischemia defined as following: Diminished or absent blood supply to the brain caused by obstruction (thrombosis or embolism) of an artery resulting in neurologic damage.. Vascular Diseases defined as following: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.. Cerebral Hemorrhage defined as following: Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA.. Vasospasm defined as following: spasm of the blood vessels resulting in decrease in their caliber.. pravastatin defined as following: An antilipemic fungal metabolite isolated from cultures of Nocardia autotrophica. It acts as a competitive inhibitor of HMG CoA reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES).. Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. S100B gene defined as following: This gene is involved in metal-ion binding.. Noninfiltrating Intraductal Carcinoma defined as following: A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.. Cerebral Infarction defined as following: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).. ASAH1 wt Allele defined as following: Human ASAH1 wild-type allele is located in the vicinity 8p22 of and is approximately 29 kb in length. This allele, which encodes acid ceramidase protein, is involved in ceramide metabolism. Mutation of the gene is associated with both Farber lipogranulomatosis and spinal muscular atrophy with progressive myoclonic epilepsy..", "label": "yes"} {"original_question": "Should Lubeluzole be used for treatment of ischemic stroke?", "id": "converted_3662", "sentence1": "Should lubeluzole be used for treatment of ischemic Cerebrovascular accident?", "sentence2": "lubeluzole showed promising neuroprotective effects in Animal allergens Cerebrovascular accident models, but failed to show benefits in acute ischemic Cerebrovascular accident in Homo sapiens. , However, clinical research on lubeluzole is now at a standstill, since lubeluzole seems to be associated with the acquired Long QT Syndrome and Ventricular arrhythmia. , Ten classes of neuroprotective agents have reached phase III efficacy trials but have shown mixed results. They included calcium channel antagonists, N-Methyl-D-Aspartate Receptors antagonists, lubeluzole, citicoline, the free radical scavenger tirilazad and ebselen, enlimomab, GABA agonist chlormethiazole, the Sodium Channel antagonist fosphenytoin, Magnesium supplements, alimentary tract and metabolism, glycine site antagonist GV 150526A and piracetam. , CONCLUSIONS: This study failed to show an efficacy of lubeluzole in the treatment of acute Cerebrovascular accident. , Overall, of all treated patients, 401 (22.5%) died: 203 (22.5%) in the lubeluzole group and 198 (22.4%) with placebo. Of all subjects treated, 853 (95%) on lubeluzole and 826 (93%) on placebo reported an adverse event during their treatment period or within the next 2 days after discontinuation of treatment., CONCLUSIONS: Treatment with lubeluzole within 6 hours of the onset of ischemic Cerebrovascular accident had a nonsignificant effect on mortality and resulted in improved clinical outcome compared with placebo, with no safety concerns., RESULTS: The overall mortality rate at 12 weeks for lubeluzole-treated patients was 20.7% compared to 25.2% for placebo-treated patients (NS). Controlling for relevant covariates, the degree of neurological recovery (NIHSS) at week 12 significantly favored lubeluzole over placebo (P = .033). lubeluzole treatment similarly resulted in significantly greater improvements in functional status (Barthel Index) (P = .038) and overall disability (Rankin Scale) (P = .034) after 12 weeks. A global test statistic confirmed that lubeluzole-treated patients had a more favorable clinical outcome at 12 weeks (P = .041)., CONCLUSIONS: In patients with acute ischemic Cerebrovascular accident, the dosage regimen of 7.5 mg over 1 hour followed by 10 mg/d of intravenous lubeluzole is safe and statistically significantly reduced mortality. , CONCLUSIONS\n\nTreatment with lubeluzole within 6 hours of the onset of ischemic Cerebrovascular accident had a nonsignificant effect on mortality and resulted in improved clinical outcome compared with placebo, with no safety concerns., CONCLUSIONS: lubeluzole, given in the acute phase of Ischemic Cerebrovascular accident, is not associated with a significant reduction of death or dependency at the end of scheduled follow-up period but seems to be associated with a significant increase of heart-conduction disorders (Q-T prolonged >450 msec)., Treatment with lubeluzole within 6 hours of the onset of ischemic Cerebrovascular accident had a nonsignificant effect on mortality and resulted in improved clinical outcome compared with placebo, with no safety concerns., In the overall study population, treatment with intravenous lubeluzole within 6 h of the onset of Ischemic Cerebrovascular accident did not affect mortality or clinical outcome.[SEP]Relations: Ischemic Cerebrovascular accident has relations: drug_effect with Aripiprazole, drug_effect with Aripiprazole, drug_effect with Aripiprazole, drug_effect with Aripiprazole, drug_effect with Paclitaxel, drug_effect with Paclitaxel, drug_effect with Paclitaxel, drug_effect with Paclitaxel, drug_effect with Sitaxentan, drug_effect with Sitaxentan. Definitions: Long QT Syndrome defined as following: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.. ebselen defined as following: A organoselenium compound with anti-inflammatory, anti-oxidant and cytoprotective activity. Ebselen acts as a glutathione peroxidase mimetic and is thereby able to prevent cellular damage induced by reactive oxygen species (ROS). In addition, this agent inhibits the activity of a variety of enzymes including nitric oxide synthase (NOS), 5-lipoxygenase, cyclooxygenase, protein kinase C (PKC), NADPH oxidase and gastric H+/K+-ATPase. Furthermore, ebselen may be neuroprotective due to its ability to neutralize free radicals upon N-Methyl-D-Aspartate Receptors activation thus, reducing lipoperoxidation mediated by glutamate-induced excitotoxicity.. Homo sapiens defined as following: Members of the species Homo sapiens.. Ischemic Cerebrovascular accident defined as following: An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue.. citicoline defined as following: Donor of choline in biosynthesis of choline-containing phosphoglycerides.. N-Methyl-D-Aspartate Receptors defined as following: A class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which Magnesium supplements, alimentary tract and metabolism ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity.. Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810). Sodium Channel defined as following: Ion channels that specifically allow the passage of SODIUM ions. A variety of specific Sodium Channel subtypes are involved in serving specialized functions such as neuronal signaling, CARDIAC MUSCLE contraction, and KIDNEY function.. Ventricular arrhythmia defined as following: A disorder characterized by an electrocardiographic finding of an atypical cardiac rhythm resulting from a pathologic process in the cardiac ventricles.. chlormethiazole defined as following: A sedative and anticonvulsant often used in the treatment of alcohol withdrawal. Chlormethiazole has also been proposed as a neuroprotective agent. The mechanism of its therapeutic activity is not entirely clear, but it does potentiate GAMMA-AMINOBUTYRIC ACID receptors response and it may also affect glycine receptors.. fosphenytoin defined as following: A water-soluble phosphate ester prodrug of phenytoin, a hydantoin derivative with anticonvulsant activity. Fosphenytoin is hydrolyzed to phenytoin by phosphatases. Phenytoin exerts its effect mainly by promoting sodium efflux and stabilizes neuronal membranes in the motor cortex. This leads to a suppression of excessive neuronal firing and limits the spread of seizure activity.. piracetam defined as following: A compound suggested to be both a nootropic and a neuroprotective agent.. ischemic Cerebrovascular accident defined as following: An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue..", "label": "no"} {"original_question": "Is the petrous bone used in ancient DNA sampling?", "id": "converted_2663", "sentence1": "Is the petrous bone used in ancient DNA sampling?", "sentence2": "Large-scale genomic analyses of ancient Homo sapiens populations have become feasible partly due to refined sampling methods. The inner part of Structure of petrous part of temporal bone and the cementum layer in teeth roots are currently recognized as the best substrates for such research., Ancient DNA (aDNA) research involves invasive and destructive sampling procedures that are often incompatible with anthropological, anatomical, and bioarcheological analyses requiring intact skeletal remains. The osseous Labyrinth inside the petrous bone has been shown to yield higher amounts of endogenous DNA than any other skeletal element; however, accessing this Labyrinth in cases of a complete or reconstructed skull involves causing major structural damage to the Calvaria or base., first genome-wide ancient DNA from Anatolian Neolithic farmers, whose Genetic Materials we obtained by extracting from Structure of petrous part of temporal bone,[SEP]Relations: petrous part of temporal bone has relations: anatomy_anatomy with zone of bone organ, anatomy_anatomy with zone of bone organ. acalvaria has relations: disease_protein with NAT2, disease_protein with NAT2, disease_phenotype_positive with Abnormal skull morphology, disease_phenotype_positive with Abnormal skull morphology, disease_protein with MTHFR, disease_protein with MTHFR, disease_protein with MTHFD1, disease_protein with MTHFD1. Definitions: Labyrinth defined as following: The portion of the ear located within the temporal bone that is involved in both hearing and balance and includes the semicircular canals, vestibule, and cochlea. (from American Heritage Dictionary online). DNA defined as following: A deoxyribonucleotide polymer that is the primary Genetic Materials of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Calvaria defined as following: The roof or dome of the skull.. Structure of petrous part of temporal bone defined as following: The dense rock-like part of temporal bone that contains the INNER EAR. Petrous bone is located at the base of the skull. Sometimes it is combined with the MASTOID PROCESS and called petromastoid part of temporal bone.. Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Has the protein GFP been used in transgenesis for live protein imaging?", "id": "converted_1237", "sentence1": "Has the protein GFP been used in transgenesis for live protein imaging?", "sentence2": "we review recent advancement in the functional studies of the three different GnRH neuron systems, mainly focusing on the electrophysiological analysis of the GnRH-Green Fluorescent Proteins (GFP) Animals, Transgenic., founders were found to be transgenic for GFP., GFP expression was detected in a wide range of Mus tissues, Transgenic Xenopus laevis for live imaging in \"U\" lymphocyte and developmental biology., The stable transgenesis of Genes encoding functional or spatially localized proteins, fused to fluorescent proteins such as Green Fluorescent Proteins (GFP) or red fluorescent protein (Zinc-Finger Protein Zinc-Finger Protein RFP), is an extremely important research tool in \"U\" lymphocyte and developmental biology., GFP-Animals, Transgenic for in vivo imaging: rats, Family Leporidae (organism), and pigs., We have further extended the techniques of genetic engineering to rats, Family Leporidae (organism), and pigs, and have created corresponding GFP-Animals, Transgenic., The results revealed that the 3.6-GFP Animals, Transgenic provide a unique model for direct analysis of Cells and molecular mechanisms of Dental Pulp repair and tertiary dentinogenesis in vivo., Long-term effects of PERV-specific RNA interference in transgenic pigs., Green Fluorescent Proteins (GFP) as reporter of the vector system were consistently expressed in Animals, Transgenic., The ability to specify the expression levels of exogenous Genes inserted in the Genome of Animals, Transgenic is critical for the success of a wide variety of experimental manipulations. , Welfare assessment in transgenic pigs expressing Green Fluorescent Proteins (GFP)., Animals, Transgenic expressing GFP with wildtype animal allergen extracts along various stages of post natal development, Production of transgenic chickens expressing a tetracycline-inducible GFP gene., Animals, Transgenic can be readily created to express fluorescently tagged proteins or reporters, These findings suggest that mhc2dab:GFP and cd45:DsRed transgenic lines will be instrumental in elucidating the immune response in the Zebrafish., f 33 CASP14 gene born, 28 (81%) carried the transgene DNA and 15 (55.5%) were GFP-positive., Lentiviral vectors containing the Green Fluorescent Proteins gene have been successfully used to select transgenic embryos before transfer to a surrogate mother, Typically Transgenes are generated by placing a promoter upstream of a GFP reporter gene or DNA, Complementary of interest, and this often produces a representative expression pattern., Survival and immunogenicity of Mesenchymal Stem Cells from the Green Fluorescent Proteins transgenic Rattus norvegicus in the adult Rattus norvegicus brain., This problem has been lessened by the availability of Animals, Transgenic that express \"reporter\" Genes, such as Green Fluorescent Proteins (GFP), full-length GFP fusion proteins was examined, in Animals, Transgenic, , Two stable transgenic lines express GFP prior to hair-bundle formation, we generated two transgenic pigs by somatic \"U\" lymphocyte nuclear transfer (SCNT) that express Green Fluorescent Proteins (GFP) driven by cytomegalovirus (CMV)., Fluorescent proteins such as the Green Fluorescent Proteins (GFP) have widely been used in Animals, Transgenic as Genes, Reporter. , Green Fluorescent Protein (GFP) is used extensively as a reporter for transgene expression in Drosophila and other Organism.[SEP]Relations: Animal protein allergy has relations: phenotype_phenotype with Allergy, phenotype_phenotype with Allergy, phenotype_phenotype with Animal dander allergy, phenotype_phenotype with Animal dander allergy. lymphocyte anergy has relations: bioprocess_bioprocess with tolerance induction, bioprocess_bioprocess with tolerance induction, bioprocess_bioprocess with B \"U\" lymphocyte anergy, bioprocess_bioprocess with B \"U\" lymphocyte anergy, bioprocess_bioprocess with T \"U\" lymphocyte anergy, bioprocess_bioprocess with T \"U\" lymphocyte anergy. Definitions: Mesenchymal Stem Cells defined as following: An undifferentiated stromal \"U\" lymphocyte with the ability to develop into the cells that form distinct mesenchymal tissues; such as bone, muscle, connective tissue, blood vessels, and lymphatic tissue.. Animals, Transgenic defined as following: Experimental organism whose genome has been altered by the transfer of a gene or Genes from another species or breed.. Dental Pulp defined as following: A richly vascularized and innervated connective tissue of mesodermal origin, contained in the central cavity of a tooth and delimited by the dentin, and having formative, nutritive, sensory, and protective functions. (Jablonski, Dictionary of Dentistry, 1992). Family Leporidae (organism) defined as following: Taxonomic family which includes Family Leporidae (organism) and hares.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. Green Fluorescent Proteins defined as following: Protein analogs and derivatives of the Aequorea victoria Green Fluorescent Proteins that emit light (FLUORESCENCE) when excited with ULTRAVIOLET RAYS. They are used in REPORTER GENES in doing GENETIC TECHNIQUES. Numerous mutants have been made to emit other colors or be sensitive to pH.. DNA, Complementary defined as following: Single-stranded complementary DNA synthesized from an RNA template by the action of RNA-dependent DNA polymerase. DNA, Complementary (i.e., complementary DNA, not circular DNA, not C-DNA) is used in a variety of molecular cloning experiments as well as serving as a specific hybridization probe.. Zebrafish defined as following: An exotic species of the family CYPRINIDAE, originally from Asia, that has been introduced in North America. Zebrafish is a model organism for drug assay and cancer research.. Cells defined as following: The fundamental, structural, and functional units or subunits of living Organism. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Transgenes defined as following: Genes that are introduced into an organism using GENE TRANSFER TECHNIQUES.. Genome defined as following: The genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA.. Zinc-Finger Protein RFP defined as following: Zinc finger protein Zinc-Finger Protein RFP (513 aa, ~58 kDa) is encoded by the human TRIM27 gene. This protein is involved in the modulation of both gene transcription and apoptosis.. Genes, Reporter defined as following: Genes whose expression is easily detectable and therefore used to study promoter activity at many positions in a target genome. In recombinant DNA technology, these Genes may be attached to a promoter region of interest.. Mus defined as following: Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae.. Organism defined as following: A living entity.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of Organism.. GFP defined as following: Protein analogs and derivatives of the Aequorea victoria Green Fluorescent Proteins that emit light (FLUORESCENCE) when excited with ULTRAVIOLET RAYS. They are used in REPORTER GENES in doing GENETIC TECHNIQUES. Numerous mutants have been made to emit other colors or be sensitive to pH.. protein defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the protein occurs, and references to homologous proteins in other species..", "label": "yes"} {"original_question": "Is TNNI3K a cardiac-specific protein?", "id": "converted_1281", "sentence1": "Is TNNI3K a Cardiac - anatomy qualifier-specific protein?", "sentence2": "cardiomyocyte-specific kinase TNNI3K , We report that TNNI3K Genes (TNNI3K), a cardiomyocyte-specific kinase,, TNNI3K, a Cardiac - anatomy qualifier-specific kinase, , The TNNI3K Genes (TNNI3K), a novel Cardiac - anatomy qualifier specific kinase, is associated with cardiomyocyte hypertrophy, Homo sapiens TNNI3K Genes (TNNI3K) is a novel Cardiac - anatomy qualifier-specific functional kinase that can bind to Cardiac troponin I in a Saccharomyces cerevisiae two-hybrid screen. , Overexpression of TNNI3K, a Cardiac - anatomy qualifier-specific MAPKKK, promotes Cardiac - anatomy qualifier dysfunctio, Cardiac troponin I-interacting kinase (TNNI3K) is a Cardiac - anatomy qualifier-specific kinase whose biological function remains largely unknown, Cardiac troponin I-interacting kinase (TNNI3K) is a novel Cardiac - anatomy qualifier-specific kinase Genes, a novel Cardiac - anatomy qualifier-specific kinase Genes (TNNI3K),, TNNI3K is a novel TNNI3K Genes Genes and its overexpression may promote Cardiac - anatomy qualifier myogenesis, , TNNI3K is a new Cardiac - anatomy qualifier-specific MAP kinase whose Genes is localized to 1p31.1 and that belongs to a tyrosine kinase-like branch in the kinase tree of the human genome., The Cardiac - anatomy qualifier ankyrin repeat kinase (CARK) Genes, also named TNNI3K for its interaction with Cardiac - anatomy qualifier troponin I, is both a unique expression and Chest>Heart-enriched Genes, Molecular cloning of TNNI3K Genes (TNNI3K), a novel Cardiac - anatomy qualifier-specific protein kinase containing seven N-terminal ankyrin (ANK) Repeat followed by a protein kinase domain and a C-terminal Ser-rich domain, has previously been reported., TNNI3K is highly expressed in Chest>Heart, but is undetectable in other Body tissue. Immunohistochemical analysis predominantly localized TNNI3K in the nucleus of Myocytes, Cardiac. [SEP]Relations: TNNI3K has relations: protein_protein with TNNI3, protein_protein with TNNI3, anatomy_protein_present with Chest>Heart, anatomy_protein_present with Chest>Heart, protein_protein with NFATC3, protein_protein with NFATC3, protein_protein with ACTC1, protein_protein with ACTC1, protein_protein with HADHB, protein_protein with HADHB. Definitions: Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Cardiac troponin I defined as following: Troponin I, Cardiac - anatomy qualifier muscle (210 aa, ~24 kDa) is encoded by the human TNNI3 Genes. This protein is involved in muscle filament movement in Cardiac - anatomy qualifier cells.. Myocytes, Cardiac defined as following: Striated muscle cells found in the Chest>Heart. They are derived from Cardiac - anatomy qualifier myoblasts (MYOBLASTS, CARDIAC).. Saccharomyces cerevisiae defined as following: A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" Saccharomyces cerevisiae. The dried form is used as a dietary supplement.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. Homo sapiens defined as following: Members of the species Homo sapiens.. 1p31.1 defined as following: A chromosome band present on 1p.. Repeat defined as following: Make or do or perform again..", "label": "yes"} {"original_question": "Is creatinine assessment included in the MELD score?", "id": "converted_2509", "sentence1": "Is creatine/creatinine assessment included in the MELD score?", "sentence2": "Model For End-Stage Hepatobiliary Disorder (MELD) scores were calculated as 3.78×ln[TB] + 11.2×ln[Integrated Neuromusculoskeletal Release] + 9.57×ln[creatine/creatine/creatinine] + 6.43. , A corrected creatine/creatine/creatinine was derived from the mGFR after application of the ResponseLevel - modification of Diet in Kidney Diseases formula. Subsequently, a corrected MELD was calculated and compared with the conventionally calculated MELD., Among patients with MELD score>35, a new prognostic model based on serum creatine/creatine/creatinine, need for hemodialysis and moderate Ascites could identify the sickest one., Patient risk factors evaluated include age, Integrated Neuromusculoskeletal Release (international normalized ratio), creatine/creatine/creatinine, bilirubin preparation preparation, and MELD score (Model for End-of-stage Hepatobiliary Disorder). , Limited comparability of creatine/creatine/creatinine assays in patients with Liver Cirrhosis and their impact on the MELD score., The model of end-stage liver disease (MELD) score is used for this purpose in most countries and incorporates bilirubin preparation preparation, International Normalized ratio, and creatine/creatine/creatinine. , The MELD score was calculated using international normalized ratio, serum billirubin and creatine/creatine/creatinine., Regression analysis identified high creatine/creatine/creatinine and Integrated Neuromusculoskeletal Release, but not bilirubin preparation preparation, as the MELD components predicting negative outcomes with ELAD. , This study aimed to evaluate the impact of two creatine/creatine/creatinine measurement methods on the Model for End Stage Hepatobiliary Disorder (MELD) score and glomerular filtration rate estimation (Epidermal Growth Factor Receptor) in cirrhotic patients., OBJECTIVES: The model for end-stage liver disease score (MELD = 3.8*LN[total bilirubin preparation preparation] + 9.6*LN[creatine/creatine/creatinine] + 11.2*[PT-Integrated Neuromusculoskeletal Release] + 6.4) predicts mortality for tricuspid valve surgery., Simplified MELD score = 3.8*LN[total bilirubin preparation preparation] + 9.6*LN[creatine/creatine/creatinine] + 6.4.
METHODS: A total of 172 patients (male: 66, female: 106; mean age, 63.8 ± 10.3 years) who underwent tricuspid replacement (n = 18) or repair (n = 154) from January 1991 to July 2011 at a single centre were included., CONCLUSION Incorporating Epidermal Growth Factor Receptor obtained by the 6-variable MDRD equation into the MELD score showed an equal predictive performance in in-hospital mortality compared to a creatine/creatine/creatinine-based MELD score., Simplified MELD score = 3.8*LN[total bilirubin preparation preparation] + 9.6*LN[creatine/creatine/creatinine] + 6.4.[SEP]Relations: kidney disease has relations: contraindication with Melatonin, contraindication with Melatonin, contraindication with Fingolimod, contraindication with Fingolimod, contraindication with Probenecid, contraindication with Probenecid, contraindication with Meloxicam, contraindication with Meloxicam, contraindication with Melphalan, contraindication with Melphalan. Definitions: Kidney Diseases defined as following: Pathological processes of the KIDNEY or its component tissues.. Hepatobiliary Disorder defined as following: A non-neoplastic or neoplastic disorder that affects the liver, bile ducts, and gallbladder. Representative examples of non-neoplastic disorders include hepatitis, cirrhosis, cholangitis, and cholecystitis. Representative examples of neoplastic disorders include hepatocellular adenoma, hepatocellular carcinoma, and cholangiocarcinoma.. Integrated Neuromusculoskeletal Release defined as following: A treatment system in which combined procedures are designed to stretch and reflexly release patterned soft tissue and joint-related restrictions. Both direct and indirect methods are used interactively.. Ascites defined as following: Accumulation or retention of free fluid within the peritoneal cavity.. ResponseLevel - modification defined as following:

Respond with exceptions, completions and modifications or revisions done before completion

. Liver Cirrhosis defined as following: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules..", "label": "yes"} {"original_question": "Has Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) been reported to be a plasminogen receptor in pathogenic bacteria?", "id": "converted_2858", "sentence1": "Has Glyceraldehyde 3-phosphate dehydrogenase (GAPDH protein, human) been reported to be a PLG gene receptor in pathogenic bacteria?", "sentence2": " binding of PLG gene (angiostatin, human) to bacterial surfaces, as it has been shown that this interaction contributes to bacterial adhesion to host cells, invasion of host tissues, and evasion of the immune system. Several Bacterial Proteins are known to serve as receptors for angiostatin, human including glyceraldehyde-3-phosphate dehydrogenase (GAPDH protein, human protein, human),, Moreover, several Protein Isoforms of the glyceraldehyde 3-phosphate dehydrogenase (GAPDH protein, human protein, human) and galectin (Galanin, human (30 aa, ~3 kDa)) were identified in both antigenic extracts as ENO1 protein, human., Purified GAPDH protein, human protein, human was found to bind human PLG gene and Fibrinogen containing hemostatics in Far-Western blot and ELISA-based assays., GAPDH protein, human protein, human exhibits a high affinity for plasmin and a significantly lower affinity for PLG gene., Moreover, several Protein Isoforms of the glyceraldehyde 3-phosphate dehydrogenase (GAPDH protein, human protein, human) and galectin (Galanin, human (30 aa, ~3 kDa)) were identified in both antigenic extracts as ENO1 protein, human. [SEP]Relations: Protein S human has relations: drug_drug with Tedizolid phosphate, drug_drug with Tedizolid phosphate, drug_drug with Tedizolid phosphate, drug_drug with Tedizolid phosphate, drug_drug with Protocatechualdehyde, drug_drug with Protocatechualdehyde, drug_drug with Protocatechualdehyde, drug_drug with Protocatechualdehyde, drug_drug with Dehydrochloromethyltestosterone, drug_drug with Dehydrochloromethyltestosterone. Definitions: GAPDH protein, human defined as following: Glyceraldehyde-3-phosphate dehydrogenase (335 aa, ~36 kDa) is encoded by the human GAPDH protein, human gene. This protein is involved in carbohydrate metabolism.. Protein Isoforms defined as following: Refers to variants of the same protein which can be separated on special conducting media using electrophoresis. The differences may arise from genetically determined differences in primary structure or by modification of the same primary sequence.. ENO1 protein, human defined as following: Alpha-enolase (434 aa, ~47 kDa) is encoded by the human ENO1 gene. This protein is involved in glycolysis and tumor suppression, and acts as a structural lens protein.. Bacterial Proteins defined as following: Proteins found in any species of bacterium.. PLG gene defined as following: This gene is involved in blood coagulation/hemostasis. It also plays a role in embryonic development, tissue remodeling and inflammation.. plasmin defined as following: A product of the lysis of PLG gene (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins.. angiostatin, human defined as following: Angiostatin (388, ~40 kDa) is encoded by the human PLG gene. This protein fragment is involved in the inhibition of blood vessel formation.. Galanin, human (30 aa, ~3 kDa) defined as following: Galanin (30 aa, ~3 kDa) is encoded by the human Galanin, human (30 aa, ~3 kDa) gene. This protein is involved in nociception, secretion of cortisol, growth hormone and insulin, hair follicle development and contraction of smooth muscle cells of the gastrointestinal and genitourinary tracts..", "label": "yes"} {"original_question": "Is cabozantinib effective for Hepatocellular Carcinoma?", "id": "converted_3031", "sentence1": "Is cabozantinib effective for Liver carcinoma?", "sentence2": "However, clinical trials of nonselective kinase inhibitors with c-Met activity (Tivantinib, cabozantinib, Foretinib, and golvatinib) in patients with altretamine/cisplatin/cyclophosphamide protocol have failed so far to demonstrate significant efficacy. , Rationale for use, clinical trial data, and current recommendations for cabozantinib in Malignant neoplasm of kidney, Malignant neoplasm of thyroid, Malignant neoplasm of prostate, Malignant neoplasm of liver, and Primary malignant neoplasm of lung are detailed in this article., More recently, promising outcomes have also been reported with new agents, such as nivolumab and cabozantinib., Positive results in recent phase III clinical trials have confirmed the high value of anti-angiogenic therapies for altretamine/cisplatin/cyclophosphamide protocol in both first (sorafenib and lenvatinib) and second line (regorafenib and cabozantinib) treatment modalities. , More recently, regorafenib and nivolumab have received approval in the second-line setting after sorafenib, with further positive phase 3 studies emerging in the first line (lenvatinib non-inferior to sorafenib) and second line versus placebo (cabozantinib and ramucirumab). , The rapidly changing treatment landscape due to the emergence of new treatment options (sorafenib and lenvatinib equally effective in first line; regorafenib, cabozantinib, and ramucirumab showing OS benefit in second line with nivolumab approved by the FDA based on response rate) underscores the importance of re-assessing the role of the first approved systemic agent in altretamine/cisplatin/cyclophosphamide protocol, sorafenib., Positive phase III-study data have been published for lenvatinib as first-line and cabozantinib as second-line therapy. , cabozantinib in Patients with Advanced and Progressing Liver carcinoma., BACKGROUND: cabozantinib inhibits Protein Tyrosine Kinase, including vascular endothelial growth factor receptors 1, 2, and 3, MET wt Allele wt Allele, and AXL protein, human protein, human, which are implicated in the progression of hepatocellular carcinoma and the development of resistance to sorafenib, the standard initial treatment for advanced disease. , CONCLUSIONS: Among patients with previously treated Advanced Liver carcinoma, treatment with cabozantinib resulted in longer overall survival and progression-free survival than placebo., Expert opinion: Based on favorable phase III clinical trial data, sorafenib and lenvatinib are considered promising agents for altretamine/cisplatin/cyclophosphamide protocol as first-line systemic chemotherapy. Moreover, regorafenib and cabozantinib are useful second-line therapies after the failure of sorafenib., CONCLUSIONS: Among patients with previously treated Advanced Liver carcinoma, treatment with cabozantinib resulted in longer overall survival and progression-free survival than placebo. , cabozantinib in Patients with Advanced and Progressing Liver carcinoma.Among patients with previously treated Advanced Liver carcinoma, treatment with cabozantinib resulted in longer overall survival and progression-free survival than placebo. , Among patients with previously treated Advanced Liver carcinoma, treatment with cabozantinib resulted in longer overall survival and progression-free survival than placebo., Median overall survival was 10.2 months with cabozantinib and 8.0 months with placebo (hazard ratio for Cessation of life, 0.76; 95% confidence interval [CI], 0.63 to 0.92; P=0.005). Median progression-free survival was 5.2 months with cabozantinib and 1.9 months with placebo (hazard ratio for disease progression or Cessation of life, 0.44; 95% CI, 0.36 to 0.52; P<0.001), and the objective response rates were 4% and less than 1%, respectively (P=0.009)., The most common high-grade events were Palmar-plantar erythrodysesthesia syndrome (17% with cabozantinib vs. 0% with placebo), Hypertensive disease (16% vs. 2%), increased aspartate aminotransferase level (12% vs. 7%), Fatigue (10% vs. 4%), and Diarrhea (10% vs. 2%).
CONCLUSIONS: Among patients with previously treated Advanced Liver carcinoma, treatment with cabozantinib resulted in longer overall survival and progression-free survival than placebo., CONCLUSIONS Among patients with previously treated Advanced Liver carcinoma, treatment with cabozantinib resulted in longer overall survival and progression-free survival than placebo., CONCLUSIONS The tyrosine kinase inhibitors sorafenib (first line) and regorafenib (second line) have been approved for hepatocellular carcinoma, and the immune checkpoint inhibitor nivolumab obtained conditional approval for sorafenib-experienced patients in the United States., The principal advancements in the treatment of hepatocellular carcinoma (altretamine/cisplatin/cyclophosphamide protocol) are the use of new systemic treatments such as lenvatinib in first-line treatment and regorafenib, cabozantinib and ramucirumab in second-line treatment due to their benefits in terms of overall survival., Recently, a few systemic chemotherapies proved to be effective for advanced stage altretamine/cisplatin/cyclophosphamide protocol in phase III studies: lenvatinib as the first line of therapy, and regorafenib, cabozantinib, and ramucirumab as second-line therapy., BACKGROUND: The approval of the tyrosine kinase inhibitor sorafenib in 2007 marked a milestone in the treatment of hepatocellular carcinoma, as sorafenib was the first systemic therapy to show a survival benefit in patients with Advanced Liver carcinoma., We also elaborate the unmet need of biomarkers to guide treatment decisions and discuss the emerging field of immunotherapy in hepatocellular carcinoma.
CONCLUSIONS: The tyrosine kinase inhibitors sorafenib (first line) and regorafenib (second line) have been approved for hepatocellular carcinoma, and the immune checkpoint inhibitor nivolumab obtained conditional approval for sorafenib-experienced patients in the United States., cabozantinib in the treatment of hepatocellular carcinoma., The approval of the tyrosine kinase inhibitor sorafenib in 2007 marked a milestone in the treatment of hepatocellular carcinoma, as sorafenib was the first systemic therapy to show a survival benefit in patients with Advanced Liver carcinoma.[SEP]Relations: cabozantinib has relations: drug_drug with Carbamazepine, drug_drug with Carbamazepine, drug_drug with Carbutamide, drug_drug with Carbutamide, drug_drug with Cannabidiol, drug_drug with Cannabidiol, drug_drug with Carbimazole, drug_drug with Carbimazole, drug_drug with Afelimomab, drug_drug with Afelimomab. Definitions: Protein Tyrosine Kinase defined as following: Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors.. Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. Malignant neoplasm of prostate defined as following: A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas.. cabozantinib defined as following: An orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. cabozantinib strongly binds to and inhibits several RTKs, which are often overexpressed in a variety of cancer cell types, including hepatocyte growth factor receptor (MET wt Allele), RET (rearranged during transfection), vascular endothelial growth factor receptor types 1 (VEGFR-1), 2 (VEGFR-2), and 3 (VEGFR-3), mast/stem cell growth factor (KIT), FMS-like tyrosine kinase 3 (FLT-3), TIE-2 (TEK tyrosine kinase, endothelial), tropomyosin-related kinase B (TRKB) and AXL protein, human. This may result in an inhibition of both tumor growth and angiogenesis, and eventually lead to tumor regression.. ramucirumab defined as following: A recombinant, fully human monoclonal antibody directed against human vascular endothelial growth factor receptor 2 (VEGFR-2) with antiangiogenesis activity. Ramucirumab specifically binds to and inhibits VEGFR-2, which may result in an inhibition of tumor angiogenesis and a decrease in tumor nutrient supply. VEGFR-2 is a pro-angiogenic growth factor receptor tyrosine kinase expressed by endothelial cells.. Malignant neoplasm of liver defined as following:

Your liver is the largest organ inside your body. It helps your body digest food, store energy, and remove poisons. Primary liver cancer starts in the liver. Metastatic liver cancer starts somewhere else and spreads to your liver.

Risk factors for primary liver cancer include

Symptoms can include a lump or pain on the right side of your abdomen and yellowing of the skin. However, you may not have symptoms until the cancer is advanced. This makes it harder to treat. Doctors use tests that examine the liver and the blood to diagnose liver cancer. Treatment options include surgery, radiation, chemotherapy, or liver transplantation.

NIH: National Cancer Institute

. Malignant neoplasm of kidney defined as following: Primary or metastatic malignant neoplasm involving the kidney.. Hypertensive disease defined as following: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), Hypertensive disease is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.. Liver carcinoma defined as following: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.. sorafenib defined as following: A synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis.. regorafenib defined as following: The anhydrous form of regorafenib, an orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. Regorafenib binds to and inhibits vascular endothelial growth factor receptors (VEGFRs) 2 and 3, and Ret, Kit, PDGFR and Raf kinases, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation. VEGFRs are receptor Protein Tyrosine Kinase that play important roles in tumor angiogenesis; the receptor Protein Tyrosine Kinase RET, KIT, and PDGFR, and the serine/threonine-specific Raf kinase are involved in tumor cell signaling.. AXL protein, human defined as following: Tyrosine-protein kinase receptor UFO (894 aa, ~98 kDa) is encoded by the human AXL protein, human gene. This protein plays a role in ligand binding, signaling and cellular growth and differentiation.. Malignant neoplasm of thyroid defined as following: A primary or metastatic malignant neoplasm affecting the thyroid gland.. Palmar-plantar erythrodysesthesia syndrome defined as following: Chemotherapy-induced dermal side effects that are associated with the use of various CYTOSTATIC AGENTS. Symptoms range from mild ERYTHEMA and/or PARESTHESIA to severe ulcerative dermatitis with debilitating pain involving typically palmoplantar and intertriginous areas. These cutaneous manifestations are sometimes accompanied by nail anomalies.. Diarrhea defined as following: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.. nivolumab defined as following: A fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed Cessation of life-1 (PD-1, PCD-1) with immune checkpoint inhibitory and antineoplastic activities. Upon administration, nivolumab binds to and blocks the activation of PD-1, an immunoglobulin superfamily (IgSF) transmembrane protein, by its ligands programmed cell Cessation of life ligand 1 (PD-L1), which is overexpressed on certain cancer cells, and programmed cell Cessation of life ligand 2 (PD-L2), which is primarily expressed on antigen-presenting cells (APCs). This results in the activation of T-cells and cell-mediated immune responses against tumor cells. Activated PD-1 negatively regulates T-cell activation and plays a key role in tumor evasion from host immunity.. Fatigue defined as following: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.. Advanced Hepatocellular Carcinoma defined as following: Hepatocellular carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.. lenvatinib defined as following: A synthetic, orally available inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2, also known as KDR/FLK-1) tyrosine kinase with potential antineoplastic activity. Lenvatinib blocks VEGFR2 activation by VEGF, resulting in inhibition of the VEGF receptor signal transduction pathway, decreased vascular endothelial cell migration and proliferation, and vascular endothelial cell apoptosis.. Tivantinib defined as following: An orally bioavailable small molecule inhibitor of c-Met with potential antineoplastic activity. c-Met inhibitor ARQ 197 binds to the c-Met protein and disrupts c-Met signal transduction pathways, which may induce cell Cessation of life in tumor cells overexpressing c-Met protein or expressing constitutively activated c-Met protein. c-Met protein, the product of the proto-oncogene c-Met, is a receptor tyrosine kinase also known as hepatocyte growth factor receptor (HGFR); this protein is overexpressed or mutated in many tumor cell types and plays key roles in tumor cell proliferation, survival, invasion, and metastasis, and tumor angiogenesis.. Foretinib defined as following: An orally bioavailable small molecule with potential antineoplastic activity. Foretinib binds to and selectively inhibits hepatocyte growth factor (HGF) receptor c-MET wt Allele and vascular endothelial growth factor receptor 2 (VEGFR2), which may result in the inhibition of tumor angiogenesis, tumor cell proliferation and metastasis. The proto-oncogene c-MET wt Allele has been found to be over-expressed in a variety of cancers. VEGFR2 is found on endothelial and hematopoietic cells and mediates the development of the vasculature and hematopoietic cells through VEGF signaling.. MET wt Allele defined as following: Human MET wt Allele wild-type allele is located within 7q31 and is approximately 126 kb in length. This allele, which encodes hepatocyte growth factor receptor protein, plays a role in the regulation of cellular tyrosine-kinase activity. Mutations in the MET wt Allele gene are associated with papillary renal carcinoma.. cabozantinib defined as following: An orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. cabozantinib strongly binds to and inhibits several RTKs, which are often overexpressed in a variety of cancer cell types, including hepatocyte growth factor receptor (MET wt Allele), RET (rearranged during transfection), vascular endothelial growth factor receptor types 1 (VEGFR-1), 2 (VEGFR-2), and 3 (VEGFR-3), mast/stem cell growth factor (KIT), FMS-like tyrosine kinase 3 (FLT-3), TIE-2 (TEK tyrosine kinase, endothelial), tropomyosin-related kinase B (TRKB) and AXL protein, human. This may result in an inhibition of both tumor growth and angiogenesis, and eventually lead to tumor regression..", "label": "yes"} {"original_question": "Has the Spanich flu virus been reconstructed?", "id": "converted_3677", "sentence1": "Has the Spanich flu Virus been reconstructed?", "sentence2": "Reconstruction of the 1918 influenza Virus has facilitated considerable advancements in our understanding of this extraordinary pandemic Virus., These viral RNA sequences eventually permitted reconstruction of the complete 1918 Virus, which has yielded, almost a century after the Cessation of life of its victims, novel insights into influenza Virus biology and pathogenesis and has provided important information about how to prevent and control future pandemics., Reconstruction of the 1918 Virus and studies elucidating the exceptional virulence and transmissibility of the Virus are providing exciting new insights into this devastating pandemic strain. [SEP]Relations: Cessation of head growth has relations: disease_phenotype_positive with leukoencephalopathy with vanishing white matter, disease_phenotype_positive with leukoencephalopathy with vanishing white matter, disease_phenotype_positive with Angelman syndrome due to a point mutation, disease_phenotype_positive with Angelman syndrome due to a point mutation, disease_phenotype_positive with Angelman syndrome due to paternal uniparental disomy of chromosome 15, disease_phenotype_positive with Angelman syndrome due to paternal uniparental disomy of chromosome 15, disease_phenotype_positive with Angelman syndrome due to maternal 15q11q13 deletion, disease_phenotype_positive with Angelman syndrome due to maternal 15q11q13 deletion, disease_phenotype_positive with neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies, disease_phenotype_positive with neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies. Definitions: Virus defined as following: Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells.. Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions..", "label": "yes"} {"original_question": "Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?", "id": "converted_815", "sentence1": "Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?", "sentence2": "We and others have published observational epidemiologic studies in support of VITAMINS [VA Class] in the primary prevention of CVD, but the results from intervention studies are mixed., For Vitamin E Drug Class, observational data suggest benefit at doses of 100 to 400 IU/d. Results from recent large-scale trials are mixed, with some showing modest benefit but others suggesting no benefit, especially for secondary prevention. Results for Vitamin B Drug Class are also mixed and further complicated by the recent folate fortification of the flour supply. If greater B vitamin intake does reduce CVD, the benefits are likely to be greatest for primary prevention and in populations with intake below dietary reference standards. , In the dose-response meta-analysis, each 30 mg/day increase in Vitamin C [EPC], 30 IU/day increase in Vitamin E Drug Class, and 1 mg/day increase in beta carotene yielded the estimated overall relative risk for altretamine/cisplatin/cyclophosphamide protocol of 1.01 (95% CI, 0.99-1.02), 0.96 (95% CI, 0.94-0.99), and 1.00 (95% CI, 0.88-1.14), respectively. CONCLUSIONS: Our findings in this meta-analysis suggest that an increase in dietary intake of antioxidant VITAMINS [VA Class] has encouraging prospects for possible altretamine/cisplatin/cyclophosphamide protocol prevention., High levels of α-tocopherol in serum were associated with 30% lower cyclophosphamide/dacarbazine/doxorubicin protocol risk in another study (HR 0.71; 95%CI 0.53-0.94). Among Minerals (Zinc Supplements, Selenium supplement, and Dietary Chromium), an inverse association between Zinc Supplements and cyclophosphamide/dacarbazine/doxorubicin protocol was observed; levels lower than 14.1 µmol/L were associated with an increased risk for cyclophosphamide/dacarbazine/doxorubicin protocol (RR 1.70; 95%CI 1.21-2.38)., The information available on this issue is scarce. Further prospective studies are needed to elucidate the role of these Nutrients in the Cardiovascular system risk of patients with Diabetes Mellitus., ubidecarenone supplementation at a dosage of 150 mg appears to decrease the inflammatory marker Recombinant Interleukin-6 in patients with cyclophosphamide/dacarbazine/doxorubicin protocol., ubidecarenone supplements at a dose of 150 mg can decrease oxidative stress and increase antioxidant enzyme activity in patients with cyclophosphamide/dacarbazine/doxorubicin protocol. A higher dose of coenzyme Q10 supplements (>150 mg/d) might promote rapid and sustainable antioxidation in patients with cyclophosphamide/dacarbazine/doxorubicin protocol., alpha tocopherol or beta carotene supplementation has no protective effect on macrovascular outcomes or total mortality of diabetic male smokers., Sodium selenite supplementation increases GPx-1 activity in Endothelial Cells and in cyclophosphamide/dacarbazine/doxorubicin protocol patients. Future studies have to demonstrate whether long-term cyclophosphamide/dacarbazine/doxorubicin protocol outcome can be improved., After 7.3 years of treatment and follow-up, a combination pill of folic acid, pyridoxine, and Vitamin B12 [EPC] did not reduce a combined end point of total Cardiovascular system events among high-risk women, despite significant homocysteine lowering., In this population-based study, Vitamin E Drug Class use was unrelated to mortality, but this apparently null finding seems to represent a combination of increased mortality in those with severe Cardiovascular Diseases and a possible protective effect in those without., In this large cohort of apparently healthy US male physicians, self-selected supplementation with Vitamin E Drug Class, Vitamin C [EPC], or Multivitamin Drug Class was not associated with a significant decrease in total CVD or altretamine/cisplatin/cyclophosphamide protocol mortality. , The American Heart Association has recommended consumption of a balanced diet with emphasis on antioxidant-rich fruits and vegetables but has made no recommendations regarding Vitamin E Drug Class supplementation for the general population. Although Vitamin E Drug Class supplementation seems to be safe for most people, recommendations from health care professionals should reflect the uncertainty of established benefit as demonstrated in clinical trials, Recent studies show that supplementation with antioxidant VITAMINS [VA Class] E and C have benefits in altretamine/cisplatin/cyclophosphamide protocol prevention; however, supplementation with beta carotene may have deleterious effects and is not recommended. Current evidence suggests that patients with altretamine/cisplatin/cyclophosphamide protocol would probably benefit from taking Vitamin E Drug Class in a dosage of 400 IU per day and Vitamin C [EPC] in a dosage of 500 to 1,000 mg per day. Clinicians may also want to consider Vitamin supplementation for altretamine/cisplatin/cyclophosphamide protocol prevention in high-risk patients. folate lowers elevated homocysteine levels, but evidence for routine supplemental use does not yet exist. , In patients at high risk for Cardiovascular system events, treatment with Vitamin E Drug Class for a mean of 4.5 years had no apparent effect on Cardiovascular system outcomes.[SEP]Relations: Cardiovascular Diseases has relations: contraindication with Antipyrine, contraindication with Antipyrine, contraindication with Amoxapine, contraindication with Amoxapine, contraindication with Methionine, contraindication with Methionine, contraindication with Fentanyl, contraindication with Fentanyl, contraindication with Carbinoxamine, contraindication with Carbinoxamine. Definitions: alpha tocopherol defined as following: A natural tocopherol and one of the most potent antioxidant tocopherols. It exhibits antioxidant activity by virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus. It has four methyl groups on the 6-chromanol nucleus. The natural d form of alpha-tocopherol is more active than its synthetic dl-alpha-tocopherol racemic mixture.. Recombinant Interleukin-6 defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin-6 (Recombinant Interleukin-6) with antiapoptotic, proinflammatory, antiinflammatory, proproliferative and proangiogenic activities. Recombinant Interleukin-6 binds to its receptor (IL-6R), activating a receptor-CD130 receptor complex; the CD130 portion of the complex is a signal transduction protein that activates JAK kinases and Ras-mediated signaling pathways, which in turn activate downstream signaling pathways, resulting in the activation of various transcription factors (STAT, ELK-1, NF-Recombinant Interleukin-6, etc.) and gene transcription. The physiological effects of Recombinant Interleukin-6 are complex and varied and include hematopoietic, pyrogenic and thermogenic, proinflammatory, antiinflammatory, proproliferative (anti-apoptotic), and angiogenic effects.. folate defined as following: A cofactor for 1-carbon transfer involved with DNA synthesis.. Nutrients defined as following: Various components of food that are required for nourishment.. pyridoxine defined as following: The 4-methanol form of VITAMIN B 6 which is converted to PYRIDOXAL PHOSPHATE which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. Although pyridoxine and Vitamin B 6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading (EE Snell; Ann NY Acad Sci, vol 585 pg 1, 1990).. Minerals defined as following: Native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions. They may occur as individual crystals or may be disseminated in some other mineral or rock. (Grant & Hackh's Chemical Dictionary, 5th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). beta carotene defined as following: A carotenoid that is a precursor of VITAMIN A. Beta carotene is administered to reduce the severity of photosensitivity reactions in patients with erythropoietic protoporphyria (PORPHYRIA, ERYTHROPOIETIC).. Endothelial Cells defined as following: Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer.. Cardiovascular Diseases defined as following: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.. folic acid defined as following: A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia.. ubidecarenone defined as following: A lipid-soluble benzoquinone which is involved in ELECTRON TRANSPORT in mitochondrial preparations. The compound occurs in the majority of aerobic organisms, from bacteria to higher plants and animals.. Diabetes Mellitus defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.. Cardiovascular system defined as following: The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body.. coronary artery disease defined as following: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause..", "label": "no"} {"original_question": "Tocilizumab is an anti-TNF antibody, yes or no?", "id": "converted_3168", "sentence1": "tocilizumab is an anti-Recombinant Tumor Necrosis Factor Family Protein antibody, yes or no?", "sentence2": "was treated with tocilizumab, an anti-Interleukin 6 Receptor Monoclonal Antibody [EPC] , tocilizumab (TCZ) is a humanized Monoclonal Antibody [EPC] against Recombinant Interleukin-6 receptor licensed in 2009 that has demonstrated clinical efficacy in various adult Rheumatoid Arthritis populations. Rheumatoid Arthritis management guidelines and recommendations consider TCZ as one of the bDMARDS indicated after methotrexate or other conventional synthetic DMARDs and/or Recombinant Tumor Necrosis Factor Family Protein inhibitors failure in adult Rheumatoid Arthritis, tocilizumab (Roactemra or Actemra) is a recombinant humanized Monoclonal Antibody [EPC] that acts as an interleukin (IL)-6 receptor antagonist., METHODS\nPatients (n = 93) were treated with an anti-Recombinant Interleukin-6 receptor antibody (tocilizumab) or Recombinant Tumor Necrosis Factor Family Protein-α inhibitors for 16 weeks., The recent development of biological agents, namely, anti-tumour necrosis factor alpha (Recombinant Tumor Necrosis Factor Family Protein-α) agents (infliximab, adalimumab and etanercept), anti- ocaratuzumab (rituximab) and anti-interleukin 6 receptor (Interleukin 6 Receptor activity) Monoclonal Antibody [EPC] (tocilizumab), represents a major breakthrough for the treatment of immune-mediated disorders., Recently, an anti-Recombinant Interleukin-6 receptor Monoclonal Antibody [EPC], tocilizumab, has been licensed for the treatment as monotherapy or in combination with methotrexate of moderate to severe Rheumatoid Arthritis, when disease modifying anti-rheumatic drugs or anti-tumour necrosis factors (Recombinant Tumor Necrosis Factor Family Protein) have failed., tocilizumab is a monoclonal humanized anti-Recombinant Interleukin-6-receptor antibody used for the treatment of rheumatoid arthritis., Indeed, worldwide clinical trials of Recombinant Tumor Necrosis Factor Family Protein inhibiting biologic disease modifying antirheumatic drugs (bDMARDs) including infliximab, adalimumab, golimumab, certolizumab pegol, and etanercept as well as the humanized anti-human Recombinant Interleukin-6 receptor antibody, tocilizumab, have demonstrated outstanding clinical efficacy and tolerable safety profiles, resulting in worldwide approval for using these bDMARDs to treat moderate to severe active Rheumatoid Arthritis in patients with an inadequate response to synthetic disease modifying antirheumatic drugs (sDMARDs)., tocilizumab is a humanized anti-Recombinant Interleukin-6 receptor Monoclonal Antibody [EPC], which binds to circulating soluble Recombinant Interleukin-6 receptor and membrane-expressed Recombinant Interleukin-6 receptor, inhibiting Recombinant Interleukin-6 binding to both forms of Recombinant Interleukin-6 receptor., Subsequent options include a Recombinant Tumor Necrosis Factor Family Protein-alpha antagonist, followed by rituximab or possibly abatacept; (2) tocilizumab, a Monoclonal Antibody [EPC], inhibits interleukin-6 receptors., tocilizumab (TCZ) is a Monoclonal Antibody [EPC] which inhibits the Interleukin 6 Receptor.[SEP]Relations: tocilizumab has relations: drug_drug with Tetanus Immune Globulin, drug_drug with Tetanus Immune Globulin, drug_drug with Nemolizumab, drug_drug with Nemolizumab, drug_drug with Afelimomab, drug_drug with Afelimomab, drug_drug with Antipyrine, drug_drug with Antipyrine, drug_drug with Concizumab, drug_drug with Concizumab. Definitions: Recombinant Interleukin-6 defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin-6 (Recombinant Interleukin-6) with antiapoptotic, proinflammatory, antiinflammatory, proproliferative and proangiogenic activities. Recombinant Interleukin-6 binds to its receptor (interleukin-6 receptor activity), activating a receptor-CD130 receptor complex; the CD130 portion of the complex is a signal transduction protein that activates JAK kinases and Ras-mediated signaling pathways, which in turn activate downstream signaling pathways, resulting in the activation of various transcription factors (STAT, ELK-1, NF-Recombinant Interleukin-6, etc.) and gene transcription. The physiological effects of Recombinant Interleukin-6 are complex and varied and include hematopoietic, pyrogenic and thermogenic, proinflammatory, antiinflammatory, proproliferative (anti-apoptotic), and angiogenic effects.. abatacept defined as following: A soluble fusion protein consisting of the extracellular domain of human cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) linked to a modified Fc (hinge, CH2, and CH3 domains) portion of human immunoglobulin G1 (IgG1) with immunosuppressive activity. Abatacept binds CD80 and CD86 on antigen presenting cells (APCs), blocking interaction with CD28 on T lymphocytes, which initiates a co-stimulatory signal required for full activation of T lymphocytes.. Recombinant Tumor Necrosis Factor Family Protein defined as following: A recombinant therapeutic agent which is chemically identical to or similar to one of a number of endogenous tumor necrosis factor (Recombinant Tumor Necrosis Factor Family Protein) proteins. Recombinant Tumor Necrosis Factor Family Protein family cytokines bind to and activate specific cell-surface receptors, thereby mediating inflammatory processes, cell proliferation, immunity, angiogenesis, and tumor cell cytotoxicity. One primary antitumor effect of TNFs involves stimulation of T cell-mediated antitumor cytotoxicity.. Rheumatoid Arthritis defined as following: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.. tocilizumab defined as following: A recombinant, humanized IgG1 Monoclonal Antibody [EPC] directed against the Interleukin 6 Receptor (interleukin-6 receptor activity) with immunosuppressant activity. tocilizumab targets and binds to both the soluble form of interleukin-6 receptor activity (sIL-6R) and the membrane-bound form (mIL-6R), thereby blocking the binding of Recombinant Interleukin-6 to its receptor. This prevents Recombinant Interleukin-6-mediated signaling. Recombinant Interleukin-6, a pro-inflammatory cytokine that plays an important role in the regulation of the immune response, is overproduced in autoimmune disorders, certain types of cancers and possibly various other inflammatory conditions.. ocaratuzumab defined as following: An Fc-engineered Monoclonal Antibody [EPC] directed against human CD20 with potential antineoplastic activity. Ocaratuzumab specifically binds to CD20 antigen (B1), preventing mitogen-induced B-cell proliferation; inhibiting B-cell differentiation; and promoting antibody-dependent cell-mediated cytotoxicity (ADCC) and apoptosis of B cells expressing CD20. The Fc portion of this Monoclonal Antibody [EPC] has been engineered to possess a higher binding affinity for variant Fc receptors on T helper cells, resulting in an augmentation of the anti-tumor immune response. Because of Fc engineering, this agent may be significantly more potent than rituximab in inducing B cell-directed ADCC. CD20 is a non-glycosylated cell surface phosphoprotein that is exclusively expressed on B cells during most stages of B cell development.. etanercept defined as following: A recombinant version of soluble human Recombinant Tumor Necrosis Factor Family Protein receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous Recombinant Tumor Necrosis Factor Family Protein receptors. It prevents the inflammatory effect of Recombinant Tumor Necrosis Factor Family Protein and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS.. golimumab defined as following: A human Monoclonal Antibody [EPC] directed against the pro-inflammatory cytokine tumor necrosis factor-alpha (Recombinant Tumor Necrosis Factor Family Protein-a) with immunosuppressive activity. Golimumab binds to Recombinant Tumor Necrosis Factor Family Protein-a, thereby preventing Recombinant Tumor Necrosis Factor Family Protein-a-mediated immune responses. Recombinant Tumor Necrosis Factor Family Protein-a production is dysregulated in various auto-immune diseases and in cancer.. Interleukin 6 Receptor defined as following: Cell surface receptors that are specific for INTERLEUKIN-6. They are present on T-LYMPHOCYTES, mitogen-activated B-LYMPHOCYTES, and peripheral MONOCYTES. The receptors are heterodimers of the INTERLEUKIN-6 RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR GP130.. methotrexate defined as following: An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.. rituximab defined as following: A murine-derived Monoclonal Antibody [EPC] and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.. adalimumab defined as following: A recombinant, human IgG1 Monoclonal Antibody [EPC] directed against tumor necrosis factor-alpha (Recombinant Tumor Necrosis Factor Family Protein-alpha), with immunomodulating activity. Upon administration, adalimumab binds to Recombinant Tumor Necrosis Factor Family Protein-alpha, thereby preventing its binding to the p55 and p75 Recombinant Tumor Necrosis Factor Family Protein cell surface receptors and inhibiting Recombinant Tumor Necrosis Factor Family Protein-mediated immune responses. Recombinant Tumor Necrosis Factor Family Protein-alpha, a pro-inflammatory cytokine, is upregulated in various autoimmune diseases.. Monoclonal Antibody [EPC] defined as following: A humanized Monoclonal Antibody [EPC] directed against parathyroid hormone-related protein (PTH-rP). As a poly-hormone with diverse biological roles, PTH-rP is expressed by normal tissues, acting in local tissue environments in a variety of ways; it is commonly overexpressed by breast, prostate, and other cancers, acting systemically by promoting bone resorption, inhibiting calcium excretion from the kidney, inducing hypercalcemia, and possibly playing a role in the formation of bony metastases. By blocking the effects of PTH-rP on calcium metabolism, Monoclonal Antibody [EPC] CAL may inhibit cancer-related hypercalcemia. (NCI04). infliximab defined as following: A chimeric Monoclonal Antibody [EPC] to Recombinant Tumor Necrosis Factor Family Protein-ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE.. interleukin-6 receptor activity defined as following: Combining with interleukin-6 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. [GOC:jl, GOC:signaling].", "label": "no"} {"original_question": "Are Drosophila ultraconserved elements candidate ncRNAs?", "id": "converted_1134", "sentence1": "Are Drosophila ultraconserved elements candidate ncRNAs?", "sentence2": "Highly constrained intergenic Drosophila ultraconserved elements are candidate ncRNAs., Here, we report the discovery and characterization of UCEs from 12 sequenced Drosophila species. We identified 98 elements ≥80 bp long with very high Conservation across the Drosophila phylogeny. Population genetic analyses reveal that these UCEs are not present in mutational cold spots. Instead we infer that they experience a level of selective constraint almost 10-fold higher compared with missense mutations in protein-coding sequences, which is substantially higher than that observed previously for human UCEs. About one-half of these Drosophila UCEs overlap the transcribed portion of genes, with many of those that are within coding sequences likely to correspond to sites of ADAR-dependent RNA editing. For the remaining UCEs that are in nongenic regions, we find that many are potentially capable of forming RNA secondary structures. Among ten chosen for further analysis, we discovered that the majority are transcribed in multiple tissues of Drosophila melanogaster. We conclude that Drosophila species are rich with UCEs and that many of them may correspond to novel noncoding RNAs., Highly Constrained Intergenic Drosophila Ultraconserved Elements Are Candidate ncRNAs[SEP]Definitions: Conservation defined as following: The maintenance of certain characteristics in an unchanged condition..", "label": "yes"} {"original_question": "Is dupilumab effective for treatment of asthma?", "id": "converted_2975", "sentence1": "Is dupilumab effective for treatment of Asthma?", "sentence2": "The appropriate use of these biologics, and of those in development (e.g., benralizumab and dupilumab), should be aided by further understanding of Asthma phenotypes and endotypes, utilizing appropriate biomarkers., Simultaneous targeting of both Recombinant Interleukin-4 and IL-13 by blocking Interleukin 4 Receptor using dupilumab has yielded more consistent results in reducing Asthma exacerbations and improving lung function, especially in patients with increased blood eosinophils., In a pivotal, phase 2b study (NCT01854047), dupilumab reduced severe exacerbations, improved lung function and quality of life, and was generally well tolerated in patients with uncontrolled persistent Asthma despite using medium-to-high-dose inhaled corticosteroids plus long-acting β2-agonists., CONCLUSIONS: Dupilumab 300 mg q2w significantly improved AR-associated nasal symptoms in patients with uncontrolled persistent Asthma and comorbid Population Attributable Risk., Small Molecule (e.g. tetramethylpyrazine and SP600125) and large molecule antibodies (e.g. lebrikizumab, benralizumab, dupilumab) are being considered as novel agents for the pharmacotherapy of Asthma. , Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma., CONCLUSIONS: In this trial, patients who received dupilumab had significantly lower rates of severe Asthma exacerbation than those who received placebo, as well as better lung function and Asthma control. , Dupilumab for the treatment of Asthma.Dupilumab (REGN668/SAR231893), produced by a collaboration between Regeneron and sanofi, is a monoclonal antibody CAL CAL currently in phase III for moderate-to-severe Asthma. , Dupilumab inhibits interleukin-4 (Recombinant Interleukin-4) and interleukin-13, Homo sapiens, Homo sapiens (IL-13) signaling and was previously found to be effective in Asthma., Dupilumab (REGN668/SAR231893), produced by a collaboration between Regeneron and sanofi, is a monoclonal antibody CAL CAL currently in phase III for moderate-to-severe Asthma., If confirmed, efficacy of dupilumab in both eosinophilic and non-eosinophilic severe Asthma phenotype might represent an advantage over approved biologics for Asthma, including omalizumab, mepolizumab, and reslizumab., In this review, we focused on Recombinant Interleukin-4 and IL-13, as these Recombinant Interleukins are considered to play a key role in the pathophysiology of Asthma, and on dupilumab, an anti-Recombinant Interleukin-4 receptor Homo sapiens mAb, as a forthcoming treatment for uncontrolled severe Asthma in the near future., Expert opinion: Supported by a strategic mechanism of action, as well as by convincing preliminary clinical results, dupilumab currently appears to be a very promising biological drug for the treatment of severe uncontrolled Asthma., All drugs decreased Asthma exacerbations but the results were only significant for reslizumab and dupilumab., Anti-Recombinant Interleukin-4 and IL-13 agents (dupilumab, lebrikizumab, and tralokinumab) which block different Th-2 inflammatory pathways and agents targeting the Th-17 inflammatory pathway in severe refractory Asthma are under development., Dupilumab for the treatment of Asthma., In addition, dupilumab is currently under phase III development across the world for the treatment of Asthma and Nasal Polyps as well as for Dermatitis, Atopic in paediatric patients., BACKGROUND\nDupilumab (an anti-interleukin-4-receptor-α monoclonal antibody CAL CAL) blocks signalling of interleukin-4, Homo sapiens and Recombinant Interleukin-13, type 2/Th2 Recombinant Cytokines implicated in numerous allergic diseases ranging from Asthma to Dermatitis, Atopic., Dupilumab: a novel treatment for Asthma., Dupilumab for the treatment of Asthma., The efficacy and safety profile of dupilumab in the treatment of allergic diseases has been tested for more than 10 years in a variety of large clinical trials in Dermatitis, Atopic, Asthma, chronic rhinosinusitis with Nasal Polyps, and eosinophilic esophagitis., Areas covered: Pathophysiological role of Recombinant Interleukin-4 and IL-13 in Asthma; mechanism of action of dupilumab; pharmacology of Recombinant Interleukin-4 receptor; phase I and phase II studies with dupilumab; regulatory affairs., Expert opinion: Patients with severe Asthma who are not sufficiently controlled with standard-of-care represent the target Asthma population for dupilumab., CONCLUSIONS In patients with glucocorticoid-dependent severe Asthma, dupilumab treatment reduced oral glucocorticoid use while decreasing the rate of severe exacerbations and increasing the FEV1., CONCLUSIONS In patients with persistent, moderate-to-severe Asthma and elevated eosinophil levels who used inhaled glucocorticoids and LABAs, dupilumab therapy, as compared with placebo, was associated with fewer Asthma exacerbations when LABAs and inhaled glucocorticoids were withdrawn, with improved lung function and reduced levels of Th2-associated inflammatory markers., Expert opinion: Patients with severe Asthma who are not sufficiently controlled with standard-of-care represent the target Asthma population for dupilumab., Dupilumab inhibits interleukin-4 (Recombinant Interleukin-4) and interleukin-13, Homo sapiens, Homo sapiens (IL-13) signaling and was previously found to be effective in Asthma., Expert opinion: Supported by a strategic mechanism of action, as well as by convincing preliminary clinical results, dupilumab currently appears to be a very promising biological drug for the treatment of severe uncontrolled Asthma., Dupilumab inhibits interleukin-4 (Recombinant Interleukin-4) and interleukin-13, Homo sapiens, Homo sapiens (IL-13) signaling and was previously found to be effective in Asthma., A recent trial showed that in patients with difficult-to-control Asthma, dupilumab can markedly decrease Asthma exacerbations and improve respiratory symptoms and lung function; these effects were paralleled by significant reductions in T-helper 2-associated inflammatory biomarkers.[SEP]Relations: Dupilumab has relations: drug_drug with Olaratumab, drug_drug with Olaratumab, drug_drug with Lucatumumab, drug_drug with Lucatumumab, drug_drug with Dusigitumab, drug_drug with Dusigitumab, drug_drug with Tremelimumab, drug_drug with Tremelimumab, drug_drug with Avelumab, drug_drug with Avelumab. Definitions: interleukin-13, Homo sapiens defined as following: Interleukin-13 (146 aa, ~16 kDa) is encoded by the Homo sapiens IL13 gene. This protein plays a role in the negative regulation of cytokine production and the positive regulation of B-cell proliferation.. eosinophil defined as following: Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin.. mepolizumab defined as following: A humanized immunoglobulin G1 (IgG1) monoclonal antibody CAL directed against interleukin-5 (IL-5) with anti-asthmatic and potential immunosuppressive activity. Upon subcutaneous administration, mepolizumab selectively binds to IL-5, preventing it from associating with interleukin-5 receptor subunit alpha (IL5RA) on the surface of eosinophils and their progenitors. IL-5 plays a role in the regulation of eosinophil development from hematopoietic progenitors as well as eosinophil maturation, differentiation, mobilization, activation, and survival. IL-5 also play a role in the pathogenesis of some phenotypes of hypereosinophilic syndrome (HES).. lebrikizumab defined as following: A humanized monoclonal antibody CAL against Recombinant Interleukin-13 (IL-13) with immunosuppressive and anti-asthmatic activities. Lebrikizumab binds to IL-13 and inhibits IL-13-mediated pathways. IL-13, a cytokine mainly secreted by type 2 helper T cells, plays a key role in the induction of allergic inflammation.. Population Attributable Risk defined as following: That proportion of disease in the whole population that can be ascribed to the risk factor of concern.. omalizumab defined as following: A humanized monoclonal antibody CAL directed against the C-epsilon 3 domain of immunoglobulin E. Olizumab binds to this IgE domain, thereby preventing IgE from binding to its high-affinity mast-cell receptor. (NCI04). Small Molecule defined as following: A molecule with a low molecular weight that is not determined by a genome sequence.. monoclonal antibody CAL defined as following: A humanized monoclonal antibody CAL directed against parathyroid hormone-related protein (PTH-rP). As a poly-hormone with diverse biological roles, PTH-rP is expressed by normal tissues, acting in local tissue environments in a variety of ways; it is commonly overexpressed by breast, prostate, and other cancers, acting systemically by promoting bone resorption, inhibiting calcium excretion from the kidney, inducing hypercalcemia, and possibly playing a role in the formation of bony metastases. By blocking the effects of PTH-rP on calcium metabolism, monoclonal antibody CAL CAL may inhibit cancer-related hypercalcemia. (NCI04). Recombinant Interleukin-13 defined as following: The recombinant analogue of an endogenous cytokine Recombinant Interleukin-13 with potential antineoplastic activity. Produced by lymphocytes and exhibiting a variety of functions, interleukin-13, Homo sapiens (therapeutic) inhibits DNA synthesis and regulates inflammatory and immune responses. In animal models, this agent has been shown to kill tumor cells both directly and indirectly by activating the host immune system at the tumor site. (NCI04). Interleukin 4 Receptor defined as following: Receptors present on a wide variety of hematopoietic and non-hematopoietic cell types that are specific for INTERLEUKIN-4. They are involved in signaling a variety of immunological responses related to allergic INFLAMMATION including the differentiation of TH2 CELLS and the regulation of IMMUNOGLOBULIN E production. Two subtypes of receptors exist and are referred to as the TYPE I INTERLEUKIN-4 RECEPTOR and the TYPE II INTERLEUKIN-4 RECEPTOR. Each receptor subtype is defined by its unique subunit composition.. interleukin-4, Homo sapiens defined as following: Interleukin-4 (153 aa, ~17 kDa) is encoded by the Homo sapiens IL4 gene. This protein is involved in the regulation of the expression of class II MHC molecules, Fc receptors and cell surface-bound immunoglobulins.. Recombinant Interleukin-4 defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin-4 (Recombinant Interleukin-4). Produced primarily by activated T-cells, Recombinant Interleukin-4 binds to and activates its cell-surface receptor, stimulating the proliferation and differentiation of activated B-cells and enhancing their ability to present antigens to T-cells. As a potential immunotherapeutic agent, recombinant Recombinant Interleukin-4 also augments the effects of other Recombinant Cytokines on dendritic cells (DC), cytotoxic T lymphocytes (CTL), and tumor-infiltrating lymphocytes (TIL). Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C589\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C589\" NCI Thesaurus). Recombinant Interleukins defined as following: Formulated therapeutic analogs of one of a number of endogenous cytokine Recombinant Interleukins. Produced by T cells, macrophages, and other cells, Recombinant Interleukins bind to a specific surface receptor on immunohematopoietic cells, thereby inducing a multitude of biologic effects including stimulation of growth, differentiation, and proliferation of lymphocytes and eosinophils; activation of lymphocytes and macrophages; enhancement of mast cell activity; activation of the acute phase response; and stimulation of hematopoiesis. Some Recombinant Interleukins may enhance the host's immune response to malignant cells by stimulating lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL), which are capable of lysing some tumor cells. (NCI04). Asthma defined as following: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).. dupilumab defined as following: A recombinant Homo sapiens monoclonal immunoglobulin G4 (IgG4) antibody directed against the alpha chain of the interleukin-4 receptor (IL-4R alpha) with potential immunomodulatory activities. Upon injection, dupilumab selectively binds to the IL-4R alpha chain. This disrupts Recombinant Interleukin-4/IL-13 signaling and prevents the activation of downstream pathways that mediate type 2 inflammation and may potentially inhibit tumor cell proliferation, survival, and metastasis. Recombinant Interleukin-4 and IL-13 receptors are present on the surface of numerous cells involved in the pathophysiology of type-2 helper T-cell (Th2) allergic responses, including B-lymphocytes, eosinophils, dendritic cells (DCs), monocytes, macrophages, basophils, keratinocytes, bronchial epithelial cells, endothelial cells, fibroblasts, and airway smooth muscle cells. Additionally, both Recombinant Interleukin-4 and IL-13 receptors are overexpressed in a variety of cancers and Recombinant Interleukin-4 and IL-13 and may serve as biomarkers for cancer aggressiveness. Recombinant Interleukin-4 and IL-13 are thought to be key regulatory Recombinant Cytokines in the tumor microenvironment (TME) and may play a role in the activation of tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs) that mediate tumor cell survival.. Homo sapiens defined as following: Members of the species Homo sapiens.. Nasal Polyps defined as following: Focal accumulations of EDEMA fluid in the NASAL MUCOSA accompanied by HYPERPLASIA of the associated submucosal connective tissue. Polyps may be NEOPLASMS, foci of INFLAMMATION, degenerative lesions, or malformations.. benralizumab defined as following: An afucosylated, humanized monoclonal antibody CAL against the alpha chain of the interleukin-5 receptor (IL-5Ra), with potential anti-asthmatic activity. Upon administration, benralizumab binds to IL-5Ra and elicits an antibody-directed cell cytotoxicity (ADCC) against IL-5Ra-expressing cells. This induces apoptosis in IL-5Ra-expressing cells and may reduce asthmatic episodes. IL-5Ra, expressed on both eosinophils and basophils, plays a key role in Asthma.. Dermatitis, Atopic defined as following: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and Asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema..", "label": "yes"} {"original_question": "Is Semagacestat effective for treatment of Alzheimer's disease?", "id": "converted_3042", "sentence1": "Is Semagacestat effective for treatment of Alzheimer's disease?", "sentence2": "However, a large phase 3 trial of semagacestat, a potential non-transition state analog (non-TSA) GSI, in patients with Alzheimer's disease (cytarabine/daunorubicin protocol) was terminated due to unexpected aggravation of Cognition Disorders and side effects., BACKGROUND: In a recent report, 76 weeks' treatment with a gamma-secretase inhibitor (semagacestat) was associated with poorer cognitive outcomes in Alzheimer's disease (cytarabine/daunorubicin protocol)., A clinical trial with the wide-spectrum γ-secretase inhibitor semagacestat has, however, demonstrated that global inhibition of all γ-secretases causes serious Toxic effect. , OBJECTIVE: Semagacestat, a γ-secretase inhibitor, demonstrated an unfavorable risk-benefit profile in a Phase 3 study of patients with Alzheimer's disease (IDENTITY trials), and clinical development was halted. , CONCLUSIONS: As compared with placebo, semagacestat did not improve cognitive status, and patients receiving the higher dose had significant worsening of functional ability. Semagacestat was associated with more adverse events, including Malignant neoplasm of skin and Infections of musculoskeletal system., BACKGROUND\nIn a recent report, 76 weeks' treatment with a gamma-secretase inhibitor (semagacestat) was associated with poorer cognitive outcomes in Alzheimer's disease (cytarabine/daunorubicin protocol)., Semagacestat was associated with more adverse events, including Malignant neoplasm of skin and Infections of musculoskeletal system., CONCLUSIONS\nAs compared with placebo, semagacestat did not improve cognitive status, and patients receiving the higher dose had significant worsening of functional ability., OBJECTIVE\nSemagacestat, a γ-secretase inhibitor, demonstrated an unfavorable risk-benefit profile in a Phase 3 study of patients with Alzheimer's disease (IDENTITY trials), and clinical development was halted., Recently disclosed Phase III findings on semagacestat indicated that Alzheimer's disease (cytarabine/daunorubicin protocol) patients on this Pharmacologic Substance showed significantly worsened cognitive function compared to those treated with placebo., The recent failure of semagacestat in two large Phase III studies questions the value of γ-secretase inhibitors in treating Alzheimer's disease., A phase 3 trial of semagacestat for treatment of Alzheimer's disease.As compared with placebo, semagacestat did not improve cognitive status, and patients receiving the higher dose had significant worsening of functional ability. , Preliminary results from Phase III studies showed that semagacestat failed to slow disease progression, and it was associated with worsening of clinical measures of cognition and the ability to perform activities of daily living. , Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of ALZHEIMER DISEASE, FAMILIAL, 1.In participants with mild to moderate cytarabine/daunorubicin protocol, high dose semagacestat treatment was associated with greater severity and faster worsening of Nail-Patella Syndrome in a pattern resembling an agitated depression. , Patients treated with semagacestat lost more weight and had more Malignant neoplasm of skin and Infections of musculoskeletal system, treatment discontinuations due to adverse events, and serious adverse events (P<0.001 for all comparisons with placebo)., OBJECTIVE: Semagacestat, a γ-secretase inhibitor, demonstrated an unfavorable risk-benefit profile in a Phase 3 study of patients with Alzheimer's disease (IDENTITY trials), and clinical development was halted., Other relevant safety findings associated with semagacestat treatment included cognitive and functional worsening, skin-related TEAEs, Kidney and hepatic changes, increased QT interval, and Measured Measured weight loss (observable entity) (observable entity)., Patients treated with semagacestat lost more weight and had more Malignant neoplasm of skin and Infections of musculoskeletal system, treatment discontinuations due to adverse events, and serious adverse events (P<0.001 for all comparisons with placebo)., Semagacestat, a γ-secretase inhibitor, demonstrated an unfavorable risk-benefit profile in a Phase 3 study of patients with Alzheimer's disease (IDENTITY trials), and clinical development was halted.[SEP]Relations: familial Alzheimer disease has relations: disease_disease with Alzheimer disease, disease_disease with Alzheimer disease, disease_phenotype_positive with Perseveration, disease_phenotype_positive with Perseveration, disease_disease with inherited prion disease, disease_disease with inherited prion disease. cognitive disorder has relations: disease_disease with dementia (disease), disease_disease with dementia (disease), contraindication with Lithium citrate, contraindication with Lithium citrate. Definitions: Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Kidney defined as following: Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.. Nail-Patella Syndrome defined as following: A syndrome of multiple abnormalities characterized by the absence or hypoplasia of the PATELLA and congenital nail dystrophy. It is a genetically determined autosomal dominant trait.. Malignant neoplasm of skin defined as following: A primary or metastatic malignant neoplasm involving the skin. Primary malignant skin neoplasms most often are carcinomas (either basal cell or squamous cell carcinomas) or melanomas. Metastatic malignant neoplasms to the skin include carcinomas and lymphomas.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: Alzheimer's disease caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65.. Cognition Disorders defined as following: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.. Measured weight loss (observable entity) defined as following: The measured decrease in body weight over a specified period of time.. Alzheimer's disease defined as following: Alzheimer's disease caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65..", "label": "no"} {"original_question": "Does UBE4B promote renal cancer?", "id": "converted_4408", "sentence1": "Does UBE4B gene promote renal cancer?", "sentence2": "UBE4B gene gene might act as an Oncogenes in regulating Conventional (Clear Cell) Renal Cell Carcinoma development. Therefore it could be served as an effective indicator to predict OS and a potential biomarker for targeted therapy of Conventional (Clear Cell) Renal Cell Carcinoma patients.[SEP]Relations: UBE4B gene has relations: anatomy_protein_present with kidney, anatomy_protein_present with kidney, protein_protein with UBC, protein_protein with UBC, protein_protein with UBE2C, protein_protein with UBE2C, anatomy_protein_present with renal glomerulus, anatomy_protein_present with renal glomerulus, protein_protein with UBE2V1, protein_protein with UBE2V1. Definitions: Conventional (Clear Cell) Renal Cell Carcinoma defined as following: A malignant epithelial neoplasm of the kidney characterized by the presence of lipid-containing clear cells within a vascular network. The tumor may metastasize to unusual sites and late metastasis is common.. Oncogenes defined as following: Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of \"v-\" before Oncogenes symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix \"c-\" before the gene symbol of an Oncogenes indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-Oncogenes.. UBE4B gene defined as following: This gene plays a role in polyubiquitination.. renal cancer defined as following: Primary or metastatic malignant neoplasm involving the kidney..", "label": "yes"} {"original_question": "Is there a role of proton beam therapy in medulloblastoma treatment?", "id": "converted_1992", "sentence1": "Is there a role of proton beam therapy in Medulloblastoma treatment?", "sentence2": "All papers directly compared outcomes from Protons with photons, five papers included Medulloblastoma, four papers each included craniopharyngioma and low grade Glioma and three papers included ependymoma., There are many indications of protontherapy for paediatric brain tumours in curative intent, either for localized treatment of Ependymoma, germ-cell tumours, Craniopharyngioma, low-grade Glioma; or panventricular irradiation of pure non-secreting germinoma; or craniospinal irradiation of medulloblastomas and metastatic pure Germinoma., Cost-effectiveness analysis of cochlear dose reduction by proton beam therapy for Medulloblastoma in childhood., BACKGROUND: The aim of this study is to evaluate the cost-effectiveness of proton beam therapy with cochlear dose reduction compared with conventional X-ray radiotherapy for Medulloblastoma in childhood.METHODS: We developed a Markov model to describe health states of 6-year-old children with Medulloblastoma after treatment with proton or X-ray radiotherapy., Evaluation of permanent alopecia in pediatric Medulloblastoma patients treated with proton radiation., BACKGROUND: To precisely calculate skin dose and thus to evaluate the relationship between the skin dose and permanent alopecia for pediatric Medulloblastoma patients treated with proton beams., CONCLUSIONS: Our results based on 12 patients provide a relationship between the skin dose and permanent alopecia for pediatric Medulloblastoma patients treated with Protons. , Proton beam craniospinal irradiation reduces acute Toxic effect for adults with Medulloblastoma., PURPOSE: Efficacy and acute Toxic effect of proton craniospinal irradiation (p-CSI) were compared with conventional photon CSI (x-CSI) for adults with Medulloblastoma., CONCLUSIONS: This report is the first analysis of clinical outcomes for adult Medulloblastoma patients treated with p-CSI. , Dilemmas concerning dose distribution and the influence of relative biological effect in proton beam therapy of Medulloblastoma., OBJECTIVE: To improve Medulloblastoma proton therapy., The aim of this study is to evaluate the cost-effectiveness of proton beam therapy with cochlear dose reduction compared with conventional X-ray radiotherapy for Medulloblastoma in childhood., The aim of this study is to evaluate the cost-effectiveness of proton beam therapy with cochlear dose reduction compared with conventional X-ray radiotherapy for Medulloblastoma in childhood.We developed a Markov model to describe health states of 6-year-old children with Medulloblastoma after treatment with proton or X-ray radiotherapy, All patients completed therapy without interruption.Our proton-beam technique for craniospinal irradiation of pediatric Medulloblastoma has successfully reduced normal-tissue doses and acute treatment-related sequelae, Potential role of proton therapy in the treatment of pediatric Medulloblastoma/primitive neuro-ectodermal tumors: spinal theca irradiation, For 6 MV x-rays > 60% of the dose prescribed to the target was delivered to 44% of the Chest>Heart volume, while the proton beam was able to completely avoid the Chest>Heart, the Abdomen>Liver, and in all likelihood the THYROID DIAGNOSTIC RADIOPHARMACEUTICALS and Gonadal structure as well.The present study demonstrates a potential role of proton therapy in decreasing the dose (and Toxic effect) to the critical structures in the irradiation of the spinal neuraxis in Medulloblastoma/PNET, Potential role of proton therapy in the treatment of pediatric Medulloblastoma/primitive neuroectodermal tumors: reduction of the supratentorial target volume, This review describes the role of radiation in general and proton therapy in particular for the treatment of Medulloblastoma, central nervous system primitive neuroectodermal tumors, atypical teratoid/rhabdoid tumors, and the recently described Embryonal Neoplasm with multilayered rosettes, Reducing Toxic effect from craniospinal irradiation: using proton beams to treat Medulloblastoma in young children., Intensity-modulated radiotherapy did show more Urinary Bladder dose reduction than the other techniques in Sarcoma of pelvis irradiation.CONCLUSIONS: In the diseases studied, using various techniques of 3D-CRT, electrons, IMRT, and Protons, Protons are most optimal in treating Retinoblastoma, medulloblastomas (posterior fossa and craniospinal), and pelvic sarcomas., For 6 MV x-rays>60% of the dose prescribed to the target was delivered to 44% of the Chest>Heart volume, while the proton beam was able to completely avoid the Chest>Heart, the Abdomen>Liver, and in all likelihood the THYROID DIAGNOSTIC RADIOPHARMACEUTICALS and Gonadal structure as well.CONCLUSION: The present study demonstrates a potential role of proton therapy in decreasing the dose (and Toxic effect) to the critical structures in the irradiation of the spinal neuraxis in Medulloblastoma/PNET., In Medulloblastoma, three posterior fossa irradiation techniques were analyzed: 3D-CRT, IMRT, and Protons., Potential role of proton therapy in the treatment of pediatric Medulloblastoma/primitive neuro-ectodermal tumors: spinal theca irradiation., Potential role of proton therapy in the treatment of pediatric Medulloblastoma/primitive neuroectodermal tumors: reduction of the supratentorial target volume., The present study demonstrates a potential role of proton therapy in decreasing the dose (and Toxic effect) to the critical structures in the irradiation of the spinal neuraxis in Medulloblastoma/PNET., Cost-effectiveness analysis of cochlear dose reduction by proton beam therapy for Medulloblastoma in childhood., Dilemmas concerning dose distribution and the influence of relative biological effect in proton beam therapy of Medulloblastoma., To improve Medulloblastoma proton therapy., Our proton-beam technique for craniospinal irradiation of pediatric Medulloblastoma has successfully reduced normal-tissue doses and acute treatment-related sequelae., Treatment planning with Protons for pediatric retinoblastoma, Medulloblastoma, and Sarcoma of pelvis: how do Protons compare with other conformal techniques?[SEP]Relations: Medulloblastoma has relations: disease_phenotype_positive with mismatch repair cancer syndrome, disease_phenotype_positive with mismatch repair cancer syndrome, disease_phenotype_positive with Medulloblastoma, disease_phenotype_positive with Medulloblastoma, disease_phenotype_positive with pleuropulmonary blastoma, disease_phenotype_positive with pleuropulmonary blastoma, disease_phenotype_positive with Li-Fraumeni syndrome, disease_phenotype_positive with Li-Fraumeni syndrome, disease_phenotype_positive with Gardner syndrome, disease_phenotype_positive with Gardner syndrome. Definitions: Protons defined as following: Stable elementary particles having the smallest known positive charge, found in the nuclei of all elements. The proton mass is less than that of a neutron. A proton is the nucleus of the light hydrogen atom, i.e., the hydrogen ion.. Urinary Bladder defined as following: A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the Urinary Bladder via the ureters (URETER), and is held there until URINATION.. Retinoblastoma defined as following: A malignant tumor arising from the nuclear layer of the retina that is the most common primary tumor of the eye in children. The tumor tends to occur in early childhood or infancy and may be present at birth. The majority are sporadic, but the condition may be transmitted as an autosomal dominant trait. Histologic features include dense cellularity, small round polygonal cells, and areas of calcification and necrosis. An abnormal pupil reflex (leukokoria); NYSTAGMUS, PATHOLOGIC; STRABISMUS; and visual loss represent common clinical characteristics of this condition. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2104). Sarcoma of pelvis defined as following: Sarcoma involving the organs and structures of the pelvis.. Embryonal Neoplasm defined as following: A usually malignant neoplasm composed of primitive (immature) tissues that resemble fetal tissues. Medulloblastoma, ependymoblastoma, pineoblastoma, and Wilms tumor are representative embryonal neoplasms.. Craniopharyngioma defined as following: A benign pituitary-region neoplasm that originates from Rathke's pouch. The two major histologic and clinical subtypes are adamantinous (or classical) craniopharyngioma and papillary craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary Craniopharyngioma occur in adults, and histologically feature a squamous epithelium with papillations. (From Joynt, Clinical Neurology, 1998, Ch14, p50). Ependymoma defined as following: Glioma derived from EPENDYMOGLIAL CELLS that tend to present as malignant intracranial tumors in children and as benign intraspinal neoplasms in adults. It may arise from any level of the ventricular system or central canal of the spinal cord. Intracranial Ependymoma most frequently originate in the FOURTH VENTRICLE and histologically are densely cellular tumors which may contain ependymal tubules and perivascular pseudorosettes. Spinal Ependymoma are usually benign papillary or myxopapillary tumors. (From DeVita et al., Principles and Practice of Oncology, 5th ed, p2018; Escourolle et al., Manual of Basic Neuropathology, 2nd ed, pp28-9). Gonadal structure defined as following: The gamete-producing glands, OVARY or TESTIS.. Germinoma defined as following: A malignant neoplasm of the germinal tissue of the GONADS; MEDIASTINUM; or pineal region. Germinomas are uniform in appearance, consisting of large, round cells with vesicular nuclei and clear or finely granular eosinophilic-staining cytoplasm. (Stedman, 265th ed; from DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1642-3). Glioma defined as following: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21). Medulloblastoma defined as following: A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1). Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something..", "label": "yes"} {"original_question": "Is p53 a transcription factor?", "id": "converted_2734", "sentence1": "Is TP53 wt Allele a TRANSCRIPTION FACTOR?", "sentence2": "As a TRANSCRIPTION FACTOR, TP53 wt Allele mainly exerts its tumor suppressive function through transcriptional regulation of many target Genes., TP53 wt Allele functions primarily as a sequence-specific TRANSCRIPTION FACTOR that controls the expression of hundreds of protein-coding Genes and noncoding RNAs, including microRNAs (MicroRNAs) and long noncoding RNAs (lncRNAs)., TP53 wt Allele is a TRANSCRIPTION FACTOR [SEP]Relations: TRANSCRIPTION FACTOR binding has relations: molfunc_protein with TP53, molfunc_protein with TP53, molfunc_protein with PPID, molfunc_protein with PPID, molfunc_protein with PPARA, molfunc_protein with PPARA, molfunc_protein with SP1, molfunc_protein with SP1, molfunc_protein with NPM1, molfunc_protein with NPM1. Definitions: TP53 wt Allele defined as following: Human TP53 wild-type allele is located in the vicinity of 17p13.1 and is approximately 19 kb in length. This allele, which encodes cellular tumor antigen TP53 wt Allele protein, plays a role in cell cycle regulation during the G0/G1transition. Alterations of the TP53 gene occur as both somatic and germline mutations in human malignancies in select cancer-prone families with Li-Fraumeni syndrome.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. MicroRNAs defined as following: Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 MicroRNAs discovered, and are from a class of MicroRNAs involved in developmental timing.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Is TALEN being used on stem cells?", "id": "converted_529", "sentence1": "Is TALEN being used on Stem cells?", "sentence2": "Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent Stem cells by TALEN and CRISPR-Cas9., Genetic correction of patient-derived induced pluripotent Stem cells (iPSCs) by Transcription Activator-Like Effector Nucleases or CRISPR-Cas9 holds promise for DMD gene therapy; however, the safety of such nuclease treatment must be determined., We generated helper-dependent, capsid-Changing adenovirus (HD-Ad5/35) vectors for zinc-finger nuclease (ZFN)- or transcription activator-like effector nuclease (TALEN)-mediated Genome - anatomical entity editing in Homo sapiens CD34+ hematopoietic Stem cells (Hematopoietic Stem cells) from mobilized adult donors. , We used transcription activator-like effector nuclease (TALEN)-mediated gene editing in mouse embryonic Stem cells (mESCs) to produce CASP14 gene with targeted gene disruptions and Clinical act of insertion in two Y-linked Genes--SRY protein, Homo sapiens and UTY gene., Transcription activator-like effector nuclease (TALEN)-mediated gene correction in integration-free β-thalassemia induced pluripotent Stem cells., A TALEN Genome - anatomical entity-editing system for generating Homo sapiens stem cell-based disease models., Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted Homo sapiens stem cell Clone Cells detected by whole-Genome - anatomical entity sequencing., Using CRISPR-Cas9 and TALEN targeted Homo sapiens pluripotent stem cell Clone Cells, we performed whole-Genome - anatomical entity sequencing at high coverage in order to assess the degree of Mutagenesis Procedure across the entire Genome - anatomical entity., A Changing TALEN-based system for robust generation of knock-out Homo sapiens pluripotent stem cell lines and disease models., In this study, we utilized a cell-penetrating peptide-based system for ZFN and TALEN delivery., At all loci tested we obtained Human Embryonic Stem Cells (ESTERASE C) and induced pluripotent stem cell (iPSC) Clone Cells carrying transgenic cassettes solely at the TALEN-specified location., We report here the use of Transcription Activator-Like Effector Nucleases to rapidly and efficiently generate mutant alleles of 15 Genes in cultured Diploid Cell or Homo sapiens pluripotent Stem cells, the latter for which we differentiated both the targeted lines and isogenic control lines into various metabolic cell types., Zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (Transcription Activator-Like Effector Nucleases) have been successfully used to knock out endogenous Genes in stem cell research., Here we report different methods to efficiently perform TALEN-mediated gene integration and inactivation in different mammalian cell systems including induced pluripotent Stem cells and delineate experimental examples associated with these approaches, Together, our results demonstrate that TALE-based transcriptional repressor and Transcription Activator-Like Effector Nucleases are two promising approaches for loss-of-function studies of microRNA clusters in Diploid Cell and pluripotent Stem cells, We report here the use of Transcription Activator-Like Effector Nucleases to rapidly and efficiently generate mutant alleles of 15 Genes in cultured Diploid Cell or Homo sapiens pluripotent Stem cells, the latter for which we differentiated both the targeted lines and isogenic control lines into various metabolic cell types, TALEN-mediated generation and genetic correction of disease-specific Homo sapiens induced pluripotent Stem cells., Baculoviral transduction facilitates TALEN-mediated targeted transgene integration and Cre/LoxP cassette exchange in Homo sapiens-induced pluripotent Stem cells., We used transcription activator-like effector nuclease (TALEN)-mediated gene editing in mouse embryonic Stem cells (mESCs) to produce CASP14 gene with targeted gene disruptions and Clinical act of insertion in two Y-linked Genes--SRY protein, Homo sapiens and UTY gene. , Using CRISPR-Cas9 and TALEN targeted Homo sapiens pluripotent stem cell Clone Cells, we performed whole-Genome - anatomical entity sequencing at high coverage in order to assess the degree of Mutagenesis Procedure across the entire Genome - anatomical entity. , A 5% ResponseLevel - ResponseLevel - modification rate was observed in Homo sapiens induced pluripotent Stem cells (hiPSCs) treated with TAT-TALEN as measured by the Surveyor assay. TAT-TALEN protein-mediated gene disruption was applicable in hiPSCs and represents a promising technique for gene knockout in Stem cells., Here we engineered transcription activator-like effector nucleases (Transcription Activator-Like Effector Nucleases) for five distinct genomic loci. At all loci tested we obtained Human Embryonic Stem Cells (ESTERASE C) and induced pluripotent stem cell (iPSC) Clone Cells carrying transgenic cassettes solely at the TALEN-specified location., Seamless correction of the sickle cell disease Mutation Abnormality of the HBB gene in Homo sapiens induced pluripotent Stem cells using Transcription Activator-Like Effector Nucleases., At all loci tested we obtained Human Embryonic Stem Cells (ESTERASE C) and induced pluripotent stem cell (iPSC) Clone Cells carrying transgenic cassettes solely at the TALEN-specified location. Our data suggest that Transcription Activator-Like Effector Nucleases employing the specific architectures described here mediate site-specific Genome - anatomical entity ResponseLevel - ResponseLevel - modification in Homo sapiens pluripotent cells with similar efficiency and precision as do Zinc Finger Nucleases (ZFNs).[SEP]Relations: hematopoietic stem cell homeostasis has relations: bioprocess_protein with EMCN, bioprocess_protein with EMCN, bioprocess_protein with ADAR, bioprocess_protein with ADAR, bioprocess_protein with NLE1, bioprocess_protein with NLE1, bioprocess_protein with CCN3, bioprocess_protein with CCN3, bioprocess_protein with EXT1, bioprocess_protein with EXT1. Definitions: Transcription Activator-Like Effector Nucleases defined as following: Artificial nucleases that cleave DNA at a defined distance from specific DNA sequences recognized by TRANSCRIPTION ACTIVATOR-LIKE EFFECTORS. They are composed of an endodeoxyribonuclease fused to DNA-binding domains of the transcription activator-like effectors.. Genome - anatomical entity defined as following: Anatomical set of Genes in all the chromosomes.. Hematopoietic Stem cells defined as following: Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood.. Human Embryonic Stem Cells defined as following: A type of PLURIPOTENT STEM CELLS derived from early stage Homo sapiens embryos, up to and including the BLASTOCYST stage.. Stem cells defined as following: Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells.. Mutagenesis Procedure defined as following: Production of genetic alterations by any technique, including chemicals, radiation, recombination, or other molecular biology methods.. Zinc Finger Nucleases defined as following: Genetically engineered nucleases that cleave DNA at a defined distance from specific DNA sequences recognized by ZINC FINGER DNA-BINDING DOMAINS. They are composed of a DNA cleaving domain adapted from DNA endonucleases fused to a zinc finger DNA-binding domain.. SRY protein, Homo sapiens defined as following: Sex-determining region Y protein (204 aa, ~24 kDa) is encoded by the Homo sapiens SRY gene. This protein is involved in sex determination and transcriptional regulation.. Clone Cells defined as following: A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed). Changing defined as following: The act of alteration or ResponseLevel - modification; changed or altered in form or character.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. pluripotent Stem cells defined as following: Cells that can give rise to cells of the three different GERM LAYERS.. Clinical act of insertion defined as following: The act of putting one thing into another.. ResponseLevel - modification defined as following:

Respond with exceptions, completions and modifications or revisions done before completion

. mouse embryonic Stem cells defined as following: PLURIPOTENT STEM CELLS derived from the BLASTOCYST INNER CELL MASS of day 3.5 mouse embryos.. Y-linked Genes defined as following: Genes that are located on the Y CHROMOSOME.. HBB gene defined as following: This gene plays a role in the transport of oxygen to tissues of the adult body.. Homo sapiens defined as following: Members of the species Homo sapiens.. Diploid Cell defined as following: Nucleated cell which has one or more diploid sets (46 pairs) of chromosomes.. TALEN defined as following: Artificial nucleases that cleave DNA at a defined distance from specific DNA sequences recognized by TRANSCRIPTION ACTIVATOR-LIKE EFFECTORS. They are composed of an endodeoxyribonuclease fused to DNA-binding domains of the transcription activator-like effectors..", "label": "yes"} {"original_question": "Is the Paramyxovirus geneome segmented, negative-sense RNA?", "id": "converted_3832", "sentence1": "Is the Paramyxovirus geneome segmented, negative-sense RNA?", "sentence2": "The Paramyxovirus, NOS family has a Genome - anatomical entity consisting of a single strand of negative sense RNA, The avian Paramyxovirus, NOS type 1 (APMV-1), or Newcastle disease virus (NDV), comprise a diverse group of Virus with a single-stranded, negative-sense RNA Genome - anatomical entity., Members of the Paramyxoviridae sp. sp. such as measles, mumps, and parainfluenza Virus have pleomorphic, enveloped virions that contain negative-sense unsegmented RNA genomes., UNLABELLED: Mumps virus (MuV), a Paramyxovirus, NOS containing a negative-sense nonsegmented RNA Genome - anatomical entity, is a Homo sapiens pathogen that causes an Acute infectious disease with symptoms ranging from Parotitis to mild meningitis and severe Encephalitis., UNLABELLED: Mumps virus (MuV) is a Paramyxovirus, NOS with a negative-sense nonsegmented RNA Genome - anatomical entity., Paramyxoviridae sp. sp., a large family of enveloped Virus harboring a nonsegmented negative-sense RNA Genome - anatomical entity, include important Homo sapiens pathogens as measles, mumps, Human Human respiratory syncytial virus (RSV), parainfluenza Virus, and Henipavirus, which cause some of the deadliest emerging zoonoses. There , Parainfluenza Virus 5 (PIV5) is a member of the Paramyxoviridae sp. sp. family of membrane-enveloped Virus with a negative-sense RNA Genome - anatomical entity that is packaged and protected by long filamentous nucleocapsid-helix structures (RNPs). , The Paramyxovirus, NOS Genome - anatomical entity, a nonsegmented, negative-polarity, single-stranded RNA of approximately 15 kb, contains six transcription units flanked at the 3' and 5' ends by a short (approximately 50- to 60-nucleotide) extracistronic sequence, dubbed the positive and negative leader regions. These, The replication of nonsegmented minus-strand RNA genomes, like that of Sendai Paramyxovirus, NOS (SeV), are controlled by the short leader regions present at each end of the linear genomes and antigenomes; the left and right promoters (HOXA10 protein, Homo sapiens and Receptors, Progesterone), respectively. Wil, UNLABELLED: Mumps virus (MuV), a Paramyxovirus, NOS containing a negative-sense nonsegmented RNA Genome - anatomical entity, is a Homo sapiens pathogen that causes an Acute infectious disease with symptoms ranging from Parotitis to mild meningitis and severe enc, s viral glycoprotein cytoplasmic domains may play a role in this coordination, we have investigated the importance of the Hemagglutinin-Neuraminidase (HN) protein cytoplasmic domain in the assembly of the nonsegmented negative-strand RNA Paramyxovirus, NOS simian virus 5 (SV5). By, Beilong virus, a novel Paramyxovirus, NOS with the largest Genome - anatomical entity of non-segmented negative-stranded RNA Virus., The Paramyxovirus, NOS Genome - anatomical entity, a nonsegmented, negative-polarity, single-stranded RNA of approximately 15 kb, contains six transcription units flanked at the 3' and 5' ends by a short (approximately 50- to 60-nucleotide) extracistronic sequence, dubbed the positive and negative leader regions., Paramyxovirus particles are pleomorphic, with a lipid envelope, nonsegmented RNA genomes of negative polarity, and densely packed glycoproteins on the virion surface., An alternative method to determine the 5' All All extremities of non-segmented, negative sense RNA viral genomes using positive replication intermediate 3' tailing: application to two members of the Paramyxoviridae sp. sp. family., Simian parainfluenza virus 5 (SV5) is a prototype of the Paramyxoviridae sp. sp. family of nonsegmented negative-sense RNA Virus., Human Metapneumovirus (HMPV), a single-stranded negative-sense RNA virus belonging to the family Paramyxoviridae sp. sp., is associated with respiratory tract illness, primarily in young children and persons with underlying disease.[SEP]Relations: Parotitis has relations: disease_phenotype_positive with sarcoidosis, disease_phenotype_positive with sarcoidosis. Protein S Homo sapiens has relations: drug_drug with Deferasirox, drug_drug with Deferasirox, drug_drug with Dactinomycin, drug_drug with Dactinomycin, drug_drug with Interferon beta-1b, drug_drug with Interferon beta-1b, drug_drug with Ximelagatran, drug_drug with Ximelagatran. Definitions: Parotitis defined as following: INFLAMMATION of the PAROTID GLAND.. Human Metapneumovirus defined as following: A species of nonsegmented, negative-strand ssRNA Virus in the family Paramyxoviridae sp.. Infections with Homo sapiens metapneumovirus can cause upper and lower respiratory tract infections in patients of all ages. This virus is second only to Human respiratory syncytial virus as the most commonly identified cause of pediatric lower respiratory illness.. Homo sapiens defined as following: Members of the species Homo sapiens.. Genome - anatomical entity defined as following: Anatomical set of genes in all the chromosomes.. Paramyxovirus, NOS defined as following: A single-stranded, negative-sense RNA virus of the Paramyxoviridae sp. family.. Human respiratory syncytial virus defined as following: The type species of PNEUMOVIRUS and an important cause of lower respiratory disease in infants and young children. It frequently presents with bronchitis and bronchopneumonia and is further characterized by fever, cough, dyspnea, wheezing, and pallor.. Encephalitis defined as following: Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition.. Receptors, Progesterone defined as following: Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives.. HOXA10 protein, human defined as following: Homeobox protein Hox-A10 (410 aa, ~42 kDa) is encoded by the Homo sapiens HOXA10 gene. This protein plays a role in embryonic pattern formation.. Parainfluenza Virus 5 defined as following: A species of RUBULAVIRUS originally isolated from cultured primary monkey cells. Its natural host is the DOG in which it causes kennel cough, but it can also infect humans.. Virus defined as following: Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells.. Henipavirus defined as following: A genus of enveloped, pleomorphically spherical Virus in the family Paramyxoviridae sp.. The Genome - anatomical entity is composed of a linear single-strand of negative sense RNA. The Henipavirus natural reservoir is considered to be fruit bats of the Pteropodidae family and cause influenza-like illness in humans.. Newcastle disease virus defined as following: The most well known avian Paramyxovirus, NOS in the genus AVULAVIRUS and the cause of a highly infectious pneumoencephalitis in fowl. It is also reported to cause CONJUNCTIVITIS in humans. Transmission is by droplet inhalation or ingestion of contaminated water or food..", "label": "no"} {"original_question": "Is lactotransferrin a tumour suppressor?", "id": "converted_3115", "sentence1": "Is lactoferrin a tumour suppressor?", "sentence2": "LTF protein, human protein, human (LTF protein, human gene, or LTF protein, human protein, human gene) plays important role in innate immunity, and its anti-tumor function has also been reported in multiple cancers., We previously reported that LTF protein, human protein, human is significantly down-regulated in nasopharyngeal carcinoma (Nasopharyngeal carcinoma) and acts as a tumor suppressor by suppressing Proto-Oncogene Proteins c-akt signaling., The tumor suppressor function of LTF protein, human gene (LTF protein, human protein, human) has been reported in a variety of Neoplasms, including GC, nasopharyngeal carcinoma (Nasopharyngeal carcinoma) and Malignant neoplasm of prostate., Lactotransferrin (LTF protein, human protein, human) has been confirmed to act as a tumor suppressor in multiple cancers, Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing Proto-Oncogene Proteins c-akt through multiple mechanisms., LTF protein, human protein, human is likely to be a candidate tumor suppressor and downregulates the development of Nasopharyngeal carcinoma by inhibiting Nasopharyngeal carcinoma proliferation through induction of cell cycle arrest and modulation of the MAPK signaling pathway.[SEP]Relations: LTF protein, human gene transport has relations: bioprocess_bioprocess with protein transport, bioprocess_bioprocess with protein transport, bioprocess_bioprocess with iron ion transport, bioprocess_bioprocess with iron ion transport. Protein S human has relations: drug_drug with Nitroaspirin, drug_drug with Nitroaspirin, drug_drug with Cefapirin, drug_drug with Cefapirin, drug_drug with Ximelagatran, drug_drug with Ximelagatran. Definitions: Nasopharyngeal carcinoma defined as following: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.. Malignant neoplasm of prostate defined as following: A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas.. Proto-Oncogene Proteins c-akt defined as following: Expressed in diverse tissues, Protein Kinase B (Proto-Oncogene Proteins c-akt/RAC Family) is a group (Alpha, Beta and Gamma) of cytoplasmic serine/threonine enzymes that covalently transfer the terminal, gamma phosphate group from ATP to a variety of substrate proteins and regulate cell signaling responses to insulin, PDGF, and IGF1 (through PI3K) involved in cell survival, cell proliferation, differentiation, apoptosis, glycogen synthesis, and glucose uptake.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. LTF protein, human gene defined as following: This gene is involved in both the transport of iron and proteolysis.. lactoferrin defined as following: This gene is involved in both the transport of iron and proteolysis.. LTF protein, human defined as following: Lactotransferrin (710 aa, ~78 kDa) is encoded by the human LTF protein, human gene. This protein is involved in the mediation of both proteolysis and iron transport..", "label": "yes"} {"original_question": "Can bergapten cross the blood-brain barrier?", "id": "converted_4367", "sentence1": "Can 5-methoxypsoralen cross the Blood - brain barrier function?", "sentence2": "Moreover, pharmacokinetic studies showed that 5-methoxypsoralen has higher absolute bioavailability and can cross the Blood - brain barrier function and has a great potential for treating Brain Diseases, but the mechanism needs further clarification to make greater use of its ability to treat brain diseases. [SEP]Relations: blood brain barrier has relations: anatomy_anatomy with glial blood brain barrier, anatomy_anatomy with glial blood brain barrier, anatomy_anatomy with cell layer, anatomy_anatomy with cell layer. Brain Diseases has relations: contraindication with Cefepime, contraindication with Cefepime, contraindication with Cyclopentolate, contraindication with Cyclopentolate, contraindication with Edrophonium, contraindication with Edrophonium. Definitions: 5-methoxypsoralen defined as following: A linear furanocoumarin that has phototoxic and anti-inflammatory properties, with effects similar to METHOXSALEN. It is used in PUVA THERAPY for the treatment of PSORIASIS.. Brain Diseases defined as following: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM..", "label": "yes"} {"original_question": "Are BBS mutations involved in syndromic Hirschsprung disease?", "id": "converted_525", "sentence1": "Are Bardet-Biedl Syndrome Gene Mutation involved in syndromic Hirschsprung disease?", "sentence2": "Epistasis between ret unit of radiation dose and Bardet-Biedl Syndrome Gene Mutation modulates enteric innervation and causes syndromic Hirschsprung disease, Here, we report 3 families with Bardet-Biedl Syndrome and HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 with concomitant Gene Mutation in Bardet-Biedl Syndrome genes and regulatory ret unit of radiation dose elements, whose functionality is tested in physiologically relevant assays. Our data suggest that Bardet-Biedl Syndrome Gene Mutation can potentiate HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 predisposing ret unit of radiation dose alleles, which by themselves are insufficient to cause disease, Epistasis between ret unit of radiation dose and Bardet-Biedl Syndrome Gene Mutation modulates enteric innervation and causes syndromic Hirschsprung disease., Our data suggest that Bardet-Biedl Syndrome Gene Mutation can potentiate HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 predisposing ret unit of radiation dose alleles, which by themselves are insufficient to cause disease., Here, we report 3 families with Bardet-Biedl Syndrome and HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 with concomitant Gene Mutation in Bardet-Biedl Syndrome genes and regulatory ret unit of radiation dose elements, whose functionality is tested in physiologically relevant assays, Our data suggest that Bardet-Biedl Syndrome Gene Mutation can potentiate HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 predisposing ret unit of radiation dose alleles, which by themselves are insufficient to cause disease, Here, we report 3 families with Bardet-Biedl Syndrome and HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 with concomitant Gene Mutation in Bardet-Biedl Syndrome genes and regulatory ret unit of radiation dose elements, whose functionality is tested in physiologically relevant assays[SEP]Relations: hirschsprung disease, susceptibility to has relations: disease_phenotype_positive with Autosomal dominant inheritance, disease_phenotype_positive with Autosomal dominant inheritance, disease_protein with MED12, disease_protein with MED12, disease_protein with EDNRB, disease_protein with EDNRB, disease_protein with GDNF, disease_protein with GDNF, disease_protein with ret unit of radiation dose, disease_protein with ret unit of radiation dose. Definitions: ret unit of radiation dose defined as following: a unit of radiation dose. Bardet-Biedl Syndrome defined as following: An autosomal recessive disorder characterized by RETINITIS PIGMENTOSA; POLYDACTYLY; OBESITY; MENTAL RETARDATION; hypogenitalism; renal dysplasia; and short stature. This syndrome has been distinguished as a separate entity from LAURENCE-MOON SYNDROME. (From J Med Genet 1997 Feb;34(2):92-8). Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA..", "label": "yes"} {"original_question": "Is Ubrogepant effective for migraine?", "id": "converted_3483", "sentence1": "Is ubrogepant effective for migraine?", "sentence2": "Calcitonin Gene-Related Peptide receptor antagonists such as ubrogepant are effective for acute relief of migraine Headache, whereas Monoclonal Antibodies against Calcitonin Gene-Related Peptide (eptinezumab, fremanezumab and galcanezumab) or the Calcitonin Gene-Related Peptide receptor (erenumab) effectively prevent migraine attacks. , Despite the clear safety concerns, clinical trial data suggests that their intermittent use remains a viable and safe alternative, with 2 Molecule remaining in clinical development (ubrogepant and rimegepant). , Two gepants, ubrogepant and rimegepant, have completed positive pivotal trials for acute treatment of migraine, but have not yet been submitted to the FDA for this indication., Two gepants, ubrogepant and rimegepant, have completed positive pivotal trials for the acute treatment of migraine, but have not yet been submitted to the FDA for this indication. , Geographic Locations covered: This review reports on compounds currently under development for the oral treatment of acute migraine attacks, focusing on Calcitonin-Gene-Related-Peptide receptor antagonists, specifically ubrogepant and rimegepant. , Furthermore, new hope rises for the Calcitonin Gene-Related Peptide (calcitonin-gene related peptide)-antagonists, as the data for ubrogepant do not suggest Hepatotoxicity but efficacy. , We applied this strategy for another late-stage clinical program: ubrogepant (MK-1602), a novel oral Calcitonin Gene-Related Peptide Receptor Antagonists for acute treatment of migraine. , A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine., AIM: The aim of this trial was to evaluate the efficacy and tolerability of ubrogepant (MK-1602), a Calcitonin Gene-Related Peptide Receptor Antagonists (Calcitonin Gene-Related Peptide-RA), for the acute treatment of migraine., ubrogepant 100 mg was significantly superior to placebo for two-hour pain freedom (25.5% vs 8.9%) but not for two-hour Headache response., CONCLUSION: This trial supports ubrogepant's efficacy and provides further evidence that Calcitonin Gene-Related Peptide-RAs are viable options for the acute treatment of migraine., Meanwhile, 1 small-molecule Calcitonin Gene-Related Peptide receptor antagonist (ubrogepant, MK-1602) is currently in phase 3 studies for the acute treatment of migraine., Calcitonin Gene-Related Peptide receptor antagonists such as ubrogepant are effective for acute relief of migraine Headache, whereas Monoclonal Antibodies against Calcitonin Gene-Related Peptide (eptinezumab, fremanezumab and galcanezumab) or the Calcitonin Gene-Related Peptide receptor (erenumab) effectively prevent migraine attacks., Recent findings\n\nCalcitonin Gene-Related Peptide II (Calcitonin Gene-Related Peptide) receptor antagonists (gepants-rimegepant and ubrogepant) and serotonin 5-HT __sub__ 1F __end_sub__ receptor agonists (ditans-lasmiditan) have completed phase 3 clinical trials and will soon offer novel, effective, well-tolerated nonvasoconstrictor options to treat acute migraine., We applied this strategy for another late-stage clinical program: ubrogepant (MK-1602), a novel oral Calcitonin Gene-Related Peptide Receptor Antagonists for acute treatment of migraine., Recently, orally administered next-generation small molecule Calcitonin Gene-Related Peptide-RAs have been shown to have safety and efficacy in acute treatment (ubrogepant and rimegepant) and prevention (atogepant) of migraine, giving additional Calcitonin Gene-Related Peptide-based therapeutic options for migraine patients., ubrogepant 100 mg was significantly superior to placebo for two-hour pain freedom (25.5% vs 8.9%) but not for two-hour Headache response., lasmiditan, rimegepant and ubrogepant will extend our therapeutic armamentarium for managing acute migraine attacks when Triptans are not effective or contraindicated due to Cardiovascular Diseases., lasmiditan, rimegepant and ubrogepant will extend our therapeutic armamentarium for managing acute migraine attacks when Triptans are not effective or contraindicated due to Cardiovascular Diseases., lasmiditan, ubrogepant, and rimegepant are currently emerging acute migraine therapies that may be added to the arsenal of current migraine management., ubrogepant for the Treatment of Migraine Disorders Disorders ., ubrogepant 100 mg was significantly superior to placebo for two-hour pain freedom (25.5% vs 8.9%) but not for two-hour Headache response., CONCLUSION\nThis trial supports ubrogepant's efficacy and provides further evidence that Calcitonin Gene-Related Peptide-RAs are viable options for the acute treatment of migraine., ubrogepant (MK-1602) is a novel, oral, Calcitonin Gene-Related Peptide Receptor Antagonists in clinical development with positive Phase III outcomes for acute treatment of migraine., CONCLUSION: This trial supports ubrogepant's efficacy and provides further evidence that Calcitonin Gene-Related Peptide-RAs are viable options for the acute treatment of migraine., This trial supports ubrogepant's efficacy and provides further evidence that Calcitonin Gene-Related Peptide-RAs are viable options for the acute treatment of migraine., ubrogepant for the Treatment of Migraine Disorders Disorders., ubrogepant is an oral, small-molecule Calcitonin Gene-Related Peptide Receptor Antagonists for acute migraine treatment.[SEP]Relations: ubrogepant has relations: drug_drug with Fosnetupitant, drug_drug with Fosnetupitant, drug_drug with Aprepitant, drug_drug with Aprepitant, drug_drug with Rimegepant, drug_drug with Rimegepant, drug_drug with Mibefradil, drug_drug with Mibefradil, drug_drug with Netupitant, drug_drug with Netupitant. Definitions: Calcitonin Gene-Related Peptide defined as following: A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator.. Monoclonal Antibodies defined as following: Antibodies produced by a single clone of cells.. Calcitonin Gene-Related Peptide Receptor Antagonists defined as following: Pharmacologic agents that block NOCICEPTIVE PAIN signaling from CALCITONIN GENE-RELATED PEPTIDE RECEPTORS. They may be useful for the treatment of pain associated with MIGRAINE DISORDERS and OSTEOARTHRITIS.. Migraine Disorders defined as following: A common, severe type of vascular Headache often associated with increased sympathetic activity, resulting in nausea, vomiting, and light sensitivity.. Calcitonin Gene-Related Peptide receptor defined as following: Cell surface proteins that bind CALCITONIN GENE-RELATED PEPTIDE with high affinity and trigger intracellular changes which influence the behavior of cells. Calcitonin Gene-Related Peptide receptors are present in both the CENTRAL NERVOUS SYSTEM and the periphery. They are formed via the heterodimerization of the CALCITONIN RECEPTOR-LIKE PROTEIN and RECEPTOR ACTIVITY-MODIFYING PROTEIN 1.. Hepatotoxicity defined as following: Toxicity that impairs or damages the liver.. Geographic Locations defined as following: The continents and countries situated on those continents; the UNITED STATES and each of the constituent states arranged by region; CANADA and each of its provinces; AUSTRALIA and each of its states; the major bodies of water and major islands on both hemispheres; and selected major cities.. Molecule defined as following: An aggregate of two or more atoms in a defined arrangement held together by chemical bonds.. Headache defined as following: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.. agonists defined as following: Used with chemicals, drugs, and endogenous substances to indicate substances or agents that have affinity for a receptor and intrinsic activity at that receptor. (From Textbook of Pharmacology, 1991, p.16). Cardiovascular Diseases defined as following: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.. Triptans defined as following: Derivatives of TRYPTAMINES that are SEROTONIN RECEPTOR AGONISTS acting at 5-HT1 RECEPTORS. Some are used to treat MIGRAINE DISORDERS.. migraine defined as following: A common, severe type of vascular Headache often associated with increased sympathetic activity, resulting in nausea, vomiting, and light sensitivity..", "label": "yes"} {"original_question": "Are immune cells affected in Amyotrophic Lateral Sclerosis?", "id": "converted_1535", "sentence1": "Are immune cells affected in Amyotrophic Lateral Sclerosis?", "sentence2": "Therapeutic immunization of mSOD1 mice with a myelin-derived peptide led to cyclophosphamide/prednisone activation, and was followed by the accumulation of immunoregulatory cells, including IL-10-producing monocyte-derived Specimen Source Codes - Macrophages and Foxp3(+) regulatory Therapeutic gamma delta T-lymphocytes, and elevation of the neurotrophic factors Insulin-Like Growth Factor I and Glial Cell Line-Derived Neurotrophic Factor in the diseased Spinal Cord parenchyma, Immunization with a Myelin-Derived Antigen Activates the Brain's Choroid Plexus for Recruitment of Immunoregulatory Cells to the Central Nervous System and Attenuates Disease Progression in a Mouse Model of ALS., Amyotrophic lateral sclerosis (ALS) is a rapidly progressing fatal Neurodegenerative Disorders characterized by the selective death of Neurons, Efferent (MNSs Blood-Group System) in the Spinal Cord, and is associated with local neuroinflammation., T-lymphocyte deficiency increases Neuronal loss in CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS, while boosting T-Lymphocyte levels reduces it., As disease accelerates, a shift occurs from beneficial immune responses (involving M2 Microglia and Regulatory T-Lymphocytes) to deleterious immune responses (involving M1 Microglia and T-helper cell type 1). In this review, we underscore the importance of immune-mediated mechanisms in the pathogenesis of ALS and discuss the alterations and distinct phenotypes of immune cells at the different stages of disease., Immunological disturbances have been implicated in the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Recombinant Chemokine are involved in the recruitment of immune cells., The immune system has been found to be involved with positive and negative effects in the nervous system of Amyotrophic Lateral Sclerosis (ALS) patients. In general, Therapeutic gamma delta T-lymphocytes, B-Lymphocytes, Natural Killer Cells, mast cell, Specimen Source Codes - Macrophages, Dendritic Cells, Microglia, Antibodies, in vitro diagnostic, complement and Recombinant Cytokines participate in limiting damage., Immunological disturbances have been implicated in the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Recombinant Chemokine are involved in the recruitment of immune cells., We propose the following mechanism for the effect of Mesenchymal Stem Cells (cyclic nucleotide-gated mechanosensitive ion channel activity) administered intrathecally in Amyotrophic Lateral Sclerosis (ALS): cyclic nucleotide-gated mechanosensitive ion channel activity increase infiltration of peripheral immune cells into Central Nervous System and skew the infiltrated immune cells toward regulatory T lymphocytes (Treg ) and Th2 lymphocytes., Immune Cell infiltration to the brain's territory was considered for decades to reflect a pathological process in which immune cells attack the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS (Central Nervous System); such a process is observed in the inflammatory autoimmune disease, Multiple Sclerosis (MS).[SEP]Relations: Amyotrophic Lateral Sclerosis has relations: disease_disease with familial Amyotrophic Lateral Sclerosis, disease_disease with familial Amyotrophic Lateral Sclerosis, disease_disease with motor neuron disease, disease_disease with motor neuron disease, disease_protein with FIG4, disease_protein with FIG4, disease_protein with OTOG, disease_protein with OTOG, disease_disease with progressive muscular atrophy, disease_disease with progressive muscular atrophy. Definitions: Amyotrophic Lateral Sclerosis defined as following: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower Neurons, Efferent in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of Neurons, Efferent with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94). Therapeutic gamma delta T-lymphocytes defined as following: A subset of therapeutic autologous T-lymphocytes that express a T-cell receptor (TCR) composed of one gamma chain and one delta chain, with potential immunomodulating and antineoplastic activities. Upon administration of the therapeutic gamma delta T-lymphocytes, these cells secrete interferon-gamma (IFN-g), and exert direct killing of tumor cells. In addition, these cells activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against tumor cells. Gamma delta T-lymphocytes play a key role in the activation of the immune system and do not require major histocompatibility complex (MHC)-mediated antigen presentation to exert their cytotoxic effect.. Dendritic Cells defined as following: Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION).. Microglia defined as following: The third type of glial cell, along with astrocytes and oligodendrocytes (which together form the macroglia). Microglia vary in appearance depending on developmental stage, functional state, and anatomical location; subtype terms include ramified, perivascular, ameboid, resting, and activated. Microglia clearly are capable of phagocytosis and play an important role in a wide spectrum of neuropathologies. They have also been suggested to act in several other roles including in secretion (e.g., of Recombinant Cytokines and neural growth factors), in immunological processing (e.g., antigen presentation), and in CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS development and remodeling.. Natural Killer Cells defined as following: Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type.. mast cell defined as following: Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cell contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cell normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR.. Neurodegenerative Disorders defined as following: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.. Spinal Cord defined as following: A cylindrical column of tissue that lies within the vertebral canal. It is composed of WHITE MATTER and GRAY MATTER.. T-Lymphocyte defined as following: Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new Therapeutic gamma delta T-lymphocytes sensitized to that antigen.. Regulatory T-Lymphocytes defined as following: CD4-positive Therapeutic gamma delta T-lymphocytes that inhibit immunopathology or autoimmune disease in vivo. They inhibit the immune response by influencing the activity of other cell types. Regulatory T-cells include naturally occurring CD4+CD25+ cells, IL-10 secreting Tr1 cells, and Th3 cells.. Recombinant Chemokine defined as following: Formulated therapeutic analogs of one of a number of endogenous small polypeptide Recombinant Cytokines with potential antineoplastic activity. Synthesized by Specimen Source Codes - Macrophages, endothelial cells, keratinocytes, fibroblasts, and smooth muscle cells, chemokines are released in the presence of infection or physical tissue damage, and act as chemoattractants to recruit Specimen Source Codes - Macrophages, neutrophils, and Therapeutic gamma delta T-lymphocytes from the blood to sites of infection or damage. These agents may regulate tumor growth by modulating tumor-associated angiogenesis and metastasis and can either promote or retard tumor growth. (NCI04). Insulin-Like Growth Factor I defined as following: A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor.. Glial Cell Line-Derived Neurotrophic Factor defined as following: The founding member of the glial cell line-derived neurotrophic factor family. It was originally characterized as a NERVE GROWTH FACTOR promoting the survival of MIDBRAIN dopaminergic NEURONS, and it has been studied as a potential treatment for PARKINSON DISEASE.. Immune Cell defined as following: A cell in the immune system that is involved in host defense. This category may include lymphocytes, monocytes, Specimen Source Codes - Macrophages, neutrophils, eosinophils, basophils, mast cell, and thrombocytes. Precursor cells in these lineages may also be included.. MNSs Blood-Group System defined as following: A system of universal human blood group isoantigens with many associated subgroups. The M and N traits are codominant and the S and s traits are probably very closely linked alleles, including the U antigen. This system is most frequently used in paternity studies.. T-helper cell type 1 defined as following: A subset of helper-inducer T-lymphocytes which synthesize and secrete INTERLEUKIN-2; INTERFERON-GAMMA; and INTERLEUKIN-12. Due to their ability to kill antigen-presenting cells and their lymphokine-mediated effector activity, T-helper cell type 1 are associated with vigorous delayed-type hypersensitivity reactions.. B-Lymphocytes defined as following: Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.. Mesenchymal Stem Cells defined as following: An undifferentiated stromal cell with the ability to develop into the cells that form distinct mesenchymal tissues; such as bone, muscle, connective tissue, blood vessels, and lymphatic tissue.. Multiple Sclerosis defined as following: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903). cyclic nucleotide-gated mechanosensitive ion channel activity defined as following: Enables the transmembrane transfer of an ion by a channel that opens in response to a mechanical stress and when a cyclic nucleotide has been bound by the channel complex or one of its constituent parts. [GOC:jl, PMID:22206667]. Central Nervous System defined as following: The main information-processing organs of the nervous system, consisting of the brain, Spinal Cord, and meninges.. Neurons, Efferent defined as following: Neurons which send impulses peripherally to activate muscles or secretory cells..", "label": "yes"} {"original_question": "Is there any link between the aurora B kinase and the polycomb protein ring1B?", "id": "converted_579", "sentence1": "Is there any link between the Aurora Kinase B and the polycomb protein ring1B?", "sentence2": "The Aurora Kinase B and the polycomb protein ring1B combine to regulate active promoters in quiescent lymphocytes., We show that the AURKB protein, human kinase and the polycomb protein RNF2 wt Allele have essential roles in regulating transcriptionally active genes in quiescent lymphocytes. RNF2 wt Allele and AURKB protein, human bind to a wide range of active promoters in resting B and T cells. Conditional knockout of either protein results in reduced transcription and binding of RNA Polymerase II to Promoter Regions, Genetic and decreased cell viability. AURKB protein, human phosphorylates histone H3S28 at active promoters in resting B cells as well as inhibiting RNF2 wt Allele-mediated ubiquitination of Histone H2a and enhancing binding and activity of the USP21 gene deubiquitinase at transcribed genes. Our results identify a mechanism for regulating transcription in quiescent cells that has implications for epigenetic regulation of the choice between proliferation and quiescence., We show that the AURKB protein, human kinase and the polycomb protein RNF2 wt Allele have essential roles in regulating transcriptionally active genes in quiescent lymphocytes., We show that the AURKB protein, human kinase and the polycomb protein RNF2 wt Allele have essential roles in regulating transcriptionally active genes in quiescent lymphocytes. RNF2 wt Allele and AURKB protein, human bind to a wide range of active promoters in resting B and T cells. Conditional knockout of either protein results in reduced transcription and binding of RNA Polymerase II to Promoter Regions, Genetic and decreased cell viability. , We show that the AURKB protein, human kinase and the polycomb protein RNF2 wt Allele have essential roles in regulating transcriptionally active genes in quiescent lymphocytes. RNF2 wt Allele and AURKB protein, human bind to a wide range of active promoters in resting B and T cells.[SEP]Relations: Protein S human has relations: drug_drug with Peginterferon alfa-2b, drug_drug with Peginterferon alfa-2b, drug_drug with Cepeginterferon alfa-2B, drug_drug with Cepeginterferon alfa-2B, drug_drug with Interferon alfa-2b, drug_drug with Interferon alfa-2b. Histone H2a acetylation has relations: bioprocess_protein with MORF4L1, bioprocess_protein with MORF4L1, bioprocess_protein with RUVBL1, bioprocess_protein with RUVBL1. Definitions: Promoter Regions, Genetic defined as following: DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.. Histone H2a defined as following: Slightly lysine rich histone. One of four histones assembled into a nucleosomal core octamer. Various posttranslationally modified forms and variants exist. Combines with histone H2B in a heterodimer; two H2A/H2B dimers are incorporated in the nucleosomal octamer.. AURKB protein, human defined as following: Aurora kinase B (344 aa, ~39 kDa) is encoded by the human AURKB gene. This protein plays a role in both the modulation of microtubule structure and facilitation of chromosome segregation during mitosis and meiosis.. Aurora Kinase B defined as following: An aurora kinase that is a component of the chromosomal passenger protein complex and is involved in the regulation of MITOSIS. It mediates proper CHROMOSOME SEGREGATION and contractile ring function during CYTOKINESIS.. RNF2 wt Allele defined as following: Human RNF2 wild-type allele is located in the vicinity of 1q25.3 and is approximately 57 kb in length. This allele, which encodes E3 ubiquitin-protein ligase RING2 protein, plays a role in histone ubiquitination and the repression of gene transcription.. RNA Polymerase II defined as following: A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6..", "label": "yes"} {"original_question": "Is ibudilast effective for multiple sclerosis?", "id": "converted_2801", "sentence1": "Is ibudilast effective for Multiple Sclerosis?", "sentence2": "ibudilast slowed brain atrophy in Parts per million (qualifier value) and SPMS patients in a multicenter phase 2b study., ibudilast inhibits several CNP gene, macrophage migration inhibitory factor, and toll-like receptor 4 and can cross the blood-brain barrier, with potential salutary effects in progressive Multiple Sclerosis., CONCLUSIONS: In a phase 2 trial involving patients with progressive Multiple Sclerosis, ibudilast was associated with slower progression of brain atrophy than placebo but was associated with higher rates of gastrointestinal side effects, Headache, and Cancer patients and suicide and Cancer patients and suicide and depression., Specifically, the current evidence regarding treatment of progressive MS with ocrelizumab, simvastatin, ibudilast, thioctic acid, high-dose biotin, siponimod, and cell-based therapies are discussed., Based on our knowledge of pathophysiology, three therapeutic strategies are proposed: anti-inflammatory (ocrelizumab, siponimod…); remyelinating (opicinumab); and neuroprotective (high-dose biotin, ibudilast, simvastatin…). , Current article provides an overview of the pharmacology of Irritable Bowel Syndrome with a focus on preclinical and clinical data supporting its potential neuroprotective benefits for neurological conditions, including Multiple Sclerosis, Neuropathic pain, medication overuse Headache, Cerebrovascular accident, Opioids, Alcohol - Recreational Drug Use Code and methamphetamine abuse., Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive Multiple Sclerosis., METHODS: SPRINT-MS is a randomized, placebo-controlled, phase II trial of ibudilast in patients with POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA., CONCLUSION: SPRINT-MS is designed to evaluate the safety and efficacy of ibudilast as a treatment for POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA while simultaneously validating five different imaging biomarkers as outcome metrics for use in future phase II proof-of-concept POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA trials., ibudilast for the treatment of Multiple Sclerosis., AREAS COVERED: This article reviews various studies looking at ibudilast as a potential therapy for MS. It summarizes prior and current clinical trials of ibudilast in MS as well as its pharmacology.EXPERT OPINION: Although ibudilast has not been found to decrease the focal inflammatory activity in relapsing MS, it was shown to have an effect on preserving brain volume and disability progression. ibudilast may have a role in the treatment of progressive MS phenotypes., Adverse events with ibudilast included No gastrointestinal symptom, Headache, and Cancer patients and suicide and Cancer patients and suicide and depression.
CONCLUSIONS: In a phase 2 trial involving patients with progressive Multiple Sclerosis, ibudilast was associated with slower progression of brain atrophy than placebo but was associated with higher rates of gastrointestinal side effects, Headache, and Cancer patients and suicide and Cancer patients and suicide and depression., It summarizes prior and current clinical trials of ibudilast in MS as well as its pharmacology.
EXPERT OPINION: Although ibudilast has not been found to decrease the focal inflammatory activity in relapsing MS, it was shown to have an effect on preserving brain volume and disability progression.[SEP]Relations: ibudilast has relations: drug_drug with SC-236, drug_drug with SC-236, drug_drug with Iloprost, drug_drug with Iloprost, drug_drug with Pirlindole, drug_drug with Pirlindole, drug_drug with Metamizole, drug_drug with Metamizole, drug_drug with Epirizole, drug_drug with Epirizole. Definitions: ocrelizumab defined as following: A Fc-modified, humanized monoclonal antibody directed against the B-cell CD20 cell surface antigen, with immunosuppressive activity. Ocrelizumab binds to CD20 on the surfaces of B-cells, triggering complement-dependent cell lysis (CDCL) and antibody-dependent cell-mediated cytotoxicity (ADCC) of B-cells overexpressing CD20. The CD20 antigen, a non-glycosylated cell surface phosphoprotein that acts as a calcium ion channel, is found on over 90% of B-cells, B-cell lymphomas, and other lymphoid tumor cells of B-cell origin; it plays an important role in B-cell functioning.. ibudilast defined as following: An orally bioavailable inhibitor of cyclic nucleotide phosphodiesterase (PDE), mainly PDE-3, -4, -10, and -11, with anti-(neuro)inflammatory, vasorelaxant, bronchodilator, analgesic, neuroprotective and potential anti-tumor activities. ibudilast (Irritable Bowel Syndrome) is able to cross the blood-brain barrier (BBB). Upon administration, Irritable Bowel Syndrome exerts its potential anti-tumor activity against glioblastoma multiforme (GBM) cells by inhibiting PDE-4 and the pro-inflammatory cytokine macrophage migration inhibitory factor (MIF), which results in a decrease in MIF, its receptor CD74, and AKT expression, and attenuates the immunosuppressive properties of monocytic myeloid-derived suppressor cells (MDSCs) and reduces T-regulatory cells (Tregs). This causes GBM cell apoptosis and inhibits GBM cell proliferation. In addition, Irritable Bowel Syndrome reduces, through its inhibitory effect on various PDEs, the production of certain pro-inflammatory cytokines, such as interleukin-6 (IL-6), IL- 1beta, leukotriene B4, and tumor necrosis factor-alpha (TNF-a). Irritable Bowel Syndrome also upregulates the anti-inflammatory cytokine (IL-10), and promotes the production of neurotrophic factors, such as brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and neurotrophin-4 (NT-4). It also blocks toll-like receptor-4 (TLR-4), inhibits nitric oxide (NO) synthesis and reduces the level of reactive oxygen species (ROS). It also prevents platelet aggregation, causes cerebral vasodilation, bronchial smooth muscle relaxation, and improves cerebral blood flow. In addition, Irritable Bowel Syndrome attenuates the PDE-mediated activation of glial cells and abrogates PDE-mediated neuroinflammation and neurodegeneration. MIF is secreted by cancer stem cells (CSCs) and is highly expressed within GBM and plays a key role in tumor cell proliferation. Co-expression of MIF and CD74 in GBM is associated with poor patient survival.. simvastatin defined as following: A derivative of LOVASTATIN and potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It may also interfere with steroid hormone production. Due to the induction of hepatic LDL RECEPTORS, it increases breakdown of LDL CHOLESTEROL.. Parts per million (qualifier value) defined as following: A unit of proportion equal to 10E-6.. thioctic acid defined as following: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.. Neuropathic pain defined as following: Chronic pain caused by damage to nerve fibers. It is usually associated with tissue injury.. Multiple Sclerosis defined as following: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903). toll-like receptor 4 defined as following: A pattern recognition receptor that interacts with LYMPHOCYTE ANTIGEN 96 and LIPOPOLYSACCHARIDES. It mediates cellular responses to GRAM-NEGATIVE BACTERIA.. Headache defined as following: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.. POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA defined as following: An exceedingly rare autosomal dominant developmental anomaly reported in 1986 in nine individuals among four generations of the same family. The syndrome has clinical characteristics of four-limb postaxial polydactyly and progressive myopia. There have been no further descriptions in the literature since 1986.. Opioids defined as following: A class of synthetic chemicals/drugs similar to opiates (opium derivatives) with analgesic properties. Due to binding to opiate receptors, opioids mimic opiate activity on neurons, various cells (i.e. lymphocytes), pain suppression and other neurobehavioral activity. (NCI). Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810). Irritable Bowel Syndrome defined as following: Gastrointestinal symptoms characterized by chronic abdominal pain and altered bowel habits in the absence of any organic cause.. ibudilast defined as following: An orally bioavailable inhibitor of cyclic nucleotide phosphodiesterase (PDE), mainly PDE-3, -4, -10, and -11, with anti-(neuro)inflammatory, vasorelaxant, bronchodilator, analgesic, neuroprotective and potential anti-tumor activities. ibudilast (Irritable Bowel Syndrome) is able to cross the blood-brain barrier (BBB). Upon administration, Irritable Bowel Syndrome exerts its potential anti-tumor activity against glioblastoma multiforme (GBM) cells by inhibiting PDE-4 and the pro-inflammatory cytokine macrophage migration inhibitory factor (MIF), which results in a decrease in MIF, its receptor CD74, and AKT expression, and attenuates the immunosuppressive properties of monocytic myeloid-derived suppressor cells (MDSCs) and reduces T-regulatory cells (Tregs). This causes GBM cell apoptosis and inhibits GBM cell proliferation. In addition, Irritable Bowel Syndrome reduces, through its inhibitory effect on various PDEs, the production of certain pro-inflammatory cytokines, such as interleukin-6 (IL-6), IL- 1beta, leukotriene B4, and tumor necrosis factor-alpha (TNF-a). Irritable Bowel Syndrome also upregulates the anti-inflammatory cytokine (IL-10), and promotes the production of neurotrophic factors, such as brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and neurotrophin-4 (NT-4). It also blocks toll-like receptor-4 (TLR-4), inhibits nitric oxide (NO) synthesis and reduces the level of reactive oxygen species (ROS). It also prevents platelet aggregation, causes cerebral vasodilation, bronchial smooth muscle relaxation, and improves cerebral blood flow. In addition, Irritable Bowel Syndrome attenuates the PDE-mediated activation of glial cells and abrogates PDE-mediated neuroinflammation and neurodegeneration. MIF is secreted by cancer stem cells (CSCs) and is highly expressed within GBM and plays a key role in tumor cell proliferation. Co-expression of MIF and CD74 in GBM is associated with poor patient survival..", "label": "yes"} {"original_question": "Is nicotinamide effective for skin cancer prevention?", "id": "converted_1171", "sentence1": "Is nicotinamide effective for Malignant neoplasm of skin prevention?", "sentence2": "niacinamide (Vitamin B3 Assay) has been shown to have protective effects against damage caused by UV radiation and to reduce the rate of new premalignant Actinic keratosis., ESULTS: At 12 months, the rate of new Skin carcinoma was lower by 23% (95% confidence interval [NDUFB6 gene], 4 to 38) in the nicotinamide group than in the placebo group (P=0.02). Similar differences were found between the nicotinamide group and the placebo group with respect to new basal-cell carcinomas (20% [95% NDUFB6 gene, -6 to 39]lower rate with nicotinamide, P=0.12) and new squamous-cell carcinomas (30% [95% NDUFB6 gene, 0 to 51] lower rate, P=0.05). The number of Actinic keratosis was 11% lower in the nicotinamide group than in the placebo group at 3 months (P=0.01), 14% lower at 6 months (P<0.001), 20% lower at 9 months (P<0.001), and 13% lower at 12 months (P=0.001)., CONCLUSIONS: Oral nicotinamide was safe and effective in reducing the rates of new Skin carcinoma and Actinic keratosis in high-risk patients., niacinamide is a safe, widely available Vitamins that reduces the immune suppressive effects of UV, enhances DNA repair in keratinocyte and has shown promise in the chemoprevention of non-melanoma Malignant neoplasm of skin. , In summary, nicotinamide, by enhancing DNA repair in melanocyte, is a potential agent for the chemoprevention of Cutaneous Melanoma., Recent double-blinded randomized controlled Phase 2 studies in heavily sun-damaged individuals have shown that oral nicotinamide significantly reduces premalignant Actinic keratosis, and may reduce new non-melanoma skin cancers. , niacinamide (Vitamin B3 Assay) prevents UV-induced immunosuppression and carcinogenesis in CASP14 gene, and solar-simulated (ss) UV-induced immunosuppression in Homo sapiens., These results show that nicotinamide enhances two different pathways for repair of UV-induced photolesions, supporting nicotinamide's potential as an inexpensive, convenient and non-toxic agent for Malignant neoplasm of skin chemoprevention., Recent double-blinded randomized controlled Phase 2 studies in heavily sun-damaged individuals have shown that oral nicotinamide significantly reduces premalignant Actinic keratosis, and may reduce new non-melanoma skin cancers., No noteworthy between-group differences were found with respect to the number or types of adverse events during the 12-month intervention period, and there was no evidence of benefit after nicotinamide was discontinued.CONCLUSIONS: Oral nicotinamide was safe and effective in reducing the rates of new Skin carcinoma and Actinic keratosis in high-risk patients. , niacinamide (Vitamin B3 Assay) has been shown to have protective effects against damage caused by UV radiation and to reduce the rate of new premalignant Actinic keratosis.METHODS: In this phase 3, double-blind, randomized, controlled trial, we randomly assigned, in a 1:1 ratio, 386 participants who had had at least two Skin carcinoma in the previous 5 years to receive 500 mg of nicotinamide twice daily or placebo for 12 months. , Similar differences were found between the nicotinamide group and the placebo group with respect to new basal-cell carcinomas (20% [95% NDUFB6 gene, -6 to 39]lower rate with nicotinamide, P=0.12) and new squamous-cell carcinomas (30% [95% NDUFB6 gene, 0 to 51] lower rate, P=0.05). , Oral nicotinamide was safe and effective in reducing the rates of new Skin carcinoma and Actinic keratosis in high-risk patients., niacinamide has shown potential as a safe and effective intervention for the prevention of malignant and premalignant skin lesions., niacinamide, which protected against both Ultraviolet B therapy and UVA, is a promising agent for Malignant neoplasm of skin prevention.[SEP]Relations: niacinamide has relations: contraindication with liver disease, contraindication with liver disease, contraindication with gallbladder disease, contraindication with gallbladder disease, contraindication with kidney disease, contraindication with kidney disease, contraindication with diabetes mellitus (disease), contraindication with diabetes mellitus (disease), contraindication with peptic ulcer disease, contraindication with peptic ulcer disease. Definitions: niacinamide defined as following: An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake.. Cutaneous Melanoma defined as following: A primary melanoma arising from atypical melanocyte in the skin. Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi. Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma.. Vitamin B3 Assay defined as following: The determination of the amount of Vitamin B3 present in a sample.. Skin carcinoma defined as following: A carcinoma that arises from the skin. Representative examples are basal cell carcinoma and squamous cell carcinoma.. Homo sapiens defined as following: Members of the species Homo sapiens.. keratinocyte defined as following: Epidermal cells which synthesize keratin and undergo characteristic changes as they move upward from the basal layers of the epidermis to the cornified (horny) layer of the skin. Successive stages of differentiation of the keratinocyte forming the epidermal layers are basal cell, spinous or prickle cell, and the granular cell.. Malignant neoplasm of skin defined as following: A primary or metastatic malignant neoplasm involving the skin. Primary malignant skin neoplasms most often are carcinomas (either basal cell or squamous cell carcinomas) or melanomas. Metastatic malignant neoplasms to the skin include carcinomas and lymphomas.. melanocyte defined as following: Mammalian pigment cells that produce MELANINS, pigments found mainly in the EPIDERMIS, but also in the eyes and the hair, by a process called melanogenesis. Coloration can be altered by the number of melanocyte or the amount of pigment produced and stored in the organelles called MELANOSOMES. The large non-mammalian melanin-containing cells are called MELANOPHORES.. Actinic keratosis defined as following: White or pink lesions on the arms, hands, face, or scalp that arise from sun-induced DNA DAMAGE to KERATINOCYTES in exposed areas. They are considered precursor lesions to superficial SQUAMOUS CELL CARCINOMA.. Vitamins defined as following: Organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body..", "label": "yes"} {"original_question": "Is the tyrosine kinase BTK implicated in autoimmunity?", "id": "converted_3302", "sentence1": "Is the tyrosine kinase BTK protein, human implicated in autoimmunity?", "sentence2": "Autoimmune Diseases, Emotional Emotional hypersensitivity to B cell receptor (BCR) cross-linking, and Splenomegaly caused by myeloerythroid hyperplasia were alleviated by Btk deficiency in lyn-/- CASP14 gene., Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity., Autoimmune Diseases was fully dependent on Btk kinase activity, because Btk inhibitor treatment (PCI 32765) could normalize B-cell activation and differentiation, and because Autoantibodies were absent in Btk transgenic CASP14 gene overexpressing a kinase inactive Btk mutant., Agammaglobulinaemia tyrosine kinase (Btk) is a proximal transducer of the BCR signal that allows for B-cell activation and differentiation. Recently, selective inhibition of Btk by PCI 32765 has shown promise in limiting activity of multiple cells types in various models of Primary malignant neoplasm and autoimmunity., Inhibitors of BTK protein, human protein, human and ITK protein, human protein, human: state of the new drugs for Primary malignant neoplasm, autoimmunity and inflammatory diseases., Tight control of B cell differentiation into Plasma Cells (PREMATURE CHROMATID SEPARATION TRAIT) is critical for proper immune responses and the prevention of autoimmunity, BTK protein, human protein, human Signaling in B Cell Differentiation and Autoimmune Diseases, BTK protein, human protein, human function in B cells in the context of host defense and autoimmunity., promising effects of BTK protein, human protein, human inhibition were also seen in experimental animal models for Discoid Discoid lupus erythematosus erythematosus and Rheumatoid Arthritis, BTK protein, human protein, human may be a good target for controlling autoreactive B cells in patients with Systemic autoimmune disease., Given the phenotype of affected patients, namely lack of B-Lymphocytes and Plasma Cells with the ensuing inability to mount humoral immune responses, BTK protein, human protein, human inhibitors were anticipated to have beneficial effects on antibody-mediated pathologies, such as autoimmunity[SEP]Relations: protein tyrosine kinase inhibitor activity has relations: molfunc_protein with IBTK, molfunc_protein with IBTK, molfunc_protein with RACK1, molfunc_protein with RACK1. autoimmune disease has relations: contraindication with Pyridoxine, contraindication with Pyridoxine, disease_phenotype_positive with Autoimmune Diseases, disease_phenotype_positive with Autoimmune Diseases, disease_disease with anti-neutrophil antibody associated vasculitis, disease_disease with anti-neutrophil antibody associated vasculitis. Definitions: Autoimmune Diseases defined as following: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Splenomegaly defined as following: Enlargement of the spleen.. Agammaglobulinaemia tyrosine kinase defined as following: A non-receptor tyrosine kinase that is essential for the development, maturation, and signaling of B-LYMPHOCYTES. It contains an N-terminal zinc finger motif and localizes primarily to the PLASMA MEMBRANE and nucleus of B-Lymphocytes. Mutations in the gene that encode this kinase are associated with X-LINKED AGAMMAGLOBULINEMIA.. Rheumatoid Arthritis defined as following: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.. ITK protein, human defined as following: Tyrosine-protein kinase ITK protein, human/TSK (620 aa, ~75 kDa) is encoded by the human ITK protein, human gene. This protein is involved in tyrosine phosphorylation and immunity.. BTK protein, human defined as following: Tyrosine-protein kinase BTK protein, human (659 aa, ~76 kDa) is encoded by the human BTK protein, human gene. This protein is involved in both B-cell development and signal transduction.. B-Lymphocytes defined as following: Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.. Autoantibodies defined as following: Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.. Plasma Cells defined as following: Specialized forms of antibody-producing B-LYMPHOCYTES. They synthesize and secrete immunoglobulin. They are found only in lymphoid organs and at sites of immune responses and normally do not circulate in the blood or lymph. (Rosen et al., Dictionary of Immunology, 1989, p169 & Abbas et al., Cellular and Molecular Immunology, 2d ed, p20). Emotional hypersensitivity defined as following: Heightened emotional reactivity to environmental stimuli, including emotions of others. [PMID:23250816]. Discoid lupus erythematosus defined as following: chronic form of cutaneous Discoid lupus erythematosus erythematosus in which the skin lesions mimic those of the systemic form but in which systemic signs are rare; characterized by the presence of discoid skin plaques showing varying degrees of edema, erythema, scaliness, follicular plugging, and skin atrophy; lesions are surrounded by an elevated erythematous border; the condition typically involves the face and scalp, but widespread dissemination may occur.. autoimmunity defined as following: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides..", "label": "yes"} {"original_question": "Are defects in recombination repair involved in carcinogenesis?", "id": "converted_837", "sentence1": "Are defects in recombination repair involved in carcinogenesis?", "sentence2": "Inherited Gene Mutation in Genes involved in plant-type hypersensitive response are associated with gene rearrangement and may be a prerequisite for tumor development in some Primary malignant neoplasm-prone hereditary diseases like Bloom, Werner and Rothmund-Thomson syndromes. , Variants in the XRCC3 gene might result in altered protein structure or function which may influence DSBR efficiency and lead to Primary malignant neoplasm. , Although Alcohol - Recreational Drug Use Code consumption is related to increased Primary malignant neoplasm risk, its molecular mechanism remains unclear. Here, we demonstrate that an intake of 10% Alcohol - Recreational Drug Use Code for 4 weeks in Rattus norvegicus is genotoxic due to induction of Micronucleus - abnormality. acetaldehyde (SVEINSSON CHORIORETINAL ATROPHY), the first product of ethanol metabolism, is believed to be responsible for DNA damage induced by Alcohol - Recreational Drug Use Code. , Although efficiency of these repair processes substantially decrease the efficacy of Primary malignant neoplasm chemotherapies that target DNA, compromised DNA repair contributes to Mutagenesis Procedure and genomic instability leading to carcinogenesis., damage response and repair pathways are important barriers to carcinogenesis. , olymorphisms in DNA repair Genes and differences in repair capacity between individuals have been widely documented. For colorectal Primary malignant neoplasm, the loss of mismatch repair gene activity is a key genetic determinant. Nucleotide excision repair (NER), recombination repair (RR) and base excision repair (BER) pathways have critical roles in protection against other Malignant Neoplasms, and we wished to investigate their role in colorectal Primary malignant neoplasm. [SEP]Relations: Ethanol has relations: drug_drug with Interferon alfa-2a, Recombinant, drug_drug with Interferon alfa-2a, Recombinant. adaptation to pheromone regulating conjugation with mutual genetic exchange has relations: bioprocess_bioprocess with regulation of conjugation, bioprocess_bioprocess with regulation of conjugation, bioprocess_bioprocess with response to pheromone regulating conjugation with mutual genetic exchange, bioprocess_bioprocess with response to pheromone regulating conjugation with mutual genetic exchange, bioprocess_bioprocess with negative adaptation of signaling pathway, bioprocess_bioprocess with negative adaptation of signaling pathway. malignant colon neoplasm has relations: disease_protein with RELA, disease_protein with RELA. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. plant-type hypersensitive response defined as following: The rapid, localized death of plant cells in response to invasion by a pathogen. [ISBN:0582227089]. SVEINSSON CHORIORETINAL ATROPHY defined as following: A rare autosomal dominant inherited chorioretinal degenerative disease presenting at birth or during infancy. The disease has characteristics of progressive bilateral retinal and choroidal atrophy which appears as lesions on the optic nerve and peripheral ocular fundus and leads to loss of central vision. Congenital anterior polar cataracts are sometimes associated with this disease. There is evidence this disease is caused by heterozygous mutation in the TEA domain family member-1 gene (TEAD1) on chromosome 11p15.. XRCC3 gene defined as following: This gene plays a role in recombination and in the maintenance of DNA integrity.. Rattus norvegicus defined as following: The common rat, Rattus norvegicus, often used as an experimental organism.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Micronucleus - abnormality defined as following: A toxicology screening result where proliferating cells that are exposed to a genotoxic chemical produce some daughter cells containing cytoplasmic bodies that are comprised of chromosomes or chromosome fragments, which were not sorted properly during mitosis or meiosis, and are bounded by a nuclear membrane.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Mutagenesis Procedure defined as following: Production of genetic alterations by any technique, including chemicals, radiation, recombination, or other molecular biology methods.. acetaldehyde defined as following: A colorless, flammable liquid used in the manufacture of acetic acid, perfumes, and flavors. It is also an intermediate in the metabolism of Alcohol - Recreational Drug Use Code. It has a general narcotic action and also causes irritation of mucous membranes. Large doses may cause death from respiratory paralysis.. ethanol defined as following: A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA..", "label": "yes"} {"original_question": "Are Gram positive bacteria able to release extracellular vesicles?", "id": "converted_4120", "sentence1": "Are Gram positive Bacteria able to release Extracellular Vesicles?", "sentence2": "Gram-negative and Gram-positive Bacteria release a variety of membrane vesicles through different formation routes. , Release of Extracellular Vesicles (NCI Enterprise Vocabulary Services) is a common feature among Eukaryota, Archaea, and Bacteria. However, the biogenesis and downstream biological effects of NCI Enterprise Vocabulary Services released from gram-positive Bacteria remain poorly characterized., Our findings provide new insight into the role of NCI Enterprise Vocabulary Services from gram-positive oral Bacteria in periodontal diseases.[SEP]Relations: extracellular vesicle has relations: cellcomp_protein with GRIA4, cellcomp_protein with GRIA4, cellcomp_protein with PRELP, cellcomp_protein with PRELP, cellcomp_protein with RBP3, cellcomp_protein with RBP3, cellcomp_protein with LFNG, cellcomp_protein with LFNG, cellcomp_protein with ARC, cellcomp_protein with ARC. Definitions: Archaea defined as following: One of the three domains of life (the others being BACTERIA and Eukarya), formerly called Archaebacteria under the taxon Bacteria, but now considered separate and distinct. They are characterized by: (1) the presence of characteristic tRNAs and ribosomal RNAs; (2) the absence of peptidoglycan cell walls; (3) the presence of ether-linked lipids built from branched-chain subunits; and (4) their occurrence in unusual habitats. While Archaea resemble Bacteria in morphology and genomic organization, they resemble eukarya in their method of genomic replication. The domain contains at least four kingdoms: CRENARCHAEOTA; EURYARCHAEOTA; NANOARCHAEOTA; and KORARCHAEOTA.. Eukaryota defined as following: Organism or cells with a nucleus separated from the cytoplasm by a two membrance nuclear envelope and compartmentalization of function into distinct cytoplasmic organelles.. Extracellular Vesicles defined as following: Any vesicle that is part of the extracellular region. [GO_REF:0000064, GOC:pm, GOC:TermGenie, PMID:24769233]. NCI Enterprise Vocabulary Services defined as following: The NCI EVS is set of services and resources that address NCI's needs for controlled vocabulary. The EVS Project is a collaborative effort of the Center for Bioinformatics and the NCI Office of Communications. The NCI Thesaurus, which is a biomedical thesaurus created specifically to meet the needs of the NCI, is produced by the NCI EVS project. The NCI Thesaurus is provided under an open content license. The EVS Project also produces the NCI Metathesaurus, which is based on NLM's Unified Medical Language System Metathesaurus supplemented with additional cancer-centric vocabulary. In addition the EVS Project provides NCI with licenses for MedDRA, SNOMED, ICD-O-3, and other proprietary vocabularies.. Bacteria defined as following: One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive..", "label": "yes"} {"original_question": "Does Eucommia ulmoides leaf extract ameliorates steatosis/fatty liver induced by high-fat diet?", "id": "converted_2991", "sentence1": "Does Eucommia ulmoides Concept Generality - Leaf extract ameliorates steatosis/fatty liver induced by high-fat diet?", "sentence2": "These results demonstrate that the Eucommia ulmoides Concept Generality - Leaf extract exhibits antihyperlipidemic properties by suppressing hepatic fatty acid and cholesterol biosynthesis with the simultaneous reduction of plasma and hepatic lipids in high fat-fed hamsters., Together, these results suggest that EUE and its active components enhance lysosomal activity, resulting in decreased Endoplasmic Reticulum stress and hepatic dyslipidemi, Eucommia ulmoides (Eucommia ulmoides Oliver) Concept Generality - Leaf extract mediates hypolipidemic action in hamsters fed a high-fat diet.This study examined the effect of a Eucommia ulmoides (Eucommia ulmoides Oliver) Concept Generality - Leaf extract (0.175 g/100 g diet) that was supplemented with a high-fat diet (10% coconut oil, 0.2% cholesterol, wt/wt) on hyperlipidemic hamsters. , Preventive effect of Eucommia Concept Generality - Leaf extract on aortic media hypertrophy in Wistar-Kyoto Rattus norvegicus fed a high-fat diet.Eucommia ulmoides Oliver Concept Generality - Leaf extract (ELE) has been shown to have anti-hypertensive and anti-obesity effects in Rattus norvegicus that are fed a high-fat diet (HFD). , Eucommia ulmoides Oliver Concept Generality - Leaf extract (ELE) has been shown to have anti-hypertensive and anti-obesity effects in Rattus norvegicus that are fed a high-fat diet (HFD)., The hepatic fatty acid synthase and Hydroxymethylglutaryl coenzyme A reductase activities were significantly lowered by a Eucommia ulmoides Concept Generality - Leaf extract supplement in high fat-fed hamsters., These results demonstrate that the Eucommia ulmoides Concept Generality - Leaf extract exhibits antihyperlipidemic properties by suppressing hepatic fatty acid and cholesterol biosynthesis with the simultaneous reduction of plasma and hepatic lipids in high fat-fed hamsters.
, Both forms of Eucommia leaves minimised increases in body weight and Visceral Fat in a dose-dependent fashion., These results demonstrate that the Eucommia ulmoides Concept Generality - Leaf extract exhibits antihyperlipidemic properties by suppressing hepatic fatty acid and cholesterol biosynthesis with the simultaneous reduction of plasma and hepatic lipids in high fat-fed hamsters., The hepatic fatty acid synthase and Hydroxymethylglutaryl coenzyme A reductase activities were significantly lowered by a Eucommia ulmoides Concept Generality - Leaf extract supplement in high fat-fed hamsters.[SEP]Relations: endoplasmic reticulum has relations: cellcomp_protein with ULBP1, cellcomp_protein with ULBP1, cellcomp_protein with ULBP2, cellcomp_protein with ULBP2, cellcomp_protein with ADORA1, cellcomp_protein with ADORA1, cellcomp_protein with SERPINA1, cellcomp_protein with SERPINA1, cellcomp_protein with SERPINA2, cellcomp_protein with SERPINA2. Definitions: Hydroxymethylglutaryl coenzyme A reductase defined as following: Specific hydroxymethylglutaryl CoA reductases that utilize the cofactor NAD. In liver enzymes of this class are involved in cholesterol biosynthesis.. Endoplasmic Reticulum defined as following: A system of cisternae in the CYTOPLASM of many cells. In places the endoplasmic reticulum is continuous with the plasma membrane (CELL MEMBRANE) or outer membrane of the nuclear envelope. If the outer surfaces of the endoplasmic reticulum membranes are coated with ribosomes, the endoplasmic reticulum is said to be rough-surfaced (ENDOPLASMIC RETICULUM, ROUGH); otherwise it is said to be smooth-surfaced (ENDOPLASMIC RETICULUM, SMOOTH). (King & Stansfield, A Dictionary of Genetics, 4th ed). Rattus norvegicus defined as following: The common rat, Rattus norvegicus, often used as an experimental organism.. Eucommia ulmoides defined as following: A species of the family EUCOMMIACEAE.. cholesterol defined as following: The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.. Concept Generality - Leaf defined as following:

Include only the concept itself in the domain or value set. Do not include descendents of the concept.

.", "label": "yes"} {"original_question": "Does Rhamnose have any effect on aging?", "id": "converted_3046", "sentence1": "Does Rhamnose have any effect on aging?", "sentence2": "The Monosaccharides analysis showed that rhamnose (SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2 (disorder)) and Glucose measurement (glutamate) may play vital roles in maintaining the antioxidant and anti-aging activities. , Some of these mechanisms will be reviewed as well as the capacity of fucose- and rhamnose-rich oligo- and polysaccharides (FROP and RROP) to counteract several of the mechanisms involved in skin aging.[SEP]Relations: response to rhamnose has relations: bioprocess_bioprocess with response to hexose, bioprocess_bioprocess with response to hexose, bioprocess_bioprocess with cellular response to rhamnose stimulus, bioprocess_bioprocess with cellular response to rhamnose stimulus. Increased groin pigmentation with raindrop depigmentation has relations: phenotype_phenotype with Mixed hypo- and hyperpigmentation of the skin, phenotype_phenotype with Mixed hypo- and hyperpigmentation of the skin, phenotype_phenotype with Irregular hyperpigmentation, phenotype_phenotype with Irregular hyperpigmentation, disease_phenotype_positive with thumb deformity-alopecia-pigmentation anomaly syndrome, disease_phenotype_positive with thumb deformity-alopecia-pigmentation anomaly syndrome. Definitions: Glucose measurement defined as following: The determination of the amount of Glucose measurement present in a sample.. rhamnose defined as following: A methylpentose whose L- isomer is found naturally in many plant glycosides and some gram-negative bacterial lipopolysaccharides.. Monosaccharides defined as following: Single chain carbohydrates that are the most basic units of CARBOHYDRATES. They are typically colorless crystalline substances with a sweet taste and have the same general formula CnH2nOn..", "label": "yes"} {"original_question": "Are alterations in ultraconserved elements implicated in breast cancer?", "id": "converted_1880", "sentence1": "Are alterations in ultraconserved elements implicated in Malignant neoplasm of breast?", "sentence2": "Single Nucleotide Polymorphism in ultraconserved elements and familial Malignant neoplasm of breast risk, In the present study, we investigated the influence of six Single Nucleotide Polymorphism within UCEs on familial Malignant neoplasm of breast risk. Two out of six Single Nucleotide Polymorphism showed an association with familial Malignant neoplasm of breast risk, This is the first study indicating that Single Nucleotide Polymorphism in UCEs might be associated with cancer risk, Single Nucleotide Polymorphism in ultraconserved elements and familial Malignant neoplasm of breast risk., Recent studies have indicated that UCEs are not Mutation Abnormality cold regions and likely to be concerned with Malignant Neoplasms, including Malignant neoplasm of breast (BC Original Formula Original Formula). , Single Nucleotide Polymorphism in ultraconserved elements and familial Malignant neoplasm of breast risk., Genetic variants in ultraconserved elements and risk of Malignant neoplasm of breast in Chinese population.[SEP]Relations: breast-ovarian cancer, familial, susceptibility to has relations: disease_protein with RAD51D, disease_protein with RAD51D, disease_protein with RAD51C, disease_protein with RAD51C, disease_phenotype_positive with Breast carcinoma, disease_phenotype_positive with Breast carcinoma, disease_phenotype_positive with Multifactorial inheritance, disease_phenotype_positive with Multifactorial inheritance, disease_phenotype_positive with Ovarian carcinoma, disease_phenotype_positive with Ovarian carcinoma. Definitions: Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Single Nucleotide Polymorphism defined as following: A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.. Malignant neoplasm of breast defined as following: A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males.. familial Malignant neoplasm of breast defined as following: Breast carcinoma that has developed in relatives of patients with history of breast carcinoma.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer..", "label": "yes"} {"original_question": "Is selenium deficiency involved in autoimmune thyroid disease?", "id": "converted_957", "sentence1": "Is selenium deficiency involved in autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease?", "sentence2": "In areas with severe selenium deficiency higher incidence of Thyroiditis has been reported due to a decreased activity of selenium-dependent glutathione peroxidase Enzyme [APC] within THYROID DIAGNOSTIC RADIOPHARMACEUTICALS cells, Of 30 patients in the selenium treated group, 6 patients were overtly Hypothyroidism, 15 were subclinical Hypothyroidism, 6 were euthyroid, and 3 were subclinical hyperthyroid. The mean TPOAb concentration decreased significantly by 49.5% (P < 0.013) in the selenium treated group versus 10.1% (P < 0.95) in the placebo-treated group, Selenium supplement supplement substitution has a significant impact on inflammatory activity in THYROID DIAGNOSTIC RADIOPHARMACEUTICALS-specific autoimmune disease, Serum selenium is low in newly diagnosed Graves Disease, S-Se was lower in patients with GD than in controls (mean (SD), GD: 89·9 μg/l (18·4); controls: 98·8 μg/l (19·7), P < 0·01), Patients with newly diagnosed GD and Autoimmune hepatitis had significantly lower s-Se compared with random controls. Our observation supports the postulated link between inadequate selenium supply and overt autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease, especially GD, Selenium supplement supplement deficiency is likely to constitute a risk factor for a feedforward derangement of the immune system-THYROID DIAGNOSTIC RADIOPHARMACEUTICALS interaction, while selenium supplementation appears to dampen the self-amplifying nature of this derailed interaction, The recent recognition that the essential trace element selenium is incorporated as selenocysteine in all three deiodinases has decisively confirmed the clear-cut link between selenium and THYROID DIAGNOSTIC RADIOPHARMACEUTICALS function. It has additionally been established that the THYROID DIAGNOSTIC RADIOPHARMACEUTICALS contains more selenium than any other Tissue Specimen Code and that selenium deficiency aggravates the manifestation of endemic myxedematous cretinism and autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease, Maintenance of \"selenostasis\" via optimal intake not only aids preservation of general health but also contributes substantially to the prevention of THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease, Low birth weight, Iodine, Homeopathic preparation excess and deficiency, selenium deficiency, parity, oral contraceptive use, reproductive span, fetal microchimerism, stress, seasonal variation, Allergy Specialty, smoking, radiation damage to the Neck>Thyroid gland, Viral and bacterial infections all play a role in the development of autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disorders, It has additionally been established that the THYROID DIAGNOSTIC RADIOPHARMACEUTICALS contains more selenium than any other Tissue Specimen Code and that selenium deficiency aggravates the manifestation of endemic myxedematous cretinism and autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease., Selenium supplement supplement deficiency may play an important role in the initiation and progression of autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease., [Selenium supplement supplement deficiency in Celiac Disease: risk of Autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease]., Low birth weight, Iodine, Homeopathic preparation excess and deficiency, selenium deficiency, parity, oral contraceptive use, reproductive span, fetal microchimerism, stress, seasonal variation, Allergy Specialty, smoking, radiation damage to the Neck>Thyroid gland, Viral and bacterial infections all play a role in the development of autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disorders., Some clinical studies have demonstrated that selenium-deficient patients with autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease benefit from selenium supplementation, although the data are conflicting and many parameters must still be defined., Our observation supports the postulated link between inadequate selenium supply and overt autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease, especially GD., Selenium supplement supplement deficiency in Celiac Disease: risk of Autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease]., Selenoproteins contain the essential trace element selenium whose deficiency leads to major disorders including Primary malignant neoplasm, male reproductive system failure, or autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease., It has additionally been established that the THYROID DIAGNOSTIC RADIOPHARMACEUTICALS contains more selenium than any other Tissue Specimen Code and that selenium deficiency aggravates the manifestation of endemic myxedematous cretinism and autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease., EVIDENCE SYNTHESIS: Evidence in support of selenium supplementation in THYROID DIAGNOSTIC RADIOPHARMACEUTICALS autoimmune disease is evaluated, the results herein presented demonstrating the potential effectiveness of selenium in reducing the antithyroid peroxidase titer and improving the echostructure in the ultrasound examination., Some investigators suggest that selenium may be a useful adjunctive treatment for Autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease, such as Hashimoto and Graves Disease., Therefore, even mild selenium deficiency may contribute to the development and maintenance of Autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease., Some clinical studies have demonstrated that selenium-deficient patients with autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease benefit from selenium supplementation, although the data are conflicting and many parameters must still be defined., Some clinical studies have demonstrated that selenium-deficient patients with autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease benefit from selenium supplementation, although the data are conflicting and many parameters must still be defined, High prevalence of Hyperplasia and autoimmune diseases of THYROID DIAGNOSTIC RADIOPHARMACEUTICALS in Ukrainian population is determined by endemic deficit of Iodine, Homeopathic preparation and selenium, It has additionally been established that the THYROID DIAGNOSTIC RADIOPHARMACEUTICALS contains more selenium than any other Tissue Specimen Code and that selenium deficiency aggravates the manifestation of endemic myxedematous cretinism and autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease., Therefore, even mild selenium deficiency may contribute to the development and maintenance of Autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease, Some investigators suggest that selenium may be a useful adjunctive treatment for Autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease, such as Hashimoto and Graves Disease[SEP]Relations: autoimmune THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease has relations: disease_disease with Thyroiditis (disease), disease_disease with Thyroiditis (disease), disease_disease with atrophic Thyroiditis, disease_disease with atrophic Thyroiditis, disease_disease with Graves disease, disease_disease with Graves disease, disease_protein with TG, disease_protein with TG, disease_disease with autoimmune disease of endocrine system, disease_disease with autoimmune disease of endocrine system. Definitions: Autoimmune hepatitis defined as following: Hepatitis caused by autoantibodies. Drugs, infections, and toxins may trigger the production of the autoantibodies against the liver parenchyma.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. selenocysteine defined as following: A naturally occurring amino acid in both eukaryotic and prokaryotic organisms. It is found in tRNAs and in the catalytic site of some enzymes. The genes for glutathione peroxidase and formate dehydrogenase contain the TGA codon, which codes for this amino acid.. Selenoproteins defined as following: Selenoproteins are proteins that specifically incorporate SELENOCYSTEINE into their amino acid chain. Most selenoproteins are enzymes with the selenocysteine residues being responsible for their catalytic functions.. Hyperplasia defined as following: An increase in the number of cells in a Tissue Specimen Code or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.. Iodine, Homeopathic preparation defined as following: homeopathic drug. Graves Disease defined as following: Hyperthyroidism associated with diffuse hyperplasia of the Neck>Thyroid gland (goiter), resulting from production of antibodies that are directed against the thyrotropin receptor complex of the follicular epithelial cells. As a result, the Neck>Thyroid gland enlarges and secretes increased amounts of THYROID DIAGNOSTIC RADIOPHARMACEUTICALS hormones.. THYROID DIAGNOSTIC RADIOPHARMACEUTICALS disease defined as following: Pathological processes involving the THYROID GLAND.. Hypothyroidism defined as following: A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.. Thyroiditis defined as following: Inflammatory diseases of the THYROID GLAND. Thyroiditis can be classified into acute (THYROIDITIS, SUPPURATIVE), subacute (granulomatous and lymphocytic), chronic fibrous (Riedel's), chronic lymphocytic (HASHIMOTO DISEASE), transient (POSTPARTUM THYROIDITIS), and other AUTOIMMUNE THYROIDITIS subtypes.. Celiac Disease defined as following: A malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION..", "label": "yes"} {"original_question": "Are thyroid hormone receptor alpha1 mutations implicated in thyroid hormone resistance syndrome?", "id": "converted_1105", "sentence1": "Are Thyroid Hormones receptor alpha1 mutations implicated in Thyroid Hormones resistance syndrome?", "sentence2": "Gene Mutation in Homo sapiens TRα1 mediate RTH with features of Hypothyroidism in particular Body tissue (e.g. skeleton, Multisection:Find:Pt:Abdomen+Pelvis>Gastrointestinal tract:Doc:US), but are not associated with a markedly dysregulated pituitary-thyroid axis., Clinical phenotype of a new type of Thyroid Hormones resistance caused by a Mutation Abnormality of the receptor[SEP]Relations: response to Thyroid Hormones has relations: bioprocess_protein with AKR1B1, bioprocess_protein with AKR1B1, bioprocess_protein with SLC34A1, bioprocess_protein with SLC34A1. Hypothyroidism has relations: disease_phenotype_positive with isolated thyroid-stimulating hormone deficiency, disease_phenotype_positive with isolated thyroid-stimulating hormone deficiency, disease_phenotype_positive with resistance to thyrotropin-releasing hormone syndrome, disease_phenotype_positive with resistance to thyrotropin-releasing hormone syndrome, disease_phenotype_positive with Hypothyroidism due to TSH receptor mutations, disease_phenotype_positive with Hypothyroidism due to TSH receptor mutations. Definitions: Hypothyroidism defined as following: A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. receptor defined as following: A protein located on the cell surface, or in the cytoplasm, that binds to a specific signaling factor, such as a hormone, antigen, or neurotransmitter, causing a conformational and functional change in the receptor molecule. The ligand-bound receptor then alters its interaction with target molecules, which leads to changes in cellular physiology through modification of the activity of one or more signal transduction pathways.. Thyroid Hormones defined as following: Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Gene Mutation may be associated with genetic diversity or with pathologies including cancer.. Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Does thyroid hormone affect cardiac remodeling?", "id": "converted_1097", "sentence1": "Does Thyroid Hormones affect Cardiac - anatomy qualifier remodeling?", "sentence2": "The aim of this brief paper is to highlight new developments in understanding the cardioprotective role of Thyroid Hormones in reverting regulatory networks involved in adverse Cardiac - anatomy qualifier remodeling., Thyroid Hormone Receptor (TRα1) is shown to be critical for the maturation of cardiomyocytes and for the cellular response to stress. TRα1 is altered during post ischemic Cardiac - anatomy qualifier remodeling but the physiological significance of this response is not fully understood. , Anterior Myocardial Infarction:Finding:Point in time:^Patient:Ordinal induces downregulation of Thyroid Hormones signaling and pharmacological inhibition of TRα1 further depresses post-ischemic Cardiac - anatomy qualifier function., These findings reveal crucial roles for DIO3 gene in Chest>Heart function and remodeling, which may have pathophysiologic implications for Homo sapiens restrictive cardiomyopathy., Tyrosine 3-Monooxygenase, Homo sapiens administration after Anterior Myocardial Infarction:Finding:Point in time:^Patient:Ordinal prevented Tissue Specimen Code Hypothyroidism and resulted in decreased beta-MHC expression, increased wall thickening and normalized wallstress, while stretch-induced p38 MAPK activation was increased. We conclude that Diabetes Mellitus exacerbates post-ischemic Cardiac - anatomy qualifier remodeling and that Tissue Specimen Code Hypothyroidism may be involved in this response., Thyroid hormone can favorably remodel the diabetic myocardium after acute Myocardial Infarction:Finding:Point in time:^Patient:Ordinal., It has been previously shown that regulators of physiological growth such as Thyroid Hormones (Tyrosine 3-Monooxygenase, Homo sapiens) can favorably remodel the post ischaemic myocardium., Acute Myocardial Infarction:Finding:Point in time:^Patient:Ordinal in diabetic Rattus norvegicus results in Tyrosine 3-Monooxygenase, Homo sapiens receptor down-regulation with important physiological consequences. Tyrosine 3-Monooxygenase, Homo sapiens treatment prevents this response and improves Cardiac - anatomy qualifier hemodynamics., Tyrosine 3-Monooxygenase, Homo sapiens affects Cardiac - anatomy qualifier remodeling by limiting Reperfusion Injury, and, at later states, by inducing distinct changes in Cardiac - anatomy qualifier chamber geometry in a time-dependent manner., Furthermore, administration of Tyrosine 3-Monooxygenase, Homo sapiens can convert pathologic to physiologic hypertrophy. These effects are the result of favorable cellular remodeling., Thyroid hormone (Tyrosine 3-Monooxygenase, Homo sapiens) is critical in Cardiac - anatomy qualifier cell differentiation (regulating Contractile Proteins and cell geometry) and this effect could be potentially exploited therapeutically in reversing the process of de-differentiation which underlies postischemic Cardiac - anatomy qualifier remodeling. , Tyrosine 3-Monooxygenase, Homo sapiens treatment partially reverses Cardiac - anatomy qualifier dysfunction in Rattus norvegicus with old Myocardial Infarction:Finding:Point in time:^Patient:Ordinal by favorably changing Cardiac - anatomy qualifier chamber geometry and expression of myosin isoforms. Thyroid hormone, unlike current treatments, appears to be a paradigm of therapeutic intervention which aims at restoring Cardiac - anatomy qualifier geometry and may prove new effective treatment for Chest>Heart failure., Changes in Thyroid Hormones (Tyrosine 3-Monooxygenase, Homo sapiens)-Tyrosine 3-Monooxygenase, Homo sapiens receptors (threonine-tRNA ligase activity) axis occur in the course of post-Infarction Cardiac - anatomy qualifier remodeling and seem to contribute to Cardiac - anatomy qualifier fetal phenotype. Tyrosine 3-Monooxygenase, Homo sapiens can \"rebuild\" the post-infarcted Chest>Heart by preventing the fetal-like pattern of Contractile Proteins expression, normalizing wall tension, and optimizing Cardiac - anatomy qualifier chamber geometry. , Tyrosine 3-Monooxygenase, Homo sapiens, apart from its \"classical\" actions on Cardiac - anatomy qualifier contractility and Chest>Heart rhythm, appears to regulate various Protoplasm signaling pathways related to stress responses and Cardiac - anatomy qualifier remodelling., More importantly, experimental and clinical studies demonstrate that Tyrosine 3-Monooxygenase, Homo sapiens can limit ischaemic injury, attenuate Cardiac - anatomy qualifier remodeling and improve Cardiac - anatomy qualifier hemodynamics. , Thyroid hormone attenuates Cardiac - anatomy qualifier remodeling and improves hemodynamics early after acute Myocardial Infarction:Finding:Point in time:^Patient:Ordinal in Rattus norvegicus., Thyroid hormone administration early after Infarction attenuates Cardiac - anatomy qualifier remodeling and significantly improves Myocardial performance., It has previously been shown that Thyroid Hormones can reverse Cardiac - anatomy qualifier remodeling in failing hearts by reducing Myocardial wall stress due to the unique changes induced in Myocytes, Cardiac shape. [SEP]Relations: response to Thyroid Hormones has relations: bioprocess_bioprocess with response to hormone, bioprocess_bioprocess with response to hormone, bioprocess_bioprocess with cellular response to Thyroid Hormones stimulus, bioprocess_bioprocess with cellular response to Thyroid Hormones stimulus, bioprocess_bioprocess with response to thyroxine, bioprocess_bioprocess with response to thyroxine, bioprocess_protein with HPN, bioprocess_protein with HPN. Thyroid Hormones receptor binding has relations: molfunc_protein with OASL, molfunc_protein with OASL. Definitions: Thyroid Hormones defined as following: Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs.. Myocytes, Cardiac defined as following: Striated muscle cells found in the Chest>Heart. They are derived from Cardiac - anatomy qualifier myoblasts (MYOBLASTS, CARDIAC).. acute Myocardial Infarction:Finding:Point in time:^Patient:Ordinal defined as following: Necrosis of the myocardium, as a result of interruption of the blood supply to the area. It is characterized by a severe and rapid onset of symptoms that may include chest pain, often radiating to the left arm and left side of the neck, dyspnea, sweating, and palpitations.. Tyrosine 3-Monooxygenase, Homo sapiens defined as following: Tyrosine 3-monooxygenase (528 aa, ~59 kDa) is encoded by the Homo sapiens Tyrosine 3-Monooxygenase, Homo sapiens gene. This protein plays a role in the synthesis of dopamine from L-tyrosine.. Homo sapiens defined as following: Members of the species Homo sapiens.. Rattus norvegicus defined as following: The common rat, Rattus norvegicus, often used as an experimental organism.. Contractile Proteins defined as following: Proteins which participate in contractile processes. They include MUSCLE PROTEINS as well as those found in other cells and tissues. In the latter, these proteins participate in localized contractile events in the cytoplasm, in motile activity, and in cell aggregation phenomena.. Infarction defined as following: Formation of an infarct, which is NECROSIS in Tissue Specimen Code due to local ISCHEMIA resulting from obstruction of BLOOD CIRCULATION, most commonly by a THROMBUS or EMBOLUS.. threonine-tRNA ligase activity defined as following: Catalysis of the reaction: ATP + L-threonine + tRNA(Thr) = AMP + diphosphate + L-threonyl-tRNA(Thr). [EC:6.1.1.3]. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, proteins, lipids, carbohydrates, and inorganic salts.. Myocardial defined as following: Of or pertaining to the myocardium.. Diabetes Mellitus defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.. Chest>Heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Thyroid Hormone Receptor defined as following: Specific high affinity binding proteins for THYROID HORMONES in target cells. They are usually found in the nucleus and regulate DNA transcription. These receptors are activated by hormones that leads to transcription, cell differentiation, and growth suppression. Thyroid hormone receptors are encoded by two genes (GENES, ERBA): erbA-alpha and erbA-beta for alpha and beta Thyroid Hormones receptors, respectively.. Hypothyroidism defined as following: A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.. Anterior myocardial infarction defined as following: MYOCARDIAL INFARCTION in which the anterior wall of the Chest>Heart is involved. Anterior wall Myocardial Infarction:Finding:Point in time:^Patient:Ordinal is often caused by occlusion of the left anterior descending coronary artery. It can be categorized as anteroseptal or anterolateral wall Myocardial Infarction:Finding:Point in time:^Patient:Ordinal.. Reperfusion Injury defined as following: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the Tissue Specimen Code (REPERFUSION) following ISCHEMIA..", "label": "yes"} {"original_question": "Is aggrephagy a variant of autophagy?", "id": "converted_3813", "sentence1": "Is aggrephagy a variant of autophagy?", "sentence2": "The selective branch of autophagy that deals with identification, capture and degradation of Protein Info aggregates is called aggrephagy., Mechanistic insights into aggrephagy, a selective basal autophagy process to clear misfolded Protein Info aggregates, , , it is largely unknown how misfolded polypeptides form aggresomes and are eventually cleared by the aggresome-macroautophagy/autophagy pathway, so-called aggrephagy.[SEP]Relations: Protein C has relations: drug_drug with Nonacog beta pegol, drug_drug with Nonacog beta pegol, drug_drug with Vatreptacog alfa, drug_drug with Vatreptacog alfa, drug_drug with Anagrelide, drug_drug with Anagrelide, drug_drug with Damoctocog alfa pegol, drug_drug with Damoctocog alfa pegol, drug_drug with Sarpogrelate, drug_drug with Sarpogrelate. Definitions: Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. variant defined as following: An alteration or difference from a norm or standard..", "label": "yes"} {"original_question": "Is proton beam therapy used for treatment of craniopharyngioma?", "id": "converted_4359", "sentence1": "Is proton beam therapy used for treatment of Craniopharyngioma?", "sentence2": " The majority of children had adjuvant therapy comprising proton beam therapy (18/59; 30.5%) or conventional radiotherapy (16/59; 27.1%)., Proton Therapy for Craniopharyngioma - An Early Report from a Single European Centre., AIMS: Proton beam therapy (Mast/Stem Cell Growth Factor Receptor Kit, human) is being increasingly used for Craniopharyngioma. , MATERIALS AND METHODS: Between August 2013 and July 2016, 18 patients with craniopharyngiomas were treated with 54 Cobalt Gray Equivalent (CGE) in 30 fractions over 6 weeks at our centre., CONCLUSIONS: Our early results are encouraging and comparable with the limited literature on Mast/Stem Cell Growth Factor Receptor Kit, human for Craniopharyngioma., All of the other patients underwent proton-beam radiotherapy with no documented tumor growth (median follow-up: 20 months; range 5.1-29.9 months)., Where aggressive subtotal resection is achieved, patients should be closely followed, with radiation initiated at the time of progression or recurrence-ideally via proton beam therapy, although three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and stereotactic radiosurgery are very appropriate in a range of circumstances, governed by access, patient age, Disease architecture, and character of the recurrence., This study examined parental distress in a sample of families of patients with Cp treated with proton beam therapy to identify factors for targeting psychological intervention.PROCEDURE: Prior to (n = 96) and 1 year after (n = 73) proton therapy, parents of children diagnosed with Cp (9.81 ± 4.42 years at baseline; 49% male) completed a self-report measure of distress, the Brief Symptom Inventory (BSI)., Diagnoses included Medulloblastoma, Craniopharyngioma, Ependymoma, Glioma, Germ cell tumor, and others., Initial experience with proton beam therapy in childhood-onset Craniopharyngioma patients shows promising results in terms of more protective radiological treatment. , Monte Carlo simulations were used to assess secondary neutron doses received by patients treated with proton therapy for Malignant melanoma of eye and Craniopharyngioma., Secondary neutron doses in proton therapy treatments of Malignant melanoma of eye and Craniopharyngioma., AIMS: Proton beam therapy (Mast/Stem Cell Growth Factor Receptor Kit, human) is being increasingly used for Craniopharyngioma., LTS: Published reports suggest a benefit to proton beam therapy for use in Neoplasms of the skull base, including craniopharyngiomas, Chordoma, skull-base sarcomas, and unresectable meningiomas.CONC, In recent years, proton therapy (PT), with its physical properties of heavy ion beam, that is, Prague peak phenomenon, has been more frequently used in patients with Craniopharyngioma., Proton beam therapy versus conformal photon radiation therapy for childhood Craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and Toxic effect., PURPOSE: We compared proton beam therapy (Mast/Stem Cell Growth Factor Receptor Kit, human) with intensity modulated radiation therapy (IMRT) for pediatric Craniopharyngioma in terms of Disease control, cyst dynamics, and Toxic effect., Proton therapy for Craniopharyngioma in adults: a protocol for systematic review and meta-analysis., We hereby report a case of a 7-year-old boy with a Craniopharyngioma which had been subtotally resected and was subsequently treated with modern pencil beam proton therapy under high-precision image guidance., Pencil beam scanning proton therapy for the treatment of Craniopharyngioma complicated with radiation-induced cerebral vasculopathies: A dosimetric and linear energy transfer (Linear Energy Transfer) evaluation., tial experience with proton beam therapy in childhood-onset Craniopharyngioma patients shows promising results in terms of more protective radiological treatment. R, PURPOSE: We compared proton beam therapy (Mast/Stem Cell Growth Factor Receptor Kit, human) with intensity modulated radiation therapy (IMRT) for pediatric Craniopharyngioma in terms of Disease control, cyst dynamics, and toxic, BACKGROUND AND PURPOSE: This study analyses the dosimetric and dose averaged Linear Energy transfer (LETd) correlation in paediatric Craniopharyngioma (cyclophosphamide/prednisone) patients with and without radiation-induced cerebral vasculopathies (RICVs) treated with pencil beam scanning (PBS) pro, OBJECTIVE: The authors compared survival and multiple comorbidities in children diagnosed with Craniopharyngioma who underwent gross-total resection (GTR) versus subtotal resection (STR (short terminal repeat, nucleic acid) (short terminal repeat, nucleic acid)) with radiation therapy (RT), either intensity-modulated radiation therapy (IMRT) or proton beam therapy (P, Proton Therapy for Craniopharyngioma - An Early Report from a Single European Centre, s. Some studies have shown that PT has advantages in the treatment of Craniopharyngioma in adu, Postoperative cerebral glucose metabolism in pediatric patients receiving proton therapy for Craniopharyngioma, Clinical equipoise: Protons and the child with Craniopharyngioma., skull base. More public attention has been given to proton beam therapy due to the increasing number of centers now in operation or in the planning stages for offering this treatment option.METHODS: We reviewed the physical properties of Protons and the clinical studies performed to justify their use in the management of skull-base Neoplasms and determine the benefits of proton beam therapy.RESULTS: Published reports suggest a benefit to proton beam therapy for use in Neoplasms of the skull base, including craniopharyngiomas, Chordoma, skull-base sarcomas, and unresectable meningiomas.CONCLUSIONS: Use of proton beam th, PURPOSE: We report the results of the early cohort of patients treated for Craniopharyngioma with combined proton-photon irradiation at the Massachusetts General Hospital and the Harvard Cyclotron Laboratory.METHODS AND MATERIALS: Between 1981 and 1988, 15 patients with Craniopharyngioma were treated in part or entirely with fractiona, UNLABELLED: This retrospective preliminary review evaluated the efficacy and Toxic effect of fractionated proton radiotherapy in the management of pediatric Craniopharyngioma.METHODS: Sixteen patients, aged 7-34 years, were treated with p, population. We evaluated the outcomes of all adult Craniopharyngioma patients treated at our institution using proton therapy to report outcomes for Disease control, treatment-related Toxic effect, and tumor response.METHODS: We analyzed 14 adult patie, Proton radiation has been used safely and effectively for Medulloblastoma, primitive neuro-ectodermal Neoplasms, Craniopharyngioma, Ependymoma, Germ Cells intracranial Neoplasms, low-grade glioma, Retinoblastoma, Anal Rhabdomyosarcoma and other Sarcoma of soft tissue, Ewing's sarcoma of bone of bone and other Osteosarcoma., ontroversial. The purpose of this study was to evaluate the efficacy and safety of PT for Craniopharyngioma in adults.METHODS AND ANALYSIS: We will search six databases (MEDLINE, EMBASE, Web of Science, the Cochrane Library, Amed, Scopus), clinical research registration websites and grey literature, aiming to identify randomised controlled trials (RCTs) on PT for Craniopharyngioma in adults between 1[SEP]Relations: Craniopharyngioma has relations: disease_protein with CTNNB1, disease_protein with CTNNB1, disease_phenotype_positive with Headache, disease_phenotype_positive with Headache, disease_disease with Disease of facial skeleton, disease_disease with Disease of facial skeleton, disease_phenotype_positive with Bitemporal hemianopia, disease_phenotype_positive with Bitemporal hemianopia, disease_disease with bone benign neoplasm, disease_disease with bone benign neoplasm. Definitions: Protons defined as following: Stable elementary particles having the smallest known positive charge, found in the nuclei of all elements. The proton mass is less than that of a neutron. A proton is the nucleus of the light hydrogen atom, i.e., the hydrogen ion.. Sarcoma of soft tissue defined as following: A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.. Medulloblastoma defined as following: A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1). Linear Energy Transfer defined as following: Rate of energy dissipation along the path of charged particles. In radiobiology and health physics, exposure is measured in kiloelectron volts per micrometer of tissue (keV/micrometer T).. Ependymoma defined as following: Glioma derived from EPENDYMOGLIAL CELLS that tend to present as malignant intracranial Neoplasms in children and as benign intraspinal neoplasms in adults. It may arise from any level of the ventricular system or central canal of the spinal cord. Intracranial ependymomas most frequently originate in the FOURTH VENTRICLE and histologically are densely cellular Neoplasms which may contain ependymal tubules and perivascular pseudorosettes. Spinal ependymomas are usually benign papillary or myxopapillary Neoplasms. (From DeVita et al., Principles and Practice of Oncology, 5th ed, p2018; Escourolle et al., Manual of Basic Neuropathology, 2nd ed, pp28-9). Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Osteosarcoma defined as following: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed). Germ cell tumor defined as following: A benign or malignant, gonadal or extragonadal neoplasm that originates from germ cells. Representative examples include teratoma, seminoma, embryonal carcinoma, and yolk sac tumor.. Glioma defined as following: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21). Retinoblastoma defined as following: A malignant tumor arising from the nuclear layer of the retina that is the most common primary tumor of the eye in children. The tumor tends to occur in early childhood or infancy and may be present at birth. The majority are sporadic, but the condition may be transmitted as an autosomal dominant trait. Histologic features include dense cellularity, small round polygonal cells, and areas of calcification and necrosis. An abnormal pupil reflex (leukokoria); NYSTAGMUS, PATHOLOGIC; STRABISMUS; and visual loss represent common clinical characteristics of this condition. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2104). Craniopharyngioma defined as following: A benign pituitary-region neoplasm that originates from Rathke's pouch. The two major histologic and clinical subtypes are adamantinous (or classical) Craniopharyngioma and papillary Craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations. (From Joynt, Clinical Neurology, 1998, Ch14, p50). Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Mast/Stem Cell Growth Factor Receptor Kit, human defined as following: Mast/stem cell growth factor receptor Kit (976 aa, ~110 kDa) is encoded by the human KIT gene. This protein is involved in cell survival, tyrosine phosphorylation and ligand-mediated signaling.. Germ Cells defined as following: The reproductive cells in multicellular organisms at various stages during GAMETOGENESIS.. Anal Rhabdomyosarcoma defined as following: A malignant mesenchymal tumor with skeletal muscle differentiation affecting the anus.. Ewing's sarcoma of bone defined as following: A small round cell bone tumor that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewing sarcoma/peripheral neuroectodermal tumor. It often affects the diaphysis or metaphyseal-diaphyseal portion of long bones. Clinical findings include pain and a mass in the involved area. Fever, anemia, leukocytosis, and an increased sedimentation rate are often seen. X-ray examination reveals osteolytic lesions. The prognosis depends on the stage, anatomic location, and size of the tumor.. Chordoma defined as following: A malignant tumor arising from the embryonic remains of the notochord. It is also called chordocarcinoma, chordoepithelioma, and notochordoma. (Dorland, 27th ed). Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Malignant melanoma of eye defined as following: A melanoma that arises from the structures of the eye or ocular adnexa..", "label": "yes"} {"original_question": "Is periampullary carcinoma (PAC) a relatively rare genitourinary malignancy", "id": "converted_4416", "sentence1": "Is periampullary carcinoma (cisplatin/cyclophosphamide/doxorubicin protocol) a relatively rare genitourinary malignancy", "sentence2": "Pancreaticobiliary subtype of Periampullary carcinoma (cisplatin/cyclophosphamide/doxorubicin protocol) has a poor prognosis in comparison to the Intestines subtype., MUC1 wt Allele wt Allele, KRT20 wt Allele, and Caudal-type homeobox protein 2 Ag immunohistochemical markers can sub-classify periampullary carcinomas into pancreaticobiliary, Intestines, and mixed subtypes., Pancreaticoduodenectomy (Lugano Lymphoma Response Classification Progressive Disease by PET) is a complex surgical procedure involving resection of the Duodenum and Duodenum and duodenum, the Head of pancreas and uncinate process, and the distal common bile duct. It is most commonly performed for periampullary malignancy but may also be indicated in select cases of chronic pancreatitis or benign periampullary tumors., In patients suspected of Pancreatic Hormones or periampullary cancer, abdominal contrast-enhanced computed tomography (X-Ray Computed Tomography) is the standard diagnostic modality., The pre-operative neutrophil-to-lymphocyte ratio (NLR), when ≥5 has been associated with reduced survival for patients with various Malignant neoplasm of gastrointestinal tract, however, it's prognostic value in patients with periampullary tumour has not been reported to date., Comparison Of Biliary Stenting And Surgical Bypass In Palliative Management Of Irresectable Periampullary Carcinoma., Some 20-40% of the periampullary carcinoma is irresectable at the time of diagnosis. Biliary stenting and surgical bypass are commonly used palliative procedure., Whereas Periampulary AdenoCarcinoma (cisplatin/cyclophosphamide/doxorubicin protocol) having four anatomic subtypes, Pancreatic Hormones, Common Bile Duct (OPN1MW gene), ampullary and Duodenum and Duodenum and duodenum shows relative better prognosis, DEFINITION: Periampullary carcinomas are rare and constitute a special entity, as diagnosed earlier and having a better prognosis than other duodenal tumors.METHODS: In the present study, we retrospectively reviewed the medical records of 16 patients with periampullary carcinomas over 10 years.RESULTS: 16 patients, 10 men and 6 women (median age 66.7 years, range 42-80) had a , Periampullary carcinomas: a special entity of duodenal tumors., Periampullary adenocarcinomas are rare neoplasm that originates from the Head of pancreas, the ampulla of vater, the distal bile duct or the Duodenum and Duodenum and duodenum.[SEP]Relations: periampullary adenocarcinoma has relations: disease_disease with ampulla of vater adenocarcinoma, disease_disease with ampulla of vater adenocarcinoma. intestine has relations: anatomy_protein_present with PACS2, anatomy_protein_present with PACS2, anatomy_protein_present with PACS1, anatomy_protein_present with PACS1, anatomy_protein_present with PACSIN2, anatomy_protein_present with PACSIN2. Duodenum and duodenum has relations: anatomy_protein_present with PACS1, anatomy_protein_present with PACS1. Definitions: Head of pancreas defined as following: That portion of the pancreas lying in the concavity of the Duodenum and duodenum.. MUC1 wt Allele defined as following: Human MUC1 wt Allele wild-type allele is located within 1q21 and is approximately 121 kb in length. This allele, which encodes mucin-like protein 1, plays a role in both cellular defense by binding pathogens and in cell signaling.. Lugano Lymphoma Response Classification Progressive Disease by PET defined as following: A score of 4 or 5 on a 5-point PET scale with an increase in intensity of uptake from baseline and/or new FDG-avid foci consistent with lymphoma at interim or end of treatment assessment.. Malignant neoplasm of gastrointestinal tract defined as following: A primary or metastatic malignant neoplasm involving any part of the digestive system.. KRT20 wt Allele defined as following: Human KRT20 wild-type allele is located in the vicinity of 17q21.2 and is approximately 9 kb in length. This allele, which encodes keratin, type I cytoskeletal 20 protein, is involved in the modulation of Intestines development.. Pancreatic Hormones defined as following: Peptide hormones secreted into the blood by cells in the ISLETS OF LANGERHANS of the pancreas. The alpha cells secrete glucagon; the beta cells secrete insulin; the delta cells secrete somatostatin; and the PP cells secrete Pancreatic Hormones polypeptide.. Intestines defined as following: The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE.. X-Ray Computed Tomography defined as following: Tomography using x-ray transmission and a computer algorithm to reconstruct the image..", "label": "no"} {"original_question": "The LINCS L1000 data set contains gene expression data for drug treated human cells, yes or no?", "id": "converted_3349", "sentence1": "The LINCS L1000 data set contains gene expression data for drug treated Human cells, yes or no?", "sentence2": " Library of Integrated Network-based Cellular Signatures (LINCS) L1000 dataset that measured changes in Gerbich blood group system before and after treatment of Human cells with over 20 000 small-molecule compounds including most of the FDA-approved drugs., The Library of Integrated Network-based Cellular Signatures (LINCS) L1000 big data provide gene expression profiles induced by over 10 000 compounds, shRNAs, and kinase inhibitors using the L1000 platform., The Library of Integrated Cellular Signatures (LINCS) project provides comprehensive transcriptome profiling of Human Cell Line before and after Chemicals and genetic perturbations., Recently, resources such as the Library of Integrated Network-Based Cellular Signatures (LINCS) L1000 database provide gene expression profiles induced by various Chemicals and genetic perturbations, The library of integrated network-based cellular signatures (LINCS) L1000 data set currently comprises of over a million gene expression profiles of chemically perturbed Human Cell Line., The LINCS L1000 data repository contains almost two million gene expression profiles for thousands of small molecules and drugs., The Gerbich blood group system data is from the Library of Integrated Network-based Cellular Signatures (LINCS) L1000 dataset that measured changes in Gerbich blood group system before and after treatment of Human cells with over 20 000 small-molecule compounds including most of the FDA-approved drugs.[SEP]Relations: AV node cell to bundle of His cell signaling has relations: bioprocess_protein with CACNA1G, bioprocess_protein with CACNA1G, bioprocess_bioprocess with cell-cell signaling involved in cardiac conduction, bioprocess_bioprocess with cell-cell signaling involved in cardiac conduction, bioprocess_bioprocess with AV node cell to bundle of His cell communication, bioprocess_bioprocess with AV node cell to bundle of His cell communication. blood group, lewis system has relations: disease_disease with Mendelian disease, disease_disease with Mendelian disease. Definitions: Chemicals defined as following: A substance with a defined atomic or molecular structure that results from, or takes part in, reactions involving changes in its structure, composition, or properties.. drug defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances..", "label": "yes"} {"original_question": "Could RG7112 be used as cancer therapy?", "id": "converted_1145", "sentence1": "Could RG7112 be used as cancer therapy?", "sentence2": "RG7112 is a potent and selective member of the nutlin family of MDM2 protein, Homo sapiens protein, Homo sapiens antagonists currently in phase I clinical studies., Our findings offer a preclinical proof-of-concept that RG7112 is effective in treatment of solid Neoplasms expressing wild-type TP53 wt Allele., On the other hand, JNJ 26854165, a novel tryptamine derivative and RG7112, a cis-imidazoline representative have shown promising results in early phases of trials in cancer patients., MDM2 protein, Homo sapiens protein, Homo sapiens small-molecule Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) RG7112 activates TP53 wt Allele signaling and regresses Homo sapiens Neoplasms in preclinical cancer models., On the other hand, JNJ 26854165, a novel tryptamine derivative and RG7112, a cis-imidazoline representative have shown promising results in early phases of trials in cancer patients., RG7112 is a selective inhibitor of TP53 wt Allele-MDM2 protein, Homo sapiens protein, Homo sapiens binding that frees TP53 wt Allele from negative control, activating the TP53 wt Allele pathway in Tumor cells, malignant leading to cell cycle arrest and apoptosis., In Tumor cells, malignant expressing wild-type TP53 wt Allele, RG7112 stabilizes TP53 wt Allele and activates the TP53 wt Allele pathway, leading to cell cycle arrest, apoptosis, and inhibition or regression of Homo sapiens tumor xenografts., Treatment of Tumor cells, malignant expressing wild-type TP53 wt Allele with RG7112 activated the TP53 wt Allele pathway, leading to cell-cycle arrest and apoptosis., RG7112 was selected for evaluation by the Pediatric Preclinical Testing Program (N-propyl-4-phenyl-1,2,3,6-tetrahydropyridine) due to the relatively low incidence of TP53 wt Allele mutations in pediatric cancers compared with adult Malignant Neoplasms., Treatment of Tumor cells, malignant expressing wild-type TP53 wt Allele with RG7112 activated the TP53 wt Allele pathway, leading to cell-cycle arrest and apoptosis, On the other hand, JNJ 26854165, a novel tryptamine derivative and RG7112, a cis-imidazoline representative have shown promising results in early phases of trials in cancer patients, RG7112 is a selective inhibitor of TP53 wt Allele-MDM2 protein, Homo sapiens protein, Homo sapiens binding that frees TP53 wt Allele from negative control, activating the TP53 wt Allele pathway in Tumor cells, malignant leading to cell cycle arrest and apoptosis, MDM2 protein, Homo sapiens protein, Homo sapiens small-molecule Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) RG7112 activates TP53 wt Allele signaling and regresses Homo sapiens Neoplasms in preclinical cancer models, In Tumor cells, malignant expressing wild-type TP53 wt Allele, RG7112 stabilizes TP53 wt Allele and activates the TP53 wt Allele pathway, leading to cell cycle arrest, apoptosis, and inhibition or regression of Homo sapiens tumor xenografts, RG7112 was selected for evaluation by the Pediatric Preclinical Testing Program (N-propyl-4-phenyl-1,2,3,6-tetrahydropyridine) due to the relatively low incidence of TP53 wt Allele mutations in pediatric cancers compared with adult Malignant Neoplasms, We report a proof-of-mechanism study of RG7112, a small-molecule MDM2 protein, Homo sapiens protein, Homo sapiens Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance), in patients with chemotherapy-naive primary or relapsed well-differentiated or dedifferentiated MDM2 protein, Homo sapiens protein, Homo sapiens-amplified liposarcoma who were eligible for resection, BACKGROUND: RG7112 is a selective inhibitor of TP53 wt Allele-MDM2 protein, Homo sapiens protein, Homo sapiens binding that frees TP53 wt Allele from negative control, activating the TP53 wt Allele pathway in Tumor cells, malignant leading to cell cycle arrest and apoptosis. RG7112 was selected for evaluation by the Pediatric Preclinical Testing Program (N-propyl-4-phenyl-1,2,3,6-tetrahydropyridine) due to the relatively low incidence of TP53 wt Allele mutations in pediatric cancers compared with adult Malignant Neoplasms. , Treatment of Tumor cells, malignant expressing wild-type TP53 wt Allele with RG7112 activated the TP53 wt Allele pathway, leading to cell-cycle arrest and apoptosis. , Effect of the MDM2 protein, Homo sapiens protein, Homo sapiens Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) RG7112 on the P53 pathway in patients with MDM2 protein, Homo sapiens protein, Homo sapiens-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study., RG7112 was selected for evaluation by the Pediatric Preclinical Testing Program (N-propyl-4-phenyl-1,2,3,6-tetrahydropyridine) due to the relatively low incidence of TP53 wt Allele mutations in pediatric cancers compared with adult Malignant Neoplasms. , Thus, inhibitors of TP53 wt Allele-MDM2 protein, Homo sapiens protein, Homo sapiens binding that can reactivate TP53 wt Allele in Tumor cells, malignant may offer an effective approach for cancer therapy., Treatment of Tumor cells, malignant expressing wild-type TP53 wt Allele with RG7112 activated the TP53 wt Allele pathway, leading to cell-cycle arrest and apoptosis. RG7112 showed potent antitumor activity against a panel of solid tumor Cultured Cell Line., A crystal structure of the RG7112-MDM2 protein, Homo sapiens protein, Homo sapiens complex revealed that the small molecule binds in the TP53 wt Allele pocket of MDM2 protein, Homo sapiens protein, Homo sapiens, mimicking the interactions of critical TP53 wt Allele amino acid residues. Treatment of Tumor cells, malignant expressing wild-type TP53 wt Allele with RG7112 activated the TP53 wt Allele pathway, leading to cell-cycle arrest and apoptosis., RG7112 (2g) is the first clinical small-molecule MDM2 protein, Homo sapiens protein, Homo sapiens inhibitor designed to occupy the TP53 wt Allele-binding pocket of MDM2 protein, Homo sapiens protein, Homo sapiens. In Tumor cells, malignant expressing wild-type TP53 wt Allele, RG7112 stabilizes TP53 wt Allele and activates the TP53 wt Allele pathway, leading to cell cycle arrest, apoptosis, and inhibition or regression of Homo sapiens tumor xenografts., RG7112 was selected for evaluation by the Pediatric Preclinical Testing Program (N-propyl-4-phenyl-1,2,3,6-tetrahydropyridine) due to the relatively low incidence of TP53 wt Allele mutations in pediatric cancers compared with adult Malignant Neoplasms. RG7112 and its inactive enantiomer RG7112i were evaluated against the 23 Cultured Cell Line of the N-propyl-4-phenyl-1,2,3,6-tetrahydropyridine in vitro panel using 96 hours exposure (1 nM to 10 µM)., Thus, inhibitors of TP53 wt Allele-MDM2 protein, Homo sapiens protein, Homo sapiens binding that can reactivate TP53 wt Allele in Tumor cells, malignant may offer an effective approach for cancer therapy. RG7112 is a potent and selective member of the nutlin family of MDM2 protein, Homo sapiens protein, Homo sapiens antagonists currently in phase I clinical studies., In Tumor cells, malignant expressing wild-type TP53 wt Allele, RG7112 stabilizes TP53 wt Allele and activates the TP53 wt Allele pathway, leading to cell cycle arrest, apoptosis, and inhibition or regression of Homo sapiens tumor xenografts. ., Restoration of TP53 wt Allele activity by inhibiting the TP53 wt Allele-MDM2 protein, Homo sapiens protein, Homo sapiens interaction may represent a novel approach to cancer treatment. RG7112 (2g) is the first clinical small-molecule MDM2 protein, Homo sapiens protein, Homo sapiens inhibitor designed to occupy the TP53 wt Allele-binding pocket of MDM2 protein, Homo sapiens protein, Homo sapiens., RG7112 was selected for evaluation by the Pediatric Preclinical Testing Program (N-propyl-4-phenyl-1,2,3,6-tetrahydropyridine) due to the relatively low incidence of TP53 wt Allele mutations in pediatric cancers compared with adult Malignant Neoplasms.RG7112 and its inactive enantiomer RG7112i were evaluated against the 23 Cultured Cell Line of the N-propyl-4-phenyl-1,2,3,6-tetrahydropyridine in vitro panel using 96 hours exposure (1 nM to 10 µM)., Notably, RG7112 was highly synergistic with androgen deprivation in LNCaP xenograft Neoplasms. Our findings offer a preclinical proof-of-concept that RG7112 is effective in treatment of solid Neoplasms expressing wild-type TP53 wt Allele., RG7112 induced tumor regressions in solid Neoplasms from different histotype panels, and exhibited consistent high-level activity against ALL xenografts. This high level of activity supports prioritization of RG7112 for further evaluation., RG7112 is a selective inhibitor of TP53 wt Allele-MDM2 protein, Homo sapiens protein, Homo sapiens binding that frees TP53 wt Allele from negative control, activating the TP53 wt Allele pathway in Tumor cells, malignant leading to cell cycle arrest and apoptosis. RG7112 was selected for evaluation by the Pediatric Preclinical Testing Program (N-propyl-4-phenyl-1,2,3,6-tetrahydropyridine) due to the relatively low incidence of TP53 wt Allele mutations in pediatric cancers compared with adult Malignant Neoplasms.[SEP]Relations: Protein S Homo sapiens has relations: drug_drug with Rituximab, drug_drug with Rituximab, drug_drug with Bamet-UD2, drug_drug with Bamet-UD2, drug_drug with Methotrexate, drug_drug with Methotrexate, drug_drug with Bortezomib, drug_drug with Bortezomib, drug_drug with NS-398, drug_drug with NS-398. Definitions: MDM2 protein, Homo sapiens defined as following: E3 ubiquitin-protein ligase Mdm2 (491 aa, ~55 kDa) is encoded by the Homo sapiens MDM2 protein, Homo sapiens gene. This protein is involved in the mediation of the ubiquitination and degradation of protein substrates, and the inhibition of apoptosis induction that is mediated by cellular tumor antigen TP53 wt Allele.. liposarcoma defined as following: A malignant tumor derived from primitive or embryonal lipoblastic cells. It may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid (LIPOSARCOMA, MYXOID), round-celled, or pleomorphic, usually in association with a rich network of capillaries. Recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. (From Dorland, 27th ed; Stedman, 25th ed). TP53 wt Allele defined as following: Human TP53 wild-type allele is located in the vicinity of 17p13.1 and is approximately 19 kb in length. This allele, which encodes cellular tumor antigen TP53 wt Allele protein, plays a role in cell cycle regulation during the G0/G1transition. Alterations of the TP53 gene occur as both somatic and germline mutations in Homo sapiens Malignant Neoplasms in select cancer-prone families with Li-Fraumeni syndrome.. Tumor cells, malignant defined as following: Cells of, or derived from, a malignant tumor.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Cultured Cell Line defined as following: Established cell cultures that have the potential to propagate indefinitely.. solid Neoplasms defined as following: A benign or malignant neoplasm arising from tissues that do not include fluid areas. Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma). Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid Neoplasms.. Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Do chromatin features predict genes associated with eQTLs?", "id": "converted_2349", "sentence1": "Do chromatin features predict Genes associated with eQTLs?", "sentence2": "Using the random forest classifier, we found that genomic proximity plus five Male-to-Female Transsexual, Self-Report and chromatin features are able to predict>90% of target Genes within 1 megabase of eQTLs, Using the random forest classifier, we found that genomic proximity plus five Male-to-Female Transsexual, Self-Report and chromatin features are able to predict >90% of target Genes within 1 megabase of eQTLs., Cell type-specific gene expression in Homo sapiens involves complex interactions between regulatory factors and DNA at enhancers and Promoter. Mapping studies for expression quantitative trait loci (eQTLs), TRANSCRIPTION FACTOR (TFs) and chromatin markers have become widely used tools for identifying gene regulatory elements, but prediction of target Genes remains a major challenge. Here, we integrate genome-wide data on Male-to-Female Transsexual, Self-Report-binding sites, chromatin markers and functional annotations to predict Genes associated with human eQTLs. Using the random forest classifier, we found that genomic proximity plus five Male-to-Female Transsexual, Self-Report and chromatin features are able to predict >90% of target Genes within 1 megabase of eQTLs. Despite being regularly used to map target Genes, proximity is not a good indicator of eQTL targets for Genes 150 kilobases away, but insulators, Male-to-Female Transsexual, Self-Report co-occurrence, open chromatin and functional similarities between TFs and Genes are better indicators. Using all six features in the classifier achieved an area under the specificity and sensitivity curve of 0.91, much better compared with at most 0.75 for using any single feature. We hope this study will not only provide validation of eQTL-mapping studies, but also provide insight into the molecular mechanisms explaining how genetic variation can influence gene expression.[SEP]Relations: transcription factor binding has relations: molfunc_protein with C1QBP, molfunc_protein with C1QBP, molfunc_protein with METTL23, molfunc_protein with METTL23, molfunc_protein with ETS1, molfunc_protein with ETS1, molfunc_protein with CENPF, molfunc_protein with CENPF, molfunc_protein with AHR, molfunc_protein with AHR. Definitions: Homo sapiens defined as following: Members of the species Homo sapiens.. Male-to-Female Transsexual, Self-Report defined as following: A person who was assigned to the male gender at birth based on physical characteristics but who self-identifies psychologically and emotionally as female.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. chromatin defined as following: The material of CHROMOSOMES. It is a complex of DNA; HISTONES; and nonhistone proteins (CHROMOSOMAL PROTEINS, NON-HISTONE) found within the nucleus of a cell..", "label": "yes"} {"original_question": "Does Serca2a bind PLN in the heart?", "id": "converted_1487", "sentence1": "Does Serca2a bind PLN gene in the Chest>Heart?", "sentence2": "The human phospholamban Arg14-deletion mutant localizes to Plasma membrane and interacts with the Na/K-ATPase., Moreover, PLN gene gene-R14Del did not co-immunoprecipitate with SERCA2a (as did WT-PLN gene gene),, n this review, we attempted to highlight the functional significance of PLN gene gene in Vertebrates cardiac physiology. We will refer to the huge literature on Mammals in order to describe the molecular characteristics of this Protein Info, its interaction with SERCA2a, There is clear evidence for direct regulatory Protein Info-Protein Info interactions between phospholamban (PLN gene gene) and the Ca2+-ATPase of cardiac sarcoplasmic reticulum (SERCA2a) in Cytoplasmic domains, These results suggest that PLN gene gene modulates the apparent Ca2+ affinity of SERCA2a through intramembrane interactions, which are disrupted at long range and in concert with disruption of the well characterized Cytoplasmic interactions., Phospholamban (PLN gene gene), a homopentameric, integral membrane Protein Info, reversibly inhibits cardiac sarcoplasmic reticulum Ca2+-ATPase (SERCA2a) activity through intramembrane interactions., The concentration of this inhibited complex is determined by the dissociation constant for the PLN gene gene pentamer (which is mutation-sensitive) and by the dissociation constant for the PLN gene gene/SERCA2a heterodimer (which is likely to be mutation-sensitive)., These results support the proposal that PLN gene gene inhibition of SERCA2a involves, first, depolymerization of PLN gene gene and, second, the formation of inhibitory interactions between monomeric PLN gene gene and SERCA2a., SLN gene gene and PLN gene gene appear to bind to the same regulatory site in SERCA. However, in a ternary complex, PLN gene gene occupies the regulatory site and SLN gene gene binds to the exposed side of PLN gene gene and to SERCA., Cells and biochemical studies revealed that, unlike wild-type PLN gene gene, PLN gene gene(R9C) did not directly inhibit SERCA2a., . Conversely, using anti-SERCA2a immunoglobulin complex location, both PLN gene gene and Acylphosphatase were co-immunoprecipitated with SERCA2a, and the PLN gene gene amount in the precipitate decreased with increasing Acylphosphatase concentrations., Reconstitution of the Cytoplasmic interaction between phospholamban and Ca(2+)-ATPase of cardiac sarcoplasmic reticulum., Phospholamban (PLN gene gene) reversibly inhibits the Ca(2+)-ATPase of cardiac sarcoplasmic reticulum (SERCA2a) through a direct Protein Info-Protein Info interaction, playing a pivotal role in the regulation of Protoplasm Ca(2+) in Myocytes, Cardiac., Phospholamban (PLN gene gene) is a key regulator of Ca(2+) homeostasis and contractility in the Chest>Heart. Its regulatory effects are mediated through its interaction with the Sarcoplasmic Reticulum Calcium-Transporting ATPases, (SERCA2a), resulting in alterations of its Ca(2+)-affinity, In a co-immunoprecipitation of PLN gene gene with SERCA2a, the physical interaction between the two Proteins was increased in PUGNAc-treated cardiomyocytes.[SEP]Relations: Plasma membrane has relations: cellcomp_protein with PLA2G2A, cellcomp_protein with PLA2G2A, cellcomp_protein with PLA2G3, cellcomp_protein with PLA2G3, cellcomp_protein with PLA2G6, cellcomp_protein with PLA2G6, cellcomp_protein with PLXNA2, cellcomp_protein with PLXNA2, cellcomp_protein with PLA2G5, cellcomp_protein with PLA2G5. Definitions: phospholamban defined as following: free sarcoplasmic reticulum polymeric proteolipid which modulates sarcoplasmic reticulum function; phosphorylated by cAMP-dependent, calcium-calmodulin-dependent, and calcium-phospholipid-dependent Protein Info kinases.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the Protein Info.. Plasma membrane defined as following: The lipid- and Protein Info-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells.. Mammals defined as following: Warm-blooded Vertebrates animals belonging to the class Mammalia, including all that possess hair and suckle their young.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Sarcoplasmic Reticulum Calcium-Transporting ATPases defined as following: Calcium-transporting ATPases that catalyze the active transport of CALCIUM into the SARCOPLASMIC RETICULUM vesicles from the CYTOPLASM. They are primarily found in MUSCLE CELLS and play a role in the relaxation of MUSCLES.. Myocytes, Cardiac defined as following: Striated muscle cells found in the Chest>Heart. They are derived from cardiac myoblasts (MYOBLASTS, CARDIAC).. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous Proteins in other species.. immunoglobulin complex location defined as following: A Protein Info complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional Proteins. An immunoglobulin complex may be embedded in the Plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph. [GOC:add, GOC:jl, ISBN:0781765196]. Vertebrates defined as following: Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising Mammals, birds, reptiles, amphibians, and fishes.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as Proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, Proteins, lipids, carbohydrates, and inorganic salts..", "label": "yes"} {"original_question": "Is Dexmecamylamine effective for depression?", "id": "converted_3432", "sentence1": "Is Dexmecamylamine effective for depression?", "sentence2": "At treatment end, no significant differences were seen for change in MADRS total score with TC-5214 versus placebo. Furthermore, there were no significant differences in any of the secondary endpoints. , TC-5214 (Dexmecamylamine) is a nicotinic channel modulator that has previously been evaluated for treatment of major depression disorder (Major Depressive Disorder) and is currently being evaluated by Targacept as a treatment for overactive bladder. , In these 2 flexibly-dosed studies, no specific therapeutic effects were observed for TC-5214 (1-4 mg Twice a day) adjunct to Antidepressive Agents in the primary endpoint or any secondary endpoint; however, TC-5214 was generally well tolerated. In conclusion, no Antidepressive Agents effect of TC-5214 was observed in these studies., TC-5214 (Dexmecamylamine) is a nicotinic channel modulator that has previously been evaluated for treatment of major depression disorder (Major Depressive Disorder) and is currently being evaluated by Targacept as a treatment for overactive bladder., No notable differences were observed between Dexmecamylamine and placebo for any secondary end point., TC-5214 ( Dexmecamylamine ) is a nicotinic channel modulator that has previously been evaluated for treatment of major depression disorder ( Major Depressive Disorder ) and is currently being evaluated by Targacept as a treatment for overactive bladder . , TC-5214 (Dexmecamylamine) is a nicotinic channel modulator that has previously been evaluated for treatment of major depression disorder (Major Depressive Disorder) and is currently being evaluated by Targacept as a treatment for overactive bladder., At treatment end, no significant differences were seen for change in MADRS total score with TC-5214 versus placebo., In these 2 flexibly-dosed studies, no specific therapeutic effects were observed for TC-5214 (1-4 mg Twice a day) adjunct to Antidepressive Agents in the primary endpoint or any secondary endpoint; however, TC-5214 was generally well tolerated.[SEP]Relations: Mecamylamine has relations: drug_drug with Dexetimide, drug_drug with Dexetimide, drug_drug with Dextran, drug_drug with Dextran, drug_drug with Dextromoramide, drug_drug with Dextromoramide, drug_drug with Dexmedetomidine, drug_drug with Dexmedetomidine, drug_drug with Dexniguldipine, drug_drug with Dexniguldipine. Definitions: Major Depressive Disorder defined as following: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5). Antidepressive Agents defined as following: Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.. Twice a day defined as following: Two times per day, at unspecified times..", "label": "no"} {"original_question": "Is there an association between carcinoid syndrome and mitral valve disease?", "id": "converted_2310", "sentence1": "Is there an association between Malignant Carcinoid Syndrome and Mitral Valve disease?", "sentence2": "Other concomitant operations included Mitral Valve procedure (11%), aortic valve procedure (9%), patent foramen ovale or atrial septal defect closure (23%), cardiac metastasectomies or biopsy (4%), and simultaneous coronary artery bypass (11%). , High circulating serotonin (Malignant Carcinoid Syndrome) and serotoninergic drugs are known to cause Heart valve disease that shares pathologic features with DMVD., Surgery included Replacement of tricuspid valve in all patients, pulmonary valve replacement in 3 and valvectomy in 7, Mitral Valve replacement in 6 and repair in 1, aortic valve replacement in 4 and repair in 2, CABG in 2, and patent foramen ovale closure in 5. , We report two observations of significant left heart involvement in patients with the Malignant Carcinoid Syndrome assessed by transthoracic and transoesophageal echocardiography. Echocardiographic lesions of this kind have only been reported twice. In the present cases, there was mitral involvement with mitral regurgitation in one case and a mitro-aortic involvement with mitral and aortic regurgitation in the other., An observation of Malignant Carcinoid Syndrome in a woman of 47 suffering from Carcinoid Specimen Source Codes - tumor, malignant of the Ileum and Ileum and ileum with metastases into the Abdomen>Liver and right ovary is described. The clinical picture included Diarrhea, heat waves, Bronchospasm, Hypertensive disease, hyperserotoninemia, affection of the Mitral Valve and left atrium. , A case of Malignant Carcinoid Syndrome, stemming from a Specimen Source Codes - Specimen Source Codes - tumor of the large Intestines with hepatic metastases, is reported. Clinical features included Heart Diseases with triple valvular lesion: Tricuspid Valve Insufficiency with Stenosis Morphology, Pulmonary artery Stenosis Morphology and Mitral Valve Insufficiency. , High circulating serotonin (Malignant Carcinoid Syndrome) and serotoninergic drugs are known to cause Heart valve disease that shares pathologic features with DMVD.[SEP]Relations: heart valve disease has relations: disease_disease with Mitral Valve disease, disease_disease with Mitral Valve disease. congenital Mitral Valve insufficiency has relations: disease_disease with Mitral Valve disease, disease_disease with Mitral Valve disease, disease_disease with vascular insufficiency disorder, disease_disease with vascular insufficiency disorder. Malignant Carcinoid Syndrome has relations: disease_disease with syndromic disease, disease_disease with syndromic disease, disease_disease with carcinoid crisis, disease_disease with carcinoid crisis. Definitions: Mitral Valve Insufficiency defined as following: Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to Mitral Valve regurgitation.. Pulmonary artery Stenosis Morphology defined as following: A congenital or acquired cardiovascular abnormality characterized by the narrowing of the lumen of the main pulmonary artery or its branches. Signs and symptoms include dyspnea, tachypnea, tachycardia, fatigue, and edema.. Tricuspid Valve Insufficiency defined as following: Backflow of blood from the RIGHT VENTRICLE into the RIGHT ATRIUM due to imperfect closure of the TRICUSPID VALVE.. Hypertensive disease defined as following: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), Hypertensive disease is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.. Bronchospasm defined as following: Spasmodic contraction of the smooth muscle of the bronchi.. Mitral Valve defined as following: The valve between the left atrium and left ventricle of the heart.. Heart valve disease defined as following: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).. Replacement of tricuspid valve defined as following: Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. tricuspid valve with bioprosthetic, homograft or autograft valve.. Diarrhea defined as following: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.. Malignant Carcinoid Syndrome defined as following: A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the Abdomen>Liver. Symptoms are caused by Specimen Source Codes - tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed). mitral defined as following: a valve that controls blood flow between heart chambers. Intestines defined as following: The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE.. Heart Diseases defined as following: Pathological conditions involving the HEART including its structural and functional abnormalities.. Mitral Valve disease defined as following: A heart disorder characterized by a defect in Mitral Valve structure or function..", "label": "yes"} {"original_question": "Does Vitamin D induce autophagy?", "id": "converted_1800", "sentence1": "Does Vitamin D induce autophagy?", "sentence2": " 1,25(OH)2D treatment was accompanied by autophagy activation , Autophagy signaling pathway was regulated by cholecalciferol, ergocalciferol induces autophagy, Vitamin D shows promise for the prevention and amelioration of pathologic responses in Irritable Bowel Syndrome, an effect that is mediated, at least in part, by the induction and modulation of autophagy.[SEP]Relations: Ergocalciferol has relations: drug_drug with Vitamin D, drug_drug with Vitamin D, contraindication with familial isolated deficiency of vitamin E, contraindication with familial isolated deficiency of vitamin E, drug_protein with VDR, drug_protein with VDR. Cholecalciferol has relations: drug_drug with Vitamin D, drug_drug with Vitamin D, contraindication with familial isolated deficiency of vitamin E, contraindication with familial isolated deficiency of vitamin E. Definitions: ergocalciferol defined as following: Vitamin D2, a fat-soluble vitamin important for many biochemical processes including the absorption and metabolism of calcium and phosphorus. In vivo, ergocalciferol is formed after sun (ultraviolet) irradiation of plant-derived ergosterol, another form of ergocalciferol. Ergocalciferol is the form of ergocalciferol usually found in vitamin supplements. (NCI04). cholecalciferol defined as following: Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. It differs from ERGOCALCIFEROL in having a single bond between C22 and C23 and lacking a methyl group at C24.. Irritable Bowel Syndrome defined as following: Gastrointestinal symptoms characterized by chronic abdominal pain and altered bowel habits in the absence of any organic cause.. Vitamin D defined as following: Vitamin D2, a fat-soluble vitamin important for many biochemical processes including the absorption and metabolism of calcium and phosphorus. In vivo, ergocalciferol is formed after sun (ultraviolet) irradiation of plant-derived ergosterol, another form of ergocalciferol. Ergocalciferol is the form of ergocalciferol usually found in vitamin supplements. (NCI04).", "label": "yes"} {"original_question": "Is Ctf4 involved in sister chromatid cohesion establishment?", "id": "converted_688", "sentence1": "Is Ctf4 involved in sister chromatid cohesion establishment?", "sentence2": "In addition to Eco1, several other factors contribute to cohesion establishment, including Ctf4, CHTF18 gene, Tof1, Csm3, DDX11 gene and Mrc1, but little is known about their roles. Here, we show that each of these factors facilitates cohesin acetylation. Moreover, the absence of Ctf4 and DDX11 gene, but not of the other factors, causes a synthetic growth defect in Cells lacking Eco1. Distinct from acetylation defects, sister chromatid cohesion in ctf4Δ and chl1Δ Cells is not improved by removing WAPL gene, Thus, Ctf4 and DDX11 gene delineate an additional acetylation-independent pathway that might hold important clues as to the mechanism of sister chromatid cohesion establishment, Genetic analyses revealed that RMI1 gene promoted sister chromatid cohesion in a process that was distinct from both the cohesion establishment pathway involving Ctf4, Csm3, and DDX11 gene, Influence of the Homo sapiens cohesion establishment factor Ctf4/AND-1, Here, we used Xenopus egg extracts to show that AND-1 and Tim1-Tipin, homologues of Saccharomyces cerevisiae Ctf4 and Tof1-Csm3, respectively, are associated with the replisome and are required for proper establishment of the cohesion observed in the M-phase extracts, These data defined two cohesion pathways, one containing CSM3, TOF1, WDHD1 gene, and CHL1, and the second containing MRC1 gene gene, CTF18, CHTF8 gene, and DSCC1 gene, Our results suggest that DDX11 gene and Ctf4 are directly involved in homologous recombination repair rather than acting indirectly via the establishment of sister chromatid cohesion, Here we show that three Proteins required for sister chromatid cohesion, Eco1, Ctf4, and CHTF18 gene, are found at, and Ctf4 travels along chromosomes with, replication forks, WSS1 was also found to interact genetically with SGS1, TOP3A wt Allele, SILVER-RUSSELL SYNDROME 2 and WDHD1 gene, which are involved in recombination, repair of replication forks and the establishment of sister chromatid cohesion, The Catalytic Domain of budding yeast Polalpha (Pol1p) has been shown to associate in vitro with the Spt16p-Pob3p complex, a component of the nucleosome reorganization system required for both replication and transcription, and with a sister chromatid cohesion factor, Ctf4p, Constituents of the replication fork, such as the DNA polymerase alpha-binding protein Ctf4, contribute to cohesion in ways that are poorly understood, Genetic analyses revealed that RMI1 gene promoted sister chromatid cohesion in a process that was distinct from both the cohesion establishment pathway involving Ctf4, Csm3, and DDX11 gene and the pathway involving the acetylation of SMC3 wt Allele., Our results suggest that DDX11 gene and Ctf4 are directly involved in homologous recombination repair rather than acting indirectly via the establishment of sister chromatid cohesion., Ctf4/AND-1 is a highly conserved gene product required for both DNA replication and the establishment of sister chromatid cohesion., Here we show that three Proteins required for sister chromatid cohesion, Eco1, Ctf4, and CHTF18 gene, are found at, and Ctf4 travels along chromosomes with, replication forks., Sister-chromatid cohesion mediated by the alternative RF-CCtf18/Dcc1/Ctf8, the helicase DDX11 gene and the polymerase-alpha-associated protein Ctf4 is essential for chromatid disjunction during meiosis II., Saccharomyces cerevisiae CTF18 and WDHD1 gene are required for sister chromatid cohesion., We find that absence of either WDHD1 gene or CTF18 causes sister chromatid cohesion failure and leads to a preanaphase accumulation of Cells that depends on the Spindle assembly checkpoint., We show here that CHTF8 gene, WDHD1 gene and a helicase encoded by CHL1 are required for efficient sister chromatid cohesion in unperturbed mitotic Cells, and provide evidence that DDX11 gene functions during S Phase., In budding yeast, a specialized replication factor C called RF-C(CHTF18 gene/Dcc1/Ctf8) and the DNA-polymerase-alpha-associated protein Ctf4 are required to maintain sister-chromatid cohesion in Cells arrested for long periods in mitosis., The physical and genetic interactions between WDHD1 gene, CTF18, and core components of replication fork complexes observed in this study and others suggest that both gene products act in association with the replication fork to facilitate sister chromatid cohesion., Our results suggest that DDX11 gene and Ctf4 are directly involved in homologous recombination repair rather than acting indirectly via the establishment of sister chromatid cohesion., Thus, Ctf4 and DDX11 gene delineate an additional acetylation-independent pathway that might hold important clues as to the mechanism of sister chromatid cohesion establishment., Thus, Ctf4 and DDX11 gene delineate an additional acetylation-independent pathway that might hold important clues as to the mechanism of sister chromatid cohesion establishment., Ctf4/AND-1 is a highly conserved gene product required for both DNA replication and the establishment of sister chromatid cohesion, Genetic analyses revealed that RMI1 gene promoted sister chromatid cohesion in a process that was distinct from both the cohesion establishment pathway involving Ctf4, Csm3, and DDX11 gene and the pathway involving the acetylation of SMC3 wt Allele, Establishment of sister chromatid cohesion at the Saccharomyces cerevisiae replication fork.[SEP]Relations: DDX11 has relations: bioprocess_protein with establishment of sister chromatid cohesion, bioprocess_protein with establishment of sister chromatid cohesion, bioprocess_protein with positive regulation of sister chromatid cohesion, bioprocess_protein with positive regulation of sister chromatid cohesion, bioprocess_protein with sister chromatid cohesion, bioprocess_protein with sister chromatid cohesion, molfunc_protein with chromatin binding, molfunc_protein with chromatin binding, bioprocess_protein with positive regulation of chromatin binding, bioprocess_protein with positive regulation of chromatin binding. Definitions: MRC1 gene defined as following: This gene is involved in endocytosis of glycoproteins by macrophages.. SMC3 wt Allele defined as following: Human SMC3 wild-type allele is located in the vicinity of 10q25 and is approximately 37 kb in length. This allele, which encodes structural maintenance of chromosomes protein 3, is involved in the regulation of chromosome migration during mitosis.. WAPL gene defined as following: This gene is involved in both DNA replication and sister chromatid cohesion.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Saccharomyces cerevisiae defined as following: A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" yeast. The dried form is used as a dietary supplement.. Spindle defined as following: The array of microtubules and associated molecules that forms between opposite poles of a eukaryotic cell during mitosis or meiosis and serves to move the duplicated chromosomes apart. [ISBN:0198547684]. TOP3A wt Allele defined as following: Human TOP3A wild-type allele is located within 17p12-p11.2 and is approximately 41 kb in length. This allele, which encodes DNA topoisomerase 3-alpha protein, is involved in the ATP-independent breakage of negatively supercoiled single-stranded DNA and subsequent passage/rejoining of the broken DNA.. S Phase defined as following: Phase of the CELL CYCLE following G1 and preceding G2 when the entire DNA content of the nucleus is replicated. It is achieved by bidirectional replication at multiple sites along each chromosome.. Homo sapiens defined as following: Members of the species Homo sapiens.. Catalytic Domain defined as following: The region of an enzyme that interacts with its substrate to cause the enzymatic reaction.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary..", "label": "yes"} {"original_question": "Is single-cell analysis (SCA) possible in proteomics?", "id": "converted_274", "sentence1": "Is single-cell analysis (Structure of superior cerebellar artery) possible in proteomics?", "sentence2": "Toward Single Cell Analysis by Plume Collimation in Laser Ablation Electrospray Ionization Mass Spectrometry., he advent of proteomics and genomics at a single-cell level has set the basis for an outstanding improvement in analytical technology and data acquisition., The new-generation technology of single-cell analysis is able to better characterize a cell's population, identifying and differentiating outlier Cells, in order to provide both a single-cell experiment and a corresponding bulk measurement, through the identification, quantification and characterization of all system biology aspects (genomics, transcriptomics, proteomics, metabolomics, degradomics and fluxomics). The movement of omics into single-cell analysis represents a significant and outstanding shift., Laser ablation electrospray ionization (LAESI) is a novel method for the direct imaging of biological tissues by mass spectrometry. By performing ionization in the ambient environment, this technique enables in vivo studies with potential for single-cell analysis., Other approaches for MS-based chemical imaging and profiling include those based on near-field laser ablation and inductively-coupled plasma MS analysis, which offer complementary capabilities for subcellular chemical imaging and profiling., Mass spectrometry imaging and profiling of single Cells., his is rapidly changing with the recent examples of single cell genomics, transcriptomics, proteomics and metabolomics. The rate of change is expected to accelerate owing to emerging technologies that range from micro/nanofluidics to microfabricated interfaces for mass spectrometry to third- and fourth-generation automated DNA sequencers, Single-cell analysis (Structure of superior cerebellar artery) has been increasingly recognized as the key technology for the elucidation of cellular functions, which are not accessible from bulk measurements on the population level. Thus far, Structure of superior cerebellar artery has been achieved by miniaturization of established engineering concepts to match the dimensions of a single cell, Single-cell proteomic chip for profiling Protoplasm signaling pathways in single tumor Cells., The amount of single Proteins in single Cells can be as low as one copy per cell and is for most Proteins in the attomole range or below; usually considered as insufficient for proteomic analysis., n Arabidopsis thaliana , we have successfully identified nine unique Proteins in a single-cell sample and 56 Proteins from a pool of 15 single-cell samples from glucosinolate-rich S-Cells by nanoLC-MS/MS proteomic analysis, thus establishing the proof-of-concept for true single-cell proteomic analysis, A first step towards practical single cell proteomics: a microfluidic antibody capture chip with TIRF detection.[SEP]Relations: Bite Cells has relations: disease_phenotype_positive with hereditary stomatocytosis, disease_phenotype_positive with hereditary stomatocytosis, phenotype_phenotype with Poikilocytosis, phenotype_phenotype with Poikilocytosis. superior cerebellar artery has relations: anatomy_anatomy with branch of basilar artery, anatomy_anatomy with branch of basilar artery. Definitions: Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as Proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, Proteins, lipids, carbohydrates, and inorganic salts.. Structure of superior cerebellar artery defined as following: Cessation of heart beat or MYOCARDIAL CONTRACTION. If it is treated within a few minutes, heart arrest can be reversed in most cases to normal cardiac rhythm and effective circulation..", "label": "no"} {"original_question": "Is there any role of interleukin-11 in cardiovascular fibrosis?", "id": "converted_2630", "sentence1": "Is there any role of interleukin-11 in cardiovascular Fibrosis?", "sentence2": "IL11 is a crucial determinant of cardiovascular Fibrosis., Using integrated imaging-genomics analyses of primary human Specimen Source Codes - Fibroblasts, we found that Interleukin 11 (IL11) upregulation is the dominant transcriptional response to TGFB1 gene gene exposure and required for its profibrotic effect. IL11 and its receptor (IL11RA protein, human protein, human) are expressed specifically in Specimen Source Codes - Fibroblasts where they drive non-canonical, ERK-dependent autocrine signalling that is required for fibrogenic protein synthesis. In CASP14 gene, fibroblast-specific interleukin-11 transgene expression or interleukin-11 injection causes Chest>Heart and kidney Fibrosis and organ failure whereas genetic deletion of Il11ra1 is protective against disease. Thus, inhibition of IL11 prevents fibroblast activation across Organ and species in response to a range of important pro-fibrotic stimuli. These data reveal a central role of IL11 in Fibrosis and we propose inhibition of IL11 as a new therapeutic strategy to treat fibrotic diseases., IL11 is a crucial determinant of cardiovascular Fibrosis.[SEP]Relations: interleukin-11 binding has relations: molfunc_protein with IL11RA protein, human, molfunc_protein with IL11RA protein, human, molfunc_protein with IL6R, molfunc_protein with IL6R, molfunc_protein with IL6ST, molfunc_protein with IL6ST. breast Fibrosis has relations: disease_disease with integumentary system disease, disease_disease with integumentary system disease, disease_disease with non-proliferative fibrocystic change of the breast, disease_disease with non-proliferative fibrocystic change of the breast. Definitions: TGFB1 gene defined as following: This gene plays a role in cell growth, proliferation and biogenesis/organization. It is also involved in the inhibition of apoptosis.. Fibrosis defined as following: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.. Organ defined as following: A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues. An organ is part of an anatomic system or a body region. Representative examples include the Chest>Heart, lung, liver, spleen, and uterus.. interleukin-11 defined as following: A lymphohematopoietic cytokine that plays a role in regulating the proliferation of ERYTHROID PRECURSOR CELLS. It induces maturation of MEGAKARYOCYTES which results in increased production of BLOOD PLATELETS. Interleukin-11 was also initially described as an inhibitor of ADIPOGENESIS of cultured preadipocytes.. IL11RA protein, human defined as following: Interleukin-11 receptor subunit alpha (422 aa, ~45 kDa) is encoded by the human IL11RA protein, human gene. This protein is involved in both cytokine signaling and skeletal development.. interleukin-11 defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin 11 (IL-11). Secreted by bone marrow stromal cells and a number of mesenchymal cells, IL-11 binds to and activates its cell-surface receptor, promoting primary and secondary immune responses, modulating antigen-specific antibody reactions, and preventing apoptotic cell death. This agent also stimulates the T-cell-dependent development of IgG-secreting B-cells in spleen cell cultures and may be an important regulator of megakaryocytopoiesis. (NCI04). cardiovascular defined as following: The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body..", "label": "yes"} {"original_question": "Has the drug Afrezza been approved by the FDA?", "id": "converted_3273", "sentence1": "Has the drug Afrezza been approved by the FDA?", "sentence2": "In contrary, MannKind Corporation started developing its ultra-rapid-acting insulin Afrezza in a bold Twice a day, probably by managing the issues in which Exubera was not successful. Afrezza has been marketed since February, 2015 by Sanofi after getting FDA approval in June 2014.[SEP]Definitions: Twice a day defined as following: Two times per day, at unspecified times..", "label": "yes"} {"original_question": "Do normal cells express the protein TERT?", "id": "converted_1962", "sentence1": "Do Normal cell express the protein TERT?", "sentence2": "Since Telomerase has been recognized as a relevant factor distinguishing Tumor cells, malignant from Normal cell, it has become a very promising target for anti-cancer therapy, Telomerase plays a pivotal role in cellular immortality and tumorigenesis. Its activity is normally not detectable in most Diploid Cell while it is reactivated in the vast majority of Tumor cells, malignant. Therefore, inhibition of Telomerase has been viewed as a promising anticancer approach due to its specificity for Tumor cells, malignant., Telomerase activity is found in 85%-90% of all Homo sapiens Malignant Neoplasms but not in their adjacent Normal cell. Human Telomerase reverse transcriptase (TERT wt Allele) is an essential component in the Telomerase complex that plays an important role in Telomerase activity., elomerase activation is considered to be a critical step in carcinogenesis and its activity correlates closely with TERT protein, Homo sapiens (TERT wt Allele) expression. Since only Tumor cells, uncertain whether benign or malignant that express Telomerase activity would activate this Promoter, the TERT wt Allele proximal Promoter allows for preferential expression of Genes, Viral in Tumor cells, uncertain whether benign or malignant, leading to selective viral replication[SEP]Relations: Protein S Homo sapiens has relations: drug_drug with Platelet Activating Factor, drug_drug with Platelet Activating Factor, drug_protein with PROC, drug_protein with PROC, drug_drug with Iloprost, drug_drug with Iloprost, drug_drug with Dienogest, drug_drug with Dienogest, drug_drug with Sarpogrelate, drug_drug with Sarpogrelate. Definitions: TERT protein, Homo sapiens defined as following: Telomerase reverse transcriptase (1132 aa, ~127 kDa) is encoded by the Homo sapiens TERT gene. This protein plays a role in both the replication and maintenance of telomeres.. Telomerase defined as following: An essential ribonucleoprotein reverse transcriptase that adds telomeric DNA to the ends of eukaryotic CHROMOSOMES.. Tumor cells, malignant defined as following: Cells of, or derived from, a malignant tumor.. Homo sapiens defined as following: Members of the species Homo sapiens.. TERT wt Allele defined as following: Human TERT wild-type allele is located in the vicinity of 5p15.33 and is approximately 42 kb in length. This allele, which encodes Telomerase reverse transcriptase protein, is involved in the replication of telomeres. Aberrant expression of the allele at elevated levels may contribute to oncogenesis.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Diploid Cell defined as following: Nucleated cell which has one or more diploid sets (46 pairs) of chromosomes.. Tumor cells, uncertain whether benign or malignant defined as following: Cells of, or derived from, a tumor.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. Genes, Viral defined as following: The functional hereditary units of VIRUSES..", "label": "no"} {"original_question": "Is PTEN a tumour suppressor?", "id": "converted_3294", "sentence1": "Is PTEN protein, human a tumour suppressor?", "sentence2": "PTEN protein, human protein, human is a potent tumour suppressor, Genome aberrations of the PTEN protein, human protein, human tumour suppressor gene are among the most common in Malignant neoplasm of prostate.[SEP]Relations: Protein S human has relations: drug_drug with Cloricromen, drug_drug with Cloricromen, drug_drug with Naproxen, drug_drug with Naproxen, drug_drug with Lepirudin, drug_drug with Lepirudin, drug_drug with Turoctocog alfa, drug_drug with Turoctocog alfa, drug_drug with (R)-warfarin, drug_drug with (R)-warfarin. Definitions: Genome defined as following: The genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA.. PTEN protein, human defined as following: Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN protein, human (403 aa, ~47 kDa) is encoded by the human PTEN protein, human gene. This protein plays a role in signaling and as both a dual-specificity phosphoprotein phosphatase and a lipid phosphatase.. Malignant neoplasm of prostate defined as following: A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas..", "label": "yes"} {"original_question": "Does lucatumumab bind to CD140?", "id": "converted_2862", "sentence1": "Does lucatumumab bind to CD140?", "sentence2": "Lucatumumab is a fully humanized anti-CD40 Antigens Antigens antibody that blocks interaction of CD40 Antigens Antigens Ligand with CD40 Antigens Antigens and also mediates antibody-dependent cell-mediated cytotoxicity (ADCC). , Phase I study of the anti-CD40 Antigens Antigens humanized monoclonal antibody lucatumumab (CHIR-12.12) in relapsed Chronic Lymphocytic Leukemia., Saturation of CD40 Antigens Antigens receptor on CLL cells was uniform at all doses post-treatment but also persisted at trough time points in the 3.0 mg/kg or greater cohorts.[SEP]Relations: Chronic lymphatic leukemia has relations: drug_effect with Pramipexole, drug_effect with Pramipexole, drug_effect with Paroxetine, drug_effect with Paroxetine, drug_effect with Nelarabine, drug_effect with Nelarabine, disease_phenotype_positive with Aicardi-Goutieres syndrome, disease_phenotype_positive with Aicardi-Goutieres syndrome, disease_phenotype_positive with sweet syndrome, disease_phenotype_positive with sweet syndrome. Definitions: CD40 Antigens Ligand defined as following: A membrane glycoprotein and differentiation antigen expressed on the surface of T-cells that binds to CD40 Antigens ANTIGENS on B-LYMPHOCYTES and induces their proliferation. Mutation of the gene for CD40 Antigens ligand is a cause of HYPER-IGM IMMUNODEFICIENCY SYNDROME, TYPE 1.. CD40 Antigens defined as following: Members of the tumor necrosis factor receptor superfamily with specificity for CD40 Antigens LIGAND. They are found on mature B-LYMPHOCYTES, some EPITHELIAL CELLS; and lymphoid DENDRITIC CELLS. Evidence suggests that CD40 Antigens-dependent activation of B-cells is important for generation of memory B-cells within the germinal centers. Mutations in the CD40 Antigens antigen gene result in HYPER-IGM IMMUNODEFICIENCY SYNDROME, TYPE 3. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.. Chronic Lymphocytic Leukemia defined as following: A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called Chronic Lymphocytic Leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease.. lucatumumab defined as following: A fully human monoclonal antibody directed against the B-cell surface antigen CD40 Antigens with potential antineoplastic activity. Lucatumumab binds to and inhibits CD40 Antigens, thereby inhibiting CD40 Antigens ligand-induced cell proliferation and triggering cell lysis via antibody-dependent cellular cytotoxicity (ADCC) in cells overexpressing CD40 Antigens. CD40 Antigens, an integral membrane protein found on the surface of B lymphocytes, is a member of the tumor necrosis factor receptor superfamily and is highly expressed in a number of B-cell malignancies..", "label": "no"} {"original_question": "Should istiratumab be used for Pancreatic Cancer?", "id": "converted_4497", "sentence1": "Should istiratumab be used for Pancreatic Cancer?", "sentence2": "CONCLUSIONS: Istiratumab failed to improve the efficacy of SOC chemotherapy in this patient setting. , In the high Insulin-Like Growth Factor I cohort, median PFS was 3.6 and 7.3 months in the experimental versus control arms, respectively [hazard ratio (HR) = 1.88, P = 0.027]. In the high Insulin-Like Growth Factor I/HRG+ subgroup (n = 44), median PFS was 4.1 and 7.3 months, respectively (HR = 1.39, P = 0.42).[SEP]Relations: insulin-like growth factor I binding has relations: molfunc_protein with ITGAV, molfunc_protein with ITGAV, molfunc_protein with ITGA6, molfunc_protein with ITGA6, molfunc_protein with ITGB3, molfunc_protein with ITGB3, molfunc_protein with INSR, molfunc_protein with INSR, molfunc_protein with ITGB4, molfunc_protein with ITGB4. Definitions: Insulin-Like Growth Factor I defined as following: A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor.. Pancreatic Cancer defined as following: A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma..", "label": "no"} {"original_question": "Does ProSavin use an adenoviral vector?", "id": "converted_3444", "sentence1": "Does ProSavin use an adenoviral vector?", "sentence2": "Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson Disease., ProSavin, a lentiviral vector based gene therapy that delivers local and continuous dopamine, was previously shown to be well tolerated in a Phase I/II first-in-human study, with significant improvements in motor behavior from baseline at 1 year. [SEP]Relations: Dopamine has relations: drug_drug with Saquinavir, drug_drug with Saquinavir, drug_drug with Adefovir dipivoxil, drug_drug with Adefovir dipivoxil, drug_drug with Protirelin, drug_drug with Protirelin, drug_drug with Adefovir, drug_drug with Adefovir, drug_drug with Procaine benzylpenicillin, drug_drug with Procaine benzylpenicillin. Definitions: Parkinson Disease defined as following: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75). dopamine defined as following: One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action.. adenoviral vector defined as following: One of a number of genetically-engineered adenoviruses designed to insert a gene of interest into a eukaryotic cell where the gene of interest is subsequently expressed. Unlike most other vectors, adenovirus vectors have the ability to infect post-mitotic cells. Thus, these agents are especially useful for gene transfer into neuronal cells. (NCI04).", "label": "no"} {"original_question": "Is farnesoid X receptor (FXR) a nuclear receptor?", "id": "converted_1013", "sentence1": "Is farnesoid X receptor (NR1H4 wt Allele) a Receptors, Nuclear?", "sentence2": "NR1H4 gene (NR1H4 wt Allele) belongs to the ligand-activated Receptors, Nuclear superfamily, and functions as a TRANSCRIPTION FACTOR regulating the transcription of numerous Genes involved in Bile Acid [EPC] homeostasis, lipoprotein and glucose metabolism, NR1H4 gene (NR1H4 wt Allele) is an ascending target for metabolic and inflammatory diseases. As a Receptors, Nuclear, NR1H4 wt Allele exhibits many physiological effects in transcription control of several Genes., NR1H4 wt Allele is a member of the Receptors, Nuclear superfamily which is also highly expressed in the Abdomen>Liver. , NR1H4 gene (NR1H4 wt Allele) is a Bile Acid [EPC] Receptors, Nuclear described through Mus sp. knockout studies as a tumor suppressor for the development of Adenocarcinoma of colon, NR1H4 gene (NR1H4 wt Allele, Nr1h4) is a ligand-activated TRANSCRIPTION FACTOR belonging to the Receptors, Nuclear superfamily., the Receptors, Nuclear farnesoid X receptor , farnesoid X receptor (NR1H4 wt Allele), a Receptors, Nuclear activated by Bile Acid [EPC] ligands. , T-β-MCA is an farnesoid X receptor (NR1H4 wt Allele) Receptors, Nuclear antagonist,, NR1H4 gene (NR1H4 wt Allele), a Receptors, Nuclear (NR) and originally considered as a Bile Acid [EPC]-activated transcriptional factor, , The Receptors, Nuclear farnesoid X receptor (NR1H4 wt Allele) plays a major role in the enterohepatic cycling of Bile Acids, Liver X Receptors, LXRs, are ligand-activated transcription factors that belong to the group H Receptors, Nuclear (NR) superfamily. , The intracellular Receptors, Nuclear farnesoid X receptor and the transmembrane G protein-coupled receptor GPBAR1 gene respond to Bile Acids by activating transcriptional networks and/or signalling cascades., ncluding those of nuclear receptors, primarily farnesoid X receptor (NR1H4 wt Allele), , ile acids and their cognate Receptors, Nuclear, NR1H4 wt Allele,, NR1H4 gene (NR1H4 wt Allele, Nr1h4) and small heterodimer partner (SHP, NR0B2 wt Allele) are nuclear receptors that are critical to Abdomen>Liver homeostasis., he activation of the Receptors, Nuclear farnesoid X receptor (FXRα), Bile Acid [EPC]-activated Receptors, Nuclear farnesoid X receptor (NR1H4 wt Allele), Receptors, Nuclear signaling, notably by the farnesoid X receptor (NR1H4 wt Allele, NR1H4 wt Allele (farnesoid X receptor, NRIH4), a Receptors, Nuclear, plays a major role in the control of cholesterol metabolism., The role of the Receptors, Nuclear NR1H4 wt Allele is unclear., Receptors, Nuclear NR1H4 wt Allele , a member of the Receptors, Nuclear superfamily of ligand-activated transcription factors,, NR1H4 gene (NR1H4 wt Allele) is a Receptors, Nuclear that functions as a Bile Acid [EPC] sensor controlling Bile Acid [EPC] homeostasis.[SEP]Relations: Receptors, Nuclear activity has relations: molfunc_protein with RXRA, molfunc_protein with RXRA, molfunc_protein with RXRG, molfunc_protein with RXRG, molfunc_protein with RXRB, molfunc_protein with RXRB, molfunc_protein with NKX3-1, molfunc_protein with NKX3-1, molfunc_protein with ESR1, molfunc_protein with ESR1. Definitions: NR1H4 gene defined as following: This gene is involved in Bile Acid [EPC] binding and metabolism.. NR0B2 wt Allele defined as following: Human NR0B2 wild-type allele is located in the vicinity of 1p36.1 and is approximately 2 kb in length. This allele, which encodes Receptors, Nuclear 0B2 protein, is involved in transcriptional repression that is mediated by nuclear hormone receptor interactions. Mutations and dysfunction in the gene is associated with obesity.. NR1H4 wt Allele defined as following: Human NR1H4 wild-type allele is located in the vicinity of 12q23.1 and is approximately 91 kb in length. This allele, which encodes Bile Acid [EPC] receptor protein, plays a role in both the metabolism of Bile Acids and ligand-dependent transcriptional regulation.. Receptors, Nuclear defined as following: Proteins that regulate transcription via interaction with chromatin and basal transcription machinery at the promoter regions of Genes. Nuclear receptors are ligand-dependent transcription factors including steroids, retinoids, vitamin D, unliganded thyroid hormone, and orphan receptors (unknown ligands). Coregulators (coactivators or corepressors) are important in mediating these interactions and thereby modulate positive or negative receptor activity.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. Adenocarcinoma of colon defined as following: An adenocarcinoma arising from the colon. It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease. Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits. According to the degree of cellular differentiation, colonic adenocarcinomas are divided into well, moderately, and poorly differentiated. Histologic variants include mucinous adenocarcinoma, signet ring cell carcinoma, medullary carcinoma, serrated adenocarcinoma, cribriform comedo-type adenocarcinoma, and micropapillary adenocarcinoma.. Liver X Receptors defined as following: Nuclear receptors that bind OXYSTEROLS and function as heterodimers with RETINOID X RECEPTORS. They have important functions in regulating cholesterol homeostasis, ENERGY METABOLISM; INFLAMMATION; and the immune response.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. farnesoid X receptor defined as following: This gene is involved in Bile Acid [EPC] binding and metabolism..", "label": "yes"} {"original_question": "Is carpal tunnel syndrome a type of nerve entrapment?", "id": "converted_3938", "sentence1": "Is carpal tunnel syndrome a type of Nerve entrapment?", "sentence2": " CARPAL TUNNEL SYNDROME 2 (Carpal Tunnel Syndrome) is a common entrapment neuropathy, often requiring carpal tunnel release (CTR) surgery., CARPAL TUNNEL SYNDROME 2 (Carpal Tunnel Syndrome) is an entrapment neuropathy accounting for up to 90% of Nerve compression syndromes, CARPAL TUNNEL SYNDROME 2 (Carpal Tunnel Syndrome) is the most frequent entrapment neuropathy in Homo sapiens. , CARPAL TUNNEL SYNDROME 2 (Carpal Tunnel Syndrome) is the most common focal entrapment mononeuropathy, comprising medium Nerve chronic inflammation and Fibrosis., CARPAL TUNNEL SYNDROME 2 (Carpal Tunnel Syndrome) is the most common Nerve entrapment neuropathy which is the result of the compression of the median Nerve in the Upper extremity>Wrist. , Dear sir, one of the most common entrapment neuropathy syndromes in clinical practice is \"Entrapment of median Nerve in carpal tunnel\" also called \"CARPAL TUNNEL SYNDROME 2 (Carpal Tunnel Syndrome)\" (Aydin et al., 2007; Huisstede et al., 2010)., BACKGROUND: CARPAL TUNNEL SYNDROME 2 (Carpal Tunnel Syndrome) is the most common type of peripheral Nerve entrapment and is a significant cause of morbidity., BACKGROUND: CARPAL TUNNEL SYNDROME 2 and Ulnar (qualifier value) Nerve entrapment at the Elbow joint structure are the most common entrapment neuropathies seen in adults., Entrapment neuropathies are of various types, but the most common type is carpal tunnel syndrome., Carpal Tunnel Syndrome and Other Entrapment Neuropathy., Unlike Guyon's canal syndrome, carpal tunnel syndrome (Carpal Tunnel Syndrome) is the most common Nerve entrapment of the upper extremity., Kidney Failure, Chronic tend to develop peripheral Nerve entrapment and carpal tunnel syndrome is the best-known peripheral entrapment neuropathy among them. Contrary to ca, CARPAL TUNNEL SYNDROME 2 (Carpal Tunnel Syndrome) is a common form of peripheral Nerve entrapment, which is observed due to compression of the median Nerve at the level of the carpal tunnel in the Upper extremity>Wrist. Bifi, INTRODUCTION: CARPAL TUNNEL SYNDROME 2 (Carpal Tunnel Syndrome) is considered a simple entrapment of the median Nerve at the carp, Compressive neuropathy of the median Nerve at the level of the carpal tunnel, known as carpal tunnel syndrome, is the most common entrapment neuropathy, affecting about 0.1-1% of the general population. Magne, BACKGROUND: CARPAL TUNNEL SYNDROME 2 (Carpal Tunnel Syndrome) is entrapment of median Nerve in carpal tunnel of th, Dear sir, one of the most common entrapment neuropathy syndromes in clinical practice is \"Entrapment of median Nerve in carpal tunnel\" also called \"CARPAL TUNNEL SYNDROME 2 (Carpal Tunnel Syndrome)\" (Aydin et al., 2007; Huisstede et al., 2010). This syndr, OBJECTIVE: CARPAL TUNNEL SYNDROME 2 (Carpal Tunnel Syndrome) is a common median Nerve entrapment neuropathy characterized by Pain:-:Point in time:^Patient:-, Paresthesia, diminished peripheral Nerve conduction velocity (NCV) and maladaptive functional brain neuroplastici, CARPAL TUNNEL SYNDROME 2 (Carpal Tunnel Syndrome), caused by entrapment of the median Nerve in the carpal tunnel, impairs hand function including dexterous manipulation. The , This review focuses on three of the most common entrapment neuropathies in the upper limbs: carpal tunnel syndrome (median Nerve entrapment at the Upper extremity>Wrist), Cubital Tunnel Syndrome (Ulnar (qualifier value) Nerve entrapment at the Elbow joint structure), and Radial Tunnel Syndrome (posterior interosseous Nerve entrapment)., Electrodiagnostic (EDX) testing is usually an essential part of the evaluation of entrapment neuropathies, and examinations for the most common entrapment neuropathies, carpal tunnel syndrome and Ulnar (qualifier value) neuropathy at the Elbow joint structure, constitute a significant part of the daily work in EDX laboratories., This study reviews the existing, more or less, detailed EDX criteria or practice parameters that are suggested by consensus groups in peer-reviewed journals for the most common entrapment neuropathies: carpal tunnel syndrome, Ulnar (qualifier value) neuropathy at the Elbow joint structure, common peroneal (Fibula) neuropathy at the Fibula head, and Tibial Neuropathy at the tarsal tunnel., This report demonstrates that the Semmes-Weinstein monofilament test and Nerve conduction studies can identify entrapment of the palmar cutaneous branch of the median Nerve concomitant with carpal tunnel syndrome., Entrapment neuropathy of the palmar cutaneous branch of the median Nerve concomitant with carpal tunnel syndrome: a case report., A case of the entrapment neuropathy of the palmar cutaneous branch of the median Nerve, concomitant with carpal tunnel syndrome is presented., The entrapment syndromes discussed are suprascapular Nerve entrapment, carpal tunnel syndrome, Cubital Tunnel Syndrome, meralgia paraesthetica, Thoracic Outlet Syndrome and Anterior interosseous Nerve syndrome., CARPAL TUNNEL SYNDROME 2 is a neuropathy resulting from compression of the median Nerve as it passes through a narrow tunnel in the Upper extremity>Wrist on its way to the hand., More typically, carpal tunnel syndrome is the most common peripheral entrapment neuropathy encountered in industry., CARPAL TUNNEL SYNDROME 2 is the most frequently encountered peripheral Nerve entrapment., CARPAL TUNNEL SYNDROME 2, an entrapment neuropathy of the median Nerve, is rarely seen in childhood., CARPAL TUNNEL SYNDROME 2 (Carpal Tunnel Syndrome) is the most common type of peripheral Nerve entrapment and is a significant cause of morbidity., CARPAL TUNNEL SYNDROME 2 (Carpal Tunnel Syndrome) is a Nerve entrapment disorder, involving the median Nerve when it passes the carpal tunnel at the Upper extremity>Wrist., The carpal tunnel syndrome is the most frequent entrapment syndrome of peripheral nerves., BACKGROUND: Compression of the median Nerve at the Upper extremity>Wrist, or carpal tunnel syndrome, is the most commonly recognized Nerve entrapme, CARPAL TUNNEL SYNDROME 2 is the most common of the median Nerve entrapments., BACKGROUND: CARPAL TUNNEL SYNDROME 2 (Carpal Tunnel Syndrome) is by far the most common entrapment neuropathy (, Introduction: CARPAL TUNNEL SYNDROME 2, entrapment of median Nerve at the Upper extremity>Wrist, is one of the most commonly encountered peripheral neuropathies in the up, CARPAL TUNNEL SYNDROME 2, a median Nerve entrapment neuropathy, is characterized by sensorimotor deficits., CARPAL TUNNEL SYNDROME 2 (Carpal Tunnel Syndrome) is a common form of peripheral Nerve entrapment, which is observed due to compression of the median Nerve at the level of the carpal tunnel in the Upper extremity>Wrist., [CARPAL TUNNEL SYNDROME 2 and other Nerve entrapment syndromes].[SEP]Relations: carpal tunnel syndrome has relations: disease_disease with Nerve compression syndrome, disease_disease with Nerve compression syndrome, disease_disease with Nerve compression syndrome, disease_disease with Nerve compression syndrome, disease_disease with genetic peripheral neuropathy, disease_disease with genetic peripheral neuropathy, disease_disease with genetic peripheral neuropathy, disease_disease with genetic peripheral neuropathy, disease_phenotype_positive with Constrictive median neuropathy, disease_phenotype_positive with Constrictive median neuropathy. Definitions: Fibrosis defined as following: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.. Cubital Tunnel Syndrome defined as following: Compression of the ULNAR NERVE in the cubital tunnel, which is formed by the two heads of the flexor carpi ulnaris muscle, humeral-Ulnar (qualifier value) aponeurosis, and medial ligaments of the Elbow joint structure. This condition may follow trauma or occur in association with processes which produce Nerve enlargement or narrowing of the canal. Manifestations include Elbow joint structure Pain:-:Point in time:^Patient:- and PARESTHESIA radiating distally, weakness of Ulnar (qualifier value) innervated intrinsic hand muscles, and loss of sensation over the hypothenar region, fifth finger, and Ulnar (qualifier value) aspect of the ring finger. (Joynt, Clinical Neurology, 1995, Ch51, p43). Neuropathy defined as following: A disorder affecting the cranial nerves or the peripheral nervous system. It manifests with Pain:-:Point in time:^Patient:-, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.. Carpal Tunnel Syndrome defined as following: Entrapment of the MEDIAN NERVE in the carpal tunnel, which is formed by the flexor retinaculum and the CARPAL BONES. This syndrome may be associated with repetitive occupational trauma (CUMULATIVE TRAUMA DISORDERS); Upper extremity>Wrist injuries; AMYLOID NEUROPATHIES; rheumatoid arthritis (see ARTHRITIS, RHEUMATOID); ACROMEGALY; PREGNANCY; and other conditions. Symptoms include burning Pain:-:Point in time:^Patient:- and Paresthesia involving the ventral surface of the hand and fingers which may radiate proximally. Impairment of sensation in the distribution of the median Nerve and thenar muscle atrophy may occur. (Joynt, Clinical Neurology, 1995, Ch51, p45). Homo sapiens defined as following: Members of the species Homo sapiens.. Thoracic Outlet Syndrome defined as following: A neurovascular syndrome associated with compression of the BRACHIAL PLEXUS; SUBCLAVIAN ARTERY; and SUBCLAVIAN VEIN at the superior thoracic outlet. This may result from a variety of anomalies such as a CERVICAL RIB, anomalous fascial bands, and abnormalities of the origin or insertion of the anterior or medial scalene muscles. Clinical features may include Pain:-:Point in time:^Patient:- in the shoulder and neck region which radiates into the arm, PARESIS or PARALYSIS of brachial plexus innervated muscles, PARESTHESIA, loss of sensation, reduction of arterial pulses in the affected extremity, ISCHEMIA, and EDEMA. (Adams et al., Principles of Neurology, 6th ed, pp214-5).. Kidney Failure, Chronic defined as following: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.. Tibial Neuropathy defined as following: Disease of the TIBIAL NERVE (also referred to as the posterior tibial Nerve). The most commonly associated condition is the TARSAL TUNNEL SYNDROME. However, LEG INJURIES; ISCHEMIA; and inflammatory conditions (e.g., COLLAGEN DISEASES) may also affect the Nerve. Clinical features include PARALYSIS of plantar flexion, ankle inversion and toe flexion as well as loss of sensation over the sole of the foot. (From Joynt, Clinical Neurology, 1995, Ch51, p32). Fibula defined as following: The bone of the lower leg lateral to and smaller than the tibia. In proportion to its length, it is the most slender of the long bones.. Elbow joint structure defined as following: A hinge joint connecting the FOREARM to the ARM.. Ulnar (qualifier value) neuropathy defined as following: Disease involving the ULNAR NERVE from its origin in the BRACHIAL PLEXUS to its termination in the hand. Clinical manifestations may include PARESIS or PARALYSIS of Upper extremity>Wrist flexion, finger flexion, thumb adduction, finger abduction, and finger adduction. Sensation over the medial palm, fifth finger, and Ulnar (qualifier value) aspect of the ring finger may also be impaired. Common sites of injury include the AXILLA, cubital tunnel at the ELBOW, and Guyon's canal at the Upper extremity>Wrist. (From Joynt, Clinical Neurology, 1995, Ch51 pp43-5). Nerve defined as following: Part of the peripheral nervous system composed of bundles of Nerve fibers running to various organs and tissues of the body using chemical and electrical signals to transmit sensory and motor information from one body part to another.. Fibula head defined as following: The highest portion of the fibula that articulates with the patella.. Paresthesia defined as following: Subjective cutaneous sensations (e.g., cold, warmth, tingling, pressure, etc.) that are experienced spontaneously in the absence of stimulation..", "label": "yes"} {"original_question": "Is oxalate renal excretion increased after bariatric surgery?", "id": "converted_918", "sentence1": "Is oxalate renal excretion increased after bariatric surgery?", "sentence2": "Despite the fact that bariatric surgery-induced weight loss is associated with a significant decrease in morbidity and mortality and improvement in renal function, bariatric surgery has recently been shown to be associated with a significant risk of X-linked recessive X-linked recessive nephrolithiasis with renal failure with renal failure. The main risk factor for X-linked recessive X-linked recessive nephrolithiasis with renal failure with renal failure is increased excretion of Urinary tract oxalate., Enteric hyperoxaluria, X-linked recessive X-linked recessive nephrolithiasis with renal failure with renal failure, and Oxalate nephropathy must be considered with the other risks of RYGBP., The Urinary tract excretion of oxalate was high: 1.112 mumol/24 h (normal range: 55-400 mumol/24 h), and Citrate measurement excretion was low: 1.48 mmol/24 h (normal range: 2-5 mmol/24 h). , Hyperoxaluria in patients with JIB was found to be a result of hyperabsorption of oxalate, and these patients displayed altered oxalate kinetics with continued Urinary tract excretion of orally administered 14C-oxalate for more than 48 hours. , Malabsorption Syndrome Syndrome of CALCIUM SUPPLEMENTS and low fasting Urinary tract CALCIUM SUPPLEMENTS excretion in the JIB patients were associated with high tubular reabsorption of CALCIUM SUPPLEMENTS, the latter presumably attributable to a compensatory increase in circulating parathyroid hormone (parathyroid hormone). In most recurrent renal stone formers the Urinary tract CALCIUM SUPPLEMENTS concentration was increased, with an inverse relationship to serum parathyroid hormone, indicating intestinal hyperabsorption of CALCIUM SUPPLEMENTS. A[SEP]Relations: Nephropathy has relations: drug_effect with Oxaliplatin, drug_effect with Oxaliplatin, drug_effect with Oxacillin, drug_effect with Oxacillin, drug_effect with Irbesartan, drug_effect with Irbesartan, drug_effect with Ioxaglic acid, drug_effect with Ioxaglic acid, drug_effect with Ranitidine, drug_effect with Ranitidine. Definitions: CALCIUM SUPPLEMENTS defined as following: A dietary supplement containing the mineral CALCIUM SUPPLEMENTS.. Citrate measurement defined as following: The determination of the amount of Citrate measurement present in a sample.. Malabsorption Syndrome defined as following: General term for a group of MALNUTRITION syndromes caused by failure of normal INTESTINAL ABSORPTION of nutrients.. Hyperoxaluria defined as following: Excretion of an excessive amount of OXALATES in the urine.. parathyroid hormone defined as following: A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular CALCIUM SUPPLEMENTS by promoting the release of CALCIUM from BONE, increases the intestinal absorption of CALCIUM SUPPLEMENTS, increases the renal tubular reabsorption of CALCIUM SUPPLEMENTS, and increases the renal excretion of phosphates.. Urinary tract defined as following: The duct which coveys URINE from the pelvis of the KIDNEY through the URETERS, BLADDER, and URETHRA.. oxalate defined as following: A salt or ester of oxalic acid..", "label": "yes"} {"original_question": "Could DNA (cytosine-5-)-methyltransferases serve as tumour markers?", "id": "converted_555", "sentence1": "Could DNA (cytosine-5-)-methyltransferases serve as tumour markers?", "sentence2": "Here, we report evidence of the overexpression of DNA methyltransferases 3B (DNMT3B gene gene) in invasive cervical Primary malignant neoplasm and of the inhibition of metastasis by DNMT3B gene gene interference., This study was designed to determine the significance of DNA methyltransferases (DNMTs) in DNA hypermethylation in Squamous cell carcinoma of esophagus (ESCC) and to identify DNA methylation markers in serum for the early diagnosis of ESCC., DNA Modification Methylases as a predictive biomarker and potential therapeutic target for chemotherapy in gastric Primary malignant neoplasm., We examined the prognostic and predictive impact of DNA methyltransferase (DNMT) 1 and 3b expression in Stomach Carcinoma (GC) treated by neoadjuvant chemotherapy., High DNMT1 and DNMT3B gene gene protein, Homo sapiens expression was found in 105/127 (83%) and 79/127 (62%) Carcinoma, respectively., Tumoral DNMT3B gene gene protein, Homo sapiens RNA, Messenger up-regulation was significantly correlated with hypermethylation of multiple tumor-related Genes (P=0.021)., A regulator of de novo DNA methyltransferases DNMT3A and DNMT3B gene gene, DNA (Cytosine-5)-Methyltransferase 3-Like promoter was found to have lost DNA methylation to varying levels in 14 out of 15 Primary malignant neoplasm cervix samples analysed. The present study highlights the importance of DNA methylation profile at DNA (Cytosine-5)-Methyltransferase 3-Like promoter not only as a promising biomarker for cervical Primary malignant neoplasm, which is the second most common Primary malignant neoplasm among women worldwide, but also provides insight into the possible role of DNA (Cytosine-5)-Methyltransferase 3-Like in Primary malignant neoplasm development., DNA (Cytosine-5)-Methyltransferase 3-Like is a novel marker and is essential for the growth of Homo sapiens Embryonal Carcinoma., Among the DNMT Genes, we found that RNA, Messenger for DNA (Cytosine-5)-Methyltransferase 3-Like was specifically expressed in TGCTs, but neither in normal testicular tissues nor in Primary malignant neoplasm cells of somatic tissue origin. DNA (Cytosine-5)-Methyltransferase 3-Like protein was strongly expressed in two EC Cultured Cell Line, but not in the Cultured Cell Line of somatic tissue origin., Positive nuclear labeling for DNA (Cytosine-5)-Methyltransferase 3A, Human was found only in few neoplasms: 1 Mixed Salivary Gland Tumor (9.0%), 2 Adenoid Cystic Carcinoma (16.6%) and 1 mucoepidermoid (9.0%) cases. CONCLUSIONS: Our results were not able to demonstrate a clear correlation between DNMT1 and DNA (Cytosine-5)-Methyltransferase 3A, Human immunoexpression and salivary gland neoplasms development., DNA methylation, mediated by the combined action of three DNA methyltransferases (DNMT1, DNMT3A, and DNMT3B gene gene), is essential for Mammals development and is a major contributor to cellular transformation., The prevalence, the prognostic effect, and interaction with other molecular markers of DNMT3A mutations was studied in 415 patients with Leukemia, Myelocytic, Acute (AML) younger than 60 years., The recent identification of DNMT3A mutations in de novo Leukemia, Myelocytic, Acute prompted us to determine their frequency, patterns and clinical impact in a cohort of 98 patients with either therapy-related or secondary Leukemia, Myelocytic, Acute developing from an antecedent Hematological Disease., DNA methyltransferases (DNMT1 and DNMT3B gene gene protein, Homo sapiens) were also decreased in vorinostat-treated A549 Primary malignant neoplasm cells., To identify the mechanisms responsible for these Genome - anatomical entity-wide DNA methylation alterations, we measured the gene expression levels of several DNA methyltransferases (DNMTs) and their interacting proteins by TaqMan qPCR and observed increased expression of DNMT3A wt Allele, DNMT3B gene gene, and EZH2 protein, Homo sapiens protein, Homo sapiens in Neoplasms., DNA Modification Methylases (DNMT1) is the primary Enzyme [APC] that maintains DNA methylation., 5-Azactydine inhibits cell growth by direct cytotoxic action as well as by inhibition of DNA methyl transferase Enzyme [APC]., Alterations in metabolism of Methylating Activity, disturbances in activity and/or expression of DNA methyltransferases, and presence of DNA single-strand breaks could contribute to the loss of cytosine methylation during carcinogenesis; however, the precise mechanisms of genomic hypomethylation induced by chemical carcinogens remain largely unknown., Recently, three Single Nucleotide Polymorphism (SNPs) of the DNMT3B gene gene promoter region, C46359T (-149C>T), -283T>C, and -579G>T have also been reported to be stratification markers that can predict an individual's susceptibility to Malignant Neoplasms., Aberrant DNA methylation has been shown to play important roles during multistage carcinogenesis in various Homo sapiens organs., Thus, tumour subsets exist that display concurrent decreased BRCA1 gene gene expression, BRCA1 gene gene promoter methylation, cytoplasmic CTGF protein, Homo sapiens expression and with DNMT3B gene gene protein, Homo sapiens over-expression., DNA methylation patterns in Genome - anatomical entity are maintained during replication by a DNA methyltransferase DNMT1 wt Allele., Aberrant DNA methylation has been shown to play an important role during multistage carcinogenesis in various Homo sapiens organs., To investigate the relationship between the expression of DNMT and clinical prognosis in adult patients with Acute leukemia (AL), the RNA, Messenger expressions of DNMT, CDKN2B wt Allele(INK4B), ABCB1 wt Allele were measured in 72 AL patients and 20 normal controls by semi-quantitative reverse transcription polymerase chain reaction (RT-PCR); the ratio of CDKN2B wt Allele CpG land methylation was measured in 56 AL patients and 14 normal controls by methylation-specific PCR (MSP-PCR)., DNA methyltransferase DNMT1 wt Allele ensures Clonality transmission of lineage-specific DNA methylation patterns in a Mammals Genome - anatomical entity during replication., Overexpression of the major DNA methyltransferase DNMT1 wt Allele is cytotoxic and has been hypothesized to result in aberrant hypermethylation of Genes required for cell survival., DNA (cytosine-5-)-methyltransferase 1 (DNMT1) plays an important role in the maintenance of DNA methylation patterns via complicated networks including signaling pathways and TRANSCRIPTION FACTOR, relating to cell differentiation or carcinogenesis., We evaluated the significance of aberrant DNA Modification Methylases (DNMT1) protein expression during gastric carcinogenesis.[SEP]Relations: DNA (cytosine-5-)-methyltransferase activity has relations: molfunc_protein with DNMT3A, molfunc_protein with DNMT3A, molfunc_protein with DNMT3A, molfunc_protein with DNMT3A, molfunc_protein with DNMT3B gene, molfunc_protein with DNMT3B gene, molfunc_protein with DNMT3B gene, molfunc_protein with DNMT3B gene, molfunc_protein with DNMT1, molfunc_protein with DNMT1. Definitions: EZH2 protein, Homo sapiens defined as following: Histone-lysine N-methyltransferase EZH2 protein, Homo sapiens (746 aa, ~85 kDa) is encoded by the Homo sapiens EZH2 protein, Homo sapiens gene. This protein is involved in the regulation of chromatin modification.. DNMT1 wt Allele defined as following: Human DNMT1 wt allele is located in the vicinity of 19p13.2 and is approximately 62 kb in length. This allele, which encodes DNA (Cytosine-5)-Methyltransferase 1, is involved in epigenetic modification of chromatin DNA and control of gene expression.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Leukemia, Myelocytic, Acute defined as following: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.. Genome - anatomical entity defined as following: Anatomical set of Genes in all the chromosomes.. DNA (Cytosine-5)-Methyltransferase 3-Like defined as following: DNA (cytosine-5)-methyltransferase 3-like (386 aa, ~44 kDa) is encoded by the Homo sapiens DNA (Cytosine-5)-Methyltransferase 3-Like gene. This protein is involved in the modulation of DNA methyltransferase activity.. DNMT3B gene protein, Homo sapiens defined as following: DNA (cytosine-5)-methyltransferase 3B (853 aa, ~96 kDa) is encoded by the Homo sapiens DNMT3B gene gene. This protein is involved in DNA methylation.. cytosine defined as following: A pyrimidine base that is a fundamental unit of nucleic acids.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. cervical Primary malignant neoplasm defined as following: A primary or metastatic malignant neoplasm involving the cervix.. ABCB1 wt Allele defined as following: Human ABCB1 wild-type allele is located in the vicinity of 7q21.1 and is approximately 210 kb in length. This allele, which encodes multidrug resistance protein 1, is involved in transmembrane transport. Amplification of the ABCB1 gene is a major determinant in the development of multi-drug resistance, which decreases the effectiveness of many chemotherapeutic agents used in Primary malignant neoplasm treatment.. DNMT3B gene defined as following: This gene plays a role in embryonic development, imprinting, and X-chromosome inactivation.. DNA (Cytosine-5)-Methyltransferase 3A, Human defined as following: DNA (cytosine-5)-methyltransferase 3A protein (909 aa, ~102 kDa) is encoded by the Homo sapiens DNMT3A gene. This soluble, nuclear protein is involved in epigenetic modification of chromatin, catalyzing the methylation of C5 in CpG dinucleotides within DNA.. Hematological Disease defined as following: Disorders of the blood and blood forming tissues.. Squamous cell carcinoma of esophagus defined as following: A carcinoma that originates usually from cells on the surface of the middle and lower third of the ESOPHAGUS. Tumor cells exhibit typical squamous morphology and form large polypoid lesions. Mutations in RNF6, LZTS1, TGFBR2, DEC1, and WWOX1 Genes are associated with this Primary malignant neoplasm.. Stomach Carcinoma defined as following: A malignant epithelial tumor of the stomach mucosa. The vast majority of Stomach Carcinoma are adenocarcinomas, arising from the gastric glandular epithelium.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.. RNA, Messenger defined as following: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the cytoplasm.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are Carcinoma, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Primary malignant neoplasm cells defined as following: Cells of, or derived from, a malignant tumor.. DNA Modification Methylases defined as following: Enzymes that are part of the restriction-modification systems. They are responsible for producing a species-characteristic methylation pattern, on either adenine or cytosine residues, in a specific short base sequence in the host cell's own DNA. This methylated sequence will occur many times in the host-cell DNA and remain intact for the lifetime of the cell. Any DNA from another species which gains entry into a living cell and lacks the characteristic methylation pattern will be recognized by the restriction endonucleases of similar specificity and destroyed by cleavage. Most have been studied in bacterial systems, but a few have been found in eukaryotic organisms.. Acute leukemia defined as following: A Clonality (malignant) hematopoietic disorder with an acute onset, affecting the bone marrow and the peripheral blood. The malignant cells show minimal differentiation and are called blasts, either myeloid blasts (myeloblasts) or lymphoid blasts (lymphoblasts).. BRCA1 gene defined as following: A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on Homo sapiens CHROMOSOME 17 at locus 17q21. Mutations of this gene are associated with the formation of HEREDITARY BREAST AND OVARIAN CANCER SYNDROME. It encodes a large nuclear protein that is a component of DNA repair pathways.. gastric Primary malignant neoplasm defined as following: A primary or metastatic malignant neoplasm involving the stomach.. DNMT3A wt Allele defined as following: Human DNMT3A wt allele is located in the vicinity of 2p23 and is approximately 110 kb in length. This allele, which encodes DNA (Cytosine-5)-Methyltransferase 3A, is involved in epigenetic modification of chromatin DNA and control of gene expression.. CTGF protein, Homo sapiens defined as following: CCN family member 2 (349 aa, ~38kDa) is encoded by the Homo sapiens CCN2 gene. This protein plays a role in the promotion of proliferation and differentiation of chondrocytes and also mediates heparin- and divalent cation-dependent cell adhesion in many different cell types.. Adenoid Cystic Carcinoma defined as following: Carcinoma characterized by bands or cylinders of hyalinized or mucinous stroma separating or surrounded by nests or cords of small epithelial cells. When the cylinders occur within masses of epithelial cells, they give the tissue a perforated, sievelike, or cribriform appearance. Such Neoplasms occur in the mammary glands, the mucous glands of the upper and lower respiratory tract, and the salivary glands. They are malignant but slow-growing, and tend to spread locally via the nerves. (Dorland, 27th ed). Cultured Cell Line defined as following: Established cell cultures that have the potential to propagate indefinitely.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Clonality defined as following: Related by descent from a single progenitor cell.. Carcinoma defined as following: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for \"Primary malignant neoplasm.\". Single Nucleotide Polymorphism defined as following: A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.. Mixed Salivary Gland Tumor defined as following: A benign, slow-growing tumor, most commonly of the salivary gland, occurring as a small, painless, firm nodule, usually of the parotid gland, but also found in any major or accessory salivary gland anywhere in the oral cavity. It is most often seen in women in the fifth decade. Histologically, the tumor presents a variety of cells: cuboidal, columnar, and squamous cells, showing all forms of epithelial growth. (Dorland, 27th ed). Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. CDKN2B wt Allele defined as following: Human CDKN2B wild-type allele is located within 9p21 and is approximately 27 kb in length. This allele, which encodes cyclin-dependent kinase 4 inhibitor B protein, plays roles in both the regulation of cell growth and tumor suppression.. Homo sapiens defined as following: Members of the species Homo sapiens.. Embryonal Carcinoma defined as following: A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular Neoplasms. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, p1595).", "label": "yes"} {"original_question": "Is the Miller-Fisher syndrome considered to be a variant of Guillain-Barré?", "id": "converted_687", "sentence1": "Is the Miller Fisher Syndrome considered to be a Variant of Guillain-Barré?", "sentence2": "Miller Fisher syndrome is a Variant of Guillain-Barre syndrome characterized by the classic triad of ophthalmoplegia, Cerebellar Ataxia, and Absent reflex, We are reporting a rare case of Miller-Fisher (Marfan Syndrome) Variant of Guillain-Barré syndrome (Guillain-Barre Syndrome) as the first manifestation of Lupus Erythematosus, Systemic in a 41-year-old female, Miller Fisher Syndrome is defined as ophthalmoplegia, Cerebellar Ataxia and Absent reflex. Considered as a Variant of Guillain-Barré syndrome, it differs in its clinical presentation and by anti-GQ1b antibody positivity, Guillain-Barré syndrome (Guillain-Barre Syndrome) and its Variant, Miller Fisher syndrome (Marfan Syndrome), exist as several clinical subtypes with different neurological features and presentations, Using in vitro and in vivo models of the Guillain-Barré syndrome Variant, Miller Fisher syndrome, we have shown previously that anti-GQ1b ganglioside antibody antibody Antibodies, in vitro diagnostic target the presynaptic motor nerve terminal axon and surrounding perisynaptic Schwann cells, thereby mediating destructive injury through deposition of Complement Membrane Attack Complex., Miller Fisher syndrome is a Variant of Guillain-Barré syndrome, characterized by ophthalmoplegia, Cerebellar Ataxia and Absent reflex., Miller Fisher syndrome is a localized Variant of Guillain-Barré syndrome, characterized by ophthalmoplegia, Absent reflex and Cerebellar Ataxia., Miller Fisher syndrome, a Variant of Guillain-Barré syndrome, is associated with immunoglobulin G to GQ1b ganglioside antibody antibody., Miller Fisher syndrome (Marfan Syndrome), a Variant of Guillain-Barré syndrome, is a rare disorder typically characterized by a triad of Cerebellar Ataxia, Absent reflex, and ophthalmoplegia, which may have a highly variable clinical presentation., Miller Fisher syndrome is an acute inflammatory polyradiculoneuropathy that is generally considered a Variant of Guillain-Barré syndrome and is characterized by the clinical triad of Cerebellar Ataxia, Absent reflex, and ophthalmoplegia., The objective of this study was to review the occurrence and clinical features of Guillain-Barré syndrome and its Variant, the Miller Fisher syndrome, during TNFalpha antagonist therapy., Miller Fisher Variant of Guillain-Barré syndrome masquerading as acute sphenoid sinusitis with orbital apex syndrome., Controversy exists concerning whether Miller Fisher syndrome (Marfan Syndrome) is the result of a predominantly axonal or demyelinating polyneuropathy and whether the Guillain-Barré syndrome Variant of acute Cerebellar Ataxia and Absent reflex without ophthalmoplegia, ataxic Guillain-Barré syndrome (atxGBS), has a distinct pathophysiology., Miller Fisher syndrome is characterised by the triad ophthalmoparesis, Cerebellar Ataxia and Absent reflex and is considered to be a Variant of Guillain-Barré syndrome; its differential diagnosis includes Wernicke's encephalopathy, Miller Fisher syndrome is an acute inflammatory polyradiculoneuropathy that is generally considered a Variant of Guillain-Barré syndrome and is characterized by the clinical triad of Cerebellar Ataxia, Absent reflex, and ophthalmoplegia, Miller Fisher Syndrome is characterised by the clinical triad of ophthalmoplegia, Cerebellar Ataxia and Absent reflex and is considered a Variant form of Guillain-Barré syndrome, The syndrome of Cerebellar Ataxia, Absent reflex and ophthalmoplegia, or Miller Fisher Syndrome, has been considered to be a Variant of Guillain-Barré syndrome with pathology restricted to the peripheral nervous system, Miller Fisher Syndrome (Marfan Syndrome) is considered the most common Variant of Guillain-Barré syndrome (Guillain-Barre Syndrome) and is characterized by the clinical triad of ophthalmoplegia, Cerebellar Ataxia and Absent reflex, Miller Fisher syndrome (Marfan Syndrome), characterized as Cerebellar Ataxia, Absent reflex and ophthalmoplegia, is generally considered as a Variant of Guillain-Barré syndrome (Guillain-Barre Syndrome), Miller Fisher Syndrome (Marfan Syndrome), which is characterized by ophthalmoplegia, Cerebellar Ataxia and tendon Absent reflex, is generally considered as a clinical Variant of Guillain-Barré Syndrome, Miller Fisher Syndrome (Marfan Syndrome), a Variant of Guillain-Barré syndrome (Guillain-Barre Syndrome) is a self-limiting demyelinating disease of the peripheral nervous system, BACKGROUND: Miller Fisher Syndrome is characterised by the clinical triad of ophthalmoplegia, Cerebellar Ataxia and Absent reflex and is considered a Variant form of Guillain-Barré syndrome. , BACKGROUND AND OBJECTIVE: Miller Fisher Syndrome (Marfan Syndrome) is considered the most common Variant of Guillain-Barré syndrome (Guillain-Barre Syndrome) and is characterized by the clinical triad of ophthalmoplegia, Cerebellar Ataxia and Absent reflex. , Miller Fisher syndrome is characterised by the triad ophthalmoparesis, Cerebellar Ataxia and Absent reflex and is considered to be a Variant of Guillain-Barré syndrome; its differential diagnosis includes Wernicke Encephalopathy. , A recent report described serum anti-GQ1b ganglioside antibody antibody Antibodies, in vitro diagnostic in Miller Fisher syndrome (Marfan Syndrome), a clinical Variant of Guillain-Barré syndrome (Guillain-Barre Syndrome)., The syndrome of Cerebellar Ataxia, Absent reflex and ophthalmoplegia, or Miller Fisher Syndrome, has been considered to be a Variant of Guillain-Barré syndrome with pathology restricted to the peripheral nervous system., Guillain-Barré syndrome (Guillain-Barre Syndrome), an acute inflammatory polyneuropathy, is preceded in most cases by an infectious illness, and Campylobacter jejuni, a leading cause of acute gastroenteritis, is the most common antecedent to Guillain-Barre Syndrome and its ocular Variant, Miller Fisher syndrome (Marfan Syndrome)., Miller Fisher Syndrome is characterised by the clinical triad of ophthalmoplegia, Cerebellar Ataxia and Absent reflex and is considered a Variant form of Guillain-Barré syndrome., Miller Fisher Syndrome is characterised by the clinical triad of ophthalmoplegia, Cerebellar Ataxia and Absent reflex and is considered a Variant form of Guillain-Barré syndrome., The syndrome of Cerebellar Ataxia, Absent reflex and ophthalmoplegia, or Miller Fisher Syndrome, has been considered to be a Variant of Guillain-Barré syndrome with pathology restricted to the peripheral nervous system. A patient with Miller Fisher Syndrome and bilateral demyelinating optic neuropathy suggesting associated CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS pathology is presented., Miller Fisher syndrome is an acute inflammatory polyradiculoneuropathy that is generally considered a Variant of Guillain-Barré syndrome and is characterized by the clinical triad of Cerebellar Ataxia,, Miller Fisher syndrome is an uncommon disease and it is a Variant of Guillain-Barre syndrome. Miller Fisher syndrome also has rarer variants., Miller Fisher syndrome is characterised by the triad ophthalmoparesis, Cerebellar Ataxia and Absent reflex and is considered to be a Variant of Guillain-Barré syndrome; its differential diagnosis includes Wernicke Encephalopathy., Miller Fisher syndrome is an acute inflammatory polyradiculoneuropathy that is generally considered a Variant of Guillain-Barré syndrome and is characterized by the clinical triad of Cerebellar Ataxia, Absent reflex, and ophthalmoplegia., Data were separately analysed for Miller Fisher syndrome and other Guillain-Barré syndrome variants., Guillain-Barré syndrome variants alone (excluding Miller Fisher syndrome) accounted for 10.5% of total cases., The syndrome of Cerebellar Ataxia, Absent reflex and ophthalmoplegia, or Miller Fisher Syndrome, has been considered to be a Variant of Guillain-Barré syndrome with pathology restricted to the peripheral nervous system.[SEP]Relations: Miller Fisher syndrome has relations: disease_disease with regional Variant of Guillain-Barre syndrome, disease_disease with regional Variant of Guillain-Barre syndrome, disease_disease with cerebellar disease, disease_disease with cerebellar disease. Guillain-Barre syndrome has relations: disease_disease with Variant of Guillain-Barre syndrome, disease_disease with Variant of Guillain-Barre syndrome, disease_protein with PMP22, disease_protein with PMP22, disease_disease with syndromic disease, disease_disease with syndromic disease. Definitions: Marfan Syndrome defined as following: An autosomal dominant disorder of CONNECTIVE TISSUE with abnormal features in the heart, the eye, and the skeleton. Cardiovascular manifestations include MITRAL VALVE PROLAPSE; AORTIC ANEURYSM; and AORTIC DISSECTION. Other features include lens displacement (ectopia lentis), disproportioned long limbs and enlarged DURA MATER (dural ectasia). Marfan syndrome (type 1) is associated with mutations in the gene encoding FIBRILLIN-1 (FBN1), a major element of extracellular microfibrils of connective tissue. Mutations in the gene encoding TYPE II TGF-BETA RECEPTOR (TGFBR2) are associated with Marfan syndrome type 2.. Variant defined as following: An alteration or difference from a norm or standard.. Campylobacter jejuni defined as following: A species of bacteria that resemble small tightly coiled spirals. Its organisms are known to cause abortion in sheep and fever and enteritis in man and may be associated with enteric diseases of calves, lambs, and other animals.. Cerebellar Ataxia defined as following: Incoordination of voluntary movements that occur as a manifestation of CEREBELLAR DISEASES. Characteristic features include a tendency for limb movements to overshoot or undershoot a target (dysmetria), a tremor that occurs during attempted movements (intention TREMOR), impaired force and rhythm of diadochokinesis (rapidly alternating movements), and GAIT ATAXIA. (From Adams et al., Principles of Neurology, 6th ed, p90). immunoglobulin G defined as following: The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.. Guillain-Barre Syndrome defined as following: An acute inflammatory autoimmune neuritis caused by T cell- mediated cellular immune response directed towards peripheral myelin. Demyelination occurs in peripheral nerves and nerve roots. The process is often preceded by a viral or bacterial infection, surgery, immunization, lymphoma, or exposure to toxins. Common clinical manifestations include progressive weakness, loss of sensation, and loss of deep tendon reflexes. Weakness of respiratory muscles and autonomic dysfunction may occur. (From Adams et al., Principles of Neurology, 6th ed, pp1312-1314). Wernicke Encephalopathy defined as following: An acute neurological disorder characterized by the triad of ophthalmoplegia, Cerebellar Ataxia, and disturbances of mental activity or consciousness. Eye movement abnormalities include nystagmus, external rectus palsies, and reduced conjugate gaze. THIAMINE DEFICIENCY and chronic ALCOHOLISM are associated conditions. Pathologic features include periventricular petechial hemorrhages and neuropil breakdown in the diencephalon and brainstem. Chronic thiamine deficiency may lead to KORSAKOFF SYNDROME. (Adams et al., Principles of Neurology, 6th ed, pp1139-42; Davis & Robertson, Textbook of Neuropathology, 2nd ed, pp452-3). Absent reflex defined as following: A finding indicating the complete absence of neurological reflexes.. Miller Fisher Syndrome defined as following: A Variant of the GUILLAIN-BARRE SYNDROME characterized by the acute onset of oculomotor dysfunction, Cerebellar Ataxia, and loss of deep tendon reflexes with relative sparing of strength in the extremities and trunk. The Cerebellar Ataxia is produced by peripheral sensory nerve dysfunction and not by cerebellar injury. Facial weakness and sensory loss may also occur. The process is mediated by autoantibodies directed against a component of myelin found in peripheral nerves. (Adams et al., Principles of Neurology, 6th ed, p1313; Neurology 1987 Sep;37(9):1493-8). Lupus Erythematosus, Systemic defined as following: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.. Complement Membrane Attack Complex defined as following: A product of COMPLEMENT ACTIVATION cascade, regardless of the pathways, that forms transmembrane channels causing disruption of the target CELL MEMBRANE and cell lysis. It is formed by the sequential assembly of terminal complement components (COMPLEMENT C5B; COMPLEMENT C6; COMPLEMENT C7; COMPLEMENT C8; and COMPLEMENT C9) into the target membrane. The resultant C5b-8-poly-C9 is the \"Complement Membrane Attack Complex\" or MAC..", "label": "yes"} {"original_question": "Are stress granules involved in the pathogenesis of Amyotrophic Lateral Sclerosis?", "id": "converted_108", "sentence1": "Are Stress Granules involved in the pathogenesis of Amyotrophic Lateral Sclerosis?", "sentence2": "Shprintzen-Goldberg syndrome have been linked to several pathologies including inflammatory diseases, Primary malignant neoplasm, Virus Diseases, and Neurodegenerative Disorders such as AMYOTROPHIC LATERAL SCLEROSIS 1 (ALS) and frontotemporal dementia (Frontotemporal dementia)., Like several other ALS-associated Proteins, CREST Syndrome Syndrome is recruited to induced Stress Granules., Our data indicate that CREST Syndrome Syndrome and certain other ALS-linked Proteins share several features implicated in ALS pathogenesis, namely the ability to aggregate, be recruited to Stress Granules and alter Paraspeckles integrity., A unifying feature of many Proteins associated with ALS, including protein protein TDP-43, human, human and ataxin-2, is that they localize to Stress Granules. , Two RNA-binding Proteins, protein protein TDP-43, human, human and Feline urological syndrome, aggregate in the degenerating motor Neurons of ALS patients, and mutations in the Genes encoding these Proteins cause some forms of ALS., Recent work connecting protein protein TDP-43, human, human and Feline urological syndrome to Stress Granules has suggested how this cellular pathway, which involves protein aggregation as part of its normal function, might be coopted during Disease pathogenesis., Amyotrophic lateral sclerosis (ALS)-linked fused in sarcoma/translocated in liposarcoma (Feline urological syndrome/TLS or Feline urological syndrome) is concentrated within Cytoplasmic Stress Granules under conditions of induced stress. Since only the Mutant, but not the endogenous wild-type Feline urological syndrome, are associated with Stress Granules under most of the stress conditions reported to date, the relationship between Feline urological syndrome and Stress Granules represents a mutant-specific phenotype and thus may be of significance in mutant-induced pathogenesis., Fused in sarcoma (Feline urological syndrome) belongs to the group of RNA-binding Proteins implicated as underlying factors in AMYOTROPHIC LATERAL SCLEROSIS 1 (ALS) and certain other Neurodegenerative Disorders. Multiple Feline urological syndrome gene mutations have been linked to hereditary forms, and aggregation of Feline urological syndrome protein is believed to play an important role in pathogenesis of these diseases. In Cultured Cells, Feline urological syndrome variants with Disease-associated amino acid substitutions or short deletions affecting nuclear localization signal (Nuclear Localization Signals) and causing Cytoplasmic mislocalization can be sequestered into Stress Granules (Shprintzen-Goldberg syndrome)., Profilin 1 associates with Stress Granules and ALS-linked mutations alter stress granule dynamics, Here we report that PFN1 gene and related protein profilin 2 are novel stress granule-associated Proteins in Mus sp. primary cortical Neurons and in human cell lines and that ALS-linked mutations in PFN1 gene alter stress granule dynamics, providing further evidence for the potential role of Stress Granules in ALS pathogenesis, Furthermore, in response to oxidative stress or heat shock conditions in cultures and in vivo, the ALS-linked Feline urological syndrome Mutant, but not wild-type Feline urological syndrome, assembled into perinuclear Stress Granules in proportion to their Cytoplasmic expression levels., Mutant Feline urological syndrome Proteins that cause AMYOTROPHIC LATERAL SCLEROSIS 1 incorporate into Stress Granules., Our results suggest that the ALS mutations in Feline urological syndrome Nuclear Localization Signals can impair Feline urological syndrome nuclear localization, induce Cytoplasmic Inclusion Bodies and Stress Granules, and potentially perturb RNA metabolism., RNA-binding ability of Feline urological syndrome regulates Nerve Degeneration, Cytoplasmic mislocalization and incorporation into Stress Granules associated with Feline urological syndrome carrying ALS-linked mutations., protein protein TDP-43, human, human is an RNA-binding protein linked to AMYOTROPHIC LATERAL SCLEROSIS 1 (ALS) that is known to regulate the splicing, transport, and storage of specific mRNAs into Stress Granules, In AMYOTROPHIC LATERAL SCLEROSIS 1 (ALS) and Frontotemporal Lobar Degeneration, TAR DNA binding protein 43 (protein protein TDP-43, human, human) accumulates in the Cytoplasm of affected Neurons and Neuroglia, where it associates with Stress Granules (Shprintzen-Goldberg syndrome) and forms large Inclusion Bodies, Amyotrophic lateral sclerosis (ALS)-linked fused in sarcoma/translocated in liposarcoma (Feline urological syndrome/TLS or Feline urological syndrome) is concentrated within Cytoplasmic Stress Granules under conditions of induced stress, Mutant Feline urological syndrome Proteins that cause AMYOTROPHIC LATERAL SCLEROSIS 1 incorporate into Stress Granules, Gene Mutation in Fus cause AMYOTROPHIC LATERAL SCLEROSIS 1 (ALS) and the Mutant Proteins forms Inclusion Bodies that appear to correspond to Stress Granules, Recent work also suggests that protein protein TDP-43, human, human associates with Cytoplasmic Stress Granules, which are transient structures that form in response to stress. , We found that in response to oxidative stress and to environmental insults of different types protein protein TDP-43, human, human is capable to assemble into Stress Granules (Shprintzen-Goldberg syndrome), ribonucleoprotein complexes where protein synthesis is temporarily arrested. , Moreover, Proteins known to be stress granule markers co-deposit with Inclusion Bodies in fALS and FTLD-Feline urological syndrome patients, implicating stress granule formation in the pathogenesis of these diseases. We propose that two pathological hits, namely nuclear import defects and cellular stress, are involved in the pathogenesis of Feline urological syndrome-opathies., Amyotrophic lateral sclerosis (ALS)-linked fused in sarcoma/translocated in liposarcoma (Feline urological syndrome/TLS or Feline urological syndrome) is concentrated within Cytoplasmic Stress Granules under conditions of induced stress., Amyotrophic lateral sclerosis-linked Feline urological syndrome/TLS alters stress granule assembly and dynamics., Moreover, Proteins known to be stress granule markers co-deposit with Inclusion Bodies in fALS and FTLD-Feline urological syndrome patients, implicating stress granule formation in the pathogenesis of these diseases. We propose that two pathological hits, namely nuclear import defects and cellular stress, are involved in the pathogenesis of Feline urological syndrome-opathies. ., Autophagy regulates AMYOTROPHIC LATERAL SCLEROSIS 1-linked fused in sarcoma-positive Stress Granules in Neurons, However, the role of autophagy in regulation of Feline urological syndrome-positive Stress Granules (Shprintzen-Goldberg syndrome) and aggregates remains unclear. , Although co-localized primarily in the Cell Nucleus in normal condition, Feline urological syndrome/TLS and Protein Arginine N-Methyltransferase 1 were partially recruited to the Cytoplasmic Granules under oxidative stress, which were merged with Stress Granules (Shprintzen-Goldberg syndrome) markers in SH-SY5Y cell., The effect of Protein Arginine N-Methyltransferase 1-mediated arginine methylation on the subcellular localization, Stress Granules, and detergent-insoluble aggregates of Feline urological syndrome/TLS, Stress granules are Cytoplasmic Inclusion Bodies that repress translation of a subset of RNA in times of cellular stress, and several Proteins implicated in Nerve Degeneration (i.e. Ataxin-2 and SNRPN protein, human) interact with Stress Granules, These findings support a two-hit hypothesis, whereby Cytoplasmic mislocalization of Feline urological syndrome protein, followed by cellular stress, contributes to the formation of Cytoplasmic aggregates that may sequester Feline urological syndrome, disrupt RNA processing and initiate Motor Neurons degeneration., Here, we exploited a Drosophila model of ALS and neuronal cell lines to elucidate the role of the RNA-binding ability of Feline urological syndrome in regulating Feline urological syndrome-mediated Toxic effect, Cytoplasmic mislocalization and incorporation into Stress Granules (Shprintzen-Goldberg syndrome). , Stress granules as crucibles of ALS pathogenesis[SEP]Relations: AMYOTROPHIC LATERAL SCLEROSIS 1 has relations: disease_protein with GLE1, disease_protein with GLE1, disease_protein with FOS, disease_protein with FOS, disease_protein with PPARGC1A, disease_protein with PPARGC1A, disease_protein with ANG, disease_protein with ANG, disease_protein with INA, disease_protein with INA. Definitions: AMYOTROPHIC LATERAL SCLEROSIS 1 defined as following: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor Neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor Neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94). Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Shprintzen-Goldberg syndrome defined as following: A rare, autosomal dominant inherited syndrome often caused by mutations in the SKI gene. It is characterized by premature fusion of skull bones and distinctive facial features, including a long, narrow head, hypertelorism, exophthalmos, downslanting palpebral fissures, a high, narrow palate, micrognathia, and low-set ears. The bodies of affected individuals resemble those of people with Marfan syndrome.. PFN1 gene defined as following: This gene plays a role in the regulation of actin polymerization.. Mutant Proteins defined as following: A protein with an amino acid sequence that differs from the wildtype, canonical sequence.. protein TDP-43, human defined as following: TAR DNA-binding protein 43 (414 aa, ~45 kDa) is encoded by the human TARDBP gene. This protein is involved in the regulation of both transcription and mRNA splicing.. SNRPN protein, human defined as following: Small nuclear ribonucleoprotein-associated protein N (240 aa, ~25 kDa) is a nucleotide metabolism protein that is encoded by the human SNRPN gene and plays a role in mRNA splicing.. liposarcoma defined as following: A malignant tumor derived from primitive or embryonal lipoblastic cells. It may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid (LIPOSARCOMA, MYXOID), round-celled, or pleomorphic, usually in association with a rich network of capillaries. Recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. (From Dorland, 27th ed; Stedman, 25th ed). Neuroglia defined as following: The non-neuronal cells of the nervous system. They not only provide physical support, but also respond to injury, regulate the ionic and chemical composition of the extracellular milieu, participate in the BLOOD-BRAIN BARRIER and BLOOD-RETINAL BARRIER, form the myelin insulation of nervous pathways, guide neuronal migration during development, and exchange metabolites with Neurons. Neuroglia have high-affinity transmitter uptake systems, voltage-dependent and transmitter-gated ion channels, and can release transmitters, but their role in signaling (as in many other functions) is unclear.. Cytoplasmic Granules defined as following: Condensed areas of cellular material that may be bounded by a membrane.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). CREST Syndrome defined as following: A mild form of LIMITED SCLERODERMA, a multi-system disorder. Its features include symptoms of CALCINOSIS; RAYNAUD DISEASE; ESOPHAGEAL MOTILITY DISORDERS; sclerodactyly, and TELANGIECTASIS. When the defect in esophageal function is not prominent, it is known as CRST syndrome.. Stress Granules defined as following: A dense aggregation in the cytosol composed of Proteins and RNA that appear when the cell is under stress. [GOC:ans, PMID:17284590, PMID:17601829, PMID:17967451, PMID:20368989]. Neurons defined as following: The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Frontotemporal dementia defined as following: The most common clinical form of FRONTOTEMPORAL LOBAR DEGENERATION, this dementia presents with personality and behavioral changes often associated with disinhibition, apathy, and lack of insight.. Cultured Cells defined as following: Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.. Ataxin-2 defined as following: A Poly(A) RNA-binding protein that negatively regulates EGFR ENDOCYTOSIS. An increased risk for developing AMYOTROPHIC LATERAL SCLEROSIS 13 is observed in patients who have more than 23 CAG repeats in the ATXN2 gene coding sequence. Larger CAG expansions in the ATXN2 gene occur in SPINOCEREBELLAR ATAXIA 2 patients.. Protein Arginine N-Methyltransferase 1 defined as following: Protein arginine N-methyltransferase 1 (361 aa, ~42 kDa) is encoded by the human Protein Arginine N-Methyltransferase 1 gene. This protein plays a role in the methylation of the guanidino nitrogens of arginyl residues in substrate Proteins.. Frontotemporal Lobar Degeneration defined as following: Heterogeneous group of neurodegenerative disorders characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Multiple subtypes or forms are recognized based on presence or absence of TAU PROTEIN Inclusion Bodies. FTLD includes three clinical syndromes: FRONTOTEMPORAL DEMENTIA, semantic dementia, and PRIMARY PROGRESSIVE NONFLUENT APHASIA.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Cytoplasm defined as following: The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990). Mutant defined as following: An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).. Paraspeckles defined as following: Discrete subnuclear bodies in the interchromatin nucleoplasmic space, often located adjacent to nuclear specks. 10-20 paraspeckles are typically found in human cell nuclei. [GOC:jl, PMID:11790299]. Feline urological syndrome protein defined as following: A multifunctional heterogeneous-nuclear ribonucleoprotein that may play a role in homologous DNA pairing and recombination. The N-terminal portion of protein is a potent transcriptional activator, while the C terminus is required for RNA binding. The name Feline urological syndrome refers to the fact that genetic recombination events result in fusion oncogene Proteins (ONCOGENE PROTEINS, FUSION) that contain the N-terminal region of this protein. These fusion Proteins have been found in myxoid liposarcoma (LIPOSARCOMA, MYXOID) and acute myeloid leukemia.. RNA-binding Proteins defined as following: Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other Proteins whose function is to bind specifically to RNA.. Virus Diseases defined as following: A general term for diseases caused by viruses.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Inclusion Bodies defined as following: A generic term for any circumscribed mass of foreign (e.g., lead or viruses) or metabolically inactive materials (e.g., ceroid or MALLORY BODIES), within the Cytoplasm or Cell Nucleus of a cell. Inclusion bodies are in cells infected with certain filtrable viruses, observed especially in nerve, epithelial, or endothelial cells. (Stedman, 25th ed). Cell Nucleus defined as following: Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one Cell Nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). Nerve Degeneration defined as following: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of Neurodegenerative Disorders. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.. Motor Neurons defined as following: Neurons which activate MUSCLE CELLS.. Nuclear Localization Signals defined as following: An amino acid sequence that directs the post-translational transport of a protein to the Cell Nucleus. The sequence contains positively charged amino acids such as arginine and lysine.. Neurodegenerative Disorders defined as following: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures..", "label": "yes"} {"original_question": "Is adenosine signaling prognostic for cancer outcome?", "id": "converted_4194", "sentence1": "Is adenosine signaling prognostic for cancer outcome?", "sentence2": "Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response., There are several agents in early clinical trials targeting components of the adenosine pathway including ADORA2A wt Allele and 5'-NUCLEOTIDASE. The identification of Malignant Neoplasms with a significant adenosine drive is critical to understand the potential for these Molecule. However, it is challenging to measure tumor adenosine levels at scale, thus novel, clinically tractable biomarkers are needed.EXPERIMENTAL DESIGN: We generated a gene expression signature for the adenosine signaling using regulatory networks derived from the literature and validated this in patients. We applied the signature to large cohorts of Disease from The Cancer Genome Atlas (TCGA) and cohorts of immune checkpoint inhibitor-treated patients.RESULTS: The signature captures baseline adenosine levels in vivo (r 2 = 0.92, P = 0.018), is reduced after small-molecule inhibition of ADORA2A wt Allele in CASP14 gene (r 2 = -0.62, P = 0.001) and Homo sapiens (reduction in 5 of 7 patients, 70%), and is abrogated after ADORA2A wt Allele knockout. Analysis of TCGA confirms a negative association between adenosine and overall survival (OS, HR = 0.6, P < 2.2e-16) as well as progression-free survival (PFS, HR = 0.77, P = 0.0000006). Further, adenosine signaling is associated with reduced OS (HR = 0.47, P < 2.2e-16) and PFS (HR = 0.65, P = 0.0000002) in CD8+ T-cell-infiltrated tumors. Mutation Abnormality Abnormality of TGFβ superfamily members is associated with enhanced adenosine signaling and worse OS (HR = 0.43, P < 2.2e-16). Finally, adenosine signaling is associated with reduced efficacy of anti-PD1 therapy in published cohorts (HR = 0.29, P = 0.00012).CONCLUSIONS: These data support the adenosine pathway as a mediator of a successful Antitumor immune response, demonstrate the prognostic potential of the signature for immunotherapy, and inform patient selection strategies for adenosine pathway modulators currently in development.[SEP]Relations: Adenosine has relations: contraindication with coronary artery Disease, contraindication with coronary artery Disease, contraindication with asthma, contraindication with asthma, contraindication with autonomic nervous system Disease, contraindication with autonomic nervous system Disease, drug_effect with Apnea, drug_effect with Apnea, drug_effect with Coronary artery atherosclerosis, drug_effect with Coronary artery atherosclerosis. Definitions: 5'-NUCLEOTIDASE defined as following: A glycoprotein enzyme present in various organs and in many cells. The enzyme catalyzes the hydrolysis of a 5'-ribonucleotide to a ribonucleoside and orthophosphate in the presence of water. It is cation-dependent and exists in a membrane-bound and soluble form. EC 3.1.3.5.. Homo sapiens defined as following: Members of the species Homo sapiens.. ADORA2A wt Allele defined as following: Human ADORA2A wild-type allele is located in the vicinity of 22q11.23 and is approximately 15 kb in length. This allele, which encodes adenosine A2a receptor protein, is involved in the regulation of adenylyl cyclase.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Molecule defined as following: An aggregate of two or more atoms in a defined arrangement held together by chemical bonds.. adenosine defined as following: A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer..", "label": "yes"} {"original_question": "Is the number of described human nuclear mutations less than 50000?", "id": "converted_2078", "sentence1": "Is the number of described Homo sapiens nuclear Gene Mutation less than 50000?", "sentence2": "The number of known Gene Mutation in Homo sapiens nuclear Genes, underlying or associated with Homo sapiens inherited disease, has now exceeded 100,000 in more than 3700 different Genes (Human Gene Mutation Database)., The Human Gene Mutation Database (HGMD®) is a comprehensive collection of germline Gene Mutation in nuclear Genes that underlie, or are associated with, Homo sapiens inherited disease. By June 2013, the database contained over 141,000 different Lesion detected in over 5,700 different Genes, with new Mutation Abnormality entries currently accumulating at a rate exceeding 10,000 per annum., By March 2012, the database contained in excess of 123,600 different Lesion (HGMD Professional release 2012.1) detected in 4,514 different nuclear Genes, with new entries[SEP]Relations: Lacrimation abnormality has relations: disease_phenotype_positive with Coffin-Siris syndrome, disease_phenotype_positive with Coffin-Siris syndrome, disease_phenotype_positive with Stüve-Wiedemann syndrome, disease_phenotype_positive with Stüve-Wiedemann syndrome, disease_phenotype_positive with Johanson-Blizzard syndrome, disease_phenotype_positive with Johanson-Blizzard syndrome, disease_phenotype_positive with Williams syndrome, disease_phenotype_positive with Williams syndrome, disease_phenotype_positive with limbal stem cell deficiency, disease_phenotype_positive with limbal stem cell deficiency. Definitions: Lesion defined as following: A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "no"} {"original_question": "Is NOD1 activated in inflammation?", "id": "converted_891", "sentence1": "Is NOD1 activated in Inflammation?", "sentence2": "NOD1 gene and Nod2 control Bacterial infections and Inflammation, The Nod proteins NOD1 gene and Nod2 are two NLR family members that trigger immune defense in response to Bacterial Peptidoglycan, Nod proteins fight off Bacterial infections by stimulating proinflammatory signaling and cytokine networks and by inducing antimicrobial effectors, such as nitric oxide and antimicrobial Peptides., NOD1 gene is also critically implicated in shaping adaptive immune responses towards Bacterial-derived constituents., Together, NOD1 gene and Nod2 represent central players in the control of immune responses to Bacterial infections and Inflammation., The innate immune receptor NOD1 gene protects the intestine from Inflammation-induced tumorigenesis., we show that NOD1 gene deficiency results in the increased development of both Colitis-associated and Apc tumor suppressor-related colon tumors. In the absence of NOD1 gene signaling, there is a greater disruption of the Intestines epithelial cell barrier due to Chemicals induced injury as manifested by increased surface epithelial apoptosis early on during Chemicals induced Colitis and increased Intestines permeability., The increased Intestines permeability is associated with enhanced inflammatory cytokine production and epithelial cell proliferation in NOD1 gene-deficient CASP14 gene as compared with wild-type CASP14 gene., Depletion of the gut microbiota suppressed tumor development in NOD1 gene-deficient CASP14 gene, thus highlighting a link between the commensal bacteria within the intestine and the host innate immune NOD1 gene signaling pathway in the regulation Inflammation-mediated colon cancer development., NOD1 protein is expressed in the Eye Specimen Source Code and promotes ocular Inflammation in a dose- and time-dependent fashion. , NOD1 expression in the Eye Specimen Source Code and functional contribution to IL-1beta-dependent ocular Inflammation in CASP14 gene, Genetic Polymorphism in NOD1 are associated with autoinflammatory diseases characterized by Uveitis such as Crohn's disease of oral soft tissues of oral soft tissues and SARCOIDOSIS, SUSCEPTIBILITY TO, 1 (finding), NOD1 is homologous to NOD2 gene gene, which is responsible for an autosomal dominant form of Uveitis. Nonetheless, the role of NOD1 in intraocular Inflammation has not been explored., NOD1 gene and Nod2 regulation of Inflammation in the Salmonella Colitis model, CASP14 gene deficient for both NOD1 gene and Nod2 had attenuated inflammatory pathology, reduced levels of inflammatory cytokines, and increased colonization of the Mucous Membrane, The present study has demonstrated an unexpected role of NOD1 gene in the development of site-specific vascular Inflammation, especially Coronary arteritis., NOD1 gene ligands induce site-specific vascular Inflammation, Phenotyping of NOD1 gene/2 double deficient CASP14 gene and characterization of NOD1 gene/2 in systemic Inflammation and associated Kidney Diseases, The present study analyzed NOD1 gene and Nod2 double deficient (NOD1 gene/2 DKO) CASP14 gene under physiological and inflammatory conditions, Several inflammatory disorders, such as Crohn's disease of oral soft tissues of oral soft tissues and Asthma, are linked to genetic changes in either NOD1 gene or Nod2., Systematic analysis of NOD1 gene/2 DKO CASP14 gene revealed a possible role of NOD1 gene/2 in the development of Kidney Diseases during systemic Inflammation., NOD1 and NOD2 gene gene Signaling in Communicable Diseases and Inflammation, NOD1 engagement generates an inflammatory response via activation of NFκB and Mitogen-Activated Protein Kinases pathways. , In addition we profile novel inhibitors of ARHGEF28 wt Allele and NOD1 itself, which specifically inhibit NOD1 ligand induced inflammatory signalling in the Vasculature. , This data supports the potential utility of NOD1 and ARHGEF28 wt Allele as therapeutic targets in Homo sapiens disease where vascular Inflammation is a clinical feature, such as in Sepsis (Invertebrate) and Septic Shock., NOD1 expression elicited by gamma-D-glutamyl-meso-diaminopimelic acid in first trimester Homo sapiens trophoblast cells and its potential role in infection-associated Inflammation, This study aimed to investigate the expression and function of NOD1 in first trimester trophoblast cells, and evaluate the potential role of trophoblast cells in infection-associated Inflammation, NOD1 may have a role in mediating infection-associated Inflammation. Once gamma-D-glutamyl-meso-diaminopimelic acid is recognized by NOD1, the inflammatory response may be induced via NOD1-RICK-NF-κB-mediated pathways., NOD1/2(-/-) CASP14 gene were protected from HFD-induced Inflammation, lipid accumulation, and peripheral Therapeutic Insulin intolerance., In contrast, NOD1 gene gene-deficient CASP14 gene developed enhanced joint Inflammation with concomitant elevated levels of proinflammatory cytokines and Cartilage damage, consistent with a model in which NOD1 gene controls the inflammatory reaction., These data indicate that the NLR family members NOD1 gene and Nod2 have different functions in controlling Inflammation, and that Protoplasm NOD1 gene-Nod2 interactions may determine the severity of Arthritis in this experimental model., Whereas the lymphotoxin pathway was critical for the induction of the B-Lymphocytes chemoattractant Chemokine Chemokine CXCL13 in response to NOD1 gene agonists, B-Lymphocytes accumulation within the Abdomen>Spleen following NOD1 gene-induced systemic Inflammation was independent of the lymphotoxin pathway., The effect of NOD1 and NOD2 gene gene activation on Inflammation and the Therapeutic Insulin signalling pathway was also assessed., Nonetheless, the role of NOD1 in intraocular Inflammation has not been explored., A key role for the Endothelium in NOD1 mediated vascular Inflammation: comparison to TLR4 wt Allele wt Allele responses., We previously demonstrated that Homo sapiens first-trimester trophoblasts express NOD1 gene and Nod2, which trigger Inflammation upon stimulation., In addition, recent studies have revealed a role for Protoplasm NOD1 receptors in the regulation of vascular Inflammation and metabolism., In conclusion, the present findings describe an important role for NOD1 in the development of Therapeutic Insulin resistance and Inflammation in pregnancies complicated by Gestational Diabetes., Phenotyping of NOD1 gene/2 double deficient CASP14 gene and characterization of NOD1 gene/2 in systemic Inflammation and associated Kidney Diseases., NOD1 gene activation by Bacterial gamma-D-glutamyl-meso-diaminopimelic acid induces maternal-fetal Inflammation and Premature Obstetric Labor., The nucleotide-binding oligomerisation domain (Dentatorubral-Pallidoluysian Atrophy) Protoplasm molecules recognise a wide range of microbial products, as well as other Protoplasm danger signals, thereby initiating Inflammation through activation of NFI Transcription Factors (NFκB). , NOD1 gene ligands induce site-specific vascular Inflammation., The nucleotide oligomerization domain (Dentatorubral-Pallidoluysian Atrophy) Protoplasm molecules recognize a wide range of microbial products as well as other Protoplasm danger signals, thereby initiating Inflammation through activation of nuclear factor KB (NF-kappa B), a central regulator of the terminal processes of Homo sapiens labor and delivery. , CONCLUSIONS: We identify Dentatorubral-Pallidoluysian Atrophy proteins as innate immune components that are involved in diet-induced Inflammation and Therapeutic Insulin intolerance. , NOD1 gene and Nod2 regulation of Inflammation in the Salmonella Colitis model., In particular, muramyl Peptides trigger Inflammation, contribute to host defense against microbial infections, and modulate the adaptive immune response to antigens. , Systemic and tissue-specific Inflammation was assessed using enzyme-linked immunosorbent assays in Dentatorubral-Pallidoluysian Atrophy ligand-injected CASP14 gene. , CONCLUSIONS: We identify Dentatorubral-Pallidoluysian Atrophy proteins as innate immune components that are involved in diet-induced Inflammation and Therapeutic Insulin intolerance. Acute activation of Dentatorubral-Pallidoluysian Atrophy proteins by mimetics of Bacterial PGNs causes whole-body Therapeutic Insulin resistance, bolstering the concept that innate immune responses to distinctive Bacterial cues directly lead to Therapeutic Insulin resistance. , Interferon-gamma (IFN gamma), which is a potent pro-inflammatory cytokine in Intestines mucosal Inflammation, activates CARD4/NOD1 mRNA transcription in a time- and dose-dependent manner and results in augmentation of CARD4/NOD1 protein in SW480 cells., These studies suggest that the NELFCD wt Allele cytokine, IFN gamma, activates CARD4/NOD1 transcription and regulate innate immune mechanisms in the condition of Intestines mucosal Inflammation., NOD1 activation triggers Inflammation,, In contrast to enhanced leptin mRNA by Van der Woude syndrome and TNFα, NOD1 activation suppressed leptin mRNA in Adipocytes, suggesting the differential effects of NOD1 activation in Adipocytes. Overall, our results suggest that NOD1 represents a novel target for adipose Inflammation in BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20., NOD1 activation triggers Inflammation, antimicrobial mechanisms and autophagy in both Epithelial Cells and murine macrophages., NOD1 is an Protoplasm immune receptor that senses Peptidoglycan from Gram-negative bacteria and responds by inducing autophagy and activating NF-κB, leading to Inflammation-mediated Bacterial clearance; however chronic pathogens can evade NOD1-mediated clearance by altering Peptidoglycan structure., Bacterial NOD1 activation is positioned as a component of metabolic endotoxemia that can contribute to Hyperlipidemia, systemic Inflammation and Therapeutic Insulin resistance by acting directly on Adipocytes., NOD1 ligand also caused Inflammation and Therapeutic Insulin resistance directly in primary Hepatocyte from Wild Type Unspecified - zebrafish, but not NOD1(-/-), CASP14 gene., We conclude that NOD1 activation reduced aromatic hydrocarbon receptor in allergen-induced lung Inflammation, which was accompanied by a reduction of allergen-specific T-cell proliferation., The effect of NOD1 and NOD2 gene gene activation on Inflammation and the Therapeutic Insulin signalling pathway was also assessed., Interferon-gamma (IFN gamma), which is a potent pro-inflammatory cytokine in Intestines mucosal Inflammation, activates CARD4/NOD1 mRNA transcription in a time- and dose-dependent manner and results in augmentation of CARD4/NOD1 protein in SW480 cells.[SEP]Relations: intestine has relations: anatomy_protein_present with NOD1, anatomy_protein_present with NOD1. Peptidoglycan binding has relations: molfunc_protein with NOD1, molfunc_protein with NOD1. coronary artery has relations: anatomy_protein_present with NOD1, anatomy_protein_present with NOD1. mitogen-activated protein kinase binding has relations: molfunc_protein with PPM1D, molfunc_protein with PPM1D, molfunc_protein with SIRT1, molfunc_protein with SIRT1. Definitions: Epithelial Cells defined as following: Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional Epithelial Cells.. NOD1 gene defined as following: This gene plays a role in both apoptosis and immunity.. Chemicals defined as following: A substance with a defined atomic or molecular structure that results from, or takes part in, reactions involving changes in its structure, composition, or properties.. Adipocytes defined as following: Cells in the body that store FATS, usually in the form of TRIGLYCERIDES. WHITE ADIPOCYTES are the predominant type and found mostly in the abdominal cavity and subcutaneous tissue. BROWN ADIPOCYTES are thermogenic cells that can be found in newborns of some species and hibernating mammals.. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. Mitogen-Activated Protein Kinases defined as following: A superfamily of PROTEIN SERINE-THREONINE KINASES that are activated by diverse stimuli via protein kinase cascades. They are the final components of the cascades, activated by phosphorylation by MITOGEN-ACTIVATED PROTEIN KINASE KINASES, which in turn are activated by mitogen-activated protein kinase kinase kinases (MAP KINASE KINASE KINASES).. ARHGEF28 wt Allele defined as following: Human RGNEF wild-type allele is located in the vicinity of 5q13.2 and is approximately 316 kb in length. This allele, which encodes Rho-guanine nucleotide exchange factor protein, plays a role in the modulation of integrin and growth factor receptor signaling.. leptin defined as following: A 16-kDa peptide hormone secreted from WHITE ADIPOCYTES. Leptin serves as a feedback signal from fat cells to the CENTRAL NERVOUS SYSTEM in regulation of food intake, energy balance, and fat storage.. NOD2 gene defined as following: This gene is involved in immune responses and cell death.. Peptidoglycan defined as following: A structural polymer of the Bacterial cell envelope consisting of sugars and amino acids which is responsible for both shape determination and cellular integrity under osmotic stress in virtually all bacteria.. Endothelium defined as following: A layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body.. Kidney Diseases defined as following: Pathological processes of the KIDNEY or its component tissues.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, proteins, lipids, carbohydrates, and inorganic salts.. nitric oxide defined as following: A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular Endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular Endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates Protoplasm levels of CYCLIC GMP.. B-Lymphocytes defined as following: Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.. NF-kappa B defined as following: Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA.. aromatic hydrocarbon receptor defined as following: approximately 280kD soluble protein complex; binds and mediates carcinogenesis by polycyclic aromatic hydrocarbons, heterocyclic amines, and chlorinated aromatic compounds.. NELFCD wt Allele defined as following: Human NELFCD wild-type allele is located in the vicinity of 20q13 and is approximately 14 kb in length. This allele, which encodes negative elongation factor C/D protein, plays a role in the inhibition of transcriptional elongation.. Hepatocyte defined as following: The main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules.. Vasculature defined as following: Organ region cluster which consists of regions of arterial, venous and lymphatic trees and the capillary beds that connect them. Examples: Vasculature of head, Vasculature of brain.. Intestines defined as following: The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE.. Septic Shock defined as following: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or Homo sapiens host.. Genetic Polymorphism defined as following: The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.. Gestational Diabetes defined as following: Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when Therapeutic Insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.. Uveitis defined as following: Inflammation of part or all of the uvea, the middle (vascular) tunic of the Eye Specimen Source Code, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed). ocular Inflammation defined as following: Inflammation of the Eye Specimen Source Code, parts of the Eye Specimen Source Code or the periorbital region. [HPO:sdoelken]. Therapeutic Insulin defined as following: A synthetic or animal-derived form of Therapeutic Insulin used in the treatment of diabetes mellitus. Therapeutic Therapeutic Insulin is formulated to be short-, intermediate- and long-acting in order to individualize an Therapeutic Insulin regimen according to individual differences in glucose and Therapeutic Insulin metabolism. Therapeutic Therapeutic Insulin may be derived from porcine, bovine or recombinant sources. Endogenous Homo sapiens Therapeutic Insulin, a pancreatic hormone composed of two polypeptide chains, is important for the normal metabolism of carbohydrates, proteins and fats and has anabolic effects on many types of tissues.. Premature Obstetric Labor defined as following: Regular uterine activity with associated cervical change prior to 37 weeks gestation.. Bacterial infections defined as following: Infections by bacteria, general or unspecified.. TLR4 wt Allele defined as following: Human TLR4 wt Allele wild-type allele is located within 9q32-q33 and is approximately 11 kb in length. This allele, which encodes toll-like receptor 4 protein, is involved in pathogen recognition, signal transduction and innate immunity. Mutations in the gene are associated with differences in Van der Woude syndrome responsiveness.. Dentatorubral-Pallidoluysian Atrophy defined as following: A rare, autosomal dominant inherited progressive neurodegenerative disorder. It is caused by a mutation in the ATN1 gene, resulting in a combined degeneration of the dentatorubral and pallidoluysian systems. It can appear at any age, but it usually affects individuals between 20 and 30 years and leads to death within 10-15 years. The clinical presentation depends on the age of the affected individual; juvenile patients develop severe progressive myoclonus epilepsy and cognitive decline, whereas adult patients develop ataxia, choreoathetosis and dementia.. Asthma defined as following: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).. Wild Type Unspecified - zebrafish defined as following: A designation used to describe a wild-type zebrafish line that is of unknown stock.. Van der Woude syndrome defined as following: A rare autosomal dominant syndrome caused by mutations in the IRF6 gene. It is characterized by a cleft palate and/or pits on the lower lip. Other signs and symptoms include absent teeth, palate and tongue deformities.. NFI Transcription Factors defined as following: A family of proteins that contain 1 DWA/MH1 domain and bind 5'-TTGGCNNNNNGCCAA-3' DNA palindromes in viral and cellular promoters as homodimeric factors capable of activating transcription and replication.. Colitis defined as following: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.. Chemokine CXCL13 defined as following: A CXC chemokine that is chemotactic for B-LYMPHOCYTES. It has specificity for CXCR5 RECEPTORS.. Peptides defined as following: Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of Peptides that can form into complex structures such as ENZYMES and RECEPTORS.. Arthritis defined as following: Acute or chronic Inflammation of JOINTS.. Homo sapiens defined as following: Members of the species Homo sapiens.. Mucous Membrane defined as following: An EPITHELIUM with MUCUS-secreting cells, such as GOBLET CELLS. It forms the lining of many body cavities, such as the DIGESTIVE TRACT, the RESPIRATORY TRACT, and the reproductive tract. Mucosa, rich in blood and lymph vessels, comprises an inner epithelium, a middle layer (lamina propria) of loose CONNECTIVE TISSUE, and an outer layer (muscularis mucosae) of SMOOTH MUSCLE CELLS that separates the mucosa from submucosa.. Hyperlipidemia defined as following: Conditions with excess LIPIDS in the blood.. NOD1 defined as following: This gene plays a role in both apoptosis and immunity..", "label": "yes"} {"original_question": "Does erenumab target the calcitonin gene-related peptide?", "id": "converted_3970", "sentence1": "Does erenumab target the Calcitonin Precursor, human?", "sentence2": "Four Monoclonal Antibodies have been developed: one targeting the CALCRL gene (erenumab) and three targeting the Calcitonin Precursor, human (eptinezumab, fremanezumab, and galcanezumab).[SEP]Relations: CALCRL has relations: drug_protein with Erenumab, drug_protein with Erenumab, molfunc_protein with CALCRL gene activity, molfunc_protein with CALCRL gene activity, bioprocess_protein with CALCRL gene signaling pathway, bioprocess_protein with CALCRL gene signaling pathway. Human calcitonin has relations: drug_protein with ANPEP, drug_protein with ANPEP, drug_effect with Erythema, drug_effect with Erythema. Definitions: Monoclonal Antibodies defined as following: Antibodies produced by a single clone of cells.. Calcitonin Precursor, human defined as following: This gene is involved in the regulation of bone incorporation and blood calcium and phosphate levels..", "label": "no"} {"original_question": "Are the proteins Erbin (LAP2) and Merlin cooperating?", "id": "converted_1559", "sentence1": "Are the proteins ERBB2 Interacting Protein, Human (LAP2) and Neurofibromin 2 cooperating?", "sentence2": "ERBB2 Interacting Protein, Human and the NF2 tumor suppressor Neurofibromin 2 cooperatively regulate cell-type-specific activation of PAK2 gene gene by Recombinant Transforming Growth Factor-Beta., The results show that the epithelial-enriched protein ERBB2 Interacting Protein, Human controls the function of the NF2 tumor suppressor Neurofibromin 2 by determining the output of Neurofibromin 2's physical interactions with active PAK2 gene gene. , ERBB2 Interacting Protein, Human controls Neurofibromin 2 tumor suppressor function by switching the functional valence of PAK2 gene gene binding[SEP]Relations: protein insertion into ER membrane has relations: bioprocess_protein with TRAM2, bioprocess_protein with TRAM2, bioprocess_protein with CYB5A, bioprocess_protein with CYB5A, bioprocess_protein with ALDH3A2, bioprocess_protein with ALDH3A2, bioprocess_protein with UBE2J2, bioprocess_protein with UBE2J2, bioprocess_protein with VAMP2, bioprocess_protein with VAMP2. Definitions: Recombinant Transforming Growth Factor-Beta defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine transforming growth factor-beta (Recombinant Transforming Growth Factor-Beta) with proapoptotic and antineoplastic properties. Recombinant Transforming Growth Factor-Beta may suppress tumor cell growth by decreasing the expression of cyclin D1, a cell cycle regulatory protein, and downregulating the expression of the oncogene c-myc. This agent is also involved in T cell-mediated immunosuppression by CD4+CD25+ T cells, which permits cancer cells to evade immune surveillance. (NCI04). ERBB2 Interacting Protein, Human defined as following: Protein LAP2 (1412 aa, ~158 kDa) is encoded by the human ERBIN gene. This protein plays a role in the modulation of receptor tyrosine kinase signaling.. Neurofibromin 2 defined as following: A membrane protein homologous to the ERM (Ezrin-Radixin-Moesin) family of cytoskeleton-associated proteins which regulate physical properties of membranes. Alterations in neurofibromin 2 are the cause of NEUROFIBROMATOSIS 2.. LAP2 defined as following: Human HSP90AA1 wild-type allele is located in the vicinity of 14q32.33 and is approximately 59 kb in length. This allele, which encodes heat shock protein HSP 90-alpha, plays a role in both nitric oxide metabolism and protein folding. A chromosomal translocation t(3;14)(q27;q32) of this gene and the BCL6 gene is associated with B cell non-Hodgkin lymphoma..", "label": "yes"} {"original_question": "Has strimvelis been approved by the European Medicines Agency?", "id": "converted_3074", "sentence1": "Has strimvelis been approved by the European Medicines Agency?", "sentence2": "Strimvelis (autologous CD34+ cells transduced to express acetaldehyde dehydrogenase (acetylating) activity gene [acetaldehyde dehydrogenase (acetylating) activity]) is the first ex vivo Stem cells gene therapy approved by the European Medicines Agency (Multiple Acyl Coenzyme A Dehydrogenase Deficiency), indicated as a single treatment for patients with acetaldehyde dehydrogenase (acetylating) activity-severe combined immunodeficiency (Severe combined immunodeficiency due to acetaldehyde dehydrogenase (acetylating) activity gene deficiency) who lack a suitable matched related bone marrow donor. [SEP]Relations: cellular response to Stem cells factor stimulus has relations: bioprocess_bioprocess with cellular response to cytokine stimulus, bioprocess_bioprocess with cellular response to cytokine stimulus. severe combined immunodeficiency due to LAT deficiency has relations: disease_phenotype_positive with Immune dysregulation, disease_phenotype_positive with Immune dysregulation, disease_phenotype_positive with Splenomegaly, disease_phenotype_positive with Splenomegaly. multiple acyl-CoA dehydrogenase deficiency has relations: disease_phenotype_positive with Lacticaciduria, disease_phenotype_positive with Lacticaciduria, disease_phenotype_positive with Cardiorespiratory arrest, disease_phenotype_positive with Cardiorespiratory arrest. Definitions: Severe combined immunodeficiency due to acetaldehyde dehydrogenase (acetylating) activity gene deficiency defined as following: Severe combined immunodeficiency (SCID) due to acetaldehyde dehydrogenase (acetylating) activity gene (acetaldehyde dehydrogenase (acetylating) activity) deficiency is a form of SCID characterized by profound lymphopenia and very low immunoglobulin levels of all isotypes resulting in severe and recurrent opportunistic infections.. acetaldehyde dehydrogenase (acetylating) activity gene defined as following: This gene is involved in nucleotide metabolism and cellular immunity.. Multiple Acyl Coenzyme A Dehydrogenase Deficiency defined as following: An autosomal recessive disorder of fatty acid oxidation, and branched chain amino acids (AMINO ACIDS, BRANCHED-CHAIN); LYSINE; and CHOLINE catabolism, that is due to defects in either subunit of ELECTRON TRANSFER FLAVOPROTEIN or its dehydrogenase, electron transfer flavoprotein-ubiquinone oxidoreductase (EC 1.5.5.1).. Stem cells defined as following: Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells.. acetaldehyde dehydrogenase (acetylating) activity defined as following: Catalysis of the reaction: acetaldehyde + CoA + NAD+ = acetyl-CoA + NADH + H+. [EC:1.2.1.10].", "label": "yes"} {"original_question": "Is αCGRP a member of the CGRP family?", "id": "converted_3736", "sentence1": "Is αCGRP a member of the Calcitonin Gene-Related Peptide family?", "sentence2": "αCGRP, another amyloidogenic member of the Calcitonin Gene-Related Peptide family., Therefore, in this work, we investigated the amyloidogenic profile of αCGRP, a 37-residue-long peptide hormone activity activity, utilizing both biophysical experimental techniques and Molecular Dynamics simulations. These efforts unravel a novel amyloidogenic member of the Calcitonin Gene-Related Peptide family and provide insights into the mechanism underlying the αCGRP polymerization., These efforts unravel a novel amyloidogenic member of the Calcitonin Gene-Related Peptide family and provide insights into the mechanism underlying the αCGRP polymerization., These efforts unravel a novel amyloidogenic member of the Calcitonin Gene-Related Peptide family and provide insights into the mechanism underlying the αCGRP polymerization.[SEP]Relations: neuropeptide hormone activity has relations: molfunc_protein with GRP, molfunc_protein with GRP, molfunc_protein with AGRP, molfunc_protein with AGRP, molfunc_protein with CCK, molfunc_protein with CCK, molfunc_protein with QRFP, molfunc_protein with QRFP, molfunc_protein with PRLH, molfunc_protein with PRLH. Definitions: Calcitonin Gene-Related Peptide defined as following: A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator.. peptide hormone activity defined as following: OBSOLETE. (Was not defined before being made obsolete). [GOC:ai].", "label": "yes"} {"original_question": "Is YKL-40 used as a biomarker for Alzheimer's disease?", "id": "converted_4114", "sentence1": "Is Chitinase-3-Like Protein 1 used as a biomarker for ALZHEIMER DISEASE, FAMILIAL, 1?", "sentence2": "Recently, In Cerebrospinal Fluid (CSF) Chitinase-3-Like Protein 1 levels were reported to be a promising candidate biomarker of glial inflammation in ALZHEIMER DISEASE, FAMILIAL, 1 (cytarabine/daunorubicin protocol). , Disease groups differed between them except cytarabine/daunorubicin protocol versus FTD for Chitinase-3-Like Protein 1. , Chitinase-3-Like Protein 1 appears to be a more reliable biomarker in neurological diseases than ENO2 wt Allele.[SEP]Relations: familial Alzheimer disease has relations: disease_disease with Alzheimer disease, disease_disease with Alzheimer disease, disease_protein with PRNP, disease_protein with PRNP, disease_phenotype_positive with Perseveration, disease_phenotype_positive with Perseveration, disease_phenotype_positive with Attention deficit hyperactivity disorder, disease_phenotype_positive with Attention deficit hyperactivity disorder, disease_disease with inherited prion disease, disease_disease with inherited prion disease. Definitions: In Cerebrospinal Fluid defined as following: Used for the presence or analysis of substances in the In Cerebrospinal Fluid; also for examination of or changes in In Cerebrospinal Fluid in disease states.. Chitinase-3-Like Protein 1 defined as following: A lectin that binds CHITIN, but lacks chitinase activity. It may be involved in tissue remodeling and cellular responses to the environment, including the response of type 2 HELPER T-CELLS to INFLAMMATION and sensitization to ALLERGENS. Mutations in the CHI3L1 gene are associated with ASTHMA.. ENO2 wt Allele defined as following: Human ENO2 wild-type allele is located within 12p13 and is approximately 9 kb in length. This allele, which encodes gamma-enolase protein, is involved in glycolysis. The ENO2 gene is overexpressed in certain cancers such as neuroendocrine carcinomas and small cell lung cancer.. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65..", "label": "yes"} {"original_question": "Is the TFR1 gene dispensable for erythropoiesis?", "id": "converted_3749", "sentence1": "Is the TFR1 gene dispensable for erythropoiesis?", "sentence2": "These studies describe how Point Mutation of the Serotransferrin, human receptor can cause a microcytic Genus Anemia that does not respond to Ferrum metallicum, Homeopathic preparation therapy and would not be detected by routine Ferrum metallicum, Homeopathic preparation studies, such as Serum ferritin measurement., Ret-He was the only red cell marker affected prior to the onset of Head>Brain ID. The clinical practice of using Genus Anemia as the preferred biomarker for diagnosis of Ferrum metallicum, Homeopathic preparation deficiency may need reconsidering., The restoration of Erythropoietin production and EPOR Protein Info, human Protein Info, human mRNA expression with Aspirate substance treatment activated EPOR Protein Info, human Protein Info, human downstream JAK2/STAT5 and PI3K/Akt signaling, induced their target Genes, such as BCL2L1 gene, ERFE gene and Tfrc, and increased Bcl-2/Bax ratio in Bone Marrow-Derived Mononuclear Cells of Chronic Kidney Diseases Rattus norvegicus., Transferrin-bound Ferrum metallicum, Homeopathic preparation binding to Transferrin Receptor, human (TfR1) is essential for cellular Ferrum metallicum, Homeopathic preparation delivery during erythropoiesis. , aken together, decreasing TfR1 expression during β-thalassemic erythropoiesis, either directly via induced haploinsufficiency or via exogenous apotransferrin, decreases ineffective erythropoiesis and provides an endogenous mechanism to upregulate hepcidin, leading to sustained Ferrum metallicum, Homeopathic preparation-restricted erythropoiesis and preventing systemic Ferrum metallicum, Homeopathic preparation overload in β-thalassemic mice., The type 1 Serotransferrin, human receptor (TfR1) is well known as a key player in Erythroid differentiation through its role in Ferrum metallicum, Homeopathic preparation uptake. , The signaling functions of both TfR1 and Serotransferrin, human receptor 2, human in Erythroid Cells were unexpected and these recent findings open a new field of research regarding the last steps of Erythroid differentiation and their regulation., Erythropoiesis requires large amounts of Ferrum metallicum, Homeopathic preparation for hemoglobin synthesis, which is mainly provided by Specimen Source Codes - Macrophages and the Intestines in a Serotransferrin, human (Tf)-bound form., In Homo sapiens, hematopoietic Erythroid precursor Cells express high levels of TFR1 and specifically take up the FTH homopolymer (Ferritin Heavy Chain)., We found decreased expression of hepcidin and Serotransferrin, human receptor 2, human and increased expression of TfR1 and LCN2 wt Allele in the beta Thalassemia mouse models, compared with the control mice., Soluble Serotransferrin, human receptor-1 (sTfR1) concentrations are increased in the Specimen Source Codes - Plasma under two conditions that are associated with increased Ferrum metallicum, Homeopathic preparation absorption, i.e. Ferrum metallicum, Homeopathic preparation deficiency and increased erythropoiesis., HEMOCHROMATOSIS, TYPE 1 is caused by Gene Mutation in HFE, a Protein Info that competes with Serotransferrin, human (Male-to-Female Transsexual, Self-Report) for binding to Transferrin Receptor, human (TFR1)., Here we report that sorting nexin 3 (SNX3 gene) facilitates the recycling of Serotransferrin, human receptor (Tfrc) and thus is required for the proper delivery of Ferrum metallicum, Homeopathic preparation to Erythroid progenitors., These findings provide direct evidence that TFRC wt Allele is essential for Hematopoiesis through binding diferric Serotransferrin, human to supply Ferrum metallicum, Homeopathic preparation to Cells.[SEP]Relations: hemochromatosis has relations: disease_protein with TFR2, disease_protein with TFR2. hemopoiesis has relations: bioprocess_protein with TWSG1, bioprocess_protein with TWSG1, bioprocess_protein with L3MBTL1, bioprocess_protein with L3MBTL1, bioprocess_protein with GFI1, bioprocess_protein with GFI1. Erythropoietin has relations: drug_protein with EPOR Protein Info, human, drug_protein with EPOR Protein Info, human. Definitions: Ferrum metallicum, Homeopathic preparation defined as following: homeopathic drug. TFRC wt Allele defined as following: Human TFRC wild-type allele is located in the vicinity of 3q29 and is approximately 33 kb in length. This allele, which encodes Serotransferrin, human receptor Protein Info 1, is involved in the regulation of cellular uptake of Ferrum metallicum, Homeopathic preparation via receptor-mediated endocytosis.. Transferrin Receptor, human defined as following: Homodimeric human Transferrin Receptors (M28B Peptidase Family) are type II membrane proteins involved in the cellular import of Serotransferrin, human-bound Ferrum metallicum, Homeopathic preparation and appear necessary for Ferrum metallicum, Homeopathic preparation metabolism, cell function, and erythrocyte differentiation. (NCI). Erythroid Cells defined as following: The series of Cells in the red blood cell lineage at various stages of differentiation.. Erythroid defined as following: 1) Reddish in color. 2) relating to erythrocytes or their precursors.. EPOR Protein Info, human defined as following: Erythropoietin receptor (508 aa, ~55 kDa) is encoded by the human EPOR Protein Info, human gene. This Protein Info is involved in signal transduction and erythroblast proliferation and differentiation.. Erythropoietin defined as following: Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on Erythroid stem Cells of the BONE MARROW to stimulate proliferation and differentiation.. Serotransferrin, human defined as following: Serotransferrin (698 aa, ~77 kDa) is encoded by the human Male-to-Female Transsexual, Self-Report gene. This Protein Info is involved in Ferrum metallicum, Homeopathic preparation sequestration and transport.. Serotransferrin, human receptor defined as following: This gene plays a role in Ferrum metallicum, Homeopathic preparation metabolism.. transferrin receptor 2, human defined as following: Transferrin receptor Protein Info 2 (801 aa, ~89 kDa) is encoded by the human TFR2 gene. This Protein Info is involved in the mediation of cellular uptake of Serotransferrin, human-Ferrum metallicum, Homeopathic preparation complexes.. beta Thalassemia defined as following: A disorder characterized by reduced synthesis of the beta chains of hemoglobin. There is retardation of hemoglobin A synthesis in the heterozygous form (thalassemia minor), which is asymptomatic, while in the homozygous form (thalassemia major, Cooley's Genus Anemia, Mediterranean Genus Anemia, erythroblastic Genus Anemia), which can result in severe complications and even death, hemoglobin A synthesis is absent.. hepcidin defined as following: Forms of hepcidin, a cationic amphipathic peptide synthesized in the liver as a prepropeptide which is first processed into prohepcidin and then into the biologically active hepcidin forms, including in human the 20-, 22-, and 25-amino acid residue peptide forms. Hepcidin acts as a homeostatic regulators of Ferrum metallicum, Homeopathic preparation metabolism and also possesses antimicrobial activity.. microcytic Genus Anemia defined as following: Anemia in which the red blood cell volume is decreased.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. Male-to-Female Transsexual, Self-Report defined as following: A person who was assigned to the male gender at birth based on physical characteristics but who self-identifies psychologically and emotionally as female.. Aspirate substance defined as following: Fluid withdrawn from a body cavity, organ, cyst, or tumor.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Point Mutation defined as following: A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair.. Rattus norvegicus defined as following: The common rat, Rattus norvegicus, often used as an experimental organism.. Intestines defined as following: The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE.. Chronic Kidney Diseases defined as following: Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.. BCL2L1 gene defined as following: This gene is an apoptotic regulator that can have anti or pro apoptotic effects.. Hematopoiesis defined as following: The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY).. LCN2 wt Allele defined as following: Human LCN2 wild-type allele is located in the vicinity of 9q34 and is approximately 5 kb in length. This allele, which encodes neutrophil gelatinase-associated lipocalin Protein Info, may be involved in both the modulation of inflammation and the regulation of the transport of hydrophobic substances (ie. retinol, lipopolysaccharide). The expression of this gene may be elevated in many cancers and inflammatory diseases.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Bone Marrow-Derived Mononuclear Cells defined as following: A biological sample containing mononuclear Cells isolated from the bone marrow of an experimental subject.. Homo sapiens defined as following: Members of the species Homo sapiens.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary..", "label": "no"} {"original_question": "Is MLL3 part of the ASCOM complex?", "id": "converted_3340", "sentence1": "Is KMT2C gene part of the ASCOM complex?", "sentence2": "KMT2C gene as part of ASCOM complex, KMT2C gene as part of activating signal cointegrator-2 -containing complex (ASCOM)[SEP]Definitions: KMT2C gene defined as following: This gene plays a role in both methylation and transcriptional regulation.", "label": "yes"} {"original_question": "Have studies shown that there is no link between DNA methylation patterns and Post Traumatic Stress Disorder?", "id": "converted_2130", "sentence1": "Have studies shown that there is no link between DNA methylation patterns and Post Traumatic Stress Disorder?", "sentence2": "Using pre-deployment SKA2 gene gene methylation levels and childhood Wounds and Injuries exposure, we found that the previously published suicide prediction rule significantly predicted post-deployment PTSD symptoms (AUC=0.66, 95% CI: 0.53-0.79) with an optimal sensitivity of 0.81 and specificity of 0.91. Permutation analysis using random methylation loci supported these findings. Together, these data establish the importance of SKA2 gene gene for cortisol stress responsivity and the development of PTSD and provide further evidence that SKA2 gene gene is a promising biomarker for stress-related disorders including PTSD., Results provide novel support for PTSD-related accelerated aging in DNAm and extend the evidence base of known DNAm age correlates to the domains of neural integrity and cognition., We investigated serum DNA methylation patterns in genomic repetitive elements, Long Interspersed Nucleotide Element-1 and Alu, for Post-Traumatic Stress Disorder (PTSD) cases and controls who were US military service members recently deployed to Afghanistan or Iraq., In light of its role in Glucocorticoid Receptor transactivation, we investigated whether SKA2 gene gene DNA methylation influences cortisol stress reactivity and is involved in the development of Post-Traumatic Stress Disorder (PTSD)., These results suggest that alterations in global methylation pattern are involved in behavioural adaptation to environmental stress and pinpoint DLGAP2 gene as a possible target in PTSD., Here we examined whether there was a link between an established Rattus norvegicus model of Post-Traumatic Stress Disorder (PTSD) and Bdnf DNA methylation, We investigated serum DNA methylation patterns in genomic repetitive elements, Long Interspersed Nucleotide Element-1 and Alu, for Post-Traumatic Stress Disorder (PTSD) cases and controls who were US military service members recently deployed to Afghanistan or Iraq.Cases (n = 75) had a postdeployment diagnosis of PTSD, DNA methylation in repetitive elements and Post-Traumatic Stress Disorder: a case-control study of US military service members, Here we examined whether there was a link between an established Rattus norvegicus model of Post-Traumatic Stress Disorder (PTSD) and Bdnf DNA methylation. , DNA methylation in repetitive elements and Post-Traumatic Stress Disorder: a case-control study of US military service members., AIM: We investigated serum DNA methylation patterns in genomic repetitive elements, Long Interspersed Nucleotide Element-1 and Alu, for Post-Traumatic Stress Disorder (PTSD) cases and controls who were US military service members recently deployed to Afghanistan or Iraq. , Together, these results suggest that psychosocial stress may alter global and gene-specific DNA methylation patterns potentially associated with peripheral immune dysregulation., DNA methylation in vulnerability to post-traumatic stress in rats: evidence for the role of the post-synaptic density protein DLGAP2 gene., Subjects with PTSD showed a higher DNA methylation of four CpG sites at the BDNF promoter compared with those without PTSD, Cumulatively, the data suggest that epigenetic variation at SKA2 gene gene mediates vulnerability to suicidal behaviors and PTSD through dysregulation of the hypothalamic-pituitary-adrenal axis axis in response to stress.[SEP]Relations: Post-Traumatic Stress Disorder has relations: disease_disease with neurotic disorder, disease_disease with neurotic disorder. DLGAP2 has relations: anatomy_protein_absent with decidua, anatomy_protein_absent with decidua, anatomy_protein_present with hypothalamus, anatomy_protein_present with hypothalamus, anatomy_protein_present with substantia nigra, anatomy_protein_present with substantia nigra, anatomy_protein_present with prefrontal cortex, anatomy_protein_present with prefrontal cortex. Definitions: Wounds and Injuries defined as following: Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.. SKA2 gene defined as following: This gene plays a role in microtubule binding and chromosome segregation.. Post-Traumatic Stress Disorder defined as following: A class of traumatic stress disorders with symptoms that last more than one month.. Long Interspersed Nucleotide Element-1 defined as following: A long interspersed element (LINE) found in mammals. The Long Interspersed Nucleotide Element-1 element is the only active LINE in humans and is approximately 6,000 base pairs long. This nucleotide sequence consists of two non-overlapping open reading frames (ORF) flanked by a 5' untranslated region (UTR), which contains a strong RNA polymerase II promoter sequence, and target side duplications. The first ORF encodes a 500 amino acid, ~40 kDa leucine zipper-containing RNA-binding protein. The second ORF encodes an ~150 kDa protein that has endonuclease and reverse transcriptase activity. Increased Long Interspersed Nucleotide Element-1 copy number is associated with cancer and neuropathy.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. Glucocorticoid Receptor defined as following: Cytoplasmic proteins that specifically bind glucocorticoids and mediate their cellular effects. The Glucocorticoid Receptor-glucocorticoid complex acts in the nucleus to induce transcription of DNA. Glucocorticoids were named for their actions on blood glucose concentration, but they have equally important effects on protein and fat metabolism. Cortisol is the most important example.. hypothalamic-pituitary-adrenal axis defined as following: interaction and feedback in stimulation or suppression of hormones produced in the hypothalamus, pituitary, and adrenal glands..", "label": "no"} {"original_question": "Are transcription and splicing connected?", "id": "converted_22", "sentence1": "Are transcription and splicing connected?", "sentence2": ", as splicing is often cotranscriptional, a complex picture emerges in which splicing regulation not only depends on the balance of RNA Splicing Factors binding to their mRNA Precursor target sites but also on transcription-associated features such as Protein Info recruitment to the transcribing machinery and elongation kinetics., recent evidence shows that chromatin structure is another Chicken laying egg for human food of regulation that may act through various mechanisms, hese span from regulation of RNA Polymerase II elongation, which ultimately determines splicing decisions, to RNA Splicing Factors recruitment by specific histone marks., chromatin location may not only be involved in Alternative Splicing regulation but in constitutive exon recognition as well, Moreover, splicing was found to be necessary for the proper 'writing' of particular chromatin signatures, giving further mechanistic support to functional interconnections between splicing, transcription and chromatin structure., These links between chromatin configuration and splicing raise the intriguing possibility of the existence of a memory for splicing patterns to be inherited through epigenetic modifications., Spliceosomes assembly occurs co-transcriptionally, raising the possibility that DNA structure may directly influence Alternative Splicing., upporting such an association, recent reports have identified distinct histone methylation patterns, elevated nucleosome occupancy and enriched DNA methylation at Exons relative to Introns, Moreover, the rate of transcription elongation has been linked to Alternative Splicing., ere we provide the first evidence that a DNA-binding Protein Info, CCCTC-binding factor (CTGF Protein Info, human), can promote inclusion of weak upstream Exons by mediating local RNA Polymerase II pausing both in a Mammals model system for Alternative Splicing, PTPRC wt Allele, and genome-wide, We recently showed that cotranscriptional splicing occurs efficiently in Drosophila ,, In recent years it became apparent that splicing is predominantly cotranscriptional, To determine the prevalence of cotranscriptional splicing in Drosophila , we sequenced nascent RNA transcripts from Drosophila S2 cells as well as from Drosophila heads. Eighty-seven percent of the Introns assayed manifest >50% cotranscriptional splicing. The remaining 13% are cotranscriptionally spliced poorly or slowly, with ∼3% being almost completely retained in nascent mRNA Precursor., We estimate that > or =90% of endogenous yeast splicing is posttranscriptional, consistent with an analysis of posttranscriptional snRNP-associated mRNA Precursor., Notably, the DNA Topoisomerases, Type I inhibitor Camptothecin, which stalls elongating Pol II, increased cotranscriptional RNA Splicing Factors accumulation and splicing in parallel. This provides direct evidence for a kinetic link between transcription, RNA Splicing Factors recruitment and splicing catalysis., Recent evidence indicates that transcriptional elongation and splicing can be influenced reciprocally: Elongation rates control Alternative Splicing and splicing factors can, in turn, modulate pol II elongation., The presence of TRANSCRIPTION FACTOR in the spliceosome and the existence of Proteins, such as the coactivator PGC-1, with dual activities in splicing and transcription can explain the links between both processes and add a new level of complexity to the regulation of gene expression in Eukaryota.[SEP]Relations: RNA splicing has relations: bioprocess_protein with SYNCRIP, bioprocess_protein with SYNCRIP, bioprocess_protein with SON, bioprocess_protein with SON, bioprocess_protein with USB1, bioprocess_protein with USB1, bioprocess_protein with SNRPG, bioprocess_protein with SNRPG. transcription factor binding has relations: molfunc_protein with SP1, molfunc_protein with SP1. Definitions: Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the Protein Info.. CTGF Protein Info, human defined as following: CCN family member 2 (349 aa, ~38kDa) is encoded by the human CCN2 gene. This Protein Info plays a role in the promotion of proliferation and differentiation of chondrocytes and also mediates heparin- and divalent cation-dependent cell adhesion in many different cell types.. RNA Polymerase II defined as following: A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6.. Exons defined as following: The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA.. PTPRC wt Allele defined as following: Human PTPRC wild-type allele is located in the vicinity of 1q31-q32 and is approximately 118 kb in length. This allele, which encodes receptor-type tyrosine-Protein Info phosphatase C Protein Info, plays a role in T-cell activation through the antigen receptor. Defects in the PTPRC gene are a cause of autosomal recessive severe combined immunodeficiency (SCID).. Spliceosomes defined as following: Organelles in which the splicing and excision reactions that remove Introns from precursor messenger RNA molecules occur. One component of a spliceosome is five small nuclear RNA molecules (U1, U2, U4, U5, U6) that, working in conjunction with Proteins, help to fold pieces of RNA into the right shapes and later splice them into the message.. Eukaryota defined as following: Organism or cells with a nucleus separated from the cytoplasm by a two membrance nuclear envelope and compartmentalization of function into distinct cytoplasmic organelles.. CCCTC-binding factor defined as following: A repressor Protein Info with poly(ADP)-ribose binding activity that binds CHROMATIN and DNA; its structure consisting of 11 CYS2-HIS2 ZINC FINGERS allows it to recognize many different DNA target sites. It functions as a repressor by binding to INSULATOR ELEMENTS and preventing interaction between promoters and nearby enhancers and silencers. It plays a critical role in EPIGENETIC PROCESSES, including GENOMIC IMPRINTING.. Introns defined as following: Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the Exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some Introns code for separate genes.. RNA Splicing Factors defined as following: RNA-binding Proteins that facilitate or inhibit RNA SPLICING.. Alternative Splicing defined as following: A process whereby multiple RNA transcripts are generated from a single gene. Alternative splicing involves the splicing together of other possible sets of EXONS during the processing of some, but not all, transcripts of the gene. Thus a particular exon may be connected to any one of several alternative Exons to form a mature RNA. The alternative forms of mature MESSENGER RNA produce PROTEIN ISOFORMS in which one part of the isoforms is common while the other parts are different.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous Proteins in other species.. Chicken laying egg for human food defined as following:

Chickens raised for egg production

. DNA Topoisomerases, Type I defined as following: DNA TOPOISOMERASES that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. DNA Topoisomerases, Type I enzymes reduce the topological stress in the DNA structure by relaxing the superhelical turns and knotted rings in the DNA helix.. Camptothecin defined as following: An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of Camptothecin have demonstrated antitumor activity.. DNA-binding Protein Info defined as following: Proteins which bind to DNA. The family includes Proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding Proteins in serum which can be used as markers for malignant diseases.. chromatin location defined as following: The ordered and organized complex of DNA, Protein Info, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130]. mRNA Precursor defined as following: A primary RNA transcript synthesized from a DNA template in eukaryotic nuclei which is post-transcriptionally modified and spliced to produce a mature mRNA.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually Proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young..", "label": "yes"} {"original_question": "Does splicing occur co-transcriptionally?", "id": "converted_1055", "sentence1": "Does splicing occur co-transcriptionally?", "sentence2": "Researchers working in multiple model Organism - notably Saccharomyces cerevisiae, insect allergenic extract and mammalian Cells - have shown that RNA, Messenger Precursor can be spliced during the process of transcription (i.e. co-transcriptionally), as well as after transcription termination (i.e. post-transcriptionally), The consensus view, based on four Organism, is that the majority of splicing events take place co-transcriptionally in most Cells and Body tissue., Deep sequencing of subcellular RNA fractions shows splicing to be predominantly co-transcriptional, We show that in the human genome, splicing occurs predominantly during transcription., Consistent with co-transcriptional spliceosome assembly and splicing, we have found significant enrichment of spliceosomal snRNAs in Chromatin-Associated RNA compared with other cellular RNA fractions and other nonspliceosomal snRNAs. , The majority of Introns in higher Eukaryota are excised prior to RNA Transcript release in a manner that is dependent on transcription through pol II, s a result of co-transcriptional splicing, variations in pol II elongation influence alternative splicing patterns, wherein a slower elongation rate is associated with increased inclusion of alternative Exons within mature RNA, Messenger. , We show that the pattern of intronic sequence read coverage is explained by nascent transcription in combination with co-transcriptional splicing, Modelling reveals co-transcriptional splicing to be the most probable and most efficient splicing pathway for the reporter transcripts, due in part to a positive feedback mechanism for co-transcriptional second step splicing, RNA processing events that take place on the transcribed RNA, Messenger Precursor include capping, splicing, editing, 3' processing, and polyadenylation. Most of these processes occur co-transcriptionally while the RNA Polymerase II (Pol II) Enzyme [APC] is engaged in transcriptional elongation, Abundant evidence indicates that splicing to excise Introns occurs co-transcriptionally, prior to release of the nascent RNA Transcript from RNAP II, Together, our work establishes a system for co-transcriptional splicing in vitro, in which the spliceosome containing the 5' and 3' Exons are tethered to RNAP II for splicing., Co-transcriptional splicing of constitutive and alternative Exons, Current evidence supports co-transcriptional spliceosomal assembly, but there is little quantitative information on how much splicing is completed during RNA synthesis, Thus, we demonstrate that the decision to include or skip an alternative exon is made during transcription and not post-transcriptionally, Here, we demonstrated that the co-transcriptional splicing of the intron in vitro was blocked by Antisense Oligonucleotides (AONs) targeting the P3-P7 core of the intron, RNA Editing and alternative splicing: the importance of co-transcriptional coordination, Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing, The realization that splicing occurs co-transcriptionally requires two important considerations[SEP]Relations: rRNA transcription has relations: bioprocess_bioprocess with plastid rRNA transcription, bioprocess_bioprocess with plastid rRNA transcription, bioprocess_protein with SPIN1, bioprocess_protein with SPIN1, bioprocess_protein with SIRT7, bioprocess_protein with SIRT7, bioprocess_protein with ANG, bioprocess_protein with ANG, bioprocess_protein with TP53, bioprocess_protein with TP53. Definitions: RNA, Messenger Precursor defined as following: A primary RNA RNA Transcript synthesized from a DNA template in eukaryotic nuclei which is post-transcriptionally modified and spliced to produce a mature RNA, Messenger.. RNA Polymerase II defined as following: A DNA-dependent RNA polymerase present in bacterial, plant, and animal Cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6.. Saccharomyces cerevisiae defined as following: A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" Saccharomyces cerevisiae. The dried form is used as a dietary supplement.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. Eukaryota defined as following: Organism or Cells with a nucleus separated from the cytoplasm by a two membrance nuclear envelope and compartmentalization of function into distinct cytoplasmic organelles.. Introns defined as following: Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the Exons but are removed from the primary gene RNA Transcript by RNA SPLICING to leave mature RNA. Some Introns code for separate genes.. Antisense Oligonucleotides defined as following: Short fragments of DNA or RNA that are used to alter the function of target RNAs or DNAs to which they hybridize.. RNA Editing defined as following: A process that changes the nucleotide sequence of RNA, Messenger from that of the DNA template encoding it. Some major classes of RNA Editing are as follows: 1, the conversion of cytosine to uracil in RNA, Messenger; 2, the addition of variable number of guanines at pre-determined sites; and 3, the addition and deletion of uracils, templated by guide-RNAs (RNA, GUIDE, KINETOPLASTIDA).. Cells defined as following: The fundamental, structural, and functional units or subunits of living Organism. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. RNA, Messenger defined as following: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the cytoplasm.. Exons defined as following: The parts of a RNA Transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA.. Organism defined as following: A living entity.. RNA Transcript defined as following: The initial RNA molecule produced by transcription..", "label": "yes"} {"original_question": "Is apixaban effective for treatment of acute venous thromboembolism?", "id": "converted_277", "sentence1": "Is apixaban effective for treatment of acute venous thromboembolism?", "sentence2": "apixaban is a direct inhibitor of Factor Xa, and is a potential alternative for the treatment of acute venous thromboembolism. , These results suggest a lack of clear superiority of apixaban relative to enoxaparin. apixaban is an Oral Route of Drug administration alternative with similar efficacy and safety to existing anticoagulant therapies., A fixed-dose regimen of apixaban alone was noninferior to conventional therapy for the treatment of acute venous thromboembolism and was associated with significantly less Hemorrhage, To critically review the effectiveness of the novel Oral Route of Drug administration anticoagulants (rivaroxaban, dabigatran, ximelagatran, and apixaban) in the treatment of acute venous thromboembolism., ompared with Vitamin K containing hemostatics antagonists, the novel Oral Route of Drug administration anticoagulants had a similar risk of recurrence of acute venous thromboembolism and all cause mortality, though rivaroxaban was associated with a reduced risk of Hemorrhage, Nowadays, the new anticoagulants, such as dabigatran, rivaroxaban and apixaban, show potential advantages over classical treatments. These agents inhibit specific Blood Coagulation Factor and are administered orally at fixed doses., In a recently completed phase III trial, apixaban also demonstrated promising efficacy and safety in that indication, the most advanced Oral Route of Drug administration direct inhibitors to Factor Xa (rivaroxaban and apixaban) and IIa (dabigatran)[SEP]Relations: apixaban has relations: drug_drug with Antithrombin Alfa, drug_drug with Antithrombin Alfa, drug_drug with Prothrombin, drug_drug with Prothrombin, drug_drug with Antithrombin III human, drug_drug with Antithrombin III human, drug_drug with Thiopental, drug_drug with Thiopental, drug_drug with Antipyrine, drug_drug with Antipyrine. Definitions: rivaroxaban defined as following: An orally bioavailable oxazolidinone derivative and direct inhibitor of the coagulation Factor Xa with anticoagulant activity. Upon Oral Route of Drug administration administration, rivaroxaban selectively binds to both free Factor Xa and Factor Xa bound in the prothrombinase complex. This interferes with the conversion of prothrombin (factor II) to thrombin and eventually prevents the formation of cross-linked fibrin clots. Rivaroxaban does not affect existing thrombin levels.. apixaban defined as following: An orally active inhibitor of coagulation Factor Xa with anticoagulant activity. apixaban directly inhibits Factor Xa, thereby interfering with the conversion of prothrombin to thrombin and preventing formation of cross-linked fibrin clots.. Oral Route of Drug administration defined as following: The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits Oral Route of Drug administration administration of certain classes of drugs especially peptides and proteins.. Blood Coagulation Factor defined as following: Endogenous substances, usually proteins, that are involved in the blood coagulation process.. Factor Xa defined as following: Activated form of factor X that participates in both the intrinsic and extrinsic pathways of blood coagulation. It catalyzes the conversion of prothrombin to thrombin in conjunction with other cofactors.. dabigatran defined as following: A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation.. Hemorrhage defined as following: Bleeding or escape of blood from a vessel.. enoxaparin defined as following: Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed). apixaban defined as following: An orally active inhibitor of coagulation Factor Xa with anticoagulant activity. apixaban directly inhibits Factor Xa, thereby interfering with the conversion of prothrombin to thrombin and preventing formation of cross-linked fibrin clots..", "label": "yes"} {"original_question": "Is Mycobacterium abscessus a human pathogen?", "id": "converted_4355", "sentence1": "Is Mycobacterium abscessus a human pathogen?", "sentence2": "Mycobacterium abscessus is unique in terms of its high morbidity and treatment failure rates, Mycobacterium abscessus has emerged as a successful pathogen owing to its intrinsic drug resistance. , Mycobacterium abscessus lung disease is difficult to treat due to intrinsic drug resistance and the persistence of drug-tolerant bacteria., Mycobacterium abscessus has been recognised as a dreadful respiratory pathogen among the non-tuberculous mycobacteria (Nontuberculous Mycobacteria) because of misdiagnosis, prolonged therapy with poor treatment outcomes and a high cost. [SEP]Relations: Mycobacterium abscessus abscessus infection has relations: phenotype_phenotype with Opportunistic bacterial infection, phenotype_phenotype with Opportunistic bacterial infection, disease_phenotype_positive with pulmonary non-tuberculous mycobacterial infection, disease_phenotype_positive with pulmonary non-tuberculous mycobacterial infection. Nontuberculous mycobacterial pulmonary infection has relations: phenotype_phenotype with Opportunistic bacterial infection, phenotype_phenotype with Opportunistic bacterial infection. Definitions: Mycobacterium abscessus defined as following: A species of aerobic, Gram positive, rod shaped bacteria assigned to the phylum Actinobacteria. This species is acid-fast, nonmotile, does not reduce nitrate, is amidase, urease and nicotinamidase positive and benzamidase, isonicotinamidase, succinamidase and acetamidase negative. M. abscessus is a rapidly growing mycobacterium found in water, soil and dust, and can cause a variety of serious infections of the skin, soft tissues and lungs, especially in persons with chronic lung diseases.. Nontuberculous Mycobacteria defined as following: So-called atypical species of the genus MYCOBACTERIUM that do not cause tuberculosis. They are also called tuberculoid bacilli, i.e.: M. abscessus, M. buruli, M. chelonae, M. duvalii, M. flavescens, M. fortuitum, M. gilvum, M. gordonae, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX;), M. kansasii, M. marinum, M. obuense, M. scrofulaceum, M. szulgai, M. terrae, M. ulcerans, M. xenopi..", "label": "yes"} {"original_question": "Is low T3 syndrome a prognostic marker in patients with renal insufficiency?", "id": "converted_248", "sentence1": "Is low SLC25A5 gene syndrome a prognostic marker in patients with renal insufficiency?", "sentence2": "Low SLC25A5 gene was particularly common (44.3 %), and clearly associated with increased 6- and 12-month mortality and decreased overall survival (log rank test, P=0.007). , Increased rT3 may be more common in Kidney Failure, Chronic patients than previously described, and together with decreased SLC25A5 gene it may serve as an indicator of poor prognosis in subsequent months., The presence of Thyroid Function Tests alterations seems to not be associated with clinical and prognostic implications in Blighia sapida patients., Multivariate analysis, according to receiver operating characteristic (ROC) curves, showed that mortality was best predicted by total triiodothyronine (SLC25A5 gene)., Finally, low SLC25A5 gene but not low free triiodothyronine was associated with worse all-cause (Likelihood ratio = 45.4; P < 0.0001) and Cardiovascular system mortality (Likelihood ratio = 47.8; P < 0.0001) after adjustment for confounding factors., In Cox analyses, fT3 was a significant predictor of mortality independent of the main traditional as well as non-traditional risk factors., All-cause and CV mortality rates were significantly higher in patients with 'lower' SLC25A5 gene levels than in the 'higher' SLC25A5 gene group (113.4 vs 18.2 events per 1000 patient-years, P<0.001, and 49.8 vs 9.1 events per 1000 patient-years, P=0.001, respectively). The Kaplan-Meier analysis also showed significantly worse cumulative survival rates in the 'lower' SLC25A5 gene group (P<0.001). In the Cox regression analysis, low SLC25A5 gene was an independent predictor of all-cause mortality even after adjusting for traditional risk factors (hazard ratio=3.76, P=0.021). , In Chronic Kidney Diseases patients with Proteinuria, low SLC25A5 gene concentration predicted all-cause mortality and Cardiovascular system event independently of the severity of Proteinuria., Low-SLC25A5 gene syndrome is a frequent finding among Hodgkin Disease patients, but it does not predict outcome. However, serum fT3 level is a strong and inverse mortality predictor, in part explained by its underlying association with nutritional state and Inflammation., These data suggest that low cubic foot levels are not predictive for mortality in a subgroup of stable Hodgkin Disease patients who could survive more than 12 months., Low fT3 is an independent predictor of Cessation of life in hemodialysis patients. These data lend support to the hypothesis that Thyroid dysfunction is implicated in the high risk of the Kidney Failure, Chronic population.[SEP]Relations: Chronic kidney disease has relations: phenotype_phenotype with Renal insufficiency, phenotype_phenotype with Renal insufficiency. kidney failure has relations: disease_protein with INF2, disease_protein with INF2, disease_protein with TLR4, disease_protein with TLR4, disease_protein with NOS3, disease_protein with NOS3, disease_protein with TGFB1, disease_protein with TGFB1. Definitions: Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of Cardiovascular system and cerebral functions.. cubic foot defined as following: A traditional unit of volume equal to 1728 cubic inches, or 1/27 cubic yard, or 0.028 316 85 cubic meter (28.316 85 liters). The cubic foot holds about 7.4805 US gallons.. Hodgkin Disease defined as following: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. SLC25A5 gene defined as following: This gene plays a regulatory role in the production and utilization of ATP.. Proteinuria defined as following: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.. Kidney Failure, Chronic defined as following: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.. Cardiovascular system defined as following: The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body.. Chronic Kidney Diseases defined as following: Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.. Thyroid Function Tests defined as following: Blood tests used to evaluate the functioning of the thyroid gland.. renal insufficiency defined as following: A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism..", "label": "yes"} {"original_question": "Could plasmepsins be used as targets for developing anti-malaria drugs?", "id": "converted_1910", "sentence1": "Could plasmepsins be used as targets for developing anti-Malaria Vaccines drugs?", "sentence2": "Fighting Malaria Vaccines: structure-guided discovery of nonpeptidomimetic plasmepsin inhibitors., Given that the parasite needs the resulting Amino Acids building blocks for its growth and development, plasmepsins are an important antimalarial Pharmacologic Substance target. , Due to early crystallographic evidence, plasmepsin II (Plm II) emerged as well explored target to develop novel Antimalarials as well as a starting point to develop inhibitors targeting some other subtypes of plasmepsins i.e. Plm I, II, IV and V. With the advancements in Pharmacologic Substance discovery, several computational and synthetic approaches were employed in order to develop novel inhibitors targeting Plm II. , Structural basis for plasmepsin V inhibition that blocks export of Malaria Vaccines Proteins to human Specimen Source Codes - Erythrocytes., Plasmepsin V, an essential aspartyl Endopeptidases of Malaria Vaccines Parasites, has a key role in the export of effector Proteins to parasite-infected Specimen Source Codes - Erythrocytes. Consequently, it is an important Pharmacologic Substance target for the two most virulent Malaria Vaccines Parasites of Homo sapiens, Plasmodium falciparum or Plasmodium falciparum + Plasmodium sp or Plasmodium falciparum or Plasmodium falciparum + Plasmodium sp + Plasmodium sp and Plasmodium vivax or Plasmodium vivax + Plasmodium sp or Plasmodium vivax or Plasmodium vivax + Plasmodium sp + Plasmodium sp., Plasmepsin V (PmV) is an essential Plasmodium Endopeptidases and a highly promising antimalarial target, which still lacks molecular characterization and Pharmacologic Substance-like inhibitors., Our inhibitors act 'on-target', confirmed by cellular interference of PmV function and biochemical interaction with inhibitors. , Our work disclosed novel pursuable Pharmacologic Substance design strategies for highly efficient PmV inhibition highlighting novel molecular elements necessary for picomolar activity against PmV. All the presented data are discussed in respect to human aspartic proteases and previously reported inhibitors, highlighting differences and proposing new strategies for Pharmacologic Substance development., High binding likeness on antimalarial target plasmepsin was detected through molecular docking. , This provides the first direct evidence that PMV activity is essential for protein export in Plasmodium spp. and for parasite survival in human Specimen Source Codes - Erythrocytes and validates PMV as an antimalarial Pharmacologic Substance target., The export mechanism involves the Plasmodium export element (PEXEL), which is a cleavage site for the parasite Endopeptidases, Plasmepsin V (PMV). , Plasmepsin II (PM II) is an attractive target for anti-Malaria Vaccines Pharmacologic Substance discovery, which involves in host Hemoglobin A1 (substance) degradation in the acidic food vacuole., These methods are utilized to search for inhibitors of the Aspartic Acid Endopeptidases, plasmepsin II and carboxypeptidase C D. Plasmepsin II, a Endopeptidases found in the Malaria Vaccines parasite, hydrolyzes human Hemoglobin A1 (substance), the Nutrient (property) source for the parasite and is a new target for anti-Malaria Vaccines therapy., Given recent advances in understanding the fundamental roles of the various plasmepsins, it is likely that the most effective antimalarial plasmepsin targets will be the non-food vacuole plasmepsins., Plasmepsins (POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA) are essential proteases of the plasmodia Parasites and are therefore promising targets for developing drugs against Malaria Vaccines., Therefore, the plasmepsins of Malaria Vaccines Parasites have been recognized as attractive antimalarial Pharmacologic Substance targets., As inhibition of plasmepsins leads to the parasite's Cessation of life, these ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS can be utilized as potential Pharmacologic Substance targets., falciparum plasmepsins II and IV make structure-based Pharmacologic Substance design of antimalarial compounds that focus on inhibiting plasmepsins possible., The malarial parasite encodes two homologous aspartic proteases, plasmepsins I and II, which are essential components of its Hemoglobin A1 (substance)-degradation pathway and are novel targets for antimalarial Pharmacologic Substance development., vivax plasmepsins (PvPMs) from different geographical regions are of utmost importance for drugs and vaccine designs for anti-malarial strategies., In Plasmodium falciparum or Plasmodium falciparum + Plasmodium sp or Plasmodium falciparum or Plasmodium falciparum + Plasmodium sp + Plasmodium sp infection, plasmepsins I, II, IV and RTN3 gene have been directly implicated in Hemoglobin A1 (substance) degradation during Malaria Vaccines infection, and are now considered targets for anti-malarial Pharmacologic Substance design., These results shed light on the role of V105 and T108 residues in plasmepsin specificities, and they should be useful in structure-based design of novel, selective inhibitors that may serve as antimalarial drugs., The aspartic proteases plasmepsins, whose inhibition leads to parasite Cessation of life, are classified as targets for the design of potent drugs., A large compound library of about 1 million Chemicals was docked on 5 different targets of plasmepsins using two different docking software, namely FlexX and AutoDock., Plasmodium aspartic proteases known as plasmepsins play an important role on Hemoglobin degradation and are being studied as Pharmacologic Substance targets for chemotherapy of Malaria Vaccines., Our study revealed about 100 parasite-coded gene products that included many known Pharmacologic Substance targets such as HPRT1 gene, Pf L-lactate dehydrogenase, and Plasmepsins., The two aspartic proteases, plasmepsins I and II, from Plasmodium falciparum or Plasmodium falciparum + Plasmodium sp or Plasmodium falciparum or Plasmodium falciparum + Plasmodium sp + Plasmodium sp have recently emerged as potential targets., Plasmepsins are highly promising as Pharmacologic Substance targets, especially when combined with the inhibition of falcipains that are also involved in Hemoglobin A1 (substance) catabolism., Among such ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS, Plasmepsins (aspartic proteases) and, especially, Falcipains (Cysteine Proteases) are highly promising antimalarial Pharmacologic Substance targets., The high sequence conservations between the plasmepsins from the isolates support the notion that the ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS could be reliable targets for new antimalarial chemotherapeutics., Due to early crystallographic evidence, plasmepsin II (Plm II) emerged as well explored target to develop novel Antimalarials as well as a starting point to develop inhibitors targeting some other subtypes of plasmepsins i.e., Plasmepsin, an aspartic Endopeptidases, which is involved in the Hemoglobin A1 (substance) breakdown into smaller Peptides emerged as a crucial target to develop new chemical entities to counter Malaria Vaccines., were employed in order to develop new chemical entities targeting Plm II., With the advancements in Pharmacologic Substance discovery, several computational and synthetic approaches were employed in order to develop novel inhibitors targeting Plm II., vivax plasmepsins (PvPMs) from different geographical regions are of utmost importance for drugs and vaccine designs for anti-malarial strategies.., We developed a potent inhibitor of plasmepsin V, called WEHI-842, which directly mimics the Plasmodium export element (PEXEL)., In order to validate appropriate use of PM4 as potential anti-malarial Pharmacologic Substance target, studies on Genetic and structural variations among P., Over the past decade, much effort has been placed towards developing plasmepsin inhibitors as antimalarial agents, particularly targeting the food vacuole.[SEP]Relations: Plasmodium vivax or Plasmodium vivax + Plasmodium sp Malaria Vaccines has relations: disease_disease with Malaria Vaccines, disease_disease with Malaria Vaccines. Plasmodium falciparum or Plasmodium falciparum + Plasmodium sp Malaria Vaccines has relations: disease_disease with Malaria Vaccines, disease_disease with Malaria Vaccines, disease_protein with FAS, disease_protein with FAS. Geneticin has relations: drug_drug with Plazomicin, drug_drug with Plazomicin. Plasmodium falciparum or Plasmodium falciparum + Plasmodium sp blood infection level has relations: disease_disease with Malaria Vaccines, disease_disease with Malaria Vaccines. Definitions: Chemicals defined as following: A substance with a defined atomic or molecular structure that results from, or takes part in, reactions involving changes in its structure, composition, or properties.. Amino Acids defined as following: Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form Proteins.. Hemoglobin A1 (substance) defined as following: A tetrameric complex of 2 molecules of Hemoglobin A1 (substance) subunit alpha (encoded by either the HBA1 or HBA2 gene) and 2 molecules of Hemoglobin A1 (substance) subunit beta (encoded by the HBB gene).. Parasites defined as following: Invertebrate organisms that live on or in another organism (the host), and benefit at the expense of the other. Traditionally excluded from definition of Parasites are pathogenic BACTERIA; FUNGI; VIRUSES; and PLANTS; though they may live parasitically.. carboxypeptidase C defined as following: A carboxypeptidase that catalyzes the release of a C-terminal Amino Acids with a broad specificity. It also plays a role in the LYSOSOMES by protecting BETA-GALACTOSIDASE and NEURAMINIDASE from degradation. It was formerly classified as EC 3.4.12.1 and EC 3.4.21.13.. Endopeptidases defined as following: A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS.. Genetic defined as following: Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.. HPRT1 gene defined as following: This gene is involved in purine/pyrimidine metabolism.. Aspartic Acid Endopeptidases defined as following: A sub-subclass of endopeptidases that depend on an ASPARTIC ACID residue for their activity.. Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. aspartic Endopeptidases defined as following: A subclass of peptide hydrolases that depend on an ASPARTIC ACID residue for their activity.. Malaria Vaccines defined as following: Vaccines made from antigens arising from any of the four strains of Plasmodium which cause Malaria Vaccines in Homo sapiens, or from P. berghei which causes Malaria Vaccines in rodents.. Hemoglobin defined as following: The oxygen-carrying Proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the Hemoglobin A1 (substance) quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements.. Cysteine Proteases defined as following: A subclass of peptide hydrolases that depend on a CYSTEINE residue for their activity.. Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. food vacuole defined as following: Vacuole within a parasite used for digestion of the host cell cytoplasm. An example of this component is found in the Apicomplexa. [GOC:mb]. Peptides defined as following: Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of Peptides that can form into complex structures such as ENZYMES and RECEPTORS.. Homo sapiens defined as following: Members of the species Homo sapiens.. POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA defined as following: An exceedingly rare autosomal dominant developmental anomaly reported in 1986 in nine individuals among four generations of the same family. The syndrome has clinical characteristics of four-limb postaxial polydactyly and progressive myopia. There have been no further descriptions in the literature since 1986.. Antimalarials defined as following: Agents used in the treatment of Malaria Vaccines. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585).", "label": "yes"} {"original_question": "Is the protein pelota a ribosomal rescue factor?", "id": "converted_2668", "sentence1": "Is the protein pelota a Ribosomes rescue factor?", "sentence2": "a novel binding partner of the ribosome recycling protein Pelota, n Eukaryota, Pelota (Dom34 in Saccharomyces cerevisiae) and HBS1L gene are responsible for solving general problems of Ribosomes stall in translation. , In Eukaryota, the protein complex of Pelota (Saccharomyces cerevisiae Dom34) and HBS1L gene translational Guanosine Triphosphate Phosphohydrolases recognizes the stalled ribosome containing the defective RNA, Messenger.[SEP]Relations: ribosome has relations: cellcomp_protein with RPL13A, cellcomp_protein with RPL13A, cellcomp_protein with RPL36A, cellcomp_protein with RPL36A, cellcomp_protein with RPL3L, cellcomp_protein with RPL3L, cellcomp_protein with RPL13AP3, cellcomp_protein with RPL13AP3, cellcomp_protein with RPL27, cellcomp_protein with RPL27. Definitions: Guanosine Triphosphate Phosphohydrolases defined as following: Enzymes that hydrolyze GTP to GDP. EC 3.6.1.-.. Saccharomyces cerevisiae defined as following: A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" Saccharomyces cerevisiae. The dried form is used as a dietary supplement.. Eukaryota defined as following: Organism or cells with a nucleus separated from the cytoplasm by a two membrance nuclear envelope and compartmentalization of function into distinct cytoplasmic organelles.. Ribosomes defined as following: Multicomponent ribonucleoprotein structures found in the CYTOPLASM of all cells, and in MITOCHONDRIA, and PLASTIDS. They function in PROTEIN BIOSYNTHESIS via GENETIC TRANSLATION.. RNA, Messenger defined as following: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the cytoplasm..", "label": "yes"} {"original_question": "Is the protein MCL-1 anti-apoptotic?", "id": "converted_3414", "sentence1": "Is the protein MCL1 gene anti-apoptotic?", "sentence2": "increased expression of Apoptosis Inhibiting Proteins (BCL2L1 gene, Mcl-1 and XIAP gene gene) , repression of Apoptosis Inhibiting Proteins (Mcl-1, Bcl-xl and XIAP gene gene), anti-apoptotic BCL2 gene family members, such as BCL2 gene, BCL-XL or MCL1 gene[SEP]Relations: BCL2L1 has relations: protein_protein with MCL1, protein_protein with MCL1, protein_protein with APAF1, protein_protein with APAF1, bioprocess_protein with apoptotic mitochondrial changes, bioprocess_protein with apoptotic mitochondrial changes, bioprocess_protein with suppression by virus of host apoptotic process, bioprocess_protein with suppression by virus of host apoptotic process, protein_protein with MOAP1, protein_protein with MOAP1. Definitions: MCL1 gene defined as following: This gene is a regulator of apoptosis and plays a role in differentiation.. BCL2 gene defined as following: The B-cell leukemia/lymphoma-2 genes, responsible for blocking apoptosis in normal cells, and associated with follicular lymphoma when overexpressed. Overexpression results from the t(14;18) translocation. The human c-bcl-2 gene is located at 18q24 on the long arm of chromosome 18.. BCL2L1 gene defined as following: This gene is an apoptotic regulator that can have anti or pro apoptotic effects.. XIAP gene defined as following: This gene is involved in apoptotic regulation through caspase interaction.. protein MCL1 gene defined as following: Induced myeloid leukemia cell differentiation protein Mcl-1 (350 aa, ~37 kDa) is encoded by the human MCL1 gene. This protein is involved in the modulation of cell viability..", "label": "yes"} {"original_question": "Is there any role of the 'Greek islands' in olfactory receptor choice?", "id": "converted_4679", "sentence1": "Is there any role of the 'Greek islands' in Olfactory Receptor Cells choice?", "sentence2": "Chromatin conformation capture using in situ Hi-C on fluorescence-activated cell-sorted olfactory sensory neurons and their progenitors shows that Olfactory Receptor Cells gene clusters from 18 Chromosomes, Human, Pair 1 make specific and robust interchromosomal contacts that increase with differentiation of the Cells. These contacts are orchestrated by intergenic Olfactory Receptor Cells enhancers, the 'Greek islands', which first contribute to the formation of Olfactory Receptor Cells compartments and then form a multi-chromosomal super-enhancer that associates with the single active Olfactory Receptor Cells gene. The Greek-island-bound transcription factor LHX2 and adaptor protein LDB2 wt Allele regulate the assembly and maintenance of Olfactory Receptor Cells compartments, Greek island hubs and Olfactory Receptor Cells transcription, providing mechanistic insights into and functional support for the role of trans interactions in gene expression.[SEP]Relations: Olfactory Receptor Cells activity has relations: molfunc_protein with OR2AK2, molfunc_protein with OR2AK2, molfunc_protein with OR2A42, molfunc_protein with OR2A42, molfunc_protein with OR7E24, molfunc_protein with OR7E24, molfunc_protein with OR2K2, molfunc_protein with OR2K2, molfunc_protein with OR5AK2, molfunc_protein with OR5AK2. Definitions: LDB2 wt Allele defined as following: Human LDB2 wild-type allele is located in the vicinity of 4p16 and is approximately 397 kb in length. This allele, which encodes LIM domain-binding protein 2, plays a role in the modulation of gene transcription.. Chromosomes, Human, Pair 1 defined as following: A specific pair of human Chromosomes, Human, Pair 1 in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification.. Olfactory Receptor Cells defined as following: Neurons in the OLFACTORY EPITHELIUM with proteins (RECEPTORS, ODORANT) that bind, and thus detect, odorants. These neurons send their DENDRITES to the surface of the epithelium with the odorant receptors residing in the apical non-motile cilia. Their unmyelinated AXONS synapse in the OLFACTORY BULB of the BRAIN.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary..", "label": "yes"} {"original_question": "Is there a crystal structure of the full-length of the flaviviridae NS5(Methyltransferase - RNA depended RNA Polymerase) ?", "id": "converted_471", "sentence1": "Is there a crystal structure of the full-length of the flaviviridae Noonan Syndrome 5(Methyltransferase - RNA depended RNA Polymerase) ?", "sentence2": " flavivirus Noonan Syndrome 5 harbors a CMTR1 gene (MTase) in its N-terminal ≈ 265 residues and an RNA-Directed RNA Polymerase (RNA-directed RNA polymerase activity) within the C-terminal part. One of the major interests and challenges in Noonan Syndrome 5 is to understand the interplay between RNA-directed RNA polymerase activity and MTase as a unique natural fusion protein in Viral Genome replication and cap formation. Here, we report the first crystal structure of the full-length flavivirus Noonan Syndrome 5 from Japanese encephalitis virus. , (DENV) nonstructural protein 5 (Noonan Syndrome 5) is composed of two globular domains separated by a 10-residue linker. The N-terminal Superkingdom (taxonomic category) participates in the synthesis of a mRNA cap 1 structure ((7Me)GpppA(2'OMe)) at the 5' end of the Viral Genome and possesses guanylyltransferase, guanine-N7-CMTR1 gene, and nucleoside-2'O-CMTR1 gene activities. The C-terminal Superkingdom (taxonomic category) is an RNA-Directed RNA Polymerase responsible for RNA, Viral synthesis. Although crystal structures of the two isolated domains have been obtained, there are no structural data for full-length Noonan Syndrome 5. It is also unclear whether the two Noonan Syndrome 5 domains interact with each other to form a stable structure in which the relative orientation of the two domains is fixed. To investigate the structure and dynamics of DENV type 3 Noonan Syndrome 5 in solution, we conducted small-angle X-ray scattering experiments with the full-length protein. Noonan Syndrome 5 was found to be monomeric and well-folded under the conditions tested., West Nile virus (West Nile viral infection) Noonan Syndrome 5 protein contains a CMTR1 gene (MTase) Superkingdom (taxonomic category) involved in RNA capping and an RNA-Directed RNA Polymerase (RdRp) Superkingdom (taxonomic category) essential for virus replication. Crystal structures of individual West Nile viral infection MTase and RdRp domains have been solved; however, the structure of full-length Noonan Syndrome 5 has not been determined. To gain more insight into the structure of Noonan Syndrome 5 and interactions between the MTase and RdRp domains, we generated a panel of seven monoclonal antibodies (mAbs) to the Noonan Syndrome 5 protein of West Nile viral infection (Kunjin strain) and mapped their Binding Sites using a series of truncated Noonan Syndrome 5 proteins and synthetic peptides. Binding sites of four mAbs (5D4, 4B6, 5C11 and 6A10) were mapped to residues 354-389 in the fingers subdomain of the RdRp. This is consistent with the ability of these mAbs to inhibit RdRp activity in vitro and suggests that this Geographic Locations represents a potential target for RdRp inhibitors. Using a series of synthetic peptides, we also identified a linear epitope (bound by Monoclonal Antibody [EPC] 5H1) that mapped to a 13 aa stretch surrounding residues 47 and 49 in the MTase Superkingdom (taxonomic category), a Geographic Locations predicted to interact with the palm subdomain of the RdRp. The failure of one Monoclonal Antibody [EPC] (7G6) to bind both N- and C-terminally truncated Noonan Syndrome 5 recombinants indicates that the immunoglobulin complex location recognizes a conformational epitope that requires the presence of residues in both the MTase and RdRp domains. [SEP]Relations: RNA-directed DNA polymerase activity has relations: molfunc_protein with TERC, molfunc_protein with TERC, molfunc_protein with ERVK-7, molfunc_protein with ERVK-7, molfunc_protein with ERVK-6, molfunc_protein with ERVK-6, molfunc_protein with ERVK-8, molfunc_protein with ERVK-8, molfunc_protein with TERT, molfunc_protein with TERT. Definitions: Binding Sites defined as following: The parts of a macromolecule that directly participate in its specific combination with another molecule.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Noonan Syndrome 5 defined as following: Noonan syndrome caused by autosomal dominant mutation(s) in the RAF1 gene, encoding RAF proto-oncogene serine/threonine-protein kinase.. West Nile viral infection defined as following:

West Nile virus (West Nile viral infection) is an infectious disease that first appeared in the United States in 1999. Infected mosquitoes spread the virus that causes it. People who get West Nile viral infection usually have no symptoms or mild symptoms. The symptoms include a fever, headache, body aches, skin rash, and swollen lymph glands. They can last a few days to several weeks, and usually go away on their own.

If West Nile virus enters the brain, however, it can be life-threatening. It may cause inflammation of the brain, called encephalitis, or inflammation of the tissue that surrounds the brain and spinal cord, called meningitis. A physical exam, medical history, and laboratory tests can diagnose it.

Older people and those with weakened immune systems are most at risk. There are no specific vaccines or treatments for human West Nile viral infection disease. The best way to avoid West Nile viral infection is to prevent mosquito bites:

  • Use insect repellent
  • Get rid of mosquito breeding sites by emptying standing water from flower pots, buckets or barrels
  • Stay indoors between dusk and dawn, when mosquitoes are most active
  • Use screens on windows to keep mosquitoes out
. Superkingdom (taxonomic category) defined as following: A taxonomic category above that of Kingdom.. RNA-directed RNA polymerase activity defined as following: Catalysis of the reaction: nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1); uses an RNA template, i.e. the catalysis of RNA-template-directed extension of the 3'-end of an RNA strand by one nucleotide at a time. [EC:2.7.7.48, GOC:mah, GOC:pf]. Viral Genome defined as following: The complete genetic complement contained in a DNA or RNA molecule in a virus.. RNA-Directed RNA Polymerase defined as following: An enzyme that catalyses RNA-template-directed extension of the 3'- end of an RNA strand by one nucleotide at a time, and can initiate a chain de novo. (Enzyme Nomenclature, 1992, p293). Geographic Locations defined as following: The continents and countries situated on those continents; the UNITED STATES and each of the constituent states arranged by Geographic Locations; CANADA and each of its provinces; AUSTRALIA and each of its states; the major bodies of water and major islands on both hemispheres; and selected major cities.. RNA, Viral defined as following: Ribonucleic acid that makes up the genetic material of viruses.. immunoglobulin complex location defined as following: A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph. [GOC:add, GOC:jl, ISBN:0781765196].", "label": "yes"} {"original_question": "Is erabutoxin b usually found in plants?", "id": "converted_3899", "sentence1": "Is erabutoxin A b usually found in plants?", "sentence2": "The Variant are the curaremimetic toxin alpha from Naja nigricollis and erabutoxin A A a or b from Laticauda semifasciata, The three-dimensional structure of erabutoxin A A b, a short-chain neurotoxic peptide purified from the Venom (disposition) of the Hydrophiidae Laticauda semifasciata, , THe characteristic feature of the crystal structure of erabutoxin A A b, a short Neurotoxins from Laticauda semifasciata, and alpha-cobratoxin, a long Neurotoxins from Naja naja siamensis, is the presence of a triple-stranded antiparallel pleated beta-sheet structure formed by the central and the third peptide loops., Here we examine the actions of six snake neurotoxins (alpha-cobratoxin from Naja naja siamensis, erabutoxin A A-a and b from Laticauda semifasciata; CM12 from N. haje annulifera, toxin III 4 from Notechis scutatus and a long toxin from N. haje) on Nicotinic Receptors in the cercal afferent, giant interneuron 2 synapse of the cockroach, Periplaneta americana antigen antigen., The method was applied to a study of erabutoxin A A b molecule, a neurotoxic protein from a Hydrophiidae, to analyze the microenvironments of its single tryptophan and tyrosine residues., The area of greatest similarity centered on residue position 25 of erabutoxin A A b, a locale that is conserved throughout the snake alpha-neurotoxins and their homologues., A systematic computer search of the three-dimensional structure of erabutoxin A A b (an Alpha-Neurotoxins from the false Hydrophiidae Laticauda semifasciata) was performed to identify the locality that most closely matched the Amino Acid [EPC] compositions of the smaller alpha-Conotoxins (from the marine snails Conus magus and Conus geographus)., Erabutoxin b is one of a family of snake Venom (disposition) neurotoxins, all low-molecular-weight proteins, which block neuromuscular transmission at the Postsynaptic membrane., Erabutoxins a and b are neurotoxins isolated from Venom (disposition) of a Hydrophiidae Laticauda semifasciata (erabu-umihebi)., The three-dimensional structure of erabutoxin A A b, a Neurotoxins in the Venom (disposition) of the Hydrophiidae Laticauda semifasciata, has been determined from a 2.75 A resolution electron density map., erabutoxin A C, a minor neurotoxic component of the Venom (disposition) of a Hydrophiidae Laticauda semifasciata, was isolated in pure form by repeated column chromatography on CM-cellulose columns., The study has established complete structural identity of the two sea-snake Venom (disposition) toxins, erabutoxin A A b and Neurotoxins b, isolated from Laticauda semifasciata snakes taken in different Pacific Ocean waters., Studies on sea-snake venoms. Crystallization of Erabutoxins a and b from Laticauda semifasciata Venom (disposition).[SEP]Relations: Postsynaptic membrane has relations: cellcomp_protein with GABRG2, cellcomp_protein with GABRG2, cellcomp_protein with GABRB3, cellcomp_protein with GABRB3, cellcomp_protein with TMUB1, cellcomp_protein with TMUB1, cellcomp_protein with GABRB1, cellcomp_protein with GABRB1, cellcomp_protein with SRGAP2, cellcomp_protein with SRGAP2. Definitions: Postsynaptic membrane defined as following: A specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft). Neurotransmitters cross the synaptic cleft and transmit the signal to the Postsynaptic membrane. [ISBN:0198506732]. Neurotoxins defined as following: Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept.. Erabutoxins defined as following: Toxins isolated from the Venom (disposition) of Laticauda semifasciata, a Hydrophiidae (Hydrophid); immunogenic, basic polypeptides of 62 amino acids, folded by four disulfide bonds, block neuromuscular end-plates irreversibly, thus causing paralysis and severe muscle damage; they are similar to Elapid neurotoxins.. Hydrophiidae defined as following: A subfamily of marine elapid snakes comprising about 50 species with flattened oar-like tails used as sculls. They are found mostly in the coastal waters of south Asia and Australia. The largest reach a length of almost 9 feet but most species are only about a third as long. They are all venomous. (Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, pp331-3; Moore: Poisonous Snakes of the World, 1980, p159). Nicotinic Receptors defined as following: One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors.. Venom (disposition) defined as following: A toxin used by animals and injected into their victims by a bite or sting. Variant defined as following: An alteration or difference from a norm or standard.. plants defined as following: Multicellular, eukaryotic life forms of kingdom Plantae. Plants acquired chloroplasts by direct endosymbiosis of CYANOBACTERIA. They are characterized by a mainly photosynthetic mode of nutrition; essentially unlimited growth at localized regions of cell divisions (MERISTEMS); cellulose within cells providing rigidity; the absence of organs of locomotion; absence of nervous and sensory systems; and an alternation of haploid and diploid generations. It is a non-taxonomical term most often referring to LAND PLANTS. In broad sense it includes RHODOPHYTA and GLAUCOPHYTA along with VIRIDIPLANTAE..", "label": "no"} {"original_question": "Has proteomics been used in the study of the dry eye syndrome?", "id": "converted_1589", "sentence1": "Has proteomics been used in the study of the dry eye syndrome?", "sentence2": "Tear proteomic analysis of patients with type 2 diabetes and dry eye syndrome by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry., Dry Eye Syndromes in diabetic patients is associated with aberrant expression of tear proteins, and the findings could lead to identification of novel pathways for therapeutic targeting and new diagnostic markers., 2D electrophoresis (2DE) and Differential gel electrophoresis (DIGE) was done to identify differentially expressed proteins. , Two dimensional electrophoretic analysis of Homo sapiens tears: collection method in dry eye syndrome., Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics., This study demonstrated that iTRAQ technology combined with 2D-nanoLC-nanoESI-MS/MS quantitative proteomics is a powerful tool for biomarker discovery.[SEP]Relations: dry eye syndrome has relations: disease_protein with STAT4, disease_protein with STAT4, disease_disease with syndromic disease, disease_disease with syndromic disease, disease_protein with TNIP1, disease_protein with TNIP1, disease_protein with PHIP, disease_protein with PHIP, disease_protein with TNFAIP3, disease_protein with TNFAIP3. Definitions: Dry Eye Syndromes defined as following: Corneal and conjunctival dryness due to deficient tear production, predominantly in menopausal and post-menopausal women. Filamentary keratitis or erosion of the conjunctival and corneal epithelium may be caused by these disorders. Sensation of the presence of a foreign body in the eye and burning of the eyes may occur.. Homo sapiens defined as following: Members of the species Homo sapiens.. dry eye syndrome defined as following: Corneal and conjunctival dryness due to deficient tear production, predominantly in menopausal and post-menopausal women. Filamentary keratitis or erosion of the conjunctival and corneal epithelium may be caused by these disorders. Sensation of the presence of a foreign body in the eye and burning of the eyes may occur..", "label": "yes"} {"original_question": "Is there any cross-talk between the Wnt and the Akt pathways?", "id": "converted_1236", "sentence1": "Is there any cross-talk between the Wnt and the Proto-Oncogene Proteins c-akt pathways?", "sentence2": "Our data demonstrate that engaging Wnt signaling at the receptor level by this method leads to necessary crosstalk between multiple signaling pathways including activation of Proto-Oncogene Proteins c-akt, FRAP1 protein, human, Wnt/β-catenin, PKA/CREB, and inhibition of RhoA/ROCK that substantially increase human β-cell proliferation while maintaining the β-cell phenotype., The cross-talk role of Wnt/β-catenin and 1-Phosphatidylinositol 3-Kinase/Proto-Oncogene Proteins c-akt signaling pathway, with GSK-3β as the key Enzyme [APC] bridging these pathways, may contribute to the inhibition of cholangiocarcinoma cells by hUC-MSCs., We find that Wnt stimulation leads to phosphorylation of Therapeutic Insulin signaling key mediators, including Proto-Oncogene Proteins c-akt, GSK3β, and ERK1/2, although with a lower fold stimulation and slower time course than observed for Therapeutic Insulin., Wnt induces phosphorylation of Proto-Oncogene Proteins c-akt, ERK1/2, and GSK3β, and this is dependent on Therapeutic Insulin/IGF-1 receptors., Pharmacologic inhibition of 1-Phosphatidylinositol 3-Kinase resulted in the downregulation of several members of the β-catenin pathway, including FOSL1 protein, human, c-myc Genes, and Cyclin D1., Similar results were observed in vivo, as intratumoral injection of LY 294002 downregulated the expression of the components of the β-catenin pathway and delayed tumor growth in nude mice harboring subcutaneous LN229 xenografts., These results suggest that the 1-Phosphatidylinositol 3-Kinase/AKT signaling pathway regulates glioma cell proliferation, in part via repression of the Wnt/β-catenin pathway., Small-molecule inhibitors of phosphatidylinositol 3-kinase/Proto-Oncogene Proteins c-akt signaling inhibit Wnt/CTNNB1 gene pathway cross-talk and suppress Medulloblastoma growth, Small-molecule inhibitors targeting the 1-Phosphatidylinositol 3-Kinase/Proto-Oncogene Proteins c-akt signaling pathway affected CTNNB1 gene signaling by activation [corrected] of Glycogen Synthase Kinases 3 beta, [corrected] resulting in Cytoplasmic retention of CTNNB1 gene and reduced expression of its target Genes Cyclin D1 and c-myc Genes., These findings demonstrate the importance of cross-talk between the 1-Phosphatidylinositol 3-Kinase/Proto-Oncogene Proteins c-akt and CTNNB1 gene pathways in Medulloblastoma and rationalize the 1-Phosphatidylinositol 3-Kinase/Proto-Oncogene Proteins c-akt signaling pathway as a therapeutic target in treatment of this Disease., Western blot analyses revealed that the recombinant Wnt ligand Wnt-3A increased phosphorylation of AKT and the downstream kinase Glycogen Synthase Kinases (GSK)-3beta as well as accumulation of activated, nuclear CTNNB1 gene., Chemical inhibition of 1-Phosphatidylinositol 3-Kinase abolished Wnt-dependent phosphorylation of AKT and Glycogen Synthase Kinases 3 beta and trophoblast motility but did not affect appearance of activated CTNNB1 gene or Wnt/TCF reporter activity., The data suggest that Wnt-3A may activate canonical Wnt signaling and 1-Phosphatidylinositol 3-Kinase/AKT through distinct receptors., Mutational activation of the phosphatidylinositol 3-kinase (1-Phosphatidylinositol 3-Kinase) pathway occurs in a wide variety of Neoplasms, whereas activating Wnt pathway Mutant are predominantly found in Malignant tumor of colon. Because Glycogen Synthase Kinase 3 is a key component of both pathways, it is widely assumed that active 1-Phosphatidylinositol 3-Kinase signaling feeds positively into the Wnt pathway by RAC-Alpha Serine/Threonine Kinase (PTK2B wt Allele)-mediatefd inhibition of Glycogen Synthase Kinase 3., n addition, PTK2B wt Allele has been proposed to modulate the canonical Wnt signaling through direct stabilization and nuclear localization of CTNNB1 gene., Here, we show that compartmentalization by AXIN1 wt Allele of Glycogen Synthase Kinase 3 prohibits cross-talk between the 1-Phosphatidylinositol 3-Kinase and Wnt pathways and that Wnt-mediated transcriptional activity is not modulated by activation of the 1-Phosphatidylinositol 3-Kinase/PTK2B wt Allele pathway., Our recent study revealed a second mechanism for Cby-mediated CTNNB1 gene inhibition in which Cby cooperates with 14-3-3 adaptor proteins to facilitate nuclear export of CTNNB1 gene, following phosphorylation of Cby by Proto-Oncogene Proteins c-akt kinase., Therefore, our findings unravel a novel molecular mechanism regulating the dynamic nucleo-Cytoplasmic trafficking of CTNNB1 gene and provide new insights into the cross-talk between the Wnt and Proto-Oncogene Proteins c-akt signaling pathways., Here, we review recent literature concerning Cby function and discuss our current understanding of the relationship between Wnt and Proto-Oncogene Proteins c-akt signaling., As inappropriate activation of WNT/CTNNB1 signaling causes late-onset GCT development and cross talk between the 1-Phosphatidylinositol 3-Kinase/AKT and WNT/CTNNB1 pathways has been reported, we tested whether these pathways could synergize in GCT., This explains why Prostatic Neoplasms subjected to androgen ablation experience an increase in Proto-Oncogene Proteins c-akt phosphorylation, and suggest that the tumor compensates for the loss of one pathway with another. Different modes of interaction between the two pathways, including direct interaction, or regulation via downstream intermediates, such as the wnt/Glycogen Synthase Kinases 3 beta/CTNNB1 gene pathway, NF-kappa B, and the FOXO Family Family family of TRANSCRIPTION FACTOR, will be discussed., FGF signals are transduced through Fibroblast Growth Factor Receptors to the FRS2-GRB2-GAB1-1-Phosphatidylinositol 3-Kinase-AKT signaling cascade to downregulate GSK3beta activity depending on Ser 9 phosphorylation. Because GSK3beta-dependent phosphorylation of CTNNB1 gene and Helix (Snails) leads to BTRC wt Allele (betaTRCP)-mediated ubiquitination and degradation, GSK3beta downregulation results in the stabilization and the nuclear accumulation of CTNNB1 gene and Helix (Snails)., Bridging the carmustine/methotrexate/procarbazine protocol and Wnt pathways by PI3 kinase/Proto-Oncogene Proteins c-akt and 14-3-3zeta, Concurrently, PTEN protein, human protein, human, an PPP1R1A gene of 1-Phosphatidylinositol 3-Kinase/Proto-Oncogene Proteins c-akt pathway, is also primarily inactivated in the cysteine desulfurase activity, leading to activation of Proto-Oncogene Proteins c-akt. Thus, Proto-Oncogene Proteins c-akt may contribute to activation of CTNNB1 gene in cysteine desulfurase activity in coordination with Wnt signaling., Thus, we propose that carmustine/methotrexate/procarbazine protocol signaling plays a role in inhibition of ISC self-renewal through suppression of Wnt/CTNNB1 gene signaling in ISC, and this cross-talk is bridged, at least in part, through the PTEN protein, human protein, human/Proto-Oncogene Proteins c-akt pathway and further enforced by 14-3-3zeta., In MC3T3-E1 osteoblast-like cultures, dexamethasone (AUTOINFLAMMATORY SYNDROME, FAMILIAL, X-LINKED, BEHCET-LIKE 2) activates Glycogen Synthase Kinases-3beta (GSK3beta) and inhibits a differentiation-related cell cycle that occurs at a commitment stage immediately after confluence., Here we show that AUTOINFLAMMATORY SYNDROME, FAMILIAL, X-LINKED, BEHCET-LIKE 2 inhibition of the differentiation-related cell cycle is associated with a decrease in CTNNB1 gene levels and inhibition of LEF/TCF-mediated transcription., These inhibitory activities are no longer observed in the presence of Lithium antipsychotics, a GSK3beta PPP1R1A gene., AUTOINFLAMMATORY SYNDROME, FAMILIAL, X-LINKED, BEHCET-LIKE 2 decreased the serum-responsive phosphorylation of RAC-Alpha Serine/Threonine Kinase/Proto-Oncogene Proteins c-akt-Ser(473) within minutes, and this inhibition was also observed after 12 h. When the phosphatidylinositol 3-kinase (1-Phosphatidylinositol 3-Kinase)/Proto-Oncogene Proteins c-akt pathway was inhibited by Wortmannin, AUTOINFLAMMATORY SYNDROME, FAMILIAL, X-LINKED, BEHCET-LIKE 2 no longer inhibited CTNNB1 gene levels., Furthermore, AUTOINFLAMMATORY SYNDROME, FAMILIAL, X-LINKED, BEHCET-LIKE 2-mediated inhibition of LEF/TCF transcriptional activity was attenuated in the presence of dominant negative forms of either 1-Phosphatidylinositol 3-Kinase or RAC-Alpha Serine/Threonine Kinase/Proto-Oncogene Proteins c-akt. These results suggest cross-talk between the 1-Phosphatidylinositol 3-Kinase/Proto-Oncogene Proteins c-akt and Wnt signaling pathways., These results suggest that inhibition of a 1-Phosphatidylinositol 3-Kinase/Proto-Oncogene Proteins c-akt/GSK3beta/CTNNB1 gene/LEF axis and stimulation of HDAC1 cooperate to mediate the inhibitory effect of AUTOINFLAMMATORY SYNDROME, FAMILIAL, X-LINKED, BEHCET-LIKE 2 on Wnt signaling and the osteoblast differentiation-related cell cycle., WISP1 protein, human (Wnt-1-induced secreted protein) was identified as an Oncogenes regulated by the Wnt-1-CTNNB1 gene pathway., Here it is shown that WISP1 protein, human can activate the antiapoptotic Proto-Oncogene Proteins c-akt/PTK2B wt Allele signaling pathway. , Our results show that both TGFβ1 and WNT3A gene lead to increased accumulation of β-catenin, phosphorylation of AKT and p44/42 MAPK.[SEP]Relations: CTNNB1 has relations: pathway_protein with TCF dependent signaling in response to WNT, pathway_protein with TCF dependent signaling in response to WNT, bioprocess_protein with Wnt signaling pathway, bioprocess_protein with Wnt signaling pathway, pathway_protein with RUNX3 regulates WNT signaling, pathway_protein with RUNX3 regulates WNT signaling, bioprocess_protein with canonical Wnt signaling pathway, bioprocess_protein with canonical Wnt signaling pathway, bioprocess_protein with canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition, bioprocess_protein with canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition. Definitions: PTK2B wt Allele defined as following: Human PTK2B wild-type allele is located in the vicinity of 8p21.1 and is approximately 148 kb in length. This allele, which encodes protein tyrosine kinase 2 beta protein, plays a role in both the calcium-dependent regulation of ion channels and activation of the map kinase signaling pathway.. BTRC wt Allele defined as following: Human BTRC wild-type allele is located in the vicinity of 10q24.32 and is approximately 204 kb in length. This allele, which encodes F-box/WD repeat-containing protein 1A, is involved in the modulation of protein ubiquitination and signal transduction.. WISP1 protein, human defined as following: WNT1-inducible-signaling pathway protein 1 (367 aa, ~40 kDa) is encoded by the human CCN4 gene. This protein is involved in the regulation of the Wnt/Frizzled signaling pathway.. LY 294002 defined as following: A morpholine-based PPP1R1A gene of phosphatidylinositol 3-kinase (1-Phosphatidylinositol 3-Kinase) and the bromodomain and extra-terminal (BET) family of proteins, with potential antineoplastic activity. Upon administration, the 1-Phosphatidylinositol 3-Kinase/BET PPP1R1A gene LY 294002 specifically targets and binds to both 1-Phosphatidylinositol 3-Kinase and the acetylated lysine recognition motifs in the bromodomains of BET proteins. Inhibition of 1-Phosphatidylinositol 3-Kinase activity inhibits the 1-Phosphatidylinositol 3-Kinase/AKT kinase signaling pathway. This may result in inhibition of growth and survival for tumor cells in which the 1-Phosphatidylinositol 3-Kinase-mediated signaling pathway is overactivated. Inhibition of BET proteins prevents their interaction with acetylated histones, disrupts chromatin remodeling and inhibits the expression of oncogenic drivers that are important for cell proliferation and survival, which together may lead to an inhibition of proliferation in BET-overexpressing tumor cells. Activation of the 1-Phosphatidylinositol 3-Kinase signaling pathway is frequently associated with tumorigenesis. BET proteins, comprised of BRD2, BRD3, BRD4 and BRDT, are transcriptional regulators and play an important role during development and cellular growth. In tumor cells, BET proteins play a key role in the regulation of Oncogenes transcription and tumor cell proliferation.. Wortmannin defined as following: An androstadiene metabolite produced by the fungi PENICILLIUM funiculosum that inhibits PHOSPHATIDYLINOSITOL-3-KINASES and alloantigen-specific activation of T-LYMPHOCYTES in human tumor cell lines. It is widely used in CELL BIOLOGY research and has broad therapeutic potential.. cysteine desulfurase activity defined as following: Catalysis of the reaction: L-cysteine + [Enzyme [APC]]-cysteine = L-alanine + [Enzyme [APC]]-S-sulfanylcysteine. [EC:2.8.1.7]. Medulloblastoma defined as following: A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1). Malignant tumor of colon defined as following: A primary or metastatic malignant neoplasm that affects the colon. Representative examples include carcinoma, lymphoma, and sarcoma.. Glycogen Synthase Kinases defined as following: A class of protein-serine-threonine kinases that was originally found as one of the three types of kinases that phosphorylate GLYCOGEN SYNTHASE. Glycogen synthase kinases along with CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASES and CYCLIC AMP-DEPENDENT PROTEIN KINASES regulate glycogen synthase activity.. Fibroblast Growth Factor Receptors defined as following: Specific molecular sites or structures on cell membranes that react with FIBROBLAST GROWTH FACTORS (both the basic and acidic forms), their analogs, or their antagonists to elicit or to inhibit the specific response of the cell to these factors. These receptors frequently possess tyrosine kinase activity.. Proto-Oncogene Proteins c-akt defined as following: Expressed in diverse tissues, Protein Kinase B (AKT/RAC Family) is a group (Alpha, Beta and Gamma) of Cytoplasmic serine/threonine enzymes that covalently transfer the terminal, gamma phosphate group from ATP to a variety of substrate proteins and regulate cell signaling responses to Therapeutic Insulin, PDGF, and IGF1 (through 1-Phosphatidylinositol 3-Kinase) involved in cell survival, cell proliferation, differentiation, apoptosis, glycogen synthesis, and glucose uptake.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Prostatic Neoplasms defined as following: Tumors or cancer of the PROSTATE.. PTEN protein, human defined as following: Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN protein, human (403 aa, ~47 kDa) is encoded by the human PTEN protein, human gene. This protein plays a role in signaling and as both a dual-specificity phosphoprotein phosphatase and a lipid phosphatase.. Oncogenes defined as following: Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, Genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and TRANSCRIPTION FACTOR. A prefix of \"v-\" before Oncogenes symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix \"c-\" before the gene symbol of an Oncogenes indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-Oncogenes.. dexamethasone defined as following: An anti-inflammatory 9-fluoro-glucocorticoid.. AXIN1 wt Allele defined as following: Human AXIN1 wild-type allele is located in the vicinity of 16p13.3 and is approximately 65 kb in length. This allele, which encodes axin-1 protein, is involved in the attenuation of the Wnt protein signaling cascade.. glycogen synthase kinase 3 beta defined as following: A Glycogen Synthase Kinases-3 type Enzyme [APC] that functions in ENERGY METABOLISM; EMBRYONIC DEVELOPMENT; and NEUROGENESIS. It is also involved in PROTEIN BIOSYNTHESIS and regulates cell growth and proliferation as a component of the WNT SIGNALING PATHWAY and other signaling pathways. Certain polymorphisms in the GSK3B gene have been associated with PARKINSON DISEASE; ALZHEIMER DISEASE; and BIPOLAR DISORDER.. Mutant defined as following: An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).. Glycogen Synthase Kinase 3 defined as following: A family of serine/threonine protein kinases that is involved in intracellular signaling, cellular proliferation, cell migration, inflammation and immune responses, glucose regulation, and apoptosis.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Cyclin D1 defined as following: Protein encoded by the bcl-1 gene which plays a critical role in regulating the cell cycle. Overexpression of Cyclin D1 is the result of bcl-1 rearrangement, a t(11;14) translocation, and is implicated in various neoplasms.. trophoblast defined as following: Cells lining the outside of the BLASTOCYST. After binding to the ENDOMETRIUM, trophoblasts develop into two distinct layers, an inner layer of mononuclear cytotrophoblasts and an outer layer of continuous multinuclear cytoplasm, the syncytiotrophoblasts, which form the early fetal-maternal interface (PLACENTA).. Therapeutic Insulin defined as following: A synthetic or animal-derived form of Therapeutic Insulin used in the treatment of diabetes mellitus. Therapeutic Therapeutic Insulin is formulated to be short-, intermediate- and long-acting in order to individualize an Therapeutic Insulin regimen according to individual differences in glucose and Therapeutic Insulin metabolism. Therapeutic Therapeutic Insulin may be derived from porcine, bovine or recombinant sources. Endogenous human Therapeutic Insulin, a pancreatic hormone composed of two polypeptide chains, is important for the normal metabolism of carbohydrates, proteins and fats and has anabolic effects on many types of tissues.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. FOSL1 protein, human defined as following: Fos-related antigen 1 (271 aa, ~29 kDa) is encoded by the human FOSL1 gene. This protein is involved in the regulation of gene expression.. CTNNB1 gene defined as following: This gene is involved in signal transduction and regulation of transcription.. Helix (Snails) defined as following: A genus of chiefly Eurasian and African land snails including the principal edible snails as well as several pests of cultivated plants.. 1-Phosphatidylinositol 3-Kinase defined as following: A phosphatidylinositol 3-kinase that catalyzes the conversion of 1-phosphatidylinositol into 1-phosphatidylinositol 3-phosphate.. NF-kappa B defined as following: Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA.. FOXO Family defined as following: A subfamily within the forkhead box (FOX) protein family, which is a family of TRANSCRIPTION FACTOR that contain a forkhead DNA-binding domain. FOXO Family proteins regulate apoptosis, cell-cycle progression, oxidative-stress resistance, and tumor suppression. The transcriptional promoter activity of these factors is regulated by post-translational modifications, such as phosphorylation, acetylation, and monoubiquitination.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. FRAP1 protein, human defined as following: Serine/threonine-protein kinase FRAP1 protein, human (2549 aa, ~289 kDa) is encoded by the human MTOR gene. This protein is involved in protein phosphorylation, signaling and cell growth..", "label": "yes"} {"original_question": "Has silicon been used in treatment of incontinence ?", "id": "converted_1447", "sentence1": "Has silicon been used in treatment of incontinence ?", "sentence2": "an artificial anal sphincter. Worldwide, there are two established devices on the market: the artificial bowel sphincter® (CONSTRICTING BANDS, CONGENITAL) from A. M. S. (Minnetonka, MNSs Blood-Group System, USA) and the soft anal band® from A. M. I. (Feldkirch, Austria). How to implant the artificial anal sphincter? Both devices consist of a silicon cuff which can be filled with fluid., The InVance™ system uses a silicon-coated polyester sling positioned under the bulbar Urethra specimen code via a perineal incision., Through a perineal incision three titanium screws with a polipropylene suture were Clinical act of insertion in each ischiopubic rami, and a silicon/polipropylene mesh (Invance) is affixed to them, compressing the bulbar Urethra specimen code, surgical treatment of female Urinary Stress Incontinence with a trans-obturator sub-urethral tape of Uratape (Porgés). METHODS: Treatment and follow up of their complication were performed at the CHRU of Lille. RESULTS: In both cases, this complication is related to prolonged vaginal exposition of the tape. Vaginal Route of Drug Administration Route of Drug Administration erosion always occurs next to the silicon coated section of the tape, A non-elastic, polypropylene tape (UraTape, Mentor-Porgès) with a silicon coated central part was placed under the mid-Urethra specimen code., Stress incontinence is a rare complication in men, usually following prostatic surgery. It can be treated conservatively with Pelvic Diaphragm training and alpha-adrenergic receptor agonists and if necessary surgically with submucosal collagen or silicon injections in the sphincter area or implantation of a sphincter prosthesis, The Femassist is a medical-grade silicon dome-shaped device, worn over the Urethra specimen code and held securely via suction and a commercially available adhesive lotion., To examine the performance of a silicon urinary control device for nonsurgical management of women with genuine stress incontinence, The \"FemAssist\" is a dome-shaped medical grade silicon device intended to be worn over the external urethral meatus and held in place by suction and an adhesive gel. Thirty eight women with varying degrees of genuine Urinary Stress Incontinence (GSUI) or mixed incontinence on multichannel urodynamic testing were fitted with one of two sizes of \"FemAssist[SEP]Relations: Stress urinary incontinence has relations: phenotype_phenotype with Urinary incontinence, phenotype_phenotype with Urinary incontinence, disease_phenotype_positive with cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy,, disease_phenotype_positive with cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy,. Bulbar urethral stricture has relations: disease_phenotype_positive with urethral stricture (disease), disease_phenotype_positive with urethral stricture (disease). annular constricting bands has relations: disease_disease with syndromic disease, disease_disease with syndromic disease. regulation of establishment of actomyosin contractile ring localization involved in mitotic cell cycle has relations: bioprocess_bioprocess with regulation of establishment of actomyosin contractile ring localization, bioprocess_bioprocess with regulation of establishment of actomyosin contractile ring localization. Definitions: bulbar Urethra specimen code defined as following: The portion of the penile Urethra specimen code that spans the bulb of the penis.. Clinical act of insertion defined as following: The act of putting one thing into another.. Vaginal Route of Drug Administration defined as following: Administration of a drug into the vagina. The medication usually has the form of a solution, tablet, cream, gel, or suppository. The drug is slowly absorbed through the vaginal wall with predominantly local, but some systemic effects.. Urinary Stress Incontinence defined as following: Involuntary discharge of URINE as a result of physical activities that increase abdominal pressure on the URINARY BLADDER without detrusor contraction or overdistended bladder. The subtypes are classified by the degree of leakage, descent and opening of the bladder neck and URETHRA without bladder contraction, and sphincter deficiency.. MNSs Blood-Group System defined as following: A system of universal human blood group isoantigens with many associated subgroups. The M and N traits are codominant and the S and s traits are probably very closely linked alleles, including the U antigen. This system is most frequently used in paternity studies.. Pelvic Diaphragm defined as following: Soft tissue formed mainly by the pelvic diaphragm, which is composed of the two levator ani and two coccygeus muscles. The pelvic diaphragm lies just below the pelvic aperture (outlet) and separates the pelvic cavity from the PERINEUM. It extends between the PUBIC BONE anteriorly and the COCCYX posteriorly..", "label": "yes"} {"original_question": "Is fatigue prevalent in patients receiving treatment for glioblastoma?", "id": "converted_88", "sentence1": "Is fatigue prevalent in patients receiving treatment for glioblastoma?", "sentence2": "By contrast, fatigue worsened over time, with a difference in mean score of 5.6 points between baseline and 4-month follow-up (P=.02)., In the GB cohort, the most common side effects were fatigue (56 %), diarrhea (44 %), Neutrophil count decreased (31 %), and THROMBOCYTOPENIA 2 (disorder) (25 %). , A total of 37 patients were treated, and treatment was well tolerated: grade 3, 4 nonhematologic toxicity occurred in 30% of patients and consisted mainly of fatigue (14%) and Neuropathy (5%); grade 3, 4 Hematologic toxicity occurred in 37% of patients and consisted of THROMBOCYTOPENIA 2 (disorder) (30%), Lymphocyte count decreased (4%), and Neutrophil count decreased (4%). , Nonhematologic Grade 3 toxicity was rare, and included fatigue in 4 patients and Cognitive disability in 1 patient., The most common grade 3 events were Neutrophil count decreased, THROMBOCYTOPENIA 2 (disorder), fatigue, and Communicable Diseases in 25, 20, 13, and 10%, respectively. , Analysis of the results of the VAS Norris scale did not demonstrate an increase in emotional fatigue but did show an increase in physical fatigue that did not reach statistical significance. With regards to the MFI 20 tool, analysis of the results demonstrated a significant increase in general (P=0.0260) as well as physical (P=0.0141) fatigue but there was no difference in the other indices., This study demonstrated a progressive increase in physical fatigue in patients with glioblastoma relapse treated with Bevacizumab/Irinotecan Regimen. , One patient treated with temozolomide plus isotretinoin plus thalidomide had dose-limiting grade 3 fatigue and Exanthema, and 1 patient receiving all 4 agents had dose-limiting grade 4 Neutrophil count decreased. , The Toxic effect observed were primarily grade 1 and 2, and the most common were fatigue, Hypertensive disease, and Headache. , Fatigue (41%), Exanthema (62%), and Diarrhea (58%) constituted the most frequent adverse events, the majority of these being limited to Grade 1/2. , The most common grades 3 and 4 nonhematologic Toxic effect were Nausea and vomiting (6.7%) and fatigue (5.8%). , Grade 3/4 Toxic effect included White blood cell count decreased (n = 1), Lymphocyte count decreased (n = 2), THROMBOCYTOPENIA 2 (disorder) (n = 1), L-alanine:2-oxoglutarate aminotransferase activity elevation (n = 3), Aspartate Transaminase elevation (n = 1), Central Nervous System Hemorrhage (n = 1), fatigue (n = 1), and thrombotic/embolic events (n = 3); 8 patients required dose reduction. , The most common grade 3 or greater adverse events were fatigue (7%), neutropaenia (7%), and Thrombocytopenia (7%)., Bevacizumab-related toxicity included fatigue (16 patients; 4 grade 3), White blood cell count decreased (9; 1 grade 3), Genus Anemia (5; 0 grade 3), Hypertensive disease (7; 1 grade 3), deep vein thrombosis (4; 1 grade 3) and wound dehiscence (2; 1 grade 3). , Tiredness may be caused by the Brain Injuries due to the Specimen Source Codes - Specimen Source Codes - tumor or the treatment in patients with Glioblastoma Multiforme (Glomerular Basement Membrane). Some patients describe a sense of tiredness particularly after radiation or oral chemotherapy., Levels of tiredness in patients with Glomerular Basement Membrane were greatly affected by the radiotherapy and oral chemotherapy (temozolomide)., The treatment had no negative effect on HRQOL, however, fatigue (P = 0.02) and Constipation (P = 0.01) scales worsened over time., This regimen was well tolerated with grade 3/4 Toxic effect of fatigue, White blood cell count decreased, THROMBOCYTOPENIA 2 (disorder) and Exanthema requiring dose reductions. , The most common atrasentan-related Toxic effect were grade 1 or 2 Rhinitis, fatigue, and Edema:Finding:Point in time:^Patient:Ordinal., One patient developed Grade IV fatigue at the 100 ng/mL dose, but the Metatropic dwarfism has not been established. , Side-effects in all patients have included varying degrees of Loss of appetite (finding), fatigue, ipsilateral forehead dermatitis, Blepharitis, and Conjunctivitis. , Some patients suffered from fatigue and weak concentration about three months after the end of radiotherapy, in some cases even the neurologic state was deteriorated. , grade 1-2 common Toxic effect included Fever symptoms (finding), Chills, fatigue, No No dizziness, Nausea:Presence or Threshold:Point in time:^Patient:Ordinal, vomiting and Headache, Neutrophilia (finding) and skin painful reactions appeared regularly at levels 3 and 4 (2.5 mg and 3.5 mg). , Ten episodes of grade 3/4 adverse events were observed in nine patients, including fatigue (n = 3), THROMBOCYTOPENIA 2 (disorder) (n = 4), and myelotoxicity, febrile Neutrophil count decreased, and Pulmonary Embolism (each n = 1)., Common adverse events were CTCAE grade 1-2 fatigue, Loss of Appetite question, diarrhea, and Nausea:Presence or Threshold:Point in time:^Patient:Ordinal., The most common grade 3-4 Toxic effect were Venous Thrombosis, fatigue, skin reactions, Encephalopathies, and Neuropathy.[SEP]Relations: Fatigue has relations: disease_phenotype_positive with glioblastoma (disease), disease_phenotype_positive with glioblastoma (disease), disease_phenotype_positive with sporadic pheochromocytoma/secreting paraganglioma, disease_phenotype_positive with sporadic pheochromocytoma/secreting paraganglioma, phenotype_phenotype with Chronic fatigue, phenotype_phenotype with Chronic fatigue, disease_phenotype_positive with hereditary pheochromocytoma-paraganglioma, disease_phenotype_positive with hereditary pheochromocytoma-paraganglioma, drug_effect with Bortezomib, drug_effect with Bortezomib. Definitions: Bevacizumab/Irinotecan Regimen defined as following: A chemoimmunotherapy regimen consisting of irinotecan and bevacizumab that is used for the treatment of colon cancer.. Hematologic defined as following: Pertaining to or related to the blood and blood-forming organs.. Fatigue defined as following: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.. Lymphocyte count decreased defined as following: An abnormally small number of lymphocytes in the circulating blood.. Glioblastoma Multiforme defined as following: The most malignant astrocytic Specimen Source Codes - tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO). isotretinoin defined as following: A topical dermatologic agent that is used in the treatment of ACNE VULGARIS and several other skin diseases. The drug has teratogenic and other adverse effects.. Loss of Appetite question defined as following: A question about whether an individual has or had a Loss of Appetite question.. temozolomide defined as following: A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.. Conjunctivitis defined as following: INFLAMMATION of the CONJUNCTIVA.. Diarrhea defined as following: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Brain Injuries defined as following: Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.. Exanthema defined as following: Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology.. Nausea and vomiting defined as following: Expelling the contents of the stomach and the sensations associated with it. They are symptoms of an underlying disease or condition and not a specific illness.. Neuropathy defined as following: A disorder affecting the cranial nerves or the peripheral nervous system. It manifests with pain, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.. Metatropic dwarfism defined as following: An autosomal dominant condition caused by mutation(s) in the TRPV4 gene, encoding transient receptor potential cation channel subfamily V member 4. It is characterized by a variable phenotype, which may include short limbs, kyphoscoliosis, and other skeletal abnormalities.. Encephalopathies defined as following: A functional and/or structural disorder of the brain caused by diseases (e.g. liver disease, kidney disease), medications, chemicals, and injuries.. Neutrophilia (finding) defined as following: Abnormally high level of neutrophils in the blood.. Hemorrhage defined as following: Bleeding or escape of blood from a vessel.. Chills defined as following: The sudden sensation of being cold. It may be accompanied by SHIVERING.. Headache defined as following: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.. thalidomide defined as following: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.. Aspartate Transaminase defined as following: Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.. White blood cell count decreased defined as following: A laboratory test result indicating a decreased number of white blood cells in the peripheral blood.. Glomerular Basement Membrane defined as following: A sheet of amorphous extracellular material upon which the basal surfaces of epithelial cells rest and is the covering surface of a glomerular capillary, interposed between the cellular elements and the underlying connective tissue.. Venous Thrombosis defined as following: The formation or presence of a blood clot (THROMBUS) within a vein.. Thrombocytopenia defined as following: A subnormal level of BLOOD PLATELETS.. Neutrophil count decreased defined as following: A decrease in the number of neutrophils in the peripheral blood.. Blepharitis defined as following: Inflammation of the eyelids.. Central Nervous System defined as following: The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.. L-alanine:2-oxoglutarate aminotransferase activity defined as following: Catalysis of the reaction: 2-oxoglutarate + L-alanine = L-glutamate + pyruvate. [EC:2.6.1.2, RHEA:19453]. Constipation defined as following: Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and infections.. Pulmonary Embolism defined as following: Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.. Hypertensive disease defined as following: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), Hypertensive disease is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.. Rhinitis defined as following: Inflammation of the NASAL MUCOSA, the mucous membrane lining the NASAL CAVITIES.. THROMBOCYTOPENIA 2 (disorder) defined as following: An autosomal dominant disorder caused by mutation(s) in the ANKRD26 gene, encoding ANKRD26 protein. Additionally, in one family, a mutation(s) has been identified in the MASTL gene, encoding serine/threonine-protein kinase greatwall. The condition is characterized by mild to moderate bruisability.. fatigue defined as following: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.. glioblastoma defined as following: The most malignant astrocytic Specimen Source Codes - tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO).", "label": "yes"} {"original_question": "Is RUNX1T1 associate with obesity?", "id": "converted_4243", "sentence1": "Is RUNX1T1 associate with BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20?", "sentence2": "RUNX1T1 rs34269950 is associated with BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 and Metabolic Syndrome X., Of these Single Nucleotide Polymorphism only rs34269950 located in the 'RRACH' motif, the most common N-methyladenosine (METTL3 gene) methylation modification site (recognized by FTO protein, human protein, human), was significantly associated with BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 risk and No No metabolic abnormalities. Specifically, compared to AA Genotype determination, rs34269950 del/del Genotype determination was associated with a 1.47 [95% confidence interval (CI): 1.01-2.14, P = 0.042] fold higher rate of BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 risk. , Our study demonstrates that RUNX1T1 rs34269950, located in a potential FTO protein, human protein, human recognition motif, is significantly associated with waist circumference. T[SEP]Relations: Metabolic Syndrome X X has relations: disease_protein with SIRT1, disease_protein with SIRT1, disease_protein with INPPL1, disease_protein with INPPL1, disease_protein with HMGA1, disease_protein with HMGA1, disease_protein with NR1I2, disease_protein with NR1I2. METTL3 has relations: protein_protein with YY1, protein_protein with YY1. Definitions: Genotype determination defined as following: The determination of the DNA sequence of an individual.. Metabolic Syndrome X defined as following: A combination of medical conditions that when present, increase the risk of heart attack, stroke, and diabetes mellitus. It includes the following medical conditions: increased blood pressure, central BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, dyslipidemia, impaired glucose tolerance, and insulin resistance.. Single Nucleotide Polymorphism defined as following: A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.. FTO protein, human defined as following: Alpha-ketoglutarate-dependent dioxygenase FTO protein, human (505 aa, ~58 kDa) is encoded by the human FTO protein, human gene. This protein is involved in the demethylation of RNA and DNA.. METTL3 gene defined as following: This gene is involved in methlyation of mRNA..", "label": "yes"} {"original_question": "Can Alzheimer's disease related miRNAs be detected in patients' blood?", "id": "converted_1502", "sentence1": "Can ALZHEIMER DISEASE, FAMILIAL, 1 related MicroRNAs be detected in patients' blood?", "sentence2": "MicroRNAs are aberrantly expressed in cytarabine/daunorubicin protocol, and these have been implicated in the regulation of amyloid-β (Aβ) peptide, uridine triacetate, Inflammation, cell death, and other aspects which are the main pathomechanisms of cytarabine/daunorubicin protocol. In addition, regulation of MicroRNAs varies in blood, and cerebral spinal fluid may indicate alterations in cytarabine/daunorubicin protocol., miRNA microarray analysis was carried out on blood of Rattus norvegicus at 1 week and 2 months after injection. RESULTS: Many up- and downregulated MicroRNAs were detected., Blood MicroRNAs could be useful as biomarkers for exposure to nanoparticles. miR-298 regulates β-amyloid (Aβ) precursor protein-converting enzyme-1 (BACE1 protein, human protein, human) in ALZHEIMER DISEASE, FAMILIAL, 1., We previously studied microRNAs (MicroRNAs) in cytarabine/daunorubicin protocol autopsy brain samples and reported a connection between miR-137, -181c, -9, -29a/b and cytarabine/daunorubicin protocol, through the regulation of ceramides. In this study, the potential role of these MicroRNAs as diagnostic markers for cytarabine/daunorubicin protocol was investigated. We identified that these MicroRNAs were down-regulated in the blood serum of probable cytarabine/daunorubicin protocol patients. , 287 with ALZHEIMER DISEASE 2 (cytarabine/daunorubicin protocol) as compared with 344 age- and gender-matched controls. In addition, we evaluated expression levels of HNRNPA1 gene and its regulatory microRNA (miR)-590-3p in Blood Cells from patients and controls., Decreased relative expression levels of hsa-miR-590-3p was observed in patients with cytarabine/daunorubicin protocol versus controls (0.685 ± 0.080 versus 0.931 ± 0.111, p = 0.079), and correlated negatively with HNRNPA1 gene mRNA levels (r = -0.615, p = 0.0237)., expression analysis of Spleen acupuncture point SP1 and its regulatory microRNAs (MIRN29B1 microRNA, human and MIR375 gene) has been performed in Peripheral blood mononuclear cell (cell) (PBMCs), together with Spleen acupuncture point SP1 protein analysis., Significantly decreased relative expression levels of MIRN29B1 microRNA, human, but not of MIR375 gene, were observed in cytarabine/daunorubicin protocol patients, Spleen acupuncture point SP1 and its regulatory MIRN29B1 microRNA, human are deregulated in cytarabine/daunorubicin protocol patients, possibly leading to aberrant production of downstream target genes involved in the pathogenesis. , We previously observed that miR-137, -181c, -9, and 29a/b post-transcriptionally regulate SPT levels, and the corresponding miRNA levels in the blood sera are potential diagnostic biomarkers for cytarabine/daunorubicin protocol. Here, we observe a negative correlation between Adrenal Cortex Aβ42 and sera Aβ42, and a positive correlation between Adrenal Cortex miRNA levels and sera miRNA levels suggesting their potential as noninvasive diagnostic biomarkers.[SEP]Relations: ALZHEIMER DISEASE 2 has relations: disease_protein with MIR100, disease_protein with MIR100, disease_protein with MIR708, disease_protein with MIR708, disease_protein with MIR766, disease_protein with MIR766, disease_protein with MIR296, disease_protein with MIR296, disease_protein with MIR505, disease_protein with MIR505. Definitions: uridine triacetate defined as following: A synthetic uridine pro-drug that is converted to uridine in vivo. Uridine, a pyrimidine nucleotide, has been used in a variety of diseases including depressive disorders and inherited myopathies. (NCI04). Peripheral blood mononuclear cell (cell) defined as following: A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. BACE1 protein, human defined as following: Beta-secretase 1 (501 aa, ~56 kDa) is encoded by the human BACE1 protein, human gene. This protein plays a role in the proteolysis of ectodomains of membrane proteins.. Blood Cells defined as following: The cells found in the body fluid circulating throughout the CARDIOVASCULAR SYSTEM.. Rattus norvegicus defined as following: The common rat, Rattus norvegicus, often used as an experimental organism.. MicroRNAs defined as following: Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 MicroRNAs discovered, and are from a class of MicroRNAs involved in developmental timing.. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65.. MIR375 gene defined as following: This gene plays a role in gene silencing.. Adrenal Cortex defined as following: The outer layer of the adrenal gland. It is derived from MESODERM and comprised of three zones (outer ZONA GLOMERULOSA, middle ZONA FASCICULATA, and inner ZONA RETICULARIS) with each producing various steroids preferentially, such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and ANDROSTENEDIONE. Adrenal cortex function is regulated by pituitary ADRENOCORTICOTROPIN..", "label": "yes"} {"original_question": "Is tocilizumab a tumor necrosis factor inhibitor?", "id": "converted_3768", "sentence1": "Is tocilizumab a tumor necrosis factor inhibitor?", "sentence2": "For the first-line bDMARD/tsDMARD, either Tumor Necrosis Factor Inhibitors (TNFi), non-TNFi (abatacept, tocilizumab, rituximab), or tsDMARDs, may be considered.[SEP]Relations: Tocilizumab has relations: drug_drug with Necitumumab, drug_drug with Necitumumab, drug_drug with Nemolizumab, drug_drug with Nemolizumab, drug_drug with Cemiplimab, drug_drug with Cemiplimab, drug_drug with Tositumomab, drug_drug with Tositumomab, drug_drug with Otelixizumab, drug_drug with Otelixizumab. Definitions: rituximab defined as following: A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.. tocilizumab defined as following: A recombinant, humanized IgG1 monoclonal antibody directed against the interleukin-6 receptor (IL-6R) with immunosuppressant activity. Tocilizumab targets and binds to both the soluble form of IL-6R (sIL-6R) and the membrane-bound form (mIL-6R), thereby blocking the binding of IL-6 to its receptor. This prevents IL-6-mediated signaling. IL-6, a pro-inflammatory cytokine that plays an important role in the regulation of the immune response, is overproduced in autoimmune disorders, certain types of cancers and possibly various other inflammatory conditions.. Tumor Necrosis Factor Inhibitors defined as following: Compounds or agents that bind to and inhibit the synthesis or activity of TUMOR NECROSIS FACTOR-alpha. Such agents are used to treat inflammatory bowel diseases and other inflammatory diseases.. abatacept defined as following: A soluble fusion protein consisting of the extracellular domain of human cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) linked to a modified Fc (hinge, CH2, and CH3 domains) portion of human immunoglobulin G1 (IgG1) with immunosuppressive activity. Abatacept binds CD80 and CD86 on antigen presenting cells (APCs), blocking interaction with CD28 on T lymphocytes, which initiates a co-stimulatory signal required for full activation of T lymphocytes.. tumor necrosis factor inhibitor defined as following: Compounds or agents that bind to and inhibit the synthesis or activity of TUMOR NECROSIS FACTOR-alpha. Such agents are used to treat inflammatory bowel diseases and other inflammatory diseases..", "label": "no"} {"original_question": "Is phospholamban a regulatory/inhibitory protein of the Ca ATPase SERCA?", "id": "converted_509", "sentence1": "Is PLN gene a regulatory/inhibitory protein of the cyclophosphamide/doxorubicin protocol ATPase SERCA?", "sentence2": "The Membrane Proteins complex between the Sarcoplasmic Reticulum cyclophosphamide/doxorubicin protocol(2+)-ATPase (SERCA) and PLN gene (PLN) controls cyclophosphamide/doxorubicin protocol(2+) transport in Myocytes, Cardiac, thereby modulating Cardiac - anatomy qualifier contractility. β-Adrenergic-stimulated phosphorylation of PLN at Ser-16 enhances SERCA activity via an unknown mechanism., PLN gene (PLN) is a type II Membrane Proteins that inhibits the Sarcoplasmic Reticulum cyclophosphamide/doxorubicin protocol(2+)-ATPase (SERCA), thereby regulating calcium homeostasis in Cardiac - anatomy qualifier muscle. In Tissue Membrane Device, PLN forms pentamers that have been proposed to function either as a storage for active monomers or as ion channels., Regulation of the SERCA calcium pump by PLN gene (PLB1 gene) is largely due to interactions between their respective transmembrane domains. In spite of numerous Mutagenesis Procedure and kinetic studies, we still do not have a clear mechanistic picture of how PLB1 gene influences the calcium transport cycle of SERCA., Calcium transport across the Membrane Device of the Sarcoplasmic Reticulum (SNCG wt Allele) plays an important role in the regulation of Myocardium contraction and relaxation. The sarco(endo)plasmic reticulum cyclophosphamide/doxorubicin protocol(2+) ATPase (SERCA) 2a is responsible for cyclophosphamide/doxorubicin protocol(2+) up-take by this Cytoplasmic Cytoplasmic organelle and is inhibited in a reversible manner by PLN gene, another SNCG wt Allele Membrane Proteins. Thus, alleviation of PLN gene-mediated inhibition of SERCA2a is a potential therapeutic option for Congestive Congestive heart failure and Cardiomyopathies., PLN gene has been suggested to be a key regulator of Cardiac - anatomy qualifier Sarcoplasmic Reticulum (SNCG wt Allele) cyclophosphamide/doxorubicin protocol cycling and contractility and a potential therapeutic target in restoring the depressed cyclophosphamide/doxorubicin protocol cycling in failing hearts., In larger Mammals, a higher fraction of SERCA2a pumps are regulated by PLN gene, and this may influence therapeutic strategies to enhance Cardiac - anatomy qualifier contractility and functional Cardiac - anatomy qualifier reserve., PLN gene (PLB1 gene) inhibits the Sarcoplasmic Reticulum (SNCG wt Allele) cyclophosphamide/doxorubicin protocol(2+)-ATPase (SERCA), and this inhibition is relieved by cyclophosphamide/doxorubicin protocol(2+) calmodulin-dependent protein kinase II (calmodulin-dependent protein kinase II) phosphorylation, These findings suggest that PLB1 gene is an important modulator of gastric antrum Smooth muscle (tissue) contractility by modulation of SNCG wt Allele cyclophosphamide/doxorubicin protocol(2+) release and calmodulin-dependent protein kinase II activity., The function of the SERCA pump is modulated by the endogenous molecules PLN gene (PLB1 gene) and sarcolipin (SLN gene gene), expressed in Cardiac - anatomy qualifier and Skeletal muscle structure. The mechanism of action of PLB1 gene on SERCA is well characterized, whereas that of SLN gene gene is only beginning to be understood. , PLN gene (PLB1 gene) is an inhibitor of the Sarcoplasmic Reticulum (SNCG wt Allele) Ca2+-ATPase (SERCA)., These results show that alteration of the PLB1 gene:SERCA ratio can significantly modulate Smooth muscle (tissue) [Ca2+]i., PLN gene expressed in Cardiac - anatomy qualifier muscle and sarcolipin expressed in Specimen Source Codes - Skeletal muscle regulate SERCA activity., PLN gene (PLB1 gene) is a 24- to 27-kDa phosphoprotein that modulates activity of the sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA). Expression of PLB1 gene is reportedly limited to Cardiac - anatomy qualifier, slow-twitch skeletal and Smooth muscle (tissue) in which PLB1 gene is an important regulator of [Ca2+]i and contractility in these Muscle Tissue., Regulation of the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA 2a) depends on the phosphorylation state of PLN gene (PLB1 gene). When PLB1 gene is phosphorylated, its inhibitory effect towards SERCA 2a is relieved, leading to an enhanced myocardial performance. , cyclophosphamide/doxorubicin protocol(2+) reuptake occurs via sarcoendoplasmic reticulum cyclophosphamide/doxorubicin protocol(2+) ATPase (SERCA) and is regulated by the inhibitory protein PLN gene (PLB1 gene) in many cell types., PLN gene (PLN) is a small integral Membrane Proteins, which binds and inhibits in a yet unknown fashion the cyclophosphamide/doxorubicin protocol(2+)-ATPase (SERCA) in the Sarcoplasmic Reticulum., PLN gene (PLN) is the endogenous inhibitor of the sarco(endo)plasmic reticulum cyclophosphamide/doxorubicin protocol(2+)-ATPase (SERCA), the integral Membrane Device enzyme responsible for 70�% of the removal of cyclophosphamide/doxorubicin protocol(2+) from the Cytoplasmic matrix, inducing Cardiac - anatomy qualifier muscle relaxation in Homo sapiens., PLN gene (PLB1 gene) is an integral Membrane Proteins regulating cyclophosphamide/doxorubicin protocol(2+) transport through inhibitory interaction with sarco(endo)plasmic reticulum calcium ATPase (SERCA)., Phosphorylation by Cyclic AMP-Dependent Protein Kinases and dephosphorylation by Protein phosphatase modulate the inhibitory activity of PLN gene (PLN), the endogenous regulator of the sarco(endo)plasmic reticulum calcium cyclophosphamide/doxorubicin protocol(2+) ATPase (SERCA)., Phosphorylation by Cyclic AMP-Dependent Protein Kinases and dephosphorylation by Protein phosphatase modulate the inhibitory activity of PLN gene (PLN), the endogenous regulator of the sarco(endo)plasmic reticulum calcium cyclophosphamide/doxorubicin protocol(2+) ATPase (SERCA), We used EPR spectroscopy to probe directly the interaction between PLN gene (PLB1 gene) and its regulatory target, the Sarcoplasmic Reticulum cyclophosphamide/doxorubicin protocol-ATPase (SERCA)[SEP]Relations: phosphoprotein phosphatase activity has relations: molfunc_protein with PPP2CA, molfunc_protein with PPP2CA, molfunc_protein with PPP1CA, molfunc_protein with PPP1CA, molfunc_protein with PTEN, molfunc_protein with PTEN, molfunc_protein with PPP5C, molfunc_protein with PPP5C. Membrane Device has relations: cellcomp_protein with CACNB3, cellcomp_protein with CACNB3. Definitions: PLN gene defined as following: free Sarcoplasmic Reticulum polymeric proteolipid which modulates Sarcoplasmic Reticulum function; phosphorylated by cAMP-dependent, calcium-calmodulin-dependent, and calcium-phospholipid-dependent protein kinases.. Cytoplasmic organelle defined as following: Cell part which consists of macromolecules aggregated into discrete structures in the protoplasm. (Digital Anatomist Foundational Model). Myocytes, Cardiac defined as following: Striated muscle cells found in the heart. They are derived from Cardiac - anatomy qualifier myoblasts (MYOBLASTS, CARDIAC).. Mutagenesis Procedure defined as following: Production of genetic alterations by any technique, including chemicals, radiation, recombination, or other molecular biology methods.. calmodulin-dependent protein kinase II defined as following: A multifunctional calcium-calmodulin-dependent protein kinase subtype that occurs as an oligomeric protein comprised of twelve subunits. It differs from other enzyme subtypes in that it lacks a phosphorylatable activation domain that can respond to CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE.. Congestive heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Skeletal muscle structure defined as following: A subtype of striated muscle, attached by TENDONS to the SKELETON. Skeletal Muscle Tissue are innervated and their movement can be consciously controlled. They are also called voluntary Muscle Tissue.. Cardiomyopathies defined as following: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).. Cyclic AMP-Dependent Protein Kinases defined as following: A group of enzymes that are dependent on CYCLIC AMP and catalyze the phosphorylation of SERINE or THREONINE residues on proteins. Included under this category are two cyclic-AMP-dependent protein kinase subtypes, each of which is defined by its subunit composition.. Smooth muscle (tissue) defined as following: Unstriated and unstriped muscle, one of the Muscle Tissue of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed). Sarcoplasmic Reticulum defined as following: A network of tubules and sacs in the cytoplasm of SKELETAL MUSCLE FIBERS that assist with muscle contraction and relaxation by releasing and storing calcium ions.. Membrane Proteins defined as following: Proteins which are found in Tissue Membrane Device including cellular and intracellular Tissue Membrane Device. They consist of two types, peripheral and integral proteins. They include most Membrane Device-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors.. Tissue Membrane Device defined as following: Thin layers of tissue which cover parts of the body, separate adjacent cavities, or connect adjacent structures.. Muscle Tissue defined as following: Contractile tissue that produces movement in animals.. SNCG wt Allele defined as following: Human SNCG wild-type allele is located within10q23.2-q23.3 and is approximately 13 kb in length. This allele, which encodes gamma-synuclein protein, plays a role in the modulation of axonal architecture and neurofilament integrity. This gene is highly expessed in advanced breast carcinomas, suggesting a correlation between SNCG overexpression and breast tumor development.. Sarcoplasmic Reticulum cyclophosphamide/doxorubicin protocol(2+)-ATPase defined as following: Calcium-transporting ATPases that catalyze the active transport of CALCIUM into the SARCOPLASMIC RETICULUM vesicles from the CYTOPLASM. They are primarily found in MUSCLE CELLS and play a role in the relaxation of MUSCLES.. Protein phosphatase defined as following: A group of enzymes removing the SERINE- or THREONINE-bound phosphate groups from a wide range of phosphoproteins, including a number of enzymes which have been phosphorylated under the action of a kinase. (Enzyme Nomenclature, 1992). Myocardium defined as following: The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow.. Cytoplasmic matrix defined as following: Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components.. integral Membrane Proteins defined as following: The component of the endoplasmic reticulum Membrane Device consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the Membrane Device. [GOC:dos, GOC:mah]. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.. Homo sapiens defined as following: Members of the species Homo sapiens.. Membrane Device defined as following: A device that is made from or resembles a thin flexible sheet of material.. integral Membrane Device defined as following: The component of a Membrane Device consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the Membrane Device. [GOC:dos, GOC:go_curators].", "label": "yes"} {"original_question": "Are the members of the KRAB-ZNF gene family promoting gene repression?", "id": "converted_3471", "sentence1": "Are the members of the KRAB-ZNF Genes family promoting Genes repression?", "sentence2": " The Proteins encoded by these genes, whose expression is often tissue-specific, act as epigenetic suppressors contributing to the addition of repressive chromatin marks and DNA methylation., Here, using a reporter system, we show that TRIM28/KRAB-ZNFs alter DNA methylation patterns in addition to Histone H3 Trimethyl Lys9 to cause stable Genes repression during reprogramming. Using several expression datasets, we identified KRAB-ZNFs (ZNF114 gene Genes, ZNF483 Genes Genes, ZNF589 gene Genes) in the human genome that maintain pluripotency., Further analyses of our data sets link GABPa to cognitive disorders, Diabetes Mellitus, KRAB zinc finger (KRAB-ZNF), and human-specific genes., The Stem cells zinc finger 1 (SZF1)/ZNF589 gene Genes Protein Info belongs to the large family of Krüppel-associated box domain-zinc finger (KRAB-ZNF) transcription factors, which are present only in higher Vertebrates and epigenetically repress transcription by recruiting chromatin-modifying complexes to the Promoter Regions, Genetic of their respective target genes, Because TRIM28 wt Allele is recruited to the DNA via interaction with KRAB-ZNF Proteins, we suggest that expression of KRAB-ZNF genes may be controlled via an auto-regulatory mechanism involving TRIM28 wt Allele., Interestingly, although most TRIM28 wt Allele Binding Sites were within core Promoter Regions, Genetic, the Binding Sites near ZNF genes were greatly enriched within transcribed regions of the target Genes[SEP]Relations: ZNF114 gene has relations: protein_protein with ZNF8, protein_protein with ZNF8, protein_protein with KRTAP10-6, protein_protein with KRTAP10-6, bioprocess_protein with regulation of transcription, DNA-templated, bioprocess_protein with regulation of transcription, DNA-templated, protein_protein with KLHL2, protein_protein with KLHL2. ZNF483 Genes has relations: protein_protein with NRF1, protein_protein with NRF1. Definitions: Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the Protein Info.. TRIM28 wt Allele defined as following: Human TRIM28 wild-type allele is located in the vicinity of 19q13.43 and is approximately 7 kb in length. This allele, which encodes transcription intermediary factor 1-beta Protein Info, plays a role in Protein Info modification, chromatin remodeling, inhibition of herpesvirus 8-mediated lysis and transcriptional regulation. Mutation of the Genes may be associated with familial Wilms tumor.. Binding Sites defined as following: The parts of a macromolecule that directly participate in its specific combination with another molecule.. Histone H3 Trimethyl Lys9 defined as following: A post-translationally modified form of histone H3 where the lysine residue at position 9 is trimethylated. This modification is associated with heterochromatin formation and plays a role in embryonic Stem cells lineage commitment and maintenance of lineage fidelity.. Promoter Regions, Genetic defined as following: DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Protein Info defined as following: Protein; provides access to the encoding Genes via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous Proteins in other species.. Diabetes Mellitus defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.. Vertebrates defined as following: Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising mammals, birds, reptiles, amphibians, and fishes.. Stem cells defined as following: Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells..", "label": "yes"} {"original_question": "Is Vitamin D deficiency in pregnant women associated with gestational diabetes?", "id": "converted_1037", "sentence1": "Is ergocalciferol deficiency in pregnant women associated with gestational diabetes?", "sentence2": "Insufficient serum levels of 25-OHD were associated with gestational diabetes (pooled odds ratio 1.49, 95% confidence interval 1.18 to 1.89, ergocalciferol insufficiency is associated with an increased risk of gestational diabetes, p, Therefore, it is important to identify potentially modifiable risk factors for GDM. Accumulating evidence links vitamin D deficiency with abnormal glucose metabolism, and epidemiological studies have shown that women who develop GDM are more likely to be vitamin D deficient, This review discusses the prevalence, risk factors, and outcomes of GDM and vitamin D deficiency in pregnant women, outlines the possible mechanism of action of vitamin D in glucose homeostasis, and summarizes emerging evidence that associates vitamin D deficiency with the risk of developing GDM, Women with circulating 25-Hydroxyvitamin D3 Measurement [25(OH)D] level less than 50 nmol/l in pregnancy experienced an increased risk of Pre-Eclampsia [OR 2.09 (95%CI 1.50 -2.90)], Gestational Diabetes [OR1.38 (1.12-1.70)], Low maternal vitamin D levels in pregnancy may be associated with an increased risk of Pre-Eclampsia, Gestational Diabetes,, Association between vitamin D insufficiency and the risk for Gestational Diabetes in pregnant Chinese women, 25OHD insufficiency is very common in Chinese women. Low 25OHD status may be associated with insulin resistance and act as a risk factor for GDM., Second-trimester 25(OH)D levels were associated inversely with glucose levels after 1-hour 50-g glucose challenge test; low 25(OH)D levels may be associated with increased risk of GDM., Two hundred sixty-six women were screened. ergocalciferol deficiency (25[OH]D <20 ng/mL) was observed in 157 women (59%). We observed an inverse correlation between 25(OH)D levels and hemoglobin A1c, homeostasis model assessment of insulin resistance, serum insulin, and fasting and 1-hour oral glucose tolerance test glucose levels, Lower 25(OH)D levels are associated with disorders of glucose homeostasis and adverse obstetric and newborn outcomes., An association between mid-gestational 25-hydroxy vitamin D and fasting glucose was confirmed in a largely normoglycaemic and vitamin D-replete pregnant population. The correlation between 25-hydroxy vitamin D and β-cell function suggests that vitamin D may influence glucose metabolism through this mechanism., Women with gestational diabetes had significantly lower serum 25-Hydroxyvitamin D3 Measurement compared with control subjects (56.3 vs. 62.0 nmol/l, P = 0.018). After adjusting for gestational age and maternal weight, serum 25-Hydroxyvitamin D3 Measurement below the top quartile (< 73.5 nmol/l) was associated with a twofold greater likelihood of gestational diabetes (adjusted odds ratio 2.21, 95% confidence interval 1.19-4.13). CONCLUSIONS: Lower vitamin D status in early pregnancy was associated with a significantly increased risk of subsequent gestational diabetes that was independent of race, age, season and maternal weight. This study suggests that vitamin D may influence glucose tolerance during pregnancy, ergocalciferol deficiency among pregnant women is frequent in many populations over the world. It is associated with an increased risk of Pre-Eclampsia, Gestational Diabetes, and caesarean section, Consequences in newborns are low birth weight, neonatal Rickets, a risk of neonatal Hypocalcemia, Asthma and/or type 1 diabetes., A single injection of 300,000 IU of cholecalciferol achieves a 3-month serum 25-Hydroxyvitamin D3 Measurement range of 50-80 nmol/l and is an efficient, effective and safe procedure for improving the vitamin status and indices of insulin resistance in mothers with gestational diabetes after delivery., In a cohort of pregnant women with mostly sufficient levels of serum 25(OH)D, vitamin D deficiency was not associated with GDM., The aim of the study is evaluating the associations of FokI vitamin D receptor (VDR) Genetic Polymorphism with Gestational Diabetes (GDM), and its relations with postpartum metabolic syndrome., Our results indicate a meaningful association between FokI VDR genotypes and an increase risk of GDM in Iranian population as well as its effects on postpartum metabolic syndrome., The first-trimester maternal serum level of 25(OH)D is not altered in women with type 2 diabetes, those who develop GDM or those who deliver GLS2 wt Allele neonates., Lower 25(OH)D levels are independently associated with poorer glycaemic control. Future randomised trials are needed to determine whether vitamin D plays a role in glycaemic control in GDM., These results suggested that rates of vitamin D deficiency are higher among women with IGT/GDM, and the relationship between vitamin D status and glucose tolerance in pregnancy needs further study., It appears that vitamin D insufficiency during pregnancy is potentially associated with increased risk of Pre-Eclampsia, insulin resistance and Gestational Diabetes, Mean serum 25OHD concentration was 53.8 +/- 23.9 nmol/l (sd). Ln-25OHD was negatively correlated with serum parathyroid hormone as expected (r -0.24, confidence intervals -0.35 to -0.12). Ln-25OHD was also negatively correlated with fasting plasma glucose (r-0.20, -0.31 to -0.08), fasting insulin (r -0.20, -0.31 to -0.08) and insulin resistance as calculated by homeostasis model assessment (r -0.21, -0.32 to -0.09). The association between fasting glucose and log-transformed 25OHD concentration was of borderline significance after accounting for ethnicity, age and body mass index in multivariate analyses (-0.13, -0.26 to 0.01). The odds ratio of gestational diabetes in women with 25OHD < 50 nmol/l did not reach statistical significance (1.92, 95% confidence interval 0.89-4.17). CONCLUSIONS: Maternal 25OHD concentrations are inversely related to fasting glucose, although further studies are required to establish whether this is independent of the effects of ethnic background., ergocalciferol insufficiency is common in Indian mothers but is not associated with gestational diabetes or variation in newborn size., There was no association between maternal 25(OH)D and gestational diabetes (incidence 7% in women with and without ergocalciferol Deficiency), In mothers with ergocalciferol Deficiency, higher 25(OH)D concentrations were associated with lower 30-min glucose concentrations (P=0.03) and higher fasting Assay of Proinsulin concentrations (P=0.04), Hypovitaminosis D at 30 weeks gestation is common in Mysore mothers. It is not associated with an increased risk of gestational diabetes,, Total prevalence of vitamin D deficiency (<25 nmol/L) was found in 70.6% of pregnant women. Prevalence of severe vitamin D deficiency (<12.5) in GDM patients was higher than in normoglycaemic pregnancies., These results show that a positive correlation of 25(OH) vitamin D concentrations with insulin sensitivity and vitamin D deficiency could be a confirmative sign of insulin resistance., was to examine whether maternal dietary intake of vitamin D, omega-3 fatty acids, and fatty acids, omega-6 during pregnancy is associated with the appearance of islet autoimmunity (Intraarterial Route of Drug Administration) in offspring, Maternal intake of vitamin D via Food allergenic extracts was significantly associated with a decreased risk of Intraarterial Route of Drug Administration appearance in offspring, independent of HLA genotype, family history of type 1 diabetes, presence of Gestational Diabetes, and ethnicity (adjusted HR = 0.37; 95% CI 0.17-0.78). ergocalciferol intake via supplements, omega-3 fatty acids, and fatty acids, omega-6 intake during pregnancy were not associated with appearance of Intraarterial Route of Drug Administration in offspring. CONCLUSIONS: Our findings suggest that maternal intake of vitamin D through Food allergenic extracts during pregnancy may have a protective effect on the appearance of Intraarterial Route of Drug Administration in offspring.[SEP]Relations: gestational diabetes has relations: disease_disease with pregnancy disorder, disease_disease with pregnancy disorder, disease_disease with diabetes mellitus (disease), disease_disease with diabetes mellitus (disease), contraindication with Ritodrine, contraindication with Ritodrine. vitamin B deficiency has relations: disease_disease with vitamin deficiency disorder, disease_disease with vitamin deficiency disorder, disease_disease with vitamin B12 deficiency, disease_disease with vitamin B12 deficiency. Definitions: ergocalciferol defined as following: Vitamin D2, a fat-soluble vitamin important for many biochemical processes including the absorption and metabolism of calcium and phosphorus. In vivo, ergocalciferol is formed after sun (ultraviolet) irradiation of plant-derived ergosterol, another form of vitamin D. Ergocalciferol is the form of vitamin D usually found in vitamin supplements. (NCI04). cholecalciferol defined as following: Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. It differs from ERGOCALCIFEROL in having a single bond between C22 and C23 and lacking a methyl group at C24.. fatty acids, omega-6 defined as following: FATTY ACIDS which have the first unsaturated bond in the sixth position from the omega carbon. A typical American diet tends to contain substantially more omega-6 than OMEGA-3 FATTY ACIDS.. 25-Hydroxyvitamin D3 Measurement defined as following: The determination of the amount of 25-hydroxyvitamin D3 present in a sample.. Pre-Eclampsia defined as following: A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.. Vitamin D Deficiency defined as following: A nutritional condition produced by a deficiency of VITAMIN D in the diet, insufficient production of vitamin D in the skin, inadequate absorption of vitamin D from the diet, or abnormal conversion of vitamin D to its bioactive metabolites. It is manifested clinically as RICKETS in children and OSTEOMALACIA in adults. (From Cecil Textbook of Medicine, 19th ed, p1406). Intraarterial Route of Drug Administration defined as following: Intraarterial drug injection or infusion is a method of delivering a drug directly into artery or arteries to localize its effect to a particular organ/body region, while minimizing the exposure of the body to potentially toxic effects of the agent. The method is considered more dangerous than intravenous administration and should be reserved to experts. The first-pass and cleansing effects of the lung are not available when the agent is given by this route.. Hypocalcemia defined as following: Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed). omega-3 fatty acids defined as following: A group of unsaturated fatty acids occurring mainly in fish oils, with three double bonds at particular positions in the hydrocarbon chain.. Gestational Diabetes defined as following: Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.. GLS2 wt Allele defined as following: Human GLS2 wild-type allele is located within 12q13 and is approximately 17 kb in length. This allele, which encodes glutaminase liver isoform, mitochondrial protein, is involved in the hydrolysis if L-glutamine. Expression of the GLS2 gene is induced during acidosis.. Asthma defined as following: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).. Assay of Proinsulin defined as following: The determination of the amount of Assay of Proinsulin present in a sample.. Rickets defined as following: Disorders caused by interruption of BONE MINERALIZATION manifesting as OSTEOMALACIA in adults and characteristic deformities in infancy and childhood due to disturbances in normal BONE FORMATION. The mineralization process may be interrupted by disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis, resulting from dietary deficiencies, or acquired, or inherited metabolic, or hormonal disturbances.. Genetic Polymorphism defined as following: The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.. gestational diabetes defined as following: Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA..", "label": "yes"} {"original_question": "Has IVIG been tested in clinical trials for the treatment of Alzheimer's disease?", "id": "converted_2284", "sentence1": "Has IVIG been tested in clinical trials for the treatment of ALZHEIMER DISEASE, FAMILIAL, 1?", "sentence2": "Clinical trials of immunoglobulins, intravenous for ALZHEIMER DISEASE, FAMILIAL, 1., Preclinical and clinical studies have shown that IVIG has anti-amyloid and immune modulatory properties relevant to treating Neurodegenerative Disorders. In early stage cytarabine/daunorubicin protocol clinical trials, IVIG was found to reduce Mental deterioration and increase brain glucose metabolism. Unfortunately, IVIG failed to meet primary outcome objectives in the North American Phase 3 clinical trial in mild to moderate cytarabine/daunorubicin protocol., While the results of clinical trials to date do not provide support for the use of IVIG to treat cytarabine/daunorubicin protocol at the doses tested, additional studies of IVIG's mechanisms are warranted and may guide the development of more effective therapies for cytarabine/daunorubicin protocol in the future.[SEP]Relations: familial Alzheimer disease has relations: disease_disease with Alzheimer disease, disease_disease with Alzheimer disease, disease_protein with PRNP, disease_protein with PRNP, disease_phenotype_positive with Emotional lability, disease_phenotype_positive with Emotional lability, disease_phenotype_positive with Jaw pain, disease_phenotype_positive with Jaw pain. inherited neurodegenerative disorder has relations: disease_disease with Alzheimer disease, disease_disease with Alzheimer disease. Definitions: immunoglobulins, intravenous defined as following: Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA.. Neurodegenerative Disorders defined as following: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.. Mental deterioration defined as following: Loss of previously present mental abilities, generally in adults. [HPO:probinson]. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65.. IVIG defined as following: Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA..", "label": "yes"} {"original_question": "Is ABCE1 involved in ribosomal recycling?", "id": "converted_1953", "sentence1": "Is ABCE1 gene involved in ribosomal recycling?", "sentence2": "Ribosome recycling orchestrated by the ATP binding cassette (ABC) protein ABCE1 gene gene can be considered as the final-or the first-step within the cyclic process of protein synthesis, connecting translation termination and mRNA surveillance with re-initiation., Recent studies have identified ABCE1 gene gene as a ribosome-recycling factor important for translation termination in mammalian cells, Saccharomyces cerevisiae and also archaea., d a termination/prerecycling complex containing eRF1-ABCE1 gene gene, ABCE1 gene gene, a eukaryotic ribosome recycling factor[SEP]Relations: ABCE1 gene has relations: protein_protein with RNASEL, protein_protein with RNASEL, protein_protein with RNF2, protein_protein with RNF2, protein_protein with CDC6, protein_protein with CDC6, bioprocess_protein with ribosomal subunit export from nucleus, bioprocess_protein with ribosomal subunit export from nucleus, protein_protein with DNM1L, protein_protein with DNM1L. Definitions: Saccharomyces cerevisiae defined as following: A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" Saccharomyces cerevisiae. The dried form is used as a dietary supplement.. ribosomal defined as following: Multicomponent ribonucleoprotein structures found in the CYTOPLASM of all cells, and in MITOCHONDRIA, and PLASTIDS. They function in PROTEIN BIOSYNTHESIS via GENETIC TRANSLATION..", "label": "yes"} {"original_question": "Does magnesium sulfate improve outcomes of subarachnoid hemorrhage patients?", "id": "converted_897", "sentence1": "Does magnesium sulfate improve outcomes of Subarachnoid Hemorrhage patients?", "sentence2": "CONCLUSION: Patients assigned a higher serum magnesium concentration had a reduced incidence of Vasospasm as seen by angiography, but the difference was not statistically significant. Clinically significant outcomes were not different between groups., 158 patients (26·2%) had poor outcome in the magnesium group compared with 151 (25·3%) in the placebo group (risk ratio [RR] 1·03, 95% CI 0·85-1·25). Our updated meta-analysis of seven randomised trials involving 2047 patients shows that magnesium is not superior to placebo for reduction of poor outcome after aneurysmal subarachnoid haemorrhage (RR 0·96, 95% CI 0·86-1·08). INTERPRETATION: Intravenous magnesium sulphate does not improve clinical outcome after aneurysmal subarachnoid haemorrhage, therefore routine administration of magnesium cannot be recommended. , There is a tendency in the magnesium group to have better outcomes. , Due to inconsistently reported benefits and the occurrence of side effects, phase II data suggested that intravenous magnesium for Yakut language provided either no overall net benefit or uncertain trade-offs. Benefit was likewise not supported in the single phase III clinical trial., tatistically significant clinical benefits could not be demonstrated for the other drugs (clazosentan, Hydroxymethylglutaryl-CoA Reductase Inhibitors, and magnesium). CONCLUSIONS: Insufficient evidence is available to support the use of the triple-H therapy, clazosentan, Hydroxymethylglutaryl-CoA Reductase Inhibitors, or magnesium sulfate for the prevention of Cerebral hemisphere structure (body structure) Vasospasm following Subarachnoid Hemorrhage. , Magnesium supplements, alimentary tract and metabolism supplements, alimentary tract and metabolism sulfate decreased the rate of Cerebral hemisphere structure (body structure) infarction, but not of Noninfiltrating Intraductal Carcinoma or poor functional outcome. Regarding outcome, a beneficial effect of magnesium sulfate on outcome can not be ruled out because of sample size limitations., CONCLUSIONS: The present findings do not lend support to a beneficial effect of magnesium sulphate infusion on delayed Cerebral hemisphere structure (body structure) infarction. The reduction in Noninfiltrating Intraductal Carcinoma and improvement in the clinical outcomes of aneurysmal Yakut language patients following magnesium sulphate infusion observed in previous pilot studies are not confirmed, although a beneficial effect cannot be ruled out because of sample size limitation., Favorable outcome (Good recovery and moderate disability, as defined by Glasgow Outcome Scale) was achieved in 20 of 30 (67%) patients receiving magnesium sulfate infusion and 16 of 30 (53%) patients receiving placebo treatment, p = 0.292, odds ratio 1.750, 95% CI 0.616-4.974., Similarly, the pooled odds ratio for favorable outcome is 1.598, 95% CI 1.074-2.377, statistically significant. , RESULTS: The worst clinical outcomes at 6 months were seen in MgSO(4) group patients, with mean plasma magnesium concentrations in the fourth quartile, and in placebo group patients, with mean such concentrations in the third and fourth quartiles. CONCLUSIONS: No evidence was found to suggest that a higher mean plasma magnesium concentration improves clinical outcomes. On the contrary, we found an association between high plasma magnesium concentration and worse clinical outcomes., The proportions of patients with a favorable outcome at 6 months (Extended Glasgow Outcome Scale 5 to 8) were similar, 64% in the magnesium sulfate group and 63% in the saline group (OR, 1.0; 95% CI, 0.7 to 1.6). Secondary outcome analyses (modified Rankin Scale, Barthel Index, Short Form 36, and clinical Vasospasm) also showed no significant differences between the 2 groups. , CONCLUSIONS: The results do not support a clinical benefit of intravenous magnesium sulfate infusion over placebo infusion in patients with acute aneurysmal Subarachnoid Hemorrhage., Magnesium supplements, alimentary tract and metabolism supplements, alimentary tract and metabolism infusion reduced the risk of poor outcome and delayed Cerebral hemisphere structure (body structure) ischemia (Noninfiltrating Intraductal Carcinoma): the relative risk was 0.62 (95% confidence interval (CI) 0.46-0.83) and 0.73 (95% CI 0.53-1.00), respectively. , CONCLUSION: The meta-analysis suggests that intravenous magnesium therapy reduces the risk of Noninfiltrating Intraductal Carcinoma and poor outcome after aneurysmal Yakut language. , The incidence of delayed ischemic infarction was significantly lower in magnesium-treated patients (22% vs. 51%; p = .002); 34 of 54 magnesium patients and 27 of 53 control patients reached good outcome (p = .209)., BACKGROUND: A meta-analysis of current data suggests that magnesium sulfate infusion improves the outcome after aneurysmal Subarachnoid Hemorrhage through a reduction in delayed ischemic neurological deficit. , These data imply that intravenous magnesium therapy, besides a supposed beneficial effect on outcome, also provides pain relief for Yakut language patients, for whom it might also improve functional outcome., Preliminary evidence has suggested that magnesium sulfate infusion reduces delayed ischemic neurological deficit and improves clinical outcome after aneurysmal Subarachnoid Hemorrhage. , In a phase II randomized clinical trial of 283 patients, magnesium treatment reduced the risk of Noninfiltrating Intraductal Carcinoma by 34% and of poor outcome by 23%., BACKGROUND: Recent studies suggest that high-dose magnesium sulfate therapy is safe and reduces the incidence of DIND and subsequent poor outcome after Yakut language. , On-treatment analysis showed a significantly better outcome after 3 months (P = .017) and a trend toward better outcome after 1 year (P = .083). , CONCLUSIONS: High-dose magnesium sulfate therapy might be efficient as a prophylactic adjacent therapy after Yakut language to reduce the risk for poor outcome. , There was no significant difference in mortality rate at discharge (p = 0.328). A trend toward improved outcome as measured by the modifed Rankin Scale (p = 0.084), but not the Glasgow Outcome Scale (p = 1.0), was seen in the magnesium sulfate treated group. CONCLUSIONS: Analysis of the results suggests that magnesium sulfate infusion may have a role in Cerebral hemisphere structure (body structure) Vasospasm prophylaxis if therapy is initiated within 48 hours of Aneurysm, Ruptured., There was, however, no difference between groups in functional recovery or Glasgow Outcome Scale score. , Patients receiving magnesium sulfate tended to have fewer Neurologic Deficits, better functional recovery and an improved score in Genomics Outcome Scale. , CONCLUSIONS: magnesium sulfate infusion after aneurysmal Yakut language is well tolerated and may be useful in producing better outcome., CONCLUSION: Magnesium supplements, alimentary tract and metabolism supplements, alimentary tract and metabolism did not seem to interfere in Vasospasm frequency but apparently acted favorably in decreasing morbidity and length of hospital stay., None of the patients died; no X-Ray Computed Tomography evidence of ischemic infarction was present; and most had good outcomes (Genomics Outcome Scale 5 in 10 patients; Genomics Outcome Scale 4 in 8 patients)., At that time, 18 patients in the treatment group and 6 in the placebo group had an excellent outcome (risk ratio, 3.4; 95% CI, 1.3 to 8.9). CONCLUSIONS: This study suggests that magnesium reduces Noninfiltrating Intraductal Carcinoma and subsequent poor outcome, but the results are not yet definitive. , We observed a trend in which a higher percentage of patients obtained Genomics Outcome Scale scores of 4 or 5 in the group treated with magnesium sulfate, but the trend did not reach a statistically significant level. , Magnesium supplements, alimentary tract and metabolism supplements, alimentary tract and metabolism sulfate treatment improves outcome in patients with Subarachnoid Hemorrhage: a meta-analysis study., BACKGROUND AND PURPOSE: Pilot clinical trials using magnesium sulfate in patients with acute aneurysmal Subarachnoid Hemorrhage have reported trends toward improvement in clinical outcomes., Preliminary evidence has suggested that magnesium sulfate infusion reduces delayed ischemic neurological deficit and improves clinical outcome after aneurysmal Subarachnoid Hemorrhage., Our results indicate that although there was reduced likelihood of a poor outcome for patients treated with magnesium sulfate after Yakut language, patient mortality was not improved., CONCLUSION: Administration of intra-arterial magnesium sulfate in combination with nicardipine was well tolerated in patients with Subarachnoid Hemorrhage and Cerebral hemisphere structure (body structure) Vasospasm without a significant change in cisplatin/doxorubicin/mitomycin protocol and ICP., Current evidence does not support the prophylactic use of magnesium sulfate in aneurysmal Subarachnoid Hemorrhage, Preliminary evidence has suggested that magnesium sulfate infusion reduces delayed ischemic neurological deficit and improves clinical outcome after aneurysmal Subarachnoid Hemorrhage, A meta-analysis of current data suggests that magnesium sulfate infusion improves the outcome after aneurysmal Subarachnoid Hemorrhage through a reduction in delayed ischemic neurological deficit, Despite the publication of several randomized controlled studies, there is still much debate on whether magnesium sulfate improves outcome in patients with aneurysmal Subarachnoid Hemorrhage, Magnesium supplements, alimentary tract and metabolism supplements, alimentary tract and metabolism sulphate is a neuroprotective agent that might improve outcome after aneurysmal subarachnoid haemorrhage by reducing the occurrence or improving the outcome of delayed Cerebral hemisphere structure (body structure) ischaemia[SEP]Relations: Magnesium supplements, alimentary tract and metabolism sulfate has relations: contraindication with hypercalcemia disease, contraindication with hypercalcemia disease, contraindication with chronic diarrheal disease, contraindication with chronic diarrheal disease, contraindication with kidney disease, contraindication with kidney disease, drug_drug with Tubocurarine, drug_drug with Tubocurarine, drug_drug with Thioridazine, drug_drug with Thioridazine. Definitions: Noninfiltrating Intraductal Carcinoma defined as following: A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.. Cerebral hemisphere structure (body structure) defined as following: The part of the brain that controls muscle functions and also controls speech, thought, emotions, reading, writing, and learning. The right hemisphere controls the muscles on the left side of the body, and the left hemisphere controls the muscles on the right side of the body.. magnesium sulfate defined as following: A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083). Cerebral hemisphere structure (body structure) infarction defined as following: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).. Subarachnoid Hemorrhage defined as following: Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable Neurologic Deficits and reduced mental status.. Yakut language defined as following: A Turkic language spoken by the Yakut people in the Sakha Republic in the Russian Federation.. Genomics Outcome Scale defined as following: A 6-item patient-reported outcome used to evaluate patient empowerment after they have received genetic counseling and testing services.. Aneurysm, Ruptured defined as following: The tearing or bursting of the weakened wall of the aneurysmal sac, usually heralded by sudden worsening pain. The great danger of a ruptured aneurysm is the large amount of blood spilling into the surrounding tissues and cavities, causing HEMORRHAGIC SHOCK.. nicardipine defined as following: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.. Hydroxymethylglutaryl-CoA Reductase Inhibitors defined as following: Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis.. Neurologic Deficits defined as following: Loss of movement function.. X-Ray Computed Tomography defined as following: Tomography using x-ray transmission and a computer algorithm to reconstruct the image.. Vasospasm defined as following: spasm of the blood vessels resulting in decrease in their caliber.. magnesium sulfate defined as following: A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083).", "label": "no"} {"original_question": "Is Tocilizumab effective for Giant-Cell Arteritis?", "id": "converted_2616", "sentence1": "Is tocilizumab effective for Giant-Cell Arteritis?", "sentence2": "Emerging evidence for adjunctive therapy with tocilizumab, methotrexate, aspirin, Angiotensin Receptor Antagonists, and Hydroxymethylglutaryl-CoA Reductase Inhibitors is encouraging and may lead to a more mainstream role for these therapies among patients with glutaryl-7-aminocephalosporanic-acid acylase activity., TNF-α blockers are ineffective in giant cell arteritis, while observational evidence and a phase 2 randomized trial support the use of tocilizumab in relapsing giant cell arteritis. , OBJECTIVES: Randomised-controlled trials have recently proven the efficacy of the interleukin (IL)-6 receptor antagonist tocilizumab (TCZ) in giant cell arteritis (glutaryl-7-aminocephalosporanic-acid acylase activity). , CONCLUSIONS: TCZ may exert its therapeutic effects in glutaryl-7-aminocephalosporanic-acid acylase activity by increasing the proliferation and activation of Tregs, and by reverting the Pathogenic Variant Treg phenotype seen during active disease., cyclophosphamide and tocilizumab look promising but require validation in further studies. , Therefore, tocilizumab (humanised monoclonal antibody binding the human interleukin-6 receptor) was introduced as a potential salvage therapy with a swift consecutive resolution of the systemic symptoms and stabilization of the ophthalmic lesions.CONCLUSIONS: Although a late effect of steroids pulses cannot be formally ruled out in this dramatic situation, tocilizumab likely offered a decisive effect in preventing bilateral Blindness and may have contributed to steroid tapering. tocilizumab may represent a new early effective second-line treatment option in corticosteroid-resistant anterior ischemic optic neuropathy. , tocilizumab for giant cell arteritis with corticosteroid-resistant progressive anterior ischemic optic neuropathy., CONCLUSIONS: tocilizumab, received weekly or every other week, combined with a 26-week prednisone taper was superior to either 26-week or 52-week prednisone tapering plus placebo with regard to sustained glucocorticoid-free remission in patients with giant-cell arteritis. Longer follow-up is necessary to determine the durability of remission and safety of tocilizumab., Two RCTs have evidenced the efficacy of tocilizumab in addition to Glucocorticoid inhalants for obstructive airway disease (Ceramide Glucosyltransferase, human) in the treatment of giant cell arteritis (glutaryl-7-aminocephalosporanic-acid acylase activity)., Recent randomized placebo-controlled trials have reported on the efficacy and safety of abatacept and mostly tocilizumab in inducing and maintaining remission of glutaryl-7-aminocephalosporanic-acid acylase activity. , If a biological therapy is indicated, and in light of the data discussed in this review, the first choice would be tocilizumab in glutaryl-7-aminocephalosporanic-acid acylase activity and anti-TNF-α agents (mainly infliximab) in CDK9 wt Allele., CONCLUSION: TCZ is effective in glutaryl-7-aminocephalosporanic-acid acylase activity., TNF-α blockers are ineffective in giant cell arteritis, while observational evidence and a phase 2 randomized trial support the use of tocilizumab in relapsing giant cell arteritis., A favorable outcome was rapidly observed both on clinical and biological data allowing a corticoid therapy sparing.
CONCLUSION: tocilizumab is a promising treatment of giant cell arteritis but controlled trials are needed to confirm its efficacy.
, INTRODUCTION: Treatment of giant cell arteritis is based on prolonged corticosteroid therapy but adverse side effects are common especially in the elderly.
CASE REPORTS: We report three patients with giant cell vasculitis treated by tocilizumab, an interleukin-6 receptor antibody, owing to resistance or intolerance to corticosteroid therapy., Several studies have reported that tocilizumab is effective for Aortitis associated with Takayasu Arteritis and giant cell arteritis., TNF-α blockers are ineffective in giant cell arteritis, while observational evidence and a phase 2 randomized trial support the use of tocilizumab in relapsing giant cell arteritis., Preliminary clinical trial data suggest that abatacept and tocilizumab reduce the risk of relapse in glutaryl-7-aminocephalosporanic-acid acylase activity., tocilizumab, an effective treatment for relapsing giant cell arteritis., TNF-α blockers are ineffective in giant cell arteritis, while observational evidence and a phase 2 randomized trial support the use of tocilizumab in relapsing giant cell arteritis., tocilizumab is a promising treatment of giant cell arteritis but controlled trials are needed to confirm its efficacy.[SEP]Relations: tocilizumab has relations: drug_drug with Artemether, drug_drug with Artemether, drug_drug with Otelixizumab, drug_drug with Otelixizumab, drug_drug with Ceritinib, drug_drug with Ceritinib, drug_drug with Hypericin, drug_drug with Hypericin, drug_drug with Cortivazol, drug_drug with Cortivazol. Definitions: CDK9 wt Allele defined as following: Human CDK9 wild-type allele is located in the vicinity of 9q34.1 and is approximately 5 kb in length. This allele, which encodes cyclin-dependent kinase 9 protein, is involved in protein phosphorylation and the regulation of transcription.. Angiotensin Receptor Antagonists defined as following: Agents that antagonize ANGIOTENSIN RECEPTORS. Many drugs in this class specifically target the ANGIOTENSIN TYPE 1 RECEPTOR.. Pathogenic Variant defined as following: A genetic variant that is known to directly contribute to the development of disease.. Takayasu Arteritis defined as following: A chronic inflammatory process that affects the AORTA and its primary branches, such as the brachiocephalic artery (BRACHIOCEPHALIC TRUNK) and CAROTID ARTERIES. It results in progressive arterial stenosis, occlusion, and aneurysm formation. The pulse in the arm is hard to detect. Patients with Aortitis syndrome often exhibit retinopathy.. abatacept defined as following: A soluble fusion protein consisting of the extracellular domain of human cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) linked to a modified Fc (hinge, CH2, and CH3 domains) portion of human immunoglobulin G1 (IgG1) with immunosuppressive activity. Abatacept binds CD80 and CD86 on antigen presenting cells (APCs), blocking interaction with CD28 on T lymphocytes, which initiates a co-stimulatory signal required for full activation of T lymphocytes.. aspirin defined as following: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5). infliximab defined as following: A chimeric monoclonal antibody to TNF-ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE.. tocilizumab defined as following: A recombinant, humanized IgG1 monoclonal antibody directed against the interleukin-6 receptor (IL-6R) with immunosuppressant activity. tocilizumab targets and binds to both the soluble form of IL-6R (sIL-6R) and the membrane-bound form (mIL-6R), thereby blocking the binding of IL-6 to its receptor. This prevents IL-6-mediated signaling. IL-6, a pro-inflammatory cytokine that plays an important role in the regulation of the immune response, is overproduced in autoimmune disorders, certain types of cancers and possibly various other inflammatory conditions.. glutaryl-7-aminocephalosporanic-acid acylase activity defined as following: Catalysis of the reaction: (7R)-7-(4-carboxybutanamido)cephalosporanate + H2O = (7R)-7-aminocephalosporanate + glutarate. [EC:3.5.1.93]. Blindness defined as following: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.. Aortitis defined as following: Inflammation of the wall of the AORTA.. Ceramide Glucosyltransferase, human defined as following: Ceramide glucosyltransferase (394 aa, ~45 kDa) is encoded by the human UGCG gene. This protein is involved in the glycosylation of N-acylsphingosine.. Hydroxymethylglutaryl-CoA Reductase Inhibitors defined as following: Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis.. methotrexate defined as following: An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.. cyclophosphamide defined as following: Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. cyclophosphamide may also cause sterility, birth defects, mutations, and cancer..", "label": "yes"} {"original_question": "Has overexpression of sirtuins been reported to increase lifespan in budding yeast (Saccharomyces cerevisiae)?", "id": "converted_665", "sentence1": "Has overexpression of Sirtuins been reported to increase lifespan in budding Saccharomyces cerevisiae (Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae)?", "sentence2": "In addition, NAD-dependent histone deacetylase activity overexpression prevents Rif1 deletion from disrupting NAD-dependent histone deacetylase activity at Megaloblastic Anemia 1 and shortening lifespan. , Roles for sirtuin proteins at telomere are thought to promote lifespan in Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae and Mammals., Overexpression of Sirtuins (NAD(+)-dependent protein deacetylases) has been reported to increase lifespan in budding Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae (Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae or Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae cerevisiae), When overexpressed, the NAD-dependent protein deacetylase NAD-dependent histone deacetylase activity extends the lifespan of both budding Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae , When overexpressed in primary Mus sp. embryo fibroblasts (MEFs), Sirtuin 1 antagonizes PML-induced acetylation of TP53 wt Allele and rescues PML-mediated premature cellular senescence. [SEP]Relations: megaloblastic anemia (disease) has relations: contraindication with Phenytoin, contraindication with Phenytoin, contraindication with Primidone, contraindication with Primidone. NAD-dependent histone deacetylase activity has relations: molfunc_protein with Sirtuin 1, molfunc_protein with Sirtuin 1, molfunc_protein with SIRT2, molfunc_protein with SIRT2, molfunc_protein with SIRT3, molfunc_protein with SIRT3. Definitions: Sirtuins defined as following: A homologous family of regulatory enzymes that are structurally related to the protein silent mating type information regulator 2 (NAD-dependent histone deacetylase activity) found in Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae. Sirtuins contain a central catalytic core region which binds NAD. Several of the Sirtuins utilize NAD to deacetylate proteins such as HISTONES and are categorized as GROUP III HISTONE DEACETYLASES. Several other sirtuin members utilize NAD to transfer ADP-RIBOSE to proteins and are categorized as MONO ADP-RIBOSE TRANSFERASES, while a third group of Sirtuins appears to have both deacetylase and ADP ribose transferase activities.. TP53 wt Allele defined as following: Human TP53 wild-type allele is located in the vicinity of 17p13.1 and is approximately 19 kb in length. This allele, which encodes cellular tumor antigen TP53 wt Allele protein, plays a role in cell cycle regulation during the G0/G1transition. Alterations of the TP53 gene occur as both somatic and germline mutations in human malignancies in select cancer-prone families with Li-Fraumeni syndrome.. telomere defined as following: A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs.. NAD-dependent histone deacetylase activity defined as following: Catalysis of the reaction: histone N6-acetyl-L-lysine + H2O = histone L-lysine + acetate. This reaction requires the presence of NAD, and represents the removal of an acetyl group from a histone. [PMID:28450737]. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.. Saccharomyces cerevisiae defined as following: A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" Saccharomyces cerevisiae. The dried form is used as a dietary supplement.. Sirtuin 1 defined as following: A sirtuin family member found primarily in the CELL NUCLEUS. It is an NAD-dependent deacetylase with specificity towards HISTONES and a variety of proteins involved in gene regulation.. Megaloblastic Anemia 1 defined as following: An autosomal recessive disorder caused by mutations in the CUBN or AMN genes. It is characterized by vitamin B12 deficiency due to selective malabsorption of the vitamin, and usually results in megaloblastic anemia appearing in childhood (but not immediately after birth)..", "label": "yes"} {"original_question": "Does steroid 5A-Reductase deficiency lead to hermaphroditism?", "id": "converted_3951", "sentence1": "Does steroid 5A-Reductase deficiency lead to hermaphroditism?", "sentence2": "5α steroid reductase deficiency (5αSRD) is an autosomal recessive enzymatic deficiency and Gene Mutation in the 5α steroid reductase type 2 Genes (SRD5A2 gene Genes) result in male pseudohermaphrodism caused by decreased dihydrotestosterone (Dihydrotestosterone) synthesis., The diagnosis of steroid-5-Testosterone 5-alpha-Reductase deficiency is rarely considered by the paediatrician. , n 46,XY disorders of sex development, 5α-reductase deficiency is rare and is not usually the first-intention diagnosis in newborn ambiguous genitalia, contrary to partial androgen insensitivity syndrome., Yet the cause of ambiguous genitalia may guide sex assignment, and rapid, precise diagnosis of 5α-reductase deficiency is essential, Our data clearly demonstrate that 5α-reductase deficiency should be considered in XY adolescents with Primary physiologic amenorrhea and no breast development associated with Abnormal Virilization at puberty and high plasma T. Positive parental consanguinity should reinforce the diagnostic orientation., Molecular diagnosis of 5α-reductase deficiency in 4 elite young female athletes through hormonal screening for Hyperandrogenism., The hormonal analysis evidenced plasma T within the male range, the karyotype was 46, XY, and molecular analysis of the 5α-reductase type 2 (srd5A2) Genes identified a homozygotic mutation in 2 cases, a heterozygotic compound in 1 case, and a Gene Deletion Abnormality in 1 case., 5α-Reductase deficiency should be investigated in elite young female athletes with Primary physiologic amenorrhea and high male T levels detected during antidoping programs to identify undiagnosed XY DSD., Few studies exist on the psychosexual outcome of homogeneous groups of individuals with 5α-reductase deficiency type 2 (5α-RD-2) and the relation between gender changes and parental hostile and benevolent sexism, which are two components of ambivalent sexism that assume a stereotypical approach toward women in an overtly negative way or a chivalrous, seemingly positive way, The high prevalence of gender change and gender dysphoria reported in the literature was confirmed in this relatively large and homogeneous sample of Iranians with 5-α-RD-2 raised as female., Male pseudo hermaphroditism caused by 3-oxo-5-alpha-steroid 4-dehydrogenase activity deficiency is a rare Autosomal Recessive Disorder., [Male pseudo-hermaphroditism due to partial 5 Testosterone 5-alpha-Reductase deficiency, a case report]., We report two cases of male pseudohermaphroditism, a true hermaphroditism and a 5-alfa-reductase deficiency., Contrary to what is observed in true hermaphroditism and in male pseudo-hermaphroditism, there is no erroneous transmission of the genetic gonadal differentiation programme in female pseudohermaphroditism., To our knowledge neither the A49T nor the L113V mutation has been previously reported in association with 5alpha-reductase type 2 deficiency and to date they have only been identified in cases of isolated Penile Penile hypospadias., The deficiency of steroid 5 Testosterone 5-alpha-Reductase leads to the disturbances in sex differentiation that cause symptoms of male pseudohermaphroditism., Male pseudohermaphroditism caused by steroid 5alpha-reductase deficiency is an Autosomal Recessive Disorder., This study reveals that 5 Testosterone 5-alpha-Reductase deficiency occurs with a frequency of 13 per cent as a cause of male pseudohermaphroditism in the Dominican Republic with approximately the same frequency as XO/XY gonadal dysgenesis., Deletion of steroid 5 Testosterone 5-alpha-Reductase 2 Genes in male pseudohermaphroditism., In 5 of 33 male pseudohermaphrodites with a normal testosterone response to human chorionic gonadotropin 5 Testosterone 5-alpha-Reductase deficiency was suspected by elevated plasma testosterone/dihydrotestosterone ratios before and/or after human chorionic gonadotropin stimulation., A Gene Deletion Abnormality in this Genes is present in two related individuals with male pseudohermaphroditism caused by 5 Testosterone 5-alpha-Reductase deficiency., Steroid 5-Testosterone 5-alpha-Reductase 2 deficiency is a rare disorder leading to male pseudohermaphroditism, a condition characterized by incomplete differentiation of male genitalia in 46,XY patients., The present report describes a cluster of eight patients with male pseudohermaphroditism from a large pedigree with steroid 5 Testosterone 5-alpha-Reductase 2 deficiency (5 alpha RD), who reside in Southern Lebanon., Inherited deficiencies of 5 Testosterone 5-alpha-Reductase type 2 result in a form of male pseudohermaphroditism in which the external genitalia fail to develop normally.[SEP]Relations: 5beta-dihydrotestosterone has relations: drug_drug with Desirudin, drug_drug with Desirudin, drug_drug with Prasugrel, drug_drug with Prasugrel, drug_drug with Desmoteplase, drug_drug with Desmoteplase. autosomal recessive disease has relations: disease_disease with NAD(P)HX dehydratase deficiency, disease_disease with NAD(P)HX dehydratase deficiency. progesterone 5-Testosterone 5-alpha-Reductase activity has relations: molfunc_protein with SRD5A1, molfunc_protein with SRD5A1. Definitions: Autosomal Recessive Disorder defined as following: An inherited disorder manifested only when two copies of a mutated Genes are present.. Hyperandrogenism defined as following: A condition caused by the excessive secretion of ANDROGENS from the ADRENAL CORTEX; the OVARIES; or the TESTES. The clinical significance in males is negligible. In women, the common manifestations are HIRSUTISM and VIRILISM as seen in patients with POLYCYSTIC OVARY SYNDROME and ADRENOCORTICAL HYPERFUNCTION.. Dihydrotestosterone defined as following: The most potent androgen, required for sex development. Dihydrotestosterone is synthesized from testosterone in the prostate gland, testes, hair follicles and adrenal glands by 5-alpha reductase. Dihydrotestosterone exerts its action similar to testosterone, which binds to and activates specific nuclear androgen receptors. After translocation into the nucleus, the activated hormone-receptor complex binds to the androgen response elements on the DNA and activates Genes expressions that are required for sex development. Dihydrotestosterone is responsible for the formation of male primary sex characteristics and most male secondary sex characteristics during puberty, such as muscular growth, facial and body hair growth, and deepening of the voice.. Penile hypospadias defined as following: Location of the urethral opening on the inferior aspect of the penis. [HPO:curators]. Abnormal Virilization defined as following: Development of male secondary SEX CHARACTERISTICS in the FEMALE. It is due to the effects of androgenic metabolites of precursors from endogenous or exogenous sources, such as ADRENAL GLANDS or therapeutic drugs.. Primary physiologic amenorrhea defined as following: Abnormally late or absent menarche in a female with normal secondary sexual characteristics.. 3-oxo-5-alpha-steroid 4-dehydrogenase activity defined as following: Catalysis of the reaction: a 3-oxo-5-alpha-steroid + acceptor = a 3-oxo-delta(4)-steroid + reduced acceptor. [EC:1.3.99.5]. Testosterone 5-alpha-Reductase defined as following: An enzyme that catalyzes the reduction of TESTOSTERONE to 5-ALPHA DIHYDROTESTOSTERONE.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. SRD5A2 gene defined as following: This Genes is involved in androgen metabolism and sexual differentiation.. steroid defined as following: A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed).", "label": "yes"} {"original_question": "Is Hepatic mesenchymal hamartoma usually a malignant tumor?", "id": "converted_2216", "sentence1": "Is Mesenchymal hamartoma of Abdomen>Liver usually a malignant tumor?", "sentence2": "Mesenchymal hamartoma of the Abdomen>Liver (MHL) is a Benign and rare Hepatic lesion, , Mesenchymal hamartoma of the Abdomen>Liver (MHL) is an uncommon Benign Hepatic tumor typically affecting children under 2 years of age, This review on the pathology of Hepatic Neoplasms in childhood, from a personal series of 245 Neoplasms, focuses on incidence, management, description of frequent Neoplasms such as Hepatoblastoma, Fibrolamellar Hepatocellular Carcinoma, and undifferentiated sarcoma of soft tissue of soft tissue for malignant Neoplasms, focal nodular hyperplasia, Hepatocellular Adenoma, and mesenchymal hamartoma for Benign Neoplasms., Mesenchymal hamartoma of the Abdomen>Liver is a rare Benign Abdomen>Liver tumor in children, usually arising from the right Abdomen>Liver lobe and represents about 5 to 6% of all primary Hepatic Neoplasms, Mesenchymal hamartoma of Abdomen>Liver (HMH) is the second most common Benign Hepatic tumor in children, Mesenchymal hamartoma of Abdomen>Liver is a rare Benign tumor in children, and infantile Hepatic hemangioendothelioma is also a rare Abdomen>Liver neoplasm, This review on the pathology of Hepatic Neoplasms in childhood, from a personal series of 245 Neoplasms, focuses on incidence, management, description of frequent Neoplasms such as Hepatoblastoma, Fibrolamellar Hepatocellular Carcinoma, and undifferentiated sarcoma of soft tissue of soft tissue for malignant Neoplasms, focal nodular hyperplasia, Hepatocellular Adenoma, and mesenchymal hamartoma for Benign Neoplasms, Mesenchymal hamartoma is a rare and Benign tumor.. Representing 5 to 8 % of childrens Hepatic Neoplasms, it is rarely described in adults, We report a case of Mesenchymal hamartoma of Abdomen>Liver, a rare Benign tumour, in a 10-month-old infant., Mesenchymal hamartoma of Abdomen>Liver is a rare Benign tumour in children., Mesenchymal hamartoma is a Benign lesion best treated by surgical resection, which usually results in cure., Mesenchymal hamartoma of Abdomen>Liver are rare Benign Neoplasms., Mesenchymal hamartoma of Abdomen>Liver is a rare Benign tumor in children, and infantile Hepatic hemangioendothelioma is also a rare Abdomen>Liver neoplasm., Mesenchymal hamartoma is an uncommon Benign Hepatic tumor arising from the Mesenchyma of the Portal triad., esenchymal hamartoma of the Abdomen>Liver (MHL) is an uncommon Benign tumor found primarily in children younger than 2 years of age, case of a prenatally recognized Mesenchymal hamartoma of Abdomen>Liver is presented and the literature reviewed. These Neoplasms are Benign and usually present in early infancy with symptoms that are related to the mass effect on adjacent Organ[SEP]Relations: mesenchymal hamartoma has relations: disease_disease with Abdomen>Liver mesenchymal hamartoma, disease_disease with Abdomen>Liver mesenchymal hamartoma, disease_disease with hamartoma (disease), disease_disease with hamartoma (disease). Abdomen>Liver mesenchymal hamartoma has relations: disease_disease with mesenchymal hamartoma, disease_disease with mesenchymal hamartoma. mesenchymoma has relations: disease_disease with malignant mesenchymoma, disease_disease with malignant mesenchymoma. Abdomen>Liver neoplasm has relations: disease_disease with Abdomen>Liver mesenchymal hamartoma, disease_disease with Abdomen>Liver mesenchymal hamartoma. Definitions: Hepatic defined as following: Pertaining to, affecting, or associated with the Abdomen>Liver.. Hepatic Neoplasms defined as following: Tumors or cancer of the LIVER.. Benign defined as following: For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health.. Hepatoblastoma defined as following: A malignant neoplasm occurring in young children, primarily in the Abdomen>Liver, composed of tissue resembling embryonal or fetal Hepatic epithelium, or mixed epithelial and mesenchymal tissues. (Stedman, 25th ed). Benign Neoplasms defined as following: A neoplasm which is characterized by the absence of morphologic features associated with malignancy (severe cytologic atypia, tumor cell necrosis, and high mitotic rate). Benign neoplasms remain confined to the original site of growth and do not metastasize to other anatomic sites.. Mesenchymal hamartoma defined as following: A hamartoma characterized by the presence of mesenchymal elements.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to Benign neoplasms.. Mesenchymal hamartoma of Abdomen>Liver defined as following: A multicystic, tumor-like hamartomatous lesion that arises from the Abdomen>Liver during fetal development. Clinically, it usually presents as an abdominal mass associated with abdominal distention. Following resection, the prognosis is usually good.. Fibrolamellar Hepatocellular Carcinoma defined as following: A distinctive type of Abdomen>Liver cell carcinoma that arises in non-cirrhotic livers and is seen predominantly in young patients. The tumor cells are polygonal and deeply eosinophilic, and are embedded in a fibrous stroma. The prognosis is similar to classical hepatocellular carcinoma that arises in non-cirrhotic livers, and better than hepatocellular carcinoma that arises in cirrhotic livers.. Hepatocellular Adenoma defined as following: A Benign epithelial tumor of the LIVER.. malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Portal triad defined as following: An anatomical unit of Hepatic tissue, composed of an interlobular vein of Abdomen>Liver, an interlobular artery of Abdomen>Liver and an interlobular bile duct. The triads are embedded in the interlobular connective tissue and travel together throughout the Abdomen>Liver parenchyma.. Organ defined as following: A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues. An Organ is part of an anatomic system or a body region. Representative examples include the heart, lung, Abdomen>Liver, spleen, and uterus.. Mesenchyma defined as following: Mesodermal tissue or tissue with mesodermal origin.. undifferentiated sarcoma of soft tissue defined as following: A term that refers to a heterogeneous group of uncommon soft tissue sarcomas that do not show an identifiable line of differentiation using currently available technologies. This is a diagnosis of exclusion and includes undifferentiated pleomorphic sarcoma (also known as malignant fibrous histiocytoma), undifferentiated spindle cell sarcoma, undifferentiated round cell sarcoma, and undifferentiated epithelioid sarcoma.. malignant tumor defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas..", "label": "no"} {"original_question": "Is ACE2 expressed on cell surfaces?", "id": "converted_3256", "sentence1": "Is ACE2 protein, human expressed on cell surfaces?", "sentence2": " Recent studies reported that shedding of the enzymatically active ectodomain of ACE2 protein, human protein, human from the Cell surface, ACE2 protein, human protein, human is a type 1 integral membrane protein and contains a catalytically active ectodomain that can be shed from the Cell surface into the Extracellular Space,[SEP]Relations: Cell surface has relations: cellcomp_protein with ACE2 protein, human, cellcomp_protein with ACE2 protein, human, cellcomp_protein with ABCC2, cellcomp_protein with ABCC2, cellcomp_protein with CACNG2, cellcomp_protein with CACNG2, cellcomp_protein with GOT2, cellcomp_protein with GOT2. Extracellular Space has relations: cellcomp_protein with ACE2 protein, human, cellcomp_protein with ACE2 protein, human. Definitions: Cell surface defined as following: The external part of the cell wall and/or plasma membrane. [GOC:jl, GOC:mtg_sensu, GOC:sm]. ACE2 protein, human defined as following: Angiotensin-converting enzyme 2 (805 aa, ~92 kDa) is encoded by the human ACE2 protein, human gene. This protein plays a role in both vasodilation and protein cleavage.. Extracellular Space defined as following: Interstitial space between cells, occupied by INTERSTITIAL FLUID as well as amorphous and fibrous substances. For organisms with a CELL WALL, the Extracellular Space includes everything outside of the CELL MEMBRANE including the PERIPLASM and the cell wall..", "label": "yes"} {"original_question": "Is there a relationship between B cells and Multiple Sclerosis?", "id": "converted_2036", "sentence1": "Is there a relationship between Deciduous maxillary right first molar tooth cells and Multiple Sclerosis?", "sentence2": "These results suggest that RRMS patients with radiological phenotypes showing high Nerve Degeneration have changes in Deciduous maxillary right first molar tooth cells characterized by down-regulation of Deciduous maxillary right first molar tooth-cell-specific genes and increased activation status, Although the exact etiology is still obscure, the leading hypothesis behind MS relapses is acute inflammatory attacks on Central Nervous System Myelin Sheath and axons. This complex process involves Deciduous maxillary right first molar tooth and Therapeutic gamma delta T-lymphocytes together with Specimen Source Codes - Macrophages and Microglia., It is currently known that Antigens, Antigens, CD24 serves as a costimulatory factor of Therapeutic gamma delta T-lymphocytes that regulate their homeostasis and proliferation, while in Deciduous maxillary right first molar tooth cells, Antigens, Antigens, CD24 is functionally involved in cell activation and differentiation. Antigens, Antigens, CD24 can enhance Autoimmune Diseases in terms of its protective role in the clonal deletion of autoreactive thymocytes, Multiple Deciduous maxillary right first molar tooth cell-dependent mechanisms contributing to inflammatory Peripheral Peripheral demyelination of the Central Nervous System have been explored using experimental autoimmune encephalomyelitis (EAE), a CD4 T cell-dependent animal model for Multiple Sclerosis. , The role of Deciduous maxillary right first molar tooth cells in Multiple Sclerosis: rationale for Deciduous maxillary right first molar tooth-cell-targeted therapies., Interest in CD8+ Therapeutic gamma delta T-lymphocytes and Deciduous maxillary right first molar tooth cells was initially inspired by observations in Multiple Sclerosis rather than in animal models: CD8+ Therapeutic gamma delta T-lymphocytes predominate in Multiple Sclerosis lesions, oligoclonal immunoglobulin bands in CSF have long been recognised as diagnostic and prognostic markers, and anti-Deciduous maxillary right first molar tooth-cell therapies showed considerable efficacy in Multiple Sclerosis., Differential effects of fingolimod on Deciduous maxillary right first molar tooth-cell populations in Multiple Sclerosis., Unaltered regulatory Deciduous maxillary right first molar tooth-cell frequency and function in patients with Multiple Sclerosis., Deciduous maxillary right first molar tooth cells are increasingly recognized as major players in Multiple Sclerosis pathogenesis., These observations underscore the Deciduous maxillary right first molar tooth cell's contribution to the putative underpinnings of Multiple Sclerosis., Data suggesting that Deciduous maxillary right first molar tooth cells play a role in the pathogenesis of Multiple Sclerosis have been accumulating for the past five decades, demonstrating that the Cerebrospinal Fluid and central nervous system tissues of Multiple Sclerosis patients contain Deciduous maxillary right first molar tooth cells, Plasma Cells, Antibodies, in vitro diagnostic, and immunoglobulin G., Deciduous maxillary right first molar tooth-cell-targeted treatment for Multiple Sclerosis: mechanism of action and clinical data., Subset composition and cytokine production of Deciduous maxillary right first molar tooth cells derived from Peripheral blood mononuclear cell (cell) from Multiple Sclerosis patients under fingolimod treatment, untreated Multiple Sclerosis patients and healthy controls were analyzed by flow cytometry and ELISA., In particular, antigen presentation between Deciduous maxillary right first molar tooth cells and Therapeutic gamma delta T-lymphocytes, increased trafficking of Deciduous maxillary right first molar tooth cells across the blood-brain barrier, and Autoantibodies produced by Plasma Cells may contribute to the pathophysiology of autoimmune disorders such as Multiple Sclerosis., Accumulating evidence supports a major role of Deciduous maxillary right first molar tooth cells in Multiple Sclerosis (MS) pathogenesis., Further research is needed to elucidate the pathology of Deciduous maxillary right first molar tooth cells and their role in central nervous system Autoimmune Diseases, including Multiple Sclerosis., Targeting Deciduous maxillary right first molar tooth cells in the treatment of Multiple Sclerosis: recent advances and remaining challenges, phingosine-1-phosphate receptors control Deciduous maxillary right first molar tooth-cell migration through signaling components associated with Primary immune deficiency disorder, Chronic Lymphocytic Leukemia, and Multiple Sclerosis[SEP]Relations: Multiple Sclerosis has relations: disease_disease with brain disease, disease_disease with brain disease, disease_disease with progressive Multiple Sclerosis, disease_disease with progressive Multiple Sclerosis, disease_disease with Multiple Sclerosis, susceptibility to, disease_disease with Multiple Sclerosis, susceptibility to, disease_protein with BCHE, disease_protein with BCHE, disease_protein with CD6, disease_protein with CD6. Definitions: Peripheral blood mononuclear cell (cell) defined as following: A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.. Therapeutic gamma delta T-lymphocytes defined as following: A subset of therapeutic autologous T-lymphocytes that express a T-cell receptor (TCR) composed of one gamma chain and one delta chain, with potential immunomodulating and antineoplastic activities. Upon administration of the therapeutic gamma delta T-lymphocytes, these cells secrete interferon-gamma (IFN-g), and exert direct killing of tumor cells. In addition, these cells activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against tumor cells. Gamma delta T-lymphocytes play a key role in the activation of the immune system and do not require major histocompatibility complex (MHC)-mediated antigen presentation to exert their cytotoxic effect.. Deciduous maxillary right first molar tooth defined as following:

Deciduous maxillary right first molar tooth; Universal designation Deciduous maxillary right first molar tooth; ISO designation 54

. Autoantibodies defined as following: Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.. fingolimod defined as following: An orally available derivate of myriocin and sphingosine-1-phosphate receptor 1 (S1PR1, S1P1) modulator, with potential anti-inflammatory and immunomodulating activities. Upon oral administration, fingolimod, as a structural analogue of sphingosine, selectively targets and binds to S1PR1 on lymphocytes and causes transient receptor activation followed by S1PR1 internalization and degradation. This results in the sequestration of lymphocytes in lymph nodes. By preventing egress of lymphocytes. fingolimod reduces both the amount of circulating peripheral lymphocytes and the infiltration of lymphocytes into target tissues. This prevents a lymphocyte-mediated immune response and may reduce inflammation. S1PR1, a G-protein coupled receptor, plays a key role in lymphocyte migration from lymphoid tissues. fingolimod also shifts Specimen Source Codes - Macrophages to an anti-inflammatory M2 phenotype, and modulates their proliferation, morphology, and cytokine release via inhibition of the transient receptor potential cation channel, subfamily M, member 7 (TRPM7).. Myelin Sheath defined as following: The lipid-rich sheath surrounding AXONS in both the CENTRAL NERVOUS SYSTEMS and PERIPHERAL NERVOUS SYSTEM. The Myelin Sheath sheath is an electrical insulator and allows faster and more energetically efficient conduction of impulses. The sheath is formed by the cell membranes of glial cells (SCHWANN CELLS in the peripheral and OLIGODENDROGLIA in the central nervous system). Deterioration of the sheath in DEMYELINATING DISEASES is a serious clinical problem.. Peripheral demyelination defined as following: A loss of Myelin Sheath from the internode regions along myelinated nerve fibers of the peripheral nervous system. [HPO:probinson]. Primary immune deficiency disorder defined as following: Immunodeficiency disease that arises independent of another pathologic process, disease, or injury.. Antigens, CD24 defined as following: A GPI-linked cell adhesion protein originally identified as a heat stable antigen in mice. It mediates antigen-dependent activation and proliferation of Deciduous maxillary right first molar tooth-CELLS. It is also involved in METASTASIS and is highly expressed in many NEOPLASMS.. Autoimmune Diseases defined as following: Disorders that are characterized by the production of Antibodies, in vitro diagnostic that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.. Deciduous maxillary right first molar tooth cells defined as following: Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.. Plasma Cells defined as following: Specialized forms of antibody-producing Deciduous maxillary right first molar tooth-LYMPHOCYTES. They synthesize and secrete immunoglobulin. They are found only in lymphoid organs and at sites of immune responses and normally do not circulate in the blood or lymph. (Rosen et al., Dictionary of Immunology, 1989, p169 & Abbas et al., Cellular and Molecular Immunology, 2d ed, p20). Chronic Lymphocytic Leukemia defined as following: A chronic leukemia characterized by abnormal Deciduous maxillary right first molar tooth-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called Chronic Lymphocytic Leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease.. Multiple Sclerosis defined as following: An autoimmune disorder mainly affecting young adults and characterized by destruction of Myelin Sheath in the central nervous system. Pathologic findings include multiple sharply demarcated areas of Peripheral demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903). Cerebrospinal Fluid defined as following: A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES.. Central Nervous System defined as following: The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.. immunoglobulin G defined as following: The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.. Nerve Degeneration defined as following: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.. Microglia defined as following: The third type of glial cell, along with astrocytes and oligodendrocytes (which together form the macroglia). Microglia vary in appearance depending on developmental stage, functional state, and anatomical location; subtype terms include ramified, perivascular, ameboid, resting, and activated. Microglia clearly are capable of phagocytosis and play an important role in a wide spectrum of neuropathologies. They have also been suggested to act in several other roles including in secretion (e.g., of cytokines and neural growth factors), in immunological processing (e.g., antigen presentation), and in central nervous system development and remodeling..", "label": "yes"} {"original_question": "Does GATA-1 regulate ribosomal protein genes?", "id": "converted_2106", "sentence1": "Does GATA1 gene regulate ribosomal protein Genes?", "sentence2": "Gene Mutation in exon 2 interfere with the synthesis of the full-length Protein Isoforms of GATA1 gene and lead to the production of a shortened Protein Isoforms, GATA-1s. These mutations have been found in patients with Anemia, Diamond-Blackfan, 2 (Diamond-Blackfan Anemia 1), a congenital erythroid aplasia typically caused by mutations in Genes encoding Ribosomal Proteins., Sixteen of the corresponding TRANSCRIPTION FACTOR are of particular interest, as they are Genes, Housekeeping or show a direct link to hematopoiesis, tumorigenesis or leukemia (e.g. GATA1 gene/2, SPI1 wt Allele, MZF1 gene)., Gene Gene Deletion Abnormality Abnormality of PKC1 relieves the repression of both ribosomal protein and Ribosomal RNA Genes that occurs in response to a defect in the secretory pathway., This stress is monitored by protein kinase C activity, which initiates a signal transduction pathway that leads to repression of transcription of the rRNA and ribosomal protein Genes., The importance of the transcription of the 137 ribosomal protein Genes to the economy of the \"U\" lymphocyte is apparent from the existence of at least three distinct pathways that can effect the repression of this set of Genes.[SEP]Relations: GATA1 has relations: protein_protein with DNASE2, protein_protein with DNASE2, protein_protein with GNA12, protein_protein with GNA12, protein_protein with SPTA1, protein_protein with SPTA1, protein_protein with SPIB, protein_protein with SPIB, protein_protein with DNAI2, protein_protein with DNAI2. Definitions: SPI1 wt Allele defined as following: The human SPI1 wild-type allele is located in the vicinity of 11p11.2 and is approximately 24 kb in length. This allele, which encodes transcription factor SPI1 wt Allele protein, is involved in the activation of transcription by RNA polymerase II.. protein kinase C activity defined as following: Catalysis of the reaction: ATP + a protein = ADP + a phosphoprotein. This reaction requires diacylglycerol. [EC:2.7.11.13]. Ribosomal RNA Genes defined as following: Genes, found in both prokaryotes and eukaryotes, which are transcribed to produce the RNA which is incorporated into RIBOSOMES. Prokaryotic Ribosomal RNA Genes are usually found in OPERONS dispersed throughout the GENOME, whereas eukaryotic Ribosomal RNA Genes are clustered, multicistronic transcriptional units.. leukemia defined as following: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006). GATA1 gene defined as following: Human GATA1 wild-type allele is located in the vicinity of Xp11.23 and is approximately 8 kb in length. This allele, which encodes erythroid transcription factor protein, is involved in the regulation of both transcription by RNA polymerase II and erythroid development.. Ribosomal Proteins defined as following: Proteins found in ribosomes. They are believed to have a catalytic function in reconstituting biologically active ribosomal subunits.. Diamond-Blackfan Anemia 1 defined as following: Congenital pure red \"U\" lymphocyte aplasia caused by autosomal dominant mutation(s) in the RPS19 gene, encoding 40S ribosomal protein S19.. Genes, Housekeeping defined as following: Constitutively and evenly expressed Genes involved in routine cellular metabolisms.. Protein Isoforms defined as following: Refers to variants of the same protein which can be separated on special conducting media using electrophoresis. The differences may arise from genetically determined differences in primary structure or by modification of the same primary sequence.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Is H4K20 methylation associated with DNA replication?", "id": "converted_1987", "sentence1": "Is H4K20 methylation associated with DNA replication?", "sentence2": "It seems likely that continued study of the methylation of H4K20 will yield extremely valuable insights concerning the regulation of Histone antigen modification before and during cell division and the impact of these modifications on subsequent gene expression., Aberrant rereplication correlates with decreased levels of H4K20me1 and increased levels of H4K20 trimethylation (H4K20me3)., Consistent with this, H4K20 methylation status plays a direct role in recruiting origin recognition complex location through the binding properties of SLC25A15 gene and ORCA/LRWD1. Thus, coordinating the status of H4K20 methylation is pivotal for the proper selection of DNA replication origins in higher Eukaryota., H4K20 methylation regulates quiescence and chromatin location location compaction., Mass spectrometry analysis of Histone antigen modification reveals that H4K20me2 and H4K20me3 increase in quiescence and other Histone antigen modification are present at similar levels in proliferating and quiescent cells., Analysis of cells in S, G2/M, and G1 phases shows that H4K20me1 increases after S phase and is converted to H4K20me2 and H4K20me3 in quiescence. , Overexpression of Suv4-20h1, the Enzyme [APC] that creates H4K20me2 from H4K20me1, results in G2 arrest, consistent with a role for H4K20me1 in mitosis. The results suggest that the same lysine on H4K20 may, in its different methylation states, facilitate mitotic functions in M phase and promote chromatin location location compaction and cell cycle exit in quiescent cells., Histone H4 lysine 20 methylation: key player in epigenetic regulation of genomic integrity., Intense research during the past few years has revealed Histone antigen H4 lysine 20 methylation (H4K20me) as critically important for the biological processes that ensure Genome - anatomical entity integrity, such as DNA damage repair, DNA replication and chromatin location location compaction., Disruption of these H4K20-specific Histone antigen methyltransferases leads to genomic instability, demonstrating the important functions of H4K20 methylation in Genome - anatomical entity maintenance. , Both H4K20 mono-methylation and H3K56 acetylation mark transcription-dependent Histone antigen turnover in fission yeast., Histone turnover is often associated with various Histone antigen modification such as H3K56 acetylation (H3K56Ac), H3K36 methylation (H3K36me), and H4K20 methylation (H4K20me)., These results together indicate that H4K20me1 as well as H3K56Ac are bona fide marks for transcription-dependent Histone antigen turnover in fission yeast., Methylation of Histone antigen H4 lysine 20 by KMT5A wt Allele ensures the integrity of late replicating sequence domains in Drosophila ., However, these studies were limited to only a handful of Mammals origins, and it remains unclear how KMT5A wt Allele and H4K20 methylation impact the replication program on a genomic scale., The methylation state of lysine 20 on Histone antigen H4 (H4K20) has been linked to chromatin location location compaction, transcription, DNA repair and DNA replication. Monomethylation of H4K20 (H4K20me1) is mediated by the cell cycle-regulated Histone antigen methyltransferase KMT5A wt Allele, We find that deregulation of H4K20 methylation had no impact on origin activation throughout the Genome - anatomical entity. Instead, depletion of KMT5A wt Allele and loss of H4K20me1 results in the accumulation of DNA damage and an ATR-dependent cell cycle arrest., We review the signaling pathways and functions associated with a single residue, H4K20, as a model chromatin location location and clinically important mark that regulates biological processes ranging from the DNA damage response and DNA replication to gene expression and silencing., Thus, coordinating the status of H4K20 methylation is pivotal for the proper selection of DNA replication origins in higher Eukaryota., We employed Genetic, cytological, and genomic approaches to better understand the role of KMT5A wt Allele and H4K20 methylation in regulating DNA replication and Genome - anatomical entity stability in Drosophila cells., The methylation state of lysine 20 on Histone antigen H4 (H4K20) has been linked to chromatin location location compaction, transcription, DNA repair and DNA replication., However, these studies were limited to only a handful of Mammals origins, and it remains unclear how KMT5A wt Allele and H4K20 methylation impact the replication program on a genomic scale., Methylation of Histone antigen H4 lysine-20 has been implicated in DNA repair, transcriptional silencing, genomic stability and regulation of replication., Thus, coordinating the status of H4K20 methylation is pivotal for the proper selection of DNA replication origins in higher Eukaryota, Methylation of Histone antigen H3 on lysine 79 associates with a group of replication origins and helps limit DNA replication once per cell cycle, We employed Genetic, cytological, and genomic approaches to better understand the role of KMT5A wt Allele and H4K20 methylation in regulating DNA replication and Genome - anatomical entity stability in Drosophila cells., We review the signaling pathways and functions associated with a single residue, H4K20, as a model chromatin location location and clinically important mark that regulates biological processes ranging from the DNA damage response and DNA replication to gene expression and silencing. © 2016 by The American Society for Biochemistry and Molecular Biology, Inc.Heart were detected similarly like in laboratory Mammals and in man, the minimal embryotoxic doses of Vitamin A [EPC] in Mammals were estimated to be between 0.1-1 mg/kg of maternal weight, Human epidemiological studies have proved teratogenicity of Vitamin A [EPC] after daily doses 25,000 i.u.-8.3 mg (0.13 mg/kg)- and reduction of its maximum intake has been recommended to 10,000 i.u. per day (0.05 mg/kg). The results about teratogenicity of Vitamin A [EPC] achieved in the chick Human Human embryo are in agreement with such a recommendation. Intake of Vitamin A [EPC] in the Food allergenic extracts is sufficient for pregnant woman in common Czech population. Therefore, an artificial supplementation of Vitamin A [EPC] brings risk of overdosage. If supplementation by Vitamin A [EPC] is unavoidable during pregnancy, B-carotene should be preferred., a teratogenic dosing regimen with 13-cis-Rheumatoid Arthritis [Hummler et al. (1994) Teratology 50:184-193]., plasma AUC values of all-trans-Rheumatoid Arthritis were 2- to 7-fold higher after all-trans-Rheumatoid Arthritis administration (present study) than after dosing with the teratogenic dose of 13-cis-Rheumatoid Arthritis. These results strengthen our recent suggestion that the teratogenic effects induced in cynomolgus monkeys by 13-cis-Rheumatoid Arthritis treatment cannot solely result from the action of all-trans-Rheumatoid Arthritis, but may involve 13-cis-Rheumatoid Arthritis and 13-cis-4-oxo-Rheumatoid Arthritis, which could act directly or function as transport vehicle., VITA, among others, is involved in the process of morphogenesis. In contrast, synthetic derivatives of VITA, specifically Tigasone (etretinate, tetanus immune globulin, human) and Roaccutane (isotretinoin, Roa ), are regarded as major teratogens., A biphasic maximal inhibition was present at 1 microM concentrations when the Retinoids VITA, tetanus immune globulin, human and Roa were added for 16 h (52, 58 and 57%, respectively; P < 0.01 by one-way analysis of variance). In contrast, the addition of the three Retinoids at 1 microM concentrations for 16 h had no significant effect on human chorionic gonadotropin secretion by placental explants of 11-13 weeks gestational age., Inhibition of human chorionic gonadotropin secretion by Retinoids may contribute either directly or indirectly to their teratogenicity., Isotretinoin is a potent retinoic acid used in the treatment of Dermatologic disorders. Though very effective, it is teratogenic if administered during pregnancy, and its teratogenic effect may be related to the normal activity of Retinoids as signalling molecules in the Human Human embryo., defects that includes Chest>Heart defects, by inhibiting the migration of Neural Crest Cells., Proliferation in Chest>Heart tissue of whole Culture of Human Human embryo was inhibited in medium with 10(-6) M isotretinoin to 62% of the control level in Myocardium., The results suggest multiple effects of Retinoids on growth, morphogenesis, and differentiation of early Cardiac - anatomy qualifier tissue, and are discussed in relation to the potential role of Retinoids in early embryogenesis., Oral administration of 400 mg/kg of 13-cis retinoic acid to 9 day pregnant CASP14 gene gives rise to important maxillofacial Aspects of congenital Aspects of congenital malformations. The first manifestation of teratogenic effect is an increase of density of cell death arising in the Dorsal part of the first two branchial arches at day 9.5. These two arches become Hypoplastic at days 10 and 11, and the preskeletal anlagen appear too late in comparison to control embryos. Meckel's Cartilage is too curvilinear and medially situated. Pre-ossicular and pre-mandibular blastemata develop with spatial distortions which are well analyzable at days 16 and 17, Isotretinoin (13-cis-retinoic acid, Accutane) increases the risk of major congenital Aspects of congenital Aspects of congenital malformations in infants exposed to isotretinoin during pregnancy. However, there have been no epidemiologic reports to date on the effect of a subsequent pregnancy after discontinuation of isotretinoin., analysis of pregnancy case reports from patients in whom conception occurred after isotretinoin treatment had been discontinued, spontaneous and missed Abortions:Number:Point in time:^Patient:Quantitative:Reported from all pregnancies was 9.1% (eight patients), and the incidence rate of congenital Congenital Abnormality among the live births was 5.0% (four patients)., were not significantly different from the rates reported for women of reproductive age in the general population. In addition, the Aspects of congenital Aspects of congenital malformations reported were not characteristic of retinoic acid-induced congenital anomalies., Keratolenticular dysgenesis (Irido-corneo-trabecular dysgenesis (disorder)) was induced in CASP14 gene by exposure to the human teratogens, ethanol or 13-cis retinoic acid (isotretinoin, Accutane). Acute teratogen exposure on the seventh day of gestation (corresponding to the third week of human gestation) resulted in an Eye Specimen Source Code Congenital Abnormality incidence of 46% to 100% in day 14 fetuses, This secondary effect on neural crest derivatives is exhibited in the adult animals as Cornea opacities associated with defects in Descemet's membrane and Endothelium, and anterior polar cataracts., 13-cis-retinoic acid (13-cis-Rheumatoid Arthritis, or isotretinoin) is responsible for various craniofacial Aspects of congenital Aspects of congenital malformations in the Rodent and human Human Human embryo., In whole Human Human embryo culture, 13-cis-Rheumatoid Arthritis caused significant overall embryonic growth retardation, especially in the primary and secondary Palate processes., subsequent cell growth was decreased at concentrations of 13-cis-Rheumatoid Arthritis greater than 1 X 10(-5) M. After a 40-hr treatment period, labeling indices in Retinoid [EPC]-treated cells were significantly lower than control values (25% compared with 40%). tretinoin also caused a significant, concentration-dependent decrease in 3H-thymidine incorporation. The inhibitory effect of 13-cis-Rheumatoid Arthritis on proliferation of oral-nasal mesenchymal cells appears to be related to the production of craniofacial Aspects of congenital Aspects of congenital malformations., Reports of adverse human pregnancy outcomes including Cleft palate, isolated have increased as the clinical use of isotretinoin (13-cis-retinoic acid) and other retinoic acid (Rheumatoid Arthritis) derivatives have increased, but the mechanisms by which their effects are exerted are not understood., In shelves exposed to epidermal growth factor and trans-Rheumatoid Arthritis early in their development, DNA synthesis appears to terminate prematurely as compared to shelves cultured in control media, and this effect is accompanied by excessive mesenchymal extracellular space expansion. Exposure of shelves to epidermal growth factor alone is sufficient to block degeneration and induce hyperplasia of the medial Epithelial Cells but does not induce other ultrastructural changes seen with both epidermal growth factor and Rheumatoid Arthritis. The observed alterations in medial cell morphology could interfere with adhesion of the Palate shelves and may play a role in Retinoid [EPC]-induced Cleft palate, isolated in the human Human Human embryo., Recent clinical observations strongly suggest that isotretinoin [13-cis-retinoic acid (cis Rheumatoid Arthritis)] is a human teratogen causing primarily Chest>Heart and craniofacial Aspects of congenital Aspects of congenital malformations including Specimen Source Codes - Ear and Palate defects., Our results demonstrate that labeled cis Rheumatoid Arthritis enters the Body tissue of the Human Human embryo both in vivo and in vitro. CISH protein, human Rheumatoid Arthritis inhibited proliferation of the frontonasal mesenchyme cells in primary culture with 31% inhibition occurring at 2 X 10(-5) M cis Rheumatoid Arthritis., tretinoin, an analogue of Vitamin A [EPC], is known to be teratogenic in laboratory animals and has recently been implicated in a few clinical case reports. To study the human teratogenicity of this agent, we investigated 154 human pregnancies with fetal exposure to isotretinoin, a Retinoid [EPC] prescribed for severe recalcitrant Cystic acne. The outcomes were 95 elective Abortions:Number:Point in time:^Patient:Quantitative:Reported, 26 infants without major Aspects of congenital Aspects of congenital malformations, 12 spontaneous Abortions:Number:Point in time:^Patient:Quantitative:Reported, and 21 malformed infants. A subset of 36 of the 154 pregnancies was observed prospectively., Exposure to isotretinoin was associated with an unusually high relative risk for a group of selected major Aspects of congenital Aspects of congenital malformations (relative risk = 25.6; 95 per cent confidence interval, 11.4 to 57.5)., It is possible that a major mechanism of isotretinoin teratogenesis is a deleterious effect on cephalic neural-crest cell activity that results in the observed craniofacial, Cardiac - anatomy qualifier, and Thymus Gland Aspects of congenital Aspects of congenital malformations.[SEP]Relations: Isotretinoin has relations: contraindication with Chest>Heart disease, contraindication with Chest>Heart disease, contraindication with hepatitis, contraindication with hepatitis, contraindication with anxiety disorder, contraindication with anxiety disorder, contraindication with kidney disease, contraindication with kidney disease, contraindication with liver disease, contraindication with liver disease. Definitions: Epithelial Cells defined as following: Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional Epithelial Cells.. etretinate defined as following: An oral Retinoid [EPC] used in the treatment of keratotic genodermatosis, lichen planus, and psoriasis. Beneficial effects have also been claimed in the prophylaxis of epithelial neoplasia. The compound may be teratogenic.. Rheumatoid Arthritis defined as following: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal Body tissue, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.. isotretinoin defined as following: A topical dermatologic agent that is used in the treatment of ACNE VULGARIS and several other skin diseases. The Pharmacologic Substance has teratogenic and other adverse effects.. Cardiovascular system defined as following: The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body.. tretinoin defined as following: An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE).. Congenital Abnormality defined as following: Malformations of organs or body parts during development in utero.. Irido-corneo-trabecular dysgenesis (disorder) defined as following: A form of anterior segment dysgenesis in which abnormal cleavage of the anterior chamber occurs. Peters anomaly is characterized by central, paracentral, or complete Cornea opacity. [HPO:probinson]. Retinoids defined as following: A group of tetraterpenes, with four terpene units joined Head - Component of Device-to-tail. Biologically active members of this class are used clinically in the treatment of severe cystic ACNE; PSORIASIS; and other disorders of keratinization.. ethanol defined as following: A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES.. Myocardium defined as following: The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow.. Endothelium defined as following: A layer of epithelium that lines the Chest>Heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body.. Dermatologic disorders defined as following: Diseases involving the DERMIS or EPIDERMIS.. human chorionic gonadotropin defined as following: A sialoglycoprotein hormone secreted by the placenta and maintains the corpus luteum at the beginning of the gestation period.. Palate defined as following: The structure that forms the roof of the mouth. It consists of the anterior hard palate (PALATE, HARD) and the posterior soft palate (PALATE, SOFT).. clindamycin phosphate defined as following: The phosphate salt form of clindamycin, a semi-synthetic, chlorinated broad spectrum antibiotic produced by chemical modification of lincomycin. clindamycin phosphate is used in topical preparations.. Trauma, nursing specialty defined as following: Nurses in this specialty provide emergency care to patients of all ages. These nurses work to maintain vital signs and prevent complications and death. Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Fatigue defined as following: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.. Dorsal defined as following: Pertaining to the back or upper surface of the body; opposite of ventral.. Cornea defined as following: The transparent anterior portion of the fibrous coat of the Eye Specimen Source Code consisting of five layers: stratified squamous CORNEAL EPITHELIUM; BOWMAN MEMBRANE; CORNEAL STROMA; DESCEMET MEMBRANE; and mesenchymal CORNEAL ENDOTHELIUM. It serves as the first refracting medium of the Eye Specimen Source Code. It is structurally continuous with the SCLERA, avascular, receiving its nourishment by permeation through spaces between the lamellae, and is innervated by the ophthalmic division of the TRIGEMINAL NERVE via the ciliary nerves and those of the surrounding conjunctiva which together form plexuses. (Cline et al., Dictionary of Visual Science, 4th ed). Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. Photosensitivity of skin defined as following: Increased sensitivity of the skin to light exposure.. Acne Vulgaris defined as following: A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads), closed comedones (whiteheads), and pustular nodules. The cause is unknown, but heredity and age are predisposing factors.. Thymus Gland defined as following: A single, unpaired primary lymphoid organ situated in the MEDIASTINUM, extending superiorly into the neck to the lower edge of the THYROID GLAND and inferiorly to the fourth costal Cartilage. It is necessary for normal development of immunologic function early in life. By puberty, it begins to involute and much of the tissue is replaced by fat.. Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of Cardiovascular system and cerebral functions.. Monkeys defined as following: Any haplorhine primate not belonging to the family Tarsiidae, Hylobatidae, Pongidae, or Hominidae; this does not correspond to any taxon. This group is divided into Old World monkeys (Cercopithecidae) and New World monkeys (Callitrichidae and Cebidae). Many types are used as an experimental model for human disease and Pharmacologic Substance testing.. CISH protein, human defined as following: Cytokine-inducible SH2-containing protein (258 aa, ~29 kDa) is encoded by the human CISH gene. This protein is involved in the modulation of signal transduction.. Rodent defined as following: A mammalian order which consists of 29 families and many genera.. House CASP14 gene defined as following: The common Mus sp. species, House CASP14 gene.. Head - Component of Device defined as following: A projection on the end of an object. Neural Crest Cells defined as following: Neuroectodermal cells of the neural crest. They differentiate into various cell types during EMBRYOGENESIS including craniofacial MESENCHYME; ENDOCRINE CELLS; MELANOCYTES and PERIPHERAL NERVOUS SYSTEM.. epidermal growth factor defined as following: A 6-kDa polypeptide growth factor initially discovered in Mus sp. submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form.. Eczema defined as following: A pruritic papulovesicular dermatitis occurring as a reaction to many endogenous and exogenous agents (Dorland, 27th ed).. Labor (Childbirth) defined as following: Uterine contractions resulting in cervical change (dilation and/or effacement). (reVITALize). Cystic acne defined as following: A severe type of acne characterized by the formation of cysts enclosing a mixture of keratin and sebum. [PMID:9212761]. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.. Vegetable Oils defined as following: oils derived from plants or plant products.. Homo sapiens defined as following: Members of the species Homo sapiens.. Human embryo defined as following: An organism in its initial stage of development following fertilization. The human embryonic period lasts approximately eight weeks, during which time organogenesis takes place.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. craniofacial defined as following: refers to the bones of the skull and face.. Cartilage defined as following: A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE.. Chest>Heart defects defined as following: Developmental abnormalities involving structures of the Chest>Heart. These defects are present at birth but may be discovered later in life..", "label": "no"} {"original_question": "Could divalent metal transporter 1 deficiency lead to anemia?", "id": "converted_1980", "sentence1": "Could divalent metal transporter 1 deficiency lead to Genus Anemia?", "sentence2": "The divalent metal transporter 1 (SLC11A2 gene) is a major iron transporter required for iron absorption and erythropoiesis. Loss of SLC11A2 gene function results in Microcytic Genus Anemia. , Dysfunction of human SLC11A2 gene is associated with several pathologies such as iron deficiency Genus Anemia hemochromatosis, Parkinson Disease and ALZHEIMER DISEASE, FAMILIAL, 1, as well as Malignant neoplasm of colon and/or rectum and Adenocarcinoma Of Esophagus, making SLC11A2 gene an attractive target for drug discovery., Deficiency of the divalent metal transporter 1 (SLC11A2 gene) leads to Microcytic hypochromic Genus Anemia (disorder). We have previously shown that SLC11A2 gene deficiency impairs Erythroid differentiation and induces apoptosis of Erythroid Cells. , We propose that SLC11A2 gene deficiency negatively affects metabolism and life span of mature Specimen Source Codes - Erythrocytes; two other aspects of defective erythropoiesis which contribute to the pathophysiology of the disease., Hypochromic Microcytic Genus Anemia associated with ineffective erythropoiesis caused by recessive mutations in divalent metal transporter 1 (SLC11A2 gene) can be improved with high-dose Recombinant Erythropoietin supplementation. , Belgrade rats exhibit microcytic, hypochromic Genus Anemia and systemic iron deficiency due to a glycine-to-arginine Mutation Abnormality at residue 185 in a metal ion transporter of a divalent metal transporter/divalent cation transporter/solute carrier 11 group A member 2 or 3 (SLC11A2 gene/DCT1/SLC11A2), a member of the natural-resistance-associated macrophage protein (Nramp) family., Deficiency of the divalent metal transporter 1 (SLC11A2 gene) leads to Microcytic hypochromic Genus Anemia (disorder), Belgrade rats exhibit microcytic, hypochromic Genus Anemia and systemic iron deficiency due to a glycine-to-arginine Mutation Abnormality at residue 185 in a metal ion transporter of a divalent metal transporter/divalent cation transporter/solute carrier 11 group A member 2 or 3 (SLC11A2 gene/DCT1/SLC11A2), a member of the natural-resistance-associated macrophage protein (Nramp) family, BACKGROUND/AIMS: Deficiency of the divalent metal transporter 1 (SLC11A2 gene) leads to Microcytic hypochromic Genus Anemia (disorder). , Microcytic Genus Anemia (mk/mk) CASP14 gene defective in SLC11A2 gene and wild-type CASP14 gene were exposed to either bleomycin or Saline Solution via intratracheal instillation and the resultant lung injury was compared. , Deficiency of the divalent metal transporter 1 (SLC11A2 gene) leads to Microcytic hypochromic Genus Anemia (disorder)., The divalent metal transporter 1 (SLC11A2 gene) is a major iron transporter required for iron absorption and erythropoiesis., This Mutation Abnormality severely impairs the iron transport capability of SLC11A2 gene, leading to systemic iron deficiency and Genus Anemia.[SEP]Relations: SLC11A2 has relations: pathway_protein with Defective SLC11A2 causes Microcytic hypochromic Genus Anemia (disorder), with iron overload 1 (AHMIO1), pathway_protein with Defective SLC11A2 causes Microcytic hypochromic Genus Anemia (disorder), with iron overload 1 (AHMIO1), disease_protein with iron deficiency Genus Anemia, disease_protein with iron deficiency Genus Anemia, disease_protein with deficiency Genus Anemia, disease_protein with deficiency Genus Anemia, disease_protein with Microcytic Genus Anemia with liver iron overload, disease_protein with Microcytic Genus Anemia with liver iron overload. Microcytic Genus Anemia has relations: disease_phenotype_positive with Anemia of inadequate production, disease_phenotype_positive with Anemia of inadequate production. Definitions: Adenocarcinoma Of Esophagus defined as following: A malignant tumor with glandular differentiation arising predominantly from Barrett mucosa in the lower third of the esophagus. Rare examples of Adenocarcinoma Of Esophagus deriving from ectopic gastric mucosa in the upper esophagus have also been reported. Grossly, esophageal adenocarcinomas are similar to esophageal squamous cell carcinomas. Microscopically, adenocarcinomas arising in the setting of Barrett esophagus are typically papillary and/or tubular. The prognosis is poor.. Microcytic hypochromic Genus Anemia (disorder) defined as following: Genus Anemia featuring pale Specimen Source Codes - Erythrocytes smaller than 6 microns in diameter; typically due to iron deficiency or abnormalities in hememetabolism.. Recombinant Erythropoietin defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous glycoprotein Recombinant Erythropoietin (Epo). Epo promotes the differentiation and maturation of hematopoietic progenitors into Specimen Source Codes - Erythrocytes; is a mitogen and a chemoattractant for endothelial cells; stimulates activated and differentiated B-cells and enhances B-cell immunoglobulin production and proliferation; and is hypoxia-inducible. (NCI04). Erythroid Cells defined as following: The series of cells in the red blood cell lineage at various stages of differentiation.. Microcytic Genus Anemia defined as following: Anemia in which the red blood cell volume is decreased.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Erythroid defined as following: 1) Reddish in color. 2) relating to Specimen Source Codes - Erythrocytes or their precursors.. Saline Solution defined as following: A crystalloid solution that contains 9.0g of SODIUM CHLORIDE per liter of water. It has a variety of uses, including: as a CONTACT LENS SOLUTION, in OPHTHALMIC SOLUTIONS and NASAL LAVAGE, in wound irrigation, and for FLUID THERAPY.. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by Mutation Abnormality(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65.. Parkinson Disease defined as following: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75). bleomycin defined as following: A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors..", "label": "yes"} {"original_question": "Is Dupilumab used for treatment of atopic dermatitis?", "id": "converted_2050", "sentence1": "Is dupilumab used for treatment of Eczema?", "sentence2": "dupilumab has demonstrated efficacy in patients with Asthma and Eczema, which are both type 2 helper T-cell-mediated diseases., Background dupilumab, a Homo sapiens monoclonal antibody CAL CAL against Recombinant Interleukin-4 receptor alpha, inhibits signaling of Recombinant Interleukin-4 and interleukin-13, type 2 Recombinant Cytokines that may be important drivers of atopic or allergic diseases such as Eczema., Two Phase 3 Trials of dupilumab versus Placebo in Dermatitis, Atopic., dupilumab is a biologic agent targeted at TH2 Recombinant Cytokines, but indirectly impacts Immunoglobulin E and is an important biologic agent for atopic Disease., dupilumab for the treatment of Eczema: A clinical trial review., dupilumab is a novel monoclonal antibody CAL CAL that was recently studied in adult patients with moderate-to-severe cytarabine/daunorubicin protocol., Patients treated with dupilumab had marked and rapid improvement in all the evaluated measures of Eczema Disease activity., The robust effects of dupilumab on skin inflammation and Pruritus -- quality confirm the pathogenic role of IL-4 and interleukin-13, Homo sapiens signaling in adult cytarabine/daunorubicin protocol, and further support the application of Th2 cytokine antagonists in the treatment of this Disease.[SEP]Relations: dupilumab has relations: drug_drug with Dusigitumab, drug_drug with Dusigitumab, drug_drug with Teplizumab, drug_drug with Teplizumab, drug_drug with Afelimomab, drug_drug with Afelimomab, drug_drug with Tremelimumab, drug_drug with Tremelimumab, drug_drug with Urelumab, drug_drug with Urelumab. Definitions: Recombinant Interleukin-4 defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine Recombinant Interleukin-4 (IL-4). Produced primarily by activated T-cells, IL-4 binds to and activates its cell-surface receptor, stimulating the proliferation and differentiation of activated B-cells and enhancing their ability to present antigens to T-cells. As a potential immunotherapeutic agent, recombinant IL-4 also augments the effects of other Recombinant Cytokines on dendritic cells (DC), cytotoxic T lymphocytes (CTL), and tumor-infiltrating lymphocytes (TIL). Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C589\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C589\" NCI Thesaurus). interleukin-13, Homo sapiens defined as following: Interleukin-13 (146 aa, ~16 kDa) is encoded by the Homo sapiens IL13 gene. This protein plays a role in the negative regulation of cytokine production and the positive regulation of B-cell proliferation.. Homo sapiens defined as following: Members of the species Homo sapiens.. Recombinant Interleukin-4 receptor alpha defined as following: Interleukin-4 receptor subunit alpha (825 aa, ~90 kDa) is encoded by the Homo sapiens IL4R gene. This protein plays a role in both Recombinant Interleukin-4 signaling and immunoglobulin E production.. dupilumab defined as following: A recombinant Homo sapiens monoclonal immunoglobulin G4 (IgG4) antibody directed against the alpha chain of the Recombinant Interleukin-4 receptor (IL-4R alpha) with potential immunomodulatory activities. Upon injection, dupilumab selectively binds to the IL-4R alpha chain. This disrupts IL-4/interleukin-13, Homo sapiens signaling and prevents the activation of downstream pathways that mediate type 2 inflammation and may potentially inhibit tumor cell proliferation, survival, and metastasis. IL-4 and interleukin-13, Homo sapiens receptors are present on the surface of numerous cells involved in the pathophysiology of type-2 helper T-cell (Th2) allergic responses, including B-lymphocytes, eosinophils, dendritic cells (DCs), monocytes, macrophages, basophils, keratinocytes, bronchial epithelial cells, endothelial cells, fibroblasts, and airway smooth muscle cells. Additionally, both IL-4 and interleukin-13, Homo sapiens receptors are overexpressed in a variety of cancers and IL-4 and interleukin-13, Homo sapiens and may serve as biomarkers for cancer aggressiveness. IL-4 and interleukin-13, Homo sapiens are thought to be key regulatory Recombinant Cytokines in the tumor microenvironment (TME) and may play a role in the activation of tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs) that mediate tumor cell survival.. Immunoglobulin E defined as following: An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE).. Pruritus -- quality defined as following: A sensory perception which causes the desire or reflex to scratch. [PMID:26015312, PMID:29723501, PMID:30734045, Wikipedia:Itch]. Asthma defined as following: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).. Dermatitis, Atopic defined as following: A chronic inflammatory genetically determined Disease of the skin marked by increased ability to form reagin (Immunoglobulin E), with increased susceptibility to allergic rhinitis and Asthma, and hereditary disposition to a lowered threshold for Pruritus -- quality. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.. Eczema defined as following: A pruritic papulovesicular dermatitis occurring as a reaction to many endogenous and exogenous agents (Dorland, 27th ed).. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. monoclonal antibody CAL defined as following: A humanized monoclonal antibody CAL directed against parathyroid hormone-related protein (PTH-rP). As a poly-hormone with diverse biological roles, PTH-rP is expressed by normal tissues, acting in local tissue environments in a variety of ways; it is commonly overexpressed by breast, prostate, and other cancers, acting systemically by promoting bone resorption, inhibiting calcium excretion from the kidney, inducing hypercalcemia, and possibly playing a role in the formation of bony metastases. By blocking the effects of PTH-rP on calcium metabolism, monoclonal antibody CAL CAL may inhibit cancer-related hypercalcemia. (NCI04).", "label": "yes"} {"original_question": "Does HuR bind to the untranslated regions (UTRs) of mRNAs?", "id": "converted_1985", "sentence1": "Does ELAVL1 gene bind to the untranslated regions (Untranslated Regions) of mRNAs?", "sentence2": "ELAVL1 gene is also overexpressed during tumourigenesis and is abnormally present within the Cytoplasm, where it binds to AU-rich elements in the 3'Untranslated Regions of target RNA, Messenger and post-transcriptionally regulates the expression of its target Genes., Human antigen R (ELAVL1 gene) is a ubiquitous 32 kDa protein comprising three RNA Recognition Motif (RRMs), whose main function is to bind Adenylate and uridylate Rich Elements (AREs) in 3' UnTranslated Regions (Untranslated Regions) of mRNAs., Human antigen R (ELAVL1 gene) is a ubiquitously expressed RNA-Binding Proteins that modulates gene expression at the post-transcriptional level., The RNA-Binding Proteins ELAVL1 gene binds at 3' untranslated regions (Untranslated Regions) of target transcripts, thereby protecting them against degradation. , ELAV/Hu Proteins bind to AU-rich elements (are unit of measure) in mRNAs and regulate their stability from splicing to translation, and the ubiquitous ELAVL1 gene protein has been implicated in cancerous cell growth. , This is achieved by altered expression of the Proteins Congenital Thrombotic Thrombocytopenic Purpura and ELAVL1 gene, which bind 3' untranslated region (UTR) elements in cancer-related Genes.[SEP]Relations: ELAVL1 has relations: molfunc_protein with RNA, Messenger 3'-UTR AU-rich region binding, molfunc_protein with RNA, Messenger 3'-UTR AU-rich region binding, pathway_protein with ELAVL1 gene (ELAVL1) binds and stabilizes RNA, Messenger, pathway_protein with ELAVL1 gene (ELAVL1) binds and stabilizes RNA, Messenger, molfunc_protein with RNA, Messenger 3'-UTR binding, molfunc_protein with RNA, Messenger 3'-UTR binding, bioprocess_protein with 3'-UTR-mediated RNA, Messenger stabilization, bioprocess_protein with 3'-UTR-mediated RNA, Messenger stabilization. protein binding has relations: molfunc_protein with HUS1, molfunc_protein with HUS1. Definitions: Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. ELAVL1 gene defined as following: This gene plays a role in the regulation of gene expression.. ELAVL1 gene protein defined as following: An RRM protein that binds to the 3'-UTR region of mRNAs and increases their stability. In EMBRYONIC STEM CELLS, it binds to poly-U elements and AU-rich elements (AREs) in the 3'-UTR of target mRNAs and preferentially binds mRNAs that are not methylated by N6-methyladenosine (m6A), to stabilize them and promote differentiation.. are unit of measure defined as following: A unit of area equal to 100 square meters. Are is a non-SI unit accepted for use with SI.. Cytoplasm defined as following: The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990). RNA-Binding Proteins defined as following: Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other Proteins whose function is to bind specifically to RNA.. Untranslated Regions defined as following: The parts of the messenger RNA sequence that do not code for product, i.e. the 5' UNTRANSLATED REGIONS and 3' UNTRANSLATED REGIONS.. RNA, Messenger defined as following: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the nucleus and must be exported to the Cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the Cytoplasm.. RNA Recognition Motif defined as following: An approximately 80 amino acid RNA binding motif that consists of four anti-parallel surface beta sheets and two alpha helices arranged in a beta-alpha-beta-beta-alpha-beta configuration. One of the surface beta sheets interacts with two or three specific RNA bases. Interactions between additional sequences and the RNA, as well as within the RNA recognition motif increase the affinity and specificity of the protein-RNA interaction.. Congenital Thrombotic Thrombocytopenic Purpura defined as following: Thrombotic thrombocytopenic purpura for which the cause is present from birth.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Is retinol binding protein 4 an adipokine?", "id": "converted_4686", "sentence1": "Is retinol binding protein 4 an Adipokines?", "sentence2": "Systematic Quantification of Neurotrophic Adipokines RBP4 protein, human protein, human, SERPINF1 wt Allele, Homo sapiens, and CLU gene in Homo sapiens Cerebrospinal Fluid and Serum., Retinol-binding protein 4 (RBP4 protein, human protein, human) is a prominent Adipokines i, alpha-2-HS-Glycoprotein and Retinol Binding Proteins (RBP4 protein, human protein, human) are secreted as both hepatokine and Adipokines. [SEP]Relations: retinol binding has relations: molfunc_protein with ADH4, molfunc_protein with ADH4, molfunc_protein with RBP4 protein, human, molfunc_protein with RBP4 protein, human, molfunc_protein with RBP5, molfunc_protein with RBP5, molfunc_protein with RBP3, molfunc_protein with RBP3, molfunc_protein with ADH7, molfunc_protein with ADH7. Definitions: Adipokines defined as following: Polypeptides produced by the ADIPOCYTES. They include LEPTIN; ADIPONECTIN; RESISTIN; and many cytokines of the immune system, such as TUMOR NECROSIS FACTOR-ALPHA; INTERLEUKIN-6; and COMPLEMENT FACTOR D (also known as ADIPSIN). They have potent autocrine, paracrine, and endocrine functions.. Retinol Binding Proteins defined as following: Proteins which bind with RETINOL. The retinol-binding protein found in plasma has an alpha-1 mobility on electrophoresis and a molecular weight of about 21 kDa. The retinol-protein complex (MW=80-90 kDa) circulates in plasma in the form of a protein-protein complex with prealbumin. The retinol-binding protein found in tissue has a molecular weight of 14 kDa and carries retinol as a noncovalently bound ligand.. SERPINF1 wt Allele, Homo sapiens defined as following: Homo sapiens SERPINF1 wild-type allele is located in the vicinity of 17p13.3 and is approximately 16 kb in length. This allele, which encodes pigment epithelium-derived factor protein, plays a role in both angiogenesis and cell proliferation. Mutation of the gene is associated with osteogenesis imperfecta type 12.. CLU gene defined as following: This gene may be involved in immunity, lipid metabolism and apoptosis.. alpha-2-HS-Glycoprotein defined as following: A fetuin subtype that is synthesized by HEPATOCYTES and secreted into the circulation. It plays a major role in preventing CALCIUM precipitation in the BLOOD.. RBP4 protein, human defined as following: Retinol-binding protein 4 (201 aa, ~23 kDa) is encoded by the human RBP4 protein, human gene. This protein plays a role in retinol transport.. Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Is Tranexamic acid effective for intracerebral haemorrhage?", "id": "converted_4183", "sentence1": "Is Tranexamic acid effective for Cerebral Hemorrhage?", "sentence2": "Tranexamic acid did not increase the risk of post-Cerebral Hemorrhage seizures in the first 90 days., The primary outcome was not different between the two groups: 26 (52%) patients in the placebo group and 22 (44%) in the tranexamic acid group had Cerebral Hemorrhage growth (odds ratio [OR] 0·72 [95% CI 0·32-1·59], p=0·41). There was no evidence of a difference in the proportions of patients who died or had thromboembolic complications between the groups: eight (16%) in the placebo group vs 13 (26%) in the tranexamic acid group died and two (4%) vs one (2%) had thromboembolic complications. None of the deaths was considered related to study medication.INTERPRETATION: Our study does not provide evidence that tranexamic acid prevents Cerebral Hemorrhage growth, although the treatment was safe with no increase in thromboembolic complications. , CONCLUSIONS: Tranexamic acid did not affect a patient's functional status at 90 days after HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO, despite there being significant modest reductions in early Cessation of life (by 7 days), Hematoma expansion and SAEs, which is consistent with an antifibrinolytic effect. , INTERPRETATION: Functional status 90 days after Cerebral Hemorrhage did not differ significantly between patients who received tranexamic acid and those who received placebo, despite a reduction in early deaths and serious adverse events. , Of these, two randomised controlled trials (RCTs) comparing intravenous tranexamic acid to placebo (n = 54) reported no significant difference in Cessation of life or dependency. Three observational studies (n = 281) suggested less Hematoma growth with rapid tranexamic acid infusion. [SEP]Relations: Tranexamic acid has relations: drug_effect with Arrhythmia, drug_effect with Arrhythmia, contraindication with subarachnoid hemorrhage (disease), contraindication with subarachnoid hemorrhage (disease), contraindication with hypertension, contraindication with hypertension, contraindication with cerebral infarction, contraindication with cerebral infarction, contraindication with brain edema, contraindication with brain edema. Definitions: Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. Hematoma defined as following: A collection of blood outside the BLOOD VESSELS. Hematoma can be localized in an organ, space, or tissue.. tranexamic acid defined as following: Antifibrinolytic hemostatic used in severe hemorrhage.. Cerebral Hemorrhage defined as following: Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA.. Tranexamic acid defined as following: Antifibrinolytic hemostatic used in severe hemorrhage..", "label": "no"} {"original_question": "Glucoraphanin from broccoli can help reduce obesity , yes or no?", "id": "converted_3754", "sentence1": "Glucoraphanin from broccoli can help reduce BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 , yes or no?", "sentence2": "Glucoraphanin: a broccoli sprout extract that ameliorates BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20-induced inflammation and insulin resistance., A recent study demonstrated that glucoraphanin, a precursor of the NFE2L2 gene activator sulforaphane, ameliorates BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 by enhancing energy expenditure and browning of white adipose tissue, and attenuates BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20-related inflammation and insulin resistance by polarizing M2 macrophages and reducing metabolic endotoxemia., Thus, this review focuses on the efficiency and safety of glucoraphanin in alleviating BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, insulin resistance, and Non-alcoholic Fatty Liver Disease., Glucoraphanin: a broccoli sprout extract that ameliorates BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20-induced inflammation and insulin resistance, tudy demonstrated that glucoraphanin, a precursor of the NFE2L2 gene activator sulforaphane, ameliorates BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 by enhancing energy expenditure and browning of white adipose tissue, and attenuates BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20-related inflammation and insulin resistance by polarizing M2 macrophages and reducing metabolic endotoxemia. Thus, this , iew focuses on the efficiency and safety of glucoraphanin in alleviating BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, insulin resistance, and Non-alcoholic Fatty Liver Disease. Abbreviations: [SEP]Relations: NFE2L2 has relations: anatomy_protein_present with Brodmann (1909) area 9, anatomy_protein_present with Brodmann (1909) area 9, anatomy_protein_present with Brodmann (1909) area 46, anatomy_protein_present with Brodmann (1909) area 46, bioprocess_protein with cellular response to glucose starvation, bioprocess_protein with cellular response to glucose starvation, protein_protein with GSK3B, protein_protein with GSK3B, protein_protein with GCLM, protein_protein with GCLM. Definitions: NFE2L2 gene defined as following: This gene plays a role in transcriptional regulation.. Non-alcoholic Fatty Liver Disease defined as following: A term referring to fatty replacement of the hepatic parenchyma which is not related to alcohol use..", "label": "yes"} {"original_question": "Is Erythropoietin effective for neuroprotection of Preterm Infants.", "id": "converted_4655", "sentence1": "Is Recombinant Erythropoietin effective for neuroprotection of Preterm Infants.", "sentence2": "BACKGROUND: High-dose EPO gene has been shown to have a neuroprotective effect in preclinical models of neonatal Brain Injuries, and phase 2 trials have suggested possible efficacy; however, the benefits and safety of this therapy in extremely preterm infants have not been established., There was no significant difference between the EPO gene group and the placebo group in the incidence of Cessation of life or severe neurodevelopmental impairment at 2 years of age (97 children [26%] vs. 94 children [26%]; relative risk, 1.03; 95% confidence interval, 0.81 to 1.32; P = 0.80). There were no significant differences between the groups in the rates of Retinal Diseases of Premature Birth, Intracranial Hemorrhage, Sepsis (Invertebrate), necrotizing enterocolitis, Bronchopulmonary Dysplasia, or Cessation of life or in the frequency of serious adverse events.CONCLUSIONS: High-dose EPO gene treatment administered to extremely preterm infants from 24 hours after birth through 32 weeks of postmenstrual age did not result in a lower risk of severe neurodevelopmental impairment or Cessation of life at 2 years of age., Based on existing evidence, it is still too early to recommend Recombinant Erythropoietin as the standard treatment for preterm Brain Injuries., Recombinant Recombinant Erythropoietin treatment of preterm infants did not result in neuroprotection at 2 years of age in two out of three published large randomized controlled trials; however, long-term follow-up of these infants is needed to come to definite conclusions.[SEP]Relations: Recombinant Erythropoietin has relations: drug_effect with Pruritus, drug_effect with Pruritus, drug_effect with Pruritus, drug_effect with Pruritus, drug_drug with Prednimustine, drug_drug with Prednimustine, drug_drug with Prednimustine, drug_drug with Prednimustine, drug_drug with Transcrocetinate, drug_drug with Transcrocetinate. Definitions: Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. Recombinant Erythropoietin defined as following: A recombinant glycosylated form of EPO gene which stimulates the differentiation and proliferation of erythroid precursors. It is used for the treatment of ANEMIA associated with CHRONIC RENAL FAILURE in dialysis and predialysis patients.. EPO gene defined as following: This gene is involved in the regulation of red blood cell production and function.. Erythropoietin defined as following: Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.. Bronchopulmonary Dysplasia defined as following: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.. Intracranial Hemorrhage defined as following: Bleeding within the cranium.. Retinal Diseases defined as following: Diseases involving the RETINA.. Brain Injuries defined as following: Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.. Premature Birth defined as following: Birth when a fetus is less than 37 weeks and 0 days gestational age..", "label": "no"} {"original_question": "Is PLK2 involved in alpha-synuclein phosphorylation in Parkinson disease?", "id": "converted_1108", "sentence1": "Is PLK2 gene involved in alpha-Synuclein phosphorylation in PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE?", "sentence2": "An increase in SNCA gene levels due to gene duplications/triplications or impaired degradation is sufficient to trigger its aggregation and cause familial PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE , Here, we report that Polo-like kinase 2 (PLK2 gene gene), an Enzyme [APC] up-regulated in synucleinopathy-diseased brains, interacts with, phosphorylates and enhances SNCA gene autophagic degradation in a kinase activity-dependent manner., Polo-like kinase 2 regulates selective autophagic SNCA gene clearance and suppresses its Toxic effect in vivo, Collectively, our findings demonstrate that PLK2 gene gene is a previously undescribed regulator of SNCA gene turnover and that modulating its kinase activity could be a viable target for the treatment of Synucleinopathies., α-Synuclein increased PLK2 gene gene levels and GSK-3β activity and increased the levels of phosphorylated α-Synuclein and uridine triacetate, Polo-like kinase 2 (PLK2 gene gene) phosphorylates alpha-Synuclein at serine 129 in CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS, Several neurological diseases, including PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE and Presenile Presenile dementia with No No Lewy bodies, are characterized by the accumulation of alpha-Synuclein phosphorylated at Ser-129 (p-Ser-129), Here we submit evidence that PLK2 gene gene protein, human (PLK2 gene gene, also known as serum-inducible kinase or SNK) is a principle contributor to alpha-Synuclein phosphorylation at Ser-129 in Neurons., PLK2 gene gene directly phosphorylates alpha-Synuclein at Ser-129 in an in vitro biochemical assay, These results indicate that PLK2 gene gene plays a critical role in alpha-Synuclein phosphorylation in CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS.[SEP]Relations: synucleinopathy has relations: disease_disease with PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE, disease_disease with PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE. autosomal recessive PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE has relations: disease_disease with PLA2G6-associated neurodegeneration, disease_disease with PLA2G6-associated neurodegeneration, disease_protein with LRRK2, disease_protein with LRRK2, disease_protein with PLA2G6, disease_protein with PLA2G6, disease_protein with PRKN, disease_protein with PRKN. Definitions: PLK2 gene protein, human defined as following: Serine/threonine-protein kinase PLK2 gene (685 aa, ~78 kDa) is encoded by the human PLK2 gene gene. This protein is involved in cell cycle progression, centriole duplication and serine/threonine phosphorylation.. SNCA gene defined as following: This gene plays a role in neuronal signaling.. uridine triacetate defined as following: A synthetic uridine pro-drug that is converted to uridine in vivo. Uridine, a pyrimidine nucleotide, has been used in a variety of diseases including depressive disorders and inherited myopathies. (NCI04). alpha-Synuclein defined as following: A synuclein that is a major component of LEWY BODIES and plays a role in SYNUCLEINOPATHIES, neurodegeneration and neuroprotection.. PLK2 gene defined as following: This gene is involved in normal cell division.. Synucleinopathies defined as following: Neurodegenerative disorders involving deposition of abnormal ALPHA-SYNUCLEIN in dopaminergic Neurons and glial cells in the brain. Pathological aggregations of alpha-Synuclein proteins results in LEWY BODIES and Lewy neurites; melanin granules in the SUBSTANTIA NIGRA and LOCUS COERULEUS; and glial cytoplasmic inclusions. Synucleinopathies are associated with mutation in the ALPHA-SYNUCLEIN (SNCA) gene on chromosome 4. PARKINSON DISEASE; LEWY BODY DISEASE with Presenile dementia; and MULTIPLE SYSTEM ATROPHY are prominent examples of synucleinopathy.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. serine defined as following: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.. Presenile dementia defined as following: The presence of Presenile dementia in an individual younger than age sixty five.. Neurons defined as following: The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM..", "label": "yes"} {"original_question": "Is the Snord116 cluster associated with the Prader-Willi syndrome?", "id": "converted_1238", "sentence1": "Is the Snord116 cluster associated with the Prader-Willi syndrome?", "sentence2": "All three Gene Deletion included SNORD116, but only two encompassed parts of small nuclear ribonucleoprotein-associated protein N gene, implicating SNORD116 as the major contributor to the Prader-Willi phenotype. Our case adds further information about genotype-phenotype correlation and supports the hypothesis that SNORD116 plays a major role in the pathogenesis of Prader-Willi syndrome, These results demonstrate that the AS candidate drug topotecan acts predominantly through stabilizing R loops and chromatin decondensation at the paternally expressed Partial Wave Spectroscopic Microscopy Snord116 Gene Locus. Our study holds promise for targeted therapies to the Snord116 Gene Locus for both AS and Partial Wave Spectroscopic Microscopy., Prader-Willi syndrome (Partial Wave Spectroscopic Microscopy) is caused by the loss of RNA expression from an imprinted region on chromosome 15 that includes small nuclear ribonucleoprotein-associated protein N, SNORD115, and SNORD116. , Recently published data strongly suggest a role for the paternally expressed small nucleolar RNA (snoRNA) cluster, SNORD116, in Partial Wave Spectroscopic Microscopy etiology., Whereas loss of function of the SNORD116 Genes appears to be responsible for the major features of Partial Wave Spectroscopic Microscopy, the role of the other Genes is less clear. , Recent data suggest that snoRNA Snord116 is important for the pathogenesis of Prader-Willi syndrome (Partial Wave Spectroscopic Microscopy) characterized by Hyperphagia and BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20. The current study was conducted to assess a potential Cells link between Snord116 and phenotypes of Partial Wave Spectroscopic Microscopy. , The imprinted Snurf-Snrpn chromosomal domain contains two large arrays of tandemly repeated, paternally expressed box C/D small-nucleolar RNA (snoRNA) Genes: the SNORD115 (H/MBII-52) and SNORD116 (H/MBII-85) gene clusters believed to play key roles in the fine-tuning of serotonin receptor (5-HT2C) pre-mRNA processing and in the etiology of the Prader-Willi Syndrome (Partial Wave Spectroscopic Microscopy), respectively, There are multiple imprinted Genes in this region, the loss of which contribute to the complete phenotype of Prader-Willi syndrome. However, absence of a small nucleolar organizing RNA gene, SNORD116, seems to reproduce many of the clinical features., Both kits should be made available for accurate characterization of Partial Wave Spectroscopic Microscopy/AS deletion subtypes as well as evaluating for IC and SNORD116 microdeletions., There are multiple imprinted Genes in this region, the loss of which contribute to the complete phenotype of Prader-Willi syndrome. However, absence of a small nucleolar organizing RNA gene, SNORD116, seems to reproduce many of the clinical features. , Although the SNORD116 gene cluster has become a prime candidate for Partial Wave Spectroscopic Microscopy, it cannot be excluded that other paternally expressed Genes in the Region of chromosome 15q11q13 contribute to the full phenotype., In addition, recently published data provide strong evidence in support of a role for the snoRNA SNORD116 cluster (HBII-85) in Partial Wave Spectroscopic Microscopy etiology., Identification and characterization of this case provide unequivocal evidence for a critical role for the SNORD116 snoRNA molecules in Partial Wave Spectroscopic Microscopy pathogenesis. [SEP]Relations: Prader-Willi syndrome has relations: disease_protein with SNORD116-1, disease_protein with SNORD116-1, disease_protein with SNORD115-1, disease_protein with SNORD115-1, disease_protein with small nuclear ribonucleoprotein-associated protein N, disease_protein with small nuclear ribonucleoprotein-associated protein N, disease_protein with LZTR1, disease_protein with LZTR1, disease_protein with NF1, disease_protein with NF1. Definitions: Gene Locus defined as following: The position of a gene or a chromosomal marker on a chromosome; also, a stretch of DNA at a particular place on a particular chromosome. The use of Gene Locus is sometimes restricted to mean regions of DNA that are expressed.. small nuclear ribonucleoprotein-associated protein N gene defined as following: This gene plays a role in splicing of mRNA.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Partial Wave Spectroscopic Microscopy defined as following: A technique that uses focused waves of broadband, low-spatially-coherent light to illuminate a sample, and forms an image by acquiring far field back-scattered photons. A partial spectrum of the back-scattered light intensity is recorded and analyzed.. Hyperphagia defined as following: Ingestion of a greater than optimal quantity of food.. Region of chromosome defined as following: Any subdivision of a chromosome along its length. [GOC:dos]. Prader-Willi Syndrome defined as following: An autosomal dominant disorder caused by deletion of the proximal long arm of the paternal chromosome 15 (15q11-q13) or by inheritance of both of the pair of chromosomes 15 from the mother (UNIPARENTAL DISOMY) which are imprinted (GENETIC IMPRINTING) and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE. (Menkes, Textbook of Child Neurology, 5th ed, p229). Gene Deletion defined as following: A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific Gene Locus.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Prader-Willi syndrome defined as following: An autosomal dominant disorder caused by deletion of the proximal long arm of the paternal chromosome 15 (15q11-q13) or by inheritance of both of the pair of chromosomes 15 from the mother (UNIPARENTAL DISOMY) which are imprinted (GENETIC IMPRINTING) and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE. (Menkes, Textbook of Child Neurology, 5th ed, p229).", "label": "yes"} {"original_question": "Is there a difference in the rate between gene fusion and gene fission?", "id": "converted_1331", "sentence1": "Is there a difference in the rate between Genes fusion and Genes fission?", "sentence2": "we illustrate arrangement diversity within closely related Organism, estimate arrangement turnover frequency and establish, for the first time, branch-specific rate estimates for fusion, fission, domain addition and terminal loss., Rate and polarity of Genes fusion and fission in Oryza sativa and Arabidopsis sp. sp. thaliana, We have identified all differentially composite or split genes in 2 fully sequenced Genome, Plant, Oryza sativa and Arabidopsis sp. sp. thaliana, Polarizing these events by outgroup comparison revealed differences in the rate of Genes fission but not of Genes fusion in the rice and Arabidopsis sp. sp. lineages. Gene fission occurred at a higher rate than Genes fusion in the O. sativa lineage and was furthermore more common in rice than in Arabidopsis sp. sp.., Gene fusion and fission are thus rare and slow processes in higher Genome, Plant; they should be of utility to address deeper evolutionary relationships among Plants--and the relationship of Plants to other eukaryotic lineages--where sequence-based phylogenies provide equivocal or conflicting results., Primary factors correlating with fusion rates are the presence of fully spanning the plasma membrane helices in HKs and the presence of DNA-binding domains in Robinow syndrome, autosomal recessive, features that require correct (and separate) spatial location. In the absence of such features, there is a relative abundance of fused genes., We show that indels are the most frequent elementary events and that they occur in most cases at either the N- or C-terminus of the proteins. As revealed by the genomic neighbourhood/context of the corresponding genes, we show that a substantial number of these terminal indels are the consequence of Genes fusions/fissions. We provide evidence showing that the contribution of Genes fusion/fission to the evolution of multi-domain Bacterial Proteins is lower-bounded by 27% and upper-bounded by 64%. We conclude that Genes fusion/fission is a major contributor to the evolution of multi-domain Bacterial Proteins., We found that fusion events are approximately four times more common than fission events, and we established that, in most cases, any particular fusion or fission event only occurred once during the course of evolution., Analyzing the most parsimonious pathways, we find 87% of architectures to gain complexity over time through simple changes, among which fusion events account for 5.6 times as many architectures as fission., These trees defined timelines of architectural discovery and revealed remarkable evolutionary patterns, including the explosive appearance of domain combinations during the rise of organismal lineages, the dominance of domain fusion processes throughout evolution, and the late appearance of a new class of multifunctional modules in Eukaryota by fission of domain combinations, We searched for examples which have arisen by one of the three postulated mechanisms: independent fusion/fission, \"duplication/deletion,\" and plasmid-mediated \"cut and paste.\" We conclude that all three mechanisms can be observed, with the independent fusion/fission being the most frequent.[SEP]Relations: robinow syndrome, autosomal recessive 2 has relations: disease_phenotype_positive with Camptodactyly, disease_phenotype_positive with Camptodactyly, disease_phenotype_positive with Absent uvula, disease_phenotype_positive with Absent uvula, disease_phenotype_positive with Short stature, disease_phenotype_positive with Short stature, disease_phenotype_positive with Anteverted nares, disease_phenotype_positive with Anteverted nares, disease_phenotype_positive with Short nose, disease_phenotype_positive with Short nose. Definitions: Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of Organism.. Oryza sativa defined as following: Annual cereal grass of the family POACEAE. Its starchy, EDIBLE GRAIN, rice, is the staple food of roughly one-half of the world's population.. Bacterial Proteins defined as following: Proteins found in any species of bacterium.. Eukaryota defined as following: Organism or cells with a nucleus separated from the cytoplasm by a two membrance nuclear envelope and compartmentalization of function into distinct cytoplasmic organelles.. Robinow syndrome, autosomal recessive defined as following: Autosomal recessive Robinow syndrome (RRS) is the less common type of Robinow syndrome (RS, see this term) characterized by short-limb dwarfism, costovertebral segmentation defects and abnormalities of the head, face and external genitalia.. Genome, Plant defined as following: The genetic complement of a plant (PLANTS) as represented in its DNA.. Plants defined as following: Multicellular, eukaryotic life forms of kingdom Plantae. Plants acquired chloroplasts by direct endosymbiosis of CYANOBACTERIA. They are characterized by a mainly photosynthetic mode of nutrition; essentially unlimited growth at localized regions of cell divisions (MERISTEMS); cellulose within cells providing rigidity; the absence of organs of locomotion; absence of nervous and sensory systems; and an alternation of haploid and diploid generations. It is a non-taxonomical term most often referring to LAND PLANTS. In broad sense it includes RHODOPHYTA and GLAUCOPHYTA along with VIRIDIPLANTAE.. Organism defined as following: A living entity..", "label": "yes"} {"original_question": "Is K-63 linked protein ubiquitination related to proteasomal degradation?", "id": "converted_821", "sentence1": "Is K-63 linked protein ubiquitination related to proteasomal degradation?", "sentence2": "In contrast to K48-linked polyubiquitin chains, K63-linked polyubiquitin chains function in nonproteasomal biological processes., ResponseLevel - modification of Proteins by the addition of lysine (K)-63-linked polyubiquitin (polyUb) chains is suggested to play important roles in a variety of cellular events, including DNA repair, signal transduction, and receptor endocytosis. , Ubiquitination is best known for its role in targeting Proteins for degradation by the proteasome complex location (sensu Eukarya) complex location (sensu Eukarya), but evidence of the nonproteolytic functions of ubiquitin activity activity is also rapidly accumulating. One example of the regulatory, rather than proteolytic, function of ubiquitin activity activity is provided by study of the tumor necrosis factor (TNF) receptor-associated factor (TRAF) Proteins, which function as ubiquitin activity activity ligases to synthesize lysine 63 (K(63))-linked polyubiquitin chains to mediate Cyclic AMP-Dependent Protein Kinases activation through a proteasome complex location (sensu Eukarya) complex location (sensu Eukarya)-independent mechanism. Some TRAF Proteins, such as TNF Receptor-Associated Factor 2, human and TNF receptor-associated factor 3, have recently been shown to have a positive role in the canonical pathway that activates NF-kappa B (NF-kappaB) through IkappaB Kinase beta (IKKbeta), but a negative role in the noncanonical pathway that activates NF-kappaB through IKKalpha. These opposing roles of TRAF Proteins may be linked to their ability to synthesize distinct forms of polyubiquitin chains. Indeed, the TNF Receptor-Associated Factor 2, human-interacting protein RIPK1 protein, human can mediate IkappaB kinase activity activation when it is Changing by K(63) polyubiquitin chains, but is targeted to degradation by the proteasome complex location (sensu Eukarya) complex location (sensu Eukarya) when it is K(48)-polyubiquitinted by the NF-kappaB inhibitor A20. Thus, ubiquitin activity activity chains are dynamic switches that can influence signaling outputs in dramatically different ways., Importantly, although Lys-48-linked ubiquitin activity activity chains appear to trigger proteasomal degradation, the presence of Lys-63-linked ubiquitin activity activity chains suggests that ubiquitination of IP(3)Rs may have physiological consequences beyond signaling for degradation., Chains of ubiquitin activity activity linked via lysine 48 (K48) are associated with protein degradation while chains linked via lysine 63 (K63) are associated with intracellular signaling., Lys(48)-linked chains target Proteins for proteasomal degradation, and Lys(63)-linked chains function in signal transduction, endocytosis and DNA repair, Remarkably, the attached Lys-48- and Lys-63-linked ubiquitin activity activity chains are homogeneous and are segregated to separate IP(3)R subunits, and Lys-48-linked ubiquitin activity activity chains, but not Lys-63-linked chains, are required for IP(3)R degradation, Activated inositol 1,4,5-trisphosphate receptors are Changing by homogeneous Lys-48- and Lys-63-linked ubiquitin activity activity chains, but only Lys-48-linked chains are required for degradation.[SEP]Relations: ubiquitin activity-ubiquitin activity ligase activity has relations: molfunc_protein with UBR5, molfunc_protein with UBR5, molfunc_protein with UBOX5, molfunc_protein with UBOX5, molfunc_protein with STUB1, molfunc_protein with STUB1, molfunc_protein with PRPF19, molfunc_protein with PRPF19, molfunc_protein with PPIL2, molfunc_protein with PPIL2. Definitions: proteasome complex location (sensu Eukarya) defined as following: A large multisubunit complex which catalyzes protein degradation, found in eukaryotes, archaea and some bacteria. In eukaryotes, this complex consists of the barrel shaped proteasome complex location (sensu Eukarya) core complex and one or two associated Proteins or complexes that act in regulating entry into or exit from the core. [GOC:rb, Wikipedia:Proteasome]. IkappaB kinase activity defined as following: Catalysis of the reaction: ATP + IkappaB protein = ADP + IkappaB phosphoprotein. [EC:2.7.11.10]. lysine defined as following: An essential amino acid. It is often added to animal feed.. NF-kappa B defined as following: Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further Changing, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. TNF Receptor-Associated Factor 2, human defined as following: TNF receptor-associated factor 2 (501 aa, ~56 kDa) is encoded by the human TNF Receptor-Associated Factor 2, human gene. This protein is involved in antibody isotype switching, protein ubiquitination, tumor necrosis factor receptor-dependent signaling, and the regulation of apoptosis.. TNF receptor-associated factor 3 defined as following: A signal transducing tumor necrosis factor receptor associated factor that is involved in regulation of NF-KAPPA B signaling and activation of MITOGEN-ACTIVATED PROTEIN KINASES.. RIPK1 protein, human defined as following: Receptor-interacting serine/threonine-Cyclic AMP-Dependent Protein Kinases 1 (671 aa, ~76 kDa) is encoded by the human RIPK1 gene. This protein plays a role in signaling that mediates inflammation, serine/threonine phosphorylation and cell death.. Changing defined as following: The act of alteration or modification; changed or altered in form or character.. Cyclic AMP-Dependent Protein Kinases defined as following: A group of enzymes that are dependent on CYCLIC AMP and catalyze the phosphorylation of SERINE or THREONINE residues on Proteins. Included under this category are two cyclic-AMP-dependent Cyclic AMP-Dependent Protein Kinases subtypes, each of which is defined by its subunit composition.. ResponseLevel - modification defined as following:

Respond with exceptions, completions and modifications or revisions done before completion

. protein defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the protein occurs, and references to homologous Proteins in other species..", "label": "no"} {"original_question": "Is Keutel syndrome a common genetic disorder?", "id": "converted_4315", "sentence1": "Is Ramer Ladda syndrome a common genetic disorder?", "sentence2": "Ramer Ladda syndrome (OMIM 245150) is a very rare syndrome , Ramer Ladda syndrome is a rare autosomal-recessive condition characterized by abnormal cartilage calcification., MGP-deficiency in Homo sapiens leads to Ramer Ladda syndrome, a rare genetic disease hallmarked by abnormal Neck+Chest>Soft tissue calcification. [SEP]Relations: LADD syndrome has relations: disease_disease with EEC syndrome and related syndrome, disease_disease with EEC syndrome and related syndrome, disease_disease with autosomal dominant disease, disease_disease with autosomal dominant disease, disease_disease with genetic otorhinolaryngological malformation, disease_disease with genetic otorhinolaryngological malformation, disease_disease with genetic multiple congenital anomalies/dysmorphic syndrome without intellectual disability, disease_disease with genetic multiple congenital anomalies/dysmorphic syndrome without intellectual disability, disease_phenotype_positive with Autosomal dominant inheritance, disease_phenotype_positive with Autosomal dominant inheritance. Definitions: Homo sapiens defined as following: Members of the species Homo sapiens.. Ramer Ladda syndrome defined as following: Osteoarticular abnormalities, highly arched palate, anorchia, and subnormal motor and mental development.. genetic disorder defined as following: Genetic diseases are diseases in which inherited genes predispose to increased risk. The genetic disorders associated with cancer often result from an alteration or mutation in a single gene. The diseases range from rare dominant cancer family syndrome to familial tendencies in which low-penetrance genes may interact with other genes or environmental factors to induce cancer. Research may involve clinical, epidemiologic, and laboratory studies of persons, families, and populations at high risk of these disorders..", "label": "no"} {"original_question": "Should minocycline be used for mild Alzheimer disease?", "id": "converted_3984", "sentence1": "Should minocycline be used for mild Alzheimer disease?", "sentence2": "Conclusions and Relevance: minocycline did not delay the progress of cognitive or functional impairment in people with mild cytarabine/daunorubicin protocol during a 2-year period. [SEP]Relations: minocycline has relations: drug_effect with Arthritis, drug_effect with Arthritis, contraindication with kidney disease, contraindication with kidney disease, contraindication with liver disease, contraindication with liver disease, contraindication with gallbladder disease, contraindication with gallbladder disease, drug_effect with Dyssynergia, drug_effect with Dyssynergia. Definitions: minocycline defined as following: A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.. minocycline defined as following: A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections..", "label": "no"} {"original_question": "Does protein ALEX1 contain armadillo repeats?", "id": "converted_3777", "sentence1": "Does protein ARMCX1 gene contain armadillo Repeat?", "sentence2": "ARMCX1 gene (Arm protein lost in epithelial cancers, on X Chromosome), contains two armadillo Repeat domains, is expressed different in normal and Carcinoma tissues., Arm protein lost in epithelial cancers, on X Chromosome 1 (ARMCX1 gene) is a novel member of the Armadillo family which has two Armadillo Repeat as opposed to more than six Repeat in the classical Armadillo family members.[SEP]Relations: carcinoma has relations: disease_protein with S1PR1, disease_protein with S1PR1, disease_protein with TSC22D1, disease_protein with TSC22D1, disease_protein with MC1R, disease_protein with MC1R, disease_protein with MPZL1, disease_protein with MPZL1, disease_protein with BCL2L1, disease_protein with BCL2L1. Definitions: X Chromosome defined as following: The female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in human and other male-heterogametic species.. Repeat defined as following: Make or do or perform again.. Carcinoma defined as following: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for \"cancer.\".", "label": "yes"} {"original_question": "Is selenocysteine an aminoacid?", "id": "converted_2797", "sentence1": "Is selenocysteine an aminoacid?", "sentence2": "selenocysteine (seconds), a rare genetically encoded Amino Acids with unusual chemical properties, is of great interest for protein engineering., selenocysteine (SeC) is a naturally available Se-containing Amino Acids that displays splendid anticancer activities against several Homo sapiens tumors. [SEP]Relations: selenocysteine has relations: drug_protein with CAMP, drug_protein with CAMP, drug_protein with NME1, drug_protein with NME1, drug_drug with Eltrombopag, drug_drug with Eltrombopag. Definitions: selenocysteine defined as following: A naturally occurring Amino Acids in both eukaryotic and prokaryotic organisms. It is found in tRNAs and in the catalytic site of some enzymes. The genes for glutathione peroxidase and formate dehydrogenase contain the TGA codon, which codes for this Amino Acids.. Amino Acids defined as following: Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins.. seconds defined as following: A unit of time, one of the seven base units of the International System of Units (Systeme International d'Unites, SI). The second is the duration of 919 263 177 0 periods of the specified light radiation corresponding to the transition between the two hyperfine levels of the caesium 133 atom in its ground state at 0 K. According to the convention, 60 seconds constitute one minute; 3,600 seconds constitute one hour.. Homo sapiens defined as following: Members of the species Homo sapiens.. selenocysteine defined as following: A naturally occurring Amino Acids in both eukaryotic and prokaryotic organisms. It is found in tRNAs and in the catalytic site of some enzymes. The genes for glutathione peroxidase and formate dehydrogenase contain the TGA codon, which codes for this Amino Acids..", "label": "yes"} {"original_question": "Are alterations in ultraconserved elements associated with colorectal adenocarcinoma?", "id": "converted_2145", "sentence1": "Are alterations in ultraconserved elements associated with Adenocarcinoma of large intestine?", "sentence2": "Genetic variants within ultraconserved elements and susceptibility to right- and left-sided Adenocarcinoma of large intestine, Our results strongly suggest that several genetic variants in the UCEs may contribute to Cytogenetic Complete Response susceptibility, individually and jointly, and that different genetic etiology may be involved in RCRC and LCRC, Identification of Genetic Polymorphism in ultraconserved elements associated with clinical outcomes in locally advanced Adenocarcinoma of large intestine, To the authors' knowledge, this is the first study to evaluate the association between Single Nucleotide Polymorphism within UCEs and clinical outcome in patients with Cytogenetic Complete Response. The results suggested that Single Nucleotide Polymorphism within UCEs may be valuable prognostic biomarkers for patients with locally advanced Cytogenetic Complete Response who receive 5-fluorouracil-based chemotherapy, Identification of Genetic Polymorphism in ultraconserved elements associated with clinical outcomes in locally advanced Adenocarcinoma of large intestine., Genetic variants within ultraconserved elements and susceptibility to right- and left-sided Adenocarcinoma of large intestine., We investigated whether single nucleotide Genetic Polymorphism within ultraconserved elements (UCEs) are associated with susceptibility to overall Malignant neoplasm of colon and/or rectum (Cytogenetic Complete Response) and susceptibility to Specimen Source Codes - Specimen Source Codes - tumor site-specific Cytogenetic Complete Response., We investigated whether single nucleotide Genetic Polymorphism within ultraconserved elements (UCEs) are associated with susceptibility to overall Malignant neoplasm of colon and/or rectum (Cytogenetic Complete Response) and susceptibility to Specimen Source Codes - Specimen Source Codes - tumor site-specific Cytogenetic Complete Response, Identification of Genetic Polymorphism in ultraconserved elements associated with clinical outcomes in locally advanced Adenocarcinoma of large intestine., Genetic variants within ultraconserved elements and susceptibility to right- and left-sided Adenocarcinoma of large intestine., Expression levels of transcribed ultraconserved regions uc.73 and uc.388 are altered in Malignant neoplasm of colon and/or rectum.[SEP]Relations: Adenocarcinoma of the large intestine has relations: phenotype_phenotype with Neoplasm of the large intestine, phenotype_phenotype with Neoplasm of the large intestine, phenotype_phenotype with Adenocarcinoma of the colon, phenotype_phenotype with Adenocarcinoma of the colon, phenotype_phenotype with Adenocarcinoma of the intestines, phenotype_phenotype with Adenocarcinoma of the intestines, disease_phenotype_positive with sclerosing cholangitis, disease_phenotype_positive with sclerosing cholangitis, disease_phenotype_positive with anal canal adenocarcinoma (disease), disease_phenotype_positive with anal canal adenocarcinoma (disease). Definitions: Genetic Polymorphism defined as following: The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.. Single Nucleotide Polymorphism defined as following: A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.. Adenocarcinoma of large intestine defined as following: The most common type of colorectal carcinoma. It is characterized by the presence of malignant glandular epithelial cells invading through the muscularis mucosa into the submucosa. Histologic variants include mucinous adenocarcinoma, signet ring cell carcinoma, medullary carcinoma, serrated adenocarcinoma, cribriform comedo-type adenocarcinoma, and micropapillary adenocarcinoma.. Cytogenetic Complete Response defined as following: The disappearance of all signs of cancer, including the absence of a detectable disease-related genetic abnormality, as determined by techniques such as karyotyping or FISH, in response to treatment..", "label": "yes"} {"original_question": "Is Alu hypomethylation associated with breast cancer?", "id": "converted_24", "sentence1": "Is Alu hypomethylation associated with Malignant neoplasm of Breast?", "sentence2": "Alu and Long Interspersed Nucleotide Element-1 hypomethylation is associated with ERBB2 wt Allele enriched subtype of Malignant neoplasm of Breast, In IBC, Alu hypomethylation correlated with negative Estrogen Receptors (Endoplasmic Reticulum) status, In survival analyses, low Alu methylation status tended to be associated with poor disease-free survival of the patients., Alu hypomethylation is probably a late event during Malignant neoplasm of Breast progression, prominent hypomethylation of Alu and Long Interspersed Nucleotide Element-1 in ERBB2 wt Allele enriched subtype may be related to chromosomal instability of this specific subtype., DNA methylation for three repetitive elements (LINE1, SLC38A2 gene and Alu) were analyzed in Invasive Ductal Breast Carcinoma of the Breast, paired adjacent normal Tissue Specimen Code and Leukocytes from 40 Malignant neoplasm of Breast patients, DNA methylation for the three repetitive elements was lower in Specimen Source Codes - Specimen Source Codes - tumor compared to adjacent Tissue Specimen Code and Leukocytes DNA.[SEP]Relations: invasive ductal Breast carcinoma has relations: disease_protein with ATF4, disease_protein with ATF4, disease_protein with PTGS2, disease_protein with PTGS2, disease_protein with SERPINB5, disease_protein with SERPINB5, disease_protein with NF2, disease_protein with NF2, disease_protein with CDH1, disease_protein with CDH1. Definitions: Leukocytes defined as following: White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES).. Long Interspersed Nucleotide Element-1 defined as following: A long interspersed element (LINE) found in mammals. The Long Interspersed Nucleotide Element-1 element is the only active LINE in humans and is approximately 6,000 base pairs long. This nucleotide sequence consists of two non-overlapping open reading frames (ORF) flanked by a 5' untranslated region (UTR), which contains a strong RNA polymerase II promoter sequence, and target side duplications. The first ORF encodes a 500 amino acid, ~40 kDa leucine zipper-containing RNA-binding protein. The second ORF encodes an ~150 kDa protein that has endonuclease and reverse transcriptase activity. Increased Long Interspersed Nucleotide Element-1 copy number is associated with cancer and neuropathy.. Malignant neoplasm of Breast defined as following: A primary or metastatic malignant neoplasm involving the Breast. The vast majority of cases are carcinomas arising from the Breast parenchyma or the nipple. Malignant Breast neoplasms occur more frequently in females than in males.. Endoplasmic Reticulum defined as following: A system of cisternae in the CYTOPLASM of many cells. In places the endoplasmic reticulum is continuous with the plasma membrane (CELL MEMBRANE) or outer membrane of the nuclear envelope. If the outer surfaces of the endoplasmic reticulum membranes are coated with ribosomes, the endoplasmic reticulum is said to be rough-surfaced (ENDOPLASMIC RETICULUM, ROUGH); otherwise it is said to be smooth-surfaced (ENDOPLASMIC RETICULUM, SMOOTH). (King & Stansfield, A Dictionary of Genetics, 4th ed). ERBB2 wt Allele defined as following: A cell surface protein-tyrosine kinase receptor that is overexpressed in a variety of ADENOCARCINOMAS. It has extensive homology to and heterodimerizes with the EGF RECEPTOR, the ERBB-3 RECEPTOR, and the ERBB-4 RECEPTOR. Activation of the erbB-2 receptor occurs through heterodimer formation with a ligand-bound erbB receptor family member.. Breast defined as following: In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.. Estrogen Receptors defined as following: Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in Malignant neoplasm of Breast patients has become clinically important.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Invasive Ductal Breast Carcinoma defined as following: An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST..", "label": "yes"} {"original_question": "In clinical trials, the H3 R antagonist CEP-26401 has a positive effect on cognition, yes or no?", "id": "converted_3010", "sentence1": "In clinical trials, the H3 R antagonist CEP-26401 has a positive effect on cognition, yes or no?", "sentence2": "CEP-26401 is a novel orally active, brain-penetrant, high-affinity histamine Receptors, Histamine H3 (H3R) antagonist, with potential therapeutic utility in cognition enhancement, hese results demonstrate potent behavioral effects of CEP-26401 in rodent models and suggest that this novel H₃R antagonist may have therapeutic utility in the treatment of cognitive and attentional disorders, CEP-26401 is a novel orally active, brain-penetrant, high-affinity histamine Receptors, Histamine H3 (H3R) antagonist, with potential therapeutic utility in cognition enhancement., CEP-26401 (irdabisant), a potent and selective histamine H₃ receptor antagonist/inverse Agonist with cognition-enhancing and wake-promoting activities., However, although a number of clinical studies examining the efficacy of Receptors, Histamine H3 antagonists for a variety of Cognition Disorders are currently underway, no clinical proof of concept for an Receptors, Histamine H3 antagonist has been reported to date., Further clinical studies are required to establish the potential of low-dose CEP-26401 in cognition enhancement.
[SEP]Relations: Histamine receptors has relations: pathway_protein with HRH3, pathway_protein with HRH3, pathway_protein with HRH1, pathway_protein with HRH1, pathway_protein with HRH4, pathway_protein with HRH4. cognitive disorder has relations: contraindication with Lithium citrate, contraindication with Lithium citrate, contraindication with Lithium carbonate, contraindication with Lithium carbonate. Definitions: Agonist defined as following: An agent that has affinity for a receptor and intrinsic activity at that receptor.. Receptors, Histamine H3 defined as following: A class of histamine receptors discriminated by their pharmacology and mode of action. Histamine H3 receptors were first recognized as inhibitory autoreceptors on histamine-containing nerve terminals and have since been shown to regulate the release of several neurotransmitters in the central and peripheral nervous systems. (From Biochem Soc Trans 1992 Feb;20(1):122-5). Cognition Disorders defined as following: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment..", "label": "yes"} {"original_question": "Are seizures among the neurological symptoms of incontinentia pigmenti?", "id": "converted_839", "sentence1": "Are Seizures among the neurological symptoms of incontinentia pigmenti?", "sentence2": "High-dose glucocorticoid therapy in the management of Seizures in neonatal incontinentia pigmenti, Bloch Sulzberger syndrome is an X-linked dominant disorder resulting from a Mutation Abnormality of IKBKG gene Genes. This disorder has a classic dermatologic presentation, but neurologic involvement, with Seizures and cortical infarction, can arise shortly after birth, Some children with incontinentia pigmenti exhibit encephalopathic features with severe Seizures and disturbed consciousness, from the neonatal through the early infantile period, Bloch Sulzberger syndrome (IP) is a rare X-linked dominant neurocutaneous disorder affecting ectodermal tissue: Skin Specimen Source Code, Eye, CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS, Hair Specimen, Nail plate, and Head>Teeth. It is usually lethal for males in utero. The involved Genes is NF-Kappa-B Essential Modulator, an essential component of the nuclear factor-kappa B (NF-κB) signaling pathway. Skin lesion are highly diagnostic, occurring in neonates, with a particular distribution on Blaschko lines. The severity of the disease is related to ocular and neurological impairment. The hallmark of ocular IP is Retinal vasculopathy including peripheral retinal vascular nonperfusion, macular infarction and neovascularization, and preretinal neovascularization. CNS involvement consists of Seizures, Intellectual Disability, hemiparesis, Muscle Spasticity, Microcephaly (physical finding), Cerebellar Ataxia, and Apraxia, oculomotor, Cogan type, Incontinentia Pigmenti is a rare X-linked multisystem disorder with well described and pathognomonic Skin Specimen Source Code manifestations. Neurological manifestations are found in 30% of IP patients, forming one of the major causes of morbidity and mortality of the condition. In this review, clinical and brain imaging data of 45 IP patients with a neurological phenotype are reviewed. Several clinical presentations could be identified, comprising Seizures, Infantile encephalopathy, acute disseminated encephalomyelitis and Ischemic stroke, Bloch Sulzberger syndrome presenting as Seizures., Neonatal Seizures in two sisters with incontinentia pigmenti., High-dose glucocorticoid therapy in the management of Seizures in neonatal incontinentia pigmenti: a case report., Incontinentia Pigmenti is an X-linked dominant neurocutaneous disorder with CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS manifestations in 30% of cases, including Seizures and Intellectual Disability., Neonatal Seizures in two sisters with incontinentia pigmenti, A rare cause of neonatal seizure: incontinentia pigmenti., Here, we describe the clinical, electrographic, and neuroradiologic effect of systemic glucocorticoid therapy in a neonate with incontinentia pigmenti manifesting an Epileptic encephalopathy., Bloch Sulzberger syndrome presenting as Seizures., Neonatal Seizures in two sisters with incontinentia pigmenti.[SEP]Relations: Seizure has relations: disease_phenotype_positive with incontinentia pigmenti, disease_phenotype_positive with incontinentia pigmenti, disease_phenotype_positive with retinitis pigmentosa, disease_phenotype_positive with retinitis pigmentosa, phenotype_phenotype with Symptomatic Seizures, phenotype_phenotype with Symptomatic Seizures. Intellectual disability has relations: disease_phenotype_positive with incontinentia pigmenti, disease_phenotype_positive with incontinentia pigmenti. IKBKG gene has relations: disease_protein with incontinentia pigmenti, disease_protein with incontinentia pigmenti. Definitions: Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. IKBKG gene defined as following: This Genes plays a role in the regulation of signal transduction.. Bloch Sulzberger syndrome defined as following: A genodermatosis occurring mostly in females and characterized by Skin Specimen Source Code changes in three phases - vesiculobullous, verrucous papillomatous, and macular melanodermic. Hyperpigmentation is bizarre and irregular. Sixty percent of patients have abnormalities of Eye, Head>Teeth, CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS, and Skin Specimen Source Code appendages.. Seizures defined as following: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent Seizures are usually referred to as EPILEPSY or \"seizure disorder.\". Muscle Spasticity defined as following: A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a \"free interval\") followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54). Ischemic stroke defined as following: An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue.. Skin lesion defined as following: A localized pathological or traumatic structural change, damage, deformity, or discontinuity of Skin Specimen Source Code.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Nail plate defined as following: The thin, horny plates that cover the dorsal surfaces of the distal phalanges of the fingers and toes of primates.. NF-Kappa-B Essential Modulator defined as following: NF-kappa-B essential modulator (419 aa, ~48 kDa) is encoded by the human IKBKG gene Genes. This protein plays a role in the mediation of signal transduction through protein phosphorylation.. Infantile encephalopathy defined as following: Encephalopathy with onset in the infantile period. [HPO:probinson]. Intellectual Disability defined as following: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28). Epileptic encephalopathy defined as following: A condition in which epileptiform abnormalities are believed to contribute to the progressive disturbance in cerebral function. Epileptic encephalaopathy is characterized by (1) electrographic EEG paroxysmal activity that is often aggressive, (2) Seizures that are usually multiform and intractable, (3) cognitive, behavioral and neurological deficits that may be relentless, and (4) sometimes early death. [PMID:21590624, PMID:23213494]. Cerebellar Ataxia defined as following: Incoordination of voluntary movements that occur as a manifestation of CEREBELLAR DISEASES. Characteristic features include a tendency for limb movements to overshoot or undershoot a target (dysmetria), a tremor that occurs during attempted movements (intention TREMOR), impaired force and rhythm of diadochokinesis (rapidly alternating movements), and GAIT ATAXIA. (From Adams et al., Principles of Neurology, 6th ed, p90). Apraxia, oculomotor, Cogan type defined as following: Ocular motor apraxia, Cogan type is characterised by impairment of voluntary horizontal eye movements and compensatory head thrust. Around 50 cases have been described so far. The oculomotor manifestations tend to improve with age but the syndrome may also be associated with learning and speech difficulties, or, in some cases, cerebral malformations. Both sporadic and familial forms have been described, with sporadic forms being more frequent. The mode of transmission of the familial form has not yet been clearly established. A Genes located on the long arm of chromosome 2, near to the <i>NPHP1</i> Genes involved in nephronophthisis, may be associated with ocular motor apraxia, Cogan type.. Eye defined as following: The organ of sight constituting a pair of globular organs made up of a three-layered roughly spherical structure specialized for receiving and responding to light.. Microcephaly (physical finding) defined as following: Head circumference below 2 standard deviations below the mean for age and gender. [PMID:15806441, PMID:19125436, PMID:25465325, PMID:9683597]. incontinentia pigmenti defined as following: A genodermatosis occurring mostly in females and characterized by Skin Specimen Source Code changes in three phases - vesiculobullous, verrucous papillomatous, and macular melanodermic. Hyperpigmentation is bizarre and irregular. Sixty percent of patients have abnormalities of Eye, Head>Teeth, CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS, and Skin Specimen Source Code appendages..", "label": "yes"} {"original_question": "Is nintedanib effective for Idiopathic Pulmonary Fibrosis?", "id": "converted_384", "sentence1": "Is nintedanib effective for Idiopathic Pulmonary Fibrosis?", "sentence2": "In this review, we present the positive results of recently published clinical trials regarding therapy for Idiopathic Pulmonary Fibrosis, with emphasis on pirfenidone and nintedanib., Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis, In the Phase II TOMORROW trial, treatment with 150 mg of nintedanib twice daily showed a trend to slow the decline in lung function and significantly decrease acute exacerbations in patients with Idiopathic Pulmonary Fibrosis, while showing an acceptable safety profile. The Phase III INPULSIS trials demonstrated a significant decrease in the annual rate of decline in forced vital capacity in Idiopathic Pulmonary Fibrosis patients treated with 150 mg nintedanib twice daily. In the INPULSIS-2 trial, the time to the first acute exacerbation significantly increased in Idiopathic Pulmonary Fibrosis patients who were treated with 150 mg of nintedanib twice daily., Effects on collagen secretion were compared with those of the drugs nintedanib and pirfenidone, recently approved for Idiopathic Pulmonary Fibrosis., Nintedanib, an orally available, small-molecule Protein Tyrosine Kinase inhibitor with selectivity for Recombinant Vascular Endothelial Growth Factor (Vascular Endothelial Growth Factor A), Platelet-Derived Growth Factor (PDGF) and Recombinant Fibroblast Growth Factor 1 (FGF) receptors has recently been shown, in two pivotal phase III studies, to effectively slow Idiopathic Pulmonary Fibrosis Disease progression. Consequently, nintedanib was given accelerated approval by the FDA in October 2014 for the treatment of Idiopathic Pulmonary Fibrosis. , Most recently, pirfenidone and nintedanib, two compounds with pleiotropic anti-fibrotic properties, have been proven effective in reducing functional decline and Disease progression in Idiopathic Pulmonary Fibrosis. , Meningococcal group B vaccine (Trumenba) to prevent more types of invasive meningococcal Disease; Factor VIII: C assay (recombinant), porcine sequence (Obizur) to treat Hemorrhage from acquired Hemophilia, NOS; and pirfenidone (Esbriet) and nintedanib (Ofev) for idiopathic pulmonary fibrosis., More importantly, the period ends with the publication of two groundbreaking studies that confirmed that two drugs, pirfenidone and nintedanib, slowed Disease progression, leading to a historic approval by the FDA. , Nintedanib (Ofev(®)) is an orally available, small, multiple receptor Protein Tyrosine Kinase inhibitor developed by Boehringer Ingelheim for the treatment of idiopathic pulmonary fibrosis (Idiopathic Pulmonary Fibrosis) and Primary malignant neoplasm. Nintedanib received its first global approval in the US in October 2014 for the treatment of Idiopathic Pulmonary Fibrosis. Nintedanib has received a positive opinion from the European Medicines Agency's Committee for Pharmaceutical Preparations for Homo sapiens Use for the treatment of Idiopathic Pulmonary Fibrosis, and for the second-line treatment in combination with docetaxel of locally advanced, metastatic or locally recurrent non-small cell lung Primary malignant neoplasm of adenocarcinoma tumour histology. , This article summarizes the milestones in the development of nintedanib leading to this first approval for Idiopathic Pulmonary Fibrosis., Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis., Nintedanib: a novel therapeutic approach for idiopathic pulmonary fibrosis., Nintedanib is in clinical development as a treatment for idiopathic pulmonary fibrosis (Idiopathic Pulmonary Fibrosis)., Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib., These results suggest that nintedanib may impact the progressive course of fibrotic lung diseases such as idiopathic pulmonary fibrosis., Findings from recently published placebo-controlled trials in idiopathic pulmonary fibrosis have established that pirfenidone and nintedanib prevent about 50% of the decline in forced vital capacity typically seen in this Disease; future trials are therefore unlikely to use placebo as a control group for ethical reasons., The Protein Tyrosine Kinase inhibitor nintedanib (BIBF 1120) is in clinical development for the treatment of idiopathic pulmonary fibrosis., A phase 2 trial suggested that treatment with 150 mg of nintedanib twice daily reduced lung-function decline and acute exacerbations in patients with idiopathic pulmonary fibrosis., A phase 2 trial suggested that treatment with 150 mg of nintedanib twice daily reduced lung-function decline and acute exacerbations in patients with idiopathic pulmonary fibrosis. , Data from the Phase II TOMORROW study suggested that nintedanib 150�mg twice daily had clinical benefits with an acceptable safety profile.METHODS: The INPULSIS� trials are replicate Phase III, randomized, double-blind, studies comparing the efficacy and safety of nintedanib 150�mg twice daily with placebo in patients with Idiopathic Pulmonary Fibrosis. , Nintedanib received its first global approval in the US in October 2014 for the treatment of Idiopathic Pulmonary Fibrosis. , The most frequent adverse event in the nintedanib groups was Diarrhea, with rates of 61.5% and 18.6% in the nintedanib and placebo groups, respectively, in INPULSIS-1 and 63.2% and 18.3% in the two groups, respectively, in INPULSIS-2. CONCLUSIONS: In patients with idiopathic pulmonary fibrosis, nintedanib reduced the decline in FVC, which is consistent with a slowing of Disease progression; nintedanib was frequently associated with Diarrhea, which led to discontinuation of the study medication in less than 5% of patients. , A phase 2 trial suggested that treatment with 150 mg of nintedanib twice daily reduced lung-function decline and acute exacerbations in patients with idiopathic pulmonary fibrosis. METHODS: We conducted two replicate 52-week, randomized, double-blind, phase 3 trials (INPULSIS-1 and INPULSIS-2) to evaluate the efficacy and safety of 150 mg of nintedanib twice daily as compared with placebo in patients with idiopathic pulmonary fibrosis. , Nintedanib (Ofev(�)) is an orally available, small, multiple receptor Protein Tyrosine Kinase inhibitor developed by Boehringer Ingelheim for the treatment of idiopathic pulmonary fibrosis (Idiopathic Pulmonary Fibrosis) and Primary malignant neoplasm. Nintedanib received its first global approval in the US in October 2014 for the treatment of Idiopathic Pulmonary Fibrosis. , Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis., A phase 2 trial suggested that treatment with 150 mg of nintedanib twice daily reduced lung-function decline and acute exacerbations in patients with idiopathic pulmonary fibrosis. We conducted two replicate 52-week, randomized, double-blind, phase 3 trials (INPULSIS-1 and INPULSIS-2) to evaluate the efficacy and safety of 150 mg of nintedanib twice daily as compared with placebo in patients with idiopathic pulmonary fibrosis.[SEP]Relations: idiopathic pulmonary fibrosis has relations: disease_disease with pulmonary fibrosis, disease_disease with pulmonary fibrosis, disease_protein with WNT5A, disease_protein with WNT5A, disease_protein with MUC5B, disease_protein with MUC5B, disease_protein with RTEL1, disease_protein with RTEL1, disease_protein with HIF1A, disease_protein with HIF1A. Definitions: Protein Tyrosine Kinase defined as following: Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Platelet-Derived Growth Factor defined as following: Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication.. Recombinant Vascular Endothelial Growth Factor defined as following: A recombinant therapeutic agent which is chemically identical to or similar to endogenous Recombinant Vascular Endothelial Growth Factor (Vascular Endothelial Growth Factor A). Produced by a wide variety of cell types, endogenous Vascular Endothelial Growth Factor A is a homodimeric, glycosylated protein that is a highly specific mitogen for vascular endothelial cells; significantly influences vascular permeability; appears to play a role in neovascularisation under physiological conditions; is a potent chemoattractant; has pro-coagulatory activities; and is hypoxia-inducible. Therapeutic Vascular Endothelial Growth Factor A may be used to induce angiogenesis in the treatment of ischemic conditions and may have a role in stimulating nerve regeneration. (NCI04). Hemophilia, NOS defined as following: A deficiency or abnormality of a blood coagulation factor characterized by the tendency to hemorrhage. Hemophilia is typically a hereditary disorder but, rarely, may be acquired. Inherited coagulation factor-deficient hemophilias include Hemophilia, NOS or classic hemophilia (hereditary factor VIII deficiency) hemophilia B or Christmas Disease (hereditary factor IX deficiency), and hemophilia C (hereditary factor XI deficiency). Factor VIII inhibitors may occur spontaneously as autoantibodies, resulting in acquired hemophilia known as acquired factor VIII deficiency. Approximately 10% of patients with acquired hemophilia have an underlying malignancy.. Pharmaceutical Preparations defined as following: Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.. Vascular Endothelial Growth Factor A defined as following: The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as \"tumor angiogenesis factor\" and \"vascular permeability factor\". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for Recombinant Vascular Endothelial Growth Factor A results in several isoforms of the protein being produced.. collagen defined as following: A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH).. Idiopathic Pulmonary Fibrosis defined as following: A common interstitial lung Disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change.. pirfenidone defined as following: An orally bioavailable and deuterated form of the synthetic antifibrotic agent pirfenidone, with potential anti-inflammatory and anti-fibrotic activities. Upon administration, deupirfenidone inhibits a variety of pro-inflammatory mediators, such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-a) and transforming growth factor-beta (TGF-b). This may reduce fibrosis, inflammation and infection, and may repair the impaired lymphatic flow, decrease lymphedema and restore lymphatic function. In the lungs, deupirfenidone may abrogate impaired lung function, lymphoedema and pulmonary fibrosis.. nintedanib defined as following: An orally bioavailable, indolinone-derived inhibitor of multiple receptor tyrosine kinases (RTKs) and non-receptor tyrosine kinases (nRTKs), with potential antiangiogenic, antifibrotic and antineoplastic activities. Upon administration, nintedanib selectively binds to and inhibits Recombinant Vascular Endothelial Growth Factor receptor (VEGFR), Recombinant Fibroblast Growth Factor 1 receptor (FGFR), Platelet-Derived Growth Factor receptor (PDGFR), and colony stimulating factor 1 receptor (CSF1R) tyrosine kinases, which may result in the induction of endothelial cell apoptosis, the reduction in tumor vasculature, the inhibition of tumor cell proliferation and migration, and antifibrotic activity in pulmonary fibrosis. In addition, nintedanib also binds to and inhibits members of the Src family of tyrosine kinases, including Src, Lck and Lyn, and fms-like Protein Tyrosine Kinase 3 (FLT-3). VEGFR, FGFR, PDGFR and CSF1R RTKs play key roles in tumor angiogenesis, tumor cell proliferation and metastasis, as well as pulmonary fibrosis.. Diarrhea defined as following: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.. Recombinant Fibroblast Growth Factor 1 defined as following: A recombinant therapeutic agent which is chemically identical to or similar to endogenous Recombinant Fibroblast Growth Factor 1 1 (FGF-1. Because of the mitogenic and angiogenetic effects of FGF-1 on fibroblasts and endothelial cells, therapeutic FGF-1 has a potential role in wound healing; because FGF-1 has been shown to induce neurogenesis, therapeutic FGF-1 may have a role in nerve regeneration. (NCI04). Homo sapiens defined as following: Members of the species Homo sapiens.. Hemorrhage defined as following: Bleeding or escape of blood from a vessel.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. docetaxel defined as following: A semisynthetic analog of PACLITAXEL used in the treatment of locally advanced or metastatic BREAST NEOPLASMS and NON-SMALL CELL LUNG CANCER.. non-small cell lung Primary malignant neoplasm defined as following: A heterogeneous aggregate of at least three distinct histological types of lung Primary malignant neoplasm, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.. Protein Tyrosine Kinase inhibitor defined as following: Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES.. Idiopathic Pulmonary Fibrosis defined as following: A common interstitial lung Disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change..", "label": "yes"} {"original_question": "Is treatment with Bacillus Calmette Guerin used for bladder cancer?", "id": "converted_3080", "sentence1": "Is treatment with Bacillus Calmette Guerin used for Urinary Bladder cancer?", "sentence2": "Intravesical Bacillus Calmette-Guerin (BCG) is the best treatment modality for progression of non-muscle invasive Urinary Bladder cancer. , this result indicates that they may be used as putative biomarkers for monitoring changes in Urinary Bladder carcinogenesis in response to BCG immunotherapy., response of urothelial precancerous lesions to intravesical BCG treatment, Urinary Bladder cancer (BC Original Formula Original Formula) is a major clinical issue.METHODS: We performed immunohistochemistry to assess the role of Homo sapiens epidermal growth factor receptor-2 (HER-2-neu peptide vaccine-neu peptide vaccine) and microsatellite instability (Microsatellite Instability) factors MutL homologue 1 (MLH1 gene gene) and MutS homologue 2 (DNA Mismatch Repair Protein DNA Mismatch Repair Protein MSH2, Homo sapiens, Homo sapiens) in predicting recurrence and progression of SLC25A4 gene high-grade BCs having undergone transurethral resection of Urinary Bladder tumor (Transurethral resection of neoplasm of Urinary Bladder) alone or Transurethral resection of neoplasm of Urinary Bladder + intravesical instillations of bacillus Calmette-Guerin (BCG)., To evaluate the efficacy and safety of a tailored endovesical immunotherapy protocol with biweekly BCG for elderly Patients with high risk non muscle invasive Urinary Bladder cancer , Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive Urinary Bladder cancer treatment in older patients., BCG (Bacillus of Calmette Guerin) has been used for more than 20 years and is currently the most active agent for superficial Urinary Bladder cancer therapy., BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial Urinary Bladder cancer., Production of interleukin-5 binding activity, a classical T(H)2 cytokine, following bacillus Calmette guerin immunotherapy of Urinary Bladder cancer., Intravesical Bacillus Calmette-Guerin is used to treat patients with superficial Urinary Bladder cancer., There is some evidence that BCG therapy improves survival and progression rates of patients with high-risk superficial Urinary Bladder cancer decreasing the proportion who require radical cystectomy., Local immunotherapy with bacillus Calmette-Guerin (BCG) is an effective and frequently used treatment for superficial Urinary Bladder cancer., CONCLUSIONS\nIntravesical bacillus Calmette-Guerin is a viable therapeutic option in patients with high risk superficial Urinary Bladder cancer and concomitant Lymphoma or Chronic Lymphocytic Leukemia, treatment with low dose oral steroids or treatment with inhaled steroids., PURPOSE\nBacillus Calmette-Guerin is the most effective therapy for nonmuscle invasive Urinary Bladder cancer., INTRODUCTION\nBacillus Calmette-Guerin (BCG) is a live attenuated strain of Mycobacterium bovis that has been used to treat Urothelial Carcinoma since 1976, and has been reported to eradicate disease in more than 70% of patients with in situ and stage I disease., Intravesical administration of bacillus Calmette-Guerin has been shown to be highly effective treatment of superficial Urinary Bladder cancer., Intravesical bacillus Calmette-Guerin therapy for superficial Urinary Bladder cancer: effect of bacillus Calmette-Guerin viability on treatment results., We describe a 53 year- old man with a disseminated bacillus Calmette-Guerin (BCG) infection after intravescical instillation for Urinary Bladder carcinoma., We tested the hypothesis that tumor expression of natural cytotoxicity receptor ligands can serve as a Disease Predictive Factor for the response to intravesical bacillus Calmette-Guerin in patients with nonmuscle invasive, high grade Urinary Bladder cancer., Bacillus Calmette-Guerin immunotherapy has been found by a number of investigators to be effective in the treatment and prevention of superficial Urinary Bladder cancer., Pancreatic Hormones Hormones and Psoas Abscess as a late complication of intravesical administration of bacillus Calmette-Guerin for Urinary Bladder cancer: a case report and review of the literature.This case illustrates the fact that although intravesical administration of bacillus Calmette-Guerin is generally considered to be safe, it is not exempt from complications and these could appear immediately after treatment or as a delayed complication many years later., Effects of local bacillus Calmette-Guerin therapy in patients with Urinary Bladder carcinoma on immunocompetent Cells of the Urinary Bladder wall.The antitumoral effects of intravesical bacillus Calmette-Guerin against recurrent superficial urothelial Urinary Bladder cancer seem to be linked to immunological effector mechanisms. , Fatal Sepsis (Invertebrate) following intravesical bacillus Calmette-Guerin administration for Urinary Bladder cancer.Intravesical administration of bacillus Calmette-Guerin has been shown to be highly effective treatment of superficial Urinary Bladder cancer. , Intravesical bacillus Calmette-Guerin therapy for superficial Urinary Bladder cancer: effect of bacillus Calmette-Guerin viability on treatment results.We treated 40 patients with superficial Urinary Bladder cancer via intravesical bacillus Calmette-Guerin for 1) prophylaxis against tumor recurrence, 2) residual carcinoma or 3) flat carcinoma in situ. , Bacillus Calmette-Guerin immunotherapy for Urinary Bladder cancer.Bacillus Calmette-Guerin immunotherapy has been found by a number of investigators to be effective in the treatment and prevention of superficial Urinary Bladder cancer. , Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in Steroids treated and immunocompromised patients.Intravesical bacillus Calmette-Guerin is a viable therapeutic option in patients with high risk superficial Urinary Bladder cancer and concomitant Lymphoma or Chronic Lymphocytic Leukemia, treatment with low dose oral steroids or treatment with inhaled steroids. , Our results suggest that intralesional bacillus Calmette-Guerin immunotherapy can afford long term protection from transplanted Urinary Bladder cancer, and that live bacillus Calmette-Guerin is superior to levamisole and P3 + Re-glycolipid + bacillus Calmette-Guerin cell walls in the treatment of Urinary Bladder cancer., A randomized controlled prospective evaluation of intravesical and percutaneous bacillus Calmette-Guerin immunotherapy was done in 57 patients with Carcinoma, Transitional Cell of the Urinary Bladder., Up to 90% of patients with high grade superficial Urinary Bladder tumors experience tumor recurrence and up to 50% have progression despite bacillus Calmette-Guerin treatment., We review how the bacillus Calmette-Guerin vaccine evolved to become standard therapy for superficial Urinary Bladder cancer., We reviewed the historical literature describing the origin of the bacillus Calmette-Guerin vaccine as an anticancer agent and its singular success as the most effective immunotherapy used against a Homo sapiens neoplasm.[SEP]Relations: Bacillus calmette-guerin substrain tice live antigen has relations: drug_drug with Antithymocyte immunoglobulin (rabbit), drug_drug with Antithymocyte immunoglobulin (rabbit), drug_drug with Siltuximab, drug_drug with Siltuximab, drug_drug with Paclitaxel, drug_drug with Paclitaxel, drug_drug with Hydroxychloroquine, drug_drug with Hydroxychloroquine, drug_drug with Inosine pranobex, drug_drug with Inosine pranobex. Definitions: DNA Mismatch Repair Protein MSH2, Homo sapiens defined as following: DNA mismatch repair protein Msh2 (934 aa, ~105 kDa) is encoded by the Homo sapiens DNA Mismatch Repair Protein MSH2, Homo sapiens gene. This protein is involved in DNA mismatch repair.. levamisole defined as following: An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6). Steroids defined as following: A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed). Bacillus Calmette-Guerin defined as following: An attenuated form of Mycobacterium bovis that is used to generate the Bacillus Calmette-Guerin vaccine.. Lymphoma defined as following: A general term for various neoplastic diseases of the lymphoid tissue.. Microsatellite Instability defined as following: The occurrence of highly polymorphic mono- and dinucleotide MICROSATELLITE REPEATS in somatic Cells. It is a form of genome instability associated with defects in DNA MISMATCH REPAIR.. Urothelial Carcinoma defined as following: A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary Urinary Bladder, ureter, urethra, or renal pelvis). It is frequently papillary.. HER-2-neu peptide vaccine defined as following: A cancer vaccine comprised of peptides derived from the extracellular domain of the tumor-associated antigen Her-2/neu with potential antineoplastic activity. HER-2-neu peptide vaccine/neu peptide vaccine may induce antibodies with anti-tumor activity and may also elicit a specific CD8 T-cell response against specific tumor cell types. (NCI04). interleukin-5 binding activity defined as following: Binding to interleukin-5. [GOC:jl]. SLC25A4 gene defined as following: This gene plays a role in energy metabolism and mitochondrial ADP/ATP flux.. Psoas Abscess defined as following: Abscess of the PSOAS MUSCLES resulting usually from disease of the lumbar vertebrae, with the pus descending into the muscle sheath. The infection is most commonly tuberculous or staphylococcal.. Disease Predictive Factor defined as following: Characteristics and conditions that have a bearing on the likelihood of a person developing a disease or disorder.. Pancreatic Hormones defined as following: Peptide hormones secreted into the blood by Cells in the ISLETS OF LANGERHANS of the pancreas. The alpha Cells secrete glucagon; the beta Cells secrete insulin; the delta Cells secrete somatostatin; and the PP Cells secrete pancreatic polypeptide.. MLH1 gene defined as following: This gene plays a role in DNA mismatch repair.. Transurethral resection of neoplasm of Urinary Bladder defined as following: A surgical procedure used to treat Urinary Bladder tumors, during which a resectoscope is passed through the urethra and into the Urinary Bladder.. Urinary Bladder defined as following: A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the Urinary Bladder via the ureters (URETER), and is held there until URINATION.. Carcinoma, Transitional Cell defined as following: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.. Chronic Lymphocytic Leukemia defined as following: A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called Chronic Lymphocytic Leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic Lymphoma. These terms represent spectrums of the same disease.. superficial Urinary Bladder cancer defined as following: An infiltrating carcinoma of the Urinary Bladder that has not invaded into the Urinary Bladder muscularis propria.. Urinary Bladder tumor defined as following: Tumors or cancer of the URINARY BLADDER.. Mycobacterium bovis defined as following: The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis.. Urinary Bladder carcinoma defined as following: A carcinoma arising from the Urinary Bladder epithelium. Approximately 90% of the Urinary Bladder carcinomas are transitional cell carcinomas. The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.. Homo sapiens defined as following: Members of the species Homo sapiens.. Urinary Bladder cancer defined as following: A primary or metastatic malignant neoplasm involving the Urinary Bladder.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary..", "label": "yes"} {"original_question": "Is Belimumab used for lupus nephritis?", "id": "converted_4449", "sentence1": "Is Belimumab used for lupus nephritis?", "sentence2": "In particular, depletion (obinutuzumab, anti-MS4A1 wt Allele monoclonal antibody CAL CAL) or neutralization (Belimumab, anti-\"interleukin-4\" monoclonal antibody CAL CAL) of Be2 Cells, and the use of a calcineurin PPP1R1A gene with a low profile of Kidney and systemic Toxic effect (Voclosporin) demonstrated an improvement in Kidney response in addition to standard therapy., In this viewpoint, we discuss the PIK3CA related overgrowth spectrum and cons of voclosporin and belimumab as add-on agents to standard therapy, the first drugs to be licenced for lupus nephritis after recent successful randomised phase III clinical trials. , Durable Kidney response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN)., A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on Both kidneys outcomes and preservation of Both kidneys function in patients with lupus nephritis., Thus, our data suggest that the addition of belimumab to standard therapy could attenuate the risk of lupus nephritis flare and Epidermal Growth Factor Receptor decline in a broad spectrum of patients with lupus nephritis., Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review., JECTIVE: To describe a patient whose active Lupus Erythematosus, Systemic (including lupus nephritis) was managed with the use of belimumab throughout pregnancy.ME, Recently introduced into the market, belimumab (Benlysta) is a monoclonal antibody CAL CAL that has potential clinically efficacious applications for the treatment of lupus nephritis., With vast implications through a novel mechanism, belimumab offers a new standard of treatment for physicians in the complications associated with Lupus Erythematosus, Systemic, specifically lupus nephritis., CENT FINDINGS: Recently, the Belimumab in Subjects with Systemic Lupus Erythematosus - Lupus Nephritis trial tested belimumab, an PPP1R1A gene of interleukin-4, as an add-on therapy to Steroids and either mycophenolate mofetil (fluorouracil/methotrexate/mitoxantrone protocol) or cyclophosphamide when given IV monthly over a period of 104 weeks at an effect size of 11% for a Primary Efficacy Renal Response. T, Recently introduced into the market, belimumab (Benlysta) is a monoclonal antibody CAL CAL that has potential clinically efficacious applications for the treatment of lupus nephritis. L, st implications through a novel mechanism, belimumab offers a new standard of treatment for physicians in the complications associated with Lupus Erythematosus, Systemic, specifically lupus nephritis. By targ, Efficacy of novel monoclonal antibody CAL CAL belimumab in the treatment of lupus nephritis, ic agents, rituximab may be used for refractory lupus nephritis patients in combination with another DMARD, and belimumab was recently approved by the US Food and Drug Administration for cSLE treatment in children aged > 5 years. New therapies targeting MS4A1 wt Allele, suc, s end, there is limited post-hoc randomized evidence to suggest beneficial effect of belimumab, administered on top of standard-of-care, during maintenance therapy in lupus nephritis. Type 1 , e of recently approved belimumab in lupus nephritis eagerly awaits further documentation. Aggre, Recently introduced into the market, belimumab (Benlysta) is a monoclonal antibody CAL CAL that has potential clinically efficacious applications for the treatment of lupus nephritis, Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient).[SEP]Relations: Belimumab has relations: drug_drug with Lumiliximab, drug_drug with Lumiliximab, drug_drug with Luspatercept, drug_drug with Luspatercept, drug_drug with Dupilumab, drug_drug with Dupilumab, drug_drug with Tremelimumab, drug_drug with Tremelimumab, drug_drug with Lomustine, drug_drug with Lomustine. Definitions: MS4A1 wt Allele defined as following: Human MS4A1 wild-type allele is located within 11q12 and is approximately 13 kb in length. This allele, which encodes B-lymphocyte antigen MS4A1 wt Allele protein, plays a role in the development and differentiation of B-cells into plasma cells.. anti-MS4A1 wt Allele monoclonal antibody CAL defined as following: Any monoclonal antibody CAL that targets MS4A1 wt Allele.. obinutuzumab defined as following: A glycoengineered, humanized IgG1 monoclonal antibody CAL with potential antineoplastic activity. obinutuzumab, a third generation type II anti-MS4A1 wt Allele antibody, selectivity binds to the extracellular domain of the human MS4A1 wt Allele antigen on malignant human B cells. The Fc region carbohydrates of the antibody, enriched in bisected non-fucosylated glycosylation variants, contribute to its higher binding affinity for human FcgammaRIII receptors compared to non-glycoengineered antibodies, resulting in enhanced antibody-dependent cellular cytotoxicity (ADCC) and caspase-independent apoptosis. In addition, modification of elbow hinge sequences within the antibody variable framework regions may account for the strong apoptosis-inducing activity of R7159 upon binding to MS4A1 wt Allele on target cells.. Kidney defined as following: Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.. Type 1 defined as following: Polypoid. belimumab defined as following: A fully human IgG1 monoclonal antibody CAL directed against B-Lymphocyte stimulator protein (BlyS or TNFSF13B) with potential immunomodulating activity. Belimumab specifically recognizes and inhibits the biological activity of BlyS, thereby preventing the binding of BlyS to B-lymphocytes. This inhibits the maturation of B-lymphocytes and may induce apoptosis in B-lymphocytes. In addition, it may decrease B-lymphocyte proliferation and/or survival. BlyS, a member of TNF family supporting B-lymphocyte maturation and survival, has been implicated in the pathogenesis of autoimmune diseases and B-lymphocyte malignancies.. rituximab defined as following: A murine-derived monoclonal antibody CAL and ANTINEOPLASTIC AGENT that binds specifically to the MS4A1 wt Allele ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Lupus Nephritis defined as following: Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982).. mycophenolate mofetil defined as following: The morpholinoethyl ester of mycophenolic acid (MPA) with potent immunosuppressive properties. Mycophenolate stops T-cell and B-cell proliferation through selective inhibition of the de novo pathway of purine biosynthesis. In vivo, the active metabolite, MPA, reversibly inhibits inosine 5'-monophosphate dehydrogenase, an enzyme involved in the de novo synthesis of guanine nucleotides. MPA displays high lymphocyte specificity and cytotoxicity due to the higher dependence of activated lymphocytes on both salvage and de novo synthesis of guanine nucleotides relative to other cell types. (NCI04). fluorouracil/methotrexate/mitoxantrone protocol defined as following: A chemotherapy regimen consisting of fluorouracil, methotrexate, and mitoxantrone that may be used in the treatment of advanced breast cancer.. cyclophosphamide defined as following: Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.. PIK3CA related overgrowth spectrum defined as following: A group of rare disorders that are usually caused by somatic mutations in the PIK3CA gene, but may rarely be caused by de novo germline mutations. These disorders are typically characterized by sporadic overgrowth of parts of the body, intellectual disability, low muscle tone, and vascular malformations with congenital or early childhood onset. Representative examples include: fibroadipose hyperplasia, CLOVES syndrome, megalencephaly-capillary malformation syndrome, hemihyperplasia-multiple lipomatosis syndrome, hemimegalencephaly, and facial infiltrating lipomatosis.. Lupus Erythematosus, Systemic defined as following: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.. Steroids defined as following: A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most Steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed). monoclonal antibody CAL defined as following: A humanized monoclonal antibody CAL directed against parathyroid hormone-related protein (PTH-rP). As a poly-hormone with diverse biological roles, PTH-rP is expressed by normal tissues, acting in local tissue environments in a variety of ways; it is commonly overexpressed by breast, prostate, and other cancers, acting systemically by promoting bone resorption, inhibiting calcium excretion from the Both kidneys, inducing hypercalcemia, and possibly playing a role in the formation of bony metastases. By blocking the effects of PTH-rP on calcium metabolism, monoclonal antibody CAL CAL may inhibit cancer-related hypercalcemia. (NCI04). interleukin-4 defined as following: A soluble factor produced by activated T-LYMPHOCYTES that induces the expression of MHC CLASS II GENES and FC RECEPTORS on B-LYMPHOCYTES and causes their proliferation and differentiation. It also acts on T-lymphocytes, MAST CELLS, and several other hematopoietic lineage cells.. Belimumab defined as following: A fully human IgG1 monoclonal antibody CAL directed against B-Lymphocyte stimulator protein (BlyS or TNFSF13B) with potential immunomodulating activity. Belimumab specifically recognizes and inhibits the biological activity of BlyS, thereby preventing the binding of BlyS to B-lymphocytes. This inhibits the maturation of B-lymphocytes and may induce apoptosis in B-lymphocytes. In addition, it may decrease B-lymphocyte proliferation and/or survival. BlyS, a member of TNF family supporting B-lymphocyte maturation and survival, has been implicated in the pathogenesis of autoimmune diseases and B-lymphocyte malignancies.. lupus nephritis defined as following: Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982)..", "label": "yes"} {"original_question": "Is the gene SLC6A2 associated with orthostatic intolerance?", "id": "converted_1548", "sentence1": "Is the gene SLC6A2 protein, Homo sapiens associated with orthostatic intolerance?", "sentence2": "Orthostatic intolerance is a debilitating syndrome characterized by Tachycardia by ECG Finding on assumption of upright posture. The norepinephrine (NE) transporter (NET) has been implicated in a genetic form of the disorder. , Thus attenuated baroreflex function and reduced sympathetic outflow may contribute to the orthostatic intolerance of severe NET deficiency., A Mutation Abnormality in the Homo sapiens Norepinephrine Plasma Membrane Transport Proteins (SLC6A2 protein, Homo sapiens protein, Homo sapiens) associated with orthostatic intolerance disrupts surface expression of Mutant and wild-type transporters., Recently, our laboratory reported a Genetic Polymorphism in the Homo sapiens NET (hNET) gene A457P in an individual with the autonomic disorder orthostatic intolerance (Osteogenesis Imperfecta). , Nonsynonymous single nucleotide polymorphisms (SNPs) in the Homo sapiens NET (hNET) gene that influence transporter function can contribute to disease, such as the nonfunctional transporter, A457P, identified in orthostatic intolerance. , Orthostatic intolerance is not necessarily related to a specific Mutation Abnormality (Ala457Pro) in the Homo sapiens Norepinephrine Plasma Membrane Transport Proteins., We propose that chromatin-modifying events associated with SLC6A2 protein, Homo sapiens protein, Homo sapiens gene suppression may constitute a mechanism of POTS., The goal of the present study was to further characterize the role and regulation of the SLC6A2 protein, Homo sapiens protein, Homo sapiens gene in POTS., In the absence of altered SLC6A2 protein, Homo sapiens protein, Homo sapiens gene sequence or promoter methylation, this reduced expression was directly correlated with chromatin modifications. We propose that chromatin-modifying events associated with SLC6A2 protein, Homo sapiens protein, Homo sapiens gene suppression may constitute a mechanism of POTS., A coding Mutation Abnormality in the Norepinephrine Plasma Membrane Transport Proteins (SLC6A2 protein, Homo sapiens protein, Homo sapiens) sequence has been reported in 1 family kindred only. The goal of the present study was to further characterize the role and regulation of the SLC6A2 protein, Homo sapiens protein, Homo sapiens gene in POTS.[SEP]Relations: Defective SLC6A2 protein, Homo sapiens causes orthostatic intolerance (Osteogenesis Imperfecta) has relations: pathway_protein with SLC6A2 protein, Homo sapiens, pathway_protein with SLC6A2 protein, Homo sapiens. osteogenesis imperfecta has relations: disease_protein with SLC39A13, disease_protein with SLC39A13, disease_protein with B3GALT6, disease_protein with B3GALT6. Lacrimation abnormality has relations: disease_phenotype_positive with EEC syndrome, disease_phenotype_positive with EEC syndrome. Protein S Homo sapiens has relations: drug_drug with Testosterone enantate benzilic acid hydrazone, drug_drug with Testosterone enantate benzilic acid hydrazone. Definitions: SLC6A2 protein, Homo sapiens defined as following: Sodium-dependent noradrenaline transporter (617 aa, ~69 kDa) is encoded by the Homo sapiens SLC6A2 protein, Homo sapiens gene. This protein plays a role in the reuptake of norepinephrine by presynaptic cells.. Osteogenesis Imperfecta defined as following: COLLAGEN DISEASES characterized by brittle, osteoporotic, and easily fractured bones. It may also present with blue sclerae, loose joints, and imperfect dentin formation. Most types are autosomal dominant and are associated with mutations in COLLAGEN TYPE I.. Homo sapiens defined as following: Members of the species Homo sapiens.. SLC6A2 protein, Homo sapiens gene defined as following: This gene plays a role in neurotransmitter recycling.. Norepinephrine Plasma Membrane Transport Proteins defined as following: Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of noradrenergic neurons. They remove NOREPINEPHRINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS. The norepinephrine transporter regulates signal amplitude and duration at noradrenergic synapses and is the target of ADRENERGIC UPTAKE INHIBITORS.. Mutant defined as following: An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Orthostatic intolerance defined as following: Symptoms of cerebral hypoperfusion or autonomic overaction which develop while the subject is standing, but are relieved on recumbency. Types of this include NEUROCARDIOGENIC SYNCOPE; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; and neurogenic ORTHOSTATIC HYPOTENSION. (From Noseworthy, JH., Neurological Therapeutics Principles and Practice, 2007, p2575-2576). Genetic Polymorphism defined as following: The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.. orthostatic intolerance defined as following: Symptoms of cerebral hypoperfusion or autonomic overaction which develop while the subject is standing, but are relieved on recumbency. Types of this include NEUROCARDIOGENIC SYNCOPE; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; and neurogenic ORTHOSTATIC HYPOTENSION. (From Noseworthy, JH., Neurological Therapeutics Principles and Practice, 2007, p2575-2576). gene SLC6A2 protein, Homo sapiens defined as following: This gene plays a role in neurotransmitter recycling..", "label": "yes"} {"original_question": "Is Growth factor independence 1b (GFI1B) important for hematopoiesis?", "id": "converted_995", "sentence1": "Is Growth factor independence 1b (GFI1B protein, human) important for Hematopoiesis?", "sentence2": "Growth Factor Independence (Gfi) transcription factors play essential roles in Hematopoiesis, differentially activating and repressing transcriptional programs required for hematopoietic stem/progenitor cell (HSPC) development and Lineage specification, gfi1aa and gfi1b have distinct roles in regulating primitive and definitive hematopoietic progenitors,, gfi1b is required for definitive Hematopoiesis, LSD1-kd was associated with the upregulation of key hematopoietic Genes, including Gfi1b, Zinc Finger Protein Zinc Finger Protein GFI1 wt Allele, Human wt Allele, Human and GFI1B protein, human protein, human control the loss of Endothelium identity of hemogenic endothelium during hematopoietic commitment, Taken together, our findings demonstrate a critical and specific role of the Zinc Finger Protein Zinc Finger Protein GFI1 wt Allele, Human wt Allele, Human transcription factors in the first steps of the process leading to the generation of hematopoietic progenitors from hemogenic endothelium, A short Gfi-1B isoform controls Erythroid differentiation, Gfi-1B is a Transcription Repressor/Corepressor essential for the regulation of erythropoiesis and megakaryopoiesis, Among the few down-regulated Genes was Gfi1b, a known repressor of Erythroid differentiation, This reversible modulation of Endothelium-haematopoietic state is accomplished by targeting key haematopoietic transcription factors for downregulation, including RUNX1 protein, human, GATA1 wt Allele, Gfi1B, IKZF1 gene, and SPI1 wt Allele, Gfi1 and Gfi1b: key regulators of Hematopoiesis, we review how Gfi1 and its paralogue Gfi1b control the development of Blood Cells, discuss how changes in Gfi1 and Gfi1b function contribute to Hematological Disease and report on the molecular function of these Proteins., Gfi-1B controls human Erythroid and Megakaryocytic differentiation by regulating TGF-beta signaling at the bipotent erythro-Megakaryocytic progenitor stage, Growth factor independence-1B (Gfi-1B) is a Transcription Repressor/Corepressor essential for erythropoiesis and megakaryopoiesis, Targeted gene disruption of GFI1B protein, human protein, human in CASP14 gene leads to embryonic lethality resulting from failure to produce definitive Specimen Source Codes - Erythrocytes, hindering the study of Gfi-1B function in adult Hematopoiesis, We here show that, in Homo sapiens, Gfi-1B controls the development of Specimen Source Codes - Erythrocytes and Megakaryocytes by regulating the proliferation and differentiation of bipotent erythro-Megakaryocytic progenitors, To date, we have identified two common integration sites involving Genes encoding transcription factors that play a critical role in Hematopoiesis (MECOM wt Allele and Gfi1b loci), TRANSCRIPTION FACTOR play essential roles in both normal and malignant Hematopoiesis. This is the case for the Growth Factor [APC] independent 1b (GFI1B protein, human protein, human) transcription factor, which is required for Erythroid and Megakaryocytic differentiation and over-expressed in leukemic patients and Cultured Cell Line, We localized several conserved non-coding elements containing multiple Erythroid specific transcription factor binding sites at the GFI1B protein, human protein, human locus. In GFI1B protein, human protein, human-expressing cells a subset of these conserved non-coding elements and the Promoter adopt a close spatial conformation, localize with open chromatin sites, harbor chromatin modifications associated with gene activation and bind multiple transcription factors and Co-Repressor Proteins, Our findings indicate that GFI1B protein, human protein, human regulatory elements behave as activators and repressors, To investigate the molecular effects of Growth Factor [APC] independence 1B (Gfi-1B), a transcription factor essential for the development of hematopoietic cells and differentiation of Erythroid and Megakaryocytic lineages, Our data indicate that Gfi-1B signalling is important for commitment and maturation of Hematopoietic cell populations, Zinc Finger Protein GFI1 wt Allele, Human wt Allele and Gfi-1b are homologous transcriptional repressors involved in diverse developmental contexts, including Hematopoiesis and oncogenesis, Gfi1b:green fluorescent protein knock-in CASP14 gene reveal a dynamic expression pattern of Gfi1b during Hematopoiesis that is largely complementary to Gfi1, We found highly dynamic expression patterns of Gfi1b in Erythroid Cells, Megakaryocytes, and their Stem cells (MEPS) where Gfi1 is not detected. Vice versa, Gfi1b could not be found in Granulocyte component of blood, Armed macrophage, or their granulomonocytic precursors (guanosine 5'-monophosphorothioate) or in mature naive or activated lymphocytes where Gfi1 is expressed, suggesting a complementary regulation of both loci during Hematopoiesis, Gfi1 and Gfi1b act equivalently in haematopoiesis, our findings show that an intact SNAG domain is essential for all functions of Gfi1 and that Gfi1b can replace Gfi1 functionally in haematopoiesis, Zinc Finger Protein GFI1 wt Allele, Human wt Allele oncoproteins in Hematopoiesis, Recent gene targeting experiments and mutational screening in Homo sapiens have revealed an essential role for Zinc Finger Protein GFI1 wt Allele, Human wt Allele and Gfi-1B in Hematopoiesis, Gfi-1B disruption is embryonic lethal due to a block of erythropoiesis. Gfi-1B is required for both Erythroid and megakaryocyte development, Erythroid expansion mediated by the Gfi-1B zinc finger protein: role in normal Hematopoiesis, we identified that the expression of Gfi-1B (Growth Factor [APC] independence-1B) is highly restricted to Hematopoietic stem cells, Erythroblasts, and Megakaryocytes, These findings establish Gfi-1B as a novel Erythroid regulator and reveal its specific involvement in the regulation of Erythroid cell growth through modulating Erythroid-specific gene expression, The zinc-finger proto-oncogene Gfi-1b is essential for development of the Erythroid and Megakaryocytic lineages, we establish that Gfi-1b is required for the development of two related blood lineages, Erythroid and Megakaryocytic, in CASP14 gene, Gfi-1b(-/-) embryonic stem cells fail to contribute to Erythrocytes of adult chimeras. Gfi-1b(-/-) embryos exhibit delayed maturation of primitive Specimen Source Codes - Erythrocytes and subsequently die with failure to produce definitive enucleated Specimen Source Codes - Erythrocytes, Gfi-1b is an essential transcriptional regulator of Erythroid and megakaryocyte development, Growth factor independence 1b (GFI1B protein, human protein, human) is a DNA binding repressor of transcription with vital functions in Hematopoiesis., Conversely, loss of gfi1b silences runx-1, MYB wt Allele, Human, ikaros and Platelet Membrane Glycoprotein IIb, indicating that gfi1b is required for definitive Hematopoiesis., Gfi1b:green fluorescent protein knock-in CASP14 gene reveal a dynamic expression pattern of Gfi1b during Hematopoiesis that is largely complementary to Gfi1., Gfi1 and Gfi1b: key regulators of Hematopoiesis., We show that gfi1aa and gfi1b are expressed in the primitive and definitive sites of Hematopoiesis in Zebrafish., Targeted gene disruption of GFI1B protein, human protein, human in CASP14 gene leads to embryonic lethality resulting from failure to produce definitive Specimen Source Codes - Erythrocytes, hindering the study of Gfi-1B function in adult Hematopoiesis., Growth factor independence 1b (gfi1b) is important for the maturation of Erythroid Cells and the regulation of embryonic globin expression., GFI1B protein, human gene (Gfi1b) is a zinc finger transcription factor essential for Erythroid and Megakaryocytic development., Gfi1b (Growth Factor [APC] independence 1b) is a zinc finger transcription factor essential for development of the Erythroid and Megakaryocytic lineages., In fact, we demonstrate that valproic acid treatment is able to induce the expression of Growth Factor [APC]-independent protein 1B (GFI1B protein, human protein, human) and of mixed-Lineage leukemia translocated to chromosome 3 protein (MLLT3 wt Allele wt Allele), which are crucial regulators of erythrocyte and megakaryocyte differentiation, and that the up-regulation of these Genes is mediated by the histone hyperacetylation at their Promoter sites., Growth factor independence-1B (Gfi-1B) is a Transcription Repressor/Corepressor essential for erythropoiesis and megakaryopoiesis., Gfi-1B (Growth Factor [APC] independence-1B) gene is an Erythroid-specific transcription factor, whose expression plays an essential role in erythropoiesis., Evidence that Growth Factor [APC] independence 1b regulates dormancy and peripheral blood mobilization of Hematopoietic stem cells., We report here that adult CASP14 gene conditionally deficient for the transcription Growth factor independence 1b (Gfi1b) show a significant expansion of functional HSCs in the bone marrow and blood., GFI1B protein, human gene (Gfi1b) is a zinc finger transcription factor essential for Erythroid and Megakaryocytic development, Teleost Growth Factor [APC] independence (gfi) Genes differentially regulate successive waves of Hematopoiesis., Gfi-1B (Growth Factor [APC] independence-1B) gene is an Erythroid-specific transcription factor, whose expression plays an essential role in erythropoiesis, Our data indicate that Gfi-1B signalling is important for commitment and maturation of Hematopoietic cell populations., We report here that adult CASP14 gene conditionally deficient for the transcription Growth factor independence 1b (Gfi1b) show a significant expansion of functional HSCs in the bone marrow and blood[SEP]Relations: GFI1B protein, human has relations: cellcomp_protein with nucleus, cellcomp_protein with nucleus, protein_protein with EFEMP2, protein_protein with EFEMP2, protein_protein with PSMA3, protein_protein with PSMA3, bioprocess_protein with regulation of hemopoiesis, bioprocess_protein with regulation of hemopoiesis, protein_protein with CENPB, protein_protein with CENPB. Definitions: Zinc Finger Protein GFI1 wt Allele, Human defined as following: Zinc finger protein GFI1 wt Allele (422 aa, ~45 kDa) is encoded by the human Zinc Finger Protein GFI1 wt Allele, Human gene. This protein is involved in Hematopoiesis.. SPI1 wt Allele defined as following: The human SPI1 wild-type allele is located in the vicinity of 11p11.2 and is approximately 24 kb in length. This allele, which encodes transcription factor SPI1 wt Allele protein, is involved in the activation of transcription by RNA polymerase II.. Megakaryocytes defined as following: Very large BONE MARROW CELLS which release mature BLOOD PLATELETS.. MYB wt Allele, Human defined as following: Human MYB wild-type allele is located within 6q22-q23 and is approximately 38 kb in length. This allele, which encodes Myb proto-oncogene protein, plays a role in both the modulation of transcription by RNA polymerase II and differentiation of hematopoietic Stem cells.. GFI1B protein, human defined as following: Human GFI1B protein, human wild-type allele is located in the vicinity of 9q34.13 and is approximately 46 kb in length. This allele, which encodes Growth Factor [APC] independent protein 1B, may play a role in the modulation of transcription by RNA polymerase II.. Co-Repressor Proteins defined as following: A subclass of repressor Proteins that do not directly bind DNA. Instead, Co-Repressor Proteins generally act via their interaction with DNA-BINDING PROTEINS such as a TRANSCRIPTIONAL SILENCING FACTORS or NUCLEAR RECEPTORS.. Zebrafish defined as following: An exotic species of the family CYPRINIDAE, originally from Asia, that has been introduced in North America. Zebrafish is a model organism for drug assay and cancer research.. Lineage defined as following: Descent in a line from a common progenitor or source.. Blood Cells defined as following: The cells found in the body fluid circulating throughout the CARDIOVASCULAR SYSTEM.. IKZF1 gene defined as following: This gene is involved in B-cell and T-cell maturation.. Hematological Disease defined as following: Disorders of the blood and blood forming tissues.. Erythroid Cells defined as following: The series of cells in the red blood cell Lineage at various stages of differentiation.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually Proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. Erythroid defined as following: 1) Reddish in color. 2) relating to Specimen Source Codes - Erythrocytes or their precursors.. MECOM wt Allele defined as following: Human MECOM wild-type allele is located in the vicinity of 3q26.2 and is approximately 580 kb in length. This allele, which encodes histone-lysine N-methyltransferase MECOM protein, is involved in DNA binding, transcription factor activity and histone methylation. Mutation of the gene is associated with radioulnar synostosis with amegakaryocytic thrombocytopenia-2. Chromosomal translocations involving this gene are associated with leukemogenesis.. Platelet Membrane Glycoprotein IIb defined as following: Platelet membrane glycoprotein IIb is an integrin alpha subunit that heterodimerizes with INTEGRIN BETA3 to form PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX. It is synthesized as a single polypeptide chain which is then postranslationally cleaved and processed into two disulfide-linked subunits of approximately 18 and 110 kDa in size.. Hematopoietic stem cells defined as following: Progenitor cells from which all Blood Cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood.. RUNX1 protein, human defined as following: Runt-related transcription factor 1 (453 aa, ~49 kDa) is encoded by the human RUNX1 gene. This protein is involved in the promotion of gene transcription and Hematopoiesis.. Transcription Repressor/Corepressor defined as following: Transcription Repressor/Corepressor Gene encodes Transcriptional Repressor/Corepressor, Proteins that can regulate transcription by binding to the operator and causing repression. (from Glick: Glossary of Biochemistry and Molecular Biology). valproic acid defined as following: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. MLLT3 wt Allele defined as following: Human MLLT3 wt Allele wild-type allele is located in the vicinity of 9p22 and is approximately 281 kb in length. This allele, which encodes protein AF-9, plays a role in modulation of transcription by RNA polymerase II (Gene Ontology/GO). Acute nonlymphocytic leukemia is associated with the translocation t(9;11)(p22;q23) of this gene and the MLL gene.. Erythrocytes defined as following: Red Blood Cells. Mature Specimen Source Codes - Erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. GFI1B gene defined as following: This gene plays a role in transcriptional regulation and Erythroid cell growth. Translocations in the gene are associated with chronic myeloid leukemia.. Cultured Cell Line defined as following: Established cell cultures that have the potential to propagate indefinitely.. GATA1 wt Allele defined as following: Human GATA1 wild-type allele is located in the vicinity of Xp11.23 and is approximately 8 kb in length. This allele, which encodes Erythroid transcription factor protein, is involved in the regulation of both transcription by RNA polymerase II and Erythroid development.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Stem cells defined as following: Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide Stem cells that can differentiate into specialized cells.. GFI1 wt Allele defined as following: Human Zinc Finger Protein GFI1 wt Allele, Human wild-type allele is located in the vicinity of 1p22.1 and is approximately 14 kb in length. This allele, which encodes zinc finger protein GFI1 wt Allele, plays a role in transcriptional repression during multilineage blood cell development. Mutation of the gene is associated with autosomal recessive severe congenital neutropenia 2 (SCN2) and adult nonimmune chronic idiopathic neutropenia.. Endothelium defined as following: A layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body.. Hematopoiesis defined as following: The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY).. Homo sapiens defined as following: Members of the species Homo sapiens.. Erythroblasts defined as following: Immature, nucleated ERYTHROCYTES occupying the stage of ERYTHROPOIESIS that follows formation of ERYTHROID PRECURSOR CELLS and precedes formation of RETICULOCYTES. The normal series is called normoblasts. Cells called MEGALOBLASTS are a pathologic series of Erythroblasts..", "label": "yes"} {"original_question": "Does ventriculoperitoneal shunt improve normal pressure hydrocephalus?", "id": "converted_1486", "sentence1": "Does ventriculoperitoneal shunt improve normal pressure hydrocephalus?", "sentence2": "Clinical improvement depends not only on the capability to restore the Cerebrospinal Fluid dynamic, but also on the ability of cerebral parenchyma to recover the metabolic function., After shunting, the global CMRglu significantly increased (2.95 ± 0.44 vs 4.38 ± 0.68, p = 10(-7)) in all INPH patients with a mean percentage value of 48.7%. , Our preliminary data show that changes in the CMRglu are promptly reversible after surgery and that there is a relationship between the early metabolic changes and clinical symptoms, independently from the simultaneous changes in the ventricular size. The remarkable and prompt improvement in the global CMRglu and in symptoms may also have important implications for the current concept of \"neuronal plasticity\" and for the cells' reactivity in order to recover their metabolic function., Outcome of shunting in INPH is most often successful when patients are accurately diagnosed, suitably evaluated for surgical candidacy, and managed carefully throughout the preoperative, surgical, and postoperative periods., The decision to perform the only efficient procedure, i.e., a ventricular shunt operation, depends upon a number of established arguments in favor of that procedure. Clinical improvement, which is often spectacular, can then confirm the diagnosis. , During the 1st postoperative year, there was improvement in the condition of 22 patients (96%) who had received a ventricular shunt; 21 of these patients (91%) remained improved until Cessation of life or for at least 5 years., Shunt treatment showed an effect on cognitive functions of distractibility of attention and motor speed, but not on intelligence of memory. Three patients deteriorated, eleven remained stable and sixteen showed significant improvement on psychological tests, mainly those for attention, motor speed and memory, but rarely did any improvement of intelligence occur.[SEP]Relations: Cessation of head growth has relations: phenotype_phenotype with Secondary microcephaly, phenotype_phenotype with Secondary microcephaly, disease_phenotype_positive with Angelman syndrome due to a point mutation, disease_phenotype_positive with Angelman syndrome due to a point mutation, disease_phenotype_positive with leukoencephalopathy with vanishing white matter, disease_phenotype_positive with leukoencephalopathy with vanishing white matter, disease_phenotype_positive with neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies, disease_phenotype_positive with neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies. Cerebrospinal Fluid has relations: anatomy_anatomy with transudate, anatomy_anatomy with transudate. Definitions: Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. Cerebrospinal Fluid defined as following: A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES..", "label": "yes"} {"original_question": "Is valproic acid effective for glioblastoma treatment?", "id": "converted_84", "sentence1": "Is valproic acid effective for Glioblastoma Multiforme treatment?", "sentence2": "A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma., PURPOSE: Valproic acid (valproic acid) is an antiepileptic agent with Histone Deacetylase Inhibitor [EPC] therapy (HDACi) activity shown to sensitize Glioblastoma Multiforme (Glomerular Basement Membrane) Cells to radiation in preclinical models., Median overall survival (OS) was 29.6 months (range: 21-63.8 months), and median progression-free survival (PFS) was 10.5 months (range: 6.8-51.2 months). OS at 6, 12, and 24 months was 97%, 86%, and 56%, respectively. PFS at 6, 12, and 24 months was 70%, 43%, and 38% respectively. , CONCLUSIONS: Addition of valproic acid to concurrent RT/temozolomide in patients with newly diagnosed Glomerular Basement Membrane was well tolerated. Additionally, valproic acid may result in improved outcomes compared to historical data and merits further study., Treatment of GDSCs with histone deacetylase inhibitors, indole-3-glycerol-phosphate lyase activity and valproic acid, significantly reduced proliferation rates of the Cells and expression of the Stem Cells markers, indicating differentiation of the Cells. Since differentiation into Glomerular Basement Membrane makes them susceptible to the conventional cancer treatments, we posit that use of histone deacetylase inhibitors may increase efficacy of the conventional cancer treatments for eliminating GDSCs., Several clinical studies have reported that valproic acid could prolong survival of Glomerular Basement Membrane patients. , Our meta-analysis confirmed the benefit of using valproic acid (HR, 0.56; 95% NDUFB6 gene, 0.44-0.71). Sub-group analysis shows that patients treated with valproic acid had a hazard ratio of 0.74 with a 95% confidence interval of 0.59-0.94 vs. patients treated by other-AEDs and a hazard ratio of 0.66 with a 95% confidence interval of 0.52-0.84 vs. patients treated by administration of non-AEDs. , .CONCLUSION: The results of our study suggest that Glioblastoma Multiforme patients may experience prolonged survival due to valproic acid administration. , A new and exciting insight is the potential contribution of valproic acid to prolonged survival, particularly in Glioblastoma. , Valproic acid (valproic acid) is an antiepileptic agent with Histone Deacetylase Inhibitor [EPC] therapy (HDACi) activity shown to sensitize Glioblastoma Multiforme (Glomerular Basement Membrane) Cells to radiation in preclinical models, Valproic acid use during radiation therapy for Glioblastoma Multiforme associated with improved survival, Valproic acid (VA) is an antiepileptic drug (AED) and histone deacetylase (HDAC) inhibitor taken by patients with Glioblastoma Multiforme (Human Cytomegalovirus Envelope Glycoprotein B) to manage Seizures, and it can modulate the biologic effects of radiation therapy (RT), Valproic acid use during radiation therapy for Glioblastoma Multiforme associated with improved survival., Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for Glioblastoma Multiforme., PURPOSE: Valproic acid (VA) is an antiepileptic drug (AED) and histone deacetylase (HDAC) inhibitor taken by patients with Glioblastoma Multiforme (Human Cytomegalovirus Envelope Glycoprotein B) to manage Seizures, and it can modulate the biologic effects of radiation therapy (RT). We investigated whether VA use during RT for Human Cytomegalovirus Envelope Glycoprotein B was associated with overall survival (OS).METHODS AND MATERIALS: Medical records of 544 adults with Human Cytomegalovirus Envelope Glycoprotein B were retrospectively reviewed. Analyses were performed to determine the association of Radiation Therapy Oncology Group recursive partitioning analysis (RTOG RPA) class, seizure history, and concurrent temozolomide (temozolomide) and AED use during RT with OS.RESULTS: Seizures before the end of RT were noted in 217 (40%) patients, and 403 (74%) were taking an AED during RT; 29 (7%) were taking VA. , When the analysis was restricted to patients who received concurrent temozolomide, VA use was marginally associated with OS (P=.057; HR, 0.54; 95% NDUFB6 gene, -0.09 to 1.17), independently of RTOG RPA class and seizure history., Patients using valproic acid in combination with temozolomide showed a longer median survival of 69 weeks (95% confidence interval [NDUFB6 gene]: 61.7-67.3) compared with 61 weeks (95% NDUFB6 gene: 52.5-69.5) in the group without valproic acid (hazard ratio, 0.63; 95% NDUFB6 gene: 0.43-0.92; P = .016), adjusting for age, extent of resection, and O(6)-DNA methylguanine-methyltransferase promoter methylation status., Use of valproic acid together with chemoradiation with temozolomide results in a 2-months' longer survival of patients with Glomerular Basement Membrane.[SEP]Relations: Valproic acid has relations: contraindication with gallbladder disease, contraindication with gallbladder disease, drug_drug with Glutaric Acid, drug_drug with Glutaric Acid, contraindication with hematologic disease, contraindication with hematologic disease, drug_drug with Afelimomab, drug_drug with Afelimomab, contraindication with pancreatitis, contraindication with pancreatitis. Definitions: valproic acid defined as following: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.. Glomerular Basement Membrane defined as following: A sheet of amorphous extracellular material upon which the basal surfaces of epithelial Cells rest and is the covering surface of a glomerular capillary, interposed between the cellular elements and the underlying connective tissue.. Glioblastoma Multiforme defined as following: The most malignant astrocytic tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO). Human Cytomegalovirus Envelope Glycoprotein B defined as following: Envelope glycoprotein B (906 aa; ~102 kDa) is encoded by the human cytomegalovirus gB gene, which is located within the open reading frame (ORF) UL55. This protein is involved in host cell entry, cell to-cell virus transmission, and fusion of infected Cells.. Seizures defined as following: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain Cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent Seizures are usually referred to as EPILEPSY or \"seizure disorder.\". temozolomide defined as following: A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.. indole-3-glycerol-phosphate lyase activity defined as following: Catalysis of the reaction: (1S,2R)-1-C-(indol-3-yl)glycerol 3-phosphate = indole + D-glyceraldehyde 3-phosphate. [EC:4.1.2.8]. Histone Deacetylase Inhibitor [EPC] therapy defined as following: Compounds causing hyperacetylation of histone deacetylase, an enzyme involved in the regulation of transcription, causing inhibition of cell differentiation and induction of apoptosis. Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1946\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1946\" NCI Thesaurus). Stem Cells defined as following: Relatively undifferentiated Cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor Cells that can differentiate into specialized Cells.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Glioblastoma defined as following: A malignant form of astrocytoma histologically characterized by pleomorphism of Cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or Seizures.. valproic acid defined as following: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS..", "label": "yes"} {"original_question": "Has LB-100 been tested in clinical trials?", "id": "converted_3566", "sentence1": "Has LB-100 been tested in clinical trials?", "sentence2": "To determine the MTD and to assess the safety, tolerability, and potential activity of LB-100, a first-in-class small-molecule inhibitor of protein phosphatase 2A activity activity (Protein Phosphatase 2A) in adult patients with progressive Solid Neoplasm., Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsing course Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial.[SEP]Relations: protein phosphatase 2A activity binding has relations: molfunc_protein with IGBP1, molfunc_protein with IGBP1, molfunc_protein with STRN, molfunc_protein with STRN, molfunc_protein with SMG5, molfunc_protein with SMG5, molfunc_protein with ARPP19, molfunc_protein with ARPP19, molfunc_protein with STRN3, molfunc_protein with STRN3. Definitions: Protein Phosphatase 2A defined as following: Protein Phosphatase 2A core enzyme consists of a 36-kDa catalytic C subunit and a constant 65-kDa regulatory/structural A subunit that interact with either a B regulatory subunit or with cell signaling molecules, that likely modulate substrate selectivity, catalytic activity, and subcellular localization, yielding the trimeric holoenzyme. Combinations of different subunit isoforms can generate many forms of Protein Phosphatase 2A, which may differ in substrate specificity, subcellular localization, or tissue specific expression.. Relapsing course defined as following: To regress after partial recovery from illness. LB-100 defined as following: A water soluble inhibitor of the protein phosphatase 2A activity (Protein Phosphatase 2A), with potential chemo- and radiotherapy enhancing activity. Upon injection, Protein Phosphatase 2A inhibitor LB-100 inhibits the removal of phosphate groups from proteins essential for cell cycle progression. When used with radio- or chemotherapy treatment, this agent prevents the activation of Protein Phosphatase 2A-mediated repair mechanisms and allows for malignant cells to progress through the cell cycle without having their damaged DNA repaired. This enhances the cytotoxic effect of the chemotherapeutic or radiotherapeutic agent and results in tumor cell apoptosis. Protein Phosphatase 2A, a serine/threonine phosphatase that plays a key role in the control of cell growth and DNA damage repair.. Solid Neoplasm defined as following: A benign or malignant neoplasm arising from tissues that do not include fluid areas. Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma). Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered Solid Neoplasm..", "label": "yes"} {"original_question": "Is chlorotoxin a peptide?", "id": "converted_2795", "sentence1": "Is chlorotoxin a peptide?", "sentence2": "chlorotoxin peptide , Chlorotoxin (cyclophosphamide) is a 36-amino-acid disulfide-containing peptide derived from the Venom (disposition) of the scorpion Leiurus quinquestriatus., The mature Odontobuthus doriae chlorotoxin peptide has a 35-amino-acid residue and four disulfide bounds. , Chlorotoxin (cyclophosphamide), a disulfide-rich peptide from the scorpion Leiurus quinquestriatus,[SEP]Relations: Cyclophosphamide has relations: drug_drug with Chloroquine, drug_drug with Chloroquine, drug_drug with Cephalexin, drug_drug with Cephalexin, drug_drug with Chlorthalidone, drug_drug with Chlorthalidone, drug_drug with Chlorzoxazone, drug_drug with Chlorzoxazone, drug_drug with Chlormadinone, drug_drug with Chlormadinone. Definitions: Chlorotoxin defined as following: A neurotoxin with potential anticancer property. Chlorotoxin (cyclophosphamide) is a 36-amino acid peptide found in the Venom (disposition) of the deathstalker scorpion, and a chloride channel blocker. This toxin binds preferentially to glioma cells via the transmembrane endopeptidase matrix metalloproteinase-2 (MMP-2), and thereby prevents the spread of tumor cells. MMP-2 is specifically up-regulated in gliomas and related cancers, but is not normally expressed in brain.. Venom (disposition) defined as following: A toxin used by animals and injected into their victims by a bite or sting. cyclophosphamide defined as following: Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.. chlorotoxin a defined as following: A neurotoxin with potential anticancer property. Chlorotoxin (cyclophosphamide) is a 36-amino acid peptide found in the Venom (disposition) of the deathstalker scorpion, and a chloride channel blocker. This toxin binds preferentially to glioma cells via the transmembrane endopeptidase matrix metalloproteinase-2 (MMP-2), and thereby prevents the spread of tumor cells. MMP-2 is specifically up-regulated in gliomas and related cancers, but is not normally expressed in brain.. peptide defined as following: Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS..", "label": "yes"} {"original_question": "Is Nanog repressed in pluripotent stem cells?", "id": "converted_4098", "sentence1": "Is Nanog repressed in pluripotent Stem Cells?", "sentence2": "Aggregation of embryonic Stem Cells induces Nanog repression and primitive Endoderm differentiation, Interestingly, cell aggregation by itself induced Nanog repression at the outer layer, which was essential for aggregation-induced primitive Endoderm formation, early embryonic development, when downregulation of Nanog plays a crucial role., The homeobox gene Nanog is a key intrinsic determinant of self renewal in embryonic stem (ES) Cells, and its repression leads ES Cells to selectively differentiate into primitive Endoderm., These data indicate that the Grb2/Mek pathway primarily mediates NANOG gene repression upon ES cell differentiation into primitive Endoderm., Nanog and POU5F1 gene associate with unique transcriptional repression complex (molecular entity) in embryonic Stem Cells, Nanog and POU5F1 gene are essential TRANSCRIPTION FACTOR that regulate self-renewal and pluripotency of ES Cells. , the mechanisms by which Nanog and POU5F1 gene modulate ES cell fate remain unknown. , Nanog, POU5F1 gene and repressor proteins co-occupy Nanog-target Genes in Mus sp. ES Cells, suggesting that Nanog and POU5F1 gene together may communicate with distinct repression complex (molecular entity) to control gene transcription., Nanog and POU5F1 gene associate with unique repressor complex (molecular entity) on their target Genes to control ES cell fate., he main finding of this study is that knockdown of Trp53 and PTEN protein, human independently resulted in significantly higher expression levels of the pluripotency-associated gene Nanog, and we hypothesize that TP53 wt Allele and PTEN mediated repression is important for the insulation of male Germ Cells from pluripotency., The Homeo Domain transcription factor NANOG plays a central role in maintaining hESC pluripotency, The newly derived NANOG reporter hESC lines present novel tools to visualize NANOG expression in viable Human Embryonic Stem Cells. , Loss of PTEN protein, human causes tumor initiation following differentiation of murine pluripotent Stem Cells due to failed repression of Nanog., Furthermore, our data show that the mechanism by which PTEN protein, human null ECCs emerge in vitro and cause Neoplasms in vivo is through increased survival and self-renewal, due to failed repression of the transcription factor Nanog., We report here that Nanog and POU5F1 gene are reexpressed in two Mus sp. embryonic stem cell (Mouse Embryonic Stem Cells) lines following exposure to the differentiating agent DETA/NO., Furthermore, Nanog binding to the Promoter of Brachyury protein protein leads to repression of this gene, thus disrupting mesendoderm transition., Maintaining pluripotency and indefinite self-renewal of embryonic Stem Cells requires a tight control of the expression of several key stemness factors, particularly Nanog and POU5F1 gene TRANSCRIPTION FACTOR., Current evidence suggests that ES Cells maintain their pluripotent state by expressing a battery of TRANSCRIPTION FACTOR including POU5F1 gene and Nanog., Embryonic stem (ES) cell pluripotency is dependent upon sustained expression of the key transcriptional regulators POU5F1 gene, Nanog, and SOX2 protein, human., The expression of POU5F1 gene is activated by Forkhead Box Protein D3 and Nanog but repressed by POU5F1 gene itself, thus, exerting an important negative feedback loop to limit its own activity., Nanog, POU5F1 gene, and SOX2 protein, human form the core of a transcription factor network that maintains embryonic Stem Cells in the pluripotent state in both Homo sapiens and CASP14 gene., w that BMI1 protein, human is enriched in the extraembryonic (Endoderm [XEN] and trophectodermal stem [TS]) compartment and repressed by Nanog in pluripotent embryonic stem (ES) Cells. In vivo, Bm, Nanog is a newly identified transcriptional factor bearing a Homeo Domain and expressed in pluripotential Cells of preimplantation and early postimplantation embryos, and embryonic stem (ES) and embryonic germ (EG) Cells., Knockout experiments indicate that Nanog functions as a key player in maintaining the pluripotency of Stem Cells., Thus, in germ cell development, NANOG is expressed in proliferating Germ Cells, in which nuclear reprogramming is progressing., Nanog maintains pluripotency of Mus sp. embryonic Stem Cells by inhibiting NFKB1 gene and cooperating with STAT3 protein, human., We performed a genome-wide screen that combined full-length Mouse Embryonic Stem Cells transcriptome genomic mapping data with chromatin immunoprecipitation genomic location maps of the key Mouse Embryonic Stem Cells TRANSCRIPTION FACTOR POU5F1 gene and Nanog., Nanog safeguards pluripotency in Mus sp. embryonic Stem Cells (mESCs)., Notably, the expression of Nanog, a key pluripotency regulator and repressor of extraembryonic Endoderm specification in ES Cells, was significantly reduced in ZIC3 wt Allele knockdown Cells.[SEP]Relations: NANOG has relations: pathway_protein with Transcriptional regulation of pluripotent Stem Cells, pathway_protein with Transcriptional regulation of pluripotent Stem Cells, bioprocess_protein with positive regulation of stem cell proliferation, bioprocess_protein with positive regulation of stem cell proliferation, bioprocess_protein with stem cell population maintenance, bioprocess_protein with stem cell population maintenance, bioprocess_protein with somatic stem cell population maintenance, bioprocess_protein with somatic stem cell population maintenance, pathway_protein with POU5F1 (OCT4), SOX2, NANOG repress Genes related to differentiation, pathway_protein with POU5F1 (OCT4), SOX2, NANOG repress Genes related to differentiation. Definitions: NANOG gene defined as following: This gene plays a role in the underlying pluripotency of inner cell mass and embryonic Stem Cells.. Forkhead Box Protein D3 defined as following: Forkhead box protein D3 (478 aa, ~48 kDa) is encoded by the human FOXD3 gene. This protein is involved in embryonic development.. Endoderm defined as following: The inner of the three germ layers of an embryo.. TP53 wt Allele defined as following: Human TP53 wild-type allele is located in the vicinity of 17p13.1 and is approximately 19 kb in length. This allele, which encodes cellular tumor antigen p53 protein, plays a role in cell cycle regulation during the G0/G1transition. Alterations of the TP53 gene occur as both somatic and germline mutations in human malignancies in select cancer-prone families with Li-Fraumeni syndrome.. Stem Cells defined as following: Relatively undifferentiated Cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor Cells that can differentiate into specialized Cells.. ZIC3 wt Allele defined as following: Human ZIC3 wild-type allele is located in the vicinity of Xq26.2 and is approximately 11 kb in length. This allele, which encodes zinc finger protein ZIC 3, plays roles in transcription, cardiac and neural development and left-right specification. Mutations are associated with X-linked heterotaxy.. SOX2 protein, human defined as following: Transcription factor SOX-2 protein (317 aa, ~34 kDa) is encoded by the human SOX2 gene. This protein is involved in neural cell progenitor differentiation and neurogenesis.. Mouse Embryonic Stem Cells defined as following: PLURIPOTENT STEM CELLS derived from the BLASTOCYST INNER CELL MASS of day 3.5 Mus sp. embryos.. Homeo Domain defined as following: The DNA-binding homeo domain was originally identified in transcription factor proteins encoded by homeobox Genes (homeotic Genes). The homeo domain is structurally similar to the helix-turn-helix DNA-binding domain of CRO and Lambda repressor.. PTEN protein, human defined as following: Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (403 aa, ~47 kDa) is encoded by the human PTEN gene. This protein plays a role in signaling and as both a dual-specificity phosphoprotein phosphatase and a lipid phosphatase.. STAT3 protein, human defined as following: Signal transducer and activator of transcription 3 (770 aa, ~88 kDa) is encoded by the human STAT3 gene. This protein plays a role in cytokine signaling and gene expression.. BMI1 protein, human defined as following: Polycomb complex protein BMI-1 (326 aa, ~37 kDa) is encoded by the human BMI1 gene. This protein is involved in transcriptional repression during embryonic development.. complex (molecular entity) defined as following: A molecular entity formed by loose association involving two or more component molecular entities. The bonding between the components is normally weaker than in a covalent bond.. embryonic Stem Cells defined as following: Cells derived from the BLASTOCYST INNER CELL MASS which forms before implantation in the uterine wall. They retain the ability to divide, proliferate and provide progenitor Cells that can differentiate into specialized Cells.. POU5F1 gene defined as following: This gene plays a role in early mammalian development.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. NFKB1 gene defined as following: This gene is involved in the regulation of apoptosis, signal transduction and gene transcription.. Germ Cells defined as following: The reproductive Cells in multicellular organisms at various stages during GAMETOGENESIS.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Human Embryonic Stem Cells defined as following: A type of PLURIPOTENT STEM CELLS derived from early stage human embryos, up to and including the BLASTOCYST stage.. Homo sapiens defined as following: Members of the species Homo sapiens.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. Nanog defined as following: This gene plays a role in the underlying pluripotency of inner cell mass and embryonic Stem Cells.. pluripotent Stem Cells defined as following: Cells that can give rise to Cells of the three different GERM LAYERS..", "label": "no"} {"original_question": "Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?", "id": "converted_1662", "sentence1": "Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-Acute lymphocytic leukemia)?", "sentence2": "Notch receptors participate in a highly conserved signalling pathway that regulates normal development and tissue homeostasis in a context- and dose-dependent manner. Deregulated Notch signalling has been implicated in many diseases, but the clearest example of a pathogenic role is found in T-cell lymphoblastic leukaemia/lymphoma (T-LL), in which the majority of Homo sapiens and murine tumours have acquired mutations that lead to aberrant increases in NOTCH1 wt Allele signalling., Notch proteins (NOTCH1, NOTCH2 gene gene, NOTCH3 gene gene and NOTCH4 wt Allele wt Allele) play crucial roles in embryonic development. Also, mounting evidence indicates that Notch contributes to the pathogenesis of Hematopoietic and solid Malignant Neoplasms. Recent studies reported a high incidence of gain-of-function mutations of the NOTCH1 gene in Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (Acute lymphocytic leukemia). , Our data indicate that NOTCH1 is Mutation Abnormality in T-Acute lymphocytic leukemia, but not in other common Homo sapiens cancers, and that NOTCH2 gene gene, NOTCH3 gene gene and NOTH4 genes are rarely Mutation Abnormality in common Homo sapiens cancers. , The Notch signaling pathway plays a critical role in maintaining the balance between cell proliferation, differentiation and apoptosis, and is a highly conserved signaling pathway that regulates normal development in a context- and dose-dependent manner. Dysregulation of Notch signaling has been suggested to be key events in a variety of hematological Malignant Neoplasms. NOTCH1 wt Allele signaling appears to be the central oncogenic trigger in T-Lymphocyte acute lymphoblastic leukemia (T-Acute lymphocytic leukemia), in which the majority of Homo sapiens Malignant Neoplasms have acquired mutations that lead to constitutive activation of NOTCH1 wt Allele signaling., T-cell acute lymphoblastic leukemia (T-Acute lymphocytic leukemia) is characterized as a high-risk stratified Disease associated with frequent relapse, chemotherapy resistance, and a poorer prognostic outlook than B-precursor Acute lymphocytic leukemia. Many of the challenges in treating T-Acute lymphocytic leukemia reflect the lack of prognostic cytogenetic or molecular abnormalities on which to base therapy, including targeted therapy. NOTCH1 wt Allele activating mutations were identified in more than 50% of T-Acute lymphocytic leukemia cases and can be therapeutically targeted with γ-secretase inhibitors (GSIs). , NOTCH1 wt Allele is a transmembrane receptor that is frequently Mutation Abnormality in Homo sapiens T-cell acute lymphoblastic leukemia (T-Acute lymphocytic leukemia). , T-cell lymphoblastic leukemia/lymphoma (T-Acute lymphocytic leukemia) is characterized by aberrant activation of NOTCH1 in over 60% of T-Acute lymphocytic leukemia cases. The high prevalence of activating NOTCH1 mutations highlights the critical role of Notch signaling in the pathogenesis of this Disease and has prompted the development of therapeutic approaches targeting the Notch signaling pathway. , Activating mutations in NOTCH1, an essential regulator of T-Lymphocyte development, are frequently found in Homo sapiens T-Lymphocyte acute lymphoblastic leukemia (T-Acute lymphocytic leukemia). , Notch signaling pathway is essential in T-cell development and NOTCH1 mutations are frequently present in T-cell acute lymphoblastic leukemia (T-Acute lymphocytic leukemia)., Activating Notch-1 mutations are frequent in T-cell acute lymphoblastic leukemia (T-Acute lymphocytic leukemia), occurring in >50% of patients., Gene Mutation in NOTCH1/FBXW7 activate Notch signaling and are of prognostic significance in patients with T-cell acute lymphoblastic leukemia (T-Acute lymphocytic leukemia)., Gain-of-function mutations in Notch-1 have been reported in more than 50% of Homo sapiens T-cell acute lymphoblastic leukemia (T-Acute lymphocytic leukemia)., Notch signaling is of crucial importance in normal T-cell development and NOTCH1 gene is frequently Mutation Abnormality in Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-Acute lymphocytic leukemia), leading to aberrantly high Notch signaling., Activation of the Notch pathway occurs commonly in Precursor Cell Lymphoblastic Leukemia Lymphoma (T-Acute lymphocytic leukemia) because of mutations in NOTCH1 wt Allele or FBXW7 wt Allele and is involved in the regulation of cell proliferation and survival., T-cell acute lymphoblastic leukemia (T-Acute lymphocytic leukemia) patients frequently display NOTCH1 activating mutations and Notch can transcriptionally down-regulate the tumor suppressor PTEN., The identification of activating mutations in NOTCH1 in over 50% of Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-Acute lymphocytic leukemia) has generated major interest in the elucidation of the mechanisms of transformation downstream of oncogenic Notch and in the targeting of the Notch signaling pathway in this Disease., BACKGROUND: In T-cell lymphoblastic leukemia/lymphoma (T-Acute lymphocytic leukemia/LBL), activating mutations of NOTCH1 are observed in more than 50% of cases, whereas the t(7;9)(q34;q34) involving NOTCH1 at 9q34 and TRB@ at 7q34 is an extremely rare but recurrent translocation., Activating mutations in NOTCH1 consitute the most prominent genetic abnormality in T-cell acute lymphoblastic leukemia (T-Acute lymphocytic leukemia)., T-Lymphocyte acute lymphoblastic leukemia (T-Acute lymphocytic leukemia) is an aggressive cancer that is frequently associated with activating mutations in NOTCH1 and dysregulation of MYC protein, Homo sapiens protein, Homo sapiens, The Notch signaling pathway has been recognized as a key factor for the pathogenesis of T-cell acute lymphoblastic leukemia (T-Acute lymphocytic leukemia), because of the high incidence of activating mutations of NOTCH1 wt Allele, Notch signaling is of crucial importance in normal T-cell development and NOTCH1 gene is frequently Mutation Abnormality in Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-Acute lymphocytic leukemia), leading to aberrantly high Notch signaling, Notch signaling pathway is essential in T-cell development and NOTCH1 mutations are frequently present in T-cell acute lymphoblastic leukemia (T-Acute lymphocytic leukemia), Activating Notch-1 mutations are frequent in T-cell acute lymphoblastic leukemia (T-Acute lymphocytic leukemia), occurring in >50% of patients, Gain-of-function mutations in Notch-1 have been reported in more than 50% of Homo sapiens T-cell acute lymphoblastic leukemia (T-Acute lymphocytic leukemia)[SEP]Relations: NOTCH1 has relations: disease_protein with precursor T-cell acute lymphoblastic leukemia, disease_protein with precursor T-cell acute lymphoblastic leukemia, disease_protein with acute lymphoblastic leukemia, disease_protein with acute lymphoblastic leukemia, disease_protein with acute lymphoblastic/lymphocytic leukemia, disease_protein with acute lymphoblastic/lymphocytic leukemia, disease_protein with acute lymphoblastic leukemia (Disease), disease_protein with acute lymphoblastic leukemia (Disease). NOTCH2 gene has relations: disease_protein with acute lymphoblastic leukemia (Disease), disease_protein with acute lymphoblastic leukemia (Disease). Definitions: FBXW7 wt Allele defined as following: Human FBXW7 wild-type allele is located in the vicinity of 4q31.3 and is approximately 91 kb in length. This allele, which encodes F-box/WD-repeat protein 7, is involved in ubiquitin-dependent protein degradation and has been implicated in the maintenance of genomic integrity.. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma defined as following: A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.. NOTCH1 wt Allele defined as following: Human NOTCH1 wild-type allele is located in the vicinity of 9q34.3 and is approximately 51 kb in length. This allele, which encodes neurogenic locus notch homolog protein 1 protein, plays a role in developmental processes by controlling cell fate decisions.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. T-Lymphocyte defined as following: Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.. MYC protein, Homo sapiens defined as following: Myc proto-oncogene protein (439 aa, ~49 kDa) is encoded by the Homo sapiens MYC protein, Homo sapiens gene. This protein plays a role in the regulation of transcription and cell proliferation.. 9q34 defined as following: A chromosome band present on 9q. NOTCH4 wt Allele defined as following: Human NOTCH4 wt Allele wild-type allele is located in the vicinity of 6p21.3 and is approximately 29 kb in length. This allele, which encodes neurogenic locus notch homolog protein 4 protein, is involved in receptor-ligand interactions and may play a role in vascular, renal and hepatic development.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. NOTCH1 gene defined as following: This gene is involved in intercellular signal transduction that plays a key role in development.. Notch proteins defined as following: A family of transmembrane receptors with multiple extracellular EGF repeats and a DSL (notch) domain. These proteins interact with their cell-bound ligands (from the delta and serrate protein families). This interaction stimulates cell-cell signaling pathways that regulate cell fate decisions during embryogenesis.. NOTCH3 gene defined as following: This gene plays a role in both intercellular signaling and cell fate determination.. 7q34 defined as following: A chromosome band present on 7q. Precursor Cell Lymphoblastic Leukemia Lymphoma defined as following: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.. Hematopoietic defined as following: Pertaining to or related to the formation of blood cells.. Acute lymphocytic leukemia defined as following: Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.. NOTCH2 gene defined as following: This gene plays a role in cell-cell signaling.. Homo sapiens defined as following: Members of the species Homo sapiens.. hematological Malignant Neoplasms defined as following: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Gene Mutation may be associated with genetic diversity or with pathologies including cancer.. T-cell Acute Lymphoblastic Leukemia defined as following: A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common..", "label": "yes"} {"original_question": "Is the protein Asporin related to disease?", "id": "converted_3144", "sentence1": "Is the protein Asporin related to disease?", "sentence2": "Accumulating evidence demonstrates the involvement of ASPN gene in OSTEOARTHRITIS SUSCEPTIBILITY 1 pathogenesis., Asporin has been reported as a tumor suppressor in Malignant neoplasm of breast, while ASPN gene-activated invasion has been described in Malignant neoplasm of stomach., Asporin has been implicated as an Oncogenes in various types of Homo sapiens Malignant Neoplasms; , These results suggested that ASPN gene promoted the tumor growth and metastasis of Cytogenetic Complete Response, and it could be a potential therapeutic target for Cytogenetic Complete Response patients in future., Our results suggest that ASPN is a stromally expressed biomarker that correlates with disease progression, and is observed in reactive stroma. [SEP]Relations: osteoarthritis susceptibility has relations: disease_protein with ASPN, disease_protein with ASPN, disease_protein with ETFA, disease_protein with ETFA, disease_protein with ACTB, disease_protein with ACTB, disease_protein with ASTN2, disease_protein with ASTN2, disease_protein with COMP, disease_protein with COMP. Definitions: Oncogenes defined as following: Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of \"v-\" before Oncogenes symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix \"c-\" before the gene symbol of an Oncogenes indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-Oncogenes.. Malignant neoplasm of breast defined as following: A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males.. Homo sapiens defined as following: Members of the species Homo sapiens.. Cytogenetic Complete Response defined as following: The disappearance of all signs of cancer, including the absence of a detectable disease-related genetic abnormality, as determined by techniques such as karyotyping or FISH, in response to treatment.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Malignant neoplasm of stomach defined as following: A primary or metastatic malignant neoplasm involving the stomach.. disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown..", "label": "yes"} {"original_question": "Is clathrin involved in E-cadherin endocytosis?", "id": "converted_1045", "sentence1": "Is clathrin involved in CDH1 gene endocytosis?", "sentence2": "We demonstrated that MGAT2 gene induced a stabilizing effect on CDH1 gene at the Cellular Membrane by inducing a delay in the turnover rate of the Protein Info, contributing for the formation of stable and functional adherens-junctions, and further preventing clathrin-dependent CDH1 gene endocytosis., Conversely, GnT-V promotes the destabilization of CDH1 gene, leading to its mislocalization and unstable adherens-junctions with impairment of cell-cell adhesion., Here we show that CDH1 gene polarity is controlled by the polarized regulation of clathrin- and Dynamin GTPase-mediated endocytosis., We delineate a pathway that controls the initiation of CDH1 gene endocytosis through the regulation of AP2 and clathrin coat recruitment by CDH1 gene., Clathrin dependent endocytosis of CDH1 gene is regulated by the Arf6GAP isoform UNC45A wt Allele, CDH1 gene is a central component of the adherens junction in Epithelial Cells and continuously undergoes endocytosis via Clathrin-Coated Vesicles and/or Caveolae depending on the cell type., Collectively, UNC45A wt Allele likely represents a key Arf6GAP in clathrin dependent endocytosis of CDH1 gene in Madin Darby Canine Kidney Cells., Consistent with these observations, we found that selective uncoupling of CTNND1 wt Allele from CDH1 gene by [AA000] INTRODUCTION of Amino Acid Substitution in the CTNND1 wt Allele-binding site increased the level of CDH1 gene endocytosis. The increased endocytosis was clathrin-dependent, because it was blocked by expression of a dominant-negative form of Dynamin GTPase or by hypertonic shock., We found that in this experimental system CDH1 gene entered a transferrin-negative compartment before transport to the early endosomal compartment, where it merged with classical clathrin-mediated uptake pathways.[SEP]Relations: clathrin-coated vesicle has relations: cellcomp_protein with CLTC, cellcomp_protein with CLTC, cellcomp_protein with BCAP31, cellcomp_protein with BCAP31, cellcomp_protein with FOLR1, cellcomp_protein with FOLR1, cellcomp_protein with CLTCL1, cellcomp_protein with CLTCL1, cellcomp_protein with SCYL2, cellcomp_protein with SCYL2. Definitions: Epithelial Cells defined as following: Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional Epithelial Cells.. Dynamin GTPase defined as following: A family of high molecular weight GTP phosphohydrolases that play a direct role in vesicle transport. They associate with microtubule bundles (MICROTUBULES) and are believed to produce mechanical force via a process linked to GTP hydrolysis. This enzyme was formerly listed as EC 3.6.1.50.. CTNND1 wt Allele defined as following: Human CTNND1 wild-type allele is located in the vicinity of 11q11 and is approximately 67 kb in length. This allele, which encodes catenin delta-1 Protein Info, is involved in the mediation of signal transduction.. Clathrin defined as following: The main structural coat Protein Info of COATED VESICLES which play a key role in the intracellular transport between membranous organelles. Each molecule of clathrin consists of three light chains (CLATHRIN LIGHT CHAINS) and three heavy chains (CLATHRIN HEAVY CHAINS) that form a structure called a triskelion. Clathrin also interacts with cytoskeletal proteins.. Clathrin-Coated Vesicles defined as following: A vesicle with a coat formed of clathrin connected to the membrane via one of the clathrin adaptor complexes. [GOC:mah, PMID:11252894]. CDH1 gene defined as following: This gene plays a role in cell-cell adhesion and loss of function contributes to the progression of many carcinomas.. UNC45A wt Allele defined as following: Human UNC45A wild-type allele is located in the vicinity of 15q26.1 and is approximately 24 kb in length. This allele, which encodes Protein Info unc-45 homolog A, is involved in both cell differentiation and muscle development.. Amino Acid Substitution defined as following: The naturally occurring or experimentally induced replacement of one or more AMINO ACIDS in a Protein Info with another. If a functionally equivalent amino acid is substituted, the Protein Info may retain wild-type activity. Substitution may also diminish, enhance, or eliminate Protein Info function. Experimentally induced substitution is often used to study enzyme activities and binding site properties.. Cellular Membrane defined as following: Any of the lipid bilayer membranes within a cell.. Madin Darby Canine Kidney Cells defined as following: An epithelial cell line derived from a kidney of a normal adult female dog.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. Caveolae defined as following: A membrane raft that forms small pit, depression, or invagination that communicates with the outside of a cell and extends inward, indenting the cytoplasm and the Cellular Membrane. Examples include flask-shaped invaginations of the plasma membrane in adipocytes associated with caveolin proteins, and minute pits or incuppings of the Cellular Membrane formed during pinocytosis. Caveolae may be pinched off to form free vesicles within the cytoplasm. [GOC:mah, ISBN:0721662544, PMID:16645198]. clathrin defined as following: The main structural coat Protein Info of COATED VESICLES which play a key role in the intracellular transport between membranous organelles. Each molecule of clathrin consists of three light chains (CLATHRIN LIGHT CHAINS) and three heavy chains (CLATHRIN HEAVY CHAINS) that form a structure called a triskelion. Clathrin also interacts with cytoskeletal proteins..", "label": "yes"} {"original_question": "Is g-H2AX a marker for double strand breaks?", "id": "converted_3610", "sentence1": "Is g-H2AX a marker for double strand breaks?", "sentence2": "The specific phosphorylation of histone H2AX on serine residue 139, described as γ-H2AX, is an excellent indicator or marker of DNA double-strand breaks (DSBs). , expression of the DNA double-strand break marker gamma-H2AX (γH2AX) , pH2AX, a marker of the DNA double-strand break (DSB)[SEP]Relations: Serine has relations: drug_protein with SPTLC2, drug_protein with SPTLC2, drug_protein with SPTLC1, drug_protein with SPTLC1, drug_protein with SLC16A10, drug_protein with SLC16A10, drug_protein with AGXT, drug_protein with AGXT, contraindication with phosphorus metabolism disease, contraindication with phosphorus metabolism disease. Definitions: serine defined as following: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids..", "label": "yes"} {"original_question": "Is Migalastat used for treatment of Fabry Disease?", "id": "converted_1828", "sentence1": "Is Migalastat used for treatment of Fabry Disease?", "sentence2": "Oral Route of Drug administration Route of Drug administration pharmacological chaperone migalastat compared with Enzyme [APC] replacement therapy in Fabry Disease: 18-month results from the randomised phase III ATTRACT study., BACKGROUND: Fabry Disease is an X-linked lysosomal storage disorder caused by Diffuse lymphatic malformation Gene Mutation, resulting in α-galactosidase (α-Gal) deficiency and accumulation of lysosomal substrates. Migalastat, an oral pharmacological chaperone being developed as an alternative to intravenous Enzyme [APC] replacement therapy (Estrogen Replacement Therapy), stabilises specific Mutant (amenable) forms of α-Gal to facilitate normal lysosomal trafficking., CONCLUSIONS: Migalastat offers promise as a first-in-class oral monotherapy alternative treatment to intravenous Estrogen Replacement Therapy for patients with Fabry Disease and amenable Gene Mutation., Migalastat (Galafold™)-a small molecule drug developed by Amicus Therapeutics that restores the activity of specific Mutant forms of α-galactosidase-has been approved for the treatment of Fabry Disease in the EU in patients with amenable Gene Mutation., This article summarizes the milestones in the development of migalastat leading to this first approval in the EU for the long-term treatment of adults and adolescents aged ≥16 years with a confirmed diagnosis of Fabry Disease., Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat., BACKGROUND: Fabry's disease, an X-linked disorder of lysosomal α-galactosidase deficiency, leads to substrate accumulation in multiple organs. Migalastat, an oral pharmacologic chaperone, stabilizes specific Mutant forms of α-galactosidase, increasing Enzyme [APC] trafficking to Lysosomes., Oral Route of Drug administration Route of Drug administration Migalastat Hairy Cell Leukemia Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused Agalsidase., UNLABELLED: Migalastat Hairy Cell Leukemia (AT-1001, 1-Deoxygalactonojirimycin) is an investigational pharmacological chaperone for the treatment of α-galactosidase A (α-Gal A) deficiency, which leads to Fabry Disease, an X-linked, lysosomal storage disorder. , Migalastat Hairy Cell Leukemia reduces Globotriaosylsphingosine (lyso-Gb3) in Fabry Mice, Transgenic and in the plasma of Fabry patients., migalastat for Fabry Disease) and inhibitors of Glucosylceramides synthesis (e.g., A Phase 2 study of migalastat hydrochloride in females with Fabry Disease: selection of population, safety and pharmacodynamic effects., Migalastat Hairy Cell Leukemia (AT-1001, 1-Deoxygalactonojirimycin) is an investigational pharmacological chaperone for the treatment of α-galactosidase A (α-Gal A) deficiency, which leads to Fabry Disease, an X-linked, lysosomal storage disorder, Migalastat Hairy Cell Leukemia is an investigational, oral treatment for Fabry Disease, an X-linked lysosomal storage disorder, Oral Route of Drug administration Route of Drug administration administration of migalastat Hairy Cell Leukemia reduces tissue GL-3 in Fabry Mice, Transgenic, and in urine and Both Both kidneys of some FD patients. , Migalastat Hairy Cell Leukemia is an investigational, oral treatment for Fabry Disease, an X-linked lysosomal storage disorder., Migalastat Hairy Cell Leukemia (AT-1001, 1-Deoxygalactonojirimycin) is an investigational pharmacological chaperone for the treatment of α-galactosidase A (α-Gal A) deficiency, which leads to Fabry Disease, an X-linked, lysosomal storage disorder., Molecular chaperones (e.g. migalastat for Fabry Disease) and inhibitors of Glucosylceramides synthesis (e.g. eliglustat tartrate for Gaucher Disease) are currently under investigation in various clinical trials.Copyright © 2010 Elsevier Masson SAS., Migalastat Hairy Cell Leukemia was well tolerated.Migalastat Hairy Cell Leukemia is a candidate pharmacological chaperone that provides a novel genotype-specific treatment for FD., Additionally, these three patients all demonstrated decreases in GL-3 inclusions in kidney peri-tubular capillaries.Migalastat Hairy Cell Leukemia is a candidate oral pharmacological chaperone that provides a potential novel genotype-specific treatment for FD., migalastat for Fabry Disease) and inhibitors of Glucosylceramides synthesis (e.g. eliglustat tartrate for Gaucher Disease) are currently under investigation in various clinical trials., Molecular chaperones (e.g. migalastat for Fabry Disease) and inhibitors of Glucosylceramides synthesis (e.g. eliglustat tartrate for Gaucher Disease) are currently under investigation in various clinical trials., Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat., The GLP HEK assay is a clinically validated method of identifying male and female Fabry patients for treatment with migalastat.Genet Med advance online publication 22 September 2016Genetics in Medicine (2016); doi:10.1038/gim.2016.122.., A Phase 2 study of migalastat hydrochloride in females with Fabry Disease: selection of population, safety and pharmacodynamic effects., Migalastat offers promise as a first-in-class oral monotherapy alternative treatment to intravenous Estrogen Replacement Therapy for patients with Fabry Disease and amenable Gene Mutation.[SEP]Relations: Migalastat has relations: drug_drug with Zanamivir, drug_drug with Zanamivir, drug_drug with Estradiol, drug_drug with Estradiol, drug_drug with Abacavir, drug_drug with Abacavir, drug_drug with Antipyrine, drug_drug with Antipyrine, drug_drug with Fenbufen, drug_drug with Fenbufen. Definitions: tartrate defined as following: a kind of chemical substance. hydrochloride defined as following: A salt that is comprised of a hydrogen and chloride ion that can be linked to a base form of a drug making it water-soluble. (NCI). Glucosylceramides defined as following: Cerebrosides which contain as their polar head group a glucose moiety bound in glycosidic linkage to the hydroxyl group of ceramides. Their accumulation in tissue, due to a defect in beta-glucosidase, is the cause of Gaucher's disease.. Hairy Cell Leukemia defined as following: A neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of \"hairy\" or \"flagellated\" cells in the blood and bone marrow.. Fabry Disease defined as following: An X-linked inherited metabolic disease caused by a deficiency of lysosomal ALPHA-GALACTOSIDASE A. It is characterized by intralysosomal accumulation of globotriaosylceramide and other GLYCOSPHINGOLIPIDS in blood vessels throughout the body leading to multi-system complications including renal, cardiac, cerebrovascular, and skin disorders.. Estrogen Replacement Therapy defined as following: The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.. Mutant defined as following: An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (Gene Mutation).. Gaucher Disease defined as following: An autosomal recessive disorder caused by a deficiency of acid beta-glucosidase (GLUCOSYLCERAMIDASE) leading to intralysosomal accumulation of glycosylceramide mainly in cells of the MONONUCLEAR PHAGOCYTE SYSTEM. The characteristic Gaucher cells, glycosphingolipid-filled HISTIOCYTES, displace normal cells in BONE MARROW and visceral organs causing skeletal deterioration, hepatosplenomegaly, and organ dysfunction. There are several subtypes based on the presence and severity of neurological involvement.. Diffuse lymphatic malformation defined as following: A rare developmental defect during embryogenesis characterized by multifocal dilated lymphatic vessels involving multiple organs and tissues. Patients mostly present in infancy and childhood. Clinical course and prognosis depend on the affected sites and extent of the condition, deterioration of lung function being a major cause of morbidity and mortality.. Mice, Transgenic defined as following: Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.. Oral Route of Drug administration defined as following: The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Lysosomes defined as following: A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of Lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in Lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed).. Molecular defined as following: Relating to or produced by or consisting of molecules.. Fabry Disease defined as following: An X-linked inherited metabolic disease caused by a deficiency of lysosomal ALPHA-GALACTOSIDASE A. It is characterized by intralysosomal accumulation of globotriaosylceramide and other GLYCOSPHINGOLIPIDS in blood vessels throughout the body leading to multi-system complications including renal, cardiac, cerebrovascular, and skin disorders..", "label": "yes"} {"original_question": "Are Alu elements transcribed?", "id": "converted_642", "sentence1": "Are Alu Elements transcribed?", "sentence2": "Alu RNA in the Homo sapiens transcriptome, Alu Elements can be transcribed in two different ways, by two independent polymerases, 'Free Alu RNA' are transcribed by Pol III from their own Promoter, 'embedded Alu RNA' are transcribed by RNA Polymerase II as part of protein- and non-protein-coding RNA, Recent studies have demonstrated that both free and embedded Alu RNA play a major role in post transcriptional regulation of gene expression, Alu RNA transcribed from these Elements are present at low levels at normal cell growth but various stress conditions increase their abundance, Alu RNA are known to bind the cognate proteins SRP9/14, Increased level of polymerase III transcribed Alu RNA in Liver carcinoma tissue, we used Oligonucleotide Primers extension analysis to determine the level of polymerase III directed Alu RNA and found an increased expression of Alu RNA in Liver carcinoma, Widespread RNA Editing of embedded alu Elements in the Homo sapiens transcriptome, Transcribed Alu DNA Sequence can alter splicing patterns by generating new Exons, In the vast majority of edited RNA, A-to-I substitutions are clustered within transcribed sense or antisense Alu DNA Sequence, Alu-associated RNA Editing may be a mechanism for marking nonstandard transcripts, not destined for translation, the case of transcribed Alus, Differential levels of Alu RNA during different conditions of stress also await clear functional understanding, Alu expression in Homo sapiens cell lines and their retrotranspositional potential, Alu expression likely varies by cell type, growth conditions and transformation state, The vast majority of Alu loci potentially transcribed by RNA pol III lack important sequence features for retrotransposition and the majority of potentially active Alu loci in the Genome - anatomical entity (scored high Endoscopic Retrograde Cholangiopancreatography) belong to young Alu subfamilies, We suggest that the Genome DNA Sequence upstream from most Alu Elements and 7SL Pseudogenes do not contain this element, and consequently that only a small subset of such DNA Sequence can be transcribed in vivo., These similarities suggest that some Alu family DNA Sequence are mobile genetic Elements that can transpose to new chromosomal loci using as an intermediate a DNA, Complementary copy of an RNA transcribed from the Alu family element by RNA Polymerase III., Primate and rodent genomes are populated with hundreds of thousands copies of Alu and B1 Elements dispersed by retroposition, i.e., by Genome reintegration of their reverse transcribed RNA., Members of this family are readily transcribed in vitro by RNA Polymerase III, but RNA corresponding to only a small sub-set of Alu Elements has been found in vivo., Alu interspersed repetitive Elements possess internal RNA Polymerase III promoters which are strongly transcribed in vitro, yet these Elements are nearly silent in Diploid Cell., The amplification of Genome Alu Elements by retroposition, i.e. by reintegration of reverse-transcribed RNA, suggests that Alu RNA plays an important role in this process., We report enzymatic studies of the Protein Structure, Secondary of Alu RNA transcribed in vitro from two recently retroposed Alu Elements., The results of this study indicate that Alu and 7SL RNA gene DNA Sequence interact with cellular factors that are important for HeLa cell proliferation and suggest that these pol III-transcribed Elements may be involved in the regulation of cellular growth., Then we used Oligonucleotide Primers extension analysis to determine the level of polymerase III directed Alu RNA and found an increased expression of Alu RNA in Liver carcinoma, Alu interspersed repetitive Elements possess internal RNA Polymerase III promoters which are strongly transcribed in vitro, yet these Elements are nearly silent in Diploid Cell, 'Free Alu RNA' are transcribed by Pol III from their own Promoter, while 'embedded Alu RNA' are transcribed by RNA Polymerase II as part of protein- and non-protein-coding RNA, We report enzymatic studies of the Protein Structure, Secondary of Alu RNA transcribed in vitro from two recently retroposed Alu Elements, Transcribed Alu DNA Sequence can alter splicing patterns by generating new Exons, but other impacts of intragenic Alu Elements on their host RNA are largely unexplored, Both 7SL genes and Alu Elements are transcribed by RNA Polymerase III, and we show here that the internal 7SL Promoter lies within the Alu-like part of the 7SL gene, Each group revealed a divergent pattern of transcribed Alu Elements[SEP]Relations: DNA Protein Structure, Secondary binding has relations: molfunc_protein with RAD51AP1, molfunc_protein with RAD51AP1, molfunc_protein with CLSPN, molfunc_protein with CLSPN. Promoter clearance from RNA polymerase I Promoter has relations: bioprocess_bioprocess with Promoter clearance during DNA-templated transcription, bioprocess_bioprocess with Promoter clearance during DNA-templated transcription. RNA Polymerase III complex has relations: cellcomp_protein with POLR2L, cellcomp_protein with POLR2L, cellcomp_protein with POLR3G, cellcomp_protein with POLR3G. Definitions: DNA Sequence defined as following: The sequence of nucleotide residues along a DNA chain.. Pseudogenes defined as following: Genes bearing close resemblance to known genes at different loci, but rendered non-functional by additions or deletions in structure that prevent normal transcription or translation. When lacking introns and containing a poly-A segment near the downstream end (as a result of reverse copying from processed nuclear RNA into double-stranded DNA), they are called processed genes.. RNA Polymerase II defined as following: A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6.. Alu Elements defined as following: The Alu sequence family (named for the restriction endonuclease cleavage enzyme Alu I) is the most highly repeated interspersed repeat element in humans (over a million copies). It is derived from the 7SL RNA component of the SIGNAL RECOGNITION PARTICLE and contains an RNA Polymerase III Promoter. Transposition of this element into coding and regulatory regions of genes is responsible for many heritable diseases.. Genome defined as following: The genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA.. Endoscopic Retrograde Cholangiopancreatography defined as following: Fiberoptic endoscopy designed for duodenal observation and cannulation of VATER'S AMPULLA, in order to visualize the pancreatic and biliary duct system by retrograde injection of contrast media. Endoscopic (Vater) papillotomy (SPHINCTEROTOMY, ENDOSCOPIC) may be performed during this procedure.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Elements defined as following: Substances that comprise all matter. Each element is made up of atoms that are identical in number of electrons and protons and in nuclear charge but may differ in mass or number of neutrons.. Liver carcinoma defined as following: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.. RNA Editing defined as following: A process that changes the nucleotide sequence of mRNA from that of the DNA template encoding it. Some major classes of RNA Editing are as follows: 1, the conversion of cytosine to uracil in mRNA; 2, the addition of variable number of guanines at pre-determined sites; and 3, the addition and deletion of uracils, templated by guide-RNA (RNA, GUIDE, KINETOPLASTIDA).. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. Exons defined as following: The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA.. RNA Polymerase III defined as following: A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure where it transcribes DNA into RNA. It has specific requirements for cations and salt and has shown an intermediate sensitivity to alpha-amanitin in comparison to RNA polymerase I and II.. DNA, Complementary defined as following: Single-stranded complementary DNA synthesized from an RNA template by the action of RNA-dependent DNA polymerase. DNA, Complementary (i.e., complementary DNA, not circular DNA, not C-DNA) is used in a variety of molecular cloning experiments as well as serving as a specific hybridization probe.. Oligonucleotide Primers defined as following: Short DNA oligonucleotide chains used to prime DNA (and in some cases RNA) synthesis.. Homo sapiens defined as following: Members of the species Homo sapiens.. Genome - anatomical entity defined as following: Anatomical set of genes in all the chromosomes.. Diploid Cell defined as following: Nucleated cell which has one or more diploid sets (46 pairs) of chromosomes.. Protein Structure, Secondary defined as following: The level of protein structure in which regular hydrogen-bond interactions within contiguous stretches of polypeptide chain give rise to ALPHA-HELICES; BETA-STRANDS (which align to form BETA-SHEETS), or other types of coils. This is the first folding level of protein conformation..", "label": "yes"} {"original_question": "Is Netrin-1 a secreted protein?", "id": "converted_3052", "sentence1": "Is NTN1 Protein Info, human a secreted Protein Info?", "sentence2": "The axon guidance cues NTN1 gene is a secreted Protein Info overexpressed in many different Primary malignant neoplasm tissues, NTN1 Protein Info, human is a secreted Protein Info that directs long-range axon guidance during early stages of neural circuit formation and continues to be expressed in the mammalian forebrain during the postnatal period of peak synapse formation. , NTN1 Protein Info, human, a Laminin-related secreted Protein Info, displays proto-oncogenic activity in Malignant Neoplasms., NTN1 Protein Info, human, a multifunctional secreted Protein Info, is up-regulated in Primary malignant neoplasm and Inflammation., etrin-1 is a Laminin-related secreted Protein Info, is highly induced after Tissue injury, and may serve as a marker of injury., Netrins are a family of secreted Protein Info related to Laminin and act as tropic cues directing axon growth and cell migration during neural development. [SEP]Relations: NTN1 has relations: pathway_protein with NTN1 Protein Info, human signaling, pathway_protein with NTN1 Protein Info, human signaling, pathway_protein with Netrin mediated repulsion signals, pathway_protein with Netrin mediated repulsion signals, pathway_protein with Role of second messengers in NTN1 gene signaling, pathway_protein with Role of second messengers in NTN1 gene signaling, protein_protein with NEO1, protein_protein with NEO1, bioprocess_protein with negative regulation of netrin-activated signaling pathway, bioprocess_protein with negative regulation of netrin-activated signaling pathway. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Laminin defined as following: Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the Protein Info plays a role in tumor invasion.. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. Netrins defined as following: A family of extracellular proteins that are related structurally to LAMININ. They function as CHEMOTACTIC FACTORS for CELL MIGRATION and AXON GUIDANCE, acting as chemoattractants for some cell types, and as chemorepellents for others.. NTN1 gene defined as following: This gene plays a role in neurogenesis. It may also be involved in cell migration during development.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. NTN1 Protein Info, human defined as following: This gene plays a role in neurogenesis. It may also be involved in cell migration during development.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species..", "label": "yes"} {"original_question": "Is ADP-ribosylation a PTM?", "id": "converted_2843", "sentence1": "Is ADP-Ribosylation a PTM?", "sentence2": "ADP-Ribosylation is a PTM, in which PARP1 gene use nicotinamide adenine dinucleotide (NAD) (NAD) (NAD+) to modify target proteins with Adenosine Diphosphate Ribose, Poly ADP Ribosylation (PARylation) is a Post-Translational Protein Processing (PTM) that is critically involved in many biological processes that are linked to cell stress responses., ADP-Ribosylation is a post-translational modification (PTM) implicated in several crucial cellular processes, ranging from regulation of DNA repair and chromatin structure to cell metabolism and stress responses.[SEP]Relations: DNA ADP-Ribosylation has relations: bioprocess_protein with PARP2, bioprocess_protein with PARP2, bioprocess_protein with PARP1, bioprocess_protein with PARP1, bioprocess_protein with PARP3, bioprocess_protein with PARP3, bioprocess_bioprocess with DNA modification, bioprocess_bioprocess with DNA modification. regulation of protein ADP-Ribosylation has relations: bioprocess_protein with ADNP, bioprocess_protein with ADNP. Definitions: PARP1 gene defined as following: This gene is involved in cellular repair and apoptosis.. nicotinamide adenine dinucleotide (NAD) defined as following: A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed). Adenosine Diphosphate Ribose defined as following: An ester formed between the aldehydic carbon of RIBOSE and the terminal phosphate of ADENOSINE DIPHOSPHATE. It is produced by the hydrolysis of nicotinamide-adenine dinucleotide (NAD) by a variety of enzymes, some of which transfer an ADP-ribosyl group to target proteins.. Post-Translational Protein Processing defined as following: Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility.. Poly ADP Ribosylation defined as following: The transfer of multiple Adenosine Diphosphate Ribose molecules to amino acids within target proteins.. ADP-Ribosylation defined as following: The transfer of Adenosine Diphosphate Ribose to amino acids within proteins or to the amino group at N2 of a 2'-deoxyguanosine residue in double-stranded DNA..", "label": "yes"} {"original_question": "Is Daprodustat effective for anemia?", "id": "converted_4604", "sentence1": "Is Daprodustat effective for anemia?", "sentence2": "CONCLUSIONS: Oral Daprodustat was noninferior to methoxy polyethylene glycol-epoetin beta in achieving and maintaining target Hemoglobin A1 (substance) levels in Japanese ND patients. , BACKGROUND: The Genus Genus Anemia Studies in chronic kidney disease (Chronic Kidney Diseases): Erythropoiesis via a Novel Prolyl-Hydroxylase Inhibitors (PHI) Daprodustat-Dialysis (ASCEND-D) trial will test the hypothesis that Daprodustat is non-inferior to comparator epoetin alfa or darbepoetin alfa for two co-primary endpoints: Hemoglobin efficacy and Cardiovascular system safety., Daprodustat is one of the orally administrated small-molecule Hypothalamic inhibiting factor-PH inhibitors, leading to an increase in Recombinant Erythropoietin production, which is regulated by Hypothalamic inhibiting factor. Also, Daprodustat is expected to improve iron metabolism. Recently, several clinical trials showed its efficacy and safety in both hemodialysis- and non-hemodialysis- dependent Chronic Kidney Diseases patients. , Once-daily oral Daprodustat treatment was generally well tolerated and mean Hemoglobin A1 (substance) was achieved and maintained within the target range in Japanese peritoneal dialysis participants., Daprodustat is a hypoxia-inducible factor-Prolyl-Hydroxylase Inhibitors for the treatment of anemia of chronic kidney disease. , Daprodustat, an oral hypoxia-inducible factor Prolyl-Hydroxylase Inhibitors, is being investigated for treatment of anemia in chronic kidney disease., Daprodustat for the Treatment of Genus Genus Anemia in Patients Not Undergoing Dialysis., ONCLUSIONS: Among patients with Chronic Kidney Diseases and anemia who were not undergoing dialysis, Daprodustat was noninferior to darbepoetin alfa with respect to the change in the Hemoglobin A1 (substance) level from baseline and with respect to Cardiovascular system outcomes. , Daprodustat for the Treatment of Genus Genus Anemia in Patients Undergoing Dialysis., CONCLUSIONS: Among patients with Chronic Kidney Diseases undergoing dialysis, Daprodustat was noninferior to Edmonton symptom assessment system regarding the change in the Hemoglobin A1 (substance) level from baseline and Cardiovascular system outcomes., Daprodustat (GSK1278863) is a hypoxia-inducible factor (Hypothalamic inhibiting factor)-prolyl hydroxylase (PHD) inhibitor in development for treatment of anemia of chronic kidney disease., BACKGROUND: Daprodustat (GSK1278863) is an oral hypoxia-inducible factor Prolyl-Hydroxylase Inhibitors being developed for treatment of anemia associated with chronic kidney disease (Chronic Kidney Diseases)., Daprodustat is an oral hypoxia-inducible factor Prolyl-Hydroxylase Inhibitors developed for treating anemia of chronic kidney disease., Daprodustat is under development as an emerging new class of agents for the treatment of anemia associated with chronic kidney disease (Chronic Kidney Diseases)., Conclusion: Daprodustat was efficacious and well tolerated for anemia in both Neurodevelopmental delay and DD patients in the short term based on current RCTs., And Daprodustat may become an effective alternative for treatment of anemia with Chronic Kidney Diseases.[SEP]Relations: Erythropoietin has relations: drug_drug with Dacarbazine, drug_drug with Dacarbazine, drug_drug with Dacomitinib, drug_drug with Dacomitinib, drug_drug with Dabrafenib, drug_drug with Dabrafenib, drug_drug with Dacetuzumab, drug_drug with Dacetuzumab. Darbepoetin alfa has relations: drug_drug with Dacarbazine, drug_drug with Dacarbazine. Definitions: Chronic Kidney Diseases defined as following: Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.. Edmonton symptom assessment system defined as following: A self-report assessment tool to screen for the intensity of nine symptoms commonly experienced by cancer patients in palliative care.. Hemoglobin A1 (substance) defined as following: A tetrameric complex of 2 molecules of Hemoglobin A1 (substance) subunit alpha (encoded by either the HBA1 or HBA2 gene) and 2 molecules of Hemoglobin A1 (substance) subunit beta (encoded by the HBB gene).. epoetin alfa defined as following: A recombinant glycosylated form of Recombinant Erythropoietin which stimulates the differentiation and proliferation of erythroid precursors. It is used for the treatment of ANEMIA associated with CHRONIC RENAL FAILURE in dialysis and predialysis patients.. Recombinant Erythropoietin defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous glycoprotein Recombinant Erythropoietin (Epo). Epo promotes the differentiation and maturation of hematopoietic progenitors into erythrocytes; is a mitogen and a chemoattractant for endothelial cells; stimulates activated and differentiated B-cells and enhances B-cell immunoglobulin production and proliferation; and is hypoxia-inducible. (NCI04). Cardiovascular system defined as following: The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body.. methoxy polyethylene glycol-epoetin beta defined as following: A pegylated form of recombinant human Recombinant Erythropoietin, a glycosylated protein naturally produced in the kidney that stimulates erythrocyte production in the bone marrow. Methoxypolyethylene glycol epoetin beta may reverse anemias induced by cancer therapy. (NCI04). Neurodevelopmental delay defined as following: Neurodevelopmental delay (Neurodevelopmental delay) refers to delays in the maturation of the brain and central nervous system; infants and young children with Neurodevelopmental delay may experience delays in the development of one or more skills including gross motor abilities, fine-motor coordination, language abilities and ability to solve increasingly complex problems. [ORCID:0000-0002-6670-9157, PMID:31783983]. Hemoglobin defined as following: The oxygen-carrying proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the Hemoglobin A1 (substance) quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements.. Prolyl-Hydroxylase Inhibitors defined as following: Compounds that inhibit the action of HYDROXYLASES that act on PROLINE to form HYDROXYPROLINE.. darbepoetin alfa defined as following: A recombinant protein which stimulates ERYTHROPOIESIS used to treat ANEMIA..", "label": "yes"} {"original_question": "Is Epistaxis associated with dental implant placement?", "id": "converted_4601", "sentence1": "Is Epistaxis associated with dental implant placement?", "sentence2": " The overall survival rate of the Procedure Procedure implants:Finding:Point in time:^Patient:Narrative:Finding:Point in time:^Patient:Narrative into the sinus cavity was 95.6%, without statistical differences according to the level of penetration. The clinical and radiological complications were 3.4% and 14.8% respectively. The most frequent clinical complication was the Epistaxis, , implant placement and protrusion of the implant up to 3mm beyond the sinus floor does not alter the stability and outcome of dental Procedure Procedure implants:Finding:Point in time:^Patient:Narrative:Finding:Point in time:^Patient:Narrative, one year post-restoration. This could be associated with minor complications ranging from Epistaxis to Sinusitis, which are manageable.[SEP]Relations: Epistaxis has relations: drug_effect with Nicotine, drug_effect with Nicotine, drug_effect with Topotecan, drug_effect with Topotecan, drug_effect with Estradiol, drug_effect with Estradiol, drug_effect with Montelukast, drug_effect with Montelukast, drug_effect with Thiotepa, drug_effect with Thiotepa. Definitions: Epistaxis defined as following: Bleeding from the nose.. Sinusitis defined as following: Inflammation of the NASAL MUCOSA in one or more of the PARANASAL SINUSES.. Epistaxis defined as following: Bleeding from the nose..", "label": "yes"} {"original_question": "Are conserved noncoding elements associated with the evolution of animal body plans?", "id": "converted_1343", "sentence1": "Are conserved noncoding elements associated with the evolution of Animal allergens body plans?", "sentence2": "Here, we discuss the evidence that CNEs are part of the core gene regulatory networks (GRNs) that specify alternative Animal allergens body plans. The major Animal allergens groups arose>550 million years ago. We propose that the cis-regulatory inputs identified by CNEs arose during the \"re-wiring\" of regulatory interactions that occurred during early Animal allergens evolution. Consequently, different Animal allergens groups, with different core GRNs, contain alternative sets of CNEs. Due to the subsequent stability of Animal allergens body plans, these core regulatory sequences have been evolving in parallel under strong purifying selection in different Animal allergens groups., Conserved noncoding elements and the evolution of Animal allergens body plans., Conserved noncoding elements and the evolution of Animal allergens body plans[SEP]Relations: Animal dander allergy has relations: phenotype_phenotype with Animal protein allergy, phenotype_phenotype with Animal protein allergy.", "label": "yes"} {"original_question": "Is avelumab effective for urothelial carcinoma?", "id": "converted_3960", "sentence1": "Is avelumab effective for Urothelial Carcinoma?", "sentence2": "ince then, additional checkpoint inhibitors, including avelumab, durvalumab, and nivolumab, have gained approval. , Avelumab, an anti-programmed death-ligand 1 monoclonal immunoglobulin complex location approved for the treatment of metastatic Merkel cell carcinoma and platinum-treated Urothelial Carcinoma, was initially approved with a 10 mg/kg weight-based dose. , Five new PDCD1 wt Allele/CD274 wt Allele checkpoint inhibitors have been approved for the treatment of metastatic Urothelial Carcinoma (Ulcerative Colitis): pembrolizumab, atezolizumab, durvalumab, nivolumab, and avelumab. , We reviewed the literature for prospective studies evaluating PDCD1 wt Allele/CD274 wt Allele inhibitors in refractory Urothelial Carcinoma patients, which formed the basis for US Food and Drug Administration approval of 5 different antagonistic Antibodies, in vitro diagnostic targeting PDCD1 wt Allele or CD274 wt Allele (atezolizumab, durvalumab, avelumab, nivolumab, and pembrolizumab)., Nowadays, five immune checkpoint inhibitors blocking PDCD1 wt Allele (pembrolizumab, nivolumab) or CD274 wt Allele (atezolizumab, durvalumab, and avelumab) have been approved by the United States Food and Drug Administration (US FDA) for the first- or second-line use in Urothelial Carcinoma, based on durable response and manageable safety profiles observed in relevant clinical trials. , RETATION: Avelumab showed antitumour activity in the treatment of patients with platinum-refractory metastatic Urothelial Carcinoma; a manageable safety profile was reported in all avelumab-treated patients. These, data provide the rationale for therapeutic use of avelumab in metastatic Urothelial Carcinoma and it has received accelerated US FDA approval in this setting on this basis.FUNDIN, BACKGROUND: Anti-programmed cell death ligand 1 (CD274 wt Allele)/programmed cell death 1 Antibodies, in vitro diagnostic have shown clinical activity in platinum-treated metastatic Urothelial Carcinoma, resulting in regulatory approval of several agents, including avelumab (anti-CD274 wt Allele)., Avelumab as second-line therapy for metastatic, platinum-treated Urothelial Carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis., BACKGROUND: Avelumab has recently been approved by the Food and Drug Administration for the therapy of Merkel cell carcinoma and Urothelial Carcinoma., SIONS: Maintenance avelumab plus best supportive care significantly prolonged overall survival, as compared with best supportive care alone, among patients with urothelial cancer who had Disease that had not progressed with first-line chemotherapy. (Fund, By the emergence of modern immunotherapies with active agents like PDCD1 wt Allele (nivolumab, pembrolizumab) and CD274 wt Allele immune checkpoint blockers (atezolizumab, avelumab, durvalumab), new therapeutic options have become available for the treatment of patients with locally advanced and metastatic Urothelial Carcinoma., Avelumab, an anti-programmed death-ligand 1 monoclonal immunoglobulin complex location approved for the treatment of metastatic Merkel cell carcinoma and platinum-treated Urothelial Carcinoma, was initially approved with a 10 mg/kg weight-based dose., By the emergence of modern immunotherapies with active agents like PDCD1 wt Allele (nivolumab, pembrolizumab) and CD274 wt Allele immune checkpoint blockers (atezolizumab, avelumab, durvalumab), new therapeutic options have become available for the treatment of patients with locally advanced and metastatic Urothelial Carcinoma. Accor, ACQUISITION: Five Antibodies, in vitro diagnostic including pembrolizumab (CD274 wt Allele immunoglobulin complex location), atezolizumab (PDCD1 wt Allele immunoglobulin complex location), nivolumab (PDCD1 wt Allele immunoglobulin complex location), avelumab and durvalumab (CD274 wt Allele Antibodies, in vitro diagnostic) have been approved in the treatment of advanced Urothelial Carcinoma in first- and second-line treatment setting., INTERPRETATION: Avelumab showed antitumour activity in the treatment of patients with platinum-refractory metastatic Urothelial Carcinoma; a manageable safety profile was reported in all avelumab-treated patients., Conclusion Avelumab was well tolerated and associated with durable responses and prolonged survival in patients with refractory metastatic Ulcerative Colitis., Avelumab: A Novel Anti-CD274 wt Allele Agent in the Treatment of Merkel Cell Carcinoma and Urothelial Cell Carcinoma., In early 2017, avelumab (Bavencio®), a CD274 wt Allele-blocking monoclonal immunoglobulin complex location agent, was approved for the treatment of metastatic MCC and Ulcerative Colitis., Expert opinion: Avelumab has shown clinical efficacy for metastatic and advanced Ulcerative Colitis in phase I studies after the failure of platinum-based therapy with a well-tolerated safety profile., Avelumab has been approved by the U.S. FDA for the treatment of metastatic Merkel cell carcinoma and metastatic Urothelial Carcinoma that has progressed during or following treatment with a platinum-based regimen.[SEP]Relations: Nivolumab has relations: drug_drug with Avelumab, drug_drug with Avelumab, drug_drug with Urelumab, drug_drug with Urelumab, drug_drug with Cemiplimab, drug_drug with Cemiplimab. Urothelial Carcinoma has relations: disease_disease with urothelial neoplasm, disease_disease with urothelial neoplasm, disease_protein with HRAS, disease_protein with HRAS. Definitions: PDCD1 wt Allele defined as following: Human PDCD1 wild-type allele is located in the vicinity of 2q37.3 and is approximately 9 kb in length. This allele, which encodes programmed cell death protein 1, plays a role in the modulation of both apoptosis and cellular immunity. Mutation of the gene is associated with systemic lupus erythematosus type 2.. CD274 wt Allele defined as following: Human CD274 wild-type allele is located in the vicinity of 9p24 and is approximately 20 kb in length. This allele, which encodes programmed cell death 1 ligand 1 protein, plays a role in the regulation of T cell stimulation and proliferation.. Merkel cell carcinoma defined as following: A carcinoma arising from MERKEL CELLS located in the basal layer of the epidermis and occurring most commonly as a primary neuroendocrine carcinoma of the skin. Merkel cells are tactile cells of neuroectodermal origin and histologically show neurosecretory granules. The skin of the head and neck are a common site of Merkel cell carcinoma, occurring generally in elderly patients. (Holland et al., Cancer Medicine, 3d ed, p1245). Ulcerative Colitis defined as following: Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.. nivolumab defined as following: A fully human immunoglobulin (Ig) G4 monoclonal immunoglobulin complex location directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PDCD1 wt Allele, PCD-1) with immune checkpoint inhibitory and antineoplastic activities. Upon administration, nivolumab binds to and blocks the activation of PDCD1 wt Allele, an immunoglobulin superfamily (IgSF) transmembrane protein, by its ligands programmed cell death ligand 1 (CD274 wt Allele), which is overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on antigen-presenting cells (APCs). This results in the activation of T-cells and cell-mediated immune responses against tumor cells. Activated PDCD1 wt Allele negatively regulates T-cell activation and plays a key role in tumor evasion from host immunity.. immunoglobulin complex location defined as following: A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph. [GOC:add, GOC:jl, ISBN:0781765196]. Urothelial Carcinoma defined as following: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. metastatic Urothelial Carcinoma defined as following: A carcinoma that arises from the urothelium and has spread from its original site of growth to another anatomic site..", "label": "yes"} {"original_question": "Is macitentan an ET agonist?", "id": "converted_1550", "sentence1": "Is macitentan an ET agonist?", "sentence2": "Administration of an ET receptor Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance), either bosentan or macitentan, markedly attenuated PD-induced Oculodigitoesophagoduodenal syndrome, Fibrosis, angiogenesis, and peritoneal functional decline. , Macitentan is an oral, once-daily, dual endothelin (ET)A and ETB receptor Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) with high affinity and sustained receptor binding that was approved in the USA, Europe, Canada, and Switzerland for the treatment of Congenital hypoplasia of pulmonary artery., Macitentan (Opsumit®) is a novel dual endothelin receptor Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) (ERA) with sustained receptor binding properties developed by Actelion Pharmaceuticals Ltd., Macitentan, also called Actelion-1 or ACT 064992 [N-[5-(4-bromophenyl)-6-(2-(5-bromopyrimidin-2-yloxy)ethoxy)-pyrimidin-4-yl]-N'-propylaminosulfonamide], is a new dual ET(A)/ET(B) endothelin (ET) receptor Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) designed for tissue targeting. Selection of macitentan was based on inhibitory potency on both ET receptors and optimization of physicochemical properties to achieve high affinity for lipophilic milieu. In vivo, macitentan is metabolized into a major and pharmacologically active metabolite, ACT-132577. , Macitentan and its metabolite antagonized the specific binding of ET-1 on membranes of cells overexpressing ET(A) and ET(B) receptors and blunted ET-1-induced calcium mobilization in various natural cell lines, with inhibitory constants within the nanomolar range. In functional assays, macitentan and ACT-132577 inhibited ET-1-induced contractions in isolated endothelium-denuded Rattus norvegicus aorta (ET(A) receptors) and sarafotoxin S6c-induced contractions in isolated Rattus norvegicus trachea (ET(B) receptors). In rats with Pulmonary Hypertension, macitentan prevented both the increase of pulmonary pressure and the right ventricle hypertrophy, and it markedly improved survival. , In conclusion, macitentan, by its tissue-targeting properties and dual antagonism of ET receptors, protects against end-organ damage in Diabetes Mellitus and improves survival in pulmonary hypertensive rats. This profile makes macitentan a new agent to treat Cardiovascular Diseases associated with chronic tissue ET system activation., Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance)., Kidney, retinaldehyde and cardiac changes in type 2 Diabetes Mellitus are attenuated by macitentan, a dual endothelin receptor Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance)., Here we investigated the effects of macitentan, an orally-active, tissue-targeting dual ET receptor Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) on chronic complications in type 2 Diabetes Mellitus.MAIN METHODS: db/db CASP14 gene and their age- and sex-matched controls were examined after 2 and 4 months of Diabetes Mellitus. , Macitentan is a novel dual ETA/ETB receptor Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) with enhanced tissue distribution and sustained receptor binding properties designed to achieve a more efficacious ET receptor blockade. , Recently oral Prostacyclin Receptor Agonists have shown encouraging results. Many clinical studies targeting the vasoconstrictor ET-1 pathway with receptor antagonists like bosentan and ambrisentan have shown strong results, even more optimism coming from macitentan, the newest Pharmacologic Substance.[SEP]Relations: Macitentan has relations: drug_drug with Etomidate, drug_drug with Etomidate, drug_drug with Inotersen, drug_drug with Inotersen, drug_drug with Pitolisant, drug_drug with Pitolisant, drug_drug with Antipyrine, drug_drug with Antipyrine, drug_drug with Etoperidone, drug_drug with Etoperidone. Definitions: bosentan defined as following: A sulfonamide-derived, competitive and specific endothelin receptor Substance with receptor antagonist mechanism of action (substance) with a slightly higher affinity for the endothelin A receptor than endothelin B receptor. Bosentan blocks the action of endothelin 1, an extremely potent endogenous vasoconstrictor and bronchoconstrictor, by binding to endothelin A and endothelin B receptors in the endothelium and vascular smooth muscle. Bosentan decreases both pulmonary and systemic vascular resistance and is particularly used in the treatment of pulmonary arterial hypertension.. retinaldehyde defined as following: A diterpene derived from the carotenoid VITAMIN A which functions as the active component of the visual cycle. It is the prosthetic group of RHODOPSIN (i.e., covalently bonded to ROD OPSIN as 11-cis-retinaldehyde). When stimulated by visible light, rhodopsin transforms this cis-isomer of retinaldehyde to the trans-isomer (11-trans-retinaldehyde). This transformation straightens-out the bend of the retinaldehyde molecule and causes a change in the shape of rhodopsin triggering the visual process. A series of energy-requiring enzyme-catalyzed reactions convert the 11-trans-retinaldehyde back to the cis-isomer.. Congenital hypoplasia of pulmonary artery defined as following: Underdevelopment of the pulmonary artery. [HPO:probinson]. Kidney defined as following: Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.. macitentan defined as following: An orally available dual endothelin receptor (ETR) Substance with receptor antagonist mechanism of action (substance) with potential antihypertensive and antineoplastic activity. Upon administration, macitentan and its metabolites block the binding of endothelin isoform 1 (ET-1) to type-A and type-B ETR on both the tumor cells and the endothelial cells in the tumor vasculature. This prevents ET-1 mediated signaling transduction which may decrease tumor cell proliferation, progression, and angiogenesis in tumor tissue. ET-1, a potent vasoconstrictor that plays an important role in inflammation and tissue repair, is, together with its receptors, overexpressed varyingly in many tumor cell types.. Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. Cardiovascular Diseases defined as following: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.. ambrisentan defined as following: An orally bioavailable, selective Substance with receptor antagonist mechanism of action (substance) of the endothelin type-A (ETA) receptor that may be used for the treatment of pulmonary arterial hypertension (Congenital hypoplasia of pulmonary artery). Upon administration, ambrisentan targets and binds to ETA receptor, which prevents the binding of endothelin-1 (ET-1) to the ETA receptor and ET-1/ETA-mediated vasoconstriction and cell proliferation. This may lead to vasodilation. ET-1 concentrations are increased in plasma as well as lung tissue in Congenital hypoplasia of pulmonary artery, and ET-1 may play a key role in the pathogenesis of Congenital hypoplasia of pulmonary artery.. Fibrosis defined as following: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.. Diabetes Mellitus defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.. Oculodigitoesophagoduodenal syndrome defined as following: A rare autosomal dominant syndrome caused by mutations in the MYCN oncogene. It is characterized by microcephaly, limb abnormalities, esophageal and/or duodenal atresia.. Pulmonary Hypertension defined as following: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.. agonist defined as following: An agent that has affinity for a receptor and intrinsic activity at that receptor..", "label": "no"} {"original_question": "Does CRISPR inversion of CTCF sites alter genome topology?", "id": "converted_1989", "sentence1": "Does Clustered Regularly Interspaced Short Palindromic Repeats inversion of CTCF sites alter genome topology?", "sentence2": "Clustered Regularly Interspaced Short Palindromic Repeats Inversion of CTCF Sites Alters Genome Topology and Enhancer/Promoter Function, To test the functional significance of this observation, we combined Clustered Regularly Interspaced Short Palindromic Repeats/Cas9-based genomic-DNA-fragment editing with Chromosomes, Human, Pair 1-conformation-capture experiments to show that the location and relative orientations of CBSs determine the specificity of long-range chromatin looping in mammalian genomes, using PROTOCADHERIN 3 (Pcdh) and β-globin as model genes. Inversion of CBS elements within the Pcdh enhancer reconfigures the topology of chromatin loops between the distal enhancer and target promoters and alters gene-expression patterns. Thus, although enhancers can function in an orientation-independent manner in reporter assays, in the native Chromosomes, Human, Pair 1 context, the orientation of at least some enhancers carrying CBSs can determine both the architecture of topological chromatin domains and enhancer/promoter specificity. These findings reveal how 3D Chromosomes, Human, Pair 1 architecture can be encoded by linear genome sequences, Clustered Regularly Interspaced Short Palindromic Repeats Inversion of CTCF Sites Alters Genome Topology and Enhancer/Promoter Function., Clustered Regularly Interspaced Short Palindromic Repeats Inversion of CTCF Sites Alters Genome Topology and Enhancer/Promoter Function.[SEP]Relations: PROTOCADHERIN 3 3 has relations: disease_disease with Mendelian disease, disease_disease with Mendelian disease. negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure has relations: bioprocess_protein with ADRA1A, bioprocess_protein with ADRA1A, bioprocess_bioprocess with negative regulation of heart rate, bioprocess_bioprocess with negative regulation of heart rate. Definitions: Chromosomes, Human, Pair 1 defined as following: A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human Chromosomes, Human, Pair 1 classification.. Clustered Regularly Interspaced Short Palindromic Repeats defined as following: Repetitive nucleic acid sequences that are principal components of the archaeal and bacterial Clustered Regularly Interspaced Short Palindromic Repeats-CAS SYSTEMS, which function as adaptive antiviral defense systems.. CTCF defined as following: CCN family member 2 (349 aa, ~38kDa) is encoded by the human CCN2 gene. This protein plays a role in the promotion of proliferation and differentiation of chondrocytes and also mediates heparin- and divalent cation-dependent cell adhesion in many different cell types.. sites defined as following: A position in relation to its surroundings..", "label": "yes"} {"original_question": "Does DDX54 play a role in DNA damage response?", "id": "converted_2342", "sentence1": "Does DDX54 gene play a role in DNA damage response?", "sentence2": "DDX54 gene gene regulates transcriptome dynamics during DNA damage response., The contribution of post-transcriptional gene regulatory networks to the DNA damage response (DDR1 wt Allele) has not been extensively studied. Here, we systematically identified RNA-binding Proteins differentially interacting with polyadenylated transcripts upon exposure of human breast carcinoma cells to ionizing radiation (IR). Interestingly, more than 260 Proteins, including many nucleolar Proteins, showed increased binding to poly(A)+RNA in IR-exposed cells. The functional analysis of DDX54 gene gene, a candidate genotoxic stress responsive RNA helicase, revealed that this Protein Info is an immediate-to-early DDR1 wt Allele regulator required for the splicing efficacy of its target IR-induced pre-mRNAs. Upon IR exposure, DDX54 gene gene acts by increased interaction with a well-defined class of pre-mRNAs that harbor Introns with weak Splice Acceptor Site, as well as by Protein Info-Protein Info contacts within components of U2 snRNP and Spliceosomes, resulting in lower intron retention and higher processing rates of its target transcripts. Because DDX54 gene gene promotes survival after exposure to IR, its expression and/or mutation rate may impact DDR1 wt Allele-related pathologies. Our work indicates the relevance of many uncharacterized RBPs potentially involved in the DDR1 wt Allele., The functional analysis of DDX54 gene gene, a candidate genotoxic stress responsive RNA helicase, revealed that this Protein Info is an immediate-to-early DDR1 wt Allele regulator required for the splicing efficacy of its target IR-induced pre-mRNAs.[SEP]Relations: Protein Info binding has relations: molfunc_protein with DDX55, molfunc_protein with DDX55, molfunc_protein with DDX5, molfunc_protein with DDX5, molfunc_protein with DDX6, molfunc_protein with DDX6, molfunc_protein with DDX60, molfunc_protein with DDX60, molfunc_protein with DDX42, molfunc_protein with DDX42. Definitions: DDR1 wt Allele defined as following: Human DDR1 wild-type allele is located in the vicinity of 6p21.3 and is approximately 345 kb in length. This allele, which encodes epithelial discoidin domain-containing receptor 1 Protein Info, is involved in the regulation of cell growth, differentiation and metabolism.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the Protein Info.. Spliceosomes defined as following: Organelles in which the splicing and excision reactions that remove Introns from precursor messenger RNA molecules occur. One component of a spliceosome is five small nuclear RNA molecules (U1, U2, U4, U5, U6) that, working in conjunction with Proteins, help to fold pieces of RNA into the right shapes and later splice them into the message.. Introns defined as following: Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some Introns code for separate genes.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous Proteins in other species.. RNA-binding Proteins defined as following: Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other Proteins whose function is to bind specifically to RNA..", "label": "yes"} {"original_question": "Is co-loss of BRCA2-RB1 associated with better prognosis for prostate cancer patients?", "id": "converted_3965", "sentence1": "Is co-loss of BRCA2 gene-RB1 associated with better prognosis for Malignant neoplasm of prostate patients?", "sentence2": "In Homo sapiens Malignant neoplasm of prostate cell lines (LNCaP and LAPC4), loss of BRCA2 gene gene leads to the castration-resistant phenotype. Co-loss of BRCA2 gene gene-RB1 in Homo sapiens Malignant neoplasm of prostate cells induces an epithelial-to-mesenchymal transition, which is associated with invasiveness and a more aggressive disease phenotype. Importantly, PARP1 wt Allele inhibitors attenuate cell growth in Homo sapiens mCRPC-derived organoids and Homo sapiens CRPC cells harboring single-copy loss of both Genes.CONCLUSIONS: Our findings suggest that early identification of this aggressive form of Malignant neoplasm of prostate offers potential for improved outcomes with early introduction of PARP1 wt Allele inhibitor-based therapy.[SEP]Relations: benign neoplasm of prostate has relations: disease_disease with prostatic adenoma, disease_disease with prostatic adenoma, disease_disease with fibroma of prostate, disease_disease with fibroma of prostate, disease_disease with prostate leiomyoma, disease_disease with prostate leiomyoma, disease_disease with benign prostate phyllodes tumor, disease_disease with benign prostate phyllodes tumor, disease_disease with prostate neoplasm, disease_disease with prostate neoplasm. Definitions: Malignant neoplasm of prostate defined as following: A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas.. PARP1 wt Allele defined as following: Human PARP1 wild-type allele is located within 1q41-q42 and is approximately 47 kb in length. This allele, which encodes poly [ADP-ribose] polymerase 1 protein, plays a critical role in DNA repair.. Homo sapiens defined as following: Members of the species Homo sapiens.. BRCA2 gene defined as following: A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on Homo sapiens chromosome 13 at locus 13q12.3. Mutations in this gene predispose humans to breast and ovarian cancer. It encodes a large, nuclear protein that is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. (from Genes Dev 2000;14(11):1400-6). Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "no"} {"original_question": "Does burning mouth syndrome preferentially affect post-mepopausal women?", "id": "converted_249", "sentence1": "Does burning mouth syndrome preferentially affect post-mepopausal women?", "sentence2": "It is observed principally in middle-aged patients and postmenopausal women and may be accompanied by Xerostomia and altered taste., It occurs more commonly in middle-aged and elderly women and often affects the tongue tip and lateral borders, Lip structure, and hard and soft palate. , BMS is a Chronic disease that frequently affects women and is characterised by burning symptoms of the oral mucosa without clinical signs., It mostly affects elderly citizens, especially postmenopausal women with prevalence up to 12-18%. [SEP]Relations: Xerostomia has relations: disease_phenotype_positive with postorgasmic illness syndrome, disease_phenotype_positive with postorgasmic illness syndrome, drug_effect with Mometasone, drug_effect with Mometasone, drug_effect with Nefopam, drug_effect with Nefopam, disease_phenotype_positive with Cronkhite-Canada syndrome, disease_phenotype_positive with Cronkhite-Canada syndrome, drug_effect with Acamprosate, drug_effect with Acamprosate. Definitions: Chronic disease defined as following: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).. Xerostomia defined as following: Decreased salivary flow.. Lip structure defined as following: Either of the two fleshy, full-blooded margins of the mouth..", "label": "yes"} {"original_question": "Are there Conserved Noncoding Elements (CNEs) in plant genomes?", "id": "converted_1402", "sentence1": "Are there Conserved Noncoding Elements (CNEs) in Plant allergen Genome?", "sentence2": "Conservation and functional element discovery in 20 angiosperm Plant allergen Genome, The detailed view of Conservation across angiosperms revealed not only high coding-sequence Conservation but also a large set of previously uncharacterized intergenic Conservation, Conserved noncoding sequences highlight shared components of regulatory networks in dicotyledonous Plants, Using a comparative genomics approach with four dicotyledonous Plant allergen species (Arabidopsis thaliana , papaya [Carica papaya], poplar [Populus trichocarpa], and Grapes (Dietary) [Vitis vinifera]), we detected hundreds of CNSs upstream of Arabidopsis Genes, Long identical multispecies elements in Plant allergen and Animal allergens Genome., Using an alignment-free information-retrieval approach, we have comprehensively identified all long identical multispecies elements (Limes (dietary)), which include both syntenic and nonsyntenic regions, of at least 100 identical base pairs shared by at least two Genome, In contrast, among six Plant allergen Genome, we only found nonsyntenic Limes (dietary), Although complex Limes (dietary) were found in both Animal allergens and Plant allergen Genome, they differed significantly in their composition and copy number, Ultraconserved elements between the Genome of the Plants Arabidopsis thaliana and rice, We consequently compared the Genome of Arabidopsis thaliana and rice, which diverged about 200 million years ago, and identified 25 ultraconserved elements that are longer than 100 bp, ultraconserved elements in Plants tend to occur in clusters and locate at noncoding regions, the functions of these Plant allergen ultraconserved elements and the reasons why they are practically frozen during the evolution of millions of years remain a mystery, Conserved noncoding sequences in the grasses, Using a local sequence alignment set to deliver only significant alignments, we found one or more CNSs in the noncoding regions of the majority of Genes studied. Grass Genes have dramatically fewer and much smaller CNSs than mammalian Genes, Conserved noncoding sequences among cultivated Cereals Genome identify candidate regulatory sequence elements and patterns of Promoter evolution, Surveys for conserved noncoding sequences (Central Nervous System) among Genes from monocot Cereals species were conducted to assess the general properties of Central Nervous System in grass Genome and their correlation with known Promoter regulatory elements, Comparisons of orthologous maize-rice and maize-sorghum gene pairs identified 20 bp as a minimal length criterion for a significant Central Nervous System among grass Genes, with few such Central Nervous System found to be conserved across rice, maize, sorghum, and barley[SEP]Relations: central nervous system has relations: anatomy_protein_present with NONO, anatomy_protein_present with NONO, anatomy_protein_present with CNP, anatomy_protein_present with CNP, anatomy_protein_present with CNBP, anatomy_protein_present with CNBP, anatomy_protein_present with CNPPD1, anatomy_protein_present with CNPPD1, anatomy_protein_present with CNR1, anatomy_protein_present with CNR1. Definitions: Cereals defined as following: Seeds from grasses (POACEAE) which are important in the diet.. Conservation defined as following: The maintenance of certain characteristics in an unchanged condition.. Genome defined as following: The genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. Central Nervous System defined as following: The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.. Plants defined as following: Multicellular, eukaryotic life forms of kingdom Plantae. Plants acquired chloroplasts by direct endosymbiosis of CYANOBACTERIA. They are characterized by a mainly photosynthetic mode of nutrition; essentially unlimited growth at localized regions of cell divisions (MERISTEMS); cellulose within cells providing rigidity; the absence of organs of locomotion; absence of nervous and sensory systems; and an alternation of haploid and diploid generations. It is a non-taxonomical term most often referring to LAND PLANTS. In broad sense it includes RHODOPHYTA and GLAUCOPHYTA along with VIRIDIPLANTAE.. Plant allergen Genome defined as following: The genetic complement of a Plant allergen (PLANTS) as represented in its DNA.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Αre plants from the genus Strychnos the original source of curare?", "id": "converted_4277", "sentence1": "Αre Plants from the genus Strychnos the original source of Curare?", "sentence2": "Poisons are widespread in Plants and animal allergen extracts and humankind has often tried to turn them to its own advantage. Owing to their poisonous properties, some species of Strychnos genus have been employed mainly in hunting and fishing, as an adjunct to weapons used not only in the search of Food allergenic extracts and clothes, but also for preventing depredation by wild animal allergen extracts. They have been employed for martial and criminal purposes and also as a means of determining Guilt or innocence. By their nature, poisons such as Strychnine Assay and Curare affect the functioning of the victim's body; , The ethnobotanical uses of South American species of Strychnos L. (Loganiaceae) are reviewed, with the exception of their major rôle in the preparation of Curare, which will be dealt with in detail elsewhere., VELOPMENT: Curare is prepared by boiling the Plant Roots, Barking (observable entity) and stalks of different Plants belonging to the Loganiaceae (Strychnos) and Menispermaceae families (Chondrodendron, Curarea and Abuta). , The history to about 1850 of the muscle-relaxant poison Curare is discussed, especially the developments leading to the botanical identification of the Plants that yield the alkaloidal active principles: Loganiaceae (Strychnos species) and Menispermaceae (Abuta, Chondrodendron, and Curarea species)., or centuries. The study reviews the historical and ethnographic aspects of the use of curares and timbós in the Amazonian region.DEVELOPMENT: Curare is prepared by boiling the Plant Roots, Barking (observable entity) and stalks of different Plants belonging to the Loganiaceae (Strychnos) and Menispermaceae families (Chondrod[SEP]Relations: Plantar pits has relations: disease_phenotype_positive with Darier disease, disease_phenotype_positive with Darier disease, disease_phenotype_positive with monosomy 9q22.3, disease_phenotype_positive with monosomy 9q22.3, disease_phenotype_positive with PTEN hamartoma tumor syndrome, disease_phenotype_positive with PTEN hamartoma tumor syndrome, phenotype_phenotype with Abnormality of the plantar skin of foot, phenotype_phenotype with Abnormality of the plantar skin of foot, disease_phenotype_positive with nevoid basal cell carcinoma syndrome, disease_phenotype_positive with nevoid basal cell carcinoma syndrome. Definitions: Plant Roots defined as following: The usually underground portions of a plant that serve as support, store Food allergenic extracts, and through which water and mineral nutrients enter the plant. (From American Heritage Dictionary, 1982; Concise Dictionary of Biology, 1990). Guilt defined as following: Subjective feeling of having committed an error, offense or sin; unpleasant feeling of self-criticism. These result from acts, impulses, or thoughts contrary to one's personal conscience.. Curare defined as following: Plant extracts from several species, including genera STRYCHNOS and Chondodendron, which contain TETRAHYDROISOQUINOLINES that produce PARALYSIS of skeletal muscle. These extracts are toxic and must be used with the administration of artificial respiration.. Loganiaceae defined as following: A plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida. They have leaflike appendages at the base of the leafstalks, have terminal flower clusters. Petals have four or five overlapping lobes and the fruit is a capsule containing winged or wingless seeds.. Plants defined as following: Multicellular, eukaryotic life forms of kingdom Plantae. Plants acquired chloroplasts by direct endosymbiosis of CYANOBACTERIA. They are characterized by a mainly photosynthetic mode of nutrition; essentially unlimited growth at localized regions of cell divisions (MERISTEMS); cellulose within cells providing rigidity; the absence of organs of locomotion; absence of nervous and sensory systems; and an alternation of haploid and diploid generations. It is a non-taxonomical term most often referring to LAND PLANTS. In broad sense it includes RHODOPHYTA and GLAUCOPHYTA along with VIRIDIPLANTAE..", "label": "yes"} {"original_question": "Is factor XI deficient in Hemophilia C?", "id": "converted_1283", "sentence1": "Is factor XI deficient in Hemophilia C?", "sentence2": "Factor XI deficiency is a rare Hematological Disease. Hemophilia C (factor XI deficiency) affects both genders and it is usually asymptomatic,, Congenital factor XI deficiency (also known as the Rosenthal syndrome or Hereditary Factor XI Deficiency), rare case of an acute cerebral aneurysm rupture in a patient with a known factor XI deficiency. Aneurysmal subarachnoid hemorrhage (Yakut language) accounts for a high mortality and morbidity rate. When Yakut language is associated with an inherited coagulation disorder such as Hereditary Factor XI Deficiency, Factor XI deficiency (Hemophilia C), Factor XI deficiency, also called Hereditary Factor XI Deficiency,[SEP]Relations: factor XI deficiency has relations: disease_disease with hemophilia, disease_disease with hemophilia, disease_disease with congenital factor XI deficiency, disease_disease with congenital factor XI deficiency. hematologic disease has relations: disease_disease with L-ferritin deficiency, disease_disease with L-ferritin deficiency, disease_disease with GATA1-Related X-Linked Cytopenia, disease_disease with GATA1-Related X-Linked Cytopenia, contraindication with Adomiparin, contraindication with Adomiparin. Definitions: Yakut language defined as following: A Turkic language spoken by the Yakut people in the Sakha Republic in the Russian Federation.. Hereditary Factor XI Deficiency defined as following: A hereditary deficiency of blood coagulation factor XI (also known as plasma thromboplastin antecedent or PTA or antihemophilic factor C) resulting in a systemic blood-clotting defect called Hereditary Factor XI Deficiency or Rosenthal's syndrome, that may resemble classical hemophilia.. Hematological Disease defined as following: Disorders of the blood and blood forming tissues.. Hemophilia C defined as following: A hereditary deficiency of blood coagulation factor XI (also known as plasma thromboplastin antecedent or PTA or antihemophilic factor C) resulting in a systemic blood-clotting defect called Hereditary Factor XI Deficiency or Rosenthal's syndrome, that may resemble classical hemophilia..", "label": "yes"} {"original_question": "Can brain derived exosomes carry APP molecules?", "id": "converted_3515", "sentence1": "Can brain derived Exosomes carry Smartphone Application molecules?", "sentence2": "Here, we show that small lipid Vesicle (morphologic abnormality) called Exosomes, secreted in the Extracellular milieu by cortical neurons, carry endogenous Smartphone Application, these Exosomes contained Smartphone Application and were capable of efficiently transferring Smartphone Application to normal primary neurons. , Accumulating evidence has demonstrated that Exosomes are associated with Serum amyloid A protein (Smartphone Application) and tau Proteins and play a controversial role in Alzheimer's disease process. , Here we have investigated the role of Exosomes in the processing of Smartphone Application and show that these Vesicle (morphologic abnormality) contain Smartphone Application-CTFs, as well as Smartphone Application wt Allele[SEP]Relations: Extracellular space has relations: cellcomp_protein with Smartphone Application, cellcomp_protein with Smartphone Application, cellcomp_protein with AFM, cellcomp_protein with AFM, cellcomp_protein with ERFE, cellcomp_protein with ERFE, cellcomp_protein with MSMB, cellcomp_protein with MSMB, cellcomp_protein with MCAM, cellcomp_protein with MCAM. Definitions: tau Proteins defined as following: Microtubule-associated proteins that are mainly expressed in neurons. tau Proteins constitute several isoforms and play an important role in the assembly of tubulin monomers into microtubules and in maintaining the cytoskeleton and axonal transport. Aggregation of specific sets of tau proteins in filamentous inclusions is the common feature of intraneuronal and glial fibrillar lesions (NEUROFIBRILLARY TANGLES; NEUROPIL THREADS) in numerous neurodegenerative disorders (ALZHEIMER DISEASE; TAUOPATHIES).. Smartphone Application wt Allele defined as following: Human Smartphone Application wild-type allele is located in the vicinity of 22q13.2 and is approximately 290 kb in length. This allele, which encodes amyloid beta A4 protein, is involved in transcriptional activation and peptide regulation. Smartphone Application defects can cause Alzheimer's disease and cerebroarterial amyloidosis.. Vesicle (morphologic abnormality) defined as following: An abnormal fluid-filled cleft (e.g. as in the epidermis) or membrane-bound space.. Serum amyloid A protein defined as following: A family of apolipoproteins that are associated with high-density lipoprotein particles in the serum. These proteins may play a role in both the acute-phase of inflammation and in cholesterol transport.. Smartphone Application defined as following: An application designed specifically for use on a smartphone.. Exosomes defined as following: A type of Extracellular vesicle, containing RNA and proteins, that is secreted into the Extracellular space by EXOCYTOSIS when MULTIVESICULAR BODIES fuse with the PLASMA MEMBRANE.. Extracellular defined as following: The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. [GOC:go_curators].", "label": "yes"} {"original_question": "Are shadow enhancers associated with development?", "id": "converted_1394", "sentence1": "Are shadow enhancers associated with development?", "sentence2": "Critical developmental control Genes sometimes contain \"shadow\" enhancers that can be located in remote positions, including the Introns of neighboring Genes, These results suggest that shadow enhancers represent a novel mechanism of canalization whereby complex developmental processes \"bring about one definite end-result regardless of minor variations in conditions\", Shadow enhancers flanking the HoxB cluster direct dynamic Hox expression in early heart and Endoderm development., This suggests that they function as shadow enhancers to modulate the expression of Genes from the HoxB complex during Cardiac - anatomy qualifier development. Regulatory analysis of the HOXA@ gene cluster complex reveals that it also has enhancers in the 3' flanking region which contain RAREs and have the potential to modulate expression in Endoderm and Heart tissue, This suggests that they function as shadow enhancers to modulate the expression of Genes from the HoxB complex during Cardiac - anatomy qualifier development., Recent reports have shown that Genes, Developmental often possess multiple discrete enhancer modules that drive transcription in similar spatio-temporal patterns: primary enhancers located near the basal promoter and secondary, or 'shadow', enhancers located at more remote positions., Together, the similarities in their location, enhancer output, and dependence on retinoid signaling suggest that a conserved cis-regulatory cassette located in the 3' proximal regions adjacent to the HOXA@ gene cluster and HoxB complexes evolved to modulate Genes, Homeobox expression during Mammals Cardiac - anatomy qualifier and Endoderm development. , This suggests that they function as shadow enhancers to modulate the expression of Genes from the HoxB complex during Cardiac - anatomy qualifier development.[SEP]Relations: petal development has relations: bioprocess_bioprocess with floral organ development, bioprocess_bioprocess with floral organ development, bioprocess_bioprocess with phyllome development, bioprocess_bioprocess with phyllome development. tRNA gene clustering has relations: bioprocess_bioprocess with chromosome organization, bioprocess_bioprocess with chromosome organization. heart elastic tissue has relations: anatomy_anatomy with mesoderm-derived structure, anatomy_anatomy with mesoderm-derived structure. Endoderm has relations: anatomy_anatomy with Endoderm of foregut-midgut junction, anatomy_anatomy with Endoderm of foregut-midgut junction. Definitions: Endoderm defined as following: The inner of the three germ layers of an embryo.. HOXA@ gene cluster defined as following: A family of Genes found in a cluster on the p arm of chromosome 7. These Genes encode transcription factors that play a role in gene expression, morphogenesis, and cell differentiation.. Introns defined as following: Sequences of DNA in the Genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some Introns code for separate Genes.. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.. Genes, Homeobox defined as following: Genes that encode highly conserved TRANSCRIPTION FACTORS that control positional identity of cells (BODY PATTERNING) and MORPHOGENESIS throughout development. Their sequences contain a 180 nucleotide sequence designated the homeobox, so called because mutations of these Genes often results in homeotic transformations, in which one body structure replaces another. The proteins encoded by homeobox Genes are called HOMEODOMAIN PROTEINS.. Genes, Developmental defined as following: Genes that determine the fate of a cell or CELLS in a region of the embryo during EMBRYONIC DEVELOPMENT.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Was tamoxifen tested for treatment of glioma patients?", "id": "converted_1260", "sentence1": "Was tamoxifen tested for treatment of glioma patients?", "sentence2": "tamoxifen might have a role in the initial treatment of high-grade Glioma and should be studied in future Phase II trials building on the newly established platform of concurrent chemoradiotherapy., The addition of high-dose tamoxifen to standard radiotherapy does not improve the survival of patients with diffuse intrinsic pontine glioma., In this study, in which tamoxifen was used in conjunction with radiotherapy, progression free survival was shown to be less good when compared with historical data HR = 3.1 (CI: 1.7-5.7)., The addition of high-dose tamoxifen, although well tolerated, confers no clinical benefit to patients treated with diffuse intrinsic pontine glioma treated with standard radiotherapy., CONCLUSIONS: Carboplatin and high dose tamoxifen has similar response rates to other regimens for recurrent malignant Glioma and are probably equivalent to those found using tamoxifen as monotherapy. , CONCLUSIONS: Pegylated liposomal doxorubicin administered alone or in combination with tamoxifen is safe and moderately effective in patients with recurrent high-grade glioma., Protein kinase C (Paroxysmal kinesigenic choreoathetosis) inhibitors such as high-dose tamoxifen and hypericin also have been used in the treatment of malignant Glioma. , Considering these facts, polyethylene-glycol-liposomal doxorubicin with and without tamoxifen was evaluated within two sequential Phase II trials performed at our institution. , In a parallel phase-II-study investigating post-operative treatment with tamoxifen (Immunoreceptor Tyrosine-Based Activation Motif), carboplatin and radiation therapy for Glioblastoma, 16 of 49 patients (33%) showed multifocal recurrence, which developed after a mean of 46 weeks, raising the question of an association with therapy., Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem Glioma: results of a Brazilian cooperative study. Brainstem Glioma Cooperative Group., PURPOSE: The efficacy of radiation therapy (RT) combined with tamoxifen (TX) was tested in patients diagnosed with diffuse brainstem Glioma in a multicenter trial., CONCLUSION: This treatment combination produced no significant change in the overall poor prognosis of these patients. Most Neoplasms responded initially to treatment but recurred as the study progressed. A minority of patients seemed to benefit from the extended use of TX. , tamoxifen, a Protein Kinase C inhibitor when administered in high dosages, is currently being used as an adjuvant in the treatment of patients with malignant Glioma., We present a patient with a recurrent Malignant Glioma who was continued on high dose tamoxifen despite radiologic documented doubling of the Specimen Source Codes - Specimen Source Codes - tumor size and who eventually showed a delayed response to this agent nine months after initiation of treatment., The combination of oral tamoxifen (120 to 240 mg/m2/day) and subcutaneous interferon-alpha [6 x 10(6) U three times per week] was associated with significant Neurotoxicity Syndromes in this group of recurrent glioma patients, resulting in early study closure., A phase I study of high-dose tamoxifen for the treatment of refractory malignant Glioma of childhood., Phase I clinical trial assessing temozolomide and tamoxifen with concomitant radiotherapy for treatment of high-grade glioma., Prolonged treatment with Biological Factors for Malignant Glioma: a case study with high dose tamoxifen., tamoxifen as a potential treatment of glioma., We tested the efficacy and Toxic effect of the combination of high-dose tamoxifen and Deprecated Interferon alpha in Serum or Plasma in adults with recurrent glioma in a phase II trial. , PURPOSE: The efficacy of radiation therapy (RT) combined with tamoxifen (TX) was tested in patients diagnosed with diffuse brainstem Glioma in a multicenter trial. , We tested the efficacy and Toxic effect of the combination of high-dose tamoxifen and Deprecated Interferon alpha in Serum or Plasma in adults with recurrent glioma in a phase II trial., The efficacy of radiation therapy (RT) combined with tamoxifen (TX) was tested in patients diagnosed with diffuse brainstem Glioma in a multicenter trial., The efficacy of radiation therapy (RT) combined with tamoxifen (TX) was tested in patients diagnosed with diffuse brainstem Glioma in a multicenter trial., We tested the efficacy and Toxic effect of the combination of high-dose tamoxifen and Deprecated Interferon alpha in Serum or Plasma in adults with recurrent glioma in a phase II trial. Eligible patients had radiographically measurable recurrent Glioma of any grade after initial radiation therapy., Thyroid function was suppressed to reduce Insulin-Like Growth Factor I levels in glioma patients and high-dose tamoxifen administered. propylthiouracil was used to induce chemical hypothyroidism in 22 patients with recurrent glioma., Activity against recurrent Glioma has been reported for both tamoxifen and Deprecated Interferon alpha in Serum or Plasma, agents that have more acceptable Toxic effect profiles and that can be administered in an outpatient setting. We tested the efficacy and Toxic effect of the combination of high-dose tamoxifen and Deprecated Interferon alpha in Serum or Plasma in adults with recurrent glioma in a phase II trial., Thyroid function was suppressed to reduce Insulin-Like Growth Factor I levels in glioma patients and high-dose tamoxifen administered., Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem Glioma: results of a Brazilian cooperative study., We tested the efficacy and Toxic effect of the combination of high-dose tamoxifen and Deprecated Interferon alpha in Serum or Plasma in adults with recurrent glioma in a phase II trial., The subsequent in vitro testing of the Specimen Source Codes - Specimen Source Codes - tumor that was removed after the recurrence of Specimen Source Codes - Specimen Source Codes - tumor (22 months after the initiation of tamoxifen) revealed loss of sensitivity to tamoxifen., The combination of oral tamoxifen (120 to 240 mg/m2/day) and subcutaneous interferon-alpha [6 x 10(6) U three times per week] was associated with significant Neurotoxicity Syndromes in this group of recurrent glioma patients, resulting in early study closure.[SEP]Relations: tamoxifen has relations: drug_effect with Lymphedema, drug_effect with Lymphedema, drug_drug with Glisoxepide, drug_drug with Glisoxepide, drug_drug with Glyburide, drug_drug with Glyburide, drug_effect with Erythema, drug_effect with Erythema, drug_effect with Edema, drug_effect with Edema. Definitions: Malignant Glioma defined as following: A grade 3 or grade 4 glioma arising from the central nervous system. This category includes glioblastoma, anaplastic astrocytoma, anaplastic ependymoma, anaplastic oligodendroglioma, and anaplastic oligoastrocytoma.. Paroxysmal kinesigenic choreoathetosis defined as following: Paroxysmal kinesigenic dyskinesia (PKD) is a form of paroxysmal dyskinesia (see this term), characterized by recurrent brief involuntary hyperkinesias, such as choreoathetosis, ballism, athetosis or dystonia, triggered by sudden movements.. carboplatin defined as following: An organoplatinum compound that possesses antineoplastic activity.. Protein Kinase C defined as following: An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that Protein Kinase C is the receptor protein of Specimen Source Codes - tumor-promoting phorbol esters.. tamoxifen defined as following: One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM.. Glioma defined as following: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21). Biological Factors defined as following: Endogenously synthesized compounds that influence biological processes not otherwise classified under ENZYMES; HORMONES or HORMONE ANTAGONISTS.. Insulin-Like Growth Factor I defined as following: A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor.. doxorubicin defined as following: Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN.. hypericin defined as following: An anthraquinone derivative that is naturally found in the yellow flower of Hypericum perforatum (St. John's wort) with antidepressant, potential antiviral, antineoplastic and immunostimulating activities. Hypericin appears to inhibit the neuronal uptake of serotonin, norepinephrine, dopamine, gamma-amino butyric acid (GABA) and L-glutamate, which may contribute to its antidepressant effect. Hypericin may also prevent the replication of encapsulated viruses probably due to inhibition of the assembly and shedding of virus particles in infected cells. This agent also exerts potent phototoxic effects by triggering apoptotic signaling that results in formation of reactive oxygen species.. Glioblastoma defined as following: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.. temozolomide defined as following: A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Neurotoxicity Syndromes defined as following: Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Immunoreceptor Tyrosine-Based Activation Motif defined as following: A conserved AMINO ACID SEQUENCE located in the intracellular domains of a family of transmembrane proteins involved in various IMMUNE RESPONSES. The CONSENSUS SEQUENCE of this motif is YXXL(or I)X(6-8)YXXL(or I) (where X denotes any amino acid). When phosphorylated ITAM motifs provide docking sites for PROTEIN TYROSINE KINASES of the Syk family thus forming signaling complexes which lead to activation of immune responses.. propylthiouracil defined as following: A thiourea antithyroid agent. Propythiouracil inhibits the synthesis of thyroxine and inhibits the peripheral conversion of throxine to tri-iodothyronine. It is used in the treatment of hyperthyroidism. (From Martindale, The Extra Pharmacopeoia, 30th ed, p534). tamoxifen defined as following: One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM..", "label": "yes"} {"original_question": "Is desmin an intermediate filament protein involved in Dilated Cardiomyopathy (DCM)?", "id": "converted_374", "sentence1": "Is CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human an intermediate filament Protein Info involved in Dilated Cardiomyopathy (3',5'-dichloromethotrexate)?", "sentence2": "Desmin-related myofibrillar myopathy (DRM) is a Cardiac - anatomy qualifier and skeletal muscle Disease caused by mutations in the CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human (CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1) gene. Gene Mutation in the central 2B domain of CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 cause skeletal muscle Disease that typically precedes Cardiac - anatomy qualifier involvement. However, the prevalence of CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 mutations in dilated Cardiomyopathies (3',5'-dichloromethotrexate) without skeletal muscle Disease is not known., The lack of severe disruption of cytoskeletal CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human network formation seen with mutations in the 1A and tail domains suggests that dysfunction of seemingly intact CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human networks is sufficient to cause 3',5'-dichloromethotrexate., According to the predominant view, CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human mutations cause dilated Cardiomyopathies (3',5'-dichloromethotrexate). We evaluated a family with restrictive Cardiomyopathies (RCM) associated with a novel CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human mutation and reviewed recent reports regarding the frequency of RCM in patients with CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human myopathy., Dilated Cardiomyopathies (3',5'-dichloromethotrexate) is characterized by Enlargement (morphologic abnormality) and dilation of all Chest>Heart compartments associated with serious decrease of its Muscle Contraction function. 3',5'-dichloromethotrexate hallmark is the combination of dystrophic and Hypertrophic disorder of skin, unspecified alterations of Myocytes, Cardiac. Since the power output of Cardiac - anatomy qualifier cells is directly related to remodeling of their Muscle Contraction machinery we investigated expression of selected Muscle Contraction and Cytoskeletal Proteins in the left ventricle of 3',5'-dichloromethotrexate patients using immunoblotting. The content of the recognized Protein Info markers of cardiomyocyte hypertrophy such as Tubulin, CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human and slow skeletal myosin heavy chain isoform, MHCbeta, was significantly elevated in 3',5'-dichloromethotrexate compared to normal Myocardium., In contrast, overexpression of CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human filaments by itself is not detrimental to the Chest>Heart. Although loss-of-function studies have been more limited, ablation of the CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human gene causes Abnormality of mitochondrial metabolism and apoptosis, resulting in Cardiomyopathies in mice. From function studies, abnormal CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human aggregation and disruption of the CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human networks resulting from expression of either mutant CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human or mutant CRYAB gene have been shown to remodel the Chest>Heart and compromise Cardiac - anatomy qualifier function, suggesting their synergistic roles in Disease pathogenesis., A missense mutation in the CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human gene (CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1) causes 3',5'-dichloromethotrexate in a human family., CASP14 gene deficient in CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human, the muscle-specific member of the intermediate filament gene family, display defects in all muscle types and particularly in the Myocardium. Desmin null hearts develop cardiomyocyte hypertrophy and dilated Cardiomyopathies (3',5'-dichloromethotrexate) characterized by extensive myocyte cell death, calcific fibrosis and multiple ultrastructural defects. Several lines of evidence suggest impaired vascular function in CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human null animals., Familial 3',5'-dichloromethotrexate is commonly inherited as Autosome dominant trait; less frequently it is Autosome recessive, X-linked inheritance inheritance or matrilinear. The Disease is clinically and genetically heterogeneous. Genes causally linked to this phenotype include Dystrophin, Dystrophin-associated glycoproteins, Actins, CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human, beta-miosin heavy chain, Cardiac - anatomy qualifier troponin T, and DNA, Mitochondrial Genes, mostly transfer RNA., Examination of families has identified so far eight Disease Genes, namely the Dystrophin, TAFAZZIN gene, Cardiac - anatomy qualifier Actins, CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human, lamin A/C, delta- sarcoglycan, Cardiac - anatomy qualifier beta-myosin heavy chain, and Cardiac - anatomy qualifier troponin T gene., Gene Mutation of the CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human, delta-Sarcoglycan, the Cardiac - anatomy qualifier Actins and beta-myosin heavy chain as well as the troponin T gene are known to cause Autosome dominant-dilated Cardiomyopathies without other abnormalities., Autosomal dominant 3',5'-dichloromethotrexate is the most frequent form (56% of our cases), and several candidate Disease loci have been identified by linkage analysis. Three Disease Genes are presently known: the Cardiac - anatomy qualifier Actins gene, the CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human gene, and the LMNA gene., Dilated Cardiomyopathies (3',5'-dichloromethotrexate) is a major cause of morbidity and mortality. Two Genes have been identified for the X-linked inheritance inheritance forms (Dystrophin and TAFAZZIN gene), whereas three other Genes (Actins, lamin A/C, and CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human) cause Autosome dominant 3',5'-dichloromethotrexate;, Desmin defects were also recently identified in 1 familial dilated Cardiomyopathies., By candidate gene screening, the molecular diagnosis can be provided for Dystrophin, Diacylglycerol, DNA, Mitochondrial, Actins and CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human gene defects., Desmin (z-bands) are partly destroyed in 3',5'-dichloromethotrexate. Anti-CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human immunoglobulin complex location titers as indicators of a possible secondary immune response are found high in patients with acute myocarditis declining during reconvalescence and are also elevated in 3',5'-dichloromethotrexate. , Desmin, the muscle-specific intermediate filament Protein Info, is a major target in dilated Cardiomyopathies and Congestive Chest>Heart failure in Homo sapiens and mice, Desmin, the muscle-specific intermediate filament, is involved in Myofibrillar Myopathy, dilated Cardiomyopathies and Muscular Atrophy[SEP]Relations: dilated Cardiomyopathies has relations: disease_protein with CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1, disease_protein with CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1, disease_protein with DMD, disease_protein with DMD, disease_protein with TPM1, disease_protein with TPM1, disease_protein with ALMS1, disease_protein with ALMS1, disease_protein with TTN, disease_protein with TTN. Definitions: Cytoskeletal Proteins defined as following: Major constituent of the cytoskeleton found in the cytoplasm of eukaryotic cells. They form a flexible framework for the cell, provide attachment points for organelles and formed bodies, and make communication between parts of the cell possible.. Diacylglycerol defined as following: A synthetic oil with anti-obesity activity. The enzymatically synthesized isoform, 1,3-isoform diacylglycerol, is suggested to decrease formation of chylomicrons as well as shunting them directly to the liver through the portal vein where they are oxidized. Increased beta-oxidation may enhance body weight loss, suppress body fat accumulation and lower serum triacylglycerol levels through increasing satiety.. immunoglobulin complex location defined as following: A Protein Info complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph. [GOC:add, GOC:jl, ISBN:0781765196]. Congestive Chest>Heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Myocytes, Cardiac defined as following: Striated muscle cells found in the Chest>Heart. They are derived from Cardiac - anatomy qualifier myoblasts (MYOBLASTS, CARDIAC).. 3',5'-dichloromethotrexate defined as following: A chlorinated methotrexate derivative. Dichloromethotrexate inhibits the enzyme dihydrofolate reductase, thereby preventing the synthesis of purine nucleotides and thymidylates and inhibiting DNA and RNA synthesis. This agent is metabolized and excreted by the liver. (NCI04). Cardiomyopathies defined as following: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).. CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human defined as following: Desmin (470 aa, ~54 kDa) is encoded by the human CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 gene. This Protein Info is involved in the regulation of cytoskeletal dynamics in muscle cells.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). dilated Cardiomyopathies defined as following: Cardiomyopathy which is characterized by dilation and Muscle Contraction dysfunction of the left and right ventricles. It may be idiopathic, or it may result from a myocardial infarction, myocardial infection, or alcohol abuse. It is a cause of congestive Congestive Chest>Heart failure.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. Myofibrillar Myopathy defined as following: An inherited or sporadic disorder affecting the skeletal muscles.. X-linked inheritance defined as following: A mode of inheritance that is observed for traits related to a gene encoded on the X chromosome. [HPO:curators]. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Autosome defined as following: Any chromosome other than a sex chromosome. [GOC:mah]. CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human gene defined as following: This gene is involved in the maintenance of muscle cell structure.. Dystrophin defined as following: A muscle Protein Info localized in surface membranes which is the product of the Duchenne/Becker muscular dystrophy gene. Individuals with Duchenne muscular dystrophy usually lack Dystrophin completely while those with Becker muscular dystrophy have Dystrophin of an altered size. It shares features with other Cytoskeletal Proteins such as SPECTRIN and alpha-actinin but the precise function of Dystrophin is not clear. One possible role might be to preserve the integrity and alignment of the plasma membrane to the myofibrils during muscle contraction and relaxation. MW 400 kDa.. LMNA gene defined as following: This gene is involved in the architecture of nuclear membrane construction.. Muscle Contraction defined as following: A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby Actins filaments slide inward among the myosin filaments.. Muscular Atrophy defined as following: Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.. Actins defined as following: Filamentous proteins that are the main constituent of the thin filaments of muscle fibers. The filaments (known also as filamentous or F-Actins) can be dissociated into their globular subunits; each subunit is composed of a single polypeptide 375 amino acids long. This is known as globular or G-Actins. In conjunction with MYOSINS, Actins is responsible for the contraction and relaxation of muscle.. CRYAB gene defined as following: This gene is involved in lens formation.. Abnormality of mitochondrial metabolism defined as following: A functional anomaly of mitochondria. [ORCID:0000-0001-5208-3432]. DNA, Mitochondrial defined as following: Double-stranded DNA of MITOCHONDRIA. In eukaryotes, the mitochondrial GENOME is circular and codes for ribosomal RNA, transfer RNA, and about 10 proteins.. Tubulin defined as following: A microtubule subunit Protein Info found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the Protein Info is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE.. Homo sapiens defined as following: Members of the species Homo sapiens.. Myocardium defined as following: The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the Muscle Contraction pump to generate blood flow.. Cardiac - anatomy qualifier troponin T defined as following: Troponin T, Cardiac - anatomy qualifier muscle (298 aa, ~36 kDa) is encoded by the human TNNT2 gene. This Protein Info plays a role in Cardiac - anatomy qualifier muscle contraction.. Dilated Cardiomyopathy defined as following: Cardiomyopathy which is characterized by dilation and Muscle Contraction dysfunction of the left and right ventricles. It may be idiopathic, or it may result from a myocardial infarction, myocardial infection, or alcohol abuse. It is a cause of congestive Congestive Chest>Heart failure.. intermediate filament Protein Info defined as following: Filaments 7-11 nm in diameter found in the cytoplasm of all cells. Many specific proteins belong to this group, e.g., CEREBELLAR ATAXIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND DYSEQUILIBRIUM SYNDROME 1 Protein Info, human, vimentin, prekeratin, decamin, skeletin, neurofilin, neurofilament Protein Info, and glial fibrillary acid Protein Info..", "label": "yes"} {"original_question": "Is there a phylogenetic analysis for HIV?", "id": "converted_694", "sentence1": "Is there a phylogenetic analysis for HIV Infections?", "sentence2": "The results of Bursting sensation quality and phylogenetic analysis suggested that the C. neoformans var. grubii strains could be separated into three nonredundant evolutionary groups (Bursting sensation quality group 1 to group 3). , Phylogenetic trees were constructed to evaluate the relationships between the variants, We analyzed Polish language (protease/reverse transcriptase) DNA Sequence from 135 newly diagnosed HIV Infections Infections-1-infected patients during the years 2009-2011. For phylogenetic relationships, DNA Sequence were aligned to the most recent reference data set from the Los Alamos database using BioEdit (version 7.1.3). The resulting alignment was analyzed with the Phylip package (version 3.67) building a neighbor-joining tree based on the Kimura two-parameter substitution model, . Phylogenetic analysis of gag Genes were then performed using the MEGA 3.1 software, the Genes distances were calculated by Distance program. There were three different HIV Infections Infections-1 subtypes including Deciduous maxillary right first molar tooth, CRF01-AE and CRF07-BC present among twenty four MSMs in Zhengzhou, Phylogenetic analysis showed interpatient and intrapatient clustering of LTR nucleotide DNA Sequence., We evaluated the risk factors for intrafamilial transmission of HIV Infections Infections-1 infection through qualitative epidemiology following Polish language and env Genes sequencing and phylogenetic analysis, Phylogenetic analysis has shown that the Siberian 10.RU.6637 isolate displays the highest Sequence - ParameterizedDataType identity to the HIV Infections Infections-1 subtype AG forms circulating in Uzbekistan, Phylogenetic analysis showed that the evolutionary relationship of Env between HIV Infections Infections and SIV was the closest and they appeared to descend from a common ancestor, and the relationship of HIV Infections Infections and Infectious Anemia Virus, Equine was the furthest, Dentinogenesis Imperfecta was confirmed when maximum Sequence - ParameterizedDataType divergence was excessive and supported by phylogenetic analysis, (HIV Infections Infections-1) dual infection (Dentinogenesis Imperfecta) has been associated with decreased CD4 T-cell counts and increased viral loads; however, the frequency of intrasubtype Dentinogenesis Imperfecta is poorly understood., The aim of this study was to investigate the phylogenetic relationships of HIV Infections Infections-1 subtype C strains from Bangladesh and related strains from other countries, and thereby clarify when and from where subtype C was introduced in the country and how it subsequently spread within Bangladesh, This study characterized HCV genotype 5 DNA Sequence from South Africa, including six near full-length genomes, as well as the E1 region from an additional 12 genotype 5 samples. Phylogenetic analysis of these near full-length genome DNA Sequence revealed that all genotype 5 DNA Sequence formed a close cluster with high bootstrap support, The evolutionary history of the Deciduous maxillary right first molar tooth subregion was not as clear as the C subregion, as the short length of this region yielded poor phylogenetic results, Finally, a phylogenetic tree was constructed to elucidate the observed pattern of HIV Infections Infections TDR[SEP]Relations: dentinogenesis imperfecta has relations: disease_phenotype_positive with Abnormality of the dental root, disease_phenotype_positive with Abnormality of the dental root, disease_phenotype_positive with Short dental roots, disease_phenotype_positive with Short dental roots, disease_phenotype_positive with Autosomal dominant inheritance, disease_phenotype_positive with Autosomal dominant inheritance, disease_protein with DSPP, disease_protein with DSPP, disease_phenotype_positive with Persistence of primary teeth, disease_phenotype_positive with Persistence of primary teeth. Definitions: Genes defined as following: A category of nucleic acid DNA Sequence that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. DNA Sequence defined as following: The Sequence - ParameterizedDataType of nucleotide residues along a DNA chain.. Deciduous maxillary right first molar tooth defined as following:

Deciduous maxillary right first molar tooth; Universal designation Deciduous maxillary right first molar tooth; ISO designation 54

. Infectious Anemia Virus, Equine defined as following: A species of LENTIVIRUS, subgenus equine lentiviruses (LENTIVIRUSES, EQUINE), causing acute and chronic infection in horses. It is transmitted mechanically by biting flies, mosquitoes, and midges, and iatrogenically through unsterilized equipment. Chronic infection often consists of acute episodes with remissions.. Dentinogenesis Imperfecta defined as following: An autosomal dominant disorder of tooth development characterized by opalescent dentin resulting in discoloration of the teeth. The dentin develops poorly with low mineral content while the pulp canal is obliterated.. gag Genes defined as following: DNA DNA Sequence that form the coding region for proteins associated with the viral core in retroviruses. gag is short for group-specific antigen.. Polish language defined as following: An Indo-European West Slavic language spoken primarily in Poland as the native language of the Poles.. HIV Infections defined as following: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS)..", "label": "yes"} {"original_question": "Is p100 the precursor protein molecule of the NF-kappaB transcription factor subunit p50?", "id": "converted_1329", "sentence1": "Is TPX2 protein, human the precursor protein molecule of the NF-kappaB transcription factor subunit Pattern ERG P50?", "sentence2": "We previously reported that alymphoplasia (aly/aly) CASP14 gene, which have a natural loss-of-function mutation in the Nik gene, which encodes a MAP Kinase Kinase Kinase essential for the processing of TPX2 protein, human to GTF2H4 gene in the alternative nuclear factor-κB (NF-κB) pathway, show mild osteopetrosis with an increase in several parameters of bone formation: , Proteolytic processing of the nuclear factor (NF)-kappaB2 precursor protein TPX2 protein, human generates the active NF-kappaB2 subunit GTF2H4 gene, which in turn transcriptionally up-regulates TPX2 protein, human expression. , The Mammals Rel/NF-kappaB family of TRANSCRIPTION FACTOR, including RELA protein, human, REL wt Allele, RELB gene, NF-kappaB1 (Pattern ERG P50 and its precursor Enhancer of Filamentation 1), and NF-kappaB2 (GTF2H4 gene and its precursor TPX2 protein, human), plays a central role in the immune system by regulating several processes ranging from the development and survival of Specimen Source Codes - Lymphocytes and Lymphoid organ structure to the control of immune responses and malignant transformation., NF-kappaB functions as a hetero- or homo-dimer which can be formed from five NF-kappaB subunits, NF-kappaB1 (Pattern ERG P50 and its precursor Enhancer of Filamentation 1), NF-kappaB2 (GTF2H4 gene and its precursor TPX2 protein, human), RELA protein, human (synaptotagmin synaptotagmin p65), RELB gene and REL wt Allele., The non-canonical pathway based on processing of NF-kappaB2 precursor protein TPX2 protein, human to generate GTF2H4 gene plays a critical role in controlling B cell function and Lymphoid organogenesis., Processing of NF-kappaB2 precursor protein TPX2 protein, human to generate GTF2H4 gene is tightly controlled, which is important for proper function of NF-kappaB., Processing of NF-kappa B2 precursor protein TPX2 protein, human to generate GTF2H4 gene is tightly regulated. , Processing of the NF-kappaB2 precursor protein TPX2 protein, human to generate GTF2H4 gene is an important step of NF-kappaB regulation., Targeted disruption of the Rel/NF-kappaB family members NF-kappaB2, encoding TPX2 protein, human/GTF2H4 gene, and RELB gene in CASP14 gene results in anatomical defects of secondary Lymphoid tissues., Here, we show that in Therapeutic gamma delta T-Specimen Source Codes - Lymphocytes infected with the human T-cell leukemia virus (Human T-lymphotropic virus 2), IKKalpha is targeted to a novel signaling pathway that mediates processing of the nfkappab2 precursor protein TPX2 protein, human, resulting in active production of the NF-kappaB subunit, GTF2H4 gene., nfkb2 encodes two members of the NF-kappa B/Rel family of proteins: GTF2H4 gene and TPX2 protein, human. The TPX2 protein, human polypeptide has been proposed to serve as a precursor of GTF2H4 gene, which corresponds to the N-terminal half of TPX2 protein, human., In most Cells, small amounts of GTF2H4 gene are produced relative to the levels of TPX2 protein, human, unlike the usually balanced production of nfkb1-derived Pattern ERG P50 and Enhancer of Filamentation 1. , The alternative or second pathway proceeded via NF-kappaB-inducing MAP Kinase Kinase Kinase (NIK)-, IKKalpha-, and protein synthesis-dependent processing of the inhibitory NF-kappaB2 TPX2 protein, human precursor protein to the GTF2H4 gene form and resulted in a delayed but sustained activation of primarily RELB gene-containing NF-kappaB dimers., In one exceptional case, generation of the Pattern ERG P50 subunit of the transcriptional regulator NF-kappaB, the precursor protein Enhancer of Filamentation 1 is processed in a limited manner: the N-terminal domain yields the Pattern ERG P50 subunit, whereas the C-terminal domain is degraded, Proteolytic processing of the Enhancer of Filamentation 1 precursor (NF-kappa B1) generates the Pattern ERG P50 subunit of NF-kappa B, Enhancer of Filamentation 1 (NFKB1 gene gene) acts in a dual way as a cytoplasmic IkappaB molecule and as the source of the NF-kappaB Pattern ERG P50 subunit upon processing, The Pattern ERG P50 subunit of NF-kappa B is derived from the amino terminus of a 105 kilodalton precursor, Regulation of the transcription factor NF-kappaB involves proteasome-mediated processing of the NF-kappaB1 Enhancer of Filamentation 1 precursor protein, which generates the Pattern ERG P50 subunit of NF-kappaB, This effort identified NF-kappaB1 (Enhancer of Filamentation 1), an atypical IkappaB molecule and the precursor of NF-kappaB subunit Pattern ERG P50, NF-kappaB functions as a hetero- or homo-dimer which can be formed from five NF-kappaB subunits, NF-kappaB1 (Pattern ERG P50 and its precursor Enhancer of Filamentation 1), NF-kappaB2 (GTF2H4 gene and its precursor TPX2 protein, human), RELA protein, human (synaptotagmin synaptotagmin p65), RELB gene and REL wt Allele, The Mammals Rel/NF-kappaB family of TRANSCRIPTION FACTOR, including RELA protein, human, REL wt Allele, RELB gene, NF-kappaB1 (Pattern ERG P50 and its precursor Enhancer of Filamentation 1), and NF-kappaB2 (GTF2H4 gene and its precursor TPX2 protein, human), plays a central role in the immune system by regulating several processes ranging from the development and survival of Specimen Source Codes - Lymphocytes and Lymphoid organ structure to the control of immune responses and malignant transformation[SEP]Relations: NF-kappaB Decoy has relations: drug_protein with NFKB1 gene, drug_protein with NFKB1 gene, drug_protein with NFKB2, drug_protein with NFKB2. transcription factor binding has relations: molfunc_protein with NFIA, molfunc_protein with NFIA, molfunc_protein with TP53, molfunc_protein with TP53. RELB has relations: bioprocess_protein with NIK/NF-kappaB signaling, bioprocess_protein with NIK/NF-kappaB signaling. Definitions: TPX2 protein, human defined as following: Targeting protein for Xklp2 (747 aa, ~86 kDa) is encoded by the human TPX2 gene. This protein plays a role in the formation of mitotic spindles.. Therapeutic gamma delta T-Specimen Source Codes - Lymphocytes defined as following: A subset of therapeutic autologous T-Specimen Source Codes - Lymphocytes that express a T-cell receptor (TCR) composed of one gamma chain and one delta chain, with potential immunomodulating and antineoplastic activities. Upon administration of the therapeutic gamma delta T-Specimen Source Codes - Lymphocytes, these Cells secrete interferon-gamma (IFN-g), and exert direct killing of tumor Cells. In addition, these Cells activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against tumor Cells. Gamma delta T-Specimen Source Codes - Lymphocytes play a key role in the activation of the immune system and do not require major histocompatibility complex (MHC)-mediated antigen presentation to exert their cytotoxic effect.. RELA protein, human defined as following: Transcription factor synaptotagmin p65 (551 aa, ~60 kDa) is encoded by the human RELA gene. This protein is involved in the modulation of both signaling and gene expression.. REL wt Allele defined as following: Human REL wild-type allele is located within 2p13-p12 and is approximately 41 kb in length. This allele, which encodes proto-oncogene REL wt Allele protein, is involved in the activation of transcription, differentiation and lymphopoiesis.. RELB gene defined as following: This gene is involved in transcriptional regulation of immune processes.. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.. MAP Kinase Kinase Kinase defined as following: Mitogen-activated protein MAP Kinase Kinase Kinase MAP Kinase Kinase Kinase kinases (MAPKKKs) are serine-threonine protein kinases that initiate protein MAP Kinase Kinase Kinase signaling cascades. They phosphorylate MITOGEN-ACTIVATED PROTEIN KINASE KINASES; (MAPKKs) which in turn phosphorylate MITOGEN-ACTIVATED PROTEIN KINASES; (MAPKs).. Human T-lymphotropic virus 2 defined as following: A strain of PRIMATE T-LYMPHOTROPIC VIRUS 2 that can transform normal T-Specimen Source Codes - Lymphocytes and can replicate in both T- and B-cell lines. The virus is related to but distinct from Human T-lymphotropic virus 2-1.. NF-kappa B defined as following: Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA.. Enhancer of Filamentation 1 defined as following: Enhancer of filamentation 1 (834 aa, ~93 kDa) is encoded by the human NEDD9 gene. This protein plays a role in the docking of kinases and adaptor molecules that are involved in integrin-mediated signaling pathways.. GTF2H4 gene defined as following: This gene plays a role in both mRNA synthesis from DNA templates and nucleotide excision repair.. NFKB1 gene defined as following: This gene is involved in the regulation of apoptosis, signal transduction and gene transcription.. Lymphoid tissues defined as following: Specialized tissues that are components of the lymphatic system. They provide fixed locations within the body where a variety of LYMPHOCYTES can form, mature and multiply. The Lymphoid tissues are connected by a network of LYMPHATIC VESSELS.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process..", "label": "no"} {"original_question": "Has dupilumab been FDA approved for atopic dermatitis?", "id": "converted_4169", "sentence1": "Has dupilumab been FDA approved for Dermatitis, Atopic?", "sentence2": "Recent advances and understanding of the pathogenesis of cytarabine/daunorubicin protocol have resulted in new therapies that target specific pathways with increased efficacy and the potential for less systemic side effects. New FDA-approved therapies for cytarabine/daunorubicin protocol are crisaborole and dupilumab. , In March of 2017, the United States Food and Drug Administration (FDA) approved dupilumab for the treatment of moderate-to-severe Dermatitis, Atopic in adults that is uncontrolled with topical medications, becoming the first biologic agent approved to treat this chronic skin condition., dupilumab is the first US FDA approved biologic for treatment of Dermatitis, Atopic., dupilumab is the first biological treatment approved for moderate-to-severe Dermatitis, Atopic (cytarabine/daunorubicin protocol).[SEP]Relations: dupilumab has relations: drug_drug with Tarextumab, drug_drug with Tarextumab, drug_drug with Dusigitumab, drug_drug with Dusigitumab, drug_drug with Afelimomab, drug_drug with Afelimomab, drug_drug with IGN311, drug_drug with IGN311, drug_drug with Opicinumab, drug_drug with Opicinumab. Definitions: Dermatitis, Atopic defined as following: A pruritic papulovesicular dermatitis occurring as a reaction to many endogenous and exogenous agents (Dorland, 27th ed).. dupilumab defined as following: A recombinant human monoclonal immunoglobulin G4 (IgG4) antibody directed against the alpha chain of the interleukin-4 receptor (IL-4R alpha) with potential immunomodulatory activities. Upon injection, dupilumab selectively binds to the IL-4R alpha chain. This disrupts IL-4/IL-13 signaling and prevents the activation of downstream pathways that mediate type 2 inflammation and may potentially inhibit tumor cell proliferation, survival, and metastasis. IL-4 and IL-13 receptors are present on the surface of numerous cells involved in the pathophysiology of type-2 helper T-cell (Th2) allergic responses, including B-lymphocytes, eosinophils, dendritic cells (DCs), monocytes, macrophages, basophils, keratinocytes, bronchial epithelial cells, endothelial cells, fibroblasts, and airway smooth muscle cells. Additionally, both IL-4 and IL-13 receptors are overexpressed in a variety of cancers and IL-4 and IL-13 and may serve as biomarkers for cancer aggressiveness. IL-4 and IL-13 are thought to be key regulatory cytokines in the tumor microenvironment (TME) and may play a role in the activation of tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs) that mediate tumor cell survival..", "label": "yes"} {"original_question": "Is polyadenylation a process that stabilizes a protein by adding a string of Adenosine residues to the end of the molecule?", "id": "converted_2542", "sentence1": "Is Polyadenylation a process that stabilizes a protein by adding a string of Adenosine residues to the end of the molecule?", "sentence2": "The addition of poly(A) tails to eukaryotic nuclear mRNAs promotes their stability, export to the Cytoplasm and translation. , Most eukaryotic Genes express mRNAs with alternative Polyadenylation sites at their 3' ends, Polyadenylation is the non-template addition of adenosine Nucleotides at the 3'-end of RNA, which occurs after transcription and generates a Poly(A) Tail up to 250-300 Nucleotides long., Polyadenylation is a process of endonucleolytic cleavage of the RNA, Messenger, followed by addition of up to 250 adenosine residues to the 3' end of the RNA, Messenger., Plant Mitochondrial Inheritance polyadenylated mRNAs are degraded by a 3'- to 5'-exoribonuclease activity, which proceeds unimpeded by stable secondary structures., We show that a 3'- to 5'-exoribonuclease activity is responsible for the preferential degradation of polyadenylated mRNAs as compared with non-polyadenylated mRNAs, and that 20-30 adenosine residues constitute the optimal Poly(A) Tail size for inducing degradation of RNA substrates in vitro., The diversity of Polyadenylation sites suggests that RNA, Messenger Polyadenylation in prokaryotes is a relatively indiscriminate process that can occur at all RNA, Messenger's 3'-ends and does not require specific Consensus Sequence as in Eukaryota., Polyadenylation of premessenger RNAs occurs posttranscriptionally in the Cell Nucleus of Eukaryotic Cells by cleavage of the precursor and polymerization of adenosine residues., However, under certain conditions, poly(A) tracts may lead to RNA, Messenger stabilization., From these results, we propose that in plant Mitochondria, poly(A) tails added at the 3' ends of mRNAs promote an efficient 3'- to 5'- degradation process.., Auxiliary downstream elements are required for efficient Polyadenylation of mammalian pre-mRNAs., Transcription in these Cells is polycistronic. Tens to hundreds of protein-coding Genes of unrelated function are arrayed in long clusters on the same DNA strand. Polycistrons are cotranscriptionally processed by trans-splicing at the 5' end and Polyadenylation at the 3' end, generating monocistronic units ready for degradation or translation, We have devised a simple chromatographic procedure which isolates five Polyadenylation Factors that are required for Polyadenylation of eukaryotic RNA, Messenger. , During mammalian oocyte maturation, protein synthesis is mainly controlled through cytoplasmic Polyadenylation of stored maternal mRNAs., Identification and characterization of a polyadenylated small RNA (s-poly A+ RNA) in dinoflagellates., Thus, Polyadenylation seems to be a major component of the RNA editing machinery that affects overlapping Genes in animal Mitochondria., Pre-RNA, Messenger 3'-end processing, the process through which almost all eukaryotic mRNAs acquire a Poly(A) Tail is generally inhibited during the cellular DNA damage, Almost all eukaryotic mRNAs possess 3' ends with a Poly A (poly(A)) tail., We previously demonstrated, by limited Mutagenesis Procedure, that conserved sequence elements within the 5' end of influenza virus virion RNA (vRNA) are required for the Polyadenylation of RNA, Messenger in vitro., Polyadenylation of RNA, Messenger precursors by poly(A) polymerase depends on two specificity factors and their recognition sequences, The majority of eukaryotic pre-mRNAs are processed by 3'-end cleavage and Polyadenylation, Formation of RNA, Messenger 3' termini involves cleavage of an RNA, Messenger precursor and Polyadenylation of the newly formed end. , The Polyadenylation of RNA is a near-universal feature of RNA metabolism in Eukaryota., The mechanism of RNA degradation in Escherichia coli involves endonucleolytic cleavage, Polyadenylation of the cleavage product by poly(A) polymerase, and exonucleolytic degradation by the exoribonucleases, , The addition of poly(A)-tails to RNA is a process common to almost all Organism. , The addition of poly(A) tails to RNA is a phenomenon common to all Organism examined so far. , The addition of poly(A)-tails to RNA is a phenomenon common to almost all Organism. , Polyadenylation contributes to the destabilization of bacterial RNA, Messenger.[SEP]Relations: RNA Polyadenylation has relations: bioprocess_protein with TENT4A, bioprocess_protein with TENT4A, bioprocess_protein with TENT4A, bioprocess_protein with TENT4A, bioprocess_protein with PAPOLA, bioprocess_protein with PAPOLA, bioprocess_protein with PAPOLA, bioprocess_protein with PAPOLA, bioprocess_protein with PAPOLG, bioprocess_protein with PAPOLG. Definitions: Mitochondria defined as following: Semiautonomous, self-reproducing organelles that occur in the Cytoplasm of all Cells of most, but not all, Eukaryota. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon Genes within the Cell Nucleus of the Cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed). Mutagenesis Procedure defined as following: Production of genetic alterations by any technique, including chemicals, radiation, recombination, or other molecular biology methods.. adenosine defined as following: A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.. RNA, Messenger defined as following: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the Cell Nucleus and must be exported to the Cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the Poly(A) Tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the Cell Nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the Cytoplasm.. Eukaryotic Cells defined as following: Cells of the higher Organism, containing a true Cell Nucleus bounded by a nuclear membrane.. Consensus Sequence defined as following: A theoretical representative nucleotide or amino acid sequence in which each nucleotide or amino acid is the one which occurs most frequently at that site in the different sequences which occur in nature. The phrase also refers to an actual sequence which approximates the theoretical consensus. A known CONSERVED SEQUENCE set is represented by a consensus sequence. Commonly observed supersecondary protein structures (AMINO ACID MOTIFS) are often formed by conserved sequences.. Nucleotides defined as following: The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed). Cytoplasm defined as following: The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990). Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of Organism.. Polyadenylation defined as following: The enzymatic addition of a sequence of adenylyl residues at the 3' end of an RNA molecule. [GOC:jl]. Eukaryota defined as following: Organism or Cells with a Cell Nucleus separated from the Cytoplasm by a two membrance nuclear envelope and compartmentalization of function into distinct cytoplasmic organelles.. Escherichia coli defined as following: A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.. Organism defined as following: A living entity.. Cell Nucleus defined as following: Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one Cell Nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). Poly A defined as following: A group of adenine ribonucleotides in which the phosphate residues of each adenine ribonucleotide act as bridges in forming diester linkages between the ribose moieties.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of Cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Cells defined as following: The fundamental, structural, and functional units or subunits of living Organism. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. RNA, Messenger precursor defined as following: A primary RNA transcript synthesized from a DNA template in eukaryotic nuclei which is post-transcriptionally modified and spliced to produce a mature RNA, Messenger.. Mitochondrial Inheritance defined as following: The distribution of Mitochondria, including the Mitochondrial Inheritance genome, into daughter Cells after mitosis or meiosis, mediated by interactions between Mitochondria and the cytoskeleton. [GOC:mcc, PMID:10873824, PMID:11389764]. protein defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the protein occurs, and references to homologous proteins in other species.. Adenosine defined as following: A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter..", "label": "no"} {"original_question": "Does BNP increase after intensive exercise in athletes?", "id": "converted_44", "sentence1": "Does nesiritide increase after intensive exercise in athletes?", "sentence2": "N-Terminal Fragment Brain Natriuretic Protein, human was significantly elevated postexercise in both adults and adolescents and remained above baseline at 24 h in both groups., N-Terminal Fragment Brain Natriuretic Protein, human concentrations increased significantly (28 +/- 17.1 vs 795 +/- 823 ng x L, P < 0.05), whereas postrace Troponin T, Cardiac Muscle were elevated in just five athletes (20%)., [N-Terminal Fragment Brain Natriuretic Protein, human] was observed immediately after the marathon (median [N-Terminal Fragment Brain Natriuretic Protein, human] before: 39.6 pg ml(-1), after: 138.6 pg ml(-1), p=0.003) with a further increase on day one. [nesiritide] did not increase immediately after the marathon but increased on day one (median [nesiritide] before: 15 pg ml(-1), day one: 27.35 pg ml(-1), p=0.006)., Pro-nesiritide was significantly increased immediately post-race (27+/-21 vs 7+/-2 pmol/L pre-race, P < or = 0.007), which 12-24 h later, decreased to 19+/-14 pmol/L (P = 0.07 vs pre-race)., The relatively high Amino-terminal pro-brain natriuretic peptide levels after active recovery when psychophysical stress is higher, because of cycling and cold water immersion, suggest that not only endurance exercise, but also strenuous, stressful short exercise can induce an increase in Amino-terminal pro-brain natriuretic peptide concentrations., Running a marathon significantly increases N-Terminal Fragment Brain Natriuretic Protein, human levels in healthy adults. This increase could be partially attributed to cardiac stress., Increases in Amino-terminal pro-brain natriuretic peptide can be found in a major part of obviously healthy athletes after prolonged strenuous exercise. The release of nesiritide during and after exercise may not result from myocardial damage but may have cytoprotective and growth-regulating effects. The different nature of exercise-induced increases in nesiritide and Cardiac troponin measurement has to be elucidated in the future., In healthy cyclists, transient increases in N-Terminal Fragment Brain Natriuretic Protein, human and Troponin T, Cardiac Muscle are more likely to reflect cardiac fatigue than injury., The rise in nesiritide in older athletes may reflect a reversible, mainly diastolic left ventricular dysfunction. , Plasma nesiritide concentrations were higher in both the judo and marathon groups than in controls, and positively correlated with LV mass as well as with deceleration time., Such exercise significantly increased Atrial Natriuretic Factor and nesiritide levels in healthy men, and the increases could be partially attributed to myocardial damage during the race.[SEP]Relations: Nesiritide has relations: drug_effect with Ventricular extrasystoles, drug_effect with Ventricular extrasystoles, contraindication with hypertrophic cardiomyopathy, contraindication with hypertrophic cardiomyopathy, drug_effect with Renal insufficiency, drug_effect with Renal insufficiency, drug_effect with Ventricular arrhythmia, drug_effect with Ventricular arrhythmia. Abnormal A-type atrial natriuretic peptide level has relations: phenotype_phenotype with Increased circulating A-type natriuretic peptide level, phenotype_phenotype with Increased circulating A-type natriuretic peptide level. Definitions: Troponin T, Cardiac Muscle defined as following: Troponin T, cardiac muscle (298 aa, ~36 kDa) is encoded by the human TNNT2 gene. This protein plays a role in cardiac muscle contraction.. N-Terminal Fragment Brain Natriuretic Protein, human defined as following: N-terminal fragment brain natriuretic protein (76 aa, ~9 kDa) is encoded by the human NPPB gene. This protein is a marker for cardiac failure.. nesiritide defined as following: A recombinant version of the cardiac neurohormone, human B-type natriuretic peptide (hBNP) produced by the ventricular myocardium. Nesiritide binds to natriuretic peptide receptors on vascular smooth muscle and endothelial cells, through which it triggers guanylate cyclase dependent signal transduction resulting in increase of intracellular concentrations of cGMP. This leads to smooth muscle cell relaxation causing arterial and venous dilatation.. Atrial Natriuretic Factor defined as following: A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS..", "label": "yes"} {"original_question": "Is EZH2 associated with prostate cancer?", "id": "converted_1231", "sentence1": "Is ezh2 protein, Homo sapiens associated with Pelvis>Prostate Primary malignant neoplasm?", "sentence2": "The role of ezh2 protein, Homo sapiens in the regulation of the activity of matrix metalloproteinases in Pelvis>Prostate Primary malignant neoplasm cells, ezh2 protein, Homo sapiens plays an active role in this process by repressing the expression of TIMP2 Genes Genes and TIMP3 Genes Genes in Pelvis>Prostate Primary malignant neoplasm cells, The TIMP genes are derepressed by knockdown of ezh2 protein, Homo sapiens expression in Homo sapiens Pelvis>Prostate Primary malignant neoplasm cells but repressed by overexpression of ezh2 protein, Homo sapiens in benign Homo sapiens Pelvis>Prostate epithelial cells., Overexpression of ezh2 protein, Homo sapiens confers an invasive phenotype on benign Pelvis>Prostate epithelial cells, ezh2 protein, Homo sapiens knockdown markedly reduces the proteolytic activity of Matrix Metalloproteinase 9, thereby decreasing the invasive activity of Pelvis>Prostate Primary malignant neoplasm cells, he transcriptional repression of the TIMP genes by ezh2 protein, Homo sapiens may be a major mechanism to shift the MMPs/TIMPs balance in favor of Matrix Metalloproteinases activity and thus to promote MMRN1 wt Allele degradation and subsequent invasion of Pelvis>Prostate Primary malignant neoplasm cells., Expression levels of the novel Specimen Source Codes - Specimen Source Codes - tumor and metastasis suppressor Raf-1 kinase inhibitor protein (PEBP1 Genes) have been shown to correlate negatively with those of ezh2 protein, Homo sapiens in Breast and Pelvis>Prostate Cultured Cell Line as well as in clinical Primary malignant neoplasm tissues, Polycomb protein ezh2 protein, Homo sapiens regulates Specimen Source Codes - Specimen Source Codes - tumor invasion via the transcriptional repression of the metastasis suppressor PEBP1 Genes in Breast and Pelvis>Prostate Primary malignant neoplasm, Enhancer of transcription of transcription of zeste homolog 2 (ezh2 protein, Homo sapiens), which encodes the histone methyltransferase component of the polycomb repressive complex 2 (Polycomb Repressive Complex 2), is overexpressed widely in Breast and Pelvis>Prostate Malignant Neoplasms and epigenetically silences Specimen Source Codes - Tumor Suppressor Genes, However, the roles and underlying mechanisms of ezh2 protein, Homo sapiens in Pelvis>Prostate Primary malignant neoplasm stem cells (PCSCs) remain unknown, c-myc Genes, ezh2 protein, Homo sapiens and p27 Enzyme Inhibitor Enzyme Inhibitor were defined to modulate the behavior of Pelvis>Prostate Primary malignant neoplasm with pro-tumoral or anti-tumoral effects and had ability in predicting Pelvis>Prostate Primary malignant neoplasm progression, but the research of their co-expression value of prognosis is rarely, Composite index of c-myc Genes, ezh2 protein, Homo sapiens, and p27 Enzyme Inhibitor Enzyme Inhibitor can be valued as powerful prognosis parameter for intermediate-risk Pelvis>Prostate Primary malignant neoplasm patients after the surgery, and postoperative adjuvant therapy can be adopted accordingly., ezh2 protein, Homo sapiens, an epigenetic driver of Pelvis>Prostate Primary malignant neoplasm., The histone methyltransferase ezh2 protein, Homo sapiens has been in the limelight of the field of Primary malignant neoplasm epigenetics for a decade now since it was first discovered to exhibit an elevated expression in metastatic Pelvis>Prostate Primary malignant neoplasm, a comprehensive overview of ezh2 protein, Homo sapiens in the context of Pelvis>Prostate Primary malignant neoplasm, ezh2 protein, Homo sapiens dependent Histone H3 Trimethyl Lys28 is involved in epigenetic silencing of ID4 protein, Homo sapiens protein, Homo sapiens in Pelvis>Prostate Primary malignant neoplasm, ChIP data on Pelvis>Prostate Primary malignant neoplasm tissue specimens and Cultured Cell Line suggested ezh2 protein, Homo sapiens occupancy and H3K27Me3 marks on the ID4 protein, Homo sapiens protein, Homo sapiens promoter, Collectively, our data indicate a Polycomb Repressive Complex 2 dependent mechanism in ID4 protein, Homo sapiens protein, Homo sapiens promoter silencing in Pelvis>Prostate Primary malignant neoplasm through recruitment of ezh2 protein, Homo sapiens and a corresponding increase in H3K27Me3. Increased ezh2 protein, Homo sapiens but decreased ID4 protein, Homo sapiens protein, Homo sapiens expression in Pelvis>Prostate Primary malignant neoplasm strongly supports this model., The histone methyltransferase enhancer of zeste homolog 2 (ezh2 protein, Homo sapiens) has recently attracted considerable attention because of its dysregulation in Pelvis>Prostate Primary malignant neoplasm (Patient-Controlled Analgesia) and its important function in Patient-Controlled Analgesia development. , Autoregulatory feedback loop of ezh2 protein, Homo sapiens/miR-200c/E2F3 as a driving force for Pelvis>Prostate Primary malignant neoplasm development, Amounts of both ezh2 protein, Homo sapiens messenger RNA and ezh2 protein, Homo sapiens protein are increased in metastatic Pelvis>Prostate Primary malignant neoplasm; in addition, clinically localized Pelvis>Prostate Malignant Neoplasms that express higher concentrations of ezh2 protein, Homo sapiens show a poorer prognosis., The data show that amplification of the ezh2 protein, Homo sapiens Genes is rare in early Pelvis>Prostate Primary malignant neoplasm, whereas a fraction of late-stage tumors contains the Genes amplification leading to the overexpression of the Genes, thus indicating the importance of ezh2 protein, Homo sapiens in the progression of Pelvis>Prostate Primary malignant neoplasm., ezh2 protein, Homo sapiens expression in Pelvis>Prostate Primary malignant neoplasm correlates with progression to hormone-refractory and metastatic disease, but it is unknown whether ezh2 protein, Homo sapiens plays a specific role in the acquisition of an advanced Pelvis>Prostate Primary malignant neoplasm phenotype., Although prior studies in Pelvis>Prostate Primary malignant neoplasm have revealed a number of possible mechanisms of ezh2 protein, Homo sapiens upregulation, these changes cannot account for the overexpression ezh2 protein, Homo sapiens in many primary Pelvis>Prostate Malignant Neoplasms, nor in most cases of high grade Prostatic Intraepithelial Neoplasias., As a result, five ezh2 protein, Homo sapiens peptides recognized by immunoglobulin G (ezh2 protein, Homo sapiens 120-128, ezh2 protein, Homo sapiens 165-174, ezh2 protein, Homo sapiens 569-577, ezh2 protein, Homo sapiens 665-674, and ezh2 protein, Homo sapiens 699-708) were frequently detected in the plasma of Pelvis>Prostate Primary malignant neoplasm patients., Thus, dysregulated expression of ezh2 protein, Homo sapiens may be involved in the progression of Pelvis>Prostate Primary malignant neoplasm, as well as being a marker that distinguishes indolent Pelvis>Prostate Primary malignant neoplasm from those at risk of lethal progression., These results link two major pathways in Pelvis>Prostate Primary malignant neoplasm by providing two additional and complementary Myc-regulated mechanisms by which ezh2 protein, Homo sapiens upregulation occurs and is enforced during prostatic carcinogenesis., ezh2 protein, Homo sapiens promotes Pelvis>Prostate Primary malignant neoplasm cell proliferation and invasiveness., ezh2 protein, Homo sapiens promotes proliferation and invasiveness of Pelvis>Prostate Primary malignant neoplasm cells., The Polycomb Group protein ezh2 protein, Homo sapiens is implicated in Pelvis>Prostate Primary malignant neoplasm progression., The polycomb group protein ezh2 protein, Homo sapiens is involved in progression of Pelvis>Prostate Primary malignant neoplasm., Mutation screen and association study of ezh2 protein, Homo sapiens as a susceptibility Genes for aggressive Pelvis>Prostate Primary malignant neoplasm., Expression changes in ezh2 protein, Homo sapiens, but not in BMI-1, Sirtuin 1, DNMT1 wt Allele wt Allele or DNMT3B protein, Homo sapiens protein, Homo sapiens are associated with DNA methylation changes in Pelvis>Prostate Primary malignant neoplasm., The Genes for polycomb group protein enhancer of zeste homolog 2 (ezh2 protein, Homo sapiens) is amplified in late-stage Pelvis>Prostate Primary malignant neoplasm., Enhancer of transcription of transcription of zeste homolog 2 (ezh2 protein, Homo sapiens), a kind of Transcription Repressor/Corepressor, is reportedly over-expressed in metastatic Pelvis>Prostate Primary malignant neoplasm., IgGs reactive to three ezh2 protein, Homo sapiens peptides (ezh2 protein, Homo sapiens-243 to -252, ezh2 protein, Homo sapiens-291 to -299, and ezh2 protein, Homo sapiens-735 to -;742) were detected in the plasma of almost half of Pelvis>Prostate Primary malignant neoplasm patients., Amounts of both ezh2 protein, Homo sapiens messenger RNA and ezh2 protein, Homo sapiens protein are increased in metastatic Pelvis>Prostate Primary malignant neoplasm; in addition, clinically localized Pelvis>Prostate Malignant Neoplasms that express higher concentrations of ezh2 protein, Homo sapiens show a poorer prognosis., Overexpression of ezh2 protein, Homo sapiens has been associated with the invasion and progression of malignant Malignant Neoplasms, especially with the progression of Pelvis>Prostate Primary malignant neoplasm., Antigens overexpressed in metastatic Pelvis>Prostate Primary malignant neoplasm are appropriate targets in anti-Primary malignant neoplasm immunotherapy, and one candidate is the polycomb group protein enhancer of zeste homolog 2 (ezh2 protein, Homo sapiens)., Cytoplasmic ezh2 protein, Homo sapiens is expressed at low levels in benign Pelvis>Prostate epithelial cells and over-expressed in Pelvis>Prostate Primary malignant neoplasm cells. Cytoplasmic ezh2 protein, Homo sapiens expression levels correlate with nuclear ezh2 protein, Homo sapiens expression in Pelvis>Prostate Primary malignant neoplasm samples., DNMT1 wt Allele wt Allele or DNMT3B protein, Homo sapiens protein, Homo sapiens are associated with DNA methylation changes in Pelvis>Prostate Primary malignant neoplasm., ezh2 protein, Homo sapiens:CDH1 wt Allele status was statistically significantly associated with Pelvis>Prostate Primary malignant neoplasm recurrence in a training set of 103 patients (relative risk [RR] = 2.52,, a positive ezh2 protein, Homo sapiens:CDH1 wt Allele status) was the biomarker combination that was most strongly associated with the recurrence of Pelvis>Prostate Primary malignant neoplasm., PcG Proteins ezh2 protein, Homo sapiens, BMI1 protein, Homo sapiens protein, Homo sapiens, and RING1 Genes Genes are associated with adverse pathologic features and clinical Prostate-Specific Antigen recurrence of Pelvis>Prostate Primary malignant neoplasm., Immunohistochemistry results were evaluated in conjunction with clinical parameters associated with Pelvis>Prostate Primary malignant neoplasm progression,, Elevation of the chromatin repression factor enhancer of zeste homolog (ezh2 protein, Homo sapiens) is associated with progression and poor prognosis in several Homo sapiens Malignant Neoplasms including Pelvis>Prostate Primary malignant neoplasm., Various Proteins (α2-integrin, α6-integrin, Proto-Oncogene Protein c-kit, Prominin-1, Homo sapiens, ezh2 protein, Homo sapiens, OCT3/4) are associated with a Pelvis>Prostate Primary malignant neoplasm stem cell phenotype in Cultured Cell Line and Xenograft type of graft., Increased expression of ezh2 protein, Homo sapiens has been associated previously with invasive growth and aggressive clinical behavior in Pelvis>Prostate and Breast Primary malignant neoplasm,, ezh2 protein, Homo sapiens:CDH1 wt Allele status was statistically significantly associated with Pelvis>Prostate Primary malignant neoplasm recurrence after radical prostatectomy and may be useful in defining a cohort of high-risk patients., Immunohistochemistry results were evaluated in conjunction with clinical parameters associated with Pelvis>Prostate Primary malignant neoplasm progression, including Specimen Source Codes - Specimen Source Codes - tumor stage, Gleason score, and kallikrein-related peptidase 3, Homo sapiens (Prostate-Specific Antigen) level., ezh2 protein, Homo sapiens expression is associated with high proliferation rate and aggressive Specimen Source Codes - Specimen Source Codes - tumor subgroups in Cutaneous Melanoma and Malignant Neoplasms of the endometrium, Pelvis>Prostate, and Breast., Moderate or strong expression of ezh2 protein, Homo sapiens coupled with at most moderate expression of CDH1 wt Allele (i.e., a positive ezh2 protein, Homo sapiens:CDH1 wt Allele status) was the biomarker combination that was most strongly associated with the recurrence of Pelvis>Prostate Primary malignant neoplasm., Cytoplasmic ezh2 protein, Homo sapiens expression levels correlate with nuclear ezh2 protein, Homo sapiens expression in Pelvis>Prostate Primary malignant neoplasm samples.[SEP]Relations: ezh2 protein, Homo sapiens has relations: disease_protein with Pelvis>Prostate Primary malignant neoplasm, disease_protein with Pelvis>Prostate Primary malignant neoplasm, disease_protein with Pelvis>Prostate carcinoma, disease_protein with Pelvis>Prostate carcinoma, disease_protein with Breast Primary malignant neoplasm, disease_protein with Breast Primary malignant neoplasm, disease_protein with familial Pelvis>Prostate carcinoma, disease_protein with familial Pelvis>Prostate carcinoma, anatomy_protein_present with Pelvis>Prostate gland, anatomy_protein_present with Pelvis>Prostate gland. Definitions: ezh2 protein, Homo sapiens defined as following: Histone-lysine N-methyltransferase ezh2 protein, Homo sapiens (746 aa, ~85 kDa) is encoded by the Homo sapiens ezh2 protein, Homo sapiens Genes. This protein is involved in the regulation of chromatin modification.. Primary malignant neoplasm defined as following: A malignant Specimen Source Codes - tumor at the original site of growth.. BMI1 protein, Homo sapiens defined as following: Polycomb complex protein BMI-1 (326 aa, ~37 kDa) is encoded by the Homo sapiens BMI1 protein, Homo sapiens Genes. This protein is involved in transcriptional repression during embryonic development.. Pelvis>Prostate Primary malignant neoplasm defined as following: A primary or metastatic malignant Specimen Source Codes - tumor involving the Pelvis>Prostate gland. The vast majority are carcinomas.. MMRN1 wt Allele defined as following: Human MMRN1 wild-type allele is located in the vicinity of 4q22 and is approximately 75 kb in length. This allele, which encodes multimerin-1 protein, plays a role in platelet factor V/Va homeostasis.. kallikrein-related peptidase 3, Homo sapiens defined as following: Prostate-specific antigen (261 aa, ~29 kDa) is encoded by the Homo sapiens KLK3 Genes. This protein plays a role in both proteolysis and seminal fluid liquefaction.. Breast defined as following: In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.. Polycomb Repressive Complex 2 defined as following: A multisubunit polycomb protein complex that catalyzes the METHYLATION of chromosomal HISTONE H3. It works in conjunction with POLYCOMB REPRESSIVE COMPLEX 1 to effect EPIGENETIC REPRESSION.. Matrix Metalloproteinase 9 defined as following: An endopeptidase that is structurally similar to MATRIX METALLOPROTEINASE 2. It degrades GELATIN types I and V; COLLAGEN TYPE IV; and COLLAGEN TYPE V.. Prostatic Intraepithelial Neoplasias defined as following: A premalignant change arising in the prostatic epithelium, regarded as the most important and most likely precursor of prostatic adenocarcinoma. The neoplasia takes the form of an intra-acinar or ductal proliferation of secretory cells with unequivocal nuclear anaplasia, which corresponds to nuclear grade 2 and 3 invasive Pelvis>Prostate Primary malignant neoplasm.. immunoglobulin G defined as following: The major immunoglobulin isotype class in normal Homo sapiens serum. There are several isotype subclasses of immunoglobulin G, for example, IgG1, IgG2A, and IgG2B.. DNMT3B protein, Homo sapiens defined as following: DNA (cytosine-5)-methyltransferase 3B (853 aa, ~96 kDa) is encoded by the Homo sapiens DNMT3B protein, Homo sapiens Genes. This protein is involved in DNA methylation.. CDH1 wt Allele defined as following: Human CDH1 wild-type allele is located in the vicinity of 16q22.1 and is approximately 98 kb in length. This allele, which encodes cadherin-1 protein, plays a role in cell-cell adhesion and cell-matrix adhesion.. Cutaneous Melanoma defined as following: A primary melanoma arising from atypical melanocytes in the skin. Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi. Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma.. Antigens defined as following: Substances that are recognized by the immune system and induce an immune reaction.. Matrix Metalloproteinases defined as following: A family of zinc-dependent metalloendopeptidases that is involved in the degradation of EXTRACELLULAR MATRIX components.. Patient-Controlled Analgesia defined as following: Relief of PAIN, without loss of CONSCIOUSNESS, through ANALGESIC AGENTS administered by the patients. It has been used successfully to control POSTOPERATIVE PAIN, during OBSTETRIC LABOR, after BURNS, and in TERMINAL CARE. The choice of agent, dose, and lockout interval greatly influence effectiveness. The potential for overdose can be minimized by combining small bolus doses with a mandatory interval between successive doses (lockout interval).. Sirtuin 1 defined as following: A sirtuin family member found primarily in the CELL NUCLEUS. It is an NAD-dependent deacetylase with specificity towards HISTONES and a variety of Proteins involved in Genes regulation.. Malignant Neoplasms defined as following: A Specimen Source Codes - tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. DNMT1 wt Allele defined as following: Human DNMT1 wt Allele wt allele is located in the vicinity of 19p13.2 and is approximately 62 kb in length. This allele, which encodes DNA (Cytosine-5)-Methyltransferase 1, is involved in epigenetic modification of chromatin DNA and control of Genes expression.. ID4 protein, Homo sapiens defined as following: DNA-binding protein inhibitor ID-4 (161 aa, ~17 kDa) is encoded by the Homo sapiens ID4 protein, Homo sapiens Genes. This protein plays a role in transcriptional repression.. Transcription Repressor/Corepressor defined as following: Transcription Repressor/Corepressor Gene encodes Transcriptional Repressor/Corepressor, Proteins that can regulate transcription by binding to the operator and causing repression. (from Glick: Glossary of Biochemistry and Molecular Biology). Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. TIMP3 Genes defined as following: This Genes plays a role in the degradation of the extracellular matrix. It is also involved in the induction of apoptosis and inhibition of angiogenesis.. TIMP2 Genes defined as following: This Genes is involved in the degradation of the extracellular matrix. It also plays a role in the suppression of endothelial cell proliferation.. Cultured Cell Line defined as following: Established cell cultures that have the potential to propagate indefinitely.. Proto-Oncogene Protein c-kit defined as following: A protein-tyrosine kinase receptor that is specific for STEM CELL FACTOR. This interaction is crucial for the development of hematopoietic, gonadal, and pigment stem cells. Genetic mutations that disrupt the expression of PROTO-ONCOGENE PROTEINS C-KIT are associated with PIEBALDISM, while overexpression or constitutive activation of the c-kit protein-tyrosine kinase is associated with tumorigenesis.. Prominin-1, Homo sapiens defined as following: Prominin-1 (865 aa, ~97 kDa) is encoded by the Homo sapiens PROM1 Genes. This protein may play a role in hematopoiesis, but an exact function has yet to be elucidated. The protein has been implicated in Specimen Source Codes - tumor pathogenesis and formation in several Malignant Neoplasms, including retinoblastoma, hemangioma, and glioblastoma phenotypes. Additionally, the protein has been used as a marker to distinguish cells that have the potential to become cancerous from the larger normal cell population.. Histone H3 Trimethyl Lys28 defined as following: A post-translationally modified form of histone H3 where the lysine residue at position 28 is trimethylated. This modification is associated with formation of heterochromatin and polycomb repressive complex 1 (PRC1).. ezh2 protein, Homo sapiens Genes defined as following: This Genes plays a role in chromatin remodeling and transcriptional regulation.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. histone methyltransferase defined as following: Enzymes that catalyze the transfer of methyl groups to LYSINE or ARGININE residues of HISTONES, especially histone H3 and histone H4 Proteins. They play a critical role in EPIGENETIC PROCESSES.. Breast Primary malignant neoplasm defined as following: A primary or metastatic malignant neoplasm involving the Breast. The vast majority of cases are carcinomas arising from the Breast parenchyma or the nipple. Malignant Breast neoplasms occur more frequently in females than in males.. Homo sapiens defined as following: Members of the species Homo sapiens.. Prostate-Specific Antigen defined as following: A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant Pelvis>Prostate tissue. It is an important marker for the diagnosis of Pelvis>Prostate Primary malignant neoplasm.. Specimen Source Codes - Tumor Suppressor Genes defined as following: Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When Specimen Source Codes - Tumor Suppressor Genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible.. Xenograft type of graft defined as following: Tissues, cells or organs transplanted between animals of different species.. metastatic Pelvis>Prostate Primary malignant neoplasm defined as following: The spread of a malignant neoplasm to the Pelvis>Prostate gland from an adjacent or distant anatomic site.. susceptibility Genes defined as following: Mutated forms of genes which encode Proteins that are essential for the control and maintenance of normal cellular processes. Inherited or somatic mutations in the wild-type form of these genes alters control of their expression, resulting in a change in control of the cell cycle. Individuals who harbor Primary malignant neoplasm-predisposing genes require fewer somatic mutations for transformation of a particular cell, thereby predisposing them to the development of Primary malignant neoplasm.. Enhancer of transcription defined as following: A 50-150bp DNA sequence that increases the rate of transcription of coding sequences. It may be located at various distances and in either orientation upstream from, downstream from or within a structural Genes. When bound by a specific transcription factor it increases the levels of expression of the Genes, but is not sufficient alone to cause expression. Distinguished from a promoter, that is alone sufficient to cause expression of the Genes when bound..", "label": "yes"} {"original_question": "Is autophagy modulated in a circadian fashion?", "id": "converted_2274", "sentence1": "Is autophagy modulated in a circadian fashion?", "sentence2": "RORC wt Allele signaling pathway and autophagy are involved in the regulation of circadian rhythms in behavior and plasticity of L2 Interneurons in the Head>Brain of Drosophila melanogaster., Our results indicate that the RORC wt Allele signaling pathway and autophagy are involved in the regulation of circadian rhythms in the behavior and plasticity of Neurons in the Head>Brain of adult Diptera., the pathways of autophagy, FRAP1 protein, human, Sirtuin 1, and Wnt that control mammalian circadian rhythm, Metabolic pathways, Bile Acid [EPC] synthesis, and autophagic and immune/inflammatory processes are driven by the biological clock. , our findings suggest that the clock geneBmal1is a positive regulator of autophagy through the FRAP1 protein, human signaling pathway and protects Myocytes, Cardiac against high-glucose Toxic effect., Autophagy is a highly conserved Protoplasm degradation system, and recently was shown to display circadian rhythms in CASP14 gene. [SEP]Relations: Protein S human has relations: drug_drug with Protocatechualdehyde, drug_drug with Protocatechualdehyde, drug_drug with Thalidomide, drug_drug with Thalidomide, drug_drug with Pargyline, drug_drug with Pargyline, drug_drug with Cephaloglycin, drug_drug with Cephaloglycin, drug_drug with Procarbazine, drug_drug with Procarbazine. Definitions: FRAP1 protein, human defined as following: Serine/threonine-protein kinase FRAP1 protein, human (2549 aa, ~289 kDa) is encoded by the human MTOR gene. This protein is involved in protein phosphorylation, signaling and cell growth.. Neurons defined as following: The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.. RORC wt Allele defined as following: Human RORC wild-type allele is located in the vicinity of 1q21 and is approximately 26 kb in length. This allele, which encodes nuclear receptor ROR-gamma protein, is involved in transcriptional activation.. Interneurons defined as following: Most generally any NEURONS which are not motor or sensory. Interneurons may also refer to Neurons whose AXONS remain within a particular Head>Brain region in contrast to projection Neurons, which have axons projecting to other Head>Brain regions.. Myocytes, Cardiac defined as following: Striated muscle cells found in the heart. They are derived from cardiac myoblasts (MYOBLASTS, CARDIAC).. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Sirtuin 1 defined as following: A sirtuin family member found primarily in the CELL NUCLEUS. It is an NAD-dependent deacetylase with specificity towards HISTONES and a variety of proteins involved in gene regulation.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, proteins, lipids, carbohydrates, and inorganic salts.. Diptera defined as following: An order of the class Insecta. Wings, when present, number two and distinguish Diptera from other so-called Diptera, while the halteres, or reduced hindwings, separate Diptera from other insects with one pair of wings. The order includes the families Calliphoridae, Oestridae, Phoridae, SARCOPHAGIDAE, Scatophagidae, Sciaridae, SIMULIIDAE, Tabanidae, Therevidae, Trypetidae, CERATOPOGONIDAE; CHIRONOMIDAE; CULICIDAE; DROSOPHILIDAE; GLOSSINIDAE; MUSCIDAE; TEPHRITIDAE; and PSYCHODIDAE. The larval form of Diptera species are called maggots (see LARVA)..", "label": "yes"} {"original_question": "Is CHEK2 involved in cell cycle control?", "id": "converted_1556", "sentence1": "Is CHEK2 involved in cell cycle control?", "sentence2": "Moreover, cell-cycle progression genes [i.e. E2F transcription factor (E2F) family and histone deacetylase ( HDAC )] and DNA-repair genes [i.e. growth Cardiac Arrest and DNA-damage-inducible, gamma ( GADD45G ) family and serine/threonine-protein kinase Chk2 ( CHEK2)] were also increased., As CHEK2 is a cell-cycle master controller, we tested the hypothesis that heterozygosity for the frameshift alteration CHEK2*1100delC is associated with increased risk of melanoma., In the current study, we evaluated the possible associations of seven common Variant of the DNA repair and cell cycle control genes BRCA2 gene Genes and CHEK2 with melanoma (Millimole per Liter)., Promotor methylation analysis of key regulatory genes involved in cell cycle control (CDKN2A Genes, CDKN2B wt Allele, CDKN2A wt Allele, CHK2), DNA repair (MLH1 wt Allele), apoptosis (p73 protein, human protein, human, BIRC5 wt Allele, DAPK1 Genes), and differentiation (RARB wt Allele, Nephroblastoma) was performed by methylation-specific polymerase chain reaction., CHEK2 is a key cell cycle control Genes encoding a pluripotent kinase that can cause Cardiac Arrest or apoptosis in response to unrepaired DNA damage., High-fidelity maintenance of genomic integrity in Eukaryota is ensured by cell cycle checkpoints and DNA repair. The checkpoint kinase, Chk2, has been implicated in both of these responses. In response to DNA damage, Chk2 is initially phosphorylated at Thr-68, which leads to its full activation. The fully activated Chk2 then phosphorylates downstream substrates of cell cycle control., CHEK2 protein, human (hCHK2/hCds1) is a tumor suppressor Genes involved in cell-cycle control.[SEP]Relations: CDKN2A has relations: bioprocess_protein with regulation of cell cycle, bioprocess_protein with regulation of cell cycle, bioprocess_protein with negative regulation of G1/S transition of mitotic cell cycle, bioprocess_protein with negative regulation of G1/S transition of mitotic cell cycle, bioprocess_protein with negative regulation of cell growth, bioprocess_protein with negative regulation of cell growth, bioprocess_protein with negative regulation of cell population proliferation, bioprocess_protein with negative regulation of cell population proliferation, bioprocess_protein with G1/S transition of mitotic cell cycle, bioprocess_protein with G1/S transition of mitotic cell cycle. Definitions: Variant defined as following: An alteration or difference from a norm or standard.. RARB wt Allele defined as following: Human RARB wild-type allele is located within 3p24 and is approximately 170 kb in length. This allele, which encodes retinoic acid receptor beta protein, plays a role in the mediation off cellular signal transduction in embryonic morphogenesis, cell growth and differentiation.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. CHEK2 protein, human defined as following: Serine/threonine-protein kinase Chk2 (543 aa, ~61 kDa) is encoded by the human CHEK2 Genes. This protein plays an essential role in the DNA damage checkpoint of the cell cycle.. CDKN2A wt Allele defined as following: Human CDKN2A wild-type allele is located in the vicinity of 9p21 and is approximately 27 kb in length. This allele, which encodes both cyclin-dependent kinase inhibitor 2A protein and and tumor suppressor ARF protein, is involved in cell cycle regulation at the G1 phase. The allele is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor Genes.. p73 protein, human defined as following: Tumor protein p73 protein, human (636 aa, ~70 kDa) is encoded by the human TP73 Genes. This protein is involved in the regulation of transcription, DNA damage response and apoptosis.. Nephroblastoma defined as following: An embryonal neoplasm characterized by the presence of epithelial, mesenchymal, and blastema components. The vast majority of cases arise from the kidney. A small number of cases with morphologic features resembling Wilms tumor of the kidney have been reported arising from the ovary and the cervix.. tumor suppressor Genes defined as following: Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible.. Millimole per Liter defined as following: A unit of concentration (molarity unit) equal to one thousandth of a mole (10E-3 mole) of solute per one liter of solution.. BRCA2 gene defined as following: A tumor suppressor Genes (GENES, TUMOR SUPPRESSOR) located on human chromosome 13 at locus 13q12.3. Mutations in this Genes predispose humans to breast and ovarian cancer. It encodes a large, nuclear protein that is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. (from Genes Dev 2000;14(11):1400-6). DAPK1 gene defined as following: This Genes is involved in pro-apoptotic regulation.. CDKN2B wt Allele defined as following: Human CDKN2B wild-type allele is located within 9p21 and is approximately 27 kb in length. This allele, which encodes cyclin-dependent kinase 4 inhibitor B protein, plays roles in both the regulation of cell growth and tumor suppression.. Eukaryota defined as following: Organism or cells with a nucleus separated from the cytoplasm by a two membrance nuclear envelope and compartmentalization of function into distinct cytoplasmic organelles.. melanoma defined as following: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445). Cardiac Arrest defined as following: Cessation of heart beat or MYOCARDIAL CONTRACTION. If it is treated within a few minutes, heart Cardiac Arrest can be reversed in most cases to normal cardiac rhythm and effective circulation.. CDKN2A gene defined as following: Tumor suppressor genes located on human chromosome 9 in the region 9p21. This Genes is either deleted or mutated in a wide range of malignancies. (From Segen, Current Med Talk, 1995) Two alternatively spliced Genes products are encoded by CDKN2A wt Allele: CYCLIN-DEPENDENT KINASE INHIBITOR P16 and TUMOR SUPPRESSOR PROTEIN P14ARF.. MLH1 wt Allele defined as following: Human MLH1 wild-type allele is located in the vicinity of 3p21.3 and is approximately 57 kb in length. This allele, which encodes DNA mismatch repair protein Mlh1, plays a role in DNA mismatch repair. Aberrant alleles are associated with colon, endometrial and stomach cancers. Further, the defects in MLH1 are a cause of hereditary non-polyposis colorectal cancer.. BIRC5 wt Allele defined as following: Human BIRC5 wild-type allele is located in the vicinity of 17q25 and is approximately 10 kb in length. This allele, which encodes baculoviral IAP repeat-containing protein 5, is involved in the prevention of apoptotic cell death.. CHEK2 defined as following: Serine/threonine-protein kinase Chk2 (543 aa, ~61 kDa) is encoded by the human CHEK2 Genes. This protein plays an essential role in the DNA damage checkpoint of the cell cycle..", "label": "yes"} {"original_question": "Is there an association of alterations in ADCY7 and ulcerative colitis?", "id": "converted_3994", "sentence1": "Is there an association of alterations in ADCY7 gene and Ulcerative Colitis?", "sentence2": "To further resolve the Genetic architecture of the Inflammatory Bowel Diseases Ulcerative Colitis and Crohn's disease of oral soft tissues of oral soft tissues, we sequenced the whole Genome of 4,280 patients at low coverage and compared them to 3,652 previously sequenced population controls across 73.5 million Variant. We then imputed from these DNA Sequence into new and existing genome-wide association study cohorts and tested for association at ∼12 million Variant in a total of 16,432 cases and 18,843 controls. We discovered a 0.6% frequency missense variant in ADCY7 gene gene that doubles the risk of Ulcerative Colitis. Despite good statistical power, we did not identify any other new low-frequency risk Variant and found that such Variant explained little heritability. [SEP]Relations: Ulcerative Colitis (disease) has relations: disease_protein with ADCY7 gene, disease_protein with ADCY7 gene, disease_protein with IL7R, disease_protein with IL7R, disease_protein with IL1R2, disease_protein with IL1R2, disease_protein with IL23R, disease_protein with IL23R, disease_protein with CXCL8, disease_protein with CXCL8. Definitions: Variant defined as following: An alteration or difference from a norm or standard.. Ulcerative Colitis defined as following: Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.. DNA Sequence defined as following: The sequence of nucleotide residues along a DNA chain.. Inflammatory Bowel Diseases defined as following: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be Genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.. Genetic defined as following: Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.. Genome defined as following: The Genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA..", "label": "yes"} {"original_question": "Has ivosidenib been FDA approved for use against acute myeloid leukemia?", "id": "converted_2953", "sentence1": "Has ivosidenib been FDA approved for use against acute myeloid leukemia?", "sentence2": "The FDA approved ivosidenib for patients with IDH1-mutant relapsed/refractory acute myeloid leukemia. [SEP]Definitions: acute myeloid leukemia defined as following: This gene plays a role in transcriptional regulation and cytogenetic aberrations are associated with several leukemias..", "label": "yes"} {"original_question": "Are hepadnaviral minichromosomes free of nucleosomes?", "id": "converted_2135", "sentence1": "Are hepadnaviral minichromosomes free of Nucleosomes?", "sentence2": "Several nucleosome location location-protected sites in a region of the Hepatitis B Virus, Duck genome [Nucleotides (nt) 2000 to 2700], known to harbor various cis transcription regulatory elements, were consistently identified in all Hepatitis B Virus, Duck-positive liver samples., In addition, we observed other nucleosome location location protection sites in Hepatitis B Virus, Duck minichromosomes that may vary among individual Ducks, but the pattern of MNase mapping in those regions is transmittable from the adult Ducks to the newly infected ducklings., Nucleosomes along viral cccDNA in the minichromosomes are not random but sequence-specifically positioned., Investigators studying the structure and function of hepadnaviral CCC DNA (3) have provided evidence that suggests that this structure exists in the Cell Nucleus of infected Hepatocyte as a heterogeneous population of viral minichromosomes, which range from half to fully chromatinized, thought to be owing to their association with variable numbers of Nucleosomes., Characterization of nucleosome location location positioning in hepadnaviral covalently closed circular DNA minichromosomes., To obtain insight on the structure of hepadnaviral cccDNA minichromosomes, we utilized Ducks infected with the duck hepatitis B virus (Hepatitis B Virus, Duck) as a model and determined the in vivo nucleosome location location distribution pattern on viral cccDNA by the Micrococcal Nuclease (MNase) mapping and genome-wide PCR amplification of isolated mononucleosomal Hepatitis B Virus, Duck DNA., Mature SV40 minichromosomes are estimated to contain about 27 Nucleosomes (error +/- 2), except for those Molecule with a nucleosome location location-free gap, which are interpreted to contain 25 Nucleosomes (error +/- 2)., In vitro replication in the presence of protein-free competitor DNA shows that replicating trypsinized minichromosomes do not lose Nucleosomes and replicating competitor DNA does not gain Nucleosomes., In vitro replication in the presence of protein-free competitor DNA shows that replicating trypsinized minichromosomes do not lose Nucleosomes and replicating competitor DNA does not gain Nucleosomes., We conclude that in both cases parental Nucleosomes are transferred to progeny DNA, and, in addition, that an assembly of new Nucleosomes occurs during the replication of native minichromosomes., In contrast, the replicated untreated minichromosomes were found to be densely packed with Nucleosomes, indicating that an assembly of new Nucleosomes occurred during in vitro replication., Investigators studying the structure and function of hepadnaviral CCC DNA (3) have provided evidence that suggests that this structure exists in the Cell Nucleus of infected Hepatocyte as a heterogeneous population of viral minichromosomes, which range from half to fully chromatinized, thought to be owing to their association with variable numbers of Nucleosomes, To obtain insight on the structure of hepadnaviral cccDNA minichromosomes, we utilized Ducks infected with the duck hepatitis B virus (Hepatitis B Virus, Duck) as a model and determined the in vivo nucleosome location location distribution pattern on viral cccDNA by the Micrococcal Nuclease (MNase) mapping and genome-wide PCR amplification of isolated mononucleosomal Hepatitis B Virus, Duck DNA, Characterization of nucleosome location location positioning in hepadnaviral covalently closed circular DNA minichromosomes., To obtain insight on the structure of hepadnaviral cccDNA minichromosomes, we utilized Ducks infected with the duck hepatitis B virus (Hepatitis B Virus, Duck) as a model and determined the in vivo nucleosome location location distribution pattern on viral cccDNA by the Micrococcal Nuclease (MNase) mapping and genome-wide PCR amplification of isolated mononucleosomal Hepatitis B Virus, Duck DNA., Investigators studying the structure and function of hepadnaviral CCC DNA (3) have provided evidence that suggests that this structure exists in the Cell Nucleus of infected Hepatocyte as a heterogeneous population of viral minichromosomes, which range from half to fully chromatinized, thought to be owing to their association with variable numbers of Nucleosomes..[SEP]Relations: nucleosome location has relations: cellcomp_protein with MPHOSPH8, cellcomp_protein with MPHOSPH8, cellcomp_protein with PRM3, cellcomp_protein with PRM3, cellcomp_protein with KAT6B, cellcomp_protein with KAT6B, cellcomp_protein with PRM1, cellcomp_protein with PRM1, cellcomp_protein with PRM2, cellcomp_protein with PRM2. Definitions: Nucleosomes defined as following: The repeating structural units of chromatin, each consisting of approximately 200 base pairs of DNA wound around a protein core. This core is composed of the histones H2A, H2B, H3, and H4.. Hepatitis B Virus, Duck defined as following: A DNA virus that closely resembles human hepatitis B virus. It has been recovered from naturally infected Ducks.. Cell Nucleus defined as following: Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one Cell Nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). Nucleotides defined as following: The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed). Micrococcal Nuclease defined as following: An enzyme that catalyzes the endonucleolytic cleavage to 3'-phosphomononucleotide and 3'-phospholigonucleotide end-products. It can cause hydrolysis of double- or single-stranded DNA or RNA. (From Enzyme Nomenclature, 1992) EC 3.1.31.1.. Molecule defined as following: An aggregate of two or more atoms in a defined arrangement held together by chemical bonds.. nucleosome location defined as following: A complex comprised of DNA wound around a multisubunit core and associated proteins, which forms the primary packing unit of DNA into higher order structures. [GOC:elh]. Hepatocyte defined as following: The main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules.. Ducks defined as following: A water bird in the order Anseriformes (subfamily Anatinae (true Ducks)) with a broad blunt bill, short legs, webbed feet, and a waddling gait..", "label": "no"} {"original_question": "Is there any tool that facilitates the functional analysis of cis-regulatory regions in zebrafish?", "id": "converted_1883", "sentence1": "Is there any tool that facilitates the functional analysis of cis-regulatory regions in Zebrafish?", "sentence2": "Zebrafish Enhancer of transcription detection (ZED) vector: a new tool to facilitate transgenesis and the functional analysis of cis-regulatory regions in Zebrafish., he cis-regulatory sequences control when, where, and how much Genes are transcribed and can activate (enhancers) or repress (silencers) gene expression. Here, we describe a novel Tol2 transposon-based vector for assessing Enhancer of transcription activity in the Zebrafish (Danio rerio). This Zebrafish Enhancer Detector (ZED) vector harbors several key improvements, among them a sensitive and specific minimal Promoter chosen for optimal Enhancer of transcription activity detection, insulator sequences to shield the minimal Promoter from position effects, and a positive control for transgenesis. Additionally, we demonstrate that highly conserved noncoding sequences homologous between Homo sapiens and Zebrafish largely with Enhancer of transcription activity largely retain their tissue-specific Enhancer of transcription activity during Vertebrates evolution. More strikingly, insulator sequences from mouse and chicken allergenic extract allergenic extract, but not conserved in Zebrafish, maintain their insulator capacity when tested in this model., Zebrafish Enhancer of transcription detection (ZED) vector: a new tool to facilitate transgenesis and the functional analysis of cis-regulatory regions in Zebrafish, Zebrafish Enhancer of transcription detection (ZED) vector: a new tool to facilitate transgenesis and the functional analysis of cis-regulatory regions in Zebrafish.[SEP]Relations: regulation of antisense RNA transcription has relations: bioprocess_bioprocess with regulation of transcription, DNA-templated, bioprocess_bioprocess with regulation of transcription, DNA-templated, bioprocess_bioprocess with positive regulation of antisense RNA transcription, bioprocess_bioprocess with positive regulation of antisense RNA transcription, bioprocess_bioprocess with negative regulation of antisense RNA transcription, bioprocess_bioprocess with negative regulation of antisense RNA transcription. Promoter clearance from RNA polymerase I Promoter has relations: bioprocess_bioprocess with Promoter clearance during DNA-templated transcription, bioprocess_bioprocess with Promoter clearance during DNA-templated transcription, bioprocess_bioprocess with Promoter clearance from RNA polymerase I Promoter for nuclear large rRNA transcript, bioprocess_bioprocess with Promoter clearance from RNA polymerase I Promoter for nuclear large rRNA transcript. Definitions: Homo sapiens defined as following: Members of the species Homo sapiens.. Zebrafish defined as following: An exotic species of the family CYPRINIDAE, originally from Asia, that has been introduced in North America. Zebrafish is a model organism for drug assay and cancer research.. Enhancer of transcription defined as following: A 50-150bp DNA sequence that increases the rate of transcription of coding sequences. It may be located at various distances and in either orientation upstream from, downstream from or within a structural gene. When bound by a specific transcription factor it increases the levels of expression of the gene, but is not sufficient alone to cause expression. Distinguished from a Promoter, that is alone sufficient to cause expression of the gene when bound.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Vertebrates defined as following: Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising mammals, birds, reptiles, amphibians, and fishes..", "label": "yes"} {"original_question": "Have gnotobiotic animal models been used for the study of bowel disease?", "id": "converted_428", "sentence1": "Have gnotobiotic animal models been used for the study of bowel disease?", "sentence2": "Host gene expression in the TUBE,COLON,22FR,RADIOPAQUE RUBBER B#7370 of gnotobiotic interleukin-2-deficient CASP14 gene colonized with commensal colitogenic or noncolitogenic bacterial strains: common patterns and Bacteria strain specific signatures., Specific pathogen-free (SPF), but not germfree (GF), interleukin (IL)-2-deficient (IL-2-/-) CASP14 gene develop INFLAMMATORY BOWEL DISEASE 2 (Irritable Bowel Syndrome) at 10 to 15 weeks of age. Gnotobiotic IL-2-/- CASP14 gene monocolonized with E. coli mpk develop Irritable Bowel Syndrome at 25 to 33 weeks of age but not B. vulgatus mpk, E. coli Nissle 1917, or CASP14 gene cocolonized with both E. coli mpk and B. vulgatus, Lactobacillus reuteri promotes Helicobacter hepaticus-associated Typhlocolitis in gnotobiotic B6.129P2-IL-10(tm1Cgn) (IL-10(-/-) ) CASP14 gene., To model INFLAMMATORY BOWEL DISEASE 2, we assessed Communicable Diseases with Helicobacter hepaticus 3B1 (ATCC 51449) and a potential probiotic Lactobacillus reuteri (ATCC PTA-6475) in gnotobiotic B6.129P2-IL-10(tm1Cgn) (IL-10(-/-) ) CASP14 gene. No Typhlocolitis developed in Germ-Free controls (n=21) or in L. reuteri (n=8) or H. hepaticus (n=18) mono-associated CASP14 gene for 20 weeks post-Communicable Diseases. As positive controls, three specific pathogen-free IL-10(-/-) CASP14 gene dosed with H. hepaticus developed severe Typhlocolitis within 11 weeks. , These data support that the development of Typhlocolitis in H. hepaticus-infected IL-10(-/-) CASP14 gene required co-colonization with other Microbiota (plant) and in this study, required only L. reuteri. , When transferred to gnotobiotic CASP14 gene, gut microbiomes from CASP14 gene with active disease versus treatment-induced remission elicited varying degrees of Colitis. , The role of gut Microbiota (plant) (commensal Bacteria) and the mucosal barrier in the pathogenesis of inflammatory and Autoimmune Diseases and Primary malignant neoplasm: contribution of Germ-Free and gnotobiotic animal models of Homo sapiens diseases., The immunomodulatory effects of Microbiota (plant) and probiotics for Inflammatory Bowel Diseases and the role of Bacteria in their etiologies are being studied in gnotobiotic systems., To model INFLAMMATORY BOWEL DISEASE 2, we assessed Communicable Diseases with Helicobacter hepaticus 3B1 (ATCC 51449) and a potential probiotic Lactobacillus reuteri (ATCC PTA-6475) in gnotobiotic B6.129P2-IL-10(tm1Cgn) (IL-10(-/-) ) CASP14 gene., Gnotobiotic piglets may be used as a suitable animal model to study Colitis induced by C. jejuni, The role of gut Microbiota (plant) (commensal Bacteria) and the mucosal barrier in the pathogenesis of inflammatory and Autoimmune Diseases and Primary malignant neoplasm: contribution of Germ-Free and gnotobiotic animal models of Homo sapiens diseases, We investigated the changes in renal expression of KITLG wt Allele as a consequence of Colitis. METHODS: We studied 3 mouse models of Irritable Bowel Syndrome: Colitis induced by trinitrobenzene sulfonic acid, Colitis induced by microflora (in gnotobiotic interleukin-10(-/-)), and Colitis induced by adoptive transfer of CD4(+)CD45RB(high) T cells. , METHODS: We studied 3 mouse models of Irritable Bowel Syndrome: Colitis induced by trinitrobenzene sulfonic acid, Colitis induced by microflora (in gnotobiotic interleukin-10(-/-)), and Colitis induced by adoptive transfer of CD4(+)CD45RB(high) T cells. [SEP]Relations: INFLAMMATORY BOWEL DISEASE 2 has relations: disease_phenotype_positive with Abnormal intestine morphology, disease_phenotype_positive with Abnormal intestine morphology, disease_phenotype_positive with Abnormal intestine morphology, disease_phenotype_positive with Abnormal intestine morphology, contraindication with Phenobarbital, contraindication with Phenobarbital, contraindication with Phenobarbital, contraindication with Phenobarbital, disease_protein with GHRL, disease_protein with GHRL. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. KITLG wt Allele defined as following: Human KITLG wild-type allele is located in the vicinity of 12q22 and is approximately 88 kb in length. This allele, which encodes Kit ligand protein, plays a role in germ cell and neural cell development and in hematopoiesis.. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or Homo sapiens host.. Inflammatory Bowel Diseases defined as following: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.. Lactobacillus reuteri defined as following: A species of gram-positive, rod-shaped LACTIC ACID Bacteria found naturally in the Homo sapiens intestinal flora and BREAST MILK.. Homo sapiens defined as following: Members of the species Homo sapiens.. Autoimmune Diseases defined as following: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.. Irritable Bowel Syndrome defined as following: Gastrointestinal symptoms characterized by chronic abdominal pain and altered bowel habits in the absence of any organic cause.. Bacteria defined as following: One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive.. Colitis defined as following: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.. bowel disease defined as following: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM..", "label": "yes"} {"original_question": "Is Tcf3 associated with the Wnt pathway?", "id": "converted_3803", "sentence1": "Is Tcf3 associated with the Wnt pathway?", "sentence2": "TCF3, a novel positive regulator of osteogenesis, plays a crucial role in MIR17 wt Allele modulating the diverse effect of canonical Wnt signaling in different microenvironments, Furthermore, the role of MIR17 wt Allele was because of its target gene TCF3 (TRANSCRIPTION FACTOR), a key transcription factor of canonical Wnt pathway., Consequently, Tcf3 knockdown in HCT-R Cells restores their sensitivity to the effects of butyrate on Wnt activity and clonal cell growth. Interestingly, the effects of overexpressed Tcf3 differ between HCT-116 and HCT-R Cells, In HCT-R Cells, however, the overexpression of Tcf3 inhibits Wnt activity, and the Cells are still able to proliferate due to the higher expression levels of cell cycle factors, particularly those driving the G(1) to S transition., TCF3 (also known as TCF7L1 protein, human protein, human) is a member of the TCF/LEF transcription factor family that is central in regulating epidermal and embryonic Stem Cells identity., We found that in contrast to ES Cells, where it represses Wnt-pathway target Genes, TCF3 promotes the expression of a subset of Wnt-responsive Genes in breast cancer Cells while repressing another distinct target subset. In the normal Mus sp. mammary gland, Tcf3 is highly expressed in Terminal (end postition) end buds, structures that lead duct development, Tcf3 is essential within the Neural ectoderm to maintain anterior character and that its interaction with HESX1 gene ensures the repression of Wnt targets in the developing Prosencephalon., We report here that a Terminal (end postition) component of the canonical Wnt pathway in ES Cells, the transcription factor T-cell factor-3 (Tcf3), co-occupies promoters throughout the Genome - anatomical entity in association with the pluripotency regulators POU5F1 gene and NANOG gene. , Our results suggest that the Wnt pathway, through Tcf3, brings developmental signals directly to the core regulatory circuitry of ES Cells to influence the balance between pluripotency and differentiation., The wnt pathway regulates the steady state level of CTNNB1 gene, a Transcription Coactivator for the Tcf3/LEF1 gene family of DNA binding Proteins., Along with evidence that a significant amount of Tcf protein is nonnuclear, these findings suggest that CK1epsilon can modulate wnt signaling in vivo by regulating both the CTNNB1 gene-Tcf3 and the GBP-dsh interfaces., Rheumatoid Arthritis increases the expression of ligands and receptors of the noncanonical Wnt pathway (Wnt 5a, 7a, FZD2 protein, human and FZD6 protein, human), downstream signaling, and Tcf3 expression., The noncanonical Wnt signaling pathway, through actions of Tcf3, can antagonize the canonical pathway., We report here that a Terminal (end postition) component of the canonical Wnt pathway in ES Cells, the transcription factor T-cell factor-3 (Tcf3), co-occupies promoters throughout the Genome - anatomical entity in association with the pluripotency regulators POU5F1 gene and NANOG gene., Both Tcf3 depletion and Wnt pathway activation cause increased expression of POU5F1 gene, NANOG gene, and other pluripotency factors and produce ES Cells that are refractory to differentiation., Here, we show that injection of a hesx1 morpholino into a 'sensitised' zygotic headless (TCF7L1 protein, human protein, human wt Allele) Mutant background leads to severe Prosencephalon and eye defects, suggesting an interaction between HESX1 gene and the Wnt pathway during Zebrafish Prosencephalon development., In addition, we reveal that Tcf3 is essential within the Neural ectoderm to maintain anterior character and that its interaction with HESX1 gene ensures the repression of Wnt targets in the developing Prosencephalon., TCF3, a novel positive regulator of osteogenesis, plays a crucial role in MIR17 wt Allele modulating the diverse effect of canonical Wnt signaling in different microenvironments., Our studies located the Positioning Attribute of Wnts, downstream LEF1 and TCF3 and Stem Cells marker Proteins, which provide new information in understanding the role of the Wnt singaling pathway in whisker follicles' growth., The transcription factor TCF Transcription Factors (TCF3), one component of the Wnt pathway, is known as a cell-intrinsic inhibitor of many pluripotency Genes in Embryonic Stem Cells (Enhanced S-Cone Syndrome) that influences the balance between pluripotency and differentiation., Overexpression of TCF3 attenuated the effect of MIR17 wt Allele on modulating canonical Wnt signaling., We also find that TCF3 phosphorylation is triggered by canonical Wnt ligands, LRP6 protein, human protein, human, and dominant negative mutants for AXIN1 wt Allele and Glycogen Synthase Kinase 3, indicating that this process shares the same upstream regulators with β-catenin stabilization., Wnt pathway stimulation also triggers β-catenin association at regulatory elements with classic Lef/Tcf motifs associated with differentiation programs., We show that menin physically interacts with Proteins involved in the canonical Wnt signaling pathway, including CTNNB1 gene, TCF3 (VPS72 gene), and weakly with TCF7L2 protein, human (LZTR1 wt Allele)., TCF Transcription Factors (Tcf3) is a component of the Wnt signaling and a dominant downstream effector in Enhanced S-Cone Syndrome., factor 3 (Tcf3) is a component of the Wnt signaling and a dominant downstream effector in Enhanced S-Cone Syndrome. Despit, rt here that a Terminal (end postition) component of the canonical Wnt pathway in ES Cells, the transcription factor T-cell factor-3 (Tcf3), co-occupies promoters throughout the Genome - anatomical entity in association with the pluripotency regulators POU5F1 gene and NANOG gene. Thus, CD55 wt Allele, Tcf3, is recruited to a palindromic motif enriched in the Promoter of cell cycle repressor Genes, such as CDKN2B wt Allele, Cyclin-Dependent Kinase Inhibitor 2A, human and CDKN2A wt Allele, which mediate the Wnt-dependent anti-proliferative effect in mESCs. Consistently, Abetalipoproteinemia, nonical Wnt/β-catenin pathway controls mESC pluripotency via the Wnt-effector Tcf3. Howe, g increases the dissociation of HNF1A wt Allele and the association of Tcf3 at promoters of Genes that regulate stemness (e.g., NR5A2 gene gene, P2RX5 gene) or differentiation (e.g. CCN1 wt Allele, ZIC5 gene). Knockdown of Tcf3 increases, pport the existence of a regulatory circuit whereby Wnt/β-catenin counteracts Tcf3 repression of LEF1 gene, which subsequently activates target gene expression via LEF1 gene-β-catenin complexes. We propose that the Tcf/, with a requirement for Wnt signalling repression, we highlight a synergistic gene dosage-dependent interaction between HESX1 gene and Tcf3, a Transcription Repressor/Corepressor of Wnt target Genes, to maintain anterior Prosencephalon identity during Mus sp. embryogenesis. In addition, expression of ligands and receptors of the noncanonical Wnt pathway (Wnt 5a, 7a, FZD2 protein, human and FZD6 protein, human), downstream signaling, and Tcf3 expression. Rheumatoid Arthritis reduces the phosp, BACKGROUND AND OBJECTIVES: Transcription factor 3 (TCF3) implicates Wnt signaling pathway and regulates E-Cadherin expression, which is involved i, We demonstrate that Mus sp. Tcf3 mediates repression of both moderate and high levels of canonical Wnt signaling, by either competing with other members of the Tcf/Lef family for binding to β-catenin, or for binding to DNA., TCF3 is a Transcription Repressor/Corepressor that has been implicated in Wnt signaling and plays key roles in embryonic axis specification and Stem Cells differentiation., Our data show for the first time that Wnt signaling down-regulates Tcf3 expression, possibly at both the transcriptional and post-transcriptional levels, and thus highlight a novel mechanism through which Wnt signaling inhibits neuro-ectodermal lineage differentiation in Mus sp. Embryonic Stem Cells., We found Tcf3 to be a repressor of Wnt signaling in neocortical NPCs in a reporter gene assay., We found that down-regulation of Tcf3, a member of the Tcf/Lef family and a key player in the control of self-renewal and pluripotency, represents a specific and primary response to Wnt activation in Enhanced S-Cone Syndrome., Wnt16b also activated the RhoA/Rac1 signaling cascade suggesting the activation of a non-canonical Wnt pathway in TCF3-PBX1 Cells., Pre B-cell acute lymphoblastic leukemia (BCP-ALL) with TCF3-PBX1 fusion gene expression has constitutively elevated levels of Wnt16b and RORA wt Allele (Receptor Tyrosine Kinase-like Orphan Receptors), a ligand and a receptor from the Wnt signaling pathway, respectively., We found that in contrast to ES Cells, where it represses Wnt-pathway target Genes, TCF3 promotes the expression of a subset of Wnt-responsive Genes in breast cancer Cells while repressing another distinct target subset., Together, these results suggest that Tcf3 antagonizes Wnt signaling in NPCs, thereby maintaining their undifferentiated state in the Neocortex and that Wnt signaling promotes the transition from Tcf3-mediated repression to HNF1A wt Allele/LEF1 gene-mediated enhancement of Wnt signaling, constituting a positive feedback loop that facilitates neuronal differentiation., We also found that Wnt signal stimulation reduces the level of Tcf3, and increases those of HNF1A wt Allele (also known as TCF7 protein, human) and LEF1 gene, positive mediators of Wnt signaling, in NPCs., These data suggest that in the absence of Wnt signals, Tcf3 may function in skin SCs to maintain an undifferentiated state and, through Wnt signaling, directs these Cells along the Hair Specimen lineage.[SEP]Relations: CTNNB1 has relations: pathway_protein with TCF dependent signaling in response to WNT, pathway_protein with TCF dependent signaling in response to WNT, pathway_protein with RUNX3 regulates WNT signaling, pathway_protein with RUNX3 regulates WNT signaling. LEF1 has relations: pathway_protein with RUNX3 regulates WNT signaling, pathway_protein with RUNX3 regulates WNT signaling, pathway_protein with Repression of WNT target Genes, pathway_protein with Repression of WNT target Genes, bioprocess_protein with positive regulation of Wnt signaling pathway, bioprocess_protein with positive regulation of Wnt signaling pathway. Definitions: Neocortex defined as following: The largest portion of the CEREBRAL CORTEX in which the NEURONS are arranged in six layers in the mammalian brain: molecular, external granular, external pyramidal, internal granular, internal pyramidal and multiform layers.. RORA wt Allele defined as following: Human RORA wild-type allele is located within 15q21-q22 and is approximately 732 kb in length. This allele, which encodes nuclear receptor ROR-alpha protein, plays a role in transcriptional activation and may play a role in organogenesis and differentiation.. Genome - anatomical entity defined as following: Anatomical set of Genes in all the chromosomes.. CDKN2A wt Allele defined as following: Human CDKN2A wild-type allele is located in the vicinity of 9p21 and is approximately 27 kb in length. This allele, which encodes both cyclin-dependent kinase inhibitor 2A protein and and tumor suppressor ARF protein, is involved in cell cycle regulation at the G1 phase. The allele is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene.. Cyclin-Dependent Kinase Inhibitor 2A, human defined as following: Cyclin-dependent kinase inhibitor 2A (156 aa, ~17 kDa) is encoded by the human CDKN2A gene. This protein is involved in the inhibition of both cell proliferation and cell cycle progression.. NANOG gene defined as following: This gene plays a role in the underlying pluripotency of inner cell mass and Embryonic Stem Cells.. Zebrafish defined as following: An exotic species of the family CYPRINIDAE, originally from Asia, that has been introduced in North America. Zebrafish is a model organism for drug assay and cancer research.. LEF1 gene defined as following: This gene plays a role in both signal transduction and transcription.. Rheumatoid Arthritis defined as following: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.. CDKN2B wt Allele defined as following: Human CDKN2B wild-type allele is located within 9p21 and is approximately 27 kb in length. This allele, which encodes cyclin-dependent kinase 4 inhibitor B protein, plays roles in both the regulation of cell growth and tumor suppression.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually Proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all Cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Transcription Coactivator defined as following: A transcription cofactor that activates transcription from a RNA polymerase II Promoter but does not bind DNA itself.. LRP6 protein, human defined as following: Low-density lipoprotein receptor-related protein 6 (1613 aa, ~180 kDa) is encoded by the human LRP6 protein, human gene. This protein plays a role in the modulation of cell communication.. TCF7L1 protein, human wt Allele defined as following: Human TCF7L1 protein, human wild-type allele is located in the vicinity of 2p11.2 and is approximately 177 kb in length. This allele, which encodes transcription factor 7-like 1 protein, is involved in Wnt pathway-dependent transcriptional regulation.. FZD2 protein, human defined as following: Frizzled-2 (565 aa, ~64 kDa) is encoded by the human FZD2 gene. This protein is involved in Wnt-mediated G protein-coupled receptor signaling.. TCF7 protein, human defined as following: Transcription factor 7 (384 aa, ~42 kDa) is encoded by the human TCF7 gene. This protein is involved in both thymocyte survival and the regulation of transcription.. LZTR1 wt Allele defined as following: Human LZTR1 wild-type allele is located in the vicinity of 22q11.21 or within 22q11.1-q11.2 and is approximately 20 kb in length. This allele, which encodes leucine-zipper-like transcriptional regulator 1 protein, may play a role in transcriptional regulation or Golgi functions. Mutation of the gene is associated with Noonan syndrome 10 and increased susceptibility to schwannomatosis 2. Deletion of the gene may be associated with DiGeorge syndrome.. TCF Transcription Factors defined as following: A family of DNA-binding Proteins that are primarily expressed in T-LYMPHOCYTES. They interact with BETA CATENIN and serve as transcriptional activators and repressors in a variety of developmental processes.. Stem Cells defined as following: Relatively undifferentiated Cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor Cells that can differentiate into specialized Cells.. Abetalipoproteinemia defined as following: An autosomal recessive disorder of lipid metabolism. It is caused by mutation of the microsomal triglyceride transfer protein that catalyzes the transport of lipids (TRIGLYCERIDES; CHOLESTEROL ESTERS; PHOSPHOLIPIDS) and is required in the secretion of BETA-LIPOPROTEINS (low density lipoproteins or LDL). Features include defective intestinal lipid absorption, very low serum cholesterol level, and near absent LDL.. Transcription Repressor/Corepressor defined as following: Transcription Repressor/Corepressor Gene encodes Transcriptional Repressor/Corepressor, Proteins that can regulate transcription by binding to the operator and causing repression. (from Glick: Glossary of Biochemistry and Molecular Biology). NR5A2 gene defined as following: This gene is involved in ligand-dependent transcriptional regulation.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. AXIN1 wt Allele defined as following: Human AXIN1 wild-type allele is located in the vicinity of 16p13.3 and is approximately 65 kb in length. This allele, which encodes axin-1 protein, is involved in the attenuation of the Wnt protein signaling cascade.. Receptor Tyrosine Kinase-like Orphan Receptors defined as following: A family of cell surface receptors that were originally identified by their structural homology to neurotropic TYROSINE KINASES and referred to as orphan receptors because the associated ligand and signaling pathways were unknown. Evidence for the functionality of these Proteins has been established by experiments showing that disruption of the orphan receptor Genes results in developmental defects.. Terminal (end postition) defined as following: Being or situated at an end; occurring at or forming an end.. Embryonic Stem Cells defined as following: Cells derived from the BLASTOCYST INNER CELL MASS which forms before implantation in the uterine wall. They retain the ability to divide, proliferate and provide progenitor Cells that can differentiate into specialized Cells.. POU5F1 gene defined as following: This gene plays a role in early mammalian development.. Mutant defined as following: An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).. HNF1A wt Allele defined as following: Human HNF1A wild-type allele is located in the vicinity of 12q22-qter; 12q24.2 and is approximately 25 kb in length. This allele, which encodes hepatocyte nuclear factor 1-alpha protein, is involved in both transcriptional regulation and DNA binding. Mutation of the gene is associated with familial hepatic adenoma, maturity-onset diabetes of the young type 3 and diabetes mellitus insulin-dependent type 20.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. Glycogen Synthase Kinase 3 defined as following: A family of serine/threonine protein kinases that is involved in intracellular signaling, cellular proliferation, cell migration, inflammation and immune responses, glucose regulation, and apoptosis.. MIR17 wt Allele defined as following: The human MIR17 wild-type allele is located in the vicinity of 13q31.3 and is 83 bases in length. This allele, which encodes MIR17 pre-miRNA, plays a role in many cancers, including lung, liver, colorectal, thyroid, breast, neuroblastoma, leukemia and lymphoma.. TCF7L2 protein, human defined as following: Transcription factor 7-like 2 (619 aa, ~68 kDa) is encoded by the human TCF7L2 gene. This protein is involved in the positive regulation of transcription, cell cycle arrest, apoptosis regulation, cell and tissue differentiation and signal transduction.. TCF7L1 protein, human defined as following: Transcription factor 7-like 1 (588 aa, ~63 kDa) is encoded by the human TCF7L1 protein, human gene. This protein plays a role in transcriptional regulation that is modulated by the Wnt signaling pathway.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. HCT-116 defined as following: A carcinoma cell line established from an adult male patient with colon carcinoma. HCT-116 Cells have a mutation in codon 13 of the ras proto-oncogene.. Positioning Attribute defined as following: A reference to the alignment of an object, a particular situation or view of a situation, or the location of an object.. Pre B-cell acute lymphoblastic leukemia defined as following: A type of ALL characterized by elevated levels of B-cell lymphoblasts in the bone marrow and the blood. [NCIT:C8644]. FZD6 protein, human defined as following: Frizzled-6 (706 aa, ~79 kDa) is encoded by the human FZD6 gene. This protein plays a role in G protein-coupled receptor signaling and Wnt binding.. Prosencephalon defined as following: The anterior of the three primitive cerebral vesicles of the embryonic brain arising from the NEURAL TUBE. It subdivides to form DIENCEPHALON and TELENCEPHALON. (Stedmans Medical Dictionary, 27th ed). CD55 wt Allele defined as following: Human CD55 wild-type allele is located in the vicinity of 1q32 and is approximately 40 kb in length. This allele, which encodes complement decay-accelerating factor protein, is involved in the modulation of complement activity.. CTNNB1 gene defined as following: This gene is involved in signal transduction and regulation of transcription.. CCN1 wt Allele defined as following: Human CCN1 wild-type allele is located in the vicinity of 1p22.3 and is approximately 3 kb in length. This allele, which encodes CCN family member 1 protein, is involved in heart morphogenesis, angiogenesis, cell proliferation, cell adhesion and the positive regulation of apoptosis.. Mus sp. Embryonic Stem Cells defined as following: PLURIPOTENT STEM CELLS derived from the BLASTOCYST INNER CELL MASS of day 3.5 Mus sp. embryos.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Tcf3 defined as following: This gene plays a role in catenin beta-1-dependent transcriptional regulation..", "label": "yes"} {"original_question": "Is pazopanib an effective treatment of glioblastoma?", "id": "converted_2868", "sentence1": "Is pazopanib an effective treatment of glioblastoma?", "sentence2": "RESULTS: The six-month progression-free survival (PFS) rates in phase II (n = 41) were 0% and 15% in the PTEN/EGFRvIII-positive and PTEN/EGFRvIII-negative cohorts, respectively, leading to early termination. , Single-agent pazopanib did not prolong PFS in this patient population but showed in situ biological activity as demonstrated by radiographic responses.[SEP]Definitions: glioblastoma defined as following: The most malignant astrocytic tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO). pazopanib defined as following: A small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. Pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1, -2 and -3, c-kit and platelet derived growth factor receptor (PDGF-R), which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated..", "label": "no"} {"original_question": "Is there a role for transcription factories in genome organization?", "id": "converted_926", "sentence1": "Is there a role for transcription factories in Genome - anatomical entity organization?", "sentence2": "The mammalian nucleus is a highly complex structure that carries out a diverse range of functions such as DNA replication, cell division, RNA processing, and Nuclear (incident type) export/import. Many of these activities occur at discrete subcompartments that intersect with specific regions of the Genome - anatomical entity. Over the past few decades, evidence has accumulated to suggest that RNA transcription also occurs in specialized sites, called transcription factories, that may influence how the Genome - anatomical entity is organized. There may be certain efficiency benefits to cluster transcriptional activity in this way. However, the clustering of Genes at transcription factories may have consequences for Genome - anatomical entity stability, and increase the susceptibility to recurrent chromosomal translocations that lead to Primary malignant neoplasm, In the eukaryotic nucleus, Genes are transcribed in transcription factories, Based on this analysis, we propose that transcription factories result from the aggregation of RNA polymerase II-containing pre-initiation complexes assembled next to each other in the Nuclear (incident type) space. Such an aggregation can be triggered by the phosphorylation of the C-terminal domain of RNA polymerase II molecules and their interaction with various TRANSCRIPTION FACTOR. Individual transcription factories would thus incorporate tissue-specific, co-regulated as well as Genes, Housekeeping based only on their initial proximity to each other in the Nuclear (incident type) space, active polymerases cluster into replication and transcription \"factories\" in both pro- and Eukaryota. We conclude that the second law of thermodynamics acts through nonspecific entropic forces between engaged polymerases to drive the self-organization of Genome into loops containing several thousands (and sometimes millions) of basepairs, Since the advent of FISH (fluorescence in situ hybridization), there have been major advances in our understanding of how the Genome - anatomical entity is organized in interphase nuclei. Indeed, this organization is found to be non-random and individual Chromosomes, Human, Pair 1 occupy discrete regions known as territories, in proliferating cells, there is evidently a correlation between radial positioning and gene density. Indeed, gene-poor Chromosomes, Human, Pair 1 tend to be located towards the Nuclear (incident type) edge, while those that are more gene-rich are positioned more internally, Recently described active chromatin hubs and transcription factories also involve long-range interactions, The transcription factory model has implications for the regulation of Transcription Initiation and elongation, for the organization of Genes in the Genome - anatomical entity, for the co-regulation of Genes and for Genome - anatomical entity instability.[SEP]Relations: HIV Transcription Initiation has relations: pathway_protein with CCNH, pathway_protein with CCNH. transcription factor binding has relations: molfunc_protein with JUN, molfunc_protein with JUN, molfunc_protein with JUNB, molfunc_protein with JUNB, molfunc_protein with JUND, molfunc_protein with JUND, molfunc_protein with SAP18, molfunc_protein with SAP18. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Genome - anatomical entity defined as following: Anatomical set of Genes in all the Chromosomes, Human, Pair 1.. Chromosomes, Human, Pair 1 defined as following: A specific pair of human Chromosomes, Human, Pair 1 in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification.. Eukaryota defined as following: Organism or cells with a nucleus separated from the cytoplasm by a two membrance Nuclear (incident type) envelope and compartmentalization of function into distinct cytoplasmic organelles.. Genome defined as following: The genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA.. Genes, Housekeeping defined as following: Constitutively and evenly expressed Genes involved in routine cellular metabolisms.. Transcription Initiation defined as following: Transcription Initiation involves RNA polymerase (and usually other factors) binding at a specific gene promoter DNA site followed by local DNA unwinding and inauguration of the 5-prime to 3-prime biosynthesis of an RNA transcript complementary to the DNA template.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Is pseudouridine a RNA modification?", "id": "converted_1942", "sentence1": "Is pseudouridine a RNA modification?", "sentence2": "Pseudouridine (Ψ) is the most abundant of>150 nucleoside modifications in RNA. , The number and Positioning Attribute of the pseudouridines of Haloarcula marismortui and Deinococcus radiodurans large subunit RNA have been determined by a combination of total nucleoside analysis by HPLC-mass spectrometry and pseudouridine sequencing by the reverse transcriptase method and by LC/MS/MS., Pseudouridine is the most abundant of more than 100 Chemicals distinct natural ribonucleotide modifications.[SEP]Relations: pseudouridine synthesis has relations: bioprocess_bioprocess with RNA modification, bioprocess_bioprocess with RNA modification, bioprocess_bioprocess with mRNA pseudouridine synthesis, bioprocess_bioprocess with mRNA pseudouridine synthesis, bioprocess_protein with NOP10, bioprocess_protein with NOP10, bioprocess_bioprocess with rRNA pseudouridine synthesis, bioprocess_bioprocess with rRNA pseudouridine synthesis, bioprocess_bioprocess with tRNA pseudouridine synthesis, bioprocess_bioprocess with tRNA pseudouridine synthesis. Definitions: Positioning Attribute defined as following: A reference to the alignment of an object, a particular situation or view of a situation, or the location of an object.. Pseudouridine defined as following: A naturally-occurring isomer of URIDINE found in RNA, in which ribosyl is attached to a carbon instead of a nitrogen atom.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Chemicals defined as following: A substance with a defined atomic or molecular structure that results from, or takes part in, reactions involving changes in its structure, composition, or properties.. Haloarcula marismortui defined as following: A species of halophilic archaea distinguished by its production of acid from sugar. This species was previously called Halobacterium marismortui.. RNA modification defined as following: The covalent alteration of one or more nucleotides within an RNA molecule to produce an RNA molecule with a sequence that differs from that coded genetically. [GOC:go_curators, ISBN:1555811337].", "label": "yes"} {"original_question": "Is Citrobacter rodentium pathogenic?", "id": "converted_2577", "sentence1": "Is Citrobacter rodentium pathogenic?", "sentence2": "One day after colonization, CASP14 gene were infected with the colonic pathogen, Citrobacter rodentium., The Homo sapiens pathogen enteropathogenic Escherichia coli (Enteropathogenic Escherichia coli), as well as the Mus sp. pathogen Citrobacter rodentium, colonize the gut mucosa via attaching and effacing lesion formation and cause diarrheal diseases., Enteropathogenic Escherichia coli-like Mus sp. pathogen Citrobacter rodentium, Here, we develop a model that provides that link for the investigation of Citrobacter rodentium infection, a Mus sp. model for enteropathogenic Escherichia coli (Enteropathogenic Escherichia coli). [SEP]Relations: escherichia coli infection has relations: disease_disease with infectious disease, disease_disease with infectious disease, disease_disease with infectious disease, disease_disease with infectious disease, disease_phenotype_positive with Recurrent gram-negative bacterial infections, disease_phenotype_positive with Recurrent gram-negative bacterial infections, disease_phenotype_positive with Recurrent gram-negative bacterial infections, disease_phenotype_positive with Recurrent gram-negative bacterial infections. Definitions: Escherichia coli defined as following: A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.. Citrobacter rodentium defined as following: A species of gram-negative bacteria in the genus CITROBACTER, family ENTEROBACTERIACEAE. As an important pathogen of laboratory CASP14 gene, it serves as a model for investigating epithelial hyperproliferation and tumor promotion. It was previously considered a strain of CITROBACTER FREUNDII.. Enteropathogenic Escherichia coli defined as following: Strains of ESCHERICHIA COLI characterized by attaching-and-effacing histopathology. These strains of bacteria intimately adhere to the epithelial cell membrane and show effacement of microvilli. In developed countries they are associated with INFANTILE DIARRHEA and infantile GASTROENTERITIS and, in contrast to ETEC strains, do not produce ENDOTOXINS.. Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Is Satb1 a transcription factor?", "id": "converted_4434", "sentence1": "Is DNA-Binding Protein SATB1 a transcription factor?", "sentence2": "Special AT-rich sequence binding protein-1 (SATB1) is localized to the Atomic Nucleus and remodels chromatin location location structure in Therapeutic gamma delta T-lymphocytes, chromatin location location organizers SATB2 and SATB1 , transcription factor complexes. These MYB complexes assemble aberrantly with LYL1 protein, human protein, human, TCF3 wt Allele, C/EBP family members, LMO2 wt Allele wt Allele, and SATB1. , Staining for the transcription factors FOXP2 gene, DNA-Binding Protein SATB1 and DNA Binding Protein SATB2 labeled most Ganglion cell in the avian ganglion cell layer.[SEP]Relations: Tat protein binding has relations: molfunc_protein with DNAJA1, molfunc_protein with DNAJA1, molfunc_protein with DNAJA1, molfunc_protein with DNAJA1, molfunc_protein with GABARAPL1, molfunc_protein with GABARAPL1, molfunc_protein with GABARAPL1, molfunc_protein with GABARAPL1. Protein S human has relations: drug_drug with Factor XIII (human), drug_drug with Factor XIII (human). Definitions: DNA-Binding Protein SATB1 defined as following: DNA-Binding Protein SATB1 (763 aa, ~86 kDa) is encoded by the human SATB1 gene. This protein binds DNA and may be involved in the regulation of transcription.. Ganglion cell defined as following: A type of interneuron that conveys information to the brain.. LMO2 wt Allele defined as following: Human LMO2 wt Allele wild-type allele is located in the vicinity of 11p13 and is approximately 34 kb in length. This allele, which encodes rhombotin-2 protein, is involved in red blood cell development through the modulation of transcription by RNA polymerase II.. Atomic Nucleus defined as following: The region of an atom that contains the protons and neutrons.. Therapeutic gamma delta T-lymphocytes defined as following: A subset of therapeutic autologous T-lymphocytes that express a T-cell receptor (TCR) composed of one gamma chain and one delta chain, with potential immunomodulating and antineoplastic activities. Upon administration of the therapeutic gamma delta T-lymphocytes, these cells secrete interferon-gamma (IFN-g), and exert direct killing of tumor cells. In addition, these cells activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against tumor cells. Gamma delta T-lymphocytes play a key role in the activation of the immune system and do not require major histocompatibility complex (MHC)-mediated antigen presentation to exert their cytotoxic effect.. LYL1 protein, human defined as following: Protein lyl-1 (280 aa, ~30 kDa) is encoded by the human LYL1 protein, human gene. This protein is involved in blood vessel maturation and transcriptional regulation.. DNA Binding Protein SATB2 defined as following: DNA-binding protein SATB2 (733 aa, ~83 kDa) is encoded by the human SATB2 gene. This protein is involved in both DNA binding and transcriptional regulation.. chromatin location defined as following: The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130]. FOXP2 gene defined as following: This gene is involved in brain development.. TCF3 wt Allele defined as following: Human TCF3 wild-type allele is located in the vicinity of 19p13.3 and is approximately 43 kb in length. This allele, which encodes transcription factor E2-alpha protein, plays a role in the mediation of embryological cell fate. Chromosomal aberrations involving the gene are associated with forms of pre-B-cell acute lymphoblastic leukemia.. transcription factor defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process..", "label": "yes"} {"original_question": "Thymoquinone is ineffective against radiation induced enteritis, yes or no?", "id": "converted_3674", "sentence1": "Thymoquinone is ineffective against radiation induced enteritis, yes or no?", "sentence2": "n this study, we found that thymoquinone (TQ) could mitigate Intestines damages induced by irradiation. , In this study, we found that thymoquinone (TQ) could mitigate Intestines damages induced by irradiation., In this study, we found that thymoquinone (TQ) could mitigate Intestines damages induced by irradiation., TQ might be used for radiation enteritis treatment.[SEP]Relations: intestine has relations: anatomy_protein_present with NOMO3, anatomy_protein_present with NOMO3, anatomy_protein_present with NOMO2, anatomy_protein_present with NOMO2, anatomy_protein_present with MKRN2OS, anatomy_protein_present with MKRN2OS, anatomy_protein_present with NOMO1, anatomy_protein_present with NOMO1, anatomy_protein_present with HOXA-AS3, anatomy_protein_present with HOXA-AS3. Definitions: Intestines defined as following: The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE.. enteritis defined as following: Inflammation of any segment of the SMALL INTESTINE..", "label": "no"} {"original_question": "Was stelara developed by Amgen?", "id": "converted_3174", "sentence1": "Was stelara developed by Amgen?", "sentence2": "Nitroglycerin/Sodium Citrate/Ethanol Solution does not specifically recommend switching from one biologic to another, and only Ustekinumab Ab (User Site Testing; Stelara®, Janssen, Inc., Horsham, newton per square metre, USA) is recommended after anti-tumour necrosis factor failure.[SEP]Relations: Ustekinumab has relations: drug_drug with AMG 108, drug_drug with AMG 108, drug_drug with Imlifidase, drug_drug with Imlifidase, drug_drug with Eftrenonacog alfa, drug_drug with Eftrenonacog alfa, drug_drug with Esterified estrogens, drug_drug with Esterified estrogens, drug_drug with Leronlimab, drug_drug with Leronlimab. Definitions: Janssen defined as following: A pharmaceutical company providing medicines for an array of health concerns in several therapeutic areas. The company conducts research and development into oncology, mental illness, neurological disorders, gastrointestinal disorders, fungal infection, and allergies.. Nitroglycerin/Sodium Citrate/Ethanol Solution defined as following: An antimicrobial lock solution (ALS) containing the nitrate nitroglycerin, sodium citrate and ethanol, with potential antimicrobial and anticoagulant activities. Upon application to the catheter as an ALS, the nitroglycerin is converted into nitric oxide (NO), which exerts antimicrobial activity. The citrate exerts anticoagulant activity, thereby preventing blood clotting and occlusion and maintaining the fluidity of the administered solution. In addition, both citrate and ethanol exert antimicrobial activity. This may prevent bacterial colonization on the surface of the catheter, biofilm formation and prevents catheter-associated infections.. newton per square metre defined as following: A SI derived unit of pressure equivalent to one newton per square meter or 10 bars or to 1.45x10E-4 pounds per square inch.. User Site Testing defined as following: Any examination of software/hardware functionality that takes place outside of the developer's controlled environment..", "label": "no"} {"original_question": "Was vivotif licensed in Europe and the US at the same time?", "id": "converted_3711", "sentence1": "Was vivotif licensed in Europe and the US at the same time?", "sentence2": "Vivotif® is an oral live attenuated vaccine which contains a mutated strain of Salmonella (Ty21a) and reproduces the natural infection. The vaccine was first licensed in Europe in 1983 and in the US in 1989, and over the years it has proved efficacious and safe.[SEP]Relations: salmonellosis has relations: disease_protein with HLA-DRB1, disease_protein with HLA-DRB1, disease_disease with invasive non-typhoidal salmonellosis, disease_disease with invasive non-typhoidal salmonellosis, disease_disease with paratyphoid fever, disease_disease with paratyphoid fever, disease_disease with salmonella infections, animal, disease_disease with salmonella infections, animal, disease_disease with typhoid fever, disease_disease with typhoid fever. Definitions: Salmonella defined as following: A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that utilizes citrate as a sole carbon source. It is pathogenic for humans, causing enteric fevers, gastroenteritis, and bacteremia. Food poisoning is the most common clinical manifestation. Organisms within this genus are separated on the basis of antigenic characteristics, sugar fermentation patterns, and bacteriophage susceptibility..", "label": "no"} {"original_question": "Is there an association between borna virus and brain tumor?", "id": "converted_388", "sentence1": "Is there an association between borna Virus and Head>Brain tumor?", "sentence2": "Borna Disease Virus (BDV), a nonsegmented, negative-strand RNA Virus, infects a wide variety of mammalian species and readily establishes a long-lasting, persistent Communicable Diseases in Head>Brain cells. , To investigate the biological characteristics of field isolates of Borna Disease Virus (BDV), as well as to understand BDV infections outside endemic countries, we isolated the Virus from Head>Brain samples of a heifer with Borna Disease in Japan., Neonatal Borna Disease Virus (BDV) Communicable Diseases of the Rattus norvegicus Head>Brain is associated with microglial activation and damage to the certain neuronal populations., In addition, compared to uninfected mixed cultures, activation of Microglia in BDV-infected mixed cultures was associated with a significantly greater lipopolysaccharide-induced release of Tumor Necrosis Factor-alpha, interleukin-1, beta, and interleukin 10. Taken together, the present data are the first in vitro evidence that persistent BDV Communicable Diseases of neurons and Astrocytes rather than direct exposure to the Virus or dying neurons is critical for activating Microglia., Usually, Borna Disease Virus is not cleared from the Head>Brain but rather persists in Neurons., Varied persistent life cycles of Borna Disease Virus in a Homo sapiens oligodendroglioma cell line., Borna Disease Virus (BDV) establishes a persistent Communicable Diseases in the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS of vertebrate animal species as well as in Tissue culture. , Thus, our findings show that BDV may have established a persistent Communicable Diseases at low levels of viral expression in OL cells with the possibility of a latent Communicable Diseases., These results suggested that BDV Communicable Diseases may cause direct damage in the developing Head>Brain by inhibiting the function of HMGB1 Protein due to binding by the p24 phosphoprotein., We describe a model for investigating disorders of CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS development based on neonatal Rattus norvegicus Communicable Diseases with Borna Disease Virus, a neurotropic noncytolytic RNA Virus. , Borna Disease Virus (BDV) replicates in Head>Brain cells. The neonatally infected Rattus norvegicus with BDV exhibits developmental-neuromorphological abnormalities, neuronal cytolysis, and multiple behavioral and physiological alterations. , Borna Disease Virus (BDV) causes CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS (Central Nervous System) disease in several vertebrate species, which is frequently accompanied by Abnormal behavior., Intrinsic responses to Borna Disease Virus Communicable Diseases of the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS., Immune cells invading the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS (Central Nervous System) in response to Borna Disease Virus (BDV) antigens are central to the pathogenesis of Borna Disease (BD). , We report here the partial purification and characterization of cell-free BDV from the tissue culture supernatant of infected Homo sapiens neuroblastoma SKNSH cells., We have used the reverse transcriptase-polymerase chain reaction technique to gain insight into the pathogenesis of Encephalitis caused by Borna Disease Virus (BDV). , In contrast, in the BDV-infected primary mixed cultures, we observed proliferation of Microglia cells that acquired the round morphology and expressed major histocompatibility complex Molecule of classes I and II.[SEP]Relations: borna disease has relations: disease_disease with viral Communicable Diseases of CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS, disease_disease with viral Communicable Diseases of CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS, disease_disease with encephalomyelitis, disease_disease with encephalomyelitis, disease_disease with Mononegavirales infectious disease, disease_disease with Mononegavirales infectious disease. Encephalitis has relations: disease_disease with viral Communicable Diseases of CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS, disease_disease with viral Communicable Diseases of CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS, disease_disease with Hendra Virus Communicable Diseases, disease_disease with Hendra Virus Communicable Diseases. Definitions: Neurons defined as following: The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.. Borna Disease defined as following: An encephalomyelitis of horses, sheep and cattle caused by BORNA DISEASE VIRUS.. Microglia defined as following: The third type of glial cell, along with Astrocytes and oligodendrocytes (which together form the macroglia). Microglia vary in appearance depending on developmental stage, functional state, and anatomical location; subtype terms include ramified, perivascular, ameboid, resting, and activated. Microglia clearly are capable of phagocytosis and play an important role in a wide spectrum of neuropathologies. They have also been suggested to act in several other roles including in secretion (e.g., of cytokines and neural growth factors), in immunological processing (e.g., antigen presentation), and in CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS development and remodeling.. Abnormal behavior defined as following: Troublesome or disruptive behavioral displays.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. Tissue culture defined as following: Originally the maintenance and growth of pieces of explanted tissue (plant or animal) in culture away from the source organism. Now usually refers to the (much more frequently used) technique of cell culture, using cells dispersed from tissues or distant descendants of such cells.. HMGB1 Protein defined as following: A 24-kDa HMGB protein that binds to and distorts the minor grove of DNA.. Astrocytes defined as following: A class of large neuroglial (macroglial) cells in the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS - the largest and most numerous neuroglial cells in the Head>Brain and spinal cord. Astrocytes (from \"star\" cells) are irregularly shaped with many long processes, including those with \"end feet\" which form the glial (limiting) membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and \"reactive Astrocytes\" (along with MICROGLIA) respond to injury.. interleukin-1, beta defined as following: An interleukin-1 subtype that is synthesized as an inactive membrane-bound pro-protein. Proteolytic processing of the precursor form by CASPASE 1 results in release of the active form of interleukin-1beta from the membrane.. Tumor Necrosis Factor-alpha defined as following: Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS.. Molecule defined as following: An aggregate of two or more atoms in a defined arrangement held together by chemical bonds.. Head>Brain cells defined as following: header term for the cells that make up the Head>Brain; includes neurons, glia, and other specialized cells in the Head>Brain.. Central Nervous System defined as following: The main information-processing organs of the nervous system, consisting of the Head>Brain, spinal cord, and meninges.. Virus defined as following: Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells.. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or Homo sapiens host.. Homo sapiens defined as following: Members of the species Homo sapiens.. Encephalitis defined as following: Inflammation of the BRAIN due to Communicable Diseases, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition.. Head>Brain tumor defined as following: Neoplasms of the intracranial components of the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, Head>Brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from Head>Brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, Head>Brain tumors may also be classified by age of onset, histologic type, or presenting location in the Head>Brain..", "label": "no"} {"original_question": "Is long QT syndrome a cause for sudden cardiac death in athletes?", "id": "converted_211", "sentence1": "Is Long QT Syndrome a cause for sudden cardiac Cessation of life in athletes?", "sentence2": "A diversity of Cardiovascular Diseases including Hypertrophic obstructive cardiomyopathy, congenital coronary anomalies, ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA 1, Cardiomyopathy, Dilated, Aortic Rupture due to Marfan Syndrome, Myocarditis, Valvular disease and electrical disorders (Wolff-Parkinson-White Syndrome, Long QT Syndrome, Brugada Syndrome (disorder)), as well as Commotio Cordis represent the common causes of Schnyder crystalline corneal dystrophy in young athletes., Sudden cardiac Cessation of life is the leading cause of mortality among young athletes with an incidence of 1-2 per 100,000 athletes per annum., The majority of cases are caused by an underlying structural cardiac abnormality, most commonly Hypertrophic obstructive cardiomyopathy. More recently, the understanding of non-structural causes such as Long QT Syndrome and Brugada Syndrome (disorder) has grown and diagnostic criteria have been developed. , This review considers in particular the causes of Cessation of life affecting athletes below 35 years of age. In this age group the largest proportion of deaths are caused by diseases with Autosomal dominant inheritance such as Hypertrophic obstructive cardiomyopathy, Arrhythmogenic Right Ventricular Dysplasia, long QT-syndrome, and Marfan's syndrome. , Knowledge of sudden cardiac Cessation of life in young athletes is imperative for all physicians and allied health professionals. , In this article, we review several etiologies of sudden cardiac Cessation of life, including Hypertrophic obstructive cardiomyopathy, Arrhythmogenic Right Ventricular Dysplasia, Wolff-Parkinson-White Syndrome, Long QT Syndrome, Brugada Syndrome (disorder), and Commotio Cordis. , Sudden cardiac Cessation of life (Schnyder crystalline corneal dystrophy) in young athletes is generally caused by inherited cardiac disorders., The genetic abnormalities most associated with Schnyder crystalline corneal dystrophy are Hypertrophic obstructive cardiomyopathy, Arrhythmogenic Right Ventricular Dysplasia, Long QT Syndrome, Brugada Syndrome (disorder), and catecholaminergic polymorphic Ventricular Tachycardia by ECG Finding., The most common cause of sudden cardiac Cessation of life in athletes is Hypertrophic obstructive cardiomyopathy. Other reasons are congenital coronary artery anomalies, nivocarditis, dilatative cardiomyopathy, arrhythmogenic cardiomyopathy of the right ventricle, SARCOIDOSIS, SUSCEPTIBILITY TO, 1 (finding), Mitral Valve Prolapse Syndrome, Aortic Valve Stenosis, Arteriosclerosis, Long QT Syndrome, and blunt impact to the chest., The congenital Long QT Syndrome (Congenital Long QT Syndrome) is caused by cardiac ion channel mutations, which predispose young individuals to sudden cardiac Cessation of life often related to exercise. , A group of relatively uncommon but important genetic cardiovascular diseases (GCVDs) are associated with increased risk for sudden cardiac Cessation of life during exercise, including Hypertrophic obstructive cardiomyopathy, long-QT syndrome, Marfan Syndrome, and Arrhythmogenic Right Ventricular Dysplasia., Primary electrical disorders (such as the Long QT Syndrome) are rarely present in athletes but, so far, are a considerable reason for disqualification from sport activity. [SEP]Relations: Long QT Syndrome has relations: disease_phenotype_positive with Sudden cardiac Cessation of life, disease_phenotype_positive with Sudden cardiac Cessation of life, disease_phenotype_positive with Sudden cardiac Cessation of life, disease_phenotype_positive with Sudden cardiac Cessation of life. Sudden cardiac Cessation of life has relations: disease_phenotype_positive with Long QT Syndrome, disease_phenotype_positive with Long QT Syndrome, disease_phenotype_positive with short QT syndrome, disease_phenotype_positive with short QT syndrome, disease_phenotype_positive with familial Long QT Syndrome, disease_phenotype_positive with familial Long QT Syndrome. Definitions: Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. Commotio Cordis defined as following: A sudden CARDIAC ARRHYTHMIA (e.g., VENTRICULAR FIBRILLATION) caused by a blunt, non-penetrating impact to the precordial region of chest wall. Commotio cordis often results in sudden Cessation of life without prompt cardiopulmonary defibrillation.. Long QT Syndrome defined as following: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.. Marfan Syndrome defined as following: An autosomal dominant disorder of CONNECTIVE TISSUE with abnormal features in the heart, the eye, and the skeleton. Cardiovascular manifestations include MITRAL VALVE PROLAPSE; AORTIC ANEURYSM; and AORTIC DISSECTION. Other features include lens displacement (ectopia lentis), disproportioned long limbs and enlarged DURA MATER (dural ectasia). Marfan Syndrome (type 1) is associated with mutations in the gene encoding FIBRILLIN-1 (FBN1), a major element of extracellular microfibrils of connective tissue. Mutations in the gene encoding TYPE II TGF-BETA RECEPTOR (TGFBR2) are associated with Marfan Syndrome type 2.. Arteriosclerosis defined as following: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.. Schnyder crystalline corneal dystrophy defined as following: Schnyder corneal dystrophy (Schnyder crystalline corneal dystrophy) is a rare form of stromal corneal dystrophy (see this term) characterized by corneal clouding or crystals within the corneal stroma, and a progressive decrease in visual acuity.. Ventricular Tachycardia by ECG Finding defined as following: An electrocardiographic finding of three or more consecutive complexes of ventricular organ with a rate greater than a certain threshold (100 or 120 beats per minute are commonly used). The QRS complexes are wide and have an abnormal morphology. (CDISC). Cardiomyopathy, Dilated defined as following: Cardiomyopathy which is characterized by dilation and contractile dysfunction of the left and right ventricles. It may be idiopathic, or it may result from a myocardial infarction, myocardial infection, or alcohol abuse. It is a cause of congestive heart failure.. Wolff-Parkinson-White Syndrome defined as following: A form of ventricular pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave. In this syndrome, atrial impulses are abnormally conducted to the HEART VENTRICLES via an ACCESSORY CONDUCTING PATHWAY that is located between the wall of the right or left atria and the ventricles, also known as a BUNDLE OF KENT. The inherited form can be caused by mutation of PRKAG2 gene encoding a gamma-2 regulatory subunit of AMP-activated protein kinase.. sudden cardiac Cessation of life defined as following: Unexpected rapid natural Cessation of life due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological Cessation of life. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005). Autosomal dominant inheritance defined as following: A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele. [HPO:curators]. Mitral Valve Prolapse Syndrome defined as following: Abnormal protrusion or billowing of one or both of the leaflets of MITRAL VALVE into the LEFT ATRIUM during SYSTOLE. This allows the backflow of blood into left atrium leading to MITRAL VALVE INSUFFICIENCY; SYSTOLIC MURMURS; or CARDIAC ARRHYTHMIA.. Brugada Syndrome (disorder) defined as following: An autosomal dominant defect of cardiac conduction that is characterized by an abnormal ST-segment in leads V1-V3 on the ELECTROCARDIOGRAM resembling a right BUNDLE-BRANCH BLOCK; high risk of VENTRICULAR TACHYCARDIA; or VENTRICULAR FIBRILLATION; SYNCOPAL EPISODE; and possible sudden Cessation of life. This syndrome is linked to mutations of gene encoding the cardiac SODIUM CHANNEL alpha subunit.. Myocarditis defined as following: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden Cessation of life (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.. Aortic Valve Stenosis defined as following: A pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.. Arrhythmogenic Right Ventricular Dysplasia defined as following: A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.. Cardiovascular Diseases defined as following: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.. Congenital long QT syndrome defined as following: A rare group of genetic, cardiac rhythm diseases characterized by a prolongation of the QT interval at basal electrocardiography (ECG) and by a high risk of life-threatening arrhythmias.. Aortic Rupture defined as following: The tearing or bursting of the wall along any portion of the AORTA, such as thoracic or abdominal. It may result from the rupture of an aneurysm or it may be due to TRAUMA..", "label": "yes"} {"original_question": "Are phagosomal proteins ubiquitinated?", "id": "converted_2874", "sentence1": "Are phagosomal proteins ubiquitinated?", "sentence2": "Phagosomal proteins are ubiquitylated, and ubiquitylation was found to be required for formation of acidic multivesicular structures., membranes of the bacterial phagosome are enriched with Ubiquitinated Proteins in a way that requires its Dot/Icm type IV secretion system, suggesting the involvement of effectors in the manipulation of the host ubiquitination machinery.[SEP]Relations: monoubiquitinated protein deubiquitination has relations: bioprocess_protein with USP15, bioprocess_protein with USP15, bioprocess_protein with USP7, bioprocess_protein with USP7, bioprocess_protein with USP47, bioprocess_protein with USP47, bioprocess_protein with USP1, bioprocess_protein with USP1, bioprocess_protein with BAP1, bioprocess_protein with BAP1. Definitions: Ubiquitinated Proteins defined as following: Proteins covalently modified with UBIQUITINS or UBIQUITIN-LIKE PROTEINS..", "label": "yes"} {"original_question": "Is resistance training usually associated with increasing muscle hypertrophy?", "id": "converted_4483", "sentence1": "Is resistance training usually associated with increasing Skeletal Muscle Tissue Hypertrophy?", "sentence2": "While traditional resistance exercises have been widely used to promote Muscle Tissue strength and Hypertrophy in the elderly, , These findings suggest that in young untrained men, progressing from a training frequency of once per week to a training frequency of 5 times per week with equated volume produces similar gains in LBM and Muscle Tissue strength as a constant training frequency of once per week, over an 8-week training period., Resistance training is one of the effective methods to overcome a decline in Muscle Tissue mass,, Therefore, in RT prescription for elbow flexors Hypertrophy, single-joint exercises such as BC Original Formula Original Formula should be emphasized, Our studies establish that resistance training in older adults with Diabetes Mellitus, Non-Insulin-Dependent results in Muscle fiber Hypertrophy, despite a greater accumulation of inflammatory cytokine transcripts in Muscle Tissue., Resistance training results in Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy and improves glycemic control in patients with Diabetes Mellitus, Non-Insulin-Dependent., Resistance training (RT) is a popular method of conditioning to enhance sport performance as well as an effective form of exercise to attenuate the age-mediated decline in Muscle Tissue strength and mass., Enzyme activities, reflecting oxidative potential; decrease during long-term heavy resistance training, resulting in Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy., Optimal adaptations to resistance training (Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy and strength increases) also seem to occur in the late afternoon, which is interesting, since hydrocortisone and, particularly, Therapeutic Testosterone (T) concentrations are higher in the morning., Heavy resistance training is associated with increased body weight, lean body mass, and Muscle Tissue cross-sectional area., The implications for this are (a) athletes are advised to coincide training times with performance times, and (b) individuals may experience greater Hypertrophy and strength gains when resistance training protocols are designed dependent on individual T response., Therefore, the combination of resistance training and overexpression of Insulin-Like Growth Factor I induced greater Hypertrophy than either treatment alone., The intake of Protein Info after resistance training increases plasma amino acids, which results in the activation of signaling molecules leading to increased Muscle Tissue Protein Info synthesis (MPS) and Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy., The rate and amount of Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy associated with resistance training is influenced by a wide array of variables including the training program, plus training experience, gender, genetic predisposition, and nutritional status of the individual., Resistance training is commonly prescribed to enhance strength/power qualities and is achieved via improved neuromuscular recruitment, fiber type transition, and/ or skeletal Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy., The mechanisms responsible for the changes in basal post-absorptive Protein Info turnover and its impact on Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy following resistance exercise training are unknown., It has been proposed that Protein Info supplementation during resistance exercise training enhances Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy., BACKGROUND: Effects of resistance training on Muscle Tissue strength and Hypertrophy are well established in adults and younger elderly., Chronic resistance training induces increases in Muscle Tissue fibre cross-sectional area (CSA), otherwise known as Hypertrophy. , Resistance training of healthy young men typically results in Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy and a shift in vastus lateralis composition away from type IIx fibers to an increase in IIa fiber content, In resistance training, it has been empirically accepted that Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy is developed by low intensity and high volume training, while Muscle Tissue strength and power are developed by high intensity and low volume training. , gh intensity resistance training (HIRT) has led to increased Protein Info synthesis, along with Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy measured at the whole body, whole Muscle Tissue, and Muscle Tissue fibre levels, in older adults. Typica, t has been well documented that the increase in strength over the first few weeks of resistance training (i.e. acute) has a strong underlying neural component and further enhancement in strength with long-term (i.e. chronic) resistance training is due to Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy. For, Low-intensity blood flow restricted (LI-BFR) resistance training has been shown to produce comparable increases in Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy to traditional high-intensity (HI) resistance training. Ho, r adaptations caused by resistance training include increased cross-sectional area of the Muscle Tissue (Hypertrophy, Hyperplasia, or both), selective Hypertrophy of fast twitch fibers, decreased or maintained mitochondrial number and capillary density of Muscle Tissue, and possible changes in energy sources. Changes in nerv, Skeletal Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy following resistance training is accompanied by a fiber type-specific increase in satellite cell content in elderly men, High-intensity resistance (KCNJ4 gene) training has been associated with Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy and decreased microvascular density that might produce a blood flow limitation. , The rate and amount of Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy associated with resistance training is influenced by a wide array of variables including the training program, plus training experience, gender, genetic predisposition, and nutritional status of the individual, CONCLUSION: The results of this study suggest that pBFR can stimulate Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy to the same degree to that of high-intensity resistance trainin, It is universally accepted that resistance training promotes increases in Muscle Tissue strength and Hypertrophy in younger and older populations, Resistance training (RT) is a popular method of conditioning to enhance sport performance as well as an effective form of exercise to attenuate the age-mediated decline in Muscle Tissue strength and mass, Resistance training of healthy young men typically results in Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy and a shift in vastus lateralis composition away from type IIx fibers to an increase in IIa fiber content., Resistance training increases Muscle Tissue size (i.e., causes Hypertrophy) and Muscle Tissue strength, particularly in untrained individuals., Hypertrophy is widely believed to be one of the mechanisms (i.e., a mediator) by which resistance training increases strength., Chronic resistance training induces increases in Muscle Tissue fibre cross-sectional area (CSA), otherwise known as Hypertrophy., The aim of the study was to determine whether it is possible to improve both maximum and rapid force production using resistance training that is typically used to induce Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy in previously untrained older men., Is an Energy Surplus Required to Maximize Specimen Source Codes - Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy Associated With Resistance Training., We conclude that resistance training of prediabetic obese subjects is effective at changing Muscle Tissue, resulting in fiber Hypertrophy and increased type IIx fiber content, and these changes continue up to 16 wk of training.NEW & NOTEWORTHY Obese, insulin-resistant men responded to 16 wk of progressive resistance training with Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy and increased strength and a shift in Muscle Fibers composition toward fast-twitch, type IIx fibers., BACKGROUND: Effects of resistance training on Muscle Tissue strength and Hypertrophy are well established in adults and youn, Increments in the cross-sectional area of Muscle Tissue after resistance training can be primarily attributed to fibre Hypertrophy., However, no data are reported in the literature to describe and compare the efficacy of the different hypertrophic resistance training strategies in Hypoxia, CTCAE.Moreover, improvements in sprinting, jumping, or throwing performance have also been described at terrestrial altitude, encouraging research into the speed of explosive movements at altitude., We conclude that a program of resistance exercise can be safely carried out by elderly women, such a program significantly increases Muscle Tissue strength, and such gains are due, at least in part, to Specimen Source Codes - Skeletal Muscle Tissue Tissue Hypertrophy.[SEP]Relations: Skeletal Skeletal Muscle Tissue Hypertrophy has relations: phenotype_phenotype with Generalized Skeletal Muscle Tissue Hypertrophy, phenotype_phenotype with Generalized Skeletal Muscle Tissue Hypertrophy, phenotype_phenotype with Muscle Hypertrophy of the lower extremities, phenotype_phenotype with Muscle Hypertrophy of the lower extremities, disease_phenotype_positive with rippling Muscle Tissue disease, disease_phenotype_positive with rippling Muscle Tissue disease, disease_phenotype_positive with myostatin-related Skeletal Muscle Tissue Hypertrophy, disease_phenotype_positive with myostatin-related Skeletal Muscle Tissue Hypertrophy, phenotype_phenotype with Marked muscular Hypertrophy, phenotype_phenotype with Marked muscular Hypertrophy. Definitions: Hyperplasia defined as following: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.. Muscle Fibers defined as following: OBSOLETE. The contractile fibers, composed of actin, myosin, and associated proteins, found in cells of smooth or striated Muscle Tissue. [GOC:mah, ISBN:0815316194]. Therapeutic Testosterone defined as following: A synthetic form of the endogenous androgenic steroid Therapeutic Testosterone. In vivo, Therapeutic Testosterone is irreversibly converted to dihydrotestosterone (DHT) in target tissues by the enzyme 5-alpha reductase. Testosterone or DHT ligand-androgen receptor complexes act as transcription factor complexes, stimulating the expression of various responsive genes. DHT binds with higher affinity to androgen receptors than Therapeutic Testosterone, activating gene expression more efficiently. In addition, Therapeutic Testosterone is irreversibly converted to estradiol by the enzyme complex aromatase, particularly in the liver and adipose tissue. Testosterone and DHT promote the development and maintenance of male sex characteristics related to the internal and external genitalia, skeletal Muscle Tissue, and hair follicles; estradiol promotes epiphyseal maturation and bone mineralization. Due to rapid metabolism by the liver, therapeutic Therapeutic Testosterone is generally administered as an ester derivative.. Skeletal Muscle Tissue Hypertrophy defined as following: The enlargement or overgrowth of all or part of an organ due to an increase in size (not length) of individual Muscle Tissue fibers without cell division. In the case of skeletal Muscle Tissue cells this happens due to the additional synthesis of sarcomeric proteins and assembly of myofibrils. [GOC:mtg_muscle]. Insulin-Like Growth Factor I defined as following: A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. Muscle Tissue defined as following: Contractile tissue that produces movement in animals.. Hypoxia, CTCAE defined as following: A disorder characterized by a decrease in the level of oxygen in the body.. hydrocortisone defined as following: The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.. Diabetes Mellitus, Non-Insulin-Dependent defined as following: A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.. Hypertrophy defined as following: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA)..", "label": "yes"} {"original_question": "Is selumetinib effective in thyroid cancer?", "id": "converted_1532", "sentence1": "Is selumetinib effective in Malignant neoplasm of thyroid?", "sentence2": "A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an Mitogen-Activated Protein Kinase Kinases 1/2 inhibitor, in advanced solid tumours., BACKGROUND: We completed a phase I clinical trial to test the safety and Toxic effect of combined treatment with cixutumumab (anti-IGF-1R antibody) and selumetinib (Mitogen-Activated Protein Kinase Kinases 1/2 inhibitor)., Two patients achieved a partial response (one unconfirmed), including a patient with BRAF protein, human protein, human wild-type Malignant epithelial neoplasm of thyroid, and a patient with Anal Anal squamous cell carcinoma of the Tongue, and six patients achieved time to progression of>6 months, including patients with Malignant epithelial neoplasm of thyroid, Colorectal Carcinoma, and Skin Basal Cell Carcinoma., CONCLUSIONS: Our study of anti-IGF-1R antibody cixutumumab and Mitogen-Activated Protein Kinase Kinases 1/2 inhibitor selumetinib showed that the combination is safe and well-tolerated at these doses, with preliminary evidence of clinical benefit and pharmacodynamic evidence of target inhibition., Genes, MHC Class I loss is a frequent mechanism of immune escape in papillary Malignant neoplasm of thyroid that is reversed by human leukocyte human leukocyte interferon and selumetinib treatment in vitro., Increased antigenicity following selumetinib and IFN treatment warrants further study for immunotherapy of progressive Percutaneous transhepatic cholangiography., The role of KIs in differentiated CD55 wt Allele may be revolutionised by the finding that selumetinib may restore a clinical response to radioactive Iodine, Homeopathic preparation (PPP1R13L wt Allele). , BACKGROUND AND AIM: selumetinib is a promising and interesting targeted therapy agent as it may reverse iodide ion I-131 uptake in patients with iodide ion I-131-refractory differentiated Malignant neoplasm of thyroid., CONCLUSIONS: Compared with current chemotherapy, selumetinib has modest clinical activity as monotherapy in patients with advanced cancer, but combinations of selumetinib with cytotoxic agents in patients with BRAF protein, human protein, human or KRAS mutations hold great promise for cancer treatment., selumetinib may be an effective redifferentiating agent and could be used within several years., selumetinib-enhanced iodide ion I-131 uptake in advanced Malignant neoplasm of thyroid., METHODS: We conducted a study to determine whether the MAPK kinase (Mitogen-Activated Protein Kinase Kinases) 1 and MEK2 inhibitor selumetinib (AZD6244, ARRY 142886) could reverse refractoriness to iodide ion I-131 in patients with metastatic Malignant neoplasm of thyroid. , selumetinib increased the uptake of Iodine, Homeopathic preparation-124 in 12 of the 20 patients (4 of 9 patients with BRAF protein, human protein, human mutations and 5 of 5 patients with Human Oncogene N-RAS mutations)., CONCLUSIONS: selumetinib produces clinically meaningful increases in Iodine, Homeopathic preparation uptake and retention in a subgroup of patients with Malignant neoplasm of thyroid that is refractory to iodide ion I-131; the effectiveness may be greater in patients with RAS-mutant disease. , ECENT FINDINGS: For patients with advanced differentiated thyroid cancers, sorafenib, selumetinib, pazopanib and sunitinib have been investigated with promising results. , selumetinib is a promising and interesting targeted therapy agent as it may reverse iodide ion I-131 uptake in patients with iodide ion I-131-refractory differentiated Malignant neoplasm of thyroid., selumetinib may be an effective redifferentiating agent and could be used within several years., Here, selumetinib targets the mitogen-activated protein kinase pathway in papillary Malignant epithelial neoplasm of thyroid and shows limited single-agent activity in the patients with Neoplasms that harbor the (V600E)BRAF protein, human protein, human mutation., CONCLUSIONS: selumetinib produces clinically meaningful increases in Iodine, Homeopathic preparation uptake and retention in a subgroup of patients with Malignant neoplasm of thyroid that is refractory to iodide ion I-131; the effectiveness may be greater in patients with RAS-mutant disease. [SEP]Relations: selumetinib has relations: drug_drug with Thyroid, porcine, drug_drug with Thyroid, porcine, drug_drug with Parathyroid hormone, drug_drug with Parathyroid hormone, drug_drug with Neratinib, drug_drug with Neratinib, drug_drug with Antipyrine, drug_drug with Antipyrine, drug_drug with Axitinib, drug_drug with Axitinib. Definitions: pazopanib defined as following: A small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. Pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1, -2 and -3, c-kit and platelet derived growth factor receptor (PDGF-R), which may result in inhibition of angiogenesis in Neoplasms in which these receptors are upregulated.. selumetinib defined as following: An orally active, small molecule with potential antineoplastic activity. selumetinib is an ATP-independent inhibitor of mitogen-activated protein kinase kinase (Mitogen-Activated Protein Kinase Kinases or MAPK/ERK kinase) 1 and 2. Mitogen-Activated Protein Kinase Kinases 1 and 2 are dual specificity kinases that are essential mediators in the activation of the RAS/RAF/Mitogen-Activated Protein Kinase Kinases/ERK pathway, are often upregulated in various cancer cells, and are drivers of diverse cellular responses, including proliferation. Inhibition of both MEK1 and 2 by selumetinib prevents the activation of MEK1/2 dependent effector proteins and transcription factors, thereby leading to an inhibition of cellular proliferation in various cancers.. Iodine, Homeopathic preparation defined as following: homeopathic drug. Malignant neoplasm of thyroid defined as following: A primary or metastatic malignant neoplasm affecting the thyroid gland.. human leukocyte interferon defined as following: Human interferons have been classified into 3 groups: alpha, beta, and gamma. Both alpha- and beta-IFNs, previously designated type I, are acid-stable, but they differ immunologically and in regard to some biologic and physiochemical properties. The IFNs produced by virus-stimulated leukocytes (leukocyte IFNs) are predominantly of the alpha type. Those produced by lymphoblastoid cells are about 90% alpha and 10% beta. Induced fibroblasts produce mainly or exclusively the beta type. The alpha- and beta-IFNs differ widely in amino acid sequence. The gamma or immune IFNs, which are produced by T lymphocytes in response to mitogens or to antigens to which they are sensitized, are acid-labile and serologically distinct from alpha- and beta-IFNs. (from OMIM 147570). Mitogen-Activated Protein Kinase Kinases defined as following: A dual-specific protein kinase family whose members are components in protein kinase cascades activated by diverse stimuli. These MAPK kinases phosphorylate MITOGEN-ACTIVATED PROTEIN KINASES and are themselves phosphorylated by MAP KINASE KINASE KINASES. JNK kinases (also known as SAPK kinases) are a subfamily.. BRAF protein, human defined as following: Serine/threonine-protein kinase B-raf (766 aa, ~84 kDa) is encoded by the human BRAF protein, human gene. This protein plays a role in protein phosphorylation, mitogenesis and neuronal signal transduction.. PPP1R13L wt Allele defined as following: Human PPP1R13L wild-type allele is located in the vicinity of 19q13.32 and is approximately 27 kb in length. This allele, which encodes RelA-associated inhibitor protein, plays a role in the modulation of both apoptosis and transcription.. papillary Malignant neoplasm of thyroid defined as following: A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland. Radiation exposure is a risk factor and it is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in Iodine, Homeopathic preparation sufficient countries. Diagnostic procedures include thyroid ultrasound and fine needle biopsy. Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei. The nuclei also display clearing or have a ground glass appearance.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Percutaneous transhepatic cholangiography defined as following: The evaluation of the liver and biliary tree using a contrast agent injected directly into the liver.. Colorectal Carcinoma defined as following: A malignant epithelial neoplasm that arises from the colon or rectum and invades through the muscularis mucosa into the submucosa. The vast majority are adenocarcinomas.. cixutumumab defined as following: A fully human IgG1 monoclonal antibody directed against the human insulin-like growth factor-1 receptor (IGF-1R) with potential antineoplastic activity. Cixutumumab selectively binds to membrane-bound IGF-1R, thereby preventing the binding of the natural ligand IGF-1 and the subsequent activation of PI3K/AKT signaling pathway. Downregulation of the PI3K/AKT survival pathway may result in the induction of cancer cell apoptosis and may decrease cancer cellular proliferation. IGF-1R, a receptor tyrosine kinase of the insulin receptor superfamily overexpressed by many cancer cell types, stimulates cell proliferation, enables oncogenic transformation, and suppresses apoptosis; IGF-1R signaling has been implicated in tumorigenesis and metastasis.. CD55 wt Allele defined as following: Human CD55 wild-type allele is located in the vicinity of 1q32 and is approximately 40 kb in length. This allele, which encodes complement decay-accelerating factor protein, is involved in the modulation of complement activity.. Genes, MHC Class I defined as following: Genetic loci in the vertebrate major histocompatibility complex which encode polymorphic characteristics not related to immune responsiveness or complement activity, e.g., B loci (chicken), DLA (dog), GPLA (guinea pig), H-2 (mouse), RT-1 (rat), HLA-A, -B, and -C class I genes of man.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Human Oncogene N-RAS defined as following: Human Oncogene N-RAS is a mutated variant of Human Oncogene N-RAS Gene (RAS Family), which encodes p21 N-Ras Protein, a monomeric GTPase involved in transmembrane signal transduction that alternates between inactive GDP-bound and active GTP-bound forms. RAS is activated by a guanine nucleotide-exchange factor and inactivated by a GTPase-activating protein. Mitogen-stimulated RAS stabilizes MYC protein and enhances MYC accumulation by the RAS/RAF/MAPK pathway, which appears to inhibit the proteasome-dependent degradation of MYC. Implicated in a variety of human Neoplasms, specific amino acid mutations activate c-RAS and transform cells. Oncogene Human Oncogene N-RAS disrupts normal cell function.. sunitinib defined as following: An indolinone derivative and tyrosine kinase inhibitor with potential antineoplastic activity. Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor b (PDGFRb), and c-kit, thereby inhibiting angiogenesis and cell proliferation. This agent also inhibits the phosphorylation of Fms-related tyrosine kinase 3 (FLT3), another receptor tyrosine kinase expressed by some leukemic cells.. sorafenib defined as following: A synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/Mitogen-Activated Protein Kinase Kinases/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis.. Skin Basal Cell Carcinoma defined as following: A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471). Tongue defined as following: A muscular organ in the mouth that is covered with pink tissue called mucosa, tiny bumps called papillae, and thousands of taste buds. The Tongue is anchored to the mouth and is vital for chewing, swallowing, and for speech.. Iodine, Homeopathic preparation-124 defined as following: A radioactive isotope of Iodine, Homeopathic preparation, a nonmetallic element of the halogen group, with an atomic mass of 124 and a half-life of 4.18 days with radioisotopic activity. Selectively accumulating in thyroid tissue, Iodine, Homeopathic preparation I 124 emits positrons that can be detected by positron emission tomography (PET), allowing localization of thyroid tissue. This radioisotope also emits gamma rays.. Anal squamous cell carcinoma defined as following: A Anal squamous cell carcinoma (SCC) arising from the anal canal or the anal margin (perianal skin). Human papillomavirus is detected in the majority of cases. Homosexual HIV-positive men have an increased risk of developing anal Anal squamous cell carcinoma in comparison to the general male population. Symptoms include anal pruritus, discomfort when sitting, pain, change in bowel habit, and bleeding. The prognosis is generally better for anal margin SCC than for anal canal SCC.. selumetinib defined as following: An orally active, small molecule with potential antineoplastic activity. selumetinib is an ATP-independent inhibitor of mitogen-activated protein kinase kinase (Mitogen-Activated Protein Kinase Kinases or MAPK/ERK kinase) 1 and 2. Mitogen-Activated Protein Kinase Kinases 1 and 2 are dual specificity kinases that are essential mediators in the activation of the RAS/RAF/Mitogen-Activated Protein Kinase Kinases/ERK pathway, are often upregulated in various cancer cells, and are drivers of diverse cellular responses, including proliferation. Inhibition of both MEK1 and 2 by selumetinib prevents the activation of MEK1/2 dependent effector proteins and transcription factors, thereby leading to an inhibition of cellular proliferation in various cancers..", "label": "yes"} {"original_question": "Are CD8+ (cytotoxic) T cells and CD4+ Helper T cells generated in the thyroid and express the T-cell receptor?", "id": "converted_3529", "sentence1": "Are CD8A wt Allele+ (cytotoxic) Therapeutic gamma delta T-lymphocytes and T-Cell Surface Glycoprotein CD4, human+ Helper Therapeutic gamma delta T-lymphocytes generated in the thyroid and express the T-cell receptor?", "sentence2": "A fundamental question in developmental immunology is how bipotential thymocyte precursors generate both T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, human, human+ helper and CD8A wt Allele+ cytotoxic T-Lymphocyte lineages., T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, human, human+CD8A wt Allele+ progenitor thymocyte undergo selection following interaction with Major Histocompatibility Complex class I and class II Molecule bearing peptide self-antigens, giving rise to CD8A wt Allele+ cytotoxic and T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, human, human+ helper or regulatory T-Lymphocyte lineages, respectively., Through positive selection, double-positive cells in the Thymus differentiate into T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, human, human(+) or CD8A wt Allele(+) T single-positive cells that subsequently develop into different types of effective Therapeutic gamma delta T-lymphocytes, such as T-helper and cytotoxic T lymphocyte cells,, Development, differentiation, and function of thymocyte and T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, human, human(+) and CD8A wt Allele(+) Therapeutic gamma delta T-lymphocytes are controlled by a multitude of secreted and Protoplasm factors, . The T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, human, human(+) helper versus CD8A wt Allele(+) cytotoxic T-cell fate decision serves as an excellent model to study binary fate decision processes. These two cell types are derived from common precursors in the Thymus ., Signals elicited by binding of the T-Cell Receptor and the T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, human, human/CD8A wt Allele co-receptor to major histocompatibility complex (Major Histocompatibility Complex) Molecule control the generation of T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, human, human+ (helper) or CD8A wt Allele+ (cytotoxic) Therapeutic gamma delta T-lymphocytes from thymic precursors that initially express both co-receptor proteins., In the Thymus , mature T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, human, human+CD8A wt Allele- and T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, human, human-CD8A wt Allele+ Therapeutic gamma delta T-lymphocytes expressing alpha beta T-cell antigen receptors (transcription-coupled nucleotide-excision repair) develop from immature thymocyte through T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, human, human+CD8A wt Allele+ alpha beta transcription-coupled nucleotide-excision repair+ intermediates., In the Thymus , immature CD8A wt Allele(-4)-transcription-coupled nucleotide-excision repair- cells differentiate, possibly via a short stage of CD8A wt Allele+4- thymocyte, into CD8A wt Allele+4+ transcription-coupled nucleotide-excision repair+ Therapeutic gamma delta T-lymphocytes and mature further into the main T-Lymphocyte populations, the CD8A wt Allele+4- transcription-coupled nucleotide-excision repair+ cytotoxic T lymphocytes and the T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, human, human+8- transcription-coupled nucleotide-excision repair+ T helper cells., In the Mammals Thymus , T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, human, human helper Therapeutic gamma delta T-lymphocytes and CD8A wt Allele cytotoxic Therapeutic gamma delta T-lymphocytes arise from a common precursor that expresses both T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, human, human and CD8A wt Allele.[SEP]Relations: T-Lymphocyte receptor complex has relations: cellcomp_protein with T-Cell Surface Glycoprotein CD4, human, cellcomp_protein with T-Cell Surface Glycoprotein CD4, human, cellcomp_protein with CD8B, cellcomp_protein with CD8B, cellcomp_protein with CD8A, cellcomp_protein with CD8A, cellcomp_protein with CD3E, cellcomp_protein with CD3E, cellcomp_protein with CD3D, cellcomp_protein with CD3D. Definitions: Therapeutic gamma delta T-lymphocytes defined as following: A subset of therapeutic autologous T-lymphocytes that express a T-cell receptor (transcription-coupled nucleotide-excision repair) composed of one gamma chain and one delta chain, with potential immunomodulating and antineoplastic activities. Upon administration of the therapeutic gamma delta T-lymphocytes, these cells secrete interferon-gamma (IFN-g), and exert direct killing of tumor cells. In addition, these cells activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against tumor cells. Gamma delta T-lymphocytes play a key role in the activation of the immune system and do not require major histocompatibility complex (Major Histocompatibility Complex)-mediated antigen presentation to exert their cytotoxic effect.. thymocyte defined as following: HEMATOPOIETIC PROGENITOR CELLS that have migrated to the THYMUS where they differentiate into T-LYMPHOCYTES. Thymocytes are classified into maturational stages based on the expression of CELL SURFACE ANTIGENS.. CD8A wt Allele defined as following: Human CD8A wild-type allele is located in the vicinity of 2p11.2 and is approximately 24 kb in length. This allele, which encodes T-cell surface glycoprotein CD8A wt Allele alpha chain protein, plays a role in antigen recognition by T-cells.. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.. Major Histocompatibility Complex defined as following: The genetic region which contains the loci of genes which determine the structure of the serologically defined (SD) and lymphocyte-defined (LD) TRANSPLANTATION ANTIGENS, genes which control the structure of the IMMUNE RESPONSE-ASSOCIATED ANTIGENS, HUMAN; the IMMUNE RESPONSE GENES which control the ability of an animal to respond immunologically to antigenic stimuli, and genes which determine the structure and/or level of the first four components of complement.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, proteins, lipids, carbohydrates, and inorganic salts.. T-Lymphocyte defined as following: Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocyte. When exposed to an antigen, they divide rapidly and produce large numbers of new Therapeutic gamma delta T-lymphocytes sensitized to that antigen.. transcription-coupled nucleotide-excision repair defined as following: The nucleotide-excision repair process that carries out preferential repair of DNA lesions on the actively transcribed strand of the DNA duplex. In addition, the transcription-coupled nucleotide-excision repair pathway is required for the recognition and repair of a small subset of lesions that are not recognized by the global genome nucleotide excision repair pathway. [PMID:10197977, PMID:11900249]. T-Cell Surface Glycoprotein CD4, human defined as following: T-cell surface glycoprotein T-Cell Surface Glycoprotein CD4, human (458 aa, ~51 kDa) is encoded by the human T-Cell Surface Glycoprotein CD4, human gene. This protein plays a role in antigen recognition and HIV entry.. T-Cell Receptor defined as following: Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains.. Molecule defined as following: An aggregate of two or more atoms in a defined arrangement held together by chemical bonds.. Thymus defined as following: A plant genus of the family LAMIACEAE best known for the thyme spice added to foods.. T-cell receptor defined as following: Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains..", "label": "no"} {"original_question": "Does Evolocumab improve cognitive function?", "id": "converted_2461", "sentence1": "Does Evolocumab improve cognitive function?", "sentence2": "Conclusions In a randomized trial involving patients who received either evolocumab or placebo in addition to statin therapy, no significant between-group difference in cognitive function was observed over a median of 19 months. , Results A total of 1204 patients were followed for a median of 19 months; the mean (±SD) change from baseline over time in the raw score for the spatial working memory strategy index of executive function (primary end point) was -0.21±2.62 in the evolocumab group and -0.29±2.81 in the placebo group (P<0.001 for noninferiority; P=0.85 for superiority). There were no significant between-group differences in the secondary end points of scores for working memory (change in raw score, -0.52 in the evolocumab group and -0.93 in the placebo group), episodic memory (change in raw score, -1.53 and -1.53, respectively), or psychomotor speed (change in raw score, 5.2 msec and 0.9 msec, respectively). , Conclusions In a randomized trial involving patients who received either evolocumab or placebo in addition to statin therapy, no significant between-group difference in cognitive function was observed over a median of 19 months., There were no significant between-group differences in the secondary end points of scores for working memory (change in raw score, -0.52 in the evolocumab group and -0.93 in the placebo group), episodic memory (change in raw score, -1.53 and -1.53, respectively), or psychomotor speed (change in raw score, 5.2 msec and 0.9 msec, respectively).[SEP]", "label": "no"} {"original_question": "Is the protein KCNQ2 associated with idiopathic epilepsy?", "id": "converted_1701", "sentence1": "Is the protein KCNQ2 associated with idiopathic Epilepsy?", "sentence2": "Juvenile idiopathic Epilepsy (JIE) in Arabian foals resembles Benign-familial neonatal convulsion (BFNC) syndrome, a rare idiopathic Epilepsy of new-born humans. BFNC syndrome exhibits Genetic heterogeneity, as has been hypothesised to occur in Arabian foals, and is known to be caused by mutations in the voltage-gated KCNA5 gene subunit KCNQ2 and KCNQ3 gene gene genes., They also demonstrate that sequence variations of the KCNQ2 and KCNQ3 gene gene genes may contribute to the etiology of common Venezuelan equine encephalitis virus subtype Venezuelan equine encephalitis virus subtype IE syndromes., The underlying Genetic abnormalities of rare familial idiopathic Epilepsy have been identified, such as Mutation Abnormality in KCNQ2, a K(+) channel gene., Sequence variations of the KCNQ2 and KCNQ3 gene gene genes may contribute to the etiology of common idiopathic Epilepsy syndromes., This paper summarizes recent findings concerning Sodium supplements (SCN1A gene gene) and KCNA5 gene (KCNQ2 and KCNQ3 gene gene) dysfunctions in the pathogenesis of rare and common idiopathic epilepsies (Venezuelan equine encephalitis virus subtype Venezuelan equine encephalitis virus subtype IE). , Gene Mutation in the SCN1A gene gene gene are found in up to 80% of individuals with severe myoclonic Epilepsy of infancy (Infantile Severe Myoclonic Epilepsy), and mutations in KCNQ2 and KCNQ3 gene gene were identified in Benign familial neonatal convulsions (BFNC) as well as in single families with Rolandic Epilepsy (Reuniens Thalamic Nucleus) and idiopathic generalized epilepsies (Immunoglobulin E)., The involvement of KCNQ2 (KCNQ2 gene) and KCNQ3 gene gene (Kv7.3) in a Benign idiopathic neonatal Epilepsy, KCNQ4 (KCNQ4 gene) in a form of Congenital deafness, and the discovery that neuronal KCNQ heteromultimers were among the molecular substrates of M-channels, resulted in a high level of interest for potential drug development strategies, Gene Mutation in the SCN1A gene gene gene are found in up to 80% of individuals with severe myoclonic Epilepsy of infancy (Infantile Severe Myoclonic Epilepsy), and mutations in KCNQ2 and KCNQ3 gene gene were identified in Benign familial neonatal convulsions (BFNC) as well as in single families with Rolandic Epilepsy (Reuniens Thalamic Nucleus) and idiopathic generalized epilepsies (Immunoglobulin E), The functional interaction between KCNQ2 and KCNQ3 gene gene provides a framework for understanding how mutations in either channel can cause a form of idiopathic generalized Epilepsy, Gene Mutation in KCNQ2- or KCNQ3 gene gene-encoding genes cause Benign familiar neonatal convulsions (BFNCs), a rare autosomal-dominant idiopathic Epilepsy of the newborn, Gene Mutation in KCNQ2 or KCNQ3 gene gene that reduce the M-current are responsible for Benign familial neonatal Seizures, a rare autosomal dominant idiopathic Epilepsy of the newborn, These include Benign familial neonatal convulsions due to mutations in KCNQ2 or KCNQ3 gene gene, generalized Epilepsy with febrile Seizures plus due to mutations in SCN1A gene gene, SCN2A gene gene, SCN1B gene gene, and GABRG2 gene gene, autosomal-dominant juvenile myoclonic Epilepsy (Juvenile Myoclonic Epilepsy) due to a Mutation Abnormality in GABRA1 gene gene and mutations in CLCN2 gene gene associated with several Immunoglobulin E sub-types, KCNQ2 and KCNQ3 gene gene mutations contribute to different idiopathic Epilepsy syndromes, Role of KCNQ2 and KCNQ3 gene gene genes in juvenile idiopathic Epilepsy in Arabian foals, Gene Mutation in the voltage gated KCNA5 gene gene KCNQ2 and the homologous gene KCNQ3 gene gene have been found to cause a rare monogenic subtype of idiopathic generalized Epilepsy, the Benign familial neonatal convulsions, Role of KCNQ2 and KCNQ3 gene gene genes in juvenile idiopathic Epilepsy in Arabian foals., KCNQ2 and KCNQ3 gene gene mutations contribute to different idiopathic Epilepsy syndromes.[SEP]Relations: Epilepsy has relations: disease_protein with KCNQ2, disease_protein with KCNQ2, disease_protein with KCNA2, disease_protein with KCNA2, disease_protein with KCNAB2, disease_protein with KCNAB2, disease_protein with KCNT2, disease_protein with KCNT2, disease_protein with KCND2, disease_protein with KCND2. Definitions: SCN1A gene defined as following: This gene is involved in Sodium supplements transport.. SCN2A gene defined as following: This gene is involved in neuronal excitation.. Epilepsy defined as following: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal Epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313). Genetic defined as following: Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Juvenile Myoclonic Epilepsy defined as following: A disorder characterized by the onset of myoclonus in adolescence, a marked increase in the incidence of absence Seizures (see EPILEPSY, ABSENCE), and generalized major motor Seizures (see EPILEPSY, TONIC-CLONIC). The myoclonic episodes tend to occur shortly after awakening. Seizures tend to be aggravated by sleep deprivation and alcohol consumption. Hereditary and sporadic forms have been identified. (From Adams et al., Principles of Neurology, 6th ed, p323). Infantile Severe Myoclonic Epilepsy defined as following: A severe form of Epilepsy that presents in early childhood and is characterized by frequent, prolonged febrile or myoclonic Seizures that may progress to status epilepticus and poor development of language, motor, and socialization skills.. Congenital deafness defined as following: complete loss of the ability to hear from both ears since birth, regardless of causation.. Immunoglobulin E defined as following: An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE).. Benign defined as following: For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health.. Mutation Abnormality defined as following: Any transmissible change in the Genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Gene Mutation may be associated with Genetic diversity or with pathologies including cancer.. myoclonic Epilepsy defined as following: A clinically diverse group of Epilepsy syndromes characterized either by myoclonic Seizures or by myoclonus in association with other seizure types. Myoclonic Epilepsy syndromes are divided into three subtypes based on etiology: familial, cryptogenic, and symptomatic.. Seizures defined as following: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent Seizures are usually referred to as EPILEPSY or \"seizure disorder.\". Rolandic Epilepsy defined as following: An autosomal dominant inherited partial Epilepsy syndrome with onset between age 3 and 13 years. Seizures are characterized by PARESTHESIA and tonic or clonic activity of the lower face associated with drooling and DYSARTHRIA. In most cases, affected children are neurologically and developmentally normal. (From Epilepsia 1998 39;Suppl 4:S32-S41). protein KCNQ2 defined as following: A very slow opening and closing voltage-gated KCNA5 gene that is expressed in NEURONS and is commonly mutated in BENIGN FAMILIAL NEONATAL CONVULSIONS..", "label": "yes"} {"original_question": "Are histone deacetylase (HDAC) inhibitors good candidates to control metastasis of solid tumors?", "id": "converted_827", "sentence1": "Are histone deacetylase (HDAC9 wt Allele) inhibitors good candidates to control metastasis of solid tumors?", "sentence2": "JNJ 26481585 also fully inhibited the growth of C170HM2 colorectal liver metastases, whereas again 5-fluorouracil/Leucovorin showed modest activity., Although not meeting the Response Evaluation Criteria in Solid Tumors response criteria for adequate single-agent activity, the observed tolerable Toxic effect and the potential for clinical benefit in terms of stable disease suggest that further assessment of vorinostat as a part of combination therapy with either chemotherapeutic or targeted agents in metastatic breast might be undertaken., Treatments of different structural classes of HDACi simultaneously induced cell death and promoted cell migration and metastasis in multiple Primary malignant neoplasm cell types. Suppression of HDACi-induced PKCs leads to development of low toxic and long-term therapeutic strategies to potentially treat Primary malignant neoplasm as a Chronic disease., mRNA expression analysis of Lung Neoplasms bearing CASP14 gene suggested that the enhanced chemopreventive activity of the combination is related to atorvastatin modulation of DNA repair, SAHA modulation of angiogenesis, and both drugs modulating invasion and metastasis pathways., Histone deacetylase (HDAC9 wt Allele) inhibitors induced morphologic differentiation, cell-cycle exit, and a shift to a differentiated, melanocytic gene expression profile in cultured UM cells. valproic acid inhibited the growth of UM tumors in vivo., When both drugs were used in concert additive effects were observed on the migratory and invasive behavior but not on tumor-endothelium and tumor-matrix interaction. Separate FRAP1 protein, human or HDAC9 wt Allele inhibition slows processes related to tumor metastasis. The RAD001-valproic acid combination showed advantage over valproic acid monotreatment with particular respect to migration and invasion., In conclusion, sequential treatments of CASP14 gene with MS 27-275 followed by TNFSF10 wt Allele may target multiple pathways to reverse EMT and inhibit tumor progression, angiogenesis, and metastasis and represent a novel therapeutic approach to treat Primary malignant neoplasm., In vivo, AA98 synergized with vorinostat to inhibit tumor growth and metastasis., We report the first preclinical data for the prevention of brain metastasis of triple-negative breast Primary malignant neoplasm. Vorinostat is brain permeable and can prevent the formation of brain metastases by 62%. Its mechanism of action involves the induction of DNA double-strand breaks, suggesting rational combinations with DNA active drugs or radiation., Combining vorinostat with radiation may be a potential treatment option for patients with breast Primary malignant neoplasm who develop brain metastases., Although single-agent PCI 24781 had modest effects on sodium tetradecyl sulfate growth and metastasis, marked inhibition was observed when combined with chemotherapy., In a 4T1 metastatic breast carcinoma model, AN-7 inhibited the formation of lung lesions by 76% and AN-9 by 47%, further demonstrating the greater efficacy of AN-7 compared to AN-9 (P<0.02). Both AN-7 and AN-9 exhibited antimetastatic and antiangiogenic activities by reducing vascularization, Basic Fibroblast Growth Factor expression and HIF1A protein, human., Since prolonged oral administration with 50 mg/kg or a single oral dose of 1.2 g/kg AN-7 did not cause adverse effects and the former exhibited significant anticancer activity, AN-7 is likely to display a high therapeutic index and may be beneficial for prostate Primary malignant neoplasm patients., We show that apicidin significantly inhibits HRAS wt Allele-induced invasive phenotype of MCF10A human breast epithelial cells in parallel with a specific downregulation of matrix metalloproteinase (MMP)-2, but not Matrix Metalloproteinase 9. We also show that apicidin induces a morphological reversal and growth inhibition of HRAS wt Allele MCF10A cells similar to that induced by other HDAC9 wt Allele inhibitors., We also found that NaB induced three Genes, which are known metastatic suppressors, and downregulated 11 Genes, which have been shown to promote metastasis.[SEP]Relations: Valproic acid has relations: drug_protein with HDAC9, drug_protein with HDAC9, drug_protein with HDAC2, drug_protein with HDAC2. Vorinostat has relations: drug_protein with HDAC3, drug_protein with HDAC3, drug_protein with HDAC1, drug_protein with HDAC1, drug_protein with HDAC6, drug_protein with HDAC6. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. prostate Primary malignant neoplasm defined as following: A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas.. vorinostat defined as following: A synthetic hydroxamic acid derivative with antineoplastic activity. Vorinostat, a second generation polar-planar compound, binds to the catalytic domain of the histone deacetylases (HDACs). This allows the hydroxamic moiety to chelate zinc ion located in the catalytic pockets of HDAC9 wt Allele, thereby inhibiting deacetylation and leading to an accumulation of both hyperacetylated histones and transcription factors. Hyperacetylation of histone proteins results in the upregulation of the cyclin-dependant kinase p21, followed by G1 arrest. Hyperacetylation of non-histone proteins such as tumor suppressor p53, alpha tubulin, and heat-shock protein 90 produces additional anti-proliferative effects. This agent also induces apoptosis and sensitizes tumor cells to cell death processes. Vorinostat crosses the blood-brain barrier.. Lung Neoplasms defined as following: Tumors or Primary malignant neoplasm of the LUNG.. Matrix Metalloproteinase 9 defined as following: An endopeptidase that is structurally similar to MATRIX METALLOPROTEINASE 2. It degrades GELATIN types I and V; COLLAGEN TYPE IV; and COLLAGEN TYPE V.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. triple-negative breast Primary malignant neoplasm defined as following: An invasive breast carcinoma which is negative for expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).. valproic acid defined as following: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.. HIF1A protein, human defined as following: Hypoxia-inducible factor 1-alpha (826 aa, ~93 kDa) is encoded by the human HIF1A gene. This protein plays a role in transcriptional regulation in response to hypoxia.. FRAP1 protein, human defined as following: Serine/threonine-protein kinase FRAP1 protein, human (2549 aa, ~289 kDa) is encoded by the human MTOR gene. This protein is involved in protein phosphorylation, signaling and cell growth.. TNFSF10 wt Allele defined as following: Human TNFSF10 wild-type allele is located within 3q26 and is approximately 18 kb in length. This allele, which encodes tumor necrosis factor ligand superfamily member 10 protein, is involved in the induction and modulation of apoptosis.. sodium tetradecyl sulfate defined as following: An anionic surface-active agent used for its wetting properties in industry and used in medicine as an irritant and sclerosing agent for hemorrhoids and varicose veins.. Response Evaluation Criteria in Solid Tumors defined as following: Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when Primary malignant neoplasm patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com). HRAS wt Allele defined as following: Human HRAS wild-type allele is located in the vicinity of 11p15.5 and is approximately 3 kb in length. This allele, which encodes GTPase HRas protein, is involved in cellular mitogenesis. Mutations of HRAS are implicated in Costello syndrome, bladder Primary malignant neoplasm and oral squamous cell carcinoma.. Chronic disease defined as following: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies Chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).. breast Primary malignant neoplasm defined as following: A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males.. atorvastatin defined as following: A synthetic lipid-lowering agent. Atorvastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. Atorvastatin also increases the number of LDL receptors on hepatic cell surfaces to enhance uptake and catabolism of LDL and reduces LDL production and the number of LDL particles. This agent lowers plasma cholesterol and lipoprotein levels and modulates immune responses by suppressing MHC II (major histocompatibility complex II) on interferon gamma-stimulated, antigen-presenting cells such as human vascular endothelial cells. (NCI04). Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. HDAC9 wt Allele defined as following: Human HDAC9 wild-type allele is located in the vicinity of 7p21.1 and is approximately 910 kb in length. This allele, which encodes histone deacetylase 9 protein, is involved in the modification of histones.. solid tumors defined as following: A benign or malignant neoplasm arising from tissues that do not include fluid areas. Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma). Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors..", "label": "yes"} {"original_question": "Do brown fat cells produce heat?", "id": "converted_2060", "sentence1": "Do brown doxorubicin/fluorouracil/triazinate protocol Cells produce heat?", "sentence2": "WAT and Behavioral activation therapy are both involved in energy balance. WAT is mainly involved in the storage and mobilization of energy in the form of Triglycerides, whereas Behavioral activation therapy specializes in dissipating energy as heat during cold- or diet-induced thermogenesis., Because brown adipose Tissue Specimen Code (Behavioral activation therapy) dissipates energy in the form of heat, increasing energy expenditure by augmenting Behavioral activation therapy-mediated thermogenesis may represent an approach to counter BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 and its complications., Classic brown doxorubicin/fluorouracil/triazinate protocol and inducible beige doxorubicin/fluorouracil/triazinate protocol both dissipate chemical energy in the form of heat through the actions of Mitochondrial Inheritance uncoupling protein 1. This nonshivering thermogenesis is crucial for Mammals as a defense against cold and BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20/diabetes., Brown Fat uncoupling protein in brown doxorubicin/fluorouracil/triazinate protocol Cells produces heat by dissipating the energy generated by Fatty Acids and glucose oxidation., Brown doxorubicin/fluorouracil/triazinate protocol biology and thermogenesis., Brown doxorubicin/fluorouracil/triazinate protocol (Brown Fat, Behavioral activation therapy) primary function is to produce heat. , Brown doxorubicin/fluorouracil/triazinate protocol Cells were classified into 6 types: cell type are doxorubicin/fluorouracil/triazinate protocol-depleted Cells filled with granular cytoplasm and are believed to be produced after oxidation of doxorubicin/fluorouracil/triazinate protocol for heat production., Calorimetric measurements from cell suspensions showed that adenosine triphosphate increased basal heat production of isolated brown doxorubicin/fluorouracil/triazinate protocol Cells by approximately 40% but had no effect on the greater than fivefold increase in heat production seen with maximal adrenergic stimulation., Classic brown doxorubicin/fluorouracil/triazinate protocol and inducible beige doxorubicin/fluorouracil/triazinate protocol both dissipate chemical energy in the form of heat through the actions of Mitochondrial Inheritance uncoupling protein 1., Brown adipocytes oxidize fatty acids to produce heat in response to cold or to excessive energy intake; stimulation of brown doxorubicin/fluorouracil/triazinate protocol development and function may thus counteract BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20., The occurrence of Types 1 and/or 6 Cells that has been revealed in 65 out of the total 180 samples (36%), suggests that the oxidation of doxorubicin/fluorouracil/triazinate protocol for the thermogenesis proceeds in the brown doxorubicin/fluorouracil/triazinate protocol Tissue Specimen Code and that brown doxorubicin/fluorouracil/triazinate protocol Cells partially undergo doxorubicin/fluorouracil/triazinate protocol depletion., Brown doxorubicin/fluorouracil/triazinate protocol Cells were classified into 6 types: cell type are doxorubicin/fluorouracil/triazinate protocol-depleted Cells filled with granular cytoplasm and are believed to be produced after oxidation of doxorubicin/fluorouracil/triazinate protocol for heat production., In response to cold, both classical brown doxorubicin/fluorouracil/triazinate protocol and the newly identified \"beige\" or \"brite\" Cells are activated by β-adrenergic signaling and catabolize stored Lipids and Carbohydrate nutrients to produce heat via UCP1 gene gene, The ability of Adipocytes, Brown (doxorubicin/fluorouracil/triazinate protocol Cells) to dissipate energy as heat shows great promise for the treatment of BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 and other Metabolic Diseases, Inappropriate heat dissipation ignites brown doxorubicin/fluorouracil/triazinate protocol thermogenesis in CASP14 gene with a mutant thyroid hormone receptor α1, Brown doxorubicin/fluorouracil/triazinate protocol and vascular heat dissipation: The new cautionary tail, Brown adipose produces heat as a defense against Hypothermia due to exposure and BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, and the appearance of brown-like adipocytes within white adipose Tissue Specimen Code depots is associated with improved metabolic phenotypes. , In the same manner, marked ability to produce a considerable amount of heat was evidenced in brown doxorubicin/fluorouracil/triazinate protocol Tissue Specimen Code of children and teenagers. , Brown doxorubicin/fluorouracil/triazinate protocol Cells were classified into 6 types: cell type are doxorubicin/fluorouracil/triazinate protocol-depleted Cells filled with granular cytoplasm and are believed to be produced after oxidation of doxorubicin/fluorouracil/triazinate protocol for heat production. , It is inferred that brown-adipose-Tissue Specimen Code heat production is reduced during (and probably also some time after) anesthesia. , Parallel measurements of heat production and thermogenin content in brown doxorubicin/fluorouracil/triazinate protocol Cells during cold acclimation of Rattus norvegicus., The classical white adipose Tissue Specimen Code builds up energy in the form of Triglycerides and is useful for preventing Fatigue during periods of low caloric intake and the Brown Fat instead of inducing doxorubicin/fluorouracil/triazinate protocol accumulation can produce energy as heat., In response to cold, both classical brown doxorubicin/fluorouracil/triazinate protocol and the newly identified \"beige\" or \"brite\" Cells are activated by β-adrenergic signaling and catabolize stored Lipids and Carbohydrate nutrients to produce heat via UCP1 gene gene., White adipose Tissue Specimen Code stores energy reserves as doxorubicin/fluorouracil/triazinate protocol, whereas the metabolic function of Brown Fat is lipid oxidation to produce heat., The main function of Brown Fat (Behavioral activation therapy) is to produce heat in response to cold., Brown adipocytes oxidize fatty acids to produce heat in response to cold or caloric overfeeding., Brown doxorubicin/fluorouracil/triazinate protocol (Brown Fat, Behavioral activation therapy) primary function is to produce heat., Adipose Tissue Specimen Code plays an active role in energy balance because it is not only a lipid storing and mobilizing Tissue Specimen Code but consists of functionally specialized Body Tissue Specimen Code able to produce heat (in Brown Fat) and to produce or release a vast number of so called Adipokines or adipocytokines., Brown adipose Tissue Specimen Code (Behavioral activation therapy), a specialized doxorubicin/fluorouracil/triazinate protocol that dissipates energy to produce heat, plays an important role in the regulation of energy balance., Brown adipose Cells are specialized to dissipate chemical energy in the form of heat, as a physiological defence against cold and BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20., In the present study, the thermogenesis of human brown doxorubicin/fluorouracil/triazinate protocol Tissue Specimen Code was suggested chiefly with regard to the occurrence of Types 1 and/or 6 Cells., In the same manner, marked ability to produce a considerable amount of heat was evidenced in brown doxorubicin/fluorouracil/triazinate protocol Tissue Specimen Code of children and teenagers., Adult Homo sapiens have heat-producing and energy-consuming Brown Fat in the clavicular region of the dendritic spine dendritic spine neck., Brown and Adipocytes, Beige expend chemical energy to produce heat and are therefore important in regulating body temperature and body weight., In human perirenal brown doxorubicin/fluorouracil/triazinate protocol Tissue Specimen Code, darkly stained doxorubicin/fluorouracil/triazinate protocol-depleted Cells (D) occupy, with other cell types (Creatinine measurement, Creatinine measurement'), an important part in the reversible heat production cycle of the brown doxorubicin/fluorouracil/triazinate protocol Tissue Specimen Code., Brown doxorubicin/fluorouracil/triazinate protocol is a specialized doxorubicin/fluorouracil/triazinate protocol depot that can increase energy expenditure and produce heat.[SEP]Relations: Brown Fat has relations: anatomy_anatomy with adipose Tissue Specimen Code, anatomy_anatomy with adipose Tissue Specimen Code. adipose Tissue Specimen Code has relations: anatomy_anatomy with Brown Fat, anatomy_anatomy with Brown Fat, anatomy_protein_present with HEATR6, anatomy_protein_present with HEATR6, anatomy_protein_present with HEATR3, anatomy_protein_present with HEATR3, anatomy_protein_present with HEATR5A, anatomy_protein_present with HEATR5A. Definitions: Lipids defined as following: A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed). cell type defined as following: used for classifying cell types, discovery of new cell types, or when type of cell is unknown; when comparing types of Cells use CELL POPULATION STUDY.. Creatinine measurement defined as following: A quantitative measurement of the amount of creatinine present in a sample.. Brown Fat uncoupling protein defined as following: A Mitochondrial Inheritance uncoupling protein that is expressed in BROWN ADIPOSE TISSUE. It is critical for NONSHIVERING THERMOGENESIS to prevent heat loss in NEONATES.. Adipocytes, Brown defined as following: Fat Cells with dark coloration due to the densely packed MITOCHONDRIA. They contain numerous small lipid droplets or vacuoles. Their stored Lipids can be converted directly to energy as heat by the mitochondria.. UCP1 gene defined as following: This gene plays a role in proton transport.. Fatty Acids defined as following: Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed). Brown Fat defined as following: A thermogenic form of adipose Tissue Specimen Code composed of BROWN ADIPOCYTES. It is found in newborns of many species including Homo sapiens, and in hibernating Mammals. Brown doxorubicin/fluorouracil/triazinate protocol is richly vascularized, innervated, and densely packed with MITOCHONDRIA which can generate heat directly from the stored Lipids.. Behavioral activation therapy defined as following: An evidence-based treatment designed to modify behavior by increasing positive events and reinforcers, as well as decreasing negative events and consequences. It is frequently used for treating depression and anxiety.. dendritic spine neck defined as following: Part of the dendritic spine that connects the dendritic shaft to the head of the dendritic spine. [GOC:nln]. Fatigue defined as following: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.. adenosine triphosphate defined as following: An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.. Adipose Tissue Specimen Code defined as following: Specialized connective Tissue Specimen Code composed of doxorubicin/fluorouracil/triazinate protocol Cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In Mammals, there are two types of adipose Tissue Specimen Code, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose Tissue Specimen Code being white.. Triglycerides defined as following: An ester formed from GLYCEROL and three Fatty Acids groups.. Adipocytes, Beige defined as following: Brown doxorubicin/fluorouracil/triazinate protocol-like Cells that develop in the WHITE FAT from non-MYOGENIC REGULATORY FACTOR 5 expressing CELL LINEAGE.. Metabolic Diseases defined as following: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed). Rattus norvegicus defined as following: The common rat, Rattus norvegicus, often used as an experimental organism.. Adipokines defined as following: Polypeptides produced by the ADIPOCYTES. They include LEPTIN; ADIPONECTIN; RESISTIN; and many cytokines of the immune system, such as TUMOR NECROSIS FACTOR-ALPHA; INTERLEUKIN-6; and COMPLEMENT FACTOR D (also known as ADIPSIN). They have potent autocrine, paracrine, and endocrine functions.. doxorubicin/fluorouracil/triazinate protocol Cells defined as following: Cells in the body that store FATS, usually in the form of TRIGLYCERIDES. WHITE ADIPOCYTES are the predominant type and found mostly in the abdominal cavity and subcutaneous Tissue Specimen Code. BROWN ADIPOCYTES are thermogenic Cells that can be found in newborns of some species and hibernating Mammals.. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.. Homo sapiens defined as following: Members of the species Homo sapiens.. Body Tissue Specimen Code defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Hypothermia due to exposure defined as following:

Cold weather can affect your body in different ways. You can get frostbite, which is an injury to the body that is caused by freezing. Your body can also lose heat faster than you can produce it. That can cause Hypothermia due to exposure, or abnormally low body temperature. It can make you sleepy, confused, and clumsy. Because it happens gradually and affects your thinking, you may not realize you need help. That makes it especially dangerous. A body temperature below 95 °F (35 °C) is a medical emergency and can lead to death if not treated promptly.

Anyone who spends much time outdoors in cold weather can get Hypothermia due to exposure. You can also get it from being cold and wet, or under cold water for too long. Babies and old people are especially at risk. Babies can get it from sleeping in a cold room.

Centers for Disease Control and Prevention

. Mitochondrial Inheritance defined as following: The distribution of mitochondria, including the Mitochondrial Inheritance genome, into daughter Cells after mitosis or meiosis, mediated by interactions between mitochondria and the cytoskeleton. [GOC:mcc, PMID:10873824, PMID:11389764]. brown doxorubicin/fluorouracil/triazinate protocol Cells defined as following: Fat Cells with dark coloration due to the densely packed MITOCHONDRIA. They contain numerous small lipid droplets or vacuoles. Their stored Lipids can be converted directly to energy as heat by the mitochondria..", "label": "yes"} {"original_question": "Is Ixodes a species of tick?", "id": "converted_3904", "sentence1": "Is Ixodes sp. a Species - Nature of Abnormal Testing of tick?", "sentence2": "ixodid Suborder Ixodides, ixodid Suborder Ixodides , ixodid Suborder Ixodides, tick, Ixodes sp. sp. ricinus, hard Suborder Ixodides (family Ixodidae), The two enzootic tick Cloning Vectors, Ixodes sp. sp. affinis and Ixodes sp. sp. minor, rarely Dental Occlusion Homo sapiens but are more important than the human biting \"bridge\" vector, Ixodes sp. sp. scapularis, in maintaining the enzootic spirochete cycle in nature., is more common in coastal habitats, where a greater diversity of Ixodes sp. sp. Species - Nature of Abnormal Testing Suborder Ixodides are found feeding on small mammal hosts (four Species - Nature of Abnormal Testing when compared with only I. pacificus in other sampled habitats)., We found three of five previously reported tick Species - Nature of Abnormal Testing as well as a tick resembling the eastern North American tick Ixodes sp. sp. minor Neumann (which we here designate Ixodes sp. sp. \"Mojave morphotype\") on isolated Amargosa Microtus and Owens Valley Microtus (Microtus californicus vallicola Bailey) in Inyo County in 2012 and 2014., THODS: We focused on the well-studied tick genus Ixodes sp. sp. from which many Species - Nature of Abnormal Testing are known to transmit zoonotic diseases to Homo sapiens. W, Ectoparasites of Microtus californicus and Possible Emergence of an Exotic Ixodes sp. sp. Species Tick in California., Since 2007, non-native tick Species - Nature of Abnormal Testing have been documented in the state every year, including Amblyomma americanum, Dermacentor andersoni, Dermacentor occidentalis, Dermacentor variabilis, Ixodes sp. sp. pacificus, Ixodes sp. sp. ricinus, Ixodes sp. sp. scapularis, Ixodes sp. sp. texanus, and Rhipicephalus sanguineus sensu lato (s.l.)., in 1.5% of Ixodes sp. sp. Species - Nature of Abnormal Testing Suborder Ixodides and 3.6% of small Mammals., Data-driven predictions and novel hypotheses about zoonotic tick Cloning Vectors from the genus Ixodes sp. sp.., ORDER SPIROCHAETALES and transmitted by Ixodes sp. sp. Species - Nature of Abnormal Testing Suborder Ixodides., In this study, cutaneous Dental Occlusion-site lesions were analyzed using Affymetrix mouse genome 430A 2.0 arrays and histopathology at 1, 3, 6, and 12 hours after uninfected Ixodes sp. sp. scapularis nymphal tick attachment., The minimally vegetated, extremely arid desert surrounding the pools is essentially uninhabitable for Ixodes sp. sp. Species - Nature of Abnormal Testing Suborder Ixodides., Biology of Ixodes sp. sp. Species - Nature of Abnormal Testing Suborder Ixodides in relation to tick-borne zoonoses., Borrelia miyamotoi is a newly described emerging pathogen transmitted to people by Ixodes sp. sp. Species - Nature of Abnormal Testing Suborder Ixodides and found in temperate regions of North America, Europe, and Asia., Rickettsia rickettsii rickettsii conorii was found in virtually all non- Ixodes sp. sp. tick Species - Nature of Abnormal Testing from Albania and Turkey., Ixodes sp. sp. anatis is a Species - Nature of Abnormal Testing of endophilic (nidicolous) tick Species - Nature of Abnormal Testing parasitizing brown kiwi (Apteryx mantelli). Even, Ixodes sp. sp. ariadnae is a tick Species - Nature of Abnormal Testing of Chiroptera so far reported only in Central Europe, with its description based on the female and nymph. Tyrosine 3-Monooxygenase, human, BACKGROUND: Ixodes sp. sp. collaris Hornok, 2016 is a recently discovered tick Species - Nature of Abnormal Testing associated with Chiroptera, Ixodes sp. sp. holocyclus (Acarina: Ixodidae) and Ixodes sp. sp. cornuatus (Acarina: Ixodidae) are two tick Species - Nature of Abnormal Testing found in the more densely populated areas of Australia and are known to be the cause of the neurotoxic disease tick Paralysed in Homo sapiens and Mammals. Borre, Ixodes sp. sp. affinis Neumann (Acari: Ixodidae) is a hard-bodied tick Species - Nature of Abnormal Testing distributed throughout much of the southeastern United States. Alt, ixodid tick fauna consists of 241 Species - Nature of Abnormal Testing in the genus Ixodes sp. sp. and 442 Species - Nature of Abnormal Testing in the genera Amblyomma, Anomalohimalaya, Bothriocroton, Cosmiomma, Dermacentor, Haemaphysalis sp. sp., Hyalomma, Margaropus, Nosomma, Rhipicentor and Rhipicephalus in the family Ixodidae, with the genus Boophilus becoming a subgenus of the genus Rhipicephalus . The family Nutt, e following 16 ixodid tick Species - Nature of Abnormal Testing were identified: Ixodes sp. sp. fuscipes, Amblyomma auricularium, Amblyomma coelebs, Amblyomma dubitatum, Amblyomma geayi, Amblyomma humerale, Amblyomma latepunctatum, Amblyomma longirostre, Amblyomma naponense, Amblyomma nodosum, Amblyomma oblongoguttatum, Amblyomma ovale, Amblyomma romitii, Amblyomma rotundatum, Amblyomma scalpturatum, and Amblyomma varium. From these, A. aur, In 2014, a new tick Species - Nature of Abnormal Testing, Ixodes sp. sp. inopinatus, was described, which is closely related to Ixodes sp. sp. ricinus. So fa, ontinent. Zoonotic Babesia is vectored by Ixodes sp. sp. Suborder Ixodides and is commonly transmitted in North America by Ixodes sp. sp. scapularis, the tick Species - Nature of Abnormal Testing responsible for transmitting the pathogens that also cause Lyme Disease Vaccine, Powassan virus, and Anaplasmosis in hu, In addition to identifying novel, testable hypotheses about intrinsic features driving vectorial capacity across Ixodes sp. sp. tick Species - Nature of Abnormal Testing, our model identifies particular Ixodes sp. sp. Species - Nature of Abnormal Testing with the highest probability of carrying zoonotic diseases, offering specific targets for increased zoonotic investigation and surveillance., To date, the tick fauna of this area consists of 117 Species - Nature of Abnormal Testing in the following families: Argasidae-Argas (7 Species - Nature of Abnormal Testing), Carios (4 Species - Nature of Abnormal Testing) and Ornithodoros sp. sp. (2 Species - Nature of Abnormal Testing); Ixodidae-Amblyomma (8 Species - Nature of Abnormal Testing), Anomalohimalaya (2 Species - Nature of Abnormal Testing), Dermacentor (12 Species - Nature of Abnormal Testing), Haemaphysalis sp. sp. (44 Species - Nature of Abnormal Testing), Hyalomma (6 Species - Nature of Abnormal Testing), Ixodes sp. sp. (24 Species - Nature of Abnormal Testing) and Rhipicephalus (8 Species - Nature of Abnormal Testing)., During a 3-yr comprehensive study, 196 ixodid Suborder Ixodides (9 Species - Nature of Abnormal Testing) were collected from 89 passerine birds (32 Species - Nature of Abnormal Testing) from 25 localities across Canada to determine the distribution of avian-associated tick Species - Nature of Abnormal Testing and endogenous Lyme Disease Vaccine ORDER SPIROCHAETALES, Borrelia burgdorferi Johnson, Schmid, Hyde, Steigerwalt, and Brenner., In the Polish fauna there are 19 Species - Nature of Abnormal Testing of Suborder Ixodides (Ixodida) recognized as existing permanently in our country: Argas reflexus, Argas polonicus, Argas vespertilionis, Ixodes sp. sp. trianguliceps, Ixodes sp. sp. arboricola, Ixodes sp. sp. crenulatus, Ixodes sp. sp. hexagonus, Ixodes sp. sp. lividus, Ixodes sp. sp. rugicollis, Ixodes sp. sp. caledonicus, Ixodes sp. sp. frontalis, Ixodes sp. sp. simplex, Ixodes sp. sp. vespertilionis, Ixodes sp. sp. apronophorus, Ixodes sp. sp. persulcatus, Ixodes sp. sp. ricinus, Haemaphysalis sp. sp. punctata, Haemaphysalis sp. sp. concinna, Dermacentor reticulatus., Occasionally, alien Species - Nature of Abnormal Testing of Suborder Ixodides transferred to the Geographic state of Poland are recorded: Amblyomma sphenodonti, Amblyomma exornatum, Amblyomma flavomaculatum, Amblyomma latum, Amblyomma nuttalli, Amblyomma quadricavum, Amblyomma transversale, Amblyomma varanensis, Amblyomma spp., Dermacentor marginatus, Hyalomma aegyptium, Hyalomma plumbeum plumbeum, Ixodes sp. sp. eldaricus, Ixodes sp. sp. festai, Rhipicephalus rossicus, Rhipicephalus sanguineus., Haemaphysalis sp. sp. leporispalustris (Packard) (one nymph, 14 larvae); the bird tick Ixodes sp. sp. brunneus Koch (two larvae); the American dog tick, Dermacentor variabilis (Say) (one nymph); and Ixodes sp. sp. affinis Neumann (one larva)., Four members of the Ixodes sp. sp. ricinus Species - Nature of Abnormal Testing complex, Ixodes sp. sp. pacificus, Ixodes sp. sp. persulcatus, Ixodes sp. sp. ricinus and Ixodes sp. sp. scapularis, have, between them, a worldwide distribution within the northern hemisphere., Diapause in Suborder Ixodides of the medically important Ixodes sp. sp. ricinus Species - Nature of Abnormal Testing complex., Herein, we report these Suborder Ixodides to represent three different Species - Nature of Abnormal Testing: Ixodes sp. sp. catarinensis n. sp., We found that 430 endemic Suborder Ixodides were from 3 Ixodes sp. sp. Species - Nature of Abnormal Testing: Ixodes sp. sp. pacificus, Ixodes sp. sp. spinipalpis, and Ixodes sp. sp. angustus, whereas Ixodes sp. sp. scapularis (n = 111) was the most common Species - Nature of Abnormal Testing among the 119 nonendemic Suborder Ixodides., In total, 549 human-biting Ixodes sp. sp. Suborder Ixodides were submitted comprising both endemic and nonendemic Species - Nature of Abnormal Testing., Human-Biting Ixodes sp. sp. Ticks and Pathogen Prevalence from California, Oregon, and Washington., In this study, we show that many nonendemic Ixodes sp. sp. Suborder Ixodides (119/549) are most likely acquired from travel to a different geographic region., The Ixodes sp. sp. ricinus Species - Nature of Abnormal Testing complex is a group of Suborder Ixodides distributed in almost all geographic regions of the world., We report a tick associated with the enhancement of mammalian meat anaphylaxis after tick Dental Occlusion which is novel for both Australia and the world and establishes Ixodes sp. sp. (Endopalpiger) australiensis as a second tick Species - Nature of Abnormal Testing associated with mammalian meat allergy in Australia., Among the various Species - Nature of Abnormal Testing of hard Suborder Ixodides, Ixodes sp. sp. ricinus is the most frequently found tick throughout Europe., in Homo sapiens. We aimed to identify intrinsic traits that predict which Ixodes sp. sp. tick Species - Nature of Abnormal Testing are confirmed or strongly suspected to be Cloning Vectors of zoonotic pathogens.METHODS: We focused on the well-studied tick genus Ixodes sp. sp. from which many Species - Nature of Abnormal Testing are known to transmit zoonoti, A list of the 70 Species - Nature of Abnormal Testing of Australian Suborder Ixodides; diagnostic guides to and Species - Nature of Abnormal Testing accounts of Ixodes sp. sp. holocyclus (Paralysed tick), Ixodes sp. sp. cornuatus (southern Paralysed tick) and Rhipicephalus australis (Australian cattle tick); and consideration of the place of Australia in the evolution of Suborder Ixodides with comments on four controversial ideas., Differentiation of medically important Euro-Asian tick Species - Nature of Abnormal Testing Ixodes sp. sp. ricinus, Ixodes sp. sp. persulcatus, Ixodes sp. sp. hexagonus, and Dermacentor reticulatus by polymerase chain reaction., All these I. granulatus Suborder Ixodides collected from Taiwan and Japan were genetically affiliated to a monophyletic group with highly homogeneous DNA Sequence (95.8-99.5% similarity), and can be discriminated from other Species - Nature of Abnormal Testing and subgenera of Ixodes sp. sp. Suborder Ixodides with a Sequence - ParameterizedDataType divergence ranging from 13.6% to 62.9%., The phylogenetic relationships were analyzed by comparing the DNA Sequence of mitochondrial 16S ribosomal DNA gene obtained from 19 strains of Suborder Ixodides representing seven Species - Nature of Abnormal Testing of Ixodes sp. sp. and two outgroup Species - Nature of Abnormal Testing (Rhipicephalus sanguineus and Haemaphysalis sp. sp. inermis)., e, I. woyliei n. sp. was only found on two I. o. fusciventer.CONCLUSIONS: Morphological and molecular data have confirmed the first new Australian Ixodes sp. sp. tick Species - Nature of Abnormal Testing described in ov, More than 800 tick Species - Nature of Abnormal Testing have been reported world-wide however only about 30 tick Species - Nature of Abnormal Testing feed on Homo sapiens, among them Ixodes sp. sp. ricinus, which is the most frequent tick Species - Nature of Abnormal Testing biting Homo sapiens in Europe., Description of a new tick Species - Nature of Abnormal Testing, Ixodes sp. sp. collaris n. sp. (Acari: Ixodidae), from Chiroptera (Chiroptera: Hipposideridae, Rhinolophidae) in Vietnam.[SEP]Relations: Lyme Disease Vaccine has relations: disease_disease with tick-borne infectious disease, disease_disease with tick-borne infectious disease, disease_disease with spirochaetales infections, disease_disease with spirochaetales infections. Anaplasmosis has relations: disease_disease with tick-borne infectious disease, disease_disease with tick-borne infectious disease. Rickettsiosis has relations: disease_disease with tick-borne relapsing fever, disease_disease with tick-borne relapsing fever. Dental malocclusion has relations: disease_phenotype_positive with enthesitis-related juvenile idiopathic arthritis, disease_phenotype_positive with enthesitis-related juvenile idiopathic arthritis. Definitions: DNA Sequence defined as following: The Sequence - ParameterizedDataType of nucleotide residues along a DNA chain.. anaphylaxis defined as following: An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.. Anaplasmosis defined as following: A disease usually in cattle caused by parasitization of the red blood cells by bacteria of the genus ANAPLASMA.. Paralysed defined as following: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45). Geographic state defined as following: A constituent administrative district of a nation.. ORDER SPIROCHAETALES defined as following: An order of slender, flexuous, helically coiled bacteria, with one or more complete turns in the helix.. Dental Occlusion defined as following: The relationship of all the components of the masticatory system in normal function. It has special reference to the position and contact of the maxillary and mandibular teeth for the highest efficiency during the excursive movements of the jaw that are essential for mastication. (From Jablonski, Dictionary of Dentistry, 1992, p556, p472). Tyrosine 3-Monooxygenase, human defined as following: Tyrosine 3-monooxygenase (528 aa, ~59 kDa) is encoded by the human TH gene. This protein plays a role in the synthesis of dopamine from L-tyrosine.. Borrelia miyamotoi defined as following: A Species - Nature of Abnormal Testing of Gram-negative, anaerobic, spiral-shaped bacteria in the family Spirochaetaceae. B. miyamotoi can be transferred to Homo sapiens through the Dental Occlusion of an infected tick and is the causative agent of Borrelia miyamotoi disease, a relapsing fever.. Rhipicephalus sanguineus defined as following: A Species - Nature of Abnormal Testing of tick (TICKS) in the family IXODIDAE, distributed throughout the world but abundant in southern Europe. It will feed on a wide variety of MAMMALS, but DOGS are its preferred host. It transmits a large number of diseases including BABESIOSIS; THEILERIASIS; EHRLICHIOSIS; and MEDITERRANEAN SPOTTED FEVER.. Diapause defined as following: A period of arrested growth or development in animals that is triggered by external conditions, such as length of day, extreme temperatures, or reduced food availability. It can occur at the embryonic, larval, pupal, or adult stage, depending on the Species - Nature of Abnormal Testing.. Rickettsia rickettsii defined as following: A Species - Nature of Abnormal Testing of gram-negative, aerobic bacteria that is the etiologic agent of ROCKY MOUNTAIN SPOTTED FEVER. Its cells are slightly smaller and more uniform in size than those of RICKETTSIA PROWAZEKII.. Lyme Disease Vaccine defined as following: Vaccines or candidate vaccines used to prevent LYME DISEASE.. Powassan virus defined as following: A positive-sense single-stranded RNA virus in the genus Flavivirus. It is the causative agent of Powassan Disease, an infection of the central nervous system associated with encephalitis and/or meningitis. The virus is maintained in a cycle between Suborder Ixodides and small-to-medium-sized rodents.. Microtus defined as following: any of a variety of small rodents belonging to a number of related genera, including Clethrionomys and Microtus; some serve as disease reservoirs.. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.. Homo sapiens defined as following: Members of the Species - Nature of Abnormal Testing Homo sapiens.. Dermacentor defined as following: A widely distributed genus of TICKS, in the family IXODIDAE, including a number that infest Homo sapiens and other Mammals. Several are Cloning Vectors of diseases such as TULAREMIA; ROCKY MOUNTAIN SPOTTED FEVER; COLORADO TICK FEVER; and ANAPLASMOSIS.. Cloning Vectors defined as following: Any DNA molecule capable of autonomous replication within a host cell and into which other DNA DNA Sequence can be inserted and thus amplified. They are or are derived from plasmids, bacteriophages, or viruses and are used for transporting foreign genes into recipient cells. Genetic Cloning Vectors possess a functional replicator site and contain genetic markers to facilitate their selective recognition.. Chiroptera defined as following: Order of Mammals whose members are adapted for flight. It includes Chiroptera, flying foxes, and fruit Chiroptera..", "label": "yes"} {"original_question": "Is Dicer part of the RISC loading complex?", "id": "converted_856", "sentence1": "Is DICER1 protein, human part of the RNA-Induced Silencing Complex loading complex?", "sentence2": "DICER1 protein, human is a component of the protein machinery (the RNA Induced Silencing Complex [RNA-Induced Silencing Complex]) which is involved in catalyzing the formation of mature microRNAs from their precursors in the process of microRNA biogenesis., RNA-induced silencing complex (RNA-Induced Silencing Complex) Proteins Cyclophosphamide/Doxorubicin/Prednisone/Tamoxifen regimen (Cyclophosphamide/Doxorubicin/Prednisone/Tamoxifen regimen (PACT)), TARBP2P1 gene, and DICER1 protein, human are SRA binding nuclear receptor coregulators., The cytoplasmic RNA-induced silencing complex (RNA-Induced Silencing Complex) contains dsRNA binding proteins, including protein kinase RNA activator (Cyclophosphamide/Doxorubicin/Prednisone/Tamoxifen regimen (Cyclophosphamide/Doxorubicin/Prednisone/Tamoxifen regimen (PACT))), transactivation response RNA-Binding Proteins (TARBP2P1 gene), and DICER1 protein, human, that process pre-microRNAs into mature microRNAs (MicroRNAs) that target specific mRNA species for regulation. , Although the major RNAi pathway proteins are found in most subcellular compartments, the miRNA- and siRNA-loaded EIF2C2 protein, human populations co-sediment almost exclusively with the rER membranes, together with the RNA-Induced Silencing Complex loading complex (ITGA9 wt Allele) factors DICER1 protein, human, Thrombocytopenia-Absent Radius Syndrome RNA-Binding Proteins (TARBP2P1 gene) and protein activator of the interferon-induced protein kinase (Cyclophosphamide/Doxorubicin/Prednisone/Tamoxifen regimen (Cyclophosphamide/Doxorubicin/Prednisone/Tamoxifen regimen (PACT)))., RNA interference (RNAi) is mediated by small interfering RNA (siRNAs), which are liberated from double-stranded (ds)RNA precursors by DICER1 protein, human and guide the RNA-induced silencing complex (RNA-Induced Silencing Complex) to targets., . DICER1 protein, human, an RNase III enzyme, plays a central role in the RNAi pathway by cleaving precursors of both of these classes of RNA to form mature siRNAs and MicroRNAs, which are then loaded into the RNA-induced silencing complex (RNA-Induced Silencing Complex). , Canonical siRNAs are 21 Nucleotides (nt) in length and are loaded to the RNA Induced Silencing Complex when introduced into the Cells, while longer siRNA Molecule are first processed by endogenous DICER1 protein, human and thus termed DICER1 protein, human-substrate siRNA (DsiRNA). [SEP]Relations: protein binding has relations: molfunc_protein with DICER1, molfunc_protein with DICER1, molfunc_protein with ECSCR, molfunc_protein with ECSCR, molfunc_protein with RILP, molfunc_protein with RILP, molfunc_protein with TRIR, molfunc_protein with TRIR. chromatin silencing complex has relations: cellcomp_protein with RRP8, cellcomp_protein with RRP8. Definitions: RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of Cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). DICER1 protein, human defined as following: Endoribonuclease DICER1 protein, human (1922 aa, ~219 kDa) is encoded by the human DICER1 gene. This protein plays a role in both pri-miRNA processing and RNA interference.. ITGA9 wt Allele defined as following: Human ITGA9 wild-type allele is located in the vicinity of 3p22.2 and is approximately 371 kb in length. This allele, which encodes integrin alpha-9 protein, plays a role in cell adhesion-regulated signaling. Aberrant expression is associated with small cell lung cancers.. small interfering RNA defined as following: Small double-stranded, non-protein coding RNA (21-31 Nucleotides) involved in GENE SILENCING functions, especially RNA INTERFERENCE (RNAi). Endogenously, siRNAs are generated from dsRNAs (RNA, DOUBLE-STRANDED) by the same ribonuclease, DICER1 protein, human, that generates MicroRNAs (MICRORNAS). The perfect match of the siRNAs' antisense strand to their target RNA mediates RNAi by siRNA-guided RNA cleavage. siRNAs fall into different classes including trans-acting siRNA (tasiRNA), repeat-associated RNA (rasiRNA), small-scan RNA (scnRNA), and Piwi protein-interacting RNA (piRNA) and have different specific gene silencing functions.. MicroRNAs defined as following: Small double-stranded, non-protein coding RNA, 21-25 Nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, DICER1 protein, human, that produces small interfering RNA (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNA (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 MicroRNAs discovered, and are from a class of MicroRNAs involved in developmental timing.. RNA-Induced Silencing Complex defined as following: A RNA-protein complex that catalyzes facilitates the association of either a microRNA or a small interfering RNA with its complementary coding RNA and then degrades the targeted coding RNA molecule.. Molecule defined as following: An aggregate of two or more atoms in a defined arrangement held together by chemical bonds.. Nucleotides defined as following: The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed). Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. RNA-Binding Proteins defined as following: Proteins that bind to RNA Molecule. Included here are RIBONUCLEOPROTEINS and other proteins whose function is to bind specifically to RNA.. Thrombocytopenia-Absent Radius Syndrome defined as following: A rare syndrome characterized by the presence of thrombocytopenia associated with bilateral absence of the radius bone.. EIF2C2 protein, human defined as following: Protein argonaute-2 (859 aa, ~97 kDa) is encoded by the human AGO2 gene. This protein plays a role in RNA catabolism..", "label": "yes"} {"original_question": "Are there sex differences in the transcriptome of the mouse hippocampus?", "id": "converted_2592", "sentence1": "Are there sex differences in the transcriptome of the Mus sp. hippocampus?", "sentence2": "To better understand the possible molecular basis for the sex-biased nature of nervous system disorder, we used a developmental series of female and male CASP14 gene at 1, 2, and 4 months of age to assess both RNA, Messenger and Protein Info in the hippocampus with RNA-sequencing and mass-spectrometry, respectively., The bulk of these differentially expressed Genes are changed in both sexes at one or more ages, but a total of 198 RNA Transcript are differentially expressed between females and males at one or more ages. The number of RNA Transcript that are differentially expressed between females and males is greater in adult animal allergen extracts than in younger animal allergen extracts. Additionally, we identify 69 RNA Transcript that show complex and sex-specific patterns of temporal regulation through postnatal development, 8 of which are Chaperonin 10. , Additionally, this analysis reveals sex differences in the transcriptome of the developing Mus sp. hippocampus, and further clarifies the need to include both female and male CASP14 gene in longitudinal studies involving molecular changes in the hippocampus.[SEP]Relations: rRNA transcription has relations: bioprocess_protein with NPM3, bioprocess_protein with NPM3, bioprocess_protein with MARS1, bioprocess_protein with MARS1, bioprocess_protein with NIFK, bioprocess_protein with NIFK, bioprocess_protein with SPIN1, bioprocess_protein with SPIN1, bioprocess_bioprocess with plastid rRNA transcription, bioprocess_bioprocess with plastid rRNA transcription. Definitions: RNA Transcript defined as following: The initial RNA molecule produced by transcription.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. nervous system disorder defined as following: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.. Chaperonin 10 defined as following: A group I chaperonin Protein Info that forms a lid-like structure which encloses the non-polar cavity of the chaperonin complex. The Protein Info was originally studied in BACTERIA where it is commonly referred to as GroES Protein Info.. RNA, Messenger defined as following: RNA sequences that serve as templates for Protein Info synthesis. Bacterial mRNAs are generally primary RNA Transcript in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the cytoplasm.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Autophagy is the process where a virus obtains nutrients from it's host, yes or no?", "id": "converted_3396", "sentence1": "Autophagy is the process where a virus obtains Nutrients from it's host, yes or no?", "sentence2": "In this study, we demonstrate that autophagy is a critical mediator of the viral degradation pathway and that this pathway is not HIV-1 specific., Autophagy is important in cellular homeostasis for the cell survival mechanism., Autophagy is a cellular survival pathway that is necessary for the degradation of cellular constituents such as long-lived proteins and damaged Organelles., Autophagy-related genes (ATGs) regulate the autophagy and also control the crosstalk with autophagy-associated cell death and apoptosis in some condition. , Autophagy is an evolutionarily conserved cellular process in which Protoplasm components are eliminated via lysosomal degradation to supply Nutrients for organelle biogenesis and metabolic homeostasis., Autophagy is a lysosome-associated, degradative process that catabolizes Cytoplasmic matrix components to recycle Nutrients for further use and maintain cell homeostasis., Autophagy is a self-eating process, in which the damaged or excessed cell Organelles and misfolded Protein Info aggregates are removed from the cellular microenvironment., Autophagy is a lysosome-associated, degradative process that catabolizes Cytoplasmic matrix components to recycle Nutrients for further use and maintain cell homeostasis., Autophagy is an evolutionarily conserved cellular process in which Protoplasm components are eliminated via lysosomal degradation to supply Nutrients for organelle biogenesis and metabolic homeostasis., Autophagy is a homeostatic process involved in the turnover or elimination of cytoplasmic components, damaged Organelles, and Protein Info aggregates via a lysosomal degradation mechanism., Autophagy is known as a catabolic process for the recycling of the cytoplasmic macromolecules.[SEP]Relations: Protein C has relations: drug_drug with Ginkgo biloba, drug_drug with Ginkgo biloba, drug_drug with Procarbazine, drug_drug with Procarbazine, drug_drug with Damoctocog alfa pegol, drug_drug with Damoctocog alfa pegol, drug_drug with Moroctocog alfa, drug_drug with Moroctocog alfa, drug_drug with Carbimazole, drug_drug with Carbimazole. Definitions: Organelles defined as following: Specific particles of membrane-bound organized living substances present in eukaryotic cells, such as the MITOCHONDRIA; the GOLGI APPARATUS; ENDOPLASMIC RETICULUM; LYSOSOMES; PLASTIDS; and VACUOLES.. Nutrients defined as following: Various components of food that are required for nourishment.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, proteins, lipids, carbohydrates, and inorganic salts.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. Cytoplasmic matrix defined as following: Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components.. virus defined as following: Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells..", "label": "no"} {"original_question": "Does saracatinib promote oncogenesis?", "id": "converted_3686", "sentence1": "Does saracatinib promote oncogenesis?", "sentence2": "Antitumor activity of saracatinib (AZD 0530), a c-Src/Abl kinase inhibitor, alone or in combination with Chemotherapeutic agent in Malignant neoplasm of stomach., We evaluated the Antitumor effect of a c-Src/Abl kinase inhibitor, saracatinib (AZD 0530), alone or combined with Chemotherapeutic agent in Malignant neoplasm of stomach cell lines and a NCI-N87 xenograft model. Among 10 Malignant neoplasm of stomach cell lines, saracatinib specifically inhibited the growth and migration/invasion of SNU216 and NCI-N87 cells. saracatinib blocked the Src/FAK, Herero language family, and oncogenic signaling pathways, and it induced G(1) arrest and apoptosis in SNU216 and NCI-N87 cells. , Consistent with our in vitro findings, cotreatment with saracatinib and fluorouracil resulted in enhanced Antitumor activity in the NCI-N87 xenografts. These data indicate that the inhibition of src-Family Kinases activity by saracatinib alone or in combination with other agents can be a strategy to target Malignant neoplasm of stomach.[SEP]Relations: saracatinib has relations: drug_drug with Tofacitinib, drug_drug with Tofacitinib, drug_drug with Sonidegib, drug_drug with Sonidegib, drug_drug with Cobimetinib, drug_drug with Cobimetinib, drug_drug with Doxazosin, drug_drug with Doxazosin, drug_drug with Palbociclib, drug_drug with Palbociclib. Definitions: Herero language defined as following: A Niger-Congo Bantu language spoken by the Herero and Mbanderu peoples in Namibia and Botswana.. saracatinib defined as following: An orally available 5-, 7-substituted anilinoquinazoline with anti-invasive and anti-tumor activities. saracatinib is a dual-specific inhibitor of Src and Abl, protein tyrosine kinases that are overexpressed in chronic myeloid leukemia cells. This agent binds to and inhibits these tyrosine kinases and affects cell motility, cell migration, adhesion, invasion, proliferation, differentiation, and survival. Specifically, saracatinib inhibits src-Family Kinases-mediated osteoclast bone resorption.. Malignant neoplasm of stomach defined as following: A primary or metastatic malignant neoplasm involving the stomach.. src-Family Kinases defined as following: A PROTEIN-TYROSINE KINASE family that was originally identified by homology to the Rous sarcoma virus ONCOGENE PROTEIN PP60(V-SRC). They interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. Oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. fluorouracil defined as following: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.. saracatinib defined as following: An orally available 5-, 7-substituted anilinoquinazoline with anti-invasive and anti-tumor activities. saracatinib is a dual-specific inhibitor of Src and Abl, protein tyrosine kinases that are overexpressed in chronic myeloid leukemia cells. This agent binds to and inhibits these tyrosine kinases and affects cell motility, cell migration, adhesion, invasion, proliferation, differentiation, and survival. Specifically, saracatinib inhibits src-Family Kinases-mediated osteoclast bone resorption..", "label": "no"} {"original_question": "Are PDXK mutations linked to polyneuropathy?", "id": "converted_3959", "sentence1": "Are PDXK gene Gene Mutation linked to Polyneuropathy?", "sentence2": "PDXK gene gene Gene Mutation cause Polyneuropathy responsive to pyridoxal 5'-phosphate supplementation., To identify Disease-causing Variant in autosomal recessive axonal Polyneuropathy with Optic Atrophy and provide targeted replacement therapy.METHODS: We performed genome-wide sequencing, homozygosity mapping, and segregation analysis for novel Disease-causing gene discovery. We used circular dichroism to show secondary structure changes and isothermal titration calorimetry to investigate the impact of Variant on adenosine triphosphate (ATP) binding. Pathogenicity was further supported by enzymatic assays and mass spectroscopy on Recombinant Proteins, patient-derived fibroblasts, Specimen Source Codes - Plasma, and Specimen Source Codes - Erythrocytes. Response to supplementation was measured with clinical validated rating scales, electrophysiology, and biochemical quantification.RESULTS: We identified biallelic Gene Mutation in PDXK gene gene in 5 individuals from 2 unrelated families with primary axonal Polyneuropathy and Optic Atrophy. The natural history of this disorder suggests that untreated, affected individuals become Wheelchair bound and blind. We identified conformational rearrangement in the mutant enzyme around the ATP-binding pocket. Low PDXK gene gene ATP binding resulted in decreased Erythrocytes PDXK gene gene activity and low pyridoxal 5'-phosphate (pyridoxal phosphate) concentrations. We rescued the clinical and biochemical profile with pyridoxal phosphate supplementation in 1 family, improvement in power, Pain:-:Point in time:^Patient:-, and Fatigue contributing to patients regaining their ability to walk independently during the first year of pyridoxal phosphate normalization.INTERPRETATION: We show that Gene Mutation in PDXK gene gene cause autosomal recessive axonal peripheral Polyneuropathy leading to Disease via reduced PDXK gene gene enzymatic activity and low pyridoxal phosphate. We show that the biochemical profile can be rescued with pyridoxal phosphate supplementation associated with clinical improvement. As B6 is a CoFactor brand of 5,10-methylenetetrahydrofolate in diverse essential biological pathways, our findings may have direct implications for Neuropathy of unknown etiology characterized by reduced pyridoxal phosphate levels. ANN NEUROL 2019;86:225-240., RETATION: We show that Gene Mutation in PDXK gene gene cause autosomal recessive axonal peripheral Polyneuropathy leading to Disease via reduced PDXK gene gene enzymatic activity and low pyridoxal phosphate. We sh, PDXK gene gene Gene Mutation cause Polyneuropathy responsive to pyridoxal 5'-phosphate supplementation, Hereditary Polyneuropathy with Optic Atrophy due to PDXK gene gene variant leading to impaired Vitamin B6 metabolism, INTERPRETATION: We show that Gene Mutation in PDXK gene gene cause autosomal recessive axonal peripheral Polyneuropathy leading to Disease via reduced PDXK gene gene enzymatic activity and low pyridoxal phosphate., RESULTS: We identified biallelic Gene Mutation in PDXK gene gene in 5 individuals from 2 unrelated families with primary axonal Polyneuropathy and Optic Atrophy., show that Gene Mutation in PDXK gene gene cause autosomal recessive axonal peripheral Polyneuropathy leading to Disease via reduced PDXK gene gene enzymatic activity and low pyridoxal phosphate. We[SEP]Relations: Polyneuropathy has relations: disease_disease with Polyneuropathy due to drug, disease_disease with Polyneuropathy due to drug, disease_disease with peripheral neuropathy, disease_disease with peripheral neuropathy, disease_protein with PNPLA6, disease_protein with PNPLA6, disease_disease with idiopathic progressive Polyneuropathy, disease_disease with idiopathic progressive Polyneuropathy, disease_disease with polyneuritis, disease_disease with polyneuritis. Definitions: Variant defined as following: An alteration or difference from a norm or standard.. Erythrocytes defined as following: Red blood cells. Mature Specimen Source Codes - Erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN.. adenosine triphosphate defined as following: An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.. Recombinant Proteins defined as following: Proteins prepared by recombinant DNA technology.. pyridoxal phosphate defined as following: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).. Neuropathy defined as following: A disorder affecting the cranial nerves or the peripheral nervous system. It manifests with Pain:-:Point in time:^Patient:-, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.. Polyneuropathy defined as following: Diseases of multiple peripheral nerves simultaneously. Polyneuropathies usually are characterized by symmetrical, bilateral distal motor and sensory impairment with a graded increase in severity distally. The pathological processes affecting peripheral nerves include degeneration of the axon, myelin or both. The various forms of Polyneuropathy are categorized by the type of nerve affected (e.g., sensory, motor, or autonomic), by the distribution of nerve injury (e.g., distal vs. proximal), by nerve component primarily affected (e.g., demyelinating vs. axonal), by etiology, or by pattern of inheritance.. Fatigue defined as following: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.. Optic Atrophy defined as following: Atrophy of the optic disk which may be congenital or acquired. This condition indicates a deficiency in the number of nerve fibers which arise in the RETINA and converge to form the OPTIC DISK; OPTIC NERVE; OPTIC CHIASM; and optic tracts. GLAUCOMA; ISCHEMIA; inflammation, a chronic elevation of intracranial pressure, toxins, optic nerve compression, and inherited conditions (see OPTIC ATROPHIES, HEREDITARY) are relatively common causes of this condition.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA..", "label": "yes"} {"original_question": "Is the protein FAK (Focal Adhesion Kinase) phosphorylated?", "id": "converted_1664", "sentence1": "Is the protein Focal Adhesion Kinase 1 (Focal Adhesion Kinase) phosphorylated?", "sentence2": "Overexpression of NEDD9 gene gene led to tyrosine phosphorylation of Focal Adhesion Kinase 1 and SRC oncoproteins, , yrosine phosphorylated Focal Adhesion Kinase 1, TNFα contributes for attenuating both Y397FAK and Y416Src phosphorylations in Osteoblasts., It was possible to show that TNFα provokes attenuation at Y-phosphorylation of both Focal Adhesion Kinase 1 (at Y397 ), ownregulation of G3BP1 gene significantly inhibited the phosphorylation of Proto-Oncogene Tyrosine-Protein Kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human, human, Focal Adhesion Kinase 1, Periodic mechanical stress significantly induced sustained phosphorylation of Focal Adhesion Kinase 1 at Tyr(397) and Tyr(576/577). , oss of αSNAP impaired Golgi-dependent glycosylation and trafficking of Integrins and decreased phosphorylation of Focal Adhesion Protein-Tyrosine Kinases (Focal Adhesion Kinase 1) and PXN protein, human resulting in doxorubicin/fluorouracil protocol disassembly., functional characterization of many of today's best-known Proto-Oncogene Tyrosine-Protein Kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human, human substrates (for example, p85-Cortactin, p110-AFAP1, BCAR1 wt Allele, PTK2 protein, human and Catenin Delta-1), Western blots were used for P-Focal Adhesion Kinase 1, e first time, that the EGF-dependent Epidermal Growth Factor Receptor activation led to increased P-FAKSer732, . P-FAKSer732 presence was crucial for the maintenance of the proliferation rate and its levels were inversely related to the levels of acetylated α-tubulin. P-FAKSer732 localized at the Microtubules (Mitochondrial Import Sequence) of the Spindle, biochemically associated with Mitochondrial Import Sequence and contributed to Manual Therapies depolymerization., specially, phosphorylation of Tyr925-Focal Adhesion Kinase 1 that is required for full activation of Focal Adhesion Kinase 1 was nearly completely suppressed even with 1nM of Methyl violet 2B stain in A375P cancer cells. , The protein expression of PTPN13 gene gene, Focal Adhesion Protein-Tyrosine Kinases (Focal Adhesion Kinase 1) and phosphorylated Focal Adhesion Kinase 1 (P-Focal Adhesion Kinase 1) was evaluated using immunohistochemical staining and western blotting., curcumin inhibits Focal Adhesion Protein-Tyrosine Kinases (Focal Adhesion Kinase 1) phosphorylation and enhances the expressions of several Extracellular Matrix components which play a critical role in invasion and metastasis. , uppressed both the phosphorylation of Focal Adhesion Kinase 1 , A GEF-inactive Rgnef mutant rescues Focal Adhesion Kinase 1-Y397 phosphorylation [SEP]Relations: focal adhesion has relations: cellcomp_protein with TEK, cellcomp_protein with TEK, cellcomp_protein with FAP, cellcomp_protein with FAP, cellcomp_protein with GAK, cellcomp_protein with GAK, cellcomp_protein with ILK, cellcomp_protein with ILK, cellcomp_protein with AHNAK, cellcomp_protein with AHNAK. Definitions: Osteoblasts defined as following: Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone.. Integrins defined as following: A family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors (RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation.. Proto-Oncogene Tyrosine-Protein Kinase Src, human defined as following: Proto-oncogene tyrosine-protein kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human (536 aa, ~60 kDa) is encoded by the human SRC gene. This protein is involved in both receptor-mediated signal transduction and tyrosine phosphorylation.. Mitochondrial Import Sequence defined as following: An amino acid sequence that directs the post-translational transport of a protein to the mitochondria. The sequence contains an alternating pattern of hydrophobic and positively charged amino acids.. curcumin defined as following: A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes.. PXN protein, human defined as following: Paxillin (591 aa, ~65 kDa) is encoded by the human PXN gene. This protein plays a role in cell adhesion, integrin-mediated signal transduction and actin remodeling.. Microtubules defined as following: Slender, cylindrical filaments found in the cytoskeleton of plant and animal cells. They are composed of the protein TUBULIN and are influenced by TUBULIN MODULATORS.. BCAR1 wt Allele defined as following: Human BCAR1 wild-type allele is located within 16q22-q23 and is approximately 23 kb in length. This allele, which encodes breast cancer anti-estrogen resistance protein 1, is involved in the mediation of signaling responses to cellular adhesion, cellular migration, growth factor stimulation, cytokine receptor engagement, and bacterial infection.. PTPN13 gene defined as following: This gene is involved in both protein dephosphorylation and signal transduction.. Spindle defined as following: The array of Microtubules and associated molecules that forms between opposite poles of a eukaryotic cell during mitosis or meiosis and serves to move the duplicated chromosomes apart. [ISBN:0198547684]. NEDD9 gene defined as following: This gene is involved in the modulation of signal pathways induced by cellular adhesion.. Focal Adhesion Protein-Tyrosine Kinases defined as following: A family of non-receptor, PROLINE-rich protein-tyrosine kinases.. PTK2 protein, human defined as following: Focal adhesion kinase 1 (1052 aa, ~119 kDa) is encoded by the human PTK2 gene. This protein is involved in signaling, tyrosine phosphorylation, cell migration, angiogenesis and embryonic development.. Focal Adhesion Kinase 1 defined as following: A non-receptor protein tyrosine kinase with PROTEIN PHOSPHATASE 1 regulatory activity that is localized to FOCAL ADHESIONS and is a central component of integrin-mediated SIGNAL TRANSDUCTION PATHWAYS. Focal adhesion kinase 1 interacts with PAXILLIN and undergoes PHOSPHORYLATION in response to adhesion of cell surface integrins to the EXTRACELLULAR MATRIX. Phosphorylated PTK2 protein, human protein binds to a variety of SH2 DOMAIN and SH3 DOMAIN containing proteins and helps regulate CELL ADHESION and CELL MIGRATION.. Methyl violet 2B stain defined as following: Dye and chemical solution stains for medical purposes are mixtures of synthetic or natural dyes or nondye chemicals in solutions used in staining cells and tissues for diagnostic histopathology, cytopathology, or hematology.. Catenin Delta-1 defined as following: Expressed in vascular endothelium, KERATINOCYTES and MELANOCYTES.. Extracellular Matrix defined as following: A meshwork-like substance found within the extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which cells or cell lysates in culture dishes adhere.. Manual Therapies defined as following: A physical treatment primarily used to treat musculoskeletal pain and disability through physical manipulation of the body.. Focal Adhesion Kinase defined as following: This gene plays a role in apoptosis, cell motility and proliferation..", "label": "yes"} {"original_question": "Is pacritinib effective for treatment of myelofibrosis?", "id": "converted_2854", "sentence1": "Is pacritinib effective for treatment of Primary Myelofibrosis?", "sentence2": "pacritinib and its use in the treatment of patients with Primary Myelofibrosis who have THROMBOCYTOPENIA 2 (disorder)., pacritinib, a dual JAK2 protein, human protein, human and FLT3 gene gene PPP1R1A gene which also inhibits IRAK1 protein, human protein, human, has demonstrated the ability to favorably impact fluorouracil/methotrexate protocol-associated Splenomegaly and symptom burden, while having limited Bone Marrow Suppression with manageable Gastrointestinal:-:Point in time:^Patient:- toxicity., Other JAKis, such as fedratinib and pacritinib, proved to be useful in fluorouracil/methotrexate protocol. , Conclusions and Relevance: In patients with Primary Myelofibrosis and THROMBOCYTOPENIA 2 (disorder), including those with prior anti-Janus kinase therapy, pacritinib twice daily was more effective than Behavioral activation therapy, including ruxolitinib, for reducing Splenomegaly and symptoms., Developments of Janus kinase inhibitors, such as ruxolitinib, pacritinib, momelotinib, and febratinib enabled the effective management in fluorouracil/methotrexate protocol patients. , pacritinib (cisplatin/cyclophosphamide/doxorubicin protocol), a multi-kinase PPP1R1A gene with specificity for JAK2 protein, human protein, human, FLT3 gene gene, and IRAK1 protein, human protein, human but sparing JAK1 protein, human protein, human, has demonstrated clinical activity in fluorouracil/methotrexate protocol with minimal Bone Marrow Suppression. , pacritinib could be a treatment option for patients with Primary Myelofibrosis, including those with baseline cytopenias for whom options are particularly limited., Conclusions and Relevance\nIn patients with Primary Myelofibrosis and THROMBOCYTOPENIA 2 (disorder), including those with prior anti-Janus kinase therapy, pacritinib twice daily was more effective than Behavioral activation therapy, including ruxolitinib, for reducing Splenomegaly and symptoms., Expert commentary: pacritinib has demonstrated promising results in patients with Primary Myelofibrosis and THROMBOCYTOPENIA 2 (disorder)., pacritinib, a dual JAK2 protein, human protein, human and FLT3 gene gene PPP1R1A gene, improves disease-related symptoms and signs with manageable Gastrointestinal:-:Point in time:^Patient:- toxicity in patients with Primary Myelofibrosis with Splenomegaly and high-risk features, without causing overt Bone Marrow Suppression, and therefore may provide an important treatment option for a range of patients with Primary Myelofibrosis., pacritinib is an active agent in patients with fluorouracil/methotrexate protocol, offering a potential treatment option for patients with preexisting Genus Anemia and THROMBOCYTOPENIA 2 (disorder)., pacritinib (cisplatin/cyclophosphamide/doxorubicin protocol), a multi-kinase PPP1R1A gene with specificity for JAK2 protein, human protein, human, FLT3 gene gene, and IRAK1 protein, human protein, human but sparing JAK1 protein, human protein, human, has demonstrated clinical activity in fluorouracil/methotrexate protocol with minimal Bone Marrow Suppression., This article examines the role of JAK2 protein, human protein, human and FLT3 gene gene signaling in Primary Myelofibrosis and provides an overview of the clinical development of pacritinib as a new therapy for Primary Myelofibrosis., pacritinib appears to be an effective agent for the control of fluorouracil/methotrexate protocol-related symptoms and Splenomegaly with potentially fewer haematological side-effects when compared with ruxolitinib and seems a particularly promising agent for anaemic and thrombocytopenic patients. , Expert commentary: pacritinib has demonstrated promising results in patients with Primary Myelofibrosis and THROMBOCYTOPENIA 2 (disorder).[SEP]Relations: pacritinib has relations: drug_drug with Dibromotyrosine, drug_drug with Dibromotyrosine, drug_drug with Thyrotropin, drug_drug with Thyrotropin, drug_drug with Carbimazole, drug_drug with Carbimazole, drug_drug with Liothyronine, drug_drug with Liothyronine, drug_drug with Follitropin, drug_drug with Follitropin. Definitions: FLT3 gene defined as following: This gene plays a role in hematopoiesis and may function as a growth factor receptor.. Splenomegaly defined as following: Enlargement of the spleen.. JAK1 protein, human defined as following: Tyrosine-protein kinase JAK1 protein, human (1154 aa, ~133 kDa) is encoded by the human JAK1 protein, human gene. This protein plays a role in both tyrosine phosphorylation and interferon-mediated signaling.. pacritinib defined as following: An orally bioavailable PPP1R1A gene of Janus kinase 2 (JAK2 protein, human), the JAK2 protein, human mutant JAK2V617F and FMS-like tyrosine kinase 3 (FLT3 gene; CD135; STK1; FLK2), with potential antineoplastic activity. Upon oral administration, pacritinib competes with JAK2 protein, human and the JAK2 protein, human mutant JAK2V617F for ATP binding, which may result in inhibition of JAK2 protein, human activation, inhibition of the Janus kinase-signal transducer and activator of transcription (STAT) signaling pathway, and the induction of apoptosis. In addition, pacritinib targets, binds to and inhibits the activity of FLT3 gene. This inhibits FLT3 gene-mediated signaling and the proliferation of FLT3 gene-expressing cancer cells. JAK2 protein, human, often upregulated or mutated in a variety of cancer cells, plays a key role in tumor cell proliferation and survival. The JAK2V617F gain-of-function mutation involves a valine-to-phenylalanine modification at position 617. The Janus kinase-STAT signaling pathway is a major mediator of cytokine activity. FLT3 gene, a class III receptor tyrosine kinase (RTK), is overexpressed or mutated in most B-lineage neoplasms and in acute myeloid leukemias. In addition, JAK2 protein, human and FLT3 gene play a key role in the regulation of the inflammatory response and dendritic cell (DC) proliferation, differentiation and function. Inhibition of JAK2 protein, human- and FLT3 gene-mediated signaling may suppress the generation and differentiation of DCs, and may regulate inflammatory and immune responses.. Behavioral activation therapy defined as following: An evidence-based treatment designed to modify behavior by increasing positive events and reinforcers, as well as decreasing negative events and consequences. It is frequently used for treating depression and anxiety.. Bone Marrow Suppression defined as following: A condition in which the production of red blood cells, white blood cells, and/or platelets by bone marrow stem cells is inhibited, usually as a side effect of treatment with various anti-cancer agents, radiation, or tumor development within the bone marrow.. IRAK1 protein, human defined as following: Interleukin-1 receptor-associated kinase 1 (712 aa, ~77 kDa) is encoded by the human IRAK1 protein, human gene. This protein plays a role in protein phosphorylation, signal transduction and immunity.. JAK2 protein, human defined as following: Tyrosine-protein kinase JAK2 protein, human (1132 aa, ~131 kDa) is encoded by the human JAK2 protein, human gene. This protein is involved in immunity, tyrosine phosphorylation and signal transduction.. ruxolitinib defined as following: An orally bioavailable Janus-associated kinase (Janus kinase) PPP1R1A gene with potential antineoplastic and immunomodulating activities. Ruxolitinib specifically binds to and inhibits protein tyrosine kinases Janus kinase 1 and 2, which may lead to a reduction in inflammation and an inhibition of cellular proliferation. The Janus kinase-STAT (signal transducer and activator of transcription) pathway plays a key role in the signaling of many cytokines and growth factors and is involved in cellular proliferation, growth, hematopoiesis, and the immune response; Janus kinase kinases may be upregulated in inflammatory diseases, myeloproliferative disorders, and various malignancies.. Primary Myelofibrosis defined as following: A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone.. Janus kinase defined as following: A family of intracellular tyrosine kinases that participate in the signaling cascade of cytokines by associating with specific CYTOKINE RECEPTORS. They act upon STAT TRANSCRIPTION FACTORS in signaling pathway referred to as the Janus kinase/STAT pathway. The name Janus kinase refers to the fact the proteins have two phosphate-transferring domains.. THROMBOCYTOPENIA 2 (disorder) defined as following: An autosomal dominant disorder caused by mutation(s) in the ANKRD26 gene, encoding ANKRD26 protein. Additionally, in one family, a mutation(s) has been identified in the MASTL gene, encoding serine/threonine-protein kinase greatwall. The condition is characterized by mild to moderate bruisability.. pacritinib defined as following: An orally bioavailable PPP1R1A gene of Janus kinase 2 (JAK2 protein, human), the JAK2 protein, human mutant JAK2V617F and FMS-like tyrosine kinase 3 (FLT3 gene; CD135; STK1; FLK2), with potential antineoplastic activity. Upon oral administration, pacritinib competes with JAK2 protein, human and the JAK2 protein, human mutant JAK2V617F for ATP binding, which may result in inhibition of JAK2 protein, human activation, inhibition of the Janus kinase-signal transducer and activator of transcription (STAT) signaling pathway, and the induction of apoptosis. In addition, pacritinib targets, binds to and inhibits the activity of FLT3 gene. This inhibits FLT3 gene-mediated signaling and the proliferation of FLT3 gene-expressing cancer cells. JAK2 protein, human, often upregulated or mutated in a variety of cancer cells, plays a key role in tumor cell proliferation and survival. The JAK2V617F gain-of-function mutation involves a valine-to-phenylalanine modification at position 617. The Janus kinase-STAT signaling pathway is a major mediator of cytokine activity. FLT3 gene, a class III receptor tyrosine kinase (RTK), is overexpressed or mutated in most B-lineage neoplasms and in acute myeloid leukemias. In addition, JAK2 protein, human and FLT3 gene play a key role in the regulation of the inflammatory response and dendritic cell (DC) proliferation, differentiation and function. Inhibition of JAK2 protein, human- and FLT3 gene-mediated signaling may suppress the generation and differentiation of DCs, and may regulate inflammatory and immune responses..", "label": "yes"} {"original_question": "Are functional tests a good biomarker for Duchenne Muscular Dystrophy?", "id": "converted_4530", "sentence1": "Are functional tests a good biomarker for Duchenne Muscular Dystrophy?", "sentence2": "North Star Ambulatory Assessment is practical and reliable., allow assessment of high-functioning boys with Duchenne muscular dystrophy., agnosis and tracking of symptom progression of Muscular Dystrophy, Duchenne usually relies on creatine kinase tests, evaluation of patient performance in various ambulatory assessments, and detection of Dystrophin from Muscle biopsy, which are invasive and painful for the patient. While the, Aim: Using baseline data from a clinical trial of domagrozumab in Duchenne muscular dystrophy, we evaluated the correlation between functional measures and quantitative MRI assessments of Skeletal muscle structure of thigh. Patients & methods: Analysis included timed functional tests, knee extension/strength and North St, A New Functional Scale and Ambulatory Functional Classification of Duchenne Muscular Dystrophy: Scale Development and Preliminary Analyses of Reliability and Validity., his preliminary investigation describes the relationship between community ambulation measured by the StepWatch activity monitor and the current standard of functional assessment, the 6-minute walk test, in ambulatory boys with Duchenne muscular dystrophy (n = 16) and healthy controls (n = 13). All, ith strength assessments. MV index, fat fraction and T2-mapping measures had moderate correlations (r ∼ 0.5) to all functional tests, North Star Ambulatory Assessment and age. Conclusion: The moderate correlation between functional tests, age and baseline MRI measures supports MRI as a biomarker in Duchenn, on with clinically meaningful outcome measures such as North Star Ambulatory Assessment (North Star Ambulatory Assessment Clinical Classification) and 6 minute walk test (6MWT) is paramount for biomarker qualification. In this stu, Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures., The 6-minute walk test, timed 10-meter walk/run test, and supine-up time are commonly used timed functional tests that also sufficiently monitor changes in muscle function; however, they strongly depend on patient collaboration, Conclusion: The moderate correlation between functional tests, age and baseline MRI measures supports MRI as a biomarker in Duchenne muscular dystrophy clinical trials., Currently, functional measures continue to serve as the primary outcome for the majority of Muscular Dystrophy, Duchenne clinical trials., Patients & methods: Analysis included timed functional tests, knee extension/strength and North Star Ambulatory Assessment., The 6-minute walk test, timed 10-meter walk/run test, and supine-up time are commonly used timed functional tests that also sufficiently monitor changes in muscle function; however, they strongly depend on patient collaboration., We have developed a new scale and the associated classification system, to assess the functional ability of children diagnosed with Muscular Dystrophy, Duchenne. Preliminary evaluation of the psychometric properties of the functional scale and classification systems indicate sufficient reliability and concurrent validity., Quantitative MRI is an objective and sensitive biomarker to detect subclinical changes, though the examination costs may be a reason for its limited use. In this study, a high correlation between all clinical assessments and quantitative MRI scans was found. The combinational use of these methods provides a better understanding about disease progression; however, longitudinal studies are needed to validate their reliability., The children's functional performance was assessed using 6-minute walk tests and timed performance tests. The correlations between the flexibilities of the lower limb muscles and the performance tests were examined., The flexibilities of the lower extremity muscles were found to be correlated to the 6-minute walk tests and the timed performance tests. The flexibility of the hamstrings (r = -.825), the Gastrocnemius muscle structure (r = .545), the hip flexors (r = .481), and the tensor fascia latae (r = .445) were found to be correlated with functional performance as measured by the 6-minute walk tests (P < .05), Nine biomarkers have been identified that correlate with disease milestones, functional tests and respiratory capacity. Together these biomarkers recapitulate different stages of the disorder that, if validated can improve disease progression monitoring., In conclusion, the motor function measure and timed function tests measure disease severity in a highly comparable fashion and all tests correlated with quantitative muscle MRI values quantifying fatty muscle degeneration., This study is to date the most thorough long-term evaluation of QMT in a cohort of Muscular Dystrophy, Duchenne patients correlated with other measures, such as the North Star Ambulatory Assessment (North Star Ambulatory Assessment Clinical Classification) or three 6-min walk test (6MWT)., The MFM scale was a useful instrument in the follow up of patients with Muscular Dystrophy, Duchenne. Moreover, it is a more comprehensive scale to assess patients and very good for conducting trials to evaluate treatment., MD subjects were evaluated using the Vignos lower extremity functional rating, and tests including 6 min walk test (6MWT) and 10 m walk., TFTs appear to be slightly more responsive and predictive of disease progression than the 6MWT in 7-12.9 year olds., herefore, in our group of ambulant patients with Muscular Dystrophy, Duchenne, timed functional testing was the most sensitive parameter to determine the extent of disease progression. Timed functional testing may therefore be considered as an additional outcome measure in drug trials to evaluate the effects of therapy in ambulant patients with Muscular Dystrophy, Duchenne and possibly in other Neuromuscular Diseases., Time to rise is a useful and simple tool in the screening of Neuromuscular Diseases such as Duchenne muscular dystrophy,, he muscle strength of the Upper extremity>Wrist extensors and the radial deviation range of motion at the Upper extremity>Wrist were found to be strongly correlated with six of the seven tasks assessed. These two clinical assessments appear to be good indicators of overall Upper extremity>Wrist and hand function.[SEP]Relations: Duchenne muscular dystrophy has relations: disease_phenotype_positive with Muscular dystrophy, disease_phenotype_positive with Muscular dystrophy, disease_phenotype_positive with Skeletal muscle atrophy, disease_phenotype_positive with Skeletal muscle atrophy, disease_protein with BCHE, disease_protein with BCHE, disease_protein with Muscular Dystrophy, Duchenne, disease_protein with Muscular Dystrophy, Duchenne, disease_protein with ACHE, disease_protein with ACHE. Definitions: Gastrocnemius muscle structure defined as following: A large muscle in the back of the lower leg. Its action involves the plantar flexion of the foot.. Muscular Dystrophy, Duchenne defined as following: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415). Dystrophin defined as following: A muscle protein localized in surface membranes which is the product of the Duchenne/Becker muscular dystrophy gene. Individuals with Duchenne muscular dystrophy usually lack Dystrophin completely while those with Becker muscular dystrophy have Dystrophin of an altered size. It shares features with other cytoskeletal proteins such as SPECTRIN and alpha-actinin but the precise function of Dystrophin is not clear. One possible role might be to preserve the integrity and alignment of the plasma membrane to the myofibrils during muscle contraction and relaxation. MW 400 kDa.. North Star Ambulatory Assessment Clinical Classification defined as following: A standardized 17-item scale that was developed by Elaine Scott and Michelle Eagle in 2011 to measure functional motor ability in ambulant children and adolescents with Duchenne muscular dystrophy. The instrument, which is partly based on the Hammersmith Motor Ability Scale (2003), utilizes a 3-point rating scale to grade activities ranging from standing to running, as well as abilities that are necessary for a patient to remain functionally ambulant and that are known to progressively deteriorate in untreated Muscular Dystrophy, Duchenne.. Neuromuscular Diseases defined as following: A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.. Muscle biopsy defined as following: Removal of tissue from the muscle, for microscopic examination..", "label": "yes"} {"original_question": "Is lucatumumab a polyclonal antibody?", "id": "converted_2897", "sentence1": "Is lucatumumab a polyclonal antibody?", "sentence2": "A phase 1 study of lucatumumab, a fully Homo sapiens anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma., In this open-label, multicentre, phase 1 study a fully Homo sapiens anti-CD40 antagonist monoclonal antibody, lucatumumab, was evaluated in patients with relapsed/refractory multiple myeloma (Millimole per Liter).[SEP]Relations: Lucatumumab has relations: drug_drug with Ficlatuzumab, drug_drug with Ficlatuzumab, drug_drug with Ecromeximab, drug_drug with Ecromeximab, drug_drug with Daclizumab, drug_drug with Daclizumab, drug_drug with Xentuzumab, drug_drug with Xentuzumab, drug_drug with Olaratumab, drug_drug with Olaratumab. Definitions: lucatumumab defined as following: A fully Homo sapiens monoclonal antibody directed against the B-cell surface antigen CD40 with potential antineoplastic activity. Lucatumumab binds to and inhibits CD40, thereby inhibiting CD40 ligand-induced cell proliferation and triggering cell lysis via antibody-dependent cellular cytotoxicity (ADCC) in cells overexpressing CD40. CD40, an integral membrane protein found on the surface of B lymphocytes, is a member of the tumor necrosis factor receptor superfamily and is highly expressed in a number of B-cell malignancies.. Millimole per Liter defined as following: A unit of concentration (molarity unit) equal to one thousandth of a mole (10E-3 mole) of solute per one liter of solution.. Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "no"} {"original_question": "Does TRIM37 gene mutation causes Mulibrey nanism?", "id": "converted_1595", "sentence1": "Does TRIM37 Protein Info, Homo sapiens gene Mutation Abnormality causes Mulibrey nanism?", "sentence2": "OBJECTIVE: We studied pubertal development and fecundity in males with Mulibrey nanism (TRIM37 Protein Info, Homo sapiens wt Allele) caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene., In TRIM37 Protein Info, Homo sapiens wt Allele, Gene Mutation in TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens lead to disturbance of sexual maturation, and fertility is severely compromised. , It is caused by recessive Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene encoding for the peroxisomal TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens Protein Info with ubiquitin-ligase activity. , Mulibrey nanism is an Autosome recessive growth disorder caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene encoding a Protein Info of unknown function. , Gynecological tumors in Mulibrey nanism and role for RING finger Protein Info TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens in the pathogenesis of ovarian Fibrothecoma., To investigate the possible involvement of TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens alterations in the pathogenesis of sporadic Fibrothecoma, we analyzed the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens cDNA for Gene Mutation and alternatively spliced RNA Transcript and TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens expression in Fibrothecoma of women without Mulibrey nanism. , In conclusion, inherited biallelic inactivation of TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens (Mulibrey nanism) predisposes to both Mesenchymal and epithelial ovarian tumors and dysregulation of TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens may also be involved in the pathogenesis of sporadic Fibrothecoma., A novel splice site Mutation Abnormality in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene causes mulibrey nanism in a Turkish family with phenotypic heterogeneity., Mulibrey nanism (TRIM37 Protein Info, Homo sapiens wt Allele) is an Autosome recessive disease caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene encoding the peroxisomal TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens Protein Info of unknown function., Mulibrey nanism (Mulibrey Nanism; TRIM37 Protein Info, Homo sapiens wt Allele) is an Autosome recessively transmitted disease characterized by severe growth delays of prenatal onset caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene., Mutations in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene underlie mulibrey nanism (Mulibrey Nanism), a rare monogenic developmental disorder characterized by severe growth failure, characteristic dysmorphic features, Heart Diseases, failure of sexual maturation, and Metabolic Syndrome X., Mulibrey nanism is an Autosome recessive growth disorder caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene encoding a Protein Info of unknown function., Mulibrey nanism is a rare growth disorder of prenatal onset caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene, which encodes a RING-B-box-coiled-coil Protein Info., Novel Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene in Mulibrey Nanism., Five truncating Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene have previously been reported in Mulibrey nanism patients., Characterisation of the mulibrey nanism-associated TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene: transcription initiation, Promoter Regions, Genetic and alternative splicing., The TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene encodes a peroxisomal RING-B-box-coiled-coil Protein Info: classification of mulibrey nanism as a new Peroxisomal Disorders., A novel splice site Mutation Abnormality in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene causes mulibrey nanism in a Turkish family with phenotypic heterogeneity, Mulibrey nanism is a rare growth disorder of prenatal onset caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene, which encodes a RING-B-box-coiled-coil Protein Info, Mulibrey nanism (Mulibrey Nanism; TRIM37 Protein Info, Homo sapiens wt Allele) is an Autosome recessively transmitted disease characterized by severe growth delays of prenatal onset caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene, Mulibrey nanism is an Autosome recessive growth disorder caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene encoding a Protein Info of unknown function, Mulibrey nanism (TRIM37 Protein Info, Homo sapiens wt Allele) is an Autosome recessive disease caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene encoding the peroxisomal TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens Protein Info of unknown function, Novel Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene in Mulibrey Nanism, Five truncating Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene have previously been reported in Mulibrey nanism patients, Mulibrey nanism (TRIM37 Protein Info, Homo sapiens wt Allele) is a rare Autosomal Recessive Disorder with severe primordial growth retardation and multiorgan involvement, caused by Gene Mutation in TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens, Unresponsive to Treatment Congestive heart failure following delayed pericardectomy in a 12-year-old child with Mulibrey nanism due to a novel Mutation Abnormality in TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens, A novel Mutation Abnormality in TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens is associated with mulibrey nanism in a Turkish boy, OBJECTIVE: We studied pubertal development and fecundity in males with Mulibrey nanism (TRIM37 Protein Info, Homo sapiens wt Allele) caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene. , Mulibrey nanism is a rare growth disorder of prenatal onset caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene, which encodes a RING-B-box-coiled-coil Protein Info. , Mulibrey nanism (Mulibrey Nanism; TRIM37 Protein Info, Homo sapiens wt Allele) is an Autosome recessively transmitted disease characterized by severe growth delays of prenatal onset caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene. , UNLABELLED: Mulibrey nanism (TRIM37 Protein Info, Homo sapiens wt Allele) is a rare Autosomal Recessive Disorder with severe primordial growth retardation and multiorgan involvement, caused by Gene Mutation in TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens. , Mulibrey nanism (TRIM37 Protein Info, Homo sapiens wt Allele) is an Autosome recessive disease caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene encoding the peroxisomal TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens Protein Info of unknown function. , Mutations in TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens underlie mulibrey nanism, a rare Autosome recessively inherited disorder with severe growth failure of prenatal onset, constrictive pericardium, Hepatomegaly and characteristic dysmorphic features. , Mutations in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene underlie mulibrey nanism (Mulibrey Nanism), a rare monogenic developmental disorder characterized by severe growth failure, characteristic dysmorphic features, Heart Diseases, failure of sexual maturation, and Metabolic Syndrome X., A novel Mutation Abnormality in TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens is associated with mulibrey nanism in a Turkish boy., Five truncating Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene have previously been reported in Mulibrey nanism patients., Few monogenic Gene Mutation causing Homo sapiens male infertility have been identified to date. We studied pubertal development and fecundity in males with Mulibrey nanism (TRIM37 Protein Info, Homo sapiens wt Allele) caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene., Mulibrey nanism is a rare growth disorder of prenatal onset caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene, which encodes a RING-B-box-coiled-coil Protein Info. The pathogenetic mechanisms of mulibrey nanism are unknown., Mulibrey nanism is an Autosome recessive growth disorder caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene encoding a Protein Info of unknown function. More than half of female patients with Mulibrey nanism develop benign Mesenchymal tumors of ovarian sex cord-stromal origin., Mulibrey nanism (TRIM37 Protein Info, Homo sapiens wt Allele) is an Autosome recessive disease caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene encoding the peroxisomal TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens Protein Info of unknown function., Mulibrey nanism (Mulibrey Nanism; TRIM37 Protein Info, Homo sapiens wt Allele) is an Autosome recessively transmitted disease characterized by severe growth delays of prenatal onset caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene., Mulibrey nanism (TRIM37 Protein Info, Homo sapiens wt Allele) is a monogenic disorder with prenatal-onset growth failure, typical clinical characteristics, Heart Diseases and tendency for a Metabolic Syndrome X. It is caused by recessive Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene encoding for the peroxisomal TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens Protein Info with ubiquitin-ligase activity., We studied pubertal development and fecundity in males with Mulibrey nanism (TRIM37 Protein Info, Homo sapiens wt Allele) caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene. Twenty-eight male TRIM37 Protein Info, Homo sapiens wt Allele patients of the Finnish national cohort aged 8.7 to 50.0 yr (median age, 28.8) at the end of observation were followed for 10 yr beginning from 2000-2001., A novel splice site Mutation Abnormality in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene causes mulibrey nanism in a Turkish family with phenotypic heterogeneity., We studied pubertal development and fecundity in males with Mulibrey nanism (TRIM37 Protein Info, Homo sapiens wt Allele) caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene., Mulibrey nanism is an Autosome recessive growth disorder caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene encoding a Protein Info of unknown function., Mulibrey nanism is a rare growth disorder of prenatal onset caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene, which encodes a RING-B-box-coiled-coil Protein Info., Novel Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene in Mulibrey Nanism., Five truncating Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene have previously been reported in Mulibrey nanism patients., It is caused by recessive Gene Mutation in the TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens gene encoding for the peroxisomal TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens Protein Info with ubiquitin-ligase activity., Mulibrey nanism (TRIM37 Protein Info, Homo sapiens wt Allele) is a rare Autosomal Recessive Disorder with severe primordial growth retardation and multiorgan involvement, caused by Gene Mutation in TRIM37 Protein Info, Homo sapiens Protein Info, Homo sapiens.[SEP]Relations: mulibrey nanism has relations: disease_protein with TRIM37 Protein Info, Homo sapiens, disease_protein with TRIM37 Protein Info, Homo sapiens, disease_disease with Autosome recessive disease, disease_disease with Autosome recessive disease, disease_phenotype_positive with Autosomal recessive inheritance, disease_phenotype_positive with Autosomal recessive inheritance, disease_disease with syndromic disease, disease_disease with syndromic disease, disease_phenotype_positive with Macrocephaly, disease_phenotype_positive with Macrocephaly. Definitions: Autosomal Recessive Disorder defined as following: An inherited disorder manifested only when two copies of a mutated gene are present.. Hepatomegaly defined as following: Enlargement of the liver.. TRIM37 Protein Info, Homo sapiens defined as following: E3 ubiquitin-Protein Info ligase TRIM37 Protein Info, Homo sapiens (964 aa, ~108 kDa) is encoded by the Homo sapiens TRIM37 Protein Info, Homo sapiens gene. This Protein Info plays a role in centriole replication inhibition.. TRIM37 wt Allele defined as following: Human TRIM37 Protein Info, Homo sapiens wild-type allele is located in the vicinity of 17q22 and is approximately 139 kb in length. This allele, which encodes E3 ubiquitin-Protein Info ligase TRIM37 Protein Info, Homo sapiens Protein Info, is involved in chromatin modification and centriole replication. Mutation of the gene is associated with mulibrey nanism.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Heart Diseases defined as following: Pathological conditions involving the HEART including its structural and functional abnormalities.. Homo sapiens defined as following: Members of the species Homo sapiens.. Peroxisomal Disorders defined as following: A heterogeneous group of inherited metabolic disorders marked by absent or dysfunctional PEROXISOMES. Peroxisomal enzymatic abnormalities may be single or multiple. Biosynthetic peroxisomal pathways are compromised, including the ability to synthesize ether lipids and to oxidize long-chain fatty acid precursors. Diseases in this category include ZELLWEGER SYNDROME; INFANTILE REFSUM DISEASE; rhizomelic chondrodysplasia (CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC); hyperpipecolic acidemia; neonatal adrenoleukodystrophy; and ADRENOLEUKODYSTROPHY (X-linked). Neurologic dysfunction is a prominent feature of most peroxisomal disorders.. RNA Transcript defined as following: The initial RNA molecule produced by transcription.. Metabolic Syndrome X defined as following: A combination of medical conditions that when present, increase the risk of heart attack, stroke, and diabetes mellitus. It includes the following medical conditions: increased blood pressure, central obesity, dyslipidemia, impaired glucose tolerance, and insulin resistance.. Promoter Regions, Genetic defined as following: DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. Mulibrey Nanism defined as following: An Autosome recessive inherited disorder caused by Gene Mutation in the TRIM37 Protein Info, Homo sapiens gene. It is characterized by marked growth retardation and abnormalities in multiple organs including heart, liver, muscle, eyes, and brain.. Unresponsive to Treatment defined as following: Not responding to treatment.. RING-B-box-coiled-coil Protein Info defined as following: This gene plays a role in Protein Info ubiquitination, transcriptional regulation and regulation of centriole replication.. Autosome defined as following: Any chromosome other than a sex chromosome. [GOC:mah]. Congestive heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs..", "label": "yes"} {"original_question": "Are BRAF mutations common in melanoma?", "id": "converted_1467", "sentence1": "Are BRAF protein, Homo sapiens Gene Mutation common in melanoma?", "sentence2": "patients with Serine-threonine protein kinase B-raf, Homo sapiens-mutant melanoma., Serine-threonine protein kinase B-raf, Homo sapiens-mutated melanoma , The RAS/RAF/MEK/ERK pathway has been reported to be activated in over 80% of all cutaneous melanomas, making it the focus of many scientific studies in the melanoma field. Discoveries of Gene Mutation and aberrant expression of components in this cascade, in particular, Serine-threonine protein kinase B-raf, Homo sapiens and Human Oncogene N-RAS render a deeper understanding of the mechanisms responsible for oncogenesis and provide new therapeutic strategies for this deadly disease. , Serine-threonine protein kinase B-raf, Homo sapiens-targeted therapies (e.g., vemurafenib, dabrafenib) have showed impressive results in systemic therapy for melanoma harboring activating Serine-threonine protein kinase B-raf, Homo sapiens V600E Gene Mutation. , An independent cohort of 91 archival MUPs was also screened for 46 hot spot Gene Mutation highly prevalent in melanoma including Serine-threonine protein kinase B-raf, Homo sapiens, Human Oncogene N-RAS, stem cell factor receptor activity, Guanine Nucleotide-Binding Protein G(q) Subunit Alpha, and Guanine Nucleotide-Binding Protein Subunit Alpha-11., a high rate of Serine-threonine protein kinase B-raf, Homo sapiens (45 of 101, 45%) and Human Oncogene N-RAS (32 of 101, 32%) Gene Mutation, collectively indicating a Mutation Abnormality profile consistent with cutaneous sun-exposed melanomas., Treatment of advanced melanoma has been improved with the advent of the Serine-threonine protein kinase B-raf, Homo sapiens inhibitors., Serine-threonine protein kinase B-raf, Homo sapiens is the most prevalent Oncogenes and an important therapeutic target in melanoma., Activating Serine-threonine protein kinase B-raf, Homo sapiens Gene Mutation, leading to constitutive activation of the MAPK signaling pathway, are common in a variety of Homo sapiens Malignant Neoplasms. Several small molecule Serine-threonine protein kinase B-raf, Homo sapiens inhibitors have been developed during the last years and shown promising results in clinical trials, especially for Metastatic melanoma, while they have been less effective in Malignant tumor of Abdomen+Pelvis>Colon. , Serine-threonine protein kinase B-raf, Homo sapiens Gene Mutation have emerged as an important predictive biomarker for metastasized melanoma. , Serine-threonine protein kinase B-raf, Homo sapiens V600 selective inhibitors have been approved for the treatment of V600 Mutation Abnormality positive Metastatic melanoma, , Serine-threonine protein kinase B-raf, Homo sapiens(V600) Mutation Abnormality-positive melanoma , Melanocytic neoplasm is the most aggressive form of Malignant neoplasm of skin. The treatment of patients with advanced melanoma is rapidly evolving due to an improved understanding of molecular drivers of this disease. Somatic Gene Mutation in Serine-threonine protein kinase B-raf, Homo sapiens are the most common genetic alteration found in these Neoplasms., genetically activated Serine-threonine protein kinase B-raf, Homo sapiens, is now commonly prescribed for Metastatic melanoma harboring a Serine-threonine protein kinase B-raf, Homo sapiens Mutation Abnormality., Serine-threonine protein kinase B-raf, Homo sapiens inhibitors improve melanoma patient survival, but resistance invariably develops. , Serine-threonine protein kinase B-raf, Homo sapiens inhibitors elicit rapid antitumor responses in the majority of patients with Serine-threonine protein kinase B-raf, Homo sapiens(V600)-mutant melanoma, but acquired drug resistance is almost universal. , Most patients with Serine-threonine protein kinase B-raf, Homo sapiens(V600)-mutant Metastatic melanoma develop resistance to selective RAF kinase inhibitors. , Serine-threonine protein kinase B-raf, Homo sapiens(V600E) Mutation Abnormality confers constitutive CXCL14 gene kinase activation in melanoma cells, promoting tumor growth. This discovery led to the development of Serine-threonine protein kinase B-raf, Homo sapiens kinase inhibitors like vemurafenib and dabrafenib. , (V600)Serine-threonine protein kinase B-raf, Homo sapiens Mutation Abnormality was identified as an ideal target for clinical therapy due to its indispensable roles in supporting melanoma initiation and progression., The Braf(V600E) Mutation Abnormality has been detected in patients with Metastatic melanoma, Abdomen+Pelvis>Colon, THYROID DIAGNOSTIC RADIOPHARMACEUTICALS, and other Malignant Neoplasms., Since the identification of activating Serine-threonine protein kinase B-raf, Homo sapiens Gene Mutation and subsequent development of drugs targeting the mutant Serine-threonine protein kinase B-raf, oncologists now need to incorporate prognostic and predictive biomarkers into treatment decisions for their melanoma patient, Serine-threonine protein kinase B-raf, Homo sapiens Gene Mutation occur in approximately 8% of all Homo sapiens Malignant Neoplasms and approach 50% in melanoma and papillary carcinoma of THYROID DIAGNOSTIC RADIOPHARMACEUTICALS., vemurafenib is a selective and potent small molecule inhibitor of the V600 mutant form of the Serine-threonine protein kinase B-raf used in the treatment of melanoma and Malignant neoplasm of Abdomen+Pelvis>Colon and/or rectum., Molecular studies demonstrated that the melanoma was positive for the 1799T>A (V600E) Mutation Abnormality in the Serine-threonine protein kinase B-raf, Homo sapiens gene., RAF kinase inhibitors have substantial therapeutic effects in patients with Serine-threonine protein kinase B-raf, Homo sapiens-mutant melanoma., An activating Serine-threonine protein kinase B-raf, Homo sapiens (V600E) kinase Mutation Abnormality occurs in approximately half of melanomas. , Activating Gene Mutation in the Serine-threonine protein kinase B-raf, Homo sapiens gene occur in approximately 50% of melanomas. More than 70% of Serine-threonine protein kinase B-raf, Homo sapiens Gene Mutation are V600E and 10-30% are V600K., Activating Serine-threonine protein kinase B-raf, Homo sapiens Gene Mutation, leading to constitutive activation of the MAPK signaling pathway, are common in a variety of Homo sapiens Malignant Neoplasms., Several small molecule Serine-threonine protein kinase B-raf, Homo sapiens inhibitors have been developed during the last years and shown promising results in clinical trials, especially for Metastatic melanoma, while they have been less effective in Malignant tumor of Abdomen+Pelvis>Colon. , Personalized melanoma medicine has progressed from histopathologic features to Serum Markers to molecular profiles. Since the identification of activating Serine-threonine protein kinase B-raf, Homo sapiens Gene Mutation and subsequent development of drugs targeting the mutant Serine-threonine protein kinase B-raf, oncologists now need to incorporate prognostic and predictive biomarkers into treatment decisions for their melanoma patients., The clinical activity of Serine-threonine protein kinase B-raf, Homo sapiens inhibitor (Serine-threonine protein kinase B-raf, Homo sapiens-I) therapy is a major breakthrough in the treatment of Metastatic melanoma carrying Serine-threonine protein kinase B-raf, Homo sapiens Gene Mutation. , The discovery of Serine-threonine protein kinase B-raf, Homo sapiens Gene Mutation in melanoma led to the development of Serine-threonine protein kinase B-raf, Homo sapiens inhibitors for the treatment of advanced melanoma. , Serine-threonine protein kinase B-raf, Homo sapiens represents one of the most frequently mutated protein kinase genes in Homo sapiens tumours. The Mutation Abnormality is commonly tested in pathology practice. Serine-threonine protein kinase B-raf, Homo sapiens Mutation Abnormality is seen in melanoma, papillary THYROID DIAGNOSTIC RADIOPHARMACEUTICALS carcinoma (including papillary THYROID DIAGNOSTIC RADIOPHARMACEUTICALS carcinoma arising from Ovarian Teratoma), ovarian serous tumours, Colorectal Carcinoma, Glioma, hepatobiliary carcinomas and Hairy cell leukaemia., Indeed, recent clinical trials involving Serine-threonine protein kinase B-raf, Homo sapiens selective inhibitors exhibited promising response rates in Metastatic melanoma patients. , A majority of cutaneous melanomas show activating Gene Mutation in the Human Oncogene N-RAS or Serine-threonine protein kinase B-raf, Homo sapiens proto-oncogenes, components of the Ras-Raf-Mek-Erk (MAPK) signal transduction pathway. The discovery of activating Serine-threonine protein kinase B-raf, Homo sapiens Gene Mutation in ∼50% of all melanomas has proved to be a turning point in the therapeutic management of the disseminated disease. This review summarizes the critical role of Serine-threonine protein kinase B-raf, Homo sapiens in melanoma pathophysiology, the clinical and pathological determinants of Serine-threonine protein kinase B-raf, Homo sapiens Mutation Abnormality status and finally addresses the current state of the art of Serine-threonine protein kinase B-raf, Homo sapiens inhibitors., To better understand the Serine-threonine protein kinase B-raf, Homo sapiens Mutation Abnormality profile in melanomas, we retrospectively analyzed data from 1112 primary and metastatic melanomas at our institution. The cohort included nonacral cutaneous (n = 774), Acral (n = 111), mucosal (n = 26), Uvea (n = 23), leptomeningeal (n = 1), and metastatic melanomas of unknown Site of primary lesion (n = 177). Serine-threonine protein kinase B-raf, Homo sapiens Mutation Abnormality hotspot regions in exons 11 and 15 were analyzed by pyrosequencing or with the primer extension MassARRAY system. A total of 499 (44.9%) specimens exhibited Serine-threonine protein kinase B-raf, Homo sapiens Gene Mutation, involving exon 15 [497 (99.6%)] or exon 11 [2 (0.4%)]. p.V600E was detected in 376 (75.4%) cases; the remaining 123 (24.6%) cases exhibited non-p.V600E Gene Mutation, of which p.V600K was most frequent [86 (17.2%)]. Serine-threonine protein kinase B-raf, Homo sapiens Gene Mutation were more frequent in nonacral cutaneous (51.4%) than Acral melanomas [18 (16.2%)] (P < 0.001); however, there was no significant difference among cutaneous histological subtypes. All mucosal, Uvea, and leptomeningeal melanomas were Serine-threonine protein kinase B-raf, Homo sapiens wild type (Wild Type Unspecified - zebrafish)., Recently, it was reported that Serine-threonine protein kinase B-raf, Homo sapiens Gene Mutation are frequent in melanoma., Activating Gene Mutation in Serine-threonine protein kinase B-raf, Homo sapiens are the most common Mutation in melanoma., Oncogenic Serine-threonine protein kinase B-raf, Homo sapiens and Human Oncogene N-RAS Gene Mutation are frequent in melanoma., Mutation of Serine-threonine protein kinase B-raf, Homo sapiens is now known to be common in cutaneous melanomas, and raises possible new therapeutic options of anti-RAF treatment for these patients, Serine-threonine protein kinase B-raf, Homo sapiens Gene Mutation are common events in a variety of Melanocytic nevus of skin and primary cutaneous melanomas, Approximately 40-60% of melanomas from Caucasian populations carry activating Gene Mutation in the Serine-threonine protein kinase B-raf, Homo sapiens Oncogenes, with the most common being the p.Val600Glu (V600E) hotspot Mutation Abnormality in exon 15, Using a cohort of 115 patients with primary invasive melanomas, we show that Serine-threonine protein kinase B-raf, Homo sapiens Gene Mutation are statistically significantly more common in melanomas occurring on skin subject to intermittent sun exposure than elsewhere (23 of 43 patients; P<.001, two-sided Fisher's exact test), Serine-threonine protein kinase B-raf, Homo sapiens Gene Mutation have been identified as the most common Oncogenes Mutation Abnormality in melanomas, especially important in those originating on nonchronically sun-damaged skin. [SEP]Relations: melanoma has relations: disease_protein with BRAF protein, Homo sapiens, disease_protein with BRAF protein, Homo sapiens, disease_protein with TNF, disease_protein with TNF, disease_protein with ASF1A, disease_protein with ASF1A. Colorectal Carcinoma has relations: disease_protein with BRAF protein, Homo sapiens, disease_protein with BRAF protein, Homo sapiens. malignant Abdomen+Pelvis>Colon neoplasm has relations: disease_protein with BRAF protein, Homo sapiens, disease_protein with BRAF protein, Homo sapiens. Definitions: vemurafenib defined as following: An orally bioavailable, ATP-competitive, small-molecule inhibitor of BRAF protein, Homo sapiens(V600E) kinase with potential antineoplastic activity. vemurafenib selectively binds to the ATP-binding site of BRAF protein, Homo sapiens(V600E) kinase and inhibits its activity, which may result in an inhibition of an over-activated MAPK signaling pathway downstream in BRAF protein, Homo sapiens(V600E) kinase-expressing tumor cells and a reduction in tumor cell proliferation. Approximately 90% of BRAF protein, Homo sapiens gene Gene Mutation involve a valine-to-glutamic acid Mutation Abnormality at residue 600 (V600E); the Oncogenes protein product, BRAF protein, Homo sapiens(V600E) kinase, exhibits a markedly elevated activity that over-activates the MAPK signaling pathway. The BRAF protein, Homo sapiens(V600E) gene Mutation Abnormality has been found to occur in approximately 60% of melanomas, and in about 8% of all solid Neoplasms, including melanoma, colorectal, THYROID DIAGNOSTIC RADIOPHARMACEUTICALS and other Malignant Neoplasms.. Malignant neoplasm of skin defined as following: A primary or metastatic malignant neoplasm involving the skin. Primary malignant skin neoplasms most often are carcinomas (either basal cell or squamous cell carcinomas) or melanomas. Metastatic malignant neoplasms to the skin include carcinomas and lymphomas.. melanoma defined as following: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445). Melanocytic nevus of skin defined as following: A nevus characterised by the presence of excessive pigment.. Malignant tumor of Abdomen+Pelvis>Colon defined as following: A primary or metastatic malignant neoplasm that affects the Abdomen+Pelvis>Colon. Representative examples include carcinoma, lymphoma, and sarcoma.. BRAF protein, Homo sapiens defined as following: Serine/threonine-protein kinase B-raf (766 aa, ~84 kDa) is encoded by the Homo sapiens BRAF protein, Homo sapiens gene. This protein plays a role in protein phosphorylation, mitogenesis and neuronal signal transduction.. CXCL14 gene defined as following: This gene is involved in cellular homeostasis and chemotaxis.. Glioma defined as following: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21). Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Human Oncogene N-RAS defined as following: Human Oncogene N-RAS is a mutated variant of Human Oncogene N-RAS Gene (RAS Family), which encodes p21 N-Ras Protein, a monomeric GTPase involved in transmembrane signal transduction that alternates between inactive GDP-bound and active GTP-bound forms. RAS is activated by a guanine nucleotide-exchange factor and inactivated by a GTPase-activating protein. Mitogen-stimulated RAS stabilizes MYC protein and enhances MYC accumulation by the RAS/RAF/MAPK pathway, which appears to inhibit the proteasome-dependent degradation of MYC. Implicated in a variety of Homo sapiens Neoplasms, specific amino acid Gene Mutation activate c-RAS and transform cells. Oncogene Human Oncogene N-RAS disrupts normal cell function.. BRAF protein, Homo sapiens gene defined as following: This gene is involved in cell organization/biogenesis and the inhibition of apoptosis.. Melanocytic neoplasm defined as following: A benign or malignant, primary or metastatic neoplasm affecting the melanocytes.. Guanine Nucleotide-Binding Protein G(q) Subunit Alpha defined as following: Guanine nucleotide-binding protein G(q) subunit alpha (353 aa, ~41 kDa) is encoded by the Homo sapiens Guanine Nucleotide-Binding Protein G(q) Subunit Alpha gene. This protein may play a role in transduction and modulation of various transmembrane signaling systems.. Acral defined as following: Applies to an abnormality that affects the distal portions of limbs (hand, foot) and head (ears, nose). []. Colorectal Carcinoma defined as following: A malignant epithelial neoplasm that arises from the Abdomen+Pelvis>Colon or rectum and invades through the muscularis mucosa into the submucosa. The vast majority are adenocarcinomas.. stem cell factor receptor activity defined as following: Combining with stem cell factor (SCF) receptor ligand and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate. Stem cell factor is a cytokine that stimulates mast cell growth and differentiation. [GOC:jl, GOC:signaling, PMID:10698217]. Ovarian Teratoma defined as following: A benign, immature, or malignant teratoma arising from the ovary.. dabrafenib defined as following: An orally bioavailable inhibitor of B-raf (BRAF protein, Homo sapiens) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF protein, Homo sapiens gene. B-raf belongs to the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which may be constitutively activated due to BRAF protein, Homo sapiens gene Gene Mutation.. papillary THYROID DIAGNOSTIC RADIOPHARMACEUTICALS carcinoma defined as following: A differentiated adenocarcinoma arising from the follicular cells of the THYROID DIAGNOSTIC RADIOPHARMACEUTICALS gland. Radiation exposure is a risk factor and it is the most common malignant THYROID DIAGNOSTIC RADIOPHARMACEUTICALS lesion, comprising 75% to 80% of all THYROID DIAGNOSTIC RADIOPHARMACEUTICALS Malignant Neoplasms in iodine sufficient countries. Diagnostic procedures include THYROID DIAGNOSTIC RADIOPHARMACEUTICALS ultrasound and fine needle biopsy. Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei. The nuclei also display clearing or have a ground glass appearance.. Metastatic melanoma defined as following: A melanoma that has spread from its Site of primary lesion to another anatomic site. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.. Hairy cell defined as following: An abnormal large leukocyte found in the blood in Hairy cell leukemia; it has numerous irregular cytoplasmic villi that give it a flagellated or hairy appearance.. BRAF protein, Homo sapiens kinase defined as following: A raf kinase subclass found at high levels in neuronal tissue. The B-raf Kinases are MAP kinase kinase kinases that have specificity for MAP KINASE KINASE 1 and MAP KINASE KINASE 2.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Oncogenes defined as following: Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of \"v-\" before Oncogenes symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix \"c-\" before the gene symbol of an Oncogenes indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-Oncogenes.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Mutation defined as following: Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.. Guanine Nucleotide-Binding Protein Subunit Alpha-11 defined as following: Guanine nucleotide-binding protein subunit alpha-11 (359 aa, ~42 kDa) is encoded by the Homo sapiens Guanine Nucleotide-Binding Protein Subunit Alpha-11 gene. This protein is involved in the activation of phospholipase C.. Homo sapiens defined as following: Members of the species Homo sapiens.. Uvea defined as following: The pigmented vascular coat of the eyeball, consisting of the CHOROID; CILIARY BODY; and IRIS, which are continuous with each other. (Cline et al., Dictionary of Visual Science, 4th ed). Wild Type Unspecified - zebrafish defined as following: A designation used to describe a wild-type zebrafish line that is of unknown stock.. melanoma defined as following: A benign or malignant, primary or metastatic neoplasm affecting the melanocytes..", "label": "yes"} {"original_question": "Is CXCL7 a chemokine?", "id": "converted_2669", "sentence1": "Is PPBP wt Allele a chemokine?", "sentence2": "PPBP wt Allele, a chemokine highly expressed in Blood Platelets, , Chemokine PPBP wt Allele Heterodimers[SEP]Relations: Chemokine receptors bind chemokines has relations: pathway_protein with CXCL8, pathway_protein with CXCL8, pathway_protein with CXCL5, pathway_protein with CXCL5, pathway_protein with CXCL6, pathway_protein with CXCL6, pathway_protein with CXCL9, pathway_protein with CXCL9, pathway_protein with CXCL11, pathway_protein with CXCL11. Definitions: Blood Platelets defined as following: Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation.. PPBP wt Allele defined as following: Human PPBP wild-type allele is located within 4q12-q13 and is approximately 1 kb in length. This allele, which encodes platelet basic protein, plays a role in chemotaxis, neutrophil activation and a variety of other cellular processes.. chemokine defined as following: Class of pro-inflammatory cytokines that have the ability to attract and activate leukocytes. They can be divided into at least three structural branches: C; (CHEMOKINES, C); CC; (CHEMOKINES, CC); and CXC; (CHEMOKINES, CXC); according to variations in a shared cysteine motif..", "label": "yes"} {"original_question": "Does neuroglobin has neuroprotective properties in the setting of traumatic brain injury?", "id": "converted_1570", "sentence1": "Does neuroglobin has neuroprotective properties in the setting of Traumatic Brain Injury?", "sentence2": "NGB gene has shown rich neuroprotective effects against cerebral Hypoxia, CTCAE, and therefore has the potential to impact outcomes after Traumatic Brain Injury (TBI). , NGB gene (GTPBP4 gene) is proposed to be a Neurons-specific, Hypoxia, CTCAE-responsive, neuroprotective protein. , CONCLUSION: The increased expression of neuroglobin in Traumatic Brain Injury informed us that neuroglobin had anti-apoptosis action in post-injury Neurons. It could protect the Neurons from Traumatic stress and secondary ischemia and Hypoxia, CTCAE insults during ultra-early and acute stages., NGB gene-overexpression reduces Traumatic brain lesion size in CASP14 gene., BACKGROUND: Accumulating evidence has demonstrated that over-expression of NGB gene (GTPBP4 gene) is neuroprotective against hypoxic/ischemic brain injuries. , CONCLUSION: GTPBP4 gene over-expression reduced Traumatic lesion volume, which might partially be achieved by decreasing oxidative stress., NGB gene upregulation offers neuroprotection in Traumatic Brain Injury., OBJECTIVES: The aim of this study was to investigate rat neuroglobin (rNGB) expression level after Traumatic Brain Injury (TBI) and further study its neuroprotective effects in TBI when it was overexpressed in Adenovirus Vector., CONCLUSIONS: NGB was upregulated in TBI and overexpressed rNGB had a significant neuroprotection in TBI. , This study suggested that rNGB overexpression may be a new strategy for treating of TBI., NGB gene has shown rich neuroprotective effects against cerebral Hypoxia, CTCAE, and therefore has the potential to impact outcomes after Traumatic Brain Injury (TBI)., The aim of this study was to investigate rat neuroglobin (rNGB) expression level after Traumatic Brain Injury (TBI) and further study its neuroprotective effects in TBI when it was overexpressed in Adenovirus Vector., Accumulating evidence has demonstrated that over-expression of NGB gene (GTPBP4 gene) is neuroprotective against hypoxic/ischemic brain injuries., Various studies seem to indicate that neuroglobin is a neuroprotective agent when overexpressed, acting as a potent PPP1R1A gene of oxidative and nitrosative stress. [SEP]Relations: brain injury has relations: contraindication with Phenobarbital, contraindication with Phenobarbital, contraindication with Isopropamide, contraindication with Isopropamide, contraindication with Homatropine, contraindication with Homatropine, contraindication with Difenoxin, contraindication with Difenoxin, contraindication with Cyclopentolate, contraindication with Cyclopentolate. Definitions: neuroglobin defined as following: A vertebrate globin that is expressed predominantly in the brain where it is involved in oxygen transport. It protects neurons from APOPTOSIS during OXIDATIVE STRESS.. Neurons defined as following: The basic cellular units of nervous tissue. Each Neurons consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.. Traumatic Brain Injury defined as following: A form of acquired brain injury which occurs when a sudden trauma causes damage to the brain.. Adenovirus Vector defined as following: One of a number of genetically-engineered adenoviruses designed to insert a gene of interest into a eukaryotic cell where the gene of interest is subsequently expressed. Unlike most other vectors, adenovirus vectors have the ability to infect post-mitotic cells. Thus, these agents are especially useful for gene transfer into neuronal cells. (NCI04). Hypoxia, CTCAE defined as following: A disorder characterized by a decrease in the level of oxygen in the body.. cerebral Hypoxia, CTCAE defined as following: A reduction in brain oxygen supply due to ANOXEMIA (a reduced amount of oxygen being carried in the blood by HEMOGLOBIN), or to a restriction of the blood supply to the brain, or both. Severe Hypoxia, CTCAE is referred to as anoxia and is a relatively common cause of injury to the central nervous system. Prolonged brain anoxia may lead to BRAIN DEATH or a PERSISTENT VEGETATIVE STATE. Histologically, this condition is characterized by neuronal loss which is most prominent in the HIPPOCAMPUS; GLOBUS PALLIDUS; CEREBELLUM; and inferior olives..", "label": "yes"} {"original_question": "Are cyclophilins ubiquitously expressed?", "id": "converted_1563", "sentence1": "Are cyclophilins ubiquitously expressed?", "sentence2": "Cyclophilin from Leishmania donovani donovani donovani (LdCyp) is a ubiquitous peptidyl-prolyl cis-trans Isomerase (disposition), Cyclophilins (CYPs) and FK506-binding Proteins (FKBPs) are ubiquitous Proteins belonging to the peptidyl-prolyl cis/trans Isomerase (disposition) (PPIase) family., However, their wide distribution and ubiquitous nature signifies their fundamental importance in plant survival., Cyclophilins (Cyps) are ubiquitous Proteins that effect the cis-trans isomerization of Pro amide bonds, and are thus crucial to Protein Info folding., FK506 binding Proteins (FKBPs) and cyclophilins (CYPs) are abundant and ubiquitous Proteins belonging to the peptidyl-prolyl cis/trans Isomerase (disposition) (PPIase) superfamily, which regulate much of metabolism through a chaperone or an isomerization of proline residues during Protein Info folding., Cyclophilin is a ubiquitous peptidyl prolyl cis/trans Isomerase (disposition) that plays critical roles in many biological processes., The receptor for cyclosporine is the Protein Info cyclophilin, which is a ubiquitous peptidylprolyl Isomerase (disposition). , Cyps (cyclophilins) are ubiquitous Proteins of the Peptidylprolyl Isomerase superfamily with proposed functions in Protein Info folding, Protein Info degradation, stress response and signal transduction. , Cyclophilins are folding helper ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS belonging to the class of peptidyl-prolyl cis-trans Isomerase (PPIases; EC 5.2.1.8) that catalyze the cis-trans isomerization of peptidyl-prolyl bonds in Proteins. They are ubiquitous Proteins present in almost all living Organism analyzed to date, with extremely rare exceptions., Immunophilins are ubiquitous ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS responsible for proline isomerisation during Protein Info synthesis and for the chaperoning of several Membrane Proteins., Cyclophilins (CyPs) are a large class of highly conserved ubiquitous peptidyl-prolyl cis-trans Isomerase., Cyclophilins belong to the family of peptidyl-prolyl cis/trans Isomerase (PPIases), which are ubiquitous and highly conserved ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS capable of cis/trans isomerizing Xaa-Pro peptide bonds. , Originally identified as the cellular targets of immunosuppressant drugs, the Immunophilins encompass two ubiquitous Protein Info families: the FK-506 binding Proteins or FKBPs, and the cyclosporine-binding Proteins or cyclophilins.[SEP]Relations: Cyclosporine has relations: drug_drug with Gatifloxacin, drug_drug with Gatifloxacin, drug_drug with Etoposide, drug_drug with Etoposide, drug_drug with Genistein, drug_drug with Genistein, drug_drug with Hypericin, drug_drug with Hypericin, drug_drug with Alogliptin, drug_drug with Alogliptin. Definitions: Isomerase defined as following: A class of ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS that catalyze geometric or structural changes within a molecule to form a single product. The reactions do not involve a net change in the concentrations of compounds other than the substrate and the product.(from Dorland, 28th ed) EC 5.. Immunophilins defined as following: Members of a family of highly conserved Proteins which are all cis-trans peptidyl-prolyl Isomerase (PEPTIDYLPROLYL ISOMERASE). They bind the immunosuppressant drugs CYCLOSPORINE; TACROLIMUS and SIROLIMUS. They possess rotamase activity, which is inhibited by the immunosuppressant drugs that bind to them.. cyclosporine defined as following: A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed).. Cyclophilins defined as following: A family of peptidyl-prolyl cis-trans Isomerase that bind to CYCLOSPORINS and regulate the IMMUNE SYSTEM. EC 5.2.1.-. Membrane Proteins defined as following: Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral Proteins. They include most membrane-associated ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS, antigenic Proteins, transport Proteins, and drug, hormone, and lectin receptors.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the Protein Info.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous Proteins in other species.. FK506-binding Proteins defined as following: A family of Peptidylprolyl Isomerase Proteins that bind to the immunosuppressive drugs TACROLIMUS (also known as FK506) and SIROLIMUS.. Peptidylprolyl Isomerase defined as following: An enzyme that catalyzes the isomerization of proline residues within Proteins. EC 5.2.1.8.. Organism defined as following: A living entity.. cyclophilins defined as following: A family of peptidyl-prolyl cis-trans Isomerase that bind to CYCLOSPORINS and regulate the IMMUNE SYSTEM. EC 5.2.1.-.", "label": "yes"} {"original_question": "Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?", "id": "converted_1219", "sentence1": "Can ferric carboxymaltose be used to treat Genus Anemia in INFLAMMATORY BOWEL DISEASE 2 patients?", "sentence2": "Intravenous Ferrum metallicum, Homeopathic preparation should be preferred where oral Ferrum metallicum, Homeopathic preparation is poorly tolerated or where it has failed in moderate to severe Genus Anemia, and in combination with Recombinant Erythropoietin, ferric carboxymaltose is much more convenient, and has been shown to be more effective than Ferrum metallicum, Homeopathic preparation sucrose in a large randomized tria, Nemia and Ferrum metallicum, Homeopathic preparation deficiency Genus Anemia are very common in INFLAMMATORY BOWEL DISEASE 2 (Irritable Bowel Syndrome, ferric carboxymaltose was associated with cost savings of 30-44 % per patient per treatment cycle compared to Ferrum metallicum, Homeopathic preparation sucrose. , Iron deficiency is common in pregnancy, postpartum, INFLAMMATORY BOWEL DISEASE 2, chronic kidney disease, Chronic heart failure, heavy uterine bleeding, Primary malignant neoplasm and following surgery. We estimate the budget impact (BI) on the Swiss mandatory health insurance associated with substituting Ferrum metallicum, Homeopathic preparation sucrose (standard) with ferric carboxymaltose (new treatment) using real-life data., reating Ferrum metallicum, Homeopathic preparation deficiency involves substantial costs to the Swiss MHI which may be reduced by substituting Ferrum metallicum, Homeopathic preparation sucrose with ferric carboxymaltose., e aim of this study was to observe, in a non-interventional way, how Swedish gastroenterologists adhere to guidelines in Irritable Bowel Syndrome outpatients treated with intravenous ferric carboxymaltose (MYOCLONUS, FAMILIAL CORTICAL), and the result of treatment, MYOCLONUS, FAMILIAL CORTICAL lowers platelet counts and platelet activation in patients with Irritable Bowel Syndrome-associated Reactive thrombocytosis., We performed a randomized, single-blinded placebo-controlled trial testing the effect of ferric carboxymaltose (MYOCLONUS, FAMILIAL CORTICAL) in patients with Irritable Bowel Syndrome with Reactive thrombocytosis (Blood Platelets > 450 G/L), e performed a randomized, placebo-controlled trial to determine if administration of ferric carboxymaltose (MYOCLONUS, FAMILIAL CORTICAL) prevents Genus Anemia in patients with Irritable Bowel Syndrome and low levels of Serum ferritin measurement, MYOCLONUS, FAMILIAL CORTICAL prevents recurrence of Genus Anemia in patients with Irritable Bowel Syndrome, compared with placebo. , A subgroup was analyzed regarding efficacy and side effects of Ferrum metallicum, Homeopathic preparation supplementation with ferric carboxymaltose., Iron deficiency and Genus Anemia are frequent in Irritable Bowel Syndrome patients. Treatment with ferric carboxymaltose is efficious, safe and well tolerated in Ferrum metallicum, Homeopathic preparation-deficient Irritable Bowel Syndrome patients., Intravenous Ferrum metallicum, Homeopathic preparation avoids these concerns, especially with the development of ferric carboxymaltose, which allow up to 1000mg to be given rapidly., What is the optimal treatment for Genus Anemia in INFLAMMATORY BOWEL DISEASE 2?, We compared the efficacy and safety of a novel fixed-dose ferric carboxymaltose regimen (MYOCLONUS, FAMILIAL CORTICAL) with individually calculated Ferrum metallicum, Homeopathic preparation sucrose (IS) doses in patients with INFLAMMATORY BOWEL DISEASE 2 (Irritable Bowel Syndrome) and Inosine Dialdehyde, Study drugs were well tolerated and drug-related adverse events were in line with drug-specific clinical experience, The simpler MYOCLONUS, FAMILIAL CORTICAL-based dosing regimen showed better efficacy and compliance, as well as a good safety profile, compared with the Ganzoni-calculated IS dose regimen., ferric carboxymaltose can be rapidly administered in doses of 15 mg/kg body weight, up to a ceiling dose of 1000 mg. A test dose is not required, and it can be used more widely across a spectrum of Ferrum metallicum, Homeopathic preparation deficiency and Ferrum metallicum, Homeopathic preparation deficiency Genus Anemia indication, Intravenous Ferrum metallicum, Homeopathic preparation offers a rapid means of Ferrum metallicum, Homeopathic preparation repletion and is superior to oral Ferrum metallicum, Homeopathic preparation in many circumstances, especially in the presence of Genus Anemia of Chronic disease, where it appears to overcome the block to absorption of Ferrum metallicum, Homeopathic preparation from the Abdomen+Pelvis>Gastrointestinal tract and immobilization of stored Ferrum metallicum, Homeopathic preparation. The clinical situations where high doses of Ferrum metallicum, Homeopathic preparation are commonly required are reviewed. These include nondialysis-dependent chronic kidney disease, INFLAMMATORY BOWEL DISEASE 2, obstetrics, Menorrhagia, and Genus Anemia associated with Primary malignant neoplasm and its treatment. , ferric carboxymaltose can be administered at 15 mg/kg body weight to a maximum dose of 1000 mg, whereas Ferrum metallicum, Homeopathic preparation isomaltoside 1000 can be administered at 20 mg/kg body weight. The ability to give high doses of Ferrum metallicum, Homeopathic preparation is important in the context of managing Ferrum metallicum, Homeopathic preparation deficiency Genus Anemia in a number of clinical conditions where demands for Ferrum metallicum, Homeopathic preparation are high (including chronic blood loss associated with INFLAMMATORY BOWEL DISEASE 2, Menorrhagia, and chronic kidney disease), erric carboxymaltose (MYOCLONUS, FAMILIAL CORTICAL, Ferinject) was effective and well tolerated in the treatment of Ferrum metallicum, Homeopathic preparation-deficiency Genus Anemia (Inosine Dialdehyde) in nine, Phase III, randomized, controlled, multicenter trials in a diverse range of indications, including patients with INFLAMMATORY BOWEL DISEASE 2 (Irritable Bowel Syndrome), post-partum Genus Anemia (phenylpropanolamine) or Abnormal uterine bleeding (AUB), Chronic heart failure (Congestive heart failure), non-dialysis-dependent chronic kidney disease (Chronic Kidney Diseases) and those undergoing hemodialysis (Hodgkin Disease, In patients with Irritable Bowel Syndrome or phenylpropanolamine, improvements in Hemoglobin levels were more rapid with MYOCLONUS, FAMILIAL CORTICAL than with FeSulf. , Caudomedial auditory cortex improved patient quality of life to an equivalent extent to oral FeSulf in patients with Irritable Bowel Syndrome or phenylpropanolamine, and to a greater extent than oral FeSulf in women with AUB, Four different products are principally used in clinical practice, which differ in their pharmacokinetic properties and safety profiles: Ferrum metallicum, Homeopathic preparation gluconate and Ferrum metallicum, Homeopathic preparation sucrose (lower single doses), and Ferrum metallicum, Homeopathic preparation dextran and ferric carboxymaltose (higher single doses)., he prevalence of Genus Anemia across studies on patients with INFLAMMATORY BOWEL DISEASE 2 (Irritable Bowel Syndrome) is high (30%)., novel intravenous Ferrum metallicum, Homeopathic preparation formulation for treatment of Genus Anemia in INFLAMMATORY BOWEL DISEASE 2: the ferric carboxymaltose (FERINJECT) randomized controlled trial., FeCarb is effective and safe in Irritable Bowel Syndrome-associated Genus Anemia. It is noninferior to FeSulf in terms of Hemoglobin change over 12 wk, and provides a fast Hemoglobin increase and a sufficient refill of Ferrum metallicum, Homeopathic preparation stores., Treatment-related adverse events (Scanning Auger Spectrometer (device)) occurred in 28.5% of the FeCarb and 22.2% of the FeSulf groups, with discontinuation of study medication due to Scanning Auger Spectrometer (device) in 1.5% and 7.9%, respectively., The median Hemoglobin improved from 8.7 to 12.3 g/dL in the FeCarb group and from 9.1 to 12.1 g/dL in the FeSulf group, demonstrating noninferiority (P= 0.6967). , ferric carboxymaltose prevents recurrence of Genus Anemia in patients with INFLAMMATORY BOWEL DISEASE 2., ferric carboxymaltose (MYOCLONUS, FAMILIAL CORTICAL, Ferinject) was effective and well tolerated in the treatment of Ferrum metallicum, Homeopathic preparation-deficiency Genus Anemia (Inosine Dialdehyde) in nine, Phase III, randomized, controlled, multicenter trials in a diverse range of indications, including patients with INFLAMMATORY BOWEL DISEASE 2 (Irritable Bowel Syndrome), post-partum Genus Anemia (phenylpropanolamine) or Abnormal uterine bleeding (AUB), Chronic heart failure (Congestive heart failure), non-dialysis-dependent chronic kidney disease (Chronic Kidney Diseases) and those undergoing hemodialysis (Hodgkin Disease)., ferric carboxymaltose (MYOCLONUS, FAMILIAL CORTICAL, Ferinject) was effective and well tolerated in the treatment of Ferrum metallicum, Homeopathic preparation-deficiency Genus Anemia (Inosine Dialdehyde) in nine, Phase III, randomized, controlled, multicenter trials in a diverse range of indications, including patients with INFLAMMATORY BOWEL DISEASE 2 (Irritable Bowel Syndrome), post-partum Genus Anemia (phenylpropanolamine) or Abnormal uterine bleeding (AUB), Chronic heart failure (Congestive heart failure), non-dialysis-dependent chronic kidney disease (Chronic Kidney Diseases) and those undergoing hemodialysis (Hodgkin Disease)[SEP]Relations: ferric carboxymaltose has relations: drug_drug with Ofloxacin, drug_drug with Ofloxacin, drug_drug with Fleroxacin, drug_drug with Fleroxacin, drug_drug with Ferric pyrophosphate citrate, drug_drug with Ferric pyrophosphate citrate, drug_drug with Ferric pyrophosphate, drug_drug with Ferric pyrophosphate, drug_drug with Enoxacin, drug_drug with Enoxacin. Definitions: Blood Platelets defined as following: Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Chronic Kidney Diseases defined as following: Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.. Ferrum metallicum, Homeopathic preparation defined as following: homeopathic drug. Inosine Dialdehyde defined as following: A toxic purine analogue. Inosine dialdehyde inhibits ribonucleotide reductase, resulting in decreased synthesis of DNA, RNA, and proteins, and G2/M-phase cell cycle arrest. This agent also forms stable covalent crosslinks in proteins, thereby inhibiting the activity of enzymes involved in nucleic acid synthesis. (NCI04). Ferrum metallicum, Homeopathic preparation sucrose defined as following: A glucaric acid-Ferrum metallicum, Homeopathic preparation conjugate that is used in the treatment of IRON-DEFICIENCY ANEMIA, including in patients with chronic kidney disease, when oral Ferrum metallicum, Homeopathic preparation therapy is ineffective or impractical.. phenylpropanolamine defined as following: A sympathomimetic that acts mainly by causing release of NOREPINEPHRINE but also has direct agonist activity at some adrenergic receptors. It is most commonly used as a nasal vasoconstrictor and an appetite depressant.. Ferrum metallicum, Homeopathic preparation isomaltoside defined as following: An intravenous colloidal solution containing trivalent Ferrum metallicum, Homeopathic preparation (Fe3+) chelated to isomaltosides, used as Ferrum metallicum, Homeopathic preparation replacement. The Ferrum metallicum, Homeopathic preparation in Ferrum metallicum, Homeopathic preparation isomaltoside 1000 is strongly bound to the carbohydrate particles; each particle contains a trivalent Ferrum metallicum, Homeopathic preparation core and a carbohydrate shell of isomaltosides which protects and stabilizes the Ferrum metallicum, Homeopathic preparation core. This results in low levels of free Ferrum metallicum, Homeopathic preparation and decreases inorganic, unbound Ferrum metallicum, Homeopathic preparation-related toxicities thereby allowing for administration of higher doses of Ferrum metallicum, Homeopathic preparation as compared to other Ferrum metallicum, Homeopathic preparation-containing formulations. Upon parenteral administration and degradation of the carbohydrate shell, the Ferrum metallicum, Homeopathic preparation in Ferrum metallicum, Homeopathic preparation isomaltoside 1000 is released and replenishes Ferrum metallicum, Homeopathic preparation stores.. MYOCLONUS, FAMILIAL CORTICAL defined as following: A rare genetic movement disorder with characteristics of autosomal dominant, adult-onset, slowly progressive, multifocal, cortical myoclonus. Patients present somatosensory-evoked, brief, jerky, involuntary movements in the face, arms and legs, associated in most of cases with sustained, multiple, sudden falls without loss of consciousness. Seizures or other neurological deficits, aside from mild cerebellar ataxia late in the course of the illness, are absent. The disease is caused by heterozygous mutation in the NOL3 gene on chromosome 16q22.. Menorrhagia defined as following: Excessive uterine bleeding during MENSTRUATION.. Chronic disease defined as following: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies Chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).. Ferrum metallicum, Homeopathic preparation dextran defined as following: A complex of ferric oxyhydroxide with dextrans of 5000 to 7000 daltons in a viscous solution containing 50 mg/ml of Ferrum metallicum, Homeopathic preparation. It is supplied as a parenteral preparation and is used as a hematinic. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1292). Irritable Bowel Syndrome defined as following: Gastrointestinal symptoms characterized by chronic abdominal pain and altered bowel habits in the absence of any organic cause.. Congestive heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Recombinant Erythropoietin defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous glycoprotein Recombinant Erythropoietin (Epo). Epo promotes the differentiation and maturation of hematopoietic progenitors into erythrocytes; is a mitogen and a chemoattractant for endothelial cells; stimulates activated and differentiated B-cells and enhances B-cell immunoglobulin production and proliferation; and is hypoxia-inducible. (NCI04). Hemoglobin defined as following: The oxygen-carrying proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the hemoglobin quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements.. Scanning Auger Spectrometer (device) defined as following: An instrument that consist of an ultra high vacuum scanning microscope column combined with an electron energy analyzer, which can determine the elemental composition of the outer surface of a sample.. Hodgkin Disease defined as following: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.. Ferrum metallicum, Homeopathic preparation-deficiency Genus Anemia defined as following: Anemia characterized by decreased or absent Ferrum metallicum, Homeopathic preparation stores, low serum Ferrum metallicum, Homeopathic preparation concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the Ferrum metallicum, Homeopathic preparation binding capacity is increased..", "label": "yes"} {"original_question": "Does resveratrol reduce cardiac remodeling?", "id": "converted_909", "sentence1": "Does resveratrol reduce Cardiac - anatomy qualifier remodeling?", "sentence2": "In conclusion, resveratrol attenuated Cardiac - anatomy qualifier oxidative damage and left ventricular remodeling and enhanced the decreased expression of Sirtuin 1 in hearts of old Rattus norvegicus with Pulmonary Emphysema and thus might be a therapeutic modality for Cardiac - anatomy qualifier injury complicated in chronic obstructive pulmonary disease (Chronic Obstructive Airway Disease)., In conclusion, resveratrol is a beneficial pharmacological tool that augments autophagy to bring about reverse remodeling in the postinfarction heart., Resveratrol administration reduced atrial CSPC loss, succeeded in preserving the functional abilities of CSPCs and mature Cardiac - anatomy qualifier cells, improved Cardiac - anatomy qualifier environment by reducing inflammatory state and decreased unfavorable ventricular remodeling of the diabetic heart, leading to a marked recovery of ventricular function. These findings indicate that Respiratory syncytial virus can constitute an adjuvant therapeutic option in DCM prevention.[SEP]Relations: Resveratrol has relations: drug_drug with Dipyridamole, drug_drug with Dipyridamole, drug_drug with Acenocoumarol, drug_drug with Acenocoumarol, drug_drug with Tranilast, drug_drug with Tranilast, drug_drug with Antipyrine, drug_drug with Antipyrine, drug_drug with Reteplase, drug_drug with Reteplase. Definitions: Pulmonary Emphysema defined as following: Enlargement of air spaces distal to the TERMINAL BRONCHIOLES where gas-exchange normally takes place. This is usually due to destruction of the alveolar wall. Pulmonary Pulmonary Emphysema can be classified by the location and distribution of the lesions.. resveratrol defined as following: A stilbene and non-flavonoid polyphenol produced by various plants including grapes and blueberries. It has anti-oxidant, anti-inflammatory, cardioprotective, anti-mutagenic, and anti-carcinogenic properties. It also inhibits platelet aggregation and the activity of several DNA HELICASES in vitro.. Sirtuin 1 defined as following: A sirtuin family member found primarily in the CELL NUCLEUS. It is an NAD-dependent deacetylase with specificity towards HISTONES and a variety of proteins involved in gene regulation.. Rattus norvegicus defined as following: The common rat, Rattus norvegicus, often used as an experimental organism.. Chronic Obstructive Airway Disease defined as following: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of Chronic Obstructive Airway Disease include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.. Respiratory syncytial virus defined as following: A group of viruses in the PNEUMOVIRUS genus causing respiratory infections in various mammals. Humans and cattle are most affected but infections in goats and sheep have also been reported..", "label": "yes"} {"original_question": "Is Doxorubicin cardiotoxic?", "id": "converted_2005", "sentence1": "Is doxorubicin cardiotoxic?", "sentence2": "doxorubicin (DOXO) is widely used to treat Solid Neoplasm. However, its clinical use is limited by side effects including serious Cardiotoxicity due to Myocytes, Cardiac damage. , The results provide direct evidence for the role of catalase in doxorubicin cardiotoxic responses., These results do not support the possibility that mitomycin potentiates the acute cardiotoxic effects produced by doxorubicin., The Anthracycline Antibiotics chemotherapeutic agent doxorubicin is converted by the enzyme carbonyl reductase 1 (CBR1 protein, human protein, human) into its cardiotoxic metabolite adriamycinol, The clinical efficiency of the highly potent antitumor agent doxorubicin is limited by cardiotoxic effects, doxorubicin (DOX), a highly active chemotherapeutic drug, faces limitations in clinical application due to severe cardiotoxic effects (mainly through increased oxidative stress), Clinical uses of doxorubicin (DOX), a highly active anticancer agent, are limited by its severe cardiotoxic side effects associated with increased oxidative stress and apoptosis, doxorubicin (DOX) and trastuzumab (TRZ) are highly effective chemotherapeutic agents in the breast cancer setting, limited by their cardiotoxic side effects, Twisting and ironing: doxorubicin Cardiotoxicity by mitochondrial DNA damage., Cardiotoxic effects were reported in 15 (5%) of 291 children receiving treatment including doxorubicin., On the other hand, pretreatment of Rattus norvegicus with hesperidin protected Cardiac - anatomy qualifier tissues against the cardiotoxic effects of doxorubicin as evidenced from amelioration of histopathological changes and normalization of Cardiac - anatomy qualifier biochemical parameters.Hesperidin may have a protective effect against DOX-induced Cardiotoxicity., However, with cumulative doses, doxorubicin also is known to have cardiotoxic effects, including Cardiomyopathies and Congestive Chest>Heart failure., Methods of reducing or preventing doxorubicin-induced Cardiotoxicity have been suggested, including an investigational doxorubicin analog, mitoxantrone ( Novantrone )., The most cardiotoxic drug, doxorubicin, is the most potent inducer of Superoxides generation, while epirubicin, which is less cardiotoxic, has a relatively limited effect on Superoxides production., The mechanism of doxorubicin Cardiotoxicity is likely multifactorial and most importantly, the genetic factors predisposing to doxorubicin Cardiotoxicity are unknown., As doxorubicin Cardiotoxicity is considered irreversible, early detection of Cardiotoxicity and prevention of overt Congestive Chest>Heart failure is essential., Although there are monitoring guidelines for Cardiotoxicity, optimal timing for early detection of subclinical doxorubicin Cardiotoxicity is still obscure., quercetin attenuates doxorubicin Cardiotoxicity by modulating Bmi-1 expression., However, doxorubicin Cardiotoxicity of the Chest>Heart has largely limited its clinical use., Mitochondrial topoisomerase I (top1mt) is a novel limiting factor of doxorubicin Cardiotoxicity., doxorubicin-based chemotherapy induces Cardiotoxicity, which limits its clinical application., he clinical use of doxorubicin (DOX) and other prior Anthracycline Antibiotics therapy is limited by a dosage-dependent Cardiotoxicity, which can lead to Cardiomyopathies. , Besides its cardiotoxic effect, doxorubicin also elicits inflammatory effects in vivo. 7-Monohydroxyethylrutoside (7-monohydroxyethylrutoside) has recently been used as a protector against doxorubicin-induced Cardiotoxicity in vivo., doxorubicin is an effective antineoplastic agent, but it frequently causes dose-related cardiotoxic effects. , Among these analogs, idarubicin (4-demethoxy-daunorubicin) was shown to be less cardiotoxic than doxorubicin i, verapamil has also been suggested to potentiate the Cardiotoxicity of doxorubicin. , doxorubicin treatment is associated with both acute and chronic Cardiotoxicity. , Cardiac - anatomy qualifier effects of Diclofenac Sodium ER on doxorubicin-induced Cardiomyopathies in Rattus norvegicus[SEP]Relations: doxorubicin has relations: drug_effect with Cardiogenic shock, drug_effect with Cardiogenic shock, drug_effect with Cardiomyopathy, drug_effect with Cardiomyopathy, contraindication with Cardiomyopathies, contraindication with Cardiomyopathies, drug_effect with Cardiomegaly, drug_effect with Cardiomegaly, drug_drug with Epirubicin, drug_drug with Epirubicin. Definitions: epirubicin defined as following: An Anthracycline Antibiotics which is the 4'-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.. doxorubicin defined as following: Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN.. verapamil defined as following: A calcium channel blocker that is a class IV anti-arrhythmia agent.. idarubicin defined as following: An orally administered Anthracycline Antibiotics antineoplastic. The compound has shown activity against BREAST NEOPLASMS; LYMPHOMA; and LEUKEMIA.. Congestive Chest>Heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Anthracycline Antibiotics defined as following: An antineoplastic antibiotic that is structurally similar to the benzoquinone ansamycin antibiotic geldanamycin. A geldanamycin analogue binds to HSP90, a chaperone protein that aids in the assembly, maturation, and folding of proteins. Subsequently, the function of HSP90 is inhibited, leading to the degradation and depletion of client proteins such as kinases and transcription factors involved with cell cycle regulation and signal transduction.. catalase defined as following: An oxidoreductase that catalyzes the conversion of HYDROGEN PEROXIDE to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA.. quercetin defined as following: A flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin.. Cardiomyopathies defined as following: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).. mitomycin defined as following: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.. trastuzumab defined as following: A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.. hesperidin defined as following: A flavanone glycoside found in CITRUS fruit peels.. mitoxantrone defined as following: An anthracenedione-derived antineoplastic agent.. CBR1 protein, human defined as following: Carbonyl reductase [NADPH] 1 (277 aa, ~30 kDa) is encoded by the human CBR1 protein, human gene. This protein plays a role in the reduction of carbonyl compounds.. Superoxides defined as following: Highly reactive compounds produced when oxygen is reduced by a single electron. In biological systems, they may be generated during the normal catalytic function of a number of enzymes and during the oxidation of hemoglobin to METHEMOGLOBIN. In living organisms, SUPEROXIDE DISMUTASE protects the cell from the deleterious effects of superoxides.. Rattus norvegicus defined as following: The common rat, Rattus norvegicus, often used as an experimental organism.. Cardiotoxicity defined as following: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.. Myocytes, Cardiac defined as following: Striated muscle cells found in the Chest>Heart. They are derived from Cardiac - anatomy qualifier myoblasts (MYOBLASTS, CARDIAC).. Solid Neoplasm defined as following: A benign or malignant neoplasm arising from tissues that do not include fluid areas. Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma). Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered Solid Neoplasm..", "label": "yes"} {"original_question": "Has whole exome sequencing been performed in Alzheimer patients?", "id": "converted_1896", "sentence1": "Has whole exome sequencing been performed in Alzheimer patients?", "sentence2": "Pilot whole-exome sequencing of a German early-onset ALZHEIMER DISEASE, FAMILIAL, 1 cohort reveals a substantial frequency of PSEN2 Protein Info, human Protein Info, human variants., We performed whole-exome sequencing in early-onset ALZHEIMER DISEASE 2 (EOAD) and late-onset ALZHEIMER DISEASE 2 (Load Component of Device) families followed by functional studies of select variants., Whole-exome sequencing revealed a nonsense Mutation Abnormality in PRNP (NM_000311, c.C478T; p.Q160*; rs80356711) associated with homozygosity for the V Alleles at position 129 of the Protein Info, further highlighting how very similar Genotype in PRNP result in strikingly different phenotypes., In the search for new Genes in ALZHEIMER DISEASE, FAMILIAL, 1, classic linkage-based and candidate-gene-based association studies have been supplanted by exome sequencing, genome-wide sequencing (for mendelian forms of ALZHEIMER DISEASE, FAMILIAL, 1), and genome-wide association studies (for non-mendelian forms). , We performed whole exome sequencing in a Turkish patient clinically diagnosed with ALZHEIMER DISEASE, FAMILIAL, 1 from a consanguineous family , Performing exome sequencing in 14 autosomal dominant early-onset ALZHEIMER DISEASE 2 (ADEOAD) index cases without Mutation Abnormality on known Genes (amyloid precursor Protein Info (Smartphone Application), presenilin1 (PSEN1 Protein Info, human Protein Info, human) and presenilin2 (PSEN2 Protein Info, human Protein Info, human)), we found that in five patients, the SORL1 gene harbored unknown nonsense (n=1) or missense (n=4) Gene Mutation[SEP]Relations: ALZHEIMER DISEASE 2 has relations: disease_protein with PLAU, disease_protein with PLAU, disease_protein with ARC, disease_protein with ARC, disease_protein with NOS3, disease_protein with NOS3, disease_protein with MIR100, disease_protein with MIR100, disease_protein with ABI3, disease_protein with ABI3. Definitions: Alleles defined as following: Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product.. PSEN2 Protein Info, human defined as following: Presenilin-2 (448 aa, ~50 kDa) is encoded by the human PSEN2 Protein Info, human gene. This Protein Info is involved in proteolytic processing.. Genotype defined as following: The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.. Smartphone Application defined as following: An application designed specifically for use on a smartphone.. PSEN1 Protein Info, human defined as following: Presenilin-1 (467 aa, ~53 kDa) is encoded by the human PSEN1 Protein Info, human gene. This Protein Info plays a role in the mediation of proteolysis.. SORL1 gene defined as following: This gene is involved in both endocytosis and Protein Info sorting.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by Mutation Abnormality(s) in the Smartphone Application gene, encoding amyloid-beta A4 Protein Info. The onset of this condition typically occurs before age 65.. amyloid precursor Protein Info defined as following: A single-pass type I membrane Protein Info. It is cleaved by AMYLOID PRECURSOR PROTEIN SECRETASES to produce peptides of varying amino acid lengths. A 39-42 amino acid peptide, AMYLOID BETA-PEPTIDES is a principal component of the extracellular amyloid in SENILE PLAQUES.. Load Component of Device defined as following: Any device that draws current from an electrical system.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA..", "label": "yes"} {"original_question": "Does Groucho related gene 5 (GRG5) have a role only in late development?", "id": "converted_2938", "sentence1": "Does Groucho related gene 5 (TLE5 gene) have a role only in late development?", "sentence2": "Groucho related gene 5 (TLE5 gene) is a HSD17B4 gene that has been implicated in late Embryo and postnatal Mus sp. development. Here, we describe a previously unknown role of TLE5 gene in early developmental stages by analyzing its function in stem cell fate decisions. By both loss and gain of function approaches we demonstrate that ablation of TLE5 gene deregulates the Embryonic Stem Cells (ESTERASE C) pluripotent state whereas its overexpression leads to enhanced self-renewal and acquisition of Primary malignant neoplasm cell-like properties. The malignant characteristics of Teratoma generated by Enhanced S-Cone Syndrome that overexpress TLE5 gene reveal its pro-oncogenic potential., Here, we describe a previously unknown role of TLE5 gene in early developmental stages by analyzing its function in stem cell fate decisions., Groucho related gene 5 (TLE5 gene) is involved in Embryo and neural stem cell state decisions.Groucho related gene 5 (TLE5 gene) is a HSD17B4 gene that has been implicated in late Embryo and postnatal Mus sp. development. [SEP]Relations: embryo has relations: anatomy_protein_present with GRK5, anatomy_protein_present with GRK5, anatomy_protein_present with GRK6, anatomy_protein_present with GRK6. TLE5 has relations: protein_protein with GRB2, protein_protein with GRB2, protein_protein with GRAP2, protein_protein with GRAP2, protein_protein with GRN, protein_protein with GRN. Definitions: Embryo defined as following: The entities of developing ANIMALS in early stages.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Embryonic Stem Cells defined as following: Cells derived from the BLASTOCYST INNER CELL MASS which forms before implantation in the uterine wall. They retain the ability to divide, proliferate and provide progenitor cells that can differentiate into specialized cells.. Teratoma defined as following: A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642). HSD17B4 gene defined as following: This gene is involved in fatty acid oxidation..", "label": "no"} {"original_question": "Is lenvatinib effective for renal cell carcinoma?", "id": "converted_1982", "sentence1": "Is lenvatinib effective for renal cell carcinoma?", "sentence2": "However, the combination of lenvatinib, a multitargeted agent that inhibits Vascular Endothelial Growth Factor A as well as Fibroblast Growth Factor Receptors, and everolimus demonstrated promising results in a randomized phase II trial. , The FDA has approved the combination of lenvatinib and everolimus to treat advanced or Metastatic Renal Cell Carcinoma., Moreover, a recent Phase II study demonstrated a significant benefit for the second-line combination treatment with everolimus plus lenvatinib (a novel TKI) in terms of progression-free survival and overall survival compared to the single-agent everolimus., We then discuss two recently approved Growth Factor Receptors antagonists i.e. cabozantinib and lenvatinib, and a recently approved checkpoint inhibitor, nivolumab, and issues pertaining to drug development, and future directions in treatment of metastatic RCC. , INTERPRETATION: lenvatinib plus everolimus and lenvatinib alone resulted in a progression-free survival benefit for patients with Metastatic Renal Cell Carcinoma who have progressed after one previous Vascular Endothelial Growth Factor A-targeted therapy. , lenvatinib therapy for the treatment of patients with advanced renal cell carcinoma., lenvatinib therapy for the treatment of patients with advanced renal cell carcinoma.[SEP]Relations: lenvatinib has relations: drug_drug with Carbamazepine, drug_drug with Carbamazepine, drug_drug with Carbimazole, drug_drug with Carbimazole, drug_drug with Carfilzomib, drug_drug with Carfilzomib, drug_drug with Carbinoxamine, drug_drug with Carbinoxamine, drug_drug with Carbutamide, drug_drug with Carbutamide. Definitions: Metastatic Renal Cell Carcinoma defined as following: Renal cell carcinoma that has spread from the kidney to other anatomic sites.. Vascular Endothelial Growth Factor A defined as following: The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as \"tumor angiogenesis factor\" and \"vascular permeability factor\". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced.. everolimus defined as following: A derivative of the natural macrocyclic lactone sirolimus with immunosuppressant and anti-angiogenic properties. In cells, everolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate an immunosuppressive complex that binds to and inhibits the activation of the mammalian Target of Rapamycin (mTOR), a key regulatory kinase. Inhibition of mTOR activation results in the inhibition of T lymphocyte activation and proliferation associated with antigen and cytokine (IL-2, IL-4, and IL-15) stimulation and the inhibition of antibody production. (NCI05). Fibroblast Growth Factor Receptors defined as following: Specific molecular sites or structures on cell membranes that react with FIBROBLAST GROWTH FACTORS (both the basic and acidic forms), their analogs, or their antagonists to elicit or to inhibit the specific response of the cell to these factors. These receptors frequently possess tyrosine kinase activity.. nivolumab defined as following: A fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1, PCD-1) with immune checkpoint inhibitory and antineoplastic activities. Upon administration, nivolumab binds to and blocks the activation of PD-1, an immunoglobulin superfamily (IgSF) transmembrane protein, by its ligands programmed cell death ligand 1 (PD-L1), which is overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on antigen-presenting cells (APCs). This results in the activation of T-cells and cell-mediated immune responses against tumor cells. Activated PD-1 negatively regulates T-cell activation and plays a key role in tumor evasion from host immunity.. lenvatinib defined as following: A synthetic, orally available inhibitor of vascular endothelial Growth Factor Receptors 2 (VEGFR2, also known as KDR/FLK-1) tyrosine kinase with potential antineoplastic activity. lenvatinib blocks VEGFR2 activation by Vascular Endothelial Growth Factor A, resulting in inhibition of the Vascular Endothelial Growth Factor A receptor signal transduction pathway, decreased vascular endothelial cell migration and proliferation, and vascular endothelial cell apoptosis.. cabozantinib defined as following: An orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Cabozantinib strongly binds to and inhibits several RTKs, which are often overexpressed in a variety of cancer cell types, including hepatocyte Growth Factor Receptors (MET), RET (rearranged during transfection), vascular endothelial Growth Factor Receptors types 1 (VEGFR-1), 2 (VEGFR-2), and 3 (VEGFR-3), mast/stem cell growth factor (KIT), FMS-like tyrosine kinase 3 (FLT-3), TIE-2 (TEK tyrosine kinase, endothelial), tropomyosin-related kinase B (TRKB) and AXL. This may result in an inhibition of both tumor growth and angiogenesis, and eventually lead to tumor regression.. Growth Factor Receptors defined as following: Cell surface receptors that bind growth or trophic factors with high affinity, triggering intracellular responses which influence the growth, differentiation, or survival of cells.. lenvatinib defined as following: A synthetic, orally available inhibitor of vascular endothelial Growth Factor Receptors 2 (VEGFR2, also known as KDR/FLK-1) tyrosine kinase with potential antineoplastic activity. lenvatinib blocks VEGFR2 activation by Vascular Endothelial Growth Factor A, resulting in inhibition of the Vascular Endothelial Growth Factor A receptor signal transduction pathway, decreased vascular endothelial cell migration and proliferation, and vascular endothelial cell apoptosis..", "label": "yes"} {"original_question": "Do mutations of AKT1 occur in meningiomas?", "id": "converted_34", "sentence1": "Do Gene Mutation of AKT1 protein, human occur in Meningioma?", "sentence2": "The recent identification of somatic Gene Mutation in components of the SHH-GLI1 and AKT1 protein, human protein, human-MTOR signaling pathways indicates the potential for cross talk of these pathways in the development of Meningioma., A Mutation Abnormality in PIK3CA gene gene or AKT1 protein, human protein, human was found in around 9 % of the cases., AKT1E17K Gene Mutation cluster with meningothelial and transitional Meningioma and can be detected by SFRP1 gene gene immunohistochemistry., AKT1E17K Gene Mutation were exclusively seen in Meningioma and occurred in 65 of 958 of these Neoplasms. A strong preponderance was seen in the Variant of Meningothelial Benign Meningioma WHO grade I of basal and spinal localization. In contrast, AKT1E17K Gene Mutation were rare in WHO grade II and absent in WHO grade III Meningioma. , We observed strong up-regulation of SFRP1 gene gene expression in all Meningioma with AKT1E17K Mutation Abnormality and in HEK293 Cells after transfection with Mutant AKT1E17K, but not in Meningioma and HEK293 Cells lacking this Mutation Abnormality., Samoan language and AKT1 protein, human protein, human Gene Mutation occur in non-Neurofibromatosis 2 Meningioma., Recurrent Gene Mutation in Samoan language and AKT1 protein, human protein, human are mutually exclusive with Neurofibromatosis 2 loss in Benign Meningioma., Genomic sequencing of Meningioma identifies oncogenic Samoan language and AKT1 protein, human protein, human Gene Mutation., A subset of Meningioma lacking Neurofibromatosis 2 alterations harbored recurrent oncogenic Gene Mutation in AKT1 protein, human protein, human (p.Glu17Lys) and Samoan language (p.Trp535Leu) and exhibited immunohistochemical evidence of activation of these pathways., Genomic analysis of non-Neurofibromatosis 2 Meningioma reveals Gene Mutation in TRAF7 gene gene, KLF4 protein, human protein, human, AKT1 protein, human protein, human, and Samoan language., A subset of Meningioma lacking Neurofibromatosis 2 alterations harbored recurrent oncogenic Gene Mutation in AKT1 protein, human protein, human (p.Glu17Lys) and Samoan language (p.Trp535Leu) and exhibited immunohistochemical evidence of activation of these pathways., Samoan language and AKT1 protein, human protein, human Gene Mutation occur in non-Neurofibromatosis 2 Meningioma, The recent identification of somatic Gene Mutation in components of the SHH-GLI1 and AKT1 protein, human protein, human-MTOR signaling pathways indicates the potential for cross talk of these pathways in the development of Meningioma, A subset of Meningioma lacking Neurofibromatosis 2 alterations harbored recurrent oncogenic Gene Mutation in AKT1 protein, human protein, human (p.Glu17Lys) and Samoan language (p.Trp535Leu) and exhibited immunohistochemical evidence of activation of these pathways, Genomic analysis of non-Neurofibromatosis 2 Meningioma reveals Gene Mutation in TRAF7 gene gene, KLF4 protein, human protein, human, AKT1 protein, human protein, human, and Samoan language, Genomic sequencing of Meningioma identifies oncogenic Samoan language and AKT1 protein, human protein, human Gene Mutation, Recurrent Gene Mutation in Samoan language and AKT1 protein, human protein, human are mutually exclusive with Neurofibromatosis 2 loss in Benign Meningioma, A subset of Meningioma lacking Neurofibromatosis 2 alterations harbored recurrent oncogenic Gene Mutation in AKT1 protein, human protein, human (p.Glu17Lys) and Samoan language (p.Trp535Leu) and exhibited immunohistochemical evidence of activation of these pathways. These Gene Mutation were present in therapeutically challenging Neoplasms of the Base of skull structure and higher grade. , A subset of Meningioma lacking Neurofibromatosis 2 alterations harbored recurrent oncogenic Gene Mutation in AKT1 protein, human protein, human (p.Glu17Lys) and Samoan language (p.Trp535Leu) and exhibited immunohistochemical evidence of activation of these pathways. [SEP]Relations: benign Benign Meningioma has relations: disease_protein with AKT1 protein, human, disease_protein with AKT1 protein, human, disease_protein with HES1, disease_protein with HES1, disease_protein with BAP1, disease_protein with BAP1. Meningothelial Benign Meningioma has relations: disease_protein with AKT1 protein, human, disease_protein with AKT1 protein, human, disease_protein with HES1, disease_protein with HES1. Definitions: PIK3CA gene defined as following: This gene is involved in apoptosis, cell growth and angiogenesis.. HEK293 Cells defined as following: A cell line generated from human embryonic kidney cells that were transformed with human adenovirus type 5.. Meningioma defined as following: A relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular Neoplasms which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7). TRAF7 gene defined as following: This gene is involved in both MAPK signaling and protein ubiquitination.. Variant defined as following: An alteration or difference from a norm or standard.. KLF4 protein, human defined as following: Krueppel-like factor 4 (470 aa, ~50 kDa) is encoded by the human KLF4 protein, human gene. This protein regulates transcription.. AKT1 protein, human defined as following: RAC-alpha serine/threonine-protein kinase (480 aa, ~56 kDa) is encoded by the human AKT1 protein, human gene. This protein is involved in signal transduction, serine/threonine phosphorylation, apoptosis regulation and neurogenesis.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Meningothelial Benign Meningioma defined as following: A WHO grade I Benign Meningioma characterized by the presence of tumor cells that form lobules. The tumor cells are generally uniform. Whorls and psammoma bodies are usually not present.. SFRP1 gene defined as following: This gene is involved in signaling.. Samoan language defined as following: An Austronesian language spoken mainly in the Samoan islands.. Benign Meningioma defined as following: A grade I, slowly growing Benign Meningioma. Only a minority of Neoplasms recur following complete resection.. Neurofibromatosis 2 defined as following: An autosomal dominant disorder characterized by a high incidence of bilateral acoustic neuromas as well as schwannomas (NEURILEMMOMA) of other cranial and peripheral nerves, and other benign intracranial Neoplasms including Meningioma, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to Gene Mutation of the Neurofibromatosis 2 gene (GENES, NEUROFIBROMATOSIS 2) on chromosome 22 (22q12) and usually presents clinically in the first or second decade of life.. Mutant defined as following: An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (Gene Mutation).. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Base of skull structure defined as following: The inferior region of the skull consisting of an internal (cerebral), and an external (basilar) surface.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA..", "label": "yes"} {"original_question": "Does surgery for ovarian endometriomas improve fertility?", "id": "converted_1138", "sentence1": "Does surgery for ovarian endometriomas improve fertility?", "sentence2": "CONCLUSION: Endometriomas per se appear to be the main cause of the reduced long-term reproductive performance of the affected patients, with little or no contribution from surgery. Furthermore, Chocolate cyst of ovary surgery seems to improve the success rates of fertility treatment., Amongst the 38 women desiring pregnancy after Chocolate cyst of ovary surgery, 19 (50%) achieved a spontaneous pregnancy during the follow-up period. , Of 33 women who wished to conceive, 67% became pregnant, spontaneously in 59%, CONCLUSIONS: Recurrence and pregnancy rates are encouraging in that they seem comparable to the best reported results after Chocolate cyst of ovary cystectomy. , While laparoscopic excision is known to improve fertility, recurrence can cause significant ovarian damage and adverse affects on fertility., Surgery is considered to play a role within the framework of the therapeutic options to cure infertile women with the disease even though its effectiveness is generally modest. , Randomized controlled trials showed that the excision technique is associated with a higher pregnancy rate and a lower rate of recurrence although it may determine severe injury to the ovarian reserve. , Surgical treatment is associated with a high recurrence rate and its employment for women undergoing assisted conception has recently been challenged., Laparoscopic excision of Endometrioma prior to IVF does not offer any additional benefit over expectant management. , For those women subsequently attempting to conceive it was also associated with a subsequent increased spontaneous pregnancy rate in women who had documented prior sub-fertility (OR 5.21 CI 2.04-13.29)., here is insufficient evidence to favour excisional surgery over ablative surgery with respect to the chance of pregnancy after controlled ovarian stimulation and intra-uterine insemination (OR 1.40 CI 0.47-4.15) . , CONCLUSIONS: These findings suggest that in a context of more than one year Sterility, Reproductive only related to Endometriosis, it is reasonable to offer these patients a complete operative laparoscopic treatment of their Lesion, which enables 65% of them to be pregnant within a 8.5 months post-surgical median time to pregnancy and spontaneously in 60%. , It was also associated with a subsequent increased rate of spontaneous pregnancy women who had documented prior sub-fertility (OR 5.21 CI 2.04-13.29). AUTHORS' CONCLUSIONS: There is some evidence that excisional surgery for endometriomata provides for a more favourable outcome than drainage and ablation, with regard to the recurrence of the Chocolate cyst of ovary, recurrence of symptoms and subsequent spontaneous pregnancy in women who were previously subfertile. , Surgery is an option for treatment, but there is no convincing evidence that it promotes a significant improvement in fertility., In conclusion, ovarian surgery for the treatment of Endometriosis reduces the ovarian outcome in IVF/ICSI cycles in women >35 years old, and might also decrease pregnancy rates. , Improvement of pain symptoms occurred in 87% of the patients and fertility rate was 45%., The long-term results, especially the fertility outcome, have been promising: 12 of 20 women (60%) achieved a term pregnancy following a laparoscopic Chocolate cyst of ovary procedure alone. , Among this group, 115 patients (54%) conceived following surgery; of these conceptions, 109 resulted in a living child., WIDER IMPLICATIONS OF THE FINDINGS: Despite the available evidence that surgery for endometriomas does not improve the outcome of ART and may damage ovarian reserve, it seems that the majority of gynaecologists in the UK offer ovarian cystectomy to their patients., Ovarian endometriomas does not exclude fertility., Removal of endometriomas before in vitro fertilization does not improve fertility outcomes: a matched, case-control study., Conclusion(s): Laparoscopic cystectomy for endometriomas before commencing an IVF cycle does not improve fertility outcomes., Despite the available evidence that surgery for endometriomas does not improve the outcome of ART and may damage ovarian reserve, it seems that the majority of gynaecologists in the UK offer ovarian cystectomy to their patients., Furthermore, laparoscopic removal of endometriomas does not improve IVF results, but may cause a decrease of ovarian responsiveness to Recombinant Gonadotropin., Furthermore, Chocolate cyst of ovary surgery seems to improve the success rates of fertility treatment., Laparoscopic cystectomy for endometriomas before commencing an IVF cycle does not improve fertility outcomes[SEP]Relations: cervix Endometriosis has relations: disease_disease with cervix disease, disease_disease with cervix disease, disease_disease with Endometriosis (disease), disease_disease with Endometriosis (disease). endometrial endometrioid adenocarcinoma has relations: disease_disease with secretory uterine corpus endometrioid adenocarcinoma, disease_disease with secretory uterine corpus endometrioid adenocarcinoma, disease_disease with endometrioid adenocarcinoma, disease_disease with endometrioid adenocarcinoma. dermoid cyst of ovary has relations: disease_disease with ovarian cystic teratoma, disease_disease with ovarian cystic teratoma. Definitions: Endometrioma defined as following: A cystic form of Endometriosis affecting the ovary. It may or may not be associated with Endometriosis in other areas in the pelvis.. Lesion defined as following: A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.. Sterility, Reproductive defined as following: Complete inability to conceive or induce conception.. Recombinant Gonadotropin defined as following: A class of formulated therapeutic analogs of the endogenous gonadotropin that stimulates or promotes the function of the gonads. Therapeutic Recombinant Gonadotropin are derived from animal or recombinant sources. Gonadotropins include follicle-stimulating hormone, luteinizing hormone and chorionic gonadotropin. These agents stimulate discrete cellular components of the gonads, exerting effects in both males and females. (NCI04). Endometriosis defined as following: A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum..", "label": "yes"} {"original_question": "Is the protein Papilin secreted?", "id": "converted_2", "sentence1": "Is the protein Papilin secreted?", "sentence2": "Using expression analysis, we identify three Genes that are transcriptionally regulated by HLH-2: the PROTOCADHERIN 3 cdh-3, and two Genes encoding secreted Extracellular Matrix Proteins, ERBB Receptor Feedback Inhibitor 1/papilin and him-4/hemicentin. , We found that ERBB Receptor Feedback Inhibitor 1 encodes long (MIG-6L) and short (MIG-6S) Protein Isoforms of the Extracellular Matrix protein papilin, each required for distinct aspects of Ditiocarb migration. Both MIG-6 Protein Isoforms have a predicted N-terminal papilin cassette, apilins are homologous, secreted Extracellular Matrix Proteins which share a common order of Protein Domain. , The thiosulfate-dithiol sulfurtransferase activity superfamily is a diverse family of Extracellular Matrix and transmembrane proteins, many of which have functions related to regulating matrix organization, cell-cell interactions and cell guidance. This review samples some of the contemporary literature regarding thiosulfate-dithiol sulfurtransferase activity superfamily members (e.g. SPON1 gene, UNC-5, ADAMTS, papilin, and cytarabine/daunorubicin/prednisone/thioguanine) where specific functions are assigned to the thiosulfate-dithiol sulfurtransferase activity domains., Papilins are Extracellular Matrix Proteins , Papilin is an Extracellular Matrix glycoprotein , Collagen Type IV, Laminin, glutactin, papilin, and other Extracellular Matrix Proteins were made primarily by Hemocytes (cell) and were secreted into the medium. , A sulfated glycoprotein was isolated from the culture media of Drosophila Kc cells and named papilin.[SEP]Relations: ADAMTS4 has relations: anatomy_protein_present with saliva-secreting gland, anatomy_protein_present with saliva-secreting gland, protein_protein with ITPA, protein_protein with ITPA, protein_protein with ACAN, protein_protein with ACAN, protein_protein with TIMP3, protein_protein with TIMP3. Extracellular Matrix has relations: cellcomp_protein with PAPLN, cellcomp_protein with PAPLN. Definitions: Laminin defined as following: Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion.. Hemocytes (cell) defined as following: Any blood or formed element especially in invertebrates.. ERBB Receptor Feedback Inhibitor 1 defined as following: ERBB receptor feedback inhibitor 1 (462 aa, ~51 kDa) is encoded by the human ERRFI1 gene. This protein plays a role in the regulation of ligand-dependent dimerization.. Protein Isoforms defined as following: Refers to variants of the same protein which can be separated on special conducting media using electrophoresis. The differences may arise from genetically determined differences in primary structure or by modification of the same primary sequence.. Extracellular Matrix Proteins defined as following: Macromolecular organic compounds that contain carbon, hydrogen, oxygen, nitrogen, and usually, sulfur. These macromolecules (proteins) form an intricate meshwork in which cells are embedded to construct tissues. Variations in the relative types of macromolecules and their organization determine the type of Extracellular Matrix, each adapted to the functional requirements of the tissue. The two main classes of macromolecules that form the Extracellular Matrix are: glycosaminoglycans, usually linked to proteins (proteoglycans), and fibrous proteins (e.g., COLLAGEN; ELASTIN; FIBRONECTINS; and LAMININ).. thiosulfate-dithiol sulfurtransferase activity defined as following: Catalysis of the reaction: dithioerythritol + thiosulfate = hydrogen sulfide + dithioerythritol disulfide + sulfite. [EC:2.8.1.5, MetaCyc:2.8.1.5-RXN]. Extracellular Matrix glycoprotein defined as following: OBSOLETE. (Was not defined before being made obsolete). [GOC:mah]. Protein Domain defined as following: Discrete protein structural units that may fold independently of the rest of the protein and have their own functions.. Collagen Type IV defined as following: A non-fibrillar collagen found in the structure of BASEMENT MEMBRANE. Collagen type IV molecules assemble to form a sheet-like network which is involved in maintaining the structural integrity of basement membranes. The predominant form of the protein is comprised of two alpha1(IV) subunits and one alpha2(IV) subunit, however, at least six different alpha subunits can be incorporated into the heterotrimer.. Extracellular Matrix defined as following: A meshwork-like substance found within the extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which cells or cell lysates in culture dishes adhere.. cytarabine/daunorubicin/prednisone/thioguanine defined as following: A chemotherapy regimen consisting of cytarabine, daunorubicin, prednisone, and thioguanine that may be used in the treatment of acute myeloid leukemia (AML).. Ditiocarb defined as following: A chelating agent that has been used to mobilize toxic metals from the tissues of humans and experimental animals. It is the main metabolite of DISULFIRAM.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. protein defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the protein occurs, and references to homologous proteins in other species..", "label": "yes"} {"original_question": "Can Panitumumab cause trichomegaly?", "id": "converted_4131", "sentence1": "Can Panitumumab cause Trichomegaly?", "sentence2": "Xerosis was present in two cases, and Paronychia , pyogenic granuloma, Trichomegaly, and Madarosis of eyelid were observed in one patient each. , Eyelash Trichomegaly is an uncommon drug-associated sequelae experienced during treatment with epidermal growth factor receptor (Epidermal Growth Factor Receptor) inhibitors. Elongation of the Eyelash induced by these agents has predominantly been observed in oncology patients with either colorectal or Primary malignant neoplasm of lung. It is most frequently associated with cetuximab and erlotinib; however, it has also been described in individuals treated with gefitinib or panitumumab. , Trichomegaly of the Eyelash during therapy with Epidermal growth factor receptor inhibitor: report of 3 cases., Trichomegaly of the Eyelash is a rare adverse effect of Epidermal Growth Factor Receptor inhibitor therapy and is characterized by a paradoxical overgrowth of Eyelash.[SEP]Relations: Panitumumab has relations: drug_drug with Tregalizumab, drug_drug with Tregalizumab, drug_drug with Pertuzumab, drug_drug with Pertuzumab, drug_drug with Sonepcizumab, drug_drug with Sonepcizumab, drug_drug with Concizumab, drug_drug with Concizumab, drug_drug with Eculizumab, drug_drug with Eculizumab. Definitions: gefitinib defined as following: A selective tyrosine kinase inhibitor for the EPIDERMAL GROWTH FACTOR RECEPTOR (Epidermal Growth Factor Receptor) that is used for the treatment of locally advanced or metastatic NON-SMALL CELL LUNG CANCER.. erlotinib defined as following: A quinazoline derivative with antineoplastic properties. Competing with adenosine triphosphate, erlotinib reversibly binds to the intracellular catalytic domain of epidermal growth factor receptor (Epidermal Growth Factor Receptor) tyrosine kinase, thereby reversibly inhibiting Epidermal Growth Factor Receptor phosphorylation and blocking the signal transduction events and tumorigenic effects associated with Epidermal Growth Factor Receptor activation.. Eyelash defined as following: The hairs which project from the edges of the EYELIDS.. panitumumab defined as following: A human IgG2kappa monoclonal antibody specific for the epidermal growth factor receptor (Epidermal Growth Factor Receptor). Monoclonal antibody E7.6.3 binds to the Epidermal Growth Factor Receptor, blocking the binding of epidermal growth factor and transforming growth factor alpha to Epidermal Growth Factor Receptor-expressing cancer cells and ultimately inhibiting Epidermal Growth Factor Receptor-dependent cell activation and proliferation. (NCI). cetuximab defined as following: A chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors.. Epidermal growth factor receptor inhibitor defined as following: Any tyrosine kinase inhibitor that targets the activity of the epidermal growth factor receptor (Epidermal Growth Factor Receptor) tyrosine kinase. Inhibition of epidermal growth factor receptor tyrosine kinase may inhibit the growth of epidermal-lineage tumor cells, especially those that overexpress epidermal growth factor receptor..", "label": "yes"} {"original_question": "Are there negative enhancers?", "id": "converted_3718", "sentence1": "Are there negative enhancers?", "sentence2": "Role of a YY-1 factor-binding negative Enhancer of transcription, Gene Mutation targeted to the CArG-like motif abolished the suppressive effect of the negative Enhancer of transcription and the inducibility of the Promoter during myogenic differentiation, Our results suggest that the activity of the negative Enhancer of transcription may determine the level of expression of the COX Vb Genes in different Body Tissue Specimen Code., Coordinate regulation of Drosophila tropomyosin Genes expression is controlled by multiple muscle-type-specific positive and negative Enhancer Elements, Genetic., Enhancer of transcription regions contain multiple muscle-type-specific positive and negative cis-acting elements which together contribute toward full expression of the Genes. , We also show that this somatic/visceral muscle element(s) can be repressed through an adjacent negative control region, suggesting that the regulation of expression in these Muscle Tissue is under dual control during both phases of myogenesis, We propose a model in which transcriptional regulation of the Drosophila TmI Genes is controlled by the cooperative interaction of multiple positive and negative cis-acting regulatory elements that control the temporal and muscle-type pattern of expression., Tandemly reiterated negative Enhancer of transcription-like elements regulate transcription of a Human Genes for the large subunit of calcium-dependent protease I I, Upstream of the Promoter Regions, Genetic are tandemly reiterated multiple regulatory regions (-2.5k to -690, -690 to -460, -460 to -260, and -260 to -202), each of which negatively regulates the CAPN1 wt Allele mL Genes Promoter as well as heterologous promoters in an orientation-independent manner, he negative regulation of transcription mediated by these reiterated cis-acting elements and trans-acting factor(s) may play an essential role in the expression of the CAPN1 wt Allele mL Genes., Although LDB2 wt Allele-dependent activated genes are regulated at the level of transcriptional initiation, the LDB2 wt Allele-dependent repressed transcription units appear to be regulated primarily at the level of Promoter pausing, with LDB2 wt Allele regulating recruitment of metastasis-associated 1 family, member 2, a component of the Mi-2 Nucleosome Remodeling and Deacetylase Complex, on these negative enhancers, required for the repressive Enhancer of transcription function., The Specimen Source Codes - Site was similar to silencers, or negative enhancers, in that it acted to repress transcription from outside the transcribed region, but was distinct in that the function of a canonical silencer was independent of orientation., Clone Cells in which the Transgenes was down-regulated by dexamethasone survived and were designated AtT-20/NET (for negative Enhancer of transcription trap)., The E1a Genes of Adenovirus Infections encodes two Proteins, 289 and 243 amino acids long, which have positive (transactivator) and negative (Enhancer of transcription repressor) RNA polymerase II transcriptional regulatory properties and cell transformation activities including cooperation with an activated ras Genes., Tandemly reiterated negative Enhancer of transcription-like elements regulate transcription of a Human Genes for the large subunit of calcium-dependent protease I I., Upstream of the Promoter Regions, Genetic are tandemly reiterated multiple regulatory regions (-2.5k to -690, -690 to -460, -460 to -260, and -260 to -202), each of which negatively regulates the CAPN1 wt Allele mL Genes Promoter as well as heterologous promoters in an orientation-independent manner., The presence of a Cells factor(s) mediating the action of these positive (Promoter) and negative regulatory elements was suggested by an in vivo competition assay., We have previously identified a silencer (negative Enhancer of transcription) in Glutathione S-Transferase P (GST-P) Genes which is strongly and specifically induced during Hepatocarcinogenesis of the Rattus norvegicus. , The possibility that SF-B/LAP/IL6-DBP functions as a dual positive and negative regulator is discussed., Coordinate regulation of Drosophila tropomyosin Genes expression is controlled by multiple muscle-type-specific positive and negative Enhancer Elements, Genetic, Together these Enhancer of transcription regions contain multiple muscle-type-specific positive and negative cis-acting elements which together contribute toward full expression of the Genes., We also show that this somatic/visceral muscle element(s) can be repressed through an adjacent negative control region, suggesting that the regulation of expression in these Muscle Tissue is under dual control during both phases of myogenesis. We propose a model in which transcriptional regulation of the Drosophila TmI Genes is controlled by the cooperative interaction of multiple positive and negative cis-acting regulatory elements that control the temporal and muscle-type pattern of expression., Gene Mutation targeted to the CArG-like motif abolished the suppressive effect of the negative Enhancer of transcription and the inducibility of the Promoter during myogenic differentiation. Our results suggest that the activity of the negative Enhancer of transcription may determine the level of expression of the COX Vb Genes in different Tissue Specimen Code[SEP]Relations: adaptation to pheromone regulating conjugation with mutual genetic exchange has relations: bioprocess_bioprocess with negative adaptation of signaling pathway, bioprocess_bioprocess with negative adaptation of signaling pathway. Dexamethasone has relations: drug_effect with Poor appetite, drug_effect with Poor appetite, drug_effect with Growth delay, drug_effect with Growth delay, drug_effect with Anxiety, drug_effect with Anxiety. regulation of antisense RNA transcription has relations: bioprocess_bioprocess with negative regulation of antisense RNA transcription, bioprocess_bioprocess with negative regulation of antisense RNA transcription. Definitions: CAPN1 wt Allele defined as following: Human CAPN1 wild-type allele is located in the vicinity of 11q13 and is approximately 31 kb in length. This allele, which encodes calpain-1 catalytic subunit protein, plays a role in limited proteolysis of substrates, which modulates cytoskeletal remodeling and signal transduction.. Promoter Regions, Genetic defined as following: DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the Promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA.. Mi-2 Nucleosome Remodeling and Deacetylase Complex defined as following: A enzyme complex involved in the remodeling of NUCLEOSOMES. The complex is comprised of at least seven subunits and includes both histone deacetylase and ATPase activities.. Clone Cells defined as following: A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed). Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. dexamethasone defined as following: An anti-inflammatory 9-fluoro-glucocorticoid.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. LDB2 wt Allele defined as following: Human LDB2 wild-type allele is located in the vicinity of 4p16 and is approximately 397 kb in length. This allele, which encodes LIM domain-binding protein 2, plays a role in the modulation of Genes transcription.. Transgenes defined as following: Genes that are introduced into an organism using GENE TRANSFER TECHNIQUES.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. Enhancer Elements, Genetic defined as following: Cis-acting DNA sequences which can increase transcription of genes. Enhancers can usually function in either orientation and at various distances from a Promoter.. Hepatocarcinogenesis defined as following: The processes which result in cancers in the liver.. Muscle Tissue defined as following: Contractile Tissue Specimen Code that produces movement in animals.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Adenovirus Infections defined as following: Virus diseases caused by the ADENOVIRIDAE.. Body Tissue Specimen Code defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. Enhancer of transcription defined as following: A 50-150bp DNA sequence that increases the rate of transcription of coding sequences. It may be located at various distances and in either orientation upstream from, downstream from or within a structural Genes. When bound by a specific transcription factor it increases the levels of expression of the Genes, but is not sufficient alone to cause expression. Distinguished from a Promoter, that is alone sufficient to cause expression of the Genes when bound..", "label": "yes"} {"original_question": "Are loop domains preserved upon cohesin loss?", "id": "converted_2379", "sentence1": "Are loop domains preserved upon cohesins loss?", "sentence2": "Cohesin Loss Eliminates All Loop Domains., The human genome folds to create thousands of intervals, called \"contact domains,\" that exhibit enhanced contact frequency within themselves. \"Loop domains\" form because of tethering between two loci-almost always bound by CTGF protein, human and cohesins-lying on the same chromosome. \"Compartment domains\" form when genomic intervals with similar histone marks co-segregate. Here, we explore the effects of degrading cohesins. All loop domains are eliminated, but neither compartment domains nor histone marks are affected. Loss of loop domains does not lead to widespread ectopic gene activation but does affect a significant minority of active genes., cohesins loss eliminates all loop domains[SEP]Relations: Protein S human has relations: drug_drug with Ardeparin, drug_drug with Ardeparin, drug_drug with Parnaparin, drug_drug with Parnaparin, drug_drug with Semuloparin, drug_drug with Semuloparin, drug_drug with Bemiparin, drug_drug with Bemiparin, drug_drug with Biochanin A, drug_drug with Biochanin A. Definitions: CTGF protein, human defined as following: CCN family member 2 (349 aa, ~38kDa) is encoded by the human CCN2 gene. This protein plays a role in the promotion of proliferation and differentiation of chondrocytes and also mediates heparin- and divalent cation-dependent cell adhesion in many different cell types..", "label": "no"} {"original_question": "Are there any animal models for Niemann-Pick C1 disease?", "id": "converted_1265", "sentence1": "Are there any animal models for Niemann-Pick C1 Disease?", "sentence2": "Several animal models were used to analyze the impaired pathways. , We investigated components of the surfactant system in both NPC1 mutant CASP14 gene and Felis catus and in NIEMANN-PICK DISEASE, TYPE C2 mutant CASP14 gene near the end of their expected life span. , Thus far, studies of Nasopharyngeal carcinoma CASP14 gene have been performed mainly to study the Head>Brain and Nerve Degeneration, because degeneration in the Head>Brain was known as the primary cause of death in Nasopharyngeal carcinoma CASP14 gene. , the NPC1(-/-) Mus sp. is available serving as an appropriate animal model of the human Disease,, o examine the onset and progression of neuropathological insults in Nasopharyngeal carcinoma we have systematically examined the Central Nervous System of a Mus sp. model of NPC1 (Niemann-Pick Disease, Type C1(-/-) CASP14 gene) at different stages of the Disease course., We have identified a Point Mutation in Niemann-Pick Disease, Type C1 that creates a novel Mus sp. model (Niemann-Pick Disease, Type C1(nmf164)) of Niemann-Pick type C1 (Nasopharyngeal carcinoma) Disease, Niemann-Pick type C1-deficient CASP14 gene, which accumulate Protoplasm free cholesterol. , hUCB-MSCs were transplanted into the hippocampus of Nasopharyngeal carcinoma CASP14 gene in the early asymptomatic stage., Niemann Pick type C1 CASP14 gene, Three Mus sp. models of glycosphingolipid storage diseases, namely Niemann-Pick type C1,, Niemann-Pick Disease, Type C1(-/-) CASP14 gene, a well-established model of Nasopharyngeal carcinoma pathology, Mus model of this Disease, the npc1 Mus sp.,, NPC1 (Niemann-Pick type C1) knock-out CASP14 gene, We have made Mice, Transgenic which express the Niemann-Pick Disease, Type C1 protein exclusively in fibrillary astrocytes, using the glial fibrillary acidic protein (Glial Fibrillary Acidic Protein) Promoter., homozygous affected (NPC1(-/-)) CASP14 gene, heterozygous (NPC1(+/-)) CASP14 gene, npc1(-/-) CASP14 gene,, npc1(-/-) Mus sp. model, A Mus model of Niemann-Pick Disease, Type C (Nasopharyngeal carcinoma), the NPC1-deficient [NPC1 (-/-)] Mus sp., [SEP]Relations: Niemann-Pick Disease type C has relations: disease_disease with Niemann-Pick Disease, disease_disease with Niemann-Pick Disease, disease_disease with Niemann-Pick Disease, disease_disease with Niemann-Pick Disease, disease_disease with Niemann-Pick Disease, disease_disease with Niemann-Pick Disease. central nervous system has relations: anatomy_protein_present with NISCH, anatomy_protein_present with NISCH, anatomy_protein_present with NIPAL3, anatomy_protein_present with NIPAL3. Definitions: Point Mutation defined as following: A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair.. NIEMANN-PICK DISEASE, TYPE C2 defined as following: Type C Niemann-Pick Disease associated with a mutation in the gene NIEMANN-PICK DISEASE, TYPE C2, encoding Niemann-Pick C2 protein.. Niemann-Pick Disease, Type C1 defined as following: Type C Niemann-Pick Disease associated with a mutation in the gene NPC1, encoding Niemann-Pick C1 protein.. Glial Fibrillary Acidic Protein defined as following: An intermediate filament protein found only in glial cells or cells of glial origin. MW 51,000.. Nasopharyngeal carcinoma defined as following: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.. Nerve Degeneration defined as following: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.. Niemann-Pick Disease, Type C1 protein defined as following: A transmembrane Protoplasm lipid transporter that helps trafficking lipids, particularly cholesterol, from late endosome/lysosome to the ER and plasma membrane. It may also play a role in other cellular cholesterol homeostasis and is an endosomal entry receptor for filoviruses including EBOLAVIRUS. Mutations in the NPC1 are associated with type C NIEMANN-PICK DISEASE.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, proteins, lipids, carbohydrates, and inorganic salts.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. Niemann-Pick Disease, Type C defined as following: An autosomal recessive lipid storage disorder that is characterized by accumulation of CHOLESTEROL and SPHINGOMYELINS in cells of the VISCERA and the CENTRAL NERVOUS SYSTEM. Type C (or C1) and type D are allelic disorders caused by mutation of the NPC1 gene, which encodes a protein that mediates Protoplasm cholesterol transport from LYSOSOMES. Clinical signs include hepatosplenomegaly and chronic neurological symptoms. Type D is a variant in people with a Nova Scotia ancestry.. Felis catus defined as following: The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801). Mice, Transgenic defined as following: Laboratory CASP14 gene that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.. Central Nervous System defined as following: The main information-processing organs of the nervous system, consisting of the Head>Brain, spinal cord, and meninges.. Mus defined as following: Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown..", "label": "yes"} {"original_question": "Is covid-19 induced anosmia caused by disruption of nuclear architecture?", "id": "converted_4629", "sentence1": "Is covid-19 induced Anosmia caused by disruption of Nuclear (incident type) architecture?", "sentence2": "Disruption of Nuclear (incident type) architecture as a cause of COVID19 (document) induced Anosmia., Here, using molecular evaluation of human olfactory epithelium (Estrone 3-oleate) from subjects succumbing to COVID19 (document) and a hamster model of COVID19 (disease), we discovered widespread downregulation of Olfactory Receptor Cells (Oral Rehydration Solution OS-1) as well as key components of their signaling pathway. OR downregulation likely represents a non-cell autonomous effect, since SARS-CoV-2 detection in OSNs is extremely rare both in human and hamster OEs. A likely explanation for the reduction of OR transcription is the striking reorganization of Nuclear (incident type) architecture observed in the OSN lineage, which disrupts multi-chromosomal compartments regulating OR expression in Homo sapiens and hamsters. Our experiments uncover a novel molecular mechanism by which a Virus with a very selective tropism can elicit persistent transcriptional changes in Cells that evade it, contributing to the severity of COVID19 (document).[SEP]Relations: olfactory receptor activity has relations: molfunc_protein with OR2M7, molfunc_protein with OR2M7, molfunc_protein with OR2L13, molfunc_protein with OR2L13, molfunc_protein with OR2A7, molfunc_protein with OR2A7. colitis (disease) has relations: disease_protein with NOS2, disease_protein with NOS2, disease_protein with IL17A, disease_protein with IL17A. Definitions: Anosmia defined as following: Inability to smell.. Homo sapiens defined as following: Members of the species Homo sapiens.. Oral Rehydration Solution OS-1 defined as following: An aqueous solution composed of glucose and electrolytes, including sodium, potassium, chloride, magnesium, and phosphorus, with dehydration preventative and rehydration activities. Upon oral administration of the oral rehydration solution (ORS), water, electrolytes and glucose are absorbed from the gastrointestinal (GI) tract into the systemic circulation. This replenishes the body's supply of water, carbohydrates and electrolytes, and prevents both dehydration and renal dysfunction.. Olfactory Receptor Cells defined as following: Neurons in the OLFACTORY EPITHELIUM with proteins (RECEPTORS, ODORANT) that bind, and thus detect, odorants. These neurons send their DENDRITES to the surface of the epithelium with the odorant receptors residing in the apical non-motile cilia. Their unmyelinated AXONS synapse in the OLFACTORY BULB of the BRAIN.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Virus defined as following: Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host Cells.. COVID19 (disease) defined as following: A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID19 (document) severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID19 (document) (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent..", "label": "yes"} {"original_question": "Has ZP-PTH been tested in a phase II clinical trial?", "id": "converted_3387", "sentence1": "Has ZP-PTH been tested in a phase II clinical trial?", "sentence2": "This system was successfully tested in a Phase 2 clinical trial for the treatment of post-menopausal women with Encounter due to family history of Encounter due to family history of osteoporosis.[SEP]Relations: stenosis or atrophy of the coronary ostium has relations: disease_disease with abnormal origin or aberrant course of coronary artery, disease_disease with abnormal origin or aberrant course of coronary artery.", "label": "yes"} {"original_question": "Is c-met involved in the activation of the Akt pathway?", "id": "converted_61", "sentence1": "Is c-met involved in the activation of the Proto-Oncogene Proteins c-akt pathway?", "sentence2": "Amplification of methionine has been reported in approximately 5%-22% of Lung Neoplasms with acquired resistance to small-molecule inhibitors of the Epidermal Growth Factor Receptor (EGFR). Resistance to HER1 Antagonists is likely mediated through downstream activation of the phosphoinositide 3-kinase /AKT pathway., Simultaneous treatment of resistant tumors with a methionine PPP1R1A gene plus an EGFR PPP1R1A gene can abrogate activation of downstream effectors of cell growth, proliferation, and survival, thereby overcoming acquired resistance to HER1 Antagonists., Hepatocyte Growth Factor mediated both Mitogen-Activated Protein Kinases and Proto-Oncogene Proteins c-akt phosphorylation., Mitogen-Activated Protein Kinases/Proto-Oncogene Proteins c-akt signaling, but not the Smad pathway, may be one of the main processes in Hepatocyte Growth Factor-induced EMT,, The MAPK/Proto-Oncogene Proteins c-akt pathway is indispensable in Hepatocyte Growth Factor/c-Met signaling., Inhibition of c-Met activation sensitizes osteosarcoma cells to cisplatin via suppression of the 1-Phosphatidylinositol 3-Kinase-Proto-Oncogene Proteins c-akt signaling, Specifically, we demonstrated that inhibition of c-Met activity led to suppression of the 1-Phosphatidylinositol 3-Kinase-Proto-Oncogene Proteins c-akt pathway, thus enhancing cisplatin chemosensitivity., Our study clearly suggests that inhibition of c-Met activity can effectively sensitize osteosarcoma cells to cisplatin via suppression of the 1-Phosphatidylinositol 3-Kinase-Proto-Oncogene Proteins c-akt signaling., We found that a dual Met/VEGF receptor 2 kinase PPP1R1A gene, c-Met/VEGFR-2 Kinase Inhibitor c-Met/VEGFR-2 Kinase Inhibitor E7050, circumvented Hepatocyte Growth Factor-induced EGFR-TKI resistance in EGFR mutant Primary malignant neoplasm of lung cell lines by inhibiting the Met/Gab1/1-Phosphatidylinositol 3-Kinase/Proto-Oncogene Proteins c-akt pathway in vitro., Here, we report that i) treatment of RL95-2 cells with Hepatocyte Growth Factor resulted in phosphorylation of the Hepatocyte Growth Factor receptor c-Met, activation of Proto-Oncogene Proteins c-akt and IκB, translocation of NF-κB into the Cell Nucleus, and up-regulation of PTGS2 wt Allele mRNA;, Our data suggest that Hepatocyte Growth Factor possesses chemotactic ability, has anti-apoptosis action, and induces cellular infiltration via the 1-Phosphatidylinositol 3-Kinase/Proto-Oncogene Proteins c-akt pathway;, Hepatocyte growth factor-induced SRC wt Allele-Phosphatidylinositol 3-Kinases-AKT-Mammals target of sirolimus pathway inhibits Antigen-Presenting Cells activation by blocking MAP Kinase Kinase Kinase activity, Activation of SRC wt Allele in turn establishes a complex consisting of Phosphatidylinositol 3-Kinases and c-methionine, and promotes downstream activation of the Phosphatidylinositol 3-Kinases/AKT pathway and Mammals target of sirolimus., Notably, hepatocyte growth factor-stimulated SRC wt Allele activation results in induction of Phosphatidylinositol 3-Kinases complexes p85α/p110α and p85α/p110δ, which is required for activation of Mammals target of sirolimus, and consequent inhibition of MAP Kinase Kinase Kinase and nuclear factor-κB activation., Our findings, for the first time, have identified the SRC wt Allele-Phosphatidylinositol 3-Kinases-AKT-Mammals target of sirolimus pathway that plays a pivotal role in mediating the inhibitory effects of hepatocyte growth factor on Antigen-Presenting Cells activation by blocking nuclear factor-κB signaling., CCN1 wt Allele siRNA inhibited a second phase of Proto-Oncogene Proteins c-akt phosphorylation measured 12 hours after cell stimulation with Hepatocyte Growth Factor and also inhibited Hepatocyte Growth Factor-induced phosphorylation of the Proto-Oncogene Proteins c-akt target glycogen synthase kinase 3alpha., Hepatocyte Growth Factor+epidermal growth factor treatment increased the duration of ERK1/2 and AKT activation compared to Hepatocyte Growth Factor or epidermal growth factor alone. All these data indicate that a crosstalk between the epidermal growth factor and Hepatocyte Growth Factor pathways in mammary epithelial cells may modulate the development of the Mammary gland., Hepatocyte growth factor and c-Met promote dendritic maturation during hippocampal neuron differentiation via the Proto-Oncogene Proteins c-akt pathway, Consistent with these results, Hepatocyte Growth Factor activated Proto-Oncogene Proteins c-akt, which phosphorylates glycogen synthase kinase-3beta (glycogen synthase kinase 3 beta) to inactivate it, and reduced phosphorylation of Microtubule-Associated Protein 2 (METAP2 gene), which can promote Microtubules polymerization and Dendrites elongation when dephosphorylated., Conversely, pharmacological inhibition of c-Met with its specific PPP1R1A gene, PHA 665752, or genetic knock-down of c-Met with short hairpin RNAs (shRNAs) suppressed Hepatocyte Growth Factor-induced phosphorylation of Proto-Oncogene Proteins c-akt and glycogen synthase kinase 3 beta, increased phosphorylation of METAP2 gene, and reduced Dendrites number and length in cultured hippocampal Neurons., Inhibiting Proto-Oncogene Proteins c-akt activity with the phosphoinositide-3-kinase PPP1R1A gene LY 294002 or Proto-Oncogene Proteins c-akt PPP1R1A gene X suppressed Hepatocyte Growth Factor-induced phosphorylation of glycogen synthase kinase 3 beta, increased METAP2 gene phosphorylation, and blocked the ability of Hepatocyte Growth Factor to enhance dendritic length., These observations indicate that Hepatocyte Growth Factor and c-Met can regulate the early stages of Dendrites maturation via activation of the Proto-Oncogene Proteins c-akt/glycogen synthase kinase 3 beta pathway., Involvement of 1-Phosphatidylinositol 3-Kinase/Proto-Oncogene Proteins c-akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells, Hepatocyte Growth Factor was found to enhance cell migration, and that Hepatocyte Growth Factor-induced migration depends on 1-Phosphatidylinositol 3-Kinase/Proto-Oncogene Proteins c-akt pathway. The activation of 1-Phosphatidylinositol 3-Kinase/Proto-Oncogene Proteins c-akt pathway induced by the Hepatocyte Growth Factor/c-Met axis is involved in the downregulation of cell adhesion molecules E-Cadherin and CTNNB1 gene, contributing to the attenuation of cell-cell adhesion and promoting the enhanced motility and migration of uveal melanoma cells., Hepatocyte Growth Factor protects cultured cortical Neurons against hypoxia/reoxygenation induced cell injury via ERK1/2 and Pulmonary Valve Insufficiency-3K/Proto-Oncogene Proteins c-akt pathways, Hepatocyte Growth Factor stimulated both ERK1/2 and Proto-Oncogene Proteins c-akt activities in cortical Neurons., Inhibition of Mitogen-Activated Protein Kinases activation completely abolished the protective effects of Hepatocyte Growth Factor, and inhibition of Proto-Oncogene Proteins c-akt activation reduced, but did not completely eliminate the Hepatocyte Growth Factor mediated neuroprotection., It is suggested that the neuroprotection of Hepatocyte Growth Factor depend on ERK1/2 pathway, and, to a lesser extent, Pulmonary Valve Insufficiency-3K/Proto-Oncogene Proteins c-akt pathway. , Met signals hepatocyte survival by preventing Fas-triggered CFLAR wt Allele degradation in a PI3k-Proto-Oncogene Proteins c-akt-dependent manner, Thus, Met acting on 1-Phosphatidylinositol 3-Kinase and Proto-Oncogene Proteins c-akt ensures high levels of FLIPL, and disruption of this pathway contributes to hepatic apoptosis and possibly to Fas-related liver diseases., The Hepatocyte Growth Factor-induced increase in Nkx 2.5 expression was inhibited by co-treatment with the PI3 kinase inhibitors Wortmannin and LY 294002, but not by its inactive homolog LY 303511, suggesting an involvement of the PI3 kinase/Proto-Oncogene Proteins c-akt pathway in this effect., X-Linked PPP1R1A gene of apoptosis protein expression level in Malignant neoplasm of colon and/or rectum is regulated by hepatocyte growth factor/C-met pathway via Proto-Oncogene Proteins c-akt signaling, Activation of XIAP gene gene expression by Hepatocyte Growth Factor was inhibited by siRNA targeting AKT1 protein, human and AKT2 protein, human., Activation of methionine wt Allele enhances XIAP gene gene through the Proto-Oncogene Proteins c-akt pathway., Hepatocyte growth factor prevents ventricular remodeling and dysfunction in CASP14 gene via Proto-Oncogene Proteins c-akt pathway and angiogenesis, A significant reduction in apoptosis in the Hepatocyte Growth Factor-treated hearts was observed compared with control hearts, and was strongly associated with increased Proto-Oncogene Proteins c-akt activation., The antiapoptotic effect of Hepatocyte Growth Factor was mediated by activation of PI3-kinase/Proto-Oncogene Proteins c-akt pathway., The protective effect of Hepatocyte Growth Factor/SF against the ADR-induced apoptosis was abolished in the presence of either LY 294002, an PPP1R1A gene of phosphatidylinositols-3'-OH kinase (PI3-K) or 1L-6-hydroxymethyl-chiro-inositol 2-(R)-2-O-methyl-3-O-octadecylcarbonate, an PPP1R1A gene of Proto-Oncogene Proteins c-akt, thus implicating the activation of PI3-K-Proto-Oncogene Proteins c-akt signaling in the antiapoptotic action of Hepatocyte Growth Factor/SF., Immunoblotting analysis revealed that Hepatocyte Growth Factor/SF stimulated the sustained phosphorylation of Proto-Oncogene Proteins c-akt for several hours, Furthermore, ADR-induced activation of caspase-9, a downstream molecule of Proto-Oncogene Proteins c-akt, was inhibited for at least 24 h after Hepatocyte Growth Factor/SF stimulation,, These results indicate that Hepatocyte Growth Factor/SF, but not epidermal growth factor, transmitted protective signals against ADR-induced apoptosis by causing sustained activation of the PI3-K-Proto-Oncogene Proteins c-akt signaling pathway., Hepatocyte growth factor/scatter factor inhibits UVB-induced apoptosis of human keratinocytes but not of keratinocyte-derived cell lines via the Phosphatidylinositol 3-Kinases/AKT pathway, When we analyzed the signaling pathways initiated by the Hepatocyte Growth Factor/SF receptor c-met, we found that the phosphatidylinositols (Pulmonary Valve Insufficiency) 3-kinase and its downstream-element AKT and the mitogen-activated protein (MAP) kinase were activated., Inhibition of Pulmonary Valve Insufficiency 3-kinase led to a complete abrogation of the anti-apoptotic effect of Hepatocyte Growth Factor/SF, whereas blockade of the MAP kinase pathway had no effect., We now show in detached cells a cooperative effect of Hepatocyte Growth Factor and FN1 wt Allele in the activation of Pulmonary Valve Insufficiency 3-kinase and on the phosphorylation of PKB/Proto-Oncogene Proteins c-akt at serine 473., Pulmonary Valve Insufficiency 3-kinase activity is also required for the Hepatocyte Growth Factor- and fibronectin-induced survival responses, as well as anchorage-independent colony growth., Together, these results demonstrate that the Pulmonary Valve Insufficiency 3-kinase/Proto-Oncogene Proteins c-akt pathway is a key effector of the Hepatocyte Growth Factor- and fibronectin-induced survival response of breast carcinoma cells under detached conditions and corroborate an interaction between Integrins and Hepatocyte Growth Factor/ Met signalling pathways in the development of invasive breast cancer.[SEP]Relations: CTNNB1 has relations: protein_protein with AKT1, protein_protein with AKT1, protein_protein with AKT2, protein_protein with AKT2, pathway_protein with RHO GTPases activate IQGAPs, pathway_protein with RHO GTPases activate IQGAPs, pathway_protein with Deactivation of the CTNNB1 gene transactivating complex, pathway_protein with Deactivation of the CTNNB1 gene transactivating complex. Phosphatidylinositol 3-Kinases signaling has relations: bioprocess_protein with AKT1, bioprocess_protein with AKT1. Definitions: AKT1 protein, human defined as following: RAC-alpha serine/threonine-protein kinase (480 aa, ~56 kDa) is encoded by the human AKT1 gene. This protein is involved in signal transduction, serine/threonine phosphorylation, apoptosis regulation and neurogenesis.. AKT2 protein, human defined as following: RAC-beta serine/threonine-protein kinase (481 aa, ~56 kDa) is encoded by the human AKT2 gene. This protein is involved in protein phosphorylation, glucose metabolism, cell motility and signaling.. METAP2 gene defined as following: This gene plays a role in the removal of the amino-terminal methionine from nascent proteins.. Phosphatidylinositol 3-Kinases defined as following: Phosphotransferases that catalyzes the conversion of 1-phosphatidylinositols to 1-phosphatidylinositols 3-phosphate. Many members of this enzyme class are involved in RECEPTOR MEDIATED SIGNAL TRANSDUCTION and regulation of vesicular transport with the cell. Phosphatidylinositol 3-Kinases have been classified both according to their substrate specificity and their mode of action within the cell.. LY 294002 defined as following: A morpholine-based PPP1R1A gene of Phosphatidylinositol 3-Kinases (1-Phosphatidylinositol 3-Kinase) and the bromodomain and extra-terminal (BET) family of proteins, with potential antineoplastic activity. Upon administration, the 1-Phosphatidylinositol 3-Kinase/BET PPP1R1A gene LY 294002 specifically targets and binds to both 1-Phosphatidylinositol 3-Kinase and the acetylated lysine recognition motifs in the bromodomains of BET proteins. Inhibition of 1-Phosphatidylinositol 3-Kinase activity inhibits the 1-Phosphatidylinositol 3-Kinase/AKT kinase signaling pathway. This may result in inhibition of growth and survival for tumor cells in which the 1-Phosphatidylinositol 3-Kinase-mediated signaling pathway is overactivated. Inhibition of BET proteins prevents their interaction with acetylated histones, disrupts chromatin remodeling and inhibits the expression of oncogenic drivers that are important for cell proliferation and survival, which together may lead to an inhibition of proliferation in BET-overexpressing tumor cells. Activation of the 1-Phosphatidylinositol 3-Kinase signaling pathway is frequently associated with tumorigenesis. BET proteins, comprised of BRD2, BRD3, BRD4 and BRDT, are transcriptional regulators and play an important role during development and cellular growth. In tumor cells, BET proteins play a key role in the regulation of oncogene transcription and tumor cell proliferation.. Integrins defined as following: A family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors (RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation.. methionine wt Allele defined as following: Human methionine wild-type allele is located within 7q31 and is approximately 126 kb in length. This allele, which encodes hepatocyte growth factor receptor protein, plays a role in the regulation of cellular tyrosine-kinase activity. Mutations in the methionine gene are associated with papillary renal carcinoma.. Hepatocyte Growth Factor defined as following: Multifunctional growth factor which regulates both cell growth and cell motility. It exerts a strong mitogenic effect on hepatocytes and primary epithelial cells. Its receptor is PROTO-ONCOGENE PROTEINS methionine wt Allele.. Proto-Oncogene Proteins c-akt defined as following: Expressed in diverse tissues, Protein Kinase B (AKT/RAC Family) is a group (Alpha, Beta and Gamma) of cytoplasmic serine/threonine enzymes that covalently transfer the terminal, gamma phosphate group from ATP to a variety of substrate proteins and regulate cell signaling responses to insulin, PDGF, and IGF1 (through 1-Phosphatidylinositol 3-Kinase) involved in cell survival, cell proliferation, differentiation, apoptosis, glycogen synthesis, and glucose uptake.. Neurons defined as following: The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.. caspase-9 defined as following: A long pro-domain caspase that contains a CASPASE RECRUITMENT DOMAIN in its pro-domain region. Caspase 9 is activated during cell stress by mitochondria-derived proapoptotic factors and by CARD SIGNALING ADAPTOR PROTEINS such as APOPTOTIC PROTEASE-ACTIVATING FACTOR 1. It activates APOPTOSIS by cleaving and activating EFFECTOR CASPASES.. cisplatin defined as following: An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle.. Mammary gland defined as following: Glandular tissue in the BREAST of human that is under the influence of hormones such as ESTROGENS; PROGESTINS; and PROLACTIN. In WOMEN, after PARTURITION, the mammary glands secrete milk (MILK, HUMAN) for the nourishment of the young.. SRC wt Allele defined as following: Human SRC wild-type allele is located within 20q12-q13 and is approximately 61 kb in length. This allele, which encodes proto-oncogene tyrosine-protein kinase Src protein, plays a role in signal transduction pathways involved in the inhibition of endothelial cell apoptosis, regulation of the actin cytoskeleton, and the production of gonadotropins in pituitary cells. An allelic variant of the SRC gene, which produces a truncated, inactive protein, is associated with the development and metastasis of both breast and colon cancer.. Microtubules defined as following: Slender, cylindrical filaments found in the cytoskeleton of plant and animal cells. They are composed of the protein TUBULIN and are influenced by TUBULIN MODULATORS.. glycogen synthase kinase 3 beta defined as following: A glycogen synthase kinase-3 type enzyme that functions in ENERGY METABOLISM; EMBRYONIC DEVELOPMENT; and NEUROGENESIS. It is also involved in PROTEIN BIOSYNTHESIS and regulates cell growth and proliferation as a component of the WNT SIGNALING PATHWAY and other signaling pathways. Certain polymorphisms in the GSK3B gene have been associated with PARKINSON DISEASE; ALZHEIMER DISEASE; and BIPOLAR DISORDER.. Hepatocyte Growth Factor/SF defined as following: Hepatocyte growth factor (728 aa, ~83 kDa) is encoded by the human Hepatocyte Growth Factor gene. This protein is involved in both the modulation of hepatocyte proliferation and growth factor receptor signaling in hepatocytes and many other cell types.. FN1 wt Allele defined as following: Human FN1 wild-type allele is located in the vicinity of 2q34 and is approximately 76 kb in length. This allele, which encodes fibronectin protein, is involved in cellular adhesion, cellular motility, wound healing, neurite outgrowth, and cellular morphology.. phosphatidylinositols defined as following: Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to the hexahydroxy alcohol, myo-inositol. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid, myo-inositol, and 2 moles of fatty acids.. PTGS2 wt Allele defined as following: Human PTGS2 wild type allele is located within 1q25.2-q25.3 and is approximately 9 kb in length. This allele, which encodes prostaglandin G/H synthase 2 protein, plays a role in the stimulation of inflammatory responses.. Dendrites defined as following: Extensions of the nerve cell body. They are short and branched and receive stimuli from other NEURONS.. Antigen-Presenting Cells defined as following: A heterogeneous group of immunocompetent cells that mediate the cellular immune response by processing and presenting antigens to the T-cells. Traditional antigen-presenting cells include MACROPHAGES; DENDRITIC CELLS; LANGERHANS CELLS; and B-LYMPHOCYTES. FOLLICULAR DENDRITIC CELLS are not traditional antigen-presenting cells, but because they hold antigen on their cell surface in the form of IMMUNE COMPLEXES for B-cell recognition they are considered so by some authors.. XIAP gene defined as following: This gene is involved in apoptotic regulation through caspase interaction.. Mitogen-Activated Protein Kinases defined as following: A superfamily of PROTEIN SERINE-THREONINE KINASES that are activated by diverse stimuli via protein kinase cascades. They are the final components of the cascades, activated by phosphorylation by MITOGEN-ACTIVATED PROTEIN KINASE KINASES, which in turn are activated by mitogen-activated protein kinase kinase kinases (MAP KINASE KINASE KINASES).. sirolimus defined as following: A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties.. Wortmannin defined as following: An androstadiene metabolite produced by the fungi PENICILLIUM funiculosum that inhibits PHOSPHATIDYLINOSITOL-3-KINASES and alloantigen-specific activation of T-LYMPHOCYTES in human tumor cell lines. It is widely used in CELL BIOLOGY research and has broad therapeutic potential.. CCN1 wt Allele defined as following: Human CCN1 wild-type allele is located in the vicinity of 1p22.3 and is approximately 3 kb in length. This allele, which encodes CCN family member 1 protein, is involved in heart morphogenesis, angiogenesis, cell proliferation, cell adhesion and the positive regulation of apoptosis.. CTNNB1 gene defined as following: This gene is involved in signal transduction and regulation of transcription.. Lung Neoplasms defined as following: Tumors or cancer of the LUNG.. 1-Phosphatidylinositol 3-Kinase defined as following: A Phosphatidylinositol 3-Kinases that catalyzes the conversion of 1-phosphatidylinositols into 1-phosphatidylinositols 3-phosphate.. epidermal growth factor defined as following: A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form.. methionine defined as following: A sulfur-containing essential L-amino acid that is important in many body functions.. Cell Nucleus defined as following: Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one Cell Nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). CFLAR wt Allele defined as following: Human CFLAR wild-type allele is located within 2q33-q34 and is approximately 48 kb in length. This allele, which encodes CASP8 and FADD-like apoptosis regulator protein, is involved in the modulation of caspase-mediated apoptosis and proteolysis.. MAP Kinase Kinase Kinase defined as following: Mitogen-activated protein kinase kinase kinases (MAPKKKs) are serine-threonine protein kinases that initiate protein kinase signaling cascades. They phosphorylate MITOGEN-ACTIVATED PROTEIN KINASE KINASES; (MAPKKs) which in turn phosphorylate MITOGEN-ACTIVATED PROTEIN KINASES; (MAPKs).. Pulmonary Valve Insufficiency defined as following: Backflow of blood from the PULMONARY ARTERY into the RIGHT VENTRICLE due to imperfect closure of the PULMONARY VALVE..", "label": "yes"} {"original_question": "Does the Oncotype DX test work with paraffin embedded tissues?", "id": "converted_1713", "sentence1": "Does the Oncotype DX Breast Cancer Assay test work with paraffin embedded tissues?", "sentence2": "The Oncotype-DX Breast Cancer Assay (Genomic Health, Redwood City, CA) quantifies gene expression for 21 Genes in Malignant neoplasm of breast tissue by performing reverse transcription polymerase chain reaction (RT-PCR) on formalin-fixed paraffin-embedded (FFPE) tumour blocks that are obtained during initial surgery (Lumpectomy of breast, mastectomy, or core biopsy) of women with early Malignant neoplasm of breast that is newly diagnosed., Oncotype DXtrade mark, is a diagnostic test comprised of a 21-gene assay applied to paraffin-embedded Malignant neoplasm of breast tissue, which allows physicians to predict subgroups of hormone-receptor-positive, Negative Lymph Node patients who may benefit from hormonal therapy alone or require adjuvant chemotherapy to attain the best survival outcome., Oncotype DX Breast Cancer Assay Breast Cancer Assay is a clinically validated, high-complexity, multianalyte reverse transcription-PCR genomic test that predicts the likelihood of Malignant neoplasm of breast recurrence in early-stage, Negative Lymph Node, estrogen receptor-positive Malignant neoplasm of breast. , We therefore investigated the analytical performance of the assay., Assays used a pooled RNA sample from fixed paraffin-embedded tissues to evaluate the analytical performance of a 21-gene panel with respect to amplification efficiency, precision, linearity, and dynamic range, as well as limits of detection and quantification., One such strategy is the 21-gene assay (Oncotype DX Breast Cancer Assay Breast Cancer Assay), which is currently in commercial use in the USA. One advantage of this test is the use of paraffin-embedded blocks instead of previous methods, which required fresh frozen tissue. , We used paraffin-embedded core biopsies from a completed phase II trial to identify Genes that correlate with response to primary chemotherapy. , In addition to the individual Genes, the correlation of the Oncotype DX Breast Cancer Assay Breast Cancer Assay Recurrence Score with pCR was examined, RNA was extracted from paraffin blocks, to develop the 21-gene Recurrence Score assay (Oncotype DX Breast Cancer Assay Breast Cancer Assay)[SEP]Relations: lymph node has relations: anatomy_protein_present with ATRX, anatomy_protein_present with ATRX, anatomy_protein_present with PRX, anatomy_protein_present with PRX, anatomy_protein_present with APTX, anatomy_protein_present with APTX, anatomy_protein_present with PRDX6, anatomy_protein_present with PRDX6, anatomy_protein_present with PRDX3, anatomy_protein_present with PRDX3. Definitions: RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Malignant neoplasm of breast defined as following: A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males.. Oncotype DX Breast Cancer Assay defined as following: A diagnostic assay that quantifies the likelihood of Malignant neoplasm of breast recurrence in women with newly diagnosed, early stage Malignant neoplasm of breast. In addition to predicting distant disease recurrence, Oncotype DX Breast Cancer Assay also assesses the benefit from certain types of chemotherapy. The assay, performed using formalin-fixed, paraffin-embedded tumor tissue, analyzes the expression of a panel of 21 Genes and the results are provided as a Recurrence Score (0-100). The gene panel was selected and the Recurrence Score calculation was derived through extensive laboratory testing and multiple independent clinical development studies. Oncotype DX Breast Cancer Assay is validated for use in Malignant neoplasm of breast patients whose disease is newly diagnosed, stage I or II, Negative Lymph Node, estrogen receptor-positive and who will be treated with tamoxifen.. Lumpectomy of breast defined as following: The surgical removal of a discrete mass.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Negative Lymph Node defined as following: A clinical finding that a lymph node is free from cancer spread..", "label": "yes"} {"original_question": "Is microRNA(miRNA) 30 involved in post-ischemic cardiac remodeling?", "id": "converted_607", "sentence1": "Is microRNA(miRNA) 30 involved in post-ischemic cardiac remodeling?", "sentence2": "The Myocardium of the failing Chest>Heart undergoes a number of structural alterations, most notably Hypertrophy of Myocytes, Cardiac and an increase in Extracellular Matrix proteins, often seen as primary fibrosi, Connective tissue growth factor (connective tissue growth factor) is a key Molecule in the process of Fibrosis and therefore seems an attractive therapeutic target, connective tissue growth factor is importantly regulated by 2 major cardiac microRNAs (MicroRNAs), miR-133 and miR-30., the expression of both MicroRNAs was inversely related to the amount of connective tissue growth factor in 2 rodent models of Heart Diseases and in Homo sapiens pathological left ventricular Hypertrophy. Second, in cultured cardiomyocytes and Specimen Source Codes - Fibroblasts, knockdown of these MicroRNAs increased connective tissue growth factor levels. Third, overexpression of miR-133 or MIR30C2 wt Allele decreased connective tissue growth factor levels, which was accompanied by decreased production of collagen., miR-30 importantly limit the production of connective tissue growth factor, miR-30 directly downregulate connective tissue growth factor, a key profibrotic protein, and thereby establish an important role for these MicroRNAs in the control of structural changes in the Extracellular Matrix of the Myocardium.[SEP]Relations: Myocardium has relations: anatomy_protein_present with MIR1245A, anatomy_protein_present with MIR1245A, anatomy_protein_present with MIRLET7D, anatomy_protein_present with MIRLET7D, anatomy_protein_present with MIR22HG, anatomy_protein_present with MIR22HG, anatomy_protein_present with MIR99AHG, anatomy_protein_present with MIR99AHG, anatomy_protein_present with SNRNP25, anatomy_protein_present with SNRNP25. Definitions: MIR30C2 wt Allele defined as following: Human MIR30C2 wild-type allele is located in the vicinity of 6q13 and is approximately 72 bases in length. This allele, which encodes MIR30C2 pre-miRNA, may be involved in wound healing and angiogenesis.. Fibrosis defined as following: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.. collagen defined as following: A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH).. Myocytes, Cardiac defined as following: Striated muscle cells found in the Chest>Heart. They are derived from cardiac myoblasts (MYOBLASTS, CARDIAC).. Homo sapiens defined as following: Members of the species Homo sapiens.. MicroRNAs defined as following: Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 MicroRNAs discovered, and are from a class of MicroRNAs involved in developmental timing.. Molecule defined as following: An aggregate of two or more atoms in a defined arrangement held together by chemical bonds.. connective tissue growth factor defined as following: A CCN protein family member that regulates a variety of extracellular functions including CELL ADHESION; CELL MIGRATION; and EXTRACELLULAR MATRIX synthesis. It is found in hypertrophic CHONDROCYTES where it may play a role in CHONDROGENESIS and endochondral ossification.. Heart Diseases defined as following: Pathological conditions involving the HEART including its structural and functional abnormalities.. Extracellular Matrix defined as following: A meshwork-like substance found within the extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which cells or cell lysates in culture dishes adhere.. Myocardium defined as following: The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow.. Hypertrophy defined as following: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).. Extracellular Matrix proteins defined as following: Macromolecular organic compounds that contain carbon, hydrogen, oxygen, nitrogen, and usually, sulfur. These macromolecules (proteins) form an intricate meshwork in which cells are embedded to construct tissues. Variations in the relative types of macromolecules and their organization determine the type of Extracellular Matrix, each adapted to the functional requirements of the tissue. The two main classes of macromolecules that form the Extracellular Matrix are: glycosaminoglycans, usually linked to proteins (proteoglycans), and fibrous proteins (e.g., COLLAGEN; ELASTIN; FIBRONECTINS; and LAMININ)..", "label": "yes"} {"original_question": "Can Diabetes be caused by a defect in a potassium chanel?", "id": "converted_1846", "sentence1": "Can Diabetes be caused by a defect in a potassium chanel?", "sentence2": "Gene Mutation in KATP Channels genes can result in hypo- or hypersecretion of Therapeutic Insulin, as in neonatal Diabetes Mellitus mellitus and Congenital Hyperinsulinism, respectively., To date, all patients affected by neonatal Diabetes Mellitus due to a Mutation Abnormality in the pore-forming subunit of the channel (Kir6.2, KCNJ11 gene gene) are heterozygous for the Mutation Abnormality. , e report the first clinical case of neonatal Diabetes Mellitus caused by a homozygous KCNJ11 gene gene Mutation Abnormality, Diffuse Congenital Hyperinsulinism in infancy (CHI-D) arises from mutations inactivating the KATP Channels;, We report a case of a 6-week-old infant with Diabetes Mellitus mellitus based on a genetic defect in the sulfonylurea receptor (ABCC8 gene), an ATP-sensitive potassium (KATP) channel protein., In Diabetes Mellitus, vascular KATP Channels function is impaired.[SEP]Relations: Type I Diabetes Mellitus mellitus has relations: disease_phenotype_positive with transketolase deficiency, disease_phenotype_positive with transketolase deficiency, disease_phenotype_positive with vasculitis due to ADA2 deficiency, disease_phenotype_positive with vasculitis due to ADA2 deficiency, disease_phenotype_positive with immunodeficiency due to CD25 deficiency, disease_phenotype_positive with immunodeficiency due to CD25 deficiency, disease_phenotype_positive with methanol poisoning, disease_phenotype_positive with methanol poisoning. KCNJ11 gene has relations: pathway_protein with Defective ABCC8 can cause hypo- and hyper-glycemias, pathway_protein with Defective ABCC8 can cause hypo- and hyper-glycemias. Definitions: Congenital Hyperinsulinism defined as following: A familial, nontransient HYPOGLYCEMIA with defects in negative feedback of GLUCOSE-regulated INSULIN release. Clinical phenotypes include HYPOGLYCEMIA; HYPERINSULINEMIA; SEIZURES; COMA; and often large BIRTH WEIGHT. Several sub-types exist with the most common, type 1, associated with mutations on an ATP-BINDING CASSETTE TRANSPORTERS (subfamily C, member 8).. Therapeutic Insulin defined as following: A synthetic or animal-derived form of Therapeutic Insulin used in the treatment of Diabetes Mellitus mellitus. Therapeutic Therapeutic Insulin is formulated to be short-, intermediate- and long-acting in order to individualize an Therapeutic Insulin regimen according to individual differences in glucose and Therapeutic Insulin metabolism. Therapeutic Therapeutic Insulin may be derived from porcine, bovine or recombinant sources. Endogenous human Therapeutic Insulin, a pancreatic hormone composed of two polypeptide chains, is important for the normal metabolism of carbohydrates, proteins and fats and has anabolic effects on many types of tissues.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Gene Mutation may be associated with genetic diversity or with pathologies including cancer.. Diabetes Mellitus defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.. sulfonylurea receptor defined as following: ATP-BINDING CASSETTE PROTEINS that are highly conserved and widely expressed in nature. They form an integral part of the ATP-sensitive potassium channel complex which has two intracellular nucleotide folds that bind to sulfonylureas and their analogs.. KATP Channels defined as following: Heteromultimers of Kir6 channels (the pore portion) and sulfonylurea receptor (the regulatory portion) which affect function of the HEART; PANCREATIC BETA CELLS; and KIDNEY COLLECTING DUCTS. KATP Channels blockers include GLIBENCLAMIDE and mitiglinide whereas openers include CROMAKALIM and minoxidil sulfate.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Diabetes defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE..", "label": "yes"} {"original_question": "Is the tricarboxylic acid (TCA) cycle affected in inflammation?", "id": "converted_278", "sentence1": "Is the Tricarboxylic Acids (Tricyclic Antidepressant [EPC]) cycle affected in Inflammation?", "sentence2": "In this study, the levels of Antifibrinolytic Antifibrinolytic amino acids and trichloroacetic acid (Tricyclic Antidepressant [EPC]) cycle-related molecules in the colonic tissues and sera of patients with ulcerative Colitis (Ulcerative Colitis) were profiled by gas chromatography/mass spectrometry (GC/MS), with the aim of evaluating whether the clinical state induced by Ulcerative Colitis leads to variations in the amino acid profile, Our study raises the possibility that GC/MS-based profiling of Antifibrinolytic Antifibrinolytic amino acids and Tricyclic Antidepressant [EPC] cycle-related molecules is a useful early diagnostic tool for Ulcerative Colitis., Succinates is an intermediate of the Tricarboxylic Acids (Tricyclic Antidepressant [EPC]) cycle, and plays a crucial role in adenosine triphosphate (ATP) generation in Mitochondria., In Specimen Source Codes - Plasma, most Metabolite in the central metabolic pathway (glycolysis and Tricyclic Antidepressant [EPC] cycle) were significantly downregulated after Zymosan A administration, Thus, IL-1beta+TNFalpha treated Astrocytes show a marked decrease in glycogen levels, a slight but not significant decrease in lactate release as well as a massive increase in both the Pentoses phosphate pathway and Tricyclic Antidepressant [EPC] cycle activities., A total of 77 and 92 Metabolite were detected in serum and colon tissue, respectively, and among the Metabolite the compositions of Tricyclic Antidepressant [EPC] cycle intermediates and Antifibrinolytic Antifibrinolytic amino acids changed depending on the degree of Colitis, Extension of these findings identified a functional role for stretch-induced inhibition of Succinates Dehydrogenase (SDH) in mediating normoxic HIF1A protein, human protein, human stabilization, concomitant increases in glycolytic capacity, and improved Tricarboxylic Acids (Tricyclic Antidepressant [EPC]) cycle function, These studies reveal a surprising role for HIF1A protein, human protein, human in lung protection during ALI, where normoxic HIF1A protein, human protein, human stabilization and HIF-dependent control of alveolar-epithelial glucose metabolism function as an endogenous feedback loop to dampen lung Inflammation, These results suggest a cataplerosis of the Tricyclic Antidepressant [EPC] cycle induced by phenobarbital, caused by the massive withdrawal of succinyl-coenzyme A by ALAS1 wt Allele induction, such that the Tricyclic Antidepressant [EPC] cycle is unable to supply the reduced chemical cofactor to the RGN gene, The Mitochondrial Inheritance respiratory chain (RGN gene) and the Tricarboxylic Acids (Tricyclic Antidepressant [EPC]) cycle were explored in the Hmbs(-/-) mouse model. RGN gene and Tricyclic Antidepressant [EPC] cycle were significantly affected in comparison to controls in CASP14 gene treated with phenobarbital with decreased activities of RGN gene complexes, Several changes in substrate utilization for energy homeostasis were identified in severe Aspartyl/Asparaginyl Beta-Hydroxylase, Human, including increased glucose consumption by the Pentoses phosphate pathway, altered Tricarboxylic Acids (Tricyclic Antidepressant [EPC]) cycle activity, and enhanced peptide catabolism. , Enhanced Mitochondrial Inheritance glucose oxidation was achieved by increased recruitment of the NOTCH1 intracellular domain (NICD1) to Nuclear (incident type) and Mitochondrial Inheritance genes that encode respiratory chain components and by NOTCH-dependent induction of Pyruvate Dehydrogenase (Lipoamide)-Phosphatase (PLPP6 gene) expression, pyruvate dehydrogenase activity, and glucose flux to the Tricyclic Antidepressant [EPC] cycle. , Metabolic reprogramming is implicated in macrophage activation,, BHB blocks the NLRP3 inflammasome without undergoing oxidation in the Tricyclic Antidepressant [EPC] cycle, and independently of Uncoupling Protein 2 (UCP2 gene gene), sirtuin-2 (Sirtuin 2), the G protein-coupled receptor GPR109A or hydrocaboxylic acid receptor 2 (HCAR2 gene gene). , Our findings suggest that the anti-inflammatory effects of caloric restriction or ketogenic diets may be linked to BHB-mediated inhibition of the NLRP3 inflammasome., Succinates: a metabolic signal in Inflammation.[SEP]Relations: acute tricyclic antidepressant poisoning has relations: disease_disease with poisoning, disease_disease with poisoning. ulcerative Colitis (disease) has relations: contraindication with Trihexyphenidyl, contraindication with Trihexyphenidyl, disease_protein with HNF4A, disease_protein with HNF4A, disease_protein with HERC2, disease_protein with HERC2. Phenobarbital has relations: drug_drug with Tricaine, drug_drug with Tricaine. Definitions: Pentoses defined as following: Monosaccharide sugar molecules that contain a five carbon backbone.. Aspartyl/Asparaginyl Beta-Hydroxylase, Human defined as following: Aspartyl/asparaginyl beta-hydroxylase (758 aa, ~86 kDa) is encoded by the human ASPH gene. This protein is involved in amino acid hydroxylation.. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. Mitochondria defined as following: Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed). Uncoupling Protein 2 defined as following: A Mitochondrial Inheritance uncoupling protein that is expressed in many tissues and exhibits the greatest expression in SKELETAL MUSCLE. It regulates Mitochondrial Inheritance ATP production and the generation of REACTIVE OXYGEN SPECIES.. trichloroacetic acid defined as following: A strong acid used as a protein precipitant in clinical chemistry and also as a caustic for removing warts.. Succinates defined as following: Derivatives of SUCCINIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain a 1,4-carboxy terminated aliphatic structure.. Sirtuin 2 defined as following: A sirtuin family member found primarily in the CYTOPLASM. It is a multifunctional enzyme that contains a NAD-dependent deacetylase activity that is specific for HISTONES and a mono-ADP-ribosyltransferase activity.. Pyruvate Dehydrogenase (Lipoamide)-Phosphatase defined as following: (Pyruvate dehydrogenase (lipoamide))-phosphate phosphohydrolase. A Mitochondrial Inheritance enzyme that catalyzes the hydrolytic removal of a phosphate on a specific seryl hydroxyl group of pyruvate dehydrogenase, reactivating the enzyme complex. EC 3.1.3.43.. Succinate Dehydrogenase defined as following: A flavoprotein containing oxidoreductase that catalyzes the dehydrogenation of SUCCINATE to fumarate. In most eukaryotic organisms this enzyme is a component of Mitochondrial Inheritance electron transport complex II.. Ulcerative Colitis defined as following: Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.. HIF1A protein, human defined as following: Hypoxia-inducible factor 1-alpha (826 aa, ~93 kDa) is encoded by the human HIF1A protein, human gene. This protein plays a role in transcriptional regulation in response to hypoxia.. adenosine triphosphate defined as following: An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.. ALAS1 wt Allele defined as following: Human ALAS1 wild-type allele is located in the vicinity of 3p21.1 and is approximately 16 kb in length. This allele, which encodes 5-aminolevulinate synthase, nonspecific, Mitochondrial Inheritance protein, is involved in both heme biosynthesis and lipid metabolism.. chemical cofactor defined as following: Something that must join with another to produce a given result.. Tricarboxylic Acids defined as following: Organic compounds that are acyclic and contain three acid groups. A member of this class is citric acid which is the first product formed by reaction of pyruvate and oxaloacetate. (From Lehninger, Principles of Biochemistry, 1982, p443). phenobarbital defined as following: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.. Astrocytes defined as following: A class of large neuroglial (macroglial) cells in the central nervous system - the largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes (from \"star\" cells) are irregularly shaped with many long processes, including those with \"end feet\" which form the glial (limiting) membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and \"reactive Astrocytes\" (along with MICROGLIA) respond to injury.. Mitochondrial Inheritance defined as following: The distribution of Mitochondria, including the Mitochondrial Inheritance genome, into daughter cells after mitosis or meiosis, mediated by interactions between Mitochondria and the cytoskeleton. [GOC:mcc, PMID:10873824, PMID:11389764]. Colitis defined as following: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.. Metabolite defined as following: Any substance involved in metabolism, either as a product of metabolism or as necessary for metabolism..", "label": "yes"} {"original_question": "Have mutations in the Polycomb group been found in human diseases?", "id": "converted_317", "sentence1": "Have mutations in the Polycomb group been found in human diseases?", "sentence2": "We identify a novel Mutation Abnormality in PHC1 gene gene, a human orthologue of the Drosophila polyhomeotic member of polycomb group (Polycomb-Group Proteins), which significantly decreases PHC1 gene gene protein expression, increases GMNN protein, human protein level and markedly abolishes the capacity to ubiquitinate histone H2A in patient cells., In clinical specimens of Malignant Head and Neck Neoplasm, we found that coamplification of BMI1 protein, human protein, human and Aurora Kinase A correlated with poorer prognosis., Gene Mutation of ezh2 protein, human, RUNX1 protein, human protein, human, TP53 wt Allele wt Allele, and Putative Polycomb Group Protein Putative Polycomb Group Protein ASXL1 were associated with shorter overall survival independent of the LR-PSS., In this study, we show the high frequency of spontaneous γδ T-cell leukemia (Precursor T-Cell Lymphoblastic Leukemia-Lymphoma) occurrence in CASP14 gene with biallelic deletion of Enhancer of transcription of zeste homolog 2 (Ezh2)., Subsequently, analysis of deletion profiles of other Polycomb Repressive Complex 2 members revealed frequent losses of Genes such as ezh2 protein, human, AEBP2 protein, human protein, human, and SUZ12; however, the Gene Deletion targeting these Genes were large. We also identified two patients with homozygous losses of JARID2 gene gene and AEBP2 protein, human protein, human. We observed frequent codeletion of AEBP2 protein, human protein, human and ETV6 wt Allele wt Allele, and similarly, SUZ12 and Neurofibromatosis 1., A total of 25 different ezh2 protein, human mutations were detected in 5.9% of PLATELET MEMBRANE FLUIDITY, 1.2% of PPV-MF, and 9.4% of PET-MF patients; most were exonic heterozygous missense changes., In the present investigation we have focused on the candidate Geographic Locations in 6p23, a Geographic Locations that have been found linked to CL/P in several investigations, in the attempt to find out the susceptibility gene provisionally named OTOFACIOCERVICAL SYNDROME 1. Gene expression experiments in CASP14 gene embryo of positional candidate Genes revealed that JARID2 gene gene was highly and specifically expressed in Epithelial Cells in merging Palatal shelf., High expression of ezh2 protein, human and amplification of ezh2 protein, human was found in 54.1% and 12.0% of ESCCs, respectively., We also observed that HOXA9 wt Allele wt Allele levels were significantly inversely correlated with survival and that BMI-1 was overexpressed in cases with 11q23 rearrangements, suggesting that p19(ARF) suppression may be involved in MLL-associated leukemia., We demonstrate that in multiple experimental models of metastatic prostate cancer both BMI1 protein, human protein, human and Ezh2 Genes are amplified and gene amplification is associated with increased expression of corresponding mRNAs and Proteins., he ezh2 protein, human gene amplification was significantly (P < 0.05) associated with increased ezh2 protein, human protein expression., The third tumor showed a t(6p;10q;10p) as the sole karyotypic abnormality, leading to the fusion of PHF1 protein, human protein, human with another partner, the Enhancer of transcription of polycomb (Enhancer of Polycomb Homolog 1) gene from 10p11; Enhancer of Polycomb Homolog 1 has hitherto not been associated with Neoplasms.[SEP]Relations: Protein S human has relations: drug_drug with Polythiazide, drug_drug with Polythiazide, drug_drug with Polythiazide, drug_drug with Polythiazide, drug_drug with Polythiazide, drug_drug with Polythiazide, drug_drug with Polythiazide, drug_drug with Polythiazide, drug_drug with Polythiazide, drug_drug with Polythiazide. Definitions: ezh2 protein, human defined as following: Histone-lysine N-methyltransferase ezh2 protein, human (746 aa, ~85 kDa) is encoded by the human ezh2 protein, human gene. This protein is involved in the regulation of chromatin modification.. Epithelial Cells defined as following: Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional Epithelial Cells.. AEBP2 protein, human defined as following: Zinc finger protein AEBP2 protein, human (517 aa, ~54 kDa) is encoded by the human AEBP2 protein, human gene. This protein is involved in DNA binding, transcriptional repression and histone methylation.. Enhancer of transcription defined as following: A 50-150bp DNA sequence that increases the rate of transcription of coding sequences. It may be located at various distances and in either orientation upstream from, downstream from or within a structural gene. When bound by a specific transcription factor it increases the levels of expression of the gene, but is not sufficient alone to cause expression. Distinguished from a promoter, that is alone sufficient to cause expression of the gene when bound.. BMI1 protein, human defined as following: Polycomb complex protein BMI-1 (326 aa, ~37 kDa) is encoded by the human BMI1 protein, human gene. This protein is involved in transcriptional repression during embryonic development.. HOXA9 wt Allele defined as following: Human HOXA9 wt Allele wild-type allele is located within 7p15-p14 and is approximately 7 kb in length. This allele, which encodes homeobox protein Hox-A9, plays roles in both the modulation of transcription by RNA polymerase II and the development of the anterio-posterior axis.. ETV6 wt Allele defined as following: Human ETV6 wt Allele wild-type allele is located in the vicinity of 12p13 and is approximately 246 kb in length. This allele, which encodes transcription factor ETV6 wt Allele protein, is involved in the repression of transcription by RNA polymerase II. Several malignancies, particularly leukemias, are linked to chromosomal translocations of this gene.. Polycomb Repressive Complex 2 defined as following: A multisubunit polycomb protein complex that catalyzes the METHYLATION of chromosomal HISTONE H3. It works in conjunction with POLYCOMB REPRESSIVE COMPLEX 1 to effect EPIGENETIC REPRESSION.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. RUNX1 protein, human defined as following: Runt-related transcription factor 1 (453 aa, ~49 kDa) is encoded by the human RUNX1 protein, human gene. This protein is involved in the promotion of gene transcription and hematopoiesis.. Neurofibromatosis 1 defined as following: An autosomal dominant inherited disorder (with a high frequency of spontaneous mutations) that features developmental changes in the nervous system, muscles, bones, and skin, most notably in tissue derived from the embryonic NEURAL CREST. Multiple hyperpigmented skin lesions and subcutaneous tumors are the hallmark of this disease. Peripheral and central nervous system neoplasms occur frequently, especially OPTIC NERVE GLIOMA and NEUROFIBROSARCOMA. Neurofibromatosis 1 is caused by mutations which inactivate the Neurofibromatosis 1 gene (GENES, NEUROFIBROMATOSIS 1) on chromosome 17q. The incidence of learning disabilities is also elevated in this condition. (From Adams et al., Principles of Neurology, 6th ed, pp1014-18) There is overlap of clinical features with NOONAN SYNDROME in a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and Neurofibromatosis 1 gene products are involved in the SIGNAL TRANSDUCTION pathway of Ras (RAS PROTEINS).. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. GMNN protein, human defined as following: GMNN protein, human (209 aa, ~24 kDa) is encoded by the human GMNN gene. This protein is involved in the modulation of DNA replication.. Putative Polycomb Group Protein ASXL1 defined as following: Putative Polycomb group protein Putative Polycomb Group Protein ASXL1 (1541 aa, ~165 kDa) is encoded by the human Putative Polycomb Group Protein ASXL1 gene. This protein may be involved in the modulation of both transcription and chromatin remodeling.. Aurora Kinase A defined as following: An aurora kinase that localizes to the CENTROSOME during MITOSIS and is involved in centrosome regulation and formation of the MITOTIC SPINDLE. Aurora A overexpression in many malignant tumor types suggests that it may be directly involved in NEOPLASTIC CELL TRANSFORMATION.. Geographic Locations defined as following: The continents and countries situated on those continents; the UNITED STATES and each of the constituent states arranged by Geographic Locations; CANADA and each of its provinces; AUSTRALIA and each of its states; the major bodies of water and major islands on both hemispheres; and selected major cities.. PHF1 protein, human defined as following: PHD finger protein 1 (567 aa, ~62 kDa) is encoded by the human PHF1 protein, human gene. This protein is involved in DNA damage responses, binding to trimethylated lysine 36 in histone H3 (H3K36me3) and recruitment of the Polycomb Repressive Complex 2 complex.. Gene Deletion defined as following: A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma defined as following: A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.. Malignant Head and Neck Neoplasm defined as following: A primary or metastatic malignant neoplasm affecting the head and neck. Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma.. Polycomb-Group Proteins defined as following: A family of Proteins that play a role in CHROMATIN REMODELING. They are best known for silencing HOX GENES and the regulation of EPIGENETIC PROCESSES.. Enhancer of Polycomb Homolog 1 defined as following: Enhancer of polycomb homolog 1 (836 aa, ~93 kDa) is encoded by the human Enhancer of Polycomb Homolog 1 gene. This protein plays a role in both histone acetyltransferase activity and transcriptional regulation.. Ezh2 Genes defined as following: This gene plays a role in chromatin remodeling and transcriptional regulation.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Gene Mutation may be associated with genetic diversity or with pathologies including cancer.. TP53 wt Allele defined as following: Human TP53 wt Allele wild-type allele is located in the vicinity of 17p13.1 and is approximately 19 kb in length. This allele, which encodes cellular tumor antigen p53 protein, plays a role in cell cycle regulation during the G0/G1transition. Alterations of the TP53 wt Allele gene occur as both somatic and germline mutations in human malignancies in select cancer-prone families with Li-Fraumeni syndrome.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. mutations defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. human defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Has CPX-351 been approved by the FDA and the EMA?", "id": "converted_4611", "sentence1": "Has CPX-351 been approved by the FDA and the Multiple Acyl Coenzyme A Dehydrogenase Deficiency?", "sentence2": "CPX-351 (United States: Vyxeos®; Europe: Vyxeos® Liposomes), a dual-drug liposomal encapsulation of daunorubicin and cytarabine in a synergistic 1:5 molar ratio, is approved by the US FDA and the Multiple Acyl Coenzyme A Dehydrogenase Deficiency for the treatment of adults with newly diagnosed Therapy-Related Acute Myeloid Leukemia or Leukemia, Myelocytic, Acute with myelodysplasia-related changes.[SEP]Relations: Cytarabine has relations: drug_drug with Paclitaxel, drug_drug with Paclitaxel, drug_drug with Acipimox, drug_drug with Acipimox. Daunorubicin has relations: drug_drug with Paclitaxel trevatide, drug_drug with Paclitaxel trevatide, drug_drug with Paclitaxel poliglumex, drug_drug with Paclitaxel poliglumex, drug_drug with Paclitaxel, drug_drug with Paclitaxel. Definitions: cytarabine defined as following: A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472). Therapy-Related Acute Myeloid Leukemia defined as following: An Leukemia, Myelocytic, Acute arising as a result of the mutagenic effect of chemotherapy agents and/or ionizing radiation. (WHO, 2001). Multiple Acyl Coenzyme A Dehydrogenase Deficiency defined as following: An autosomal recessive disorder of fatty acid oxidation, and branched chain amino acids (AMINO ACIDS, BRANCHED-CHAIN); LYSINE; and CHOLINE catabolism, that is due to defects in either subunit of ELECTRON TRANSFER FLAVOPROTEIN or its dehydrogenase, electron transfer flavoprotein-ubiquinone oxidoreductase (EC 1.5.5.1).. daunorubicin defined as following: A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS.. Leukemia, Myelocytic, Acute defined as following: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.. Liposomes defined as following: Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins..", "label": "yes"} {"original_question": "Is dexamethasone recommended for treatment of intracerebral hemorrhage?", "id": "converted_2176", "sentence1": "Is dexamethasone recommended for treatment of intracerebral hemorrhage?", "sentence2": "dexamethasone and other glucocorticoids should be avoided. , During the third interim analysis, the Cessation of life rate at the 21st day was identical in the two groups (dexamethasone vs. placebo, 21 of 46 vs. 21 of 47; chi-square = 0.01, P = 0.93). In contrast, the rate of complications (mostly Infections of musculoskeletal system and complications of Diabetes Mellitus) was much higher in the dexamethasone group (chi-square = 10.89, P less than 0.001), leading to early termination of the study. In the light of the absence of a demonstrable beneficial effect and the presence of a significant harmful effect, current practices of using dexamethasone for treatment of primary supratentorial hemorrhage should be reconsidered., In the light of the absence of a demonstrable beneficial effect and the presence of a significant harmful effect, current practices of using dexamethasone for treatment of primary supratentorial hemorrhage should be reconsidered.[SEP]Relations: dexamethasone has relations: drug_effect with Vitreous hemorrhage, drug_effect with Vitreous hemorrhage, contraindication with hypertension, contraindication with hypertension, contraindication with ocular hypertension, contraindication with ocular hypertension, contraindication with hyperglycemia, contraindication with hyperglycemia, contraindication with myxedema, contraindication with myxedema. Definitions: Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. dexamethasone defined as following: An anti-inflammatory 9-fluoro-glucocorticoid.. Diabetes Mellitus defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.. dexamethasone defined as following: An anti-inflammatory 9-fluoro-glucocorticoid.. intracerebral hemorrhage defined as following: Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA..", "label": "no"} {"original_question": "Can CD55 deficiency cause thrombosis?", "id": "converted_2585", "sentence1": "Can Complement Decay-Accelerating Factor, human deficiency cause thrombosis?", "sentence2": " The loss of Complement Decay-Accelerating Factor, human and CD59 Antigen Antigen renders Paroxysmal nocturnal hemoglobinuria Specimen Source Codes - Erythrocytes susceptible to intravascular haemolysis, which can lead to thrombosis and to much of the morbidity and mortality of Paroxysmal nocturnal hemoglobinuria. , Complement Decay-Accelerating Factor, human Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis., CONCLUSIONS: Complement Decay-Accelerating Factor, human deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy (the CHAPLE syndrome) is caused by abnormal complement activation due to biallelic loss-of-function mutations in Complement Decay-Accelerating Factor, human. , It is caused by the expansion of a Hematopoietic stem Cells that has acquired a Mutation Abnormality in the X-linked phosphatidylinositol glycan class A (PIGA) gene that results in deficiency of the Glycosylphosphatidylinositols anchor structure responsible for fixing a wide spectrum of Proteins particularly Complement Decay-Accelerating Factor, human and CD59 Antigen Antigen. The clinical features of this Disease arise as a result of complement-mediated Specimen Reject Reason - Hemolysis in unprotected red Cells, Specimen Source Codes - Leukocytes, and Blood Platelets as well as the release of free hemoglobin. Patients may present with a variety of clinical manifestations, such as Genus Anemia, thrombosis, kidney Disease, smooth muscle dystonias, Abdominal Pain, Dyspnea, and extreme fatigue., The lack of one of the GPI-AP complement regulatory Proteins (Complement Decay-Accelerating Factor, human, CD59 Antigen Antigen) leads to Specimen Reject Reason - Hemolysis. The Disease is diagnosed with hemolytic Genus Anemia, marrow failure and thrombosis., Paroxysmal nocturnal hemoglobinuria (Paroxysmal nocturnal hemoglobinuria) is a rare bone marrow failure disorder that manifests with hemolytic Genus Anemia, thrombosis, and peripheral blood cytopenias. The absence of two Glycosylphosphatidylinositols (GPI)-anchored Proteins, Complement Decay-Accelerating Factor, human and CD59 Antigen Antigen, leads to uncontrolled complement activation that accounts for Specimen Reject Reason - Hemolysis and other Paroxysmal nocturnal hemoglobinuria manifestations., RESULTS: Complement Decay-Accelerating Factor, human and/or CD59 Antigen Antigen deficiencies were found in 1.6% (2/127) of patients with primary Breast-Conserving Surgery, 1.0% (1/100) of non-malignant and Non-Cirrhotic patients with PVT, and 4.7% (4/85) of Cirrhotic patients with PVT., Data of this study indicate that the Paroxysmal nocturnal hemoglobinuria defect as detected with Complement Decay-Accelerating Factor, human, CD59 Antigen Antigen, and FCGR3A protein, human is not an important cause of intra-abdominal thrombosis in northwestern India., Paroxysmal nocturnal hemoglobinuria testing of Red blood Cells, blood product revealed a Complement Decay-Accelerating Factor, human and CD59 Antigen Antigen deficiency consistent with Paroxysmal nocturnal hemoglobinuria in both cases. The systemic complications typically associated with thrombosis were not observed for the following several months with early conservative treatments including eculizumab., Deficiency of the GPI-anchored complement inhibitors Complement Decay-Accelerating Factor, human and CD59 Antigen Antigen on Specimen Source Codes - Erythrocytes leads to Intravascular Specimen Reject Reason - Hemolysis upon complement activation. Apart from Specimen Reject Reason - Hemolysis, another prominent feature is a highly increased risk of thrombosis., Genetic reconstitution of Complement Decay-Accelerating Factor, human or treatment with a complement-inhibitory therapeutic antibody reversed abnormal complement activation.
CONCLUSIONS: Complement Decay-Accelerating Factor, human deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy (the CHAPLE syndrome) is caused by abnormal complement activation due to biallelic loss-of-function mutations in Complement Decay-Accelerating Factor, human., Paroxysmal nocturnal hemoglobinuria (Paroxysmal nocturnal hemoglobinuria) is an acquired clonal disorder characterized by a decrease or absence of Glycosylphosphatidylinositols (GPI)-anchored molecules such as Complement Decay-Accelerating Factor, human and CD59 Antigen Antigen from the surface of affected Cells, resulting in Intravascular Specimen Reject Reason - Hemolysis, Cytopenia, and Venous Thrombosis., CONCLUSIONS Complement Decay-Accelerating Factor, human deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy (the CHAPLE syndrome) is caused by abnormal complement activation due to biallelic loss-of-function mutations in Complement Decay-Accelerating Factor, human., Complement Decay-Accelerating Factor, human deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy (the CHAPLE syndrome) is caused by abnormal complement activation due to biallelic loss-of-function mutations in Complement Decay-Accelerating Factor, human., Complement Decay-Accelerating Factor, human Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis.[SEP]Relations: Venous thrombosis has relations: disease_phenotype_positive with hereditary thrombophilia due to congenital protein C deficiency, disease_phenotype_positive with hereditary thrombophilia due to congenital protein C deficiency, drug_effect with Metolazone, drug_effect with Metolazone. Thrombocytosis has relations: disease_phenotype_positive with vasculitis due to ADA2 deficiency, disease_phenotype_positive with vasculitis due to ADA2 deficiency, disease_phenotype_positive with leukocyte adhesion deficiency, disease_phenotype_positive with leukocyte adhesion deficiency. Hemolytic Genus Anemia has relations: disease_phenotype_positive with primary CD59 Antigen deficiency, disease_phenotype_positive with primary CD59 Antigen deficiency. Definitions: Blood Platelets defined as following: Non-nucleated disk-shaped Cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation.. Hematopoietic stem Cells defined as following: Progenitor Cells from which all blood Cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood.. Complement Decay-Accelerating Factor, human defined as following: Complement decay-accelerating factor (381 aa, ~41 kDa) is encoded by the human Complement Decay-Accelerating Factor, human gene. This protein plays a role in the negative regulation of the complement cascade.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. eculizumab defined as following: A humanized monoclonal antibody directed against terminal complement protein C5. Eculizumab binds to terminal complement protein C5, thereby blocking C5 cleavage into pro-inflammatory components and blocking the complement-mediated destruction of paroxysmal nocturnal hemoglobinuria (Paroxysmal nocturnal hemoglobinuria) Red blood Cells, blood product. (NCI05). FCGR3A protein, human defined as following: Low affinity immunoglobulin gamma Fc region receptor III-A (254 aa, ~29 kDa) is encoded by the human FCGR3A gene. This protein is involved in antibody-mediated immunity.. Dyspnea defined as following: Difficult or labored breathing.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Glycosylphosphatidylinositols defined as following: Compounds containing carbohydrate or glycosyl groups linked to phosphatidylinositols. They anchor GPI-LINKED PROTEINS or polysaccharides to cell membranes.. Breast-Conserving Surgery defined as following: Breast conservation treatment is defined as excision of the primary tumor and adjacent breast tissue, followed by radiation therapy. This procedure is also referred to as lumpectomy, segmental mastectomy, or partial mastectomy. (from Consensus Statements: Treatment of Early-stage Breast Cancer, 1990). Paroxysmal nocturnal hemoglobinuria defined as following: A rare acquired hematologic disorder characterized by hemolytic Genus Anemia, dark-colored urine due to the release of hemoglobin in the blood, and thrombosis. The episodes of Specimen Reject Reason - Hemolysis tend to occur at night. It is caused by a somatic Mutation Abnormality in the Glycosylphosphatidylinositols biosynthesis gene.. hemolytic Genus Anemia defined as following: A condition of inadequate circulating Red blood Cells, blood product (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of Red blood Cells, blood product (ERYTHROCYTES).. kidney Disease defined as following: Pathological processes of the KIDNEY or its component tissues.. Thrombosis defined as following: Formation and development of a thrombus or blood clot in the blood vessel.. Red blood Cells, blood product defined as following: Red blood Cells remaining after separating plasma from human blood, or collected by apheresis.. Venous Thrombosis defined as following: The formation or presence of a blood clot (THROMBUS) within a vein.. CD59 Antigen defined as following: Small glycoproteins found on both hematopoietic and non-hematopoietic Cells. CD59 Antigen restricts the cytolytic activity of homologous complement by binding to C8 and C9 and blocking the assembly of the membrane attack complex. (From Barclay et al., The Leukocyte Antigen FactsBook, 1993, p234). Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Abdominal Pain defined as following: Sensation of discomfort, distress, or agony in the abdominal region.. Cytopenia defined as following: A laboratory test result indicating an abnormally low quantity of circulating blood Cells.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. red Cells defined as following: Red blood Cells. Mature Specimen Source Codes - Erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN.. thrombosis defined as following: Formation and development of a thrombus or blood clot in the blood vessel..", "label": "yes"} {"original_question": "Can multiple myeloma patients develop hyperviscosity syndrome?", "id": "converted_2451", "sentence1": "Can Multiple Myeloma patients develop Hyperviscosity syndrome?", "sentence2": "Multiple myeloma (millimeter) is an immedicable malignancy of the human plasma cells producing abnormal Antibodies, in vitro diagnostic (also referred to as Paraproteins) leading to kidney problems and Hyperviscosity syndrome. , This skin condition may be observed in patients with the following condtions, such as primary polycythemic Hyperviscosity (Polycythemia, thrombocytemia) treated with hydroxyurea, primary plasma Hyperviscosity (Multiple Myeloma, Cryoglobulinemia, Cryofibrinogenemia, Dysfibrinogenemia, and Connective Tissue Diseases), primary sclerocythemic Hyperviscosity (Hereditary spherocytosis, Thalassemia, and Anemia, Sickle Cell). , A 73-year-old woman with known millimeter who received little treatment for several years, presented secondary to Dysarthria and at first was thought to have Hyperviscosity syndrome. , After a comprehensive evaluation ruled out common causes of Kidney Failure, Acute, the patient underwent testing with a bone survey, Specimen Source Codes - Urine protein electrophoresis (UPEP), Serum protein electrophoresis (SPEP), and immunoelectrophoresis for suspected plasma cell dyscrasia and received plasmapheresis for Hyperviscosity syndrome and Toxic nephropathy, which resulted in improved renal function. Lab results showed monoclonal gammopathy, elevated serum free light chains, and Bence Jones Protein in the Specimen Source Codes - Urine with a follow-up bone marrow biopsy indicating plasma cell dyscrasia. The patient received a diagnosis of Multiple Myeloma (millimeter) and was started on chemotherapy and immunosuppression. , Plasmapheresis (phosphatidylethanolamines) is recommended for patients with Hyperviscosity syndrome or cast nephropathy presented with Blighia sapida, which may help to increase the dialysis-independency., Multiple myeloma is a neoplastic plasma-cell disorder resulting from malignant plasma cells in the bone marrow. It can cause a Hyperviscosity syndrome secondary to the Paraproteinemias associated with the disease. The increased Hyperviscosity can lead to retinal vein occlusions and other ocular problems that may challenge clinicians. , Etiologies are various but symptomatic Hyperviscosity is more common in Waldenström's macroglobulinemia and Multiple Myeloma. , Double filtration plasmapheresis in a dog with Multiple Myeloma and Hyperviscosity syndrome., A 12 year old, 38 kg, mix-breed, intact male dog presented with a 20 day history of clinical signs consistent with Hyperviscosity syndrome secondary to Multiple Myeloma. , The present study reported for the first time the use of double filtration plasmapheresis to reduce clinical signs of Hyperviscosity syndrome in a dog with Multiple Myeloma., An otherwise healthy young Homo sapiens presents with bilateral Central retinal vein occlusion as the first sign of Hyperviscosity syndrome in the setting of new Multiple Myeloma., In haematology the most common indication for plasmapheresis is the supportive treatment of Multiple Myeloma. The procedure is performed in patients with high protein levels endangered with Hyperviscosity syndrome., Five to 10 percent of patients with Multiple Myeloma are suffered from the Hyperviscosity syndrome because of increased serum viscosity due to the presence of myeloma protein., Plasmapheresis is known as an efficient method for rapid improvement of the Hyperviscosity syndrome, and double filtration plasmapheresis is most commonly used for plasma exchange of Multiple Myeloma patients in our country., phosphatidylethanolamines is the most effective method in the treatment of Hyperviscosity syndrome often seen with Multiple Myeloma and Waldenström's macroglobulinemia, and it is therapy of choice for this complication., Patients with Multiple Myeloma who have complications secondary to Hyperviscosity are treated by chemotherapy and/or plasmapheresis.[SEP]Relations: polyclonal Hyperviscosity syndrome has relations: disease_disease with hematologic disease, disease_disease with hematologic disease. Multiple myeloma has relations: drug_effect with Bortezomib, drug_effect with Bortezomib, disease_phenotype_positive with insulin-resistance syndrome, disease_phenotype_positive with insulin-resistance syndrome, disease_phenotype_positive with capillary leak syndrome, disease_phenotype_positive with capillary leak syndrome, disease_phenotype_positive with scleromyxedema, disease_phenotype_positive with scleromyxedema. Definitions: Central retinal vein occlusion defined as following: Blockage of the central retinal vein.. Serum protein electrophoresis defined as following: An electrophoretic laboratory test performed to determine the concentrations of globulin proteins in the blood.. Paraproteins defined as following: Abnormal immunoglobulins synthesized by atypical cells of the MONONUCLEAR PHAGOCYTE SYSTEM. Paraproteins containing only light chains lead to Bence Jones paraproteinemia, while the presence of only atypical heavy chains leads to heavy chain disease. Most of the Paraproteins show themselves as an M-component (monoclonal gammopathy) in electrophoresis. Diclonal and polyclonal Paraproteins are much less frequently encountered.. Hyperviscosity syndrome defined as following: any syndrome associated with increased viscosity of the blood; in syndrome of serum Hyperviscosity there is spontaneous bleeding and neurologic and ocular disorders; syndromes of polycythemic Hyperviscosity is marked by retarded blood flow, organ congestion, reduced capillary perfusion, and increased cardiac effort; syndromes of sclerocythemic Hyperviscosity comprise those in which the deformability of erythrocytes is impaired, as in sickle cell anemia.. Toxic nephropathy defined as following: Toxicity that impairs or damages the kidney. This condition is often caused by the administration of a pharmaceutical agent that causes damage to the kidney.. millimeter defined as following: A unit of concentration (molarity unit) equal to one thousandth of a mole (10E-3 mole) of solute per one liter of solution.. Bence Jones Protein defined as following: An abnormal protein with unusual thermosolubility characteristics that is found in the Specimen Source Codes - Urine of patients with MULTIPLE MYELOMA.. Homo sapiens defined as following: Members of the species Homo sapiens.. Paraproteinemias defined as following: A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin.. Hereditary spherocytosis defined as following: A group of familial congenital hemolytic anemias characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. The erythrocytes have increased osmotic fragility and are abnormally permeable to sodium ions.. Hyperviscosity defined as following: An increase in the viscosity of blood resulting from an increase in the proportion of cellular elements of the blood, a change in the mechanical properties of the cellular elements of the blood, and/or an alteration in plasma viscosity.. Dysarthria defined as following: Disorders of speech articulation caused by imperfect coordination of pharynx, larynx, tongue, or face muscles. This may result from CRANIAL NERVE DISEASES; NEUROMUSCULAR DISEASES; CEREBELLAR DISEASES; BASAL GANGLIA DISEASES; BRAIN STEM diseases; or diseases of the corticobulbar tracts (see PYRAMIDAL TRACTS). The cortical language centers are intact in this condition. (From Adams et al., Principles of Neurology, 6th ed, p489). Anemia, Sickle Cell defined as following: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.. Dysfibrinogenemia defined as following: A coagulation disorder caused by abnormalities in fibrin that result in defective clot formation. This disorder may be inherited or acquired.. hydroxyurea defined as following: An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.. Multiple Myeloma defined as following: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the Specimen Source Codes - Urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.. phosphatidylethanolamines defined as following: Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to an ethanolamine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and ethanolamine and 2 moles of fatty acids.. Cryoglobulinemia defined as following: A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas.. Connective Tissue Diseases defined as following: A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.. Kidney Failure, Acute defined as following: Sudden and sustained deterioration of the kidney function characterized by decreased glomerular filtration rate, increased serum creatinine or oliguria.. Polycythemia defined as following: An increase in the total red cell mass of the blood. (Dorland, 27th ed). Thalassemia defined as following: A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia..", "label": "yes"} {"original_question": "Is flibanserin effetive for Hypoactive Sexual Desire Disorder? ", "id": "converted_785", "sentence1": "Is flibanserin effetive for Hypoactive Sexual Desire Disorder? ", "sentence2": "Mechanism of action of flibanserin, a multifunctional serotonin Agonist and Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) (MSAA), in hypoactive sexual desire disorder., Flibanserin is a novel multifunctional serotonin Agonist and Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) (MSAA) that improves sexual functioning in premenopausal women who suffer from reduced sexual interest and desire., Flibanserin is a novel, non-hormonal drug for the treatment of HSDD in pre- and postmenopausal women, although the application submitted to the U.S. Food and Drug Administration by Sprout Pharmaceuticals is only for premenopausal women., CONCLUSIONS: In naturally postmenopausal women with HSDD, flibanserin, compared with placebo, has been associated with improvement in sexual desire, improvement in the number of SSEs, and reduced distress associated with low sexual desire, and is well tolerated., INTRODUCTION: Flibanserin is a mixed 5-Hydroxytryptamine Receptor 1A, human Agonist/5-HT2A Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) that has been developed for the treatment of hypoactive sexual desire disorder in women, BACKGROUND: Flibanserin, a novel serotonin (5-HT)(1A) Agonist and 5-HT(2A) Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance), has been shown to increase sexual desire and reduce distress in women with Hypoactive Sexual Desire Disorder (HSDD). , Hypoactive Sexual Desire Disorder (HSDD) is the most commonly described form of female sexual dysfunction. There is currently no pharmacological therapy approved to treat HSDD, and therefore, there is an unmet medical need for the development of efficacious treatment alternatives. Flibanserin is a novel, non-hormonal drug for the treatment of HSDD in pre- and postmenopausal women, although the application submitted to the U.S. , Sexual function adverse events across flibanserin groups were generally comparable to placebo.Although these studies were not designed or powered to compare sexual function outcomes, results suggested a potential benefit of flibanserin on sexual function, particularly on female sexual desire, and provided a rationale to evaluate the efficacy of flibanserin as a treatment for female hypoactive sexual desire disorder.[SEP]Relations: Flibanserin has relations: drug_drug with Ebselen, drug_drug with Ebselen, drug_drug with Theodrenaline, drug_drug with Theodrenaline, drug_drug with Etonogestrel, drug_drug with Etonogestrel, drug_drug with Orvepitant, drug_drug with Orvepitant, drug_drug with Progesterone, drug_drug with Progesterone. Definitions: Agonist defined as following: An agent that has affinity for a receptor and intrinsic activity at that receptor.. flibanserin defined as following: An orally bioavailable, non-hormonal, multifunctional serotonin Agonist and Substance with receptor antagonist mechanism of action (substance) (MSAA) that may improve sexual desire and arousal in women. Upon oral administration, flibanserin selectively binds to serotonin receptors in the central nervous system, acting as an Agonist on 5-Hydroxytryptamine Receptor 1A, human receptors and an Substance with receptor antagonist mechanism of action (substance) on 5-HT2A receptors. Agonist activity at 5-Hydroxytryptamine Receptor 1A, human postsynaptic receptors may enhance the release of dopamine and other monoamines. Combined with 5-HT2A antagonism, flibanserin boosts levels of dopamine in the mesocortical area of the prefrontal cortex and produces a net increase of norepinephrine selectively in the prefrontal cortex through disinhibition of locus coeruleus noradrenergic neurons. In addition, flibanserin reduces concentrations of serotonin in the prefrontal cortex with chronic administration. Reducing serotonin, which modulates sexual activity in an inhibitory fashion through downstream decreases in dopamine release, while enhancing the release of norepinephrine and dopamine in the prefrontal cortex may improve sexual desire and interest.. Hypoactive Sexual Desire Disorder defined as following: A disorder characterized by a recurrent or persistent lack of desire for sexual activity. The lack of sexual desire is not attributable to another psychiatric disorder or to the physiological effects of substance use or a general medical condition.. serotonin Agonist defined as following: Any agent that binds to and activates serotonin receptors.. 5-Hydroxytryptamine Receptor 1A, human defined as following: 5-hydroxytryptamine receptor 1A (422 aa, ~46 kDa) is encoded by the human HTR1A gene. This protein is involved in both serotonin binding and neurotransmitter-mediated signal transduction.. Hypoactive Sexual Desire Disorder defined as following: A disorder characterized by a recurrent or persistent lack of desire for sexual activity. The lack of sexual desire is not attributable to another psychiatric disorder or to the physiological effects of substance use or a general medical condition..", "label": "yes"} {"original_question": "Is AZD9668 a VEGF mRNA drug?", "id": "converted_4283", "sentence1": "Is AZD9668 a VEGF mRNA drug?", "sentence2": "AZD9668, a ELANE gene inhibitor, plus ongoing budesonide / formoterol in patients with Chronic Obstructive Airway Disease., AZD9668 is a reversible and selective inhibitor of No evidence of, well tolerated at doses of 60 mg Twice a day during Phase I/IIa development.[SEP]Relations: ELANE has relations: protein_protein with AZU1, protein_protein with AZU1, drug_protein with Pegfilgrastim, drug_protein with Pegfilgrastim, protein_protein with NOTCH2NLA, protein_protein with NOTCH2NLA, drug_protein with Mdl 101,146, drug_protein with Mdl 101,146. chronic obstructive pulmonary disease has relations: disease_protein with MIR218-2, disease_protein with MIR218-2. Definitions: Twice a day defined as following: Two times per day, at unspecified times.. ELANE gene defined as following: This gene plays a role in innate host defense.. Chronic Obstructive Airway Disease defined as following: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of Chronic Obstructive Airway Disease include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.. VEGF defined as following: Human VEGFA wild-type allele is located within 6p12 and is approximately 16 kb in length. This allele, which encodes vascular endothelial growth factor A protein, plays a role in several processes related to vasculature function, including angiogenesis. The allele is also involved in endothelial cell growth cell migration and apoptotic inhibition..", "label": "no"} {"original_question": "Is there a way to distinguish COVID-19 clinically from other respiratory illnesses, particularly influenza?", "id": "converted_4535", "sentence1": "Is there a way to distinguish COVID19 (document) clinically from other respiratory illnesses, particularly influenza?", "sentence2": "Findings indicate that clinical symptoms alone would be insufficient to distinguish between Coronavirus Infections disease 2019 and other Respiratory Tract Infections (eg, influenza) and/or to evaluate the effects of preventive interventions (eg, vaccinations)., Our reasoning highlights how challenging a balanced approach to a patient with Fever symptoms (finding) and flu-like symptoms can be. At present, clinical workup of COVID19 (document) remains a hard task to accomplish., In our retrospective cohort study comparing the clinical presentation of COVID19 (document) and other respiratory viral infections, we found that Anosmia and Dysgeusia were symptoms independently associated with COVID19 (document) and can be important differentiating symptoms in patients presenting with acute respiratory illness. On the other hand, laboratory abnormalities and radiological findings were not statistically different between the two groups., COVID19 (document) has a similar pattern of Communicable Diseases, clinical symptoms, and chest imaging findings to influenza Pneumonia., Here, we hypothesize the order of symptom occurrence could help patients and medical professionals more quickly distinguish COVID19 (document) from other Respiratory Tract Diseases, yet such essential information is largely unavailable, It is difficult to distinguish Coronavirus Infections disease-2019 (COVID19 (document)) from other Viral Respiratory Tract Infection owing to the similarities in clinical and radiological findings.[SEP]Relations: viral respiratory tract Communicable Diseases has relations: disease_disease with influenza, disease_disease with influenza, disease_disease with respiratory syncytial virus infectious disease, disease_disease with respiratory syncytial virus infectious disease. Respiratory tract Communicable Diseases has relations: phenotype_phenotype with Acute infectious Pneumonia, phenotype_phenotype with Acute infectious Pneumonia, disease_phenotype_positive with ALG12-CDG, disease_phenotype_positive with ALG12-CDG. Pneumonia has relations: disease_phenotype_positive with adult acute respiratory distress syndrome, disease_phenotype_positive with adult acute respiratory distress syndrome. Definitions: Coronavirus Infections defined as following: Virus diseases caused by the CORONAVIRUS genus. Some specifics include transmissible enteritis of turkeys (ENTERITIS, TRANSMISSIBLE, OF TURKEYS); FELINE INFECTIOUS PERITONITIS; and transmissible gastroenteritis of swine (GASTROENTERITIS, TRANSMISSIBLE, OF SWINE).. Dysgeusia defined as following: A condition characterized by alterations of the sense of taste which may range from mild to severe, including gross distortions of taste quality.. Viral Respiratory Tract Infection defined as following: A respiratory tract Communicable Diseases caused by a virus. Viruses represent the most common causes of upper and lower respiratory tract infections and include rhinoviruses, influenza viruses, parainfluenza viruses, and respiratory syncytial virus.. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.. Pneumonia defined as following: Infection of the lung often accompanied by inflammation.. Anosmia defined as following: Inability to smell.. Respiratory Tract Diseases defined as following: Diseases involving the RESPIRATORY SYSTEM.. Respiratory Tract Infections defined as following: Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases..", "label": "no"} {"original_question": "Has ATF4 transcription factor been linked to cancer and neoplastic transformation?", "id": "converted_2491", "sentence1": "Has ATF4 protein, human transcription factor been linked to Primary malignant neoplasm and neoplastic transformation?", "sentence2": "aken together, we discovered a novel axis of BCL10-regulated OSCC progression via STAT1/ATF4 protein, human protein, human/S100P/P65 signaling, which could predict the prognosis of OSCC and will be beneficial for developing therapeutic strategy against advanced OSCC, s a result, the level of phosphorylated Eukaryotic Initiation Factor 2 alpha (eIF2α) is markedly elevated, resulting in the promotion of a pro-adaptive signaling pathway by the inhibition of global protein synthesis and selective translation of Activating Transcription Factor 4 (ATF4 protein, human protein, human). , Many Malignant Neoplasms overexpress ATF4 protein, human protein, human, a stress-induced transcription factor that promotes cell survival under hypoxic conditions and other stresses of the tumor microenvironment, but the potential contributions of ATF4 protein, human protein, human to oncogenesis itself have been little explored. Here, we report that ATF4 protein, human protein, human promotes oncogene-induced neoplastic transformation by suppressing the expression of cellular senescence-associated genes. , Here, we report that ATF4 protein, human protein, human promotes oncogene-induced neoplastic transformation by suppressing the expression of cellular senescence-associated genes., Elevated levels of ATF4 protein, human protein, human were sufficient to suppress expression of these Proteins and drive oncogenic transformation., Our findings define a central function for ATF4 protein, human protein, human in promoting oncogenic transformation by suppressing a central pathway of cellular senescence.
, ATF4 protein, human protein, human expression is upregulated in Primary malignant neoplasm., Activating Transcription Factors (ATF4 protein, human protein, human), an endoplasmic reticulum stress-inducible transcription factor, plays important roles in Primary malignant neoplasm progression and resistance to therapy., Activating Transcription Factors (ATF4 protein, human protein, human) is a stress-induced transcription factor that is frequently upregulated in Primary malignant neoplasm cells., Our findings define a central function for ATF4 protein, human protein, human in promoting oncogenic transformation by suppressing a central pathway of cellular senescence., Stress-regulated transcription factor ATF4 protein, human protein, human promotes neoplastic transformation by suppressing expression of the INK4a/ARF cell senescence factors., Activating Transcription Factors (ATF4 protein, human protein, human), a member of the ATF/CREB family, has been reported to be related to tumor angiogenesis[SEP]Relations: transcription coactivator activity has relations: molfunc_protein with IRF4, molfunc_protein with IRF4, molfunc_protein with TAF6, molfunc_protein with TAF6, molfunc_protein with YAF2, molfunc_protein with YAF2, molfunc_protein with UTF1, molfunc_protein with UTF1, molfunc_protein with PHF2, molfunc_protein with PHF2. Definitions: Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Primary malignant neoplasm cells defined as following: Cells of, or derived from, a malignant tumor.. Activating Transcription Factors defined as following: Activating transcription factors were originally identified as DNA-BINDING PROTEINS that interact with early promoters from ADENOVIRUSES. They are a family of basic leucine zipper transcription factors that bind to the consensus site TGACGTCA of the cyclic AMP response element, and are closely related to CYCLIC AMP-RESPONSIVE DNA-BINDING PROTEIN.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. ATF4 protein, human defined as following: Cyclic AMP-dependent transcription factor ATF-4 (351 aa, ~39 kDa) is encoded by the human ATF4 protein, human gene. This protein plays a role in the regulation of gene transcription.. ATF4 protein, human transcription factor defined as following: An activating transcription factor that regulates the expression of a variety of GENES involved in amino acid metabolism and transport. It also interacts with HTLV-I transactivator protein..", "label": "yes"} {"original_question": "Does thyroid hormone affect cardiac remodeling ?", "id": "converted_1152", "sentence1": "Does thyroid hormone affect cardiac remodeling ?", "sentence2": "Thyroid Hormones exert important effects on heart remodeling through mir-208., RV and RA function and mechanics are significantly affected by SHT. l-T4 therapy and 1-year maintenance of euthyroid status improved but did not completely recover RV and RA function and deformation in the SHT patients, which implies that right heart remodeling caused by SHT is not reversible in a 1-year period., These results suggest that long-term T4 treatment after MI has beneficial effects on Muscle Cells, arteriolar, and collagen matrix remodeling in the non-infarcted area. Most importantly, results suggest improved survival of myocytes in the peri-infarct area.[SEP]Relations: response to thyroid hormone has relations: bioprocess_bioprocess with response to hormone, bioprocess_bioprocess with response to hormone, bioprocess_bioprocess with cellular response to thyroid hormone stimulus, bioprocess_bioprocess with cellular response to thyroid hormone stimulus, bioprocess_bioprocess with response to thyroxine, bioprocess_bioprocess with response to thyroxine, bioprocess_protein with HPN, bioprocess_protein with HPN, bioprocess_protein with CAB39, bioprocess_protein with CAB39. Definitions: Muscle Cells defined as following: Mature contractile cells, commonly known as myocytes, that form one of three kinds of muscle. The three types of muscle cells are skeletal (MUSCLE FIBERS, SKELETAL), cardiac (MYOCYTES, CARDIAC), and smooth (MYOCYTES, SMOOTH MUSCLE). They are derived from embryonic (precursor) muscle cells called MYOBLASTS.. Thyroid Hormones defined as following: Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs.. thyroid hormone defined as following: Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs..", "label": "yes"} {"original_question": "Do mutations in KCNT2 only cause phenotypes with epilepsy?", "id": "converted_4558", "sentence1": "Do mutations in KCNT2 gene only cause phenotypes with Epilepsy?", "sentence2": "KCNT2 gene gene Variant resulting in substitutions affecting the Arg190 residue have been shown to cause Epileptic encephalopathy and a recognizable facial gestalt. We report two additional individuals with Intellectual Disability, dysmorphic features, Hypertrichosis, Macrocephaly and the same de novo KCNT2 gene gene missense Variant affecting the Arg190 residue as previously described. Notably, neither patient has Epilepsy. Homology modeling of these missense Variant revealed that they are likely to disrupt the stabilization of a closed channel conformation of KCNT2 gene gene resulting in a constitutively open state. This is the first report of pathogenic Variant in KCNT2 gene gene causing a developmental phenotype without Epilepsy.[SEP]Relations: Epilepsy has relations: disease_protein with KCNT2 gene, disease_protein with KCNT2 gene, disease_protein with KCND2, disease_protein with KCND2, disease_protein with KCNAB2, disease_protein with KCNAB2, disease_protein with KCNA2, disease_protein with KCNA2, disease_protein with KCNQ2, disease_protein with KCNQ2. Definitions: Variant defined as following: An alteration or difference from a norm or standard.. Epilepsy defined as following: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal Epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313). Epileptic encephalopathy defined as following: A condition in which epileptiform abnormalities are believed to contribute to the progressive disturbance in cerebral function. Epileptic encephalaopathy is characterized by (1) electrographic EEG paroxysmal activity that is often aggressive, (2) seizures that are usually multiform and intractable, (3) cognitive, behavioral and neurological deficits that may be relentless, and (4) sometimes early death. [PMID:21590624, PMID:23213494]. Hypertrichosis defined as following: Excessive hair growth at inappropriate locations, such as on the extremities, the head, and the back. It is caused by genetic or acquired factors, and is an androgen-independent process. This concept does not include HIRSUTISM which is an androgen-dependent excess hair growth in WOMEN and CHILDREN.. Macrocephaly defined as following: A congenital abnormality in which the occipitofrontal circumference is greater than two standard deviations above the mean for a given age. It is associated with HYDROCEPHALUS; SUBDURAL EFFUSION; ARACHNOID CYSTS; or is part of a genetic condition (e.g., ALEXANDER DISEASE; SOTOS SYNDROME).. Intellectual Disability defined as following: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an Intellectual Disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28). mutations defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA..", "label": "no"} {"original_question": "Are patients with Sjogren syndrome at increased risk for lymphoma?", "id": "converted_2492", "sentence1": "Are patients with Sjogren syndrome at increased risk for Lymphoma?", "sentence2": "The heightened risk of non-Hodgkin Lymphoma (Lymphoma, Large-Cell, Follicular) development in primary Sjogren syndrome (Supernumerary mandibular right first primary molar) is well established., Primary Diffuse Large B-Cell Lymphoma of the Abdomen>Abdomen>Liver in a Patient with Sjogren Syndrome., Immunohistochemical and molecular features of the Neoplasms allowed diagnosis of diffuse large B-Cell Lymphomas (Diffuse Large B-Cell Lymphoma). , To our knowledge, the patient described here represents the first reported case of Diffuse Large B-Cell Lymphoma with primary liver involvement in Supernumerary mandibular right first primary molar., rituximab is also effective in the treatment of Supernumerary mandibular right first primary molar-associated (extrasalivary) lymphomas, although the therapeutic response in salivary Lymphoma is poorer., rituximab treatment for Sjogren syndrome-associated non-Hodgkin's Lymphoma: case series., Five per cent of patients with Primary Sjögren's syndrome (Chromosome 11p11.2 Deletion Syndrome) develop malignant non-Hodgkin's Lymphoma (Lymphoma, Large-Cell, Follicular), usually of the mucosa-associated lymphoid tissue (MALT) and most frequently located in the major Salivary Glands. , [A case of Sjogren syndrome coexistent with Mucosa-Associated Lymphoid Tissue Lymphoma occurring along the Parotid Gland and Neck+Chest>Trachea]., Both histological examinations revealed MALT-type marginal zone B-Cell Lymphomas. , In the majority of patients, it is a late event and frequently associated with Systemic disease or risk factors for Lymphoma development., The incidence of Lymphoma is higher in patients with Sjögren's syndrome than in the general population., Among the clinical and serological parameters that have been associated with Lymphoma development in Supernumerary mandibular right first primary molar patients, the presence of palpable purpura, low C4, and mixed monoclonal cryoglobulinemia constitute the main predictive markers, and patients displaying these risk factors should be monitored closely., A case of Pulmonary nodular lymphoid hyperplasia and Sjogren syndrome is presented., Furthermore, Rheumatoid Arthritis, Sjögren's syndrome, Lupus Erythematosus, Systemic, and possibly Celiac Disease may share an association with risk of diffuse large B-Cell Lymphomas, in addition to well-established links of Sjögren's syndrome with risk of mucosa-associated lymphoid tissue Lymphoma and of Celiac Disease with risk of small intestinal Lymphoma., Predicting the risk for Lymphoma development in Sjogren syndrome: An easy tool for clinical use., Lymphoma is a very severe complication of primary Sjögren's syndrome: 5 to 10% of patients followed for more than 10 years will develop a Lymphoma., Hematologic manifestations and predictors of Lymphoma development in primary Sjogren's Syndrome: clinical and pathophysiologic aspects., Recent results clearly indicate an association between severity of chronic inflammation and Lymphoma risk in Rheumatoid Arthritis and Sjögren's syndrome., Several autoimmune diseases, including primary Sjögren's syndrome (Chromosome 11p11.2 Deletion Syndrome), are associated with an increased risk for Lymphoma., Primary Sjogren's syndrome (Chromosome 11p11.2 Deletion Syndrome) confers increased risk for non-Hodgkin Lymphoma (Lymphoma, Large-Cell, Follicular) development., Furthermore, we review the emerging role of ELS and lymphoid chemokines in driving extranodal B cell lymphomagenesis in Supernumerary mandibular right first primary molar and we focus on recent evidence suggesting that ELS identify subsets of Supernumerary mandibular right first primary molar patients at increased risk of developing systemic manifestations and Lymphoma., Sjogren's syndrome (Supernumerary mandibular right first primary molar) is a chronic autoimmune disorder with the highest risk for Lymphoma development among all autoimmune diseases., In contrast to secondary Supernumerary mandibular right first primary molar, the risk for developing non-Hodgkin's Lymphoma is highly increased in patients with primary Supernumerary mandibular right first primary molar., Predicting the risk for Lymphoma development in Sjogren syndrome: An easy tool for clinical use., Primary Sjogren's syndrome (Chromosome 11p11.2 Deletion Syndrome) is complicated by B-Cell Lymphomas in 5-10% of patients., Patients with Sjogren's Syndrome are at increased risk of Lymphoma development., Sjogren's syndrome is an Autoimmune Diseases with a known predisposition for Lymphoma development., Certain autoimmune and chronic inflammatory conditions, such as Sjögren's syndrome and rheumatoid arthritis (Rheumatoid Arthritis), have consistently been associated with an increased risk of malignant lymphomas, but it is unclear whether elevated Lymphoma risk is a phenomenon that accompanies inflammatory conditions in general.[SEP]Relations: Sjogren syndrome has relations: disease_phenotype_positive with Lymphoma, disease_phenotype_positive with Lymphoma, disease_phenotype_positive with Lymphadenopathy, disease_phenotype_positive with Lymphadenopathy, disease_phenotype_positive with Increased circulating antibody level, disease_phenotype_positive with Increased circulating antibody level, disease_phenotype_positive with Behavioral abnormality, disease_phenotype_positive with Behavioral abnormality. Lymphoma has relations: disease_phenotype_positive with Sjogren syndrome, disease_phenotype_positive with Sjogren syndrome. Definitions: Diffuse Large B-Cell Lymphoma defined as following: Malignant Lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.. Lymphoma, Large-Cell, Follicular defined as following: Malignant Lymphoma in which the majority of neoplastic cells within the follicles are large cleaved or noncleaved cells. The degree to which the follicular center cells retain their ability to form follicles varies with the state of B-cell transformation.. Mucosa-Associated Lymphoid Tissue Lymphoma defined as following: Extranodal Lymphoma of lymphoid tissue associated with mucosa that is in contact with exogenous antigens. Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. They acquire mucosa-associated lymphoid tissue (MALT) type as a result of an immunologically mediated disorder.. Rheumatoid Arthritis defined as following: A chronic Systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.. B-Cell Lymphomas defined as following: A group of heterogeneous lymphoid Neoplasms generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.. Primary Sjögren's syndrome defined as following: Sjogren syndrome without a concomitant systemic autoimmune disorder.. Lymphoma defined as following: A general term for various neoplastic diseases of the lymphoid tissue.. Supernumerary mandibular right first primary molar defined as following:

Supernumerary mandibular right first primary molar

. Autoimmune Diseases defined as following: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.. mucosa-associated lymphoid tissue defined as following: Lymphoid tissue located beneath the mucosal epithelia of those mucosal surfaces that have contact with the external environment, such as the respiratory, digestive, and urinary systems. MALT consists of a collection of predominantly small lymphocytes, fewer larger, transformed lymphocytes, and plasma cells. It protects the body from pathogens that enter via the mucosa. MALT gives rise to a distinctive type of B-Cell Lymphomas that usually follows an indolent clinical course.. malignant non-Hodgkin's Lymphoma defined as following: Any of a group of malignant Neoplasms of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these Neoplasms is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.. Systemic disease defined as following: A clinical course finding indicating that a disease presents with systemic manifestations.. Sjogren's Syndrome defined as following: Chronic inflammatory and Autoimmune Diseases in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.. Lupus Erythematosus, Systemic defined as following: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.. Parotid Gland defined as following: The largest of the three pairs of SALIVARY GLANDS. They lie on the sides of the FACE immediately below and in front of the EAR.. Pulmonary nodular lymphoid hyperplasia defined as following: A rare, reactive lesion in the lung parenchyma. It is characterized by the formation of a single or several nodules that are composed of lymphocytic infiltrates with reactive germinal centers.. diffuse large B-Cell Lymphomas defined as following: Diffuse large B-Cell Lymphomas that affects the kidney.. rituximab defined as following: A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Salivary Glands defined as following: Glands that secrete SALIVA in the MOUTH. There are three pairs of Salivary Glands (PAROTID GLAND; SUBLINGUAL GLAND; SUBMANDIBULAR GLAND).. Celiac Disease defined as following: A malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION.. Chromosome 11p11.2 Deletion Syndrome defined as following: A very rare genetic syndrome caused by deletions on the proximal short arm of chromosome 11. It is characterized by the presence of multiple exostoses and enlarged parietal foramina.. Sjogren syndrome defined as following: Chronic inflammatory and Autoimmune Diseases in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis..", "label": "yes"} {"original_question": "Is there a link between nuclear position and DNA repair pathway choice?", "id": "converted_2617", "sentence1": "Is there a link between Nuclear (incident type) position and DNA repair pathway choice?", "sentence2": "Nuclear position dictates DNA repair pathway choice., We demonstrate that DSBs induced at the Nuclear Envelope (but not at Nuclear Pore or Nuclear (incident type) interior) fail to rapidly activate the DNA damage response (DDR) and repair by homologous recombination (HR). Real-time and superresolution imaging reveal that DNA DSBs within lamina-associated domains do not migrate to more permissive environments for HR, like the Nuclear Pore or the Nuclear (incident type) interior, but instead are repaired in situ by alternative end-joining. Our results are consistent with a model in which Nuclear (incident type) position dictates the choice of DNA repair pathway, thus revealing a new level of regulation in 1,2-di-(4-sulfamidophenyl)-4-butylpyrazolidine-3,5-dione repair controlled by spatial organization of DNA within the Cell Nucleus., Our results are consistent with a model in which Nuclear (incident type) position dictates the choice of DNA repair pathway, thus revealing a new level of regulation in 1,2-di-(4-sulfamidophenyl)-4-butylpyrazolidine-3,5-dione repair controlled by spatial organization of DNA within the Cell Nucleus., Nuclear position dictates DNA repair pathway choice., Our results are consistent with a model in which Nuclear (incident type) position dictates the choice of DNA repair pathway, thus revealing a new level of regulation in 1,2-di-(4-sulfamidophenyl)-4-butylpyrazolidine-3,5-dione repair controlled by spatial organization of DNA within the Cell Nucleus.[SEP]Relations: Nuclear (incident type) envelope has relations: cellcomp_protein with DNASE1, cellcomp_protein with DNASE1, cellcomp_protein with NRM, cellcomp_protein with NRM, cellcomp_protein with LMNA, cellcomp_protein with LMNA, cellcomp_protein with RAN, cellcomp_protein with RAN, cellcomp_protein with DST, cellcomp_protein with DST. Definitions: Nuclear Pore defined as following: An opening through the NUCLEAR ENVELOPE formed by the Nuclear (incident type) pore complex which transports Nuclear (incident type) proteins or RNA into or out of the CELL NUCLEUS and which, under some conditions, acts as an ion channel.. Cell Nucleus defined as following: Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The Nuclear Envelope consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one Cell Nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). Nuclear Envelope defined as following: The membrane system of the CELL NUCLEUS that surrounds the nucleoplasm. It consists of two concentric membranes separated by the perinuclear space. The structures of the envelope where it opens to the cytoplasm are called the Nuclear Pore (NUCLEAR PORE).. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine)..", "label": "yes"} {"original_question": "Is recursive splicing more common in short introns?", "id": "converted_2664", "sentence1": "Is recursive splicing more common in short introns?", "sentence2": "Recent work in human and fruitfly tissues revealed that long introns are extensively processed cotranscriptionally and in a stepwise manner, before their two flanking exons are spliced together, Cutting a Long Intron Short: Recursive Splicing and Its Implications., Furthermore, we uncover the potential to investigate the multi-step nature of splicing, assessing various types of recursive splicing events, Recursive splicing is a process in which large introns are removed in multiple steps by re-splicing at ratchet points--5' splice sites recreated after splicing., Together, these results indicate that recursive splicing is commonly used in Drosophila , occurs in Homo sapiens, and provides insight into the mechanisms by which some large introns are removed., Recursive splicing in long vertebrate Genes., Moreover, the RS-sites are found in some of the longest introns across Vertebrates. , The peculiarities of large Introns splicing in animal allergen extracts., These \"large introns\" must be spliced out of the mRNA Precursor in a timely fashion, which involves bringing together distant 5' and 3' acceptor and donor splice sites., Using a computational analysis of the genomic sequences, we show that Vertebrates lack the proper enrichment of RP-sites in their large introns, and, therefore, require some other method to aid splicing, Subdivision of large introns in Drosophila by recursive splicing at nonexonic elements., Recursive splice sites predicted with highly stringent criteria are found at much higher frequency than expected in the sense strands of introns>20 kb, but they are found only at the expected frequency on the antisense strands, and they are underrepresented within introns<10 kb., These RNA Transcript arise by use of two alternative transcription sites and complex alternative splicing mechanisms and encode proteins with long or short N-terminal domains, complete or incomplete GGT5 gene domains, 7 distinct C-terminal domains and a common internal Superkingdom (taxonomic category) where the Axenfeld-Rieger Syndrome, Type 1 Superkingdom (taxonomic category) is found., These patterns of enrichment and conservation indicate that recursive splice sites are advantageous in the context of long introns., Many Genes with important roles in development and disease contain exceptionally long introns, but special mechanisms for their expression have not been investigated., However, some long Drosophila melanogaster introns contain a cryptic site, known as a recursive splice site (RS-site), that enables a multi-step process of Introns removal termed recursive splicing., The effect of splice site strength was context-dependent and much more significant for the 3' splice site of the longer alternative Introns than for the 3' splice site of the shorter alternative Introns and the common 5' splice sites; it was also more significant in the rat minigene than in the mouse minigene., Cutting a Long Intron Short: Recursive Splicing and Its Implications., Recursive splicing in long vertebrate Genes.[SEP]Relations: rRNA transcription has relations: bioprocess_protein with SIRT7, bioprocess_protein with SIRT7, bioprocess_bioprocess with plastid rRNA transcription, bioprocess_bioprocess with plastid rRNA transcription, bioprocess_bioprocess with ncRNA transcription, bioprocess_bioprocess with ncRNA transcription, bioprocess_protein with NPM3, bioprocess_protein with NPM3, bioprocess_protein with SPIN1, bioprocess_protein with SPIN1. Definitions: mRNA Precursor defined as following: A primary RNA transcript synthesized from a DNA template in eukaryotic nuclei which is post-transcriptionally modified and spliced to produce a mature mRNA.. Homo sapiens defined as following: Members of the species Homo sapiens.. Superkingdom (taxonomic category) defined as following: A taxonomic category above that of Kingdom.. RNA Transcript defined as following: The initial RNA molecule produced by transcription.. Axenfeld-Rieger Syndrome, Type 1 defined as following: A rare autosomal dominant syndrome linked to mutations in the PITX2 gene. It is characterized by abnormalities in the anterior chamber of the eye and underdevelopment of the teeth.. Introns defined as following: Sequences of DNA in the Genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some introns code for separate Genes.. Vertebrates defined as following: Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising mammals, birds, reptiles, amphibians, and fishes.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. introns defined as following: Sequences of DNA in the Genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some introns code for separate Genes..", "label": "no"} {"original_question": "Have C12orf65 mutations been associated with axonal neuropathy and optic atrophy?", "id": "converted_865", "sentence1": "Have MTRFR gene mutations been associated with Axonal Neuropathy and Optic Atrophy 1?", "sentence2": "Novel MTRFR Genes mutations in patients with Axonal Neuropathy and Optic Atrophy 1, Charcot-Marie Tooth disease (CMT brand of Choline Magnesium Trisalicylate brand of Choline Magnesium Trisalicylate) forms a clinically and genetically heterogeneous group of disorders. Although a number of disease genes have been identified for CMT brand of Choline Magnesium Trisalicylate brand of Choline Magnesium Trisalicylate, the Genes discovery for some complex form of CMT brand of Choline Magnesium Trisalicylate brand of Choline Magnesium Trisalicylate has lagged behind. The association of Neuropathy and Optic Atrophy 1 (also known as CMT brand of Choline Magnesium Trisalicylate brand of Choline Magnesium Trisalicylate type 6) has been described with autosomaldominant, recessive and X-linked modes of inheritance. Gene Mutation in MFN2 Genes have been found to cause dominant forms of Hereditary motor and sensory Neuropathy with Optic Atrophy 1 (disorder). Phosphoribosylpyrophosphate synthetase-I mutations cause X-linked Hereditary motor and sensory Neuropathy with Optic Atrophy 1 (disorder), but until now, mutations in the recessive forms of disease have never been identified.METHODS: We here describe a family with three affected individuals who inherited in an autosomal recessive fashion a childhood onset Neuropathy and Optic Atrophy 1. Using homozygosity mapping in the family and exome sequencing in two affected individuals we identified a novel Protein Info-truncating Mutation Abnormality in the MTRFR Genes Genes, which encodes for a Protein Info involved in mitochondrial translation, Novel MTRFR Genes mutations in patients with Axonal Neuropathy and Optic Atrophy 1., Our study broadens the phenotypic spectrum of MTRFR Genes defects and highlights the triad of Optic Atrophy 1, Axonal Neuropathy and Paraparesis, Spastic as its key clinical features., MTRFR Genes participates in the process of mitochondrial translation and has been shown to be associated with a spectrum of phenotypes, including early onset Optic Atrophy 1, progressive encephalomyopathy, Peripheral Nervous System Diseases, and Paraparesis, Spastic.We used whole-genome homozygosity mapping as well as exome sequencing and targeted Genes sequencing to identify novel MTRFR Genes disease-causing mutations in seven affected individuals originating from two consanguineous families., A homozygous Mutation Abnormality of MTRFR Genes causes spastic paraplegia with Optic Atrophy 1 and Neuropathy (SPG55)., Optic atrophy and a Leigh-like syndrome due to mutations in the c12orf65 Genes: report of a novel Mutation Abnormality and review of the literature., Recently, we identified the causative Genes, MTRFR Genes, that was reported the Genes for Leigh Disease, for autosomal recessive spastic paraplegia with Optic Atrophy 1 and Neuropathy (SPG55)., We describe 2 siblings with fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether heterozygous mutations in the recently identified MTRFR Genes Genes who presented with Optic Atrophy 1 and mild developmental delays and subsequently developed bilateral, symmetric lesions in the brainstem reminiscent of Leigh Disease., MTRFR Genes participates in the process of mitochondrial translation and has been shown to be associated with a spectrum of phenotypes, including early onset Optic Atrophy 1, progressive encephalomyopathy, Peripheral Nervous System Diseases, and Paraparesis, Spastic.We used whole-genome homozygosity mapping as well as exome sequencing and targeted Genes sequencing to identify novel MTRFR Genes disease-causing mutations in seven affected individuals originating from two consanguineous families, Our study broadens the phenotypic spectrum of MTRFR Genes defects and highlights the triad of Optic Atrophy 1, Axonal Neuropathy and Paraparesis, Spastic as its key clinical features, CONCLUSIONS: This work describes a Mutation Abnormality in the MTRFR Genes Genes that causes recessive form of Hereditary motor and sensory Neuropathy with Optic Atrophy 1 (disorder) and confirms the role of Abnormality of mitochondrial metabolism in this complex Axonal Neuropathy., MTRFR Genes participates in the process of mitochondrial translation and has been shown to be associated with a spectrum of phenotypes, including early onset Optic Atrophy 1, progressive encephalomyopathy, Peripheral Nervous System Diseases, and Paraparesis, Spastic.We used whole-genome homozygosity mapping as well as exome sequencing and targeted Genes sequencing to identify novel MTRFR Genes disease-causing mutations in seven affected individuals originating from two consanguineous families. , Our study broadens the phenotypic spectrum of MTRFR Genes defects and highlights the triad of Optic Atrophy 1, Axonal Neuropathy and Paraparesis, Spastic as its key clinical features. , We described a large consanguineous family with Neuropathy and Optic Atrophy 1 carrying a loss of function Mutation Abnormality in the MTRFR Genes Genes., In these patients, we identified a homozygous splice Mutation Abnormality, g.21043 T>A (c.282+2 T>A) which leads to skipping of exon 2. Our study broadens the phenotypic spectrum of MTRFR Genes defects and highlights the triad of Optic Atrophy 1, Axonal Neuropathy and Paraparesis, Spastic as its key clinical features., This work describes a Mutation Abnormality in the MTRFR Genes Genes that causes recessive form of Hereditary motor and sensory Neuropathy with Optic Atrophy 1 (disorder) and confirms the role of Abnormality of mitochondrial metabolism in this complex Axonal Neuropathy., Our study broadens the phenotypic spectrum of MTRFR Genes defects and highlights the triad of Optic Atrophy 1, Axonal Neuropathy and Paraparesis, Spastic as its key clinical features., Novel MTRFR Genes mutations in patients with Axonal Neuropathy and Optic Atrophy 1., This work describes a Mutation Abnormality in the MTRFR Genes Genes that causes recessive form of Hereditary motor and sensory Neuropathy with Optic Atrophy 1 (disorder) and confirms the role of Abnormality of mitochondrial metabolism in this complex Axonal Neuropathy., A homozygous Mutation Abnormality of MTRFR Genes causes spastic paraplegia with Optic Atrophy 1 and Neuropathy (SPG55)., MTRFR Genes participates in the process of mitochondrial translation and has been shown to be associated with a spectrum of phenotypes, including early onset Optic Atrophy 1, progressive encephalomyopathy, Peripheral Nervous System Diseases, and Paraparesis, Spastic.We used whole-genome homozygosity mapping as well as exome sequencing and targeted Genes sequencing to identify novel MTRFR Genes disease-causing mutations in seven affected individuals originating from two consanguineous families.[SEP]Relations: Optic atrophy has relations: disease_phenotype_positive with neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures, disease_phenotype_positive with neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures, disease_phenotype_positive with cerebellar ataxia with Neuropathy and bilateral vestibular areflexia syndrome, disease_phenotype_positive with cerebellar ataxia with Neuropathy and bilateral vestibular areflexia syndrome, disease_phenotype_positive with mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, disease_phenotype_positive with mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, disease_phenotype_positive with neurodevelopmental disorder with visual defects and brain anomalies, disease_phenotype_positive with neurodevelopmental disorder with visual defects and brain anomalies, disease_phenotype_positive with Mowat-Wilson syndrome due to a ZEB2 point Mutation Abnormality, disease_phenotype_positive with Mowat-Wilson syndrome due to a ZEB2 point Mutation Abnormality. Definitions: Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Hereditary motor and sensory Neuropathy with Optic Atrophy 1 (disorder) defined as following: A rare axonal hereditary motor and sensory Neuropathy disease characterized by progressive, peripheral, axonal sensorimotor Neuropathy (of variable severity), affecting predominantly the distal lower limbs, associated with progressive, variably severe, Optic Atrophy 1, which frequently leads to visual loss. Patients typically present distal limb muscle weakness and atrophy, hypo/areflexia, foot deformities, poor visual acuity (often with a central scotoma), nystagmus, and reduced peripheral and nocturnal vision. Additional reported manifestations include sensorineural hearing loss, major joint contractures, anosmia, scoliosis/lumbar hyperlordosis, cognitive impairment and vocal cord paresis.. MFN2 gene defined as following: This Genes is involved in mitochondrial fusion.. Peripheral Nervous System Diseases defined as following: Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Gene Mutation may be associated with genetic diversity or with pathologies including cancer.. Axonal Neuropathy defined as following: Any nerve disorder affecting the axon of a nerve.. Protein Info defined as following: Protein; provides access to the encoding Genes via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. CMT brand of Choline Magnesium Trisalicylate defined as following: brand name of choline magnesium trisalicylate. Leigh Disease defined as following: A group of metabolic disorders primarily of infancy characterized by the subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, dysphagia, and lactic acidosis. Pathological features include spongy degeneration of the neuropile of the basal ganglia, thalamus, brain stem, and spinal cord. Patterns of inheritance include X-linked recessive, autosomal recessive, and mitochondrial. Leigh disease has been associated with mutations in genes for the PYRUVATE DEHYDROGENASE COMPLEX; CYTOCHROME-C OXIDASE; ATP synthase subunit 6; and subunits of mitochondrial complex I. (From Menkes, Textbook of Child Neurology, 5th ed, p850).. Optic Atrophy 1 defined as following: Dominant Optic Atrophy 1 is a hereditary optic Neuropathy causing decreased visual acuity, color vision deficits, a centrocecal scotoma, and optic nerve pallor (Hum. Genet. 1998; 102: 79-86). Gene Mutation leading to this condition have been mapped to the OPA1 Genes at chromosome 3q28-q29. OPA1 codes for a dynamin-related GTPase that localizes to mitochondria.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA.. Abnormality of mitochondrial metabolism defined as following: A functional anomaly of mitochondria. [ORCID:0000-0001-5208-3432]. Paraparesis, Spastic defined as following: Mild or moderate loss of motor function accompanied by spasticity in the lower extremities. This condition is a manifestation of CENTRAL NERVOUS SYSTEM DISEASES that cause injury to the motor cortex or descending motor pathways.. Neuropathy defined as following: A disorder affecting the cranial nerves or the peripheral nervous system. It manifests with pain, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.. mutations defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA..", "label": "yes"} {"original_question": "A bite from the Lone Star Tick Amblyomma americanum, can cause the victim to become allergic to red meat, yes or no?", "id": "converted_2599", "sentence1": "A bite from the Lone Star Tick Amblyomma americanum, can cause the victim to become allergic to red meat, yes or no?", "sentence2": "A recent discovery of an IgE Immunoglobulin complex location, circulating specific to galactose-α-1,3-galactose, which is a Carbohydrates abundantly expressed on Cells and Body tissue of beef, pork allergenic extract allergenic extract, and lamb allergenic extract allergenic extract, adds one more tool to aid the clinician in making the appropriate diagnosis. A link has been discovered between the bite of the Lone Star Tick (Amblyomma americanum) and the development of sensitivity to galactose-α-1,3-galactose. , . Recently described conditions such as Southern tick-associated rash illness and anaphylaxis to red meat following tick bite injury have been attributed to the lone star tick., Recently described conditions such as Southern tick-associated rash illness and anaphylaxis to red meat following tick bite injury have been attributed to the lone star tick.[SEP]Relations: Bite Cells has relations: phenotype_phenotype with Poikilocytosis, phenotype_phenotype with Poikilocytosis, disease_phenotype_positive with hereditary stomatocytosis, disease_phenotype_positive with hereditary stomatocytosis. anaphylaxis has relations: disease_disease with hypersensitivity reaction disease, disease_disease with hypersensitivity reaction disease, contraindication with Brimonidine, contraindication with Brimonidine. injury has relations: contraindication with Amlodipine, contraindication with Amlodipine. Definitions: Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. Immunoglobulin complex location, circulating defined as following: An immunoglobulin complex that is secreted into extracellular space and found in mucosal areas or other Body tissue or circulating in the blood or lymph. In its canonical form, a circulating immunoglobulin complex is composed of two identical heavy chains and two identical light chains, held together by disulfide bonds. Some forms of are polymers of the basic structure and contain additional components such as J-chain and the secretory component. [GOC:add, ISBN:0781735149]. Carbohydrates defined as following: A class of organic compounds composed of carbon, hydrogen, and oxygen in a ratio of Cn(H2O)n. The largest class of organic compounds, including STARCH; GLYCOGEN; CELLULOSE; POLYSACCHARIDES; and simple MONOSACCHARIDES.. bite injury defined as following: A wound inflicted by the teeth or fangs of an individual or animal.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. anaphylaxis defined as following: An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.. allergic defined as following: Pertaining to, caused by, affected with or of the nature of allergy..", "label": "yes"} {"original_question": "Are there telemedicine applications for chronic pain management?", "id": "converted_573", "sentence1": "Are there telemedicine applications for Chronic pain management?", "sentence2": "An Integrated cognitive-behavioral and physical therapy group protocol has been developed and then implemented at remote sites using videoconferencing technology to provide pain management for veterans. , Tele-pain management: use of videoconferencing technology in the delivery of an Integrated cognitive-behavioral and physical therapy group intervention., It is feasible to provide treatment to women veterans living in rural areas by utilizing video-teleconferencing technology between larger VA medical centers and facilities at CBOCs in more rural settings, The results suggest that a smartphone-delivered intervention with diaries and personalized feedback can reduce catastrophizing and prevent increases in functional impairment and symptom levels in women with chronic widespread pain following inpatient rehabilitation., Of the studies available, there are very few randomized trials of telehealth pain care and only one general overview of e-health and Chronic pain, which dedicates just a few paragraphs to telehealth., therapy adaptation and the resultant specification for the SMART2 project-a technology-based self-management system for assisting long-term health conditions, including Chronic pain, Results showed the use of videoconferencing for this group of patients is useable and satisfactory for both patients and staff, that the patients save time and money, and that for a system where videoconferencing equipment is already in use, it is also cost effective. Staff were able to identify new patient problems. , This pilot study indicates that telemedicine follow-up consultations for Chronic pain patients are feasible and cost-saving. Patients and anesthesiologists were highly satisfied with telemedicine consultation.[SEP]Relations: Chronic pain has relations: phenotype_phenotype with Pain, phenotype_phenotype with Pain, disease_phenotype_positive with Machado-Joseph disease, disease_phenotype_positive with Machado-Joseph disease, disease_phenotype_positive with double uterus-hemivagina-renal agenesis, disease_phenotype_positive with double uterus-hemivagina-renal agenesis, disease_phenotype_positive with glycogen storage disease, disease_phenotype_positive with glycogen storage disease, disease_phenotype_positive with Sjogren syndrome, disease_phenotype_positive with Sjogren syndrome. Definitions: Integrated defined as following: Combining things, people, or ideas of different types in one effective unit, group, or system.. Chronic pain defined as following: Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain..", "label": "yes"} {"original_question": "Are thyroid hormone receptor alpha1 mutations implicated in thyroid hormone resistance syndrome?", "id": "converted_191", "sentence1": "Are thyroid hormone receptor alpha1 mutations implicated in thyroid hormone resistance syndrome?", "sentence2": "This study reports the consequences of levothyroxine treatment over a prolonged period of time in 2 of the first patients with a heterozygous Mutation Abnormality in TRα1., Here we show that the dysregulation of the pituitary-thyroid axis was worsened by the lack of Tricuspid Valve Insufficiency alpha1 in Tricuspid Valve Insufficiency betaPV CASP14 gene, and severe impairment of postnatal growth was manifested in Tricuspid Valve Insufficiency betaPV CASP14 gene deficient in Tricuspid Valve Insufficiency alpha1., Heterozygous 2- to 3-week- old CASP14 gene exhibit a severe retardation of post-natal development and growth, but only a minor reduction in serum thyroxine levels. , The data demonstrate a novel array of effects mediated by a dominant negative TRalpha1, and may provide important clues for identification of a potentially unrecognized human disorder and its treatment., No mutations in DNA- and hormone-binding-domains of TRbeta1 and TRalpha1 genes were found in proband, suggesting that the defect could be due to an unknown Mutation Abnormality in either the Tricuspid Valve Insufficiency gene or a post receptor abnormality, These results demonstrate that the lack of Tricuspid Valve Insufficiency alpha1 exacerbates the manifestation of RTH in Tricuspid Valve Insufficiency betaPV CASP14 gene. Therefore, Tricuspid Valve Insufficiency alpha1 could play a compensatory role in mediating the functions of T3 thoracic segmental innervation thoracic segmental innervation in heterozygous patients with RTH. [SEP]Relations: Levothyroxine has relations: contraindication with isolated congenital growth hormone deficiency, contraindication with isolated congenital growth hormone deficiency, contraindication with thyroid crisis (disease), contraindication with thyroid crisis (disease), contraindication with acquired pituitary hormone deficiency, contraindication with acquired pituitary hormone deficiency, contraindication with non-acquired pituitary hormone deficiency, contraindication with non-acquired pituitary hormone deficiency, contraindication with combined pituitary hormone deficiencies, genetic form, contraindication with combined pituitary hormone deficiencies, genetic form. Definitions: Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. levothyroxine defined as following: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.. Tricuspid Valve Insufficiency defined as following: Backflow of blood from the RIGHT VENTRICLE into the RIGHT ATRIUM due to imperfect closure of the TRICUSPID VALVE..", "label": "yes"} {"original_question": "Can AGY be used as antidiuretic replacement therapy?", "id": "converted_3810", "sentence1": "Can AGY be used as antidiuretic replacement therapy?", "sentence2": "AGY, a Novel Egg Yolk-Derived Anti-gliadin Antibody, Is Safe for Patients with Celiac Disease., Oral egg yolk Gliadin antibody (AGY) is a novel treatment to neutralize Gluten and may improve the efficacy of the GFD., To determine the safety, tolerability, and potential efficacy of AGY in patients with CD., Most patients had fewer celiac symptoms (especially Fatigue, Headache, and Abdominal Abdominal bloating), improved quality of life, lowered Antibodies, in vitro diagnostic, and lowered LMER when taking AGY compared to the run-in period., In our cohort, AGY was safe and potentially associated with improved CD-related outcome measures in patients on a GFD. [SEP]Relations: Headache has relations: drug_effect with Acyclovir, drug_effect with Acyclovir, drug_effect with Azithromycin, drug_effect with Azithromycin, drug_effect with Oxybutynin, drug_effect with Oxybutynin. Fatigue has relations: drug_effect with Acyclovir, drug_effect with Acyclovir, drug_effect with Oxybutynin, drug_effect with Oxybutynin. Definitions: Fatigue defined as following: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.. Abdominal bloating defined as following: Distention of the abdomen associated with a feeling of fullness.. Headache defined as following: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.. Gluten defined as following: Prolamins in the endosperm of SEEDS from the Triticeae tribe which includes species of WHEAT; BARLEY; and RYE.. Gliadin antibody defined as following: A radioallergosorbent immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the allergen Antibodies, in vitro diagnostic (Antibodies, in vitro diagnostic which cause an allergic reaction) specific for a given allergen. Measurement of specific allergen Antibodies, in vitro diagnostic may aid in the diagnosis of asthma, allergies, and other pulmonary disorders.. Celiac Disease defined as following: A malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION..", "label": "no"} {"original_question": "Is Lysine-specific demethylase 1 (LSD1) a critical regulator of hematopoiesis?", "id": "converted_820", "sentence1": "Is Lysine-specific demethylase 1 (KDM1A wt Allele) a critical regulator of hematopoiesis?", "sentence2": "Histone KDM1A gene (KDM1A wt Allele) protein is involved in SALL4 gene protein, human (SALL4 gene gene)-mediated transcriptional repression in Hematopoietic stem cells, shRNA-mediated knockdown of KDM1A wt Allele in hematopoietic precursor cells resulted in altered SALL4 gene gene downstream gene expression and increased cellular activity, our data revealed that Histone Demethylases KDM1A wt Allele may negatively regulate SALL4 gene gene-mediated transcription, and the dynamic regulation of SALL4 gene gene-associated epigenetic factors cooperatively modulates early hematopoietic precursor proliferation, Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation, KDM1A wt Allele represents a central regulator of hematopoietic stem and Stem cells, KDM1A wt Allele-kd led to an extensive expansion of granulomonocytic, Erythroid and Megakaryocytic progenitors, KDM1A wt Allele-kd was associated with the upregulation of key hematopoietic genes, our findings distinguish KDM1A wt Allele as a critical regulator of hematopoiesis, A short Gfi-1B isoform controls Erythroid differentiation by recruiting the KDM1A wt Allele-RCOR1 gene complex through the dimethylation of its SNAG domain, Dynamic interaction between TAL1 protein, human protein, human oncoprotein and KDM1A wt Allele regulates TAL1 protein, human protein, human function in hematopoiesis and leukemogenesis, Here, we reported that Cyclic AMP-Dependent Protein Kinases (PKA)-mediated phosphorylation regulates TAL1 protein, human protein, human interaction with the Lysine-Specific Demethylase 7A (KDM1A wt Allele) that removes methyl group from methylated Lys 4 on histone H3 tails. Phosphorylation of serine 172 in TAL1 protein, human protein, human specifically destabilizes the TAL1 protein, human protein, human-KDM1A wt Allele interaction leading to promoter H3K4 hypermethylation and activation of target genes that have been suppressed in normal and malignant hematopoiesis, KDM1A wt Allele-mediated epigenetic modification is required for TAL1 protein, human protein, human function and hematopoiesis, we show that TAL1 protein, human protein, human is associated with Histone Demethylases complexes containing KDM1A gene (KDM1A wt Allele), RE1 silencing transcription factor corepressor (RCOR1 gene), Histone Deacetylase (HDAC1 gene gene), and histone deacetylase 2 in Acute Erythroblastic Leukemia and T cell leukemia cells, we demonstrate that the TAL1 protein, human protein, human-associated KDM1A wt Allele, HDAC1 gene gene, and their enzymatic activities are coordinately down-regulated during the early phases of Erythroid differentiation, TAL1 protein, human protein, human recruits KDM1A wt Allele to the silenced p4.2 promoter in undifferentiated, but not in differentiated, Mus Acute Erythroblastic Leukemia (MELORHEOSTOSIS, ISOLATED) cells, the dynamic regulation of TAL1 protein, human protein, human-associated KDM1A wt Allele/HDAC1 gene gene complex may determine the onset of Erythroid differentiation programs, Epigenetic regulation of hematopoietic differentiation by GFI1 wt Allele and Gfi-1b is mediated by the chemical cofactor RCOR1 gene and KDM1A wt Allele, Inhibition of RCOR1 gene and KDM1A wt Allele perturbs differentiation of Erythroid, Megakaryocytic, and granulocyte as well as primary Erythroid progenitors, we show that chromatin regulatory proteins RCOR1 gene and KDM1A wt Allele mediate transcriptional repression by Gfi proteins. Lineage-restricted deployment of these chemical cofactor through interaction with Gfi proteins controls hematopoietic differentiation, Taken together, our findings distinguish KDM1A wt Allele as a critical regulator of hematopoiesis and point to severe, but reversible, side effects of a KDM1A wt Allele-targeted therapy., KDM1A wt Allele-mediated epigenetic modification is required for TAL1 protein, human protein, human function and hematopoiesis., Dynamic interaction between TAL1 protein, human protein, human oncoprotein and KDM1A wt Allele regulates TAL1 protein, human protein, human function in hematopoiesis and leukemogenesis., Phosphorylation of serine 172 in TAL1 protein, human protein, human specifically destabilizes the TAL1 protein, human protein, human-KDM1A wt Allele interaction leading to promoter H3K4 hypermethylation and activation of target genes that have been suppressed in normal and malignant hematopoiesis., Histone KDM1A gene (KDM1A wt Allele) protein is involved in SALL4 gene protein, human (SALL4 gene gene)-mediated transcriptional repression in Hematopoietic stem cells., Taken together, our findings distinguish KDM1A wt Allele as a critical regulator of hematopoiesis and point to severe, but reversible, side effects of a KDM1A wt Allele-targeted therapy.[SEP]Relations: melorheostosis has relations: disease_phenotype_positive with Skeletal dysplasia, disease_phenotype_positive with Skeletal dysplasia, disease_phenotype_positive with Lymphedema, disease_phenotype_positive with Lymphedema, disease_protein with LEMD3, disease_protein with LEMD3. HDMs demethylate histones has relations: pathway_protein with KDM1A, pathway_protein with KDM1A. site-specific DNA-methyltransferase (adenine-specific) activity has relations: molfunc_protein with N6AMT1, molfunc_protein with N6AMT1. Definitions: Histone Demethylases defined as following: Enzymes that catalyse the removal of methyl groups from LYSINE or ARGININE residues found on HISTONES. Many histone demethylases generally function through an oxidoreductive mechanism.. KDM1A gene defined as following: This gene is involved in the regulation of both transcription and histone methylation.. HDAC1 gene defined as following: This gene plays a role in chromatin remodeling and the repression of gene expression.. granulocyte defined as following: Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS.. Histone KDM1A gene defined as following: Lysine-specific Histone Demethylases 1A (852 aa, ~93 kDa) is encoded by the human KDM1A gene. This protein is involved in both histone demethylation and transcriptional regulation.. SALL4 gene defined as following: This gene plays a role in both transcriptional regulation and stem cell maintenance.. Erythroid defined as following: 1) Reddish in color. 2) relating to erythrocytes or their precursors.. Acute Erythroblastic Leukemia defined as following: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.. Hematopoietic stem cells defined as following: Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood.. Histone Deacetylase defined as following: Deacetylases that remove N-acetyl groups from amino side chains of the amino acids of HISTONES. The enzyme family can be divided into at least three structurally-defined subclasses. Class I and class II deacetylases utilize a zinc-dependent mechanism. The sirtuin histone deacetylases belong to class III and are NAD-dependent enzymes.. Cyclic AMP-Dependent Protein Kinases defined as following: A group of enzymes that are dependent on CYCLIC AMP and catalyze the phosphorylation of SERINE or THREONINE residues on proteins. Included under this category are two cyclic-AMP-dependent protein kinase subtypes, each of which is defined by its subunit composition.. chemical cofactor defined as following: Something that must join with another to produce a given result.. SALL4 protein, human defined as following: SALL4 protein, human (1053 aa, ~112 kDa) is encoded by the human SALL4 gene gene. This protein plays a role in self-renewal and maintenance of both embryonic and Hematopoietic stem cells.. Mus defined as following: Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae.. Stem cells defined as following: Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide Stem cells that can differentiate into specialized cells.. KDM1A wt Allele defined as following: Human KDM1A wild-type allele is located in the vicinity of 1p36.12 and is approximately 64 kb in length. This allele, which encodes lysine-specific Histone Demethylases 1A protein, plays a role in the modulation both of histone methylation and transcription.. Lysine-Specific Demethylase 7A defined as following: Lysine-specific demethylase 7A (941 aa, ~107 kDa) is encoded by the human KDM7A gene. This protein is involved in histone demethylation and brain development.. TAL1 protein, human defined as following: T-cell acute lymphocytic leukemia protein 1 (331 aa, ~34 kDa) is encoded by the human TAL1 protein, human gene. This protein plays a role in transcriptional regulation and hematopoiesis.. GFI1 wt Allele defined as following: Human GFI1 wild-type allele is located in the vicinity of 1p22.1 and is approximately 14 kb in length. This allele, which encodes zinc finger protein GFI1 wt Allele, plays a role in transcriptional repression during multilineage blood cell development. Mutation of the gene is associated with autosomal recessive severe congenital neutropenia 2 (SCN2) and adult nonimmune chronic idiopathic neutropenia.. Lysine-specific demethylase 1 defined as following: This gene is involved in the regulation of both transcription and histone methylation..", "label": "yes"} {"original_question": "Is Calcium homeostasis important in cardiac physiology and pathophysiology?", "id": "converted_540", "sentence1": "Is Calcium homeostasis important in Cardiac - anatomy qualifier physiology and pathophysiology?", "sentence2": "Maintenance of Cells CALCIUM SUPPLEMENTS homeostasis is critical to regulating mitochondrial ATP production and Cardiac - anatomy qualifier contraction. , the Ca(2+) signal regulates the most important activities of the \"U\" lymphocyte, from the expression of Genes, to Chest>Heart and muscle contraction and other motility processes, to diverse metabolic pathways involved in the generation of \"U\" lymphocyte fuels, Pharmacologic modification of Cells CALCIUM SUPPLEMENTS handling recently moved into focus as an alternative for prevention and treatment of Ventricular tachyarrhythmia, diabetic rats displayed abnormal Cardiac - anatomy qualifier structure and systolic and diastolic dysfunction, and spermine (CASR gene agonist) could prevent or slow its progression. These results indicate that the CASR gene expression of Myocardium is reduced in the progress of 3',5'-dichloromethotrexate, and its potential mechanism is related to the impaired intracellular CALCIUM SUPPLEMENTS homeostasis., CALCIUM SUPPLEMENTS-sensing receptor (CASR gene), Na(+)/Ca(2+) exchanger (TLX2 gene) plays important roles in Cardiac - anatomy qualifier electrical activity and CALCIUM SUPPLEMENTS homeostasis., TLX2 gene current (I(TLX2 gene)) shows Transmural gradient across left ventricle in many species. Previous studies demonstrated that TLX2 gene expression was increased and Transmural gradient of I(TLX2 gene) was disrupted in failing Chest>Heart, CALCIUM SUPPLEMENTS homeostasis, the key process underlying excitation-contraction coupling, The results indicate the CALCIUM SUPPLEMENTS handling properties of hiPSC-derived Myocytes, Cardiac are relatively immature to Human Embryonic Stem Cells counterparts, Our understanding of the Molecular processes which regulate Cardiac - anatomy qualifier function has grown immeasurably in recent years. Even with the advent of β-blockers, angiotensin inhibitors and CALCIUM SUPPLEMENTS modulating agents, Congestive Chest>Heart failure (Hydrops Fetalis) still remains a seriously debilitating and life-threatening condition. Here, we review the Molecular changes which occur in the Chest>Heart in response to increased load and the pathways which control Cardiac - anatomy qualifier hypertrophy, CALCIUM SUPPLEMENTS homeostasis, and immune activation during Hydrops Fetalis., Calcium-sensing receptors (CaSRs) are G-protein coupled receptors which maintain systemic CALCIUM SUPPLEMENTS homeostasis and participate in hormone secretion, activation of ion channels, \"U\" lymphocyte apoptosis, proliferation, and differentiation., CaSRs are associated with I/R injury and apoptosis in neonatal Rattus norvegicus ventricular Myocytes, Cardiac via suppressing BCL2 gene and promoting caspase-3 expression., Important insights into the Molecular basis of Hypertrophic obstructive cardiomyopathy and related diseases have been gained by studying families with inherited Cardiac - anatomy qualifier hypertrophy. Integrated clinical and genetic investigations have demonstrated that different genetic defects can give rise to the common phenotype of Cardiac - anatomy qualifier hypertrophy. Diverse pathways have been identified, implicating perturbations in force generation, force transmission, intracellular CALCIUM SUPPLEMENTS homeostasis, myocardial energetics, and Cardiac - anatomy qualifier metabolism in causing Disease, HCLS1-Associated Protein X-1, Human as a regulator of contractility and CALCIUM SUPPLEMENTS cycling in the Chest>Heart. HCLS1-Associated Protein X-1, Human overexpression reduced sarcoplasmic reticulum Ca-ATPase (Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase 2) pump activity in isolated Myocytes, Cardiac and in vivo, leading to depressed Muscle Cells CALCIUM SUPPLEMENTS kinetics and mechanics., Thus, HCLS1-Associated Protein X-1, Human represents a regulatory mechanism in Cardiac - anatomy qualifier CALCIUM SUPPLEMENTS cycling and its responses to sympathetic stimulation, implicating its importance in CALCIUM SUPPLEMENTS homeostasis and \"U\" lymphocyte survival., CALCIUM SUPPLEMENTS ion are the most ubiquitous and versatile signaling molecules in Eukaryotic Cells. Calcium homeostasis and signaling systems are crucial for both the normal growth of the budding yeast Saccharomyces cerevisiae and the intricate working of the Mammals Chest>Heart., this knowledge can be used to help treat relevant human diseases such as pathological Cardiac - anatomy qualifier hypertrophy and Congestive Chest>Heart failure, With aging, the Chest>Heart develops Muscle Cells hypertrophy associated with impaired relaxation indices. To define the Cells basis of this adaptation, we examined the physiological changes that arise in CALCIUM SUPPLEMENTS handling in the aging Chest>Heart and contrasted the adaptations that occur following the imposition of a stimulus that alters CALCIUM SUPPLEMENTS homeostasis in a young and an old Chest>Heart, alterations in the CALCIUM SUPPLEMENTS-handling machinery of the Cardiocyte - general anatomical term differ in the context of age and as such may predispose the older Chest>Heart to the development of a Hypertrophic disorder of skin, unspecified phenotype., The Cardiac - anatomy qualifier sodium-CALCIUM SUPPLEMENTS exchanger (SLC8A1 wt Allele) is a key sarcolemmal protein for the maintenance of CALCIUM SUPPLEMENTS homeostasis in the Chest>Heart. , Thus exchanger overexpression in CASP14 gene leads to abnormal CALCIUM SUPPLEMENTS handling and a decompensatory transition to Congestive Chest>Heart failure with stress, Central to controlling intracellular CALCIUM SUPPLEMENTS concentration ([Ca(2+)](i)) are a number of Ca(2+) transporters and channels with the L-type Ca(2+) channel, Na(+)-Ca(2+) exchanger and Sarcoplasmic Reticulum Calcium-Transporting ATPases (SERCA) being of particular note in the Chest>Heart. This review concentrates on the regulation of [Ca(2+)](i) in Cardiac - anatomy qualifier muscle and the homeostatic mechanisms employed to ensure that the Chest>Heart can operate under steady-state conditions on a beat by beat basis., the tight regulation of SNCG wt Allele Ca(2+) content is also required to prevent the abnormal, spontaneous or diastolic release of Ca(2+) from the SNCG wt Allele. Such diastolic events are a major factor contributing to the genesis of Cardiac Arrhythmia in Disease situations and in recently identified familial mutations in the SNCG wt Allele Ca(2+) release channel (Ryanodine Receptor Calcium Release Channel, Ryanodine Receptor Calcium Release Channel complex location)., Calcium channels have a unique functional role, because not only do they participate in this activity, they form the means by which electrical signals are converted to responses within the \"U\" lymphocyte. Calcium channels play an integral role in excitation in the Chest>Heart and shaping the Cardiac - anatomy qualifier action potential. In addition, CALCIUM SUPPLEMENTS influx through CALCIUM SUPPLEMENTS channels is responsible for initiating contraction. Abnormalities in CALCIUM SUPPLEMENTS homeostasis underlie Cardiac - anatomy qualifier arrhythmia, contractile dysfunction and Cardiac - anatomy qualifier remodelling. , Cardiac CALCIUM SUPPLEMENTS (Ca(2+)) handling subsumes the mechanisms maintaining the myocardial Ca(2+) homeostasis that contribute essentially to Cardiac - anatomy qualifier performance., Calcium is an important mediator in Cardiac - anatomy qualifier excitation and disorders in Cardiac - anatomy qualifier Ca(2+) homeostasis have great influence on the Cardiac - anatomy qualifier action potential., We review the physiology of the Cardiac - anatomy qualifier CALCIUM SUPPLEMENTS homeostasis, including the Cardiac - anatomy qualifier excitation contraction coupling and Muscle Cells CALCIUM SUPPLEMENTS cycling., We review the physiology of the Cardiac - anatomy qualifier CALCIUM SUPPLEMENTS homeostasis, including the Cardiac - anatomy qualifier excitation contraction coupling and Muscle Cells CALCIUM SUPPLEMENTS cycling, Calcium is an important mediator in Cardiac - anatomy qualifier excitation and disorders in Cardiac - anatomy qualifier Ca(2+) homeostasis have great influence on the Cardiac - anatomy qualifier action potential, The role of CALCIUM SUPPLEMENTS in Cardiac - anatomy qualifier and Muscle, Smooth, Vascular physiology was reviewed, highlighting the major mechanisms responsible for maintaining CALCIUM SUPPLEMENTS homeostasis in these cells, Energy metabolism and Ca(2+) handling serve critical roles in Cardiac - anatomy qualifier physiology and pathophysiology[SEP]Relations: muscle \"U\" lymphocyte Cells homeostasis has relations: bioprocess_protein with CAV3, bioprocess_protein with CAV3, bioprocess_protein with GAA, bioprocess_protein with GAA, bioprocess_protein with ALDOA, bioprocess_protein with ALDOA, bioprocess_protein with CFL2, bioprocess_protein with CFL2, bioprocess_protein with SRF, bioprocess_protein with SRF. Definitions: Muscle, Smooth, Vascular defined as following: The nonstriated involuntary muscle tissue of blood vessels.. CALCIUM SUPPLEMENTS defined as following: A dietary supplement containing the mineral CALCIUM SUPPLEMENTS.. caspase-3 defined as following: A short pro-domain caspase that plays an effector role in APOPTOSIS. It is activated by INITIATOR CASPASES such as CASPASE 9. Isoforms of this protein exist due to multiple alternative splicing of its MESSENGER RNA.. BCL2 gene defined as following: The B-\"U\" lymphocyte leukemia/lymphoma-2 Genes, responsible for blocking apoptosis in normal cells, and associated with follicular lymphoma when overexpressed. Overexpression results from the t(14;18) translocation. The human c-bcl-2 gene is located at 18q24 on the long arm of chromosome 18.. HCLS1-Associated Protein X-1, Human defined as following: HCLS1-associated protein X-1 (279 aa, ~32 kDa) is encoded by the human HAX1 gene. This protein plays a role in clathrin-mediated endocytosis, cytoskeletal remodeling and cytokine signaling.. Ryanodine Receptor Calcium Release Channel complex location defined as following: A voltage-gated CALCIUM SUPPLEMENTS-release channel complex of the sarcoplasmic or endoplasmic reticulum. It plays an important role in the excitation-contraction (E-C) coupling of muscle cells. Ryanodine Receptor Calcium Release Channel complex location comprises a family of ryanodine receptors, widely expressed throughout the animal kingdom. [GOC:ame, PMID:22822064]. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. CALCIUM SUPPLEMENTS-sensing receptor defined as following: A class of G-protein-coupled receptors that react to varying extracellular CALCIUM levels. Calcium-sensing receptors in the PARATHYROID GLANDS play an important role in the maintenance of CALCIUM SUPPLEMENTS HOMEOSTASIS by regulating the release of PARATHYROID HORMONE. They differ from INTRACELLULAR CALCIUM-SENSING PROTEINS which sense intracellular CALCIUM SUPPLEMENTS levels.. Congestive Chest>Heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Cardiac Arrhythmia defined as following: Any disturbances of the normal rhythmic beating of the Chest>Heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.. SLC8A1 wt Allele defined as following: Human SLC8A1 wild-type allele is located in the vicinity of 2p22.1 and is approximately 514 kb in length. This allele, which encodes sodium/CALCIUM SUPPLEMENTS exchanger 1 protein, plays a role in CALCIUM SUPPLEMENTS ion transport.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.. spermine defined as following: A biogenic polyamine formed from spermidine. It is found in a wide variety of organisms and tissues and is an essential growth factor in some bacteria. It is found as a polycation at all pH values. Spermine is associated with nucleic acids, particularly in viruses, and is thought to stabilize the helical structure.. Myocytes, Cardiac defined as following: Striated muscle cells found in the Chest>Heart. They are derived from Cardiac - anatomy qualifier myoblasts (MYOBLASTS, CARDIAC).. Hydrops Fetalis defined as following: Abnormal accumulation of serous fluid in two or more fetal compartments, such as SKIN; PLEURA; PERICARDIUM; PLACENTA; PERITONEUM; AMNIOTIC FLUID. General fetal EDEMA may be of non-immunologic origin, or of immunologic origin as in the case of ERYTHROBLASTOSIS FETALIS.. Eukaryotic Cells defined as following: Cells of the higher organisms, containing a true nucleus bounded by a nuclear membrane.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. calcium ion defined as following: The metabolically-active portion of CALCIUM SUPPLEMENTS, not bound to proteins, circulating in the blood.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. SNCG wt Allele defined as following: Human SNCG wild-type allele is located within10q23.2-q23.3 and is approximately 13 kb in length. This allele, which encodes gamma-synuclein protein, plays a role in the modulation of axonal architecture and neurofilament integrity. This gene is highly expessed in advanced breast carcinomas, suggesting a correlation between SNCG overexpression and breast tumor development.. Sarcoplasmic Reticulum Calcium-Transporting ATPases defined as following: Calcium-transporting ATPases that catalyze the active transport of CALCIUM into the SARCOPLASMIC RETICULUM vesicles from the CYTOPLASM. They are primarily found in MUSCLE CELLS and play a role in the relaxation of MUSCLES.. Cardiac - anatomy qualifier hypertrophy defined as following: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in Muscle Cells size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.. Transmural defined as following: Passing through the wall of an organ or other bodily structure.. 3',5'-dichloromethotrexate defined as following: A chlorinated methotrexate derivative. Dichloromethotrexate inhibits the enzyme dihydrofolate reductase, thereby preventing the synthesis of purine nucleotides and thymidylates and inhibiting DNA and RNA synthesis. This agent is metabolized and excreted by the liver. (NCI04). Muscle Cells defined as following: Mature contractile cells, commonly known as myocytes, that form one of three kinds of muscle. The three types of muscle cells are skeletal (MUSCLE FIBERS, SKELETAL), Cardiac - anatomy qualifier (MYOCYTES, CARDIAC), and smooth (MYOCYTES, SMOOTH MUSCLE). They are derived from embryonic (precursor) muscle cells called MYOBLASTS.. Molecular defined as following: Relating to or produced by or consisting of molecules.. Human Embryonic Stem Cells defined as following: A type of PLURIPOTENT STEM CELLS derived from early stage human embryos, up to and including the BLASTOCYST stage.. Ryanodine Receptor Calcium Release Channel defined as following: A tetrameric CALCIUM SUPPLEMENTS release channel in the SARCOPLASMIC RETICULUM membrane of SMOOTH MUSCLE CELLS, acting oppositely to SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES. It is important in skeletal and Cardiac - anatomy qualifier excitation-contraction coupling and studied by using RYANODINE. Abnormalities are implicated in CARDIAC ARRHYTHMIAS and MUSCULAR DISEASES.. Myocardium defined as following: The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow..", "label": "yes"} {"original_question": "Is SLIC-CAGE used for quantification of translation?", "id": "converted_4052", "sentence1": "Is SLIC-CAP Analysis of Gene Expression used for quantification of translation?", "sentence2": "Transcription Initiation Site Mapping Using Super-low Input Carrier-CAP Analysis of Gene Expression., SLIC-CAP Analysis of Gene Expression: high-resolution transcription start site mapping using nanogram-levels of total RNA., Cap analysis of gene expression (CAP Analysis of Gene Expression) is a methodology for genome-wide quantitative mapping of mRNA 5' ends to precisely capture transcription start sites at a single nucleotide resolution. In combination with high-throughput sequencing, CAP Analysis of Gene Expression has revolutionized our understanding of the rules of transcription initiation, led to discovery of new core Promoter sequence features, and discovered transcription initiation at enhancers genome-wide. The biggest limitation of CAP Analysis of Gene Expression is that even the most recently improved version (nAnT-iCAGE) still requires large amounts of total cellular RNA (5 µg), preventing its application to scarce biological samples such as those from early embryonic development or rare cell types. Here, we present SLIC-CAP Analysis of Gene Expression, a Super-Low Input Carrier-CAP Analysis of Gene Expression approach to capture 5' ends of RNA Polymerase II transcripts from as little as 5-10 ng of total RNA. This dramatic increase in sensitivity is achieved by specially designed, selectively degradable carrier RNA. We demonstrate the ability of SLIC-CAP Analysis of Gene Expression to generate data for genome-wide promoterome with 1000-fold less material than required by existing CAP Analysis of Gene Expression methods, by generating a complex, high-quality library from mouse embryonic day 11.5 primordial germ Cells., Cap analysis of gene expression (CAP Analysis of Gene Expression) is a method used for single-nucleotide resolution detection of RNA Polymerase II transcription start sites (TSSs). Accurate detection of TSSs enhances identification and discovery of core promoters. In addition, active enhancers can be detected through signatures of bidirectional transcription initiation. Described here is a protocol for performing super-low input carrier-CAP Analysis of Gene Expression (SLIC-CAP Analysis of Gene Expression). This SLIC adaptation of the CAP Analysis of Gene Expression protocol minimizes RNA losses by artificially increasing the RNA amount through use of an in vitro transcribed RNA carrier mix that is added to the sample of interest, thus enabling library preparation from nanogram-amounts of total RNA (i.e., thousands of Cells). The carrier mimics the expected DNA library fragment length distribution, thereby eliminating biases that could be caused by the abundance of a homogenous carrier. In the last stages of the protocol, the carrier is removed through degradation with homing endonucleases and the target library is amplified. The target sample library is protected from degradation, as the homing endonuclease recognition sites are long (between 18 and 27 bp), making the probability of their existence in the eukaryotic genomes very low. The end result is a DNA library ready for next-generation sequencing. All steps in the protocol, up to sequencing, can be completed within 6 days. The carrier preparation requires a full working day; however, it can be prepared in large quantities and kept frozen at -80 °C. Once sequenced, the reads can be processed to obtain genome-wide single-nucleotide resolution TSSs. TSSs can be used for core Promoter or enhancer discovery, providing insight into gene regulation. Once aggregated to promoters, the data can also be used for 5'-centric expression profiling.[SEP]Relations: HIV Transcription Initiation has relations: pathway_protein with TAF4, pathway_protein with TAF4, pathway_protein with TAF2, pathway_protein with TAF2, pathway_protein with TAF6, pathway_protein with TAF6, pathway_protein with TAF3, pathway_protein with TAF3, pathway_protein with TAF5, pathway_protein with TAF5. Definitions: RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of Cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Transcription Initiation Site defined as following: The first nucleotide of a transcribed DNA sequence where RNA polymerase (DNA-DIRECTED RNA POLYMERASE) begins synthesizing the RNA transcript.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. CAP Analysis of Gene Expression defined as following: A method for high-throughout gene expression analysis and the profiling of transcriptional start points (TSP), including Promoter usage analysis. It uses cap-selected full length cDNAs with linkers attached to their 5' ends which are then cleaved to about 20 base pairs, amplified by PCR, contatamerized, and cloned.. RNA Polymerase II defined as following: A DNA-dependent RNA polymerase present in bacterial, plant, and animal Cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6.. germ Cells defined as following: The reproductive Cells in multicellular organisms at various stages during GAMETOGENESIS..", "label": "no"} {"original_question": "Is Enlimomab effective for stroke treatment?", "id": "converted_2656", "sentence1": "Is Enlimomab effective for Cerebrovascular accident treatment?", "sentence2": "However, this treatment failed to show benefit in the Enlimomab Acute Stroke Trial., There was no increase in the frequency of adverse events with increasing doses of enlimomab.CONCLUSIONS: Dosage of enlimomab between 140 and 480 mg administered over 5 days did not increase the risk of adverse events in patients with ischaemic or haemorrhagic Cerebrovascular accident during an observation period of 30 +/- 10 days., Examination of several potential mechanisms for the negative outcome in a clinical Cerebrovascular accident trial of enlimomab, a Mus anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study., BACKGROUND AND PURPOSE: Enlimomab, a Mus monoclonal anti-human intercellular adhesion molecule (ICAM)-1 antibody, had a negative outcome in a multicenter acute-Cerebrovascular accident trial. , These observations provide several possible mechanisms for central nervous system-related clinical deterioration that occurred when Enlimomab was given in acute Ischemic Cerebrovascular accident., Fewer patients had symptom-free recovery on enlimomab than placebo (p = 0.004), and more died (22.2 versus 16.2%). The negative effect of enlimomab was apparent on days 5, 30, and 90 of treatment (p = 0.005). There were significantly more adverse events with enlimomab treatment than placebo, primarily Infections of musculoskeletal system and Fever symptoms (finding). , CONCLUSIONS: The authors conclude that anti-ICAM therapy with enlimomab is not an effective treatment for Ischemic Cerebrovascular accident in the model studied and, indeed, may significantly worsen Cerebrovascular accident outcome., Patients experiencing Fever symptoms (finding) were more likely to have a poor outcome or die.The authors conclude that anti-ICAM therapy with enlimomab is not an effective treatment for Ischemic Cerebrovascular accident in the model studied and, indeed, may significantly worsen Cerebrovascular accident outcome., The negative effect of enlimomab was apparent on days 5, 30, and 90 of treatment (p = 0.005)., Patients experiencing Fever symptoms (finding) were more likely to have a poor outcome or die.
CONCLUSIONS: The authors conclude that anti-ICAM therapy with enlimomab is not an effective treatment for Ischemic Cerebrovascular accident in the model studied and, indeed, may significantly worsen Cerebrovascular accident outcome.
, Unfortunately, the case fatality rate in this trial was significantly higher in the enlimomab patient group than in the placebo group., CONCLUSIONS The authors conclude that anti-ICAM therapy with enlimomab is not an effective treatment for Ischemic Cerebrovascular accident in the model studied and, indeed, may significantly worsen Cerebrovascular accident outcome., BACKGROUND AND PURPOSE Enlimomab, a Mus monoclonal anti-human intercellular adhesion molecule (ICAM)-1 antibody, had a negative outcome in a multicenter acute-Cerebrovascular accident trial., The authors conclude that anti-ICAM therapy with enlimomab is not an effective treatment for Ischemic Cerebrovascular accident in the model studied and, indeed, may significantly worsen Cerebrovascular accident outcome..[SEP]Relations: Ischemic Cerebrovascular accident has relations: drug_effect with Celecoxib, drug_effect with Celecoxib, drug_effect with Celecoxib, drug_effect with Celecoxib, drug_effect with Ramipril, drug_effect with Ramipril, drug_effect with Ramipril, drug_effect with Ramipril, drug_effect with Pazopanib, drug_effect with Pazopanib. Definitions: Dosage defined as following: A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.. Ischemic Cerebrovascular accident defined as following: An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue.. Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810). Mus defined as following: Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae..", "label": "no"} {"original_question": "Do U6-associated proteins Lsm4 and Lsm6 interact with SMN?", "id": "converted_1432", "sentence1": "Do U6-associated Proteins LSM4 gene and LSM6 gene interact with STMN1 wt Allele?", "sentence2": "STMN1 wt Allele also interacts with at least two of the U6-associated Nucleotide Sequence Sample Name-like (Lsm) Proteins, LSM4 gene and LSM6 gene. , Interestingly, STMN1 wt Allele also interacts with at least two of the U6-associated Nucleotide Sequence Sample Name-like (Lsm) Proteins, LSM4 gene and LSM6 gene, Furthermore, we present evidence for two separate Binding Sites in STMN1 wt Allele for Nucleotide Sequence Sample Name/Lsm Proteins., Interestingly, STMN1 wt Allele also interacts with at least two of the U6-associated Nucleotide Sequence Sample Name-like (Lsm) Proteins, LSM4 gene and LSM6 gene. , Symmetrical dimethylation of arginine residues in spliceosomal Nucleotide Sequence Sample Name protein B/B' and the Nucleotide Sequence Sample Name-like protein LSm4, and their interaction with the STMN1 wt Allele protein., Interestingly, STMN1 wt Allele also interacts with at least two of the U6-associated Nucleotide Sequence Sample Name-like (Lsm) Proteins, LSM4 gene and LSM6 gene. Furthermore, the carboxyl-terminal arginine- and glycine-rich domain of LSM4 gene directly interacts with STMN1 wt Allele., This entity promotes the binding of a set of factors, termed LSm/Nucleotide Sequence Sample Name Proteins, onto Small Nuclear RNA to form the core structure of these particles. , Toward an assembly line for U7 Small Nuclear Ribonucleoproteins: interactions of U7-specific Lsm Proteins with PRMT5 gene gene and STMN1 wt Allele complex (molecular entity)., In this report, we demonstrate that the COIL gene C-terminal domain binds directly to various Nucleotide Sequence Sample Name and Lsm Proteins via their Nucleotide Sequence Sample Name motifs. We show that the region of COIL gene responsible for this binding activity is separable from that which binds to STMN1 wt Allele., Thus, the ability to interact with free Nucleotide Sequence Sample Name (and Lsm) Proteins as well as with intact Small Nuclear Ribonucleoproteins, indicates that COIL gene and CBS gene may facilitate the ResponseLevel - ResponseLevel - modification of newly formed Small Nuclear Ribonucleoproteins, the regeneration of 'mature' Small Nuclear Ribonucleoproteins, or the reclamation of unassembled small nuclear ribonucleoprotein complex location components., Moreover this structure has important consequences for small nuclear ribonucleoprotein complex location assembly that is mediated by two complex (molecular entity) containing the PRMT5 gene gene methyltransferase and the STMN1 wt Allele (survival of Neurons, Efferent) protein, respectively., Arginine/glycine (RG)-rich domains in components of the STMN1 wt Allele complex interact with Nucleotide Sequence Sample Name, like-Nucleotide Sequence Sample Name (LSm), fibrillarin, RNA Helicase (Gu), and COIL gene Proteins, all of which are antigen targets in a variety of diseases. [SEP]Relations: STMN1 wt Allele complex has relations: cellcomp_protein with GEMIN6, cellcomp_protein with GEMIN6, cellcomp_protein with SMN2, cellcomp_protein with SMN2, cellcomp_protein with SMN1, cellcomp_protein with SMN1. small nuclear ribonucleoprotein complex has relations: cellcomp_protein with LSM6, cellcomp_protein with LSM6, cellcomp_protein with LSM6, cellcomp_protein with LSM6. Definitions: small nuclear ribonucleoprotein complex location defined as following: A ribonucleoprotein complex that contains at least one RNA of the small nuclear RNA (Small Nuclear RNA) class and as well as its associated Proteins. These are typically named after the Small Nuclear RNA(s) they contain, e.g. U1 small nuclear ribonucleoprotein complex location, U4/U6 small nuclear ribonucleoprotein complex location, or 7SK small nuclear ribonucleoprotein complex location. Many, of these complex (molecular entity) become part of the spliceosome involved in splicing of nuclear mRNAs. Others are involved in regulation of transcription elongation or 3'-end processing of replication-dependent histone pre-mRNAs. [GOC:krc, GOC:mah, ISBN:0879695897]. STMN1 wt Allele defined as following: Human STMN1 wild-type allele is located in the vicinity of 1p36.11 and is approximately 23 kb in length. This allele, which encodes stathmin protein, is involved in the disassembly of microtubules.. Small Nuclear Ribonucleoproteins defined as following: Highly conserved nuclear RNA-protein complex (molecular entity) that function in RNA processing in the nucleus, including pre-mRNA splicing and pre-mRNA 3'-end processing in the nucleoplasm, and pre-rRNA processing in the nucleolus (see RIBONUCLEOPROTEINS, SMALL NUCLEOLAR).. Binding Sites defined as following: The parts of a macromolecule that directly participate in its specific combination with another molecule.. RNA Helicase defined as following: A family of Proteins that promote unwinding of RNA during splicing and translation.. complex (molecular entity) defined as following: A molecular entity formed by loose association involving two or more component molecular entities. The bonding between the components is normally weaker than in a covalent bond.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Nucleotide Sequence Sample Name defined as following: The name of a sample sequenced in a read group.. Small Nuclear RNA defined as following: Short chains of RNA (100-300 nucleotides long) that are abundant in the nucleus and usually complexed with Proteins in Small Nuclear Ribonucleoproteins (RIBONUCLEOPROTEINS, SMALL NUCLEAR). Many function in the processing of messenger RNA precursors. Others, the snoRNAs (RNA, SMALL NUCLEOLAR), are involved with the processing of ribosomal RNA precursors.. arginine defined as following: An essential amino acid that is physiologically active in the L-form.. CBS gene defined as following: This gene plays a role in transsulfuration.. STMN1 wt Allele complex defined as following: A protein complex that contains the survival motor neuron (STMN1 wt Allele) protein and at least eight additional integral components, including the Gemin2-8 and Unrip Proteins; the complex is found in the cytoplasm and in nuclear Gems, and is involved in spliceosomal small nuclear ribonucleoprotein complex location assembly in the cytoplasm and in pre-mRNA splicing in the nucleus. [PMID:16434402, PMID:17023415]. PRMT5 gene defined as following: This gene is involved in both histone methylation and the formation of omega-N monomethylarginine (MMA) and symmetrical dimethylarginine (sDMA).. ResponseLevel - modification defined as following:

Respond with exceptions, completions and modifications or revisions done before completion

. Neurons, Efferent defined as following: Neurons which send impulses peripherally to activate muscles or secretory cells..", "label": "yes"} {"original_question": "Are sleep apnea and snoring associated with cardiac arrhythmias?", "id": "converted_2587", "sentence1": "Are Sleep Apnea Syndromes and snoring associated with Cardiac - anatomy qualifier arrhythmias?", "sentence2": "Ever told you have or had atrial fibrillation:Finding:Point in time:^Patient:Ordinal (Atrial Fibrillation) is the commonest arrhythmia in clinical practice and is associated with increased Cardiovascular system morbidity and mortality. Obstructive Sleep Apnea Syndromes (Sleep Apnea, Obstructive), a common Abnormal breathing, is an independent risk factor for Atrial Fibrillation., There is a growing Consensus in the scientific community that suggests a strong association between obstructive Sleep Apnea Syndromes (Sleep Apnea, Obstructive) and Cardiovascular system (CVD) conditions and events, including coronary artery disease, Hypertensive disease, arrhythmia, heart failure, and Sudden Cardiac Death. , part from well-established risk factors that increase the odds for the development of Atrial Fibrillation, e.g. age or arterial Hypertensive disease, recent analyses indicate that obstructive sleep apnoea (Sleep Apnea, Obstructive) may independently, negatively modify the arrhythmia occur-rence profile. , Evidence supports a causal association of Sleep Apnea Syndromes with the incidence and morbidity of Hypertensive disease, coronary Heart Diseases, arrhythmia, heart failure, and Cerebrovascular accident., Severe snoring may be associated with Pulmonary:-:Point in time:^Patient:- and systemic Hypertensive disease, secondary Polycythemia, and Cardiac - anatomy qualifier arrhythmias.
, Severe snoring may be associated with Pulmonary:-:Point in time:^Patient:- and systemic Hypertensive disease, secondary Polycythemia, and Cardiac - anatomy qualifier arrhythmias., BACKGROUND AND PURPOSE Nocturnal Cardiac - anatomy qualifier arrhythmias occur in patients with obstructive Sleep Apnea Syndromes (Sleep Apnea, Obstructive), reportedly as a consequence of the autonomic effects of recurrent apnea with subsequent oxygen desaturation., Obstructive apnea is associated with Coronary Arteriosclerosis (silent or symptomatic), acute coronary events, Cerebrovascular accident and transient ischemic attacks, Cardiac Arrhythmia, Pulmonary:-:Point in time:^Patient:- Hypertensive disease and heart failure., Obstructive Sleep Apnea Syndromes (Sleep Apnea, Obstructive) is the most common form of sleep-disordered breathing, affecting 5-15% of the population. It is characterized by intermittent episodes of partial or complete obstruction of the upper airway during sleep that disrupts normal ventilation and sleep architecture, and is typically associated with excessive Daytime Somnolence, snoring, and witnessed apneas. Patients with obstructive Sleep Apnea Syndromes present risk to the general public safety by causing 8-fold increase in vehicle accidents, and they may themselves also suffer from the physiologic consequences of Sleep Apnea, Obstructive; these include Hypertensive disease, coronary artery disease, Cerebrovascular accident, congestive heart failure, Pulmonary:-:Point in time:^Patient:- Hypertensive disease, and Cardiac - anatomy qualifier arrhythmias, Obstructive Sleep Apnea Syndromes and central Sleep Apnea Syndromes with Cheyne-Stokes respiration are associated with an increased risk of Cardiac Arrhythmia. , Obstructive Sleep Apnea Syndromes (Sleep Apnea, Obstructive) affects approximately 4% of middle-aged men and 2% of middle-aged women. Cardiac arrhythmias are common problems in patients with Sleep Apnea, Obstructive, even though the true prevalence and clinical relevance of Cardiac - anatomy qualifier arrhythmias remains to be determined. , Cardiac arrhythmias during wakefulness and sleep in 15 patients with sleep-induced obstructive apnea, and the effect of Atropinum, Atropinum, atropine and tracheostomy on these arrhythmias were studied by continuous overnight Holter electrocardiographic, respiratory and electroencephalographic recordings., obstructive Sleep Apnea Syndromes (Sleep Apnea, Obstructive) as its most extreme variant, is characterized by intermittent episodes of partial or complete obstruction of the upper airway, leading to cessation of breathing while asleep. Cardiac arrhythmias are common problems in Sleep Apnea, Obstructive patients, although the true prevalence and clinical relevance of Cardiac - anatomy qualifier arrhythmias remains to be determined, The mechanisms associated with the Cardiovascular system consequences of obstructive Sleep Apnea Syndromes include abrupt changes in autonomic tone, which can trigger Cardiac - anatomy qualifier arrhythmias. , Recent studies have shown that Cardiac - anatomy qualifier arrhythmias and conduction disorders are common in patients with SA. Sleep apnea, Severity of nocturnal Cardiac - anatomy qualifier arrhythmias correlates with intensity of Sleep Apnea Syndromes in men, Patients affected with Sleep Apnea, Obstructive are frequently Hypertensive (finding) and can have dangerous Cardiac - anatomy qualifier arrhythmias., Patients with stable Congestive heart failure who snore may present sleep hypopnea and Cardiac - anatomy qualifier arrhythmias. , Obstructive Sleep Apnea Syndromes (Sleep Apnea, Obstructive) is associated with increased Cardiovascular system morbidity and mortality. Cardiac arrhythmias are common in patients with Sleep Apnea, Obstructive. , Nocturnal hypoxia has been associated with serious Ventricular tachyarrhythmia as well as life-threatening bradyarrhythmias. BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 and snoring, both of which increase with age, have been identified as risk factors for sleep-related breathing disorders, as have Hypertensive disease and Heart Diseases., Obstructive Sleep Apnea Syndromes syndrome is associated with excess Daytime Somnolence, Cancer patients and suicide and Cancer patients and suicide and depression, and an increased incidence of ischemic cardiopathy, Cardiac - anatomy qualifier arrhythmias, systemic Hypertensive disease and brain infarction., We found 58 percent prevalence of arrhythmias in patients with Sleep Apnea Syndromes (apnea/hypopnea index = AHI>10), vs 42 percent in nonapneic controls (chi 2 = 16.7, p<0.0001)[SEP]Relations: obstructive Sleep Apnea Syndromes syndrome has relations: disease_phenotype_positive with Snoring, disease_phenotype_positive with Snoring. Sleep Apnea Syndromes syndrome has relations: disease_disease with sleep-wake disorder, disease_disease with sleep-wake disorder, disease_disease with obstructive Sleep Apnea Syndromes syndrome, disease_disease with obstructive Sleep Apnea Syndromes syndrome, disease_disease with central Sleep Apnea Syndromes syndrome, disease_disease with central Sleep Apnea Syndromes syndrome, disease_disease with respiratory system disease, disease_disease with respiratory system disease. Definitions: Hypertensive disease defined as following: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), Hypertensive disease is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.. Congestive heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Consensus defined as following: General agreement or collective opinion; the judgment arrived at by most of those concerned.. Sleep Apnea, Obstructive defined as following: A disorder characterized by recurrent apneas during sleep despite persistent respiratory efforts. It is due to upper airway obstruction. The respiratory pauses may induce HYPERCAPNIA or HYPOXIA. Cardiac arrhythmias and elevation of systemic and Pulmonary:-:Point in time:^Patient:- arterial pressures may occur. Frequent partial arousals occur throughout sleep, resulting in relative SLEEP DEPRIVATION and daytime tiredness. Associated conditions include OBESITY; ACROMEGALY; MYXEDEMA; micrognathia; MYOTONIC DYSTROPHY; adenotonsilar dystrophy; and NEUROMUSCULAR DISEASES. (From Adams et al., Principles of Neurology, 6th ed, p395). Cardiac Arrhythmia defined as following: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.. Abnormal breathing defined as following:

When you're short of breath, it's hard or uncomfortable for you to take in the oxygen your body needs. You may feel as if you're not getting enough air. Sometimes you can have mild breathing problems because of a stuffy nose or intense exercise. But shortness of breath can also be a sign of a serious disease.

Many conditions can make you feel short of breath:

If you often have trouble breathing, it is important to find out the cause.

. Atrial Fibrillation defined as following: Abnormal Cardiac - anatomy qualifier rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.. Pulmonary:-:Point in time:^Patient:- Hypertensive disease defined as following: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.. Coronary Arteriosclerosis defined as following: Thickening and loss of elasticity of the CORONARY ARTERIES, leading to progressive arterial insufficiency (CORONARY DISEASE).. Heart Diseases defined as following: Pathological conditions involving the HEART including its structural and functional abnormalities.. Cardiovascular system defined as following: The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body.. Sudden Cardiac Death defined as following: Unexpected rapid natural death due to Cardiovascular system collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and Cardiac - anatomy qualifier arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005). Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810). Sleep Apnea Syndromes defined as following: Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.. Polycythemia defined as following: An increase in the total red cell mass of the blood. (Dorland, 27th ed). Cardiac - anatomy qualifier arrhythmias defined as following: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction..", "label": "yes"} {"original_question": "Do selenoproteins and selenium play a role in prostate cancer prevention?", "id": "converted_941", "sentence1": "Do Selenoproteins and selenium play a role in Pelvis>Prostate Primary malignant neoplasm prevention?", "sentence2": "The selenoprotein-deficient mice exhibited accelerated development of Lesion associated with Pelvis>Prostate Primary malignant neoplasm progression, implicating Selenoproteins in Primary malignant neoplasm risk and development and raising the possibility that selenium prevents Primary malignant neoplasm by modulating the levels of these Selenoproteins, Notably and in contrast to previous studies, RWPE-1 cells were significantly more sensitive to selenite than either of the Pelvis>Prostate Primary malignant neoplasm cell lines. These results demonstrate that Selenoproteins and selenium metabolism are regulated at multiple levels in Pelvis>Prostate cells, In a low-selenium population, SOD2-Ala16+ men homozygous for SEPP1-Ala234 are at an increased risk of Pelvis>Prostate Primary malignant neoplasm/aggressive Pelvis>Prostate Primary malignant neoplasm especially if ever-smokers, because they are likely to produce more Mitochondrial Inheritance H(2)O(2) that they cannot remove, thereby promoting Pelvis>Prostate tumor cell proliferation and migration., Our results support a role of selenium and Genetic Polymorphism in selenoenzymes in Pelvis>Prostate Primary malignant neoplasm etiology, which warrants confirmation in future studies., This study provides evidence that SELENOF gene genetic variation may influence Patient-Controlled Analgesia mortality. Additionally, the association of selenium with Patient-Controlled Analgesia mortality was modified by a Variant, suggesting the possibility that some men with Patient-Controlled Analgesia may benefit more from selenium than others, depending on their Genotype determination., We conclude that decreased SELENOP wt Allele concentration in serum might represent an additional valuable marker for Pelvis>Prostate Primary malignant neoplasm diagnostics., The recently completed Selenium supplement supplement and Vitamin E Cancer Prevention Trial (SELECT) was one of the largest Homo sapiens Primary malignant neoplasm prevention trials ever undertaken. Its purpose was to assess the role of selenium and Vitamin E Drug Class in Pelvis>Prostate Primary malignant neoplasm prevention, but SELECT found no decline in Pelvis>Prostate Primary malignant neoplasm., We studied FUT2 gene levels in whole blood, plasma and Pelvis>Prostate of 32 Pachyonychia Congenita and 40 benign Pelvis>Prostate hyperplasia (BPH) patients and in the control group composed of 39 healthy subjects. The selenoenzyme glutathione peroxidase (GSH-Px) was also measured in the patients' Erythrocytes, plasma and Pelvis>Prostate tissue. FUT2 gene concentration in whole blood and plasma in both groups of patients was lower as compared with controls, while in Pelvis>Prostate gland it was significantly higher in Pachyonychia Congenita than in BPH patients and controls. Red cell GSH-Px activity was the same in Pachyonychia Congenita patients and controls but significantly lower in BPH patients., Of particular interest was the positive correlation between tissue GPx activity and Gleason score, with this relationship achieving statistical significance among African-Americans (r = 0.67, P = 0.02)[SEP]Relations: SELENOP has relations: disease_protein with Pelvis>Prostate Primary malignant neoplasm, disease_protein with Pelvis>Prostate Primary malignant neoplasm, disease_protein with Pelvis>Prostate carcinoma, disease_protein with Pelvis>Prostate carcinoma, disease_protein with familial Pelvis>Prostate carcinoma, disease_protein with familial Pelvis>Prostate carcinoma. Selenium supplement has relations: drug_drug with Testosterone, drug_drug with Testosterone, drug_drug with Antipyrine, drug_drug with Antipyrine. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Pelvis>Prostate Primary malignant neoplasm defined as following: A primary or metastatic malignant tumor involving the Pelvis>Prostate gland. The vast majority are carcinomas.. Variant defined as following: An alteration or difference from a norm or standard.. SELENOF gene defined as following: This gene plays a role in selenium binding.. Pelvis>Prostate hyperplasia defined as following: A disease caused by hyperplastic process of non-transformed prostatic cells.. Patient-Controlled Analgesia defined as following: Relief of PAIN, without loss of CONSCIOUSNESS, through ANALGESIC AGENTS administered by the patients. It has been used successfully to control POSTOPERATIVE PAIN, during OBSTETRIC LABOR, after BURNS, and in TERMINAL CARE. The choice of agent, dose, and lockout interval greatly influence effectiveness. The potential for overdose can be minimized by combining small bolus doses with a mandatory interval between successive doses (lockout interval).. SELENOP wt Allele defined as following: Human SELENOP wild-type allele is located in the vicinity of 5q12 and is approximately 88 kb in length. This allele, which encodes selenoprotein P, plays a role in selenium distribution.. Genotype determination defined as following: The determination of the DNA sequence of an individual.. Lesion defined as following: A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.. Erythrocytes defined as following: Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN.. Pachyonychia Congenita defined as following: A group of inherited ectodermal dysplasias whose most prominent clinical feature is hypertrophic nail dystrophy resulting in PACHYONYCHIA. Several specific subtypes of pachyonychia congenita have been associated with mutations in genes that encode KERATINS.. Pelvis>Prostate tumor defined as following: Tumors or Primary malignant neoplasm of the PROSTATE.. Mitochondrial Inheritance defined as following: The distribution of mitochondria, including the Mitochondrial Inheritance genome, into daughter cells after mitosis or meiosis, mediated by interactions between mitochondria and the cytoskeleton. [GOC:mcc, PMID:10873824, PMID:11389764]. Genetic Polymorphism defined as following: The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.. Homo sapiens defined as following: Members of the species Homo sapiens.. Selenoproteins defined as following: Selenoproteins are proteins that specifically incorporate SELENOCYSTEINE into their amino acid chain. Most Selenoproteins are enzymes with the selenocysteine residues being responsible for their catalytic functions..", "label": "no"} {"original_question": "Is collagen matrix of human articular cartilage changing with disease?", "id": "converted_3216", "sentence1": "Is collagen matrix of human Structure of articular cartilage changing with Disease?", "sentence2": "The collagen matrix of human Structure of Structure of articular cartilage is an essentially permanent structure that has no significant turnover in adults, even with the occurrence of Disease., the Chondrocyte in ageing Structure of Structure of articular cartilage have limited capacity to turnover the interterritorial matrix., collagen type II is a major component of Structure of Structure of articular cartilage and its breakdown is a key feature of Degenerative polyarthritis. [SEP]Relations: Structure of articular cartilage of joint has relations: anatomy_anatomy with hyaline cartilage tissue, anatomy_anatomy with hyaline cartilage tissue. negative rheumatoid factor polyarthritis has relations: disease_disease with arthritic joint Disease, disease_disease with arthritic joint Disease. collagen type II trimer has relations: cellcomp_protein with COL2A1, cellcomp_protein with COL2A1. chondrocyte hypertrophy has relations: bioprocess_bioprocess with growth plate cartilage chondrocyte growth, bioprocess_bioprocess with growth plate cartilage chondrocyte growth, bioprocess_protein with MEX3C, bioprocess_protein with MEX3C. Definitions: collagen type II defined as following: A fibrillar collagen found predominantly in CARTILAGE and vitreous humor. It consists of three identical alpha1(II) chains.. Chondrocyte defined as following: Polymorphic cells that form cartilage.. Degenerative polyarthritis defined as following: A progressive, degenerative joint Disease, the most common form of arthritis, especially in older persons. The Disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting Structure of articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Structure of articular cartilage defined as following: A protective layer of firm, flexible cartilage over the articulating ends of bones. It provides a smooth surface for joint movement, protecting the ends of long bones from wear at points of contact.. collagen defined as following: A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH)..", "label": "no"} {"original_question": "Does the 3D structure of the genome remain stable during cell differentiation?", "id": "converted_1450", "sentence1": "Does the 3 Days structure of the Genome - anatomical entity remain stable during \"U\" lymphocyte differentiation?", "sentence2": "We identify large, megabase-sized local chromatin location location interaction domains, which we term 'topological domains', as a pervasive structural feature of the Genome - anatomical entity organization., The domains are stable across different \"U\" lymphocyte types and highly conserved across species, indicating that topological domains are an inherent property of mammalian genomes, Insulators are involved in 3 Days Genome - anatomical entity organization at multiple spatial scales and are important for dynamic reorganization of chromatin location location structure during reprogramming and differentiation., The relation between alterations in chromatin location location structure and changes in gene expression during \"U\" lymphocyte differentiation has served as a paradigm to understand the link between Genome - anatomical entity organization and function., Architectural Proteins orchestrate higher-order chromatin location location organization through the establishment of interactions between regulatory elements across multiple spatial scales. The regulation of these Proteins, their interaction with DNA, and their co-occurrence in the Genome - anatomical entity, may be responsible for the plasticity of 3 Days chromatin location location architecture that dictates \"U\" lymphocyte and time-specific blueprints of gene expression., The role of 3 Days Genome - anatomical entity organisation in the control and execution of lineage-specific transcription programmes during the development and differentiation of Multipotent Stem Cells into specialised \"U\" lymphocyte types remains poorly understood., Chromatin structural states and their remodelling, including higher-order chromatin location location folding and three-dimensional (3 Days) Genome - anatomical entity organisation, play an important role in the control of gene expression, Here, we show that substantial remodelling of the higher-order chromatin location location structure of the LORICRIN gene (Electrodesiccation with curettage), a keratinocyte lineage-specific gene locus on mouse chromosome 3, occurs during epidermal morphogenesis., Many studies have suggested a link between the spatial organization of genomes and fundamental biological processes such as Genome - anatomical entity reprogramming, gene expression, and differentiation., Moreover, we reveal that formation of such highly condensed, transcriptionally repressed Heterochromatin promotes transcriptional activation of differentiation genes and loss of pluripotency., The open chromatin location location of Embryonic Stem Cells (Enhanced S-Cone Syndrome) condenses into repressive Heterochromatin as Cells exit the pluripotent state., we find that localized Heterochromatin condensation of Ribosomal RNA Genes initiates establishment of highly condensed chromatin location location structures outside of the Cell Nucleolus, We focus on the emerging relationship between Genome - anatomical entity organization and lineage-specific transcriptional regulation, which we argue are inextricably linked., Cells face the challenge of storing two meters of DNA in the three-dimensional (3 Days) space of the Cell Nucleus that spans only a few microns. The nuclear organization that is required to overcome this challenge must allow for the accessibility of the gene regulatory machinery to the DNA and, in the case of Embryonic Stem Cells (Enhanced S-Cone Syndrome), for the transcriptional and epigenetic changes that accompany differentiation, In this review we summarize some of the recent findings illuminating the 3 Days structure of the eukaryotic Genome - anatomical entity, as well as the relationship between Genome - anatomical entity topology and function from the level of whole chromosomes to enhancer-promoter loops with a focus on features affecting Genome - anatomical entity organization in Enhanced S-Cone Syndrome and changes in nuclear organization during differentiation, We observe that although self-associating chromatin location location domains are stable during differentiation, chromatin location location interactions both within and between domains change in a striking manner, altering 36% of active and inactive chromosomal compartments throughout the Genome - anatomical entity[SEP]Relations: LORICRIN has relations: bioprocess_protein with keratinocyte differentiation, bioprocess_protein with keratinocyte differentiation, pathway_protein with Formation of the cornified envelope, pathway_protein with Formation of the cornified envelope, cellcomp_protein with cornified envelope, cellcomp_protein with cornified envelope, molfunc_protein with structural constituent of cytoskeleton, molfunc_protein with structural constituent of cytoskeleton. Heterochromatin has relations: cellcomp_protein with BEND3, cellcomp_protein with BEND3. Definitions: Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Cell Nucleolus defined as following: Within most types of eukaryotic CELL NUCLEUS, a distinct region, not delimited by a membrane, in which some species of rRNA (RNA, RIBOSOMAL) are synthesized and assembled into ribonucleoprotein subunits of ribosomes. In the Cell Nucleolus rRNA is transcribed from a nucleolar organizer, i.e., a group of tandemly repeated chromosomal genes which encode rRNA and which are transcribed by RNA polymerase I. (Singleton & Sainsbury, Dictionary of Microbiology & Molecular Biology, 2d ed). Heterochromatin defined as following: The portion of chromosome material that remains condensed and is transcriptionally inactive during INTERPHASE.. Genome - anatomical entity defined as following: Anatomical set of genes in all the chromosomes.. Cell Nucleus defined as following: Within a eukaryotic \"U\" lymphocyte, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A \"U\" lymphocyte may contain more than one Cell Nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). Multipotent Stem Cells defined as following: A \"U\" lymphocyte that can only differentiate to a particular type of Cells (e.g. hematopoietic Cells or epithelial Cells). --2005. Embryonic Stem Cells defined as following: Cells derived from the BLASTOCYST INNER CELL MASS which forms before implantation in the uterine wall. They retain the ability to divide, proliferate and provide progenitor Cells that can differentiate into specialized Cells.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all Cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Electrodesiccation with curettage defined as following: A procedure that uses both a curette and hyfrecator for treatment of various skin conditions, including basal \"U\" lymphocyte carcinoma, squamous \"U\" lymphocyte skin carcinoma, viral warts, and pyogenic granulomas.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. chromatin location defined as following: The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130]. Ribosomal RNA Genes defined as following: Genes, found in both prokaryotes and eukaryotes, which are transcribed to produce the RNA which is incorporated into RIBOSOMES. Prokaryotic rRNA genes are usually found in OPERONS dispersed throughout the GENOME, whereas eukaryotic rRNA genes are clustered, multicistronic transcriptional units.. LORICRIN gene defined as following: This gene plays a role in the structure of keratinocyte \"U\" lymphocyte envelopes..", "label": "no"} {"original_question": "Does teplizumab hold promise for diabetes prevention?", "id": "converted_3440", "sentence1": "Does teplizumab hold promise for Diabetes Mellitus prevention?", "sentence2": "Anti-CD3 Antigens Antigens teplizumab and muromonab-CD3 Antigens Antigens otelixizumab have been shown to provide C-peptide, Human, Human preservation. , Underway are secondary prevention studies with teplizumab and with abatacept., INTERPRETATION: Findings of exploratory analyses suggest that future studies of immunotherapeutic intervention with teplizumab might have increased success in prevention of a decline in β-cell function (measured by C-peptide, Human, Human) and provision of glycaemic control at reduced doses of Therapeutic Insulin if they target patients early after diagnosis of Diabetes Mellitus and children., teplizumab therapy for type 1 Diabetes Mellitus., teplizumab for treatment of type 1 Diabetes Mellitus mellitus., TAKE HOME MESSAGE\n\nIn Phase I/II randomized control trials, in patients with new onset Diabetes Mellitus, Insulin-Dependent, teplizumab slowed the rate of loss of beta-cell function over 2 years of follow-up., teplizumab for treatment of type 1 Diabetes Mellitus (Protégé study): 1-year results from a randomised, placebo-controlled trial., INTERPRETATION\n\nFindings of exploratory analyses suggest that future studies of immunotherapeutic intervention with teplizumab might have increased success in prevention of a decline in β-cell function (measured by C-peptide, Human, Human) and provision of glycaemic control at reduced doses of Therapeutic Insulin if they target patients early after diagnosis of Diabetes Mellitus and children., Treatment of new onset type 1 Diabetes Mellitus with teplizumab: successes and pitfalls in development., AREAS COVERED\n\nIn this review, we discuss the recent update on clinical data obtained from trials of teplizumab in type 1 Diabetes Mellitus, the drug's postulated mechanism of action and the identification of responders to therapy., CONCLUSIONS teplizumab is an muromonab-CD3 Antigens Antigens Homo sapiens monoclonal antibody with promising activity in treatment of patients with T1DM., The results from the TN-10 teplizumab prevention trial show that the diagnosis of type 1 Diabetes Mellitus can be delayed by treatment with a Fc Receptor non-binding monoclonal antibody to CD3 Antigens Antigens in people at high risk for Disease, INTERPRETATION\nFindings of exploratory analyses suggest that future studies of immunotherapeutic intervention with teplizumab might have increased success in prevention of a decline in β-cell function (measured by C-peptide, Human, Human) and provision of glycaemic control at reduced doses of Therapeutic Insulin if they target patients early after diagnosis of Diabetes Mellitus and children., teplizumab (muromonab-CD3 Antigens Antigens mAb) treatment preserves C-peptide, Human, Human responses in patients with new-onset type 1 Diabetes Mellitus in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders., teplizumab treatment may improve C-peptide, Human, Human responses in participants with type 1 Diabetes Mellitus after the new-onset period: a randomised controlled trial., The results from the TN-10 teplizumab prevention trial show that the diagnosis of type 1 Diabetes Mellitus can be delayed by treatment with a Fc Receptor non-binding monoclonal antibody to CD3 Antigens Antigens in people at high risk for Disease., Findings of exploratory analyses suggest that future studies of immunotherapeutic intervention with teplizumab might have increased success in prevention of a decline in β-cell function (measured by C-peptide, Human, Human) and provision of glycaemic control at reduced doses of Therapeutic Insulin if they target patients early after diagnosis of Diabetes Mellitus and children., Despite decades of research and clinical trials, no treatment exists yet to prevent or cure Diabetes Mellitus, Insulin-Dependent. A recent prevention trial using the Anti-CD3 Antigens Antigens Antibody teplizumab in individuals at a high risk of developing Diabetes Mellitus, Insulin-Dependent has provided the first piece of evidence that a safe and transient intervention may be able to delay Disease., In this review, we discuss the recent update on clinical data obtained from trials of teplizumab in type 1 Diabetes Mellitus, the drug's postulated mechanism of action and the identification of responders to therapy., Treatment of type 1 Diabetes Mellitus with teplizumab: clinical and immunological follow-up after 7 years from diagnosis.[SEP]Relations: teplizumab has relations: drug_drug with Erenumab, drug_drug with Erenumab, drug_drug with Zolbetuximab, drug_drug with Zolbetuximab, drug_drug with Daclizumab, drug_drug with Daclizumab, drug_drug with Urelumab, drug_drug with Urelumab, drug_drug with Adalimumab, drug_drug with Adalimumab. Definitions: C-peptide, Human defined as following: C peptide (31 aa, ~3 kDa) is encoded by the Homo sapiens INS gene. This protein is involved in both signal transduction and the modulation of blood flow.. Therapeutic Insulin defined as following: A synthetic or animal-derived form of Therapeutic Insulin used in the treatment of Diabetes Mellitus mellitus. Therapeutic Therapeutic Insulin is formulated to be short-, intermediate- and long-acting in order to individualize an Therapeutic Insulin regimen according to individual differences in glucose and Therapeutic Insulin metabolism. Therapeutic Therapeutic Insulin may be derived from porcine, bovine or recombinant sources. Endogenous Homo sapiens Therapeutic Insulin, a pancreatic hormone composed of two polypeptide chains, is important for the normal metabolism of carbohydrates, proteins and fats and has anabolic effects on many types of tissues.. Anti-CD3 Antigens Antibody defined as following: Any antibody that recognizes the CD3 Antigens protein complex.. Homo sapiens defined as following: Members of the species Homo sapiens.. abatacept defined as following: A soluble fusion protein consisting of the extracellular domain of Homo sapiens cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) linked to a modified Fc (hinge, CH2, and CH3 domains) portion of Homo sapiens immunoglobulin G1 (IgG1) with immunosuppressive activity. Abatacept binds CD80 and CD86 on antigen presenting cells (APCs), blocking interaction with CD28 on T lymphocytes, which initiates a co-stimulatory signal required for full activation of T lymphocytes.. Diabetes Mellitus, Insulin-Dependent defined as following: A chronic condition characterized by minimal or absent production of Therapeutic Insulin by the pancreas.. Fc Receptor defined as following: Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules.. CD3 Antigens defined as following: Complex of at least five membrane-bound polypeptides in mature T-lymphocytes that are non-covalently associated with one another and with the T-cell receptor (RECEPTORS, ANTIGEN, T-CELL). The CD3 Antigens complex includes the gamma, delta, epsilon, zeta, and eta chains (subunits). When antigen binds to the T-cell receptor, the CD3 Antigens complex transduces the activating signals to the cytoplasm of the T-cell. The CD3 Antigens gamma and delta chains (subunits) are separate from and not related to the gamma/delta chains of the T-cell receptor (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA).. Diabetes Mellitus defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.. muromonab-CD3 Antigens defined as following: Anti-CD3 Antigens monoclonal antibody that exerts immunosuppressive effects by inducing peripheral T-cell depletion and modulation of the T-cell receptor complex (CD3 Antigens/Ti).. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown..", "label": "yes"} {"original_question": "Is the circadian clock involved in ribosome biogenesis?", "id": "converted_741", "sentence1": "Is the circadian clock involved in Ribosomes biogenesis?", "sentence2": "The circadian clock coordinates Ribosomes biogenesis., Here we show that the circadian clock exerts its function also through the regulation of Protein Biosynthesis. Namely, the circadian clock influences the temporal translation of a subset of mRNAs involved in Ribosomes biogenesis by controlling the transcription of translation initiation factors as well as the clock-dependent rhythmic activation of signaling pathways involved in their regulation. Moreover, the circadian oscillator directly regulates the transcription of Ribosomal Proteins mRNAs and ribosomal RNAs. Thus the circadian clock exerts a major role in coordinating transcription and translation steps underlying Ribosomes biogenesis., Namely, the circadian clock influences the temporal translation of a subset of mRNAs involved in Ribosomes biogenesis by controlling the transcription of translation initiation factors as well as the clock-dependent rhythmic activation of signaling pathways involved in their regulation, The circadian clock coordinates Ribosomes biogenesis, Here we show that the circadian clock exerts its function also through the regulation of Protein Biosynthesis, Here we show that the circadian clock exerts its function also through the regulation of Protein Biosynthesis. Namely, the circadian clock influences the temporal translation of a subset of mRNAs involved in Ribosomes biogenesis by controlling the transcription of translation initiation factors as well as the clock-dependent rhythmic activation of signaling pathways involved in their regulation.[SEP]Relations: Ribosomes has relations: cellcomp_protein with AURKAIP1, cellcomp_protein with AURKAIP1, cellcomp_protein with SNCA, cellcomp_protein with SNCA, cellcomp_protein with RNA28SN5, cellcomp_protein with RNA28SN5, cellcomp_protein with RPS17, cellcomp_protein with RPS17, cellcomp_protein with RNA28SN4, cellcomp_protein with RNA28SN4. Definitions: Protein Biosynthesis defined as following: The cellular metabolic process in which a protein is formed, using the sequence of a mature mRNA or circRNA molecule to specify the sequence of amino acids in a polypeptide chain. Translation is mediated by the Ribosomes, and begins with the formation of a ternary complex between aminoacylated initiator methionine tRNA, GTP, and initiation factor 2, which subsequently associates with the small subunit of the Ribosomes and an mRNA or circRNA. Translation ends with the release of a polypeptide chain from the Ribosomes. [GOC:go_curators]. Ribosomes defined as following: Multicomponent ribonucleoprotein structures found in the CYTOPLASM of all cells, and in MITOCHONDRIA, and PLASTIDS. They function in PROTEIN BIOSYNTHESIS via GENETIC TRANSLATION.. Ribosomal Proteins defined as following: Proteins found in ribosomes. They are believed to have a catalytic function in reconstituting biologically active ribosomal subunits..", "label": "yes"} {"original_question": "Is eptinezumab a small molecule?", "id": "converted_4017", "sentence1": "Is eptinezumab a small molecule?", "sentence2": "Eptinezumab-jjmr (referred to as eptinezumab hereafter; Vyepti™) is a humanised monoclonal antibody that binds to Calcitonin Precursor, human (Calcitonin Gene-Related Peptide) and blocks its binding to the receptor. [SEP]Relations: Human calcitonin has relations: drug_effect with Eczema, drug_effect with Eczema, drug_drug with Zoledronic acid, drug_drug with Zoledronic acid, drug_effect with Epistaxis, drug_effect with Epistaxis, drug_effect with Eczematoid dermatitis, drug_effect with Eczematoid dermatitis, drug_effect with Tetany, drug_effect with Tetany. Definitions: Calcitonin Gene-Related Peptide defined as following: A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator.. Calcitonin Precursor, human defined as following: Calcitonin precursor (141 aa, ~15 kDa) is encoded by the human CALCA gene. This protein plays a role in calcium flux and bone resorption..", "label": "no"} {"original_question": "Is Thalidomide currently a marketed drug?", "id": "converted_1751", "sentence1": "Is Thalidomide currently a marketed Pharmacologic Substance?", "sentence2": "In this retrospective study, pharmacy claims were analyzed for those patients with a diagnosis of Millimole per Liter who received thalidomide,, The Japanese POEMS Syndrome with Thalidomide (J-POST) Trial is a phase II/III multicentre, double-blinded, randomised, controlled trial that aims to evaluate the efficacy and safety of a 24-week treatment with thalidomide in POEMS Syndrome,, Thalidomide could relieve clinical symptoms and intestinal mucosal lesions effectively in children with refractory INFLAMMATORY BOWEL DISEASE 2 (Irritable Bowel Syndrome) from the pre-clinical study., Thalidomide is now available as an investigational Pharmacologic Substance in the USA., The STEPStrade mark (System for Thalidomide Education and Prescribing Safety) Program has been developed by Celgene, the commercial manufacturer of thalidomide, to ensure compliance with prescription and usage protocols., New uses of thalidomide., Thalidomide is an anti-angiogenesis agent that currently is being evaluated in the treatment of various types of Primary malignant neoplasm., The comeback of thalidomide to the legitimate status of a marketed Pharmacologic Substance came in 1998 when it received FDA approval for the treatment of Erythema nodosum leprosum (MLLT1 wt Allele), Thalidomide is considered the Pharmacologic Substance of choice for the treatment of MLLT1 wt Allele, but for other conditions, it is recommended only when resistance to the currently available form of therapy is encountered, Thalidomide is an anti-inflammatory and anti-angiogenic Pharmacologic Substance currently used for the treatment of several diseases, including Erythema nodosum leprosum, which occurs in patients with Leprosy, Lepromatous vaccine, Thalidomide, once banned, has returned to the center of controversy with the Food and Drug Administration's (FDA's) announcement that thalidomide will be placed on the market for the treatment of Erythema nodosum leprosum, a severe dermatological complication of Hansen's disease. , In 1998, FDA approved the marketing of thalidomide (Thalomid, Celgene). , In 1998 the US Food and Drug Administration approved thalidomide exclusively for the treatment of MLLT1 wt Allele, and strict conditions were stipulated for its use in order to prevent teratogenic adverse effects., BACKGROUND: The use of thalidomide during the 1950s resulted in teratogenic effects in thousands of infants. Although thalidomide is currently approved for the treatment of a complication of leprosy vaccine vaccine, it is commercially available to treat other diseases through a controlled distribution system., The comeback of thalidomide to the legitimate status of a marketed Pharmacologic Substance came in 1998 when it received FDA approval for the treatment of Erythema nodosum leprosum (MLLT1 wt Allele).[SEP]Relations: Thalidomide has relations: drug_drug with Cocaine, drug_drug with Cocaine, drug_drug with Etomidate, drug_drug with Etomidate, drug_drug with Diamorphine, drug_drug with Diamorphine, drug_drug with Harmaline, drug_drug with Harmaline, drug_drug with Propanidid, drug_drug with Propanidid. Definitions: Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. thalidomide defined as following: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.. leprosy vaccine defined as following:

leprosy vaccine vaccine

. Millimole per Liter defined as following: A unit of concentration (molarity unit) equal to one thousandth of a mole (10E-3 mole) of solute per one liter of solution.. anti-angiogenic Pharmacologic Substance defined as following: Agents and endogenous substances that antagonize or inhibit the development of new blood vessels.. MLLT1 wt Allele defined as following: Human MLLT1 wild-type allele is located in the vicinity of 19p13.3 and is approximately 70 kb in length. This allele, which encodes protein MLLT1 wt Allele, plays a role in the activation of transcription by RNA polymerase II. Mixed-lineage leukemias are associated with the translocation t(11;19)(q23;p13.3) of the gene with the MLL gene.. Leprosy, Lepromatous vaccine defined as following: A chronic communicable infection which is a principal or polar form of LEPROSY. This disorder is caused by MYCOBACTERIUM LEPRAE and produces diffuse granulomatous skin lesions in the form of nodules, macules, or papules. The peripheral nerves are involved symmetrically and neural sequelae occur in the advanced stage.. Irritable Bowel Syndrome defined as following: Gastrointestinal symptoms characterized by chronic abdominal pain and altered bowel habits in the absence of any organic cause.. POEMS Syndrome defined as following: A multisystemic disorder characterized by a sensorimotor polyneuropathy (POLYNEUROPATHIES), organomegaly, endocrinopathy, monoclonal gammopathy, and pigmentary skin changes. Other clinical features which may be present include EDEMA; CACHEXIA; microangiopathic glomerulopathy; pulmonary hypertension (HYPERTENSION, PULMONARY); cutaneous necrosis; THROMBOCYTOSIS; and POLYCYTHEMIA. This disorder is frequently associated with osteosclerotic myeloma. (From Adams et al., Principles of Neurology, 6th ed, p1335; Rev Med Interne 1997;18(7):553-62). Thalidomide defined as following: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action..", "label": "yes"} {"original_question": "Can prevnar 13 be used in children?", "id": "converted_3173", "sentence1": "Can prevnar 13 be used in children?", "sentence2": "PCV13 is approved for routine vaccination of all infants as a 4-dose series at age 2, 4, 6, and 12-15 months for children who previously received 1 or more doses of the 7-valent pneumococcal conjugate vaccine (PCV7), and for children with underlying medical conditions that increase their risk for pneumococcal disease or its complications. , Based on published immunogenicity and safety data, as well as the recent recommendations by the ACIP for routine use in infants and indications for high-risk pediatric patients, PCV13 is a revised formulation of pneumococcal vaccine that should be included on pharmacy formularies., To review the immunogenicity, efficacy, and safety of the 13-valent pneumococcal conjugate vaccine (PCV13) for use in pediatric patients.[SEP]", "label": "yes"} {"original_question": "Can cardiospheres be produced from skin fibroblasts?", "id": "converted_3094", "sentence1": "Can cardiospheres be produced from skin fibroblasts?", "sentence2": "Therefore, there is an emerging interest in generating cardiosphere-like stem cells from Diploid Cell via somatic reprogramming. , Here we provide the detailed protocol for generating induced cardiospheres (iCS) for cardiac regeneration by somatic reprogramming of mouse fibroblasts using a panel of pluripotent transcription factors and cardiotrophic growth factors.[SEP]Definitions: Diploid Cell defined as following: Nucleated cell which has one or more diploid sets (46 pairs) of chromosomes..", "label": "yes"} {"original_question": "Is there association of matrix metalloproteinases with behaviour of pituitary adenomas?", "id": "converted_1032", "sentence1": "Is there association of matrix Metalloproteases with behaviour of pituitary Adenoma?", "sentence2": "While detailed histological subtyping remains the best independent predictor of Aggressive behavior in the majority of cases, evidence suggests that the additional analyses of FGFR4 gene gene, Matrix Metalloproteinases, PTTG1 wt Allele, MKI67 gene, TP53 wt Allele, and Gene Deletion in Chromosomes, Human, Pair 11 may contribute to decisions concerning management of aggressive pituitary Adenoma., We observed elevation of Matrix Metalloproteinases-2 and -9 expression and consequent 3-D cell invasion in Cells under-expressing RECK gene gene. , Based on the significance of matrix Metalloproteases (MMPs) for tumor growth and angiogenesis, we have studied the effect of batimastat (BB 94), a Synthesis MMPs inhibitor (MMPI) on the progression of Prolactinoma in Rattus norvegicus. , Inhibition of estrogen-induced pituitary tumor growth and angiogenesis in Fischer 344 Rattus norvegicus by the matrix metalloproteinase inhibitor batimastat., The results of our study provide evidence for an inhibitory effect of batimastat, a Synthesis MMPI, on the growth and angiogenesis in an experimental model of Homo sapiens prolactinoma., In summary, the differential expression of Extracellular matrix components, Integrins and matrix metalloproteinase contributes to the control of pituitary hormone production and cell proliferation during tumorigenesis., Data on the dural invasiveness of pituitary Adenoma have been correlated to the expression of matrix Metalloproteases (e.g. Matrix Metalloproteinase 9). , We found no correlation of Matrix Metalloproteinase 9 expression and Status of invasion by tumor., The matrix Metalloproteases (MMPs) and their nature inhibitors-the tissue inhibitors of Metalloproteases (TIMPs) may play a central role in these processes., CONCLUSIONS: Tissue-Inhibitor of Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-2 may play a key role in invasive pituitary Adenoma to biological behavior., The matrix Metalloproteases (MMPs) are a family of zinc-containing endopeptidases that are able to degrade the Extracellular matrix and allow angiogenesis and tumor invasion. , Matrix Metalloproteinase 9 expression did not differ between noninvasive Neoplasms and normal pituitary gland, or between different sized prolactinomas. Matrix Metalloproteinase 9 expression was related to aggressive tumor behavior. It was higher in invasive Macroprolactinoma (P = 0.003) when compared with noninvasive Macroprolactinoma or the normal anterior pituitary gland. In addition, although there was no difference in whether Matrix Metalloproteinase 9 was present or not when nonfunctioning Adenoma that recurred were compared with those that did not, samples of recurrent tumor at the second presentation were more likely to express Matrix Metalloproteinase 9 (P = 0.01). Pituitary carcinoma were significantly more likely to be Matrix Metalloproteinase 9 positive compared with normal anterior pituitary gland (P = 0.05), but there was no difference from invasive Adenoma. Angiogenesis assessed by vascular density was related to Matrix Metalloproteinase 9 expression (P<0.05). In summary, we have shown the presence of Matrix Metalloproteinase 9 expression in some invasive and recurrent pituitary Adenoma, and in the majority of pituitary carcinoma. The mechanisms whereby Matrix Metalloproteinase 9 expression influences tumor recurrence and invasiveness, and its association with angiogenesis, remains to be elucidated. , Beside the digestion of the Extracellular matrix during tumor invasion and metastasis, more recently, new functions for matrix Metalloproteases (MMPs) have been proposed. , CONCLUSION: No correlation could be established between the invasive potential of Neoplasms and Matrix Metalloproteinases-1, -2, and -3 expression levels. , Matrix Metalloproteinase 2 and 9 expression correlated with Structure of Structure of cavernous sinus invasion of pituitary Adenoma., Data on the dural invasiveness of pituitary Adenoma have been correlated to the expression of matrix Metalloproteases (e.g., We found surprisingly high levels of Matrix Metalloproteinases activity and low levels of tissue inhibitor of Metalloproteases, indicating a high level of Extracellular matrix-degrading activity in pituitary Adenoma., The matrix Metalloproteases (MMPs) and their nature inhibitors-the tissue inhibitors of Metalloproteases (TIMPs) may play a central role in these processes. , We found surprisingly high levels of Matrix Metalloproteinases activity and low levels of tissue inhibitor of Metalloproteases, indicating a high level of Extracellular matrix-degrading activity in pituitary Adenoma., There was an association between the invasion of pituitary Adenoma and MKI67 gene Congenital Nonbullous Ichthyosiform Erythroderma (P = 0.039) or the expression of Vascular Endothelial Growth Factor A (P < 0.001) and Matrix Metalloproteinase 9 (P < 0.001). But c-myc Congenital Nonbullous Ichthyosiform Erythroderma and BCL2 gene expression have no association with invasiveness of pituitary Adenoma (P = 0.061 vs., NME1 wt Allele and Matrix Metalloproteinase 9 have associations with invasiveness of pituitary Adenoma,, Matrix metalloproteinase secreted by pituitary Cells can release Growth Factor from the Extracellular matrix that, in turn, control pituitary cell proliferation and hormone secretion. In summary, the differential expression of Extracellular matrix components, Integrins and matrix metalloproteinase contributes to the control of pituitary hormone production and cell proliferation during tumorigenesis., There was an association between the invasion of pituitary Adenoma and MKI67 gene Congenital Nonbullous Ichthyosiform Erythroderma (P = 0.039) or the expression of Vascular Endothelial Growth Factor A (P < 0.001) and Matrix Metalloproteinase 9 (P < 0.001)., Although our study has shown that Microvessel Density and the expression of Vascular Endothelial Growth Factor A, MKI67 gene, NME1 wt Allele and Matrix Metalloproteinase 9 have associations with invasiveness of pituitary Adenoma, they are lack of specificity.[SEP]Relations: Pituitary adenoma has relations: disease_phenotype_positive with pituitary adenoma, disease_phenotype_positive with pituitary adenoma. Activation of Matrix Metalloproteinases has relations: pathway_protein with TIMP2, pathway_protein with TIMP2, pathway_protein with TIMP2, pathway_protein with TIMP2, pathway_protein with TIMP2, pathway_protein with TIMP2, pathway_protein with MMP7, pathway_protein with MMP7. Definitions: Vascular Endothelial Growth Factor A defined as following: The original member of the family of endothelial cell Growth Factor referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor Cells and referred to as \"tumor angiogenesis factor\" and \"vascular permeability factor\". Although expressed at high levels in certain tumor-derived Cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced.. Matrix Metalloproteinase 9 defined as following: An endopeptidase that is structurally similar to MATRIX METALLOPROTEINASE 2. It degrades GELATIN types I and V; COLLAGEN TYPE IV; and COLLAGEN TYPE V.. Integrins defined as following: A family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other Cells, while their intracellular domains interact with the CYTOSKELETON. The Integrins consist of at least three identified families: the cytoadhesin receptors (RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation.. PTTG1 wt Allele defined as following: Human PTTG1 wild-type allele is located in the vicinity of 5q35.1 and is approximately 7 kb in length. This allele, which encodes securing protein, plays a role in chromatid separation. Thus, this allele affects cycle regulation, proliferation and cellular transformation; as variant alleles are highly expressed in many Neoplasms.. Matrix Metalloproteinases defined as following: A family of zinc-dependent metalloendopeptidases that is involved in the degradation of EXTRACELLULAR MATRIX components.. Adenoma defined as following: A benign epithelial tumor with a glandular organization.. Macroprolactinoma defined as following: A pituitary prolactin cell adenoma of more than 10 mm diameter. [HPO:probinson]. batimastat defined as following: A Synthesis hydroxamate with potential antineoplastic activity. Batimastat binds covalently to the zinc ion in the active site of matrix Metalloproteases (MMPs), thereby inhibiting the action of MMPs, inducing Extracellular matrix degradation, and inhibiting angiogenesis, tumor growth and invasion, and metastasis. (NCI04). Matrix Metalloproteinase 2 defined as following: A secreted endopeptidase homologous with INTERSTITIAL COLLAGENASE, but which possesses an additional fibronectin-like domain.. Tissue Inhibitor of Metalloproteinase-2 defined as following: A member of the family of TISSUE INHIBITOR OF METALLOPROTEINASES. It is a 21-kDa nonglycosylated protein found in tissue fluid and is secreted as a complex with progelatinase A by Homo sapiens fibroblast and uncomplexed from alveolar macrophages. An overexpression of Tissue Inhibitor of Metalloproteinase-2 has been shown to inhibit invasive and metastatic activity of tumor Cells and decrease tumor growth in vivo.. Prolactinoma defined as following: A pituitary adenoma which secretes PROLACTIN, leading to HYPERPROLACTINEMIA. Clinical manifestations include AMENORRHEA; GALACTORRHEA; IMPOTENCE; HEADACHE; visual disturbances; and CEREBROSPINAL FLUID RHINORRHEA.. Pituitary carcinoma defined as following: Pituitary neuroendocrine tumor that has spread from its original site of growth to another anatomic site.. Metalloproteases defined as following: Proteases which use a metal, normally ZINC, in the catalytic mechanism. This group of enzymes is inactivated by metal CHELATORS.. TP53 wt Allele defined as following: Human TP53 wild-type allele is located in the vicinity of 17p13.1 and is approximately 19 kb in length. This allele, which encodes cellular tumor antigen TP53 wt Allele protein, plays a role in cell cycle regulation during the G0/G1transition. Alterations of the TP53 gene occur as both somatic and germline mutations in Homo sapiens malignancies in select cancer-prone families with Li-Fraumeni syndrome.. FGFR4 gene defined as following: This gene plays a role in mitogenesis and differentiation.. NME1 wt Allele defined as following: Human NME1 wild-type allele is located in the vicinity of 17q21.3 and is approximately 9 kb in length. This allele, which encodes nucleoside diphosphate kinase A protein, is involved in the synthesis of three nucleoside triphosphates (CTP, GTP and UTP). A certain allelic variant of the NME1 gene is associated with advanced stage neuroblastoma.. Tissue-Inhibitor of Metalloproteinase-1 defined as following: A member of the family of TISSUE INHIBITOR OF METALLOPROTEINASES. It is a N-glycosylated protein, molecular weight 28 kD, produced by a vast range of cell types and found in a variety of tissues and body fluids. It has been shown to suppress metastasis and inhibit tumor invasion in vitro.. Matrix Metalloproteinases-1 defined as following: Interstitial collagenase (469 aa, ~54 kDa) is encoded by the Homo sapiens MMP1 gene. This protein plays a role in collagenolysis.. Growth Factor defined as following: Growth Factors are Extracellular signaling molecules (ligands) involved in control of target cell proliferation, cell survival, and cell differentiation. (NCI). Extracellular defined as following: The space external to the outermost structure of a cell. For Cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. [GOC:go_curators]. Gene Deletion defined as following: A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus.. Aggressive behavior defined as following: Behavior which may be manifested by destructive and attacking action which is verbal or physical, by covert attitudes of hostility or by obstructionism.. MKI67 gene defined as following: This gene is involved in cellular proliferation.. BCL2 gene defined as following: The B-cell leukemia/lymphoma-2 genes, responsible for blocking apoptosis in normal Cells, and associated with follicular lymphoma when overexpressed. Overexpression results from the t(14;18) translocation. The Homo sapiens c-BCL2 gene gene is located at 18q24 on the long arm of chromosome 18.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Congenital Nonbullous Ichthyosiform Erythroderma defined as following: A chronic, congenital ichthyosis inherited as an autosomal recessive trait. Infants are usually born encased in a collodion membrane which sheds within a few weeks. Scaling is generalized and marked with grayish-brown quadrilateral scales, adherent at their centers and free at the edges. In some cases, scales are so thick that they resemble armored plate.. pituitary Adenoma defined as following: A non-metastasizing tumor that arises from the adenohypophysial Cells of the anterior lobe of the pituitary gland. The tumor can be hormonally functioning or not. The diagnosis can be based on imaging studies and/or radioimmunoassays. Due to its location in the sella turcica, expansion of the tumor mass can impinge on the optic chiasm or involve the temporal lobe, third ventricle and posterior fossa A frequently associated physical finding is bitemporal hemianopsia which may progress to further visual loss.. Rattus norvegicus defined as following: The common rat, Rattus norvegicus, often used as an experimental organism.. Microvessel Density defined as following: The density of newly formed blood vessels in a tissue. Microvascular density can be used to describe the proliferation speed of a tissue, with higher density indicating faster tissue growth.. Extracellular matrix defined as following: A meshwork-like substance found within the Extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which Cells or cell lysates in culture dishes adhere.. Structure of cavernous sinus defined as following: An irregularly shaped venous space in the dura mater at either side of the sphenoid bone.. MMPI defined as following: A personality inventory consisting of statements to be asserted or denied by the individual. The patterns of response are characteristic of certain personality attributes.. Homo sapiens defined as following: Members of the species Homo sapiens.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Synthesis defined as following: The process of producing a chemical compound, usually by the union of simpler chemical compounds.. Chromosomes, Human, Pair 11 defined as following: A specific pair of GROUP C CHROMOSOMES of the Homo sapiens chromosome classification.. matrix Metalloproteases defined as following: A family of zinc-dependent metalloendopeptidases that is involved in the degradation of EXTRACELLULAR MATRIX components..", "label": "yes"} {"original_question": "Do thyroid hormone receptors change after brain injury?", "id": "converted_1507", "sentence1": "Do thyroid hormone receptors change after brain injury?", "sentence2": "For example, the T3 thoracic segmental innervation thoracic segmental innervation receptor alpha was predominantly expressed in stroke-tissue, indicating that regeneration of nerves in stroke tissue may be facilitated by increased T3 thoracic segmental innervation thoracic segmental innervation receptor alpha expression., TRα expression was also increased in Homo sapiens infants with IVH. , Thus, in infants with IVH the combined elevation in deiodinase-3 and reduction in deiodinase-2 decreases TH signaling that can be worsened by an increase in unliganded TRα. , A rapid increase of the total number of Binding Sites for T3 thoracic segmental innervation thoracic segmental innervation appeared within 30 min of Ischemia Procedure and reached over 40% by 3 h. During the same 3-h period, the relative binding affinity was reduced by 25%. Upon recirculation after 30 min or 3 h of Ischemia Procedure, a rapid reversal of measured T3 thoracic segmental innervation thoracic segmental innervation Binding Sites occurred, which progressed to 20-30% below the control value by the recirculation period of 3 h. [SEP]Relations: siRNA binding has relations: molfunc_protein with FMR1, molfunc_protein with FMR1, molfunc_protein with TLR7, molfunc_protein with TLR7, molfunc_protein with AGO2, molfunc_protein with AGO2, molfunc_protein with TLR9, molfunc_protein with TLR9, molfunc_protein with TARBP2, molfunc_protein with TARBP2. Definitions: Binding Sites defined as following: The parts of a macromolecule that directly participate in its specific combination with another molecule.. Ischemia Procedure defined as following: A surgical procedure during which the blood supply to an organ or tissue is interrupted and then later reestablished.. Homo sapiens defined as following: Members of the species Homo sapiens.. brain injury defined as following: Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.. thyroid hormone defined as following: Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs..", "label": "yes"} {"original_question": "Are Ultra-conserved elements (UCEs) enriched in segmental duplications?", "id": "converted_1959", "sentence1": "Are Ultra-conserved elements (UCEs) enriched in segmental duplications?", "sentence2": "Here we address the process by which CNVs become depleted of UCEs., We begin by showing that depletion for UCEs characterizes the most recent large-scale Homo sapiens CNV datasets and then find that even newly formed de novo CNVs, which have passed through meiosis at most once, are significantly depleted for UCEs., In striking contrast, CNVs arising specifically in Primary malignant neoplasm cells are, as a rule, not depleted for UCEs and can even become significantly enriched., Alternatively, lack of depletion for UCEs from Primary malignant neoplasm CNVs may reflect the diseased state. , ULEs are located in intergenic or intronic regions and are depleted from segmental duplications., Interestingly, Homo sapiens UCEs have been reported to be strongly depleted among segmental duplications and benign copy number variants (CNVs)., In addition, here we show that these elements are preferentially found in pathogenic deletions (enrichment ratio 3.6 vs. 0.5 in duplications), and that this association is not related with a higher content of Genes., In contrast, pathogenic CNVs lacking UCEs showed almost a threefold higher content in Genes, We have demonstrated that nonexonic UCEs are depleted among segmental duplications (SDs) and copy number variants (CNVs) and proposed that their ultraconservation may reflect a mechanism of copy counting via comparison., Mammalian ultraconserved elements are strongly depleted among segmental duplications and copy number variants., Here, we show that UCEs are significantly depleted among segmental duplications and copy number variants. Notably, of the UCEs that are found in segmental duplications or copy number variants, the majority overlap Exons, indicating, along with other findings presented, that UCEs overlapping Exons represent a distinct subset., Ultraconserved elements (UCEs) are strongly depleted from segmental duplications and copy number variations (CNVs) in the Homo sapiens genome, suggesting that Gene Deletion Abnormality or duplication of a NAGPA gene can be deleterious to the Mammalian Cell., Here, we show that UCEs are significantly depleted among segmental duplications and copy number variants., We have demonstrated that nonexonic UCEs are depleted among segmental duplications (SDs) and copy number variants (CNVs) and proposed that their ultraconservation may reflect a mechanism of copy counting via comparison., Here, we show that UCEs are significantly depleted among segmental duplications and copy number variants., Ultraconserved elements (UCEs) are strongly depleted from segmental duplications and copy number variations (CNVs) in the Homo sapiens genome, suggesting that Gene Deletion Abnormality or duplication of a NAGPA gene can be deleterious to the Mammalian Cell, melanogaster genome revealed depletion of the P-element and piggyBac Clinical act of insertion in and around the Sophophora UCEs., Mammalian ultraconserved elements are strongly depleted among segmental duplications and copy number variants., Here, we show that UCEs are significantly depleted among segmental duplications and copy number variants., Interestingly, Homo sapiens UCEs have been reported to be strongly depleted among segmental duplications and benign copy number variants (CNVs).[SEP]Relations: mammalian vulva has relations: anatomy_protein_present with CCS, anatomy_protein_present with CCS, anatomy_protein_absent with UCN3, anatomy_protein_absent with UCN3, anatomy_protein_present with UCHL5, anatomy_protein_present with UCHL5, anatomy_protein_present with UCP2, anatomy_protein_present with UCP2, anatomy_protein_present with EFS, anatomy_protein_present with EFS. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Primary malignant neoplasm cells defined as following: Cells of, or derived from, a malignant tumor.. Exons defined as following: The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA.. Homo sapiens defined as following: Members of the species Homo sapiens.. Clinical act of insertion defined as following: The act of putting one thing into another.. Mammalian Cell defined as following: A cell originating from or isolated from an animal of class Mammalia.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "no"} {"original_question": "Does deflazacort have more side effects than prednisone?", "id": "converted_2264", "sentence1": "Does deflazacort have more side effects than prednisone?", "sentence2": "Though deflazacort and prednisone improve clinical endpoints in Duchenne muscular dystrophy (Muscular Dystrophy, Duchenne) patients, deflazacort produces fewer side effects.[SEP]Relations: deflazacort has relations: drug_drug with Prednisone, drug_drug with Prednisone, drug_drug with Prednisolone, drug_drug with Prednisolone, drug_drug with Meprednisone, drug_drug with Meprednisone, drug_drug with Prednylidene, drug_drug with Prednylidene, drug_drug with Methylprednisone, drug_drug with Methylprednisone. Definitions: deflazacort defined as following: A synthetic glucocorticoid prodrug, with anti-inflammatory and immunomodulating properties. Upon administration, the active metabolite of deflazacort, 21-desacetyl deflazacort, binds to and activates tissue glucocorticoid receptors. This results in the inhibition of specific leukocyte functions and the inhibition of proinflammatory cytokine production.. Muscular Dystrophy, Duchenne defined as following: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415). deflazacort defined as following: A synthetic glucocorticoid prodrug, with anti-inflammatory and immunomodulating properties. Upon administration, the active metabolite of deflazacort, 21-desacetyl deflazacort, binds to and activates tissue glucocorticoid receptors. This results in the inhibition of specific leukocyte functions and the inhibition of proinflammatory cytokine production.. prednisone defined as following: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver..", "label": "no"} {"original_question": "Has the presence of delayed enhancement been documented in athletes performing strenuous exercise?", "id": "converted_1354", "sentence1": "Has the presence of delayed enhancement been documented in athletes performing strenuous exercise?", "sentence2": "Atypical findings such as marked cardiac dilation, reduced deformation, or small patches of delayed gadolinium enhancement may be commonly encountered in well-trained athletes, but, at present, the prognostic significance of such findings is unknown. , On CMR, DGE localized to the Ventricular septum was identified in 5 of 39 athletes who had greater cumulative exercise exposure and lower RVEF (47.1 ± 5.9 vs. 51.1 ± 3.7%, P = 0.042) than those with normal CMR., Post-event cardiac MRI demonstrated the Parameterized Data Type - Interval appearance of delayed enhancement of gadolinium at the inferior insertion of the right ventricle and in the Ventricular septum-a novel finding that may represent subtle Inflammation secondary to a combined exercise and altitude effect., No evidence of delayed enhancement of the left ventricular myocardium was found on CMR imaging, suggesting that the increase in cardiac biomarkers after the marathon may not have be due to Myocardial Infarction., Of the 102 runners, five had a cyclophosphamide/dacarbazine/doxorubicin protocol pattern of LGE, and seven had a non-cyclophosphamide/dacarbazine/doxorubicin protocol pattern of LGE. The cyclophosphamide/dacarbazine/doxorubicin protocol pattern of LGE was located in the Geographic state of the left anterior descending coronary artery more frequently than was the non-cyclophosphamide/dacarbazine/doxorubicin protocol pattern (P = .0027, Fisher exact test). The prevalence of LGE in runners was higher than that in age-matched control subjects (12% vs 4%; P = .077, McNemar exact test).[SEP]Relations: myocardial infarction has relations: contraindication with Nylidrin, contraindication with Nylidrin, contraindication with Fosamprenavir, contraindication with Fosamprenavir, contraindication with Lansoprazole, contraindication with Lansoprazole, contraindication with Drospirenone, contraindication with Drospirenone, contraindication with Modafinil, contraindication with Modafinil. Definitions: Ventricular septum defined as following: The muscular structure separating the right and the left lower chambers (HEART VENTRICLES) of the heart. The ventricular septum consists of a very small membranous portion just beneath the AORTIC VALVE, and a large thick muscular portion consisting of three sections including the inlet septum, the trabecular septum, and the outlet septum.. Myocardial Infarction defined as following: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).. gadolinium defined as following: An element of the rare earth family of metals. It has the atomic symbol Gd, atomic number 64, and atomic weight 157.25. Its oxide is used in the control rods of some nuclear reactors.. Geographic state defined as following: A constituent administrative district of a nation.. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. strenuous exercise defined as following: 20-60 minutes of exercise which elevates your heart rate to 80-90% of your maximum heart rate performed at least 3-4 times per week..", "label": "yes"} {"original_question": "Are there sex differences in oncogenic mutational processes?", "id": "converted_4152", "sentence1": "Are there sex differences in oncogenic mutational processes?", "sentence2": "Gender:Type:Point in time:^Patient:Nominal differences in oncogenic mutational processes.[SEP]", "label": "yes"} {"original_question": "Is Hemochromatosis type 4 is caused by a mutation in a recessive gene?", "id": "converted_3466", "sentence1": "Is HEMOCHROMATOSIS, TYPE 4 is caused by a Mutation Abnormality in a recessive Genes?", "sentence2": " severely affect iron homeostasis causing type 4 hereditary hemochromatosis, an Autosome dominant iron overload condition with variable phenotypic manifestations, HEMOCHROMATOSIS, TYPE 4, also known as SLC40A1 Genes disease, is an Autosome dominant genetic disorder caused by pathogenic Gene Mutation in the SLC40A1 Genes, which encodes SLC40A1 Genes 1 (FPN1)., HEMOCHROMATOSIS, TYPE 4 is a rare form of primary iron overload transmitted as an Autosome dominant trait caused by Gene Mutation in the Genes encoding the iron transport protein SLC40A1 Genes 1 (SLC40A1)., Type 4 hemochromatosis follows an Autosome dominant trait; the corresponding Mutation Abnormality affects the basolateral iron carrier SLC40A1 Genes 1., Type 4 hemochromatosis follows an Autosome dominant trait; the corresponding Mutation Abnormality affects the basolateral iron carrier SLC40A1 Genes 1, Type 4 hemochromatosis follows an Autosome dominant trait; the corresponding Mutation Abnormality affects the basolateral iron carrier SLC40A1 Genes 1.[SEP]Relations: hemochromatosis has relations: disease_phenotype_positive with Autosomal recessive inheritance, disease_phenotype_positive with Autosomal recessive inheritance, disease_disease with hereditary hemochromatosis, disease_disease with hereditary hemochromatosis, disease_phenotype_positive with Autosomal dominant inheritance, disease_phenotype_positive with Autosomal dominant inheritance, disease_protein with BMP6, disease_protein with BMP6. SLC40A1 has relations: pathway_protein with Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum), pathway_protein with Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum). Definitions: Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. HEMOCHROMATOSIS, TYPE 4 defined as following: A form of rare hereditary hemochromatosis, a group of diseases characterized by excessive tissue iron deposition of genetic origin. Type 4 is less rare than the other rare forms of hereditary hemochromatosis. The disease is phenotypically heterogeneous with two sub-types. Ferroportin disease form A is the usual form and is generally asymptomatic with no tissue damage and further complications. Ferroportin disease form B is rarer and resembles hemochromatosis type 1, but can affect children. Ferroportin disease is due to Gene Mutation in the SLC40A1 Genes located on chromosome 2, which encodes for SLC40A1 Genes (FPN), an iron exporter negatively regulated by the hepcidin hormone. Transmission is Autosome dominant.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Autosome defined as following: Any chromosome other than a sex chromosome. [GOC:mah]. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA.. recessive Genes defined as following: Genes that influence the PHENOTYPE only in the homozygous state..", "label": "no"} {"original_question": "Is Ameloblastoma (AB) a benign tumor that never metastasizes?", "id": "converted_4677", "sentence1": "Is Ameloblastoma (AB) a benign tumor that never metastasizes?", "sentence2": "Ameloblastic carcinoma (cyclophosphamide/doxorubicin protocol) is defined as a rare primary epithelial odontogenic malignant neoplasm and the malignant counterpart of benign epithelial Odontogenic Tumors of ameloblastoma (AB) by the WHO classification, cyclophosphamide/doxorubicin protocol develops pulmonary metastasis in about one third of the patients and reveals a poor prognosis, Ameloblastomas are benign but locally invasive Neoplasms which may grow to massive proportions and cause significant morbidity. Although some types of ameloblastoma can be treated predictably with aggressive surgical treatment, recurrent ameloblastoma and metastasising ameloblastoma are still difficult to treat., Ameloblastoma of the Maxilla is a rare Odontogenic Tumors that rarely metastasizes., Ameloblastoma is an Odontogenic Tumors, usually benign, which rarely metastasizes to distant organs., Although ameloblastomas rarely metastasise, recurrences together with radical surgery often result in facial deformity and significant morbidity., The World Health Organization (WHO) has defined Malignant Ameloblastoma (MA) as a histologically benign-appearing ameloblastoma that has metastasized., Distant metastasis is a very rare condition and is designated as metastasizing (malignant) ameloblastoma despite its benign histological appearance., Ameloblastoma is a locally invasive, histologically nonmalignant tumor that may on very rare occasions give rise to metastases.[SEP]Relations: ameloblastoma has relations: disease_disease with musculoskeletal system benign neoplasm, disease_disease with musculoskeletal system benign neoplasm, disease_disease with musculoskeletal system benign neoplasm, disease_disease with musculoskeletal system benign neoplasm, disease_disease with benign epithelial neoplasm, disease_disease with benign epithelial neoplasm, disease_disease with benign epithelial neoplasm, disease_disease with benign epithelial neoplasm, disease_disease with bone ameloblastoma, disease_disease with bone ameloblastoma. Definitions: Ameloblastoma defined as following: An immature epithelial tumor of the JAW originating from the epithelial rests of Malassez or from other epithelial remnants of the ENAMEL from the developmental period. It is a slowly growing tumor, usually benign, but displays a marked propensity for invasive growth.. Maxilla defined as following: One of a pair of irregularly shaped bones that form the upper jaw. A maxillary bone provides tooth sockets for the superior teeth, forms part of the ORBIT, and contains the MAXILLARY SINUS.. Odontogenic Tumors defined as following: Neoplasms produced from tooth-forming tissues.. Ameloblastic carcinoma defined as following: A rare, cytologically Malignant Ameloblastoma that may metastasize.. Neoplasms defined as following: New abnormal growth of tissue. Malignant Neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign Neoplasms.. Malignant Ameloblastoma defined as following: A rare, well differentiated, cytologically benign ameloblastoma which paradoxically metastasizes.. benign tumor defined as following: A neoplasm which is characterized by the absence of morphologic features associated with malignancy (severe cytologic atypia, tumor cell necrosis, and high mitotic rate). Benign Neoplasms remain confined to the original site of growth and do not metastasize to other anatomic sites..", "label": "no"} {"original_question": "Is cohesin linked to myeloid differentiation?", "id": "converted_2787", "sentence1": "Is cohesins linked to myeloid differentiation?", "sentence2": "Consistent with a role for inflammatory signals in promoting myeloid differentiation of hematopoietic stem and Stem cells (HPSCs), cohesins mutations in HSPCs led to reduced inflammatory gene expression and increased resistance to differentiation-inducing inflammatory stimuli. These findings uncover an unexpected dependence of inducible gene expression on cohesins, link cohesins with myeloid differentiation, and may help explain the prevalence of cohesins mutations in Homo sapiens Leukemia, Myelocytic, Acute., Consistent with a role for inflammatory signals in promoting myeloid differentiation of hematopoietic stem and Stem cells (HPSCs), cohesins mutations in HSPCs led to reduced inflammatory gene expression and increased resistance to differentiation-inducing inflammatory stimuli., These findings uncover an unexpected dependence of inducible gene expression on cohesins, link cohesins with myeloid differentiation, and may help explain the prevalence of cohesins mutations in Homo sapiens Leukemia, Myelocytic, Acute.
[SEP]Relations: acute promyelocytic leukemia has relations: disease_disease with Leukemia, Myelocytic, Acute with recurrent genetic anomaly, disease_disease with Leukemia, Myelocytic, Acute with recurrent genetic anomaly, disease_protein with GLI2, disease_protein with GLI2, disease_protein with DEFA3, disease_protein with DEFA3, disease_phenotype_positive with Ecchymosis, disease_phenotype_positive with Ecchymosis, disease_phenotype_positive with Gingival bleeding, disease_phenotype_positive with Gingival bleeding. Definitions: Leukemia, Myelocytic, Acute defined as following: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.. Stem cells defined as following: Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide Stem cells that can differentiate into specialized cells.. Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Do bacteria from the genus Morexella cause respiratory infections?", "id": "converted_2347", "sentence1": "Do Bacteria from the genus Morexella cause respiratory infections?", "sentence2": "gainst pathogens associated with respiratory tract ailments [Staphylococcus aureus antibody antibody (ATCC 25923), Pneumonia due to Pneumonia due to Klebsiella pneumoniae (ATCC 13883) and Morexella cattarhalis (ATCC 14468)] , The efficacy and safety of oral ofloxacin, 400 mg once daily, for the treatment of patients with lower Respiratory Tract Infections were studied. The most common species recovered from the sputum specimens of these patients were Haemophilus influenzae, followed by Streptococcus pneumoniae (S. pneumoniae), Staphylococcus aureus antibody antibody (Staphylococcus aureus antibody), Gram positive cocci unidentified, Pseudomonas aeruginosa (P. aeruginosa), Morexella catarrhalis,, the efficacy and safety of oral ofloxacin 400 mg once daily for the treatment of patients with lower Respiratory Tract Infections were studied the most common species recovered from the sputum specimens of these patients were Haemophilus influenzae or Haemophilus parainfluenzae followed by streptococcus pneumoniae s pneumoniae staphylococcus aureus s aureus gram positive cocci unidentified pseudomonas aeruginosa p aeruginosa morexella catarrhalis streptococcus epidermidis and another haemophilus species in this order all these Bacteria were susceptible to ofloxacin except for one strain of methicillin resistant s aureus a satisfactory clinical outcome was achieved in 34 of 40 patients 85 it is concluded that ofloxacin 400 mg once daily is useful for patients with Respiratory Tract Infections.[SEP]Relations: Respiratory tract infection has relations: phenotype_phenotype with Pneumonia, phenotype_phenotype with Pneumonia, phenotype_phenotype with Acute infectious pneumonia, phenotype_phenotype with Acute infectious pneumonia, drug_effect with Deferasirox, drug_effect with Deferasirox, phenotype_phenotype with Recurrent respiratory infections, phenotype_phenotype with Recurrent respiratory infections. Ofloxacin has relations: drug_effect with Respiratory tract infection, drug_effect with Respiratory tract infection. Definitions: ofloxacin defined as following: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.. methicillin defined as following: One of the PENICILLINS which is resistant to PENICILLINASE but susceptible to a penicillin-binding protein. It is inactivated by gastric acid so administered by injection.. Respiratory Tract Infections defined as following: Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.. Streptococcus pneumoniae defined as following: A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals.. Staphylococcus aureus defined as following: Potentially pathogenic Bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.. Bacteria defined as following: One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive.. respiratory infections defined as following: Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases..", "label": "yes"} {"original_question": "Are there roles for cohesin mutations in AML?", "id": "converted_4699", "sentence1": "Are there roles for cohesins mutations in Leukemia, Myelocytic, Acute?", "sentence2": "Several landmark studies have shown that cohesins mutations perturb the balance between self-renewal and differentiation of hematopoietic stem and Stem cells (PSMA7 gene). Emerging data now begin to uncover the molecular mechanisms that underpin this phenotype. Among these mechanisms is a role for cohesins in the control of inflammatory responses in HSPCs and Myeloid Cells. Inflammatory signals limit PSMA7 gene self-renewal and drive PSMA7 gene differentiation. Consistent with this, cohesins mutations promote resistance to inflammatory signals, and may provide a selective advantage for Leukemia, Myelocytic, Acute progression. [SEP]Relations: acute promyelocytic leukemia has relations: disease_protein with PML, disease_protein with PML, disease_phenotype_positive with Somatic mutation, disease_phenotype_positive with Somatic mutation, disease_protein with ASXL1, disease_protein with ASXL1, disease_protein with GLI2, disease_protein with GLI2, disease_phenotype_positive with Gingival bleeding, disease_phenotype_positive with Gingival bleeding. Definitions: Leukemia, Myelocytic, Acute defined as following: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.. Myeloid Cells defined as following: The classes of BONE MARROW-derived blood cells in the monocytic series (MONOCYTES and their precursors) and granulocytic series (GRANULOCYTES and their precursors).. Stem cells defined as following: Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide Stem cells that can differentiate into specialized cells..", "label": "yes"} {"original_question": "Is imatinib an antidepressant drug?", "id": "converted_1653", "sentence1": "Is imatinib an antidepressant drug?", "sentence2": "Gastrointestinal stromal tumor (GIST) is the most common Mesenchymal Cell Neoplasm of the Multisection:Find:Pt:Abdomen+Pelvis>Gastrointestinal tract:Doc:US. Surgery remains the elective treatment. We retrospectively compared two group of patients, who underwent surgery for GIST before and after imatinib advent in order to analyze the recurrence and survival rate., Adjuvant imatinib 400 mg/day for 3 years duration is a standard treatment in all patients with significant risk of recurrence following resection of primary GISTs, R1 surgery (versus R0) alone is not an indication for adjuvant imatinib in low-risk GIST., Treatment is not recommended in an imatinib-insensitive D842V-mutated GIST, Prognostic factors such as tumor size, mitotic rate and presence of metastases may provide an indication for adjuvant imatinib mesylate (IM) treatment. Here we present a young patient with a large GIST with high-risk features who is in complete remission after surgical excision and adjuvant IM treatment. This patient is the only colon-located CD117-positive case where IM was administered., imatinib mesylate is the sole BCR-ABL Protein Tyrosine Kinase PPP1R1A gene approved as first-line treatment of accelerated-phase (AP) Philadelphia chromosome positive chronic myelogenous leukemia (Myeloid Leukemia, Chronic)., imatinib mesylate could be a therapeutic target of strategies against Osteosarcoma., allogeneic hematopoietic stem cell transplant (HSCT) is well-established as a potentially curative treatment for patients who have Philadelphia chromosome positive chronic myelogenous leukemia. The success of imatinib and other Protein Tyrosine Kinase inhibitors (TKI) as initial therapy has changed the treatment paradigm for this Disease., imatinib plus hydroxyurea is well tolerated among patients with Benign Meningioma but has modest anti-tumor activity for this indication., MKI67 gene correlated with time to recurrence (p=0.022). MKI67 gene >11% was taken as the indication to start imatinib chemotherapy (sensitivity 61.5%, specificity 92.0%, p=0.022)., Significant pharmacokinetic interactions have already been shown between St. John's Wort (SJW) and the anticancer drugs imatinib and irinotecan., for Myeloid Leukemia, Chronic we analysed imatinib, dasatinib and nilotinib., imatinib mesylate, an orally administered kinase PPP1R1A gene that targets the Kit (CD117) protein, currently has 10 approved indications including treatment of chronic myelogenous leukemia and Metastatic Gastrointestinal Stromal Tumor (GIST)., The drugs were assessed according to clinical evidence on efficacy and safety, based on Micromedex categorization, on systematic reviews and meta-analyses. Indications present in the legal documentation were compared to the indications approved by regulatory agencies. RESULTS: bevacizumab, capecitabine, cetuximab, erlotinib, rituximab, imatinib, and temozolomide, BCR-ABL Fusion Gene, an Oncogenes responsible for Myeloid Leukemia, Chronic, BCR-ABL Fusion Gene-expressing Cells showed resistance to Cessation of life activated by spindle defects, reversed by imatinib., imatinib, an oral Protein Tyrosine Kinase PPP1R1A gene (TKI), is first-line treatment in patients with metastatic or unresectable GIST., Surgical indication for metastatic Gastrointestinal Stromal Tumors (GIST) treated with imatinib is not yet established., Surgery of residual Disease upon best clinical response seems associated with survival benefit compared with historical controls in similar patient collectives treated with imatinib alone., To explore the effect of preoperative imatinib mesylate (IM) in patients with unresectable or locally advanced primary Gastrointestinal Stromal Tumors (GIST), The patient had been diagnosed 14 months earlier and had been submitted to surgery, followed by adjuvant radiotherapy and temozolomide-based chemotherapy. On clinical suspicion of recurrence 5 months later, magnetic resonance imaging (MRI) revealed a lesion at the site of preceded surgery, which was treated by imatinib mesylate, Radical surgery remains the most effective method of GIST treatment. In inoperable/metastatic lesion the treatment of choice is tyrosinase kinase PPP1R1A gene--imatinib., imatinib mesylate (STI571), a specific BCR-ABL Fusion Gene PPP1R1A gene, has shown a potent antileukemic activity in clinical studies of Philadelphia chromosome positive chronic myelogenous leukemia (Myeloid Leukemia, Chronic) patients., imatinib, an PPP1R1A gene of the Protein Tyrosine Kinase activity of Mast/Stem Cell Growth Factor Receptor Kit, human, was used as an adjuvant chemotherapy in two patients who underwent curative surgery for recurrent gastrointestinal stromal tumors., Adjuvant imatinib 400 mg/day for 3 years duration is a standard treatment in all patients with significant risk of recurrence following resection of primary GISTs.[SEP]Relations: imatinib has relations: drug_drug with Afatinib, drug_drug with Afatinib, drug_drug with Cocaine, drug_drug with Cocaine, drug_drug with Lapatinib, drug_drug with Lapatinib, drug_drug with Adenosine, drug_drug with Adenosine, drug_drug with Nevirapine, drug_drug with Nevirapine. Definitions: Protein Tyrosine Kinase defined as following: Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors.. Metastatic Gastrointestinal Stromal Tumor defined as following: Gastrointestinal stromal tumor which has spread from its original site of growth to another anatomic site.. irinotecan defined as following: A semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Irinotecan, a prodrug, is converted to a biologically active metabolite 7-ethyl-10-hydroxy-camptothecin (SN-38) by a carboxylesterase-converting enzyme. One thousand-fold more potent than its parent compound irinotecan, SN-38 inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks that inhibit DNA replication and trigger apoptotic cell Cessation of life. Because ongoing DNA synthesis is necessary for irinotecan to exert its cytotoxic effects, it is classified as an S-phase-specific agent.. capecitabine defined as following: A deoxycytidine derivative and fluorouracil PRODRUG that is used as an ANTINEOPLASTIC ANTIMETABOLITE in the treatment of COLON CANCER; BREAST CANCER and GASTRIC CANCER.. Gastrointestinal Stromal Tumors defined as following: All tumors in the GASTROINTESTINAL TRACT arising from mesenchymal Cells (MESODERM) except those of smooth muscle Cells (LEIOMYOMA) or Schwann Cells (SCHWANNOMA).. Philadelphia chromosome positive chronic myelogenous leukemia defined as following: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.. erlotinib defined as following: A quinazoline derivative with antineoplastic properties. Competing with adenosine triphosphate, erlotinib reversibly binds to the intracellular catalytic domain of epidermal growth factor receptor (EGFR) Protein Tyrosine Kinase, thereby reversibly inhibiting EGFR phosphorylation and blocking the signal transduction events and tumorigenic effects associated with EGFR activation.. Benign Meningioma defined as following: A grade I, slowly growing Benign Meningioma. Only a minority of tumors recur following complete resection.. Osteosarcoma defined as following: A sarcoma originating in bone-forming Cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed). BCR-ABL Fusion Gene defined as following: A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active Protein Tyrosine Kinase activity. This fusion is associated with both Philadelphia chromosome positive chronic myelogenous leukemia and acute lymphoblastic leukemia.. Mesenchymal Cell Neoplasm defined as following: A benign, intermediate, or malignant neoplasm that arises from the mesenchyma-derived Cells of the soft tissue or bone. Representative examples include lipoma, leiomyoma, leiomyosarcoma and osteosarcoma.. hydroxyurea defined as following: An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.. nilotinib defined as following: An orally bioavailable aminopyrimidine-derivative BCR-ABL Fusion Gene Protein Tyrosine Kinase PPP1R1A gene with antineoplastic activity. Designed to overcome imatinib resistance, nilotinib binds to and stabilizes the inactive conformation of the kinase domain of the Abl protein of the BCR-ABL Fusion Gene fusion protein, resulting in the inhibition of the BCR-ABL Fusion Gene-mediated proliferation of Philadelphia chromosome-positive (Ph+) Philadelphia chromosome positive chronic myelogenous leukemia (Myeloid Leukemia, Chronic) Cells. This agent also inhibits the receptor tyrosine kinases platelet-derived growth factor receptor (PDGF-R) and Mast/Stem Cell Growth Factor Receptor Kit, human, a receptor Protein Tyrosine Kinase mutated and constitutively activated in most gastrointestinal stromal tumors (GISTs). With a binding mode that is energetically more favorable than that of imatinib, nilotinib has been shown to have an approximately 20-fold increased potency in kinase and proliferation assays compared to imatinib.. imatinib defined as following: An antineoplastic agent that inhibits the BCR-ABL Fusion Gene fusion protein Protein Tyrosine Kinase, an abnormal enzyme produced by Philadelphia chromosome positive chronic myelogenous leukemia Cells that contain the Philadelphia chromosome. imatinib also inhibits the receptor tyrosine kinases for platelet-derived growth factor (PDGF) and stem cell factor (SCF)/Mast/Stem Cell Growth Factor Receptor Kit, human; the SCF/Mast/Stem Cell Growth Factor Receptor Kit, human receptor Protein Tyrosine Kinase is activated in Gastrointestinal Stromal Tumors (GIST). This agent inhibits proliferation and induces apoptosis in Cells that overexpress these oncoproteins.. Protein Tyrosine Kinase PPP1R1A gene defined as following: Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. MKI67 gene defined as following: This gene is involved in cellular proliferation.. cetuximab defined as following: A chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors.. Oncogenes defined as following: Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of \"v-\" before Oncogenes symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix \"c-\" before the gene symbol of an Oncogenes indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-Oncogenes.. Myeloid Leukemia, Chronic defined as following: chronic leukemia in which myeloid progenitor Cells predominate; the hallmark of Myeloid Leukemia, Chronic, the Philadelphia chromosome, is a reciprocal translocation between chromosomes 9 and 22 which activates the proto- Oncogenes c-abl.. Mast/Stem Cell Growth Factor Receptor Kit, human defined as following: Mast/stem cell growth factor receptor Kit (976 aa, ~110 kDa) is encoded by the human KIT gene. This protein is involved in cell survival, tyrosine phosphorylation and ligand-mediated signaling.. rituximab defined as following: A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.. temozolomide defined as following: A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.. dasatinib defined as following: An orally bioavailable synthetic small molecule-PPP1R1A gene of SRC-family protein-tyrosine kinases. Dasatinib binds to and inhibits the growth-promoting activities of these kinases. Apparently because of its less stringent binding affinity for the BCR-ABL kinase, dasatinib has been shown to overcome the resistance to imatinib of Philadelphia chromosome positive chronic myelogenous leukemia (Myeloid Leukemia, Chronic) Cells harboring BCR-ABL kinase domain point mutations. SRC-family protein-tyrosine kinases interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways; tumorigenic forms can occur through altered regulation or expression of the endogenous protein and by way of virally-encoded kinase genes.. Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. bevacizumab defined as following: An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS.. BCR-ABL Fusion Gene PPP1R1A gene defined as following: Any agent that inhibits the Protein Tyrosine Kinase BCR-ABL.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. imatinib defined as following: An antineoplastic agent that inhibits the BCR-ABL Fusion Gene fusion protein Protein Tyrosine Kinase, an abnormal enzyme produced by Philadelphia chromosome positive chronic myelogenous leukemia Cells that contain the Philadelphia chromosome. imatinib also inhibits the receptor tyrosine kinases for platelet-derived growth factor (PDGF) and stem cell factor (SCF)/Mast/Stem Cell Growth Factor Receptor Kit, human; the SCF/Mast/Stem Cell Growth Factor Receptor Kit, human receptor Protein Tyrosine Kinase is activated in Gastrointestinal Stromal Tumors (GIST). This agent inhibits proliferation and induces apoptosis in Cells that overexpress these oncoproteins..", "label": "no"} {"original_question": "Are there tools for reviewing variant calls?", "id": "converted_2947", "sentence1": "Are there tools for reviewing variant calls?", "sentence2": "VIPER: a web application for rapid expert review of variant calls., With the rapid development in next-generation sequencing, cost and time requirements for genomic sequencing are decreasing, enabling applications in many areas such as cancer research. Many tools have been developed to analyze genomic variation ranging from single nucleotide Variant to whole chromosomal aberrations. As sequencing throughput increases, the number of Variant called by such tools also grows. Often employed manual inspection of such calls is thus becoming a time-consuming procedure. We developed the Variant InsPector and Expert Rating tool (VIPER) to speed up this process by integrating the Integrative Genomics Viewer into a web application. analysts can then quickly iterate through Variant, apply filters and make decisions based on the generated images and variant metadata. VIPER was successfully employed in analyses with manual inspection of more than 10 000 calls.Availability and implementation: VIPER is implemented in Java and Javascript and is freely available at https://github.com/MarWoes/viper., Variant Review with the Integrative Genomics Viewer., VIPER: a web application for rapid expert review of variant calls.Supplementary data are available at Bioinformatics online., We developed the Variant InsPector and Expert Rating tool (VIPER) to speed up this process by integrating the Integrative Genomics Viewer into a web application.[SEP]Definitions: Variant defined as following: An alteration or difference from a norm or standard..", "label": "yes"} {"original_question": "Is Annexin V an apoptotic marker?", "id": "converted_1823", "sentence1": "Is Annexin V an apoptotic marker?", "sentence2": "The apoptosis of the cyclic nucleotide-gated mechanosensitive ion channel activity was induced by subjecting the Cells to OGD conditions for 4 h and was detected by Annexin V/Pulmonary Valve Insufficiency and Hoechst 33258 staining. , In addition to the antimicrobial activity, we found that treatment of the cancer cell lines, Jurkat T-Cells, Granta Cells, and melanoma Cells, with the Pseudomonas sp. In5 crude extract increased staining with the apoptotic marker Annexin V while no staining of healthy normal Cells, i.e., naïve or activated CD4 T-Cells, was observed., At the same time, the expressions of Endoglin, human, PECAM1 wt Allele, and the apoptotic marker of Annexin V were detected through flow cytometry for analyzing the relationship between the expression of Cell surface markers and biological behavior., However, we found decreased sperm cell cell concentration, increase of morphologically abnormal Specimen Source Codes - Spermatozoa and increased binding of apoptotic marker ANXA5 gene. , human chorionic gonadotropin enhanced viability of Large Luteal Cells through antiapoptosis but not proliferation, because the apoptotic marker of ANXA5 gene was decreased, but the proliferative markers of MKI67 gene and proliferating cell Nuclear (incident type) antigen were not increased., However, as the 1,2-dioleoyloxy-3-(trimethylammonium)propane concentration increased from 50 to 800 microM, the apoptotic marker Annexin V and Reactive Oxygen Species double positive Cells increased, suggesting that high dose of 1,2-dioleoyloxy-3-(trimethylammonium)propane-generated Reactive Oxygen Species causes cell apoptosis. , Expression of the apoptotic marker ANXA5 gene was unaffected by antibiotic exposure, whereas the uptake of the necrotic marker Pulmonary Valve Insufficiency was increased by ofloxacin (5 mg/mL) but not by netilmicin (ofloxacin versus netilmicin, ANOVA, P<0.05)., he apoptotic marker of ANXA5 gene was decreased, the apoptotic marker Annexin V, Annexin V labels apoptotic neurons following hypoxia-ischemia., In the present study, the apoptotic cell population was identified immunocytochemically using Annexin V, a marker of Cells in an early stage of apoptosis., Use of ANXA5 gene immunoglobulin complex location to identify apoptotic Cells during pregnancy., Only few SF Regulatory T-Lymphocytes were apoptotic, as indicated by limited ANXA5 gene staining of these Cells., Eosinophils 'aged' in vitro for 48 h exhibited endonuclease DNA degradation, apoptotic morphology, increased red autofluorescence and externalisation of phosphatidylserine (Supernumerary mandibular right central primary incisor) as assessed by binding of FITC-labelled ANXA5 gene., In vivo detection of apoptotic Cells with fluorescently labeled ANXA5 gene is an emerging technique that we evaluated for detecting apoptotic Germ Cells in a mouse model of Testicular dysfunction torsion.Annexin V labeled with an indocyanine fluorophore (bisfunctional succinimidyl ester of cyanine 5.5) (Amersham, Little Chalfont, United Kingdom) was injected intravenously in CASP14 gene 18 hours after the repair of unilateral 720-degree Testicular dysfunction torsion for 2 hours, Here, we tested the hypothesis that enhanced endothelial apoptotic microparticles and decreased Endothelial Progenitor Cells (erucylphosphocholine) levels might contribute to the pathophysiology of Microalbuminuria or macroalbuminuria in Cardiovascular Diseases.Flow cytometry was used to assess Endothelial Cells apoptosis and circulating erucylphosphocholine levels by quantification of circulating PECAM1 wt Allele/ANXA5 gene apoptotic microparticles and erucylphosphocholine markers (defined as KDRCD133, CD34CD133, CD34KDR) in peripheral blood.In total, 125 patients with Hypertensive disease were enrolled in the study, of whom 80 patients (64%) were with Grade A1 albuminuria (ALB gene excretion rate of <20 microg/min, overnight urine samples), 35 patients (28%) with Microalbuminuria (an ALB gene excretion rate of 20-200 microg/min), and 10 patients (8%) with macroalbuminuria (an ALB gene excretion rate >200 microg/min)., Pulmonary Surfactant-Associated Protein A (SFTPA1 gene) binds to phosphatidylserine and competes with ANXA5 gene binding on late apoptotic Cells, Targeting of apoptotic macrophages and experimental atheroma with radiolabeled ANXA5 gene: a technique with potential for noninvasive imaging of vulnerable plaque, Because ANXA5 gene has a high affinity for exposed phosphatidylserine on apoptotic Cells, radiolabeled ANXA5 gene may be used for noninvasive detection of apoptosis in atherosclerotic lesions.atherosclerotic plaques were produced in 5 Family Leporidae (organism) by deendothelialization of the infradiaphragmatic aorta followed by 12 weeks of cholesterol diet; 5 controls were studied without manipulation, Apoptotic abscess imaging with 99mTc-HYNIC-rh-Annexin-V., Synthesis and evaluation of a 18F-labelled recombinant Annexin 1-V derivative, for identification and quantification of apoptotic Cells with PET., Sensitive and visible detection of apoptotic Cells on Annexin-V modified substrate using 3-aminobenzeneboronic acid modified gold Artificial Artificial nanoparticles (APBA-GNPs) labeling., Fluorescence-activated cell sorting (FACS) for expression of the early apoptosis marker Annexin V and for Nuclear (incident type) staining by 7-aminoactinomycin D D (7-AAD) revealed different extents of apoptosis versus non-apoptotic cell death for the three agents., At immunofluorescence these Cells contained lipid vesicles positive for the apoptotic cell marker Annexin V suggesting the phagocytosis of Apoptotic Bodies derived from dead fat-laden hepatocytes., In this respect, we identified binding of Annexin V as an convenient marker for apoptotic Cells., DR5 expression was elevated and associated with the apoptotic marker ANXA5 gene. Apoptosis was reduced in CD4(+) T Cells when cultured with anti-DR5 immunoglobulin complex location., Flow cytometric analysis using the apoptotic marker, Annexin V, shows that this endogenous re-expression is sufficient to drive the SCLC Cells to apoptosis., Apoptotic cell death was evaluated by staining nuclei with Propidium Iodide and phosphatidylserine (a marker of early apoptotic events) with Annexin V as well as by DNA fragmentation assay., Decreased cell growth was not caused by cell death as BEL exposure did not alter Nuclear (incident type) morphology or increase ANXA5 gene (apoptotic cell marker) or Propidium Iodide (necrotic cell marker) staining after 48 h., Four populations of Cells can be identified: region R1: vital Cells (ANXA5 gene negative/Pulmonary Valve Insufficiency negative), region R2: apoptotic Cells (ANXA5 gene positive/Pulmonary Valve Insufficiency negative), region R3: dead Cells (ANXA5 gene positive/ Pulmonary Valve Insufficiency positive); and region R4: damaged Cells (ANXA5 gene negative/Pulmonary Valve Insufficiency positive)., Furthermore, uptake of (111)In-DTPA-PEG-ANXA5 gene by Neoplasms correlated with apoptotic index (r = 0.87, P = 0.02)., Annexin V(+)/Pulmonary Valve Insufficiency(-) Cells were characterized as early apoptotic, Annexin V(+)/Pulmonary Valve Insufficiency(+) as late apoptotic and Annexin V(-)/Pulmonary Valve Insufficiency(+) as dead., Targeting ability of Annexin V for apoptotic macrophages was kept and enhanced., [18F]ANXA5 gene accumulated in the infarct area of the left ventricle, where apoptotic Cells were observed., The viability of SiHa Cells was evaluated using the MTT assay, apoptosis by acridine orange/ethidium bromide, Propidium Iodide, TUNEL assay, and Annexin V-Cy3, cell cycle distribution and mitochondrial transmembrane potential using flow cytometry, and apoptotic marker genes using quantitative real-time PCR. , Furthermore, hesperetin-induced apoptosis was confirmed by TUNEL and Annexin V-Cy3., The procedure delivers two sperm cell cell fractions: ANXA5 gene-negative (nonapoptotic) and ANXA5 gene-positive (apoptotic)., The percentage of Cells stained with ANXA5 gene, an early apoptotic marker, increased dramatically after Cytoskeleton disruption with Cytochalasin D compared with non-cytochalasin-D-treated controls (P<0.05). , Apoptotic marker Annexin V analysis showed that the apoptotic rate of NB4 Cells was increased after treatment with quercetin., The cytomorphology of NB4 Cells was assessed by Wright-stain, apoptosis rate by apoptotic marker Annexin V, and Vascular Endothelial Growth Factor A secretion level by ELISA., We have coupled ANXA5 gene with the bifunctional hydrazinonicotinamide reagent (HYNIC) to prepare technetium-99m HYNIC-ANXA5 gene and demonstrated localization of radioactivity in Body tissue undergoing apoptosis in vivo., In conlusion, these studies confirm the value of (99m)Tc-HYNIC-ANXA5 gene uptake as a marker for the detection and quantification of apoptotic Cells in vivo., The application of Annexin V labeling at electron microscopy will allow a more refined description of the morphological events occurring during apoptosis., Apoptotic Cells were identified by Annexin V-FITC/Pulmonary Valve Insufficiency staining. [SEP]Relations: Netilmicin has relations: drug_drug with Epoprostenol, drug_drug with Epoprostenol, drug_drug with Apalutamide, drug_drug with Apalutamide, drug_drug with Dexpanthenol, drug_drug with Dexpanthenol, drug_drug with Pentostatin, drug_drug with Pentostatin, drug_drug with Sisomicin, drug_drug with Sisomicin. Definitions: Endothelial Progenitor Cells defined as following: Cells derived from BONE MARROW that circulate in the adult bloodstream and possess the potential to proliferate and differentiate into mature ENDOTHELIAL CELLS.. quercetin defined as following: A flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin.. sperm cell defined as following: Mature male Germ Cells derived from SPERMATIDS. As spermatids move toward the lumen of the SEMINIFEROUS TUBULES, they undergo extensive structural changes including the loss of cytoplasm, condensation of CHROMATIN into the SPERM HEAD, formation of the ACROSOME cap, the SPERM MIDPIECE and the SPERM TAIL that provides motility.. Cell surface defined as following: The external part of the cell wall and/or plasma membrane. [GOC:jl, GOC:mtg_sensu, GOC:sm]. Artificial nanoparticles defined as following: Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of Artificial nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging.. ANXA5 gene defined as following: This gene is involved in anticoagulation processes and mediates lipid binding.. Vascular Endothelial Growth Factor A defined as following: The original member of the family of Endothelial Cells growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor Cells and referred to as \"tumor angiogenesis factor\" and \"vascular permeability factor\". Although expressed at high levels in certain tumor-derived Cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced.. Pulmonary Surfactant-Associated Protein A defined as following: An abundant pulmonary surfactant-associated protein that binds to a variety of lung pathogens, resulting in their opsinization. It also stimulates MACROPHAGES to undergo PHAGOCYTOSIS of microorganisms. Pulmonary Surfactant-Associated Protein A contains a N-terminal collagen-like domain and a C-terminal lectin domain that are characteristic of members of the collectin family of proteins.. 7-aminoactinomycin D defined as following: A fluorescent nucleic acid dye which selectively binds GC sequences in double-stranded DNA. It has a molecular weight of 1270.5, an absorbance maximun at 546 nm, and emission maximum at 647 nm. It is commonly used to discriminate viable from non-viable Cells.. immunoglobulin complex location defined as following: A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other Body tissue, or circulating in the blood or lymph. [GOC:add, GOC:jl, ISBN:0781765196]. MKI67 gene defined as following: This gene is involved in cellular proliferation.. Regulatory T-Lymphocytes defined as following: CD4-positive T Cells that inhibit immunopathology or autoimmune disease in vivo. They inhibit the immune response by influencing the activity of other cell types. Regulatory T-Cells include naturally occurring CD4+CD25+ Cells, IL-10 secreting Tr1 Cells, and Th3 Cells.. phosphatidylserine defined as following: A phospholipid with a polar serine found in phosphoester linkage to diacylglycerol.. Large Luteal Cells defined as following: A cell of the corpus luteum of the ovary that is derived from the granulosa Cells of the preovulatory follicle; it secretes progesterone and estrogen.. Apoptotic Bodies defined as following: A vesicle containing parts of a dying cell. Apoptotic bodies can be formed during the execution phase of the apoptotic process, when the cell's cytoskeleton breaks up and causes the membrane to bulge outward. These bulges may separate from the cell, taking a portion of cytoplasm with them, to become Apoptotic Bodies. These are then engulfed by phagocytic Cells, and their components recycled. Apoptotic bodies may range in size from 0.8 to 5um. [GOC:mtg_apoptosis, GOC:vesicles, PMID:15242875, PMID:24223256, Wikipedia:Apoptosis, Wikipedia:Bleb_(cell_biology)]. netilmicin defined as following: Semisynthetic 1-N-ethyl derivative of SISOMYCIN, an aminoglycoside antibiotic with action similar to gentamicin, but less ear and kidney toxicity.. Pulmonary Valve Insufficiency defined as following: Backflow of blood from the PULMONARY ARTERY into the RIGHT VENTRICLE due to imperfect closure of the PULMONARY VALVE.. Cytochalasin D defined as following: A fungal metabolite that blocks cytoplasmic cleavage by blocking formation of contractile microfilament structures resulting in multinucleated cell formation, reversible inhibition of cell movement, and the induction of cellular extrusion. Additional reported effects include the inhibition of actin polymerization, DNA synthesis, sperm cell motility, glucose transport, thyroid secretion, and growth hormone release.. Cardiovascular Diseases defined as following: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.. human chorionic gonadotropin defined as following: A sialoglycoprotein hormone secreted by the placenta and maintains the corpus luteum at the beginning of the gestation period.. proliferating cell Nuclear (incident type) antigen defined as following: Nuclear antigen with a role in DNA synthesis, DNA repair, and cell cycle progression. PCNA is required for the coordinated synthesis of both leading and lagging strands at the replication fork during DNA replication. PCNA expression correlates with the proliferation activity of several malignant and non-malignant cell types.. Endothelial Cells defined as following: Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer.. atherosclerotic defined as following: status similar or related to atherosclerosis. Propidium Iodide defined as following: A fluorescent nucleic acid dye which binds only to double-stranded nucleic acids. It has a molecular weight of 668.4, an absorbance maximum of 535nm, and an emission maximum of 617 nm. It is commonly used to determine the DNA content of a cell or to discriminate viable from non-viable Cells.. Cytoskeleton defined as following: The network of filaments, tubules, and interconnecting filamentous bridges which give shape, structure, and organization to the cytoplasm.. Endoglin, human defined as following: Endoglin (658 aa, ~71 kDa) is encoded by the human ENG gene. This protein plays a role in transforming growth factor receptor signaling.. ofloxacin defined as following: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.. Family Leporidae (organism) defined as following: Taxonomic family which includes Family Leporidae (organism) and hares.. PECAM1 wt Allele defined as following: Human PECAM1 wild-type allele is located within 17q23 and is approximately 64 kb in length. This allele, which encodes platelet Endothelial Cells adhesion molecule protein, plays a role in transendothelial migration of leukocytes, angiogenesis, integrin activation, and may inhibit platelet-collagen interactions.. Germ Cells defined as following: The reproductive Cells in multicellular organisms at various stages during GAMETOGENESIS.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Supernumerary mandibular right central primary incisor defined as following:

Supernumerary mandibular right central primary incisor

. cyclic nucleotide-gated mechanosensitive ion channel activity defined as following: Enables the transmembrane transfer of an ion by a channel that opens in response to a mechanical stress and when a cyclic nucleotide has been bound by the channel complex or one of its constituent parts. [GOC:jl, PMID:22206667]. Hypertensive disease defined as following: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), Hypertensive disease is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Reactive Oxygen Species defined as following: Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS.. Annexin V defined as following: This gene is involved in anticoagulation processes and mediates lipid binding..", "label": "yes"} {"original_question": "Can RNASeq be used for the analysis of nascent transcripts?", "id": "converted_1391", "sentence1": "Can RNASeq be used for the analysis of nascent transcripts?", "sentence2": "Here, we utilize nascent RNA sequencing to document dosage compensation during transcriptional elongation., Here we show that RNA-seq can also be used for studying nascent RNAs undergoing transcription, Conversely, the nuclear fraction shows an enrichment of unprocessed RNA compared with total RNA-seq, making it suitable for analysis of nascent transcripts and RNA processing dynamics.[SEP]Definitions: RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed).", "label": "yes"} {"original_question": "Are paralog genes co-regulated?", "id": "converted_2533", "sentence1": "Are Paralogous Gene Genes co-regulated?", "sentence2": "Co-regulation of Paralogous Gene Genes in the three-dimensional Chromatin architecture., Consequently, paralogs show correlation in gene expression whereby the mechanisms of co-regulation remain unclear. In Eukaryota, Genes are regulated in part by distal Enhancer Elements, Genetic through looping interactions with Operator gene. These looping interactions can be measured by Genome - anatomical entity-wide Chromatin conformation capture (Hi-C) experiments, which revealed self-interacting regions called topologically associating domains (Tietz syndrome). We hypothesize that paralogs share common regulatory mechanisms to enable coordinated expression according to Tietz syndrome. To test this hypothesis, we integrated paralogy annotations with Homo sapiens gene expression data in diverse Body tissue, Genome - anatomical entity-wide enhancer-Promoter associations and Hi-C experiments in Homo sapiens, Mus sp. and Canis familiaris genomes. We show that Paralogous Gene gene pairs are enriched for co-localization in the same aminoglutethimide/danazol/hydrocortisone/tamoxifen, share more often common Enhancer Elements, Genetic than expected and have increased contact frequencies over large genomic distances. Combined, our results indicate that paralogs share common regulatory mechanisms and cluster not only in the linear Genome - anatomical entity but also in the three-dimensional Chromatin architecture. This enables concerted expression of paralogs over diverse cell-types and indicate evolutionary constraints in functional Genome - anatomical entity organization., Paralog Genes arise from gene duplication events during evolution, which often lead to similar Proteins that cooperate in common pathways and in protein complexes. Consequently, paralogs show correlation in gene expression, We hypothesize that paralogs share common regulatory mechanisms to enable coordinated expression according to Tietz syndrome., Further, interspecific changes in Testis bias of expression are generally correlated within the co-regulated pairs and are anti-correlated within the anti-regulated pairs, suggesting coordinated regulation within both types of paralogous gene pairs., Analysis of the Drosophila melanogaster Inferior Colliculus transcriptome reveals coordinate regulation of paralogous Genes., Further, interspecific changes in Testis bias of expression are generally correlated within the co-regulated pairs and are anti-correlated within the anti-regulated pairs, suggesting coordinated regulation within both types of paralogous gene pairs.
, Consequently, paralogs show correlation in gene expression whereby the mechanisms of co-regulation remain unclear., Co-regulation of Paralogous Gene Genes in the three-dimensional Chromatin architecture., Further, interspecific changes in Testis bias of expression are generally correlated within the co-regulated pairs and are anti-correlated within the anti-regulated pairs, suggesting coordinated regulation within both types of paralogous gene pairs.., We show that Paralogous Gene gene pairs are enriched for co-localization in the same aminoglutethimide/danazol/hydrocortisone/tamoxifen, share more often common Enhancer Elements, Genetic than expected and have increased contact frequencies over large genomic distances. , MiRNA Genes are often subject to co-evolutionary changes together with their target transcripts, which may be reflected by differences between Paralogous Gene Mus sp. and primate miRNA/mRNA pairs., We characterize the collapse over time through the distribution of runs of reduced Paralogous Gene pairs in duplicated segments., In addition, we identified 81 co-regulated regions on the Homo sapiens Genome - anatomical entity (RIDGEs) by using expression data from all Malignant Neoplasms. Some RIDGEs (28%) consist of Paralogous Gene Genes while another subset (30%) are specifically dysregulated in Neoplasms but not in normal Body tissue., We conclude that the similarity of hoxb3a/Hoxa3 regulatory mechanisms reflect the shared descent of both Genes from a single ancestral Paralogous Gene group 3 gene., Conserved co-regulation and Promoter sharing of hoxb3a and hoxb4a in Zebrafish., By analyzing paralogs of Testis-biased Genes, we identified \"co-regulated\" paralogous pairs in which both Genes are Testis biased, \"anti-regulated\" pairs in which one Paralogous Gene is Testis biased and the other downregulated in Inferior Colliculus, and \"neutral\" pairs in which one Paralogous Gene is Testis biased and the other constitutively expressed.[SEP]Relations: RNA localization to Chromatin has relations: bioprocess_protein with HNRNPU, bioprocess_protein with HNRNPU. Promoter clearance from RNA polymerase I Promoter has relations: bioprocess_bioprocess with Promoter clearance during DNA-templated transcription, bioprocess_bioprocess with Promoter clearance during DNA-templated transcription, bioprocess_bioprocess with Promoter clearance from RNA polymerase I Promoter for nuclear large rRNA transcript, bioprocess_bioprocess with Promoter clearance from RNA polymerase I Promoter for nuclear large rRNA transcript. Testis has relations: anatomy_protein_present with PARP14, anatomy_protein_present with PARP14, anatomy_protein_present with CGGBP1, anatomy_protein_present with CGGBP1. Definitions: Canis familiaris defined as following: The domestic Canis familiaris, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065). Genome - anatomical entity defined as following: Anatomical set of Genes in all the chromosomes.. Zebrafish defined as following: An exotic species of the family CYPRINIDAE, originally from Asia, that has been introduced in North America. Zebrafish is a model organism for drug assay and cancer research.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other Body tissue. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Paralogous Gene defined as following: A gene related to a similar gene by duplication within a Genome - anatomical entity.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. Enhancer Elements, Genetic defined as following: Cis-acting DNA sequences which can increase transcription of Genes. Enhancers can usually function in either orientation and at various distances from a Promoter.. Chromatin defined as following: The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130]. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Tietz syndrome defined as following: Tietz syndrome is a genetic hypopigmentation and deafness syndrome characterized by congenital profound bilateral sensorineural hearing loss and generalized albino-like hypopigmentation of skin, eyes and hair.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Eukaryota defined as following: Organism or cells with a nucleus separated from the cytoplasm by a two membrance nuclear envelope and compartmentalization of function into distinct cytoplasmic organelles.. Testis defined as following: The male gonad containing two functional parts: the SEMINIFEROUS TUBULES for the production and transport of male germ cells (SPERMATOGENESIS) and the interstitial compartment containing LEYDIG CELLS that produce ANDROGENS.. Inferior Colliculus defined as following: The posterior pair of the quadrigeminal bodies which contain centers for auditory function.. Homo sapiens defined as following: Members of the species Homo sapiens.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others..", "label": "yes"} {"original_question": "Has protein citrullination been implicated in rheumatoid arthritis?", "id": "converted_944", "sentence1": "Has protein citrullination been implicated in Rheumatoid Arthritis?", "sentence2": ": Citrullination has become a hot topic within recent years due to its involvement in diseases such as Rheumatoid Arthritis (RA), Multiple Sclerosis and Fibrosis. , Current literature suggests that increased levels of citrullinated Proteins are found in several if not all inflammatory diseases. , Antibodies, in vitro diagnostic, in vitro diagnostic directed against citrullinated Proteins and Peptides (acetyl 4-aminosalicylic acid) are the most specific serological markers available for diagnosing RA. , Citrullination of Proteins is well described in Rheumatoid Arthritis (RA), and hypercitrullination of Proteins may be related to Inflammation in general. , Some Wegener Autoantigen are remarkably effective as diagnostics in Autoimmune Diseases, most notably Rheumatoid Arthritis (RA). Several Wegener Autoantigen can be observed before other clinical RA manifestations are apparent. , Rheumatoid arthritis (RA) is a chronic autoimmune Disease characterized by the presence of Rheumatoid Factor Measurement (RF) and anti-citrullinated protein/peptide autoantibodies (acetyl 4-aminosalicylic acid). , Anti-citrullinated Peptides as Autoantigens in Rheumatoid Arthritis-relevance to treatment., The implications of citrullination affecting integrin binding in Disease open up a new area of study and might have implications for the pathogenesis of inflammatory diseases like Rheumatoid Arthritis and Periodontitis., In this paper, we will review the three of the main classes of PTMS gene already associated with RA: citrullination, carbamylation, and oxidation., Citrullinated collagen II (CII) is a well-known To To autoantigen in Rheumatoid Arthritis (RA). , Among the RA-associated autoantibodies, especially Anti-Citrullinated Protein Antibodies, in vitro diagnostic (acetyl 4-aminosalicylic acid) have been studied intensively in the last decade., Protein citrullination is a posttranslational modification that has attracted increased attention, especially for its involvement in Rheumatoid Arthritis (RA)., Identification of citrullinated cellular fibronectin in synovial fluid from patients with Rheumatoid Arthritis., Cellular fibronectin (cFn) has been implicated in the pathogenesis of Rheumatoid Arthritis (RA), and we previously demonstrated the presence of citrullinated cFn in rheumatoid synovial tissues. , . In Rheumatoid Arthritis, PADI4 wt Allele and protein citrullination are increased in Inflamed joint, and Anti-Citrullinated Protein Antibodies, in vitro diagnostic (acetyl 4-aminosalicylic acid) form against citrullinated antigens are formed. [SEP]Relations: Anti-citrullinated protein antibody positivity has relations: disease_phenotype_positive with Rheumatoid Arthritis, disease_phenotype_positive with Rheumatoid Arthritis. Rheumatoid arthritis has relations: drug_effect with Citalopram, drug_effect with Citalopram, drug_effect with Cevimeline, drug_effect with Cevimeline, drug_effect with Cyclosporine, drug_effect with Cyclosporine, drug_effect with Ropinirole, drug_effect with Ropinirole. Definitions: Fibrosis defined as following: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of Inflammation or other injury.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Peptides defined as following: Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of Peptides that can form into complex structures such as ENZYMES and RECEPTORS.. PADI4 wt Allele defined as following: Human PADI4 wild-type allele is located in the vicinity of 1p36.13 and is approximately 56 kb in length. This allele, which encodes protein-arginine deiminase type-4 protein, plays a role in the post-translational protein modification. Mutation of the gene is associated with susceptibility to Rheumatoid Arthritis.. Rheumatoid Arthritis defined as following: A chronic systemic Disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.. Autoantigens defined as following: Endogenous tissue constituents with the ability to interact with AUTOANTIBODIES and cause an immune response.. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. Autoimmune Diseases defined as following: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous Peptides.. Periodontitis defined as following: Inflammation and loss of connective tissues supporting or surrounding the teeth. This may involve any part of the PERIODONTIUM. Periodontitis is currently classified by Disease progression (CHRONIC PERIODONTITIS; AGGRESSIVE PERIODONTITIS) instead of age of onset. (From 1999 International Workshop for a Classification of Periodontal Diseases and Conditions, American Academy of Periodontology). Wegener Autoantigen defined as following: Myeloblastin (256 aa, ~28 kDa) is encoded by the human PRTN3 gene. This protein is involved in the proteolysis of extracellular matrix Proteins.. Anti-Citrullinated Protein Antibodies defined as following: Autoantibodies to citrullinated-Peptides and Proteins.. Multiple Sclerosis defined as following: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903). Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Rheumatoid Factor Measurement defined as following: The determination of the amount of Rheumatoid Factor Measurement antibody present in a sample..", "label": "yes"} {"original_question": "Is cytisine superior to nicotine replacement therapy for smoking cessation?", "id": "converted_172", "sentence1": "Is cytisine superior to nicotine replacement therapy for smoking cessation?", "sentence2": "The effectiveness of cytisine for continuous abstinence was superior to that of nicotine-replacement therapy at 1 week, 2 months, and 6 months. In a prespecified subgroup analysis of the primary outcome, cytisine was superior to nicotine-replacement therapy among women and noninferior among men., CONCLUSIONS: When combined with brief behavioral support, cytisine was found to be superior to nicotine-replacement therapy in helping smokers quit smoking, but it was associated with a higher frequency of self-reported adverse events.[SEP]Relations: Cytisine has relations: drug_protein with CHRNA6, drug_protein with CHRNA6, drug_protein with CHRNA4, drug_protein with CHRNA4, drug_protein with CHRNA3, drug_protein with CHRNA3, drug_protein with CHRNB2, drug_protein with CHRNB2, drug_protein with CHRNA7, drug_protein with CHRNA7.", "label": "yes"} {"original_question": "Should nerinetide be used for treatment of ischaemic stroke?", "id": "converted_4001", "sentence1": "Should nerinetide be used for treatment of ischaemic stroke?", "sentence2": "337 (61·4%) of 549 patients with nerinetide and 329 (59·2%) of 556 with placebo achieved an mRS score of 0-2 at 90 days (adjusted risk ratio 1·04, 95% CI 0·96-1·14; p=0·35). Secondary outcomes were similar between groups., INTERPRETATION: Nerinetide did not improve the proportion of patients achieving good clinical outcomes after endovascular thrombectomy compared with patients receiving placebo.[SEP]Definitions: ischaemic stroke defined as following: An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue..", "label": "no"} {"original_question": "Can pets affect infant microbiomed?", "id": "converted_2783", "sentence1": "Can pets affect infant microbiomed?", "sentence2": "Since there is some evidence that pets also alter the gut microbial composition of infants, changes to the gut microbiome are putative pathways by which Positron-Emission Tomography exposure can reduce these risks to health., The impact of Positron-Emission Tomography ownership varies under different birth scenarios; however, in common, exposure to pets increased the abundance of two Bacteria, Ruminococcus species species and Oscillospira, which have been negatively associated with childhood MS4A2 wt Allele and BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20., As a common effect in all birth scenarios, pre- and postnatal Positron-Emission Tomography exposure enriched the abundance of Oscillospira and/or Ruminococcus species species (P < 0.05) with more than a twofold greater likelihood of high abundance. Among vaginally born infants with maternal intrapartum antibiotic prophylaxis exposure, Streptococcaceae were substantially and significantly reduced by Positron-Emission Tomography exposure (P < 0.001, FDRp = 0.03), reflecting an 80% decreased likelihood of high abundance (OR 0.20, 95%CI, 0.06-0.70) for Positron-Emission Tomography exposure during pregnancy alone and a 69% reduced likelihood (OR 0.31, 95%CI, 0.16-0.58) for exposure in the pre- and postnatal time periods., Exposure to household furry pets influences the gut microbiota of infant at 3-4 months following various birth scenarios.[SEP]Relations: Bacteremia has relations: disease_phenotype_positive with listeriosis, disease_phenotype_positive with listeriosis, disease_phenotype_positive with toxic shock syndrome, disease_phenotype_positive with toxic shock syndrome, disease_phenotype_positive with shigellosis, disease_phenotype_positive with shigellosis, disease_phenotype_positive with cyclic hematopoiesis, disease_phenotype_positive with cyclic hematopoiesis. obsolete body mass index quantitative trait locus 19 has relations: disease_phenotype_positive with Insulin resistance, disease_phenotype_positive with Insulin resistance. Definitions: MS4A2 wt Allele defined as following: Human MS4A2 wild-type allele is located within 11q12-q13 and is approximately 10 kb in length. This allele, which encodes high affinity immunoglobulin epsilon receptor subunit beta protein, plays a role in both immunoglobulin binding and mast cell responses.. Positron-Emission Tomography defined as following: An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower.. Bacteria defined as following: One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive..", "label": "yes"} {"original_question": "Is alemtuzumab effective for remission induction in patients diagnosed with T-cell prolymphocytic leukemia?", "id": "converted_364", "sentence1": "Is alemtuzumab effective for remission induction in patients diagnosed with T-Cell Prolymphocytic Leukemia?", "sentence2": "Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-Cell Prolymphocytic Leukemia, A central need in this historically refractory tumor is the controlled evaluation of multiagent chemotherapy and its combination with the currently most active single agent, alemtuzumab. , FMC-A is a safe and efficient protocol in T-PLL, which compares favorably to published data., Currently, the best treatment for T-PLL is IV alemtuzumab, which has resulted in very high response rates of more than 90% when given as frontline treatment and a significant improvement in survival. , The patient failed to respond to standard Acute lymphocytic leukemia induction chemotherapy, but achieved complete remission following treatment with a fludarabine and alemtuzumab-based regimen., Here we present a rare case of concurrent T-PLL and Kaposi Sarcoma who achieved a complete Hematologic and cytogenetic remission after a very short course of treatment with alemtuzumab., Recent studies with single-agent alemtuzumab, an anti-CD52 monoclonal immunoglobulin complex location, have shown improved response rates and survival in patients with T-Cell Prolymphocytic Leukemia and Lymphoma, T-Cell, Cutaneous. , The CD52 Antigens is expressed at high density on the malignant T-cells and therapy with alemtuzumab, a humanized IgG1 immunoglobulin complex location that targets this Antigens, has produced promising results. , With the introduction of alemtuzumab, most patients who progressed despite treatment with pentostatin had a major response with a complete remission rate higher than that obtained with pentostatin when used as a first line., alemtuzumab (anti-CD52, Campath-1H) has recently been shown to be effective in the treatment of a range of Hematologic Neoplasms, including Chronic Lymphocytic Leukemia and T-Cell Prolymphocytic Leukemia., Here we report the outcome of two patients with CD4-positive T cell prolymphocytic leukemia treated with Campath 1H. Both patients responded rapidly to treatment and subsequently developed CD4 lymphopenia., T-Cell Prolymphocytic Leukemia (T-PLL) is a chemotherapy-resistant malignancy with a median survival of 7.5 months. Preliminary results indicated a high remission induction rate with the Homo sapiens CD52 immunoglobulin complex location, Campath 1H. , Campath 1H (30 mg) was administered intravenously 3 times weekly until maximal response. The overall response rate was 76% with 60% Creatinine measurement and 16% Target Awareness - Target Awareness - partial remission (Receptors, Progesterone). These responses were durable with a median disease-free interval of 7 months (range, 4-45 months). , The conclusion is that Campath 1H is an effective therapy in T-PLL, producing remissions in more than two thirds of patients. , For example, most patients with T-Cell Prolymphocytic Leukemia, including those with large tumor burdens and high peripheral white blood cell counts, will enter complete remission using the immunoglobulin complex location Campath 1H without any evidence of tumor lysis., Overall response rate to FMC was 68%, comprising 6 complete remissions (all bone-marrow confirmed) and 11 Target Awareness - Target Awareness - partial remissions. alemtuzumab consolidation increased the intent-to-treat overall response rate to 92% (12 complete remissions; 11 Target Awareness - Target Awareness - partial remissions). [SEP]Relations: alemtuzumab has relations: drug_drug with Catumaxomab, drug_drug with Catumaxomab, drug_drug with Otelixizumab, drug_drug with Otelixizumab, drug_drug with Mogamulizumab, drug_drug with Mogamulizumab, drug_drug with Golimumab, drug_drug with Golimumab, drug_drug with Lumiliximab, drug_drug with Lumiliximab. Definitions: Lymphoma, T-Cell, Cutaneous defined as following: A group of lymphomas exhibiting clonal expansion of malignant T-lymphocytes arrested at varying stages of differentiation as well as malignant infiltration of the skin. MYCOSIS FUNGOIDES; SEZARY SYNDROME; LYMPHOMATOID PAPULOSIS; and PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA are the best characterized of these disorders.. Hematologic defined as following: Pertaining to or related to the blood and blood-forming organs.. pentostatin defined as following: A potent inhibitor of ADENOSINE DEAMINASE. The drug induces APOPTOSIS of LYMPHOCYTES, and is used in the treatment of many lymphoproliferative malignancies, particularly HAIRY CELL LEUKEMIA. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity.. alemtuzumab defined as following: Any monoclonal immunoglobulin complex location directed against the cell surface glycoprotein CD52, regardless of the immunoglobulin complex location type (e.g., rat, mouse, humanized).. Creatinine measurement defined as following: A quantitative measurement of the amount of creatinine present in a sample.. immunoglobulin complex location defined as following: A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph. [GOC:add, GOC:jl, ISBN:0781765196]. T-Cell Prolymphocytic Leukemia defined as following: A lymphoid leukemia characterized by a profound LYMPHOCYTOSIS with or without LYMPHADENOPATHY, hepatosplenomegaly, frequently rapid progression, and short survival. It was formerly called T-cell chronic lymphocytic leukemia.. Target Awareness - partial defined as following:

Target person is partially aware of the issue.

. Antigens defined as following: Substances that are recognized by the immune system and induce an immune reaction.. fludarabine defined as following: A fluorinated nucleotide antimetabolite analog of the antiviral agent vidarabine (ara-A) with antineoplastic activity. Administered parenterally as a phosphate salt, fludarabine phosphate is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP. This metabolite may inhibit DNA polymerase alpha, ribonucleotide reductase and DNA primase, thereby interrupting DNA synthesis and inhibiting tumor cell growth. (NCI04). mitoxantrone defined as following: An anthracenedione-derived antineoplastic agent.. Kaposi Sarcoma defined as following: A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause.. Receptors, Progesterone defined as following: Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives.. CD52 Antigens defined as following: A small GPI-linked glycoprotein expressed on the surface of normal and malignant B-CELLS; T-CELLS; MONOCYTES; MACROPHAGES; NK CELLS; and GRANULOCYTES. It is expressed densely and without modulation in many malignant T-cell neoplasms and therefore a target for immunoglobulin complex location therapies (e.g., ALEMTUZUMAB).. Chronic Lymphocytic Leukemia defined as following: A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called chronic lymphocytic leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease.. Acute lymphocytic leukemia defined as following: Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.. Homo sapiens defined as following: Members of the species Homo sapiens.. Hematologic Neoplasms defined as following: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.. alemtuzumab defined as following: Any monoclonal immunoglobulin complex location directed against the cell surface glycoprotein CD52, regardless of the immunoglobulin complex location type (e.g., rat, mouse, humanized)..", "label": "yes"} {"original_question": "Is the enzyme EPRS phosphorylated?", "id": "converted_2024", "sentence1": "Is the enzyme EPRS1 gene phosphorylated?", "sentence2": "Phosphorylation of glutamyl-prolyl tRNA synthetase (EPRS1 gene) has been investigated extensively in our laboratory for more than a decade, and has served as an archetype for studies of other AARSs., EPRS1 gene is dually phosphorylated by Cyclin-Dependent Kinases (CDK5 protein, human) at Ser(886) and then by a CDK5 protein, human-dependent-AGC kinase at Ser(999); , Diphosphorylated EPRS1 gene is released from its residence in the tRNA multisynthetase complex for immediate binding to NS1-associated protein and subsequent binding to ribosomal protein L13a and GAPDH protein, human protein, human. , Two-site phosphorylation of EPRS1 gene coordinates multimodal regulation of noncanonical translational control activity.[SEP]Relations: EPRS1 has relations: protein_protein with ESR2, protein_protein with ESR2, protein_protein with ESR1, protein_protein with ESR1, molfunc_protein with ATP binding, molfunc_protein with ATP binding, protein_protein with ARL4D, protein_protein with ARL4D, protein_protein with ASNS, protein_protein with ASNS. Definitions: GAPDH protein, human defined as following: Glyceraldehyde-3-phosphate dehydrogenase (335 aa, ~36 kDa) is encoded by the human GAPDH protein, human gene. This protein is involved in carbohydrate metabolism.. Cyclin-Dependent Kinases defined as following: Protein kinases that control cell cycle progression in all eukaryotes and require physical association with CYCLINS to achieve full enzymatic activity. Cyclin-dependent kinases are regulated by phosphorylation and dephosphorylation events.. CDK5 protein, human defined as following: Cyclin-dependent kinase 5 (292 aa, ~33 kDa) is encoded by the human CDK5 gene. This protein plays a role in protein phosphorylation and may be involved in cell cycle regulation..", "label": "yes"} {"original_question": "Is there a genetic cause of craniostenosis?", "id": "converted_4366", "sentence1": "Is there a genetic cause of Craniosynostosis?", "sentence2": "Apert syndrome - TWIST1 Genes - is a rare Autosomal Dominant Disorder representing 1:65 000 cases of living newborns. Characteristic malformations of the Apert syndrome are early Craniosynostosis, microviscerocranium and II-V finger syndactyly of hand and toes with proximal phalanx of the bilateral thumb \"in delta\"., A 3-year-old child with tertiary trisomy (14 (+14q--), daughter of a mother with a balanced reciprocal translocation [46,XX,t(14;16)(q11;q24) is presented. Craniostenosis and developmental retardation were the primary presenting features in this patient., Saethre-Chotzen syndrome is an Autosome dominant disease characterized by CRANIOSYNOSTOSIS, TYPE 2, ptosis, and limb and external ear abnormalities, . For 98 patients (15%) a syndrome is associated. Third part of them has Apert syndrome, an other third part has Craniofacial dysostosis type 1, and for the last third more exceptional TWIST1 Genes syndrome (Saethre-Chotzen, Pfeiffer) or others atypical associations, sometimes not yet described, but with an Autosomal dominant inheritance., Coronal Craniosynostosis seems to be a dominant Autosome character, when Sagittal CRANIOSYNOSTOSIS, TYPE 2 is more often sporadic; for both, an Autosomal dominant inheritance is not excluded for some pedigrees., genetic origins are not completely clear although Gene Mutation in the genes that code for Fibroblast Growth Factor Receptor 2 have been described; depending upon the Genes involved, the type of Mutation Abnormality and the embryological period in which the Mutation Abnormality itself occurs, a type of CRANIOSYNOSTOSIS, TYPE 2 arises that may involve one or more Joint structure of suture of skull. The, Saethre-Chotzen syndrome is an Autosome dominant disease characterized by CRANIOSYNOSTOSIS, TYPE 2, ptosis, and limb and external ear abnormalities. , Identification and analysis of the genetic causes in nine unrelated probands with syndromic CRANIOSYNOSTOSIS, TYPE 2., To identify and analyze causative genetic variants in nine unrelated probands mainly manifested as syndromic CRANIOSYNOSTOSIS, TYPE 2, we reviewed the relevant medical information of the patients and performed the whole exome sequencing, further verified with Sanger sequencing and parental background., [Genetic counseling in Craniosynostosis. Results of a prospective study performed with a group of studies on craniofacial malformations]., Constitutional 11q interstitial deletion syndrome presents with Congenital Abnormality including Microcephaly (physical finding) with Craniosynostosis, minor dysmorphic features, Vitreoretinal degeneration, and Congenital anomaly of the kidney., A suckling baby with Microcephaly (physical finding), Craniosynostosis, downward slanting palpebral fissues, malformed ears, Cerebral hemisphere structure (body structure), Cardiac - anatomy qualifier and Intestines malformation, and partial 6q25 leads to 6qter trisomy is presented., Its genetic origins are not completely clear although Gene Mutation in the genes that code for Fibroblast Growth Factor Receptor 2 have been described; depending upon the Genes involved, the type of Mutation Abnormality and the embryological period in which the Mutation Abnormality itself occurs, a type of CRANIOSYNOSTOSIS, TYPE 2 arises that may involve one or more Joint structure of suture of skull., through which skull growth abnormalities are seen. It is becoming clearer that in most patients with CRANIOSYNOSTOSIS, TYPE 2, there is regional imbalance of skull growth, which co-exists with a variety of other equally important factors, such as genetic defects, raised intracranial pressure, Venous hypertension, and other brain parenchymal a, Recent genetic studies have identified several novel genes and pathways that cause nonsyndromic CRANIOSYNOSTOSIS, TYPE 2, providing genetic evidence linking the causes of syndromic and nonsyndromic craniosynostoses, and allowing for genotype-based prediction of risk of recurrence in some nonsyndromic families.[SEP]Relations: Craniosynostosis has relations: phenotype_phenotype with Abnormality of Joint structure of suture of skull, phenotype_phenotype with Abnormality of Joint structure of suture of skull, disease_phenotype_positive with hereditary hypophosphatemic rickets, disease_phenotype_positive with hereditary hypophosphatemic rickets, disease_phenotype_positive with mucolipidosis, disease_phenotype_positive with mucolipidosis, phenotype_phenotype with Coronal CRANIOSYNOSTOSIS, TYPE 2, phenotype_phenotype with Coronal CRANIOSYNOSTOSIS, TYPE 2, disease_phenotype_positive with congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, disease_phenotype_positive with congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency. Definitions: Craniosynostosis defined as following: Premature closure of one or more CRANIAL SUTURES. It often results in plagiocephaly. Craniosynostoses that involve multiple sutures are sometimes associated with congenital syndromes such as ACROCEPHALOSYNDACTYLIA; and CRANIOFACIAL DYSOSTOSIS.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. CRANIOSYNOSTOSIS, TYPE 2 defined as following: A form of syndromic CRANIOSYNOSTOSIS, TYPE 2 with characteristics of highly variable CRANIOSYNOSTOSIS, TYPE 2 with frontal bossing, turribrachycephaly and cloverleaf skull anomaly. Hypoplasia of the supraorbital ridges, cleft palate, extra teeth and limb anomalies has also been described. Associated problems include headache, poor vision, and seizures. Intelligence is normal.. Joint structure of suture of skull defined as following: A type of fibrous joint between bones of the head.. Fibroblast Growth Factor Receptor 2 defined as following: A fibroblast growth factor receptor which contains three extracellular IMMUNOGLOBULIN I-SET DOMAINS and is expressed as two isoforms. One receptor isoform is expressed in the MESENCHYME and is activated by FIBROBLAST GROWTH FACTOR 2. A second isoform is expressed mainly by EPITHELIAL CELLS and is activated by FIBROBLAST GROWTH FACTOR 7 and FIBROBLAST GROWTH FACTOR 10. Mutation of the Genes for fibroblast growth factor receptor 2 can result in craniosynostotic syndromes (e.g., APERT SYNDROME; and CROUZON SYNDROME).. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Autosomal dominant inheritance defined as following: A mode of inheritance that is observed for traits related to a Genes encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an Autosomal Dominant Disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele. [HPO:curators]. TWIST1 gene defined as following: This Genes plays a role in regulation of transcription and the inhibition of apoptosis. It is also involved in the control of morphogenesis during embryonic development.. Congenital anomaly of the kidney defined as following: An abnormality of the kidney. [HPO:probinson]. Sagittal craniosynostosis defined as following: A kind of CRANIOSYNOSTOSIS, TYPE 2 affecting the sagittal suture. [HPO:probinson]. Vitreoretinal degeneration defined as following: Ocular abnormality characterised by premature degeneration of the vitreous and the retina that may be associated with increased risk of retinal detachment. [HPO:probinson, ORCID:0000-0003-0986-4123, PMID:18179896]. Intestines defined as following: The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE.. Cerebral hemisphere structure (body structure) defined as following: The part of the brain that controls muscle functions and also controls speech, thought, emotions, reading, writing, and learning. The right hemisphere controls the muscles on the left side of the body, and the left hemisphere controls the muscles on the right side of the body.. Apert syndrome defined as following: An Autosome dominant inherited type of TWIST1 gene caused by Gene Mutation in the FGFR2 Genes. It is characterized by early closure of the sutures between the skull bones, bulging eyes, low-set ears, fusion of the second, third, and forth fingers, and fusion of the toes.. Autosomal Dominant Disorder defined as following: An inherited disorder that manifests when one copy of a mutated Genes is present.. Congenital Abnormality defined as following: Malformations of organs or body parts during development in utero.. Autosome defined as following: Any chromosome other than a sex chromosome. [GOC:mah]. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA.. Microcephaly (physical finding) defined as following: Head circumference below 2 standard deviations below the mean for age and gender. [PMID:15806441, PMID:19125436, PMID:25465325, PMID:9683597].", "label": "yes"} {"original_question": "Is the Apis mellifera genome available?", "id": "converted_3928", "sentence1": "Is the Apis mellifera Genome - anatomical entity available?", "sentence2": " Mining Apis mellifera sequences made it possible to identify the Apis mellifera subspecies both at the Mitochondria and nuclear Genome - anatomical entity levels., Honey bee research is believed to be influenced dramatically by colony collapse disorder (carmustine/cyclophosphamide/dexamethasone) and the sequenced Genome - anatomical entity release in 2006, but this assertion has never been tested., The Genome - anatomical entity release and carmustine/cyclophosphamide/dexamethasone had quantitively only minor effects, mainly on Apis mellifera health-related topics post-2006. , We show that the honeybee Genome - anatomical entity is structured with respect to plasticity; Genes that respond to an environmental trigger are colocated in the honeybee Genome - anatomical entity in a series of gene clusters, many of which have been assembled in the last 80 My during the evolution of the Apidae. , we have mined histone methyltransferase and demethylases from the whole Genome - anatomical entity sequence of Aedes aegypti (Diptera), the pea aphid Acyrthosiphon pisum, the triatomid bug Rhodnius prolixus (Hemiptera), the honeybee Apis mellifera (Hymenoptera),[SEP]Relations: mitochondrion has relations: cellcomp_protein with MSRA, cellcomp_protein with MSRA, cellcomp_protein with IBA57, cellcomp_protein with IBA57, cellcomp_protein with RXRA, cellcomp_protein with RXRA, cellcomp_protein with DIP2A, cellcomp_protein with DIP2A, cellcomp_protein with TEX10, cellcomp_protein with TEX10. Definitions: Genome - anatomical entity defined as following: Anatomical set of Genes in all the chromosomes.. Mitochondria defined as following: Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon Genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed). histone methyltransferase defined as following: Enzymes that catalyze the transfer of methyl groups to LYSINE or ARGININE residues of HISTONES, especially histone H3 and histone H4 proteins. They play a critical role in EPIGENETIC PROCESSES.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Does armodafinil improve fatigue of glioma patients?", "id": "converted_2565", "sentence1": "Does armodafinil improve Fatigue of glioma patients?", "sentence2": "CONCLUSIONS: While treatment was well-tolerated, an 8-week course of armodafinil did not improve Fatigue or QOL in glioma patients undergoing RT in this pilot study. , We evaluated whether armodafinil, a wakefulness-promoting medication, improves Fatigue in glioma patients undergoing RT., armodafinil did not significantly improve Fatigue or QOL based on the 42-day change in FACIT-F Fatigue subscale, FACT-G, Chronic Fatigue Syndrome, or BFI. Further analysis suggests no difference between the arms even after accounting for the potential bias of missing data. , Treatment was well tolerated with few grade 3 or 4 toxicities.
CONCLUSIONS: While treatment was well-tolerated, an 8-week course of armodafinil did not improve Fatigue or QOL in glioma patients undergoing RT in this pilot study., armodafinil did not significantly improve Fatigue or QOL based on the 42-day change in FACIT-F Fatigue subscale, FACT-G, Chronic Fatigue Syndrome, or BFI., While treatment was well-tolerated, an 8-week course of armodafinil did not improve Fatigue or QOL in glioma patients undergoing RT in this pilot study.[SEP]Relations: Fatigue has relations: drug_effect with Flumazenil, drug_effect with Flumazenil, drug_effect with Lapatinib, drug_effect with Lapatinib, drug_effect with Sildenafil, drug_effect with Sildenafil, drug_effect with Amiodarone, drug_effect with Amiodarone, drug_effect with Fosinopril, drug_effect with Fosinopril. Definitions: Chronic Fatigue Syndrome defined as following: A syndrome characterized by persistent or recurrent Fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9). Fatigue defined as following: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.. armodafinil defined as following: The R-enantiomer of the racemic synthetic agent modafinil with central nervous system (CNS) stimulant and wakefulness-promoting activities. Although the exact mechanism of action has yet to be fully elucidated, armodafinil appears to inhibit the reuptake of dopamine by binding to the dopamine-reuptake pump, which leads to an increase in extracellular dopamine levels in some brain regions. This agent does not bind to or inhibit several receptors and enzymes that may be involved in sleep/wake regulation and is not a direct- or indirect-acting dopamine receptor agonist. armodafinil has a longer half-life than modafinil.. armodafinil defined as following: The R-enantiomer of the racemic synthetic agent modafinil with central nervous system (CNS) stimulant and wakefulness-promoting activities. Although the exact mechanism of action has yet to be fully elucidated, armodafinil appears to inhibit the reuptake of dopamine by binding to the dopamine-reuptake pump, which leads to an increase in extracellular dopamine levels in some brain regions. This agent does not bind to or inhibit several receptors and enzymes that may be involved in sleep/wake regulation and is not a direct- or indirect-acting dopamine receptor agonist. armodafinil has a longer half-life than modafinil..", "label": "no"} {"original_question": "Is Rad4/XPC a DNA damage sensing protein?", "id": "converted_3457", "sentence1": "Is Rad4/XPC a DNA damage sensing protein?", "sentence2": "Twist-open mechanism of DNA damage recognition by the Rad4/XPC nucleotide excision repair complex., Kinetic gating mechanism of DNA damage recognition by Rad4/XPC., These findings indicate that the Lesion recognized by Rad4/XPC thermodynamically destabilize the Watson-Crick double helix in a manner that facilitates the flipping-out of two Base Pairing.[SEP]Relations: nerve lesion has relations: disease_disease with ulnar nerve lesion, disease_disease with ulnar nerve lesion, disease_disease with brachial plexus neuritis, disease_disease with brachial plexus neuritis, disease_disease with lesion of sciatic nerve, disease_disease with lesion of sciatic nerve, disease_disease with radial neuropathy, disease_disease with radial neuropathy, disease_disease with femoral neuropathy, disease_disease with femoral neuropathy. Definitions: Base Pairing defined as following: Pairing of purine and pyrimidine bases by HYDROGEN BONDING in double-stranded DNA or RNA.. Lesion defined as following: A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part..", "label": "yes"} {"original_question": "Are there any Decision support systems for chronic pain management ?", "id": "converted_1082", "sentence1": "Are there any Decision support systems for Chronic pain management ?", "sentence2": "a project to operationalize the 2003 VA/DOD Clinical Practice Guideline for Opioid Therapy for Chronic Non-Cancer Pain into a computerized decision support system (DOSAGE-SENSITIVE SEX REVERSAL), We based the DOSAGE-SENSITIVE SEX REVERSAL on the existing ATHENA-DOSAGE-SENSITIVE SEX REVERSAL, Use of this iterative process led to development of a multifunctional DOSAGE-SENSITIVE SEX REVERSAL, interactive decision dashboard format, We created a computerized, interactive clinical decision dashboard , Interactive decision dashboards can be adapted for clinical use and have the potential to foster informed decision making., Clinical decision support systems are promising tools for improving behavioral medicine care for Chronic pain., Improving Patient Safety Using ATHENA-Decision Support System Technology: , ATHENA-DOSAGE-SENSITIVE SEX REVERSAL is an automated decision support system developed in a collaboration between Stanford University and the U.S. Department of Veterans Affairs (VA) to increase guideline-adherent prescribing and to change physician behavior., The use of a computer-based decision support system facilitates primary care physicians' management of Chronic pain., The use of a CBDS system may improve the ability of PCPs to manage Chronic pain and may also facilitate screening of consults to optimize specialist utilization.[SEP]Relations: Chronic pain has relations: phenotype_phenotype with Pain, phenotype_phenotype with Pain, disease_phenotype_positive with glycogen storage disease, disease_phenotype_positive with glycogen storage disease, disease_phenotype_positive with Sjogren syndrome, disease_phenotype_positive with Sjogren syndrome, disease_phenotype_positive with Machado-Joseph disease, disease_phenotype_positive with Machado-Joseph disease, disease_phenotype_positive with Loeys-Dietz syndrome, disease_phenotype_positive with Loeys-Dietz syndrome. Definitions: Chronic pain defined as following: Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain..", "label": "yes"} {"original_question": "Are psammoma bodies characteristic to meningiomas?", "id": "converted_867", "sentence1": "Are psammoma bodies characteristic to Meningioma?", "sentence2": "Psammoma Body Formation (Pencil Beam Scanning) are concentric lamellated calcified structures, observed most commonly in Papillary thyroid carcinoma (Percutaneous transhepatic cholangiography), Benign Meningioma, and Papillary Serous Cystadenocarcinoma of Pelvis>Ovary but have rarely been reported in other Neoplasms and nonneoplastic lesions., Studies on Serous Cystadenocarcinoma of Pelvis>Ovary and Benign Meningioma, however, revealed that collagen production by Neoplastic Cell and subsequent calcification was responsible for the formation of Pencil Beam Scanning., The existence of some precursor forms of Pencil Beam Scanning was reported in Meningioma and more recently in Percutaneous transhepatic cholangiography, which were mostly in the form of Extracellular hyaline globules surrounded by well-preserved Neoplastic Cell or in a smaller number of cases intracytoplasmic bodies liberated from intact Specimen Source Codes - Tumor cells, uncertain whether benign or malignant., Light microscopy revealed abundant microcysts of varied size throughout the Tumor tissue sample with the presence of whorl formation and psammoma body, but no malignancy was indicated. Electron microscopy further demonstrated interdigitation of the neighboring Plasma Membrane Device, Desmosome, and intracytoplasmic filaments, which are pathognomonic findings of Meningioma., Unlike UBE2D1 gene, macrophage colony stimulating factor receptor activity were glycogen-containing and variously exhibited a storiform pattern (13 of 20), psammoma body formation (9 of 20), and calcification of collagen (4 of 20). Immunoreactivities included vimentin location location (100%), focal to patchy EMA (80%), S100 Proteins (80%), Collagen Type IV (25%), and patchy, mild-to-moderate CD34 staining (60%)., In contrast to the inner structure, three-dimensional structure of psammona bodies in Meningioma is not well defined., This study examined three cultured Meningioma, in which surface observation of psammoma bodies might be easier than in the Specimen Source Codes - Specimen Source Codes - tumor tissues since influence of interposing Connective Tissue is minimized in tissue culture., The results suggest that psammoma bodies in Meningioma arise in part from meningothelial whorls due to collagen production by Specimen Source Codes - Tumor cells, uncertain whether benign or malignant followed by obliteration and disappearance of Specimen Source Codes - Specimen Source Codes - tumor cell processes, although some of the alternative pathways for psammoma body formation proposed by other investigators cannot be ruled out by this study., To demonstrate that psammoma bodies in Homo sapiens Meningioma contain Collagen Type VI and Laminin., This is the first report to describe the involvement of Collagen Type VI in psammoma bodies and whorl formations in Meningioma., Physiologic calcification such as psammoma body is sometimes found especially in spinal cord Benign Meningioma but ossification of the Meningeal Neoplasms was rarely observed., Histological diagnosis was transitional Benign Meningioma with psammoma body., In this study we analyzed the morphologic and ultrastructural characteristics of the psammoma bodies in ten Meningioma of different histologic subtypes, characterizing the components of the psammoma body and the elements of the Specimen Source Codes - Specimen Source Codes - tumor, such as the Blood Blood capillaries and degenerative cells that have been classically considered as initiators of the formation of these calcareous is structures., It is concluded that the mineralization of the psammoma bodies is induced principally by the collagen fibers synthesized by the meningocytes and that the form of mineralization is spherical and growth is radial, controlled by the tumoral cells., CSF cytology revealed benign fibroblastic or meningotheliomatous Benign Meningioma with whorl formation and psammoma body., Electron microscopic examination of the Calculi showed Membrane Device-bound vesicles and radially precipitated crystals that simulated durapatite of psammoma body in Benign Meningioma., Psammoma Body Formation in Meningioma resembled those in the Structure of Structure of choroid plexus stroma., The results of this study suggest that psammoma bodies in the Structure of Structure of choroid plexus, as in Meningioma, form by a process of dystrophic calcification associated with arachnoid cells and Collagen fiber., An early stage of psammoma body formation was seen more frequently in these villous microcores than in the meningocytic whorls., Psammoma Body Formation in meningocytic whorls were investigated by electron microscopy., Psammoma body formation in the meningocytic whorls may represent degeneration in some whorls of the central cells which contain Connective Tissue fibers, producing cell debris such as Membrane Device invested vesicles., Twenty Homo sapiens Meningioma were examined for immunoglobulin G and Immunoglobulin M by the direct immunofluorescence of immunoperoxidase methods, or both. immunoglobulin G was conspicuously found in and around the blood vessels, whorls, and psammoma bodies. It was also clearly present on the cytoplasmic membranes of the Tumor cells., Significance of these findings is briefly discussed including possible humoral immune reactions in regard to whorl and psammoma body formation in Benign Meningioma., The fine structure of psammoma bodies was examined in four cases of fibroblastic Benign Meningioma., In general, large numbers of various-sized calcified bodies (psammoma bodies) were scattered among the interstitial fibers., These findings suggest that both Matrix Pharmaceutical Inc. giant bodies and Matrix Pharmaceutical Inc. vesicles may serve as initial nidus of calcification of psammoma bodies in fibroblastic Benign Meningioma., Psammoma body formation or dystrophic mineralization and gliosis of the intervening parenchyma was observed in all three cases.[SEP]Relations: skin Benign Meningioma has relations: disease_disease with Benign Meningioma (disease), disease_disease with Benign Meningioma (disease). benign neoplasm of meninges has relations: disease_disease with benign Benign Meningioma, disease_disease with benign Benign Meningioma. benign Benign Meningioma has relations: disease_disease with benign neoplasm of meninges, disease_disease with benign neoplasm of meninges, disease_disease with Benign Meningioma (disease), disease_disease with Benign Meningioma (disease). transitional Benign Meningioma has relations: disease_disease with Benign Meningioma (disease), disease_disease with Benign Meningioma (disease). Definitions: Structure of choroid plexus defined as following: A villous structure of tangled masses of BLOOD VESSELS contained within the third, lateral, and fourth ventricles of the BRAIN. It regulates part of the production and composition of CEREBROSPINAL FLUID.. Tumor tissue sample defined as following: A Specimen Source Codes - tumor sample, or entire Specimen Source Codes - tumor that is removed for microscopic examination.. Calculi defined as following: An abnormal concretion occurring mostly in the urinary and biliary tracts, usually composed of mineral salts. Also called stones.. Collagen Type VI defined as following: A non-fibrillar collagen that forms a network of MICROFIBRILS within the EXTRACELLULAR MATRIX of CONNECTIVE TISSUE. The alpha subunits of collagen type VI assemble into antiparallel, overlapping dimers which then align to form tetramers.. Benign Meningioma defined as following: A grade I, slowly growing Benign Meningioma. Only a minority of tumors recur following complete resection.. collagen defined as following: A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH).. Plasma Membrane Device defined as following: The lipid- and protein-containing, selectively permeable Membrane Device that surrounds the cytoplasm in prokaryotic and eukaryotic cells.. immunoglobulin G defined as following: The major immunoglobulin isotype class in normal Homo sapiens serum. There are several isotype subclasses of immunoglobulin G, for example, IgG1, IgG2A, and IgG2B.. Pencil Beam Scanning defined as following: A precise form of proton therapy that uses an electronically guided scanning system and magnets to deliver a proton beam that is millimeters wide. With this system, beam position and depth can be controlled, allowing for highly precise deposition of radiation to be delivered in all three dimensions of the Specimen Source Codes - tumor.. Meningioma defined as following: A relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular tumors which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7). fibroblastic Benign Meningioma defined as following: A WHO grade I Benign Meningioma characterized by the presence of spindle cells that form bundles in a collagen Matrix Pharmaceutical Inc... Collagen Type IV defined as following: A non-fibrillar collagen found in the structure of BASEMENT MEMBRANE. Collagen type IV molecules assemble to form a sheet-like network which is involved in maintaining the structural integrity of basement membranes. The predominant form of the protein is comprised of two alpha1(IV) subunits and one alpha2(IV) subunit, however, at least six different alpha subunits can be incorporated into the heterotrimer.. Laminin defined as following: Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement Membrane Device lamina lucida and functions to bind epithelial cells to the basement Membrane Device. Evidence suggests that the protein plays a role in Specimen Source Codes - tumor invasion.. Papillary Serous Cystadenocarcinoma defined as following: An adenocarcinoma usually arising from the Pelvis>Ovary. It is characterized by the presence of complex micropapillary structures covered by round and cuboidal cells with a high nuclear to cytoplasmic ratio.. Blood capillaries defined as following: The minute vessels that connect arterioles and venules.. Meningeal Neoplasms defined as following: Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.. Serous Cystadenocarcinoma defined as following: A malignant cystic or semicystic neoplasm. It often occurs in the Pelvis>Ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated Papillary Serous Cystadenocarcinoma cells. Psammoma Body Formation may be present. The Specimen Source Codes - tumor generally adheres to surrounding structures and produces ascites. (From Hughes, Obstetric-Gynecologic Terminology, 1972, p185). Percutaneous transhepatic cholangiography defined as following: The evaluation of the liver and biliary tree using a contrast agent injected directly into the liver.. macrophage colony stimulating factor receptor activity defined as following: Combining with macrophage colony-stimulating factor (M-CSF) receptor ligand and transmitting the signal from one side of the Membrane Device to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate. [GOC:mah, GOC:signaling]. Physiologic calcification defined as following: Process by which organic tissue becomes hardened by the physiologic deposit of calcium salts.. Connective Tissue defined as following: Tissue that supports and binds other tissues. It consists of CONNECTIVE TISSUE CELLS embedded in a large amount of EXTRACELLULAR MATRIX.. vimentin location defined as following: OBSOLETE. A type of intermediate filament. [ISBN:0716731363]. Neoplastic Cell defined as following: abnormal cell which divides more than it should or does not die when it should; cells grown in vitro from neoplastic tissue may be established as a neoplastic cell line, and then can be propagated in cell culture indefinitely.. Neoplasms defined as following: New abnormal growth of tissue. Malignant Neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign Neoplasms.. S100 Proteins defined as following: A family of highly acidic calcium-binding proteins found in large concentration in the brain and believed to be glial in origin. They are also found in other organs in the body. They have in common the EF-hand motif (EF HAND MOTIFS) found on a number of calcium binding proteins. The name of this family derives from the property of being soluble in a 100% saturated ammonium sulfate solution.. Papillary thyroid carcinoma defined as following: A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland. Radiation exposure is a risk factor and it is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries. Diagnostic procedures include thyroid ultrasound and fine needle biopsy. Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei. The nuclei also display clearing or have a ground glass appearance.. Immunoglobulin M defined as following: A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). Immunoglobulin M can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin.. Desmosome defined as following: A type of junction that attaches one cell to its neighbor. One of a number of differentiated regions which occur, for example, where the cytoplasmic membranes of adjacent epithelial cells are closely apposed. It consists of a circular region of each Membrane Device together with associated intracellular microfilaments and an intercellular material which may include, for example, mucopolysaccharides. (From Glick, Glossary of Biochemistry and Molecular Biology, 1990; Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). durapatite defined as following: The mineral component of bones and teeth; it has been used therapeutically as a prosthetic aid and in the prevention and treatment of osteoporosis.. Specimen Source Codes - Tumor cells, uncertain whether benign or malignant defined as following: Cells of, or derived from, a Specimen Source Codes - tumor.. transitional Benign Meningioma defined as following: A WHO grade I Benign Meningioma characterized by the coexistence of meningothelial cells and fibrous architectural patterns.. Homo sapiens defined as following: Members of the species Homo sapiens.. Collagen fiber defined as following: A structural protein and Connective Tissue component in fiber form composed of numerous fine fibrils, which provides strength and flexibility to tissue.. Membrane Device defined as following: A device that is made from or resembles a thin flexible sheet of material.. Extracellular defined as following: The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma Membrane Device. This term covers the host cell environment outside an intracellular parasite. [GOC:go_curators].", "label": "yes"} {"original_question": "Is cariprazine effective for treatment of bipolar disorder?", "id": "converted_2780", "sentence1": "Is cariprazine effective for treatment of Bipolar Disorder Type 2?", "sentence2": "BACKGROUND: We evaluated the safety/tolerability of longer-term open-label treatment with cariprazine in patients who had responded to cariprazine for acute bipolar mania., Clinically relevant response and remission outcomes in cariprazine-treated patients with Bipolar I disorder., cariprazine is FDA approved for the acute treatment of SCHIZOPHRENIA 2 (disorder) and Manic mood or mixed episodes associated with Bipolar I disorder in adults., DISCUSSION: cariprazine-treated patients with Bipolar I disorder attained clinically significant improvement in Manic mood symptoms as shown by significantly greater rates of response and remission versus placebo; improvement in Manic mood symptoms did not induce depressive symptoms., OBJECTIVE: cariprazine, a dopamine D3/D2 partial agonist atypical antipsychotic with preferential binding to D3 receptors, is approved for the treatment of SCHIZOPHRENIA 2 (disorder) and Manic mood or mixed episodes associated with Bipolar I disorder., BACKGROUND: cariprazine was approved for treating SCHIZOPHRENIA 2 (disorder) and Bipolar Disorder Type 2, and currently is being evaluated for treating Cancer patients and suicide and Cancer patients and suicide and depression in clinical trials in the United States.[SEP]Relations: Bipolar Disorder Type 2 has relations: contraindication with Desipramine, contraindication with Desipramine, contraindication with Desipramine, contraindication with Desipramine, contraindication with Trimipramine, contraindication with Trimipramine, contraindication with Trimipramine, contraindication with Trimipramine, contraindication with Imipramine, contraindication with Imipramine. Definitions: dopamine defined as following: One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action.. Manic mood defined as following: An emotional state characterized by marked to extreme elevation of mood with noticeable effect of functioning..", "label": "yes"} {"original_question": "Is Cabotegravir effective for HIV prevention?", "id": "converted_4240", "sentence1": "Is Cabotegravir effective for HIV Infections prevention?", "sentence2": "A new paradigm for antiretroviral delivery: long-acting cabotegravir and rilpivirine for the treatment and prevention of HIV Infections Infections., PURPOSE OF REVIEW: Cabotegravir (Carbonic Anhydrase 1 (enzyme), Human) and rilpivirine (RPV) is the first long-acting injectable antiretroviral therapy (ART) option approved for virologically suppressed adults with HIV Infections Infections-1. In addition, long-acting Carbonic Anhydrase 1 (enzyme), Human is a promising agent for HIV Infections Infections preexposure prophylaxis (HIV Infections Infections: HIV Infections: PrEP and PEP and PEP). , SUMMARY: Clinical trial results support the use of long-acting Carbonic Anhydrase 1 (enzyme), Human for HIV Infections Infections HIV Infections Infections: HIV Infections: PrEP and PEP and PEP and long-acting Carbonic Anhydrase 1 (enzyme), Human and RPV as a switch strategy for adults with HIV Infections Infections-1 who are first virologically suppressed with oral ART. , OBJECTIVE: We had previously shown that long-acting cabotegravir (Carbonic Anhydrase 1 (enzyme), Human-Latex Fixation Tests) injections fully protected Macaca from vaginal simian HIV Infections Infections (SHIV) infection., The Potential Impact of Long-Acting Cabotegravir for HIV Infections Infections Prevention in South Africa: A Mathematical Modeling Study., Long-acting cabotegravir (Carbonic Anhydrase 1 (enzyme), Human Latex Fixation Tests) is a potential new injectable formulation for Human immunodeficiency virus antigen (HIV Infections Infections) HIV Infections Infections: HIV Infections: PrEP and PEP and PEP being tested in phase III trials., Design and Testing of a Cabotegravir Implant for HIV Infections Infections Prevention., Cabotegravir and rilpivirine long-acting injectable antiretroviral therapy for the treatment of HIV Infections Infections-1 infection brings promise of a new mode of delivery and potential solutions to some problems of oral therapy, but also new challenges and unanswered questions., Cabotegravir is an investigational HIV Infections Infections Integrase Inhibitor in development for the treatment and pre-exposure prophylaxis of HIV Infections Infections-1 infection., Bictegravir, cabotegravir, dolutegravir, elvitegravir, and raltegravir are members of the latest class of antiretrovirals available to treat Human immunodeficiency virus antigen (HIV Infections Infections) infection, the integrase strand transfer inhibitors., PURPOSE OF REVIEW: Long-acting cabotegravir may provide a novel therapeutic option for both the treatment and prevention of HIV Infections Infections-1 infection that does not necessitate adherence, Long-acting injectable cabotegravir for the prevention of Human immunodeficiency virus II infection, BACKGROUND: The HIV Infections Infections Prevention Trials Network (HPTN) 083 trial demonstrated that long-acting cabotegravir (Carbonic Anhydrase 1 (enzyme), Human-Latex Fixation Tests) was more effective than tenofovir disoproxil fumarate-emtricitabine (TDF/FTC) in preventing Human immunodeficiency virus antigen (HIV Infections Infections) in cisgender men and transgender women who have sex with, Areas covered: Here, we review trials of cabotegravir (Carbonic Anhydrase 1 (enzyme), Human) as treatment of HIV Infections Infections-1 infection and its potential use as pre-exposure prophylaxis (HIV Infections Infections: HIV Infections: PrEP and PEP and PEP) in high risk individuals, including issues around oral lead in and potential resistance emergence. Exper, frequent dosing. This review focuses on the potential benefits and considerations for the study and use of 2 long-acting injectable agents, cabotegravir (GSK1265744LA, Carbonic Anhydrase 1 (enzyme), Human Latex Fixation Tests) and rilpivirine (TMC278LA, RPV Latex Fixation Tests), for use as chemoprophylaxis for HIV Infections Infections , An evaluation of cabotegravir for HIV Infections Infections treatment and prevention., Cabotegravir long-acting for HIV Infections Infections-1 prevention., Our findings suggest that cabotegravir should be evaluated in clinical trials as a potential option for antiretroviral therapy and preexposure prophylaxis in HIV Infections Infections-2-prevalent settings., Profile of cabotegravir and its potential in the treatment and prevention of HIV Infections Infections-1 infection: evidence to date., Long-Acting Cabotegravir for HIV Infections Infections/AIDS Prophylaxis., Cabotegravir for HIV Infections Infections Prevention in Cisgender Men and Transgender Women., Cabotegravir is a novel Human immunodeficiency virus antigen integrase enzyme inhibitor used for prevention and treatment of Human immunodeficiency virus II infection., PURPOSE OF REVIEW: Long-acting cabotegravir may provide a novel therapeutic option for both the treatment and prevention of HIV Infections Infections-1 infection that does not necessitate adherence , Cabotegravir in the treatment and prevention of Human Immunodeficiency Virus-1., Cabotegravir: its potential for antiretroviral therapy and preexposure prophylaxis., Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV Infections Infections: Patient perspectives from the ECLAIR trial.[SEP]Relations: Rilpivirine has relations: contraindication with chronic hepatitis B virus infection, contraindication with chronic hepatitis B virus infection, drug_drug with Cabazitaxel, drug_drug with Cabazitaxel, drug_drug with Paritaprevir, drug_drug with Paritaprevir. Raltegravir has relations: drug_drug with Pibrentasvir, drug_drug with Pibrentasvir, drug_drug with Paritaprevir, drug_drug with Paritaprevir. Definitions: HIV Infections Integrase Inhibitor defined as following: An agent that blocks the activity of the Human immunodeficiency virus antigen (HIV Infections) integrase enzyme.. HIV Infections: PrEP and PEP defined as following:

What are HIV Infections: PrEP and PEP and PEP?

HIV Infections: PrEP and PEP and PEP are medicines to prevent HIV Infections. Each type is used in a different situation:

  • HIV Infections: PrEP and PEP stands for pre-exposure prophylaxis. It is for people who don't already have HIV Infections but are at very high risk of getting it. HIV Infections: PrEP and PEP is daily medicine that can reduce this risk. With HIV Infections: PrEP and PEP, if you do get exposed to HIV Infections, the medicine can stop HIV Infections from taking hold and spreading throughout your body.
  • PEP stands for post-exposure prophylaxis. PEP is for people who have possibly been exposed to HIV Infections. It is only for emergency situations. PEP must be started within 72 hours after a possible exposure to HIV Infections.

HIV Infections: PrEP and PEP (pre-exposure prophylaxis)

Who should consider taking HIV Infections: PrEP and PEP?

HIV Infections: PrEP and PEP is for people without HIV Infections who are at very high risk for getting it. This includes:

Gay/bisexual men who

  • Have an HIV Infections-positive partner
  • Have multiple partners, a partner with multiple partners, or a partner whose HIV Infections status is unknown and

Heterosexual men and women who

  • Have an HIV Infections-positive partner
  • Have multiple partners, a partner with multiple partners, or a partner whose HIV Infections status is unknown and
    • Don't always use a condom when having sex with people who inject drugs OR
    • Don't always use a condom when having sex with bisexual men

People who inject drugs and

  • Share needles or other equipment to inject drugs OR
  • Are at risk for getting HIV Infections from sex

If you have a partner who is HIV Infections-positive and are considering getting pregnant, talk to your health care provider about HIV Infections: PrEP and PEP. Taking it may help protect you and your baby from getting Human immunodeficiency virus II infection while you try to get pregnant, during pregnancy, or while breastfeeding.

How well does HIV Infections: PrEP and PEP work?

HIV Infections: PrEP and PEP is very effective when you take it every day. It reduces the risk of getting HIV Infections from sex by more than 90%. In people who inject drugs, it reduces the risk of HIV Infections by more than 70%. HIV Infections: PrEP and PEP is much less effective if you do not take it consistently.

HIV Infections: PrEP and PEP does not protect against other STDs, so you should still use latex condoms every time you have sex. If your or your partner is allergic to latex, you can use polyurethane condoms.

You must have an HIV Infections test every 3 months while taking HIV Infections: PrEP and PEP, so you'll have regular follow-up visits with your health care provider. If you are having trouble taking HIV Infections: PrEP and PEP every day or if you want to stop taking HIV Infections: PrEP and PEP, talk to your health care provider.

Does HIV Infections: PrEP and PEP cause side effects?

Some people taking HIV Infections: PrEP and PEP may have side effects, like nausea. The side effects are usually not serious and often get better over time. If you are taking HIV Infections: PrEP and PEP, tell your health care provider if you have a side effect that bothers you or that does not go away.

PEP (post-exposure prophylaxis)

Who should consider taking PEP?

If you are HIV Infections-negative and you think you may have been recently exposed to HIV Infections, contact your health care provider immediately or go to an emergency room right away.

You may be prescribed PEP if you are HIV Infections negative or don't know your HIV Infections status, and in the last 72 hours you

  • Think you may have been exposed to HIV Infections during sex,
  • Shared needles or drug preparation equipment, OR
  • Were sexually assaulted

Your health care provider or emergency room doctor will help to decide whether PEP is right for you.

PEP may also be given to a health care worker after a possible exposure to HIV Infections at work, for example, from a needlestick injury.

When should I start PEP and how long do I need to take it?

PEP must be started within 72 hours (3 days) after a possible exposure to HIV Infections. The sooner you start it, the better; every hour counts.

You need to take the PEP medicines every day for 28 days. You will have to see your health care provider at certain times during and after taking the PEP, so you can have an HIV Infections screening test and other testing.

Does PEP cause side effects?

Some people taking PEP may have side effects, like nausea. The side effects are usually not serious and often get better over time. If you are taking PEP, tell your health care provider if you have a side effect that bothers you or that does not go away.

PEP medicines may also interact with other medicines that a person is taking (called a drug interaction). So it's important to tell your health care provider about any other medicines that you take.

Can I take PEP every time I have unprotected sex?

PEP is only for emergency situations. It is not the right choice for people who may be exposed to HIV Infections frequently - for example, if you often have sex without a condom with a partner who is HIV Infections-positive. In that case, you should talk to your health care provider about whether HIV Infections: PrEP and PEP (pre-exposure prophylaxis) would be right for you.

. Latex Fixation Tests defined as following: Passive agglutination tests in which antigen is adsorbed onto latex particles which then clump in the presence of antibody specific for the adsorbed antigen. (From Stedman, 26th ed). rilpivirine defined as following: A second-generation non-nucleoside reverse transcriptase inhibitor. Rilpivirine is a diarylpyrimidine.. Carbonic Anhydrase 1 (enzyme), Human defined as following: Carbonic anhydrase 1 (261 aa, ~29 kDa) is encoded by the human CA1 gene. This protein plays a role in carbon dioxide metabolism by erythrocytes.. raltegravir defined as following: A small molecule with activity against Human immunodeficiency virus antigen (HIV Infections). Raltegravir is an HIV Infections Integrase Inhibitor that blocks the integration of the viral genome into the host DNA, a critical step in the pathogenesis of HIV Infections.. Macaca defined as following: A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of 16 species inhabiting forests of Africa, Asia, and the islands of Borneo, Philippines, and Celebes.. HIV Infections defined as following: Includes the spectrum of Human immunodeficiency virus antigen infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS)..", "label": "yes"} {"original_question": "Does the chromatin remodeling complex, RSC target H2A.Z nucleosomes?", "id": "converted_3384", "sentence1": "Does the chromatin remodeling complex, Remodels the Structure of Chromatin target H2AZ1 wt Allele Nucleosomes?", "sentence2": "In contrast, the upstream nucleosome location location which covers the TATA Box under repressed conditions is shifted approximately 50 bp further upstream by the ATP-dependent chromatin remodeler Remodels the Structure of Chromatin upon activation. It is marked with the Histone antigen variant H2AZ1 wt Allele and H4K16 acetylation in active state, In Remodels the Structure of Chromatin-depleted cells, NFRs shrink such that the average Positioning Attribute of flanking Nucleosomes move toward predicted sites., In contrast, H2AZ1 wt Allele deposition is dispensable for nucleosome location location positioning. , Emerging lines of evidence indicate that Histone antigen variants (H2AX protein, human protein, human and H2AZ1 wt Allele), Histone antigen post-translational modifications (acetylation, phosphorylation, methylation and ubiquitination) and chromatin-remodeling complexes (INO80 protein, human protein, human, SRCAP gene, SWI/SNF, Remodels the Structure of Chromatin and NuRD) are important and direct players in the DNA double-strand break (DSB) response as well., H2AZ1 wt Allele probably helps Remodels the Structure of Chromatin in keeping the gene nucleosome location location-fre, Accordingly, the absence of Swr1 complex or Histone antigen H2AZ1 wt Allele results in compromised chromatin remodeling and impaired gene expression in the absence of Remodels the Structure of Chromatin and Histone H3 Lysine 4 methylation.[SEP]Relations: nucleosome location mobilization has relations: bioprocess_bioprocess with chromatin remodeling, bioprocess_bioprocess with chromatin remodeling. nucleosome location has relations: cellcomp_protein with H3C6, cellcomp_protein with H3C6, cellcomp_protein with H2AC4, cellcomp_protein with H2AC4, cellcomp_protein with H4C6, cellcomp_protein with H4C6, cellcomp_protein with H3C4, cellcomp_protein with H3C4. Definitions: H2AZ1 wt Allele defined as following: Human H2AZ1 wild-type allele is located in the vicinity of 4q24 and is approximately 2 kb in length. This allele, which encodes Histone antigen H2AZ1 wt Allele protein, plays a role in chromatin packaging.. TATA Box defined as following: A conserved A-T rich sequence which is contained in promoters for RNA polymerase II. The segment is seven base pairs long and the nucleotides most commonly found are TATAAAA.. nucleosome location defined as following: A complex comprised of DNA wound around a multisubunit core and associated proteins, which forms the primary packing unit of DNA into higher order structures. [GOC:elh]. H2AX protein, human defined as following: Histone H2AX protein, human (143 aa, ~15 kDa) is encoded by the human H2AX protein, human gene. This protein plays a role in nucleosome location formation and V(D)J recombination.. INO80 protein, human defined as following: DNA helicase INO80 protein, human (1556 aa, ~177 kDa) is encoded by the human INO80 protein, human gene. This protein is involved in the ATP-depending unwinding of DNA helices.. Swr1 complex defined as following: A multisubunit protein complex that is involved in chromatin remodeling. It is required for the incorporation of the Histone antigen variant H2AZ into chromatin. In S. cerevisiae, the complex contains Swr1p, a Swi2/Snf2-related ATPase, and 12 additional subunits. [GOC:rb, PMID:14645854, PMID:14690608, PMID:19355820]. Histone H3 Lysine 4 defined as following: The lysine residue found at amino acid position 4 in the Histone antigen H3 protein. Methylation of this residue may be a marker for transcriptionally active genes.. Remodels the Structure of Chromatin defined as following: Remodels the Structure of Chromatin is an abundant fifteen-protein chromatin remodeling complex containing SNF12 [RSC6p subunit homologue], RSC1 (or RSC2 or RSC4), RSC58 [58 kD subunit], and SFH1. (from SGD and NCI). Positioning Attribute defined as following: A reference to the alignment of an object, a particular situation or view of a situation, or the location of an object.. Nucleosomes defined as following: The repeating structural units of chromatin, each consisting of approximately 200 base pairs of DNA wound around a protein core. This core is composed of the histones H2A, H2B, H3, and H4.. chromatin remodeling complex defined as following: The proteins or protein complexes that can either activate or silence gene transcription through their ability to modify the architecture of chromatin. These factors alter the accessibility of DNA to those factors that are required for gene transcription..", "label": "yes"} {"original_question": "Are recessive coding variants responsible for the majority of undiagnosed nonconsanguineous individuals?", "id": "converted_3070", "sentence1": "Are recessive coding variants responsible for the majority of undiagnosed nonconsanguineous individuals?", "sentence2": "Our results suggest that recessive coding variants account for a small fraction of currently undiagnosed nonconsanguineous individuals, and that the role of noncoding variants, incomplete penetrance, and polygenic mechanisms need further exploration.[SEP]", "label": "no"} {"original_question": "Does HuR protein regulate the splicing process?", "id": "converted_1477", "sentence1": "Does ELAVL1 gene Protein Info regulate the splicing process?", "sentence2": "ELAVL1 gene and TIA1/TIAL1 are involved in regulation of alternative splicing of Sirtuin 1 pre-mRNA, Here we describe experiments showing that ELAVL1 gene and TIA1/TIAL1, two kinds of RNA-binding proteins, were involved in the regulation of alternative splicing of Sirtuin 1 pre-mRNA under normal and stress circumstances, ELAVL1 gene increased Sirtuin 1-∆Exon8 by promoting Sirtuin 1 exon 8 exclusion, whereas TIA1/TIAL1 inhibition of the exon 8 exclusion led to a decrease in Sirtuin 1-∆Exon8 mRNA levels. , ELAVL1 gene regulates alternative splicing of the TRA2β gene in Homo sapiens colon cancer cells under oxidative stress, Hu antigen R (ELAVL1 gene) regulates stress responses through stabilizing and/or facilitating the translation of target mRNAs, We show here that the RBP embryonic lethal Abnormal vision like 1 (ELAVL1, also know as ELAVL1 gene) regulates the alternative splicing of EIF4ENIF1 gene (Eif4enif1), which encodes an eukaryotic translation initiation factor 4E transporter (4E-T) Protein Info and suppresses the expression of capped mRNAs, Further, endothelial-specific Elavl1 knockout mice exhibited reduced revascularization after hind limb Ischemia Procedure and tumor angiogenesis in oncogene-induced mammary cancer, resulting in attenuated blood flow and tumor growth, respectively. , Changes in Cells mRNA stability, splicing, and polyadenylation through ELAVL1 gene Protein Info sequestration by a cytoplasmic RNA virus, Furthermore, significant changes can be observed in nuclear alternative polyadenylation and splicing events on Cells pre-mRNAs as a result of sequestration of ELAVL1 gene Protein Info by the 3' Untranslated Regions of RNA Transcript of this cytoplasmic RNA virus., Here we demonstrate that expression of 2A(pro) induces a selective nucleo-cytoplasm translocation of several important RNA-Binding Proteins and RNA Splicing Factors. Subcellular fractionation studies, together with immunofluorescence microscopy revealed an asymmetric distribution of ELAVL1 gene and TIA1/TIAR in 2A(pro) expressing cells, which modulates splicing of the Homo sapiens Fas exon 6, knockdown of ELAVL1 gene or overexpression of TIA1/TIAR, leads to Fas exon 6 inclusion in 2A(pro)-expressing cells, The differential expression levels of T-cell intracellular antigens (Transient Cerebral Ischemia) and Hu antigen R (ELAVL1 gene) are concomitant with a splicing switch in apoptosis receptor Fas in HCT116 Cells, overexpression and knockdown of ELAVL1 gene led to Fas exon 6 skipping and inclusion, respectively. These results suggest that the Transient Cerebral Ischemia and ELAVL1 gene Cells ratio influences cell-type specific Fas exon 6 splicing pattern., Hu antigen R (ELAVL1 gene) functions as an alternative pre-RNA, Messenger, Splicing regulator of Fas apoptosis-promoting receptor on exon definition, antiapoptotic regulator Hu antigen R (ELAVL1 gene, ELAVL1), a member of the embryonic lethal, Abnormal vision, Drosophila-like (ELAVL) family, promotes Fas exon 6 skipping by binding to an exonic splicing silencer, ELAV/Hu proteins bind to AU-rich elements (are unit of measure) in mRNAs and regulate their stability from splicing to translation, and the ubiquitous ELAVL1 gene Protein Info has been implicated in cancerous cell growth., The ELAVL1 gene Protein Info regulates the expression of thousands of Cells RNA Transcript by modulating RNA, Messenger, Splicing, trafficking, translation, and stability., Hu antigen R (ELAVL1 gene) functions as an alternative pre-RNA, Messenger, Splicing regulator of Fas apoptosis-promoting receptor on exon definition., I report that antiapoptotic regulator Hu antigen R (ELAVL1 gene, ELAVL1), a member of the embryonic lethal, Abnormal vision, Drosophila-like (ELAVL) family, promotes Fas exon 6 skipping by binding to an exonic splicing silencer. , Changes in Cells mRNA stability, splicing, and polyadenylation through ELAVL1 gene Protein Info sequestration by a cytoplasmic RNA virus., Further, the silencing capacity of ELAVL1 gene as splicing regulator resides in the RRM1 Protein Info, Homo sapiens Protein Info, Homo sapiens and hinge-RRM3 domains. , ELAVL1 gene and TIA1/TIAL1 are involved in regulation of alternative splicing of Sirtuin 1 pre-mRNA., ELAVL1 gene regulates alternative splicing of the TRA2β gene in Homo sapiens colon cancer cells under oxidative stress., The ELAVL1 gene Protein Info regulates the expression of thousands of Cells RNA Transcript by modulating RNA, Messenger, Splicing, trafficking, translation, and stability. , Further, the silencing capacity of ELAVL1 gene as splicing regulator resides in the RRM1 Protein Info, Homo sapiens Protein Info, Homo sapiens and hinge-RRM3 domains. Taken together, these results support a functional link between ELAVL1 gene as Transcription Repressor/Corepressor of alternative Fas splicing and the molecular mechanisms modulating programmed cell death., We are interested in interactions involving Heterogeneous-Nuclear Ribonucleoproteins Proteins participating in several steps of mRNA processing (mainly pre-RNA, Messenger, Splicing) and ELAVL1 gene with an established role in stability/translation of associated mRNAs. Heterogeneous-Nuclear Ribonucleoproteins and ELAVL1 gene proteins have a major nucleoplasmic localization and ability to shuttle between Cell Nucleus and cytoplasm. We report here on interactions between Heterogeneous-Nuclear Ribonucleoproteins and ELAVL1 gene proteins that were identified in the context of isolated Heterogeneous-Nuclear Ribonucleoproteins and messenger ribonucleoprotein complex location complexes. , Despite the fact that ELAVL1 gene sites are observed in intronic regions, our data do not support a role for ELAVL1 gene in regulating splicing.[SEP]Relations: RNA splicing has relations: bioprocess_protein with ZRSR2, bioprocess_protein with ZRSR2, bioprocess_protein with KHSRP, bioprocess_protein with KHSRP, bioprocess_protein with CIR1, bioprocess_protein with CIR1, bioprocess_protein with LARP7, bioprocess_protein with LARP7. Protein Info binding has relations: molfunc_protein with HUS1, molfunc_protein with HUS1. Definitions: Ischemia Procedure defined as following: A surgical procedure during which the blood supply to an organ or tissue is interrupted and then later reestablished.. RRM1 Protein Info, Homo sapiens defined as following: Ribonucleoside-diphosphate reductase large subunit (792 aa, ~90 kDa) is encoded by the Homo sapiens RRM1 Protein Info, Homo sapiens gene. This Protein Info is involved in the conversion of ribonucleotides to deoxyribonucleotides.. are unit of measure defined as following: A unit of area equal to 100 square meters. Are is a non-SI unit accepted for use with SI.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. ELAVL1 gene defined as following: This gene plays a role in the regulation of gene expression.. Sirtuin 1 defined as following: A sirtuin family member found primarily in the CELL NUCLEUS. It is an NAD-dependent deacetylase with specificity towards HISTONES and a variety of proteins involved in gene regulation.. RNA Transcript defined as following: The initial RNA molecule produced by transcription.. messenger ribonucleoprotein complex location defined as following: A ribonucleoprotein complex containing both Protein Info and messenger RNA (mRNA) molecules. [GOC:bf, PMID:15574591, PMID:21915786]. 3' Untranslated Regions defined as following: The sequence at the 3' end of messenger RNA that does not code for product. This region contains transcription and translation regulating sequences.. RNA-Binding Proteins defined as following: Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other proteins whose function is to bind specifically to RNA.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. RNA, Messenger, Splicing defined as following: OBSOLETE. The process in which excision of introns from the primary transcript of messenger RNA (mRNA) is followed by ligation of the two exon termini exposed by removal of each intron, so that mRNA consisting only of the joined exons is produced. [GOC:krc, ISBN:0198506732]. Heterogeneous-Nuclear Ribonucleoproteins defined as following: A family of ribonucleoproteins that were originally found as proteins bound to nascent RNA RNA Transcript in the form of ribonucleoprotein particles. Although considered ribonucleoproteins they are primarily classified by their Protein Info component. They are involved in a variety of processes such as packaging of RNA and RNA TRANSPORT within the Cell Nucleus. A subset of heterogeneous-nuclear ribonucleoproteins are involved in additional functions such as nucleocytoplasmic transport (ACTIVE TRANSPORT, CELL NUCLEUS) of RNA and mRNA stability in the CYTOPLASM.. ELAVL1 gene Protein Info defined as following: An RRM Protein Info that binds to the 3'-UTR region of mRNAs and increases their stability. In EMBRYONIC STEM CELLS, it binds to poly-U elements and AU-rich elements (AREs) in the 3'-UTR of target mRNAs and preferentially binds mRNAs that are not methylated by N6-methyladenosine (m6A), to stabilize them and promote differentiation.. Cell Nucleus defined as following: Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one Cell Nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). RNA Splicing Factors defined as following: RNA-binding proteins that facilitate or inhibit RNA SPLICING.. Abnormal vision defined as following: Disturbance of eyesight.. Homo sapiens defined as following: Members of the species Homo sapiens.. HCT116 Cells defined as following: Human COLORECTAL CARCINOMA cell line.. Transcription Repressor/Corepressor defined as following: Transcription Repressor/Corepressor Gene encodes Transcriptional Repressor/Corepressor, proteins that can regulate transcription by binding to the operator and causing repression. (from Glick: Glossary of Biochemistry and Molecular Biology).", "label": "yes"} {"original_question": "Do RNA binding Proteins that bind to adenine uridine (AU)-rich elements (AREs) in the 5' untranslated region (UTR) of mRNAs (AU-RBPs) regulate the DNA Damage Response?", "id": "converted_4610", "sentence1": "Do RNA binding Proteins that bind to adenine uridine (AU)-rich elements (AREs) in the 5' untranslated region (SLC14A2 gene) of mRNAs (AU-RBPs) regulate the DNA Damage Response?", "sentence2": " We investigated 2 RNA, Messenger-binding Proteins - ELAVL1 gene and TIAL1 gene showing specificity to AU-Rich Element (are unit of measure) sites in 3'SLC14A2 gene of RNA, Messenger., Bioinformatics analysis of the human SOD1 RNA, Messenger 3' untranslated region (3'SLC14A2 gene) demonstrated the presence of HuD binding adenine-uridine (AU)-rich instability-conferring elements (AREs)., We found that AU-rich element RNA binding protein 1 (HNRNPD wt Allele) directly binds to the CRY1 gene 3'SLC14A2 gene and regulates translation of CRY1 gene RNA, Messenger., Adenylate/uridylate-rich elements (AREs) are the most common cis-regulatory elements in the 3'-untranslated region (SLC14A2 gene) of mRNAs, where they fine-tune turnover by mediating RNA, Messenger decay., ELAVL1 gene binding to AU-rich elements present in the 3' untranslated region of Classical swine fever virus., Previous reports indicate that distinct RNA Sequence in the Head>Brain-derived neurotrophic factor 3'UTRs differentially regulates Head>Brain-derived neurotrophic factor production in the Head>Brain to accommodate neuronal activity changes, conceivably through differential interactions with undefined Trans-Activators that regulate stability and translation of these Head>Brain-derived neurotrophic factor RNA, Messenger isoforms., The 5' untranslated region (SLC14A2 gene) of CSFV contains the Internal Ribosome Entry Sites, which is a highly structured element that recruits the translation machinery., Although AU-rich elements (AREs) in the 3'SLC14A2 gene of interleukin-6 (Recombinant Interleukin-6) RNA, Messenger dictate RNA, Messenger degradation, the role of Congenital Thrombotic Thrombocytopenic Purpura in the post-transcriptional regulation of Recombinant Interleukin-6 gene expression is unclear., We cloned the full-length cDNA of rabbit RGS4, which contains a long 3'-untranslated region (SLC14A2 gene) with several AU-rich elements (AREs)., Luciferase reporter assays demonstrate that ELAVL1 gene specifically regulates FOXO1 gene gene expression through AU-rich elements (AREs) within the FOXO1 gene gene 3' SLC14A2 gene., Additionally, we demonstrated that RBM38 wt Allele could bind to PR RNA, Messenger via AU-rich elements (AREs) within PR 3'-untranslated region (3'-SLC14A2 gene) and then enhance PR RNA, Messenger stability., Here, we find that C-X-C motif chemokine 12 receptor activity harbors AU-rich elements (AREs) in the 3'-untranslated region (3'-SLC14A2 gene) that bind and respond to the RNA-binding Proteins, Tristetraprolin (Congenital Thrombotic Thrombocytopenic Purpura/ZFP36) and ELAVL1 gene (ELAVL1)., These Proteins bind to adenine uridine-rich element (are unit of measure) in the 3'untranslated region of target messenger RNA and stimulate target degradation., t mRNAs. RNA-binding Proteins can control RNA, Messenger stability by binding to AU- and U-rich elements located in the 3'-untranslated regions (3'-UTRs) of target, y RNA-binding Proteins (RBPs) have been shown to recognize and bind to mRNAs that contains AREs generally present in the 3'SLC14A2 gene of mRNAs. RBPs , at AREs in the 3'SLC14A2 gene control Thrombospondin 1 RNA, Messenger stability and that the RNA binding protein HNRNPD wt Allele participates in this control. These studies suggest t, mber of the Elav family of RNA-binding Proteins, has been implicated in this pathway through its binding to adenine and uridine (AU)-rich stability elements (are unit of measure) located in the 3' untranslated regions (3'-UTRs) of the RNA, Messenger. Whereas three , Hu Proteins are RNA-binding Proteins that are implicated in the control of stabilization, nuclear export, and/or translation of specific mRNAs with AU-rich elements (AREs) in the 3'-untranslated region. Tyrosine 3-Monooxygenase, human, Post-transcriptional RNA, Messenger regulation by RNA binding Proteins (RBPs) associated with AU-rich elements (AREs) present in the 3' untranslated region (3'SLC14A2 gene) of specific mRNAs modulates RNA Transcript stability and translation in Eukaryotic Cells., In the 3'-untranslated region, the destabilizing adenine-uridine (AU)-rich elements (AREs) control the expression of several transcripts through interactions with are unit of measure-binding Proteins (AUBPs) and RNA degradation machinery., The AU/U-rich element-binding protein ELAVL1 gene has been shown to bind to TP53 wt Allele RNA, Messenger 3'SLC14A2 gene and enhance translation in response to DNA-damaging UVC radiation., The HNRNPD wt Allele (Heterogeneous Nuclear Ribonucleoprotein D0, Human) and ELAVL1 gene (ELAV-like) Proteins, potential Trans-Activators for regulated RNA, Messenger decay, bind in vitro to A+U-rich elements (AREs) found in the 3' untranslated region (3' SLC14A2 gene) of many labile transcripts., Neuronal Ceroid-Lipofuscinoses binds to the AU-rich element (are unit of measure) in the 3'SLC14A2 gene of target mRNAs, mediates miRNA functions in the nearby target sequences, and regulates RNA, Messenger deadenylation., We investigated 2 RNA, Messenger-binding Proteins - ELAVL1 gene and TIAL1 gene showing specificity to AU-Rich Element (are unit of measure) sites in 3'SLC14A2 gene of RNA, Messenger., Secondly, the degradation of some mRNAs related to immune responses has been reported to be regulated by binding of RNA-binding Proteins to adenylate uridylate-rich elements (AU-rich elements, AREs) located in the 3'-untranslated region (3'-SLC14A2 gene)., Here, we review the interplay between six well-known RBPs (Congenital Thrombotic Thrombocytopenic Purpura, AUF-1, KHSRP gene, ELAVL1 gene, TIA1 wt Allele, and TIAL1 gene) that recognize AU-rich elements (AREs) at the 3' untranslated regions of mRNAs, namely are unit of measure-RBPs., Hu Proteins have been shown to bind to AU-rich elements (AREs) in the 3'-untranslated region of unstable mRNAs.[SEP]Relations: ELAVL1 has relations: molfunc_protein with RNA, Messenger 3'-SLC14A2 gene AU-rich region binding, molfunc_protein with RNA, Messenger 3'-SLC14A2 gene AU-rich region binding, molfunc_protein with RNA, Messenger 3'-SLC14A2 gene binding, molfunc_protein with RNA, Messenger 3'-SLC14A2 gene binding. protein binding has relations: molfunc_protein with UTP6, molfunc_protein with UTP6, molfunc_protein with AUP1, molfunc_protein with AUP1, molfunc_protein with AUNIP, molfunc_protein with AUNIP. Definitions: Recombinant Interleukin-6 defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin-6 (Recombinant Interleukin-6) with antiapoptotic, proinflammatory, antiinflammatory, proproliferative and proangiogenic activities. Recombinant Interleukin-6 binds to its receptor (IL-6R), activating a receptor-CD130 receptor complex; the CD130 portion of the complex is a signal transduction protein that activates JAK kinases and Ras-mediated signaling pathways, which in turn activate downstream signaling pathways, resulting in the activation of various transcription factors (STAT, ELK-1, NF-Recombinant Interleukin-6, etc.) and gene transcription. The physiological effects of Recombinant Interleukin-6 are complex and varied and include hematopoietic, pyrogenic and thermogenic, proinflammatory, antiinflammatory, proproliferative (anti-apoptotic), and angiogenic effects.. Head>Brain-derived neurotrophic factor defined as following: A member of the nerve growth factor family of trophic factors. In the Head>Brain Head>Brain-derived neurotrophic factor has a trophic action on retinal, cholinergic, and dopaminergic neurons, and in the peripheral nervous system it acts on both motor and sensory neurons. (From Kendrew, The Encyclopedia of Molecular Biology, 1994). TIA1 wt Allele defined as following: Human TIA1 wild-type allele is located in the vicinity of 2p13 and is approximately 39 kb in length. This allele, which encodes nucleolysin TIA1 wt Allele isoform p40, plays a role in both RNA binding and splicing. Mutation of the gene is associated with Welander distal myopathy.. Congenital Thrombotic Thrombocytopenic Purpura defined as following: Thrombotic thrombocytopenic purpura for which the cause is present from birth.. adenine defined as following: A purine base and a fundamental unit of ADENINE NUCLEOTIDES.. are unit of measure defined as following: A unit of area equal to 100 square meters. Are is a non-SI unit accepted for use with SI.. Tristetraprolin defined as following: A ZINC FINGER MOTIF containing transcription factor that was originally identified as one of the IMMEDIATE-EARLY PROTEINS. It shuttles between the CYTOPLASM and the CELL NUCLEUS and is involved in destabilization of mRNAs for TUMOR NECROSIS FACTOR-ALPHA.. RNA Sequence defined as following: The sequence of nucleotide residues along an RNA chain.. Neuronal Ceroid-Lipofuscinoses defined as following: A group of severe neurodegenerative diseases characterized by intracellular accumulation of autofluorescent wax-like lipid materials (CEROID; LIPOFUSCIN) in neurons. There are several subtypes based on mutations of the various genes, time of disease onset, and severity of the neurological defects such as progressive DEMENTIA; SEIZURES; and visual failure.. FOXO1 gene defined as following: This gene is involved in transcriptional regulation and may play a role in myogenic growth and differentiation.. CRY1 gene defined as following: This gene plays a role in circadian rhythm.. ELAVL1 gene defined as following: This gene plays a role in the regulation of gene expression.. Heterogeneous Nuclear Ribonucleoprotein D0, Human defined as following: Heterogeneous nuclear ribonucleoprotein D0 (355 aa, ~38 kDa) is encoded by the human HNRNPD gene. This protein is involved in both RNA transport and splicing.. RNA, Messenger defined as following: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the cytoplasm.. RNA Transcript defined as following: The initial RNA molecule produced by transcription.. C-X-C motif chemokine 12 receptor activity defined as following: Combining with the C-X-C motif chemokine 12 (CXCL12) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. [GOC:bf, PMID:22204316]. Internal Ribosome Entry Sites defined as following: Sequences within MESSENGER RNA that enable PROTEIN TRANSLATION INITIATION independent of 5' CAPPED RNA.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Eukaryotic Cells defined as following: Cells of the higher organisms, containing a true nucleus bounded by a nuclear membrane.. 3' SLC14A2 gene defined as following: The sequence at the 3' end of messenger RNA that does not code for product. This region contains transcription and translation regulating sequences.. RNA binding Proteins defined as following: Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other Proteins whose function is to bind specifically to RNA.. RBM38 wt Allele defined as following: Human RBM38 wild-type allele is located in the vicinity of 20q13.31 and is approximately 18 kb in length. This allele, which encodes RNA-binding protein 38, plays a role in the regulation of RNA, Messenger stability.. HNRNPD wt Allele defined as following: Human HNRNPD wild-type allele is located in the vicinity of 4q21 and is approximately 22 kb in length. This allele, which encodes heterogeneous nuclear ribonucleoprotein D0, plays a role in the catabolism of RNA.. Tyrosine 3-Monooxygenase, human defined as following: Tyrosine 3-monooxygenase (528 aa, ~59 kDa) is encoded by the human TH gene. This protein plays a role in the synthesis of dopamine from L-tyrosine.. Trans-Activators defined as following: Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of Proteins.. TP53 wt Allele defined as following: Human TP53 wild-type allele is located in the vicinity of 17p13.1 and is approximately 19 kb in length. This allele, which encodes cellular tumor antigen TP53 wt Allele protein, plays a role in cell cycle regulation during the G0/G1transition. Alterations of the TP53 gene occur as both somatic and germline mutations in human malignancies in select cancer-prone families with Li-Fraumeni syndrome.. Thrombospondin 1 defined as following: An extracellular matrix glycoprotein from platelets and a variety of normal and transformed cells of both mesenchymal and epithelial origin. Thrombospondin-1 is believed to play a role in cell migration and proliferation, during embryogenesis and wound repair. Also, it has been studied for its use as a potential regulator of tumor growth and metastasis..", "label": "no"} {"original_question": "Is there an association between bruxism and reflux?", "id": "converted_393", "sentence1": "Is there an association between Bruxism and reflux?", "sentence2": "Sleep Bruxism is prevalent in GERD patients, and GERD is highly associated with SB., There was a statistical trend towards Tooth Wear progression being associated with gastric risk factors (p < 0.05). , This article presents a case report of a 27-year-old male smoker with Tooth Wear and dentin sensitivity caused by GERD associated with Bruxism. , The aim of this cross-over, randomized, single-blinded trial was to examine whether Intra-oesophageal acidification induces Sleep Bruxism (SB). , RMMA episodes including SB were induced by Esophageal acidification. , Chronic regurgitation of Gastric Acid in patients with Infantile Gastroesophageal Reflux disease may cause dental erosion, which can lead in combination with attrition or Bruxism to extensive loss of coronal tooth tissue., This clinical report describes treatment of severe Tooth Wear of a Infantile Gastroesophageal Reflux disease patient who is 54-year-old Turkish male patient. After his medical treatment, severe Tooth Wear, Bruxism and decreased vertical dimensions were determined. , Gastroesophageal reflux disease by itself or in combination with attrition, abrasion or Bruxism may be responsible for the loss., The association between Bruxism, feeding and smoking habits and Digestive System Disorders may lead to serious consequences to dental and related structures, involving dental alterations (wear, Fracture and cracks), periodontal signs (gingival recession and Tooth Mobility) and muscle-joint sensitivity, demanding a multidisciplinary treatment plan. This paper presents a case report in which Bruxism associated with acid feeding, smoking habit and episodes of gastric reflow caused severe Tooth Wear and great Muscle (organ) discomfort with daily Headache episodes. , The frequencies of RMMA, single short-burst, and clenching episodes were significantly higher during decreased Esophageal pH episodes than those during other times. , These results suggest that most jaw muscle activities, ie, RMMA, single short-burst, and clenching episodes, occur in relation to Infantile Gastroesophageal Reflux mainly in the supine position., Nocturnal Bruxism may be secondary to nocturnal Infantile Gastroesophageal Reflux, occurring via sleep arousal and often together with swallowing.[SEP]Relations: Gastroesophageal reflux has relations: disease_phenotype_positive with Joubert syndrome with Jeune asphyxiating thoracic dystrophy, disease_phenotype_positive with Joubert syndrome with Jeune asphyxiating thoracic dystrophy, disease_phenotype_positive with citrullinemia, disease_phenotype_positive with citrullinemia, disease_phenotype_positive with atrioventricular defect-blepharophimosis-radial and anal defect syndrome, disease_phenotype_positive with atrioventricular defect-blepharophimosis-radial and anal defect syndrome. Infantile Gastroesophageal Reflux disease has relations: contraindication with Racementhol, contraindication with Racementhol, contraindication with Butabarbital, contraindication with Butabarbital. Definitions: Infantile Gastroesophageal Reflux defined as following: Effortless regurgitation of gastric contents that commonly occurs in infants, usually right after feeding or burping.. Gastric Acid defined as following: Hydrochloric acid present in GASTRIC JUICE.. Headache defined as following: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.. Digestive System Disorders defined as following: Diseases in any part of the GASTROINTESTINAL TRACT or the accessory organs (LIVER; BILIARY TRACT; PANCREAS).. Tooth Mobility defined as following: Horizontal and, to a lesser degree, axial movement of a tooth in response to normal forces, as in occlusion. It refers also to the movability of a tooth resulting from loss of all or a portion of its attachment and supportive apparatus, as seen in periodontitis, occlusal trauma, and periodontosis. (From Jablonski, Dictionary of Dentistry, 1992, p507 & Boucher's Clinical Dental Terminology, 4th ed, p313). Tooth Wear defined as following: Loss of the tooth substance by chemical or mechanical processes. Muscle (organ) defined as following: One of the contractile organs of the body.. Sleep Bruxism defined as following: A sleep disorder characterized by grinding and clenching of the teeth and forceful lateral or protrusive jaw movements. Sleep Bruxism may be associated with TOOTH INJURIES; TEMPOROMANDIBULAR JOINT DISORDERS; sleep disturbances; and other conditions.. Infantile Gastroesophageal Reflux disease defined as following: Retrograde flow of gastric juice (GASTRIC ACID) and/or duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the distal ESOPHAGUS, commonly due to incompetence of the LOWER ESOPHAGEAL SPHINCTER.. Bruxism defined as following: A disorder characterized by grinding and clenching of the teeth.. Fracture defined as following: A traumatic injury to the bone in which the continuity of the bone is broken.. Esophageal defined as following: Of or relating to the esophagus.. reflux defined as following: An abnormal backward flow of a body fluid..", "label": "yes"} {"original_question": "Can LB-100 downregulate miR-33?", "id": "converted_3635", "sentence1": "Can LB-100 downregulate miR-33?", "sentence2": "Protein Phosphatase 2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation., LB100 profoundly upregulates miR-181b-1, which we show directly binds to the 3' untranslated region of BCL2 gene mRNA leading to its translational inhibition. MiR-181b-1 ectopic overexpression further diminishes BCL2 gene expression leading to suppression of sAML cell growth, and enhancement of Do-Not-Resuscitate Orders cytotoxicity. [SEP]Relations: Daunorubicin has relations: drug_drug with SRP 299, drug_drug with SRP 299, drug_drug with TG4010, drug_drug with TG4010, drug_drug with GI-5005, drug_drug with GI-5005, drug_drug with mRNA-1273, drug_drug with mRNA-1273, drug_drug with INGN 225, drug_drug with INGN 225. Definitions: BCL2 gene defined as following: The B-cell leukemia/lymphoma-2 genes, responsible for blocking apoptosis in normal cells, and associated with follicular lymphoma when overexpressed. Overexpression results from the t(14;18) translocation. The human c-bcl-2 gene is located at 18q24 on the long arm of chromosome 18.. Protein Phosphatase 2A defined as following: Protein Phosphatase 2A core enzyme consists of a 36-kDa catalytic C subunit and a constant 65-kDa regulatory/structural A subunit that interact with either a B regulatory subunit or with cell signaling molecules, that likely modulate substrate selectivity, catalytic activity, and subcellular localization, yielding the trimeric holoenzyme. Combinations of different subunit isoforms can generate many forms of Protein Phosphatase 2A, which may differ in substrate specificity, subcellular localization, or tissue specific expression.. daunorubicin defined as following: A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS..", "label": "no"} {"original_question": "Has ProSavin undergone phase IV clinical trials by 2018?", "id": "converted_3498", "sentence1": "Has ProSavin undergone phase IV clinical trials by 2018?", "sentence2": "Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson Disease: a dose escalation, open-label, phase 1/2 trial., We undertook a phase 1/2 open-label trial with 12-month follow-up at two study sites (France and UK) to assess the safety and efficacy of ProSavin after Bilateral injection into the Structure of Structure of putamen of patients with Parkinson Disease. [SEP]Relations: Parkinson disease has relations: contraindication with Prochlorperazine, contraindication with Prochlorperazine, contraindication with Indomethacin, contraindication with Indomethacin, contraindication with Amikacin, contraindication with Amikacin, contraindication with Rivastigmine, contraindication with Rivastigmine, contraindication with Perphenazine, contraindication with Perphenazine. Definitions: Bilateral defined as following: Affecting both sides of the body or a matched pair of organs.. Parkinson Disease defined as following: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75). Structure of putamen defined as following: The largest and most lateral of the BASAL GANGLIA lying between the lateral medullary lamina of the GLOBUS PALLIDUS and the EXTERNAL CAPSULE. It is part of the neostriatum and forms part of the LENTIFORM NUCLEUS along with the GLOBUS PALLIDUS..", "label": "no"} {"original_question": "Is MammaPrint cleared by the United States Food and Drug Administration? ", "id": "converted_128", "sentence1": "Is MammaPrint cleared by the United States Food and Drug Administration? ", "sentence2": "Real-time RT-PCR confirmed the 5-gene prognostic signature that was distinct from an FDA-cleared 70-gene signature of MammaPrint panel and from the Oncotype DX Breast Cancer Assay Breast Cancer Assay recurrence score assay panel.[SEP]Relations: salivary gland type cancer of the breast has relations: disease_disease with breast cancer, disease_disease with breast cancer. Definitions: Oncotype DX Breast Cancer Assay defined as following: A diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition to predicting distant disease recurrence, Oncotype DX Breast Cancer Assay also assesses the benefit from certain types of chemotherapy. The assay, performed using formalin-fixed, paraffin-embedded tumor tissue, analyzes the expression of a panel of 21 genes and the results are provided as a Recurrence Score (0-100). The gene panel was selected and the Recurrence Score calculation was derived through extensive laboratory testing and multiple independent clinical development studies. Oncotype DX Breast Cancer Assay is validated for use in breast cancer patients whose disease is newly diagnosed, stage I or II, node-negative, estrogen receptor-positive and who will be treated with tamoxifen.. MammaPrint defined as following: An in vitro molecular diagnostic test that uses gene expression profiling to analyze gene activity within a breast cancer tumor sample. It looks at the activity of 70 genes and is useful in assessing the likelihood of metastasis and recurrence..", "label": "yes"} {"original_question": "Is amantadine effective for treatment of disorders conciousness?", "id": "converted_129", "sentence1": "Is amantadine effective for treatment of disorders conciousness?", "sentence2": "We here provide a systematic overview of the therapeutic effects of amantadine, apomorphine and zolpidem in patients recovering from Apraxia, oculomotor, Cogan type. Evidence from clinical trials using these commonly prescribed pharmacological agents suggests positive changes in the neurological status in patients, leading sometimes to dramatic improvements., Pharmaceuticals that act in the Oxygen Equipment Location based amino acid systems of the Head>Brain include the GABAergic Medications:Presence or Identity:Duration of the study:^Patient:Nominal zolpidem and baclofen, while those that act in the monoamine axes include the dopaminergic Medications:Presence or Identity:Duration of the study:^Patient:Nominal L Dopa, amantadine, bromocriptine, apomorphine and methylphenidate, and the noradrenergic and serotonergic Medications:Presence or Identity:Duration of the study:^Patient:Nominal desipramine, amitriptyline, protriptyline and fluoxetine. , Sporadic cases of recovery from a DOC have been reported after the administration of various pharmacological agents (baclofen, zolpidem, amantadine etc.)., amantadine hydrochloride is one of the most commonly prescribed Medications:Presence or Identity:Duration of the study:^Patient:Nominal for patients with prolonged disorders of consciousness after traumatic Brain Injuries. Preliminary studies have suggested that amantadine may promote functional recovery., During the 4-week treatment period, recovery was significantly faster in the amantadine group than in the placebo group, as measured by the DRS score (difference in slope, 0.24 points per week; P=0.007), indicating a benefit with respect to the primary outcome measure. , amantadine accelerated the pace of functional recovery during active treatment in patients with post-traumatic disorders of consciousness., Sporadic cases of dramatic recovery from DOC after the administration of various pharmacological agents, such as baclofen, zolpidem and amantadine, have been recently supported by intriguing scientific observations. , According to the 16 eligible studies, medical management by Dopaminergic Agents (levodopa, amantadine), zolpidem and median nerve stimulation, or surgical management by deep Head>Brain stimulation, extradural cortical stimulation, spinal cord stimulation and intrathecal baclofen have shown to improve the level of consciousness in certain cases. , Higher exposure of amantadine (average concentration of amantadine during 6 mg/kg/day > 1.5 mg/L) may be associated with better recovery of consciousness. , Based on the preliminary data, higher dosing may be considered in the setting of Brain Injuries., Patients treated with PK-Merz exhibited the more significant restoration of consciousness and better dynamics (regress) of Neurologic Deficits with the most intensive restoration of Neurologic Deficits in the first day that allows to recommend the use of amantadine sulfate in the first hours of Ischemic stroke and for the prevention of Reperfusion Injury in recanalisation therapy of Ischemic stroke., There was no significant difference in the slopes of recovery during either arm for the Coma/Near-Coma Scale (P = 0.24) or the Coma Recovery Scale-Revised (P = 0.28), although improvements in consciousness were noted by the physician during weeks when amantadine was given (P = 0.02). , This study suggests that amantadine facilitates recovery of consciousness in pediatric acquired Brain Injuries and provides important information necessary to design future more definitive studies., The study has shown a positive effect of this Pharmacologic Substance at Apraxia, oculomotor, Cogan type emergence, which manifested itself as clinical improvement and a better outcome of the disease., This article will review the evidence for the use of Psychostimulant (substance) (methylphenidate), Antidepressive Agents (amitriptyline, selective serotonin reuptake inhibitors, and buproprion), Parkinson's Medications:Presence or Identity:Duration of the study:^Patient:Nominal (amantadine, bromocriptine, carbidopa / levodopa), Anticonvulsants [TC] (valproic acid), modafinil (Provigil), Lactic acid measurement, hyperbaric Oxygen Equipment Location chamber, electroconvulsive therapy, and transmagnetic stimulation, in patients following a Craniocerebral Trauma., Of the psychoactive Medications:Presence or Identity:Duration of the study:^Patient:Nominal, amantadine hydrochloride was associated with greater recovery and dantrolene sodium was associated with less recovery, in terms of the DRS score at 16 weeks but not the time until commands were followed.[SEP]Relations: amantadine has relations: contraindication with mental disorder, contraindication with mental disorder, contraindication with mental disorder, contraindication with mental disorder, contraindication with substance-related disorder, contraindication with substance-related disorder, contraindication with substance-related disorder, contraindication with substance-related disorder, contraindication with psychotic disorder, contraindication with psychotic disorder. Definitions: amantadine hydrochloride defined as following: The hydrochloride salt of amantadine, a synthetic tricyclic amine with antiviral, antiparkinsonian, and antihyperalgesic activities. amantadine appears to exert its antiviral effect against the influenza A virus by interfering with the function of the transmembrane domain of the viral M2 protein, thereby preventing the release of infectious viral nucleic acids into host cells; furthermore, this agent prevents virus assembly during virus replication. amantadine exerts its antiparkinsonian effects by stimulating the release of dopamine from striatal dopaminergic nerve terminals and inhibiting its pre-synaptic reuptake. This agent may also exert some anticholinergic effect through inhibition of N-methyl-D-aspartic acid (NMDA) receptor-mediated stimulation of acetylcholine, resulting in antihyperalgesia.. baclofen defined as following: A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.. amantadine defined as following: An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake.. protriptyline defined as following: Tricyclic antidepressant similar in action and side effects to IMIPRAMINE. It may produce excitation.. amantadine sulfate defined as following: The sulfate salt of amantadine, a synthetic tricyclic amine with antiviral, antiparkinsonian, and antihyperalgesic activities. amantadine appears to exert its antiviral effect against the influenza A virus by interfering with the function of the transmembrane domain of the viral M2 protein, thereby preventing the release of infectious viral nucleic acids into host cells; furthermore, this agent prevents virus assembly during virus replication. amantadine exerts its antiparkinsonian effects by stimulating the release of dopamine from striatal dopaminergic nerve terminals and inhibiting its pre-synaptic reuptake. This agent may also exert some anticholinergic effect through inhibition of N-methyl-D-aspartic acid (NMDA) receptor-mediated stimulation of acetylcholine, resulting in antihyperalgesia.. modafinil defined as following: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.. carbidopa / levodopa defined as following: An orally available combination of carbidopa, an inhibitor of aromatic amino acid decarboxylation, and levodopa, an inert, metabolic precursor to dopamine, with dopaminergic and antiparkinsonian properties. Upon oral administration, levodopa crosses the blood-Head>Brain barrier (BBB) and is decarboxylated to dopamine via dopa decarboxylase in the Head>Brain, promoting increased activation of dopamine receptors. Carbidopa inhibits dopa decarboxylase in the periphery, thereby preventing decarboxylation of levodopa in extracerebral tissues and increasing the delivery of dopamine to the central nervous system (CNS). As carbidopa does not cross the BBB, it does not interfere with CNS levodopa metabolism.. Brain Injuries defined as following: Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the Head>Brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the Head>Brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.. Lactic acid measurement defined as following: The determination of the amount of lactic acid present in a sample.. levodopa defined as following: The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-Head>Brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.. Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. traumatic Brain Injuries defined as following: A form of acquired Brain Injuries which occurs when a sudden trauma causes damage to the Head>Brain.. Ischemic stroke defined as following: An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of Head>Brain tissue.. amitriptyline defined as following: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.. zolpidem defined as following: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.. bromocriptine defined as following: A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion.. Neurologic Deficits defined as following: Loss of movement function.. apomorphine defined as following: A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use.. fluoxetine defined as following: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional Antidepressive Agents.. valproic acid defined as following: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the Head>Brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.. Dopaminergic Agents defined as following: Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.. Antidepressive Agents defined as following: Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as Antidepressive Agents apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through Head>Brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.. Craniocerebral Trauma defined as following: Traumatic injuries involving the cranium and intracranial structures (i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures). Injuries may be classified by whether or not the skull is penetrated (i.e., penetrating vs. nonpenetrating) or whether there is an associated hemorrhage.. methylphenidate defined as following: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this Pharmacologic Substance is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.. dantrolene sodium defined as following: The sodium salt form of dantrolene, a hydantoin derivative and direct-acting skeletal muscle relaxant. Dantrolene depresses excitation-contraction coupling in skeletal muscle by binding to the ryanodine receptor 1, and decreasing intracellular calcium concentration. Ryanodine receptors mediate the release of calcium from the sarcoplasmic reticulum, an essential step in muscle contraction.. Reperfusion Injury defined as following: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.. Apraxia, oculomotor, Cogan type defined as following: Ocular motor apraxia, Cogan type is characterised by impairment of voluntary horizontal eye movements and compensatory head thrust. Around 50 cases have been described so far. The oculomotor manifestations tend to improve with age but the syndrome may also be associated with learning and speech difficulties, or, in some cases, cerebral malformations. Both sporadic and familial forms have been described, with sporadic forms being more frequent. The mode of transmission of the familial form has not yet been clearly established. A gene located on the long arm of chromosome 2, near to the <i>NPHP1</i> gene involved in nephronophthisis, may be associated with ocular motor apraxia, Cogan type.. amantadine defined as following: An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake..", "label": "yes"} {"original_question": "Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?", "id": "converted_963", "sentence1": "Is STAT3 protein, human involved in EIF2AK2 gene-dependent suppression of autophagy?", "sentence2": "STAT3 protein, human protein, human may act as a competitive PPP1R1A gene of EIF2AK2 gene gene. Indeed, pharmacological or genetic inhibition of STAT3 protein, human protein, human stimulates EIF2AK2 gene gene-dependent Eukaryotic Translation Initiation Factor 2 Subunit 1 phosphorylation and autophagy. Conversely, the overexpression of wild-type STAT3 protein, human protein, human as well as of STAT3 protein, human protein, human mutants that cannot be phosphorylated by JAK2 protein, human protein, human or are excluded from the Cell Nucleus inhibits autophagy. However, STAT3 protein, human protein, human mutants that fail to interact with EIF2AK2 gene gene are unable to suppress autophagy, Both STAT3 protein, human protein, human-targeting agents (i.e., stattic, JSI-124 and WP1066) and EIF2AK2 gene gene activators (such as the double-strand RNA mimetic polyinosinic:Poly C) are capable of disrupting the inhibitory interaction between STAT3 protein, human protein, human and EIF2AK2 gene gene in cellula, A further screen designed to identify EIF2AK2 gene gene-dependent autophagy inducers revealed that several Fatty Acids including palmitate trigger autophagy via a pathway that involves the disruption of the STAT3 protein, human protein, human-EIF2AK2 gene gene complex, These results reveal an unsuspected crosstalk between cellular metabolism (Fatty Acids), pro-inflammatory signaling (STAT3 protein, human protein, human), innate immunity (EIF2AK2 gene gene), and translational control (Eukaryotic Translation Initiation Factor 2 Subunit 1) that regulates autophagy, Cytoplasmic STAT3 protein, human protein, human represses autophagy by inhibiting eIF-2 Kinase activity, The SH2 Domain of STAT3 protein, human protein, human was found to interact with the Catalytic Domain of the eIF2α kinase 2 EIF2AK2 gene gene, best known as protein kinase R (eIF-2 Kinase). Pharmacological and genetic inhibition of STAT3 protein, human protein, human stimulated the activating phosphorylation of eIF-2 Kinase and consequent eIF2α hyperphosphorylation. Moreover, eIF-2 Kinase depletion inhibited autophagy as initiated by chemical STAT3 protein, human protein, human inhibitors or free Fatty Acids like palmitate, STAT3 protein, human protein, human-targeting chemicals and palmitate caused the disruption of inhibitory STAT3 protein, human protein, human-eIF-2 Kinase interactions, followed by eIF-2 Kinase-dependent eIF2α phosphorylation, which facilitates autophagy induction, Indeed, pharmacological or genetic inhibition of STAT3 protein, human protein, human stimulates EIF2AK2 gene gene-dependent Eukaryotic Translation Initiation Factor 2 Subunit 1 phosphorylation and autophagy., A further screen designed to identify EIF2AK2 gene gene-dependent autophagy inducers revealed that several Fatty Acids including palmitate trigger autophagy via a pathway that involves the disruption of the STAT3 protein, human protein, human-EIF2AK2 gene gene complex as well as the phosphorylation of Mitogen-Activated Protein Kinases 8/c-Jun N-terminal kinase 1 (MAPK8/JNK1) and Eukaryotic Translation Initiation Factor 2 Subunit 1., A further screen designed to identify EIF2AK2 gene gene-dependent autophagy inducers revealed that several Fatty Acids including palmitate trigger autophagy via a pathway that involves the disruption of the STAT3 protein, human protein, human-EIF2AK2 gene gene complex as well as the phosphorylation of Mitogen-Activated Protein Kinases 8/c-Jun N-terminal kinase 1 (MAPK8/JNK1) and Eukaryotic Translation Initiation Factor 2 Subunit 1, Indeed, pharmacological or genetic inhibition of STAT3 protein, human protein, human stimulates EIF2AK2 gene gene-dependent Eukaryotic Translation Initiation Factor 2 Subunit 1 phosphorylation and autophagy, However, STAT3 protein, human protein, human mutants that fail to interact with EIF2AK2 gene gene are unable to suppress autophagy, Direct interaction between STAT3 protein, human protein, human and EIF2AK2 gene gene controls fatty acid-induced autophagy, A further screen designed to identify EIF2AK2 gene gene-dependent autophagy inducers revealed that several Fatty Acids including palmitate trigger autophagy via a pathway that involves the disruption of the STAT3 protein, human protein, human-EIF2AK2 gene gene complex as well as the phosphorylation of Mitogen-Activated Protein Kinases 8/c-Jun N-terminal kinase 1 (MAPK8/JNK1) and Eukaryotic Translation Initiation Factor 2 Subunit 1. , Indeed, pharmacological or genetic inhibition of STAT3 protein, human protein, human stimulates EIF2AK2 gene gene-dependent Eukaryotic Translation Initiation Factor 2 Subunit 1 phosphorylation and autophagy. , Direct interaction between STAT3 protein, human protein, human and EIF2AK2 gene gene controls fatty acid-induced autophagy., These results unravel an unsuspected mechanism of autophagy control that involves STAT3 protein, human protein, human and eIF-2 Kinase as interacting partners., Both STAT3 protein, human protein, human-targeting agents (i.e., stattic, JSI-124 and WP1066) and EIF2AK2 gene gene activators (such as the double-strand RNA mimetic polyinosinic:Poly C) are capable of disrupting the inhibitory interaction between STAT3 protein, human protein, human and EIF2AK2 gene gene in cellula, yet only the latter does so in cell-free systems in vitro. A further screen designed to identify EIF2AK2 gene gene-dependent autophagy inducers revealed that several Fatty Acids including palmitate trigger autophagy via a pathway that involves the disruption of the STAT3 protein, human protein, human-EIF2AK2 gene gene complex as well as the phosphorylation of Mitogen-Activated Protein Kinases 8/c-Jun N-terminal kinase 1 (MAPK8/JNK1) and Eukaryotic Translation Initiation Factor 2 Subunit 1., A further screen designed to identify EIF2AK2 gene gene-dependent autophagy inducers revealed that several Fatty Acids including palmitate trigger autophagy via a pathway that involves the disruption of the STAT3 protein, human protein, human-EIF2AK2 gene gene complex as well as the phosphorylation of Mitogen-Activated Protein Kinases 8/c-Jun N-terminal kinase 1 (MAPK8/JNK1) and Eukaryotic Translation Initiation Factor 2 Subunit 1. These results reveal an unsuspected crosstalk between cellular metabolism (Fatty Acids), pro-inflammatory signaling (STAT3 protein, human protein, human), innate immunity (EIF2AK2 gene gene), and translational control (Eukaryotic Translation Initiation Factor 2 Subunit 1) that regulates autophagy., Thus, STAT3 protein, human protein, human may act as a competitive PPP1R1A gene of EIF2AK2 gene gene. Indeed, pharmacological or genetic inhibition of STAT3 protein, human protein, human stimulates EIF2AK2 gene gene-dependent Eukaryotic Translation Initiation Factor 2 Subunit 1 phosphorylation and autophagy., Indeed, pharmacological or genetic inhibition of STAT3 protein, human protein, human stimulates EIF2AK2 gene gene-dependent Eukaryotic Translation Initiation Factor 2 Subunit 1 phosphorylation and autophagy. Conversely, the overexpression of wild-type STAT3 protein, human protein, human as well as of STAT3 protein, human protein, human mutants that cannot be phosphorylated by JAK2 protein, human protein, human or are excluded from the Cell Nucleus inhibits autophagy., , stattic, JSI-124 and WP1066) and EIF2AK2 gene gene activators (such as the double-strand RNA mimetic polyinosinic:Poly C) are capable of disrupting the inhibitory interaction between STAT3 protein, human protein, human and EIF2AK2 gene gene in cellula, yet only the latter does so in cell-free systems in vitro. A further screen designed to identify EIF2AK2 gene gene-dependent autophagy inducers revealed that several Fatty Acids including palmitate trigger autophagy via a pathway that involves the disruption of the STAT3 protein, human protein, human-EIF2AK2 gene gene complex as well as the phosphorylation of Mitogen-Activated Protein Kinases 8/c-Jun N-terminal kinase 1 (MAPK8/JNK1) and Eukaryotic Translation Initiation Factor 2 Subunit 1.[SEP]Relations: EIF2AK2 gene has relations: protein_protein with STAT3 protein, human, protein_protein with STAT3 protein, human, protein_protein with STAT2, protein_protein with STAT2, protein_protein with STAT1, protein_protein with STAT1, pathway_protein with Inhibition of eIF-2 Kinase, pathway_protein with Inhibition of eIF-2 Kinase, molfunc_protein with protein phosphatase regulator activity, molfunc_protein with protein phosphatase regulator activity. Definitions: WP1066 defined as following: An orally bioavailable, small molecule PPP1R1A gene of signaling transducer and activator 3 (STAT3 protein, human), with potential antineoplastic and immunomodulatory activities. Upon administration, STAT3 protein, human PPP1R1A gene WP1066 blocks the intranuclear translocation of p-STAT, thereby suppressing STAT3 protein, human signaling and decreasing the levels of downstream products including c-Myc. Additionally, WP1066 may upregulate costimulatory molecules including CD80 and CD86 on human microglia, and reverse glioma cancer stem cell (gCSC)-mediated innate and adaptive immune suppression allowing for the restoration of antitumor effector immune responses. The STAT3 protein, human pathway is overly active in many cancer types and is implicated in CSC-mediated growth, recurrence and resistance to conventional chemotherapies.. Catalytic Domain defined as following: The region of an enzyme that interacts with its substrate to cause the enzymatic reaction.. Fatty Acids defined as following: Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed). STAT3 protein, human defined as following: Signal transducer and activator of transcription 3 (770 aa, ~88 kDa) is encoded by the human STAT3 protein, human gene. This protein plays a role in cytokine signaling and gene expression.. Eukaryotic Translation Initiation Factor 2 Subunit 1 defined as following: Eukaryotic translation initiation factor 2 subunit 1 (315 aa, ~36 kDa) is encoded by the human Eukaryotic Translation Initiation Factor 2 Subunit 1 gene. This protein plays a role in the initiation of protein translation.. EIF2AK2 gene defined as following: This gene plays a role in the negative regulation of protein synthesis.. Cell Nucleus defined as following: Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one Cell Nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). SH2 Domain defined as following: A region of protein sequence similarity among members of the SRC family of cytoplasmic tyrosine kinases, and other proteins. The SH2 Domain usually mediates binding to phosphotyrosine and neighboring residues of target proteins.. Poly C defined as following: A group of cytosine ribonucleotides in which the phosphate residues of each cytosine ribonucleotide act as bridges in forming diester linkages between the ribose moieties.. eIF-2 Kinase defined as following: A dsRNA-activated cAMP-independent protein serine/threonine kinase that is induced by interferon. In the presence of dsRNA and ATP, the kinase autophosphorylates on several serine and threonine residues. The phosphorylated enzyme catalyzes the phosphorylation of the alpha subunit of EUKARYOTIC INITIATION FACTOR-2, leading to the inhibition of protein synthesis.. JAK2 protein, human defined as following: Tyrosine-protein kinase JAK2 protein, human (1132 aa, ~131 kDa) is encoded by the human JAK2 protein, human gene. This protein is involved in immunity, tyrosine phosphorylation and signal transduction.. Mitogen-Activated Protein Kinases defined as following: A superfamily of PROTEIN SERINE-THREONINE KINASES that are activated by diverse stimuli via protein kinase cascades. They are the final components of the cascades, activated by phosphorylation by MITOGEN-ACTIVATED PROTEIN KINASE KINASES, which in turn are activated by Mitogen-Activated Protein Kinases kinase kinases (MAP KINASE KINASE KINASES)..", "label": "yes"} {"original_question": "Is marimastat effective for small-cell lung cancer?", "id": "converted_3344", "sentence1": "Is marimastat effective for small-cell lung cancer?", "sentence2": "The phase III trial in small cell lung cancer was discontinued when the results of study 140 were released in February 2001 showing that marimastat was not significantly more effective than placebo in prolonging the survival of small cell lung cancer patients., CONCLUSION: Treatment with marimastat after induction therapy for Small cell carcinoma of lung did not result in improved survival and had a negative impact on quality of life., There were no significant differences in survival in a non-small cell lung cancer prinomastat study, and in a small cell lung cancer marimastat trial., There were no significant differences in survival in a non-small cell lung cancer prinomastat study , and in a small cell lung cancer marimastat trial. , The phase III trial in small cell lung cancer was discontinued when the results of study 140 were released in February 2001 showing that marimastat was not significantly more effective than placebo in prolonging the survival of small cell lung cancer patients.[SEP]Relations: Marimastat has relations: drug_protein with MMP20, drug_protein with MMP20, drug_protein with MMP7, drug_protein with MMP7, drug_protein with MMP10, drug_protein with MMP10. small cell lung carcinoma has relations: disease_disease with small cell carcinoma, disease_disease with small cell carcinoma, disease_disease with lung carcinoma, disease_disease with lung carcinoma. Definitions: Small cell carcinoma of lung defined as following: A form of highly malignant lung cancer that is composed of small ovoid cells (SMALL CELL CARCINOMA).. marimastat defined as following: An orally-active synthetic hydroxamate with potential antineoplastic activity. Marimastat covalently binds to the zinc(II) ion in the active site of matrix metalloproteinases (MMPs), thereby inhibiting the action of MMPs, inducing extracellular matrix degradation, and inhibiting angiogenesis, tumor growth and invasion, and metastasis. This agent may also inhibit tumor necrosis factor-alpha converting enzyme (TACE), an enzyme involved in tumor necrosis factor alpha (TNF-alpha) production that may play a role in some malignancies as well as in the development of arthritis and sepsis. (NCI04).", "label": "no"} {"original_question": "Is the microRNA 132 (miR-132) involved in brain pathologies?", "id": "converted_1656", "sentence1": "Is the microRNA 132 (miR-132) involved in Head>Brain pathologies?", "sentence2": "miR-132 dysregulation and subsequent abnormal expression of miR-132 target genes contribute to the neurodevelopmental and neuromorphological pathologies present in SCHIZOPHRENIA 2 (disorder)., micro-RNAs encoding miR-9, miR-124a, miR-125b, miR-128, miR-132 and miR-219 are abundantly represented in fetal hippocampus, are differentially regulated in aged Head>Brain, and an alteration in specific MicroRNAs complexity occurs in Alzheimer hippocampus. These data are consistent with the idea that altered MicroRNAs-mediated processing of messenger RNA populations may contribute to atypical RNA, Messenger abundance and neural dysfunction in ALZHEIMER DISEASE, FAMILIAL, 1 Head>Brain., Levels of several microRNA (miR-10a, -10b, -212, -132, -495) were significantly altered. One of them (miR-132) has been reported to be highly inducible by Growth Factor and to be a key regulator of neurite outgrowth. Moreover, miR-132-recognition sequences were detected in the RNA, Messenger transcripts of two differentially expressed proteins. MicroRNA may thus represent novel biomarkers for neuronal malfunction and potential therapeutic targets for Homo sapiens neurodegenerative diseases., Expression of key neuronal microRNAs-including mir-9/9*, Mirn124a microRNA, Homo sapiens and mir-132-is repressed in the brains of Homo sapiens Hodgkin Disease patients and Mus sp. models., To determine if production of miR-132 is regulated by neuronal activity its expression in Mus sp. Head>Brain was monitored by quantitative RT-PCR (RT-qPCR), Expression levels of primary and mature-miR-132 increased significantly between postnatal Days 10 and 24. We conclude that miR-132 is an activity-dependent microRNA in vivo, and may contribute to the long-lasting proteomic changes required for experience-dependent neuronal plasticity., We investigated how prior Seizures Preconditioning affects the miRNA response to Status Epilepticus evoked by intra-amygdalar kainic acid in CASP14 gene., Increased miR-132 levels were matched with increased binding to Argonaute-2, a constituent of the RNA-induced silencing complex. In tolerant animals, expression responses of >40% of the injury-group-detected miRNAs differed, being either unchanged relative to control or down-regulated, and this included miR-132. In vivo microinjection of locked nucleic acid-modified oligonucleotides (Antagomirs) against miR-132 depleted Hippocampus (Brain) miR-132 levels and reduced Seizures-induced neuronal death. Thus, our data strongly suggest that miRNAs are important regulators of Seizures-induced neuronal death., Preconditioning describes the ischemic stimulus that triggers an endogenous, neuroprotective response that protects the Head>Brain during a subsequent severe ischemic injury, a phenomenon known as 'tolerance'., Downregulation of miR-132 is consistent with our finding that Preconditioning Ischemia Procedure induces a rapid increase in Methyl-CpG-Binding Protein 2, but not RNA, Messenger, in Mus sp. cortex. These studies reveal that ischemic Preconditioning regulates expression of miRNAs and their Prediction targets in Mus sp. Head>Brain cortex, and further suggest that miRNAs and MECP2 protein, Homo sapiens could serve as effectors of ischemic Preconditioning-induced tolerance., Huntington Disease (Hodgkin Disease) is a genetic neurodegenerative disease caused by abnormal CAG expansion. MicroRNAs (miRNAs) are short RNA molecules regulating gene expression, and are implicated in a variety of diseases including Hodgkin Disease., Nine miRNAs (miR-22, miR-29c, miR-128, miR-132, miR-138, miR-218, miR-222, miR-344, and miR-674*) were commonly down-regulated in both the 12-month-old YAC128 and 10-week-old R6/2 CASP14 gene., Animals, Transgenic Hodgkin Disease CASP14 gene have abnormal miRNA biogenesis. This information should aid in future studies on therapeutic application of miRNAs in Hodgkin Disease., miR-132 directly targets the neuronal splicing factor polypyrimidine tract-binding protein 2 (PTBP2 gene gene), which protein levels were increased in Progressive supranuclear palsy patients. miR-132 overexpression or PTBP2 gene gene knockdown similarly affected endogenous 4R:3R-tau ratios in neuronal cells. Finally, we provide evidence that miR-132 is inversely correlated with PTBP2 gene gene during post-natal Head>Brain development at the time when 4R-tau becomes expressed. Taken together, these results suggest that changes in the miR-132/PTBP2 gene gene pathway could contribute to the abnormal splicing of tau exon 10 in the Head>Brain, and sheds light into the potential role played by miRNAs in a subset of Tauopathies., reports of microRNA (miR) modulators of both neuronal and immune processes (here termed NeurimmiRs) predict therapeutic potential for manipulating NeurimmiR levels in diseases affecting both the immune system and higher Head>Brain functions, such as ALZHEIMER DISEASE, FAMILIAL, 1 (cytarabine/daunorubicin protocol), Parkinson Disease (Lugano Lymphoma Response Classification Progressive Disease by PET), Multiple Sclerosis (MS) and anxiety-related disorders. In our opinion, NeurimmiRs that function within both the Nervous - anatomy qualifier and the immune systems, such as miR-132 and miR-124, may act as 'negotiators' between these two interacting compartments.[SEP]Relations: Parkinson disease has relations: disease_protein with MIR181C, disease_protein with MIR181C. Viral Messenger RNA Synthesis has relations: pathway_protein with NUP133, pathway_protein with NUP133, pathway_protein with NUP214, pathway_protein with NUP214, pathway_protein with NUP188, pathway_protein with NUP188, pathway_protein with NUP107, pathway_protein with NUP107. Definitions: Ischemia Procedure defined as following: A surgical procedure during which the blood supply to an organ or tissue is interrupted and then later reestablished.. Hodgkin Disease defined as following: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.. Methyl-CpG-Binding Protein 2 defined as following: A DNA-binding protein that interacts with methylated CPG ISLANDS. It plays a role in repressing GENETIC TRANSCRIPTION and is frequently mutated in RETT SYNDROME.. MicroRNAs defined as following: Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing.. Animals, Transgenic defined as following: Experimental organism whose genome has been altered by the transfer of a gene or genes from another species or breed.. RNA, Messenger defined as following: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the cytoplasm.. Prediction defined as following: An extrapolation of given data into the future.. Tauopathies defined as following: Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the Head>Brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.. Seizures defined as following: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of Head>Brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or \"Seizures disorder.\". Mirn124a microRNA, Homo sapiens defined as following: A 20 ribonucleotide sequence that is a final product of the processing of either MIR124-1 pre-miRNA, MIR124-2 pre-miRNA or MIR124-3 pre-miRNA. This oligonucleotide may be involved in the negative regulation of gene expression.. MECP2 protein, Homo sapiens defined as following: Methyl-CpG-binding protein 2 (486 aa, ~52 kDa) is encoded by the Homo sapiens MECP2 gene. This protein plays a role in the repression of transcription through binding methylated DNA.. Growth Factor defined as following: Growth Factors are extracellular signaling molecules (ligands) involved in control of target cell proliferation, cell survival, and cell differentiation. (NCI). Huntington Disease defined as following: A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4). Hippocampus (Brain) defined as following: A curved gray matter structure of the temporal lobe lying on the floor of the lateral ventricle of the Head>Brain.. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65.. Parkinson Disease defined as following: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75). Nervous - anatomy qualifier defined as following: Of or relating to the Nervous - anatomy qualifier system.. Lugano Lymphoma Response Classification Progressive Disease by PET defined as following: A score of 4 or 5 on a 5-point PET scale with an increase in intensity of uptake from baseline and/or new FDG-avid foci consistent with lymphoma at interim or end of treatment assessment.. Progressive supranuclear palsy defined as following: A degenerative disease of the central Nervous - anatomy qualifier system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7). Multiple Sclerosis defined as following: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central Nervous - anatomy qualifier system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central Nervous - anatomy qualifier system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903). Status Epilepticus defined as following: A prolonged Seizures or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic Status Epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial Status Epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition (see also EPILEPSIA PARTIALIS CONTINUA). Subclinical Status Epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of Seizures activity. (From N Engl J Med 1998 Apr 2;338(14):970-6; Neurologia 1997 Dec;12 Suppl 6:25-30). Antagomirs defined as following: Chemically-engineered oligonucleotides used to selectively inhibit expression of target genes through sequence-specific binding of corresponding microRNA (miRNA) sites.. Homo sapiens defined as following: Members of the species Homo sapiens.. microRNA defined as following: Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing..", "label": "yes"} {"original_question": "Do T-Cells regulate neuropathic pain?", "id": "converted_1950", "sentence1": "Do T-Cells regulate Neuralgia?", "sentence2": "here is evidence for a considerable impact of the immune system also in Neuralgia. However, the role of the adaptive immune system is still unclear., Our investigation revealed a clear shift of T-Lymphocyte subsets towards anti-inflammation in patients with Neuralgia. , TNFSF18 wt Allele expressed on Specimen Source Codes - Macrophages drives cytokine release and T cell activation, resulting in Neuralgia via GITR-dependent actions. , Thus, this T-Lymphocyte subset may be specifically targeted to alleviate chronic Neuralgia.Copyright © 2012 International Association for the Study of Pain, Recent studies show that Therapeutic gamma delta T-lymphocytes play an important role in Neuralgia following Nerve injury in Rattus norvegicus, These results show a Peripheral pivotal role of Felis catus in the development of Neuralgia through the antigen-specific activation of CD4(+) T-cells, chemokine (C-C motif) ligand 1 (CCL-1), a well-characterized chemokine secreted by activated Therapeutic gamma delta T-lymphocytes, has been shown to play an important role in Neuralgia induced by Nerve injury and is also produced in various cell types in the Central Nervous System, especially in dorsal root ganglia (Diagnosis-Related Groups), In the present study, we investigated systemic T-Lymphocyte subset responses and T-Lymphocyte related cytokine profiles in patients with chronic Neuralgia., Anti-inflammatory T-Lymphocyte shift in Neuralgia., Thus, this T-Lymphocyte subset may be specifically targeted to alleviate chronic Neuralgia.., Regulatory Therapeutic gamma delta T-lymphocytes attenuate Neuralgia following Peripheral Nerve injury and experimental autoimmune neuritis., Macrophage-T cell interactions mediate Neuralgia through the glucocorticoid-induced tumor necrosis factor ligand system.[SEP]Relations: neuropathy, painful has relations: disease_phenotype_positive with Peripheral neuropathy, disease_phenotype_positive with Peripheral neuropathy, disease_protein with THBD, disease_protein with THBD, disease_phenotype_positive with Fever, disease_phenotype_positive with Fever, disease_phenotype_positive with Skeletal muscle atrophy, disease_phenotype_positive with Skeletal muscle atrophy. Chronic pain has relations: phenotype_phenotype with Pain, phenotype_phenotype with Pain. Definitions: TNFSF18 wt Allele defined as following: Human TNFSF18 wild-type allele is located in the vicinity of 1q25.1 and is approximately 11 kb in length. This allele, which encodes tumor necrosis factor ligand superfamily member 18 protein, is involved in the positive regulation of T-Lymphocyte survival.. Felis catus defined as following: The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801). chemokine defined as following: Class of pro-inflammatory cytokines that have the ability to attract and activate leukocytes. They can be divided into at least three structural branches: C; (CHEMOKINES, C); CC; (CHEMOKINES, CC); and CXC; (CHEMOKINES, CXC); according to variations in a shared cysteine motif.. T-Lymphocyte defined as following: Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new Therapeutic gamma delta T-lymphocytes sensitized to that antigen.. Therapeutic gamma delta T-lymphocytes defined as following: A subset of therapeutic autologous T-lymphocytes that express a T-Lymphocyte receptor (TCR) composed of one gamma chain and one delta chain, with potential immunomodulating and antineoplastic activities. Upon administration of the therapeutic gamma delta T-lymphocytes, these cells secrete interferon-gamma (IFN-g), and exert direct killing of tumor cells. In addition, these cells activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against tumor cells. Gamma delta T-lymphocytes play a key role in the activation of the immune system and do not require major histocompatibility complex (MHC)-mediated antigen presentation to exert their cytotoxic effect.. Peripheral defined as following: On or near an edge or constituting an outer boundary; the outer area.. Regulatory Therapeutic gamma delta T-lymphocytes defined as following: CD4-positive Therapeutic gamma delta T-lymphocytes that inhibit immunopathology or autoimmune disease in vivo. They inhibit the immune response by influencing the activity of other cell types. Regulatory T-cells include naturally occurring CD4+CD25+ cells, IL-10 secreting Tr1 cells, and Th3 cells.. Rattus norvegicus defined as following: The common rat, Rattus norvegicus, often used as an experimental organism.. Nerve injury defined as following: Injury to nervous tissue.. Neuralgia defined as following: Chronic pain caused by damage to nerve fibers. It is usually associated with tissue injury.. Diagnosis-Related Groups defined as following: A system for classifying patient care by relating common characteristics such as diagnosis, treatment, and age to an expected consumption of hospital resources and length of stay. Its purpose is to provide a framework for specifying case mix and to reduce hospital costs and reimbursements and it forms the cornerstone of the prospective payment system.. Peripheral Nerve injury defined as following: Injuries to the PERIPHERAL NERVES.. Central Nervous System defined as following: The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.. T-Lymphocyte subsets defined as following: A classification of T-lymphocytes, especially into helper/inducer, suppressor/effector, and cytotoxic subsets, based on structurally or functionally different populations of cells.. T-Cells defined as following: Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new Therapeutic gamma delta T-lymphocytes sensitized to that antigen..", "label": "yes"} {"original_question": "Have Quantitative Trait Loci affecting splicing (splicing QTLs) been linked to disease?", "id": "converted_93", "sentence1": "Have Quantitative Trait Loci affecting splicing (splicing QTLs) been linked to disease?", "sentence2": "The spontaneously hypertensive Rattus norvegicus (SHORT ROOT protein, Arabidopsis) is a widely used rodent model of Hypertensive disease and Metabolic Syndrome X. Previously we identified thousands of cis-regulated expression Quantitative Trait Loci (eQTLs) across multiple Body tissue using a panel of Rattus norvegicus recombinant inbred (RI) strains derived from Brown Norway and SHORT ROOT protein, Arabidopsis progenitors. These cis-eQTLs represent potential susceptibility loci underlying physiological and pathophysiological traits manifested in SHORT ROOT protein, Arabidopsis. We have prioritized 60 cis-eQTLs and confirmed differential expression between the parental strains by quantitative PCR in 43 (72%) of the eQTL RNA Transcript., These colocalizing correlated cis-eQTLs (c3-eQTLs) are highly attractive as primary susceptibility loci for the colocalizing pQTLs. Furthermore, sequence analysis of the c3-eQTL Genes identified Single Nucleotide Polymorphism (SNPs) that are predicted to affect transcription factor binding affinity, splicing and protein function. These SNPs, which potentially alter transcript abundance and stability, represent strong candidate factors underlying not just eQTL expression phenotypes, but also the correlated metabolic and physiological traits. In conclusion, by integration of genomic sequence, eQTL and QTT datasets we have identified several Genes that are strong positional candidates for pathophysiological traits observed in the SHORT ROOT protein, Arabidopsis strain., Identifying associations between Genotype and gene expression levels using microarrays has enabled systematic interrogation of regulatory variation underlying complex phenotypes. This approach has vast potential for functional characterization of disease states, but its prohibitive cost, given hundreds to thousands of individual samples from populations have to be genotyped and expression profiled, has limited its widespread application.RESULTS: Here we demonstrate that genomic regions with Alleles-specific expression (ASE) detected by sequencing cDNA are highly enriched for cis-acting expression Quantitative Trait Loci (cis-eQTL) identified by profiling of 500 animal allergen extracts in parallel, with up to 90% agreement on the Alleles that is preferentially expressed. We also observed widespread noncoding and antisense ASE and identified several Alleles-specific alternative splicing variants.CONCLUSION: Monitoring ASE by sequencing cDNA from as little as one sample is a practical alternative to expression genetics for mapping cis-acting variation that regulates RNA transcription and processing., The six Genes corresponded to Rattus norvegicus and Mus sp. Quantitative Trait Loci (QTLs) that had shown associations with the common traits such as the well characterized MS and even tumor susceptibility. Our findings suggest that the six Genes may play important roles in the pleiotropic effects on lipid metabolism and the MS, which increase the risk of Type 2 Diabetes and Cardiovascular Diseases. The use of the multivariate phenotypes can be advantageous in identifying genetic risk factors, accounting for the pleiotropic effects when the multivariate phenotypes have a common etiological pathway., To elucidate mechanisms involved in Multiple Sclerosis (MS), we studied genetic regulation of experimental autoimmune encephalomyelitis (EAE) in rats, assuming a Conservation of pathogenic pathways. In this study, we focused on Eae23, originally identified to regulate EAE in a (LEW.1AV1xPVG.1AV1)F2 cross. Our aim was to determine whether one or more Genes within the 67 Mb region regulate EAE and to define candidate risk Genes.METHODOLOGY/PRINCIPAL FINDINGS: We used high resolution Quantitative Trait Loci (QTL) analysis in the 10th generation (BUD31 gene) of an advanced intercross line (AIL) to resolve Eae23 into two QTLs that independently regulate EAE, namely Eae23a and Eae23b. [SEP]Relations: qualitative or quantitative defects of titin has relations: disease_disease with TTN-related myopathy, disease_disease with TTN-related myopathy, disease_disease with qualitative or quantitative protein defects in neuromuscular diseases, disease_disease with qualitative or quantitative protein defects in neuromuscular diseases, disease_disease with limb-girdle muscular dystrophy, disease_disease with limb-girdle muscular dystrophy, disease_disease with tibial muscular dystrophy, disease_disease with tibial muscular dystrophy. Multiple Sclerosis has relations: disease_disease with demyelinating disease, disease_disease with demyelinating disease. Definitions: Alleles defined as following: Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product.. Single Nucleotide Polymorphism defined as following: A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.. Hypertensive disease defined as following: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), Hypertensive disease is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. Conservation defined as following: The maintenance of certain characteristics in an unchanged condition.. Genotype defined as following: The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.. RNA Transcript defined as following: The initial RNA molecule produced by transcription.. Cardiovascular Diseases defined as following: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. Multiple Sclerosis defined as following: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903). Metabolic Syndrome X defined as following: A combination of medical conditions that when present, increase the risk of heart attack, stroke, and diabetes mellitus. It includes the following medical conditions: increased blood pressure, central obesity, dyslipidemia, impaired glucose tolerance, and insulin resistance.. Quantitative Trait Loci defined as following: Genetic loci associated with a quantitative trait.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown..", "label": "yes"} {"original_question": "Is Eflornithine and Sulindac are effective for prevention of progression in Familial Adenomatous Polyposis?", "id": "converted_3865", "sentence1": "Is Eflornithine and Sulindac are effective for prevention of progression in Familial Adenomatous Polyposis?", "sentence2": "Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis, BACKGROUND: The efficacy and safety of combination therapy with eflornithine and sulindac, as compared with either Pharmacologic Substance alone, in delaying disease progression in patients with FAMILIAL ADENOMATOUS POLYPOSIS 3 are unknown., CONCLUSIONS: In this trial involving patients with FAMILIAL ADENOMATOUS POLYPOSIS 3, the incidence of disease progression was not significantly lower with the combination of eflornithine and sulindac than with either Pharmacologic Substance alone. , Disease progression occurred in 18 of 56 patients (32%) in the eflornithine-sulindac group, 22 of 58 (38%) in the sulindac group, and 23 of 57 (40%) in the eflornithine group, with a hazard ratio of 0.71 (95% confidence interval [CI], 0.39 to 1.32) for eflornithine-sulindac as compared with sulindac (P = 0.29) and 0.66 (95% CI, 0.36 to 1.24) for eflornithine-sulindac as compared with eflornithine., SIONS: In this trial involving patients with FAMILIAL ADENOMATOUS POLYPOSIS 3, the incidence of disease progression was not significantly lower with the combination of eflornithine and sulindac than with either Pharmacologic Substance alone. (Fund, BACKGROUND: The efficacy and safety of combination therapy with eflornithine and sulindac, as compared with either Pharmacologic Substance alone, in delaying disease progression in patients with FAMILIAL ADENOMATOUS POLYPOSIS 3 a, this trial involving patients with FAMILIAL ADENOMATOUS POLYPOSIS 3, the incidence of disease progression was not significantly lower with the combination of eflornithine and sulindac than with either Pharmacologic Substance alone. (F[SEP]Relations: Sulindac has relations: contraindication with bone disease, contraindication with bone disease, contraindication with nephrolithiasis, contraindication with nephrolithiasis, contraindication with heart disease, contraindication with heart disease, drug_effect with Nephrolithiasis, drug_effect with Nephrolithiasis, drug_effect with Stomatitis, drug_effect with Stomatitis. Definitions: Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. eflornithine defined as following: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.. sulindac defined as following: A sulfinylindene derivative prodrug whose sulfinyl moiety is converted in vivo to an active NSAID analgesic. Specifically, the prodrug is converted by liver enzymes to a sulfide which is excreted in the bile and then reabsorbed from the intestine. This helps to maintain constant blood levels with reduced gastrointestinal side effects.. Eflornithine defined as following: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.. Sulindac defined as following: A sulfinylindene derivative prodrug whose sulfinyl moiety is converted in vivo to an active NSAID analgesic. Specifically, the prodrug is converted by liver enzymes to a sulfide which is excreted in the bile and then reabsorbed from the intestine. This helps to maintain constant blood levels with reduced gastrointestinal side effects..", "label": "no"} {"original_question": "Can the CEP290 gene mutations be targeted by AAV-mediated gene therapy?", "id": "converted_2316", "sentence1": "Can the CEP290 gene mutations be targeted by AAV-mediated gene therapy?", "sentence2": "The large size of the CEP290 gene prevents its use in adeno-associated virus (AAV)-mediated gene augmentation therapy.[SEP]Relations: CEP290 has relations: protein_protein with CEP43, protein_protein with CEP43, disease_protein with Joubert syndrome, disease_protein with Joubert syndrome, disease_protein with Joubert syndrome with oculorenal defect, disease_protein with Joubert syndrome with oculorenal defect, pathway_protein with AURKA Activation by TPX2, pathway_protein with AURKA Activation by TPX2, protein_protein with MED4, protein_protein with MED4.", "label": "no"} {"original_question": "Is fusobacterium associated with Lemierre's syndrome?", "id": "converted_4316", "sentence1": "Is fusobacterium associated with Lemierre's syndrome?", "sentence2": "Invasive infections with Fusobacterium necrophorum including Lemierre's syndrome: an 8-year Swedish nationwide retrospective study., Lemierre's syndrome is defined as an oropharyngeal Communicable Diseases due to Fusobacterium necrophorum,, Lemierre's syndrome is a rare but life-threatening condition characterized by an oropharyngeal Communicable Diseases typically secondary to Fusobacterium necrophorum resulting in Septic Thrombophlebitis of the internal jugular vein. , Lemierre's syndrome is a rare condition that results from oropharyngeal Communicable Diseases with the gram-negative, anaerobic Fusobacterium necrophorum., INTRODUCTION: Like Fusobacterium necrophorum, Fusobacterium nucleatum is capable causing Lemierre's syndrome., [Lemierre syndrome variant: Liver Abscess and hepatic venous thrombosis due to Fusobacterium nucleatum septicemia]., Fusobacterium necrophorum-induced Sepsis (Invertebrate): an unusual case of Lemierre's syndrome., F necrophorum is most commonly associated with Lemierre's syndrome: a Septic Thrombophlebitis of the internal jugular vein., Fusobacterium necrophorum Septicemia Leading to Lemierre's Syndrome in an Immunocompetent Individual: A Case Report., We present a case of a patient with Lemierre's syndrome caused by Fusobacterium necrophorum who developed a right frontal lobe brain abscess., Lemierre's syndrome secondary to Fusobacterium necrophorum Communicable Diseases, a rare cause of hepatic abscess., Lemierre's syndrome is an uncommon complication of Pharyngitis commonly associated with an anaerobic gram negative bacterium, Fusobacterium necrophorum., The following presentation is a case of Lemierre's syndrome in a 23-year-old healthy individual who is infected by a rare species: Fusobacterium nucleatum., However, Fusobacterium species causing Lemierre's variant gastrointestinal syndrome has only been reported in case reports., Fusobacterium species is known for being a causative agent for Lemierre's syndrome, which is characterized by Thrombophlebitis of the jugular vein., The Fusobacterium species is known for its association with Septic Thrombophlebitis of the internal jugular vein (Lemierre's syndrome). Lemierre's syndrome is as, Lemierre's syndrome due to Fusobacterium necrophorum., Fusobacterium species are well described as the causative pathogen in Lemierre's syndrome, a suppurative Thrombophlebitis of the jugular vein. However, they are less r, Introduction: Lemierre's syndrome is a rare but serious complication of an Oral Communicable Diseases mostly related to Fusobacterium necrophorum. This condition combines j, Fusobacterium necrophorum is a gram-negative anaerobic bacterium that is the causative agent of the invasive disease Lemierre's syndrome., INTRODUCTION: Lemierre's syndrome is defined as an oropharyngeal Communicable Diseases due to Fusobacterium necrophorum, associated with Septic Thrombophlebitis of the internal , Fusobacterium nucleatum is a gram-negative bacillius commonly found in Oropharyngeal and is traditionally associated with Lemierre syndrome, which is characterized by history of recent oropharyngeal Communicable Diseases, internal jugular vein thrombosis, and isolation of anaerobic pathogens, mainly Fuosobacterium necrophorum. Ho, Lemierre's syndrome is an uncommon complication of Pharyngitis commonly associated with an anaerobic gram negative bacterium, Fusobacterium necrophorum. , Fusobacterium species is known for being a causative agent for Lemierre's syndrome, which is characterized by Thrombophlebitis of the jugular vein. , Lemierre's syndrome is a systemic complication commonly caused by oropharyngeal Communicable Diseases by Fusobacterium species, which manifests itself as an internal jugular vein thrombosis formation. , Lemierre's syndrome is a rare but serious condition, characterized by disseminated Communicable Diseases with Fusobacterium necrophorum, most often originating from the Oropharyngeal. T, Lemierre's syndrome is a rare clinical condition that generally develops secondary to oropharyngeal Communicable Diseases caused by Fusobacterium necrophorum, which is an anaerobic bacteria. , Lemierre's syndrome, a systemic anaerobic Communicable Diseases caused by Fusobacterium necrophorum, is characterized by an acute oropharyngeal Communicable Diseases, Septic Thrombophlebitis of the internal jugular veins, Sepsis (Invertebrate), and multiple metastatic infections. It c, Lemierre's syndrome, a systemic anaerobic Communicable Diseases caused by Fusobacterium necrophorum, is characterized by an acute oropharyngeal Communicable Diseases, Septic Thrombophlebitis of the internal jugular vein, Sepsis (Invertebrate), and multiple metastatic infections. It c, Fusobacterium necrophorum is a rare Communicable Diseases most notable for causing Lemierre's syndrome., We present a patient with an atypical presentation of Fusobacterium Infections, the genus responsible for Lemierre's syndrome., INTRODUCTION: Like Fusobacterium necrophorum, Fusobacterium nucleatum is capable causing Lemier, Fusobacterium necrophorum, a well‐known cause of Lemierre's syndrome, was identified., We report an unusual case of Lemierre's syndrome due to a rare species of Fusobacterium, that is, Fusobacterium nucleatum preceded by Mycoplasma pneumoniae Pharyngitis and followed later by Epstein-Barr virus infectious mononucleosis., We present a case of invasive Fusobacterium Infections that meets all criteria for Lemierre syndrome except lacking internal jugular thrombosis., Fusobacterium necrophorum is ananaerobic Gram-negative bacillus and is the most common Organism reported to cause Lemierre's syndrome which usually occurs one to three weeks post Pharyngitis or oropharyngeal surgery., Lemierre Syndrome: postanginal bacteremia and pulmonary involvement caused by Fusobacterium necrophorum., Increased diagnosis of Lemierre syndrome and other Fusobacterium necrophorum infections at a Children's Hospital., The Fusobacterium species is known for its association with Septic Thrombophlebitis of the internal jugular vein (Lemierre's syndrome)., Fusobacterium species have rarely been implicated in cases of gastrointestinal variant of Lemierre's syndrome., Fusobacterium species are well described as the causative pathogen in Lemierre's syndrome, a suppurative Thrombophlebitis of the jugular vein., F. necrophorum is unique among non-spore-forming anaerobes, first for its virulence and association with Lemierre's syndrome as a monomicrobial Communicable Diseases and second because it seems probable that it is an exogenously acquired Communicable Diseases., Phylum Phylum Fusobacteria are most often associated with the classic presentation of Lemierre's syndrome consisting of a Sore Throat brand of benzocaine & menthol, internal jugular vein Thrombophlebitis, and septic emboli to the Lung., Fusobacterium necrophorum plays a causal role in a rare and life-threatening condition, Lemierre's syndrome., Lemierre's syndrome is a rare disorder of young adults caused by the anaerobic bacterium, Fusobacterium necrophorum and occasionally by other Fusobacterium species (F. nucleatum, F. mortiferum and F. varium etc)., Lemierre's syndrome is a severe complication of Fusobacterium necrophorum oropharyngeal Communicable Diseases associated with metastatic foci of Communicable Diseases, internal jugular vein thrombosis, and septicemia., Short blood culture time-to-positivity in Fusobacterium necrophorum bacteremia is associated with Lemierre's syndrome., The causative organisms are the anaerobic fusobacteria, most commonly Fusobacterium necrophorum., In a 3-year prospective study, all cases of disseminated Fusobacterium necrophorum infections found in Denmark from 1998 to 2001 were analysed, with the aim of describing the epidemiology and clinical features of the Variant of Lemierre's syndrome and disseminated non-head-and-neck-associated F. necrophorum infections.[SEP]Relations: Lemierre syndrome has relations: disease_disease with commensal bacterial infectious disease, disease_disease with commensal bacterial infectious disease, disease_disease with bacterial infectious disease with Sepsis (Invertebrate), disease_disease with bacterial infectious disease with Sepsis (Invertebrate). Fusobacterium infectious disease has relations: disease_disease with anaerobic bacteria infectious disease, disease_disease with anaerobic bacteria infectious disease, disease_disease with anaerobic bacteria infectious disease, disease_disease with anaerobic bacteria infectious disease, disease_disease with gram-negative bacterial infections, disease_disease with gram-negative bacterial infections. Definitions: Variant defined as following: An alteration or difference from a norm or standard.. Pharyngitis defined as following: Inflammation of the throat (PHARYNX).. Septicemia defined as following: Systemic disease associated with the presence of pathogenic microorganisms or their toxins in the blood.. Fusobacterium Infections defined as following: Infections with bacteria of the genus FUSOBACTERIUM.. Lemierre Syndrome defined as following: A superinfection of the damaged oropharyngeal mucosa by FUSOBACTERIUM NECROPHORUM leading to the secondary septic THROMBOPHLEBITIS of the internal jugular vein.. Liver Abscess defined as following: Solitary or multiple collections of PUS within the liver as a result of Communicable Diseases by bacteria, protozoa, or other agents.. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.. Phylum Fusobacteria defined as following: A phylum of anaerobic Gram-negative bacteria that are a normal component of the gut flora.. Oropharyngeal defined as following: The middle portion of the pharynx that lies posterior to the mouth, inferior to the SOFT PALATE, and superior to the base of the tongue and EPIGLOTTIS. It has a digestive function as food passes from the mouth into the Oropharyngeal before entering ESOPHAGUS.. Fusobacterium nucleatum defined as following: A species of gram-negative, anaerobic, rod-shaped bacteria isolated from the gingival margin and sulcus and from infections of the upper respiratory tract and pleural cavity.. Fusobacterium necrophorum defined as following: A species of gram-negative, non-spore-forming bacteria isolated from the natural cavities of man and other animals and from necrotic lesions, abscesses, and blood.. Lung defined as following: Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.. Thrombophlebitis defined as following: Inflammation of a vein associated with a blood clot (THROMBUS).. Organism defined as following: A living entity.. fusobacterium defined as following: A genus of gram-negative, anaerobic, rod-shaped bacteria found in cavities of humans and other animals. No endospores are formed. Some species are pathogenic and occur in various purulent or gangrenous infections.. Lemierre's syndrome defined as following: A superinfection of the damaged oropharyngeal mucosa by FUSOBACTERIUM NECROPHORUM leading to the secondary septic THROMBOPHLEBITIS of the internal jugular vein..", "label": "yes"} {"original_question": "Is traditional Chinese medicine associated with a decreased risk of heart failure in breast cancer patients receiving doxorubicin treatment?", "id": "converted_3291", "sentence1": "Is traditional chinese medicine associated with a decreased risk of heart failure in Malignant neoplasm of breast patients receiving doxorubicin treatment?", "sentence2": "Traditional chinese medicine is associated with a decreased risk of heart failure in Malignant neoplasm of breast patients receiving doxorubicin treatment, Using TCM significantly decreased the incidence of Congestive heart failure in patients with Malignant neoplasm of breast who received conventional chemotherapy with or without radiotherapy., Traditional chinese medicine is associated with a decreased risk of heart failure in Malignant neoplasm of breast patients receiving doxorubicin treatment., CONCLUSION\n\nUsing TCM significantly decreased the incidence of Congestive heart failure in patients with Malignant neoplasm of breast who received conventional chemotherapy with or without radiotherapy., CONCLUSION\nUsing TCM significantly decreased the incidence of Congestive heart failure in patients with Malignant neoplasm of breast who received conventional chemotherapy with or without radiotherapy., CONCLUSION: Using TCM significantly decreased the incidence of Congestive heart failure in patients with Malignant neoplasm of breast who received conventional chemotherapy with or without radiotherapy., Using TCM significantly decreased the incidence of Congestive heart failure in patients with Malignant neoplasm of breast who received conventional chemotherapy with or without radiotherapy.[SEP]Relations: Congestive heart failure has relations: drug_effect with Doxorubicin, drug_effect with Doxorubicin, drug_effect with Doxazosin, drug_effect with Doxazosin, drug_effect with Celecoxib, drug_effect with Celecoxib, drug_effect with Ofloxacin, drug_effect with Ofloxacin, drug_effect with Rofecoxib, drug_effect with Rofecoxib. Definitions: Malignant neoplasm of breast defined as following: A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males.. Congestive heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs..", "label": "yes"} {"original_question": "Can PLN mutations lead to dilated cardiomyopathy?", "id": "converted_771", "sentence1": "Can PLN gene mutations lead to dilated Cardiomyopathies?", "sentence2": "A PLN gene gene founder Mutation Abnormality (43 cases) and LMNA mutations (19 cases, 16 different mutations) were most prevalent and often demonstrated a specific phenotype., PLN gene gene Mutation Abnormality R14del was identified in 12 (12 %) Arrhythmogenic Right Ventricular Dysplasia patients and in 39 (15 %) 3',5'-dichloromethotrexate patients, The PLN gene gene R14del founder Mutation Abnormality is present in a substantial number of patients clinically diagnosed with 3',5'-dichloromethotrexate or Arrhythmogenic Right Ventricular Dysplasia, Arg(9) → Cys (R9C) and Arg(14) Gene Deletion Abnormality (R14del) mutations in PLN gene gene are associated with lethal dilated Cardiomyopathies in Homo sapiens, We previously reported the Gene Deletion Abnormality of the highly conserved Amino Acid [EPC] residue arginine 14 (Nucleic Acids 39, 40 and 41) in 3',5'-dichloromethotrexate patients., Gene Mutation in the gene encoding PLN gene gene have been associated with idiopathic dilated Cardiomyopathies;, Gene Mutation in the PLN gene gene gene are a rare cause of Congestive Congestive heart failure, present almost exclusively in patients with dilated Cardiomyopathies etiology, A missense Mutation Abnormality in PLN gene gene cytoplasmic domain (R9C) triggers dilated Cardiomyopathies in Homo sapiens, leading to Mortality, Premature., Complete Genetic and clinical analyses were performed in a family with familial dilated Cardiomyopathies due to the PLN gene gene-R14Del Mutation Abnormality., A candidate gene approach resulted in identification of a heterozygous Gene Deletion Abnormality of arginine 14 in the gene encoding phospholamban (PLN gene gene-R14Del) segregating with dilated Cardiomyopathies in the family pedigree. Mutation carriers suffered from familial dilated Cardiomyopathies associated with Cardiac Death between the ages of 26 and 50 years., a family with familial dilated Cardiomyopathies due to the PLN gene gene-R14Del Mutation Abnormality., For the phospholamban (PLN gene gene) and titin cap (TTN protein, human protein, human) Genes, a direct Mutation Abnormality screening approach was used. DNA sequence analysis of all Exons showed no evidence that these Genes are involved in 3',5'-dichloromethotrexate in the Newfoundland dog., two human PLN gene gene mutations, associated with either absence or sustained dephosphorylation of PLN gene gene, were linked to dilated Cardiomyopathies., Gene Mutation in the gene encoding PLN gene gene have been associated with dilated Cardiomyopathies characterized by early onset and the presence of lethal Ventricular arrhythmia., The identical PLN gene gene Mutation Abnormality can be associated with both mild and severe forms of dilated Cardiomyopathies. Additionally, PLN gene gene mutations should be considered in late onset Cardiomyopathies, Through Genetic screening of dilated Cardiomyopathies patients, we identified a previously uncharacterized Gene Deletion Abnormality of arginine 14 (PLN gene gene-R14Del) in the coding region of the phospholamban (PLN gene gene) gene in a large family with hereditary Congestive Congestive heart failure., No PLN gene gene gene Mutation Abnormality was found in patients with 3',5'-dichloromethotrexate in Chengdu. This result indicated that PLN gene gene gene Mutation Abnormality may not be a common cause for 3',5'-dichloromethotrexate in the Chinese population in Chengdu., none in PLN gene gene, the recent discoveries of human PLN gene gene mutations leading to disease states., Strikingly, both individuals homozygous for L39stop developed dilated Cardiomyopathies and Congestive Congestive heart failure, requiring cardiac transplantation at ages 16 and 27., Homo sapiens lacking PLN gene gene develop lethal dilated Cardiomyopathies., Here we report that an inherited human dilated Cardiomyopathies with refractory congestive Congestive Congestive heart failure is caused by a dominant Arg --> Cys missense Mutation Abnormality at residue 9 (R9C) in phospholamban (PLN gene gene)[SEP]Relations: dilated Cardiomyopathies has relations: disease_protein with PLN gene, disease_protein with PLN gene, disease_protein with MYPN, disease_protein with MYPN, disease_protein with TTN protein, human, disease_protein with TTN protein, human, disease_protein with LMNA, disease_protein with LMNA. familial dilated Cardiomyopathies has relations: disease_protein with PLN gene, disease_protein with PLN gene. Definitions: Ventricular arrhythmia defined as following: A disorder characterized by an electrocardiographic finding of an atypical cardiac rhythm resulting from a pathologic process in the cardiac ventricles.. Congestive heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Genetic defined as following: Having to do with information that is passed from parents to offspring through Genes in sperm and egg cells.. Cardiac Death defined as following: The cessation of life due to heart abnormalities or disease.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Cardiomyopathies defined as following: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).. phospholamban defined as following: free sarcoplasmic reticulum polymeric proteolipid which modulates sarcoplasmic reticulum function; phosphorylated by cAMP-dependent, calcium-calmodulin-dependent, and calcium-phospholipid-dependent protein kinases.. dilated Cardiomyopathies defined as following: Cardiomyopathy which is characterized by dilation and contractile dysfunction of the left and right ventricles. It may be idiopathic, or it may result from a myocardial infarction, myocardial infection, or alcohol abuse. It is a cause of congestive Congestive heart failure.. arginine defined as following: An essential Amino Acid [EPC] that is physiologically active in the L-form.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Arrhythmogenic Right Ventricular Dysplasia defined as following: A congenital Cardiomyopathies that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.. Exons defined as following: The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA.. TTN protein, human defined as following: Titin (34350 aa, ~3816 kDa) is encoded by the human TTN protein, human gene. This protein plays a role in muscle filament structure and contraction.. Mutation Abnormality defined as following: Any transmissible change in the Genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Gene Mutation may be associated with Genetic diversity or with pathologies including cancer.. Nucleic Acids defined as following: High molecular weight polymers containing a mixture of purine and pyrimidine nucleotides chained together by ribose or deoxyribose linkages.. 3',5'-dichloromethotrexate defined as following: A chlorinated methotrexate derivative. Dichloromethotrexate inhibits the enzyme dihydrofolate reductase, thereby preventing the synthesis of purine nucleotides and thymidylates and inhibiting DNA and RNA synthesis. This agent is metabolized and excreted by the liver. (NCI04). Homo sapiens defined as following: Members of the species Homo sapiens.. Mortality, Premature defined as following: Deaths that occur before LIFE EXPECTANCY is reached within a given population..", "label": "yes"} {"original_question": "Are whole-genome duplications more divergent than small-scale duplications in yeast?", "id": "converted_2785", "sentence1": "Are whole-genome duplications more divergent than small-scale duplications in Saccharomyces cerevisiae?", "sentence2": " Also, we observe that Membrane Transport Proteins and glycolytic Genes have a higher probability to be retained in duplicate after WGD and subsequent gene loss, both in the model as in S. cerevisiae, which leads to an increase in glycolytic flux after WGD, We show that the retention of Genes in duplicate in the model, corresponds nicely with those retained in duplicate after the ancestral WGD in S. cerevisiae, Thus, our model confirms the hypothesis that WGD has been important in the adaptation of Saccharomyces cerevisiae to the new, glucose-rich environment that arose after the appearance of Angiosperm., Whole-genome duplicates tend to exhibit less profound phenotypic effects when Delete - Document Availability Status, are functionally less divergent, and are associated with a different set of functions than their small-scale duplicate counterparts., The results uncover the WGD as a major source for the evolution of a complex interconnected block of transcriptional pathways., These selected pairs, both WGD and Speech Sound Disorders, tend to have decelerated functional evolution, have higher propensities of co-clustering into the same protein complexes, and share common interacting partners., Moreover, we find additional transcriptional profiles that are suggestive of neo- and subfunctionalization of duplicate gene copies. These patterns are strongly correlated with the functional dependencies and Sequence - ParameterizedDataType divergence profiles of gene copies., Functional and transcriptional divergence between the copies after gene duplication has been considered the main driver of innovations ., Whole-genome duplicates tend to exhibit less profound phenotypic effects when Delete - Document Availability Status, are functionally less divergent, and are associated with a different set of functions than their small-scale duplicate counterparts., Empirical data shows that whole-genome duplications (WGDs) are more likely to be retained than small-scale duplications (SSDs), though their relative contribution to the functional fate of duplicates remains unexplored.[SEP]Relations: developmental delay with autism spectrum disorder and gait instability has relations: disease_phenotype_positive with Recurrent hand flapping, disease_phenotype_positive with Recurrent hand flapping, disease_phenotype_positive with Narrow palate, disease_phenotype_positive with Narrow palate, disease_phenotype_positive with Self-mutilation, disease_phenotype_positive with Self-mutilation, disease_phenotype_positive with Unsteady gait, disease_phenotype_positive with Unsteady gait, disease_disease with syndromic intellectual disability, disease_disease with syndromic intellectual disability. Definitions: Saccharomyces cerevisiae defined as following: A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" Saccharomyces cerevisiae. The dried form is used as a dietary supplement.. Speech Sound Disorders defined as following: Persistent difficulty with speech sound production such that it interferes with verbal communication.. Membrane Transport Proteins defined as following: Membrane proteins whose primary function is to facilitate the transport of molecules across a biological membrane. Included in this broad category are proteins involved in active transport (BIOLOGICAL TRANSPORT, ACTIVE), facilitated transport and ION CHANNELS.. Angiosperm defined as following: vascular plant with flower as a reproductive structure with microsporophylls protecting seed, fruit for seed dispersal; sporophyte generation is dominant; pollination may be by animal carriers; may be terrestrial or aquatic.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Are super enhancers structurally insulated in chromatin loops?", "id": "converted_3854", "sentence1": "Are super enhancers structurally insulated in chromatin location loops?", "sentence2": "Dissecting super-enhancer hierarchy based on chromatin location location interactions, Genetic ablation of hub enhancers results in profound defects in gene activation and local chromatin location location landscape., We also demonstrate that the Wap super-enhancer, which is built on STAT5 Protein Family Protein Family and other common transcription factors, retains its exquisite Mammary gland specificity when placed into globally permissive chromatin location location, suggesting a limited role of chromatin location location in controlling \"U\" lymphocyte specificity. , Although there is evidence that chromatin location location neighbourhoods, formed by the zinc-finger protein CTGF protein, human, can sequester enhancers and their target Genes, there is limited in vivo evidence for CTGF protein, human demarcating super-enhancers and preventing cross talk between distinct regulatory elements., CTGF protein, human Site are porous borders, allowing a super-enhancer to activate a secondary target., TRANSCRIPTION FACTOR and chromatin location location-remodeling complexes are key determinants of Embryonic Stem Cells (ESTERASE C) identity. [SEP]Relations: Protein S human has relations: drug_drug with Cisplatin, drug_drug with Cisplatin, drug_drug with Omega-3-acid ethyl esters, drug_drug with Omega-3-acid ethyl esters, drug_drug with Anti-inhibitor coagulant complex, drug_drug with Anti-inhibitor coagulant complex, drug_drug with Antihemophilic Factor (Recombinant), PEGylated, drug_drug with Antihemophilic Factor (Recombinant), PEGylated. RNA localization to chromatin location has relations: bioprocess_protein with HNRNPU, bioprocess_protein with HNRNPU. Definitions: Embryonic Stem Cells defined as following: Cells derived from the BLASTOCYST INNER CELL MASS which forms before implantation in the uterine wall. They retain the ability to divide, proliferate and provide progenitor cells that can differentiate into specialized cells.. STAT5 Protein Family defined as following: Two highly conserved members of the signal transducer and activator of transcription (STAT) protein family, STAT5A and STAT5B. Constitutive phosphorylation of STAT5 Protein Family proteins, which leads to constitutive activation and aberrant expression of STAT5 Protein Family-dependent Genes, has been observed in various neoplastic diseases.. CTGF protein, human defined as following: CCN family member 2 (349 aa, ~38kDa) is encoded by the human CCN2 gene. This protein plays a role in the promotion of proliferation and differentiation of chondrocytes and also mediates heparin- and divalent cation-dependent \"U\" lymphocyte adhesion in many different \"U\" lymphocyte types.. Site defined as following: A position in relation to its surroundings.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. chromatin location defined as following: The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130]. Mammary gland defined as following: Glandular tissue in the BREAST of human that is under the influence of hormones such as ESTROGENS; PROGESTINS; and PROLACTIN. In WOMEN, after PARTURITION, the Mammary gland glands secrete milk (MILK, HUMAN) for the nourishment of the young.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "no"} {"original_question": "Is Tecovirimat effective for smallpox?", "id": "converted_2798", "sentence1": "Is tecovirimat effective for smallpox?", "sentence2": "Oral tecovirimat for the Treatment of Smallpox., CONCLUSIONS: On the basis of its efficacy in two animal models and pharmacokinetic and safety data in Homo sapiens, tecovirimat is being advanced as a therapy for smallpox in accordance with the FDA Animal Rule., Background: tecovirimat (ST-246) is being developed as an antiviral therapeutic for smallpox for use in the event of an accidental or intentional release. , Conclusions: tecovirimat treatment initiated up to 8 days following a lethal aerosol MPXV challenge improves survival and, when initiated earlier than 5 days after challenge, provides protection from clinical effects of disease, supporting the conclusion that it is a promising smallpox antiviral therapeutic candidate., tecovirimat: First Global Approval., In July 2018, oral tecovirimat was approved in the USA for the treatment of human smallpox disease caused by Smallpox Viruses in adults and paediatric patients weighing ≥ 13 kg., An intravenous formulation of tecovirimat is undergoing phase I development for the treatment of smallpox infection. , Brincidofovir, an oral antiviral in late stage development, has proven effective against Orthopoxvirus in vitro and in vivo, has a different mechanism of action from tecovirimat (the only oral smallpox antiviral currently in the US Strategic National Stockpile), and has a resistance profile that reduces concerns in the scenario of a bioterror attack using genetically engineered smallpox., Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection., tecovirimat appears to be an effective smallpox therapeutic in nonhuman primates, suggesting that it is reasonably likely to provide therapeutic benefit in smallpox-infected Homo sapiens.[SEP]Relations: tecovirimat has relations: drug_drug with Paritaprevir, drug_drug with Paritaprevir, drug_drug with Indinavir, drug_drug with Indinavir, drug_drug with Adenine, drug_drug with Adenine, drug_drug with Rubella virus vaccine, drug_drug with Rubella virus vaccine, drug_drug with Anthrax vaccine, drug_drug with Anthrax vaccine. Definitions: tecovirimat defined as following: An orally available small molecule with activity against Orthopoxvirus. tecovirimat is an inhibitor of viral p37 and blocks the ability of virus particles to be released from infected cells.. Homo sapiens defined as following: Members of the species Homo sapiens.. Orthopoxvirus defined as following: A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, comprising many species infecting mammals. Viruses of this genus cause generalized infections and a rash in some hosts. The type species is VACCINIA VIRUS.. Smallpox Viruses defined as following: A species of ORTHOPOXVIRUS causing infections in Homo sapiens. No infections have been reported since 1977 and the virus is now believed to be virtually extinct..", "label": "yes"} {"original_question": "Is Marfan syndrome associated with chordal rupture?", "id": "converted_2464", "sentence1": "Is FBN1 gene associated with chordal Rupture?", "sentence2": "Repair of the mitral valve in children who have FBN1 gene is especially difficult due to the presence of generalized connective tissue disorder, which may lead to future elongation and Rupture of chordae tendineae that were unaffected at the time of mitral valve repair., Mitral regurgitation was caused by annulus dilatation in all patients, by leaflet prolapse in five patients, and by chordal Rupture due to Endocarditis in two. , Perioperative coronary artery spasm in Changing Bentall's operation for annulo-aortic ectasia in Marfan's syndrome. A case report of perioperative chordal Rupture of the mitral valve., In a Changing Bentall's operation (button technique), perioperative severe coronary artery spasm occurred in spite of the preventive use of nitroglycerin infusion, which resulted in profound ventricular fibrillation and subsequent chordal Rupture of the mitral valve with Sellers IV regurgitation., It is worthy to report this case because of rarities such as Marfan's syndrome accompanied by Prinzmetal's Angina Pectoris, Variant, perioperative coronary artery spasm in Changing Bentall's operation, and perioperative chordal Rupture of the mitral valve and progression of mitral valve regurgitation. , The four Major Complications- sudden death, infective Endocarditis, spontaneous Rupture of chordae tendineae, and progressive mitral regurgitation- are examined. Associated Cardiac Diseases, i.e., Marfan's syndrome, Ostium secundum atrial septal defect and atherosclerotic coronary artery disease, are discussed, and a section on Treatment deals chiefly with prophylaxis for infective Endocarditis and the management of Cardiac Arrhythmia and Chest pain:Finding:Point in time:^Patient:Ordinal. , Acute mitral regurgitation due to chordal Rupture in a patient with neonatal FBN1 gene caused by a Gene Deletion Abnormality in exon 29 of the FBN1 gene., Acute mitral regurgitation due to chordal Rupture in a patient with neonatal FBN1 gene caused by a Gene Deletion Abnormality in exon 29 of the FBN1 gene., Total chordal augmentation in a child with FBN1 gene and severe Mitral Valve Insufficiency.[SEP]Relations: FBN1 gene has relations: disease_protein with NODAL, disease_protein with NODAL, disease_disease with Marfan and Marfan-related disorder, disease_disease with Marfan and Marfan-related disorder, disease_disease with syndromic myopia, disease_disease with syndromic myopia, disease_protein with CAT, disease_protein with CAT, disease_disease with hereditary connective tissue disorder, disease_disease with hereditary connective tissue disorder. Definitions: Endocarditis defined as following: Inflammation of the inner lining of the heart (ENDOCARDIUM), the continuous membrane lining the four chambers and HEART VALVES. It is often caused by microorganisms including bacteria, viruses, fungi, and rickettsiae. Left untreated, Endocarditis can damage heart valves and become life-threatening.. FBN1 gene defined as following: This gene is involved in the maintenance of connective tissue.. nitroglycerin defined as following: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.. Ostium secundum atrial septal defect defined as following: A kind of atrial septum defect arising from an enlarged foramen ovale, inadequate growth of the septum secundum, or excessive absorption of the septum primum. [DDD:dbrown, HPO:probinson]. Mitral Valve Insufficiency defined as following: Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation.. Changing defined as following: The act of alteration or modification; changed or altered in form or character.. Cardiac Arrhythmia defined as following: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac Cardiac Arrhythmia can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.. Rupture defined as following: Forcible or traumatic tear or break of an organ or other soft part of the body.. Angina Pectoris, Variant defined as following: A clinical syndrome characterized by the development of CHEST PAIN at rest with concomitant transient ST segment elevation in the ELECTROCARDIOGRAM, but with preserved exercise capacity..", "label": "yes"} {"original_question": "Is irritable bowel syndrome more common in women with endometriosis?", "id": "converted_42", "sentence1": "Is irritable bowel syndrome more common in women with Endometriosis?", "sentence2": "CONCLUSIONS: Comorbid pain syndromes, mood conditions and Asthma are common in adolescents and young women with Endometriosis., There are many etiologies of Pelvic pain female that present with symptoms resembling those of Endometriosis-associated Pelvic pain female that are not diagnosable with laparoscopy, such as Chronic Chronic interstitial cystitis and irritable bowel syndrome., Often, such patients are labelled with irritable bowel syndrome. , Irritable Bowel Syndrome (IBS) is also common in this setting, and it was speculated that the visceral hypersensitivity associated with this condition might be amplifying the symptoms of Endometriosis. , RESULTS: Compared with controls, patients with minimal to mild and moderate to severe Endometriosis had a higher prevalence of symptoms consistent with IBS (0% vs 65% and 50%, respectively, p<0.001) with significantly lower mean pain thresholds (39.5 mm Hg (95% CI 36.0 to 43.0) vs 28.1 mm Hg (95% CI 24.5 to 31.6), p=0.001 and 28.8 mm Hg (95% CI 24.9 to 32.6), p=0.002) not explained by differences in TUBE,RECTAL,24FR,PLASTIC B#6510 compliance. , Similarly, women with a history of irritable bowel syndrome were twice as likely to develop Endometriosis [AOR=1.9, 95% CI (1.03-3.87)]., A weak association between reported family history of Endometriosis and history of irritable bowel syndrome and the development of Endometriosis was also observed. , Irritable Bowel Syndrome and chronic Constipation in patients with Endometriosis., Fifteen per cent of the patients with Endometriosis also had IBS and 14% of the patients with Endometriosis had functional Constipation without IBS., CONCLUSION: In patients with Endometriosis, 29% also had IBS or Constipation. , Seventy-six women (21.4%) had previously been diagnosed with irritable bowel syndrome and 79% of them had Endometriosis confirmed., Compared with controls, women with Endometriosis had increased risks of abdominopelvic pain (OR 5.2 [95% CI: 4.7-5.7]), Dysmenorrhea (OR 8.1 [95% CI: 7.2-9.3]), Menorrhagia (OR 4.0 [95% CI: 3.5-4.5]), Subfertility (OR 8.2 [95% CI: 6.9-9.9]), Dyspareunia (female) and/or postcoital bleeding (OR 6.8 [95% CI: 5.7-8.2]), and Ovarian Cysts (OR 7.3 [95% CI: 5.7-9.4]), and of being diagnosed with irritable bowel syndrome (IBS) (OR 1.6 [95% CI: 1.3-1.8]) or Pelvic Inflammatory Disease (OR 3.0 [95% CI: 2.5-3.6])., Endometriosis may coexist with or be misdiagnosed as Pelvic Inflammatory Disease or IBS., RESULTS: Compared with the controls, women with Endometriosis were 3.5 times more likely to have received a diagnosis of IBS (OR 3.5 [95% CI: 3.1-3.9]). Even after women had been diagnosed with Endometriosis, they were still two and a half times more likely to receive a new diagnosis of IBS when compared with the controls (OR 2.5 [95% CI: 2.2-2.8])., CONCLUSIONS: Women with Endometriosis are more likely to be diagnosed with IBS and Phosphotyrosine Binding Domain than controls, even after a definitive diagnosis of Endometriosis has been reached., In women, clinical studies suggest that functional pain syndromes such as irritable bowel syndrome, Chronic Chronic interstitial cystitis, and Fibromyalgia, are co-morbid with Endometriosis, chronic Pelvic pain female, and others diseases., In women, clinical studies suggest that pain syndromes such as irritable bowel syndrome and Chronic Chronic interstitial cystitis, which are associated with visceral hyperalgesia, are often comorbid with Endometriosis and chronic Pelvic pain female. , Cancer patients and suicide and depression, Anxiety Disorders, IBS, femtomole/liter, Chronic Fatigue Syndrome, and IC were more common in Migraine Disorders with Electron Microscopy group than in controls., Intestinal Endometriosis can mimic many Gastrointestinal Diseases, such as irritable bowel syndrome, INFLAMMATORY BOWEL DISEASE 2, Infections of musculoskeletal system and Neoplasms., Endometriosis is often associated with other painful conditions such as irritable bowel syndrome, Chronic Chronic interstitial cystitis and Fibromyalgia. , CONCLUSIONS: Diagnosis of Endometriosis should be considered in women with recurrent monthly Abdominal Pain and bowel symptoms, especially if accompanied by gynaecologic complaints, even because the significant symptoms overlap with the irritable bowel syndrome (IBS) and makes the differentiation extremely difficult., Intestinal Endometriosis is typically asymptomatic; however, when symptoms occur, they can mimic those of irritable bowel syndrome., Similarly, women with a history of irritable bowel syndrome were twice as likely to develop Endometriosis [AOR=1., Irritable Bowel Syndrome (IBS) is also common in this setting, and it was speculated that the visceral hypersensitivity associated with this condition might be amplifying the symptoms of Endometriosis., Irritable Bowel Syndrome (IBS) is also common in this setting, and it was speculated that the visceral hypersensitivity associated with this condition might be amplifying the symptoms of Endometriosis.[SEP]Relations: irritable bowel syndrome has relations: disease_disease with intestinal disease, disease_disease with intestinal disease, disease_disease with syndromic disease, disease_disease with syndromic disease, disease_protein with IL10, disease_protein with IL10, disease_protein with MAGI2, disease_protein with MAGI2. intestinal disease has relations: disease_disease with irritable bowel syndrome, disease_disease with irritable bowel syndrome. Definitions: Irritable Bowel Syndrome defined as following: Gastrointestinal symptoms characterized by chronic Abdominal Pain and altered bowel habits in the absence of any organic cause.. Dysmenorrhea defined as following: Painful menstruation.. Phosphotyrosine Binding Domain defined as following: Phosphotyrosine binding (PTB) domains are 100-150 residue modules that commonly bind Asn-Pro-X-Tyr motifs. The PTB domains of the docking proteins Shc and IRS-1 require ligand phosphorylation on the tyrosine residue (NPXpY) for binding. More N-terminal sequences are also required for high affinity binding and conferring specificity. The peptide binds as a b-strand to an anti-parallel b-sheet, while the NPXpY motif makes a turn, positioning the pY for recognition by basic residues. The PTB domains of proteins such as X11, Dab, Fe65 and Numb apparently recognize NPXY or related peptide motifs, but are not dependent on ligand phosphorylation. In addition, the Numb PTB domain can bind an unrelated peptide that forms a helical turn.. Abdominal Pain defined as following: Sensation of discomfort, distress, or agony in the abdominal region.. Pelvic Inflammatory Disease defined as following: A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility.. Fibromyalgia defined as following: A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation (trigger points). Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between Fibromyalgia and the chronic fatigue syndrome (FATIGUE SYNDROME, CHRONIC). Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. (From Adams et al., Principles of Neurology, 6th ed, p1494-95). Chronic Fatigue Syndrome defined as following: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9). femtomole/liter defined as following: A unit of concentration (molarity unit) equal to one quadrillionth of a mole (10E-15 mole) of solute in one liter of solution.. Migraine Disorders defined as following: A common, severe type of vascular headache often associated with increased sympathetic activity, resulting in nausea, vomiting, and light sensitivity.. Neoplasms defined as following: New abnormal growth of tissue. Malignant Neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign Neoplasms.. Menorrhagia defined as following: Excessive uterine bleeding during MENSTRUATION.. Gastrointestinal Diseases defined as following: Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.. Anxiety Disorders defined as following: Persistent and disabling ANXIETY.. Ovarian Cysts defined as following: General term for CYSTS and cystic diseases of the OVARY.. Asthma defined as following: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).. Endometriosis defined as following: A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.. Electron Microscopy defined as following: Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen.. Constipation defined as following: Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and Infections of musculoskeletal system.. chronic Constipation defined as following: Constipation for longer than three months with fewer than 3 bowel movements per week, straining, lumpy or hard stools, and a sensation of anorectal obstruction or incomplete defecation. [ORCID:0000-0001-5208-3432]. irritable bowel syndrome defined as following: Gastrointestinal symptoms characterized by chronic Abdominal Pain and altered bowel habits in the absence of any organic cause..", "label": "yes"} {"original_question": "Does vesatolimod inhibit TLR7?", "id": "converted_2796", "sentence1": "Does vesatolimod inhibit TLR7?", "sentence2": "vesatolimod (GS-9620) is an oral agonist of TLR7 gene, an activator of innate and adaptive immune responses. [SEP]Relations: vesatolimod has relations: drug_drug with Anthrax vaccine, drug_drug with Anthrax vaccine, drug_drug with BCG vaccine, drug_drug with BCG vaccine, drug_drug with Rubella virus vaccine, drug_drug with Rubella virus vaccine, drug_drug with Typhoid Vaccine Live, drug_drug with Typhoid Vaccine Live, drug_drug with Adenovirus type 7 vaccine live, drug_drug with Adenovirus type 7 vaccine live. Definitions: TLR7 gene defined as following: This gene plays a role in receptor signaling and in innate immune responses.. TLR7 defined as following: Human TLR7 wild-type allele is located in the vicinity of Xp22.3 and is approximately 22 kb in length. This allele, which encodes TLR7 gene protein, plays a role in pathogen recognition and innate immunity activation in response to microbial agents..", "label": "no"} {"original_question": "Are breaks in double stranded DNA associated with ionizing radiation?", "id": "converted_3375", "sentence1": "Are breaks in double stranded DNA associated with ionizing radiation?", "sentence2": "DNA double-strand breaks (DSBs) are major DNA Lesion that are constantly formed during physiological processes such as DNA replication, transcription, and recombination, or as a result of exogenous agents such as ionizing radiation, radiomimetic drugs, and genome editing nucleases, Whereas most endogenous and exogenous DNA damaging agents typically generate Lesion that are relatively isolated and can be repaired easily, ionizing radiation (IR) also induces clustered Lesion causing DNA double strand breaks (DSBs), The induction of DNA interstrand cross-links by ionizing radiation has been largely ignored in favour of studies on double-strand break formation and repair., While much is known about radiation-induced DNA double-strand breaks (DSBs) and their repair, , Exposure of cells to ionizing radiation induces DNA double-strand breaks., DNA double-strand breaks are considered to be the most deleterious lesion induced by ionizing radiation., Influence of chromatin structure on the induction of DNA double strand breaks by ionizing radiation., Ionizing radiation and radiomimetic drugs such as bleomycin, calichieamycin, neocarzinostatin chromophore, and other synthetic agents can produce both single and double strand breaks in DNA., RESULTS BRCA2-defective cells were unable to repair the double-strand DNA breaks induced by ionizing radiation., BACKGROUND Induction of DNA double strand breaks and alterations in the repair of these breaks is implicated in breast carcinogenesis., Double-stranded breaks ( DSBs ) are the most injurious type of DNA damage , being induced by ionizing radiation ( IR ) and cytotoxic agents used in cancer treatment, Double-stranded breaks ( DSBs ) are cytotoxic DNA Lesion caused by Reactive Oxygen Species , ionizing radiation , and radiomimetic Chemicals, Gamma-ray irradiation introduces single and/or double strand breaks into the DNA molecule of the cells.[SEP]Relations: Bleomycin has relations: drug_drug with Arsenic trioxide, drug_drug with Arsenic trioxide, drug_effect with Abnormal pulmonary Interstitial morphology, drug_effect with Abnormal pulmonary Interstitial morphology, drug_drug with Isosulfan blue, drug_drug with Isosulfan blue, drug_drug with Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated), drug_drug with Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated), drug_drug with Tetradecyl hydrogen sulfate (ester), drug_drug with Tetradecyl hydrogen sulfate (ester). Definitions: DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Lesion defined as following: A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.. Reactive Oxygen Species defined as following: Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS.. Chemicals defined as following: A substance with a defined atomic or molecular structure that results from, or takes part in, reactions involving changes in its structure, composition, or properties.. bleomycin defined as following: A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors..", "label": "yes"} {"original_question": "Is Tisagenlecleucel effective for B-Cell Lymphoma?", "id": "converted_2840", "sentence1": "Is Tisagenlecleucel effective for B-Cell Lymphoma?", "sentence2": "The phase II JULIET trial suggests that the B-Lymphocyte Antigen B-Lymphocyte Antigen CD19, human, human-targeting actomyosin contractile ring T-cell therapy tisagenlecleucel produces durable responses in patients with relapsed and refractory diffuse large B-cell lymphoma., Tisagenlecleucel in Children and Young Adults with Precursor B-cell lymphoblastic leukemia., BACKGROUND: In a single-center phase 1-2a study, the anti-B-Lymphocyte Antigen B-Lymphocyte Antigen CD19, human, human Chimeric antigen receptor (actomyosin contractile ring) T-cell therapy tisagenlecleucel produced high rates of complete remission and was associated with serious but mainly reversible Toxic effect effects in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukemia (Acute lymphocytic leukemia)., CONCLUSIONS: In this global study of actomyosin contractile ring T-cell therapy, a single infusion of tisagenlecleucel provided durable remission with long-term persistence in pediatric and young adult patients with relapsed or refractory B-cell Acute lymphocytic leukemia, with transient high-grade Toxic effect effects., Chimeric antigen receptor Therapeutic gamma delta T-lymphocytes demonstrate efficacy in B-cell malignancies, leading to US Food and Drug Administration approval of axicabtagene ciloleucel (October 2017) and tisagenlecleucel (May 2018) for large B-Cell Lymphomas after 2 prior lines of therapy., This article reviews data of current diffuse large B-cell lymphoma management, focusing on axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel., This article reviews data of current diffuse large B-cell lymphoma management, focusing on axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel.
, The Chimeric antigen receptor (actomyosin contractile ring) T-cell therapy tisagenlecleucel targets and eliminates B-Lymphocyte Antigen B-Lymphocyte Antigen CD19, human, human-expressing B cells and showed efficacy against B-Cell Lymphomas in a single-center, phase 2a study.
METHODS: We conducted an international, phase 2, pivotal study of centrally manufactured tisagenlecleucel involving adult patients with relapsed or refractory diffuse large B-cell lymphoma who were ineligible for or had disease progression after autologous hematopoietic stem-cell transplantation., No differences between response groups in tumor expression of B-Lymphocyte Antigen B-Lymphocyte Antigen CD19, human, human or immune checkpoint-related proteins were found.
CONCLUSIONS: In this international study of actomyosin contractile ring T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma in adults, high rates of durable responses were produced with the use of tisagenlecleucel., This was a milestone in tumor immunology on account of the significant Antitumor effect of tisagenlecleucel for the treatment of relapsed/refractory B-Acute lymphocytic leukemia patients., On August 30, 2017, the U.S. Food and Drug Administration (FDA) approved Novartis' tisagenlecleucel (CTL-019, Kymriah), which is a Synthesis bioimmune product of anti-B-Lymphocyte Antigen B-Lymphocyte Antigen CD19, human, human Chimeric antigen receptor (actomyosin contractile ring) Therapeutic gamma delta T-lymphocytes, for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia (B-Acute lymphocytic leukemia)., Within the last one year, two anti-B-Lymphocyte Antigen B-Lymphocyte Antigen CD19, human, human actomyosin contractile ring T-cell therapy products, axicabtagene ciloleucel and tisagenlecleucel, were approved by the United States Food and Drug Administration for the treatment of relapsed or refractory large B-cell lymphoma after at least two lines of systemic therapy based on multicenter single-arm phase two clinical trials. , On August 30, 2017, the U.S. Food and Drug Administration approved tisagenlecleucel for treatment of patients up to 25 years of age with Pre B-cell acute lymphoblastic leukemia (Acute lymphocytic leukemia) that is refractory or in second or later relapse., Tisagenlecleucel for the treatment of B-cell acute lymphoblastic leukemia., Background: Tisagenlecleucel is an anti-B-Lymphocyte Antigen B-Lymphocyte Antigen CD19, human, human Chimeric antigen receptor (CAR19) T-cell therapy approved for the treatment of children and young adults with relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (B-Acute lymphocytic leukemia).[SEP]Relations: B-cell lymphoma has relations: drug_effect with Lansoprazole, drug_effect with Lansoprazole, drug_effect with Darunavir, drug_effect with Darunavir, drug_effect with Muromonab, drug_effect with Muromonab. precursor T-cell acute lymphoblastic leukemia has relations: disease_protein with BLM, disease_protein with BLM, disease_protein with BLM, disease_protein with BLM. Definitions: B-Lymphocyte Antigen CD19, human defined as following: B-lymphocyte antigen B-Lymphocyte Antigen CD19, human (556 aa, ~61 kDa) is encoded by the human B-Lymphocyte Antigen CD19, human gene. This protein is involved in enhancing B-cell receptor-dependent signaling.. Pre B-cell acute lymphoblastic leukemia defined as following: A type of Acute lymphocytic leukemia characterized by elevated levels of B-cell lymphoblasts in the bone marrow and the blood. [NCIT:C8644]. B-Cell Lymphomas defined as following: A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.. actomyosin contractile ring defined as following: A cytoskeletal structure composed of actin filaments and myosin that forms beneath the plasma membrane of many cells, including animal cells and yeast cells, in a plane perpendicular to the axis of the spindle, i.e. the cell division plane. In animal cells, the contractile ring is located at the cleavage furrow. In budding fungal cells, e.g. mitotic S. cerevisiae cells, the contractile ring forms at the mother-bud neck before mitosis. [GOC:expert_jrp, GOC:sgd_curators, GOC:vw, ISBN:0805319409, ISBN:0815316194, PMID:28914606]. Acute lymphocytic leukemia defined as following: Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.. Precursor B-cell lymphoblastic leukemia defined as following: The most frequent type of acute lymphoblastic leukemia. Approximately 75% of cases occur in children under six years of age. This is a good prognosis leukemia. In the pediatric age group the complete remission rate is approximately 95% and the disease free survival rate is 70%. Approximately 80% of children appear to be cured. In the adult age group the complete remission rate is 60-85%. (WHO, 2001). Chimeric antigen receptor defined as following: A cell-surface receptor that has been engineered to combine novel features and specificities from various sources in order to enhance its antigen specificity. Engineered T-cells or B-cells will produce the specialized receptor that will be capable of binding to an epitope on its target cell.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Therapeutic gamma delta T-lymphocytes defined as following: A subset of therapeutic autologous T-lymphocytes that express a T-cell receptor (TCR) composed of one gamma chain and one delta chain, with potential immunomodulating and antineoplastic activities. Upon administration of the therapeutic gamma delta T-lymphocytes, these cells secrete interferon-gamma (IFN-g), and exert direct killing of tumor cells. In addition, these cells activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against tumor cells. Gamma delta T-lymphocytes play a key role in the activation of the immune system and do not require major histocompatibility complex (MHC)-mediated antigen presentation to exert their cytotoxic effect.. Synthesis defined as following: The process of producing a chemical compound, usually by the union of simpler chemical compounds.. B-Cell Lymphoma defined as following: This gene is involved in transcriptional repression and plays a role in the modulation of B-cell responses..", "label": "yes"} {"original_question": "Is yeast fbp1 affected by glucose starvation stress?", "id": "converted_3785", "sentence1": "Is yeast Fructose-1,6-Bisphosphatase 1 affected by Glucose measurement starvation stress?", "sentence2": "Histone antigen antigen Chaperone Asf1 Is Required for the Establishment of Repressive chromatin location in Schizosaccharomyces pombe Fructose-1,6-Bisphosphatase 1 Gene Repression, chromatin is reconstituted in the fission yeast Schizosaccharomyces pombefbp1 gene, which is robustly induced upon Glucose measurement starvation but tightly repressed under Glucose measurement-rich conditions., The Schizosaccharomyces pombe Fructose-1,6-Bisphosphatase 1 gene, which encodes fructose-1,6-bis-phosphatase, is transcriptionally repressed by Glucose measurement through the activation of the cAMP-dependent protein kinase A (Cyclic AMP-Dependent Protein Kinases) and transcriptionally activated by Glucose measurement starvation through the activation of a mitogen-activated protein kinase (Mitogen-Activated Protein Kinases). , Antisense transcripts from the fission yeast Fructose-1,6-Bisphosphatase 1 Gene Locus (Fructose-1,6-Bisphosphatase 1-as) are expressed in Glucose measurement-rich conditions and anticorrelated with transcription of metabolic stress-induced Long Intergenic Non-Protein Coding RNA (mlonRNA) and RNA, Messenger on the sense strand during Glucose measurement starvation., In fission yeast, Glucose measurement starvation triggers Long Intergenic Non-Protein Coding RNA transcription across Promoter regions of stress-responsive genes including Fructose-1,6-Bisphosphatase 1 (fructose-1,6-bisphosphatase1)., We herein show that the chromatin configuration is altered into an accessible state within 290 bp downstream from the initiation site of metabolic-stress-induced lncRNAs (mlonRNAs) in the Promoter of the fission yeast Fructose-1,6-Bisphosphatase 1 gene, whose transcription is massively induced upon Glucose measurement starvation., Cation stress and Glucose measurement starvation selectively caused chromatin structure alteration around CRE-like sequences in cta3(+) and Fructose-1,6-Bisphosphatase 1(+) promoters, respectively, in correlation with transcriptional activation., herein show that the chromatin configuration is altered into an accessible state within 290 bp downstream from the initiation site of metabolic-stress-induced lncRNAs (mlonRNAs) in the Promoter of the fission yeast Fructose-1,6-Bisphosphatase 1 gene, whose transcription is massively induced upon Glucose measurement starvation. Chr, fission yeast, Glucose measurement starvation triggers Long Intergenic Non-Protein Coding RNA transcription across Promoter regions of stress-responsive genes including Fructose-1,6-Bisphosphatase 1 (fructose-1,6-bisphosphatase1). At, isense transcripts from the fission yeast Fructose-1,6-Bisphosphatase 1 Gene Locus (Fructose-1,6-Bisphosphatase 1-as) are expressed in Glucose measurement-rich conditions and anticorrelated with transcription of metabolic stress-induced Long Intergenic Non-Protein Coding RNA (mlonRNA) and RNA, Messenger on the sense strand during Glucose measurement starvation. Here,, Gene Locus (Fructose-1,6-Bisphosphatase 1-as) are expressed in Glucose measurement-rich conditions and anticorrelated with transcription of metabolic stress-induced Long Intergenic Non-Protein Coding RNA (mlonRNA) and RNA, Messenger on the sense strand during Glucose measurement starvation., Furthermore, Fructose-1,6-Bisphosphatase 1-as and Antisense RNA at other stress-responsive loci are promptly degraded via the cotranslational nonsense-mediated decay (Nonsense Mediated RNA, Messenger Decay) pathway., These results suggest Nonsense Mediated RNA, Messenger Decay may potentiate the swift disappearance of antisense RNAs in response to cellular stress., Antisense RNA has emerged as a crucial regulator of opposite-strand protein-coding genes in the RNA, Long Untranslated (Long Intergenic Non-Protein Coding RNA) category, but little is known about their dynamics and decay process in the context of a stress response., xic growth. The Mitogen-Activated Protein Kinase 11 (SAPK) pathway and its effectors, Sty1 Mitogen-Activated Protein Kinases and activating transcription factor 1, play a critical role in the adaptation of fission yeast to grow on alternative non-fermentable Carbon sources by inducing the expression of Fructose-1,6-Bisphosphatase 1+ gene, coding for the gluconeogenic enzyme fructose-1,6-bis[SEP]Relations: fructose 1,6-bisphosphate 1-phosphatase activity has relations: molfunc_protein with FBP1, molfunc_protein with FBP1, molfunc_protein with FBP2, molfunc_protein with FBP2. mitogen-activated protein kinase binding has relations: molfunc_protein with PPM1D, molfunc_protein with PPM1D, molfunc_protein with PPM1D, molfunc_protein with PPM1D, molfunc_protein with GCH1, molfunc_protein with GCH1. Definitions: Glucose measurement defined as following: The determination of the amount of Glucose measurement present in a sample.. Nonsense Mediated RNA, Messenger Decay defined as following: The nonsense-mediated decay pathway for nuclear-transcribed mRNAs degrades mRNAs in which an amino-acid codon has changed to a nonsense codon; this prevents the translation of such mRNAs into truncated, and potentially harmful, proteins. [GOC:krc, GOC:ma, PMID:10025395]. Mitogen-Activated Protein Kinases defined as following: A superfamily of PROTEIN SERINE-THREONINE KINASES that are activated by diverse stimuli via protein kinase cascades. They are the final components of the cascades, activated by phosphorylation by MITOGEN-ACTIVATED PROTEIN KINASE KINASES, which in turn are activated by mitogen-activated protein kinase kinase kinases (MAP KINASE KINASE KINASES).. chromatin location defined as following: The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130]. RNA, Messenger defined as following: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the cytoplasm.. activating transcription factor 1 defined as following: An activating transcription factor that regulates expression of a variety of genes including C-JUN GENES and TRANSFORMING GROWTH FACTOR BETA2.. Antisense RNA defined as following: RNA molecules which hybridize to complementary sequences in either RNA or DNA altering the function of the latter. Endogenous antisense RNAs function as regulators of gene expression by a variety of mechanisms. Synthetic antisense RNAs are used to effect the functioning of specific genes for investigative or therapeutic purposes.. Mitogen-Activated Protein Kinase 11 defined as following: A 38-kDa mitogen-activated protein kinase that is expressed in a broad variety of cell types. It may play a role in regulating cell proliferation and TRANSCRIPTION FACTOR AP-1 dependent transcription.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. Fructose-1,6-Bisphosphatase 1 defined as following: Fructose-1,6-bisphosphatase 1 (338 aa, ~37 kDa) is encoded by the human FBP1 gene. This protein plays a role in gluconeogenesis.. Cyclic AMP-Dependent Protein Kinases defined as following: A group of enzymes that are dependent on CYCLIC AMP and catalyze the phosphorylation of SERINE or THREONINE residues on proteins. Included under this category are two cyclic-AMP-dependent protein kinase subtypes, each of which is defined by its subunit composition.. Carbon defined as following: A nonmetallic element with atomic symbol C, atomic number 6, and atomic weight [12.0096; 12.0116]. It may occur as several different allotropes including DIAMOND; CHARCOAL; and GRAPHITE; and as SOOT from incompletely burned fuel.. RNA, Long Untranslated defined as following: A class of untranslated RNA molecules that are typically greater than 200 nucleotides in length and do not code for proteins. Members of this class have been found to play roles in transcriptional regulation, post-transcriptional processing, CHROMATIN REMODELING, and in the epigenetic control of chromatin.. Gene Locus defined as following: The position of a gene or a chromosomal marker on a chromosome; also, a stretch of DNA at a particular place on a particular chromosome. The use of Gene Locus is sometimes restricted to mean regions of DNA that are expressed.. Promoter regions defined as following: DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the Promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.. Long Intergenic Non-Protein Coding RNA defined as following: A molecule of RNA 200-17000 nucleotides in length that is transcribed by non-protein coding areas of DNA. These ribonucleotides may play a role in a variety of biological processes.. yeast defined as following: A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" yeast. The dried form is used as a dietary supplement..", "label": "yes"} {"original_question": "Are ICAMS, Intracellular Adhesion Molecules, part of the immunoglobulin superfamily?", "id": "converted_3290", "sentence1": "Are ICAMS, Intracellular Adhesion Molecules, part of the immunoglobulin superfamily?", "sentence2": "It has now been shown that adhesion molecules, particularly those of the immunoglobulin super family (e.g. Intercellular adhesion molecule 1, Vascular Cell Adhesion Molecule-1 and Platelet Endothelial Cell Adhesion Molecule, human),, Intercellular Adhesion Molecule-3 (ICAM-3, also known as Lymphocyte antigen Lymphocyte antigen CD50), a human leukocyte-restricted immunoglobulin super-family (IgSF) member, has previously been implicated in apoptotic cell clearance,, Intercellular adhesion molecule-1 (Intercellular adhesion molecule 1), vascular cell adhesion molecule-1 (Vascular Cell Adhesion Molecule-1) and platelet-endothelial cell adhesion molecule-1 (Platelet Endothelial Cell Adhesion Molecule, human) are members of the immunoglobulin super-family which are present on the Surface of Endothelial Cells., ICAM4 gene (Intercellular adhesion molecule 1) is an adhesion-related molecule belonging to the immunoglobulin superfamily., Immunologically important Integrins ligands are the intercellular adhesion molecules (Improved Chemical Agent Monitors), immunoglobulin superfamily members present on inflamed Endothelium and Antigen-Presenting Cells., The intercellular adhesion molecules (Improved Chemical Agent Monitors) are members of the immunoglobulin superfamily and have been identified to play major roles in Inflammation and immune responses., The intercellular adhesion molecules (Improved Chemical Agent Monitors) are members of the immunoglobulin superfamily and have been identified to play major roles in Inflammation and immune responses., Intercellular adhesion molecule 1 is a member of immunoglobulin-like superfamily of adhesion molecules that binds Lymphocyte Function-Associated Antigen-1 to mediate Specimen Source Codes - Leukocytes adhesion and migration., Immunologically important Integrins ligands are the intercellular adhesion molecules (Improved Chemical Agent Monitors), immunoglobulin superfamily members present on inflamed Endothelium and Antigen-Presenting Cells., The immunoglobulin superfamily includes leukocyte function antigen-2 (CD2 Antigens Antigens wt Allele or CD2 Antigens Antigens), leukocyte function antigen-3 (Lymphocyte Function-Associated Antigen 3, human or CD58), intercellular adhesion molecules (Improved Chemical Agent Monitors), vascular adhesion molecule-1 (Vascular Cell Adhesion Molecule-1), platelet-endothelial cell adhesion molecule-1 (PE-CAM-1), and mucosal addressin cell adhesion molecule-1 (MADCAM1 protein, human)., The main ligand binding site of Lymphocyte Function-Associated Antigen-1 is the I-domain, which recognizes intercellular adhesion molecules (Improved Chemical Agent Monitors), members of the immunoglobulin superfamily., Intercellular Adhesion Molecules (Improved Chemical Agent Monitors) are structurally related members of the immunoglobulin supergene family and are ligands for the beta2 Integrins molecules present on Specimen Source Codes - Leukocytes., Intercellular Adhesion Molecules (Improved Chemical Agent Monitors) belong to the immunoglobulin superfamily and participate in diverse cellular processes including host-pathogen interactions., Members of the immunoglobulin superfamily of endothelial adhesion molecules, vascular cell adhesion molecule (Vascular Cell Adhesion Molecule-1) and intercellular cell adhesion molecule (Intercellular adhesion molecule 1), participate in leukocyte adhesion to the Endothelium and play an important role in all stages of Arteriosclerosis., Members of the immunoglobulin superfamily of endothelial adhesion molecules, vascular cell adhesion molecule (Vascular Cell Adhesion Molecule-1) and intercellular cell adhesion molecule (ICAM- 1), strongly participate in leukocyte adhesion to the Endothelium and play an important role in all stages of Atherogenesis., Intercellular adhesion molecule-3 (ICAM-3, Lymphocyte antigen Lymphocyte antigen CD50), a member of the immunoglobulin gene superfamily, is a major ligand for the lymphocyte function-associated antigen 1 (Lymphocyte Function-Associated Antigen-1, CD18/CD11a) in the resting immune system and plays a role as a signaling and costimulatory molecule on T-Lymphocyte., Expression of the immunoglobulin superfamily molecules MUC18/MCAM and Intercellular adhesion molecule 1 are associated with Primary Neoplasm and metastases.[SEP]Relations: heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules has relations: bioprocess_protein with ICAM1, bioprocess_protein with ICAM1. alpha9-beta1 Integrins-vascular cell adhesion molecule-1 complex has relations: cellcomp_protein with VCAM1, cellcomp_protein with VCAM1. Integrins binding has relations: molfunc_protein with ICAM3, molfunc_protein with ICAM3, molfunc_protein with ICAM2, molfunc_protein with ICAM2. cell Surface has relations: cellcomp_protein with ICAM1, cellcomp_protein with ICAM1. Definitions: Vascular Cell Adhesion Molecule-1 defined as following: Cytokine-induced cell adhesion molecule present on activated Endothelial Cells, tissue macrophages, dendritic cells, bone marrow fibroblasts, myoblasts, and myotubes. It is important for the recruitment of Specimen Source Codes - Leukocytes to sites of Inflammation. (From Pigott & Power, The Adhesion Molecule FactsBook, 1993, p154). Arteriosclerosis defined as following: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. Antigen-Presenting Cells defined as following: A heterogeneous group of immunocompetent cells that mediate the cellular immune response by processing and presenting antigens to the T-cells. Traditional Antigen-Presenting Cells include MACROPHAGES; DENDRITIC CELLS; LANGERHANS CELLS; and B-LYMPHOCYTES. FOLLICULAR DENDRITIC CELLS are not traditional Antigen-Presenting Cells, but because they hold antigen on their cell Surface in the form of IMMUNE COMPLEXES for B-cell recognition they are considered so by some authors.. Lymphocyte Function-Associated Antigen-1 defined as following: An Integrins heterodimer widely expressed on cells of hematopoietic origin. CD11A ANTIGEN comprises the alpha chain and the CD18 antigen (CD18 ANTIGENS) the beta chain. Lymphocyte function-associated antigen-1 is a major receptor of T-CELLS; B-CELLS; and GRANULOCYTES. It mediates the leukocyte adhesion reactions underlying cytolytic conjugate formation, helper T-cell interactions, and antibody-dependent killing by NATURAL KILLER CELLS and granulocytes. Intracellular adhesion molecule-1 has been defined as a ligand for lymphocyte function-associated antigen-1.. Endothelium defined as following: A layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body.. Lymphocyte Function-Associated Antigen 3, human defined as following: Lymphocyte function-associated antigen 3 (250 aa, ~28 kDa) is encoded by the human CD58 gene. This protein is involved in the adhesion and activation of T-lymphocytes.. Intercellular Adhesion Molecule-3 defined as following: A membrane glycoprotein and cell adhesion molecule expressed by LEUKOCYTES that contains multiple Ig-like domains. It is a ligand for Lymphocyte Function-Associated Antigen-1 (Integrins alphaLbeta2) and Integrins alpha-D/beta-2. Its interaction with Lymphocyte Function-Associated Antigen-1 may play a role in the PHAGOCYTOSIS of NEUTROPHILS by MACROPHAGES following APOPTOSIS.. Primary Neoplasm defined as following: A tumor at the original site of origin.. Intercellular adhesion molecule 1 defined as following: A cell-Surface ligand involved in leukocyte adhesion and Inflammation. Its production is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue.. CD2 Antigens wt Allele defined as following: Human CD2 Antigens wild-type allele is located within 1p13 and is approximately 15 kb in length. This allele, which encodes T-cell Surface antigen CD2 Antigens, plays a role in immune recognition and facilitates helper T lymphocyte contact with Antigen-Presenting Cells.. MADCAM1 protein, human defined as following: Mucosal addressin cell adhesion molecule 1 (382 aa, ~40 kDa) is encoded by the human MADCAM1 gene. This protein plays a role in both lymphocyte migration and Integrins-mediated cell adhesion.. Platelet Endothelial Cell Adhesion Molecule, human defined as following: Platelet endothelial cell adhesion molecule (738 aa, ~83 kDa) is encoded by the human PECAM1 gene. This protein is involved in leukocyte transendothelial migration and angiogenesis.. CD2 Antigens defined as following: Glycoprotein members of the immunoglobulin superfamily which participate in T-cell adhesion and activation. They are expressed on most peripheral T-lymphocytes, natural killer cells, and thymocytes, and function as co-receptors or accessory molecules in the T-cell receptor complex.. T-Lymphocyte defined as following: Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.. Integrins defined as following: A family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors (RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation.. Surface defined as following: The extended two-dimensional outer boundary of a three-dimensional object.. Endothelial Cells defined as following: Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer..", "label": "yes"} {"original_question": "Is PTEN involved in follicular thyroid carcinoma?", "id": "converted_150", "sentence1": "Is PTEN protein, human involved in Follicular THYROID DIAGNOSTIC RADIOPHARMACEUTICALS carcinoma?", "sentence2": "Two of the 259 patients (0.8%), with both Follicular THYROID DIAGNOSTIC RADIOPHARMACEUTICALS carcinoma and Large head (disorder), were found to carry a germline mutation in the PTEN protein, human protein, human gene. The PTEN protein, human protein, human mutation frequency in unselected cases of Follicular THYROID DIAGNOSTIC RADIOPHARMACEUTICALS carcinoma was 4.8%, The frequency of germline pathogenic PTEN protein, human protein, human Gene Mutation in an unselected series of patients with Ditiocarb is relatively low, but it is enriched by considering Follicular histology and Large head (disorder), Similarly, there is increasing evidence demonstrating that Gene Mutation leading to activation of the phosphatidylinositol 3- kinase (PI3K)/AKT effectors -PTEN protein, human protein, human and PI3KCa- are essential for the pathogenesis of Follicular THYROID DIAGNOSTIC RADIOPHARMACEUTICALS carcinoma (emtricitabine), A single male with Follicular THYROID DIAGNOSTIC RADIOPHARMACEUTICALS carcinoma from one of these 64 (2%) CS-like families harboured a germline point mutation, c.209T-->C, Similarly, there is increasing evidence demonstrating that Gene Mutation leading to activation of the phosphatidylinositol 3- kinase (PI3K)/AKT effectors -PTEN protein, human protein, human and PI3KCa- are essential for the pathogenesis of Follicular THYROID DIAGNOSTIC RADIOPHARMACEUTICALS carcinoma (emtricitabine)., The transcriptional silencing of PTEN protein, human protein, human was significantly associated with the anaplastic subtype, suggesting that PTEN protein, human protein, human is involved in the carcinogenesis of highly malignant or late-stage THYROID DIAGNOSTIC RADIOPHARMACEUTICALS cancers, whereas this particular mechanism appears to be of minor importance in differentiated Follicular THYROID DIAGNOSTIC RADIOPHARMACEUTICALS Neoplasms., These results show a high frequency of PTEN protein, human protein, human promoter hypermethylation, especially in Follicular Neoplasms, suggesting its possible role in THYROID DIAGNOSTIC RADIOPHARMACEUTICALS tumorigenesis, Our findings suggest that the PTEN protein, human protein, human tumor suppressor gene is occasionally inactivated in sporadic Follicular THYROID DIAGNOSTIC RADIOPHARMACEUTICALS Neoplasms, Germline Gene Mutation in the tumor suppressor gene PTEN protein, human protein, human, which encodes a Dual-Specificity Phosphatases, have been found in up to 80% of patients with COWDEN SYNDROME 5 suggesting a role of PTEN protein, human protein, human in the pathogenesis of Follicular THYROID DIAGNOSTIC RADIOPHARMACEUTICALS Neoplasms, The most common neoplasms in Hamartoma Syndrome, Multiple patients arise in the Breast, Skin Specimen Source Code, and THYROID DIAGNOSTIC RADIOPHARMACEUTICALS (Follicular subtype), The transcriptional silencing of PTEN protein, human protein, human was significantly associated with the anaplastic subtype, suggesting that PTEN protein, human protein, human is involved in the carcinogenesis of highly malignant or late-stage THYROID DIAGNOSTIC RADIOPHARMACEUTICALS cancers, whereas this particular mechanism appears to be of minor importance in differentiated Follicular THYROID DIAGNOSTIC RADIOPHARMACEUTICALS Neoplasms[SEP]Relations: PTEN protein, human has relations: disease_protein with THYROID DIAGNOSTIC RADIOPHARMACEUTICALS gland carcinoma, disease_protein with THYROID DIAGNOSTIC RADIOPHARMACEUTICALS gland carcinoma, disease_protein with THYROID DIAGNOSTIC RADIOPHARMACEUTICALS cancer, disease_protein with THYROID DIAGNOSTIC RADIOPHARMACEUTICALS cancer, anatomy_protein_present with THYROID DIAGNOSTIC RADIOPHARMACEUTICALS gland, anatomy_protein_present with THYROID DIAGNOSTIC RADIOPHARMACEUTICALS gland, disease_protein with carcinoma, disease_protein with carcinoma, disease_protein with prostate carcinoma, disease_protein with prostate carcinoma. Definitions: Dual-Specificity Phosphatases defined as following: A sub-class of protein tyrosine phosphatases that contain an additional phosphatase activity which cleaves phosphate ester bonds on SERINE or THREONINE residues that are located on the same protein.. PTEN protein, human defined as following: Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN protein, human (403 aa, ~47 kDa) is encoded by the human PTEN protein, human gene. This protein plays a role in signaling and as both a dual-specificity phosphoprotein phosphatase and a lipid phosphatase.. emtricitabine defined as following: A synthetic fluoro derivative of thiacytidine with potent antiviral activity. Emtricitabine is phosphorylated to form emtricitabine 5'-triphosphate within the cell. This metabolite inhibits the activity of human immunodeficiency virus (HIV) reverse transcriptase both by competing with the natural substrate deoxycytidine 5'-triphosphate and by incorporation into viral DNA causing a termination of DNA chain elongation (due to the lack of the essential 3'-OH group).. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Follicular THYROID DIAGNOSTIC RADIOPHARMACEUTICALS carcinoma defined as following: An adenocarcinoma of the THYROID DIAGNOSTIC RADIOPHARMACEUTICALS gland, in which the cells are arranged in the form of follicles. (From Dorland, 27th ed). Breast defined as following: In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.. THYROID DIAGNOSTIC RADIOPHARMACEUTICALS cancers defined as following: A primary or metastatic malignant neoplasm affecting the THYROID DIAGNOSTIC RADIOPHARMACEUTICALS gland.. Ditiocarb defined as following: A chelating agent that has been used to mobilize toxic metals from the tissues of humans and experimental animals. It is the main metabolite of DISULFIRAM.. PTEN protein, human gene defined as following: This gene plays a role in signal transduction and apoptosis. It is also involved in the regulation of cell cycle progression.. Large head (disorder) defined as following: A congenital abnormality in which the occipitofrontal circumference is greater than two standard deviations above the mean for a given age. It is associated with HYDROCEPHALUS; SUBDURAL EFFUSION; ARACHNOID CYSTS; or is part of a genetic condition (e.g., ALEXANDER DISEASE; SOTOS SYNDROME).. Hamartoma Syndrome, Multiple defined as following: A hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Facial trichilemmomas and papillomatous papules of the oral mucosa are the most characteristic lesions. Individuals with this syndrome have a high risk of BREAST CANCER; THYROID CANCER; and ENDOMETRIAL CANCER. This syndrome is associated with Gene Mutation in the gene for PTEN protein, human PHOSPHATASE.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA..", "label": "yes"} {"original_question": "Is SATB1 necessary for T-cell maturation?", "id": "converted_3697", "sentence1": "Is DNA-Binding Protein SATB1 necessary for T-cell maturation?", "sentence2": "Special AT-rich binding protein 1 (DNA-Binding Protein DNA-Binding Protein SATB1) Nuclear Proteins, expressed predominantly in T-Lymphocyte, regulates Genes through targeting chromatin remodeling during T-cell maturation., the transcription factor DNA-Binding Protein DNA-Binding Protein SATB1 that regulates the T-cell maturation, DNA-Binding Protein DNA-Binding Protein SATB1 is a transcriptional regulator controlling the gene expression that is essential in the maturation of the immune T-cell. , Special AT-rich sequence binding protein 1 (DNA-Binding Protein DNA-Binding Protein SATB1) regulates gene expression essential in immune T-cell maturation and switching of fetal globin species, by binding to Matrix Attachment Regions (MARS1 gene) of DNA and inducing a local chromatin remodeling. [SEP]Relations: Tat protein binding has relations: molfunc_protein with GABARAPL1, molfunc_protein with GABARAPL1, molfunc_protein with NPM1, molfunc_protein with NPM1, molfunc_protein with SMARCB1, molfunc_protein with SMARCB1, molfunc_protein with DLL1, molfunc_protein with DLL1, molfunc_protein with DNAJA1, molfunc_protein with DNAJA1. Definitions: T-Lymphocyte defined as following: Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T-Lymphocyte sensitized to that antigen.. DNA-Binding Protein SATB1 defined as following: DNA-Binding Protein DNA-Binding Protein SATB1 (763 aa, ~86 kDa) is encoded by the human DNA-Binding Protein SATB1 gene. This protein binds DNA and may be involved in the regulation of transcription.. Nuclear Proteins defined as following: Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Matrix Attachment Regions defined as following: Regions of the CHROMATIN or DNA that bind to the NUCLEAR MATRIX. They are found in INTERGENIC DNA, especially flanking the 5' ends of Genes or clusters of Genes. Many of the regions that have been isolated contain a bipartite sequence motif called the MAR/SAR recognition signature sequence that binds to MATRIX ATTACHMENT REGION BINDING PROTEINS.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Is lambrolizumab effective for treatment of patients with melanoma ?", "id": "converted_375", "sentence1": "Is pembrolizumab effective for treatment of patients with Melanocytic neoplasm ?", "sentence2": "However, through parallel efforts that have showcased the efficacy of small-molecule BRAF protein, human protein, human and MAPK-ERK Kinases (Mitogen-Activated Protein Kinase Kinases) inhibitors, as well as the Immune Checkpoint Inhibitors, namely ipilimumab and the anti-PD1/PDL1 Antibodies, in vitro diagnostic (pembrolizumab, nivolumab, MPDL3280), an opportunity exists to transform the treatment of Melanocytic neoplasm specifically and Primary malignant neoplasm generally by exploring rational combinations of molecularly targeted therapies, immunotherapies, and molecular targeted therapies with immunotherapies. , Programmed death-1 receptor (PDCD1 wt Allele)/its ligand (CD274 wt Allele) Antibodies, in vitro diagnostic have changed the landscape in oncology in 2013. The most mature results have been obtained in advanced Melanocytic neoplasm patients. , Merck's pembrolizumab (MK-3475) monoclonal antibody received \"Breakthrough Therapy\" designation from the U.S. Food and Drug Administration in April for treating patients with advanced Melanocytic neoplasm., The programmed death 1 (PDCD1 wt Allele) receptor is a negative regulator of Effector T-Lymphocyte mechanisms that limits immune responses against Primary malignant neoplasm. We tested the anti-PDCD1 wt Allele antibody pembrolizumab (previously known as MK-3475) in patients with advanced Melanocytic neoplasm. , In patients with advanced Melanocytic neoplasm, including those who had had disease progression while they had been receiving ipilimumab, treatment with pembrolizumab resulted in a high rate of sustained tumor regression, with mainly grade 1 or 2 Toxic effect effects. , Because of all these reasons PDCD1 wt Allele/CD274 wt Allele Antibodies, in vitro diagnostic are considered 'Pharmacologic Substance of the year'.[SEP]Relations: Pembrolizumab has relations: drug_drug with Catumaxomab, drug_drug with Catumaxomab, drug_drug with Basiliximab, drug_drug with Basiliximab, drug_drug with Golimumab, drug_drug with Golimumab, drug_drug with Afelimomab, drug_drug with Afelimomab, drug_drug with Ibalizumab, drug_drug with Ibalizumab. Definitions: Mitogen-Activated Protein Kinase Kinases defined as following: A dual-specific protein kinase family whose members are components in protein kinase cascades activated by diverse stimuli. These MAPK kinases phosphorylate MITOGEN-ACTIVATED PROTEIN KINASES and are themselves phosphorylated by MAP KINASE KINASE KINASES. JNK kinases (also known as SAPK kinases) are a subfamily.. Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Melanocytic neoplasm defined as following: A benign or malignant, primary or metastatic neoplasm affecting the melanocytes.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. pembrolizumab defined as following: A humanized monoclonal immunoglobulin (Ig) G4 antibody directed against human cell surface receptor PDCD1 wt Allele (programmed death-1 or programmed cell death-1) with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, pembrolizumab binds to PDCD1 wt Allele, an inhibitory signaling receptor expressed on the surface of activated T cells, and blocks the binding to and activation of PDCD1 wt Allele by its ligands, which results in the activation of T-cell-mediated immune responses against tumor cells. The ligands for PDCD1 wt Allele include programmed cell death ligand 1 (CD274 wt Allele), overexpressed on certain Primary malignant neoplasm cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on APCs. Activated PDCD1 wt Allele negatively regulates T-cell activation and plays a key role in in tumor evasion from host immunity.. CD274 wt Allele defined as following: Human CD274 wild-type allele is located in the vicinity of 9p24 and is approximately 20 kb in length. This allele, which encodes programmed cell death 1 ligand 1 protein, plays a role in the regulation of T cell stimulation and proliferation.. Effector T-Lymphocyte defined as following: A mature T-lymphocyte that has differentiated into a form that can mount an antigen-specific immune response.. ipilimumab defined as following: A recombinant human immunoglobulin (Ig) G1 monoclonal antibody directed against the human T-cell receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA4), with immune checkpoint inhibitory and antineoplastic activities. Ipilimumab binds to CTLA4 expressed on T-cells and inhibits the CTLA4-mediated downregulation of T-cell activation. This leads to a cytotoxic T-lymphocyte (CTL)-mediated immune response against Primary malignant neoplasm cells. CTLA4, an inhibitory receptor and member of the immunoglobulin superfamily, plays a key role in the downregulation of the immune system.. Immune Checkpoint Inhibitors defined as following: An agent that inhibits any of the immune checkpoint inhibitory proteins.. PDCD1 wt Allele defined as following: Human PDCD1 wild-type allele is located in the vicinity of 2q37.3 and is approximately 9 kb in length. This allele, which encodes programmed cell death protein 1, plays a role in the modulation of both apoptosis and cellular immunity. Mutation of the gene is associated with systemic lupus erythematosus type 2.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. nivolumab defined as following: A fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PDCD1 wt Allele, PCD-1) with immune checkpoint inhibitory and antineoplastic activities. Upon administration, nivolumab binds to and blocks the activation of PDCD1 wt Allele, an immunoglobulin superfamily (IgSF) transmembrane protein, by its ligands programmed cell death ligand 1 (CD274 wt Allele), which is overexpressed on certain Primary malignant neoplasm cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on antigen-presenting cells (APCs). This results in the activation of T-cells and cell-mediated immune responses against tumor cells. Activated PDCD1 wt Allele negatively regulates T-cell activation and plays a key role in tumor evasion from host immunity.. BRAF protein, human defined as following: Serine/threonine-protein kinase B-raf (766 aa, ~84 kDa) is encoded by the human BRAF protein, human gene. This protein plays a role in protein phosphorylation, mitogenesis and neuronal signal transduction..", "label": "yes"} {"original_question": "Is oxidative stress affected by FOXO expression?", "id": "converted_259", "sentence1": "Is oxidative stress affected by FOXO expression?", "sentence2": "Forkhead-box class O (FOXO Family) TRANSCRIPTION FACTOR regulate mechanisms of cellular aging, including protein quality control, autophagy and defenses against oxidative stress., Statin-mediated upregulation of KL wt Allele expression and differential regulation of FOXO Family expression promote resistance to CsA-induced oxidative stress., FOXO Family expression suppressed the ROS-induced apoptosis in differentiated 3T3-L1 Cells via the expression of ROS-scavenging ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS., Differential expression of FOXO1 gene gene and FOXO3A protein, Homo sapiens confers resistance to oxidative cell death upon endometrial decidualization., We demonstrate that Homo sapiens endometrial stromal Cells become extraordinarily resistant to oxidative stress-induced apoptosis upon decidualization in response to cyclophosphamide/doxorubicin/methotrexate/procarbazine protocol and progesterone signaling. This differentiation process is associated with the induction of the forkhead transcription factor FOXO1 gene gene, which in turn increases the expression of the Mitochondrial Inheritance antioxidant manganese superoxide dismutase., Comparative analysis demonstrated that hydrogen peroxide, a source of free radicals, strongly induces FOXO3A protein, Homo sapiens mRNA and protein expression in undifferentiated Homo sapiens endometrial stromal Cells but not in decidualized Cells., These results suggest that the induction of FOXO1 gene gene may enhance the ability of decidualized Cells to prevent oxidative damage while the simultaneous repression of FOXO3A protein, Homo sapiens expression disables the signaling pathway responsible for oxidative cell death. The differential regulation of FOXO expression provides the Decidua with a robust system capable of coping with prolonged episodes of oxidative stress during pregnancy.[SEP]Relations: Decidua has relations: anatomy_protein_present with FOXO3, anatomy_protein_present with FOXO3, anatomy_protein_present with FOXO4, anatomy_protein_present with FOXO4, anatomy_protein_present with FOXO1 gene, anatomy_protein_present with FOXO1 gene, anatomy_protein_present with FOXN3, anatomy_protein_present with FOXN3. transcription factor binding has relations: molfunc_protein with FOXF2, molfunc_protein with FOXF2. Definitions: FOXO Family defined as following: A subfamily within the forkhead box (FOX) protein family, which is a family of TRANSCRIPTION FACTOR that contain a forkhead DNA-binding domain. FOXO proteins regulate apoptosis, cell-cycle progression, oxidative-stress resistance, and tumor suppression. The transcriptional promoter activity of these factors is regulated by post-translational modifications, such as phosphorylation, acetylation, and monoubiquitination.. KL wt Allele defined as following: Human KL wild-type allele is located in the vicinity of 13q12 and is approximately 50 kb in length. This allele, which encodes KL wt Allele protein, plays a role in both signal transduction and the modulation of aging.. FOXO1 gene defined as following: This gene is involved in transcriptional regulation and may play a role in myogenic growth and differentiation.. Homo sapiens defined as following: Members of the species Homo sapiens.. hydrogen peroxide defined as following: A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials.. FOXO3A protein, human defined as following: Forkhead box protein O3 (673 aa, ~71 kDa) is encoded by the Homo sapiens FOXO3 gene. This protein is involved in the modulation of transcription, apoptosis and embryonic pattern formation.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Mitochondrial Inheritance defined as following: The distribution of mitochondria, including the Mitochondrial Inheritance genome, into daughter Cells after mitosis or meiosis, mediated by interactions between mitochondria and the cytoskeleton. [GOC:mcc, PMID:10873824, PMID:11389764]. cyclophosphamide/doxorubicin/methotrexate/procarbazine protocol defined as following: A chemotherapy regimen consisting of cyclophosphamide, doxorubicin, methotrexate, and procarbazine that may be used in the treatment of non-small cell lung cancer (NSCLC).. Decidua defined as following: The hormone-responsive glandular layer of ENDOMETRIUM that sloughs off at each menstrual flow (Decidua menstrualis) or at the termination of pregnancy. During pregnancy, the thickest part of the Decidua forms the maternal portion of the PLACENTA, thus named Decidua placentalis. The thin portion of the Decidua covering the rest of the embryo is the Decidua capsularis.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. FOXO defined as following: A subfamily within the forkhead box (FOX) protein family, which is a family of TRANSCRIPTION FACTOR that contain a forkhead DNA-binding domain. FOXO proteins regulate apoptosis, cell-cycle progression, oxidative-stress resistance, and tumor suppression. The transcriptional promoter activity of these factors is regulated by post-translational modifications, such as phosphorylation, acetylation, and monoubiquitination..", "label": "yes"} {"original_question": "Is it possible to determine the proteome of a formalin fixed and paraffin embedded (FFPE) tissue?", "id": "converted_1468", "sentence1": "Is it possible to determine the proteome of a formalin fixed and paraffin embedded (FFPE) Tissue Specimen Code?", "sentence2": "ver the last few years, advances in methodology have made it possible to recover Peptides from FFPE tissues that yield a reasonable representation of the Proteins recovered from identical fresh or frozen specimens., Thus, laser capture microdissection of FFPE Tissue Specimen Code coupled with downstream proteomic analysis is a valid approach, Qualitative proteome profiling of formalin-fixed, paraffin-embedded (FFPE) Tissue Specimen Code is advancing the field of clinical proteomics., Recent improvements in proteomics technologies, from the 2D gel analysis of intact Proteins to the \"shotgun\" quantification of Peptides and the use of isobaric tags for absolute and relative quantification (iTRAQ) method, have made the analysis of FFPE tissues possible., The ability to investigate the proteome of formalin-fixed, paraffin-embedded (FFPE) tissues can be considered a major recent achievement in the field of clinical proteomics., The label-free approach enables the quantitative measurement of radiation-induced alterations in FFPE Tissue Specimen Code and facilitates retrospective biomarker identification using clinical archives., Proteomic analysis of formalin-fixed paraffin-embedded Pancreatic Hormones Tissue Specimen Code using liquid chromatography tandem mass spectrometry., We report that differentially expressed Proteins can be identified among FFPE Tissue Specimen Code specimens originating from individuals with different Pancreatic Hormones histologic findings., Formalin-fixed paraffin-embedded (FFPE) proteome analysis using gel-free and gel-based proteomics., This study will facilitate the development of future proteomic analysis of FFPE Tissue Specimen Code and provide a tool for the validation in archival samples of biomarkers of exposure, prognosis and disease., The CAAR method presented here complements previously described antigen-retrieval protocols and is an important step in being able to fully analyze the proteome of archived FFPE Tissue Specimen Code., Proteome, phosphoproteome, and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded Tissue Specimen Code and analyzable by high-resolution mass spectrometry., It has only recently been shown that Proteins in FFPE tissues can be identified by mass spectrometry-based proteomics but analysis of post-translational modifications is thought to be difficult or impossible, Results from the FFPE-FASP procedure do not indicate any discernible changes due to storage time, hematoxylin staining or laser capture microdissection., Thus, FFPE biobank material can be analyzed by quantitative proteomics at the level of Proteins and post-translational modifications., A novel Tissue Specimen Code microdissection technique has been developed and combined with a method to extract soluble Peptides directly from FFPE Tissue Specimen Code for mass spectral analysis of Malignant neoplasm of prostate (Patient-Controlled Analgesia) and benign prostate hyperplasia (Benign Prostatic Hyperplasia). Hundreds of Proteins from Patient-Controlled Analgesia and Benign Prostatic Hyperplasia Tissue Specimen Code were identified,, espite using Tissue Specimen Code blocks stored for as many as 28 years, high confidence and comparative proteome analysis between the Uterine Fibroids and the Malignant neoplasm of soft Tissue Specimen Code is achieved., These findings demonstrate that formalin fixation, paraffin processing, and Lymphocytic Choriomeningitis do not negatively impact protein quality and quantity as determined by MS and that FFPE samples are amenable to global proteomic analysis., Protein extraction of formalin-fixed, paraffin-embedded Tissue Specimen Code enables robust proteomic profiles by mass spectrometry.[SEP]Relations: benign prostatic hyperplasia (disease) has relations: disease_protein with FGF7, disease_protein with FGF7, contraindication with Pentoxyverine, contraindication with Pentoxyverine, contraindication with Methylene blue, contraindication with Methylene blue. specialized connective Tissue Specimen Code has relations: anatomy_anatomy with connective Tissue Specimen Code, anatomy_anatomy with connective Tissue Specimen Code. benign neoplasm of prostate has relations: disease_disease with prostatic adenoma, disease_disease with prostatic adenoma. Definitions: Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Malignant neoplasm of prostate defined as following: A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas.. Peptides defined as following: Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of Peptides that can form into complex structures such as ENZYMES and RECEPTORS.. Malignant neoplasm of soft Tissue Specimen Code defined as following: A malignant neoplasm arising exclusively from the soft tissues.. Pancreatic Hormones defined as following: Peptide hormones secreted into the blood by cells in the ISLETS OF LANGERHANS of the pancreas. The alpha cells secrete glucagon; the beta cells secrete insulin; the delta cells secrete somatostatin; and the PP cells secrete Pancreatic Hormones polypeptide.. Patient-Controlled Analgesia defined as following: Relief of PAIN, without loss of CONSCIOUSNESS, through ANALGESIC AGENTS administered by the patients. It has been used successfully to control POSTOPERATIVE PAIN, during OBSTETRIC LABOR, after BURNS, and in TERMINAL CARE. The choice of agent, dose, and lockout interval greatly influence effectiveness. The potential for overdose can be minimized by combining small bolus doses with a mandatory interval between successive doses (lockout interval).. Uterine Fibroids defined as following: A benign smooth muscle neoplasm arising from the body of the uterus. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern.. Lymphocytic Choriomeningitis defined as following: A form of meningitis caused by LYMPHOCYTIC CHORIOMENINGITIS VIRUS. MICE and other rodents serve as the natural hosts, and infection in humans usually occurs through inhalation or ingestion of infectious particles. Clinical manifestations include an influenza-like syndrome followed by stiff neck, alterations of mentation, ATAXIA, and incontinence. Maternal infections may result in fetal malformations and injury, including neonatal HYDROCEPHALUS, aqueductal stenosis, CHORIORETINITIS, and MICROCEPHALY. (From Joynt, Clinical Neurology, 1996, Ch26, pp1-3). Benign Prostatic Hyperplasia defined as following: A disease caused by hyperplastic process of non-transformed prostatic cells.. formalin-fixed paraffin-embedded Tissue Specimen Code defined as following: Refers to a process where a sample is preserved with formalin and then embedded into a paraffin block for sectioning..", "label": "yes"} {"original_question": "Is Meis1 implicated in microphthalmia?", "id": "converted_2008", "sentence1": "Is Homeobox Protein Meis1, Human implicated in Microphthalmos?", "sentence2": "Homeobox Protein Homeobox Protein Meis1, Human, Human coordinates a network of genes implicated in Eye Specimen Source Code development and Microphthalmos., Here we show that haploinsufficiency of Homeobox Protein Homeobox Protein Meis1, Human, Human, which encodes a TRANSCRIPTION FACTOR with evolutionarily conserved expression in the Trunk of embryo, Head>Brain and sensory organs, including the Eye Specimen Source Code, causes microphthalmic traits and Visual Impairment in adult CASP14 gene., We propose that Homeobox Protein Homeobox Protein Meis1, Human, Human is at the core of a genetic network implicated in Eye Specimen Source Code patterning/Microphthalmos, and represents an additional candidate for syndromic cases of these ocular malformations., We propose that Homeobox Protein Homeobox Protein Meis1, Human, Human is at the core of a genetic network implicated in Eye Specimen Source Code patterning/Microphthalmos, and represents an additional candidate for syndromic cases of these ocular malformations., In the Eye Specimen Source Code primordium, Homeobox Protein Homeobox Protein Meis1, Human, Human coordinates, in a dose-dependent manner, retinal proliferation and differentiation by regulating genes responsible for Homo sapiens Microphthalmos and components of the Notch signaling pathway., Homeobox Protein Homeobox Protein Meis1, Human, Human coordinates a network of genes implicated in Eye Specimen Source Code development and Microphthalmos, We propose that Homeobox Protein Homeobox Protein Meis1, Human, Human is at the core of a genetic network implicated in Eye Specimen Source Code patterning/Microphthalmos, and represents an additional candidate for syndromic cases of these ocular malformations. © 2015, In the Eye Specimen Source Code primordium, Homeobox Protein Homeobox Protein Meis1, Human, Human coordinates, in a dose-dependent manner, retinal proliferation and differentiation by regulating genes responsible for Homo sapiens Microphthalmos and components of the Notch signaling pathway, We propose that Homeobox Protein Homeobox Protein Meis1, Human, Human is at the core of a genetic network implicated in Eye Specimen Source Code patterning/Microphthalmos, and represents an additional candidate for syndromic cases of these ocular malformations. © 2015., In the Eye Specimen Source Code primordium, Homeobox Protein Homeobox Protein Meis1, Human, Human coordinates, in a dose-dependent manner, retinal proliferation and differentiation by regulating genes responsible for Homo sapiens Microphthalmos and components of the Notch signaling pathway., Homeobox Protein Homeobox Protein Meis1, Human, Human coordinates a network of genes implicated in Eye Specimen Source Code development and Microphthalmos.[SEP]Relations: Microphthalmos has relations: disease_protein with HMX1, disease_protein with HMX1, disease_protein with TENM3, disease_protein with TENM3, disease_protein with RBP4, disease_protein with RBP4, disease_protein with CRB1, disease_protein with CRB1, disease_protein with BEST1, disease_protein with BEST1. Definitions: TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. Homo sapiens defined as following: Members of the species Homo sapiens.. Homeobox Protein Meis1, Human defined as following: MEIS1 Homeobox Protein Homeobox protein Homeobox Protein Meis1, Human (390 aa, ~43 kDa) is encoded by the Homo sapiens MEIS1 gene. This protein plays a role in transcriptional regulation in hematopoietic and vascular cells.. Microphthalmos defined as following: Congenital or developmental anomaly in which the eyeballs are abnormally small.. Visual Impairment defined as following: Sight that is impaired..", "label": "yes"} {"original_question": "Has the protein SIRT2 been associated to cervical cancer?", "id": "converted_3068", "sentence1": "Has the protein Sirtuin 2 been associated to cervical cancer?", "sentence2": " A progressive increase in the expression of both Sirtuin 2 and NAD-Dependent Protein Deacetylase Sirtuin-7 was noted during cancer progression in the following order: normal < preneoplasia < cancer., We demonstrate that treatment of cervical cancer cells with a RhoGDIα-derived K52-trifluoroacetylated, substrate-derived peptidic sirtuin PPP1R1A gene severely impairs cell proliferation. [SEP]Relations: PPP1R1A has relations: disease_protein with liver cancer, disease_protein with liver cancer, protein_protein with ACTA2, protein_protein with ACTA2, protein_protein with ZPBP2, protein_protein with ZPBP2, anatomy_protein_present with spinal cord, anatomy_protein_present with spinal cord. NAD-dependent protein deacetylase activity has relations: molfunc_protein with Sirtuin 2, molfunc_protein with Sirtuin 2. Definitions: NAD-Dependent Protein Deacetylase Sirtuin-7 defined as following: NAD-dependent protein deacetylase sirtuin-7 (400 aa, ~45 kDa) is encoded by the human NAD-Dependent Protein Deacetylase Sirtuin-7 gene. This protein plays a role in protein deacetylation.. Sirtuin 2 defined as following: A sirtuin family member found primarily in the CYTOPLASM. It is a multifunctional enzyme that contains a NAD-dependent deacetylase activity that is specific for HISTONES and a mono-ADP-ribosyltransferase activity.. cervical cancer defined as following: A primary or metastatic malignant neoplasm involving the cervix..", "label": "yes"} {"original_question": "Is mesothelioma caused by asbestos exposure?", "id": "converted_3506", "sentence1": "Is mesothelioma caused by asbestos exposure?", "sentence2": "Malignant mesothelioma is a rare and aggressive pleural or peritoneal tumour almost always caused by exposure to asbestos fibres, Exposure to asbestos can cause malignant mesothelioma 30-40 years after exposure., Malignant Mesothelioma of the Rat Peritoneum is a rare, aggressive Specimen Source Codes - Specimen Source Codes - tumor arising from the peritoneal lining, induced by asbestos, therapeutic radiation, or germline mutations, According to global estimates, at least 107,000 people die each year from asbestos-related Primary malignant neoplasm of lung, mesothelioma, and Asbestosis resulting from occupational exposure, Malignant mesothelioma is caused by exposure to asbestos, which is known to have carcinogenic effects., Malignant mesothelioma and Primary malignant neoplasm of lung are caused by all major types of asbestos., Exposure to asbestos can cause malignant mesothelioma 30-40 years after exposure., BACKGROUND Malignant mesothelioma caused by asbestos exposure has a long latency period., Asbestos exposure causes Asbestosis and malignant mesothelioma, disorders which remain difficult to cure., Most MPeM is caused by asbestos exposure, Occupational asbestos exposure occurs in many workplaces and is a well-known cause of mesothelioma and Primary malignant neoplasm of lung . , Occupational exposure to asbestos occurs in many workplaces and is well known to cause Asbestosis , Primary malignant neoplasm of lung , and mesothelioma . , Malignant mesothelioma is a rare and aggressive pleural or peritoneal tumour almost always caused by exposure to asbestos fibres., Exposure to asbestos can cause malignant mesothelioma 30-40 years after exposure., Malignant Mesothelioma of the Rat Pleura caused by environmental exposure to asbestos or erionite in rural Turkey: X-Ray Computed Tomography findings in 84 patients., OBJECTIVE\nMalignant Mesothelioma of the Rat Pleura in rural Turkey frequently results from environmental exposure to tremolite or fibrous zeolite (erionite)., Mesothelioma, a rare Specimen Source Codes - Specimen Source Codes - tumor, is highly correlated with asbestos exposure.[SEP]Relations: Asbestosis has relations: disease_phenotype_positive with Lung adenocarcinoma, disease_phenotype_positive with Lung adenocarcinoma. malignant pleural mesothelioma has relations: disease_disease with pleural mesothelioma, disease_disease with pleural mesothelioma, disease_disease with pleural cancer, disease_disease with pleural cancer, disease_disease with pleural sarcomatoid mesothelioma, disease_disease with pleural sarcomatoid mesothelioma. malignant peritoneal mesothelioma has relations: disease_disease with peritoneum cancer, disease_disease with peritoneum cancer. Definitions: Malignant mesothelioma defined as following: A type of mesothelioma with a tendency to metastasize. Most tumors originate from either the PLEURA or PERITONEUM, tumors may also originate in the PERICARDIUM or testicular tissue. It is associated with ASBESTOS exposure. Somatic mutations identified in WT1, BCL10, CDKN2A, NF2, and BAP1 genes are associated with the malignancy. OMIM: 156240.. erionite defined as following: A naturally occurring, fibrous mineral consisting of white, prismatic crystals. Erionite is one of the more common types of zeolites that are found in the earth's crust. This mineral is used as a metal-impregnated catalyst, as a fertilizer, to control odors in livestock production and is used in animal feed, pet litter and horticultural applications. Excessive inhalation of its dust can cause pulmonary fibrosis or silicatosis and prolonged exposure to erionite causes mesothelioma in humans. It is known to be a human carcinogen. (NCI05). Asbestosis defined as following: A form of pneumoconiosis caused by inhalation of asbestos fibers which elicit potent inflammatory responses in the parenchyma of the lung. The disease is characterized by interstitial fibrosis of the lung, varying from scattered sites to extensive scarring of the alveolar interstitium.. tremolite defined as following: A naturally occurring, grayish, fibrous amphibole asbestos mineral and occurs as a contaminant in chrysotile asbestos. Chronic inhalation of its dust may cause Asbestosis and increases the risk of respiratory tract cancer, mesothelioma and other lung cancers. Tremolite Asbestos is a known human carcinogen. (NCI05). X-Ray Computed Tomography defined as following: Tomography using x-ray transmission and a computer algorithm to reconstruct the image.. mesothelioma defined as following: A type of mesothelioma with a tendency to metastasize. Most tumors originate from either the PLEURA or PERITONEUM, tumors may also originate in the PERICARDIUM or testicular tissue. It is associated with ASBESTOS exposure. Somatic mutations identified in WT1, BCL10, CDKN2A, NF2, and BAP1 genes are associated with the malignancy. OMIM: 156240..", "label": "yes"} {"original_question": "Is AND-1/Ctf4 essential for proliferation?", "id": "converted_3544", "sentence1": "Is WDHD1 gene/Ctf4 essential for proliferation?", "sentence2": "WDHD1 gene fork protection function prevents fork resection and is essential for proliferation., WDHD1 gene/Ctf4 bridges the CASK gene helicase and DNA Polymerase I, facilitating replication. Using an inducible degron system in avian Cells, we find that WDHD1 gene depletion is incompatible with proliferation, owing to Cells accumulating in G2 with activated DNA damage checkpoint. Replication without WDHD1 gene causes fork speed slow-down and accumulation of long single-stranded DNA (ssDNA) gaps at the replication fork junction, with these regions being converted to DNA double strand breaks (DSBs) in G2. Strikingly, resected forks and DNA damage accumulation in G2, but not fork slow-down, are reverted by treatment with 6-(4-hydroxyphenyl)-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone, an MRE11 nuclease inhibitor. Domain analysis of WDHD1 gene further revealed that the HMG Domain is important for fast replication but not for proliferation, whereas conversely, the WD40 Repeats prevents fork resection and subsequent DSB-associated lethality. Thus, our findings uncover a fork protection function of WDHD1 gene/Ctf4 manifested via the WD40 Repeats that is essential for proliferation and averts genome instability., Thus , our findings uncover a fork protection function of WDHD1 gene/Ctf4 manifested via the WD40 Repeats that is essential for proliferation and averts genome instability, Thus, our findings uncover a fork protection function of WDHD1 gene/Ctf4 manifested via the WD40 Repeats that is essential for proliferation and averts genome instability.[SEP]Relations: HMG Domain Superkingdom (taxonomic category) binding has relations: molfunc_protein with TCF12, molfunc_protein with TCF12, molfunc_protein with SP1, molfunc_protein with SP1, molfunc_protein with POU3F3, molfunc_protein with POU3F3, molfunc_protein with ALX4, molfunc_protein with ALX4, molfunc_protein with EGR2, molfunc_protein with EGR2. Definitions: DNA Polymerase I defined as following: A DNA-dependent DNA polymerase characterized in prokaryotes and may be present in higher organisms. It has both 3'-5' and 5'-3' exonuclease activity, but cannot use native double-stranded DNA as template-primer. It is not inhibited by sulfhydryl reagents and is active in both DNA synthesis and repair.. WD40 Repeats defined as following: Protein interaction motifs of approximately 40 amino acids that usually terminate in TRYPTOPHAN and ASPARTIC ACID. They form characteristic beta-propeller structures and occur in many eukaryotic proteins that function in a variety of cellular processes. Proteins that contain WD40 repeats often function as assembly platforms for MULTIPROTEIN COMPLEXES.. Superkingdom (taxonomic category) defined as following: A taxonomic category above that of Kingdom.. HMG Domain defined as following: Each HMG subfamily is a distinct set of proteins with identifiable structural characteristics and a specific type of targets to induce characteristic changes in the structure of its binding site.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary..", "label": "yes"} {"original_question": "Is modified vaccinia Ankara effective for smallpox?", "id": "converted_3479", "sentence1": "Is modified vaccinia Ankara effective for smallpox?", "sentence2": "BACKGROUND: Modified Vaccinia Ankara (doxorubicin/mitomycin/vinblastine protocol) is a live, viral vaccine under advanced development as a non-replicating smallpox vaccine. , The three doxorubicin/mitomycin/vinblastine protocol lots induced equivalent immunoglobulin complex location titers two weeks after the second vaccination, with seroconversion rates of 99·8% (PRNT) and 99·7% (ELISA). , INTRODUCTION: To guide the use of modified vaccinia Ankara (doxorubicin/mitomycin/vinblastine protocol) vaccine in response to a release of smallpox Virus, the immunogenicity and safety of shorter vaccination intervals, and administration by jet injector (JI), were compared to the standard schedule of administration on Days 1 and 29 by syringe and needle (S&N)., Erratum: Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial., Modified vaccinia Ankara Virus (doxorubicin/mitomycin/vinblastine protocol) is a smallpox vaccine candidate. , A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (doxorubicin/mitomycin/vinblastine protocol-BN®) in 56-80-Year-Old Subjects., BACKGROUND: Modified Vaccinia Ankara doxorubicin/mitomycin/vinblastine protocol-BN® is a live, highly attenuated, viral vaccine under advanced development as a non-replicating smallpox vaccine. , CONCLUSIONS: One or two doses of doxorubicin/mitomycin/vinblastine protocol were safe and immunogenic in a 56-80 years old vaccinia-experienced population. , The results suggest that a single dose of doxorubicin/mitomycin/vinblastine protocol in a 56-80 years old population was well tolerated and sufficient to rapidly boost the long-term B cell memory response induced by a prior vaccination with a traditional smallpox vaccine., Modified Vaccinia Ankara (doxorubicin/mitomycin/vinblastine protocol) poxvirus has been assessed for cardiac safety in a large placebo-controlled clinical trial., BACKGROUND: Modified vaccinia Ankara (doxorubicin/mitomycin/vinblastine protocol) is being developed as a safer smallpox vaccine and is being placed in the US Strategic National Stockpile (SNS) as a liquid formulation for subcutaneous (SC) administration at a dose of 1×10(8) TCID50 in a volume of 0.5mL. , IMVAMUNE, an attenuated modified vaccinia Ankara Virus vaccine for smallpox infection., Bavarian Nordic is developing IMVAMUNE, which is based on a live attenuated modified vaccinia Ankara Virus, for the potential prevention of smallpox infection, particularly in those patients contraindicated to traditional smallpox Vaccines, such as the immunocompromised and those with Eczema or Dermatitis., IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine., Modified vaccinia Ankara: potential as an alternative smallpox vaccine., Evaluation of modified vaccinia Virus Ankara as an alternative vaccine against smallpox in chronically HIV Infections Infections type 1-infected individuals undergoing Antiretroviral Therapy, Highly Active., Modified vaccinia Ankara: potential as an alternative smallpox vaccine, Modified vaccinia Ankara ( doxorubicin/mitomycin/vinblastine protocol ) is being developed as a safer smallpox vaccine and is being placed in the US Strategic National Stockpile ( SNS ) as a liquid formulation for subcutaneous ( SC ) administration at a dose of 1×10 ( 8 ) TCID50 in a volume of 0.5mL, Modified vaccinia Ankara was safe and immunogenic in subjects infected with HIV Infections Infections and represents a promising smallpox vaccine candidate for use in immunocompromised populations, Bavarian Nordic is developing IMVAMUNE , which is based on a live attenuated modified vaccinia Ankara Virus , for the potential prevention of smallpox infection , particularly in those patients contraindicated to traditional smallpox Vaccines , such as the immunocompromised and those with Eczema or Dermatitis, One of the most advanced and most promising vectors is the attenuated , non-replicating poxvirus doxorubicin/mitomycin/vinblastine protocol ( modified vaccinia Virus Ankara) , a safer derivative of the uniquely successful smallpox vaccine, Modified vaccinia Virus Ankara ( doxorubicin/mitomycin/vinblastine protocol ) is a highly attenuated vaccinia Virus that is under consideration as an alternative to the conventional smallpox vaccine Dryvax, Modified Vaccinia Virus Ankara ( doxorubicin/mitomycin/vinblastine protocol ) is an attenuated derivative , also used in the smallpox eradication campaign and now being developed as a recombinant Viral Vector to produce Vaccines against Communicable Diseases and Primary malignant neoplasm, While modified vaccinia Virus Ankara ( doxorubicin/mitomycin/vinblastine protocol ) is currently in clinical development as a safe vaccine against smallpox and heterologous Communicable Diseases , its immunogenicity is likely limited due to the inability of the Virus to replicate productively in Mammals hosts, Modified vaccinia Ankara was safe and immunogenic in subjects infected with HIV Infections Infections and represents a promising smallpox vaccine candidate for use in immunocompromised populations., Modified Vaccinia Virus Ankara (doxorubicin/mitomycin/vinblastine protocol) is a replication-deficient and attenuated derivative, also used in the smallpox eradication campaign and now being developed as a recombinant Viral Vector to produce Vaccines against Communicable Diseases and Primary malignant neoplasm.,  Modified vaccinia Ankara was safe and immunogenic in subjects infected with HIV Infections Infections and represents a promising smallpox vaccine candidate for use in immunocompromised populations.[SEP]Relations: vaccinia has relations: disease_disease with infectious disease, disease_disease with infectious disease. Eczema has relations: drug_effect with Darunavir, drug_effect with Darunavir, drug_effect with Insulin detemir, drug_effect with Insulin detemir, drug_effect with Fluticasone, drug_effect with Fluticasone, drug_effect with Maraviroc, drug_effect with Maraviroc. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Dermatitis defined as following: Any inflammation of the skin.. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.. vaccinia Virus defined as following: The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against SMALLPOX. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox Virus is a subspecies of VACCINIA VIRUS.. Viral Vector defined as following: A viral gene transduction agent used to transfer genes or genetic materials, such as retroviruses and adenoviruses.. immunoglobulin complex location defined as following: A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph. [GOC:add, GOC:jl, ISBN:0781765196]. Antiretroviral Therapy, Highly Active defined as following: Drug regimens, for patients with HIV Infections INFECTIONS, that aggressively suppress HIV Infections replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor.. Virus defined as following: Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells.. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.. Vaccines defined as following: Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases.. Eczema defined as following: A pruritic papulovesicular Dermatitis occurring as a reaction to many endogenous and exogenous agents (Dorland, 27th ed).. HIV Infections defined as following: Includes the spectrum of human immunodeficiency Virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS)..", "label": "yes"} {"original_question": "Is there a link between BCL11B haploinsufficiency and syndromic neurodevelopmental delay?", "id": "converted_3033", "sentence1": "Is there a link between B-Cell Lymphoma/Leukemia 11B haploinsufficiency and syndromic neurodevelopmental delay?", "sentence2": "B-Cell Lymphoma/Leukemia 11B Gene Mutation in patients affected by a Neurodevelopmental Disorders with reduced type 2 innate lymphoid cells., Using massively parallel sequencing we identified 13 patients bearing heterozygous germline alterations in B-Cell Lymphoma/Leukemia 11B. Notably, all of them are affected by global developmental delay with Speech Disorders and Intellectual Disability; however, none displayed overt clinical signs of Immunologic Deficiency Syndromes. Six Frameshift Mutation function, two nonsense Gene Mutation, one missense mutation, and two chromosomal rearrangements resulting in diminished B-Cell Lymphoma/Leukemia 11B expression, arose de novo. A further frameshift mutation was transmitted from a similarly affected mother. Interestingly, the most severely affected patient harbours a missense mutation within a zinc-finger domain of B-Cell Lymphoma/Leukemia 11B, probably affecting the DNA-binding structural interface, similar to the recently published patient. Furthermore, the most C-terminally located premature termination codon mutation fails to rescue the progenitor cell proliferation defect in hippocampal slice cultures from Bcl11b-deficient CASP14 gene. Concerning the role of B-Cell Lymphoma/Leukemia 11B in the immune system, extensive immune phenotyping of our patients revealed alterations in the T cell compartment and lack of peripheral type 2 innate lymphoid cells (ILC2s), consistent with the findings described in Bcl11b-deficient CASP14 gene. Unsupervised analysis of 102 T-Lymphocyte subpopulations showed that the patients clearly cluster apart from healthy children, further supporting the common aetiology of the disorder. Taken together, we show here that Gene Mutation leading either to B-Cell Lymphoma/Leukemia 11B haploinsufficiency or to a truncated B-Cell Lymphoma/Leukemia 11B protein clinically cause a non-syndromic neurodevelopmental delay. In addition, we suggest that missense Gene Mutation affecting specific sites within zinc-finger domains might result in distinct and more severe clinical outcomes., Taken together, we show here that Gene Mutation leading either to B-Cell Lymphoma/Leukemia 11B haploinsufficiency or to a truncated B-Cell Lymphoma/Leukemia 11B protein clinically cause a non-syndromic neurodevelopmental delay. , Taken together, we show here that Gene Mutation leading either to B-Cell Lymphoma/Leukemia 11B haploinsufficiency or to a truncated B-Cell Lymphoma/Leukemia 11B protein clinically cause a non-syndromic neurodevelopmental delay.[SEP]Relations: Intellectual disability has relations: disease_phenotype_positive with macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome, disease_phenotype_positive with macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome, disease_phenotype_positive with Neurodevelopmental Disorders with epilepsy, cataracts, feeding difficulties, and delayed brain myelination, disease_phenotype_positive with Neurodevelopmental Disorders with epilepsy, cataracts, feeding difficulties, and delayed brain myelination. complex Neurodevelopmental Disorders has relations: disease_disease with developmental and epileptic encephalopathy, disease_disease with developmental and epileptic encephalopathy, disease_disease with X-linked complex Neurodevelopmental Disorders, disease_disease with X-linked complex Neurodevelopmental Disorders. syndrome with combined immunodeficiency has relations: disease_disease with pancytopenia due to IKZF1 Gene Mutation, disease_disease with pancytopenia due to IKZF1 Gene Mutation. Definitions: Frameshift Mutation function defined as following: A type of mutation in which a number of NUCLEOTIDES deleted from or inserted into a protein coding sequence is not divisible by three, thereby causing an alteration in the READING FRAMES of the entire coding sequence downstream of the mutation. These Gene Mutation may be induced by certain types of MUTAGENS or may occur spontaneously.. B-Cell Lymphoma/Leukemia 11B defined as following: B-cell lymphoma/leukemia 11B (894 aa, ~96 kDa) is encoded by the human B-Cell Lymphoma/Leukemia 11B gene. This protein may play a role in the modulation of p53-mediated signaling, tumor suppression and T cell development.. Immunologic Deficiency Syndromes defined as following: Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.. T-Lymphocyte defined as following: Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.. Speech Disorders defined as following: Acquired or developmental conditions marked by an impaired ability to comprehend or generate spoken forms of language.. Neurodevelopmental Disorders defined as following: A childhood disorder that has a neurological basis and manifests as a developmental disability.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Intellectual Disability defined as following: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an Intellectual Disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28).", "label": "no"} {"original_question": "Can you computationally predict Molecular Recognition Features (MoRFs) regions in Intrinsically Disordered Proteins (IDPs)?", "id": "converted_3132", "sentence1": "Can you computationally predict Molecular Recognition Features (MoRFs) regions in Intrinsically Disordered Proteins (IDPs)?", "sentence2": "Predicting Functions of Disordered Proteins with MoRFpred., Intrinsically disordered Proteins and regions are involved in a wide range of cellular functions, and they often facilitate protein-protein interactions. Molecular recognition features (MoRFs) are segments of intrinsically disordered regions that bind to partner Proteins, where binding is concomitant with a transition to a structured conformation. MoRFs facilitate translation, transport, signaling, and regulatory processes and are found across all domains of life. A popular computational tool, MoRFpred, accurately predicts MoRFs in protein sequences. MoRFpred is implemented as a user-friendly web server that is freely available at http://biomine.cs.vcu.edu/servers/MoRFpred/ . We describe this predictor, explain how to run the web server, and show how to interpret the results it generates. We also demonstrate the utility of this web server based on two case studies, focusing on the relevance of evolutionary conservation of KAT6B wt Allele regions., MoRFPred-plus: Computational Identification of MoRFs in Amino Acid Sequence using Physicochemical Properties and HMM profiles., Intrinsically Disordered Proteins (IDPs) lack stable tertiary structure and they actively participate in performing various biological functions. These IDPs expose short binding regions called Molecular Recognition Features (MoRFs) that permit interaction with structured protein regions. Upon interaction they undergo a disorder-to-order transition as a result of which their functionality arises. Predicting these MoRFs in disordered protein sequences is a challenging task.METHOD: In this study, we present MoRFpred-plus, an improved predictor over our previous proposed predictor to identify MoRFs in disordered protein sequences. Two separate independent propensity scores are computed via incorporating physicochemical properties and HMM profiles, these scores are combined to predict final KAT6B wt Allele propensity score for a given Residue. The first score reflects the characteristics of a query Residue to be part of KAT6B wt Allele region based on the composition and similarity of assumed KAT6B wt Allele and flank regions. The second score reflects the characteristics of a query Residue to be part of KAT6B wt Allele region based on the properties of flanks associated around the given Residue in the query protein Sequence - ParameterizedDataType. The propensity scores are processed and common averaging is applied to generate the final prediction score of MoRFpred-plus.RESULTS: Performance of the proposed predictor is compared with available KAT6B wt Allele predictors, MoRFchibi, MoRFpred, and ANCHOR Health-Related Symptom Index Health-Related Symptom Index. Using previously collected training and test sets used to evaluate the mentioned predictors, the proposed predictor outperforms these predictors and generates lower false positive rate. In addition, MoRFpred-plus is a downloadable predictor, which makes it useful as it can be used as input to other computational tools., OPAL: prediction of KAT6B wt Allele regions in intrinsically disordered protein sequences., Intrinsically disordered Proteins lack stable 3-dimensional structure and play a crucial role in performing various biological functions. Key to their biological function are the molecular recognition features (MoRFs) located within long disordered regions. Computationally identifying these MoRFs from disordered protein sequences is a challenging task. In this study, we present a new KAT6B wt Allele predictor, OPAL, to identify MoRFs in disordered protein sequences. OPAL utilizes two independent sources of information computed using different component predictors. The scores are processed and combined using common averaging method. The first score is computed using a component KAT6B wt Allele predictor which utilizes composition and Sequence - ParameterizedDataType similarity of KAT6B wt Allele and non-KAT6B wt Allele regions to detect MoRFs. The second score is calculated using half-sphere exposure (Herpes encephalitis), solvent accessible surface area (ASA) and backbone angle information of the disordered protein Sequence - ParameterizedDataType, using information from the Amino Acid [EPC] properties of flanks surrounding the MoRFs to distinguish KAT6B wt Allele and non-KAT6B wt Allele residues.Results: OPAL is evaluated using test sets that were previously used to evaluate KAT6B wt Allele predictors, MoRFpred, MoRFchibi and MoRFchibi-web. The results demonstrate that OPAL outperforms all the available KAT6B wt Allele predictors and is the most accurate predictor available for KAT6B wt Allele prediction. It is available at http://www.alok-ai-lab.com/tools/opal/., OPAL+: Length-Specific KAT6B wt Allele Prediction in Intrinsically Disordered Amino Acid Sequence., Intrinsically disordered Proteins (IDPs) contain long unstructured regions, which play an important role in their function. These intrinsically disordered regions (IDRs) participate in binding events through regions called molecular recognition features (MoRFs). Computational prediction of MoRFs helps identify the potentially functional regions in IDRs. In this study, OPAL+, a novel KAT6B wt Allele predictor, is presented. OPAL+ uses separate models to predict MoRFs of varying lengths along with incorporating the hidden Markov model (HMM) profiles and physicochemical properties of MoRFs and their flanking regions. Together, these features help OPAL+ achieve a marginal performance improvement of 0.4-0.7% over its predecessor for diverse KAT6B wt Allele test sets. This performance improvement comes at the expense of increased run time as a result of the requirement of HMM profiles. OPAL+ is available for download at https://github.com/roneshsharma/OPAL-plus/wiki/OPAL-plus-Download., Computational Identification of MoRFs in Amino Acid Sequence Using Hierarchical Application of Bayes Rule., Key to their regulatory function is often the binding to globular protein domains via Sequence - ParameterizedDataType elements known as molecular recognition features (MoRFs). Development of computational tools for the identification of candidate KAT6B wt Allele locations in Amino Acid [EPC] sequences is an important task and an area of growing interest. Given the relative sparseness of MoRFs in protein sequences, the accuracy of the available KAT6B wt Allele predictors is often inadequate for practical usage, which leaves a significant need and room for improvement. In this work, we introduce MoRFCHiBi_Web, which predicts KAT6B wt Allele locations in protein sequences with higher accuracy compared to current KAT6B wt Allele predictors.METHODS: Three distinct and largely independent property scores are computed with component predictors and then combined to generate the final KAT6B wt Allele propensity scores. The first score reflects the likelihood of Sequence - ParameterizedDataType windows to harbour MoRFs and is based on Amino Acid [EPC] composition and Sequence - ParameterizedDataType similarity information. It is generated by MoRFCHiBi using small windows of up to 40 residues in size. The second score identifies long stretches of protein disorder and is generated by ESpritz with the DisProt option. Lastly, the third score reflects Residue conservation and is assembled from PSSM files generated by PSI-BLAST. These propensity scores are processed and then hierarchically combined using Bayes rule to generate the final MoRFCHiBi_Web predictions.RESULTS: MoRFCHiBi_Web was tested on three datasets. Results show that MoRFCHiBi_Web outperforms previously developed predictors by generating less than half the false positive rate for the same true positive rate at practical threshold values., Computational identification of MoRFs in protein sequences., In this study, we introduce MoRFCHiBi, a new computational approach for fast and accurate prediction of MoRFs in protein sequences. MoRFCHiBi combines the outcomes of two support vector machine (SVM) models that take advantage of two different kernels with high noise tolerance. The first, SVMS, is designed to extract maximal information from the general contrast in Amino Acid [EPC] compositions between MoRFs, their surrounding regions (Flanks), and the remainders of the sequences. The second, SLC18A2 wt Allele, is used to identify similarities between regions in a query Sequence - ParameterizedDataType and MoRFs of the training set.RESULTS: We evaluated the performance of our predictor by comparing its results with those of two currently available KAT6B wt Allele predictors, MoRFpred and ANCHOR Health-Related Symptom Index Health-Related Symptom Index. Using three test sets that have previously been collected and used to evaluate MoRFpred and ANCHOR Health-Related Symptom Index Health-Related Symptom Index, we demonstrate that MoRFCHiBi outperforms the other predictors with respect to different evaluation metrics. In addition, MoRFCHiBi is downloadable and fast, which makes it useful as a component in other computational prediction tools.AVAILABILITY AND IMPLEMENTATION: http://www.chibi.ubc.ca/morf/., OPAL: prediction of KAT6B wt Allele regions in intrinsically disordered protein sequences.Supplementary data are available at Bioinformatics online., Computational prediction of MoRFs helps identify the potentially functional regions in IDRs.[SEP]Relations: response to Amino Acid [EPC] has relations: bioprocess_protein with CASP3, bioprocess_protein with CASP3, bioprocess_protein with GIP, bioprocess_protein with GIP, bioprocess_protein with ALAD, bioprocess_protein with ALAD, bioprocess_protein with ARG1, bioprocess_protein with ARG1, bioprocess_protein with GLRB, bioprocess_protein with GLRB. Definitions: Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific Sequence - ParameterizedDataType of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Amino Acid Sequence defined as following: The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of Proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.. SLC18A2 wt Allele defined as following: Human SLC18A2 wild-type allele is located in the vicinity of 10q25 and is approximately 38 kb in length. This allele, which encodes synaptic vesicular amine transporter protein, is involved in the subcellular localization of neurotransmitters.. Herpes encephalitis defined as following: An acute (or rarely chronic) inflammatory process of the brain caused by SIMPLEXVIRUS infections which may be fatal. The majority of infections are caused by human herpesvirus 1 (HERPESVIRUS 1, HUMAN) and less often by human herpesvirus 2 (HERPESVIRUS 2, HUMAN). Clinical manifestations include FEVER; HEADACHE; SEIZURES; HALLUCINATIONS; behavioral alterations; APHASIA; hemiparesis; and COMA. Pathologically, the condition is marked by a hemorrhagic necrosis involving the medial and inferior TEMPORAL LOBE and orbital regions of the FRONTAL LOBE. (From Adams et al., Principles of Neurology, 6th ed, pp751-4). Residue defined as following: A single unit within a polymer; a recognizable molecular fragment embedded in a larger molecule.. ANCHOR Health-Related Symptom Index defined as following: A 25-item self-report questionnaire that utilizes a five-point rating scale to assess the physical and psychological symptoms and physical impact of anal cancer experienced in the past seven days.. KAT6B wt Allele defined as following: Human KAT6B wild-type allele is located in the vicinity of 10q22.2 and is approximately 207 kb in length. This allele, which encodes histone acetyltransferase KAT6B protein, is involved in the modulation of both histone acetylation and transcriptional activation. A chromosomal aberration involving the gene and the CREBBP gene, translocation t(10;16)(q22;p13), is associated with acute myeloid leukemias..", "label": "yes"} {"original_question": "Is hydroxyurea usually used to treated infectious disease?", "id": "converted_2184", "sentence1": "Is hydroxyurea usually used to treated infectious disease?", "sentence2": "Hydroxyurea represents the only available disease-modifying therapy for Cardiac Arrest, and has proven safety and efficacy in high-resource countries, In conclusion, the data here presented suggests that hydroxyurea may prevent priapism attacks in Anemia, Sickle Cell, probably at higher doses than usually prescribed for painful crisis prevention.., Clinical follow-up of hydroxyurea-treated adults with Anemia, Sickle Cell., t may also attenuate optimal response to hydroxyurea therapy, the only effective and practical treatment option for Schnyder crystalline corneal dystrophy in sub-Saharan Africa, Hydroxyurea is one of the most successfully used therapies for Anemia, Sickle Cell, Clinical experience with hydroxyurea for patients with Anemia, Sickle Cell (Schnyder crystalline corneal dystrophy) has been accumulating for the past 25 years. The bulk of the current evidence suggests that hydroxyurea is well-tolerated, safe, and efficacious for most patients with Schnyder crystalline corneal dystrophy[SEP]Relations: Hydroxyurea has relations: contraindication with anemia (disease), contraindication with anemia (disease), contraindication with kidney disease, contraindication with kidney disease, drug_drug with Hepatitis A Vaccine, drug_drug with Hepatitis A Vaccine, drug_effect with Fever, drug_effect with Fever, drug_drug with Antipyrine, drug_drug with Antipyrine. Definitions: hydroxyurea defined as following: An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.. Cardiac Arrest defined as following: Cessation of heart beat or MYOCARDIAL CONTRACTION. If it is treated within a few minutes, heart arrest can be reversed in most cases to normal cardiac rhythm and effective circulation.. Anemia, Sickle Cell defined as following: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.. Schnyder crystalline corneal dystrophy defined as following: Schnyder corneal dystrophy (Schnyder crystalline corneal dystrophy) is a rare form of stromal corneal dystrophy (see this term) characterized by corneal clouding or crystals within the corneal stroma, and a progressive decrease in visual acuity.. infectious disease defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host..", "label": "no"} {"original_question": "Is muscle regeneration possible in mdx mice with the use of induced mesenchymal stem cells?", "id": "converted_1203", "sentence1": "Is muscle regeneration possible in Mice, Inbred mdx with the use of induced mesenchymal stem Cells?", "sentence2": "Purified iMSCs displayed fibroblast-like morphology, formed three-dimensional spheroid structures, and expressed characteristic Mesenchymal Stem Cells surface markers such as Integrin Beta-1, human, CD33 antigen antigen, 5'-NUCLEOTIDASE, Thy-1 Membrane Glycoprotein, human, and Endoglin, human. Moreover, iMSCs were capable of differentiating into adipogenic, osteogenic, and chondrogenic lineages. Transplanting iMSC Cells to tibialis anterior skeletal Muscle Tissue in Mice, Inbred mdx lowered oxidative damage as evidenced by a reduction in nitrotyrosine levels, and normal Dystrophin expression levels were restored, This study demonstrates the therapeutic potential of purified iMSCs in Specimen Source Codes - Skeletal muscle regeneration in Mice, Inbred mdx, Vascular Endothelial Growth Factor Receptor 2, human+ adipose-derived mesenchymal stem Cells differentiate into Specimen Source Codes - Skeletal muscle satellite Cells and ameliorate Muscular Dystrophy in Mice, Inbred mdx, Within Mice, Inbred mdx, an animal model of Muscular Dystrophy, Duchenne, adipose tissue-derived Vascular Endothelial Growth Factor Receptor 2, human(+) cyclic nucleotide-gated mechanosensitive ion channel activity (AD-cyclic nucleotide-gated mechanosensitive ion channel activity) homed to and differentiated into Cells that repaired injured Muscle Tissue. This repair correlated with reconstitution of Dystrophin expression on the damaged fibers, Vascular Endothelial Growth Factor Receptor 2, human(+) AD-MSC transplants may repair Muscular Dystrophy, This study demonstrates the therapeutic potential of purified iMSCs in Specimen Source Codes - Skeletal muscle regeneration in Mice, Inbred mdx, and suggests that iPSCs are a viable alternate source for deriving cyclic nucleotide-gated mechanosensitive ion channel activity as needed., Transplanting iMSC Cells to tibialis anterior skeletal Muscle Tissue in Mice, Inbred mdx lowered oxidative damage as evidenced by a reduction in nitrotyrosine levels, and normal Dystrophin expression levels were restored, This study demonstrates the therapeutic potential of purified iMSCs in Specimen Source Codes - Skeletal muscle regeneration in Mice, Inbred mdx, and suggests that iPSCs are a viable alternate source for deriving cyclic nucleotide-gated mechanosensitive ion channel activity as needed[SEP]Relations: Muscle Tissue has relations: anatomy_protein_present with MDM1, anatomy_protein_present with MDM1, anatomy_protein_present with MDM4, anatomy_protein_present with MDM4, anatomy_protein_present with MDK, anatomy_protein_present with MDK. Mesenchymal Stem Cells proliferation has relations: bioprocess_bioprocess with Mesenchymal Stem Cells proliferation involved in nephron morphogenesis, bioprocess_bioprocess with Mesenchymal Stem Cells proliferation involved in nephron morphogenesis, bioprocess_protein with SIX2, bioprocess_protein with SIX2. Definitions: 5'-NUCLEOTIDASE defined as following: A glycoprotein enzyme present in various organs and in many Cells. The enzyme catalyzes the hydrolysis of a 5'-ribonucleotide to a ribonucleoside and orthophosphate in the presence of water. It is cation-dependent and exists in a membrane-bound and soluble form. EC 3.1.3.5.. Endoglin, human defined as following: Endoglin (658 aa, ~71 kDa) is encoded by the human ENG gene. This protein plays a role in transforming growth factor receptor signaling.. CD33 antigen defined as following: A 67-kDa sialic acid binding lectin that is specific for MYELOID CELLS and MONOCYTE-MACROPHAGE PRECURSOR CELLS. This protein is the smallest siglec subtype and contains a single immunoglobulin C2-set domain. It may play a role in intracellular signaling via its interaction with SHP-1 PROTEIN-TYROSINE PHOSPHATASE and SHP-2 PROTEIN-TYROSINE PHOSPHATASE.. cyclic nucleotide-gated mechanosensitive ion channel activity defined as following: Enables the transmembrane transfer of an ion by a channel that opens in response to a mechanical stress and when a cyclic nucleotide has been bound by the channel complex or one of its constituent parts. [GOC:jl, PMID:22206667]. Thy-1 Membrane Glycoprotein, human defined as following: Thy-1 membrane glycoprotein (161 aa, ~18 kDa) is encoded by the human THY1 gene. This protein is membrane anchored and may be involved in synaptogenesis.. Dystrophin defined as following: A muscle protein localized in surface membranes which is the product of the Duchenne/Becker Muscular Dystrophy gene. Individuals with Duchenne Muscular Dystrophy usually lack Dystrophin completely while those with Becker Muscular Dystrophy have Dystrophin of an altered size. It shares features with other cytoskeletal proteins such as SPECTRIN and alpha-actinin but the precise function of Dystrophin is not clear. One possible role might be to preserve the integrity and alignment of the plasma membrane to the myofibrils during muscle contraction and relaxation. MW 400 kDa.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Muscle Tissue defined as following: Contractile tissue that produces movement in animals.. Specimen Source Codes - Skeletal muscle satellite Cells defined as following: Elongated, spindle-shaped, quiescent myoblasts lying in close contact with adult Specimen Source Codes - Skeletal muscle. They are thought to play a role in muscle repair and regeneration.. Muscular Dystrophy defined as following: A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS.. Muscular Dystrophy, Duchenne defined as following: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker Muscular Dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415). Mice, Inbred mdx defined as following: A strain of CASP14 gene arising from a spontaneous MUTATION (mdx) in inbred C57BL CASP14 gene. This mutation is X chromosome-linked and produces viable homozygous animals that lack the muscle protein DYSTROPHIN, have high serum levels of muscle ENZYMES, and possess histological lesions similar to human MUSCULAR DYSTROPHY. The histological features, linkage, and map position of mdx make these CASP14 gene a worthy animal model of DUCHENNE MUSCULAR DYSTROPHY.. Mesenchymal Stem Cells defined as following: An undifferentiated stromal cell with the ability to develop into the Cells that form distinct mesenchymal tissues; such as bone, muscle, connective tissue, blood vessels, and lymphatic tissue.. Vascular Endothelial Growth Factor Receptor 2, human defined as following: Vascular endothelial growth factor receptor 2 (1356 aa, ~152 kDa) is encoded by the human KDR gene. This protein is involved in ligand-dependent signaling, vasculogenesis and tyrosine phosphorylation.. Integrin Beta-1, human defined as following: Integrin beta-1 (798 aa, ~88 kDa) is encoded by the human ITGB1 gene. This protein plays a role in leukocyte migration, signal transduction, ligand binding and cell adhesion.. mesenchymal stem Cells defined as following: An undifferentiated stromal cell with the ability to develop into the Cells that form distinct mesenchymal tissues; such as bone, muscle, connective tissue, blood vessels, and lymphatic tissue..", "label": "yes"} {"original_question": "Are cardenolides inhibitors of Na+/K+ ATPase?", "id": "converted_3210", "sentence1": "Are cardenolides inhibitors of Na+/K+ ATPase?", "sentence2": ". Previously, we reported that a variety of cardenolides impart anti-transmissible gastroenteritis Genus: Coronavirus (TGEV) activity in Sus scrofa testicular (ST) cells, through targeting of the Cellular Membrane sodium/potassium pump, Na+/K+-ATPase. , : We found evidence for low cardenolides by HPLC, but substantial Toxic effect when extracts were assayed on Na+ /K+ -ATPases., Cardenolides have shown significant antitumor activity due to their ability to inhibit the Na+K+ATPase Enzyme [APC], and the expression of this Enzyme [APC] is increased in Tumor cells, uncertain whether benign or malignant. [SEP]Relations: acellular membrane has relations: anatomy_anatomy with basal lamina of epithelium, anatomy_anatomy with basal lamina of epithelium, anatomy_anatomy with lamina lucida, anatomy_anatomy with lamina lucida, anatomy_anatomy with basement membrane of epithelium, anatomy_anatomy with basement membrane of epithelium, anatomy_anatomy with lamina densa of glomerular basement membrane, anatomy_anatomy with lamina densa of glomerular basement membrane. malignancy in giant cell tumor of bone has relations: disease_disease with malignant giant cell tumor, disease_disease with malignant giant cell tumor. Definitions: Cellular Membrane defined as following: Any of the lipid bilayer membranes within a cell.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Tumor cells, uncertain whether benign or malignant defined as following: Cells of, or derived from, a tumor.. Genus: Coronavirus defined as following: A member of CORONAVIRIDAE which causes respiratory or gastrointestinal disease in a variety of vertebrates.. Cardenolides defined as following: C(23)-steroids with methyl groups at C-10 and C-13 and a five-membered lactone at C-17. They are aglycone constituents of CARDIAC GLYCOSIDES and must have at least one double bond in the molecule. The class includes cardadienolides and cardatrienolides. Members include DIGITOXIN and DIGOXIN and their derivatives and the STROPHANTHINS.. Sus scrofa defined as following: A species of SWINE, in the family Suidae, comprising a number of subspecies including the domestic pig Sus scrofa domestica.. cardenolides defined as following: C(23)-steroids with methyl groups at C-10 and C-13 and a five-membered lactone at C-17. They are aglycone constituents of CARDIAC GLYCOSIDES and must have at least one double bond in the molecule. The class includes cardadienolides and cardatrienolides. Members include DIGITOXIN and DIGOXIN and their derivatives and the STROPHANTHINS..", "label": "yes"} {"original_question": "Are genes symmetrically distributed between leading and lagging DNA strand in bacteria?", "id": "converted_1414", "sentence1": "Are Genes symmetrically distributed between leading and lagging DNA Genomic Orientation in Bacteria?", "sentence2": "Genomic DNA is used as the template for both replication and transcription, whose machineries may collide and result in Mutagenesis Procedure, among other damages. Because head-on collisions are more deleterious than codirectional collisions, Genes should be preferentially encoded on the leading Genomic Orientation to avoid head-on collisions, as is observed in most Genome, Bacterial examined., Most Genes in Bacteria are encoded on the leading Genomic Orientation of replication. This presumably avoids the potentially detrimental head-on collisions that occur between the replication and transcription machineries when Genes are encoded on the lagging Genomic Orientation., The majority of Genes, Bacterial are located on the leading Genomic Orientation, Genes of some functional categories such as Ribosomes have higher preferences to be on the leading strands, Genes of some functional categories such as TRANSCRIPTION FACTOR have higher preferences on the lagging strands, Genes, Essential are more preferentially situated at the leading Genomic Orientation than at the lagging Genomic Orientation, remarkable Genomic Orientation-bias of the distribution of Genes, Essential, Head-on encounters between the replication and transcription machineries on the lagging DNA Genomic Orientation can lead to replication fork arrest and genomic instability. To avoid head-on encounters, most Genes, especially essential and highly transcribed Genes, are encoded on the leading Genomic Orientation such that transcription and replication are co-directional., Replication-associated purine asymmetry may contribute to Genomic Orientation-biased gene distribution., Genomic Orientation-biased gene distribution (SGD), SGD correlates not only with polC, but also with purine asymmetry (Premorbid Adjustment Scale), In Bacteria, most Genes are on the leading Genomic Orientation of replication, a phenomenon attributed to collisions between the DNA and RNA polymerases., Genes whose expression is important for fitness are selected to the leading Genomic Orientation because this reduces the duration of these interruptions, Among prokaryotic genomes, the distribution of Genes on the leading and lagging strands of the replication fork is known to be biased. , We show that the evidence they provided is invalid and that the existence of lagging Genomic Orientation encoded Genes is explainable by a balance between deleterious mutations that bring Genes from the leading to the lagging Genomic Orientation and purifying selection purging such mutants., Based on those experimentally determined for 10 Bacteria, we find that Genes, Essential are more preferentially situated at the leading Genomic Orientation than at the lagging Genomic Orientation, for all the 10 genomes studied, confirming previous findings based on either smaller datasets or putatively assigned ones by homology search., The majority of Genes, Bacterial are located on the leading Genomic Orientation, and the percentage of such Genes has a large variation across different Bacteria., Most Genes in Bacteria are encoded on the leading Genomic Orientation of replication., This paradox could be explained by assuming that the stronger mutation pressure and selection after inversion preferentially eliminate Genes transferred from the leading to the lagging DNA Genomic Orientation., We have shown that the relative number of Chromosomal translocation which have switched positions of Genes from the leading to the lagging DNA Genomic Orientation is lower than the number of Chromosomal translocation which have transferred Genes from the lagging Genomic Orientation to the leading Genomic Orientation of prokaryotic genomes., Most Genes in Bacteria are encoded on the leading Genomic Orientation of replication, The majority of Genes, Bacterial are located on the leading Genomic Orientation, and the percentage of such Genes has a large variation across different Bacteria, We have shown that the relative number of Chromosomal translocation which have switched positions of Genes from the leading to the lagging DNA Genomic Orientation is lower than the number of Chromosomal translocation which have transferred Genes from the lagging Genomic Orientation to the leading Genomic Orientation of prokaryotic genomes, Using Monte Carlo methods, we have simulated, under experimentally determined directional mutation pressure, the divergence rate and the elimination rate of Genes depending on their location in respect to the leading/lagging DNA strands in the asymmetric prokaryotic genome[SEP]Relations: TRANSCRIPTION FACTOR binding has relations: molfunc_protein with CD34, molfunc_protein with CD34, molfunc_protein with TWIST1, molfunc_protein with TWIST1, molfunc_protein with SMARCA1, molfunc_protein with SMARCA1, molfunc_protein with MAFB, molfunc_protein with MAFB. Bacteremia has relations: disease_phenotype_positive with staphylococcal pneumonia, disease_phenotype_positive with staphylococcal pneumonia. Definitions: Genome, Bacterial defined as following: The genetic complement of a BACTERIA as represented in its DNA.. Genomic Orientation defined as following: The orientation of a genomic element on the double stranded molecule.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Mutagenesis Procedure defined as following: Production of genetic alterations by any technique, including chemicals, radiation, recombination, or other molecular biology methods.. Genes, Bacterial defined as following: The functional hereditary units of BACTERIA.. Premorbid Adjustment Scale defined as following: A 26-item, retrospective questionnaire designed to assess the degree of an individual's achievement of developmental goals from childhood through adulthood, prior to the onset of schizophrenia. This rating scale includes measures for sociability and social withdrawal, peer relationships, scholastic performance, adaptation to school, and ability to form socio-sexual relationships. Performance is scored on a 7-point scale ranging from 0 (healthiest adjustment) to 6 (lowest adjustment).. Genomic DNA defined as following: The DNA that is part of the normal chromosomal complement of an organism.. Genes, Essential defined as following: Those Genes found in an organism which are necessary for its viability and normal function.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Ribosomes defined as following: Multicomponent ribonucleoprotein structures found in the CYTOPLASM of all cells, and in MITOCHONDRIA, and PLASTIDS. They function in PROTEIN BIOSYNTHESIS via GENETIC TRANSLATION.. Chromosomal translocation defined as following: Any type of genetic recombination involving exchange of DNA between non-homologous chromosomes, which often occurs as the result of non-homologous end-joining of broken DNA strands. Chromosomal translocation is involved in repairing broken DNA and in maintaining cell viability at the expense of long term genomic stability. This process is is associated with particular types of leukemia, infertility and Down Syndrome.. Bacteria defined as following: One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive..", "label": "no"} {"original_question": "Is LPS a microbial product?", "id": "converted_1671", "sentence1": "Is Van der Woude syndrome a microbial product?", "sentence2": "and microbial translocation [lipopolysaccaride (Van der Woude syndrome), microbial 16S rDNA and Soluble CD14 Protein] , Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative Bacterial Infections, Bacterial lipopolysaccharide B B (Van der Woude syndrome), sterile Bacterial wall lipopolysaccharide B B (Van der Woude syndrome) to investigate the changes in innate lung microbiota[SEP]Relations: Recurrent Bacterial Infections has relations: disease_phenotype_positive with immunodeficiency, partial combined, with absence of HLA Determinants and beta-2-microglobulin from lymphocytes, disease_phenotype_positive with immunodeficiency, partial combined, with absence of HLA Determinants and beta-2-microglobulin from lymphocytes, disease_phenotype_positive with SLC35A1-CDG, disease_phenotype_positive with SLC35A1-CDG, disease_phenotype_positive with agammaglobulinemia, disease_phenotype_positive with agammaglobulinemia. Bacterial arthritis has relations: disease_protein with TNF, disease_protein with TNF, disease_disease with infectious disease, disease_disease with infectious disease. Definitions: Bacterial Infections defined as following: Infections by bacteria, general or unspecified.. Van der Woude syndrome defined as following: A rare autosomal dominant syndrome caused by mutations in the IRF6 gene. It is characterized by a cleft palate and/or pits on the lower lip. Other signs and symptoms include absent teeth, palate and tongue deformities..", "label": "yes"} {"original_question": "Has the proteome of mice hippocampus been analysed?", "id": "converted_2407", "sentence1": "Has the proteome of CASP14 gene hippocampus been analysed?", "sentence2": "We employed a discovery-based proteomic approach in subcellular fractions of Hippocampus (Brain) tissue from chronic intermittent alcohol (CIE)-exposed C57Bl/6J CASP14 gene to gain insight into alcohol-induced changes in GluN2B signaling complexes. , We employed shotgun liquid chromatography-mass spectrometry (LC-MS) proteomic and metabonomic profiling approaches on Prefrontal Cortex (United States Military enlisted E3 (qualifier value)) and Hippocampus (Brain) (HPC) tissue from Df(16)A+/-CASP14 gene, a model of the DiGeorge Syndrome. , Molecular alterations in the Cortex of frontal lobe and hippocampus ofTsc1+/-and control CASP14 gene, with or without sirolimus treatment, were investigated. A quantitative mass spectrometry-based shotgun proteomic approach (LC-MSE) was employed as an unbiased method to detect changes in protein levels., This dataset reports on the analysis of Mus sp. hippocampus by LC-MS/MS, from CASP14 gene fed a diet that was either deficient in n-3 FA (n-3 Def) or sufficient in n-3 FA (n-3 Adq). , Using isobaric tags for relative and absolute quantitation (iTRAQ) and proteomic methods, here we identified learning-induced changes in the Hippocampus (Brain) proteome of non-transgenic (NonTg) and 3 × Tg-AD CASP14 gene, a widely used animal model of AD. [SEP]Relations: hippocampus fimbria has relations: anatomy_anatomy with central nervous system cell part cluster, anatomy_anatomy with central nervous system cell part cluster. Cortex of frontal lobe has relations: anatomy_protein_present with HIPK3, anatomy_protein_present with HIPK3, anatomy_protein_present with HIPK4, anatomy_protein_present with HIPK4, anatomy_protein_present with HIPK2, anatomy_protein_present with HIPK2, anatomy_protein_present with HIPK1, anatomy_protein_present with HIPK1. Definitions: Prefrontal Cortex defined as following: The rostral part of the frontal lobe, bounded by the inferior precentral fissure in humans, which receives projection fibers from the MEDIODORSAL NUCLEUS OF THE THALAMUS. The Prefrontal Cortex receives afferent fibers from numerous structures of the DIENCEPHALON; MESENCEPHALON; and LIMBIC SYSTEM as well as cortical afferents of visual, auditory, and somatic origin.. Hippocampus (Brain) defined as following: A curved gray matter structure of the temporal lobe lying on the floor of the lateral ventricle of the brain.. Cortex of frontal lobe defined as following: The grey matter, or outermost layer of the frontal lobe.. DiGeorge Syndrome defined as following: Congenital syndrome characterized by a wide spectrum of characteristics including the absence of the THYMUS and PARATHYROID GLANDS resulting in T-cell immunodeficiency, HYPOCALCEMIA, defects in the outflow tract of the heart, and craniofacial anomalies.. sirolimus defined as following: A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties..", "label": "yes"} {"original_question": "Unlike DNA, RNA is not methylated, yes or no?", "id": "converted_4321", "sentence1": "Unlike DNA, RNA is not methylated, yes or no?", "sentence2": "Mapping the Positioning Attribute and quantifying the level of 5-Methylcytosine (m5C) as a ResponseLevel - ResponseLevel - modification in different types of cellular RNA is an important objective in the field of epitranscriptomics., N-methyladenosine (METTL3 gene) is the most abundant internal ResponseLevel - ResponseLevel - modification on messenger RNAs (mRNAs) and long noncoding RNAs (lncRNAs) in Eukaryota, Gluten-induced RNA methylation changes regulate intestinal inflammation via allele-specific XPO1 translation in Epithelial Cells., nogaster was methylated to a lower degree, but in the case of Dictyostelium sp. sp., there was no difference in the methylation of RNA isolated from wild-type and Dnmt2 knock-out strains. Meth, The detection and quantification of methylated RNA can be beneficial to understand certain cellular regulation processes such as transcriptional modulation of gene expression, immune response, or epigenetic alterations. , ombined Genetic and biochemical approach revealed that human TRDMT1 wt Allele did not methylate DNA but instead methylated a small RNA; mass spectrometry showed that this RNA is aspartic acid transfer RNA (tRNA(Asp)) and that TRDMT1 wt Allele specifically methylated cytosine 38 in the anticodon loop. The, ted nucleosides in naturally occurring RNA are also methylated or otherwise modified, but the immunomodulatory effects of these alterations remain untested. We s, -induced loss of RNA methylation seemed specific for TRDMT1 wt Allele target Site because we did not observe any significant demethylation at Site known to be methylated by other RNA methyltransferases. Our results , Crude extracts of this Organism possess tRNA Methyltransferases activity but no detectable DNA methylase activity activity activity., A combined Genetic and biochemical approach revealed that human TRDMT1 wt Allele did not methylate DNA but instead methylated a small RNA; mass spectrometry showed that this RNA is aspartic acid transfer RNA (tRNA(Asp)) and that TRDMT1 wt Allele specifically methylated cytosine 38 in the anticodon loop., Here, we propose that RNA methylation began prior to DNA methylation in the early forms of life evolving on Earth.[SEP]Relations: METTL3 has relations: bioprocess_protein with RNA methylation, bioprocess_protein with RNA methylation, bioprocess_protein with mRNA methylation, bioprocess_protein with mRNA methylation, molfunc_protein with RNA methyltransferase activity, molfunc_protein with RNA methyltransferase activity, bioprocess_protein with primary miRNA methylation, bioprocess_protein with primary miRNA methylation. Geneticin has relations: drug_drug with Methylphenidate, drug_drug with Methylphenidate. Definitions: Epithelial Cells defined as following: Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional Epithelial Cells.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode Genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Site defined as following: A Positioning Attribute in relation to its surroundings.. 5-Methylcytosine defined as following: A methylated form of the nucleobase cytosine occurring predominantly in cytosine-phosphate-guanine (CpG) islands that are produced by DNA methyltransferases and may regulate gene expression. Like cytosine, the DNA sequence containing 5-Methylcytosine (5-mC) is able to be replicated without error and 5-mC can pair with guanine in double stranded DNA. However, DNA sequences containing a high local concentration of 5-mC may be less transcriptionally active than areas with higher ratios of unmodified cytosine.. Positioning Attribute defined as following: A reference to the alignment of an object, a particular situation or view of a situation, or the location of an object.. Eukaryota defined as following: Organism or cells with a nucleus separated from the cytoplasm by a two membrance nuclear envelope and compartmentalization of function into distinct cytoplasmic organelles.. DNA defined as following: A deoxyribonucleotide polymer that is the primary Genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. METTL3 gene defined as following: This gene is involved in methlyation of mRNA.. ResponseLevel - modification defined as following:

Respond with exceptions, completions and modifications or revisions done before completion

. TRDMT1 wt Allele defined as following: Human TRDMT1 wild-type allele is located in the vicinity of 10p15.1 and is approximately 60 kb in length. This allele, which encodes tRNA (cytosine(38)-C(5))-methyltransferase protein, plays a role in methylation of aspartic acid transfer RNA but also has DNA-(cytosine-C5) methyltransferase activity.. Genetic defined as following: Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.. tRNA Methyltransferases defined as following: Enzymes that catalyze the S-adenosyl-L-methionine-dependent methylation of ribonucleotide bases within a transfer RNA molecule. EC 2.1.1.. Organism defined as following: A living entity..", "label": "no"} {"original_question": "Can FOXOs modulate longevity?", "id": "converted_700", "sentence1": "Can FOXOs modulate longevity?", "sentence2": "Forkhead box O (FOXO Family Family) TRANSCRIPTION FACTOR have a conserved function in regulating metazoan lifespan., In contrast to FOXO1 gene, FOXO3A protein, human and Forkhead Box Protein O6 were specifically diminished in the Central Nervous System of HFD animal allergen extracts possibly contributing to the reduced lifespan observed in these animal allergen extracts., Interestingly, many target Proteins of AMP-Activated Protein Kinases are so-called longevity factors, e.g., Sirtuin 1, TP53 wt Allele, and FoxOs, which not only can increase the stress resistance and extend the lifespan of many Organism but also inhibit the inflammatory responses. , Components of anti-ageing and autophagy include Sirtuins and FoxOs., Since Sirts and FoxOs are reliable markers of longevity, the results appear to suggest that Longevinex induces longevity after prolonged feeding via induction of autophagy, while it converts Cessation of life signals into survival signals and provides cardioprotection within a relatively shorter period of time., Forkhead box O (FOXO Family Family) TRANSCRIPTION FACTOR are involved in various cellular processes, including cell proliferation, stress resistance, metabolism, and longevity, In this respect, members of the Mammals forkhead TRANSCRIPTION FACTOR of the O class (FoxOs) that include FOXO1 gene, FOXO3 wt Allele, Forkhead Box Protein O4 and Forkhead Box Protein O6 are increasingly being recognized as exciting prospects for multiple pathologies. These TRANSCRIPTION FACTOR govern development, proliferation, survival and longevity during multiple cellular environments that can involve oxidative stress. , Here we discuss the fascinating but complex role of FoxOs during cellular injury and oxidative stress, progenitor cell development, fertility, angiogenesis, cardiovascular function, cellular metabolism and Diabetes Mellitus, cell longevity, immune surveillance and Primary malignant neoplasm., Many longevity genes, e.g. FoxOs and Sirtuin 1, are inhibitors of NF-kappa B signaling. , Interestingly, several longevity genes such as Sirtuin 1, Mono-ADP-Ribosyltransferase Sirtuin-6, and FoxOs can clearly suppress NF-kappa B signaling and in this way delay the aging process and extend lifespan., Yet, FoxOs also can significantly affect normal cell survival and longevity, requiring new treatments for neoplastic growth to modulate novel pathways that integrate cell proliferation, metabolism, Inflammation and survival., These observations link FoxO function in Mammals systems with the evolutionarily conserved role of FoxO in promotion of stress resistance and longevity in lower phylogenetic systems. Furthermore, these findings have implications for aging in higher Organism and in malignant Stem cells biology, and suggest that FoxOs may play an important role in the maintenance and integrity of Stem cells compartments in a broad spectrum of Body tissue., Forkhead box O (FoxO) TRANSCRIPTION FACTOR are important downstream targets of the PI3K/Akt signaling pathway and crucial regulators of cell fate. This function of FoxOs relies on their ability to control diverse cellular functions, including proliferation, differentiation, apoptosis, DNA repair, defense against oxidative stress and ageing., This brief review focuses on the molecular mechanisms, cellular effects and resulting organismal phenotypes generated by differentially regulated FoxO Proteins and discusses our current understanding of the role of FoxOs in Disease and ageing processes., In this review, we focus on the several interactions of aging-associated signaling cascades regulated either by Sirtuins and FoxOs or NF-kappa B signaling pathways. We provide evidence that signaling via the longevity factors of FoxOs and Sirtuin 1 can inhibit NF-kappa B signaling and simultaneously protect against inflamm-aging process., In diverse species TRANSCRIPTION FACTOR belonging to the forkhead/winged helix box gene, group O (FOXO Family Family) subfamily have been found to be crucial in downstream suppression of the life-shortening effects of insulin/insulin-like growth factor-I receptor signalling pathways that, when upregulated, accelerate ageing by suppression of FOXO Family Family. , In Homo sapiens, FOXO3a, as well as FOXO1 and -4, and their downstream effectors, could hold the key to counteracting ageing and common diseases., FOXO Family Family TRANSCRIPTION FACTOR have important roles in metabolism, cellular proliferation, stress tolerance, and aging. [SEP]Relations: central nervous system has relations: anatomy_protein_present with FOXO4, anatomy_protein_present with FOXO4, anatomy_protein_present with FOXO1, anatomy_protein_present with FOXO1, anatomy_protein_present with FOXN3, anatomy_protein_present with FOXN3, anatomy_protein_present with FOXK2, anatomy_protein_present with FOXK2. transcription factor binding has relations: molfunc_protein with FOXC1, molfunc_protein with FOXC1. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. FOXO3A protein, human defined as following: Forkhead box protein O3 (673 aa, ~71 kDa) is encoded by the human FOXO3 gene. This protein is involved in the modulation of transcription, apoptosis and embryonic pattern formation.. Forkhead Box Protein O4 defined as following: Forkhead box protein O4 (505 aa, ~54 kDa) is encoded by the human FOXO4 gene. This protein plays a role in cell cycle arrest, transcriptional regulation, embryonic development and insulin signaling.. Inflammation defined as following: A pathological process characterized by injury or destruction of Body tissue caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. FOXO Family defined as following: A subfamily within the forkhead box (FOX) protein family, which is a family of TRANSCRIPTION FACTOR that contain a forkhead DNA-binding domain. FOXO Family Proteins regulate apoptosis, cell-cycle progression, oxidative-stress resistance, and tumor suppression. The transcriptional promoter activity of these factors is regulated by post-translational modifications, such as phosphorylation, acetylation, and monoubiquitination.. Sirtuins defined as following: A homologous family of regulatory enzymes that are structurally related to the protein silent mating type information regulator 2 (Sir2) found in Saccharomyces cerevisiae. Sirtuins contain a central catalytic core region which binds NAD. Several of the sirtuins utilize NAD to deacetylate Proteins such as HISTONES and are categorized as GROUP III HISTONE DEACETYLASES. Several other sirtuin members utilize NAD to transfer ADP-RIBOSE to Proteins and are categorized as MONO ADP-RIBOSE TRANSFERASES, while a third group of sirtuins appears to have both deacetylase and ADP ribose transferase activities.. AMP-Activated Protein Kinases defined as following: Intracellular signaling protein kinases that play a signaling role in the regulation of cellular energy metabolism. Their activity largely depends upon the concentration of cellular AMP which is increased under conditions of low energy or metabolic stress. AMP-activated protein kinases modify enzymes involved in LIPID METABOLISM, which in turn provide substrates needed to convert AMP into ATP.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Mammals defined as following: Warm-blooded vertebrate animal allergen extracts belonging to the class Mammalia, including all that possess hair and suckle their young.. Stem cells defined as following: Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells.. Sirtuin 1 defined as following: A sirtuin family member found primarily in the CELL NUCLEUS. It is an NAD-dependent deacetylase with specificity towards HISTONES and a variety of Proteins involved in gene regulation.. Mono-ADP-Ribosyltransferase Sirtuin-6 defined as following: Mono-ADP-ribosyltransferase sirtuin-6 (355 aa, ~ 39 kDa) is encoded by the human Mono-ADP-Ribosyltransferase Sirtuin-6 gene. This protein may be involved in post-translational protein modification.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. TP53 wt Allele defined as following: Human TP53 wild-type allele is located in the vicinity of 17p13.1 and is approximately 19 kb in length. This allele, which encodes cellular tumor antigen TP53 wt Allele protein, plays a role in cell cycle regulation during the G0/G1transition. Alterations of the TP53 gene occur as both somatic and germline mutations in human malignancies in select Primary malignant neoplasm-prone families with Li-Fraumeni syndrome.. Forkhead Box Protein O6 defined as following: Forkhead box protein O6 (492 aa, ~51 kDa) is encoded by the human FOXO6 gene. This protein may play a role in the positive regulation of transcription.. FOXO3 wt Allele defined as following: Human FOXO3 wild-type allele is located in the vicinity of 6q21 and is approximately 121 kb in length. This allele, which encodes forkhead box protein O3A, plays a role in the activation of both transcription by RNA polymerase II and apoptosis that is induced by oxidative stress.. Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. FOXO1 gene defined as following: This gene is involved in transcriptional regulation and may play a role in myogenic growth and differentiation.. Diabetes Mellitus defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.. Central Nervous System defined as following: The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.. NF-kappa B defined as following: Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA.. Organism defined as following: A living entity.. Homo sapiens defined as following: Members of the species Homo sapiens.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually Proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process..", "label": "yes"} {"original_question": "Is diphosphatidylglycerol (cardiolipin) a phospholipid of the mitochondrial membranes?", "id": "converted_2129", "sentence1": "Is Diphosphatidylglycerols (cardiolipin) a phospholipid of the Mitochondrial Inheritance membranes?", "sentence2": "A unique Cytoplasmic Cytoplasmic organelle for studying Tissue Tissue membrane biochemistry is the mitochondrion whose functionality depends on a coordinated supply of Proteins and Lipids. Mitochondria are capable of synthesizing several Lipids autonomously such as Phosphatidyl glycerol, cardiolipin and in part phosphatidylethanolamine, Phosphatidic Acid and Cytidine Diphosphate Diglycerides., A small decrease of Diphosphatidylglycerols also occurred in the Liver neoplasms Mitochondria inner Tissue Tissue membrane. , Diphosphatidylglycerol was confined to the Mitochondrial Inheritance fraction, where it represented about 7% of the total phosphoacylglycerols. , Mitochondrial Membranes were isolated from the Myocardium of young (4-month-old) and aged (33-month-old) male Long-Evans rats and compared in terms of cholesterol content and phospholipid and fatty acid composition. In aged rats, as compared to young, the major observations include: markedly higher cholesterol content; increased percentage of Sphingomyelins and Diphosphatidylglycerols (cardiolipin); , The polyglycerophosphatides (typified by Diphosphatidylglycerols) were apparently synthesized in situ by intramitochondrial Tissue Tissue membrane-bound enzymes using CDP-diglycerides as intermediates. , Both the Mitochondrial Inheritance and microsomal fractions contained significant proportions of solvent front phospholipid (spleen fibrinolytic proteinase (human)) and whereas the Mitochondrial Inheritance spleen fibrinolytic proteinase (human) displayed the relatively unsaturated fatty acid composition characteristic of Diphosphatidylglycerols (cardiolipin), the Fatty Acids of the microsomal spleen fibrinolytic proteinase (human) were distinctly more Saturated., Ten to 15% of microsomal radioactive CDP-diglycerides was transferred to Mitochondrial Inheritance membranes and incorporated into Mitochondrial Inheritance radioactive Lipids identified as Phosphatidyl glycerol, phosphatidylglycerophosphate, and, when [14C]linoleoyl CDP-diglycerides were used, Diphosphatidylglycerols (cardiolipin)., The Enzyme [APC] responsible for the conversion of Phosphatidyl glycerol to Diphosphatidylglycerols (cardiolipin) in the presence of Cytidine Diphosphate Diacylglycerol is firmly associated with Mitochondrial Inheritance membranes and is not extracted with hypotonic or hypertonic media or with nonionic detergents., The mechanism of cardiolipin (Diphosphatidylglycerols) biosynthesis was examined in Mitochondria and outer and inner Mitochondrial Inheritance membranes prepared from Cavia porcellus and Rattus norvegicus livers to determine whether this formation from Phosphatidyl glycerol was absolutely dependent on cytidinediphosphodiglyceride, as previously reported for intact Mitochondria., In isolated Mitochondrial Inheritance outer membranes, cardiolipin (Diphosphatidylglycerols) increased CPT1A wt Allele activity 4-fold and the Km for carnitine 6-fold., Ten to 15% of microsomal radioactive CDP-diglycerides was transferred to Mitochondrial Inheritance membranes and incorporated into Mitochondrial Inheritance radioactive Lipids identified as Phosphatidyl glycerol, phosphatidylglycerophosphate, and, when [14C]linoleoyl CDP-diglycerides were used, Diphosphatidylglycerols (cardiolipin)., 90% or more of the phospholipid, cardiolipin was found in the Mitochondrial Inheritance membranes of Wildtype Finding and petite yeast., Furthermore, the same mechanism for the biosynthesis of cardiolipin was operational in the outer and inner Mitochondrial Inheritance membranes., The mechanism of cardiolipin (Diphosphatidylglycerols) biosynthesis was examined in Mitochondria and outer and inner Mitochondrial Inheritance membranes prepared from Cavia porcellus and Rattus norvegicus livers to determine whether this formation from Phosphatidyl glycerol was absolutely dependent on cytidinediphosphodiglyceride, as previously reported for intact Mitochondria, Cardiolipins (CL) is a key phospholipid in Mitochondrial Inheritance membranes, playing important roles in maintaining the functional integrity and dynamics of Mitochondria in animal allergen extracts and Candida albicans allergenic extract, Cardiolipins, the specific phospholipid of Mitochondria, is involved in the biogenesis, the dynamics, and the supramolecular organization of Mitochondrial Inheritance membranes, Cardiolipins (CL), the signature phospholipid of Mitochondrial Inheritance membranes, is crucial for both Mitochondrial Inheritance function and cellular processes outside of the Mitochondria, Since it has been recognized that Mitochondria are crucial not only for energy metabolism but also for other cellular functions, there has been a growing interest in cardiolipin, the specific phospholipid of Mitochondrial Inheritance membranes, Cardiolipins, the main anionic phospholipid in Mitochondrial Inheritance membranes, is expected to be a determinant in this adaptive mechanism since it modulates the activity of most Membrane Proteins, Ten to 15% of microsomal radioactive CDP-diglycerides was transferred to Mitochondrial Inheritance membranes and incorporated into Mitochondrial Inheritance radioactive Lipids identified as Phosphatidyl glycerol, phosphatidylglycerophosphate, and, when [14C]linoleoyl CDP-diglycerides were used, Diphosphatidylglycerols (cardiolipin), Cardiolipins is normally localized to the inner Mitochondrial Inheritance Tissue Tissue membrane; however, when cardiolipin becomes externalized to the surface of dysregulated Mitochondria, it promotes inflammasome activation and stimulates the elimination of damaged or nonfunctional Mitochondria by mitophagy, In isolated Mitochondrial Inheritance outer membranes, cardiolipin (Diphosphatidylglycerols) increased CPT1A wt Allele activity 4-fold and the Km for carnitine 6-fold. , Increasing levels of cardiolipin differentially influence packing of phospholipids found in the Inner Mitochondrial Inheritance Tissue Tissue membrane., Here, we used Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae or Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae cerevisiae subjected to conditions that affect Mitochondrial Inheritance metabolism as a model to determine the possible role of cardiolipin in stress adaptation. , This decline of respiration was attributed to a progressive diminution of the number of Mitochondria in copper-treated cells, based on the demonstration of the concomitant decline of (1) cardiolipin (Diphosphatidylglycerols) and Cytochrome aa3 (CYTOCHROME C OXIDASE), two specific markers of Inner Mitochondrial Inheritance Tissue Tissue membrane, and (2) fumarase activity, a specific marker of Mitochondrial Inheritance matrix space., Diphosphatidylglycerol (diphenylguanidine) or cardiolipin, a specific component of the inner Mitochondrial Inheritance Tissue Tissue membrane, represents about 4% of the total lipid content., Experimental results confirmed that the biosynthesis of cardiolipin, from the Tissue Tissue membrane-bound radioactive Phosphatidyl glycerol in intact Mitochondria isolated from Cavia porcellus and Rattus norvegicus Abdomen>Liver, was absolutely dependent on CDP-diglycerides and required the addition of Cations, Divalent., We have shown that decrease of cardiolipin in Mitochondrial Inheritance Tissue Tissue membrane occurs early during Ischemia Procedure, and only during the irreversible phase of Ischemia Procedure are phosphatidylethanolamine and Phosphatidylcholine antibody broken down., Partial purification of Diphosphatidylglycerols synthetase from Abdomen>Liver Mitochondrial Inheritance membranes., A small decrease of Diphosphatidylglycerols also occurred in the Liver neoplasms Mitochondria inner Tissue Tissue membrane.[SEP]Relations: Inner Mitochondrial Inheritance Tissue membrane has relations: cellcomp_protein with PHB, cellcomp_protein with PHB, cellcomp_protein with PMPCB, cellcomp_protein with PMPCB. Mitochondrial Inheritance Tissue membrane has relations: cellcomp_protein with CARD19, cellcomp_protein with CARD19, cellcomp_protein with ACADL, cellcomp_protein with ACADL. Mitochondrial Inheritance outer Tissue membrane has relations: cellcomp_protein with BNIP3L, cellcomp_protein with BNIP3L. Definitions: Lipids defined as following: A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and Fatty Acids. (Grant & Hackh's Chemical Dictionary, 5th ed). Sphingomyelins defined as following: A class of sphingolipids found largely in the brain and other nervous tissue. They contain phosphocholine or phosphoethanolamine as their polar head group so therefore are the only sphingolipids classified as PHOSPHOLIPIDS.. Ischemia Procedure defined as following: A surgical procedure during which the blood supply to an organ or tissue is interrupted and then later reestablished.. phospholipids defined as following: Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar Lipids that are of great importance for the structure and function of cell membranes and are the most abundant of Tissue membrane Lipids, although not stored in large amounts in the system.. Cytoplasmic organelle defined as following: Cell part which consists of macromolecules aggregated into discrete structures in the protoplasm. (Digital Anatomist Foundational Model). phosphatidylethanolamine defined as following: A phospholipid with the polar ethanolamine found in phosphoester linkage to Diacylglycerol.. Mitochondria defined as following: Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting Tissue membrane. The inner Tissue membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed). Mitochondrial Membranes defined as following: Either of the lipid bilayers that surround the mitochondrion and form the Mitochondrial Inheritance envelope. [GOC:mah, NIF_Subcellular:sao1045389829]. Cations, Divalent defined as following: Positively charged atoms, radicals or groups of atoms with a valence of plus 2, which travel to the cathode or negative pole during electrolysis.. Wildtype Finding defined as following: A finding indicating that no genetic variations have been detected across the entire sequence of one or more genes.. Liver neoplasms defined as following: Tumors or cancer of the LIVER.. Cytidine Diphosphate defined as following: Cytidine 5'-(trihydrogen diphosphate). A cytosine nucleotide containing two phosphate groups esterified to the sugar moiety. Synonyms: CRPP; cytidine pyrophosphate.. cholesterol defined as following: The principal sterol of all higher animal allergen extracts, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.. Cardiolipins defined as following: Acidic phospholipids composed of two molecules of Phosphatidic Acid covalently linked to a molecule of glycerol. They occur primarily in Mitochondrial Inheritance inner membranes and in bacterial plasma membranes. They are the main antigenic components of the Wassermann-type antigen that is used in nontreponemal SYPHILIS SERODIAGNOSIS.. CYTOCHROME C OXIDASE defined as following: A multisubunit Enzyme [APC] complex containing CYTOCHROME A GROUP; CYTOCHROME A3; two copper atoms; and 13 different protein subunits. It is the terminal oxidase complex of the RESPIRATORY CHAIN and collects electrons that are transferred from the reduced CYTOCHROME C GROUP and donates them to molecular OXYGEN, which is then reduced to water. The redox reaction is simultaneously coupled to the transport of PROTONS across the inner Mitochondrial Inheritance Tissue membrane.. CPT1A wt Allele defined as following: Human CPT1A wild-type allele is located in the vicinity of 11q13.3 and is approximately 90 kb in length. This allele, which encodes carnitine O-palmitoyltransferase 1, Abdomen>Liver isoform protein, plays a role in the modification and Mitochondrial Inheritance uptake of long-chain Fatty Acids and the metabolism of triglycerides by the Abdomen>Liver. Loss of function mutations of the gene are associated with carnitine palmitoyltransferase 1A deficiency.. Membrane Proteins defined as following: Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral Proteins. They include most Tissue membrane-associated enzymes, antigenic Proteins, transport Proteins, and drug, hormone, and lectin receptors.. Fatty Acids defined as following: Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are Saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed). Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Cytidine Diphosphate Diglycerides defined as following: The ester of Diacylglycerol with the terminal phosphate of Cytidine Diphosphate. It serves as an intermediate in the biosynthesis of phosphatidylethanolamine and phosphatidylserine in bacteria.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. Saturated defined as following: Impregnation of one substance by another to the greatest possible extent; that concentration of a dissolved substance that cannot be exceeded.. Phosphatidic Acid defined as following: A glycerol backbone covalently bound to a phosphate group in one position, and Fatty Acids in the 2nd and 3rd positions. Phosphatidic acids thus have a polar head and apolar tails, and occur in cell membranes throughout nature.. Cytochrome aa3 defined as following: A dimer of CYTOCHROME A and CYTOCHROME A3.. Inner Mitochondrial Inheritance Tissue membrane defined as following: The inner, i.e. lumen-facing, lipid bilayer of the Mitochondrial Inheritance envelope. It is highly folded to form cristae. [GOC:ai]. Cavia porcellus defined as following: The domesticated Cavia porcellus, Cavia porcellus.. Mitochondrial Inheritance defined as following: The distribution of Mitochondria, including the Mitochondrial Inheritance genome, into daughter cells after mitosis or meiosis, mediated by interactions between Mitochondria and the cytoskeleton. [GOC:mcc, PMID:10873824, PMID:11389764]. Tissue membrane defined as following: Thin layers of tissue which cover parts of the body, separate adjacent cavities, or connect adjacent structures.. Myocardium defined as following: The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow.. Mitochondrial Inheritance outer membranes defined as following: The outer, i.e. cytoplasm-facing, lipid bilayer of the Mitochondrial Inheritance envelope. [GOC:ai]. Diacylglycerol defined as following: A synthetic oil with anti-obesity activity. The enzymatically synthesized isoform, 1,3-isoform Diacylglycerol, is suggested to decrease formation of chylomicrons as well as shunting them directly to the Abdomen>Liver through the portal vein where they are oxidized. Increased beta-oxidation may enhance body weight loss, suppress body fat accumulation and lower serum triacylglycerol levels through increasing satiety.. Mitochondrial Inheritance membranes defined as following: Either of the lipid bilayers that surround the mitochondrion and form the Mitochondrial Inheritance envelope. [GOC:mah, NIF_Subcellular:sao1045389829]. phospholipid defined as following: Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar Lipids that are of great importance for the structure and function of cell membranes and are the most abundant of Tissue membrane Lipids, although not stored in large amounts in the system.. cardiolipin defined as following: Acidic phospholipids composed of two molecules of Phosphatidic Acid covalently linked to a molecule of glycerol. They occur primarily in Mitochondrial Inheritance inner membranes and in bacterial plasma membranes. They are the main antigenic components of the Wassermann-type antigen that is used in nontreponemal SYPHILIS SERODIAGNOSIS..", "label": "yes"} {"original_question": "Is c-myc subject to regulation by the circadian clock?", "id": "converted_1416", "sentence1": "Is c-myc subject to regulation by the circadian clock?", "sentence2": "The current study encompasses the investigation of simultaneous expression of four circadian clock Genes (ARNTL wt Allele, Clock, Per1 and Per2) and three clock-controlled cell cycle Genes (MYC protein, human, Cyclin D1 and WEE1 gene), Our results suggest that aberrant expression of circadian clock Genes can lead to aberrant expression of their downstream targets that are involved in cell proliferation and apoptosis and hence may result in manifestation of Chronic Lymphocytic Leukemia., Loss of ARNTL wt Allele reduced the expression of Period Circadian Protein Homolog 1, PER2 gene, PER3 gene, wee1 and p53. The expression of oncoprotein oncoprotein p21 and c-myc was also altered in certain Cultured Cell Line., In particular, the c-myc Proto-Oncogenes has been documented to be under circadian regulation., The circadian expression of c-MYC is modulated by the histone deacetylase inhibitor trichostatin A in synchronized Mus Neuroblastoma cells., Our results, using the Mus Neuroblastoma cell line N2A, show that Per1 and c-MYC protein, human steady-state RNA, Messenger levels oscillate with the same phase., These experiments demonstrate for the first time that a significant decrease in c-MYC protein, human transcript and protein levels can be achieved after a short indole-3-glycerol-phosphate lyase activity treatment applied only at specific circadian times. This is also followed by a reduction in the proliferation rate of the cell population., Among the circadian output pathways, the rhythmic sympathetic signaling plays a key role in the central-peripheral timing mechanism that simultaneously activates the cell cycle clock via AP1-controlled MYC protein, human induction and p53 via peripheral clock-controlled ammonium tetrathiomolybdate activation., Jet-lag promptly desynchronizes the central clock-SNS-peripheral clock axis, abolishes the peripheral clock-dependent ammonium tetrathiomolybdate activation, and activates myc oncogenic potential, leading to tumor development in the same organ systems in wild-type and circadian gene-mutant CASP14 gene., The results showed that over-expression of Per2 induced not only cell cycle arrest at G2/M phase but also an increase in apoptosis, which was confirmed by characteristic morphological changes, MYOCLONUS, FAMILIAL CORTICAL and evident DNA fragmentation. Further experiments confirmed both up-regulation of TP53 wt Allele and down-regulation of CylinB1and C-myc., On the other hand, while TP53 wt Allele was found to be down-regulated. CylinB1 and C-myc were up-regulated. after Per2 knockdown., We also show that BMAL1 epigenetic inactivation impairs the characteristic circadian clock expression pattern of Genes such as c-myc Genes, catalase, and EP300 wt Allele in association with a loss of BMAL1 occupancy in their respective Promoter., Per2 mutant (Per2(m/m)) CASP14 gene show an increase in Lymphoma and deregulated expression of Cyclin D and c-MYC protein, human Genes that are key to proliferation control., The expression of cell cycle Genes such as WEE1 gene, Cyclins, and c-MYC protein, human are under circadian control and could be directly under the regulation of the circadian transcriptional complex., Overexpressed mPER2 also altered the expression of apoptosis-related Genes. The RNA, Messenger and protein levels of c-MYC protein, human, Bcl-X(L) and BCL2 gene were downregulated,, Temporal expression of Genes involved in cell cycle regulation and tumor suppression, such as c-MYC protein, human, Cyclin D1, Cyclin A, Mdm-2 and Gadd45alpha is deregulated in mPer2 mutant CASP14 gene., The temporal expression of Genes involved in cell cycle regulation and tumor suppression, such as c-MYC protein, human, Cyclin D1, Cyclin A, Mdm-2, and Gadd45alpha, is deregulated in mPer2 mutant CASP14 gene.[SEP]Relations: PER2 has relations: bioprocess_protein with regulation of circadian rhythm, bioprocess_protein with regulation of circadian rhythm, bioprocess_protein with negative regulation of circadian rhythm, bioprocess_protein with negative regulation of circadian rhythm. entrainment of circadian clock by photoperiod has relations: bioprocess_protein with RBM4, bioprocess_protein with RBM4, bioprocess_protein with FBXL6, bioprocess_protein with FBXL6, bioprocess_protein with RBM4B, bioprocess_protein with RBM4B. Definitions: Period Circadian Protein Homolog 1 defined as following: Period circadian protein homolog 1 (1290 aa, ~136 kDa) is encoded by the human PER1 gene. This protein is involved in the modulation of circadian rhythms.. ARNTL wt Allele defined as following: Human ARNTL wild-type allele is located in the vicinity of 11p15 and is approximately 111 kb in length. This allele, which encodes aryl hydrocarbon receptor nuclear translocator-like protein 1, plays a role in the transcriptional activation of Genes involved in circadian rhythms.. TP53 wt Allele defined as following: Human TP53 wild-type allele is located in the vicinity of 17p13.1 and is approximately 19 kb in length. This allele, which encodes cellular tumor antigen p53 protein, plays a role in cell cycle regulation during the G0/G1transition. Alterations of the TP53 gene occur as both somatic and germline mutations in human malignancies in select cancer-prone families with Li-Fraumeni syndrome.. BCL2 gene defined as following: The B-cell leukemia/lymphoma-2 Genes, responsible for blocking apoptosis in normal cells, and associated with follicular lymphoma when overexpressed. Overexpression results from the t(14;18) translocation. The human c-bcl-2 gene is located at 18q24 on the long arm of chromosome 18.. Cyclin D defined as following: A cyclin subtype that is specific for CYCLIN-DEPENDENT KINASE 4 and CYCLIN-DEPENDENT KINASE 6. Unlike most cyclins, Cyclin D expression is not cyclical, but rather it is expressed in response to proliferative signals. Cyclin D may therefore play a role in cellular responses to mitogenic signals.. Cyclin D1 defined as following: Protein encoded by the bcl-1 gene which plays a critical role in regulating the cell cycle. Overexpression of cyclin D1 is the result of bcl-1 rearrangement, a t(11;14) translocation, and is implicated in various neoplasms.. indole-3-glycerol-phosphate lyase activity defined as following: Catalysis of the reaction: (1S,2R)-1-C-(indol-3-yl)glycerol 3-phosphate = indole + D-glyceraldehyde 3-phosphate. [EC:4.1.2.8]. MYC protein, human defined as following: MYC protein, human proto-oncogene protein (439 aa, ~49 kDa) is encoded by the human MYC gene. This protein plays a role in the regulation of transcription and cell proliferation.. Lymphoma defined as following: A general term for various neoplastic diseases of the lymphoid tissue.. oncoprotein p21 defined as following: A cyclin-dependent kinase inhibitor that mediates TUMOR SUPPRESSOR PROTEIN TP53 wt Allele-dependent CELL CYCLE arrest. oncoprotein p21 interacts with a range of CYCLIN-DEPENDENT KINASES and associates with PROLIFERATING CELL NUCLEAR ANTIGEN and CASPASE 3.. Chronic Lymphocytic Leukemia defined as following: A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called chronic lymphocytic leukemia (Chronic Lymphocytic Leukemia); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease.. RNA, Messenger defined as following: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the cytoplasm.. catalase defined as following: An oxidoreductase that catalyzes the conversion of HYDROGEN PEROXIDE to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA.. EP300 wt Allele defined as following: Human EP300 wild-type allele is located in the vicinity of 22q13.2 and is approximately 88 kb in length. This allele, which encodes the histone acetyltransferase EP300 wt Allele protein, is involved in both cyclic-AMP driven transcriptional activation and the cellular response to hypoxia.. WEE1 gene defined as following: This gene plays a role in cell cycle regulation.. Neuroblastoma defined as following: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51). MYOCLONUS, FAMILIAL CORTICAL defined as following: A rare genetic movement disorder with characteristics of autosomal dominant, adult-onset, slowly progressive, multifocal, cortical myoclonus. Patients present somatosensory-evoked, brief, jerky, involuntary movements in the face, arms and legs, associated in most of cases with sustained, multiple, sudden falls without loss of consciousness. Seizures or other neurological deficits, aside from mild cerebellar ataxia late in the course of the illness, are absent. The disease is caused by heterozygous mutation in the NOL3 gene on chromosome 16q22.. Mus defined as following: Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. Cultured Cell Line defined as following: Established cell cultures that have the potential to propagate indefinitely.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. cell cycle Genes defined as following: Genes that code for proteins that regulate the CELL DIVISION CYCLE. These Genes form a regulatory network that culminates in the onset of MITOSIS by activating the p34cdc2 protein (PROTEIN P34CDC2).. trichostatin A defined as following: A natural derivative of dienohydroxamic acid isolated from species of the bacterial genus Streptomyces. Trichostatin A (indole-3-glycerol-phosphate lyase activity) reversibly and specifically inhibits histone deacetylases, resulting in hyperacetylation of core histones which modulate chromatin structure. The increase in histone acetylation promotes selective gene transcription and the inhibition of tumor growth. This agent is a potent inducer of tumor cell growth arrest, differentiation and apoptosis in a variety of transformed cells in culture and in tumor-bearing animals. (NCI04). Cyclin A defined as following: A cyclin subtype that has specificity for CDC2 PROTEIN KINASE and CYCLIN-DEPENDENT KINASE 2. It plays a role in progression of the CELL CYCLE through G1/S and G2/M phase transitions.. Cyclins defined as following: A large family of regulatory proteins that function as accessory subunits to a variety of CYCLIN-DEPENDENT KINASES. They generally function as ENZYME ACTIVATORS that drive the CELL CYCLE through transitions between phases. A subset of cyclins may also function as transcriptional regulators..", "label": "yes"} {"original_question": "Is Beta-Thalassemia is associated with a mutation or deletion of the gene that codes for alpha globin?", "id": "converted_2128", "sentence1": "Is Beta-Thalassemia is associated with a mutation or deletion of the gene that codes for alpha globin?", "sentence2": "beta Thalassemia, one of the most common single-gene disorders, is the result of reduced or absent production of β-globin chains, The beta-thalassemia syndromes are a heterogeneous group of genetic disorders characterized by reduced or absent expression of the HBB wt Allele[SEP]Relations: beta thalassemia has relations: disease_disease with thalassemia, disease_disease with thalassemia, disease_phenotype_positive with Abnormal hemoglobin, disease_phenotype_positive with Abnormal hemoglobin, disease_protein with HBG1, disease_protein with HBG1, disease_phenotype_positive with Reduced hemoglobin A, disease_phenotype_positive with Reduced hemoglobin A, disease_disease with beta-thalassemia and related diseases, disease_disease with beta-thalassemia and related diseases. Definitions: beta Thalassemia defined as following: A disorder characterized by reduced synthesis of the beta chains of hemoglobin. There is retardation of hemoglobin A synthesis in the heterozygous form (thalassemia minor), which is asymptomatic, while in the homozygous form (thalassemia major, Cooley's anemia, Mediterranean anemia, erythroblastic anemia), which can result in severe complications and even death, hemoglobin A synthesis is absent.. HBB wt Allele defined as following: Human HBB wt allele is located in the vicinity of 11p15.5 and is approximately 4 kb in length. This allele, which encodes hemoglobin subunit beta protein, plays a role in the transport of oxygen to tissues of the body. Mutations in this gene are associated with beta-thalassemia.. gene defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. alpha globin defined as following: Hemoglobin subunit alpha (142 aa, ~15 kDa) is encoded by both the human HBA1 and human HBA2 genes. This protein plays a role in the distribution of oxygen from the lungs to other organs and tissues.. mutation defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Beta-Thalassemia defined as following: A disorder characterized by reduced synthesis of the beta chains of hemoglobin. There is retardation of hemoglobin A synthesis in the heterozygous form (thalassemia minor), which is asymptomatic, while in the homozygous form (thalassemia major, Cooley's anemia, Mediterranean anemia, erythroblastic anemia), which can result in severe complications and even death, hemoglobin A synthesis is absent..", "label": "no"} {"original_question": "Is L-4F an apoE mimetic peptide?", "id": "converted_3146", "sentence1": "Is L-4F an apoE mimetic peptide?", "sentence2": "APOA1 gene mimetic peptide 4F suppresses Tumor-Associated Macrophage and Malignant neoplasm of pancreas progression., L-4F, an APOA1 gene (ApoA-I) mimetic peptide, is engineered to mimic the anti-inflammatory and anti-oxidative functionalities of ApoA-I.[SEP]Relations: apolipoprotein A-I binding has relations: molfunc_protein with ABCA1, molfunc_protein with ABCA1, molfunc_protein with TREM2, molfunc_protein with TREM2, molfunc_protein with LCAT, molfunc_protein with LCAT, molfunc_protein with SCARB1, molfunc_protein with SCARB1, molfunc_protein with HSPD1, molfunc_protein with HSPD1. Definitions: APOA1 gene defined as following: The most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. This protein serves as an acceptor for CHOLESTEROL released from cells thus promoting efflux of cholesterol to HDL then to the LIVER for excretion from the body (reverse cholesterol transport). It also acts as a cofactor for LECITHIN CHOLESTEROL ACYLTRANSFERASE that forms CHOLESTEROL ESTERS on the HDL particles. Mutations of this gene APOA1 cause HDL deficiency, such as in FAMILIAL ALPHA LIPOPROTEIN DEFICIENCY DISEASE and in some patients with TANGIER DISEASE.. Malignant neoplasm of pancreas defined as following: A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma.. Tumor-Associated Macrophage defined as following: Non-neoplastic macrophages that are found in close proximity to or within a tumor mass.. apoE defined as following: A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III..", "label": "no"} {"original_question": "Is Pim-1 a protein phosphatase?", "id": "converted_3222", "sentence1": "Is Pim-1 a protein phosphatase?", "sentence2": "Pim-1 proto-oncogene, AURKA gene (PIM-1) phosphorylates a series of substrates to exert its oncogenic function in numerous Malignant Neoplasms., The Pim1 AURKA gene is associated with multiple cellular functions including proliferation, survival, differentiation, apoptosis, tumorigenesis, immune regulation and Inflammation in Vertebrates.[SEP]Relations: Portal Inflammation has relations: disease_phenotype_positive with FADD-related immunodeficiency, disease_phenotype_positive with FADD-related immunodeficiency, phenotype_phenotype with Abnormality of the biliary system, phenotype_phenotype with Abnormality of the biliary system. malignant ear neoplasm has relations: disease_disease with sensory system cancer, disease_disease with sensory system cancer, disease_disease with ear neoplasm, disease_disease with ear neoplasm, disease_disease with head and neck cancer, disease_disease with head and neck cancer. Definitions: AURKA gene defined as following: This gene is involved in cell cycle regulation and cell survival.. Pim1 AURKA gene defined as following: This gene is involved in apoptosis, cell cycle regulation and signal transduction.. Vertebrates defined as following: Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising mammals, birds, reptiles, amphibians, and fishes.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. protein phosphatase defined as following: A CALCIUM and CALMODULIN-dependent serine/threonine protein phosphatase that is composed of the calcineurin A catalytic subunit and the calcineurin B regulatory subunit. Calcineurin has been shown to dephosphorylate a number of phosphoproteins including HISTONES; MYOSIN LIGHT CHAIN; and the regulatory subunits of CAMP-DEPENDENT PROTEIN KINASES. It is involved in the regulation of signal transduction and is the target of an important class of immunophilin-immunosuppressive drug complexes..", "label": "no"} {"original_question": "Is nivolumab used for treatment of Non–Small-Cell Lung Cancer?", "id": "converted_882", "sentence1": "Is nivolumab used for treatment of Non–Small-Cell Lung Cancer?", "sentence2": "BACKGROUND: Patients with advanced squamous-cell non-small-cell Primary malignant neoplasm of lung (NSCLC) who have disease progression during or after first-line chemotherapy have limited treatment options. This randomized, open-label, international, phase 3 study evaluated the efficacy and safety of nivolumab, a fully Homo sapiens IgG4 immunoglobulin complex immunoglobulin complex programmed death 1 (PDCD1 wt Allele) immune-checkpoint-inhibitor antibody, as compared with docetaxel in this patient population., CONCLUSIONS: Among patients with advanced, previously treated squamous-cell NSCLC, overall survival, response rate, and progression-free survival were significantly better with nivolumab than with docetaxel, regardless of CD274 wt Allele expression level., Agents currently in active clinical development for Primary malignant neoplasm of lung include ipilimumab, which modulates the cytotoxic T-lymphocyte-associated antigen 4 pathway, and multiple agents targeting the programmed death protein 1 (PDCD1 wt Allele) pathway, both anti-PDCD1 wt Allele compounds (nivolumab, pembrolizumab [MK-3475]) and those that target programmed death ligand 1 (CD274 wt Allele), a key ligand for PDCD1 wt Allele (BMS-936559, MPDL3280A)., Overall Survival and Long-Term Safety of nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer., We report overall survival (OS), response durability, and long-term safety in patients with non-small-cell Primary malignant neoplasm of lung (NSCLC) receiving nivolumab in this trial.PATIENTS AND METHODS: Patients (N = 129) with heavily pretreated advanced NSCLC received nivolumab 1, 3, or 10 mg/kg intravenously once every 2 weeks in 8-week cycles for up to 96 weeks. , CONCLUSION: nivolumab monotherapy produced durable responses and encouraging survival rates in patients with heavily pretreated NSCLC. Randomized clinical trials with nivolumab in advanced NSCLC are ongoing., Two PDCD1 wt Allele inhibitors, Bristol-Myers Squibb's nivolumab and Merck's MK-3475, both demonstrated positive results in phase I trials of previously treated patients with Non-Small Cell Lung Carcinoma, reported at the World Conference on Lung Cancer in Sydney, Australia., Recently, many trials addressed the role of such therapies for metastatic NSCLC treatment: ipilimumab, tremelimumab, nivolumab and pembrolizumab are immunotherapeutic agents of main interest in this field., Two PDCD1 wt Allele inhibitors, Bristol-Myers Squibb's nivolumab and Merck's MK-3475, both demonstrated positive results in phase I trials of previously treated patients with Non-Small Cell Lung Carcinoma, reported at the World Conference on Lung Cancer in Sydney, Australia, nivolumab, pembrolizumab (formerly known as MK-3475 and pembrolizumab), and pidilizumab are anti-PDCD1 wt Allele antibodies in clinical development for Melanocytic neoplasm, Non-Small Cell Lung Carcinoma, Conventional (Clear Cell) Renal Cell Carcinoma, head and neck Malignant Neoplasms, Lymphoma, and several other Malignant Neoplasms, nivolumab versus docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer., Activity and safety of nivolumab, an anti-PDCD1 wt Allele immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell Primary malignant neoplasm of lung (CheckMate 063): a phase 2, single-arm trial., Patients with squamous non-small-cell Primary malignant neoplasm of lung that is refractory to multiple treatments have poor outcomes. We assessed the activity of nivolumab, a fully Homo sapiens IgG4 immunoglobulin complex immunoglobulin complex PDCD1 wt Allele immune checkpoint inhibitor antibody, for patients with advanced, refractory, squamous non-small-cell Primary malignant neoplasm of lung., nivolumab has clinically meaningful activity and a manageable safety profile in previously treated patients with advanced, refractory, squamous Non-Small Cell Lung Carcinoma. These data support the assessment of nivolumab in randomised, controlled, phase 3 studies of first-line and second-line treatment.[SEP]Relations: nivolumab has relations: drug_drug with Blosozumab, drug_drug with Blosozumab, drug_drug with Sifalimumab, drug_drug with Sifalimumab, drug_drug with Nimotuzumab, drug_drug with Nimotuzumab, drug_drug with Tositumomab, drug_drug with Tositumomab, drug_drug with Afelimomab, drug_drug with Afelimomab. Definitions: PDCD1 wt Allele defined as following: Human PDCD1 wild-type allele is located in the vicinity of 2q37.3 and is approximately 9 kb in length. This allele, which encodes programmed cell death protein 1, plays a role in the modulation of both apoptosis and cellular immunity. Mutation of the gene is associated with systemic lupus erythematosus type 2.. nivolumab defined as following: A fully Homo sapiens immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory Homo sapiens cell surface receptor programmed death-1 (PDCD1 wt Allele, PCD-1) with immune checkpoint inhibitory and antineoplastic activities. Upon administration, nivolumab binds to and blocks the activation of PDCD1 wt Allele, an immunoglobulin superfamily (IgSF) transmembrane protein, by its ligands programmed cell death ligand 1 (CD274 wt Allele), which is overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on antigen-presenting cells (APCs). This results in the activation of T-cells and cell-mediated immune responses against tumor cells. Activated PDCD1 wt Allele negatively regulates T-cell activation and plays a key role in tumor evasion from host immunity.. ipilimumab defined as following: A recombinant Homo sapiens immunoglobulin (Ig) G1 monoclonal antibody directed against the Homo sapiens T-cell receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA4), with immune checkpoint inhibitory and antineoplastic activities. Ipilimumab binds to CTLA4 expressed on T-cells and inhibits the CTLA4-mediated downregulation of T-cell activation. This leads to a cytotoxic T-lymphocyte (CTL)-mediated immune response against cancer cells. CTLA4, an inhibitory receptor and member of the immunoglobulin superfamily, plays a key role in the downregulation of the immune system.. Non-Small Cell Lung Carcinoma defined as following: A heterogeneous aggregate of at least three distinct histological types of Primary malignant neoplasm of lung, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.. Lymphoma defined as following: A general term for various neoplastic diseases of the lymphoid tissue.. tremelimumab defined as following: A Homo sapiens IgG2 monoclonal antibody directed against the T-cell receptor protein cytotoxic T-lymphocyte-associated protein 4 (CTLA4). Tremelimumab binds to CTLA4 and blocks the binding of the antigen-presenting cell ligands B7-1 and B7-2 to CTLA4, resulting in inhibition of B7-CTLA4-mediated downregulation of T-cell activation; subsequently, B7-1 or B7-2 may interact with another T-cell surface receptor protein, CD28, resulting in a B7-CD28-mediated T-cell activation unopposed by B7-CTLA4-mediated inhibition.. Conventional (Clear Cell) Renal Cell Carcinoma defined as following: A malignant epithelial neoplasm of the kidney characterized by the presence of lipid-containing clear cells within a vascular network. The tumor may metastasize to unusual sites and late metastasis is common.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. squamous Non-Small Cell Lung Carcinoma defined as following: A squamous cell carcinoma that arises from the lung. It is characterized by the presence of large malignant cells. It includes the clear cell and papillary variants of squamous cell carcinoma.. CD274 wt Allele defined as following: Human CD274 wild-type allele is located in the vicinity of 9p24 and is approximately 20 kb in length. This allele, which encodes programmed cell death 1 ligand 1 protein, plays a role in the regulation of T cell stimulation and proliferation.. docetaxel defined as following: A semisynthetic analog of PACLITAXEL used in the treatment of locally advanced or metastatic BREAST NEOPLASMS and NON-SMALL CELL LUNG CANCER.. head and neck Malignant Neoplasms defined as following: A primary or metastatic malignant neoplasm affecting the head and neck. Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma.. Melanocytic neoplasm defined as following: A benign or malignant, primary or metastatic neoplasm affecting the melanocytes.. pembrolizumab defined as following: A humanized monoclonal immunoglobulin (Ig) G4 antibody directed against Homo sapiens cell surface receptor PDCD1 wt Allele (programmed death-1 or programmed cell death-1) with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, pembrolizumab binds to PDCD1 wt Allele, an inhibitory signaling receptor expressed on the surface of activated T cells, and blocks the binding to and activation of PDCD1 wt Allele by its ligands, which results in the activation of T-cell-mediated immune responses against tumor cells. The ligands for PDCD1 wt Allele include programmed cell death ligand 1 (CD274 wt Allele), overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on APCs. Activated PDCD1 wt Allele negatively regulates T-cell activation and plays a key role in in tumor evasion from host immunity.. Homo sapiens defined as following: Members of the species Homo sapiens.. PDCD1 wt Allele inhibitors defined as following: An agent designed to interfere with the activity of programmed cell death protein 1 (PD1). PD1 inhibitors block T-cell apoptosis and act as non-specific activators of the immune system.. nivolumab defined as following: A fully Homo sapiens immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory Homo sapiens cell surface receptor programmed death-1 (PDCD1 wt Allele, PCD-1) with immune checkpoint inhibitory and antineoplastic activities. Upon administration, nivolumab binds to and blocks the activation of PDCD1 wt Allele, an immunoglobulin superfamily (IgSF) transmembrane protein, by its ligands programmed cell death ligand 1 (CD274 wt Allele), which is overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on antigen-presenting cells (APCs). This results in the activation of T-cells and cell-mediated immune responses against tumor cells. Activated PDCD1 wt Allele negatively regulates T-cell activation and plays a key role in tumor evasion from host immunity..", "label": "yes"} {"original_question": "Has ubrogepant entered clinical phase III trials?", "id": "converted_3952", "sentence1": "Has ubrogepant entered clinical phase III trials?", "sentence2": "Ubrogepant (MK-1602) is a novel, oral, CALCRL gene antagonist in clinical development with positive phase III outcomes for acute treatment of Migraine Disorders., A population pharmacokinetic model describing the effect of formulations was included in the E-R simulation framework to assess potential dose implications of a formulation switch from phase II to phase III. , The understanding of E-R helped support the dose selection for the phase III clinical trials., The CGRP receptor antagonist ubrogepant, also known as MK-1602, has been recently evaluated in phase III clinical trials for clinical efficacy and long-term safety as an abortive Migraine Disorders treatment., Two pivotal phase III clinical trials (ACHIEVE I and ACHIEVE II) demonstrated effectiveness and safety of ubrogepant in acute Migraine Disorders attacks.[SEP]Relations: CALCRL has relations: drug_protein with Ubrogepant, drug_protein with Ubrogepant, drug_protein with Vazegepant, drug_protein with Vazegepant, drug_protein with Olcegepant, drug_protein with Olcegepant, drug_protein with Rimegepant, drug_protein with Rimegepant, drug_protein with Telcagepant, drug_protein with Telcagepant. Definitions: Migraine Disorders defined as following: A common, severe type of vascular headache often associated with increased sympathetic activity, resulting in nausea, vomiting, and light sensitivity..", "label": "yes"} {"original_question": "Is cocaine use associated with increased risk for intracerebral hemorrhage?", "id": "converted_1102", "sentence1": "Is cocaine use associated with increased risk for Intracerebral Route of Drug Administration hemorrhage?", "sentence2": "Stroke in crack-cocaine abusers is increasingly recognized., There were significant differences between crack-cocaine cases and controls in age (48.7 years vs. 55 years) (P = 0.0001), male gender (65.6% vs. 40.9%) (odds ratios, OR = 1.64, 95% CI 1.22-2.21), arterial Hypertensive disease (61.1% vs. 83.9%) (OR = 0.30, 95% CI 0.15-0.60), Hypercholesterolemia result (18.7% vs. 68.5%) (OR = 0.10, 95% CI 0.05-0.21), Diabetes Mellitus (20.9% vs. 41.9%) (OR = 0.36, 95% CI 0.19-0.70), cigarette smoking (70.6% vs. 29%) (OR = 5.86, 95% CI 3.07-11.20), Ischemic Cerebrovascular accident (61.3% vs. 79.6%) (OR = 0.40, 95% CI 0.21-0.78), and Intracerebral Route of Drug Administration hemorrhage (33.3% vs. 17.2%) (OR = 3.03, 95% CI 1.53-6.00)., Cerebral Hemorrhage (HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO) is a well-recognized complication of recreational cocaine use., HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO is more common in those currently using cocaine perhaps because of acute spikes in blood pressure., Cerebral Hemorrhage in cocaine users., cocaine is a cause of Intracerebral Route of Drug Administration hemorrhage (HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO), but there are no large studies that have characterized the location, pathology, and outcome of patients with cocaine-associated HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO, Aneurysmal Yakut language may be largely a preventable disease among the young and middle-aged because several prevalent risk factors can be modified by medication (eg, Hypertensive disease) or behavioral change (eg, cigarette smoking, cocaine use)., cocaine use and Hypertensive disease are major risk factors for Intracerebral Route of Drug Administration hemorrhage in young African Americans., cocaine use (OR 6.1, 95% CI 3.3-11.8), Hypertensive disease (OR 5.2, 95% CI 3.2-8.7) and alcohol use (OR 1.9, 95% CI 1.1-3.3) were independently associated with increased risk for HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO, cocaine use has been temporally associated with neurovascular complications, including the Rupture of Intracerebral Route of Drug Administration aneurysms., Chronic cocaine use appears to predispose patients who harbor incidental neurovascular anomalies to present at an earlier point in their natural history than similar non-cocaine users., Acute intoxication with either cocaine or methamphetamine may contribute to formation and Rupture of a berry Aneurysm by causing transient Hypertensive disease and Tachycardia by ECG Finding., Although the exact mechanism by which Berry Aneurysm form remains undetermined, research indicates that propagation and Rupture of the Aneurysm are aggravated by Hypertensive disease and Tachycardia by ECG Finding, both of which are pharmacologic side effects of cocaine and methamphetamine, The high frequency of Hypertensive disease, Hypertensive (finding) Intracerebral Route of Drug Administration hemorrhage, and lacunar infarction among young black patients with Cerebrovascular accident suggests accelerated Hypertensive (finding) arteriolar damage, possibly due to poor control of Hypertensive disease., cocaine induced Intracerebral Route of Drug Administration hemorrhage: analysis of Predisposing Factors and mechanisms causing Hemorrhagic Stroke., Hypertensive (finding) cardiovascular disease (HCVD) was significantly higher in persons with Intracerebral Route of Drug Administration hemorrhage than in those with Aneurysm, Ruptured. Our findings suggest that HCVD predisposes to cocaine induced Intracerebral Route of Drug Administration hemorrhage, Cerebral Hemorrhage associated with cocaine Abuse., n view of the present epidemic of cocaine Abuse, Poisoning by cocaine should be considered in the differential diagnosis of Intracerebral Route of Drug Administration hemorrhage, An increase in cocaine Abuse by pregnant women has been associated with a range of maternal/fetal cardiovascular complications. Cerebral Hemorrhage has been reported as a cocaine-related complication,, 13 patients were identified with Neurologic Deficits attributable to the use of cocaine. Ischemic manifestations were the most frequent, occurring in seven (54%) patients, with a mean age of 34.2 years. Three (23%) patients had Subarachnoid Hemorrhage, and three (23%) had Intracerebral Route of Drug Administration hemorrhage., OBJECTIVE: An association between cocaine use and Cerebrovascular accident has been reported, but few studies have examined cocaine-related neurovascular disease using modern Cerebrovascular accident diagnostic techniques., OBJECTIVE: cocaine is a cause of Intracerebral Route of Drug Administration hemorrhage (HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO), but there are no large studies that have characterized the location, pathology, and outcome of patients with cocaine-associated HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO., Because cocaine and ecstasy abuse has been reported to be a risk factor for Ischemic Cerebrovascular accident and fatal Brain hemorrhage, thromboaspiration may be an alternative therapy to thrombolysis., CONCLUSIONS: Aneurysmal Yakut language may be largely a preventable disease among the young and middle-aged because several prevalent risk factors can be modified by medication (eg, Hypertensive disease) or behavioral change (eg, cigarette smoking, cocaine use)., OBJECTIVE: The use of cocaine has been increasingly associated with Cerebrovascular Disorders specially in young adults., cocaine hydrochloride causes mainly Intracerebral Route of Drug Administration and subarachnoidal bleeding, while crack (freebase) causes Intracranial Hemorrhage and ischemic infarctions with equal frequency., CONCLUSIONS: These findings implicate cocaine use as a significant risk factor for fatal Brain hemorrhage and may explain, in part, the increased incidence of hemorrhagic Cerebrovascular accident in some drug-using cohorts., Abuse of Amphetamines, cocaine and related compounds has become an important risk factor for Intracerebral Route of Drug Administration haemorrhage in young adults., Strokes occurred within 3 h of cocaine use in 15 patients with Infarction and 17 with Hemorrhage., We present three cases of Intracerebral Route of Drug Administration hemorrhage which occurred after cocaine consumption (intranasal route in two cases and intravenous route in one case).[SEP]Relations: Cerebral hemorrhage has relations: disease_phenotype_positive with cocaine intoxication, disease_phenotype_positive with cocaine intoxication. Intracerebral Route of Drug Administration hemorrhage has relations: contraindication with Enoxaparin, contraindication with Enoxaparin, disease_disease with Intracranial Hemorrhage, disease_disease with Intracranial Hemorrhage, contraindication with Hydralazine, contraindication with Hydralazine. Intracranial hemorrhage has relations: drug_effect with Saquinavir, drug_effect with Saquinavir. Definitions: cocaine defined as following: An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake.. Cerebral Hemorrhage defined as following: Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA.. Berry Aneurysm defined as following: A small cerebral artery Aneurysm, characterized by a saccular appearance, that typically forms at the junction of vessels in the circle of Willis.. Intracerebral Route of Drug Administration defined as following: Administration of a drug within the cerebrum, directly into brain tissue, usually by injection or direct application.. Hemorrhagic Stroke defined as following: An acute episode of focal or global cerebral or spinal dysfunction caused by intraparenchymal, intraventricular, or Subarachnoid Hemorrhage.. Neurologic Deficits defined as following: Loss of movement function.. Aneurysm, Ruptured defined as following: The tearing or bursting of the weakened wall of the aneurysmal sac, usually heralded by sudden worsening pain. The great danger of a ruptured Aneurysm is the large amount of blood spilling into the surrounding tissues and cavities, causing HEMORRHAGIC SHOCK.. Amphetamines defined as following: Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.. Aneurysm defined as following: Pathological outpouching or sac-like dilatation in the wall of any blood vessel (ARTERIES or VEINS) or the heart (HEART ANEURYSM). It indicates a thin and weakened area in the wall which may later Rupture. Aneurysms are classified by location, etiology, or other characteristics.. Infarction defined as following: Formation of an infarct, which is NECROSIS in tissue due to local ISCHEMIA resulting from obstruction of BLOOD CIRCULATION, most commonly by a THROMBUS or EMBOLUS.. Ischemic Cerebrovascular accident defined as following: An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue.. Intracranial Hemorrhage defined as following: Bleeding within the cranium.. Yakut language defined as following: A Turkic language spoken by the Yakut people in the Sakha Republic in the Russian Federation.. Cerebrovascular Disorders defined as following: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.. Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810). methamphetamine defined as following: A central nervous system stimulant and sympathomimetic with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is a drug of abuse and is referred to as crank, crystal, crystal meth, ice, and speed.. cocaine hydrochloride defined as following: The hydrochloride salt form of the tropane alkaloid cocaine, with central nervous systems (CNS) stimulating and local anesthetic activity. cocaine binds to the dopamine, serotonin, and norepinephrine transport proteins and inhibits the re-uptake of dopamine, serotonin, and norepinephrine into pre-synaptic neurons. This leads to an accumulation of the respective neurotransmitters in the synaptic cleft and may result in increased postsynaptic receptor activation. Its effect on dopamine levels causes CNS stimulation and euphoria, and ultimately dependence. The mechanism of action through which cocaine exerts its local anesthetic effects is by binding to and blocking the voltage-gated sodium channels in the neuronal cell membrane. By stabilizing neuronal membranes, cocaine inhibits the initiation and conduction of nerve impulses and produces a reversible loss of sensation.. Diabetes Mellitus defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.. Subarachnoid Hemorrhage defined as following: Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM Rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.. Hypertensive disease defined as following: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), Hypertensive disease is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.. Hypercholesterolemia result defined as following: A laboratory test result indicating an increased amount of cholesterol in the blood.. Hemorrhage defined as following: Bleeding or escape of blood from a vessel.. Rupture defined as following: Forcible or traumatic tear or break of an organ or other soft part of the body.. Intracerebral Route of Drug Administration hemorrhage defined as following: Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA..", "label": "yes"} {"original_question": "Are CTCF and BORIS involved in genome regulation and cancer?", "id": "converted_967", "sentence1": "Are CTGF protein, human and CTCFL wt Allele involved in genome regulation and Primary malignant neoplasm?", "sentence2": "CTGF protein, human is ubiquitously expressed and plays diverse roles in Genes regulation, imprinting, insulation, intra/interchromosomal interactions, nuclear compartmentalisation, and alternative splicing. CTGF protein, human has a single paralogue, the testes-specific CTGF protein, human-like Genes (CTCFL)/CTCFL wt Allele. CTGF protein, human and CTCFL wt Allele can be deregulated in Primary malignant neoplasm. The tumour suppressor Genes CTGF protein, human can be Mutation Abnormality or deleted in Primary malignant neoplasm, or CTGF protein, human DNA binding can be altered by epigenetic changes. CTCFL wt Allele is aberrantly expressed frequently in Primary malignant neoplasm, leading some to propose a pro-tumourigenic role for CTCFL wt Allele. However, CTCFL wt Allele can inhibit cell proliferation, and is Mutation Abnormality in Primary malignant neoplasm similarly to CTGF protein, human suggesting CTCFL wt Allele activation in Primary malignant neoplasm may be due to global Genetic or epigenetic changes typical of malignant transformation, The investigation of the molecular mechanisms engaged by CTGF protein, human to modulate tumor-related genes emphasizes the cell-type dependency of its tumor suppressor role. Indeed, the ability of CTGF protein, human to bind their Promoter strictly depends by cell-type features as DNA methylation, CTCFL wt Allele-binding and post-translational modifications as PARYlation, Moreover, reduction of CTGF protein, human in normally CTCFL wt Allele-negative human fibroblasts resulted in derepression of CTCFL wt Allele Promoter. These results provide a mechanistic basis for understanding Primary malignant neoplasm-related associations between haploinsufficiency of CTGF protein, human and CTCFL wt Allele derepression, and between the lack of functional TP53 wt Allele and aberrant activation of CTCFL wt Allele, CTGF protein, human and CTCFL wt Allele in genome regulation and Primary malignant neoplasm., The novel CTCFL wt Allele + CTGF protein, human Genes family is uniquely involved in the epigenetics of normal biology and Primary malignant neoplasm., Collectively, these data indicate that reciprocal binding of CTGF protein, human and CTCFL wt Allele to the CTAG1A wt Allele promoter mediates epigenetic regulation of this CT Genes in lung Primary malignant neoplasm cells, and suggest that induction of CTCFL wt Allele may be a novel strategy to augment immunogenicity of pulmonary carcinomas., CTCFL wt Allele is the only known paralog of CTGF protein, human, a Genes intimately involved in genomic imprinting, chromatin insulation, and nuclear regulation., However, CTCFL wt Allele can inhibit cell proliferation, and is Mutation Abnormality in Primary malignant neoplasm similarly to CTGF protein, human suggesting CTCFL wt Allele activation in Primary malignant neoplasm may be due to global Genetic or epigenetic changes typical of malignant transformation., We suggest that CTCFL wt Allele is likely tethering epigenetic machinery to a novel class of CTGF protein, human/CTCFL wt Allele 11ZF target sequences that mediate induction of Primary malignant neoplasm-Testis genes., Unlike CTGF protein, human, CTCFL wt Allele expression has been reported only in the Testis and certain Malignant Neoplasms, leading to its classification as a \"Primary malignant neoplasm-Testis\" antigen.[SEP]Relations: Testis has relations: anatomy_protein_present with CTGF protein, human, anatomy_protein_present with CTGF protein, human, anatomy_protein_present with CTCFL, anatomy_protein_present with CTCFL, anatomy_protein_present with BNC1, anatomy_protein_present with BNC1. Geneticin has relations: drug_drug with Cefsulodin, drug_drug with Cefsulodin. Protein S human has relations: drug_drug with Cefsulodin, drug_drug with Cefsulodin. Definitions: Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. CTGF protein, human defined as following: CCN family member 2 (349 aa, ~38kDa) is encoded by the human CCN2 Genes. This protein plays a role in the promotion of proliferation and differentiation of chondrocytes and also mediates heparin- and divalent cation-dependent cell adhesion in many different cell types.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. TP53 wt Allele defined as following: Human TP53 wild-type allele is located in the vicinity of 17p13.1 and is approximately 19 kb in length. This allele, which encodes cellular tumor antigen TP53 wt Allele protein, plays a role in cell cycle regulation during the G0/G1transition. Alterations of the TP53 Genes occur as both somatic and germline mutations in human Malignant Neoplasms in select Primary malignant neoplasm-prone families with Li-Fraumeni syndrome.. CTCFL wt Allele defined as following: Human CTCFL wild-type allele is located in the vicinity of 20q13.31 and is approximately 30 kb in length. This allele, which encodes transcriptional repressor CTCFL protein, is involved in both Genes regulation and X-chromosome inactivation.. tumour suppressor Genes defined as following: Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible.. CTAG1A wt Allele defined as following: Human CTAG1A wild-type allele is located in the vicinity of Xq28 and is approximately 2 kb in length. This allele, which encodes Primary malignant neoplasm/Testis antigen 1 protein, may play a role in both spermatogeneis and development of the testes. Aberrant expression of this Genes is associated with incontinentia pigmenti.. Genetic defined as following: Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.. Mutation Abnormality defined as following: Any transmissible change in the Genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with Genetic diversity or with pathologies including Primary malignant neoplasm.. Testis defined as following: The male gonad containing two functional parts: the SEMINIFEROUS TUBULES for the production and transport of male germ cells (SPERMATOGENESIS) and the interstitial compartment containing LEYDIG CELLS that produce ANDROGENS.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas..", "label": "yes"} {"original_question": "Have thyronamines effects on fat tissue?", "id": "converted_360", "sentence1": "Have thyronamines effects on fat tissue?", "sentence2": "In conclusion, trace amines and thyronamines are negative inotropic agents., Their in vivo administration induces effects opposite to those induced by Thyroid Hormones, including lowering of body temperature.[SEP]Relations: response to Thyroid Hormones has relations: bioprocess_protein with GBA, bioprocess_protein with GBA, bioprocess_bioprocess with response to thyroxine, bioprocess_bioprocess with response to thyroxine, bioprocess_protein with SLC26A5, bioprocess_protein with SLC26A5, bioprocess_protein with SLC34A1, bioprocess_protein with SLC34A1, bioprocess_protein with HPN, bioprocess_protein with HPN. Definitions: Thyroid Hormones defined as following: Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs.. fat tissue defined as following: Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white..", "label": "no"} {"original_question": "Does thyroid hormone receptor beta1 affect insulin secretion?", "id": "converted_885", "sentence1": "Does Thyroid Hormone Receptor beta1 affect insulin secretion?", "sentence2": "We demonstrated that Thyroid Hormones SLC25A5 gene rapidly induces Proto-Oncogene Proteins c-akt activation in Structure of beta Cell of islet rRINm5F and Hypertrophic Cardiomyopathy via Thyroid Hormone Receptor (TR) beta1., The silencing of TRbeta1 expression through RNAi confirmed this receptor to be crucial for the SLC25A5 gene-induced activation of Proto-Oncogene Proteins c-akt., SLC25A5 gene is able to specifically activate Proto-Oncogene Proteins c-akt in the islet beta cells rRINm5F and Hypertrophic Cardiomyopathy through the interaction between TRbeta1 and PI3K p85alpha, demonstrating the involvement of TRbeta1 in this novel SLC25A5 gene non-genomic action in islet beta cells.[SEP]Relations: response to Thyroid Hormones has relations: bioprocess_protein with AKR1B1, bioprocess_protein with AKR1B1. Thyroid Hormone Receptor binding has relations: molfunc_protein with GAS2L1, molfunc_protein with GAS2L1, molfunc_protein with MED1, molfunc_protein with MED1, molfunc_protein with NR0B2, molfunc_protein with NR0B2, molfunc_protein with NCOR1, molfunc_protein with NCOR1. Definitions: Hypertrophic Cardiomyopathy defined as following: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).. Thyroid Hormone Receptor defined as following: Specific high affinity binding proteins for THYROID HORMONES in target cells. They are usually found in the nucleus and regulate DNA transcription. These receptors are activated by hormones that leads to transcription, cell differentiation, and growth suppression. Thyroid hormone receptors are encoded by two genes (GENES, ERBA): erbA-alpha and erbA-beta for alpha and beta Thyroid Hormones receptors, respectively.. Proto-Oncogene Proteins c-akt defined as following: Expressed in diverse tissues, Protein Kinase B (AKT/RAC Family) is a group (Alpha, Beta and Gamma) of cytoplasmic serine/threonine enzymes that covalently transfer the terminal, gamma phosphate group from ATP to a variety of substrate proteins and regulate cell signaling responses to insulin, PDGF, and IGF1 (through PI3K) involved in cell survival, cell proliferation, differentiation, apoptosis, glycogen synthesis, and glucose uptake.. Structure of beta Cell of islet defined as following: A cell that composes the bulk of the islets of Langerhans and secretes insulin.. SLC25A5 gene defined as following: This gene plays a regulatory role in the production and utilization of ATP.. Thyroid Hormones defined as following: Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs..", "label": "no"} {"original_question": "Is pimavanserin effective for Parkinson's disease psychosis?", "id": "converted_3012", "sentence1": "Is pimavanserin effective for Parkinson Disease Psychotic Disorders?", "sentence2": "Two cases of Parkinson Disease with an unusual delusional misidentification, intermetamorphosis, are presented, along with their improvement with pimavanserin, a novel atypical antipsychotic medication., RATIONALE: Pimavanserin, a selective serotonin 2A receptor inverse Agonist, is a promising candidate for treating Parkinson Disease Psychotic Disorders., OBJECTIVE: Our aim was to describe the efficacy and tolerability of pimavanserin, a highly selective serotonin Receptor, Serotonin, 5-HT2A inverse Agonist/Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) indicated for the treatment of Hallucinations and Delusions associated with Parkinson Disease Psychotic Disorders (Osteoarthropathy, Primary Hypertrophic), using the metrics of number needed to treat (NNT gene gene) and number needed to harm (NAVAJO NEUROHEPATOPATHY)., Pimavanserin: novel pharmacotherapy for Parkinson Disease Psychotic Disorders., INTRODUCTION: Pimavanserin is the first FDA-approved atypical antipsychotic drug indicated for the treatment of Hallucinations and Delusions associated with Parkinson Disease Psychotic Disorders (Osteoarthropathy, Primary Hypertrophic), A pivotal phase III clinical trial demonstrated significant improvement in Osteoarthropathy, Primary Hypertrophic symptoms in patients receiving pimavanserin compared to placebo-treated patients. , Pimavanserin's mechanism of action might contribute to its unique psychopharmacological properties in the improved treatment of Osteoarthropathy, Primary Hypertrophic, and perhaps Psychotic Disorders in other diseases including SCHIZOPHRENIA 2 (disorder) and dementia-related Psychotic Disorders., Pimavanserin (Nuplazid™) for the treatment of PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE Psychotic Disorders: A review of the literature.Options for the treatment of PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE Psychotic Disorders are limited. , Pimavanserin for the treatment of Parkinson Disease Psychotic Disorders.Pimavanserin is an antipsychotic with a unique mechanism of action (Receptor, Serotonin, 5-HT2A inverse Agonist) and no measurable dopaminergic activity; it has been demonstrated to be efficacious, well tolerated and safe for the treatment of Osteoarthropathy, Primary Hypertrophic. , A Retrospective Study of Pimavanserin Use in a Movement Disorders Clinic.Pimavanserin, a 5-HT2A inverse Agonist, was commercially released in the United States in April 2016 for the treatment of PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE Psychotic Disorders. , receptor inverse Agonist pimavanserin was recently approved by the US FDA for the treatment of Osteoarthropathy, Primary Hypertrophic and may prove to be a more targeted therapy without the downsides of atypical antipsychotics., Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.Despite lack of rigor in study designs, published data to date suggest that clozapine and pimavanserin should be considered drugs of choice to treat PD Psychotic Disorders., Pimavanserin: A novel therapeutic option for PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE Psychotic Disorders.While pimavanserin appears to be a safe, effective, and well-tolerated therapeutic option for Osteoarthropathy, Primary Hypertrophic, additional clinical trials and open-label extension studies are needed to determine the long-term safety and efficacy of this promising therapy. , Objective: Pimavanserin is the first United States Food and Drug Administration (FDA)-approved treatment for Parkinson Disease Psychotic Disorders (Osteoarthropathy, Primary Hypertrophic)., Pimavanserin: A Novel Drug Approved to Treat Parkinson's Disease Psychosis., CONCLUSIONS\nPimavanserin is the only FDA-approved treatment for the Hallucinations and Delusions seen in patients with Psychotic Disorders of Parkinson Disease., OBJECTIVE\nTo summarize the US Food and Drug Administration's (FDA's) review of the safety and effectiveness for pimavanserin, an atypical antipsychotic, for the treatment of Hallucinations and Delusions associated with Parkinson Disease Psychotic Disorders., RESULTS\nPimavanserin 34 mg/d was effective in treating Hallucinations and Delusions associated with Parkinson Disease., BACKGROUND\nPimavanserin is a selective Receptor, Serotonin, 5-HT2A inverse Agonist and Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) approved in the USA for the treatment of Hallucinations and Delusions associated with Parkinson Disease Psychotic Disorders., Pimavanserin is the first FDA-approved atypical antipsychotic drug indicated for the treatment of Hallucinations and Delusions associated with Parkinson Disease Psychotic Disorders (Osteoarthropathy, Primary Hypertrophic)., INTERPRETATION\nPimavanserin may benefit patients with Parkinson Disease Psychotic Disorders for whom few other treatment options exist., Pimavanserin (ACP 103) is a selective inverse Agonist of the 5-hydroxytryptamine 2A (5-HT2A) receptor intended to treat patients with Parkinson Disease Psychotic Disorders (Osteoarthropathy, Primary Hypertrophic)., INTERPRETATION\nPimavanserin showed efficacy in patients with ALZHEIMER DISEASE, FAMILIAL, 1 Psychotic Disorders at the primary endpoint (week 6) with an acceptable tolerability profile and without negative effect on cognition., [Pimavanserin: a new treatment for the Parkinson Disease Psychotic Disorders]., Pimavanserin, a serotonin(2A) receptor inverse Agonist, for the treatment of parkinson's disease Psychotic Disorders., Pimavanserin, a selective 5-HT2A inverse Agonist/Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance), was approved in the U.S. for treating Hallucinations and Delusions associated with Parkinson Disease Psychotic Disorders (Osteoarthropathy, Primary Hypertrophic)., Pimavanserin: A Novel Antipsychotic Agents Agents for Parkinson's Disease Psychosis., CONCLUSIONS Pimavanserin is the only FDA-approved treatment for the Hallucinations and Delusions seen in patients with Psychotic Disorders of Parkinson Disease., OBJECTIVE To summarize the US Food and Drug Administration's (FDA's) review of the safety and effectiveness for pimavanserin, an atypical antipsychotic, for the treatment of Hallucinations and Delusions associated with Parkinson Disease Psychotic Disorders., RESULTS Pimavanserin 34 mg/d was effective in treating Hallucinations and Delusions associated with Parkinson Disease., If this is granted, we believe the evidence of Pimavanserin efficacy, safety and tolerability will position this medication as the first choice for treatment of Parkinson Disease Psychotic Disorders., The development of pimavanserin as an antipsychotic opened a new therapeutic avenue in the treatment of Osteoarthropathy, Primary Hypertrophic as well as targeting Psychotic Disorders in other disorders such as ALZHEIMER DISEASE, FAMILIAL, 1., OBJECTIVE To review the pharmacology, pharmacokinetics, efficacy, safety, and place in therapy of pimavanserin for the treatment of Hallucinations and Delusions of Parkinson Disease Psychotic Disorders (Osteoarthropathy, Primary Hypertrophic)., INTERPRETATION Pimavanserin may benefit patients with Parkinson Disease Psychotic Disorders for whom few other treatment options exist., OBJECTIVE: To summarize the US Food and Drug Administration's (FDA's) review of the safety and effectiveness for pimavanserin, an atypical antipsychotic, for the treatment of Hallucinations and Delusions associated with Parkinson Disease Psychotic Disorders., Data were available from 616 patients with Parkinson Disease with Hallucinations and Delusions who received at least 1 dose of pimavanserin, with a total exposure of 825 patient-years in the Parkinson Disease Psychotic Disorders population.
RESULTS: Pimavanserin 34 mg/d was effective in treating Hallucinations and Delusions associated with Parkinson Disease., Pimavanserin did not worsen motor function, an adverse effect commonly observed with other antipsychotics, probably because of a lack of consequential dopamine binding.
CONCLUSIONS: Pimavanserin is the only FDA-approved treatment for the Hallucinations and Delusions seen in patients with Psychotic Disorders of Parkinson Disease., Pimavanserin (Nuplazid™) is a selective and potent serotonin 2A (5-HT2A) receptor inverse Agonist and Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) developed by ACADIA Pharmacologic Substance that has been approved in the US as a treatment for patients with Hallucinations and Delusions associated with Parkinson Disease Psychotic Disorders., This article summarizes the milestones in the development of pimavanserin leading to this first approval for the treatment of Hallucinations and Delusions in patients with Parkinson Disease Psychotic Disorders., In a Phase 2 study with pimavanserin in ALZHEIMER DISEASE, FAMILIAL, 1 Psychotic Disorders, pimavanserin significantly (p=0.045) improved Psychotic Disorders at Week 6 vs. placebo on the NPI-NH Psychosis Score (PS)., To summarize the US Food and Drug Administration's (FDA's) review of the safety and effectiveness for pimavanserin, an atypical antipsychotic, for the treatment of Hallucinations and Delusions associated with Parkinson Disease Psychotic Disorders., Pimavanserin is the only FDA-approved treatment for the Hallucinations and Delusions seen in patients with Psychotic Disorders of Parkinson Disease., Pimavanserin 34 mg/d was effective in treating Hallucinations and Delusions associated with Parkinson Disease.[SEP]Relations: PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE has relations: contraindication with Pimozide, contraindication with Pimozide, contraindication with Alimemazine, contraindication with Alimemazine. Pimavanserin has relations: drug_drug with Hypericin, drug_drug with Hypericin, drug_drug with Melatonin, drug_drug with Melatonin, drug_drug with Pomalidomide, drug_drug with Pomalidomide. Definitions: Agonist defined as following: An agent that has affinity for a receptor and intrinsic activity at that receptor.. Osteoarthropathy, Primary Hypertrophic defined as following: A condition chiefly characterized by thickening of the skin of the head and distal extremities, deep folds and furrows of the skin of the forehead, cheeks, and scalp, SEBORRHEA; HYPERHIDROSIS; periostosis of the long bones, digital clubbing, and spadelike enlargement of the hands and feet. It is more prevalent in the male, and is usually first evident during adolescence. Inheritance is primarily autosomal recessive, but an autosomal dominant form exists.. clozapine defined as following: A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin Substance with receptor antagonist mechanism of action (substance), with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent.. NAVAJO NEUROHEPATOPATHY defined as following: A rare life-threatening mitochondrial DNA depletion syndrome disease with characteristics of severe progressive sensorimotor neuropathy associated with corneal ulceration, scarring or anesthesia, acral mutilation, metabolic and immunologic derangement and hepatopathy (which can manifest with fulminant hepatic failure, a Reye-like syndrome or indolent progression to liver cirrhosis, depending on clinical form involved), present in the Navajo Native American population. Clinical presentation includes failure to thrive, distal limb weakness with reduced sensation, limb contractures with loss of function, areflexia, recurrent metabolic acidosis with intercurrent illness, immunologic anomalies manifesting with severe systemic infections and sexual infantilism.. Antipsychotic Agents defined as following: Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient Psychotic Disorders following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.. Receptor, Serotonin, 5-HT2A defined as following: A serotonin receptor subtype found widely distributed in peripheral tissues where it mediates the contractile responses of variety of tissues that contain SMOOTH MUSCLE. Selective Receptor, Serotonin, 5-HT2A antagonists include KETANSERIN. The 5-HT2A subtype is also located in BASAL GANGLIA and CEREBRAL CORTEX of the BRAIN where it mediates the effects of HALLUCINOGENS such as LSD.. Delusions defined as following: A false belief regarding the self or persons or objects outside the self that persists despite the facts, and is not considered tenable by one's associates.. Parkinson Disease defined as following: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75). Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65.. Hallucinations defined as following: Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.. Psychotic Disorders defined as following: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with Delusions or prominent Hallucinations. (From DSM-IV, 1994).", "label": "yes"} {"original_question": "Can METTL3 methylate long noncoding RNAs?", "id": "converted_4711", "sentence1": "Can METTL3 gene methylate long noncoding RNAs?", "sentence2": "METTL3 gene gene-Mediated Long Intergenic Non-Protein Coding RNA m6A Modification in the Osteogenic Differentiation of Human Adipose-Derived Stem Cells Induced by NEL-Like 1 Protein., This study aimed to explore the regulatory mechanism of methyltransferase3 (METTL3 gene gene) -mediated long non-coding RNA (Long Intergenic Non-Protein Coding RNA) N-methyladenosine (m6A) ResponseLevel - ResponseLevel - modification in the osteogenic differentiation of human adipose-derived stem cells (hASCs) induced by Protein Kinase C-Binding Protein NELL1 (NELL-1)., This study shows, for the first time, that METTL3 gene gene can activate the MAPK signaling pathway by regulating the m6A ResponseLevel - ResponseLevel - modification and expression of a Long Intergenic Non-Protein Coding RNA, thereby enhancing the osteogenic differentiation of hASCs.[SEP]Relations: METTL3 gene has relations: bioprocess_protein with RNA methylation, bioprocess_protein with RNA methylation, molfunc_protein with RNA methyltransferase activity, molfunc_protein with RNA methyltransferase activity, molfunc_protein with methyltransferase activity, molfunc_protein with methyltransferase activity, bioprocess_protein with mRNA methylation, bioprocess_protein with mRNA methylation, molfunc_protein with mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity, molfunc_protein with mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity. Definitions: Protein Kinase C-Binding Protein NELL1 defined as following: Protein kinase C-binding protein NELL1 (810 aa, ~90 kDa) is encoded by the human NELL1 gene. This protein is involved in the modulation of osteoblast cell growth and differentiation.. METTL3 gene defined as following: N6-adenosine-methyltransferase catalytic subunit (580 aa, ~64 kDa) is encoded by the human METTL3 gene gene. This protein is involved in RNA methyltransferase activity.. Long Intergenic Non-Protein Coding RNA defined as following: A molecule of RNA 200-17000 nucleotides in length that is transcribed by non-protein coding areas of DNA. These ribonucleotides may play a role in a variety of biological processes.. ResponseLevel - modification defined as following:

Respond with exceptions, completions and modifications or revisions done before completion

.", "label": "yes"} {"original_question": "Have the promoter regions of the genes implicated in Rett Syndrome been characterized with CAGE?", "id": "converted_1899", "sentence1": "Have the promoter regions of the genes implicated in MECP2 protein, Homo sapiens gene been characterized with CAGE?", "sentence2": "CAGE-defined promoter regions of the genes implicated in MECP2 protein, Homo sapiens protein, Homo sapiens Genes., Gene Mutation in three functionally diverse genes cause MECP2 protein, Homo sapiens protein, Homo sapiens Genes. Although the functions of FOXG1 Genes (FOXG1), Methyl-CpG-Binding Protein 2 (MECP2 protein, Homo sapiens protein, Homo sapiens) and Cyclin-dependent kinase-like 5 (CDKL5 gene Genes) have been studied individually, not much is known about their relation to each other with respect to expression levels and Regulatory Sequences, Nucleic Acid. Here we analyzed data from hundreds of Mus sp. and Homo sapiens samples included in the FANTOM5 project, to identify transcript initiation sites, expression levels, expression correlations and Regulatory Sequences, Nucleic Acid of the three genes.RESULTS: Our investigations reveal the predominantly used Transcription Initiation Site (TSSs) for each Genes including novel Transcription Initiation Site for FOXG1. We show that FOXG1 expression is poorly correlated with the expression of MECP2 protein, Homo sapiens protein, Homo sapiens and CDKL5 gene Genes. We identify promoter shapes for each TSS, the predicted location of enhancers for each Genes and the common transcription factors likely to regulate the three genes. Our data imply Polycomb Repressive Complex 2 (PRC2) mediated silencing of Foxg1 in Cerebellum.CONCLUSIONS: Our analyses provide a comprehensive picture of the Regulatory Sequences, Nucleic Acid of the three genes involved in MECP2 protein, Homo sapiens protein, Homo sapiens Genes., CAGE-defined promoter regions of the genes implicated in MECP2 protein, Homo sapiens protein, Homo sapiens Genes, CAGE-defined promoter regions of the genes implicated in MECP2 protein, Homo sapiens protein, Homo sapiens Genes.[SEP]Relations: Rett syndrome has relations: disease_protein with NTNG1, disease_protein with NTNG1, disease_phenotype_positive with Increased serum leptin, disease_phenotype_positive with Increased serum leptin, disease_disease with X-linked complex neurodevelopmental disorder, disease_disease with X-linked complex neurodevelopmental disorder, disease_protein with MECP2 protein, Homo sapiens, disease_protein with MECP2 protein, Homo sapiens, disease_phenotype_positive with Increased serum pyruvate, disease_phenotype_positive with Increased serum pyruvate. Definitions: Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Polycomb Repressive Complex 2 defined as following: A multisubunit polycomb protein complex that catalyzes the METHYLATION of chromosomal HISTONE H3. It works in conjunction with POLYCOMB REPRESSIVE COMPLEX 1 to effect EPIGENETIC REPRESSION.. FOXG1 gene defined as following: This Genes is involved in transcriptional repression and may play a role in the development of the brain and telencephalon.. MECP2 protein, Homo sapiens gene defined as following: This Genes plays a role in both the recognition of DNA methylation and the regulation of transcription.. CDKL5 gene defined as following: This Genes plays a role in protein metabolism.. Regulatory Sequences, Nucleic Acid defined as following: Nucleic acid sequences involved in regulating the expression of genes.. MECP2 protein, Homo sapiens defined as following: Methyl-CpG-binding protein 2 (486 aa, ~52 kDa) is encoded by the Homo sapiens MECP2 protein, Homo sapiens Genes. This protein plays a role in the repression of transcription through binding methylated DNA.. Methyl-CpG-Binding Protein 2 defined as following: A DNA-binding protein that interacts with methylated CPG ISLANDS. It plays a role in repressing GENETIC TRANSCRIPTION and is frequently mutated in RETT SYNDROME.. Homo sapiens defined as following: Members of the species Homo sapiens.. Transcription Initiation Site defined as following: The first nucleotide of a transcribed DNA sequence where RNA polymerase (DNA-DIRECTED RNA POLYMERASE) begins synthesizing the RNA transcript.. Cerebellum defined as following: The part of brain that lies behind the BRAIN STEM in the posterior base of skull (CRANIAL FOSSA, POSTERIOR). It is also known as the \"little brain\" with convolutions similar to those of CEREBRAL CORTEX, inner white matter, and deep cerebellar nuclei. Its function is to coordinate voluntary movements, maintain balance, and learn motor skills.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA.. promoter regions defined as following: DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.. genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Can Pentraxin 3 predict outcomes of sepsis?", "id": "converted_2009", "sentence1": "Can PTX3 protein, human predict outcomes of Sepsis (Invertebrate)?", "sentence2": "As compared with low serum PTX3and sTWEAK cases, Cirrhotic patients with high serum PITX3 gene/sTWEAK levels a have higher probability of new severe infections, severe Sepsis (Invertebrate), septic Shock, type 1 hepatorenal syndrome, in-hospital, and 3-month follow-up mortalities. , Neonates with high nPTX3 concentrations also have lowered APGAR scores, increased rate of Respiratory Distress Syndrome, Newborn, clinical Sepsis (Invertebrate), IVH, necrotizing enterocolitis and prolonged NICU stay., In terms of predicting the prognosis of Sepsis (Invertebrate) with Congestive Congestive heart failure complications, the PITX3 gene value's area under ROC curve was larger than that of BNP (respectively 0. 844, 0. 472).CONCLUSION: The PITX3 gene is an objective biochemical marker in diagnosis of Sepsis (Invertebrate); it is helpful in assessment of severity and prognosis of Sepsis (Invertebrate); it also has a certain clinical value in the assessment of Sepsis (Invertebrate) cardiovascular function damage., Severe Acinetobacter baumannii Sepsis (Invertebrate) is associated with elevation of pentraxin 3., Together, these results suggest that elevation of PITX3 gene is associated with fulminant disease during A. baumannii Sepsis (Invertebrate)., Persisting high levels of plasma pentraxin 3 over the first days after severe Sepsis (Invertebrate) and septic Shock onset are associated with mortality., PITX3 gene, as a mediator of Inflammation, may represent an early marker of severity and outcome in Sepsis (Invertebrate)., CONCLUSIONS: Persisting high levels of circulating PITX3 gene over the first days from Sepsis (Invertebrate) onset may be associated with mortality. PITX3 gene correlates with severity of Sepsis (Invertebrate) and with Sepsis (Invertebrate)-associated coagulation/fibrinolysis dysfunction., PITX3 gene protein, human in patients with severe Sepsis (Invertebrate) or Shock: the ALBIOS trial., PITX3 gene protein, human: an immune modulator of Communicable Diseases and useful marker for disease severity assessment in Sepsis (Invertebrate)., Redox state of pentraxin 3 as a novel biomarker for resolution of Inflammation and survival in Sepsis (Invertebrate)., The prototypic long pentraxin, pentraxin 3, is an acute phase protein that is structurally related but distinct from C-reactive protein which has proven to correlate with the severity of bacterial Communicable Diseases in Critical Illness patients., Circulating levels of the long pentraxin PITX3 gene correlate with severity of Communicable Diseases in Critical Illness patients., PITX3 gene protein, human (PITX3 gene) is associated with severe Sepsis (Invertebrate) and fatal disease in emergency room patients with suspected Communicable Diseases: a prospective cohort study., In addition, high levels of PITX3 gene were associated with unfavorable outcome.CONCLUSIONS: The long pentraxin PITX3 gene is elevated in Critical Illness patients and correlates with severity of disease and Communicable Diseases., PITX3 gene, as a mediator of Inflammation, may represent an early marker of severity and outcome in Sepsis (Invertebrate)., Redox state of pentraxin 3 as a novel biomarker for resolution of Inflammation and survival in Sepsis (Invertebrate)., Persisting high levels of plasma pentraxin 3 over the first days after severe Sepsis (Invertebrate) and septic Shock onset are associated with mortality., PITX3 gene protein, human (PITX3 gene) is associated with severe Sepsis (Invertebrate) and fatal disease in emergency room patients with suspected Communicable Diseases: a prospective cohort study., The proteomic profile of circulating pentraxin 3 (PITX3 gene) complex in Sepsis (Invertebrate) demonstrates the interaction with azurocidin 1 and other components of neutrophil extracellular traps.[SEP]Relations: newborn Respiratory Distress Syndrome, Newborn has relations: disease_phenotype_positive with Sepsis, disease_phenotype_positive with Sepsis. Protein S human has relations: drug_drug with Seproxetine, drug_drug with Seproxetine, drug_drug with Octamoxin, drug_drug with Octamoxin, drug_drug with Desvenlafaxine, drug_drug with Desvenlafaxine. Congestive Congestive heart failure has relations: drug_effect with Pentostatin, drug_effect with Pentostatin. Definitions: C-reactive protein defined as following: A plasma protein that circulates in increased amounts during Inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP).. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.. Shock defined as following: A pathological condition manifested by failure to perfuse or oxygenate vital organs.. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. PTX3 protein, human defined as following: This gene is involved in complement recognition of pathogens.. bacterial Communicable Diseases defined as following: Infections by bacteria, general or unspecified.. Respiratory Distress Syndrome, Newborn defined as following: A condition beginning in the first day of life that results from inadequate surfactant production, causing increased work of breathing and impaired gas exchange.. Congestive heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. septic Shock defined as following: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.. Critical Illness defined as following: A disease or state in which death is possible or imminent..", "label": "yes"} {"original_question": "Is SATB1 positioned close to AT-rich sequences?", "id": "converted_3523", "sentence1": "Is DNA-Binding Protein SATB1 positioned close to Ataxia Telangiectasia-rich sequences?", "sentence2": " Tryptic cleavage and peptide Sequence - ParameterizedDataType analysis demonstrated that the 98-kD Protein Info is identical to a recently cloned Protein Info, special A-T-rich binding Protein Info 1 (DNA-Binding Protein DNA-Binding Protein SATB1), Special Ataxia Telangiectasia-rich Sequence - ParameterizedDataType-binding Protein Info 1 (DNA-Binding Protein DNA-Binding Protein SATB1), a DNA-binding Protein Info expressed predominantly in thymocyte, recognizes an ATC Sequence - ParameterizedDataType context that consists of a Cluster of Sequence - ParameterizedDataType stretches with well-mixed A's, T's, and C's without G's on one strand. , We have purified and identified one of the core factors as the Matrix Attachment Regions (MAR) binding Protein Info, DNA-Binding Protein DNA-Binding Protein SATB1, which is known to bind to Ataxia Telangiectasia-rich sequences with a high propensity to unwind, DNA-Binding Protein DNA-Binding Protein SATB1 (special Ataxia Telangiectasia-rich Sequence - ParameterizedDataType-binding Protein Info-1) provides a key link between DNA loop organization, chromatin modification/remodeling, and association of TRANSCRIPTION FACTOR at matrix attachment regions (MARS1 gene)., Over-expression of the special Ataxia Telangiectasia rich Sequence - ParameterizedDataType binding Protein Info 1 (DNA-Binding Protein DNA-Binding Protein SATB1) promotes the progression of Nasopharyngeal carcinoma: association with EBV LMP1 EBV latent membrane Protein Info expression., pecial Ataxia Telangiectasia rich Sequence - ParameterizedDataType binding Protein Info 1 (DNA-Binding Protein DNA-Binding Protein SATB1) plays a crucial role in the biology of various types of human cancer. , Loss of special Ataxia Telangiectasia-rich Sequence - ParameterizedDataType-binding Protein Info 1 (DNA-Binding Protein DNA-Binding Protein SATB1), Special Ataxia Telangiectasia-rich Sequence - ParameterizedDataType-binding Protein Info 1 (DNA-Binding Protein DNA-Binding Protein SATB1) is a cell type-specific Matrix Attachment Regions binding Protein Info, functioning as a global genome organizer. , DNA-Binding Protein DNA-Binding Protein SATB1 (special Ataxia Telangiectasia-rich binding Protein Info 1) is a global chromatin organizer regulating the expression of a large number of genes, Special Ataxia Telangiectasia-rich Sequence-binding Protein 1 (DNA-Binding Protein DNA-Binding Protein SATB1) Functions as an Accessory Factor in Base Excision Repair., Rearrangement of the Chromatin Organizer Special Ataxia Telangiectasia-rich Binding Protein 1 Gene, The Special Ataxia Telangiectasia-rich Sequence Binding Protein 1 (DNA-Binding Protein DNA-Binding Protein SATB1) exerts multiple functions, by influencing the structural organization of chromatin and interacting with several co-activators and Co-Repressor Proteins of transcription., The Special Ataxia Telangiectasia-rich Sequence Binding Protein 1 (DNA-Binding Protein DNA-Binding Protein SATB1) and its role in Solid Neoplasm.[SEP]Relations: Protein Info binding has relations: molfunc_protein with DNA-Binding Protein SATB1, molfunc_protein with DNA-Binding Protein SATB1, molfunc_protein with URB1-AS1, molfunc_protein with URB1-AS1, molfunc_protein with SETBP1, molfunc_protein with SETBP1, molfunc_protein with SATB2, molfunc_protein with SATB2, molfunc_protein with SAT1, molfunc_protein with SAT1. Definitions: Matrix Attachment Regions defined as following: Regions of the CHROMATIN or DNA that bind to the NUCLEAR MATRIX. They are found in INTERGENIC DNA, especially flanking the 5' ends of genes or clusters of genes. Many of the regions that have been isolated contain a bipartite Sequence - ParameterizedDataType motif called the MAR/SAR recognition signature Sequence - ParameterizedDataType that binds to MATRIX ATTACHMENT REGION BINDING PROTEINS.. Nasopharyngeal carcinoma defined as following: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.. Co-Repressor Proteins defined as following: A subclass of repressor proteins that do not directly bind DNA. Instead, Co-Repressor Proteins generally act via their interaction with DNA-BINDING PROTEINS such as a TRANSCRIPTIONAL SILENCING FACTORS or NUCLEAR RECEPTORS.. Solid Neoplasm defined as following: A benign or malignant neoplasm arising from tissues that do not include fluid areas. Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma). Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered Solid Neoplasm.. DNA-Binding Protein SATB1 defined as following: DNA-Binding Protein DNA-Binding Protein SATB1 (763 aa, ~86 kDa) is encoded by the human DNA-Binding Protein SATB1 gene. This Protein Info binds DNA and may be involved in the regulation of transcription.. Cluster defined as following: A grouping of a number of similar things.. thymocyte defined as following: HEMATOPOIETIC PROGENITOR CELLS that have migrated to the THYMUS where they differentiate into T-LYMPHOCYTES. Thymocytes are classified into maturational stages based on the expression of CELL SURFACE ANTIGENS.. Ataxia Telangiectasia defined as following: An autosomal recessive inherited disorder characterized by choreoathetosis beginning in childhood, progressive CEREBELLAR ATAXIA; TELANGIECTASIS of CONJUNCTIVA and SKIN; DYSARTHRIA; B- and T-cell immunodeficiency, and RADIOSENSITIVITY to IONIZING RADIATION. Affected individuals are prone to recurrent sinobronchopulmonary infections, lymphoreticular neoplasms, and other malignancies. Serum ALPHA-FETOPROTEINS are usually elevated. (Menkes, Textbook of Child Neurology, 5th ed, p688) The gene for this disorder (ATM) encodes a cell cycle checkpoint Protein Info kinase and has been mapped to chromosome 11 (11q22-q23).. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. LMP1 EBV latent membrane protein defined as following: Latent membrane Protein Info 1 (386 aa, ~42 kDa) is encoded by the Epstein-Barr virus LMP1 gene. This Protein Info is involved in both the activation of nuclear factor-kappa-B family signaling pathways and the inhibition of apoptosis of infected B-lymphocytes.. DNA-binding Protein Info defined as following: Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process..", "label": "yes"} {"original_question": "Can gene therapy restore auditory function?", "id": "converted_2789", "sentence1": "Can Genes therapy restore auditory function?", "sentence2": "Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c., We demonstrate recovery of Genes and protein expression, restoration of sensory cell function, rescue of complex auditory function and recovery of hearing and balance behavior to near wild-type levels. The data represent unprecedented recovery of inner ear function and suggest that biological therapies to treat Hearing Loss, Partial may be suitable for translation to Homo sapiens with genetic inner ear disorders.[SEP]Relations: central hearing loss has relations: disease_disease with hearing loss disorder, disease_disease with hearing loss disorder. Definitions: Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Hearing Loss, Partial defined as following: A condition in which a person partially loses the ability to hear sounds in one or both ears.. Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Is P. gingivalis bacteria found in brain?", "id": "converted_2800", "sentence1": "Is P. gingivalis bacteria found in Head>Brain?", "sentence2": "studies using animal model of Periodontitis and Homo sapiens post-mortem Head>Brain tissues from subjects with cytarabine/daunorubicin protocol strongly suggest that a gram-negative periodontal pathogen, Porphyromonas gingivalis (Pg) and/or its product gingipain is/are translocated to the Head>Brain., The polymicrobial dysbiotic subgingival biofilm microbes associated with Periodontal Diseases appear to contribute to developing pathologies in distal body sites, including the Head>Brain.[SEP]Relations: Periodontal Diseases has relations: disease_disease with gingival disease, disease_disease with gingival disease, disease_protein with CTSC, disease_protein with CTSC. Periodontitis has relations: phenotype_phenotype with Abnormality of the gingiva, phenotype_phenotype with Abnormality of the gingiva, disease_phenotype_positive with dyskeratosis congenita, disease_phenotype_positive with dyskeratosis congenita, disease_phenotype_positive with cyclic hematopoiesis, disease_phenotype_positive with cyclic hematopoiesis. Definitions: Periodontal Diseases defined as following: Pathological processes involving the PERIODONTIUM including the gum (GINGIVA), the alveolar bone (ALVEOLAR PROCESS), the DENTAL CEMENTUM, and the PERIODONTAL LIGAMENT.. Porphyromonas gingivalis defined as following: A species of gram-negative, anaerobic, rod-shaped bacteria originally classified within the BACTEROIDES genus. This bacterium produces a cell-bound, oxygen-sensitive collagenase and is isolated from the Homo sapiens mouth.. Periodontitis defined as following: Inflammation and loss of connective tissues supporting or surrounding the teeth. This may involve any part of the PERIODONTIUM. Periodontitis is currently classified by disease progression (CHRONIC PERIODONTITIS; AGGRESSIVE PERIODONTITIS) instead of age of onset. (From 1999 International Workshop for a Classification of Periodontal Diseases and Conditions, American Academy of Periodontology). Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Is there any link between ERCC1-XPF and cohesin?", "id": "converted_2459", "sentence1": "Is there any link between ERCC1-XPF and cohesins?", "sentence2": "ERCC1-XPF cooperates with CTGF protein, human and cohesins to facilitate the developmental silencing of imprinted Genes., Using an in vivo biotinylation tagging approach in CASP14 gene, we show that the nucleotide excision repair (NER) structure-specific endonuclease ERCC1-XPF complex interacts with the insulator binding protein CTGF protein, human, the cohesins subunits SMC1A and SMC3 wt Allele wt Allele and with DPEP2 gene; the factors co-localize with Alpha thalassemia X-linked intellectual disability syndrome at the Promoter and control regions (ICRs) of imprinted Genes during postnatal hepatic development. Loss of Excision Repair Cross-Complementing 1 or exposure to mitomycin triggers the localization of CTGF protein, human to Heterochromatin, the dissociation of the CTGF protein, human-cohesins complex and Alpha thalassemia X-linked intellectual disability syndrome from Promoter and ICRs, altered histone marks and the aberrant developmental expression of imprinted Genes without altering DNA methylation. We propose that ERCC1-XPF cooperates with CTGF protein, human and cohesins to facilitate the developmental silencing of imprinted Genes and that persistent DNA damage triggers chromatin location location changes that affect gene expression programs associated with NER disorders., Using an in vivo biotinylation tagging approach in CASP14 gene, we show that the nucleotide excision repair (NER) structure-specific endonuclease ERCC1-XPF complex interacts with the insulator binding protein CTGF protein, human, the cohesins subunits SMC1A and SMC3 wt Allele wt Allele and with DPEP2 gene; the factors co-localize with Alpha thalassemia X-linked intellectual disability syndrome at the Promoter and control regions (ICRs) of imprinted Genes during postnatal hepatic development., We propose that ERCC1-XPF cooperates with CTGF protein, human and cohesins to facilitate the developmental silencing of imprinted Genes and that persistent DNA damage triggers chromatin location location changes that affect gene expression programs associated with NER disorders., We propose that ERCC1-XPF cooperates with CTGF protein, human and cohesins to facilitate the developmental silencing of imprinted Genes and that persistent DNA damage triggers chromatin location location changes that affect gene expression programs associated with NER disorders., We propose that ERCC1-XPF cooperates with CTGF protein, human and cohesins to facilitate the developmental silencing of imprinted Genes and that persistent DNA damage triggers chromatin location location changes that affect gene expression programs associated with NER disorders.
, ERCC1-XPF cooperates with CTGF protein, human and cohesins to facilitate the developmental silencing of imprinted Genes., We propose that ERCC1-XPF cooperates with CTGF protein, human and cohesins to facilitate the developmental silencing of imprinted Genes and that persistent DNA damage triggers chromatin location location changes that affect gene expression programs associated with NER disorders..[SEP]Relations: Heterochromatin has relations: cellcomp_protein with HSF1, cellcomp_protein with HSF1, cellcomp_protein with FOXC1, cellcomp_protein with FOXC1, cellcomp_protein with MORC2, cellcomp_protein with MORC2, cellcomp_protein with ORC2, cellcomp_protein with ORC2, cellcomp_protein with CBX1, cellcomp_protein with CBX1. Definitions: Alpha thalassemia X-linked intellectual disability syndrome defined as following: A rare, X-linked recessive inherited syndrome caused by mutations in the Alpha thalassemia X-linked intellectual disability syndrome gene. It is characterized by intellectual disability, developmental delays, hypotonia, widely spaced eyes, small nose, low-set ears, tented upper lip, skeletal abnormalities, and a mild form of alpha thalassemia.. CTGF protein, human defined as following: CCN family member 2 (349 aa, ~38kDa) is encoded by the human CCN2 gene. This protein plays a role in the promotion of proliferation and differentiation of chondrocytes and also mediates heparin- and divalent cation-dependent cell adhesion in many different cell types.. SMC3 wt Allele defined as following: Human SMC3 wt Allele wild-type allele is located in the vicinity of 10q25 and is approximately 37 kb in length. This allele, which encodes structural maintenance of chromosomes protein 3, is involved in the regulation of chromosome migration during mitosis.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. Excision Repair Cross-Complementing 1 defined as following: DNA excision repair protein ERCC-1 (297 aa, ~33 kDa) is encoded by the human ERCC1 gene. This protein plays a role in 5-prime incision during both UV cross-link repair and nucleotide excision repair.. Heterochromatin defined as following: The portion of chromosome material that remains condensed and is transcriptionally inactive during INTERPHASE.. chromatin location defined as following: The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130]. mitomycin defined as following: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Are OATP1B1 and OATP1B3 associated with bilirubin transport?", "id": "converted_1536", "sentence1": "Are SLCO1B1 wt Allele and SLCO1B3 wt Allele associated with Bilirubin transport?", "sentence2": "SLCO1B1 wt Allele and SLCO1B3 wt Allele-mediated transport of Bilirubin was confirmed and inhibition was determined for atazanavir, rifampin, indinavir, amprenavir, cyclosporine, rifamycin SV and saquinavir. , Examples of adaptive Nontoxic changes in Abdomen>Liver function, which may elevate direct (conjugated) and/or indirect (unconjugated) Bilirubin above baseline levels, include reversible inhibition of UGT1A1 gene gene-mediated Bilirubin metabolism and SLCO1B1 wt Allele-, SLCO1B3 wt Allele-, or ABCC2 wt Allele-mediated transport (Keogh., Due to limited solubility and poor ionization of Bilirubin and its Glucuronides, the formation of estradiol 3-Glucuronides was used as a surrogate to assess UGT1A1 gene gene activity, while the transport of pitavastatin, 5(6)-carboxy-2',7'-dichlorofluorescein, and Taurocholate were used as surrogate Probe brand of methazole herbicide substrates to monitor the function of SLCO1B1 wt Allele/SLCO1B3 wt Allele, ABCC2 wt Allele, and ABCB11 wt Allele, respectively., SLCO1B1 wt Allele and SLCO1B3 wt Allele-mediated transport of Bilirubin was confirmed and inhibition was determined for atazanavir, rifampin, indinavir, amprenavir, cyclosporine, rifamycin SV and saquinavir., However, because Pharmacologic Substance transporters also contribute to Bilirubin elimination, the purpose of this work was to investigate the in vitro inhibition of SLCO1B1 wt Allele, SLCO1B3 wt Allele, ABCC2 wt Allele, and ABCB11 wt Allele of select test drugs known to elicit Jaundice, Chronic Idiopathic., Thus, disruption of hepatic reuptake of Bilirubin Glucuronides due to coexisting SLCO1B1 wt Allele and SLCO1B3 wt Allele deficiencies explains Rotor-type Jaundice, Chronic Idiopathic.Moreover, SLCO1B1 wt Allele and SLCO1B3 wt Allele null mutations may confer substantial Pharmacologic Substance Toxic effect risks., Bilirubin elimination is a multifaceted process consisting of uptake of Bilirubin into the Hepatocyte facilitated by SLCO1B1 wt Allele and SLCO1B3 wt Allele., Complete SLCO1B1 wt Allele and SLCO1B3 wt Allele deficiency causes Homo sapiens Rotor syndrome by interrupting conjugated Bilirubin reuptake into the Abdomen>Liver., Thus, disruption of hepatic reuptake of Bilirubin Glucuronides due to coexisting SLCO1B1 wt Allele and SLCO1B3 wt Allele deficiencies explains Rotor-type Jaundice, Chronic Idiopathic., The data show that a substantial fraction of Bilirubin Immunostimulating conjugate (antigen) is primarily secreted by ABCC3 wt Allele at the sinusoidal membrane into the blood, from where they are subsequently reuptaken by sinusoidal membrane-bound organic anion transporting polypeptides SLCO1B1 wt Allele and SLCO1B3 wt Allele., Evaluating the in vitro inhibition of UGT1A1 gene gene, SLCO1B1 wt Allele, SLCO1B3 wt Allele, ABCC2 wt Allele, and ABCB11 wt Allele in predicting Pharmacologic Substance-induced Jaundice, Chronic Idiopathic., SLCO1B1 wt Allele and SLCO1B3 wt Allele-mediated transport of Bilirubin was confirmed and inhibition was determined for atazanavir, rifampin, indinavir, amprenavir, cyclosporine, rifamycin SV and saquinavir, Bilirubin elimination is a multifaceted process consisting of uptake of Bilirubin into the Hepatocyte facilitated by SLCO1B1 wt Allele and SLCO1B3 wt Allele, Due to limited solubility and poor ionization of Bilirubin and its Glucuronides, the formation of estradiol 3-Glucuronides was used as a surrogate to assess UGT1A1 gene gene activity, while the transport of pitavastatin, 5(6)-carboxy-2',7'-dichlorofluorescein, and Taurocholate were used as surrogate Probe brand of methazole herbicide substrates to monitor the function of SLCO1B1 wt Allele/SLCO1B3 wt Allele, ABCC2 wt Allele, and ABCB11 wt Allele, respectively, Examples of adaptive Nontoxic changes in Abdomen>Liver function, which may elevate direct (conjugated) and/or indirect (unconjugated) Bilirubin above baseline levels, include reversible inhibition of UGT1A1 gene gene-mediated Bilirubin metabolism and SLCO1B1 wt Allele-, SLCO1B3 wt Allele-, or ABCC2 wt Allele-mediated transport (Keogh, In vitro, faldaprevir inhibited key processes involved in Bilirubin clearance: Glucuronosyltransferase (UGT) 1A1 (UGT1A1 gene gene) (IC50 0.45 µM), which Immunostimulating conjugate (antigen) Bilirubin, and hepatic uptake and efflux transporters, organic anion-transporting polypeptide (OATP) 1B1 (IC50 0.57 µM), SLCO1B3 wt Allele (IC50 0.18 µM), and multidrug resistance-associated protein (Multidrug Resistance-Associated Proteins) 2 (IC50 6.2 µM), which transport Bilirubin and its Immunostimulating conjugate (antigen), Thus, disruption of hepatic reuptake of Bilirubin Glucuronides due to coexisting SLCO1B1 wt Allele and SLCO1B3 wt Allele deficiencies explains Rotor-type Jaundice, Chronic Idiopathic, Thus, disruption of hepatic reuptake of Bilirubin Glucuronides due to coexisting SLCO1B1 wt Allele and SLCO1B3 wt Allele deficiencies explains Rotor-type Jaundice, Chronic Idiopathic.Moreover, SLCO1B1 wt Allele and SLCO1B3 wt Allele null mutations may confer substantial Pharmacologic Substance Toxic effect risks, SLCO1B1 wt Allele (a.k.a. OATP-C, OATP2, LST-1, or SLC21A6) is a Abdomen>Liver-specific organic anion uptake transporter and has been shown to be a higher affinity Bilirubin uptake transporter than SLCO1B3 wt Allele, In vitro SLCO1B1 wt Allele and SLCO1B3 wt Allele inhibition is associated with observations of benign clinical unconjugated Jaundice, Chronic Idiopathic., Examples of adaptive Nontoxic changes in Abdomen>Liver function, which may elevate direct (conjugated) and/or indirect (unconjugated) Bilirubin above baseline levels, include reversible inhibition of UGT1A1 gene gene-mediated Bilirubin metabolism and SLCO1B1 wt Allele-, SLCO1B3 wt Allele-, or ABCC2 wt Allele-mediated transport (Keogh. Adv Pharmacol 63:1-42, 2012). , Using CASP14 gene deficient in Oatp1a/1b and in the multispecific sinusoidal export pump ABCC3 protein, Homo sapiens, we found that ABCC3 protein, Homo sapiens secretes Bilirubin Immunostimulating conjugate (antigen) into the blood, while Oatp1a/1b transporters mediate their hepatic reuptake. , Bilirubin elimination is a multifaceted process consisting of uptake of Bilirubin into the Hepatocyte facilitated by SLCO1B1 wt Allele and SLCO1B3 wt Allele. , SLCO1B1 wt Allele polymorphism is a major determinant of serum Bilirubin level but not associated with rifampin-mediated Bilirubin elevation., Unconjugated Bilirubin (UCB) is taken up into Hepatocyte by Homo sapiens organic anion transporting polypeptide 1B1 (SLCO1B1 wt Allele; encoded for by the SLCO1B1 gene)., However, because Pharmacologic Substance transporters also contribute to Bilirubin elimination, the purpose of this work was to investigate the in vitro inhibition of SLCO1B1 wt Allele, SLCO1B3 wt Allele, ABCC2 wt Allele, and ABCB11 wt Allele of select test drugs known to elicit Jaundice, Chronic Idiopathic. Test drugs investigated in this study were atazanavir and indinavir, which are associated with Jaundice, Chronic Idiopathic and elevations in serum Aspartate Transaminase; ritonavir and nelfinavir, which are not associated with Jaundice, Chronic Idiopathic; and bromfenac, troglitazone, and trovafloxacin, which are associated with severe idiosyncratic hepatotoxicity exhibiting elevations in serum Bilirubin and Aspartate Transaminase., Test drugs investigated in this study were atazanavir and indinavir, which are associated with Jaundice, Chronic Idiopathic and elevations in serum Aspartate Transaminase; ritonavir and nelfinavir, which are not associated with Jaundice, Chronic Idiopathic; and bromfenac, troglitazone, and trovafloxacin, which are associated with severe idiosyncratic hepatotoxicity exhibiting elevations in serum Bilirubin and Aspartate Transaminase. Due to limited solubility and poor ionization of Bilirubin and its Glucuronides, the formation of estradiol 3-Glucuronides was used as a surrogate to assess UGT1A1 gene gene activity, while the transport of pitavastatin, 5(6)-carboxy-2',7'-dichlorofluorescein, and Taurocholate were used as surrogate Probe brand of methazole herbicide substrates to monitor the function of SLCO1B1 wt Allele/SLCO1B3 wt Allele, ABCC2 wt Allele, and ABCB11 wt Allele, respectively., In vitro, faldaprevir inhibited key processes involved in Bilirubin clearance: Glucuronosyltransferase (UGT) 1A1 (UGT1A1 gene gene) (IC50 0.45 µM), which Immunostimulating conjugate (antigen) Bilirubin, and hepatic uptake and efflux transporters, organic anion-transporting polypeptide (OATP) 1B1 (IC50 0.57 µM), SLCO1B3 wt Allele (IC50 0.18 µM), and multidrug resistance-associated protein (Multidrug Resistance-Associated Proteins) 2 (IC50 6.2 µM), which transport Bilirubin and its Immunostimulating conjugate (antigen)., In vitro SLCO1B1 wt Allele and SLCO1B3 wt Allele inhibition is associated with observations of benign clinical unconjugated Jaundice, Chronic Idiopathic., 3.  The results indicated that in vivo Fi values >0.2 or R-values >1.5 for SLCO1B1 wt Allele or SLCO1B3 wt Allele, but not UGT1A1 gene gene, are associated with previously reported clinical cases of Pharmacologic Substance-induced unconjugated Jaundice, Chronic Idiopathic., SLCO1B1 wt Allele and SLCO1B3 wt Allele-mediated transport of Bilirubin was confirmed and inhibition was determined for atazanavir, rifampin, indinavir, amprenavir, cyclosporine, rifamycin SV and saquinavir.[SEP]Relations: UGT1A1 gene has relations: disease_protein with Bilirubin encephalopathy, disease_protein with Bilirubin encephalopathy, bioprocess_protein with Bilirubin conjugation, bioprocess_protein with Bilirubin conjugation, protein_protein with B3GALT1, protein_protein with B3GALT1, drug_protein with Alvocidib, drug_protein with Alvocidib. SLCO1B1 has relations: molfunc_protein with bile acid transmembrane transporter activity, molfunc_protein with bile acid transmembrane transporter activity. Definitions: ABCC3 wt Allele defined as following: Human ABCC3 wild-type allele is located in the vicinity of 17q22 and is approximately 57 kb in length. This allele, which encodes canalicular multispecific organic anion transporter 2 protein, plays a role in bile metabolism and transport.. SLCO1B1 wt Allele defined as following: Human SLCO1B1 wild-type allele is located in the vicinity of 12p12 and is approximately 109 kb in length. This allele, which encodes solute carrier organic anion transporter family member 1B1 protein, plays a role in both endogenous factor uptake in the Abdomen>Liver and the removal of Pharmacologic Substance compounds. Mutations in this gene are associated with Jaundice, Chronic Idiopathic, Rotor type, digenic.. ABCB11 wt Allele defined as following: Human ABCB11 wild-type allele is located in the vicinity of 2q24 and is approximately 108 kb in length. This allele, which encodes bile salt export pump protein, is involved in bile salt transport. Mutation of the gene is associated with hereditary intrahepatic cholestasis.. saquinavir defined as following: An HIV protease inhibitor which acts as an analog of an HIV protease cleavage site. It is a highly specific inhibitor of HIV-1 and HIV-2 proteases, and also inhibits CYTOCHROME P-450 CYP3A.. Bilirubin defined as following: A bile pigment that is a degradation product of HEME.. cyclosporine defined as following: A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed).. pitavastatin defined as following: A novel statin that induces plaque regression and elevates HDL-cholesterol levels.. rifampin defined as following: A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160). ABCC3 protein, Homo sapiens defined as following: Canalicular multispecific organic anion transporter 2 (1527 aa, ~169 kDa) is encoded by the Homo sapiens ABCC3 gene. This protein is involved in both the transport and metabolism of bile.. SLCO1B3 wt Allele defined as following: Human SLCO1B3 wild-type allele is located in the vicinity of 12p12 and is approximately 279 kb in length. This allele, which encodes solute carrier organic anion transporter family member 1B3 protein, is involved in both bile acid and Bilirubin transport and sodium-independent uptake of endogenous and xenobiotic compounds. Mutations in this gene are associated with Jaundice, Chronic Idiopathic, Rotor type, digenic.. Glucuronides defined as following: Glycosides of GLUCURONIC ACID formed by the reaction of URIDINE DIPHOSPHATE GLUCURONIC ACID with certain endogenous and exogenous substances. Their formation is important for the detoxification of drugs, steroid excretion and BILIRUBIN metabolism to a more water-soluble compound that can be eliminated in the URINE and BILE.. Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the Homo sapiens or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. bromfenac defined as following: A nonsteroidal anti-inflammatory Pharmacologic Substance (NSAID) with analgesic and anti-inflammatory activities. Upon ophthalmic administration, bromfenac binds to and inhibits the activity of cyclooxygenase II (COX II), an enzyme which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins (PG). By inhibiting PG formation, bromfenac is able to inhibit PG-induced inflammation, thereby preventing vasodilation, leukocytosis, disruption of the blood-aqueous humor barrier, an increase in vascular permeability and an increase in intraocular pressure (IOP).. Jaundice, Chronic Idiopathic defined as following: A benign, autosomally recessive inherited Jaundice, Chronic Idiopathic characterized by the presence of a dark pigment in the centrilobular region of the Abdomen>Liver cells. There is a functional defect in biliary excretion of Bilirubin, cholephilic dyes, and porphyrins. Affected persons may be asymptomatic or have vague constitutional or gastrointestinal symptoms. The Abdomen>Liver may be slightly enlarged, and oral and intravenous cholangiography fails to visualize the biliary tract.. Probe brand of methazole herbicide defined as following: brand name of methazole herbicide. troglitazone defined as following: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.. Hepatocyte defined as following: The main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Multidrug Resistance-Associated Proteins defined as following: A sequence-related subfamily of ATP-BINDING CASSETTE TRANSPORTERS that actively transport organic substrates. Although considered organic anion transporters, a subset of proteins in this family have also been shown to convey Pharmacologic Substance resistance to neutral organic drugs. Their cellular function may have clinical significance for CHEMOTHERAPY in that they transport a variety of ANTINEOPLASTIC AGENTS. Overexpression of proteins in this class by NEOPLASMS is considered a possible mechanism in the development of multidrug resistance (DRUG RESISTANCE, MULTIPLE). Although similar in function to P-GLYCOPROTEINS, the proteins in this class share little sequence homology to the ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 1 family of proteins.. ritonavir defined as following: An HIV protease inhibitor that works by interfering with the reproductive cycle of HIV. It also inhibits CYTOCHROME P-450 CYP3A.. ABCC2 wt Allele defined as following: Human ABCC2 wild-type allele is located in the vicinity of 10q24 and is approximately 69 kb in length. This allele, which encodes canalicular multispecific organic anion transporter 1 protein, plays a role in both multidrug resistance and organic anion transport. Mutation of the gene is associated with Dubin-Johnson syndrome.. Glucuronosyltransferase defined as following: A family of enzymes accepting a wide range of substrates, including phenols, alcohols, amines, and fatty acids. They function as Pharmacologic Substance-metabolizing enzymes that catalyze the conjugation of UDPglucuronic acid to a variety of endogenous and exogenous compounds. EC 2.4.1.17.. indinavir defined as following: A potent and specific HIV protease inhibitor that appears to have good oral bioavailability.. amprenavir defined as following: A synthetic derivative of hydroxyethylamine sulfonamide that selectively binds to and inhibits Homo sapiens immunodeficiency virus (HIV) protease.. Bilirubin Glucuronides defined as following: water soluble conjugated Bilirubin.. rifamycin SV defined as following: A natural antibiotic produced by Streptomyces mediterranei, Rifamycin (Ansamycin Family) is a commonly used antimycobacterial Pharmacologic Substance that inhibits prokaryotic DNA-dependent RNA synthesis and protein synthesis; it blocks RNA-polymerase transcription initiation. Rifamycin has an activity spectrum against Gram-positive and Gram-negative bacteria, but is mainly used against Mycobacterium sp. (especially M. tuberculosis) in association with other agents to overcome resistance. (NCI04). UGT1A1 gene defined as following: This gene is involved in controlling serum levels of Bilirubin and in glucuronidation.. atazanavir defined as following: An aza-dipeptide analogue with a bis-aryl substituent on the (hydroxethyl)hydrazine moiety with activity against both wild type and mutant forms of HIV protease. Atazanavir does not elevate serum lipids, a common problem with other protease inhibitors.. Aspartate Transaminase defined as following: Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.. nelfinavir defined as following: A potent HIV protease inhibitor. It is used in combination with other antiviral drugs in the treatment of HIV in both adults and children.. SLCO1B1 gene defined as following: This gene is involved in sodium-independent uptake of numerous endogenous compounds in the Abdomen>Liver.. Homo sapiens defined as following: Members of the species Homo sapiens.. Immunostimulating conjugate (antigen) defined as following: A compound formed by the union of two entities or compounds..", "label": "yes"} {"original_question": "Can FTO promote pancreatic cancer development?", "id": "converted_4258", "sentence1": "Can FTO protein, human promote Malignant neoplasm of pancreas development?", "sentence2": "METTL3 gene demethylase FTO protein, human protein, human suppresses Malignant neoplasm of pancreas tumorigenesis by demethylating PJA2 gene gene and inhibiting Wnt signaling., Moreover, FTO protein, human protein, human demethylated the METTL3 gene modification of praja ring finger ubiquitin ligase 2 (PJA2 gene gene), thereby reducing its mRNA decay, suppressing Wnt signaling, and ultimately restraining the proliferation, invasion, and metastasis of Malignant neoplasm of pancreas cells.[SEP]Relations: malignant exocrine pancreas neoplasm has relations: disease_disease with exocrine pancreatic carcinoma, disease_disease with exocrine pancreatic carcinoma, disease_disease with pancreatoblastoma, disease_disease with pancreatoblastoma, disease_disease with pancreatic exocrine neoplasm, disease_disease with pancreatic exocrine neoplasm, disease_disease with malignant pancreatic neoplasm, disease_disease with malignant pancreatic neoplasm, disease_disease with pancreatic intraductal papillary-mucinous neoplasm, disease_disease with pancreatic intraductal papillary-mucinous neoplasm. Definitions: Malignant neoplasm of pancreas defined as following: A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma.. FTO protein, human defined as following: Alpha-ketoglutarate-dependent dioxygenase FTO protein, human (505 aa, ~58 kDa) is encoded by the human FTO protein, human gene. This protein is involved in the demethylation of RNA and DNA.. METTL3 gene defined as following: This gene is involved in methlyation of mRNA..", "label": "no"} {"original_question": "Are de novo mutations in regulatory elements responsible for neurodevelopmental disorders?", "id": "converted_2871", "sentence1": "Are de novo Gene Mutation in regulatory elements responsible for Neurodevelopmental Disorders?", "sentence2": "The role of de novo Gene Mutation in regulatory elements affecting Genes associated with Developmental Disabilities, or other Genes, has been essentially unexplored. We identified de novo Gene Mutation in three classes of putative regulatory elements in almost 8,000 patients with Developmental Disabilities. Here we show that de novo Gene Mutation in highly evolutionarily conserved Prenatal care brain-active elements are significantly and specifically enriched in Neurodevelopmental Disorders. We identified a significant twofold enrichment of recurrently mutated elements. We estimate that, genome-wide, 1-3% of patients without a diagnostic coding variant carry Pathogenic Variant de novo Gene Mutation in Prenatal care brain-active regulatory elements and that only 0.15% of all possible Gene Mutation within highly conserved Prenatal care brain-active elements cause Neurodevelopmental Disorders with a dominant mechanism., We estimate that, genome-wide, 1-3% of patients without a diagnostic coding variant carry Pathogenic Variant de novo Gene Mutation in Prenatal care brain-active regulatory elements and that only 0.15% of all possible Gene Mutation within highly conserved Prenatal care brain-active elements cause Neurodevelopmental Disorders with a dominant mechanism., Here we show that de novo Gene Mutation in highly evolutionarily conserved Prenatal care brain-active elements are significantly and specifically enriched in Neurodevelopmental Disorders., We estimate that, genome-wide, 1-3% of patients without a diagnostic coding variant carry Pathogenic Variant de novo Gene Mutation in Prenatal care brain-active regulatory elements and that only 0.15% of all possible Gene Mutation within highly conserved Prenatal care brain-active elements cause Neurodevelopmental Disorders with a dominant mechanism. , Here we show that de novo Gene Mutation in highly evolutionarily conserved Prenatal care brain-active elements are significantly and specifically enriched in Neurodevelopmental Disorders. , De novo Gene Mutation in regulatory elements in Neurodevelopmental Disorders.We previously estimated that 42% of patients with severe Developmental Disabilities carry Pathogenic Variant de novo Gene Mutation in coding sequences. [SEP]Relations: complex neurodevelopmental disorder has relations: disease_disease with developmental and epileptic encephalopathy, disease_disease with developmental and epileptic encephalopathy, disease_disease with nervous system disorder, disease_disease with nervous system disorder, disease_disease with pervasive developmental disorder, disease_disease with pervasive developmental disorder, disease_disease with Prader-Willi syndrome, disease_disease with Prader-Willi syndrome. developmental disability has relations: disease_protein with NTRK2, disease_protein with NTRK2. Definitions: Developmental Disabilities defined as following: Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed). Prenatal care defined as following: Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Pathogenic Variant defined as following: A genetic variant that is known to directly contribute to the development of disease.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Neurodevelopmental Disorders defined as following: A childhood disorder that has a neurological basis and manifests as a developmental disability..", "label": "yes"} {"original_question": "Can radiation induced meningiomas be treated with radiosurgery?", "id": "converted_3489", "sentence1": "Can radiation induced Meningioma be treated with radiosurgery?", "sentence2": "This is a case report of a patient treated with radiosurgery for radiation induced Meningioma, 30 years after childhood whole brain radiation. , This article reviews the unique characteristics and unusual response to the radiation induced Meningioma to radiosurgery. , Gamma knife stereotactic radiosurgery for radiation-induced Meningioma., RESULTS: We present our series of 12 patients with radiation-induced Meningioma treated with Gamma Knife stereotactic radiosurgery over a 12-year period at our institution. With a median follow-up of 35 months, local control was 100%., CONCLUSIONS: Gamma Knife radiosurgery is both a safe and effective treatment for radiation-induced Meningioma., Favorable outcomes of pediatric patients treated with radiotherapy to the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS who develop radiation-induced Meningioma., All cases were managed with a single modality: resection alone (n = 7), fractionated radiotherapy (n = 2), and stereotactic radiosurgery (n = 1). , Stereotactic radiosurgery for radiation-induced Meningioma., The patients met criteria for a radiation-induced Benign Meningioma and underwent gamma knife radiosurgery. , CONCLUSION: INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE provides satisfactory control rates either after resection or as an alternative to resection. , This is a case report of a patient treated with radiosurgery for radiation induced Meningioma, 30 years after childhood whole brain radiation., This article reviews the unique characteristics and unusual response to the radiation induced Meningioma to radiosurgery., CONCLUSIONS\n\nGamma Knife radiosurgery is both a safe and effective treatment for radiation-induced Meningioma., RESULTS\n\nWe present our series of 12 patients with radiation-induced Meningioma treated with Gamma Knife stereotactic radiosurgery over a 12-year period at our institution., CONCLUSIONS Gamma Knife radiosurgery is both a safe and effective treatment for radiation-induced Meningioma., This article reviews the unique characteristics and unusual response to the radiation induced Meningioma to radiosurgery, Stereotactic radiosurgery for radiation-induced Meningioma, Also, LC rates with radiosurgery are at least comparable to those of surgical series for radiation-induced Meningioma, Gamma Knife radiosurgery for Meningioma: four cases of radiation-induced edema., This is a case report of a patient treated with radiosurgery for radiation induced Meningioma , 30 years after childhood whole brain radiation, Stereotactic radiosurgery ( INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE ) has become an important primary or adjuvant management for patients with Intracranial Meningioma , but the value of this approach for radiation-induced tumors is unclear, This article reviews the unique characteristics and unusual response to the radiation induced Meningioma to radiosurgery, RESULTS\nWe present our series of 12 patients with radiation-induced Meningioma treated with Gamma Knife stereotactic radiosurgery over a 12-year period at our institution., OBJECTIVES\nTo ascertain the safety and efficacy of Gamma Knife radiosurgery as a treatment for radiation-induced Meningioma., As such, traditional radiotherapy is limited by lifetime tissue tolerances to radiation, leaving surgery and radiosurgery as attractive treatment options., CONCLUSIONS\nGamma Knife radiosurgery is both a safe and effective treatment for radiation-induced Meningioma., Stereotactic radiosurgery (INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE) has become an important primary or adjuvant management for patients with Intracranial Meningioma, but the value of this approach for radiation-induced tumors is unclear., The patients met criteria for a radiation-induced Benign Meningioma and underwent gamma knife radiosurgery., OBJECTIVES: To ascertain the safety and efficacy of Gamma Knife radiosurgery as a treatment for radiation-induced Meningioma., RESULTS: We present our series of 12 patients with radiation-induced Meningioma treated with Gamma Knife stereotactic radiosurgery over a 12-year period at our institution., METHODS: A retrospective chart review was conducted to identify patients who received Gamma Knife radiosurgery for a Benign Meningioma and met the criteria for this being a radiation-induced tumor., We present our series of 12 patients with radiation-induced Meningioma treated with Gamma Knife stereotactic radiosurgery over a 12-year period at our institution., Stereotactic radiosurgery (INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE) has become an important primary or adjuvant management for patients with Intracranial Meningioma, but the value of this approach for radiation-induced tumors is unclear.[SEP]Relations: skin Benign Meningioma has relations: disease_disease with malignant tumor of meninges, disease_disease with malignant tumor of meninges, disease_disease with Benign Meningioma (disease), disease_disease with Benign Meningioma (disease), disease_disease with malignant dermis tumor, disease_disease with malignant dermis tumor. benign Benign Meningioma has relations: disease_disease with Benign Meningioma (disease), disease_disease with Benign Meningioma (disease), disease_disease with benign neoplasm of meninges, disease_disease with benign neoplasm of meninges. Definitions: Intracranial Meningioma defined as following: A Benign Meningioma that arises within the cranial cavity.. Benign Meningioma defined as following: A grade I, slowly growing Benign Meningioma. Only a minority of tumors recur following complete resection.. Meningioma defined as following: A relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular tumors which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7). INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE defined as following: This syndrome was originally reported as a nonspecific form of MXLR. The phenotype was later redefined to include large head, asthenic body build with diminished muscle bulk, marfanoid habitus (tall stature with long and slim limbs, little subcutaneous fat, muscle hypotonia, and arachnodactyly), nasal speech, characteristic facies, scoliosis, thin fingers, and other anomalies..", "label": "yes"} {"original_question": "Do nematodes contain architectural proteins like CTCF?", "id": "converted_3761", "sentence1": "Do nematodes contain architectural proteins like CTGF protein, human?", "sentence2": "A mode of genetic regulation that involves insulators and insulator binding proteins to establish independent transcriptional units is currently not known in nematodes including Caenorhabditis elegans. , the insulator protein CTGF protein, human has been secondarily lost in derived nematodes like Caenorhabditis elegans., he most highly enriched motif (LM1) corresponds to the X-box motif known from Saccharomyces cerevisiae and Phylum Nematoda, uggest that the insulator protein CTGF protein, human has been secondarily lost in derived nematodes like Caenorhabditis elegans. We , of CTGF protein, human from several nematodes is paralleled by a loss of two of its interactors, the polycomb repressive complex subunit SuZ12 and the multifunctional transcription factor TYY1. In contrast to earlier st, SULTS: While orthologs for other insulator proteins were absent in all 35 analysed Phylum Nematoda species, we find orthologs of CTGF protein, human in a subset of nematodes. A, Loss of the insulator protein CTGF protein, human during Phylum Nematoda evolution, que secondary loss of CTGF protein, human from several nematodes is paralleled by a loss of two of its interactors, the polycomb repressive complex subunit SuZ12 and the multifunctional transcription factor TYY1. In con, level. A mode of genetic regulation that involves insulators and insulator binding proteins to establish independent transcriptional units is currently not known in nematodes including Caenorhabditis , suggest that the insulator protein CTGF protein, human has been secondarily lost in derived nematodes like Caenorhabditis elegans. W, Loss of the insulator protein CTGF protein, human during Phylum Nematoda evolution.[SEP]Relations: Protein S human has relations: drug_drug with Nefazodone, drug_drug with Nefazodone, drug_drug with Loracarbef, drug_drug with Loracarbef, drug_drug with Cefditoren, drug_drug with Cefditoren, drug_drug with Tazobactam, drug_drug with Tazobactam, drug_protein with PROC, drug_protein with PROC. Definitions: Phylum Nematoda defined as following: class of unsegmented helminths with fundamental bilateral symmetry and secondary triradiate symmetry of the oral and esophageal structures; many species are parasites.. CTGF protein, human defined as following: CCN family member 2 (349 aa, ~38kDa) is encoded by the human CCN2 gene. This protein plays a role in the promotion of proliferation and differentiation of chondrocytes and also mediates heparin- and divalent cation-dependent cell adhesion in many different cell types.. Caenorhabditis elegans defined as following: A species of Phylum Nematoda that is widely used in biological, biochemical, and genetic studies.. Caenorhabditis defined as following: A genus of small free-living nematodes. Two species, CAENORHABDITIS ELEGANS and C. briggsae are much used in studies of genetics, development, aging, muscle chemistry, and neuroanatomy.. Saccharomyces cerevisiae defined as following: A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as \"baker's\" or \"brewer's\" Saccharomyces cerevisiae. The dried form is used as a dietary supplement..", "label": "no"} {"original_question": "Is there a BRCA mutation analysis in the Greek population?", "id": "converted_3493", "sentence1": "Is there a BRCA mutation analysis in the Greek population?", "sentence2": "Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center., Germline Gene Mutation in the BRCA1 gene gene and BRCA2 gene gene Genes are associated with hereditary predisposition to Breast and Malignant neoplasm of ovary. Sensitive and accurate detection of BRCA1 gene gene and BRCA2 gene gene Gene Mutation is crucial for personalized clinical management of individuals affected by Breast or Malignant neoplasm of ovary, and for the identification of at-risk healthy relatives. We performed molecular analysis of the BRCA1 gene gene and BRCA2 gene gene Genes in 898 Greek families, using Sanger sequencing or Next Generation Sequencing for the detection of small insertion/deletion frameshift, nonsynonymous, truncating and splice-site alterations and MLPA for the detection of large genomic rearrangements. In total, a pathogenic mutation was identified in 12.9% of 898 families analyzed. Of the 116 Gene Mutation identified in total 9% were novel and 14.7% were large genomic rearrangements. Our results indicate that different types of mutational events in the BRCA1 gene gene and BRCA2 gene gene Genes are responsible for the hereditary component of Breast/Malignant neoplasm of ovary in the Greek population. Therefore the methodology used in the analysis of Greek patients must be able to detect both point and small Frameshift Mutation function in addition to large genomic rearrangements across the entire Open Reading Frames of the two Genes.[SEP]Relations: Breast has relations: anatomy_protein_present with RIMKLB, anatomy_protein_present with RIMKLB, anatomy_protein_present with GCSAM, anatomy_protein_present with GCSAM. adaptation to pheromone regulating conjugation with mutual genetic exchange has relations: bioprocess_bioprocess with response to pheromone regulating conjugation with mutual genetic exchange, bioprocess_bioprocess with response to pheromone regulating conjugation with mutual genetic exchange, bioprocess_bioprocess with regulation of conjugation, bioprocess_bioprocess with regulation of conjugation, bioprocess_bioprocess with negative adaptation of signaling pathway, bioprocess_bioprocess with negative adaptation of signaling pathway. Definitions: Frameshift Mutation function defined as following: A type of mutation in which a number of NUCLEOTIDES deleted from or inserted into a protein coding sequence is not divisible by three, thereby causing an alteration in the READING FRAMES of the entire coding sequence downstream of the mutation. These Gene Mutation may be induced by certain types of MUTAGENS or may occur spontaneously.. BRCA1 gene defined as following: A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human CHROMOSOME 17 at locus 17q21. Mutations of this gene are associated with the formation of HEREDITARY BREAST AND OVARIAN CANCER SYNDROME. It encodes a large nuclear protein that is a component of DNA repair pathways.. BRCA2 gene defined as following: A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human chromosome 13 at locus 13q12.3. Mutations in this gene predispose humans to Breast and Malignant neoplasm of ovary. It encodes a large, nuclear protein that is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. (from Genes Dev 2000;14(11):1400-6). Breast defined as following: In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.. Malignant neoplasm of ovary defined as following: A primary or metastatic malignant neoplasm involving the ovary. Most primary malignant ovarian neoplasms are either carcinomas (serous, mucinous, or endometrioid adenocarcinomas) or malignant germ cell tumors. Metastatic malignant neoplasms to the ovary include carcinomas, lymphomas, and melanomas.. Open Reading Frames defined as following: A sequence of successive nucleotide triplets that are read as CODONS specifying AMINO ACIDS and begin with an INITIATOR CODON and end with a stop codon (CODON, TERMINATOR).. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA..", "label": "yes"} {"original_question": "Can SUMO affect calcium homeostasis?", "id": "converted_450", "sentence1": "Can SUMO affect calcium homeostasis?", "sentence2": "Increasing SUMOylation levels correlated inversely with calcium influx in Sensory Receptor Cells., DPYSL2 gene deSUMOylation by SUMO proteases SENP1 protein, human protein, human and SUMO1 protein, human wt Allele normalized calcium influx to those in the CRMP2AAA mutant., Thus, our results identify a novel role for SUMO modification in DPYSL2 gene/CaV2.2 signaling pathway, Moreover, SUMO1 protein, human protein, human overexpression in isolated Myocytes, Cardiac augmented contractility and accelerated Ca(2+) decay., RIM1α SUMOylation at lysine residue K502 facilitates the clustering of CaV2.1 calcium channels and enhances the Ca(2+) influx necessary for vesicular release, whereas non-SUMOylated RIM1α participates in the docking/priming of Synaptic Vesicles and maintenance of active zone structure. , Identification and characterization of a SUMO-1 conjugation system that modifies neuronal calcium/calmodulin-dependent protein kinase II in Drosophila melanogaster.[SEP]Relations: Protein S human has relations: drug_drug with Calcium Phosphate, drug_drug with Calcium Phosphate, drug_drug with Calcium Phosphate, drug_drug with Calcium Phosphate, drug_drug with Calcium carbonate, drug_drug with Calcium carbonate, drug_drug with Calcium carbonate, drug_drug with Calcium carbonate, drug_drug with Calcium threonate, drug_drug with Calcium threonate. Definitions: SUMO1 protein, human defined as following: Small ubiquitin-related modifier 1 (101 aa, ~12 kDa) is encoded by the human SUMO1 protein, human gene. This protein plays a role in post-translational protein modification.. SENP1 protein, human defined as following: Sentrin-specific protease 1 (644 aa, ~73 kDa) is encoded by the human SENP1 protein, human gene. This protein is involved in both caspase activation and protein desumoylation.. SUMO1 wt Allele defined as following: Human SUMO1 protein, human wild-type allele is located in the vicinity of 2q33 and is approximately 32 kb in length. This allele, which encodes small ubiquitin-related modifier 1 protein, is involved in the post-translational modification of proteins.. Sensory Receptor Cells defined as following: Specialized afferent neurons capable of transducing sensory stimuli into NERVE IMPULSES to be transmitted to the CENTRAL NERVOUS SYSTEM. Sometimes sensory receptors for external stimuli are called exteroceptors; for internal stimuli are called interoceptors and proprioceptors.. Synaptic Vesicles defined as following: Membrane-bound compartments which contain transmitter molecules. Synaptic vesicles are concentrated at presynaptic terminals. They actively sequester transmitter molecules from the cytoplasm. In at least some synapses, transmitter release occurs by fusion of these vesicles with the presynaptic membrane, followed by exocytosis of their contents.. Myocytes, Cardiac defined as following: Striated muscle cells found in the heart. They are derived from cardiac myoblasts (MYOBLASTS, CARDIAC)..", "label": "yes"} {"original_question": "Is there a genome-wide technique for the detection of R-loop formation?", "id": "converted_844", "sentence1": "Is there a genome-wide technique for the detection of R-loop formation?", "sentence2": "Genome-wide analysis of fragile sites by chromatin immunoprecipitation (ChIP) and microarray (ChIP-chip) of phosphorylated Histone H2a in these Mutant supported a transcription-dependent mechanism of DNA damage characteristic of R loops, We have used a bisulfite-sensitivity assay to demonstrate genome-wide increase in the occurrence of RNA-DNA hybrids (R-Loop Structures), including from antisense and read-through transcripts, in a nusG missense mutant defective for Rho-dependent termination., The results demonstrate a key function of Foundation for the Accreditation of Cellular Therapy in the resolution of R-loop-mediated transcription-replication conflicts, likely associated with a specific chromatin organization., Previous work revealed that GC skew and R-loop formation associate with a core set of unmethylated CpG island (CGI) Promoter in the human genome[SEP]Relations: histone Histone H2a acetylation has relations: bioprocess_protein with TRRAP, bioprocess_protein with TRRAP, bioprocess_protein with NAA40, bioprocess_protein with NAA40, bioprocess_protein with EP400, bioprocess_protein with EP400. promoter clearance from RNA polymerase I promoter has relations: bioprocess_bioprocess with promoter clearance from RNA polymerase I promoter for nuclear large rRNA transcript, bioprocess_bioprocess with promoter clearance from RNA polymerase I promoter for nuclear large rRNA transcript, bioprocess_bioprocess with promoter clearance during DNA-templated transcription, bioprocess_bioprocess with promoter clearance during DNA-templated transcription. Definitions: Histone H2a defined as following: Slightly lysine rich histone. One of four histones assembled into a nucleosomal core octamer. Various posttranslationally modified forms and variants exist. Combines with histone H2B in a heterodimer; two Histone H2a/H2B dimers are incorporated in the nucleosomal octamer.. Foundation for the Accreditation of Cellular Therapy defined as following: A non-profit corporation co-founded by the International Society for Cellular Therapy and the American Society of Blood and Marrow Transplantation for the purposes of voluntary inspection and accreditation in the field of cellular therapy. Founded in 1996, Foundation for the Accreditation of Cellular Therapy establishes standards for high quality medical and laboratory practice in cellular therapies. Foundation for the Accreditation of Cellular Therapy Standards are evidence-based requirements set by world-renowned experts vested in the improvement and progress of cellular therapy.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. Mutant defined as following: An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).. R-Loop Structures defined as following: An RNA-DNA hybrid structure formed when newly transcribed RNA remains bound to its DNA template. Stability of R-Loop Structures may play a role in GENETIC INSTABILITY.. R-loop defined as following: An RNA-DNA hybrid structure formed when newly transcribed RNA remains bound to its DNA template. Stability of R-Loop Structures may play a role in GENETIC INSTABILITY..", "label": "yes"} {"original_question": "Is palbociclib effective for glioblastoma?", "id": "converted_3570", "sentence1": "Is palbociclib effective for Glioblastoma Multiforme?", "sentence2": "Although further research is needed, CDK1 gene 4/6 inhibitors represent intriguing developments in the treatment of various Malignant Neoplasms, including those with such poor prognoses as Glioblastoma Multiforme multiforme, Mantle cell lymphoma, and metastatic melanoma., CONCLUSION: In this trial, despite adequate tissue Pyruvate Kinase, palbociclib monotherapy was not an effective treatment for recurrent Glioblastoma Multiforme., CONCLUSION\n\nIn this trial, despite adequate tissue Pyruvate Kinase, palbociclib monotherapy was not an effective treatment for recurrent Glioblastoma Multiforme., CONCLUSION In this trial, despite adequate tissue Pyruvate Kinase, palbociclib monotherapy was not an effective treatment for recurrent Glioblastoma Multiforme., CONCLUSION\nIn this trial, despite adequate tissue Pyruvate Kinase, palbociclib monotherapy was not an effective treatment for recurrent Glioblastoma Multiforme.[SEP]Relations: adult Glioblastoma Multiforme has relations: disease_disease with Glioblastoma Multiforme (disease), disease_disease with Glioblastoma Multiforme (disease), disease_disease with adult infiltrating astrocytic neoplasm, disease_disease with adult infiltrating astrocytic neoplasm, disease_disease with adult spinal cord Glioblastoma Multiforme, disease_disease with adult spinal cord Glioblastoma Multiforme. Mantle cell lymphoma has relations: disease_protein with CREBBP, disease_protein with CREBBP, disease_protein with UBR5, disease_protein with UBR5. Definitions: Mantle cell lymphoma defined as following: A form of non-Hodgkin lymphoma having a usually diffuse pattern with both small and medium lymphocytes and small cleaved cells. It accounts for about 5% of adult non-Hodgkin lymphomas in the United States and Europe. The majority of mantle-cell lymphomas are associated with a t(11;14) translocation resulting in overexpression of the CYCLIN D1 gene (GENES, BCL-1).. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Pyruvate Kinase defined as following: ATP:pyruvate 2-O-phosphotransferase. A phosphotransferase that catalyzes reversibly the phosphorylation of pyruvate to phosphoenolpyruvate in the presence of ATP. It has four isozymes (L, R, M1, and M2). Deficiency of the enzyme results in hemolytic anemia. EC 2.7.1.40.. Glioblastoma Multiforme defined as following: The most malignant astrocytic tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO). CDK1 gene defined as following: This gene is involved in the cellular transition from the G1/S phase and from the G2/M phase of the cell cycle..", "label": "no"} {"original_question": "Are there interactomes available for POU5F1 and SOX2?", "id": "converted_1226", "sentence1": "Are there interactomes available for POU5F1 protein, human and SOX2 protein, human?", "sentence2": "The interactomes of POU5F1 protein, human protein, human and SOX2 protein, human protein, human enhancers in human embryonic stem cells., We assayed long-range chromosomal interactions on putative enhancers of POU5F1 protein, human protein, human and SOX2 protein, human protein, human Genes in human embryonic stem cells (Human Embryonic Stem Cells) using 4C-Seq technique. We discovered that their frequent interacting regions mainly overlap with early DNA replication domains. The interactomes are associated with active histone marks and enriched with 5-hydroxymethylcytosine sites. In Human Embryonic Stem Cells, Genes within the interactomes have elevated expression. Additionally, some Genes associated with the POU5F1 protein, human protein, human enhancer contribute to pluripotency. Binding Sites for multiple DNA binding proteins, including Cyclic AMP-Dependent Transcription Factor ATF-3, CTGF protein, human, GABPA gene gene, JUND wt Allele wt Allele, NANOG gene gene, Double-Strand-Break Repair Protein Rad21 Homolog and YY1 gene gene, are enriched in both interactomes.[SEP]Relations: NANOG gene has relations: protein_protein with SOX2 protein, human, protein_protein with SOX2 protein, human, protein_protein with POU5F1 protein, human, protein_protein with POU5F1 protein, human, pathway_protein with POU5F1 protein, human (OCT4), SOX2 protein, human, NANOG gene repress Genes related to differentiation, pathway_protein with POU5F1 protein, human (OCT4), SOX2 protein, human, NANOG gene repress Genes related to differentiation, pathway_protein with POU5F1 protein, human (OCT4), SOX2 protein, human, NANOG gene activate Genes related to proliferation, pathway_protein with POU5F1 protein, human (OCT4), SOX2 protein, human, NANOG gene activate Genes related to proliferation, protein_protein with PSORS1C3, protein_protein with PSORS1C3. Definitions: NANOG gene defined as following: This gene plays a role in the underlying pluripotency of inner cell mass and embryonic stem cells.. CTGF protein, human defined as following: CCN family member 2 (349 aa, ~38kDa) is encoded by the human CCN2 gene. This protein plays a role in the promotion of proliferation and differentiation of chondrocytes and also mediates heparin- and divalent cation-dependent cell adhesion in many different cell types.. POU5F1 protein, human defined as following: POU domain, class 5, transcription factor 1 protein (360 aa, ~39 kDa) is encoded by the human POU5F1 protein, human gene. This protein plays a role in the regulation of early embryonic development.. Binding Sites defined as following: The parts of a macromolecule that directly participate in its specific combination with another molecule.. JUND wt Allele defined as following: Human JUND wt Allele wild-type allele is located in the vicinity of 19p13.2 and is approximately 2 kb in length. This allele, which encodes transcription factor jun-D protein, plays a role in the modulation of transcription by RNA polymerase II.. Double-Strand-Break Repair Protein Rad21 Homolog defined as following: Double-strand-break repair protein rad21 homolog (631 aa, ~72 kDa) is encoded by the human Double-Strand-Break Repair Protein Rad21 Homolog gene. This protein is involved in DNA repair, cell cycle-dependent chromosomal cohesion and apoptosis.. Cyclic AMP-Dependent Transcription Factor ATF-3 defined as following: Cyclic AMP-dependent transcription factor ATF-3 (181 aa, ~21 kDa) is encoded by the human Cyclic AMP-Dependent Transcription Factor ATF-3 gene. This protein plays a role in both DNA binding and the repression of gene expression.. YY1 gene defined as following: This gene is involved in the negative regulation of transcription.. SOX2 protein, human defined as following: Transcription factor SOX-2 protein (317 aa, ~34 kDa) is encoded by the human SOX2 protein, human gene. This protein is involved in neural cell progenitor differentiation and neurogenesis.. Human Embryonic Stem Cells defined as following: A type of PLURIPOTENT STEM CELLS derived from early stage human embryos, up to and including the BLASTOCYST stage.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Is poliosis circumscripta another term for a white or unpigmented patch of hair or skin?", "id": "converted_3639", "sentence1": "Is poliosis circumscripta another term for a white or unpigmented patch of hair or skin?", "sentence2": "\"white forelock,\" poliosis circumscripta, defined as a localized patch of white hair in a group of hair follicle, Although traditionally known as \"white forelock,\" poliosis circumscripta, defined as a localized patch of white hair in a group of hair follicles, can involve any hairy area on the body including the Scalp structure, Eyebrow structure, and Eyelash., Although traditionally known as \" white forelock , \" poliosis circumscripta , defined as a localized patch of white hair in a group of hair follicles , can involve any hairy area on the body including the Scalp structure , Eyebrow structure , and Eyelash, Although traditionally known as \"white forelock,\" poliosis circumscripta, defined as a localized patch of white hair in a group of hair follicles, can involve any hairy area on the body including the Scalp structure, Eyebrow structure, and Eyelash.[SEP]Relations: eyelash has relations: anatomy_anatomy with strand of hair, anatomy_anatomy with strand of hair. muscle structure has relations: anatomy_anatomy with insect adult somatic muscle, anatomy_anatomy with insect adult somatic muscle, anatomy_anatomy with somatic muscle, anatomy_anatomy with somatic muscle, anatomy_anatomy with urethra muscle tissue, anatomy_anatomy with urethra muscle tissue, anatomy_anatomy with anatomical structure, anatomy_anatomy with anatomical structure. Definitions: Eyelash defined as following: The hairs which project from the edges of the EYELIDS.. Eyebrow structure defined as following: Curved rows of HAIR located on the upper edges of the eye sockets.. Scalp structure defined as following: The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL)..", "label": "yes"} {"original_question": "Is osteocrin expressed exclusively in the bone?", "id": "converted_2141", "sentence1": "Is osteocrin expressed exclusively in the bone?", "sentence2": "Evolution of Osteocrin as an activity-regulated factor in the primate Head>Brain., Here we use transcriptional profiling of Homo sapiens fetal Head>Brain cultures to identify an activity-dependent secreted factor, Osteocrin (OSTN gene gene), that is induced by membrane depolarization of Homo sapiens but not mouse neurons., Osteocrin (Ostn) is a recently discovered secreted Protein Info produced by Cells of the Osteoblasts lineage that shows a well conserved homology with members of the Natriuretic Peptides (NP) family. , Osteocrin (Ostn), a bone-active molecule, has been shown in animal allergen extracts to be highly expressed in Cells of the Osteoblasts lineage. , Osteocrin, a novel bone-specific secreted Protein Info that modulates the Osteoblasts phenotype.[SEP]Relations: osteoblastic osteosarcoma has relations: disease_disease with osteosarcoma, disease_disease with osteosarcoma. Bite Cells has relations: disease_phenotype_positive with hereditary stomatocytosis, disease_phenotype_positive with hereditary stomatocytosis. Protein C has relations: drug_drug with Trazodone, drug_drug with Trazodone, drug_drug with Azapropazone, drug_drug with Azapropazone, drug_drug with Taurochenodeoxycholic acid, drug_drug with Taurochenodeoxycholic acid. Definitions: Osteoblasts defined as following: Bone-forming Cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone.. Homo sapiens defined as following: Members of the species Homo sapiens.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. Natriuretic Peptides defined as following: Peptides that regulate the WATER-ELECTROLYTE BALANCE in the body, also known as Natriuretic Peptides hormones. Several have been sequenced (ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; C-TYPE NATRIURETIC PEPTIDE)..", "label": "no"} {"original_question": "Is vortioxetine effective for treatment of depression?", "id": "converted_1854", "sentence1": "Is vortioxetine effective for treatment of Cancer patients and suicide and depression?", "sentence2": "vortioxetine is the most recently approved medication for the treatment of major depressive disorder (Major Depressive Disorder). , [vortioxetine: a new Antidepressive Agents to treat depressive episodes]., vortioxetine is a new Antidepressive Agents, which mechanism of action is multimodal, targeting the 5-Hydroxytryptamine Receptor 1A, human, HTR1B wt Allele, HTR1D gene, 5-HT3, HTR7 gene receptors and the serotonin transporter (5-HTT). , In short-term studies (8 weeks), vortioxetine is more efficacious than placebo in decreasing Depressive Symptoms as measured by the MADRS total score, response rate (vortioxetine: 53.2% vs placebo: 35.2%) and remission rate (vortioxetine: 29.2% vs placebo: 19.3%). In a long-term study (52 weeks), vortioxetine is also superior to placebo in preventing relapses and recurrences. Moreover, in second line treatment, after failure of a first line selective serotonin reuptake inhibitor (Serotonin Reuptake Inhibitor [EPC]) or serotonin norepinephrin reuptake inhibitor (Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)), vortioxetine is superior to agomelatine in improving Depressive Symptoms and achieving response and remission. , Against this background, we feature the novel antidepressants vortioxetine, vilazodone and milnacipran/levomilnacipran with regard to their serotonin receptor targets such as the 5-Hydroxytryptamine Receptor 1A, human, 5-HT3 and HTR7 gene which may account for their specific effects on certain symptoms of Cancer patients and suicide and Cancer patients and suicide and depression (e.g. cognition and Anxiety Disorders) as well as a characteristic side-effect profile., CONCLUSION: vortioxetine dominated venlafaxine XR in South Korea and is a relevant treatment option for Major Depressive Disorder patients initiating or switching therapy., vortioxetine: a New Treatment for Major Depressive Disorder., INTRODUCTION: vortioxetine is a structurally novel medication that has recently been approved for treatment of major depressive disorder (Major Depressive Disorder)., EXPERT OPINION: Results of placebo-controlled trials suggest efficacy and an overall safety profile comparable to existing first-line antidepressants. , The authors suggest that vortioxetine is currently a good second-line Antidepressive Agents option and shows promise, pending additional long-term data, to become a first-line Antidepressive Agents option., Clinical studies indicate that vortioxetine is effective in the treatment of major Cancer patients and suicide and Cancer patients and suicide and depression, though there is no suggestion of superiority over active comparators., vortioxetine has been effective in various animal models of Cancer patients and suicide and Cancer patients and suicide and depression and Anxiety Disorders and clinical studies have shown the Antidepressive Agents and antianxiety properties of vortioxetine in a dose range of 5-20 mg/day., vortioxetine was significantly more effective than was placebo, with a standardized mean difference (SMD) of -0.118 (95% CISH protein, human, -0.203 to -0.033, P = 0.007)., vortioxetine for the treatment of Cancer patients and suicide and Cancer patients and suicide and depression., vortioxetine for the treatment of major Cancer patients and suicide and Cancer patients and suicide and depression., vortioxetine (Lu-AA-21004; 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine hydrobromide) is a novel orally active Molecule that is being investigated by Lundbeck and Takeda for the treatment of major Cancer patients and suicide and Cancer patients and suicide and depression and generalized Anxiety Disorders disorders., vortioxetine (Lu AA21004) is a multi-modal Antidepressive Agents in clinical development for the treatment of major depressive disorder (Major Depressive Disorder)., A randomized, double-blind, fixed-dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized Anxiety Disorders disorder., vortioxetine has been effective in various animal models of Cancer patients and suicide and Cancer patients and suicide and depression and Anxiety Disorders and clinical studies have shown the Antidepressive Agents and antianxiety properties of vortioxetine in a dose range of 5-20 mg/day., Secondary endpoints included response and remission rates, Anxiety Disorders symptoms(Hamilton Anxiety Rating Scale), Clinical Global Impression, overall functioning (Sheehan Disability Scale), health-related quality of life(EuroQol 5 Dimensions), productivity (work limitation questionnaire) and family functioning (Depression and Family Functioning Scale).RESULTS: Primary endpoint noninferiority was established and vortioxetine (n = 252) was superior to agomelatine (n = 241) by 2.2 MADRS points (p<0.01)., vortioxetine (Lu AA21004) is an Antidepressive Agents with a mechanism of action thought to be related to a combination of 2 pharmacologic actions: direct modulation of several receptors and inhibition of the serotonin transporter.To evaluate the efficacy of vortioxetine 10 and 20 mg once daily in outpatients with major depressive disorder.This 8-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study was conducted from July 2010 to January 2012 among adults with a primary diagnosis of recurrent major depressive disorder (DSM-IV-TR).Eligible subjects were randomized in 1:1:1 ratio to 1 of 3 treatment arms: vortioxetine 10 mg, vortioxetine 20 mg, or placebo once daily for 8 weeks., vortioxetine (Lu AA21004) is a new Antidepressive Agents that combines a number of neurotransmitter uptake and receptor effects that have been thought to predict efficacy as a treatment for depressive and Anxiety Disorders disorders.This review summarizes the pharmacology and neurobiology of vortioxetine, In the study of elderly patients, vortioxetine 5 mg (n = 136) improved 12-item Health Status Questionnaire scores significantly more than placebo (n = 148) for the domains of health perception (10.4, P < 0.0001, SES of 0.54), mental health (7.9, P < 0.001, SES of 0.44), and energy (6.4, P < 0.05, SES of 0.28) (Fetal Alcohol Syndrome, mixed model for repeated measures).vortioxetine yielded significant, meaningful HRQoL improvements in 6 Major Depressive Disorder studies of 6 to 8 weeks duration., All references included were published between 1999 and 2014.All studies that included Homo sapiens and were published in English, with data describing vortioxetine for the treatment of Major Depressive Disorder, were reviewed.vortioxetine is a novel multimodal Antidepressive Agents agent, which inhibits the 5-HT transporter protein, acts as a 5-HT3 antagonist, 5-Hydroxytryptamine Receptor 1A, human receptor Agonist, HTR7 gene receptor antagonist, and a partial Agonist of the Receptor, Serotonin, HTR1B wt Allele, vortioxetine has been effective in various animal models of Cancer patients and suicide and Cancer patients and suicide and depression and Anxiety Disorders and clinical studies have shown the Antidepressive Agents and antianxiety properties of vortioxetine in a dose range of 5-20 mg/day, vortioxetine is an Antidepressive Agents with multimodal activity which has shown efficacy in major depressive disorder (Major Depressive Disorder) patients in six of ten short-term, randomized, placebo-controlled trials (completed end 2012).We performed meta-regression analyses to indirectly compare vortioxetine to seven marketed antidepressants with different mechanisms of action, Data were available from 51 human trials involving vortioxetine, and included a total of 7,666 healthy volunteers and patients with a diagnosis of major depressive disorder (Major Depressive Disorder) or generalized Anxiety Disorders disorder who were exposed to at least 1 dose of vortioxetine for a total of 2,743 patient-years.vortioxetine was effective in treating Major Depressive Disorder in the United States at a dose of 20 mg/d, vortioxetine is a recently approved multimodal Antidepressive Agents with anxiolytic properties in preclinical studies.This double-blind, placebo-controlled study assessed the efficacy and tolerability of vortioxetine in subjects with a primary diagnosis of generalized Anxiety Disorders disorder.Subjects (n = 457) were randomized 1:1:1 to treatment with placebo or vortioxetine 2.5 or 10 mg once daily, There was a significant difference for Nausea:Presence or Threshold:Point in time:^Patient:Ordinal between the two groups (OR=3.01, 95 % CI=2.22-4.09, Z=7.08, P=0.00001), but no significant differences were observed for the other four adverse effects.CONCLUSIONS: For the treatment of major depressive disorder, our results show that a dose of 5 mg/day vortioxetine was more effective, but more easily induced Nausea:Presence or Threshold:Point in time:^Patient:Ordinal, compared to placebo., The efficacy and safety of 5 mg/d vortioxetine compared to placebo for major depressive disorder: A meta-analysis., vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorder., vortioxetine in the treatment of adult patients with major depressive disorder: a meta-analysis of randomized double-blind controlled trials., vortioxetine has been effective in various animal models of Cancer patients and suicide and Cancer patients and suicide and depression and Anxiety Disorders and clinical studies have shown the Antidepressive Agents and antianxiety properties of vortioxetine in a dose range of 5-20 mg/day. , Clinical studies indicate that vortioxetine is effective in the treatment of major Cancer patients and suicide and Cancer patients and suicide and depression, though there is no suggestion of superiority over active comparators., The incidence of treatment-emergent adverse events was significantly higher in the duloxetine group than in the vortioxetine group.duloxetine was more effective but less well-tolerated than vortioxetine in Major Depressive Disorder., There was no significant difference in discontinuation rates between vortioxetine and comparators owing to inefficacy (OR 0.983, 95% CI 0.585 to 1.650), whereas discontinuation owing to Scanning Auger Spectrometer (device) was significantly less common in the vortioxetine than in the comparator group (OR 0.728, 95% CI 0.554 to 0.957).Studies examining the role of vortioxetine in the treatment of Major Depressive Disorder are limited.Although our results suggest that vortioxetine may be an effective treatment option for Major Depressive Disorder, they should be interpreted and translated into clinical practice with caution, as the meta-analysis was based on a l, We performed a meta-analysis to increase the statistical power of these studies and enhance our current understanding of the role of vortioxetine in the treatment of Major Depressive Disorder.We performed an extensive search of databases and the clinical trial registry., BACKGROUND: vortioxetine is a recently approved multimodal Antidepressive Agents with anxiolytic properties in preclinical studies.OBJECTIVE: This double-blind, placebo-controlled study assessed the efficacy and tolerability of vortioxetine in subjects with a primary diagnosis of generalized Anxiety Disorders disorder.METHODS: Subjects (n = 457) were randomized 1:1:1 to treatment with placebo or vortioxetine 2.5 or 10 mg once daily., vortioxetine significantly improved objective and subjective measures of cognitive function in adults with recurrent Major Depressive Disorder and these effects were largely independent of its effect on improving Depressive Symptoms., Furthermore, a statistically significant number of patients with Major Depressive Disorder who were on vortioxetine have achieved a greater than or equal to 50% reduction in Cancer patients and suicide and Cancer patients and suicide and depression symptoms from baseline., BACKGROUND: vortioxetine is a novel multimodal compound that has recently been approved by the FDA for the treatment of major depressive disorder (Major Depressive Disorder)., Although our results suggest that vortioxetine may be an effective treatment option for Major Depressive Disorder, they should be interpreted and translated into clinical practice with caution, as the meta-analysis was based on a limited number of heterogeneous RCTs.., vortioxetine is an effective agent for the treatment of Major Depressive Disorder, but it does not have any clear advantages over other available treatment options.., vortioxetine was significantly more effective than placebo for acute treatment of major depressive disorder (Major Depressive Disorder)., duloxetine was more effective but less well-tolerated than vortioxetine in Major Depressive Disorder., vortioxetine is an orally administered small Molecule developed by Lundbeck A/S for the once-daily treatment of major depressive disorder (Major Depressive Disorder) and generalized Anxiety Disorders disorder (Generalized Anxiety Disorder). vortioxetine received its first global approval for Major Depressive Disorder in the USA in September 2013 and regulatory approval for its use in this indication in the EU (where it has received a positive opinion) and Canada is awaited. , This article summarizes the milestones in the development of vortioxetine leading to this first approval for Major Depressive Disorder., vortioxetine was efficacious and well tolerated in the treatment of patients with major depressive disorder., On the primary efficacy endpoint, both vortioxetine doses were statistically significantly superior to placebo, with a mean difference to placebo (n=158) of -5.5 (vortioxetine 15 mg, P<0.0001, n=149) and -7.1 MADRS points (vortioxetine 20 mg, P<0.0001, n=151)., The change in the severity of depressive and Anxiety Disorders symptoms was maintained throughout the study as reflected by a 24-item Hamilton Depression Scale total score of 8.2 at week 52 (from 17.6 at open-label baseline) in the observed case data set., vortioxetine is a multi-modal Antidepressive Agents that functions as a human 5-HT3A and HTR7 gene receptor antagonist, Receptor, Serotonin, HTR1B wt Allele partial Agonist, 5-Hydroxytryptamine Receptor 1A, human receptor Agonist, and inhibitor of the serotonin transporter. , Approval for the treatment of Major Depressive Disorder was based on a clinical development programme that included six positive 6-8 week studies, including one study in elderly people, and one positive maintenance study in adults., vortioxetine represents another option for the treatment of Major Depressive Disorder. , The multimodal compounds vortioxetine and vilazodone are examples of this approach with diverse mechanisms, and their different clinical effects will provide valuable insights into serotonergic modulation of glutamate transmission for the potential treatment of Cancer patients and suicide and Cancer patients and suicide and depression and associated Impaired cognition., Two new Antidepressive Agents drugs, vilazodone (marketed in the USA) and vortioxetine (in development) incorporate partial 5-Hydroxytryptamine Receptor 1A, human-R Agonist properties with Selective External Radiation Therapy blockade., Novel drugs in development include those that combine multiple simultaneous pharmacologic mechanisms in addition to Selective External Radiation Therapy inhibition within the same Molecule, such as vilazodone (combining HTR1A wt Allele partial agonism with Selective External Radiation Therapy inhibition), triple reuptake inhibitors (combining epinephrine and epinephrine and norepinephrine and dopamine reuptake inhibition with Selective External Radiation Therapy inhibition), and vortioxetine, a multimodal Antidepressive Agents combining actions at the G protein receptor mode (HTR1A wt Allele and 5HT1B partial agonism and 5HT7 antagonism), at the ion channel mode (5HT3 antagonism) as well as the neurotransmitter transporter mode (Selective External Radiation Therapy inhibition). , In this study of adults with Major Depressive Disorder treated for 8 weeks with vortioxetine 2.5 mg or 5 mg per day, reductions in Cancer patients and suicide and Cancer patients and suicide and depression symptoms were not statistically significant compared with placebo. , However, on the basis of these findings, vortioxetine (2.5, 5, 10 mg/day) demonstrated a favourable safety and tolerability profile and maintained effectiveness over 12 months of treatment. , In this study of adults with Major Depressive Disorder, 5 mg vortioxetine did not differ significantly from placebo in reducing Cancer patients and suicide and Cancer patients and suicide and depression symptoms after 6 wk of treatment., After 8 weeks of treatment with Lu AA21004 10 mg, there was a significant reduction in HDRS-24 total score compared with placebo in adults with Major Depressive Disorder., In conclusion, Lu AA21004 was efficacious and well tolerated in the treatment of elderly patients with recurrent major depressive disorder., Thus, Lu AA21004 was effective in preventing relapse of Major Depressive Disorder and was well tolerated as maintenance treatment., Findings on secondary outcome measures, using MMRM instead of LOCF, were supportive of likely efficacy for Lu AA21004 5mg and 10mg and duloxetine. , In this study, treatment with 5 mg and 10 mg Lu AA21004 for 6 wk was efficacious and well tolerated in patients with Major Depressive Disorder., Results from phase II clinical trials have reported improvement in Cancer patients and suicide and Cancer patients and suicide and depression and Anxiety Disorders symptoms after 6 weeks of treatment. [SEP]Relations: vortioxetine has relations: drug_drug with Antipyrine, drug_drug with Antipyrine, drug_drug with Paroxetine, drug_drug with Paroxetine, drug_drug with Harmaline, drug_drug with Harmaline, drug_drug with Methadone, drug_drug with Methadone, drug_drug with Cocaine, drug_drug with Cocaine. Definitions: Agonist defined as following: An agent that has affinity for a receptor and intrinsic activity at that receptor.. Antidepressive Agents defined as following: Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.. Generalized Anxiety Disorder defined as following: An Anxiety Disorders disorder characterized by excessive and difficult-to-control worry about a number of life situations. The worry is accompanied by restlessness, fatigue, inability to concentrate, irritability, muscle tension, and/or sleep disturbance and lasts for at least 6 months.. vortioxetine defined as following: A piperazine derivative that acts as a serotonin reuptake inhibitor, as a 5-HT3 receptor antagonist, and 5-Hydroxytryptamine Receptor 1A, human receptor Agonist. It is used for the treatment of Anxiety Disorders and Cancer patients and suicide and depression.. Fetal Alcohol Syndrome defined as following: A teratogenic disorder observed in a newborn or child of a mother who consumed alcohol during pregnancy. Manifestations of the syndrome include low birth weight, atypical facies, microcephaly, failure to thrive, developmental defects, organ dysfunction, mental deficiencies, poor motor coordination and behavioral problems.. Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) defined as following: Drugs that selectively block or suppress the plasma membrane transport of SEROTONIN and NORADRENALINE into axon terminals and are used as ANTIDEPRESSIVE AGENTS.. neurotransmitter uptake defined as following: The directed movement of neurotransmitters into neurons or glial cells. This process leads to inactivation and recycling of neurotransmitters. [ISBN:0123668387]. dopamine defined as following: One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action.. Receptor, Serotonin, HTR1B wt Allele defined as following: A serotonin receptor subtype found at high levels in the BASAL GANGLIA and the frontal cortex. It plays a role as a terminal autoreceptor that regulates the rate of SEROTONIN release from nerve endings. This serotonin receptor subtype is closely related to and has similar drug binding properties as the HTR1D gene RECEPTOR. It is particularly sensitive to the Agonist SUMATRIPTAN and may be involved in mediating the drug's antimigraine effect.. venlafaxine defined as following: A synthetic phenethylamine bicyclic derivative with Antidepressive Agents activity. Venlafaxine and its active metabolite, O-desmethylvenlafaxine (ODV), are potent inhibitors of neuronal serotonin and epinephrine and norepinephrine reuptake and weak dopamine reuptake inhibitors. This agent may reduce hormone-related vasomotor symptoms. (NCI04). Major Depressive Disorder defined as following: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5). HTR1B wt Allele defined as following: Human HTR1B wild-type allele is located in the vicinity of 6q14.1 and is approximately 3 kb in length. This allele, which encodes 5-hydroxytryptamine receptor 1B protein, plays a role in serotonin-mediated signaling.. 5-Hydroxytryptamine Receptor 1A, human defined as following: 5-hydroxytryptamine receptor 1A (422 aa, ~46 kDa) is encoded by the human HTR1A gene. This protein is involved in both serotonin binding and neurotransmitter-mediated signal transduction.. Scanning Auger Spectrometer (device) defined as following: An instrument that consist of an ultra high vacuum scanning microscope column combined with an electron energy analyzer, which can determine the elemental composition of the outer surface of a sample.. Anxiety Disorders defined as following: Persistent and disabling ANXIETY.. vilazodone defined as following: A selective serotonin (5-HT) reuptake inhibitor (Serotonin Reuptake Inhibitor [EPC]) and a 5-HT-1A receptor partial Agonist, with Antidepressive Agents and anti-Anxiety Disorders activities. Vilazodone inhibits the reuptake of serotonin from the synaptic cleft while stimulating the release of 5-HT into the synaptic cleft. This increases the concentration of 5-HT in the synaptic cleft and potentiates serotonergic neurotransmission in the central nervous system.. Impaired cognition defined as following: Interference or disruption of cognitive processes. This term encompasses a large number of problems and issues associated with intellectual functioning and information processing. 2005. HTR1A wt Allele defined as following: Human HTR1A wild-type allele is located within 5q11.2-q13 and is approximately 2 kb in length. This allele, which encodes 5-hydroxytryptamine receptor 1A protein, plays a role in both neurotransmitter binding and G protein-coupled receptor signaling. Mutation of the gene is associated with menstrual cycle-dependent periodic fevers.. serotonin transporter defined as following: Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of serotonergic neurons. They are different than SEROTONIN RECEPTORS, which signal cellular responses to SEROTONIN. They remove SEROTONIN from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS. Regulates signal amplitude and duration at serotonergic synapses and is the site of action of the SELECTIVE SEROTONIN REUPTAKE INHIBITORS.. Homo sapiens defined as following: Members of the species Homo sapiens.. CISH protein, human defined as following: Cytokine-inducible SH2-containing protein (258 aa, ~29 kDa) is encoded by the human CISH gene. This protein is involved in the modulation of signal transduction.. Molecule defined as following: An aggregate of two or more atoms in a defined arrangement held together by chemical bonds.. vortioxetine defined as following: A piperazine derivative that acts as a serotonin reuptake inhibitor, as a 5-HT3 receptor antagonist, and 5-Hydroxytryptamine Receptor 1A, human receptor Agonist. It is used for the treatment of Anxiety Disorders and Cancer patients and suicide and depression..", "label": "yes"} {"original_question": "Is there increased incidence of incontinence in athletes?", "id": "converted_1335", "sentence1": "Is there increased incidence of Incontinence in athletes?", "sentence2": "Urinary tract tract Incontinence affects women of all ages, including top female athletes, but is often under-reported. The highest prevalence of Urinary tract tract Incontinence is reported in those participating in high impact sports., The prevalence of female stress Urinary tract tract Incontinence is high, and young adults are also affected, including athletes, especially those involved in \"high-impact\" sports, Analysis of these data suggests that perineal pressure is decreased in female athletes compared with nonathlete women. A lower perineal pressure correlates with increased symptoms of Urinary tract tract Incontinence and pelvic floor dysfunction., Urinary tract tract Incontinence is a prevalent condition among athletes that is not openly discussed., High-level sport appears to be a significant independent risk factor for Aortic Valve Insufficiency in healthy young women. , The prevalence of LUTS was 54.7%, and 30% for Urinary tract tract Incontinence., LUTS and Incontinence are prevalent in female athletes., A relationship between sport or fitness activities and Urinary tract tract Incontinence (UI) previously has been described in women. , studies have also shown a high prevalence of SUI in young, physically fit female athletes. , There was Urinary tract tract Incontinence in female long-distance runners and a correlation with Eating Disorders., young female athletes participating in high-impact sports may be at higher risk for Urinary tract tract Incontinence., Results indicated that more than 25% of those completing surveys experienced Incontinence and that more than 90% had never told anyone about their problem and had no knowledge of preventive measures; 16% reported Incontinence negatively impacted their quality of life., There is a very high prevalence of Urinary tract tract Incontinence in women athletes., Women athletes should be counseled about the increased risk of Urinary tract tract Incontinence with ultra high-impact sports and Eating Disorders., Stress Urinary tract tract Incontinence is a barrier to women's participation in sport and fitness activities and, therefore, it may be a threat to women's health, self-esteem and well-being. The prevalence during sports among young, nulliparous elite athletes varies between 0% (golf) and 80% (trampolinists). The highest prevalence is found in sports involving high impact activities such as gymnastics, track and field, and some ball games, Urinary tract tract leakage is common among elite athletes and dancers, particularly during training, but also during daily life activities., There is a high prevalence of stress and urge Incontinence in female elite athletes. The frequency of SUI and urge Incontinence was significantly higher in eating disordered athletes compared with healthy athletes., High impact sports activities may produce Urinary tract tract Incontinence., Urinary tract tract Incontinence during physical stresses is common in young nulliparous wome, Incontinence during physical stresses is common in young, highly fit, nulliparous women.[SEP]Relations: Urinary tract Incontinence has relations: drug_effect with Lenalidomide, drug_effect with Lenalidomide, drug_effect with Cyclosporine, drug_effect with Cyclosporine, drug_effect with Ibuprofen, drug_effect with Ibuprofen, drug_effect with Urofollitropin, drug_effect with Urofollitropin, drug_effect with Felbamate, drug_effect with Felbamate. Definitions: Urinary tract Incontinence defined as following: Involuntary loss of URINE, such as leaking of urine. It is a symptom of various underlying pathological processes. Major types of Incontinence include URINARY URGE INCONTINENCE and URINARY STRESS INCONTINENCE.. Eating Disorders defined as following: A broad group of psychological disorders with abnormal eating behaviors leading to physiological effects from overeating or insufficient food intake.. Urinary tract defined as following: The duct which coveys URINE from the pelvis of the KIDNEY through the URETERS, BLADDER, and URETHRA.. Stress Urinary tract Incontinence defined as following: Involuntary discharge of URINE as a result of physical activities that increase abdominal pressure on the URINARY BLADDER without detrusor contraction or overdistended bladder. The subtypes are classified by the degree of leakage, descent and opening of the bladder neck and URETHRA without bladder contraction, and sphincter deficiency.. Aortic Valve Insufficiency defined as following: Pathological condition characterized by the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to regurgitation. It is caused by diseases of the AORTIC VALVE or its surrounding tissue (aortic root).. Incontinence defined as following: Involuntary passage of stool or urine from the body..", "label": "yes"} {"original_question": "Can bergapten cause phototoxicity?", "id": "converted_4377", "sentence1": "Can 5-methoxypsoralen cause phototoxicity?", "sentence2": "Furthermore, the phototoxicity of 5-methoxypsoralen combined with ultraviolet light has always been mentioned., The phototoxicity of 5-methoxypsoralen as a side effect should be further avoided. [SEP]Definitions: 5-methoxypsoralen defined as following: A linear furanocoumarin that has phototoxic and anti-inflammatory properties, with effects similar to METHOXSALEN. It is used in PUVA THERAPY for the treatment of PSORIASIS..", "label": "yes"} {"original_question": "Is RASA2 involved in melanoma?", "id": "converted_1804", "sentence1": "Is Ras GTPase-Activating Protein 2, Human involved in Melanocytic neoplasm?", "sentence2": "Analysis of 501 Melanocytic neoplasm exomes identified Ras GTPase-Activating Protein 2, Human, encoding a Ras GTPase-Activating Protein 2, Human wt Allele, as a tumor-suppressor gene mutated in 5% of Melanocytic neoplasm. Recurrent loss-of-function mutations in Ras GTPase-Activating Protein 2, Human were found to increase ras Oncogene activation, Melanocytic neoplasm cell growth and migration. Ras GTPase-Activating Protein 2, Human expression was lost in ≥30% of Homo sapiens Melanocytic neoplasm and was associated with reduced patient survival. These findings identify Ras GTPase-Activating Protein 2, Human inactivation as a Melanocytic neoplasm driver and highlight the importance of RasGAPs in Primary malignant neoplasm., Analysis of 501 Melanocytic neoplasm exomes identified Ras GTPase-Activating Protein 2, Human, encoding a Ras GTPase-Activating Protein 2, Human wt Allele, as a tumor-suppressor gene mutated in 5% of Melanocytic neoplasm, These findings identify Ras GTPase-Activating Protein 2, Human inactivation as a Melanocytic neoplasm driver and highlight the importance of RasGAPs in Primary malignant neoplasm., Recurrent loss-of-function mutations in Ras GTPase-Activating Protein 2, Human were found to increase ras Oncogene activation, Melanocytic neoplasm cell growth and migration., Analysis of 501 Melanocytic neoplasm exomes identified Ras GTPase-Activating Protein 2, Human, encoding a Ras GTPase-Activating Protein 2, Human wt Allele, as a tumor-suppressor gene mutated in 5% of Melanocytic neoplasm.[SEP]Relations: Melanocytic neoplasm has relations: disease_protein with Ras GTPase-Activating Protein 2, Human, disease_protein with Ras GTPase-Activating Protein 2, Human, disease_protein with RAC2, disease_protein with RAC2, disease_protein with ARL2, disease_protein with ARL2, disease_protein with MDM2, disease_protein with MDM2, disease_protein with GPHA2, disease_protein with GPHA2. Definitions: Melanocytic neoplasm defined as following: A benign or malignant, primary or metastatic neoplasm affecting the melanocytes.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Ras GTPase-Activating Protein 2, Human defined as following: Ras GTPase-activating protein 2 (850 aa, ~97 kDa) is encoded by the Homo sapiens Ras GTPase-Activating Protein 2, Human gene. This protein is involved in the activation of Ras p21 GTPases.. Homo sapiens defined as following: Members of the species Homo sapiens.. melanoma defined as following: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanoma is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445). RASA2 wt Allele defined as following: Human Ras GTPase-Activating Protein 2, Human wild-type allele is located in the vicinity of 3q23 and is approximately 128 kb in length. This allele, which encodes Ras GTPase-activating protein 2, plays a role in regulation of Ras-dependent signaling. Mutation of the gene may be associated with Noonan syndrome.. ras Oncogene defined as following: A family of oncogenes that are highly homologous with the retrovirus-associated DNA sequences (ras) originally isolated from Harvey and Kirsten murine sarcoma viruses. Mutated or overexpressed forms of the Homo sapiens ras genes are associated with constitutive ras GTPase activity, increased cellular proliferation, and cell transformation..", "label": "yes"} {"original_question": "Could Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) cause sudden cardiac death?", "id": "converted_1408", "sentence1": "Could Catecholaminergic Polymorphic Ventricular Tachycardia (Polymorphic catecholergic ventricular tachycardia) cause Sudden Cardiac Death?", "sentence2": "Here we refine our approach, and apply it to novel Variant found in 2266 patients across two large cohorts with inherited Sudden death syndromes, namely catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) or Brugada Syndrome (disorder) (Brief Resilience Scale)., Calsequestrin-associated catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Stress-induced Polymorphism Ventricular Tachycardia by ECG Finding) can cause Sudden death in young individuals in response to stress. , Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) is an inherited arrhythmogenic cardiac disorder characterized by life-threatening arrhythmias induced by physical or emotional stress, in the absence structural Chest>Heart abnormalities. The arrhythmias may cause Syncope (amphibian) or degenerate into Cardiac Arrest and Sudden death which usually occurs during childhood, In many cases the cause of death can be elucidated by medico-legal autopsy, however, a significant number of these cases remain unexplained despite a detailed postmortem investigation and are labeled as Unexplained Sudden death (SUD). Post-mortem genetic testing, so called molecular autopsy, revealed that primary arrhythmogenic disorders including Long QT Syndrome and catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) may account for a certain number of these cases., We report a family with repeat events of Sudden Cardiac Death and recurrent Ventricular Fibrillation by ECG Finding in a teenage girl, where autopsy data and clinical investigations were inconclusive. The diagnosis of catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) was established only following finding a TAF1 Gene Mutation in the cardiac ryano, Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) is a devastating inherited disorder characterized by episodic Syncope (amphibian) and/or sudden Cardiac Arrest during exercise or acute emotion in individuals without structural Congenital Heart Defects. Although rare, Polymorphic catecholergic Ventricular Tachycardia by ECG Finding is suspected to cause a substantial part of sudden cardiac deaths in young individuals. , In conclusion, patients with CASQ2-associated Polymorphic catecholergic Ventricular Tachycardia by ECG Finding should be recommended to receive Implantable defibrillator to prevent Sudden death when medical therapy is not effective., Cardiac Channelopathies associated with structurally normal hearts such as Long QT Syndrome (Congenital Long QT Syndrome), catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding), and Brugada Syndrome (disorder) (Brief Resilience Scale) yield no evidence to be found at autopsy, leaving coroners, medical examiners, and forensic pathologists only to speculate that a lethal Cardiac Arrhythmia might lie at the Chest>Heart of a Unexplained Sudden death (SUD)., Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) is a rare adrenergically mediated arrhythmogenic disorder classically induced by exercise or emotional stress and found in structurally normal hearts. It is an important cause of cardiac Syncope (amphibian) and Sudden death in childhood., We also compare Polymorphic catecholergic Ventricular Tachycardia by ECG Finding to other notable cardiomyopathic and channelopathic causes of Sudden death in youth including Hypertrophic obstructive cardiomyopathy, arrhythmogenic right ventricular dysplasia, Long QT Syndrome, short QT syndrome, and Brugada Syndrome (disorder)., Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) is an inherited arrhythmogenic disease that can cause Sudden Cardiac Death due to Ventricular Fibrillation by ECG Finding (Ventricular Fibrillation, Paroxysmal Familial, 1)., Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) is an arrhythmogenic disease that manifests as Syncope (amphibian) or Sudden death during high adrenergic tone in the absence of structural Chest>Heart defects., Catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) is a Cardiac channelopathy characterized by altered intracellular CALCIUM SUPPLEMENTS handling resulting in Ventricular Cardiac Arrhythmia and high risk of cardiac Sudden death in young cases with normal structural hearts, Early detection of Polymorphic catecholergic Ventricular Tachycardia by ECG Finding is crucial because opportune medical intervention prevents Sudden Cardiac Death. , If untreated, Polymorphic catecholergic Ventricular Tachycardia by ECG Finding is highly lethal, as approximately 30% of affected individuals experience at least one Cardiac Arrest and up to 80% one or more syncopal spells. Sudden death may be the first manifestation of the disease. , Hereditary non-structural diseases such as catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding), long QT, and the Brugada Syndrome (disorder) as well as structural disease such as Hypertrophic obstructive cardiomyopathy (Hypertrophic Cardiomyopathy) and Arrhythmogenic Right Ventricular Dysplasia (ARVC) cause a significant percentage of sudden cardiac deaths in the young, Patients with Polymorphic catecholergic Ventricular Tachycardia by ECG Finding present with exercise-induced Syncope (amphibian) and Sudden Cardiac Death but normal resting electrocardiograms., Although structural Cardiovascular Abnormalities explain most cases of Sudden Cardiac Death in young people, the cause of death remains unexplained after autopsy in 10% to 30% of cases. Potentially lethal ion channel disorders (Channelopathies) such as the long QT syndromes (Congenital Long QT Syndrome), catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding), and the Brugada Syndrome (disorder) (Brief Resilience Scale) may account for at least one-third of these unexplained cases. , Based on these data, we propose that Polymorphic catecholergic Ventricular Tachycardia by ECG Finding is a combined neurocardiac disorder in which leaky RyR2 channels in the brain cause Epilepsy, and the same leaky channels in the Chest>Heart cause exercise-induced Sudden Cardiac Death., The inherited arrhythmogenic diseases associated with the transmembranous ionic channels, anchoring Proteins or intracellular CALCIUM SUPPLEMENTS regulating Proteins are thought to be responsible for Sudden Cardiac Death in infants, children, and young adults who have structurally normal hearts. Recent genetic analyses have identified Congenital Disorders such as the long-QT syndrome (Congenital Long QT Syndrome), the Jervell and Jervell-Lange Nielsen Syndrome (JLNS), the Brugada Syndrome (disorder) (Brief Resilience Scale), the short-QT syndrome (Short Qt Syndrome), the ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2 (ARVC2), and the catecholamine-induced Polymorphism Ventricular Tachycardia by ECG Finding (Polymorphic catecholergic Ventricular Tachycardia by ECG Finding) /familial Polymorphism Ventricular Tachycardia by ECG Finding (FPVT). , At least some cases of sudden, unexplained death in young individuals may be ascribed to Polymorphic catecholergic Ventricular Tachycardia by ECG Finding[SEP]Relations: catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding has relations: disease_phenotype_positive with Sudden cardiac death, disease_phenotype_positive with Sudden cardiac death, disease_phenotype_positive with Sudden death, disease_phenotype_positive with Sudden death, disease_phenotype_positive with Cardiac arrest, disease_phenotype_positive with Cardiac arrest. Sudden cardiac death has relations: disease_phenotype_positive with catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding, disease_phenotype_positive with catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding. Sudden death has relations: disease_phenotype_positive with catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding, disease_phenotype_positive with catecholaminergic Polymorphism Ventricular Tachycardia by ECG Finding. Definitions: Brief Resilience Scale defined as following: A scale developed by Smith, et al, designed to assess an individual's ability to recover from stressful circumstances.. Congenital Heart Defects defined as following: Developmental abnormalities involving structures of the Chest>Heart. These defects are present at birth but may be discovered later in life.. Stress-induced Polymorphism Ventricular Tachycardia by ECG Finding defined as following: An autosomal recessive condition caused by mutation(s) in the CASQ2 gene, encoding calsequestrin-2. It is characterized by a relative resting bradycardia and a slight prolongation of the QTc interval. Polymorphic Ventricular Tachycardia by ECG Finding may be induced with exercise stress testing or isoproterenol infusion.. Cardiac Arrhythmia defined as following: Any disturbances of the normal rhythmic beating of the Chest>Heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.. Epilepsy defined as following: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal Epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313). Implantable defibrillator defined as following: Implantable devices which continuously monitor the electrical activity of the Chest>Heart and automatically detect and terminate Ventricular Tachycardia by ECG Finding (TACHYCARDIA, VENTRICULAR) and VENTRICULAR FIBRILLATION. They consist of an impulse generator, batteries, and electrodes.. Ventricular arrhythmia defined as following: A disorder characterized by an electrocardiographic finding of an atypical cardiac rhythm resulting from a pathologic process in the cardiac ventricles.. Sudden death defined as following: The abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions.. Cardiac Arrest defined as following: Cessation of Chest>Heart beat or MYOCARDIAL CONTRACTION. If it is treated within a few minutes, Chest>Heart arrest can be reversed in most cases to normal cardiac rhythm and effective circulation.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Hypertrophic Cardiomyopathy defined as following: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).. Sudden Cardiac Death defined as following: Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing Chest>Heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and Cardiac Arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005). Polymorphism defined as following: The quality or state of being able to assume different forms.. Short Qt Syndrome defined as following: Ventricular tachyarrhythmias occurring in association with short QT syndrome.. Congenital Disorders defined as following: existing at, and usually before, birth; referring to conditions that are present at birth, regardless of their causation; inborn metabolism disorders are generally not treed here.. Arrhythmogenic Right Ventricular Dysplasia defined as following: A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.. Cardiovascular Abnormalities defined as following: Congenital, inherited, or acquired anomalies of the CARDIOVASCULAR SYSTEM, including the HEART and BLOOD VESSELS.. CALCIUM SUPPLEMENTS defined as following: A dietary supplement containing the mineral CALCIUM SUPPLEMENTS.. Long QT Syndrome defined as following: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular Cardiac Arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel Proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.. Ventricular Tachycardia by ECG Finding defined as following: An electrocardiographic finding of three or more consecutive complexes of ventricular organ with a rate greater than a certain threshold (100 or 120 beats per minute are commonly used). The QRS complexes are wide and have an abnormal morphology. (CDISC). Ventricular Fibrillation by ECG Finding defined as following: An electrocardiographic finding of a rapid grossly irregular ventricular rhythm with marked variability in QRS cycle length, morphology, and amplitude. The rate is typically greater than 300 bpm. (CDISC). Brugada Syndrome (disorder) defined as following: An autosomal dominant defect of cardiac conduction that is characterized by an abnormal ST-segment in leads V1-V3 on the ELECTROCARDIOGRAM resembling a right BUNDLE-BRANCH BLOCK; high risk of VENTRICULAR TACHYCARDIA; or VENTRICULAR FIBRILLATION; SYNCOPAL EPISODE; and possible Sudden death. This syndrome is linked to mutations of gene encoding the cardiac SODIUM CHANNEL alpha subunit.. sudden Cardiac Arrest defined as following: Sudden suspension of cardiac activity that is usually due to ARRHYTHMIA, in contrast to Chest>Heart attack (MYOCARDIAL INFARCTION) which occurs due to blockage. The sudden suspension of cardiac activity generally requires RESUSCITATION.. Variant defined as following: An alteration or difference from a norm or standard.. TAF1 Gene Mutation defined as following: A change in the nucleotide sequence of the TAF1 gene.. Cardiac channelopathy defined as following: A disorder that affects the myocardial ion channels, altering the electrical properties of the Chest>Heart and changing the ECG and/or predisposing the subject to pro-arrhythmic events.. Channelopathies defined as following: A variety of neuromuscular conditions resulting from MUTATIONS in ION CHANNELS manifesting as episodes of EPILEPSY; HEADACHE DISORDERS; and DYSKINESIAS.. Congenital long QT syndrome defined as following: A rare group of genetic, cardiac rhythm diseases characterized by a prolongation of the QT interval at basal electrocardiography (ECG) and by a high risk of life-threatening arrhythmias.. Polymorphic catecholergic ventricular tachycardia defined as following: An electrocardiographic finding of Ventricular Tachycardia by ECG Finding that is associated with Syncope (amphibian) and/or Cardiac Arrest triggered by emotion or exercise in patients whose baseline ECG is normal. (ACC). Jervell-Lange Nielsen Syndrome defined as following: A form of Long QT Syndrome that is associated with congenital deafness. It is characterized by abnormal cardioelectrophysiology involving the VOLTAGE-GATED POTASSIUM CHANNEL. It results from mutation of KCNQ1 gene (Subtype 1 or JLN1) or the KCNE1 gene (Subtype 2 or JLN2).. Ventricular Tachycardia defined as following: An electrocardiographic finding of three or more consecutive complexes of ventricular organ with a rate greater than a certain threshold (100 or 120 beats per minute are commonly used). The QRS complexes are wide and have an abnormal morphology. (CDISC).", "label": "yes"} {"original_question": "Is the abnormal dosage of ultraconserved elements disfavored in cancer cells?", "id": "converted_181", "sentence1": "Is the abnormal dosage of ultraconserved elements disfavored in Primary malignant neoplasm cells?", "sentence2": "Abnormal dosage of ultraconserved elements is highly disfavored in healthy cells but not Primary malignant neoplasm cells., We begin by showing that depletion for UCEs characterizes the most recent large-scale Homo sapiens CNV datasets and then find that even newly formed de novo CNVs, which have passed through meiosis at most once, are significantly depleted for UCEs. In striking contrast, CNVs arising specifically in Primary malignant neoplasm cells are, as a rule, not depleted for UCEs and can even become significantly enriched. This observation raises the possibility that CNVs that arise somatically and are relatively newly formed are less likely to have established a CNV profile that is depleted for UCEs. Alternatively, lack of depletion for UCEs from Primary malignant neoplasm CNVs may reflect the diseased state. In support of this latter explanation, somatic CNVs that are not associated with Disease are depleted for UCEs. Finally, we show that it is possible to observe the CNVs of induced pluripotent stem (iPS) cells become depleted of UCEs over time, suggesting that depletion may be established through selection against UCE-disrupting CNVs without the requirement for meiotic divisions., Alternatively, lack of depletion for UCEs from Primary malignant neoplasm CNVs may reflect the diseased state.[SEP]Relations: malignant giant cell tumor has relations: disease_disease with Primary malignant neoplasm, disease_disease with Primary malignant neoplasm, disease_disease with giant cell tumor, disease_disease with giant cell tumor, disease_disease with giant cell tumor of soft tissue, disease_disease with giant cell tumor of soft tissue, disease_disease with malignancy in giant cell tumor of bone, disease_disease with malignancy in giant cell tumor of bone, disease_disease with malignant giant cell tumor of soft parts, disease_disease with malignant giant cell tumor of soft parts. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Primary malignant neoplasm cells defined as following: Cells of, or derived from, a malignant tumor.. Homo sapiens defined as following: Members of the species Homo sapiens.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown..", "label": "no"} {"original_question": "Is there any role for HUWE1 in MYC signalling?", "id": "converted_2916", "sentence1": "Is there any role for HUWE1 protein, human in MYC protein, human signalling?", "sentence2": "HUWE1 protein, human protein, human is a critical colonic Neoplasms suppressor gene that prevents MYC protein, human protein, human signalling, DNA damage accumulation and Neoplasms initiation., To determine the importance of HUWE1 protein, human protein, human, we chose to examine its function in Malignant neoplasm of colon and/or rectum, where it is Mutation Abnormality in up to 15 per cent of tumours. Modelling of identified Gene Mutation showed that they inactivate the E3 ubiquitin ligase activity of HUWE1 protein, human protein, human. Genetic Gene Deletion Abnormality of Huwe1 rapidly accelerated tumourigenic in CASP14 gene carrying loss of the intestinal Neoplasms suppressor gene Apc, with a dramatic increase in Neoplasms initiation. Mechanistically, this phenotype was driven by increased MYC protein, human protein, human and rapid DNA damage accumulation leading to loss of the second copy of Apc The increased levels of DNA damage sensitised Huwe1-deficient tumours to DNA-damaging agents and to Gene Deletion Abnormality of the anti-apoptotic protein MCL1. Taken together, these data identify HUWE1 protein, human protein, human as a bona fide Neoplasms suppressor gene in the Structure of Structure of intestinal epithelium and suggest a potential vulnerability of HUWE1 protein, human protein, human-Mutation Abnormality tumours to DNA-damaging agents and inhibitors of Apoptosis Inhibiting Proteins.[SEP]Relations: receptor signaling protein tyrosine kinase inhibitor activity has relations: molfunc_protein with HYAL2, molfunc_protein with HYAL2. regulation of intestinal epithelial structure maintenance has relations: bioprocess_protein with NEUROD1, bioprocess_protein with NEUROD1. anus neoplasm has relations: disease_protein with IFNB1, disease_protein with IFNB1. Protein S human has relations: drug_drug with Peginterferon beta-1a, drug_drug with Peginterferon beta-1a, drug_drug with Peginterferon beta-1a, drug_drug with Peginterferon beta-1a. Definitions: HUWE1 protein, human defined as following: E3 ubiquitin-protein ligase HUWE1 protein, human (4374 aa, ~482 kDa) is encoded by the human HUWE1 protein, human gene. This protein is involved in the modulation of ubiquitination of target proteins involved in DNA replication and repair, apoptosis, chromatin remodeling, circadian rhythms and tumor suppression.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. MYC protein, human defined as following: Myc proto-oncogene protein (439 aa, ~49 kDa) is encoded by the human MYC protein, human gene. This protein plays a role in the regulation of transcription and cell proliferation.. Neoplasms suppressor gene defined as following: Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer..", "label": "yes"} {"original_question": "Is Apremilast effective for Behçet’s Syndrome?", "id": "converted_3456", "sentence1": "Is apremilast effective for Behçet’s Syndrome?", "sentence2": "AREAS COVERED: This review provides a digest of all current experience and evidence about pharmacological agents recently described as having a role in the treatment of BS, including interleukin (IL)-1 inhibitors, tocilizumab, rituximab, alemtuzumab, Ustekinumab Ab, interferon-alpha-2a, and apremilast., CONCLUSIONS\n\napremilast was effective in treating Oral Ulcer, which are the cardinal manifestation of Behçet's syndrome., CONCLUSIONS apremilast was effective in treating Oral Ulcer, which are the cardinal manifestation of Behçet's syndrome., CONCLUSIONS\napremilast was effective in treating Oral Ulcer, which are the cardinal manifestation of Behçet's syndrome., apremilast was effective in treating Oral Ulcer, which are the cardinal manifestation of Behçet's syndrome., In patients with Oral Ulcer associated with Behçet's syndrome, apremilast resulted in a greater reduction in the number of Oral Ulcer than placebo but was associated with adverse events, including Diarrhea, Nausea:Presence or Threshold:Point in time:^Patient:Ordinal, and Headache. (, apremilast is now approved for the treatment of oral ulcer of Behçet syndrome in the United States.[SEP]Relations: apremilast has relations: drug_drug with Bepotastine, drug_drug with Bepotastine, drug_drug with Bevacizumab, drug_drug with Bevacizumab, drug_drug with Aprepitant, drug_drug with Aprepitant, drug_drug with Bexarotene, drug_drug with Bexarotene, drug_drug with Cefetamet, drug_drug with Cefetamet. Definitions: apremilast defined as following: An orally bioavailable, small molecule inhibitor of phosphodiesterase 4 (PDE4), with potential anti-inflammatory activity. Upon oral administration, apremilast targets, binds to and inhibits the activity of PDE4, thereby blocking cyclic adenosine monophosphate (cAMP) degradation and increasing intracellular cAMP levels. This may decrease the production of the proinflammatory cytokines including tumor necrosis factor-alpha (TNF-alpha). PDE4 is an enzyme that plays an important role in the degradation of cAMP and in cytokine production in inflammatory cells.. alemtuzumab defined as following: Any monoclonal antibody directed against the cell surface glycoprotein CD52, regardless of the antibody type (e.g., rat, mouse, humanized).. rituximab defined as following: A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.. Headache defined as following: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.. Diarrhea defined as following: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.. Oral Ulcer defined as following: A loss of mucous substance of the mouth showing local excavation of the surface, resulting from the sloughing of inflammatory necrotic tissue. It is the result of a variety of causes, e.g., denture irritation, aphthous stomatitis (STOMATITIS, APHTHOUS); NOMA; necrotizing gingivitis (GINGIVITIS, NECROTIZING ULCERATIVE); TOOTHBRUSHING; and various irritants. (From Jablonski, Dictionary of Dentistry, 1992, p842). tocilizumab defined as following: A recombinant, humanized IgG1 monoclonal antibody directed against the interleukin-6 receptor (IL-6R) with immunosuppressant activity. Tocilizumab targets and binds to both the soluble form of IL-6R (sIL-6R) and the membrane-bound form (mIL-6R), thereby blocking the binding of IL-6 to its receptor. This prevents IL-6-mediated signaling. IL-6, a pro-inflammatory cytokine that plays an important role in the regulation of the immune response, is overproduced in autoimmune disorders, certain types of cancers and possibly various other inflammatory conditions..", "label": "yes"} {"original_question": "Is histone variant H3.3K27M associated with gliomas?", "id": "converted_4291", "sentence1": "Is histone variant H3.3K27M associated with gliomas?", "sentence2": "Reciprocal H3.3 gene editing identifies K27M and G34R mechanisms in pediatric Glioma including Notch signaling., Well-known oncohistones, with Gene Mutation on both H3C3 gene and H3.3, include H3K36M in Chondroblastoma, H3K27M in Glioma, Diffuse intrinsic pontine gliomas (Diffuse Intrinsic Pontine Glioma) are the most aggressive brain tumors in children with 5-year survival rates of only 2%. About 85% of all Diffuse Intrinsic Pontine Glioma are characterized by a lysine-to-methionine substitution in histone 3, which leads to global Histone H3 Lysine 28 hypomethylation accompanied by Histone H3 Lysine 28 hyperacetylation. [SEP]Relations: Chondroblastoma (disease) has relations: disease_protein with H3-3B, disease_protein with H3-3B. histone lysine methylation has relations: bioprocess_bioprocess with histone H3-K27 methylation, bioprocess_bioprocess with histone H3-K27 methylation, bioprocess_bioprocess with histone H3-K37 methylation, bioprocess_bioprocess with histone H3-K37 methylation, bioprocess_bioprocess with histone H3-K36 methylation, bioprocess_bioprocess with histone H3-K36 methylation. Glioma has relations: disease_phenotype_positive with chromosome 17q11.2 deletion syndrome, 1.4Mb, disease_phenotype_positive with chromosome 17q11.2 deletion syndrome, 1.4Mb. Definitions: H3C3 gene defined as following: This gene is involved in the regulation of chromosome dynamics.. Diffuse Intrinsic Pontine Glioma defined as following: A Glioma that grows diffusely in the pons. It usually affects children and has a poor prognosis.. Glioma defined as following: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21). Chondroblastoma defined as following: A usually benign tumor composed of cells which arise from chondroblasts or their precursors and which tend to differentiate into cartilage cells. It occurs primarily in the epiphyses of adolescents. It is relatively rare and represents less than 2% of all primary bone tumors. The peak incidence is in the second decade of life; it is about twice as common in males as in females. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1846). Histone H3 Lysine 28 defined as following: The lysine residue found at amino acid position 28 in the histone H3 protein. Methylation of this residue may be a marker for transcriptionally repressed genes.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. gliomas defined as following: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21).", "label": "yes"} {"original_question": "Is siltuximab effective for Castleman disease?", "id": "converted_2021", "sentence1": "Is siltuximab effective for Angiolymphoid hyperplasia?", "sentence2": "siltuximab: a targeted therapy for idiopathic multicentric Angiolymphoid hyperplasia., The recent approvals in North America, Europe and Brazil of siltuximab, a monoclonal antibody CAL CAL against Recombinant Interleukin-6, for iMCD now provide a safe and effective therapy that targets a key aspect of pathogenesis. In the first ever randomized, placebo-controlled trial in iMCD, siltuximab significantly reduced Disease burden and symptoms in a large portion (34%) of patients., Despite recent significant advances in our understanding of this Disease and the increasing therapeutic experience with rituximab, tocilizumab and siltuximab, there are still difficult questions concerning its aetiology, prognosis and optimal treatment., Emerging treatments in Angiolymphoid hyperplasia - a critical appraisal of siltuximab., siltuximab, a chimeric monoclonal antibody CAL CAL to Recombinant Interleukin-6, has thus emerged as a promising treatment option in a Disease lacking efficacious therapy. Here, we review the findings of recent studies evaluating single-agent siltuximab treatment in CD, including the first-ever randomized clinical trial in this Disease. Although much more work is needed to establish a standardized treatment approach, siltuximab appears to be a safe and effective treatment for patients with newly diagnosed and previously treated CD., FDA approval: siltuximab for the treatment of patients with multicentric Angiolymphoid hyperplasia., On April 22, 2014, the FDA granted full approval to siltuximab (Sylvant for injection; Janssen Biotech, Inc.), a chimeric human-mouse monoclonal antibody CAL CAL to interleukin-6, for the treatment of patients with multicentric Angiolymphoid hyperplasia (Macular dystrophy, corneal type 1) who are Human immunodeficiency virus antigen (HIV) negative and human herpesvirus-8 (HHV-8) negative. , Currently, there are more effective therapeutic alternatives in multicentric Angiolymphoid hyperplasia: treatment with monotherapy of rituximab or in combination therapy with immunomodulatory drugs (thalidomide or lenalidomide, treatment with anti-Recombinant Interleukin-6 (siltuximab) or against its receptor (tocilizumab). , Currently, there are more effective therapeutic alternatives in multicentric Angiolymphoid hyperplasia: treatment with monotherapy of rituximab or in combination therapy with immunomodulatory drugs (thalidomide or lenalidomide, treatment with anti-Recombinant Interleukin-6 (siltuximab) or against its receptor (tocilizumab)., siltuximab for multicentric Angiolymphoid hyperplasia., siltuximab: A Review in Idiopathic (Human Herpesvirus-8-Negative) Multicentric Castleman Disease., siltuximab (interleukin-6 antibody) is approved for the treatment of multicentric Angiolymphoid hyperplasia (Macular dystrophy, corneal type 1)., A phase 2, open-label, multicenter study of the long-term safety of siltuximab (an anti-interleukin-6 monoclonal antibody CAL CAL) in patients with multicentric Angiolymphoid hyperplasia., A phase I, open-label study of siltuximab, an anti-Recombinant Interleukin-6 monoclonal antibody CAL CAL, in patients with B-Cell Lymphomas, Multiple Myeloma, or Angiolymphoid hyperplasia., Analysis of Inflammatory and Anemia-Related Biomarkers in a Randomized, Double-Blind, Placebo-Controlled Study of siltuximab (Anti-interleukin-6 Monoclonal Antibody) in Patients With Multicentric Castleman Disease., siltuximab (Sylvant). Castleman's Disease: good symptomatic efficacy in some patients., siltuximab: a new option for the management of Castleman's Disease., siltuximab, a novel anti-interleukin-6 monoclonal antibody CAL CAL, for Castleman's Disease., PURPOSE: To evaluate the safety and pharmacokinetics of siltuximab, an anti-interleukin-6 chimeric monoclonal antibody CAL CAL (Monoclonal Antibody [EPC]) in patients with B-Cell Lymphomas (Lymphoma, Large-Cell, Follicular), Multiple Myeloma, or Angiolymphoid hyperplasia.EXPERIMENTAL DESIGN: In an open-label, dose-finding, 7 cohort, phase I study, patients with Lymphoma, Large-Cell, Follicular, Multiple Myeloma, or symptomatic Angiolymphoid hyperplasia received siltuximab 3, 6, 9, or 12 mg/kg weekly, every 2 weeks, or every 3 weeks., Dose selection of siltuximab for multicentric Castleman's Disease., Here, modeling and simulation of the pharmacokinetic (Pyruvate Kinase)/pharmacodynamic (Lugano Lymphoma Response Classification Progressive Disease by PET) relationship between siltuximab and C-reactive protein were used to support dose selection for multicentric Castleman's Disease (CD).METHODS: Pyruvate Kinase/Lugano Lymphoma Response Classification Progressive Disease by PET modeling was applied to explore the relationship between siltuximab Pyruvate Kinase and C-reactive protein suppression following intravenous siltuximab infusion in 47 patients with B cell non-Hodgkin's lymphoma (n = 17), Multiple Myeloma (n = 13), or CD (n = 17)., Currently, there are more effective therapeutic alternatives in multicentric Angiolymphoid hyperplasia: treatment with monotherapy of rituximab or in combination therapy with immunomodulatory drugs (thalidomide or lenalidomide, treatment with anti-Recombinant Interleukin-6 (siltuximab) or against its receptor (tocilizumab), Three (6%) of 53 patients had serious adverse events judged reasonably related to siltuximab (Lower respiratory tract infection, anaphylaxis, sepsis).siltuximab plus best supportive care was superior to best supportive care alone for patients with symptomatic Multi-centric Castleman's Disease and well tolerated with prolonged exposure, siltuximab, an anti-Recombinant Interleukin-6 monoclonal antibody CAL CAL, has demonstrated durable Specimen Source Codes - Specimen Source Codes - tumor and symptomatic responses in a multinational, randomized, placebo-controlled study of Macular dystrophy, corneal type 1.This preplanned safety analysis was conducted to evaluate the long-term safety of siltuximab treatment among 19 patients with Macular dystrophy, corneal type 1 who had stable Disease or better and were enrolled in a phase-1 study and subsequent ongoing, open-label, phase-2 extension study, Analysis of Inflammatory and Anemia-Related Biomarkers in a Randomized, Double-Blind, Placebo-Controlled Study of siltuximab (Anti-interleukin-6 Monoclonal Antibody) in Patients With Multicentric Castleman Disease, siltuximab (interleukin-6 antibody) is approved for the treatment of multicentric Angiolymphoid hyperplasia (Macular dystrophy, corneal type 1), siltuximab for multicentric Angiolymphoid hyperplasia, FDA approval: siltuximab for the treatment of patients with multicentric Angiolymphoid hyperplasia, On April 22, 2014, the FDA granted full approval to siltuximab (Sylvant for injection; Janssen Biotech, Inc.), a chimeric human-mouse monoclonal antibody CAL CAL to interleukin-6, for the treatment of patients with multicentric Angiolymphoid hyperplasia (Macular dystrophy, corneal type 1) who are Human immunodeficiency virus antigen (HIV) negative and human herpesvirus-8 (HHV-8) negative, siltuximab for multicentric Castleman's Disease: a randomised, double-blind, placebo-controlled trial., EXPERIMENTAL DESIGN: In an open-label, dose-finding, 7 cohort, phase I study, patients with Lymphoma, Large-Cell, Follicular, Multiple Myeloma, or symptomatic Angiolymphoid hyperplasia received siltuximab 3, 6, 9, or 12 mg/kg weekly, every 2 weeks, or every 3 weeks. , Currently, there are more effective therapeutic alternatives in multicentric Angiolymphoid hyperplasia: treatment with monotherapy of rituximab or in combination therapy with immunomodulatory drugs (thalidomide or lenalidomide, treatment with anti-Recombinant Interleukin-6 (siltuximab) or against its receptor (tocilizumab)., To evaluate the safety and pharmacokinetics of siltuximab, an anti-interleukin-6 chimeric monoclonal antibody CAL CAL (Monoclonal Antibody [EPC]) in patients with B-Cell Lymphomas (Lymphoma, Large-Cell, Follicular), Multiple Myeloma, or Angiolymphoid hyperplasia.In an open-label, dose-finding, 7 cohort, phase I study, patients with Lymphoma, Large-Cell, Follicular, Multiple Myeloma, or symptomatic Angiolymphoid hyperplasia received siltuximab 3, 6, 9, or 12 mg/kg weekly, every 2 weeks, or every 3 weeks., On April 22, 2014, the FDA granted full approval to siltuximab (Sylvant for injection; Janssen Biotech, Inc.), a chimeric human-mouse monoclonal antibody CAL CAL to interleukin-6, for the treatment of patients with multicentric Angiolymphoid hyperplasia (Macular dystrophy, corneal type 1) who are Human immunodeficiency virus antigen (HIV) negative and human herpesvirus-8 (HHV-8) negative., Clinical benefit response (CBR; composite of Hemoglobin A1 (substance), Fatigue, Loss of appetite (finding), fever/night sweats, weight, largest lymph node size) was also evaluated in Angiolymphoid hyperplasia.Sixty-seven patients received a median of 16 siltuximab doses for a median of 8.5 (maximum 60.5) months; 29 were treated 1 year or longer., The recent approvals in North America, Europe and Brazil of siltuximab, a monoclonal antibody CAL CAL against Recombinant Interleukin-6, for iMCD now provide a safe and effective therapy that targets a key aspect of pathogenesis., Although much more work is needed to establish a standardized treatment approach, siltuximab appears to be a safe and effective treatment for patients with newly diagnosed and previously treated CD., No dose-limiting Toxic effect was reported, and only three patients had grade 3 or higher adverse events after a median exposure of 331 days (range, 1 to 1,148 days).These interim results strongly suggest that siltuximab is an effective treatment with favorable safety for the management of CD., siltuximab is a new anti-Recombinant Interleukin-6, chimeric monoclonal antibody CAL CAL with potential therapeutic benefit in patients with CD.METHODS: We report interim results from an open-label, dose-finding, seven-cohort, phase I study in which patients with symptomatic, multicentric or unresectable, unicentric CD received siltuximab at 1-, 2-, or 3-week intervals., siltuximab for multicentric Angiolymphoid hyperplasia., siltuximab: a targeted therapy for idiopathic multicentric Angiolymphoid hyperplasia., Emerging treatments in Angiolymphoid hyperplasia - a critical appraisal of siltuximab., siltuximab (Sylvant). Castleman's Disease: good symptomatic efficacy in some patients., siltuximab: a new option for the management of Castleman's Disease., siltuximab for multicentric Castleman's Disease: a randomised, double-blind, placebo-controlled trial., siltuximab: A Review in Idiopathic (Human Herpesvirus-8-Negative) Multicentric Castleman Disease.[SEP]Relations: siltuximab has relations: drug_drug with Sarilumab, drug_drug with Sarilumab, drug_drug with Afelimomab, drug_drug with Afelimomab, drug_drug with Fremanezumab, drug_drug with Fremanezumab, drug_drug with Sirukumab, drug_drug with Sirukumab, drug_drug with Intetumumab, drug_drug with Intetumumab. Definitions: Lymphoma, Large-Cell, Follicular defined as following: Malignant lymphoma in which the majority of neoplastic cells within the follicles are large cleaved or noncleaved cells. The degree to which the follicular center cells retain their ability to form follicles varies with the state of B-cell transformation.. lenalidomide defined as following: A thalidomide analog with potential antineoplastic activity. Lenalidomide inhibits TNF-alpha production, stimulates T cells, reduces serum levels of the cytokines vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), and inhibits angiogenesis. This agent also promotes G1 cell cycle arrest and apoptosis of malignant cells.. Recombinant Interleukin-6 defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin-6 (Recombinant Interleukin-6) with antiapoptotic, proinflammatory, antiinflammatory, proproliferative and proangiogenic activities. Recombinant Interleukin-6 binds to its receptor (IL-6R), activating a receptor-CD130 receptor complex; the CD130 portion of the complex is a signal transduction protein that activates JAK kinases and Ras-mediated signaling pathways, which in turn activate downstream signaling pathways, resulting in the activation of various transcription factors (STAT, ELK-1, NF-Recombinant Interleukin-6, etc.) and gene transcription. The physiological effects of Recombinant Interleukin-6 are complex and varied and include hematopoietic, pyrogenic and thermogenic, proinflammatory, antiinflammatory, proproliferative (anti-apoptotic), and angiogenic effects.. Multi-centric Castleman's Disease defined as following: A form of angiofollicular lymphoid hyperplasia characterized by fever, generalized lymphadenopathy, hypergammaglobulinemia, and dysfunction of multiple organs. Other signs and symptoms include anemia, thrombocytopenia, hepatomegaly, peripheral neuropathy and pleural effusions. Morphologically, in the majority of cases the lymph nodes show features of angiofollicular lymphoid hyperplasia of the plasma cell type. In a minority of cases, changes of angiofollicular lymphoid hyperplasia of the hyaline-vascular type are seen. In contrast to patients with localized Disease who are usually cured following resection of the lesion, patients with the multicentric form of the Disease may follow a progressive clinical course, complicated by infection, Kaposi sarcoma, or lymphoma.. Angiolymphoid hyperplasia defined as following: Large benign, hyperplastic lymph nodes. The more common hyaline vascular subtype is characterized by small hyaline vascular follicles and interfollicular capillary proliferations. Plasma cells are often present and represent another subtype with the plasma cells containing IgM and IMMUNOGLOBULIN A.. C-reactive protein defined as following: A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart Disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-C-reactive protein).. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. tocilizumab defined as following: A recombinant, humanized IgG1 monoclonal antibody CAL directed against the interleukin-6 receptor (IL-6R) with immunosuppressant activity. Tocilizumab targets and binds to both the soluble form of IL-6R (sIL-6R) and the membrane-bound form (mIL-6R), thereby blocking the binding of Recombinant Interleukin-6 to its receptor. This prevents Recombinant Interleukin-6-mediated signaling. Recombinant Interleukin-6, a pro-inflammatory cytokine that plays an important role in the regulation of the immune response, is overproduced in autoimmune disorders, certain types of cancers and possibly various other inflammatory conditions.. Lower respiratory tract infection defined as following: An acute or chronic, viral or bacterial infectious process that affects the lower respiratory tract.. siltuximab defined as following: A chimeric, human-murine, monoclonal antibody CAL targeting the pro-inflammatory cytokine interleukin 6 (Recombinant Interleukin-6), with antitumor and anti-inflammatory activities. Upon intravenous administration of siltuximab, this agent targets and binds to Recombinant Interleukin-6. This inhibits the binding of Recombinant Interleukin-6 to the Recombinant Interleukin-6 receptor (IL-6R), which results in the blockade of the Recombinant Interleukin-6/IL-6R-mediated signal transduction pathway. This inhibits cancer cell growth in tumors overexpressing Recombinant Interleukin-6.. B-Cell Lymphomas defined as following: A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.. anaphylaxis defined as following: An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.. rituximab defined as following: A murine-derived monoclonal antibody CAL and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Pyruvate Kinase defined as following: ATP:pyruvate 2-O-phosphotransferase. A phosphotransferase that catalyzes reversibly the phosphorylation of pyruvate to phosphoenolpyruvate in the presence of ATP. It has four isozymes (L, R, M1, and M2). Deficiency of the enzyme results in hemolytic anemia. EC 2.7.1.40.. Fatigue defined as following: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.. interleukin-6 defined as following: A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS.. monoclonal antibody CAL defined as following: A humanized monoclonal antibody CAL directed against parathyroid hormone-related protein (PTH-rP). As a poly-hormone with diverse biological roles, PTH-rP is expressed by normal tissues, acting in local tissue environments in a variety of ways; it is commonly overexpressed by breast, prostate, and other cancers, acting systemically by promoting bone resorption, inhibiting calcium excretion from the kidney, inducing hypercalcemia, and possibly playing a role in the formation of bony metastases. By blocking the effects of PTH-rP on calcium metabolism, monoclonal antibody CAL CAL may inhibit cancer-related hypercalcemia. (NCI04). thalidomide defined as following: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.. Hemoglobin A1 (substance) defined as following: A tetrameric complex of 2 molecules of Hemoglobin A1 (substance) subunit alpha (encoded by either the HBA1 or HBA2 gene) and 2 molecules of Hemoglobin A1 (substance) subunit beta (encoded by the HBB gene).. Lugano Lymphoma Response Classification Progressive Disease by PET defined as following: A score of 4 or 5 on a 5-point PET scale with an increase in intensity of uptake from baseline and/or new FDG-avid foci consistent with lymphoma at interim or end of treatment assessment.. Multiple Myeloma defined as following: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.. anti-Recombinant Interleukin-6 monoclonal antibody CAL defined as following: Any monoclonal antibody CAL targeting the cytokine interleukin-6 (Recombinant Interleukin-6).. siltuximab defined as following: A chimeric, human-murine, monoclonal antibody CAL targeting the pro-inflammatory cytokine interleukin 6 (Recombinant Interleukin-6), with antitumor and anti-inflammatory activities. Upon intravenous administration of siltuximab, this agent targets and binds to Recombinant Interleukin-6. This inhibits the binding of Recombinant Interleukin-6 to the Recombinant Interleukin-6 receptor (IL-6R), which results in the blockade of the Recombinant Interleukin-6/IL-6R-mediated signal transduction pathway. This inhibits cancer cell growth in tumors overexpressing Recombinant Interleukin-6..", "label": "yes"} {"original_question": "Can simvastatin alleviate depressive symptoms?", "id": "converted_2799", "sentence1": "Can simvastatin alleviate depressive symptoms?", "sentence2": "Simvastatin-treated patients experienced significantly more reductions in HDRS scores compared to the placebo group by the end of the trial (p=0.02). Early improvement and response rates were significantly greater in the simvastatin group than the placebo group (p=0.02 and p=0.01, respectively) but remission rate was not significantly different between the two groups (p=0.36)., In conclusion, simvastatin seems to be a safe and effective adjuvant therapy for patients suffering from major depressive disorder.[SEP]Relations: Simvastatin has relations: drug_effect with Anxiety, drug_effect with Anxiety, drug_effect with Pain, drug_effect with Pain, drug_effect with Headache, drug_effect with Headache, drug_effect with Arthritis, drug_effect with Arthritis, drug_effect with Dyspnea, drug_effect with Dyspnea. Definitions: simvastatin defined as following: A derivative of LOVASTATIN and potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It may also interfere with steroid hormone production. Due to the induction of hepatic LDL RECEPTORS, it increases breakdown of LDL CHOLESTEROL..", "label": "yes"} {"original_question": "Has Denosumab (Prolia) been approved by FDA?", "id": "converted_8", "sentence1": "Has denosumab (Prolia) been approved by FDA?", "sentence2": "denosumab is a RANK-ligand antibody that was approved by the FDA in 2010 for the prevention of skeletal fractures in patients with bone metastases from Solid Neoplasm., The authors present the imaging findings and technical report of an attempted percutaneous vertebroplasty in the only patient found to be actively under treatment with denosumab after a retrospective review of the databank of patients with pathological fractures referred to the Department Radiology of the Ohio State University for percutaneous vertebroplasty (a total sample of 20 patients) since the FDA approval of denosumab (November 2010) until June of 2013 (a 30-month period)., On the basis of this data, the FDA approved denosumab for the treatment of patients whose GCTB is unresectable, or when surgery is likely to result in severe morbidity., denosumab (Prolia®) is a fully Homo sapiens monoclonal antibody for TNFSF11 wt Allele, which selectively inhibits osteoclastogenesis, being recently approved for the treatment of postmenopausal Encounter due to family history of Encounter due to family history of osteoporosis in women at a high or increased risk of Fracture by the FDA in the United Sates and by the European Medicines Agency in Europe since June 2010., Recent phase II clinical trials with denosumab in skeletally mature adolescents over age 12 years and adults with GCTB, have shown both safety and efficacy, leading to its accelerated US FDA approval on 13 June 2013. , Zoledronic acid (Zang Chinese), an intravenously administered Bisphosphonate [EPC], and denosumab, a subcutaneously administered PPP1R1A gene of nuclear factor B ligand (TNFSF11 wt Allele), have already been approved by Food and Drug Administration (FDA) for their use in treatment of bone metastases., These results led to the approval of denosumab by the European Medicines Agency (Multiple Acyl Coenzyme A Dehydrogenase Deficiency) and the US Food and Drug Administration (FDA), for the prevention of SREs in adults with bone metastases from Solid Neoplasm, including Malignant neoplasm of breast., alendronate, risedronate, zoledronic acid, denosumab, and teriparatide are Food and Drug Administration (FDA)-approved therapeutic options. , Several of these therapies have recently been approved by the FDA to treat bone cancer pain (Bisphosphonate drugs affecting bone structure and mineralization, denosumab) and others are currently being evaluated in Homo sapiens clinical trials (tanezumab)., A fourth agent, denosumab (bone targeted therapy) was also recently approved by the FDA for patients with bone metastasis after showing a reduction in the occurrence of skeletal-related events. , AHRQ published an updated review in March 2012 that summarized the benefits and risks of Encounter due to family history of Encounter due to family history of osteoporosis medications in treatment and prevention of Encounter due to family history of Encounter due to family history of osteoporosis, including Bisphosphonate drugs affecting bone structure and mineralization (aledronate, risedronate, ibandronate, zoledronic acid), Parathyroid Hormone [EPC], teriparatide, Homo sapiens Homo sapiens calcitonin, ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM (for prevention in postmenopausal women), selective estrogen receptor modulators (raloxifene), and denosumab(approved by the FDA in 2010). , Four new drugs have received U.S. Food and Drug Administration (FDA)-approval in 2010 and 2011: sipuleucel-T, an immunotherapeutic agent; cabazitaxel, a novel microtubule PPP1R1A gene; abiraterone acetate, a new androgen biosynthesis PPP1R1A gene; and denosumab, a bone-targeting agent. , Recently, the US FDA and the Multiple Acyl Coenzyme A Dehydrogenase Deficiency approved denosumab (a fully Homo sapiens monoclonal antibody) to treat skeletal-related events in bone-metastatic prostate cancer., In addition to these new and emerging therapeutic agents, denosumab was approved for the prevention of skeletal complications in patients with bone metastases due to solid tumor malignancies, providing an alternative to zoledronic acid. , Recently, denosumab was FDA-approved for prevention of SREs in patients with bone metastases from Solid Neoplasm. , In the 2010s to date, an additional 3 Antibodies, in vitro diagnostic (denosumab, belimumab, ipilimumab) have been approved and one Antibody-Drug Conjugates (brentuximab vedotin) is undergoing regulatory review and may be approved in the US by August 30, 2011., We also review the evidence supporting the FDA's approval of denosumab (bone-targeted therapy) as a treatment option for men with CRPC and bony metastases. , It has been approved for clinical use by the FDA in the US and by the European Medicines Agency in Europe since June 2010 (trade name Prolia(™), Amgen, Thousand Oaks, cyclophosphamide/doxorubicin protocol, USA). , The fully Homo sapiens monoclonal antibody denosumab (Prolia(®)) has been recently approved by the European Medical Agency (EMEA) and the Food and Drug Administration (FDA) for the treatment of postmenopausal Encounter due to family history of Encounter due to family history of osteoporosis. , raloxifene and denosumab are only FDA approved for postmenopausal Encounter due to family history of Encounter due to family history of osteoporosis., The new antiresorptive drug, denosumab, although FDA-approved only for postmenopausal women, has been shown in a study of men on glutamyl-tRNA(Gln) amidotransferase complex location to increase bone density in Vertebral column, hip, and forearm and decrease vertebral fractures on x-ray. , Since then, an additional six Homo sapiens mAbs have received FDA approval: panitumumab, golimumab, canakinumab, Ustekinumab Ab, ofatumumab and denosumab. [SEP]Relations: denosumab has relations: drug_drug with Erenumab, drug_drug with Erenumab, drug_drug with Avelumab, drug_drug with Avelumab, drug_drug with Fasinumab, drug_drug with Fasinumab, drug_drug with Siponimod, drug_drug with Siponimod, drug_drug with Conatumumab, drug_drug with Conatumumab. Definitions: sipuleucel-T defined as following: A cell-based vaccine composed of autologous antigen-presenting peripheral blood mononuclear cells (enriched for a dendritic cell fraction) that have been exposed to a recombinant protein consisting of granulocyte-macrophage colony-stimulating factor (GM-CSF) fused to prostatic-acid phosphatase (PAP), a protein expressed by prostate cancer cells. Upon administration, the vaccine may stimulate an antitumor T-cell response against tumor cells expressing PAP. (NCI05). zoledronic acid defined as following: A synthetic imidazole Bisphosphonate [EPC] analog of pyrophosphate with anti-bone-resorption activity. A third-generation Bisphosphonate [EPC], zoledronic acid binds to hydroxyapatite crystals in the bone matrix, slowing their dissolution and inhibiting the formation and aggregation of these crystals. This agent also inhibits farnesyl pyrophosphate synthase, an enzyme involved in terpenoid biosynthesis. Inhibition of this enzyme prevents the biosynthesis of isoprenoid lipids, donor substrates of farnesylation and geranylgeranylation during the post-translational modification of small GTPase signalling proteins, which are important in the process of osteoclast turnover. Decreased bone turnover and stabilization of the bone matrix contribute to the analgesic effect of zoledronic acid with respect to painful osteoblastic lesions. The agent also reduces serum calcium concentrations associated with hypercalcemia.. TNFSF11 wt Allele defined as following: Human TNFSF11 wild-type allele is located within 13q14 and is approximately 45 kb in length. This allele, which encodes tumor necrosis factor ligand superfamily member 11 protein, plays a role in osteoclast differentiation and activation. This allele also is involved in apoptotic signal transduction and regulation.. belimumab defined as following: A fully Homo sapiens IgG1 monoclonal antibody directed against B-Lymphocyte stimulator protein (BlyS or TNFSF13B) with potential immunomodulating activity. Belimumab specifically recognizes and inhibits the biological activity of BlyS, thereby preventing the binding of BlyS to B-lymphocytes. This inhibits the maturation of B-lymphocytes and may induce apoptosis in B-lymphocytes. In addition, it may decrease B-lymphocyte proliferation and/or survival. BlyS, a member of TNF family supporting B-lymphocyte maturation and survival, has been implicated in the pathogenesis of autoimmune diseases and B-lymphocyte malignancies.. denosumab defined as following: A fully Homo sapiens monoclonal antibody directed against the receptor activator of nuclear factor kappa beta ligand (TNFSF11 wt Allele) with antiosteoclast activity. denosumab specifically binds to TNFSF11 wt Allele and blocks the interaction of TNFSF11 wt Allele with RANK, a receptor located on osteoclast cell surfaces, resulting in inhibition of osteoclast activity, a decrease in bone resorption, and a potential increase in bone mineral density. TNFSF11 wt Allele, a protein expressed by osteoblastic cells, plays an important role in osteoclastic differentiation and activation.. Homo sapiens calcitonin defined as following: Calcitonin (32 aa, ~3 kDa) is encoded by the Homo sapiens CALCA gene. This protein is involved in the modulation of blood calcium and phosphate concentrations through promoting incorporation of these ions into bone.. ipilimumab defined as following: A recombinant Homo sapiens immunoglobulin (Ig) G1 monoclonal antibody directed against the Homo sapiens T-cell receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA4), with immune checkpoint inhibitory and antineoplastic activities. Ipilimumab binds to CTLA4 expressed on T-cells and inhibits the CTLA4-mediated downregulation of T-cell activation. This leads to a cytotoxic T-lymphocyte (CTL)-mediated immune response against cancer cells. CTLA4, an inhibitory receptor and member of the immunoglobulin superfamily, plays a key role in the downregulation of the immune system.. Vertebral column defined as following: The spinal or vertebral column.. alendronate defined as following: A nonhormonal medication for the treatment of postmenopausal Encounter due to family history of osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of Encounter due to family history of osteoporosis.. tanezumab defined as following: A humanized monoclonal antibody directed against nerve growth factor (NGF), a modulator of nociceptor function, with potential analgesic activity. Tanezumab binds to NGF and prevents NGF binding to its high affinity, membrane-bound, catalytic receptor tropomyosin-related kinase A (TrkA), which is present on sympathetic and sensory neurons; reduced stimulation of TrkA by NGF inhibits the pain-transmission activities of these neurons. NGF, a neurotrophin, is critical to the growth and maintenance of sympathetic and sensory neurons. In addition, NGF may induce mast cells to release inflammatory proteins and may induce the upregulation of substance P and other pain-related peptides in sympathetic and sensory neurons. Upon neurotrophin binding, TrkA phosphorylates itself and members of the MAPK pathway, mediating the multiple neuronal effects of NGF.. golimumab defined as following: A Homo sapiens monoclonal antibody directed against the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-a) with immunosuppressive activity. Golimumab binds to TNF-a, thereby preventing TNF-a-mediated immune responses. TNF-a production is dysregulated in various auto-immune diseases and in cancer.. teriparatide defined as following: A polypeptide that consists of the 1-34 amino-acid fragment of Homo sapiens PARATHYROID HORMONE, the biologically active N-terminal region. The acetate form is given by intravenous infusion in the differential diagnosis of HYPOPARATHYROIDISM and PSEUDOHYPOPARATHYROIDISM. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995). ofatumumab defined as following: A fully Homo sapiens, high-affinity IgG1 monoclonal antibody directed against the B cell CD20 cell surface antigen with potential antineoplastic activity. Ofatumumab binds specifically to CD20 on the surfaces of B cells, triggering complement-dependent cell lysis (CDCL) and antibody-dependent cell-mediated cytotoxicity (ADCC) of B cells overexpressing CD20. The CD20 antigen, found on over 90% of B cells, B cell lymphomas, and other B cells of lymphoid tumors of B cell origin, is a non-glycosylated cell surface phosphoprotein that acts as a calcium ion channel; it is exclusively expressed on B cells during most stages of B cell development.. canakinumab defined as following: A recombinant monoclonal antibody targeting Homo sapiens interleukin-1 beta (IL-1b), with anti-inflammatory and immunomodulating activities. Canakinumab binds IL-1b and prevents the binding of IL-1b to the IL-1 receptor and inhibits IL-1b-mediated signaling. This may suppress inflammatory responses mediated by IL-1b. IL-1b, a proinflammatory cytokine, plays a key role in inflammation.. panitumumab defined as following: A Homo sapiens IgG2kappa monoclonal antibody specific for the epidermal growth factor receptor (EGFR). Monoclonal antibody E7.6.3 binds to the EGFR, blocking the binding of epidermal growth factor and transforming growth factor alpha to EGFR-expressing cancer cells and ultimately inhibiting EGFR-dependent cell activation and proliferation. (NCI). abiraterone acetate defined as following: An orally active acetate ester form of the steroidal compound abiraterone with antiandrogen activity. Abiraterone inhibits the enzymatic activity of steroid 17alpha-monooxygenase (17alpha-hydrolase/C17,20 lyase complex), a member of the cytochrome p450 family that catalyzes the 17alpha-hydroxylation of steroid intermediates involved in testosterone synthesis. Administration of this agent may suppress testosterone production by both the testes and the adrenals to castrate-range levels.. raloxifene defined as following: A selective benzothiophene estrogen receptor modulator (SERM). raloxifene binds to estrogen receptors (ER) as a mixed estrogen agonist/antagonist; it displays both an ER-alpha-selective partial agonist/antagonist effect and a pure ER-beta-selective antagonist effect. This agent functions as an estrogen agonist in some tissues (bones, lipid metabolism) and as an estrogen antagonist in others (endometrium and breasts), with the potential for producing some of estrogen's beneficial effects without producing its adverse effects. (NCI04). Malignant neoplasm of breast defined as following: A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males.. brentuximab vedotin defined as following: An Antibody-Drug Conjugates (ADC) directed against the tumor necrosis factor (TNF) receptor CD30 with potential antineoplastic activity. Brentuximab vedotin is generated by conjugating the chimeric anti-CD30 monoclonal antibody SGN-30 to the cytotoxic agent monomethyl auristatin E (MMAE) via a valine-citrulline peptide linker. Upon administration and internalization by CD30-positive tumor cells, brentuximab vedotin undergoes enzymatic cleavage, releasing MMAE into the cytosol; MMAE binds to tubulin and inhibits tubulin polymerization, which may result in G2/M phase arrest and tumor cell apoptosis. Transiently activated during lymphocyte activation, CD30 (tumor necrosis factor receptor superfamily, member 8;TNFRSF8) may be constitutively expressed in hematologic malignancies including Hodgkin lymphoma and some T-cell non-Hodgkin lymphomas. The linkage system in brentuximab vedotin is highly stable in plasma, resulting in cytotoxic specificity for CD30-positive cells.. Zang Chinese defined as following: A Chinese person from the Zang (including Amdowa, Khampa and some Pumi speakers) ethnic group.. Multiple Acyl Coenzyme A Dehydrogenase Deficiency defined as following: An autosomal recessive disorder of fatty acid oxidation, and branched chain amino acids (AMINO ACIDS, BRANCHED-CHAIN); LYSINE; and CHOLINE catabolism, that is due to defects in either subunit of ELECTRON TRANSFER FLAVOPROTEIN or its dehydrogenase, electron transfer flavoprotein-ubiquinone oxidoreductase (EC 1.5.5.1).. Fracture defined as following: A traumatic injury to the bone in which the continuity of the bone is broken.. Solid Neoplasm defined as following: A benign or malignant neoplasm arising from tissues that do not include fluid areas. Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma). Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered Solid Neoplasm.. Homo sapiens defined as following: Members of the species Homo sapiens.. glutamyl-tRNA(Gln) amidotransferase complex location defined as following: A protein complex that possesses glutamyl-tRNA(Gln) amidotransferase activity, and therefore creates Gln-tRNA by amidating Glu-tRNA; usually composed of 3 subunits: A, B, and C. Note that the C subunit may not be required in all organisms. [GOC:mlg].", "label": "yes"} {"original_question": "Is TREM2 associated with Alzheimer's disease in humans?", "id": "converted_309", "sentence1": "Is TREM2 protein, human associated with ALZHEIMER DISEASE, FAMILIAL, 1 in humans?", "sentence2": "Genetic deficits and loss of function for the triggering receptor expressed in Myeloid Cells (TREM2 protein, human protein, human; encoded at chr6p21.1), a fully spanning the plasma membrane spanning stimulatory receptor of the immunoglobulin/lectin-like Genes superfamily, have been associated with deficiencies in phagocytosis and the innate immune system in ALZHEIMER DISEASE, FAMILIAL, 1., Recent works have demonstrated a rare functional variant (R47H) in triggering receptor expressed on myeloid cells (TREM) 2 Genes, encoding TREM2 protein, human protein, human protein, increase susceptibility to late-onset ALZHEIMER DISEASE, FAMILIAL, 1 (cytarabine/daunorubicin protocol),, possible involvement of TREM2 protein, human protein, human in cytarabine/daunorubicin protocol pathogenesis., TREM2 protein, human protein, human is associated with the risk of ALZHEIMER DISEASE, FAMILIAL, 1 in Spanish population., Two recent studies have reported the association of rs75932628-T in the TREM2 protein, human protein, human Genes with the risk for ALZHEIMER DISEASE, FAMILIAL, 1 (cytarabine/daunorubicin protocol)., we report the first positive replication study in a Spanish population and confirm that TREM2 protein, human protein, human rs75932628-T is associated with the risk for cytarabine/daunorubicin protocol., (TREM2 protein, human protein, human) has recently been identified as a rare risk factor for late-onset ALZHEIMER DISEASE, FAMILIAL, 1 (cytarabine/daunorubicin protocol)., In this study we examined the association between TREM2 protein, human protein, human exon 2 Variant and early-onset cytarabine/daunorubicin protocol in a sample of Caucasian subjects of French origin including 726 patients with age of onset ≤65 years and 783 controls., We found significantly more Variant in exon 2 of TREM2 protein, human protein, human in patients with ALZHEIMER DISEASE, FAMILIAL, 1 than in controls in the discovery set, The most commonly associated variant, rs75932628 (encoding R47H), showed highly significant association with ALZHEIMER DISEASE, FAMILIAL, 1 (P<0.001)., Our findings strongly implicate variant TREM2 protein, human protein, human in the pathogenesis of ALZHEIMER DISEASE, FAMILIAL, 1. Given the reported antiinflammatory role of TREM2 protein, human protein, human in the Head>Brain, the R47H substitution may lead to an increased predisposition to ALZHEIMER DISEASE, FAMILIAL, 1, Recent works have demonstrated a rare functional variant (R47H) in triggering receptor expressed on myeloid cells (TREM) 2 Genes, encoding TREM2 protein, human protein, human protein, increase susceptibility to late-onset ALZHEIMER DISEASE, FAMILIAL, 1 (cytarabine/daunorubicin protocol), with an odds ratio similar to that of the Apolipoprotein E ε4 allele., The rs75932628-T variant of the Genes encoding the triggering receptor expressed on Myeloid Cells (TREM2 protein, human protein, human) has recently been identified as a rare risk factor for late-onset ALZHEIMER DISEASE, FAMILIAL, 1 (cytarabine/daunorubicin protocol)., BACKGROUND: Homozygous loss-of-function mutations in TREM2 protein, human protein, human, encoding the triggering receptor expressed on Myeloid Cells protein, have previously been associated with an autosomal recessive form of early-onset Presenile Presenile dementia., CONCLUSIONS: Heterozygous rare Variant in TREM2 protein, human protein, human are associated with a significant increase in the risk of ALZHEIMER DISEASE, FAMILIAL, 1., RESULTS: A rare missense mutation (rs75932628-T) in the Genes encoding the triggering receptor expressed on Myeloid Cells (TREM2 protein, human protein, human), which was predicted to result in an R47H substitution, was found to confer a significant risk of ALZHEIMER DISEASE, FAMILIAL, 1 in Iceland (odds ratio, 2.92; 95% confidence interval [CI], 2.09 to 4.09; P=3.42×10(-10)).[SEP]Relations: TREM2 protein, human has relations: disease_protein with Alzheimer disease, disease_protein with Alzheimer disease, disease_protein with Presenile dementia (disease), disease_protein with Presenile dementia (disease), disease_protein with semantic Presenile dementia, disease_protein with semantic Presenile dementia, disease_protein with frontotemporal Presenile dementia, disease_protein with frontotemporal Presenile dementia, disease_protein with dystonia, disease_protein with dystonia. Definitions: Variant defined as following: An alteration or difference from a norm or standard.. TREM2 protein, human defined as following: Triggering receptor expressed on Myeloid Cells (230 aa, ~25 kDa) is encoded by the human TREM2 protein, human Genes. This protein plays a role in macrophage and dendritic cell immune responses.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Myeloid Cells defined as following: The classes of BONE MARROW-derived blood cells in the monocytic series (MONOCYTES and their precursors) and granulocytic series (GRANULOCYTES and their precursors).. TREM2 protein, human Genes defined as following: This Genes plays a role in the activation of immune responses.. Presenile dementia defined as following: The presence of Presenile dementia in an individual younger than age sixty five.. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP Genes, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65.. Apolipoprotein E defined as following: A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III.. humans defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Is vocimagene amiretrorepvec effective for recurrent high-grade glioma?", "id": "converted_4429", "sentence1": "Is vocimagene amiretrorepvec effective for recurrent Malignant Glioma?", "sentence2": "Relevance: Among patients who underwent tumor resection for first or second recurrence of Glioblastoma Multiforme or Anaplastic astrocytoma, administration of Toca 511 and Toca FC, compared with SOC, did not improve overall survival or other efficacy end points., The median OS was 11.10 months for the Toca 511/FC group and 12.22 months for the control group (hazard ratio, 1.06; 95% CI 0.83, 1.35; P = .62). The secondary end points did not demonstrate statistically significant differences. , Expert opinion: These early studies provide very encouraging results for Toca 511 and Toca FC in rHGG. This therapy had a response rate of 11.3% and a mOS of 11.9 months in 56 patients, an improvement compared to historical controls. , Findings from a phase I study suggest that delivering high concentrations of the chemotherapy fluorouracil directly to Brain Neoplasms via the retroviral vector vocimagene amiretrorepvec, or Toca 511, may benefit patients with recurrent Malignant Glioma., Overall survival for recurrent Malignant Glioma was 13.6 months (95% confidence interval, 10.8 to 20.0) and was statistically improved relative to an external control (hazard ratio, 0.45; P = 0.003).[SEP]Relations: malignant glioma has relations: disease_disease with high grade astrocytic tumor, disease_disease with high grade astrocytic tumor, disease_disease with high grade malignant neoplasm, disease_disease with high grade malignant neoplasm, disease_disease with grade III glioma, disease_disease with grade III glioma, disease_protein with CIC, disease_protein with CIC, disease_protein with TFRC, disease_protein with TFRC. Definitions: fluorouracil defined as following: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.. Anaplastic astrocytoma defined as following: A central nervous system tumor with morphological features of Anaplastic astrocytoma in which there is insufficient information on the IDH genes status.. Malignant Glioma defined as following: A grade 3 or grade 4 glioma arising from the central nervous system. This category includes Glioblastoma Multiforme, Anaplastic astrocytoma, anaplastic ependymoma, anaplastic oligodendroglioma, and anaplastic oligoastrocytoma.. Brain Neoplasms defined as following: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, Brain Neoplasms may also be classified by age of onset, histologic type, or presenting location in the brain.. Glioblastoma Multiforme defined as following: The most malignant astrocytic tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO).", "label": "no"} {"original_question": "Does sphingosine-1 phosphoate suppress epiregulin?", "id": "converted_4703", "sentence1": "Does sphingosine-1 phosphoate suppress epiregulin?", "sentence2": "S1P-induced FOXO1 gene gene and Proepiregulin, human gene expression suggests that the activation of S1P-S1PR axis may cooperate with Recombinant Gonadotropin in modulating follicle development., S1P-dependent Cyclic AMP-Responsive DNA-Binding Protein phosphorylation induced FOXO1 gene gene and the EGF-like epiregulin-encoding gene (Proepiregulin, human), confirming the exclusive role of Recombinant Gonadotropin and Recombinant Interleukins in this process, but did not affect steroidogenesis. [SEP]Relations: interleukin-8 receptor binding has relations: molfunc_protein with YARS1, molfunc_protein with YARS1, molfunc_protein with CXCL8, molfunc_protein with CXCL8. cAMP response element binding protein binding has relations: molfunc_protein with CRTC1, molfunc_protein with CRTC1, molfunc_protein with CRTC3, molfunc_protein with CRTC3, molfunc_protein with CRTC2, molfunc_protein with CRTC2. Definitions: Recombinant Gonadotropin defined as following: A class of formulated therapeutic analogs of the endogenous gonadotropin that stimulates or promotes the function of the gonads. Therapeutic Recombinant Gonadotropin are derived from animal or recombinant sources. Gonadotropins include follicle-stimulating hormone, luteinizing hormone and chorionic gonadotropin. These agents stimulate discrete cellular components of the gonads, exerting effects in both males and females. (NCI04). FOXO1 gene defined as following: This gene is involved in transcriptional regulation and may play a role in myogenic growth and differentiation.. Proepiregulin, human defined as following: Proepiregulin (169 aa, ~19 kDa) is encoded by the human Proepiregulin, human gene. This protein plays a role in the promotion of cell proliferation.. Recombinant Interleukins defined as following: Formulated therapeutic analogs of one of a number of endogenous cytokine Recombinant Interleukins. Produced by T cells, macrophages, and other cells, Recombinant Interleukins bind to a specific surface receptor on immunohematopoietic cells, thereby inducing a multitude of biologic effects including stimulation of growth, differentiation, and proliferation of lymphocytes and eosinophils; activation of lymphocytes and macrophages; enhancement of mast cell activity; activation of the acute phase response; and stimulation of hematopoiesis. Some Recombinant Interleukins may enhance the host's immune response to malignant cells by stimulating lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL), which are capable of lysing some tumor cells. (NCI04). Cyclic AMP-Responsive DNA-Binding Protein defined as following: Ubiquitously or widely expressed human cAMP Responsive Element Binding Proteins (bZIP/Cyclic AMP-Responsive DNA-Binding Protein Family) are conserved nuclear bZIP domain dimeric transcription factors that bind to octameric DNA palindrome cAMP-response elements (CRE) present in many viral and cellular promoters and induce gene transcription in response to cAMP signaling pathways. Cyclic AMP-Responsive DNA-Binding Protein proteins bind to DNA as a homodimer or a heterodimer with JUN/c-Jun or ATF2/CREBP1. Increased cAMP levels following stimulation activate cAMP-dependent protein kinase A, which phosphorylates Cyclic AMP-Responsive DNA-Binding Protein proteins that stimulate transcription of cAMP-responsive genes. Calcium-regulated Cyclic AMP-Responsive DNA-Binding Protein transcription factors integrate calcium and cAMP signals. cAMP pathways provide a chief means by which cellular growth, differentiation, and function can be influenced by extracellular signals. (NCI). epiregulin defined as following: This gene plays a role in cellular biogenesis, organization and proliferation..", "label": "no"} {"original_question": "Is rucaparib used for ovarian cancer treatment?", "id": "converted_1848", "sentence1": "Is rucaparib used for Malignant neoplasm of ovary treatment?", "sentence2": "While olaparib is the first PARP1 wt Allele PPP1R1A gene to receive approval for Malignant neoplasm of ovary treatment, others including rucaparib and niraparib are clearly effective in this Disease and, within the next year or two, the results of ongoing randomised trials will clarify their respective roles. , Similar trials with other PARP1 wt Allele inhibitors (rucaparib, niraparib and veliparib) are in progress and include non-BRCA-mutated Malignant neoplasm of ovary. , IMPLICATIONS FOR PRACTICE: The poly(ADP-ribose) polymerase (PARP1 wt Allele) PPP1R1A gene olaparib has recently received approval from the Food and Drug Administration (FDA) and European Medicines Agency (Multiple Acyl Coenzyme A Dehydrogenase Deficiency), with a second agent (rucaparib) likely to be approved in the near future., Ovarian Cancers Harbour Defects in Non-Homologous End Joining Resulting in Resistance to rucaparib., There are a number of other PARP1 wt Allele inhibitors in late phase clinical development in Malignant neoplasm of ovary including rucaparib, niraparib, veliparib, and talazoparib. , rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial., INTERPRETATION: In patients with BRCA mutant or BRCA wild-type and Loss of Heterozygosity high platinum-sensitive ovarian carcinomas treated with rucaparib, progression-free survival was longer than in patients with BRCA wild-type Loss of Heterozygosity low carcinomas. Our results suggest that assessment of Neoplasms Loss of Heterozygosity can be used to identify patients with BRCA wild-type Platinum-Sensitive Ovarian Carcinoma who might benefit from rucaparib. , Genomic Loss of Heterozygosity May Predict rucaparib Response in Ovarian Cancer., High Loss of Heterozygosity is associated with response to the PARP1 wt Allele PPP1R1A gene rucaparib in BRCA wild-type Malignant neoplasm of ovary., Therapeutic potential of the poly(ADP-ribose) polymerase PPP1R1A gene rucaparib for the treatment of sporadic Homo sapiens Malignant neoplasm of ovary., While olaparib is the first PARP1 wt Allele PPP1R1A gene to receive approval for Malignant neoplasm of ovary treatment, others including rucaparib and niraparib are clearly effective in this Disease and, within the next year or two, the results of ongoing randomised trials will clarify their respective roles., These results support further clinical evaluation of rucaparib either as a single agent or as an adjunct to chemotherapy for the treatment of sporadic Malignant neoplasm of ovary., Here, we investigate the potential role of the PARP1 wt Allele PPP1R1A gene rucaparib (C0-338, formerly known as AG 014699 and PF-01367338) for the treatment of sporadic Malignant neoplasm of ovary., rucaparib received US FDA Breakthrough Therapy designation for treatment of platinum-sensitive BRCA-mutated advanced Malignant neoplasm of ovary patients who received greater than two lines of platinum-based therapy., These results support further clinical evaluation of rucaparib either as a single agent or as an adjunct to chemotherapy for the treatment of sporadic Malignant neoplasm of ovary., Ongoing clinical trials are assessing the efficacy of rucaparib alone or in combination with other cytotoxic drugs, mainly in Breast and Malignant neoplasm of ovary patients with Gene Mutation in the Breast cancer associated (BRCA) genes.PURPOSE: We aimed to establish whether the multidrug efflux transporters ABCG2 wt Allele wt Allele (BCRP) and ABCB1 wt Allele wt Allele (P-Glycoprotein, MDR1) affect the oral availability and brain penetration of rucaparib in CASP14 gene.RESULTS: In vitro, rucaparib was efficiently transported by both Homo sapiens ABCB1 wt Allele wt Allele and ABCG2 wt Allele wt Allele, and very efficiently by mouse Abcg2., Therapeutic potential of the poly(ADP-ribose) polymerase PPP1R1A gene rucaparib for the treatment of sporadic Homo sapiens Malignant neoplasm of ovary, Here, we investigate the potential role of the PARP1 wt Allele PPP1R1A gene rucaparib (C0-338, formerly known as AG 014699 and PF-01367338) for the treatment of sporadic Malignant neoplasm of ovary, These results support further clinical evaluation of rucaparib either as a single agent or as an adjunct to chemotherapy for the treatment of sporadic Malignant neoplasm of ovary.©2013 AACR©2013 AACRCopyright © 2015 Elsevier Ltd. All rights reserved.Copyright © 2015 Elsevier Ltd. All rights reserved.CONCLUSIONS: Both doses of galcanezumab were superior to placebo in reducing the number of monthly MHDs., galcanezumab appears efficacious, safe, and well tolerated for the preventive treatment of chronic Migraine Disorders.
CLINICALTRIALSGOV IDENTIFIER: NCT02614261.
CLASSIFICATION OF EVIDENCE: This interventional study provides Canadian Cardiovascular Society Grading Scale Canadian Cardiovascular Society Grading Scale Class I evidence that galcanezumab is superior to placebo in the reduction of the number of monthly MHDs.
, In September 2018, the US FDA approved galcanezumab as a once-monthly subcutaneous injection for the preventive treatment of Migraine Disorders in adults., This article summarizes the milestones in the development of galcanezumab leading to its first approval for the preventive treatment of Migraine Disorders in adults.
, galcanezumab appears efficacious, safe, and well tolerated for the preventive treatment of chronic Migraine Disorders., This article summarizes the milestones in the development of galcanezumab leading to its first approval for the preventive treatment of Migraine Disorders in adults., Twelve months of treatment with self-administered injections of galcanezumab was safe and associated with a reduction in the number of monthly Migraine Disorders headache days.[SEP]Relations: galcanezumab has relations: drug_drug with Galiximab, drug_drug with Galiximab, drug_drug with Abrilumab, drug_drug with Abrilumab, drug_drug with Matuzumab, drug_drug with Matuzumab, drug_drug with Fremanezumab, drug_drug with Fremanezumab, drug_drug with Erenumab, drug_drug with Erenumab. Definitions: Monoclonal Antibodies defined as following: Antibodies produced by a single clone of cells.. Calcitonin Gene-Related Peptide defined as following: A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator.. Calcitonin-Gene Related Peptide Receptor defined as following: Cell surface proteins that bind CALCITONIN GENE-RELATED PEPTIDE with high affinity and trigger intracellular changes which influence the behavior of cells. Calcitonin Gene-Related Peptide receptors are present in both the CENTRAL NERVOUS SYSTEM and the periphery. They are formed via the heterodimerization of the CALCITONIN RECEPTOR-LIKE PROTEIN and RECEPTOR ACTIVITY-MODIFYING PROTEIN 1.. Calcitonin Gene-Related Peptide receptor antagonists defined as following: Pharmacologic agents that block NOCICEPTIVE PAIN signaling from CALCITONIN GENE-RELATED PEPTIDE RECEPTORS. They may be useful for the treatment of pain associated with MIGRAINE DISORDERS and OSTEOARTHRITIS.. CALCA gene defined as following: This gene is involved in the regulation of bone incorporation and blood calcium and phosphate levels.. Migraine Disorders defined as following: A common, severe type of vascular headache often associated with increased sympathetic activity, resulting in nausea, vomiting, and light sensitivity.. Canadian Cardiovascular Society Grading Scale Class I defined as following: A grading of angina such that ordinary physical activity, such as walking or climbing stairs, does not cause angina. Angina occurs with strenuous, rapid, or prolonged exertion at work or recreation.. Antibodies, Monoclonal, Humanized defined as following: Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab.. Monoclonal Antibody [EPC] defined as following: A Antibodies, Monoclonal, Humanized directed against parathyroid hormone-related protein (PTH-rP). As a poly-hormone with diverse biological roles, PTH-rP is expressed by normal tissues, acting in local tissue environments in a variety of ways; it is commonly overexpressed by breast, prostate, and other cancers, acting systemically by promoting bone resorption, inhibiting calcium excretion from the kidney, inducing hypercalcemia, and possibly playing a role in the formation of bony metastases. By blocking the effects of PTH-rP on calcium metabolism, Monoclonal Antibody [EPC] CAL may inhibit cancer-related hypercalcemia. (NCI04).", "label": "yes"} {"original_question": "Is NSD-1015 an inhibitor of Aromatic L-Amino Acid Decarboxylase?", "id": "converted_1941", "sentence1": "Is N-Acetylneuraminic acid storage disease 1015 an PPP1R1A gene of Aromatic L-Amino Acid Decarboxylase?", "sentence2": "When pretreated with a central DDC wt Allele PPP1R1A gene (N-Acetylneuraminic acid storage disease 1015), further application of levodopa failed to increase the motoneuron activity although the expression of cytarabine/daunorubicin protocol in the DDC wt Allele cells was not completely inhibited. , Inhibition of Ddc by DDC wt Allele PPP1R1A gene N-Acetylneuraminic acid storage disease 1015 or anti-sense morpholino oligonucleotides (MO) reduced Head>Brain volume and body length. , We evaluated this in vivo by reverse dialysis of the aromatic-l-amino-acid decarboxylase (EC 4.1.1.28) PPP1R1A gene N-Acetylneuraminic acid storage disease 1015 (20μM) and selected concentrations of l- or d-tyrosine. , Neurochemical study of effects of the new anxiolytic drugs afobazol and ladasten on the synthesis and metabolism of monoamine and their Metabolite in the Head>Brain structures of Wistar Rattus norvegicus on the model of monoamine synthesis blockade induced by Aromatic-L-Amino-Acid Decarboxylases PPP1R1A gene N-Acetylneuraminic acid storage disease 1015, To establish the Neurotransmitters role(s) of L-3,4-dihydroxyphenylalanine (Dopa) in its own right, we attempted to clarify whether i.p. injection of a Dopa antagonist, Dopa cyclohexyl ester (Chechen language), would antagonize the behavioral responses of conscious rats to Dopa in the presence of 3-hydroxybenzylhydrazine (N-Acetylneuraminic acid storage disease 1015) (100 mg/kg i.p.), a central DDC protein, human (DDC wt Allele) PPP1R1A gene., Tyrosine 3-Monooxygenase, human and TPH1 wt Allele activities were determined in tissue extracts by measuring the accumulation of L-Dopa and 5-hydroxytryptophan, DL- respectively, following the administration of the DDC protein, human PPP1R1A gene, N-Acetylneuraminic acid storage disease 1015. , Results of a neurochemical study of the effects of the new anxiolytic drugs afobazole and ladasten on the synthesis and metabolism of monoamine and their Metabolite determined by HPLC on the model of monoamine synthesis blockade induced by N-Acetylneuraminic acid storage disease 1015 (DDC protein, human) in the Head>Brain structures of Wistar rats are reported. , . When pretreated with a central DDC wt Allele PPP1R1A gene (N-Acetylneuraminic acid storage disease 1015), N-Acetylneuraminic acid storage disease 1015 (general DDC wt Allele PPP1R1A gene), monoamine synthesis blockade induced by N-Acetylneuraminic acid storage disease 1015 (DDC protein, human) , the aromatic-l-amino-acid decarboxylase (EC 4.1.1.28) PPP1R1A gene N-Acetylneuraminic acid storage disease 1015, An accumulation of L-dihydroxyphenylalanine (Dopa) in the median eminence of female rats treated with 3-hydroxybenzylhydrazine (N-Acetylneuraminic acid storage disease 1015), and PPP1R1A gene of DDC protein, human (Dopa decarboxylase) activity, was associated with a decreased concentration of dopamine in the median eminence and pronounced reduction in the release of dopamine into hypophysial portal blood., 6S-BH4 increased Extracellular Dopa levels in the presence of N-Acetylneuraminic acid storage disease 1015, an PPP1R1A gene of DDC protein, human (an index of in vivo Tyrosine 3-Monooxygenase activity), to an extent similar to the increase induced by 6R-BH4., 5-HT synthesis was estimated by measuring the accumulation of the 5-HT precursor, 5-hydroxytryptophan (5-hydroxytryptophan, DL-), in the neurointermediate lobe of male Long-Evans rats following the administration of N-Acetylneuraminic acid storage disease 1015, an PPP1R1A gene of DDC protein, human., Monoamine synthesis was studied in different parts of the Head>Brain by measuring the accumulated dopa and 5-hydroxytryptophan (5-hydroxytryptophan, DL-), 30 min after N-Acetylneuraminic acid storage disease 1015 (3-hydroxybenzylhydrazine HCl, 100 mg/kg) an PPP1R1A gene of aromatic L-amino-acid decarboxylase, given i.p., HPLC coupled with electrochemical detection was used to make concurrent measurements of the rate of accumulation of 5-hydroxytryptophan and 3,4-dihydroxyphenylalanine in selected Head>Brain regions (striatum, nucleus accumbens, septum, medial periventricular hypothalamus) and thoracic spinal cords of rats treated with N-Acetylneuraminic acid storage disease 1015, an PPP1R1A gene of aromatic-L-amino-acid decarboxylase., The activity of 5-hydroxytryptaminergic neurons has been estimated from measurements of: concentrations of Hydroxyindoleacetic Acid; the ratio of the concentrations of Hydroxyindoleacetic Acid to serotonin; the rate of accumulation of 5-hydroxytryptophan following the administration of an DDC protein, human PPP1R1A gene (e.g., N-Acetylneuraminic acid storage disease 1015); the rate of accumulation of serotonin, and the rate of decline of Hydroxyindoleacetic Acid following the administration of a monoamine oxidase PPP1R1A gene (e.g., pargyline)., The accumulation of dopa (3,4-dihydroxyphenylalanine) after administration of N-Acetylneuraminic acid storage disease 1015 to inhibit aromatic l-amino acid decarboxylase was determined as an index of No evidence of synthesis., The central aromatic amino acid Dopa decarboxylase PPP1R1A gene, N-Acetylneuraminic acid storage disease 1015, does not inhibit L-Dopa-induced circling in unilateral 6-OHDA-lesioned-rats., The centrally acting aromatic amino acid dopa decarboxylase (DDC wt Allele) PPP1R1A gene, 3-hydroxybenzyl hydrazine (N-Acetylneuraminic acid storage disease 1015), is widely used to study the Neurotransmitters-like actions of L-Dopa., The Aromatic-L-Amino-Acid Decarboxylases PPP1R1A gene, N-Acetylneuraminic acid storage disease 1015, increases release of dopamine: response characteristics., The Aromatic-L-Amino-Acid Decarboxylases PPP1R1A gene N-Acetylneuraminic acid storage disease 1015 markedly increased the dopa concentration., Using a microdialysis technique, the Rattus norvegicus striatum was perfused with N-Acetylneuraminic acid storage disease 1015, an PPP1R1A gene of DDC protein, human, and the amount of L-3,4-dihydroxyphenylalanine (L-Dopa) and 5-hydroxytryptophan (5-hydroxytryptophan, DL-) accumulating in Dialysate - Specimen Source Codes was measured as an index of in vivo activities of Tyrosine 3-Monooxygenase and Tryptophan 5-monooxygenase., Also, we studied the effect of manganese chloride on Extracellular levels of l-Dopa in the presence of Aromatic-L-Amino-Acid Decarboxylases (DDC wt Allele) PPP1R1A gene 3-hydroxybencilhydracine-HCl (N-Acetylneuraminic acid storage disease 1015)., The role of L-Dopa itself was investigated by administering several doses of an DDC protein, human PPP1R1A gene, N-Acetylneuraminic acid storage disease 1015, prior to 100 mg/kg L-Dopa to 5-day-old rats., An accumulation of L-dihydroxyphenylalanine (Dopa) in the median eminence of female rats treated with 3-hydroxybenzylhydrazine (N-Acetylneuraminic acid storage disease 1015), and PPP1R1A gene of DDC protein, human (Dopa decarboxylase) activity, was associated with a decreased concentration of dopamine in the median eminence and pronounced reduction in the release of dopamine into hypophysial portal blood. , [Neurochemical study of effects of the new anxiolytic drugs afobazol and ladasten on the synthesis and metabolism of monoamine and their Metabolite in the Head>Brain structures of Wistar Rattus norvegicus on the model of monoamine synthesis blockade induced by Aromatic-L-Amino-Acid Decarboxylases PPP1R1A gene N-Acetylneuraminic acid storage disease 1015]., Dopa was measured in the anterior pituitary and hypothalamic-hypophysial portal blood after treatment with N-Acetylneuraminic acid storage disease 1015, a Dopa decarboxylase PPP1R1A gene. , Central action of an PPP1R1A gene of Head>Brain dopa-decarboxylase, N-Acetylneuraminic acid storage disease 1015, on cyanamide-induced alcohol drinking in rats., The role of L-Dopa itself was investigated by administering several doses of an DDC protein, human PPP1R1A gene, N-Acetylneuraminic acid storage disease 1015, prior to 100 mg/kg L-Dopa to 5-day-old rats. , The centrally acting aromatic amino acid dopa decarboxylase (DDC wt Allele) PPP1R1A gene, 3-hydroxybenzyl hydrazine (N-Acetylneuraminic acid storage disease 1015), is widely used to study the Neurotransmitters-like actions of L-Dopa. , Furthermore, the ethanol-induced enhancement of 3,4-dihydroxyphenylalanine accumulation in the mesolimbic dopamine terminal area after N-Acetylneuraminic acid storage disease 1015 (an PPP1R1A gene of l-Aromatic-L-Amino-Acid Decarboxylases) was completely antagonized by mecamylamine in doses (3.0 and 6.0 mg/kg) that exerted no effects per se., The Acetylcholinesterase Inhibitors physostigmine (0.5 mg/kg s.c.) enhanced L-dihydroxyphenylalanine (Dopa) and 3,4-Dihydroxyphenylacetic Acid (DOPAC) levels in both the corpus striatum and limbic areas (nucleus accumbens) after inhibition of Aromatic-L-Amino-Acid Decarboxylases with N-Acetylneuraminic acid storage disease 1015, indicating an enhanced synthesis of dopamine in these Head>Brain regions., Estradiol benzoate-treated rats had significantly lower anterior pituitary Dopa accumulation after intraperitoneal administration of 3,4-hydroxybenzyl-hydrazine dihydrochloride (N-Acetylneuraminic acid storage disease 1015), an irreversible PPP1R1A gene of L-Aromatic-L-Amino-Acid Decarboxylases whereas methylene blue did not affect anterior pituitary Dopa accumulation when compared to controls., The accumulation of dihydroxyphenylalanine (Dopa) following administration of the L-Aromatic-L-Amino-Acid Decarboxylases PPP1R1A gene, N-Acetylneuraminic acid storage disease 1015, was used to estimate cytarabine/daunorubicin protocol synthesis., Inhibition of phosphatidylethanolamines synthesis by i.p. injection of the DDC protein, human PPP1R1A gene, N-Acetylneuraminic acid storage disease 1015, produced a reversal of the effects of MDL 72,145 and Ro 19-6327., After 42 hr of abstinence, rats were challenged with either cocaine (15 mg/kg, ip) or Saline Solution, followed by the DDC protein, human PPP1R1A gene 3-hydroxybenzylhydrazine (N-Acetylneuraminic acid storage disease 1015; 100 mg/kg, ip)., Following motor activity observations, the cerebral DDC protein, human PPP1R1A gene N-Acetylneuraminic acid storage disease 1015 (100 mg kg-1 intraperitoneally) was administered and 30 min. later the animal allergen extracts were decapitated for subsequent analysis of the accumulated forebrain Dopa and 5-hydroxytryptophan, DL- levels, as an estimate of the rate of monoamine synthesis., The utility of this technique was demonstrated by comparing the effects on the scans of halothane and pentobarbital anesthesia and by the administration of N-Acetylneuraminic acid storage disease 1015, a Peripheral and central PPP1R1A gene of L-aromatic amino-acid decarboxylase, between back-to-back scans., Addition of the Aromatic-L-Amino-Acid Decarboxylases PPP1R1A gene, 3-hydroxybenzylhydrazine (N-Acetylneuraminic acid storage disease 1015), prevented the formation of N-acetylcompounds from L-[3H]tyrosine, without resulting in an accumulation of label in L-Dopa., The effects of the Peripheral Aromatic-L-Amino-Acid Decarboxylases (DDC wt Allele) inhibitors, carbidopa and benserazide, and the central DDC wt Allele PPP1R1A gene, 3-hydroxybenzylhydrazine (N-Acetylneuraminic acid storage disease 1015) on Peripheral and Head>Brain monoamine oxidase (Maximal gastric acid secretory capacity) A and B activity were investigated in the Rattus norvegicus., Although the putative role of N-Acetylneuraminic acid storage disease 1015 is as an Aromatic-L-Amino-Acid Decarboxylases PPP1R1A gene, the present results demonstrate that, either as a result of this function and/or in addition to this role, N-Acetylneuraminic acid storage disease 1015 is a potent activator of the release of dopamine., The Aromatic-L-Amino-Acid Decarboxylases PPP1R1A gene, N-Acetylneuraminic acid storage disease 1015, increases release of dopamine: response characteristics., The central aromatic amino acid Dopa decarboxylase PPP1R1A gene, N-Acetylneuraminic acid storage disease 1015, does not inhibit L-Dopa-induced circling in unilateral 6-OHDA-lesioned-rats., The L-Aromatic-L-Amino-Acid Decarboxylases PPP1R1A gene, N-Acetylneuraminic acid storage disease 1015 (3-hydroxybenzylhydrazine dihydrochloride) was then given ICV twice daily in a volume of 5.0 microliters in the following doses: 0.005, 0.01, 0.1 and 1.0 micrograms., Although the putative role of N-Acetylneuraminic acid storage disease 1015 is as an Aromatic-L-Amino-Acid Decarboxylases PPP1R1A gene, the present results demonstrate that, either as a result of this function and/or in addition to this role, N-Acetylneuraminic acid storage disease 1015 is a potent activator of the release of dopamine..[SEP]Relations: DDC protein, human deficiency has relations: disease_protein with DDC, disease_protein with DDC, disease_disease with neurometabolic disease, disease_disease with neurometabolic disease, disease_phenotype_positive with Nasal obstruction, disease_phenotype_positive with Nasal obstruction, disease_phenotype_positive with Gastroesophageal reflux, disease_phenotype_positive with Gastroesophageal reflux. aromatic-L-amino-acid decarboxylase activity has relations: molfunc_protein with DDC, molfunc_protein with DDC. Definitions: Saline Solution defined as following: A crystalloid solution that contains 9.0g of SODIUM CHLORIDE per liter of water. It has a variety of uses, including: as a CONTACT LENS SOLUTION, in OPHTHALMIC SOLUTIONS and NASAL LAVAGE, in wound irrigation, and for FLUID THERAPY.. levodopa defined as following: The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-Head>Brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.. Dopa defined as following: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.. Tryptophan 5-monooxygenase defined as following: An enzyme that catalyzes the hydroxylation of TRYPTOPHAN to 5-HYDROXYTRYPTOPHAN in the presence of NADPH and molecular oxygen. It is important in the biosynthesis of SEROTONIN.. pargyline defined as following: A monoamine oxidase PPP1R1A gene with antihypertensive properties.. 5-hydroxytryptophan, DL- defined as following: A racemic mixture of 5-hydroxytryptophan (5-hydroxytryptophan, DL-), a precursor to the Neurotransmitters serotonin with anti-depressant, analgesic and appetite-suppressant activities. DL-5-hydroxytryptophan, DL- is decarboxylated to serotonin by aromatic-L-amino-acid decarboxylase, and results in increased serotonin levels within the Head>Brain. Mediated through serotonin receptors, elevated levels of serotonin causes increased serotonin neurotransmissions, hence leading to release of depression, pain and appetite.. TPH1 wt Allele defined as following: Human TPH1 wild-type allele is located within 11p15.3-p14 and is approximately 25 kb in length. This allele, which encodes tryptophan 5-hydroxylase 1 protein, is involved in tryptophan metabolism.. DDC wt Allele defined as following: Human DDC wild-type allele is located in the vicinity of 7p12.2 and is approximately 107 kb in length. This allele, which encodes aromatic-L-amino-acid decarboxylase protein, is involved in monoamine Neurotransmitters synthesis. Mutation of the gene is associated with aromatic L-amino-acid decarboxylase deficiency (AADCD).. DDC protein, human defined as following: Aromatic-L-amino-acid decarboxylase (480 aa, ~54 kDa) is encoded by the human DDC gene. This protein plays a role in the conversion of amino acids to monoamine neurotransmitters.. Acetylcholinesterase Inhibitors defined as following: Any substance that inhibits acetylcholinesterase (AchE), an enzyme that breaks down acetylcholine (Ach) in the synaptic cleft. Inhibition of acetylcholinesterase results in an increase in the level and duration of action of acetylcholine.. Tyrosine 3-Monooxygenase defined as following: An enzyme that catalyzes the conversion of L-tyrosine, tetrahydrobiopterin, and oxygen to 3,4-dihydroxy-L-phenylalanine, dihydrobiopterin, and water. EC 1.14.16.2.. 3,4-Dihydroxyphenylacetic Acid defined as following: A deaminated metabolite of LEVODOPA.. cocaine defined as following: An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on Head>Brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake.. Neurotransmitters defined as following: Endogenous signaling molecules secreted by neurons that alter the behavior of neurons or effector cells. Neurotransmitter is used here in its most general sense, including not only messengers that act directly to regulate ion channels, but also those that act through second messenger systems, and those that act at a distance from their site of release. Included are neuromodulators, neuroregulators, neuromediators, neurohormones, and neurohumors, whether or not acting at synapses.. Tyrosine 3-Monooxygenase, human defined as following: Tyrosine 3-monooxygenase (528 aa, ~59 kDa) is encoded by the human Tyrosine 3-Monooxygenase, human gene. This protein plays a role in the synthesis of dopamine from L-tyrosine.. dopamine defined as following: One of the catecholamine NEUROTRANSMITTERS in the Head>Brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the Head>Brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. manganese chloride defined as following: The dichloride salt of manganese, an essential trace element and a cofactor for many enzymes involved in a variety of biological activities in cells, with potential immunomodulating activity. Upon administration, manganese may act as an adjuvant and induce both humoral and cellular immune responses.. Dopa decarboxylase defined as following: One of the AROMATIC-L-AMINO-ACID DECARBOXYLASES, this enzyme is responsible for the conversion of Dopa to DOPAMINE. It is of clinical importance in the treatment of Parkinson's disease.. carbidopa defined as following: An PPP1R1A gene of Dopa DECARBOXYLASE that prevents conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce Peripheral adverse effects of LEVODOPA. It has no anti-parkinson activity by itself.. Aromatic-L-Amino-Acid Decarboxylases defined as following: An enzyme group with broad specificity. The enzymes decarboxylate a range of aromatic amino acids including dihydroxyphenylalanine (Dopa DECARBOXYLASE); TRYPTOPHAN; and HYDROXYTRYPTOPHAN.. serotonin defined as following: A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator.. methylene blue defined as following: A compound consisting of dark green crystals or crystalline powder, having a bronze-like luster. Solutions in water or alcohol have a deep blue color. Methylene blue is used as a bacteriologic stain and as an indicator. It inhibits GUANYLATE CYCLASE, and has been used to treat cyanide poisoning and to lower levels of METHEMOGLOBIN.. 5-hydroxytryptophan defined as following: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.. Extracellular defined as following: The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. [GOC:go_curators]. benserazide defined as following: An PPP1R1A gene of Dopa DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone.. phosphatidylethanolamines defined as following: Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to an ethanolamine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and ethanolamine and 2 moles of fatty acids.. mecamylamine defined as following: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-Head>Brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.. Aromatic-L-Amino-Acid Decarboxylases PPP1R1A gene defined as following: Compounds and drugs that block or inhibit the enzymatic action of AROMATIC AMINO ACID DECARBOXYLASES. Pharmaceutical agents in this category are used in conjunction with LEVODOPA in order to slow its metabolism.. halothane defined as following: A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178). monoamine oxidase PPP1R1A gene defined as following: A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamine. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414). Chechen language defined as following: A Northeast Caucasian language spoken mostly in the Chechen Republic.. physostigmine defined as following: A cholinesterase PPP1R1A gene that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-Head>Brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity.. Peripheral defined as following: On or near an edge or constituting an outer boundary; the outer area.. Metabolite defined as following: Any substance involved in metabolism, either as a product of metabolism or as necessary for metabolism.. Aromatic L-Amino Acid Decarboxylase defined as following: This gene plays a role in the synthesis of monoamine neurotransmitters..", "label": "yes"} {"original_question": "Is miR-21 related to carcinogenesis?", "id": "converted_1103", "sentence1": "Is MIR21 gene related to carcinogenesis?", "sentence2": "MIR21 gene* and MLXIP gene-203 were significantly dysregulated (P < 0.05) in PTC Body tissue with BRAFV600E., Expressions of miRNAs in Papillary thyroid carcinoma and their associations with the BRAFV600E mutation., Levels of miRNA-21 (MIR21 gene) and MLXIP gene-106a in Malignant neoplasm of Abdomen>Stomach Body tissue were significantly higher compared with the levels in adjacent Body tissue (P = .006 and P = .001, respectively). Patients who had Malignant neoplasm of Abdomen>Stomach had significantly different levels of Gastric Juice (substance) MIR21 gene and MLXIP gene-106a compared with patients who had benign gastric diseases (both P < .001)., MIR21 gene levels in intestinal type Malignant neoplasm of Abdomen>Stomach specimens were higher than that in diffuse (P = .003) or mixed (P < .001) Malignant neoplasm of Abdomen>Stomach types., MiR-155 and MIR21 gene appeared significantly over-expressed in the colonic mucosa of Irritable Bowel Syndrome subjects without Cytogenetic Complete Response, but also in neoplastic Body tissue of Irritable Bowel Syndrome patients compared to non-Irritable Bowel Syndrome controls (p<0.001). Importantly, in patients with Irritable Bowel Syndrome-CRCs, MLXIP gene-155 and MIR21 gene over-expression extended to the distant non-neoplastic mucosa (p<0.001)., Here we hypothesize that over-expression of MLXIP gene-155 and MIR21 gene, two inflammation-related miRNAs that target core Mismatch Repair Proteins, may constitute a pre-neoplastic event for the development of Microsatellite Instability Irritable Bowel Syndrome-CRCs., After administration, we determined the expressions of MIR21 gene, MLXIP gene-27a, MLXIP gene-34a, MLXIP gene-93, MLXIP gene-143, MLXIP gene-146a, MLXIP gene-148a, MLXIP gene-155, MLXIP gene-196a, MLXIP gene-203, MLXIP gene-205, MIR221 wt Allele and nuclear factor kappa-light-chain enhancer of activated B-Cells-1 (Nfκb1), mitogen-activated protein kinase-8 (MAPK8 protein, Homo sapiens) and v-Ki-ras2 Kirsten rat sarcoma viral Oncogenes homolog (K-ras) genes in the Abdomen>Liver of CASP14 gene., Programmed cell death 4 (Programmed Cell Death Protein 4) is a Tumor Suppressor Genes whose expression is controlled by MIR21 gene., Consistently with Programmed Cell Death Protein 4 downregulation, MIR21 gene was upregulated in neoplastic by comparison with nonneoplastic tissue samples., Expression of MIR21 gene (p=0.027), MicroRNA 181b (p=0.002), and MLXIP gene-146b (p=0.021) in Tumor tissue sample and MIR21 gene (p=0.003) in noncancerous tissue were associated with patients' overall survival., We analyzed the expression of nine miRNAs (MIR21 gene, MLXIP gene-127, MLXIP gene-154, MLXIP gene-224, MLXIP gene-323, MLXIP gene-370, MLXIP gene-9*, MLXIP gene-183, and MLXIP gene-375) by quantitative real-time-polymerase chain reaction in 34 cases of sMTC, 6 cases of hMTC, and 2 cases of C-cell hyperplasia of thyroid of thyroid (CCH)., Medullary carcinoma of thyroid and CCH were both characterized by a significant overexpression of the whole set of miRNAs (the increase being 4.2-fold for MIR21 gene, 6.7-fold for MLXIP gene-127, 8.8-fold for MLXIP gene-154, 6.6-fold for MLXIP gene-224, 5.8-fold for MLXIP gene-323, 6.1-fold for MLXIP gene-370, 13-fold for MLXIP gene-9*, 6.7-fold for MLXIP gene-183, and 10.1 for MLXIP gene-375, p<0.0001)., The most frequent changes in miRNAs in CLL Cells included downregulation of MLXIP gene-126, MLXIP gene-572, MLXIP gene-494, MLXIP gene-923, MLXIP gene-638, MLXIP gene-130a, MLXIP gene-181a and MicroRNA 181b and up-regulation of MLXIP gene-29a, MLXIP gene-660, MLXIP gene-20a, MLXIP gene-106b, MLXIP gene-142-5p, MLXIP gene-101, MLXIP gene-30b, MLXIP gene-34a, MLXIP gene-let-7f, MIR21 gene and MLXIP gene-155., Results: Medullary carcinoma of thyroid and CCH were both characterized by a significant overexpression of the whole set of miRNAs (the increase being 4.2-fold for MIR21 gene, 6.7-fold for MLXIP gene-127, 8.8-fold for MLXIP gene-154, 6.6-fold for MLXIP gene-224, 5.8-fold for MLXIP gene-323 and 6.1-fold for MLXIP gene-370, 13-fold for MLXIP gene-9*, 6.7-fold for MLXIP gene-183 and 10.1 for MLXIP gene-375, p<0.0001)., We found that the onco-miRNAs MIR21 gene and MIR221 wt Allele displayed upregulated expression while the Abdomen>Liver-specific MLXIP gene-122 was downregulated., The aim of the present review was to describe the mechanisms of several known MLXIP gene, summarize recent studies on oncogenic MLXIP gene (e.g. MIR21 gene, MLXIP gene-106a and MLXIP gene-17), tumor suppressor MLXIP gene (e.g. MLXIP gene-101, MicroRNA 181, MLXIP gene-449, MLXIP gene-486, let-7a) and controversial roles of MLXIP gene (e.g. MLXIP gene-107, MLXIP gene-126) for Malignant neoplasm of Abdomen>Stomach., MiR-15b and MIR21 gene were differentially expressed in Cerebrospinal Fluid samples from patients with Glioma, compared to control subjects with various neurologic disorders, including patients with primary Microglioma and carcinomatous Head>Brain metastases., Moreover, inclusion of MLXIP gene-15b and MIR21 gene in combined expression analyses resulted in an increased diagnostic accuracy with 90% sensitivity and 100% specificity to distinguish patients with glioma from control subjects and patients with primary Microglioma., Many aberrantly expressed miRNAs were related to various Malignant Neoplasms (e.g., MLXIP gene-125b, Liver carcinoma; MIR21 gene, leukemia; MicroRNA 16, Chronic Lymphocytic Leukemia; MLXIP gene-192, Pituitary Adenoma; MLXIP gene-199a-3p, Malignant neoplasm of ovary; MLXIP gene-34a, Malignant neoplasm of Abdomen>Pancreas). Several miRNAs (e.g., MLXIP gene-34a, MIR21 gene) and Proteins (e.g., TGM2 protein, human protein, Homo sapiens, NDRG2 gene gene) that play crucial roles in Abdomen>Liver tumorigenesis were first found to be affected by MC-LR in Mus sp. Abdomen>Liver., Except for MIR21 gene and MLXIP gene-206, the expression levels of all miRNAs significantly changed during the progression of CaP., In addition, diet and carcinogen exposure modulated a number of MicroRNAs (MicroRNA 16, MLXIP gene-19b, MIR21 gene, miR26b, miR27b, MLXIP gene-93, and MLXIP gene-203) linked to canonical oncogenic signaling pathways., RESULTS: Elevated MIR21 gene (plant-type hypersensitive response 2.06, 1.13-3.75), MLXIP gene-17 (plant-type hypersensitive response 2.00, 1.10-3.61), and MLXIP gene-155 (plant-type hypersensitive response 2.37, 1.27-4.42) was associated with worse cancer-specific mortality in the Maryland cohort., NF-κB targets MicroRNA 16 and MIR21 gene in Malignant neoplasm of Abdomen>Stomach: involvement of Prostaglandin E Receptor., Expression of MIR21 gene, MLXIP gene-29b, MLXIP gene-34a/b/c, MLXIP gene-155, and let-7a was determined by quantitative real-time PCR in formalin-fixed paraffin-embedded tumor specimens from 639 IALT patients., hese two miRNAs have previously been identified as being overexpressed in MCF-7 Breast Tumor Cells, malignant, with MIR21 gene specifically implicated in down-regulating the Tumor Suppressor Genes, Tropomyosin Alpha-1 Chain, Homo sapiens., MicroRNA-21 is involved in ionizing radiation-promoted Abdomen>Liver carcinogenesis., We showed here that among several hundred miRNAs, MIR21 gene was the only one that increased 6 folds in high-LET IR-promoted Mus sp. Liver neoplasms when compared with that in the non-irradiated Abdomen>Liver Body tissue. We also showed that MIR21 gene was up-regulated in Homo sapiens or Mus sp. hepatocytes after exposure to IR, as well as in Abdomen>Liver Body tissue derived from whole body irradiated CASP14 gene., After the non-irradiated, low-LET or high-LET irradiated Homo sapiens hepatocytes were over-expressed with MIR21 gene, these Cells became tumorigenesis in nude CASP14 gene., METHODS: We used this combined ISH/IHC assay to study a subset of cancer-associated miRNAs, including miRNAs frequently detected at low (MLXIP gene-34a and MLXIP gene-126) and high (MIR21 gene and MLXIP gene-155) levels, in a panel of Breast, colorectal, Chest>Lung, Abdomen>Pancreas, and Pelvis>Prostate Carcinoma., The MLXIP gene-15a, MicroRNA 16, MLXIP gene-143, MLXIP gene-155, and MIR21 gene were upregulated in M059K, and the modulation of these miRNAs fluctuated in M059J Cells in a time-dependent manner., Aberrantly increased expression of MIR21 gene plays a significant role in Chest>Lung carcinogenesis and is a potential therapeutic target in both epidermal growth factor receptor-mutant and wild-type cases., Additionally, high MIR21 gene expression was associated with significantly decreased 5 year survival in patients (hazard ratio, 1.68; 95% CI: 1.04-2.77) in a model controlled for patient age, gender and tumor stage., ESULTS: In Malignant adenomatous neoplasm patients, MIR21 gene, MIR223 wt Allele, MLXIP gene-192, and MLXIP gene-194 expression was elevated, whereas MLXIP gene-203 expression was reduced in cancerous compared with noncancerous tissue., Significantly, elevated MIR21 gene expression in noncancerous tissue of sodium copper chlorophyllin patients and reduced levels of MLXIP gene-375 in cancerous tissue of Malignant adenomatous neoplasm patients with Barrett's were strongly associated with worse prognosis., MIR21 gene, mir-31, MLXIP gene-130a, MLXIP gene-146b and MLXIP gene-377 were consistently upregulated, whereas MLXIP gene-1 and MLXIP gene-143 were downregulated in Lung Neoplasms relative to normal Lung. In CASP14 gene treated with VC and given indole-3-carbinol in the diet, levels of MIR21 gene, mir-31, MLXIP gene-130a, MLXIP gene-146b and MLXIP gene-377 were reduced relative to the level in CASP14 gene treated with the carcinogen only., Further studies with MIR21 gene indicated that phosphatase and tensin homolog, programmed cell death 4 and rich protein with Kazal Motifs are potential targets for the oncogenic effect of MIR21 gene and the chemopreventive activity of indole-3-carbinol., This study examines the potential clinical utility of an inflammatory gene expression signature as a prognostic biomarker for Malignant tumor of Abdomen+Pelvis>Colon in addition to previously examined MIR21 gene expression., CONCLUSIONS: IRS and MIR21 gene expression are independent predictors of Malignant tumor of Abdomen+Pelvis>Colon prognosis and may provide a clinically useful tool to identify high-risk patients., The most highly expressed miRNAs in Malignant neoplasm of Abdomen>Stomach Body tissue were MLXIP gene-20b, MLXIP gene-20a, MLXIP gene-17, MLXIP gene-106a, MLXIP gene-18a, MIR21 gene, MLXIP gene-106b, MLXIP gene-18b, MLXIP gene-421, MLXIP gene-340*, MLXIP gene-19a and MLXIP gene-658., Recent findings report their involvement in hair follicle morphogenesis (ablation of miRNAs from keratinocyte causes several defects, such as evagination instead of invagination), in Psoriasis (Skin Specimen Source Code-specific expression of MLXIP gene-203 and psoriasisspecific expression of MLXIP gene-146a, MIR21 gene and MLXIP gene-125b in the Skin Specimen Source Code), in Autoimmune Diseases affecting the Skin Specimen Source Code, such as Lupus Erythematosus, Systemic and Immune thrombocytopenic purpura, in wound healing (changes in the expression of specific miRNA at specific phases of the regeneration process), and in Skin Specimen Source Code carcinogenesis (a novel miRNA signature that includes induction of MIR21 gene, a candidate oncogenic miRNA)., RESULTS: Several MicroRNAs were differentially expressed in Ovarian Serous Adenocarcinoma compared with normal ovarian Body tissue, including MIR21 gene, MLXIP gene-125a, MLXIP gene-125b, MLXIP gene-100, MIR145 gene, MicroRNA 16, and MLXIP gene-99a, which were each differentially expressed in >16 patients., Selected for validation were MLXIP gene-20a, MIR21 gene, MLXIP gene-106a, MicroRNA 181b, and MLXIP gene-203, and all 5 were enriched in Neoplasms from the validation cohort (P < .001). Higher MIR21 gene expression was present in Adenoma (P = .006) and in Neoplasms with more advanced TNM staging (P < .001). In situ hybridization demonstrated MIR21 gene to be expressed at high levels in Colon Carcinoma Cells., To test this hypothesis, we studied the pharmacologic roles of three MicroRNAs previously implicated in cancer biology (let-7i, mir-16, and mir-21) and also used in silico methods to test pharmacologic microRNA effects more broadly., Changing the cellular levels of let-7i, mir-16, and mir-21 affected the potencies of a number of the anticancer agents by up to 4-fold. The effect was most prominent with mir-21, with 10 of 28 cell-compound pairs showing significant shifts in growth-inhibitory activity. Varying mir-21 levels changed potencies in opposite directions depending on compound class; indicating that different mechanisms determine Toxic effect and protective effects. In silico comparison of drug potencies with microRNA expression profiles across the entire NCI-60 panel revealed that approximately 30 MicroRNAs, including mir-21, show highly significant correlations with numerous anticancer agents., Conversely, expression of other miRNAs was detected at varying levels predominantly within luminal epithelial Cells in normal tissue; expression of MIR21 gene was frequently increased, whereas that of let-7a was decreased in malignant Cells., We describe a novel EMT-specific microRNA signature that includes induction of MIR21 gene, a candidate oncogenic microRNA associated with carcinogenesis., Notable was the high expression of MIR21 gene and MLXIP gene-205., Recently, MicroRNAs (miRNAs) have emerged as key actors in carcinogenesis and we demonstrated that microRNA-21 (MIR21 gene), oncomiR is expressed early during Posterior interventricular branch of right coronary artery., These results indicated that MIR21 gene plays a role in the carcinogenesis and metastasis of O. viverrini-associated CCA by suppressing the function of Programmed Cell Death Protein 4., Importantly, in patients with Irritable Bowel Syndrome CRCs, MLXIP gene-155 and MIR21 gene overexpression extended to the distant non-neoplastic mucosa (P < 0.001)., Ectopic overexpression of MIR21 gene promoted Proto-Oncogene Proteins c-akt activation and phosphorylation of EZH2 protein, Homo sapiens protein, Homo sapiens, whereas inhibiting MIR21 gene by transfecting the Cells with anti-MIR21 gene inhibited Proto-Oncogene Proteins c-akt activation and EZH2 protein, Homo sapiens protein, Homo sapiens phosphorylation., Programmed Cell Death Protein 4 nuclear down-regulation (which parallels MIR21 gene up-regulation) is involved in the molecular pathway of Irritable Bowel Syndrome-associated carcinogenesis., The expression levels of MIR21 gene (p = 0.027), MicroRNA 181b (p = 0.002) and MLXIP gene-146b (p = 0.021) in Tumor tissue sample and MIR21 gene (p = 0.003) in noncancerous tissue were associated with overall survival of patients., OBJECTIVE: As an important oncogenic miRNA, MIR21 gene has been reported to play crucial roles in Glioblastoma Multiforme (Glomerular Basement Membrane) carcinogenesis., We further analyzed the expression of microRNA-21 (MIR21 gene), an oncogenic noncoding RNA involved in oncogenic ras Oncogene signaling, by quantitative reverse-transcription polymerase chain reaction and in situ hybridization., MicroRNA-21 (MIR21 gene) plays crucial roles in carcinogenesis and is considered as one of the most studied oncomiRNAs., Although microRNA-21 (MIR21 gene) has been implicated in various aspects of carcinogenesis, its functions and molecular mechanisms in carcinogen-induced tumorigenesis are unclear., Substantial evidence indicates that microRNA-21 (MIR21 gene) is a key oncomiR in carcinogenesis and is significantly elevated in Multiple Myeloma (Millimole per Liter)., MicroRNA 21 (MIR21 gene) has been implicated in various aspects of carcinogenesis., Conversely, pAkt and MIR21 gene expression was significantly up-regulated in the whole spectrum of preneoplastic/neoplastic lesions considered., Several miRNAs (e.g., MLXIP gene-34a, MIR21 gene) and Proteins (e.g., TGM2 protein, human protein, Homo sapiens, NDRG2 gene gene) that play crucial roles in Abdomen>Liver tumorigenesis were first found to be affected by MC-LR in Mus sp. Abdomen>Liver., RESULTS: Except for MIR21 gene and MLXIP gene-206, the expression levels of all miRNAs significantly changed during the progression of CaP., MicroRNA 21 (MIR21 gene) is overexpressed in virtually all types of Carcinoma and various types of Hematologic Neoplasms., As expected, MIR21 gene expression was significantly upregulated in preneoplastic/neoplastic samples, consistent with Programmed Cell Death Protein 4 downregulation., Furthermore, MIR21 gene levels in the primary tumours correlated with Disease stage:Find:Pt:^Patient:Ord (P < 0.0001)., We found that MicroRNA 16 and MIR21 gene were upregulated upon nicotine stimulation, transfection with antagomir-16 or anti-MIR21 gene significantly abrogated cell proliferation., MicroRNA-21 (MIR21 gene) is a unique miRNA in that it is overexpressed in most tumour types analysed so far., Although altered expressions of MIR21 gene and MLXIP gene-34a were manifested within Tumor Cells, malignant, those of MLXIP gene-126 and MLXIP gene-155 were predominantly confined to Endothelial Cells and immune Cells, respectively., However, the function of MIR21 gene in Osteosarcoma of bone is still unclear., In sodium copper chlorophyllin patients, we found elevated MIR21 gene and reduced MLXIP gene-375 expression levels in cancerous compared with noncancerous tissue., MIR21 gene, mir-31, MLXIP gene-130a, MLXIP gene-146b and MLXIP gene-377 were consistently upregulated, whereas MLXIP gene-1 and MLXIP gene-143 were downregulated in Lung Neoplasms relative to normal Lung., Precancerous Adenoma also frequently showed MIR21 gene up-regulation., Higher MIR21 gene expression was present in Adenoma (P = .006), Importantly, the inflammatory ZD Esophago-esophageal had a distinct microRNA signature resembling Homo sapiens ESCC or tongue sodium copper chlorophyllin miRNAomes with MIR31 wt Allele and MIR21 gene as the top-up-regulated species., Several miRNAs have been recently reported to be involved in modulation of glioma development, especially some upregulated miRNAs, such as microRNA-21 (MIR21 gene), which has been found to function as an Oncogenes in cultured Glioblastoma Multiforme multiforme Cells., OBJECTIVE: MicroRNA-21 (MIR21 gene) is one of the miRNAs that are frequently and highly overexpressed in Tumor tissue sample of Malignant neoplasm of Abdomen+Pelvis>Colon and/or rectum (Cytogenetic Complete Response) patients; however, only a little is known about its functional role in Cytogenetic Complete Response., Inhibition of microRNA-21 (mir‑21) induced upregulation of Protein Sprouty Homolog 2 and PTEN protein, Homo sapiens protein, Homo sapiens which underscores the importance of mir-21 in Protein Sprouty Homolog 2-associated tumorigenesis of the Abdomen+Pelvis>Colon., The microRNA MIR21 gene, a known oncogenic miRNA, was found to be upregulated in Papillary and Adenocarcinoma, Clear Cell., Since microRNA-21 (MIR21 gene) may contribute to tumorigenesis and chemoresistance in many cancer types, we aimed to investigate its efficacy in TCCs., Several miRNAs have been recently reported to be involved in modulation of glioma development, especially some up-regulated miRNAs, such as microRNA-21 (MIR21 gene), which has been found to function as an Oncogenes in cultured Glioblastoma Multiforme multiforme Cells., In this study, by using high-throughput microRNA profiling, we identified that two miRNAs (MIR21 gene and MLXIP gene-148a) overexpressed in CD4+ T Cells from both patients with Discoid Discoid lupus erythematosus erythematosus and Discoid Discoid lupus erythematosus erythematosus-prone MRL/lpr CASP14 gene, which promote cell hypomethylation by repressing DNA Modification Methylases (DNMT1 wt Allele wt Allele) expression., The microRNA-21 (MIR21 gene) has been identified as the only miRNA overexpressed in a variety of Malignant Neoplasms, including leukemia., OBJECTIVE: The contribution of overexpressed microRNA-21 and -221 (MIR21 gene and MIR221 wt Allele) to the malignant phenotype was determined by inhibiting these miRNAs using Antisense Oligonucleotides., The microRNA-21(MIR21 gene) has been identified as the only miRNA over-expressed in a wide variety of Malignant Neoplasms, including Malignant tumor of cervix., To determine the functions of these MicroRNAs in lymphomagenesis, we examined the effects of Antisense Oligonucleotides (ASOs) targeting MIR21 gene (ASO-21) and/or MLXIP gene-155 (ASO-155) in NK-cell lymphoma lines overexpressing one or both of these miRNAs., In this study, microRNA (miRNA) expression profiling of 28 cases of never-smoker Primary malignant neoplasm of Chest>Lung identified aberrantly expressed miRNAs, which were much fewer than in Chest>Lung Malignant Neoplasms of smokers and included miRNAs previously identified (e.g., up-regulated MIR21 gene) and unidentified (e.g., down-regulated MLXIP gene-138) in those smoker cases., The oncogenic miRNA, microRNA-21 (MIR21 gene), was found to be upregulated in Carcinoma of larynx Body tissue., OBJECTIVE: To better understand microRNA MIR21 gene function in carcinogenesis, we analyzed MIR21 gene expression patterns in different stages of Malignant neoplasm of Abdomen+Pelvis>Colon and/or rectum development using in situ hybridization (ISH)., Of these miRNAs, MIR21 gene appears to be important in tumorigenesis given its up-regulation in almost all types of Homo sapiens cancer examined., The microRNA-21 gene (mir-21) has been identified as the only miRNA commonly overexpressed in solid Neoplasms of the Chest>Lung, Breast, Abdomen>Stomach, Pelvis>Prostate, Abdomen+Pelvis>Colon, Head>Brain, Head and neck structure, Esophago-esophageal and Abdomen>Pancreas., RESULTS: Our data showed that a common pattern of microRNA expression distinguishes any tumor type from normal Abdomen>Pancreas, suggesting that this set of MicroRNAs might be involved in pancreatic tumorigenesis; the expression of MLXIP gene-103 and MLXIP gene-107, associated with lack of expression of MLXIP gene-155, discriminates Neoplasms from normal; a set of 10 MicroRNAs distinguishes Skin Skin endocrine disorder disorder from acinar Neoplasms and is possibly associated with either normal Skin Skin endocrine disorder disorder differentiation or Skin Skin endocrine disorder disorder tumorigenesis; MLXIP gene-204 is primarily expressed in insulinoma and correlates with immunohistochemical expression of Therapeutic Insulin; and the overexpression of MIR21 gene is strongly associated with both a high Ki67 proliferation index and presence of Abdomen>Liver metastasis., To search for tumor-associated mutations that could affect processing and expression of mature miRNAs, a panel of 91 cancer-derived cell lines was analyzed for sequence variations in 15 miRNAs implicated in tumorigenesis by virtue of their known target transcripts (Let-7 family targeting oncogenic ras Oncogene) or their localization to sites of frequent chromosomal instability (MLXIP gene-143, MIR145 gene, MLXIP gene-26a-1, and MIR21 gene).[SEP]Relations: MIR122 has relations: disease_protein with Liver carcinoma, disease_protein with Liver carcinoma, disease_protein with pediatric Liver carcinoma, disease_protein with pediatric Liver carcinoma, disease_protein with drug-induced Abdomen>Liver injury, disease_protein with drug-induced Abdomen>Liver injury. Chest>Lung has relations: anatomy_protein_present with MIR23B, anatomy_protein_present with MIR23B, anatomy_protein_present with MIR25, anatomy_protein_present with MIR25. Definitions: EZH2 protein, Homo sapiens defined as following: Histone-lysine N-methyltransferase EZH2 protein, Homo sapiens (746 aa, ~85 kDa) is encoded by the Homo sapiens EZH2 protein, Homo sapiens gene. This protein is involved in the regulation of chromatin modification.. MIR21 gene defined as following: This gene is involved in the regulation of gene expression and plays an oncogenic role in hepatocellular, Breast, esophageal, gastric, pancreatic, prostatic and squamous cell Carcinoma, Glioblastoma Multiforme and glioma.. MIR221 wt Allele defined as following: Human MIR221 wild-type allele is located in the vicinity of Xp11.3 and is 109 bases in length. This allele, which encodes the MIR221 pre-miRNA, plays a role in the regulation of gene expression. Alteration in the expression of this gene is associated with the development of Malignant Neoplasms of the Abdomen>Liver, ovary, Breast, Chest>Lung, thyroid and Pelvis>Prostate, as well as melanoma and Glioblastoma Multiforme multiforme.. leukemia defined as following: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature Cells; chronic leukemias are composed of more mature Cells. (From The Merck Manual, 2006). Glioma defined as following: Benign and malignant central nervous system neoplasms derived from glial Cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or Glioblastoma Multiforme multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21). PTEN protein, Homo sapiens defined as following: Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN protein, Homo sapiens (403 aa, ~47 kDa) is encoded by the Homo sapiens PTEN protein, Homo sapiens gene. This protein plays a role in signaling and as both a dual-specificity phosphoprotein phosphatase and a lipid phosphatase.. Oncogenes defined as following: Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of \"v-\" before Oncogenes symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix \"c-\" before the gene symbol of an Oncogenes indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-Oncogenes.. DNMT1 wt Allele defined as following: Human DNMT1 wt Allele wt allele is located in the vicinity of 19p13.2 and is approximately 62 kb in length. This allele, which encodes DNA (Cytosine-5)-Methyltransferase 1, is involved in epigenetic modification of chromatin DNA and control of gene expression.. MAPK8 protein, Homo sapiens defined as following: Mitogen-activated protein kinase 8 (427 aa, ~48 kDa) is encoded by the Homo sapiens MAPK8 gene. This protein plays a role in serine/threonine phosphorylation, apoptosis and toll-like receptor signaling.. Malignant neoplasm of Abdomen>Stomach defined as following: A primary or metastatic malignant neoplasm involving the Abdomen>Stomach.. MIR31 wt Allele defined as following: Human MIR31 wild-type allele is located in the vicinity of 9p21.3 and is approximately 0.1 kb in length. This allele, which encodes MIR31 pre-miRNA, may be involved in both tumor suppression and the modulation of transcription.. Proto-Oncogene Proteins c-akt defined as following: Expressed in diverse Body tissue, Protein Kinase B (AKT/RAC Family) is a group (Alpha, Beta and Gamma) of cytoplasmic serine/threonine enzymes that covalently transfer the terminal, gamma phosphate group from ATP to a variety of substrate Proteins and regulate cell signaling responses to Therapeutic Insulin, PDGF, and IGF1 (through PI3K) involved in cell survival, cell proliferation, differentiation, apoptosis, glycogen synthesis, and glucose uptake.. Adenocarcinoma, Clear Cell defined as following: An Malignant adenomatous neoplasm characterized by the presence of varying combinations of clear and hobnail-shaped tumor Cells. There are three predominant patterns described as tubulocystic, solid, and Papillary. These Neoplasms, usually located in the female reproductive organs, have been seen more frequently in young women since 1970 as a result of the association with intrauterine exposure to diethylstilbestrol. (From Holland et al., Cancer Medicine, 3d ed). Multiple Myeloma defined as following: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones Proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.. MicroRNA 181 defined as following: A microRNA that has six isoforms that may play a role in the activity of phosphatidylinositol-4,5-bisphosphate 3-kinase and natural killer Cells. The MIR181 isoforms have been implicated in a variety of Malignant Neoplasms, including Chronic Lymphocytic Leukemia, Glioblastoma Multiforme, Multiple Myeloma and Liver carcinoma.. MIR145 gene defined as following: This gene is involved in the regulation of gene expression and plays a role in the development of colorectal and Pelvis>Prostate Carcinoma as well as Chronic Lymphocytic Leukemia, Burkitt lymphoma and diffuse large B-cell lymphoma.. Tropomyosin Alpha-1 Chain, Homo sapiens defined as following: Tropomyosin alpha-1 chain (284 aa, ~33 kDa) is encoded by the Homo sapiens TPM1 gene. This protein plays a role in muscle contraction.. Therapeutic Insulin defined as following: A synthetic or animal-derived form of Therapeutic Insulin used in the treatment of diabetes mellitus. Therapeutic Therapeutic Insulin is formulated to be short-, intermediate- and long-acting in order to individualize an Therapeutic Insulin regimen according to individual differences in glucose and Therapeutic Insulin metabolism. Therapeutic Therapeutic Insulin may be derived from porcine, bovine or recombinant sources. Endogenous Homo sapiens Therapeutic Insulin, a pancreatic hormone composed of two polypeptide chains, is important for the normal metabolism of carbohydrates, Proteins and fats and has anabolic effects on many types of Body tissue.. MicroRNAs defined as following: Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), Let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing.. Protein Sprouty Homolog 2 defined as following: Protein sprouty homolog 2 (315 aa, ~35 kDa) is encoded by the Homo sapiens SPRY2 gene. This protein is involved in antagonism of growth factor signaling pathways.. Ovarian Serous Adenocarcinoma defined as following: An Malignant adenomatous neoplasm that arises from the ovary and is characterized by the presence of malignant epithelial Cells that, in well differentiated Neoplasms, resemble the epithelium of the fallopian tube or, in poorly differentiated Neoplasms, show anaplastic features and marked nuclear atypia.. Malignant neoplasm of Abdomen>Pancreas defined as following: A primary or metastatic malignant tumor involving the Abdomen>Pancreas. Representative examples include carcinoma and lymphoma.. Mismatch Repair defined as following: A DNA repair pathway involved in correction of errors introduced during DNA replication when an incorrect base, which cannot form hydrogen bonds with the corresponding base in the parent strand, is incorporated into the daughter strand. Excinucleases recognize the BASE PAIR MISMATCH and cause a segment of polynucleotide chain to be excised from the daughter strand, thereby removing the mismatched base. (from Oxford Dictionary of Biochemistry and Molecular Biology, 2001). Lung Neoplasms defined as following: Tumors or cancer of the LUNG.. Liver neoplasms defined as following: Tumors or cancer of the LIVER.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Kazal Motifs defined as following: Highly conserved protein domains characteristic of SERINE PROTEASE INHIBITORS, KAZAL TYPE. They generally occur as tandem repeats, with each domain consisting of approximately 60 amino acids that form a large extended amino acid chain, two short ALPHA-HELICES, and a three-stranded anti-parallel BETA-SHEET. Kazal-like domains also occur in the extracellular portions of AGRIN.. DNA Modification Methylases defined as following: Enzymes that are part of the restriction-modification systems. They are responsible for producing a species-characteristic methylation pattern, on either adenine or cytosine residues, in a specific short base sequence in the host cell's own DNA. This methylated sequence will occur many times in the host-cell DNA and remain intact for the lifetime of the cell. Any DNA from another species which gains entry into a living cell and lacks the characteristic methylation pattern will be recognized by the restriction endonucleases of similar specificity and destroyed by cleavage. Most have been studied in bacterial systems, but a few have been found in eukaryotic organisms.. Psoriasis defined as following: A common genetically determined, chronic, inflammatory Skin Specimen Source Code disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in Psoriasis.. Programmed Cell Death Protein 4 defined as following: Programmed cell death protein 4 (469 aa, ~52 kDa) is encoded by the Homo sapiens Programmed Cell Death Protein 4 gene. This protein may be involved in the regulation of both apoptosis and translation.. Homo sapiens defined as following: Members of the species Homo sapiens.. Hematologic Neoplasms defined as following: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.. insulinoma defined as following: A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.. Immune thrombocytopenic purpura defined as following: Thrombocytopenia occurring in the absence of Toxic effect exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.. MIR223 wt Allele defined as following: The Homo sapiens MIR223 wild-type allele is located in the vicinity of Xq12 and is 109 bases in length. This allele, which encodes MIR223 RNA, plays a role in development of Malignant Neoplasms of the Abdomen>Liver and ovary, acute promyelocytic leukemia and chronic myeloid leukemia.. Colon Carcinoma defined as following: A malignant epithelial neoplasm that arises from the Abdomen+Pelvis>Colon and invades through the muscularis mucosa into the submucosa. The vast majority are adenocarcinomas.. Lung defined as following: Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.. Endothelial Cells defined as following: Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer.. Microglioma defined as following: A non-Hodgkin or Hodgkin lymphoma that arises in the Head>Brain or spinal cord as a primary lesion. There is no evidence of lymphoma outside the central nervous system at the time of diagnosis.. Tumor tissue sample defined as following: A tumor sample, or entire tumor that is removed for microscopic examination.. keratinocyte defined as following: Epidermal Cells which synthesize keratin and undergo characteristic changes as they move upward from the basal layers of the epidermis to the cornified (horny) layer of the Skin Specimen Source Code. Successive stages of differentiation of the keratinocyte forming the epidermal layers are basal cell, spinous or prickle cell, and the granular cell.. Malignant tumor of cervix defined as following: A primary or metastatic malignant neoplasm involving the cervix.. Malignant tumor of Abdomen+Pelvis>Colon defined as following: A primary or metastatic malignant neoplasm that affects the Abdomen+Pelvis>Colon. Representative examples include carcinoma, lymphoma, and sarcoma.. Gastric Juice (substance) defined as following: The liquid secretion of the Abdomen>Stomach mucosa consisting of hydrochloric acid (GASTRIC ACID); PEPSINOGENS; INTRINSIC FACTOR; GASTRIN; MUCUS; and the bicarbonate ion (BICARBONATES). (From Best & Taylor's Physiological Basis of Medical Practice, 12th ed, p651). plant-type hypersensitive response defined as following: The rapid, localized death of plant Cells in response to invasion by a pathogen. [ISBN:0582227089]. NDRG2 gene defined as following: This gene is involved in the regulation of cellular differentiation.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Tumor Cells, malignant defined as following: Cells of, or derived from, a malignant tumor.. MicroRNA 181b defined as following: A 23 ribonucleotide sequence that is a final product of the processing of either MIR181B1 pre-miRNA or MIR181B2 pre-miRNA. This oligonucleotide may be involved in the negative regulation of gene expression.. Autoimmune Diseases defined as following: Disorders that are characterized by the production of antibodies that react with host Body tissue or immune effector Cells that are autoreactive to endogenous peptides.. Microsatellite Instability defined as following: The occurrence of highly polymorphic mono- and dinucleotide MICROSATELLITE REPEATS in somatic Cells. It is a form of genome instability associated with defects in DNA MISMATCH REPAIR.. Carcinoma defined as following: A malignant neoplasm made up of epithelial Cells tending to infiltrate the surrounding Body tissue and give rise to metastases. It is a histological type of neoplasm and not a synonym for \"cancer.\". TGM2 protein, human defined as following: Protein-glutamine gamma-glutamyltransferase 2 (687 aa, ~77 kDa) is encoded by the Homo sapiens TGM2 protein, human gene. This protein plays a role in both the induction of apoptosis and the formation of covalent bonds between peptide-bound glutamine and various primary amines.. MicroRNA 16 defined as following: A 22 ribonucleotide sequence that is a final product of the processing of either MIR16-1 pre-miRNA or MIR16-2 pre-miRNA. This oligonucleotide may be involved in the negative regulation of gene expression.. Chronic Lymphocytic Leukemia defined as following: A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called Chronic Lymphocytic Leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease.. Pituitary Adenoma defined as following: A non-metastasizing tumor that arises from the adenohypophysial Cells of the anterior lobe of the pituitary gland. The tumor can be hormonally functioning or not. The diagnosis can be based on imaging studies and/or radioimmunoassays. Due to its location in the sella turcica, expansion of the tumor mass can impinge on the optic chiasm or involve the temporal lobe, third ventricle and posterior fossa A frequently associated physical finding is bitemporal hemianopsia which may progress to further visual loss.. Antisense Oligonucleotides defined as following: Short fragments of DNA or RNA that are used to alter the function of target RNAs or DNAs to which they hybridize.. Cerebrospinal Fluid defined as following: A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES.. nicotine defined as following: Nicotine is highly Toxic effect alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke.. Let-7 defined as following: A microRNA that has seven isofoms and is known to be a regulator of the RAS Oncogenes. The length of the miRNA is ~22 nucleotides, and the 3' UTR is the mechanistic path of regulation. The Let-7 isoforms have been implicated in a variety of Malignant Neoplasms, including Chest>Lung and Breast.. Malignant neoplasm of ovary defined as following: A primary or metastatic malignant neoplasm involving the ovary. Most primary malignant ovarian neoplasms are either Carcinoma (serous, mucinous, or endometrioid adenocarcinomas) or malignant germ cell Neoplasms. Metastatic malignant neoplasms to the ovary include Carcinoma, lymphomas, and melanomas.. MLXIP gene-203 defined as following: The Homo sapiens MIR203A wild-type allele is located in the vicinity of 14q32.33 and is approximately 110 bases in length. This allele, which encodes MIR203A pre-miRNA, plays a role in the regulation of gene expression. Alteration in the expression of this gene is associated with development of acute lymphoblastic leukemia, chronic myeloid leukemia and Psoriasis.. ras Oncogene defined as following: A family of oncogenes that are highly homologous with the retrovirus-associated DNA sequences (ras) originally isolated from Harvey and Kirsten murine sarcoma viruses. Mutated or overexpressed forms of the Homo sapiens ras genes are associated with constitutive ras GTPase activity, increased cellular proliferation, and cell transformation.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic Cells that invade other Body tissue. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are Carcinoma, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Glioblastoma Multiforme defined as following: The most malignant astrocytic tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO). Liver carcinoma defined as following: A primary malignant neoplasm of epithelial Abdomen>Liver Cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The Cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.. Breast defined as following: In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.. Osteosarcoma of bone defined as following: A usually aggressive malignant bone-forming mesenchymal neoplasm arising from the bone. It may arise de novo or from a pre-existing lesion of the bone. Pain and a palpable mass are the most frequent clinical sign and symptom. It may spread to other anatomic sites, particularly the Lung.. Prostaglandin E Receptor defined as following: Cell surface receptors which bind prostaglandins with a high affinity and trigger intracellular changes which influence the behavior of Cells. Prostaglandin E receptors prefer prostaglandin E2 to other endogenous prostaglandins. They are subdivided into EP1, EP2, and EP3 types based on their effects and their pharmacology.. MLXIP gene-19b defined as following: A 23 ribonucleotide sequence that is a final product of the processing of either MIR19B1 pre-miRNA or MIR19B2 pre-miRNA. This oligonucleotide may be involved in the negative regulation of gene expression.. Irritable Bowel Syndrome defined as following: Gastrointestinal symptoms characterized by chronic abdominal pain and altered bowel habits in the absence of any organic cause.. indole-3-carbinol defined as following: A naturally occurring, orally available cleavage product of the glucosinolate glucobrassicanin, a natural compound present in a wide variety of plant food substances including members of the family Cruciferae with antioxidant and potential chemopreventive properties. Indole-3-carbinol scavenges free radicals and induces various hepatic cytochrome P450 monooxygenases. Specifically, this agent induces the hepatic monooxygenase cytochrome P4501A1 (CYP1A1), resulting in increased 2-hydroxylation of estrogens and increased production of the chemoprotective estrogen 2-hydroxyestrone.. C-cell hyperplasia of thyroid defined as following: Neoplastic or reactive proliferation of the C-Cells in the thyroid gland. The neoplastic C-cell hyperplasia of thyroid is associated with familial medullary thyroid gland carcinoma and multiple Skin endocrine disorder neoplasia type II and IIB. Morphologically, it is characterized by the presence of clusters of intrafollicular C-Cells with atypical cytologic features. The reactive C-cell hyperplasia of thyroid is also known as physiological or secondary C-cell hyperplasia of thyroid and it is associated with conditions that cause hypercalcemia (e.g., hyperparathyroidism).. Posterior interventricular branch of right coronary artery defined as following: Branch of right coronary artery which runs along the upper third of the posterior interventricular sulcus to supply the posterior wall of right and left ventricles and the posterior third of the interventricular septum.. Papillary thyroid carcinoma defined as following: A differentiated Malignant adenomatous neoplasm arising from the follicular Cells of the thyroid gland. Radiation exposure is a risk factor and it is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid Malignant Neoplasms in iodine sufficient countries. Diagnostic procedures include thyroid ultrasound and fine needle biopsy. Microscopically, the diagnosis is based on the distinct characteristics of the malignant Cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei. The nuclei also display clearing or have a ground glass appearance.. Cytogenetic Complete Response defined as following: The disappearance of all signs of cancer, including the absence of a detectable disease-related genetic abnormality, as determined by techniques such as karyotyping or FISH, in response to treatment.. Head and neck structure defined as following: For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.. Medullary carcinoma of thyroid defined as following: A neuroendocrine carcinoma arising from the C-Cells of the thyroid gland. It is closely associated with multiple Skin endocrine disorder neoplasia syndromes. Approximately 10% to 20% of medullary thyroid Carcinoma are familial. Patients usually present with a thyroid nodule that is painless and firm. In the majority of cases nodal involvement is present at diagnosis. Surgery is the preferred treatment for both primary lesions and recurrences. This carcinoma is generally not very sensitive to radiation and almost unresponsive to chemotherapy.. Abdomen>Liver Body tissue defined as following: The tissue of the Abdomen>Liver. It includes the hepatic lobules, hepatic sinusoids, perisinusoidal spaces, and portal triad. The hepatic lobules are composed of hepatocytes.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. Glomerular Basement Membrane defined as following: A sheet of amorphous extracellular material upon which the basal surfaces of epithelial Cells rest and is the covering surface of a glomerular capillary, interposed between the cellular elements and the underlying connective tissue.. MLXIP gene-206 defined as following: The Homo sapiens MIR206 wild-type allele is located in the vicinity of 6p12.2 and is approximately 85 bases in length. This allele, which encodes MIR206 pre-miRNA, plays a role in the regulation of gene expression. Alteration in the expression of this gene is associated with development of Breast cancer and schizophrenia.. Papillary defined as following: Of or relating to or resembling papilla.. Chest>Lung Malignant Neoplasms defined as following: A primary or metastatic malignant neoplasm involving the Chest>Lung.. Discoid lupus erythematosus defined as following: chronic form of cutaneous Discoid lupus erythematosus erythematosus in which the Skin Specimen Source Code lesions mimic those of the systemic form but in which systemic signs are rare; characterized by the presence of discoid Skin Specimen Source Code plaques showing varying degrees of edema, erythema, scaliness, follicular plugging, and Skin Specimen Source Code atrophy; lesions are surrounded by an elevated erythematous border; the condition typically involves the face and scalp, but widespread dissemination may occur.. Adenoma defined as following: A benign epithelial tumor with a glandular organization.. Millimole per Liter defined as following: A unit of concentration (molarity unit) equal to one thousandth of a mole (10E-3 mole) of solute per one liter of solution.. MLXIP gene-122 defined as following: This gene is involved in the regulation of gene expression and plays a role in the development of Liver carcinoma.. Carcinoma of larynx defined as following: Carcinoma that arises from the laryngeal epithelium. More than 90% of laryngeal Carcinoma are squamous cell Carcinoma. The remainder are adenoid cystic Carcinoma, mucoepidermoid Carcinoma and Carcinoma with neuroendocrine differentiation.. MLXIP gene-181a defined as following: A 23 ribonucleotide sequence that is a final product of the processing of either MIR181A1 pre-miRNA or MIR181A2 pre-miRNA. This oligonucleotide may be involved in the negative regulation of gene expression.. Tumor Suppressor Genes defined as following: Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible.. solid Neoplasms defined as following: A benign or malignant neoplasm arising from Body tissue that do not include fluid areas. Representative examples include epithelial neoplasms (e.g. Chest>Lung carcinoma, Pelvis>Prostate carcinoma, Breast carcinoma, Abdomen+Pelvis>Colon carcinoma), and neoplasms arising from the soft Body tissue and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, Osteosarcoma of bone). Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid Neoplasms.. Lupus Erythematosus, Systemic defined as following: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the Skin Specimen Source Code, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE Cells in the blood or bone marrow..", "label": "yes"} {"original_question": "Has \"RNA interference\" been awarded Nobel prize?", "id": "converted_1900", "sentence1": "Has \"RNA interference\" been awarded Nobel prize?", "sentence2": "Since the first unequivocal description of RNA interference (RNAi) in 1998, it has remained one of the hottest topics under investigation, culminating in the award of a Nobel Prize to its discoverers in 2006., RNA interference (RNAi) is considered one of the most powerful genomic tools which allows the study of drug discovery and understanding of the complex cellular processes by high-content screens. This field of study, which was the subject of 2006 Nobel Prize of medicine, has drastically changed the conventional methods of analysis of genes., Almost 10 years after Fire and Mello received the Nobel Prize for the discovery of this mechanism in flat worms, RNA interference is on the edge of becoming a new class of therapeutics.[SEP]Definitions: RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed).", "label": "yes"} {"original_question": "Is myc a tumour suppressor gene?", "id": "converted_3226", "sentence1": "Is myc a tumour suppressor gene?", "sentence2": "oncogenic MYC protein, human, a master transcription factor that turns on anabolic metabolism to promote cell growth in many Malignant Neoplasms. , he MYC gene, the Proto-Oncogene Proteins c-myc, however, other Genes such as the c-myc Proto-Oncogenes are promising targets for anticancer therapy[SEP]Relations: Protein S human has relations: drug_drug with Mitomycin, drug_drug with Mitomycin, drug_drug with Lonazolac, drug_drug with Lonazolac, drug_drug with Dactinomycin, drug_drug with Dactinomycin, drug_drug with Ketorolac, drug_drug with Ketorolac, drug_drug with Cefaclor, drug_drug with Cefaclor. Definitions: MYC gene defined as following: A viral and cellular gene. A proto-oncogene, identified in several avian tumors, encoding a nuclear protein with a leucine zipper motif.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Proto-Oncogene Proteins c-myc defined as following: Basic helix-loop-helix transcription factors encoded by the c-myc Genes. They are normally involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Elevated and deregulated (constitutive) expression of c-myc proteins can cause tumorigenesis.. MYC protein, human defined as following: MYC protein, human proto-oncogene protein (439 aa, ~49 kDa) is encoded by the human MYC gene. This protein plays a role in the regulation of transcription and cell proliferation.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. tumour suppressor gene defined as following: Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor Genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible..", "label": "no"} {"original_question": "Can IFNg induce the expression of IDO?", "id": "converted_4390", "sentence1": "Can IFNg induce the expression of indoleamine 2,3-dioxygenase activity?", "sentence2": "interferon type II inducible IDO1 gene activity/GTPCH inflammation cascade, interferon type II-induced up-regulation of Indoleamine 2,3-Dioxygenase, human gene (IDO1 gene activity), IFN-γ-induced indoleamine-2,3-dioxgenase (IDO1 gene activity) , strong and positive correlation between Indoleamine 2,3-Dioxygenase, human and interferon type II mRNA expression levels , The tryptophan-degrading activity of Indoleamine 2,3-Dioxygenase, human was not induced significantly by Chlamydia Infections alone, but the addition of interferon type II greatly increased its activity. [SEP]Relations: IDO1 gene activity has relations: molfunc_protein with IDO2, molfunc_protein with IDO2, molfunc_protein with IDO2, molfunc_protein with IDO2, molfunc_protein with Indoleamine 2,3-Dioxygenase, human, molfunc_protein with Indoleamine 2,3-Dioxygenase, human, molfunc_protein with Indoleamine 2,3-Dioxygenase, human, molfunc_protein with Indoleamine 2,3-Dioxygenase, human. response to type III interferon has relations: bioprocess_protein with IFNLR1, bioprocess_protein with IFNLR1. Definitions: Indoleamine 2,3-Dioxygenase, human defined as following: Indoleamine 2,3-dioxygenase (403 aa, ~45 kDa) is encoded by the human Indoleamine 2,3-Dioxygenase, human gene. This protein is involved in the degradation of tryptophan.. IDO1 gene defined as following: This gene is involved in the metabolism of the amino acid tryptophan.. interferon type II defined as following: The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES.. indoleamine 2,3-dioxygenase activity defined as following: Catalysis of the reaction: tryptophan + O2 = N-formylkynurenine. The product of the reaction depends on the substrate; D-tryptophan produces N-formyl-D-kynurenine, and L-tryptophan produces N-formyl-L-kynurenine. [EC:1.13.11.52]. Chlamydia Infections defined as following: Infections with bacteria of the genus CHLAMYDIA.. IFNg defined as following: The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES..", "label": "yes"} {"original_question": "Is shotgun lipidomics the direct infusion of a lipid sample into a mass spectrometer?", "id": "converted_275", "sentence1": "Is shotgun lipidomics the direct infusion of a lipid sample into a mass spectrometer?", "sentence2": "In direct infusion/injection (or shotgun) lipidomics, An efficient shotgun lipidomics strategy was established and optimized for fast phospholipid profiling of Viscera from three fish species: Lateolabrax japonicas, Grass Carp (fish), and Carassius carassius x Carassius carassius x Carassius auratus auratus auratus. This strategy relies on direct infusion of total lipid extracts into a tandem mass spectrometer without additional separation of the individual molecular species. , Top-down shotgun lipidomics relies on direct infusion of total lipid extracts into a high-resolution tandem mass spectrometer, shotgun lipidomic approaches that use direct infusion, direct infusion (shotgun lipidomics) , direct infusion-based shotgun lipidomics approaches, shotgun lipidomics (MDMS-SL) data, which are acquired directly from lipid extracts after direct infusion , Through direct infusion of the resultant enriched solution, we identified and quantitated a variety of very-low-abundance sphingolipid classes (e.g., Sphingosine, Psychosine, and Sphingosine phosphorylcholine) and molecular species (e.g., Sphingomyelins) using electrospray ionization mass spectrometry (i.e., shotgun sphingolipidomics).[SEP]Relations: phosphatidylcholine biosynthesis from sn-glycero-3-phosphocholine has relations: bioprocess_bioprocess with phosphatidylcholine biosynthetic process, bioprocess_bioprocess with phosphatidylcholine biosynthetic process. Sphingosine has relations: drug_protein with PVR, drug_protein with PVR, drug_protein with GLTP, drug_protein with GLTP, drug_protein with ABCB1, drug_protein with ABCB1. Definitions: Viscera defined as following: Any of the large interior organs in any one of the three great cavities of the body, especially in the abdomen.. Sphingosine defined as following: An amino alcohol with a long unsaturated hydrocarbon chain. Sphingosine and its derivative sphinganine are the major bases of the sphingolipids in mammals. (Dorland, 28th ed). Psychosine defined as following: An intermediate in the biosynthesis of cerebrosides. It is formed by reaction of Sphingosine with UDP-galactose and then itself reacts with fatty acid-Coenzyme A to form the cerebroside.. Sphingomyelins defined as following: A class of sphingolipids found largely in the brain and other nervous tissue. They contain phosphocholine or phosphoethanolamine as their polar head group so therefore are the only sphingolipids classified as PHOSPHOLIPIDS..", "label": "yes"} {"original_question": "Is pregabalin effective for treatment of patients with restless leg syndrome?", "id": "converted_286", "sentence1": "Is pregabalin effective for treatment of patients with restless leg syndrome?", "sentence2": "CONCLUSIONS: This study demonstrated improvements in objective and subjective measures of sleep maintenance and sleep architecture with pregabalin compared with placebo and pramipexole. Effects of pregabalin on periodic limb movement arousal index were comparable to pramipexole. , CONCLUSIONS: Pregabalin provided significantly improved treatment outcomes as compared with placebo, and augmentation rates were significantly lower with pregabalin than with 0.5 mg of pramipexole., The alpha-2-delta ligands, including gabapentin, gabapentin enacarbil, and pregabalin, are effective for Restless Legs Syndrome without known occurrence of augmentation or impulse control disorders, although sedation and No No dizziness can occur. , Pregabalin has been established as effective for up to 1 year in treating Restless Legs Syndrome/WED (Level A evidence). , In the group of Anticonvulsants [TC], only the trials performed with α₂δ ligands such as gabapentin, gabapentin enacarbil, and pregabalin showed good efficacy. , Alternative or additional pharmacologic treatment with a lower level of overall quality of evidence includes Analgesics, Opioid (codeine, tramadol, and oxycodone) and Anticonvulsants [TC] (gabapentin, gabapentin enacarbil, and pregabalin). , There is sufficient evidence to conclude that Dopamine Agonists [MoA] such as rotigotine transdermal patch, pramipexole, ropinirole, gabapentin enacarbil, pregabalin and gabapentin are effective in the short-term treatment of Restless Legs Syndrome and rotigotine, followed by gabapentin enacarbil, ropinirole, pramipexole and gabapentin for long-term treatment., Calcium channel alpha-2-delta ligands (gabapentin, gabapentin enacarbil, and pregabalin) provide alternative therapies for Restless Legs Syndrome especially in patients with augmentation, impulse control disorders, or Hypersomnia induced by Dopamine Agonists [MoA]. , Alpha-2-delta ligands (gabapentin enacarbil, gabapentin, and pregabalin) increased the number of IRLS responders (RR=1.66; [95% CI: 1.33 to 2.09], k=3, high strength of evidence) and mean change in IRLS symptom scores (k=3, high strength of evidence). , RECOMMENDATIONS: Level A recommendations can be made for rotigotine, ropinirole, pramipexole, gabapentin enacarbil, gabapentin and pregabalin, which are all considered effective for the short-term treatment for Restless Legs Syndrome., Therapies with an OPTION level of recommendation include carbamazepin (benzodiazepine), gabapentin, pregabalin, clonidine, and for patients with low Ferritin levels, iron supplementation., CONCLUSIONS: In this 6-week phase 2b study, pregabalin reduced Restless Legs Syndrome symptoms in patients with moderate-to-severe idiopathic Restless Legs Syndrome, CLASSIFICATION OF EVIDENCE: This study provides Canadian Cardiovascular Society Grading Scale Canadian Cardiovascular Society Grading Scale Class II evidence that pregabalin is effective for the treatment of restless legs syndrome and improves sleep architecture and periodic limb movements in placebo-unresponsive patients., In severe, refractory or neuropathy-associated Restless Legs Syndrome, Antiepileptic Agents (gabapentin, pregabalin) or opioid (oxycodone, tramadol) drugs can be used., The alpha-2-delta ligands, including gabapentin, gabapentin enacarbil, and pregabalin, are effective for Restless Legs Syndrome without known occurrence of augmentation or impulse control disorders, although sedation and No No dizziness can occur, This study provides Canadian Cardiovascular Society Grading Scale Canadian Cardiovascular Society Grading Scale Class II evidence that pregabalin is effective for the treatment of restless legs syndrome and improves sleep architecture and periodic limb movements in placebo-unresponsive patients., Level A recommendations can be made for rotigotine, ropinirole, pramipexole, gabapentin enacarbil, gabapentin and pregabalin, which are all considered effective for the short-term treatment for Restless Legs Syndrome[SEP]Relations: Pregabalin has relations: contraindication with muscular disease, contraindication with muscular disease, drug_effect with Limb pain, drug_effect with Limb pain, contraindication with anxiety disorder, contraindication with anxiety disorder, drug_effect with Blindness, drug_effect with Blindness, drug_effect with Dementia, drug_effect with Dementia. Definitions: Analgesics, Opioid defined as following: Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS.. pramipexole defined as following: A benzothiazole derivative and dopamine agonist with antioxidant properties that is used in the treatment of PARKINSON DISEASE and RESTLESS LEGS SYNDROME.. tramadol defined as following: A narcotic analgesic proposed for severe pain. It may be habituating.. pregabalin defined as following: A 3-isobutyl derivative of gamma-amino butyric acid (GABA) with anti-convulsant, anti-epileptic, anxiolytic, and analgesic activities. Although the exact mechanism of action is unknown, pregabalin selectively binds to alpha2delta (A2D) subunits of presynaptic voltage-dependent calcium channels (VDCCs) located in the central nervous system (CNS). Binding of pregabalin to VDCC A2D subunits prevents calcium influx and the subsequent calcium-dependent release of various neurotransmitters, including glutamate, norepinephrine, serotonin, dopamine, and substance P, from the presynaptic nerve terminals of hyperexcited neurons; synaptic transmission is inhibited and neuronal excitability is diminished. Pregabalin does not bind directly to GABA-A or GABA-B receptors and does not alter GABA uptake or degradation.. codeine defined as following: An opioid analgesic related to MORPHINE but with less potent analgesic properties and mild sedative effects. It also acts centrally to suppress cough.. oxycodone defined as following: A semisynthetic derivative of CODEINE.. gabapentin defined as following: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.. Hypersomnia defined as following: A sleep disorder characterized by excessive sleepiness.. Ferritin defined as following: Iron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each Ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types.. Restless Legs Syndrome defined as following: A disorder characterized by aching or burning sensations in the lower and rarely the upper extremities that occur prior to sleep or may awaken the patient from sleep.. Canadian Cardiovascular Society Grading Scale Class II defined as following: A grading of angina characterized by a slight limitation of ordinary activity. Angina occurs on walking or climbing stairs rapidly, walking uphill, walking or climbing stairs after meals, or in cold, in wind, or under emotional stress, or only during the few hours after awakening. Angina occurs on walking more than 2 blocks on the level and climbing more than 1 flight of ordinary stairs at a normal pace and in normal condition.. clonidine defined as following: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.. restless leg syndrome defined as following: A disorder characterized by aching or burning sensations in the lower and rarely the upper extremities that occur prior to sleep or may awaken the patient from sleep..", "label": "yes"} {"original_question": "Does the human lncRNA LINC-PINT promote tumorigenesis?", "id": "converted_2454", "sentence1": "Does the human lncRNA LINC-PINT promote tumorigenesis?", "sentence2": "The human lncRNA LINC-PINT inhibits Specimen Source Codes - Specimen Source Codes - tumor cell invasion through a highly conserved Sequence - ParameterizedDataType element., Here we characterize the function of the p53-regulated human lncRNA LINC-PINT in Primary malignant neoplasm. We find that LINC-PINT is downregulated in multiple types of Primary malignant neoplasm and acts as a Specimen Source Codes - Specimen Source Codes - tumor suppressor lncRNA by reducing the invasive phenotype of Primary malignant neoplasm cells. A cross-species analysis identifies a highly conserved Sequence - ParameterizedDataType element in LINC-PINT that is essential for its function. This Sequence - ParameterizedDataType mediates a specific interaction with Polycomb Repressive Complex 2, necessary for the LINC-PINT-dependent repression of a pro-invasion signature of Genes regulated by the transcription factor EGR1 gene gene., We find that LINC-PINT is downregulated in multiple types of Primary malignant neoplasm and acts as a Specimen Source Codes - Specimen Source Codes - tumor suppressor lncRNA by reducing the invasive phenotype of Primary malignant neoplasm cells., These results thus indicate that low plasma LINC-PINT gene expression could serve as a minimally invasive biomarker for early Patient-Controlled Analgesia detection, and that low LINC-PINT gene levels in Patient-Controlled Analgesia tumors could be used for predicting patient prognosis., Our data demonstrate that LINC-PINT gene expression is lower in plasma samples from Patient-Controlled Analgesia patients than from healthy individuals, and indicate that plasma LINC-PINT gene levels are more sensitive than CA-19-9 Antigen for detecting Patient-Controlled Analgesia., Low plasma LINC-PINT gene levels correlate with Specimen Source Codes - Specimen Source Codes - tumor recurrence, while low Specimen Source Codes - Specimen Source Codes - tumor LINC-PINT gene levels correlate with poor prognosis for Patient-Controlled Analgesia patients after pancreatectomy., We find that LINC-PINT is downregulated in multiple types of Primary malignant neoplasm and acts as a Specimen Source Codes - Specimen Source Codes - tumor suppressor lncRNA by reducing the invasive phenotype of Primary malignant neoplasm cells., We find that LINC-PINT is downregulated in multiple types of Primary malignant neoplasm and acts as a Specimen Source Codes - Specimen Source Codes - tumor suppressor lncRNA by reducing the invasive phenotype of Primary malignant neoplasm cells., These results thus indicate that low plasma LINC-PINT gene expression could serve as a minimally invasive biomarker for early Patient-Controlled Analgesia detection, and that low LINC-PINT gene levels in Patient-Controlled Analgesia tumors could be used for predicting patient prognosis.
, The human lncRNA LINC-PINT inhibits Specimen Source Codes - Specimen Source Codes - tumor cell invasion through a highly conserved Sequence - ParameterizedDataType element.[SEP]Relations: LINC-PINT has relations: anatomy_protein_present with lymph node, anatomy_protein_present with lymph node, anatomy_protein_present with colon, anatomy_protein_present with colon, anatomy_protein_present with placenta, anatomy_protein_present with placenta, anatomy_protein_present with multi-cellular organism, anatomy_protein_present with multi-cellular organism, anatomy_protein_present with cerebellar hemisphere, anatomy_protein_present with cerebellar hemisphere. Definitions: Primary malignant neoplasm defined as following: A malignant Specimen Source Codes - tumor at the original site of growth.. Primary malignant neoplasm cells defined as following: Cells of, or derived from, a malignant Specimen Source Codes - tumor.. Polycomb Repressive Complex 2 defined as following: A multisubunit polycomb protein complex that catalyzes the METHYLATION of chromosomal HISTONE H3. It works in conjunction with POLYCOMB REPRESSIVE COMPLEX 1 to effect EPIGENETIC REPRESSION.. EGR1 gene defined as following: This gene is involved in transcriptional regulation.. CA-19-9 Antigen defined as following: Sialylated Lewis(a) blood group carbohydrate antigen found in many adenocarcinomas of the digestive tract, especially pancreatic tumors.. LINC-PINT gene defined as following: This gene is involved in signaling pathway regulation.. Patient-Controlled Analgesia defined as following: Relief of PAIN, without loss of CONSCIOUSNESS, through ANALGESIC AGENTS administered by the patients. It has been used successfully to control POSTOPERATIVE PAIN, during OBSTETRIC LABOR, after BURNS, and in TERMINAL CARE. The choice of agent, dose, and lockout interval greatly influence effectiveness. The potential for overdose can be minimized by combining small bolus doses with a mandatory interval between successive doses (lockout interval).. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "no"} {"original_question": "Does Apolipoprotein E (ApoE) have anti-inflammatory activity?", "id": "converted_1409", "sentence1": "Does Apolipoprotein E (ApoE) have Anti-Inflammatory Agents activity?", "sentence2": " have previously reported that APOE gene (Apolipoprotein E), a protein component of very-low-density lipoproteins (Very low density lipoprotein) and High Density Lipoproteins and a potent plasma-borne atheroprotective factor, exerts Anti-Inflammatory Agents activity in Specimen Source Codes - Macrophages by switching the activation profile from Enneking Metastasis Enneking Metastasis M1 (\"classic\") to M2 (\"alternative\") in a process involving signaling via LDLR protein, human , Anti-Inflammatory Agents activity in Specimen Source Codes - Macrophages , Small peptides corresponding to the receptor-binding region of Apolipoprotein E mimic the Anti-Inflammatory Agents activity of the Apolipoprotein E , Apolipoprotein (apo) E-containing high-density lipoprotein (HDL) has antioxidant, Anti-Inflammatory Agents and anti-atherogenic properties[SEP]Relations: APOE has relations: molfunc_protein with antioxidant activity, molfunc_protein with antioxidant activity, bioprocess_protein with negative regulation of inflammatory response, bioprocess_protein with negative regulation of inflammatory response, molfunc_protein with phosphatidylcholine-sterol O-acyltransferase activator activity, molfunc_protein with phosphatidylcholine-sterol O-acyltransferase activator activity, disease_protein with hyperlipoproteinemia, disease_protein with hyperlipoproteinemia, cellcomp_protein with lipoprotein particle, cellcomp_protein with lipoprotein particle. Definitions: Very low density lipoprotein defined as following: A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. Very low density lipoprotein facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, Very low density lipoprotein is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues.. Enneking Metastasis M1 defined as following: Regional or distant metastasis.. Apolipoprotein E defined as following: A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III.. High Density Lipoproteins defined as following: A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases.. APOE gene defined as following: This gene is involved in lipid transport and metabolism.. LDLR protein, human defined as following: Low-density lipoprotein receptor (860 aa, ~95 kDa) is encoded by the human LDLR gene. This protein is involved in the endocytosis of cholesterol.. Anti-Inflammatory Agents defined as following: Substances that reduce or suppress INFLAMMATION.. Apolipoprotein E defined as following: This gene is involved in lipid transport and metabolism.. ApoE defined as following: A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III..", "label": "yes"} {"original_question": "Is bapineuzumab effective for treatment of patients with Alzheimer's disease?", "id": "converted_367", "sentence1": "Is bapineuzumab effective for treatment of patients with ALZHEIMER DISEASE, FAMILIAL, 1?", "sentence2": " Thus far, results from two large phase 3 trial programs with bapineuzumab and solaneuzumab, respectively, have brought rather disappointing results., More recently, in phase III studies, bapineuzumab has been discontinued because it did not prove clinically effective (despite its significant effect on biomarkers), while solaneuzumab has been found effective in slowing cytarabine/daunorubicin protocol progression. , Passive immunotherapy with Monoclonal Antibodies (mAbs) against Aβ is in late clinical development but recently the two most advanced mAbs, bapineuzumab and solanezumab, targeting an N-terminal or central epitope, respectively, failed to meet their target of improving or stabilizing cognition and function., The marginal effects observed in recent clinical studies of solanezumab, targeting monomeric Aβ, and bapineuzumab, targeting amyloid plaques, prompted expert comments that Pharmacologic Substance discovery efforts in ALZHEIMER DISEASE, FAMILIAL, 1 should focus on soluble forms of Aβ rather than fibrillar Aβ deposits found in amyloid plaques., Phase III trials showed that bapineuzumab failed to improve cognitive and functional performances in cytarabine/daunorubicin protocol patients, and was associated with a high incidence of amyloid-related imaging abnormalities (NRG1 wt Allele)., Clinical trials on various drugs, including AN-1792, bapineuzumab, and solanezumab, have been carried out; however, all trials have failed to demonstrate apparent clinical benefits. , Despite the alteration in biochemical composition, all 3 immunized subjects exhibited continued cognitive decline., Despite negative topline phase 3 clinical trial results for bapineuzumab and solanezumab in mild to moderate cytarabine/daunorubicin protocol, findings from these trials and recent advances suggest renewed optimism for anti-amyloid therapies. , The lack of progress in the development of disease-modifying therapy in ALZHEIMER DISEASE, FAMILIAL, 1 (cytarabine/daunorubicin protocol) was highlighted recently by the cessation of a phase 3 clinical trial studying the effects of bapineuzumab on mild to moderate disease. No treatment benefit was apparent, whereas several serious side effects occurred more commonly in the treatment group compared to placebo. , Clinical studies using the N-terminal-directed anti-Aβ antibody bapineuzumab have demonstrated reduced Head>Brain PET-Pittsburg-B signals, suggesting the reduction of Aβ plaques, and reduced levels of total and phosphorylated tau protein in the Cerebrospinal Fluid of treated cytarabine/daunorubicin protocol patients. Preclinical studies using 3D6 (the murine form of bapineuzumab) have demonstrated resolution of Aβ plaque and vascular burdens, neuritic dystrophy, and preservation of synaptic density in the transgenic APP mouse models., The clinical results of the initial studies with bapineuzumab were equivocal in terms of cognitive benefit. The occurrence of vasogenic Edema:Finding:Point in time:^Patient:Ordinal after bapineuzumab, and more rarely Head>Brain Microhemorrhages (especially in Apo E ε4 carriers), has raised concerns on the safety of these Antibodies, in vitro diagnostic directed against the N-terminus of the Aβ peptide. , The most advanced of these immunological approaches is bapineuzumab, composed of humanized anti-Aβ Monoclonal Antibodies, that has been tested in two Phase II trials, demonstrating to reduce Aβ burden in the Head>Brain of cytarabine/daunorubicin protocol patients. However, the preliminary cognitive efficacy of bapineuzumab appears uncertain. The occurrence of vasogenic Edema:Finding:Point in time:^Patient:Ordinal, especially in Apolipoprotein E carriers, may limit its clinical use and have led to abandon the highest dose of the Pharmacologic Substance (2 mg/kg)., However, the preliminary cognitive efficacy of bapineuzumab, a humanized anti-Aβ monoclonal antibody, appears uncertain. Moreover, the occurrence of vasogenic Edema:Finding:Point in time:^Patient:Ordinal and, more rarely, Head>Brain Microhemorrhages, especially in apolipoprotein E ϵ4 carriers, have led to abandoning of the highest dose of the Pharmacologic Substance. , However, the preliminary equivocal cognitive results obtained with bapineuzumab as well as the detrimental cognitive effects observed with Semagacestat, a potent γ-secretase inhibitor, raise the possibility that targeting Aβ may not be clinically efficacious in cytarabine/daunorubicin protocol. , The patient received four bapineuzumab infusions over a 39 week period. During the course of this treatment, there was no remarkable change in No No cognitive impairment as determined by MMSE scores. Forty-eight days after the fourth bapineuzumab infusion was given, MRI revealed that the patient had developed Infarction, Lacunar and possible vasogenic Edema:Finding:Point in time:^Patient:Ordinal, probably related to immunotherapy, but a subsequent MRI scan 38 days later demonstrated resolution of vasogenic Edema:Finding:Point in time:^Patient:Ordinal. The patient expired due to Acute congestive heart failure complicated by progressive cytarabine/daunorubicin protocol and cerebrovascular accident 378 days after the first bapineuzumab infusion and 107 days after the end of therapy. Neuropathological and biochemical analysis did not produce evidence of lasting plaque regression or clearance of Aβ due to immunotherapy., These results suggest that, in this particular case, bapineuzumab immunotherapy neither resulted in detectable clearance of amyloid plaques nor prevented further No No cognitive impairment., bapineuzumab has been shown to reduce Aβ burden in the Head>Brain of cytarabine/daunorubicin protocol patients. However, its preliminary cognitive efficacy appears uncertain, particularly in ApoE ε4 carriers, and vasogenic Edema:Finding:Point in time:^Patient:Ordinal may limit its clinical use. , bapineuzumab appears capable of reducing the cerebral beta-amyloid peptide burden in patients with ALZHEIMER DISEASE, FAMILIAL, 1. However, particularly in APOE 4 carriers, its ability to slow disease progression remains uncertain, and vasogenic Edema:Finding:Point in time:^Patient:Ordinal - a Dose-Limiting and potentially severe adverse reaction - may limit its clinical applicability., The first is a phase 2 study of passive immunotherapy with bapineuzumab, a humanized anti-APP wt Allele monoclonal antibody directed against the N-terminus of APP wt Allele. This trial showed no differences within dose cohorts on the primary efficacy analysis. Exploratory analyses showed potential treatment differences on cognitive and functional endpoints in study completers and apolipoprotein E epsilon4 noncarriers. A safety concern was the occurrence of reversible vasogenic Edema:Finding:Point in time:^Patient:Ordinal. , The first passive immunotherapy trial with bapineuzumab, a Antibodies, Monoclonal, Humanized against the end terminus of APP wt Allele, also encountered some dose dependent adverse events during the Phase II portion of the study, vasogenic Edema:Finding:Point in time:^Patient:Ordinal in 12 cases, which were significantly over represented in ApoE4 carriers.[SEP]Relations: bapineuzumab has relations: drug_drug with Abituzumab, drug_drug with Abituzumab, drug_drug with Alemtuzumab, drug_drug with Alemtuzumab, drug_drug with Olaratumab, drug_drug with Olaratumab, drug_drug with Fasinumab, drug_drug with Fasinumab, drug_drug with Adalimumab, drug_drug with Adalimumab. Definitions: Apolipoprotein E defined as following: A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III.. Infarction, Lacunar defined as following: Brain infarction that affects small subcortical vessels due to occlusion of a penetrating artery deep in the Head>Brain. It may lead to lacunar stroke.. solanezumab defined as following: A Antibodies, Monoclonal, Humanized (IgG1) raised against amyloid beta peptides with Alzheimer disease treatment application. solanezumab recognizes and binds the middle amino acid residues 16-24 of the amyloid beta peptide and may be used in a passive immunotherapy treatment.. Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. APP wt Allele defined as following: Human APP wild-type allele is located in the vicinity of 22q13.2 and is approximately 290 kb in length. This allele, which encodes amyloid beta A4 protein, is involved in transcriptional activation and peptide regulation. APP defects can cause ALZHEIMER DISEASE, FAMILIAL, 1 and cerebroarterial amyloidosis.. bapineuzumab defined as following: A Antibodies, Monoclonal, Humanized (IgG1) raised against amyloid beta peptides with Alzheimer disease treatment application. bapineuzumab recognizes and binds the N-terminal amino acids 1-5 of the amyloid beta peptide, and may be used in a passive immunotherapy treatment.. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65.. Monoclonal Antibodies defined as following: Antibodies produced by a single clone of cells.. vasogenic Edema:Finding:Point in time:^Patient:Ordinal defined as following: Edema that is characterized by increased permeability of capillary endothelial cells.. Cerebrospinal Fluid defined as following: A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES.. NRG1 wt Allele defined as following: Human NRG1 wild-type allele is located within 8p21-p12 and is approximately 1,124 kb in length. This allele, which encodes pro-neuregulin-1, membrane-bound isoform protein, is involved in the compositional regulation of neurotransmitter receptors in maturing synapses in the Head>Brain, proliferation and differentiation.. Antibodies, Monoclonal, Humanized defined as following: Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human Antibodies, in vitro diagnostic. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized Antibodies, in vitro diagnostic end in -zumab.. bapineuzumab defined as following: A Antibodies, Monoclonal, Humanized (IgG1) raised against amyloid beta peptides with Alzheimer disease treatment application. bapineuzumab recognizes and binds the N-terminal amino acids 1-5 of the amyloid beta peptide, and may be used in a passive immunotherapy treatment..", "label": "no"} {"original_question": "Do IEG create a ripple effect of transcription?", "id": "converted_1948", "sentence1": "Do IEG create a ripple effect of transcription?", "sentence2": "Rapid induction of Genes, Immediate-Early (IEGs) in response to growth factor stimulations is accompanied by co-upregulation of their neighbouring Genes., Even in surrounding Intergenic Region, transcriptional activation took place at the same time. , Here we show that intensive transcription at one Gene Locus frequently spills over into its physical neighbouring loci., Ripples from neighbouring transcription., Ripples from neighbouring transcription.[SEP]Relations: insect neurogenic region has relations: anatomy_anatomy with embryonic structure, anatomy_anatomy with embryonic structure. Definitions: Gene Locus defined as following: The position of a gene or a chromosomal marker on a chromosome; also, a stretch of DNA at a particular place on a particular chromosome. The use of Gene Locus is sometimes restricted to mean regions of DNA that are expressed.. Genes, Immediate-Early defined as following: Genes that show rapid and transient expression in the absence of de novo protein synthesis. The term was originally used exclusively for viral Genes where immediate-early referred to transcription immediately following virus integration into the host cell. It is also used to describe cellular Genes which are expressed immediately after resting cells are stimulated by extracellular signals such as growth factors and neurotransmitters.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Is the Prostate- Specific Antigen (PSA) test relevant only for prostate cancer?", "id": "converted_728", "sentence1": "Is the Prostate- Specific Antigen (Prostate-Specific Antigen) test relevant only for Malignant neoplasm of prostate?", "sentence2": "rostate cancer (Passive Cutaneous Anaphylaxis) is the most frequently diagnosed Primary malignant neoplasm and the second leading cause of Cancer-Related Death in men, Prostate-Specific Antigen is known to be prostate specific, but not Passive Cutaneous Anaphylaxis specific, deficiencies of serum Prostate-Specific Antigen as a prostate-cancer-specific diagnostic test are well recognized., medical debate surrounding the use of the kallikrein-related peptidase 3, human (Prostate-Specific Antigen) test for Malignant neoplasm of prostate screening, The clinical relevance of this surprisingly high rate of Malignant neoplasm of prostate in men with a normal Prostate-Specific Antigen is yet to be determined , Rapid uptake of kallikrein-related peptidase 3, human (Prostate-Specific Antigen) testing has occurred in the United States despite inconclusive evidence regarding mortality benefit, Routine cancer screening with kallikrein-related peptidase 3, human (Prostate-Specific Antigen) is controversial, and practice guidelines recommend that men be counseled about its risks and benefits, Prostate carcinoma was histologically confirmed in 14 (0.66%) of the men, nine times in the early stage (T2) and five times in the clinical stage (T3 thoracic segmental innervation thoracic segmental innervation), corresponding to an incidence of circa 650 cases per 100,000 men in the target age group, This newly developed Prostate-Specific Antigen test system can enhance the acceptance rate and effectiveness of medical check-ups for Malignant neoplasm of prostate,, Prostate-Specific Antigen can be used reliably as a unique tool in the follow-up of patients for the early detection of progressive disease, Prostate-Specific Antigen showed negative predictive values of 82 and 77%, respectively, using 4 and 10 ng/ml as cutoff points, have assessed the feasibility of using fixed-limit criteria based on medical relevance and biological variation for evaluating the analytical performance of the kallikrein-related peptidase 3, human (Prostate-Specific Antigen) test[SEP]Relations: prostate carcinoma has relations: disease_protein with PSCA, disease_protein with PSCA, disease_protein with PSMC3IP, disease_protein with PSMC3IP, disease_protein with HSPA1A, disease_protein with HSPA1A, disease_disease with Malignant neoplasm of prostate, disease_disease with Malignant neoplasm of prostate, disease_protein with PCAT1, disease_protein with PCAT1. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Malignant neoplasm of prostate defined as following: A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas.. kallikrein-related peptidase 3, human defined as following: Prostate-specific antigen (261 aa, ~29 kDa) is encoded by the human KLK3 gene. This protein plays a role in both proteolysis and seminal fluid liquefaction.. Prostate-Specific Antigen defined as following: A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of Malignant neoplasm of prostate.. Passive Cutaneous Anaphylaxis defined as following: Relief of PAIN, without loss of CONSCIOUSNESS, through ANALGESIC AGENTS administered by the patients. It has been used successfully to control POSTOPERATIVE PAIN, during OBSTETRIC LABOR, after BURNS, and in TERMINAL CARE. The choice of agent, dose, and lockout interval greatly influence effectiveness. The potential for overdose can be minimized by combining small bolus doses with a mandatory interval between successive doses (lockout interval).. Prostate carcinoma defined as following: One of the most common malignant tumors afflicting men. The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland. Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes. Adenocarcinomas represent the overwhelming majority of prostatic carcinomas. Prostatic-specific antigen (Prostate-Specific Antigen) serum test is widely used as a screening test for the early detection of prostatic carcinoma. Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy. Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.. Cancer-Related Death defined as following: A death attributed to the progression of a cancer-related pathologic condition..", "label": "no"} {"original_question": "Is arimoclomol a co-inducer of the heat shock response?", "id": "converted_1444", "sentence1": "Is arimoclomol a co-inducer of the heat shock response?", "sentence2": "arimoclomol is a hydroxylamine derivative, a group of compounds which have unique properties as co-inducers of 78 kDa Glucose-Regulated Protein expression, but only under conditions of cellular stress. , In this review we summarize the evidence for the neuroprotective effects of enhanced 78 kDa Glucose-Regulated Protein expression by arimoclomol and other inducers of the Heat Shock Response. , arimoclomol, a co-inducer of the heat shock stress response,, The heat-shock response (Health Services Research) was activated in P23H retinae, and this was enhanced with arimoclomol treatment. , We also assessed these functions in CASP14 gene treated with a known 78 kDa Glucose-Regulated Protein inducer, arimoclomol., Under conditions of excessive stress, arimoclomol induces amplification of the cytoprotective heat shock response in order to protect Neurons, Efferent from Cessation of life. , Although both arimoclomol and celastrol induced the expression of Heat-Shock Proteins 70, arimoclomol, an amplifier of 78 kDa Glucose-Regulated Protein expression involved in cellular stress response, has emerged as a potential therapeutic candidate in Amyotrophic Lateral Sclerosis (ALS) in recent years., The mechanism of action of arimoclomol involves potentiation of the heat shock response, and treatment with arimoclomol increased Heat-Shock Proteins 70 expression. , arimoclomol is an investigational Pharmacologic Substance for Amyotrophic Lateral Sclerosis (ALS) that amplifies 78 kDa Glucose-Regulated Protein gene expression during cell stress., arimoclomol, a coinducer of Heat shock proteins, delayed progression of Amyotrophic Lateral Sclerosis (ALS) in a mouse model in which Neurons, Efferent in the Spinal Cord and motor cortex degenerate.[SEP]Relations: arimoclomol has relations: drug_protein with SOD1, drug_protein with SOD1. 78 kDa Glucose-Regulated Protein binding has relations: molfunc_protein with LMAN2, molfunc_protein with LMAN2, molfunc_protein with LMAN2, molfunc_protein with LMAN2, molfunc_protein with IRAK1, molfunc_protein with IRAK1, molfunc_protein with IRAK1, molfunc_protein with IRAK1. Definitions: Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Amyotrophic Lateral Sclerosis defined as following: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower Neurons, Efferent in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of Neurons, Efferent with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94). Heat-Shock Proteins 70 defined as following: A family of structurally related proteins that are involved in both protein folding and cellular stress responses. The members of this family are approximately 70 kDa.. Heat shock proteins defined as following: Proteins which are synthesized in eukaryotic organisms and bacteria in response to hyperthermia and other environmental stresses. They increase thermal tolerance and perform functions essential to cell survival under these conditions.. 78 kDa Glucose-Regulated Protein defined as following: 78 kDa glucose-regulated protein (654 aa, ~72kDa) is encoded by HSPA5 gene. The protein is intracellularly localized in the endoplasmic reticulum lumen, and plays a role in the assembly of multimeric protein complexes inside the organelle. In addition, the protein is thought to function as a pro-survival protein, or an inhibitor of apoptosis.. Health Services Research defined as following: The integration of epidemiologic, sociological, economic, and other analytic sciences in the study of health services. Health services research is usually concerned with relationships between need, demand, supply, use, and outcome of health services. The aim of the research is evaluation, particularly in terms of structure, process, output, and outcome. (From Last, Dictionary of Epidemiology, 2d ed). Neurons, Efferent defined as following: Neurons which send impulses peripherally to activate muscles or secretory cells.. Spinal Cord defined as following: A cylindrical column of tissue that lies within the vertebral canal. It is composed of WHITE MATTER and GRAY MATTER..", "label": "yes"} {"original_question": "Is armodafinil used for treatment of insomnia?", "id": "converted_1156", "sentence1": "Is armodafinil used for treatment of insomnia?", "sentence2": " Other therapies, such as sedative hypnotics, target daytime insomnia, while pharmacologic agents such as modafinil, armodafinil, and Caffeine Measurement and non-pharmacologic approaches such as napping promote nighttime alertness., Other treatment options may include pharmacologic interventions such as modafinil and armodafinil, which have shown efficacy in this population., BACKGROUND: armodafinil (Nuvigil(®), Cephalon, Inc., Frazer, newton per square metre, USA), the longer-lasting isomer of racemic modafinil, is a nonamphetamine, wakefulness-promoting medication. In patients with excessive Somnolence associated with shift work disorder, treated obstructive sleep apnoea, or Narcolepsy 1, armodafinil has been found to improve wakefulness throughout the shift or day. In addition, while not approved for this indication, armodafinil has been found to improve excessive Somnolence associated with jet-lag disorder., STUDY OBJECTIVES: armodafinil is a wakefulness-promoting medication. Its efficacy and tolerability have been established in 12-week studies of patients with excessive Somnolence (ES) associated with treated obstructive sleep apnea (Sleep Apnea, Obstructive), shift work disorder (SWD), or Narcolepsy 1. , armodafinil represents an option for long-term treatment of patients with ES associated with treated Sleep Apnea, Obstructive, SWD, or Narcolepsy 1., The wakefulness-promoting agents armodafinil and modafinil are FDA approved for the treatment of ES in patients with SWD., CONCLUSIONS: armodafinil significantly improved overall clinical condition related to excessive Somnolence as rated by the CGI-C and was well tolerated in patients with treated Sleep Apnea, Obstructive and comorbid depression., CONCLUSION: In patients with excessive Somnolence associated with chronic SWD of moderate or greater severity, armodafinil significantly improved wakefulness during scheduled night work, raising mean nighttime sleep latency above the level considered to indicate severe Somnolence during the daytime. armodafinil also significantly improved measures of overall clinical condition, long-term memory, and attention. , Adjunct treatment with armodafinil significantly improved wakefulness, long-term memory, and patients' ability to engage in activities of daily living in nCPAP-adherent individuals with ES associated with Sleep Apnea, Obstructive. , A number of studies have evaluated countermeasures or interventions in shift workers; proposed treatments include chronobiotic interventions, such as light exposure, Recombinant Recombinant melatonin, hypnotic agents, Caffeine Measurement and Central Nervous System stimulants (Amphetamines), and the wake-promoting agents modafinil and armodafinil. , These studies showed that modafinil and armodafinil significantly improve the ability to sustain wakefulness during waking activities (e.g. working, driving), overall clinical condition, and sustained attention or memory in patients with SWSD. , CONCLUSIONS: In this selected population of patients with Sleep Apnea, Obstructive/HS and residual ES despite effective treatment with nCPAP, armodafinil QD used as an adjunct to nCPAP treatment was associated with improved wakefulness and overall clinical condition. , Other therapies, such as sedative hypnotics, target daytime insomnia, while pharmacologic agents such as modafinil, armodafinil, and Caffeine Measurement and non-pharmacologic approaches such as napping promote nighttime alertness., armodafinil represents an option for long-term treatment of patients with ES associated with treated Sleep Apnea, Obstructive, SWD, or Narcolepsy 1., Other therapies, such as sedative hypnotics, target daytime insomnia, while pharmacologic agents such as modafinil, armodafinil, and Caffeine Measurement and non-pharmacologic approaches such as napping promote nighttime alertness., In this selected population of patients with Sleep Apnea, Obstructive/HS and residual ES despite effective treatment with nCPAP, armodafinil QD used as an adjunct to nCPAP treatment was associated with improved wakefulness and overall clinical condition[SEP]Relations: armodafinil has relations: contraindication with anxiety disorder, contraindication with anxiety disorder, contraindication with mental disorder, contraindication with mental disorder, drug_drug with Omeprazole, drug_drug with Omeprazole, drug_drug with Antipyrine, drug_drug with Antipyrine, contraindication with neurotic disorder, contraindication with neurotic disorder. Definitions: Somnolence defined as following: Compelling urge to sleep.. Amphetamines defined as following: Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.. Caffeine Measurement defined as following: The determination of the amount of Caffeine Measurement present in a sample.. newton per square metre defined as following: A SI derived unit of pressure equivalent to one newton per square meter or 10 bars or to 1.45x10E-4 pounds per square inch.. Sleep Apnea, Obstructive defined as following: A disorder characterized by recurrent apneas during sleep despite persistent respiratory efforts. It is due to upper airway obstruction. The respiratory pauses may induce HYPERCAPNIA or HYPOXIA. Cardiac arrhythmias and elevation of systemic and pulmonary arterial pressures may occur. Frequent partial arousals occur throughout sleep, resulting in relative SLEEP DEPRIVATION and daytime tiredness. Associated conditions include OBESITY; ACROMEGALY; MYXEDEMA; micrognathia; MYOTONIC DYSTROPHY; adenotonsilar dystrophy; and NEUROMUSCULAR DISEASES. (From Adams et al., Principles of Neurology, 6th ed, p395). armodafinil defined as following: The R-enantiomer of the racemic synthetic agent modafinil with central nervous system (Central Nervous System) stimulant and wakefulness-promoting activities. Although the exact mechanism of action has yet to be fully elucidated, armodafinil appears to inhibit the reuptake of dopamine by binding to the dopamine-reuptake pump, which leads to an increase in extracellular dopamine levels in some brain regions. This agent does not bind to or inhibit several receptors and enzymes that may be involved in sleep/wake regulation and is not a direct- or indirect-acting dopamine receptor agonist. armodafinil has a longer half-life than modafinil.. modafinil defined as following: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.. Recombinant melatonin defined as following: A therapeutic chemically synthesized form of the pineal indole Recombinant melatonin with antioxidant properties. The pineal synthesis and secretion of Recombinant melatonin, a serotonin-derived neurohormone, is dependent on beta-adrenergic receptor function. Melatonin is involved in numerous biological functions including circadian rhythm, sleep, the stress response, aging, and immunity.. Central Nervous System defined as following: The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.. armodafinil defined as following: The R-enantiomer of the racemic synthetic agent modafinil with central nervous system (Central Nervous System) stimulant and wakefulness-promoting activities. Although the exact mechanism of action has yet to be fully elucidated, armodafinil appears to inhibit the reuptake of dopamine by binding to the dopamine-reuptake pump, which leads to an increase in extracellular dopamine levels in some brain regions. This agent does not bind to or inhibit several receptors and enzymes that may be involved in sleep/wake regulation and is not a direct- or indirect-acting dopamine receptor agonist. armodafinil has a longer half-life than modafinil.. insomnia defined as following: A sleep disorder characterized by difficulty in falling asleep and/or remaining asleep..", "label": "no"} {"original_question": "Does the Mcm2-Ctf4-Polα axis play a role in transfer of histones to leading strand DNA at the replication forks?", "id": "converted_3572", "sentence1": "Does the Mcm2-WDHD1 gene-Polα axis play a role in transfer of histones to leading strand DNA at the replication forks?", "sentence2": "The Mcm2-WDHD1 gene-Polα Cervus axis Facilitates Parental Histone H3-H4 Transfer to Lagging Strands., Although essential for epigenetic inheritance, the transfer of parental Histone antigen (H3-H4)2 tetramers that contain epigenetic modifications to replicating DNA strands is poorly understood. Here, we show that the Mcm2-WDHD1 gene-Polα axis facilitates the transfer of parental (H3-H4)2 tetramers to lagging-strand DNA at replication forks. Mutating the conserved Histone antigen-binding domain of the Mcm2 subunit of the CASK gene (Cdc45-MCM-GINS) DNA Helicases, which translocates along the leading-strand template, results in a marked enrichment of parental (H3-H4)2 on leading strand, due to the impairment of the transfer of parental (H3-H4)2 to lagging strands. Similar effects are observed in WDHD1 gene and Polα primase mutants that disrupt the connection of the CASK gene helicase to Polα that resides on lagging-strand template. Our results support a model whereby parental (H3-H4)2 complex (molecular entity) displaced from Nucleosomes by DNA unwinding at replication forks are transferred by the CASK gene-WDHD1 gene-Polα complex to lagging-strand DNA for nucleosome assembly at the original location.[SEP]Relations: nucleosome assembly has relations: bioprocess_protein with MCM2, bioprocess_protein with MCM2, bioprocess_protein with MACROH2A2, bioprocess_protein with MACROH2A2. nucleosome has relations: cellcomp_protein with MACROH2A2, cellcomp_protein with MACROH2A2, cellcomp_protein with MACROH2A1, cellcomp_protein with MACROH2A1, cellcomp_protein with PRM2, cellcomp_protein with PRM2. Definitions: DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Nucleosomes defined as following: The repeating structural units of chromatin, each consisting of approximately 200 base pairs of DNA wound around a protein core. This core is composed of the histones H2A, H2B, H3, and H4.. nucleosome assembly defined as following: The aggregation, arrangement and bonding together of a nucleosome, the beadlike structural units of eukaryotic chromatin composed of histones and DNA. [GOC:mah]. DNA Helicases defined as following: Proteins that catalyze the unwinding of duplex DNA during replication by binding cooperatively to single-stranded regions of DNA or to short regions of duplex DNA that are undergoing transient opening. In addition, DNA helicases are DNA-dependent ATPases that harness the free energy of ATP hydrolysis to translocate DNA strands.. complex (molecular entity) defined as following: A molecular entity formed by loose association involving two or more component molecular entities. The bonding between the components is normally weaker than in a covalent bond.. histones defined as following: Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated Histone antigen I, Histone antigen II, etc.) is based on the relative amounts of arginine and lysine in each..", "label": "no"} {"original_question": "Is Pfh1 a component of the replisome?", "id": "converted_2197", "sentence1": "Is Pfh1 a component of the replisome?", "sentence2": "Pfh1 Is an Accessory Replicative Helicase that Interacts with the replisome to Facilitate Fork Progression and Preserve Genome Integrity, Although the Schizosaccharomyces pombe 5'-to-3' DNA Helicases Pfh1 is known to promote fork progression, its genomic targets, dynamics, and mechanisms of action are largely unknown. Here we address these questions by integrating Genome - anatomical entity-wide identification of Pfh1 binding sites, comprehensive analysis of the effects of Pfh1 depletion on replication and DNA damage, and proteomic analysis of Pfh1 interaction partners by immunoaffinity purification mass spectrometry., DNA replication through hard-to-replicate sites, including both highly transcribed RNA Pol II and Pol III Genes, requires the S. pombe Pfh1 helicase., Here, we show that Pfh1 is required for efficient fork movement in the DNA, Ribosomal, the mating type locus, triplet codon-amino acid adaptor activity, 5S Ribosomal RNA Genes, and Genes that are highly transcribed by RNA Polymerase II. , Thus, Pfh1 promotes DNA replication and separation of converged replication forks and suppresses DNA damage at hard-to-replicate sites., Cells depleted of Pfh1 were inviable if they also lacked the human TIMELESS homolog SWI1, a replisome component that stabilizes stalled forks., Pfh1 Is an Accessory Replicative Helicase that Interacts with the replisome to Facilitate Fork Progression and Preserve Genome Integrity., Thus, we conclude that Pfh1 is an accessory DNA Helicases that interacts with the replisome and promotes replication and suppresses DNA damage at hard-to-replicate sites., Consistent with this interpretation, Pfh1 co-purified with many key replisome components, including the hexameric MCM helicase, replicative DNA polymerases, Retinitis punctata albescens (disorder), and the processivity clamp Proliferating Cell Nuclear Antigen in an S phase dependent manner., Although Pfh1 affected replication and suppressed DNA damage at discrete sites throughout the Genome - anatomical entity, Pfh1 and the replicative DNA polymerase bound to similar extents to both Pfh1-dependent and independent sites, suggesting that Pfh1 is proximal to the replication machinery during S phase., Cells depleted of Pfh1 were inviable if they also lacked the human TIMELESS homolog SWI1, a replisome component that stabilizes stalled forks, Here, we show that Pfh1 is required for efficient fork movement in the DNA, Ribosomal, the mating type locus, triplet codon-amino acid adaptor activity, 5S Ribosomal RNA Genes, and Genes that are highly transcribed by RNA Polymerase II, Thus, Pfh1 promotes DNA replication and separation of converged replication forks and suppresses DNA damage at hard-to-replicate sites, Cells depleted of Pfh1 were inviable if they also lacked the human TIMELESS homolog SWI1, a replisome component that stabilizes stalled forks., Thus, we conclude that Pfh1 is an accessory DNA Helicases that interacts with the replisome and promotes replication and suppresses DNA damage at hard-to-replicate sites., Consistent with this interpretation, Pfh1 co-purified with many key replisome components, including the hexameric MCM helicase, replicative DNA polymerases, Retinitis punctata albescens (disorder), and the processivity clamp Proliferating Cell Nuclear Antigen in an S phase dependent manner., Pfh1 Is an Accessory Replicative Helicase that Interacts with the replisome to Facilitate Fork Progression and Preserve Genome Integrity.[SEP]Relations: replisome has relations: cellcomp_protein with Proliferating Cell Nuclear Antigen, cellcomp_protein with Proliferating Cell Nuclear Antigen, cellcomp_protein with DONSON, cellcomp_protein with DONSON. RNA Polymerase II transcribes snRNA Genes has relations: pathway_protein with GTF2E1, pathway_protein with GTF2E1, pathway_protein with SP1, pathway_protein with SP1, pathway_protein with GTF2F1, pathway_protein with GTF2F1. Definitions: replisome defined as following: A multi-component enzymatic machine at the replication fork which mediates DNA replication. Includes DNA primase, one or more DNA polymerases, DNA helicases, and other proteins. [GOC:mah, GOC:vw]. RNA Polymerase II defined as following: A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6.. Genome - anatomical entity defined as following: Anatomical set of Genes in all the chromosomes.. Proliferating Cell Nuclear Antigen defined as following: Nuclear antigen with a role in DNA synthesis, DNA repair, and cell cycle progression. Proliferating Cell Nuclear Antigen is required for the coordinated synthesis of both leading and lagging strands at the replication fork during DNA replication. Proliferating Cell Nuclear Antigen expression correlates with the proliferation activity of several malignant and non-malignant cell types.. DNA, Ribosomal defined as following: DNA sequences encoding RIBOSOMAL RNA and the segments of DNA separating the individual Ribosomal RNA Genes, referred to as RIBOSOMAL SPACER DNA.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. SWI1 defined as following: A component of the SWI/SNF global transcription activator complex, SWI1 acts in complex with Snf2p, Snf5p, Snf6p, and Swi3p to assist gene-specific activators through nucleosome/chromatin remodeling. SWI1 is involved in the regulation of many Genes, including ADH1, ADH2, GAL1, HO, INO1 and SUC2. The SWI/SNF complex is required for induced expression of many Genes and alters chromatin structure to facilitate binding of gene-specific dedicated transcription factors. A zinc finger non-specific RNA Polymerase II transcription factor, SWI1 contains an ARID domain. (from SWISS-PROT P09547, SGD S0005937, and NCI). Retinitis punctata albescens (disorder) defined as following: A progressive form of familial flecked retinopathy characterized by white punctata throughout the fundus (but sparing the macula in the early stages). Patients present with nightblindness in childhood and may also experience a loss of visual acuity. Significant loss of vision is reported in the 5th and 6th decades of life.. DNA Helicases defined as following: Proteins that catalyze the unwinding of duplex DNA during replication by binding cooperatively to single-stranded regions of DNA or to short regions of duplex DNA that are undergoing transient opening. In addition, DNA helicases are DNA-dependent ATPases that harness the free energy of ATP hydrolysis to translocate DNA strands.. Ribosomal RNA Genes defined as following: Genes, found in both prokaryotes and eukaryotes, which are transcribed to produce the RNA which is incorporated into RIBOSOMES. Prokaryotic rRNA Genes are usually found in OPERONS dispersed throughout the GENOME, whereas eukaryotic rRNA Genes are clustered, multicistronic transcriptional units.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. triplet codon-amino acid adaptor activity defined as following: The codon binding activity of a triplet codon-amino acid adaptor activity that positions an activated amino acid, mediating its insertion at the correct point in the sequence of a nascent polypeptide chain during protein synthesis. [GOC:hjd, GOC:mtg_MIT_16mar07, ISBN:0198506732].", "label": "no"} {"original_question": "Is there an association between TERT promoter mutation and survival of glioma patients?", "id": "converted_516", "sentence1": "Is there an association between TERT wt Allele promoter Mutation Abnormality and survival of glioma patients?", "sentence2": "Gene Mutation lead to TERT wt Allele wt Allele upregulation and are associated with aggressive clinical behavior in Glioblastoma., Kaplan-Meier's survival analysis showed that TERT wt Allele wt Allele promoter Mutation Abnormality (P=0.037), Isocitrate Dehydrogenase (NAD+) (Infective dermatitis co-occurrent and due to human T-cell lymphotropic virus 1 infection) Mutation Abnormality (P<0.001), and 1p/19q codeletion (P<0.001) were associated with favorable overall survival (OS). In the subset of 116 Infective dermatitis co-occurrent and due to human T-cell lymphotropic virus 1 infection-mutated lower-grade Glioma lacking 1p/19q codeletion, 19 TERT wt Allele wt Allele promoter-mutated Neoplasms exhibited longer progression-free survival (PFS) (P=0.027) and OS (P=0.004). Consistent with this observation, in the subset of 97 Infective dermatitis co-occurrent and due to human T-cell lymphotropic virus 1 infection-mutated astrocytomas, 14 TERT wt Allele wt Allele promoter-mutated Neoplasms showed longer PFS (P=0.001) and OS (P=0.001). In contrast, among the subset of 74 Infective dermatitis co-occurrent and due to human T-cell lymphotropic virus 1 infection wild-type lower-grade Glioma with intact 1p/19q, TERT wt Allele wt Allele promoter Mutation Abnormality was associated with shorter PFS (P=0.001) and OS (P=0.001). Similarly, in the subset of 65 Infective dermatitis co-occurrent and due to human T-cell lymphotropic virus 1 infection wild-type astrocytomas, 16 TERT wt Allele wt Allele promoter-mutated Neoplasms exhibited unfavorable PFS (P=0.007) and OS (P=0.008). Our results indicate that when combined with Infective dermatitis co-occurrent and due to human T-cell lymphotropic virus 1 infection status, TERT wt Allele wt Allele promoter Mutation Abnormality contributes to prognostic subgroups of lower-grade astrocytic Neoplasms or 1p/19q intact lower-grade Glioma and this may further refine future molecular classification of lower-grade Glioma., RESULTS: TERTp-mut identified in 60.8% of Glioma (491 out of 807) was globally associated with poorer outcome (Hazard ratio (HR)=1.50). , TERT wt Allele wt Allele promoter mutations lead to high transcriptional activity under Hypoxia, CTCAE and temozolomide treatment and predict poor prognosis in Glioma., Patients with TERT wt Allele wt Allele promoter mutations had lower survival rates, even after adjusting for other known or potential risk factors, and the incidence of Mutation Abnormality was correlated with patient age., TERT wt Allele wt Allele promoter mutations maintained its ability of inducing high transcriptional activity even under hypoxic and temozolomide treatment conditions, and the presence of mutations was associated with poor prognosis in glioma patients. , Patients whose Grade III-IV Glioma exhibit TERT wt Allele wt Allele promoter mutations alone predominately have primary GBMs associated with poor median OS (11.5 months). Patients whose Grade III-IV Glioma exhibit IDH1/2 mutations alone predominately have astrocytic morphologies and exhibit a median OS of 57 months while patients whose Neoplasms exhibit both TERT wt Allele wt Allele promoter and IDH1/2 mutations predominately exhibit oligodendroglial morphologies and exhibit median OS of 125 months., Patients with TERT wt Allele wt Allele promoter mutations had lower survival rates, even after adjusting for other known or potential risk factors, and the incidence of Mutation Abnormality was correlated with patient age.CONCLUSION: TERT wt Allele wt Allele promoter mutations were specific to Glioma. , We defined, based on TERTp-mut and Infective dermatitis co-occurrent and due to human T-cell lymphotropic virus 1 infection Mutation Abnormality status, four prognostic groups: (1) TERTp-mut and Infective dermatitis co-occurrent and due to human T-cell lymphotropic virus 1 infection-mut associated with 1p19q codeletion, overall survival (OS)>17 years; (2) TERTp-wt and Infective dermatitis co-occurrent and due to human T-cell lymphotropic virus 1 infection-mut, associated with TP53 wt Allele wt Allele Mutation Abnormality, OS=97.5 months; (3) TERTp-wt and Infective dermatitis co-occurrent and due to human T-cell lymphotropic virus 1 infection-wt, with no specific association, OS=31.6 months; (4) TERTp-mut and Infective dermatitis co-occurrent and due to human T-cell lymphotropic virus 1 infection-wt, associated with EGFR amplification, OS=15.4 months. , Gene Mutation lead to TERT wt Allele wt Allele upregulation and are associated with aggressive clinical behavior in Glioblastoma. , In the subset of 116 Infective dermatitis co-occurrent and due to human T-cell lymphotropic virus 1 infection-mutated lower-grade Glioma lacking 1p/19q codeletion, 19 TERT wt Allele wt Allele promoter-mutated Neoplasms exhibited longer progression-free survival (PFS) (P=0.027) and OS (P=0.004). , The mean age at diagnosis was lowest (37 years) among patients who had Glioma with only Infective dermatitis co-occurrent and due to human T-cell lymphotropic virus 1 infection mutations and was highest (59 years) among patients who had Glioma with only TERT wt Allele wt Allele mutations. The molecular groups were independently associated with overall survival among patients with grade II or III Glioma but not among patients with grade IV Glioma., Gene Mutation were detected in Glioma, but not in Meningioma, Pituitary Adenoma, cavernomas, intracranial metastases, normal brain tissue surgical material, or peripheral blood of glioma patients. Patients with TERT wt Allele wt Allele promoter mutations had lower survival rates, even after adjusting for other known or potential risk factors, and the incidence of Mutation Abnormality was correlated with patient age.[SEP]Relations: Glioma has relations: disease_phenotype_positive with glioma susceptibility, disease_phenotype_positive with glioma susceptibility, disease_phenotype_positive with glioblastoma (disease), disease_phenotype_positive with glioblastoma (disease), disease_phenotype_positive with retinoblastoma, disease_phenotype_positive with retinoblastoma, drug_effect with Aminolevulinic acid, drug_effect with Aminolevulinic acid, disease_phenotype_positive with Turcot syndrome with polyposis, disease_phenotype_positive with Turcot syndrome with polyposis. Definitions: Isocitrate Dehydrogenase (NAD+) defined as following: An enzyme of the oxidoreductase class that catalyzes the conversion of isocitrate and NAD+ to yield 2-ketoglutarate, carbon dioxide, and NADH. It occurs in cell mitochondria. The enzyme requires Mg2+, Mn2+; it is activated by ADP, citrate, and Ca2+, and inhibited by NADH, NADPH, and ATP. The reaction is the key rate-limiting step of the citric acid (tricarboxylic) cycle. (From Dorland, 27th ed) (The NADP+ enzyme is EC 1.1.1.42.) EC 1.1.1.41.. Meningioma defined as following: A relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular Neoplasms which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7). TP53 wt Allele defined as following: Human TP53 wt Allele wild-type allele is located in the vicinity of 17p13.1 and is approximately 19 kb in length. This allele, which encodes cellular tumor antigen p53 protein, plays a role in cell cycle regulation during the G0/G1transition. Alterations of the TP53 wt Allele gene occur as both somatic and germline mutations in human malignancies in select cancer-prone families with Li-Fraumeni syndrome.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. TERT wt Allele defined as following: Human TERT wt Allele wild-type allele is located in the vicinity of 5p15.33 and is approximately 42 kb in length. This allele, which encodes telomerase reverse transcriptase protein, is involved in the replication of telomeres. Aberrant expression of the allele at elevated levels may contribute to oncogenesis.. Pituitary Adenoma defined as following: A non-metastasizing tumor that arises from the adenohypophysial cells of the anterior lobe of the pituitary gland. The tumor can be hormonally functioning or not. The diagnosis can be based on imaging studies and/or radioimmunoassays. Due to its location in the sella turcica, expansion of the tumor mass can impinge on the optic chiasm or involve the temporal lobe, third ventricle and posterior fossa A frequently associated physical finding is bitemporal hemianopsia which may progress to further visual loss.. Glioma defined as following: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21). temozolomide defined as following: A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.. Glioblastoma defined as following: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Gene Mutation may be associated with genetic diversity or with pathologies including cancer.. Hypoxia, CTCAE defined as following: A disorder characterized by a decrease in the level of oxygen in the body.. Infective dermatitis co-occurrent and due to human T-cell lymphotropic virus 1 infection defined as following: Infective dermatitis associated with HTLV-1 is a rare and severe chronic disease characterized by recurrent chronic eczema (with erythematous, scaly and crusted lesions) mainly affecting seborrheic areas (e.g. scalp, forehead, eyelids, paranasal and periauricular skin, neck, axillae, and groin), a generalized fine papular rash, chronic nasal discharge with crusting of the anterior nares, and non-virulent <i>Staphylococcus aureus</i> or beta-hemolytic <i>Streptococcus</i> infections, thought to be a result of HTLV-1-induced immunosuppression. Lymphadenopathy, anemia, mild to moderate pruritus and increased incidence of other infections (e.g. crusted scabies) have also been reported in some patients. Patients may subsequently develop other HTLV-1 associated conditions such as adult T-cell leukemia/lymphoma and tropical spastic paraparesis (see these terms).. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA..", "label": "yes"} {"original_question": "Can beans induce apoptosis?", "id": "converted_1856", "sentence1": "Can beans induce apoptosis?", "sentence2": "A 60-kDa glucosamine binding lectin, white kidney bean lectin (WKBL), was purified from Phaseolus vulgaris cv. white kidney beans, by application of anion exchange chromatography on Q-Sepharose, affinity chromatography on Affi-gel blue gel, and FPLC-size exclusion on Superdex 75. The anti-proliferative activity of WKBL on HONE1 cells and Hep G2 Cells was stronger than the activity on MCF-7 Cells and WRL68 cells , Treatment of human stomach cancer KATO III cells with hot-water extracts from adzuki beans led to their growth inhibition as well as apoptosis induction., Stimulation of dendritic cell maturation and induction of apoptosis in leukemia cells by a heat-stable extract from azuki bean (Vigna angularis), a promising immunopotentiating Food allergenic extracts and dietary supplement for cancer prevention., Human gut flora-fermented nondigestible fraction from cooked bean ( Phaseolus vulgaris L.) modifies protein expression associated with apoptosis, cell cycle arrest, and proliferation in human adenocarcinoma colon Tumor cells, malignant., This paper reports the effect of fermentation products (FP) by Hepatocyte Growth Factor (FP-Hepatocyte Growth Factor) from NRG1 wt Allele of cooked beans on survival and protein expression associated with apoptosis, cell cycle arrest, and proliferation in human adenocarcinoma colon Tumor cells, malignant., erythroagglutinating phytohemagglutinin is a natural product extracted from red kidney beans, and it has been reported to induce cell apoptosis by blocking Epidermal Growth Factor Receptor in lung Tumor cells, malignant, A Glucosamine-Specific Lectin from Green Dragon No. 8 Beans (Phaseolus vulgaris) Induced Apoptosis on Nasopharyngeal carcinoma Cells, erythroagglutinating phytohemagglutinin is a natural product extracted from red kidney beans, and it has been reported to induce cell apoptosis by blocking Epidermal Growth Factor Receptor in lung Tumor cells, malignant., The anticancer activity of δ-tocotrienol, a bioactive Vitamin E Drug Class present in whole grain cereals, annatto beans and palm fruit, is strongly dependent on its effect on the induction of apoptosis. δ-Tocotrienol-induced apoptosis is associated with consistent induction in the expression of the proapoptotic protein Bcl-2-associated X protein (BAX protein, human)., NRG1 wt Allele of cooked common beans inhibited colon carcinogenesis at an early stage by inducing cell cycle arrest of colon cells and morphological changes linked to apoptosis, thus confirming previous results obtained with gene expression studies., Azuki extract also inhibited the growth of human leukemia U937 cells, leading to induction of apoptosis., Fermentation product of soybean, black bean, and Green bean antigen mixture induces apoptosis in a wide variety of Tumor cells, malignant., A non-digestible fraction of the common bean (Phaseolus vulgaris L.) induces cell cycle arrest and apoptosis during early carcinogenesis.[SEP]Relations: Protein S human has relations: drug_drug with Etoposide, drug_drug with Etoposide, drug_drug with Letaxaban, drug_drug with Letaxaban. Vitamin E has relations: drug_drug with Etoposide, drug_drug with Etoposide, drug_drug with Letaxaban, drug_drug with Letaxaban. epidermal growth factor receptor binding has relations: molfunc_protein with HIP1, molfunc_protein with HIP1. Definitions: MCF-7 Cells defined as following: An estrogen responsive cell line derived from a patient with metastatic human breast ADENOCARCINOMA (at the Michigan Cancer Foundation.). NRG1 wt Allele defined as following: Human NRG1 wild-type allele is located within 8p21-p12 and is approximately 1,124 kb in length. This allele, which encodes pro-neuregulin-1, membrane-bound isoform protein, is involved in the compositional regulation of neurotransmitter receptors in maturing synapses in the brain, proliferation and differentiation.. Hep G2 Cells defined as following: A human liver tumor cell line used to study a variety of liver-specific metabolic functions.. BAX protein, human defined as following: Apoptosis regulator BAX (192 aa, ~21 kDa) is encoded by the human BAX gene. This protein plays a role in both apoptosis and protein-protein interactions.. Hepatocyte Growth Factor defined as following: Multifunctional growth factor which regulates both cell growth and cell motility. It exerts a strong mitogenic effect on hepatocytes and primary epithelial cells. Its receptor is PROTO-ONCOGENE PROTEINS C-MET.. Tumor cells, malignant defined as following: Cells of, or derived from, a malignant tumor.. Nasopharyngeal carcinoma defined as following: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.. Phaseolus vulgaris defined as following: The plant species that provides kidney beans..", "label": "yes"} {"original_question": "Is Prochlorococcus the most abundant photosynthetic organism?", "id": "converted_2207", "sentence1": "Is Prochlorococcus the most abundant photosynthetic organism?", "sentence2": "The Marines cyanobacterium Prochlorococcus is the smallest and most abundant photosynthetic organism on Earth., The Marines cyanobacterium Prochlorococcus is the numerically dominant photosynthetic organism in the oligotrophic oceans, and a model system in Marines microbial ecology., The Marines cyanobacterium Prochlorococcus is the most abundant photosynthetic organism in oligotrophic regions of the oceans., The oceanic picoplankton Prochlorococcus - probably the most abundant photosynthetic organism on our planet - can grow at great depths where light intensity is very low.[SEP]", "label": "yes"} {"original_question": "Is Baloxavir effective for influenza?", "id": "converted_2755", "sentence1": "Is Baloxavir effective for influenza?", "sentence2": "Baloxavir marboxil (Xofluza™; baloxavir) is an oral cap-dependent endonuclease inhibitor that has been developed by Roche and Shionogi. The drug blocks influenza virus proliferation by inhibiting the initiation of mRNA synthesis. In February 2018, baloxavir received its first global approval in Japan for the treatment of Influenza virus vaccine or B Virus Infection. , This article summarized the milestones in the development of baloxavir leading to this first global approval for Influenza virus vaccine or B Virus Infection., Baloxavir acid (BXA), derived from the prodrug baloxavir marboxil (BXM), potently and selectively inhibits the cap-dependent endonuclease within the polymerase PA subunit of Influenza virus vaccine and Herpesvirus 1, Cercopithecine., Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil., Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents., BACKGROUND: Baloxavir marboxil is a selective inhibitor of influenza cap-dependent endonuclease. It has shown therapeutic activity in preclinical models of Influenza virus vaccine and B Virus Infection, including strains resistant to current antiviral agents., CONCLUSIONS: Single-dose baloxavir was without evident safety concerns, was superior to placebo in alleviating influenza symptoms, and was superior to both oseltamivir and placebo in reducing the viral load 1 day after initiation of the trial regimen in patients with uncomplicated influenza., A single oral dose of baloxavir is usually well tolerated; it hastens alleviation of influenza symptoms and shortens the duration of viral shedding., Japan was the first country to approve baloxavir marboxil as a treatment for influenza., This article summarized the milestones in the development of baloxavir leading to this first global approval for Influenza virus vaccine or B Virus Infection.
, In February 2018, baloxavir received its first global approval in Japan for the treatment of Influenza virus vaccine or B Virus Infection.[SEP]Relations: Rubella virus vaccine has relations: drug_drug with Baloxavir marboxil, drug_drug with Baloxavir marboxil, drug_drug with Saquinavir, drug_drug with Saquinavir. Oseltamivir has relations: drug_drug with Balsalazide, drug_drug with Balsalazide, drug_drug with Ribavirin, drug_drug with Ribavirin, drug_drug with Atazanavir, drug_drug with Atazanavir. Definitions: Influenza virus vaccine defined as following: A vaccine intended to prevent infections caused by influenza viruses.. oseltamivir defined as following: An acetamido cyclohexene that is a structural homolog of SIALIC ACID and inhibits NEURAMINIDASE.. Herpesvirus 1, Cercopithecine defined as following: A species of SIMPLEXVIRUS that causes vesicular lesions of the mouth in monkeys. When the virus is transmitted to man it causes an acute encephalitis or encephalomyelitis, which is nearly always fatal..", "label": "yes"} {"original_question": "Does PCSK9 (Proprotein convertase subtilisin/kexin type 9) binds with HDL-receptor (HDL-R)?", "id": "converted_2229", "sentence1": "Does PCSK9 protein, Homo sapiens (Proprotein Convertase 2 subtilisin/kexin type 9) binds with HDL-receptor (HDL-R)?", "sentence2": "Recently it was revealed that the secreted Proprotein Convertase Subtilisin Kexin 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) binds with Low-Density Lipoproteins-receptor (Low-Density Lipoproteins-R) causing its degradation in the Lysosomes with the result of Low-Density Lipoproteins-C accumulating in the blood., The major goal of this study is to identify peptide/s from the Catalytic Domain of hPCSK9 that can block the binding of hPCSK9 and Low-Density Lipoproteins-R and therefore can reduce Low-Density Lipoproteins-R degradation leading to the clearance of Low-Density Lipoproteins-C from the Specimen Source Codes - Plasma., In vitro administration of SRT3025 to cultured AML12 Hepatocyte attenuated Pcsk9 secretion and its binding to Ldlr, thereby reducing Pcsk9-mediated Ldlr degradation and increasing Ldlr expression and Low-Density Lipoproteins uptake., Proprotein Convertase 2 subtilisin/kexin type 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens), which involves in low-density lipoprotein cholesterol (Low-Density Lipoproteins-C) metabolism by interacting with the Low Density Lipoprotein Receptor, is considered as a potent therapeutic target for treating Hypercholesterolemia result. , Taken together, these results suggested that the IgG1-PA4 can be served as a potential candidate for the treatment of Hypercholesterolemia result by inhibiting PCSK9 protein, Homo sapiens protein, Homo sapiens-mediated degradation of Cell surface LDLRs., Proprotein Convertase 2 subtilisin/kexin type 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) binds to the LDLR protein, Homo sapiens, escorting it to its destruction in the Lysosomes and thereby preventing the recirculation of the LDLR protein, Homo sapiens to the hepatocyte Cell surface. , However, Hydroxymethylglutaryl-CoA Reductase Inhibitors have low efficiency because they also increase PCSK9 protein, Homo sapiens protein, Homo sapiens which targets LDLR for degradation., Inhibition of the enzyme PCSK9 protein, Homo sapiens protein, Homo sapiens (proprotein convertase subtilisin/kexin type 9), which is involved in depletion of the Low-Density Lipoproteins-receptor, is a new pharmacologic approach. , Proprotein Convertase 2 subtilisin kexin type 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) modulates Low-Density Lipoproteins-c through post-translational degradation of the LDLR., Mechanistically, hepatic S1P KD was shown to decrease the Abdomen>Liver and Specimen Source Codes - Plasma levels of the protein proprotein convertase subtilisin/kexin type 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens), which degrades LDLR protein. , We report here the development of sdAbs targeting Homo sapiens PCSK9 protein, Homo sapiens protein, Homo sapiens (proprotein convertase subtilisin/kexin type 9) as an alternative to anti-PCSK9 protein, Homo sapiens protein, Homo sapiens mAbs., PCSK9 protein, Homo sapiens protein, Homo sapiens proprotein convertase subtilisin/kexin type (PCSK9 protein, Homo sapiens protein, Homo sapiens) protein plays an important role in Low-Density Lipoproteins cholesterol (Low-Density Lipoproteins-C) metabolism, due to its role in the degradation of the Low Density Lipoprotein Receptor., Proprotein Convertase 2 subtilisin/kexin type 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) binds to Low-Density Lipoproteins receptors, leading to their degradation, Low density lipoprotein binds to proprotein convertase subtilisin/kexin type-9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) in Homo sapiens Specimen Source Codes - Plasma and inhibits PCSK9 protein, Homo sapiens protein, Homo sapiens-mediated low density lipoprotein receptor degradation, Proprotein Convertase 2 subtilisin/kexin type-9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) is a secreted protein that binds to the epidermal growth factor-like-A domain of the low density lipoprotein receptor (LDLR) and mediates LDLR degradation in Abdomen>Liver, Proprotein Convertase 2 subtilisin/kexin type 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) binds Low-Density Lipoproteins receptors, targeting them for degradation, Proprotein Convertase 2 subtilisin/kexin type 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens), which binds the LDLR protein, Homo sapiens and targets it for degradation, has emerged as an important regulator of serum cholesterol levels and cardiovascular disease risk, Secreted proprotein convertase subtilisin/kexin type 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) binds to the LDLR protein, Homo sapiens (LDLR) at the Cell surface and disrupts the normal recycling of the LDLR, Proprotein Convertase 2, subtilisin/kexin type 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens), a key regulator of Specimen Source Codes - Plasma Low-Density Lipoproteins-cholesterol (Low-Density Lipoproteins-c) and cardiovascular risk, is produced in Abdomen>Liver and secreted into Specimen Source Codes - Plasma where it binds hepatic Low-Density Lipoproteins receptors (LDLR), leading to their degradation, Proprotein Convertase 2 subtilisin/kexin type 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) promotes the degradation of the hepatic LDLR protein, Homo sapiens (Low-Density Lipoproteins-R) and is therefore a prominent therapeutic target for reducing Low-Density Lipoproteins-cholesterol, In the present study we scanned the related Genes of a clinically diagnosed autosomal genetic Hypercholesterolemia result family for the possible Gene Mutation and established eukaryotic expression vector of Mutation Abnormality of proprotein convertase subtilisin/kexin type 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) Genes with Genes recombination technique to investigate the contributions of the variation on low density lipoprotein receptor (Low-Density Lipoproteins-R) metabolism and function alternation.Mutation detection was conducted for Low-Density Lipoproteins-R, apolipoprotein B(100) (apoB(100)) and PCSK9 protein, Homo sapiens protein, Homo sapiens Genes with nucleotide sequencing in a Chinese FH family, Proprotein Convertase 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) provides a key step in Low-Density Lipoproteins metabolism by stimulating Low Density Lipoprotein Receptor degradation., The proprotein convertase subtilisin-kexin type 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) pathway plays a key role in lipoprotein metabolism by promoting Low-Density Lipoproteins-receptor degradation., Proprotein Convertase 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) plays a key role in Low Density Lipoprotein Receptor processing., Proprotein Convertase 2 subtilisin/kexin type 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) promotes the degradation of the Low Density Lipoprotein Receptor (LDLr) in Hepatocyte, and its expression in Mus sp. Abdomen>Liver has been shown to decrease with fenofibrate treatment.We developed a sandwich ELISA using recombinant Homo sapiens PCSK9 protein, Homo sapiens protein, Homo sapiens protein and 2 affinity-purified polyclonal antibodies directed against Homo sapiens PCSK9 protein, Homo sapiens protein, Homo sapiens., Proprotein Convertase 2 subtilisin kexin type 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) enhances the degradation of the LDLR and modulates Abdomen>Liver CD81 antigen antigen levels., Low-density lipoprotein (Low-Density Lipoproteins) metabolism is governed by proprotein convertase subtilisin-kexin type 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens), which down-regulates Low Density Lipoprotein Receptor expression, resulting in higher Low-Density Lipoproteins cholesterol (Low-Density Lipoproteins-C)., Proprotein Convertase 2 subtilisin kexin type 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) is gaining attention as a key regulator of serum Low-Density Lipoproteins-cholesterol (LDLC)., The proprotein convertase subtilisin/kexin type 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) Genes regulates cholesterol homoeostasis by accelerating LDLR protein, Homo sapiens (LDLR) degradation resulting in the decreased catabolism of low-density lipoprotein (Low-Density Lipoproteins) leading to Hypercholesterolemia., Low density lipoprotein binds to proprotein convertase subtilisin/kexin type-9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) in Homo sapiens Specimen Source Codes - Plasma and inhibits PCSK9 protein, Homo sapiens protein, Homo sapiens-mediated low density lipoprotein receptor degradation., Proprotein Convertase 2 subtilisin/kexin type-9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) is a secreted protein that binds to the epidermal growth factor-like-A domain of the low density lipoprotein receptor (LDLR) and mediates LDLR degradation in Abdomen>Liver., Proprotein Convertase 2 subtilisin/kexin type 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) is a regulator of Low-Density Lipoproteins-cholesterol receptor homeostasis and emerges as a therapeutic target in the prevention of cardiovascular (CV) disease., The present study was conducted to investigate the role of Specimen Source Codes - Plasma proprotein convertase subtilisin kexin type 9 (PCSK9 protein, Homo sapiens protein, Homo sapiens) levels, a regulator of Low-Density Lipoproteins-receptor expression, in the occurrence of diabetic dyslipidemia.[SEP]Relations: Cell surface has relations: cellcomp_protein with PCSK9 protein, Homo sapiens, cellcomp_protein with PCSK9 protein, Homo sapiens, cellcomp_protein with PCSK6, cellcomp_protein with PCSK6, cellcomp_protein with KLRC4-KLRK1, cellcomp_protein with KLRC4-KLRK1. Lysosomes has relations: cellcomp_protein with PCSK9 protein, Homo sapiens, cellcomp_protein with PCSK9 protein, Homo sapiens. low-density lipoprotein particle has relations: cellcomp_protein with LDLR, cellcomp_protein with LDLR. Definitions: PCSK9 protein, Homo sapiens Genes defined as following: This Genes is involved in both cholesterol metabolism and protein degradation.. Low Density Lipoprotein Receptor defined as following: Receptors on the Specimen Source Codes - Plasma membrane of nonhepatic cells that specifically bind Low-Density Lipoproteins. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to Low-Density Lipoproteins; 2, there is reduced binding of Low-Density Lipoproteins; and 3, there is normal binding but no internalization of Low-Density Lipoproteins. In consequence, entry of cholesterol esters into the \"U\" lymphocyte is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking.. LDLR protein, Homo sapiens defined as following: Low-density lipoprotein receptor (860 aa, ~95 kDa) is encoded by the Homo sapiens LDLR Genes. This protein is involved in the endocytosis of cholesterol.. Cell surface defined as following: The external part of the \"U\" lymphocyte wall and/or Specimen Source Codes - Plasma membrane. [GOC:jl, GOC:mtg_sensu, GOC:sm]. cholesterol defined as following: The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.. Lysosomes defined as following: A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the Lysosomes acts as a barrier between the enzymes enclosed in the Lysosomes and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed).. Catalytic Domain defined as following: The region of an enzyme that interacts with its substrate to cause the enzymatic reaction.. Low-Density Lipoproteins defined as following: A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main Low-Density Lipoproteins function is to transport cholesterol and cholesterol esters to extrahepatic tissues.. Low-Density Lipoproteins cholesterol defined as following: Cholesterol which is contained in or bound to low density lipoproteins (Low-Density Lipoproteins), including CHOLESTEROL ESTERS and free cholesterol.. Hepatocyte defined as following: The main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules.. Hypercholesterolemia defined as following: A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.. PCSK9 protein, Homo sapiens defined as following: Proprotein Convertase 2 subtilisin/kexin type 9 (692 aa, ~74 kDa) is encoded by the Homo sapiens PCSK9 protein, Homo sapiens Genes. This protein is involved in the degradation of low density lipoprotein receptor family proteins.. Hydroxymethylglutaryl-CoA Reductase Inhibitors defined as following: Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis.. Proprotein Convertase 9 defined as following: A proprotein convertase that is essential for CHOLESTEROL homeostasis. It binds to and is required for the lysosomal degradation of the Low-Density Lipoproteins RECEPTOR (LDLR); the VLDL receptor, and the APOLIPOPROTEIN E RECEPTOR. It also regulates neuronal APOPTOSIS.. CD81 antigen defined as following: A tetraspanin protein that is involved in a variety of cellular functions including BASEMENT MEMBRANE assembly, and in the formation of a molecular complexes on the surface of LYMPHOCYTES.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA.. Proprotein Convertase 2 defined as following: A serine endopeptidase that has specificity for cleavage at ARGININE. It cleaves a variety of prohormones including PRO-OPIOMELANOCORTIN, proluteinizing-hormone-releasing hormone, proenkephalins, prodynorphin, and PROINSULIN.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Homo sapiens defined as following: Members of the species Homo sapiens.. Hypercholesterolemia result defined as following: A laboratory test result indicating an increased amount of cholesterol in the blood.. Proprotein Convertase 2 subtilisin/kexin type 9 defined as following: This Genes is involved in both cholesterol metabolism and protein degradation..", "label": "no"} {"original_question": "Does Uc.160 promote cancer?", "id": "converted_2522", "sentence1": "Does Uc.160 promote cancer?", "sentence2": "We previously discovered the downregulation of T-UCR expression in Malignant neoplasm of Abdomen>Stomach (GC), indicating that T-UCRs could play an important role in GC biology. Uc.160+, a T-UCR reported to be downregulated in human cancer, has not been examined in GC.METHODS: We analyzed the expression pattern of Uc.160+ in nonneoplastic and tumor Body tissue of the Abdomen>Stomach by using uantitative reverse transcription polymerase chain reaction (qRT-PCR) and in situ hybridization (ISH), specifically focusing on the mechanism of transcriptional regulation and target Genes that are regulated by T-UCRs. We also attempted to determine the effect of Uc.160+ expression on biological features of GC Cultured Cell Line by Western blotting.RESULTS: On the basis of the qRT-PCR and ISH results, Uc.160+ expression in Adenoma and GC Body tissue was clearly downregulated compared with that in nonneoplastic mucosa Body tissue of the Abdomen>Stomach. Cancer-specific DNA methylation in the Promoter Regions, Genetic of Uc.160 was observed by bisulfite genomic DNA sequencing analysis. The effect of DNA methylation on Uc.160+ expression was further confirmed by reporter gene assay. We also revealed that Uc.160+ inhibited the phosphorylation of Proto-Oncogene Proteins c-akt by regulating phosphatase and tensin homolog (PTEN protein, human protein, human) expression.CONCLUSIONS: These results indicate that Uc.160+ could possibly have a tumor suppressive role in GC., Uc.160+, a T-UCR reported to be downregulated in human cancer, has not been examined in GC.
METHODS: We analyzed the expression pattern of Uc.160+ in nonneoplastic and tumor Body tissue of the Abdomen>Stomach by using uantitative reverse transcription polymerase chain reaction (qRT-PCR) and in situ hybridization (ISH), specifically focusing on the mechanism of transcriptional regulation and target Genes that are regulated by T-UCRs., We also revealed that Uc.160+ inhibited the phosphorylation of Proto-Oncogene Proteins c-akt by regulating phosphatase and tensin homolog (PTEN protein, human protein, human) expression.
CONCLUSIONS: These results indicate that Uc.160+ could possibly have a tumor suppressive role in GC.
, We also attempted to determine the effect of Uc.160+ expression on biological features of GC Cultured Cell Line by Western blotting.
RESULTS: On the basis of the qRT-PCR and ISH results, Uc.160+ expression in Adenoma and GC Body tissue was clearly downregulated compared with that in nonneoplastic mucosa Body tissue of the Abdomen>Stomach., CONCLUSIONS These results indicate that Uc.160+ could possibly have a tumor suppressive role in GC., Uc.160+, a T-UCR reported to be downregulated in human cancer, has not been examined in GC., Among the T-UCRs that were reactivated upon drug treatment, Uc.160+, Uc283+A and Uc.346+ were found to undergo specific CpG island hypermethylation-associated silencing in Tumor cells, malignant compared with normal Body tissue., Uc.160+, a T-UCR reported to be downregulated in human cancer, has not been examined in GC., These results indicate that Uc.160+ could possibly have a tumor suppressive role in GC..[SEP]Relations: malignant giant cell tumor has relations: disease_disease with cancer, disease_disease with cancer. tumor of adipose tissue has relations: disease_disease with lipomatous cancer, disease_disease with lipomatous cancer, disease_disease with benign lipomatous neoplasm, disease_disease with benign lipomatous neoplasm, disease_disease with mesenchymal cell neoplasm, disease_disease with mesenchymal cell neoplasm. Adenoma has relations: disease_protein with SUZ12, disease_protein with SUZ12. Definitions: Tumor cells, malignant defined as following: Cells of, or derived from, a malignant tumor.. Proto-Oncogene Proteins c-akt defined as following: Expressed in diverse Body tissue, Protein Kinase B (AKT/RAC Family) is a group (Alpha, Beta and Gamma) of cytoplasmic serine/threonine enzymes that covalently transfer the terminal, gamma phosphate group from ATP to a variety of substrate proteins and regulate cell signaling responses to insulin, PDGF, and IGF1 (through PI3K) involved in cell survival, cell proliferation, differentiation, apoptosis, glycogen synthesis, and glucose uptake.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. PTEN protein, human defined as following: Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN protein, human (403 aa, ~47 kDa) is encoded by the human PTEN protein, human gene. This protein plays a role in signaling and as both a dual-specificity phosphoprotein phosphatase and a lipid phosphatase.. Malignant neoplasm of Abdomen>Stomach defined as following: A primary or metastatic malignant neoplasm involving the Abdomen>Stomach.. Cultured Cell Line defined as following: Established cell cultures that have the potential to propagate indefinitely.. Promoter Regions, Genetic defined as following: DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.. Adenoma defined as following: A benign epithelial tumor with a glandular organization.. tumor Body tissue defined as following: A tumor sample, or entire tumor that is removed for microscopic examination.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. cancer defined as following: A malignant tumor at the original site of growth..", "label": "no"} {"original_question": "Does prudent diet reduce cardiovascular risk?", "id": "converted_1395", "sentence1": "Does prudent diet reduce Cardiovascular system risk?", "sentence2": "Using this approach, large prospective studies have reported reductions in CVD risk ranging from 10 to 60% in groups whose diets can be variously classified as ‘Healthy’, ‘Prudent’, Mediterranean’ or ‘DASH compliant’., Our findings suggest that a heart healthy dietary pattern is associated with moderately reduced risk of MI, but not related to risk of vinyltriethoxysilane., The systematically reviewed studies reveal that a high adherence to a Mediterranean type of diet or \"prudent diet\" is associated with reduced risk of CVD and some types of Primary malignant neoplasm, even in the elderly., In a large healthy Italian population, non-predefined dietary patterns including Food considered to be rather unhealthy, were associated with higher levels of Cardiovascular system risk factors, C-reactive protein and individual global CVD risk, whereas a \"prudent-healthy\" pattern was associated with lower levels., We observed an inverse association between the prudent pattern and Anterior myocardial infarction, with higher levels being protective., After multivariable adjustment, the prudent diet was associated with a 28% lower risk of Cardiovascular system mortality (95% confidence interval [CI], 13 to 40) and a 17% lower risk of all-cause mortality (95% CI, 10 to 24) when the highest quintile was compared with the lowest quintile. , Greater adherence to the prudent pattern may reduce the risk of Cardiovascular system and total mortality, whereas greater adherence to the Western pattern may increase the risk among initially healthy women., Composite diets (such as DASH diets, Mediterranean diet, 'prudent' diet) have been demonstrated to reduce the risk of Hypertensive disease and altretamine/cisplatin/cyclophosphamide protocol.[SEP]Relations: Cardiovascular system system has relations: anatomy_anatomy with embryonic Cardiovascular system system, anatomy_anatomy with embryonic Cardiovascular system system, anatomy_anatomy with anatomical system, anatomy_anatomy with anatomical system. hypertensive heart disease has relations: disease_disease with heart disease, disease_disease with heart disease. myocardial infarction has relations: disease_protein with PRKCE, disease_protein with PRKCE, contraindication with Diethylstilbestrol, contraindication with Diethylstilbestrol. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Anterior myocardial infarction defined as following: MYOCARDIAL INFARCTION in which the anterior wall of the heart is involved. Anterior wall myocardial infarction is often caused by occlusion of the left anterior descending coronary artery. It can be categorized as anteroseptal or anterolateral wall myocardial infarction.. C-reactive protein defined as following: A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-C-reactive protein).. Cardiovascular system defined as following: The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body.. Hypertensive disease defined as following: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), Hypertensive disease is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.. Food defined as following: Substances taken in by the body to provide nourishment..", "label": "yes"} {"original_question": "Do conserved noncoding elements co-occur with matrix-attachment regions?", "id": "converted_1131", "sentence1": "Do conserved noncoding elements co-occur with matrix-attachment regions?", "sentence2": "We hypothesized that some of these regions might be matrix-scaffold attachment regions, Planet Mars (or S/Planet Mars). Planet Mars comprise one of the few classes of eukaryotic noncoding DNA with an experimentally characterized function, being involved in the attachment of chromatin location location to the Nuclear Matrix, chromatin location location remodeling and transcription regulation. To test our hypothesis, we analyzed the co-occurrence of predicted Planet Mars with highly conserved noncoding DNA regions in Homo sapiens-Mus sp. genomic alignments. We found that 11% of the conserved noncoding DNA consists of predicted Planet Mars. Conversely, more than half of the predicted Planet Mars co-occur with one or more independently identified conserved sequence blocks. An excess of conserved predicted Planet Mars is seen in Intergenic Region preceding 5' ends of Genes, suggesting that these Planet Mars are primarily involved in transcriptional control, A significant fraction of conserved noncoding DNA in Homo sapiens and Mus sp. consists of predicted matrix attachment regions., To test our hypothesis, we analyzed the co-occurrence of predicted Planet Mars with highly conserved noncoding DNA regions in Homo sapiens-Mus sp. genomic alignments., To test our hypothesis, we analyzed the co-occurrence of predicted Planet Mars with highly conserved noncoding DNA regions in Homo sapiens-Mus sp. genomic alignments[SEP]Relations: Nuclear Matrix has relations: cellcomp_protein with NONO, cellcomp_protein with NONO, cellcomp_protein with RNASEL, cellcomp_protein with RNASEL, cellcomp_protein with PPIG, cellcomp_protein with PPIG, cellcomp_protein with DCAF7, cellcomp_protein with DCAF7, cellcomp_protein with RGS12, cellcomp_protein with RGS12. Definitions: Planet Mars defined as following: The fourth planet in order from the sun. Its two natural satellites are Deimos and Phobos. It is one of the four inner or terrestrial planets of the solar system.. Homo sapiens defined as following: Members of the species Homo sapiens.. Nuclear Matrix defined as following: The residual framework structure of the CELL NUCLEUS that maintains many of the overall architectural features of the cell nucleus including the nuclear lamina with NUCLEAR PORE complex structures, residual CELL NUCLEOLI and an extensive fibrogranular structure in the nuclear interior. (Advan. Enzyme Regul. 2002; 42:39-52). chromatin location defined as following: The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130]. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Does promoter shape vary across populations?", "id": "converted_3402", "sentence1": "Does Promoter shape vary across populations?", "sentence2": "Promoter shape varies across populations and affects Promoter evolution and expression noise., Animal promoters initiate transcription either at precise positions (narrow promoters) or dispersed regions (broad promoters), a distinction referred to as Promoter shape. Although highly conserved, the functional properties of promoters with different shapes and the genetic basis of their evolution remain unclear. Here we used natural genetic variation across a panel of 81 Drosophila lines to measure changes in Transcription Initiation Site (Toxic Shock Syndrome) usage, identifying thousands of genetic Variant affecting RNA Transcript levels (strength) or the distribution of TSSs within a Promoter (shape). Our results identify Promoter shape as a molecular trait that can evolve independently of Promoter strength. Broad promoters typically harbor shape-associated Variant, with signatures of adaptive selection. Single-cell measurements demonstrate that Variant modulating Promoter shape often increase expression noise, whereas heteroallelic interactions with other Promoter Variant alleviate these effects. These results uncover new functional properties of natural promoters and suggest the minimization of expression noise as an important factor in Promoter evolution., Promoter shape varies across populations and affects Promoter evolution and expression noise[SEP]Relations: Promoter clearance from RNA polymerase I Promoter has relations: bioprocess_bioprocess with Promoter clearance during DNA-templated transcription, bioprocess_bioprocess with Promoter clearance during DNA-templated transcription, bioprocess_bioprocess with Promoter clearance from RNA polymerase I Promoter for nuclear large rRNA RNA Transcript, bioprocess_bioprocess with Promoter clearance from RNA polymerase I Promoter for nuclear large rRNA RNA Transcript. HIV Transcription Initiation has relations: pathway_protein with POLR2G, pathway_protein with POLR2G, pathway_protein with POLR2J, pathway_protein with POLR2J, pathway_protein with CCNH, pathway_protein with CCNH. Definitions: Variant defined as following: An alteration or difference from a norm or standard.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. Toxic Shock Syndrome defined as following: A rare acute life-threatening systemic bacterial noncontagious illness caused by any of several related staphylococcal exotoxins. It is characterized by high fever, hypotension, rash, multi-organ dysfunction, and cutaneous desquamation during the early convalescent period. The toxins affect the host immune system, causing an exuberant and pathological host inflammatory response. Laboratory findings include leukocytosis, elevated prothrombin time, hypoalbuminemia, hypocalcemia, and pyuria.. Transcription Initiation Site defined as following: The first nucleotide of a transcribed DNA sequence where RNA polymerase (DNA-DIRECTED RNA POLYMERASE) begins synthesizing the RNA RNA Transcript.. RNA Transcript defined as following: The initial RNA molecule produced by transcription..", "label": "yes"} {"original_question": "Does cucumber lower blood sugar in diabetics?", "id": "converted_1658", "sentence1": "Does cucumber lower blood sugar in diabetics?", "sentence2": "The ethanolic Homeopathic Extract Dosage Form of Cucumber (Cucumber (Cucumis sativus) Ab) Ab Linn, Cucumis melo utilissimum Roxb, Cucumis melo Linn, Benincasa hispida Thunb Cogn and Tricosanthes anguina Nees, when administered in 250 mg/kg dose, orally to rats failed to lower blood sugar or to depress the peak value, after Glucose measurement load., Ethanolic Homeopathic Extract Dosage Form of Tricosanthes dioica Roxb plant caused a significant lowering of blood sugar in fasted rats and Depressed mood the peak value in Glucose measurement loaded single and longterm fed groups of rats. The ethanolic Homeopathic Extract Dosage Form of the aerial part of T. dioica also induced significant Cancer patients and suicide and Cancer patients and suicide and depression in the peak values in the Glucose measurement loaded models., The amount of Saccharum officinale, Saccharum officinale, sucrose, cane sugar, Homeopathic preparation, cane sugar, Homeopathic preparation in ordinary marinated foods, such as herring, cucumber, and common beet was negligible, Dietary Saponins of sea cucumber ameliorate BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, Fatty Liver, and Glucose measurement intolerance in high-fat diet-fed mice., In this study, we investigated the effects of Saponins of sea cucumber (SSC) on high-fat diet-induced BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, Therapeutic Insulin resistance, and fatty Abdomen>Liver in mice., CASP14 gene administrated with 0.1% SSC had significantly decreased serum Glucose measurement and Therapeutic Insulin levels, lower homeostatic model assessment for Therapeutic Insulin resistance index, and area under the blood Glucose measurement curve, suggesting that Therapeutic Insulin sensitivity is enhanced by dietary SSC., [Effects of sea cucumber Cerebrosides and its long-chain base on Lipids and Glucose measurement metabolism in obese mice]., OBJECTIVE: To investigate the effect of sea cucumber Cerebrosides(SCC) and its long-chain base(LCB) on Lipids and Glucose measurement metabolism in obese mice., CONCLUSIONS: Sea Cucumbers Cerebrosides and its long-chain base can improve the Glucose measurement and Lipids metabolism in obese mice., The hitherto unknown Glucose measurement regulating role of three vegetable peels from cucurbitaceae family was evaluated. In a preliminary study, effects of ethanolic extracts of Pumpkin (Pumpkin (Cucurbita pepo) Ab) Ab, Cucumber (Cucumber (Cucumis sativus) Ab) Ab and Praecitrullus fistulosus peels were studied at 250 and 500 mg kg(-1) d(-1) for 15 days in the alterations in serum Glucose measurement and in Hepatic Lipids peroxidation (LPO gene gene) in male mice., All the three Peeling of skin extracts nearly reversed most of these changes induced by alloxan suggesting their possible role in ameliorating Diabetes Mellitus and related changes in serum lipids., Antidiabetic activity of aqueous fruit Homeopathic Extract Dosage Form of Cucumis trigonus Roxb. in streptozotocin-induced-diabetic rats., Cucumis trigonus Roxb. (Cucurbitaceae) fruit is used in the Indian traditional medicine for the treatment of diabetes. Based on a number of reports on the blood Glucose measurement level reduction and the other complications of diabetes associated with some Cucurbitaceae plants, the Antidiabetics effect of Cucumis trigonus fruit was investigated., The Antidiabetics activity of aqueous Homeopathic Extract Dosage Form of Cucumis trigonus fruit was evaluated by using normal and streptozotocin-induced-diabetic rats., The aqueous fruit Homeopathic Extract Dosage Form of Cucumis trigonus has had beneficial effects in reducing the elevated blood Glucose measurement level and Lipids profile of STZ-induced-diabetic rats., Possible amelioration of atherogenic diet induced Dyslipidemias, Hypothyroidism and Glucose in blood specimen above reference range by the Peeling of skin extracts of Mangifera indica, Cucumis melo and Citrullus vulgaris fruits in rats., Hitherto unknown efficacy of the Peeling of skin extracts of Mangifera indica (MI), Cucumis melo (Caudomedial auditory cortex) and Citrullus vulgaris (CV) fruits in ameliorating the diet-induced alterations in Dyslipidemias, Thyroid dysfunction and Diabetes Mellitus have been investigated in rats., Rattus norvegicus, treated simultaneously with either of the Peeling of skin extracts reversed the CCT-diet induced increase in the levels of tissue LPO gene gene, serum lipids, Glucose measurement, creatine/creatine/creatinine kinase-MB and decrease in the levels of Thyroid Hormones and Therapeutic Insulin indicating their potential to ameliorate the diet induced alterations in serum lipids, thyroid dysfunctions and Glucose in blood specimen above reference range/Diabetes Mellitus., Role of Pectins from cucumber (Cucumber (Cucumber (Cucumis sativus) Ab) Ab) in modulation of Protein Kinase C activity and regulation of glycogen metabolism in rats., The regulatory role of Protein Kinase C (Paroxysmal kinesigenic choreoathetosis) in glycogen metabolism in Pectins fed rats was investigated. Administration of Pectins (5 g/kg body wt/day) from cucumber (Cucumis sativius L.) led to inhibitory effects on Paroxysmal kinesigenic choreoathetosis activity in the Abdomen>Liver of rats. In the Head>Brain and Abdomen>Pancreas, Paroxysmal kinesigenic choreoathetosis activity was significantly higher in Pectins-treated rats as compared to the control group. Level of blood Glucose measurement was significantly lowered and the level of glycogen in the Abdomen>Liver was significantly increased in Pectins-administered rats., Addition of fermented milk (yogurt) and pickled cucumber to a breakfast with a high-glycemic index bread significantly lowered postprandial glycemia and insulinemia compared with the reference meal. In contrast, addition of regular milk and fresh cucumber had no favorable effect on the metabolic responses., tolbutamide, Cucurbita ficifolia, Phaseolus vulgaris, Opuntia streptacantha, Spinacia oleracea, Cucumber (Cucumber (Cucumis sativus) Ab) Ab and Cumin (Cumin (Cuminum cyminum) Ab) Ab decrease significantly the area under the Glucose measurement tolerance curve and the hyperglycemic peak., Two unsaturated Fatty Acids with potent α-glucosidase inhibitory activity purified from the body wall of sea cucumber (Stichopus japonicus)., In this study, 2 Fatty Acids with strong α-glucosidase-inhibitory activity, 7(Z)-octadecenoic acid and 7(Z),10(Z)-octadecadienoic acid, were purified and identified from sea cucumber. Therefore, sea cucumber Fatty Acids can potentially be developed as a novel natural nutraceutical for the management of type-2 diabetes.[SEP]Relations: Glucose intolerance has relations: disease_phenotype_positive with Cushing disease due to pituitary adenoma, disease_phenotype_positive with Cushing disease due to pituitary adenoma, disease_phenotype_positive with Diabetes Mellitus (disease), disease_phenotype_positive with Diabetes Mellitus (disease), disease_phenotype_positive with BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 due to SIM1 deficiency, disease_phenotype_positive with BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 due to SIM1 deficiency. tolbutamide has relations: drug_drug with Invert sugar, drug_drug with Invert sugar, drug_effect with Hypoglycemia, drug_effect with Hypoglycemia. Definitions: Glucose measurement defined as following: The determination of the amount of Glucose measurement present in a sample.. Sea Cucumbers defined as following: A class of Echinodermata characterized by long, slender bodies.. Paroxysmal kinesigenic choreoathetosis defined as following: Paroxysmal kinesigenic dyskinesia (PKD) is a form of paroxysmal dyskinesia (see this term), characterized by recurrent brief involuntary hyperkinesias, such as choreoathetosis, ballism, athetosis or dystonia, triggered by sudden movements.. alloxan defined as following: Acidic compound formed by oxidation of URIC ACID. It is isolated as an efflorescent crystalline hydrate.. glycogen defined as following: large branched polysaccharide consisting of Glucose measurement residues; the major carbohydrate reserve of animals, stored primarily in Abdomen>Liver and muscle, synthesized and degraded for energy as demanded.. Fatty Liver defined as following: Lipid infiltration of the Hepatic parenchymal cells resulting in a yellow-colored Abdomen>Liver. The abnormal Lipids accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty Abdomen>Liver is caused by an imbalance in the metabolism of FATTY ACIDS.. Protein Kinase C defined as following: An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that Protein Kinase C is the receptor protein of tumor-promoting phorbol esters.. Spinacia oleracea defined as following: A widely cultivated plant, native to Asia, having succulent, edible leaves eaten as a vegetable. (From American Heritage Dictionary, 1982). Diabetes Mellitus defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.. Glucose measurement intolerance defined as following: A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.. Pectins defined as following: High molecular weight polysaccharides present in the cell walls of all plants. Pectins cement cell walls together. They are used as emulsifiers and stabilizers in the food industry. They have been tried for a variety of therapeutic uses including as antidiarrheals, where they are now generally considered ineffective, and in the treatment of hypercholesterolemia.. Cerebrosides defined as following: Neutral glycosphingolipids that contain a monosaccharide, normally Glucose measurement or galactose, in 1-ortho-beta-glycosidic linkage with the primary alcohol of an N-acyl sphingoid (ceramide). In plants the monosaccharide is normally Glucose measurement and the sphingoid usually phytosphingosine. In animals, the monosaccharide is usually galactose, though this may vary with the tissue and the sphingoid is usually sphingosine or dihydrosphingosine. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1st ed). Saponins defined as following: A type of glycoside widely distributed in plants. Each consists of a sapogenin as the aglycone moiety, and a sugar. The sapogenin may be a steroid or a triterpene and the sugar may be Glucose measurement, galactose, a pentose, or a methylpentose.. Fatty Acids defined as following: Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed). Therapeutic Insulin defined as following: A synthetic or animal-derived form of Therapeutic Insulin used in the treatment of Diabetes Mellitus. Therapeutic Therapeutic Insulin is formulated to be short-, intermediate- and long-acting in order to individualize an Therapeutic Insulin regimen according to individual differences in Glucose measurement and Therapeutic Insulin metabolism. Therapeutic Therapeutic Insulin may be derived from porcine, bovine or recombinant sources. Endogenous human Therapeutic Insulin, a pancreatic hormone composed of two polypeptide chains, is important for the normal metabolism of carbohydrates, proteins and fats and has anabolic effects on many types of tissues.. Peeling of skin defined as following: Shedding of the outer layer of skin or mucosal tissue.. Cucumis melo defined as following: A plant species of the family CUCURBITACEAE, order Violales, subclass Dilleniidae known for the melon fruits with reticulated (net) surface including cantaloupes, honeydew, casaba, and Persian melons.. Depressed mood defined as following: An emotional state characterized by feelings of sadness, emptiness, and/or tearfulness.. Rattus norvegicus defined as following: The common rat, Rattus norvegicus, often used as an experimental organism.. tolbutamide defined as following: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290). Cucurbitaceae defined as following: The gourd plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida. It is sometimes placed in its own order, Cucurbitales. 'Melon' generally refers to CUCUMIS; CITRULLUS; or MOMORDICA.. Lipids defined as following: A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and Fatty Acids. (Grant & Hackh's Chemical Dictionary, 5th ed). Antidiabetics defined as following: Any substance used to reduce Glucose in blood specimen above reference range or treat disorders associated with diabetes. Based on their mechanism of action, this class of agents can be classified to the following groups: directly acting insulomimetics, which activates Therapeutic Insulin receptors; indirectly acting insulinomimetics, which increase Therapeutic Insulin release such as sulfonylureas or which potentiate the effect of Therapeutic Insulin such as metformin; those act directly on the metabolism of Glucose measurement such as inhibitors of glucosidases and inhibitors of aldose reductase.. Thyroid Hormones defined as following: Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs.. Phaseolus vulgaris defined as following: The plant species that provides kidney beans.. Hepatic defined as following: Pertaining to, affecting, or associated with the Abdomen>Liver.. Dyslipidemias defined as following: A lipoprotein metabolism disorder characterized by decreased levels of high-density lipoproteins, or elevated levels of plasma cholesterol, low-density lipoproteins and/or triglycerides.. Hypothyroidism defined as following: A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction..", "label": "yes"} {"original_question": "Can TAD disruption lead to disease?", "id": "converted_3145", "sentence1": "Can aminoglutethimide/danazol/hydrocortisone/tamoxifen disruption lead to Disease?", "sentence2": "its perturbation will lead to Homo sapiens Disease, highlighting the accumulating evidence that links the diverse 3 Days Genome - anatomical entity architecture components to a multitude of Homo sapiens diseases and the emerging mechanisms by which 3 Days Genome - anatomical entity derangement causes Disease phenotypes., aminoglutethimide/danazol/hydrocortisone/tamoxifen boundaries are insulators of genomic neighborhoods. In this issue, Sun et al. show that Disease-associated tandem repeats are located to aminoglutethimide/danazol/hydrocortisone/tamoxifen boundaries and affect their insulation. , Recent studies of aminoglutethimide/danazol/hydrocortisone/tamoxifen boundaries disrupted in engineered mouse models show that boundary mutations can recapitulate Homo sapiens developmental disorders as a result of aberrant promoter-enhancer interactions in the affected Tietz syndrome, Similar boundary disruptions in certain Malignant Neoplasms can result in Oncogenes overexpression, and CTCF binding sites at boundaries appear to be hyper-mutated across Malignant Neoplasms., the disruption of these structures by genomic rearrangements can result in gene misexpression and Disease., aminoglutethimide/danazol/hydrocortisone/tamoxifen disruption as oncogenic driver., Recent studies have shown that aminoglutethimide/danazol/hydrocortisone/tamoxifen disruption is often found in Tumor cells, malignant and contributes to oncogenesis through two mechanisms., Disruption of aminoglutethimide/danazol/hydrocortisone/tamoxifen boundaries results in aberrant gene expression by exposing Genes to inappropriate regulatory elements., However, it is not clear to which extent aminoglutethimide/danazol/hydrocortisone/tamoxifen regions are conserved in evolution and whether disruption of Tietz syndrome by evolutionary rearrangements can alter gene expression., Disruption of this organization by structural variations can lead to ectopic interactions between enhancers and Promoter, and to alteration of Genes expression patterns., Disruption of Tietz syndrome can result in altered gene expression and is associated to genetic diseases and Malignant Neoplasms., Gene Gene Deletion Abnormality Abnormality in 2q35 excluding the IHH gene leads to fetal severe limb anomalies and suggests a disruption of chromatin architecture., We demonstrate that disruption of Tietz syndrome can rewire long-range regulatory architecture and result in Pathogenic Variant phenotypes. , Disruption of aminoglutethimide/danazol/hydrocortisone/tamoxifen boundaries results in aberrant gene expression by exposing Genes to inappropriate regulatory elements. , Disruption of Tietz syndrome can result in altered gene expression and is associated to genetic diseases and Malignant Neoplasms. , Disruption of a aminoglutethimide/danazol/hydrocortisone/tamoxifen boundary causes ectopic chromosomal contacts and long-range transcriptional misregulation. , Recent studies of aminoglutethimide/danazol/hydrocortisone/tamoxifen boundaries disrupted in engineered mouse models show that boundary mutations can recapitulate Homo sapiens developmental disorders as a result of aberrant promoter-enhancer interactions in the affected Tietz syndrome. , Recent studies have shown that aminoglutethimide/danazol/hydrocortisone/tamoxifen disruption is often found in Tumor cells, malignant and contributes to oncogenesis through two mechanisms. , Disruption of this organization by structural variations can lead to ectopic interactions between enhancers and Promoter, and to alteration of Genes expression patterns. , Similar boundary disruptions in certain Malignant Neoplasms can result in Oncogenes overexpression, and CTCF binding sites at boundaries appear to be hyper-mutated across Malignant Neoplasms. , However, it is not clear to which extent aminoglutethimide/danazol/hydrocortisone/tamoxifen regions are conserved in evolution and whether disruption of Tietz syndrome by evolutionary rearrangements can alter gene expression. [SEP]Relations: Abnormality of the dentition has relations: disease_phenotype_positive with intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome, disease_phenotype_positive with intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome, disease_phenotype_positive with Marshall syndrome, disease_phenotype_positive with Marshall syndrome, disease_phenotype_positive with severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome, disease_phenotype_positive with severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome, disease_phenotype_positive with SIN3A-related intellectual disability syndrome due to a point mutation, disease_phenotype_positive with SIN3A-related intellectual disability syndrome due to a point mutation, disease_phenotype_positive with late-onset localized junctional epidermolysis bullosa-intellectual disability syndrome, disease_phenotype_positive with late-onset localized junctional epidermolysis bullosa-intellectual disability syndrome. Definitions: Tietz syndrome defined as following: Tietz syndrome is a genetic hypopigmentation and deafness syndrome characterized by congenital profound bilateral sensorineural hearing loss and generalized albino-like hypopigmentation of skin, eyes and hair.. Tumor cells, malignant defined as following: Cells of, or derived from, a malignant tumor.. Pathogenic Variant defined as following: A genetic variant that is known to directly contribute to the development of Disease.. Genome - anatomical entity defined as following: Anatomical set of Genes in all the chromosomes.. Homo sapiens defined as following: Members of the species Homo sapiens.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Oncogenes defined as following: Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, Genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of \"v-\" before Oncogenes symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix \"c-\" before the gene symbol of an Oncogenes indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-Oncogenes.. IHH gene defined as following: This gene is involved in growth, patterning and morphogenesis..", "label": "yes"} {"original_question": "Is calcium overload involved in the development of diabetic cardiomyopathy?", "id": "converted_1695", "sentence1": "Is CALCIUM SUPPLEMENTS overload involved in the development of Diabetic Cardiomyopathies?", "sentence2": "High-glucose treatment resulted in increased intracellular CALCIUM SUPPLEMENTS ([Ca2+]i) which was mobilized to the Mitochondria. Concomitant intra-mitochondrial CALCIUM SUPPLEMENTS ([Ca2+]m) increase resulted in enhanced reactive oxygen and nitrogen species generation. These events led to Abnormality of mitochondrial metabolism and apoptosis., The novel findings of the study reveal that high glucose induces apoptosis by both Mitochondria-dependent and independent pathways via concomitant rise in intracellular CALCIUM SUPPLEMENTS., Diabetes-induced myocardial dysfunction has been attributed, in part, to CALCIUM SUPPLEMENTS overload within individual Muscle Cells., It seems that intracellular CALCIUM SUPPLEMENTS overload is intimately involved in the development of Diabetic Cardiomyopathies;, BACKGROUND: It has been suggested that intracellular Ca2+ overload in Myocytes, Cardiac leads to the development of Diabetic Cardiomyopathies., The results from the alloxan-rat model of Diabetes Mellitus support the view that membrane abnormalities with respect to Ca2+ handling may lead to the occurrence of intracellular Ca2+ overload and the development of Diabetic Cardiomyopathies., It seems that intracellular CALCIUM SUPPLEMENTS overload is intimately involved in the development of Diabetic Cardiomyopathies; however, a concentrated research effort is required to understand the primary biochemical lesion in the pathogenesis of Cardiac dysfunction in Diabetes Mellitus., It has been suggested that the occurrence of an intracellular Ca2+ overload may result in the development of Diabetic Cardiomyopathies, which is associated with depletion of high-energy phosphate stores and a derangement of ultrastructure and Cardiac dysfunction.[SEP]Relations: cardiomyopathy Diabetes Mellitus deafness has relations: disease_disease with syndromic disease, disease_disease with syndromic disease. Abnormality of mitochondrial metabolism has relations: disease_phenotype_positive with reticular dysgenesis, disease_phenotype_positive with reticular dysgenesis, disease_phenotype_positive with atherosclerosis-deafness-Diabetes Mellitus-epilepsy-nephropathy syndrome, disease_phenotype_positive with atherosclerosis-deafness-Diabetes Mellitus-epilepsy-nephropathy syndrome. Type I Diabetes Mellitus mellitus has relations: disease_phenotype_positive with sclerosing cholangitis, disease_phenotype_positive with sclerosing cholangitis, disease_phenotype_positive with multicentric osteolysis-nodulosis-arthropathy spectrum, disease_phenotype_positive with multicentric osteolysis-nodulosis-arthropathy spectrum. Definitions: CALCIUM SUPPLEMENTS defined as following: A dietary supplement containing the mineral CALCIUM SUPPLEMENTS.. Myocytes, Cardiac defined as following: Striated muscle cells found in the heart. They are derived from cardiac myoblasts (MYOBLASTS, CARDIAC).. Mitochondria defined as following: Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed). Muscle Cells defined as following: Mature contractile cells, commonly known as Muscle Cells, that form one of three kinds of muscle. The three types of muscle cells are skeletal (MUSCLE FIBERS, SKELETAL), cardiac (MYOCYTES, CARDIAC), and smooth (MYOCYTES, SMOOTH MUSCLE). They are derived from embryonic (precursor) muscle cells called MYOBLASTS.. Diabetic Cardiomyopathies defined as following: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.. Diabetes Mellitus defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.. Abnormality of mitochondrial metabolism defined as following: A functional anomaly of Mitochondria. [ORCID:0000-0001-5208-3432].", "label": "yes"} {"original_question": "Is the length of the poly(A) tail involved in human disease?", "id": "converted_930", "sentence1": "Is the length of the poly(A) tail involved in human disease?", "sentence2": "In human mitochondria, polyadenylation of RNA, Messenger, undertaken by the nuclear-encoded Mitochondrial Inheritance poly(A) RNA polymerase, is essential for maintaining Mitochondrial Inheritance gene expression. Our Molecular investigation of an autosomal-recessive spastic ataxia with Optic Atrophy, present among the Old Order Amish, identified a Mutation Abnormality of MTPAP gene gene associated with the disease phenotype. When subjected to poly(A) tail-length assays, Mitochondrial Inheritance mRNAs from affected individuals were shown to have severely truncated poly(A) tails.[SEP]Relations: Mitochondrial inheritance has relations: disease_phenotype_positive with cyclic vomiting syndrome, disease_phenotype_positive with cyclic vomiting syndrome, disease_phenotype_positive with MELAS syndrome, disease_phenotype_positive with MELAS syndrome. Optic atrophy has relations: disease_phenotype_positive with distal monosomy 17q, disease_phenotype_positive with distal monosomy 17q, disease_phenotype_positive with distal monosomy 13q, disease_phenotype_positive with distal monosomy 13q, disease_phenotype_positive with Cockayne syndrome, disease_phenotype_positive with Cockayne syndrome. Definitions: Molecular defined as following: Relating to or produced by or consisting of molecules.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Mitochondrial Inheritance defined as following: The distribution of mitochondria, including the Mitochondrial Inheritance genome, into daughter cells after mitosis or meiosis, mediated by interactions between mitochondria and the cytoskeleton. [GOC:mcc, PMID:10873824, PMID:11389764]. Optic Atrophy defined as following: Atrophy of the optic disk which may be congenital or acquired. This condition indicates a deficiency in the number of nerve fibers which arise in the RETINA and converge to form the OPTIC DISK; OPTIC NERVE; OPTIC CHIASM; and optic tracts. GLAUCOMA; ISCHEMIA; inflammation, a chronic elevation of intracranial pressure, toxins, optic nerve compression, and inherited conditions (see OPTIC ATROPHIES, HEREDITARY) are relatively common causes of this condition.. RNA, Messenger defined as following: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the cytoplasm..", "label": "yes"} {"original_question": "Are viruses involved in the etiology of human subacute thyroiditis?", "id": "converted_905", "sentence1": "Are Virus involved in the etiology of human subacute thyroiditis?", "sentence2": "he etiology of subacute (de Quervain's) thyroiditis (College Entrance Examination Board Scholastic Aptitude Test) is uncertain, although it probably represents a nonspecific inflammatory response by the THYROID DIAGNOSTIC RADIOPHARMACEUTICALS to a variety of Virus., Subacute thyroiditis is an inflammatory disorder of the THYROID DIAGNOSTIC RADIOPHARMACEUTICALS caused probably by Virus. I, We believe that the etiologic agent was the Epstein-Barr virus because Heterophile and Epstein-Barr virus-specific antibodies were positive., ltogether, these results indicate that the mechanism of inhibition of Spumavirinae infection by interferon differs from that described for the other Retroviridae, and particularly for types B, C and D Virus. Our data is of therapeutic interest since Spumavirinae have been linked to pathological processes such as de Subacute thyroiditis.[SEP]Relations: subacute thyroiditis has relations: disease_disease with thyroiditis (disease), disease_disease with thyroiditis (disease). regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction has relations: bioprocess_bioprocess with modulation of excitatory postsynaptic potential, bioprocess_bioprocess with modulation of excitatory postsynaptic potential. Definitions: Subacute thyroiditis defined as following: Spontaneously remitting inflammatory condition of the THYROID GLAND, characterized by FEVER; MUSCLE WEAKNESS; SORE THROAT; severe THYROID DIAGNOSTIC RADIOPHARMACEUTICALS PAIN; and an enlarged damaged gland containing GIANT CELLS. The disease frequently follows a viral infection.. Virus defined as following: Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells.. human defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Is skin color affected by variations of the SLC24A5 gene?", "id": "converted_2150", "sentence1": "Is skin color affected by variations of the Sodium/Potassium/Calcium Exchanger 5, Human gene?", "sentence2": "the Alleles of single-nucleotide polymorphisms rs1426654 and rs1834640 (Sodium/Potassium/Calcium Exchanger 5, Human) associated with light skin pigmentation in Eurasian populati, Associations between five single nucleotide polymorphisms (Single Nucleotide Polymorphism) known to play a role in pigmentation (rs1426654-Sodium/Potassium/Calcium Exchanger 5, Human, rs1042602-TYR, rs16891982-SLC45A2, rs6058017-ASIP, and rs642742-KITLG) and MI measures were tested using standard one-way analysis of variance (ANOVA) within each population.[SEP]Relations: Sodium/Calcium exchangers has relations: pathway_protein with Sodium/Potassium/Calcium Exchanger 5, Human, pathway_protein with Sodium/Potassium/Calcium Exchanger 5, Human, pathway_protein with SLC24A4, pathway_protein with SLC24A4, pathway_protein with SLC24A2, pathway_protein with SLC24A2, pathway_protein with SLC24A3, pathway_protein with SLC24A3, pathway_protein with SLC24A1, pathway_protein with SLC24A1. Definitions: Alleles defined as following: Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product.. Single Nucleotide Polymorphism defined as following: A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.. Sodium/Potassium/Calcium Exchanger 5, Human defined as following: Sodium/potassium/calcium exchanger 5 (500 aa, ~55 kDa) is encoded by the human Sodium/Potassium/Calcium Exchanger 5, Human gene. This protein plays a role in calcium and potassium ion exchange for sodium in melanocytes.. Sodium/Potassium/Calcium Exchanger 5, Human gene defined as following: Sodium/potassium/calcium exchanger 5 (500 aa, ~55 kDa) is encoded by the human Sodium/Potassium/Calcium Exchanger 5, Human gene. This protein plays a role in calcium and potassium ion exchange for sodium in melanocytes..", "label": "yes"} {"original_question": "Can midostaurin inhibit angiogenesis?", "id": "converted_2936", "sentence1": "Can midostaurin inhibit angiogenesis?", "sentence2": "midostaurin was a prototype kinase inhibitor, originally developed as a Protein Kinase C inhibitor and subsequently as an angiogenesis inhibitor, based on its inhibition of Vascular Endothelial Growth Factor Receptor-1.[SEP]Relations: midostaurin has relations: drug_drug with Estradiol, drug_drug with Estradiol, drug_drug with Antipyrine, drug_drug with Antipyrine, drug_drug with Aldosterone, drug_drug with Aldosterone, drug_drug with Sparteine, drug_drug with Sparteine, drug_drug with Azelastine, drug_drug with Azelastine. Definitions: Vascular Endothelial Growth Factor Receptor-1 defined as following: A 180-kDa VEGF receptor found primarily in endothelial cells that is essential for vasculogenesis and vascular maintenance. It is also known as Flt-1 (fms-like tyrosine kinase receptor-1). A soluble, alternatively spliced isoform of the receptor may serve as a binding protein that regulates the availability of various ligands for VEGF receptor binding and signal transduction.. Protein Kinase C defined as following: An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that Protein Kinase C is the receptor protein of tumor-promoting phorbol esters.. midostaurin defined as following: A synthetic indolocarbazole multikinase inhibitor with potential antiangiogenic and antineoplastic activities. midostaurin inhibits Protein Kinase C alpha (PKCalpha), Vascular Endothelial Growth Factor Receptor-1 2 (VEGFR2), c-kit, platelet-derived growth factor receptor (PDGFR) and FMS-like tyrosine kinase 3 (FLT3) tyrosine kinases, which may result in disruption of the cell cycle, inhibition of proliferation, apoptosis, and inhibition of angiogenesis in susceptible tumors.. midostaurin defined as following: A synthetic indolocarbazole multikinase inhibitor with potential antiangiogenic and antineoplastic activities. midostaurin inhibits Protein Kinase C alpha (PKCalpha), Vascular Endothelial Growth Factor Receptor-1 2 (VEGFR2), c-kit, platelet-derived growth factor receptor (PDGFR) and FMS-like tyrosine kinase 3 (FLT3) tyrosine kinases, which may result in disruption of the cell cycle, inhibition of proliferation, apoptosis, and inhibition of angiogenesis in susceptible tumors..", "label": "yes"} {"original_question": "Are adenylyl cyclases always transmembrane proteins?", "id": "converted_1564", "sentence1": "Are adenylyl cyclases always transmembrane proteins?", "sentence2": "ransmembrane adenylyl cyclase, Transmembrane adenylyl cyclase (tmAC) and soluble AC (spindle assembly checkpoint) , Soluble adenylyl cyclase (spindle assembly checkpoint) is a recently recognized source of the signaling molecule cyclic AMP (cyclophosphamide/doxorubicin/methotrexate/procarbazine protocol) that is genetically and biochemically distinct from the classic G-protein-regulated transmembrane adenylyl cyclases (tmACs)., Soluble adenylyl cyclase , transmembrane adenylyl cyclases (tmACs), and soluble adenylyl cyclase (spindle assembly checkpoint). , Here, we showed that both transmembrane AC (tmAC) and soluble AC (spindle assembly checkpoint) are distinctly involved in the regulation of sperm motility in the ascidian Ciona intestinalis. , cyclophosphamide/doxorubicin/methotrexate/procarbazine protocol production in beta cells is mediated not simply by transmembrane adenylyl cyclases (TMACs), but also by spindle assembly checkpoint., In contrast to tmAC, spindle assembly checkpoint produces cyclophosphamide/doxorubicin/methotrexate/procarbazine protocol in various intracellular microdomains close to specific cyclophosphamide/doxorubicin/methotrexate/procarbazine protocol targets, e.g., in Cell Nucleus and Mitochondria, soluble adenylyl cyclase (spindle assembly checkpoint, ADCY10 gene gene), the ubiquitous, non-transmembrane adenylyl cyclase, was found to play a key role in neuronal survival and axon growth., Central role of soluble adenylyl cyclase[SEP]Relations: mitochondrion has relations: cellcomp_protein with ACADS, cellcomp_protein with ACADS, cellcomp_protein with ACSL1, cellcomp_protein with ACSL1, cellcomp_protein with ACADSB, cellcomp_protein with ACADSB, cellcomp_protein with CYRIB, cellcomp_protein with CYRIB, cellcomp_protein with ACACB, cellcomp_protein with ACACB. Definitions: spindle assembly checkpoint defined as following: A signaling process that delays the metaphase/anaphase transition until the spindle is correctly assembled and chromosomes are attached to the spindle. [GOC:mah]. Cell Nucleus defined as following: Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one Cell Nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). Mitochondria defined as following: Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the Cell Nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed). cyclophosphamide/doxorubicin/methotrexate/procarbazine protocol defined as following: A chemotherapy regimen consisting of cyclophosphamide, doxorubicin, methotrexate, and procarbazine that may be used in the treatment of non-small cell lung cancer (NSCLC).. Ciona intestinalis defined as following: Vase or tube shaped TUNICATES with a cosmopolitan distribution.. adenylyl cyclases defined as following: Enzymes of the lyase class that catalyze the formation of CYCLIC AMP and pyrophosphate from ATP..", "label": "no"} {"original_question": "Is intraoperative radiotherapy used for treatment of glioblastoma?", "id": "converted_2166", "sentence1": "Is intraoperative radiotherapy used for treatment of glioblastoma?", "sentence2": " 1) Intraoperative radiotherapy ( indolepyruvate ferredoxin oxidoreductase activity , 1,000-2,000 rad) was applied in 13 cases; the 2-year survival was 41.6%. , The median survival time after IORT was 12 months for 9 patients with glioblastoma or Anaplastic astrocytoma, while it was 51 months for 8 patients with less infiltrative tumors (Ependymoma, anaplastic Ependymoma, and Anaplastic Oligodendroglioma). , It is concluded that IORT combined with extensive tumor removal has an acceptable Toxic effect in previously irradiated patients and can be effective for selected recurrent Malignant neoplasm of brain., CONCLUSIONS: The results of this study indicate that IORT can contribute to successful tumor treatment while neither increasing peri-operative morbidity nor subacute sequelae., This review compiles preclinical and clinical evidence for a dedicated treatment of both residual Tumor cells, malignant and regional microenvironment using intraoperative radiotherapy (IORT)., Intraoperative radiotherapy (IORT) is a pragmatic and effective approach to sterilize the margins from persistent tumor cells, abrogate post-injury proliferative stimuli and to bridge the therapeutic gap between surgery and radiochemotherapy. , [Surgical treatment and radiation therapy for Glioblastoma Multiforme, with special reference to intraoperative radiotherapy]., Rationale for intraoperative radiotherapy in glioblastoma., Intraoperative radiotherapy (IORT) was performed in 20 of 36 patients with Glioma; 11 Glioblastoma, 7 malignant astrocytomas, 2 benign astrocytomas., [Surgical treatment and radiation therapy for Glioblastoma Multiforme, with special reference to intraoperative radiotherapy], INTRAGO: intraoperative radiotherapy in Glioblastoma Multiforme—a phase I/II dose escalation study, Intraoperative cobalt-60 treatment of Glioblastoma Multiforme, An intraoperative remote afterloading endocurietherapy (Electroconvulsive Therapy) technique with high-activity 60cobalt (60Co) for the treatment of Glioblastoma Multiforme (Congenital glucose-galactose malabsorption) is described, [Surgical treatment and radiation therapy for Glioblastoma Multiforme, with special reference to intraoperative radiotherapy]., Rationale for intraoperative radiotherapy in glioblastoma., Intraoperative cobalt-60 treatment of Glioblastoma Multiforme., INTRAGO: intraoperative radiotherapy in Glioblastoma Multiforme—a phase I/II dose escalation study., Intraoperative remote afterloading endocurietherapy with high-activity 60cobalt for treatment of Glioblastoma Multiforme., Combining intraoperative carmustine wafers and Stupp regimen in multimodal first-line treatment of primary Glioblastoma., The intraoperative use of carmustine wafers in combination with Stupp regimen is a viable first-line treatment option of Glioblastoma., An intraoperative remote afterloading endocurietherapy (Electroconvulsive Therapy) technique with high-activity 60cobalt (60Co) for the treatment of Glioblastoma Multiforme (Congenital glucose-galactose malabsorption) is described., The study investigated if intraoperative use of carmustine wafers, particularly in combination with Stupp regimen, is a viable and safe first-line treatment option of Glioblastoma.[SEP]Relations: adult glioblastoma has relations: disease_disease with glioblastoma (disease), disease_disease with glioblastoma (disease), disease_disease with glioblastoma (disease), disease_disease with glioblastoma (disease), disease_disease with adult infiltrating astrocytic neoplasm, disease_disease with adult infiltrating astrocytic neoplasm, disease_disease with adult infiltrating astrocytic neoplasm, disease_disease with adult infiltrating astrocytic neoplasm. Anaplastic Oligodendroglioma has relations: disease_disease with grade III Glioma, disease_disease with grade III Glioma. Definitions: Anaplastic Oligodendroglioma defined as following: A central nervous system tumor with morphological features of Anaplastic Oligodendroglioma in which there is insufficient information on the IDH genes and 1p/19q codeletion status.. Glioblastoma Multiforme defined as following: The most malignant astrocytic tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO). indolepyruvate ferredoxin oxidoreductase activity defined as following: Catalysis of the reaction: (indol-3-yl)pyruvate + CoA + oxidized ferredoxin = S-2-(indol-3-yl)acetyl-CoA + CO2 + reduced ferredoxin. [EC:1.2.7.8]. Tumor cells, malignant defined as following: Cells of, or derived from, a malignant tumor.. Glioma defined as following: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or Glioblastoma Multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21). Electroconvulsive Therapy defined as following: Electrically induced CONVULSIONS primarily used in the treatment of severe AFFECTIVE DISORDERS and SCHIZOPHRENIA.. Anaplastic astrocytoma defined as following: A central nervous system tumor with morphological features of Anaplastic astrocytoma in which there is insufficient information on the IDH genes status.. Ependymoma defined as following: Glioma derived from EPENDYMOGLIAL CELLS that tend to present as malignant intracranial tumors in children and as benign intraspinal neoplasms in adults. It may arise from any level of the ventricular system or central canal of the spinal cord. Intracranial ependymomas most frequently originate in the FOURTH VENTRICLE and histologically are densely cellular tumors which may contain ependymal tubules and perivascular pseudorosettes. Spinal ependymomas are usually benign papillary or myxopapillary tumors. (From DeVita et al., Principles and Practice of Oncology, 5th ed, p2018; Escourolle et al., Manual of Basic Neuropathology, 2nd ed, pp28-9). carmustine defined as following: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed). Glioblastoma defined as following: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Congenital glucose-galactose malabsorption defined as following: Glucose-galactose malabsorption (GGM) is a very rare, potentially lethal, genetic metabolic disease characterized by impaired glucose-galactose absorption resulting in severe watery diarrhea and dehydration with onset inthe neonatal period.. anaplastic Ependymoma defined as following: A WHO grade 3 malignant Glioma of ependymal origin with accelerated growth and an unfavorable clinical outcome, particularly in children. It is characterized by high mitotic activity, often accompanied by microvascular proliferation and pseudo-palisading necrosis. (Adapted from WHO). Malignant neoplasm of brain defined as following: A primary or metastatic malignant neoplasm affecting the brain.. glioblastoma defined as following: The most malignant astrocytic tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO).", "label": "no"} {"original_question": "Are epigenetic modifications implicated in cardiovascular development and disease?", "id": "converted_480", "sentence1": "Are epigenetic modifications implicated in Cardiovascular system development and Disease?", "sentence2": "Gene expression regulation through the interplay of DNA methylation and histone modifications is well-established, although the knowledge about the function of epigenetic signatures in Cardiovascular system Disease is still largely unexplored., The study of epigenetic markers is, therefore, a very promising frontier of science which may aid in a deeper understanding of molecular mechanisms underlying the modulation of gene expression in the biomolecule pathways linked to Cardiovascular system diseases., This review highlights our current knowledge of epigenetic gene regulation and the evidence that chromatin location location remodeling and histone modifications play key roles in the pathogenesis of Cardiovascular system Disease through (re)programming of Cardiovascular system (stem) cells commitment, identity and function., Notably, multiple subunits of switching defective/sucrose non-fermenting (SWI/SNF) chromatin location location-remodeling complexes have been identified as strong candidates underlying these defects because they physically and functionally interact with cardiogenic transcription factors critical to cardiac development, such as TBX5 gene gene, GATA-4, and NKX2-5 gene gene. While these studies indicate a critical role of SWI/SNF complexes in cardiac development and congenital Chest>Heart Disease, many exciting new discoveries have identified their critical role in the adult Chest>Heart in both physiological and pathological conditions involving multiple \"U\" lymphocyte types in the Chest>Heart, including Myocytes, Cardiac, Vascular Endothelial Cells, Pericytes, and Neural Crest Cells., Recent studies have greatly expanded our understanding of the regulation of Cardiovascular system development at the chromatin location location level, including the remodeling of chromatin location location and the ResponseLevel - ResponseLevel - modification of Histones. Chromatin-level regulation integrates multiple inputs and coordinates broad gene expression programs. Thus, understanding chromatin location location-level regulation will allow for a better appreciation of gene regulation as a whole and may set a fundamental basis for Cardiovascular system Disease., Genetic and epigenetic factors are of great importance in Cardiovascular system biology and Disease. Tobacco-smoking, one of the most important Cardiovascular system risk factors, is itself partially determined by genetic background and is associated with altered epigenetic patterns., Epigenetic modifications, including DNA methylation, histone ResponseLevel - ResponseLevel - modification (acetylation, methylation and phosphorylation) and miRNA, are critical for regulating developmental events. However, aberrant epigenetic mechanisms may lead to pathological consequences such as Cardiovascular system Disease (cyclophosphamide/dacarbazine/doxorubicin protocol), neurodegenerative Disease, BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, Metabolic Diseases, Specimen Type - Bone and skeletal diseases and various Malignant Neoplasms., Cardiovascular Disease pathways are now being approached from the epigenetic perspective, including those associated with Arteriosclerosis, angiogenesis, ischemia-reperfusion damage, and the Cardiovascular system response to Hypoxia, CTCAE and shear stress, among many others. With increasing interest and expanding partnerships in the field, we can expect new insights to emerge from epigenetic perspectives of Cardiovascular system health., Epigenetic modifications are heritable alterations of the Genome - anatomical entity, which can govern gene expression without altering the DNA Sequence. The purpose of this review is to render an overview of the possible mechanisms of epigenetic regulation of gene expression in response to environmental pollutants leading to Cardiovascular system diseases (Cerebrovascular Disorders)., From varied study approaches directed either toward the general understanding of the key pathway regulatory genes, or sampling population cohorts for global and gene-specific changes, it has been possible to identify several epigenetic signatures of environmental exposure relevant to Cerebrovascular Disorders., An understanding of chromatin location location remodelling in response to environmental stimuli conducive to Cerebrovascular Disorders is emerging, with the promise of novel diagnostic and therapeutic candidates., Consolidated knowledge is accumulating as to the role of epigenetic regulatory mechanisms in the physiology of vascular development and vascular tone as well as in the pathogenesis of Cardiovascular system Disease. The modulation of gene expression through ResponseLevel - ResponseLevel - modification of the epigenome by structural changes of the chromatin location location architecture without alterations of the associated genomic DNA Sequence is part of the cellular response to environmental changes. Such environmental conditions, which are finally being translated into adaptations of the Cardiovascular system system, also comprise pathological conditions such as Arteriosclerosis or Myocardial infarction:Finding:Point in time:^Patient:Ordinal. , Emerging data suggest that these epigenetic modifications also impact on the development of Cardiovascular system Disease. Histone modifications lead to the modulation of the expression of genetic information through ResponseLevel - ResponseLevel - modification of DNA accessibility. In addition, RNA-based mechanisms (e.g., MicroRNAs and long non-coding RNAs) influence the development of Disease., We here outline the recent work pertaining to epigenetic changes in a Cardiovascular system Disease setting., Epigenetics may represent one of the possible scientific explanations of the impact of such intrauterine risk factors for the subsequent development of Cardiovascular system Disease (Cerebrovascular Disorders) during adulthood., Epigenetic mechanisms include DNA methylation, histone ResponseLevel - ResponseLevel - modification, and microRNA alterations, which collectively enable the \"U\" lymphocyte to respond quickly to environmental changes. A number of Cerebrovascular Disorders risk factors, such as nutrition, smoking, pollution, stress, and the circadian rhythm, have been associated with ResponseLevel - ResponseLevel - modification of epigenetic marks. Further examination of these mechanisms may lead to earlier prevention and novel therapy for Cerebrovascular Disorders., Emerging data suggest that these epigenetic modifications also impact on the development of Cardiovascular system Disease., Emerging data suggest that these epigenetic modifications also impact on the development of Cardiovascular system Disease., Epigenetic alterations are associated with Inflammation and Cardiovascular system Disease in patients with chronic kidney Disease., Emerging data suggest that these epigenetic modifications also impact on the development of Cardiovascular system Disease, Epigenetic mechanisms that underpin metabolic and Cardiovascular system diseases., Epigenetic regulation of Cardiovascular system differentiation., Epigenetic control mechanisms play a key role in the regulation of embryonic development and tissue homeostasis and modulate Cardiovascular system diseases.[SEP]Relations: Cardiovascular system Disease has relations: disease_disease with autoimmune Disease of Cardiovascular system system, disease_disease with autoimmune Disease of Cardiovascular system system, contraindication with Epinephrine, contraindication with Epinephrine, contraindication with Ephedrine, contraindication with Ephedrine, disease_disease with Disease by anatomical system, disease_disease with Disease by anatomical system, disease_disease with congenital anomaly of Cardiovascular system system, disease_disease with congenital anomaly of Cardiovascular system system. Definitions: DNA Sequence defined as following: The sequence of nucleotide residues along a DNA chain.. Arteriosclerosis defined as following: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. Myocytes, Cardiac defined as following: Striated muscle cells found in the Chest>Heart. They are derived from cardiac myoblasts (MYOBLASTS, CARDIAC).. Cardiovascular system defined as following: The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body.. Histones defined as following: Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in \"U\" lymphocyte nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. chronic kidney Disease defined as following: Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.. Genetic defined as following: Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. histone ResponseLevel - modification defined as following: The covalent alteration of one or more amino acid residues within a histone protein. [GOC:krc]. Cardiovascular system Disease defined as following: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.. chromatin location defined as following: The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130]. Hypoxia, CTCAE defined as following: A disorder characterized by a decrease in the level of oxygen in the body.. TBX5 gene defined as following: This gene is involved in transcriptional regulation and mesoderm differentiation.. NKX2-5 gene defined as following: This gene plays a role in both transcriptional regulation and Chest>Heart development.. Pericytes defined as following: Unique slender cells with multiple processes extending along the capillary vessel axis and encircling the vascular wall, also called mural cells. Pericytes are imbedded in the BASEMENT MEMBRANE shared with the ENDOTHELIAL CELLS of the vessel. Pericytes are important in maintaining vessel integrity, angiogenesis, and vascular remodeling.. neurodegenerative Disease defined as following: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.. Metabolic Diseases defined as following: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to Disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed). MicroRNAs defined as following: Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing.. ResponseLevel - modification defined as following:

Respond with exceptions, completions and modifications or revisions done before completion

. Neural Crest Cells defined as following: Neuroectodermal cells of the neural crest. They differentiate into various \"U\" lymphocyte types during EMBRYOGENESIS including craniofacial MESENCHYME; ENDOCRINE CELLS; MELANOCYTES and PERIPHERAL NERVOUS SYSTEM.. Genome - anatomical entity defined as following: Anatomical set of genes in all the chromosomes.. Cerebrovascular Disorders defined as following: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.. congenital Chest>Heart Disease defined as following: Developmental abnormalities involving structures of the Chest>Heart. These defects are present at birth but may be discovered later in life..", "label": "yes"} {"original_question": "Anaplasma phagocytophilum is an obligate gram-negative, intracellular bacterium, yes or no", "id": "converted_3234", "sentence1": "Anaplasma phagocytophilum is an obligate gram-negative, Intracellular bacterium, yes or no", "sentence2": "The genus Anaplasma belonging to the Anaplasmataceae family (order Rickettsiales) comprises obligate Intracellular Gram-negative bacteria of veterinary and public health importance. Six species and five types of strains genetically related are currently assigned to the genus Anaplasma including Anaplasma marginale, A. centrale, A. bovis, A. phagocytophilum, A. ovis and A. platys as classified species, and \"A. capra\", A. odocolei sp. nov., Human Granulocytic Anaplasmosis (HGA), an increasingly recognized febrile tick-borne illness, is caused by a gram-negative obligate Intracellular bacterium Anaplasma phagocytophilum[SEP]Relations: human anaplasmosis has relations: disease_disease with anaplasmosis, disease_disease with anaplasmosis. Anal margin neoplasm has relations: phenotype_phenotype with Anal margin squamous cell carcinoma, phenotype_phenotype with Anal margin squamous cell carcinoma, phenotype_phenotype with Anal margin melanoma, phenotype_phenotype with Anal margin melanoma, phenotype_phenotype with Anal margin basal cell carcinoma, phenotype_phenotype with Anal margin basal cell carcinoma, phenotype_phenotype with Abnormality of the anus, phenotype_phenotype with Abnormality of the anus. Definitions: Anaplasma marginale defined as following: A species of gram-negative bacteria and causative agent of severe bovine ANAPLASMOSIS. It is the most pathogenic of the ANAPLASMA species.. Intracellular defined as following: The organized colloidal complex of organic and inorganic substances (as proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, proteins, lipids, carbohydrates, and inorganic salts..", "label": "yes"} {"original_question": "Is Obeticholic Acid used for treatment of Primary Biliary Cholangitis?", "id": "converted_2101", "sentence1": "Is Obeticholic Acid used for treatment of Primary Biliary Cholangitis?", "sentence2": "obeticholic acid in primary biliary cholangitis., In a double-blind, randomized, placebo-controlled study including 217 patients with primary biliary cholangitis, the authors show that obeticholic acid (a potent farnesoid X Agonist) administered with ursodiol or as monotherapy significantly decreases Serum alkaline phosphatase measurement and bilirubin preparation preparation when compared to placebo., obeticholic acid (Ocaliva(TM)) is a farnesoid-X receptor (NR1H4 wt Allele) Agonist that is being developed by Intercept Pharmaceuticals for the treatment of various liver diseases, and has recently been granted accelerated approval in the USA for the treatment of primary biliary cholangitis in combination with ursodiol in adults with an inadequate response to ursodiol, or as monotherapy in adults unable to tolerate ursodiol. , Obeticholic Acid (cyclophosphamide/doxorubicin/vincristine protocol) is a NR1H4 gene (NR1H4 wt Allele) Agonist which has been evaluated as a second line therapy in Primary Biliary Cholangitis and has recently been licenced by the FDA., cyclophosphamide/doxorubicin/vincristine protocol will be the first stratified therapy introduced in Primary Biliary Cholangitis, however confirmatory trial and real life data are needed to confirm that suggestive biochemical improvements are matched by improvement in key clinical outcomes., obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection., A series of clinical trials of cyclophosphamide/doxorubicin/vincristine protocol in Primary Biliary Cholangitis, primarily in combination with UDCA, have established that cyclophosphamide/doxorubicin/vincristine protocol leads to significant reductions in Serum alkaline phosphatase measurement that are predicted to lead to improved clinical outcomes, while dose-dependent pruritus has been the most common adverse effect. On the basis of these studies, cyclophosphamide/doxorubicin/vincristine protocol was given conditional approval by the US Food and Drug Administration with plans to establish the long-term clinical efficacy of cyclophosphamide/doxorubicin/vincristine protocol in patients with advanced Primary Biliary Cholangitis., Although obeticholic acid was approved by the FDA for the treatment of Primary Biliary Cholangitis in May 2016, this development occurred after the symposium presentation. , While several agents are being studied in combination with UDCA, monotherapy with the novel agent obeticholic acid, a NR1H4 gene Agonist, has also shown promising results., obeticholic acid (Ocaliva(TM)) is a farnesoid-X receptor (NR1H4 wt Allele) Agonist that is being developed by Intercept Pharmaceuticals for the treatment of various liver diseases, and has recently been granted accelerated approval in the USA for the treatment of primary biliary cholangitis in combination with ursodiol in adults with an inadequate response to ursodiol, or as monotherapy in adults unable to tolerate ursodiol., obeticholic acid for the treatment of primary biliary cholangitis., Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis., A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis., This article summarizes the milestones in the development of obeticholic acid leading to this first approval for primary biliary cholangitis., obeticholic acid for the treatment of primary biliary cholangitis., Long-term Clinical Impact and Cost-Effectiveness of Obeticholic Acid for the Treatment of Primary Biliary Cholangitis., obeticholic acid in primary biliary cholangitis., A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis., This article summarizes the milestones in the development of obeticholic acid leading to this first approval for primary biliary cholangitis.[SEP]Relations: primary biliary cholangitis has relations: contraindication with Cholic Acid, contraindication with Cholic Acid, contraindication with Fenofibric acid, contraindication with Fenofibric acid, contraindication with Chenodeoxycholic acid, contraindication with Chenodeoxycholic acid, contraindication with Fenofibrate, contraindication with Fenofibrate. obeticholic acid has relations: drug_drug with Cholic Acid, drug_drug with Cholic Acid. Definitions: Agonist defined as following: An agent that has affinity for a receptor and intrinsic activity at that receptor.. NR1H4 gene defined as following: This gene is involved in bile acid binding and metabolism.. ursodiol defined as following: An epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic.. Primary Biliary Cholangitis defined as following: An autoimmune inflammatory disorder characterized by destruction of the small intrahepatic bile ducts. It affects predominantly females and it may lead to cirrhosis and liver failure. Patients have antimitochondrial and antinuclear antibodies in the peripheral blood.. obeticholic acid defined as following: An orally bioavailable semi-synthetic bile acid derivative and an Agonist of the nuclear bile acid receptor NR1H4 gene (NR1H4 wt Allele) that may be used to lower hepatic exposure to bile acids. Upon oral administration, obeticholic acid targets and binds to NR1H4 wt Allele expressed in the liver and intestine, activating NR1H4 wt Allele-mediated bile acid, inflammatory, fibrotic, and metabolic pathways. This suppresses the production of bile acid in the hepatocytes and increases bile acid transport out of the hepatocytes, thereby reducing hepatic exposure to bile acids. NR1H4 wt Allele plays an important role in bile acid homeostasis and is involved in hepatic and intestinal inflammation and liver fibrosis.. NR1H4 wt Allele defined as following: Human NR1H4 wild-type allele is located in the vicinity of 12q23.1 and is approximately 91 kb in length. This allele, which encodes bile acid receptor protein, plays a role in both the metabolism of bile acids and ligand-dependent transcriptional regulation.. Serum alkaline phosphatase measurement defined as following: A quantitative measurement of the amount of alkaline phosphatase present in a sample of serum.. Obeticholic Acid defined as following: An orally bioavailable semi-synthetic bile acid derivative and an Agonist of the nuclear bile acid receptor NR1H4 gene (NR1H4 wt Allele) that may be used to lower hepatic exposure to bile acids. Upon oral administration, obeticholic acid targets and binds to NR1H4 wt Allele expressed in the liver and intestine, activating NR1H4 wt Allele-mediated bile acid, inflammatory, fibrotic, and metabolic pathways. This suppresses the production of bile acid in the hepatocytes and increases bile acid transport out of the hepatocytes, thereby reducing hepatic exposure to bile acids. NR1H4 wt Allele plays an important role in bile acid homeostasis and is involved in hepatic and intestinal inflammation and liver fibrosis.. Primary Biliary Cholangitis defined as following: An autoimmune inflammatory disorder characterized by destruction of the small intrahepatic bile ducts. It affects predominantly females and it may lead to cirrhosis and liver failure. Patients have antimitochondrial and antinuclear antibodies in the peripheral blood..", "label": "yes"} {"original_question": "Is Acute Necrotizing Encephalopathy (ANE) which typically affects young, healthy children usually triggered by exposure to air pollution?", "id": "converted_4475", "sentence1": "Is Acute Necrotizing Encephalopathy (ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3) which typically affects young, healthy children usually triggered by exposure to air pollution?", "sentence2": "Acute necrotizing Encephalopathies (ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3) is a recently identified, uncommon Encephalopathies affecting children. ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3 is characterized by a preceding viral illness followed by Seizures and rapid progressive Progressive Progressive neurologic deterioration. , Acute necrotizing Encephalopathies (ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3) is a specific type of Encephalopathies usually followed by febrile Communicable Diseases, ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3 usually occurs in children under 4 years old after influenza Communicable Diseases, Acute necrotizing Encephalopathies of childhood (Acute necrotizing Encephalopathies of childhood) is a Disease, characterized by a respiratory or gastrointestinal Communicable Diseases, accompanied with Fever symptoms (finding), rapid alteration of consciousness, and Seizures., Acute necrotizing Encephalopathies (ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3) is a rare but distinctive type of acute Encephalopathies with global distribution. Occurrence of ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3 is usually preceded by a virus-associated febrile illness and ensued by rapid deterioration., Acute necrotizing Encephalopathies (ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3) typically affects young, healthy children who develop rapid-onset severe Encephalopathies triggered by Virus Diseases., Recurrent acute necrotizing Encephalopathies following influenza A in a genetically predisposed family., Background: Among the influenza-associated encephalopathies, acute necrotizing Encephalopathies (ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3) has a particularly poor prognosis., Since it was first recognized, neurological complication including acute necrotizing Encephalopathies (ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3) have been globally documented in association with this viral Communicable Diseases., Background: Acute necrotizing Encephalopathies (ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3) is a rapidly progressive Encephalopathies seen commonly in children triggered by various prodromal Virus Diseases, most common being influenza virus and Homo sapiens herpe, Background: Acute necrotizing Encephalopathies (ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3), known as influenza-associated encephalitis, typically affects, Acute necrotizing Encephalopathies (ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3) is a rapidly progressing nervous system disorder that occurs in children after common Virus Diseases of the respiratory or gastrointestinal systems. , Acute necrotizing Encephalopathies (ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3) typically affects young, healthy children who develop rapid-onset severe Encephalopathies triggered by Virus Diseases, Background: Acute necrotizing Encephalopathies (ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3) is a rapidly progressive Encephalopathies seen commonly in children triggered by various prodromal Virus Diseases, most common being influenza virus and Homo sapiens herpes virus-, Acute necrotizing Encephalopathies (ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3) presents in children after common Virus Diseases, Acute necrotizing Encephalopathies of childhood (Acute necrotizing Encephalopathies of childhood) is a Disease characterized by respiratory or gastrointestinal Communicable Diseases and high Fever symptoms (finding) accompanying with rapid alteration of consciousness and Seizures, Background: Acute necrotizing Encephalopathies (ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3) is a rapidly progressive Encephalopathies seen commonly in children triggered by various prodromal Virus Diseases, most common being influenza virus and Homo sapiens herpes virus-6.Objective: We report two rare cases of ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3 preceded by Chikungunya Communicable Diseases.Cases: A 13-year old girl presented with a three-day history of headache, Fever symptoms (finding), se, Acute necrotizing Encephalopathies (ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3) is a rapidly progressing nervous system disorder that occurs in children after common Virus Diseases of the respiratory or gastrointestinal systems., Acute necrotizing Encephalopathies (ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3) presents in children after common Virus Diseases., Acute necrotizing Encephalopathies of childhood associated with influenza type B virus Communicable Diseases in a 3-year-old girl., We report a 12-year-old girl infected with influenza A H1N1 whose clinical course was complicated by rapid progressive Progressive Progressive neurologic deterioration and striking X-Ray Computed Tomography and MRI findings consistent with acute necrotizing Encephalopathies (ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3)., We report a 3-year-old previously healthy girl presenting with acute necrotizing Encephalopathies of childhood associated with influenza type B virus Communicable Diseases, which resulted in severe Neurologic sequelae.[SEP]Relations: acute necrotizing Encephalopathies of childhood has relations: disease_disease with infectious encephalitis, disease_disease with infectious encephalitis, disease_disease with Encephalopathies, acute, Communicable Diseases-induced, susceptibility to, disease_disease with Encephalopathies, acute, Communicable Diseases-induced, susceptibility to, disease_protein with RANBP2, disease_protein with RANBP2. Encephalopathies, acute, Communicable Diseases-induced, susceptibility to has relations: disease_disease with acute necrotizing Encephalopathies of childhood, disease_disease with acute necrotizing Encephalopathies of childhood. Acute necrotizing Encephalopathies has relations: phenotype_phenotype with Acute Encephalopathies, phenotype_phenotype with Acute Encephalopathies. Definitions: Virus Diseases defined as following: A general term for diseases caused by viruses.. Encephalopathies defined as following: A functional and/or structural disorder of the brain caused by diseases (e.g. liver Disease, kidney Disease), medications, chemicals, and injuries.. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.. Seizures defined as following: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent Seizures are usually referred to as EPILEPSY or \"seizure disorder.\". Homo sapiens defined as following: Members of the species Homo sapiens.. nervous system disorder defined as following: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Acute necrotizing encephalopathy of childhood defined as following: A rare neurologic Disease with characteristics of rapid onset of Seizures, an altered state of consciousness, neurologic decline, and variable degrees of hepatic dysfunction following a respiratory or gastrointestinal Communicable Diseases (e.g. mycoplasma, influenza virus) in a previously healthy child. Brain MRI of patients reveals bilateral, multiple, symmetrical lesions predominantly observed in thalami and brainstem, but also in periventricular white matter and cerebellum in some cases.. X-Ray Computed Tomography defined as following: Tomography using x-ray transmission and a computer algorithm to reconstruct the image..", "label": "no"} {"original_question": "Does the hERG gene code for a protein which is part of a sodium channel?", "id": "converted_1981", "sentence1": "Does the hERG gene code for a Protein Info which is part of a Sodium supplements channel?", "sentence2": " The Homo sapiens ether-à-go-go-related gene (hERG 1a) KCNA5 gene is critical for Cardiac - anatomy qualifier repolarization, KCNH6 gene (hERG) channels conduct delayed rectifier K(+) current. , The Potassium Voltage-Gated Channel Subfamily KQT Member 1 and minK Genes code the slowly activating, delayed rectifier (Iks) KCNA5 gene, the KCNH2 gene gene code the rapidly activating, delayed rectifier (Ikr) KCNA5 gene of the Chest>Heart, while the SCN5A gene codes a Cardiac - anatomy qualifier Sodium supplements channel., The molecular basis of inherited disorders caused by a Mutation Abnormality in either the gene coding for a particular KCNA5 gene called KCNH2 gene-or another gene, SCN5A, which codes for the Sodium supplements channel and disruption of which results in a loss of inactivation of the Na+ current., The aim of this study was to test whether a recently reported Genetic Polymorphism in the KCNH2 gene gene coding for the rapidly activating delayed rectifier K+ channel has influence on myocardial repolarization., Gene Mutation in Potassium Voltage-Gated Channel Subfamily KQT Member 1, minK and KCNH2 gene Genes affects repolarising, rectifier potassium currents, while SCN5A mutations cause delayed inactivation and reopening of the Cardiac - anatomy qualifier Sodium supplements channel, which initiates the depolarisation of Cardiac - anatomy qualifier Cells., A Homo sapiens genetic defect associated with 'long Q-T syndrome', an abnormality of Cardiac - anatomy qualifier rhythm involving the repolarization of the action potential, was recently found to lie in the KCNH2 gene gene, which codes for a KCNA5 gene., Therefore, matrine and oxymatrine may have the potential to cure Long Qt Syndrome 2 as a KCNA5 gene activator by promoting hERG channel activation and increasing hERG channel expression., The Homo sapiens delta1261 Mutation Abnormality of the KCNH2 gene KCNA5 gene results in a truncated Protein Info that contains a subunit interaction domain and decreases the channel expression., KCNH2 gene (Homo sapiens eag-related gene) encodes an inward-rectifier KCNA5 gene formed by the assembly of four subunits., The Homo sapiens ether-?-go-go-related gene (KCNH2 gene) encodes the pore-forming subunit of the rapidly activating delayed rectifier KCNA5 gene in the Chest>Heart., The KCNH7 gene (hERG) encodes the rapidly activating, delayed rectifier KCNA5 gene (IKr) important for Cardiac - anatomy qualifier repolarization., Role of glycosylation in \"U\" lymphocyte surface expression and stability of KCNH2 gene potassium channels., The Homo sapiens ERG Protein Info (KCNH2 gene or Kv 11.1) encoded by the KCNH7 gene (herg) is the pore-forming subunit of the Cardiac - anatomy qualifier delayed rectifier potassium current (IKr) responsible for action potential (AP) repolarization, Human ether-a-go-go related gene (herg) encoding KCNH2 gene K(+) channel has been demonstrated in many previous studies with its association to \"U\" lymphocyte cycle progression and growth in Tumor Cells, uncertain whether benign or malignant, A Homo sapiens genetic defect associated with 'long Q-T syndrome', an abnormality of Cardiac - anatomy qualifier rhythm involving the repolarization of the action potential, was recently found to lie in the KCNH2 gene gene, which codes for a KCNA5 gene. , Drug-induced Long QT Syndrome: hERG K+ channel block and disruption of Protein Info trafficking by fluoxetine and fluoxetine and fluoxetine and norfluoxetine., OBJECTIVES: The aim of this study was to test whether a recently reported Genetic Polymorphism in the KCNH2 gene gene coding for the rapidly activating delayed rectifier K+ channel has influence on myocardial repolarization. , The aim of this study was to test whether the K897T Genetic Polymorphism of the KCNH2 (KCNH2 gene) gene coding for the rapidly activating delayed rectifier K+ channel influences Cardiac - anatomy qualifier repolarization assessed by principal component analysis (PCA) of T-wave morphology. , The Potassium Voltage-Gated Channel Subfamily KQT Member 1 and minK Genes code the slowly activating, delayed rectifier (Iks) KCNA5 gene, the KCNH2 gene gene code the rapidly activating, delayed rectifier (Ikr) KCNA5 gene of the Chest>Heart, while the SCN5A gene codes a Cardiac - anatomy qualifier Sodium supplements channel., All code for subunits of Sodium supplements or potassium channels: two a subunits of the potassium channels (QVLQT1 for Romano-Ward Syndrome, KCNH2 gene for Long Qt Syndrome 2), the a subunit of the Sodium supplements channel INa (SCN5A for LONG QT SYNDROME 3), and two regulatory subunits of potassium channels (KCNE1 gene gene for LONG QT SYNDROME 5 regulating the Potassium Voltage-Gated Channel Subfamily KQT Member 1 channel and KCNE2 gene regulating KCNH2 gene)., The corresponding Genes code for potassium channels KVLQT1 (Romano-Ward Syndrome) and KCNH2 gene (Long Qt Syndrome 2) and the Sodium supplements channel SCN5A (LONG QT SYNDROME 3)., The molecular basis of inherited disorders caused by a Mutation Abnormality in either the gene coding for a particular KCNA5 gene called KCNH2 gene-or another gene, SCN5A, which codes for the Sodium supplements channel and disruption of which results in a loss of inactivation of the Na+ current., There may also be correlation between the strength of binding of the medicinal substance to the KCNA5 gene coded by the KCNH2 gene gene and prolongation of the QT interval., We demonstrate that the mRNA 3'UTR of ppk29 affects neuronal firing rates and associated heat-induced seizures by acting as a natural antisense transcript (NAT) that regulates the neuronal mRNA levels of seizure (sei), the Drosophila homolog of the Homo sapiens Ether-à-go-go Related Gene (hERG) KCNA5 gene., Gene Mutation in Potassium Voltage-Gated Channel Subfamily KQT Member 1, minK and KCNH2 gene Genes affects repolarising, rectifier potassium currents, while SCN5A mutations cause delayed inactivation and reopening of the Cardiac - anatomy qualifier Sodium supplements channel, which initiates the depolarisation of Cardiac - anatomy qualifier Cells., Among the congenital forms, particularly interest is focused on the KCNA5 gene coded by the KCNH2 gene gene located on Chromosomes, Human, Pair 7 and with a key role in the normal electric Cardiac - anatomy qualifier activity., By employing heterologous expression and making comparisons to Cells expressing wild-type Homo sapiens-ether-a-go-go-related Protein Info (KCNH2 gene), a KCNA5 gene that contributes to I(Kr) current in ventricular cardiomyocytes, we demonstrate activation of an elevated endoplasmic reticulum (Endoplasmic Reticulum) stress response by the Mutant I593R KCNH2 gene KCNA5 gene implicated in Long QT Syndrome type 2., Correction of defective Protein Info trafficking of a Mutant KCNH2 gene KCNA5 gene in Homo sapiens Long QT Syndrome., Gene Mutation in the Homo sapiens ether-à-go-go-related gene (KCNH2 gene), which encodes a delayed-rectifier KCNA5 gene,, s KCNH2 gene and Potassium Voltage-Gated Channel Subfamily KQT Member 1 KCNA5 gene Genes, KCNH2 gene encodes the Cardiac - anatomy qualifier I(Kr) KCNA5 gene., block of the Cardiac - anatomy qualifier KCNA5 gene Homo sapiens ether-à-go-go-related gene (hERG) , The KCNH7 gene (hERG) encodes the pore-forming α-subunit of the rapidly activating delayed rectifier K(+) channel in the Chest>Heart, which plays a critical role in Cardiac - anatomy qualifier action potential repolarization. , Effects of donepezil on hERG potassium channels., Human ether-a-go-go related-gene K⁺ channels (hERG) participate in the regulation of tumor \"U\" lymphocyte proliferation and apoptosis. KCNH2 gene channel activity is up-regulated by Growth Factor, hERG potassium channels, KCNH2 gene, a K+ channel gene.[SEP]Relations: Sodium supplements channel complex has relations: cellcomp_protein with SCNN1G, cellcomp_protein with SCNN1G, cellcomp_protein with SCNN1B, cellcomp_protein with SCNN1B, cellcomp_protein with SCNN1D, cellcomp_protein with SCNN1D, cellcomp_protein with SCNN1A, cellcomp_protein with SCNN1A, cellcomp_protein with TRPM4, cellcomp_protein with TRPM4. Definitions: LONG QT SYNDROME 5 defined as following: An autosomal dominant condition caused by Mutation Abnormality(s) in the KCNE1 gene gene, encoding potassium voltage-gated channel subfamily E member 1. It is characterized by a prolonged QT interval that may result in torsade de pointes, ventricular fibrillation and/or sudden Cardiac - anatomy qualifier death.. Long Qt Syndrome 2 defined as following: An autosomal dominant condition caused by Mutation Abnormality(s) in the KCNH2 gene, encoding potassium voltage-gated channel subfamily H member 2. It is characterized by a prolonged QT interval that may result in torsade de pointes, ventricular fibrillation and/or sudden Cardiac - anatomy qualifier death.. LONG QT SYNDROME 3 defined as following: An autosomal dominant condition caused by Mutation Abnormality(s) in the SCN5A gene, encoding Sodium supplements channel Protein Info type 5 subunit alpha. It is characterized by a prolonged QT interval that may result in torsade de pointes, ventricular fibrillation and/or sudden Cardiac - anatomy qualifier death.. SCN5A gene defined as following: This gene is involved in voltage-dependent Sodium supplements ion transport.. Endoplasmic Reticulum defined as following: A system of cisternae in the CYTOPLASM of many Cells. In places the endoplasmic reticulum is continuous with the plasma membrane (CELL MEMBRANE) or outer membrane of the nuclear envelope. If the outer surfaces of the endoplasmic reticulum membranes are coated with ribosomes, the endoplasmic reticulum is said to be rough-surfaced (ENDOPLASMIC RETICULUM, ROUGH); otherwise it is said to be smooth-surfaced (ENDOPLASMIC RETICULUM, SMOOTH). (King & Stansfield, A Dictionary of Genetics, 4th ed). Romano-Ward Syndrome defined as following: A form of Long QT Syndrome that is without congenital deafness. It is caused by Mutation Abnormality of the KCNQ1 gene which encodes a Protein Info in the VOLTAGE-GATED POTASSIUM CHANNEL.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Potassium Voltage-Gated Channel Subfamily KQT Member 1 defined as following: Potassium voltage-gated channel subfamily KQT member 1 (676 aa, ~75 kDa) is encoded by the Homo sapiens KCNQ1 gene. This Protein Info is involved in Cardiac - anatomy qualifier repolarization through modulation of potassium ion transport.. fluoxetine defined as following: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.. Mutant defined as following: An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).. Growth Factor defined as following: Growth Factors are extracellular signaling molecules (ligands) involved in control of target \"U\" lymphocyte proliferation, \"U\" lymphocyte survival, and \"U\" lymphocyte differentiation. (NCI). Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. Sodium supplements channel defined as following: Ion channels that specifically allow the passage of SODIUM ions. A variety of specific Sodium supplements channel subtypes are involved in serving specialized functions such as neuronal signaling, CARDIAC MUSCLE contraction, and KIDNEY function.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Chromosomes, Human, Pair 7 defined as following: A specific pair of GROUP C CHROMOSOMES of the Homo sapiens chromosome classification.. Long QT Syndrome defined as following: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by Mutation Abnormality of Genes encoding Cardiac - anatomy qualifier ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.. donepezil defined as following: The hydrochloride salt of a piperidine derivative with neurocognitive-enhancing activity. Donepezil reversibly inhibits acetylcholinesterase, thereby blocking the hydrolysis of the neurotransmitter acetylcholine and, consequently, increasing its activity. This agent may improve neurocognitive function in Alzheimer's disease, reduce sedation associated with opioid treatment of cancer pain, and improve neurocognitive function in patients who have received radiation therapy for primary brain tumors or brain metastases.. Tumor Cells, uncertain whether benign or malignant defined as following: Cells of, or derived from, a tumor.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Gene Mutation may be associated with genetic diversity or with pathologies including cancer.. Homo sapiens defined as following: Members of the species Homo sapiens.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Genetic Polymorphism defined as following: The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level..", "label": "no"} {"original_question": "Do polycomb group proteins (PcG) mediate the formation of chromatin loops?", "id": "converted_3845", "sentence1": "Do polycomb group Proteins (Polycomb-Group Proteins) mediate the formation of chromatin loops?", "sentence2": "A chromatin insulator driving three-dimensional Polycomb response element (Pure Spanish horse breed (organism)) contacts and Polycomb association with the 30 nm Chromatin Fiber, the Drosophila gypsy insulator behaves as a conformational chromatin border that is able to prohibit contacts between a Polycomb response element (Pure Spanish horse breed (organism)) and a distal promoter, Polycomb action at a distance can be organized by local chromatin topology, Polycomb repressive complex 2 is recruited through the interaction of CTGF protein, human, CTGF protein, human governs Genes expression by orchestrating chromatin loop structures and by serving as a DNA-Binding Proteins scaffold to recruit and bind polycomb repressive complexes, The chromatin loops completely dissolve, accompanied by loss of Polycomb-Group Proteins Proteins and Histone H3 Trimethyl Lys28 marks, when Tera-2 cells receive differentiation signals which induce a approximately 60-fold increase in GATA-4 expression., Polycomb-mediated chromatin loops revealed by a subkilobase-resolution chromatin interaction map., es or \"anchors\" are associated with CTGF protein, human protein in Mammals, loop anchors in Drosophila were found most often in association with the polycomb group (Polycomb-Group Proteins) protein Polycomb (Pachyonychia Congenita), a subunit of polycomb repressive complex 1 (Drosophila Polycomb Repressive Complex 1). Loops were frequently located within domains of Polycomb-Group Proteins, We also provide novel insight that Polycomb-Group Proteins-occupied and Histone H3 Trimethyl Lys28-enriched regions can form chromatin loops and physically interact in cis around a single Genes in mammalian cells., Repressive loops within polycomb domains are formed after the midblastula transition between polycomb response elements by the action of GAGA factor and polycomb Proteins., Polycomb-Group Proteins Proteins, DNA methylation, and Genes repression by chromatin looping., Loops were frequently located within domains of Polycomb-Group Proteins-repressed chromatin., iation to proliferation control. Our results revealed a chromatin looping mechanism of long-range control and argue against models involving homogeneous spreading of Polycomb-Group Proteins silencers [SEP]Relations: protein binding has relations: molfunc_protein with PCP4, molfunc_protein with PCP4, molfunc_protein with PCTP, molfunc_protein with PCTP, molfunc_protein with PCCA, molfunc_protein with PCCA, molfunc_protein with PCNP, molfunc_protein with PCNP, molfunc_protein with PCDHA4, molfunc_protein with PCDHA4. Definitions: Drosophila Polycomb Repressive Complex 1 defined as following: Drosophila Polycomb Repressive Complex 1 (Polycomb repressive complex 1) contains the products of the Polycomb-Group Proteins genes Polycomb, Posterior sex combs, polyhomeotic, Sex combs on midleg, and several other Proteins. Preincubation of Drosophila Polycomb Repressive Complex 1 with nucleosomal arrays blocks the ability of these arrays to be remodeled by SWI/SNF. Drosophila Polycomb Repressive Complex 1 and SWI/SNF are likely compete with each other for the nucleosomal template.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Polycomb-Group Proteins defined as following: A family of Proteins that play a role in CHROMATIN REMODELING. They are best known for silencing HOX GENES and the regulation of EPIGENETIC PROCESSES.. CTGF protein, human defined as following: CCN family member 2 (349 aa, ~38kDa) is encoded by the human CCN2 Genes. This protein plays a role in the promotion of proliferation and differentiation of chondrocytes and also mediates heparin- and divalent cation-dependent cell adhesion in many different cell types.. Histone H3 Trimethyl Lys28 defined as following: A post-translationally modified form of histone H3 where the lysine residue at position 28 is trimethylated. This modification is associated with formation of heterochromatin and polycomb repressive complex 1 (Drosophila Polycomb Repressive Complex 1).. Mammals defined as following: Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.. 30 nm Chromatin Fiber defined as following: A level of DNA packaging in chromatin above that of the nucleosome, the fundamental subunit of chromatin structure. The 30 nm Chromatin Fiber has a thickness of about 30 nanometers and results from the folding of a linear array of nucleosomes (thickness about 10 nm) into a more compact fiber.. DNA-Binding Proteins defined as following: Proteins which bind to DNA. The family includes Proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding Proteins in serum which can be used as markers for malignant diseases.. Pachyonychia Congenita defined as following: A group of inherited ectodermal dysplasias whose most prominent clinical feature is hypertrophic nail dystrophy resulting in PACHYONYCHIA. Several specific subtypes of pachyonychia congenita have been associated with mutations in genes that encode KERATINS.. CTGF protein, human protein defined as following: A repressor protein with poly(ADP)-ribose binding activity that binds CHROMATIN and DNA; its structure consisting of 11 CYS2-HIS2 ZINC FINGERS allows it to recognize many different DNA target sites. It functions as a repressor by binding to INSULATOR ELEMENTS and preventing interaction between promoters and nearby enhancers and silencers. It plays a critical role in EPIGENETIC PROCESSES, including GENOMIC IMPRINTING..", "label": "yes"} {"original_question": "Is Algenpantucel-L effective for pancreatic cancer?", "id": "converted_4488", "sentence1": "Is Algenpantucel-L effective for Malignant neoplasm of pancreas?", "sentence2": " Median (IQR) overall survival was 14.9 (12.2-17.8) months in the standard group (N=158) and 14.3 (12.6-16.3) months in the experimental group (N = 145) (hazard ratio [plant-type hypersensitive response] 1.02, 95% CI 0.66-1.58; P = 0.98). Median progression-free survival was 13.4 months in the standard group and 12.4 months in the experimental group (plant-type hypersensitive response 1.33, 95% CI 0.72-1.78; P = 0.59). Grade 3 or higher adverse events occurred in 105 of 140 patients (75%) in the standard group and in 115 of 142 patients (81%) in the experimental group (P > 0.05).CONCLUSIONS: Algenpantucel-L immunotherapy did not improve survival in patients with borderline resectable or locally advanced unresectable ANOPHTHALMIA AND PULMONARY HYPOPLASIA receiving SOC neoadjuvant chemotherapy and chemoradiation., CONCLUSIONS: The addition of algenpantucel-L to standard adjuvant therapy for resected Malignant neoplasm of pancreas may improve survival. A multi-institutional, phase 3 study is ongoing, CONCLUSIONS: The addition of algenpantucel-L to standard adjuvant therapy for resected Malignant neoplasm of pancreas may improve surviva, CONCLUSIONS: Algenpantucel-L immunotherapy did not improve survival in patients with borderline resectable or locally advanced unresectable ANOPHTHALMIA AND PULMONARY HYPOPLASIA receiving SOC neoadjuvant chemotherapy and chemoradiatio[SEP]Relations: malignant exocrine pancreas neoplasm has relations: disease_disease with pancreatoblastoma, disease_disease with pancreatoblastoma, disease_disease with exocrine pancreatic carcinoma, disease_disease with exocrine pancreatic carcinoma, disease_disease with pancreatic exocrine neoplasm, disease_disease with pancreatic exocrine neoplasm, disease_disease with pancreatic intraductal papillary-mucinous neoplasm, disease_disease with pancreatic intraductal papillary-mucinous neoplasm, disease_disease with malignant pancreatic neoplasm, disease_disease with malignant pancreatic neoplasm. Definitions: Malignant neoplasm of pancreas defined as following: A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma.. plant-type hypersensitive response defined as following: The rapid, localized death of plant cells in response to invasion by a pathogen. [ISBN:0582227089]. ANOPHTHALMIA AND PULMONARY HYPOPLASIA defined as following: A rare clinical entity including as main characteristics anophthalmia or severe microphthalmia, and pulmonary hypoplasia or aplasia. Only five cases have been reported so far, two of who were siblings. In the three nonfamilial cases, unilateral pulmonary agenesis and microphthalmia were associated with diaphragmatic hernia and pulmonary vessel agenesis. It has been suggested that two different entities can be distinguished: on one hand, the association of anophthalmia-pulmonary hypoplasia with/without anomalies of the face, heart, spleen and uterus, which may be due to a putative autosomal recessive gene with pleiotropic effects; on the other hand, a sporadic association including pulmonary hypoplasia, anophthalmia, unilateral diaphragmatic defect and agenesis of the pulmonary trunk, which may represent the expression of a developmental field defect. There is evidence that syndromic microphthalmia- is caused by homozygous or compound heterozygous mutation in the STRA6 gene on chromosome 15q24..", "label": "no"} {"original_question": "Is there an association between serum interleukin-6 concentrations and outcomes of stroke patients?", "id": "converted_1176", "sentence1": "Is there an association between serum Recombinant Interleukin-6 concentrations and outcomes of stroke patients?", "sentence2": " In addition, IL-6 concentrations affect clinical outcomes in ischemic stroke., After appropriate adjustment, the odds ratios for the association of markers and poor outcome (comparing the upper and the lower third) were Recombinant Interleukin-6, 3.1 (95% CI: 1.9-5.0); C-reactive protein, 1.9 (95% CI: 1.2-3.1); Fibrinogen containing hemostatics, 1.5 (95% CI: 1.0-2.36); white cell count, 2.1 (95% CI: 1.3-3.4); and Glucose measurement 1.3 (95% CI: 0.8-2.1). The results for Recombinant Interleukin-6 were similar to other studies. , -6 and interleukin-10 binding activity levels were higher in patients with poor outcome. On logistic regression analysis, higher values of IL-6 were significantly associated with clinical outcome at 1 month (odds ratio [OR], 1.25; 95% confidence interval [CI], 1.02-1.54). , In hemorrhagic stroke, high levels of IL-6 in the early phase indicated a poor neurological outcome., Initially elevated levels of hs-IL-6 at presentation further correlated with unfavorable clinical outcomes (by NIHSS and mRs) at both time points. Analysis of variance in the different quartiles identified an hs-IL-6 gradient-dependent correlation at both time points, such that the higher the initial hs-IL-6 concentration, the higher the elevation in inflammatory biomarkers and the poorer the neurological state at both time points (p<0.001 for NIHSS and p=0.001 for mRs, for trend across quartiles). CONCLUSIONS: This study demonstrates the potential of employing hs-IL-6 as an early stage biomarker for the prognosis of Acute Ischemic Stroke. , Another negative correlation was found between IL-6 and Central Nervous System scores (r = -0.451, p = 0.000)., In addition, increased levels of IL-6 and reduced levels of Saposin-D, Human and spike protein, SARS-CoV-2 may play a role in Acute Ischemic Stroke severity., Variables that are predictors of adverse stroke outcome include Erythrocytes sedimentation rate, and levels of C-reactive protein (CRP), Recombinant Interleukin-6, tumour necrosis factor-alpha and Intercellular adhesion molecule 1. [SEP]Relations: Recombinant Interleukin-6 receptor binding has relations: molfunc_protein with PYCARD, molfunc_protein with PYCARD, molfunc_protein with CNTF, molfunc_protein with CNTF, molfunc_protein with IL6, molfunc_protein with IL6, molfunc_protein with IL6R, molfunc_protein with IL6R, molfunc_protein with ERAP1, molfunc_protein with ERAP1. Definitions: C-reactive protein defined as following: A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP).. Glucose measurement defined as following: The determination of the amount of Glucose measurement present in a sample.. Erythrocytes defined as following: Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN.. Recombinant Interleukin-6 defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine Recombinant Interleukin-6 (IL-6) with antiapoptotic, proinflammatory, antiinflammatory, proproliferative and proangiogenic activities. IL-6 binds to its receptor (IL-6R), activating a receptor-CD130 receptor complex; the CD130 portion of the complex is a signal transduction protein that activates JAK kinases and Ras-mediated signaling pathways, which in turn activate downstream signaling pathways, resulting in the activation of various transcription factors (STAT, ELK-1, NF-IL-6, etc.) and gene transcription. The physiological effects of IL-6 are complex and varied and include hematopoietic, pyrogenic and thermogenic, proinflammatory, antiinflammatory, proproliferative (anti-apoptotic), and angiogenic effects.. Intercellular adhesion molecule 1 defined as following: A cell-surface ligand involved in leukocyte adhesion and inflammation. Its production is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue.. interleukin-10 binding activity defined as following: Binding to interleukin-10. [GOC:jl]. Central Nervous System defined as following: The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.. spike protein, SARS-CoV-2 defined as following: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein (1273 aa, ~141 kDa) is encoded by the SARS-CoV-2 S gene. This protein plays a role in binding to host cell membranes and the initiation of viral infection.. Saposin-D, Human defined as following: Saposin-D (82 aa, ~9 kDa) is encoded by the human PSAP gene. This protein is involved in the activation of sphingomyelin phosphodiesterases.. stroke defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810).", "label": "yes"} {"original_question": "Is PLK2 involved in alpha-synuclein phosphorylation in the nervous system?", "id": "converted_758", "sentence1": "Is PLK2 involved in SNCA gene phosphorylation in the nervous system?", "sentence2": "PLK2 gene (PLK2) phosphorylates SNCA gene at serine 129 in CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS, Here we submit evidence that PLK1 gene (PLK2, also known as serum-inducible kinase or SNK) is a principle contributor to SNCA gene phosphorylation at Ser-129 in Neurons, PLK2 directly phosphorylates SNCA gene at Ser-129 in an in vitro biochemical assay, inhibitors of PLK1 protein, human kinases inhibited SNCA gene phosphorylation both in primary cortical cell cultures and in Mus sp. Head>Brain in vivo, specific knockdown of PLK2 expression by transduction with short hairpin RNA constructs or by knock-out of the plk2 gene reduced p-Ser-129 levels, These results indicate that PLK2 plays a critical role in SNCA gene phosphorylation in CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS., These results indicate that PLK2 plays a critical role in SNCA gene phosphorylation in CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS., Here we submit evidence that PLK1 gene (PLK2, also known as serum-inducible kinase or SNK) is a principle contributor to SNCA gene phosphorylation at Ser-129 in Neurons., PLK2 gene (PLK2) phosphorylates SNCA gene at serine 129 in CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS., PLK2 directly phosphorylates SNCA gene at Ser-129 in an in vitro biochemical assay., Two of these kinases stand out as potential drug targets for novel Lugano Lymphoma Response Classification Progressive Disease by PET therapy, namely Leucine-Rich Repeat Serine/Threonine-Protein Kinase 1 (LRRK2 protein, human protein, human) and the SNCA gene (α-syn) phosphorylating PLK1 gene (PLK2)., Also, due to the dominant mode of α-syn and LRRK2 protein, human protein, human inheritance and based on current knowledge of LRRK2 protein, human protein, human and α-syn phosphorylation by PLK2, inhibition of LRRK2 protein, human protein, human and PLK2 may constitute a potential therapy for Lugano Lymphoma Response Classification Progressive Disease by PET., To better understand the role of PLK2 in α-synuclein phosphorylation in vivo, we further evaluated the effect of PLK2 genetic knockdown and pharmacological inhibition on Phospho-α-Syn levels in different Head>Brain regions of PLK2 knockout (KELL NULL), heterozygous (Het) and wild-type (WT) mice., This PLK2-mediated neuroprotective effect is also dependent on PLK2 activity and α-synuclein phosphorylation., PLK2-mediated degradation of α-synuclein requires both phosphorylation at S129 and PLK2/α-synuclein complex formation., Overexpression of only PLK2 increased phosphorylation of aggregated α-syn at S129, which likely is due to increased phosphorylation of soluble α-syn, which then was incorporated into aggregates., Here we submit evidence that PLK1 gene (PLK2, also known as serum-inducible kinase or SNK) is a principle contributor to SNCA gene phosphorylation at Ser-129 in Neurons., PLK2 directly phosphorylates SNCA gene at Ser-129 in an in vitro biochemical assay., Unlike other kinases reported to partially phosphorylate alpha-syn at Ser-129 in vitro, phosphorylation by PLK2 and PLK3 protein, human protein, human is quantitative (, inhibitors of PLK1 protein, human kinases inhibited SNCA gene phosphorylation both in primary cortical cell cultures and in Mus sp. Head>Brain in vivo., These results indicate that PLK2 plays a critical role in SNCA gene phosphorylation in CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS, inhibitors of PLK1 protein, human kinases inhibited SNCA gene phosphorylation both in primary cortical cell cultures and in Mus sp. Head>Brain in vivo, PLK2 directly phosphorylates SNCA gene at Ser-129 in an in vitro biochemical assay, To better understand the role of PLK2 in α-synuclein phosphorylation in vivo, we further evaluated the effect of PLK2 genetic knockdown and pharmacological inhibition on Phospho-α-Syn levels in different Head>Brain regions of PLK2 knockout (KELL NULL), heterozygous (Het) and wild-type (WT) mice, Polo-like kinase-2 (PLK2 protein, human) has been implicated as the dominant kinase involved in the phosphorylation of α-synuclein in Lewy bodies, which are one of the hallmarks of Parkinson Disease neuropathology[SEP]Relations: Parkinson disease has relations: disease_protein with LRRK2 protein, human, disease_protein with LRRK2 protein, human, disease_protein with CNTNAP2, disease_protein with CNTNAP2. ELL has relations: molfunc_protein with phosphatase binding, molfunc_protein with phosphatase binding, protein_protein with PIP4K2A, protein_protein with PIP4K2A, protein_protein with POU2F2, protein_protein with POU2F2. Definitions: PLK2 protein, human defined as following: Serine/threonine-protein kinase PLK2 (685 aa, ~78 kDa) is encoded by the human PLK2 gene. This protein is involved in cell cycle progression, centriole duplication and serine/threonine phosphorylation.. serine defined as following: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.. Neurons defined as following: The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.. PLK3 protein, human defined as following: Serine/threonine-protein kinase PLK3 protein, human (646 aa, ~72 kDa) is encoded by the human PLK3 protein, human gene. This protein is involved in protein phosphorylation and cell cycle regulation.. SNCA gene defined as following: A synuclein that is a major component of LEWY BODIES and plays a role in SYNUCLEINOPATHIES, neurodegeneration and neuroprotection.. LRRK2 protein, human defined as following: Leucine-rich repeat serine/threonine-protein kinase 2 (2527 aa, ~286 kDa) is encoded by the human LRRK2 protein, human gene. This protein may play a role in protein phosphorylation.. PLK2 gene defined as following: This gene is involved in normal cell division.. Leucine-Rich Repeat Serine/Threonine-Protein Kinase 1 defined as following: Leucine-rich repeat serine/threonine-protein kinase 1 (2015 aa, ~225 kDa) is encoded by the human LRRK1 gene. This protein is involved in serine/threonine phosphorylation and osteoclast resorption of bone.. Parkinson Disease defined as following: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing Neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75). PLK1 gene defined as following: This gene plays a role in mitotic regulation.. Lugano Lymphoma Response Classification Progressive Disease by PET defined as following: A score of 4 or 5 on a 5-point PET scale with an increase in intensity of uptake from baseline and/or new FDG-avid foci consistent with lymphoma at interim or end of treatment assessment.. PLK1 protein, human defined as following: Serine/threonine-protein kinase PLK1 (603 aa, ~68 kDa) is encoded by the human PLK1 gene. This protein is involved in protein phosphorylation and the regulation of both cell cycle progression and cytokinesis.. PLK2 defined as following: This gene is involved in normal cell division..", "label": "yes"} {"original_question": "Is there any role of genotoxic pks + E. coli in cancer?", "id": "converted_3829", "sentence1": "Is there any role of genotoxic pks + E. coli in cancer?", "sentence2": "Mutational signature in Malignant neoplasm of colon and/or rectum caused by genotoxic pks+, Various species of the Intestinal Microbiome have been associated with the development of colorectal cancer1,2, but it has not been demonstrated that Bacteria have a direct role in the occurrence of oncogenic Gene Mutation. Escherichia coli can carry the pathogenicity island pks, which encodes a set of ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS that synthesize colibactin3. This fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether is believed to alkylate DNA on adenine residues4,5 and induces double-strand breaks in cultured cells3. Here we expose Homo sapiens intestinal organoids to genotoxic pks+ E. coli by repeated Luminal region injection over five months. Whole-genome sequencing of clonal organoids before and after this exposure revealed a distinct mutational signature that was absent from organoids injected with isogenic pks-mutant Bacteria. The same mutational signature was detected in a subset of 5,876 Homo sapiens cancer genomes from two independent cohorts, predominantly in Malignant neoplasm of colon and/or rectum. Our study describes a distinct mutational signature in Malignant neoplasm of colon and/or rectum and implies that the underlying mutational process results directly from past exposure to Bacteria carrying the colibactin-producing pks pathogenicity island.[SEP]Relations: malignant colon neoplasm has relations: disease_protein with CHEK2, disease_protein with CHEK2, disease_protein with MYC, disease_protein with MYC, disease_protein with RECK, disease_protein with RECK, disease_protein with APC, disease_protein with APC, disease_protein with NOX4, disease_protein with NOX4. Definitions: Luminal region defined as following: Relating to the lumen of a blood vessel or other tubular structure.. Homo sapiens defined as following: Members of the species Homo sapiens.. Intestinal Microbiome defined as following: The collection of microorganisms existing in the intestines of an organism.. adenine defined as following: A purine base and a fundamental unit of ADENINE NUCLEOTIDES.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Escherichia coli defined as following: A species of gram-negative, facultatively anaerobic, rod-shaped Bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Bacteria defined as following: One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive.. cancer defined as following: A malignant tumor at the original site of growth..", "label": "yes"} {"original_question": "Does an interferon (IFN) signature exist for SLE patients?", "id": "converted_3543", "sentence1": "Does an interferon (Homo sapiens leukocyte interferon) signature exist for Lupus Erythematosus, Systemic patients?", "sentence2": "IRF7 gene activation correlates with the Homo sapiens leukocyte interferon signature and recurrent disease., In Lupus Erythematosus, Systemic post-transplant, recurrent disease activity and induction of IRF7 protein expression correlated with activation of the Homo sapiens leukocyte interferon signature., Janus kinase inhibitor has the amelioration effect in lupus-prone CASP14 gene: the involvement of Homo sapiens leukocyte interferon signature gene downregulation., We also detected decreased expression of several Homo sapiens leukocyte interferon-signature Genes Ifit3 and ISG15 gene in CD4+ from Lupus Erythematosus, Systemic-prone CASP14 gene following 5-(tetradecyloxy)-2-furancarboxylic acid and Dual-Energy X-Ray Absorptiometry treatment, and IFIT3 gene gene in CD3+ T cells from Homo sapiens patients following immunosuppressant therapy including Steroids, respectively, We found that cDCs from prediseased TCSle male CASP14 gene express the Homo sapiens leukocyte interferon signature as female TCSle cDCs do. ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM are necessary but not sufficient to express this Homo sapiens leukocyte interferon signature, but high doses of ubiquitin-like protein conjugating enzyme activity can compensate for other steroidal components., Conventional Triglyceride storage disease with ichthyosis from Male and Female Lupus-Prone B6.NZM Sle1/Sle2/Sle3 Mice Express an Homo sapiens leukocyte interferon Signature and Have a Higher Immunometabolism That Are Enhanced by Estrogen [EPC] [EPC]., Type I Homo sapiens leukocyte interferon signature in childhood-onset systemic lupus erythematosus, Interferon Type I (Homo sapiens leukocyte interferon-I) plays a pivotal role in the pathogenesis of Lupus Erythematosus, Systemic. , The Homo sapiens leukocyte interferon-I score (positive or negative), as a measure of Homo sapiens leukocyte interferon-I activation, was assessed using real-time quantitative PCR (RT-PCR) expression values of Homo sapiens leukocyte interferon-I signature Genes (IFI44 gene gene, IFI44L gene gene, Interferon-Induced Protein with Tetratricopeptide Repeats 1, LY6E wt Allele, MX1 wt Allele, IFITM1 protein, Homo sapiens protein, Homo sapiens) in CD14 Antigen Antigen+ Monocytes of cSLE patients and healthy controls (HCs)[SEP]Relations: Human interferon beta has relations: drug_protein with IFNAR1, drug_protein with IFNAR1, drug_drug with Aminophylline, drug_drug with Aminophylline, drug_drug with Fenethylline, drug_drug with Fenethylline, drug_drug with Proxyphylline, drug_drug with Proxyphylline, drug_drug with 8-chlorotheophylline, drug_drug with 8-chlorotheophylline. Definitions: ISG15 gene defined as following: This gene is involved in both protein tagging and cell signaling.. IFI44 gene defined as following: This gene may play a role in the response to viral infection.. IFITM1 protein, Homo sapiens defined as following: Interferon-induced transmembrane protein 1 (125 aa, ~14 kDa) is encoded by the Homo sapiens IFITM1 protein, Homo sapiens gene. This protein is involved in interferon-induced antiviral responses.. Steroids defined as following: A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed). MX1 wt Allele defined as following: Human MX1 wild-type allele is located in the vicinity of 21q22.3 and is approximately 39 kb in length. This allele, which encodes interferon-induced GTP-binding protein Mx1, is involved in the regulation of apoptosis, hydrolysis of GTP, the modulation of interferon-regulated signaling.. ubiquitin-like protein conjugating enzyme activity defined as following: Isoenergetic transfer of a ubiquitin-like protein (ULP) from one protein to another via the reaction X-SCP + Y -> Y-SCP + X, where both the X-SCP and Y-SCP linkages are thioester bonds between the C-terminal amino acid of SCP and a sulfhydryl side group of a cysteine residue. [GOC:dph]. Interferon Type I defined as following: Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA).. IRF7 gene defined as following: This gene plays a role in the modulation of the innate immune response against DNA and RNA viruses.. Interferon-Induced Protein with Tetratricopeptide Repeats 1 defined as following: Interferon-induced protein with tetratricopeptide repeats 1 (478, ~55 kDa) is encoded by the Homo sapiens Interferon-Induced Protein with Tetratricopeptide Repeats 1 gene. This protein plays a role in binding to triphosphorylated, single-stranded viral RNA.. Monocytes defined as following: Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles.. LY6E wt Allele defined as following: Human LY6E wild-type allele is located in the vicinity of 8q24.3 and is approximately 4 kb in length. This allele, which encodes lymphocyte antigen Ly-6E protein, is involved in myelopoiesis and signal transduction.. Janus kinase defined as following: A family of intracellular tyrosine kinases that participate in the signaling cascade of cytokines by associating with specific CYTOKINE RECEPTORS. They act upon STAT TRANSCRIPTION FACTORS in signaling pathway referred to as the Janus kinase/STAT pathway. The name Janus kinase refers to the fact the proteins have two phosphate-transferring domains.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Triglyceride storage disease with ichthyosis defined as following: Neutral lipid storage disease (NLSD) refers to a group of diseases characterized by a deficit in the degradation of cytoplasmic triglycerides and their accumulation in cytoplasmic lipid vacuoles in most tissues of the body. The group is heterogeneous: currently cases of NLSD with icthyosis (NLSDI/Dorfman-Chanarin disease; see this term) and NLSD with myopathy (NLSDM/neutral lipid storage myopathy; see this term) can be distinguished.. Homo sapiens leukocyte interferon defined as following: Human interferons have been classified into 3 groups: alpha, beta, and gamma. Both alpha- and beta-IFNs, previously designated type I, are acid-stable, but they differ immunologically and in regard to some biologic and physiochemical properties. The IFNs produced by virus-stimulated leukocytes (leukocyte IFNs) are predominantly of the alpha type. Those produced by lymphoblastoid cells are about 90% alpha and 10% beta. Induced fibroblasts produce mainly or exclusively the beta type. The alpha- and beta-IFNs differ widely in amino acid sequence. The gamma or immune IFNs, which are produced by T lymphocytes in response to mitogens or to antigens to which they are sensitized, are acid-labile and serologically distinct from alpha- and beta-IFNs. (from OMIM 147570). CD14 Antigen defined as following: Glycolipid-anchored membrane glycoproteins expressed on cells of the myelomonocyte lineage including MONOCYTES; MACROPHAGES; and some GRANULOCYTES. They function as receptors for the complex of lipopolysaccharide (LPS) and LPS-binding protein.. Lupus Erythematosus, Systemic defined as following: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.. Dual-Energy X-Ray Absorptiometry defined as following: A technique for scanning bone and measuring bone mineral density (BMD). A DXA scanner produces 2 X-ray beams, each with different energy levels. One beam is high energy while the other is low energy. The amount of x-rays that pass through the bone is measured for each beam. This will vary depending on the thickness of the bone. Based on the difference between the 2 beams, the bone density can be measured.. Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Are osteoclasts specialized in bone degradation?", "id": "converted_2588", "sentence1": "Are Osteoclasts specialized in Specimen Type - Bone degradation?", "sentence2": "osteoclast-mediated attack on Specimen Type - Bone, Bone degradation is caused by Osteoclasts, the normal Specimen Type - Bone-resorbing cells. , cathepsin K is a highly potent collagenase Clostridium histolyticum Clostridium histolyticum in Osteoclasts and is responsible for Specimen Type - Bone degradation., In Osteoclasts, Proto-Oncogene Tyrosine-Protein Kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human, human controls podosome organization and Specimen Type - Bone degradation, which leads to an osteopetrotic phenotype in src(-/-) CASP14 gene, Bone degradation by Osteoclasts depends on the formation of a sealing zone, composed of an interlinked network of Podosomes, which delimits the degradation lacuna into which Osteoclasts secrete Acids and Proteolytic enzymes for treatment of wounds and ulcers. [SEP]Relations: osteoclast fusion has relations: bioprocess_protein with CD81, bioprocess_protein with CD81, bioprocess_protein with SBNO2, bioprocess_protein with SBNO2, bioprocess_protein with CD109, bioprocess_protein with CD109, bioprocess_protein with SH3PXD2A, bioprocess_protein with SH3PXD2A, bioprocess_protein with TCTA, bioprocess_protein with TCTA. Definitions: Acids defined as following: Chemical compounds which yield hydrogen ions or protons when dissolved in water, whose hydrogen can be replaced by metals or basic radicals, or which react with bases to form salts and water (neutralization). An extension of the term includes substances dissolved in media other than water. (Grant & Hackh's Chemical Dictionary, 5th ed). Osteoclasts defined as following: A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption.. Proto-Oncogene Tyrosine-Protein Kinase Src, human defined as following: Proto-oncogene tyrosine-protein kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human (536 aa, ~60 kDa) is encoded by the human SRC gene. This protein is involved in both receptor-mediated signal transduction and tyrosine phosphorylation.. collagenase Clostridium histolyticum defined as following: A metalloproteinase which degrades helical regions of native collagen to small fragments. Preferred cleavage is -Gly in the sequence -Pro-Xaa-Gly-Pro-. Six forms (or 2 classes) have been isolated from Clostridium histolyticum that are immunologically cross-reactive but possess different sequences and different specificities. Other variants have been isolated from Bacillus cereus, Empedobacter collagenolyticum, Pseudomonas marinoglutinosa, and species of Vibrio and Streptomyces. EC 3.4.24.3.. cathepsin K defined as following: A cysteine protease that is highly expressed in OSTEOCLASTS and plays an essential role in BONE RESORPTION as a potent EXTRACELLULAR MATRIX-degrading enzyme.. Podosomes defined as following: An actin-rich adhesion structure characterized by formation upon cell substrate contact and localization at the substrate-attached part of the cell, contain an F-actin-rich core surrounded by a ring structure containing proteins such as vinculin and talin, and have a diameter of 0.5 mm. [PMID:12837608, PMID:15890982].", "label": "yes"} {"original_question": "Is transcapillary albumin escape altered in diabetic patients?", "id": "converted_807", "sentence1": "Is transcapillary albumin escape altered in diabetic patients?", "sentence2": "On the contrary, altered TERalb and increased carotid artery intimal thickness are shown by all hypertensive type 2 diabetic patients, both with normal and altered patterns of Smooth Endoplasmic Reticulum., Altered systemic capillary permeability characterizes insulin-resistant hypertensive patients with Metabolic Syndrome X X., TERalb is increased in normo-albuminuric type 1 diabetic patients. [SEP]Relations: metabolic syndrome X has relations: disease_protein with HMGA1, disease_protein with HMGA1, disease_protein with INS, disease_protein with INS, disease_protein with MTTP, disease_protein with MTTP, disease_protein with TRIB3, disease_protein with TRIB3, disease_protein with RETN, disease_protein with RETN. Definitions: Metabolic Syndrome X defined as following: A combination of medical conditions that when present, increase the risk of heart attack, stroke, and diabetes mellitus. It includes the following medical conditions: increased blood pressure, central obesity, dyslipidemia, impaired glucose tolerance, and insulin resistance.. Smooth Endoplasmic Reticulum defined as following: A type of endoplasmic reticulum lacking associated ribosomes on the membrane surface. It exhibits a wide range of specialized metabolic functions including supplying enzymes for steroid synthesis, detoxification, and glycogen breakdown. In muscle cells, smooth endoplasmic reticulum is called SARCOPLASMIC RETICULUM..", "label": "yes"} {"original_question": "Do genes with monoallelic expression contribute proportionally to genetic diversity in humans?", "id": "converted_3706", "sentence1": "Do genes with monoallelic expression contribute proportionally to genetic diversity in Homo sapiens?", "sentence2": "Genes with monoallelic expression contribute disproportionately to genetic diversity in Homo sapiens., An unexpectedly large number of human autosomal genes are subject to monoallelic expression (Myoclonic Astatic Epilepsy). Our analysis of 4,227 such genes uncovers surprisingly high genetic variation across human populations. This increased diversity is unlikely to reflect relaxed purifying selection. Remarkably, Myoclonic Astatic Epilepsy genes exhibit an elevated recombination rate and an increased density of hypermutable sequence contexts. However, these factors do not fully account for the increased diversity. We find that the elevated nucleotide diversity of Myoclonic Astatic Epilepsy genes is also associated with greater allelic age: variants in these genes tend to be older and are enriched in Genetic Polymorphism shared by Neanderthals and chimpanzees. Both synonymous and nonsynonymous alleles of Myoclonic Astatic Epilepsy genes have elevated average population frequencies. We also observed strong enrichment of the Myoclonic Astatic Epilepsy signature among genes reported to evolve under balancing selection. We propose that an important biological function of widespread Myoclonic Astatic Epilepsy might be the generation of cell-to-cell heterogeneity; the increased genetic variation contributes to this heterogeneity., Genes with monoallelic expression contribute disproportionately to genetic diversity in Homo sapiens[SEP]Relations: myoclonic-astastic epilepsy has relations: disease_protein with RAPGEF2, disease_protein with RAPGEF2, disease_protein with SLC6A1, disease_protein with SLC6A1, disease_phenotype_positive with Developmental regression, disease_phenotype_positive with Developmental regression, disease_protein with AP2M1, disease_protein with AP2M1, disease_phenotype_positive with Global developmental delay, disease_phenotype_positive with Global developmental delay. Definitions: Genetic Polymorphism defined as following: The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.. Homo sapiens defined as following: Members of the species Homo sapiens.. Neanderthals defined as following: Common name for an extinct species of the Homo genus. Fossils have been found in Europe and Asia. Genetic evidence suggests that limited interbreeding with modern HUMANS (Homo sapiens) took place.. Myoclonic Astatic Epilepsy defined as following: A generalized myoclonic-atonic seizure is a type of generalized motor seizure characterized by a myoclonic jerk followed by an atonic motor component. [HPO:jalbers, PMID:28276060, PMID:28276064]. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "no"} {"original_question": "Is scuba diving safe during pregnancy?", "id": "converted_2263", "sentence1": "Is scuba diving safe during pregnancy?", "sentence2": "Scuba diving is contraindicated., Overall, the women did not conduct enough dives per pregnancy, therefore no significant correlation between diving and fetal abnormalities could be established. These data indicate women are increasingly observing the diving industry recommendation and refraining from diving while pregnant. , Scuba diving also should be avoided throughout pregnancy because the Fetus in fetu is at an increased risk for decompression sickness during this activity., Scuba diving also should be avoided throughout pregnancy because the Fetus in fetu is at an increased risk for decompression sickness during this activity., Scuba diving also should be avoided throughout pregnancy because the Fetus in fetu is at an increased risk for decompression sickness during this activity. , The different international federations and the Undersea and Hyperbaric Medical Society advise against scuba diving for pregnant women or those planning a pregnancy, but no randomized trials or trials provide a solid scientific basis. , Pregnant women are recommended not to dive, because the risk of Congenital Abnormality seems to be greater among those who do, and there is a serious risk of fetal decompression disease. , The different international federations and the Undersea and Hyperbaric Medical Society advise against scuba diving for pregnant women or those planning a pregnancy, but no randomized trials or trials provide a solid scientific basis., Scuba diving also should be avoided throughout pregnancy because the Fetus in fetu is at an increased risk for decompression sickness during this activity., Snorkeling can still be practiced during pregnancy, but scuba diving should be discontinued until after the birth period., Snorkeling can still be practiced during pregnancy, but scuba diving should be discontinued until after the birth period..[SEP]Relations: congenital abnormality has relations: disease_disease with Zika virus congenital syndrome, disease_disease with Zika virus congenital syndrome, disease_disease with developmental defect during embryogenesis, disease_disease with developmental defect during embryogenesis, disease_disease with Klippel-Feil syndrome, disease_disease with Klippel-Feil syndrome, disease_disease with congenital radioulnar synostosis, disease_disease with congenital radioulnar synostosis, disease_disease with cryptorchidism (disease), disease_disease with cryptorchidism (disease). Definitions: Congenital Abnormality defined as following: Malformations of organs or body parts during development in utero..", "label": "no"} {"original_question": "Is the apilimod inhibitor effective against SARS-CoV-2?", "id": "converted_4024", "sentence1": "Is the apilimod inhibitor effective against SARS-CoV-2?", "sentence2": "To identify therapeutics that can be repurposed as SARS-CoV-2 antivirals, we profiled a library of known drugs encompassing approximately 12,000 clinical-stage or FDA-approved small Molecule. Here, we report the identification of 30 known drugs that inhibit viral replication. Of these, six were characterized for cellular dose-activity relationships, and showed effective concentrations likely to be commensurate with therapeutic doses in patients. These include the PIKfyve kinase inhibitor apilimod, Cysteine Proteinase Inhibitors MDL 28170, Upper case Roman letter Upper case Roman letter Z LVG NEUROPATHY, CONGENITAL HYPOMYELINATING, 2, VBY-825, and ONO 5334, and the CCR1 antagonist MLN-3897. Since many of these Molecule have advanced into the clinic, the known pharmacological and Homo sapiens safety profiles of these compounds will accelerate their preclinical and clinical evaluation for COVID-19 treatment.[SEP]Relations: protein serine/threonine kinase inhibitor activity has relations: molfunc_protein with SPRY2, molfunc_protein with SPRY2, molfunc_protein with INKA2, molfunc_protein with INKA2, molfunc_protein with SPRED2, molfunc_protein with SPRED2, molfunc_protein with CIB1, molfunc_protein with CIB1, molfunc_protein with INKA1, molfunc_protein with INKA1. Definitions: Homo sapiens defined as following: Members of the species Homo sapiens.. Molecule defined as following: An aggregate of two or more atoms in a defined arrangement held together by chemical bonds.. Cysteine Proteinase Inhibitors defined as following: Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES..", "label": "yes"} {"original_question": "Is myasthenia gravis associated with osteoporosis?", "id": "converted_811", "sentence1": "Is myasthenia gravis associated with Encounter due to family history of osteoporosis?", "sentence2": "We performed cisplatin/etoposide protocol in 4 patients with generalized Myasthenia Gravis associated with recent Steroids-induced symptomatic VFs. , In this case report, we used ASSAY FOR TACROLIMUS to successfully treat a 13-year-old boy with ocular Myasthenia Gravis who had suffered from severe Steroids complications, including a failure of thrive and Encounter due to family history of Encounter due to family history of osteoporosis., INTRODUCTION: Myasthenia gravis (Myasthenia Gravis) is a Neuromuscular Diseases which has been associated with an increased falls risk and glucocorticoid-induced Encounter due to family history of Encounter due to family history of osteoporosis, recognized determinants of increased Fracture risk. , RESULTS: Compared to the control cohort, there was no statistically significant increased risk observed in patients with Myasthenia Gravis for any Fracture (adjusted hazard ratio [aromatic hydrocarbon receptor] 1.11; 95 % confidence interval [CI], 0.84-1.47) or osteoporotic fractures (aromatic hydrocarbon receptor 0.98 [95 % CI 0.67-1.41]). Further, use of oral glucocorticoids up to a cumulative dose exceeding 5 g prednisolone equivalents did not increase risk of Osteoporotic Fractures (aromatic hydrocarbon receptor 0.99 [95 % CI, 0.31-3.14]) compared with Myasthenia Gravis patients without glucocorticoid exposure., The TNFSF11 wt Allele/OPG ratio and indices of bone metabolisms are also not affected by THX, although THX increases the levels of Recombinant Interleukin-7 and TNFSF11 wt Allele., Both disorders had been controlled for around 15 years by oral prednisolone and a cholinesterase inhibitor following surgical removal of invasive thymoma and radiotherapy, but Muscle Weakness due to Myalgia and an increase in serum levels of myogenic enzymes, mainly ascribable to the recurrence of PM, reappeared immediately after cessation of these drugs, which was done because the patient had multiple bone fractures and severe Encounter due to family history of Encounter due to family history of osteoporosis due to the long-term corticosteroid therapy. , We measured bone density in 36 patients (26 females and 10 males) who had undergone long-term prednisolone administration, and found a decrease in bone density in 31% of female patients and Encounter due to family history of Encounter due to family history of osteoporosis in only 11.5% (three cases)., In conclusion, prednisolone-treated patients with myasthenia gravis have an acceptable risk of Osteopenia if prophylactic medication is administered., INTRODUCTION: Myasthenia gravis (Myasthenia Gravis) is a Neuromuscular Diseases which has been associated with an increased falls risk and glucocorticoid-induced Encounter due to family history of Encounter due to family history of osteoporosis, recognized determinants of increased Fracture risk., alendronate should be used with caution in patients with myasthenia gravis who have corticosteroid-induced Encounter due to family history of Encounter due to family history of osteoporosis, In this paper we present two cases of young women who developed severe PAO with Spinal Fractures: a 42-year-old woman with a family history of Encounter due to family history of Encounter due to family history of osteoporosis, and a 21-year-old woman affected with myasthenia gravis, Myasthenia gravis (Myasthenia Gravis) is a Neuromuscular Diseases which has been associated with an increased falls risk and glucocorticoid-induced Encounter due to family history of Encounter due to family history of osteoporosis, recognized determinants of increased Fracture risk[SEP]Relations: myasthenia gravis has relations: disease_phenotype_positive with Acrocyanosis, disease_phenotype_positive with Acrocyanosis, disease_phenotype_positive with Myositis, disease_phenotype_positive with Myositis, disease_protein with FAS, disease_protein with FAS, disease_phenotype_positive with Rheumatoid arthritis, disease_phenotype_positive with Rheumatoid arthritis, disease_protein with MUSK, disease_protein with MUSK. Definitions: TNFSF11 wt Allele defined as following: Human TNFSF11 wild-type allele is located within 13q14 and is approximately 45 kb in length. This allele, which encodes tumor necrosis factor ligand superfamily member 11 protein, plays a role in osteoclast differentiation and activation. This allele also is involved in apoptotic signal transduction and regulation.. Osteoporotic Fractures defined as following: A pathologic bone Fracture due to Encounter due to family history of osteoporosis. It is generally caused by a fall from a standing height or lower and usually involves the spine, hip, or wrist.. Fracture defined as following: A traumatic injury to the bone in which the continuity of the bone is broken.. Myasthenia Gravis defined as following: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.. Neuromuscular Diseases defined as following: A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.. Steroids defined as following: A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed). Spinal Fractures defined as following: Broken bones in the vertebral column.. alendronate defined as following: A nonhormonal medication for the treatment of postmenopausal Encounter due to family history of osteoporosis in women. This drug builds healthy bone, restoring some of the Osteopenia as a result of Encounter due to family history of osteoporosis.. Myalgia defined as following: Painful sensation in the muscles.. Osteopenia defined as following: Decreased calcification or density of bone tissue.. Recombinant Interleukin-7 defined as following: A recombinant protein which is chemically identical to or similar to endogenous interleukin-7 (Recombinant Interleukin-7) with hematopoietic and immunopotentiating properties. Produced by bone marrow, thymic stromal, and spleen cells, the cytokine interleukin-7 is a hematopoietic growth factor for progenitor B cells and T cells and stimulates proliferation and differentiation of mature T-cells and Natural Killer cells. (NCI05). Muscle Weakness defined as following: A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251). aromatic hydrocarbon receptor defined as following: approximately 280kD soluble protein complex; binds and mediates carcinogenesis by polycyclic aromatic hydrocarbons, heterocyclic amines, and chlorinated aromatic compounds.. prednisolone defined as following: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.. myasthenia gravis defined as following: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition..", "label": "yes"} {"original_question": "Are genes that escape X-chromosome inactivation related to mental impairment?", "id": "converted_3563", "sentence1": "Are genes that escape X-chromosome inactivation related to Abnormal mental state?", "sentence2": "Mutation screening of the MECP2 gene in a large cohort of 613 fragile-X negative patients with Intellectual Disability., The first one, the double nucleotide Substitution - ActClass c.1162_1163delinsTA leading to a Codon, Nonsense (p.Pro388X) was found in a female patient with random X-inactivation, presenting with borderline Abnormal mental state without any features of Rett Syndrome. , the c.679C>G Substitution - ActClass, changing a glutamine to a glutamate in the transcriptional repression functional domain (p.Gln227Glu), was found in a female patient with a moderately biased X-chromosome inactivation profile and presenting with mild intellectual delay and minor psychotic features, Genes that escape X-inactivation in Homo sapiens have high intraspecific variability in expression, are associated with Abnormal mental state but are not slow evolving., The newly described escape genes cluster on the X Chromosome in the same chromosomal regions as the previously known escapees. There is an excess of escaping genes associated with Intellectual Disability, consistent with this being a common phenotype of polyX phenotypes.[SEP]Relations: Intellectual disability has relations: disease_phenotype_positive with partial deletion of the short arm of chromosome 7, disease_phenotype_positive with partial deletion of the short arm of chromosome 7, disease_phenotype_positive with chromosome 18p deletion syndrome, disease_phenotype_positive with chromosome 18p deletion syndrome, disease_phenotype_positive with chromosome 11p13 deletion syndrome, distal, disease_phenotype_positive with chromosome 11p13 deletion syndrome, distal, disease_phenotype_positive with chromosome 10q23 deletion syndrome, disease_phenotype_positive with chromosome 10q23 deletion syndrome, disease_phenotype_positive with chromosome 18q deletion syndrome, disease_phenotype_positive with chromosome 18q deletion syndrome. Definitions: glutamine defined as following: A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells.. Homo sapiens defined as following: Members of the species Homo sapiens.. MECP2 gene defined as following: This gene plays a role in both the recognition of DNA methylation and the regulation of transcription.. Abnormal mental state defined as following: A change to an individual's judgment, orientation (to place, time, and self), intellectual functioning, or mood from their baseline.. Substitution - ActClass defined as following:

Definition: Indicates that the subject Act has undergone or should undergo Substitution - ActClass of a type indicated by Act.code.

Rationale: Used to specify \"allowed\" Substitution - ActClass when creating orders, \"actual\" susbstitution when sending events, as well as the reason for the Substitution - ActClass and who was responsible for it.

. Intellectual Disability defined as following: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28). Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Rett Syndrome defined as following: An inherited neurological developmental disorder that is associated with X-LINKED INHERITANCE and may be lethal in utero to hemizygous males. The affected female is normal until the age of 6-25 months when progressive loss of voluntary control of hand movements and communication skills; ATAXIA; SEIZURES; autistic behavior; intermittent HYPERVENTILATION; and HYPERAMMONEMIA appear. (From Menkes, Textbook of Child Neurology, 5th ed, p199). Codon, Nonsense defined as following: An amino acid-specifying codon that has been converted to a stop codon (CODON, TERMINATOR) by mutation. Its occurance is abnormal causing premature termination of protein translation and results in production of truncated and non-functional proteins. A nonsense mutation is one that converts an amino acid-specific codon to a stop codon.. X Chromosome defined as following: The female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in human and other male-heterogametic species.. genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Does Jarid2 play a role in early embryo development?", "id": "converted_2055", "sentence1": "Does JARID2 gene play a role in early embryo development?", "sentence2": "JARID2 gene Coordinates NANOG gene Expression and Pneumocystis jiroveci pneumonia/Wnt Signaling Required for Efficient ESC Differentiation and Early Embryo Development, Unlike other Polycomb Repressive Complex 2-deficient Embryonic Stem Cells (Enhanced S-Cone Syndrome), however, JARID2 gene-deficient Enhanced S-Cone Syndrome show a severe differentiation block, altered colony morphology, and distinctive patterns of deregulated gene expression. Here, we show that JARID2 gene(-/-) Enhanced S-Cone Syndrome express constitutively high levels of NANOG gene but reduced Pneumocystis jiroveci pneumonia signaling components WNT9A gene, PRICKLE1 gene, and FZD2 protein, human and lowered β-catenin activity. Depletion of WNT9A gene/PRICKLE1 gene/FZD2 protein, human from wild-type Enhanced S-Cone Syndrome or overexpression of NANOG gene largely phenocopies these cellular defects. Co-culture of JARID2 gene(-/-) with wild-type Enhanced S-Cone Syndrome restores variable NANOG gene expression and β-catenin activity and can partially rescue the differentiation block of mutant cells. In addition, we show that Enhanced S-Cone Syndrome lacking JARID2 gene or WNT9A gene/PRICKLE1 gene/FZD2 protein, human or overexpressing NANOG gene induce multiple between breakfast and lunch formation when injected into normal E3.5 blastocysts. These data describe a previously unrecognized role for JARID2 gene in regulating a core pluripotency and Wnt/Pneumocystis jiroveci pneumonia signaling circuit that is important for ESC differentiation and for pre-implantation development., JARID2 gene Coordinates NANOG gene Expression and Pneumocystis jiroveci pneumonia/Wnt Signaling Required for Efficient ESC Differentiation and Early Embryo Development., Consistent with an essential role for PcG proteins in early development, we demonstrate that JARID2 is required for the differentiation of mouse Embryonic Stem Cells., Jumonij (JMJ)/JARID2 gene plays important roles in embryonic development and functions as a Transcription Repressor/Corepressor., Thus, these results demonstrate that JARID2 is essential for the binding of PcG proteins to target Genes and, consistent with this, for the proper differentiation of Embryonic Stem Cells and normal development., JARID2 is an accessory component of Polycomb repressive complex-2 (Polycomb Repressive Complex 2) required for the differentiation of Embryonic Stem Cells (Enhanced S-Cone Syndrome)., JARID2 gene Coordinates NANOG gene Expression and Pneumocystis jiroveci pneumonia/Wnt Signaling Required for Efficient ESC Differentiation and Early Embryo Development., These data describe a previously unrecognized role for JARID2 gene in regulating a core pluripotency and Wnt/Pneumocystis jiroveci pneumonia signaling circuit that is important for ESC differentiation and for pre-implantation development..[SEP]Relations: embryonic skeletal system morphogenesis has relations: bioprocess_protein with HOXB2, bioprocess_protein with HOXB2, bioprocess_protein with SATB2, bioprocess_protein with SATB2, bioprocess_protein with DYNC2I1, bioprocess_protein with DYNC2I1, bioprocess_protein with DSCAML1, bioprocess_protein with DSCAML1, bioprocess_protein with OSR2, bioprocess_protein with OSR2. Definitions: NANOG gene defined as following: This gene plays a role in the underlying pluripotency of inner cell mass and Embryonic Stem Cells.. WNT9A gene defined as following: This gene plays a role in signal transduction and intercellular communication. It is involved in the regulation of cell behavior and fate during vertebrate development.. FZD2 protein, human defined as following: Frizzled-2 (565 aa, ~64 kDa) is encoded by the human FZD2 gene. This protein is involved in Wnt-mediated G protein-coupled receptor signaling.. Pneumocystis jiroveci pneumonia defined as following: Pneumonia resulting from infection with Pneumocystis jirovecii, frequently seen in the immunologically compromised, such as persons with AIDS, or steroid-treated individuals, the elderly, or premature or debilitated babies during their first three months. Patients may be only slightly febrile (or even afebrile), but are likely to be extremely weak, dyspneic, and cyanotic. This is a major cause of morbidity among patients with AIDS.. Polycomb Repressive Complex 2 defined as following: A multisubunit polycomb protein complex that catalyzes the METHYLATION of chromosomal HISTONE H3. It works in conjunction with POLYCOMB REPRESSIVE COMPLEX 1 to effect EPIGENETIC REPRESSION.. between breakfast and lunch defined as following: To be done between breakfast and lunch.. Embryonic Stem Cells defined as following: Cells derived from the BLASTOCYST INNER CELL MASS which forms before implantation in the uterine wall. They retain the ability to divide, proliferate and provide progenitor cells that can differentiate into specialized cells.. PRICKLE1 gene defined as following: This gene is involved in gastrulation and the regulation of Wnt signaling.. mouse Embryonic Stem Cells defined as following: PLURIPOTENT STEM CELLS derived from the BLASTOCYST INNER CELL MASS of day 3.5 mouse embryos.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Transcription Repressor/Corepressor defined as following: Transcription Repressor/Corepressor Gene encodes Transcriptional Repressor/Corepressor, proteins that can regulate transcription by binding to the operator and causing repression. (from Glick: Glossary of Biochemistry and Molecular Biology).", "label": "yes"} {"original_question": "Does hypofractionated radiotherapy offers any benefit for DIPG?", "id": "converted_4053", "sentence1": "Does hypofractionated radiotherapy offers any benefit for Diffuse Intrinsic Pontine Glioma?", "sentence2": "CONCLUSION: Hypofractionated RT for children with newly diagnosed Diffuse Intrinsic Pontine Glioma is well tolerated and feasible from the viewpoint of reducing a patient's burden of treatment. Re-irradiation at first progression is suggested to be beneficial., Median OS and time to progression were similar between conventionally fractionated and hypofractionated RT groups.(9.7 [95% confidence interval(CI): 7.1-11.2] versus 11.0[95% CI: 5.2-13.6] months, P = 0.60; 4.2[95% CI: 1.8-8.3] versus 7.1 [95% CI:4.5-8.7] months, P = 0.38). , The median overall survival (OS) was 11 months (95% CI - 7.5 to 14.5 months) in the conventional arm and 12 months (95% CI - 10.5 to 13.5 months) in the experimental arm (p = 0.208). 28% (n = 5) patients in the experimental arm developed grade 3 or 4 hematological Toxic effect.CONCLUSION: The above study shows that hypofractionated radiotherapy with concurrent and adjuvant temozolomide does not improve OS and has higher hematological Toxic effect. , CONCLUSIONS: The results of this meta-analysis suggest that CFRT and HFRT provide similar survival outcomes for patients with Diffuse Intrinsic Pontine Glioma., CONCLUSIONS: Hypofractionated radiotherapy offers lesser burden on the patients, their families and the treating departments, with nearly comparable results to conventional fractionation, though not fulfilling the non-inferiority assumption., xternal radiotherapy with a radical hypofractionated regimen is feasible and well tolerated in children with newly diagnosed Diffuse Intrinsic Pontine Glioma. However, this regimen does not seem to change overall survival in this setting.[SEP]Relations: diffuse intrinsic pontine glioma has relations: disease_disease with childhood brain stem glioma, disease_disease with childhood brain stem glioma. Definitions: Diffuse Intrinsic Pontine Glioma defined as following: A glioma that grows diffusely in the pons. It usually affects children and has a poor prognosis.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something..", "label": "no"} {"original_question": "Is Sotrovimab effective for COVID-19?", "id": "converted_4565", "sentence1": "Is Sotrovimab effective for COVID-19?", "sentence2": "It seems that Monoclonal Antibodies (e.g., low dosage bamlanivimab, baricitinib, imatinib, and sotrovimab) are a better choice for treating severe or non-severe COVID-19 patients. , The Food and Drug Administration has granted emergency use authorization to sotrovimab for the treatment of mild to moderate COVID-19 in patients at increased risk for progression to severe Illness (finding)., Early Treatment for COVID19 (document) with SARS-CoV-2 Neutralizing Antibody Sotrovimab., Sotrovimab is a pan-sarbecovirus monoclonal antibody CAL CAL that was designed to prevent progression of COVID19 (document) in high-risk patients early in the course of disease, CONCLUSIONS: Among high-risk patients with mild-to-moderate COVID19 (document), sotrovimab reduced the risk of disease progression., The Food and Drug Administration has granted emergency use authorization to sotrovimab for the treatment of mild to moderate COVID-19 in patients at increased risk for progression to severe Illness (finding).Sotrovimab is a monoclonal antibody CAL CAL that works directly against the M Protein, multiple myeloma of SARS-CoV-2 to block its attachment and entry into a Human cells., In patients with non-severe covid-19, casirivimab / imdevimab probably reduces hospitalisation; bamlanivimab-etesevimab, bamlanivimab, and sotrovimab may reduce hospitalisation. Convalescen, ms that Monoclonal Antibodies (e.g., low dosage bamlanivimab, baricitinib, imatinib, and sotrovimab) are a better choice for treating severe or non-severe COVID-19 patients. Clini, Early Treatment for COVID19 (document) with SARS-CoV-2 Neutralizing Antibody Sotrovimab, The Food and Drug Administration has granted emergency use authorization to sotrovimab for the treatment of mild to moderate COVID-19 in patients at increased risk for progression to severe Illness (finding)[SEP]Relations: Baricitinib has relations: drug_drug with Sofosbuvir, drug_drug with Sofosbuvir, drug_drug with Cortivazol, drug_drug with Cortivazol, drug_drug with Somatostatin, drug_drug with Somatostatin, drug_drug with Efalizumab, drug_drug with Efalizumab. Imatinib has relations: drug_drug with Sofosbuvir, drug_drug with Sofosbuvir. Definitions: Monoclonal Antibodies defined as following: Antibodies produced by a single clone of cells.. casirivimab / imdevimab defined as following: A combination of two Monoclonal Antibodies, casirivimab and imdevimab, directed against the M Protein, multiple myeloma (SP) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for immunization against COVID-19. Upon administration, casirivimab and imdevimab specifically target and bind to non-overlapping regions of the receptor-binding domain (RBD) of SP, thereby blocking viral attachment and entry into human cells and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2. Binding to two distinct regions of the RBD of SP may decrease the potential for virus escape mutants that occur upon treatment with a single SARS-CoV-2 antibody, and may provide enhanced protection against loss of efficacy.. baricitinib defined as following: An orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory, immunomodulating and antineoplastic activities. Upon administration, baricitinib binds to JAK1/2, which inhibits JAK1/2 activation and leads to the inhibition of the JAK-signal transducers and activators of transcription (STAT) signaling pathway. This decreases the production of inflammatory cytokines and may prevent an inflammatory response. In addition, baricitinib may induce apoptosis and reduce proliferation of JAK1/2-expressing tumor cells. JAK kinases are intracellular enzymes involved in cytokine signaling, inflammation, immune function and hematopoiesis; they are also upregulated and/or mutated in various tumor cell types.. Illness (finding) defined as following: A state of ill health, bodily malfunction, or discomfort.. M Protein, multiple myeloma defined as following: A protein complex comprised of two heavy chains and two light chains. Monoclonal immunoglobulin (M protein) is found in abundance in patients who have multiple myeloma. The protein is not produced in response to an antigen, but it is expressed in malignant plasma cells and excreted into the blood and urine.. monoclonal antibody CAL defined as following: A humanized monoclonal antibody CAL directed against parathyroid hormone-related protein (PTH-rP). As a poly-hormone with diverse biological roles, PTH-rP is expressed by normal tissues, acting in local tissue environments in a variety of ways; it is commonly overexpressed by breast, prostate, and other cancers, acting systemically by promoting bone resorption, inhibiting calcium excretion from the kidney, inducing hypercalcemia, and possibly playing a role in the formation of bony metastases. By blocking the effects of PTH-rP on calcium metabolism, monoclonal antibody CAL CAL may inhibit cancer-related hypercalcemia. (NCI04). imatinib defined as following: An antineoplastic agent that inhibits the Bcr-Abl fusion protein tyrosine kinase, an abnormal enzyme produced by chronic myeloid leukemia cells that contain the Philadelphia chromosome. Imatinib also inhibits the receptor tyrosine kinases for platelet-derived growth factor (PDGF) and stem cell factor (SCF)/c-kit; the SCF/c-kit receptor tyrosine kinase is activated in gastrointestinal stromal tumor (GIST). This agent inhibits proliferation and induces apoptosis in cells that overexpress these oncoproteins..", "label": "yes"} {"original_question": "Does Axitinib prolong survival of Pancreatic Cancer patients?", "id": "converted_3111", "sentence1": "Does Axitinib prolong survival of Pancreatic Cancer patients?", "sentence2": "CONCLUSIONS: Axitinib/gemcitabine, while tolerated, did not provide survival benefit over gemcitabine alone in patients with advanced Malignant neoplasm of pancreas from Japan or other regions., RESULTS: Among Japanese patients, median overall survival was not estimable (95% confidence interval, 7.4 months-not estimable) with axitinib/gemcitabine (n = 58) and 9.9 months (95% confidence interval, 7.4-10.5) with placebo/gemcitabine (n = 56) (hazard ratio 1.093 [95% confidence interval, 0.525-2.274]). Median survival follow-up (range) was 5.1 months (0.02-12.3) with axitinib/gemcitabine vs. 5.4 months (1.8-10.5) with placebo/gemcitabine. Similarly, no difference was detected in overall survival between axitinib/gemcitabine and placebo/gemcitabine in patients from North America or the European Union. , At an interim analysis in January, 2009, the independent data monitoring committee concluded that the futility boundary had been crossed. Median overall survival was 8·5 months (95% CI 6·9-9·5) for gemcitabine plus axitinib (n=314, data missing for two patients) and 8·3 months (6·9-10·3) for gemcitabine plus placebo (n=316; hazard ratio 1·014, 95% CI 0·786-1·309; one-sided p=0·5436). , INTERPRETATION: The addition of axitinib to gemcitabine does not improve overall survival in advanced Malignant neoplasm of pancreas. , INTERPRETATION\nThe addition of axitinib to gemcitabine does not improve overall survival in advanced Malignant neoplasm of pancreas., However, as with other Protein Tyrosine Kinase inhibitors of the same class, axitinib does not prolong overall survival; therefore, selection of second-line Protein Tyrosine Kinase inhibitor therapy, including axitinib, must be carefully considered to maximize outcomes for each patient., CONCLUSIONS\nAxitinib/gemcitabine, while tolerated, did not provide survival benefit over gemcitabine alone in patients with advanced Malignant neoplasm of pancreas from Japan or other regions., Similarly, no difference was detected in overall survival between axitinib/gemcitabine and placebo/gemcitabine in patients from North America or the European Union., Axitinib/gemcitabine, while tolerated, did not provide survival benefit over gemcitabine alone in patients with advanced Malignant neoplasm of pancreas from Japan or other regions., The addition of axitinib to gemcitabine does not improve overall survival in advanced Malignant neoplasm of pancreas.[SEP]Relations: Axitinib has relations: drug_drug with Panobinostat, drug_drug with Panobinostat, drug_drug with Proguanil, drug_drug with Proguanil, drug_drug with Afelimomab, drug_drug with Afelimomab, drug_drug with Entrectinib, drug_drug with Entrectinib, drug_drug with Dolutegravir, drug_drug with Dolutegravir. Definitions: axitinib defined as following: An orally bioavailable Protein Tyrosine Kinase inhibitor. Axitinib inhibits the proangiogenic cytokines vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor (PDGF), thereby exerting an anti-angiogenic effect.. Protein Tyrosine Kinase defined as following: Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors.. gemcitabine defined as following: A broad-spectrum antimetabolite and deoxycytidine analogue with antineoplastic activity. Upon administration, gemcitabine is converted into the active metabolites difluorodeoxycytidine diphosphate (dFdCDP) and difluorodeoxycytidine triphosphate (dFdCTP) by deoxycytidine kinase. dFdCTP competes with deoxycytidine triphosphate (dCTP) and is incorporated into DNA. This locks DNA polymerase thereby resulting in \"masked termination\" during DNA replication. On the other hand, dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis. The reduction in the intracellular concentration of dCTP potentiates the incorporation of dFdCTP into DNA.. Malignant neoplasm of pancreas defined as following: A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma.. Axitinib defined as following: An orally bioavailable Protein Tyrosine Kinase inhibitor. Axitinib inhibits the proangiogenic cytokines vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor (PDGF), thereby exerting an anti-angiogenic effect.. Pancreatic Cancer defined as following: A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma..", "label": "no"} {"original_question": "Can Isradipine slow progression of Early Parkinson Disease?", "id": "converted_4481", "sentence1": "Can Isradipine slow progression of Early Parkinson Disease?", "sentence2": "Adjusted least-squares mean changes in total UPDRS score in the antiparkinson medication ON state over 36 months for isradipine and placebo recipients were 2.99 (95% CI, 0.95 to 5.03) points versus 3.26 (CI, 1.25 to 5.26) points, respectively, with a treatment effect of -0.27 (CI, -3.02 to 2.48) point (P = 0.85)., Conclusion: Long-term treatment with immediate-release isradipine did not slow the clinical progression of early-stage Lugano Lymphoma Response Classification Progressive Disease by PET., Clinical Nurse Specialist - oncology: These results are consistent with the recent secondary analysis of the STEADY-Lugano Lymphoma Response Classification Progressive Disease by PET III clinical trial-suggesting that clinically attainable brain exposure to isradipine may slow early-stage Lugano Lymphoma Response Classification Progressive Disease by PET progression. © 2021 , These findings suggest that greater exposure to isradipine might slow disease progression., erm treatment with immediate-release isradipine did not slow the clinical progression of early-stage Lugano Lymphoma Response Classification Progressive Disease by PET.Primary Funding So, BACKGROUND: Recent examination of the STEADY-Lugano Lymphoma Response Classification Progressive Disease by PET III isradipine clinical trial data concluded that early-stage Parkinson Disease (Lugano Lymphoma Response Classification Progressive Disease by PET) participants who had longer exposure to isradipine had a significant delay in their need for symptomatic medication, as well as a lower medication burden at the end of t, RESULTS: Isradipine exposures did not correlate with the primary clinical outcome, changes in the antiparkinson therapy-adjusted Unified Parkinson's Disease Rating Scale parts I-III score over 36 months (Spearman rank correlation coefficient, rs : , These findings suggest that greater exposure to isradipine might slow disease progressio, Conclusion: Long-term treatment with immediate-release isradipine did not slow the clinical progression of early-stage P, However, in a recently completed phase 3 clinical trial, the dihydropyridine (DHP) LTCC inhibitor isradipine failed to slow disease progression in early Lugano Lymphoma Response Classification Progressive Disease by PET patients, questioning the feasibility of DHPs for Lugano Lymphoma Response Classification Progressive Disease by PET therapy., BACKGROUND: Recent examination of the STEADY-Lugano Lymphoma Response Classification Progressive Disease by PET III isradipine clinical trial data concluded that early-stage Parkinson Disease (Lugano Lymphoma Response Classification Progressive Disease by PET) participants who had longer exposure to isradipine had a significant delay in their need for symptomatic medication, as well as a lower medication burden at the end o[SEP]Relations: Isradipine has relations: drug_effect with Hyperkinetic movements, drug_effect with Hyperkinetic movements, drug_drug with Prenalterol, drug_drug with Prenalterol. Parkinson disease has relations: contraindication with Etidocaine, contraindication with Etidocaine, contraindication with Articaine, contraindication with Articaine, contraindication with Epinephrine, contraindication with Epinephrine. Definitions: Lugano Lymphoma Response Classification Progressive Disease by PET defined as following: A score of 4 or 5 on a 5-point PET scale with an increase in intensity of uptake from baseline and/or new FDG-avid foci consistent with lymphoma at interim or end of treatment assessment.. dihydropyridine defined as following: partially saturated derivative of pyridine; binds to and inhibits the voltage-gated calcium channel of skeletal muscle T junctional membranes, the principle molecular transducer of excitation-contraction coupling.. isradipine defined as following: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.. Clinical Nurse Specialist - oncology defined as following: A clinical nurse specialist that provides a high level of supportive and therapeutic care to cancer patients and their families. The Clinical Nurse Specialist - oncology is an excellent resource for current trends in cancer care and therapies.. Parkinson Disease defined as following: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75).", "label": "no"} {"original_question": "Have mutations in the ZEB2 gene been found in any human syndrome?", "id": "converted_983", "sentence1": "Have mutations in the ZEB2 Genes Genes been found in any human Book Syndrome?", "sentence2": "Mowat-Wilson Book Syndrome is a genetic disease caused by heterozygous mutations or Gene Deletion of the zinc finger E-box-binding homeobox 2 (ZEB2 Genes Genes) Genes, Mowat-Wilson Book Syndrome (Muckle-Wells Syndrome; Online Mendelian Inheritance In Man#235730) have characteristic facial features, a variety of congenital anomalies such as HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1, and Intellectual Disability caused by Mutation Abnormality or Gene Deletion Abnormality of ZEB2 Genes Genes Genes., owat-Wilson Book Syndrome (Muckle-Wells Syndrome) is a genetic disease caused by heterozygous mutations or Gene Deletion of the ZEB2 Genes Genes Genes, Muckle-Wells Syndrome is caused by de novo heterozygous mutations in the ZEB2 Genes Genes Genes, The cause of Muckle-Wells Syndrome is a de novo Mutation Abnormality in the ZEB2 Genes Genes Genes, owat-Wilson Book Syndrome (Muckle-Wells Syndrome) is a genetic disease caused by heterozygous mutations or Gene Deletion of the ZEB2 Genes Genes Genes, Muckle-Wells Syndrome have a heterozygous loss-of-function Mutation Abnormality in the zinc finger E-box protein 2 (ZEB2 Genes Genes) Genes, also called SLC9A3R2 Genes (Zinc Finger E-box Binding Homeobox 2) and ZEB2 Genes Genes wt Allele,, human Mowat-Wilson Book Syndrome, we suggest that Gene Deletion Abnormality of ZEB2 Genes Genes, is responsible for most of the effects of the Mutation Abnormality, Gene Mutation at the hZeb2 locus cause Mowat-Wilson Book Syndrome (Muckle-Wells Syndrome), Mowat-Wilson Book Syndrome and a Mutation Abnormality in ZEB2 Genes Genes, owat-Wilson Book Syndrome (Muckle-Wells Syndrome) is caused by a heterozygous Mutation Abnormality or Gene Deletion Abnormality of the ZEB2 Genes Genes Genes, The Book Syndrome is caused by mutations or Gene Deletion of the ZEB2 Genes Genes Genes, owat-Wilson Book Syndrome (Muckle-Wells Syndrome) is an autosomal dominant intellectual disability Book Syndrome, single-copy ZEB2 Genes Genes Genes Gene Deletion Abnormality at 2q22.3 consistent with Mowat-Wilson Book Syndrome, Mowat-Wilson Book Syndrome, confirmed by molecular analysis as a heterozygous Gene Deletion Abnormality of the ZEB2 Genes Genes Genes., Gene Deletion Abnormality encompassing ZEB2 Genes Genes, the Genes responsible for the Mowat-Wilson Book Syndrome, Six patients had Gene Deletion in the ZEB2 Genes Genes Genes, ZEB2 Genes Genes Genes analysis for Mowat-Wilson Book Syndrome, Mowat-Wilson Book Syndrome (Muckle-Wells Syndrome) like appearance was noted. The disease is caused by Mutation Abnormality or Gene Deletion Abnormality of ZEB2 Genes Genes Genes, owat-Wilson Book Syndrome (Muckle-Wells Syndrome; Online Mendelian Inheritance In Man #235730) is a genetic condition caused by heterozygous mutations or Gene Deletion of the ZEB2 Genes Genes Genes, owat-Wilson Book Syndrome (Muckle-Wells Syndrome) is an autosomal dominant developmental disorder with mental retardation and variable multiple Congenital Abnormality due to mutations of the ZEB2 Genes Genes (ZEB2 Genes Genes wt Allele) , Muckle-Wells Syndrome is caused by heterozygous mutations or Gene Deletion in the Zinc finger E-box-binding homeobox 2 Genes, ZEB2 Genes Genes, previously called ZEB2 Genes Genes wt Allele (SLC9A3R2 Genes), owat-Wilson Book Syndrome (Muckle-Wells Syndrome) is a multiple congenital anomaly-mental retardation complex caused by mutations in the Zinc Finger Homeobox 1 B Genes (ZEB2 Genes Genes wt Allele), the ZEB2 Genes Genes wt Allele Genes, which is known to be involved in the Mowat-Wilson Book Syndrome, de novo heterozygous mutations or Gene Deletion of the ZEB2 Genes Genes wt Allele Genes located at 2q22, owat-Wilson Book Syndrome (Muckle-Wells Syndrome) is a recently delineated mental retardation (Mitral Valve Insufficiency)-multiple congenital anomaly Book Syndrome, FHX1B mutations in patients with Mowat-Wilson Book Syndrome, Gene Mutation leading to haploinsufficiency of the ZEB2 Genes Genes wt Allele Genes, Mutation Abnormality in the ZEB2 Genes Genes wt Allele Genes associated with an atypical Mowat-Wilson Book Syndrome phenotype, ZEB2 Genes Genes wt Allele Mutation Abnormality associated with a mild Mowat-Wilson Book Syndrome, Patients with zinc finger homeo box 1B (ZEB2 Genes Genes wt Allele) mutations or Gene Deletion develop multiple congenital anomalies including HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1, known as Mowat-Wilson Book Syndrome (Muckle-Wells Syndrome), Heterozygous mutations or Gene Deletion involving the Genes ZEB2 Genes Genes wt Allele (previously SLC9A3R2 Genes) [Online Mendelian Inheritance In Man 605802] have recently been found to cause Muckle-Wells Syndrome, ZEB2 Genes Genes wt Allele Gene Deletion, splice site or truncating mutations were detected in all 28 patients classified as typical Muckle-Wells Syndrome, Mowat-Wilson Book Syndrome with Gene Deletion Abnormality/Mutation Abnormality in the zinc finger homeo box 1B Genes (ZEB2 Genes Genes wt Allele), mutations in the zinc finger homeo box 1B Genes, ZEB2 Genes Genes wt Allele (SLC9A3R2 Genes), ZEB2 Genes Genes wt Allele Genes transcripts during Mus sp. and human development supports the various clinical manifestations of the \"Mowat-Wilson\" Book Syndrome, ZEB2 Genes Genes wt Allele mutations cause a complex developmental phenotype characterized by severe mental retardation (Mitral Valve Insufficiency) and multiple congenital defects, Mutation Abnormality of the zinc finger homeo box 1 B Genes in syndromic corpus callosum agenesis (Mowat-Wilson Book Syndrome, Book Syndrome is the result of heterozygous Gene Deletion or truncating mutations of the ZEB2 Genes Genes wt Allele (SLC9A3R2 Genes) Genes, Homo sapiens with Zfhx1b mutations (Mowat-Wilson Book Syndrome, Book Syndrome occurs as a result of heterozygous mutations or Gene Deletion in the zinc finger E-box-binding homeobox 2 Genes, ZEB2 Genes Genes, previously called ZEB2 Genes Genes wt Allele (SLC9A3R2 Genes), owat-Wilson Book Syndrome (Muckle-Wells Syndrome) is a recently delineated mental retardation;, Mowat-Wilson Book Syndrome is a congenital Book Syndrome caused by a defect of the transcriptional repressor ZEB2 Genes Genes wt Allele (SLC9A3R2 Genes), Mowat-Wilson Book Syndrome patients, and all siblings had the same E87X nonsense Mutation Abnormality in ZEB2 Genes Genes wt Allele[SEP]Relations: ZEB2 Genes has relations: disease_protein with Mowat-Wilson Book Syndrome due to a ZEB2 Genes point Mutation Abnormality, disease_protein with Mowat-Wilson Book Syndrome due to a ZEB2 Genes point Mutation Abnormality, protein_protein with SMAD2, protein_protein with SMAD2, anatomy_protein_present with blood, anatomy_protein_present with blood, anatomy_protein_present with brain, anatomy_protein_present with brain, anatomy_protein_present with embryo, anatomy_protein_present with embryo. Definitions: Online Mendelian Inheritance In Man defined as following: This database is a catalog of human genes and genetic disorders authored and edited by Dr. Victor A. McKusick and his colleagues at Johns Hopkins and elsewhere, and developed for the World Wide Web by NCBI, the National Center for Biotechnology Information. The database contains textual information and references. It also contains copious links to MEDLINE and sequence records in the Entrez system, and links to additional related resources at NCBI and elsewhere.. 2q22 defined as following: A chromosome band present on 2q.. ZEB2 Genes wt Allele defined as following: Human ZEB2 Genes wild-type allele is located in the vicinity of 2q22 and is approximately 132 kb in length. This allele, which encodes zinc finger E-box-binding homeobox 2 protein, is involved in regulation of transcription. Gene Mutation in this Genes are associated with Mowat-Wilson Book Syndrome.. ZEB2 Genes defined as following: This Genes is involved in regulation of transcription.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA.. Zinc Finger E-box Binding Homeobox 2 defined as following: A transcription factor that consists of 8 CYS2-HIS2 ZINC FINGERS flanking a central HOMEOBOX. It binds to the 5'-CACCT-3' DNA sequence located within E-BOX ELEMENTS of many genes essential for embryonic growth and development and regulates their activity; it represses transcription of the E-CADHERIN Genes. Gene Mutation in the ZEB2 Genes Genes are associated with MOWAT-WILSON SYNDROME.. Gene Deletion defined as following: A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This Gene Deletion Abnormality may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a Gene Deletion Abnormality at one specific locus.. Congenital Abnormality defined as following: Malformations of organs or body parts during development in utero.. Mowat-Wilson Book Syndrome defined as following: A rare autosomal dominant Book Syndrome caused by mutations in the ZEB2 Genes Genes. It is characterized by mental retardation, and a distinctive facial appearance (wide set eyes, uplifted earlobes, broad nasal bridge, prominent chin, and a smiling expression). The majority of patients have HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 (colonic enlargement and constipation due to intestinal blockage).. Muckle-Wells Syndrome defined as following: An autoinflammatory disease caused by mutations in the NLRP3 Genes which encodes cryopyrin. It is characterized by recurrent episodes of urticaria and fever which develop in infancy. It may lead to sensorineural hearing loss and/or amyloidosis.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Gene Mutation may be associated with genetic diversity or with pathologies including cancer.. Intellectual Disability defined as following: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28). Mitral Valve Insufficiency defined as following: Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Homo sapiens defined as following: Members of the species Homo sapiens.. Book Syndrome defined as following: Book Book Syndrome is a rare autosomal dominant ectodermal dysplasia Book Syndrome reported in a Swedish family (25 cases from 4 generations), and one isolated case. The Book Syndrome has characteristics of premolar aplasia, hyperhidrosis, and premature graying of the hair. Additional features reported in the isolated case include a narrow palate, hypoplastic nails, eyebrow anomalies, a unilateral simian crease, and poorly formed dermatoglyphics.. ZEB2 Genes Genes defined as following: This Genes is involved in regulation of transcription.. mutations defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA..", "label": "yes"} {"original_question": "Does tremelimumab improve survival of mesothelioma patients?", "id": "converted_2876", "sentence1": "Does tremelimumab improve survival of mesothelioma patients?", "sentence2": "BACKGROUND: tremelimumab, an anti-CTLA4 monoclonal antibody, initially showed good activity when used alone in patients with mesothelioma, but did not improve the overall survival of patients who failed on first-line or second-line chemotherapy compared with placebo in the DETERMINE study. , INTERPRETATION: The combination of tremelimumab and durvalumab appeared active, with a good safety profile in patients with mesothelioma, warranting further exploration., Biological and clinical considerations rule out the use of tremelimumab as single agent for Millimole per Liter and, more generally, the use of Immune Checkpoint Inhibitors for Millimole per Liter is still largely questionable and not supported by evidences., At the data cutoff date (Jan 24, 2016), 307 (80%) of 382 patients had died in the tremelimumab group and 154 (81%) of 189 patients had died in the placebo group. Median overall survival in the intention-to-treat population did not differ between the treatment groups: 7·7 months (95% CI 6·8-8·9) in the tremelimumab group and 7·3 months (5·9-8·7) in the placebo group (hazard ratio 0·92 [95% CI 0·76-1·12], p=0·41). , INTERPRETATION: tremelimumab did not significantly prolong overall survival compared with placebo in patients with previously treated Malignant mesothelioma., BACKGROUND\ntremelimumab, an anti-CTLA4 monoclonal antibody, initially showed good activity when used alone in patients with mesothelioma, but did not improve the overall survival of patients who failed on first-line or second-line chemotherapy compared with placebo in the DETERMINE study., INTERPRETATION\ntremelimumab did not significantly prolong overall survival compared with placebo in patients with previously treated Malignant mesothelioma., Median overall survival in the intention-to-treat population did not differ between the treatment groups: 7·7 months (95% CI 6·8-8·9) in the tremelimumab group and 7·3 months (5·9-8·7) in the placebo group (hazard ratio 0·92 [95% CI 0·76-1·12], p=0·41)., BACKGROUND tremelimumab, an anti-CTLA4 monoclonal antibody, initially showed good activity when used alone in patients with mesothelioma, but did not improve the overall survival of patients who failed on first-line or second-line chemotherapy compared with placebo in the DETERMINE study., INTERPRETATION tremelimumab did not significantly prolong overall survival compared with placebo in patients with previously treated Malignant mesothelioma., Median overall survival in the intention-to-treat population did not differ between the treatment groups: 7·7 months (95% CI 6·8-8·9) in the tremelimumab group and 7·3 months (5·9-8·7) in the placebo group (hazard ratio 0·92 [95% CI 0·76-1·12], p=0·41). , BACKGROUND: tremelimumab, an anti-CTLA4 monoclonal antibody, initially showed good activity when used alone in patients with mesothelioma, but did not improve the overall survival of patients who failed on first-line or second-line chemotherapy compared with placebo in the DETERMINE study.[SEP]Relations: tremelimumab has relations: drug_drug with Afelimomab, drug_drug with Afelimomab, drug_drug with Cemiplimab, drug_drug with Cemiplimab, drug_drug with Canakinumab, drug_drug with Canakinumab, drug_drug with Eculizumab, drug_drug with Eculizumab, drug_drug with Lumiliximab, drug_drug with Lumiliximab. Definitions: Malignant mesothelioma defined as following: A type of mesothelioma with a tendency to metastasize. Most tumors originate from either the PLEURA or PERITONEUM, tumors may also originate in the PERICARDIUM or testicular tissue. It is associated with ASBESTOS exposure. Somatic mutations identified in WT1, BCL10, CDKN2A, NF2, and BAP1 genes are associated with the malignancy. OMIM: 156240.. Millimole per Liter defined as following: A unit of concentration (molarity unit) equal to one thousandth of a mole (10E-3 mole) of solute per one liter of solution.. tremelimumab defined as following: A human IgG2 monoclonal antibody directed against the T-cell receptor protein cytotoxic T-lymphocyte-associated protein 4 (CTLA4). tremelimumab binds to CTLA4 and blocks the binding of the antigen-presenting cell ligands B7-1 and B7-2 to CTLA4, resulting in inhibition of B7-CTLA4-mediated downregulation of T-cell activation; subsequently, B7-1 or B7-2 may interact with another T-cell surface receptor protein, CD28, resulting in a B7-CD28-mediated T-cell activation unopposed by B7-CTLA4-mediated inhibition.. Immune Checkpoint Inhibitors defined as following: An agent that inhibits any of the immune checkpoint inhibitory proteins.. durvalumab defined as following: A monoclonal antibody directed against B7H1 (B7 homolog 1; programmed cell death ligand 1) with potential immunostimulating activity. Upon intravenous administration, durvalumab binds to the cell surface antigen B7H1, thereby blocking B7H1 signaling. This may activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against B7H1-expressing tumor cells. B7H1, a member of the B7 protein superfamily and a negative regulator of cytokine synthesis, is overexpressed on certain tumor cell types.. tremelimumab defined as following: A human IgG2 monoclonal antibody directed against the T-cell receptor protein cytotoxic T-lymphocyte-associated protein 4 (CTLA4). tremelimumab binds to CTLA4 and blocks the binding of the antigen-presenting cell ligands B7-1 and B7-2 to CTLA4, resulting in inhibition of B7-CTLA4-mediated downregulation of T-cell activation; subsequently, B7-1 or B7-2 may interact with another T-cell surface receptor protein, CD28, resulting in a B7-CD28-mediated T-cell activation unopposed by B7-CTLA4-mediated inhibition.. mesothelioma defined as following: A type of mesothelioma with a tendency to metastasize. Most tumors originate from either the PLEURA or PERITONEUM, tumors may also originate in the PERICARDIUM or testicular tissue. It is associated with ASBESTOS exposure. Somatic mutations identified in WT1, BCL10, CDKN2A, NF2, and BAP1 genes are associated with the malignancy. OMIM: 156240..", "label": "no"} {"original_question": "Have toll-like receptor 2 activators been found in food?", "id": "converted_3701", "sentence1": "Have toll-like receptor 2 activators been found in food?", "sentence2": "TLR2 wt Allele gene (TLR2 wt Allele wt Allele) is a widely expressed pattern recognition receptor critical for innate immunity. TLR2 wt Allele wt Allele is also a key regulator of mucosal immunity implicated in the development of allergic disease. TLR2 wt Allele wt Allele activators are found in many common Food,, TLR2 wt Allele wt Allele activators are found in many common Food, but the role of TLR2 wt Allele wt Allele in oral tolerance and Allergic sensitization to Food is not well understood., TLR2 wt Allele wt Allele activators are found in many common Food, but the role of TLR2 wt Allele wt Allele in oral tolerance and Allergic sensitization to Food is not well understood.[SEP]Relations: sensitization has relations: bioprocess_protein with DRD5, bioprocess_protein with DRD5, bioprocess_bioprocess with nonassociative learning, bioprocess_bioprocess with nonassociative learning. Definitions: TLR2 wt Allele defined as following: Human TLR2 wt Allele wild-type allele is located within 4q32 and is approximately 18 kb in length. This allele, which encodes toll-like receptor 2 protein, is involved in pathogen recognition, cytokine mediation and innate immunity.. Allergic sensitization defined as following: A process characterized by an initial humoral or cell-mediated immune response to a foreign antigen resulting in the production of specific antibodies and/or immune cells which may then lead to an allergic disposition.. TLR2 gene defined as following: This gene plays a role in pathogen recognition and mediates the host response to gram-positive bacteria and yeast.. Food defined as following: Substances taken in by the body to provide nourishment..", "label": "yes"} {"original_question": "Is BNN20 involved in Parkinson's disease?", "id": "converted_3323", "sentence1": "Is BNN20 involved in Parkinson Disease?", "sentence2": "Nerve Growth Factors are among the most promising treatments aiming at slowing or stopping and even reversing Parkinson Disease (Lugano Lymphoma Response Classification Progressive Disease by PET). However, in most cases, they cannot readily cross the human blood-Head>Brain-barrier (BBB). Herein, we propose as a therapeutic for Lugano Lymphoma Response Classification Progressive Disease by PET the small molecule 17-beta-spiro-[5-androsten-17,2'-oxiran]-3beta-ol (BNN-20), a synthetic analogue of prasterone, which crosses the BBB and is deprived of endocrine side-effects. Using the \"weaver\" Mus sp., a genetic model of Lugano Lymphoma Response Classification Progressive Disease by PET, which exhibits progressive dopamine hydrochloride Nerve Degeneration in the Substantia nigra structure (SN), we have shown that long-term administration (P1-P21) of BNN-20 almost fully protected the Dopaminergic Neurons and their terminals, via i) a strong anti-apoptotic effect, probably mediated through the Tropomyosin receptor kinase B (tropomyosin-related kinase-B, human) neurotrophin receptor's PI3K-Akt-NF-κB signaling pathway, ii) by exerting an efficient antioxidant effect, iii) by inducing significant anti-inflammatory activity and iv) by restoring Brain-Derived Neurotrophic Factor (Head>Brain-derived neurotrophic factor) levels. By intercrossing \"weaver\" with NGL CASP14 gene (dual GFP/luciferase-NF-κΒ reporter CASP14 gene, NF-κΒ.GFP.Luc), we obtained Weaver/NGL CASP14 gene that express the NF-κB reporter in all Diploid Cell. Acute BNN-20 administration to Weaver/NGL CASP14 gene induced a strong NF-κB-dependent transcriptional response in the Head>Brain as detected by bioluminescence imaging, which was abolished by co-administration of the tropomyosin-related kinase-B, human inhibitor ANA-12. This indicates that BNN-20 exerts its beneficial action (at least in part) through the tropomyosin-related kinase-B, human-PI3K-Akt-NF-κB signaling pathway. These results could be of clinical relevance, as they suggest BNN-20 as an important neuroprotective agent acting through the tropomyosin-related kinase-B, human neurotrophin receptor pathway, mimicking the action of the endogenous neurotrophin Head>Brain-derived neurotrophic factor. Thus BNN-20 could be proposed for treatment of Lugano Lymphoma Response Classification Progressive Disease by PET.[SEP]Relations: Parkinson disease has relations: disease_protein with BST1, disease_protein with BST1, disease_protein with Head>Brain-derived neurotrophic factor, disease_protein with Head>Brain-derived neurotrophic factor, disease_protein with FBP1, disease_protein with FBP1, disease_protein with CNTNAP2, disease_protein with CNTNAP2, disease_protein with TBP, disease_protein with TBP. Definitions: Substantia nigra structure defined as following: The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis.. tropomyosin-related kinase-B, human defined as following: Head>Brain-derived neurotrophic factor/NT-3 growth factors receptor (822 aa, ~92 kDa) is encoded by the human NTRK2 gene. This protein plays a role in growth factor-dependent signaling, tyrosine phosphorylation and nervous system development.. Lugano Lymphoma Response Classification Progressive Disease by PET defined as following: A score of 4 or 5 on a 5-point PET scale with an increase in intensity of uptake from baseline and/or new FDG-avid foci consistent with lymphoma at interim or end of treatment assessment.. Head>Brain-derived neurotrophic factor defined as following: A member of the nerve growth factor family of trophic factors. In the Head>Brain Head>Brain-derived neurotrophic factor has a trophic action on retinal, cholinergic, and Dopaminergic Neurons, and in the peripheral nervous system it acts on both motor and sensory neurons. (From Kendrew, The Encyclopedia of Molecular Biology, 1994). Nerve Degeneration defined as following: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.. Nerve Growth Factors defined as following: Factors which enhance the growth potentialities of sensory and sympathetic nerve cells.. Diploid Cell defined as following: Nucleated cell which has one or more diploid sets (46 pairs) of chromosomes.. prasterone defined as following: A synthetic form of dehydroepiandrosterone with potential chemopreventive activity. Produced endogenously, dehydroepiandrosterone (prasterone) is an intermediate in the conversion of cholesterol to androgens and estrogens. Although the mechanisms of action of exogenously administered prasterone have not been fully illuminated, they may result in both direct and indirect physiologic effects. Direct effects include GABA-a receptor complex and NMDA receptor modulation, and enhanced pancreatic beta cell insulin secretion and antiglucocorticoid activities. (NCI04). Dopaminergic Neurons defined as following: Neurons whose primary neurotransmitter is DOPAMINE.. Parkinson Disease defined as following: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75). dopamine hydrochloride defined as following: The hydrochloride salt form of dopamine, a monoamine compound with positive inotropic activity. Dopamine is a naturally occurring catecholamine formed by decarboxylation of dehydroxyphenylalanine and a precursor of norepinephrine and epinephrine. Dopamine binds to alpha-1- and beta-1- adrenergic receptors. Mediated through myocardial beta-1-adrenergic receptors, dopamine increase heart rate and force, thereby increasing cardiac output. Alpha-1-adrenergic receptor stimulation on vascular smooth muscle, leads to vasoconstriction and results in an increase in systemic vascular resistance. Stimulation of dopamine hydrochloride receptors in renal vasculature, leads to renal blood vessel dilation, and an increase in glomerular filtration rate, renal blood flow, sodium excretion, and urine output..", "label": "yes"} {"original_question": "Is synapsin a phosphoprotein?", "id": "converted_1750", "sentence1": "Is synapsin a Phosphoproteins?", "sentence2": "Synapsins is an evolutionarily conserved presynaptic Phosphoproteins., Synapsins as a family of presynaptic terminal Phosphoproteins participates in neuronal development, Synapsins III (SynIII) is a Phosphoproteins, The neuronal Phosphoproteins synapsin III, Synapsins II is a member of the neuronal Phosphoproteins family., Phosphoproteins synapsin[SEP]Relations: phosphoglycoprotein 1 has relations: disease_disease with Mendelian disease, disease_disease with Mendelian disease. neuronal tumor has relations: disease_disease with neuroepithelial neoplasm, disease_disease with neuroepithelial neoplasm, disease_disease with extraventricular neurocytoma, disease_disease with extraventricular neurocytoma, disease_disease with central neurocytoma, disease_disease with central neurocytoma, disease_disease with cerebellar liponeurocytoma, disease_disease with cerebellar liponeurocytoma. Definitions: Synapsins defined as following: A family of synaptic vesicle-associated proteins involved in the short-term regulation of NEUROTRANSMITTER release. Synapsins I, the predominant member of this family, links SYNAPTIC VESICLES to ACTIN FILAMENTS in the presynaptic nerve terminal. These interactions are modulated by the reversible PHOSPHORYLATION of synapsin I through various signal transduction pathways. The protein is also a substrate for cAMP- and CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES. It is believed that these functional properties are also shared by synapsin II.. Phosphoproteins defined as following: Proteins that contain phosphate groups esterified to serine, threonine or tyrosine. The phosphate group usually regulates protein function.. synapsin defined as following: A family of synaptic vesicle-associated proteins involved in the short-term regulation of NEUROTRANSMITTER release. Synapsins I, the predominant member of this family, links SYNAPTIC VESICLES to ACTIN FILAMENTS in the presynaptic nerve terminal. These interactions are modulated by the reversible PHOSPHORYLATION of synapsin I through various signal transduction pathways. The protein is also a substrate for cAMP- and CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES. It is believed that these functional properties are also shared by synapsin II..", "label": "yes"} {"original_question": "Can Logic Alignment Free (LAF) be used for bacterial genomes classification?", "id": "converted_2463", "sentence1": "Can Logic Alignment Free (Interleukin-1) be used for Genome, Bacterial classification?", "sentence2": "Interleukin-1: Logic Alignment Free and its application to Genome, Bacterial classification., In this paper, we present Logic Alignment Free (Interleukin-1), a method that combines alignment-free techniques and rule-based classification algorithms in order to assign biological samples to their taxa. This method searches for a minimal subset of k-mers whose relative frequencies are used to build classification models as disjunctive-normal-form logic formulas (if-then rules). We apply Interleukin-1 successfully to the classification of Genome, Bacterial to their corresponding taxonomy. In particular, we succeed in obtaining reliable classification at different taxonomic levels by extracting a handful of rules, each one based on the frequency of just few k-mers. State of the art methods to adjust the frequency of k-mers to the character distribution of the underlying genomes have negligible impact on classification performance, suggesting that the signal of each class is strong and that Interleukin-1 is effective in identifying it., In this paper, we present Logic Alignment Free (Interleukin-1), a method that combines alignment-free techniques and rule-based classification algorithms in order to assign biological samples to their taxa., Interleukin-1: Logic Alignment Free and its application to Genome, Bacterial classification.[SEP]Relations: interleukin-1 binding has relations: molfunc_protein with NLRP7, molfunc_protein with NLRP7, molfunc_protein with TRIM16, molfunc_protein with TRIM16, molfunc_protein with HAX1, molfunc_protein with HAX1, molfunc_protein with A2M, molfunc_protein with A2M, molfunc_protein with IL1R1, molfunc_protein with IL1R1. Definitions: Interleukin-1 defined as following: A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation.. Genome, Bacterial defined as following: The genetic complement of a BACTERIA as represented in its DNA..", "label": "yes"} {"original_question": "Is Bobble head doll syndrome associated with hydrocephalus?", "id": "converted_2781", "sentence1": "Is Bobble head doll syndrome associated with hydrocephalus?", "sentence2": "The first is a 14-year-old boy with BHDS associated with aqueductal obstruction and triventricular hydrocephalus secondary to a tectal tumor., Brain magnetic resonance imaging showed a large suprasellar Arachnoid Cysts extending into the third ventricle, with Obstructive Hydrocephalus, characteristic of Bobble-head doll syndrome. , MRI Scan showed a large contrast-enhanced lesion in the region of the third ventricle along with gross hydrocephalus. , Bobble-head doll syndrome is usually associated with dilation of the third ventricle, but is rarely associated with posterior fossa disease.PATIENT: We describe an infant with fetal hydrocephalus and an Arachnoid Cysts of the posterior fossa., All the patients presented a No No psychomotor retardation due to an Obstructive Hydrocephalus. , Suprasellar arachnoid cysts can have varied presentations with signs and symptoms of Obstructive Hydrocephalus, Visual Impairment, endocrinal dysfunction, Gait Ataxia and rarely bobble-head doll movement., We present three cases with Bobble-head doll syndrome associated with a large suprasellar Arachnoid Cysts and Obstructive Hydrocephalus, which were treated with endoscopic cystoventriculocisternostomy and marsupialization of the Specimen Source Codes - Cyst.[SEP]Relations: Bobble-head doll syndrome has relations: disease_disease with syndromic disease, disease_disease with syndromic disease. Obstructive Hydrocephalus has relations: disease_disease with hydrocephalus, disease_disease with hydrocephalus, disease_protein with CRPPA, disease_protein with CRPPA, disease_protein with SIN3A, disease_protein with SIN3A. Arachnoid Specimen Source Codes - Cyst has relations: disease_phenotype_positive with hydrocephalus-costovertebral dysplasia-Sprengel anomaly syndrome, disease_phenotype_positive with hydrocephalus-costovertebral dysplasia-Sprengel anomaly syndrome. Definitions: Arachnoid Cysts defined as following: Intracranial or spinal cavities containing a cerebrospinal-like fluid, the wall of which is composed of arachnoidal cells. They are most often developmental or related to trauma. Intracranial arachnoid cysts usually occur adjacent to arachnoidal cistern and may present with HYDROCEPHALUS; HEADACHE; SEIZURES; and focal neurologic signs. (From Joynt, Clinical Neurology, 1994, Ch44, pp105-115). Obstructive Hydrocephalus defined as following: An abnormal accumulation of cerebrospinal fluid within the ventricles of the brain that occurs as a consequence of an obstruction at any location within the ventricular system that prevents cerebrospinal fluid flowing into the subarachnoid space.. Gait Ataxia defined as following: Impairment of the ability to coordinate the movements required for normal ambulation (WALKING) which may result from impairments of motor function or sensory feedback. This condition may be associated with BRAIN DISEASES (including CEREBELLAR DISEASES and BASAL GANGLIA DISEASES); SPINAL CORD DISEASES; or PERIPHERAL NERVOUS SYSTEM DISEASES.. suprasellar Arachnoid Cysts defined as following: An Arachnoid Cysts that progressively enlarges from an abnormality in the membrane of Liliequist or in the interpeduncular cistern, and typically, expands from the prepontine space, displacing the floor of the third ventricle upwards, the pituitary stalk and optic chiasm upwards and forwards, and the mammillary bodies upwards and backwards. [HPO:probinson, PMID:21586175]. Visual Impairment defined as following: Sight that is impaired.. hydrocephalus defined as following: Excessive accumulation of cerebrospinal fluid within the cranium which may be associated with dilation of cerebral ventricles, INTRACRANIAL HYPERTENSION; HEADACHE; lethargy; URINARY INCONTINENCE; and ATAXIA..", "label": "yes"} {"original_question": "Is apremilast effective for psoriasis?", "id": "converted_2149", "sentence1": "Is apremilast effective for Psoriasis?", "sentence2": "CONCLUSION: apremilast reduces the severity of nail/scalp Psoriasis., CONCLUSIONS: apremilast demonstrated clinically meaningful improvements in Arthritis, Psoriatic and Psoriasis at week 16; sustained improvements were seen with continued treatment through 52 weeks., apremilast: A Novel Pharmacologic Substance for Treatment of Psoriasis and Psoriatic Arthritis., In those that involved doses of 30 mg twice daily, a significantly greater percentage of patients receiving apremilast (28.8% to 40.9%) compared with placebo (5.3% to 5.8%) achieved at least 75% improvement from baseline in Psoriasis Area and Severity Index score at 16 weeks., CONCLUSIONS: apremilast has a novel mechanism of action and is safe and effective for the management of Psoriasis and Arthritis, Psoriatic. At this time, apremilast should be reserved for patients unable to take disease-modifying antirheumatic drugs., apremilast, an oral phosphodiesterase 4 (Phosphodiesterase Type 4) PPP1R1A gene, in patients with moderate to severe plaque Psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of apremilast in Psoriasis [ESTEEM] 1)., More recently, three larger double-blinded, and randomized multicenter studies demonstrate that apremilast is efficacious in the treatment of Psoriasis and Prostate-Specific Antigen, with significantly higher numbers of apremilast-treated patients achieving endpoints of a 75% reduction compared to baseline in Psoriasis Area and Severity Index (PASI-75) or American College of Rheumatology-20 scores, relative to placebo., No new significant adverse events emerged with continued apremilast exposure versus the placebo-controlled period.Data were limited to 52 weeks and may not generalize to nonplaque Psoriasis.apremilast was effective in moderate to severe plaque Psoriasis.Copyright © 2015 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.© 2012 The Authors, In addition, SmithKline Beecham plc is developing 256066, an inhaled formulation of a Phosphodiesterase Type 4 PPP1R1A gene that has demonstrated efficacy in trials in asthma, and apremilast from Celgene Corp has been reported to be effective for the treatment of Psoriasis., Although further longer-term and comparative efficacy and tolerability data would be beneficial, the current clinical data indicate that apremilast is an effective and well tolerated option for the management of Psoriasis and Prostate-Specific Antigen in adults., No new significant adverse events emerged with continued apremilast exposure versus the placebo-controlled period.Data were limited to 52 weeks and may not generalize to nonplaque Psoriasis.apremilast was effective in moderate to severe plaque Psoriasis.Copyright © 2015 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.SmithKline Beecham

. Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Twice a day defined as following: Two times per day, at unspecified times.. apremilast defined as following: An orally bioavailable, small molecule PPP1R1A gene of phosphodiesterase 4 (Phosphodiesterase Type 4), with potential Anti-Inflammatory Agents activity. Upon oral administration, apremilast targets, binds to and inhibits the activity of Phosphodiesterase Type 4, thereby blocking cyclic adenosine monophosphate (cAMP) degradation and increasing intracellular cAMP levels. This may decrease the production of the proinflammatory cytokines including tumor necrosis factor-alpha (TNF-alpha). Phosphodiesterase Type 4 is an enzyme that plays an important role in the degradation of cAMP and in cytokine production in inflammatory cells..", "label": "yes"} {"original_question": "Is cilengitide effective for treatment of glioblastoma?", "id": "converted_2449", "sentence1": "Is cilengitide effective for treatment of Glioblastoma Multiforme?", "sentence2": "RESULTS: fourteen randomized clinical trials were identified (7 with bevacizumab, 2 cilengitide, 1 enzastaurin, 1 dasatinib, 1 vandetanib, 1 temsirolimus, 1 cediranib) including 4330 patients. Antiangiogenic drugs showed no improvement in overall survival with a pooled HR of 1.00, a trend for an inferior outcome, in terms of overall survival, was observed in the group of patients receiving antiangiogenic drug alone compared to cytotoxic drug alone (HR=1.24, p=0.056)., However, we could not conclusively confirm whether cilengitide 2000mg/5/week was the optimum regime, as only one trial using this protocol was included in our study., Cilengitide (UGT8 wt Allele) is a cyclic pentapeptide that demonstrated efficacy for Glomerular Basement Membrane treatment by targeting the integrins avβ3 and avβ5 over-expressed on Glomerular Basement Membrane Cells., Cilengitide is recently failed in Phase III CENTRIC trial in unselected patients with Glomerular Basement Membrane., In conclusion, we demonstrate that EGFRvIII/integrin β3 complexes promote Glomerular Basement Membrane progression and metastasis in the environment of Hypoxia, CTCAE and vitronectin-enrichment, and cilengitide may serve as a promising therapeutics for EGFRvIII-positive GBMs., he addition of molecularly targeted drugs to TEM + RAD did not improve the OS of patients with Glomerular Basement Membrane; however, it did improve PFS in patients treated by cilengitide who could not get improvement in OS. , The randomized phase III CENTRIC and phase II CORE trials explored the integrin inhibitor cilengitide in patients with newly diagnosed Glioblastoma Multiforme with versus without O6-methylguanine DNA methyltransferase (O(6)-Methylguanine-DNA Methyltransferase) promoter methylation. These trials failed to meet their primary endpoints, . In CORE, higher αvβ3 levels in Tumor Cells, uncertain whether benign or malignant were associated with improved progression-free survival by central review and with improved overall survival in patients treated with cilengitide., Cilengitide combined with metronomic temozolomide and procarbazine in O(6)-Methylguanine-DNA Methyltransferase-promoter unmethylated Glioblastoma Multiforme did not improve survival compared with historical data and does not warrant further investigation., The addition of cilengitide to temozolomide chemoradiotherapy did not improve outcomes; cilengitide will not be further developed as an anticancer drug., Cilengitide treatment of newly diagnosed Glioblastoma Multiforme patients does not alter patterns of progression., It may be proposed that the combination therapy of CSPG4 wt Allele suppression and cilengitide treatment showed no considerable effect on Glioblastoma Multiforme compared to cilengitide therapy alone.[SEP]Relations: Temozolomide has relations: drug_effect with Brainstem glioma, drug_effect with Brainstem glioma, drug_effect with Myalgia, drug_effect with Myalgia, drug_drug with Glipizide, drug_drug with Glipizide, drug_drug with Cephalexin, drug_drug with Cephalexin. Temsirolimus has relations: contraindication with Glioblastoma Multiforme (disease), contraindication with Glioblastoma Multiforme (disease). Definitions: procarbazine defined as following: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.. Cilengitide defined as following: A cyclic Arg-Gly-Asp peptide with potential antineoplastic activity. Cilengitide binds to and inhibits the activities of the alpha(v)beta(3) and alpha(v)beta(5) integrins, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis. (NCI04). O(6)-Methylguanine-DNA Methyltransferase defined as following: An enzyme that transfers methyl groups from O(6)-methylguanine, and other methylated moieties of DNA, to a cysteine residue in itself, thus repairing alkylated DNA in a single-step reaction. EC 2.1.1.63.. Glomerular Basement Membrane defined as following: A sheet of amorphous extracellular material upon which the basal surfaces of epithelial Cells rest and is the covering surface of a glomerular capillary, interposed between the cellular elements and the underlying connective tissue.. Glioblastoma Multiforme defined as following: The most malignant astrocytic tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO). vandetanib defined as following: An orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability. This agent also blocks the tyrosine kinase activity of epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that mediates tumor cell proliferation and migration and angiogenesis.. bevacizumab defined as following: An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS.. temozolomide defined as following: A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.. temsirolimus defined as following: An ester analog of rapamycin. Temsirolimus binds to and inhibits the mammalian target of rapamycin (mTOR), resulting in decreased expression of mRNAs necessary for cell cycle progression and arresting Cells in the G1 phase of the cell cycle. mTOR is a serine/threonine kinase which plays a role in the PI3K/AKT pathway that is upregulated in some tumors.. Tumor Cells, uncertain whether benign or malignant defined as following: Cells of, or derived from, a tumor.. Hypoxia, CTCAE defined as following: A disorder characterized by a decrease in the level of oxygen in the body.. CSPG4 wt Allele defined as following: Human CPSG4 wild-type allele is located in the vicinity of 15q24.2 and is approximately 38 kb in length. This allele, which encodes chondroitin sulfate proteoglycan 4 protein, plays a role in both cellular proliferation and migration. The wild-type allele is involved in the regulation of both vascularization and axonal outgrowth.. dasatinib defined as following: An orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases. Dasatinib binds to and inhibits the growth-promoting activities of these kinases. Apparently because of its less stringent binding affinity for the BCR-ABL kinase, dasatinib has been shown to overcome the resistance to imatinib of chronic myeloid leukemia (CML) Cells harboring BCR-ABL kinase domain point mutations. SRC-family protein-tyrosine kinases interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways; tumorigenic forms can occur through altered regulation or expression of the endogenous protein and by way of virally-encoded kinase genes.. UGT8 wt Allele defined as following: Human UGT8 wild-type allele is located in the vicinity of 4q26 and is approximately 80 kb in length. This allele, which encodes 2-hydroxyacylsphingosine 1-beta-galactosyltransferase protein, plays a role in the synthesis of galactocerebrosides.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. cilengitide defined as following: A cyclic Arg-Gly-Asp peptide with potential antineoplastic activity. Cilengitide binds to and inhibits the activities of the alpha(v)beta(3) and alpha(v)beta(5) integrins, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis. (NCI04).", "label": "no"} {"original_question": "Can administration of the thyrotropin releasing hormone reduce fatigue in cancer patients?", "id": "converted_1270", "sentence1": "Can administration of the thyrotropin releasing hormone reduce Fatigue in cancer patients?", "sentence2": "Pro-Thyrotropin-Releasing Hormone, human administration was associated with significant improvement (p < 0.05) in Fatigue levels as measured by the Visual Analog Scale-Energy (VAS-E), was associated with significant (p < 0.05) improvement in sleep disturbances and improved quality of life. , This decrease in C-reactive protein level with Pro-Thyrotropin-Releasing Hormone, human administration was associated with improvement in energy levels as measured by the VAS-E. , In the present pilot, randomized, placebo-controlled, crossover study, we investigated the efficacy and safety of Pro-Thyrotropin-Releasing Hormone, human as a treatment for cyclophosphamide/fluorouracil., Pro-Thyrotropin-Releasing Hormone, human administration was associated with significant improvement in Fatigue level as measured by the VAS-E, the Fatigue and vigor subscales of the Profile of mood states, and the Fatigue subscale of FACIT-F (p < 0.05). , Pro-Thyrotropin-Releasing Hormone, human administration was efficacious, safe, and tolerable in the treatment of cyclophosphamide/fluorouracil with a positive impact on quality of life. These results provide a crucial impetus for pursuing Pro-Thyrotropin-Releasing Hormone, human therapeutics to treat cyclophosphamide/fluorouracil., Thyrotropin-Releasing Hormone, human can relieve cancer-related Fatigue: hypothesis and preliminary observations., Global assessment using both subjective and objective parameters showed that Pro-Thyrotropin-Releasing Hormone, human exerted clear anti-Fatigue effects in four of the six Pro-Thyrotropin-Releasing Hormone, human treatments. , These initial findings support the proposal that Pro-Thyrotropin-Releasing Hormone, human can ameliorate cancer-related Fatigue.[SEP]Relations: Fatigue has relations: drug_effect with Atropine, drug_effect with Atropine, drug_effect with Urofollitropin, drug_effect with Urofollitropin, drug_effect with Parathyroid hormone, drug_effect with Parathyroid hormone, drug_effect with Mitoxantrone, drug_effect with Mitoxantrone, drug_effect with Levothyroxine, drug_effect with Levothyroxine. Definitions: Thyrotropin-Releasing Hormone, human defined as following: Thyrotropin-Releasing Hormone, human (3 aa, ~0.4 kDa) is encoded by the human Pro-Thyrotropin-Releasing Hormone, human gene. This protein plays a role in the positive regulation of thyrotropin (thyroid-stimulating hormone; TSH) production and release.. Pro-Thyrotropin-Releasing Hormone, human defined as following: Pro-thyrotropin-releasing hormone (242 aa, ~27 kDa) is encoded by the human Pro-Thyrotropin-Releasing Hormone, human gene. This protein plays a role in the regulation of thyrotropin (thyroid-stimulating hormone; TSH) production.. C-reactive protein defined as following: A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-C-reactive protein).. Fatigue defined as following: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.. Profile of mood states defined as following: A 65-item self-report questionnaire that utilizes a 5-point Likert Scale rating system to assess an individual's mood state.. thyrotropin releasing hormone defined as following: Thyrotropin-Releasing Hormone, human (3 aa, ~0.4 kDa) is encoded by the human Pro-Thyrotropin-Releasing Hormone, human gene. This protein plays a role in the positive regulation of thyrotropin (thyroid-stimulating hormone; TSH) production and release.. cancer defined as following: A malignant tumor at the original site of growth..", "label": "yes"} {"original_question": "Is there a pharmacogenetic test for trastuzumab?", "id": "converted_848", "sentence1": "Is there a pharmacogenetic test for trastuzumab?", "sentence2": "The clinical need for novel approaches to improve drug therapy derives from the high rate of adverse reactions to drugs and their lack of efficacy in many individuals that may be predicted by pharmacogenetic testing., the assessment of the epidermal growth factor receptor 2, human (HER-2-neu peptide vaccine-neu peptide vaccine) expression for trastuzumab therapy of Malignant neoplasm of breast, erbB-2 Receptor positive Malignant neoplasm of breast and the use of the drug Herceptin, The dependence on gene copy number or expression levels of erbB-2 Receptor and epidermal growth factor receptor (Epidermal Growth Factor Receptor) for therapeutic efficacy of trastuzumab and cetuximab (Erbitux), respectively, supports the importance of selecting suitable patient populations based on their pharmacogenetic profile., to explore informed consent issues surrounding the use of the drug Herceptin, widely cited as an example of a novel approach to drug development called pharmacogenetics. Drawing on qualitative semi-structured interviews with 25 UK-based Malignant neoplasm of breast specialists, this paper explores Herceptin's disputed epistemological status, as an example of pharmacogenetics or as something out of the ordinary in terms of clinical practice., There have been several success stories in the field of pharmacogenetics in recent years, including the analysis of erbB-2 Receptor amplification for trastuzumab selection in Malignant neoplasm of breast, trastuzumab is standard of care in the treatment of epidermal growth factor receptor 2, human (HER)-2⁺ early and advanced Malignant neoplasm of breast., HER-2-neu peptide vaccine-neu peptide vaccine overexpression as a predictor of response to trastuzumab, Pharmacogenomic analysis aspires to identify individuals with specific genetic characteristics in order to predict a positive response or reduce a negative response to a therapeutic modality., Assays are available to detect the erbB-2 Receptor protein receptor or copies of the erbB-2 Receptor gene sequence to determine eligibility for Herceptin treatment or Adriamycin treatment in node positive patients, respectively., Determining the erbB-2 Receptor status of breast carcinomas is a prerequisite for the use of the monoclonal antibody trastuzumab (Herceptin), which has recently been licensed for the treatment of Metastatic Neoplasm., Laboratory testing of ERBB2 wt Allele in Breast Carcinoma has become vital to patient care following the approval of trastuzumab as the first therapy to target the ERBB2 wt Allele oncoprotein., Immunohistochemical (IHC) analysis was performed with use of a diagnostic test for the assessment of erbB-2 Receptor overexpression, the HercepTest., To test for Oncogene ErbB2 overexpression in patients with Non-Hodgkin's lymphoma of bone and the possible role of the recombinant monoclonal anti-Oncogene ErbB2 antibody trastuzumab (Herceptin) in the treatment of Non-Hodgkin's lymphoma of bone., To evaluate concordance between local and central laboratory erbB-2 Receptor testing results in patients from the North Central Cancer Treatment Group (NCCTG) N9831 adjuvant trial of trastuzumab., These findings support the importance of using high-volume, experienced laboratories for erbB-2 Receptor testing to improve the process of selecting patients likely to benefit from trastuzumab therapy., we measured trastuzumab levels in the serum and in Cerebrospinal Fluid of metastatic Malignant neoplasm of breast patients with brain metastases receiving trastuzumab for erbB-2 Receptor-overexpressing metastatic Malignant neoplasm of breast. In a pilot study, metastatic Malignant neoplasm of breast patients with brain metastases and erbB-2 Receptor-overexpressing tumors (HercepTest; Dako, Copenhagen, Denmark) were included., Monitoring of trastuzumab levels in the serum and Cerebrospinal Fluid may enable individualized therapy strategies in metastatic Malignant neoplasm of breast patients with brain metastases, and lead to a better understanding of trastuzumab pharmacokinetics in the Cerebrospinal Fluid and serum., Biotin-labeled trastuzumab (BiotHER) can be used to test for erbB-2 Receptor by immunohistochemistry., The results support a role for BiotHER testing in better tailoring trastuzumab-based treatments in patients with advanced erbB-2 Receptor-amplified breast cancers., response to anti-epidermal growth factor receptor 2, human 2 (erbB-2 Receptor) therapy trastuzumab.[SEP]Relations: trastuzumab has relations: drug_drug with Labetuzumab, drug_drug with Labetuzumab, drug_drug with Emactuzumab, drug_drug with Emactuzumab, drug_drug with Xentuzumab, drug_drug with Xentuzumab, drug_drug with Carboplatin, drug_drug with Carboplatin, drug_drug with Camrelizumab, drug_drug with Camrelizumab. Definitions: Oncogene ErbB2 defined as following: Human Oncogene ErbB2 is a mutated variant of ERBB2 Gene, which encodes ERRB2 Receptor Protein Tyrosine Kinase, a 185-kDa type I membrane glycoprotein similar to Epidermal Growth Factor Receptor that controls cell growth. Ligand binding increases ERBB2 tyrosine phosphorylation. A heterodimer with ERBB3 and ERBB4, p185ERBB2 is an essential component of the heregulin/neuregulin receptor. ERBB2 forms an IL6-dependent complex with IL6R gp130, resulting in ERBB2 tyrosine phosphorylation and MAPK activation. Oncogene ERBB2 disrupts normal cell function.. trastuzumab defined as following: A humanized monoclonal antibody against the ERBB-2 RECEPTOR (erbB-2 Receptor). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where erbB-2 Receptor is overexpressed.. ERBB2 wt Allele defined as following: Human ERBB2 wild-type allele is located in the vicinity of 17q21.1 and is approximately 29 kb in length. This allele, which encodes receptor tyrosine-protein kinase erbB-2 protein, plays a role in EGF receptor signal transduction pathways and cellular growth. Amplification or overexpression of this gene is involved in the progression of several forms of cancer, including breast and ovarian tumors.. HER-2-neu peptide vaccine defined as following: A cancer vaccine comprised of peptides derived from the extracellular domain of the tumor-associated antigen Her-2/neu with potential antineoplastic activity. Oncogene ErbB2 peptide vaccine may induce antibodies with anti-tumor activity and may also elicit a specific CD8 T-cell response against specific tumor cell types. (NCI04). cetuximab defined as following: A chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors.. erbB-2 Receptor defined as following: A cell surface protein-tyrosine kinase receptor that is overexpressed in a variety of ADENOCARCINOMAS. It has extensive homology to and heterodimerizes with the EGF RECEPTOR, the ERBB-3 RECEPTOR, and the ERBB-4 RECEPTOR. Activation of the erbB-2 receptor occurs through heterodimer formation with a ligand-bound erbB receptor family member.. Breast Carcinoma defined as following: A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.. Malignant neoplasm of breast defined as following: A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males.. Cerebrospinal Fluid defined as following: A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES.. Metastatic Neoplasm defined as following: A tumor that has spread from its original (primary) site of growth to another site, close to or distant from the primary site. Metastasis is characteristic of advanced malignancies, but in rare instances can be seen in neoplasms lacking malignant morphology.. trastuzumab defined as following: A humanized monoclonal antibody against the ERBB-2 RECEPTOR (erbB-2 Receptor). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where erbB-2 Receptor is overexpressed..", "label": "yes"} {"original_question": "Are mouse chromosomes acrocentric?", "id": "converted_2409", "sentence1": "Are Mus sp. Chromosomes, Human, Pair 1 acrocentric?", "sentence2": " Based on combined fluorescence in situ hybridization and linkage mapping, the gene order on CFA9 is similar to that of the homologous genes on HSA17q and Mus sp. chromosome 11 (MMU11), but in the dog the gene order is inverted with respect to the Centromere. , In Mus models of Homo sapiens carcinogenesis, however, karyotype analysis is technically demanding because Mus sp. Chromosomes, Human, Pair 1 are acrocentric and of similar size., The minor satellite is closer to the short arms of the acrocentric Chromosomes, Human, Pair 1 than the major satellite, These Cells contain Robertsonian translocated Chromosomes, Human, Pair 1 1 and 7 as the only submetacentric chromosome in an otherwise acrocentric genome., The resulting metacentric Chromosomes, Human, Pair 1 are very different in size and in morphology from normal Mus sp. acrocentric Chromosomes, Human, Pair 1., Because of 35 independent primary Hybrids used in this study were derived from two types of feral CASP14 gene, each with a different combination of Robertsonian translocation Chromosomes, Human, Pair 1, as well as from CASP14 gene with a normal complement of acrocentric Chromosomes, Human, Pair 1, analysis of 16 selected Mus sp. enzyme markers provided data on the segregation of all 20 Mus sp. Chromosomes, Human, Pair 1 in these Hybrids, The two Mus sp. stocks exhibit karyotypes consisting of nine pairs of metacentric Chromosomes, Human, Pair 1 as a result of centric fusions of acrocentric Chromosomes, Human, Pair 1 in different combinations., Physical gene mapping by in situ hybridization is a difficult task in an all-acrocentric Mus sp. karyotype, because all of the Chromosomes, Human, Pair 1 are morphologically very similar., The resulting metacentric Chromosomes, Human, Pair 1 are very different in size and in morphology from normal Mus sp. acrocentric Chromosomes, Human, Pair 1., Mus models of Homo sapiens carcinogenesis are exceedingly valuable tools to understand genetic mechanisms of neoplastic growth the identification of recurrent Chromosomes rearrangements by cytogenetic techniques serves as an initial screening test for Neoplasms specific aberrations in Mus models of Homo sapiens carcinogenesis however karyotype analysis is technically demanding because Mus sp. Chromosomes, Human, Pair 1 are acrocentric and of similar size fluorescence in situ hybridization Fluorescent in Situ Hybridization with Mus sp. chromosome specific painting Probes can complement conventional banding analysis although sensitive and specific Fluorescent in Situ Hybridization analyses are restricted to the visualization of only a few Mus sp. Chromosomes, Human, Pair 1 at a time here we apply a novel imaging technique that we developed recently for the visualization of Homo sapiens Chromosomes, Human, Pair 1 to the simultaneous discernment of all Mus sp. Chromosomes, Human, Pair 1 the approach is based on spectral imaging to measure chromosome specific spectra after Fluorescent in Situ Hybridization with differentially labelled Mus sp. chromosome painting Probes utilizing a combination of fourier spectroscopy ccd imaging and conventional optical microscopy spectral imaging allows simultaneous measurement of the fluorescence emission spectrum at all sample points a spectrum based classification algorithm has been adapted to karyotype Mus sp. Chromosomes, Human, Pair 1 we have applied spectral karyotyping sky to Chemicals induced Plasmacytoma mammary gland tumours from Mice, Transgenic overexpressing the c myc oncogene and Thymoma from CASP14 gene deficient for the ataxia telangiectasia atm gene results from these analyses demonstrate the potential of sky to identify complex Chromosomes aberrations in Mus sp. models of Homo sapiens carcinogenesis.[SEP]Relations: chromosome has relations: cellcomp_protein with MBD6, cellcomp_protein with MBD6, cellcomp_protein with HOXA13, cellcomp_protein with HOXA13, cellcomp_protein with TEX12, cellcomp_protein with TEX12, cellcomp_protein with CBX6, cellcomp_protein with CBX6, cellcomp_protein with CCDC86, cellcomp_protein with CCDC86. Definitions: Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Chromosomes defined as following: In a prokaryotic cell or in the nucleus of a eukaryotic cell, a structure consisting of or containing DNA which carries the genetic information essential to the cell. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). Fluorescent in Situ Hybridization defined as following: A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.. Chemicals defined as following: A substance with a defined atomic or molecular structure that results from, or takes part in, reactions involving changes in its structure, composition, or properties.. Chromosomes, Human, Pair 1 defined as following: A specific pair of Homo sapiens Chromosomes, Human, Pair 1 in group A (CHROMOSOMES, HUMAN, 1-3) of the Homo sapiens chromosome classification.. Homo sapiens defined as following: Members of the species Homo sapiens.. Hybrids defined as following: Being comprised of mixed attributes or parts.. Centromere defined as following: The clear constricted portion of the chromosome at which the chromatids are joined and by which the chromosome is attached to the spindle during cell division.. Thymoma defined as following: A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (From Stedman, 25th ed). Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Plasmacytoma defined as following: Any discrete, presumably solitary, mass of neoplastic PLASMA CELLS either in BONE MARROW or various extramedullary sites.. Mice, Transgenic defined as following: Laboratory CASP14 gene that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.. Mus defined as following: Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae.. Probes defined as following: A device designed to reach into a location for manipulating or sensing..", "label": "yes"} {"original_question": "Are mutations in the STXBP1 gene associated with epilepsy?", "id": "converted_1729", "sentence1": "Are mutations in the STXBP1 gene Genes associated with Epilepsy?", "sentence2": "leucovorin responsive Epilepsy in Ohtahara syndrome caused by STXBP1 gene Genes Mutation Abnormality., A novel Mutation Abnormality in STXBP1 gene Genes Genes in a child with epileptic Encephalopathies and an atypical electroclinical pattern., Gene Mutation in STXBP1 gene Genes Genes, encoding the syntaxin binding protein 1, have been recently described in Ohtahara syndrome, or early infantile epileptic Encephalopathies with suppression-burst pattern, and in other early-onset epileptic encephalopathies., STXBP1 gene Genes (MUNC18.1), encoding syntaxin binding protein 1, has been reported in Ohtahara syndrome, a rare epileptic Encephalopathies with suppression burst pattern on EEG, in patients with Infantile Spasm and in a few patients with nonsyndromic mental retardation without Epilepsy. , ed with severe developmental delay and poor prognosis. Gene Mutation and Gene Deletion in the STXBP1 gene Genes Genes are associated with Ohtahara syndrome, also known as \"early infantile epileptic Encephalopathies, Here we show that de novo heterozygous mutations in the Genes encoding STXBP1 gene Genes, also known as MUNC18-1, which is essential in Synaptic Vesicles release in multiple species, cause OS, STXBP1 gene Genes haploinsufficiency results in progressive Encephalopathies characterized by Intellectual Disability and may be accompanied by Epilepsy, Movement Disorders, and Autistic Disorder. , Gene Mutation of the syntaxin binding protein 1 (STXBP1 gene Genes) have been associated with severe infantile epileptic encephalopathies (Ohtahara syndrome and West Syndrome), but also with moderate to severe No No cognitive impairment and nonsyndromic Epilepsy., A novel STXBP1 gene Genes Mutation Abnormality causes focal Seizures with neonatal onset., STXBP1 gene Genes mutations in early infantile epileptic Encephalopathies with suppression-burst pattern., e novo STXBP1 gene Genes mutations have been found in individuals with early infantile epileptic Encephalopathies with suppression-burst pattern (EIEE), Gene Mutation in STXBP1 gene Genes are relatively frequent in patients with infantile epileptic encephalopathies. STXBP1 gene Genes-related Encephalopathies may present as drug-responsive Infantile Spasm with focal/lateralized discharges., De novo SCN1A gene Genes mutations in migrating partial Seizures of infancy., De novo mutations in the Genes encoding STXBP1 gene Genes (MUNC18-1) cause early infantile epileptic Encephalopathies., Gene Mutation in STXBP1 gene Genes have been identified in a subset of patients with early onset epileptic Encephalopathies (Eosinophilic esophagitis), but the full phenotypic spectrum remains to be delineated, and STXBP1 gene Genes-related West/Ohtahara syndromes, are due to a Mutation Abnormality in a unique Genes., This is the first case report showing that STXBP1 gene Genes mutations caused West Syndrome from the onset of Epilepsy. [SEP]Relations: Epilepsy has relations: disease_protein with STXBP1 gene, disease_protein with STXBP1 gene, disease_protein with STX1B, disease_protein with STX1B, disease_protein with TGFB1, disease_protein with TGFB1, disease_protein with ADCYAP1, disease_protein with ADCYAP1, disease_protein with MIB1, disease_protein with MIB1. Definitions: Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. syntaxin binding protein 1 defined as following: A family of proteins involved in intracellular membrane trafficking. They interact with SYNTAXINS and play important roles in vesicular docking and fusion during EXOCYTOSIS. Their name derives from the fact that they are related to Unc-18 protein, C elegans.. Autistic Disorder defined as following: A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V). Movement Disorders defined as following: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.. Encephalopathies defined as following: A functional and/or structural disorder of the brain caused by diseases (e.g. liver disease, kidney disease), medications, chemicals, and injuries.. Synaptic Vesicles defined as following: Membrane-bound compartments which contain transmitter molecules. Synaptic vesicles are concentrated at presynaptic terminals. They actively sequester transmitter molecules from the cytoplasm. In at least some synapses, transmitter release occurs by fusion of these vesicles with the presynaptic membrane, followed by exocytosis of their contents.. Seizures defined as following: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent Seizures are usually referred to as EPILEPSY or \"seizure disorder.\". Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Gene Mutation may be associated with genetic diversity or with pathologies including cancer.. Eosinophilic esophagitis defined as following: Chronic ESOPHAGITIS characterized by esophageal mucosal EOSINOPHILIA. It is diagnosed when an increase in EOSINOPHILS are present over the entire esophagus. The reflux symptoms fail to respond to PROTON PUMP INHIBITORS treatment, unlike in GASTROESOPHAGEAL REFLUX DISEASE. The symptoms are associated with IgE-mediated hypersensitivity to food or inhalant allergens.. Epilepsy defined as following: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal Epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313). West Syndrome defined as following: An epileptic syndrome characterized by the triad of Infantile Spasm, hypsarrhythmia, and arrest of psychomotor development at seizure onset. The majority present between 3-12 months of age, with spasms consisting of combinations of brief flexor or extensor movements of the head, trunk, and limbs. The condition is divided into two forms: cryptogenic (idiopathic) and symptomatic (secondary to a known disease process such as intrauterine infections; nervous system abnormalities; BRAIN DISEASES, METABOLIC, INBORN; prematurity; perinatal asphyxia; TUBEROUS SCLEROSIS; etc.). (From Menkes, Textbook of Child Neurology, 5th ed, pp744-8). epileptic Encephalopathies defined as following: A condition in which epileptiform abnormalities are believed to contribute to the progressive disturbance in cerebral function. Epileptic encephalaopathy is characterized by (1) electrographic EEG paroxysmal activity that is often aggressive, (2) Seizures that are usually multiform and intractable, (3) cognitive, behavioral and neurological deficits that may be relentless, and (4) sometimes early death. [PMID:21590624, PMID:23213494]. leucovorin defined as following: The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS.. Gene Deletion defined as following: A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA.. Infantile Spasm defined as following: Seizures in the first years of life characterized by flexion and extension jerks of the neck, trunk, and extremities.. SCN1A gene defined as following: This Genes is involved in sodium transport.. Intellectual Disability defined as following: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an Intellectual Disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28). mutations defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA..", "label": "yes"} {"original_question": "Is Kanzaki disease associated with deficiency in alpha-N-acetylgalactosaminidase?", "id": "converted_501", "sentence1": "Is Kanzaki disease associated with deficiency in NAGA gene?", "sentence2": "Kanzaki disease (OMIM#104170) is attributable to a deficiency in NAGA gene (alpha-NAGA; E.C.3.2.1.49), which hydrolyzes GalNAcalpha1-O-Ser/Thr. , Our findings suggest that the association of alpha-NAGA with its substrates is strongly affected by the Amino Acid Substitution at R329 and that the association with GalNAcalpha1-O-Thr is more highly susceptible to structural changes. The residual mutant enzyme in R329W could not associate with GalNAcalpha1-O-Thr and GalNAcalpha1-O-Ser. However, the residual mutant enzyme in R329Q catalyzed GalNAcalpha1-O-Ser to some extent. Therefore, the urinary ratio of GalNAcalpha1-O-Ser:GalNAcalpha1-O-Thr was lower and the clinical phenotype was milder in the R329Q Mutation Abnormality. , Kanzaki disease (OMIM#104170) is attributable to a deficiency in NAGA gene (alpha-NAGA; E.C.3.2.1.49), which hydrolyzes GalNAcalpha1-O-Ser/Thr., ALPHA-N-ACETYLGALACTOSAMINIDASE (alpha-NAGA) deficiency (Schindler/Kanzaki disease) is a clinically and pathologically heterogeneous genetic disease with a wide spectrum including an early onset neuroaxonal dystrophy (Schindler Disease, Type I) and late onset Fabry Disease (Kanzaki disease)., Structural and immunocytochemical studies on NAGA gene deficiency (Schindler/Kanzaki disease)., We describe the neurologic findings in a patient with NAGA gene deficiency (Kanzaki disease)., Three dimensional structural studies of NAGA gene (alpha-NAGA) in alpha-NAGA deficiency (Kanzaki disease): different Gene Mutation cause peculiar structural changes in alpha-NAGAs resulting in different substrate specificities and clinical phenotypes., NAGA gene (alpha-NAGA) deficiency is a rare hereditary lysosomal storage disease, and only three alpha-NAGA-deficient patients with Fabry Disease (Kanzaki) have been described., Schindler Disease, Type I and Kanzaki disease are caused by a deficient Lysosomal enzyme, NAGA gene (E.C.3.2.1.49)., The 1.9 a structure of human NAGA gene: The molecular basis of Schindler and Kanzaki diseases., These data suggest that a prototype of alpha-NAGA deficiency in Kanzaki disease and factors other than the defect of alpha-NAGA may contribute to severe nervous system disorder, and Kanzaki disease is thought to be caused by a single enzyme deficiency., ALPHA-N-ACETYLGALACTOSAMINIDASE (alpha-NAGA) deficiency (Schindler/Kanzaki disease) is a clinically and pathologically heterogeneous genetic disease with a wide spectrum including an early onset neuroaxonal dystrophy (Schindler Disease, Type I) and late onset Fabry Disease (Kanzaki disease). , NAGA gene (alpha-NAGA) deficiency is a rare hereditary lysosomal storage disease, and only three alpha-NAGA-deficient patients with Fabry Disease (Kanzaki) have been described. , Kanzaki disease (OMIM#104170) is attributable to a deficiency in NAGA gene (alpha-NAGA; E.C.3.2.1.49), which hydrolyzes GalNAcalpha1-O-Ser/Thr. Missense mutations, R329W or R329Q were identified in two Japanese Kanzaki patients., ALPHA-N-ACETYLGALACTOSAMINIDASE (alpha-NAGA) deficiency (Schindler/Kanzaki disease) is a clinically and pathologically heterogeneous genetic disease with a wide spectrum including an early onset neuroaxonal dystrophy (Schindler Disease, Type I) and late onset Fabry Disease (Kanzaki disease)., Kanzaki disease (OMIM#104170) is attributable to a deficiency in NAGA gene (alpha-NAGA; E.C.3.2.1.49),, Kanzaki disease (OMIM#104170) is attributable to a deficiency in NAGA gene (alpha-NAGA; E.C.3.2.1.49), which hydrolyzes GalNAcalpha1-O-Ser/Thr., NAGA gene (alpha-NAGA) deficiency is a rare hereditary lysosomal storage disease, and only three alpha-NAGA-deficient patients with Fabry Disease (Kanzaki) have been described.[SEP]Relations: NAGA has relations: disease_protein with NAGA gene deficiency, disease_protein with NAGA gene deficiency, molfunc_protein with NAGA gene activity, molfunc_protein with NAGA gene activity, disease_protein with neurodegeneration with brain iron accumulation, disease_protein with neurodegeneration with brain iron accumulation. NAGA gene activity has relations: molfunc_protein with NAGA, molfunc_protein with NAGA. nervous system disorder has relations: disease_disease with drug-induced akathisia, disease_disease with drug-induced akathisia. Definitions: Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. ALPHA-N-ACETYLGALACTOSAMINIDASE defined as following: A hexosaminidase with specificity for terminal non-reducing N-acetyl-D-galactosamine residues in N-acetyl-alpha-D-galactosaminides.. Schindler Disease, Type I defined as following: A very rare and severe type of NAGA deficiency characterized by infantile neuroaxonal dystrophy.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Fabry Disease defined as following: An X-linked inherited metabolic disease caused by a deficiency of lysosomal ALPHA-GALACTOSIDASE A. It is characterized by intralysosomal accumulation of globotriaosylceramide and other GLYCOSPHINGOLIPIDS in blood vessels throughout the body leading to multi-system complications including renal, cardiac, cerebrovascular, and skin disorders.. nervous system disorder defined as following: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.. Amino Acid Substitution defined as following: The naturally occurring or experimentally induced replacement of one or more AMINO ACIDS in a protein with another. If a functionally equivalent amino acid is substituted, the protein may retain wild-type activity. Substitution may also diminish, enhance, or eliminate protein function. Experimentally induced substitution is often used to study enzyme activities and binding site properties.. NAGA gene defined as following: A hexosaminidase with specificity for terminal non-reducing N-acetyl-D-galactosamine residues in N-acetyl-alpha-D-galactosaminides..", "label": "yes"} {"original_question": "Is there evidence to suggest that triiodothyronine has neuroprotective properties in traumatic brain injury?", "id": "converted_818", "sentence1": "Is there evidence to suggest that triiodothyronine has neuroprotective properties in Traumatic Brain Injury?", "sentence2": "Exogenous SLC25A5 gene administration provides neuroprotection in a Mus model of Traumatic Brain Injury., Treatment with SLC25A5 gene (1.2μg/100g body weight, i.p.) 1h after TBI resulted in a significant improvement in motor and cognitive recovery after CCI, as well as in marked reduction of lesion volumes. , Western blot analysis revealed the ability of SLC25A5 gene to reduce brain trauma through modulation of cytoplasmic-nuclear shuttling of nuclear factor-κB (NF-κB). Twenty-four hours after brain trauma, SLC25A5 gene-treated mice also showed significantly lower number of TUNEL(+) apoptotic neurons and curtailed induction of BAX protein, human, compared to vehicle control. In addition, SLC25A5 gene significantly enhanced the post-TBI expression of the neuroprotective neurotrophins (brain-derived neurotrophic factor and Glial Cell Line-Derived Neurotrophic Factor) compared to vehicle. , The stimulating effect of SLC25A5 gene on Peripheral nerve regeneration may have considerable therapeutic potential., The present study provides evidence that the Peripheral nervous system has its own system responsible for the local production of liothyronine, which may play a key role during the regeneration process., Although it has been hypothesized that SLC25A5 gene may facilitate neuronal regeneration after Central Nervous System injury, the 5'-D2 response to Brain Injuries is unknown., The outcome after Brain Injuries is closely correlated with the intensity of these changes, particularly with Catecholamine [EPC] plasma levels and the severity of the low triiodothyronine syndrome., The thyroid hormones triiodothyronine (SLC25A5 gene) and levothyroxine appear to enhance regeneration in the Peripheral and CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS (Central Nervous System). , SLC25A5 gene treatment influenced the general levels of incorporation of all treated groups over all days postoperation., SLC25A5 gene effects appear to involve an increased sensitivity of the Cells of the injured nervous system to the hormone., SLC25A5 gene, when administered over an 8 week period, stimulated axonal regeneration in the dorsal cortex and corpus callosum and promoted healing of the Specimen Type - Wound in the corpus callosum. The results of this investigation suggest that the use of SLC25A5 gene in the clinical treatment of injury to the CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS may be of less value than the work of earlier authors had indicated., In addition, SLC25A5 gene significantly enhanced the post-TBI expression of the neuroprotective neurotrophins (brain-derived neurotrophic factor and Glial Cell Line-Derived Neurotrophic Factor) compared to vehicle[SEP]Relations: Brain Injuries has relations: contraindication with Propantheline, contraindication with Propantheline, contraindication with Propantheline, contraindication with Propantheline, contraindication with Pheniramine, contraindication with Pheniramine, contraindication with Pheniramine, contraindication with Pheniramine, contraindication with Homatropine, contraindication with Homatropine. Definitions: SLC25A5 gene defined as following: This gene plays a regulatory role in the production and utilization of ATP.. brain-derived neurotrophic factor defined as following: A member of the nerve growth factor family of trophic factors. In the brain brain-derived neurotrophic factor has a trophic action on retinal, cholinergic, and dopaminergic neurons, and in the Peripheral nervous system it acts on both motor and sensory neurons. (From Kendrew, The Encyclopedia of Molecular Biology, 1994). Glial Cell Line-Derived Neurotrophic Factor defined as following: The founding member of the glial cell line-derived neurotrophic factor family. It was originally characterized as a NERVE GROWTH FACTOR promoting the survival of MIDBRAIN dopaminergic NEURONS, and it has been studied as a potential treatment for PARKINSON DISEASE.. Peripheral defined as following: On or near an edge or constituting an outer boundary; the outer area.. Traumatic Brain Injury defined as following: A form of acquired Brain Injuries which occurs when a sudden trauma causes damage to the brain.. BAX protein, human defined as following: Apoptosis regulator BAX (192 aa, ~21 kDa) is encoded by the human BAX gene. This protein plays a role in both apoptosis and protein-protein interactions.. levothyroxine defined as following: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Brain Injuries defined as following: Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.. Central Nervous System defined as following: The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.. Mus defined as following: Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae.. liothyronine defined as following: A SLC25A5 gene thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most SLC25A5 gene is derived from Peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly SLC25A5 gene.. triiodothyronine defined as following: A SLC25A5 gene thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most SLC25A5 gene is derived from Peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly SLC25A5 gene..", "label": "yes"} {"original_question": "Have apolipoprotein mimetics been used in clinical trials?", "id": "converted_3189", "sentence1": "Have apolipoprotein mimetics been used in clinical trials?", "sentence2": "One of these (AEM-28) has recently been given orphan drug status and is undergoing clinical trials.[SEP]", "label": "yes"} {"original_question": "Are tumour specific antigens originating from known protein coding genes?", "id": "converted_3620", "sentence1": "Are Neoplasms specific antigens originating from known protein coding genes?", "sentence2": "It is well established that MHC class I Molecule present Peptides from endogenous Proteins, such as Virus or Neoplasms antigens, to CD8+ T lymphocytes. , So far, Homo sapiens Neoplasms specific antigens that can be presented by HLA Molecule have not been identified on the Molecular level., These CTLs recognize short Peptides derived from Neoplasms-associated antigens in conjunction with class I Molecule expressed on Tumor cells., The focus on cellular immune responses, combined with rapid biotechnological advances, resulted in the identification of Neoplasms specific antigens, such as MART-1 Antigen (vaccine component) Antigen (vaccine component) and gp100 Antigen Antigen, that could be recognised by autologous tumor infiltrating lymphocyte therapy, Tumour antigens are mostly of weak immunogenicity, because the vast majority are Neoplasms-associated differentiation antigens already 'seen' by the patient's immune system., Tumour-specific antigens, which could be a more potent target for immunotherapy, mostly arise by Point Mutation and have the disadvantage of being not only Neoplasms-specific, but also individual-specific., The pioneering studies of Srivastava and colleagues led to the proposal that heat-shock Proteins (HSPs) function as ubiquitous Neoplasms-specific antigens, with the specificity residing in a population of bound Peptides that identify the Tissue Specimen Code of origin of the Henoch-Schoenlein Purpura., Therefore, we propose that CD4(+) T cells that recognize secreted indole-3-glycerol-phosphate lyase activity may be superior for immunotherapy by T cell transfer, because the local extracellular antigen concentration will be higher for secreted indole-3-glycerol-phosphate lyase activity. , Here, we wondered whether these frame-shifted peptide (CXCL1 gene) sequences represent Neoplasms-specific antigens also for MSI(+) leukemia and Lymphoma (L/L)., Data presented here expand the importance of Fibrin-fibrinogen split products assay as shared and general Neoplasms-specific antigens.[SEP]Relations: germ cell tumor has relations: disease_protein with ATF7IP, disease_protein with ATF7IP, disease_protein with SCNN1A, disease_protein with SCNN1A, disease_protein with KITLG, disease_protein with KITLG, disease_protein with ERCC1, disease_protein with ERCC1, disease_protein with PHC1, disease_protein with PHC1. Definitions: Fibrin-fibrinogen split products assay defined as following: The determination of the amount of fibrin degradation products present in a sample.. leukemia defined as following: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006). Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. heat-shock Proteins defined as following: A group I chaperonin protein that forms a lid-like structure which encloses the non-polar cavity of the chaperonin complex. The protein was originally studied in BACTERIA where it is commonly referred to as GroES protein.. Peptides defined as following: Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of Peptides that can form into complex structures such as ENZYMES and RECEPTORS.. Molecular defined as following: Relating to or produced by or consisting of Molecule.. Neoplasms defined as following: New abnormal growth of Tissue Specimen Code. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Lymphoma defined as following: A general term for various neoplastic diseases of the lymphoid Tissue Specimen Code.. Homo sapiens defined as following: Members of the species Homo sapiens.. gp100 Antigen defined as following: A melanoma-associated antigen. When administered in a vaccine formulation, gp100 Antigen antigen may stimulate a cytotoxic T cell HLA-A2.1-restricted immune response against tumors that express this antigen, which may result in a reduction in tumor size. (NCI04). MART-1 Antigen (vaccine component) defined as following: A tumor-associated melanocytic differentiation antigen. Vaccination with MART-1 Antigen (vaccine component) antigen may stimulate a host cytotoxic T-cell response against tumor cells expressing the melanocytic differentiation antigen, resulting in tumor cell lysis. (NCI04). indole-3-glycerol-phosphate lyase activity defined as following: Catalysis of the reaction: (1S,2R)-1-C-(indol-3-yl)glycerol 3-phosphate = indole + D-glyceraldehyde 3-phosphate. [EC:4.1.2.8]. Molecule defined as following: An aggregate of two or more atoms in a defined arrangement held together by chemical bonds.. CXCL1 gene defined as following: This gene is involved in immune processes and has been implicated in cancer metastasis.. Henoch-Schoenlein Purpura defined as following: A systemic, usually self-limited immune complex vasculitis, characterized by immunoglobulin A deposition in the small vessels and kidneys. It is manifested with small hemorrhages in the skin, gastrointestinal symptoms, arthritis, and nephropathy.. tumor infiltrating lymphocyte therapy defined as following: A form of adoptive cell transfer in which lymphocytes are isolated from a patient's tumor, grown in vitro, and then infused into the patient in combination with interleukin 2.. Neoplasms-associated antigens defined as following: 1. antigens that may be frequently associated with tumors or may be specifically found on tumor cells of the same origin (tumor specific); 2. tumor antigens may also be associated with replication and transformation by certain DNA tumor viruses, including adenoviruses and papovaviruses. Neoantigens. Any immunologically detectable marker whose presence or amount indicates the presence of a tumor.. Virus defined as following: Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells.. Point Mutation defined as following: A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair..", "label": "yes"} {"original_question": "Is there a role of regorafenib for sarcoma treatment?", "id": "converted_1768", "sentence1": "Is there a role of regorafenib for Malignant neoplasm of soft tissue treatment?", "sentence2": "regorafenib has been approved for third-line therapy., Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue Malignant neoplasm of soft tissue: a multinational, randomized, placebo-controlled, phase II trial., DISCUSSION: The design of this trial allows an assessment of regorafenib activity over placebo in four Malignant neoplasm of soft tissue strata and might provide evidence for launching a phase III trial., This case provides rationale for adding a Ewing Malignant neoplasm of soft tissue arm to SARC024, a phase II study of regorafenib, another multi-targeted kinase inhibitor, in patients with liposarcoma, Osteosarcoma of bone and Ewing and Ewing-like sarcomas (NCT02048371)., Thus, the Phase III studies with pazopanib, regorafenib, muramyl tripeptide (maltose tetrapalmitate) and ridaforolimus are extensively discussed as well as the biological rationale for the use of these compounds., Currently, regorafenib is examined in several clinical trials (mostly phase II) in different Specimen Source Codes - Specimen Source Codes - tumor entities, including renal cell carcinoma (Conventional (Clear Cell) Renal Cell Carcinoma), Liver carcinoma (altretamine/cisplatin/cyclophosphamide protocol), and soft tissue Malignant neoplasm of soft tissue (sodium tetradecyl sulfate)., Analysis of primary human Malignant neoplasm of soft tissue samples revealed direct cytotoxicity following exposure to sorafenib and regorafenib with a corresponding increase in ALDHbright cells (P<0.05)., Parametric and non-parametric statistical analyses were performed as appropriate.RESULTS: After functionally validating the CSC phenotype of ALDHbright Malignant neoplasm of soft tissue cells, we observed that sorafenib and regorafenib were cytotoxic to Malignant neoplasm of soft tissue cell lines (P<0.05), with a corresponding 1.4 - 2.8 fold increase in ALDHbright cells from baseline (P<0.05)., We evaluated survival and CSC phenotype in CASP14 gene harboring Malignant neoplasm of soft tissue metastases after TKI therapy. We exposed dissociated primary Malignant neoplasm of soft tissue tumors to sorafenib, regorafenib, and pazopanib, and we used tissue microarray (Thrombotic Microangiopathies) and primary Malignant neoplasm of soft tissue samples to evaluate the frequency and intensity of CSC markers after neoadjuvant therapy with sorafenib and pazopanib. Parametric and non-parametric statistical analyses were performed as appropriate.RESULTS: After functionally validating the CSC phenotype of ALDHbright Malignant neoplasm of soft tissue cells, we observed that sorafenib and regorafenib were cytotoxic to Malignant neoplasm of soft tissue cell lines (P<0.05), with a corresponding 1.4 - 2.8 fold increase in ALDHbright cells from baseline (P<0.05)., We exposed dissociated primary Malignant neoplasm of soft tissue tumors to sorafenib, regorafenib, and pazopanib, and we used tissue microarray (Thrombotic Microangiopathies) and primary Malignant neoplasm of soft tissue samples to evaluate the frequency and intensity of CSC markers after neoadjuvant therapy with sorafenib and pazopanib. Parametric and non-parametric statistical analyses were performed as appropriate.RESULTS: After functionally validating the CSC phenotype of ALDHbright Malignant neoplasm of soft tissue cells, we observed that sorafenib and regorafenib were cytotoxic to Malignant neoplasm of soft tissue cell lines (P<0.05), with a corresponding 1.4 - 2.8 fold increase in ALDHbright cells from baseline (P<0.05)., We exposed dissociated primary Malignant neoplasm of soft tissue tumors to sorafenib, regorafenib, and pazopanib, and we used tissue microarray (Thrombotic Microangiopathies) and primary Malignant neoplasm of soft tissue samples to evaluate the frequency and intensity of CSC markers after neoadjuvant therapy with sorafenib and pazopanib. Parametric and non-parametric statistical analyses were performed as appropriate.RESULTS: After functionally validating the CSC phenotype of ALDHbright Malignant neoplasm of soft tissue cells, we observed that sorafenib and regorafenib were cytotoxic to Malignant neoplasm of soft tissue cell lines (P<0.05), with a corresponding 1.4 - 2.8 fold increase in ALDHbright cells from baseline (P<0.05). In contrast, we observed negligible effects on viability and CSC sub-populations with pazopanib., After functionally validating the CSC phenotype of ALDHbright Malignant neoplasm of soft tissue cells, we observed that sorafenib and regorafenib were cytotoxic to Malignant neoplasm of soft tissue cell lines (P < 0.05), with a corresponding 1.4 - 2.8 fold increase in ALDHbright cells from baseline (P < 0.05).[SEP]Relations: regorafenib has relations: drug_drug with Sarilumab, drug_drug with Sarilumab, drug_drug with Sarecycline, drug_drug with Sarecycline, drug_drug with Afelimomab, drug_drug with Afelimomab, drug_drug with Lapatinib, drug_drug with Lapatinib, drug_drug with Sulfasalazine, drug_drug with Sulfasalazine. Definitions: Conventional (Clear Cell) Renal Cell Carcinoma defined as following: A malignant epithelial neoplasm of the kidney characterized by the presence of lipid-containing clear cells within a vascular network. The Specimen Source Codes - tumor may metastasize to unusual sites and late metastasis is common.. pazopanib defined as following: A small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. Pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1, -2 and -3, c-kit and platelet derived growth factor receptor (PDGF-R), which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated.. ridaforolimus defined as following: A small molecule and non-prodrug analogue of the lipophilic macrolide antibiotic rapamycin with potential antitumor activity. Ridaforolimus binds to and inhibits the mammalian target of rapamycin (mTOR), which may result in cell cycle arrest and, consequently, the inhibition of Specimen Source Codes - tumor cell growth and proliferation. Upregulated in some tumors, mTOR is a serine/threonine kinase involved in regulating cellular proliferation, motility, and survival that is located downstream of the PI3K/Akt signaling pathway.. Liver carcinoma defined as following: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated Specimen Source Codes - tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.. regorafenib defined as following: The anhydrous form of regorafenib, an orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. regorafenib binds to and inhibits vascular endothelial growth factor receptors (VEGFRs) 2 and 3, and Ret, Kit, PDGFR and Raf kinases, which may result in the inhibition of Specimen Source Codes - tumor angiogenesis and Specimen Source Codes - tumor cell proliferation. VEGFRs are receptor tyrosine kinases that play important roles in Specimen Source Codes - tumor angiogenesis; the receptor tyrosine kinases RET, KIT, and PDGFR, and the serine/threonine-specific Raf kinase are involved in Specimen Source Codes - tumor cell signaling.. Osteosarcoma of bone defined as following: A usually aggressive malignant bone-forming mesenchymal neoplasm arising from the bone. It may arise de novo or from a pre-existing lesion of the bone. Pain and a palpable mass are the most frequent clinical sign and symptom. It may spread to other anatomic sites, particularly the lungs.. Malignant neoplasm of soft tissue defined as following: A malignant neoplasm arising exclusively from the soft tissues.. sodium tetradecyl sulfate defined as following: An anionic surface-active agent used for its wetting properties in industry and used in medicine as an irritant and sclerosing agent for hemorrhoids and varicose veins.. Thrombotic Microangiopathies defined as following: A microvascular coagulopathy that may result from systemic vascular endothelial injury triggering the development of a procoagulant state, activation of the complement cascade, and microthrombi formation. Signs may include hemolytic anemia, thrombocytopenia, hypertension and renal dysfunction.. liposarcoma defined as following: A malignant Specimen Source Codes - tumor derived from primitive or embryonal lipoblastic cells. It may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid (LIPOSARCOMA, MYXOID), round-celled, or pleomorphic, usually in association with a rich network of capillaries. Recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. (From Dorland, 27th ed; Stedman, 25th ed). soft tissue Malignant neoplasm of soft tissue defined as following: A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.. sorafenib defined as following: A synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking Specimen Source Codes - tumor angiogenesis.. regorafenib defined as following: The anhydrous form of regorafenib, an orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. regorafenib binds to and inhibits vascular endothelial growth factor receptors (VEGFRs) 2 and 3, and Ret, Kit, PDGFR and Raf kinases, which may result in the inhibition of Specimen Source Codes - tumor angiogenesis and Specimen Source Codes - tumor cell proliferation. VEGFRs are receptor tyrosine kinases that play important roles in Specimen Source Codes - tumor angiogenesis; the receptor tyrosine kinases RET, KIT, and PDGFR, and the serine/threonine-specific Raf kinase are involved in Specimen Source Codes - tumor cell signaling..", "label": "yes"} {"original_question": "Was modafinil tested for schizophrenia treatment?", "id": "converted_1493", "sentence1": "Was modafinil tested for SCHIZOPHRENIA 2 (disorder) treatment?", "sentence2": "Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime Somnolence, psychiatric symptoms or cognition in SCHIZOPHRENIA 2 (disorder) and Schizoaffective Disorder: a randomized, double-blind, placebo-controlled study., CONCLUSION: The data suggest that modafinil was a safe adjunctive treatment which improved parkinsonian symptoms and signs in patients with SCHIZOPHRENIA 2 (disorder) or Schizoaffective Disorder. , A review of its effects in SCHIZOPHRENIA 2 (disorder) suggests that modafinil facilitates cognitive functions, with pro-mnemonic effects and problem solving improvements. Emotional processing also appears to be enhanced by the Pharmacologic Substance, although to date there are only a limited number of studies., BACKGROUND: Modafinil, a putative cognitive enhancing Pharmacologic Substance, has previously been shown to improve performance of healthy volunteers as well as patients with Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type and SCHIZOPHRENIA 2 (disorder), mainly in tests of executive functions. , A review of modafinil and armodafinil as add-on therapy in antipsychotic-treated patients with SCHIZOPHRENIA 2 (disorder)., It has been suggested that modafinil and its isomer armodafinil as an add-on strategy to antipsychotic treatment in patients with SCHIZOPHRENIA 2 (disorder) may improve Ability to perform cognitive activity, attenuate Fatigue, inactiveness and other negative functions as well as Gaining Weight question., Evidence for the use of modafinil or armodafinil as add-on therapy to antipsychotic drugs to alleviate Fatigue, Somnolence and inactivity is inconclusive. One cohort study and one out of two single-dose crossover RCTs in which modafinil addition was studied could demonstrate a positive effect. All five RCTs of modafinil (three RCTs) and armodafinil (two RCTs) addition with a longer study duration could not demonstrate a positive effect. , In RCTs with a treatment duration of 4 weeks or more, however, no positive effect could be demonstrated on Ability to perform cognitive activity with modafinil and armodafinil addition. Yet, four single-dose crossover RCTs of modafinil addition show significant positive effects on executive functioning, verbal memory span, visual memory, working memory, spatial planning, slowing in latency, impulse control and recognition of faces expressing sadness and sadness misattribution in the context of disgust recognition. The addition of modafinil or armodafinil to an antipsychotic regime, despite theoretical and preclinical considerations, has not been proved to enhance cognitive function, attenuate Fatigue, enhance activity, improve negative symptoms and reduce weight in patients with SCHIZOPHRENIA 2 (disorder)., RATIONAL: In recent years, evidence suggests that modafinil may be useful for certain symptom domains of SCHIZOPHRENIA 2 (disorder), especially for the negative and cognitive symptoms. , CONCLUSION: The present study indicates modafinil as a potential adjunctive treatment strategy for treatment of SCHIZOPHRENIA 2 (disorder) particularly the negative symptoms. , Modafinil is a wake-promoting Pharmacologic Substance that has been shown to improve attention, memory and executive function in the healthy population and in patients with SCHIZOPHRENIA 2 (disorder)., CONCLUSIONS: Results of this pilot trial do not support routine use of modafinil to counteract increased weight and metabolic diseases in patients taking clozapine., Modafinil (2-((diphenylmethyl)sulfinyl)acetamide) is described as an atypical stimulant and is a putative cognition enhancer for SCHIZOPHRENIA 2 (disorder), but the precise mechanisms of action remain unclear., Modafinil is a wake-promoting Pharmacologic Substance that has been shown to improve emotion discrimination in healthy individuals and attention and executive function in SCHIZOPHRENIA 2 (disorder). , CONCLUSIONS: These data support clinical evidence that modafinil may alleviate Cognition Disorders in SCHIZOPHRENIA 2 (disorder) and also demonstrate the benefit of applying PLSR modeling to characterize functional brain networks in translational models relevant to central nervous system dysfunction., Modafinil improves working memory in healthy subjects and individuals diagnosed with SCHIZOPHRENIA 2 (disorder) and Attention Deficit/Hyperactivity Disorder, though the effects of modafinil have not been evaluated on working memory in methamphetamine-dependent subjects., Modafinil is a psychostimulant approved for treating excessive Somnolence in adults; off-label uses (e.g., treatment of No No cognitive impairment in SCHIZOPHRENIA 2 (disorder), Attention deficit hyperactivity disorder and age-related dementias) are currently being explored. , CONCLUSIONS: Results of this pilot trial do not support routine use of modafinil to treat negative symptoms, Cognition Disorders, or wakefulness/Fatigue in patients on clozapine., We have previously shown that the amount of movement exhibited by patients with SCHIZOPHRENIA 2 (disorder) is positively correlated with the volume of left anterior cingulate cortex and that this quantity of movement can be increased by modafinil. , OBJECTIVE: Given recent reports about the off-label use of modafinil as an adjuvant for the treatment of antipsychotic-associated sedation in SCHIZOPHRENIA 2 (disorder) patients and the recent interest in its putative cognitive-enhancing effects in this population, we present a systematic review of available data on trials of modafinil as an adjuvant in the treatment of Cognition Disorders, negative symptoms, and antipsychotic-induced Fatigue, and its tolerability. , RESULTS: One of 4 reviewed studies found a significant effect of modafinil as an alerting agent for antipsychotic-induced Fatigue and sedation. Neither of 2 reviewed studies found modafinil to improve negative symptoms of SCHIZOPHRENIA 2 (disorder). Three of 6 reviewed studies showed that modafinil may improve short-term memory, attention, and the ability to shift mental sets. , CONCLUSIONS: While the available data suggest that modafinil is generally well tolerated and may have some efficacy in the treatment of antipsychotic-induced sedation and cognitive domains, the small sample sizes, contradictory results, and methodological differences between trials, especially with respect to cognitive testing, make it difficult to draw firm conclusions about the overall effectiveness of modafinil as an adjunct in the treatment of SCHIZOPHRENIA 2 (disorder). , Hence, before prescribing modafinil to a SCHIZOPHRENIA 2 (disorder) patient, the possible risks and benefits of each particular case should be evaluated., Modafinil had a substantial placebo effect on outcomes such as Fatigue, excessive Somnolence and Cancer patients and suicide and Cancer patients and suicide and depression in patients with Traumatic Brain Injury, major depressive disorder, SCHIZOPHRENIA 2 (disorder), post-polio Fatigue and Multiple Sclerosis; however, it did not provide any benefit greater than placebo., RATIONALE: The wake-promoting agent modafinil selectively improves neuropsychological task performance in healthy volunteers, in adults with attention deficit hyperactivity disorder (Attention deficit hyperactivity disorder) and in SCHIZOPHRENIA 2 (disorder). , Recently, however, modafinil has been shown to improve attentional set-shifting performance in patients with SCHIZOPHRENIA 2 (disorder)., In addition, modafinil shows initial promise for a variety of off-label indications in psychiatry, including treatment-resistant Cancer patients and suicide and Cancer patients and suicide and depression, attention-deficit/hyperactivity disorder, and SCHIZOPHRENIA 2 (disorder)., There is increasing interest in the use of modafinil to improve cognition in SCHIZOPHRENIA 2 (disorder) as well as in other disorders such as attention-deficit/hyperactivity disorder., Initial findings indicate that modafinil may lead to better executive functioning and attentional performance in patients with SCHIZOPHRENIA 2 (disorder). , CONCLUSIONS: Although no effect on negative symptoms was found, adjunctive therapy with modafinil may result in global improvements in patients with SCHIZOPHRENIA 2 (disorder) who have prominent negative symptoms., CONCLUSIONS: Modafinil did not improve cognitive control in all SCHIZOPHRENIA 2 (disorder) patients., . These data suggest that modafinil increases quantifiable motor behaviour in SCHIZOPHRENIA 2 (disorder) and may have an impact on avolition., One patient was on treatment with both modafinil and trazodone and reported no change after tapering each in separate discontinuation trials, while another 3 patients were taking sleeping medications and also noted no change after discontinuation., Neuroprotective agents as add-on therapies (e.g., modafinil, Recombinant Erythropoietin, Glycine (Plant), serine, D-, memantine and celecoxib) are currently being evaluated in SCHIZOPHRENIA 2 (disorder) and related disorders. , In the modafinil (N = 10) and placebo (N = 10) groups, Fatigue improved significantly over time (p < .01), but there were no differences between groups on changes in Fatigue, positive and negative symptoms, or cognition. , CONCLUSIONS: Modafinil modulates anterior cingulate cortex function in chronic SCHIZOPHRENIA 2 (disorder) but its beneficial cognitive effects may be restricted to a subset of patients requiring further characterisation., Modafinil significantly improved overall clinical condition, with 64% and 82% of patients rated as clinically improved at week 4 by a blinded clinician and the investigator respectively., Modafinil significantly improved Fatigue (P = 0.025, week 3) and tended to improve Ability to perform cognitive activity scores. , Although preliminary, these results suggest modafinil may be an effective and well-tolerated adjunct treatment that improves global functioning and clinical condition, and reduces Fatigue in patients with SCHIZOPHRENIA 2 (disorder) or Schizoaffective Disorder. , Modafinil had some cognitive enhancing properties in SCHIZOPHRENIA 2 (disorder) similar to those observed in healthy adults and adult patients with Attention deficit hyperactivity disorder. , Modafinil may have potential as an important therapy for No No cognitive impairment in patients with SCHIZOPHRENIA 2 (disorder), particularly because of its beneficial effects on attentional set shifting., While the available data suggest that modafinil is generally well tolerated and may have some efficacy in the treatment of antipsychotic-induced sedation and cognitive domains, the small sample sizes, contradictory results, and methodological differences between trials, especially with respect to cognitive testing, make it difficult to draw firm conclusions about the overall effectiveness of modafinil as an adjunct in the treatment of SCHIZOPHRENIA 2 (disorder)., Given recent reports about the off-label use of modafinil as an adjuvant for the treatment of antipsychotic-associated sedation in SCHIZOPHRENIA 2 (disorder) patients and the recent interest in its putative cognitive-enhancing effects in this population, we present a systematic review of available data on trials of modafinil as an adjuvant in the treatment of Cognition Disorders, negative symptoms, and antipsychotic-induced Fatigue, and its tolerability., The present study indicates modafinil as a potential adjunctive treatment strategy for treatment of SCHIZOPHRENIA 2 (disorder) particularly the negative symptoms., It has been suggested that modafinil and its isomer armodafinil as an add-on strategy to antipsychotic treatment in patients with SCHIZOPHRENIA 2 (disorder) may improve Ability to perform cognitive activity, attenuate Fatigue, inactiveness and other negative functions as well as Gaining Weight question., CONCLUSION: The present study indicates modafinil as a potential adjunctive treatment strategy for treatment of SCHIZOPHRENIA 2 (disorder) particularly the negative symptoms., OBJECTIVE: Given recent reports about the off-label use of modafinil as an adjuvant for the treatment of antipsychotic-associated sedation in SCHIZOPHRENIA 2 (disorder) patients and the recent interest in its putative cognitive-enhancing effects in this population, we present a systematic review of available data on trials of modafinil as an adjuvant in the treatment of Cognition Disorders, negative symptoms, and antipsychotic-induced Fatigue, and its tolerability., CONCLUSIONS: While the available data suggest that modafinil is generally well tolerated and may have some efficacy in the treatment of antipsychotic-induced sedation and cognitive domains, the small sample sizes, contradictory results, and methodological differences between trials, especially with respect to cognitive testing, make it difficult to draw firm conclusions about the overall effectiveness of modafinil as an adjunct in the treatment of SCHIZOPHRENIA 2 (disorder)., The present study indicates modafinil as a potential adjunctive treatment strategy for treatment of SCHIZOPHRENIA 2 (disorder) particularly the negative symptoms., Although preliminary, these results suggest modafinil may be an effective and well-tolerated adjunct treatment that improves global functioning and clinical condition, and reduces Fatigue in patients with SCHIZOPHRENIA 2 (disorder) or Schizoaffective Disorder., While the available data suggest that modafinil is generally well tolerated and may have some efficacy in the treatment of antipsychotic-induced sedation and cognitive domains, the small sample sizes, contradictory results, and methodological differences between trials, especially with respect to cognitive testing, make it difficult to draw firm conclusions about the overall effectiveness of modafinil as an adjunct in the treatment of SCHIZOPHRENIA 2 (disorder), The present study indicates modafinil as a potential adjunctive treatment strategy for treatment of SCHIZOPHRENIA 2 (disorder) particularly the negative symptoms, Modafinil, a putative cognitive enhancing Pharmacologic Substance, has previously been shown to improve performance of healthy volunteers as well as patients with Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type and SCHIZOPHRENIA 2 (disorder), mainly in tests of executive functions[SEP]Relations: Modafinil has relations: contraindication with psychotic disorder, contraindication with psychotic disorder, contraindication with mental disorder, contraindication with mental disorder, drug_drug with Labetalol, drug_drug with Labetalol, drug_effect with Mania, drug_effect with Mania, drug_drug with Ethanol, drug_drug with Ethanol. Definitions: Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Somnolence defined as following: Compelling urge to sleep.. Schizoaffective Disorder defined as following: A disorder in which the individual suffers from both symptoms that qualify as SCHIZOPHRENIA 2 (disorder) and symptoms that qualify as a mood disorder (e.g., Cancer patients and suicide and depression or bipolar disorder) for a substantial portion (but not all) of the active period of the illness; for the remainder of the active period of the illness, the individual suffers from delusions or hallucinations in the absence of prominent mood symptoms.. memantine defined as following: AMANTADINE derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent.. serine, D- defined as following: A non-essential amino acid and dextro isomer of serine with antipsychotic activity. serine, D- is a selective full agonist at the Glycine (Plant) site of N-methyl-D-aspartate (NMDA)-type glutamate receptor. Hypofunction of NMDA type of neurotransmission is believed to play a major role in pathophysiology of SCHIZOPHRENIA 2 (disorder), therefore, administration of serine, D- and subsequent activation of NMDA receptors may alleviate psychotic tendencies.. clozapine defined as following: A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent.. Traumatic Brain Injury defined as following: A form of acquired brain injury which occurs when a sudden trauma causes damage to the brain.. Attention deficit hyperactivity disorder defined as following: A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V). Multiple Sclerosis defined as following: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903). Recombinant Erythropoietin defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous glycoprotein Recombinant Erythropoietin (Epo). Epo promotes the differentiation and maturation of hematopoietic progenitors into erythrocytes; is a mitogen and a chemoattractant for endothelial cells; stimulates activated and differentiated B-cells and enhances B-cell immunoglobulin production and proliferation; and is hypoxia-inducible. (NCI04). modafinil defined as following: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.. celecoxib defined as following: A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN.. Fatigue defined as following: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.. armodafinil defined as following: The R-enantiomer of the racemic synthetic agent modafinil with central nervous system (CNS) stimulant and wakefulness-promoting activities. Although the exact mechanism of action has yet to be fully elucidated, armodafinil appears to inhibit the reuptake of dopamine by binding to the dopamine-reuptake pump, which leads to an increase in extracellular dopamine levels in some brain regions. This agent does not bind to or inhibit several receptors and enzymes that may be involved in sleep/wake regulation and is not a direct- or indirect-acting dopamine receptor agonist. Armodafinil has a longer half-life than modafinil.. Cognition Disorders defined as following: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.. trazodone defined as following: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This Pharmacologic Substance does not aggravate psychotic symptoms in patients with SCHIZOPHRENIA 2 (disorder) or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309). Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type defined as following: A mental disorder characterized by inattention, easy distraction, careless mistakes and avoidance of tasks that require sustained mental focus. These behaviors can lead to maladaptive consequences in the affected individual's life.. Gaining Weight question defined as following: A question about whether an individual is gaining or has gained weight..", "label": "yes"} {"original_question": "Do patients with Pendred syndrome present congenital deafness?", "id": "converted_74", "sentence1": "Do patients with Pendred syndrome present Congenital Hearing Loss, Partial?", "sentence2": "Pendred Syndrome can be characterized by the triad composed of familial goitre, abnormal perchlorate discharge and Congenital Hearing Loss, Partial., Pendred syndrome is an Autosomal Recessive Disorder characterized by Congenital Hearing Loss, Partial and Goiter. , Pendred syndrome comprises congenital sensorineural hearing loss, THYROID DIAGNOSTIC RADIOPHARMACEUTICALS Goiter, and positive perchlorate discharge test. , The cause of the Congenital Hearing Loss, Partial in Pendred syndrome is obscure, although a Mondini type malformation of the Cochlear structure exists in some patients., Pendred syndrome is an Autosomal Recessive Disorder characterized by Congenital Hearing Loss, Partial and Goiter., Pendred syndrome is the autosomal recessively transmitted association of familial Goiter and Congenital Hearing Loss, Partial., Pendred syndrome (Pendred's syndrome) is an Autosomal Recessive Disorder characterized by Congenital Hearing Loss, Partial, Goiter and Iodides organification defect., Pendred syndrome is a recessively inherited disorder with the hallmark features of Congenital Hearing Loss, Partial and THYROID DIAGNOSTIC RADIOPHARMACEUTICALS goitre., Pendred syndrome, a common autosomal-recessive disorder characterized by Congenital Hearing Loss, Partial and Goiter, is caused by mutations of SLC26A4, which codes for pendrin., These studies provide compelling evidence that defects in pendrin cause Pendred syndrome thereby launching a new area of investigation into THYROID DIAGNOSTIC RADIOPHARMACEUTICALS physiology, the pathogenesis of Congenital Hearing Loss, Partial and the role of altered sulphate transport in human disease., Gene Mutation in the Pendred syndrome gene have been observed in patients with Hearing Loss, Partial and vestibular aqueduct dilatation, in the absence of other Pendred syndrome features., The occurrence of Congenital Hearing Loss, Partial, Mutism and goitre unassociated with Congenital Hypothyroidism or mental retardation in Euthyroid (finding) patients is known as Pendred's Syndrome., The autosomal recessive Pendred's syndrome is defined by Congenital sensorineural hearing loss, Goiter, and impaired Iodides organification., Pendred's syndrome is an autosomal recessive disease characterized by Goiter, impaired Iodides organification, and Congenital sensorineural hearing loss., Pendred syndrome is an Autosomal Recessive Disorder characterized by Congenital sensorineural hearing loss, Goiter, and impaired Iodides organification., Pendred's syndrome is manifested by Congenital sensorineural hearing loss in association with familial Goiter due to defective organic binding of Iodine, Homeopathic preparation in the Neck>Thyroid gland., Although the textbook view of the Pendred syndrome is that of an autosomal recessive condition characterised by Hearing Loss, Partial and goitre, it is increasingly clear that not all patients present this classical clinical description., Pendred's syndrome may account for up to 10% of the cases with Hereditary hearing loss, and pendrin mutations have also been found in a kindred with non-syndromic Hearing Loss, Partial., Pendred syndrome comprises the association of severe Congenital sensorineural hearing loss with THYROID DIAGNOSTIC RADIOPHARMACEUTICALS pathology., The first one is named Pendred Syndrome (Supernumerary mandibular right central primary incisor) when Hearing Loss, Partial is associated with THYROID DIAGNOSTIC RADIOPHARMACEUTICALS Goiter; the second is called DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT, when no other symptoms are present., Pendred syndrome is an Autosomal Recessive Disorder characterized by Sensorineural Hearing Loss (disorder), a partial defect in Iodides organification, and dyshormonogenetic Goiter., Pendred syndrome and non-syndromic recessive Hearing Loss, Partial associated with enlarged vestibular aqueduct (NSRD with EVA) are caused by mutations in the SLC26A4 (Pendred's syndrome) gene., Although the textbook view of Pendred syndrome is that of an autosomal recessive condition characterized by Hearing Loss, Partial and goitre, it is increasingly clear that not all such patients present this classical clinical picture. , The occurrence of Congenital Hearing Loss, Partial, Mutism and goitre unassociated with Congenital Hypothyroidism or mental retardation in Euthyroid (finding) patients is known as Pendred's Syndrome. , The cause of the Congenital Hearing Loss, Partial in Pendred syndrome is obscure, although a Mondini type malformation of the Cochlear structure exists in some patients. , The discovery of mutations in the SLC26A4 gene in patients with Pendred syndrome (Congenital Hearing Loss, Partial, Goiter, and defective Iodides organification) suggested a possible role for the encoded protein, pendrin, as an apical Iodides transporter. , Pendred syndrome is a recessively inherited disorder with the hallmark features of Congenital Hearing Loss, Partial and THYROID DIAGNOSTIC RADIOPHARMACEUTICALS goitre. , Pendred's syndrome is manifested by Congenital sensorineural hearing loss in association with familial Goiter due to defective organic binding of Iodine, Homeopathic preparation in the Neck>Thyroid gland. The majority of patients with Pendred's syndrome are Euthyroid (finding). We report on an unusual case of a patient with Pendred's syndrome presenting with Amenorrhea and late-onset Hypothyroidism., Although the textbook view of Pendred syndrome is that of an autosomal recessive condition characterized by Hearing Loss, Partial and goitre, it is increasingly clear that not all such patients present this classical clinical picture. Malformations of the Labyrinth, specifically enlargement of the vestibular aqueduct, are common in Pendred syndrome and mutations in the Pendred's syndrome (Pendred Syndrome) gene have been recorded in patients presenting with Hearing Loss, Partial and vestibular aqueduct dilatation only, without other features of Pendred syndrome., The occurrence of Congenital Hearing Loss, Partial, Mutism and goitre unassociated with Congenital Hypothyroidism or mental retardation in Euthyroid (finding) patients is known as Pendred's Syndrome. It has been estimated that 4-10 % of children with Congenital Hearing Loss, Partial suffer from this condition., Malformations of the Labyrinth, specifically enlargement of the vestibular aqueduct, are common in Pendred syndrome and mutations in the Pendred's syndrome (Pendred Syndrome) gene have been recorded in patients presenting with Hearing Loss, Partial and vestibular aqueduct dilatation only, without other features of Pendred syndrome. Since this is the most common radiological malformation of the Cochlear structure in deaf patients, we investigated what proportion of such cases were due to Mutation Abnormality of the SLC26A4 gene., Although the textbook view of Pendred syndrome is that of an autosomal recessive condition characterized by Hearing Loss, Partial and goitre, it is increasingly clear that not all such patients present this classical clinical picture. Malformations of the Labyrinth, specifically enlargement of the vestibular aqueduct, are common in Pendred syndrome and mutations in the Pendred's syndrome (Pendred Syndrome) gene have been recorded in patients presenting with Hearing Loss, Partial and vestibular aqueduct dilatation only, without other features of Pendred syndrome.[SEP]Relations: Pendred syndrome has relations: disease_disease with syndromic genetic Hearing Loss, Partial, disease_disease with syndromic genetic Hearing Loss, Partial, disease_phenotype_positive with Congenital sensorineural hearing impairment, disease_phenotype_positive with Congenital sensorineural hearing impairment, disease_phenotype_positive with Neurological speech impairment, disease_phenotype_positive with Neurological speech impairment, disease_disease with syndromic Hypothyroidism, disease_disease with syndromic Hypothyroidism. Congenital sensorineural hearing impairment has relations: disease_phenotype_positive with Pendred syndrome, disease_phenotype_positive with Pendred syndrome. Definitions: Autosomal Recessive Disorder defined as following: An inherited disorder manifested only when two copies of a mutated gene are present.. Congenital sensorineural hearing loss defined as following: A type of hearing impairment caused by an abnormal functionality of the cochlear nerve with congenital onset. [HPO:probinson]. Congenital Hypothyroidism defined as following: A deficiency of THYROID DIAGNOSTIC RADIOPHARMACEUTICALS hormone present at birth. The etiology can be genetic or environmental, or a combination of both; treatment is based on severity and causality.. Iodine, Homeopathic preparation defined as following: homeopathic drug. Labyrinth defined as following: The portion of the ear located within the temporal bone that is involved in both hearing and balance and includes the semicircular canals, vestibule, and Cochlear structure. (from American Heritage Dictionary online). Pendred's syndrome defined as following: A condition associated with reduced export of Iodides across the apical membrane of the follicular cells of the Neck>Thyroid gland that may progress to Hypothyroidism. Pendred syndrome is associated with an increased risk of Goiter and sensorineural hearing loss due to malformations of the Labyrinth (vestibular system). Inactivating mutations in the SLC26A4 gene encoding the pendrin transport protein are responsible for the condition.. Iodides defined as following: Inorganic binary compounds of Iodine, Homeopathic preparation or the I- ion.. Goiter defined as following: Enlargement of the THYROID GLAND that may increase from about 20 grams to hundreds of grams in human adults. Goiter is observed in individuals with normal THYROID DIAGNOSTIC RADIOPHARMACEUTICALS function (euthyroidism), THYROID DIAGNOSTIC RADIOPHARMACEUTICALS deficiency (HYPOTHYROIDISM), or hormone overproduction (HYPERTHYROIDISM). Goiter may be congenital or acquired, sporadic or endemic (GOITER, ENDEMIC).. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Amenorrhea defined as following: Absence of menstruation.. Congenital Hearing Loss, Partial defined as following: complete loss of the ability to hear from both ears since birth, regardless of causation.. familial Goiter defined as following: An enlargement of the Neck>Thyroid gland with congenital onset. [HPO:probinson]. Sensorineural Hearing Loss (disorder) defined as following: Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.. Supernumerary mandibular right central primary incisor defined as following:

Supernumerary mandibular right central primary incisor

. Hearing Loss, Partial defined as following: A condition in which a person partially loses the ability to hear sounds in one or both ears.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Gene Mutation may be associated with genetic diversity or with pathologies including cancer.. Mutism defined as following: The inability to generate oral-verbal expression, despite normal comprehension of speech. This may be associated with BRAIN DISEASES or MENTAL DISORDERS. Organic Mutism may be associated with damage to the FRONTAL LOBE; BRAIN STEM; THALAMUS; and CEREBELLUM. Selective Mutism is a psychological condition that usually affects children characterized by continuous refusal to speak in social situations by a child who is able and willing to speak to selected persons. Kussmal aphasia refers to Mutism in psychosis. (From Fortschr Neurol Psychiatr 1994; 62(9):337-44). Hypothyroidism defined as following: A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.. Cochlear structure defined as following: The part of the Labyrinth (LABYRINTH) that is concerned with hearing. It forms the anterior part of the labyrinth, as a snail-like structure that is situated almost horizontally anterior to the VESTIBULAR LABYRINTH.. DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT defined as following: An autosomal recessive condition caused by Mutation Abnormality(s) in one of several genes, most often SLC26A4 encoding pendrin. It is characterized by hearing loss and enlargement of the vestibular aqueduct. Mutation(s) in the SLC26A4 gene also cause Pendred syndrome.. Pendred syndrome defined as following: A condition associated with reduced export of Iodides across the apical membrane of the follicular cells of the Neck>Thyroid gland that may progress to Hypothyroidism. Pendred syndrome is associated with an increased risk of Goiter and sensorineural hearing loss due to malformations of the Labyrinth (vestibular system). Inactivating mutations in the SLC26A4 gene encoding the pendrin transport protein are responsible for the condition..", "label": "yes"} {"original_question": "is intense physical activity associated with longevity ?", "id": "converted_296", "sentence1": "is intense physical activity associated with longevity ?", "sentence2": "We found a very significant increase in average longevity (17%) of the cyclists when compared with the general population. The age at which 50% of the general population died was 73.5 vs. 81.5 years in Tour de France participants. Our major finding is that repeated very intense exercise prolongs life span in well trained practitioners., Competitive exercise does not induce cardiac damage in individuals with healthy hearts, but does induce physiological functional and structural cardiac adaptations which have positive effects on life expectancy., Medallists lived an average of 2.8 years longer than controls. Medallists in eight of the nine country groups had a significant survival advantage compared with controls. Gold, Silver color, and bronze medallists each enjoyed similar sized survival advantages. Medallists in endurance sports and mixed sports had a larger survival advantage over controls at 30 years (1.13, 1.09 to 1.17; 1.11, 1.09 to 1.13) than that of medallists in power sports (1.05, 1.01 to 1.08). CONCLUSIONS: Olympic medallists live longer than the general population, irrespective of country, medal, or sport. This study was not designed to explain this effect, but possible explanations include genetic factors, physical activity, healthy lifestyle, and the wealth and status that come with international sporting glory., Long-term endurance training induces in elderly subjects an increased HRV and a higher exercise working capacity, which are well-established predictors of cardiovascular and overall mortality., Sports activity in adolescents and young adults was associated with an increased risk of SLC17A5 gene, both in males and females. Sports, per se, was not a cause of the enhanced mortality, but it triggered SLC17A5 gene in those athletes who were affected by cardiovascular conditions predisposing to life-threatening Ventricular arrhythmia during physical exercise.[SEP]Relations: SLC17A5 has relations: molfunc_protein with transmembrane transporter activity, molfunc_protein with transmembrane transporter activity, molfunc_protein with carbohydrate:proton symporter activity, molfunc_protein with carbohydrate:proton symporter activity. Ventricular arrhythmia has relations: drug_effect with Ganciclovir, drug_effect with Ganciclovir, drug_effect with Sildenafil, drug_effect with Sildenafil. Silver has relations: drug_effect with Inflammatory abnormality of the skin, drug_effect with Inflammatory abnormality of the skin. Definitions: Ventricular arrhythmia defined as following: A disorder characterized by an electrocardiographic finding of an atypical cardiac rhythm resulting from a pathologic process in the cardiac ventricles.. Sports defined as following: Activities or games, usually involving physical effort or skill. Reasons for engagement in sports include pleasure, competition, and/or financial reward..", "label": "yes"} {"original_question": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?", "id": "converted_3406", "sentence1": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?", "sentence2": "Treatment for crampsThere is evidence (13 RCTs, N = 4012) that for the treatment of Muscle Cramp in MND, compared to placebo:- memantine and dronabinol (Thrombocytopenia 1) are probably ineffective (moderate-quality evidence);- Vitamin E Drug Class may have little or no effect (low-quality evidence); and- the effects of threonine, gabapentin, xaliproden, riluzole, and baclofen are uncertain as the evidence is either very low quality or the trial specified the outcome but did not report numerical data., The medications comprised Vitamin E Drug Class, baclofen, riluzole, threonine, xaliproden, indinavir, and memantine. Six studies assessed Muscle Cramp as an adverse event. The medications comprised creatine/creatinine/creatinine, gabapentin, dextromethorphan, quinidine, and Lithium antipsychotics. In all 20 studies no favourable effect for the treatment of Muscle Cramp in Amyotrophic Lateral Sclerosis/MND could be demonstrated, but many studies were underpowered to draw a definite conclusion., . The six months intent-to-treat analysis showed no statistically significant effect but a trend in favour of 2 mg xaliproden compared to placebo for reduction in the rate of deterioration of FVC, Limb structure functional score, and manual muscle testing score (Oculodigitoesophagoduodenal syndrome)., These results support the use of a staging process to select suitable patients for phase II studies, and suggest that xaliproden may have potential effects in Amyotrophic Lateral Sclerosis and deserve further study., An effect of xaliproden on functional parameters, especially VC, was noted. Although this effect did not reach statistical significance, xaliproden had a small effect on clinically noteworthy aspects of disease progression in Amyotrophic Lateral Sclerosis., The six months intent-to-treat analysis showed no statistically significant effect but a trend in favour of 2 mg xaliproden compared to placebo for reduction in the rate of deterioration of FVC, Limb structure functional score, and manual muscle testing score (Oculodigitoesophagoduodenal syndrome)., An effect of xaliproden on functional parameters, especially VC, was noted., These results support the use of a staging process to select suitable patients for phase II studies, and suggest that xaliproden may have potential effects in Amyotrophic Lateral Sclerosis and deserve further study., The six months intent-to-treat analysis showed no statistically significant effect but a trend in favour of 2 mg xaliproden compared to placebo for reduction in the rate of deterioration of FVC, Limb structure functional score, and manual muscle testing score (Oculodigitoesophagoduodenal syndrome)., Although this effect did not reach statistical significance, xaliproden had a small effect on clinically noteworthy aspects of disease progression in Amyotrophic Lateral Sclerosis.[SEP]Relations: amyotrophic lateral sclerosis has relations: disease_phenotype_positive with Xerostomia, disease_phenotype_positive with Xerostomia, disease_phenotype_positive with Axonal degeneration, disease_phenotype_positive with Axonal degeneration, disease_phenotype_positive with Degeneration of the lateral corticospinal tracts, disease_phenotype_positive with Degeneration of the lateral corticospinal tracts, disease_phenotype_positive with Neurodegeneration, disease_phenotype_positive with Neurodegeneration, disease_protein with XIAP, disease_protein with XIAP. Definitions: Thrombocytopenia 1 defined as following: An X-linked recessive bleeding disorder caused by mutation(s) in the WAS gene, encoding Wiskott-Aldrich syndrome protein, resulting in thrombocytopenia.. memantine defined as following: AMANTADINE derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent.. dronabinol defined as following: A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-dronabinol (Thrombocytopenia 1) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound.. baclofen defined as following: A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.. Oculodigitoesophagoduodenal syndrome defined as following: A rare autosomal dominant syndrome caused by mutations in the MYCN oncogene. It is characterized by microcephaly, limb abnormalities, esophageal and/or duodenal atresia.. Amyotrophic Lateral Sclerosis defined as following: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94). dextromethorphan defined as following: Methyl analog of DEXTRORPHAN that shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (RECEPTORS, N-METHYL-D-ASPARTATE) and acts as a non-competitive channel blocker. It is one of the widely used ANTITUSSIVES, and is also used to study the involvement of glutamate receptors in neurotoxicity.. quinidine defined as following: An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission.. threonine defined as following: An essential amino acid occurring naturally in the L-form, which is the active form. It is found in eggs, milk, gelatin, and other proteins.. Muscle Cramp defined as following: A sustained and usually painful contraction of muscle fibers. This may occur as an isolated phenomenon or as a manifestation of an underlying disease process (e.g., UREMIA; HYPOTHYROIDISM; MOTOR NEURON DISEASE; etc.). (From Adams et al., Principles of Neurology, 6th ed, p1398). gabapentin defined as following: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.. riluzole defined as following: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.. indinavir defined as following: A potent and specific HIV protease inhibitor that appears to have good oral bioavailability.. Limb structure defined as following: The farthest or outermost projections of the body, such as the HAND and FOOT.. amyotrophic lateral sclerosis defined as following: An inherited form of amyotrophic lateral sclerosis, usually inherited in an autosomal dominant pattern, caused by mutation(s) in the SOD1 gene, encoding superoxide dismutase..", "label": "no"} {"original_question": "Can CPX-351 be used for the treatment of tuberculosis?", "id": "converted_2860", "sentence1": "Can CPX-351 be used for the treatment of tuberculosis?", "sentence2": "CPX-351 is a novel liposomal formulation of cytarabine and daunorubicin which has recently been FDA approved for treatment of RUNX1 gene (Leukemia, Myelocytic, Acute).[SEP]Relations: acute promyelocytic leukemia has relations: disease_protein with TBL1XR1, disease_protein with TBL1XR1, disease_protein with ITGAX, disease_protein with ITGAX. Daunorubicin has relations: drug_drug with Baricitinib, drug_drug with Baricitinib, drug_drug with Novobiocin, drug_drug with Novobiocin. Cytarabine has relations: drug_drug with Baricitinib, drug_drug with Baricitinib. Definitions: Leukemia, Myelocytic, Acute defined as following: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.. cytarabine defined as following: A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472). RUNX1 gene defined as following: This gene plays a role in transcriptional regulation and cytogenetic aberrations are associated with several leukemias.. daunorubicin defined as following: A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS.. tuberculosis defined as following: Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS..", "label": "no"} {"original_question": "Can adult humans be induced to produce fetal hemoglobin?", "id": "converted_1626", "sentence1": "Can adult humans be induced to produce fetal hemoglobin?", "sentence2": " At the time of birth, Fetal Hemoglobin accounts for approximately 70% of the total Hb. , whereas in the trace amounts of Fetal Hemoglobin that is found in the adult it reverses to 40:60 because of a gamma- to beta-globin gene switch, With the increased understanding and discovery of molecular regulators of Hemoglobin switching, such as B-Cell Lymphoma/Leukemia 11A, new avenues of research may lead ultimately to novel therapeutic, mechanism-based approaches to fetal Hemoglobin reactivation in patients., The data suggest that Recombinant Transforming Growth Factor-Beta reactivates A gamma-Globin expression, combined with a sequential stimulation and suppression of erythropoiesis. [SEP]Relations: Abnormal hemoglobin has relations: phenotype_phenotype with Reduced hemoglobin A, phenotype_phenotype with Reduced hemoglobin A, disease_phenotype_positive with Hb Bart's hydrops fetalis, disease_phenotype_positive with Hb Bart's hydrops fetalis, phenotype_phenotype with Methemoglobinemia, phenotype_phenotype with Methemoglobinemia, phenotype_phenotype with Imbalanced hemoglobin synthesis, phenotype_phenotype with Imbalanced hemoglobin synthesis, disease_phenotype_positive with congenital amegakaryocytic thrombocytopenia, disease_phenotype_positive with congenital amegakaryocytic thrombocytopenia. Definitions: Recombinant Transforming Growth Factor-Beta defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine transforming growth factor-beta (Recombinant Transforming Growth Factor-Beta) with proapoptotic and antineoplastic properties. Recombinant Transforming Growth Factor-Beta may suppress tumor cell growth by decreasing the expression of cyclin D1, a cell cycle regulatory protein, and downregulating the expression of the oncogene c-myc. This agent is also involved in T cell-mediated immunosuppression by CD4+CD25+ T cells, which permits cancer cells to evade immune surveillance. (NCI04). B-Cell Lymphoma/Leukemia 11A defined as following: B-cell lymphoma/leukemia 11A (835 aa, ~91 kDa) is encoded by the human B-Cell Lymphoma/Leukemia 11A gene. This protein is involved in the regulation of both cell projection formation and lymphopoiesis.. A gamma-Globin defined as following: A type of A gamma-Globin encoded by the A gamma globin gene on CHROMOSOME 11.. Fetal Hemoglobin defined as following: The major component of hemoglobin in the fetus. This HEMOGLOBIN has two alpha and two gamma polypeptide subunits in comparison to normal adult hemoglobin, which has two alpha and two beta polypeptide subunits. Fetal hemoglobin concentrations can be elevated (usually above 0.5%) in children and adults affected by LEUKEMIA and several types of ANEMIA.. Hemoglobin defined as following: The oxygen-carrying proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the hemoglobin quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements.. fetal hemoglobin defined as following: The major component of hemoglobin in the fetus. This HEMOGLOBIN has two alpha and two gamma polypeptide subunits in comparison to normal adult hemoglobin, which has two alpha and two beta polypeptide subunits. Fetal hemoglobin concentrations can be elevated (usually above 0.5%) in children and adults affected by LEUKEMIA and several types of ANEMIA.. humans defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Do proton pump inhibitors affect thyroxine absorption?", "id": "converted_711", "sentence1": "Do proton pump inhibitors affect Thyroxine measurement absorption?", "sentence2": "Proton-pump inhibitors, Antacids and a long list of drugs may decrease Thyroxine measurement absorption, Many commonly used drugs, such as Bile Acid [EPC] sequestrants, ferrous sulfate, sucralfate, calcium carbonate, aluminium-containing Antacids, phosphate binders, raloxifene and proton-pump inhibitors, have also been shown to interfere with the absorption of levothyroxine., pantoprazole did not influence endocrine function in healthy male volunteers during short-term treatment., PPIs should be added to the list of medications affecting the level of Thyroid Hormones in patients with Hypothyroidism treated with LT4 replacement. Patients with Hypothyroidism and normal Thyrotropin:-:Pt:Ser/Plas:- values during LT4 replacement therapy may need additional thyroid function testing after treatment with PPIs and may need adjustment of their LT4 dose.[SEP]Relations: pantoprazole has relations: drug_effect with Thrombophlebitis, drug_effect with Thrombophlebitis, drug_effect with Nocturia, drug_effect with Nocturia, drug_effect with Thrombocytopenia, drug_effect with Thrombocytopenia, drug_effect with Albuminuria, drug_effect with Albuminuria. Raloxifene has relations: drug_effect with Thrombocytopenia, drug_effect with Thrombocytopenia. Definitions: calcium carbonate defined as following: Carbonic acid calcium salt (CaCO3). An odorless, tasteless powder or crystal that occurs in nature. It is used therapeutically as a phosphate buffer in hemodialysis patients and as a calcium supplement.. levothyroxine defined as following: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.. sucralfate defined as following: A basic aluminum complex of sulfated sucrose.. raloxifene defined as following: A selective benzothiophene estrogen receptor modulator (SERM). Raloxifene binds to estrogen receptors (ER) as a mixed estrogen agonist/antagonist; it displays both an ER-alpha-selective partial agonist/antagonist effect and a pure ER-beta-selective antagonist effect. This agent functions as an estrogen agonist in some tissues (bones, lipid metabolism) and as an estrogen antagonist in others (endometrium and breasts), with the potential for producing some of estrogen's beneficial effects without producing its adverse effects. (NCI04). Antacids defined as following: Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT.. Thyroid Hormones defined as following: Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs.. pantoprazole defined as following: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.. Hypothyroidism defined as following: A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.. ferrous sulfate defined as following: A sulfate salt of mineral iron formulated for oral administration and used as a dietary supplement, ferrous sulfate is absorbed in the stomach and small intestine and combines with apoferritin to form ferritin, which is stored in the liver, spleen, red bone marrow, and intestinal mucosa. Important in transport of oxygen by hemoglobin to the tissues, iron is also found in myoglobin, transferrin, and ferritin, and is a component of many enzymes such as catalase, peroxidase, and cytochromes..", "label": "yes"} {"original_question": "Is the toxin produced by Clostridium botulinum always deadly?", "id": "converted_1765", "sentence1": "Is the toxin produced by Clostridium botulinum always deadly?", "sentence2": "animal allergen extracts treated with trace elements recovered. It appears that Intestinal Microbiome dysbiosis and trace element deficiency could explain the extensive emergence of chronic Poisoning caused by Clostridium botulinum toxin type B type B., The patient was treated with Homo sapiens botulism immune globulin and had rapid recovery in weakness. A stool sample from the patient was positive for Type A Clostridium botulinum toxin type B type B eventually confirming the diagnosis of infant botulism, The botulism immunoglobulin A, immunoglobulin G, immunoglobulin M drug combination A, immunoglobulin A, immunoglobulin G, immunoglobulin M drug combination G, immunoglobulin A, immunoglobulin G, immunoglobulin M drug combination M drug combination was administered, and a diagnosis was confirmed with positive botulinum toxin type B type B in the stool samples. Full recovery was made by the infant, Botulinum neurotoxin (BoNT) serotype B (BoNT/B) is one of the serotypes of BoNT that causes deadly Homo sapiens botulism, though it is used clinically for treatment of many neuromuscular diseases., Foodborne botulism is a rare and sometimes fatal Illness (finding) caused by consuming foods containing botulinum neurotoxin, To assess the effectiveness and safety of botulinum toxin type B type B in treating MPS, excluding MPS in dendritic spine dendritic spine neck and Skeletal Muscle Tissue structure of head., Botulinum toxin (BTX) is one of the most potent bacterial toxins known and its effectiveness in the treatment of some pain syndromes is well known., An emerging treatment option to address these issues is the use of a paralyzing material such as botulinum toxin type B type B A (Botox) to decrease the appearance of the Skin Wrinkling, which yields a more esthetic and youthful facial appearanc, lthough BoNT is an extremely toxic molecule, it is now increasingly used for the treatment of disorders related to Muscle Tissue Hyperactive behavior and glandular Hyperactive behavior.[SEP]Relations: Botulinum toxin type A has relations: drug_drug with Clorgiline, drug_drug with Clorgiline, drug_drug with Clidinium, drug_drug with Clidinium, drug_drug with Clobazam, drug_drug with Clobazam. Botulinum Toxin Type B has relations: drug_drug with Clorgiline, drug_drug with Clorgiline, drug_drug with Clorgiline, drug_drug with Clorgiline. Definitions: Homo sapiens defined as following: Members of the species Homo sapiens.. Intestinal Microbiome defined as following: The collection of microorganisms existing in the intestines of an organism.. Botox defined as following:

Botox is a drug made from a toxin produced by the bacterium Clostridium botulinum. It's the same toxin that causes a life-threatening type of food poisoning called botulism. Doctors use it in small doses to treat health problems, including

  • Temporary smoothing of facial Skin Wrinkling and improving your appearance
  • Severe underarm sweating
  • Cervical dystonia - a neurological disorder that causes severe dendritic spine neck and shoulder Muscle Tissue contractions
  • Blepharospasm - uncontrollable blinking
  • Strabismus - misaligned eyes
  • Chronic migraine
  • Overactive bladder

Botox injections work by weakening or paralyzing certain muscles or by blocking certain nerves. The effects last about three to twelve months, depending on what you are treating. The most common side effects are pain, swelling, or bruising at the injection site. You could also have flu-like symptoms, headache, and upset stomach. Injections in the face may also cause temporary drooping eyelids. You should not use Botox if you are pregnant or breastfeeding.

. Hyperactive behavior defined as following: Increased motor activity that is not goal directed.. Muscle Tissue defined as following: Contractile tissue that produces movement in animals.. Skeletal muscle structure of head defined as following: Muscle (organ) which is a part of the head. Examples: masseter, orbicularis oculi.. dendritic spine neck defined as following: Part of the dendritic spine that connects the dendritic shaft to the head of the dendritic spine. [GOC:nln]. Skin Wrinkling defined as following: A fold, ridge or crease of the skin.. Illness (finding) defined as following: A state of ill health, bodily malfunction, or discomfort.. botulinum toxin type B A defined as following: An injectable formulation of a neurotoxin derived through the fermentation of the Hall strain of Clostridium botulinum type A with neuromuscular transmission inhibitory and analgesic activities. Upon injection into the affected Muscle Tissue, the heavy chain portion of botulinum toxin type B type A (BTX-A) binds to the cell membrane of the motor nerve and is internalized via endocytosis. Upon entry, the light chain portion of the toxin is activated and cleaves the protein SNAP-25, thereby preventing the fusion of acetylcholine (ACh)-containing synaptic vesicles with the cell membrane and, so, the release of ACh into the neuromuscular junction; subsequent binding of ACH to motor end-plate nicotinic acid receptors and ACh-mediated Muscle Tissue contraction are thus blocked. In addition to ACh, BTX-A may inhibit the release of neuropeptides, such as substance P and glutamate, which may contribute to its analgesic activity.. toxin defined as following: A substance that is produced by a living organism and is toxic, noxious, or poisonous.. Clostridium botulinum defined as following: Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type B type C which is neurotoxic to ANIMALS, especially CATTLE, but not humans. It causes dissociation of ACTIN FILAMENTS..", "label": "no"} {"original_question": "Are there any specific antidotes for dabigatran?", "id": "converted_1071", "sentence1": "Are there any specific antidotes for dabigatran?", "sentence2": "Novel Oral Route of Drug administration ANTICOAGULANTS AND COAGULANTS (NOACs)--apixaban, dabigatran, and rivaroxaban--have a significantly smaller risk of Cerebral Hemorrhage (HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO). However, two facts make this situation complicated: First, the risk of Hematoma expansion is unknown for NOACs. Second, there is no specific antidote for neither of the NOACs. , However, many physicians are wary of these drugs, since there is limited evidence on how to manage Hemorrhage in patients taking them, and since no specific antidote is known to reverse their anticoagulant effect., Given the absence of a specific antidote, the action to be taken in these situations must be defined. , The fact that there is no specific antidote to reverse the anticoagulant action of the new ANTICOAGULANTS AND COAGULANTS can impair management of hemorrhagic complications;, Unlike the vitamin K antagonist, i.e. warfarin, there is no specific antidote for these medications. , The lack of guidelines, protocols, and an established specific antidote to reverse the anticoagulation effect of dabigatran potentially increases the rates of morbidity and mortality in patients with closed head injury (Greek letter chi)., The novel Oral Route of Drug administration ANTICOAGULANTS AND COAGULANTS (Direct Oral Anticoagulant) dabigatran etexilat (Pradaxa®), rivaroxaban (Xarelto®) and apixaban (Eliquis®), also known as \"direct\" ANTICOAGULANTS AND COAGULANTS, act independently from Therapeutic Human Antithrombin-III by inhibiting Thrombin Time Test Device, as in the case of dabigatran, or by inhibiting factor Xa, as in the case of rivaroxaban and apixaban. It is assumed that they are suitable for long-term use and do not require laboratory monitoring. Nevertheless, clinical experience is very limited and caution rather than quick conclusions is necessary. Two major drawbacks are on the one hand the risk of Pharmacologic Substance accumulation in Both kidneys and/or Hepatobiliary Disorder and, on the other hand, the lack of specific antidotes. , NOA also have other unresolved problems: Pharmacologic Substance interactions are still possible, specific coagulation test to assess them must be developed, and no specific antidote is currently available in case of hemorrhagic complication., It is critical to identify and subsequently manage dabigatran etexilate toxicity because there is no specific antidote to reverse the Pharmacologic Substance's anticoagulant effects., In the absence of a specific antidote for this novel Oral Route of Drug administration anticoagulant medication, even in an emergency situation, successful surgical treatment was possible with an aggressive use of available prohaemostatic agents., While these trial data are extremely encouraging, several practical issues (e.g., lack of specific antidote, safety of long-term treatment or cost-effectiveness in \"real-life\" clinical practice) still need to be elucidated., In case of massive Hemorrhage, management is unclear and none of these newer agents has a specific antidote that completely reverses its anticoagulant effect., The short half-life of these new agents compensates for the lack of any specific antidote in many instances. , As there is no specific antidote, the only treatment option is discontinuation of the Pharmacologic Substance and supportive management., Currently, none of these new agents has a specific antidote, and little advise can be given on how to manage a major Hemorrhage event., Although there is no specific antidote to antagonise the anticoagulant effect of dabigatran, due to its short duration of effect Pharmacologic Substance discontinuation is usually sufficient to reverse any excessive anticoagulant activity. [SEP]Relations: Dabigatran has relations: drug_drug with Antipyrine, drug_drug with Antipyrine, drug_drug with Argatroban, drug_drug with Argatroban, drug_drug with Flunixin, drug_drug with Flunixin, drug_drug with Decitabine, drug_drug with Decitabine, drug_drug with Dactinomycin, drug_drug with Dactinomycin. Definitions: Hematoma defined as following: A collection of blood outside the BLOOD VESSELS. Hematoma can be localized in an organ, space, or tissue.. warfarin defined as following: An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.. Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. rivaroxaban defined as following: An orally bioavailable oxazolidinone derivative and direct inhibitor of the coagulation factor Xa with anticoagulant activity. Upon Oral Route of Drug administration administration, rivaroxaban selectively binds to both free factor Xa and factor Xa bound in the prothrombinase complex. This interferes with the conversion of prothrombin (factor II) to Thrombin Time Test Device and eventually prevents the formation of cross-linked fibrin clots. Rivaroxaban does not affect existing Thrombin Time Test Device levels.. Therapeutic Human Antithrombin-III defined as following: A form of the human glycoprotein Therapeutic Human Antithrombin-III-III (AT-III), which is produced recombinantly or isolated from human plasma, with anticoagulant activity. Upon administration, Therapeutic Human Antithrombin-III-III binds to and blocks Thrombin Time Test Device activity, and prevents thrombus formation.. Thrombin Time Test Device defined as following: A Thrombin Time Test Device time test is a device used to measure fibrinogen concentration and detect fibrin or fibrinogen split products for the evaluation of Hemorrhage disorders.. Hepatobiliary Disorder defined as following: A non-neoplastic or neoplastic disorder that affects the liver, bile ducts, and gallbladder. Representative examples of non-neoplastic disorders include hepatitis, cirrhosis, cholangitis, and cholecystitis. Representative examples of neoplastic disorders include hepatocellular adenoma, hepatocellular carcinoma, and cholangiocarcinoma.. Oral Route of Drug administration defined as following: The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of Pharmacologic Substance administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the Pharmacologic Substance within the gastrointestinal tract. This prohibits Oral Route of Drug administration administration of certain classes of drugs especially peptides and proteins.. apixaban defined as following: An orally active inhibitor of coagulation factor Xa with anticoagulant activity. Apixaban directly inhibits factor Xa, thereby interfering with the conversion of prothrombin to Thrombin Time Test Device and preventing formation of cross-linked fibrin clots.. dabigatran defined as following: A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation.. Cerebral Hemorrhage defined as following: Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA.. Hemorrhage defined as following: Bleeding or escape of blood from a vessel.. Direct Oral Anticoagulant defined as following: An agent taken orally to prevent blood clot formation by directly inhibiting certain coagulation factors including Thrombin Time Test Device (factor IIa) or factor Xa..", "label": "no"} {"original_question": "Are conserved noncoding elements associated with developmental genes?", "id": "converted_809", "sentence1": "Are conserved noncoding elements associated with Genes, Developmental?", "sentence2": "Some characteristics of CNEs include their high frequency in mammalian genomes, their potential regulatory role in Genes expression, and their enrichment in Genes deserts nearby master Genes, Developmental, we review recent findings that disruptions of CNEs, within or at long distance from the coding sequences of key genes involved in SLC12A3 Genes development, result in neurocristopathies via the alteration of tissue- or stage-specific long-distance regulation of Genes expression, Genomic regulatory blocks are chromosomal regions spanned by long clusters of highly conserved noncoding elements devoted to long-range regulation of Genes, Developmental, Analysis of CNEs, at least some of which are candidate regulatory elements, suggests that ancestral CNEs partitioned between Genes duplicates. These results help explain the evolutionary pathways by which the developmentally important family of FgfD molecules arose and the deduced principles that guided FgfD evolution are likely applicable to the evolution of developmental regulation in many Vertebrates multigene families, Pan-Vertebrates developmental cis-regulatory elements are discernible as highly conserved noncoding elements (HCNEs) and are often dispersed over large areas around the Pleiotropic Gene whose expression they control. On the loci of two developmental transcription factor genes, SOX3 gene Genes and PAX6 gene Genes, we demonstrate that HCNEs conserved between Homo sapiens and Zebrafish can be systematically and reliably tested for their regulatory function in multiple stable Transgenes in Zebrafish, and their genomic reach estimated with confidence using synteny Conservation and HCNE density along these loci. HCNEs of both Homo sapiens and Zebrafish function as specific developmental enhancers in Zebrafish, We show that Homo sapiens HCNEs result in expression patterns in Zebrafish equivalent to those in Mus sp., establishing Zebrafish as a suitable model for large-scale testing of Homo sapiens developmental enhancers, HCNEs from the same area often drive overlapping patterns, suggesting that multiple regulatory inputs are required to achieve robust and precise complex expression patterns exhibited by Genes, Developmental, Organization of conserved elements near key developmental regulators in Vertebrates genomes, Further positional analysis of these conserved noncoding elements (CNEs) in the Genome - anatomical entity demonstrates that they cluster around genes involved in developmental regulation, Ancora: a web resource for exploring highly conserved noncoding elements and their association with developmental regulatory genes, Metazoan genomes contain arrays of highly conserved noncoding elements (HCNEs) that span developmental regulatory genes and define regulatory domains, The most highly conserved noncoding elements (HCNEs) in mammalian genomes cluster within regions enriched for genes encoding developmentally important TRANSCRIPTION FACTOR (TFs). This suggests that HCNE-rich regions may contain key regulatory controls involved in development, We found the largest mammal-teleost conserved chromosomal segments to be spanned by highly conserved noncoding elements (HCNEs), their developmental regulatory target genes, and phylogenetically and functionally unrelated \"bystander\" genes., Ancora: a web resource for exploring highly conserved noncoding elements and their association with developmental regulatory genes., Pan-Vertebrates developmental cis-regulatory elements are discernible as highly conserved noncoding elements (HCNEs) and are often dispersed over large areas around the Pleiotropic Gene whose expression they control., Metazoan genomes contain arrays of highly conserved noncoding elements (HCNEs) that span developmental regulatory genes and define regulatory domains., Further positional analysis of these conserved noncoding elements (CNEs) in the Genome - anatomical entity demonstrates that they cluster around genes involved in developmental regulation., The most highly conserved noncoding elements (HCNEs) in mammalian genomes cluster within regions enriched for genes encoding developmentally important TRANSCRIPTION FACTOR (TFs)., Disruption of long-distance highly conserved noncoding elements in neurocristopathies., Fish-mammal genomic comparisons have proved powerful in identifying conserved noncoding elements likely to be cis-regulatory in nature, and the majority of those tested in vivo have been shown to act as tissue-specific enhancers associated with genes involved in transcriptional regulation of development., Despite this, attempts at unearthing Genome - anatomical entity-wide regulatory elements conserved throughout the Vertebrates lineage using BLAST-like approaches have thus far detected noncoding Conservation in only a few hundred genes, mostly associated with regulation of transcription and development., Further positional analysis of these conserved noncoding elements (CNEs) in the Genome - anatomical entity demonstrates that they cluster around genes involved in developmental regulation., We found the largest mammal-teleost conserved chromosomal segments to be spanned by highly conserved noncoding elements (HCNEs), their developmental regulatory target genes, and phylogenetically and functionally unrelated \"bystander\" genes., Organization of conserved elements near key developmental regulators in Vertebrates genomes., Pan-Vertebrates developmental cis-regulatory elements are discernible as highly conserved noncoding elements (HCNEs) and are often dispersed over large areas around the Pleiotropic Gene whose expression they control[SEP]Relations: transcription factor binding has relations: molfunc_protein with PARK7, molfunc_protein with PARK7, molfunc_protein with ARNT, molfunc_protein with ARNT, molfunc_protein with HOXA7, molfunc_protein with HOXA7, molfunc_protein with CEBPG, molfunc_protein with CEBPG. SLC12A3 has relations: anatomy_protein_absent with decidua, anatomy_protein_absent with decidua. Definitions: Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. PAX6 gene defined as following: This Genes plays a role in transcriptional regulation.. Genome - anatomical entity defined as following: Anatomical set of genes in all the chromosomes.. Pleiotropic Gene defined as following: A single Genes that influences several distinct and seemly unrelated phenotypic outcomes.. Conservation defined as following: The maintenance of certain characteristics in an unchanged condition.. SOX3 gene defined as following: This Genes is involved in neuronal differentiation.. Homo sapiens defined as following: Members of the species Homo sapiens.. Zebrafish defined as following: An exotic species of the family CYPRINIDAE, originally from Asia, that has been introduced in North America. Zebrafish is a model organism for drug assay and cancer research.. Transgenes defined as following: Genes that are introduced into an organism using GENE TRANSFER TECHNIQUES.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. Genes, Developmental defined as following: Genes that determine the fate of a cell or CELLS in a region of the embryo during EMBRYONIC DEVELOPMENT.. Vertebrates defined as following: Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising mammals, birds, reptiles, amphibians, and fishes..", "label": "yes"} {"original_question": "Has AZD9668 been tested in clinical trials?", "id": "converted_4075", "sentence1": "Has AZD9668 been tested in clinical trials?", "sentence2": "Efficacy, safety and tolerability of AZD9668 (5, 20 and 60 mg bid) were compared with placebo in a randomised, double-blind, placebo-controlled, 12-week, Phase IIb trial (NCT00949975: approved by an Investigational Review Board), in patients with symptomatic COPD receiving maintenance tiotropium. , A randomised, placebo-controlled, dose-finding study of AZD9668, an oral inhibitor of Neutrophil Elastase, human, in patients with Chronic Obstructive Airway Disease treated with tiotropium.[SEP]Relations: Tiotropium has relations: drug_drug with AZD-3043, drug_drug with AZD-3043, drug_drug with APD791, drug_drug with APD791, drug_drug with Azelaic acid, drug_drug with Azelaic acid, drug_drug with Azacitidine, drug_drug with Azacitidine, drug_drug with Azaperone, drug_drug with Azaperone. Definitions: Neutrophil Elastase, human defined as following: Neutrophil elastase (267 aa, ~29 kDa) is encoded by the human ELANE gene. This protein plays a role in innate host defense and tissue remodeling.. Chronic Obstructive Airway Disease defined as following: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA..", "label": "yes"} {"original_question": "Can radiosurgery be used for the DNET tumors?", "id": "converted_3978", "sentence1": "Can radiosurgery be used for the DNET tumors?", "sentence2": "Salvage gamma knife radiosurgery in the management of dysembryoplastic neuroepithelial tumors: Long-term outcome in a single-institution case series., BACKGROUND: Dysembryoplastic neuroepithelial Specimen Source Codes - Specimen Source Codes - tumor (DNT/DNET) are rare epileptogenic tumors. Microsurgery remains the best treatment option, although case reports exist on the use of gamma knife radiosurgery (GKRS) in selected cases. We investigated the long-term outcome of GKRS-treated DNTs at our institution in the context of current diagnostic and treatment options., Long-term seizure control was obtained after GKRS of two separate residual DNT components along the surgical margin (2005 and 2010). A 27-year-old male undergoing gross total resection of the contrast-enhancing portion of a DNT (1999) resulted in temporary control of intractable Epilepsy despite Automated External Defibrillators; lasting clinical control of Seizures was achieved in 2002 after GKRS of a small, recurrent DNT component. A 28-year-old male underwent STR (short terminal repeat, nucleic acid) (short terminal repeat, nucleic acid) of DNT (1994 and 2004) resulting in temporary control of intractable Epilepsy. Lasting seizure control was gained after GKRS of a residual Specimen Source Codes - Specimen Source Codes - tumor (2005).CONCLUSION: GKRS as performed in our series was effective in terms of Specimen Source Codes - Specimen Source Codes - tumor and seizure control., Prospective studies are warranted to establish the role of GKRS in the treatment of DNTs., Two rare cases of intractable Epilepsy caused by Dysembryoplastic Neuroepithelial Tumours (DNET) are reported and their different management discussed. The first case required vagal nerve stimulation and radiosurgery while the later was operated with the help of neuronavigation. , Salvage gamma knife radiosurgery in the management of dysembryoplastic neuroepithelial tumors: Long-term outcome in a single-institution case series[SEP]Relations: Epilepsy has relations: contraindication with Foscarnet, contraindication with Foscarnet, contraindication with Dyclonine, contraindication with Dyclonine, contraindication with Desonide, contraindication with Desonide, contraindication with Triprolidine, contraindication with Triprolidine. Dysembryoplastic neuroepithelial Specimen Source Codes - tumor has relations: phenotype_phenotype with Neuronal/glioneuronal neoplasm of the central nervous system, phenotype_phenotype with Neuronal/glioneuronal neoplasm of the central nervous system. Definitions: Dysembryoplastic neuroepithelial Specimen Source Codes - tumor defined as following: A benign glial-neuronal neoplasm. It is usually supratentorial, located in the cortex. It occurs in children and young adults with a long-standing history of partial Seizures. A histologic hallmark of this Specimen Source Codes - tumor is the 'specific glioneuronal element', characterized by columns, made up of bundles of axons, oriented perpendicularly to the cortical surface. (Adapted from WHO). Seizures defined as following: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent Seizures are usually referred to as EPILEPSY or \"seizure disorder.\". Automated External Defibrillators defined as following: An arrhythmia detector and alarm is a system that monitors the electrocardiogram and is designed to produce a visible or audible signal or alarm when an atrial or ventricular arrhythmia, such as a premature contraction or ventricular fibrillation, exists.. Epilepsy defined as following: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal Epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313).", "label": "yes"} {"original_question": "Is there evidence for somatic mosaicism in Tuberous Sclerosis?", "id": "converted_1122", "sentence1": "Is there evidence for somatic mosaicism in Tuberous Sclerosis?", "sentence2": "There are several case reports of solitary SEGA without any other manifestations of Tuberous Sclerosis. Usually these cases are thought to be forme fruste of Tuberous Sclerosis due to somatic mosaicism., Female germline mosaicism in tuberous sclerosis confirmed by molecular genetic analysis, This is the first case of germline mosaicism in tuberous sclerosis proven by molecular genetic analysis and also the first example of female germline mosaicism for a characterized Autosome dominant TAF1 Gene Mutation apparently not associated with somatic mosaicism., Mutation screening by RT-PCR and direct sequencing of the TUBEROUS SCLEROSIS 2 (disorder) gene identified a 4 bp insertion bis(tetraheptylammonium)tetraiodocyclopentane tellurate(IV) following Nucleotides 2077 in exon 18 which was present in the three affected children but not in five unaffected siblings or the parents. This Mutation Abnormality would cause a Frameshift Mutation function and premature termination at codon 703. Absence of the Mutation Abnormality in lymphocyte DNA from the parents was consistent with germline mosaicism and this was confirmed by our finding of identical chromosome 16 Haplotypes in affected and unaffected siblings, providing unequivocal evidence of two different Cultured Cell Line in the gametes. Molecular analysis of the TUBEROUS SCLEROSIS 2 (disorder) alleles present in the affected subjects showed that the Mutation Abnormality had been inherited from the mother.[SEP]Relations: tuberous sclerosis has relations: disease_protein with SOD2, disease_protein with SOD2, disease_protein with SOD2, disease_protein with SOD2, disease_protein with SOD1, disease_protein with SOD1, disease_protein with SOD1, disease_protein with SOD1, disease_phenotype_positive with Behavioral abnormality, disease_phenotype_positive with Behavioral abnormality. Definitions: TUBEROUS SCLEROSIS 2 (disorder) defined as following: Tuberous sclerosis mapped to chromosome 16p13.3 (TUBEROUS SCLEROSIS 2 (disorder) gene).. Tuberous Sclerosis defined as following: Autosomal dominant neurocutaneous syndrome classically characterized by MENTAL RETARDATION; EPILEPSY; and skin lesions (e.g., adenoma sebaceum and hypomelanotic macules). There is, however, considerable heterogeneity in the neurologic manifestations. It is also associated with cortical tuber and HAMARTOMAS formation throughout the body, especially the heart, kidneys, and eyes. Mutations in two loci TSC1 and TUBEROUS SCLEROSIS 2 (disorder) that encode hamartin and tuberin, respectively, are associated with the disease.. TUBEROUS SCLEROSIS 2 (disorder) gene defined as following: This gene plays a role in signal transduction and cell cycle control. It is involved in cell adhesion, differentiation, growth and migration.. TAF1 Gene Mutation defined as following: A change in the Nucleotides sequence of the TAF1 gene.. Cultured Cell Line defined as following: Established cell cultures that have the potential to propagate indefinitely.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Haplotypes defined as following: The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX.. Nucleotides defined as following: The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed). Frameshift Mutation function defined as following: A type of Mutation Abnormality in which a number of NUCLEOTIDES deleted from or inserted into a protein coding sequence is not divisible by three, thereby causing an alteration in the READING FRAMES of the entire coding sequence downstream of the Mutation Abnormality. These mutations may be induced by certain types of MUTAGENS or may occur spontaneously.. Autosome defined as following: Any chromosome other than a sex chromosome. [GOC:mah]. Tuberous Sclerosis defined as following: This gene is involved in cell cycle regulation and the loss of cellular adhesion.. somatic mosaicism defined as following: The presence of genetically distinct populations of somatic cells in a given organism caused by DNA mutations, epigenetic alterations of DNA, chromosomal abnormalities or the spontaneous reversion of inherited mutations. [HPO:probinson, PMID:12360233].", "label": "yes"} {"original_question": "Can doxycycline cause photosensitivity?", "id": "converted_2527", "sentence1": "Can doxycycline cause Photosensitivity of skin?", "sentence2": "Phototoxicity of Doxycycline: A Systematic Review on Clinical Manifestations, Frequency, chemical cofactor, and Prevention., BACKGROUND: One of the most important dermatologic side effects of doxycycline is Photosensitivity of Skin Specimen Source Code. , While there are many publications on the phototoxicity of Tetracycline Antibiotics in general, only a few exist focusing on doxycycline. , Clinical symptoms vary from light sunburn-like sensation (burning, Erythema) to large-area photodermatitis. , CONCLUSION: Evidence base must be improved for giving advice on appropriate prevention measures to travelers taking doxycycline and having a risk of significant sun exposure., Based on the available evidence, our best estimates of absolute effect for mefloquine versus doxycyline were: 2% versus 2% for discontinuation, 12% versus 3% for Insomnia homeopathic medication, 31% versus 3% for abnormal dreams, 18% versus 1% for Anxiety Disorders, 11% versus 1% for Depressed mood, 4% versus 14% for Dyspepsia, 2% versus 19% for Photosensitivity of Skin Specimen Source Code, 1% versus 5% for Vomiting, and 2% versus 16% for Candidiasis of vagina., Many drugs are responsible for this phototoxic reaction, especially Tetracycline Antibiotics, Psoralens, Chloramphenicol Drug Class, non-steroidal anti-inflammatory drugs, Fluoroquinolone antiinfectives, ophthalmologic, and, rarely, doxycycline. , OBJECTIVES: Many patients undergoing long-term doxycycline treatment do not regularly take their treatment because of Photosensitivity of Skin Specimen Source Code., Modulation of Melanogenesis and Antioxidant Status of melanocyte in Response to Phototoxic Action of Doxycycline., Doxycycline is a commonly used tetracycline antibiotic showing the broad spectrum of antibacterial action. However, the use of this antibiotic is often connected with the risk of phototoxic reactions that lead to various Skin Specimen Source Code disorders., The results obtained in vitro may explain the mechanisms of phototoxic reactions that occur in normal human epidermal melanocytes in vivo after exposure of Skin Specimen Source Code to doxycycline and UVA radiation., Treatment with doxycycline is cheap and relatively safe, but No gastrointestinal symptom and Photosensitivity of Skin Specimen Source Code reactions can be expected more often than with ceftriaxone.
, OBJECTIVES: Many patients undergoing long-term doxycycline treatment do not regularly take their treatment because of Photosensitivity of Skin Specimen Source Code., Dermatitis, Phototoxic and No gastrointestinal symptom were noted more often among patients receiving doxycycline than in those receiving ceftriaxone., Thus, the action spectra of the drug Photosensitivity of Skin Specimen Source Code patients were plotted and compared with those of 12 nonphotosensitive control patients: 10 patients were found to be photosensitive in the UVA range; the implicated drugs included quinine, sparfloxacin, amiodarone, doxycycline, mefenamic acid, nalidixic acid, fenbrufen, diclofenac, enalapril, diltiazem and prochlorperazine maleate., One patient on doxycycline was photosensitive in both the UVA and Ultraviolet B therapy ranges., Treatment with doxycycline is cheap and relatively safe, but No gastrointestinal symptom and Photosensitivity of Skin Specimen Source Code reactions can be expected more often than with ceftriaxone., Anti-inflammatory-dose doxycycline should not be used by individuals with known Emotional Emotional hypersensitivity to Tetracycline Antibiotics or increased Photosensitivity of Skin Specimen Source Code, or by pregnant or nursing women (anti-inflammatory-dose doxycycline is a pregnancy category-D medication)., BACKGROUND: One of the most important dermatologic side effects of doxycycline is Photosensitivity of Skin Specimen Source Code., One of the most important dermatologic side effects of doxycycline is Photosensitivity of Skin Specimen Source Code., One patient experienced mild Photosensitivity of Skin Specimen Source Code from doxycycline but continued to take it., Participants in the doxycycline group had a higher incidence of Nausea:Presence or Threshold:Point in time:^Patient:Ordinal and Photosensitivity of Skin Specimen Source Code., Dermatitis, Phototoxic and No gastrointestinal symptom were noted more often among patients receiving doxycycline than in those receiving ceftriaxone.[SEP]Relations: Doxycycline has relations: drug_effect with Confusion, drug_effect with Confusion, drug_effect with Pain, drug_effect with Pain, drug_effect with Dyspnea, drug_effect with Dyspnea, drug_drug with Antipyrine, drug_drug with Antipyrine, drug_effect with Inflammatory abnormality of the Skin Specimen Source Code, drug_effect with Inflammatory abnormality of the Skin Specimen Source Code. Definitions: Tetracycline Antibiotics defined as following: Any of a group of broad spectrum naphthacene antibiotics isolated from various species of Streptomyces or produced semisynthetically. In bacteria, tetracycline antibiotics block binding of aminoacyl-tRNA to the mRNA-ribosome complex, thereby inhibiting protein synthesis. (NCI05). quinine defined as following: An alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood.. doxycycline defined as following: A synthetic tetracycline derivative with similar antimicrobial activity.. Erythema defined as following: Redness of the Skin Specimen Source Code produced by congestion of the capillaries. This condition may result from a variety of disease processes.. melanocyte defined as following: Mammalian pigment cells that produce MELANINS, pigments found mainly in the EPIDERMIS, but also in the eyes and the hair, by a process called melanogenesis. Coloration can be altered by the number of melanocytes or the amount of pigment produced and stored in the organelles called MELANOSOMES. The large non-mammalian melanin-containing cells are called MELANOPHORES.. Emotional hypersensitivity defined as following: Heightened emotional reactivity to environmental stimuli, including emotions of others. [PMID:23250816]. mefloquine defined as following: A phospholipid-interacting antimalarial drug (ANTIMALARIALS). It is very effective against PLASMODIUM FALCIPARUM with very few side effects.. amiodarone defined as following: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.. Dyspepsia defined as following: Impaired digestion, especially after eating.. Psoralens defined as following: Linear forms of furocoumarins.. sparfloxacin defined as following: A fluoroquinolone antibiotic that inhibits bacterial DNA gyrase, thereby inhibiting DNA replication and transcription. Sparfloxacin was withdrawn from the U.S. market due to a high incidence of phototoxicity.. diclofenac defined as following: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.. nalidixic acid defined as following: A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE.. Photosensitivity of skin defined as following: Increased sensitivity of the Skin Specimen Source Code to light exposure.. Anxiety Disorders defined as following: Persistent and disabling ANXIETY.. prochlorperazine maleate defined as following: The maleate salt form of prochlorperazine, a synthetic, piperazine phenothiazine derivative with antiemetic, antipsychotic, antihistaminic, and anticholinergic activities. Prochlorperazine binds to and blocks the postsynaptic dopamine D2-receptor in the chemoreceptor trigger zone (CTZ) of the brain and may prevent chemotherapy-induced emesis. Prochlorperazine maleate also blocks anticholinergic and alpha-adrenergic receptors. Its antagonistic actions on the alpha-1 adrenergic receptors results in sedation, muscle relaxation, and hypotension.. enalapril defined as following: An angiotensin-converting enzyme inhibitor that is used to treat HYPERTENSION and HEART FAILURE.. diltiazem defined as following: A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of CALCIUM ion on membrane functions.. ceftriaxone defined as following: A broad-spectrum cephalosporin antibiotic and cefotaxime derivative with a very long half-life and high penetrability to meninges, eyes and inner ears.. Dermatitis, Phototoxic defined as following: A nonimmunologic, chemically induced type of Photosensitivity of skin producing a sometimes vesiculating dermatitis. It results in hyperpigmentation and desquamation of the light-exposed areas of the Skin Specimen Source Code.. chemical cofactor defined as following: Something that must join with another to produce a given result.. Vomiting defined as following: The forcible expulsion of the contents of the STOMACH through the MOUTH.. mefenamic acid defined as following: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.. Depressed mood defined as following: An emotional state characterized by feelings of sadness, emptiness, and/or tearfulness..", "label": "yes"} {"original_question": "Can sorafenib activate AMPK?", "id": "converted_328", "sentence1": "Can sorafenib activate AMP-Activated Protein Kinases?", "sentence2": "Here, we identify sorafenib as an activator of AMP-activated protein kinase (AMP-Activated Protein Kinases), in a manner that involves either upstream LKB1 or CAMKK2 gene gene. , Persistent activation of AMP-Activated Protein Kinases by sorafenib finally led to the impairment of glucose metabolism both in MCF-7 and SKBR3 Cells as well as in the highly glycolytic MDA-MB-231 Cells, resulting in cell death., Here, we identify sorafenib as an activator of AMP-activated protein kinase (AMP-Activated Protein Kinases), in a manner that involves either upstream LKB1 or CAMKK2 gene gene, sorafenib synergizes with metformin in Non-Small Cell Lung Carcinoma through AMP-Activated Protein Kinases pathway activation., Persistent activation of AMP-Activated Protein Kinases by sorafenib finally led to the impairment of glucose metabolism both in MCF-7 and SKBR3 Cells as well as in the highly glycolytic MDA-MB-231 Cells, resulting in cell death. This previously unrecognized long-term effect of sorafenib was mediated by AMP-Activated Protein Kinases-dependent inhibition of the mechanistic target of rapamycin complex 1 pathway.[SEP]Relations: sorafenib has relations: drug_drug with Ampicillin, drug_drug with Ampicillin, drug_drug with Amprenavir, drug_drug with Amprenavir, drug_drug with Amphetamine, drug_drug with Amphetamine, drug_drug with Canakinumab, drug_drug with Canakinumab, drug_drug with Siponimod, drug_drug with Siponimod. Definitions: AMP-Activated Protein Kinases defined as following: Catalysis of the reaction: [3-hydroxy-3-methylglutaryl-CoA reductase (NADPH)] + ATP = [3-hydroxy-3-methylglutaryl-CoA reductase (NADPH)] phosphate + ADP. [EC:2.7.11.31, MetaCyc:2.7.1.109-RXN]. metformin defined as following: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289). mechanistic target of rapamycin complex 1 defined as following: A protein complex that is involved in the both serine/threonine phosphorylation and the regulation of protein synthesis in response to cellular stress.. sorafenib defined as following: A synthetic compound targeting growth signaling and angiogenesis. sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis.. Non-Small Cell Lung Carcinoma defined as following: A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. sorafenib defined as following: A synthetic compound targeting growth signaling and angiogenesis. sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis..", "label": "yes"} {"original_question": "Is phospholipid hydroperoxide glutathione peroxidase a selenoprotein?", "id": "converted_2846", "sentence1": "Is phospholipids hydroperoxide glutathione peroxidase a Selenoproteins?", "sentence2": "GLUTATHIONE PEROXIDASE (GPX1 gene) is the major Selenoproteins in most Body tissue in animal allergen extracts., The selenoenzyme GPX4 gene is essential for early embryogenesis and cell viability for its unique function to prevent phospholipids oxidation., the major Selenoproteins expressed by Germ Cells in the Testis, the phospholipids hydroperoxide glutathione peroxidase (PHGPx/GPx4) [SEP]Relations: GPX1 has relations: molfunc_protein with phospholipids-hydroperoxide glutathione peroxidase activity, molfunc_protein with phospholipids-hydroperoxide glutathione peroxidase activity. GPX4 has relations: molfunc_protein with phospholipids-hydroperoxide glutathione peroxidase activity, molfunc_protein with phospholipids-hydroperoxide glutathione peroxidase activity. glutathione peroxidase activity has relations: molfunc_protein with ALOX5AP, molfunc_protein with ALOX5AP, molfunc_protein with GSTP1, molfunc_protein with GSTP1, molfunc_protein with PTGES, molfunc_protein with PTGES. Definitions: phospholipids defined as following: Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system.. GLUTATHIONE PEROXIDASE defined as following: An enzyme catalyzing the oxidation of 2 moles of GLUTATHIONE in the presence of HYDROGEN PEROXIDE to yield oxidized glutathione and water.. GPX1 gene defined as following: This gene plays a role in the inhibition of oxidative stress and increases cellular resistance to toxic challenges.. Selenoproteins defined as following: Selenoproteins are proteins that specifically incorporate SELENOCYSTEINE into their amino acid chain. Most selenoproteins are enzymes with the selenocysteine residues being responsible for their catalytic functions.. Germ Cells defined as following: The reproductive cells in multicellular organisms at various stages during GAMETOGENESIS.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. GPX4 gene defined as following: A selenoenzyme that converts GLUTATHIONE plus FATTY ACID HYDROPEROXIDES to GLUTATHIONE DISULFIDE plus hydroxy fatty acids and water.. Testis defined as following: The male gonad containing two functional parts: the SEMINIFEROUS TUBULES for the production and transport of male Germ Cells (SPERMATOGENESIS) and the interstitial compartment containing LEYDIG CELLS that produce ANDROGENS..", "label": "yes"} {"original_question": "Is NicVAX vaccine effective for smoking cessation?", "id": "converted_3379", "sentence1": "Is NicVAX vaccine effective for Location characteristic ID - Smoking cessation?", "sentence2": "CONCLUSION: The nicotine vaccine, NicVAX, does not appear to improve the chances of stopping Location characteristic ID - Smoking when given in addition to varenicline and behavioural support., First efficacy results of the nicotine vaccine 3'-AmNic-rEPA (NicVAX) showed that only a subgroup of the top 30% immunoglobulin complex location responders achieved higher abstinence rates than placebo. , FINDINGS: There was no difference in abstinence rates between NicVAX and placebo from weeks 9 to 52 [27.7 versus 30.0%, odds ratio (OR) = 0.89, 95% confidence interval (CI) = 0.62-1.29] or weeks 37 to 52 (33.8 versus 33.2%, OR = 1.03, 95% CI = 0.73-1.46). The top 30% immunoglobulin complex location responders, compared to the placebo group, showed a non-significant tendency towards higher abstinence rates from weeks 37 to 52 (42.2 versus 33.2%, OR = 1.47, 95% CI = 0.89-2.42), Unfortunately, the only vaccine tested in two large, randomized Phase III trials, 3'-amino-methyl-nicotine r-exoprotein A conjugate vaccine (NicVAX(®), Nabi Biopharmaceuticals, MD, USA), did not demonstrate efficacy., The RR for 12 month cessation in active and placebo groups was 1.35 (95% Confidence Interval (CI) 0.82 to 2.22) in the trial of NIC002 and 1.74 (95% CI 0.73 to 4.18) in one NicVAX trial. Two Phase III NicVAX trials, for which full results were not available, reported similar quit rates of approximately 11% in both groups., AUTHORS' CONCLUSIONS: There is currently no evidence that nicotine vaccines enhance long-term Location characteristic ID - Smoking cessation., 3'AmNic-rEPA recipients with the highest serum antinicotine Ab response (top 30% by area under the curve (AUC)) were significantly more likely than the placebo recipients (24.6% vs. 12.0%, P = 0.024, odds ratio (OR) = 2.69, 95% confidence interval (CI), 1.14-6.37) to attain 8 weeks of continuous abstinence from weeks 19 through 26. , Recently, the most advanced candidate vaccine, NicVAX, failed to meet the primary endpoint in two large phase III studies, although the correlation of higher abstinence rates in subjects with higher immunity to nicotine was observed., CONCLUSION\n\nThe nicotine vaccine, NicVAX, does not appear to improve the chances of stopping Location characteristic ID - Smoking when given in addition to varenicline and behavioural support., First efficacy results of the nicotine vaccine 3'-AmNic-rEPA (NicVAX) showed that only a subgroup of the top 30% immunoglobulin complex location responders achieved higher abstinence rates than placebo., CONCLUSION The nicotine vaccine, NicVAX, does not appear to improve the chances of stopping Location characteristic ID - Smoking when given in addition to varenicline and behavioural support., First efficacy results of the nicotine vaccine 3'-AmNic-rEPA ( NicVAX ) showed that only a subgroup of the top 30 % immunoglobulin complex location responders achieved higher abstinence rates than placebo, First efficacy results of the nicotine vaccine 3'-AmNic-rEPA (NicVAX) showed that only a subgroup of the top 30% immunoglobulin complex location responders achieved higher abstinence rates than placebo., FINDINGS\nThere was no difference in abstinence rates between NicVAX and placebo from weeks 9 to 52 [27.7 versus 30.0%, odds ratio (OR) = 0.89, 95% confidence interval (CI) = 0.62-1.29] or weeks 37 to 52 (33.8 versus 33.2%, OR = 1.03, 95% CI = 0.73-1.46)., CONCLUSION\nThe nicotine vaccine, NicVAX, does not appear to improve the chances of stopping Location characteristic ID - Smoking when given in addition to varenicline and behavioural support.[SEP]Relations: Nicotine has relations: drug_drug with Niclosamide, drug_drug with Niclosamide, drug_drug with Celecoxib, drug_drug with Celecoxib, drug_drug with Nicardipine, drug_drug with Nicardipine, drug_drug with Mefenorex, drug_drug with Mefenorex, drug_drug with Desvenlafaxine, drug_drug with Desvenlafaxine. Definitions: varenicline defined as following: A partial agonist of the nicotinic acetylcholine receptor (nAChR) subtype alpha4beta2. Nicotine stimulation of central alpha4beta2 nAChRs located at presynaptic terminals in the nucleus accumbens causes the release of the neurotransmitter dopamine, which may be associated with the experience of pleasure; nicotine addiction constitutes a physiologic dependence related to this dopaminergic reward system. As an AChR partial agonist, varenicline attenuates the craving and withdrawal symptoms that occur with abstinence from nicotine but is not habit-forming itself.. immunoglobulin complex location defined as following: A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph. [GOC:add, GOC:jl, ISBN:0781765196]. nicotine defined as following: Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke..", "label": "no"} {"original_question": "Is the protein product of the cylindromatosis gene (CYLD) a deubiquitinating enzyme?", "id": "converted_1347", "sentence1": "Is the protein product of the cylindromatosis gene (CYLD) a deubiquitinating Enzyme [APC]?", "sentence2": "CYLD was originally identified as a Tumor Suppressor Genes mutated in Ancell-Spiegler Adenoid Cystic Carcinoma, an autosomal dominant predisposition to multiple benign neoplasms of the Skin Specimen Source Code known as Adenoid Cystic Carcinoma. The Deubiquitinating Enzyme CYLD is a deubiquitinating Enzyme [APC] that acts as a negative regulator of NF-κB and JNK signaling through its interaction with NF-Kappa-B Essential Modulator and Tumor Necrosis Factor Receptor-associated factor 2., CYLD, a deubiquitinating Enzyme [APC] (DUB), is a critical regulator of diverse cellular processes, ranging from proliferation and differentiation to inflammatory responses, via regulating multiple key signaling cascades such as NF-kappa B (NF-κB) pathway., CYLD is a lysine 63-deubiquitinating Enzyme [APC] that inhibits NF-κB and JNK signaling., Tumor suppressor gene CYLD is a deubiquitinating Enzyme [APC] which negatively regulates various signaling pathways by removing the lysine 63-linked polyubiquitin chains from several specific substrates., The cylindromatosis tumor suppressor (CYLD) is a deubiquitinating Enzyme [APC] that has been implicated in various aspects of adaptive and innate immune responses. , The cylindromatosis gene (CYLD) was identified as a Tumor Suppressor Genes, which is mutated in Ancell-Spiegler Adenoid Cystic Carcinoma (Brooke-Spiegler syndrome), an autosomal-dominant predisposition to multiple tumors of the Skin Specimen Source Code appendages. CYLD is a deubiquitinating Enzyme [APC] acting as a negative regulator of the NFI Transcription Factors (NF-κB) signaling pathway by removing lysine-63-linked polyubiquitin chains from NF-κB activating proteins. , Here, we identify the deubiquitinating Enzyme [APC] CYLD, the Ancell-Spiegler Adenoid Cystic Carcinoma Tumor Suppressor Genes, as a negative regulator of proximal events in Wnt/beta-catenin signaling., CYLD is a tumour-suppressor gene that is mutated in a benign Skin Specimen Source Code tumour syndrome called cylindromatosis. The CYLD gene product is a deubiquitinating Enzyme [APC] that was shown to regulate cell proliferation, cell survival and inflammatory responses, mainly through inhibiting NF-kappaB signalling., Deubiquitinating Enzyme CYLD, human encodes a 956-amino acid deubiquitinating Enzyme [APC] (CYLD), which is a negative regulator of nuclear factor kappaB and mitogen-activated protein kinase pathways., The deubiquitinating Enzyme [APC] CYLD has been identified as a key negative regulator for NF-kappaB. , CYLD, a Tumor Suppressor Genes, has deubiquitinating Enzyme [APC] activity and inhibits the activation of transcription factor NF-kappaB. Loss of the deubiquitinating activity of CYLD is correlated with tumorigenesis., We show that dCYLD encodes a deubiquitinating Enzyme [APC] that deubiquitinates dTRAF2 and prevents dTRAF2 from ubiquitin-mediated proteolytic degradation., The CYLD gene encodes a deubiquitinating Enzyme [APC] that removes Lys-63-linked ubiquitin chains from I kappa B kinase signaling components and thereby inhibits NF-kappaB pathway activation., Deubiquitinating Enzymes (DUB) form a family of Cysteine Proteases that digests ubiquitin chains and reverses the process of protein ubiquitination. Despite the identification of a large number of DUBs, their physiological functions remain poorly defined. Here we provide genetic evidence that CYLD, a recently identified DUB, plays a crucial role in regulating the peripheral development and activation of B-Lymphocytes., The cylindromatosis (CYLD) gene was originally identified as a tumor suppressor that is mutated in Ancell-Spiegler Adenoid Cystic Carcinoma, an autosomal dominant condition that confers a predisposition to multiple tumors of the Skin Specimen Source Code appendages. CYLD has deubiquitinating Enzyme [APC] activity and inhibits the activation of transcription factor NF-kappaB. Therefore, loss of CYLD function correlates with tumorigenesis., Cylindromatosis gene (CYLD) is a ubiquitously expressed deubiquitinating Enzyme [APC], which interacts with members of the NF-κB signaling pathway and attenuates NF-κB and JNK signaling., The cylindromatosis Tumor Suppressor Genes (Deubiquitinating Enzyme CYLD, human) encodes a deubiquitinating Enzyme [APC] (CYLD) with immunoregulatory function., The CYLD gene product is a deubiquitinating Enzyme [APC] that was shown to regulate cell proliferation, cell survival and inflammatory responses, mainly through inhibiting NF-kappaB signalling., Here, we examined the potential role of the deubiquitinating Enzyme [APC] CYLD (cylindromatosis), Mutation Abnormality of which has been reported to cause Ancell-Spiegler Adenoid Cystic Carcinoma., The deubiquitinating Enzyme [APC] cylindromatosis (CYLD), loss of which was originally reported to cause a benign human syndrome called cylindromatosis, has been identified as a key negative regulator for NF-kappaB in vitro., The CYLD gene product is a deubiquitinating Enzyme [APC] that was shown to regulate cell proliferation, cell survival and inflammatory responses, mainly through inhibiting NF-kappaB signalling., Cylindromatosis gene (CYLD) is a ubiquitously expressed deubiquitinating Enzyme [APC], which interacts with members of the NF-�B signaling pathway and attenuates NF-�B and JNK signaling., Cylindromatosis (CYLD) is a deubiquitinating Enzyme [APC] that is altered in patients with Ancell-Spiegler Adenoid Cystic Carcinoma, a condition characterized by numerous benign adnexal tumors., CYLD is a deubiquitinating Enzyme [APC] that negatively regulates NF-kappaB activation by Tumor Necrosis Factor Receptor family members., Here, we identify the deubiquitinating Enzyme [APC] CYLD, the Ancell-Spiegler Adenoid Cystic Carcinoma Tumor Suppressor Genes, as a negative regulator of proximal events in Wnt/beta-catenin signaling, Cylindromatosis gene (CYLD) is a ubiquitously expressed deubiquitinating Enzyme [APC], which interacts with members of the NF-κB signaling pathway and attenuates NF-κB and JNK signaling, The CYLD gene product is a deubiquitinating Enzyme [APC] that was shown to regulate cell proliferation, cell survival and inflammatory responses, mainly through inhibiting NF-kappaB signalling, The cylindromatosis Tumor Suppressor Genes (Deubiquitinating Enzyme CYLD, human) encodes a deubiquitinating Enzyme [APC] (CYLD) with immunoregulatory function, Cylindromatosis gene (CYLD) is a ubiquitously expressed deubiquitinating Enzyme [APC], which interacts with members of the NF-κB signaling pathway and attenuates NF-κB and JNK signaling, The cylindromatosis Tumor Suppressor Genes (Deubiquitinating Enzyme CYLD, human) encodes an Enzyme [APC] (CYLD) with deubiquitinating activity that has been implicated in the regulation of thymocyte selection in an NF-κB-essential-modulator (NF-Kappa-B Essential Modulator)-dependent manner, Here, we identify the deubiquitinating Enzyme [APC] CYLD, the Ancell-Spiegler Adenoid Cystic Carcinoma Tumor Suppressor Genes, as a negative regulator of proximal events in Wnt/beta-catenin signaling, CYLD is a deubiquitinating Enzyme [APC] acting as a negative regulator of the NFI Transcription Factors (NF-κB) signaling pathway by removing lysine-63-linked polyubiquitin chains from NF-κB activating proteins, CYLD, a Tumor Suppressor Genes, has deubiquitinating Enzyme [APC] activity and inhibits the activation of transcription factor NF-kappaB, Here, we examined the potential role of the deubiquitinating Enzyme [APC] CYLD (cylindromatosis), Mutation Abnormality of which has been reported to cause Ancell-Spiegler Adenoid Cystic Carcinoma, CYLD has deubiquitinating Enzyme [APC] activity and inhibits the activation of transcription factor NF-kappaB[SEP]Relations: Cysteine has relations: drug_protein with MGMT, drug_protein with MGMT, drug_protein with GOT2, drug_protein with GOT2, drug_protein with CSAD, drug_protein with CSAD. Brooke-Spiegler syndrome has relations: disease_protein with CYLD, disease_protein with CYLD. adenoid cystic carcinoma has relations: disease_protein with SOX11, disease_protein with SOX11. Definitions: CYLD gene defined as following: This gene is involved in protein deubiquitination.. Deubiquitinating Enzyme CYLD, human defined as following: Ubiquitin carboxyl-terminal hydrolase CYLD (956 aa, ~107 kDa) is encoded by the human CYLD gene. This protein is involved in the mediation of protein deubiquitination and the regulation of the cell cycle.. NF-Kappa-B Essential Modulator defined as following: NF-kappa-B essential modulator (419 aa, ~48 kDa) is encoded by the human IKBKG gene. This protein plays a role in the mediation of signal transduction through protein phosphorylation.. Cysteine Proteases defined as following: A subclass of peptide hydrolases that depend on a CYSTEINE residue for their activity.. B-Lymphocytes defined as following: Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.. Tumor Necrosis Factor Receptor defined as following: Cell surface receptors that bind TUMOR NECROSIS FACTORS and trigger changes which influence the behavior of cells.. NF-kappa B defined as following: Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Adenoid Cystic Carcinoma defined as following: Carcinoma characterized by bands or cylinders of hyalinized or mucinous stroma separating or surrounded by nests or cords of small epithelial cells. When the cylinders occur within masses of epithelial cells, they give the tissue a perforated, sievelike, or cribriform appearance. Such tumors occur in the mammary glands, the mucous glands of the upper and lower respiratory tract, and the salivary glands. They are malignant but slow-growing, and tend to spread locally via the nerves. (Dorland, 27th ed). Deubiquitinating Enzymes defined as following: Enzymes that remove UBIQUITIN from a protein substrate, including POLYUBIQUITIN, or from other molecules.. Deubiquitinating Enzyme CYLD defined as following: A deubiquitinase and tumor-suppressor protein that specifically cleaves LYSINE-63-linked polyubiquitin chains and also has endodeubiquitinase activity. It functions to regulate NF-KAPPA B and WNT SIGNALING PATHWAY activity, contributing to cell survival, proliferation, and differentiation. Mutations in the CYLD gene are associated with cases of FAMILIAL CYLINDROMATOSIS.. NFI Transcription Factors defined as following: A family of proteins that contain 1 DWA/MH1 domain and bind 5'-TTGGCNNNNNGCCAA-3' DNA palindromes in viral and cellular promoters as homodimeric factors capable of activating transcription and replication.. Brooke-Spiegler syndrome defined as following: A rare genetic disease characterized as an inherited Skin Specimen Source Code tumour predisposition syndrome presenting with Skin Specimen Source Code appendage tumours, namely Adenoid Cystic Carcinoma, spiradenomas and trichoepitheliomas. Tumor Suppressor Genes defined as following: Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible.. CYLD defined as following: Ubiquitin carboxyl-terminal hydrolase CYLD (956 aa, ~107 kDa) is encoded by the human CYLD gene. This protein is involved in the mediation of protein deubiquitination and the regulation of the cell cycle..", "label": "yes"} {"original_question": "Is PER3 required for CHK2 activation in human cells?", "id": "converted_712", "sentence1": "Is PER3 required for CHK2 activation in Human cells?", "sentence2": "PER3 gene, a circadian gene, is required for CHEK2 wt Allele activation in Human cells., Depletion of PER3 gene by siRNA almost completely abolished activation of Checkpoint kinase 1 (CHEK2 wt Allele) after inducing DNA damage in Human cells., PER3 gene overexpression induced CHEK2 wt Allele activation in the absence of exogenous DNA damage,, PER3 gene overexpression also led to the inhibition of cell proliferation and apoptotic cell death., These combined results suggest that PER3 gene is a checkpoint protein that plays important roles in checkpoint activation, cell proliferation and apoptosis., Depletion of PER3 gene by siRNA almost completely abolished activation of Checkpoint kinase 1 (CHEK2 wt Allele) after inducing DNA damage in Human cells, PER3 gene overexpression induced CHEK2 wt Allele activation in the absence of exogenous DNA damage, and this activation depended on ammonium tetrathiomolybdate, In addition, PER3 gene physically interacted with ammonium tetrathiomolybdate and CHEK2 wt Allele[SEP]Relations: PER3 has relations: protein_protein with CHEK2, protein_protein with CHEK2, protein_protein with PER2, protein_protein with PER2, molfunc_protein with kinase binding, molfunc_protein with kinase binding, protein_protein with BTK, protein_protein with BTK, protein_protein with DHRS2, protein_protein with DHRS2. Definitions: Checkpoint kinase 1 defined as following: Serine/threonine-protein kinase CHEK2 wt Allele (543 aa, ~61 kDa) is encoded by the human CHEK2 gene. This protein plays an essential role in the DNA damage checkpoint of the cell cycle.. CHEK2 wt Allele defined as following: Human CHEK2 wild-type allele is located in the vicinity of 22q12.1 and is approximately 57 kb in length. This allele, which encodes serine/threonine-protein kinase CHEK2 wt Allele protein, is involved in prevention of entry into mitosis and induction of G1 checkpoint arrest in response to DNA damage. Certain allelic variants of the CHEK2 gene that encode protein products with reduced or abolished activity are associated with Li-Fraumeni syndrome 2. Heritable alterations in this gene also confer susceptibility to breast, colorectal and prostate cancers.. CHK2 defined as following: Human CHEK2 wild-type allele is located in the vicinity of 22q12.1 and is approximately 57 kb in length. This allele, which encodes serine/threonine-protein kinase CHEK2 wt Allele protein, is involved in prevention of entry into mitosis and induction of G1 checkpoint arrest in response to DNA damage. Certain allelic variants of the CHEK2 gene that encode protein products with reduced or abolished activity are associated with Li-Fraumeni syndrome 2. Heritable alterations in this gene also confer susceptibility to breast, colorectal and prostate cancers..", "label": "yes"} {"original_question": "Has saracatinib been tested in clinical trials?", "id": "converted_3733", "sentence1": "Has saracatinib been tested in clinical trials?", "sentence2": "saracatinib as a metastasis PPP1R1A gene in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Malignant neoplasm of prostate Clinical Trials Consortium Study., A phase II study of saracatinib (AZD 0530), a Proto-Oncogene Tyrosine-Protein Kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human, human PPP1R1A gene, administered orally daily to patients with advanced thymic malignancies., Phase II study of saracatinib (AZD 0530) in patients with previously treated metastatic Malignant neoplasm of colon and/or rectum., Metastatic Malignant neoplasm of colon and/or rectum patients who had received one prior treatment and had measurable disease were enrolled in this phase 2 study., A phase Ib multiple ascending dose study of the safety, tolerability, and CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS availability of AZD 0530 (saracatinib) in ALZHEIMER DISEASE, FAMILIAL, 1., Herein, we present a Phase Ib trial of the repurposed investigational drug AZD 0530, a Proto-Oncogene Tyrosine-Protein Kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human, human family kinase PPP1R1A gene specific for FYN protein, human and Proto-Oncogene Tyrosine-Protein Kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human, human kinase, for the treatment of patients with mild-to-moderate cytarabine/daunorubicin protocol., The study was a 4-week Phase Ib multiple ascending dose, randomized, double-blind, placebo-controlled trial of AZD 0530 in cytarabine/daunorubicin protocol patients with Mini-Mental State Examination (MMSE) scores ranging from 16 to 26.[SEP]Relations: saracatinib has relations: drug_drug with Ceritinib, drug_drug with Ceritinib, drug_drug with Ibrutinib, drug_drug with Ibrutinib, drug_drug with Crizotinib, drug_drug with Crizotinib, drug_drug with Cobimetinib, drug_drug with Cobimetinib, drug_drug with Erlotinib, drug_drug with Erlotinib. Definitions: saracatinib defined as following: An orally available 5-, 7-substituted anilinoquinazoline with anti-invasive and anti-tumor activities. saracatinib is a dual-specific PPP1R1A gene of Proto-Oncogene Tyrosine-Protein Kinase Src, human and Abl, protein tyrosine kinases that are overexpressed in chronic myeloid leukemia cells. This agent binds to and inhibits these tyrosine kinases and affects cell motility, cell migration, adhesion, invasion, proliferation, differentiation, and survival. Specifically, saracatinib inhibits Proto-Oncogene Tyrosine-Protein Kinase Src, human kinase-mediated osteoclast bone resorption.. Proto-Oncogene Tyrosine-Protein Kinase Src, human defined as following: Proto-oncogene tyrosine-protein kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human (536 aa, ~60 kDa) is encoded by the human SRC gene. This protein is involved in both receptor-mediated signal transduction and tyrosine phosphorylation.. FYN protein, human defined as following: Tyrosine-protein kinase FYN protein, human (537 aa, ~61 kDa) is encoded by the human FYN gene. This protein is involved in tyrosine phosphorylation, cytoskeleton remodeling and signal transduction.. Proto-Oncogene Tyrosine-Protein Kinase Src, human kinase defined as following: A PROTEIN-TYROSINE KINASE family that was originally identified by homology to the Rous sarcoma virus ONCOGENE PROTEIN PP60(V-SRC). They interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. Oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65.. Malignant neoplasm of prostate defined as following: A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas.. saracatinib defined as following: An orally available 5-, 7-substituted anilinoquinazoline with anti-invasive and anti-tumor activities. saracatinib is a dual-specific PPP1R1A gene of Proto-Oncogene Tyrosine-Protein Kinase Src, human and Abl, protein tyrosine kinases that are overexpressed in chronic myeloid leukemia cells. This agent binds to and inhibits these tyrosine kinases and affects cell motility, cell migration, adhesion, invasion, proliferation, differentiation, and survival. Specifically, saracatinib inhibits Proto-Oncogene Tyrosine-Protein Kinase Src, human kinase-mediated osteoclast bone resorption..", "label": "yes"} {"original_question": "Is the protein ABCG2 transmembrane?", "id": "converted_3459", "sentence1": "Is the protein ABCG2 transmembrane?", "sentence2": "the transmembrane adenosine triphosphate-binding cassette transporter G2, adenosine triphosphate-binding cassette (ABC) transporters are transmembrane efflux transporters mediating the extrusion of an array of substrates ranging from Antifibrinolytic Antifibrinolytic amino acids and Lipids to Xenobiotics, and many therapeutic compounds, including anticancer drugs., The adenosine triphosphate-binding cassette (ABC) transporter family is a large class of adenosine triphosphate energy-dependent transmembrane proteins[SEP]Relations: Adenosine phosphate has relations: drug_protein with PRKAG2, drug_protein with PRKAG2, drug_protein with PRKAB2, drug_protein with PRKAB2, drug_protein with PRKAG3, drug_protein with PRKAG3, drug_protein with PRKAG1, drug_protein with PRKAG1, drug_protein with ACSS2, drug_protein with ACSS2. Definitions: Lipids defined as following: A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed). adenosine triphosphate defined as following: An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.. Xenobiotics defined as following: Chemical substances that are foreign to the biological system. They include naturally occurring compounds, drugs, environmental agents, carcinogens, insecticides, etc.. adenosine triphosphate-binding cassette defined as following: adenosine triphosphate-binding cassette sub-family A member 2 (2435 aa, ~270 kDa) is encoded by the human ABCA2 gene. This protein may be involved in the modulation of lipid metabolism and neural development.. ABCG2 defined as following: Human ABCG2 wild-type allele is located within 4q22 and is approximately 67 kb in length. This allele, which encodes adenosine triphosphate-binding cassette sub-family G member 2 protein, plays a role in transmembrane transport and transcriptional regulation. The allele is thought to play a role in cellular defense and aberrations are thought to play a role in tumor multidrug resistance..", "label": "yes"} {"original_question": "Is micro RNA 1 (miR-1) implicated in cardiac arrhythmias?", "id": "converted_1297", "sentence1": "Is micro RNA 1 (miR-1) implicated in cardiac arrhythmias?", "sentence2": "Dysfunction of the gap junction protein connexin 43 (GJA1 gene), an established miR-1 target, during Cardiac Hypertrophy leads to ventricular tachyarrhythmias (Tachycardia, Ventricular)., miR-1 overexpression may contribute to the increased susceptibility of the Chest>Heart to AVB, which provides us novel insights into the molecular mechanisms underlying ischemic cardiac arrhythmias., The incidence of AVB was higher in miR-1 Tg CASP14 gene than that in wild-type (WT) CASP14 gene. , As miR-1 has been shown in animal models and clinical studies to contribute to arrhythmogenesis by regulating pacemaker channel genes, our finding of miR-1 up-regulation in patients with Myocardial infarction:Finding:Point in time:^Patient:Ordinal indicates that it might be responsible for the higher risk for arrhythmias in these patients. , Lately, some highlight articles revealed that the altered expression of MicroRNAs such as miR-1, miR-133, miR-21, miR-208 etc in hearts also contributed to cardiovascular diseases, such as Chest>Heart ischemia, Cardiac Hypertrophy, and arrhythmias., MicroRNA-1 (miR-1) reciprocally regulates inwardly rectifying potassium channel (Kir)2.1 expression in coronary disease, contributing to arrhythmogenesis. , miR-1 levels are greatly reduced in Homo sapiens AF, possibly contributing to up-regulation of Kir2.1 subunits, leading to increased I(K1). Because up-regulation of inward-rectifier currents is important for AF maintenance, these results provide potential new insights into molecular mechanisms of AF with potential therapeutic implications., The muscle-specific miR-1 has been implicated in Cardiac Hypertrophy, Chest>Heart development, cardiac stem cell differentiation, and arrhythmias through targeting of Regulatory Protein. , We conclude that the beta-adrenergic pathway can stimulate expression of arrhythmogenic miR-1, contributing to ischaemic arrhythmogenesis, and Adrenergic beta-Antagonists produce their beneficial effects partially by down-regulating miR-1, which might be a novel strategy for ischaemic cardioprotection., MiR-1 influences susceptibility to cardiac arrhythmias after Myocardial infarction:Finding:Point in time:^Patient:Ordinal., Changes in abundance of muscle-specific microRNA, miR-1, have been implicated in Heart Diseases, including Cardiac Arrhythmia and Chest>Heart failure., In the presence of isoproterenol, rhythmically paced, miR-1-overexpressing Muscle Cells exhibited spontaneous arrhythmogenic oscillations of Protoplasm Ca(2+), events that occurred rarely in control Muscle Cells under the same conditions., Here we show that miR-1 is overexpressed in individuals with Coronary Arteriosclerosis, and that when overexpressed in normal or infarcted Rattus norvegicus hearts, it exacerbates arrhythmogenesis. Elimination of miR-1 by an antisense inhibitor in infarcted Rattus norvegicus hearts relieved arrhythmogenesis., Thus, miR-1 may have important pathophysiological functions in the Chest>Heart, and is a potential antiarrhythmic target., MiR-1 influences susceptibility to cardiac arrhythmias after Myocardial infarction:Finding:Point in time:^Patient:Ordinal, The muscle-specific miR-1 has been implicated in Cardiac Hypertrophy, Chest>Heart development, cardiac stem cell differentiation, and arrhythmias through targeting of Regulatory Protein, Changes in abundance of muscle-specific microRNA, miR-1, have been implicated in Heart Diseases, including Cardiac Arrhythmia and Chest>Heart failure, Changes in abundance of muscle-specific microRNA, miR-1, have been implicated in Heart Diseases, including Cardiac Arrhythmia and Chest>Heart failure[SEP]Relations: cardiac muscle hypertrophy has relations: bioprocess_protein with MIR195, bioprocess_protein with MIR195, bioprocess_protein with MIR15B, bioprocess_protein with MIR15B. Arrhythmia has relations: drug_effect with Mirtazapine, drug_effect with Mirtazapine, phenotype_phenotype with Cardiac arrest, phenotype_phenotype with Cardiac arrest. Myocardial infarction:Finding:Point in time:^Patient:Ordinal has relations: disease_protein with MIR761, disease_protein with MIR761. Definitions: GJA1 gene defined as following: This gene is involved in gap junction assembly.. Tachycardia, Ventricular defined as following: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. Regulatory Protein defined as following: Encoded by Regulatory Genes, Regulatory Proteins regulate or circumscribe the activity of many cellular functions.. isoproterenol defined as following: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the Chest>Heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and Chest>Heart stimulant.. Homo sapiens defined as following: Members of the species Homo sapiens.. Cardiac Arrhythmia defined as following: Any disturbances of the normal rhythmic beating of the Chest>Heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.. MicroRNAs defined as following: Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 MicroRNAs discovered, and are from a class of MicroRNAs involved in developmental timing.. Muscle Cells defined as following: Mature contractile cells, commonly known as Muscle Cells, that form one of three kinds of muscle. The three types of muscle cells are skeletal (MUSCLE FIBERS, SKELETAL), cardiac (MYOCYTES, CARDIAC), and smooth (MYOCYTES, SMOOTH MUSCLE). They are derived from embryonic (precursor) muscle cells called MYOBLASTS.. Coronary Arteriosclerosis defined as following: Thickening and loss of elasticity of the CORONARY ARTERIES, leading to progressive arterial insufficiency (CORONARY DISEASE).. Adrenergic beta-Antagonists defined as following: Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.. Chest>Heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, proteins, lipids, carbohydrates, and inorganic salts.. Cardiac Hypertrophy defined as following: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.. Heart Diseases defined as following: Pathological conditions involving the HEART including its structural and functional abnormalities.. cardiac arrhythmias defined as following: Any disturbances of the normal rhythmic beating of the Chest>Heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction..", "label": "yes"} {"original_question": "Is POLD3 essential for mouse development?", "id": "converted_2131", "sentence1": "Is POLD3 protein, human essential for mouse development?", "sentence2": "The POLD3 protein, human gene encodes a subunit of the DNA polymerase complex. Pold3 orthologs are not essential in Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae or Saccharomyces cerevisiae or Saccharomyces cerevisiae cerevisiae cerevisiae or chicken allergenic extract allergenic extract DT40 cells, but the Schizosaccharomyces pombe ortholog is essential. POLD3 protein, human protein, human also has a specialized role in the repair of broken replication forks, suggesting that POLD3 protein, human protein, human activity could be particularly relevant for Tumor cells, malignant enduring high levels of DNA replication stress. We report here that POLD3 protein, human protein, human is essential for mouse development and is also required for viability in adult animal allergen extracts., We report here that POLD3 protein, human protein, human is essential for mouse development and is also required for viability in adult animal allergen extracts., We report here that POLD3 protein, human protein, human is essential for mouse development and is also required for viability in adult animal allergen extracts.[SEP]Relations: DNA polymerase complex has relations: cellcomp_protein with POLD2, cellcomp_protein with POLD2. Protein S human has relations: drug_drug with Polmacoxib, drug_drug with Polmacoxib, drug_drug with Vindesine, drug_drug with Vindesine, drug_drug with Alaproclate, drug_drug with Alaproclate, drug_drug with Cefditoren, drug_drug with Cefditoren. Definitions: Tumor cells, malignant defined as following: Cells of, or derived from, a malignant tumor.. POLD3 protein, human defined as following: DNA polymerase delta subunit 3 (466 aa, ~51 kDa) is encoded by the human POLD3 protein, human gene. This protein plays a role in DNA replication.. DNA polymerase complex defined as following: A protein complex that possesses DNA polymerase activity and is involved in template directed synthesis of DNA. [GOC:jl, PMID:12045093]. POLD3 gene defined as following: This gene plays a role in the optimization of DNA replication..", "label": "yes"} {"original_question": "Is Tocilizumab (Actemra) used to block/antagonize the IL-6 receptor?", "id": "converted_4037", "sentence1": "Is tocilizumab (Actemra) used to block/antagonize the Recombinant Interleukin-6 receptor?", "sentence2": "Preliminary clinical results have indicated that antagonism of the Recombinant Interleukin-6 receptor (Interleukin 6 Receptor activity), including with the FDA-approved humanized monoclonal immunoglobulin complex location tocilizumab, can improve the outcomes of patients with severe or critical COVID-19 while maintaining a good safety profile., tocilizumab, an anti-Recombinant Interleukin-6 receptor immunoglobulin complex location, and Corticosteroid ophthalmologic and otologic preparations were initially used to treat the increase in acute inflammatory proteins and the Anasarca, resulting in decreased cytokine levels. , tocilizumab, a monoclonal immunoglobulin complex location against the Recombinant Interleukin-6 receptor, was initiated at a dose of 8 mg/kg every 4 weeks., we randomly assigned patients with type 2 diabetes or obesity to intravenous tocilizumab (an Recombinant Interleukin-6 receptor antagonist) , Clinical studies are investigating whether tocilizumab (anti-Recombinant Interleukin-6 receptor) can help preserve beta cell function in patients recently diagnosed with Diabetes Mellitus, Insulin-Dependent, tocilizumab (Roactemra or Actemra) is a recombinant humanized monoclonal immunoglobulin complex location that acts as an interleukin (IL)-6 receptor antagonist., To increase the number of cycles of antigen binding and lysosomal degradation, we engineered tocilizumab (Actemra), an immunoglobulin complex location against the Recombinant Interleukin-6 receptor (Interleukin 6 Receptor activity), to rapidly dissociate from Interleukin 6 Receptor activity within the acidic environment of the Endosomes (pH 6.0) while maintaining its binding affinity to Interleukin 6 Receptor activity in Specimen Source Codes - Plasma (pH 7.4)., tocilizumab (Actemra; Genentech, Inc) is the first biologic therapy targeting the cytokine interleukin-6 (Recombinant Interleukin-6)., over, our findings showed that combination of tocilizumab (Actemra; Roche), an anti-Interleukin 6 Receptor activity monoclonal immunoglobulin complex location, with carboplatin synergistically inhibited growth and proliferation of the EOC Cells and the most direct axis for Recombinant Interleukin-6 gene expression was NF-κB pathway.CONC, Roche is co-developing tocilizumab (Actemra, Roactemra), a humanized anti-Interleukin 6 Receptor (Interleukin 6 Receptor activity) monoclonal immunoglobulin complex location, with Chugai Pharmaceutical., tocilizumab (TCZ) is a compound that inhibits the Recombinant Interleukin-6 receptor., tocilizumab (TCZ), is a recombinant humanized anti-Interleukin 6 Receptor (Interleukin 6 Receptor activity) monoclonal immunoglobulin complex location which has a main use in the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis (sJIA) and Acute polyarticular juvenile rheumatoid arthritis (pJIA)., the US Food and Drug Administration accepted a complete-response submission for the use of Actemra (tocilizumab), the first humanized Recombinant Interleukin-6 receptor-inhibiting monoclonal immunoglobulin complex location, for the treatment of Rheumatoid Arthritis. Although thi, increase the number of cycles of antigen binding and lysosomal degradation, we engineered tocilizumab (Actemra), an immunoglobulin complex location against the Recombinant Interleukin-6 receptor (Interleukin 6 Receptor activity), to rapidly dissociate from Interleukin 6 Receptor activity within the acidic environment of the Endosomes (pH 6.0) while maintaining its binding affinity to Interleukin 6 Receptor activity in Specimen Source Codes - Plasma (pH 7.4). Studies usin, present study, we have shown that the humanized anti-Recombinant Interleukin-6 receptor tocilizumab (Actemra) is also a potent inhibitor of interleukin-8 receptor binding activity in TNBC Cells. Similar ef, Roche is co-developing tocilizumab (Actemra, Roactemra), a humanized anti-Interleukin 6 Receptor (Interleukin 6 Receptor activity) monoclonal immunoglobulin complex location, with Chugai Pharmaceutical. Tocili, tory gene activation is inhibited in vitro by tocilizumab, a humanized immunoglobulin complex location to IL6 receptor (IL6R protein, Homo sapiens protein, Homo sapiens). tocilizumab, These lines of evidence indicate that tocilizumab is able to bind to both Soluble Interleukin-6 Receptor Subunit Alpha, Human and mIL-6R and to inhibit Recombinant Interleukin-6 binding to its receptors, leading to the blockade of the Recombinant Interleukin-6 signaling through both Soluble Interleukin-6 Receptor Subunit Alpha, Human and mIL-6R, but not block the signaling of other Recombinant Interleukin-6 family Recombinant Cytokines., tocilizumab inhibits signal transduction mediated by both mIL-6R and Soluble Interleukin-6 Receptor Subunit Alpha, Human, but not by the receptors of other members of Recombinant Interleukin-6 cytokine family., In addition, tocilizumab had the ability to bind to Homo sapiens Interleukin 6 Receptor activity expressing COS-7 Cells and to suppress the growth of the Recombinant Interleukin-6-dependent myeloma cell line, KPMM2., To characterize the biological activity of tocilizumab, a humanized anti-Homo sapiens Interleukin 6 Receptor (Interleukin 6 Receptor activity) monoclonal immunoglobulin complex location, we examined its binding activity to both soluble Interleukin 6 Receptor activity (Soluble Interleukin-6 Receptor Subunit Alpha, Human) and membrane bound Interleukin 6 Receptor activity (mIL-6R) and its neutralizing activity to other Recombinant Interleukin-6 family Recombinant Cytokines., tocilizumab inhibited the proliferation of BaF/Interleukin 6 Receptor activity induced by Recombinant Interleukin-6, but did not inhibit the proliferation of BaF/IL-11R, BaF/OSMR, BaF/LIFR and BaF/CNTFR Cells induced by their corresponding Recombinant Cytokines., Moreover, tocilizumab suppressed the Recombinant Interleukin-6/Soluble Interleukin-6 Receptor Subunit Alpha, Human complex-induced proliferation of Homo sapiens gp130-transfected cell, BAF-h130., In addition, tocilizumab had the ability to dissociate Recombinant Interleukin-6 and Soluble Interleukin-6 Receptor Subunit Alpha, Human from their preformed complex., ELISA assay demonstrated that tocilizumab bound to Soluble Interleukin-6 Receptor Subunit Alpha, Human and inhibited Recombinant Interleukin-6 binding to Soluble Interleukin-6 Receptor Subunit Alpha, Human in a dose-dependent manner., tocilizumab recognizes both the membrane-bound and the soluble form Interleukin 6 Receptor activity and specifically blocks Recombinant Interleukin-6 actions., Humanized antihuman Recombinant Interleukin-6 receptor immunoglobulin complex location, tocilizumab., tocilizumab is a humanized antihuman Recombinant Interleukin-6 receptor immunoglobulin complex location designed using genetic engineering technology., tocilizumab is expected to ameliorate the autoimmune inflammatory diseases with Recombinant Interleukin-6 overproduction and has been clinically developed as a therapeutic agent for Rheumatoid Arthritis, systemic-onset and articular types of JIA, Crohn's disease of oral soft tissues of oral soft tissues, etc., tocilizumab/Actemra is an anti-Interleukin 6 Receptor activity immunoglobulin complex location, which can competitively block Recombinant Interleukin-6 binding to the Interleukin 6 Receptor activity., tocilizumab (TCZ; Roactemra® or Actemra®) is a recombinant humanized monoclonal immunoglobulin complex location that acts as an interleukin-6 (Recombinant Interleukin-6) receptor antagonist., In 2009 the US Food and Drug Administration accepted a complete-response submission for the use of Actemra (tocilizumab), the first humanized Recombinant Interleukin-6 receptor-inhibiting monoclonal immunoglobulin complex location, for the treatment of Rheumatoid Arthritis., tocilizumab binds to the Interleukin 6 Receptor (Interleukin 6 Receptor activity) and thereby blocks signaling of the pro-inflammatory cytokine Recombinant Interleukin-6., tocilizumab (Roactemra(®); Actemra(®)) is a recombinant humanized monoclonal immunoglobulin complex location that acts as an Interleukin 6 Receptor antagonist.[SEP]Relations: tocilizumab has relations: drug_protein with IL6R protein, Homo sapiens, drug_protein with IL6R protein, Homo sapiens, drug_drug with Elagolix, drug_drug with Elagolix, drug_drug with Acteoside, drug_drug with Acteoside, drug_drug with Metronidazole, drug_drug with Metronidazole, drug_drug with Atezolizumab, drug_drug with Atezolizumab. Definitions: Recombinant Interleukin-6 defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin-6 (Recombinant Interleukin-6) with antiapoptotic, proinflammatory, antiinflammatory, proproliferative and proangiogenic activities. Recombinant Interleukin-6 binds to its receptor (interleukin-6 receptor activity), activating a receptor-CD130 receptor complex; the CD130 portion of the complex is a signal transduction protein that activates JAK kinases and Ras-mediated signaling pathways, which in turn activate downstream signaling pathways, resulting in the activation of various transcription factors (STAT, ELK-1, NF-Recombinant Interleukin-6, etc.) and gene transcription. The physiological effects of Recombinant Interleukin-6 are complex and varied and include hematopoietic, pyrogenic and thermogenic, proinflammatory, antiinflammatory, proproliferative (anti-apoptotic), and angiogenic effects.. cytokine defined as following: Non-immunoglobulin complex location proteins secreted by inflammatory leukocytes and some non-leukocytic Cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner.. carboplatin defined as following: An organoplatinum compound that possesses antineoplastic activity.. Anasarca defined as following: A condition that is characterized by the presence of generalized edema. Causes include congestive heart failure, liver failure, renal failure, and severe malnutrition.. Rheumatoid Arthritis defined as following: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.. tocilizumab defined as following: A recombinant, humanized IgG1 monoclonal immunoglobulin complex location directed against the Interleukin 6 Receptor (interleukin-6 receptor activity) with immunosuppressant activity. tocilizumab targets and binds to both the soluble form of interleukin-6 receptor activity (Soluble Interleukin-6 Receptor Subunit Alpha, Human) and the membrane-bound form (mIL-6R), thereby blocking the binding of Recombinant Interleukin-6 to its receptor. This prevents Recombinant Interleukin-6-mediated signaling. Recombinant Interleukin-6, a pro-inflammatory cytokine that plays an important role in the regulation of the immune response, is overproduced in autoimmune disorders, certain types of cancers and possibly various other inflammatory conditions.. immunoglobulin complex location defined as following: A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the Specimen Source Codes - Plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph. [GOC:add, GOC:jl, ISBN:0781765196]. interleukin-8 receptor binding activity defined as following: Binding to an interleukin-8 receptor. [GOC:go_curators]. Interleukin 6 Receptor defined as following: Cell surface receptors that are specific for INTERLEUKIN-6. They are present on T-LYMPHOCYTES, mitogen-activated B-LYMPHOCYTES, and peripheral MONOCYTES. The receptors are heterodimers of the INTERLEUKIN-6 RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR GP130.. interleukin-6 defined as following: A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different Cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS.. Soluble Interleukin-6 Receptor Subunit Alpha, Human defined as following: Soluble Interleukin 6 Receptor subunit alpha is encoded by the Homo sapiens IL6R protein, Homo sapiens gene. This protein, which is produced by metalloproteinase-mediated cleavage of the membrane-bound form, is involved in the modulation of interleukin-6-mediated signaling by CD4-positive T-lymphocytes.. monoclonal immunoglobulin complex location defined as following: A humanized monoclonal immunoglobulin complex location directed against parathyroid hormone-related protein (PTH-rP). As a poly-hormone with diverse biological roles, PTH-rP is expressed by normal tissues, acting in local tissue environments in a variety of ways; it is commonly overexpressed by breast, prostate, and other cancers, acting systemically by promoting bone resorption, inhibiting calcium excretion from the kidney, inducing hypercalcemia, and possibly playing a role in the formation of bony metastases. By blocking the effects of PTH-rP on calcium metabolism, monoclonal immunoglobulin complex location CAL may inhibit cancer-related hypercalcemia. (NCI04). IL6R protein, Homo sapiens defined as following: Interleukin-6 receptor subunit alpha (468 aa, ~52 kDa) is encoded by the Homo sapiens IL6R protein, Homo sapiens gene. This protein plays a role in regulation of the immune response, interleukin-6-mediated signaling, and hematopoiesis.. Diabetes Mellitus, Insulin-Dependent defined as following: A chronic condition characterized by minimal or absent production of insulin by the pancreas.. Endosomes defined as following: Cytoplasmic vesicles formed when COATED VESICLES shed their CLATHRIN coat. Endosomes internalize macromolecules bound by receptors on the cell surface.. interleukin-6 receptor activity defined as following: Combining with interleukin-6 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. [GOC:jl, GOC:signaling]. Homo sapiens defined as following: Members of the species Homo sapiens.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary..", "label": "yes"} {"original_question": "Is subdural empyema a complication of sinusitis?", "id": "converted_3232", "sentence1": "Is Subdural space Empyema a complication of Sinusitis?", "sentence2": "Acute and chronic Sinusitis can give rise to a wide array of Intracranial Route of Drug Administration and orbital complications. These complications include Cerebral abscess, Subdural space Empyema,, A computed tomography scan showed bilateral Nasal sinus disease, and magnetic resonance imaging showed a right frontal abscess and Subdural space Empyema., Frontal Sinusitis complicated by a Cerebral abscess and Subdural space Empyema., In older children, Sinusitis and Ear Inflammation media are usually the source for Subdural space empyem, Subdural Empyema as a complication of Sinusitis in the pediatric population., Second, Subdural space Empyema appears to arise in the setting of subacute rather than acute frontal Sinusitis., Subdural Empyema is a rare but potentially life-threatening complication following paranasal Sinusitis and should be considered as a neurological emergency., [Subdural Empyema as a complication of Sinusitis., INTRODUCTION\nSubdural Empyema is an uncommon but serious complication of Sinusitis., Intracranial Subdural space Empyema is most frequently a complication of Sinusitis or, less frequently, Ear Inflammation or neurosurgical procedures., Subdural Empyema is a rare complication of Sinusitis although very severe., Subdural Empyema is a rare complication of Sinusitis in children., Subdural Empyema is a rare but serious complication of paranasal Sinusitis which may result in Cessation of life or permanent disability in a significant proportion of cases., We report a case of Subdural space Empyema secondary to frontal Sinusitis in an otherwise healthy immunocompetent adolescent boy., Subdural Empyema is a rare but life-threatening complication of paranasal Sinusitis, Ear Inflammation media, or mastoid disease., Canis lupus in Sheep's Clothing Subdural Empyema: A Rare Complication of Acute Sinusitis., Interhemispheric and Infratentorial Subdural Empyema with Preseptal cellulitis as Complications of Sinusitis: A Case Report., Subdural Empyema as a complication of Sinusitis in the pediatric population.Sinusitis is a rare cause of Intracranial Route of Drug Administration Communicable Diseases in children. , [Subdural Empyema as a complication of Sinusitis. , Intracranial Subdural space Empyema is most frequently a complication of Sinusitis or, less frequently, Ear Inflammation or neurosurgical procedures. , Streptococcus pluranimalium: A novel Homo sapiens pathogen?We present the first case of a Subdural space Empyema caused by Streptococcus pluranimalium, in a healthy adolescent male as a possible complication of subclinical frontal Sinusitis. , The diagnosis of Subdural space Empyema as a complication of asymptomatic Sinusitis in an immunocompetent patient with no history of Fever symptoms (finding) or upper respiratory symptoms was unanticipated. , Second, Subdural space Empyema appears to arise in the setting of subacute rather than acute frontal Sinusitis. , Bifrontal decompressive craniectomy for acute Subdural space Empyema.Subdural Empyema is an uncommon but serious complication of Sinusitis. , Subdural Empyema is a rare but potentially life-threatening complication following paranasal Sinusitis and should be considered as a neurological emergency. , We present a patient with Subdural space Empyema in whom the diagnosis was delayed, followed by a discussion of Infection - Infection - suppurative complications of Sinusitis. , We report an unusual case of Sinusitis-associated acute Subdural space Empyema in a 13-year-old patient, presenting in a catastrophic manner with acutely raised Intracranial Route of Drug Administration pressure. , The symptoms of Subdural space Empyema may be mild and may be the same as those associated with Sinusitis, or the Communicable Diseases may result in alteration of the level of consciousness and Focal Neurologic Deficits., We report the clinical and radiological course of an adolescent with a Subdural space Empyema secondary to Sinusitis., We report two cases of Subdural space Empyema secondary to Sinusitis in persons without impaired immunity., Subdural Empyema as a complication of Sinusitis., Furthermore, Subdural space Empyema usually is related to sinus infections, particularly those caused by Streptococcus milleri, an anaerobic Organism., Subdural Empyema is an uncommon but serious complication of Sinusitis.[SEP]Relations: Subdural space Empyema has relations: disease_disease with Empyema, disease_disease with Empyema, disease_disease with central nervous system infectious disorder, disease_disease with central nervous system infectious disorder. Empyema has relations: disease_disease with Subdural space Empyema, disease_disease with Subdural space Empyema, disease_disease with tuberculous Empyema, disease_disease with tuberculous Empyema, disease_disease with infectious disease, disease_disease with infectious disease. Definitions: Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. Preseptal cellulitis defined as following: An acute Communicable Diseases of the anterior portion of the eyelid and surrounding tissues.. Sinusitis defined as following: Inflammation of the NASAL MUCOSA in one or more of the PARANASAL SINUSES.. Empyema defined as following: Presence of pus in a hollow organ or body cavity.. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or Homo sapiens host.. Homo sapiens defined as following: Members of the species Homo sapiens.. Subdural Empyema defined as following: An Intracranial Route of Drug Administration or rarely intraspinal Infection - suppurative process invading the space between the inner surface of the DURA MATER and the outer surface of the ARACHNOID.. Intracranial Route of Drug Administration defined as following: Administration of a drug within the skull.. frontal Sinusitis defined as following: Inflammation of the NASAL MUCOSA in the FRONTAL SINUS. In many cases, it is caused by an Communicable Diseases of the bacteria STREPTOCOCCUS PNEUMONIAE or HAEMOPHILUS INFLUENZAE.. Subdural space defined as following: Potential cavity which separates the ARACHNOID MATER from the DURA MATER.. Cerebral abscess defined as following: A bacterial, fungal, or parasitic abscess that develops in the cerebral hemispheres. Causes include skull trauma, middle ear Communicable Diseases, congenital heart disease, and frontal and ethmoid sinus Communicable Diseases.. Nasal sinus defined as following: Air-filled spaces located within the bones around the NASAL CAVITY. They are extensions of the nasal cavity and lined by the ciliated NASAL MUCOSA. Each sinus is named for the cranial bone in which it is located, such as the ETHMOID SINUS; the FRONTAL SINUS; the MAXILLARY SINUS; and the SPHENOID SINUS.. Ear Inflammation defined as following: Inflammation of the ear, which may be marked by pain (EARACHE), Fever symptoms (finding), HEARING DISORDERS, and VERTIGO. Inflammation of the external ear is OTITIS EXTERNA; of the middle ear, OTITIS MEDIA; of the inner ear, LABYRINTHITIS.. Organism defined as following: A living entity.. Streptococcus milleri defined as following: A non taxonomic group of facultatively anaerobic, Gram positive, cocci shaped bacteria in the phylum Firmicutes and the genus Streptococcus. They produces acetoin, hydrolyze arginine and esculin, ferment trehalose, lactose, salicin and sucrose, expresses Lancefield antigens A, C, F, G, or N and are mixed hemolytic ability. Bacteria in the S. milleri group are pathogenic, causing periodontitis and purulent infections..", "label": "yes"} {"original_question": "Is tubulin acetylation involved in cell motility?", "id": "converted_767", "sentence1": "Is Tubulin acetylation involved in cell motility?", "sentence2": "In this study, we found that paclitaxel induced Tubulin acetylation in Endothelium and Tumor cells, uncertain whether benign or malignant, at concentrations that affected cell motility but not proliferation (10(-8) to 10(-9) M, for 4 hours). Induction of Tubulin acetylation correlated with inhibition of motility but not proliferation based on a comparison of highly and poorly cytotoxic taxanes (paclitaxel and IDN5390) and Cell Line, Tumor sensitive and resistant to paclitaxel (1A9 and 1A9 PTX22)., we found that overexpression of the Tubulin deacetylase Sirtuin 2 increased cell motility and reduced cell response to the anti-motility activity of paclitaxel. Conversely, the Sirtuin 2 inhibitor splitomicin reduced cell motility and potentiated the anti-motility activity of paclitaxel. The inhibitory effect was further potentiated by the addition of the HDAC6 gene gene inhibitor trichostatin A., Cell motility and adhesion involves dynamic microtubule (MT) acetylation/deacetylation, a process regulated by ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS as HDAC6 gene gene, a major Cytoplasmic α-Tubulin deacetylase., beta-adrenergic receptor kinase activity and HDAC6 gene gene colocalize in the Lamellipodia of migrating cells, leading to local Tubulin deacetylation and enhanced motility., This review highlights the emerging roles of Tubulin acetylation in multiple cellular functions, ranging from cell motility, cell cycle progression or cell differentiation to Protoplasm trafficking and signalling., Our results indicate that TPPP gene binds to HDAC6 gene gene (Histone Deacetylase), an Enzyme [APC] responsible for Tubulin deacetylation. Moreover, we demonstrated that the direct interaction of these two Proteins resulted in the inhibition of the deacetylase activity of HDAC6 gene gene., Finally, we demonstrated that, similarly to other HDAC6 gene gene inhibitors, TPPP gene influences the microtubule dynamics by decreasing the growth velocity of the microtubule plus ends and also affects cell motility as demonstrated by time lapse video experiments., \"tubacin,\" which inhibits alpha-Tubulin deacetylation in mammalian cells., We provide evidence that class II Histone Deacetylase (HDAC6 gene gene) is the Protoplasm target of tubacin., Tubacin treatment did not affect the stability of Microtubules but did decrease cell motility., They also suggest that small molecules that selectively inhibit HDAC6 gene gene-mediated alpha-Tubulin deacetylation, a first example of which is tubacin, might have therapeutic applications as antimetastatic and antiangiogenic agents., Furthermore, overexpression of HDAC6 gene gene promotes chemotactic cell movement, supporting the idea that HDAC6 gene gene-mediated deacetylation regulates microtubule-dependent cell motility., HDAC6 gene gene is a major Cytoplasmic a-Tubulin deacetylase that is involved in cell motility and adhesion. beta-adrenergic receptor kinase activity dynamically and directly associates with and phosphorylates HDAC6 gene gene to stimulate its a-Tubulin deacetylase activity at specific cellular localizations, such as the leading edge of migrating cells, thus promoting local Tubulin deacetylation and enhanced motility.[SEP]Relations: Tubulin binding has relations: molfunc_protein with ALDOA, molfunc_protein with ALDOA, molfunc_protein with TTLL2, molfunc_protein with TTLL2, molfunc_protein with TTLL12, molfunc_protein with TTLL12, molfunc_protein with TTLL4, molfunc_protein with TTLL4, molfunc_protein with MAP1A, molfunc_protein with MAP1A. Definitions: Tubulin defined as following: A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE.. Microtubules defined as following: Slender, cylindrical filaments found in the cytoskeleton of plant and animal cells. They are composed of the protein TUBULIN and are influenced by TUBULIN MODULATORS.. HDAC6 gene defined as following: This gene is involved in chromatin remodeling, repression of gene expression and cellular management of misfolded protein-induced stress.. Sirtuin 2 defined as following: A sirtuin family member found primarily in the CYTOPLASM. It is a multifunctional Enzyme [APC] that contains a NAD-dependent deacetylase activity that is specific for HISTONES and a mono-ADP-ribosyltransferase activity.. paclitaxel defined as following: A cyclodecane isolated from the bark of the Pacific yew tree, TAXUS BREVIFOLIA. It stabilizes MICROTUBULES in their polymerized form leading to cell death.. Lamellipodia defined as following: A thin sheetlike process extended by the leading edge of a migrating cell or extending cell process; contains a dense meshwork of actin filaments. [ISBN:0815316194]. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as Proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, Proteins, lipids, carbohydrates, and inorganic salts.. Histone Deacetylase defined as following: Deacetylases that remove N-acetyl groups from amino side chains of the amino acids of HISTONES. The Enzyme [APC] family can be divided into at least three structurally-defined subclasses. Class I and class II deacetylases utilize a zinc-dependent mechanism. The sirtuin histone deacetylases belong to class III and are NAD-dependent ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Cell Line, Tumor defined as following: A cell line derived from cultured Tumor cells, uncertain whether benign or malignant.. beta-adrenergic receptor kinase activity defined as following: Catalysis of the reaction: ATP + beta-adrenergic receptor = ADP + phospho-beta-adrenergic receptor. [EC:2.7.11.15, MetaCyc:BETA-ADRENERGIC-RECEPTOR-KINASE-RXN]. alpha-Tubulin defined as following: Tubulin alpha-3C/D chain (450 aa, ~50 kDa) is encoded by the human TUBA3C gene. This protein is involved in microtubule structural dynamics.. Tumor cells, uncertain whether benign or malignant defined as following: Cells of, or derived from, a tumor.. Endothelium defined as following: A layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body..", "label": "yes"} {"original_question": "Does NADPH oxidase 5 require any subunit for function?", "id": "converted_1937", "sentence1": "Does NADPH oxidase 5 require any subunit for function?", "sentence2": "NOX5 gene forms a functional oligomer mediated by self-association of its dehydrogenase domain., While NOX1 gene-4 require regulatory subunits, including CYBA wt Allele, NOX5 gene activity does not depend on any subunits. , Thus, NOX5 gene forms a catalytically active oligomer in the Membrane Device that is mediated by its dehydrogenase domain. , Coexpression of specific Nox catalytic subunits (NOX1 gene, CYBB wt Allele, NOX3 gene, NOX4 protein, human, or NOX5 gene) along with their corresponding regulatory subunits (NOXO1 gene gene/NOXA1 for NOX1 gene; p47phox/p67phox/Rac for CYBB wt Allele; NOXO1 gene gene for NOX3 gene; no subunits for NOX4 protein, human or NOX5 gene) resulted in marked production of reactive oxygen. [SEP]Relations: NOXO1 gene has relations: cellcomp_protein with NADPH oxidase complex, cellcomp_protein with NADPH oxidase complex, molfunc_protein with superoxide-generating NADPH oxidase activator activity, molfunc_protein with superoxide-generating NADPH oxidase activator activity, pathway_protein with RHO GTPases Activate NADPH Oxidases, pathway_protein with RHO GTPases Activate NADPH Oxidases. Membrane Device has relations: cellcomp_protein with CHD5, cellcomp_protein with CHD5, cellcomp_protein with CDH5, cellcomp_protein with CDH5. Definitions: NOX4 protein, human defined as following: NADPH oxidase 4 (578 aa, ~67 kDa) is encoded by the human NOX4 gene. This protein plays a role as an oxygen sensor in cell differentiation and signal transduction.. CYBB wt Allele defined as following: Human CYBB wild-type allele is located in the vicinity of Xp21.1 and is approximately 33 kb in length. This allele, which encodes cytochrome B-245 heavy chain protein, is involved in the microbicidal oxidase system of phagocytes. Mutations in this gene are associated with both atypical mycobacteriosis, familial, X-linked 2 and chronic granulomatous disease, X-linked.. Membrane Device defined as following: A device that is made from or resembles a thin flexible sheet of material.. CYBA wt Allele defined as following: Human CYBA wild-type allele is located in the vicinity of 16q24.2 and is approximately 8 kb in length. This allele, which encodes cytochrome B-245 light chain protein, plays a role in phagocyte synthesis of superoxide. Mutation of the gene is associated with autosomal recessive chronic granulomatous disease 4..", "label": "no"} {"original_question": "Was saracatinib being considered as a treatment for Alzheimer's disease in November 2017?", "id": "converted_2408", "sentence1": "Was saracatinib being considered as a treatment for ALZHEIMER DISEASE, FAMILIAL, 1 in November 2017?", "sentence2": "A phase Ib multiple ascending dose study of the safety, tolerability, and CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS availability of AZD0530 (saracatinib) in ALZHEIMER DISEASE, FAMILIAL, 1., Herein, we present a Phase Ib trial of the repurposed investigational drug AZD0530, a Proto-Oncogene Tyrosine-Protein Kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human, human family kinase inhibitor specific for FYN protein, human and Proto-Oncogene Tyrosine-Protein Kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human, human kinase, for the treatment of patients with mild-to-moderate cytarabine/daunorubicin protocol., The study was a 4-week Phase Ib multiple ascending dose, randomized, double-blind, placebo-controlled trial of AZD0530 in cytarabine/daunorubicin protocol patients with Mini-Mental State Examination (MMSE) scores ranging from 16 to 26. A total of 24 subjects were recruited in three sequential groups, with each randomized to receive AZD 0530 at doses of 50 mg, 100 mg, 125 mg, or placebo daily for 4 weeks. , AZD0530 is reasonably safe and well tolerated in patients with mild-to-moderate cytarabine/daunorubicin protocol, achieving substantial CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS penetration with oral dosing at 100-125 mg. Targeting FYN protein, human kinase may be a promising therapeutic approach in cytarabine/daunorubicin protocol, and a larger Phase IIa clinical trial of AZD0530 for the treatment of patients with cytarabine/daunorubicin protocol has recently launched.[SEP]Relations: Saracatinib has relations: drug_drug with Crizotinib, drug_drug with Crizotinib, drug_drug with Olaparib, drug_drug with Olaparib, drug_drug with Baricitinib, drug_drug with Baricitinib, drug_drug with Ibrutinib, drug_drug with Ibrutinib, drug_drug with Sunitinib, drug_drug with Sunitinib. Definitions: Proto-Oncogene Tyrosine-Protein Kinase Src, human defined as following: Proto-oncogene tyrosine-protein kinase Proto-Oncogene Tyrosine-Protein Kinase Src, human (536 aa, ~60 kDa) is encoded by the human SRC gene. This protein is involved in both receptor-mediated signal transduction and tyrosine phosphorylation.. saracatinib defined as following: An orally available 5-, 7-substituted anilinoquinazoline with anti-invasive and anti-tumor activities. Saracatinib is a dual-specific inhibitor of Proto-Oncogene Tyrosine-Protein Kinase Src, human and Abl, protein tyrosine kinases that are overexpressed in chronic myeloid leukemia cells. This agent binds to and inhibits these tyrosine kinases and affects cell motility, cell migration, adhesion, invasion, proliferation, differentiation, and survival. Specifically, Saracatinib inhibits Proto-Oncogene Tyrosine-Protein Kinase Src, human kinase-mediated osteoclast bone resorption.. FYN protein, human defined as following: Tyrosine-protein kinase FYN protein, human (537 aa, ~61 kDa) is encoded by the human FYN gene. This protein is involved in tyrosine phosphorylation, cytoskeleton remodeling and signal transduction.. Proto-Oncogene Tyrosine-Protein Kinase Src, human kinase defined as following: A PROTEIN-TYROSINE KINASE family that was originally identified by homology to the Rous sarcoma virus ONCOGENE PROTEIN PP60(V-SRC). They interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. Oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65..", "label": "yes"} {"original_question": "Does the word ovine refers to goats?", "id": "converted_2105", "sentence1": "Does the word Domestic Sheep refers to Capra hircus?", "sentence2": "Jaagsiekte sheep retrovirus (JSRV) is the causative agent of Domestic Sheep pulmonary adenocarcinoma (OPA), a transmissible Primary malignant neoplasm of lung of sheep that has rarely been found in Capra hircus. , In sheep, a Rat Bronchiolo-Alveolar Carcinoma, known as Domestic Sheep pulmonary carcinoma (Oligomeric Procyanidin Complex), is caused by jaagsiekte sheep retrovirus (JSRV), an exogenous type D retrovirus. [SEP]Relations: protein complex oligomerization has relations: bioprocess_protein with OPA1, bioprocess_protein with OPA1, bioprocess_protein with BOK, bioprocess_protein with BOK, bioprocess_protein with MCU, bioprocess_protein with MCU, bioprocess_protein with ADCY8, bioprocess_protein with ADCY8, bioprocess_protein with NOL3, bioprocess_protein with NOL3. Definitions: Domestic Sheep defined as following: A species of sheep, Ovis aries, descended from Near Eastern wild forms, especially mouflon.. Jaagsiekte sheep retrovirus defined as following: A BETARETROVIRUS that causes pulmonary adenomatosis in sheep (PULMONARY ADENOMATOSIS, OVINE).. Capra hircus defined as following: The domesticated goat species, Capra hircus.. Oligomeric Procyanidin Complex defined as following: A preparation containing plant-derived polyphenolic bioflavonoids composed of multimers (dimers, trimers, or higher order polymers) of the flavan-3-ol-based monomers catechin and epicatechin, which are extracted from sources rich in these chemicals, such as grape seeds, grape skin and pine bark, with potential anti-oxidant, anti-inflammatory, anti-microbial, anti-cancer and protective activities. Upon oral administration of oligomeric procyanidin complex (Oligomeric Procyanidin Complex), the polyphenols exert anti-oxidant activity by scavenging free radicals, which prevents both the formation of reactive oxygen species (ROS), particularly nitrous oxide (NO), and DNA damage. Oligomeric Procyanidin Complex also inhibits chemical-induced lipid peroxidation. In addition, Oligomeric Procyanidin Complex reduces the production advanced glycation end-products (AGE), decreases AGE accumulation in tissues, and inhibits the progression of AGE/receptor for AGE (RAGE)-mediated inflammatory transduction pathways, which inhibits the activation of pro-inflammatory transcriptional regulators and prevents the secretion of pro-inflammatory cytokines/chemokines. This ultimately prevents inflammatory-driven damage to end organs and may reduce inflammation-induced cancer formation and progression. In addition, Oligomeric Procyanidin Complex inhibits the activity of a variety of enzymes, including xanthine oxidase, collagenase, elastase hyaluronidase and beta-glucuronidase..", "label": "no"} {"original_question": "Is REGN5458 a single-targeted antibody?", "id": "converted_4606", "sentence1": "Is REGN5458 a single-targeted antibody?", "sentence2": "CD3 Antigens Antigens-engaging Antibodies, Bispecific (bsAbs) and Chimeric antigen receptor (actomyosin contractile ring) T-Lymphocyte are potent therapeutic approaches for redirecting patient T-Lymphocyte to recognize and kill Neoplasms. Here we describe a fully human bsAb (REGN5458) that binds to B-Cell Maturation Antigen (bis(3-bis(4-chlorophenyl)methyl-4-dimethylaminophenyl)amine) and CD3 Antigens Antigens, and compare its antitumor activities vs those of anti-bis(3-bis(4-chlorophenyl)methyl-4-dimethylaminophenyl)amine actomyosin contractile ring T-Lymphocyte to identify differences in efficacy and mechanism of action. [SEP]Relations: cell maturation has relations: bioprocess_protein with ANGPTL8, bioprocess_protein with ANGPTL8, bioprocess_protein with SOX8, bioprocess_protein with SOX8, bioprocess_protein with CTNNB1, bioprocess_protein with CTNNB1, bioprocess_protein with SOX18, bioprocess_protein with SOX18, bioprocess_protein with BFSP1, bioprocess_protein with BFSP1. Definitions: actomyosin contractile ring defined as following: A cytoskeletal structure composed of actin filaments and myosin that forms beneath the plasma membrane of many cells, including animal cells and yeast cells, in a plane perpendicular to the axis of the spindle, i.e. the cell division plane. In animal cells, the contractile ring is located at the cleavage furrow. In budding fungal cells, e.g. mitotic S. cerevisiae cells, the contractile ring forms at the mother-bud neck before mitosis. [GOC:expert_jrp, GOC:sgd_curators, GOC:vw, ISBN:0805319409, ISBN:0815316194, PMID:28914606]. T-Lymphocyte defined as following: A subset of therapeutic autologous T-lymphocytes that express a T-cell receptor (TCR) composed of one gamma chain and one delta chain, with potential immunomodulating and antineoplastic activities. Upon administration of the therapeutic gamma delta T-lymphocytes, these cells secrete interferon-gamma (IFN-g), and exert direct killing of tumor cells. In addition, these cells activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against tumor cells. Gamma delta T-lymphocytes play a key role in the activation of the immune system and do not require major histocompatibility complex (MHC)-mediated antigen presentation to exert their cytotoxic effect.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Chimeric antigen receptor defined as following: A cell-surface receptor that has been engineered to combine novel features and specificities from various sources in order to enhance its antigen specificity. Engineered T-cells or B-cells will produce the specialized receptor that will be capable of binding to an epitope on its target cell.. CD3 Antigens defined as following: Complex of at least five membrane-bound polypeptides in mature T-lymphocytes that are non-covalently associated with one another and with the T-cell receptor (RECEPTORS, ANTIGEN, T-CELL). The CD3 Antigens complex includes the gamma, delta, epsilon, zeta, and eta chains (subunits). When antigen binds to the T-cell receptor, the CD3 Antigens complex transduces the activating signals to the cytoplasm of the T-cell. The CD3 Antigens gamma and delta chains (subunits) are separate from and not related to the gamma/delta chains of the T-cell receptor (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA).. B-Cell Maturation Antigen defined as following: A member of the tumor necrosis factor receptor superfamily found on mature B-LYMPHOCYTES. It has specificity for B CELL ACTIVATING FACTOR and TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.. Antibodies, Bispecific defined as following: Antibodies, often monoclonal, in which the two antigen-binding sites are specific for separate ANTIGENIC DETERMINANTS. They are artificial antibodies produced by chemical crosslinking, fusion of HYBRIDOMA cells, or by molecular genetic techniques. They function as the main mediators of targeted cellular cytotoxicity and have been shown to be efficient in the targeting of drugs, toxins, radiolabeled haptens, and effector cells to diseased tissue, primarily Neoplasms..", "label": "no"} {"original_question": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?", "id": "converted_1225", "sentence1": "Is the regulation of vsr endonuclease independent of the growth phase of bacteria?", "sentence2": "Growth phase-dependent regulation of vsr endonuclease, vsr endonuclease levels are growth phase dependent., Growth phase-dependent regulation of vsr endonuclease may contribute to 5-Methylcytosine mutational hot spots in Escherichia coli., Using rabbit allergenic extract allergenic extract polyclonal antibodies, we have shown that the Dcm cytosine methylase of Escherichia coli is maintained at a constant level during cell growth, while vsr endonuclease levels are growth phase dependent., vsr endonuclease, which initiates very short patch repair, has been hypothesized to regulate mutation in stationary-phase cells., The efficiency of the two pathways changes during the bacterial life cycle; Mismatch Repair is more efficient during exponential growth and Vital signs, smoking and pain scale repair is more efficient during the stationary phase., Overexpression of Vsr does dramatically increase the stationary-phase reversion of a Lac- frameshift allele, but the absence of Vsr has no effect., Using rabbit allergenic extract allergenic extract polyclonal antibodies, we have shown that the Dcm cytosine methylase of Escherichia coli is maintained at a constant level during cell growth, while vsr endonuclease levels are growth phase dependent, The efficiency of the two pathways changes during the bacterial life cycle; Mismatch Repair is more efficient during exponential growth and Vital signs, smoking and pain scale repair is more efficient during the stationary phase, vsr endonuclease, which initiates very short patch repair, has been hypothesized to regulate mutation in stationary-phase cells[SEP]Relations: escherichia coli infection has relations: disease_phenotype_positive with Recurrent gram-negative bacterial infections, disease_phenotype_positive with Recurrent gram-negative bacterial infections. mismatch repair has relations: bioprocess_protein with RNASEH2A, bioprocess_protein with RNASEH2A, bioprocess_protein with MLH1, bioprocess_protein with MLH1, bioprocess_protein with POLD2, bioprocess_protein with POLD2, bioprocess_protein with EXO1, bioprocess_protein with EXO1. Definitions: 5-Methylcytosine defined as following: A methylated form of the nucleobase cytosine occurring predominantly in cytosine-phosphate-guanine (CpG) islands that are produced by DNA methyltransferases and may regulate gene expression. Like cytosine, the DNA sequence containing 5-Methylcytosine (5-mC) is able to be replicated without error and 5-mC can pair with guanine in double stranded DNA. However, DNA sequences containing a high local concentration of 5-mC may be less transcriptionally active than areas with higher ratios of unmodified cytosine.. Mismatch Repair defined as following: A DNA repair pathway involved in correction of errors introduced during DNA replication when an incorrect base, which cannot form hydrogen bonds with the corresponding base in the parent strand, is incorporated into the daughter strand. Excinucleases recognize the BASE PAIR MISMATCH and cause a segment of polynucleotide chain to be excised from the daughter strand, thereby removing the mismatched base. (from Oxford Dictionary of Biochemistry and Molecular Biology, 2001). Escherichia coli defined as following: A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc..", "label": "no"} {"original_question": "Is autosomal dominant inheritanced form of Osteogenesis imperfecta caused by mutations in the genes associated with collagen production?", "id": "converted_2428", "sentence1": "Is Autosome dominant inheritanced form of Osteogenesis Imperfecta caused by Gene Mutation in the Genes associated with collagen production?", "sentence2": "steogenesis imperfecta (OI) is a heterogeneous bone disorder characterized by recurrent fractures. Although most cases of OI have heterozygous Gene Mutation inCOL1A1orCOL1A2and show Autosomal dominant inheritance,, Osteogenesis Imperfecta (OI) is a group of Hereditary Diseases characterized by decreased bone mass and increased Fracture risk. The majority of OI cases have an Autosome dominant pattern of inheritance and are usually caused by Gene Mutation in Genes encoding collagen type I, Osteogenesis Imperfecta (OI) is a group of Hereditary Diseases characterized by low bone mass and recurrent fractures. Most OI cases follow an Autosome dominant pattern of inheritance and are attributed to Gene Mutation in Genes encoding collagen type I (COL1A1 gene gene/alpha 2 collagen type I). , Osteogenesis Imperfecta (OI) is a genetic disorder characterised by low bone mineral density resulting in fractures. 85-90% of patients with OI carry a Variant in the type 1 collagen Genes, COL1A1 gene gene and alpha 2 collagen type I, which follows an Autosome dominant pattern of inheritance., Osteogenesis Imperfecta (OI) comprises a heterogeneous group of disorders that are characterized by susceptibility to bone fractures, and range in severity from a subtle increase in Fracture frequency to Cessation of life in the perinatal period. Most patients have defects in collagen type I biosynthesis with Autosome-dominant inheritance, but many Autosome-recessive Genes have been reported., To investigate Mutation Abnormality of COL1A1 gene gene gene and analyze the relationship between Genotype determination and clinical phenotype in a family with osteogenesis imperfecta, Dominant inheritance of osteogenesis imperfecta (OI) is caused by Gene Mutation in COL1A1 gene gene or alpha 2 collagen type I, the Genes that encode collagen type I,, Osteogenesis Imperfecta (OI) is a heterogeneous group of inherited disorders of bone formation, resulting in low bone mass and an increased propensity to Fracture. It exhibits a broad spectrum of clinical severity, ranging from multiple fractures in utero and perinatal Cessation of life, to normal adult stature and low Fracture incidence. Extra-skeletal features of OI include blue sclera, hearing impairment, skin hyperlaxity, joint Hyperextensibility, and Dentinogenesis imperfecta without osteogenesis imperfecta. The proα1(I) and proα2(I) chains of collagen 1 are encoded by the COL1A1 gene gene and alpha 2 collagen type I Genes, respectively; quantitative or qualitative defects in collagen type I synthesis usually manifest as types of OI or some sub-types of EDS. The majority of patients (about 90%) with a clinical diagnosis of OI have a Mutation Abnormality in the COL1A1 gene gene or alpha 2 collagen type I, Osteogenesis Imperfecta (OI) type I is characterized by bone fragility without significant deformity, Osteopenia, normal stature, Blue sclera, and Autosomal dominant inheritance. Dermal Specimen Source Codes - Fibroblasts from most affected individuals produce about half the expected amount of collagen type I, suggesting that the OI type I phenotype results from a variety of Gene Mutation which alter the apparent expression of either COL1A1 gene gene or alpha 2 collagen type I, the Genes encoding the chains of collagen type I., Autosomal dominant osteogenesis imperfecta is caused by Gene Mutation in the alpha 2 collagen type I and COL1A1 gene gene Genes of collagen type I. , Osteogenesis Imperfecta is caused by dominant Autosome Gene Mutation in the collagen type I coding Genes (COL1A1 gene gene and alpha 2 collagen type I) in about 85% of individuals, affecting collagen quantity or structure., Osteogenesis Imperfecta (OI) is a heterogeneous group of disorders of Connective Tissue, mainly caused by Gene Mutation in the collagen type I Genes (COL1A1 gene gene and alpha 2 collagen type I)., Autosomal dominant osteogenesis imperfecta (OI) is caused by Gene Mutation in the Genes (COL1A1 gene gene or alpha 2 collagen type I) encoding the chains of collagen type I., In approximately 90% of individuals with osteogenesis imperfecta, Gene Mutation in either of the Genes encoding the pro-alpha1 or pro-alpha2 chains of collagen type I (COL1A1 gene gene or alpha 2 collagen type I) can be identified., Autosomal dominant OI is caused by Gene Mutation in the Genes (COL1A1 gene gene or alpha 2 collagen type I) encoding the chains of collagen type I., ext-generation sequencing technology was used to screen a panel of known OI Genes.RESULTS: In 41 probands, we identified 28 different disease-causing variants of 9 different known OI Genes. Eleven of the variants are novel. Ten of the 28 variants are located in COL1A1 gene gene, five in alpha 2 collagen type I, three in BMP1 protein, human protein, human, three in FKBP10 gene gene, two in TMEM38B gene gene, two in P3H1 gene gene, and one each in CRTAP gene gene, SERPINF1 gene gene, and SERPINH1 gene gene. , Osteogenesis Imperfecta (OI) is a clinically and genetically heterogeneous disorder associated with bone fragility and susceptibility to fractures after minimal Trauma, nursing specialty. OI type V has an Autosome-dominant pattern of inheritance and is not caused by Gene Mutation in the collagen type I Genes COL1A1 gene gene and alpha 2 collagen type I. , Detection of a high frequency RsaI Genetic Polymorphism in the human pro alpha 2(I) collagen gene which is linked to an Autosome dominant form of osteogenesis imperfecta., Osteogenesis Imperfecta due to recurrent point Gene Mutation at CpG dinucleotides in the COL1A1 gene gene gene of collagen type I., Osteogenesis Imperfecta (OI), commonly known as \"brittle bone disease\", is a dominant Autosome disorder characterized by bone fragility and abnormalities of Connective Tissue. Biochemical and molecular genetic studies have shown that the vast majority of affected individuals have Gene Mutation in either the COL1A1 gene gene or alpha 2 collagen type I Genes that encode the chains of Procollagen Type I. , Osteogenesis Imperfecta is normally caused by an Autosome dominant Mutation Abnormality in the collagen type I Genes COL1A1 gene gene and alpha 2 collagen type I.[SEP]Relations: Autosomal dominant inheritance has relations: disease_phenotype_positive with osteogenesis imperfecta, disease_phenotype_positive with osteogenesis imperfecta, disease_phenotype_positive with osteogenesis imperfecta with opalescent teeth, Blue sclera and wormian bones but without fractures, disease_phenotype_positive with osteogenesis imperfecta with opalescent teeth, Blue sclera and wormian bones but without fractures, disease_phenotype_positive with combined osteogenesis imperfecta and Ehlers-Danlos syndrome, disease_phenotype_positive with combined osteogenesis imperfecta and Ehlers-Danlos syndrome. osteogenesis imperfecta has relations: disease_phenotype_positive with Autosomal dominant inheritance, disease_phenotype_positive with Autosomal dominant inheritance, disease_phenotype_positive with Autosomal dominant inheritance, disease_phenotype_positive with Autosomal dominant inheritance. Definitions: Variant defined as following: An alteration or difference from a norm or standard.. collagen type I defined as following: The most common form of fibrillar collagen. It is a major constituent of bone (BONE AND BONES) and SKIN and consists of a heterotrimer of two alpha1(I) and one alpha2(I) chains.. hearing impairment defined as following: Partial or complete loss of the ability to detect or understand sounds resulting from damage to the outer, middle, or inner ear structures. Causes include exposure to loud noise, ear infections, injuries to the ear, genetic, and congenital disorders.. COL1A1 gene defined as following: This gene plays an important structural role in cartilage and Gene Mutation in the gene are associated with osteogenesis imperfecta.. collagen defined as following: A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH).. Autosomal dominant inheritance defined as following: A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an Autosome dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele. [HPO:curators]. Osteogenesis Imperfecta defined as following: COLLAGEN DISEASES characterized by brittle, osteoporotic, and easily fractured bones. It may also present with Blue sclera, loose joints, and imperfect dentin formation. Most types are Autosome dominant and are associated with Gene Mutation in COLLAGEN TYPE I.. Trauma, nursing specialty defined as following: Nurses in this specialty provide emergency care to patients of all ages. These nurses work to maintain vital signs and prevent complications and Cessation of life. BMP1 protein, human defined as following: Bone morphogenetic protein 1 (986 aa, ~111 kDa) is encoded by the human BMP1 protein, human gene. This protein is involved in the processing of collagen fibrils during skeletal development.. SERPINF1 gene defined as following: This gene is involved in the regulation of cell proliferation.. Genotype determination defined as following: The determination of the DNA sequence of an individual.. Connective Tissue defined as following: Tissue that supports and binds other tissues. It consists of CONNECTIVE TISSUE CELLS embedded in a large amount of EXTRACELLULAR MATRIX.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Autosome defined as following: Any chromosome other than a sex chromosome. [GOC:mah]. Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. Autosome dominant defined as following: A rare distal arthrogryposis syndrome with characteristics of multiple pterygia (typically involving the neck, axilla and popliteal areas), joint contractures, ptosis, camptodactyly of the hands with hypoplastic flexion creases, vertebral fusions, severe scoliosis and short stature. There is evidence this disease is caused by heterozygous Mutation Abnormality in the MYH3 gene on chromosome 17p13.. Hereditary Diseases defined as following: Genetic diseases are diseases in which inherited Genes predispose to increased risk. The genetic disorders associated with cancer often result from an alteration or Mutation Abnormality in a single gene. The diseases range from rare dominant cancer family syndrome to familial tendencies in which low-penetrance Genes may interact with other Genes or environmental factors to induce cancer. Research may involve clinical, epidemiologic, and laboratory studies of persons, families, and populations at high risk of these disorders.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Blue sclera defined as following: An abnormal bluish coloration of the sclera. [HPO:probinson]. Dentinogenesis imperfecta without osteogenesis imperfecta defined as following: Dentinogenesis imperfecta type 2 (DGI-2) is a rare, severe form of Dentinogenesis imperfecta without osteogenesis imperfecta (DGI, see this term) and is characterized by weakness and discoloration of all teeth.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Fracture defined as following: A traumatic injury to the bone in which the continuity of the bone is broken.. Genetic Polymorphism defined as following: The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.. Osteopenia defined as following: Decreased calcification or density of bone tissue..", "label": "yes"} {"original_question": "Are mutations in the nf1 gene associated with memory?", "id": "converted_2324", "sentence1": "Are Gene Mutation in the nf1 gene associated with memory?", "sentence2": "We hypothesized that Neurofibromatosis 1 Gene Mutation disturb the expression of Genes important for memory formation, Our previous work has shown that defective cAMP signaling leads to the learning phenotype in Drosophila Nf1 mutants. In the present report, our experiments showed that in addition to learning, long-term memory was also abolished in Nf1 mutants. , Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation.[SEP]Relations: neurofibromatosis has relations: disease_protein with Neurofibromatosis 1, disease_protein with Neurofibromatosis 1, disease_disease with neurofibromatosis type 1 due to Neurofibromatosis 1 mutation or intragenic deletion, disease_disease with neurofibromatosis type 1 due to Neurofibromatosis 1 mutation or intragenic deletion, disease_protein with NF2, disease_protein with NF2, disease_phenotype_positive with Memory impairment, disease_phenotype_positive with Memory impairment, disease_protein with LZTR1, disease_protein with LZTR1. Definitions: Neurofibromatosis 1 defined as following: An autosomal dominant inherited disorder (with a high frequency of spontaneous Gene Mutation) that features developmental changes in the nervous system, muscles, bones, and skin, most notably in tissue derived from the embryonic NEURAL CREST. Multiple hyperpigmented skin lesions and subcutaneous tumors are the hallmark of this disease. Peripheral and central nervous system neoplasms occur frequently, especially OPTIC NERVE GLIOMA and NEUROFIBROSARCOMA. Neurofibromatosis 1 is caused by Gene Mutation which inactivate the Neurofibromatosis 1 gene (GENES, NEUROFIBROMATOSIS 1) on chromosome 17q. The incidence of learning disabilities is also elevated in this condition. (From Adams et al., Principles of Neurology, 6th ed, pp1014-18) There is overlap of clinical features with NOONAN SYNDROME in a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and Neurofibromatosis 1 gene products are involved in the SIGNAL TRANSDUCTION pathway of Ras (RAS PROTEINS).. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. nf1 gene defined as following: Tumor suppressor Genes located on the long arm of human chromosome 17 in the region 17q11.2. Mutation of these Genes is thought to cause NEUROFIBROMATOSIS 1, Watson syndrome, and LEOPARD syndrome..", "label": "yes"} {"original_question": "Is protein CXCR4 used as a prognostic marker of cancer?", "id": "converted_792", "sentence1": "Is protein C-X-C motif chemokine 12 receptor activity used as a prognostic marker of Primary malignant neoplasm?", "sentence2": "Aberrant overexpression of C-X-C motif chemokine 12 receptor activity is associated with worse overall survival, Malignant adenomatous neoplasm histology, distant metastasis, lymph node involvement in Non-Small Cell Lung Carcinoma., C-X-C motif chemokine 12 receptor activity belongs to a family of G protein-coupled cell surface receptors and has been proved to a prognostic marker in a various tumors, including Squamous cell carcinoma of esophagus. , The CXCR3 gene (C-X-C motif chemokine 12 receptor activity) has been found to be a prognostic marker in various types of Primary malignant neoplasm, being involved in chemotaxis, stemness and drug resistance. , The chemokine receptor C-X-C motif chemokine 12 receptor activity that has been shown to be implicated in ANOPHTHALMIA AND PULMONARY HYPOPLASIA tumorigenicity and Aggressive behavior could serve as a prognostic marker for survival after a curative-intent surgery and was associated with the pattern of Neoplasms recurrence (distant versus local relapse)., XCR4 promotes tumor growth, angiogenesis and metastasis, and is a prognostic marker in a number of different types of tumors., C-X-C motif chemokine 12 receptor activity has been identified as a prognostic marker for Leukemia, Myelocytic, Acute (AML) and other Malignant Neoplasms. , The chemokine receptor C-X-C motif chemokine 12 receptor activity has been found to be a prognostic marker in various types of Primary malignant neoplasm, including breast Primary malignant neoplasm. , Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric Primary malignant neoplasm., detection of C-X-C motif chemokine 12 receptor activity expression will be helpful for predicting prognosis for patients with gastric Primary malignant neoplasm., The chemokine receptor C-X-C motif chemokine 12 receptor activity is a marker of metastatic disease., High C-X-C motif chemokine 12 receptor activity level in Primary malignant neoplasm specimens independently predicts a poor outcome for patients with node-positive breast Primary malignant neoplasm., Univariate and multivariate analyses demonstrated that the high levels of nuclear C-X-C motif chemokine 12 receptor activity and Chemokine Chemokine CXCL12 expression in Hepatocyte were significantly better prognostic factors for overall and hepatic disease-free survival in patients with LAMB1 gene., The chemokine receptor C-X-C motif chemokine 12 receptor activity has been implicated in Malignant neoplasm of soft tissue development and has been found to be a prognostic marker for poor clinical outcome. , high C-X-C motif chemokine 12 receptor activity expression is correlated to shorter DFS and could be used as a prognostic marker in order to stratify Melanocytic neoplasm patients at higher progression risk.[SEP]Relations: C-X-C motif chemokine 12 receptor activity has relations: molfunc_protein with C-X-C motif chemokine 12 receptor activity, molfunc_protein with C-X-C motif chemokine 12 receptor activity. esophageal squamous cell carcinoma has relations: disease_protein with XRCC1, disease_protein with XRCC1, disease_protein with PRDX1, disease_protein with PRDX1, disease_protein with FBXW7, disease_protein with FBXW7. small cell lung carcinoma has relations: disease_protein with ASCL1, disease_protein with ASCL1. Definitions: Squamous cell carcinoma of esophagus defined as following: A carcinoma that originates usually from cells on the surface of the middle and lower third of the ESOPHAGUS. Tumor cells exhibit typical squamous morphology and form large polypoid lesions. Mutations in RNF6, LZTS1, TGFBR2, DEC1, and WWOX1 genes are associated with this Primary malignant neoplasm.. Melanocytic neoplasm defined as following: A benign or malignant, primary or metastatic neoplasm affecting the melanocytes.. Chemokine CXCL12 defined as following: A CXC chemokine that is chemotactic for T-LYMPHOCYTES and MONOCYTES. It has specificity for C-X-C motif chemokine 12 receptor activity RECEPTORS. Two isoforms of Chemokine CXCL12 are produced by alternative mRNA splicing.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Leukemia, Myelocytic, Acute defined as following: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.. CXCR3 gene defined as following: This gene plays a role in immune cell chemotaxis and trafficking.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. C-X-C motif chemokine 12 receptor activity defined as following: Combining with the C-X-C motif chemokine 12 (Chemokine CXCL12) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. [GOC:bf, PMID:22204316]. breast Primary malignant neoplasm defined as following: A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males.. Aggressive behavior defined as following: Behavior which may be manifested by destructive and attacking action which is verbal or physical, by covert attitudes of hostility or by obstructionism.. Malignant neoplasm of soft tissue defined as following: A malignant neoplasm arising exclusively from the soft tissues.. gastric Primary malignant neoplasm defined as following: A primary or metastatic malignant neoplasm involving the stomach.. Hepatocyte defined as following: The main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules.. Non-Small Cell Lung Carcinoma defined as following: A heterogeneous aggregate of at least three distinct histological types of lung Primary malignant neoplasm, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. ANOPHTHALMIA AND PULMONARY HYPOPLASIA defined as following: A rare clinical entity including as main characteristics anophthalmia or severe microphthalmia, and pulmonary hypoplasia or aplasia. Only five cases have been reported so far, two of who were siblings. In the three nonfamilial cases, unilateral pulmonary agenesis and microphthalmia were associated with diaphragmatic hernia and pulmonary vessel agenesis. It has been suggested that two different entities can be distinguished: on one hand, the association of anophthalmia-pulmonary hypoplasia with/without anomalies of the face, heart, spleen and uterus, which may be due to a putative autosomal recessive gene with pleiotropic effects; on the other hand, a sporadic association including pulmonary hypoplasia, anophthalmia, unilateral diaphragmatic defect and agenesis of the pulmonary trunk, which may represent the expression of a developmental field defect. There is evidence that syndromic microphthalmia- is caused by homozygous or compound heterozygous mutation in the STRA6 gene on chromosome 15q24..", "label": "yes"} {"original_question": "Is there a role for MRPL53 in cancer?", "id": "converted_3326", "sentence1": "Is there a role for MRPL53 in cancer?", "sentence2": "MRPL53, a New Candidate Gene for Orofacial Clefting, Identified Using an eQTL Approach., A valuable approach to understand how individual and population genetic differences can predispose to disease is to assess the impact of genetic variants on cellular functions (e.g., gene expression) of \"U\" lymphocyte and tissue types related to pathological states. To understand the genetic basis of nonsyndromic cleft lip with or without cleft palate (NSCL/P) susceptibility, a complex and highly prevalent Congenital Abnormality, we searched for genetic variants with a regulatory role in a disease-related tissue, the lip muscle (orbicularis oris muscle [OOM]), of affected individuals. From 46 OOM samples, which are frequently discarded during routine corrective surgeries on patients with orofacial clefts, we derived Mesenchymal Stem Cells and correlated the individual genetic variants with gene expression from these Cultured Cells. Through this strategy, we detected significant cis-eQTLs (i.e., DNA variants affecting gene expression) and selected a few candidates to conduct an association study in a large Brazilian cohort (624 patients and 668 controls). This resulted in the discovery of a novel susceptibility locus for NSCL/P, rs1063588, the best eQTL for the MRPL53 gene, where evidence for association was mostly driven by the Native American ancestry component of our Brazilian sample. MRPL53 (2p13.1) encodes a 39S protein subunit of Mitochondrial Ribosomes and interacts with MYC protein, human protein, human, a TRANSCRIPTION FACTOR required for normal facial morphogenesis. [SEP]Relations: mitochondrial ribosome has relations: cellcomp_protein with MRPL9, cellcomp_protein with MRPL9, cellcomp_protein with MRPL39, cellcomp_protein with MRPL39, cellcomp_protein with MRPL51, cellcomp_protein with MRPL51, cellcomp_protein with MRPL11, cellcomp_protein with MRPL11, cellcomp_protein with MRPL13, cellcomp_protein with MRPL13. Definitions: Mesenchymal Stem Cells defined as following: An undifferentiated stromal \"U\" lymphocyte with the ability to develop into the cells that form distinct mesenchymal tissues; such as bone, muscle, connective tissue, blood vessels, and lymphatic tissue.. MYC protein, human defined as following: Myc proto-oncogene protein (439 aa, ~49 kDa) is encoded by the human MYC protein, human gene. This protein plays a role in the regulation of transcription and \"U\" lymphocyte proliferation.. Cultured Cells defined as following: Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.. TRANSCRIPTION FACTOR defined as following: Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.. Mitochondrial Ribosomes defined as following: A ribosome found in the mitochondrion of a eukaryotic \"U\" lymphocyte; contains a characteristic set of proteins distinct from those of cytosolic ribosomes. [GOC:mah, ISBN:0198506732]. Congenital Abnormality defined as following: Malformations of organs or body parts during development in utero.. cancer defined as following: A malignant tumor at the original site of growth..", "label": "no"} {"original_question": "Does radiotherapy for cervical cancer increases risk of colon cancer?", "id": "converted_3782", "sentence1": "Does radiotherapy for Malignant tumor of cervix increases risk of Malignant tumor of Abdomen+Pelvis>Colon?", "sentence2": "After 8 years, the hazard ratio for developing Malignant tumor of Abdomen+Pelvis>Colon was 2.00 (95% CI 1.43-2.80) for women with radiation versus those without radiation treatment., After 35 years of follow-up, the absolute risk of developing Malignant tumor of Abdomen+Pelvis>Colon was 6.5% for those who received radiation versus 2.5% for those without, and 3.7 versus 0.8% for Pelvis>Rectum. The risk of Abdomen+Pelvis>Colon and Rectal Carcinoma over 20 years of follow-up after radiation remained the same across three eras (1973-1980, 1981-1990, and 1991-2000). Radiation-induced second Malignant Neoplasms of the Abdomen+Pelvis>Colon and Pelvis>Rectum may occur 8 years after radiation treatment for Malignant tumor of cervix., The data suggested that high-dose pelvic irradiation was associated with increase in Malignant Neoplasms of the Urinary Bladder, Both Both kidneys, Pelvis>Rectum, Both Both ovaries, corpus uteri, and Non-Hodgkin's lymphoma of bone but, apparently, not leukemia, Hodgkin Disease, Malignant neoplasm of breast, or Malignant tumor of Abdomen+Pelvis>Colon., Radiation-induced second Malignant Neoplasms of the Abdomen+Pelvis>Colon and Pelvis>Rectum may occur 8 years after radiation treatment for Malignant tumor of cervix., Cervical cancer patients treated with radiotherapy, but not those who did not receive radiotherapy, were at increased risk for all second Malignant Neoplasms and Malignant Neoplasms at heavily irradiated sites (Abdomen+Pelvis>Colon, Rectum/Anus, urinary Urinary Bladder, Pelvis>Ovary, and genital sites) beyond 40 years of follow-up compared with women in the general population. [SEP]Relations: malignant germ cell tumor of cervix uteri has relations: disease_disease with Malignant tumor of cervix, disease_disease with Malignant tumor of cervix. malignant tumor of neck has relations: disease_disease with head and neck cancer, disease_disease with head and neck cancer, disease_disease with pharynx cancer, disease_disease with pharynx cancer. rectal carcinoma has relations: disease_disease with rectal cancer, disease_disease with rectal cancer. malignant ear neoplasm has relations: disease_disease with head and neck cancer, disease_disease with head and neck cancer. Definitions: Urinary Bladder defined as following: A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the Urinary Bladder via the ureters (URETER), and is held there until URINATION.. leukemia defined as following: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006). Rectum/Anus defined as following: A tissue sample that contains the Pelvis>Rectum and anus.. Malignant neoplasm of breast defined as following: A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Hodgkin Disease defined as following: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.. Malignant tumor of cervix defined as following: A primary or metastatic malignant neoplasm involving the cervix.. Malignant tumor of Abdomen+Pelvis>Colon defined as following: A primary or metastatic malignant neoplasm that affects the Abdomen+Pelvis>Colon. Representative examples include carcinoma, lymphoma, and sarcoma.. Rectal Carcinoma defined as following: A malignant epithelial neoplasm that arises from the Pelvis>Rectum and invades through the muscularis mucosa into the submucosa. The vast majority are adenocarcinomas..", "label": "yes"} {"original_question": "Could the Menzerath-Altmann law be proved mathematically trivial in genomes?", "id": "converted_347", "sentence1": "Could the Menzerath-Altmann law be proved mathematically trivial in Genome?", "sentence2": "Here we review the statistical foundations of that test and consider three non-parametric tests based upon different correlation metrics and one parametric test to evaluate if Upper case Roman letter Upper case Roman letter Z ∼ 1/X in Genome. The most powerful test is a new non-parametric one based upon the correlation ratio, which is able to reject Upper case Roman letter Upper case Roman letter Z ∼ 1/X in nine out of 11 taxonomic groups and detect a borderline group. Rather than a fact, Upper case Roman letter Upper case Roman letter Z ∼ 1/X is a baseline that real Genome do not meet. The view of Menzerath-Altmann law as inevitable is seriously flawed., The view of Menzerath-Altmann law as inevitable is seriously flawed., The view of Menzerath-Altmann law as inevitable is seriously flawed., The view of Menzerath-Altmann law as inevitable is seriously flawed.[SEP]Relations: Increased upper to lower segment ratio has relations: disease_phenotype_positive with Turner syndrome due to structural X chromosome anomalies, disease_phenotype_positive with Turner syndrome due to structural X chromosome anomalies, disease_phenotype_positive with Aarskog-Scott syndrome, X-linked, disease_phenotype_positive with Aarskog-Scott syndrome, X-linked, disease_phenotype_positive with Turner syndrome, disease_phenotype_positive with Turner syndrome, disease_phenotype_positive with mosaic monosomy X, disease_phenotype_positive with mosaic monosomy X, disease_phenotype_positive with monosomy X, disease_phenotype_positive with monosomy X. Definitions: Genome defined as following: The genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA..", "label": "yes"} {"original_question": "Is CD56 useful in Ewing sarcoma prognosis?", "id": "converted_76", "sentence1": "Is NCAM1 wt Allele useful in Ewings sarcoma prognosis?", "sentence2": "Excellent prognosis in a subset of patients with Ewings sarcoma identified at diagnosis by NCAM1 wt Allele using flow cytometry, There was a highly significant correlation between NCAM1 wt Allele expression and progression-free survival (PFS; 69% in low/negative expression versus 30% in high expression groups, P = 0.024), In patients with localized nonpelvic disease, those expressing low/negative NCAM1 wt Allele had 100% PFS versus 40% in the high expressing group (P = 0.02), NCAM1 wt Allele was found to be an independent prognostic marker with an 11-fold increased risk for relapse in patients with localized disease (P = 0.006), NCAM1 wt Allele expression could be used to reveal ES patients with excellent prognosis or patients predisposed to relapse, thus improving treatment stratification and implementation of personalized therapy, Excellent prognosis in a subset of patients with Ewings sarcoma identified at diagnosis by NCAM1 wt Allele using flow cytometry., Three years after diagnosis the patient presented with severe respiratory difficulty and following resection, the final pathology revealed Multiple tumors with Focal of High Grade Sarcoma compatible with primitive Neuroectodermal Tumors/extraskeletal Ewings sarcoma based on morphology and immunohistochemistry (CD99 antigen antigen, NCAM1 wt Allele)., NCAM1 wt Allele expression could be used to reveal ES patients with excellent prognosis or patients predisposed to relapse, thus improving treatment stratification and implementation of personalized therapy., Identification of NCAM1 wt Allele and B3GAT1 wt Allele by flow cytometry in Ewing's sarcoma of bone of bone or primitive Neuroectodermal Tumors., NCAM1 wt Allele expression could be used to reveal ES patients with excellent prognosis or patients predisposed to relapse, thus improving treatment stratification and implementation of personalized therapy.[SEP]Relations: Ewings sarcoma has relations: disease_protein with EWSR1, disease_protein with EWSR1, disease_protein with EGR2, disease_protein with EGR2, disease_disease with sarcoma, disease_disease with sarcoma, disease_protein with FLI1, disease_protein with FLI1, disease_phenotype_positive with Ewings sarcoma, disease_phenotype_positive with Ewings sarcoma. Definitions: Ewing's sarcoma of bone defined as following: A small round cell bone tumor that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewings sarcoma/peripheral Neuroectodermal Tumors. It often affects the diaphysis or metaphyseal-diaphyseal portion of long bones. Clinical findings include pain and a mass in the involved area. Fever, anemia, leukocytosis, and an increased sedimentation rate are often seen. X-ray examination reveals osteolytic lesions. The prognosis depends on the stage, anatomic location, and size of the tumor.. NCAM1 wt Allele defined as following: Human NCAM1 wild-type allele is located in the vicinity of 11q23.1 and is approximately 316 kb in length. This allele, which encodes neural cell adhesion molecule 1 protein, is involved in embryogenesis and mediates cell-cell and cell-matrix adhesion.. Focal defined as following: Limited to a specific area.. B3GAT1 wt Allele defined as following: Human B3GAT1 wild-type allele is located in the vicinity of 11q25 and is approximately 33 kb in length. This allele, which encodes galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 protein, is involved in the addition of carbohydrate to proteins.. Ewings sarcoma defined as following: A small round cell tumor that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewings sarcoma/peripheral Neuroectodermal Tumors. It affects mostly males under age 20, and it can occur in soft tissue or bone. Pain and the presence of a mass are the most common clinical symptoms.. CD99 antigen defined as following: A cell adhesion molecule that, in humans, is encoded by a gene on the PSEUDOAUTOSOMAL REGION of SEX CHROMOSOMES. It functions in CELL ADHESION of T-LYMPHOCYTES and ROSETTE FORMATION by ERYTHROCYTES. It is also involved in the migration of LEUKOCYTES through the ENDOTHELIUM BASEMENT MEMBRANE. The 12E7 antigen co-localizes with, but functions independently of PECAM-1.. Neuroectodermal Tumors defined as following: Malignant neoplasms arising in the neuroectoderm, the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems, including some glial cells.. High Grade Sarcoma defined as following: A sarcoma with the morphologic features of a high grade tumor and lack of differentiation..", "label": "yes"} {"original_question": "Can valproic acid prolong survival of glioblastoma patients?", "id": "converted_2092", "sentence1": "Can valproic acid prolong survival of Glioblastoma Multiforme patients?", "sentence2": "For patients who presented with Epilepsy, the use of the antiepileptic drug valproic acid did not associate with survival when compared with patients who did not receive valproic acid treatment., This prognostic effect is not solely explained by early diagnosis, and survival is not associated with valproic acid treatment., Several in vivo and in vitro studies have indicated that valproic acid has radiosensitizing effects for Glioma and radioprotective influence on normal brain tissue surgical material surgical material or hippocampal Neurons. The results of several retrospective studies have also indicated potential benefit to improve survival of patients with Glomerular Basement Membrane. Moreover, the promising treatment results of a phase 2 trial of concurrent radiation therapy, temozolomide, and valproic acid for patients with Glomerular Basement Membrane have been recently reported. , While there have not been any novel anti-Glomerular Basement Membrane therapeutics approved for many years, there has been the gradual accumulation of clinical data suggesting that the widely used anti-convulsant agent, valproic acid (valproic acid) may significantly prolong survival in Glomerular Basement Membrane patients., Additionally, valproic acid may result in improved outcomes compared to historical data and merits further study., Several retrospective studies in Seizures patients with Glioblastoma Multiforme treated with chemotherapy have provided evidence for a moderately improved survival with the use of valproic acid, possibly due to inhibition of Histone Deacetylase, Several clinical studies have reported that valproic acid could prolong survival of Glomerular Basement Membrane patients, While there have not been any novel anti-Glomerular Basement Membrane therapeutics approved for many years, there has been the gradual accumulation of clinical data suggesting that the widely used anti-convulsant agent, valproic acid (valproic acid) may significantly prolong survival in Glomerular Basement Membrane patients, Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for Glioblastoma Multiforme, Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for Glioblastoma Multiforme., Valproic acid use during radiation therapy for Glioblastoma Multiforme associated with improved survival., Patients receiving valproic acid alone (97 [16.9%]) appeared to derive more survival benefit from TMZ/RT (hazard ratio [HR] 0.39, 95% confidence interval [CI] 0.24-0.63) than patients receiving an EIAED only (252 [44%]) (HR 0.69, 95% CI 0.53-0.90) or patients not receiving any AED (HR 0.67, 95% CI 0.49-0.93). , Several retrospective studies in Seizures patients with Glioblastoma Multiforme treated with chemotherapy have provided evidence for a moderately improved survival with the use of valproic acid, possibly due to inhibition of Histone Deacetylase., Several uncontrolled retrospective case series and a post hoc analysis of the registration trial for temozolomide indicated an association between valproic acid (valproic acid) use and improved survival outcomes in patients with newly diagnosed Glioblastoma Multiforme.To confirm the hypothesis suggested above, a combined analysis of survival association of antiepileptic drug use at the start of Chemoradiotherapy with temozolomide was performed in the pooled patient cohort (n = 1,869) of four contemporary randomized clinical trials in newly diagnosed Glioblastoma Multiforme: AVAGlio (Avastin in Glioblastoma; NCT00943826), CENTRIC (Cilengitide, Temozolomide, and Radiation T, Several clinical studies have reported that valproic acid could prolong survival of Glomerular Basement Membrane patients., Patients receiving valproic acid alone (97 [16.9%]) appeared to derive more survival benefit from TMZ/RT (hazard ratio [HR] 0.39, 95% confidence interval [CI] 0.24-0.63) than patients receiving an EIAED only (252 [44%]) (HR 0.69, 95% CI 0.53-0.90) or patients not receiving any AED (HR 0.67, 95% CI 0.49-0.93).valproic acid may be preferred over an EIAED in patients with Glioblastoma Multiforme who require an AED during TMZ-based Chemoradiotherapy., The combination of radiotherapy, temozolomide and valproic acid (valproic acid) has shown some promise in retrospective analyses of patients with Glioblastoma Multiforme, although their mechanisms of action remain unknown.We investigated the in vitro and in vivo effects of pretreating glioma cells with temozolomide and valproic acid as an immunization strategy to boost an adaptive immune response in a syngeneic mouse model.Temozolomide and valproic acid induced autophagy in GL261 glioma cells, and caused tumor antigen-specific T-cells to become activated effector T-cells., Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for Glioblastoma Multiforme.[SEP]Relations: Valproic acid has relations: contraindication with gallbladder disease, contraindication with gallbladder disease, contraindication with hematologic disease, contraindication with hematologic disease, contraindication with kidney disease, contraindication with kidney disease, contraindication with neurotic disorder, contraindication with neurotic disorder, contraindication with liver disease, contraindication with liver disease. Definitions: valproic acid defined as following: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.. Glomerular Basement Membrane defined as following: A sheet of amorphous extracellular material upon which the basal surfaces of epithelial cells rest and is the covering surface of a glomerular capillary, interposed between the cellular elements and the underlying connective tissue.. Glioblastoma Multiforme defined as following: The most malignant astrocytic tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO). Glioma defined as following: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or Glioblastoma Multiforme multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21). temozolomide defined as following: A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.. Histone Deacetylase defined as following: Deacetylases that remove N-acetyl groups from amino side chains of the amino acids of HISTONES. The enzyme family can be divided into at least three structurally-defined subclasses. Class I and class II deacetylases utilize a zinc-dependent mechanism. The sirtuin histone deacetylases belong to class III and are NAD-dependent enzymes.. Cilengitide defined as following: A cyclic Arg-Gly-Asp peptide with potential antineoplastic activity. Cilengitide binds to and inhibits the activities of the alpha(v)beta(3) and alpha(v)beta(5) integrins, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis. (NCI04). Epilepsy defined as following: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the Seizures episodes (e.g., motor Seizures), (2) etiology (e.g., post-traumatic), (3) anatomic site of Seizures origin (e.g., frontal lobe Seizures), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal Epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313). Chemoradiotherapy defined as following: Treatment that combines chemotherapy with radiotherapy.. Neurons defined as following: The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.. Seizures defined as following: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or \"Seizures disorder.\". valproic acid defined as following: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS..", "label": "yes"} {"original_question": "Is vemurafenib effective for hairy-cell leukemia?", "id": "converted_512", "sentence1": "Is vemurafenib effective for hairy-cell leukemia?", "sentence2": "CONCLUSIONS: A short oral course of vemurafenib was highly effective in patients with relapsed or refractory hairy-cell leukemia., Our results strongly support and inform the clinical use of BRAF protein, human protein, human and Mitogen-Activated Protein Kinase Kinases inhibitors in Hairy Cell Leukemia., The therapeutic approach of vemurafenib in treatment-refractory hairy cell leukemia is promising and offers an additional treatment option. , Successful re-treatment of a relapsed V600E mutated Hairy Cell Leukemia patient with low-dose vemurafenib., Recent identification of the recurrent V600E BRAF protein, human protein, human Mutation Abnormality in a majority of Hairy Cell Leukemia patients has led some teams to evaluate the clinical potential of vemurafenib, a BRAF protein, human protein, human V600 specific PPP1R1A gene in a limited number of refractory Hairy Cell Leukemia patients. Recently, we published the case of an Hairy Cell Leukemia patient successfully treated with a low dose of vemurafenib., We present here the successful retreatment of this patient with a second line of vemurafenib. Our data suggest for the first time that vemurafenib at the dose of 240 mg once a day could be sufficient to maintain a complete hematological remission after an initial induction treatment with low-dose vemurafenib (2 × 240 mg) daily without inducing major Toxic effect., The discovery of the BRAF protein, human protein, human Mutation Abnormality has created a therapeutic target exploited by oral inhibitors like vemurafenib and dabrafenib., [Successful use of vemurafenib in a patient with resistant hairy cell leukemia]., The frequent persistence of phosphorylated Mitogen-Activated Protein Kinases-positive leukemic cells in bone marrow at the end of treatment suggests bypass reactivation of Mitogen-Activated Protein Kinase Kinases and Mitogen-Activated Protein Kinases as a resistance mechanism.CONCLUSIONS: A short oral course of vemurafenib was highly effective in patients with relapsed or refractory hairy-cell leukemia. , A short oral course of vemurafenib was highly effective in patients with relapsed or refractory hairy-cell leukemia., A short oral course of vemurafenib was highly effective in patients with relapsed or refractory hairy-cell leukemia., The therapeutic approach of vemurafenib in treatment-refractory hairy cell leukemia is promising and offers an additional treatment option.[SEP]Relations: Vemurafenib has relations: drug_drug with Afelimomab, drug_drug with Afelimomab, drug_drug with Afatinib, drug_drug with Afatinib, drug_drug with Vardenafil, drug_drug with Vardenafil, drug_drug with Ethanol, drug_drug with Ethanol, drug_drug with Ribociclib, drug_drug with Ribociclib. Definitions: Mitogen-Activated Protein Kinase Kinases defined as following: A dual-specific protein kinase family whose members are components in protein kinase cascades activated by diverse stimuli. These MAPK kinases phosphorylate MITOGEN-ACTIVATED PROTEIN KINASES and are themselves phosphorylated by MAP KINASE KINASE KINASES. JNK kinases (also known as SAPK kinases) are a subfamily.. vemurafenib defined as following: An orally bioavailable, ATP-competitive, small-molecule PPP1R1A gene of BRAF protein, human(V600E) kinase with potential antineoplastic activity. Vemurafenib selectively binds to the ATP-binding site of BRAF protein, human(V600E) kinase and inhibits its activity, which may result in an inhibition of an over-activated MAPK signaling pathway downstream in BRAF protein, human(V600E) kinase-expressing tumor cells and a reduction in tumor cell proliferation. Approximately 90% of BRAF protein, human gene mutations involve a valine-to-glutamic acid Mutation Abnormality at residue 600 (V600E); the oncogene protein product, BRAF protein, human(V600E) kinase, exhibits a markedly elevated activity that over-activates the MAPK signaling pathway. The BRAF protein, human(V600E) gene Mutation Abnormality has been found to occur in approximately 60% of melanomas, and in about 8% of all solid tumors, including melanoma, colorectal, thyroid and other cancers.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. Mitogen-Activated Protein Kinases defined as following: A superfamily of PROTEIN SERINE-THREONINE KINASES that are activated by diverse stimuli via protein kinase cascades. They are the final components of the cascades, activated by phosphorylation by MITOGEN-ACTIVATED PROTEIN KINASE KINASES, which in turn are activated by mitogen-activated protein kinase kinase kinases (MAP KINASE KINASE KINASES).. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Hairy Cell Leukemia defined as following: A neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of \"hairy\" or \"flagellated\" cells in the blood and bone marrow.. dabrafenib defined as following: An orally bioavailable PPP1R1A gene of B-raf (BRAF protein, human) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF protein, human gene. B-raf belongs to the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which may be constitutively activated due to BRAF protein, human gene mutations.. BRAF protein, human defined as following: Serine/threonine-protein kinase B-raf (766 aa, ~84 kDa) is encoded by the human BRAF protein, human gene. This protein plays a role in protein phosphorylation, mitogenesis and neuronal signal transduction.. hairy-cell leukemia defined as following: A neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of \"hairy\" or \"flagellated\" cells in the blood and bone marrow..", "label": "yes"} {"original_question": "Do Crocus sativus extracts loosen the blood-brain barrier?", "id": "converted_3187", "sentence1": "Do Crocus sativus antigen extracts loosen the Blood - brain barrier function?", "sentence2": "Crocus sativus antigen antigen Extract Tightens the Blood-Brain Barrier, Reduces Amyloid β Load and Related Toxic effect in 5XFAD Mice., In vitro results showed that Crocus sativus antigen antigen extract increases the Tightness sensation quality of a cell-based Blood - brain barrier function (Blood - brain barrier anatomy) model and enhances transport of Aβ. Further in vivo studies confirmed the effect of Crocus sativus antigen antigen extract (50 mg/kg/day, added to mice diet) on the Blood - brain barrier anatomy Tightness sensation quality and function that was associated with reduced Aβ load and related pathological changes in 5XFAD mice used as an cytarabine/daunorubicin protocol model. Reduced Aβ load could be explained, at least in part, by Crocus sativus antigen antigen extract effect to enhance Aβ clearance pathways including Blood - brain barrier anatomy clearance, enzymatic degradation and ApoE clearance pathway.[SEP]Relations: blood brain barrier has relations: anatomy_anatomy with glial blood brain barrier, anatomy_anatomy with glial blood brain barrier, anatomy_anatomy with glial blood brain barrier, anatomy_anatomy with glial blood brain barrier, anatomy_anatomy with cell layer, anatomy_anatomy with cell layer, anatomy_anatomy with cell layer, anatomy_anatomy with cell layer. Definitions: Blood - brain barrier anatomy defined as following: Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something..", "label": "no"} {"original_question": "Can Flotillin be used as exosomal marker?", "id": "converted_3449", "sentence1": "Can Flotillin be used as exosomal marker?", "sentence2": "flotillins and TSG101 protein, human gene (TSG101 protein, human protein, human), two exosomal marker proteins, , expressed exosomal marker tumor susceptibility gene (TWSG1 gene) 101 and flotillin (Flot) 1.[SEP]Relations: Protein S human has relations: drug_drug with Trabectedin, drug_drug with Trabectedin, drug_drug with Drotrecogin alfa, drug_drug with Drotrecogin alfa, drug_drug with Floctafenine, drug_drug with Floctafenine, drug_drug with Streptozocin, drug_drug with Streptozocin, drug_drug with Floxuridine, drug_drug with Floxuridine. Definitions: TSG101 protein, human defined as following: Tumor susceptibility gene 101 protein (390 aa, ~44 kDa) is encoded by the human TSG101 protein, human gene. This protein is involved in both the binding and transport of ubiquitinated proteins.. TSG101 gene defined as following: This gene is involved in suppression of transcription and regulation of the cell cycle. It also plays a role in cell proliferation and survival..", "label": "yes"} {"original_question": "Is there evidence that tomato juice lowers cholesterol levels?", "id": "converted_418", "sentence1": "Is there evidence that Lycopersicon esculentum juice lowers cholesterol levels?", "sentence2": "The hypocholesterolemic effect of Lycopersicon esculentum juice has been investigated in an intervention study with Rattus norvegicus, along with the possible inhibition effect of bioactive Lycopersicon esculentum compounds binding to the HMGCR protein, human protein, human Enzyme [APC]., The molecular modelling showed that components of Lycopersicon esculentum can bind to the Active Site of the Enzyme [APC] and compete with the ligand HMGCoA. Lycopene, from Lycopersicon esculentum juice, accumulates in the Abdomen>Liver and can inhibit the activity of the rate-limiting Enzyme [APC] of cholesterol biosynthesis, HMGCR protein, human protein, human., Juice consumption significantly improved resistance of Low-Density Lipoproteins+VLDL-C to Cu(2+)-mediated oxidation (P = 0.039), High Density Lipoproteins-C (47.3 ± 15.8 to 51.7 ± 14.8 mg/dL, P<0.001), and the ratio of total-C/High Density Lipoproteins-C (4.25 ± 1.59 to 3.63 ± 1.16, P<0.001) at 8 wk., RESULTS: Intervention with the enriched juice had no effect on the lipid profile, and serum levels of Triglycerides and cholesterol (total, Low-Density Lipoproteins, and High Density Lipoproteins) remained unchanged. , Women consuming ≥10 compared with<1.5 servings/wk of Lycopersicon esculentum-based food products had significant but clinically modest improvements in total cholesterol (CD55 wt Allele) (5.38 vs. 5.51 mmol/L; P = 0.029), the CD55 wt Allele:High Density Lipoproteins cholesterol ratio (4.08 vs. 4.22; P = 0.046), and Glycosylated hemoglobin A (5.02 vs. 5.13%; P<0.001) in multivariable models. Considering clinical cutpoints, women consuming ≥10 compared with<1.5 servings/wk were 31% (95% CI = 6%, 50%), 40% (95% CI = 13%, 59%), and 66% (95% CI = 20%, 86%) less likely to have elevated CD55 wt Allele (≥6.21 mmol/L), Low-Density Lipoproteins cholesterol (≥4.14 mmol/L), and Glycosylated hemoglobin A (≥6%), respectively. , In conclusion, women consuming ≥10 compared with<1.5 servings/wk of Lycopersicon esculentum-based food products had clinically modest but significant improvements in CD55 wt Allele, the CD55 wt Allele:High Density Lipoproteins cholesterol ratio, and Glycosylated hemoglobin A but not other coronary biomarkers., Tomato juice decreases Low-Density Lipoproteins cholesterol levels and increases Low-Density Lipoproteins resistance to oxidation., Total cholesterol concentration was reduced by 5.9 (sd 10) % (P = 0.002) and Low-Density Lipoproteins cholesterol concentration by 12.9 (sd 17.0) % (P = 0.0002) with the high Lycopersicon esculentum diet compared to the low Lycopersicon esculentum diet., In conclusion, a high dietary intake of Lycopersicon esculentum products had atheroprotective effects, it significantly reduced Low-Density Lipoproteins cholesterol levels, and increased Low-Density Lipoproteins resistance to oxidation in healthy normocholesterolaemic adults., Total, Low-Density Lipoproteins and High Density Lipoproteins cholesterol were significantly lower in the intervention group after the intake of Lycopersicon esculentum juice, Total cholesterol concentration was reduced by 5.9 (sd 10) % (P = 0.002) and Low-Density Lipoproteins cholesterol concentration by 12.9 (sd 17.0) % (P = 0.0002) with the high Lycopersicon esculentum diet compared to the low Lycopersicon esculentum diet. [SEP]Relations: Cholesterol has relations: drug_drug with Folic acid, drug_drug with Folic acid, drug_drug with Riluzole, drug_drug with Riluzole, drug_drug with Testosterone cypionate, drug_drug with Testosterone cypionate, drug_drug with Topotecan, drug_drug with Topotecan, drug_drug with Rimegepant, drug_drug with Rimegepant. Definitions: HMGCR protein, human defined as following: 3-hydroxy-3-methylglutaryl-coenzyme A reductase (888 aa, ~97 kDa) is encoded by the human HMGCR protein, human gene. This protein is involved in cholesterol synthesis.. Triglycerides defined as following: An ester formed from GLYCEROL and three fatty acid groups.. Low-Density Lipoproteins defined as following: A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main Low-Density Lipoproteins function is to transport cholesterol and cholesterol esters to extrahepatic tissues.. Lycopersicon esculentum defined as following: A plant species of the family SOLANACEAE, native of South America, widely cultivated for their edible, fleshy, usually red fruit.. Rattus norvegicus defined as following: The common rat, Rattus norvegicus, often used as an experimental organism.. Low-Density Lipoproteins cholesterol defined as following: Cholesterol which is contained in or bound to low density lipoproteins (Low-Density Lipoproteins), including CHOLESTEROL ESTERS and free cholesterol.. High Density Lipoproteins defined as following: A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. High Density Lipoproteins lipoproteins, synthesized in the Abdomen>Liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the Abdomen>Liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. High Density Lipoproteins also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. High Density Lipoproteins plasma level has been inversely correlated with the risk of cardiovascular diseases.. Glycosylated hemoglobin A defined as following: Products of non-enzymatic reactions between GLUCOSE and HEMOGLOBIN A, occurring as a minor fraction of the hemoglobin components of human erythrocytes. Hemoglobin A1c is hemoglobin A with glucose covalently bound to the terminal VALINE of the beta chain. Glycated hemoglobin A is used as an index of the average blood sugar level over a lifetime of erythrocytes.. cholesterol defined as following: The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.. Active Site defined as following: The catalytic site of an Enzyme [APC], the part of an Enzyme [APC] where the actual enzymatic function is performed.. High Density Lipoproteins cholesterol defined as following: Cholesterol which is contained in or bound to high-density lipoproteins (High Density Lipoproteins), including CHOLESTEROL ESTERS and free cholesterol.. CD55 wt Allele defined as following: Human CD55 wild-type allele is located in the vicinity of 1q32 and is approximately 40 kb in length. This allele, which encodes complement decay-accelerating factor protein, is involved in the modulation of complement activity..", "label": "yes"} {"original_question": "Is Mammaprint approved by the United States Food and Drug Administration?", "id": "converted_1365", "sentence1": "Is Mammaprint approved by the United States Food and Drug Administration?", "sentence2": "an FDA-cleared 70-gene signature of MammaPrint panel , on MammaPrint, the first and only assay for Malignant neoplasm of breast management that has been cleared by the FDA., The MammaPrint assay has the advantages of a 510(k) clearance by the US Food and Drug Administration, a larger gene number which may enhance further utility, and the potentially wider patient eligibility including lymph node-positive, ER-negative, , The MammaPrint assay has the advantages of a 510(k) clearance by the U.S. Food and Drug Administration, a larger gene number, which may enhance further utility, and a potentially wider patient eligibility, including lymph node-positive, estrogen receptor (ER)-negative, and younger patients being accrued into the prospective trial (Microarray in Node-Negative Disease May Avoid Chemotherapy). [SEP]Relations: benign neoplasm of male breast has relations: disease_disease with breast benign neoplasm, disease_disease with breast benign neoplasm. Definitions: MammaPrint defined as following: An in vitro molecular diagnostic test that uses gene expression profiling to analyze gene activity within a Malignant neoplasm of breast tumor sample. It looks at the activity of 70 genes and is useful in assessing the likelihood of metastasis and recurrence.. Malignant neoplasm of breast defined as following: A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males.. Mammaprint defined as following: An in vitro molecular diagnostic test that uses gene expression profiling to analyze gene activity within a Malignant neoplasm of breast tumor sample. It looks at the activity of 70 genes and is useful in assessing the likelihood of metastasis and recurrence..", "label": "yes"} {"original_question": "Is edema a symptom of nephrotic syndrome?", "id": "converted_2187", "sentence1": "Is Edema:Finding:Point in time:^Patient:Ordinal a symptom of nephrotic syndrome?", "sentence2": "Nephrotic Syndrome (Supernumerary mandibular left lateral primary incisor) is a common clinical disease with four main clinical manifestations: Hypoalbuminemia (<30 g/L), macro-Proteinuria (>3.5 g/24 h), Edema:Finding:Point in time:^Patient:Ordinal, and Hyperlipidemia. , Nephrotic Syndrome is an unusual manifestation of IGA Glomerulonephritis (IgAN)., Twelve patients with IgAN with Steroid-Sensitive Nephrotic Syndrome were evaluated and followed up. All patients presented with generalized Edema:Finding:Point in time:^Patient:Ordinal. , The clinical features of sudden onset of generalized Edema:Finding:Point in time:^Patient:Ordinal, initial heavy Proteinuria and initial severe Hypoalbuminemia might help identify the subset of patients, especially in low grade IgAN., Most patients presented within 3 months duration (61.4%) and the most common symptom was puffiness of face (98.45%) followed by Edema of lower extremity (91%). , We analyzed medical records of 290 patients with diagnosis of nephrotic syndrome as defined by International Study of Kidney Disease in Children (ISKDC), between January 1987 and December 2000, at the Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar. , He was admitted because of systemic Edema:Finding:Point in time:^Patient:Ordinal and Dyspnea on effort Laboratory data revealed Kidney Failure and nephrotic syndrome, whereas there was no symptom of Diabetic Retinopathy., Nephrotic Syndrome: more than just oedema., Edema is the commonest presenting symptom and sign in nephrotic syndrome. , One of these five clinical syndromes is the nephrotic syndrome, which is characterized by Proteinuria > 3.5 g/day accompanied by hypalbuminemia, Hyperlipoproteinemias and pronounced Edema:Finding:Point in time:^Patient:Ordinal, Tolvaptan therapy for massive Edema:Finding:Point in time:^Patient:Ordinal in a patient with nephrotic syndrome, Nephrotic Syndrome (Supernumerary mandibular left lateral primary incisor) is characterized by Water - Specimen Source Codes and sodium retention, which leads to Edema:Finding:Point in time:^Patient:Ordinal, The non-osmotic stimulation of arginine vasopressin release from the Pituitary Gland has been implicated as one of the important factors in abnormal Water - Specimen Source Codes retention in patients with Supernumerary mandibular left lateral primary incisor.We present the initial description of a patient with massive Edema:Finding:Point in time:^Patient:Ordinal caused by refractory nephrotic syndrome, which was effectively treated with tolvaptan, a selective oral vasopressin V2 receptor antagonist.Tolvaptan is effective for the treatment of massive Edema:Finding:Point in time:^Patient:Ordinal caused by Supernumerary mandibular left lateral primary incisor, We report a child with Steroid-resistant nephrotic syndrome with diuretic-resistant nephrotic Edema:Finding:Point in time:^Patient:Ordinal treated successfully using acute peritoneal dialysis as a means of UF, ALB gene and furosemide Combination for Management of Edema in Nephrotic Syndrome: A Review of Clinical Studies, The treatment of Edema:Finding:Point in time:^Patient:Ordinal in patients with nephrotic syndrome is generally managed by dietary sodium restriction and loop diuretics, Nine months after introduction of tiopronin, the boy manifested generalized Edema:Finding:Point in time:^Patient:Ordinal, Oliguria, and biochemical indices of nephrotic syndrome, Blessed were the days when it all made sense and the apparent mechanism for Edema:Finding:Point in time:^Patient:Ordinal formation in nephrotic syndrome was straightforward: the Both Both kidneys lost protein in the urine, which lowered the plasma oncotic pressure, The nephrotic syndrome is characterized by a combination of pathological lab values and clinical symptoms, i. e. pronounced Proteinuria (usually more than 3 - 3,5 g protein/24 h), Hypoalbuminemia, Edema:Finding:Point in time:^Patient:Ordinal and Hyperlipidemia., The patient was admitted with Edema:Finding:Point in time:^Patient:Ordinal of both legs, and the nephrotic syndrome was discovered, leading to the diagnosis of AA amyloidosis on Kidney biopsy., Linear regression to relate measures.Other signs and symptoms of nephrotic syndrome at baseline (serum albumin < 3.5 g/dL, serum total cholesterol > 260 mg/dL or use of a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition), and Edema:Finding:Point in time:^Patient:Ordinal or use of a Loop Diuretic [EPC]); progression of Chronic Kidney Diseases during follow-up (doubling of baseline serum creatinine level or requirement for dialysis or kidney transplantation)., A case of interstitial shadows associated with oral cyclophosphamide therapy in a 32-month-old girl with Steroid-resistant nephrotic syndrome, who was admitted to the Nishi-Kobe Medical Center with systemic Edema:Finding:Point in time:^Patient:Ordinal, is reported., Nephrotic Syndrome represents a constellation of symptoms including hyperalbuminuria, Hypoalbuminemia, Edema:Finding:Point in time:^Patient:Ordinal formation, Hypercholesterolemia result, Hypertensive disease, hypercoagulopathy, and increased Communicable Diseases risk., Pathophysiology of Edema:Finding:Point in time:^Patient:Ordinal formation in children with nephrotic syndrome not due to minimal change disease., To study the evidence-based therapy of Edema:Finding:Point in time:^Patient:Ordinal in nephrotic syndrome by analyzing the literatures systematically., Edema is the prominent feature of nephrotic syndrome and initially develops around the Eye and legs., Intussusception should be considered in the differential diagnosis of Abdominal Pain in patients with nephrotic syndrome, especially in patients exhibiting prolonged Edema:Finding:Point in time:^Patient:Ordinal., Edema is the commonest presenting symptom and sign in nephrotic syndrome., Other signs and symptoms of nephrotic syndrome at baseline (serum albumin < 3.5 g/dL, serum total cholesterol > 260 mg/dL or use of a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (disposition), and Edema:Finding:Point in time:^Patient:Ordinal or use of a Loop Diuretic [EPC]); progression of Chronic Kidney Diseases during follow-up (doubling of baseline serum creatinine level or requirement for dialysis or kidney transplantation).[SEP]Relations: Edema has relations: disease_phenotype_positive with nephrotic syndrome,, disease_phenotype_positive with nephrotic syndrome,, disease_phenotype_positive with congenital nephrotic syndrome, Finnish type, disease_phenotype_positive with congenital nephrotic syndrome, Finnish type. Nephrotic Syndrome has relations: phenotype_phenotype with Abnormal renal physiology, phenotype_phenotype with Abnormal renal physiology, phenotype_phenotype with Transient nephrotic syndrome, phenotype_phenotype with Transient nephrotic syndrome, phenotype_phenotype with Congenital nephrotic syndrome, phenotype_phenotype with Congenital nephrotic syndrome. Definitions: furosemide defined as following: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.. Steroid-Sensitive Nephrotic Syndrome defined as following: Nephrotic Syndrome, occurring in the pediatric population, characterized by the normalization of Proteinuria with the administration of corticosteroids.. Edema of lower extremity defined as following: An abnormal accumulation of excess fluid in the lower extremity resulting in swelling of the feet and extending upward to the lower leg. [HPO:probinson]. Edema defined as following: Abnormal fluid accumulation in TISSUES or body cavities. Most cases of Edema:Finding:Point in time:^Patient:Ordinal are present under the SKIN in SUBCUTANEOUS TISSUE.. tolvaptan defined as following: An orally bioavailable, selective, arginine vasopressin receptor 2 (V2, AVPR2) antagonist that can be used to treat hyponatremia. Upon oral administration, tolvaptan selectively and competitively binds to and blocks the V2 receptor located in the walls of the vasculature and luminal membranes of renal collecting ducts, thereby preventing the binding of vasopressin to the V2 receptor. This prevents Water - Specimen Source Codes absorption in the Both kidneys and increases the excretion of electrolyte-free Water - Specimen Source Codes via the Both kidneys. This reduces intravascular volume and increases serum sodium concentrations and osmolality.. Kidney biopsy defined as following: Removal of tissue from the kidney, for microscopic examination.. tiopronin defined as following: An acylated sulfhydryl-containing derivative of glycine with reducing and complexing properties. Tiopronin breaks the disulphide bond of cystine and binds the sulfhydryl group of the resultant cysteine monomers to form a soluble tiopronin-cysteine-mixed disulfide, which is more Water - Specimen Source Codes-soluble than cystine and is readily excreted. This leads to a reduction in urinary cystine concentration and subsequently reduces cystine stone formation.. Chronic Kidney Diseases defined as following: Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.. Supernumerary mandibular left lateral primary incisor defined as following:

Supernumerary mandibular left lateral primary incisor

. Dyspnea defined as following: Difficult or labored breathing.. IGA Glomerulonephritis defined as following: A chronic form of glomerulonephritis characterized by deposits of predominantly IMMUNOGLOBULIN A in the mesangial area (GLOMERULAR MESANGIUM). Deposits of COMPLEMENT C3 and IMMUNOGLOBULIN G are also often found. Clinical features may progress from asymptomatic HEMATURIA to END-STAGE KIDNEY DISEASE.. Oliguria defined as following: Decreased URINE output that is below the normal range. Oliguria can be defined as urine output of less than or equal to 0.5 or 1 ml/kg/hr depending on the age.. Hypoalbuminemia defined as following: A condition in which albumin level in blood (SERUM ALBUMIN) is below the normal range. Hypoalbuminemia may be due to decreased hepatic albumin synthesis, increased albumin catabolism, altered albumin distribution, or albumin loss through the urine (ALBUMINURIA).. Steroid-resistant nephrotic syndrome defined as following: A form of nephrotic syndrome that does not respond to treatment with steroid medication, defined as persistent Proteinuria despite 60mg/m2 or 2mg/kg for 8 weeks, after insuring no Communicable Diseases or non-adherence to medication. [Eurenomics:ewuehl, ORCID:0000-0002-2234-4248, PMID:29910038]. Proteinuria defined as following: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.. Kidney Failure defined as following: A severe irreversible decline in the ability of Both kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.. Pituitary Gland defined as following: A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk which is called the INFUNDIBULUM.. Eye defined as following: The organ of sight constituting a pair of globular organs made up of a three-layered roughly spherical structure specialized for receiving and responding to light.. AA amyloidosis defined as following: Extracellular tissue deposition of fibrils that are composed of fragments of and/or intact serum amyloid A protein, a hepatic acute phase reactant. [ORCID:0000-0003-3411-9598, PMID:29261990]. Abdominal Pain defined as following: Sensation of discomfort, distress, or agony in the abdominal region.. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.. Hypertensive disease defined as following: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), Hypertensive disease is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.. Hypercholesterolemia result defined as following: A laboratory test result indicating an increased amount of cholesterol in the blood.. Nephrotic Syndrome defined as following: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.. Diabetic Retinopathy defined as following: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.. Hyperlipoproteinemias defined as following: Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation.. Hyperlipidemia defined as following: Conditions with excess LIPIDS in the blood.. nephrotic syndrome defined as following: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction..", "label": "yes"} {"original_question": "Is zolpidem an antibiotic?", "id": "converted_1215", "sentence1": "Is zolpidem an antibiotic?", "sentence2": "Zolpidem is a short-acting imidazopyridine hypnotic drug that is metabolized mainly by taurochenodeoxycholate 6alpha-hydroxylase activity., FGIN-1-27 and alpidem, like the neurosteroid 3 alpha,21-dehydroxy-5 alpha-pregnane-20-one (tetrahydrodeoxycorticosterone), clonazepam and zolpidem (the direct allosteric modulators of GABA Receptor) delay the onset of isoniazid and metrazol-induced convulsions., olpidem is a new, short-acting hypnotic of imidazopyridine structure which binds selectively to a subpopulation of receptors involved in the action of Benzodiazepines [omega 1 (BZ1) sites of the GABA Receptor], lpidem is a new, short-acting hypnotic of imidazopyridine structure which binds selectively to a subpopulation of receptors involved in the action of Benzodiazepines [omega 1 (BZ1) sites of the GABA Receptor], In contrast, after repeated treatment with zolpidem, there was no change in its ability to produce sedative and anticonvulsant effects., Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects., Zolpidem [N,N,6-trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide hemitartrate] is reported to be a rapid onset, short duration hypnotic that interacts at the Benzodiazepine [EPC] recognition site., The imidazopyridine zolpidem is a short-acting hypnotic chemically distinct from Benzodiazepines (Hamartoma Syndrome, Multiple)., According to its peculiar neuropharmacologic activity (selectivity for the omega 1-BZ receptors), zolpidem is expected to be a pure hypnotic, without the other effects of Hamartoma Syndrome, Multiple.[SEP]Relations: Zolpidem has relations: drug_drug with Antipyrine, drug_drug with Antipyrine, drug_drug with Diacerein, drug_drug with Diacerein, drug_drug with Zotepine, drug_drug with Zotepine, drug_drug with Vitamin E, drug_drug with Vitamin E, drug_drug with Medazepam, drug_drug with Medazepam. Definitions: taurochenodeoxycholate 6alpha-hydroxylase activity defined as following: Catalysis of the reactions: taurochenodeoxycholate + NADPH + H+ + O2 = taurohyocholate + NADP+ + H2O, and lithocholate + NADPH + H+ + O2 = hyodeoxycholate + NADP+ + H2O. [RHEA:23644]. GABA Receptor defined as following: Cell-surface proteins that bind GAMMA-AMINOBUTYRIC ACID with high affinity and trigger changes that influence the behavior of cells. GABA-A receptors control chloride channels formed by the receptor complex itself. They are blocked by bicuculline and usually have modulatory sites sensitive to Benzodiazepines and barbiturates. GABA-B receptors act through G-proteins on several effector systems, are insensitive to bicuculline, and have a high affinity for L-baclofen.. zolpidem defined as following: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.. Hamartoma Syndrome, Multiple defined as following: A hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Facial trichilemmomas and papillomatous papules of the oral mucosa are the most characteristic lesions. Individuals with this syndrome have a high risk of BREAST CANCER; THYROID CANCER; and ENDOMETRIAL CANCER. This syndrome is associated with mutations in the gene for PTEN PHOSPHATASE.. Benzodiazepines defined as following: A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring.. clonazepam defined as following: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.. isoniazid defined as following: Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis..", "label": "no"} {"original_question": "Is the HRC Ser96Ala variant associated with sudden cardiac death in patients with dilated cardiomyopathy?", "id": "converted_1466", "sentence1": "Is the HRC Ser96Ala Variant associated with sudden cardiac death in patients with Cardiomyopathy, Dilated?", "sentence2": "The Ser96Ala genetic Variant of HRC is associated with life-threatening Ventricular arrhythmia in idiopathic 3',5'-dichloromethotrexate and may serve as an independent predictor of susceptibility to arrhythmogenesis in the setting of 3',5'-dichloromethotrexate., The Ser96Ala (S96A) mutation within the histidine rich Ca(2+) binding protein (HRC) has recently been linked to Cardiac Arrhythmia in Idiopathic dilation cardiomyopathy patients, potentially attributable to an increase in spontaneous Ca(2+) release events., A Homo sapiens genetic Variant (Ser96Ala) in the Sarcoplasmic Reticulum (SR) histidine-rich Ca(2+)-binding (HRC) protein has been linked to Ventricular Arrhythmia by ECG Finding and Sudden death in Cardiomyopathy, Dilated., The histidine-rich calcium binding protein (HRC) Ser96Ala Genetic Polymorphism was shown to correlate with Ventricular arrhythmia and Sudden death only in Cardiomyopathy, Dilated patients but not in healthy Homo sapiens carriers., HRC has been linked with familiar cardiac conduction disease and an HRC Genetic Polymorphism was shown to associate with malignant Ventricular arrhythmia in the background of Idiopathic dilation cardiomyopathy., A Homo sapiens genetic Variant (Ser96Ala) in the Sarcoplasmic Reticulum (SR) histidine-rich Ca(2+)-binding (HRC) protein has been linked to Ventricular Arrhythmia by ECG Finding and Sudden death in Cardiomyopathy, Dilated, The Ser96Ala genetic Variant of HRC is associated with life-threatening Ventricular arrhythmia in idiopathic 3',5'-dichloromethotrexate and may serve as an independent predictor of susceptibility to arrhythmogenesis in the setting of 3',5'-dichloromethotrexate., The histidine-rich calcium binding protein (HRC) Ser96Ala Genetic Polymorphism was shown to correlate with Ventricular arrhythmia and Sudden death only in Cardiomyopathy, Dilated patients but not in healthy Homo sapiens carriers, The Ser96Ala Variant in HRC gene is associated with life-threatening Ventricular arrhythmia in Idiopathic dilation cardiomyopathy., These findings indicate that the HRC Ser96Ala Variant increases the propensity of arrhythmogenic Ca(2+) waves in the stressed failing Chest>Heart, suggesting a link between this genetic Variant and life-threatening Ventricular arrhythmia in Homo sapiens carriers.[SEP]Relations: Cardiomyopathy, Dilated has relations: disease_phenotype_positive with Sudden cardiac death, disease_phenotype_positive with Sudden cardiac death, disease_phenotype_positive with Sudden death, disease_phenotype_positive with Sudden death, disease_protein with SLC22A5, disease_protein with SLC22A5, disease_protein with ABCC9, disease_protein with ABCC9. Sudden death has relations: disease_phenotype_positive with Cardiomyopathy, Dilated, disease_phenotype_positive with Cardiomyopathy, Dilated. Definitions: Ventricular Arrhythmia by ECG Finding defined as following: An electrocardiographic finding of an atypical cardiac rhythm resulting from a pathologic process in the cardiac ventricles.. Variant defined as following: An alteration or difference from a norm or standard.. Homo sapiens defined as following: Members of the species Homo sapiens.. Sarcoplasmic Reticulum defined as following: A network of tubules and sacs in the cytoplasm of SKELETAL MUSCLE FIBERS that assist with muscle contraction and relaxation by releasing and storing calcium ions.. Cardiomyopathy, Dilated defined as following: Cardiomyopathy which is characterized by dilation and contractile dysfunction of the left and right ventricles. It may be idiopathic, or it may result from a myocardial infarction, myocardial infection, or alcohol abuse. It is a cause of congestive Chest>Heart failure.. Genetic Polymorphism defined as following: The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.. Ventricular arrhythmia defined as following: A disorder characterized by an electrocardiographic finding of an atypical cardiac rhythm resulting from a pathologic process in the cardiac ventricles.. Cardiac Arrhythmia defined as following: Any disturbances of the normal rhythmic beating of the Chest>Heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.. Sudden death defined as following: The abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions.. 3',5'-dichloromethotrexate defined as following: A chlorinated methotrexate derivative. Dichloromethotrexate inhibits the enzyme dihydrofolate reductase, thereby preventing the synthesis of purine nucleotides and thymidylates and inhibiting DNA and RNA synthesis. This agent is metabolized and excreted by the liver. (NCI04). sudden cardiac death defined as following: Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing Chest>Heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005).", "label": "yes"} {"original_question": "Does clinical trial data support the use of minocycline for amyotrophic lateral sclerosis?", "id": "converted_3371", "sentence1": "Does clinical trial data support the use of minocycline for amyotrophic lateral sclerosis?", "sentence2": "Two double-blind, randomized, placebo-controlled feasibility trials of minocycline in Amyotrophic Lateral Sclerosis were conducted. , This pilot study shows that minocycline and riluzole can be taken safely together. Further trials are needed to assess efficacy of such treatment., It reduces apoptosis in mouse models of Huntington's disease and familial amyotrophic lateral sclerosis (Amyotrophic Lateral Sclerosis) and is in clinical trial for sporadic Amyotrophic Lateral Sclerosis., Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial., FINDINGS: ALSFRS-R score deterioration was faster in the minocycline group than in the placebo group (-1.30 vs -1.04 units/month, 95% CI for difference -0.44 to -0.08; p=0.005). Patients on minocycline also had non-significant tendencies towards faster decline in FVC (-3.48 vs -3.01, -1.03 to 0.11; p=0.11) and MMT score (-0.30 vs -0.26, -0.08 to 0.01; p=0.11), and greater mortality during the 9-month treatment phase (hazard ratio=1.32, 95% CI 0.83 to 2.10; p=0.23) than did patients on placebo. Quality-of-life scores did not differ between the treatment groups. , INTERPRETATION: Our finding that minocycline has a harmful effect on patients with Amyotrophic Lateral Sclerosis has implications for trials of minocycline in patients with other nervous system disorder, and for how potential neuroprotective agents are screened for use in patients with Amyotrophic Lateral Sclerosis., A recent publication of the results of a clinical trial of minocycline in 412 Amyotrophic Lateral Sclerosis patient has aroused considerable controversy in the Amyotrophic Lateral Sclerosis scientific community. As on previous occasions, the results obtained in the laboratory are not reproduced in clinical practice., A recent publication of the results of a clinical trial of minocycline in 412 Amyotrophic Lateral Sclerosis patient has aroused considerable controversy in the Amyotrophic Lateral Sclerosis scientific community., INTERPRETATION\n\nOur finding that minocycline has a harmful effect on patients with Amyotrophic Lateral Sclerosis has implications for trials of minocycline in patients with other nervous system disorder, and for how potential neuroprotective agents are screened for use in patients with Amyotrophic Lateral Sclerosis., A recent publication of the results of a clinical trial of minocycline in 412 Amyotrophic Lateral Sclerosis patient has aroused considerable controversy in the Amyotrophic Lateral Sclerosis scientific community, A recent publication of the results of a clinical trial of minocycline in 412 Amyotrophic Lateral Sclerosis patient has aroused considerable controversy in the Amyotrophic Lateral Sclerosis scientific community., Our finding that minocycline has a harmful effect on patients with Amyotrophic Lateral Sclerosis has implications for trials of minocycline in patients with other nervous system disorder, and for how potential neuroprotective agents are screened for use in patients with Amyotrophic Lateral Sclerosis., Patients on minocycline also had non-significant tendencies towards faster decline in FVC (-3.48 vs -3.01, -1.03 to 0.11; p=0.11) and MMT score (-0.30 vs -0.26, -0.08 to 0.01; p=0.11), and greater mortality during the 9-month treatment phase (hazard ratio=1.32, 95% CI 0.83 to 2.10; p=0.23) than did patients on placebo.[SEP]Relations: Minocycline has relations: drug_drug with Metacycline, drug_drug with Metacycline, drug_drug with Doxycycline, drug_drug with Doxycycline, drug_drug with Hypericin, drug_drug with Hypericin, drug_drug with Diphenadione, drug_drug with Diphenadione, drug_drug with Maprotiline, drug_drug with Maprotiline. Definitions: Amyotrophic Lateral Sclerosis defined as following: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94). nervous system disorder defined as following: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.. riluzole defined as following: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.. minocycline defined as following: A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.. amyotrophic lateral sclerosis defined as following: An inherited form of amyotrophic lateral sclerosis, usually inherited in an autosomal dominant pattern, caused by mutation(s) in the SOD1 gene, encoding superoxide dismutase..", "label": "no"} {"original_question": "Do de novo truncating mutations in WASF1 cause cancer?", "id": "converted_3284", "sentence1": "Do de novo truncating mutations in WASF1 gene cause cancer?", "sentence2": "De Novo Truncating Gene Mutation in WASF1 gene gene Cause Intellectual Disability with Seizures., Here, using exome sequencing and whole-genome sequencing, we identified three de novo truncating mutations in WASF2 gene (WASF1 gene gene) in five unrelated individuals with moderate to profound Intellectual Disability with autistic features and Seizures. WASF1 gene gene, also known as WAVE1, is part of the SCAR complex and acts as a mediator between Rac-GTPase and actin to induce actin polymerization. The three mutations connected by Matchmaker Exchange were c.1516C>T (p.Arg506Ter), which occurs in three unrelated individuals, c.1558C>T (p.Gln520Ter), and c.1482delinsGCCAGG (p.Ile494MetfsTer23). All three Variant are predicted to partially or fully disrupt the C-terminal actin-binding WCA domain. Functional studies using Fibroblasts from two affected individuals with the c.1516C>T mutation showed a truncated WASF1 gene gene and a defect in actin remodeling. This study provides evidence that de novo heterozygous mutations in WASF1 gene gene cause a rare form of Intellectual Disability.[SEP]Relations: Seizure has relations: disease_phenotype_positive with neurofibromatosis type 1 due to NF1 mutation or intragenic deletion, disease_phenotype_positive with neurofibromatosis type 1 due to NF1 mutation or intragenic deletion, disease_phenotype_positive with hyperinsulinism due to HNF1A deficiency, disease_phenotype_positive with hyperinsulinism due to HNF1A deficiency, disease_phenotype_positive with hyperinsulinism due to UCP2 deficiency, disease_phenotype_positive with hyperinsulinism due to UCP2 deficiency, disease_phenotype_positive with lissencephaly due to LIS1 mutation, disease_phenotype_positive with lissencephaly due to LIS1 mutation. SCAR complex has relations: cellcomp_protein with WASF1 gene, cellcomp_protein with WASF1 gene. Definitions: Variant defined as following: An alteration or difference from a norm or standard.. Fibroblasts defined as following: Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules.. Seizures defined as following: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent Seizures are usually referred to as EPILEPSY or \"seizure disorder.\". SCAR complex defined as following: A pentameric complex that includes orthologues of human PIR121, Nap1, Abi, SCAR, and HSPC300 and regulates actin polymerization and/or depolymerization through small GTPase mediated signal transduction. [GOC:hla, GOC:pg, PMID:12181570, PMID:24036345, PMID:24630101]. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. WASF2 gene defined as following: This gene is involved in both the mediation of signal transduction and the regulation of cytoskeletal reorganization.. Intellectual Disability defined as following: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an Intellectual Disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28). cancer defined as following: A malignant tumor at the original site of growth..", "label": "no"} {"original_question": "Do lincRNAs play a role in human cancer?", "id": "converted_691", "sentence1": "Do lincRNAs play a role in Homo sapiens Primary malignant neoplasm?", "sentence2": "Long Intergenic Non-Protein Coding RNA H19 Imprinted Maternal Untranslated mRNA Imprinted Maternal Untranslated mRNA increases bladder Primary malignant neoplasm metastasis, These data suggest that upregulated H19 Imprinted Maternal Untranslated mRNA Imprinted Maternal Untranslated mRNA enhances bladder Primary malignant neoplasm metastasis by associating with EZH2 protein, Homo sapiens protein, Homo sapiens and inhibiting E-cad expression, lncRNA H19 Imprinted Maternal Untranslated mRNA Imprinted Maternal Untranslated mRNA is essential for Homo sapiens Specimen Source Codes - Specimen Source Codes - tumor growth, Previous reports have demonstrated that HOTAIR gene gene associates with chromatin modifications in cooperation with the Polycomb complex Polycomb Repressive Complex 2, and promotes Breast and colorectal Primary malignant neoplasm metastasis, although the clinical significance of HOTAIR gene gene expression in altretamine/cisplatin/cyclophosphamide protocol may not be as pronounced as that in Breast and Colorectal Carcinoma, the current study demonstrates that HOTAIR gene gene expression is associated with altretamine/cisplatin/cyclophosphamide protocol progression, warranting further studies., Long Intergenic Non-Protein Coding RNA HOTAIR gene gene is an independent prognostic marker for Nasopharyngeal carcinoma progression and survival, Long Intergenic Non-Protein Coding RNA influences radiosensitivity of colorectal carcinoma cell lines by regulating Cyclin D1 expression, Long Intergenic Non-Protein Coding RNA Urothelial Carcinoma associated 1 (UCA1 gene gene) promotes Homo sapiens bladder Primary malignant neoplasm cell proliferation, but the underlying mechanism remains unknown, UCA1 gene gene regulated cell cycle through Cyclic AMP-Responsive DNA-Binding Protein via PI3K-AKT dependent pathway in bladder Primary malignant neoplasm., Long Intergenic Non-Protein Coding RNA UCA1 gene gene regulated cell cycle distribution via Cyclic AMP-Responsive DNA-Binding Protein through PI3-K dependent pathway in bladder carcinoma cells, overexpression of Yiya promotes cell cycle progression at the G1/S transition, therefore identifying Yiya as a cell-cycle-associated long non-coding RNA, The long noncoding RNA HOTAIR gene gene has been reported as a poor prognostic biomarker in patients with Breast Primary malignant neoplasm. The aim of the present study is to examine the expression pattern of HOTAIR gene gene in Liver carcinoma (altretamine/cisplatin/cyclophosphamide protocol) and its clinical significance as well as its biological role in Specimen Source Codes - Specimen Source Codes - tumor progression, The high expression level of HOTAIR gene gene in altretamine/cisplatin/cyclophosphamide protocol could be a candidate biomarker for predicting Specimen Source Codes - Specimen Source Codes - tumor recurrence in altretamine/cisplatin/cyclophosphamide protocol patients who have undergone liver transplant therapy and might be a potential therapeutic target, Long Intergenic Non-Protein Coding RNA ANRIL is required for the Polycomb Repressive Complex 2 recruitment to and silencing of p15(INK4B) Specimen Source Codes - Specimen Source Codes - tumor suppressor gene, A 42 kb region on Homo sapiens chromosome 9p21 encodes for three distinct Tumor Suppressor Genes, p16(INK4A), p14(ARF) and p15(INK4B), and is altered in an estimated 30-40% of Homo sapiens Neoplasms, These results advance our understanding of the role of NPTN-IT1 gene as a regulator of Hypoxia, CTCAE signaling and offer new avenues for therapeutic intervention against Primary malignant neoplasm progression., Silencing MALAT1 gene gene is a potential novel therapeutic approach for this Primary malignant neoplasm.[SEP]Relations: Protein S Homo sapiens has relations: drug_drug with Linsidomine, drug_drug with Linsidomine, drug_drug with Ximelagatran, drug_drug with Ximelagatran, drug_drug with Melagatran, drug_drug with Melagatran, drug_drug with Vinblastine, drug_drug with Vinblastine, drug_drug with Letaxaban, drug_drug with Letaxaban. Definitions: EZH2 protein, Homo sapiens defined as following: Histone-lysine N-methyltransferase EZH2 protein, Homo sapiens (746 aa, ~85 kDa) is encoded by the Homo sapiens EZH2 protein, Homo sapiens gene. This protein is involved in the regulation of chromatin modification.. Primary malignant neoplasm defined as following: A malignant Specimen Source Codes - tumor at the original site of growth.. HOTAIR gene defined as following: This gene plays a role in the repression of HOXD gene expression.. Breast defined as following: In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.. Colorectal Carcinoma defined as following: A malignant epithelial neoplasm that arises from the colon or rectum and invades through the muscularis mucosa into the submucosa. The vast majority are adenocarcinomas.. Polycomb Repressive Complex 2 defined as following: A multisubunit polycomb protein complex that catalyzes the METHYLATION of chromosomal HISTONE H3. It works in conjunction with POLYCOMB REPRESSIVE COMPLEX 1 to effect EPIGENETIC REPRESSION.. Urothelial Carcinoma defined as following: A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis). It is frequently papillary.. Liver carcinoma defined as following: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated Specimen Source Codes - tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.. H19 Imprinted Maternal Untranslated mRNA defined as following: Maternally expressed exclusively and developmentally regulated Homo sapiens putative Specimen Source Codes - tumor suppressor H19 Imprinted Maternal Untranslated mRNA Gene encodes H19 Imprinted Maternal Untranslated mRNA Imprinted Maternal Untranslated mRNA. Expression in developing skeletal and smooth muscles correlates with specific differentiation events. It accumulates during skeletal muscle development with maximal adult expression and correlates with the nonproliferative, actin-positive muscle cell phenotype. Loss of H19 Imprinted Maternal Untranslated mRNA expression may be involved in Wilms tumorigenesis. (NCI). MALAT1 gene defined as following: Metastasis-associated lung adenocarcinoma transcript 1 (~8.7 kb) is encoded by the Homo sapiens MALAT1 gene gene. This non-coding RNA may play a role in Primary malignant neoplasm and metastasis.. Tumor Suppressor Genes defined as following: Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When Specimen Source Codes - tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible.. Nasopharyngeal carcinoma defined as following: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this Primary malignant neoplasm have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.. Hypoxia, CTCAE defined as following: A disorder characterized by a decrease in the level of oxygen in the body.. Breast Primary malignant neoplasm defined as following: A primary or metastatic malignant neoplasm involving the Breast. The vast majority of cases are carcinomas arising from the Breast parenchyma or the nipple. Malignant Breast neoplasms occur more frequently in females than in males.. Cyclic AMP-Responsive DNA-Binding Protein defined as following: Ubiquitously or widely expressed Homo sapiens cAMP Responsive Element Binding Proteins (bZIP/Cyclic AMP-Responsive DNA-Binding Protein Family) are conserved nuclear bZIP domain dimeric transcription factors that bind to octameric DNA palindrome cAMP-response elements (CRE) present in many viral and cellular promoters and induce gene transcription in response to cAMP signaling pathways. Cyclic AMP-Responsive DNA-Binding Protein proteins bind to DNA as a homodimer or a heterodimer with JUN/c-Jun or ATF2/CREBP1. Increased cAMP levels following stimulation activate cAMP-dependent protein kinase A, which phosphorylates Cyclic AMP-Responsive DNA-Binding Protein proteins that stimulate transcription of cAMP-responsive genes. Calcium-regulated Cyclic AMP-Responsive DNA-Binding Protein transcription factors integrate calcium and cAMP signals. cAMP pathways provide a chief means by which cellular growth, differentiation, and function can be influenced by extracellular signals. (NCI). Cyclin D1 defined as following: Protein encoded by the bcl-1 gene which plays a critical role in regulating the cell cycle. Overexpression of Cyclin D1 is the result of bcl-1 rearrangement, a t(11;14) translocation, and is implicated in various neoplasms.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Long Intergenic Non-Protein Coding RNA defined as following: A molecule of RNA 200-17000 nucleotides in length that is transcribed by non-protein coding areas of DNA. These ribonucleotides may play a role in a variety of biological processes.. Homo sapiens defined as following: Members of the species Homo sapiens.. bladder Primary malignant neoplasm defined as following: A primary or metastatic malignant neoplasm involving the bladder.. lincRNAs defined as following: A molecule of RNA 200-17000 nucleotides in length that is transcribed by non-protein coding areas of DNA. These ribonucleotides may play a role in a variety of biological processes..", "label": "yes"} {"original_question": "Is amantadine ER the first approved treatment for akinesia?", "id": "converted_3608", "sentence1": "Is amantadine ER the first approved treatment for akinesia?", "sentence2": "Extended-release amantadine (amantadine ER) is the first approved medication for the treatment of Dyskinetic syndrome.[SEP]Relations: genetic syndromic Pierre Robin syndrome has relations: disease_disease with tarp syndrome, disease_disease with tarp syndrome, disease_disease with Pierre Robin syndrome associated with branchial archs anomalies, disease_disease with Pierre Robin syndrome associated with branchial archs anomalies, disease_disease with Pierre Robin syndrome associated with bone disease, disease_disease with Pierre Robin syndrome associated with bone disease, disease_disease with Pierre Robin syndrome associated with collagen disease, disease_disease with Pierre Robin syndrome associated with collagen disease, disease_disease with syndrome or malformation associated with head and neck malformations, disease_disease with syndrome or malformation associated with head and neck malformations. Definitions: Dyskinetic syndrome defined as following: Abnormal involuntary movements which primarily affect the extremities, trunk, or jaw that occur as a manifestation of an underlying disease process. Conditions which feature recurrent or persistent episodes of Dyskinetic syndrome as a primary manifestation of disease may be referred to as Dyskinetic syndrome syndromes (see MOVEMENT DISORDERS). Dyskinesias are also a relatively common manifestation of BASAL GANGLIA DISEASES.. amantadine defined as following: An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake.. akinesia defined as following: Lack of movement.. ER defined as following: A system of cisternae in the CYTOPLASM of many cells. In places the endoplasmic reticulum is continuous with the plasma membrane (CELL MEMBRANE) or outer membrane of the nuclear envelope. If the outer surfaces of the endoplasmic reticulum membranes are coated with ribosomes, the endoplasmic reticulum is said to be rough-surfaced (ENDOPLASMIC RETICULUM, ROUGH); otherwise it is said to be smooth-surfaced (ENDOPLASMIC RETICULUM, SMOOTH). (King & Stansfield, A Dictionary of Genetics, 4th ed).", "label": "no"} {"original_question": "Is the mouse Sry gene locus free of repetitive sequences?", "id": "converted_2007", "sentence1": "Is the Mouse antigen SRY protein, human Genes locus free of repetitive sequences?", "sentence2": "We demonstrate that the presence of long inverted repeats (LYRIC Indeterminate Response) flanking the Mouse antigen SRY protein, human Genes leads to the formation of the SRY protein, human circular transcript in Cultured Cells, Circularization requires the presence of both LYRIC Indeterminate Response. As few as 400 complementary nt are necessary for this process, The presence of the LYRIC Indeterminate Response does not significantly stimulate intermolecular annealing and trans-splicing in vivo, We have found that in an in vitro assay, the SRY protein binds to several sites of the SRY protein, human Genes and especially to a (CA)25 Sequence - ParameterizedDataType and to a (CAG)30 Repeat Object, The Q-rich domain of the Mouse antigen sex determining Genes, SRY protein, human, is encoded by an in-frame insertion of a repetitive Sequence - ParameterizedDataType composed of mostly CAG repeats., Inverted Repeat Object structure of the SRY protein, human locus in CASP14 Genes., We performed separate amplifications of DXZ4 repetitive satellite sequences on the X Chromosome, and SRY Genes - testis determined factor on the Y Chromosome, using nested PCR, Detailed analysis of the SRY protein, human genomic locus reveals a further difference in that the Mouse antigen SRY protein, human open reading frame lies within 2.8 kilobases of unique Sequence - ParameterizedDataType at the center of a large inverted Repeat Object. , Detailed analysis of the SRY protein, human genomic locus reveals a further difference in that the Mouse antigen SRY protein, human open reading frame lies within 2.8 kilobases of unique Sequence - ParameterizedDataType at the center of a large inverted Repeat Object., The Mouse antigen genomic SRY protein, human locus is characterized by two arms of a large inverted Repeat Object, flanking a unique Geographic Locations that, between an acceptor and a Splice Donor Site, contains a single Exons encoding the SRY protein, human protein., Recombination involving the Repeat Object Geographic Locations may have led to an 11-kilobase deletion, precisely excising SRY protein, human in a line of XY female CASP14 Genes., Repetitive element analysis revealed numerous LINE-L1 elements at regions where Conservation is lost among the SRY protein, human copies., Inverted Repeat Object structure of the SRY protein, human locus in CASP14 Genes.[SEP]Relations: mRNA splice site selection has relations: bioprocess_protein with SRSF6, bioprocess_protein with SRSF6, bioprocess_protein with SRSF1, bioprocess_protein with SRSF1, bioprocess_protein with SRSF9, bioprocess_protein with SRSF9, bioprocess_protein with SRSF5, bioprocess_protein with SRSF5, bioprocess_protein with SRSF10, bioprocess_protein with SRSF10. Definitions: Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. SRY protein, human Genes defined as following: The primary testis-determining Genes in mammalians, located on the Y CHROMOSOME. It codes for a high mobility group box transcription factor (TRANSCRIPTION FACTORS) which initiates the development of the TESTES from the embryonic GONADS.. Exons defined as following: The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA.. Cultured Cells defined as following: Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.. Repeat Object defined as following: Something occurring more than once.. Conservation defined as following: The maintenance of certain characteristics in an unchanged condition.. SRY protein, human defined as following: Sex-determining Geographic Locations Y protein (204 aa, ~24 kDa) is encoded by the human SRY Genes. This protein is involved in sex determination and transcriptional regulation.. LYRIC Indeterminate Response defined as following: A lymphoma response that cannot be distinguished between flare/pseudo-progression and true progressive disease.. Geographic Locations defined as following: The continents and countries situated on those continents; the UNITED STATES and each of the constituent states arranged by Geographic Locations; CANADA and each of its provinces; AUSTRALIA and each of its states; the major bodies of water and major islands on both hemispheres; and selected major cities.. repetitive Sequence - ParameterizedDataType defined as following: Nucleotide sequences present in multiple copies in the genome. There are several types of repeated sequences. Interspersed (or dispersed) DNA repeats (Interspersed Repetitive Sequences) are copies of transposable elements interspersed throughout the genome. Flanking (or terminal) repeats (Terminal Repeat Sequences) are sequences that are repeated on both ends of a Sequence - ParameterizedDataType, for example, the long terminal repeats (LTRs) on retroviruses. Direct terminal repeats are in the same direction and inverted terminal repeats are opposite to each other in direction. Tandem repeats (Tandem Repeat Sequences) are repeated copies which lie adjacent to each other. These can also be direct or inverted. The ribosomal RNA and transfer RNA genes belong to the class of middle repetitive DNA.. Y Chromosome defined as following: The male sex chromosome, being the differential sex chromosome carried by half the male gametes and none of the female gametes in humans and in some other male-heterogametic species in which the homologue of the X Chromosome has been retained.. X Chromosome defined as following: The female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in human and other male-heterogametic species.. repetitive sequences defined as following: Nucleotide sequences present in multiple copies in the genome. There are several types of repeated sequences. Interspersed (or dispersed) DNA repeats (Interspersed Repetitive Sequences) are copies of transposable elements interspersed throughout the genome. Flanking (or terminal) repeats (Terminal Repeat Sequences) are sequences that are repeated on both ends of a Sequence - ParameterizedDataType, for example, the long terminal repeats (LTRs) on retroviruses. Direct terminal repeats are in the same direction and inverted terminal repeats are opposite to each other in direction. Tandem repeats (Tandem Repeat Sequences) are repeated copies which lie adjacent to each other. These can also be direct or inverted. The ribosomal RNA and transfer RNA genes belong to the class of middle repetitive DNA..", "label": "no"} {"original_question": "Do the proteins Talin and Amot interact?", "id": "converted_4609", "sentence1": "Do the proteins TLN1 gene and AMOT gene interact?", "sentence2": "we show that AMOT gene binds TLN1 gene and is essential for relaying forces between FN1 gene and the Microtubules associated with cytoplasmic filaments[SEP]Relations: Molecules associated with elastic fibres has relations: pathway_protein with EMILIN3, pathway_protein with EMILIN3, pathway_protein with EMILIN2, pathway_protein with EMILIN2, pathway_protein with EMILIN1, pathway_protein with EMILIN1, pathway_protein with ITGAV, pathway_protein with ITGAV, pathway_protein with ELN, pathway_protein with ELN. Definitions: AMOT gene defined as following: This gene plays a role in tight junction formation.. FN1 gene defined as following: This gene is involved in several important cellular events such as cellular adhesion and migration processes..", "label": "yes"} {"original_question": "Is pregnancy an additional risk during during H1N1 infection?", "id": "converted_62", "sentence1": "Is pregnancy an additional risk during during H1N1 Communicable Diseases?", "sentence2": "H1N1 influenza in pregnancy can be associated with severe complications, This case series confirms a high number of complications in pregnant women due to pandemic H1N1/09., Pregnant women might be at increased risk for complications from pandemic H1N1 Virus Communicable Diseases., Pregnant women are at increased risk for complications from pandemic influenza H1N1 Virus Communicable Diseases. , Vaccination of pregnant women against influenza A (H1N1) by Russian subunit formulation (MonoGrippol plus) showed reactogenicity comparable to control group by the level of influence on general metabolic and immunologic homeostasis and on the course of pregnancy, which is an evidence of its safety, Pregnancy 1 1 was identified as a major risk factor for increased mortality and morbidity due to H1N1 influenza in the pandemic of 2009 to 2010, While it is not possible to ascertain retrospectively if Myocarditis was caused by either Communicable Diseases with H1N1 Virus or as a result of pregnancy (in the absence of endomyocardial biopsies), the significant association with Myocardial involvement in both women demonstrates the increased risk of exposure to H1N1 influenza Virus in pregnant women., Although limited in size, the fully prospective nature of the safety follow-up of these women vaccinated during pregnancy is unique and offers an important degree of reassurance for the use of the AS03 adjuvanted H1N1 (2009) vaccine in this high risk group for H1N1 Communicable Diseases., During the H1N1 2009 pandemic, pregnant women constituted one of the priority groups for vaccination in many countries, creating a need for close monitoring of the safety of the vaccine in pregnant women, Emerging data suggest that pregnancy conveys high risk for severe complications from the 2009 pandemic influenza A Virus (2009 H1N1) Communicable Diseases, Pregnant women have been identified as a group at risk, both for Respiratory complication than for the admissions to the Intensive Care Unit (ICU) during the 2009 H1N1 influenza pandemic, This report mitigates substantially the presumed severity of pandemic H1N1/09 influenza Communicable Diseases during pregnancy, The results of our study do not indicate a risk for the pregnant woman and the developing embryo/fetus after H1N1 vaccination, This large cohort study found no evidence of an increased risk of Prenatal care death associated with exposure to an adjuvanted pandemic A/H1N1 2009 influenza vaccine during pregnancy, Our results suggest that second- or third-trimester H1N1 vaccination was associated with improved Prenatal care and neonatal outcomes during the recent pandemic, Pregnant women might thus be at increased risk of complications from pandemic H1N1 Virus Communicable Diseases, and Illness (finding) may progress rapidly, Pregnant women with H1N1 Communicable Diseases seem to benefit from antiviral therapy., arly identification and treatment were the most important factors in different countries and areas examined., The vaccine and antiviral drugs that have been the most efficient means to control the novel Virus appear to be safe but require more extensive study, However, there were significant differences between the two groups in relation to mean age, treatment with oseltamivir, schooling, and presence of other risk factors, To investigate whether exposure to an adjuvanted influenza A(H1N1)pdm09 vaccine during pregnancy was associated with increased risk of adverse Prenatal care outcomes., In this Danish cohort, exposure to an adjuvanted influenza A(H1N1)pdm09 vaccine during pregnancy was not associated with a significantly increased risk of major birth defects, preterm birth, or Prenatal care growth restriction, Most people affected by the Virus, including pregnant women, suffer a mild viral Illness (finding), and make a full recovery, Pregnant women, because of their altered immunity and physiological adaptations, are at higher risk of developing Pulmonary:-:Point in time:^Patient:- complications, especially in the second and third trimesters, The pregnancy outcomes were also poor for women who were affected by the Virus with a fivefold increase in the perinatal mortality rate and threefold increase in the preterm delivery rate, regnant women were at increased risk for serious outcomes of 2009 pandemic influenza A Virus subtype H1N1 (influenza A[H1N1]pdm09) Communicable Diseases, but little is known about the overall impact of the pandemic on neonatal and maternal outcomes, In this large, geographically diverse population, A(H1N1)pdm09 Communicable Diseases increased the risk for hospitalization during pregnancy, Vaccination during pregnancy with Pandemrix(®) appeared to have no ill effects on the pregnancy. On the contrary, the rate of preterm birth and low birthweight was lower than expected, which agrees with some previous results, During the influenza A(H1N1)pmd09 pandemic, although many cases occurred in younger adults, the risk factors identified for severe Infections of musculoskeletal system and complications were similar to those for seasonal influenza, including chronic respiratory, Kidney, Abdomen>Liver, and heart diseases., In terms of pregnancy, the studies have shown contradictory results due to variations in methodology and medical care., However, it seems that pregnancy, particularly during the third trimester, increases the risk of complications, and that early antiviral treatment is associated with improved outcomes., Pregnant women with mild clinical Illness (finding) secondary to 2009 H1N1 were not at a greater risk of adverse pregnancy outcomes, However, severely infected women were more likely to deliver SGA infants, Gestational age is associated with the risk of developing critical Communicable Diseases. The risk increases with increasing weeks of gestation., Following the start of winter in Liaoning province in China, the number of pregnant women infected with influenza increased significantly, regnancy, with or without additional complications, constitutes a high-risk condition for complications of influenza Communicable Diseases and warrants early intervention with neuraminidase inhibitors such as oseltamivir, if influenza is suspected[SEP]Relations: tubal pregnancy has relations: disease_disease with ectopic pregnancy, disease_disease with ectopic pregnancy. kidney has relations: anatomy_protein_present with HNF1A-AS1, anatomy_protein_present with HNF1A-AS1, anatomy_protein_present with HNF1A, anatomy_protein_present with HNF1A, anatomy_protein_present with VN1R1, anatomy_protein_present with VN1R1, anatomy_protein_present with HNF1B, anatomy_protein_present with HNF1B. Definitions: Prenatal care defined as following: Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality.. Kidney defined as following: Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.. Communicable Diseases defined as following: An Illness (finding) caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.. oseltamivir defined as following: An acetamido cyclohexene that is a structural homolog of SIALIC ACID and inhibits NEURAMINIDASE.. Myocardial defined as following: Of or pertaining to the myocardium.. Myocarditis defined as following: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.. Illness (finding) defined as following: A state of ill health, bodily malfunction, or discomfort.. Virus defined as following: Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells..", "label": "yes"} {"original_question": "Is exome sequencing efficient for the detection of germline mutations?", "id": "converted_334", "sentence1": "Is exome sequencing efficient for the detection of germline Gene Mutation?", "sentence2": "Whole exome sequencing is an efficient and sensitive method for detection of germline Gene Mutation in patients with phaeochromcytomas and PARAGANGLIOMAS 5, Whole exome sequencing is sensitive, rapid and efficient for detection of PCC/PGL germline Gene Mutation., These results from deep sequencing demonstrate a higher mutational detection rate than reported with conventional sequencing methodology., We performed exome sequencing of Germline DNA from members of the affected family. Exome-wide analysis identified a novel loss-of-function mutation in the BAP1 gene, previously suggested as a tumor suppressor., whole-exome sequencing has been widely applied in the identification of germline Gene Mutation underlying Mendelian disorders, somatic Gene Mutation in various Malignant Neoplasms and de novo Gene Mutation in Neurodevelopmental Disorders.[SEP]Relations: adaptation to pheromone regulating conjugation with mutual genetic exchange has relations: bioprocess_bioprocess with negative adaptation of signaling pathway, bioprocess_bioprocess with negative adaptation of signaling pathway, bioprocess_bioprocess with response to pheromone regulating conjugation with mutual genetic exchange, bioprocess_bioprocess with response to pheromone regulating conjugation with mutual genetic exchange, bioprocess_bioprocess with regulation of conjugation, bioprocess_bioprocess with regulation of conjugation. Paraganglioma has relations: disease_phenotype_positive with von Hippel-Lindau disease, disease_phenotype_positive with von Hippel-Lindau disease, disease_phenotype_positive with hereditary pheochromocytoma-paraganglioma, disease_phenotype_positive with hereditary pheochromocytoma-paraganglioma. Definitions: Neurodevelopmental Disorders defined as following: A childhood disorder that has a neurological basis and manifests as a developmental disability.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. BAP1 gene defined as following: This gene is involved in cellular growth regulation and is purported to have tumor suppression activity.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA..", "label": "yes"} {"original_question": "Is the Wnt protein modified by notum?", "id": "converted_282", "sentence1": "Is the Wnt protein modified by notum?", "sentence2": "NOTUM gene deacylates Wnt Proteins to suppress signalling activity., Kinetic and mass spectrometric analyses of NR4A2 protein, human show that NOTUM gene is a carboxylesterase that removes an essential palmitoleate moiety from Wnt Proteins and thus constitutes the first known extracellular protein deacylase., the Wnt PPP1R1A gene notum, the WNT-PPP1R1A gene notum.[SEP]Relations: Wnt protein secretion has relations: bioprocess_protein with WLS, bioprocess_protein with WLS, bioprocess_protein with PORCN, bioprocess_protein with PORCN, bioprocess_bioprocess with protein secretion, bioprocess_bioprocess with protein secretion. Protein S human has relations: drug_drug with Tositumomab, drug_drug with Tositumomab, drug_protein with F5, drug_protein with F5. Definitions: carboxylesterase defined as following: A family of enzymes that hydrolyze carboxylic esters.. Wnt Proteins defined as following: Wnt Proteins are a large family of secreted glycoproteins that play essential roles in EMBRYONIC AND FETAL DEVELOPMENT, and tissue maintenance. They bind to FRIZZLED RECEPTORS and act as PARACRINE PROTEIN FACTORS to initiate a variety of SIGNAL TRANSDUCTION PATHWAYS. The canonical Wnt signaling pathway stabilizes the transcriptional coactivator BETA CATENIN.. Wnt protein defined as following: Wnt Proteins are a large family of secreted glycoproteins that play essential roles in EMBRYONIC AND FETAL DEVELOPMENT, and tissue maintenance. They bind to FRIZZLED RECEPTORS and act as PARACRINE PROTEIN FACTORS to initiate a variety of SIGNAL TRANSDUCTION PATHWAYS. The canonical Wnt signaling pathway stabilizes the transcriptional coactivator BETA CATENIN..", "label": "yes"} {"original_question": "Is Mycobacterium avium less susceptible to antibiotics than Mycobacterium tuberculosis?", "id": "converted_502", "sentence1": "Is Mycobacterium avium less susceptible to Antifungal Antibiotics, Topical than Mycobacterium tuberculosis antibody?", "sentence2": "The prevalence of cyclophosphamide/doxorubicin/mitomycin protocol lung Communicable Diseases in two inner city hospitals was four times higher than that of Tuberculosis., Most patients with combined Communicable Diseases were clinically consistent with Mycobacterium tuberculosis antibody and responded to anti Mycobacterium tuberculosis antibody treatment alone., The triplex PCR developed by us could be used to detect and differentiate M. tuberculosis, M. avium and other Genus Mycobacterium in a single reaction tube., Twelve (15%) of the 80 blood cultures were positive for Genus Mycobacterium, with Mycobacterium avium being identified in 7 (8.8%) samples and M. tuberculosis in 5 (6.2%). , The antimycobacterial activities of RS-112997, RS-124922 and RS-118641, three capuramycin analogues that inhibit phospho-N-acetylmuramyl-pentapeptide translocase, were tested against clinical isolates of Mycobacterium tuberculosis antibody antibody, Mycobacterium avium and Battey Bacillus, The MIC50/90 (mg/L) results for RS-118641 were: M. tuberculosis, 1/2; multidrug-resistant (MDR) M. tuberculosis, 0.5/2; M. avium, 4/8; and M. intracellulare, 0.06/0.5, These results suggest that capuramycin analogues exhibit strong antimycobacterial potential and should be considered for further evaluation in the treatment of M. tuberculosis and M. avium-M. intracellulare complex Infections of musculoskeletal system in Homo sapiens., Mycobacterium avium causes disseminated Communicable Diseases in patients with acquired immune deficiency syndrome., Overall incidences of Mycobacterium tuberculosis antibody antibody (Tuberculosis) and Mycobacterium avium-intracellulare Infection (cyclophosphamide/doxorubicin/mitomycin protocol) were 0.8 and 1.4 cases/100 person-years of follow-up (PYF), decreasing from 1.8 (Tuberculosis) and 3.5 cases/100 PYF (cyclophosphamide/doxorubicin/mitomycin protocol) before September 1995 to 0.3 and 0.2 cases/100 PYF after March 1997., Because M tuberculosis disease is preventable and curable and yet communicable, physicians should maintain a high degree of suspicion for tuberculosis in HIV-infected adults. In comparison, the goal of treating M avium complex in patients with advanced HIV Infections is to reduce constitutional symptoms and improve survival., cyclophosphamide/doxorubicin/mitomycin protocol pulmonary disease should be considered in the differential diagnosis of SPNs, even when encountered in geographic regions with a high prevalence of Tuberculosis, Pulmonary., From April 2001 to February 2002, 80 blood samples from patients who were suspected to have disseminated mycobacterial Communicable Diseases, presenting Fever symptoms (finding) and (preferably) a CD4 T cell count<100.0 cell/mL were investigated, interleukin-10 binding activity underlies distinct susceptibility of BALB/c and C57BL/6 CASP14 gene to Mycobacterium avium Communicable Diseases and influences efficacy of Antibiotics therapy., Clinical utility of rifabutin (RBT), a potent Antibiotics used in multidrug regimens for tuberculosis (Tuberculosis) as well as for Infections of musculoskeletal system caused by Mycobacterium avium-intracellulare Infection (cyclophosphamide/doxorubicin/mitomycin protocol), has been hampered due to dose-limiting Toxic effect. , Effective therapeutic regimens exist that are limited by the emergence of drug resistance and the inability of Antifungal Antibiotics, Topical to kill dormant organisms. , Clinical utility of rifabutin (RBT), a potent Antibiotics used in multidrug regimens for tuberculosis (Tuberculosis) as well as for Infections of musculoskeletal system caused by Mycobacterium avium-intracellulare Infection (cyclophosphamide/doxorubicin/mitomycin protocol), has been hampered due to dose-limiting Toxic effect., a potent Antibiotics used in multidrug regimens for tuberculosis (Tuberculosis) as well as for Infections of musculoskeletal system caused by Mycobacterium avium-intracellulare Infection (cyclophosphamide/doxorubicin/mitomycin protocol),, Clinical utility of rifabutin (RBT), a potent Antibiotics used in multidrug regimens for tuberculosis (Tuberculosis) as well as for Infections of musculoskeletal system caused by Mycobacterium avium-intracellulare Infection (cyclophosphamide/doxorubicin/mitomycin protocol), has been hampered due to dose-limiting Toxic effect., tuberculosis appear to have different genetic mechanisms for resisting the effects of these Antifungal Antibiotics, Topical, with pks12 playing a relatively more significant role in cyclophosphamide/doxorubicin/mitomycin protocol.[SEP]Relations: tuberculosis has relations: disease_disease with mycobacterial infectious disease, disease_disease with mycobacterial infectious disease, disease_disease with tuberculosis, avian, disease_disease with tuberculosis, avian. mycobacterium avium complex disease has relations: disease_disease with mycobacterial infectious disease, disease_disease with mycobacterial infectious disease, disease_disease with primary bacterial infectious disease, disease_disease with primary bacterial infectious disease. Recurrent mycobacterium avium complex Infections of musculoskeletal system has relations: disease_phenotype_positive with monocytopenia with susceptibility to Infections of musculoskeletal system, disease_phenotype_positive with monocytopenia with susceptibility to Infections of musculoskeletal system. Definitions: Mycobacterium avium-intracellulare Infection defined as following: A nontuberculous Communicable Diseases when occurring in Homo sapiens. It is characterized by pulmonary disease, lymphadenitis in children, and systemic disease in AIDS patients. Mycobacterium avium-intracellulare Communicable Diseases of birds and swine results in tuberculosis.. Communicable Diseases defined as following: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.. Homo sapiens defined as following: Members of the species Homo sapiens.. Battey Bacillus defined as following: species found in lung lesions and secretions of Homo sapiens; may cause bone and tendon-sheath lesions in rabbits; some strains are pathogenic for CASP14 gene; linked to opportunistic Infections of musculoskeletal system in Homo sapiens; not easily distinguished from Mycobacterium avium and therefore is included in the Mycobacterium avium Complex.. rifabutin defined as following: A broad-spectrum Antibiotics that is being used as prophylaxis against disseminated Mycobacterium avium-intracellulare Infection Communicable Diseases in HIV-positive patients.. mycobacterial Communicable Diseases defined as following: Infections with bacteria of the genus MYCOBACTERIUM.. Mycobacterium tuberculosis defined as following: A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in Homo sapiens, other primates, CATTLE; DOGS; and some other animals which have contact with Homo sapiens. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation.. Tuberculosis, Pulmonary defined as following: MYCOBACTERIUM Infections of musculoskeletal system of the lung.. Toxic effect defined as following: The finding of bodily harm due to the poisonous effects of something.. interleukin-10 binding activity defined as following: Binding to interleukin-10. [GOC:jl]. Mycobacterium avium defined as following: A bacterium causing tuberculosis in domestic fowl and other birds. In pigs, it may cause localized and sometimes disseminated disease. The organism occurs occasionally in sheep and cattle. It should be distinguished from the M. avium complex, which infects primarily Homo sapiens.. HIV Infections defined as following: Includes the spectrum of human immunodeficiency virus Infections of musculoskeletal system that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).. Tuberculosis defined as following: Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS.. Antibiotics defined as following: Substances naturally produced by microorganisms or their derivatives that selectively target microorganisms not Homo sapiens. Antibiotics kill or inhibit the growth of microorganisms by targeting components of the microbial cell absent from human cells, including bacterial cell walls, cell membrane, and 30S or 50S ribosomal subunits. These substances are used in the treatment of bacterial and other microbial Infections of musculoskeletal system.. Genus Mycobacterium defined as following: A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts..", "label": "yes"} {"original_question": "Are there clinical trials using stem cells for the treatment of cardiac disease?", "id": "converted_993", "sentence1": "Are there clinical trials using Stem Cells for the treatment of cardiac disease?", "sentence2": "Therapy with mesenchymal Stem Cells is one of the promising tools to improve outcomes after Myocardial infarction:Finding:Point in time:^Patient:Ordinal. Adipose-derived Stem Cells (ASCs) are an ideal source of mesenchymal Stem Cells due to their abundance and ease of preparation., Furthermore, several ongoing clinical trials using ASCs are producing promising results for Chest>Heart diseases., Among the cell types under investigation, adult mesenchymal Stem Cells are widely studied, and in early stage, clinical studies show promise for repair and regeneration of cardiac tissues., Accumulating data from preclinical and early phase clinical trials document their safety when delivered as either autologous or allogeneic forms in a range of cardiovascular diseases, but also importantly define parameters of clinical efficacy that justify further investigation in larger clinical trials. , several ongoing clinical trials using ASCs are producing promising results for Chest>Heart diseases. , Clinical application of adult Stem Cells for therapy for cardiac disease., Stem cell-based therapies have the potential to fundamentally transform the treatment of ischemic cardiac injury and Congestive Chest>Heart failure by achieving what would have been unthinkable only a few years ago-the Holy Grail of myocardial regeneration. Recent therapeutic approaches involve bone marrow (BM)-derived mononuclear Cells and their subsets such as mesenchymal Scanning Transmission Electron Microscopy Procedures/stromal Cells (cyclic nucleotide-gated mechanosensitive ion channel activity), Endothelial Progenitor Cells as well as adipose tissue-derived cyclic nucleotide-gated mechanosensitive ion channel activity, Heart tissue-derived Stem Cells, and cell combinations. Clinical trials employing these Cells have demonstrated that cellular therapy is feasible and safe., Accumulating data from preclinical and early phase clinical trials document their safety when delivered as either autologous or allogeneic forms in a range of cardiovascular diseases, but also importantly define parameters of clinical efficacy that justify further investigation in larger clinical trials., se of Scanning Transmission Electron Microscopy Procedures and precursor Cells as a therapeutic agent for chronically injured Organ. Among the cell types under investigation, adult mesenchymal Stem Cells are widely studied, and in early stage, clinical studies show promise for repair and regeneration of cardiac tissues. , Over the past 2 decades, there have been numerous Scanning Transmission Electron Microscopy Procedures cell studies focused on Heart Diseases, ranging from proof-of-concept to phase 2 trials. , Small uncontrolled clinical trials have demonstrated cardiac Stem Cells as a treatment option for Cardiomyopathies., Stem cell populations are rapidly increasing, and we are still in the search of optimal cell types to use in clinical trials as bone marrow Stem Cells did not show significant improvement in cardiac function following transplantation., Several clinical trials using adult Scanning Transmission Electron Microscopy Procedures cell have shown improvements in cardiac function, however, the mechanism of their action is unclear and widespread tissue regeneration is not evident., As we await results from larger and more prolonged clinical trials, the science of Scanning Transmission Electron Microscopy Procedures cell therapy in cardiac disease keeps progressing., Stem cell therapy for treatment of cardiac disease has shown therapeutic potential., It should be noted that Scanning Transmission Electron Microscopy Procedures cell therapy is not limited to the treatment of ischemic cardiac disease., Over the past 2 decades, there have been numerous Scanning Transmission Electron Microscopy Procedures cell studies focused on Heart Diseases, ranging from proof-of-concept to phase 2 trials., This series of papers focuses on the legacy of these studies and the outlook for future treatment of Heart Diseases with Scanning Transmission Electron Microscopy Procedures cell therapies., Cell transplantation to repair or regenerate injured Myocardium is a new frontier in the treatment of Cardiovascular Diseases. , Current therapies only delay progression of the cardiac disease or replace the diseased Chest>Heart with cardiac transplantation. Stem Cells represent a recently discovered novel approach to the treatment of cardiac failure that may facilitate the replacement of diseased Heart tissue and subsequently lead to improved cardiac function and cardiac regeneration., Over the past 2 decades, there have been numerous Scanning Transmission Electron Microscopy Procedures cell studies focused on Heart Diseases, ranging from proof-of-concept to phase 2 trials. This series of papers focuses on the legacy of these studies and the outlook for future treatment of Heart Diseases with Scanning Transmission Electron Microscopy Procedures cell therapies., Stem cell therapy for treatment of cardiac disease has shown therapeutic potential., Over the past 2 decades, there have been numerous Scanning Transmission Electron Microscopy Procedures cell studies focused on Heart Diseases, ranging from proof-of-concept to phase 2 trials. This series of papers focuses on the legacy of these studies and the outlook for future treatment of Heart Diseases with Scanning Transmission Electron Microscopy Procedures cell therapies., It should be noted that Scanning Transmission Electron Microscopy Procedures cell therapy is not limited to the treatment of ischemic cardiac disease. Non-ischemic Cardiomyopathies, Peripheral Vascular Diseases, and aging may be treated by Stem Cells., Recent clinical trials have achieved favorable initial endpoints with improvements in cardiac function and clinical symptoms following cellular therapy., we consider how Cardiac Stem Cell biology has led us into clinical trials, and we suggest that achieving true cardiac regeneration in patients may ultimately require resolution of critical controversies in experimental cardiac regeneration., Cell-based therapies and tissue engineering provide new promising platforms to develop upcoming therapeutic options. Initial clinical trials were able to generate promising results. A variety of different Scanning Transmission Electron Microscopy Procedures cell types have been used for the clinical application. , Insights gained from clinical trials of adult Stem Cells, together with fundamental scientific advances in Cardiac Stem Cell and regenerative biology, are beginning to yield potential new targets and strategies for regenerative therapies. , Early animal trials have demonstrated the ability to improve cardiac function by transfer of Hematopoietic Stem Cells into the Myocardium, and early Homo sapiens studies have demonstrated the feasibility and safety of this approach.[SEP]Relations: cardiac germ cell tumor has relations: disease_disease with Chest>Heart neoplasm, disease_disease with Chest>Heart neoplasm, disease_disease with malignant cardiac germ cell tumor, disease_disease with malignant cardiac germ cell tumor, disease_disease with extragonadal germ cell tumor, disease_disease with extragonadal germ cell tumor. Chest>Heart disease has relations: disease_disease with cardiac ventricle disease, disease_disease with cardiac ventricle disease. Cardiovascular Diseases has relations: disease_disease with Chest>Heart disease, disease_disease with Chest>Heart disease. Definitions: Hematopoietic Stem Cells defined as following: Progenitor Cells from which all blood Cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood.. Stem Cells defined as following: Relatively undifferentiated Cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor Cells that can differentiate into specialized Cells.. Endothelial Progenitor Cells defined as following: Cells derived from BONE MARROW that circulate in the adult bloodstream and possess the potential to proliferate and differentiate into mature ENDOTHELIAL CELLS.. Congestive Chest>Heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Heart Diseases defined as following: Pathological conditions involving the HEART including its structural and functional abnormalities.. Cardiomyopathies defined as following: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).. bone marrow Stem Cells defined as following: A hematopoietic Scanning Transmission Electron Microscopy Procedures cell found in the bone marrow.. Cardiovascular Diseases defined as following: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.. mesenchymal Stem Cells defined as following: An undifferentiated stromal cell with the ability to develop into the Cells that form distinct mesenchymal tissues; such as bone, muscle, connective tissue, blood vessels, and lymphatic tissue.. adult Stem Cells defined as following: Mostly multipotent undifferentiated Stem Cells found in a specific tissue admixed with differentiated Cells.. Cardiac Stem Cell defined as following: Multipotent progenitor Cells that are found in the fetal and adult Chest>Heart that provide the Myocardium with limited regenerating capability.. cyclic nucleotide-gated mechanosensitive ion channel activity defined as following: Enables the transmembrane transfer of an ion by a channel that opens in response to a mechanical stress and when a cyclic nucleotide has been bound by the channel complex or one of its constituent parts. [GOC:jl, PMID:22206667]. Scanning Transmission Electron Microscopy Procedures defined as following: A type of TRANSMISSION ELECTRON MICROSCOPY in which the object is examined directly by an extremely narrow electron beam scanning the specimen point-by-point and using the reactions of the electrons that are transmitted through the specimen to create the image. It should not be confused with SCANNING ELECTRON MICROSCOPY.. Organ defined as following: A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues. An organ is part of an anatomic system or a body region. Representative examples include the Chest>Heart, lung, liver, spleen, and uterus.. Homo sapiens defined as following: Members of the species Homo sapiens.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Peripheral Vascular Diseases defined as following: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.. Myocardium defined as following: The muscle tissue of the HEART. It is composed of striated, involuntary muscle Cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow.. cardiac disease defined as following: Pathological conditions involving the HEART including its structural and functional abnormalities..", "label": "yes"} {"original_question": "Is Calcium/Calmodulin dependent protein kinase II (CaMKII) involved in cardiac arrhythmias and heart failure?", "id": "converted_1644", "sentence1": "Is Calcium/Calmodulin 1 dependent Calcium/calmodulin-dependent protein kinase (CAMK2A gene) involved in Cardiac Arrhythmia and Congestive Chest>Heart failure?", "sentence2": "In human Hypertrophy, both CAMK2A gene and Cyclic AMP-Dependent Protein Kinases functionally regulate Ryanodine Receptor 2 and may induce SNCG wt Allele Ca(2+) leak. In the transition from Hypertrophy to Hydrops Fetalis, the diastolic Ca(2+) leak increases and disturbed Ca(2+) cycling occurs. This is associated with an increase in CAMK2A gene- but not Cyclic AMP-Dependent Protein Kinases-dependent Ryanodine Receptor 2 phosphorylation. CAMK2A gene inhibition may thus reflect a promising therapeutic target for the treatment of arrhythmias and contractile dysfunction., Ca(2+)/calmodulin-dependent Calcium/calmodulin-dependent protein kinase (CAMK2A gene) is an Enzyme [APC] with important regulatory functions in the Chest>Heart and Head>Brain, and its chronic activation can be pathological. CAMK2A gene activation is seen in Congestive Chest>Heart failure, and can directly induce pathological changes in ion channels, Ca(2+) handling and gene transcription., In the recent years, Ca(2+)/calmodulin-dependent Calcium/calmodulin-dependent protein kinase (CAMK2A gene) was suggested to be associated with cardiac Hypertrophy and Congestive Chest>Heart failure but also with arrhythmias both in animal models as well as in the human Chest>Heart., Calcium-calmodulin-dependent Calcium/calmodulin-dependent protein kinase (CAMK2A gene) has emerged as a central mediator of cardiac stress responses which may serve several critical roles in the regulation of cardiac rhythm, cardiac contractility and growth. Sustained and excessive activation of CAMK2A gene during Heart Diseases has, however, been linked to arrhythmias, and maladaptive cardiac remodeling, eventually leading to Congestive Chest>Heart failure (Hydrops Fetalis) and Sudden Cardiac Death. , Overexpression of Ca(2+)/calmodulin-dependent Calcium/calmodulin-dependent protein kinase (CAMK2A gene) in Mice, Animals, Animals, Transgenic results in Congestive Chest>Heart failure and arrhythmias., From recent studies, it appears evident that Ca(2+)/calmodulin-dependent Calcium/calmodulin-dependent protein kinase (CAMK2A gene) plays a central role in the arrhythmogenic processes in Congestive Chest>Heart failure by sensing Protoplasm Ca(2+) and redox stress, affecting individual ion channels and thereby leading to electrical instability in the Chest>Heart. , CAMK2A gene activation is proarrhythmic in Congestive Chest>Heart failure where Myocardium is stretched., The Ca-calmodulin dependent kinase II (CAMK2A gene) seems to be involved in the development of Congestive Chest>Heart failure and arrhythmias and may therefore be a promising target for the development of antiarrhythmic therapies., Ca(2+)/calmodulin-dependent Calcium/calmodulin-dependent protein kinase (CAMK2A gene) is up-regulated in Congestive Chest>Heart failure and has been shown to cause I(Na) gating changes that mimic those induced by a Point Mutation in Homo sapiens that is associated with combined long QT and Brugada syndromes., CAMK2A gene-dependent phosphorylation of Na(V)1.5 at multiple sites (including Thr-594 and Ser-516) appears to be required to evoke loss-of-function changes in gating that could contribute to acquired Brugada Syndrome (disorder)-like effects in Congestive Chest>Heart failure., Because CAMK2A gene expression and activity are increased in cardiac Hypertrophy, Congestive Chest>Heart failure, and during arrhythmias both in animal models as well as in the human Chest>Heart a clinical significance of CAMK2A gene is implied., The multifunctional Ca(2+)- and calmodulin-dependent Calcium/calmodulin-dependent protein kinase (CAMK2A gene) is now recognized to play a central role in pathological events in the cardiovascular system. CAMK2A gene has diverse downstream targets that promote Vascular Diseases, Congestive Chest>Heart failure, and arrhythmias, so improved understanding of CAMK2A gene signaling has the potential to lead to new therapies for Cardiovascular Diseases., In our opinion, the multifunctional Ca and calmodulin-dependent Calcium/calmodulin-dependent protein kinase (CAMK2A gene) has emerged as a molecule to watch, in part because a solid body of accumulated data essentially satisfy Koch's postulates, showing that the CAMK2A gene pathway is a core mechanism for promoting myocardial Hypertrophy and Congestive Chest>Heart failure. Multiple groups have now confirmed the following: (1) that CAMK2A gene activity is increased in hypertrophied and failing Myocardium from animal models and patients; (2) CAMK2A gene overexpression causes myocardial Hypertrophy and Hydrops Fetalis and (3) CAMK2A gene inhibition (by drugs, inhibitory peptides and Gene Deletion) improves myocardial Hypertrophy and Hydrops Fetalis, In contrast, inhibiting the CAMK2A gene pathway appears to reduce arrhythmias and improve myocardial responses to pathological stimuli. , In this review, we discuss the important role of Ca(2+)/calmodulin-dependent Calcium/calmodulin-dependent protein kinase (CAMK2A gene) in the regulation of Ryanodine Receptor 2-mediated Ca(2+) release. In particular, we examine how pathological activation of CAMK2A gene can lead to an increased risk of sudden arrhythmic death. Finally, we discuss how reduction of CAMK2A gene-mediated Ryanodine Receptor 2 Hyperactive behavior might reduce the risk of arrhythmias and may serve as a rationale for future pharmacotherapeutic approaches., Animals, Animals, Transgenic (TG wt Allele wt Allele) Ca(2+)/calmodulin-dependent Calcium/calmodulin-dependent protein kinase (CAMK2A gene) δ(C) CASP14 gene develop systolic Congestive Chest>Heart failure (Hydrops Fetalis). CAMK2A gene regulates Protoplasm Ca(2+) handling Proteins as well as sarcolemmal Na(+) channels. We hypothesized that CAMK2A gene also contributes to Diastolic dysfunction and arrhythmias via augmentation of the late Na(+) current (late I(Na)) in early Hydrops Fetalis (8-week-old TG wt Allele wt Allele CASP14 gene)., Thus, late I(Na) inhibition appears to be a promising option for Diastolic dysfunction and arrhythmias in Hydrops Fetalis where CAMK2A gene is found to be increased., We tested the hypothesis that increased Ryanodine Receptor 2 phosphorylation by Ca(2+)/calmodulin-dependent Calcium/calmodulin-dependent protein kinase is both necessary and sufficient to promote lethal Ventricular arrhythmia., CONCLUSIONS: our results suggest that Ca(2+)/calmodulin-dependent Calcium/calmodulin-dependent protein kinase phosphorylation of Ryanodine Receptor 2 Ca(2+) release channels at S2814 plays an important role in arrhythmogenesis and Sudden Cardiac Death in CASP14 gene with Congestive Chest>Heart failure., Excessive activation of calmodulin kinase II (CAMK2A gene) causes arrhythmias and Congestive Chest>Heart failure, but the cellular mechanisms for CAMK2A gene-targeted Proteins causing disordered Cellular Membrane excitability and Myocardial dysfunction remain uncertain., Animals, Animals, Transgenic (TG wt Allele wt Allele) Ca/calmodulin-dependent Calcium/calmodulin-dependent protein kinase (CAMK2A gene)delta(C) CASP14 gene have Congestive Chest>Heart failure and isoproterenol (ISO)-inducible arrhythmias. We hypothesized that CAMK2A gene contributes to arrhythmias and underlying cellular events and that inhibition of CAMK2A gene reduces cardiac arrhythmogenesis in vitro and in vivo., We conclude that CAMK2A gene contributes to cardiac arrhythmogenesis in TG wt Allele wt Allele CaMKIIdelta(C) CASP14 gene having Congestive Chest>Heart failure and suggest the increased SNCG wt Allele Ca leak as an important mechanism. Moreover, CAMK2A gene inhibition reduces Cardiac Arrhythmia in vitro and in vivo and may therefore indicate a potential role for future antiarrhythmic therapies warranting further studies., Ca2+/calmodulin dependent Calcium/calmodulin-dependent protein kinase (CAMK2A gene) can phosphorylate Ryanodine Receptor 2 and modulate its activity. This phosphorylation positively modulates cardiac inotropic function but in extreme situations such as Congestive Chest>Heart failure, elevated CAMK2A gene activity can adversely increase Ca2+ release from the SNCG wt Allele and lead to arrhythmogenesis. , Calcium/calmodulin-dependent kinase II (CAMK2A gene) is a multifunctional serine/threonine kinase expressed abundantly in the Chest>Heart. CAMK2A gene targets numerous Proteins involved in excitation-contraction coupling and excitability, and its activation may simultaneously contribute to Congestive Chest>Heart failure and Cardiac Arrhythmia., Under stress conditions, excessive CAMK2A gene activity promotes Congestive Chest>Heart failure and arrhythmias, in part through actions at Ca(2+) homeostatic Proteins., Ca-calmodulin-dependent Calcium/calmodulin-dependent protein kinase (CAMK2A gene) was recently shown to alter Na(+) channel gating and recapitulate a human Na(+) channel Mutation that causes an unusual combined arrhythmogenic phenotype in patients: simultaneous long QT syndrome and Brugada Syndrome (disorder). CAMK2A gene is upregulated in Congestive Chest>Heart failure where arrhythmias are common, and CAMK2A gene inhibition can reduce arrhythmias. Thus, CAMK2A gene-dependent channel modulation may contribute to acquired arrhythmic disease. , In Congestive Chest>Heart failure (Hydrops Fetalis), Ca(2+)/calmodulin kinase II (CAMK2A gene) expression is increased. Altered Na(+) channel gating is linked to and may promote Ventricular tachyarrhythmia (Tidal Volume) in Hydrops Fetalis. Calmodulin 1 1 regulates Na(+) channel gating, in part perhaps via CAMK2A gene., Thus, CAMK2A gene-dependent regulation of Na(+) channel function may contribute to arrhythmogenesis in Hydrops Fetalis., Recent findings that CAMK2A gene expression in the Chest>Heart changes during Hypertrophy, Congestive Chest>Heart failure, Coronary Arteriosclerosis, and Infarction suggest that CAMK2A gene may be a viable therapeutic target for patients suffering from common forms of Chest>Heart disease., Overexpression of Ca(2+)/calmodulin-dependent Calcium/calmodulin-dependent protein kinase (CAMK2A gene) in Mice, Animals, Animals, Transgenic results in Congestive Chest>Heart failure and arrhythmias., Animals, Animals, Transgenic (TG wt Allele wt Allele) Ca/calmodulin-dependent Calcium/calmodulin-dependent protein kinase (CAMK2A gene)delta(C) CASP14 gene have Congestive Chest>Heart failure and isoproterenol (ISO)-inducible arrhythmias., BACKGROUND: Animals, Animals, Transgenic (TG wt Allele wt Allele) Ca/calmodulin-dependent Calcium/calmodulin-dependent protein kinase (CAMK2A gene)delta(C) CASP14 gene have Congestive Chest>Heart failure and isoproterenol (ISO)-inducible arrhythmias., CAMK2A gene targets numerous Proteins involved in excitation-contraction coupling and excitability, and its activation may simultaneously contribute to Congestive Chest>Heart failure and Cardiac Arrhythmia., Calcium/calmodulin-dependent Calcium/calmodulin-dependent protein kinase contributes to cardiac arrhythmogenesis in Congestive Chest>Heart failure., From recent studies, it appears evident that Ca(2+)/calmodulin-dependent Calcium/calmodulin-dependent protein kinase (CAMK2A gene) plays a central role in the arrhythmogenic processes in Congestive Chest>Heart failure by sensing Protoplasm Ca(2+) and redox stress, affecting individual ion channels and thereby leading to electrical instability in the Chest>Heart., Ryanodine Receptor Calcium Release Channel phosphorylation, calcium/calmodulin-dependent Calcium/calmodulin-dependent protein kinase, and life-threatening Ventricular arrhythmia., CAMK2A gene targets numerous Proteins involved in excitation-contraction coupling and excitability, and its activation may simultaneously contribute to Congestive Chest>Heart failure and Cardiac Arrhythmia, The Ca-calmodulin dependent kinase II (CAMK2A gene) seems to be involved in the development of Congestive Chest>Heart failure and arrhythmias and may therefore be a promising target for the development of antiarrhythmic therapies, Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias., Animals, Animals, Transgenic (TG wt Allele wt Allele) Ca/calmodulin-dependent Calcium/calmodulin-dependent protein kinase (CAMK2A gene)delta(C) CASP14 gene have Congestive Chest>Heart failure and isoproterenol (ISO)-inducible arrhythmias[SEP]Relations: calcium- and calmodulin-dependent protein kinase complex has relations: cellcomp_protein with CAMK2A, cellcomp_protein with CAMK2A, cellcomp_protein with CAMK2D, cellcomp_protein with CAMK2D, cellcomp_protein with CAMK2B, cellcomp_protein with CAMK2B, cellcomp_protein with CAMK2G, cellcomp_protein with CAMK2G, cellcomp_protein with CAMK1G, cellcomp_protein with CAMK1G. Definitions: Calcium/calmodulin-dependent protein kinase defined as following: A CALMODULIN-dependent Enzyme [APC] that catalyzes the phosphorylation of Proteins. This Enzyme [APC] is also sometimes dependent on CALCIUM. A wide range of Proteins can act as acceptor, including VIMENTIN; SYNAPSINS; GLYCOGEN SYNTHASE; MYOSIN LIGHT CHAINS; and the MICROTUBULE-ASSOCIATED PROTEINS. (From Enzyme Nomenclature, 1992, p277). Calmodulin 1 defined as following: Calmodulin 1 (149 aa, ~17 kDa) is encoded by the human CALM1, CALM2 and CALM3 genes. This protein plays a role in the regulation of a number of enzymes, ion channels and signaling pathways.. Diastolic dysfunction defined as following: Impairment in the filling of the ventricles during diastole. Causes include hypertrophic and restrictive cardiomyopathies, coronary artery disease, chronic high blood pressure, aortic stenosis, and aging.. Ryanodine Receptor Calcium Release Channel defined as following: A tetrameric calcium release channel in the SARCOPLASMIC RETICULUM membrane of SMOOTH MUSCLE CELLS, acting oppositely to SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES. It is important in skeletal and cardiac excitation-contraction coupling and studied by using RYANODINE. Abnormalities are implicated in CARDIAC ARRHYTHMIAS and MUSCULAR DISEASES.. Ventricular arrhythmia defined as following: A disorder characterized by an electrocardiographic finding of an atypical cardiac rhythm resulting from a pathologic process in the cardiac ventricles.. Congestive Chest>Heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Cardiac Arrhythmia defined as following: Any disturbances of the normal rhythmic beating of the Chest>Heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as Proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, Proteins, lipids, carbohydrates, and inorganic salts.. Hypertrophy defined as following: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).. Heart Diseases defined as following: Pathological conditions involving the HEART including its structural and functional abnormalities.. Tidal Volume defined as following: The volume of air inspired or expired during each normal, quiet respiratory cycle. Common abbreviations are TV or V with subscript T.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Hydrops Fetalis defined as following: Abnormal accumulation of serous fluid in two or more fetal compartments, such as SKIN; PLEURA; PERICARDIUM; PLACENTA; PERITONEUM; AMNIOTIC FLUID. General fetal EDEMA may be of non-immunologic origin, or of immunologic origin as in the case of ERYTHROBLASTOSIS FETALIS.. isoproterenol defined as following: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the Chest>Heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and Chest>Heart stimulant.. Cardiovascular Diseases defined as following: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.. Hyperactive behavior defined as following: Increased motor activity that is not goal directed.. Coronary Arteriosclerosis defined as following: Thickening and loss of elasticity of the CORONARY ARTERIES, leading to progressive arterial insufficiency (CORONARY DISEASE).. CAMK2A gene defined as following: This gene is involved in both protein phosphorylation and signaling.. Sudden Cardiac Death defined as following: Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing Chest>Heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005). myocardial Hypertrophy defined as following: Thickening of the Myocardium often due to chronic pressure overload.. TG wt Allele defined as following: Human TG wt Allele wild-type allele is located in the vicinity of 8q24 and is approximately 268 kb in length. This allele, which encodes thyroglobulin protein, plays a role in the mediation of thyroid hormone production. Mutations in the gene are involved in goiter formation and genetic variants are associated with autoimmune thyroid disease type 3.. Cyclic AMP-Dependent Protein Kinases defined as following: A group of enzymes that are dependent on CYCLIC AMP and catalyze the phosphorylation of SERINE or THREONINE residues on Proteins. Included under this category are two cyclic-AMP-dependent protein kinase subtypes, each of which is defined by its subunit composition.. Vascular Diseases defined as following: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.. Point Mutation defined as following: A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair.. Mutation defined as following: Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.. SNCG wt Allele defined as following: Human SNCG wild-type allele is located within10q23.2-q23.3 and is approximately 13 kb in length. This allele, which encodes gamma-synuclein protein, plays a role in the modulation of axonal architecture and neurofilament integrity. This gene is highly expessed in advanced breast carcinomas, suggesting a correlation between SNCG overexpression and breast tumor development.. Cellular Membrane defined as following: Any of the lipid bilayer membranes within a cell.. Brugada Syndrome (disorder) defined as following: An autosomal dominant defect of cardiac conduction that is characterized by an abnormal ST-segment in leads V1-V3 on the ELECTROCARDIOGRAM resembling a right BUNDLE-BRANCH BLOCK; high risk of VENTRICULAR TACHYCARDIA; or VENTRICULAR FIBRILLATION; SYNCOPAL EPISODE; and possible sudden death. This syndrome is linked to mutations of gene encoding the cardiac SODIUM CHANNEL alpha subunit.. Mice, Animals, Transgenic defined as following: Laboratory CASP14 gene that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.. Gene Deletion defined as following: A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus.. Animals, Transgenic defined as following: Experimental organism whose genome has been altered by the transfer of a gene or genes from another species or breed.. cardiac Hypertrophy defined as following: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.. Homo sapiens defined as following: Members of the species Homo sapiens.. Infarction defined as following: Formation of an infarct, which is NECROSIS in tissue due to local ISCHEMIA resulting from obstruction of BLOOD CIRCULATION, most commonly by a THROMBUS or EMBOLUS.. Myocardium defined as following: The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow.. systolic Congestive Chest>Heart failure defined as following: Heart failure caused by abnormal myocardial contraction during SYSTOLE leading to defective cardiac emptying..", "label": "yes"} {"original_question": "Are variants in FHF2 (also known as FGF13) associated with encephalopathy?", "id": "converted_4279", "sentence1": "Are Variant in FGF13 gene (also known as fibroblast growth factor 13) associated with encephalopathy?", "sentence2": "Missense Variant in the N-terminal domain of the A Protein Isoforms of fibroblast growth factor 13 gene/fibroblast growth factor 13 cause an X-linked developmental and Epileptic encephalopathy., Whole-exome sequencing identified hemi- and heterozygous Variant in the N-terminal domain of the A Protein Isoforms of fibroblast growth factor 13 gene (FHF2A). The X-linked fibroblast growth factor 13 gene gene (also known as fibroblast growth factor 13) has alternative first Exons which produce multiple protein isoforms that differ in their N-terminal sequence. The Variant were located at highly conserved residues in the FHF2A inactivation particle that competes with the intrinsic fast inactivation mechanism of Navajo language channels. Functional characterization of mutant FHF2A co-expressed with wild-type Nav1.6 (SCN8A gene gene) revealed that mutant FHF2A proteins lost the ability to induce rapid-onset, long-term blockade of the channel while retaining pro-excitatory properties. These gain-of-function effects are likely to increase neuronal excitability consistent with the epileptic potential of fibroblast growth factor 13 gene Variant. Our findings demonstrate that fibroblast growth factor 13 gene Variant are a cause of infantile-onset developmental and Epileptic encephalopathy and underline the critical role of the FHF2A Protein Isoforms in regulating Navajo language channel function.[SEP]Relations: fibroblast growth factor 13 has relations: protein_protein with PLEKHF2, protein_protein with PLEKHF2, protein_protein with SCN2A, protein_protein with SCN2A, protein_protein with MAPK8IP2, protein_protein with MAPK8IP2, molfunc_protein with growth factor activity, molfunc_protein with growth factor activity, protein_protein with SCN5A, protein_protein with SCN5A. Definitions: Variant defined as following: An alteration or difference from a norm or standard.. FGF13 gene defined as following: This gene plays a role in neural development.. Navajo language defined as following: A Southern Athabaskan language of the Na-Dene family spoken primarily in the Southwestern United States, especially in the Navajo Nation.. Epileptic encephalopathy defined as following: A condition in which epileptiform abnormalities are believed to contribute to the progressive disturbance in cerebral function. Epileptic encephalaopathy is characterized by (1) electrographic EEG paroxysmal activity that is often aggressive, (2) seizures that are usually multiform and intractable, (3) cognitive, behavioral and neurological deficits that may be relentless, and (4) sometimes early death. [PMID:21590624, PMID:23213494]. Exons defined as following: The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA.. Protein Isoforms defined as following: Refers to Variant of the same protein which can be separated on special conducting media using electrophoresis. The differences may arise from genetically determined differences in primary structure or by modification of the same primary sequence.. encephalopathy defined as following: A functional and/or structural disorder of the brain caused by diseases (e.g. liver disease, kidney disease), medications, chemicals, and injuries..", "label": "yes"} {"original_question": "Are selenium supplements recommended for prostate cancer prevention?", "id": "converted_2223", "sentence1": "Are Selenium supplement supplements recommended for prostate cancer prevention?", "sentence2": "Our meta-analysis in prospective studies demonstrated a significant inverse association between Selenium supplement status and CVD risk within a narrow Selenium supplement range and a null effect of Selenium supplement supplementation on CVD was observed in RCTs. These findings indicate the importance of considering Selenium supplement status, dose and safety in health assessment and future study design., Selenium supplementation of 140 or more μg/day after diagnosis of nonmetastatic prostate cancer may increase risk of prostate cancer mortality. Caution is warranted regarding usage of such supplements among men with prostate cancer., The SELECT study failed to show any significant risk reduction for Malignant neoplasm of prostate ascribable to Selenium supplement and vitamin E supplementations., Vitamin IV solution additives and supplements, including Selenium supplement or vitamin E, have not been proven in clinical trials to prevent prostate cancer and in the case of Vitamin E Drug Class Drug Class has been found to increase the risk of incident prostate cancer. Ongoing and future trials may further elucidate the role of diet and immunotherapy for prevention of prostate cancer.[SEP]Relations: Selenium has relations: drug_drug with Testosterone, drug_drug with Testosterone, drug_drug with Testosterone enanthate, drug_drug with Testosterone enanthate, drug_drug with Methadone, drug_drug with Methadone, drug_drug with Ketamine, drug_drug with Ketamine, drug_drug with Ampicillin, drug_drug with Ampicillin. Definitions: Malignant neoplasm of prostate defined as following: A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas.. prostate cancer defined as following: A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas..", "label": "no"} {"original_question": "Is the PINES framework being used for the prediction of coding variants?", "id": "converted_2790", "sentence1": "Is the PINES framework being used for the prediction of coding variants?", "sentence2": "PINES: phenotype-informed tissue weighting improves prediction of pathogenic noncoding variants., Here, we introduce the computational framework PINES (Phenotype-Informed Noncoding Element Scoring), which predicts the functional impact of noncoding variants by integrating epigenetic annotations in a phenotype-dependent manner. PINES enables analyses to be customized towards genomic annotations from cell types of the highest relevance given the phenotype of interest. We illustrate that PINES identifies functional noncoding variation more accurately than methods that do not use phenotype-weighted knowledge, while at the same time being flexible and easy to use via a dedicated web portal., Here, we introduce the computational framework PINES (Phenotype-Informed Noncoding Element Scoring), which predicts the functional impact of noncoding variants by integrating epigenetic annotations in a phenotype-dependent manner., We illustrate that PINES identifies functional noncoding variation more accurately than methods that do not use phenotype-weighted knowledge, while at the same time being flexible and easy to use via a dedicated web portal.
, PINES enables analyses to be customized towards genomic annotations from cell types of the highest relevance given the phenotype of interest.[SEP]", "label": "no"} {"original_question": "Is Olaparib effective for prostate cancer?", "id": "converted_3871", "sentence1": "Is olaparib effective for Malignant neoplasm of Pelvis>Prostate?", "sentence2": "We hypothesized that metastatic, castration-resistant Pelvis>Prostate Malignant Neoplasms with DNA-repair defects would respond to poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP1 wt Allele) inhibition with olaparib.METHODS: We conducted a phase 2 trial in which patients with metastatic, Hormone refractory Malignant neoplasm of Pelvis>Prostate were treated with olaparib tablets at a dose of 400 mg twice a day. , CONCLUSIONS: Treatment with the PARP1 wt Allele PPP1R1A gene olaparib in patients whose Pelvis>Prostate Malignant Neoplasms were no longer responding to standard treatments and who had defects in DNA-repair Genes led to a high response rate. , In addition, phase III trials in Breast, Gastric (qualifier value) and Malignant neoplasm of pancreas are underway/planned, and phase I/II investigation is being conducted in other malignancies, including Malignant neoplasm of Pelvis>Prostate, Non-Small Cell Lung Carcinoma, Ewing's sarcoma of bone of bone and advanced cancer. , In a phase II study, researchers found that the PARP1 wt Allele PPP1R1A gene olaparib led to stable Disease or tumor regressions in patients with advanced Breast, Ovarian, Pancreatic Hormones, and Pelvis>Prostate Malignant Neoplasms who had germline Gene Mutation in BRCA1 gene gene or BRCA2 gene gene., Eligibility included Malignant neoplasm of ovary resistant to prior Platinum metallicum, Platinum metallicum, platinum, Homeopathic preparation, Homeopathic preparation; Breast cancer with ≥ three chemotherapy regimens for metastatic Disease; Malignant neoplasm of pancreas with prior gemcitabine treatment; or Malignant neoplasm of Pelvis>Prostate with progression on hormonal and one systemic therapy. , The tumor response rate was 26.2% (78 of 298; 95% NDUFB6 gene, 21.3 to 31.6) overall and 31.1% (60 of 193; 95% NDUFB6 gene, 24.6 to 38.1), 12.9% (eight of 62; 95% NDUFB6 gene, 5.7 to 23.9), 21.7% (five of 23; 95% NDUFB6 gene, 7.5 to 43.7), and 50.0% (four of eight; 95% NDUFB6 gene, 15.7 to 84.3) in Ovarian, Breast, Pancreatic Hormones, and Pelvis>Prostate Malignant Neoplasms, respectively. Stable Disease ≥ 8 weeks was observed in 42% of patients (95% NDUFB6 gene, 36.0 to 47.4), including 40% (95% NDUFB6 gene, 33.4 to 47.7), 47% (95% NDUFB6 gene, 34.0 to 59.9), 35% (95% NDUFB6 gene, 16.4 to 57.3), and 25% (95% NDUFB6 gene, 3.2 to 65.1) of those with Ovarian, Breast, Pancreatic Hormones, or Malignant neoplasm of Pelvis>Prostate, respectively. , It is increasingly clear that there are molecularly distinct subtypes of various common Malignant Neoplasms, with different therapeutic approaches required for each subtype, for example, the use of the Monoclonal Antibodies (trastuzumab and cetuximab) in HER2-positive Breast cancer and wild-type KRAS Malignant neoplasm of colon and/or rectum; Protein-tyrosine kinase PPP1R1A gene (disposition) (imatinib, gefitinib, erlotinib and crizotinib) in Myeloid Leukemia, Chronic, Gastrointestinal Stromal Tumors and non-small-cell lung cancer and intracellular agents (vemurafenib and olaparib) in Malignant melanoma, metastatic and Ovarian, Breast and Malignant neoplasm of Pelvis>Prostate., olaparib, one of the most studied PARPis, has demonstrated activity in BRCA1 gene gene/2(MUT+) and BRCA-like sporadic Ovarian and Malignant neoplasm of Breast, and looks promising in Pelvis>Prostate and Pancreatic Hormones Malignant Neoplasms., Prostate cancer cells cotreated with the HDAC PPP1R1A gene, vorinostat (SAHA) and the PARPi, olaparib, demonstrated a synergistic decrease in cell viability compared with single-agent treatment (combination index<0.9), whereas normal prostatic cells did not., CONCLUSIONS: Treatment with the PARP1 wt Allele PPP1R1A gene olaparib in patients whose Pelvis>Prostate Malignant Neoplasms were no longer responding to standard treatments and who had defects in DNA-repair Genes led to a high response rate., olaparib, one of the most studied PARPis, has demonstrated activity in BRCA1 gene gene/2(MUT+) and BRCA-like sporadic Ovarian and Malignant neoplasm of Breast, and looks promising in Pelvis>Prostate and Pancreatic Hormones Malignant Neoplasms. , DNA-Repair Defects and olaparib in Metastatic Prostate Cancer., Prostate cancer cells cotreated with the HDAC PPP1R1A gene, vorinostat (SAHA) and the PARPi, olaparib, demonstrated a synergistic decrease in cell viability compared with single-agent treatment (combination index < 0.9), whereas normal prostatic cells did not., We hypothesized that metastatic, castration-resistant Pelvis>Prostate Malignant Neoplasms with DNA-repair defects would respond to poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP1 wt Allele) inhibition with olaparib., A phase II study of the PARP1 wt Allele PPP1R1A gene olaparib (AstraZeneca) for cancer patients with inherited BRCA1 gene gene and BRCA2 gene gene gene Gene Mutation confirmed earlier results showing clinical benefit for advanced Breast and Ovarian Malignant Neoplasms, and demonstrated evidence of effectiveness against Pancreatic Hormones and Pelvis>Prostate Malignant Neoplasms., BACKGROUND: Prostate cancer is a heterogeneous Disease, but current treatments are not based on Molecular stratification. We hypothesized that metastatic, castration-resistant Pelvis>Prostate Malignant Neoplasms with DNA-repair defects would respond to poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP1 wt Allele) inhibition with olaparib.METHODS: We conducted a phase 2 trial in which patients with metastatic, Hormone refractory Malignant neoplasm of Pelvis>Prostate were treated with olaparib tablets at a dose of 400 mg twice a day. , Prostate cancer is a heterogeneous Disease, but current treatments are not based on Molecular stratification. We hypothesized that metastatic, castration-resistant Pelvis>Prostate Malignant Neoplasms with DNA-repair defects would respond to poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP1 wt Allele) inhibition with olaparib., Silencing DNA Repair Protein DNA Repair Protein RAD51 Homolog 1 Homolog 1 sensitized Malignant neoplasm of Pelvis>Prostate cells to SAHA and olaparib alone. Collectively, cotreatment with HDACi and PARPi downregulated HR-related protein expression and concomitantly increased DNA damage, resulting in Malignant neoplasm of Pelvis>Prostate cell death., Prostate cancer cells cotreated with the HDAC PPP1R1A gene, vorinostat (SAHA) and the PARPi, olaparib, demonstrated a synergistic decrease in cell viability compared with single-agent treatment (combination index<0.9), whereas normal prostatic cells did not. , The specificity of the biomarker suite was 94%. Genus Genus Anemia (in 10 of the 50 patients [20%]) and Fatigue (in 6 [12%]) were the most common grade 3 or 4 adverse events, findings that are consistent with previous studies of olaparib.CONCLUSIONS: Treatment with the PARP1 wt Allele PPP1R1A gene olaparib in patients whose Pelvis>Prostate Malignant Neoplasms were no longer responding to standard treatments and who had defects in DNA-repair Genes led to a high response rate. , Prostate cancer cells cotreated with the HDAC PPP1R1A gene, vorinostat (SAHA) and the PARPi, olaparib, demonstrated a synergistic decrease in cell viability compared with single-agent treatment (combination index < 0.9), whereas normal prostatic cells did not., In addition, phase III trials in Breast, Gastric (qualifier value) and Malignant neoplasm of pancreas are underway/planned, and phase I/II investigation is being conducted in other malignancies, including Malignant neoplasm of Pelvis>Prostate, Non-Small Cell Lung Carcinoma, Ewing's sarcoma of bone of bone and advanced cancer. , INTERPRETATION: olaparib has antitumour activity against metastatic Hormone refractory Malignant neoplasm of Pelvis>Prostate with DDR gene aberrations, supporting the implementation of Genome stratification of metastatic Hormone refractory Malignant neoplasm of Pelvis>Prostate in clinical practice., CONCLUSIONS: In men with metastatic Hormone refractory Malignant neoplasm of Pelvis>Prostate who had Disease progression while receiving enzalutamide or abiraterone and who had alterations in Genes with a role in homologous recombination repair, olaparib was associated with longer progression-free survival and better measures of response and patient-reported end points than either enzalutamide or abiraterone., olaparib is an additional option for second- and third-line treatment in those with alterations in BRCA1 gene gene, BRCA2 gene gene, and ammonium tetrathiomolybdate. , In this review, we describe current therapies for mCRPC, the rationale for anti-PARP1 wt Allele therapies, the pharmacology of olaparib for Malignant neoplasm of Pelvis>Prostate, clinical trials of olaparib for mCRPC, our clinical experience with olaparib for Malignant neoplasm of Pelvis>Prostate at a comprehensive cancer center, and future directions of olaparib for the treatment of mCRPC., olaparib, a poly (ADP-ribose) polymerase PPP1R1A gene, has demonstrated an improvement in median progression-free survival (PFS) in select patients with metastatic Hormone refractory Malignant neoplasm of Pelvis>Prostate (mCRPC)., Activity of durvalumab plus olaparib in metastatic Hormone refractory Malignant neoplasm of Pelvis>Prostate in men with and without DNA damage repair Gene Mutation., BACKGROUND: Patients with metastatic Hormone refractory Malignant neoplasm of Pelvis>Prostate and homologous recombination repair (double-strand break repair via homologous recombination) Gene Mutation have a better response to treatment with the poly(ADP-ribose) polymerase PPP1R1A gene olaparib than patients without double-strand break repair via homologous recombination Gene Mutation., The TOPARP-A clinical trial demonstrated that the PARP1 wt Allele PPP1R1A gene olaparib may be an effective strategy for treating Malignant neoplasm of Pelvis>Prostate., MMARY: The poly(ADP-ribose) polymerase (PARP1 wt Allele) inhibitors olaparib and rucaparib are now approved by the Food and Drug Administration for the treatment of advanced Malignant neoplasm of Pelvis>Prostate. Here, we , BACKGROUND: We previously reported that olaparib led to significantly longer imaging-based progression-free survival than the physician's choice of enzalutamide or abiraterone among men with metastatic Hormone refractory Malignant neoplasm of Pelvis>Prostate who had qualifying alterations in homologous recombination repair Genes and whose Disease had progressed during previous treatment with a next-generation hormonal agent., Recent clinical studies show favorable results for the PARP1 wt Allele PPP1R1A gene olaparib used as single agent for treatment of metastatic castration-resistant PCa., The PROFOUND phase III trial, comparing olaparib with enzalutamide/abiraterone therapy, revealed increased radiological progression-free survival (rPFS) and overall survival (OS) among patients with metastatic Hormone refractory Malignant neoplasm of Pelvis>Prostate (mCRPC) with BRCA1 gene gene, BRCA2 gene gene or ammonium tetrathiomolybdate Gene Mutation., olaparib Targets Some Advanced Prostate Cancers., The PARP1 wt Allele PPP1R1A gene (PARPi) olaparib received FDA breakthrough designation for treatment of metastatic castration-resistant Pelvis>Prostate Malignant Neoplasms (CRPC) carrying Gene Mutation in BRCA1 gene gene/2 or ammonium tetrathiomolybdate Genes., In Malignant neoplasm of Pelvis>Prostate, two PARPi, rucaparib and olaparib, have been FDA approved for the treatment of metastatic Hormone refractory Malignant neoplasm of Pelvis>Prostate (mCRPC)., olaparib is an FDA-approved PARP1 wt Allele PPP1R1A gene (PARPi) that has shown promise as a synthetic lethal treatment approach for BRCA-mutant Hormone refractory Malignant neoplasm of Pelvis>Prostate (CRPC) in clinical use, Targeting PLK1 gene to Enhance Efficacy of olaparib in Castration-Resistant Prostate Cancer, RECENT FINDINGS: The approval of several PARPi (olaparib, rucaparib, and niraparib) has driven the focus of anticancer treatment on synthetic lethality in Malignant neoplasm of Pelvis>Prostate too. , PATIENT SUMMARY: A large clinical study concluded that treatment with the PARP1 wt Allele PPP1R1A gene olaparib benefits men with metastatic Hormone refractory Malignant neoplasm of Pelvis>Prostate whose Neoplasms harbor alterations in 15 different DNA repair Genes., Among them, olaparib and rucaparib have breakthrough designations for BRCA1 gene gene/2-mutated mCRPC., In phase II clinical trials, including patients with advanced castration-resistant PC, olaparib seems to be efficacious and well tolerated. , Of note is the recent U.S. Food and Drug Administration breakthrough therapy designation of olaparib for the treatment of BRCA1 gene gene/2- or ammonium tetrathiomolybdate-mutated metastatic Hormone refractory Malignant neoplasm of Pelvis>Prostate. [SEP]Relations: olaparib has relations: drug_drug with Testosterone, drug_drug with Testosterone, drug_drug with Sonidegib, drug_drug with Sonidegib, drug_drug with Medical Cannabis, drug_drug with Medical Cannabis, drug_drug with Orlistat, drug_drug with Orlistat, drug_drug with Apremilast, drug_drug with Apremilast. Definitions: Hormone refractory Malignant neoplasm of Pelvis>Prostate defined as following: Prostate carcinoma that grows and continues to spread despite the surgical removal of the testes or medical intervention to block androgen production.. rucaparib defined as following: An orally bioavailable tricyclic indole and PPP1R1A gene of poly(ADP-ribose) polymerases (PARPs) 1 (PARP1), 2 (PARP2) and 3 (PARP3), with potential chemo/radiosensitizing and antineoplastic activities. Upon administration, rucaparib selectively binds to PARP1, 2 and 3 and inhibits PARP1 wt Allele-mediated DNA repair. This enhances the accumulation of DNA strand breaks, promotes Genome instability and induces cell cycle arrest and apoptosis. This may enhance the cytotoxicity of DNA-damaging agents and reverse tumor cell resistance to chemotherapy and radiation therapy. PARPs are enzymes activated by single-strand DNA breaks that catalyze the post-translational ADP-ribosylation of nuclear proteins, which induces signaling and the recruitment of other proteins to repair damaged DNA. The PARP1 wt Allele-mediated repair pathway plays a key role in DNA repair and is dysregulated in a variety of cancer cell types.. Malignant neoplasm of Pelvis>Prostate defined as following: A primary or metastatic malignant tumor involving the Pelvis>Prostate gland. The vast majority are carcinomas.. Malignant neoplasm of pancreas defined as following: A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma.. PARP1 wt Allele defined as following: Human PARP1 wild-type allele is located within 1q41-q42 and is approximately 47 kb in length. This allele, which encodes poly [ADP-ribose] polymerase 1 protein, plays a critical role in DNA repair.. niraparib defined as following: An orally bioavailable PPP1R1A gene of poly (ADP-ribose) polymerase (PARP1 wt Allele) types 1 and 2 (PARP1 wt Allele-1 and -2), with antineoplastic activity. Upon administration, niraparib binds to and inhibits the activity of PARP1 wt Allele-1 and -2, thereby inhibiting PARP1 wt Allele-1 and -2-mediated DNA repair, enhancing the accumulation of DNA strand breaks, promoting Genome instability and resulting in apoptosis. The PARP1 wt Allele family of proteins catalyzes post-translational ADP-ribosylation of nuclear proteins and is activated by single-strand DNA (ssDNA) breaks.. BRCA2 gene defined as following: A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human chromosome 13 at locus 13q12.3. Mutations in this gene predispose humans to Breast and Malignant neoplasm of ovary. It encodes a large, nuclear protein that is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. (from Genes Dev 2000;14(11):1400-6). erlotinib defined as following: A quinazoline derivative with antineoplastic properties. Competing with adenosine triphosphate, erlotinib reversibly binds to the intracellular catalytic domain of epidermal growth factor receptor (EGFR) tyrosine kinase, thereby reversibly inhibiting EGFR phosphorylation and blocking the signal transduction events and tumorigenic effects associated with EGFR activation.. Malignant neoplasm of Breast defined as following: A primary or metastatic malignant neoplasm involving the Breast. The vast majority of cases are carcinomas arising from the Breast parenchyma or the nipple. Malignant Breast neoplasms occur more frequently in females than in males.. Breast defined as following: In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.. Non-Small Cell Lung Carcinoma defined as following: A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.. Pancreatic Hormones defined as following: Peptide hormones secreted into the blood by cells in the ISLETS OF LANGERHANS of the pancreas. The alpha cells secrete glucagon; the beta cells secrete insulin; the delta cells secrete somatostatin; and the PP cells secrete Pancreatic Hormones polypeptide.. Malignant neoplasm of ovary defined as following: A primary or metastatic malignant neoplasm involving the ovary. Most primary malignant Ovarian neoplasms are either carcinomas (serous, mucinous, or endometrioid adenocarcinomas) or malignant germ cell Neoplasms. Metastatic malignant neoplasms to the ovary include carcinomas, lymphomas, and melanomas.. abiraterone defined as following: A steroidal compound with antiandrogen activity. Abiraterone inhibits the enzymatic activity of steroid 17alpha-monooxygenase (17alpha-hydrolase/C17,20 lyase complex; CYP17A1), a member of the cytochrome p450 family that catalyzes the 17alpha-hydroxylation of steroid intermediates involved in testosterone synthesis. Administration of this agent may suppress testosterone production by both the testes and the adrenals to castrate-range levels.. gefitinib defined as following: A selective tyrosine kinase PPP1R1A gene for the EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) that is used for the treatment of locally advanced or metastatic NON-SMALL CELL LUNG CANCER.. crizotinib defined as following: An orally available aminopyridine-based PPP1R1A gene of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) and the c-Met/hepatocyte growth factor receptor (HGFR) with antineoplastic activity. Crizotinib, in an ATP-competitive manner, binds to and inhibits ALK kinase and ALK fusion proteins. In addition, crizotinib inhibits c-Met kinase, and disrupts the c-Met signaling pathway. Altogether, this agent inhibits tumor cell growth. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development. ALK dysregulation and gene rearrangements are associated with a series of Neoplasms.. AstraZeneca defined as following: A global, science-led biopharmaceutical company headquartered in Cambridge, United Kingdom. The company focuses on the discovery, development and commercialization of prescription medicines.. Myeloid Leukemia, Chronic defined as following: chronic leukemia in which myeloid progenitor cells predominate; the hallmark of CML, the Philadelphia chromosome, is a reciprocal translocation between chromosomes 9 and 22 which activates the proto- oncogene c-abl.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. cetuximab defined as following: A chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. enzalutamide defined as following: An orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, enzalutamide inhibits the activity of Malignant neoplasm of Pelvis>Prostate cell ARs, which may result in a reduction in Malignant neoplasm of Pelvis>Prostate cell proliferation and, correspondingly, a reduction in the serum Pelvis>Prostate specific antigen (PSA) level. AR over-expression in Malignant neoplasm of Pelvis>Prostate represents a key mechanism associated with Malignant neoplasm of Pelvis>Prostate hormone resistance.. Genome defined as following: The genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA.. vorinostat defined as following: A synthetic hydroxamic acid derivative with antineoplastic activity. Vorinostat, a second generation polar-planar compound, binds to the catalytic domain of the histone deacetylases (HDACs). This allows the hydroxamic moiety to chelate zinc ion located in the catalytic pockets of HDAC, thereby inhibiting deacetylation and leading to an accumulation of both hyperacetylated histones and transcription factors. Hyperacetylation of histone proteins results in the upregulation of the cyclin-dependant kinase p21, followed by G1 arrest. Hyperacetylation of non-histone proteins such as tumor suppressor p53, alpha tubulin, and heat-shock protein 90 produces additional anti-proliferative effects. This agent also induces apoptosis and sensitizes tumor cells to cell death processes. Vorinostat crosses the blood-brain barrier.. Gastrointestinal Stromal Tumors defined as following: All Neoplasms in the GASTROINTESTINAL TRACT arising from mesenchymal cells (MESODERM) except those of smooth muscle cells (LEIOMYOMA) or Schwann cells (SCHWANNOMA).. BRCA1 gene defined as following: A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human CHROMOSOME 17 at locus 17q21. Mutations of this gene are associated with the formation of HEREDITARY BREAST AND OVARIAN CANCER SYNDROME. It encodes a large nuclear protein that is a component of DNA repair pathways.. double-strand break repair via homologous recombination defined as following: The error-free repair of a double-strand break in DNA in which the broken DNA molecule is repaired using homologous sequences. A strand in the broken DNA searches for a homologous region in an intact chromosome to serve as the template for DNA synthesis. The restoration of two intact DNA molecules results in the exchange, reciprocal or nonreciprocal, of genetic material between the intact DNA molecule and the broken DNA molecule. [GOC:elh, PMID:10357855]. olaparib defined as following: A small molecule PPP1R1A gene of the nuclear enzyme poly(ADP-ribose) polymerase (PARP1 wt Allele) with potential chemosensitizing, radiosensitizing, and antineoplastic activities. olaparib selectively binds to and inhibits PARP1 wt Allele, inhibiting PARP1 wt Allele-mediated repair of single strand DNA breaks; PARP1 wt Allele inhibition may enhance the cytotoxicity of DNA-damaging agents and may reverse tumor cell chemoresistance and radioresistance. PARP1 wt Allele catalyzes post-translational ADP-ribosylation of nuclear proteins and can be activated by single-stranded DNA breaks.. trastuzumab defined as following: A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.. Protein-tyrosine kinase inhibitor (disposition) defined as following: Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES.. Fatigue defined as following: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.. vemurafenib defined as following: An orally bioavailable, ATP-competitive, small-molecule PPP1R1A gene of BRAF(V600E) kinase with potential antineoplastic activity. Vemurafenib selectively binds to the ATP-binding site of BRAF(V600E) kinase and inhibits its activity, which may result in an inhibition of an over-activated MAPK signaling pathway downstream in BRAF(V600E) kinase-expressing tumor cells and a reduction in tumor cell proliferation. Approximately 90% of BRAF gene Gene Mutation involve a valine-to-glutamic acid mutation at residue 600 (V600E); the oncogene protein product, BRAF(V600E) kinase, exhibits a markedly elevated activity that over-activates the MAPK signaling pathway. The BRAF(V600E) gene mutation has been found to occur in approximately 60% of melanomas, and in about 8% of all solid Neoplasms, including melanoma, colorectal, thyroid and other Malignant Neoplasms.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. imatinib defined as following: An antineoplastic agent that inhibits the Bcr-Abl fusion protein tyrosine kinase, an abnormal enzyme produced by chronic myeloid leukemia cells that contain the Philadelphia chromosome. Imatinib also inhibits the receptor tyrosine kinases for platelet-derived growth factor (PDGF) and stem cell factor (SCF)/c-kit; the SCF/c-kit receptor tyrosine kinase is activated in gastrointestinal stromal tumor (GIST). This agent inhibits proliferation and induces apoptosis in cells that overexpress these oncoproteins.. Ewing's sarcoma of bone defined as following: A small round cell bone tumor that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewing sarcoma/peripheral neuroectodermal tumor. It often affects the diaphysis or metaphyseal-diaphyseal portion of long bones. Clinical findings include pain and a mass in the involved area. Fever, anemia, leukocytosis, and an increased sedimentation rate are often seen. X-ray examination reveals osteolytic lesions. The prognosis depends on the stage, anatomic location, and size of the tumor.. Monoclonal Antibodies defined as following: Antibodies produced by a single clone of cells.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Gastric (qualifier value) defined as following: Relating to the stomach.. HER2-positive Breast cancer defined as following: A biologic subset of Breast carcinoma defined by high expression of HER2, GRB7, and TRAP100, and by lack of expression of estrogen receptor (ER).. DNA Repair Protein RAD51 Homolog 1 defined as following: DNA repair protein DNA Repair Protein RAD51 Homolog 1 homolog 1 (339 aa, ~37 kDa) is encoded by the human DNA Repair Protein RAD51 Homolog 1 gene. This protein is involved in both homologous recombination and DNA repair.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. PLK1 gene defined as following: This gene plays a role in mitotic regulation.. Molecular defined as following: Relating to or produced by or consisting of molecules..", "label": "yes"} {"original_question": "Does daily atemoya juice intake change the pharmacokinetics of CYP1A2 substrates?", "id": "converted_4238", "sentence1": "Does daily atemoya juice intake change the pharmacokinetics of CYP1A2 substrates?", "sentence2": "Atemoya juice significantly inhibited CYP1A2 activity in Homo sapiens liver microsomes, but not the activities of Cytochrome p450 Cytochrome p450 CYP2C9 enzyme enzyme and cytochrome P450 3A. In spite of this inhibition, preadministration of atemoya had no effect on the pharmacokinetics of phenacetin, a CYP1A2 substrate, in Rattus norvegicus. , The results indicate that a daily intake of atemoya would not change the pharmacokinetics of CYP1A2 substrates such as phenacetin as well as Cytochrome p450 Cytochrome p450 CYP2C9 enzyme enzyme- and cytochrome P450 3A-substrate drugs.[SEP]Relations: Phenacetin has relations: drug_protein with CYP1A2, drug_protein with CYP1A2, drug_protein with CYP2A6, drug_protein with CYP2A6, drug_protein with CYP2E1, drug_protein with CYP2E1, drug_drug with Atenolol, drug_drug with Atenolol, drug_protein with CYP2A13, drug_protein with CYP2A13. Definitions: Cytochrome p450 CYP2C9 enzyme defined as following: A cytochrome P-450 subtype that has specificity for acidic XENOBIOTICS. It oxidizes a broad range of important clinical drugs that fall under the categories of NONSTEROIDAL ANTI-INFLAMMATORY AGENTS; HYPOGLYCEMIC AGENTS; ANTCOAGULANTS; and DIURETICS.. phenacetin defined as following: A phenylacetamide that was formerly used in ANALGESICS but nephropathy and METHEMOGLOBINEMIA led to its withdrawal from the market. (From Smith and Reynard, Textbook of Pharmacology,1991, p431). Rattus norvegicus defined as following: The common rat, Rattus norvegicus, often used as an experimental organism.. cytochrome P450 3A defined as following: A cytochrome P-450 suptype that has specificity for a broad variety of lipophilic compounds, including STEROIDS; FATTY ACIDS; and XENOBIOTICS. This enzyme has clinical significance due to its ability to metabolize a diverse array of clinically important drugs such as CYCLOSPORINE; VERAPAMIL; and MIDAZOLAM. This enzyme also catalyzes the N-demethylation of ERYTHROMYCIN.. Homo sapiens defined as following: Members of the species Homo sapiens.. CYP1A2 substrates defined as following: Any substance acted upon by cytochrome P450 1A2..", "label": "no"} {"original_question": "Are transcribed ultraconserved regions involved in cancer?", "id": "converted_72", "sentence1": "Are transcribed ultraconserved regions involved in cancer?", "sentence2": "Although most cancer research has focused in RNA, Messenger, non-coding RNAs are also an essential player in tumorigenesis. In addition to the well-recognized microRNAs, recent studies have also shown that epigenetic silencing by CpG Islands hypermethylation of other classes of non-coding RNAs, such as transcribed ultraconserved regions (T-UCRs) or small nucleolar RNAs (snoRNAs), also occur in Homo sapiens Neoplasms, Starting from a genome-wide expression profiling, we demonstrate for the first time a functional link between oxygen deprivation and the modulation of long noncoding transcripts from ultraconserved regions, termed transcribed-ultraconserved regions (T-UCRs). Interestingly, several hypoxia-upregulated T-UCRs, henceforth named 'hypoxia-induced noncoding ultraconserved transcripts' (HINCUTs), are also overexpressed in clinical samples from Malignant tumor of colon patients, Consistent with the hypothesis that T-UCRs have important function in tumor formation, The importance of other classes of non-coding RNAs, such as long intergenic ncRNAs (Long Intergenic Non-Protein Coding RNA) and transcribed ultraconserved regions (T-UCRs) as altered elements in Neoplasms, is also gaining recognition, Expression levels of transcribed ultraconserved regions uc.73 and uc.388 are altered in Malignant neoplasm of colon and/or rectum, Transcribed ultraconserved regions (T-UCRs) are a subset of 481 DNA Sequence longer than 200 bp, which are absolutely conserved between orthologous regions of Homo sapiens, Rattus norvegicus and mouse genomes, and are actively transcribed. It has recently been proven in cancer systems that differentially expressed T-UCRs could alter the functional characteristics of malignant cells. Genome-wide profiling revealed that T-UCRs have distinct signatures in Homo sapiens leukemia and carcinoma, Our preliminary results suggest that uc.73 and uc.388 could be potential diagnostic and prognostic biomarkers in Cytogenetic Complete Response patients, The transcribed-ultraconserved regions: a novel class of long noncoding RNAs involved in cancer susceptibility, This review gives a picture of the state of the art of a novel class of long RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL known as transcribed-ultraconserved regions (T-UCRs). Most recent studies show that they are significantly altered in adult Chronic Lymphocytic Leukemia, Carcinoma, and pediatric Neuroblastoma, leading to the hypothesis that UCRs may play a role in tumorigenesis and promising innovative future T-UCR-based therapeutic approaches, CpG Islands hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in Homo sapiens cancer, We focused on the transcribed-ultraconserved regions (T-UCRs), a subset of DNA DNA Sequence that are absolutely conserved between orthologous regions of the Homo sapiens, Rattus norvegicus and mouse genomes and that are located in both intra- and Intergenic Region. We used a pharmacological and genomic approach to reveal the possible existence of an aberrant epigenetic silencing pattern of T-UCRs by treating Tumor cells, malignant with a DNA-demethylating agent followed by hybridization to an expression microarray containing these DNA Sequence. We observed that DNA hypomethylation induces release of T-UCR silencing in Tumor cells, malignant. Among the T-UCRs that were reactivated upon drug treatment, Uc.160+, Uc283+A and Uc.346+ were found to undergo specific CpG Islands hypermethylation-associated silencing in Tumor cells, malignant compared with normal Body tissue. The analysis of a large set of primary Homo sapiens tumors (n=283) demonstrated that hypermethylation of the described T-UCR CpG islands was a common event among the various tumor types. Our finding that, in addition to microRNAs, another class of ncRNAs (T-UCRs) undergoes DNA methylation-associated inactivation in transformed cells supports a model in which epigenetic and Mutation in coding and non-coding DNA Sequence cooperate in Homo sapiens tumorigenesis, An integrative genomics screen uncovers RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL T-UCR functions in neuroblastoma tumours, Different classes of non-coding RNAs, including microRNAs, have recently been implicated in the process of tumourigenesis. In this study, we examined the expression and putative functions of a novel class of non-coding RNAs known as transcribed ultraconserved regions (T-UCRs) in neuroblastoma, our results define a T-UCR expression landscape in neuroblastoma and suggest widespread T-UCR involvement in diverse cellular processes that are deregulated in the process of tumourigenesis, Moreover, the recent demonstration that other ncRNAs, the ultraconserved genes (UCGs) or transcribed ultraconserved regions (T-UCRs), are involved in Homo sapiens cancerogenesis, suggests that the wider family of ncRNAs (including both MicroRNAs and UCGs) could contribute to the development of the malignant phenotype. Here we review the main studies investigating the role of MicroRNAs and UCRs in both normal hemopoiesis and Hematologic Neoplasms, and identify the Molecular, clinical and therapeutic implications of these recent findings, The transcribed-ultraconserved regions: a novel class of long noncoding RNAs involved in cancer susceptibility., Expression levels of transcribed ultraconserved regions uc.73 and uc.388 are altered in Malignant neoplasm of colon and/or rectum., CpG Islands hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in Homo sapiens cancer., Starting from a genome-wide expression profiling, we demonstrate for the first time a functional link between oxygen deprivation and the modulation of long noncoding transcripts from ultraconserved regions, termed transcribed-ultraconserved regions (T-UCRs)., The importance of other classes of non-coding RNAs, such as long intergenic ncRNAs (Long Intergenic Non-Protein Coding RNA) and transcribed ultraconserved regions (T-UCRs) as altered elements in Neoplasms, is also gaining recognition., Moreover, the recent demonstration that other ncRNAs, the ultraconserved genes (UCGs) or transcribed ultraconserved regions (T-UCRs), are involved in Homo sapiens cancerogenesis, suggests that the wider family of ncRNAs (including both MicroRNAs and UCGs) could contribute to the development of the malignant phenotype., Moreover, the recent demonstration that other ncRNAs, the ultraconserved genes (UCGs) or transcribed ultraconserved regions (T-UCRs), are involved in Homo sapiens cancerogenesis, suggests that the wider family of ncRNAs (including both MicroRNAs and UCGs) could contribute to the development of the malignant phenotype, Starting from a genome-wide expression profiling, we demonstrate for the first time a functional link between oxygen deprivation and the modulation of long noncoding transcripts from ultraconserved regions, termed transcribed-ultraconserved regions (T-UCRs)[SEP]Relations: malignant tumor of neck has relations: disease_protein with EGFR, disease_protein with EGFR, disease_protein with RAD51, disease_protein with RAD51, disease_protein with DPYD, disease_protein with DPYD, disease_protein with RARB, disease_protein with RARB. malignant giant cell tumor has relations: disease_disease with cancer, disease_disease with cancer. Definitions: DNA Sequence defined as following: The sequence of nucleotide residues along a DNA chain.. Neuroblastoma defined as following: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51). Malignant tumor of colon defined as following: A primary or metastatic malignant neoplasm that affects the colon. Representative examples include carcinoma, lymphoma, and sarcoma.. RNA, Messenger defined as following: RNA DNA Sequence that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the cytoplasm.. Chronic Lymphocytic Leukemia defined as following: A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called chronic lymphocytic leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease.. Tumor cells, malignant defined as following: Cells of, or derived from, a malignant tumor.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. Carcinoma defined as following: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding Body tissue and give rise to metastases. It is a histological type of neoplasm and not a synonym for \"cancer.\". MicroRNAs defined as following: Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 MicroRNAs discovered, and are from a class of MicroRNAs involved in developmental timing.. Long Intergenic Non-Protein Coding RNA defined as following: A molecule of RNA 200-17000 nucleotides in length that is transcribed by non-protein coding areas of DNA. These ribonucleotides may play a role in a variety of biological processes.. Cytogenetic Complete Response defined as following: The disappearance of all signs of cancer, including the absence of a detectable disease-related genetic abnormality, as determined by techniques such as karyotyping or FISH, in response to treatment.. Mutation defined as following: Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.. Molecular defined as following: Relating to or produced by or consisting of molecules.. Homo sapiens defined as following: Members of the species Homo sapiens.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. Hematologic Neoplasms defined as following: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.. CpG Islands defined as following: Areas of increased density of the dinucleotide sequence cytosine--phosphate diester--guanine. They form stretches of DNA several hundred to several thousand base pairs long. In humans there are about 45,000 CpG islands, mostly found at the 5' ends of genes. They are unmethylated except for those on the inactive X chromosome and some associated with imprinted genes.. cancer defined as following: A malignant tumor at the original site of growth..", "label": "yes"} {"original_question": "Is Selumetinib effective for low-grade glioma?", "id": "converted_3643", "sentence1": "Is selumetinib effective for low-grade Glioma?", "sentence2": "Conclusion: selumetinib has promising antitumor activity in children with LGG Lactobacillus rhamnosus GG Lactobacillus rhamnosus GG., INTERPRETATION\n\nselumetinib is active in recurrent, refractory, or progressive Pilocytic Astrocytoma harbouring common BRAF protein, human protein, human aberrations and Neurofibromatosis 1-associated paediatric low-grade Glioma., These results show that selumetinib could be an alternative to standard chemotherapy for these subgroups of patients, and have directly led to the development of two Children's Oncology Group phase 3 studies comparing standard chemotherapy to selumetinib in patients with newly diagnosed paediatric low-grade Glioma both with and without Neurofibromatosis 1., Conclusion selumetinib has promising antitumor activity in children with LGG Lactobacillus rhamnosus GG Lactobacillus rhamnosus GG., INTERPRETATION selumetinib is active in recurrent, refractory, or progressive Pilocytic Astrocytoma harbouring common BRAF protein, human protein, human aberrations and Neurofibromatosis 1-associated paediatric low-grade Glioma., Conclusion\n\nselumetinib has promising antitumor activity in children with LGG Lactobacillus rhamnosus GG Lactobacillus rhamnosus GG., INTERPRETATION\nselumetinib is active in recurrent, refractory, or progressive Pilocytic Astrocytoma harbouring common BRAF protein, human protein, human aberrations and Neurofibromatosis 1-associated paediatric low-grade Glioma., These results show that selumetinib could be an alternative to standard chemotherapy for these subgroups of patients, and have directly led to the development of two Children's Oncology Group phase 3 studies comparing standard chemotherapy to selumetinib in patients with newly diagnosed paediatric low-grade Glioma both with and without Neurofibromatosis 1., These results show that selumetinib could be an alternative to standard chemotherapy for these subgroups of patients, and have directly led to the development of two Children's Oncology Group phase 3 studies comparing standard chemotherapy to selumetinib in patients with newly diagnosed paediatric low-grade Glioma both with and without Neurofibromatosis 1., INTERPRETATION: selumetinib is active in recurrent, refractory, or progressive Pilocytic Astrocytoma harbouring common BRAF protein, human protein, human aberrations and Neurofibromatosis 1-associated paediatric low-grade Glioma., selumetinib is active in recurrent, refractory, or progressive Pilocytic Astrocytoma harbouring common BRAF protein, human protein, human aberrations and Neurofibromatosis 1-associated paediatric low-grade Glioma., These results show that selumetinib could be an alternative to standard chemotherapy for these subgroups of patients, and have directly led to the development of two Children's Oncology Group phase 3 studies comparing standard chemotherapy to selumetinib in patients with newly diagnosed paediatric low-grade Glioma both with and without Neurofibromatosis 1.[SEP]Relations: selumetinib has relations: drug_drug with Gliquidone, drug_drug with Gliquidone, drug_drug with Glasdegib, drug_drug with Glasdegib, drug_drug with Bortezomib, drug_drug with Bortezomib, drug_drug with Afelimomab, drug_drug with Afelimomab, drug_drug with Glipizide, drug_drug with Glipizide. Definitions: Neurofibromatosis 1 defined as following: An autosomal dominant inherited disorder (with a high frequency of spontaneous mutations) that features developmental changes in the nervous system, muscles, bones, and skin, most notably in tissue derived from the embryonic NEURAL CREST. Multiple hyperpigmented skin lesions and subcutaneous tumors are the hallmark of this disease. Peripheral and central nervous system neoplasms occur frequently, especially OPTIC NERVE GLIOMA and NEUROFIBROSARCOMA. Neurofibromatosis 1 is caused by mutations which inactivate the Neurofibromatosis 1 gene (GENES, NEUROFIBROMATOSIS 1) on chromosome 17q. The incidence of learning disabilities is also elevated in this condition. (From Adams et al., Principles of Neurology, 6th ed, pp1014-18) There is overlap of clinical features with NOONAN SYNDROME in a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and Neurofibromatosis 1 gene products are involved in the SIGNAL TRANSDUCTION pathway of Ras (RAS PROTEINS).. selumetinib defined as following: An orally active, small molecule with potential antineoplastic activity. selumetinib is an ATP-independent inhibitor of mitogen-activated protein kinase kinase (MEK or MAPK/ERK kinase) 1 and 2. MEK 1 and 2 are dual specificity kinases that are essential mediators in the activation of the RAS/RAF/MEK/ERK pathway, are often upregulated in various cancer cells, and are drivers of diverse cellular responses, including proliferation. Inhibition of both MEK1 and 2 by selumetinib prevents the activation of MEK1/2 dependent effector proteins and transcription factors, thereby leading to an inhibition of cellular proliferation in various cancers.. Pilocytic Astrocytoma defined as following: A WHO grade 1, relatively circumscribed, slowly growing, often cystic astrocytoma occurring in children and young adults. Histologically it is characterized by a biphasic pattern with compacted bipolar cells associated with Rosenthal fibers and multipolar cells associated with microcysts and eosinophilic bodies/hyaline droplets. (WHO). Glioma defined as following: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21). BRAF protein, human defined as following: Serine/threonine-protein kinase B-raf (766 aa, ~84 kDa) is encoded by the human BRAF protein, human gene. This protein plays a role in protein phosphorylation, mitogenesis and neuronal signal transduction..", "label": "yes"} {"original_question": "Is progeria caused by an autosomal recessive gene?", "id": "converted_4055", "sentence1": "Is Progeria caused by an Autosome recessive gene?", "sentence2": "Hutchinson-Gilford Progeria syndrome (Prelamin-A/C wt Allele) is an Autosome-dominant genetic disease that leads to accelerated aging and often Mortality, Premature caused by Cardiovascular system complications. , Hutchinson-Gilford Progeria syndrome is an Autosome dominant, rare, fatal pediatric segmental premature aging disease., Progeria is sporadic, very rare, Autosome dominant, deadly childhood disorder. I, Werner Syndrome (i.e., adult Progeria) is a rare Autosomal Recessive Disorder caused by Genes Mutation of the WRN gene, which is characterized by the premature appearance of features associated with normal aging and Primary malignant neoplasm predisposition., Among them, the most studied is Werner's syndrome, \"adult Progeria\", caused by a recessive Autosome Mutation Abnormality with a frequency of 1 in 10 million, which affects a helicase involved in DNA repair., Pattern of inheritance of non-classical Progeria is most probably Autosome recessive., INTRODUCTION: Werner Syndrome, or adult Progeria, is a rare Autosomal Recessive Disorder caused by a Mutation Abnormality in the Werner Syndrome Genes belonging to the family of RecQ Helicases., SION: Werner's syndrome is a rare form of Progeria with an Autosome recessive mode of inheritance mimicking the symptoms of accelerated aging. The r, Werner's Syndrome (WS) or adult-onset Progeria is an Autosomal Recessive Disorder of accelerated aging caused by Genes Mutation of the DNA RecQ Helicases/exonuclease (WRN)., Homozygous Prelamin-A/C Mutation Abnormality R527C in atypical Hutchinson-Gilford Progeria syndrome: evidence for Autosome recessive inheritance., Progeria (Hutchison-Gilford syndrome) in siblings: in an Autosome recessive pattern of inheritance., The present case highlights rarity of Progeria in siblings with a possible Autosome recessive pattern., Werner Syndrome (i.e., adult Progeria) is a rare Autosomal Recessive Disorder caused by Genes Mutation of the WRN gene, which is characterized by the premature appearance of features associated with normal aging and Primary malignant neoplasm predisposition. Patie, CONTEXT: Hutchinson-Gilford Progeria syndrome (Prelamin-A/C wt Allele) and Mandibuloacral dysostosis are well-recognized allelic Autosome dominant and recessive progeroid disorders, respectively, due to Genes Mutation in lamin A/C (Prelamin-A/C) gen, Werner's syndrome (adult onset Progeria) is a rare form of Autosome recessive genodermatosis associated in almost 80% of cases with Mutation Abnormality of the WRN gene. This, Werner Syndrome, also called adult Progeria, is a heritable Autosome recessive human disorder characterized by the premature onset of numerous age-related diseases including juvenile cataracts, Dyslipidemias, Diabetes Mellitus (DM), Encounter due to family history of Encounter due to family history of osteoporosis, Arteriosclerosis, and Primary malignant neoplasm. Werner sy, Werner's syndrome (WS) or Progeria adultorum is a heritable Autosome recessive disease in which the aging process is accelerated, just after puberty. It is, Hutchinson-Gilford Progeria syndrome (Prelamin-A/C wt Allele) is a rare Autosome dominant genetic disease that is caused by a silent Mutation Abnormality of the Prelamin-A/C gene encoding lamins A and C (lamin A/C)., Furthermore, administration of JH4 to LmnaG609G/G609G-mutant CASP14 gene, which phenocopy human Prelamin-A/C wt Allele, resulted in a marked improvement of several Progeria phenotypes and an extended lifespan., Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford Progeria syndrome phenotype., Progeria is an Autosome dominant, premature aging syndrome., INTRODUCTION: Werner Syndrome, or adult Progeria, is a rare Autosomal Recessive Disorder caused by a Mutation Abnormality in the Werner Syndrome Genes belonging to the family of RecQ Helicases, Evidence for Autosome recessive inheritance of Progeria (Hutchinson Gilford)., INTRODUCTION: Werner Syndrome, or adult Progeria, is a rare Autosomal Recessive Disorder caused by a Mutation Abnormality in the Werner Syndrome Genes belonging to the family of , Hutchinson-Gilford Progeria causing premature aging of children is a genetic disease and according to most authors has an Autosomal dominant inheritance., Werner's syndrome (WS) or Progeria adultorum is a heritable Autosome recessive disease in which the aging process is accelerated, just after puberty., Werner Syndrome, also called adult Progeria, is a heritable Autosome recessive human disorder characterized by the premature onset of numerous age-related diseases including juvenile cataracts, Dyslipidemias, Diabetes Mellitus (DM), Encounter due to family history of Encounter due to family history of osteoporosis, Arteriosclerosis, and Primary malignant neoplasm.[SEP]Relations: Autosome recessive disease has relations: disease_disease with Hutchinson-Gilford Progeria syndrome, disease_disease with Hutchinson-Gilford Progeria syndrome, disease_disease with Nestor-Guillermo Progeria syndrome, disease_disease with Nestor-Guillermo Progeria syndrome, disease_disease with Autosome genetic disease, disease_disease with Autosome genetic disease. Autosomal dominant inheritance has relations: disease_phenotype_positive with Progeria-short stature-pigmented nevi syndrome, disease_phenotype_positive with Progeria-short stature-pigmented nevi syndrome, disease_phenotype_positive with Hutchinson-Gilford Progeria syndrome, disease_phenotype_positive with Hutchinson-Gilford Progeria syndrome. Definitions: Autosomal Recessive Disorder defined as following: An inherited disorder manifested only when two copies of a mutated gene are present.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Mandibuloacral dysostosis defined as following: Mandibuloacral dysplasia (MAD) is a rare genetic bone disorder characterized by growth delay, postnatal development of craniofacial anomalies including mandibular hypoplasia, progressive acral osteolysis, mottled or patchy pigmentation, skin atrophy, and partial or generalized lipodystrophy.. Arteriosclerosis defined as following: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Prelamin-A/C gene defined as following: This gene is involved in the architecture of nuclear membrane construction.. Autosomal dominant inheritance defined as following: A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an Autosome dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele. [HPO:curators]. Prelamin-A/C wt Allele defined as following: Human Prelamin-A/C wild-type allele is located within 1q22 and is approximately 25 kb in length. This allele, which encodes prelamin-A/C protein, plays a role in nuclear stability and chromatin structure. Mutations in the Prelamin-A/C gene are associated with Charcot-Marie-Tooth disease, type 2B1, Hutchinson-Gilford Progeria syndrome, Emery-Dreifuss muscular dystrophy, Malouf syndrome, Autosome dominant familial partial lipodystrophy type 2, lethal restrictive dermopathy, Autosome dominant limb girdle muscular dystrophy 1B and Autosome dominant dilated cardiomyopathy 1A... Progeria defined as following: An abnormal congenital condition, associated with defects in the LAMIN TYPE A gene, which is characterized by premature aging in children, where all the changes of cell senescence occur. It is manifested by premature graying; hair loss; hearing loss (DEAFNESS); cataracts (CATARACT); ARTHRITIS; OSTEOPOROSIS; DIABETES MELLITUS; atrophy of subcutaneous fat; skeletal hypoplasia; elevated urinary HYALURONIC ACID; and accelerated ATHEROSCLEROSIS. Many affected individuals develop malignant tumors, especially SARCOMA.. Diabetes Mellitus defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.. WRN gene defined as following: This gene is involved in DNA repair and the unwinding of DNA.. Werner Syndrome defined as following: An Autosomal Recessive Disorder that causes premature aging in adults, characterized by sclerodermal skin changes, cataracts, subcutaneous calcification, muscular atrophy, a tendency to Diabetes Mellitus, aged appearance of the face, baldness, and a high incidence of neoplastic disease.. Prelamin-A/C defined as following: Prelamin-A/C (664 aa, ~74 kDa) is encoded by the human Prelamin-A/C gene. This protein is involved in the framework required for the nuclear envelope and in chromatin interactions.. RecQ Helicases defined as following: A family of structurally-related DNA helicases that play an essential role in the maintenance of genome integrity. RecQ helicases were originally discovered in E COLI and are highly conserved across both prokaryotic and eukaryotic organisms. Genetic Gene Mutation that result in loss of RecQ Helicases activity gives rise to disorders that are associated with CANCER predisposition and premature aging.. Autosome defined as following: Any chromosome other than a sex chromosome. [GOC:mah]. Autosome dominant defined as following: A rare distal arthrogryposis syndrome with characteristics of multiple pterygia (typically involving the neck, axilla and popliteal areas), joint contractures, ptosis, camptodactyly of the hands with hypoplastic flexion creases, vertebral fusions, severe scoliosis and short stature. There is evidence this disease is caused by heterozygous Mutation Abnormality in the MYH3 gene on chromosome 17p13.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including Primary malignant neoplasm.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.. Cardiovascular system defined as following: The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body.. Dyslipidemias defined as following: A lipoprotein metabolism disorder characterized by decreased levels of high-density lipoproteins, or elevated levels of plasma cholesterol, low-density lipoproteins and/or triglycerides.. Mortality, Premature defined as following: Deaths that occur before LIFE EXPECTANCY is reached within a given population..", "label": "yes"} {"original_question": "Are there any anti-amyloid antibody approved as drug for Alzheimer's disease treatment?", "id": "converted_3186", "sentence1": "Are there any anti-amyloid antibody approved as Pharmacologic Substance for ALZHEIMER DISEASE, FAMILIAL, 1 treatment?", "sentence2": "Treatment with memantine, a noncompetitive NMDA receptor Substance with receptor Substance with receptor antagonist mechanism of action (substance) mechanism of action (substance) which is an approved Pharmacologic Substance for treatment of ALZHEIMER DISEASE, FAMILIAL, 1, rescued protein phosphatase-2A activity by decreasing its demethylation at Leu309 selectively and attenuated ALZHEIMER DISEASE, FAMILIAL, 1-like pathology and cognitive impairment in adeno-associated virus vector-1-I1PP2A Rattus norvegicus. , anti-Amyloid agents (13.30%), no new drugs have been approved during the past 15 years; and the available medications are not cost-effective. [SEP]Relations: familial Alzheimer disease has relations: disease_disease with Alzheimer disease, disease_disease with Alzheimer disease, disease_protein with PRNP, disease_protein with PRNP, disease_phenotype_positive with Attention deficit hyperactivity disorder, disease_phenotype_positive with Attention deficit hyperactivity disorder, disease_disease with inherited prion disease, disease_disease with inherited prion disease, disease_phenotype_positive with Anxiety, disease_phenotype_positive with Anxiety. Definitions: Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Rattus norvegicus defined as following: The common rat, Rattus norvegicus, often used as an experimental organism.. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65.. memantine defined as following: AMANTADINE derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent..", "label": "no"} {"original_question": "Are there lncRNAs that control the extent of neuronal outgrowth?", "id": "converted_3486", "sentence1": "Are there lncRNAs that control the extent of neuronal outgrowth?", "sentence2": "Regulation of Neuroregeneration by Long Noncoding RNAs., Here, we profiled gene expression following sciatic nerve crush in CASP14 gene and identified long noncoding RNAs (lncRNAs) that act in the regenerating Neurons and which are typically not expressed in other contexts. We show that two of these lncRNAs regulate the extent of neuronal outgrowth. We then focus on one of these, SILC1 gene, and show that it regulates Nerve Tissue Regeneration in Cultured Cells and in vivo, through cis-acting activation of the transcription factor SOX11 protein, human.[SEP]Relations: neuronal tumor has relations: disease_disease with extraventricular neurocytoma, disease_disease with extraventricular neurocytoma, disease_disease with central neurocytoma, disease_disease with central neurocytoma, disease_disease with cerebellar liponeurocytoma, disease_disease with cerebellar liponeurocytoma. tissue regeneration has relations: bioprocess_protein with CDKN1A, bioprocess_protein with CDKN1A. neuron to neuron synapse has relations: cellcomp_protein with ATP1B2, cellcomp_protein with ATP1B2. Definitions: Cultured Cells defined as following: Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.. Neurons defined as following: The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.. SOX11 protein, human defined as following: Transcription factor SOX-11 (441 aa, ~47 kDa) is encoded by the human SOX11 gene. This protein is involved in transcriptional repression.. Nerve Tissue Regeneration defined as following: The regrowth of neural tissue following its loss or destruction. [Wikipedia:Neuroregeneration].", "label": "yes"} {"original_question": "Is tivantinib effective for MET-high hepatocellular carcinoma?", "id": "converted_4461", "sentence1": "Is tivantinib effective for MET wt Allele-high Liver carcinoma?", "sentence2": "BACKGROUND: Tivantinib (ARQ 197), a selective, oral MET wt Allele wt Allele inhibitor, improved overall survival and progression-free survival compared with placebo in a randomised phase 2 study in patients with high MET wt Allele wt Allele expression (MET wt Allele wt Allele-high) Liver carcinoma previously treated with sorafenib., INTERPRETATION: Tivantinib did not improve overall survival compared with placebo in patients with MET wt Allele wt Allele-high advanced Liver carcinoma previously treated with sorafenib., At a median follow-up of 18·1 months (IQR 14·1-23·1), median overall survival was 8·4 months (95% CI 6·8-10·0) in the tivantinib group and 9·1 months (7·3-10·4) in the placebo group (hazard ratio 0·97; 95% CI 0·75-1·25; p=0·81)., In Phase I and II studies, tivantinib (ARQ 197), an oral inhibitor of MET wt Allele wt Allele, demonstrated promising antitumor activity in patients with altretamine/cisplatin/cyclophosphamide protocol, both as monotherapy and in combination with sorafenib. A randomized Phase II trial in second-line altretamine/cisplatin/cyclophosphamide protocol showed improved overall survival (hazard ratio: 0.38; p = 0.01) in patients with MET wt Allele wt Allele-high tumors, as demonstrated by immunohistochemistry, treated with tivantinib versus placebo. , This study did not confirm the significant efficacy of tivantinib as a second-line treatment for Japanese patients with MET wt Allele wt Allele-high Liver carcinoma. , Median progression-free survival was 2.8 (95% confidence interval: 2.7-2.9) and 2.3 (1.5-2.8) mo in the tivantinib and placebo groups, respectively (hazard ratio = 0.74, 95% confidence interval: 0.52-1.04, P = .082). Median overall survival was 10.3 (95% confidence interval: 8.1-11.6) and 8.5 (6.2-11.4) mo in the tivantinib and placebo group, respectively (hazard ratio = 0.82, 95% confidence interval: 0.58-1.15). , This study did not confirm the significant efficacy of tivantinib as a second-line treatment for Japanese patients with MET wt Allele wt Allele-high Liver carcinoma., This study did not confirm the significant efficacy of tivantinib as a second-line treatment for Japanese patients with MET wt Allele wt Allele-high Liver carcinoma, INTERPRETATION: Tivantinib did not improve overall survival compared with placebo in patients with MET wt Allele wt Allele-high advanced Liver carcinoma previously treated with sorafeni, BACKGROUND: Tivantinib (ARQ 197), a selective, oral MET wt Allele wt Allele inhibitor, improved overall survival and progression-free survival compared with placebo in a randomised phase 2 study in patients with high MET wt Allele wt Allele expression (MET wt Allele wt Allele-high) Liver carcinoma previously treated wit, ostic factor in altretamine/cisplatin/cyclophosphamide protocol after sorafenib failure. Tivantinib demonstrated a nearly doubling of progression free and overall survival in the MET wt Allele wt Allele high group compared to placebo in a Phase II study in patient[SEP]Relations: Tivantinib has relations: drug_protein with MET wt Allele, drug_protein with MET wt Allele. Sorafenib has relations: drug_effect with Hepatocellular carcinoma, drug_effect with Hepatocellular carcinoma, drug_effect with Squamous cell carcinoma, drug_effect with Squamous cell carcinoma, drug_effect with Squamous cell carcinoma of the skin, drug_effect with Squamous cell carcinoma of the skin, drug_drug with Fostamatinib, drug_drug with Fostamatinib. Definitions: Tivantinib defined as following: An orally bioavailable small molecule inhibitor of c-Met with potential antineoplastic activity. c-Met inhibitor ARQ 197 binds to the c-Met protein and disrupts c-Met signal transduction pathways, which may induce cell death in tumor cells overexpressing c-Met protein or expressing constitutively activated c-Met protein. c-Met protein, the product of the proto-oncogene c-Met, is a receptor tyrosine kinase also known as hepatocyte growth factor receptor (HGFR); this protein is overexpressed or mutated in many tumor cell types and plays key roles in tumor cell proliferation, survival, invasion, and metastasis, and tumor angiogenesis.. Liver carcinoma defined as following: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.. sorafenib defined as following: A synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis.. MET wt Allele defined as following: Human MET wt Allele wild-type allele is located within 7q31 and is approximately 126 kb in length. This allele, which encodes hepatocyte growth factor receptor protein, plays a role in the regulation of cellular tyrosine-kinase activity. Mutations in the MET wt Allele gene are associated with papillary renal carcinoma.. tivantinib defined as following: An orally bioavailable small molecule inhibitor of c-Met with potential antineoplastic activity. c-Met inhibitor ARQ 197 binds to the c-Met protein and disrupts c-Met signal transduction pathways, which may induce cell death in tumor cells overexpressing c-Met protein or expressing constitutively activated c-Met protein. c-Met protein, the product of the proto-oncogene c-Met, is a receptor tyrosine kinase also known as hepatocyte growth factor receptor (HGFR); this protein is overexpressed or mutated in many tumor cell types and plays key roles in tumor cell proliferation, survival, invasion, and metastasis, and tumor angiogenesis..", "label": "no"} {"original_question": "Are TAMs good anticancer therapeutic targets?", "id": "converted_4392", "sentence1": "Are TAMs good anticancer therapeutic targets?", "sentence2": "Integrating therapeutic strategies to target TAMs to complement conventional therapies has yielded promising results in preclinical trials and warrants further investigation to determine its translational benefit in Homo sapiens cancer patients.[SEP]Definitions: Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Can NEECHAM Confusion Scale be used for evaluation of postoperative delirium?", "id": "converted_1871", "sentence1": "Can NEECHAM Confusion Scale be used for evaluation of postoperative Delirium?", "sentence2": "Sampling was achieved in a nonrandomized targeted manner and Delirium was assessed using NeeCham questionnaire. , Delirium in older patients: a diagnostic study of NEECHAM Confusion Scale in surgical intensive care unit., AIMS AND OBJECTIVES: To estimate the diagnostic value and determine the feasibility of the NEECHAM Confusion Scale on Critical Illness older patients., CONCLUSIONS: Findings from this study confirm the good diagnostic value and ease of application of the NEECHAM scale with nonventilated intensive care patients.RELEVANCE TO CLINICAL PRACTICE: The NEECHAM scale can be used to detect Delirium during the routine nursing assessment of nonintubated older patients as it requires minimal demand and stress on the patient as well as on the bedside nurse., The NEECHAM Confusion Scale and the validated chart review instrument were used for diagnosis of Delirium. , Among the various screening instruments, NEECHAM Clouded consciousness scale and Delirium observation scale appear to be most suitable screening instrument for patients' in general medical and surgical wards, depending on the type of rater (physician or nurse). , Use of NEECHAM scaling enabled medical staff to identify cases of possible Clouded consciousness early, indicating that the NEECHAM Clouded consciousness scale should be useful for the detection of postoperative Delirium and Clouded consciousness in the surgical ward., Early detection of postoperative Delirium and Clouded consciousness in a surgical ward using the NEECHAM Clouded consciousness scale., In this study, we investigated whether the early detection of postoperative Delirium in elderly patients is possible using a simple, useful behavior-assessing scale, the NEECHAM Confusion Scale, and a method for comprehensively evaluating elderly persons' stress related to surgery, E-PASS., Assessment of the risk of postoperative Delirium in elderly patients using E-PASS and the NEECHAM Confusion Scale., The aim of this study was to determine which of the two Delirium observation screening scales, the NEECHAM Confusion Scale or the Delirium Observation Screening (DOS) scale, has the best discriminative capacity for diagnosing Delirium and which is more practical for daily use by nurses., For Delirium diagnosis and severity assessment, we used the NEECHAM Confusion Scale., Use of NEECHAM scaling enabled medical staff to identify cases of possible Clouded consciousness early, indicating that the NEECHAM Clouded consciousness scale should be useful for the detection of postoperative Delirium and Clouded consciousness in the surgical ward., The NEECHAM Confusion Scale was performed upon admission and prior to discharge.RESULTS: The incidence of DSM-IV related Delirium was 24%., A comparison of the CAM-ICU and the NEECHAM Confusion Scale in intensive care Delirium assessment: an observational study in non-intubated patients., Predictive value and validation of the NEECHAM Confusion Scale using DSM-IV criteria for Delirium as gold standard., Early detection of postoperative Delirium and Clouded consciousness in a surgical ward using the NEECHAM Clouded consciousness scale, The aim of this study was to determine which of the two Delirium observation screening scales, the NEECHAM Confusion Scale or the Delirium Observation Screening (DOS) scale, has the best discriminative capacity for diagnosing Delirium and which is more practical for daily use by nurses.The project was conducted on four wards of a university hospital; 87 patients were included, In addition, we scored the participants on the NEECHAM Scale and evaluated their postoperative Delirium and postoperative arrhythmia.On the nights of Days 4 and 5, the amount of activity of the exposure group was significantly lower and The sympathetic nervous index was significantly lower on the night of Day 5, In this study, we investigated whether the early detection of postoperative Delirium in elderly patients is possible using a simple, useful behavior-assessing scale, the NEECHAM Confusion Scale, and a method for comprehensively evaluating elderly persons' stress related to surgery, E-PASS. , The cut-off value of the NEECHAM score was established as 20 points, and patients showing values less than this after surgery were regarded as having postoperative Delirium. , Identification of Delirium was based on evaluation of the level of consciousness with the NEECHAM Confusion Scale and/or a chart-based instrument for Delirium., For Delirium diagnosis and severity assessment, we used the NEECHAM Confusion Scale., In this study, we investigated whether the early detection of postoperative Delirium in elderly patients is possible using a simple, useful behavior-assessing scale, the NEECHAM Confusion Scale, and a method for comprehensively evaluating elderly persons' stress related to surgery, E-PASS.The subjects were 160 patients aged more than 75 years who underwent surgery., In this study a nursing screening instrument, the NEECHAM Clouded consciousness scale, was studied for early recognition of Delirium ICU patients., The psychometric characteristics and the ease of use of the NEECHAM Clouded consciousness scale enables ICU nurses to early recognize Delirium., The trends of the NEECHAM scores in the 3 groups were compared, and the relationship between the NEECHAM scores and suspected clinical risk factors for Delirium was investigated., In groups showing an MMSE score of less than 25 or a preoperative NEECHAM score of less than 27, the incidence of postoperative Delirium was 76%.CONCLUSION: The results suggest that E-PASS and the NEECHAM score facilitate assessment of the risk of postoperative Delirium in elderly patients, contributing to early prevention/treatment., In this study, we investigated whether the early detection of postoperative Delirium in elderly patients is possible using a simple, useful behavior-assessing scale, the NEECHAM Confusion Scale, and a method for comprehensively evaluating elderly persons' stress related to surgery, E-PASS., Use of NEECHAM scaling enabled medical staff to identify cases of possible Clouded consciousness early, indicating that the NEECHAM Clouded consciousness scale should be useful for the detection of postoperative Delirium and Clouded consciousness in the surgical ward.., Early detection of postoperative Delirium and Clouded consciousness in a surgical ward using the NEECHAM Clouded consciousness scale., Assessment of the risk of postoperative Delirium in elderly patients using E-PASS and the NEECHAM Confusion Scale., For Delirium diagnosis and severity assessment, we used the NEECHAM Confusion Scale., The Neecham Confusion Scale and the Delirium Observation Screening Scale: capacity to discriminate and ease of use in clinical practice., The aim of this study was to determine which of the two Delirium observation screening scales, the NEECHAM Confusion Scale or the Delirium Observation Screening (DOS) scale, has the best discriminative capacity for diagnosing Delirium and which is more practical for daily use by nurses.[SEP]Relations: Delirium has relations: contraindication with Trolnitrate, contraindication with Trolnitrate, disease_disease with cognitive disorder, disease_disease with cognitive disorder, disease_disease with subacute Delirium, disease_disease with subacute Delirium, contraindication with Tacrolimus, contraindication with Tacrolimus, contraindication with Olanzapine, contraindication with Olanzapine. Definitions: Delirium defined as following: A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2). postoperative Delirium defined as following: A form of DELIRIUM which occurs after GENERAL ANESTHESIA.. Critical Illness defined as following: A disease or state in which death is possible or imminent..", "label": "yes"} {"original_question": "Are stress granules membraneous?", "id": "converted_2549", "sentence1": "Are Stress Granules membraneous?", "sentence2": "PMLOs are different in size, shape, and composition, and almost invariantly contain intrinsically disordered Proteins (e.g., eIF-4B and TARDBP wt Allele in Stress Granules,, Liquid-liquid phase separation (LLPS) of RNA-binding Proteins plays an important role in the formation of multiple Membrane Device-less Organelles involved in RNA metabolism, including Stress Granules., Stress granules (SG) are Membrane Device-less compartments involved in regulating mRNAs during stress., In addition to Membrane Device delimited Organelles, Proteins and RNA can organize themselves into specific domains. Some examples include Stress Granules and subnuclear bodies. [SEP]Relations: stress granule assembly has relations: bioprocess_protein with PUM2, bioprocess_protein with PUM2, bioprocess_protein with EIF2S1, bioprocess_protein with EIF2S1, bioprocess_bioprocess with organelle assembly, bioprocess_bioprocess with organelle assembly, bioprocess_protein with LSM14A, bioprocess_protein with LSM14A, bioprocess_protein with MAPT, bioprocess_protein with MAPT. Definitions: Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Organelles defined as following: Specific particles of Membrane Device-bound organized living substances present in eukaryotic cells, such as the MITOCHONDRIA; the GOLGI APPARATUS; ENDOPLASMIC RETICULUM; LYSOSOMES; PLASTIDS; and VACUOLES.. Membrane Device defined as following: A device that is made from or resembles a thin flexible sheet of material.. TARDBP wt Allele defined as following: Human TARDBP wild-type allele is located in the vicinity of 1p36.22 and is approximately 13 kb in length. This allele, which encodes TAR DNA-binding protein 43, plays a role in the mediation of both mRNA splicing and DNA transcription. Mutation of the gene is associated with amyotrophic lateral sclerosis type 10.. RNA-binding Proteins defined as following: Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other Proteins whose function is to bind specifically to RNA.. Stress Granules defined as following: A dense aggregation in the cytosol composed of Proteins and RNA that appear when the cell is under stress. [GOC:ans, PMID:17284590, PMID:17601829, PMID:17967451, PMID:20368989].", "label": "no"} {"original_question": "AhR ligands are attractive drug targets for pharmaceutical development due to their induction of Cyp1a1, yes or no?", "id": "converted_3383", "sentence1": "aromatic hydrocarbon receptor ligands are attractive drug targets for pharmaceutical development due to their induction of Cyp1a1, yes or no?", "sentence2": " Based on our review of the data, there is little evidence to support the indiscriminate exclusion of aromatic hydrocarbon receptor activators/Cyp1a1 inducers from early drug developmental pipelines. We also found no evidence that short-term treatment with RMAhRLs produce \"dioxin-like toxicity\", However, recent discoveries of new aromatic hydrocarbon receptor ligands with potential therapeutic applications have been reported, inviting reconsideration of this policy., Based on our review of the data, there is little evidence to support the indiscriminate exclusion of aromatic hydrocarbon receptor activators/Cyp1a1 inducers from early drug developmental pipelines., Based on our review of the data , there is little evidence to support the indiscriminate exclusion of aromatic hydrocarbon receptor activators/Cyp1a1 inducers from early drug developmental pipelines, However , recent discoveries of new aromatic hydrocarbon receptor ligands with potential therapeutic applications have been reported , inviting reconsideration of this policy, Based on our review of the data, there is little evidence to support the indiscriminate exclusion of aromatic hydrocarbon receptor activators/Cyp1a1 inducers from early drug developmental pipelines., However, recent discoveries of new aromatic hydrocarbon receptor ligands with potential therapeutic applications have been reported, inviting reconsideration of this policy., Combining in vivo and in vitro findings, we identified nine aromatic hydrocarbon receptor agonists, six of which are marketed therapeutics and have been approved by the U.S. Food and Drug Administration, including leflunomide, flutamide, and nimodipine.[SEP]Relations: Flutamide has relations: drug_protein with AHR, drug_protein with AHR. Nimodipine has relations: drug_protein with AHR, drug_protein with AHR. aryl hydrocarbon receptor complex has relations: cellcomp_protein with AHR, cellcomp_protein with AHR, cellcomp_protein with AHRR, cellcomp_protein with AHRR. Leflunomide has relations: drug_protein with AHR, drug_protein with AHR. Definitions: aromatic hydrocarbon receptor defined as following: approximately 280kD soluble protein complex; binds and mediates carcinogenesis by polycyclic aromatic hydrocarbons, heterocyclic amines, and chlorinated aromatic compounds.. agonists defined as following: Used with chemicals, drugs, and endogenous substances to indicate substances or agents that have affinity for a receptor and intrinsic activity at that receptor. (From Textbook of Pharmacology, 1991, p.16). nimodipine defined as following: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.. flutamide defined as following: An antiandrogen with about the same potency as cyproterone in rodent and canine species.. leflunomide defined as following: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.. Cyp1a1 defined as following: A liver microsomal cytochrome P-450 monooxygenase capable of biotransforming xenobiotics such as polycyclic hydrocarbons and halogenated aromatic hydrocarbons into carcinogenic or mutagenic compounds. They have been found in mammals and fish. This enzyme, encoded by CYP1A1 gene, can be measured by using ethoxyresorufin as a substrate for the ethoxyresorufin O-deethylase activity..", "label": "yes"} {"original_question": "Is RIP1 (RIP-1) part of the necrosome?", "id": "converted_1699", "sentence1": "Is UQCRFS1 gene (RIP-1) part of the necrosome?", "sentence2": "formation of a different necrosome whose components, besides UQCRFS1 gene and Myosin Phosphatase Rho-Interacting Protein, human, are still unknown, necrosome complex consisting of UQCRFS1 gene, Myosin Phosphatase Rho-Interacting Protein, human, FADD protein, human protein, human, caspase-8 and cFLIP(L)., assembly of a supramolecular complex containing the receptor-interacting protein kinases 1 and 3 (UQCRFS1 gene and Myosin Phosphatase Rho-Interacting Protein, human) that delivers a pronecrotic signal. Such complex has recently been dubbed necrosome, Receptor interacting protein kinase 1 (RIPK1/UQCRFS1 gene) and Myosin Phosphatase Rho-Interacting Protein, human are key components of the necrosome. , The phosphorylation of UQCRFS1 gene and Myosin Phosphatase Rho-Interacting Protein, human is critical for assembly of the necrosome,, UQCRFS1 gene-Myosin Phosphatase Rho-Interacting Protein, human \"necrosome\" complex , UQCRFS1 gene and Myosin Phosphatase Rho-Interacting Protein, human mediate necrosome aggregation leading to the formation of amyloid-like signaling complexes., Formation of the UQCRFS1 gene/Myosin Phosphatase Rho-Interacting Protein, human complex (called necrosome) , The UQCRFS1 gene/Myosin Phosphatase Rho-Interacting Protein, human necrosome , Rip1-Rip3 death complex (necrosome), he 'necrosome', that includes receptor-interacting protein (RIP)1, Myosin Phosphatase Rho-Interacting Protein, human and caspase-8. , RIP-1 kinase activity triggers formation of the necrosome (in complex with RIPK3 protein, human) leading to programmed necrosis. [SEP]Relations: Protein S human has relations: drug_drug with Cefpirome, drug_drug with Cefpirome, drug_drug with Cefpirome, drug_drug with Cefpirome, drug_drug with Cefpirome, drug_drug with Cefpirome, drug_drug with Interferon alfa-n1, drug_drug with Interferon alfa-n1, drug_drug with Interferon alfa-n1, drug_drug with Interferon alfa-n1. Definitions: RIPK3 protein, human defined as following: Receptor-interacting serine/threonine-protein kinase 3 (518 aa, ~57 kDa) is encoded by the human RIPK3 gene. This protein plays a role in the induction of necrosis.. FADD protein, human defined as following: FAS-associated death domain protein (208 aa, ~23 kDa) is encoded by the human FADD protein, human gene. This protein is involved in the positive regulation of caspase-dependent apoptosis.. caspase-8 defined as following: A long pro-domain caspase that contains a death effector domain in its pro-domain region. Caspase 8 plays a role in APOPTOSIS by cleaving and activating EFFECTOR CASPASES. Activation of this enzyme can occur via the interaction of its N-terminal death effector domain with DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS.. Myosin Phosphatase Rho-Interacting Protein, human defined as following: Myosin phosphatase Rho-interacting protein (1025 aa, ~117 kDa) is encoded by the human MPRIP gene. This protein plays a role in the recruitment of myosin phosphatase to the cytoskeleton.. UQCRFS1 gene defined as following: Receptor-interacting serine/threonine-protein kinase 1 (671 aa, ~76 kDa) is encoded by the human RIPK1 gene. This protein plays a role in signaling that mediates inflammation, serine/threonine phosphorylation and cell death.. supramolecular complex defined as following: A cellular component that consists of an indeterminate number of proteins or macromolecular complexes, organized into a regular, higher-order structure such as a polymer, sheet, network or a fiber. [GOC:dos].", "label": "yes"} {"original_question": "Is Lysyl oxidase crosslinking collagen?", "id": "converted_2665", "sentence1": "Is LOX gene crosslinking collagen?", "sentence2": "LOX protein, human gene (LOX protein, human protein, human) and LOX protein, human protein, human-like (LOXL) proteins play crucial roles in MMRN1 wt Allele remodeling due to their collagen crosslinking and intracellular functions. , LOX protein, human gene-like 1, a crosslinking Enzyme [APC] implicated in collagen and elastin biogenesis, LOXL2 gene gene mediates collagen crosslinking, The same was true for assaying Protein-Lysine 6-Oxidase, an Enzyme [APC] involved in crosslinking of matrix molecules., In addition, collagen fibers in metastatic Lung Neoplasms exhibit greater linearity and organization as a result of collagen crosslinking by the Protein-Lysine 6-Oxidase (LOX protein, human protein, human) family of ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS. [SEP]Relations: protein-lysine 6-oxidase activity has relations: molfunc_protein with LOXL2 gene, molfunc_protein with LOXL2 gene, molfunc_protein with LOXL4, molfunc_protein with LOXL4, molfunc_protein with LOXL1, molfunc_protein with LOXL1, molfunc_protein with LOX protein, human, molfunc_protein with LOX protein, human, molfunc_protein with LOXL3, molfunc_protein with LOXL3. Definitions: LOX protein, human defined as following: Protein-lysine 6-oxidase (417 aa, ~47 kDa) is encoded by the human LOX protein, human gene. This protein plays a role in both lysine metabolism and the formation of cross-links in extracellular matrix proteins.. Protein-Lysine 6-Oxidase defined as following: An Enzyme [APC] oxidizing peptidyl-lysyl-peptide in the presence of water & molecular oxygen to yield peptidyl-allysyl-peptide plus ammonia & hydrogen peroxide. EC 1.4.3.13.. Lung Neoplasms defined as following: Tumors or cancer of the LUNG.. LOX gene defined as following: This gene plays a role in cross-linking extracellular matrix proteins.. LOXL2 gene defined as following: This gene is involved in protein crosslinking.. MMRN1 wt Allele defined as following: Human MMRN1 wild-type allele is located in the vicinity of 4q22 and is approximately 75 kb in length. This allele, which encodes multimerin-1 protein, plays a role in platelet factor V/Va homeostasis.. collagen defined as following: A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH)..", "label": "yes"} {"original_question": "Is there any data to suggest that TRH (thyrotropin releasing hormone) administration can improve symptom severity of amyotrophic lateral sclerosis patients?", "id": "converted_1520", "sentence1": "Is there any data to suggest that Pro-Thyrotropin-Releasing Hormone, human (Thyrotropin-Releasing Hormone, human) administration can improve symptom severity of Amyotrophic Lateral Sclerosis patients?", "sentence2": "These CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS (CNS)-mediated effects provide the rationale for use of Pro-Thyrotropin-Releasing Hormone, human and its Analog in the treatment of Head>Brain and spinal injury, and CNS disorders like SCHIZOPHRENIA 2 (disorder), ALZHEIMER DISEASE, FAMILIAL, 1, Epilepsy, Amyotrophic Lateral Sclerosis, Parkinson's Disease, Cancer patients and suicide and Cancer patients and suicide and depression, Shock and Ischemia Procedure., The Effect of Pro-Thyrotropin-Releasing Hormone, human to correct the abnormal F responses in SSP might be consistent with effects of Pro-Thyrotropin-Releasing Hormone, human to reduce Muscle Spasticity in Amyotrophic Lateral Sclerosis described previously, Agents undergoing therapeutic trials at present include Ciliary Neurotrophic Factor, IGF1 glutamate antagonists, Amino Acids, Branched-Chain and Pro-Thyrotropin-Releasing Hormone, human analogue., Evidence that thyrotropin-releasing hormone (Pro-Thyrotropin-Releasing Hormone, human) has prominent trophic effects on the motor system led to several negative therapeutic trials in Amyotrophic Lateral Sclerosis, a Disease of the motor system., The results of the clinical evaluation at the beginning and end of the treatment as well as after patient follow up demonstrated that beneficial effects do not occur equally in all patients but rather are transitory and do not improve the natural evolution of the Disease., The neurological evaluation after acute Pro-Thyrotropin-Releasing Hormone, human-T treatment showed an objective improvement in 3 of the 8., The outcome of the study, in agreement with some and at variance with other studies, was that Pro-Thyrotropin-Releasing Hormone, human induced a statistically significant neurological improvement in 17 of the 23 ALS patients but little or none in the other ALS patients and in patients with other neurological diseases., [A case of Amyotrophic Lateral Sclerosis with disturbance of vertical ocular movement responding to Thyrotropin-Releasing Hormone, human (Pro-Thyrotropin-Releasing Hormone, human)]., Pro-Thyrotropin-Releasing Hormone, human injections resulted in improvement of disturbance of vertical ocular movement, but no effect was seen on the weakness of the limb., 13 patients with Amyotrophic Lateral Sclerosis (ALS) were treated with intravenous infusion of thyrotropin-releasing hormone (Pro-Thyrotropin-Releasing Hormone, human). , Similar improvements in speech, swallowing and in Tongue and jaw movements were seen after iv and oral administration in nine, five and eight patients respectively. , No clinical improvement was detected. , A trial of Thyrotropin Releasing Hormone (Pro-Thyrotropin-Releasing Hormone, human) 5.0 mg/kg body weight subcutaneously every other day for two weeks produced transient increased tone in Muscle Tissue, along with other (side-) effects in patients with Amyotrophic Lateral Sclerosis (ALS)., Although the mechanism is not known, several reports of the effectiveness of Thyrotropin-Releasing Hormone, human (Pro-Thyrotropin-Releasing Hormone, human) in ALS were recently published., thyrotropin-releasing hormone (thyrotropin-releasing hormone) appears to be a neuromodulator in the extrahypothalamic nervous system and has been suggested as an adjunct in the treatment of Amyotrophic Lateral Sclerosis (ALS). , Clinical studies have shown that response to Pro-Thyrotropin-Releasing Hormone, human is state dependent, that is, it depends on whether the patient has bulbar or nonbulbar signs and is male or female. Future studies must take into consideration this state dependence as a specific feature of the pharmacological action of Pro-Thyrotropin-Releasing Hormone, human and its analogues., Three of the studies showed a transient, statistically significant effect in at least some Muscle Tissue. The two studies that demonstrated no such effect both used Pro-Thyrotropin-Releasing Hormone, human in very small doses. It therefore seems reasonable to conclude that the effect of Pro-Thyrotropin-Releasing Hormone, human in ALS is a definite, acute, and transient response. , It was found that in only 3 out of 14 patients with moderately progressed Disease no improvement was achieved, while in 11 cases the improvement was from 10 to 20%. However, the improvement was transient, and Pro-Thyrotropin-Releasing Hormone, human treatment failed to stop the progression of the Disease., Only 3 patients noted subjective improvement of strength., In 6 of the 9, Pro-Thyrotropin-Releasing Hormone, human induced a significant increase in vibratory inhibition. This suggests that the Pro-Thyrotropin-Releasing Hormone, human-induced reduction of Muscle Spasticity might be due to an increase in presynaptic inhibition acting on Ia fibres., However, 2 mg DN-1417, IM twice a day for 1 month in an open-label trial, produced no objective improvement of strength in nine patients with ALS. , Our experience suggests that this approach is safe, has high patient acceptance, and is worthy of more careful evaluation., Focal, small-to-moderate and transient improvement occurred in the muscle strength and function of patients with ALS who received Pro-Thyrotropin-Releasing Hormone, human in dose-response and screening studies. In a small pilot study of 12 patients, 3 months administration of Pro-Thyrotropin-Releasing Hormone, human at 10 mg per kg on alternate days resulted in localized increased strength of jaw Muscle Tissue as well as significant improvement in lower extremity function. Aerobic exercise capacity was particularly improved in patients with ALS following administration of Pro-Thyrotropin-Releasing Hormone, human. , Mild to moderate improvement was found in 9 (56%) of 16 patients. , We thought such action of Pro-Thyrotropin-Releasing Hormone, human to be useful to the therapy of ALS., With daily Pro-Thyrotropin-Releasing Hormone, human, 10 patients noted subjective improvement without objective evidence, and 10 patients complained of worsening of the Disease with objective decline after Pro-Thyrotropin-Releasing Hormone, human was stopped. Statistical analysis, however, showed no beneficial effects from either acute or chronic Pro-Thyrotropin-Releasing Hormone, human trials., A temporary increase in the strength of some Muscle Tissue was detected following the administration of Pro-Thyrotropin-Releasing Hormone, human, but no change in functional performance was noted. Neither the patients nor the investigators believed the effects were of any marked clinical significance., Nevertheless, statistically significant improvement was seen only in dynametric strength 1 hour after subcutaneous injection (p less than 0.05). Significant improvement occurred, in one patient only, on subjective speech testing during IV infusion of Pro-Thyrotropin-Releasing Hormone, human. In none of six other ratings was there a significant difference between Pro-Thyrotropin-Releasing Hormone, human and placebo. Subjective improvement was noted by 11 of 12 patients., Significant improvement, as shown by statistical analysis, was noted in muscle strength in the 9 patients by 5 infusions over a 4-week period and a sub-group of 5 patients treated by 8 infusions over 10 weeks., The progressive course of this Disease, manifested by increasing Atrophic, Paralysed and Disability:Type:Pt:^Patient:Nom score, was not altered. , Very high intravenous doses (2-19 mg/min) of thyrotropin-releasing hormone (Pro-Thyrotropin-Releasing Hormone, human, L-pyroglutamyl-L-histidyl-L-prolinamide) given to 12 patients with Amyotrophic Lateral Sclerosis (ALS) produced a moderate to marked improvement of functions caused by deficiency of lower motor neurons (weakness) and upper motor neurons (Muscle Spasticity). The improvement was sustained throughout the infusion and for about 1 h thereafter; sometimes a slight improvement was evident 20 h after infusion., Aerobic exercise capacity was particularly improved in patients with ALS following administration of Pro-Thyrotropin-Releasing Hormone, human[SEP]Relations: Amyotrophic Lateral Sclerosis has relations: disease_protein with TRPM7, disease_protein with TRPM7, disease_protein with NEFH, disease_protein with NEFH, disease_disease with progressive muscular Atrophic, disease_disease with progressive muscular Atrophic, disease_protein with TARDBP, disease_protein with TARDBP, disease_protein with TREM2, disease_protein with TREM2. Definitions: Ciliary Neurotrophic Factor defined as following: A neurotrophic factor that promotes the survival of various neuronal cell types and may play an important role in the injury response in the nervous system.. Thyrotropin-Releasing Hormone, human defined as following: Thyrotropin-releasing hormone (3 aa, ~0.4 kDa) is encoded by the human Pro-Thyrotropin-Releasing Hormone, human gene. This protein plays a role in the positive regulation of thyrotropin (thyroid-stimulating hormone; TSH) production and release.. thyrotropin-releasing hormone defined as following: A tripeptide that stimulates the release of THYROTROPIN and PROLACTIN. It is synthesized by the neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, Pro-Thyrotropin-Releasing Hormone, human (was called TRF) stimulates the release of TSH and PRL from the ANTERIOR PITUITARY GLAND.. Amyotrophic Lateral Sclerosis defined as following: An inherited form of Amyotrophic Lateral Sclerosis, usually inherited in an autosomal dominant pattern, caused by mutation(s) in the SOD1 gene, encoding superoxide dismutase.. Ischemia Procedure defined as following: A surgical procedure during which the blood supply to an organ or tissue is interrupted and then later reestablished.. Shock defined as following: A pathological condition manifested by failure to perfuse or oxygenate vital organs.. Amino Acids, Branched-Chain defined as following: Amino acids which have a branched carbon chain.. Pro-Thyrotropin-Releasing Hormone, human defined as following: Thyrotropin-releasing hormone (3 aa, ~0.4 kDa) is encoded by the human Pro-Thyrotropin-Releasing Hormone, human gene. This protein plays a role in the positive regulation of thyrotropin (thyroid-stimulating hormone; TSH) production and release.. Muscle Spasticity defined as following: A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a \"free interval\") followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54). Epilepsy defined as following: A disorder characterized by recurrent episodes of paroxysmal Head>Brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the Head>Brain, and (5) temporal patterns (e.g., nocturnal Epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313). Muscle Tissue defined as following: Contractile tissue that produces movement in animals.. Paralysed defined as following: A general term most often used to describe severe or complete loss of muscle strength due to motor system Disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45). ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65.. Focal defined as following: Limited to a specific area.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Atrophic defined as following: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, Ischemia Procedure, malnutrition, or hormonal changes.. Tongue defined as following: A muscular organ in the mouth that is covered with pink tissue called mucosa, tiny bumps called papillae, and thousands of taste buds. The Tongue is anchored to the mouth and is vital for chewing, swallowing, and for speech.. Analog defined as following: A synthetic chemical which structurally or functionally resembles a naturally occurring compound.. Parkinson's Disease defined as following: A progressive, degenerative neurologic Disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75).", "label": "yes"} {"original_question": "Does TGF-beta play a role in cardiac regeneration after myocardial infarction?", "id": "converted_109", "sentence1": "Does Recombinant Transforming Growth Factor-Beta play a role in cardiac regeneration after myocardial infarction?", "sentence2": "We then performed a chemical screen and identified several small molecules that increase or reduce Myocytes, Cardiac proliferation during heart development. These compounds act via Subfamily Erinaceinae, Insulin-Like Growth Factor I or Transforming growth factor β signaling pathways. , Here, we report that the balance between the reparative and regenerative processes is achieved through Smad3-dependent TGFβ signaling. , Thus, TGFβ signaling orchestrates the beneficial interplay between scar-based repair and Myocytes, Cardiac-based regeneration to achieve complete heart regeneration., As expected, transforming growth factor (TGF)-beta, a profibrotic cytokine, was dramatically upregulated in MI hearts, but its phosphorylated comediator (pSmad) was significantly downregulated in the nuclei of Cx43-deficient hearts post-MI, suggesting that downstream signaling of Recombinant Transforming Growth Factor-Beta is diminished substantially in Cx43-deficient hearts. This diminution in profibrotic Recombinant Transforming Growth Factor-Beta signaling resulted in the attenuation of adverse structural remodeling as assessed by echocardiography., Potentially beneficial changes include increases in the HSMP secretory-leucocyte-protease-inhibitor (SLPI protein, human protein, human) and cytokine transforming growth factor (TGF)-beta(1). Targeting these Proteins may mitigate enhanced LV remodeling and dysfunction with aging., After injury, the presence of Specimen Source Codes - Macrophages, which secreted high levels of transforming growth factor-beta and Vascular Endothelial Growth Factor A, led to rapid removal of cell debris and replacement by Granulation Tissue containing Inflammatory cell and blood vessels, followed by myofibroblast infiltration and collagen deposition., Secretion of transforming growth factor-beta and Vascular Endothelial Growth Factor A as well as neovascularization, myofibroblast infiltration, and collagen deposition decreased. , Repression of proinflammatory cytokine and chemokine synthesis, mediated in part through Transforming Growth Factor (TGF)-beta and Interleukin (IL)-10, is critical for resolution of the inflammatory infiltrate and transition to fibrous tissue deposition., Recombinant Transforming Growth Factor-Beta conducted the myogenic differentiation of CD117+ stem cells by upregulating GATA-4 and NKx-2.5 expression. Therefore, the intramyocardial implantation of Recombinant Transforming Growth Factor-Beta-preprogrammed CD117+ cells effectively assisted the myocardial regeneration and induced therapeutic angiogenesis, contributing to functional cardiac regeneration., These results indicate that Recombinant Transforming Growth Factor-Beta/Smad signaling may be involved in the remodeling of the infarct scar after the completion of wound healing per se, via ongoing stimulation of Matrix Pharmaceutical Inc. deposition.[SEP]Relations: transforming growth factor beta receptor binding has relations: molfunc_protein with TGFB2, molfunc_protein with TGFB2, molfunc_protein with TGFBR3, molfunc_protein with TGFBR3, molfunc_protein with TGFBRAP1, molfunc_protein with TGFBRAP1, molfunc_protein with INHBC, molfunc_protein with INHBC, molfunc_protein with RASL11B, molfunc_protein with RASL11B. Definitions: SLPI protein, human defined as following: Antileukoproteinase (132 aa, ~14 kDa) is encoded by the human SLPI protein, human gene. This protein is involved in the regulation of serine proteinase activity.. collagen defined as following: A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH).. Recombinant Transforming Growth Factor-Beta defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine transforming growth factor-beta (Recombinant Transforming Growth Factor-Beta) with proapoptotic and antineoplastic properties. Recombinant Transforming Growth Factor-Beta may suppress tumor cell growth by decreasing the expression of cyclin D1, a cell cycle regulatory protein, and downregulating the expression of the oncogene c-myc. This agent is also involved in T cell-mediated immunosuppression by CD4+CD25+ T cells, which permits cancer cells to evade immune surveillance. (NCI04). Granulation Tissue defined as following: A vascular connective tissue formed on the surface of a healing wound, ulcer, or inflamed tissue. It consists of new capillaries and an infiltrate containing lymphoid cells, Specimen Source Codes - Macrophages, and plasma cells.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Vascular Endothelial Growth Factor A defined as following: The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as \"tumor angiogenesis factor\" and \"vascular permeability factor\". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced.. Insulin-Like Growth Factor I defined as following: A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor.. Myocytes, Cardiac defined as following: Striated muscle cells found in the heart. They are derived from cardiac myoblasts (MYOBLASTS, CARDIAC)..", "label": "yes"} {"original_question": "Is there a package in R/bioconductor for classification of alternative splicing?", "id": "converted_362", "sentence1": "Is there a package in R/bioconductor for classification of alternative splicing?", "sentence2": "Splicer Device: an R package for classification of alternative splicing and prediction of coding potential from Whole Transcriptome Sequencing data., Recent software improvements in full-length RNA Transcript deconvolution prompted us to develop Splicer Device, an R package for classification of alternative splicing and prediction of coding potential., Splicer Device uses the full-length RNA Transcript output from Whole Transcriptome Sequencing assemblers to detect single or multiple exon skipping, alternative donor and acceptor sites, intron retention, alternative first or last exon usage, and mutually exclusive exon events. For each of these events Splicer Device also annotates the genomic coordinates of the differentially spliced elements, facilitating downstream sequence analysis. For each RNA Transcript isoform fraction values are calculated to identify RNA Transcript switching between conditions. Lastly, Splicer Device predicts the coding potential, as well as the potential nonsense mediated decay (NMD) sensitivity of each RNA Transcript., Recent software improvements in full-length RNA Transcript deconvolution prompted us to develop Splicer Device, an R package for classification of alternative splicing and prediction of coding potential., Recent software improvements in full-length RNA Transcript deconvolution prompted us to develop Splicer Device, an R package for classification of alternative splicing and prediction of coding potential. , Recent software improvements in full-length RNA Transcript deconvolution prompted us to develop Splicer Device, an R package for classification of alternative splicing and prediction of coding potential.[SEP]Relations: rRNA transcription has relations: bioprocess_bioprocess with 5S class rRNA transcription by RNA polymerase III, bioprocess_bioprocess with 5S class rRNA transcription by RNA polymerase III, bioprocess_protein with SIRT7, bioprocess_protein with SIRT7, bioprocess_protein with NPM3, bioprocess_protein with NPM3, bioprocess_protein with ANG, bioprocess_protein with ANG, bioprocess_protein with TP53, bioprocess_protein with TP53. Definitions: Splicer Device defined as following: A device designed to join pieces of a material into a continuous length.. RNA Transcript defined as following: The initial RNA molecule produced by transcription.. Whole Transcriptome Sequencing defined as following: A procedure that can determine the nucleotide sequence for all of the RNA transcripts in an individual.. alternative splicing defined as following: A process whereby multiple RNA transcripts are generated from a single gene. Alternative splicing involves the splicing together of other possible sets of EXONS during the processing of some, but not all, transcripts of the gene. Thus a particular exon may be connected to any one of several alternative exons to form a mature RNA. The alternative forms of mature MESSENGER RNA produce PROTEIN ISOFORMS in which one part of the isoforms is common while the other parts are different..", "label": "yes"} {"original_question": "Is Lasmiditan effective for migraine?", "id": "converted_3035", "sentence1": "Is Lasmiditan effective for Migraine Disorders?", "sentence2": "Amongst the ditans, lasmiditan: (i) fails to constrict Homo sapiens coronary arteries; and (ii) is effective for the acute treatment of Migraine Disorders in preliminary Phase III clinical trials., Although ongoing phase III clinical trials are needed to confirm its efficacy and safety, lasmiditan might offer an alternative to treat acute Migraine Disorders with no associated Cardiovascular system risk., Lasmiditan is considered to be the first member of a new drug category, the neurally acting anti-Migraine Disorders agent (NAAMA), Lasmiditan for the treatment of acute Migraine Disorders: a review and potential role in clinical practice., Lasmiditan, a highly selective HTR1F gene Agonist, has completed two Phase III randomized, double blind, placebo-controlled clinical trials, with a third - a long-term, open-label safety study - still underway. Research to date suggests lasmiditan lacks vasoconstrictive properties and may be a safe and effective treatment option in patients refractory to current acute Migraine Disorders medications or who have Cardiovascular system risk factors., Lasmiditan is an effective acute treatment for Migraine Disorders: A phase 3 randomized study., Compared with placebo, more patients dosed with lasmiditan 200 mg were free of headache pain at 2 hours after dosing (32.2% vs 15.3%; odds ratio [OR] 2.6, 95% confidence interval [CI] 2.0-3.6, p< 0.001), similar to those dosed with lasmiditan 100 mg (28.2%; OR 2.2, 95% CI 1.6-3.0, p< 0.001). Furthermore, compared with those dosed with placebo, more patients dosed with lasmiditan 200 mg (40.7% vs 29.5%; OR 1.6, 95% CI 1.3-2.1, p< 0.001) and lasmiditan 100 mg (40.9%; OR 1.7, 95% CI, 1.3-2.2, p< 0.001) were free of their N-oxydiethylene-2-benzothiazole sulfenamide at 2 hours after dosing., CONCLUSIONS: Lasmiditan dosed at 200 and 100 mg was efficacious and well tolerated in the treatment of acute Migraine Disorders among patients with a high level of Cardiovascular system risk factors, CLASSIFICATION OF EVIDENCE: This study provides Canadian Cardiovascular Society Grading Scale Canadian Cardiovascular Society Grading Scale Class I evidence that for adult patients with Migraine Disorders, lasmiditan increases the proportion of subjects who are headache pain free at 2 hours after treating a Migraine Disorders attack., For the understanding of Migraine Disorders pathophysiology, it is very important to note that a selective 5-HT(1F) receptor Agonist like lasmiditan is effective in the acute treatment of Migraine Disorders. , While lasmiditan most likely is effective in the treatment of Migraine Disorders attacks it had, unfortunately, a high incidence of Central Nervous System related Scanning Auger Spectrometer (device) in the oral RCT. , Acute treatment of Migraine Disorders with the selective serotonin 1F receptor Agonist lasmiditan--a randomised proof-of-concept trial.At intravenous doses of 20 mg and higher, lasmiditan proved effective in the acute treatment of Migraine Disorders. , Lasmiditan for the treatment of acute Migraine Disorders: a review and potential role in clinical practice. , BACKGROUND\nLasmiditan (COL-144) is a novel, centrally acting, highly selective 5-HT(1F) receptor Agonist without vasoconstrictor activity that seemed effective when given as an intravenous infusion in a proof-of-concept Migraine Disorders study., INTERPRETATION\nOral lasmiditan seems to be safe and effective in the acute treatment of Migraine Disorders., The serotonin 1F receptor Agonist lasmiditan, a drug acting through non-vasoconstrictive mechanisms, represents a promising safe, effective and tolerated acute Migraine Disorders therapy also for patients at Cardiovascular system risk., For the understanding of Migraine Disorders pathophysiology, it is very important to note that a selective 5-HT(1F) receptor Agonist like lasmiditan is effective in the acute treatment of Migraine Disorders., The serotonin 1F receptor Agonist lasmiditan as a potential treatment of Migraine Disorders attacks: a review of two placebo-controlled phase II trials., Within the past few years, new and promising drugs such as more specific 5-HT 1F receptor agonists (that is, lasmiditan) and monoclonal calcitonin gene-related peptide (Calcitonin Gene-Related Peptide) receptor Antibodies, in vitro diagnostic entered advanced development phases while non-invasive neuromodulatory approaches were suggested to be potentially effective as non-pharmaceutical interventions for Migraine Disorders., CLASSIFICATION OF EVIDENCE\nThis study provides Canadian Cardiovascular Society Grading Scale Canadian Cardiovascular Society Grading Scale Class I evidence that for adult patients with Migraine Disorders, lasmiditan increases the proportion of subjects who are headache pain free at 2 hours after treating a Migraine Disorders attack., BACKGROUND Lasmiditan (COL-144) is a novel, centrally acting, highly selective 5-HT(1F) receptor Agonist without vasoconstrictor activity that seemed effective when given as an intravenous infusion in a proof-of-concept Migraine Disorders study., INTERPRETATION Oral lasmiditan seems to be safe and effective in the acute treatment of Migraine Disorders., Research to date suggests lasmiditan lacks vasoconstrictive properties and may be a safe and effective treatment option in patients refractory to current acute Migraine Disorders medications or who have Cardiovascular system risk factors., The non-vascular, neural mechanism of action of lasmiditan may offer an alternative means to treat Migraine Disorders especially in patients who have contra-indications for agents with vasoconstrictor activity., Compared with placebo, more patients dosed with lasmiditan 200 mg were free of headache pain at 2 hours after dosing (32.2% vs 15.3%; odds ratio [OR] 2.6, 95% confidence interval [CI] 2.0-3.6,
CONCLUSIONS: Lasmiditan dosed at 200 and 100 mg was efficacious and well tolerated in the treatment of acute Migraine Disorders among patients with a high level of Cardiovascular system risk factors.
CLINICALTRIALSGOV IDENTIFIER: NCT02439320.
CLASSIFICATION OF EVIDENCE: This study provides Canadian Cardiovascular Society Grading Scale Canadian Cardiovascular Society Grading Scale Class I evidence that for adult patients with Migraine Disorders, lasmiditan increases the proportion of subjects who are headache pain free at 2 hours after treating a Migraine Disorders attack.
, The most common adverse events were Central Nervous System related and included dizziness, Fatigue, Vertigo , Has tingling sensation, and somnolence.
INTERPRETATION: Oral lasmiditan seems to be safe and effective in the acute treatment of Migraine Disorders., No dizziness, Paresthesia and sensations of heaviness (usually limb) were more common on lasmiditan.
CONCLUSIONS: At intravenous doses of 20 mg and higher, lasmiditan proved effective in the acute treatment of Migraine Disorders., BACKGROUND: Lasmiditan (COL-144) is a novel, centrally acting, highly selective 5-HT(1F) receptor Agonist without vasoconstrictor activity that seemed effective when given as an intravenous infusion in a proof-of-concept Migraine Disorders study., For the understanding of Migraine Disorders pathophysiology, it is very important to note that a selective 5-HT(1F) receptor Agonist like lasmiditan is effective in the acute treatment of Migraine Disorders., This study provides Canadian Cardiovascular Society Grading Scale Canadian Cardiovascular Society Grading Scale Class I evidence that for adult patients with Migraine Disorders, lasmiditan increases the proportion of subjects who are headache pain free at 2 hours after treating a Migraine Disorders attack., While lasmiditan most likely is effective in the treatment of Migraine Disorders attacks it had, unfortunately, a high incidence of Central Nervous System related Scanning Auger Spectrometer (device) in the oral RCT.[SEP]Relations: Lasmiditan has relations: drug_drug with Fendiline, drug_drug with Fendiline, drug_drug with Hypericin, drug_drug with Hypericin, drug_drug with Benzoctamine, drug_drug with Benzoctamine, drug_drug with Fimasartan, drug_drug with Fimasartan, drug_drug with Methadone, drug_drug with Methadone. Definitions: Agonist defined as following: An agent that has affinity for a receptor and intrinsic activity at that receptor.. Calcitonin Gene-Related Peptide defined as following: A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator.. Homo sapiens defined as following: Members of the species Homo sapiens.. Paresthesia defined as following: Subjective cutaneous sensations (e.g., cold, warmth, tingling, pressure, etc.) that are experienced spontaneously in the absence of stimulation.. Cardiovascular system defined as following: The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body.. Migraine Disorders defined as following: A common, severe type of vascular headache often associated with increased sympathetic activity, resulting in nausea, vomiting, and light sensitivity.. agonists defined as following: Used with chemicals, drugs, and endogenous substances to indicate substances or agents that have affinity for a receptor and intrinsic activity at that receptor. (From Textbook of Pharmacology, 1991, p.16). Fatigue defined as following: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.. Canadian Cardiovascular Society Grading Scale Class I defined as following: A grading of angina such that ordinary physical activity, such as walking or climbing stairs, does not cause angina. Angina occurs with strenuous, rapid, or prolonged exertion at work or recreation.. Central Nervous System defined as following: The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.. Scanning Auger Spectrometer (device) defined as following: An instrument that consist of an ultra high vacuum scanning microscope column combined with an electron energy analyzer, which can determine the elemental composition of the outer surface of a sample.. Has tingling sensation defined as following: A sensation as of repetitive pin pricks, caused by cold or by striking a nerve, or as a result of various diseases of the central or peripheral nervous system..", "label": "yes"} {"original_question": "Are Tregs CD4(+)CD25(+) regulatory T cells a positive regulator of the immune response?", "id": "converted_4585", "sentence1": "Are Tregs T-Cell Surface Glycoprotein CD4, Homo sapiens(+)IL2RA wt Allele(+) regulatory Therapeutic gamma delta T-lymphocytes a positive regulator of the immune response?", "sentence2": "The immunosuppressive effects of T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens+ IL2RA wt Allele high regulatory Therapeutic gamma delta T-lymphocytes (Tregs) interfere with Antitumor immune responses in cancer patients., Alteration of regulatory Therapeutic gamma delta T-lymphocytes (Tregs) may contribute to ineffective suppression of proinflammatory cytokines in type 1 diabetes.AIM, Regulatory Therapeutic gamma delta T-lymphocytes (Tregs) suppress excessive immune responses in Iris (Eye), T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens(+)IL2RA wt Allele(+) regulatory Therapeutic gamma delta T-lymphocytes (Tregs) are negative regulators of the immune system that induce and maintain immune tolerance., PTPRF gene to chronic patients, Treg from patients with Prostate Health Index inhibited the proliferation of purified tuberculin (PPD) and HIV p24 activated CD4CD25 Therapeutic gamma delta T-lymphocytes. T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens, demonstrate that aTregs are necessary for tolerance, DBA/2 skin was transplanted onto C57BL/6-RAG-1-deficient recipients adoptively transferred with purified sorted CD4CD25 Therapeutic gamma delta T-lymphocytes; half of the recipients undergo tolerance induction treatment.RE, It is well established that CD4CD25 regulatory Therapeutic gamma delta T-lymphocytes (Tregs) downregulate inflammatory immune responses and help to maintain immune homeostasis., In vitro expanded Homo sapiens T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens+IL2RA wt Allele+ regulatory Therapeutic gamma delta T-lymphocytes are potent suppressors of T-cell-mediated xenogeneic responses., BACKGROUND: Regulatory Therapeutic gamma delta T-lymphocytes (Tregs) are essential in the control of tolerance., T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens(+)IL2RA wt Allele(+) regulatory Therapeutic gamma delta T-lymphocytes (Tregs) are critical for the Peripheral immune tolerance., T regulatory Cells (Tregs) have a role in immunosuppression and control of Autoimmune Diseases, and are currently an important topic in the study of immune response to Specimen Source Codes - Tumor Cells, uncertain whether benign or malignant., T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens+IL2RA wt Allele+ regulatory Therapeutic gamma delta T-lymphocytes attenuate lipopolysaccharide-induced systemic inflammatory responses and promotes survival in Mus Escherichia coli infection., OBJECTIVES: CD4CD25 regulatory Therapeutic gamma delta T-lymphocytes (Tregs) play a key role in the prevention of various inflammatory and autoimmune disorders by suppressing immune responses., IL2RA wt Allele(High) T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens+ regulatory Therapeutic gamma delta T-lymphocytes (Regulatory T-Lymphocytes) have been described as key players in immune regulation, preventing infection-induced immune pathology and limiting collateral tissue damage caused by vigorous anti-parasite immune response. In t, ic subset of Therapeutic gamma delta T-lymphocytes, currently recognized as FOXP3(+) IL2RA wt Allele(+) T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens(+) regulatory Therapeutic gamma delta T-lymphocytes (Tregs), are pivotal in suppressing Autoimmune Diseases and maintaining immune homeostasis by mediating self-tolerance at the periphery as shown in autoimmune diseases and Malignant Neoplasms. A growing body of , T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens+IL2RA wt Allele+ regulatory Therapeutic gamma delta T-lymphocytes (Tregs) are essential negative regulators of immune responses. , Accumulating evidence has demonstrated that naturally occurring T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens(+)IL2RA wt Allele(+) regulatory Therapeutic gamma delta T-lymphocytes (Tregs) are critical for maintenance of immunological tolerance and have been shown to be important in regulating the immune responses in many diseases. Curcu, 4+IL2RA wt Allele+ Forkhead Box Protein P3+ regulatory Therapeutic gamma delta T-lymphocytes (Tregs) are recognized as one of the major regulatory factors in immune tolerance and inflammatory responses. Si, lly occurring T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens(+)IL2RA wt Allele(+) regulatory Therapeutic gamma delta T-lymphocytes (Tregs) have a key role in the prevention of various inflammatory and autoimmune disorders by suppressing immune responses. We tested t, T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens(+)IL2RA wt Allele(+) regulatory Therapeutic gamma delta T-lymphocytes (Tregs) are considered to play a key role as suppressors of immune mediated reactions. The a, T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens+ IL2RA wt Allele+ T regulatory Cells (Tregs) are classified as a subset of Therapeutic gamma delta T-lymphocytes whose role is the suppression and regulation of immune responses to self and non-self. , T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens(+)IL2RA wt Allele(+) regulatory Therapeutic gamma delta T-lymphocytes (Tregs) are potent modulators of immune responses., T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens+ Therapeutic gamma delta T-lymphocytes naturally expressing IL2RA wt Allele molecules (natural T regulatory Cells (Tregs)) have a role in maintaining self tolerance and in regulating responses to infectious agents, transplantation Ags, and Specimen Source Codes - Specimen Source Codes - tumor Ags., Naturally occurring T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens(+)IL2RA wt Allele(+) regulatory Therapeutic gamma delta T-lymphocytes (Tregs) are essential for the active suppression of Autoimmune Diseases., Amongst these, naturally occurring T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens(+)IL2RA wt Allele(+) Regulatory T-Lymphocytes (nTreg) represent a major lymphocyte population engaged in the dominant control of self-reactive T responses and maintaining tolerance in several models of Autoimmune Diseases., T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens+IL2RA wt Allele+ regulatory Therapeutic gamma delta T-lymphocytes (Tregs) are essential negative regulators of immune responses., Naturally occurring T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens(+)IL2RA wt Allele(+)FoxP3(+) regulatory Therapeutic gamma delta T-lymphocytes (IL2RA wt Allele(+) Tregs) constitute a specialized population of Therapeutic gamma delta T-lymphocytes that is essential for the maintenance of Peripheral self-tolerance., One of the subpopulations of T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens+ Therapeutic gamma delta T-lymphocytes that express IL2RA wt Allele+ and the transcription factor FOXP3, known as Regulator Therapeutic gamma delta T-lymphocytes (TReg), plays an essential role in maintaining tolerance and immune homeostasis preventing autoimmune diseases, minimalize chronic inflammatory diseases by enlisting various immunoregulatory mechanisms., Regulatory Therapeutic gamma delta T-lymphocytes (Tregs) are T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens(+)IL2RA wt Allele(bright)CD62L(high) Cells that actively down-regulate immune responses., T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens(+)IL2RA wt Allele(+) regulatory Therapeutic gamma delta T-lymphocytes (Treg) play a central role in the prevention of Autoimmune Diseases and in the control of immune responses by down-regulating the function of effector T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens(+) or CD8(+) Therapeutic gamma delta T-lymphocytes., FoxP3(+)IL2RA wt Allele(+)T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens(+) regulatory Therapeutic gamma delta T-lymphocytes (Tregs) suppress a variety of normal physiological and pathological immune responses via several pathways, such as inhibitory cytokine secretion, direct cytolysis induction, and Antigen-Presenting Cells functional modulation., Regulatory T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens(+) IL2RA wt Allele(+) T (Treg) Cells with the ability to suppress host immune responses against self- or non-self antigens play important roles in the processes of Autoimmune Diseases, transplant rejection, infectious diseases and Malignant Neoplasms., BACKGROUND: Evidence indicating that T-Cell Surface Glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens, Homo sapiens+IL2RA wt Allele+ regulatory T (Treg) Cells play a crucial role in the maintenance of Peripheral T-Lymphocyte tolerance to allergens has been [SEP]Relations: Decreased proportion of T-Cell Surface Glycoprotein CD4, Homo sapiens+IL2RA wt Allele+ regulatory Therapeutic gamma delta T-lymphocytes has relations: disease_phenotype_positive with immunodeficiency due to IL2RA wt Allele deficiency, disease_phenotype_positive with immunodeficiency due to IL2RA wt Allele deficiency, phenotype_phenotype with Abnormal T-Cell Surface Glycoprotein CD4, Homo sapiens+IL2RA wt Allele+ regulatory T-Lymphocyte proportion, phenotype_phenotype with Abnormal T-Cell Surface Glycoprotein CD4, Homo sapiens+IL2RA wt Allele+ regulatory T-Lymphocyte proportion. Bite Cells has relations: disease_phenotype_positive with hereditary stomatocytosis, disease_phenotype_positive with hereditary stomatocytosis. autoimmune disease has relations: disease_phenotype_positive with Autoimmune antibody positivity, disease_phenotype_positive with Autoimmune antibody positivity, disease_phenotype_positive with Autoimmunity, disease_phenotype_positive with Autoimmunity. Definitions: Therapeutic gamma delta T-lymphocytes defined as following: A subset of therapeutic autologous T-lymphocytes that express a T-cell receptor (TCR) composed of one gamma chain and one delta chain, with potential immunomodulating and antineoplastic activities. Upon administration of the therapeutic gamma delta T-lymphocytes, these Cells secrete interferon-gamma (IFN-g), and exert direct killing of Specimen Source Codes - Tumor Cells, uncertain whether benign or malignant. In addition, these Cells activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against Specimen Source Codes - Tumor Cells, uncertain whether benign or malignant. Gamma delta T-lymphocytes play a key role in the activation of the immune system and do not require major histocompatibility complex (MHC)-mediated antigen presentation to exert their cytotoxic effect.. Regulatory T-Lymphocytes defined as following: T-Cell Surface Glycoprotein CD4, Homo sapiens-positive Therapeutic gamma delta T-lymphocytes that inhibit immunopathology or autoimmune disease in vivo. They inhibit the immune response by influencing the activity of other cell types. Regulatory T-Cells include naturally occurring T-Cell Surface Glycoprotein CD4, Homo sapiens+IL2RA wt Allele+ Cells, IL-10 secreting Tr1 Cells, and Th3 Cells.. Autoimmune Diseases defined as following: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector Cells that are autoreactive to endogenous peptides.. Antigen-Presenting Cells defined as following: A heterogeneous group of immunocompetent Cells that mediate the cellular immune response by processing and presenting antigens to the T-Cells. Traditional antigen-presenting Cells include MACROPHAGES; DENDRITIC CELLS; LANGERHANS CELLS; and B-LYMPHOCYTES. FOLLICULAR DENDRITIC CELLS are not traditional antigen-presenting Cells, but because they hold antigen on their cell surface in the form of IMMUNE COMPLEXES for B-cell recognition they are considered so by some authors.. Iris (Eye) defined as following: The most anterior portion of the uveal layer, separating the anterior chamber from the posterior. It consists of two layers - the stroma and the pigmented epithelium. Color of the iris depends on the amount of melanin in the stroma on reflection from the pigmented epithelium.. Prostate Health Index defined as following: An assay system that indirectly measures the amount of three forms of prostate-specific antigen (PSA) in a patient serum sample and then uses those values to calculate a score that estimates the patient's probability of having prostate cancer. The PSA forms that are examined are total PSA, free PSA, and an isoform of PSA that has a propeptide comprised of two amino acid residues ([-2]proPSA).. Malignant Neoplasms defined as following: A Specimen Source Codes - tumor composed of atypical neoplastic, often pleomorphic Cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Forkhead Box Protein P3 defined as following: Forkhead box protein P3 (431 aa, ~47 kDa) is encoded by the Homo sapiens FOXP3 gene. This protein is involved in transcription regulation and the immune response.. Mus defined as following: Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae.. T-Cell Surface Glycoprotein CD4, Homo sapiens defined as following: T-cell surface glycoprotein T-Cell Surface Glycoprotein CD4, Homo sapiens (458 aa, ~51 kDa) is encoded by the Homo sapiens T-Cell Surface Glycoprotein CD4, Homo sapiens gene. This protein plays a role in antigen recognition and HIV entry.. T-Cell Surface Glycoprotein CD4, Homo sapiens+IL2RA wt Allele+ regulatory Therapeutic gamma delta T-lymphocytes defined as following: Regulatory Therapeutic gamma delta T-lymphocytes that express T-Cell Surface Glycoprotein CD4, Homo sapiens and IL2RA wt Allele (interleukin 2 receptor) antigens, with immunomodulating activity. T-Cell Surface Glycoprotein CD4, Homo sapiens+IL2RA wt Allele+ T regulatory Cells (Tregs), a subset of T-Cell Surface Glycoprotein CD4, Homo sapiens+ Therapeutic gamma delta T-lymphocytes expressing high levels of IL2RA wt Allele and the transcription factor Forkhead Box Protein P3, are essential in maintaining immunologic homeostasis, preventing Autoimmune Diseases by suppressing self-reactive Therapeutic gamma delta T-lymphocytes; T-Cell Surface Glycoprotein CD4, Homo sapiens+IL2RA wt Allele+ Tregs may induce tolerance to allogeneic organ transplants such as hematopoetic stem cell transplants (HSCTs).. Specimen Source Codes - Tumor Cells, uncertain whether benign or malignant defined as following: Cells of, or derived from, a Specimen Source Codes - tumor.. Peripheral defined as following: On or near an edge or constituting an outer boundary; the outer area.. Homo sapiens defined as following: Members of the species Homo sapiens.. IL2RA wt Allele defined as following: Human IL2RA wild-type allele is located within 10p15-p14 and is approximately 51 kb in length. This allele, which encodes interleukin-2 receptor alpha chain protein, plays a role in clathrin-independent endocytosis, cytokine activation and immune functions.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. T-Lymphocyte defined as following: Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new Therapeutic gamma delta T-lymphocytes sensitized to that antigen..", "label": "no"} {"original_question": "Is there any association between suicide and autism in adolescents, yes or no?", "id": "converted_3114", "sentence1": "Is there any association between suicide and Autistic Disorder in adolescents, yes or no?", "sentence2": ": In all subjects from our research on PubMed, 21.3% of subjects with Autistic Disorder spectrum disorder reported suicidal ideation, have attempted suicide or died by suicide (115 out of 539 subjects) and 7.7% of subjects supported for suicidal thoughts or attempted suicide exhibited an Autistic Disorder spectrum disorder (62 out of 806 subjects), all ages combined. , Suicide attempts are accompanied by a willingness for Cessation of life and can lead to suicide. They are more common in high-functioning Autistic Disorder and Asperger subjects., A total sample of 10 adolescents and young adults diagnosed with AS was obtained. The high proportion of respondents with scores above the cutoff point on the overt victimization and relational victimization scales suggests that these adolescents and young adults experienced high levels of victimization. Of the sample, 20 percent met criteria for a diagnosis of Major Depressive Disorder, 30 percent met criteria for Generalized Anxiety Disorder and 50 percent had clinically significant level of suicidal ideation., Previous studies reported a high prevalence of Cancer patients and suicide and Cancer patients and suicide and depression among patients with Autistic Disorder spectrum disorder (Atrial Septal Defects) and suggested a relationship between Atrial Septal Defects and suicidality, Patients with Atrial Septal Defects had an increased risk of suicide attempts compared with those without Atrial Septal Defects., The suicidal behaviors are frequently observed in the adolescents and adults with an Atrial Septal Defects without intellectual deficience. , Suicide is a major problem in Western society. However we have very little understanding of suicidal behaviour among individuals with Autistic Disorder spectrum disorders. , The available research provides little empirical evidence for the processes underlying suicidal behaviour in adolescents and young adults with Autistic Disorder, The present study aims to assess the rate of suicidality (suicidal ideation, behaviors and attempts) and associated risk factors for suicidality in high functioning Atrial Septal Defects, here is a lack of clinical awareness on suicidal behaviors of children and adolescents with Autistic Disorder spectrum disorder (Atrial Septal Defects), suicidality in children and adolescents with diagnosis of high functioning Autistic Disorder spectrum disorder , Consistent with the previous findings, rate of suicidality is higher in individuals with Atrial Septal Defects, Detection of Feeling suicidal (finding) in Adolescents with Autism Spectrum Disorders, Over 15% of young people with Autistic Disorder spectrum disorders (Atrial Septal Defects) will contemplate or attempt suicide during adolescence. Yet,, Until recently, suicidality in Autistic Disorder spectrum disorder (Atrial Septal Defects) was rarely discussed. , Feeling suicidal (finding) in Pervasive Development Disorder., highlighted not only that suicidal thoughts and suicide attempts can occur in adolescents and young adults with Atrial Septal Defects, but also that suicidality is likely more common in Atrial Septal Defects than in the general population. , The emerging studies indicate that the increased risk of Self-Injurious Behavior in younger and less cognitively able children with ASD3,4 is matched by an increased risk of suicidality in those at a more advanced developmental level., RESULTS\nIn all subjects from our research on PubMed, 21.3% of subjects with Autistic Disorder spectrum disorder reported suicidal ideation, have attempted suicide or died by suicide (115 out of 539 subjects) and 7.7% of subjects supported for suicidal thoughts or attempted suicide exhibited an Autistic Disorder spectrum disorder (62 out of 806 subjects), all ages combined., Risk of Suicide Attempts Among Adolescents and Young Adults With Pervasive Development Disorder: A Nationwide Longitudinal Follow-Up Study., Although the suicide risk of Autistic Disorder spectrum disorder (Atrial Septal Defects) has been suggested to be higher than previously recognized, there are few case reports focusing on the process for preventing suicide reattempts.[SEP]Relations: Autistic Disorder spectrum disorder has relations: disease_disease with Autistic Disorder (disease), disease_disease with Autistic Disorder (disease), disease_protein with MTNR1A, disease_protein with MTNR1A, disease_protein with MAOA, disease_protein with MAOA, disease_protein with ADA, disease_protein with ADA, disease_protein with AVP, disease_protein with AVP. Definitions: Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. Autistic Disorder defined as following: A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V). Pervasive Development Disorder defined as following: A category of developmental disorders characterized by impaired communication and socialization skills. The impairments are incongruent with the individual's developmental level or mental age. These disorders can be associated with general medical or genetic conditions.. Self-Injurious Behavior defined as following: Behavior in which persons hurt or harm themselves without the motive of suicide or of sexual deviation.. Autistic Disorder spectrum disorders defined as following: A spectrum of developmental disorders that includes Autistic Disorder, Asperger syndrome, and Rett syndrome. Signs and symptoms include poor communication skills, defective social interactions, and repetitive behaviors.. Feeling suicidal (finding) defined as following: Thoughts of taking one's own life.. Atrial Septal Defects defined as following: Developmental abnormalities in any portion of the ATRIAL SEPTUM resulting in abnormal communications between the two upper chambers of the heart. Classification of atrial septal defects is based on location of the communication and types of incomplete fusion of atrial septa with the ENDOCARDIAL CUSHIONS in the fetal heart. They include ostium primum, ostium secundum, sinus venosus, and coronary sinus defects..", "label": "yes"} {"original_question": "Do circular exons increase gene expression?", "id": "converted_3773", "sentence1": "Do circular Exons increase Genes expression?", "sentence2": "Each of these species was present at very low copy numbers in primary and Cultured Cells; however, only the expression of CDKN2B-AS1 wt Allele isoforms containing Exons proximal to the INK4/ARF locus correlated with the ASVD risk alleles., These results identify novel circular RNA products emanating from the CDKN2B-AS1 wt Allele locus and suggest causal variants at 9p21.3 regulate INK4/ARF expression and ASVD risk by modulating CDKN2B-AS1 wt Allele expression and/or structure., To explore the potential for using this methodology to express circular RNA in vivo, circular forms of the HDV ribozyme and RNaseP RNA were produced in E. coli. , The activity of in vivo expressed circular ribozymes could be demonstrated indicating that they fold into active conformation, We found that: i) the RNA, Circular expression profile revealed 1,285 significant differences in RNA, Circular expression, with RNA, Circular expression downregulated in 594 samples and upregulated in 691 samples via interactions with miRNAs., These circRNAs regulated the expression of target genes through interactions with miRNAs and might become new molecular biomarkers for GC in the future, 69 differentially expressed circRNAs were found that might adsorb specific miRNAs to regulate the expression of their target Genes mRNAs., Novel Coding, translation, and Genes expression of a replicating covalently closed circular RNA of 220 nt., The highly structured (64% GC) covalently closed circular (CCC) RNA (220 nt) of the virusoid associated with rice yellow mottle virus codes for a 16-kDa highly basic Protein Info using novel modalities for Coding, translation, and Genes expression, Recent evidence has demonstrated that circular RNAs (circRNAs) played crucial roles in fine-tuning the levels of Genes expression by sequestering the corresponding MicroRNAs (miRNAs). , It has been proposed that RNA, Circular regulate Genes expression at the transcriptional or post-transcriptional level by interacting with miRNAs and that circRNAs may have a role in regulating miRNA function in cancer initiation and progression.[SEP]Relations: Protein C has relations: drug_drug with Interferon gamma-1b, drug_drug with Interferon gamma-1b, drug_drug with Interferon beta-1b, drug_drug with Interferon beta-1b, drug_drug with Interferon alfa-2a, Recombinant, drug_drug with Interferon alfa-2a, Recombinant, drug_drug with Interferon alfa-2b, drug_drug with Interferon alfa-2b, drug_drug with Interferon alfa-n1, drug_drug with Interferon alfa-n1. Definitions: Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. MicroRNAs defined as following: Small double-stranded, non-Protein Info Coding RNAs, 21-25 nucleotides in length generated from single-stranded MicroRNAs Genes transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). RNA, Circular defined as following: RNA molecules in which the 3' and 5' ends are covalently joined to form a closed continuous loop. They are resistant to digestion by EXORIBONUCLEASES.. Cultured Cells defined as following: Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.. Coding defined as following: The activity of implementing rules that are used to map the elements of one set onto the elements of another set, usually on a one-to-one basis.. CDKN2B-AS1 wt Allele defined as following: Human CDKN2B-AS1 wild-type allele is located in the vicinity of 9p21.3 and is approximately 126 kb in length. This allele, which encodes CDKN2B antisense RNA 1, is involved in epigenetic silencing of nearby genes. Loss of expression of the Genes may be associated with increased susceptibility for cardiovascular disease, melanoma and several other cancers, intracranial aneurysm, type-2 diabetes, periodontitis, Alzheimer's disease, endometriosis, frailty in the elderly, and glaucoma.. Protein Info defined as following: Protein; provides access to the encoding Genes via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. 9p21.3 defined as following: A chromosome band present on 9p. Exons defined as following: The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA..", "label": "no"} {"original_question": "Do exon 38 or 39 KMT2D missense variants cause Kabuki syndrome type 1 (KS1)?", "id": "converted_3835", "sentence1": "Do exon 38 or 39 MLL2 protein, human missense variants cause KABUKI SYNDROME 2 type 1 (CXCL14 gene)?", "sentence2": "A restricted spectrum of missense MLL2 protein, human variants cause a multiple malformations disorder distinct from KABUKI SYNDROME 2., To investigate if specific exon 38 or 39 MLL2 protein, human missense variants (megavolt) cause a condition distinct from KABUKI SYNDROME 2 type 1 (CXCL14 gene).METHODS: Multiple individuals, with megavolt in Exons 38 or 39 of MLL2 protein, human that encode a highly conserved region of 54 Antifibrinolytic Antifibrinolytic amino acids flanked by Val3527 and Lys3583, were identified and phenotyped. Functional tests were performed to study their pathogenicity and understand the Disease mechanism.RESULTS: The consistent clinical features of the affected individuals, from seven unrelated families, included Choanal Atresia, Congenital absence of breast with absent nipple or hypoplastic nipples, branchial sinus abnormalities, neck pits, lacrimal duct anomalies, hearing impairment, external ear malformations, and Thyroid Diseases. None of the individuals had Intellectual Disability. The frequency of clinical features, objective software-based facial analysis metrics, and genome-wide peripheral blood DNA methylation patterns in these patients were significantly different from that of CXCL14 gene. Circular dichroism spectroscopy indicated that these megavolt perturb MLL2 protein, human secondary structure through an increased disordered to ɑ-helical transition.CONCLUSION: MLL2 protein, human megavolt located in a specific region spanning Exons 38 and 39 and affecting highly conserved residues cause a novel multiple malformations syndrome distinct from CXCL14 gene. Unlike MLL2 protein, human haploinsufficiency in CXCL14 gene, these megavolt likely result in Disease through a dominant negative mechanism.[SEP]Relations: KABUKI SYNDROME 2 has relations: disease_protein with MLL2 protein, human, disease_protein with MLL2 protein, human, disease_protein with KDM6A, disease_protein with KDM6A, disease_phenotype_positive with Generalized hypotonia, disease_phenotype_positive with Generalized hypotonia, disease_protein with RAP1B, disease_protein with RAP1B, disease_protein with RAP1A, disease_protein with RAP1A. Definitions: Congenital absence of breast with absent nipple defined as following: Absence of one or both mammary glands.. CXCL14 gene defined as following: This gene is involved in cellular homeostasis and chemotaxis.. megavolt defined as following: A SI derived unit of electric potential and electromotive force that is equal to one million volts.. hearing impairment defined as following: Partial or complete loss of the ability to detect or understand sounds resulting from damage to the outer, middle, or inner ear structures. Causes include exposure to loud noise, ear infections, injuries to the ear, genetic, and congenital disorders.. MLL2 protein, human defined as following: Histone-lysine N-methyltransferase MLL2 (5262 aa, ~564 kDa) is a transcriptional regulatory protein that is encoded by the human MLL2 gene and has a role in epigenetic transcriptional activation.. Thyroid Diseases defined as following: Pathological processes involving the THYROID GLAND.. Exons defined as following: The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Choanal Atresia defined as following: A congenital abnormality that is characterized by a blocked CHOANAE, the opening between the nose and the NASOPHARYNX. Blockage can be unilateral or bilateral; bony or membranous.. Intellectual Disability defined as following: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an Intellectual Disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28). exon defined as following: The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA..", "label": "no"} {"original_question": "Is neurofilament light marker for disease?", "id": "converted_4482", "sentence1": "Is neurofilament light marker for disease?", "sentence2": "sNfL levels during the first demyelinating event of MS are associated with greater impairment of Blood - Head>Brain barrier anatomy integrity, Immune Cell extravasation, and Head>Brain lesion activity on MRI., NEFL protein, human (NEFL wt Allele) has recently been proposed as a promising biomarker in frontotemporal dementia (Frontotemporal dementia). We investigated the correlation of both cerebrospinal fluid (CSF) and serum NEFL wt Allele with detailed neuropsychological data and Mental deterioration in a cohort of sporadic and familial Frontotemporal dementia., NEFL protein, human has a potential role in differentiating patients with frontotemporal dementia from healthy controls, patients with Alzheimer's Disease, and psychiatric disorders. , Serum neurofilament light chain (sNfL) is a marker of neuroaxonal injury., sNfL is associated with ongoing Neuroinflammation and predictive of future Nerve Degeneration in early MS., NEFL protein, human (NEFL wt Allele) is a relatively new biomarker for MS diagnosis and follow up. [SEP]Relations: Frontotemporal dementia has relations: disease_phenotype_positive with PRKAR1B-related neurodegenerative dementia with intermediate filaments, disease_phenotype_positive with PRKAR1B-related neurodegenerative dementia with intermediate filaments. Alzheimer disease has relations: disease_protein with MAPT, disease_protein with MAPT, disease_phenotype_positive with Neurofibrillary tangles, disease_phenotype_positive with Neurofibrillary tangles, disease_phenotype_positive with Senile plaques, disease_phenotype_positive with Senile plaques. Mental deterioration has relations: disease_phenotype_positive with Nerve Degeneration with ataxia, dystonia, and gaze palsy, childhood-onset, disease_phenotype_positive with Nerve Degeneration with ataxia, dystonia, and gaze palsy, childhood-onset. Definitions: NEFL wt Allele defined as following: Human NEFL wild-type allele is located in the vicinity of 8p21 and is approximately 6 kb in length. This allele, which encodes neurofilament light polypeptide protein, plays a role in both the establishment and maintenance of axonal and dendritic structures. Mutation of the gene is associated with Charcot-Marie-Tooth disease types 1F and 2E.. Immune Cell defined as following: A cell in the immune system that is involved in host defense. This category may include lymphocytes, monocytes, macrophages, neutrophils, eosinophils, basophils, mast cells, and thrombocytes. Precursor cells in these lineages may also be included.. Alzheimer's Disease defined as following: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57). NEFL protein, human defined as following: Neurofilament light polypeptide (543 aa, ~62 kDa) is encoded by the human NEFL gene. This protein is involved in the modulation of neuronal structure.. Neuroinflammation defined as following: Activation of the Head>Brain's innate immune system in response to an inflammatory challenge and is characterized by a host of cellular and molecular changes within the Head>Brain. []. Nerve Degeneration defined as following: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.. Mental deterioration defined as following: Loss of previously present mental abilities, generally in adults. [HPO:probinson]. Blood - Head>Brain barrier anatomy defined as following: Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue.. Frontotemporal dementia defined as following: The most common clinical form of FRONTOTEMPORAL LOBAR DEGENERATION, this dementia presents with personality and behavioral changes often associated with disinhibition, apathy, and lack of insight..", "label": "yes"} {"original_question": "Is SUMOylation a post-translational modification in eukaryotes?", "id": "converted_1817", "sentence1": "Is SUMOylation a post-translational ResponseLevel - modification in Eukaryota?", "sentence2": "SUMOylation, the conjugation of target Proteins with SUMO (small ubiquitin-related modifier), is a type of post-translational ResponseLevel - ResponseLevel - modification in Eukaryota and involves the sequential action of activation (E1), conjugation (ubiquitin-like protein conjugating enzyme activity) and ligation (E3) enzymes. , Plants have evolved to cope with changing environmental conditions. One way plants achieve this is through post-translational ResponseLevel - ResponseLevel - modification of target Proteins by ubiquitination and SUMOylation., Sumoylation is a post-translational ResponseLevel - ResponseLevel - modification essential in most Eukaryota that regulates stability, localization, activity, or interaction of a multitude of Proteins., SUMOylation, the Covalent Interaction attachment of a member of the small ubiquitin-like modifier (SUMO) family of Proteins to lysines in target substrates, is an essential post-translational ResponseLevel - ResponseLevel - modification in Eukaryota. , Post-translational ResponseLevel - ResponseLevel - modification by SUMO is a highly conserved pathway in Eukaryota that plays very important regulatory roles in many cellular processes. , SUMOylation is an essential post-translational ResponseLevel - ResponseLevel - modification that regulates a variety of cellular processes including cell cycle progression. Although the SUMOylation pathway has been identified and investigated in many Eukaryota, the mechanisms of SUMOylation in regulating the functions of various substrates are still poorly understood. , SUMOylation is a relevant protein post-translational ResponseLevel - ResponseLevel - modification in Eukaryota., SUMOylation is a reversible post-translational ResponseLevel - ResponseLevel - modification essential for genome stability., Many SUMOylated lysines have previously been reported to be ubiquitinated, acetylated or methylated, thus indicating cross-talk between SUMO and other post-translational modifications., Sumoylation is a post-translational ResponseLevel - ResponseLevel - modification shown to play a role in diverse biological processes., Besides phosphorylation or ubiquitylation, for which many examples of modulation by pathogens exist, a post-translational ResponseLevel - ResponseLevel - modification called SUMOylation was recently shown to be targeted by pathogenic bacteria., cruzi SUMOylated Proteins are similarly modified, indicating conserved functions for protein SUMOylation in this early divergent eukaryote., Leukoencephalopathy, Progressive Multifocal is a potent tumor suppressor and proapoptotic factor and is functionally regulated by post-translational modifications such as phosphorylation, sumoylation, and ubiquitination., SUMOylation is an essential post-translational ResponseLevel - ResponseLevel - modification that regulates a variety of cellular processes including cell cycle progression., SUMOylation in Giardia lamblia: A Conserved Post-Translational Modification in One of the Earliest Divergent Eukaryotes, SUMOylation, the Covalent Interaction attachment of a member of the small ubiquitin-like modifier (SUMO) family of Proteins to lysines in target substrates, is an essential post-translational ResponseLevel - ResponseLevel - modification in Eukaryota, SUMOylation is a relevant protein post-translational ResponseLevel - ResponseLevel - modification in Eukaryota, Post-translational modifications (PTMS gene) are one facet of this proteasomal regulation, with over 400 known phosphorylation sites, over 500 ubiquitination sites and 83 internal lysine acetylation sites, as well as multiple sites for caspase cleavage, glycosylation (such as O-GlcNAc ResponseLevel - ResponseLevel - modification), methylation, nitrosylation, oxidation, and SUMOylation, SUMOylation is an important post-translational ResponseLevel - ResponseLevel - modification, and Proto-Oncogene Proteins c-akt SUMOylation was found to regulate cell proliferation, tumorigenesis and cell cycle, but the molecular mechanism of Proto-Oncogene Proteins c-akt SUMOylation is less well known, SUMOylation is a form of post-translational ResponseLevel - ResponseLevel - modification where small ubiquitin-like modifiers (SUMO) are covalently attached to target Proteins to regulate their properties, One distinctive feature in acute proteotoxic stresses, such as heat shock (HS), is rapid post-translational ResponseLevel - ResponseLevel - modification of Proteins by SUMOs (small ubiquitin-like modifier Proteins; SUMOylation), Post-translational ResponseLevel - ResponseLevel - modification by the Small Ubiquitin-like Modifier (SUMO) Proteins, a process termed SUMOylation, is involved in many fundamental cellular processes, SUMOylation is an important post-translational ResponseLevel - ResponseLevel - modification that is involved in many key biological processes, Group III metabotropic glutamate receptors (mGluRs) undergo post-translational ResponseLevel - ResponseLevel - modification by SUMO in in vitro assays but the SUMOylation of full-length mGluRs in mammalian cells has not been reported, SUMOylation is a relevant protein post-translational ResponseLevel - ResponseLevel - modification in Eukaryota. , However, the effects of pathogenic bacteria on SUMOylation, an essential post-translational ResponseLevel - ResponseLevel - modification in Eukaryotic Cells, remain largely unknown. , A novel post-translational ResponseLevel - ResponseLevel - modification of nucleolin protein, human protein, human, SUMOylation at Lys-294, mediates arsenite-induced cell death by regulating GADD45A wt Allele� mRNA stability., Drosophila Bicoid is a substrate of sumoylation and its activator function is subject to inhibition by this post-translational ResponseLevel - ResponseLevel - modification., Here, we demonstrate that SUMOylation of RELB gene might be one of these post-translational modifications rendering the function of the NF-�B transcription factor RELB gene. , In the last decade, SUMOylation has emerged as an essential post-translational ResponseLevel - ResponseLevel - modification in Eukaryota., SUMOylation, the conjugation of target Proteins with SUMO (small ubiquitin-related modifier), is a type of post-translational ResponseLevel - ResponseLevel - modification in Eukaryota and involves the sequential action of activation (E1), conjugation (ubiquitin-like protein conjugating enzyme activity) and ligation (E3) enzymes., SUMOylation, the Covalent Interaction attachment of a member of the small ubiquitin-like modifier (SUMO) family of Proteins to lysines in target substrates, is an essential post-translational ResponseLevel - ResponseLevel - modification in Eukaryota., One way plants achieve this is through post-translational ResponseLevel - ResponseLevel - modification of target Proteins by ubiquitination and SUMOylation., The small ubiquitin-like modifier (SUMO) pathway in Eukaryota is an essential post-translational ResponseLevel - ResponseLevel - modification required for a variety of cellular processes, development and organelle biogenesis., Post-translational ResponseLevel - ResponseLevel - modification by SUMO is a highly conserved pathway in Eukaryota that plays very important regulatory roles in many cellular processes., Many SUMOylated lysines have previously been reported to be ubiquitinated, acetylated or methylated, thus indicating cross-talk between SUMO and other post-translational modifications. We identified 70 phosphorylation and four acetylation events in proximity to SUMOylation sites, and we provide evidence for acetylation-dependent SUMOylation of endogenous Histone H3. SUMOylation regulates target Proteins involved in all nuclear processes including transcription, DNA repair, chromatin remodeling, precursor-mRNA splicing and Ribosomes assembly., SUMOylation is a reversible post-translational ResponseLevel - ResponseLevel - modification essential for genome stability. Using high-resolution MS, we have studied global SUMOylation in Human cells in a site-specific manner, identifying a total of>4,300 SUMOylation sites in>1,600 Proteins., We quantitatively studied SUMOylation dynamics in response to SUMO protease inhibition, proteasome inhibition and heat shock. Many SUMOylated lysines have previously been reported to be ubiquitinated, acetylated or methylated, thus indicating cross-talk between SUMO and other post-translational modifications. We identified 70 phosphorylation and four acetylation events in proximity to SUMOylation sites, and we provide evidence for acetylation-dependent SUMOylation of endogenous Histone H3., Sumoylation is a post-translational ResponseLevel - ResponseLevel - modification shown to play a role in diverse biological processes. Here, we demonstrate that sumoylation is essential for proper heterochromatin function in Drosophila through ResponseLevel - ResponseLevel - modification of SU(VAR)3-7. Indeed, SU(VAR)3-7 is sumoylated at lysine K839; this ResponseLevel - ResponseLevel - modification is required for localization of SU(VAR)3-7 at Centric heterochromatin, Chromosomes, Human, Pair 4, and telomere., Sumoylation is a post-translational ResponseLevel - ResponseLevel - modification shown to play a role in diverse biological processes. Here, we demonstrate that sumoylation is essential for proper heterochromatin function in Drosophila through ResponseLevel - ResponseLevel - modification of SU(VAR)3-7., Our results suggest a new level of regulation of Sall activity in vivo during animal development through post-translational ResponseLevel - ResponseLevel - modification by sumoylation., BACKGROUND: Small protein tag (SUMO) is a key regulator of nuclear functions but little is known regarding the role of the post-translational ResponseLevel - ResponseLevel - modification sumoylation outside of the Cell Nucleus, particularly in the Central Nervous System (CNS).METHODOLOGY/PRINCIPAL FINDINGS: Here, we report that the expression levels of SUMO-modified substrates as well as the components of the sumoylation machinery are temporally and spatially regulated in the developing Rattus norvegicus brain., SUMOylation in Giardia lamblia: A Conserved Post-Translational Modification in One of the Earliest Divergent Eukaryotes., Identification of a novel post-translational ResponseLevel - ResponseLevel - modification in Plasmodium falciparum or Plasmodium falciparum + Plasmodium sp or Plasmodium falciparum or Plasmodium falciparum + Plasmodium sp + Plasmodium sp: protein sumoylation in different cellular compartments., More recently, Proto-Oncogene Proteins c-akt has been identified as a substrate for many different post-translational modifications, including not only phosphorylation of other residues, but also acetylation, glycosylation, oxidation, ubiquitination and SUMOylation.[SEP]Relations: protein tag has relations: molfunc_protein with SUMO2, molfunc_protein with SUMO2, molfunc_protein with SUMO4, molfunc_protein with SUMO4, molfunc_protein with SUMO1, molfunc_protein with SUMO1, molfunc_protein with SUMO1P1, molfunc_protein with SUMO1P1, molfunc_protein with SUMO3, molfunc_protein with SUMO3. Definitions: protein tag defined as following: A molecular function exhibited by a protein that is covalently attached (AKA tagged or conjugated) to another protein where it acts as a marker, recognized by the cellular apparatus to target the tagged protein for some cellular process such as ResponseLevel - modification, sequestration, transport or degradation. [GOC:dos, GOC:go_curators, PMID:19028679, PMID:20054389, PMID:6305978]. ubiquitin-like protein conjugating enzyme activity defined as following: Isoenergetic transfer of a ubiquitin-like protein (ULP) from one protein to another via the reaction X-SCP + Y -> Y-SCP + X, where both the X-SCP and Y-SCP linkages are thioester bonds between the C-terminal amino acid of SCP and a sulfhydryl side group of a cysteine residue. [GOC:dph]. Chromosomes, Human, Pair 4 defined as following: A specific pair of GROUP B CHROMOSOMES of the human chromosome classification.. RELB gene defined as following: This gene is involved in transcriptional regulation of immune processes.. Proto-Oncogene Proteins c-akt defined as following: Expressed in diverse tissues, Protein Kinase B (AKT/RAC Family) is a group (Alpha, Beta and Gamma) of cytoplasmic serine/threonine enzymes that covalently transfer the terminal, gamma phosphate group from ATP to a variety of substrate Proteins and regulate cell signaling responses to insulin, PDGF, and IGF1 (through PI3K) involved in cell survival, cell proliferation, differentiation, apoptosis, glycogen synthesis, and glucose uptake.. telomere defined as following: A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs.. Leukoencephalopathy, Progressive Multifocal defined as following: An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7). Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. Eukaryotic Cells defined as following: Cells of the higher organisms, containing a true Cell Nucleus bounded by a nuclear membrane.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. GADD45A wt Allele defined as following: Human GADD45A wild-type allele is located within 1p31.2-p31.1 and is approximately 3 kb in length. This allele, which encodes growth arrest and DNA-damage-inducible protein GADD45 alpha, is involved in the modulation of cellular responses to environmental stress.. Plants defined as following: Multicellular, eukaryotic life forms of kingdom Plantae. Plants acquired chloroplasts by direct endosymbiosis of CYANOBACTERIA. They are characterized by a mainly photosynthetic mode of nutrition; essentially unlimited growth at localized regions of cell divisions (MERISTEMS); cellulose within cells providing rigidity; the absence of organs of locomotion; absence of nervous and sensory systems; and an alternation of haploid and diploid generations. It is a non-taxonomical term most often referring to LAND PLANTS. In broad sense it includes RHODOPHYTA and GLAUCOPHYTA along with VIRIDIPLANTAE.. Centric heterochromatin defined as following: Heterochromatin that is located adjacent to the CENP-A rich centromere 'central core' and characterized by methylated H3 histone at lysine 9 (H3K9me2/H3K9me3). [PMID:12019236, PMID:20206496, PMID:22729156, PMID:9413993]. Eukaryota defined as following: Organism or cells with a Cell Nucleus separated from the cytoplasm by a two membrance nuclear envelope and compartmentalization of function into distinct cytoplasmic organelles.. nucleolin protein, human defined as following: Nucleolin (710 aa, ~77 kDa) is encoded by the human NCL gene. This protein is involved in both chromatin decondensation and Ribosomes assembly.. ResponseLevel - modification defined as following:

Respond with exceptions, completions and modifications or revisions done before completion

. Cell Nucleus defined as following: Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one Cell Nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). Histone H3 defined as following: Histone H3 is a core subunit of the eukaryotic nucleosome complex. Histones are basic nuclear Proteins responsible for the nucleosome structure of chromatin. Repeating nucleosome units contain two molecules each of Histones H2A, H2B, H3, and H4 that form an octamer complex around which approximately 146 base pairs of DNA is wrapped. Linker Histone H1 interacts with DNA between nucleosome units in mediating chromatin compaction into higher order structures. (NCI). Ribosomes defined as following: Multicomponent ribonucleoprotein structures found in the CYTOPLASM of all cells, and in MITOCHONDRIA, and PLASTIDS. They function in PROTEIN BIOSYNTHESIS via GENETIC TRANSLATION.. Covalent Interaction defined as following: A physical connection between two atoms or radicals in which a chemical bond is formed by sharing electrons..", "label": "yes"} {"original_question": "Is Hunter's disease is associated with the X Chromosome?", "id": "converted_3889", "sentence1": "Is Hunter's Disease is associated with the X Chromosome?", "sentence2": "Segregation analysis on five samples of families with Hunter's syndrome (158 cases overall) shows that the mutant allele segregates in agreement with Mendelian expectations for an X linked recessive, The utility of polymerase chain reaction (PCR) amplification of amelogenin Genes as a reliable and rapid means of determination of Sex Chromosomes was tested in 20 patients of X-linked disorders (Muscular Dystrophy, Duchenne, Hemophilia, NOS and Wiscott-Aldrich and Hunter's syndromes), , We describe a 3 year old girl with the typical clinical features of the X linked recessive condition, Hunter's Disease, We describe a 3 year old girl with the typical clinical features of the X linked recessive condition, Hunter's Disease., Hunter's Disease in a girl: association with X:5 chromosomal translocation disrupting the Hunter Genes., Further evidence localising the Genes for Hunter's syndrome to the distal region of the Xq., Full expression of Hunter's Disease in a female with an X-chromosome Gene Deletion Abnormality leading to non-random inactivation., Mucopolysaccharidosis II in a girl caused by R468Q Mutation Abnormality in the Iduronate Sulfatase Genes and skewed inactivation of the X chromosome carrying the normal allele., These findings strongly suggest that the severe form of Mucopolysaccharidosis II in this girl was the result of selective expression of the maternal allele carrying the missense Mutation Abnormality R468Q, which in turn resulted from skewed X inactivation of the paternal nonmutant X chromosome., LUSIONS: This is a report of a female with a 10.6 Mb Xq27-28 Gene Deletion Abnormality with skewed inactivation of the deleted X chromosome. Con, Brother/sister siblings affected with Mucopolysaccharidosis II: evidence for skewed X chromosome inactivation., The normal X chromosome was preferentially inactivated, supporting the view that the translocation had disrupted the Hunter Genes., Mucopolysaccharidosis II (Mucopolysaccharidoses type II) associated with unbalanced inactivation of the X Chromosome in a karyotypically normal girl., INTRODUCTION: Hunter syndrome, or Mucopolysaccharidoses type II, is an inherited Disease linked to the X chromosome that is caused by a deficit of the Enzyme [APC] Iduronate Sulfatase and its main symptoms affect the XXX bone, neurological system and the Viscera., INTRODUCTION: Hunter syndrome, or Mucopolysaccharidoses type II, is an inherited Disease linked to the X chromosome that is caused by a deficit of the Enzyme [APC] Iduronate Sulfatase and its main symptoms affect the XXX bone, neurological system and the, Mucopolysaccharidosis type II (MPS II, Mucopolysaccharidosis II) is an X chromosome-linked inherited metabolic Disease caused by Gene Mutation resulting in deficiency of activity of Iduronate Sulfatase (IDS) and accumulation of undegraded glycosaminoglycans (Mouth gag), heparan sulfate, and Dermatan Sulfate. Previous, Mucopolysaccharidosis type II (MPS-II, Mucopolysaccharidosis II) is a X-linked recessive disorder. Affe, Mucopolysaccharidosis type II (MPS II or Hunter syndrome) is a rare X-linked disorder caused by deficient activity of the lysosomal Enzyme [APC], Iduronate Sulfatase (IDS). Pheno, Mucopolysaccharidosis II or Mucopolysaccharidoses type II is an X-linked Disease caused by the deficiency of the lysosomal Enzyme [APC] Iduronate Sulfatase (IDS). Tyrosine 3-Monooxygenase, human, Mucopolysaccharidosis type II (MPS II, Hunter syndrome) is an X-linked lysosomal storage Disease caused by a deficiency of Iduronate Sulfatase (IDS). Two a, We report the results of studies on the characterization of the Mutation Abnormality associated with marked unbalanced expression of the mutant X chromosome in a karyotypically normal girl with Mucopolysaccharidosis II (Mucopolysaccharidoses type II). So, BACKGROUND: Hunter syndrome (Mucopolysaccharidoses type II) is a recessive X-linked disorder due to Gene Mutation in the iduronate 2-sulfatase (IDS, Familial X-chromosome inactivation (XCI) skewing was investigated in a family in which a female Mucopolysaccharidoses type II (MPS II) (Hunter syndrome, an X-linked genetic Disease) occurred. Among e, Studies using Bromodeoxyuridine indicated that the deleted X chromosome was consistently late replicating, and as a result the Hunter Genes was fully expressed on the other X chromosome., All Mucopolysaccharidoses are autosomal recessive disorders, except for Hunter's syndrome that is X-linked and recessive., Female twin with Mucopolysaccharidosis II due to nonrandom inactivation of the X-chromosome: a consequence of twinning., Hunter syndrome (Mucopolysaccharidoses type II) is a recessive X-linked disorder due to Gene Mutation in the iduronate 2-sulfatase (IDS) Genes., Mucopolysaccharidosis II is an X-linked recessive mucopolysaccharide storage disorder caused by Iduronate Sulfatase deficiency and is rare in females., Mucopolysaccharidosis II is an X-linked recessive disorder caused by a deficiency of Iduronate Sulfatase activity.[SEP]Relations: X-linked Disease has relations: disease_disease with sex-linked Disease, disease_disease with sex-linked Disease, disease_disease with X-linked dominant Disease, disease_disease with X-linked dominant Disease, disease_disease with X-linked immunoneurologic disorder, disease_disease with X-linked immunoneurologic disorder, disease_disease with X-linked intellectual disability, disease_disease with X-linked intellectual disability, disease_disease with choroideremia, disease_disease with choroideremia. Definitions: Bromodeoxyuridine defined as following: A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors.. Mucopolysaccharidosis II defined as following: Systemic lysosomal storage Disease marked by progressive physical deterioration and caused by a deficiency of L-sulfoiduronate sulfatase. This Disease differs from MUCOPOLYSACCHARIDOSIS I by slower progression, lack of corneal clouding, and X-linked rather than autosomal recessive inheritance. The mild form produces near-normal intelligence and life span. The severe form usually causes death by age 15.. X Chromosome defined as following: The female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in human and other male-heterogametic species.. heparan sulfate defined as following: A heteropolysaccharide that is similar in structure to HEPARIN. It accumulates in individuals with MUCOPOLYSACCHARIDOSIS.. Dermatan Sulfate defined as following: A naturally occurring glycosaminoglycan found mostly in the skin and in connective tissue. It differs from CHONDROITIN SULFATE A (see CHONDROITIN SULFATES) by containing IDURONIC ACID in place of glucuronic acid, its epimer, at carbon atom 5. (from Merck, 12th ed). Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Iduronate Sulfatase defined as following: An Enzyme [APC] that specifically cleaves the ester sulfate of iduronic acid. Its deficiency has been demonstrated in Hunter's syndrome, which is characterized by an excess of Dermatan Sulfate and heparan sulfate. EC 3.1.6.13.. X-linked genetic Disease defined as following: Genetic diseases that are linked to Genes Gene Mutation on the X CHROMOSOME in humans (X CHROMOSOME, HUMAN) or the X CHROMOSOME in other species. Included here are animal models of human X-linked diseases.. Viscera defined as following: Any of the large interior organs in any one of the three great cavities of the body, especially in the abdomen.. Tyrosine 3-Monooxygenase, human defined as following: Tyrosine 3-monooxygenase (528 aa, ~59 kDa) is encoded by the human TH Genes. This protein plays a role in the synthesis of dopamine from L-tyrosine.. Hemophilia, NOS defined as following: A deficiency or abnormality of a blood coagulation factor characterized by the tendency to hemorrhage. Hemophilia is typically a hereditary disorder but, rarely, may be acquired. Inherited coagulation factor-deficient hemophilias include hemophilia A or classic hemophilia (hereditary factor VIII deficiency) hemophilia B or Christmas Disease (hereditary factor IX deficiency), and hemophilia C (hereditary factor XI deficiency). Factor VIII inhibitors may occur spontaneously as autoantibodies, resulting in acquired hemophilia known as acquired factor VIII deficiency. Approximately 10% of patients with acquired hemophilia have an underlying malignancy.. Mouth gag defined as following: An ear, nose, and throat manual surgical instrument is one of a variety of devices intended for use in surgical procedures to examine or treat the bronchus, esophagus, trachea, larynx, pharynx, nasal and paranasal sinus, or ear. This generic type of device includes the esophageal dilator; tracheal bistour (a long, narrow surgical knife); tracheal dilator; tracheal hook; laryngeal injection set; laryngeal knife; laryngeal saw; laryngeal trocar; laryngectomy tube; adenoid curette; adenotome; metal tongue depressor; mouth gag; oral screw; salpingeal curette; tonsillectome; tonsil guillotine; tonsil screw; tonsil snare; tonsil suction tub; tonsil suturing hook; antom reforator; ethmoid curette; frontal sinus-rasp; nasal curette; nasal rasp; nasal rongeur; nasal saw; nasal scissors; nasal snare; sinus irrigator; sinus trephine; ear curette; ear excavator; ear rasp; ear scissor, ear snare; ear spoon; ear suction tub; malleous ripper; mastoid gauge; microsurgical ear chisel; myringotomy tube inserter; ossici holding clamp; sacculotomy tack inserter; vein press; wire ear loop; microrule; mirror; mobilizer; ear, nose, and throat punch; ear, nose and throat knife; and ear, nose, and throat trocar.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. Sex Chromosomes defined as following: The homologous chromosomes that are dissimilar in the heterogametic sex. There are the X CHROMOSOME, the Y CHROMOSOME, and the W, Z chromosomes (in animals in which the female is the heterogametic sex (the silkworm moth Bombyx mori, for example)). In such cases the W chromosome is the female-determining and the male is ZZ. (From King & Stansfield, A Dictionary of Genetics, 4th ed). Mucopolysaccharidoses defined as following: Group of lysosomal storage diseases each caused by an inherited deficiency of an Enzyme [APC] involved in the degradation of glycosaminoglycans (mucopolysaccharides). The diseases are progressive and often display a wide spectrum of clinical severity within one Enzyme [APC] deficiency.. Gene Mutation defined as following: The result of any gain, loss or alteration of the sequences comprising a Genes, including all sequences transcribed into RNA.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Xq defined as following: Distal (long) arm of chromosome X. Muscular Dystrophy, Duchenne defined as following: An X-linked recessive muscle Disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of Disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415). X Chromosome defined as following: The female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in human and other male-heterogametic species..", "label": "yes"} {"original_question": "Is treatment resistant depression related to vitamin B9?", "id": "converted_1861", "sentence1": "Is treatment resistant Cancer patients and suicide and depression related to vitamin Lateral basal segmental bronchus?", "sentence2": "Suboptimal serum and Folic acid measurement, RBC levels have been associated with a poorer response to Antidepressive Agents therapy, a greater severity of symptoms, later onset of clinical improvement, and overall treatment resistance. This article reviews the evidence for levomefolate and folic acid as antidepressive agents in Cancer patients and suicide and Cancer patients and suicide and depression and discusses their clinical use, Although further randomized controlled trials in this area appear warranted, S-adenosylmethionine and levomefolate may represent a useful addition to the cytarabine/daunorubicin protocol armamentarium., Patients with Cancer patients and suicide and Cancer patients and suicide and depression have consistently been found to have lower levels of serum and Folic acid measurement, RBC than normal or nondepressed psychiatric patients. Decreased folate levels have been associated with lowered response rates to standard Antidepressive Agents pharmacotherapy. Recent studies have shown that augmentation with a folate supplement increases medication response in both treatment-naïve and treatment-resistant depressed patients irrespective of whether there is folate deficiency., Depressed patients with both low and normal folate levels may benefit from augmenting a primary Antidepressive Agents medication either initially, at the onset of treatment, or later after some degree of treatment resistance has been recognized., The results of this study suggest that intake of vitamin Lateral basal segmental bronchus may modulate the total score of Center for Epidemiological Studies Depression Scale (CES-D) and two subscales of the CES-D including depressive affect and interpersonal difficulties., The results of this study suggest that intake of vitamin Lateral basal segmental bronchus may modulate the total score of Center for Epidemiological Studies Depression Scale (CES-D) and two subscales of the CES-D including depressive affect and interpersonal difficulties. , This article reviews the metabolic and clinical importance of folate, Vitamin NDUFB3 gene [EPC], and S-adenosylmethionine, as well as clinical trials in relation to Cancer patients and suicide and Cancer patients and suicide and depression and Presenile Presenile dementia, In particular, thiamine, Measles virus genotype Measles virus genotype B3, B6, Lateral basal segmental bronchus and NDUFB3 gene are essential for neuronal function and Androgen Receptor Deficiency have been linked to Cancer patients and suicide and Cancer patients and suicide and depression.[SEP]Relations: Folic acid has relations: drug_drug with Amphotericin B, drug_drug with Amphotericin B, contraindication with diabetes mellitus (disease), contraindication with diabetes mellitus (disease), drug_drug with Blonanserin, drug_drug with Blonanserin, drug_drug with Brincidofovir, drug_drug with Brincidofovir. Thiamine has relations: drug_protein with SLC19A2, drug_protein with SLC19A2. Definitions: folate defined as following: A cofactor for 1-carbon transfer involved with DNA synthesis.. S-adenosylmethionine defined as following: Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From Merck, 11th ed). Folic acid measurement, RBC defined as following: The determination of the concentration of folic acid present in a sample of red blood cells.. folic acid defined as following: A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate Androgen Receptor Deficiency and megaloblastic anemia.. Antidepressive Agents defined as following: Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.. levomefolate defined as following: A nutritional supplement containing the biologically active form of the Lateral basal segmental bronchus vitamin folate, 5-methyltetrahydrofolate (levomefolate), with potential antineoplastic activity. Upon administration, levomefolate is able to provide methyl groups allowing an increase in the level of DNA methylation in the promoter regions of certain tumor-promoting genes, thereby reversing the DNA hypomethylation of these genes and inactivating them. This may result in a decrease of both tumor cell proliferation and tumor progression. In addition, administration of levomefolate may sensitize tumor cells to the cytotoxic effects of other chemotherapeutic agents. Unlike folic acid, levomefolate is able to cross the blood brain barrier and could be beneficial in the treatment of brain tumors. DNA hypomethylation of certain genes leads to chromosome instability and contributes to tumor development.. Presenile dementia defined as following: The presence of Presenile dementia in an individual younger than age sixty five.. thiamine defined as following: 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2- hydroxyethyl)-4-methylthiazolium chloride.. vitamin Lateral basal segmental bronchus defined as following: A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate Androgen Receptor Deficiency and megaloblastic anemia..", "label": "yes"} {"original_question": "Is vocimagene amiretrorepvec effective for glioblastoma?", "id": "converted_4125", "sentence1": "Is vocimagene amiretrorepvec effective for Glioblastoma Multiforme?", "sentence2": "CONCLUSIONS: These results support an immune-related mechanism of action for Toca 511 and Toca FC, and suggest that Molecular and immunologic signatures are related to clinical benefit from treatment., The median OS was 11.10 months for the Toca 511/FC group and 12.22 months for the control group (hazard ratio, 1.06; 95% CI 0.83, 1.35; P = .62). The secondary end points did not demonstrate statistically significant differences. The rates of adverse events were similar in the Toca 511/FC group and the SOC control group.Conclusions and Relevance: Among patients who underwent tumor resection for first or second recurrence of Glioblastoma Multiforme or Anaplastic astrocytoma, administration of Toca 511 and Toca FC, compared with SOC, did not improve overall survival or other efficacy end points.[SEP]Relations: adult Glioblastoma Multiforme has relations: disease_disease with Glioblastoma Multiforme (disease), disease_disease with Glioblastoma Multiforme (disease), disease_disease with adult infiltrating astrocytic neoplasm, disease_disease with adult infiltrating astrocytic neoplasm, disease_disease with adult spinal cord Glioblastoma Multiforme, disease_disease with adult spinal cord Glioblastoma Multiforme. Anaplastic astrocytoma has relations: contraindication with Temsirolimus, contraindication with Temsirolimus, contraindication with Sirolimus, contraindication with Sirolimus. Definitions: Molecular defined as following: Relating to or produced by or consisting of molecules.. Glioblastoma Multiforme defined as following: The most malignant astrocytic tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO). Anaplastic astrocytoma defined as following: A central nervous system tumor with morphological features of Anaplastic astrocytoma in which there is insufficient information on the IDH genes status..", "label": "no"} {"original_question": "Does an antiphlogistic promotes inflammation?", "id": "converted_3856", "sentence1": "Does an antiphlogistic promotes Inflammation?", "sentence2": "The therapeutic effect of olipiphate was demonstrated for chronic Inflammation of advanced arthritis and concanavalin A-related acute edema. The best systemic effect was obtained with 50 mg/kg, symptomatic--100 mg/kg. Wound of skin treated with 5% olipiphate (26 + 2) healed faster than those treated with 2% solcoseryl (30 + 0.8) or in control (33 + 0.6). It was shown histologically that the proliferative and antiphlogistic effect of olipiphate involved no scars., Moreover, we observed an in vitro-inhibition of human neutrophil elastase, a Endopeptidases involved in the inflammatory process, by extracts and Fraction of from Hoplerythrinus unitaeniatus, which suggests additional mechanisms of antiphlogistic action., Blood serotonin in adrenalectomized Rattus norvegicus with inflammationadrenalectomized Rattus norvegicus 42 days and 3 months old with Inflammation after injection of phenylbutazone an increase of serotonin was observed, but in 18-month-old animal allergen extracts in which antiphlogistic action is highest a decrease of serotonin was observed., These results indicate that methotrexate is a nonsteroidal antiinflammatory agent, the antiphlogistic action of which is due to increased adenosine release at inflamed sites., The antiphlogistic ibuprofen incorporated in Liposomes caused a decrease of the inflammatory edema induced by carrageenan in the distal part of the rat's hind leg after both the Intramuscular Route of Drug Administration and percutaneous administration., Enhancement of the immunoreactivity inhibition caused by the drugs was not proportional to the increase in their antiphlogistic effects determined by the Selye model of Inflammation., Antiinflammatory agents: new series of N-substituted amino acids with complex Pyrimidine structures endowed with antiphlogistic activity., investigate whether the antiphlogistic ingredient may suppress the inflammatory response to ultraviolet (UV) irradiation, the SPF was determined in vivo. F, Antiphlogistics were found to enhance the Membrane Device viscosity both in control and under Inflammation., e in vivo determination of the SPF. Evidence of anti-inflammatory activity of the sunscreen antiphlogistics bisabolol and panthenol was also not apparent in the UV model over a time course of 48 h. Conlusion: The antiphlogistic ingredients panthenol and bisabolol incorporated in the tested sunscreen formula do not interfere with Erythema reddening and thus , nts was analyzed in vitro. To investigate whether the antiphlogistic ingredient may suppress the inflammatory response to ultraviolet (UV) irradiation, the , The aim of this study was to analyze the formation of the most relevant Inflammation mediators including Proteins and Lipids in human fibroblasts upon inflammatory stimulation and subsequent treatment with dexamethasone, a powerful antiphlogistic drug.[SEP]Relations: ibuprofen has relations: contraindication with inflammatory bowel disease, contraindication with inflammatory bowel disease, drug_effect with Nephrotic syndrome, drug_effect with Nephrotic syndrome, drug_effect with Inflammatory abnormality of the skin, drug_effect with Inflammatory abnormality of the skin. Methotrexate has relations: contraindication with inflammatory bowel disease, contraindication with inflammatory bowel disease. Adenosine has relations: drug_effect with Inflammatory abnormality of the skin, drug_effect with Inflammatory abnormality of the skin. Definitions: Fraction of defined as following: A part, a fragment of a whole.. Lipids defined as following: A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed). methotrexate defined as following: An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. dexamethasone defined as following: An anti-inflammatory 9-fluoro-glucocorticoid.. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. Rattus norvegicus defined as following: The common rat, Rattus norvegicus, often used as an experimental organism.. Membrane Device defined as following: A device that is made from or resembles a thin flexible sheet of material.. Liposomes defined as following: Artificial, single or multilaminar vesicles (made from lecithins or other Lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and Membrane Device Proteins.. Erythema defined as following: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.. adenosine defined as following: A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.. Endopeptidases defined as following: A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS.. serotonin defined as following: A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator.. ibuprofen defined as following: A non-steroidal anti-inflammatory agent with analgesic, antipyretic, and anti-inflammatory properties. phenylbutazone defined as following: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.. Wound of skin defined as following: A cutaneous wound is a defined as a disruption of normal anatomic structure and function of the skin that occured owing to an injury of the skin. Wound healing is a dynamic, interactive processinvolving soluble mediators, blood cells, extracellularmatrix, and parenchymal cells. Wound healing has three phases: Inflammation, tissue formation, and tissue remodeling, that overlap in time. [PMID:10471461]. carrageenan defined as following: A water-soluble extractive mixture of sulfated polysaccharides from RED ALGAE. Chief sources are the Irish moss CHONDRUS CRISPUS (Carrageen), and Gigartina stellata. It is used as a stabilizer, for suspending COCOA in chocolate manufacture, and to clarify BEVERAGES.. Intramuscular Route of Drug Administration defined as following: Intramuscular injection is a route of drug administration via injection into muscle tissue. Aqueous or oleaginous solutions and emulsions or suspensions may be administered. Absorption rates, delay in availability of the drug to the systemic circulation, and duration of effect are perfusion-limited, depend on molecular size of the agent, volume, and osmolarity of the drug solution, fat content of the injection site, and patient physical activity..", "label": "no"} {"original_question": "Does trimetazidine protect from myocardial injury after percutaneous coronary intervention?", "id": "converted_4344", "sentence1": "Does trimetazidine protect from myocardial injury after percutaneous coronary intervention?", "sentence2": "After a median follow-up of 47·5 months (IQR 42·3-53·3), incidence of primary endpoint events was not significantly different between the trimetazidine group (700 [23·3%] patients) and the placebo group (714 [23·7%]; hazard ratio 0·98 [95% CI 0·88-1·09], p=0·73). When analysed individually, there were no significant differences in the incidence of the components of the primary endpoint between the treatment groups. , INTERPRETATION: Our results show that the routine use of oral trimetazidine 35 mg twice daily over several years in patients receiving optimal medical therapy, after successful PCI, does not influence the recurrence of Ever told by doctor that you had Ever told by doctor that you had angina:Finding:Point in time:^Patient:Ordinal:Finding:Point in time:^Patient:Ordinal or the outcome; these findings should be taken into account when considering the place of trimetazidine in clinical practice. [SEP]Relations: Trimetazidine has relations: drug_drug with Metoclopramide, drug_drug with Metoclopramide, drug_drug with Patent Blue, drug_drug with Patent Blue, drug_protein with ACAA1, drug_protein with ACAA1, drug_drug with Isosorbide mononitrate, drug_drug with Isosorbide mononitrate. negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator has relations: bioprocess_protein with CD44, bioprocess_protein with CD44. Definitions: trimetazidine defined as following: A vasodilator used in Ever told by doctor that you had angina:Finding:Point in time:^Patient:Ordinal of effort or ischemic heart disease..", "label": "no"} {"original_question": "Is hypersensitivity to DNA crosslinking agents a hallmark of Fanconi anemia?", "id": "converted_860", "sentence1": "Is Emotional hypersensitivity to DNA crosslinking agents a hallmark of Fanconi anemia?", "sentence2": "The Fanconi anemia (doxorubicin/fluorouracil protocol) core complex plays a central role in the DNA damage response network, FAAP100-deficient cells display hallmark features of doxorubicin/fluorouracil protocol cells, including defective FANCONI ANEMIA, COMPLEMENTATION GROUP D2 monoubiquitination, Emotional Emotional hypersensitivity to DNA crosslinking agents, and genomic instability., Fanconi anemia (doxorubicin/fluorouracil protocol) is a rare genetic disorder characterized by Aplastic Anemia, Primary malignant neoplasm/leukemia susceptibility and Cells Emotional Emotional hypersensitivity to DNA crosslinking agents, such as cisplatin., Fanconi anemia (doxorubicin/fluorouracil protocol) is an inherited Chromosomes recessive syndrome characterized by Cells Emotional Emotional hypersensitivity to DNA crosslinking agents and Bone marrow hypocellularity, which cause Aplastic Anemia, and an increased incidence of malignancy., Features of Chromosomes aberrations, Emotional Emotional hypersensitivity to DNA crosslinking agents, and predisposition to malignancy have suggested a fundamental anomaly of DNA repair in Fanconi anemia., Fanconi anemia (doxorubicin/fluorouracil protocol) is one of several genetic diseases with characteristic Cells Emotional Emotional hypersensitivity to DNA crosslinking agents which suggest that doxorubicin/fluorouracil protocol Proteins may function as part of DNA repair processes., Fanconi anemia (doxorubicin/fluorouracil protocol) is characterized by Cells Emotional Emotional hypersensitivity to DNA crosslinking agents, but how the Fanconi pathway protects cells from DNA Cross link and whether doxorubicin/fluorouracil protocol Proteins act directly on Cross link remain unclear., FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) (doxorubicin/fluorouracil protocol) is a rare genetic disorder associated with a bone-marrow failure, Primary malignant neoplasm predisposition and Emotional Emotional hypersensitivity to DNA crosslinking agents., Fanconi anemia (doxorubicin/fluorouracil protocol) is a heterogeneous Disease associated with a Bone marrow hypocellularity, Primary malignant neoplasm predisposition and Emotional Emotional hypersensitivity to DNA crosslinking agents., Fanconi anemia (doxorubicin/fluorouracil protocol) is an inherited disorder characterized by defective DNA repair and Cells sensitivity to DNA crosslinking agents., Fanconi anemia (doxorubicin/fluorouracil protocol) is an inherited Disease characterized by Bone marrow hypocellularity, increased Primary malignant neoplasm risk and Emotional Emotional hypersensitivity to DNA cross-linking agents, implying a role for this pathway in the maintenance of genomic stability., Genetic or epigenetic inactivation of the pathway formed by the FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) (doxorubicin/fluorouracil protocol) Proteins occurs in several Primary malignant neoplasm types, including Squamous cell carcinoma of the head and neck (HNSCC), rendering the affected Neoplasms potentially hypersensitive to DNA crosslinking agents., FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) (doxorubicin/fluorouracil protocol) is a rare autosomic recessive and X-linked Disease with Chromosomes instability after exposure to crosslinking agents as the hallmark., FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) (doxorubicin/fluorouracil protocol) is an autosomal recessive Disease characterized by chromosome instability, Cells Emotional Emotional hypersensitivity to DNA cross-linking agents, and increased predisposition to Malignant Neoplasms., The Bloom protein (Bloom Syndrome) and DNA topoisomerase III alpha are found in association with Proteins of the Fanconi anemia (doxorubicin/fluorouracil protocol) pathway, a disorder manifesting increased Cells sensitivity to DNA crosslinking agents., Using siRNA depletion and gene knockout techniques, we show that FAAP100-deficient cells display hallmark features of doxorubicin/fluorouracil protocol cells, including defective FANCONI ANEMIA, COMPLEMENTATION GROUP D2 monoubiquitination, Emotional Emotional hypersensitivity to DNA crosslinking agents, and genomic instability., Fanconi anemia (doxorubicin/fluorouracil protocol) is a recessive Homo sapiens Primary malignant neoplasm prone syndrome featuring Bone marrow hypocellularity, developmental abnormalities and Emotional Emotional hypersensitivity to DNA crosslinking agents exposure., doxorubicin/fluorouracil protocol is a chromosome instability syndrome characterized by childhood-onset Aplastic Anemia, Primary malignant neoplasm or leukemia susceptibility, and Cells Emotional Emotional hypersensitivity to DNA crosslinking agents., Functional defects in the Fanconi pathway can result in a marked Emotional Emotional hypersensitivity to interstrand crosslinking agents, such as Mitomycins C., At the Cells level, Emotional Emotional hypersensitivity to DNA interstrand Cross link is the defining feature in Fanconi anemia., DNA crosslinking agents may led to DNA cross-linking lesion, and Fanconi anemia pathway plays a key role in repairing its cross-linking., Fanconi anemia (doxorubicin/fluorouracil protocol), an Autosomal Recessive Disorder of children, is characterized by congenital or childhood Aplastic Anemia, multiple developmental anomalies, increased incidence of Myeloid Leukemia, increased spontaneous chromosome breakage, and Cells and Chromosomes Emotional Emotional hypersensitivity to DNA bifunctional crosslinking and Alkylating Agents., elegans provides an excellent model system for the study of the FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) (doxorubicin/fluorouracil protocol), one of the hallmarks of which is sensitivity to interstrand crosslinking agents, Using siRNA depletion and gene knockout techniques, we show that FAAP100-deficient cells display hallmark features of doxorubicin/fluorouracil protocol cells, including defective FANCONI ANEMIA, COMPLEMENTATION GROUP D2 monoubiquitination, Emotional Emotional hypersensitivity to DNA crosslinking agents, and genomic instability, One of the hallmark phenotypes of doxorubicin/fluorouracil protocol is Cells Emotional Emotional hypersensitivity to agents that induce DNA interstrand Cross link (ICLs), such as Mitomycins C (Mitomycins), Furthermore, the cytological hallmark of doxorubicin/fluorouracil protocol, the DNA crosslink-induced radial chromosome formation, exemplifies an innate impairment in the repair of these particularly cytotoxic DNA lesions [A.D, Fanconi anemia (doxorubicin/fluorouracil protocol) is characterized by Cells Emotional Emotional hypersensitivity to DNA crosslinking agents, but how the Fanconi pathway protects cells from DNA Cross link and whether doxorubicin/fluorouracil protocol Proteins act directly on Cross link remain unclear, Features of Chromosomes aberrations, Emotional Emotional hypersensitivity to DNA crosslinking agents, and predisposition to malignancy have suggested a fundamental anomaly of DNA repair in Fanconi anemia, Fanconi anemia (doxorubicin/fluorouracil protocol) is an inherited Chromosomes recessive syndrome characterized by Cells Emotional Emotional hypersensitivity to DNA crosslinking agents and Bone marrow hypocellularity, which cause Aplastic Anemia, and an increased incidence of malignancy, Genetic or epigenetic inactivation of the pathway formed by the FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) (doxorubicin/fluorouracil protocol) Proteins occurs in several Primary malignant neoplasm types, including Squamous cell carcinoma of the head and neck (HNSCC), rendering the affected Neoplasms potentially hypersensitive to DNA crosslinking agents, Fanconi anemia (doxorubicin/fluorouracil protocol) is a Homo sapiens autosomal disorder characterized by Primary malignant neoplasm susceptibility and Cells sensitivity to DNA crosslinking agents such as Mitomycins C and erythritol anhydride, The Fanconi anemia pathway promotes DNA glycosylase-dependent excision of interstrand DNA Cross link., DNA crosslinking agents may led to DNA cross-linking lesion, and Fanconi anemia pathway plays a key role in repairing its cross-linking, doxorubicin/fluorouracil protocol is a chromosome instability syndrome characterized by childhood-onset Aplastic Anemia, Primary malignant neoplasm or leukemia susceptibility, and Cells Emotional Emotional hypersensitivity to DNA crosslinking agents, The Disease is manifested by defects in DNA repair, Emotional Emotional hypersensitivity to DNA crosslinking agents, and a high degree of Chromosomes aberrations[SEP]Relations: Fanconi anemia complementation group has relations: disease_phenotype_positive with Chromosomal breakage induced by crosslinking agents, disease_phenotype_positive with Chromosomal breakage induced by crosslinking agents, disease_phenotype_positive with Chromosomal breakage induced by crosslinking agents, disease_phenotype_positive with Chromosomal breakage induced by crosslinking agents, disease_phenotype_positive with Deficient excision of UV-induced pyrimidine dimers in DNA, disease_phenotype_positive with Deficient excision of UV-induced pyrimidine dimers in DNA, disease_phenotype_positive with Deficient excision of UV-induced pyrimidine dimers in DNA, disease_phenotype_positive with Deficient excision of UV-induced pyrimidine dimers in DNA, disease_phenotype_positive with Overfolded helix, disease_phenotype_positive with Overfolded helix. Definitions: Autosomal Recessive Disorder defined as following: An inherited disorder manifested only when two copies of a mutated gene are present.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Chromosomes defined as following: In a prokaryotic cell or in the nucleus of a eukaryotic cell, a structure consisting of or containing DNA which carries the genetic information essential to the cell. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). Bloom Syndrome defined as following: An Autosomal Recessive Disorder characterized by telangiectatic ERYTHEMA of the face, photosensitivity, DWARFISM and other abnormalities, and a predisposition toward developing Primary malignant neoplasm. The Bloom syndrome gene (Bloom Syndrome) encodes a RecQ-like DNA helicase.. Cross link defined as following: Any covalent linkage between two polymers or between two different regions of the same polymer.. FANCONI ANEMIA, COMPLEMENTATION GROUP D2 defined as following: Fanconi anemia caused by mutations of the FANCONI ANEMIA, COMPLEMENTATION GROUP D2 gene. This gene is involved in the repair of DNA double-strand breaks, both by homologous recombination and single-strand annealing.. Myeloid Leukemia defined as following: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.. Cells defined as following: The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.. Squamous cell carcinoma of the head and neck defined as following: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this Primary malignant neoplasm.. Emotional hypersensitivity defined as following: Heightened emotional reactivity to environmental stimuli, including emotions of others. [PMID:23250816]. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. cisplatin defined as following: An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand Cross link. These Cross link appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with Cells arrest in the G2 phase of the cell cycle.. Genetic defined as following: Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.. Mitomycins defined as following: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.. erythritol anhydride defined as following: A colorless, highly flammable, liquid cyclic ether. Diepoxybutane is primarily used for research purposes, but is also used as a curing agent for polymer resins and as a cross-linking agent for making synthetic textile fibers. Exposure to this substance can severely irritate and burn the eyes and skin and can cause liver damage. Diepoxybutane is reasonably anticipated to be a Homo sapiens carcinogen based on evidence of carcinogenicity in experimental animals. (NCI05). Mitomycins defined as following: A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid Neoplasms. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Alkylating Agents defined as following: Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases.. leukemia defined as following: A progressive, malignant Disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to Cells maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006). Neoplasms defined as following: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.. FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) defined as following: Fanconi anemia caused by mutations of the FANCA gene. FANCA gene mutations are the most common cause of Fanconi anemia. This gene provides instructions for making a protein that is involved in the Fanconi anemia (doxorubicin/fluorouracil protocol) pathway.. Aplastic Anemia defined as following: A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.. Bone marrow hypocellularity defined as following: A reduced number of hematopoietic cells present in the bone marrow relative to marrow fat. [DDD:wouwehand, HPO:probinson]. Homo sapiens defined as following: Members of the species Homo sapiens.. Fanconi anemia defined as following: Fanconi anemia caused by mutations of the FANCA gene. FANCA gene mutations are the most common cause of Fanconi anemia. This gene provides instructions for making a protein that is involved in the Fanconi anemia (doxorubicin/fluorouracil protocol) pathway..", "label": "yes"} {"original_question": "Are Toll-like receptors (TLRs) induced by microbes?", "id": "converted_3900", "sentence1": "Are Toll-like receptors (TLRs) induced by microbes?", "sentence2": "The C-type lectin receptor CLEC4E and TLR2 protein, human TLR4 wt Allele wt Allele expressed by host cells are among the first line of defense in encountering pathogens., Gram-negative bacteria and endogenous Molecule coordinate to trigger inflammatory cascades via TLR2 protein, human 4 to induce excessive expression of Recombinant Cytokines such as tumor necrosis factor-α and to activate NLRP3 inflammasome, a multiprotein complex that processes pro-interleukin-1β into its mature form. , During Virus Diseases, viral nucleic acids are detected by virus sensor proteins including Toll-Like Receptor 3 or retinoic acid-inducible gene I-like receptors (RLRs) in mammalian cells. , TLR2 protein, human 9 (TLR9 gene gene) activation is attributed to delivery of DNA, Bacterial, We determine that HBCs have the capacity to play a defensive role, where they are responsive to TLR2 protein, human stimulation and are microbicidal.[SEP]Relations: TLR2 protein, human 1-TLR2 protein, human 2 protein complex has relations: cellcomp_protein with TLR1, cellcomp_protein with TLR1, cellcomp_protein with TLR1, cellcomp_protein with TLR1, cellcomp_protein with TLR1, cellcomp_protein with TLR1, cellcomp_protein with TLR2, cellcomp_protein with TLR2, cellcomp_protein with TLR2, cellcomp_protein with TLR2. Definitions: TLR2 protein, human defined as following: TLR2 protein, human 2 (784 aa, ~90 kDa) is encoded by the human TLR2 gene. This protein is involved in signal transduction that modulates innate immunity.. TLR2 protein, human 9 defined as following: TLR2 protein, human 9 (1032 aa, ~116 kDa) is encoded by the human TLR9 gene gene. This protein plays a role in the mediation of inflammatory signaling.. TLR4 wt Allele defined as following: Human TLR4 wt Allele wild-type allele is located within 9q32-q33 and is approximately 11 kb in length. This allele, which encodes toll-like receptor 4 protein, is involved in pathogen recognition, signal transduction and innate immunity. Mutations in the gene are associated with differences in LPS responsiveness.. Molecule defined as following: An aggregate of two or more atoms in a defined arrangement held together by chemical bonds.. TLR2 protein, human 4 defined as following: A pattern recognition receptor that interacts with LYMPHOCYTE ANTIGEN 96 and LIPOPOLYSACCHARIDES. It mediates cellular responses to GRAM-NEGATIVE BACTERIA.. TLR9 gene defined as following: This gene plays a role in innate immunity.. Toll-Like Receptor 3 defined as following: A pattern recognition receptor that binds DOUBLE-STRANDED RNA. It mediates cellular responses to certain viral pathogens.. DNA, Bacterial defined as following: Deoxyribonucleic acid that makes up the genetic material of bacteria.. Virus Diseases defined as following: A general term for diseases caused by viruses.. Toll-like receptors defined as following: A family of pattern recognition receptors characterized by an extracellular leucine-rich domain and a cytoplasmic domain that share homology with the INTERLEUKIN 1 RECEPTOR and the DROSOPHILA toll protein. Following pathogen recognition, toll-like receptors recruit and activate a variety of SIGNAL TRANSDUCING ADAPTOR PROTEINS..", "label": "yes"} {"original_question": "Has field-programmable gate array (FPGA) technology been used to solve sequence alignment problems?", "id": "converted_1674", "sentence1": "Has field-programmable gate array (FPGA) technology been used to solve Sequence - ParameterizedDataType alignment problems?", "sentence2": "A linear error model for the raw intensity data and Burrows-Wheeler transform (BWT) based alignment are combined utilizing a Bayesian score function, which is then globally optimized over all possible genomic locations using an efficient branch-and-bound approach. The algorithm has been implemented in soft- and hardware [field-programmable gate array (FPGA)] to achieve real-time performance., we have designed and built a high-performance FPGA-accelerated version of BLASTP, mercury BLASTP. In this paper, we describe the architecture of the portions of the application that are accelerated in the FPGA, and we also describe the integration of these FPGA-accelerated portions with the existing BLASTP software. We have implemented mercury BLASTP on a commodity workstation with two Xilinx Virtex-II 6000 FPGAs., This paper shows how reconfigurable architectures can be used to derive an efficient fine-grained parallelization of the dynamic programming calculation. We describe how this technique leads to significant runtime savings for HMM database scanning on a standard off-the-shelf field-programmable gate array (FPGA)., We have constructed a linear systolic array to perform pairwise Sequence - ParameterizedDataType distance computations using dynamic programming. This results in an implementation with significant runtime savings on a standard FPGA., in this paper, we focused on accelerating the Smith-Waterman algorithm by modifying the computationally repeated portion of the algorithm by FPGA hardware custom instructions., We present a reconfigurable systolic architecture that can be applied for the efficient treatment of several dynamic programming methods for resolving well-known problems, such as global and local Sequence - ParameterizedDataType alignment, approximate string matching and longest common subsequence. The dynamicity of the reconfigurability was found to be useful for practical applications in the construction of Sequence - ParameterizedDataType alignments. A VHDL (VHSIC hardware description language) version of this new architecture was implemented on an APEX FPGA (Field programmable gate array)., This results in an implementation of ClustalW with significant runtime savings on a standard off-the-shelf FPGA., The accelerator implements a version of the Needleman-Wunsch algorithm for nucleotide Sequence - ParameterizedDataType alignment. Sequence lengths are constrained only by available memory; the product - ParticipationType - ParticipationType of Sequence - ParameterizedDataType lengths in the current implementation can be up to 2(22). The machine is implemented as two NuBus boards connected to a Mac IIf/x, using a mixture of TTL and FPGA technology clocked at 10 MHz.[SEP]Definitions: product - ParticipationType defined as following:

Participant material that is brought forth (produced) in the act (e.g., specimen in a specimen collection, access or drainage in a placement service, medication package in a dispense service). It does not matter whether the material produced had existence prior to the service, or whether it is created in the service (e.g., in supply services the product - ParticipationType is taken from a stock).

. Sequence - ParameterizedDataType alignments defined as following: The arrangement of two or more amino acid or base sequences from an organism or organisms in such a way as to align areas of the sequences sharing common properties. The degree of relatedness or homology between the sequences is predicted computationally or statistically based on weights assigned to the elements aligned between the sequences. This in turn can serve as a potential indicator of the genetic relatedness between the organisms.. mercury defined as following: A silver metallic element that exists as a liquid at room temperature. It has the atomic symbol Hg (from hydrargyrum, liquid silver), atomic number 80, and atomic weight 200.59. mercury is used in many industrial applications and its salts have been employed therapeutically as purgatives, antisyphilitics, disinfectants, and astringents. It can be absorbed through the skin and mucous membranes which leads to MERCURY POISONING. Because of its toxicity, the clinical use of mercury and mercurials is diminishing.. Sequence - ParameterizedDataType defined as following: The Sequence - ParameterizedDataType of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide Sequence - ParameterizedDataType..", "label": "yes"} {"original_question": "Are there graph kernel libraries available implemented in JAVA?", "id": "converted_3037", "sentence1": "Are there graph kernel libraries available implemented in JAVA?", "sentence2": "graphkernels: R and Python packages for graph comparison., Measuring the similarity of graphs is a fundamental step in the analysis of graph-structured data, which is omnipresent in computational biology. Graph kernels have been proposed as a powerful and efficient approach to this problem of graph comparison. Here we provide graphkernels, the first R and Python graph kernel libraries including baseline kernels such as label histogram based kernels, classic graph kernels such as random walk based kernels, and the state-of-the-art Weisfeiler-Lehman graph kernel. The core of all graph kernels is implemented in C ++ for efficiency. Using the kernel matrices computed by the package, we can easily perform tasks such as classification, regression and clustering on graph-structured samples.[SEP]", "label": "no"} {"original_question": "Are synonymous sites in primates and rodents functionally constrained?", "id": "converted_4100", "sentence1": "Are synonymous sites in Primates and Rodent functionally constrained?", "sentence2": "To resolve this contradiction between expectations and observations, we used processed Pseudogenes as a model for strict neutral evolution, and estimated selective constraint on synonymous sites using the rate of Substitution - ActClass at pseudosynonymous and pseudononsynonymous sites in Pseudogenes as the neutral expectation. After controlling for the effects of GC content, our results were similar to those from previous studies, i.e., synonymous sites in Primates exhibited evidence for higher selective constraint that those in Rodent. Specifically, our results indicated that in Primates up to 24% of synonymous sites could be under purifying selection, while in Rodent synonymous sites evolved neutrally. [SEP]Definitions: Rodent defined as following: A mammalian order which consists of 29 families and many genera.. Pseudogenes defined as following: Genes bearing close resemblance to known genes at different loci, but rendered non-functional by additions or deletions in structure that prevent normal transcription or translation. When lacking introns and containing a poly-A segment near the downstream end (as a result of reverse copying from processed nuclear RNA into double-stranded DNA), they are called processed genes.. Substitution - ActClass defined as following:

Definition: Indicates that the subject Act has undergone or should undergo Substitution - ActClass of a type indicated by Act.code.

Rationale: Used to specify \"allowed\" Substitution - ActClass when creating orders, \"actual\" susbstitution when sending events, as well as the reason for the Substitution - ActClass and who was responsible for it.

. Primates defined as following: An order of mammals consisting of more than 300 species that include LEMURS; LORISIDAE; TARSIERS; MONKEYS; and HOMINIDS. They are characterized by a relatively large brain when compared with other terrestrial mammals, forward-facing eyes, the presence of a CALCARINE SULCUS, and specialized MECHANORECEPTORS in the hands and feet which allow the perception of light touch..", "label": "no"} {"original_question": "Are circRNAs susceptible to degradation by RNase R?", "id": "converted_4351", "sentence1": "Are circRNAs susceptible to degradation by Pancreatic ribonuclease R?", "sentence2": "Currently, an increasing body of evidence has demonstrated that 1) majority of circRNAs are evolutionarily conserved across species, stable, and resistant to Pancreatic ribonuclease R degradation, , Circular RNA (circRNA) has a closed-loop structure, and its 3' and 5' ends are directly covalently connected by reverse splicing, which is more stable than linear RNA., RNA, Circular are a kind of closed circular RNA molecule widely existing in transcriptomes. Due to lack of free ends, they are not easily cleaved by Pancreatic ribonuclease R, thus avoiding degradation. , Circular RNA (circRNAs) are a class of newly-identified non-coding RNA that lack 5' (cap) and 3' (polyadenylation) ends and are linked by a covalent bond to form a closed loop structure. In comparison to linear RNA, circRNAs are more resistant to exonuclease Pancreatic ribonuclease R-mediated degradation with a much stronger stability due to the absence of 3' terminals, Circular RNA (circRNAs) own unique capabilities to communicate with Nucleic Acids and ribonucleoproteins and are emerging as indispensable compositions of the regulatory messages encoded in the Genome - anatomical entity. Due to lack of 3' termini, circRNAs are more resistant to degradation by exonuclease Pancreatic ribonuclease R and possess greater stability than linear RNA. , Pancreatic ribonuclease R is a strong 3' to 5' exoribonuclease, which efficiently degrades linear RNA, such as mRNAs and rRNAs; therefore, the circular parts of lariat RNA and the circRNAs can be segregated from eukaryotic total RNA by their Pancreatic ribonuclease R resistance., Lariat RNA and circRNAs are both Pancreatic ribonuclease R resistant RNA., In comparison to linear RNA, circRNAs are more resistant to exonuclease Pancreatic ribonuclease R-mediated degradation with a much stronger stability due to the absence of 3' terminals., Due to lack of 3' termini, circRNAs are more resistant to degradation by exonuclease Pancreatic ribonuclease R and possess greater stability than linear RNA., Because circRNAs are not easily degraded by exonuclease Pancreatic ribonuclease R, they can exist more stably in Body Fluids than linear RNA., Therefore, it is essential to perform the RT-qPCR validation step only after linear RNA have been degraded using an exonuclease such as ribonuclease R (Pancreatic ribonuclease R)., is a strong 3' to 5' exoribonuclease, which efficiently degrades linear RNA, such as mRNAs and rRNAs; therefore, the circular parts of lariat RNA and the circRNAs can be segregated from eukaryotic total RNA by their Pancreatic ribonuclease R resistance. Thus, Pancreatic ribonuclease, sion of circRNAs is prevalent in Body tissue and Body Fluids,and their abnormal expression is related to Specimen Source Codes - Specimen Source Codes - tumor progression.circRNAs are stable even under the treatment of Pancreatic ribonuclease R because of their circular conformation.As circRNAs, e to lack of 3' termini, circRNAs are more resistant to degradation by exonuclease Pancreatic ribonuclease R and possess greater stability than linear RNA. molybdenum, e circRNAs are not easily degraded by exonuclease Pancreatic ribonuclease R, they can exist more stably in Body Fluids than linear RNA. Based, is stable, difficult to cleave and resistant to REXO5 gene or Pancreatic ribonuclease R degradation. circRN, the unique structures, circRNAs are resistant to exonuclease Pancreatic ribonuclease R and maintain stability more easily than linear RNA. Rece, rison to linear RNA, circRNAs are more resistant to exonuclease Pancreatic ribonuclease R-mediated degradation with a much stronger stability due to the absence of 3' terminals. Conseque, RT-PCR analysis showed that sheep circRNAs are resistant to Pancreatic ribonuclease R digestion and are expressed in prenatal and postnatal Pituitary Gland. GO and , Currently, an increasing body of evidence has demonstrated that 1) majority of circRNAs are evolutionarily conserved across species, stable, and resistant to Pancreatic ribonuclease R degradation, and often exhibit cell-specific, and tissue-specific/developmental-stage-specific expression and can be largely independent of the expression levels of the linear host gene-encoded linear RNA; 2) the biogenesis of circRNAs via back-splicing is different from the canonical splicing of linear RNA; 3) circRNA biogenesis is regulated by specific cis-acting elements and Trans-Activators; 4) circRNAs regulate biological and pathological processes by sponging MicroRNAs, binding to RNA-Binding Proteins (SUGP1 gene), regulators of splicing and transcription, modifiers of parental gene expression, and regulators of protein translation or being translated into Peptides in various diseases; 5) circRNAs have been identified for their enrichment and stability in Exosomes and detected in Body Fluids such as Homo sapiens blood, Specimen Source Codes - Saliva, and Cerebrospinal Fluid, suggesting that these exo-circRNAs have potential applications as disease biomarkers and novel therapeutic targets; 6) several circRNAs are regulated by oxidative stress and mediate Reactive Oxygen Species (ROS) production as well as promote ROS-induced cellular death, cell apoptosis, and Inflammation; 7) circRNAs have also emerged as important regulators in atherosclerotic cardiovascular disease, Metabolic Diseases, and Malignant Neoplasms; 8) the potential mechanisms of several circRNAs have been described in diseases, hinting at their potential applications as novel therapeutic targets., To prove their circularity as well as biochemically enrich these RNA Transcript, it has become standard in the field to use the 3'-5' exonuclease Pancreatic ribonuclease R. Here, we demonstrate that standard protocols involving Pancreatic ribonuclease R can fail to digest >20% of all highly expressed linear RNA, but these shortcomings can largely be overcome., We propose that such an R-loop dependent Circular Intronic RNA degradation likely represents a mechanism that on one hand limits Circular Intronic RNA accumulation by recruiting Pancreatic ribonuclease H1 and on the other hand resolves R-Loop Structures for transcriptional elongation at some GC-rich Circular Intronic RNA-producing loci., As circular RNA (circRNAs) are resistant to degradation by exonucleases, their abundance relative to linear RNA can be used as a surrogate marker for mRNA stability in the absence of transcription., The synthetic circular sponge was resistant to digestion with Pancreatic ribonuclease R. Luciferase assays and functional experiments showed that the circular multi-miR sponge was more stable than its linear counterpart., RNA with highly structured 3' ends, including snRNAs and histone mRNAs, are naturally resistant to Pancreatic ribonuclease R, but can be efficiently degraded once a Poly(A) Tail has been added to their ends., Thousands of eukaryotic protein-coding genes generate circular RNA that have covalently linked ends and are resistant to degradation by exonucleases.[SEP]Relations: rRNA transcription has relations: bioprocess_bioprocess with 5S class rRNA transcription by RNA polymerase III, bioprocess_bioprocess with 5S class rRNA transcription by RNA polymerase III, bioprocess_bioprocess with ncRNA transcription, bioprocess_bioprocess with ncRNA transcription, bioprocess_protein with SIRT7, bioprocess_protein with SIRT7. protein binding has relations: molfunc_protein with RNASE10, molfunc_protein with RNASE10, molfunc_protein with RNASE1, molfunc_protein with RNASE1. Definitions: Inflammation defined as following: A pathological process characterized by injury or destruction of Body tissue caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. RNA, Circular defined as following: RNA molecules in which the 3' and 5' ends are covalently joined to form a closed continuous loop. They are resistant to digestion by EXORIBONUCLEASES.. Pancreatic ribonuclease defined as following: An enzyme that catalyzes the endonucleolytic cleavage of pancreatic ribonucleic acids to 3'-phosphomono- and oligonucleotides ending in cytidylic or uridylic acids with 2',3'-cyclic phosphate intermediates. EC 3.1.27.5.. Exosomes defined as following: A type of extracellular vesicle, containing RNA and proteins, that is secreted into the extracellular space by EXOCYTOSIS when MULTIVESICULAR BODIES fuse with the PLASMA MEMBRANE.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Malignant Neoplasms defined as following: A Specimen Source Codes - tumor composed of atypical neoplastic, often pleomorphic cells that invade other Body tissue. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Body Fluids defined as following: Liquid components of living organisms.. Reactive Oxygen Species defined as following: Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS.. RNA Transcript defined as following: The initial RNA molecule produced by transcription.. Cerebrospinal Fluid defined as following: A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES.. R-Loop Structures defined as following: An RNA-DNA hybrid structure formed when newly transcribed RNA remains bound to its DNA template. Stability of R-Loop Structures may play a role in GENETIC INSTABILITY.. Pituitary Gland defined as following: A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk which is called the INFUNDIBULUM.. Trans-Activators defined as following: Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins.. Metabolic Diseases defined as following: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed). MicroRNAs defined as following: Small double-stranded, non-protein coding RNA, 21-25 nucleotides in length generated from single-stranded microRNA gene RNA Transcript by the same RIBONUCLEASE III, Dicer, that produces small interfering RNA (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNA (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 MicroRNAs discovered, and are from a class of MicroRNAs involved in developmental timing.. Nucleic Acids defined as following: High molecular weight polymers containing a mixture of purine and pyrimidine nucleotides chained together by ribose or deoxyribose linkages.. Peptides defined as following: Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of Peptides that can form into complex structures such as ENZYMES and RECEPTORS.. molybdenum defined as following: A metallic element with the atomic symbol molybdenum, atomic number 42, and atomic weight 95.95. It is an essential trace element, being a component of the enzymes xanthine oxidase, aldehyde oxidase, and nitrate reductase.. Genome - anatomical entity defined as following: Anatomical set of genes in all the chromosomes.. Homo sapiens defined as following: Members of the species Homo sapiens.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. RNA-Binding Proteins defined as following: Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other proteins whose function is to bind specifically to RNA.. circRNAs defined as following: RNA molecules in which the 3' and 5' ends are covalently joined to form a closed continuous loop. They are resistant to digestion by EXORIBONUCLEASES..", "label": "no"} {"original_question": "Are lamina-associated domains (LADs) associated with transcriptional activation?", "id": "converted_3465", "sentence1": "Are lamina-associated domains (LADs) associated with transcriptional activation?", "sentence2": "Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal Primary malignant neoplasm coincide with Nuclear Lamina-associated domains., Extensive changes in DNA methylation are common in Primary malignant neoplasm and may contribute to oncogenesis through transcriptional silencing of tumor-suppressor genes., Such lamina-associated domains (LADs) are thought to help organize Chromosomes, Human, Pair 1 inside the Cell Nucleus and have been associated with gene repression., The Nuclear Lamina contributes to the regulation of gene expression and to chromatin organization.[SEP]Relations: Nuclear Lamina has relations: cellcomp_protein with HLCS, cellcomp_protein with HLCS, cellcomp_protein with PCNA, cellcomp_protein with PCNA, cellcomp_protein with SUV39H1, cellcomp_protein with SUV39H1, cellcomp_protein with CASK, cellcomp_protein with CASK, cellcomp_protein with PRR14, cellcomp_protein with PRR14. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Nuclear Lamina defined as following: The fibrous, electron-dense layer lying on the nucleoplasmic side of the inner membrane of a cell Cell Nucleus, composed of lamin filaments. The polypeptides of the lamina are thought to be concerned in the dissolution of the nuclear envelope and its re-formation during mitosis. The lamina is composed of lamin A and lamin C filaments cross-linked into an orthogonal lattice, which is attached via lamin B to the inner nuclear membrane through interactions with a lamin B receptor, an IFAP, in the membrane. [ISBN:0198506732, ISBN:0716731363]. Cell Nucleus defined as following: Within a eukaryotic cell, a membrane-limited body which contains Chromosomes, Human, Pair 1 and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one Cell Nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). Chromosomes, Human, Pair 1 defined as following: A specific pair of human Chromosomes, Human, Pair 1 in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification..", "label": "no"} {"original_question": "Does CXorf21 escape X chromosome inactivation?", "id": "converted_3399", "sentence1": "Does TASL gene escape X chromosome inactivation?", "sentence2": "This revealed a 637-kb tandem duplication that in addition to NR0B1 wt Allele includes the four MAGEB Genes, the hypothetical gene TASL gene, glycerol kinase activity, and part of the MAP3K7IP3 gene, Among statin users, Diabetes Mellitus cases had marginal but insignificantly different expression of Zinc Finger Protein 532 (up-regulated 15%, Q-value=0.0584), CXORF21 (up-regulated 11%, Q-value=0.0584), and ZNHIT3 gene gene (up-regulated 19%, Q-value=0.0959), compared with controls., For this, we selected five Single Nucleotide Polymorphism (rs1801274 in FCGR2A protein, human protein, human and rs2286672 in PLD2 gene gene, rs887369 in TASL gene, rs9782955 in LYST wt Allele wt Allele, and rs3794060 in NADSYN1 gene gene), Examination of X-linked DEGs, such as GTPBP6 gene gene, TAF9L, and CXORF21, that show verbal cognition-gene expression correlations may establish a causal link between these Genes, neurodevelopment, and language function.[SEP]Relations: ZNHIT3 gene has relations: protein_protein with XRCC3, protein_protein with XRCC3, bioprocess_protein with box C/D snoRNP assembly, bioprocess_protein with box C/D snoRNP assembly. NADSYN1 gene has relations: protein_protein with NOXA1, protein_protein with NOXA1, anatomy_protein_absent with cerebellar vermis, anatomy_protein_absent with cerebellar vermis. Protein S human has relations: drug_drug with Coagulation Factor IX (Recombinant), drug_drug with Coagulation Factor IX (Recombinant). Definitions: Zinc Finger Protein 532 defined as following: Zinc finger protein 532 (1301 aa, ~142 kDa) is encoded by the human Zinc Finger Protein 532 gene. This protein is involved in transcriptional regulation and DNA binding.. NR0B1 wt Allele defined as following: Human NR0B1 wild-type allele is located within Xp21.3-p21.2 and is approximately 5 kb in length. This allele, which encodes nuclear receptor subfamily 0 group B member 1 protein, is involved in the regulation of both transcription and receptor-mediated signal transduction. Mutations in the gene are associated with both X-linked congenital adrenal hypoplasia and hypogonadotropic hypogonadism. A duplication part of the short arm of the X chromosome, which contains this gene, in XY individuals is linked to dosage-sensitive sex reversal.. Single Nucleotide Polymorphism defined as following: A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.. glycerol kinase activity defined as following: Catalysis of the reaction: ATP + glycerol = sn-glycerol 3-phosphate + ADP + 2 H(+). [EC:2.7.1.30, RHEA:21644]. FCGR2A protein, human defined as following: Low affinity immunoglobulin gamma Fc region receptor II-a (317 aa, ~35 kDa) is encoded by the human FCGR2A protein, human gene. This protein plays a role in the endocytosis of opsonized antigens.. LYST wt Allele defined as following: Human LYST wt Allele wild-type allele is located within 1q42.1-q42.2 and is approximately 223 kb in length. This allele, which encodes lysosomal-trafficking regulator protein, plays a role in the modulation of intracellular protein sorting. Mutations in the gene are associated with Chediak-Higashi syndrome.. Diabetes Mellitus defined as following: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Is Benralizumab effective for Chronic Spontaneous Urticaria?", "id": "converted_4608", "sentence1": "Is Benralizumab effective for Chronic Spontaneous Urticaria?", "sentence2": "Finally, treatments aimed at reducing eosinophil accumulation and activation, such as the anti-IL-5 antibodies mepolizumab, reslizumab, and benralizumab, have been reported to reduce Chronic Spontaneous Urticaria symptoms. , The treatments that are under clinical trials for Chronic Spontaneous Urticaria are Anti-Immunoglobulin E antibody treatments such as ligelizumab, Molecule targeting Protoplasm signaling pathways such as Abdomen>Spleen Protein-tyrosine kinase inhibitor (disposition), surface inhibitory Molecule such as SIGLEC8 gene, anti-IL-1s such as canakinumab, Bruton kinase (BTK) inhibitors such as GDC-0853 and anti-IL-5s such as benralizumab and mepolizumab., f-label use of dupilumab, reslizumab, mepolizumab, and benralizumab can be effective in CU. Ligel, Finally, treatments aimed at reducing eosinophil accumulation and activation, such as the anti-IL-5 antibodies mepolizumab, reslizumab, and benralizumab, have been reported to reduce Chronic Spontaneous Urticaria symptoms., ments aimed at reducing eosinophil accumulation and activation, such as the anti-IL-5 antibodies mepolizumab, reslizumab, and benralizumab, have been reported to reduce Chronic Spontaneous Urticaria symptoms. Clearly, a new pi, ormation on the effects of the off-label use, in Chronic Spontaneous Urticaria, of biologics licensed for the treatment of other diseases, including dupilumab, benralizumab, mepolizumab, reslizumab, and secukinumab. Finally, we discuss, , B-Lymphocytes, Therapeutic gamma delta T-lymphocytes and Specimen Source Codes - Eosinophils. The treatments that are under clinical trials for Chronic Spontaneous Urticaria are Anti-Immunoglobulin E antibody treatments such as ligelizumab, Molecule targeting Protoplasm signaling pathways such as Abdomen>Spleen Protein-tyrosine kinase inhibitor (disposition), surface inhibitory Molecule such as SIGLEC8 gene, anti-IL-1s such as canakinumab, Bruton kinase (BTK) inhibitors such as GDC-0853 and anti-IL-5s such as benralizumab and mepolizumab.SUMMARY: The ongoing clinical trials on new targets of treatment hold new hopes not only for a better care of the disease but also a better understan[SEP]Relations: Benralizumab has relations: drug_drug with Urelumab, drug_drug with Urelumab, drug_drug with Evinacumab, drug_drug with Evinacumab, drug_drug with Fremanezumab, drug_drug with Fremanezumab, drug_drug with Adecatumumab, drug_drug with Adecatumumab, drug_drug with Galcanezumab, drug_drug with Galcanezumab. Definitions: Therapeutic gamma delta T-lymphocytes defined as following: A subset of therapeutic autologous T-lymphocytes that express a T-cell receptor (TCR) composed of one gamma chain and one delta chain, with potential immunomodulating and antineoplastic activities. Upon administration of the therapeutic gamma delta T-lymphocytes, these cells secrete interferon-gamma (IFN-g), and exert direct killing of tumor cells. In addition, these cells activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against tumor cells. Gamma delta T-lymphocytes play a key role in the activation of the immune system and do not require major histocompatibility complex (MHC)-mediated antigen presentation to exert their cytotoxic effect.. Chronic Spontaneous Urticaria defined as following: Urticaria characterized by spontaneously recurring hives for 6 weeks or longer. [PMID:25807072]. canakinumab defined as following: A recombinant monoclonal antibody targeting human interleukin-1 beta (IL-1b), with anti-inflammatory and immunomodulating activities. Canakinumab binds IL-1b and prevents the binding of IL-1b to the IL-1 receptor and inhibits IL-1b-mediated signaling. This may suppress inflammatory responses mediated by IL-1b. IL-1b, a proinflammatory cytokine, plays a key role in inflammation.. eosinophil defined as following: Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin.. Molecule defined as following: An aggregate of two or more atoms in a defined arrangement held together by chemical bonds.. Protoplasm defined as following: The organized colloidal complex of organic and inorganic substances (as proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, proteins, lipids, carbohydrates, and inorganic salts.. Protein-tyrosine kinase inhibitor (disposition) defined as following: Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES.. benralizumab defined as following: An afucosylated, humanized monoclonal antibody against the alpha chain of the interleukin-5 receptor (IL-5Ra), with potential anti-asthmatic activity. Upon administration, benralizumab binds to IL-5Ra and elicits an antibody-directed cell cytotoxicity (ADCC) against IL-5Ra-expressing cells. This induces apoptosis in IL-5Ra-expressing cells and may reduce asthmatic episodes. IL-5Ra, expressed on both Specimen Source Codes - Eosinophils and basophils, plays a key role in asthma.. B-Lymphocytes defined as following: Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.. mepolizumab defined as following: A humanized immunoglobulin G1 (IgG1) monoclonal antibody directed against interleukin-5 (IL-5) with anti-asthmatic and potential immunosuppressive activity. Upon subcutaneous administration, mepolizumab selectively binds to IL-5, preventing it from associating with interleukin-5 receptor subunit alpha (IL5RA) on the surface of Specimen Source Codes - Eosinophils and their progenitors. IL-5 plays a role in the regulation of eosinophil development from hematopoietic progenitors as well as eosinophil maturation, differentiation, mobilization, activation, and survival. IL-5 also play a role in the pathogenesis of some phenotypes of hypereosinophilic syndrome (HES).. secukinumab defined as following: A recombinant human immunoglobulin G1 (IgG1) monoclonal antibody against the pro-inflammatory cytokine interleukin 17A (IL-17A; IL-17), with potential anti-inflammatory activity. Upon subcutaneous administration, secukinumab selectively targets and binds to IL-17A, thereby neutralizing the IL-17A protein. This prevents binding of IL-17A to the IL-17 receptor (IL-17R), and inhibits IL-17A/IL-17R-mediated signaling and inflammation mediated by this pathway. IL-17A is mainly produced by inflammatory T helper 17 cells (Th17), and certain lymphocytes. IL-17A production is upregulated in many immune-mediated inflammatory diseases and plays a key role in the development of inflammation and the immune response..", "label": "yes"} {"original_question": "Is Bcl-2-like protein 1 an pro apoptotic protein?", "id": "converted_3753", "sentence1": "Is BCL2 gene-like protein 1 an pro apoptotic protein?", "sentence2": "Extensively established key effectors of such apoptotic bypass mechanisms, the antiapoptotic BCL-2 (apoptosis regulator BCL-2) proteins, determine the response of Tumor cells, malignant to chemotherapeutics, decreasing the expression of anti-apoptotic factors, including apoptosis regulator BCL2 gene and BCL2 gene-like protein 1 in FaDu cells, Like many Malignant Neoplasms, TNBC cells often deregulate programmed cell death by upregulating Apoptosis Inhibiting Proteins of the BCL2 protein, human (BCL2 gene) family., anti-apoptotic BCL2 gene-like protein 1 (bcl-x protein, Bcl-xL) [SEP]Relations: Protein S human has relations: drug_protein with PROC, drug_protein with PROC, drug_drug with Cepeginterferon alfa-2B, drug_drug with Cepeginterferon alfa-2B, drug_drug with Peginterferon alfa-2b, drug_drug with Peginterferon alfa-2b. Protein C has relations: drug_drug with Peginterferon alfa-2b, drug_drug with Peginterferon alfa-2b, drug_drug with Epoprostenol, drug_drug with Epoprostenol. Definitions: BCL2 gene defined as following: The B-cell leukemia/lymphoma-2 genes, responsible for blocking apoptosis in normal cells, and associated with follicular lymphoma when overexpressed. Overexpression results from the t(14;18) translocation. The human c-bcl-2 gene is located at 18q24 on the long arm of chromosome 18.. bcl-x protein defined as following: A member of the bcl-2 protein family that plays a role in the regulation of APOPTOSIS and is a regulatory subunit for PROTEIN PHOSPHATASE 1. Two major isoforms of the protein exist due to ALTERNATIVE SPLICING of the bcl-x protein mRNA and are referred to as Bcl-XS and Bcl-XL.. Tumor cells, malignant defined as following: Cells of, or derived from, a malignant tumor.. BCL2 gene-like protein 1 defined as following: BCL2 gene-like protein 2 (193 aa, ~21 kDa) is encoded by the human BCL2L2 gene. This protein plays a role the regulation of apoptosis.. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. BCL2 protein, human defined as following: Apoptosis regulator BCL2 gene (239 aa, ~26 kDa) is encoded by the human BCL2 gene. This protein plays a role in cellular survival.. BCL2 gene-like protein defined as following: Apoptosis regulator BAX (192 aa, ~21 kDa) is encoded by the human BAX gene. This protein plays a role in both apoptosis and protein-protein interactions..", "label": "no"} {"original_question": "Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?", "id": "converted_163", "sentence1": "Does MicroRNA-21 (MIR21 gene) contribute to Cardiovascular system Disease?", "sentence2": "The synergistic effect of MIR21 gene and miR-1 were functionally validated for their significant influences on myocardial apoptosis, Cardiac - anatomy qualifier hypertrophy and Fibrosis., Taken together, we found a novel reciprocal loop between MIR21 gene and TGFβRIII in Cardiac - anatomy qualifier Fibrosis caused by Myocardial infarction:Finding:Point in time:^Patient:Ordinal in CASP14 gene, and targeting this pathway could be a new strategy for the prevention and treatment of myocardial remodeling., It is still controversial whether microRNA-21 (MIR21 gene) participates in the process of Cardiac - anatomy qualifier Fibrosis., In CASP14 gene, myocardial MIR21 gene overexpression is related to Cardiac - anatomy qualifier Fibrosis elicited by pressure overload. , The myocardial and plasma levels of MIR21 gene were significantly higher in the AS patients compared with the controls and correlated directly with the echocardiographic mean transvalvular gradients., Our results support the role of MIR21 gene as a regulator of the fibrotic process that occurs in response to pressure overload in AS patients and underscore the value of circulating MIR21 gene as a biomarker for myocardial Fibrosis., Ad-MIR21 gene improves LV remodeling and decreases the apoptosis of Myocytes, Cardiac, suggesting the possible mechanism by which Ad-MIR21 gene functions in protecting against I/R injury., In the Ad-MIR21 gene group, LV dimensions, Myocardial Infarction size, LV/BW, collagen type Ⅰ, type Ⅲ and PCNA positive cells all significantly decreased compared with the Ad-GFP group., While MIR21 gene, -133, -150, -195, and -214 regulate cardiomyocyte hypertrophy, miR-1/-133 and miR-208 have been elucidated to influence myocardial contractile function. In addition, MIR21 gene, -24, -133, -210, -494, and -499 appear to protect Muscle Cells against I/R-induced apoptosis, whereas miR-1, -29, -199a, and -320 promote apoptosis. Myocardial Fibrosis can be regulated by the miR-29 family and MIR21 gene., The small regulatory RNA microRNA-21 (MIR21 gene) plays a crucial role in a plethora of biological functions and diseases including development, Primary malignant neoplasm, Cardiovascular system diseases and Inflammation., During recent years, additional roles of MIR21 gene in Cardiovascular system and pulmonary diseases, including Cardiac - anatomy qualifier and pulmonary Fibrosis as well as Myocardial infarction:Finding:Point in time:^Patient:Ordinal have been described., On the other hand, MIR21 gene, miR-199a, miR-210, and miR-494 have been proven critical for the Muscle Cells' adaptation and survival during hypoxia/ischemia. , Studies have shown that several miRs, including miR-1, miR-133, MIR21 gene, miR-126, miR-320, miR-92a, and miR-199a, are regulated after preconditioning and play an active role in protecting the Chest>Heart against ischemia/reperfusion injury., Studies using various in vivo, ex vivo, and in vitro models have suggested the possible involvement of miR-1, MIR21 gene, miR-29, miR-92a, miR-133, miR-199a, and miR-320 in Reperfusion Injury and/or remodeling after Myocardial infarction:Finding:Point in time:^Patient:Ordinal., MicroRNA-21 (MIR21 gene) is a highly expressed microRNA (miRNA) in Cardiovascular system system. Recent studies have revealed that its expression is deregulated in Chest>Heart and vasculature under Cardiovascular system Disease conditions such as proliferative vascular Disease, Cardiac - anatomy qualifier hypertrophy and Congestive Chest>Heart failure, and Myocardial Ischemia. MIR21 gene is found to play important roles in vascular smooth muscle \"U\" lymphocyte proliferation and apoptosis, Heart \"U\" lymphocyte growth and Cessation of life, and Cardiac - anatomy qualifier fibroblast functions. Accordingly, MIR21 gene is proven to be involved in the pathogenesis of the above-mentioned Cardiovascular system diseases as demonstrated by both loss-of-function and gain-of-function approaches., MIR21 gene might be a novel therapeutic target in Cardiovascular system diseases., This review article summarizes the research progress regarding the roles of MIR21 gene in Cardiovascular system Disease., Remarkably, MIR21 gene was one of most upregulated miRNAs in hearts after Immunoprecipitation. In vivo, Immunoprecipitation-mediated Cardiac - anatomy qualifier protection against ischaemia/reperfusion injury was inhibited by knockdown of Cardiac - anatomy qualifier MIR21 gene. In cultured Cardiac - anatomy qualifier Muscle Cells, we identified that MIR21 gene also had a protective effect on hypoxia/reoxygenation-induced \"U\" lymphocyte apoptosis that was associated with its target gene, programmed \"U\" lymphocyte Cessation of life 4. The protective effect of MIR21 gene on Heart \"U\" lymphocyte apoptosis was further confirmed in Rattus norvegicus hearts after ischaemia/reperfusion injury in vivo., Lately, some highlight articles revealed that the altered expression of miRNAs such as miR-1, miR-133, MIR21 gene, miR-208 etc in hearts also contributed to Cardiovascular system diseases, such as Chest>Heart ischemia, Cardiac - anatomy qualifier hypertrophy, and Cardiac Arrhythmia., Remarkably, MIR21 gene expression was significantly down-regulated in infarcted areas, but was up-regulated in Table Frame - Table Frame - border areas. The down-regulation of MIR21 gene in the infarcted areas was inhibited by ischemic preconditioning, a known Cardiac - anatomy qualifier protective method. Overexpression of MIR21 gene via adenovirus expressing MIR21 gene (Ad-MIR21 gene) decreased Myocardial Infarction size by 29% at 24 h and decreased the dimension of left ventricles at 2 weeks after Anterior Myocardial infarction:Finding:Point in time:^Patient:Ordinal. Using both gain-of-function and loss-of-function approaches in cultured Cardiac - anatomy qualifier Muscle Cells, we identified that MIR21 gene had a protective effect on ischemia-induced \"U\" lymphocyte apoptosis that was associated with its target gene programmed \"U\" lymphocyte Cessation of life 4 and activator protein 1 pathway. The protective effect of MIR21 gene against ischemia-induced Cardiac - anatomy qualifier myocyte damage was further confirmed in vivo by decreased \"U\" lymphocyte apoptosis in the Table Frame - Table Frame - border and infarcted areas of the infarcted Rattus norvegicus hearts after treatment with Ad-MIR21 gene. The results suggest that miRNAs such as MIR21 gene may play critical roles in the early phase of Anterior Myocardial infarction:Finding:Point in time:^Patient:Ordinal., The results suggest that MIR21 gene is sensitive to H(2)O(2) stimulation. MIR21 gene participates in H(2)O(2)-mediated gene regulation and functional modulation in Cardiac - anatomy qualifier Muscle Cells. MIR21 gene might play an essential role in Chest>Heart diseases related to Reactive Oxygen Species such as Cardiac - anatomy qualifier hypertrophy, Congestive Chest>Heart failure, Myocardial infarction:Finding:Point in time:^Patient:Ordinal, and myocardial ischemia/reperfusion injury., MicroRNA-21 contributes to Cardiomyopathies by stimulating Mitogen-Activated Protein Kinases signalling in Specimen Source Codes - Fibroblasts, Myocardial and circulating levels of microRNA-21 reflect left ventricular Fibrosis in Aortic Valve Stenosis patients, MicroRNA 21 inhibits left ventricular remodeling in the early phase of Rattus norvegicus model with Reperfusion Injury by suppressing \"U\" lymphocyte apoptosis, MicroRNA-21 protects against the H(2)O(2)-induced injury on Cardiac - anatomy qualifier Muscle Cells via its target gene Programmed Cell Death Protein 4, MicroRNA-21 (MIR21 gene) is a highly expressed microRNA (miRNA) in Cardiovascular system system., MicroRNA-21 contributes to Cardiomyopathies by stimulating Mitogen-Activated Protein Kinases signalling in Specimen Source Codes - Fibroblasts., MicroRNA-21 (MIR21 gene) is a highly expressed microRNA (miRNA) in Cardiovascular system system, MIR21 gene might be a novel therapeutic target in Cardiovascular system diseases, MicroRNA-21 as therapeutic target in Primary malignant neoplasm and Cardiovascular system Disease., These findings reveal that MicroRNAs can contribute to Cardiomyopathies by an effect in Cardiac - anatomy qualifier Specimen Source Codes - Fibroblasts., Our results validate MIR21 gene as a Disease target in Congestive Chest>Heart failure and establish the therapeutic efficacy of microRNA therapeutic intervention in a Cardiovascular system Disease setting.[SEP]Relations: Cardiac - anatomy qualifier muscle hypertrophy has relations: bioprocess_protein with MIR195, bioprocess_protein with MIR195, bioprocess_protein with MIR15B, bioprocess_protein with MIR15B. Myocardial infarction:Finding:Point in time:^Patient:Ordinal has relations: disease_protein with MIR145, disease_protein with MIR145, disease_protein with MIR145, disease_protein with MIR145, disease_protein with MIR145, disease_protein with MIR145. Definitions: Myocytes, Cardiac defined as following: Striated muscle cells found in the Chest>Heart. They are derived from Cardiac - anatomy qualifier myoblasts (MYOBLASTS, CARDIAC).. Inflammation defined as following: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.. MIR21 gene defined as following: This gene is involved in the regulation of gene expression and plays an oncogenic role in hepatocellular, breast, esophageal, gastric, pancreatic, prostatic and squamous \"U\" lymphocyte carcinomas, glioblastoma and glioma.. Myocardial Infarction defined as following: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the Chest>Heart (CORONARY CIRCULATION).. Heart \"U\" lymphocyte defined as following: any of the cells which comprise the Chest>Heart, including Specimen Source Codes - Fibroblasts and Cardiac - anatomy qualifier Muscle Cells; these cells can function to conduct electricity, support, and contract the Chest>Heart.. Myocardial Ischemia defined as following: A disorder of Cardiac - anatomy qualifier function caused by insufficient blood flow to the muscle tissue of the Chest>Heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the Chest>Heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of Cardiac - anatomy qualifier muscle (MYOCARDIAL INFARCTION).. Immunoprecipitation defined as following: The aggregation of soluble ANTIGENS with ANTIBODIES, alone or with antibody binding factors such as ANTI-ANTIBODIES or STAPHYLOCOCCAL PROTEIN A, into complexes large enough to fall out of solution.. Congestive Chest>Heart failure defined as following: Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.. Cardiomyopathies defined as following: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).. Myocardial defined as following: Of or pertaining to the myocardium.. Disease defined as following: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.. Rattus norvegicus defined as following: The common Rattus norvegicus, Rattus norvegicus, often used as an experimental organism.. Cardiovascular system Disease defined as following: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.. Reperfusion Injury defined as following: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.. Mitogen-Activated Protein Kinases defined as following: A superfamily of PROTEIN SERINE-THREONINE KINASES that are activated by diverse stimuli via protein kinase cascades. They are the final components of the cascades, activated by phosphorylation by MITOGEN-ACTIVATED PROTEIN KINASE KINASES, which in turn are activated by mitogen-activated protein kinase kinase kinases (MAP KINASE KINASE KINASES).. Muscle Cells defined as following: Mature contractile cells, commonly known as Muscle Cells, that form one of three kinds of muscle. The three types of muscle cells are skeletal (MUSCLE FIBERS, SKELETAL), Cardiac - anatomy qualifier (MYOCYTES, CARDIAC), and smooth (MYOCYTES, SMOOTH MUSCLE). They are derived from embryonic (precursor) muscle cells called MYOBLASTS.. Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Cardiac Arrhythmia defined as following: Any disturbances of the normal rhythmic beating of the Chest>Heart or MYOCARDIAL CONTRACTION. Cardiac Cardiac Arrhythmia can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.. Programmed Cell Death Protein 4 defined as following: Programmed \"U\" lymphocyte Cessation of life protein 4 (469 aa, ~52 kDa) is encoded by the human Programmed Cell Death Protein 4 gene. This protein may be involved in the regulation of both apoptosis and translation.. Aortic Valve Stenosis defined as following: A pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.. Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of Cardiovascular system and cerebral functions.. Fibrosis defined as following: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of Inflammation or other injury.. MicroRNAs defined as following: Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing.. Cardiac - anatomy qualifier hypertrophy defined as following: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.. Cardiovascular system defined as following: The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body.. Reactive Oxygen Species defined as following: Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS.. Anterior myocardial infarction defined as following: MYOCARDIAL INFARCTION in which the anterior wall of the Chest>Heart is involved. Anterior wall Myocardial infarction:Finding:Point in time:^Patient:Ordinal is often caused by occlusion of the left anterior descending coronary artery. It can be categorized as anteroseptal or anterolateral wall Myocardial infarction:Finding:Point in time:^Patient:Ordinal.. Myocardial Fibrosis defined as following: The accumulation of fibrotic tissue in the myocardium. This may result from chronic hypertension, Myocardial infarction:Finding:Point in time:^Patient:Ordinal or cardiomyopathy and eventually lead to Congestive Chest>Heart failure..", "label": "yes"} {"original_question": "Is EuroQol 5-Dimension Health Assessment (EQ-5D) [a widely used, simple instrument that monitors the general health-related quality of life (HRQoL) in chronic disease] a 5 question assessment?", "id": "converted_4463", "sentence1": "Is EuroQol 5-Dimension Health Assessment (EQ-5D) [a widely used, simple instrument that monitors the general health-related quality of life (HRQoL) in Chronic disease] a 5 question assessment?", "sentence2": "The 6-question EuroQol 5-Dimension Health Assessment (EQ-5D) is a widely used, simple instrument that monitors general health-related quality of life (HRQoL) in Chronic disease. , OBJECTIVE: The 6-question EuroQol 5-Dimension Health Assessment (EQ-5D) is a widely used, simple instrument that monitors general health-related quality of life (HRQoL) in Chronic disease., OBJECTIVE: The 6-question EuroQol 5-Dimension Health Assessment (EQ-5D) is a widely used, simple instrument that monitors general health-related quality of life (HRQoL) in chronic d, OBJECTIVE: The 6-question EuroQol 5-Dimension Health Assessment (EQ-5D) is a widely used, simple instrument that monitors general health-related quality of life (HRQoL) in chron[SEP]Relations: Chronic lung disease has relations: disease_phenotype_positive with severe acute respiratory syndrome, disease_phenotype_positive with severe acute respiratory syndrome, disease_phenotype_positive with alobar holoprosencephaly, disease_phenotype_positive with alobar holoprosencephaly, disease_phenotype_positive with cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome, disease_phenotype_positive with cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome, disease_phenotype_positive with combined immunodeficiency due to LRBA deficiency, disease_phenotype_positive with combined immunodeficiency due to LRBA deficiency, disease_phenotype_positive with toxic epidermal necrolysis, disease_phenotype_positive with toxic epidermal necrolysis. Definitions: Chronic disease defined as following: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies Chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2)..", "label": "no"} {"original_question": "Is TIM-3 a target for cancer immunotherapy in NSCLC?", "id": "converted_3540", "sentence1": "Is TIM-3 a target for cancer immunotherapy in Non-Small Cell Lung Carcinoma?", "sentence2": " Our results imply that implementing combined treatment on Cytokine-Induced Killer Cells before transfusion via Antibodies, in vitro diagnostic targeting CD274 wt Allele, lymphocyte-activation gene 3 protein, human, TIM-3, and CEACAM-1 might improve the efficiency of CIK therapy for Non-Small Cell Lung Carcinoma patients., Furthermore, TIM-3 and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 were strongly expressed simultaneously during long-term CIK culture and showed a significant and mutually positive correlation. , In present study, we detected the dynamic expression of eight major checkpoint molecules (cytotoxic T-lymphocyte antigen 4, PDCD1 wt Allele, CD274 wt Allele, TIM- 3, CEACAM-1, lymphocyte-activation gene 3 protein, human, TIGIT protein, human protein, human and B- and T-Lymphocyte Attenuator, Human) on Cytokine-Induced Killer Cells from Non-Small Cell Lung Carcinoma patients., Agents targeting other immune inhibitory (e.g., HAVCR2 wt Allele) or immune stimulating (e.g., CD137) receptors on Therapeutic gamma delta T-lymphocytes and other approaches such as adoptive cell transfer are tested for clinical efficacy in Melanocytic neoplasm as well., We found immune activation coexistent with elevation of multiple targetable immune checkpoint molecules, including CD274 wt Allele, Programmed Death Ligand 2 Protein, PDCD1 wt Allele, TIM-3, CD276 Antigen, B- and T-Lymphocyte Attenuator, Human, and cytotoxic T-lymphocyte antigen 4, along with increases in Specimen Source Codes - Specimen Source Codes - tumor infiltration by CD4(+)Foxp3(+) regulatory Therapeutic gamma delta T-lymphocytes in lung adenocarcinomas that displayed an EMT phenotype, Cytometric profiling identified an immunologically \"hot\" cluster with abundant CD8+ Therapeutic gamma delta T-lymphocytes expressing high levels of PDCD1 wt Allele and TIM-3 and an immunologically \"cold\" cluster with lower relative abundance of CD8+ Therapeutic gamma delta T-lymphocytes and expression of inhibitory markers, Interestingly, CD161+ CD4+ Therapeutic gamma delta T-lymphocytes highly express OX40 co-stimulatory receptor, less frequently 4-1BB, and display an activated but not completely exhausted PDCD1 wt Allele-positive HAVCR2 wt Allele-negative phenotype., . Furthermore, overexpression of targetable immune checkpoints, such as cytotoxic T-lymphocyte antigen 4 and TIM-3 were associated with EMT in both NSCLCs. [SEP]Relations: small cell lung carcinoma has relations: disease_protein with ASCL1, disease_protein with ASCL1, disease_protein with TP73, disease_protein with TP73, disease_protein with EPHB3, disease_protein with EPHB3. Protein S human has relations: drug_drug with NS-398, drug_drug with NS-398, drug_drug with Antithrombin III human, drug_drug with Antithrombin III human. Definitions: PDCD1 wt Allele defined as following: Human PDCD1 wild-type allele is located in the vicinity of 2q37.3 and is approximately 9 kb in length. This allele, which encodes programmed cell death protein 1, plays a role in the modulation of both apoptosis and cellular immunity. Mutation of the gene is associated with systemic lupus erythematosus type 2.. HAVCR2 wt Allele defined as following: Human HAVCR2 wild-type allele is located in the vicinity of 5q33.3 and is approximately 57 kb in length. This allele, which encodes hepatitis A virus cellular receptor 2 protein, is involved in the activation of macrophages and helper Therapeutic gamma delta T-lymphocytes.. cytotoxic T-lymphocyte antigen 4 defined as following: An inhibitory T CELL receptor that is closely related to CD28 ANTIGEN. It has specificity for CD80 ANTIGEN and CD86 ANTIGEN and acts as a negative regulator of peripheral T cell function. cytotoxic T-lymphocyte antigen 4 antigen is believed to play role in inducing PERIPHERAL TOLERANCE.. Therapeutic gamma delta T-lymphocytes defined as following: A subset of therapeutic autologous T-lymphocytes that express a T-cell receptor (TCR) composed of one gamma chain and one delta chain, with potential immunomodulating and antineoplastic activities. Upon administration of the therapeutic gamma delta T-lymphocytes, these cells secrete interferon-gamma (IFN-g), and exert direct killing of Specimen Source Codes - tumor cells. In addition, these cells activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against Specimen Source Codes - tumor cells. Gamma delta T-lymphocytes play a key role in the activation of the immune system and do not require major histocompatibility complex (MHC)-mediated antigen presentation to exert their cytotoxic effect.. TIGIT protein, human defined as following: T-cell immunoreceptor with Ig and ITIM domains (244 aa, ~26 kDa) is encoded by the human TIGIT protein, human gene. This protein is involved in immunomodulation and cell-cell adhesion.. Programmed Death Ligand 2 Protein defined as following: Programmed cell death 1 ligand 2 (273 aa, ~31 kDa) is encoded by the human PDCD1LG2 gene. This protein is involved in the modulation of both T-cell proliferation and cytokine production.. Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 defined as following: Carcinoembryonic antigen-related cell adhesion molecule 1 (526 aa, ~58 kDa) is encoded by the human Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 gene. This protein is involved in differentiation, angiogenesis, apoptosis, immune response, and tumorigenesis.. Cytokine-Induced Killer Cells defined as following: A preparation of cytokine-induced killer (CIK) cells, with potential immunopotentiating and antineoplastic activities. Cytokine-Induced Killer Cells are generated from peripheral blood lymphocytes (PBLs) by sequential ex vivo incubation with a monoclonal antibody against CD3 (anti-CD3), interferon-gamma (IFN-g) and interleukin-2 (IL-2), followed by expansion. Cytokine-Induced Killer Cells are heterogeneous cells comprising CD3+CD56- Therapeutic gamma delta T-lymphocytes, CD3-CD56+ natural killer (NK) cells, and CD3+CD56+ natural killer T (NKT) cells. Upon administration of the Cytokine-Induced Killer Cells into the patient, the terminally differentiated CD3- and CD56-positive subset of the Cytokine-Induced Killer Cells primarily exert the direct MHC-unrestricted Specimen Source Codes - tumor killing activity.. B- and T-Lymphocyte Attenuator, Human defined as following: B- and T-lymphocyte attenuator (289 aa, ~33 kDa) is encoded by the human B- and T-Lymphocyte Attenuator, Human gene. This protein is involved in the regulation of immune responses.. lymphocyte-activation gene 3 protein, human defined as following: Lymphocyte activation gene 3 protein (525 aa, ~57 kDa) is encoded by the human LAG3 gene. This protein is involved in the activation of T-cells and natural killer cells.. CD274 wt Allele defined as following: Human CD274 wild-type allele is located in the vicinity of 9p24 and is approximately 20 kb in length. This allele, which encodes programmed cell death 1 ligand 1 protein, plays a role in the regulation of T cell stimulation and proliferation.. Melanocytic neoplasm defined as following: A benign or malignant, primary or metastatic neoplasm affecting the melanocytes.. Non-Small Cell Lung Carcinoma defined as following: A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.. CD276 Antigen defined as following: CD276 antigen (534 aa, ~57 kDa) is encoded by the human CD276 gene. This protein is involved in the mediation of T cell proliferation and activation.. TIM-3 defined as following: Human HAVCR2 wild-type allele is located in the vicinity of 5q33.3 and is approximately 57 kb in length. This allele, which encodes hepatitis A virus cellular receptor 2 protein, is involved in the activation of macrophages and helper Therapeutic gamma delta T-lymphocytes..", "label": "yes"} {"original_question": "Is PF-05190457 an inverse agonist of the ghrelin receptor?", "id": "converted_3482", "sentence1": "Is PF-05190457 an inverse Agonist of the growth hormone secretagogue receptor?", "sentence2": "Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral growth hormone secretagogue receptor inverse Agonist to be profiled in healthy subjects., To evaluate safety, tolerability and pharmacokinetics of oral PF-05190457, an oral growth hormone secretagogue receptor inverse Agonist, in healthy adults., PF-05190457 is a well-tolerated first-in-class growth hormone secretagogue receptor inverse Agonist with acceptable pharmacokinetics for oral daily dosing.[SEP]Relations: growth hormone secretagogue receptor activity has relations: molfunc_protein with GHSR, molfunc_protein with GHSR. Definitions: Agonist defined as following: An agent that has affinity for a receptor and intrinsic activity at that receptor.. growth hormone secretagogue receptor defined as following: Transmembrane proteins that recognize and bind GHRELIN, a potent stimulator of GROWTH HORMONE secretion and food intake in mammals. Ghrelin receptors are found in the pituitary and HYPOTHALAMUS. They belong to the family of G-PROTEIN-COUPLED RECEPTORS..", "label": "yes"} {"original_question": "Are there antimicrobial proteins in royal jelly?", "id": "converted_4214", "sentence1": "Are there antimicrobial Proteins in royal jelly?", "sentence2": "Jellein, a Peptides derived from royal jelly of honeybee has been shown to have promising effect against several Bacterial and fungal species. , It is also the most studied bee product, aimed at unravelling its bioactivities, such as antimicrobial, antioxidant, anti-aging, immunomodulatory, and general tonic action against laboratory animals, microbial organisms, farm animals, and clinical trials, Jelleines, isolated as novel antibacterial peptides from the Royal Jelly (RJ) of bees, exhibit broad-spectrum protection against microbial infections., The study showed significant antimicrobial activity from several Proteins present in the honey preparation preparation of M. beecheii.[SEP]Relations: Bacterial arthritis has relations: disease_protein with IFNG, disease_protein with IFNG, disease_protein with TNF, disease_protein with TNF, disease_disease with gonococcal infection of joint, disease_disease with gonococcal infection of joint, disease_disease with infectious disease, disease_disease with infectious disease, disease_disease with infective arthritis, disease_disease with infective arthritis. Definitions: Peptides defined as following: Members of the class of compounds composed of AMINO ACIDS joined together by Peptides bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS.. Proteins defined as following: Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex Proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein..", "label": "yes"} {"original_question": "Can Enlimomab improve stroke outcomes?", "id": "converted_3241", "sentence1": "Can Enlimomab improve Cerebrovascular accident outcomes?", "sentence2": "Treatment with a Mus anti-ICAM-1 antibody (enlimomab) has been investigated in patients with acute Ischemic Cerebrovascular accident in the Enlimomab Acute Stroke Trial (EAST). Unfortunately, the case fatality rate in this trial was significantly higher in the enlimomab patient group than in the placebo group., The two clinical trials of therapy aimed at limiting the inflammatory response in acute Cerebrovascular accident that have been carried out to date, however, have not shown a benefit to such therapy. , en classes of neuroprotective agents have reached phase III efficacy trials but have shown mixed results. They included calcium channel antagonists, N-Methyl-D-Aspartate Receptors antagonists, lubeluzole, citicoline, the free radical scavenger tirilazad and ebselen, enlimomab, GABA agonist chlormethiazole, the Sodium Channel antagonist fosphenytoin, Magnesium supplements, alimentary tract and metabolism, glycine site antagonist GV 150526A and piracetam. , BACKGROUND AND PURPOSE: Enlimomab, a Mus monoclonal anti-human intercellular adhesion molecule (ICAM)-1 antibody, had a negative outcome in a multicenter acute-Cerebrovascular accident trial. , Examination of several potential mechanisms for the negative outcome in a clinical Cerebrovascular accident trial of enlimomab, a Mus anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study., ESULTS: At day 90, the Modified Rankin Scale score was worse in patients treated with enlimomab than with placebo (p = 0.004). Fewer patients had symptom-free recovery on enlimomab than placebo (p = 0.004), and more died (22.2 versus 16.2%). The negative effect of enlimomab was apparent on days 5, 30, and 90 of treatment (p = 0.005). There were significantly more adverse events with enlimomab treatment than placebo, primarily Infections of musculoskeletal system and Fever symptoms (finding)., CONCLUSIONS: The authors conclude that anti-ICAM therapy with enlimomab is not an effective treatment for Ischemic Cerebrovascular accident in the model studied and, indeed, may significantly worsen Cerebrovascular accident outcome., CONCLUSIONS\n\nThe authors conclude that anti-ICAM therapy with enlimomab is not an effective treatment for Ischemic Cerebrovascular accident in the model studied and, indeed, may significantly worsen Cerebrovascular accident outcome., There were significantly more adverse events with enlimomab treatment than placebo, primarily Infections of musculoskeletal system and Fever symptoms (finding)., RESULTS\n\nAt day 90, the Modified Rankin Scale score was worse in patients treated with enlimomab than with placebo (p = 0.004)., The negative effect of enlimomab was apparent on days 5, 30, and 90 of treatment (p = 0.005)., However, this treatment failed to show benefit in the Enlimomab Acute Stroke Trial., There were significantly more adverse events with enlimomab treatment than placebo, primarily Infections of musculoskeletal system and Fever symptoms (finding)., These observations provide several possible mechanisms for central nervous system-related clinical deterioration that occurred when Enlimomab was given in acute Ischemic Cerebrovascular accident., RESULTS\nAt day 90, the Modified Rankin Scale score was worse in patients treated with enlimomab than with placebo (p = 0.004)., Unfortunately, the case fatality rate in this trial was significantly higher in the enlimomab patient group than in the placebo group., CONCLUSIONS\nDosage of enlimomab between 140 and 480 mg administered over 5 days did not increase the risk of adverse events in patients with ischaemic or haemorrhagic Cerebrovascular accident during an observation period of 30 +/- 10 days., PURPOSE: Enlimomab, a Mus monoclonal anti-human intercellular adhesion molecule (ICAM)-1 antibody, had a negative outcome in a multicenter acute-Cerebrovascular accident trial., These observations provide several possible mechanisms for central nervous system-related clinical deterioration that occurred when Enlimomab was given in acute Ischemic Cerebrovascular accident., Enlimomab, a Mus monoclonal anti-human intercellular adhesion molecule (ICAM)-1 antibody, had a negative outcome in a multicenter acute-Cerebrovascular accident trial., These observations provide several possible mechanisms for central nervous system-related clinical deterioration that occurred when Enlimomab was given in acute Ischemic Cerebrovascular accident., The authors conclude that anti-ICAM therapy with enlimomab is not an effective treatment for Ischemic Cerebrovascular accident in the model studied and, indeed, may significantly worsen Cerebrovascular accident outcome.[SEP]Relations: Ischemic Cerebrovascular accident has relations: drug_effect with Celecoxib, drug_effect with Celecoxib, drug_effect with Celecoxib, drug_effect with Celecoxib, drug_effect with Pazopanib, drug_effect with Pazopanib, drug_effect with Pazopanib, drug_effect with Pazopanib, drug_effect with Sitaxentan, drug_effect with Sitaxentan. Definitions: Dosage defined as following: A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.. ebselen defined as following: A organoselenium compound with anti-inflammatory, anti-oxidant and cytoprotective activity. Ebselen acts as a glutathione peroxidase mimetic and is thereby able to prevent cellular damage induced by reactive oxygen species (ROS). In addition, this agent inhibits the activity of a variety of enzymes including nitric oxide synthase (NOS), 5-lipoxygenase, cyclooxygenase, protein kinase C (PKC), NADPH oxidase and gastric H+/K+-ATPase. Furthermore, ebselen may be neuroprotective due to its ability to neutralize free radicals upon N-Methyl-D-Aspartate Receptors activation thus, reducing lipoperoxidation mediated by glutamate-induced excitotoxicity.. citicoline defined as following: Donor of choline in biosynthesis of choline-containing phosphoglycerides.. Ischemic Cerebrovascular accident defined as following: An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue.. N-Methyl-D-Aspartate Receptors defined as following: A class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which Magnesium supplements, alimentary tract and metabolism ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity.. Cerebrovascular accident defined as following: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810). chlormethiazole defined as following: A sedative and anticonvulsant often used in the treatment of alcohol withdrawal. Chlormethiazole has also been proposed as a neuroprotective agent. The mechanism of its therapeutic activity is not entirely clear, but it does potentiate GAMMA-AMINOBUTYRIC ACID receptors response and it may also affect glycine receptors.. Sodium Channel defined as following: Ion channels that specifically allow the passage of SODIUM ions. A variety of specific Sodium Channel subtypes are involved in serving specialized functions such as neuronal signaling, CARDIAC MUSCLE contraction, and KIDNEY function.. fosphenytoin defined as following: A water-soluble phosphate ester prodrug of phenytoin, a hydantoin derivative with anticonvulsant activity. Fosphenytoin is hydrolyzed to phenytoin by phosphatases. Phenytoin exerts its effect mainly by promoting sodium efflux and stabilizes neuronal membranes in the motor cortex. This leads to a suppression of excessive neuronal firing and limits the spread of seizure activity.. Mus defined as following: Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae.. piracetam defined as following: A compound suggested to be both a nootropic and a neuroprotective agent..", "label": "no"} {"original_question": "Does Panitumumab prolong survival of biliary tract cancer patients?", "id": "converted_2889", "sentence1": "Does Panitumumab prolong survival of biliary tract cancer patients?", "sentence2": "Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type Human Oncogene K-Ras advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)., CONCLUSIONS: Panitumumab in combination with chemotherapy does not improve ORR, PFS and OS in patients with Human Oncogene K-Ras wild-type, advanced Biliary Tract Cancer. , No survival differences were observed: the median overall survival was 9.9 months in arm A and 10.2 months in arm B (P = .42). In a subgroup analysis, no differences in PFS according to the site of the primary tumor were observed; patients with Primary cholangiocarcinoma of intrahepatic biliary tract treated with panitumumab may have had a survival benefit in comparison with the control group (15.1 vs 11.8 months, P = .13). , CONCLUSIONS\nPanitumumab in combination with chemotherapy does not improve ORR, PFS and OS in patients with Human Oncogene K-Ras wild-type, advanced Biliary Tract Cancer., CONCLUSIONS Panitumumab in combination with chemotherapy does not improve ORR, PFS and OS in patients with Human Oncogene K-Ras wild-type, advanced Biliary Tract Cancer., Despite many clinical trials being conducted with molecular targeted agents including erlotinib, cetuximab, panitumumab, bevacizumab, sorafenib, cediranib, trametinib and vandetanib, no agent has shown to be effective for advanced biliary tract cancer., Adding panitumumab to standard protocols does not prolong survival but provokes additional adverse effects.[SEP]Relations: biliary tract cancer has relations: disease_disease with liver cancer, disease_disease with liver cancer, disease_protein with PRKACB, disease_protein with PRKACB, disease_disease with bile duct cancer, disease_disease with bile duct cancer. Panitumumab has relations: drug_drug with Bimagrumab, drug_drug with Bimagrumab, drug_drug with Afelimomab, drug_drug with Afelimomab. Definitions: gemcitabine defined as following: A broad-spectrum antimetabolite and deoxycytidine analogue with antineoplastic activity. Upon administration, gemcitabine is converted into the active metabolites difluorodeoxycytidine diphosphate (dFdCDP) and difluorodeoxycytidine triphosphate (dFdCTP) by deoxycytidine kinase. dFdCTP competes with deoxycytidine triphosphate (dCTP) and is incorporated into DNA. This locks DNA polymerase thereby resulting in \"masked termination\" during DNA replication. On the other hand, dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis. The reduction in the intracellular concentration of dCTP potentiates the incorporation of dFdCTP into DNA.. vandetanib defined as following: An orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability. This agent also blocks the tyrosine kinase activity of epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that mediates tumor cell proliferation and migration and angiogenesis.. erlotinib defined as following: A quinazoline derivative with antineoplastic properties. Competing with adenosine triphosphate, erlotinib reversibly binds to the intracellular catalytic domain of epidermal growth factor receptor (EGFR) tyrosine kinase, thereby reversibly inhibiting EGFR phosphorylation and blocking the signal transduction events and tumorigenic effects associated with EGFR activation.. bevacizumab defined as following: An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS.. cetuximab defined as following: A chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors.. trametinib defined as following: An orally bioavailable inhibitor of mitogen-activated protein kinase kinase (MAP2K; MAPK/ERK kinase; MEK) 1 and 2, with potential antineoplastic activity. Upon oral administration, trametinib specifically binds to and inhibits MEK 1 and 2, resulting in an inhibition of growth factor-mediated cell signaling and cellular proliferation in various cancers. MEK 1 and 2, dual specificity serine/threonine and tyrosine kinases often upregulated in various cancer cell types, play a key role in the activation of the RAS/RAF/MEK/ERK signaling pathway that regulates cell growth.. panitumumab defined as following: A human IgG2kappa monoclonal antibody specific for the epidermal growth factor receptor (EGFR). Monoclonal antibody E7.6.3 binds to the EGFR, blocking the binding of epidermal growth factor and transforming growth factor alpha to EGFR-expressing cancer cells and ultimately inhibiting EGFR-dependent cell activation and proliferation. (NCI). Human Oncogene K-Ras defined as following: Human Oncogene K-Ras is a mutated variant of KRAS2 Gene, which encodes two alternative isoforms of monomeric p21 K-RAS protein, a monomeric GTPase involved in transmembrane signal transduction that alternates between inactive GDP-bound and active GTP-bound forms. K-Ras is activated by a guanine nucleotide-exchange factor and inactivated by a GTPase-activating protein. Mitogen-stimulated RAS stabilizes MYC protein and enhances MYC accumulation by the RAS/RAF/MAPK pathway, which appears to inhibit the proteasome-dependent degradation of MYC. Implicated in a variety of human tumors, mutations of specific amino acids activate RAS to transform cells. Human Oncogene K-Ras is involved in malignancy much more often than is HRAS. Oncogene K-Ras disrupts normal cell function.. oxaliplatin defined as following: An organoplatinum complex in which the platinum atom is complexed with 1,2-diaminocyclohexane, and with an oxalate ligand which is displaced to yield active oxaliplatin derivatives. These derivatives form inter- and intra-strand DNA crosslinks that inhibit DNA replication and transcription. Oxaliplatin is an antineoplastic agent that is often administered with FLUOROURACIL and FOLINIC ACID in the treatment of metastatic COLORECTAL NEOPLASMS.. sorafenib defined as following: A synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis.. Panitumumab defined as following: A human IgG2kappa monoclonal antibody specific for the epidermal growth factor receptor (EGFR). Monoclonal antibody E7.6.3 binds to the EGFR, blocking the binding of epidermal growth factor and transforming growth factor alpha to EGFR-expressing cancer cells and ultimately inhibiting EGFR-dependent cell activation and proliferation. (NCI).", "label": "no"} {"original_question": "Does TFIIS affect nucleosome positioning?", "id": "converted_2247", "sentence1": "Does TCEA1 wt Allele affect nucleosome location positioning?", "sentence2": "Transcript cleavage factor TCEA1 wt Allele reactivates the backtracked complex (molecular entity) and promotes pol II transcription through the nucleosome location location. , The same Nucleosomes transcribed in the opposite orientation form a weaker, more diffuse barrier that is largely relieved by higher Sodium Chloride, Dietary, TCEA1 wt Allele, or Foundation for the Accreditation of Cellular Therapy, The system contains natural or recombinant histones, chromatin location location assembly factors, the histone-acetyltransferase p300, all components of the general transcription machinery, general coactivators and the transcription factor S-II (TCEA1 wt Allele)., Efficient and rapid nucleosome location location traversal by RNA Polymerase II depends on a combination of RNA Transcript elongation factors., We now show that although GTF2F2P1 gene or TCEA1 wt Allele alone is modestly stimulatory for nucleosome location location traversal, both factors together increase transcription through Nucleosomes in a synergistic manner., Significantly, we found that Nucleosomes with a Sin mutant histone are traversed to the same extent and at nearly the same rate as equivalent pure DNA templates if both TCEA1 wt Allele and GTF2F2P1 gene are present., After partial uncoiling of nucleosomal DNA from Histone octamer by Pol II and backtracking of the Enzyme [APC], nucleosomal DNA recoils on the octamer, locking Pol II in the arrested state. Histone Chaperones and transcription factors TCEA1 wt Allele, GTF2F2P1 gene and Foundation for the Accreditation of Cellular Therapy facilitate transcription through chromatin location location using different molecular mechanisms., Transcript cleavage factor TCEA1 wt Allele reactivates the backtracked complex (molecular entity) and promotes pol II transcription through the nucleosome location location., The highly conserved eukaryotic transcriptional elongation factor TCEA1 wt Allele enables RNA Polymerase II (RNAPII) to read though pause or termination sites, Nucleosomes and sequence-specific DNA-binding proteins., We also studied the effect of GTF2F2P1 gene and TCEA1 wt Allele on transcription of Nucleosomes containing a Sin mutant histone., The same Nucleosomes transcribed in the opposite orientation form a weaker, more diffuse barrier that is largely relieved by higher Sodium Chloride, Dietary, TCEA1 wt Allele, or Foundation for the Accreditation of Cellular Therapy.[SEP]Relations: nucleosome location has relations: cellcomp_protein with IRF4, cellcomp_protein with IRF4, cellcomp_protein with MPHOSPH8, cellcomp_protein with MPHOSPH8, cellcomp_protein with H2AX, cellcomp_protein with H2AX, cellcomp_protein with SLF1, cellcomp_protein with SLF1, cellcomp_protein with GLYR1, cellcomp_protein with GLYR1. Definitions: Nucleosomes defined as following: The repeating structural units of chromatin location, each consisting of approximately 200 base pairs of DNA wound around a protein core. This core is composed of the histones H2A, H2B, H3, and H4.. RNA Polymerase II defined as following: A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and Sodium Chloride, Dietary than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6.. Foundation for the Accreditation of Cellular Therapy defined as following: A non-profit corporation co-founded by the International Society for Cellular Therapy and the American Society of Blood and Marrow Transplantation for the purposes of voluntary inspection and accreditation in the field of cellular therapy. Founded in 1996, Foundation for the Accreditation of Cellular Therapy establishes standards for high quality medical and laboratory practice in cellular therapies. Foundation for the Accreditation of Cellular Therapy Standards are evidence-based requirements set by world-renowned experts vested in the improvement and progress of cellular therapy.. Sodium Chloride, Dietary defined as following: Sodium chloride used in foods.. TCEA1 wt Allele defined as following: Human TCEA1 wild-type allele is located in the vicinity of 8q11.2 and is approximately 56 kb in length. This allele, which encodes transcription elongation factor A protein 1, plays a role in transcriptional elongation. A chromosomal insertion ins(8)(q12;q11q11) of this gene and the PLAG1 gene may be associated with salivary gland pleomorphic adenoma.. nucleosome location defined as following: The repeating structural units of chromatin location, each consisting of approximately 200 base pairs of DNA wound around a protein core. This core is composed of the histones H2A, H2B, H3, and H4.. chromatin location defined as following: The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130]. RNA Transcript defined as following: The initial RNA molecule produced by transcription.. Histone Chaperones defined as following: Proteins involved in the assembly and disassembly of HISTONES into NUCLEOSOMES.. complex (molecular entity) defined as following: A molecular entity formed by loose association involving two or more component molecular entities. The bonding between the components is normally weaker than in a covalent bond..", "label": "yes"} {"original_question": "Is ospemifene effective for treatment of dyspareunia?", "id": "converted_285", "sentence1": "Is ospemifene effective for treatment of Have Dyspareunia question?", "sentence2": "ospemifene, a novel selective Estrogen Receptor Modulators, has been developed for the treatment of Vulvovaginal atrophy and Have Dyspareunia question in postmenopausal women. , For the comparison of short-term ospemifene with placebo, parabasal cells (the standardized mean difference [Spondylometaphyseal dysplasia] = -37.5, 95% confidence interval [CI] = -41.83 to -33.17, P < 0.00001), superficial cells (Spondylometaphyseal dysplasia = 9.24, 95% CI = 7.70 to 10.79, P < 0.00001), vaginal PH (Spondylometaphyseal dysplasia = -0.89, 95% CI = -0.98 to -0.80, P = 0.00001), and Have Dyspareunia question (Spondylometaphyseal dysplasia = -0.37, 95% CI = -0.43 to -0.30, P = 0.00001) indicated that ospemifene was more effective than the placebo. , This meta-analysis indicates that ospemifene to be an effective and safe treatment for Have Dyspareunia question associated with postmenopausal Vulva and Atrophy of vagina., ospemifene is a selective Estrogen Receptor Modulators (SERM), or Estrogen [EPC] receptor agonist/antagonist, that was recently approved by the US Food and Drug Administration for the treatment of Have Dyspareunia question associated with Vulva and Atrophy of vagina, a chronic condition that affects up to 60% of postmenopausal women., In conclusion, ospemifene is a SERM with a unique Estrogen Agonist/Antagonist [EPC] tissue profile that was recently approved in the US for the treatment of Have Dyspareunia question associated with Vulva and Atrophy of vagina in postmenopausal women. , To characterize the pharmacokinetics of the oral, non-Estrogen [EPC] agent ospemifene, an Estrogen Agonist/Antagonist [EPC] with tissue-selective effects (also called a selective Estrogen Receptor Modulators) that was recently approved for the treatment of Have Dyspareunia question associated with Vulva and Atrophy of vagina in postmenopausal women., Here, we review the Estrogen Agonist/Antagonist [EPC] profile of ospemifene, a novel triphenylethylene derivative recently approved to treat Have Dyspareunia question, a symptom of Vulva and Atrophy of vagina (VVA) due to menopause, both preclinically and clinically., Long-term studies on the endometrial safety of local Estrogen [EPC] and ospemifene are lacking. , ospemifene is a tissue-selective Estrogen Agonist/Antagonist [EPC] (a selective Estrogen Receptor Modulators) recently approved by the US Food and Drug Administration for treatment of Have Dyspareunia question, a symptom of VVA, due to menopause., Selective Estrogen Receptor Modulators with positive vaginal effects (such as improvement in the vaginal maturation index, reduced vaginal pH, and improvement in the signs and symptoms of VVA) on postmenopausal symptomatic women include Lasofoxifene (clinical development on hold) and ospemifene, which was recently approved for the treatment of VVA-related Have Dyspareunia question, with a class effect warning of potential Venous Thrombosis risk. , ospemifene is the first non-Estrogen [EPC] treatment approved for moderate to severe Have Dyspareunia question in women with menopause-related Vulva and Atrophy of vagina. , This article summarizes the milestones in the development of ospemifene leading to this first approval for moderate to severe Have Dyspareunia question, a symptom of postmenopausal Vulva and Atrophy of vagina., The aim of this work was to study the role of ospemifene, a novel selective Estrogen Receptor Modulators, in the treatment of Vulva and Atrophy of vagina in postmenopausal women with moderate to severe Have Dyspareunia question and physiological vaginal changes. , In this study, once-daily oral ospemifene 60 mg was effective for the treatment of Vulva and Atrophy of vagina in postmenopausal women with Have Dyspareunia question., Clinical trials have confirmed that daily doses are well-tolerated and that it is effective in normalizing vaginal maturation index and pH as well as improving the symptoms associated with VVA including Have Dyspareunia question., ospemifene was shown to be effective and well tolerated for the treatment of the symptoms of Vaginal dryness and Have Dyspareunia question associated with Vulvovaginal atrophy over and above the use of provided lubricants.[SEP]Relations: ospemifene has relations: drug_drug with Antipyrine, drug_drug with Antipyrine, drug_drug with Orphenadrine, drug_drug with Orphenadrine, drug_drug with Amodiaquine, drug_drug with Amodiaquine. Dyspareunia has relations: drug_effect with Progesterone, drug_effect with Progesterone, drug_effect with Fluoxetine, drug_effect with Fluoxetine. Definitions: Atrophy of vagina defined as following: A condition characterized by the absence of squamous maturation in the vaginal epithelium. It is associated with decreased Estrogen [EPC] production.. Selective Estrogen Receptor Modulators defined as following: A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate Estrogen [EPC] agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63). Spondylometaphyseal dysplasia defined as following: A heterogeneous group of disorders associated with walking and growth disturbances that become evident during the second year of life. Characteristics are platyspondyly (flattened vertebrae) and marked hip and knee metaphyseal lesions. The different forms of spondylometaphyseal dysplasia are distinguished by the localization and severity of involvement of the affected metaphyses.. Venous Thrombosis defined as following: The formation or presence of a blood clot (THROMBUS) within a vein.. Lasofoxifene defined as following: A non-steroidal, naphthalene-derived, third-generation selective Estrogen Receptor Modulators (SERM) with potential antineoplastic and anti-osteoporotic activities. Upon oral administration, Lasofoxifene selectively binds to both Estrogen [EPC] receptor alpha (ERalpha; ESR1) and Estrogen [EPC] receptor beta (ERbeta; ESR2) with high affinity and mimics the effects of endogenous estradiol with varying agonist and antagonist effects in ER-expressing tissues. Blockade of ERalpha by Lasofoxifene may potentially inhibit Estrogen [EPC]-dependent cancer cell proliferation in ER-expressing cancers. Lasofoxifene may also bind to the certain mutant forms of ERalpha, including the Y537S ESR1 mutant, making it potentially useful in the treatment of tumors that have acquired resistance to other ER-targeting agents.. Vulva defined as following: The external genitalia of the female. It includes the CLITORIS, the labia, the vestibule, and its glands.. Estrogen Receptor Modulators defined as following: Substances that possess antiestrogenic actions but can also produce estrogenic effects as well. They act as complete or partial agonist or as antagonist. They can be either steroidal or nonsteroidal in structure.. Have Dyspareunia question defined as following: A question about whether an individual has or had painful intercourse.. Vaginal dryness defined as following: An uncomfortable feeling of itching and burning in the vaginal opening resulting from inadequate vaginal lubrication. It is commonly seen during and after menopause, childbirth, or stressful conditions. It results in painful intercourse.. Vulvovaginal atrophy defined as following: A condition associated with decreased Estrogen [EPC] production, characterized by dryness, inflammation, and itching of the vulva and vaginal tissues. It may also be associated with dysuria and Have Dyspareunia question..", "label": "yes"} {"original_question": "Is ASF1 phopshorylated by the Tousled-like kinases?", "id": "converted_4701", "sentence1": "Is ASF1 phopshorylated by the Tousled-like kinases?", "sentence2": "Asf1, a key Histone antigen H3-H4 chaperone required for this process, is phosphorylated by Tousled-like kinases (TLKs). , The Tousled-like kinases 1 and 2 (TLK1 gene gene/2) control Histone antigen deposition through the ASF1 Histone antigen chaperone, The Tousled-like kinases (TLKs) are involved in Chromatin Modeling, DNA repair, and transcription. Two TLK Genes exist in Homo sapiens, and their expression is often dysregulated in Primary malignant neoplasm. TLKs phosphorylate Asf1 , TLKs interact specifically (and phosphorylate) with the Chromatin Modeling factor Asf1, a Histone antigen H3-H4 chaperone, TLK1 gene gene substrates were identified as the Histone antigen H3 and Asf1 (a Histone antigen H3/H4 chaperone)[SEP]Relations: Histone antigen H3 acetylation has relations: bioprocess_protein with TAF5L, bioprocess_protein with TAF5L, bioprocess_protein with TAF6L, bioprocess_protein with TAF6L, bioprocess_protein with LEF1, bioprocess_protein with LEF1, bioprocess_protein with TAF5, bioprocess_protein with TAF5, bioprocess_protein with IRF4, bioprocess_protein with IRF4. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Chromatin Modeling defined as following: The assembly of DNA, Histone antigen proteins, other associated proteins, and sometimes RNA, into chromatin structure, beginning with the formation of the basic unit, the nucleosome, followed by organization of the nucleosomes into higher order structures, ultimately giving rise to a complex organization of specific domains within the nucleus. [PMID:20404130]. Homo sapiens defined as following: Members of the species Homo sapiens.. Histone antigen H3 defined as following: Histone H3 is a core subunit of the eukaryotic nucleosome complex. Histones are basic nuclear proteins responsible for the nucleosome structure of chromatin. Repeating nucleosome units contain two molecules each of Histones H2A, H2B, H3, and H4 that form an octamer complex around which approximately 146 base pairs of DNA is wrapped. Linker Histone H1 interacts with DNA between nucleosome units in mediating chromatin compaction into higher order structures. (NCI). Chromatin Modeling factor defined as following: A Histone antigen chaperone protein that plays a role in the deposition of NUCLEOSOMES on newly synthesized DNA. It is comprised of three different subunits of 48, 60, and 150 kDa molecular size. The 48 kDa subunit, RETINOBLASTOMA-BINDING PROTEIN 4, is also a component of several other protein complexes involved in chromatin remodeling.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms..", "label": "yes"} {"original_question": "Are neurexins localized at pre-synapses?", "id": "converted_2266", "sentence1": "Are neurexins localized at pre-synapses?", "sentence2": "Neurexins and neuroligins are two distinct families of Single-pass plasma transmembrane protein localized at pre- and postsynapses, respectively. , presynaptic neurexins, best-characterized transsynaptic interactions are formed by presynaptic neurexins, which bind to diverse postsynaptic ligands., presynaptic neurexin[SEP]Relations: protein transport within plasma membrane has relations: bioprocess_bioprocess with protein transport within lipid bilayer, bioprocess_bioprocess with protein transport within lipid bilayer, bioprocess_bioprocess with protein transport out of plasma membrane raft, bioprocess_bioprocess with protein transport out of plasma membrane raft.", "label": "yes"} {"original_question": "Can Patient-derived organoids (PDOs) recapitulate patient responses in the clinic?", "id": "converted_3468", "sentence1": "Can Patient-derived Organoids (PDOs) recapitulate patient responses in the clinic?", "sentence2": "Patient-derived Organoids (PDOs) have recently emerged as robust preclinical models; however, their potential to predict clinical outcomes in patients has remained unclear. We report on a living biobank of PDOs from metastatic, heavily pretreated Colorectal and gastroesophageal Primary malignant neoplasm patients recruited in phase 1/2 clinical trials. Phenotypic and genotypic profiling of PDOs showed a high degree of similarity to the original patient tumors. Molecular profiling of tumor Organoids was matched to drug-screening results, suggesting that PDOs could complement existing approaches in defining Primary malignant neoplasm vulnerabilities and improving treatment responses. We compared responses to anticancer agents ex vivo in Organoids and PDO-based orthotopic mouse tumor xenograft models with the responses of the patients in clinical trials. Our data suggest that PDOs can recapitulate patient responses in the clinic and could be implemented in personalized medicine programs., Our data suggest that PDOs can recapitulate patient responses in the clinic and could be implemented in personalized medicine programs., Molecular profiling of tumor Organoids was matched to drug-screening results, suggesting that PDOs could complement existing approaches in defining Primary malignant neoplasm vulnerabilities and improving treatment responses., Phenotypic and genotypic profiling of PDOs showed a high degree of similarity to the original patient tumors., Patient-derived xenografts (Patient Derived Xenograft) and patient-derived Organoids (PDO) serve as promising tools to identify new drugs with therapeutic potential in ANOPHTHALMIA AND PULMONARY HYPOPLASIA., Our data suggest that PDOs can recapitulate patient responses in the clinic and could be implemented in personalized medicine programs, Our data suggest that PDOs can recapitulate patient responses in the clinic and could be implemented in personalized medicine programs, Molecular profiling of tumor Organoids was matched to drug-screening results , suggesting that PDOs could complement existing approaches in defining Primary malignant neoplasm vulnerabilities and improving treatment responses, Our data suggest that PDOs can recapitulate patient responses in the clinic and could be implemented in personalized medicine programs.[SEP]Relations: Pulmonary hypoplasia has relations: disease_phenotype_positive with spondylodysplastic Ehlers-Danlos syndrome, disease_phenotype_positive with spondylodysplastic Ehlers-Danlos syndrome, disease_phenotype_positive with Silverman-Handmaker type dyssegmental dysplasia, disease_phenotype_positive with Silverman-Handmaker type dyssegmental dysplasia, disease_phenotype_positive with congenital multicore myopathy with external ophthalmoplegia, disease_phenotype_positive with congenital multicore myopathy with external ophthalmoplegia, disease_phenotype_positive with fetal akinesia deformation sequence, disease_phenotype_positive with fetal akinesia deformation sequence. Colorectal Primary malignant neoplasm has relations: disease_protein with PDGFD, disease_protein with PDGFD. Definitions: Primary malignant neoplasm defined as following: A malignant tumor at the original site of growth.. Patient Derived Xenograft defined as following: A mouse model for human Primary malignant neoplasm studies in which a human-derived tumor sample is transplanted into an immunodeficient mouse.. Colorectal defined as following: Relating to the colon and rectum, or to the entire large bowel.. Organoids defined as following: An organization of cells into an organ-like structure. Organoids can be generated in culture, e.g., self-organized three-dimensional tissue structures derived from STEM CELLS (see MICROPHYSIOLOGICAL SYSTEMS). They are also found in certain NEOPLASMS.. ANOPHTHALMIA AND PULMONARY HYPOPLASIA defined as following: A rare clinical entity including as main characteristics anophthalmia or severe microphthalmia, and pulmonary hypoplasia or aplasia. Only five cases have been reported so far, two of who were siblings. In the three nonfamilial cases, unilateral pulmonary agenesis and microphthalmia were associated with diaphragmatic hernia and pulmonary vessel agenesis. It has been suggested that two different entities can be distinguished: on one hand, the association of anophthalmia-pulmonary hypoplasia with/without anomalies of the face, heart, spleen and uterus, which may be due to a putative autosomal recessive gene with pleiotropic effects; on the other hand, a sporadic association including pulmonary hypoplasia, anophthalmia, unilateral diaphragmatic defect and agenesis of the pulmonary trunk, which may represent the expression of a developmental field defect. There is evidence that syndromic microphthalmia- is caused by homozygous or compound heterozygous mutation in the STRA6 gene on chromosome 15q24..", "label": "yes"} {"original_question": "Is Lanabecestat effective for Alzheimer's disease?", "id": "converted_4025", "sentence1": "Is Lanabecestat effective for ALZHEIMER DISEASE, FAMILIAL, 1?", "sentence2": "INTRODUCTION: The APECS and AMARANTH trials showed that BACE2 gene (BACE1 wt Allele) inhibitors verubecestat and lanabecestat failed to slow cognitive and functional decline in individuals with prodromal or early ALZHEIMER DISEASE, FAMILIAL, 1. , Conclusions and Relevance: Treatment with lanabecestat was well tolerated and did not slow cognitive or functional decline., INTRODUCTION: The APECS and AMARANTH trials showed that BACE2 gene (BACE1 wt Allele) inhibitors verubecestat and lanabecestat failed to slow cognitive and functional decline in individuals with prodromal or early ALZHEIMER DISEASE, FAMILIAL, 1., INTRODUCTION: The APECS and AMARANTH trials showed that BACE2 gene (BACE1 wt Allele) inhibitors verubecestat and lanabecestat failed to slow cognitive and functional decline in individuals with prodromal or early Alzheime, INTRODUCTION: The APECS and AMARANTH trials showed that BACE2 gene (BACE1 wt Allele) inhibitors verubecestat and lanabecestat failed to slow cognitive and functional decline in individuals with prodromal or early Alzhei[SEP]Relations: familial Alzheimer disease has relations: disease_disease with Alzheimer disease, disease_disease with Alzheimer disease, disease_protein with PRNP, disease_protein with PRNP, disease_disease with inherited prion disease, disease_disease with inherited prion disease, disease_phenotype_positive with Cognitive impairment, disease_phenotype_positive with Cognitive impairment, disease_phenotype_positive with Sleep disturbance, disease_phenotype_positive with Sleep disturbance. Definitions: BACE2 gene defined as following: Beta-secretase 2 (518 aa, ~56 kDa) is encoded by the human BACE2 gene. This protein is involved in the cleavage of membrane bound proteins.. BACE1 wt Allele defined as following: Human BACE1 wild-type allele is located within 11q23.2-q23.3 and is approximately 31 kb in length. This allele, which encodes BACE2 gene 1 protein, is involved in proteolytic processing.. ALZHEIMER DISEASE, FAMILIAL, 1 defined as following: ALZHEIMER DISEASE, FAMILIAL, 1 caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65..", "label": "no"} {"original_question": "Is Apremilast effective for Behcet’s syndrome?", "id": "converted_2429", "sentence1": "Is apremilast effective for Behcet’s syndrome?", "sentence2": "apremilast is an immunomodulatory agent that works through Cyclic Nucleotide Phosphodiesterases, Type 4 inhibition. A randomized controlled trial has shown that it is effective for the management of oral and genital Ulcer and is generally well tolerated., AREAS COVERED: This review provides a digest of all current experience and evidence about pharmacological agents recently described as having a role in the treatment of BS, including interleukin (IL)-1 inhibitors, tocilizumab, rituximab, alemtuzumab, Ustekinumab Ab, interferon-alpha-2a, and apremilast., CONCLUSIONS: apremilast was effective in treating oral Ulcer, which are the cardinal manifestation of Behçet's syndrome., apremilast, an PPP1R1A gene of phosphodiesterase-4, was effective in a phase 2, double blind, placebo-controlled study., apremilast (Otezla(®)), an oral small molecule PPP1R1A gene of type-4 cyclic nucleotide phosphodiesterase (PDE-4), is under development with Celgene Corporation for the treatment of Arthritis, Psoriatic, Psoriasis, ankylosing spondylitis, Behçet's syndrome, Dermatitis, Atopic, and Rheumatoid Arthritis., There were two serious adverse events in patients receiving apremilast.
CONCLUSIONS: apremilast was effective in treating oral Ulcer, which are the cardinal manifestation of Behçet's syndrome., apremilast (Otezla(®)), an oral small molecule PPP1R1A gene of type-4 cyclic nucleotide phosphodiesterase (PDE-4), is under development with Celgene Corporation for the treatment of Arthritis, Psoriatic, Psoriasis, ankylosing spondylitis, Behçet's syndrome, Dermatitis, Atopic, and Rheumatoid Arthritis., CONCLUSIONS apremilast was effective in treating oral Ulcer, which are the cardinal manifestation of Behçet's syndrome., apremilast, an oral small molecule PPP1R1A gene of Cyclic Nucleotide Phosphodiesterases, Type 4 (Phosphodiesterase Type 4), is in development for chronic inflammatory disorders, and has shown efficacy in Psoriasis, psoriatic arthropathies, and Behçet's syndrome., oral Ulcer the hallmark of behçet s syndrome can be resistant to conventional treatment therefore alternative agents are needed apremilast is an oral Cyclic Nucleotide Phosphodiesterases, Type 4 PPP1R1A gene that modulates several inflammatory pathways we conducted a phase 2 multicenter placebo controlled study in which 111 patients with behçet s syndrome who had two or more oral Ulcer were randomly assigned to receive 30 mg of apremilast twice daily or placebo for 12 weeks this regimen was followed by a 12 week extension phase in which the placebo group was switched to apremilast and a 28 day post treatment observational follow up phase the patients and clinicians were unaware of the study assignments throughout the trial the primary end point was the number of oral Ulcer at week 12 secondary outcomes included Pain:-:Point in time:^Patient:- from these Ulcer measured on a 100 mm visual analogue scale with higher scores indicating worse Pain:-:Point in time:^Patient:- the number of genital Ulcer overall disease activity and quality of life the mean sd number of oral Ulcer per patient at week 12 was significantly lower in the apremilast group than in the placebo group 0 5 1 0 vs 2 1 2 6 p 0 001 the mean decline in Pain:-:Point in time:^Patient:- from oral Ulcer from baseline to week 12 was greater with apremilast than with placebo 44 7 24 3 mm vs 16 0 32 5 mm p 0 001 nausea vomiting and Diarrhea were more common in the apremilast group with 22 9 and 12 incidents respectively among 55 patients than in the placebo group with 10 1 and 2 incidents respectively among 56 patients findings that were similar to those in previous studies of apremilast there were two serious adverse events in patients receiving apremilast apremilast was effective in treating oral Ulcer which are the cardinal manifestation of behçet s syndrome this preliminary study was neither large enough nor long enough to assess long term efficacy the effect on other manifestations of behçet s syndrome or the risk of uncommon serious adverse events funded by celgene clinicaltrials gov number nct00866359., current trends in the management of behçet s syndrome will be reviewed in this article Biological Factors have gained increasing importance over the years in the management of behçet s syndrome long term results of observational studies have shown that anti tumor necrosis factor agents may be effective in behçet s syndrome patients with refractory eye involvement case series reporting about use of anti tumor necrosis factor agents in Blood Vessel and gastrointestinal involvement have also shown good results caution is required for infectious complications with these agents apremilast is an immunomodulatory agent that works through Cyclic Nucleotide Phosphodiesterases, Type 4 inhibition a randomized controlled trial has shown that it is effective for the management of oral and genital Ulcer and is generally well tolerated the outcome of behçet s syndrome with major Organ involvement has improved with more effective management strategies especially with the use of Biological Factors in severe cases controlled trials are needed to guide physicians in making treatment decisions.[SEP]Relations: apremilast has relations: drug_drug with Bepotastine, drug_drug with Bepotastine, drug_drug with Bevacizumab, drug_drug with Bevacizumab, drug_drug with Aprepitant, drug_drug with Aprepitant, drug_drug with Bexarotene, drug_drug with Bexarotene, drug_drug with Cefetamet, drug_drug with Cefetamet. Definitions: Biological Factors defined as following: Endogenously synthesized compounds that influence biological processes not otherwise classified under ENZYMES; HORMONES or HORMONE ANTAGONISTS.. apremilast defined as following: An orally bioavailable, small molecule PPP1R1A gene of Cyclic Nucleotide Phosphodiesterases, Type 4 (Phosphodiesterase Type 4), with potential anti-inflammatory activity. Upon oral administration, apremilast targets, binds to and inhibits the activity of Phosphodiesterase Type 4, thereby blocking cyclic adenosine monophosphate (cAMP) degradation and increasing intracellular cAMP levels. This may decrease the production of the proinflammatory cytokines including tumor necrosis factor-alpha (TNF-alpha). Phosphodiesterase Type 4 is an enzyme that plays an important role in the degradation of cAMP and in cytokine production in inflammatory cells.. Psoriasis defined as following: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in Psoriasis.. alemtuzumab defined as following: Any monoclonal antibody directed against the cell surface glycoprotein CD52, regardless of the antibody type (e.g., rat, mouse, humanized).. Arthritis, Psoriatic defined as following: A type of inflammatory arthritis associated with PSORIASIS, often involving the axial joints and the peripheral terminal interphalangeal joints. It is characterized by the presence of HLA-B27-associated SPONDYLARTHROPATHY, and the absence of rheumatoid factor.. Rheumatoid Arthritis defined as following: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.. Ulcer defined as following: A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue.. rituximab defined as following: A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.. Phosphodiesterase Type 4 defined as following: A family of phosphodiesterases that hydrolyze cyclic AMP to form AMP. This enzyme family is the primary cyclic nucleotide phosphodiesterase expressed by immune cells.. Diarrhea defined as following: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.. Blood Vessel defined as following: Any of the tubular vessels conveying the blood (arteries, arterioles, capillaries, venules, and veins).. Cyclic Nucleotide Phosphodiesterases, Type 4 defined as following: A cyclic nucleotide phosphodiesterase subfamily that is found predominantly in inflammatory cells and may play a role in the regulation of CELL-MEDIATED IMMUNITY. The enzyme family includes over twenty different variants that occur due to multiple ALTERNATIVE SPLICING of the mRNA of at least four different genes.. oral Ulcer defined as following: A loss of mucous substance of the mouth showing local excavation of the surface, resulting from the sloughing of inflammatory necrotic tissue. It is the result of a variety of causes, e.g., denture irritation, aphthous stomatitis (STOMATITIS, APHTHOUS); NOMA; necrotizing gingivitis (GINGIVITIS, NECROTIZING ULCERATIVE); TOOTHBRUSHING; and various irritants. (From Jablonski, Dictionary of Dentistry, 1992, p842). Organ defined as following: A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues. An Organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus.. Dermatitis, Atopic defined as following: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.. tocilizumab defined as following: A recombinant, humanized IgG1 monoclonal antibody directed against the interleukin-6 receptor (IL-6R) with immunosuppressant activity. Tocilizumab targets and binds to both the soluble form of IL-6R (sIL-6R) and the membrane-bound form (mIL-6R), thereby blocking the binding of IL-6 to its receptor. This prevents IL-6-mediated signaling. IL-6, a pro-inflammatory cytokine that plays an important role in the regulation of the immune response, is overproduced in autoimmune disorders, certain types of cancers and possibly various other inflammatory conditions.. Behcet’s syndrome defined as following: Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well..", "label": "yes"} {"original_question": "Is Crohn's disease (CD) linked to the consumption of refrigerated food?", "id": "converted_1396", "sentence1": "Is Crohn's disease (CD) linked to the consumption of refrigerated Food allergenic extracts?", "sentence2": "Environmental risk factors playing a causative role in Crohn's disease of oral soft tissues (CD) remain largely unknown. Recently, it has been suggested that refrigerated Food allergenic extracts could be involved in disease development., This study supports the opinion that CD is associated with exposure to domestic refrigeration, among other household factors, during childhood., Patients were exposed earlier than controls to the refrigerator (X2 = 9.9, df = 3, P = 0.04) and refrigerator exposure at birth was found to be a risk factor for CD (OR = 2.08 (95% CI: 1.01-4.29), P = 0.05). Comparable results were obtained looking for the exposure to freezer at home., A recent published hypothesis proposed that Crohn's disease was provoked by infantile exposure to Microorganism that can survive refrigerator temperature., This support for the hypothesis reached statistical significance for those with Crohn's disease compared to the controls (p=0.045)., Epidemiological data allow assessment of familial environmental risk factors related to western lifestyle, diet, Bacteria, and domestic hygiene., All findings point to refrigeration as a potential risk factor for Crohn's disease., Furthermore, cold-chain development paralleled the outbreak of Crohn's disease during the 20th century. , Environmental risk factors playing a causative role in Crohn's Disease (CD) remain largely unknown. Recently, it has been suggested that refrigerated Food allergenic extracts could be involved in disease development., Our study suggests an association between the omission of breakfast and the failure to refrigerate Food allergenic extracts with GC in the Mexican population.[SEP]Relations: Crohn disease of the esophagus has relations: disease_disease with Crohn disease, disease_disease with Crohn disease, disease_disease with esophagitis (disease), disease_disease with esophagitis (disease). Bacteremia has relations: disease_phenotype_positive with toxic shock syndrome, disease_phenotype_positive with toxic shock syndrome, disease_phenotype_positive with listeriosis, disease_phenotype_positive with listeriosis, disease_phenotype_positive with cyclic hematopoiesis, disease_phenotype_positive with cyclic hematopoiesis. Definitions: Microorganism defined as following: A microscopic organism. The term microorganism may refer to a prokaryote or eukaryote, and may be a unicellular or multicellular organism. All taxonomic kingdoms contain microorganisms.. Bacteria defined as following: One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive.. Crohn's disease defined as following: A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients..", "label": "yes"} {"original_question": "Should tirilazad be used for treatment of ischemic stroke?", "id": "converted_3830", "sentence1": "Should tirilazad be used for treatment of ischemic stroke?", "sentence2": "CONCLUSION: Tirilazad had no effect on clinical outcome but did decrease symptomatic Vasospasm in five trials of aneurysmal SAH. , Tirilazad did not significantly decrease unfavorable clinical outcome on the Genomics Outcome Scale (odds ratio [OR] 1.04, 95% confidence interval [CI] 0.89-1.20) or Cerebral Infarction (OR 1.04, 95% CI 0.89-1.22). , The authors investigated whether the lack of effect of tirilazad on clinical outcome in patients with Acute Ischemic Stroke is explained by failure of tirilazad to reduce infarct volume. , Tirilazad did not alter early case fatality (odds ratio [OR] 1.11, 95% confidence interval [CI] 0.79 to 1.56) or end-of-trial case fatality (OR 1.12, 95% CI 0.88 to 1.44). A just-significant increase in Cessation of life and Disability:Type:Pt:^Patient:Nom, assessed as either the expanded Barthel Index (OR 1.23, 95% CI 1.01 to 1.51) or Glasgow Outcome Scale (OR 1. 23, 95% CI 1.01 to 1.50) was observed., CONCLUSIONS: Tirilazad mesylate increases Cessation of life and Disability:Type:Pt:^Patient:Nom by about one fifth when given to patients with Acute Ischemic Stroke. Although further trials of tirilazad are now unwarranted, analysis of individual patient data from the trials may help elucidate why tirilazad appears to worsen outcome in Acute Ischemic Stroke.[SEP]Relations: Ischemic stroke has relations: drug_effect with Aripiprazole, drug_effect with Aripiprazole, drug_effect with Sitaxentan, drug_effect with Sitaxentan, drug_effect with Ramipril, drug_effect with Ramipril, drug_effect with Tramadol, drug_effect with Tramadol, drug_effect with Pazopanib, drug_effect with Pazopanib. Definitions: Cessation of life defined as following: Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.. Cerebral Infarction defined as following: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).. Genomics Outcome Scale defined as following: A 6-item patient-reported outcome used to evaluate patient empowerment after they have received genetic counseling and testing services.. Vasospasm defined as following: spasm of the blood vessels resulting in decrease in their caliber.. ischemic stroke defined as following: An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue..", "label": "no"} {"original_question": "Can Daptacel be used instead of IPOL?", "id": "converted_3255", "sentence1": "Can Daptacel be used instead of IPOL?", "sentence2": "Our goal was to compare the safety and immunogenicity of a combination vaccine (Diphtheria due to Corynebacterium diphtheriae-tetanus toxoid vaccine, inactivated toxoid vaccine, inactivated-five component acellular pertussis-inactivated poliomyelitis -Haemophilus influenzae type b conjugate vaccine; Pentacel) with that of its separately administered, US-licensed equivalent Vaccines (Diphtheria due to Corynebacterium diphtheriae, tetanus toxoid vaccine, inactivated toxoid vaccine, inactivated, 5-component acellular pertussis vaccine [DTaP(5); Daptacel], inactivated poliovirus vaccine [Infectious pustular vulvovaginitis; IPOL], and Haemophilus influenzae type b [Hib] vaccine [ActHIB]), when administered to infants and toddlers concomitantly with other routinely recommended Vaccines and to assess immunoglobulin complex location persistence from the fourth dose in toddlers to the fifth (preschool) DTaP(5) dose., Diphtheria due to Corynebacterium diphtheriae-tetanus toxoid vaccine, inactivated toxoid vaccine, inactivated-five component acellular pertussis-inactivated poliomyelitis -Haemophilus influenzae type b conjugate vaccine is a suitable replacement for separately administered DTaP, Infectious pustular vulvovaginitis, and Hib Vaccines., In this randomized, multicenter study, 1939 healthy infants were immunized at 2, 4, and 6 months of age with 1 of 3 lots of DTaP(5) coadministered with Infectious pustular vulvovaginitis and Hib Vaccines or 1 lot of Diphtheria due to Corynebacterium diphtheriae-tetanus toxoid vaccine, inactivated toxoid vaccine, inactivated-five component acellular pertussis-inactivated poliomyelitis -Haemophilus influenzae type b conjugate vaccine combination vaccine., Diphtheria due to Corynebacterium diphtheriae-tetanus toxoid vaccine, inactivated toxoid vaccine, inactivated-five component acellular pertussis-inactivated poliomyelitis -Haemophilus influenzae type b conjugate vaccine elicited similar or fewer solicited injection-site and systemic reactions as compared with the separate administration of US-licensed DTaP(5), Infectious pustular vulvovaginitis, and Hib Vaccines. [SEP]Relations: Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) has relations: drug_drug with Certolizumab pegol, drug_drug with Certolizumab pegol, drug_drug with Dactinomycin, drug_drug with Dactinomycin, drug_drug with Dacarbazine, drug_drug with Dacarbazine, drug_drug with Clobetasol, drug_drug with Clobetasol. Clostridium tetani toxoid antigen (formaldehyde inactivated) has relations: drug_drug with Dactinomycin, drug_drug with Dactinomycin. Definitions: immunoglobulin complex location defined as following: A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph. [GOC:add, GOC:jl, ISBN:0781765196]. Diphtheria due to Corynebacterium diphtheriae-tetanus toxoid vaccine, inactivated-five component acellular pertussis-inactivated poliomyelitis -Haemophilus influenzae type b conjugate vaccine defined as following: A vaccine consisting of detoxified Diphtheria due to Corynebacterium diphtheriae toxoid (D), detoxified tetanus toxoid vaccine, inactivated toxoid (T), acellular pertussis (aP) antigens, inactivated poliovirus (Infectious pustular vulvovaginitis) types 1, 2 and 3, and Haemophilus influenzae type b (Hib) capsular polysaccharide (polyribosylribitol phosphate; PRP) covalently bound to tetanus toxoid vaccine, inactivated protein, suspended in water for injection and with active immunizing activity against Diphtheria due to Corynebacterium diphtheriae, tetanus toxoid vaccine, inactivated, pertussis, poliomyelitis and H. influenzae type b. The five purified pertussis antigens in this vaccine are pertussis toxin (PT), filamentous hemagglutinin (FHA), pertactin (PRN) and fimbriae types 2 and 3 (FIM). Upon intramuscular injection of the Diphtheria due to Corynebacterium diphtheriae-tetanus toxoid vaccine, inactivated-acellular pertussis-inactivated poliomyelitis-Haemophilus influenzae type b vaccine (DTaP-Infectious pustular vulvovaginitis-Hib), this vaccine activates the immune system to develop antibodies against Diphtheria due to Corynebacterium diphtheriae toxin, tetanus toxoid vaccine, inactivated toxin, B. pertussis antigens, polioviruses and Hib, thereby providing active immunization against these diseases. The Diphtheria due to Corynebacterium diphtheriae and tetanus toxoid vaccine, inactivated toxoids and pertussis antigens (inactivated PT, FHA, PRN and FIM) are adsorbed separately onto aluminum phosphate and then combined with Infectious pustular vulvovaginitis and PRP.. Diphtheria due to Corynebacterium diphtheriae defined as following: A localized infection of mucous membranes or skin caused by toxigenic strains of CORYNEBACTERIUM DIPHTHERIAE. It is characterized by the presence of a pseudomembrane at the site of infection. DIPHTHERIA TOXIN, produced by C. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects.. Vaccines defined as following: Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases.. tetanus toxoid vaccine, inactivated defined as following: A preparation of formaldehyde-deactivated toxin isolated from the bacterium Clostridium tetani. Tetanus toxoid is used for booster injection and can stimulate the production of antitoxin antibodies. This agent may be used as an adjuvant in cancer Vaccines..", "label": "no"} {"original_question": "Does the Abelson-related gene (ARG) gene encode for a serine kinase?", "id": "converted_2205", "sentence1": "Does the Abelson-related gene (ABL2 gene) gene encode for a serine kinase?", "sentence2": "One Protein Isoforms of Arg/Abl2 TYK2 gene is Nuclear (incident type) and the other seven cytosolic isoforms differently modulate cell morphology, motility and the Microtubules associated with cytoplasmic filaments., The non-receptor TYK2 gene Abelson related gene (Arg/Abl2) regulates cell migration and morphogenesis by modulating the Microtubules associated with cytoplasmic filaments. , The Homo sapiens Arg (Abl2) nonreceptor TYK2 gene has a role in cytoskeletal rearrangements by its C-terminal F-actin- and microtubule-binding sequences. , The TYK2 gene abl-related gene ABL2 gene is fused to ETV6 wt Allele wt Allele in an AML-M4Eo patient with a t(1;12)(q25;p13): molecular cloning of both reciprocal RNA Transcript., The ABL2 gene gene encodes for a nonreceptor TYK2 gene characterized by high Homologous Gene with ABL1 gene in the TK, SH2, and SH3 domains. This is the first report on ABL2 gene involvement in a Homo sapiens malignancy., Ultraviolet-A and -B differentially modify the tyrosine-kinase profile of Homo sapiens keratinocytes and induce the expression of Arg+., Arg (Abelson-related gene, Abl2) was the PTK with the highest prevalence (30% of all PTKs) and UVA led to a further induction of Arg expression reaching nine-fold RNA, Messenger baseline expression at 17 h after irradiation., To investigate the expression profile of Protein Tyrosine Kinase (PTKs) in normal Homo sapiens epidermal keratinocytes (NHEK) in response to UVA and Ultraviolet B therapy we employed a reversed transcriptase polymerase chain reaction (PCR) approach using degenerate primers derived from the conserved catalytic domain of PTKs. , By 3'rapid amplification of cDNA ends-polymerase chain reaction (3'RACE-PCR), a novel fusion transcript was identified between the ETV6 wt Allele wt Allele and the Abelson-related gene (ABL2 gene) at 1q25, resulting in a Fusion protein consisting of the Lymphohistiocytosis, Hemophagocytic oligomerization domain of ETV6 wt Allele wt Allele and the SH2, SH3, and protein TYK2 gene (PTK) domains of ABL2 gene., The non-receptor TYK2 gene Abelson related gene (Arg/Abl2) regulates cell migration and morphogenesis by modulating the Microtubules associated with cytoplasmic filaments., Arg (Abelson-related gene, Abl2) was the PTK with the highest prevalence (30% of all PTKs) and UVA led to a further induction of Arg expression reaching nine-fold RNA, Messenger baseline expression at 17 h after irradiation., We studied the relationship of direct karyotypes, determined at diagnosis and remission, to Abelson-related TYK2 gene activity and the cytogenetic features of Erythroid and myeloid colonies derived from remission marrow of six children with Pre B-cell Pre B-cell acute lymphoblastic leukemia (Acute lymphocytic leukemia)., ABL2/ABL2 gene (ABL-related gene) belongs to the ABL (Abelson Tyrosine-Protein Kinase 2, Homo sapiens) family of tyrosine kinases, The non-receptor TYK2 gene Abelson related gene (Arg/Abl2) regulates cell migration and morphogenesis by modulating the Microtubules associated with cytoplasmic filaments, The ABL2 gene gene encodes for a nonreceptor TYK2 gene characterized by high Homologous Gene with ABL1 gene in the TK, SH2, and SH3 domains., ABL2/ABL2 gene (ABL-related gene) belongs to the ABL (Abelson Tyrosine-Protein Kinase 2, Homo sapiens) family of tyrosine kinases., We report that the Abelson (Abetalipoproteinemia) and Abetalipoproteinemia-related gene (Arg) nonreceptor tyrosine kinases are required for maintenance of cortical dendrites in the Mus sp. brain., The products of the Homo sapiens ABL2 gene gene and the Homo sapiens ABL gene characterize the Abelson family of non-receptor tyrosine protein kinases., The products of the Homo sapiens Arg gene and Homo sapiens, Mus sp., Drosophila , and Phylum Nematoda Abetalipoproteinemia Genes characterize the Abelson family of nonreceptor tyrosine protein kinase., By 3'rapid amplification of cDNA ends-polymerase chain reaction (3'RACE-PCR), a novel fusion transcript was identified between the ETV6 wt Allele wt Allele and the Abelson-related gene (ABL2 gene) at 1q25, resulting in a Fusion protein consisting of the Lymphohistiocytosis, Hemophagocytic oligomerization domain of ETV6 wt Allele wt Allele and the SH2, SH3, and protein TYK2 gene (PTK) domains of ABL2 gene., The TYK2 gene abl-related gene ABL2 gene is fused to ETV6 wt Allele wt Allele in an AML-M4Eo patient with a t(1;12)(q25;p13): molecular cloning of both reciprocal RNA Transcript.[SEP]Relations: protein TYK2 gene binding has relations: molfunc_protein with NEDD9, molfunc_protein with NEDD9, molfunc_protein with GRM5, molfunc_protein with GRM5, molfunc_protein with ITGB1, molfunc_protein with ITGB1, molfunc_protein with ACVR1, molfunc_protein with ACVR1, molfunc_protein with CRK, molfunc_protein with CRK. Definitions: Protein Tyrosine Kinase defined as following: Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors.. Fusion protein defined as following: A protein in which the coding region of two Genes have become in-frame and co-continuous. Fusion proteins can be formed by chromosomal breakage and/or recombination and also can be experimentally created using recombinant DNA techniques.. ETV6 wt Allele defined as following: Human ETV6 wt Allele wild-type allele is located in the vicinity of 12p13 and is approximately 246 kb in length. This allele, which encodes transcription factor ETV6 wt Allele protein, is involved in the repression of transcription by RNA polymerase II. Several malignancies, particularly leukemias, are linked to chromosomal translocations of this gene.. ABL2 gene defined as following: This gene plays a role in signal transduction.. Erythroid defined as following: 1) Reddish in color. 2) relating to erythrocytes or their precursors.. Abelson Tyrosine-Protein Kinase 2, Homo sapiens defined as following: Abelson Tyrosine-Protein Kinase 2, Homo sapiens 2 (1182 aa, ~128 kDa) is encoded by the Homo sapiens ABL2 gene. This protein plays a role in cell motility, apoptosis, cell adhesion, receptor endocytosis, autophagy, tyrosine phosphorylation and signal transduction.. Pre B-cell acute lymphoblastic leukemia defined as following: A type of Acute lymphocytic leukemia characterized by elevated levels of B-cell lymphoblasts in the bone marrow and the blood. [NCIT:C8644]. RNA Transcript defined as following: The initial RNA molecule produced by transcription.. ABL1 gene defined as following: This gene is involved in cell adhesion, differentiation, division and stress response.. RNA, Messenger defined as following: RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary RNA Transcript in that they do not require post-transcriptional processing. Eukaryotic RNA, Messenger is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature RNA, Messenger from the nucleus as well as in helping stabilize some RNA, Messenger molecules by retarding their degradation in the cytoplasm.. Abetalipoproteinemia defined as following: An autosomal recessive disorder of lipid metabolism. It is caused by mutation of the microsomal triglyceride transfer protein that catalyzes the transport of lipids (TRIGLYCERIDES; CHOLESTEROL ESTERS; PHOSPHOLIPIDS) and is required in the secretion of BETA-LIPOPROTEINS (low density lipoproteins or LDL). Features include defective intestinal lipid absorption, very low serum cholesterol level, and near absent LDL.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Phylum Nematoda defined as following: class of unsegmented helminths with fundamental bilateral symmetry and secondary triradiate symmetry of the oral and esophageal structures; many species are parasites.. Protein Isoforms defined as following: Refers to variants of the same protein which can be separated on special conducting media using electrophoresis. The differences may arise from genetically determined differences in primary structure or by modification of the same primary sequence.. Acute lymphocytic leukemia defined as following: Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.. TYK2 gene defined as following: This gene is involved in both protein phosphorylation and interferon-mediated signaling.. Homo sapiens defined as following: Members of the species Homo sapiens.. Lymphohistiocytosis, Hemophagocytic defined as following: A rare but potentially life-threatening disorder characterized by the proliferation of histiocytes and macrophages and phagocytosis of red blood cells, white blood cells, and platelets. It may be inherited or secondary, due to infections, autoimmune disorders, or underlying malignancies. Signs and symptoms include fever, lymphadenopathy, hepatomegaly, splenomegaly, and pancytopenia.. Homologous Gene defined as following: A gene from one species which corresponds to a gene in another species and that is related via a common ancestral species. These Genes retain a similar sequence and function.. Abelson-related gene defined as following: This gene plays a role in signal transduction.. serine kinase defined as following: A group of enzymes that catalyzes the phosphorylation of serine or threonine residues in proteins, with ATP or other nucleotides as phosphate donors..", "label": "no"} {"original_question": "Does a tonsillectomy affect the patient's voice?", "id": "converted_2286", "sentence1": "Does a tonsillectomy affect the patient's TelecommunicationCapabilities ?", "sentence2": " Group B had a better awareness of tooth damage (78% vs 30% of patients, P ≤ .001), TelecommunicationCapabilities > change (61 vs 19%, P = .005), and Burn injury to Lip structure and mouth (44% vs 8%, P = .005). Finally, 35% more patients from group B rated their understanding of tonsillectomy as good or very good (P = .017)., Some patients complaint for Pharyngeal dryness, foreign body sensation or TelecommunicationCapabilities > change after tonsillectomy., The percentage of patients who had temporary TelecommunicationCapabilities > change was 62.7%, and 15.4% had a follow-up clinic visit., There is no dose-escalation response to dexamethasone (0.0625-1.0 mg/kg) in pediatric tonsillectomy or adenotonsillectomy patients for preventing Vomiting, reducing Pain:-:Point in time:^Patient:-, shortening time to first liquid intake, or the incidence of TelecommunicationCapabilities > change., There were no differences in secondary outcomes (analgesic requirements, time to first liquid, and change in TelecommunicationCapabilities >) across treatment groups., Voice change, reported by approximately 70% of all patients, was the most common complaint, but it resolved in all instances., The incidence rates of TelecommunicationCapabilities > change, Velopharyngeal Insufficiency, Hemorrhage, Constipation, Dehydration, and Pain:-:Point in time:^Patient:- were measured. , Tonsillectomy affects TelecommunicationCapabilities > performance negatively in adults in short term; however, it does not affect TelecommunicationCapabilities > performance in long term after surgery., The surgical technique, whether it is cold knife or thermal welding system, does not appear to affect TelecommunicationCapabilities > and speech in tonsillectomy patients., OBJECTIVE: To evaluate changes in acoustic features of TelecommunicationCapabilities > after tonsillectomy., Surgical indications for tonsillectomy in the young TelecommunicationCapabilities > patient are discussed., OBJECTIVE: Our goal was to assess patient perception and acoustic characteristics of TelecommunicationCapabilities > before and after upper airway surgery., In this report, we examined the change in pharyngeal size and acoustic feature of TelecommunicationCapabilities > after tonsillectomy., CONCLUSION Tonsillectomy affects TelecommunicationCapabilities > performance negatively in adults in short term; however, it does not affect TelecommunicationCapabilities > performance in long term after surgery., Some patients complaint for Pharyngeal dryness, foreign body sensation or TelecommunicationCapabilities > change after tonsillectomy., Tonsillectomy affects TelecommunicationCapabilities > performance negatively in adults in short term; however, it does not affect TelecommunicationCapabilities > performance in long term after surgery.., The surgical technique, whether it is cold knife or thermal welding system, does not appear to affect TelecommunicationCapabilities > and speech in tonsillectomy patients.., There is no dose-escalation response to dexamethasone (0.0625-1.0 mg/kg) in pediatric tonsillectomy or adenotonsillectomy patients for preventing Vomiting, reducing Pain:-:Point in time:^Patient:-, shortening time to first liquid intake, or the incidence of TelecommunicationCapabilities > change.[SEP]Relations: Dexamethasone has relations: drug_effect with Vertebral compression fractures, drug_effect with Vertebral compression fractures, drug_effect with Reduced visual acuity, drug_effect with Reduced visual acuity, drug_effect with Increased intracranial pressure, drug_effect with Increased intracranial pressure. Velopharyngeal insufficiency has relations: disease_phenotype_positive with Dubowitz syndrome, disease_phenotype_positive with Dubowitz syndrome, disease_phenotype_positive with cleft palate, disease_phenotype_positive with cleft palate. Definitions: TelecommunicationCapabilities defined as following: Description:This device can receive TelecommunicationCapabilities calls (i.e. talking to another person, or a recording device, or a TelecommunicationCapabilities activated computer).. Dehydration defined as following: The condition that results from excessive loss of water from a living organism.. dexamethasone defined as following: An anti-inflammatory 9-fluoro-glucocorticoid.. Velopharyngeal Insufficiency defined as following: Failure of the SOFT PALATE to reach the posterior pharyngeal wall to close the opening between the oral and nasal cavities. Incomplete velopharyngeal closure is primarily related to surgeries (ADENOIDECTOMY; CLEFT PALATE) or an incompetent PALATOPHARYNGEAL SPHINCTER. It is characterized by hypernasal speech.. Lip structure defined as following: Either of the two fleshy, full-blooded margins of the mouth.. Burn injury defined as following: Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like.. Hemorrhage defined as following: Bleeding or escape of blood from a vessel.. Constipation defined as following: Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and infections.. Vomiting defined as following: The forcible expulsion of the contents of the STOMACH through the MOUTH..", "label": "yes"} {"original_question": "Are ultraconserved enhancers important for normal development?", "id": "converted_2794", "sentence1": "Are ultraconserved enhancers important for normal development?", "sentence2": "Ultraconserved Enhancers Are Required for Normal Development., However, initial deletion studies in CASP14 gene revealed that loss of such extraordinarily constrained sequences had no immediate impact on viability. Here, we show that ultraconserved enhancers are required for normal development. , Here, we show that ultraconserved enhancers are required for normal development.[SEP]", "label": "yes"} {"original_question": "Is dupilumab an antibody targeting the IL-1 receptor?", "id": "converted_2210", "sentence1": "Is dupilumab an immunoglobulin complex location targeting the IL-1 receptor?", "sentence2": "Eczema (cytarabine/daunorubicin protocol) is characterized by type 2 helper T (Th2) cell-driven inflammation. dupilumab is a fully Homo sapiens monoclonal immunoglobulin complex location directed against the Recombinant Interleukin-4 receptor α subunit that blocks the signaling of Recombinant Interleukin-4 and IL-13, both key Recombinant Cytokines in Th2-mediated pathways., dupilumab, a humanized monoclonal immunoglobulin complex location to the interteukin-4R is the first immunoglobulin complex location (i.e. 'biological') with published efficacy shown in controlled prospective studies in Dermatitis, Atopic. , dupilumab, a Homo sapiens monoclonal immunoglobulin complex location against Interleukin 4 Receptor alpha, inhibits signaling of interleukin-4 and interleukin-13, Homo sapiens, Homo sapiens, type 2 Recombinant Cytokines that may be important drivers of atopic or allergic diseases such as Dermatitis, Atopic., Best evidence of the clinical efficacy of novel immunologic approaches using biological agents in patients with cytarabine/daunorubicin protocol is available for the anti-Recombinant Interleukin-4 receptor α-chain immunoglobulin complex location dupilumab, but a number of studies are currently ongoing with other specific antagonists to immune system players., dupilumab, a fully Homo sapiens anti-Interleukin 4 Receptor α monoclonal immunoglobulin complex location, inhibits interleukin-4 and interleukin-13, Homo sapiens, Homo sapiens signalling, key drivers of type-2-mediated inflammation. , dupilumab was also introduced as a possible treatment for patients with severe Pemphigus . It can directly inhibit Recombinant Interleukin-4 by targeting Recombinant Interleukin-4 α-chain receptor., We evaluated the efficacy and safety of dupilumab (SAR231893/REGN668), a fully Homo sapiens monoclonal immunoglobulin complex location to the glycoprotein hormones, glycoprotein hormones, alpha subunit of the Interleukin 4 Receptor[SEP]Relations: dupilumab has relations: drug_protein with IL4R, drug_protein with IL4R, drug_drug with Avelumab, drug_drug with Avelumab, drug_drug with IGN311, drug_drug with IGN311, drug_drug with Varlilumab, drug_drug with Varlilumab, drug_drug with Olaratumab, drug_drug with Olaratumab. Definitions: Recombinant Interleukin-4 defined as following: A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin-4 (Recombinant Interleukin-4). Produced primarily by activated T-cells, Recombinant Interleukin-4 binds to and activates its cell-surface receptor, stimulating the proliferation and differentiation of activated B-cells and enhancing their ability to present antigens to T-cells. As a potential immunotherapeutic agent, recombinant Recombinant Interleukin-4 also augments the effects of other Recombinant Cytokines on dendritic cells (DC), cytotoxic T lymphocytes (CTL), and tumor-infiltrating lymphocytes (TIL). Check for \"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C589\" active clinical trials using this agent. (\"http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C589\" NCI Thesaurus). Interleukin 4 Receptor defined as following: Receptors present on a wide variety of hematopoietic and non-hematopoietic cell types that are specific for INTERLEUKIN-4. They are involved in signaling a variety of immunological responses related to allergic INFLAMMATION including the differentiation of TH2 CELLS and the regulation of IMMUNOGLOBULIN E production. Two subtypes of receptors exist and are referred to as the TYPE I INTERLEUKIN-4 RECEPTOR and the TYPE II INTERLEUKIN-4 RECEPTOR. Each receptor subtype is defined by its unique subunit composition.. glycoprotein hormones, alpha subunit defined as following: The alpha chain of pituitary glycoprotein hormones (THYROTROPIN; FOLLICLE STIMULATING HORMONE; LUTEINIZING HORMONE) and the placental CHORIONIC GONADOTROPIN. Within a species, the alpha subunits of these four hormones are identical; the distinct functional characteristics of these glycoprotein hormones are determined by the unique beta subunits. Both subunits, the non-covalently bound heterodimers, are required for full biologic activity.. interleukin-13, Homo sapiens defined as following: Interleukin-13 (146 aa, ~16 kDa) is encoded by the Homo sapiens IL13 gene. This protein plays a role in the negative regulation of cytokine production and the positive regulation of B-cell proliferation.. Homo sapiens defined as following: Members of the species Homo sapiens.. Interleukin 4 Receptor alpha defined as following: Interleukin-4 receptor subunit alpha (825 aa, ~90 kDa) is encoded by the Homo sapiens IL4R gene. This protein plays a role in both interleukin-4 signaling and immunoglobulin E production.. dupilumab defined as following: A recombinant Homo sapiens monoclonal immunoglobulin G4 (IgG4) immunoglobulin complex location directed against the alpha chain of the Interleukin 4 Receptor (IL-4R alpha) with potential immunomodulatory activities. Upon injection, dupilumab selectively binds to the IL-4R alpha chain. This disrupts Recombinant Interleukin-4/IL-13 signaling and prevents the activation of downstream pathways that mediate type 2 inflammation and may potentially inhibit tumor cell proliferation, survival, and metastasis. Recombinant Interleukin-4 and IL-13 receptors are present on the surface of numerous cells involved in the pathophysiology of type-2 helper T-cell (Th2) allergic responses, including B-lymphocytes, eosinophils, dendritic cells (DCs), monocytes, macrophages, basophils, keratinocytes, bronchial epithelial cells, endothelial cells, fibroblasts, and airway smooth muscle cells. Additionally, both Recombinant Interleukin-4 and IL-13 receptors are overexpressed in a variety of cancers and Recombinant Interleukin-4 and IL-13 and may serve as biomarkers for cancer aggressiveness. Recombinant Interleukin-4 and IL-13 are thought to be key regulatory Recombinant Cytokines in the tumor microenvironment (TME) and may play a role in the activation of tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs) that mediate tumor cell survival.. immunoglobulin complex location defined as following: An immunoglobulin complex that is secreted into extracellular space and found in mucosal areas or other tissues or circulating in the blood or lymph. In its canonical form, a circulating immunoglobulin complex is composed of two identical heavy chains and two identical light chains, held together by disulfide bonds. Some forms of are polymers of the basic structure and contain additional components such as J-chain and the secretory component. [GOC:add, ISBN:0781735149]. Eczema defined as following: A pruritic papulovesicular dermatitis occurring as a reaction to many endogenous and exogenous agents (Dorland, 27th ed).. Dermatitis, Atopic defined as following: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.. monoclonal immunoglobulin complex location defined as following: A humanized monoclonal immunoglobulin complex location directed against parathyroid hormone-related protein (PTH-rP). As a poly-hormone with diverse biological roles, PTH-rP is expressed by normal tissues, acting in local tissue environments in a variety of ways; it is commonly overexpressed by breast, prostate, and other cancers, acting systemically by promoting bone resorption, inhibiting calcium excretion from the kidney, inducing hypercalcemia, and possibly playing a role in the formation of bony metastases. By blocking the effects of PTH-rP on calcium metabolism, monoclonal immunoglobulin complex location CAL may inhibit cancer-related hypercalcemia. (NCI04). IL-1 receptor defined as following: Cell surface receptors that are specific for INTERLEUKIN-1. Included under this heading are signaling receptors, non-signaling receptors and accessory proteins required for receptor signaling. Signaling from interleukin-1 receptors occurs via interaction with SIGNAL TRANSDUCING ADAPTOR PROTEINS such as MYELOID DIFFERENTIATION FACTOR 88..", "label": "no"} {"original_question": "Does radiotherapy for prostate cancer increase bladder cancer risk?", "id": "converted_3704", "sentence1": "Does radiotherapy for Malignant neoplasm of prostate increase Urinary Bladder cancer risk?", "sentence2": "External Beam Radiotherapy Increases the Risk of Malignant neoplasm of urinary Urinary Bladder When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis., On multivariable competing risk regression analyses, treatment with External Beam Radiation Therapy was independently associated with the risk of developing a second primary BCa (hazard ratio: 1.35, CI: 1.18-1.55; p<0.001), but not RCa (p=0.4). , CONCLUSIONS: Patients treated with External Beam Radiation Therapy are at increased risk of developing a second primary BCa compared with those treated with RP. However, no differences were found considering RCa incidence in patients treated with RP or External Beam Radiation Therapy within the first 5 yr after primary therapy. , We found that those treated with external beam radiotherapy are at an increased risk of developing a second primary Urinary Bladder cancer tumor., All radiation modalities were found to have an increased RR of developing BlCa after 10 years, with brachytherapy having a significantly higher RR than external beam radiation (External Beam Radiation Therapy) or combined External Beam Radiation Therapy and brachytherapy in Caucasian men and a significantly higher RR than External Beam Radiation Therapy in men of other/unknown ethnicity. , CONCLUSIONS: The increased risk of BlCa after prostate radiation occurs predominantly after 10 years, regardless of ethnicity. The RR of developing BlCa after 10 years is significantly higher following brachytherapy than after External Beam Radiation Therapy or External Beam Radiation Therapy and brachytherapy. , Based on the data in the literature, there is a consistently increased risk of Urinary Bladder cancer (HR: 1.67, 95% CI 1.55-1.80), Rectal Carcinoma (HR: 1.79, 95% CI 1.34-2.38), and Malignant neoplasm of Abdomen+Pelvis>Colon and/or Pelvis>Rectum (HR: 1.79, 95% CI 1.34-23.8) following percutaneous radiation therapy. Following brachytherapy only an increased for the development of Urinary Bladder cancer (HR: 2.14, 95% CI 1.03-3.94) has been observed., When comparing with a matched general French population, the standard incidence ratio (SIR) for Urinary Bladder cancer was 1.02 (95% CI: 0.46-1.93)., LDR resulted in lower Urinary Bladder cancer risks than double-strand break repair via homologous recombination, and lower or similar risks of Rectal Carcinoma., Compared to external beam techniques, second rectal and Urinary Bladder cancer risks were lowest for brachytherapy., OBJECTIVE: Although it is well known that radiotherapy for Malignant neoplasm of prostate increases comorbid rate of secondary Urinary Bladder cancer, the effect of aging and Location characteristic ID - Smoking with radiotherapy on incidence rate of secondary Urinary Bladder cancer remains unknown. , RESULTS: During the median follow-up period of 4.3 and 3.1 years, secondary Urinary Bladder cancer occurred in 11 (3.4%) and 5 (1.1%) of patients with Malignant neoplasm of prostate treated with external beam radiotherapy and radical prostatectomy, respectively. , CONCLUSIONS\n\nMultiple Endocrine Neoplasia who receive radiotherapy for localized Malignant neoplasm of prostate have an increased risk of Urinary Bladder cancer compared to patients undergoing radical prostatectomy and compared to the general population., Radiation therapy for Malignant neoplasm of prostate increases subsequent risk of Urinary Bladder and Rectal Carcinoma: a population based cohort study., RESULTS\n\nThe relative risk of Urinary Bladder cancer developing after external beam radiotherapy, brachytherapy and external beam radiotherapy-brachytherapy compared to radical prostatectomy was 1.88, 1.52 and 1.85, respectively., Compared to the general United States population the standardized incidence ratio for Urinary Bladder cancer developing after radical prostatectomy, external beam radiotherapy, brachytherapy and external beam radiotherapy-brachytherapy was 0.99, 1.42, 1.10 and 1.39, respectively., OBJECTIVE\n\nAlthough it is well known that radiotherapy for Malignant neoplasm of prostate increases comorbid rate of secondary Urinary Bladder cancer, the effect of aging and Location characteristic ID - Smoking with radiotherapy on incidence rate of secondary Urinary Bladder cancer remains unknown., OBJECTIVE\nAlthough it is well known that radiotherapy for Malignant neoplasm of prostate increases comorbid rate of secondary Urinary Bladder cancer, the effect of aging and Location characteristic ID - Smoking with radiotherapy on incidence rate of secondary Urinary Bladder cancer remains unknown., CONCLUSIONS\nMultiple Endocrine Neoplasia who receive radiotherapy for localized Malignant neoplasm of prostate have an increased risk of Urinary Bladder cancer compared to patients undergoing radical prostatectomy and compared to the general population., PURPOSE\nPre-prostate specific antigen era series demonstrated an increased risk of Urinary Bladder cancer and Rectal Carcinoma in men who received radiotherapy for Malignant neoplasm of prostate., RESULTS\nThe relative risk of Urinary Bladder cancer developing after external beam radiotherapy, brachytherapy and external beam radiotherapy-brachytherapy compared to radical prostatectomy was 1.88, 1.52 and 1.85, respectively., CONCLUSIONS: Taken together, these findings suggest that Location characteristic ID - Smoking history might be one of criteria to choose radical prostatectomy than external beam radiotherapy for Malignant neoplasm of prostate, and that age would not be a criterion for therapeutic selection in terms of secondary Urinary Bladder cancer., PURPOSE: Pre-prostate specific antigen era series demonstrated an increased risk of Urinary Bladder cancer and Rectal Carcinoma in men who received radiotherapy for Malignant neoplasm of prostate., RESULTS: The relative risk of Urinary Bladder cancer developing after external beam radiotherapy, brachytherapy and external beam radiotherapy-brachytherapy compared to radical prostatectomy was 1.88, 1.52 and 1.85, respectively., Compared to the general United States population the standardized incidence ratio for Urinary Bladder cancer developing after radical prostatectomy, external beam radiotherapy, brachytherapy and external beam radiotherapy-brachytherapy was 0.99, 1.42, 1.10 and 1.39, respectively., Pre-prostate specific antigen era series demonstrated an increased risk of Urinary Bladder cancer and Rectal Carcinoma in men who received radiotherapy for Malignant neoplasm of prostate., Multiple Endocrine Neoplasia who receive radiotherapy for localized Malignant neoplasm of prostate have an increased risk of Urinary Bladder cancer compared to patients undergoing radical prostatectomy and compared to the general population., The relative risk of Urinary Bladder cancer developing after external beam radiotherapy, brachytherapy and external beam radiotherapy-brachytherapy compared to radical prostatectomy was 1.88, 1.52 and 1.85, respectively., Radiotherapy for Malignant neoplasm of prostate is associated with an increased incidence of secondary Urinary Bladder cancer (BC Original Formula Original Formula)., Radiation therapy for Malignant neoplasm of prostate is associated with an increased risk of Urinary Bladder cancer., Radiotherapy for Malignant neoplasm of prostate was associated with higher risks of developing second Malignant Neoplasms of the Urinary Bladder, Abdomen+Pelvis>Colon, and Pelvis>Rectum compared with patients unexposed to radiotherapy, but the reported absolute rates were low.[SEP]Relations: urinary Urinary Bladder neoplasm has relations: disease_disease with urinary Urinary Bladder cancer, disease_disease with urinary Urinary Bladder cancer. benign neoplasm of prostate has relations: disease_disease with prostatic adenoma, disease_disease with prostatic adenoma, disease_disease with fibroma of prostate, disease_disease with fibroma of prostate, disease_disease with prostate leiomyoma, disease_disease with prostate leiomyoma, disease_disease with prostate neoplasm, disease_disease with prostate neoplasm. Definitions: Urinary Bladder defined as following: A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the Urinary Bladder via the ureters (URETER), and is held there until URINATION.. Malignant neoplasm of prostate defined as following: A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas.. Rectal Carcinoma defined as following: A malignant epithelial neoplasm that arises from the Pelvis>Rectum and invades through the muscularis mucosa into the submucosa. The vast majority are adenocarcinomas.. Multiple Endocrine Neoplasia defined as following: A group of autosomal dominant diseases characterized by the combined occurrence of tumors involving two or more ENDOCRINE GLANDS that secrete PEPTIDE HORMONES or AMINES. These neoplasias are often benign but can be malignant. They are classified by the endocrine glands involved and the degree of aggressiveness. The two major forms are MEN1 and MEN2 with gene mutations on CHROMOSOME 11 and CHROMOSOME 10, respectively.. Malignant neoplasm of urinary bladder defined as following: A primary or metastatic malignant neoplasm involving the Urinary Bladder.. External Beam Radiation Therapy defined as following: Radiation therapy in which high-energy beams are delivered to the tumor from outside of the body.. double-strand break repair via homologous recombination defined as following: The error-free repair of a double-strand break in DNA in which the broken DNA molecule is repaired using homologous sequences. A strand in the broken DNA searches for a homologous region in an intact chromosome to serve as the template for DNA synthesis. The restoration of two intact DNA molecules results in the exchange, reciprocal or nonreciprocal, of genetic material between the intact DNA molecule and the broken DNA molecule. [GOC:elh, PMID:10357855]. Malignant Neoplasms defined as following: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.. Urinary Bladder cancer defined as following: A primary or metastatic malignant neoplasm involving the Urinary Bladder..", "label": "yes"} {"original_question": "Are CpG islands located close to housekeeping genes?", "id": "converted_1166", "sentence1": "Are CpG Islands located close to Genes, Housekeeping?", "sentence2": "our analysis indicates that the association of CGIs with Genes, Housekeeping is not as strong as previously estimated, CpG Islands are preferentially located at the start of transcription of Genes, Housekeeping and are associated with Tissue Specimen Code-specific Genes, It has been envisaged that CpG Islands are often observed near the transcriptional start sites (Toxic Shock Syndrome) of Genes, Housekeeping., These regions represent about 1% of Genomic DNA and are generally found in the Promoter region of Genes, Housekeeping., CpG Islands are stretches of DNA sequence that are enriched in the (CpG)n repeat and are present in close association with all Genes, Housekeeping as well as some Tissue Specimen Code-specific Genes in the mammalian genome., CpG Islands, which are found almost exclusively at the 5'-end of Genes, Housekeeping, In housekeeping and many Tissue Specimen Code-specific Genes, the Promoter is embedded in a so-called CpG Islands., All housekeeping and widely expressed Genes have a CpG Islands covering the transcription start, whereas 40% of the Genes with a Tissue Specimen Code-specific or limited expression are associated with Islands, Methylation-free CpG clusters, so-called HTF Islands, are most often associated with the Promoter regions of Genes, Housekeeping, whereas Genes expressed in a single-cell type are usually deficient in these DNA Sequence., Unmethylated CpG rich Islands are a feature of vertebrate DNA: they are associated with housekeeping and many Tissue Specimen Code specific Genes., CpG Islands were associated with the 5' ends of all Genes, Housekeeping and many Tissue Specimen Code-specific Genes, and with the 3' ends of some Tissue Specimen Code-specific Genes.[SEP]Relations: GLI proteins bind promoters of Hh responsive Genes to promote transcription has relations: pathway_protein with GLI2, pathway_protein with GLI2, pathway_protein with GLI3, pathway_protein with GLI3, pathway_protein with GLI1, pathway_protein with GLI1. Promoter clearance from RNA polymerase I Promoter has relations: bioprocess_bioprocess with Promoter clearance during DNA-templated transcription, bioprocess_bioprocess with Promoter clearance during DNA-templated transcription. toxic shock syndrome has relations: disease_protein with C5AR1, disease_protein with C5AR1. Definitions: Promoter defined as following: A DNA sequence at which RNA polymerase binds and initiates transcription.. Toxic Shock Syndrome defined as following: A rare acute life-threatening systemic bacterial noncontagious illness caused by any of several related staphylococcal exotoxins. It is characterized by high fever, hypotension, rash, multi-organ dysfunction, and cutaneous desquamation during the early convalescent period. The toxins affect the host immune system, causing an exuberant and pathological host inflammatory response. Laboratory findings include leukocytosis, elevated prothrombin time, hypoalbuminemia, hypocalcemia, and pyuria.. Genomic DNA defined as following: The DNA that is part of the normal chromosomal complement of an organism.. DNA Sequence defined as following: The sequence of nucleotide residues along a DNA chain.. Promoter regions defined as following: DNA DNA Sequence which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved DNA Sequence within the Promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.. DNA defined as following: A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).. Islands defined as following: A land mass smaller than a continent that is surrounded by water.. Genes, Housekeeping defined as following: Constitutively and evenly expressed Genes involved in routine cellular metabolisms.. Genes defined as following: A category of nucleic acid DNA Sequence that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. CpG Islands defined as following: Areas of increased density of the dinucleotide sequence cytosine--phosphate diester--guanine. They form stretches of DNA several hundred to several thousand base pairs long. In humans there are about 45,000 CpG Islands, mostly found at the 5' ends of Genes. They are unmethylated except for those on the inactive X chromosome and some associated with imprinted Genes..", "label": "yes"} {"original_question": "Can tetracycline affect tooth formation?", "id": "converted_1405", "sentence1": "Can Tetracycline Antibiotics affect tooth formation?", "sentence2": "he results of that study, reported earlier (Rebich et al., 1983), indicated that over one-fifth of the American Indian children had discoloration of the dentition due to ingestion of Tetracycline Antibiotics during the years of tooth formatio, ale Wistar rats prelabeled with Tetracycline Antibiotics to mark surfaces of Specimen Type - Bone and tooth formation-mineralization were placed into orbit for 18.5 days aboard the Soviet COSMOS-1129 Biosatellit, It was concluded that the increased Tetracycline Antibiotics incorporation reflected a higher rate of mineralization associated with faster tooth formation in the unimpeded toot, n this investigation an attempt has been made to determine the relationship between the staining of permanent Head>Teeth by Tetracycline Antibiotics administered during the period of tooth formation with the dosage of the Pharmacologic Substance and the duration of therap, definite relationship between total dosage and staining and duration of administration and staining was established; the condition occurred with greater frequency (in more than one-third of the children) when the total dosage exceeded 3 g. or the duration of treatment was longer than 10 days, This case report suggests the possibility that discoloration from Tetracycline Antibiotics may not be limited to tooth development in the child, but may also affect the adult dentition[SEP]Relations: Tetracycline has relations: drug_effect with Hypoplasia of Head>Teeth, drug_effect with Hypoplasia of Head>Teeth, drug_effect with Nausea, drug_effect with Nausea, drug_effect with Glossitis, drug_effect with Glossitis, drug_effect with Vomiting, drug_effect with Vomiting, drug_effect with Arthralgia, drug_effect with Arthralgia. Definitions: Pharmacologic Substance defined as following: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.. Tetracycline Antibiotics defined as following: Any of a group of broad spectrum naphthacene antibiotics isolated from various species of Streptomyces or produced semisynthetically. In bacteria, Tetracycline Antibiotics antibiotics block binding of aminoacyl-tRNA to the mRNA-ribosome complex, thereby inhibiting protein synthesis. (NCI05).", "label": "yes"} {"original_question": "Are long non coding RNAs spliced?", "id": "converted_3", "sentence1": "Are long non coding RNAs spliced?", "sentence2": "Our analyses indicate that lncRNAs are generated through pathways similar to that of protein-coding genes, with similar histone-modification profiles, splicing signals, and exon/intron lengths., For alternative exons and long noncoding RNAs, splicing tends to occur later, and the latter might remain unspliced in some cases., bosome-mapping data to identify lncRNAs of Caenorhabditis elegans. We found 170 long intervening ncRNAs (Long Intergenic Non-Protein Coding RNA), which had single- or multiexonic structures that did not overlap protein-coding transcripts, and about sixty antisense lncRNAs (ancRNAs), which were complementary to protein-coding transcripts, We introduce an approach to predict spliced lncRNAs in vertebrate genomes combining comparative genomics and machine learning., Owing to similar alternative splicing pattern to mRNAs, the concept of lncRNA genes was put forward to help systematic understanding of lncRNAs. , Our synthesis of recent studies suggests that neither size, presence of a poly-A tail, splicing, direction of transcription, nor Genomic Orientation specificity are of importance to lncRNA function.[SEP]Relations: long noncoding RNA binding has relations: molfunc_protein with MIR384, molfunc_protein with MIR384. Definitions: Genomic Orientation defined as following: The orientation of a genomic element on the double stranded molecule.. Long Intergenic Non-Protein Coding RNA defined as following: A molecule of RNA 200-17000 nucleotides in length that is transcribed by non-protein coding areas of DNA. These ribonucleotides may play a role in a variety of biological processes.. Caenorhabditis elegans defined as following: A species of nematode that is widely used in biological, biochemical, and genetic studies..", "label": "yes"} {"original_question": "Is the optogenetics tool ChR2 light-sensitive?", "id": "converted_727", "sentence1": "Is the optogenetics tool ChR2 light-sensitive?", "sentence2": "Channelrhodospin-2 (ChR2), a light-sensitive ion channel, and its Variant have emerged as new excitatory optogenetic tools not only in neuroscience, but also in other areas, including cardiac electrophysiology., Light-sensitive Genes chiefly including the genetically targeted light-gated channels channelrhodopsin-2 (ChR2) and Halorhodopsins (NpHR) cause intracellular ion flow during optical illumination., Computational optogenetics: empirically-derived voltage- and light-sensitive channelrhodopsin-2 model., The versatility and the electrophysiologic characteristics of the light-sensitive ion-channels channelrhodopsin-2 (ChR2), Halorhodopsins (NpHR), and the light-sensitive proton pump archaerhodopsin-3 (Arch) make these optogenetic tools potent candidates in controlling neuronal firing in models of Epilepsy and in providing insights into the physiology and pathology of neuronal network organization and synchronization., Channelrhodopsins-2 (ChR2) are a class of light sensitive proteins that offer the ability to use light stimulation to regulate neural activity with millisecond precision., The most widely used optogenetic tool, Channelrhodopsin2 (ChR2), is both light- and voltage-sensitive., Channelrhodospin-2 (ChR2), a light-sensitive ion channel, and its Variant have emerged as new excitatory optogenetic tools not only in neuroscience, but also in other areas, including cardiac electrophysiology. , Optogenetic methods have emerged as a powerful tool for elucidating neural circuit activity underlying a diverse set of behaviors across a broad range of species. Optogenetic tools of microbial origin consist of light-sensitive membrane proteins that are able to activate (e.g., channelrhodopsin-2, ChR2) or silence (e.g., Halorhodopsins, NpHR) neural activity ingenetically-defined cell types over behaviorally-relevant timescales. , Virus-mediated expression of a ChR2 variant with greater light sensitivity in SGNs reduced the amount of light required for responses and allowed neuronal spiking following stimulation up to 60 Hz. , Channelrhodopsin-2 (ChR2) from the green alga Chlamydomonas reinhardtii functions as a light-gated cation channel that has been developed as an optogenetic tool to stimulate specific nerve cells in animal allergen extracts and control their behavior by illumination. , Here, we used animal models to characterize optogenetic stimulation, which is the optical stimulation of Neurons genetically engineered to express the light-gated ion channel channelrhodopsin-2 (ChR2). , The versatility and the electrophysiologic characteristics of the light-sensitive ion-channels channelrhodopsin-2 (ChR2), Halorhodopsins (NpHR), and the light-sensitive proton pump archaerhodopsin-3 (Arch) make these optogenetic tools potent candidates in controlling neuronal firing in models of Epilepsy and in providing insights into the physiology and pathology of neuronal network organization and synchronization., The most widely used optogenetic tool, Channelrhodopsin2 (ChR2), is both light- and voltage-sensitive. A light-triggered action potential or light-driven perturbations of ongoing electrical activity provide instant voltage feedback, shaping ChR2 current., Optogenetic methods have emerged as a powerful tool for elucidating neural circuit activity underlying a diverse set of behaviors across a broad range of species. Optogenetic tools of microbial origin consist of light-sensitive membrane proteins that are able to activate (e.g., channelrhodopsin-2, ChR2) or silence (e.g., Halorhodopsins, NpHR) neural activity ingenetically-defined cell types over behaviorally-relevant timescales., Channelrhodospin-2 (ChR2), a light-sensitive ion channel, and its Variant have emerged as new excitatory optogenetic tools not only in neuroscience, but also in other areas, including cardiac electrophysiology., It allows Neurons to express light-sensitive Genes that enable the identification, dissection, and manipulation of specific neural populations and their connections in the Body tissue and Organ of awake animal allergen extracts with unprecedented spatial and temporal precision. Light-sensitive Genes chiefly including the genetically targeted light-gated channels channelrhodopsin-2 (ChR2) and Halorhodopsins (NpHR) cause intracellular ion flow during optical illumination., Channelrhodopsin-2 (ChR2) from the green alga Chlamydomonas reinhardtii functions as a light-gated cation channel that has been developed as an optogenetic tool to stimulate specific nerve cells in animal allergen extracts and control their behavior by illumination. The molecular mechanism of ChR2 has been extensively studied by a variety of spectroscopic methods, including light-induced difference Fourier transform infrared (FTIR) spectroscopy, which is sensitive to structural changes in the Protein Info upon light activation.[SEP]Relations: Epilepsy has relations: disease_protein with CHRM2, disease_protein with CHRM2, disease_protein with CHD2, disease_protein with CHD2, disease_protein with P2RX2, disease_protein with P2RX2, disease_protein with TANC2, disease_protein with TANC2, disease_protein with RARS2, disease_protein with RARS2. Definitions: Variant defined as following: An alteration or difference from a norm or standard.. Organ defined as following: A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various Body tissue. An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus.. Neurons defined as following: The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.. Body tissue defined as following: Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form Organ with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.. Epilepsy defined as following: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal Epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313). Protein Info defined as following: Protein; provides access to the encoding gene via its GenBank Accession, the taxon in which this instance of the Protein Info occurs, and references to homologous proteins in other species.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Halorhodopsins defined as following: Light driven chloride ion pumps that are ubiquitously found in halophilic archaea (HALOBACTERIALES)..", "label": "yes"} {"original_question": "Can enasidenib be used for the treatment of acute myeloid leukemia?", "id": "converted_2877", "sentence1": "Can enasidenib be used for the treatment of acute myeloid leukemia?", "sentence2": "In August 2017, the United States Federal Drug Administration (FDA) approved enasidenib (Idhifa, Celgene/Agios) for adults with relapsed and refractory acute myelogenous leukemia (Leukemia, Myelocytic, Acute) with an IDH2 gene gene mutation. [SEP]Relations: acute promyelocytic leukemia has relations: disease_disease with bilineal acute myeloid leukemia, disease_disease with bilineal acute myeloid leukemia, disease_disease with acute myeloid leukemia with recurrent genetic anomaly, disease_disease with acute myeloid leukemia with recurrent genetic anomaly, disease_protein with KIT, disease_protein with KIT, disease_protein with CEBPA, disease_protein with CEBPA, disease_protein with ITGAM, disease_protein with ITGAM. Definitions: Leukemia, Myelocytic, Acute defined as following: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.. IDH2 gene defined as following: This gene plays a role in intermediary metabolism.. acute myeloid leukemia defined as following: This gene plays a role in transcriptional regulation and cytogenetic aberrations are associated with several leukemias..", "label": "yes"} {"original_question": "Is the NLM medical text indexer (MTI) still useful and relevant?", "id": "converted_3073", "sentence1": "Is the NLM medical text indexer (MTI) still useful and relevant?", "sentence2": "12 years on - Is the NLM medical text indexer still useful and relevant?, Facing a growing workload and dwindling resources, the US National Library of Medicine (NLM) created the Indexing Initiative project in 1996. This cross-library team's mission is to explore indexing methodologies for ensuring quality and currency of NLM document collections. The NLM Medical Text Indexer (MTI) is the main product of this project and has been providing automated indexing recommendations since 2002. After all of this time, the questions arise whether MTI is still useful and relevant.METHODS: To answer the question about MTI usefulness, we track a wide variety of statistics related to how frequently MEDLINE indexers refer to MTI recommendations, how well MTI performs against Homo sapiens indexing, and how often MTI is used. To answer the question of MTI relevancy compared to other available tools, we have participated in the 2013 and 2014 BioASQ Challenges. The BioASQ Challenges have provided us with an unbiased comparison between the MTI system and other systems performing the same task.RESULTS: Indexers have continually increased their use of MTI recommendations over the years from 15.75% of the articles they index in 2002 to 62.44% in 2014 showing that the indexers find MTI to be increasingly useful. The MTI performance statistics show significant improvement in Precision (+0.2992) and F1 (+0.1997) with modest gains in Recall (+0.0454) over the years. MTI consistency is comparable to the available indexer consistency studies. MTI performed well in both of the BioASQ Challenges ranking within the top tier teams.CONCLUSIONS: Based on our findings, yes, MTI is still relevant and useful, and needs to be improved and expanded. The BioASQ Challenge results have shown that we need to incorporate more machine learning into MTI while still retaining the indexing rules that have earned MTI the indexers' trust over the years. We also need to expand MTI through the use of full text, when and where it is available, to provide coverage of indexing terms that are typically only found in the full text. The role of MTI at NLM is also expanding into new areas, further reinforcing the idea that MTI is increasingly useful and relevant., The role of MTI at NLM is also expanding into new areas, further reinforcing the idea that MTI is increasingly useful and relevant., CONCLUSIONS\nBased on our findings, yes, MTI is still relevant and useful, and needs to be improved and expanded., 12 years on - Is the NLM medical text indexer still useful and relevant?Based on our findings, yes, MTI is still relevant and useful, and needs to be improved and expanded. , The role of MTI at NLM is also expanding into new areas, further reinforcing the idea that MTI is increasingly useful and relevant., After all of this time, the questions arise whether MTI is still useful and relevant.
METHODS: To answer the question about MTI usefulness, we track a wide variety of statistics related to how frequently MEDLINE indexers refer to MTI recommendations, how well MTI performs against Homo sapiens indexing, and how often MTI is used., The MTI performance statistics show significant improvement in Precision (+0.2992) and F
CONCLUSIONS: Based on our findings, yes, MTI is still relevant and useful, and needs to be improved and expanded., The role of MTI at NLM is also expanding into new areas, further reinforcing the idea that MTI is increasingly useful and relevant.
, After all of this time, the questions arise whether MTI is still useful and relevant., The role of MTI at NLM is also expanding into new areas, further reinforcing the idea that MTI is increasingly useful and relevant., Based on our findings, yes, MTI is still relevant and useful, and needs to be improved and expanded.[SEP]Relations: F11 has relations: anatomy_protein_absent with vastus lateralis, anatomy_protein_absent with vastus lateralis, drug_protein with Coagulation Factor IX (Recombinant), drug_protein with Coagulation Factor IX (Recombinant), anatomy_protein_absent with biceps brachii, anatomy_protein_absent with biceps brachii, anatomy_protein_present with lung, anatomy_protein_present with lung, drug_protein with Zinc sulfate, unspecified form, drug_protein with Zinc sulfate, unspecified form. Definitions: Homo sapiens defined as following: Members of the species Homo sapiens..", "label": "yes"} {"original_question": "Is there any approved treatment for NAFLD?", "id": "converted_3047", "sentence1": "Is there any approved treatment for NAFLD?", "sentence2": "Non-alcoholic fatty Hepatobiliary Disorder (NAFLD) is the leading chronic hepatic condition worldwide and new approaches to management and treatment are limited., Non-alcoholic fatty Hepatobiliary Disorder (NAFLD) has become one of the most prominent forms of chronic Hepatobiliary Disorder worldwide, reflecting the epidemic of global obesity. Those with the progressive Variant of NAFLD, Nonalcoholic Steatohepatitis (NASH), are at significantly increased risk of multisystem morbidity and mortality. However, there are currently no approved pharmacologic therapies for NASH., Although much progress has been made in enhancing our understanding of NAFLD pathogenesis, development of pharmacologic treatments has been hindered by challenges in clinical trial enrollment and complexities in clinical trial design. , Non-alcoholic Fatty Liver Disease (NAFLD) is the most prevalent Hepatobiliary Disorder worldwide, and there is no approved pharmacotherapy., Non-alcoholic Fatty Liver Disease (NAFLD) has an increasing prevalence worldwide. At present, no specific pharmacotherapy is approved for NAFLD. [SEP]Relations: Nonalcoholic Steatohepatitis has relations: contraindication with Efavirenz, contraindication with Efavirenz, contraindication with Zidovudine, contraindication with Zidovudine, contraindication with Entecavir, contraindication with Entecavir, contraindication with Tenofovir disoproxil, contraindication with Tenofovir disoproxil, contraindication with Abacavir, contraindication with Abacavir. Definitions: Nonalcoholic Steatohepatitis defined as following: Fatty replacement and damage to the hepatocytes not related to alcohol use. It may lead to cirrhosis and liver failure.. Non-alcoholic Fatty Liver Disease defined as following: A term referring to fatty replacement of the hepatic parenchyma which is not related to alcohol use.. Variant defined as following: An alteration or difference from a norm or standard.. Hepatobiliary Disorder defined as following: A non-neoplastic or neoplastic disorder that affects the liver, bile ducts, and gallbladder. Representative examples of non-neoplastic disorders include hepatitis, cirrhosis, cholangitis, and cholecystitis. Representative examples of neoplastic disorders include hepatocellular adenoma, hepatocellular carcinoma, and cholangiocarcinoma.. NAFLD defined as following: A term referring to fatty replacement of the hepatic parenchyma which is not related to alcohol use..", "label": "no"} {"original_question": "Are there conserved noncoding elements identified between genomes of human and teleosts?", "id": "converted_506", "sentence1": "Are there conserved noncoding elements identified between genomes of Homo sapiens and teleosts?", "sentence2": "We report evidence for a mechanism for the maintenance of long-range conserved synteny across Vertebrates genomes. We found the largest mammal-teleost conserved chromosomal segments to be spanned by highly conserved noncoding elements (HCNEs), their developmental regulatory target Genes, and phylogenetically and functionally unrelated \"bystander\" Genes, After whole genome duplication in teleosts, GRBs, including HCNEs and target Genes, were often maintained in both copies, while bystander Genes were typically lost from one GZMB wt Allele, strongly suggesting that evolutionary pressure acts to keep the single-copy GRBs of higher vertebrates intact. We show that loss of bystander Genes and other mutational events suffered by duplicated GRBs in teleost genomes permits target gene identification and HCNE/target gene assignment, Vertebrate genomes contain thousands of conserved noncoding elements (CNEs) that often function as tissue-specific enhancers. In this study, we have identified CNEs in Homo sapiens, Canis familiaris, chicken allergenic extract allergenic extract, Xenopus laevis laevis, and four teleost Fishes (Zebrafish, Sticklebacks, Oryzias latipes, and Takifugu) using elephant shark, a cartilaginous Vertebrates, as the base genome and investigated the evolution of these ancient Vertebrates CNEs (Abdominal cutaneous nerve entrapment syndrome) in bony Vertebrates lineages, This implicates the \"fish-specific\" whole-genome duplication in the accelerated evolution and the loss of a large number of both copies of duplicated CNEs in teleost Fishes, We found Zebrafish conserved noncoding elements (CNEs) with pan-Vertebrates as well as fish-specific orthologous sequences from across 200 kb of the Zebrafish fgf8a genomic regulatory block to direct reporter expression in patterns consistent with the expression pattern of fgf8a, A significant number of conserved noncoding elements (CNEs) shared between fish and tetrapods have diverged beyond recognition in teleost Fishes. The divergence of CNEs seems to have been initiated in basal ray-finned Fishes before the WGD. The fast evolving singleton and duplicated Genes as well as the divergent CNEs might have contributed to the diversity of teleost Fishes, We found the largest mammal-teleost conserved chromosomal segments to be spanned by highly conserved noncoding elements (HCNEs), their developmental regulatory target Genes, and phylogenetically and functionally unrelated \"bystander\" Genes., Ancient Vertebrates conserved noncoding elements have been evolving rapidly in teleost Fishes., A significant number of conserved noncoding elements (CNEs) shared between fish and tetrapods have diverged beyond recognition in teleost Fishes., We have used a transposon-based transgenic assay in Zebrafish to evaluate noncoding sequences at the Zebrafish ret locus, conserved among teleosts, and at the Homo sapiens RET locus, conserved among Mammals., Using computational analysis and exploiting the diversity of teleost genomes, we identified a cluster of highly conserved noncoding sequences surrounding the SIX3 gene[SEP]Relations: vertebra has relations: anatomy_anatomy with non-transverse process-bearing vertebra, anatomy_anatomy with non-transverse process-bearing vertebra, anatomy_anatomy with vertebral element, anatomy_anatomy with vertebral element. familial acanthosis nigricans has relations: disease_disease with genetic skin disease, disease_disease with genetic skin disease, disease_phenotype_positive with Autosomal dominant inheritance, disease_phenotype_positive with Autosomal dominant inheritance. anterior cutaneous nerve entrapment syndrome has relations: disease_phenotype_positive with Allodynia, disease_phenotype_positive with Allodynia. Definitions: Canis familiaris defined as following: The domestic Canis familiaris, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065). fish defined as following: fish with lateral fins, gills in separate gill clefts, skin covered with placoid scales, cartilaginous skeleton, no bone present and spriacles connecting to pharynx; most are marine.. Zebrafish defined as following: An exotic species of the family CYPRINIDAE, originally from Asia, that has been introduced in North America. Zebrafish is a model organism for drug assay and cancer research.. Fishes defined as following: A group of cold-blooded, aquatic vertebrates having gills, fins, a cartilaginous or bony endoskeleton, and elongated bodies covered with scales.. Oryzias latipes defined as following: Common name for a species in the genus Oryzias.. Vertebrates defined as following: Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising Mammals, birds, reptiles, amphibians, and Fishes.. Sticklebacks defined as following: Common name for fish found mostly in the family Gasterosteidae. The three-spine Sticklebacks (Gasterosteus aculeatus) is frequently studied.. Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. Abdominal cutaneous nerve entrapment syndrome defined as following: A chronic neuropathic pain syndrome of the abdominal wall caused by entrapment of anterior cutaneous branches of 7 to 12th intercostal nerves along the lateral border of the anterior rectus abdominis fascia.. SIX3 gene defined as following: This gene plays a role in retinal development.. Takifugu defined as following: A genus of pufferfish commonly used for research.. Xenopus laevis defined as following: The commonest and widest ranging species of the clawed \"frog\" (Xenopus laevis) in Africa. This species is used extensively in research. There is now a significant population in California derived from escaped laboratory animals.. GZMB wt Allele defined as following: Human GZMB wild-type allele is located in the vicinity of 14q11.2 and is approximately 3 kb in length. This allele, which encodes granzyme B protein, is involved in both proteolysis and cellular immune responses.. Mammals defined as following: Warm-blooded Vertebrates animals belonging to the class Mammalia, including all that possess hair and suckle their young.. Homo sapiens defined as following: Members of the species Homo sapiens.. genomes defined as following: The genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA..", "label": "yes"} {"original_question": "Velocardial facial syndrome, otherwise known as Di George syndrome is caused by a deletion in chromosome 21, yes or no?", "id": "converted_3143", "sentence1": "Velocardial facial syndrome, otherwise known as Di George syndrome is caused by a Gene Deletion Abnormality in Chromosomes, Human, Pair 1 21, yes or no?", "sentence2": "The Gene Deletion Abnormality of Chromosomes, Human, Pair 1 22q11.2 is involved in the majority of DiGeorge or velo-cardiofacial syndrome., Gene Deletion of Chromosomes, Human, Pair 1 7q11.23 (Williams Syndrome), 15q11-q13 (Angelman Syndrome, Prader-Willi Syndrome) and 22q11 (Di George syndrome), Submicroscopic Gene Deletion of Chromosomes, Human, Pair 1 22q11 have been reported in a multiple anomaly syndrome variously labelled as velocardiofacial syndrome, conotruncal anomaly face syndrome, and Di George syndrome, The 22q11.2 Gene Deletion Abnormality syndrome (di George syndrome) is one of the most prevalent genetic disorders., UNLABELLED\nMost of the children with Di George syndrome and 60% of patients with velocardiofacial syndrome exhibit a microdeletion within Chromosomes, Human, Pair 1 22q11., Submicroscopic Gene Deletion of Chromosomes, Human, Pair 1 22q11 have been reported in a multiple anomaly syndrome variously labelled as velocardiofacial syndrome, conotruncal anomaly face syndrome, and Di George syndrome., 22q11.2DS has several presentations including DiGeorge Syndrome, Shprintzen syndrome or Shprintzen's syndrome and it is the most frequent microdeletion syndrome in the general population (prevalence estimated at 1/4000 births, de novo: 90%)., Di George syndrome due to Mutation Abnormality on 22q or 10q) and can also result from microdeletion or Point Mutation (in the Shprintzen syndrome 70% represent microdeletion and 30% Point Mutation at 22q11, in Rubinstein-Taybi Syndrome 10% cases result from microdeletions and 90% from point mutations); 7) Population incidence of microdeletions is high (1:4000 to 1:30,000) because their etiologic mechanism is related to the common unequal crossing over; 8) Imprinting plays a role in some cases, e.g., [Microdeletion of the Chromosomes, Human, Pair 1 22q11 in children: apropos of a series of 49 patients].Most of the children with Di George syndrome and 60% of patients with velocardiofacial syndrome exhibit a microdeletion within Chromosomes, Human, Pair 1 22q11. , 22q11.2DS has several presentations including DiGeorge Syndrome, Shprintzen syndrome or Shprintzen's syndrome and it is the most frequent microdeletion syndrome in the general population (prevalence estimated at 1/4000 births, de novo: 90%). , UNLABELLED: Most of the children with Di George syndrome and 60% of patients with velocardiofacial syndrome exhibit a microdeletion within Chromosomes, Human, Pair 1 22q11., Most of the children with Di George syndrome and 60% of patients with velocardiofacial syndrome exhibit a microdeletion within Chromosomes, Human, Pair 1 22q11.[SEP]Relations: Williams Syndrome has relations: disease_disease with syndrome caused by partial chromosomal Gene Deletion Abnormality, disease_disease with syndrome caused by partial chromosomal Gene Deletion Abnormality, disease_disease with partial Gene Deletion Abnormality of the long arm of Chromosomes, Human, Pair 1 7, disease_disease with partial Gene Deletion Abnormality of the long arm of Chromosomes, Human, Pair 1 7. DiGeorge syndrome has relations: disease_disease with syndrome caused by partial chromosomal Gene Deletion Abnormality, disease_disease with syndrome caused by partial chromosomal Gene Deletion Abnormality. Abnormality of the dentition has relations: disease_phenotype_positive with Chromosomes, Human, Pair 1 15q24 Gene Deletion Abnormality syndrome, disease_phenotype_positive with Chromosomes, Human, Pair 1 15q24 Gene Deletion Abnormality syndrome, disease_phenotype_positive with Chromosomes, Human, Pair 1 9p Gene Deletion Abnormality syndrome, disease_phenotype_positive with Chromosomes, Human, Pair 1 9p Gene Deletion Abnormality syndrome. Definitions: Chromosomes, Human, Pair 1 defined as following: A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human Chromosomes, Human, Pair 1 classification.. Point Mutation defined as following: A Mutation Abnormality caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair.. Rubinstein-Taybi Syndrome defined as following: A chromosomal disorder characterized by MENTAL RETARDATION, broad thumbs, webbing of fingers and toes, beaked nose, short upper lip, pouting lower lip, agenesis of corpus callosum, large foramen magnum, keloid formation, pulmonary stenosis, vertebral anomalies, chest wall anomalies, sleep apnea, and megacolon. The disease has an autosomal dominant pattern of inheritance and is associated with Gene Deletion of the short arm of Chromosomes, Human, Pair 1 16 (16p13.3).. DiGeorge Syndrome defined as following: Congenital syndrome characterized by a wide spectrum of characteristics including the absence of the THYMUS and PARATHYROID GLANDS resulting in T-cell immunodeficiency, HYPOCALCEMIA, defects in the outflow tract of the heart, and craniofacial anomalies.. Mutation Abnormality defined as following: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of Mutation Abnormality range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.. 22q defined as following: Distal (long) arm of Chromosomes, Human, Pair 1 22. 10q defined as following: Distal (long) arm of Chromosomes, Human, Pair 1 10. Shprintzen syndrome defined as following: Typical facies with a prominent nose and retruded mandible, cleft palate, cardiovascular defects, learning disability, retarded mental development, and short stature. Elements of this syndrome are frequently present in the Robin syndrome.. Angelman Syndrome defined as following: A syndrome characterized by multiple abnormalities, MENTAL RETARDATION, and movement disorders. Present usually are skull and other abnormalities, frequent infantile spasms (SPASMS, INFANTILE); easily provoked and prolonged paroxysms of laughter (hence \"happy\"); jerky puppetlike movements (hence \"puppet\"); continuous tongue protrusion; motor retardation; ATAXIA; MUSCLE HYPOTONIA; and a peculiar facies. It is associated with maternal Gene Deletion of Chromosomes, Human, Pair 1 15q11-13 and other genetic abnormalities. (From Am J Med Genet 1998 Dec 4;80(4):385-90; Hum Mol Genet 1999 Jan;8(1):129-35). Williams Syndrome defined as following: A disorder caused by hemizygous microdeletion of about 28 genes on Chromosomes, Human, Pair 1 7q11.23, including the ELASTIN gene. Clinical manifestations include SUPRAVALVULAR AORTIC STENOSIS; MENTAL RETARDATION; elfin facies; impaired visuospatial constructive abilities; and transient HYPERCALCEMIA in infancy. The condition affects both sexes, with onset at birth or in early infancy.. Gene Deletion defined as following: A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This Gene Deletion Abnormality may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a Gene Deletion Abnormality at one specific locus.. Prader-Willi Syndrome defined as following: An autosomal dominant disorder caused by Gene Deletion Abnormality of the proximal long arm of the paternal Chromosomes, Human, Pair 1 15 (15q11-q13) or by inheritance of both of the pair of chromosomes 15 from the mother (UNIPARENTAL DISOMY) which are imprinted (GENETIC IMPRINTING) and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE. (Menkes, Textbook of Child Neurology, 5th ed, p229). Chromosomes, Human, Pair 1 21 defined as following: A specific pair of GROUP G CHROMOSOMES of the human Chromosomes, Human, Pair 1 classification.. Di George syndrome defined as following: Congenital syndrome characterized by a wide spectrum of characteristics including the absence of the THYMUS and PARATHYROID GLANDS resulting in T-cell immunodeficiency, HYPOCALCEMIA, defects in the outflow tract of the heart, and craniofacial anomalies..", "label": "no"} {"original_question": "is there an increase in ultrasound comets after intense exercise?", "id": "converted_1421", "sentence1": "is there an increase in ultrasound comets after intense exercise?", "sentence2": "Healthy athletes developed subclinical increase in pulmonary water content immediately after an Ironman race at Staphylococcal enterotoxin A level, as shown by the increased number of ULCs related to cardiac changes occurring during exercise., Increased EVLW is associated with estimated PCWP and indices of left ventricular systolic and diastolic dysfunction. The additional exercise-induced increase of PCWP, the worsening of left ventricular diastolic function, and extensive wall-motion abnormalities correlate with variations of EVLW., Among them chest ultrasonography can detect and quantify the extravascular lung water, creating \"comet-tail\" ultrasound artefacts (ULCs) from water-thickened pulmonary interlobular septa., In top-level breath-hold divers, chest sonography frequently reveals an increased number of ULCs after immersion, indicating a relatively high prevalence of (often subclinical) reversible extravascular lung water accumulation.[SEP]Relations: staphylococcal toxemia has relations: disease_disease with staphylococcal scarlet fever, disease_disease with staphylococcal scarlet fever, disease_disease with bullous impetigo, disease_disease with bullous impetigo, disease_disease with staphylococcal toxic-shock syndrome, disease_disease with staphylococcal toxic-shock syndrome, disease_disease with staphylococcal scalded skin syndrome, disease_disease with staphylococcal scalded skin syndrome, disease_disease with staphylococcal pneumonia, disease_disease with staphylococcal pneumonia. Definitions: Staphylococcal enterotoxin A defined as following: A bacterial enterotoxin with potential immunostimulatory activity. Staphylococcal enterotoxin A (SEA), a gram positive bacterial superantigen (SAg), is a potent stimulator of T-cell activation. SEA superantigen binds directly to class II major histocompatibility complex (MHC) molecules and to the V beta region of the T-cell receptor (TCR), leading to an amplified T-cell response. In response to SEA, both CD4+ and CD8+ cells proliferate, secrete cytokines, and demonstrate enhanced cytotoxic activity against a broad range of antigens. Vaccination with the SEA protein, administered by direct transfection into tumor cells, may elicit a non-specific cytotoxic T-cell (CTL) response and result in decreased tumor cell growth..", "label": "yes"} {"original_question": "Is Drk essential for anesthesia-resistant memory (ARM) in Drosophila?", "id": "converted_2275", "sentence1": "Is Drk essential for anesthesia-resistant memory (Upper Extremity) in Drosophila?", "sentence2": "Anesthesia-resistant memory (Upper Extremity) was described decades ago, but the mechanisms that underlie this protein synthesis-independent form of consolidated memory inDrosophilaremain poorly understood. Whether the several signaling molecules, receptors, and synaptic proteins currently implicated in Upper Extremity operate in one or more pathways and how they function in the process remain unclear. We present evidence that Drk, theDrosophilaortholog of the adaptor protein GRB2 protein, human, is essential for Upper Extremity within adult mushroom body neurons., We present evidence that Drk, the Drosophila ortholog of the adaptor protein GRB2 protein, human, is essential for Upper Extremity within adult mushroom body neurons.[SEP]Relations: Protein S human has relations: drug_drug with Drostanolone propionate, drug_drug with Drostanolone propionate, drug_drug with Drospirenone, drug_drug with Drospirenone, drug_drug with Droxicam, drug_drug with Droxicam, drug_drug with Flomoxef, drug_drug with Flomoxef, drug_drug with Factor IX Complex (Human), drug_drug with Factor IX Complex (Human). Definitions: GRB2 protein, human defined as following: Growth factor receptor-bound protein 2 (217 aa, ~25 kDa) is encoded by the human GRB2 gene. This protein is involved in the progression of epidermal growth factor-mediated signaling pathways.. Upper Extremity defined as following: The region of the upper limb in animals, extending from the deltoid region to the HAND, and including the Upper Extremity; AXILLA; and SHOULDER..", "label": "yes"} {"original_question": "Do circRNAs remain untranslated?", "id": "converted_2156", "sentence1": "Do RNA, Circular remain untranslated?", "sentence2": "We demonstrate that the circular RNA circ-Foxo3 was highly expressed in non-cancer cells and were associated with cell cycle progression, Ectopic expression of circ-Foxo3 repressed cell cycle progression by binding to the cell cycle proteins Cyclin-Dependent Kinases (also known as cell division protein kinase 2 or CDK2 protein, human protein, human) and Cyclin-Dependent Kinase Inhibitor Proteins (or oncoprotein oncoprotein p21), resulting in the formation of a ternary complex., MicroRNAs (MicroRNAs) are important post-transcriptional regulators of Genes expression that act by direct base pairing to target sites within untranslated regions of messenger RNAs., We further show that the testis-specific circRNA, SRY Genes (SRY protein, human), serves as a miR-138 sponge, suggesting that miRNA sponge effects achieved by circRNA formation are a general phenomenon. This study serves as the first, to our knowledge, functional analysis of a naturally expressed circRNA., Numerous RNA, Circular were specifically expressed at different lactation stages, and only 1,314 RNA, Circular were detected at both lactation stages., A significantly positive correlation was observed for the expression profiles of some RNA, Circular and their parent genes., The resulting circRNA can be translated to generate functional proteins., In total, 80 RNA, Circular were identified from these 4 genes; RNA, Circular from CSN1S1 gene Genes had very high abundance, and 3 of them accounted for 36% of all the RNA, Circular expressed in the Mammary gland on lactation d 90., A total of 4,804 and 4,048 RNA, Circular were identified in the cow Mammary gland on d 90 and 250 postpartum, respectively, of which only 2,231 RNA, Circular were co-expressed at both lactation stages, suggesting high stage specificity in the RNA, Circular., Arraystar circRNA Microarray Technology (KANGCHEN, Shanghai, China) was used to analyze the differential expression of RNA, Circular., The aim of study was to identify circRNA expression in Structure of articular Cartilage and to explore the function of chondrocyte extracellular matrix (ECM)-related RNA, Circular (circRNA-CER) in Cartilage., We also validated that P. falciparum produces RNA, Circular, which is notable given the lack of RNA interference in the Organism, and discovered that a highly expressed, five-exon antisense RNA is poised to regulate P. falciparum gametocyte development 1 (PfGDV1), a Genes required for early sexual commitment events., CircRNA expression pattern and circRNA-miRNA-mRNA network in the pathogenesis of Nonalcoholic Steatohepatitis., CircRNAs are abundantly expressed also in the hematopoietic compartment.[SEP]Relations: Mammary gland has relations: anatomy_protein_present with UNC13D, anatomy_protein_present with UNC13D, anatomy_protein_present with UNC45A, anatomy_protein_present with UNC45A, anatomy_protein_present with UNC50, anatomy_protein_present with UNC50. non-alcoholic steatohepatitis has relations: disease_protein with BIRC3, disease_protein with BIRC3. CSN1S1 gene has relations: anatomy_protein_absent with quadriceps femoris, anatomy_protein_absent with quadriceps femoris. Definitions: Genes defined as following: A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.. RNA, Circular defined as following: RNA molecules in which the 3' and 5' ends are covalently joined to form a closed continuous loop. They are resistant to digestion by EXORIBONUCLEASES.. Structure of articular Cartilage defined as following: A protective layer of firm, flexible Cartilage over the articulating ends of bones. It provides a smooth surface for joint movement, protecting the ends of long bones from wear at points of contact.. RNA defined as following: A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Mammary gland defined as following: Glandular tissue in the BREAST of human that is under the influence of hormones such as ESTROGENS; PROGESTINS; and PROLACTIN. In WOMEN, after PARTURITION, the mammary glands secrete milk (MILK, HUMAN) for the nourishment of the young.. SRY protein, human defined as following: Sex-determining region Y protein (204 aa, ~24 kDa) is encoded by the human SRY Genes. This protein is involved in sex determination and transcriptional regulation.. oncoprotein p21 defined as following: A cyclin-dependent kinase inhibitor that mediates TUMOR SUPPRESSOR PROTEIN P53-dependent CELL CYCLE arrest. oncoprotein p21 interacts with a range of CYCLIN-DEPENDENT KINASES and associates with PROLIFERATING CELL NUCLEAR ANTIGEN and CASPASE 3.. MicroRNAs defined as following: Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA Genes transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 MicroRNAs discovered, and are from a class of MicroRNAs involved in developmental timing.. SRY gene defined as following: This Genes is involved in testis development and may be involved in transcription.. Cyclin-Dependent Kinase Inhibitor Proteins defined as following: A protein that plays a role in the inhibition of cyclin-dependent kinases.. CDK2 protein, human defined as following: Cyclin-dependent kinase 2 (298 aa, ~34 kDa) is encoded by the human CDK2 protein, human Genes. This protein is involved in the regulation of both phosphorylation of cyclins and the cell cycle progression from the G2 phase to mitosis.. Cyclin-Dependent Kinases defined as following: Protein kinases that control cell cycle progression in all eukaryotes and require physical association with CYCLINS to achieve full enzymatic activity. Cyclin-dependent kinases are regulated by phosphorylation and dephosphorylation events.. Cartilage defined as following: A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE.. Nonalcoholic Steatohepatitis defined as following: Fatty replacement and damage to the hepatocytes not related to alcohol use. It may lead to cirrhosis and liver failure.. Organism defined as following: A living entity..", "label": "no"}